// Reference=MNI
// Binder J R, 1996: Words > Tones - Passive
// Binder J R, 1996: Words > Tones - Active
// Binder J R, 1996: Tones > Words - Passive
// Binder J R, 1996: Tones > Words - Active
// Subjects=12
-58.73	-12.05	-4.61
-47.11	34.97	-3.11
-55.59	-12.72	-13.51
-47.89	19.3	28.32
-59.79	-36.09	-12.62
-46.48	-74.88	35.09
-46.96	-37.07	-12.69
-48.81	-35.14	26.2
-57.43	-30.51	18.11

// Buckner R L, 1998: Recognition - Fixation, Increases
// Buckner R L, 1998: Recognition - Fixation, Decreases
// Subjects=26
34.55	-90.63	3.14
20.66	-97.31	0.51
-11.46	-94.85	-6.02
34.48	-80.31	-1.07
-28.51	-94.43	0.83
-35.17	-55.32	-15.75
-34.91	-83.39	6.67
20.63	-83.31	2.68
-32.01	-42.61	-16.85
14.34	-96.32	13.88
17.3	-78.01	-11.11
-17.93	-87.74	-9.89
23.97	-99.44	14.03
40.8	-68.1	-8.86
41.16	-9.4	62.04
-31.99	-48.96	-16.32
-28.39	-99.75	14.66
-34.74	-.34	62.16
-28.29	-74.6	37.08
1.51	-85.57	16.47
37.87	-.42	54.64
50.55	14.66	42.08
37.93	3.52	64.34
11.08	-72.82	15.29
34.72	-71.31	32.74
-38.2	10.19	33.43
-4.96	14.93	50.5
1.58	3.05	61.46
11.1	15.28	53.63
44.04	13.6	28.86
34.18	28.57	3.18
14.22	22.1	45.21
-31.44	-64.08	49.62
38.05	-63.41	52.11
50.36	40.07	26.56
-25.06	-53.47	48.66
-28.87	21.59	1.14
28.37	-53.15	48.02
-25.15	-51.06	38.42
41.21	-52.81	51.19
10.85	-13.61	10.33
40.48	64.82	3.41
10.75	-14.64	-2.96
-52.16	27.02	32.18
-31.92	-75.65	-17.43
27.98	-74.78	-11.5
-11.56	-81.61	-13.82
-21.21	-81.93	-17.03
-5.22	-69.14	-18.28
7.54	-76.27	-28.98
7.65	-68.55	-11.79
1.23	-60.93	-9.01
1.12	-52.19	-19.78
7.38	58.28	4.34
7.92	-48.21	31.11
4.27	38.42	9.39
13.76	51.46	-1.85
-1.54	-49.9	51.43
1.55	-47.73	37.83
61.29	-55.09	19.92
4.75	-17.08	48.61
64.31	-6.43	15.81
1.58	-26.61	49.45
4.21	48.74	5.18
47.52	-71.49	29.26
-41.22	-75.79	22.84
61.41	-37.34	42.97
-5.47	51.34	-1.62
-58.53	-26.46	15.55
-5.47	51.34	-1.62
-21.02	25.41	49.8
43.91	-14.18	-0.04
-55.41	-10.83	10.86
-38.38	-14.67	0.95
-1.45	-45.61	65.57
-8.49	66.41	28.38
24.17	-73.26	49.75
-35.28	0.69	-7.07
-2.07	55.62	25.86
67.45	-20.3	1.32
-17.47	-39.1	68.55
-44.63	-22.94	18.44
-55.42	-1.06	13.39
64.47	-11.4	34.06

// Bush G, 1998: Interference - Neutral
// Subjects=9
47.2	32.91	30.55
-47.94	22.05	22.51
14.15	13.67	32.54
-58.6	-.82	16.75
-41.34	-2.26	37.86
47.17	-49.83	-7.12
-28.25	-65.37	46.35

// Owen A M, 1998: Spatial Working Memory vs. Control
// Owen A M, 1998: Nonspatial Working Memory vs. Control
// Subjects=6
50.73	-32.92	46.06
34.73	-39.36	46.79
24.03	-56.06	38.27
14.53	-61.43	52.22
23.89	1.81	43.46
44.14	14.62	42.15
7.62	36.64	27.34
-37.94	-39.8	47.66
-61.83	-43.88	-3.02
-38.18	10.45	36.76
-17.63	9.79	67.8
1.51	15.48	57.07
33.81	13.8	-50.22
61	-33.88	-8.62
50.54	-38.23	18.63
23.89	1.81	43.46
44.15	18.05	45.21
-32.45	16.58	-49.69
-35.24	-51.6	-22.75
-58.7	-51.23	-15.83
-41.38	10.43	36.8
-4.92	12.01	54.09

// Rao S M, 1997: Synchronization-300 vs. Rest
// Rao S M, 1997: Continuation-300 vs. Rest
// Rao S M, 1997: Listening-300 vs. Rest
// Rao S M, 1997: Discrimination-300 vs. Rest
// Rao S M, 1997: Synchronization-600 vs. Rest
// Rao S M, 1997: Continuation-600 vs. Rest
// Rao S M, 1997: Listening-600 vs. Rest
// Rao S M, 1997: Discrimination-600 vs. Rest
// Subjects=13
-36.85	-18.76	58.15
16.09	-55.35	-20.8
69.64	-13.17	10.73
-35.77	-19.72	59.33
17.16	-56.41	-20.72
0.47	1.56	56.02
-28.75	-10.13	3.8
-11.61	-19.46	5.5
65.42	-17	16.68
60.94	12.7	1.97
65.36	-14.34	9.77
-57.54	-20.62	8.36
63.27	-23.7	12.81
-59.67	-22.83	7.45
0.39	12.85	50.61
-34.69	-20.69	60.52
17.16	-54.21	-19.79
66.46	-16.19	13.25
-35.77	-19.64	60.44
17.18	-56.23	-18.51
-1.63	-3.57	58.7
-26.62	-6.86	4.62
-14.83	-20.79	2.31
66.47	-16.1	14.36
53.47	9.48	2.33
66.45	-17.42	11.13
66.46	-16.19	13.25
-60.72	-23.72	9.77
-1.74	12.83	50.64

// Rao S M, 1997: Conceptual Reasoning minus Control
// Subjects=11
-26.1	-59.73	50.31
33.76	-63.6	49.95
3.46	21.27	35.37
35.6	16.86	44.29
52.53	-55.08	-6.74
-42.39	11.11	45.67
41.67	48.51	12.57
41.63	21.76	-3.03
-44.62	-83.33	-5.49
19.68	-90.92	14.48
-25.68	-63.15	-35.28
19.28	-66.51	-27.71
-1.02	-59.94	-23.56
12.97	-5.05	10.7
15.08	7.91	12.94
16.07	-7.2	-3.65
-3.16	-21.58	-8.91
-1.2	-28.82	-33.98
3.32	-29.57	-2.74

// Rauch S L, 1997: Implicit Learning vs. Baseline
// Subjects=10
21.45	11.92	9.18
27.77	7.67	-5.03
4.25	40.37	7
-46.03	39.47	-.16
-39.36	19.18	26
-58.64	-1.25	11.21
-52.1	-22.9	19.64
-42.19	-49.51	46.29
-8.16	-70.74	16.46
-1.85	-58.61	7.56

// Rosen A C, 1999: Endogenous > Rest
// Rosen A C, 1999: Exogenous > Rest
// Rosen A C, 1999: Control > Rest
// Rosen A C, 1999: Rest > Endogenous
// Rosen A C, 1999: Rest > Exogenous
// Rosen A C, 1999: Rest > Control
// Subjects=13
-40.09	-15.78	55.71
48.45	5.13	42.9
-3.83	6.73	54.52
5.8	9.16	57.55
-49.9	-70.53	9.11
56.95	-52.46	13.06
34.76	-44.48	49.45
40.59	42.87	8.6
-36.31	-59.35	-26.55
27.8	-49.11	-23.69
-22.32	-5.52	7.8
24.65	0.85	3.38
-12.74	-73.93	-24.49
6.57	-71.99	-14.83
-39.01	-13.48	57.73
49.5	4.97	40.67
-3.84	5.51	52.39
5.79	9.08	56.44
-46.69	-71.57	9.16
52.69	-64.37	10.76
62.31	-35.79	21.64
-32.5	-51.94	55.31
-17.45	-63.05	61.64
28.35	-45.66	48.5
-34.19	-56.26	-27.95
24.6	-49.13	-23.65
-12.82	-18.72	-12.39
-35.78	-15.41	60.09
-3.83	3.48	53.68
4.73	6.96	56.63
-46.67	-68.14	12.22
52.7	-65.43	10.85
63.38	-35.79	21.62
-35.28	-55.29	-29.14
18.19	-46.88	-21.53
5.89	-70.17	36.32
10.34	-29.88	75.27
-.7	-90.67	5.77
4.67	-88.18	9.96
-4.95	-56.46	21.91
-57.57	-8.9	8.49
-.53	-74.69	33.43
5.86	-73.68	32.15
-.66	-88.04	12.24
6.01	-78.74	49.31
-1.54	-77.36	40.35
5.93	-77.4	39.16
11.43	-40.62	73.93
4.65	-88.35	7.75

// Haxby J V, 1999: Faces > Houses
// Haxby J V, 1999: Houses > Faces
// Subjects=6
-37	-81	-8
42	-79	-7
-39	-55	-23
39	-59	-16
-52	-61	4
43	-57	12
-21	-82	-14
24	-83	-11
-27	-52	-14
24	-55	-12
-23	-87	7
31	-86	14

// Ishai A, 1999: Houses > Faces and Chairs
// Ishai A, 1999: Chairs > Faces and Houses
// Ishai A, 1999: Faces > Houses and Chairs
// Subjects=12
-26.6	-60.47	-14.3
31.12	-60.04	-13.89
-25.54	-61.69	-16.44
31.1	-66.81	-18.9
-27.73	-54.56	-20.36
33.2	-51.82	-17.95
-42.58	-67.8	-11.28
52.53	-65.03	-11.48
-29.87	-60.12	-23.22
33.22	-64.77	-20.21
-43.65	-73.26	-13.04
52.59	-76.4	-7.19
-37.34	-58.93	-21
43.87	-55.19	-21.13
-40.58	-69.15	-29.03
44.96	-63.73	-21.54

// Kastner S, 1999: UNATT vs. Blank
// Kastner S, 1999: EXP vs. Blank
// Subjects=5
-6	-85	11
-13	-80	-12
-22	-79	-18
-30	-61	-11
-5	-86	8
-13	-82	-19
-29	-79	-25
-30	-65	-21
-27	-78	38
-18	-63	54
16	-61	57
-37	-32	59
38	-34	57
-41	1	49
35	-9	55
-1	-1	61
-30	33	30
32	32	39

// Petit L, 1998: Spatial Working Memory
// Petit L, 1998: Face Working Memory
// Subjects=12
0	-14	50
-1	9	50
0	-2	38
1	5	36
1	-14	50
0	8	50
1	-5	40
-1	16	33

// Gelnar P A, 1999: Motor vs. Rest
// Gelnar P A, 1999: Vibrotactile vs. Rest
// Gelnar P A, 1999: Thermal Painful vs. Rest
// Subjects=8
-2.77	-3.2	49.76
1.71	-3.24	76.48
-43.29	-9.11	59.64
-36.77	-23.36	67.46
-47.6	-24.96	47.64
-52.04	-17.9	29.26
-47.58	-31.31	48.17
-36.74	-29.7	67.99
14.38	-11.39	52.48
-56.31	-11.24	33.21
-54.02	-22.89	47.54
-47.79	-20.33	24.95
-54.01	-25	47.72
-40.97	-42.42	69.1
16.68	-5.26	76.48
-4.65	-15.97	77.62
-38.92	-19.14	67.13
-38.91	-23.37	67.48
-45.47	-22.84	47.44
-60.66	-7.72	24.04
-19.89	-25.48	38.45
-43.65	-8.48	12.76
-32.44	-33.74	70.51

// Canli T, 1998: Positive vs. Negative-Arousal Equal
// Canli T, 1998: Negative vs. Positive-Arousal Equal
// Canli T, 1998: Positive vs. Negative-Arousal Confounded
// Canli T, 1998: Negative vs. Positive-Arousal Confounded
// Subjects=14
-49.86	-5.31	40.44
-16.55	-1.03	65.35
-34.86	11.66	52.23
-62.1	0.56	-20.13
54.27	11.06	-32.38
38.49	22.43	5.88
-41.97	17.55	-36.28
-39.29	25.41	37.75
-21.15	39.44	38.59
12.88	37.93	16.02
61.03	13.64	14.16
8.38	21.33	-19.34
53.5	23.03	12.34
-12.9	34.29	-1.22
0.81	35.75	-24.92
51.02	-10.25	-46.17
18.72	-.82	64.93
-17.97	2.94	20.43
-56.63	-1.46	-5.52
36.41	8.67	7.05
65.19	-.65	-5.88
-7.52	8.26	-8.02
42.44	14.62	-40.35
32.96	2.82	-26.99
21.56	33.9	31.87
3.03	33.36	-14.71
-50.38	21.15	-16.41
-53.61	32.94	-15.14
18.16	31.91	6.43

// Kelley W M, 1998: Word Encoding vs. Fixation
// Kelley W M, 1998: Object Encoding vs. Fixation
// Kelley W M, 1998: Face Encoding vs. Fixation
// Subjects=5
-48.9	13.3	33.3
-16.97	-36.12	-3.07
-44.73	-64.64	-11.52
-36.25	-58.67	-17.69
38.53	-53.02	-20.14
-42.53	-80.49	-10.21
-33.99	-90.38	-15.06
-33.87	-89.09	1.56
26.02	-97.02	3.77
37.75	-88.49	2.92
-16.78	-97.88	-3.47
-51.35	32.03	0.53
-27.06	-65.23	61.93
-3.84	11.05	55.27
-48.88	11.35	35.69
40.82	6.8	23.89
-17.02	-36.64	-9.72
21.45	-34.2	-9.25
-42.65	-59.77	-17.52
44.96	-52.81	-18
-21.14	-92.25	-12.82
-41.46	-80.48	-10.22
46.14	-77.92	-12.56
-38.07	-84.03	12.34
-30.56	-90.25	13.89
28.22	-93.15	12.34
38.81	-86.37	2.73
30.41	-82.68	23.71
-.75	-80.26	2.67
-18.86	-97.29	4.31
18.58	-99.98	7.45
-50.27	28.87	0.78
-19.66	-63.75	52.8
30.57	-61.25	53.13
-2.8	8.51	49.9
-2.86	19.97	46.7
40.82	6.8	23.89
-16.97	-34.01	-3.25
21.52	-35.72	-1.32
-38.37	-65.11	-18.24
47.15	-68.66	-16.69
-27.58	-77.22	-10.66
-40.42	-81.79	-13.47
26.95	-86.41	-10.51
-23.08	-92.4	12.87
-37.03	-85.43	7.98
26.08	-94.22	12.46
38.82	-86.2	4.95
32.62	-81.9	33.65
-.79	-89.41	-5.48
4.53	-91.83	-9.8
-12.48	-96.54	-.29
13.17	-102.9	-2.28
-34.61	-48.35	60.61
32.75	-58.61	59.58

// Poldrack R A, 1999: Semantic > Case
// Poldrack R A, 1999: Case > Semantic
// Poldrack R A, 1999: Phonological > Case
// Poldrack R A, 1999: Case > Phonological
// Poldrack R A, 1999: Semantic > Phonological
// Poldrack R A, 1999: Phonological > Semantic
// Poldrack R A, 1999: Pseudoword Phonological > Case
// Poldrack R A, 1999: Case > Pseudoword Phonological
// Poldrack R A, 1999: Semantic > Phonological (Double Subtraction)
// Poldrack R A, 1999: Phonological > Semantic (Double Subtraction)
// Poldrack R A, 1999: Semantic > Pseudoword Phonological (Double Subtraction)
// Poldrack R A, 1999: Pseudoword Phonological > Semantic (Double Subtraction)
// Subjects=8
-48.18	21.76	-8.69
0.28	25.91	40.59
-51.1	11.54	24.55
41.61	55.57	7.52
0.26	42.2	44.8
-.72	13.47	44.99
37.33	22.53	-6.39
8.17	63.12	-29.53
56.83	12.19	23.25
-48.27	53.83	-6.91
-36.47	37.87	-7.94
47	39.57	6.57
13.97	10.73	8.25
-11.6	2.63	15.92
-23.8	63.87	-16.96
-25.97	52.51	-26.02
-4.19	56.83	28.02
-9.58	18.97	6.72
-40.21	4.94	48.39
-37.22	41.12	34.17
0.86	59.33	-9.05
-1.22	43.45	-7.7
35.32	40.27	16.68
-1.86	12.69	35.04
41.88	25.39	30.12
-49.12	31.85	11.67
6.59	24.92	27.22
65.39	12.32	24.26
-47.88	2.93	23
-23.38	46.23	30.24
0.02	45.17	14.45
-16.84	34.35	41.2
33.08	61.23	12.72
24.27	63.9	-20.86
-.17	59.75	-3.5
-6.34	56.65	25.83
-2.94	42.26	45.95
-55.41	19.89	22.78
5.74	27.14	56.04
-38.65	29.77	-16.16
-44.03	42.51	-16.05
-43.73	40.14	22.06
53.57	2.85	12.92
16.99	38.53	-4.15
36.6	26.04	39.05
-49.04	1.98	10.83
52.29	39.08	-.14
51.58	13.1	35.5
0.67	51.81	-37.42
11.6	54.45	-4.31
44.71	54.47	-6.92
29.73	65.21	-4.3
0.4	5.19	47.91
-58.61	11.24	21.31
42.77	32.4	10.57
1.4	13.31	42.75
1.35	25.91	40.58
46.17	3.58	22.98
-50.08	24.24	23.47
46.97	44.77	5.02
52.51	20.45	20.38
-52.39	38.89	6.66
14.02	2.44	11.18
-17.06	10.12	3.09
1.32	42.12	43.68
44.71	60.02	-4.04
-17.18	30.84	-4.23
-1.36	58.46	-20.11
20.51	47.26	39.69
-27.5	25.83	42.04
-2.31	43.19	-11.01
2.12	55.84	14.64
-6.56	30.22	-13.22
36.24	9.15	-14.17
-22.16	42.23	47.29
-46.03	21.95	-6.49
53.62	20.97	27.01
51.12	30.31	-17.23
42.51	42.86	-19.3
16.77	58.22	-24.76
-49	11.13	18.98
11.82	10.63	7.17
-24.9	52.51	-26.03
37.25	60.14	-1.73
-4.32	61.01	13.17
-36.48	37.78	-9.05
-22.73	63.79	-18.08
-11.56	3.06	21.46
-11.71	19.04	7.85
-8.62	44.26	3.47
-7.48	31.75	6.74
-37.22	41.2	35.28
35.43	33.72	28.38
59.94	2.46	7.3
-9.27	35.34	53.3
-6.26	41.05	30.48
-57.63	23.42	13.59
-4.95	22.67	54.31
-12.83	61.3	17.7
19.43	47.17	38.59
-45.07	53.76	-8.06
-34.4	37.2	-16.83
-40.14	5.63	57.26
53.3	22.03	-14.33
-45.76	11.57	24.48
44.69	37.75	-16.67
-11.7	19.12	8.96
56.94	13.3	37.66
4.25	18.45	-1.2
17.07	66.76	16.9
35.1	59.96	-3.92
-35.34	8.9	-11.1
44.03	3.57	23.01
36.54	34.24	35.02
-38.3	41.02	33.08
42.78	45.6	16.15
32.57	6.58	63.03
9.85	12.33	29.36
40.63	19.09	3.9
4.86	7.18	73.34
-33.1	18.74	5.89
33.18	1.79	0.98

// Rypma B, 1999: 3-1 Contrast
// Rypma B, 1999: 6-1 Contrast
// Subjects=6
-46.81	1.88	23.08
-54.23	4.63	31.85
-56.22	-4.84	47.17
-15.57	-15.17	47.57
20.73	-37.21	34.5
-12.43	-46.56	26.74
-67.11	-35.57	8.61
34.59	-56.13	22.55
56.76	-39.02	-5.91
-50.05	-40.29	1
3.74	-93.33	26.02
0.41	-3.44	46.4
21.88	-29.75	48.36
-27.74	-16.27	-6.85
24.85	-23.41	19.91
25.62	28.44	2.17
-27.98	57.12	-7.42
-38.41	33.31	15.88
30.96	39.38	5.66
32.21	36.87	28.16
45.26	6.34	45.06
-50.32	47.01	1.49
27.59	57.46	-8.09
36.36	14.75	3.2
35.35	27.41	15.53
38.57	33.06	19.48
-51.38	28.43	-4.75
-40.64	38.96	6.51
-54.34	7.84	18.2
45.14	9.46	30.31
-54.23	5.69	31.76
-39.52	25.22	7.65
-61.89	6.05	9.52
-53.03	-.59	46.77
1.35	30.4	43.55
2.33	25.06	29.49
-50.78	-31.24	49.32
-30.51	-52.33	36.36
-25.02	-61.75	51.58
-69.25	-34.52	8.54
-55.43	-30.81	0.27
-59.56	-54.55	10.11
47.23	-51.34	0.81
-51.09	-58.7	-3.02
61.06	-46.4	-5.34
-17.86	-76.05	3.63
14.14	-61.06	2.01
6.66	-6.26	23.15
22.89	-69.95	23.84
1.74	-72.17	52.15
18.2	12.53	3.59
16.22	-2.32	18.24
-18.02	9.11	17.68
-12.85	2.86	-8.62
-20.24	13.7	8.4
26.65	24.67	-5.33
-5.15	-21.11	11.14

// Shaywitz B A, 1995: Semantic - Phonological
// Shaywitz B A, 1995: Phonological - Semantic
// Subjects=9
-20.49	70.46	-.82
-22.52	44.01	1.42
-36.32	17.49	3.8
-7.36	-8.77	5.67
-4.09	-26.73	7.14
-6.17	-41.54	8.41
-22.17	-51.16	9.4
-57.56	-36.19	-.37
-3.94	-85.57	3.15
13.69	57.29	-9.03
50.11	35.3	-7.6
38.24	64.84	-9.94
9.98	-91.83	3.52
17	49.53	0.5
50.19	30.7	1.7
-62.98	3.58	5.28
34.06	58.09	-.41
-32.09	11.54	-4.67
-41.63	-7.55	-2.96
-39.74	58.02	-8.48
-25.34	-77.24	2.7
33.96	65.87	-9.98
7.37	33.99	-7
30.96	11.92	-5.42
51.48	-47.17	-.7
10.7	1.23	-4.29

// Shulman G L, 1999: Directional Cue vs. Passive Cue
// Shulman G L, 1999: Neutral Cue vs. Passive Cue
// Shulman G L, 1999: Directional Cue vs. Neutral Cue
// Shulman G L, 1999: Radial Motion
// Subjects=7
-10.36	-102.16	-4.3
21.71	-95.28	-.79
23.65	-66.51	-14.37
-16.88	-90.19	-14.15
25.84	-83.59	-15.2
40.8	-79.1	-13.52
-51	-65.42	6.47
-44.65	-72.58	-4.16
45.17	-64.84	5.31
-29.54	-92.96	6.3
34.57	-90.46	5.35
64.49	-41.87	25.47
-27.25	-78.2	31.8
-29.44	-83.13	23.32
-39.95	-48.38	60.67
-35.74	-44.64	53.62
-31.56	-41.24	42.13
30.57	-54.65	55.92
32.6	-44.75	46.15
-12.09	-67.25	61.93
-22.84	-70.11	53.37
26.38	-67.02	61.47
17.78	-71.99	53.06
-27.27	-10.24	57.33
-35.8	-5.72	61.5
-53.06	1.27	43.27
-53.2	6.41	27.23
-55.41	3.43	16.35
28.25	-6.02	51.87
45.37	-3.46	55.92
55.96	4.38	46.22
58	12.16	36.62
-1.69	4.55	53.56
-1.61	-5.51	61.09
-8.17	8.22	46.64
8.87	14.33	41.47
-8.29	15.83	34.85
8.72	25.99	27.11
38.5	51.03	17.98
-32.11	25.63	-1.39
-32.03	17.69	5.97
34.22	24.6	6.86
-10.53	-20.42	6.69
-10.57	-3.33	7.49
8.71	-20.31	6.46
10.81	-5.32	7.41
25.75	-1	6.87
-23.43	0.65	5.07
-16.75	-104.14	-1.83
0.33	-97.69	-2.57
21.69	-95.45	-3
-16.88	-90.19	-14.15
25.84	-83.59	-15.2
36.47	-79.64	-20.11
-51	-65.42	6.47
-44.65	-72.58	-4.16
45.19	-69.07	5.67
-27.42	-93.11	4.06
34.57	-90.46	5.35
32.47	-83.44	13.71
64.49	-39.75	25.29
-31.59	-78.91	22.99
43.45	-51.77	64.46
-31.52	-49.53	45.06
-35.76	-42.7	51.22
34.83	-43.79	58.31
-14.27	-69.89	55.49
-22.84	-70.11	53.37
26.34	-67.36	57.04
-31.58	-6.21	54.81
-46.58	-2.41	50.2
-48.84	0.78	36.58
-53.22	6.24	25.02
26.15	-1.29	58.19
34.71	-5.47	58.44
47.5	-1.33	55.72
55.97	2.26	46.4
57.98	14.11	34.23
-1.69	4.55	53.56
-1.61	-3.4	60.92
-8.19	8.05	44.42
6.77	12.54	46.1
-1.82	16.38	41.42
-8.29	17.94	34.67
8.72	25.99	27.11
-29.89	46.22	16.93
34.22	48.72	15.99
-32.14	35.15	-2.19
-32.03	19.8	5.79
34.22	24.6	6.86
38.44	21.83	-1.88
-8.38	-22.52	6.84
-10.57	-3.33	7.49
8.7	-18.19	6.28
10.81	-5.32	7.41
25.75	-1	6.87
-23.41	-1.29	7.46
-44.71	-79.78	-14.71
-51.01	-63.3	6.29
-44.65	-72.58	-4.16
45.23	-62.04	14
-35.98	-86.65	5.84
32.48	-85.55	13.89
-22.96	-73.6	35.82
-31.36	-54.51	63.31
-35.74	-44.64	53.62
-33.7	-41.26	42.16
-27.16	-53.05	54.22
34.8	-48.45	53.13
34.71	-42.79	43.73
-14.26	-65.32	59.56
-22.84	-70.11	53.37
-12.14	-74.28	53.6
17.72	-65.98	48.1
24.18	-69.83	52.81
-25.12	-7.94	59.34
-31.46	-9.41	68.46
-59.51	-1.4	36.88
-61.85	9.73	15.9
-6.08	-102.13	-4.35
-25.47	-70.87	-11.21
32.22	-66.29	-12.26
27.99	-83.41	-13.01
-38.3	-77.63	-14.96
40.78	-79.27	-15.73
-40.29	-76.1	5.01
45.18	-66.96	5.49
-27.42	-93.11	4.06
30.3	-88.2	7.44
40.95	-84.07	4.74
-50.93	-38.33	26.5
64.41	-33.92	18.11
-25.18	-74.47	24.77
28.32	-71.18	35.03
-31.43	-50.79	56.31
-25.09	-49.32	47.2
26.19	-60.1	40.82
26.28	-54.84	53.76
-46.54	-4.18	54.81
53.82	6.48	46.07
43.25	-3.3	58.16
47.31	7.7	34.89

// Wagner A D, 1998: Encoding Words > Textures
// Wagner A D, 1998: Encoding Textures > Words
// Wagner A D, 1998: Retrieval Words > Textures
// Wagner A D, 1998: Retrieval Textures > Words
// Subjects=9
-55.57	23.72	3.5
-38.56	30.62	-5.08
-44.47	5.09	50.66
-49.2	15.67	-4.82
-54.37	9.78	15.81
-1.71	20.84	57.77
-54.46	8.84	3.62
-28.44	20.5	55.88
-5.38	62.14	14.2
-35.24	47.25	16.91
14.62	59.18	-25.93
52.39	32.45	10.45
0.99	46.44	3.18
-7.65	45.36	-10.01
43.03	4.33	32.99
-48.03	16.79	9.57
-50.35	30.21	-9.37
-41.34	4.25	39.54
-2.81	20.49	53.35
-12.82	62.53	19.83
-50.1	9.72	14.65
-4.56	59.58	-19.05
13.66	60.29	-11.51
-17	48.13	26.66
11.68	69.56	12.27
26.58	53.65	-2.18
-25.81	52.99	-5.98
-6.46	54.39	10.4
48.26	10.82	20.12
52.38	32.28	8.24
-41.73	38.69	3.2
20.09	29.69	-22.4

// Ellermann J M, 1998: Composite Functional Maps
// Subjects=9
39.67	-62.1	-13.81
-42.61	-62.59	-12.83
20.53	-90.94	-13.41
37.64	-84.15	-9.71
36.65	-82.16	2.4
-38.16	-79.43	3.03
28.3	-78.04	28.92
5.98	-72.48	47.67
1.05	-79.36	-40.92
14.48	-49.89	50.13
27.28	-58.78	44.04
-28.27	-52.43	48.61
55.97	-35.06	31.69
-42.28	-42.71	37.92
44.32	-18.7	51.64
-37.99	-22.79	47.35
-32.52	-33.53	59.34
25.08	-18.81	51.87
-27.24	-17.64	57.95
24.01	-14.5	52.63
-17.67	-11.5	53.97
29.06	16.59	27.66
-29.74	20.39	26.91
34.17	14.14	-4.53
-40.62	8.41	-3.19
-4.82	-15.48	56.39
6.91	-11.26	54.79
6.8	-9.12	41.23
-8.12	-16.53	43.13
44.06	-65.28	-.21
-42.49	-65.8	0.82
48.29	-51.51	-1.42
-45.69	-66.79	2.06
55.88	-41.46	17.73
-46.73	-38.02	16.39
39.61	-.2	2.19
-42.68	-11.7	-1.48
14.07	-28.82	5.99
-15.86	-29.17	4.14
-12.69	-22.89	2.46
14.08	-22.22	8.79
-17.96	-22.15	12.49
-9.45	-15.93	9.64
-20.17	-13.08	6.18
18.09	-63.31	-41.34
22.44	-53.72	-27.7
-32.06	-59.59	-29.93
9.67	-61.99	-23.51
-4.19	-68.42	-22.82
1.15	-65.13	-22.04

// Shen L, 1999: Common Activation
// Shen L, 1999: Visual Recognition > Spatial Recognition
// Shen L, 1999: Spatial Recognition > Visual Recognition
// Shen L, 1999: Common Deactivation
// Subjects=9
0.36	-85.29	6.43
2.5	-85.28	6.4
28.27	-83.84	22.71
-25.16	-84.16	23.35
-28.55	-89.32	-1.83
31.29	-88.96	-2.54
-37.22	-64.34	-8.28
39.71	-63.87	-9.2
-40.39	-57.32	0.09
42.96	-56.83	-.91
52.67	-38.22	18.61
28.36	-48.83	48.77
-25.07	-49.15	49.41
1.77	-58.62	62.16
0.42	10.9	53
0.37	14.79	48.22
10.83	23.46	21.72
22.88	12.35	55.97
-19.86	12.1	56.48
45.17	12	35.67
-42.46	11.48	36.72
-47.96	26.28	22.16
50.35	26.87	20.98
39.46	21.4	-7.43
-37.47	20.94	-6.51
32.15	-65.92	-21.21
-29.83	-66.29	-20.47
-11.65	-78.16	-24.14
-31.69	-88.65	7.08
-51.11	-55.62	-4.39
-39.45	-46.63	-13.09
25.64	-30.72	-19.63
-23.52	-31.01	-19.04
-.71	-94.1	2.72
-61.78	-33.5	7.26
-32.64	-34.73	43.83
-.73	14.44	43.8
-11.28	12.49	60.81
-33.15	8.28	-5.5
-52.29	26.71	14.37
-30.04	58.94	2.49
-15.9	-76.78	-19.75
50.34	-53.49	-13.54
32.59	-81.1	30.24
61.27	-24.54	29.63
-15.33	-64.27	59.49
18.87	-64.06	59.08
-11.1	-70.22	51.02
-1.7	-38.32	35.97
28.14	18.13	47.62
58.11	-11.98	40.88
-9.85	28.28	-24.17
-0.08	40.89	0.31
-15	12.62	-6.07
-22.27	-54.39	-4.83
-50.16	-7.34	0.47
-9.17	-43.74	35.39
0.44	-11.99	46
-8.79	47.92	-18.02
52.43	-6.73	-.76
2.57	-11.97	45.98
10.44	48.04	-18.25

// Lumer E D, 1998: Rivalry > Rest
// Lumer E D, 1998: Replay > Rest
// Lumer E D, 1998: Rivalry > Replay
// Lumer E D, 1998: Replay > Rivalry
// Subjects=6
33	-45	-21
-30	-69	-18
0	0	48
9	21	36
60	15	-3
54	15	27
-57	9	3
30	-54	54
60	-27	30
-36	-12	57
39	42	18
-36	39	21
33	-45	-21
-27	-69	-18
57	21	-9
54	15	24
-60	12	3
69	-36	9
-39	-15	51
66	-30	36
36	-45	51
42	-87	9
51	15	-6
9	-75	-3
-15	-78	-12

// Chawla D, 1999: Subject 1
// Subjects=1
-50	-74	6
52	-66	6
-22	-82	28
24	-88	26
-8	-90	0
16	-88	6
-30	-72	-16
30	-64	-14

// Chawla D, 1999: Subject 2
// Subjects=1
-54	-64	0
56	-66	0
-22	-86	26
22	-90	22
-2	-96	-2
10	-94	-2
-30	-78	-16
18	-74	-6

// Chawla D, 1999: Subject 3
// Subjects=1
-50	-76	6
44	-58	12
-20	-88	30
20	-88	34
14	-98	6
-8	-98	2
-36	-78	-18
38	-62	-18

// Corfield D R, 1999: Tongue Contraction - Rest
// Subjects=8
-62	-6	22
64	-4	18
-2	14	54
2	6	52
-8	16	34
10	10	32
-62	6	4
64	12	0
-46	6	0
44	6	2
22	2	0
-14	-14	2
16	-14	4
-14	-56	-18
24	-60	-20
-14	-64	-48
14	-66	-48

// Whalen P J, 1998: Negative vs. Neutral Words
// Whalen P J, 1998: Neutral Words vs Fixation
// Subjects=9
-2.16	43.67	9.02
-25.11	-69.3	36.6
57.86	26.11	24.3
-52.13	13.02	30.01
11.1	-1.18	47.2
-1.69	-.91	51.79
-31.47	-55.62	48.91
43.97	-59.62	-9.61
-41.51	-60.13	-8.58
28.21	-89.9	13.18
-20.97	-90.45	10.45
-5	-94.29	0.55

// Dapretto M, 1999: Syntactic vs. Rest
// Dapretto M, 1999: Semantic vs. Rest
// Dapretto M, 1999: Syntactic vs. Semantic
// Dapretto M, 1999: Semantic vs. Syntactic
// Subjects=8
-52	10	28
-40	30	14
-58	-58	14
-60	-36	16
-48	20	-16
56	10	-10
-42	-56	38
40	-50	42
-56	22	2
54	24	18
-46	30	-6
50	24	-6
-42	-18	-12
-52	-44	22
-36	-28	8
-54	-54	32
-44	22	10
-48	20	-4

// Binkofski F, 1999: Complex Objects vs. Spheres
// Subjects=5
-52	8	22
56	8	20
-60	-24	20
60	-22	20
-48	-34	40
48	-34	40
-32	-56	60
32	-52	64

// Binkofski F, 1999: Complex Objects, Right Hand vs. Rest
// Binkofski F, 1999: Complex Objects, Left Hand vs. Rest
// Binkofski F, 1999: Complex Objects vs. Spheres, Right Hand
// Binkofski F, 1999: Complex Objects vs. Spheres, Left Hand
// Subjects=6
32	-10	52
44	-16	52
52	8	20
12	-16	4
60	-20	16
40	-40	44
56	-32	36
36	-52	60
0	12	28
4	-12	64
4	0	44
-46	-32	50
-28	-16	20
-52	8	28
-32	-56	56
-64	-20	24
-40	-40	40
-40	-52	44
-52	-32	36
40	-32	52
32	-10	52
52	8	20
60	-20	16
40	-40	44
56	-32	36
36	-52	60
0	12	28
4	-12	64
4	0	44
-40	-16	52
-52	8	28
-16	-16	8
-16	-76	52
-64	-20	24
-40	-40	40
-40	-52	44
-52	-32	36
-32	-56	56
52	8	20
60	-20	16
40	-48	50
56	-32	36
4	0	44
-52	8	28
-32	-56	56
-64	-20	24
-40	-40	40
-40	-52	44
52	8	20
60	-20	16
40	-40	44
40	-48	50
56	-32	36
36	-52	60
4	0	44
-52	8	28
-32	-56	56
-64	-20	24
-40	-40	40

// Brown G G, 1999: Incongruent - Non-lexical
// Brown G G, 1999: Incongruent - Neutral
// Subjects=8
8.76	28.53	32.47
-1.89	17.89	33.49
-42.7	17.71	7.2
24.05	-62.4	38.81
8.76	28.53	32.47
-1.89	17.89	33.49
-42.7	17.71	7.2
24.05	-62.4	38.81

// Chee M W L, 1999: Normal Male Early Bilinguals
// Subjects=7
-37.2	13.91	26.42
-43.63	9.3	22.42
-43.6	7.36	24.81
-43.71	26.05	18.78
-39.4	17.61	19.44
-39.33	20.58	30.34
-35.1	13.58	21.96
-37.2	13.91	26.42
-43.63	9.3	22.42
-45.74	7.34	24.84
-43.71	26.05	18.78
-39.39	15.5	19.62
-39.33	20.58	30.34
-35.1	13.58	21.96

// Chee M W L, 1999: Normal Female Early Bilinguals
// Subjects=8
-33.11	27.37	7.4
-32.89	7.76	29.12
-35.14	10.95	15.49
-35.23	25.41	9.82
-41.45	20.74	32.59
-39.29	14.41	33.09
-41.65	27.49	9.72
-45.81	19.86	21.56
-33.11	27.37	7.4
-32.89	7.76	29.12
-35.14	10.95	15.49
-35.23	25.41	9.82
-39.31	20.76	32.56
-39.29	14.41	33.09
-41.65	27.49	9.72
-45.81	21.98	21.38

// Chee M W L, 1999: Normal Male Late Bilingual
// Subjects=1
-28.63	20.82	32.43
-28.63	20.82	32.43

// Chee M W L, 1999: Normal Female Late Bilinguals
// Subjects=8
-30.84	22.24	23.42
-39.46	28.02	16.34
-26.52	16.09	26.11
-34.96	14.95	39.69
-41.53	11.08	17.78
-35.01	7.92	31.36
-30.89	21.72	16.77
-39.34	16.01	26.27
-30.84	22.24	23.42
-39.49	32.07	13.77
-26.52	16.09	26.11
-34.96	14.95	39.69
-41.53	11.08	17.78
-35.01	7.92	31.36
-28.75	21.74	16.74
-39.34	16.01	26.27

// Crosson B, 1999: Emotionally Evocative Words - Repetition
// Crosson B, 1999: Repetition - Emotionally Evocative Words
// Crosson B, 1999: Emotionally Neutral words - Repetition
// Crosson B, 1999: Repetition - Emotionally Neutral Words
// Subjects=17
-2.88	23.14	46.44
-.59	13.7	61.7
-6.41	66.97	21.62
-49.07	34.65	20.36
-42.91	49.63	-6.62
-53.48	24.36	-2.15
-14.81	-51.34	-7.4
-13.5	-90.49	9.25
-14.97	-10.1	-10.86
-21.52	-8.25	-27.66
-16	14.44	3.83
-50.18	-62.52	-25.01
-55.49	-8.35	1.73
-6.13	28.07	41.6
-20.99	16.95	50.51
-45.97	41.21	8.62
-53.47	22.25	-1.97
-57.53	-53.54	-4.49
-6.08	-74.58	7.83
-20.3	14.16	0.55
-58.6	-11.82	12.09

// Kang A M, 1999: Syntactic VPs - Fixation
// Kang A M, 1999: Semantic VPs - Fixation
// Subjects=14
-52.31	17.74	8.43
-57.54	13.45	22.23
-47.07	27.66	-1.39
-41.71	38.95	6.53
31.57	-58.67	45.1
35.66	-11.06	41.06
1.4	6.71	39.96
-57.54	13.45	22.23
43.76	26.09	-2.3
43.68	65.9	3.29
59.93	35.3	19.05
-24.07	-41.03	44.26
27.21	-37.55	43.38
29.44	-39.85	54.7

// Peterson B S, 1999: Incongruent vs. Congruent (Increases)
// Peterson B S, 1999: Incongruent vs. Congruent (Decreases)
// Subjects=34
-14.76	-7.96	16.84
16.09	8.37	5.08
17.3	-7.77	16.46
-6.16	-21.66	17.89
9.87	-21.56	17.7
-23.67	46.49	-7.69
22.33	53.88	1.19
20.36	51.18	21.52
-45.85	39.15	23.29
-44.69	35.7	33.6
48.03	40.29	2.04
47.11	40.77	22.08
-53.31	11.9	15.62
-48.88	12.41	35.6
53.63	12.25	24.4
-6.28	30.93	23.52
-6.18	23.24	34.2
8.68	31.02	23.34
-51.08	-54.13	1.06
-52.34	-1.27	-3.36
-27.37	-86	13.5
-19.78	-93.64	24.09
31.41	-86.7	12.88
21.89	-93.39	23.59
20.83	-74.65	32.06
22	-80.22	42.55
-13.68	-53.91	0.61
-14.29	-72.26	52.34
16.7	-72.08	51.97
-52.31	11.14	5.64
-50.94	-8.75	37.4
54.55	11.78	4.35
53.79	-9.18	36.23
-53.02	-45.49	30.47
-42.16	-49.17	50.72
55.98	-44.83	29.16
46.53	-48.64	49.66
-17.64	-74.88	32.53
-19.68	-79.41	42.97
25.61	54.67	11.13
-23.3	-11.18	17.21
27.89	-3.19	5.92
26.94	-14.05	16.88
-12.64	-25.64	8.26
15.16	-27.58	8.11
-24.68	52.54	1.85
-23.54	54.38	11.72
-19.2	56.23	21.55
-19.02	49.31	42.2
23.47	54.66	11.15
25.87	48.52	41.75
-47.15	38.95	-6.79
-47.1	46.06	2.65
-46.7	22.71	44.75
50.1	38.47	-7.87
51.61	23.3	43.57
-7.61	37.07	-7.09
-7.54	39.95	2.7
-8.53	39.66	12.78
9.48	39.29	-7.47
9.56	40.06	2.5
10.71	38.72	12.64
-8.15	-21.18	37.95
-8.07	-21.47	48.01
11.07	-56.45	20.61
11.07	-35.59	28.9
10.09	-20.3	47.7
-51.08	-54.13	1.06
-50.99	-57.59	11.38
-47.57	-74	32.8
53.64	-52.45	-.29
53.74	-56.96	10.13
50.75	-73.42	31.62
-52.19	-21.64	8.38
-45.56	-58.9	21.47
54.67	-21	7.1
48.47	-56.22	20.16
18.68	-71.49	31.82
-15.82	-52.86	0.55
-14.64	-61.6	11.3
16.35	-62.47	11.02
10.14	-53.85	40.48
-53.22	-12.42	17.66
-53.14	-11.65	27.63
54.71	-11.77	16.36
55.86	-12.05	26.41
57	-11.28	36.37
52.8	-9.47	46.3
56.06	-44.06	39.13
-8.17	-56.56	20.84

// Beauregard M, 1998: Depression Patients
// Subjects=7
-4	64	32
-32	60	4
0	-12	72
4	50	26
2	16	40
-50	-74	20
42	-56	18
18	58	32
42	-48	-22
-60	-38	24
-2	-22	36
-34	-86	-38
-4	6	-2
6	6	-2
52	28	-12
2	-2	-2

// Beauregard M, 1998: Normals
// Subjects=7
0	44	32
4	62	30
-40	-66	-22
56	-74	4
18	42	48
-2	45	20
-42	-48	-14
2	12	8
-4	-86	38
-12	-84	44
-2	-80	48
52	40	-10
46	-72	2

// Braver T S, 1997: Brain Areas Showing Monotonic Increases in Activity as a 
// Function of Memory Load
// Subjects=8
15.38	14.34	54.77
-43.57	28.56	37.53
40.74	43.36	28.63
-49.05	8.5	12.51
47.26	10.44	29.08
-33.13	22.8	3.32
-40.35	2.35	28.54
-48.78	2.44	44.24
-30.49	-.49	59.89
-26.1	-58.59	51.33
35.85	-54.16	48.02
20.5	4.31	20.98

// Breiter H C, 1996: Fearful - Neutral Faces
// Breiter H C, 1996: Happy - Neutral Faces
// Subjects=10
-19.29	-2.9	-13.64
27.73	-2.61	-14.2
-28.91	-9.64	-17.42
44.92	-42.24	-18.88
-45.9	-45.95	-17.53
27.95	-55.23	-6.45
-25.5	-65.66	-12.77
-35.07	-68.55	-7.95
-49.04	-56.29	-13.28
51.44	-55.34	-10.05

// Callicott J H, 1999: Significant Increases in Activation as a Function of 
// Working Memory Load
// Subjects=9
46.02	30.64	15.14
39.56	34.49	10.43
33.01	35.2	-7.4
31.34	20.26	47.4
22.88	14.55	56.9
35.69	10.06	52.67
-52.09	14.51	35.46
-50.14	27.95	16.47
-32.65	5.76	58.28
-6.93	4.48	67.01
-2.6	-1.49	71.92
1.61	6.65	66.73
18.29	-1.93	9.27
3.39	-16.82	10.69
9.69	4.02	4.41
48.47	-25.42	33.19
6.09	-57.11	67.56
-36.73	-55.94	59.04

// Carlson S, 1998: Two-Back vs. Zero-Back
// Carlson S, 1998: One-Back vs. Zero-Back
// Carlson S, 1998: Two-Back vs. One-Back
// Subjects=7
41.85	28.39	27.64
-38.32	37.51	28.91
20.78	9.42	59.58
-23.13	20.19	51.38
3.62	16.38	54.74
-8.12	16.4	55.99
40.8	18.69	26.24
-44.72	21.18	24.78
37.28	58.29	1.77
-26.81	53.76	4
41.04	-.74	50.17
-45.59	0.08	41.06
4.93	-66.78	52.77
-2.57	-62.68	51.4
10.39	-54.54	72.88
-12.09	-60.65	64.72
32.67	-57.18	50.54
-35.72	-56.53	51.27
45.37	-49.67	36.38
-46.46	-52.79	45.5
28.31	-74.61	31.97
-21.95	-76.39	27.13
3.49	19.41	38.87
-1.81	16.55	43.63
7.93	-50.24	32.4
-3.88	-49.76	25.8
37.37	19.62	-2.8
-37.39	13.08	1.96
16.49	10.28	57.33
-32.59	2.04	65.28
-7	0.54	57.3
-39.72	36.28	-14.46
13.64	53.43	-17.63
-26.89	58.36	-5.31
3.87	-49.18	60.23
-5.73	-54.52	60.79
21.04	-63.71	63.48
-14.35	-61.95	48.13
-31.46	-57.73	49.09
-57.1	-41.34	56.93
30.24	-85.54	0.53
-13.48	-81.51	15.19
9.47	34.71	-11.55
-7.69	55.93	-10.9
-6.99	-62.04	32.44
43.86	39.18	15.56
-35.15	45.99	28.17
27.09	18.29	49.85
-26.31	12.77	52.04
13.26	16.61	56.84
-10.33	29.96	52.64
57.66	27.31	-1.44
-52.22	21.94	21.46
13.7	58.43	-8.01
-12.89	61.76	9.86
54.89	5.43	46.15
-36.95	-3.24	52.39
10.24	-59.43	50.98
-6.8	-56.73	59.87
27.38	-56.7	57.25
-18.53	-58.74	62.41
32.59	-55.83	40.39
-37.91	-59.26	43.71
46.46	-46.15	40.53
-44.37	-54.35	38.92
37.81	-79.01	15.51
-27.27	-80.57	28.65
6.51	34.01	20.89
-2.86	10.11	43.07
31.03	14.89	5.48
-45.98	14.72	-3.66

// Curtis V A, 1998: Schizophrenic Patients
// Subjects=5
-1.68	2.52	54.85
1.38	16.4	41.38
32.26	-66.92	-6.63
-44.45	-1.34	50.08
14.14	-66.6	-.88
-41.54	26.4	23.19
-54.26	9.84	30.3
-33.13	25	4.25
-1.58	-48.12	46.82
4.98	-61.95	60.18
10.47	45.04	-15.77

// Curtis V A, 1998: Normal Subjects
// Subjects=5
4.68	17.36	53.53
-47.8	12.5	36.7
-44.88	12.87	-.17
-4.88	-49.08	34.68
-32.9	15.25	29.6
-39.49	35.42	15.72
46.99	19.76	-1.8
-41.48	11.6	24.43
-35.87	2.31	55.26
4.87	-59.72	47.72
7.3	47.56	-10.37
4.78	-45.34	40.94
4.97	-46.63	65.58
-4.88	-49.08	34.68
4.81	-5.39	62.13
-1.74	-68.41	18.42

// Friston K J, 1995: Activations
// Friston K J, 1995: Deactivations
// Subjects=1
1.46	0.71	44.93
24.95	-3.72	40.57
1.25	18.37	25.6
16.49	-73.16	24.18
7.99	-77.1	29.07
20.18	54.84	0.02
33.14	36.57	10.33
39.67	15.8	16.46
-37.54	49.92	-3.36
-26.87	54.21	-3.84
-1.2	56.83	0.1
-5.5	45.54	-7.82
-33.25	36.92	-6.78
12.06	-50.61	13.42
-.74	-57.03	14.11
-4.97	-67.63	15.04

// Maddock R J, 1997: Subject a
// Subjects=1
0.44	-49.31	31.29

// Maddock R J, 1997: Subject b
// Subjects=1
-7.16	-56.1	12.99

// Maddock R J, 1997: Subject c
// Subjects=1
-2.94	-42.33	11.78

// Maddock R J, 1997: Subject d
// Subjects=1
-3.94	-30.64	25.31

// Maddock R J, 1997: Subject e
// Subjects=1
-2.74	-54.53	32.88

// Maddock R J, 1997: Subject f
// Subjects=1
-.64	-54.95	27.31

// Maddock R J, 1997: Subject g
// Subjects=1
0.55	-53.65	43.92

// Maddock R J, 1997: Subject h
// Subjects=1
-10.22	-54.58	32.97

// Phillips M L, 1997: 75% Fearful Faces - Neutral Faces
// Phillips M L, 1997: 150% Fearful Faces - Neutral Faces
// Phillips M L, 1997: 75% Disgusted Faces - Neutral Faces
// Phillips M L, 1997: 150% Disgusted Faces - Neutral Faces
// Phillips M L, 1997: 150% Disgusted Faces - 75% Disgusted Faces
// Subjects=7
-41.53	-25.18	2.98
-26.76	-14.92	-17.01
-26.74	-5.94	-11.07
25.57	9.18	-12.94
32.19	14.7	16.63
22.39	-11.45	-17.86
38.51	-10.41	-5.87
41.74	-4.59	0.3
19.16	43.29	2.12
-2.17	46.85	8.76
-13.66	-75.65	-5.37
38.43	34.94	2.6
50.26	13.87	4.23
-33.08	25.51	10.9
4.62	-53.57	17.1
38.44	47.09	8.27
32.49	-76.67	18.72
29.11	-30.16	14.86
-26.57	-52.47	-7.17
-41.54	-49.39	-7.26
-44.61	-35.89	16.18
50.33	-28.32	-4.5
25.72	5.26	5.23
41.69	20.16	3.8
-20.07	-75.69	-5.3

// Phillips M L, 1998: Facial Expressions of Fear - Neutral Facial Expressions
// Phillips M L, 1998: Vocal Expressions of Fear - Neutral Vocal Expressions
// Phillips M L, 1998: Facial Expressions of Disgust - Neutral Facial 
// Expressions
// Phillips M L, 1998: Vocal Expressions of Disgust - Neutral Vocal 
// Expressions
// Phillips M L, 1998: Facial Expressions of Fear - Facial Expressions of 
// Disgust
// Phillips M L, 1998: Facial Expressions of Disgust - Facial Expressions of 
// Fear
// Phillips M L, 1998: Vocal Expressions of Fear - Vocal Expressions of 
// Disgust
// Phillips M L, 1998: Vocal Expressions of Disgust - Vocal Expressions of 
// Fear
// Subjects=6
46.99	7.62	-7.48
50.28	-1.37	-0.07
43.79	-19.78	-17.41
63.16	-31.41	-4.39
50.3	-31.92	-9.78
-44.96	34.02	-1.94
-29.99	-8.59	-17.5
-41.21	-61.36	30.55
47.17	-52.03	-8.05
44.03	-57.96	-1.94
15.95	19.06	-8.08
7.32	54.42	-4.25
25.81	-55.33	-7.53
1.12	10.4	5.08
4.14	48.06	-3.68
-16.91	-51.98	-1.74
41.73	-25.62	-10.2
-41.66	-17.66	-9.91
-54.24	-30.66	15.85
25.9	-30.18	14.89
38.7	-23.76	14.21
7.7	-44.98	4.08
7.37	27.47	-8.69
13.87	-19.96	-17.05
4.33	-1.64	0.48
7.74	-30.29	15.11
46.92	0.33	-19.13
50.21	4.46	-7.25
53.5	-4.52	0.16
38.6	-9.47	6.32
-39.44	-1.48	6.55
-39.52	7.61	0.21
-41.71	7.09	-6.41
-36.33	-2.4	-5.68
-8.24	-69.39	6.31
22.75	-84.52	0.53
25.71	-4.69	0.49
-26.56	-18.32	7.81
19.21	-19.93	-17.11
28.76	-11.84	-23.48
60.07	-23.63	13.95
-32.78	-81.17	7.58
16.02	1.09	-6.57
7.42	15.84	-7.71
-29.39	-67.21	36.48
11.22	-66.96	35.99
60.11	-32.09	14.66
56.81	-20.99	7.08
-32.88	-27.36	15.33
-54.27	-24.31	15.32
-8.16	-65.28	18.23
-1.73	-46.32	28.83
-57.57	-22.1	2.91
-44.66	-45.29	4.7
-47.83	-44.88	10.28
43.74	31.37	-2.74
-2.06	-6.97	1
-26.72	40.35	9.58
-44.97	36.13	-2.12
46.99	-17.65	-17.63
-44.42	-61.38	30.59
47.17	-52.03	-8.05
53.5	-31.9	-9.81
44.03	-57.96	-1.94
-26.86	51.04	-3.58
32.16	-13.11	1.12
19.16	19.08	-8.12
-29.98	-11.76	-17.23
-36.25	1.72	6.24
-44.92	9.18	-6.55
56.86	-20.48	13.72
-17.15	-23.75	-21.95
22.53	-37.37	-9
25.69	1.66	-0.04
-8.29	-69.91	-.34
19.27	-10.53	-5.64
16.02	1.09	-6.57
41.71	-22.45	-10.47
-11.44	-59.47	11.09
29.01	-55.31	-7.57
4.16	30.62	-8.91
7.35	48.08	-3.72
22.68	-27.03	14.67
59.87	-7.11	-6.39
-32.6	-67.23	36.52
-8.17	-62.11	17.96
-1.73	-46.32	28.83
43.73	34.55	-3.01
-57.59	-18.93	2.64
56.81	-20.99	7.08
56.89	-29.99	14.52
-2.05	-10.14	1.27

// Phillips M L, 1998: Familiar - Unfamiliar Faces
// Phillips M L, 1998: Unfamiliar - Familiar Faces
// Phillips M L, 1998: Happy - Neutral Faces
// Phillips M L, 1998: Neutral - Happy Faces
// Phillips M L, 1998: Neutral - Sad Faces
// Subjects=8
63.21	-30.9	2.26
-50.99	-17.01	26.94
-33.12	35.03	10.1
-5.41	55.29	8.09
-4.98	-58.91	17.66
16.36	-50.33	16.69
35.64	-25.58	32.24
14.19	-81.4	0.37
38.69	3.62	24.18
-29.73	-.48	18.62
38.64	3.11	17.53
-2.27	48.02	-3.61
16.43	-56.24	22.76
4.65	-62.03	17.81
-13.54	-56.85	17.58
-44.69	-12.63	14.23
-41.43	-15.35	20
1	43.18	2.34
25.79	-12.72	6.74
29.01	-17.99	7.14
-20.09	-8.88	19.21
-41.43	-15.35	20
-50.99	-32.33	21.53
50.23	35.53	9.1
-20	-93.67	-3.79
-11.51	-78.81	-5.13
-20.04	-82.04	-4.76
-8.18	-86.31	7.73

// Sprengelmeyer R, 1998: Disgust - Neutral
// Sprengelmeyer R, 1998: Fear - Neutral
// Sprengelmeyer R, 1998: Anger - Neutral
// Subjects=6
-45	24	-14
24	-12	-7
-36	0	7
-48	24	-14
-51	33	14
33	-57	-14
-48	24	-14
-57	-51	7
15	-39	42

// Teasdale J D, 1999: Negative vs. Reference
// Teasdale J D, 1999: Positive vs. Reference
// Teasdale J D, 1999: Positive vs. Negative
// Subjects=6
1.14	44.63	21.17
4.62	7.96	42.05
7.5	44.16	14.45
4.39	36.37	24.06
1.17	-13.29	1.49
10.86	-33.33	3.06
35.35	41.67	21.03
53.59	21.69	22.49
43.92	-16.21	1.25
-39.47	-5.08	1.27
-1.94	-27.69	8.31
-11.12	-68.27	48.62
-5.19	-3.93	13.05
-16.83	-8.34	25.82
0.99	58.5	7.74
-2.16	55.73	13.59
4.72	5.73	54.5
59.89	10.75	4.38
1.04	46.86	8.72
4.62	7.96	42.05

// Whalen P J, 1998: Masked Fearful vs. Masked Happy
// Subjects=10
20.21	-6.35	-20.5
-15.05	0.04	-17.28
-11.82	0.32	-14
-28.93	46.17	2.43

// Brammer M J, 1997: Auditory Subjects
// Subjects=8
-57.49	-33.31	9.42
-57.59	-16.82	2.47
66.29	-10.24	-6.2
63.19	-24.55	1.73
56.66	-19.19	-10.92
-54.44	-17.31	-4.22

// Brammer M J, 1997: Verbal Subjects
// Subjects=6
1.67	-59.74	47.76
-44.69	11.58	24.47
-44.66	15.18	29.74
-41.38	10.43	36.8
-26.09	-66.25	48.63
1.37	19.57	41.11

// Casey B J, 1998: Pooled Subjects
// Subjects=8
-11.95	61.53	-6.86
3.02	62.85	-4.91
-3.28	62.87	9.66
-39.34	30.36	32.87
48.37	21.88	39.26
-36.32	17.4	2.7
-55.15	-24.64	38.78
1.48	-41.9	30.65
-36.7	-42.39	69.05
27.28	-60.98	43.11
17.71	-65.01	46.9
-.87	37.19	35.2
4.5	36.34	37.44
2.47	8.92	40.88
-52.08	-3.98	30.32
48.52	-5.18	47.11
-3.72	-6.41	63.42
4.74	1.5	54.86
-16.35	-38.5	76.3
28.52	-31.8	76.34
5.58	-59.08	0.82
31.29	-86.76	-1.61
-40.22	-80.87	12.1
28.24	-83.04	19.3
-11.2	-84.45	32.14
7.97	-94.88	19.41
-2.91	-69.53	4.03

// Casey B J, 1998: Boston Site
// Subjects=5
-33.18	47.55	6.82
42.81	43.74	19.65
46.28	24.58	46.87
32.48	17.7	55.41
-43.78	33.02	12.62
-37.45	20.06	-4.2
0.37	21.39	51.01
26.23	-22.35	61.07
-49.7	-25.69	52.19
50.72	-28.69	45.71
-18.56	-53.54	60.86
43.41	-35.74	65.34
-3.64	-37.42	61.56
-11.28	9.23	59.97
32.49	32.13	63.12
23.88	22.68	51.75
21.66	18.46	38.74
-21.9	-6.69	61.43
-33.56	-29.86	65.73
-12.66	-56.61	-6.98
37.49	-72.49	-24.07
41.9	-54.55	1.14
-.74	-71.29	8.61
24.78	-77.97	-11.2
39.81	-56.33	5.78
6.77	-72.05	11.93
13.4	-74.18	38.8

// Casey B J, 1998: Madison Site
// Subjects=5
40.64	43.39	15.25
34.57	8.48	46.12
-26.32	2.83	47.3
3.51	18.53	41.18
-.69	-42.26	26.25
13.41	-48.83	50.06
-17.64	4.25	64.92
-.56	-1.36	59.62
-37.98	-8.36	55.06
47.42	-19.71	38.3
41.22	-38.47	57.79
22.56	-50.32	-11.26
-26.6	-51.75	-11.69

// Casey B J, 1998: Minnesota Site
// Subjects=6
-6.53	69.03	6.95
26.85	42.22	28.89
-23.23	37.83	45.44
10.39	28.86	-32.26
-23.29	24.02	32.1
28.06	24.93	39.24
19.24	-9.73	-9.05
-40.43	-11.63	12.98
-49.35	-23.19	-39.47
-5.73	-20.46	74.66
-66.27	-28.1	-18.79
2.52	-31.24	30.86
-49.16	-36.63	-20.51
19.43	-34.16	5.27
-22.72	-33.71	83.78
-14.77	-40.97	2.88
12.46	-43.15	68.55
53.92	-59.48	32.64
-31.03	-65.47	-37.25
19.33	-54.99	-16.41
-5.84	-74.38	37.92
19.7	-86.26	19.67
-36.22	58.04	32.74
27.55	26.31	-25.55
2.19	29.07	12.43
-65.19	14.86	-.1
-57.39	16.05	42.08
-40.22	14.72	50.92
-22.92	-8.39	67.16
-60.9	-17.86	-10.79
-39.95	-30.87	67.01
-31.89	-57.79	-6.66
-66.26	-76.25	-35.94
19.26	-59.02	-27.22

// Casey B J, 1998: Pittsburgh Site
// Subjects=8
-2.33	54.02	-8.57
12.02	47.81	47.54
-8.13	31.71	61.39
32.49	0.26	50.18
-32.71	21.62	56.95
39.62	43.89	21.91
32.09	12.61	3.43
-43.79	7.67	1.37
33.52	-1.3	43.61
-5.72	-48.89	64.78
14.64	-43.86	73.05
5.63	-50.82	11.28
48.6	-51.59	38.73
-59.35	-50.21	38.74
-36.67	-55.34	66.79
28.48	-57.49	60.65
60.04	-53.64	-2.49
-29.35	-76.64	38.38
-36.99	-80.6	15.38
-.55	-90.27	24.7
28.01	-90.89	-13.49
1.97	50.96	-7.25
-24.57	41.59	11.68
18.01	28.08	-15.55
9.55	24.57	-5.12
-23.86	12.66	-46.12
-44.84	16.55	6.21
41.65	17.53	-2.67
-8.19	3.65	42.56
9.8	10.68	21.69
-33.7	-8.33	55.01
53.76	-9.44	32.91
-27.68	-2.46	6.49
24.62	-3.89	-2.91
3.32	-2.11	8.34
50.38	-22.26	5.03
53.82	-26.44	33.22
-43.22	-24.88	62.08
25.33	-29.45	79.52
66.36	-36.94	-7.31
-39.35	-38.91	4.11
-40.01	-41.32	55.62
-59.37	-51.53	35.51
35.84	-56.44	45.98
-20.48	-42.65	-45.98
45.88	-58.66	-38.71
2.15	-57.01	-27.19
-41.69	-67.47	-34.73
-11.17	-70.9	42.15
12.33	-78.59	36.95
-2.8	-6.81	44.49
-15.24	-40.26	80.89
-.51	-49.17	46.9
-40.2	-82.82	14.49
-5.8	-89.27	38.06
12.4	-91.02	41.34
-12.45	-100.6	2.28

// Cohen J D, 1994: Memory - Control
// Subjects=12
19.26	55.23	18.96
-29.9	42.88	14.98
34.22	47.66	16.08
-37.41	36.95	7.76
42.71	43.86	7.38
-2.17	43.5	6.81
4.32	25.74	10.45
-24.77	28.62	-18.45
28.61	43.75	-20.33

// Cohen J D, 1997: Load
// Cohen J D, 1997: Time
// Cohen J D, 1997: Load x Time
// Subjects=10
40.74	37.81	25.75
8.75	35.05	34.16
-42.63	10.74	13.36
49.33	17.43	22.9
-36	6.49	40.41
35.73	12.69	59.14
14.58	-58.72	59.79
-41.15	-46.42	44.91
48.67	-53.02	47.77
1.39	9.88	39.7
-29.97	19.04	-4.21
35.22	24.98	-2.11
-35.81	-10.21	58.54
-46.44	-20.67	61.77
69.7	-26.83	12.99
-19.79	-66.26	34.06
-8.76	68.07	-5.21
8.83	-61.89	5.48
-38.25	-62.77	-1.71
-44.69	11.58	24.47
1.37	21.77	42.04
50.59	10.6	44.65
-26.23	1.57	58.55
34.65	4.94	55.34
-46.65	0.25	43.29
-28.34	-38.85	45.24
41.11	-41.78	42.46

// Curtis V A, 1999: Schizophrenic Subjects
// Subjects=5
4.75	-64.26	30.26
41.86	-75.84	-12.69
-32.85	-87.4	-4.17
32.28	-70.09	-6.37
-13.64	-94.14	-10.51
1.52	5.71	54.54
-48.15	15.51	-7.05
-41.34	19.66	46.06
56.81	-33.05	2.51
-51.19	20.54	17.1
-47.83	18.85	36.16
-47.73	4.47	42.94
-48.1	27.02	4.26
-39.09	-6.59	50.46
-11.25	-72.81	31.16
25.99	-92.97	1.2
7.66	-85.99	-17.02
1.63	-51.28	47.05
-39.21	-74.87	7.12
-16.83	-85.19	-4.54
22.79	-80.84	6.91
-32.76	-86.46	8.02
16.45	-88.91	13.24
29.31	-85.15	19.46
47.15	-61	-13.99
-39.43	-56.23	-13.4
4.76	9.41	60.88
-47.84	-66.97	-.13
-29.73	-76.26	-11.83
-44.49	8.18	49.29
-16.83	-85.19	-4.54
22.79	-80.84	6.91
1.66	-44.42	53.17
7.88	-58.41	23.04
16.45	-88.91	13.24
-47.75	10.82	42.41
-48.1	16.02	-.4
-29.73	-76.26	-11.83
35.4	-61.07	-13.85
-39.43	-56.23	-13.4
4.7	12.07	53.97
29.35	-82.6	24.83

// Curtis V A, 1999: Normal Subjects
// Subjects=5
-13.57	-86.86	1.14
16.45	-88.91	13.24
-1.66	-64.3	30.34
22.74	-81.35	0.26
4.9	-53.92	53.93
-57.43	-23.91	20.9
47.24	-72.12	-6.37
-19.67	-68.32	48.73
1.54	-36.9	40.27
-36.22	-56.21	-13.44
-47.8	12.5	36.7
38.6	-61.05	-13.89
-51.14	21.06	23.75
50.7	-63.98	29.71
47.57	-47.83	46.24
53.52	17.66	11.68
57.02	11.96	47.8
11.14	-20.55	44.37
-16.83	-85.19	-4.54
22.79	-80.84	6.91
-32.76	-86.46	8.02
16.45	-88.91	13.24
29.31	-85.15	19.46
47.15	-61	-13.99
-39.43	-56.23	-13.4
4.76	9.41	60.88
-47.84	-66.97	-.13
-29.73	-76.26	-11.83
-44.49	8.18	49.29
-16.83	-85.19	-4.54
22.79	-80.84	6.91
1.66	-44.42	53.17
7.88	-58.41	23.04
16.45	-88.91	13.24
-47.75	10.82	42.41
-48.1	16.02	-.4
-29.73	-76.26	-11.83
35.4	-61.07	-13.85
-39.43	-56.23	-13.4
4.7	12.07	53.97
29.35	-82.6	24.83

// D'Esposito M, 1998: Verbal Task, AA
// D'Esposito M, 1998: Spatial Task, AA
// D'Esposito M, 1998: Verbal Task, CA
// D'Esposito M, 1998: Spatial Task, CA
// D'Esposito M, 1998: Verbal Task, KH
// D'Esposito M, 1998: Spatial Task, KH
// D'Esposito M, 1998: Verbal Task, AM
// D'Esposito M, 1998: Spatial Task, AM
// D'Esposito M, 1998: Verbal Task, CM
// D'Esposito M, 1998: Spatial Task, CM
// D'Esposito M, 1998: Verbal Task, HT
// D'Esposito M, 1998: Spatial Task, HT
// D'Esposito M, 1998: Verbal Task, RK
// D'Esposito M, 1998: Spatial Task, RK
// D'Esposito M, 1998: Verbal Task, DB
// D'Esposito M, 1998: Spatial Task, DB
// Subjects=8
-31.09	38.49	25.75
42.16	50.27	9.89
-40.69	17.5	31.35
41.9	51.59	-10.4
33.27	52.73	-9.25
41.2	31.43	15.13
41.16	39.94	14.29
-31.12	42.64	24.22
-32.01	34.21	37.4
-40.62	14.72	36.11
36.81	44.08	12.84
-20.54	45.38	6.96
36.73	44.52	6.07
-25.77	53.19	21.97
39.09	58.09	24.86
43.5	54.37	30.75
-25.7	35.11	23.75
37.13	17.98	32.22
-25.77	34.59	18.2
16.37	54.51	22.24
-36.73	46.49	8.25
33.64	45.65	18.34
-32.35	49.15	13.51
36.88	45.66	18.28

// Schlosser R, 1998: Females
// Subjects=6
-52	30	12
-48	8	26
-48	14	20
-4	14	56
-50	-30	44
-42	-34	42
38	24	-8
-24	-56	52
24	-70	-24
22	-62	-22
32	-56	-26
4	-54	48
-8	-44	44
-10	-36	50
-50	-64	36
-44	-50	28
-44	-58	30
54	-60	34
58	-52	24
46	-48	26
64	-4	-24
54	-14	-20
64	2	-30

// Schlosser R, 1998: Males
// Subjects=6
-48	14	26
-46	28	20
-6	18	50
-24	-66	58
-24	-58	54
-28	-48	54
38	-56	-38
48	-64	-34
34	-76	-50
66	-16	12
66	-16	24
64	-18	32
-6	-46	46
-4	-38	48
-2	-48	38
-54	-56	24
-56	-54	36
-68	-32	30

// Honey G D, 1999: Schizophrenic Patients
// Subjects=20
-39	-45.18	47.01
39.03	-59.94	41.77
50.52	9.92	35.78
53.66	12.6	28.83
-57.7	22.74	4.73
56.61	20.88	-2.01
1.5	-1.06	49.53
-35.96	1.37	43.07
-26.27	-6.52	50.31
-32.95	-73.11	-12.06
-5.16	-76.12	-12.12
50.46	12.58	28.87
7.76	24.9	40.59
26.26	-62.76	47.73
-26.12	-59.9	48.09

// Honey G D, 1999: Normals
// Subjects=10
-39.01	-51.95	42
35.83	-63.13	42.08
-44.58	7.23	37.1
38.43	49.2	8.09
-36.32	21.81	4.56
-1.76	13.72	48.33
-44.54	7.66	42.64
-41.21	-9.78	50.76
19.43	-79.14	-12.15
-33	-71.42	-17.77
35.73	-.43	54.66
-41.5	-73.16	-11.95

// Maldjian J A, 1999: Motor Ball Squeezing vs. Rest
// Maldjian J A, 1999: Digit 1 vs. Rest
// Maldjian J A, 1999: Digit 2 vs. Rest
// Maldjian J A, 1999: Digit 3 vs. Rest
// Maldjian J A, 1999: Digit 4 vs. Rest
// Maldjian J A, 1999: Digit 5 vs. Rest
// Subjects=5
44	-24	48
36	-38	51
54	-14	36
50	-18	42
40	-24	48
44	-26	45
30	-40	48
48	-24	42
36	-36	54

// Celsis P, 1999: Standard Tone vs. Rest
// Celsis P, 1999: Deviant Tone 1 vs. Rest
// Celsis P, 1999: Deviant Tone 1 vs. Standard Tone
// Celsis P, 1999: Deviant Tone 2 vs. Rest
// Celsis P, 1999: Deviant Tone 2 vs. Standard Tone
// Celsis P, 1999: Standard Syllable vs. Rest
// Celsis P, 1999: Deviant Syllable vs. Rest
// Celsis P, 1999: Deviant Syllable vs. Standard Syllable
// Subjects=6
48	-22	10
-48	-28	10
50	-18	5
-50	-42	15
-48	-46	15
50	-22	5
-52	-40	15
48	8	5
-44	-52	15
46	2	15
-50	-24	5
50	-20	5
-50	-40	15
-46	-28	5
46	-22	5
-50	-40	15
-30	-52	30

// Griffiths T D, 1998: Add vs. Cancel
// Subjects=3
26	-72	60
32	-42	50
66	-26	26
-52	-38	32
-20	-48	76
-44	-32	62
58	8	46
34	24	-8
-36	0	58
-54	4	44
-38	8	22
-22	2	68
-4	10	50
28	-46	-36
-26	-64	-18
4	-78	-18

// Konishi S, 1998: Three Dimensional - (Two + One Dimensional)
// Subjects=7
42.88	19.16	18.37
-41.56	21.83	19.11
42.14	-30.14	41.47
-46.47	-33.07	52.77
-1.94	30.58	32.42

// Becerra L R, 1999: Normals - Group 1
// Subjects=6
14.17	31.54	43.31
4.54	-33.48	15.42
1.07	45.01	12.22
34.3	2.39	8.72
40.31	-5.11	-47.6
7.28	8.92	-28.32
43.45	44.84	-35.09
23.09	61.63	-36.27
7.47	-49.49	-26.77
62.97	-2.66	-17.95
44.19	-35.39	28.5
4.35	-72.77	-24.78
16.99	-64.72	-45.67
3.67	56.29	-62.36
20.57	-60.85	4.14
-26.05	-19.74	-65.68
7.76	31.5	43.39
7.37	47.19	-1.42
10.95	-46.64	9.76
34.28	2.14	5.4
37.31	-12.84	-23.49
10.53	17.12	-19.01
70.17	4.33	-52.08
50.23	-53.46	-26.93
26.24	63.25	-43.13
17.5	5.38	48.81
17.14	-69.78	-28.52
33.98	46.32	-15.03
-29.26	9.82	-54.74

// Becerra L R, 1999: Normals - Group 2
// Subjects=6
34.42	34.31	36.15
10.64	44.55	5.46
14.15	-30.25	15.03
43.92	2.45	8.6
30.76	2.21	-34.72
7.28	8.92	-28.32
63.73	24.9	-47.03
34.24	-63.08	-25.94
26.31	44.22	-41.53
62.99	-9.01	-17.42
-2.14	-57.21	-29.36
33.98	46.32	-15.03
-15.32	-30.25	-64.92

// Thompson-Schill S L, 1999: Living:  Visual - Baseline
// Thompson-Schill S L, 1999: Living:  Non-Visual - Baseline
// Thompson-Schill S L, 1999: Non-Living:  Visual - Baseline
// Thompson-Schill S L, 1999: Non-Living:  Non-Visual - Baseline
// Subjects=5
-42.62	-56.08	-11.14
45.06	-34.18	2.74
-35.36	20.7	-9.86
-42.44	-.41	34.37
-10.34	4.61	41.39
-46.9	-47.39	-8.48
-35.35	16.47	-9.5
-42.62	-56.08	-11.14
53.59	-29.9	2.28
-31.09	20.72	-9.91
-39.23	-.39	34.33
-51.14	-47.07	-3.99
57.87	-29.87	2.23
-31.06	21.07	-5.48
-39.2	-0.05	38.76
13.1	8.38	33

// Corbetta M, 1998: Attention vs. Fixation
// Corbetta M, 1998: Eye Movement vs. Fixation
// Corbetta M, 1998: Attention vs. Eye Movement
// Corbetta M, 1998: Eye Movement vs. Attention
// Subjects=6
28.49	-56.26	62.77
-25.01	-52.87	56.41
19.95	-62.83	61.19
-18.48	-60.43	68.12
30.46	-75.57	33.15
-25.16	-76.41	27.16
45.3	-2.03	46.88
-35.91	-4.63	48.03
38.73	2.9	28.7
32.58	3.32	62.19
-27.34	-8.81	48.28
-3.78	5.05	60.23
13.44	-4.57	71.99
-36.18	32.06	27.11
49.33	35.03	30.34
62.16	6.59	19.2
45.13	-43.35	7.97
47.36	-68.72	10.07
30.36	-89.8	14.27
45.22	-77.53	6.38
32.29	-85.32	-10.67
39.15	-54.25	60.25
-22.8	-56.57	63.39
15.73	-60.05	69.93
-5.68	-76.01	58.13
28.35	-79.64	35.74
-23.03	-83.09	23.24
45.3	-2.03	46.88
-38.05	-2.53	47.88
38.73	2.9	28.7
32.58	3.32	62.19
-29.48	-8.82	48.31
-3.8	4.88	58.02
-38.33	34.17	26.96
57.9	26.45	28.74
55.5	12.78	-10.24
51.54	-38.91	9.76
47.42	-70.32	16.9
-46.63	-73.17	15.99
32.43	-86.07	7.24
13.15	-93.21	-.86
-10.35	-82.27	5.18
0.27	-100.49	-11.26
19.57	-104.09	-4.48
34.34	-81.77	-19.91
-23.34	-86.34	-18.86
45.01	-75.36	-20.57
-44.66	-83.67	-9.92
15.17	-87.88	-14.71
-10.48	-101.24	-19.99
41.21	-41.9	54.73
17.82	-64.96	61.4
32.6	-75.55	33.12
38.88	0.05	46.78
49.5	-.58	37.79
32.53	0.69	55.72
0.43	8.79	53.18
4.84	-5.13	65.45
36.37	48.9	18.18
51.45	8.47	16.94
38.54	11.94	7.87
-32.04	21.92	5.61
64.37	-49.75	6.06
47.34	-68.89	7.86
17.55	-98.5	12.91
-22.99	-98.06	22.26
42.98	-91.78	-12.48
38.56	-71.34	-23.06
-36.38	-51.32	-32.8
-12.09	-73.77	60.25
-42.33	-79.49	16.47
-23.08	-88	14.73
4.77	-87.15	23.26
-14.44	-93.61	24.02
-3.62	-92.18	41.62
6.81	-96.97	6.22
-10.35	-82.27	5.18
-6.11	-95.79	-4.89
19.57	-104.09	-4.48
25.95	-95.59	-5.27
-23.32	-83.88	-14.61
-16.84	-102.88	-13.09

// Culham J C, 1998: Attentive Tracking vs. Passive Viewing
// Subjects=21
-48.23	-77.05	0.38
-38.64	-85.56	7.79
-29.03	-59.81	57.82
-31.66	-80.54	28.03
-16.78	-66.51	78.76
-44.25	-36.12	48.98
-26.92	-5.85	63.09
-56.23	4.61	35.89
-4.86	6.8	59.54
48.57	-69.77	0.45
40.82	-82.74	15.12
58.37	-34	38.26
21.53	-65.09	57.91
26.2	-84.64	31.84
12.16	-59.39	85.75
41.7	-36.81	51.62
27.13	-4.7	59.47
49.69	1.31	35.96
8.83	5.93	60.91

// Gitelman D R, 1999: Posner Task vs. Baseline
// Subjects=12
-21	-60	51
27	-60	57
-6	-60	57
3	-54	57
-27	-6	42
51	0	36
-33	27	-9
36	27	-6
-3	9	45
3	18	39
0	24	24
63	-39	12
-45	-69	-6
51	-60	-6
-33	-87	-3
48	-69	-24

// Kimmig H, 1999: Saccades vs. Fixation
// Kimmig H, 1999: Pursuit vs. Fixation
// Kimmig H, 1999: Saccades and Pursuit
// Subjects=6
53.46	8.49	41.78
52.11	1.43	44.28
46.28	-74.35	6.1
33.49	3.9	42.06

// LaBar K S, 1999: Working Memory and Spatial Attention
// LaBar K S, 1999: Working Memory
// LaBar K S, 1999: Spatial Attention
// Subjects=11
24	-60	60
45	-45	51
-21	-60	48
-42	-48	45
54	12	30
-54	15	27
-42	3	33
0	12	45
-27	-3	45
36	6	48
51	3	42
-12	-9	15
-9	-3	9
15	-3	15
-30	-66	-39
-39	-57	-39
48	-57	-33
36	-66	-36
36	-75	-36
3	-51	-24
-48	-63	-6
-45	-54	-12
-60	-42	6
-54	-57	-6
42	21	-6
-54	15	-6
33	15	48
30	6	54
-27	9	54
-21	18	54
-39	15	27
3	-63	45
45	-60	33
39	-60	-45
-48	-72	3
57	-54	3
54	-66	3
-30	-87	0
-42	-78	3
-24	-63	-3
33	-84	12
42	-81	0

// Ramsey N F, 1996: Subject 1
// Subjects=1
-34.54	-13.86	55.26
-30.42	-16.26	62.33
-36.15	-15.49	53.52
-33.62	-20.68	60.5

// Ramsey N F, 1996: Subject 2
// Subjects=1
-34.54	-13.86	55.26
-40.13	-15.06	51.19
-36.15	-15.49	53.52
-43.34	-18.51	48.17

// Ramsey N F, 1996: Subject 3
// Subjects=1
-34.54	-13.86	55.26
-36.91	-5.1	55.89
-36.15	-15.49	53.52
-35.81	-14.61	56.67

// Ramsey N F, 1996: Subject 4
// Subjects=1
-34.54	-13.86	55.26
-30.55	-14.37	45.44
-36.15	-15.49	53.52
-34.81	-7.63	50.5

// Ramsey N F, 1996: Subject 5
// Subjects=1
-34.54	-13.86	55.26
-31.54	-11.32	57.46
-36.15	-15.49	53.52
-41.21	-10.84	50.84

// Ramsey N F, 1996: Subject 6
// Subjects=1
-34.54	-13.86	55.26
-38.98	-14.28	61.14
-36.15	-15.49	53.52
-41.21	-10.84	50.84

// Ramsey N F, 1996: Subject 7
// Subjects=1
-34.54	-13.86	55.26
-35.86	-21.72	47.23
-36.15	-15.49	53.52
-34.79	-26.12	45.36

// Ramsey N F, 1996: Subject 8
// Subjects=1
-34.54	-13.86	55.26
-33.68	-17.94	54.7
-36.15	-15.49	53.52
-30.46	-18.89	55.86

// Ramsey N F, 1996: Subject 9
// Subjects=1
-34.54	-13.86	55.26
-33.67	-9.05	59.53
-36.15	-15.49	53.52
-30.43	-12.03	61.97

// Sunaert S, 1999: Motion (UNI) - Stationary (STA)
// Subjects=13
-42	-66	2
-24	-84	10
-34	-80	4
-20	-80	-8
-30	-44	52
-26	-76	26
-40	-64	-12
-28	-6	56
42	-62	6
22	-90	10
28	-86	2
14	-76	-10
28	-6	60

// Berman R A, 1999: Visual Pursuit Tracking and Visually Guided Saccades
// Subjects=11
-36.26	-4.59	58.29
-32.21	-4.72	56.25
-50.51	2.9	42.1
-51.78	1.01	42.61
-3.41	-4.75	62.84
-3.92	-5.28	65.67
-4.66	-61.12	57.99
-5.48	-64.57	61.63
-30.32	-54.82	59.09
-31.12	-50.11	54.02
-2.46	10.47	39.36
-3.94	13.39	42.92
-10.47	-17.75	42.71
-11.32	-21.73	42.16
42.03	-1.87	53.37
39.36	-.56	54.07
55.13	4.41	35.75
54.92	3.47	35.94
6.64	-2.81	63.67
6.06	-1	59.62
12.75	-65.11	55.67
10.64	-65.95	58.77
30.8	-53.33	59.16
25.78	-56.92	57.28
8.1	11.54	37.14
8.81	19.43	35.24
12.62	-18.8	43.53
12.33	-23	45.67

// Garavan H, 1999: Response Inhibition
// Subjects=14
45.79	43.65	-9.37
39.73	28.55	29.88
37.67	10.64	32.52
44.93	41.38	16.48
36.29	19.53	-3.89
39.49	9.6	-8.67
2.43	21.69	40.92
44.13	-82.11	2.31
35.81	-74.39	34.1
36.88	-58.98	40.6
-45.46	-36.93	44.16
52.87	-43.91	41.39
45.48	-51.81	49.94
-44.73	-66.84	-12.45

// Konishi S, 1998: Go Dominant Foci
// Konishi S, 1998: No-Go Dominant Foci
// Subjects=5
46.83	64.17	-5.53
7.73	14.69	32.53
12.76	37.88	1.53
56.89	15.07	33.05
-31.94	16.34	16.12
-2.18	62.08	13.06
-11.56	13.98	25
-40.43	16.89	23.98
-45.74	22.75	31.35
-46.95	23.48	13.46
52.48	16.85	15.11
55.64	24.1	12.23
50.37	23.78	22.35
47.03	36.65	10.16
39.57	34.58	11.54
47.16	24.73	21.2
45	30.01	20.78
39.61	24	12.42
4.3	34.28	10.85
28.85	38.57	9.09
13.79	46.26	-.3
4.26	42.65	9.03
44.82	38.07	1.15
57.7	28.8	4.01
7.45	29.38	2.3
17.12	33.21	9.68
39.5	32.75	1.65
-53.21	21.73	32.64
-2.09	44.36	17.89

// Luna B, 1998: Saccades vs. Fixation, Average Individual Subject Data
// Luna B, 1998: Saccades vs. Fixation, Group Average Data
// Subjects=10
-30.77	0.85	50.97
-44.14	12.09	40.7
-.91	4.81	58.32
-18.85	-57.27	63.63
-3.31	-59.27	54.25
-40.91	-43.49	48.34
38.03	1.81	47.65
6.39	12.41	37.53
6.45	6.58	57.09
24.21	-58.57	60.79
7.51	-56.38	59.01
46.93	-41.89	48.76
-25.15	-7.14	55.93
-54.18	4	37.48
1.52	5.79	55.65
-24.98	-54.81	58.81
-6.83	-83.39	45.38
-31.56	-38.96	44.17
42.17	-3.39	57.07
52.71	10.53	43.51
1.47	5.28	49
27.41	-65.16	57.96
13.55	-52.84	67.12
55.05	-38.98	49.87

// Petit L, 1999: Normal Subject 1
// Subjects=1
-33	-24	51
44	-7	45
-31	-61	44
38	-58	42
2	-18	56
-2	-78	40
-37	-77	-3
35	-83	1
-34	-17	47
36	-15	47
-30	-58	40
35	-56	39
0	-13	53
2	-70	45
-41	-69	8
41	-72	2
-37	-18	43
44	-7	43
-30	-62	45
28	-69	39
-1	-16	57
3	-80	39
-39	-73	2
44	-71	0
-35	-18	46
36	-10	47
-30	-58	45
37	-55	41
1	-8	55
0	-70	46
-43	-67	5
45	-63	2

// Petit L, 1999: Normal Subject 2
// Subjects=1
-42	-19	37
49	-13	43
-36	-71	36
37	-54	41
-2	-19	57
3	-75	40
-41	-73	3
53	-63	0
-29	-21	45
35	-15	45
-26	-58	42
35	-57	37
2	-5	52
1	-66	40
-41	-63	4
47	-63	2
-37	-18	43
44	-7	43
-30	-62	45
28	-69	39
-1	-16	57
3	-80	39
-39	-73	2
44	-71	0
-35	-18	46
36	-10	47
-30	-58	45
37	-55	41
1	-8	55
0	-70	46
-43	-67	5
45	-63	2

// Petit L, 1999: Normal Subject 3
// Subjects=1
-37	-15	40
39	-5	39
-27	-54	49
26	-68	39
0	-7	56
2	-79	39
-39	-75	3
37	-68	0
-37	-11	46
40	-6	48
-34	-57	47
47	-42	46
-1	-4	54
-2	-65	54
-45	-69	3
42	-57	3
-37	-18	43
44	-7	43
-30	-62	45
28	-69	39
-1	-16	57
3	-80	39
-39	-73	2
44	-71	0
-35	-18	46
36	-10	47
-30	-58	45
37	-55	41
1	-8	55
0	-70	46
-43	-67	5
45	-63	2

// Petit L, 1999: Normal Subject 4
// Subjects=1
17	-89	34
-9	-20	59
12	-86	36
-39	-72	4
50	-70	-3
-38	-24	47
43	-11	43
-24	-68	49
39	-58	41
3	-8	56
-2	-74	44
-43	-67	3
51	-65	2
-37	-18	43
44	-7	43
-30	-62	45
28	-69	39
-1	-16	57
3	-80	39
-39	-73	2
44	-71	0
-35	-18	46
36	-10	47
-30	-58	45
37	-55	41
1	-8	55
0	-70	46
-43	-67	5
45	-63	2

// Petit L, 1999: Normal Subject 5
// Subjects=1
-37	-14	45
44	-4	46
-28	-59	52
24	-77	38
2	-15	58
-41	-68	5
46	-72	0
0	-83	39
-36	-17	48
28	-6	52
-34	-48	49
28	-62	44
1	-10	59
2	-75	45
-47	-65	6
46	-61	2
-37	-18	43
44	-7	43
-30	-62	45
28	-69	39
-1	-16	57
3	-80	39
-39	-73	2
44	-71	0
-35	-18	46
36	-10	47
-30	-58	45
37	-55	41
1	-8	55
0	-70	46
-43	-67	5
45	-63	2

// Uchida I, 1999: Subject 1
// Subjects=1
-38.2	-78.8	-2.6

// Uchida I, 1999: Subject 2
// Subjects=1
-17.81	-89.8	4.78
-45.66	-82.99	-1.04
-29.47	-81.27	19.81
45.2	-82.1	2.3

// Uchida I, 1999: Subject 3
// Subjects=1
-20.07	-92.15	-11.72
31.23	-91.85	-12.34
-38.18	-85.15	-2.06
-25.18	-83.19	22.16
-32.59	-82.55	31.11
26.1	-83.05	19.33
21.95	-81.79	36

// Uchida I, 1999: Subject 4
// Subjects=1
-27.59	-86.03	-14.38

// Uchida I, 1999: Subject 5
// Subjects=1
-39.24	-85.07	-.94
35.69	-76.65	18.68
-54.15	-58.24	17.05

// Uchida I, 1999: Subject 6
// Subjects=1
-42.4	-78.06	7.43
28.3	-75.75	30.96

// Chochon F, 1999: All Conditions vs. Control
// Chochon F, 1999: Digit Naming vs. Control
// Chochon F, 1999: Comparison vs. Control
// Chochon F, 1999: Multiplication vs. Control
// Chochon F, 1999: Subtraction vs. Control
// Chochon F, 1999: Comparison vs. Digit Naming
// Chochon F, 1999: Multiplication vs. Digit Naming
// Chochon F, 1999: Multiplication vs. Comparison
// Chochon F, 1999: Subtraction vs. Digit Naming
// Chochon F, 1999: Subtraction vs. Comparison
// Chochon F, 1999: Subtraction vs. Multiplication
// Subjects=8
42	-30	45
42	-39	39
39	-42	42
33	-48	45
-45	-42	39
-39	-54	48
-27	66	42
24	9	48
42	45	18
36	27	-6
-30	-6	51
-36	27	3
-42	-3	51
-12	18	36
51	3	36
12	33	30
42	-30	45
39	-42	42
33	-48	45
-45	-42	39
-39	-54	48
-27	66	42
36	27	-6
51	3	36
22	18	-4
-36	27	3
-42	-3	51
12	33	30
-12	18	36
42	-30	45
39	-42	42
33	-48	45
-45	-42	39
-39	-54	48
-27	66	42
24	9	48
42	45	18
36	27	-6
-30	-6	51
-36	27	3
-12	18	36
42	-30	45
42	-39	39
39	-42	42
33	-48	45
-45	-42	39
-39	-54	48
-27	66	42
24	9	48
42	45	18
36	27	-6
-30	-6	51
-36	27	3
-42	-3	51
-12	18	36
42	-24	45
-51	3	39
-30	-72	33
-45	-36	36
48	-30	48
-30	-69	39
-27	-60	42
48	18	15
30	27	3
42	-30	45
-54	3	39
-48	33	21
42	42	21
-51	42	42
6	21	33
-39	24	3
-27	-9	48
27	-63	30
27	-39	33
6	21	33
-51	36	18
48	18	15
24	42	3
33	24	3
39	-42	42
-39	30	-3
42	42	18
-42	-48	48
-57	6	18
-54	6	39
48	15	30
39	-39	54
30	27	3
-42	6	27

// Dehaene S, 1999: Approximate Addition - Exact Addition
// Dehaene S, 1999: Exact Addition - Approximate Addition
// Subjects=7
44	-36	52
20	-60	60
-56	-44	52
-32	-68	56
4	-60	52
-56	12	24
48	16	20
-44	64	12
-32	8	64
-48	-48	-28
12	-16	16
-20	-8	16
-32	64	4
-8	-56	20
20	-80	28
40	-76	20
-44	-72	36
48	-16	8
-8	60	16

// Georgiewa P, 1999: Dyslexics
// Subjects=17
-47	2	0
-7	-79	0
-45	11	0
-23	23	0
34	-40	10
13	-38	0
-45	-2	0
38	-34	10
-43	-11	10
-20	-20	10
-7	-79	0
-7	-93	0
16	-93	0
-45	-9	0
-13	-79	0
-34	18	0
-7	-79	0
-7	-92	0
-18	2	-10
-36	9	10
-20	-20	10
25	-22	-10

// Georgiewa P, 1999: Controls
// Subjects=17
-47	13	10
-23	23	10
36	9	10
29	-47	10
32	-77	0
-45	-2	0
38	-34	10
-43	-11	10
-20	-20	10
25	-43	10
-45	-9	0
-13	-79	0
-47	13	10
-20	2	10
-34	-59	0
34	13	10
2	-81	10
31	-84	0
-36	9	10
-20	-20	10
25	-22	-10

// Petit L, 1996: SEQ - Rest
// Petit L, 1996: SAC - Rest
// Petit L, 1996: SEQ - SAC
// Subjects=5
10.37	15.4	51.98
-4.85	10.26	43.79
-45.92	-.94	41.11
44.83	-.62	39.53
23.35	-4.12	49.21
-15.34	-70.61	51.97
38.51	-41.06	43.64
6.23	-75.2	47.57
-35.62	10.67	3.93
-24.73	-10.57	5.85
29.27	9.18	7.45
-9.74	-79.36	-18.98
55.02	-62.12	-21.79
10.39	11.14	52.4
-2.68	8.14	43.96
-41.53	-17.94	42.72
42.79	-15.1	45.48
48.71	-3.93	3.94
-29.1	-13.12	1.69
29.23	4.51	3.43
20.64	-8.28	4.85
9.78	-67.83	-11.49
3.81	21.34	47.03
-24.21	2.1	49.41
21.14	10.77	47.78
-13.18	-70.6	51.93
34.19	-71.68	37.78
4.07	-75.21	47.61

// Omori M, 1999: Alternate vs. Rest AND Tie vs. Rest AND Win vs. Rest AND 
// Lose vs. Rest
// Omori M, 1999: Alternate vs. Rest AND Alternate vs. Tie AND Alternate vs. 
// Win AND Alternate vs. Lose
// Subjects=6
46	8	32
-2	-6	48
-46	0	28
-52	2	12
34	-6	48
-32	-24	48
20	-10	52
-14	22	4
-44	-38	40
-22	-64	40
36	-48	-16
-6	-92	-8
8	-72	-12
-44	-76	-4
24	-82	0
-26	-78	-20
28	-66	-20
-10	-64	-20
-38	24	24
-42	8	28
38	12	32
-4	-68	40
24	-66	40
-28	-78	-16
-24	-60	-12
-14	-78	-16
-30	-78	12
-38	-76	8
26	-76	20
-22	-80	28

// Kim Y H, 1999: Spatial Priming > Control
// Kim Y H, 1999: Central Expectancy > Control
// Kim Y H, 1999: Spatial Priming and Central Expectancy
// Kim Y H, 1999: Central Expectancy > Spatial Priming
// Subjects=10
0	6	48
45	-3	51
-39	-6	51
27	-48	42
-30	-45	39
60	-39	12
-45	-60	-9
54	12	-3
-36	18	9
12	21	30
0	-24	24
39	42	24
-42	-18	51
15	-6	12
-12	-18	12
27	6	-6
-27	3	-3
27	-57	-24
-21	-66	-21
0	6	51
42	-3	54
-42	0	54
33	-51	60
-39	-45	57
63	-42	12
-54	-51	6
48	21	-6
-39	15	3
12	21	30
0	-18	24
36	42	24
-42	-15	54
9	-18	9
-6	-18	9
27	6	-6
-27	6	0
27	-51	-27
-36	-63	-27
0	6	48
42	-3	54
-42	3	33
33	-54	51
-30	-48	45
60	-39	12
-51	-51	12
42	24	-6
-45	-3	3
12	21	30
3	-24	24
39	42	24
-42	-12	54
12	-15	6
-6	-18	9
27	6	-6
-27	3	0
27	-54	-24
-39	-60	-27
-39	-45	57
54	-54	3
-54	-51	6

// Konishi S, 1999: No-Go Dominant Area
// Subjects=6
44.98	19.98	14.93

// Mottaghy F M, 1999: Encoding - Reference I
// Mottaghy F M, 1999: Recall - Reference II
// Mottaghy F M, 1999: Encoding - Reference I vs. Recall - Reference II
// Mottaghy F M, 1999: Recall - Reference II vs. Encoding - Reference I
// Subjects=6
-12	-76	52
4	-68	48
-32	-36	-24
28	-72	-16
8	32	28
-32	32	44
-40	8	48
-52	28	32
44	36	28
40	20	44
-28	-36	-16
20	-76	32
-8	-72	52
4	-76	48
8	40	16
-56	24	20
-52	36	24
-48	24	-12
36	4	32
-36	-72	28
44	-48	28
-48	-6	-32
12	-44	-12
-32	32	44
-16	36	28
64	-4	20
-28	-36	-16
-48	-56	-16
-28	-20	-16
-24	-68	36
-36	-72	28
20	-76	32
28	-64	28
-4	8	56
44	20	16

// Wildgruber D, 1996: Syllable Singing vs. Rest
// Subjects=10
66.34	9.68	33.67
-33.7	-74.31	-32.52

// Poldrack R A, 1998: Mirror Reversed Increases, Pre-Training
// Poldrack R A, 1998: Mirror Reversed Decreases, Pre-Training
// Poldrack R A, 1998: Skill-Related Increases
// Poldrack R A, 1998: Skill-Related Decreases
// Poldrack R A, 1998: Item-Specific Increases
// Poldrack R A, 1998: Item-Specific Decreases
// Subjects=6
12.17	-73.62	18.69
-22.96	-80.12	34.14
27.33	-71.47	45.1
-24.44	-67.94	-14.82
21.58	-75.7	-9.12
-34.17	-78	-33.94
25.65	-77.82	-36.87
-5.16	-58.6	-5.79
16.24	-24.06	12.26
-7.3	-24.55	8.11
-3.85	-90.09	13.57
5.89	-97.63	25.24
-57.31	-65.49	19.93
-.51	-72.24	37.68
-4.62	-53.03	66.23
25.32	-36.13	75.62
-54.27	-33.12	11.6
71.87	-31.93	15.63
1.69	-71.54	46.52
-1.4	-70.44	60.96
37.39	-69.11	-35.5
-44.67	-58.58	-1.99
71.86	-30.96	14.43
-2.89	-91.28	-1.96
-39.05	-98.42	19.13
-18.68	-97.69	26.64
-45.62	-91.36	0.77
-48.66	-80.87	26.69
28.34	-97.33	27.19
49.53	-90.28	6.28
30.03	-84.42	-26.33
35.17	-52.47	-40.22
34.83	-53.65	54.68
51.89	-62.78	45.21
63.1	-43.1	-17.91
51.44	-58.6	-10.9
13.97	-34.25	-9.16
-43.23	-79.89	38.82
-.55	-72.66	32.14
55.01	-72.42	30.37
2.73	-63.07	45.8
10.41	-52.17	76.02
-70.47	-35.01	-11.47
71.63	-25.62	-12.78
-23.11	-99.26	6.75
20.59	-82.59	-1.84
-33.65	-89.07	29.44
-15.58	-89.9	17.03
-39.94	-53.76	60
21.9	-20.78	54.3
33.66	-63.49	37.67
-39.02	-46.58	42.66
2.23	-68.21	-20.68
28	-75.66	-9.2
27.86	-68.32	-24.31
44.91	-68.64	-30.05
-24.51	-68.72	-24.79
-31.89	-58.93	-7.68
-28.62	-58.23	1.14
-9.41	-24.3	11.46

// Poldrack R A, 1999: Weather Prediction > Baseline, Activations
// Poldrack R A, 1999: Weather Prediction > Baseline, Deactivations
// Poldrack R A, 1999: Learning Related Decreases in Activation
// Poldrack R A, 1999: Learning Related Increases in Activation
// Subjects=8
-2	28	36
50	26	16
40	10	36
-54	24	24
-46	4	40
-44	4	28
-36	60	-8
-36	54	4
-44	-76	-12
32	-74	-12
4	-68	28
-40	-48	32
-50	-36	36
6	2	0
4	-22	20
-10	-50	28
2	-6	40
-10	46	-16
-26	-18	-20
-24	-10	-16
-68	-6	-16
54	-62	20
50	-70	16
-60	-64	20
-52	-68	24
2	60	8
-2	26	0
-18	32	-8
0	52	-12
10	46	-8
-32	54	-4
36	-80	-12
42	46	4
-48	-18	32
-70	20	12
50	-26	36
36	-6	-8
2	-26	24

// Paulesu E, 1997: Semantic Fluency > Rest
// Paulesu E, 1997: Phonemic Fluency > Rest
// Paulesu E, 1997: Phonemic Fluency > Semantic Fluency
// Paulesu E, 1997: Semantic Fluency > Phonemic Fluency
// Subjects=6
-37.73	28.51	11.17
-31.29	23.86	7.03
-11.5	-65.41	15.53
-3.04	-16.46	10.54
-37.73	28.51	11.17
-37.6	9.78	17.5
-29.17	21.33	2.77
-.89	-14.32	10.29
-3	-27.09	11.59
-37.6	9.78	17.5
-11.45	-62.87	19.76

// Stevens A A, 1998: Schizophrenic Patients
// Subjects=12
-55.17	1.88	19.72
-6.29	-2.42	64.35
-50.37	12.42	22.12
-49.05	27.46	5.9
9.97	-5.88	65.01
-39.1	33.22	-18.23
-28.38	4.28	58.02
-59.2	-22.66	13.79
63.81	-17.97	1.5
66.26	-23.18	12.39
-57.51	-13.5	1.29
65.3	-37.59	6.36
-56.72	-39.18	10.46
58.58	-17.73	-11.51
-57.63	-14.29	-14.47
20.49	-50.55	67.18
-14.57	-54.89	65.05
12.14	-35.34	58.09
-10.16	-35.72	62.05
37.07	-17.56	54.63
-30.65	-22.15	57.69
10.18	-2.05	66.25
-6.8	-4.46	66.98
35.66	2.1	59.92
-32.67	4.67	55.24
12.99	61.14	-1.87
-11.41	62	-5.01
6.44	45.93	-25.95
-6.07	46.49	-25.85
34.41	32.7	-20.59
-34.71	27.26	-20.01
64.57	-38.16	8.65
-58.67	-35.95	8.32
63.8	-23.93	12.48
-59.52	-23.19	13.84
61.96	-11.09	-.28
-56.16	-6.91	-1.73
14.49	-55.03	63.39
-8.06	-57.5	62.41
10.34	-34.79	59.96
-11.56	-35.79	61.29
32.51	-21.65	57.15
-31.08	-20.97	57.93

// Stevens A A, 1998: Normal Subjects
// Subjects=12
-52.06	3.52	21.44
-6.1	-2.24	61.21
-50.9	13.88	23.12
-48	27.16	3.24
9.3	-3.43	62.24
-38.88	35.75	-15.88
-39.74	0.13	52.14
-57.27	-23.81	13.87
61.11	-14.49	-.1
64.76	-21.18	12.24
-59.65	-11.71	1.28
60.48	-37.03	5.81
-56.6	-41	10.28
64.25	-17.28	-10.27
-61.97	-15.94	-10.61
17.06	-53.88	64.38
-11.15	-52.94	65.18
13.26	-36.65	63.09
-8.91	-33.84	58.76
42.16	-18.74	48.54
-41.75	-16.87	47.23
11.7	-9.37	66.51
-6.91	-7.02	65.52
33.93	6.16	58.93
-26.28	1.91	65.66
15.88	61.2	-1.24
-11.25	60.08	0.39
9.98	41.51	-25.62
-5.62	41.2	-25.41
35.38	28.41	-21.13
-34.28	30.8	-18.3
63.05	-36.77	6.21
-63.8	-35.75	7.36
63.06	-25.1	12.59
-60.81	-21.61	13.72
59.5	-14.15	-1
-56.86	-13.37	1.61
17.51	-53.32	67.45
-12.83	-52.07	69.7
9.37	-33.62	59.98
-6.54	-35.21	60.18
23.99	-24.19	60.92
-20.42	-26.64	66.21

// Dolan R J, 1996: Delayed Matching, All Faces vs. Control
// Dolan R J, 1996: Delayed Matching, Emotional vs. Non-Emotional
// Subjects=8
-46.7	23.86	-15.12
31.01	30.1	-21.54
-11.64	31.97	23.82
48.59	-46.42	-14.27
-53.09	28.92	-6.54
-11.64	31.97	23.82
48.58	-44.29	-14.48
9.89	-7.9	9.47

// Fink G R, 1997: Global vs. Local
// Fink G R, 1997: Local vs. Global
// Fink G R, 1997: Large vs. Small Stimuli
// Fink G R, 1997: Small vs. Large Stimuli
// Subjects=10
18.63	-77.19	2.73
-22.45	-101.56	-3.12
-.83	-90.43	-.11
18.84	-86.57	17.11
-26.82	-101.99	-7.48
31.57	-101.37	-4.06

// Smith C D, 1999: Object Naming vs. Baseline, Low-Risk AD > High-Risk AD
// Smith C D, 1999: Letter Fluency vs. Baseline, Low-Risk AD > High-Risk AD
// Subjects=12
27.98	-65.97	-7.78
-27.59	-65.25	-7.2
-45.82	-63.76	-13.81
-9.06	-41.57	49.71
7	-47.73	51.15
19.34	-57.02	-15.12
-20.16	-61.23	-10.97
-41.43	-67.99	-.12

// Buchel C, 1999: Unpaired Neutral Tone vs. Neutral Tone
// Buchel C, 1999: Time x Condition Interaction
// Subjects=11
0	27	18
24	6	-6
-18	9	-6
9	-12	3
-12	-15	6
48	12	-6
-54	12	-9
39	42	24
-39	42	27
66	-24	18
-57	-24	24
24	-3	-24
-21	-6	-24
33	-15	-24
-24	-15	-24

// LaBar K S, 1998: Early Acquisition
// LaBar K S, 1998: Late Acquisition
// LaBar K S, 1998: Early Extinction
// LaBar K S, 1998: Late Extinction
// Subjects=10
-.69	9.41	47.57
57.73	6.08	-.78
-14.02	-4.78	-24.69
26.78	6.32	5.13
-2.64	2.57	69.35
45.13	-.49	25.57
5.69	0.31	39.33
-23.15	0.3	41.9
-6.92	2.46	68.29
-44.91	-3.94	-11.03
-18.07	-2.41	6.38
4.63	0.38	40.45
-27.27	1.82	61.89
-17.16	-4.11	-15.79
51.65	0.67	39.89
-11.23	2.09	63.91
-19.03	-1.3	20.79
52.3	-3.61	-15.52
23	2.63	67.94

// Jancke L, 1998: Normals, Group 1
// Subjects=9
56	-20	4
-56	-44	12
56	-16	4
-56	-22	12
28	56	-4
36	20	-4
-44	12	16
24	40	4
-56	12	-4
-56	-20	4
-56	-20	12
56	-36	4
56	-24	12
36	20	-8
40	41	6
36	32	12
-36	56	4
-4	-60	-8
56	-20	-4
-56	-20	4
60	-36	8
56	-24	12
-56	-20	12
36	20	-8
-4	-60	-4
-36	60	4
36	32	12

// Jancke L, 1998: Normals, Group 2
// Subjects=5
-52	-28	16
-56	-24	12
64	-12	4
56	28	16
-44	-20	4
64	-24	8
60	-20	12
-56	-20	12
-40	24	0
56	32	16
-44	-20	6
56	-24	8
52	-16	12
-56	-20	12
-40	24	2
56	32	12

// Francis S T, 1999: Subjects, Experiment 1
// Subjects=4
-19.5	32.28	-26.62
-7.71	21.69	-26.99
-8.79	22.66	-28.17
20.04	24.86	-29.8
13.67	21.91	-26.14
38.26	22.14	-25.32
45.75	30.02	-20.49

// Francis S T, 1999: Subjects, Experiment 2
// Subjects=6
7.32	19.21	-19.15
-8.77	25.12	-23.92
49.19	4.97	-.59
-45.97	1.69	-7.03
46.84	5.02	-27.33
20.18	-8.89	-25.86
-3.32	21.78	-12.55
0.12	25.34	19.46

// Francis S T, 1999: Subjects, Experiment 3
// Subjects=4
23.29	30.77	-22.53
19.11	-8.9	-25.85
45.99	1.78	-.28
-46.94	-5.04	2.47
3.44	17.75	31.21
7.46	-3.45	-9.44
43.59	-3.17	-36.64

// Henson R N A, 1999: Remember > New Responses, (Retrieval + Encoding)
// Henson R N A, 1999: New > Remember Responses, (Retrieval + Encoding)
// Henson R N A, 1999: Know > New Responses, (Retrieval + Encoding)
// Henson R N A, 1999: New > Know Responses, (Retrieval + Encoding)
// Henson R N A, 1999: Remember > Know Responses, Retrieval
// Henson R N A, 1999: Know > Remember Responses, Retrieval
// Henson R N A, 1999: Remember > Know Responses, Encoding
// Henson R N A, 1999: Know > Remember Responses, Encoding
// Subjects=12
-48	39	-12
-54	24	33
-60	27	21
-12	63	18
-6	39	27
-33	-60	45
-51	-45	39
-12	-36	3
-6	-24	27
-6	-42	36
-6	-75	42
0	-66	33
30	39	48
18	6	54
-51	-6	3
39	-3	-6
-30	3	-24
33	3	-24
-12	-45	57
-51	-21	30
21	-45	51
42	-30	45
-33	-75	12
51	-60	9
-51	15	-6
51	21	-6
-60	24	15
42	21	33
51	39	21
-9	42	24
-24	-63	42
18	54	42
-36	-6	-3
45	-12	-12
-24	-3	-24
24	-9	-18
12	-51	33
63	-15	-18
54	-21	-12
-60	-33	15
66	-21	15
-51	-51	-9
57	-63	15
-21	54	39
0	-30	36
-57	-51	39
-42	-72	39
51	30	27
-12	39	27
9	39	30
-12	9	36
-39	-42	12
-12	-60	57
-45	24	-6
-57	18	27
12	-12	-9
-27	-60	60
18	-15	-24
3	-69	33
18	-54	48

// Evans K C, 1999: Active Inspiration vs. Passive Inspiration
// Subjects=5
-6	-30	70
-44	-22	18
-38	-32	54
-46	-46	40
-28	14	-2
-38	10	-16
-46	-22	18
56	-32	48
58	-46	38
8	-12	56
16	-2	46
26	14	6
22	36	42
16	36	30

// Buchel C, 1998: CS+ Unpaired vs. CS-
// Subjects=9
-3	15	33
-6	-9	-6
-33	27	-12
-39	3	54
-24	3	-24
6	30	42
9	-21	-12
51	24	-9
15	-66	36
48	12	39
6	6	54
27	-3	-24

// Kalin N H, 1997: Subgroup of MDD Patients, Patient 1 and Patient 2
// Subjects=20
-31.21	-80.63	-8.4

// Kalin N H, 1997: Subgroup of Healthy Controls, Patient 1 and Patient 2 
// Controls
// Subjects=20
-40.85	-73.45	0.02

// Elliott R, 1999: Guessing vs. Reporting (Suit + Color)
// Elliott R, 1999: Activations Associated with Increasing Task Difficulty - 
// Suit vs. Color
// Elliott R, 1999: Modulation of Guessing by Task Difficulty - Suit vs. Color
// Elliott R, 1999: Activations Associated with Difficulty in Context of 
// Prediction - Suit vs. Color
// Subjects=5
33	42	24
-36	36	24
6	33	24
-3	33	54
36	24	-12
-39	24	-12
15	27	-12
60	-45	36
-45	-51	45
15	-72	51
9	-15	9
-39	-54	-48
24	-33	-21
-30	-33	-15
-57	-3	-12
42	-30	8
-12	-45	30
-45	-75	24
-57	-15	-15
-33	42	12
3	39	-12
-30	24	-30
45	21	-36
-30	24	-30
9	42	-12
-33	45	12

// McAllister T W, 1999: Mild Traumatic Brain Injury Patients
// Subjects=12
-30	12	54
32	10	54
-30	58	4
40	50	14
30	-70	54
52	-48	48
-16	-76	56
-40	-56	48
-40	-56	48
-40	16	34
32	-70	52
-30	58	6
46	24	32
38	48	14
58	-50	48
-16	-2	-6
26	8	60
-34	46	10
30	32	36

// McAllister T W, 1999: Healthy Controls
// Subjects=11
-30	12	54
32	10	54
-30	58	4
40	50	14
30	-70	54
52	-48	48
-16	-76	56
-40	-56	48
-36	-60	40
50	-50	50
-46	8	20
36	16	54
8	14	0
38	52	14
26	18	58

// Lobel E, 1999: Galvanic Vestibular Stimulation > Rest, Activations
// Subjects=6
-49.77	-7.72	50.68
-53.95	-24.32	56.58
60.87	14.22	-5.96
44.23	-7.5	45.12
52.6	21.48	33.67
-67.31	9.56	0.36
-67	-35.59	21.99

// Lobel E, 1998: Galvanic Vestibular Stimulation (GVS) > Rest, Activations
// Lobel E, 1998: Rest > GVS, Deactivations
// Subjects=6
-49.77	-7.72	50.68
-53.95	-24.32	56.58
60.87	14.22	-5.96
44.23	-7.5	45.12
52.6	21.48	33.67
-67.31	9.56	0.36
-67	-35.59	21.99
-3.53	72.36	-19.02

// Bush G, 1999: Healthy Controls
// Subjects=8
-1.91	26.52	34.99
7.79	20.75	42.06
7.82	4.63	40.06
-44.59	10.41	36.83
-31.48	-45.85	51.44
-44.34	-56.21	42.42
-34.91	-71.24	12.34

// Bush G, 1999: Attention Deficit Hyperactivity Disorder (ADHD) Patients
// Subjects=8
46.89	39.51	-7.92
-28.85	23.97	4.29
-44.89	20.44	1.42
-44.79	-1.51	6.61
-35.1	-13.88	10.88
40.66	11.69	4.52
47.22	-9.7	16.28
-5.3	4.82	2.28
27.88	-1.07	5.74
10.82	-10.69	6.74
-18	-20.38	7.89

// Ring H, 1999: Activations In Both Healthy Controls and Autism Group, 
// Embedded Figures Task (EFT) - Fixation
// Ring H, 1999: Autism Group > Healthy Controls, Embedded Figures Task (EFT) 
// - Fixation
// Ring H, 1999: Healthy Controls > Autism Group, Embedded Figures Task (EFT) 
// - Fixation
// Ring H, 1999: Autism Group > Healthy Controls, EFT Activations With Global 
// Mean FPQ As a Covariate
// Ring H, 1999: Healthy Controls > Autism Group, EFT Activations With Global 
// Mean FPQ As a Covariate
// Subjects=6
47.15	-58.8	-13.06
30.05	-46.84	-8.29
-16.98	-43.95	-7.99
-17.96	-67.22	-6.03
20.42	-32.72	-3.79
-24.39	-50.97	-1.74
-8.27	-75.19	0.1
58.69	49.95	2.22
17.45	-67.67	12.56
-46.69	-60.65	12.71
-12.42	-81.59	14.07
47.26	11.59	30.1
-31.81	11.11	31.05
48.35	6.31	30.53
-35	6.86	31.45
41.94	17.27	35.26
-46.74	14.62	36.51
-44.41	-38.23	40.91
-24.11	-21.74	45.99
27.32	-58.44	48.47
-18.62	-61.89	49.29
43.24	-17.73	50.45
16.65	-39.58	59.28
-14.36	-33.43	59.12
22.81	-86.13	7.35
38.76	-78.08	-.19
41.91	-75.32	-6.04
35.94	-55.42	59.27
-16.41	-70.96	55.6
-26.35	-84.31	7.77
1.42	-80.97	7.17
1.42	-80.97	7.17
53.58	9.54	16.82
44.02	18.88	28.41
-29.39	-67.21	36.48
50.72	-33.01	44.96
29.09	-63.34	-1.32
29.03	-58.48	-7.3
14.24	-80.89	7.01
19.64	-83.6	12.75
35.58	-71.25	5.96
32.46	-83.53	12.6
56.97	11.44	41.16
56.89	7.33	29.24
32.69	-53.75	53.59
35.94	-55.42	59.27
-11.06	-70.93	55.54

// Baron-Cohen S, 1999: Autism Patients
// Subjects=6
-57.46	-27.51	15.63
44.06	-26.9	14.41
-48.09	24.91	4.43
43.72	12.46	-13.42
-23.51	-11.21	-10.66
16.61	-54.36	47.14
19.44	-54.94	-1.91
4.38	-16.45	1.72
4.43	-16.02	7.26
22.72	-75.01	-.27
29.24	-89.26	7.54
-47.88	-55.34	-1.11
-44.77	-32.06	-3.1
-39.11	11.81	54.5
-51.4	51.32	2.26
-23.16	7.79	42.38
-8.26	10.62	36.4
-44.62	18.87	36.13
-41.35	-74.88	7.15
-39.36	-33.63	3.67
-23.11	-19.07	39.06
-50.62	-40.62	65.72
-44.35	-17.83	57.04
44.33	0.13	61.21
-44.82	8.01	5.81
39.09	-40.59	57.99
-13.21	-43.57	65.53
7.46	4.21	-6.74
-48.01	-22.56	-3.85
47.04	44.4	13.97
-50.67	-54.25	54.59
60.08	-38.95	8.55
-54.17	-50.75	17.54
59.75	12.55	-13.61

// Baron-Cohen S, 1999: Healthy Controls
// Subjects=12
-57.46	-27.51	15.63
44.06	-26.9	14.41
-48.09	24.91	4.43
43.72	12.46	-13.42
-23.51	-11.21	-10.66
-26.72	-11.23	-10.63
22.42	-7.76	-11.48
-26.18	-68.25	36.53
25.77	-59.01	-13.91
-13.68	-82.51	-11.49
7.82	7.98	42.01
-2.29	39.04	-9.55
-1.65	-42.21	40.75
1.46	-31.07	33.09
1.03	48.98	8.54
32.24	-60.58	-7.16
-39.41	-46.2	-7.55
-51.16	14.2	17.63
63.15	11.28	10.99
-47.88	18.33	29.52
53.6	18.51	22.76
-44.94	27.67	-1.41
56.74	23.31	15.63
-32.55	-54.65	47.73
53.63	-54.73	-2.32
35.37	-16.26	1.35
-36.18	-16.26	7.75
14.17	-75.06	-.17
-1.75	-89.45	7.91
22.64	-54.92	-1.95
-13.78	-31.87	-3.47
7.9	12.09	53.93
0.97	51.64	1.63
-44.54	7.66	42.64
41.97	10.93	35.8
-47.83	18.85	36.16
35.59	-74.42	6.23
47.19	-33.11	2.63
-47.68	-19.22	39.35
-22.84	-40.45	65.38
39	-17.33	56.04
-22.99	-.27	62.02
56.7	8.62	4.6
-1.52	-40.84	58.48
1.75	-43.48	65.36
-17.12	4.06	-6.44
32.14	-22.08	-4.82
-29.9	43.93	14.9
-32.5	-54.14	54.38
-57.47	-39.65	9.95
56.97	-50.08	16.21
50.13	12.49	-13.5
44.22	-58.19	22.61
-50.94	-57.08	18.03
-36.1	-24.21	15.1
-47.69	-43.42	29.12
-13.71	-9.27	13.6
1.23	-31.27	3

// Howard R J, 1996: Areas of activation for coherent motion
// Howard R J, 1996: Areas of activation for optical flow
// Howard R J, 1996: Areas of activation for biological motion
// Subjects=6
-42.52	-29.79	12.3
62.13	-18.93	5.73
-55.33	-20.98	17.29
47.2	-17.62	10.25
-48.91	-24.11	17.47

// Pinel P, 1999: Number Comparison vs. Rest
// Pinel P, 1999: Right Hand vs. Left Hand
// Pinel P, 1999: Arabic Number > Verbal Number
// Pinel P, 1999: Close Distance > Far Distance
// Pinel P, 1999: Far Distance > Close Distance
// Subjects=11
10.99	-3.33	12.36
1.69	22.71	50.29
-11.68	-6.6	13.07
56.81	16.52	49.96
40.99	-39.72	69.24
-27.63	-83.55	17.6
-30.73	-75.93	30.34
1.38	-74.81	6.15
34.19	-68.39	38.58
47.23	11.04	60.75
-40.06	-10.67	74.47
53.11	-65.68	-2.35
-4.48	-70.16	56.22
-46.68	1.45	66.66
-49.83	-20.9	68.93
-43.25	-36.52	73.72
-33.64	-50.49	61.49
-53.66	-68	13.14
-56.67	15.81	48.6
39.88	37.32	-2.23
34.35	11.62	67.64
59.28	27.19	-8.29
15.01	-69.78	59.21
-33.66	8.5	72.47
14.42	-61.06	14.66
-20.65	-69.9	59.83
36.98	59.56	29.23
49.69	-50.67	-13.87
2.08	-46.55	67.22
44.11	-7.8	66.03
27.12	-59.7	-5.86
-40.74	53.22	34.54
40.33	-80.74	9.44
1.55	-20.95	31.08
33.53	-53.6	-9.94
-63.82	20.69	-2.18
66.36	-27.42	27.25
43.12	-41.43	-18.03
66.08	23.01	15.54
-41.18	33.53	-3.84
50.5	-18.29	56.87
-26.91	-38.72	83.75
1.89	-18.46	57.72
-73.11	-12.27	24.77
72.67	-5.68	18.27
-24.76	-53.5	-5.59
-63.2	-27.25	36.17
44.11	-7.8	66.03
11.58	1.03	58.99
46.78	-5.46	22.05
-40.11	-10.98	71.14
-7.86	-2.23	59.64
-47.2	-8.98	24
59.5	-53.2	-7.06
-49.18	-66.74	26.39
53.59	-32.6	41.43

// Belger A, 1998: Shape Task > Fixation
// Belger A, 1998: Location Task > Fixation
// Subjects=18
23.61	57.17	29.9
33.31	40.48	33.42
-34.12	37.91	19.91
45.92	38.42	5.57
-37.43	34.57	4.61
35.36	-55.95	-16.51
-37.33	-57.7	-18.87
47.16	-56.51	-11.02
-44.78	-57.49	-15.46
-56.45	-59.96	-5.08
-59.45	-31.52	32.71
31.54	-50.13	45.5
-35.82	-54.22	39.92
6.3	49.38	-.48
-1.14	51.97	6.08
-22.43	36.24	10.99
50.2	37.39	5.6
-24.83	44.48	-19.78
7.99	-51.84	39.22
-4.2	-57.51	-19.27
3.65	-39.35	35.99
6.81	-37.64	30.24
51.67	-47.49	22.74
-59.69	-41.66	-2.12
48.59	-56	36.87
-53.03	-62.12	21.82
31.58	-49.7	51.04
-29.31	-60.89	49.33

// Chee M W L, 1999: Syllable > Fixation
// Chee M W L, 1999: Case > Fixation
// Chee M W L, 1999: Auditory Abstract/Concrete > Fixation
// Chee M W L, 1999: Visual Abstract/Concrete > Fixation
// Chee M W L, 1999: Abstract/Concrete > Syllable
// Chee M W L, 1999: Abstarct/Concrete > Case
// Subjects=8
37.46	21.7	10.41
-44.65	6.46	27.13
54.78	0.97	29.79
-47.92	-.76	16.62
37.96	-22.62	56.5
8.04	-3	65.23
-17.59	-9.5	66.07
4.57	17.3	39.04
64.27	-16.72	6.63
67.56	-32.3	11.25
-47.9	-20.3	11.57
64.27	-29.92	1.05
-61.74	-46.28	7.21
67.47	-49.7	-7.37
41.28	-27.92	70.29
-51.83	-33.28	50.62
44.52	-44.02	68.25
50.83	-58.3	48.19
-25.65	-51.89	-27.3
-41.56	-54.04	-12.44
-2.01	-56.98	-12.65
17.18	8.64	8.39
-18.12	11.34	5.23
50.22	17.84	0.55
-31.92	8.86	15.63
50.44	30.01	34.1
-44.67	6.29	24.91
58.04	4.93	39.46
-58.59	2.61	19.81
-44.82	1.41	3.02
47.57	-15.96	59.18
4.77	-.36	58.36
11.03	17.86	45.61
64.44	-41.32	18.73
-55.19	-48.13	24.02
54.65	-29.98	1.16
-41.12	-29.7	54.66
44.43	-54.91	51.33
58.29	-38.62	54.26
-37.98	-36.88	44.07
-47.52	-49.37	48.57
-34.73	-52.98	42.04
31.68	-74.02	53.08
47.7	-64.06	56.52
23.72	-85.63	-13.89
43.93	-69.91	-18.78
-25.43	-89.1	-13.03
10.71	-67.79	-29.73
-18.16	-45.16	-23.49
-21.3	-57.61	-19.07
-2.05	-67.27	-21.82
43.68	52.69	-2.3
27.62	62.11	-2.9
-29.07	61.26	-8.87
47.05	44.48	15.08
37.51	51.88	29.07
27.94	9.47	18.24
-32.02	-5.37	-3.25
40.59	20.95	0.4
-32.02	21.03	7.92
-47.98	31.57	21.72
-44.65	6.46	27.13
-41.26	-1.49	47.83
41.2	-18.92	62.84
11.12	8.94	54.16
4.81	-3.28	61.95
-20.79	-2.91	68.9
37.97	7.21	70.73
64.27	-16.72	6.63
67.56	-32.3	11.25
-61.77	-16.96	14.79
-38.32	-56.94	-8.89
41.28	-27.92	70.29
-47.47	-39	58.85
-44.22	-51.67	59.88
4.37	-57.2	-16.05
37.34	-52.03	-34.7
10.75	-70.7	-26.14
-25.61	-54.72	-22.6
0.93	-30.04	-36.13
-5.16	2.93	19.17
43.65	55.61	-5.89
27.6	58.69	-5.96
-32.25	54.9	-8.3
43.97	32.63	27.26
-28.77	21.56	14.53
57.77	35.03	15.75
54.47	17.61	-2.82
-47.86	13.05	29.96
-47.98	15.1	15.29
-41.7	36.83	6.7
-44.65	6.46	27.13
-41.18	-.64	58.91
37.96	-22.62	56.5
8.01	9.95	67.49
7.92	8.92	54.2
-1.7	28.67	62.69
-.49	-2.79	68.66
-44.34	-43.01	48
-38.01	-40.57	37.69
43.89	-63.82	-22.64
23.72	-85.63	-13.89
-35.12	-63.52	-11.72
-25.43	-89.1	-13.03
10.74	-74.13	-29.2
1.02	-55.42	-34
-18.2	-45.5	-27.92
-18	-82.97	-16.98
-21.3	-57.61	-19.07
20.46	9.43	18.33
34.02	58.72	-6.04
57.6	46.43	-1.93
-45.04	45.3	-7.35
-41.68	40.26	9.76
37.31	20.16	-9.53
-28.79	21.31	11.2
-38.54	16.54	-8.36
54.32	39.04	-14.66
-48.2	32.6	-6.25
-47.87	22.82	32.49
-47.94	12.19	18.88
-41.26	-1.49	47.83
-4.83	16.21	67.12
-5.07	30.19	41.41
-28.45	11.62	51.04
-14.68	7.16	33.42
-58.62	-37.26	-.27
-62.07	-6.84	-19.51
-38.32	-56.94	-8.89
30.92	-62.09	-40.48
16.99	-32.86	-32.73
17.1	-74.61	-35.92
-35.25	-48.43	-23.02
-25.66	-65.09	-32.89
-18.29	-33.32	-35.63
34.03	55.55	-5.77
-35.42	51.96	-4.67
-32.01	24.46	10.98
-44.93	36.56	3.42
-41.47	19.43	29.35
-38.57	29.48	-6.1
-25.77	35.9	-6.78
44.31	-.12	57.88
-1.65	15.98	63.75
13.85	-68.54	-39.74

// D'Esposito M, 1997: Concrete > Abstract
// D'Esposito M, 1997: Abstract > Concrete
// Subjects=7
-34.67	-51.59	-19.06
-47.14	1.32	30.82
-5.93	2.6	42.32
21.69	57.2	16.28
6.15	-73.6	41.81

// Toni I, 1998: Activation > Baseline
// Subjects=3
42	32	24
40	56	22
-2	18	44
-4	0	54
-6	2	70
-22	-6	72
-40	-18	64
-38	-26	36
-34	-32	68
-40	-30	52
-50	-36	56
44	-44	56
-30	-56	64
10	-64	50
-14	18	-2
-28	6	-2
28	8	0
-26	-2	4
-12	-14	6
6	-56	-12
26	-48	-22
26	-44	-30
-30	-56	-32

// Clark V P, 1997: Color Attention > Monochrome Scrambled Faces
// Subjects=6
21.6	-72.25	-5.73

// Jancke L, 1999: Right Hand, 1 Hz vs. Rest
// Jancke L, 1999: Right Hand, 3 Hz vs. Rest
// Jancke L, 1999: Left Hand, 1 Hz vs. Rest
// Jancke L, 1999: Left Hand, 3 Hz vs. Rest
// Jancke L, 1999: Both Hands, 1 Hz vs. Rest
// Jancke L, 1999: Both Hands, 3 Hz vs. Rest
// Jancke L, 1999: Right Hand, 3 Hz > Right Hand, 1 Hz
// Jancke L, 1999: Left Hand, 3 Hz > Left Hand, 1 Hz
// Jancke L, 1999: Both Hands, 3 Hz > Both Hands, 1 Hz
// Jancke L, 1999: Rate Effects, Left Hand > Right Hand
// Jancke L, 1999: Rate Effects, Both Hands > Right Hand
// Jancke L, 1999: Rate Effects, Left Hand > Right Hand, Flipped Data Set For 
// Contrast
// Jancke L, 1999: Rate Effects, Both Hands > Right Hand, Flipped Data Set For 
// Contrast
// Jancke L, 1999: Both Hands > Right Hand, Across Frequencies
// Jancke L, 1999: Both Hands > Left Hand, Across Frequencies
// Jancke L, 1999: Right Hand > Left Hand, Across Frequencies
// Jancke L, 1999: Left Hand > Right Hand, Across Frequencies
// Subjects=6
16	-56	-24
-40	-56	-28
16	-56	-24
-32	-64	-24
-24	-52	-24
24	-56	-28
-24	-52	-24
24	-56	-28
16	-56	-24
-24	-52	-24
16	-52	-24
-24	-52	-24
20	-52	-24
32	-48	-36
-28	-48	-24
20	-52	-24
16	-52	-24
-32	-64	-20
24	-72	-20
-24	-72	-20
-12	-72	-20
40	-60	-24
28	-76	-20
-32	-60	-16
-32	-52	-20
12	-72	-20
-12	-72	-20
40	-60	-24
28	-76	-20
-24	-52	-24
12	-56	-20
16	-52	-24
-24	-52	-24

// Mattay V S, 1998: Non-Dominant Hand Simple Motor
// Mattay V S, 1998: Dominant Hand Simple Motor
// Mattay V S, 1998: Dominant Hand Random Motor
// Subjects=8
-41.34	-7.77	59.64
-52.29	-15.43	47.14
-39.13	-5.22	63.83
3.83	14.96	47.66
-.38	2.6	53.43
-43.32	-39.27	67.27
-41.44	-26.03	48
13.83	-72.02	-33.55
55.69	-15.47	40.82
-54.57	-14.15	38.08
40.59	-21.9	41.71
40.7	24.84	59.5
-52.48	5.01	36.15
3.93	4.74	53.15
-4.78	6.42	48.65
44.81	-38.02	29.79
51.57	-38.05	52.09
24.78	-7.38	-8.76
-20.55	-2.87	-3.95
-1.24	-71.65	-28.85
36.56	-8.79	67.38
-36.82	-15.02	73.73
45.19	-19.81	63.84
34.34	23.52	68.7
-34.71	-2.25	72.43
3.96	11.54	56.96
-.34	5.14	57.66
36.7	-29.65	73.92
47.11	-45.69	39.47
-41.28	-22.66	61.11
55.52	13.9	33.43
-54.61	11.8	40
22.59	1.12	-9.56
-22.85	2.67	-13.43
9.52	-74.16	-33.27

// Arrington C M, 2000: Object- > Location-based Cueing
// Arrington C M, 2000: Invalid > Valid Cueing
// Subjects=12
-30.5	-32.52	44.73
-41.13	-23.18	56.34
-65	-34.75	5.17
-46.01	-27.35	-24.66
-15.92	-34.17	-5.48
-15.86	42.22	32.72
1.91	44.9	-16.78
-32.19	40.18	-5.95
7.9	-74.7	18.83
-10.31	-70.92	14.27
17.29	-72.64	-10.44
13.03	-52.69	0.2
-12.65	-49.93	-3.08
-22.3	-29.47	0.89
12.7	-53.92	-43.18
51.76	-61.86	29.52
50.3	-28.66	-8.93
12.86	53.16	20.32
2.53	21.66	54.31
48.37	16.34	36.38
45.86	24.61	-7.77

// Buckner R L, 2000: Group 1 Normals
// Subjects=8
-35.01	13.38	33.13
-28.83	25.28	7.53
-38.39	-58.77	-18.77
1.54	5.97	57.87
7.92	15.52	56.99
13.9	-70.14	-32.92
37.49	-69.14	-22.12

// Buckner R L, 2000: Group 2 Normals
// Subjects=8
-38.19	13.62	36.49
-28.85	31.62	6.99
-52.22	-61.51	-11.69
-4.81	9.87	67.65
1.55	23.65	66.42
17.1	-73.55	-36.01
47.1	-65.91	-22.5

// Buckner R L, 2000: Group 3 Normals
// Subjects=12
-41.41	10.17	33.47
-28.86	25.02	4.2
-44.76	-55.12	-12.31
-1.63	3.03	61.49
4.65	19.22	50.03
14	-72.46	-21.57
31.06	-61.78	-22.66

// Garavan H, 2000: VSWM vs. CTL
// Subjects=5
-45.75	7.26	23.73
-39.43	32.67	21.53
39.62	38.35	19.03
22.87	5.67	52.07
-37.06	1.11	39.76
-6.07	18.81	45.72
0.41	-47.37	28.9
-.91	35.7	29.75
-33.17	22.37	-2.22
35.21	25.95	-3.3
-30.41	-51.3	49.65
31.57	-47.67	49.75
-11.04	-68.47	59.79
28.4	-79.21	41.28
0.6	-47.68	52.34
-33.71	-75.41	27.18
48.27	-53.88	-4.56

// Hui K K S, 2000: Acupuncture vs. Tactile Stimulation, Increases
// Hui K K S, 2000: Acupuncture LI 4 vs. Tactile Stimulation, Decreases
// Subjects=13
61.39	-10.05	51.83
-61.54	-14.56	45.81
64.38	-18.86	20.19
-52.13	-16.64	18
-8.57	10.63	-4.86
20.24	-6.09	-17.17
-15.1	-7.07	-26.72
37.35	-15.76	-19.9
-25.7	-16.14	-19.15
27.75	-22.16	-19.26
-28.93	-23.02	-25.22
7.46	0.95	-7.58
-8.56	0.85	-7.39
13.98	-20.96	-2.47
7.76	7.29	33.15
-1.83	7.49	36.59
10.67	14.17	-2.03
-14.99	17.19	-1.99
17.03	13.7	-8.76
-15	13.76	-5.05
34.13	20.4	-6.17
-32.07	13.92	-1.52
43.66	16.26	-19.32
-52.52	5.65	-24.01

// Moore C I, 2000: Tactile vs. Motor Stimulation
// Subjects=5
-36.8	-9.36	69.63
-37.9	-18.51	61.49
-44.25	-26.66	66.7

// Stern C E, 2000: Working Memory I vs. Control
// Stern C E, 2000: Working Memory II vs. Control
// Stern C E, 2000: Working Memory I vs. Working Memory II
// Subjects=5
-35.27	53.51	15.27
-44.72	32.1	28.33
-1.75	14.95	50.46
-20.92	-10.89	48.38
-38.45	-41.85	-20.19
-52.3	-48.02	-16.17
-38.39	54.34	26.39
43.74	56.64	7.41
43.97	32.63	27.26
40.57	33.9	2.66
47.1	15.42	10.83
44.14	21.23	44.94
40.8	9.89	22.51
40.97	5.09	42.99
17.64	6.83	67.64
30.98	-41.69	-24.35
47.03	-47.94	-24.01
40.7	-47.21	-13.96
37.94	-42.51	47.02
31.58	-61.84	45.36
-35.15	37.19	24.44
-5	17.76	45.8
-38.52	30	0.55
-35.01	13.38	33.13
-7	2.74	58.23
-48.14	-29.48	-24.46
-55.53	-48.3	-19.45
-31.42	-32.04	64.78
-41.22	-33.98	40.52
50.38	32.67	27.19
34.19	25.4	3.45
50.48	13.89	32.1
47.12	12.25	11.09
4.57	17.3	39.04
34.64	12.51	56.94
23.39	-36.25	-35.87
40.54	-48.83	-35.01
31.53	-49.15	44.3
-5	17.76	45.8
-4.92	5.41	51.29
-11.11	-12.12	72.91
50.37	35.84	26.92
34.64	12.51	56.94

// Wheeler M E, 2000: Picture Recall > Sound Recall
// Wheeler M E, 2000: Sound Recall > Picture Recall
// Wheeler M E, 2000: Picture Recall - Fixation
// Wheeler M E, 2000: Sound Recall - Fixation
// Subjects=18
-22.91	-64.28	46.19
23.67	72.03	43.15
26.2	-62.22	41
-16.4	-72.02	55.69
34.68	-69.54	28.13
32.55	5.26	59.8
-16.42	-58.99	59.06
-25.16	-1.77	56.59
-46.79	-72.59	-4.13
28.17	6.33	46.38
-40.14	-81.07	23.27
-29.38	-49.52	45.03
36.78	-36.95	36.53
-51.24	15.63	8.59
-44.95	23.1	-5.49
-59.56	-39.24	15.52
-57.33	-38.2	28.79
-53.02	-.5	47.88
55.53	37.25	3.32
-21.3	-1.62	3
-1.64	-14.66	52.94
-7.97	-.64	69.68
-46.79	-72.59	-4.13
-22.91	-64.28	46.19
24.16	-61.2	54.32
-59.56	-39.24	15.52

// Gerardin E, 2000: Motor Execution vs. Rest
// Gerardin E, 2000: Motor Imagination vs. Rest
// Gerardin E, 2000: Motor Execution vs. Motor Imagination
// Gerardin E, 2000: Motor Imagination vs. Motor Execution
// Subjects=8
57	18	24
39	-15	63
-42	-18	66
42	-3	60
-36	-3	66
6	6	57
-9	9	51
3	-3	66
-3	3	66
42	-33	60
-48	-24	57
36	-36	66
-30	-42	66
-45	-36	60
60	-9	15
-60	-15	21
24	18	6
-30	6	6
27	-9	12
-33	-3	6
15	-12	9
-18	-15	9
21	-45	-18
-27	-45	-18
-54	42	15
30	51	24
48	24	6
-54	12	12
42	6	57
-42	3	51
3	6	69
-3	6	69
-6	-3	69
54	-21	39
-60	-21	39
24	-54	51
-27	-60	54
36	-30	42
-36	-42	48
-60	-57	6
15	9	15
-18	9	21
27	9	12
-27	6	12
39	-15	63
-42	-18	69
24	-9	75
-36	-6	69
3	0	57
-3	-3	57
48	-30	60
-51	-18	60
51	-9	15
-51	-15	15
3	6	42
-6	9	42
30	3	0
-30	-3	3
15	-12	9
-18	-15	9
21	-45	-18
-27	-45	-18
-57	42	15
27	54	18
51	36	0
-57	21	6
48	9	48
-42	3	51
9	18	54
-6	18	63
-15	-63	57
-48	-36	42
57	-12	0
-60	-42	0
6	24	27
9	15	3
-24	3	18

// Ishai A, 2000: Houses > Faces and Chairs, Photos
// Ishai A, 2000: Faces > Houses and Chairs, Photos
// Ishai A, 2000: Chairs > Faces and Houses, Photos
// Ishai A, 2000: Houses > Faces and Chairs, Photos and Line Drawings
// Ishai A, 2000: Faces > Houses and Chairs, Photos and Line Drawings
// Ishai A, 2000: Chairs > Faces and Houses, Photos and Line Drawings
// Subjects=12
-22	-81	-18
26	-86	-14
-26	-57	-14
28	-57	-13
-21	-84	23
29	-80	26
-32	-70	42
26	-58	45
-33	-79	-14
38	-82	-17
-36	-55	-20
40	-52	-19
-53	-45	-4
54	-47	9
-37	-80	-7
43	-79	-1
-27	-51	-19
30	-49	-16
-41	-64	-12
48	-62	-11
-21	-77	36
29	-80	35
-43	-50	49
34	-48	55
-21	-87	-24
27	-88	-14
-25	-58	-16
28	-63	-18
-24	-80	34
29	-81	37
-33	-54	57
-34	-81	-25
41	-82	-15
-39	-64	-28
41	-60	-20
-53	-53	1
51	-59	18
-39	-84	-13
41	-90	1
-29	-56	-22
30	-61	-19
-42	-69	-14
48	-73	-8
-26	-83	22
31	-79	36
-43	-48	51
33	-61	55

// Ishai A, 2000: Houses > Faces and Chairs
// Ishai A, 2000: Faces > Houses and Chairs
// Ishai A, 2000: Chairs > Faces and Houses
// Ishai A, 2000: Imagery vs. Imagery Control
// Subjects=9
-25	-57	-15
25	-56	-13
-24	-86	21
32	-85	19
-37	-60	-18
38	-56	-18
-42	-66	-11
43	-68	-7
-23	-85	22
23	-83	33
-31	-58	-31
31	-62	-36
-10	-61	27
7	-71	32
-29	-60	40
32	-55	48
-6	10	33
9	11	32
-30	2	41
34	2	40
-39	20	12
40	14	10
-28	44	11
35	38	10
-10	54	11
17	52	8

// Le Clec'H G, 2000: Group 1
// Subjects=5
-39	-63	45
-51	9	42
-6	18	51
-48	45	21
30	-54	60
54	-42	33
9	-45	33
-45	-9	18

// Le Clec'H G, 2000: Group 2
// Subjects=6
-36	-69	45
-45	15	42
6	27	48
18	-39	48
60	-21	36
39	9	18

// Nobre A C, 2000: Areas Common to Saccades and Attention
// Nobre A C, 2000: Attention > Saccades
// Nobre A C, 2000: Saccades > Attention
// Nobre A C, 2000: Areas Uniquely Identified by Attention
// Nobre A C, 2000: Areas Uniquely Identified by Saccades
// Subjects=4
45	6	42
54	3	24
45	3	51
60	-3	33
57	-6	42
-45	-3	51
-54	-6	39
-30	-6	60
51	33	15
42	27	18
51	15	-15
54	6	-9
-51	9	-3
-57	0	6
-3	3	60
6	18	48
6	18	30
9	9	42
-3	9	45
42	21	0
-36	24	3
-39	15	3
57	-45	45
33	-57	60
-51	-36	36
-30	-57	57
-24	-63	60
-24	-66	51
54	-42	9
57	-42	18
48	-60	-3
54	-63	-9
-45	-66	-9
-27	-57	-24
-33	-69	-18
27	6	3
33	-3	3
-27	3	-6
-27	-3	3
36	-45	-30
48	-54	-33
-39	-51	-30
51	-9	54
45	-15	60
-48	-12	51
48	-54	54
36	-63	54
-42	-54	54
-33	-63	54
42	48	-9
27	45	-9
39	36	-9
54	15	3
-45	24	3
-54	9	3
42	18	-12
-39	9	-9
63	-30	15
57	-36	21
51	-69	3
27	12	6
30	15	-3
-27	0	6
33	24	51
18	-54	-21
33	-66	-21
-12	-78	-21
-36	-84	-18
-36	-90	-6
-60	-36	18
24	-66	-6
-15	-60	0

// Paradis A L, 2000: Random - Static
// Paradis A L, 2000: Expansion/Contraction - Random
// Paradis A L, 2000: Random - Expansion/Contraction
// Paradis A L, 2000: SP3D - Random
// Paradis A L, 2000: Random - SP3D
// Subjects=9
-51	-72	3
-27	-81	15
-12	-81	-3
-24	-66	-12
45	-54	6
27	-84	0
21	-66	-6
-24	-84	27
-30	-63	33
18	-79	39
15	-90	3
-18	-87	21
-24	-69	-9
-33	-78	39
21	-78	39
24	-84	0

// Binder J R, 2000: Tones > Noise
// Binder J R, 2000: Words > Tones
// Binder J R, 2000: Pseudowords > Tones
// Binder J R, 2000: Reversed Speech > Tones
// Subjects=28
-55.28	-39.13	16.58
-46.78	-32.99	12.62
-61.73	-31.85	14.92
-55.38	-25.89	8.78
52.56	-21.82	10.54
67.46	-22.41	1.5
-54.4	-11.43	3.09
-56.59	-7.64	-2.78
67.48	-15.55	7.61
65.29	-9.57	2.68
63.08	-1.55	-3.55
-54.27	-43.06	6.86
-61.81	-33.85	2.83
-60.79	-27.75	-1.04
-55.51	-14.06	-3.37
-60.88	-6.69	-3.92
63.21	-32.04	1.24
63.1	-15.55	-5.72
65.19	-6.19	-8.76
-55.34	-44.13	6.96
-59.67	-33.75	3.91
-56.52	-26.67	-1.18
-56.57	-12.92	-2.33
-58.75	-5.62	-4.04
61.07	-29.85	2.2
63.12	-12.12	-2.66
65.19	-6.19	-8.76
-63.94	-33.77	3.96
-58.66	-24.48	-.23
-55.51	-11.86	-2.44
-58.75	-5.62	-4.04
63.21	-29.84	2.17
64.19	-10.97	-1.65
65.17	-4.16	-10.04

// Kuperberg G R, 2000: Normal Sentences > Random Word Strings
// Kuperberg G R, 2000: Random Word Strings > Normal Sentences
// Kuperberg G R, 2000: Pragmatically Violated Sentences > Normal Sentences
// Kuperberg G R, 2000: Normal Sentences > Pragmatically Violated Sentences
// Kuperberg G R, 2000: Semantically Violated Sentences > Normal Sentences
// Kuperberg G R, 2000: Normal Sentences > Semantically Violated Sentences
// Kuperberg G R, 2000: Syntactically Violated Sentences > Normal Sentences
// Kuperberg G R, 2000: Normal Sentences > Syntactically Violated Sentences
// Kuperberg G R, 2000: (Normal vs. Pragmatic) > (Normal vs. Semantic and 
// Syntax)
// Kuperberg G R, 2000: (Normal vs. Semantic) > (Normal vs. Syntax)
// Subjects=9
-41.56	-44.1	-7.7
-32.87	-44.79	10.1
50.37	-24.63	1.88
-44.5	-53.44	23.23
38.42	12.85	-7.82
-20.04	-82.04	-4.76
-11.37	-53.24	22.83
22.28	18.16	-20.34
-1.92	-70.3	-5.96
-11.58	-72.98	-12.31
-5.42	18.93	-7.82
-11.91	2.72	-24.23
50.1	6.69	-19.7
-17.08	-29.66	-15.88
7.62	-37.03	-3.28
-39.47	-56.66	-18.94
43.91	-52.56	-14.66
56.76	-45.62	-8.7
-47.99	-25.73	-3.59
-41.36	-47.5	17.12
-54.28	-21.14	15.06
-41.7	-6.03	-10.89
4.54	-71.94	-.32
1.13	-53.24	-19.69
7.41	19.01	-7.98
-5.34	-14.27	-10.62
-51.09	-31.15	9.17
1.43	-71.02	11.91
11.15	-85.25	19.68
-11.52	-39.38	9.4
-29.88	-38.2	-15.02
-33.19	15.6	-7.22
47.04	8.13	-.83
-5.13	-70.32	-5.92
31.91	2.98	-24.76
-39.67	8.27	-18.8
28.89	-22.53	-10.32
-36.22	-32.01	-3.2
-41.59	-34.58	-8.5
-36.13	-55.27	-1.25
-41.37	-57.53	11.27
1.37	-81.48	0.52
-23.62	27.28	-8.32
15.97	3.83	-12.38
47.01	-10.79	-11.51
53.54	-16.15	1.13
-51.17	-46.27	-7.41
-32.89	-75.77	-5.14
-8.22	-74.68	6.75
22.69	-66.55	-.98
14.13	-63.43	-1.14
14.26	-84.06	7.28
14.24	-68.83	11.58
-44.81	-7.22	1.51
29.03	-72.74	-12.8
14.1	-67.03	-6.41
-29.75	-73.09	-12.09
28.92	-4.67	0.45
1.28	-58.22	-1.43
-44.81	-32.49	-8.64
-26.76	-14.92	-17.01
14.01	-31.71	-3.8
-16.97	-34.01	-3.25
-39.38	-43.66	-2.18
-35.98	-71.25	12.36
-51	-54.42	11.12
53.48	-13.49	-5.78
-47.77	-47.54	17.2
50.13	24.55	-8.93
22.69	-54.4	4.69
22.22	57.17	-11.35
-1.84	-81.5	0.56
-8.3	-54.59	5.07
-13.61	-51.02	10.4
16.36	-50.33	16.69
10.86	-58.59	-7.09
-11.58	-21.4	7.9
-44.67	-31.12	9.09
-11.52	-39.38	9.4
4.64	-74.17	12.14
11.14	-83.14	19.5
47.14	-18.3	1.39
53.41	-7.58	-11.85
-44.81	-7.22	1.51

// Lotze M, 2000: Lip Pursing vs. Rest
// Lotze M, 2000: /pa/ vs. Rest
// Lotze M, 2000: Tip of Tongue vs. Rest
// Lotze M, 2000: /ta/ vs. Rest
// Lotze M, 2000: /ka/ vs. Rest
// Lotze M, 2000: /pataka/ vs. Rest
// Subjects=7
-52	-16	38
54	-6	38
-48	-10	52
48	-10	56
-52	2	32
66	-2	24
-46	-8	26
60	-6	24
-36	-14	36
64	-16	28
-44	-8	40
54	-8	42

// Rosen H J, 2000: Left Frontal Patients
// Subjects=6
-1.67	9.2	58.75
55.75	6.55	19.28
34.2	26.54	4.47
-51.01	2.54	31.99
-40.63	23.64	1.11
-21.55	19.93	-21.1
0.48	4.9	57.97
42.97	13.5	27.76
47.02	13.42	-1.27
34.24	20.37	7.21
-48.86	7.12	36.04
-34.19	26.13	5.29

// Rosen H J, 2000: Normal Adults-fMRI
// Subjects=8
-1.73	4.2	49.13
47.26	2.78	26.38
53.4	11	-5.6
34.18	17.57	-1.47
-48.91	2.21	27.53
-42.6	20.94	21.43
-29.95	14.9	-2.74

// Rosen H J, 2000: Normal Adults-PET
// Subjects=6
2.5	21.32	49.88
49.42	-3.55	26.89
-51.11	3.8	20.74
-42.8	23.28	-3.3
-15.19	26.05	-25.04

// Sohn M H, 2000: Foreknowlege Effects
// Sohn M H, 2000: Transition Effects
// Subjects=12
-56.09	-28.82	53.64
-36.85	-49.48	46.23
-41.27	-12.58	42.07
9.75	5.76	13.18
25.76	-1.97	8.07
57.66	30.57	-.6
57.76	-1.32	-.16
7.88	-18.89	38.69
20.87	-59.96	43.1
29.13	29.34	41.09
-37.93	-72.63	35.92
16.43	-51.76	25.73
20.72	-70.31	19.43

// Mechelli A, 2000: (Words + Pseudowords) - Rest
// Mechelli A, 2000: Words - Rest
// Mechelli A, 2000: Pseudowords - Rest
// Mechelli A, 2000: Pseudowords - Words
// Mechelli A, 2000: Words - Pseudowords
// Subjects=6
-34	-92	-10
16	-96	-6
46	-68	-14
46	-60	-16
-44	-76	2
20	-100	8
-26	-66	54
34	-56	60
-46	-64	-28
40	-66	-22
30	-60	-26
-34	-92	-10
16	-96	-6
46	-68	-14
46	-60	-16
-44	-76	2
20	-100	8
-26	-66	54
34	-56	60
-46	-64	-28
40	-66	-22
30	-60	-26
50	-26	-6
-52	-56	4
-58	-56	6
4	8	56
-50	-6	46
58	-10	48
40	10	28
-34	-92	-10
16	-96	-6
46	-68	-14
46	-60	-16
-44	-76	2
20	-100	8
-26	-66	54
34	-56	60
-46	-64	-28
40	-66	-22
30	-60	-26
-58	-14	-8
-52	-56	4
-58	-56	6
4	8	56
-50	-6	46
58	-10	48
-44	2	28
40	10	28
-40	32	-8
-34	-92	-10
46	-68	-14
-26	-66	54
-58	-14	-8
-50	-6	46
-44	2	28
-40	32	-8
50	-26	-6

// Tan L H, 2000: Semantically Vague vs. Fixation
// Tan L H, 2000: Semantically Precise vs. Fixation
// Tan L H, 2000: Two Characters vs. Fixation
// Subjects=6
52.48	25.65	18.83
49.36	7.83	22.59
46.1	-61.89	-11.67
56.02	-8.14	49.5
39.1	-82.23	42.53
24.96	-94.83	4.71
45.07	-67.01	-9
25.12	-96.37	26.03
29.96	-67.59	-28.85
-48.91	16.47	33.03
-.64	7.72	53.28
-37.01	1.62	46.41
-43.66	-64.63	-11.53
-45.85	-45.44	-10.88
-40.98	-63.36	59.71
-28.17	-77.72	51.84
-31.68	-91.83	7.34
-46.82	-76.28	-10.52
52.47	25.57	17.72
55.82	9.52	30.18
53.94	-10.9	55.33
36.94	-80.3	40.16
55.1	-33.01	58.29
24.95	-98.17	2.76
29.96	-67.59	-28.85
21.99	-92.36	36.88
-1.71	7.63	52.19
-46.54	-.84	56.76
-55.68	32.47	-7.27
-44.97	27.33	-5.84
-50.11	-59.55	-14.11
-38.82	-64.24	61.99
-32.74	-99.49	4.65
-41.08	-83.05	39.06
-41.61	-64.42	-22.72
-49.01	23.19	23.55
55.69	26.81	19.81
45.71	26.33	-26.87
47.21	6.67	21.6
56.51	11.13	-17.92
53.57	-33.41	-1.88
57.1	-12.45	48.73
24.93	-91.83	2.23
12.08	-82.3	2.7
11.16	-100.49	15.38
28.96	-77.83	-23.52
35.23	-57.32	-34.24
-48.92	17.53	32.94
-1.67	5.86	56.8
-2.9	21.83	43.2
-54.61	22.7	-9.8
-41.54	-61.45	-11.82
-38.85	-63.44	58.57
-28.32	-92.46	26.32
-28.48	-93.03	5.18
-41.5	-72.02	-10.93

// Rowe J B, 2000: Working Memory Maintenance
// Rowe J B, 2000: Selection from Memory
// Rowe J B, 2000: Visual Presentation
// Rowe J B, 2000: Cursor Positioning
// Subjects=6
24	4	54
-22	8	60
26	-60	64
44	-34	42
-22	-62	60
42	38	28
30	18	40
40	54	-12
36	22	-16
10	-80	48
-14	-76	54
38	-82	32
-8	-96	0
10	-98	12
-12	-58	70
22	-60	68
-24	-24	74
-52	-22	18
66	-22	18
-26	-92	0
34	-84	-10
-38	-2	10
42	2	10
-14	-72	-46
-30	-54	-22
14	-64	-50
24	-50	-24
-26	0	0
24	0	0
-12	-18	6
10	-16	6
0	0	52

// Elliott R, 2000: Positive correlation with reward level
// Elliott R, 2000: Negative correlation with reward level
// Elliott R, 2000: Reward during run of success
// Elliott R, 2000: Penalty during run of failure
// Elliott R, 2000: Reward during run of success and Penalty during run of 
// failure
// Subjects=9
9	-12	-3
18	9	-6
-24	-18	-18
33	-12	-15
-15	-30	-12
12	-33	-12
6	-12	0
15	-3	6
-15	-3	6
-9	36	-3
9	36	3
-30	-12	-15
33	-21	-15
-33	15	-12
51	15	-12
-36	-6	6
42	9	-6
21	24	0
-9	12	12

// MacDonald III A W, 2000: Color > Word
// MacDonald III A W, 2000: Color, Incongruent > Color, Congruent
// Subjects=12
-42.57	22.34	25.77
5.7	5.93	43.32
55.94	2.01	43.08
64.27	-7.91	10.36
3.6	-66.18	19.28
-.88	-14.56	12.78

// Banich M T, 2000: Normals Group 1
// Subjects=14
7.75	23.67	38.47
43.93	26.74	19.95
-35.14	26.27	20.9
-47.89	9.45	24.69
48.27	14.25	23.18
-21.86	-69.91	42.19
5.63	32.63	44.43
-43.65	33.25	29.33
-41.39	14.74	37.55
-8.85	-78.86	62.87
-43.24	-39.4	53.26
33.88	-69.98	63.86
-48.13	15.68	-4.83
-54.11	-58.95	21.57

// Banich M T, 2000: Normals Group 2
// Subjects=16
5.69	22.22	47.53
-39.25	17.04	39.56
37.78	16.24	49.9
-4.67	-60.15	56.79
3.97	-56.95	69.81
-25.96	-57.13	70.16
-41.06	-49.96	54.12
-41.52	-56.87	-7.74
-39.27	-73.26	0.3
-43.49	-83.69	3.45
-15.65	-91.81	6.04
22.89	-88.61	16.48
-24.14	-86.78	16.87
-26.22	-77.48	27.27
40.05	-72.51	30.55
-15.44	-63.18	46.02

// Marois R, 2000: High Interference vs. Low Interference
// Subjects=10
32.71	-56.75	56.08
34.8	-63.85	46.61
-34.64	-48.69	56.17
51.53	13.73	29.88
55.89	12.41	39.97
3.47	26.9	39.36
5.54	24.03	29.54
-58.37	-52.21	26.63

// Stevens A A, 2000: Auditory Target Stimulus Maximum Pixel Signal
// Stevens A A, 2000: Visual Target Stimulus Maximum Pixel Signal
// Stevens A A, 2000: Visual > Auditory
// Stevens A A, 2000: Auditory > Visual
// Subjects=10
-59.55	-20.49	23.98
-59.63	-21.26	14.01
38.63	34.8	28.26
38.48	12.39	0.03
57.66	5.31	-10.75
36.43	31.9	18.49
60.21	-40.92	24.32
-49.82	-31.29	34.82
58.94	-50.73	-6.07
-57.57	-1.16	12.3
59.01	-27.95	13.21
0.34	-34.93	24.51
-28.71	-3.1	12.13
65.28	-31.66	-7.74
-36.33	15.12	0.66
-2.98	-69.07	-3.82
58.95	-30.84	3.42
4.54	7.1	30.97
7.88	-30.95	34.12
51.49	4.5	20.61
-61.66	-50.88	16.52
52.9	-44.71	44.8
-50.3	12.06	-10.08
54.79	-62.59	6.13
28.94	33.97	18.4
-41.49	6.05	21.55
49.16	13.52	-.19
5.6	7.11	30.96
47.47	-43.4	34.71
4.63	3.64	41.3
-54.02	-30.55	44.84
-51.95	-33.42	35.02
49.37	-42.53	4.51
35.43	32.66	28.47
-46.92	8.42	11.38
60.3	-25.63	43.11
51.81	-40.49	44.46
-41.35	-72.68	8.08
-51.04	9.94	31.37
-61.61	-22.9	34.25
-61.59	-49.05	26.4
54.69	4.52	20.57
32.92	48.52	-14.09
41.97	-85.72	-2.94
56.96	-69.97	6.72
-32.73	-29.08	34.43
-39.35	-58.72	-4.27
2.58	-21.75	43.45
14.77	66.18	-4.21
26.11	-87.36	18.57
64.17	20.72	9.07
26.06	-32.95	34.08
-0.02	-1.38	-9.53
-27.43	2.39	41.77
-49.79	-59.56	27.15
-43.17	-54.03	56.72
-32.62	-79.54	28.63
22.69	32.3	38.69
5.46	5.57	11.02
-17.57	-40.13	55.26
-43.83	41.22	8.59
10.53	34.63	-12.67
15.32	-102.8	-1.2
-43.87	50.74	7.79
-12.38	-21.84	43.63
-39.98	-48.73	56.24
-21.55	61.73	-3.42
23.63	-39.31	-6.62
36.87	-25	53.37
-57.43	-38.17	15.41
64.33	-21.58	12.62
43.88	-1.32	1.11
42.3	-68.04	46.88
3.61	-32.03	34.26
41.84	-28.82	3.45
-48.84	-27.83	24.48
18.24	-3.59	1.6
-1.91	-69.07	-3.83
-37.04	-41.5	25.49
53.45	-11.64	-9.28
56.59	5.3	-10.74
-62.78	-36.08	15.29
-28.7	-5.21	12.31
18.38	-20.79	13.08

// Eldridge L L, 2000: Remember > Know
// Eldridge L L, 2000: Know > Remember
// Subjects=12
-30.73	38.67	43.23
15.43	-19.21	47.55
55.94	-4.6	40.28
-44.32	-54.9	45.65
58.23	-56.82	39.06
60.03	11.06	22.19
-51.98	-40.36	27.79
-45.53	-64.02	24.13
19.59	-57.71	17.27
-60.66	-39.59	11.1
-11.77	18.44	0.1
-37.36	-7.52	-3.01
-33.11	-24.21	-12.81
23.59	-39.74	-12.16
37.5	-58.06	-16.36
13.1	21.58	38.58
-11.47	19.32	39.05
25.66	58.44	18.62

// Marois R, 2000: Identity Oddballs vs. Fixation
// Marois R, 2000: Location Oddballs vs. Fixation
// Marois R, 2000: Conjunction Oddballs vs. Fixation
// Subjects=14
46.31	-79.47	8.76
-44.52	-80.01	9.85
36.86	-76.76	30.94
-33.67	-77.18	31.79
49.52	-62.99	15.14
-47.72	-64.63	16.4
23.11	-59.98	56.46
-20.69	-61.21	58.18
46.18	-68.78	-4.41
-44.65	-69.32	-3.32
38.57	-58.05	-16.37
-36.23	-58.5	-15.47
10.26	-44.91	59.8
-6.83	-45.01	60.01
58.02	-32.65	21.42
-56.3	-33.16	25.01
45.46	-31.12	56.01
-42.16	-30.51	58.08
27.8	-35.99	-19.21
-27.77	-37.38	-18.46
46.31	-79.47	8.76
-44.52	-80.01	9.85
36.86	-76.76	30.94
-33.67	-77.18	31.79
49.52	-62.99	15.14
-47.72	-64.63	16.4
23.11	-59.98	56.46
-20.69	-61.21	58.18
46.18	-68.78	-4.41
-44.65	-69.32	-3.32
38.57	-58.05	-16.37
-36.23	-58.5	-15.47
10.26	-44.91	59.8
-6.83	-45.01	60.01
58.02	-32.65	21.42
-56.3	-33.16	25.01
45.46	-31.12	56.01
-42.16	-30.51	58.08
27.8	-35.99	-19.21
-27.77	-37.38	-18.46
46.31	-79.47	8.76
-44.52	-80.01	9.85
36.86	-76.76	30.94
-33.67	-77.18	31.79
49.52	-62.99	15.14
-47.72	-64.63	16.4
23.11	-59.98	56.46
-20.69	-61.21	58.18
46.18	-68.78	-4.41
-44.65	-69.32	-3.32
38.57	-58.05	-16.37
-36.23	-58.5	-15.47
10.26	-44.91	59.8
-6.83	-45.01	60.01
58.02	-32.65	21.42
-56.3	-33.16	25.01
45.46	-31.12	56.01
-42.16	-30.51	58.08
27.8	-35.99	-19.21
-27.77	-37.38	-18.46

// Seitz R J, 2000: Group 1 Normals
// Subjects=6
39	-9	50
8	-8	38
2	-4	60

// Seitz R J, 2000: Group 2 Normals
// Subjects=6
39	-10	50
57	3	31
56	8	11
5	-2	50
5	-8	38
8	12	36

// Seitz R J, 2000: Group 3 Normals
// Subjects=8
33	-3	47
51	16	3
3	18	42
42	30	33

// Binkofski F, 2000: Somatosensory Guided Movement vs. Rest
// Binkofski F, 2000: Imagery of Somatosensory Guided Movement vs. Rest
// Binkofski F, 2000: Visually Guided Movement vs. Rest
// Binkofski F, 2000: Imagery of Visually Guided Movement vs. Rest
// Subjects=6
-44	-32	46
39	-9	49
59	2	27
-38	-10	50
4	0	50
-5	-4	50
38	-38	44
-40	-40	40
-40	-56	52
39	-9	49
-38	-10	50
4	0	50
-5	-4	50
-5	-8	38
-40	-40	40
-44	-32	46
39	-9	49
59	2	27
-38	-10	50
-5	-4	50
-5	-8	38
-40	-40	40
-40	-56	52
39	-9	49
59	2	27
-38	-10	50
4	0	50
-5	-4	50
38	-38	44
-40	-56	52
12	-76	52

// Carter C S, 2000: Interaction between expectancy, stimulus type, and scan
// Subjects=12
1.36	20.54	39.92
-49.02	62.62	38.08

// Leung H C, 2000: Stroop Positive
// Leung H C, 2000: Stroop Negative
// Leung H C, 2000: Inverse Stroop Positive
// Leung H C, 2000: Inverse Stroop Negative
// Subjects=19
9.05	7.41	62.12
-5.91	6.18	61.28
7.72	28.87	36.92
-5.11	28.71	35.96
42.81	38.28	17.88
-41.6	36.72	18.98
48.31	12.48	27.79
-47.85	11.99	30.05
48.1	25.66	5.5
-45.93	24.03	6.71
20.39	3.2	6.58
-19.14	0.85	7.23
57.9	-40.53	2.01
-55.36	-43.24	4.66
37.48	6.47	6.11
-35.19	8.24	7.91
10.06	-51.37	31.35
-7.04	-51.56	30.45
7.34	51.33	-2.88
-6.55	51.25	-2.71
7.32	40.07	-10.86
-5.5	40.08	-9.6
10.12	4.16	61.26
-8.03	2.02	62.77
9.83	31.88	34.41
-8.31	29.83	37.02
42.82	37.23	17.97
-41.6	37.86	20
50.45	12.49	27.76
-45.7	12.17	32.24
49.19	25.92	8.81
-44.84	25.36	9.93
20.4	2.23	7.78
-19.15	1.82	6.04
57.9	-41.59	2.1
-54.3	-43.32	3.53
37.5	0.13	6.64
-34.1	1.81	7.32
10.03	-47.31	28.78
-7.07	-46.35	28.9
9.45	52.06	-7.43
-8.73	52.92	-8.41
9.42	39.74	-15.32
-6.62	38.42	-17.25

// Lurito J T, 2000: Rhyming - Rhyming Control
// Lurito J T, 2000: Fluency - Fluency Control
// Subjects=5
-48	36.85	21.27
-51.06	15.23	30.93
-57.69	15.16	3.13
-65.91	-29.79	28.18
-59.64	-47.75	1.74
-45.86	-63.04	-18.33
59.87	9.44	1.14
-60.64	-55.79	8
-58.57	-32.34	8.24
-48.03	-54.68	-20.12
-44.26	-59.75	51.64
-33.63	-59.23	43.66
-48.61	-46.29	47.21
-3.92	14.59	46.05
-3.75	-2.35	60.85
-55.56	16.15	1.91
-27.75	-61.33	-25.37
50.56	-46.78	18.23
43.83	24.57	5.64
38.69	38.74	37.96
36.34	-63.41	-30.39
30.79	-66.72	-59.05

// Honey G D, 2000: Activation vs. Baseline
// Subjects=20
-35.81	-51.93	41.96
-44.72	21.1	23.67
38.42	52.38	7.83
1.44	13.74	48.29
-44.5	-1.85	43.44
35.74	-2.55	54.84
-19.8	-9.22	56.04
-36.15	-76.3	-11.75
-36.18	-67.84	-12.46
28.99	-73.17	-18.34

// Martinkauppi S, 2000: 3-Back vs. 1-Back
// Martinkauppi S, 2000: 2-Back vs. 1-Back
// Subjects=10
5.71	21.42	50.95
-2.77	20.91	58.89
27.12	13.09	51.4
-23.09	14.11	55.24
43.94	37.83	25.71
-42.58	40.91	32.02
42.05	19.44	49.58
-39.21	20.73	45.94
49.25	22.12	14.7
-45.87	22.52	14.64
32.97	55.63	-4.65
-35.37	56.88	3.84
45.19	3.46	35.27
-42.41	8.65	41.42
26.33	-65.25	56.86
-22.85	-65.88	53.02
39.12	-51.25	57.77
-35.76	-48.16	49.45
46.48	-46.95	43.94
-48.61	-47.43	46.19
8.1	-60.58	49.99
-4.65	-64.29	58.25
55.76	-46	0.26
-52.09	-52.48	8.74
46.17	-65.61	-4.67
-50.06	-57.98	-7.55
8.73	22.73	26.27
-2.97	21.06	33.23
6.86	-40.38	36.04
-.68	-43.23	27.45
37.43	20.3	6.07
-34.2	19.53	2.49
5.68	25.48	48.37
-1.74	28.24	57.15
25.05	8.31	58.51
-22.01	12	55.4
42.9	37.02	29.14
-42.56	30.17	30.69
38.82	17.05	46.47
-38.14	20.73	45.93
43.86	24.91	10.07
-45.88	24.55	13.36
23.35	56.63	-4.62
-24.65	56.14	7.12
45.24	-1.49	40.15
-40.25	0.12	40.99
22.05	-54.36	60.46
-20.7	-62.44	56.05
34.76	-48.88	47.59
-36.83	-49.22	49.55
44.36	-48.99	45.25
-40.03	-54.7	47.82
7.06	-56.99	55.28
-4.68	-62.43	54.75
53.63	-41.61	2.15
-49.97	-53.7	6.59
-47.95	-58.23	-10.9
9.7	34.91	18.54
-4.1	25.91	27.26
10.08	-42.39	37.29
40.63	5.98	-.57
-37.39	10.88	1.03

// Nystrom L E, 2000: Group 1 Normals
// Subjects=8
3.4	32.73	32.18
-42.09	-44	62.56
24.21	-73.89	55.38
51.32	37.91	12.24
7.82	16.69	44.63
-59.81	5.38	0.63
-44.57	2.92	36.35
0.14	31.05	24.55

// Nystrom L E, 2000: Group 2 Normals
// Subjects=7
-24.18	10.58	51.08
-35.15	-49.6	-10.66
28.16	12.84	48.06
24.13	-60.49	49.8
53.51	17.57	10.57
38.93	-34.56	39.65
38.4	28	-4.63
-5.07	20.33	37.78

// Nystrom L E, 2000: Group 3 Normals
// Subjects=10
13.5	-72.01	53.12
28.21	5.7	52.01
-38.38	21.51	14.64
14.07	28.22	27.98
51.52	16.9	29.61
33.48	9.27	42.72
-38.27	14.96	26.34

// Kircher T T J, 2000: Amount of words positively correlated with BOLD 
// response
// Kircher T T J, 2000: Amount of words negatively correlated with BOLD 
// response
// Subjects=6
-51.3	0.68	-5.77
-50.82	-52.53	35.49
25.82	-72.76	-12.76
-26.53	-60.93	-6.46
1.35	-50.93	10.22
19.79	-72.2	36.33
-1.5	-56.07	54.18

// Callicott J H, 2000: Schizophrenic Patients > Normals
// Callicott J H, 2000: Normals > Schizophrenic Patients
// Subjects=13
30	45	9
-2	70	4
36	-32	53
33	26	24
32	34	17
2	54	27
-2	15	36
20	-41	-38
0	-67	-24
53	-66	11
-18	-55	36
4	27	-1
32	-48	6
-59	19	-1
6	-77	-30
14	31	2
0	-17	-2
-4	-66	11
20	37	2
22	-44	13
-34	-36	20

// Francis S T, 2000: Subject 1
// Subjects=1
-49.78	-13.35	46.69
-50.84	-15.38	47.99
-45.4	-21.01	57.32
-43.3	-22.48	51.84

// Francis S T, 2000: Subject 2
// Subjects=1
-53.02	-14.77	42.39
-50.84	-15.38	47.99
-44.35	-18.97	56.02
-43.3	-22.48	51.84

// Francis S T, 2000: Subject 3
// Subjects=1
-49.76	-17.49	48.15
-50.84	-15.38	47.99
-42.22	-21.25	53.96
-43.3	-22.48	51.84

// Francis S T, 2000: Subject 4
// Subjects=1
-52.97	-16.45	48.1
-50.84	-15.38	47.99
-44.35	-24.43	54.25
-43.3	-22.48	51.84

// Francis S T, 2000: Subject 5
// Subjects=1
-48.67	-20.57	49.52
-50.84	-15.38	47.99
-40.14	-23.95	46.36
-43.3	-22.48	51.84

// Francis S T, 2000: Subject 6
// Subjects=1
-48.69	-13.08	50
-50.84	-15.38	47.99
-43.36	-21.94	45.11
-43.3	-22.48	51.84

// Chao L L, 2000: Experiment 1, Normals
// Subjects=5
-43.64	9.21	21.31
-32.58	-45.14	46.93

// Chao L L, 2000: Experiment 2, Normals
// Subjects=5
-30.97	19.72	4.67
-52.16	6.16	23.89
-30.44	-36.24	51.74

// Griffiths T D, 2000: All Movements vs. Control Sound
// Griffiths T D, 2000: Right Movement vs. Control Sound
// Griffiths T D, 2000: Left Movement vs. Control Sound
// Subjects=4
57	6	36
48	3	48
51	9	6
60	9	3
-36	6	54
-24	-3	48
-45	3	51
-42	9	3
57	-21	48
33	-39	66
42	-30	42
-48	-27	42
0	12	45
0	-36	51
3	-54	60
-15	-48	69
-42	-54	-33
-60	-54	12
-57	-63	3
-51	-69	6
-24	12	-27
-24	21	-21
57	6	36
54	0	42
45	0	51
51	9	6
60	6	0
42	9	15
-36	6	54
-24	-6	45
-45	3	51
-63	-6	12
30	-39	66
45	-27	42
57	-21	48
-54	-24	42
0	12	45
6	15	33
0	-36	51
3	-54	60
3	-42	60
-24	15	-24
3	12	-12
-6	12	-12
57	3	36
30	0	51
51	9	6
-36	6	54
-24	-6	48
-27	6	45
-63	-3	24
33	-39	66
42	-30	42
57	-21	48
-48	-27	42
0	12	45
-9	21	30
6	6	63
0	-36	51
9	-57	63
18	-63	63
-24	12	-27
-24	21	-21
-15	12	-15
21	27	-21

// Ramnani N, 2000: Unpaired CS+ > CS-
// Ramnani N, 2000: Unpaired CS+ > Paired CS+
// Subjects=5
30	-76	-30
-56	6	2
-26	-40	-2
-8	-64	4
-6	-94	14
-16	60	12
0	36	12
-22	-56	-22
-62	-6	12
40	38	10
-6	-66	6
-6	-80	-18
36	56	-12

// Tracey I, 2000: Positive regions of activation common to noxious cold and 
// noxious heat stimulation
// Subjects=6
30.81	58.7	-6
40.46	49.25	-5.32
50.15	43.47	1.75
43.79	24.14	0.1
1.46	5.11	46.79
57.79	8.88	7.91
50.38	-10.2	9.59
61.07	-10.13	9.46
-41.12	-46.16	48.23
34.86	-37.99	64.51
-68.03	-45.03	23.91
11.07	-34.44	29.92
43.79	10.94	-5.49
-41.69	20.46	1.39
27.89	8.96	11.59
-21.39	0.78	-7.23
4.43	-10.47	10.14
7.68	-16.54	13.96
14.07	-29.96	4.97
14.03	-27.05	1.39
-1.84	17.26	39.11
-1.84	17.26	39.11
-11.54	16.44	29.26
1.51	-30.56	39.74
-8.03	-29.84	49.83

// Corbetta M, 2000: Cue
// Corbetta M, 2000: Target
// Corbetta M, 2000: Valid - Invalid
// Subjects=13
-24.98	-65.73	55.26
-25.03	-55.32	52.16
-22.97	-67.08	37.51
-27.26	-76.08	31.62
30.59	-56.59	58.32
24.21	-62.97	58.93
32.53	-71.84	26.12
55.83	-56.32	4.48
-24.98	-63.61	55.08
-25.06	-55.67	47.73
-27.3	-78.71	25.15
36.94	-48.44	53.1
30.46	-71.16	35.01
58.06	-44.36	21.29
9.11	-73.24	37.66
-7.93	-70.54	46.55
43.34	-44.17	52.67
58.16	-47.74	32.72
62.27	-45.02	12.38
9.14	-75.18	40.05
-3.7	-71.03	39.85

// Hopfinger J B, 2000: Leftward-Directing Cue
// Hopfinger J B, 2000: Rightward-Directing Cue
// Hopfinger J B, 2000: Cues > Targets
// Hopfinger J B, 2000: Attended Left Target
// Hopfinger J B, 2000: Attended Right Target
// Hopfinger J B, 2000: Targets > Cues
// Subjects=6
-16	48	36
-44	36	16
-20	-4	52
24	0	56
-16	-52	56
24	-40	56
-44	-64	32
-44	-48	36
40	-68	28
36	-48	36
-12	-44	28
8	-36	28
-60	-24	8
48	-12	8
-36	-76	8
32	-80	8
-28	-4	12
28	-8	16
-16	48	36
-44	36	16
-20	0	48
24	4	52
-16	-56	56
20	-40	52
-40	-64	28
-40	-48	32
40	-64	32
32	-48	32
-8	-44	32
4	-40	28
-56	-24	8
48	-12	8
-36	-76	4
24	-84	8
-28	-8	16
24	0	16
-16	48	36
-52	32	16
-32	16	48
20	8	48
-12	-56	56
8	-40	56
-44	-64	32
-44	-48	32
44	-60	36
36	-44	32
0	-40	44
4	-44	32
-56	-24	8
48	-12	8
-36	-76	4
28	-80	0
-28	-8	20
24	-8	12
4	8	52
-40	-16	56
32	-16	52
40	-4	52
-56	12	32
-36	28	4
44	12	24
32	24	4
-36	-36	56
28	-44	56
-24	-64	48
24	-60	60
-28	-68	32
-12	-64	8
-24	-48	0
-28	-60	-4
24	-76	28
36	-68	16
12	-60	0
20	-56	4
28	-48	-8
4	8	52
-36	-16	56
36	-20	56
36	-4	52
-52	12	32
-36	28	4
44	12	24
32	24	4
-36	-40	56
24	-48	56
-20	-68	44
20	-60	60
-28	-68	24
-12	-68	0
-24	-44	-4
-28	-60	-4
24	-76	28
36	-64	12
8	-60	8
24	-64	0
24	-40	0
0	4	52
-36	-16	56
36	-16	60
32	4	60
-56	8	32
-36	24	4
52	4	40
32	28	0
-28	-32	64
28	-48	56
-16	-72	48
12	-68	52
-28	-72	28
-8	-64	4
-24	-44	8
-28	-60	-4
24	-76	28
36	-68	20
4	-64	8
20	-56	4
24	-48	-16

// van Turennout M, 2000: Main Effects, Nameable Objects > Noise
// van Turennout M, 2000: Main Effects, Nonsense Objects > Noise
// van Turennout M, 2000: Repetition Effects, 30-Sec Delay, Repeated < Novel
// van Turennout M, 2000: Repetition Effects, 3-Day Delay, Repeated < Novel
// van Turennout M, 2000: Repetition Effects, 30-Sec Delay, Repeated > Novel
// van Turennout M, 2000: Repetition Effects, 3-Day Delay, Repeated > Novel
// Subjects=8
-36	-72	-12
44	-76	-12
-44	-62	-12
36	-52	-20
-42	28	16
-40	8	8
-38	-80	-8
40	-84	-8
-38	-56	-20
36	-52	-20
-26	-78	-20
42	-68	-16
-44	-54	-12
44	-56	-16
-22	-84	0
34	-78	4
-26	-74	-16
40	-78	-12
-40	-48	-12
46	-58	-16
-40	28	16
-22	-74	-20
-40	4	8
-38	6	8

// Cohen L G, 2000: Conjunction of LVF and RVF Relative to Rest
// Subjects=5
-39	15	30
-36	48	33
42	45	27
45	6	57
0	9	54
30	33	6
51	21	0
-33	-3	57
-30	-63	57
39	-51	42
-51	-39	57
-57	-54	6
-42	-57	-6
-27	-57	21

// Connolly J D, 2000: Pro-Saccade vs. Fixation
// Connolly J D, 2000: Anti-Saccade vs. Fixation
// Connolly J D, 2000: Pro-Pointing vs. Fixation
// Connolly J D, 2000: Anti-Pointing vs. Fixation
// Subjects=7
-10.07	-72.75	45.64
14.51	-72.6	45.35
-42.23	-41.05	45.58
43.29	-44.68	46.02
2.57	1.14	50.45
-30.53	-2.06	53.33
31.43	0.34	51.3
-11.18	-77.59	38.25
16.6	-69.76	40.62
-33.66	-61.69	39.41
36.86	-61.35	37.46
-42.28	-41.56	38.94
44.31	-46.25	39.45
3.55	3.55	40.2
-30.59	2.8	47.35
30.32	3.17	46.62
-27.41	8.11	46.87
27.08	8.35	45.11
-38.13	1.01	38.66
55.88	11.27	38.95
-11.16	-67.56	44.1
19.84	-62.88	46.7
-45.54	-30.12	35.78
42.22	-47.95	45.19
2.7	-44.75	48.72
-35.86	-48.04	37.17
2.6	-4.06	52
-40.18	-19.98	42.68
-26.27	-4.32	51.24
34.65	-5.01	50.6
0.24	16.76	32.44
2.4	37.81	42.92
50.39	16.29	21.87
48.26	14.08	20.96
-10.13	-73.44	36.78
16.61	-71.88	40.8
-29.42	-59.81	35.86
32.55	-65.06	31.13
-36.88	-47.53	43.84
43.29	-47.94	45.18
2.67	-57.16	39.73
3.74	-48.26	44.54
-45.55	-35.67	32.9
2.6	-4.06	52
2.54	8.54	49.83
-43.4	-21.31	39.48
-28.43	-6.79	47.01
37.86	-7.11	50.74
-28.47	5.9	45.95
30.33	3.25	47.73
3.43	15.47	29.17
-48.96	7.15	22.66
49.35	9.94	22.41
-43.44	-1.93	42.32

// Tagamets M A, 2000: Words vs. Shapes
// Tagamets M A, 2000: Pseudowords vs. Shapes
// Tagamets M A, 2000: Letter Strings vs. Shapes
// Tagamets M A, 2000: False Fonts vs. Shapes
// Tagamets M A, 2000: Letter Strings vs. Words
// Tagamets M A, 2000: False Fonts vs. Words
// Subjects=11
-10	-100	-6
-14	-98	-8
-20	-94	-12
-38	-90	-2
-40	-86	-8
-32	-84	-16
-42	-74	-18
-46	-70	-16
-46	-56	-22
-58	-40	-6
-56	-56	-12
-34	22	-28
-48	36	-14
-46	28	16
-50	28	16
36	-96	0
22	-90	-16
24	-88	-18
-10	-100	-6
-34	-96	0
-24	-86	-16
-44	-72	-18
-42	-70	-20
-46	-52	-22
-34	-92	8
-48	30	-14
-52	32	-8
-46	48	2
38	-96	-4
16	-94	-10
16	-100	-6
14	-98	-8
22	-88	-18
44	-72	-16
44	-44	-24
44	-68	-24
-54	30	16
-52	32	10
-12	-100	-8
-16	-98	-10
-20	-96	-10
-38	-90	-2
-38	-84	-12
-26	-84	-16
-44	-66	-18
-44	-62	-20
-46	-54	-22
-38	-48	-24
-34	-94	12
-30	-90	30
-38	-88	20
-32	-70	30
-24	-70	46
-26	-68	56
-52	42	8
38	-96	-2
18	-98	-6
14	-102	0
42	-92	6
24	-86	-20
22	-88	-16
40	-74	-18
42	-42	-26
46	-76	-8
26	-100	12
28	-98	14
32	-96	14
34	-94	16
30	-82	30
-18	-96	-10
-40	-88	0
-36	-84	-12
-32	-82	-14
-42	-68	-20
-44	-70	-16
-46	-70	-12
-44	-56	-22
-30	-90	28
-26	-70	36
-18	-72	54
-42	-50	54
-40	-52	56
-40	-54	60
-52	26	30
38	-94	0
20	-92	-12
12	-100	2
10	-98	0
26	-84	-18
46	-58	-20
46	-54	-22
40	-50	-22
40	-44	-26
38	-80	20
32	-76	32
28	-72	52
38	-54	58
48	-46	56
52	-42	56
50	-76	-2
52	-68	-10
50	-64	-12
44	46	-16
36	26	-12
42	50	6
44	48	20
42	6	58
-22	-70	48
-42	-44	48
-32	-90	4
-36	-88	12
-44	-86	6
-30	-64	-8
-18	-72	50
-42	-46	48
-26	-70	34
34	-92	0
38	-92	-10
44	-62	-20
34	-80	24
32	-70	36
26	-72	48
52	-38	40
42	-44	38
54	-40	48
32	28	-8
36	56	12
40	46	22
34	0	48
38	22	52
18	32	22

// De Zubicaray G I, 2000: Increases
// De Zubicaray G I, 2000: Decreases
// De Zubicaray G I, 2000: Linear Increases With Number of Trials Equated Per 
// Block
// De Zubicaray G I, 2000: Linear Decreases With Number of Trials Equated Per 
// Block
// Subjects=8
40	34	36
34	44	20
-10	62	0
-30	56	0
-16	-10	65
-52	-76	12
-60	-46	-14
20	-68	56
14	-72	28
-24	-76	-14
44	-74	-14
-24	-98	-6
-4	-86	-12
-36	-78	32
-24	-82	14
40	50	28
34	40	36
-10	62	0
38	60	16
-52	-74	10
32	-58	56
-44	-66	46
-56	-46	44
-20	-79	-16
40	-76	-18
-28	-84	32
40	50	28
34	40	36
-10	62	0
38	60	16
-52	-74	10
32	-58	56
-44	-66	46
-56	-46	44
-20	-78	-16
40	-76	-18
-28	-84	32
-30	14	56
-16	48	-8
28	46	-16
-12	66	12
-6	32	0
66	-48	4
-52	-4	-26
22	-64	-18
-18	-50	-20
-36	-56	-22
-16	-20	-6

// Lee K M, 2000: Multiplication vs. Subtraction
// Lee K M, 2000: Subtraction vs. Multiplication
// Subjects=11
-49.7	-54.4	31
-23.3	33.2	44.2
11.1	-74.9	5.3
51.3	-9.1	23.6
2.15	49.5	15.7
-3.3	-44.5	49.1
-31.5	-52.1	49.9
-24.4	1.4	56.2
-47	8.7	29.3
-55.8	-58	-8.7
28.7	-54.6	52.4
24.2	1.8	54.8
42.5	10.8	30.8
46.6	-57.3	-1.8

// Stanescu-Cosson R, 2000: All Calculation vs. Letter Matching
// Stanescu-Cosson R, 2000: Small Numbers vs. Letter Matching
// Stanescu-Cosson R, 2000: Exact Calculation > Approximation
// Stanescu-Cosson R, 2000: Approximation > Exact Calculation
// Stanescu-Cosson R, 2000: Problem Size Effect During Exact Calculation
// Subjects=7
-52	12	24
-48	16	48
32	-64	44
48	-36	48
32	-60	28
48	44	24
40	16	40
44	32	-4
-40	-56	48
-60	-44	48
-52	44	0
-60	40	16
-52	44	28
-8	32	52
-4	24	56
4	-76	8
56	20	28
48	44	24
44	20	40
48	-36	48
4	-68	32
12	-80	36
20	-76	28
-32	64	4
-40	60	-4
-8	60	16
-8	-56	20
20	-80	28
40	-76	20
-44	-72	36
-44	-64	24
-60	-64	-28
48	-16	8
56	-12	8
68	-12	0
44	-36	52
36	-36	44
20	-60	60
28	-72	52
4	-60	52
-56	-44	52
-48	-40	44
-32	-68	56
-56	13	24
48	16	20
48	13	28
-32	4	64
-48	-48	-28
-48	-56	-40
-40	-52	-52
-44	64	12
-36	68	16
-48	36	32
12	-16	16
-20	-8	16
-52	8	28
-56	12	20
-44	-52	48
-56	-36	52
-8	20	52
8	28	36
32	28	4
44	40	32
36	52	20
-44	20	4
-36	32	0
28	-56	52
36	-48	48
44	-44	48

// Thomsen T, 2000: Males
// Subjects=6
22	-73	38
-20	-51	52
36	8	28
-41	20	18
25	-62	42
36	20	22
22	-69	42
-27	-50	43

// Thomsen T, 2000: Females
// Subjects=5
22	-73	38
-20	-51	52
36	8	28
-41	20	18
25	-62	42
36	20	22
22	-77	38
40	24	22
-20	-58	46
-38	20	22

// Banich M T, 2000: Incongruent > Congruent, Color
// Banich M T, 2000: Object > Color
// Banich M T, 2000: Incongruent > Congruent, Object
// Subjects=10
-49.97	14.35	33.22
54.73	21.32	31.43
-43.75	32.22	16.04
58.9	29.12	21.81
44.01	20.91	27.13
14.28	-87.06	9.76
-15.59	-96.59	13.13
-15.47	-94.33	28.56

// Kimberg D Y, 2000: Switch - Repeat
// Subjects=9
-35.79	-21.04	56.1
-37.32	-65.28	-20.47
-26.08	-62.82	51.68
18.64	-4.93	53.01
-3.1	-28.64	-3.86
33.76	-49.34	55.44
32.99	28.42	-12.41
53.71	-80.28	-2.41
61.22	-3.05	32.29

// Perry R J, 2000: Target vs. Null
// Perry R J, 2000: Non-Target vs. Null
// Perry R J, 2000: R Non-Target vs. Null
// Perry R J, 2000: L Non-Target vs. Null
// Perry R J, 2000: Non-Target vs. Target
// Subjects=7
-16	-100	-8
18	-96	2
-30	-76	24
38	-74	22
-36	-48	56
-22	-62	46
30	-52	54
-38	-48	56
40	-44	48
60	-36	36
-22	6	50
28	8	48
50	8	32
8	18	50
-40	40	26
-40	32	6
36	26	-12
-16	-100	-6
16	-96	0
-30	-78	24
40	-76	18
-36	-48	56
-20	-64	50
24	-58	62
-36	-48	56
36	-40	42
66	-34	32
-22	14	60
26	8	50
-34	4	46
38	2	42
6	16	50
-38	38	24
-38	20	-2
22	22	-6
-18	4	14
12	2	8
-12	-88	-4
-28	-84	22
-30	-52	56
-18	-66	52
30	-58	60
-40	-44	52
38	-36	40
58	-40	36
-28	6	54
26	8	50
-34	4	44
38	2	42
6	14	52
-40	36	24
-34	18	4
22	24	-8
-20	8	0
10	14	2
14	-90	2
-30	-76	24
34	-82	26
-26	-54	58
-20	-64	46
22	-56	60
-38	-38	44
36	-42	44
66	-34	32
-22	16	60
26	6	50
-32	2	50
38	4	42
6	16	50
-38	42	30
-42	18	0
24	22	4
-24	14	-4
10	4	8
-22	12	60
24	8	52
-34	2	42
40	4	42
4	14	52
24	22	4
-22	8	0
24	14	-4

// Thulborn K R, 2000: Elderly Normals Subjects
// Subjects=10
-3.78	-.41	58.46
-35.88	-6.58	50.43
-35.1	40.96	31.93
-26.14	-73.36	39.19
5.84	1.85	59.28
36.77	-2.97	49.29
33.27	42.25	28.81
27.29	-69.7	40.5

// Thulborn K R, 2000: Probable Alzheimer's Disease Patients
// Subjects=18
-2.67	-5.43	62.22
-35.86	-7.46	52.73
-39.38	33.19	28.17
-26.08	-63.87	51.77
3.74	-3.28	61.96
34.67	-8.1	51.97
35.4	42.27	28.78
30.56	-60.28	51.94

// Kiehl K A, 2000: Task 1, Errors of Commission
// Kiehl K A, 2000: Task 1, Correct Rejects
// Kiehl K A, 2000: Task 1, Errors of Commission vs. Correct Rejects
// Kiehl K A, 2000: Task 2, Correct Hits
// Subjects=14
4	22	40
-4	4	60
12	36	12
-34	41	20
45	-75	-10
22	-60	-10
-52	-79	-5
-8	-8	60
48	-68	-16
38	-70	-24
4	8	40
30	-88	-16
4	22	40
-8	45	15
-36	-24	52
-32	-16	64
-4	4	55
-52	-72	4
44	-80	-8
6	20	40
-36	20	0
48	-72	-4
20	-60	-20
60	-32	20
-56	-32	24
-44	-56	-12

// Riecker A, 2000: Overt Speech vs. Rest
// Riecker A, 2000: Covert Speech vs. Rest
// Riecker A, 2000: Overt Singing vs. Rest
// Riecker A, 2000: Covert Singing vs. Rest
// Subjects=18
-1.58	14.84	46.64
71.51	0.28	13.22
-72.17	-5.65	15.13
-36.9	20.05	-10.42
30.12	-48.38	-22.72
-31.46	-42.01	-20.06
-1.85	21.58	26.93
-68.96	9.46	15.82
33.32	-65.05	-28.97
-1.58	14.84	46.64
71.54	0.49	15.44
-72.14	-5.44	17.35
35.46	17.97	-13.69
26.86	-48.49	-23.78
-31.47	-48.59	-21.65
-1.55	15.04	48.86
74.76	-1.84	13.37
-29.34	-54.32	-25.61

// Pihlajamaki M, 2000: Category Fluency vs. Number Listing
// Subjects=14
-24.56	-25.22	-12.82
-20.22	-37.71	-9.59
-30.9	-48.69	-13.01
-39.57	26.82	0.83
35.33	19.49	9.5
-41.42	7.88	31.43
-4.89	12.27	57.41
-9.33	-55.31	9.6
-26.11	-67.48	46.5

// Manoach D S, 2000: Normals
// Subjects=9
-44.7	32.36	31.65
47.09	48.25	22.57
1.51	15.48	57.07
-41.36	4.08	37.33
17.6	12.92	63.79
-28.25	-65.37	46.35
41.22	-61.53	48.57
-28.83	24.22	7.61
40.66	24.9	10.11
-15.04	66.06	10.64
-47.77	17.25	42.99
27.59	42.05	-14.6
43.98	16.25	21.94

// Manoach D S, 2000: Schizophrenia Patients
// Subjects=9
-48.01	31.22	17.28
40.73	35.53	23.71
1.46	21.57	53.21
-25.24	8.46	51.27
31.41	5.63	50.86
-24.97	-71.18	53.49
34.88	-64.14	56.67
-28.86	20.54	1.23
34.2	24.34	3.53
17.1	17.64	0.95
-11.66	-1.31	6.21
13.99	-1.16	5.91
-28.8	-18.3	-5.55
-38.55	59.32	8.13
34.01	52.12	-8.83
-58.63	12.13	19.01
4.44	16.02	22.42
54.44	13.92	-9.21
4.63	-34.74	26.67
-52.2	-60.2	-8.46

// Critchley H D, 2000: Autism Spectrum Disorder (ASD) Patients
// Subjects=9
38.38	-2.89	-18.76
32.18	-52.37	-11.2
7.47	38.36	8.24
-25.71	39.85	2.92
-50	-27.72	12.21
5.79	-52.45	31.49
-54.35	-28.43	3.4
-1.99	-76.53	-17.7
-23.53	19.34	-.96
-20.15	-67.75	-12.65
-44.77	-4.68	6.88
-36.28	-26.09	-9.27
-60.76	-28.47	3.48
-20.02	-63.12	5.92
25.78	-61.13	-13.74
4.38	-64.86	-18.75
-20.18	-9.82	7.02
-51.08	-43.21	4.6
-23.53	19.34	-.96
-26.58	-73.5	-17.67
-44.77	-4.68	6.88
-30.87	-9.97	6.04

// Critchley H D, 2000: Healthy Controls
// Subjects=9
-20.15	-67.75	-12.65
-44.77	-4.68	6.88
-36.28	-26.09	-9.27
-60.76	-28.47	3.48
-20.02	-63.12	5.92
25.78	-61.13	-13.74
4.38	-64.86	-18.75
-20.18	-9.82	7.02
-51.08	-43.21	4.6
-23.53	19.34	-.96
-26.58	-73.5	-17.67
-44.77	-4.68	6.88
-30.87	-9.97	6.04

// Critchley H D, 2000: Main Effect When Processing Mixed vs. Neutral Facial 
// Expressions, Activations
// Critchley H D, 2000: Main Effect When Processing Mixed vs. Neutral Facial 
// Expressions, Deactivations
// Critchley H D, 2000: Explicit Processing, Stimulation > Control
// Critchley H D, 2000: Explicit Processing, Control > Stimulation
// Critchley H D, 2000: Implicit Processing, Stimulation > Control
// Critchley H D, 2000: Implicit Processing, Control > Stimulation
// Subjects=9
-41.43	-51.62	5.2
19.36	-59.05	-13.84
-13.56	-90.03	1.41
-23.35	-43.56	-2.38
-33.12	-14.44	-10.28
-29.76	-31.45	3.37
-11.62	-21.83	2.36
-51.16	-37.38	-2.58
-11.67	-22.34	-4.29
-36.35	16.09	-.54
53.6	-33.07	2.55
-26.57	-76.67	-17.41
32.15	-37.31	-9.11
22.58	-64.32	-13.43
-23.37	-13.01	7.33
-39.36	-58.89	-6.48
-41.43	-51.62	5.2
-51.08	-43.21	4.6
25.67	-56.78	-26.37
-41.56	-6.78	7.01
-26.73	28.21	3.91
25.7	10.55	4.79
41.88	-15.28	13.46
22.46	-17.28	-10.68
25.65	-14.09	-10.99
-36.33	-14.46	-10.24
-17.01	1.83	6.01
-13.49	-83.8	13.15
-44.82	20.15	11.48
-32.69	-52.85	29.74
26.05	-58.3	22.83
50.4	3.18	17.39
-54.44	-17.31	-4.22
56.84	-42.57	3.31
-4.97	-50.03	22.49
-23.38	-73.48	-17.71
-13.56	-90.03	1.41

// Audenaert K, 2000: Letter Fluency vs. Resting
// Audenaert K, 2000: Category Fluency vs. Resting
// Subjects=20
-39	27	-6
-51	9	6
-6	24	27
-6	9	21
18	15	39
54	-60	-9
60	-51	3
-42	45	3
-48	15	3
-54	15	24
21	18	18
-6	24	30
36	54	0

// Buchanan T W, 2000: Sad vs. Happy
// Buchanan T W, 2000: Sad vs. Verbal
// Buchanan T W, 2000: Verbal vs. Sad
// Buchanan T W, 2000: Happy vs. Verbal
// Buchanan T W, 2000: Verbal vs. Happy
// Buchanan T W, 2000: Emotion vs. Verbal
// Buchanan T W, 2000: Verbal vs. Emotion
// Subjects=10
36	44	24
40	8	28
4	-4	28
-48	32	-16
8	-76	8
32	-28	28
-60	-48	12
-60	16	4
44	20	16
-12	4	20
40	-48	32
-48	32	-16
-56	-44	8
8	-76	8

// Garavan H, 2000: Function of Switching Frequency
// Garavan H, 2000: Not a Function of Switching Frequency
// Subjects=11
-44.69	9.38	23.54
49.4	9.4	29.15
4.65	14.9	49.27
34.22	47.66	16.08
-26.28	-3.35	50.04
50.34	-29.29	-3.3
-28.75	-35.39	-6.35
-38.03	-35.28	37.24
-37.85	-47.66	56.12
41.07	-32.35	40.55
-20.77	-64.27	46.17
-12.09	-37.59	73.94
-32.46	-60.31	57.12
-4.85	-86.15	23.29
4.61	-67.92	10.5
-28.31	-81.38	32.08
0.18	-17.9	10.81
21.59	-5.28	20.66
-36.23	-61.84	-17.42
-30	-38.34	-30.62
0.39	10.65	49.68
-45.6	-3.26	39.11
34.57	4.08	44.26
27.88	32.99	19.61
40.79	14.21	23.27
55.63	22.96	11.21
49.26	6.89	10.4
59.1	1.51	36.39
40.84	2.57	24.24
47.26	-52.14	4.22
54.82	-63.39	9.54
47.54	-32.77	48.32
-35.79	-47.36	46.04
-50.78	-37.84	46.53
-25.03	-61.92	49.37
-19.67	-72.72	46.87
25.21	-57.05	52.84
5.62	-5.92	27.59
9.82	-14.33	14.86
23.62	-25.13	-2.23

// Riecker A, 2000: Horizontal Tongue Movement vs. Rest
// Riecker A, 2000: "Ta" Repetition vs. Rest
// Riecker A, 2000: "Stra" Repetition vs. Rest
// Riecker A, 2000: Lexical Word Production vs. Rest
// Riecker A, 2000: Polysyllable Repetition vs. Rest
// Subjects=10
57	-3	24
-63	-3	30
18	-63	-27
-18	-66	-24
60	0	24
-54	-6	27
51	-6	21
-57	-3	27
21	-60	-27
51	-12	23
-42	-15	33
39	-15	33

// Knutson B, 2000: Reward
// Knutson B, 2000: Punishment
// Subjects=12
36.33	18.81	0.63
11.86	3.32	8.9
-9.55	6.1	5.57
25.69	2.72	-.13
-23.45	-1.81	0.81
0.35	10.22	44.14
-38.07	-4.9	44.73
35.23	22.86	-1.93
-27.82	23.54	-1.26
12.9	5.27	6.49
-9.56	7.08	4.37
24.62	2.79	0.99
-20.28	5.53	-.95
-4.12	-16.07	7.36
5.56	18.74	29.98
0.36	10.3	45.25
-31.68	3.68	45.06

// Carlsson K, 2000: Tickle vs. Rest
// Carlsson K, 2000: Rest vs. Tickle
// Carlsson K, 2000: Anticipation vs. Rest
// Carlsson K, 2000: Rest vs. Anticipation
// Carlsson K, 2000: Tickle vs. Anticipation
// Carlsson K, 2000: Anticipation vs. Tickle
// Subjects=7
16	60	16
40	20	0
-60	4	4
4	16	40
20	-40	68
12	-48	68
-24	-36	68
-32	-40	64
56	-24	24
44	-32	32
60	-48	12
-60	-20	16
24	20	32
-32	60	4
-36	44	-8
-48	20	36
-28	16	48
-40	20	24
36	-20	40
-40	20	44
0	-24	48
-8	-68	28
40	-64	40
-36	-52	20
-36	-56	44
-4	-68	48
36	24	-4
-32	28	-4
4	16	40
-20	-44	60
48	-44	48
52	-44	20
-52	-32	24
-4	-68	48
24	20	36
-28	24	44
28	-28	64
-24	-24	56
0	-16	48
-4	-56	32
44	4	0
-60	-4	8
-48	8	0
60	-24	24
60	-48	12
-64	-20	12
24	-40	68
12	-48	68
-24	-36	68
-32	-40	64
-32	56	4
-36	40	-4
-48	32	24
36	-20	40
-32	-20	40
16	-44	32
-12	-64	32
28	-64	44

// Bartels A, 2000: Activations With Partner's Picture
// Bartels A, 2000: Deactivations With Partner's Picture
// Subjects=17
-44	6	-4
-4	30	24
-22	-2	24
-22	0	10
-38	-34	-10
-4	-60	-28
44	10	-6
6	34	16
14	4	22
26	0	2
36	-30	-2
40	-50	-38
26	-34	-38
-44	16	42
-44	24	24
-58	-2	-22
0	-54	22
-10	10	4
-22	-10	-26
22	36	46
4	42	44
32	20	50
50	34	30
46	-64	20
40	-64	40
66	-12	-12
66	-30	4
54	-24	2
56	2	-34
8	-40	32
4	-52	22
22	-8	-22

// Aziz Q, 2000: Proximal - Rest
// Aziz Q, 2000: Distal - Rest
// Aziz Q, 2000: Proximal - Distal
// Aziz Q, 2000: Distal - Proximal
// Subjects=6
-26.2	-24.49	51.82
4.66	-15.73	38.46
47.02	-1.9	-6.68
-41.2	-12.95	51.02
-39.14	8.21	49.22
35.55	22.95	40.44
-47.82	3.53	30.76
-51.1	11.54	24.55
-44.57	4.06	37.37
47.08	32.76	14.95
-29.7	30.59	34.97
-29.32	-47.78	53.81
1.49	2.11	49.27
-26.72	-62.81	-30.83
-23.47	-47.05	-19.93
-5.3	-50.11	-19.88
1.25	15.03	23.65
-41.35	0.91	37.59
-51.05	-15.41	20.11
-39.46	29.07	16.25
-54.42	-7.28	1.63
7.79	16.44	41.3
16.66	-55.96	53.96
-44.6	0.38	30.98
-41.54	26.4	23.19
50.27	-13.51	-5.74
-41.3	-1.83	43.4
32.62	-23.71	56.65
4.64	16.93	47.99
-41.2	-12.95	51.02
-26.21	-21.32	51.55
32.36	19.76	40.74
-54.31	11.52	24.59
-23.52	-60.68	-31.05
-41.61	32.23	16.01
-54.28	-9.08	19.62
10.98	16.28	39.05
-47.74	-4.42	38.11

// Delgado M R, 2000: Main Effect of Time, Increasing Activation
// Delgado M R, 2000: Main Effect of Time, Decreasing Activation
// Delgado M R, 2000: Interaction of Condition by Time
// Subjects=9
5.67	12.19	41.68
-45.52	-23.27	41.9
-53.09	2.07	39.86
73.02	-17.87	32.28
-41.41	-21.69	20.53
50.43	11.18	24.53
-45.81	3.31	14.02
51.26	20.85	-1.94
-18.18	31.6	5.76
-33.05	10.45	8.82
-7.34	-16.17	6.29
12.88	14.87	6.8
-4.25	10.11	1.82
-11.79	5.06	-7.7
-21.92	-74.91	32.58
36.66	-83.21	2.49
43.91	-56.96	-16.52
-43.71	-58.54	-15.38
11.88	54.01	31.41
-10.56	52.82	31.77
-4.88	-31.48	42.12
-1.64	-56.38	36.37
41.87	-12.02	14.3
41.83	-22.31	5.13
-57.62	-16.02	-.95
-11.75	17.55	2.4
12.83	18.76	2.02
43.94	43.29	27.48
-13.95	0.39	-12.86
-21.36	-14.37	-10.42
-33.96	20.87	33.6
34.27	21.77	11.56

// Sabatini U, 2000: Healthy Controls
// Subjects=6
-32	-18	40
32	-30	45
-32	-14	50
-4	-12	50
4	10	55
-2	10	40
-42	-32	30
-30	-50	45
30	-46	40
-32	-8	45
4	10	55
-40	-46	30
-30	8	50
44	8	35
30	-20	40
-30	-20	55
34	-12	45
-4	0	50
8	12	30
-4	0	45
6	-4	45
-27	-30	40
38	-46	35
-40	6	35
36	-10	40

// Sabatini U, 2000: Parkinson's Disease Patients
// Subjects=6
-36	-20	40
-4	-12	50
-4	-2	45
-40	-30	30
30	-48	45
38	-34	35
34	-48	40
-42	4	35
34	-12	45
4	10	55
-40	-46	30
-30	8	50
44	8	35
30	-20	40
-30	-20	55
34	-12	45
-4	0	50
8	12	30
-4	0	45
6	-4	45
-27	-30	40
38	-46	35
-40	6	35
36	-10	40

// Lotze M, 2000: Right Foot vs. Rest (n=5)
// Lotze M, 2000: Right Elbow vs. Rest (n=5)
// Lotze M, 2000: Right Fist vs. Rest (n=10)
// Lotze M, 2000: Left Fist vs. Rest (n=10)
// Lotze M, 2000: Right Thumb vs. Rest (n=5)
// Lotze M, 2000: Right Finger Opposition with Complexity vs. Rest (n=9)
// Lotze M, 2000: Lips vs. Rest (n=10)
// Lotze M, 2000: Right Finger Opposition with Simple Complexity vs. Rest 
// (n=5)
// Lotze M, 2000: Right Finger Opposition with Complex Complexity vs. Rest 
// (n=5)
// Lotze M, 2000: Right Finger Opposition with Highly Complex Complexity vs. 
// Rest (n=5)
// Subjects=30
-8	-38	76
-28	-24	64
-26	-34	64
24	-20	60
-32	-24	58
-40	-16	56
-58	-14	40
52	-8	36
-42	-10	58
-34	-18	-52
-34	-16	50

// Castelli F, 2000: ToM > Random
// Castelli F, 2000: Random > ToM
// Castelli F, 2000: Correlation: Activation vs. Intentionality Score
// Subjects=6
65.51	-56.63	13.31
39.6	-59.53	-21.83
37.17	5.5	-33.95
41.98	-100.96	-7.24
-60.68	-49.62	5.25
-39.54	-47.49	-24.17
-39.78	-6.05	-38.79
-30.71	-99.45	-8.76
-32.99	-87.8	-23.09
-3.17	67.33	26.01
-.57	-97.04	19.69
-62.81	-49.63	5.28
-37.41	-45.36	-24.37
-15.69	-105.36	-3.97
-5.3	65.2	26.21
67.66	-58.74	13.46
41.72	-57.57	-24.25
32.92	3.53	-31.51
24.46	-0.06	-22.19
44.12	-100.94	-7.26

// Badgaiyan R D, 2000: Priming > Look-only (rCBF decrease)
// Badgaiyan R D, 2000: Priming > Look-only (rCBF increase)
// Badgaiyan R D, 2000: Baseline > Look-only (rCBF increase)
// Badgaiyan R D, 2000: Priming > Baseline (rCBF decrease)
// Subjects=10
30.49	-85.08	33.94
-46.73	-8.27	29.5
42.67	39.03	-0.02
-37.45	41	5.19
-54.16	-5.68	36.06
50.18	36.07	2.37
-45.91	41.9	17.48
24.01	-83.69	24.98

// Lazar S W, 2000: Meditation vs. Control
// Lazar S W, 2000: Late vs. Early meditation
// Subjects=5
7.36	36.1	-7.18
31.01	-15.03	-9.85
1.05	-12.29	-13.09
-15.02	-16.07	-19.28
-25.67	-25.65	-18.35
-5.02	30.79	49.17
-41.48	35.8	34.67
13.79	52.77	1.39
-20.73	-45.18	59.07
-20.68	-61.04	60.39
-31.39	-54.76	59.99
-28.27	-52.43	48.61
44.44	-58.08	51.59
-34.76	-33.43	47.09
64.59	-59.5	31.41
64.38	-58.47	3.44
-28.86	-22.24	-15.25
50.72	-6.69	55.02
-24.97	-34.92	68.29
-4.67	-28.2	70.84

// Hall D A, 2000: Main Effect of Modulation: Modulated - Static Tone
// Hall D A, 2000: Main Effect of Task: Target Discrimination - Passive 
// Listening
// Subjects=6
-50	-8	-6
54	-12	-2
-58	-52	18
-58	-28	0
-44	-48	60
0	0	48
-46	-20	28
-50	-8	44
-56	-24	42
-2	-28	26
-12	-20	0
-36	20	0
46	-28	8
52	-40	0
58	-48	18
2	0	58
50	12	42
54	-16	44
50	-20	44
-2	-32	26
34	24	0

// Ng V W K, 2000: Differential Cortical Activations, ON > OFF
// Subjects=10
23.09	-59.09	54.15
-7.91	-71.42	48.85
-16.51	-68.73	43.15
-20.02	-87.32	-4.32
32.29	-75.38	-5.92

// Dupont S, 2000: Left Medial Temporal Lobe Epilepsy (LMTLE)
// Subjects=7
-33.75	-44.73	54.2
-46.9	-29.76	42.86
-66.84	-36.76	3.55
-57.09	-43.11	4.01
-57.29	30.9	3.42
-37.83	27.78	3.39
-37.88	53.62	4.2
-60.08	4.67	32.95
-60.32	32.45	20.12
-53.77	36.29	26.36
-44.2	54.84	17.63
-44.31	60.6	10.34
-50.49	26.73	27.25
-37.74	48.17	14.82
-34.69	66.39	2.88
-4.61	17.55	64.35
-1.67	41.53	45.12
-8.19	28.12	39.84
40.77	-38.09	52.28
34.45	-46.75	63.33
37.58	-50.86	53.59
46.71	36.64	24.61
30.35	64.99	18.72
36.9	58.94	22.57
40.04	51.64	13.15
8.38	11.21	64.76
-11.45	-67.23	19.07
-37.09	-42.18	47.28
-46.97	-66.42	29.68
-66.55	-44.46	24.48
-43.98	-35.43	16.48
-60.4	18.75	11.4
-57.35	23.9	-2.61
-41.06	24.58	3.77
-44.48	39.59	-7.75
-47.62	56.77	4.05
-60.32	32.45	20.12
-53.77	36.29	26.36
-50.66	38.55	15.99
-50.75	51	11.4
-40.97	58.04	17.26
-50.48	23.53	27.56
-43.94	10.79	28.71
-53.6	14.57	35.23
-47.21	40.12	32.59
-31.11	-55.78	4.82
-21.39	-55.74	4.66
-18.22	-46.47	0.32
-8.13	25.24	43.48
-1.31	14.68	67.94
40.33	30.86	32.01
50.15	28.33	38.82
53.44	5.69	37.64
11.09	-61.7	8.05
27.42	-60.71	17.76
23.95	-46.01	2.92
30.47	-55.56	3.75
4.86	38.67	48.65
8.11	25.61	46.53

// Dupont S, 2000: Healthy Controls (HC)
// Subjects=10
-14.71	-73.93	16.43
-17.87	-83.2	20.76
-27.53	-76.23	26.96
-33.74	-47.92	54.52
-33.74	-57.81	52.13
-30.56	-64.8	46.05
-60.31	-36.42	6.77
-57.32	27.4	0.4
-41.16	30.34	-3.52
-5.06	-64.64	11.98
17.68	-67.43	15.23
20.96	-76.99	16.12
24.28	-86.24	20.34
46.43	31.27	1.61
11.13	-61.39	11.38
-17.88	-80.01	20.44
-17.85	-66.63	25.84
-44.01	-61.89	9.01
-53.74	-25.89	15.7
-47.44	-23.93	1.95
-37.03	-35.17	53.31
-30.45	-60.68	55.72
-70.01	-32.96	9.95
-66.63	-35.2	20.2
-60.16	-41.87	17.39
-60.32	-33.23	6.45
-47.14	-44.7	20.81
-57.32	27.4	0.4
-44.37	20.75	-2.52
-44.41	30.33	-3.47
-50.58	16.22	18.2
-47.41	25.49	13.87
-43.96	13.99	28.4
-31.15	-56.09	1.49
-11.61	-58.59	8.13
-11.81	-50.26	-6.14
-34.54	-40.77	-6.69
-21.55	41.54	11.84
-15.08	34.87	9.03
59.51	22.37	9
43.19	31.26	1.67
7.81	-62.02	4.78
17.49	-62.3	1.28
14.22	-42.85	2.77
30.35	-46.61	-3.85
23.94	-42.82	2.6
27.23	-55.57	3.81

// Trojano L, 2000: Imagery > Experiment 1 Control
// Trojano L, 2000: Imagery > Experiment 2 Control
// Trojano L, 2000: Perception > Experiment 2 Control
// Trojano L, 2000: Syllable Counting > Experiment 2 Control
// Trojano L, 2000: Imagery > Syllable Counting
// Trojano L, 2000: Imagery > Perception
// Subjects=7
-23.93	-69.23	51.08
-21.89	-72.45	36.83
25.24	-75.37	49.92
27.3	-80.62	36.95
-31.54	-46.53	42.57
-32.04	26.32	7.48
48.07	18.71	-1.73
-16.43	-69.02	53.21
27.38	-67.7	52.59
-30.47	-48.64	42.74
-31.99	19.17	11.42
41.67	11.19	-2.14
5.56	34.14	36.5
-33.63	-21.82	59.48
-59.66	-23.8	8.65
68.51	-14.83	3.08
41.72	41.36	16.52
-26.07	-63.79	52.88
30.64	-62.68	62.17
-26.17	-48.36	46.01
35.77	-42.87	42.61
-4.97	9.3	46.51
5.74	1.96	47
-31.5	-21.9	58.35
-42.51	-70.37	-3.25
41.82	-63.15	-13.75
-35.99	-82.33	6.6
35.61	-83.05	4.72
-47.52	-46.11	49.41
48.62	-42.54	45.78
-36.36	18.12	-1.82
50.24	11.41	-0.03
-3.7	-10.56	64.89
5.82	0.53	56.04
-42.16	-27.16	60.03
-53.27	-19.54	8.22
58.83	-16.72	-6.69
49.36	30.89	31.81
-18.56	-65.69	55.18
19.85	-62.71	48.92
-51.34	16.72	-4.88
48.05	15.28	-4.79
-46.46	-43.99	49.22
57.18	-42.4	46.78
47.27	26.99	36.62
-1.93	33.93	34.37
5.57	34.23	37.61
57.88	17.48	22.8
-46.86	-60.16	-8.52
48.25	-68.31	-12.28
-35.99	-82.33	6.6
35.61	-83.05	4.72

// Kawashima R, 2000: Memory Timed Finger Movement - Rest
// Kawashima R, 2000: Visually Cued Finger Movement - Rest
// Kawashima R, 2000: Silent Articulation - Rest
// Kawashima R, 2000: Memory Timed - Visually Cued with Memory Timed - Rest
// Kawashima R, 2000: Visually Cued - Memory Timed with Visually Cued - Rest
// Subjects=8
-38.99	-4.51	63.67
-51.93	-1.38	50.17
50.67	8.2	54.88
7.94	8.12	57.61
-56.58	7.85	4.85
54.49	14.52	-1.45
-49.72	-24.81	49.88
56.99	-32.22	26.98
-24.59	-58.48	-30.11
26.67	-58.52	-35.15
-34.69	-12.94	64.33
-36.87	-4.67	61.43
50.66	8.03	52.67
59.02	17.12	31.74
50.37	42.44	29.71
54.45	16.29	-6.06
3.68	1.58	55.98
-41.06	-36.76	59.71
-54.09	-32.38	34.96
59.1	-32.55	22.52
67.51	-27.36	6.37
-48.13	9.16	-6.51
7.63	-28.06	2.66
30.94	-56.38	-35.38
3.69	8.26	59.88
-52.37	9.48	-2.03
-45.88	43.3	21.82
-56.54	3.97	9.63
-22.41	-60.24	-25.52
-20.29	-56	-25.9
59.03	23.8	35.64
-28.2	-47.26	60.44
31.66	-59.93	56.35

// Jancke L, 2000: Auditory Synchronization > Rest
// Jancke L, 2000: Auditory Continuation > Rest
// Jancke L, 2000: Rest > Auditory Continuation
// Jancke L, 2000: Auditory Synchronization > Auditory Continuation
// Jancke L, 2000: Visual Synchronization > Rest
// Jancke L, 2000: Visual Continuation > Rest
// Jancke L, 2000: Rest > Visual Continuation
// Jancke L, 2000: Visual Synchronization > Visual Continuation
// Jancke L, 2000: Visual Continuation > Visual Synchronization
// Jancke L, 2000: Auditory > Visual
// Jancke L, 2000: Visual > Auditory
// Subjects=8
-52	-8	44
-44	-20	52
-56	-24	44
-32	-28	64
-4	-4	52
-64	-28	16
-64	-36	28
-48	-36	52
56	-32	32
12	-64	-48
4	-56	-12
-16	-20	-4
-52	-8	44
-44	-20	52
-56	-24	44
-32	-28	64
-4	-4	52
-64	-36	28
-48	-36	52
56	-32	32
12	-64	-48
4	-56	-12
16	-48	-24
60	-20	4
-60	-16	8
60	-20	4
-44	-4	56
-44	-16	56
0	0	60
44	-4	56
56	8	40
-44	-32	52
-56	-32	44
40	-56	48
52	-40	48
48	-48	52
16	-48	-24
-12	-88	0
4	-80	4
-44	-4	56
-44	-16	56
0	0	60
-32	-12	60
-52	-20	44
-44	-32	52
-56	-32	44
40	-56	48
52	-40	48
48	-48	52
20	-52	68
16	-48	-24
-12	-88	0
4	-80	4
44	-4	56
56	8	40
-12	-88	0
4	-80	4
-32	-12	60
-52	-20	44
20	-52	68
12	-64	-48
-24	-16	20
-48	-4	44
64	0	32
-36	-40	40
-8	0	48
60	-52	-4
-4	-68	-24
40	-52	-28
56	-36	48

// Jancke L, 2000: Right Fast, Left Slow
// Jancke L, 2000: Right Slow, Left Fast
// Jancke L, 2000: Right Fast
// Jancke L, 2000: Right Slow
// Jancke L, 2000: Left Fast
// Jancke L, 2000: Left Slow
// Subjects=11
-40	-20	48
28	-16	60
0	0	56
-40	-16	48
32	-28	52
-4	-4	48
-44	-20	44
-40	-20	48
-8	-4	48
40	-24	48
40	-24	48
0	-8	44

// Lutz K, 2000: Random > Rest
// Lutz K, 2000: Random > Regular
// Lutz K, 2000: Regular > Rest
// Lutz K, 2000: Regular > Random
// Subjects=10
-48	-16	48
-60	-20	20
44	-4	44
4	0	60
-8	4	56
48	4	24
28	-8	48
-52	16	-4
-24	0	60
16	-52	-24
4	-60	-16
-32	-56	-28
-48	-68	8
64	-40	8
-44	-68	8
-48	-68	8
48	-68	0
-24	0	60
-4	8	48
-44	-8	44
-36	-44	52
32	-52	-48
4	-72	-20
-20	-16	12
-60	-20	20
-40	-12	60
4	0	60
-8	-4	60
48	-68	0
-44	-68	8
16	-52	-24
-4	-64	52

// Cabeza R, 2001: True/False vs. New
// Cabeza R, 2001: New vs. True/False
// Cabeza R, 2001: True vs. False
// Cabeza R, 2001: False vs. True
// Subjects=12
41.58	42.11	-1.39
41.01	14.32	52.25
-40.73	53.42	0.84
-32.85	22.37	39.04
44.21	-50.62	24.2
-48.63	-48.75	42.96
14.4	-46.34	40.92
-8.01	-68.05	37.42
62.15	-49.48	-3.98
-20.05	-33.8	13.49
-43.85	26.79	0.88
-40.11	-20.35	51.63
18.12	35.79	1.64
-55.08	-54.59	36.83
38.1	0.71	-54.75
4.38	-83.52	-26.11
17.81	55.69	-30.13

// Gosain A K, 2001: Smile vs. Rest
// Gosain A K, 2001: Finger-tapping vs. Rest
// Subjects=5
50.58	-3.74	38.04
-52	-7.61	38.43
41.11	-16.52	52.61
-45.44	-19.15	53.82

// Grafton S T, 2001: Normals-1a
// Subjects=7
24.68	-15.35	0.28
-11.62	-21.83	2.36
-15.68	-62.41	14.73
-59.58	-17.4	22.61
-2.77	-41.67	34.03
4.59	18.62	42.27
-12.17	-25.15	69.55
8.63	-71.69	-24.92
37.5	-63.6	-19.24
49.15	-31.64	-19.82

// Grafton S T, 2001: Normals-1b
// Subjects=6
-8.31	-12.95	20.53
47.35	-2.87	35.78
-11.29	-20.6	45.74
-43.36	-11.02	48.65
46.48	-17.37	54.85
0.63	-6.67	73.43
9.26	-24.51	75.95
-28.91	-65.62	-39.49
40.67	-57.32	-20.92
-51.02	-55.73	7.88
50.65	-73.3	19.34

// Herath P, 2001: Visual - Control
// Herath P, 2001: Somatosensory - Control
// Herath P, 2001: Dual-Short ISI - Control
// Herath P, 2001: Dual-Long ISI - Control
// Herath P, 2001: Dual Task - Single Tasks
// Herath P, 2001: Dual Short ISI - Long ISI
// Subjects=10
-32.53	-23.68	62.97
-2.79	-1.26	47.37
-35.53	-34.88	-54.26
-30.95	1.32	0.64
-13.79	-11.1	3.71
-26.75	4.89	-8.63
-39.36	-30.28	5.62
-52.15	-30.02	10.2
28.9	6.08	1.78
31.07	2.03	4.33
18.14	7.44	-7.13
-39.01	-17.88	55.87
-.59	-18.17	48.76
-43.42	-23.68	36.33
61.3	-31.86	31.36
-32.57	-21.9	58.36
-26.72	-3.57	-7.92
-26.57	-8.54	10.34
-13.9	-3.49	-8.08
24.73	-8.24	9.72
57.04	-34	31.58
50.67	-31.41	38.13
-28.78	-24.73	-6.12
1.57	1.91	60.44
-36.87	-24.39	54.16
-47.56	-26.74	52.25
-9.55	-13.7	-2.81
-28.82	7.85	2.3
30.98	14.38	-1.17
-34.68	-50.27	49.61
-30.52	-44.75	37.95
-26.08	-56.22	54.48
-32.71	-3.56	47.91
-19.84	-18.45	46.78
-24.1	-9.51	52.77
39.8	1.85	28.78
37.71	13.27	38.99
52.77	-36.14	31.81
50.42	10.03	23.51
56.88	3.9	26.18

// Indovina I, 2001: Move vs. No-Move
// Indovina I, 2001: Move-Attend vs. No-Move
// Indovina I, 2001: Move-Attend vs. Move
// Indovina I, 2001: Attend vs. No-Move
// Subjects=9
-38	-20	68
-44	-18	48
-30	-8	50
-60	8	24
-58	8	4
50	-24	36
-4	-4	52
-2	10	44
-10	10	40
52	18	-4
52	12	12
58	12	24
-30	-68	-26
16	-52	-26
4	-64	-26
-44	-18	56
-54	-28	56
-26	-2	54
-42	-30	42
48	-22	48
62	-22	40
60	-16	14
36	-64	56
54	-26	44
-2	-4	54
-4	16	46
8	18	44
-4	14	38
-32	16	4
42	24	-2
56	20	-4
54	18	18
42	26	-20
-32	-66	-28
-14	-62	-26
36	-54	-34
10	-62	-18
-2	-88	-24
-6	26	38
2	26	26
8	30	38
44	-26	64
32	-10	70
32	-64	62
38	20	-8
36	26	-30
-36	-74	-22
-42	-58	-20
48	-68	-26
46	-70	-16
-8	-84	-26
2	-8	8
6	-24	-2
-2	8	56
-6	14	38
48	-20	46
54	-14	38
38	-26	46
42	-8	50
38	22	2
-40	-70	-30
-38	-62	-20
42	-70	-30

// Mayer A R, 2001: Right Hand > Foot
// Mayer A R, 2001: Right Foot > Hand
// Subjects=7
-6.9	9.23	73.3
-3.83	-15.19	46.32
-4.7	-18.68	70.04
-6.04	-2.85	40.85

// Poellinger A, 2001: Short Odorant vs. No Odorant State
// Poellinger A, 2001: Long Odorant vs. No Odorant State
// Subjects=10
21	-3	-9
-25	-3	-9
28	6	-15
-21	0	-9
25	3	-28
12	-6	-15
-25	-3	-15
18	-12	-21
-21	-15	-15
25	18	9
-31	15	0
34	0	6
-37	0	12
9	-18	12
-6	-18	15
28	33	-9
9	0	18
-12	0	15
6	-3	18
-12	-3	15
21	6	9
-21	6	9
43	12	3
-50	9	9
50	-27	0
9	9	43
1	-9	34
-12	6	-5
34	-24	-12
-31	-24	-15
31	-30	9
-25	-33	-9
31	12	9
15	-9	6
-6	39	-12
21	42	0
40	39	0
-31	48	-3
31	30	-12
-18	30	-9
53	-15	-9
-1	42	25
12	9	43
3	-54	28
-15	-45	34

// Rao S M, 2001: Time-2.5 > Control
// Rao S M, 2001: Time-5.0 > Control
// Rao S M, 2001: Time-7.5 > Control
// Rao S M, 2001: Time-10.0 > Control
// Rao S M, 2001: Pitch-5.0 > Control
// Rao S M, 2001: Pitch-7.5 > Control
// Rao S M, 2001: Pitch-10.0 > Control
// Subjects=17
24.55	9.68	-6.28
-56.36	-10.7	26.47
42.18	-37.37	44.31
-2.73	4.88	58.01
13.9	8.9	-1.63
-11.73	8.92	0.89
5.44	-21.01	-2.37
5.4	-10.44	-3.25
26.08	-1.97	49.33
-46.59	-2.5	49.09
50.4	11.98	21.11
-53.14	-12.71	27.72
40.05	-40.64	43.49
55.78	-39.23	5.27
-47.82	-58	5.81
34.16	19.6	-2.76
-36.33	13	0.84
-2.82	11.68	49.63
13.91	7.93	-.43
-8.55	8.68	-2.47
-2.1	-75.44	-31.17
5.44	-21.01	-2.37
6.46	-9.37	-3.36
26.1	2.6	53.41
37.53	27.85	21.05
41.12	-45.04	41.61
38.44	18.57	-2.72
-35.3	16.98	-2.86
-6.07	15.55	44.88
40.88	5.2	30.71
-47.92	6.9	19.32
-40.66	46.36	5.89
-43.67	30.79	25.08
-31.55	-47.67	41.56
-36.82	-51.34	49.73
-20.7	-64.56	56.23
-7.42	6.03	4.43
17.24	9.24	16.15
25.7	8.35	3.86
28.82	7.51	-7.26
-20.25	0.41	1.71
3.25	-75.32	-30.13
50.63	6.72	49.43
34.2	51.89	15.72
44.96	33.98	17.1
33.65	-54.86	39.18
12.4	-66.9	50.47
37.38	19.7	-1.69
-37.41	13.97	-.35
-3.96	17.51	42.46
-49.02	7.7	15.92
-37.47	50.69	6.61
-41.48	18.2	27.22
-29.43	-51.18	37.36
-28.29	-47.14	48.16
-20.69	-61.21	58.18
-4.96	12.64	48.46
-32.62	-45.48	42.5
37.34	19.36	-6.12
-35.32	20.07	-4.23
-2.82	13.8	49.45
40.83	8.03	26.02
-46.84	6.99	20.42
-30.46	-54.1	40.97
-12.12	-70.77	57.77
-37.46	18.91	-5.22
-45.75	10.52	24.57
-37.48	43.92	1.6
-44.23	-55.1	56.82
-24.97	-63.44	57.3

// Rushworth M F, 2001: Response Switch Right vs. Left
// Rushworth M F, 2001: Visual Switch Color vs. Shape
// Rushworth M F, 2001: Response Switch minus Visual Switch
// Rushworth M F, 2001: Visual Switch minus Response Switch
// Subjects=20
-33	-72	38
-23	-71	50
-33	-60	54
17	-64	52
-29	-69	55
10	-73	55
-11	-63	51
-6	-71	48
-4	-77	44
3	-61	52
9	-57	48
-48	-41	48
-53	-34	43
-38	-44	39
50	-35	30
29	-40	45
15	-66	34
29	-69	33
-34	-59	37
-33	-54	46
-19	-72	42
16	-66	48
-23	-70	49
-10	-62	50
-45	-34	38
-17	-78	53
-26	-79	47
-29	-75	46
-53	-38	25
-26	-66	33
-29	-48	44
-30	-45	54

// Sperling R A, 2001: Novel vs. Fixation
// Sperling R A, 2001: Repeated vs. Fixation
// Sperling R A, 2001: Novel vs. Repeated
// Subjects=8
-8.17	-84.03	9.76
47.12	-70.14	-22.15
-47.98	-67.28	-17.95
47.07	-50.85	-20.42
28.36	-58.69	45.14
-25.04	-52.15	51.89
-14.8	-33.57	2.26
17.28	-29.94	4.94
-8.42	-4.21	9.76
-41.41	10.17	33.47
-48.02	21.19	11.43
-32.1	49.84	8.85
47.09	31.79	16.14
27.61	29.11	-16.86
1.19	55.09	32.56
-34.93	-91.3	0.64
14.21	-87.83	-.21
-38.32	-56.94	-8.89
44.25	-86.37	16.05
40.83	-88.7	-13.83
-25.03	-55.32	52.16
34.7	-66.02	32.3
-44.66	-56.21	1.16
40.77	-59.64	-9.57
-17.99	-36.76	2.57
14.08	-33.14	5.24
23.49	-18.76	-16.15
-65.18	0.77	-3.38
-14.86	5.27	9.04
-20.97	18.26	53.75
-11.52	46.27	43.48
47.24	10.19	25.76
-44.79	21.47	14.72
30.97	24.07	0.25
27.56	28.59	-23.51
-8.76	45.01	-14.43
-5	17.76	45.8

// Dehaene S, 2001: Visible Words vs. Visible Blanks
// Dehaene S, 2001: Visible Words > Masked Words
// Dehaene S, 2001: Same vs. Different Word, Same Case
// Dehaene S, 2001: Same vs. Different Word, Independent of Case
// Subjects=37
-40	-56	-24
-35	-72	-4
-40	-84	-12
-32	24	0
-4	8	48
8	4	64
-32	-56	40
-28	-76	28
-52	8	32
-52	-12	40
-48	8	4
32	-48	40
36	-60	-24
32	20	0
44	0	36
-32	-72	-16
-36	-88	-8
-48	-60	-12
-44	-52	-16
-56	-4	36
-44	0	28
32	-80	-16
24	-88	4
-44	-52	-20
-44	4	28
44	4	28

// Grosbras M H, 2001: New, Memory vs. Rest
// Grosbras M H, 2001: Familiar, Memory vs. Rest
// Grosbras M H, 2001: New, Memory vs. Familiar, Memory
// Grosbras M H, 2001: Familiar, Memory vs. New, Memory
// Subjects=10
-28	-12	56
-32	-8	64
-32	0	52
24	-8	48
-48	-12	52
-52	-8	48
36	-4	44
-8	-4	64
8	-16	64
-12	8	60
4	-48	-12
-32	-52	72
-28	-76	32
-28	-60	56
24	-56	56
-48	-32	44
32	-28	40
-28	-56	32
-44	-56	32
-36	-76	20
-12	-72	8
-28	-16	52
24	-8	48
-48	-12	52
4	52	-8
-16	40	52
4	56	32
-28	-60	48
24	-48	24
-44	-56	28
-12	-72	8
12	-72	8
28	-60	4
-32	0	52
20	0	56
-12	8	56
12	8	56
-12	-64	64
12	-64	64
-28	-60	56
20	-56	56
24	-44	40
-28	-64	28
28	-68	40
52	-16	36
44	-28	40
-36	-48	48
28	-48	48
-40	-52	56
-48	-36	44
32	-52	28
28	-72	32
24	-72	36
-28	-76	20
-44	-72	16
-24	-12	24
-28	0	24
24	-48	24
28	-60	4

// Kastner S, 2001: Visual Stimulation vs. Blank
// Kastner S, 2001: SEQ vs. SIM
// Subjects=8
-3	-80	8
-3	-79	-6
-12	-76	-13
-18	-74	-17
-23	-59	-11
-21	-91	24
-44	-75	8
-8	-80	-13
-14	-71	-14
-21	-74	-17
-22	-60	-11
-21	-90	23
-45	-69	4

// Pochon J B, 2001: MAT vs. MAT CONT
// Pochon J B, 2001: REP vs. REP CONT
// Pochon J B, 2001: REP vs. MAT
// Subjects=8
27	3	51
30	-51	54
-24	-51	60
-45	-39	45
27	-63	39
42	45	27
27	3	51
30	-51	54
-24	-51	57
27	-63	39
42	39	33
-36	-18	60
-6	0	57
-42	-27	60
27	6	9
-24	12	6

// Buccino G, 2001: Mouth with Object Film - Static Mouth
// Buccino G, 2001: Mouth Film - Static Mouth
// Buccino G, 2001: Hand with Object Film - Static Hand
// Buccino G, 2001: Hand Film - Static Hand
// Buccino G, 2001: Foot with Object Film - Static Foot
// Buccino G, 2001: Foot Film - Static Foot
// Subjects=20
48	0	32
-56	0	36
60	8	24
-64	12	20
60	16	20
52	-24	20
52	-32	44
-36	-52	56
-60	-24	36
52	0	32
-52	4	44
56	12	16
-60	16	16
60	28	20
48	0	44
-56	-4	44
56	12	12
-64	4	24
40	-40	52
-36	-40	52
52	0	48
-60	-4	40
40	-4	60
-32	-8	64
24	-60	68
-32	-64	60
44	-4	56
-40	-4	60

// Bunge S A, 2001: Load 6 > Load 4
// Bunge S A, 2001: Load 4 High Recency > Load 4
// Bunge S A, 2001: Load-related Activation and Load Susceptibility
// Bunge S A, 2001: Interference-related Activation and Interference 
// Susceptibility
// Subjects=16
-42	-2	32
-34	20	4
36	24	4
36	30	-4
38	46	0
40	34	20
48	26	28
26	2	56
8	20	44
2	4	28
-28	-70	36
44	-50	48
16	-46	-16
24	-62	-24
44	16	36
6	2	32
2	24	28
4	4	48
-34	30	8
-52	-40	4
6	-10	8
10	-72	-16
-46	8	-12
42	20	36
52	-52	16

// Burton H, 2001: Early Blind
// Subjects=9
-3.97	-86.97	-1.19
13.13	-91.27	-3.26
-14.54	-94.64	10.73
13.16	-90.93	1.18
-5.93	-98.3	17.63
13.3	-91.67	19.08
-16.69	-96.94	8.71
34.6	-90.11	9.78
-42.54	-72.91	-8.62
34.26	-62.9	-23.72
-23.02	-76.4	27.14
30.46	-71.16	35.01
-40.38	-74.84	-6.25
47.17	-64.09	-12.62
-46.79	-52.88	3.13
-50.73	-36.27	53.09
-42.78	32.26	2.64
-51.1	17	26.32
-53.11	5.15	38.49
36.58	7.12	28.37
-3.94	14.42	43.84
6.74	12.2	41.67
-3.81	4.7	55.8

// Burton H, 2001: Late Blind
// Subjects=7
0.33	-97.69	-2.57
13.12	-93.56	-5.29
0.36	-97.35	1.86
11.02	-95.34	-.66
-29.53	-95.07	6.47
30.32	-92.43	7.8
-31.91	-77.76	-17.25
32.18	-71.03	-18.55
-25.19	-67.95	26.45
26.2	-66.62	39.13
-44.78	-60.75	-16.3
49.27	-71.1	-20.97
-35.87	-37.21	39.61
-42.78	32.26	2.64
-44.67	10.69	26.77
-44.65	6.46	27.13
-6.1	16.35	41.47
0.45	6.85	55.57

// Just M A, 2001: Sentence Comprehension vs. Fixation
// Just M A, 2001: Mental Rotation vs. Fixation
// Just M A, 2001: Sum of Single Tasks
// Just M A, 2001: Dual Task
// Just M A, 2001: Dual Task vs. Sum of Single Tasks
// Subjects=18
-54.36	-18.74	4.82
55.7	-20.28	2.57
-29.34	-50.23	49.55
32.63	-52.15	46.77
-51.13	-15.12	10.05
53.59	-12.29	9.73
4.64	-74.26	11.03
-26.4	-72.76	5.68
35.57	-69.13	5.78
-35.06	30.38	32.82
35.43	39.27	31.26
1.32	17.91	33.45
-38.38	21.51	14.64
43.85	24.74	7.85
-41.29	3.71	46.28
42.02	7.04	40.58
0.34	22.19	47.6
-35.89	-3.32	51.27
41.01	-0.03	45.65
2.62	3.86	58.03
2.27	-58.01	-12.61
-54.36	-18.74	4.82
55.7	-20.28	2.57
-29.34	-50.23	49.55
32.63	-52.15	46.77
-51.13	-15.12	10.05
53.59	-12.29	9.73
4.64	-74.26	11.03
-26.4	-72.76	5.68
35.57	-69.13	5.78
-35.06	30.38	32.82
35.43	39.27	31.26
1.32	17.91	33.45
-38.38	21.51	14.64
43.85	24.74	7.85
-41.29	3.71	46.28
42.02	7.04	40.58
0.34	22.19	47.6
-35.89	-3.32	51.27
41.01	-0.03	45.65
2.62	3.86	58.03
2.27	-58.01	-12.61
-54.36	-18.74	4.82
55.7	-20.28	2.57
-29.34	-50.23	49.55
32.63	-52.15	46.77
-51.13	-15.12	10.05
53.59	-12.29	9.73
4.64	-74.26	11.03
-26.4	-72.76	5.68
35.57	-69.13	5.78
-35.06	30.38	32.82
35.43	39.27	31.26
1.32	17.91	33.45
-38.38	21.51	14.64
43.85	24.74	7.85
-41.29	3.71	46.28
42.02	7.04	40.58
0.34	22.19	47.6
-35.89	-3.32	51.27
41.01	-0.03	45.65
2.62	3.86	58.03
2.27	-58.01	-12.61
-54.36	-18.74	4.82
55.7	-20.28	2.57
-29.34	-50.23	49.55
32.63	-52.15	46.77
-51.13	-15.12	10.05
53.59	-12.29	9.73
4.64	-74.26	11.03
-26.4	-72.76	5.68
35.57	-69.13	5.78
-35.06	30.38	32.82
35.43	39.27	31.26
1.32	17.91	33.45
-38.38	21.51	14.64
43.85	24.74	7.85
-41.29	3.71	46.28
42.02	7.04	40.58
0.34	22.19	47.6
-35.89	-3.32	51.27
41.01	-0.03	45.65
2.62	3.86	58.03
2.27	-58.01	-12.61
-54.36	-18.74	4.82
55.7	-20.28	2.57
-29.34	-50.23	49.55
32.63	-52.15	46.77
-51.13	-15.12	10.05
53.59	-12.29	9.73
4.64	-74.26	11.03
-26.4	-72.76	5.68
35.57	-69.13	5.78
41.01	-0.03	45.65

// Michael E B, 2001: Visual Object Relative - Baseline
// Michael E B, 2001: Auditory Object Relative - Baseline
// Subjects=9
-54.31	-36.8	5.22
41.85	-26.54	5.48
-57.51	-11.56	15.41
41.86	-18.79	9.29
-43.63	14.76	24.19
49.34	19.72	24.94
-29.69	-73.64	-5.36
30.14	-73.36	-7.18
2.47	-72.42	7.55
-33.61	-61.18	46.06
34.75	-59.97	41.82
-22.9	-58.65	50.18
25.24	-62.25	54.39
-38.25	27.28	34.23
37.54	41.14	27.74
-39.16	4.78	46.17
38.9	2.42	49.93
-2.67	-3.23	63.15
-54.33	-29.4	4.6
57.86	-23.36	3.92
-47.91	-19.33	10.37
53.61	-14.32	11.02
-44.73	18.81	21.63
44.99	20.06	16.04
-45.85	-51.95	-12.57
47.13	-45.85	-10.8
4.64	-67.57	14.93
-34.71	-60.38	42.66
47.46	-44.63	32.59
-11.1	-59.21	55.67
29.52	-62.14	55.45
-35.12	35.33	27.94
40.77	33.75	28.32
-42.33	1.76	48.69
49.59	3.62	50.82
-2.62	-6.06	67.84

// Palmer E D, 2001: Increased Activation, All Conditions
// Palmer E D, 2001: Decreased Activation, All Conditions
// Palmer E D, 2001: Interaction Between Time and Rate
// Subjects=10
-46.87	5.59	16.08
-53.35	4.87	7.29
-32.09	21.4	-1.03
51.56	0.87	28.72
47.21	13.19	23.28
36.26	23.59	-6.46
-4.02	22.37	36.48
6.64	24.37	33.96
-3.79	2.76	58.2
-1.75	10.55	48.6
-24.98	-68.01	53.22
30.56	-61.34	52.02
-42.63	-62.85	-16.15
44.96	-58.27	-19.77
-53.02	-4.91	46.02
-50.98	-10.32	30.84
55.94	1.92	41.97
49.53	-9.03	38.5
55.81	-5.97	22.56
-38.43	-72.31	-28.79
32.09	-67.66	-29.99
-23.27	-19.64	17.92
-6.26	-22.68	4.6
-6.26	-9.48	10.18
-6.34	-27.94	-8.34
10.82	-18.35	4.04
-15.06	58.14	4.61
-12.33	-63.13	32.59
-8.34	43.83	39.19
-29.7	28.39	34.04
13.24	-52.75	26.97
10.83	47.66	31.96
10.92	46.41	43.21
21.64	38.01	43.8
43	27.05	37.78
40.71	-14.11	1.11
-46.57	-65.97	26.53
-55.09	-54.76	34.61
-46.58	-55.05	30.08
43.19	-65.43	25.46
59.75	-11.65	-23.85
51.78	-58.35	33.69
-59.28	-53.93	45.74
-7.96	-57.68	47.7
58.19	-51.79	35.29
-29.78	-47.11	-6.47
-18.95	-82.83	-1.36
25.94	-82.56	-1.9
34.4	-41.64	3.49
-4.02	22.37	36.48
6.64	24.37	33.96
49.53	-9.03	38.5
-53.35	4.87	7.29
36.26	23.59	-6.46

// Shulman G L, 2001: Early Onset
// Shulman G L, 2001: Late Onset
// Subjects=12
6.81	8.48	48.67
-27.33	-6.52	50.32
38.94	-5.96	51.74
-31.45	-53.25	52.06
32.39	-75.49	6.35
-29.58	-93.3	1.87
34.52	-93.09	-1.12
-44.57	-74.01	4.88
47.29	-67.29	1.03
-21.08	-96.05	-6.92
21.69	-99.85	-4.86
8.77	22.1	31.89
49.46	1.2	33.18
-34.04	40.88	30.81
36.34	48.56	13.75
53.59	15.17	20.81
-29.92	21.76	3.37
32.03	24.07	0.24
55.69	8.15	12.45
32.67	-50.58	53.33
51.83	-42.52	45.74
17.71	-68.27	46.06
55.99	-39.29	32.04
-16.92	-86.13	-16.72
30.09	-83.74	-17.46
-27.58	-74.94	-8.62
32.21	-68.58	-14.3
-42.58	-62.34	-9.5
-14.84	-14.27	3.99
8.72	-15.73	10.53
-32.1	-57.81	-34.54
25.64	-54.84	-28.76

// Vandenberghe R, 2001: Shifting Attention - Maintaining Attention
// Vandenberghe R, 2001: Overt Shifting - Fixation
// Vandenberghe R, 2001: Sustaining Attention - Fixation
// Subjects=12
-24	-57	57
-33	-54	57
15	-63	51
27	-57	60
12	-81	0
-9	-69	0
0	-87	3
0	-72	15
15	-78	-12
24	-75	-12
-18	-75	-12
-9	-75	-12
3	-81	33
54	-60	33
57	-51	30
60	-45	42
-42	-60	48
-48	-63	33
48	12	-42
39	48	21
51	33	21
12	24	42
15	42	0
6	42	33
9	9	48
39	30	-9
-30	27	-15
-45	-63	6
21	-93	-3
-18	-96	3

// Dassonville P, 2001: Spatial/CCW - Spatial/Direct
// Dassonville P, 2001: Symbolic/Direct - Spatial/Direct
// Dassonville P, 2001: Symbolic/CCW - Spatial/Direct
// Subjects=8
-37.12	4.82	32.76
-11.1	-71.36	50
-32.6	-51.91	41.92
-32.55	-70.06	41.21
-4.71	-70.35	48.72
28.23	0.41	52.45
42.98	3.82	26.34
19.86	-72.49	46.39
33.69	-61.03	41.93
12.38	-69.27	47.32
7.81	21.01	45.38
28.34	-77.61	34.46
41.11	-81.39	25.7
33.39	-88.32	-8.2
-39.28	4.55	29.46
-15.38	-68.13	50.89
-29.4	-55.23	39.93
-6.85	-68.25	48.57
-23	-77.29	29.44
-27.49	-87.2	-2.02
-43.73	9.33	9.03
20.92	-78.11	42.39
32.62	-59.89	42.96
5.72	15.97	49.17
38.79	-92	-1.26
-23.07	3.27	52.8
-37.12	3.76	32.84
-42.59	6.85	18.15
-12.19	-71.54	47.79
-27.23	-62.54	41.64
-1.51	-67.16	48.42
-1.77	15.83	48.15
-40.44	26.67	26.5
-25.11	-79.24	31.86
-28.48	-83.09	9.92
-29.63	-86.15	-2.08
-36.16	-68.82	-11.26
-45.86	10.46	10.08
-30.98	20.78	4.58
31.42	1.32	50.11
45.13	8.32	29.29
21.99	-71.5	45.17
34.73	-59.08	39.52
13.43	-70.58	44.07
7.81	17.66	43.43
42.94	30.77	30.78
34.31	38.66	23.52
47.14	26.76	19.91
41.7	40.05	13.28
31.52	-77.85	31.09
35.71	-83.08	18.1
35.67	-93.37	8.93
28	-81.12	-10.97
52.43	9.82	6.77
35.26	19.86	0.55

// Steel C, 2001: Stroop Interference vs. Control
// Steel C, 2001: Stroop Facilitation vs. Control
// Steel C, 2001: Stroop Negative Priming vs. Stroop Interference
// Subjects=7
7.43	52.19	8.2
-2.06	41.44	21.48
13.88	40.6	9.1
4.19	46.37	2.03
11.06	-61.99	17.73
-1.9	12.26	29.5
-8.34	18.57	29.04
14.2	-57.2	10.6
1.38	-71.45	6.37
-23.26	-66.82	-.43
1.07	49.41	14.08
-8.38	42.35	33.74
-39.59	12.39	-6.88
38.51	13.79	4.37
-29.95	21.42	-1.06
-23.51	25.05	4.14
-26.77	27.78	-1.63
14.3	-58.37	22.97
19.74	-60.57	35.36
-7.95	-59.79	47.88
-1.96	-72.93	-12.43
-26.11	-35.7	58.33
28.73	30.77	-9.21
-51.24	10.08	5.71
-26.62	-37.66	-8.41
13.97	-32.13	-9.34
38.51	13.79	4.37
53.84	-33.93	32.73
42.2	-27.26	51.26
-54.03	-37.23	40.94
-1.95	23.9	28.52
10.77	41.52	21.32
-1.88	31.18	40.18
-1.75	-28.98	32.95
11	-7.75	31.03
14.2	-57.2	10.6
10.96	40.23	45.96
11.06	25.86	52.74
4.64	16.93	47.99
-16.72	23.58	53.25
-11.22	-54.95	41.93
16.7	-53.42	59.33
1.58	-60.68	35.57
7.94	-49.01	34.52
1.42	-80.97	7.17
38.57	36.4	21.43
43.83	44.38	14.01
-39.24	19.33	41.6
32.44	23.87	52.66
-1.54	-35.55	58.04
4.81	-29.6	51.89
1.45	-77.37	12.44
50.25	17.04	3.96
50.52	7.72	34.85
41.92	10.41	29.15
25.65	-14.09	-10.99
-5.25	-1.27	6.14
10.91	39.72	39.31
-54.06	-28.77	40.23
42.02	-29.14	26.89
-44.62	-32.72	15.92
-51.14	-41.61	-2.22
-50.93	-59.19	18.21
4.33	47.83	20.87
-54.43	4.78	6.19
-48.1	28.08	4.17
-39.38	-18.39	7.96
-39.22	-71.69	6.86
-8.37	-9.24	13.53
-23.15	28.82	52.89
35.8	-17.35	56.08
-16.56	6.54	66.95

// Tan L H, 2001: Semantic Relatedness Judgment vs. Crosshair Fixation
// Tan L H, 2001: Homophone Decision vs. Crosshair Fixation
// Subjects=6
-46.81	17.2	28.48
-44.91	23.61	1.16
-59.73	21.64	18.22
-16.33	44.02	-26.53
-20.56	27.96	-27.37
-41.86	47.27	-9.78
-37.6	60.24	-7.57
-29.39	-11.22	58.55
-47.6	-4.1	55.93
-35.88	-8.78	49.49
-30.28	-62.07	61.71
-41.1	-16.24	63.56
-37.87	-29.17	61.26
-10.2	-98.33	17.68
-34.91	-91.04	3.97
-21.32	-1.8	0.79
-45.87	-63.21	-20.54
41.63	21.67	-4.13
55.78	13.5	26.5
48.99	47.98	-8.65
1.5	4.39	51.31
60.14	3.46	33.98
44.32	-12.1	54.43
55.97	1.21	46.49
29.57	12.98	-46.76
44.58	3.72	-43.92
34.85	-65.54	52.33
48.72	-44.85	57.12
10	-101.43	3.21
43.04	-81.32	-1.09
31.25	-95.99	-10.87
17.14	-3.85	-1.71
19.34	-76.83	-23.5
48.03	-50.9	-34.92
21.3	-41.29	-32.08
54.5	-63.38	-31.72
-44.7	16.95	25.13
-32.96	28.91	27.34
-42.81	48.46	5.74
-60.8	22.69	18.15
-49.37	35.88	-18.78
-52.48	33.54	-7.39
-17.41	42.79	-28.64
-29.43	-11.65	53.01
-48.65	-9.4	56.38
-54.32	-43.58	0.21
-32.43	-58.91	61.47
-37.86	-28.02	62.28
-33.85	-91.12	2.85
-11.25	-100.36	18.98
-26.59	-3.26	9.89
-5.22	-70.2	-18.19
36.32	23.13	1.38
54.71	13.49	26.51
29.74	15.83	-23.58
25.47	35.61	-15.15
39.29	39.32	-23.43
2.58	2.37	52.58
26.15	-4.55	57.35
44.31	-12.18	53.32
59.08	3.45	34
66.44	-30.62	5.54
29.57	14.12	-45.74
39.2	6.6	-47.45
58.62	11.95	-21.36
33.83	-63.97	58.9
37.95	-65.49	38.91
7.86	-102.59	2.22
34.45	-92.8	-11.18
29.04	-61.65	-7.04
4.53	-75.37	-3.37
5.46	3.45	11.19
36.35	1.47	-3.49
45.87	-50.03	-37.2

// Tan L H, 2001: Regular Characters vs. Fixation
// Tan L H, 2001: Irregular Characters vs. Fixation
// Subjects=10
-45.74	15.09	28.65
-50.17	19.95	9.33
-50.15	21.35	13.68
-52.36	17.22	1.78
-49.75	0.2	56.71
-62.75	-3.96	31.56
-50.09	36.21	26.93
-45.98	54.33	13.09
-56.3	7.51	41.67
-43.59	39.39	39.97
-2.88	23.14	46.44
-4.99	32.11	52.4
61.03	12.59	14.25
65.26	14.3	8.48
54.89	4.37	46.23
37.42	53.14	17.81
54.79	9.94	35.73
48.12	35.77	12.45
-63.08	12.42	-4.38
-54.66	19.9	-18.49
58.76	10.06	-4.47
67.62	-36.1	17.14
58.69	12.63	-12.49
50	19.93	-27.5
-62.7	-34.17	26.28
-58.39	-5.19	42.76
-28.24	-48.83	53.88
65.61	-28.23	36.58
67.51	-4.29	15.59
65.42	-5.99	21.33
-11.48	-98.28	-9.08
-.78	22.73	40.87
-2.99	15.34	28.14
-37.4	19.51	2.53
-28.85	-11.16	-9.49
-28.8	-54.57	-20.35
20.44	-73.22	-18.24
-56.53	18.31	16.23
-46.12	24.26	-17.84
-54.1	6	49.58
-50.24	21.47	1.4
-65.14	4.46	3
-50.02	17.18	28.52
-50.29	51.67	6.67
-52.47	49.03	0.23
-37.2	45.77	39.36
-2.87	23.23	47.55
-35.26	59.13	19.26
-.61	2.52	54.83
-2.65	-35.98	52.51
59	15.8	28.5
45.93	24.24	1.18
56.97	10.39	41.25
58.84	14.17	7.45
42.23	-4.99	63.89
33.26	47.71	30.58
33.32	48.31	38.34
43.7	58.41	2.8
54.52	40.04	12.02
37.71	34.13	47.28
7.81	40.73	52.65
10.21	-2.64	69.64
59.09	-11.78	29.7
-55.57	4	-3.76
-65.14	6.66	3.93
52.29	10.48	-12.24
67.41	-5.32	2.3
52.18	22.57	-21.06
-64.75	-28.92	39.25
-2.49	-47.56	67.98
-28.26	-55.6	48.87
65.61	-28.23	36.58
67.57	-21.21	17.01
63.23	-4.32	15.64
40.2	-50.02	59.89
-9.3	-95.63	-2.63
-6.95	-95.68	24.11
-6.86	-79.33	42.81
8.07	-83.9	37.45
-.78	22.73	40.87
-2.89	-13.21	30.53
-45.97	8.29	-4.23
35.19	23.58	-6.45
-11.63	-16.37	4.13
-11.61	-7.4	10.07
11.83	0.77	3.54
-9.41	-92.43	-16.28
20.48	-81.59	-16.42

// Fletcher P C, 2001: Decreases in activity during initial learning
// Fletcher P C, 2001: Main effects of all unpredictable events
// Fletcher P C, 2001: Modulation of unpredicitability-related responses by 
// type of causal relationship
// Fletcher P C, 2001: Effects of different unpredictable events within the 
// same learning session
// Subjects=12
38	26	50
40	28	38
46	22	48
6	20	32
-46	16	36
-42	26	30
44	-48	46
46	-78	8
-24	-2	8
46	18	42
52	22	34
22	48	44
-48	6	26
-50	14	44
44	-12	28
56	-42	38
10	-66	20
52	10	34
40	10	36
-38	-60	24
-36	-56	34
26	-36	34
52	16	44
40	10	34
42	42	-8
-32	-68	18

// Nunn J A, 2001: Synesthetes
// Subjects=12
-46.75	5.74	31.67
-52.08	-45.79	12.64
-50.07	-24	5.21
-22.34	-45.21	-10.06
-41.15	-57.42	40.25
57.79	-16.38	-2.24
-34.03	-69.95	-12.31
-33.85	-69.12	12.15
8.33	45.02	-15.75
-18.88	-55.83	17.56
-32.7	-77.06	19.5
-4.88	-61.14	30.11
24.88	33.97	46.33
36.4	-4.62	0.36
-15.71	-61.61	11.32
-27.23	-23.01	57.28
-58.61	-18.51	8.19

// Nunn J A, 2001: Healthy Controls
// Subjects=27
-57.57	-20.96	3.93
-40.39	14.06	28.67
-38.45	27.42	8.57
62.09	-16.1	1.03
-57.44	-7.53	26.22
-.85	-60.35	-1.23
7.74	19.18	35.5
-24.05	-77.12	31.67
-19.14	-51.88	-13.99
-16.93	-69.84	-12.51
4.73	3.61	54.68
-47.74	7.64	42.68

// Rossell S L, 2001: Related and Unrelated Prime-Target Pairs During Semantic 
// Priming, Short SOA Tasks
// Rossell S L, 2001: Related and Unrelated Prime-Target Pairs During Semantic 
// Priming, Long SOA Tasks
// Rossell S L, 2001: Lexical Decision Only, Short SOA Tasks
// Rossell S L, 2001: Lexical Decision Only, Long SOA Tasks
// Subjects=12
-2.24	51.62	1.67
-5.33	35.19	9.77
38.49	8.08	-.73
-4.91	-52.69	29.4
56.67	5.02	-.68
1.3	12.28	29.46
1.35	12.8	36.11
38.58	-4.18	5.88
35.34	-6.74	0.55
-1.69	-45.89	34.37
-20.02	-51.06	10.48
41.83	-27.85	2.25
-39.6	-8.65	-17.39
56.54	0.39	-19.25
53.29	-0.06	-24.75
-39.44	-37.74	-8.26
22.52	-34.2	-9.26
-17.18	8.92	-12.42
25.67	-7.32	-5.98
60.04	-15.17	13.24
47.09	29.59	15.21
53.59	21.69	22.49
-44.83	25.44	11.04
-41.47	18.37	29.44
-44.66	-70.55	-5.44
22.7	-93.93	-10.95
-39.38	-67.86	-12.42
-46.94	-59.88	-18.58
-13.58	-69.43	6.37
-18.99	-66.8	-.48
25.92	-84.93	-5.05
53.64	18.94	28.3
53.61	15.34	23.03
-32.88	9.96	30.05
25.92	-84.93	-5.05
-36.12	-70.5	-5.55
-41.52	-67.88	-12.4
-11.43	-86.84	1.12
25.92	-84.93	-5.05

// Rubia K, 2001: Generic Go/No-Go Activation
// Rubia K, 2001: Generic Stop Activation
// Rubia K, 2001: Activation Common to All Go/No-Go and Stop Task Versions
// Rubia K, 2001: Differences Between Generic Go/No-Go and Stop Task 
// Activations
// Subjects=15
-36.09	24.2	35.58
50.4	27.38	27.63
-51.25	13.26	5.45
44.07	7.25	29.39
4.51	37.56	39.57
-1.78	4.75	42.39
4.62	20.1	47.72
-54.29	33.61	35
53.94	-48.22	40.62
-39.25	-78.55	0.74
19.86	-68.09	48.25
-11.1	-62.47	54.83
53.46	5	-.64
43.83	20.17	3.77
-41.68	12.89	-.21
53.91	-39.76	39.91
4.71	8.9	54.24
7.7	30.81	34.52
-51.29	12.83	-0.09
53.46	5	-.64
47.32	7.79	36
4.47	37.14	34.03
4.58	19.59	41.08
4.64	16.93	47.99
50.71	-39.78	39.95
-51.03	-44.9	10.32
66.41	-27.71	1.95
-32.84	10.48	36.69
-54.07	-25.6	39.96
-4.99	4.73	42.43

// Shergill S S, 2001: Inner Speech - Baseline
// Shergill S S, 2001: Baseline - Inner Speech
// Shergill S S, 2001: First Person Auditory Verbal Imagery - Baseline
// Shergill S S, 2001: Baseline - First Person Auditory Verbal Imagery
// Shergill S S, 2001: Second Person Auditory Verbal Imagery - Baseline
// Shergill S S, 2001: Baseline - Second Person Auditory Verbal Imagery
// Shergill S S, 2001: Third Person Auditory Verbal Imagery - Baseline
// Shergill S S, 2001: Baseline - Third Person Auditory Verbal Imagery
// Shergill S S, 2001: Combined Imagery - Baseline
// Shergill S S, 2001: Baseline - Combined Imagery
// Shergill S S, 2001: Second and Third Person Imagery - First Person Imagery
// Subjects=8
-54.06	-52.98	29.99
28.97	-67.88	-18.78
1.52	5.71	54.54
-26.15	-51.44	47.39
-47.91	14.73	24.24
-39.55	16.07	-.5
0.89	60.73	-4.71
1.55	-40.07	40.54
4.81	-54.86	41.74
57.08	-18.16	43.64
-50.88	-10.35	44.22
4.73	2.56	54.77
-50.9	-41.33	28.98
29.03	-72.74	-12.8
32.24	-60.58	-7.16
-44.43	-6.63	50.53
-23.33	-73.05	-12.17
-44.45	-15.6	44.59
-54.3	-40.06	4.38
53.91	-27.7	44.47
14	-16.39	1.61
53.59	6.37	17.09
-39.55	16.07	-.5
53.75	13.54	41.02
4.15	58	1.06
8.01	-51.67	41.44
4.67	-31.05	33.05
-11.52	-87.79	-11.07
4.56	-50.91	10.19
25.78	-36.92	-3.5
4.69	2.13	49.23
-54.1	-43.46	29.19
-44.66	15.18	29.74
-44.44	-3.45	50.26
-4.97	-74.23	12.25
56.83	12.19	23.25
-39.57	21.36	-.94
-8.31	-75.62	-5.44
50.41	-24.2	7.42
1.67	-59.74	47.76
10.6	46.41	1.96
7.96	-27.98	45.03
1.55	-40.07	40.54
-26.23	-79.76	25.23
-8.39	-79.74	-17.36
-41.17	-9.35	56.3
4.73	2.56	54.77
-54.16	-16.6	32.52
53.66	-35.81	8.36
35.42	-67.41	-13.32
-54.1	-43.46	29.19
-60.7	-31.21	9.28
-41.7	19.23	-.74
60.08	10.52	28.93
50.11	3.52	-19.44
-1.65	-67.47	30.6
4.23	49	8.5
4.66	-41	28.31
-1.65	-67.47	30.6
4.23	49	8.5
4.66	-41	28.31
4.73	2.56	54.77
-50.9	-41.33	28.98
-44.91	19.21	-.7
-41.24	-3.44	50.22
56.83	12.19	23.25
28.98	-61.11	-13.77
50.41	-36.26	2.86
-41.35	0.91	37.59
-38.98	-36.2	52.95
50.66	-28.15	38.97
47.32	7.79	36
63.38	-25.84	26.37
7.28	53.91	-10.9
4.76	-30.11	45.24
1.5	-64.79	23.65
4.68	17.36	53.53
-41.18	-6.18	56.03
38.6	-61.05	-13.89
-60.65	-44.96	10.44
-57.34	-35.02	28.52
53.51	-25.3	-7.02
-1.55	-56.58	47.53
7.93	-30.52	39.66

// Ruff C C, 2001: Repeated Color Naming, Incongruent vs. Neutral
// Ruff C C, 2001: Switching Color Naming, Incongruent vs. Neutral
// Ruff C C, 2001: Repeated Word Reading, Incongruent vs. Neutral
// Ruff C C, 2001: Switching Word Reading, Incongruent vs. Neutral
// Subjects=12
-8	16	52
-40	0	56
32	0	64
-56	12	36
36	4	32
-36	-4	40
-44	-44	36
-48	-56	48
-44	-60	-20
36	-72	-36
-4	4	60
8	16	60
-48	44	-8
-40	0	56
-56	12	32
-8	16	48
12	-84	-40
-52	8	36
48	4	24
-36	-24	52
-36	-44	40
-28	-96	0
24	-84	-12
-40	-60	-24
-4	-20	56
48	28	20
-52	24	24
-48	32	8
-36	-28	68
-24	-36	68
-32	-24	48
-40	-52	48
-36	-92	-12
24	-88	-16
-24	-100	-12
28	-72	-12
20	-100	0
-8	-56	-32
16	-44	-32
28	-56	-36

// de Zubicaray G I, 2001: Semantically Related Distractor vs. Control
// Subjects=8
-56	-20	-14
62	4	-16
-46	-46	16
10	62	2
-4	42	-4
-30	60	0
18	28	58
-54	-34	40
8	-76	-14

// Shaywitz B A, 2001: Select - Simple, Activations
// Shaywitz B A, 2001: Select - Simple, Deactivations
// Shaywitz B A, 2001: Divide - Select, Activations
// Shaywitz B A, 2001: Divide - Select, Deactivations
// Shaywitz B A, 2001: Complex Divide - Select, Activations
// Shaywitz B A, 2001: Complex Divide - Select, Deactivations
// Shaywitz B A, 2001: Complex Divide - Divide, Activations
// Shaywitz B A, 2001: Complex Divide - Divide, Deactivations
// Subjects=25
-27.35	3.16	51.74
-35.72	-44.47	55.83
-34.72	-47.35	46.03
47.32	17.64	39.63
-49.77	-43.98	35.88
-43.6	20.56	30.4
53.62	27.49	28.7
-44.75	20.84	20.35
35.42	14.97	19.92
-35.23	48.39	17.93
-58.52	-31.83	14.89
-50.29	33.01	-.68
-56.48	-26.24	4.36
63.17	-18.12	2.3
14.29	-91.38	9.01
-56.57	-26.04	-6.81
60.96	-21.11	-8.57
-5.11	-69.09	-3.79
0.46	-5.13	52.12
-52.93	-16.02	53.64
27.21	-14.49	52.59
-15.82	40.53	38.44
3.58	-2.71	41.84
-56.2	-17.87	43.8
52.78	-12.99	42.14
51.65	-16.94	32.45
1.04	63.41	16.25
48.38	-21.96	22.87
12.71	64.82	5.96
-33.01	5.33	11.48
-.15	54.46	-3.06
8.33	49.43	-13.88
23.11	-61.04	56.55
-31.54	-39.93	45.37
34.77	-55.39	45.9
-30.56	-38.58	35.21
33.63	-58.29	36.12
-53.21	-43.14	5.74
25.43	49.53	-14.09
-52.22	-45.05	-5.27
-3.75	-22.07	53.59
15.27	36.2	48.48
0.43	-17.53	43.12
8.72	51.25	37.26
1.15	54.66	27.02
0.01	52.83	17.15
23.92	-95.55	9.25
-40.34	-79.87	-2.48
-41.04	-50.85	56.43
41.23	-48.24	55.26
-35.79	-46.3	45.95
36.89	-52.21	45.61
35.61	5.94	40.75
-4.04	36.37	38.65
37.92	-61.43	36.34
-45.73	17.37	30.69
44.02	22.14	29.26
2.63	-55.3	36.23
-46.89	20.83	20.37
44.98	29.84	18.56
34.22	50.92	16.92
56	-58.92	25.88
27.69	60.68	6.14
43.82	34.35	8.16
-25.84	65.94	-3.72
31.88	62.05	-4.06
37.17	54.89	-14.67
-32.61	-19.07	53.67
0.52	-20.99	53.45
2.55	-13.29	42.74
-41.26	-13.55	43.27
46.39	-19.37	42.75
-35.98	-16.41	33.41
45.24	-18.03	32.61
17.72	-90.1	38.97
-33.92	-16.11	23.32
36.6	-13.57	22.3
-2.33	44.07	-13.31
53.65	-66.62	-4.67
-8.32	-69.11	-3.75
12.08	31.95	48.87
2.35	39.58	38.31
2.25	46.21	27.72
-.58	-52.15	36
36.43	29.78	18.67
59.2	-56.79	25.66
-26.8	58.24	6.97
33.16	27.94	8.82
-24.74	59.6	-3.21
15.82	70.42	-4.58
-29.58	-76.84	8.29
61.01	-32.74	-7.6
9	-.85	51.66
-30.51	-9.54	52.84
7.83	4.72	41.17
-31.7	-18.49	33.53
46.29	-12.74	32.16
-34.99	-18.23	23.51
44.08	-13.52	22.21
55.72	-5.77	11.39
-38.24	-26.42	14.2
48.3	-65.6	-4.7

// Bystritsky A, 2001: Normal Subjects
// Subjects=6
-39.45	-37.83	-9.36
7.57	-37.55	-9.93
16.02	-20.92	-15.88
-41.85	23.15	-18.91

// Bystritsky A, 2001: Panic Disorder Patients
// Subjects=6
10.05	-58.05	27.45
37.5	-28.39	-4.35
30.84	30.44	-13.67
-11.58	16.01	23.72
-22.08	-19.49	33.51
-11.83	59.56	8.92
0.97	48.38	0.79
3.68	-35.75	41.27

// Hernandez A E, 2001: Between Language Mixed vs. Rest
// Hernandez A E, 2001: Between Language Blocked vs. Rest
// Hernandez A E, 2001: Between Language Mixed vs. Between Language Blocked
// Hernandez A E, 2001: Between Language Blocked vs. Between Language Mixed
// Hernandez A E, 2001: Within Language Mixed vs. Rest
// Hernandez A E, 2001: Within Language Blocked vs. Rest
// Subjects=6
-52	12	14
-50	4	22
-56	2	42
-56	8	14
-50	4	22
-38	-2	42
44	32	18
-48	18	16
-40	6	22
-56	6	16
-34	0	44
-36	6	22
-56	6	14
-46	16	24

// Heide W, 2001: Triple-step saccades vs. Fixation without peripheral 
// stimulation
// Heide W, 2001: Triple-step saccades vs. Fixation during visual stimulation
// Heide W, 2001: Visually guided saccades vs. Fixation without peripheral 
// stimulation
// Subjects=6
-32	-8	52
-48	-4	40
-48	4	28
-8	4	48
-40	-44	40
-32	-56	56
-20	-72	56
-16	-76	44
-16	-60	68
32	-4	56
44	-8	48
52	0	36
44	-48	48
38	-56	52
36	-76	44
16	-68	56
20	-60	68
12	-80	48
-32	-8	56
-44	-4	44
-48	4	28
-4	4	48
-8	-4	60
-32	-56	56
-20	-72	56
-12	-64	64
28	-4	56
48	-4	44
48	4	28
8	0	52
4	8	44
20	-60	68
20	-72	52
12	-80	48
0	-88	28
32	-76	40
40	-80	24
-28	-8	52
-44	-8	44
-4	4	48
-28	-56	60
-24	-68	60
32	-8	56
48	-8	44
52	0	36
20	-60	68
18	-68	44

// Beauregard M, 2001: Sexual Arousal > Neutral
// Beauregard M, 2001: Sexual Arousal Inhibition > Neutral Inhibition
// Subjects=10
-50.52	-75.3	3.73
56.28	-69.48	-8.76
34.19	-69.45	38.68
31.28	-52.83	67.34
-30.32	-49.86	68.1
-24.25	-85.79	27.85
-50.57	-75.61	0.4
49.99	-74.64	5.31
34.27	-77.65	42.85
-27.16	-50.47	61.38
-21.01	-85.78	27.79
34.5	-49.63	66.97
-60.16	13.93	28.68

// Gorno-Tempini M L, 2001: Main Effects
// Gorno-Tempini M L, 2001: ED vs. Control
// Gorno-Tempini M L, 2001: ID vs. Control
// Gorno-Tempini M L, 2001: EH vs. Control
// Gorno-Tempini M L, 2001: IH vs. Control
// Subjects=10
-64	-48	16
-60	-60	8
-60	-32	-12
-52	-56	40
-40	24	24
-40	20	8
56	-60	8
64	-48	0
40	-80	-8
-24	-8	-20
-64	-44	20
-60	-60	8
-60	-32	-12
-56	-52	44
-36	24	24
-48	20	8
60	-56	8
62	-46	0
44	-80	-8
-24	-8	-20
-28	-16	-12
-60	-48	12
-60	-60	8
-60	-32	-12
-48	-56	44
-40	24	24
-36	28	12
56	-64	8
64	-48	0
44	-80	-8
-24	-8	-20
-28	-16	-16
-64	-48	16
-60	-64	4
-60	-32	-8
-60	-52	36
-40	24	24
-40	20	8
56	-60	12
64	-48	2
44	-80	-8
-24	-8	-16
-28	-12	-20
-64	-48	-20
-60	-64	4
-60	-36	-8
-56	-52	40
-40	24	24
-40	20	8
60	-60	4
48	-76	0
44	-80	-8
-24	-8	-20
-20	-12	-16

// Herrmann M, 2001: Interference vs. Noninterference Retrieval
// Subjects=9
4.67	19.47	53.35
37.36	28.34	-.18
37.41	22.25	3.67
7.76	28.15	41.44
-35.99	4.37	40.59

// Kesler-West M L, 2001: Neutral - Scrambled
// Kesler-West M L, 2001: Angry - Neutral
// Kesler-West M L, 2001: Frightened - Neutral
// Kesler-West M L, 2001: Happy - Neutral
// Kesler-West M L, 2001: Sad - Neutral
// Subjects=21
42.84	-49.31	-13.81
40.66	-32.23	-12.98
-40.49	-56.15	-12.28
-38.27	-68.49	-6.81
19.21	-6.81	-12.64
60.14	-44.86	14.62
34.57	-96.97	3.67
-17.12	-9.14	-12.03
53.54	29.97	19.57
42.99	15.96	32.02
49.35	-32.92	4.82
36.14	-8.42	-35
-49.21	32.05	0.5
42.55	28.94	-20.37
-14.64	-100.07	-4.43
56.1	-64.5	36.38
-40.8	24.04	-21.23
45.08	-76.79	-11.53
40.74	-64.3	-14.76
36.77	-85.36	16.05
-47.13	24.86	-10.07
-40.45	-64.61	-11.57
-46.86	7.88	18.11
6.43	59.47	19.87
-38.66	21.94	-21.08
1.95	52.99	-8.53
-27.6	-72.99	-11.01

// Shikata E, 2001: Orientation vs. Color Discrimination
// Subjects=6
36	-33	39
6	-60	63
-12	-57	60

// Sugiura M, 2001: Visual - Rest
// Sugiura M, 2001: Auditory - Rest
// Sugiura M, 2001: Visual - Auditory
// Subjects=21
40.08	-17.24	57.14
37.85	-5.08	49.45
44.27	1.65	53.28
-32.61	-2.53	61.2
37.94	-17.25	57.16
42.15	-6.99	51.79
48.55	-4.84	51.54
-45.46	1.45	58.78
42.13	1.64	53.3
-28.36	-2.84	56.72

// Brass M, 2001: Congruent vs. Incongruent
// Subjects=10
7.39	64.96	8.24
39.62	42.84	22
-23.26	34.23	40.17
39.18	-42.99	68.23
2.85	-78.33	54.88

// Braver T S, 2001: Conjunction Analysis
// Braver T S, 2001: Disjunction Analysis
// Subjects=14
38.46	47.35	11.59
38.42	17.25	-5.96
-33.15	17.08	-1.77
3.6	8.47	48.71
61.31	-47.17	25.95
42.25	-38.89	52.24
13.48	-67.87	51.65
-6.78	-67.48	58.54
-26.72	-65.01	-31.76
35.37	45.18	25.19
48.28	13.28	24.37
54.56	8.6	4.62
13.03	23.1	30.65
16.49	12.49	58.26
57.95	-55.34	3.25
29.38	-69.06	34.84
54.95	-40.1	35.47
-58.33	-47.38	34.03
16.72	-70.76	55.2
35.99	-53.76	66.94
3.7	2.89	59.21
-.66	-1.33	46.24
-35.78	-26.41	55.43
-49.07	-4.96	3.6
-55.25	-25.67	25.48
-36.16	-76.47	-13.97
35.13	-57.21	-46.51
22.97	-6.51	59.78

// Liddle P F, 2001: Go - Baseline
// Liddle P F, 2001: Correct NoGo - Baseline
// Liddle P F, 2001: Correct NoGo - Go
// Liddle P F, 2001: Go - Correct NoGo
// Subjects=16
-38	-26	65
-8	-15	70
0	15	45
-26	-41	70
-45	-45	60
-8	-52	70
-64	-38	30
68	-30	30
8	-64	65
8	-75	55
56	-45	50
-60	15	-10
54	22	-15
-60	-19	10
68	-19	15
-68	-30	25
-1	-8	10
11	-4	15
14	-8	24
-4	-22	15
-14	-4	24
8	-34	5
-11	-4	15
8	0	5
8	-90	35
-4	-90	35
26	-52	-25
19	-68	-50
-34	-49	-50
-34	-49	-30
26	-45	-50
-26	-71	-50
8	15	65
4	19	45
26	52	35
8	-15	70
52	-52	50
-26	-41	70
-8	-34	75
-45	-49	60
8	-75	55
52	22	-15
-52	19	-15
-64	0	-5
-15	-4	15
8	-82	45
-4	-90	35
45	-49	-30
-26	-68	-50
-38	-64	-25
15	-79	-45
-38	0	50
-8	22	55
38	8	40
-45	19	30
-34	52	10
41	34	-15
-49	30	-15
-8	45	50
-30	40	34
-38	-64	40
30	-79	40
-60	-52	30
41	-56	45
-8	-68	40
52	-52	30
45	-68	35
-52	-30	0
26	-86	35
30	-75	30
34	-98	0
-19	-94	30
38	-94	-10
-26	-94	-10
-38	-26	65
-30	-41	70
0	-11	60
68	-22	25
64	-15	40
-41	0	5
64	15	5
-45	-41	60
41	-45	65
-60	11	-10
-60	-19	15
68	-19	10
0	-8	15
26	-49	-25
19	-64	-50
-26	-49	-25

// Menon V, 2001: Incorrect NoGo - Correct NoGo
// Menon V, 2001: Go/NoGo - Go
// Menon V, 2001: Go - Rest
// Subjects=14
10	34	22
-44	-4	2
40	16	-2
-8	-66	36
-34	50	32
26	46	30
-40	30	2
40	20	2
-42	-8	46
50	-4	42
4	16	46
-18	-58	-6
20	-60	8
36	-56	44
-22	-52	46
-14	-6	2
16	-6	12
38	-26	56
-8	2	56
44	-68	-20
-46	-68	-16
-34	-66	56
-42	-4	46
50	2	38

// van Veen V, 2001: (CO = SI) < RI
// van Veen V, 2001: CO < SI < RI
// van Veen V, 2001: SI < (CO = RI)
// Subjects=12
-2	37.64	27.37
-39.27	21.18	38.1
39.83	18.57	38.53
41.14	-43.72	44.85
3.7	-64.09	32.49
-45.9	18.92	9.37
50.2	47.24	9.24
-35.26	37.13	9.95
4.61	-11.93	32.57
-0.03	63.4	16.26

// Braver T S, 2001: Working Memory
// Braver T S, 2001: Long Term Memory Encoding
// Braver T S, 2001: Long Term Memory Retrieval
// Braver T S, 2001: Words
// Braver T S, 2001: Faces
// Subjects=28
-44.74	28.58	24.16
40.79	36.21	32.57
40.55	53.45	7.71
28.13	14.7	44.56
-54.53	26.73	1.01
19.18	53.32	7.97
32	13.79	-8.94
-48.03	14.59	8.64
66.39	9.45	14.45
50.26	28.13	9.72
43.84	44.46	15.12
22.31	59.17	0.75
18.71	10.1	68.47

// Druzgal T J, 2001: Working Memory Load
// Subjects=9
34	-4	55
30	-68	50
-4	11	45
-34	-79	35
-41	-8	35
-56	0	30
45	23	25
30	19	-5
-34	26	-10
-49	-64	-15
-4	-34	-20
-41	-56	-25

// Chee M W L, 2001: Singaporeans (SGP)
// Subjects=10
-4.02	35.57	42.06
-37.17	10.91	28.9
-39.61	30.87	-1.74
-24.03	-61.55	40.4
-45.83	-57.33	-13.23
-2.96	31	37.97
-38.24	10.9	28.91
-26.13	-60.07	45.88
-43.71	-61.89	-17.33
-54.33	-46.92	-1.74
-1.89	31.1	39.07
-38.24	9.85	29
-29.97	26.7	-1.5
-26.08	-62.82	51.68
-42.64	-62.94	-17.26

// Chee M W L, 2001: Chinese (PRC)
// Subjects=9
-2.85	17.94	47.99
-41.43	10	31.26
-42.76	21.51	1.31
32.02	27.25	-0.03
-24.01	-77.75	37.3
-51.13	-61.25	-8.38
-1.81	22.01	45.41
-40.39	16.26	29.6
-29.9	31.87	10.33
-27.17	-74	44.83
-1.76	13.72	48.33
-40.37	7.72	29.2
-32.11	25.63	-1.39
33.09	27.25	-0.04

// Curtis V A, 2001: Bipolar Patients
// Subjects=5
-1.84	-54.12	10.53
29.04	-75.91	-12.53
-41.71	21.35	-.92
4.67	8.47	48.7
-47.89	9.45	24.69
-50.91	-65.53	18.74
-1.97	-45.55	-2.46
-41.26	1.85	49.78
-41.42	6.74	30.41
46.97	12.9	-7.92
-19.81	-6.05	55.77
28.9	-37.85	-15.72
-32.95	-58.85	-6.56
22.72	-62.86	5.4
46.99	-5.5	-11.95
-54.36	-13.2	7.7
-54.21	-27.06	21.13
-48.17	8.73	-12.05
-54.23	-48.09	10.63
41.64	21.84	-1.92
-29.94	-20.22	-16.53
-4.92	-49.51	29.14
11.24	-72.25	36.43
38.81	23.48	47.05
-44.45	-15.6	44.59
7.52	1.55	0.18
-32.92	-67.31	-5.85
38.67	-79.03	-12.38
-29.7	-85.78	-11.03
19.51	-84.97	-4.97
4.67	8.47	48.7
-47.86	15.16	29.78
-41.42	-70.11	0.06
50.34	-31.49	-4.24
-32.8	-86.97	1.37
38.79	-86.54	0.51
4.81	-79.06	31.5
1.48	-61.62	23.39
8.02	-44.89	46.44
-51.2	-1.55	6.69
16.2	-72.82	-12.64
-51.1	11.54	24.55
35.35	-61.5	-19.39
8.02	-69.1	36.21
4.72	-55.8	29.55
1.45	11.62	48.47
-5.1	-51.4	4.76
4.71	-52.63	29.29
-1.93	-42.92	4.01
29.03	-72.74	-12.8
-36.17	-55.7	-6.79
-44.52	-59.15	18.13
29.19	-89.77	0.9
43.98	-70.54	-13.16
22.68	-75.44	-5.81
-23.26	-78.88	-4.99
-16.85	-90.99	-10.74
25.85	-79.1	-12.23

// Curtis V A, 2001: Schizophrenic Patients
// Subjects=5
4.71	-52.63	29.29
-1.93	-42.92	4.01
29.03	-72.74	-12.8
-36.17	-55.7	-6.79
-44.52	-59.15	18.13
-16.85	-90.99	-10.74
25.85	-79.1	-12.23

// Curtis V A, 2001: Normal Patients
// Subjects=5
16.2	-72.82	-12.64
-51.1	11.54	24.55
35.35	-61.5	-19.39
8.02	-69.1	36.21
4.72	-55.8	29.55
1.45	11.62	48.47
-5.1	-51.4	4.76
29.19	-89.77	0.9
43.98	-70.54	-13.16
22.68	-75.44	-5.81
-23.26	-78.88	-4.99

// Ehrsson H H, 2001: Precision Grip - Baseline
// Ehrsson H H, 2001: Small Force - Large Force
// Ehrsson H H, 2001: Large Force - Small Force
// Subjects=6
-36	-20	48
0	0	48
-64	0	16
-48	-32	20
-24	0	8
-16	-16	12
-36	16	8
-40	-40	36
-40	-4	16
-12	-20	40
-52	40	20
-32	-60	40
-48	52	12
-12	-68	36
64	-36	36
56	4	8
56	0	40
56	-36	32
24	4	8
40	0	32
40	-40	36
44	32	24
28	16	4
48	-52	52
32	40	16
44	-40	16
28	-68	40
36	-64	60
-64	12	28
0	16	32
52	-44	48
48	4	28
64	12	12
-40	-24	52
-52	-24	16
52	-24	32

// Kuo W J, 2001: Reading - Fixation
// Kuo W J, 2001: Reading - Control
// Subjects=7
-6	0	60
-44	-2	48
-52	12	30
-10	-8	26
-60	-6	20
-50	-20	42
-28	-50	50
-44	-48	16
-38	-56	-6
-12	-92	4
-18	-82	-2
-16	-88	14
-26	-86	6
-24	-28	2
-20	-16	14
-28	-12	-4
-8	-62	-12
58	-2	32
52	0	46
38	-6	44
10	-6	28
36	-64	34
32	-58	38
54	-34	0
36	-50	-12
22	-86	8
34	-72	-8
38	-62	0
30	-84	12
24	-10	4
24	-28	4
34	-58	-16
-44	-4	44
-40	12	28
-48	14	24
-34	26	10
-34	-56	48
-42	-48	16
-40	-54	-2
-26	-88	2
-34	-72	0
-36	-46	-12
-22	-18	16
-2	-72	-14
40	-56	-10
10	-70	-14
2	-66	-20

// Rama P, 2001: Two-Back vs. Zero-Back
// Rama P, 2001: One-Back vs. Zero-Back
// Subjects=8
30.93	61.05	10.53
-18.3	53.38	-1.64
48.15	22.91	11.3
-44.8	19.18	12.68
35.38	39.81	24.53
-38.33	31.97	26.03
38.84	12.82	46.83
-36.01	19.52	43.78
22.9	15.87	60.14
-17.78	22.51	53.35
6.87	15.77	60.33
-2.75	7.97	56.63
37.89	-9.05	53.13
-34.87	19.24	53.83
45.33	-15.95	45.82
-44.35	-44.24	45.87
35.86	-62.87	45.4
-33.68	-63	36.17
18.89	-71.55	58.59
-16.41	-70.96	55.6
8.13	-62.44	53.49
-6.79	-72.05	54.47
55.74	-61.66	-9.57
-58.7	-49.03	-14.89
53.59	-41.96	-2.28
-50.01	-49.72	2.91
32.55	-82.67	23.68
-31.69	-75.54	11.55
32.21	-65.23	-12.35
-7.23	-66.73	-.62
5.78	-82.2	18.37
-6.98	-82.73	26.37
30.79	46.39	-13.89
-4.38	68.07	8.12
-45.85	16.09	14.07
40.8	20.89	27.17
-43.68	36.25	26.85
24.87	43.83	49.96
-38.14	10.87	42.3
20.71	23	56.22
-7.06	15.26	54.95
3.59	19.38	52.26
-1.68	13.43	58.39
-41.26	-10.29	44.11
-45.41	-40.9	47.84
37.89	-39.77	41.21
-32.64	-53.4	36.47
19.9	-74.26	51
-21.85	-63.22	46.09
12.49	-68.16	61.73
-54.58	-30.83	-27.62
-41.66	-10	-7.21
31.53	-78.82	32.29
22.63	-84.67	-15.07
-38.48	-56.37	-29.01
-5.93	-81.84	24.05

// Zysset S, 2001: Long vs. Short Lists
// Zysset S, 2001: Linear
// Zysset S, 2001: Quadratic
// Subjects=9
-3.97	22.88	43.13
-45.72	15.26	30.86
-38.54	41.88	2.9
-5.81	-69.64	44.22
-32.56	-53.68	46.53
32	19.33	-6.06
-3.97	22.88	43.13
-45.72	15.26	30.86
-5.81	-69.64	44.22
-32.56	-53.68	46.53
-32.07	19.46	1.36
-3.97	22.88	43.13
-45.72	15.26	30.86
-38.54	41.88	2.9
-5.81	-69.64	44.22
-32.56	-53.68	46.53
-32.07	19.46	1.36
32	19.33	-6.06
12.95	-1.96	9.33

// Milham M P, 2001: Incongruent > Neutral
// Subjects=16
44.14	13.48	41.13
1.4	15.51	43.68
-23.97	-67.46	46.47
-43.51	6.1	36.07
-35.14	24.15	21.08
-34.68	-50.27	49.61
-43.24	-43.8	51.4

// Perlstein W M, 2001: Load Main Effect
// Perlstein W M, 2001: Group Main Effect
// Perlstein W M, 2001: Group By Load Interaction
// Subjects=15
30.31	7.48	47.37
-25.17	8.01	59.12
-1.04	18.93	5.51
41.78	32.02	19.53
-37.35	43.09	18.4
53.59	14.03	19.79
-48.98	10.24	21.29
46.49	-54.52	42.35
-37.94	-50.8	43.01
38.49	17.94	2.91
-41.62	12.34	6.53
-.89	-13.59	11.58
-13.92	46.77	8.9
47.14	32.31	22.79

// Ackermann H, 2001: Main Effect
// Ackermann H, 2001: First Order Positive
// Ackermann H, 2001: First Order Negative
// Ackermann H, 2001: Second Order
// Subjects=8
-45	42	-3
24	12	-3
0	-35	0
-45	-21	3
69	-21	3
27	-75	-48
-12	-21	6
24	-75	-48
42	15	3
-45	42	-12
-33	15	-3
0	-36	-6

// Monchi O, 2001: Receiving Negative Feedback minus Control Feedback 
// (Increases)
// Monchi O, 2001: Receiving Negative Feedback minus Control Feedback 
// (Decreases)
// Monchi O, 2001: Matching After Negative Feedback minus Control Matching 
// (Increases)
// Monchi O, 2001: Matching After Negative Feedback minus Control Matching 
// (Decreases)
// Monchi O, 2001: Receiving Positive Feedback minus Control Feedback 
// (Increases)
// Monchi O, 2001: Receiving Positive Feedback minus Control Feedback 
// (Decreases)
// Monchi O, 2001: Matching After Positive Feedback minus Control Matching 
// (Increases)
// Monchi O, 2001: Matching After Positive Feedback minus Control Matching 
// (Decreases)
// Monchi O, 2001: Receiving Negative Feedback minus Receiving Positive 
// Feedback
// Subjects=11
-50	30	23
42	30	28
-36	20	-2
34	22	2
-8	20	42
3	26	46
4	14	50
-44	16	30
48	14	28
41	12	40
-38	2	30
-46	4	30
32	12	54
-44	-46	46
-34	-52	44
34	-46	44
-30	-64	48
-14	-74	56
30	-56	52
16	-76	44
-26	-68	34
-26	-86	30
31	-66	28
35	-74	24
-8	-22	10
6	-16	10
10	-10	4
8	-10	8
-16	14	4
12	12	3
-12	52	10
0	-6	40
-10	-12	44
-32	-24	60
-38	-32	58
-30	-16	62
-34	-28	58
-64	-38	32
62	-28	26
50	-28	20
-26	-10	6
28	-12	4
-36	14	26
20	-11	50
-24	-68	44
-28	-60	50
40	-64	14
-26	-10	4
8	-48	26
48	36	22
38	16	42
8	-46	28
-42	-64	40
26	-6	54
-50	-6	42
24	-6	54
-28	-58	50
8	-46	28
4	-32	38
42	-48	30
62	-40	34
-34	22	0
32	24	4
18	-56	52
36	-74	24
28	-72	36
-8	8	4
4	6	4
-10	-18	12
6	-14	4

// Smith C D, 2001: Object Naming - Baseline
// Smith C D, 2001: Letter Fluency - Baseline
// Smith C D, 2001: Object Naming, Living - Non-Living
// Subjects=18
1.18	-33.98	-4.58
-35.26	-35.31	-18.54
36.34	-35.94	-19.31
-46.9	-69.39	-17.78
48.2	-67.77	-19.01
45.17	-84.65	-3.06
-39.29	-85.58	-7.59
28.31	-79.01	30.11
-26.18	-79.25	31.87
-52.26	28.2	19.82
-52.48	28.08	-9.17
46.91	26.56	-10.18
21.5	-29.37	-1.85
-18.02	-29.35	1.95
-20.34	12.67	-4.9
-19.16	55.52	26.07
2.45	-76.99	3.48
2.7	-52.41	46.02
-29.63	-96.1	-6.82
37.61	-85.55	-14.05
-18.02	-62.36	-12.01
20.47	-67.42	-12.03
-54.37	-57.29	-12.02
-55.23	-65.02	12.06
-55.03	-54.07	43.48
59.04	-56.22	5.54
59.29	-47.04	41.57
-46.71	8.36	38.14
-47.04	35.66	5.75
-47.12	27.14	-8.03
23.57	-57.51	-21.82
42.85	-50.28	-12.61
45.02	-60.93	-12.86
45.1	-75.47	-8.29
40.47	18.52	-17.24
-42.87	12.65	-16.9

// Bushara K O, 2001: Subject 1
// Subjects=1
29.9	-45.13	-27.39
24.38	-55.76	-54.32
-25.6	-46.97	-18.79
-16.6	52.2	-58.44
22.32	-30.8	-34.08
23.26	-45.28	-56.3

// Bushara K O, 2001: Subject 2
// Subjects=1
22.52	-52.86	-16.62
-16.01	-61.43	-27.73
20.18	-59.41	-46.16
-27.31	52.93	-61.72
18.11	-34.54	-27.03
-27.75	-52.53	-21.65
17.97	-45.94	-50.61
-23.77	-45.73	-57.95

// Bushara K O, 2001: Subject 3
// Subjects=1
25.66	-51.41	-25.7
19.01	-53.85	-56.65
-6.63	-71.52	-62.68
14.95	-34.13	-21.45
25.51	-49.61	-43.69
-18.08	-64.1	-20.79
-20.62	-37.51	-62.02

// Bushara K O, 2001: Subject 4
// Subjects=1
17.18	-54.03	-17.58
16.96	-62.86	-49.17
-24.53	-42.57	-16.94
-14.03	-72.91	-52.44
-18.36	-46.07	-49.06
19.04	-44.79	-49.6
17.07	-34.29	-23.69

// Bushara K O, 2001: Subject 5
// Subjects=1
20.37	-53.04	-18.81
20.17	-69.44	-52.01
18.17	-39.48	-22.15
17.97	-48.05	-50.43
-23.5	-42.9	-21.39

// Bushara K O, 2001: Subject 6
// Subjects=1
25.65	-54.75	-27.65
16.9	-56.95	-55.25
17.01	-40.43	-34.33
26.49	-51.69	-56.91
-19.25	-39.88	-23.92
-20.56	-42.37	-56.04

// Becerra L R, 2001: (Warm + Noxious) - Baseline, Early Phase
// Becerra L R, 2001: Warm - Baseline, Early Phase
// Becerra L R, 2001: (Warm + Noxious) - Baseline, Late Phase Increases
// Becerra L R, 2001: (Warm + Noxious) - Baseline, Late Phase Decreases
// Becerra L R, 2001: Warm - Baseline, Late Phase
// Subjects=8
4.75	5.98	57.83
17.64	0.23	64.85
14.28	15.04	50.27
-41.58	5.11	9.36
17.7	-15.63	66.18
40.57	27.3	-.13
-65.15	7.63	2.73
23.34	35.68	-14.02
61.15	-19.14	16.91
58.14	-27.05	38.79
-64.75	-40.98	34.68
37.51	-4.19	5.89
-47.99	-8.13	3.86
-44.65	-16.6	17.91
60.96	5.21	1.49
-65.02	-14.06	11.24
-32.21	-20.46	-33.21
4.63	8.04	43.16
-5.17	15.96	22.53
1.36	4.08	33.49
14.31	-24.14	39.05
20.34	-5.06	-3.88
-11.78	17.21	-2.03
10.73	11.51	4.88
10.78	-14.38	0.36
-11.6	-17.17	7.54
1.14	-21.29	-5.64
-15.07	-23.27	-29.82
-32.09	-45.58	-27.76
30.87	-56.01	-44.33
-25.6	-57.89	-22.34
4.44	45.6	33.32
50.54	11.23	39.02
58.08	-47.45	22.66
1.22	35.55	27.51
-5.04	37.14	48.64
4.58	27.33	44.89
-44.52	-8.63	38.43
-38.22	36.34	41.28
-52.09	16.71	36.39
43.53	1.68	-42.63
1.19	35.29	24.18
14.01	12.3	14.81
10.85	-33.41	1.96
-14.74	49.42	43.26
14.28	15.04	50.27
-17.81	1.31	40.64
-4.91	8.84	54.35
57.93	7.08	25.9
28.28	-6.82	55.29
-28.28	-6.39	65.94
-38.42	37.62	16.64
43.62	42.15	-14.79
31.02	44.39	15.27
-48.17	39.45	-.13
47.07	31.54	12.82
-35.25	27.36	7.43
54.5	17.86	0.5
-44.8	8.27	9.14
57.91	-9.64	16.15
31.63	-25.06	66.81
-25.02	-58.5	52.42
58.09	-20.96	34.94
-68.04	-25.4	30.07
58.09	-34.16	29.36
-41.24	-47.44	31.61
11.24	-39.24	50.39
34.23	21.43	7.12
37.46	8.5	4.83
-68.3	-14.85	1.31
-52.43	-13.13	-19.09
-58.56	-46.52	3.85
-68.19	-50	0.91
54.76	-51.93	6.35
-47.81	-55.71	7.84
-52.31	-31.65	-10.85
30.8	-17.17	-37.55
-41.55	-44.01	-6.59
-35.55	60.45	-18.77
-32.23	-7.52	-30.95
10.54	42.46	-7.75
1.47	-4.66	44.26
-1.79	-25	29.28
-5	-61.29	14.51
7.61	-17.31	3.99
-14.81	-17.19	7.58
-18.03	2.34	12.67
-21.32	-18.26	-5.64
4.19	-22.82	-25.62
27.76	-48.4	-28.21
-28.99	-50.02	-44.15
13.94	-51.05	-20.02
-28.88	-58.77	-33.38
-18.04	-57.07	-12.46
-15.02	6.99	-10.06

// Braddick O J, 2001: Coherent-Motion vs. Dynamic-Noise
// Subjects=3
50	-73	3
-43	-69	2
17	-82	38
-18	-85	33
35	-47	53
-22	-45	52
27	-76	-17
-13	-77	-10
16	-20	39
-12	-22	43
65	-54	14
-62	-35	16
48	-34	12
-44	-32	20

// Calhoun V D, 2001: Figure Selection vs. Fixation, Activations
// Calhoun V D, 2001: Figure Selection vs. Fixation, Deactivations
// Subjects=10
5.55	-85.71	-7.41
6.92	-79.17	16.58
-7.28	-85.89	2.92
20.74	-73.13	0.06
-33.07	-88.24	13.67
29.75	-90.06	25.11
-21.9	-77.74	44.94
25.63	-75.45	43.9
-2.72	21.01	43.81
6.12	8.25	56.13
-16.32	11.82	-7.72
16.14	12.25	-4.95
-52.52	11.28	34.41
58.79	11.88	34.7
-33.75	-57.19	-33.09
37.56	-59.06	-34.12
-27.07	-67.72	-19.84
24.83	-78.18	-19.69
-9.79	-78.61	-22.41
31.21	-76.75	-27.78
-29.32	-81.53	-29.64
33.35	-72.49	-28.24
-52.19	-56.27	46.69
56.67	-41.38	27.68

// Dukelow S P, 2001: Wide Field Optic Flow - Stationary Dots
// Dukelow S P, 2001: Contralateral Optic Flow - Stationary Dots
// Dukelow S P, 2001: Ipsilateral Optic Flow - Stationary Dots
// Dukelow S P, 2001: Visual Pursuit - Fixation
// Dukelow S P, 2001: Non-Visual Pursuit - Fixation
// Subjects=8
48.37	-68.17	3.32
28.29	-80.32	26.88
20.51	-71.39	-8.35
16.54	-78.11	29.06
48.37	-66.05	3.15
28.27	-73.89	27.45
15.17	-62.62	-4.57
13.32	-74.95	28.83
49.44	-61.56	6.1
29.34	-70.63	28.28
49.44	-68.16	3.31
27.22	-79.19	27.91
14.11	-63.6	-3.36
18.64	-75.18	25.44
51.56	-59.6	3.68

// Just M A, 2001: Axis Rotation x Path Length Interaction
// Subjects=12
-16.46	-58.36	53.43
24.15	-58.03	54.05
-35.78	-51.67	45.28
42.22	-44.69	46.03
-40.5	20.61	16.97
43.91	22.09	14.76
-37.22	32.4	31.56
35.53	30.35	39.82
-54.35	-29.57	2.38
57.85	-16.84	5.6
-35.94	6.03	48.25
38.85	8.51	46.07

// Ng V W K, 2001: Mental Rotation:  Activation - Baseline
// Ng V W K, 2001: Line Orientation:  Activation - Baseline
// Subjects=12
16.64	-62.82	47.85
-4.68	-62.43	54.75
-38.97	-39.37	53.21
35.72	-73.05	23.95
38.8	-74.4	6.19
56.82	15.36	22.99
-4.8	-57.03	42.03
19.82	-68.51	42.71
29.11	-81.74	-5.35
25.86	-70.13	-6.29
-16.45	-59.33	54.63
-47.78	7.22	37.14
-47.94	23.19	23.53
56.63	13.48	-1.39
56.83	12.19	23.25

// Vingerhoets G, 2001: Alphanumeric Rotation - Alphanumeric Control
// Vingerhoets G, 2001: Figures Rotation - Figures Control
// Vingerhoets G, 2001: Figures Control - Figures Rotation
// Vingerhoets G, 2001: Rotations - Controls
// Vingerhoets G, 2001: Controls - Rotations
// Vingerhoets G, 2001: Figures > Alphanumeric
// Vingerhoets G, 2001: Alphanumeric > Figures
// Vingerhoets G, 2001: Figures Rotation - Alphanumeric Rotation
// Vingerhoets G, 2001: Alphanumeric Rotation - Figures Rotation
// Subjects=10
-42	-6	48
-15	-72	63
18	21	39
0	-18	63
18	21	39
57	-42	18
-6	-87	0
-57	-15	-3
-3	39	45
-9	-69	-3
-12	-27	72

// Vouloumanos A, 2001: Speech vs. Complex Nonspeech
// Vouloumanos A, 2001: Speech vs. Simple Tones
// Vouloumanos A, 2001: Complex Nonspeech vs. Simple Tones
// Subjects=15
-60	-16	-8
-64	-36	0
-64	-44	12
56	-28	-4
52	-20	-16
52	-16	0
40	24	16
-64	-32	4
-60	-20	-8
52	-20	-8
-60	-16	-8
-64	-24	4
-44	-32	8
56	-12	-12
56	-28	-4
48	16	24
52	-48	8
32	24	12
-64	-24	4
-60	-16	-4
56	-12	-12
60	-28	-4
64	-16	0

// Beauchamp M S, 2001: Shifts of Attention vs. Fixation
// Subjects=9
-29.44	-3.99	55.71
33.61	-2.47	55.97
-42.44	1.79	35.3
44.14	2.48	36.48
-1.59	0.12	65.08
-26.07	-54.99	56.6
30.58	-56.76	56.1
-41.35	-71.62	7.99
47.33	-69.06	5.64
0.66	-63.46	54.78
3.66	-82.13	19.51
1.31	-78.82	-6.39

// Haist F, 2001: PH with Words, Increases
// Haist F, 2001: PH with Words, Decreases
// Haist F, 2001: PH with Pseudohomophones, Increases
// Haist F, 2001: PH with Pseudohomophones, Decreases
// Haist F, 2001: PW with Words, Decreases
// Haist F, 2001: PW with Pseudowords, Increases
// Haist F, 2001: PW with Pseudowords, Decreases
// Subjects=15
-52.36	-40.96	-21.22
-50.36	46.59	-4.05
-69.04	-32.38	36.24
-56.51	-59.51	-12.93
-61.85	22.85	20.38
-52.29	-56.74	-18.78
-56.72	38.26	-1.05
-67.94	-49.55	34.32
-58.64	-61.63	-12.72
-51.34	35.38	2.48
-52.23	-66	-14.66
-52.26	-44.33	-9.79
-64.04	-46.86	-13.9
-61.86	21.71	19.36
-62.68	-28.45	31.38

// Katanoda K, 2001: Writing - Naming
// Katanoda K, 2001: Writing - Tapping
// Katanoda K, 2001: Conjunction between Writing - Naming and Writing - 
// Tapping
// Subjects=17
-18	-42	64
-12	-52	64
40	-28	46
-20	-4	58
-28	0	46
-34	-8	50
-26	-14	66
-36	-28	48
-8	-4	44
-6	4	34
-10	-16	42
-14	-16	4
-10	10	-2
-16	-64	-16
20	-52	-22
6	-64	-16
6	-56	-12
24	-66	-50
-34	-18	52
-26	-56	40
-28	-46	58
-20	-2	56
-28	4	46
-44	12	22
-20	-88	-8
-34	-70	-14
-34	-54	-16
-24	-82	-14
28	-74	-14
50	-62	-10
50	-70	0
-26	-90	6
-20	-96	10
-34	-80	-6
-12	-98	2
-6	-84	6
32	-86	6
28	-94	8
26	-82	-10
44	-72	-14
42	-76	-6
34	-50	-22
32	-38	-24
-32	-38	56
-28	-46	58
-22	-42	64
-14	-52	64
-14	-40	68
-42	-32	46
-22	0	64
-28	4	48
-28	2	58
-2	-82	-8
26	-52	-20
8	-72	-16

// Kimmig H, 2001: Saccade vs. Fixation
// Kimmig H, 2001: Pro-Saccade and Anti-Saccade
// Subjects=15
40	-6.04	50.62
3.67	-1.77	54.03
29.58	-70.34	59.48
17.84	-82.3	57.27
7.84	-89.64	4.48
48.37	-73.71	0.44
30.5	-97.14	29.38
-42.31	-10.04	47.44
-5.95	-2.97	53.12
-31.33	-69.57	61.23
-17.43	-78.2	58.45
-10.34	-87.64	4.52
-48.86	-81.87	0.01
-16.49	-96.02	34.29
45.31	1.4	49.94
3.69	5.01	59.04
31.66	-62.13	55.42
11.39	-77.23	54.69
12.11	-96.22	1.63
48.39	-74.6	2.75
-46.61	-2.67	46.88
-2.75	4.63	54.68
-29.24	-66.72	56.51
-14.26	-77.47	53.89
-12.49	-96.62	-1.4
-50.99	-77.39	3.01

// Merriam E P, 2001: Visually Guided Saccades vs. Fixation
// Merriam E P, 2001: Compatible Task vs. Fixation
// Merriam E P, 2001: Mixed Task vs. Fixation
// Subjects=11
-48.68	-4.19	54.83
46.46	-2.14	59.14
-20.64	-69.5	61.1
19.99	-73.4	62.08
-.56	0.84	60.55
-32.67	-2.07	53.36
-19.55	-72.58	62.46
45.38	-2.23	58.05
19.99	-73.4	62.08
-.59	1.64	57.14
-31.52	3.19	66.28
-37.35	58.49	24.91
-26	-74.11	57.09
-39.96	-55.07	56.77
36.85	8.81	63.91
36.4	55.85	25.4
22.09	-80.33	54.83
44.48	-48.85	60.85
1.49	12.05	54.01

// Nagahama Y, 2001: Set Shifting Task
// Nagahama Y, 2001: Reversal Task
// Subjects=6
37.79	56.43	7.12
51.16	11.34	29.28
-56.84	15.63	35.18
3.91	8.99	52.73
8.16	12.85	47.79
40.87	-4.52	66.88
25.66	1.39	62.07
40.69	-62.73	41.27
-28.36	-55.77	50.72
45.12	-44.46	52.83
-45.59	-40.11	58.43
21.27	-69.18	42.24
-15.33	-72.74	52.18
3.73	-31.79	29.87
59.85	13.91	33.36
-43.96	6.33	26.91
10.45	9.43	57.05
8.17	10.72	48
32.18	-7.09	62.8
29.98	3.53	61.79
34.27	-62.34	45.82
-26.2	-55.76	50.68
51.64	-39.76	56.74
-47.76	-37.99	58.26
14.79	-69.21	42.35
-15.32	-74.86	52.39
5.9	-33.91	30.04

// Naccache L, 2001: Repetition Suppression
// Subjects=9
36	-44	44
-44	-56	56

// Pinel P, 2001: Verbal vs. Arabic
// Pinel P, 2001: Arabic vs. Verbal
// Pinel P, 2001: Distance Effect
// Subjects=13
16	-80	0
-24	-88	4
-52	8	32
44	-64	-8
60	-16	-8
56	-44	40
-64	-40	40
24	40	40
-36	36	44
40	-44	48
36	-64	48
8	-72	52
-4	-72	44
-40	-68	48
-72	-40	0
0	-40	32

// Poldrack R A, 2001: Rhyme Judgment
// Poldrack R A, 2001: Compression-Related Decrease
// Poldrack R A, 2001: Compression-Related Increase
// Poldrack R A, 2001: Convex Compression Response
// Poldrack R A, 2001: Convex Compression Response and Rhyme > Lettercase
// Poldrack R A, 2001: Increasing Compression Response and Rhyme > Lettercase
// Subjects=8
-48	34	12
-52	16	0
40	-14	16
6	-68	20
-26	0	24
-46	-32	12
32	-50	-8
-46	-70	20
46	-12	-4
-28	54	16
34	26	-4
4	32	20
18	4	8
66	-40	8
-64	-24	0
-52	22	12
-34	14	20
36	26	8
-38	34	8
-54	18	8
-38	12	20
14	8	4
-40	32	4
14	8	4

// Temple E, 2001: Normal-Reading Children
// Subjects=15
-12	-11	71
-49	-6	13
-55	-65	16
67	-10	9
-51	-11	31
-52	-21	44
61	-13	34
-20	-13	18
67	-10	9
-32	-74	34
55	-74	31
49	-86	-4
9	-81	-3
34	-70	0
-49	-83	15
-46	-66	50
32	-28	46
-9	-49	71
-37	-42	24
-29	-33	30
64	-43	7
13	54	17
-40	-3	42
32	26	-2
-60	6	35
-44	49	16
23	27	28
-26	9	41
12	-26	9

// Temple E, 2001: Dyslexic Children
// Subjects=24
-9	3	55
-38	27	6
-39	16	9
-46	3	21
47	19	5
32	42	35
-46	39	7
29	47	4
-57	13	16
44	-16	-14
52	-17	42
-53	-19	44
35	-77	-8
19	-97	19
9	-93	-12
-21	-8	24
8	14	8
22	-16	25
8	-53	-8
-3	-77	38
1	-87	-17
9	-83	-21
-27	-86	-12
-61	-16	16
-62	-38	12
53	-29	17
-59	5	9
-33	53	15
12	-10	17
24	-3	-2
-23	-81	22
32	-56	58
-9	-46	19
41	-57	-4
18	27	30
-62	16	15

// Jordan K, 2001: 3D > Rest
// Jordan K, 2001: Abstract > Rest
// Jordan K, 2001: Letter > Rest
// Jordan K, 2001: Control1 > Rest
// Jordan K, 2001: Control2 > Rest
// Jordan K, 2001: 3D > Control
// Jordan K, 2001: Abstract > Control
// Jordan K, 2001: Letter > Control
// Jordan K, 2001: Mental Rotation > Control
// Subjects=9
-28	-64	48
28	-64	48
32	-80	16
36	-80	0
48	8	24
40	-64	-28
-28	-64	48
24	-68	48
32	-80	16
44	-64	-16
52	8	28
-32	-4	44
44	-4	56
-28	-64	48
24	-68	48
32	-80	16
44	-64	-16
48	8	24
32	-64	48
-48	-32	48
-40	-12	56
36	-60	-32
28	-68	48
48	8	24
32	-76	-24
32	-80	16
-28	-64	48
36	-52	52
-24	-64	48
24	-56	56
32	-48	44
-32	-4	40
-24	-64	48
24	-56	56
-28	-64	48
24	-64	48

// DiGirolamo G J, 2001: Young Normals
// Subjects=8
-20.56	72.94	-9.95
-50.27	42.07	6.36
-30.49	-7.09	57.1
-32.49	-34.25	63.86
-50.21	27.27	7.6
-37.52	52.38	0.89
-31.04	31.1	0.37
-45.87	36.78	20.14
-35.34	28.61	-3.83
-19.57	-35.43	74.96
-.73	17.78	45.75
-28.52	15.33	44.04
-.73	22.19	47.61
-47.84	16.48	33.02
-41.46	20.57	30.37
-39.41	32.93	24.85
1.34	32.43	42.27
-15.84	-56.38	-3.62
-24.18	-65.29	19.53
-11.36	-100.42	4.48
-.67	-84.87	11.98
-30.53	-86.65	19.16
-37.07	-76.97	7.27
-17.62	-92.23	28.4
-34.9	-74.5	11.5
-.4	-60.12	56.74
-41.14	-39.73	48.81
-49.68	-30.98	52.63
-43.32	-59.98	34.92
-45.54	-19.12	40.44
-53.98	-20.26	54.01
-36.81	-25.99	60.99
-45.69	-71.19	0.2
-30.83	-39.21	-.43
-28.64	-38.68	6.2
50.01	56.28	-11.59
39.43	61.64	3.69
37.07	50.6	-28.81
56.66	14.88	2.96
50.24	23.47	4.54
50.33	31.01	19.52
60.85	16.16	-8.35
52.43	39.48	18.78
3.84	-38.43	61.56
12.51	-52.5	71.56
5.75	18.51	54.53
42.13	6.04	55.16
33.5	22.73	51.63
52.55	18.68	24.99
5.76	-12.13	43.72
1.49	-12.15	43.77
23.87	4.9	42.09
10.14	-39.59	45.97
20.63	-23.98	26.7
14.28	-84.95	9.58
33.56	-79.92	17.86
3.8	-95.99	32.93
20.5	-62.67	-5.74
29.54	-68.57	54.87
48.66	-38.85	52.16
48.61	-39.36	45.51
50.25	-7.17	-6.27
31.16	-45.35	-2.85
59.19	-55.82	24.47
48.33	-64.28	-1.46
43.81	14.46	-1.32
14.05	-30.13	2.76
20.73	-95.48	10.39
-26.99	72.73	-12.09
-33.4	68.29	-13.87
-56.28	-13.18	35.6
-41.45	16.34	30.72
-39.6	24.36	-3.43
-31.06	30.93	-1.84
-24.21	15.7	48.42
-.73	22.19	47.61
-45.79	35.35	29.18
-45.88	41.01	19.79
-15.61	-95.7	10.83
-19.81	-95.04	19.74
-17.82	-87.77	3.5
-.27	-67.55	70.74
-28.25	-60.97	48.21
-47.89	-49.88	0.67
-60.75	-59.1	-7.33
47.85	58.21	-13.96
4.94	78.24	-26.3
50.43	18.84	27.23
56.61	20.88	-2.01
54.56	43.73	18.4
31.38	14.09	50.15
5.62	30.34	42.39
56.87	23.62	33.45
18.64	-94.98	17.07
16.44	-93.39	10.27
27.02	-76.93	2.07
42.31	-42.6	59.24
35.88	-60.42	49.66
48.34	-64.11	0.75
-37.66	64.04	-13.47
-17.78	-91.66	8.28
-37.17	-75.88	-6.2
-37.13	-82.05	-3.45
-49.65	-21.83	60.78
37.13	66.6	-14.54
48.3	16.71	27.43
56.88	25.9	35.48
14.3	-91.29	10.12
27.03	-81.16	2.43
46.47	-87.79	25.06

// DiGirolamo G J, 2001: Old Normals
// Subjects=8
-28.95	57	4.87
-33.43	52.63	-23.71
-.75	24.13	45.22
-39.04	-7.14	57.2
-50.19	20.92	8.14
-35.37	30.56	-6.22
-41.91	44.47	-18.47
-.62	12.3	57.36
-34.74	-4.66	61.4
-.78	28.19	42.65
-41.45	16.34	30.72
-45.89	32.21	16.06
-15.69	-87.76	3.47
-30.71	-79.73	-1.49
-39.33	-69.55	-6.7
-39.05	-31.43	45.85
-26.06	-51.64	58.55
-67.19	-35.36	-2.56
-62.85	-41.17	4.57
-11.6	-1.77	14.06
-30.92	-9.43	-.69
-7.31	-14.77	10.64
47.93	54.66	-4.74
34.97	44.41	-26.04
9.77	31.28	26.65
43.73	31.2	-4.96
52.44	32.97	17.1
60.84	22.67	-6.67
52.35	38.63	7.7
50	31.99	-22.94
33.46	20.1	45.16
41.88	36.39	34.78
44	36.23	32.54
52.53	22.91	24.63
52.13	42.92	-19.42
5.69	-89.74	3.39
22.72	-75.01	-.27
37.93	-78.86	31.11
33.36	-71.06	-5.18
37.53	-54.46	-11.08
37.95	-45.77	46.17
23.2	-65.64	65.85
40.22	-35.59	67.6
48.02	-14.72	-21.23
65.22	-20.11	-9.82
16.05	3.54	-2.32
16.14	2.29	8.94
-2.92	28.17	42.67
-41.16	-6.98	59.44
-43.72	30.28	18.43
-2.74	12.46	59.6
-36.88	-2.55	61.25
-43.58	18.62	32.79
-15.69	-87.76	3.47
-32.68	-88.95	17.15
-49.77	-16.52	46.96
-49.76	-23.03	45.27
-32.49	-38.65	62
-26.06	-51.64	58.55
-39.61	-17.54	-22.22
-46.04	-8.94	-20.63
-58.64	-41.83	-4.35
-41.49	-65.33	-7.03
34.95	70.48	-19.3
37.08	66.09	-21.19
37.07	55	-26.95
3.5	26.1	42.77
60.82	26.9	-7.02
52.13	34.11	-23.14
52.53	22.91	24.63
18.59	-91.1	12.28
20.6	-79.25	0.11
27.24	-90.02	25.47
31.32	-89.76	0.87
35.52	-72.99	-2.82
55.02	-24.01	50.84
69.78	-21.57	25.94
3.91	-75.07	55.71
55	-61.5	33.91
35.8	-48.07	44.16
65.28	-43.72	-12.3
60.87	-12.19	-17.13
67.53	-46.9	1.32
54.76	-66.19	0.85
1.26	-25.47	9.21

// Banich M T, 2001: Incongruent, Color vs. Neutral
// Banich M T, 2001: Incongruent, Object vs. Neutral
// Subjects=14
-43.56	14.39	33.14
-35.36	24.04	-7.91
3.5	21.7	40.91
-4.63	-72.84	57.85
18.58	-75.78	17.69
3.44	-77.75	-6.51
14.19	-90.21	-3.36
-23.93	-73.64	49.22
-43.28	-42.03	46.79
-58.74	-9.94	-4.79
-41.53	-13.03	8.65
-60.9	29.32	7.56
-35.36	24.04	-7.91

// Zysset S, 2001: Incongruent vs. Neutral
// Zysset S, 2001: Congruent vs. Neutral
// Zysset S, 2001: Incongruent vs. Congruent
// Subjects=9
2.39	32.27	40.04
-39.3	8.78	29.1
48.33	20.39	33.81
-39.63	38.36	-1.25
34.12	58.69	7.35
-20.7	-76.7	50.56
28.43	-67.86	50.37
-39.24	-75.12	3.8
44.09	-75.94	-.44
-40.46	29.84	26.24
47.26	21.45	33.74
-41.79	44.69	-1.76
34.03	56.69	-4.75
-21.77	-76.71	50.57
25.34	-69.94	65.07
-38.22	8.87	30.2
-29.78	-54.77	-9.17
34.32	-51.3	-11.31
-13.49	-103.6	4.78

// Carter C S, 2001: Normals > Schizophrenics, Commission of Errors
// Subjects=16
3.43	26.47	33.82

// Daselaar S M, 2001: Retrieval vs. Baseline
// Daselaar S M, 2001: Retrieval Success vs. Retrieval Attempt
// Daselaar S M, 2001: Retrieval Attempt vs. Retrieval Success
// Subjects=13
-57	-21	45
9	-6	54
6	33	42
-9	33	39
-36	15	33
-36	27	-9
33	27	-9
24	9	-12
-9	-87	-6
36	-27	69
-24	-27	-27
-63	-39	-3
-48	-63	39
-39	-27	66

// Rubia K, 2001: Stop Task, Controls > Schizophrenics
// Rubia K, 2001: Stop Task, Schizophrenics > Controls
// Rubia K, 2001: Go-No-Go Task, Controls > Schizophrenics
// Subjects=6
-4.28	47.09	12.11
-27.3	14.68	63.04
16.14	-5.37	6.23
24.56	-1.15	-8.71
-4.37	44.03	0.1

// Barch D M, 2001: Main Effect of Delay
// Barch D M, 2001: Group x Delay Interaction
// Subjects=12
8.76	22.02	30.79
50.47	16.01	31.93
-50.08	9.98	17.97
44.4	-46.45	50.62
66.55	-38.31	16.22
42.13	-75.29	21.84
-35.14	29.61	22.85

// Kiehl K A, 2001: Controls > Schizophrenics, Oddball
// Subjects=11
26	52	30
0	16	40
-56	-41	30
-38	-48	60
24	-60	55
64	-34	25
0	-30	30
-56	11	-15
52	19	-15
3	-17	5
-26	-44	65

// Menon V, 2001: Average Group Activation For Controls
// Subjects=13
56	24	34
56	28	34
-58	24	2
60	22	20
-46	-58	42
50	-58	42
-32	-58	54
34	-76	44
-4	24	34
2	22	24

// Rypma B, 2001: Old Subjects
// Subjects=6
-24.59	51.37	14.21
-28.91	46.43	5.75
-7.7	65.7	-8.37
30.18	37.98	42.58
-24.72	44.45	-6.4
51.19	50.8	0.01
45.9	45.82	4.95
28.83	54.86	13.3
41.71	48.94	18.11
-44.68	22.67	30.23
46.12	30.61	28.52
52.42	1.99	1.85
-49.01	19.84	21.6
-50.29	22.09	-4.23
-50.03	7.15	22.67
-57.58	-1.33	10.09
-51.03	7.83	31.55
52.65	-0.01	31.02
-7.62	31.44	-11.08
3.23	43.08	14.59
-10.45	14.41	30.53
-6.08	17.67	44.7
6.77	10.34	45.17
41.04	-55.75	26.9
48.69	-52.85	49.99
-33.62	-48.06	50.53
44.32	-57.16	35.9
-57.72	9.36	-3.07
51.48	-26.4	6.48
-44.54	-40.75	22.17
-54.47	-14.31	-6.7
64.15	-14.66	-8.04
-41.39	-53.39	9.81
-52.02	-59.45	14.9
-30.75	-57.1	2.19
10.19	-95.06	30.55
-19.79	-59.66	36.85
22.83	-96.96	4.92
4.29	16.68	3.41
21.61	-5.11	22.88
-23.42	-29.99	-5.74
20.27	3.06	-9.02
-30.95	21.04	7.91
-5.17	-15.82	10.7
12.98	-11.48	10.13
32.19	-41.29	-5.44
22.25	46.42	-12.68
24.58	40.75	10.08
-36.48	44.38	-6.26
34.03	51.15	-7.63
41.75	20.76	11.56
39.69	36.92	28.07
17.09	25.21	2.54
-33.12	19.62	3.59
-37.27	13.23	17.56
42.8	33.8	14.91
-60.52	1.48	46.69
-49.94	1.49	32.07
-1.77	9.23	45.36
14.09	25.13	29.35
10.95	-37.93	12.37
-53.99	-30.2	49.27
-27.15	-62.82	51.7
62.13	-45.34	-5.44
-49.94	-80.9	-1.17
-8.56	-1.35	-8.32
-19.11	6.65	13.44
20.29	9.83	-4.01
34.22	15.8	3.14
-25.71	57.36	9.26
-19.91	-64.21	19.39
-45.94	4.14	-2.77

// Rypma B, 2001: Young Subjects
// Subjects=6
-27.98	57.12	-7.42
-38.41	33.31	15.88
30.96	39.38	5.66
32.21	36.87	28.16
45.26	6.34	45.06
-50.32	47.01	1.49
27.59	57.46	-8.09
36.36	14.75	3.2
35.35	27.41	15.53
38.57	33.06	19.48
-51.38	28.43	-4.75
-40.64	38.96	6.51
-54.34	7.84	18.2
45.14	9.46	30.31
-54.23	5.69	31.76
-39.52	25.22	7.65
-61.89	6.05	9.52
-53.03	-.59	46.77
1.35	30.4	43.55
2.33	25.06	29.49
-50.78	-31.24	49.32
-30.51	-52.33	36.36
-25.02	-61.75	51.58
-69.25	-34.52	8.54
-55.43	-30.81	0.27
-59.56	-54.55	10.11
47.23	-51.34	0.81
-51.09	-58.7	-3.02
61.06	-46.4	-5.34
-17.86	-76.05	3.63
14.14	-61.06	2.01
6.66	-6.26	23.15
22.89	-69.95	23.84
1.74	-72.17	52.15
18.2	12.53	3.59
16.22	-2.32	18.24
-18.02	9.11	17.68
-12.85	2.86	-8.62
-20.24	13.7	8.4
26.65	24.67	-5.33
-5.15	-21.11	11.14
22.25	46.42	-12.68
24.58	40.75	10.08
-36.48	44.38	-6.26
34.03	51.15	-7.63
41.75	20.76	11.56
39.69	36.92	28.07
17.09	25.21	2.54
-33.12	19.62	3.59
-37.27	13.23	17.56
42.8	33.8	14.91
-60.52	1.48	46.69
-49.94	1.49	32.07
-1.77	9.23	45.36
14.09	25.13	29.35
10.95	-37.93	12.37
-53.99	-30.2	49.27
-27.15	-62.82	51.7
62.13	-45.34	-5.44
-49.94	-80.9	-1.17
-8.56	-1.35	-8.32
-19.11	6.65	13.44
20.29	9.83	-4.01
34.22	15.8	3.14
-25.71	57.36	9.26
-19.91	-64.21	19.39
-45.94	4.14	-2.77

// Poldrack R A, 2001: New MR vs. Plain Text, Mirror Reading I, Pre-Training
// Poldrack R A, 2001: New MR vs. Plain Text, Mirror Reading I, Post-Training
// Poldrack R A, 2001: Learning-Related Increase
// Poldrack R A, 2001: Learning-Related Decrease
// Poldrack R A, 2001: Short-Term Priming, Pre-Training
// Poldrack R A, 2001: Short-Term Priming, Post-Training
// Poldrack R A, 2001: Pre-Training, Mirror Reading II: SB > MR
// Poldrack R A, 2001: Post-Training, Mirror Reading II: SB > MR
// Poldrack R A, 2001: Pre-Training, Mirror Reading II: MR > SB
// Poldrack R A, 2001: Post-Training, Mirror Reading II: MR > SB
// Poldrack R A, 2001: Pre-Training, Mirror Reading II: IR > MR
// Poldrack R A, 2001: Post-Training, Mirror Reading II: IR > MR
// Poldrack R A, 2001: Pre-Training, Mirror Reading II: MR > IR
// Poldrack R A, 2001: Post-Training, Mirror Reading II: MR > IR
// Subjects=16
-24	-69	45
-45	6	24
39	-72	-21
-45	-54	-18
36	-42	42
-12	60	-12
21	-30	-6
30	-51	-21
3	-27	-18
12	60	-9
24	9	3
12	0	3
30	30	-3
-48	0	36
-24	-63	45
42	-78	-15
-6	-27	-21
48	9	27
-15	-51	3
24	-27	-3
24	-60	-24
-42	3	39
-54	-60	-15
-24	-66	-9
-9	18	42
15	-78	-9
9	-15	15
15	12	42
-18	0	45
12	-51	-3
-15	-63	-21
-27	-12	-18
-21	36	-9
-39	-42	-9
33	-42	-6
-21	-78	-9
24	-48	18
-45	3	24
-12	-48	6
3	48	-15
24	-84	0
-30	-6	45
15	-72	-9
-21	-75	-18
-18	-75	42
-24	-81	18
-54	30	18
-42	3	27
-24	-63	45
-6	15	42
27	-66	42
30	27	0
48	9	27
-3	-27	-18
48	27	-3
-6	-81	-18
9	-48	-6
-9	-45	-6
3	21	9
27	-24	-3
-21	27	42
-42	-30	-21
-12	-48	-27
-15	45	6
-45	-24	45
12	-45	0
-12	-39	45
-30	36	-9
45	-30	24
12	48	0
33	-54	-18
-12	-51	3
42	-66	-21
48	24	0
30	-45	-21
-33	-72	-18
42	-66	-21
39	-36	42
-39	-57	-21
24	-78	42
-9	-81	-21
18	-78	-21
0	-21	-15
-15	-78	42
9	-45	-9
-12	-90	-3
-51	24	24
-6	48	-12
9	-45	-3
-15	-48	-27
0	-57	33

// Dolan R J, 2001: Congruent vs. Incongruent Face-Voice Combinations
// Dolan R J, 2001: Effects of Fear Congruent and Fear Incongruent Face-Voice 
// Combinations
// Subjects=12
-20	-8	-14
-14	0	-20
-20	-6	-14
30	-62	-12
0	32	22
-30	38	-12
22	50	-10

// Druzgal T J, 2001: Match > No Match
// Druzgal T J, 2001: No Match > Match
// Subjects=9
-41	-53	-25
-34	-68	-20
-38	-68	-20
8	-56	-20
4	-64	-20
-45	-75	-15
-41	-90	0
26	-90	20
-26	-38	-10
-19	-15	-5
-19	-26	10
-60	-38	-5
-53	8	35
-56	-30	50
-15	-48	60
-34	-45	60
-48	-41	60
-15	-56	-20
0	15	35
0	0	40
0	-19	40
-4	34	45
19	30	50
26	-8	55
34	-23	60
30	-30	60

// Barch D M, 2001: Manual But Not Vocal
// Barch D M, 2001: Vocal But Not Manual
// Barch D M, 2001: Word, Vocal But Not Location, Manual
// Barch D M, 2001: Word But Not Location
// Subjects=11
-.39	-69.92	-14.93
-29.46	16.59	-8.47
54.02	8.6	4.63
35.25	-32.84	48.47
12.83	-16.34	57.38
28.58	23.71	37.11
2.78	22.01	17.47
51.11	-21.34	30.59
-23.06	33	-3.22
-42.14	41.03	19.74
-6.63	-81.36	2.83
12.62	-84.41	2.87
63.5	-22.46	-26.33
-67.6	-52.66	7.82
-51.96	25.72	-12.32
15.49	67.01	20.24
-6.64	-84.79	-.23
-6.68	-95.07	-9.4
15.82	-84.4	2.83
3.1	-83.44	16.28
-16.4	-59.98	-8.89
-64.35	-22.55	25.33

// Armony J L, 2001: Safe Context (CTX-) > Conditioning Context (CTX+)
// Armony J L, 2001: Conditioning Context (CTX+) > Safe Context (CTX-)
// Armony J L, 2001: (CS+ - CS-) in CTX+ vs. (CS+ -CS-) in CTX-
// Subjects=8
62	-12	8
-56	-18	12
58	-48	22
-50	-38	34
30	-10	-8

// Frankenstein U N, 2001: Verbal Attention vs. Rest
// Frankenstein U N, 2001: Cold Pressor Test vs. Rest
// Frankenstein U N, 2001: Cold Pressor Test Masked By Verbal Attention
// Frankenstein U N, 2001: Distraction vs. Rest
// Frankenstein U N, 2001: Cold Pressor Test - Distraction
// Frankenstein U N, 2001: Distraction - Cold Pressor Test
// Subjects=12
-4	32	28
-8	18	22
0	22	20
-46	24	16
-40	0	34
-36	54	8
-28	-68	48
34	30	10
12	28	22
-8	10	32
0	24	20
52	-26	24
62	-18	20
40	0	18
34	12	12
28	-12	18
-34	50	14
-58	-12	38
-2	22	20
10	26	20
-30	20	16
12	30	28
-6	20	30
-30	46	10
-36	14	28
-48	20	16
20	4	14
16	-6	16
-38	-62	44
-24	-50	40
-12	0	34
14	-12	34
52	-22	24
-52	-24	30
-60	4	22
12	30	26
-6	26	30
4	-40	36
4	12	14
-40	22	32
-28	-54	46

// Pfefferbaum A, 2001: Controls
// Subjects=10
-33.53	33.32	19.92
-49.88	20.96	22.99
-36.21	40.16	5.95
-37.41	33.21	12.04
-30.7	-47.19	55.29
-32.19	-67.05	53.13
-6.14	-57.03	72.77
-14.39	-55.81	70.1
-13.77	-65.6	57.27
10.55	-40.17	54.68
-37.77	5.84	45.46
-37.91	18.76	37.79
-33.91	14.31	45.11
-19.85	19.57	55.78
13.5	60.65	-7.23
5.42	32.77	31.41
44.43	-61.16	46.43
44.04	-51.25	51.39
56.13	-37.56	53.64
14.68	-57.52	69.77
34.94	-40.18	69.28
51.5	27.47	16.92
28.09	28.3	37.41
55.46	38.03	16.03
32.34	13.53	45.74
59.92	25.17	16
55.5	25.49	25.45
48.59	-72.3	-10.92
-13.81	53.11	36.45
-7.23	68.21	12.77
-37.97	-55.53	-24.33
-40.78	26.51	0.32
-27.99	22.97	11.1
-25.28	2.29	7.94
-16.35	15.42	-9.42
-18.5	6.21	-2.2
-1.44	-47.91	-22.9
37.82	8.3	59.5
-41.46	42.41	9.63
33.53	15.9	54.9
66.62	19.07	31.95
28.53	-59.71	62.8
43.9	-59.07	56.2
48	-52.62	-10.51
-6.83	72.05	-13.95
-.57	62.81	0.53
8.8	68.92	-26.46
10.47	72.5	-13.51
19.27	73.61	-18.14
-6.96	-45.42	10.9
-2.49	-58.66	19.53
-2.97	-50.08	26.31
-11.57	-53.92	29.41
20.59	-51.86	34.71
14.25	-58.29	36.35
8.3	-20.9	59.98
3.82	-28.97	71.5
-4.7	-17.04	58.36
-58.89	22.83	28.56
-16.27	14.9	-11.61
-25.21	3.76	5.22
-16.43	-4.85	5.7
-7.5	8.28	-11.67
6.92	37.77	-10.46
13.02	45.77	-5.64
33.78	29.93	-32.66
14.19	10.34	-13.81
26.9	30.62	-21.52
7.56	-62.84	44.31
14.17	-57.66	38.42
12.78	-59.99	13.57
-11.2	-62.38	22.62
-6.2	-68.93	6.26
-27.26	-52.25	44.64
-61.68	-.16	16.99
-58.12	2.3	33.94
-6.83	47.38	14.93
-29.3	37.94	12.89
-23.04	44.57	5.29
26.98	33.83	2.48
38.95	60.54	-2.95
13.82	56.8	8.94
45.94	28.35	-3.13
50.46	25.55	-13.8
40.59	24.4	-25.62
-60.38	9.22	35.76
-67.92	-1.81	19.16
-33.5	-21.94	61.47
-17.16	-7.58	57.98
-55.46	-29.83	41.44
-54.13	-24.41	61.5
-38.2	-59.73	40.97
-32.17	-62.07	47.82
-37.82	-67.65	35.47
-37.22	43.77	-4.7
-29.3	37.94	12.89
-27.7	46.87	22.18
-38.06	26.7	35.44
-19.52	44.05	27.13
-39.57	42.14	5.48
38.95	60.54	-2.95
30.56	61.24	0.49
30.66	67.72	-7.21
13.83	54.82	9.59
23.73	38.68	36.23
31.08	44.89	-4.51
47.99	-40.8	50.4
46.13	-34.84	40.77
58.78	-34.51	33.35

// Pfefferbaum A, 2001: Alcoholic Patients
// Subjects=7
-14.57	-91.16	14.66
-38.36	-82.69	6.71
-53.22	-77.07	-4.68
-23.26	36.37	-13.5
-19.45	51.15	-8.31
-10.32	22.06	-1.89
-23.31	23.73	-2.84
50.13	31.14	-4.6
38.22	16.28	-26.23
52.72	26.23	-14.69
30.8	35.67	-11.33
56.9	16.35	-2.35
44.87	-63.9	29.77
38.11	-70	40.58
37.92	-71.77	50.39
40.1	15.42	52.93
40.83	19.38	26.31
51.34	24.91	29.73
45.3	29.55	14.24
-71.19	-.37	25.57
-35.36	-73.34	41.15
-40.07	-60.83	46.6
-30.68	39.68	15.43
-11.47	65.13	1.83
-29.24	49.95	28.73
36.36	60.49	-2.11
7.89	68.21	3.88
11.35	-36.88	41.56
-15.8	-28.3	75.13
-27.17	-7.69	78.1
16.36	-77.9	53.72
3.19	-47.72	35.16
27.44	-13.11	63.03
-13.73	16.53	43.65
-15.92	29.68	35.11
-24.45	22.71	34.48
-26.45	14.43	36.79
-15.66	33.01	22.56
-9.43	8.95	48.36
26.18	-80.79	17.75
23.35	-83.3	41.58
52.81	-55.55	43.94
47.66	-76.11	17.26
61.15	-36.26	40.88
69.17	-47.62	-1.84
60.99	-54.28	-9.44
-67.37	-49.06	9.82
-47.43	-59.03	4.19
-39.34	-49.76	13.33
-14.57	-91.16	14.66
-34.15	-61.65	-6.2
-53.22	-77.07	-4.68
-36.2	-82.56	6.78
-34.25	-66.03	2.08
-19.34	-75.2	16.86
-32.36	-88.16	27.1
-41.53	-80.8	38.52
-32.54	-77.82	24.06
-26.34	9.36	-31.28
-21.12	31.48	-7.34
-15.81	-10.39	-6.54
-34.62	28.98	9.16
-46.59	31.47	-22.15
-23.7	43.48	-4
-11.78	77.14	5.24
44.79	-63.37	31.96
64.04	-32.29	14.33
18.36	-25.45	17.68
5.03	-80.66	3.09
50.13	31.14	-4.6
52.72	26.23	-14.69
13.71	11.71	-.26
38.22	16.28	-26.23
43.92	25.12	-10.06
30.8	35.67	-11.33
16.83	-19	-7.47
29.7	-6.88	-12.82
44.55	-3.3	-8.72
35.98	-11.21	-4.43
42.78	24.09	27.26
40.1	15.42	52.93
49.13	12.25	40.32
33.43	27.7	49.14
49.4	27.29	22.02
51.5	16.65	32.11
-41.99	-62.62	40.2
-39.5	-64.8	31.63
-35.36	-73.34	41.15
25.21	29.61	32.06
-30.68	39.68	15.43
36.36	60.49	-2.11
5.65	68.82	5.99
-45.99	49.58	12.02
45.52	62.23	-20.82
3.19	-47.61	35.14
-1.3	-53.7	46.02
16.1	-57.95	45.58
26.07	-80.79	17.76
29.97	-64.03	22.31
23.7	-80.58	26.96
36.91	-65.86	6.9
-61.68	-.16	16.99
-58.12	2.3	33.94
-6.83	47.38	14.93
-29.3	37.94	12.89
-23.04	44.57	5.29
26.98	33.83	2.48
38.95	60.54	-2.95
13.82	56.8	8.94
45.94	28.35	-3.13
50.46	25.55	-13.8
40.59	24.4	-25.62
-60.38	9.22	35.76
-67.92	-1.81	19.16
-33.5	-21.94	61.47
-17.16	-7.58	57.98
-55.46	-29.83	41.44
-54.13	-24.41	61.5
-38.2	-59.73	40.97
-32.17	-62.07	47.82
-37.82	-67.65	35.47
-37.22	43.77	-4.7
-29.3	37.94	12.89
-27.7	46.87	22.18
-38.06	26.7	35.44
-19.52	44.05	27.13
-39.57	42.14	5.48
38.95	60.54	-2.95
30.56	61.24	0.49
30.66	67.72	-7.21
13.83	54.82	9.59
23.73	38.68	36.23
31.08	44.89	-4.51
47.99	-40.8	50.4
46.13	-34.84	40.77
58.78	-34.51	33.35

// Ullsperger M, 2001: Response Competition (Incompatible Correct vs. 
// Compatible Correct)
// Ullsperger M, 2001: Error-Related Activations (Incompatible Incorrect vs. 
// Incompatible Correct)
// Subjects=12
5.59	34.4	39.82
5.62	24.8	39.51
-3.9	1.65	43.79
32.08	20.19	5.02
48.38	-1.1	31.15
53.71	9.77	33.53
40.91	6.6	35.06
50.44	13.46	26.56
44.96	15.32	9.74
54.55	15.12	6.3
32	17.13	-6.99
47.96	37.4	-7.76
-35.24	19.78	5.83
-36.36	10.46	-4.53
-32.02	-2.03	-1.3
24.64	49.09	21.64
50.37	30.3	24.04
41.75	38.36	19
-38.41	44.31	20.54
-35.84	-23.75	48.52
45.48	-44.07	53.75
5.67	-22.93	27.9
11.73	15.15	-3.24
9.75	-31.56	-1.53
27.92	-31.45	-1.75
-13.73	-19.3	7.75
-10.61	-22.34	-4.3
50.67	-70.93	22.49
15.13	-60.85	-9.18
3.41	-58.29	-2.56
25.7	-49.84	-19.14
-9.42	-62.85	-5.38
-33.05	-68.6	-22.47
-25.43	-84.7	-11.17
3.51	18.53	41.18
-.69	10.47	47.48
8.73	23.87	27.29
-36.31	16.43	3.89
-41.65	5.48	0.41
-41.73	16.69	-6.1
-33.28	15.71	-19.5
44.91	9.35	1.32
35.3	13.69	3.3
35.19	23.58	-6.45
63.48	-44.62	31.29
66.63	-30.85	30.1
-42.17	-49.25	49.62
-60.51	-54.42	25.73

// Williams L M, 2001: Fear vs. Neutral
// Williams L M, 2001: Fear With Arousal Responses
// Williams L M, 2001: Fear Without Arousal Responses
// Subjects=11
-41.46	-78.28	-9.29
-48.93	-73.84	-6.24
-53.25	-63.29	-7.07
-2.75	-71.16	24.24
13.36	-77.87	32.42
20.39	26.26	15.8
28.04	8.3	30.6
-32.69	-29.79	38.95
55.93	-20.08	32.66
13	-43.17	-.6
-29.96	-61.06	-35.4
-25.55	-13.45	1.81
55.77	-31.66	6.87
58.87	-12.95	0.8
27.72	-3.84	-16.33
-25.68	-7.08	-12.1
20.31	-21.86	-14.73
20.33	-22.66	-11.32
-10.64	47.56	18.83
-17.94	-16.44	17.59
12.96	-23.8	2.24
20.8	-13.47	52.58
-36.94	-63.62	28.46
13.12	-57.29	9.51
-6.05	-52.32	20.46
16.23	38.35	34.91
63.5	-29.04	40.02
28.24	-20.45	44.16
-24.63	-7.33	-15.44
20.51	-16.46	13.81
-33.05	-70.88	-24.51
8.75	-81.41	-12.95
-48.91	7.67	29.31
-29.88	16.73	7.14
-3.09	26.46	20.51
-15.79	-93.19	-11.68
32.04	-22.05	-18.2
32.07	-23.91	-14.7

// Knutson B, 2001: Anticipation vs. Response
// Knutson B, 2001: Reward vs. Neutral Anticipation
// Knutson B, 2001: Large vs. Small Reward Anticipation
// Knutson B, 2001: Punishment vs. Neutral Anticipation
// Knutson B, 2001: Large vs. Small Punishment Anticipation
// Subjects=8
-4.3	17.25	-2.12
4.29	5.67	-1.25
-22.47	10.46	-5.8
22.39	11.7	-7.54
1.27	-17.72	13.02
0.48	1.64	57.12
2.54	-25.52	35.96
13.82	21.25	-7.12
-5.3	8.07	3.12
10.78	4.28	7.72
20.33	10.26	1.53
3.32	-2.11	8.34
-13.95	-1.81	-13.79
3.43	29.73	34.66
4.57	19.5	39.97
3.62	3.18	49.15
0.35	-31.51	27.57
13.82	19.05	-8.05
-6.3	2.15	9.21
9.7	5.25	6.53
-17.18	15.52	-9.63
25.71	0.77	2.26
5.43	-.15	5.92
2.31	25.95	27.19
2.32	22.78	27.45
7.55	39.21	19.32
0.51	4.19	62.49
2.51	-22.52	33.48
1.19	-51.5	-10.91
8.62	4.1	5.53
4.36	-.24	4.82
-5.23	1.1	9.28
9.69	6.31	6.44
3.3	-.16	5.94
1.35	10.6	35.18
1.45	-5.98	41.03
1.24	32.55	29.99
6.43	-66.84	-30.88

// Vuilleumier P, 2001: Spatial Attention, Faces > Houses
// Vuilleumier P, 2001: Spatial Attention, Houses > Faces
// Vuilleumier P, 2001: Faces, Fearful > Neutral
// Vuilleumier P, 2001: Faces, Neutral > Fearful
// Vuilleumier P, 2001: Unattended, Fearful > Unattended, Neutral
// Vuilleumier P, 2001: Attended Fearful > Attended Neutral
// Vuilleumier P, 2001: Attended Fearful > Unattended Fearful
// Vuilleumier P, 2001: Attended Neutral > Unattended Neutral
// Vuilleumier P, 2001: Increased response to fear with attention
// Vuilleumier P, 2001: Increased response to fear with inattention
// Subjects=12
44	-54	-20
-44	-54	-20
-40	-78	-18
32	-44	-10
28	-40	-16
-26	-42	-14
16	-56	16
-12	-56	18
36	-82	24
-32	-86	34
-30	6	-26
-26	0	-20
-14	52	14
44	-52	-20
30	40	-16
8	-36	-18
-10	-38	-16
34	34	28
10	40	48
-20	-2	-18
16	-10	-18
-14	50	12
8	52	18
42	-54	-20
-26	-2	-20
-30	4	-30
-44	-52	-20
-32	2	32
44	-56	-20
-10	-2	48
-8	-78	18
-32	0	-30
8	20	4
8	50	16
-32	20	36
2	28	-14

// Maclin E L, 2001: Incongruent > Congruent
// Subjects=8
4.75	-1.67	55.12
13.51	-71.93	54.22
38.5	57.63	20.77
34.84	-27.16	66.95
4.79	-92.44	23.7

// Spence S A, 2001: Lie > Truth, Visual
// Spence S A, 2001: Lie > Truth, Auditory
// Spence S A, 2001: Lie > Truth, Visual + Auditory
// Subjects=10
61.36	17.86	-16.36
-55.33	19.57	-14.55
1.71	26.21	53.3
5.86	33.7	41.29
-.78	45.6	31.26
61.38	20.19	-14.35
-55.3	19.78	-12.32
61.38	20.19	-14.35
-55.3	19.78	-12.32
5.84	33.49	39.07
1.71	26.21	53.3
-39.27	15.64	57.29
-49.86	-48.42	61.57

// Knutson B, 2001: Anticipation: Reward vs. No Reward Response
// Knutson B, 2001: Anticipation: Response vs. No Response
// Knutson B, 2001: Outcome: $1.00 Reward vs. $50.00 Reward
// Knutson B, 2001: Outcome: All Reward vs. No Reward
// Subjects=9
36.26	19.18	-8.32
12.79	12.87	-5.29
-7.52	13.81	-5.14
12.82	11.01	-1.79
-8.53	6.74	-0.07
-20.33	1.75	-8.44
4.35	-.33	3.72
18.15	-6.73	-11.52
6.36	45.58	5.42
4.6	16.5	42.45
2.55	4.23	49.08
-41.19	-10.58	54.17
4.48	-61.63	-4.53
26.72	7.84	-2.8
-21.31	0.49	2.83
-7.33	-16.09	7.4
4.63	10.24	44.09
-1.7	1.2	51.61
-36.92	-13.98	51.06
5.52	-63.02	-8.88
18.16	19.76	0.76
9.34	47.69	-22.67
7.26	40.62	-17.59
-2.26	55.76	0.2
4.63	-51.28	19.14
-2.56	-55.99	55.3
20.25	11.6	-8.62
11.9	-5.06	10.72
-3.48	45.41	-23.45
0.56	-26.11	56.11

// Berns G S, 2001: Preferred > Non-Preferred
// Berns G S, 2001: Unpredictable > Predictable
// Berns G S, 2001: Predictable > Unpredictable
// Berns G S, 2001: (Preferred - Non-Preferred) x (Unpredictable - 
// Predictable)
// Berns G S, 2001: (Preferred - Non-Preferred) x (Predictable - 
// Unpredictable)
// Subjects=25
-60	-12	16
20	36	-12
0	16	-8
12	-20	64
-4	-20	4
44	-68	-24
16	-76	-28
56	-40	16
-48	4	36
32	16	-16
-48	-4	-16
44	20	12
-12	-40	8
28	-52	-32

// Pariente J, 2001: Stroke Patients, Fluoxetine
// Subjects=4
-32	-8	50
0	-46	-30
12	-36	-30
49	3	20
26	-10	40
40	-49	20
32	-23	10
-12	-7	40
14	-3	20
-32	-22	50
-35	-59	-20
52	-16	25
-49	-13	35
55	-26	35

// Pariente J, 2001: Stroke Patients, Placebo
// Subjects=4
-35	-30	50
29	-16	45
-38	-23	45
-37	-22	30
40	-35	25
35	-66	-25
-23	-15	-25
-6	13	35
-6	-13	50
-35	-30	50
-6	-20	50
-32	-8	50
0	-46	-30
12	-36	-30
49	3	20
26	-10	40
40	-49	20
32	-23	10
-12	-7	40
14	-3	20

// Breiter H C, 2001: Positive Signal Changes for Good Spinner vs. 
// Intermediate Spinner
// Breiter H C, 2001: Positive Signal Changes for Bad Spinner vs. Intermediate 
// Spinner
// Breiter H C, 2001: Negative Signal Changes for Good Spinner vs. 
// Intermediate Spinner
// Breiter H C, 2001: Negative Signal Changes for Bad Spinner vs. Intermediate 
// Spinner
// Subjects=12
-55.39	-3.97	16.98
-28.84	49.31	15.55
-55.34	-44.13	6.96
-5	-80.03	6.05
-17.77	-82.77	13.11
-11.78	10.61	-4.82
31.16	-81.61	-17.65
40.71	-72.3	-21.89
23.2	59.49	-22.71
-2.43	73.85	-13.58
23.18	42.86	-31.35
-68.06	-49.78	17.62
64.2	-51.55	-17.21
-4.93	-72.66	18.81
13.95	-82.83	-31.85
37.1	43.2	-28.19
-38.72	22.4	-28.92
64.22	-4.03	5.57
-61.68	-70.86	5.93
-28.84	7.59	-1.03
23.41	-32.82	-32.81
23.54	-83.03	-35.29
-44.7	-78.64	-13.69
31.14	-78.44	-17.92
46.98	28.39	-.3
-52.53	-7.64	-30.7
-65.08	-45.47	-9.54
-1.72	-72.64	18.77
17.12	-21.71	-12.48
17.01	-36.03	-32.47
7.53	-79.7	-32.04

// Phelps E A, 2001: Threat - Safe
// Subjects=12
-13.01	-6.43	-32.37
-7.6	-5.71	-23.57
2.34	-7.88	-52.5
40.9	-1.14	31.24

// Morris J S, 2001: (Masked CS+/Noise UCS) vs. (Masked CS- + Unmasked CS- + 
// Unmasked CS+)
// Morris J S, 2001: Unmasked CS+ vs. Unmasked CS-
// Morris J S, 2001: Early Learning:  CS+ vs. CS-
// Morris J S, 2001: Late Learning:  CS- vs. CS+
// Morris J S, 2001: Late Learning:  CS+ vs. CS-
// Subjects=6
-20	-24	-4
28	-20	-4
-52	-24	6
54	-22	8
-30	-10	-10
-44	-18	12
32	-88	20
6	-22	14
-12	-8	-26
-18	2	-14
-44	-18	12
36	-62	-2
-32	-66	-2

// O'Doherty J, 2001: Glucose - Tasteless
// O'Doherty J, 2001: Salt - Tasteless
// Subjects=7
41.44	42.85	-19.29
51.1	41.14	-14.8
-29.04	38.46	-14.77
13.74	45.74	-6.95
49.27	12.43	13.28
44.77	18.81	-13.97
-27.85	18.89	-6.45
-50.25	2.72	-7.06
10.98	22.8	40.73
54.26	4.38	-36.28
35.44	18.49	24.09
-32.89	16.48	31.73
-18.8	10.96	55.45
-24.47	8.64	12.22
14.76	38.63	-16.4
-18.37	41.69	-15.16
49.13	34.04	3.67
-33.22	35.06	-3.28
-47	-2.29	-3.34
17.37	27.07	40.3
-15.98	44.36	19.16
26.51	7.9	-29.57
-34.04	20.02	22.52
-45.8	35.26	28.07

// Hobday D I, 2001: Rectal Stimulation - Rest
// Hobday D I, 2001: Anal Stimulation - Rest
// Subjects=8
59.05	-17.66	22.38
-56.36	-18.36	23.77
63.2	-7.92	10.37
-60.72	-8.32	16.29
49.74	-36.56	54.19
-46.44	-37.13	55.34
1.35	11.65	35.09
54.51	7.03	-1.94
-52.35	6.39	-.66
23.31	72.75	-2.63
-42.85	49.09	0.11
49.08	17.06	-9.41
-47.09	16.48	-8.25
55.99	-9.63	44.05
52.53	-12.21	10.85
-50.05	-12.83	12.08
17.82	-50.7	66.89
-14.24	-50.89	67.28
55.86	-29.57	20.07
43.81	5.65	-5.05
-41.68	5.14	-4.02
-42.81	45.12	3.79
59	20.2	30.36
-56.41	19.51	31.75
1.19	55.01	31.45
47.98	24.46	-10.02
-46.05	23.89	-8.89
-42.4	8.82	43.63

// Lotze M, 2001: Anal Discomfort - Anal Baseline
// Lotze M, 2001: Rectal Discomfort - Rectal Baseline
// Lotze M, 2001: Anal Discomfort - Rectal Discomfort
// Subjects=8
-24	-9	66
-18	-39	69
3	-30	16
6	3	69
-63	-15	12
60	12	15
-51	6	3
45	9	0
57	18	12
-60	-42	19
3	3	42
51	24	-9
-63	-15	15
60	-9	12
-39	12	0
36	21	-3
-57	-42	6
63	-33	9
-6	21	30
51	27	-9
60	-21	18
60	-9	18
14	-2	32

// Martin R E, 2001: Activations During Naive Saliva Swallowing
// Martin R E, 2001: Activations During Voluntary Saliva Swallowing
// Martin R E, 2001: Activations During Water Bolus Swallowing
// Subjects=14
-51.05	15.4	33.14
-51.12	10.23	21.31
-52.25	9.62	13.57
50.48	12.83	32.19
40.7	5.61	8.38
40.65	5.09	1.73
54.78	4.32	31.74
57.89	9.91	21.2
-57.51	12.65	25.64
59.96	9.24	12.31
-56.51	9.68	14.73
2.54	3.09	48.06
-50.04	10.4	23.51
-56.51	11.88	15.66
57.88	5.42	18.23
57.81	9.14	11.23
59.97	23.67	20.02
63.15	10.23	11.08
42.83	6.59	7.15
43.86	6.17	1.6
5.74	-2.44	45.14

// Suzuki Y, 2001: Young Adults
// Subjects=6
46.94	19.25	-8.45
-36.31	-57.15	-25.62
-2.44	56.08	-23.24
-23.31	-79.4	-11.64
63.21	-5.63	12.41
14.24	-93.04	1.34
-29.8	-59.35	-13.25
-51.22	4.8	6.16
63.31	-32.07	14.62
34.18	-20.9	-17.21
38.36	3.45	-19.3
-8.35	-79.31	-11.82
-44.97	36.13	-2.12
7.84	-70.98	11.83
7.63	-16	7.22

// Suzuki Y, 2001: Elderly Adults
// Subjects=6
-39.47	-56.66	-18.94
-32.81	-84.86	1.2

// Ferstl E C, 2001: Language Conditions > Non-Word Control
// Ferstl E C, 2001: (Coherent/Incohesive + Coherent/Cohesive) - 
// (Incoherent/Incohesive + Incoherent/Cohesive)
// Ferstl E C, 2001: (Coherent/Cohesive + Incoherent/Cohesive) - 
// (Coherent/Incohesive + Incoherent/Incohesive)
// Ferstl E C, 2001: (Coherent/Incohesive + Incoherent/Cohesive) - 
// (Coherent/Cohesive + Incoherent/Incohesive)
// Ferstl E C, 2001: Incoherent/Cohesive - Incoherent/Incohesive
// Ferstl E C, 2001: Coherent/Cohesive - Coherent/Incohesive
// Subjects=12
-9.24	21.42	52.23
-7.3	51.24	38.56
-52.36	-12.44	-10.23
-61.67	-49.91	15.32
-48	23.65	15.69
-48.15	30.91	-.53
-7.07	-54.01	26.19
48.08	30.94	5.05
47	-9.82	-12.71
20.46	-83.96	-19.57
-3.81	-31.47	42.11
-3.32	63.59	5.14
-25.36	3.92	33.81
27.03	5.55	36.42
-41.63	25.46	11
-45.82	12.03	16.64
-31.98	20.4	13.55
-28.21	-58.34	54.68
-46.5	-37.73	47.58

// Gusnard D A, 2001: Internally Cued Condition (ICC) > Fixation
// Gusnard D A, 2001: Externally Cued Condition (ECC) > Fixation
// Gusnard D A, 2001: Internally Cued Condition (ICC) > Externally Cued 
// Condition (ECC)
// Gusnard D A, 2001: Fixation > Internally Cued Condition (ICC)
// Gusnard D A, 2001: Fixation > Externally Cued Condition (ECC)
// Subjects=24
-3.88	8.42	48.8
-1.74	8.43	48.77
-8.35	45.95	39.01
-2.14	59.25	17.75
-10.34	29.87	51.54
-10.43	36.59	42.05
8.59	50.94	19.44
-2.22	45.19	1.09
4.15	36.08	-7.14
-12.87	30.15	0.24
-6.5	27.56	-6.3
8.47	14.62	-9.85
-4.34	3.62	-13.24
4.15	36.08	-7.14
-8.62	32.12	-2.2
-2.24	27.41	-8.57
8.43	16.39	-14.46
-.12	7.54	-18.08

// O'Doherty J, 2001: High Probability Reward - High Probability Punishment 
// Reversal
// O'Doherty J, 2001: High Probability Reward - High Probability Punishment
// O'Doherty J, 2001: High Probability Punishment Reversal - High Probability 
// Reward
// O'Doherty J, 2001: High Probability Punishment - High Probability Reward
// O'Doherty J, 2001: High Probability Reward Reversal - High Probability 
// Reward
// O'Doherty J, 2001: Voxels in Left Medial OFC Positively Correlated with 
// Reward
// O'Doherty J, 2001: Voxels in Right lateral OFC Positively Correlated with 
// Punishment
// O'Doherty J, 2001: High Probability Reward - Neutral Feedback
// O'Doherty J, 2001: High Probability Punishment - Neutral Feedback
// Subjects=9
7.13	43.56	-34.57
-9.95	41.52	-31.97
-3.46	29.21	-26.55
-3.62	49.5	-39.4
39.22	61.7	-23.07
52.43	38.34	17.76
49.26	27.75	18.69
-5.7	34.68	-38.14
30.71	64.28	-16.5
1.12	49.92	20.73
37.11	55.34	-22.52
-29.16	67.98	-18.36

// Damasio H, 2001: Action Tool Word Retrieval - Picture Control, Activations
// Damasio H, 2001: Action Tool Word Retrieval - Picture Control, 
// Deactivations
// Damasio H, 2001: Action Word Retrieval - Picture Control, Activations
// Damasio H, 2001: Action Word Retrieval - Picture Control, Deactivations
// Damasio H, 2001: Action Tool Word Retrieval - Concrete Entities, 
// Activations
// Damasio H, 2001: Action Tool Word Retrieval - Picture Control, Activations, 
// Post Hoc Analysis
// Damasio H, 2001: Action Tool Word Retrieval - Picture Control, 
// Deactivations, Post Hoc Analysis
// Damasio H, 2001: Action Word Retrieval - Picture Control, Activations, Post 
// Hoc Analysis
// Damasio H, 2001: Action Word Retrieval - Picture Control, Deactivations, 
// Post Hoc Analysis
// Damasio H, 2001: Action Tool Word Retrieval - Concrete Entities, 
// Activations, Post Hoc Analysis
// Damasio H, 2001: Concrete Entities - Picture Control, Spatial Relations, 
// Activations
// Damasio H, 2001: Concrete Entities - Picture Control, Spatial Relations, 
// Deactivations
// Damasio H, 2001: Abstract Drawings - Picture Control, Spatial Relations, 
// Activations
// Damasio H, 2001: Abstract Drawings - Picture Control, Spatial Relations, 
// Deactivations
// Damasio H, 2001: Concrete Drawings - Picture Control, Spatial Relations, 
// Activations
// Damasio H, 2001: Concrete Entities - Picture Control, Spatial Relations, 
// Activations, Post Hoc Analysis
// Damasio H, 2001: Concrete Entities - Picture Control, Spatial Relations, 
// Deactivations, Post Hoc Analysis
// Damasio H, 2001: Abstract Drawings - Picture Control, Spatial Relations, 
// Activations, Post Hoc Analysis
// Damasio H, 2001: Abstract Drawings - Picture Control, Spatial Relations, 
// Deactivations, Post Hoc Analysis
// Subjects=20
-51.26	35.18	13.64
-35.4	30.22	-10.66
-45.74	12.89	27.72
-25.34	9.55	37.8
-53.33	-50.94	-12.57
-41.67	-32.1	-17.63
-35.75	-82.14	36.69
57.08	-40.08	35.44
62.42	-46.74	31.48
-35.39	29.16	-10.57
-45.95	32.66	8.22
-36.06	11.34	34.43
-30.18	19.02	-32.08
-54.4	-53.15	-13.48
-43.79	-34.14	-16.31
-38.96	-81.1	36.64
50.7	-80.53	22.18
-48.7	-77.95	23.1
57.13	-35.25	42.84
-57.36	-24.28	29.85
-44.51	-74.47	12.73
41.2	-82.65	36.96
33.75	-79.09	42.32
-20.77	-82.93	38.81
8.93	-78.38	12.44
38.64	39.28	31.23
48.2	1.42	8.64
56.98	1.67	38.63
57.9	-19.67	10.3
70.76	-30.17	11.03
-56.54	-11.44	3.12
36.57	-87.41	-10.54
21.66	-94.65	-6.42
-35.03	-88.99	-10.7
-19.69	-81.7	40.93
3.61	-81.5	13.88
13.15	-61.35	12.08
56.72	1.13	4.11
60.2	-1.48	38.86
70.77	-28.94	13.16
-62.84	-19.16	13.87
34.46	-89.37	-8.12
-33.95	-86.69	-8.67
-41.62	-.86	0.94
33.2	-4.56	1.51
12.68	-28.91	-36.36
53.74	-71.22	4.63
-32.04	27.38	7.39
-46.9	28.4	21.97
-21.06	12.92	39.7
-55.41	-55.9	-7.66
-14.81	-51.34	-7.4
-44.03	1.84	-32.71
-34.17	27.45	8.52
-46.86	20.03	23.79
-42.39	11.02	44.56
-19.01	-56.05	0.85
-37.3	-51.99	-13.78
-64.79	-40.27	30.16
-30.09	55.17	-5
-30.18	46.48	-21
24.71	-44.67	-7.3
-26.07	-75.93	47.21
39.01	-82.03	31.36
6.81	-73.82	16.54
-6.84	-79.16	45.03
0.46	-75.46	23.44
-21.11	-61.18	3.54
19.38	53.17	33.63
58.89	9.23	12.33
-60.75	-8.58	12.96
2.96	43.59	-20.02
51.17	-11.96	-27.07
56.68	-15.67	-6.75
61.15	-37.8	9.55
38.79	-89.89	-1.44
25.49	4	-24.77
-32.24	60.53	-4.31
-24.99	-74.7	49.32
39.05	-83.89	34.86
17.64	-75.64	33.3
-5.91	-75.07	29.06
2.98	45.96	-16.88
27.59	2.53	-30.25
41.71	-42.26	-18.85
60.1	-37.63	11.78
39.83	-85.74	-2.91
-39.25	-80.75	-.19
-63.96	-5.42	12.73

// Goel V, 2001: ((Abstract Reasoning + Concrete Reasoning) - (Abstract 
// Baseline + Concrete Baseline))
// Goel V, 2001: Concrete Reasoning - Concrete Baseline
// Goel V, 2001: Abstract Reasoning - Abstract Baseline
// Goel V, 2001: Conjunction (Abstract Reasoning - Abstract Baseline)(Concrete 
// Reasoning - Concrete Baseline)
// Goel V, 2001: (Abstract Reasoning + Baseline) - (Concrete Reasoning + 
// Baseline)
// Goel V, 2001: (Concrete Reasoning + Baseline) - (Abstract Reasoning + 
// Baseline)
// Goel V, 2001: Abstract Reasoning - Concrete Reasoning
// Goel V, 2001: Concrete Reasoning - Abstract Reasoning
// Subjects=14
9	-75	27
33	-66	-51
30	-60	-33
33	-48	-45
-6	-75	-33
-33	-54	-39
-42	-60	-33
15	-99	6
-30	-81	30
36	-75	33
0	-60	48
-42	-51	48
36	-48	48
15	6	0
-18	0	-3
30	9	51
-27	3	51
3	12	51
-42	30	33
33	-66	-51
-9	-75	-36
6	-87	-3
9	-96	9
33	-87	9
-42	-51	48
36	-48	48
-18	-66	57
12	-63	57
0	-60	48
15	6	-6
-18	0	-3
9	-78	-24
-6	-75	-33
18	-99	3
30	-60	48
-27	-60	51
-6	-75	-33
-33	-54	-39
30	-57	-33
33	-63	-51
36	-51	-51
-12	-81	-15
15	-99	9
-6	-102	0
-30	-81	30
33	-72	33
-21	-69	51
24	-60	60
-30	-60	51
30	-60	54
0	-60	48
12	6	0
-15	3	-3
-27	3	48
33	3	51
3	12	51
-42	30	36
-48	-39	51
-18	-66	57
33	-54	66
48	-75	0
-48	-75	-6
9	-84	0
-9	-81	6
-6	-93	-6
-45	-36	48
27	-69	51
9	-84	0
-9	-84	6
-12	-81	-12

// Wagner A D, 2001: 4 Target > 2 Target
// Wagner A D, 2001: Weak > Strong, Associative Strength
// Wagner A D, 2001: Weak/2 Target > Strong/4 Target
// Wagner A D, 2001: 4 Target > 2 Target, Weak Association
// Wagner A D, 2001: 4 Target > 2 Target, Strong Association
// Wagner A D, 2001: Weak > Strong, 2 Target
// Wagner A D, 2001: Weak > Strong, 4 Target
// Subjects=14
-36	21	27
-39	6	24
-45	27	9
3	30	36
3	15	42
-51	21	-12
-45	27	-12
-51	18	27
-51	21	-3
6	18	39
9	27	36
0	9	57
45	21	6
30	24	-6
39	27	-9
54	24	27
45	9	27
51	9	33
51	21	27
54	12	21
54	12	36
-48	27	-12
-42	33	-12
-9	6	48
-48	30	27
-54	21	24
-57	12	30
6	6	54
-36	21	27
-45	15	16
-39	9	27
-45	30	0
-45	27	9
-45	21	24
-39	21	30
-39	6	27
-51	21	-12
-36	6	30
-51	18	27
-33	15	30
-48	27	-12
-36	27	3
-51	18	24
-45	15	15
-54	27	3

// Critchley H D, 2001: Main Effect of Delay Period
// Critchley H D, 2001: Modulation of Delay Period Activity by Arousal, 
// Independent of Risk
// Critchley H D, 2001: Modulation of Delay Period Activity by Both Arousal 
// and Risk
// Subjects=8
42	34	-14
-48	40	-12
-54	20	10
56	-28	-12
-36	8	-34
-46	-2	-32
38	10	-32
32	10	50
48	-40	46
46	-2	-26
54	-16	-26
-4	40	30
12	24	48
30	42	26
4	32	24
8	28	24
-6	28	20

// Paulus M P, 2001: Two-Choice Prediction Task vs Two-Choice Response Task 
// (Activations)
// Paulus M P, 2001: Two-Choice Prediction Task vs Two-Choice Response Task 
// (Deactivations)
// Paulus M P, 2001: Activation with the Behaviorally Defined 
// Wins-Stay/Lose-Shift Reference Function (Activations)
// Paulus M P, 2001: Activation with the Behaviorally Defined 
// Wins-Stay/Lose-Shift Reference Function (Deactivations)
// Subjects=12
11.4	-72.03	57.16
-29.12	60.23	-1.54
-6.36	-76.84	52.97
31.19	49.21	11.52
44.93	-51.52	48.25
5.19	-55.37	48.8
36.44	21.64	2.73
9.87	-11.71	8.84
-16.88	-38.02	6.79
-9.27	-39.87	37.3
51.42	-23.88	14.18
-2.81	-57.36	63.78

// Haberecht M F, 2001: Turner Syndrome Patients
// Subjects=11
-36	-56	-32
-44	-58	38
46	8	38
-32	52	36
8	-90	24
46	-54	34
8	-66	60
30	-4	52
24	50	42
-36	56	26
-18	16	4
-44	-44	28
32	-42	28
36	10	34
26	34	24
46	-12	18
30	-44	36
-44	-44	26
-36	16	28
-4	-48	40
44	-54	16
-52	-62	34
4	-76	34
-44	-44	28
-18	16	4
44	-40	26
36	10	34
10	-56	28

// Haberecht M F, 2001: Healthy Controls
// Subjects=14
18	6	58
42	8	40
-34	52	-26
36	0	42
42	-64	56
-18	16	4
-44	-44	28
32	-42	28
36	10	34
26	34	24
46	-12	18
30	-44	36
-44	-44	26
-36	16	28
-4	-48	40
44	-54	16
-52	-62	34
4	-76	34
-44	-44	28
-18	16	4
44	-40	26
36	10	34
10	-56	28

// Faillenot I, 2001: (TSDg + TSDo) - (DIMg - DIMo)
// Faillenot I, 2001: (IDg + IDo) - (DIMg + DIMo)
// Faillenot I, 2001: (IDg + IDo) - (TSDg - TSDo)
// Faillenot I, 2001: [(TSDo + IDo - 2DIMo) - (TSDg + IDg - 2DIMg) and [TSDo + 
// IDo + TSDg + IDg-2DIMo-2DIMg]
// Faillenot I, 2001: (TSDg + TSDo) - (IDg - IDo), single subject analysis
// Subjects=6
-20.42	-80.7	-9.7
22.72	-76.7	-15.31
-33.13	-87.59	9.13
-20.12	-100.31	10.16
18.77	-100.17	9.49
27.51	-95.05	17.8
18.82	-82.32	16.69
1.26	-84.46	-5.22
-28.43	-67.23	42.89
27.76	-71.29	42.34
-41.23	-35.42	62.37
-32.43	-47.32	72.37
-23.76	-55.8	73.06
-15.23	-69.78	60.85
-6.41	-55.32	77.2
40.82	-35.55	56.51
36.77	-46.66	75.6
19.44	-64.57	68.71
15.19	-55.25	76.82
10.64	-83.28	52.78
41.08	-29.22	78.29
-55.06	-63.8	-10.78
52.99	-67.67	-12.24
-59.01	17.75	35
-20.42	-80.7	-9.7
22.72	-76.7	-15.31
-37.42	-82.93	13.22
-11.48	-100.28	10.01
18.83	-99.75	13.93
27.51	-95.05	17.8
1.26	-84.46	-5.22
-32.92	-68.49	29.65
32.04	-75.94	38.24
-32.53	-52.41	63.91
-19.43	-55.79	72.98
-15.23	-69.78	60.85
-6.47	-55.74	72.76
40.82	-35.55	56.51
-23.87	-69.81	61
10.79	-64.6	68.86
-55.04	-68.05	-10.36
48.8	-71.11	-2.86
-28.38	7.58	62.38
27.74	7.37	56.96
-24.03	16.52	65.91
27.77	16.29	60.56
-6.47	-55.74	72.76
-32.56	-13.29	69
13.91	-47.37	-22.55
-2.28	-52.3	63.38
10.74	-51.84	67.59
-2.27	-69.73	60.62
44.41	-69.42	-7.44
46.54	-60.9	-8.32
50.81	-76.61	-15.8
35.47	-49.84	-27.15
57.31	-67.66	-12.31
55.13	-61.28	-12.91
46.57	-67.28	-7.69
31.41	-74.13	-11.23
35.76	-80.5	-10.68
48.76	-82.37	-8.47
46.51	-68.76	-12.02

// Herpertz S C, 2001: Borderline Personality Disorder (BPD) Patients
// Subjects=6
44.23	-54.4	-19.01
-42.2	-54.7	-17.5
18.11	-5.56	-23.39
-20.72	-8.48	-17.96
52.81	30.56	-6.27
-7.66	61.17	2.94
18.09	-1.31	-23.81
-20.73	-5.29	-18.28

// Herpertz S C, 2001: Healthy Controls
// Subjects=6
48.95	-59.02	11.63
-54.74	-75.65	11.68
18.09	-1.31	-23.81
-20.73	-5.29	-18.28

// Bense S, 2001: Galvanic Vestibular Stimulation (GVS) > Galvanic Pain 
// Stimulation (GPS), Activations
// Bense S, 2001: Acoustic Stimulation (AS) > Rest, Activations
// Bense S, 2001: GPS > Rest, Activations
// Bense S, 2001: Rest > GVS, Deactivations
// Bense S, 2001: Rest > GPS, Deactivations
// Subjects=6
-18.18	16.2	-.76
-7.38	-8.94	3.46
26.74	23.5	7.04
-22.26	-18.04	11.08
-18.01	-83.14	-19.19
9.77	-87.37	-21.39
-3.15	38.98	17.23
63.32	17.48	36.12
-45.55	2.71	47.53
-56.56	14.71	10.96
45.99	52.31	20.01
-43.71	43.65	26.23
38.34	27.4	-12.38
-60.65	-62.48	4.1
60.78	19.87	-15.35
-52.45	8.62	-13.11
-62.68	-30.65	30.45
63.41	-29.9	28.94
-67.24	-13.87	0.1
-50.25	37.84	6.72
-39.73	3.27	-28.42
73.82	-15.14	-1.42
69.46	-5.11	-8.9
63.23	-25.27	6.25
24.3	4.91	-40.45
63.4	9.54	43.47
-47.62	1.27	56.59
-39.12	2.92	49.67
14.02	-12.87	5.77
-5.12	-42.77	6.27
-3.08	-6.46	7.66
-7.3	-16.89	10.81
15.43	93.85	-45.57
31.08	-87.93	-30.51
35.29	-77.5	-33.66
-15.89	-89.81	-23.12
-7.34	-32.72	-1.24
-22.54	39.44	-2.66
-33.14	33.71	6.87
-43.9	54.8	5.22
-50.11	41.5	26.48
-26.83	23.92	-10.23
39.53	20.95	0.41
52.16	54.17	-11.44
-39.28	12.3	33.27
-65.2	22.43	1.49
-3.05	35.61	28.67
24.48	48.52	0.5
-.73	-35.03	23.41
-47.43	-53.89	58.99
-41.1	-54.7	47.83
-36.64	-72.51	64.89
65.45	-2.39	26.61
63.47	-11.78	43.03
5.93	-52.14	49.31
-64.89	-2.83	32.6
33.37	-88.49	-10.41
50.59	-89.3	5.07
-26.42	-101.54	-8.63
-32.87	-93.12	-9.26
-26.28	-104.4	9.45
-45.49	-77.93	23.06
-28.29	-96.52	28.89
-62.79	-1.05	27.97
-54.23	18.89	37.35
-43.43	-15.05	37.84

// Suzuki M, 2001: Right-Ear Caloric Stimulation, Activations
// Suzuki M, 2001: Left-Ear Caloric Stimulation, Activations
// Subjects=10
3.9	-40.03	68.39
-58.85	10.87	-10.99
52.2	10.68	-23.41
42.35	-53.18	60.13
20.35	-40.1	-16.55
43.7	-15.26	-27.82
1.28	16.43	28
-31.09	10.86	-13.54
46.59	-55.78	53.6
9.7	-17.81	-2.69
9.84	16.65	30.11
-15.93	-46.32	-11.15
54.64	-14.74	5.46
-41.73	-12.98	-18.11
-22.51	-32.75	-27.83
61.45	-39.12	47.58
37.26	-13.36	-30.14
-30.35	-60.64	52.67
5.67	-2.07	36.19
41.64	3.18	-9.27
50.11	15.58	-14.87

// Muller R A, 2001: Autistic group
// Subjects=8
-37.1	-30.27	48.35
-39.32	-15.39	46.91
-54.33	-32.04	53.3
-52.69	-29.39	12.67
-27.08	-5.44	-8.07
-16.11	-19.46	2.1
1.85	-16.54	55.29
4.02	-3.35	58.43
6.28	-.39	67.06
63.89	-18.76	5.15
7.58	-59.33	-12.29
18.28	-60.12	-21.36
-55.34	23.83	-14.97
-31.25	15.35	7.87
-55.32	32.75	-11.37
33.76	25.75	23.67
19.13	29.44	63.89
14.71	39.64	58.48
-2.82	-58.58	19.19
2.01	-72.26	56.32
1.87	-66.71	46.81
-29.11	63.4	16.53
9.85	-71.67	-6.63
1.16	-74.24	-10.71
40.66	-84.84	34.49
38.41	-89.93	26.07
49.31	-71.63	37.52
1.84	-42.9	48.93
-30.42	-68.12	56.46
-52.74	-60.42	2.29
-9.92	57.14	-5.59
-39.22	-12.43	55.58
-45.58	-13.75	64.79
-2.35	-2.55	67.42
-57.51	10.64	-18.11
-29.09	15.36	7.84
-22.52	7.29	13.01
68.42	-41.31	16.27
33.76	25.75	23.67
29.34	35.96	18.25
28.56	-58.06	23.08
33.57	-15.03	0.81
35.95	-11.23	18.32
33.57	0.28	3.78

// Muller R A, 2001: Healthy controls
// Subjects=0
-41.36	-16.69	56.04
8.46	-4.64	67.45
-56.93	-20.07	20.78
-13.95	-19.45	2.06
-60.35	11.41	13.24
-20.6	-5.42	-8.18
22.46	-54.55	-30.95
20.44	-75.42	-24.37
66.5	-15.43	40.63
61.97	-21.36	23.37
70.44	10.16	15.62
1.5	-73.87	16.14
6.19	-66.7	46.73
21.31	-93	40.11
-11.37	49.36	48.99
3.03	61.44	-6.23
32.04	29.07	59.23
-48.6	-59.52	-11.32
-46.26	-75.7	-.79
26.71	-4.78	-26.98
30.94	3.33	-32.34
33.04	18.22	-33.85
-2.82	-58.58	19.19
2.01	-72.26	56.32
1.87	-66.71	46.81
-29.11	63.4	16.53
9.85	-71.67	-6.63
1.16	-74.24	-10.71
40.66	-84.84	34.49
38.41	-89.93	26.07
49.31	-71.63	37.52
1.84	-42.9	48.93
-30.42	-68.12	56.46
-52.74	-60.42	2.29
-9.92	57.14	-5.59
-39.22	-12.43	55.58
-45.58	-13.75	64.79
-2.35	-2.55	67.42
-57.51	10.64	-18.11
-29.09	15.36	7.84
-22.52	7.29	13.01
68.42	-41.31	16.27
33.76	25.75	23.67
29.34	35.96	18.25
28.56	-58.06	23.08
33.57	-15.03	0.81
35.95	-11.23	18.32
33.57	0.28	3.78

// Kiehl K A, 2001: Criminal Psychopaths
// Subjects=8
48.33	21.65	-21
-42.44	25.58	-19.84
52.6	34.43	-22.34
-42.59	20.08	-32.74

// Kiehl K A, 2001: Criminal Nonpsychopaths
// Subjects=8
52.6	34.43	-22.34
-42.59	20.08	-32.74

// Kiehl K A, 2001: Healthy Controls
// Subjects=8
48.33	21.65	-21
-42.44	25.58	-19.84

// Christodoulou C, 2001: Healthy Controls
// Subjects=7
-45.93	9.91	42.28
-21.94	5.06	58.04
-48.46	37.81	19.39
-39.72	51.64	29.08
-15.62	17.02	47.78
-50.82	-20.62	-8.4
-67.76	-44.34	14.4
57.53	-35.39	11.38
64.31	-52.85	30.92
61.62	-19.6	-3.7
-35.4	-31.46	12.58
-41.46	-43.67	43.02
62.08	-35.84	29.28
48.99	-25.87	21.79
53.44	-29.28	31.02
40.6	-45.93	37.37
-52.67	-20.47	16.27
33.67	-25.25	6.3
18.53	0.85	10.7
-7.39	-10.09	9.98
5.4	-2.57	-2.18
20.67	-8.07	7.07
14	-20.39	-9.53
18.09	-79	-39.66
10.53	10.05	63.72
43.99	41.2	-18.38
11.7	37.66	-8.51
70.76	-13.7	35.91
-11.52	-80.92	10.34
-3.29	-48.94	-15.38
-16.13	67.91	18.1
-48.36	42.89	27.85
-44.54	8.56	-18.12
66.05	-16.63	4.9
-55.18	-47.2	-16.91
70.65	-31.97	24.27
49.05	-25.45	26.23
37.95	-73.69	-6.91
-13.48	-75.01	27.72
-20.41	-10.55	5.77
-5.26	-8.16	7.52

// Christodoulou C, 2001: Traumatic brain injury (TBI)
// Subjects=9
-50.49	12.48	24.17
-17.48	-15.78	64.51
49.3	7.03	52.15
59.52	39.9	12.86
42.23	39.84	13.16
-.4	13.44	54.6
6.19	7.7	61.78
-67.97	-34.95	0.03
72.46	-36.79	-4.42
-67.79	-44.54	12.18
-50.66	-25.96	3.33
-57.01	-29.41	12.74
72.77	-43.22	18.62
46.42	-28.99	-11.47
51.29	-44.59	28.09
2.99	-26.35	-26.68
-33.1	-37	22.05
12.34	27.13	39.58
10.53	10.05	63.72
43.99	41.2	-18.38
11.7	37.66	-8.51
70.76	-13.7	35.91
-11.52	-80.92	10.34
-3.29	-48.94	-15.38
-16.13	67.91	18.1
-48.36	42.89	27.85
-44.54	8.56	-18.12
66.05	-16.63	4.9
-55.18	-47.2	-16.91
70.65	-31.97	24.27
49.05	-25.45	26.23
37.95	-73.69	-6.91
-13.48	-75.01	27.72
-20.41	-10.55	5.77
-5.26	-8.16	7.52

// Grezes J, 2001: Activation during presentation of nonrigid biological 
// motions
// Grezes J, 2001: Common activated foci found in all tasks as compared to 
// baseline
// Grezes J, 2001: Cortical regions found activated for the walker versus cube 
// contrast
// Grezes J, 2001: Cortical regions found activated for the walker vs inverted 
// walker contrast
// Subjects=10
-36	-38	36
20	-8	58
34	-41	53
-20	-6	50
-16	-65	46
48	-25	40
-54	-15	21
46	-70	-4
-34	-60	-9
-31	-73	-2
13	-55	-23
52	-60	6
-38	-62	4
-34	-74	10
-28	50	-26
-6	43	40
4	-20	38
44	20	4
32	52	8
40	-74	12
-20	-82	20
26	-70	40
-16	-76	42
-8	-66	54

// McAllister T W, 2001: 2-back > 1-back, Control > MTBI
// McAllister T W, 2001: 2-back > 1-back, MTBI > Control
// McAllister T W, 2001: 3-back > 2-back, Control > MTBI
// McAllister T W, 2001: 3-back > 2-back, MTBI > Control
// Subjects=12
-15.84	50.43	37.76
52.85	49.48	0.82
-30.68	-37.25	42.2
-26.44	12.52	46.17
38.58	-44.89	48.5
3.85	26.01	51.04
-54.44	-54.77	39.86
-43.62	8.83	53.55
-29.38	59.2	-5.46
47.27	21.13	65.36
38.65	10.36	65.45
-4.47	-65.69	58.02
-18.14	49.38	26.69

// Lanius R A, 2001: Traumatic memory recall vs implicit baseline, control > 
// PTSD
// Subjects=9
14.08	-11.05	-1.49
-2.98	-11.58	16.78
0.73	36.37	-21.64
32.17	-85.96	45.95

// Vaina L M, 2001: Differential responses to Biological Motion (BM)
// Vaina L M, 2001: Differential responses to Non-Rigid Motion (NRM)
// Vaina L M, 2001: Differential responses to Face/Gender Discrimination (FG)
// Subjects=5
46.28	-69.95	7.96
-47.76	-70.52	9.09
7.96	-97.16	17.37
-21.9	-85.74	30.14
25.11	-78.94	31.26
22.97	-74.55	33.15
16.4	-96.02	3.8
-22.22	-78.08	-8.42
24.77	-67.05	-7.65
-26.53	-78.45	-12.8
-28.97	-15.7	-26.95
-32.76	-89.8	6.07
31.33	-87.47	2.91
-48.07	-14.44	-9
-63.09	-12.93	-15.64
48.45	-69.6	12.36
-47.69	-80.75	14.4
25.14	-78.6	35.69
-21.87	-78.88	36.25
-39.4	-70.23	-15.57
-5.19	-83.06	-19.35
44.13	-67.85	7.81
-45.62	-70.5	9.06
-19.81	-86.24	23.47
22.93	-85.98	22.95
27.25	-78.93	31.23
22.97	-74.55	33.15
22.69	-73.06	-2.66
-20.05	-77.72	-4.01
48.24	-65.14	-12.54
46.3	-56.58	15.76
50.63	-80.16	13.23
27.28	-78.59	35.67
-24.01	-78.89	36.28
18.58	-88.98	12.1
-17.77	-93.77	8.46
25.1	-76.83	31.08
25.11	-74.54	33.12
12.15	-91.48	7.93
-15.68	-94.27	1.79
31.07	-46.21	-13.93
-39.42	-55.09	-12.38
26.82	-48.18	-11.49
59.04	-44.16	10.11
-52.61	11.31	-33.41

// Shin L M, 2001: PTSD
// Subjects=8
37.42	11.42	1.24
-38.47	10.71	-1.18
-2.06	61.16	28.74
13.75	55.69	-2.2
37.54	38.94	26.81
-41.71	40.01	6.44
-38.57	29.48	-6.1
50.2	24.18	0.02
43.65	19.43	-19.58
14.16	17.1	35.6
-52.34	4.28	-.48
58.01	-28.42	21.07
-47.82	-62.31	5.05
30.96	-2.34	-10.92
50.51	4.38	32.9
37.38	-5.47	-10.73
23.68	-26.73	4.59
-32.04	-28.61	-14.68
34.26	-34.3	-11.62
1.45	-57.56	20.82
4.66	-34.48	30
-4.9	-66.86	25.01
58.15	-43.42	33.48
-41.19	-63.31	32.94
-8.31	-52.56	3.78
23.72	-52.63	0.07
43.96	-63.05	-12.67
1.54	-79.77	22.68
30.97	24.07	0.25
13.75	55.69	-2.2
-4.88	9.1	57.68
40.9	10.92	35.81
-38.18	10.45	36.76
-38.57	29.48	-6.1
50.13	23.41	-9.95
50.35	-23.66	0.68
1.52	-23.96	42.53
-1.66	-40.09	40.58
-41.26	-50.87	28.55
-34.77	-69.87	30.07
-11.12	-51.73	56.16
-28.62	-59.28	1.23
40.94	-77.64	5.32
37.33	10.39	-12.06
4.47	22.88	28.53
-8.42	48.43	29.88
-5.06	33.62	44.47
-25.78	58.88	1.33
43.71	52.95	1.03
-48.05	27.54	10.9
20.25	17.14	-5.74
-18.29	16.14	-15.25
10.98	4.14	33.38
-38.32	-63.54	-11.68
20.56	-85.14	-7.2
-35.34	9.95	-11.19
-35.05	-19.97	14.74
40.8	-19.77	10.5
37.26	19.65	-16.18
-8.62	56.32	8.04
17.02	53.05	4.67
34.24	47.92	19.4
-8.24	14.05	39.46
-52.36	4.02	-3.8
-21.38	-2.4	-6.97
-52.19	-7.38	13.88
7.55	-8.05	-.13
-28.85	-25.42	-14.99
-8.05	-23.5	49.29
4.72	-37.14	36.91
7.92	-50.32	31.29
11.27	-45.59	50.93
-4.95	-67.37	18.37
-44.44	-50.64	31.91
-8.34	-52.82	0.46
-1.67	-79.79	22.72

// Shin L M, 2001: Healthy Control
// Subjects=8
10.86	29.26	27.93
-8.45	48.18	26.56
7.8	34.04	48.75
37.37	53.68	11.07
47.23	26.56	31.08
57.95	-55.34	3.25
50.37	-13.63	6.53
58.17	-49.76	34.01
-31.46	-58.79	49.18
23.52	14.51	1.14
-35.08	-66.44	-8.13
-1.5	-68.13	49.62
-44.97	13.07	-11.34
-2.02	28.67	21.43
44.03	29.97	34.18
54.59	22.06	13.53
23.49	1.05	-7.77
-55.56	-12.37	-9.08
1.38	-45.13	16.43
-31.48	-59.05	45.85
-25.01	-68.27	49.9
11.11	-67.02	21.5
10.99	-78.08	2.35
37.33	10.39	-12.06
4.47	22.88	28.53
-8.42	48.43	29.88
-5.06	33.62	44.47
-25.78	58.88	1.33
43.71	52.95	1.03
-48.05	27.54	10.9
20.25	17.14	-5.74
-18.29	16.14	-15.25
10.98	4.14	33.38
-38.32	-63.54	-11.68
20.56	-85.14	-7.2
-35.34	9.95	-11.19
-35.05	-19.97	14.74
40.8	-19.77	10.5
37.26	19.65	-16.18
-8.62	56.32	8.04
17.02	53.05	4.67
34.24	47.92	19.4
-8.24	14.05	39.46
-52.36	4.02	-3.8
-21.38	-2.4	-6.97
-52.19	-7.38	13.88
7.55	-8.05	-.13
-28.85	-25.42	-14.99
-8.05	-23.5	49.29
4.72	-37.14	36.91
7.92	-50.32	31.29
11.27	-45.59	50.93
-4.95	-67.37	18.37
-44.44	-50.64	31.91
-8.34	-52.82	0.46
-1.67	-79.79	22.72

// Vogeley K, 2001: ToM stories > Unlinked sentences
// Vogeley K, 2001: Self and other ascription stories > Unlinked sentences
// Vogeley K, 2001: Self ascription stories > Unlinked sentences
// Vogeley K, 2001: Main effect of TOM
// Vogeley K, 2001: Main effect of SELF
// Vogeley K, 2001: SELF relative to TOM
// Vogeley K, 2001: Interaction of TOM and SELF
// Subjects=8
7.2	59.74	-18.08
9.36	59.92	-15.89
59.07	11.11	36.7
59.2	-5.12	46.98
63.38	-56.65	13.34
65.59	-7.54	42.65
2.98	49.31	-14.93
56.95	11.27	38.94
7.28	60.59	-7
-61.02	10.51	-15.4
-64.98	7.23	25.07
7.48	62.65	19.59
5.49	33.37	26.53
24.79	53.89	42.43
-58.73	29.67	11.96
63.38	-56.65	13.34
7.24	57.96	-13.47
25.14	9.25	70.7
65.59	-7.54	42.65
-8.89	-44.17	71.11
10.34	-41.94	70.7
-11.98	53.62	-12.89
61.27	-58.6	15.76
18.92	-32.74	78.76
-8.9	-42.05	70.93
42.38	-37.52	69.96
-47.72	-43.77	24.69
70.11	-22.55	68.39
60.76	35.02	-12.16

// Braus D F, 2001: Alcohol-Associated vs. Neutral and Abstract Stimuli, 
// Abstinent Alcoholics > Healthy Controls
// Subjects=4
-22.45	6.31	-4.34
23.5	6.59	-4.89
-35.21	-45.8	-16.55

// Kircher T T J, 2001: Generation - Reading
// Kircher T T J, 2001: Reading - Generation
// Kircher T T J, 2001: Generation - Decision
// Kircher T T J, 2001: Decision - Generation
// Kircher T T J, 2001: Decision - Reading
// Kircher T T J, 2001: Conjunction: (Generation - Reading) + (Generation - 
// Decision)
// Subjects=7
-16.9	-79.36	-11.72
63.34	-38.41	15.15
63.16	-6.15	5.76
63.27	-35.76	8.24
-44.55	-38.63	21.99
47.03	10.25	-1.01
-13.31	-41.34	53.08
-8.47	-34.38	-8.89
-26.23	-14.98	51.02
11.04	4.82	42.24
-47.8	10.39	36.87
-44.47	-46.58	29.34
-36.2	2.23	12.89
-13.87	44.03	14.7
14.06	-70.71	-12.8
22.67	-72.26	-6.07
4.83	-35.94	52.42
63.15	-28.24	-4.66
53.47	-10.32	-6.05
56.81	-48.37	-2.89
-54.42	-22.6	-3.78
38.63	-17.93	7.03
1.35	-11.41	25.87
-41.55	-59.42	-13.11
-48.09	24.91	4.43
22.42	-7.76	-11.48
53.62	-36.24	2.82
-50.95	-53.9	17.77
-57.43	-48.11	10.66
63.14	-25.07	-4.92
-35.87	-9.75	50.69
4.63	4.79	42.32
1.63	-35.96	52.46
-26.31	5.11	49.34

// Kircher T T J, 2001: FTD Schizophrenia
// Subjects=6
-26.57	-64.61	-12.84
7.69	-82.38	-11.74
-44.66	-70.55	-5.44
-54.35	-52.63	-6.84
1.44	1.59	42.62
-41.37	7.25	37.06
-47.89	9.45	24.69
-47.85	9.87	30.23
-48.1	16.02	-.4
16.07	13.66	4.64
-51.11	-.6	18.87
-41.48	11.6	24.43
-44.74	11.07	17.82
7.31	57.59	-4.52
56.75	-31.45	-4.31
63.07	-17.04	-11.17
-11.18	-54.53	47.47
7.65	-70.75	-12.72
-36.32	9.75	-0.01
-36.08	6.77	30.35
-41.56	-44.1	-7.7
6.19	33.92	-21.48
49.45	-15.35	25.65
50.19	-2.31	-12.26
-23.49	-56.02	-25.86
63.14	-.86	5.32
4.46	-76.06	-12.24
-51.11	14.71	24.28
-36.22	-56.21	-13.44
-51.17	-46.27	-7.41
-47.88	-67.4	-5.67
13.93	13.65	4.66

// Kircher T T J, 2001: Non-FTD Schizophrenia
// Subjects=6
7.31	20.18	-20.34
43.78	-2.35	-12.18
44.1	-14.32	25.62
19.15	-3.01	-18.53
32.01	-23.45	-22.54
31.96	-11.82	-23.52
-13.89	-50.68	-26.42
31.9	15.04	-20.19
-11.18	-54.53	47.47
7.65	-70.75	-12.72
-36.32	9.75	-0.01
-36.08	6.77	30.35
-41.56	-44.1	-7.7
6.19	33.92	-21.48
49.45	-15.35	25.65
50.19	-2.31	-12.26
-23.49	-56.02	-25.86
-11.18	-54.53	47.47
60.14	-41.61	15.46
49.46	-16.41	25.74
8.32	33.94	-21.51
50.2	-6.54	-11.9
-19.23	-52.82	-26.18

// Kircher T T J, 2001: Healthy Controls
// Subjects=7
-16.9	-79.36	-11.72
63.34	-38.41	15.15
63.16	-6.15	5.76
63.27	-35.76	8.24
-44.55	-38.63	21.99
47.03	10.25	-1.01
-13.31	-41.34	53.08
-8.47	-34.38	-8.89
-26.23	-14.98	51.02
11.04	4.82	42.24
-47.8	10.39	36.87
-44.47	-46.58	29.34
14.06	-70.71	-12.8
22.67	-72.26	-6.07
4.83	-35.94	52.42
63.15	-28.24	-4.66
53.47	-10.32	-6.05
-54.42	-22.6	-3.78
38.63	-17.93	7.03
1.35	-11.41	25.87
-48.09	24.91	4.43
22.42	-7.76	-11.48
53.62	-36.24	2.82
-50.95	-53.9	17.77
-57.43	-48.11	10.66
63.14	-.86	5.32
4.46	-76.06	-12.24
-51.11	14.71	24.28
-36.22	-56.21	-13.44
-51.17	-46.27	-7.41
-47.88	-67.4	-5.67
13.93	13.65	4.66
-11.18	-54.53	47.47
60.14	-41.61	15.46
49.46	-16.41	25.74
8.32	33.94	-21.51
50.2	-6.54	-11.9
-19.23	-52.82	-26.18

// Ohnishi T, 2001: Healthy Musicians
// Subjects=14
-60.26	-38.24	10.31
-58.33	-14.81	-3.25
61.67	-18.12	0.64
59.31	-2.15	-12.11
-42.84	27.38	33.78
-60.26	-36.01	11.21
57.47	-31.44	7.63
-41.83	29.09	29.11
-58.13	-38.44	8.05
-58.06	-36.64	13.48
-43.96	30.35	31.26

// Ohnishi T, 2001: Healthy Controls
// Subjects=14
52.92	-14.62	-7.4
64.94	-24.49	1.21
-60.44	-18.76	0.54
-60.4	-34.92	-.1
-60.26	-36.01	11.21
57.47	-31.44	7.63
-41.83	29.09	29.11

// Dupont S, 2001: Medial Temporal Lobe Epilepsy (MTLE)
// Subjects=7
-11.45	-67.23	19.07
-31.11	-55.78	4.82
-21.39	-55.74	4.66
-37.09	-42.18	47.28
-46.97	-66.42	29.68
-66.55	-44.46	24.48
-60.4	18.75	11.4
-57.35	23.9	-2.61
-41.06	24.58	3.77
-44.48	39.59	-7.75
-47.62	56.77	4.05
-60.32	32.45	20.12
-53.77	36.29	26.36
-50.66	38.55	15.99
-50.75	51	11.4
-40.97	58.04	17.26
-50.48	23.53	27.56
-43.94	10.79	28.71
-53.6	14.57	35.23
-47.21	40.12	32.59
-8.13	25.24	43.48
-1.31	14.68	67.94
-18.18	-46.16	3.65
4.61	-61.72	8.17
40.33	30.86	32.01
50.15	28.33	38.82
53.44	5.69	37.64
11.09	-61.7	8.05
27.42	-60.71	17.76
4.86	38.67	48.65
8.11	25.61	46.53
23.95	-46.01	2.92
30.47	-55.56	3.75
-8.36	-61.77	8.39
-53.63	24.15	34.28
-43.84	18.11	38.07
-11.45	-67.23	19.07
-1.27	14.99	71.27
-1.43	23.63	60.33

// Dupont S, 2001: Healthy Controls (HC)
// Subjects=10
-17.88	-80.01	20.44
-17.85	-66.63	25.84
-44.01	-61.89	9.01
-53.74	-25.89	15.7
-47.44	-23.93	1.95
-31.15	-56.09	1.49
-11.61	-58.59	8.13
-30.45	-60.68	55.72
-37.03	-35.17	53.31
-70.01	-32.96	9.95
-66.63	-35.2	20.2
-60.32	-33.23	6.45
-47.14	-44.7	20.81
-57.32	27.4	0.4
-44.37	20.75	-2.52
-44.41	30.33	-3.47
-50.58	16.22	18.2
-47.41	25.49	13.87
-43.96	13.99	28.4
-21.55	41.54	11.84
-15.08	34.87	9.03
-11.81	-50.26	-6.14
36.77	-40.52	-7.93
7.81	-62.02	4.78
17.49	-62.3	1.28
59.51	22.37	9
43.19	31.26	1.67
14.22	-42.85	2.77
30.35	-46.61	-3.85
23.94	-42.82	2.6
27.23	-55.57	3.81
-17.84	-79.7	23.77
-11.65	-58.9	4.8
-53.54	-34.22	29.97
-43.69	-33.25	39.79
-40.32	-32.31	49.72
-33.74	-47.92	54.52
-33.7	-57.5	55.46
-30.57	-28.77	52.57
-30.6	-42.16	47.17
-60.28	-32.92	9.78
-47.37	25.8	17.2
-41.03	28.08	6.78
-14.99	-43.27	-0.05
47.07	-36.12	38.53
40.72	-35.21	48.63
40.11	-23.31	3.76
56.12	27.8	-1.57
43.19	31.26	1.67
17.46	-42.84	2.72
27.17	-39.62	2.23

// Gruber O, 2001: Compound calculation > Baseline, p<0.001 uncorrected
// Gruber O, 2001: Compound calculation > Baseline, p<0.05 corrected
// Gruber O, 2001: Simple calculation > Baseline, p<0.001 uncorrected
// Gruber O, 2001: Simple calculation > Baseline, p<0.05 corrected
// Gruber O, 2001: Number substitution > Baseline, p<0.001 uncorrected
// Gruber O, 2001: Number substitution > Baseline, p<0.05 corrected
// Gruber O, 2001: Letter substitution > Baseline, p<0.001 uncorrected
// Gruber O, 2001: Letter substitution > Baseline, p<0.05 corrected
// Gruber O, 2001: Letter pseudo-calculation > Baseline, p<0.001 uncorrected
// Gruber O, 2001: Letter pseudo-calculation > Baseline, p<0.05 corrected
// Subjects=6
48	40	12
12	-76	52
-4	16	48
-48	44	8
-48	-8	40
-52	8	20
-28	-68	48
52	40	8
-4	8	56
-44	44	12
-48	0	32
44	-8	32
-52	8	16
-36	-68	48
24	-64	40
52	-8	36
-44	44	8
48	44	4
-48	0	36
52	-8	36
-52	16	16
-32	-64	52
24	-68	52
-4	8	52
-44	48	8
48	40	4
-48	4	32
52	-12	48
-4	8	52
-56	8	12
-24	-68	52
52	-8	40
-20	-72	48
32	-60	60
-12	12	52
-56	44	0
-48	-8	40
-64	12	12

// Kwon H, 2001: Fragile X Syndrome
// Subjects=10
58.03	-38.24	49.76
31.11	61.54	-6.72
-4.31	-62.32	71.13
32.03	15.89	56.05
-43.36	-59.24	60.28
39.8	29.04	-10.38
5.96	45.37	51.33
-50.47	36.71	30.74
1.43	48.15	35.45
-24.09	16.11	61.47
36.48	-59.79	50.01
60.01	-43.94	34.6
33.89	44.22	37.53
38.15	13.21	27.07

// Kwon H, 2001: Healthy Controls
// Subjects=15
46.92	11.95	36.01
3.86	30.47	52.84
-56.87	30.72	35.92
-.56	40.68	47.43
39.75	26.5	-14.61
4.24	-60.79	64.11
-26.23	9.72	62.13
20.56	-61.41	-12.31

// Cabeza R, 2002: ER - Fixation
// Cabeza R, 2002: WM - Fixation
// Subjects=20
52.03	34.97	17.96
-33.52	57.24	8.25
37.69	56.76	-.76
-27.22	24.13	-13.23
44.09	21.19	-14.16
2.67	-69.95	23.58
2.7	-33.61	33.43
1.87	52.1	-14.26
-40.77	15.81	24.8
-30.38	29.1	-5.83
34.44	29.33	-6.95
2.95	5.46	60.94
2.89	8.34	57.29
-15.35	-70.71	50.86
26.78	-70.57	50.12
-26.24	-63.72	45.87
6.15	-39.69	48.54
-22.73	-90.56	-23.25
23.71	-86.14	-24.48
-22.75	-86.31	-23.67
23.71	-86.14	-24.48
-19.51	-27.2	-11.65
23.71	-27.05	-12.4
-16.19	-33.16	-6.63
20.55	-33.03	-7.27
2.6	25.82	37.64
-5.27	-20.28	4.23
9.84	-17.03	3.66
-15.14	5.97	-1.56
16.19	6.08	-2.1
-8.31	-87.71	6.48
12.2	-79.02	6.39
-8.31	-87.71	6.48
12.2	-79.02	6.39
-43.65	-5.62	48.26
-29.48	-21.01	55.14
-43.99	12.61	25.17
-47.08	5.03	36.06
27.72	-.5	53.26
-51.4	-38.78	27.02
9.41	-63.6	45.25
-44.02	20.06	24.43
-34.71	29.09	-5.75
34.44	29.33	-6.95
2.95	8.76	61.73
2.89	8.34	57.29
-18.61	-67.53	50.6
27.86	-70.56	50.11
-26.23	-67.98	46.29
2.91	-39.7	48.6
-16.25	-90.54	-23.37
23.72	-90.4	-24.06
-27.06	-88.45	-23.39
23.71	-86.14	-24.48
-19.51	-27.2	-11.65
23.71	-27.05	-12.4
-16.19	-33.16	-6.63
20.55	-33.03	-7.27
2.51	25.2	30.98
-8.51	-21.35	4.4
12	-17.03	3.62
-16.22	5.96	-1.54
20.51	6.09	-2.18
-1.83	-87.69	6.36
12.21	-83.28	6.81
-5.06	-90.89	6.73
12.18	-74.77	5.97
-43.65	-5.62	48.26
-29.49	-16.75	54.72

// Kiehl K A, 2002: Congruent vs. Incongruent Terminal Word Endings
// Subjects=28
-48	32	4
-32	32	-16
-48	16	20
-48	-52	-16
-48	-60	-20
-48	-44	-24
24	-16	68
-40	-16	60
-32	-20	64
36	32	-16
36	12	-16
28	32	-24

// Koelsch S, 2002: Clusters vs. In-Key
// Koelsch S, 2002: Modulation vs. In-Key
// Koelsch S, 2002: Deviant Instruments versus In-Key
// Subjects=10
-52.32	12.19	5.55
-45.78	10.26	21.25
-32	16.8	8.27
-49.17	5.01	-5.04
-45.75	-21.26	12.74
-49.97	-30.63	15.8
-55.15	-39.95	33.37
-61.66	-39.96	20.07
-9.48	-18.47	4.28
-16.02	12.07	0.68
50.24	14.67	0.82
43.97	19.43	21.68
31.01	26.7	6.72
53.45	3.77	-2.77
50.43	-16.29	13.45
60.14	-33.95	18.16
53.8	-43.07	24.58
50.6	-58.41	19.21
54.82	-43.58	17.92
9.76	-15.01	6
15.98	16.06	-5.6
-52.35	10.79	1.2
-33.09	23.23	8.86
-52.36	2.96	-3.71
-45.76	-19.23	11.45
-48.87	-30.37	19.11
-58.35	-42.09	33.59
-6.26	-12.74	9.34
50.25	15.89	2.94
47.2	18.65	25.05
32.05	26.45	3.38
53.45	3.77	-2.77
50.44	-16.2	14.55
56.87	-30.25	11.2
54.88	-42.98	25.67
60.14	-44.86	14.62
4.45	-12.5	11.43
-52.32	12.19	5.55
-49	13.33	19.91
-31.99	16.97	10.49
-49.17	5.01	-5.04
-45.76	-18.09	12.47
-45.69	-30.52	16.86
-58.39	-35.92	30.84
-55.22	-47.33	20.61
-9.48	-15.13	6.23
-12.8	8.92	0.91
50.25	11.49	1.08
47.2	22.96	25.81
34.27	21.77	11.56
47.05	1.7	-1.41
50.43	-20.69	11.59
50.51	-31.89	18.1
53.8	-43.07	24.58
44.18	-55.28	19.02
53.75	-42.53	17.84
6.55	-15.03	6.04
12.86	13.56	3.57

// Lee T M C, 2002: Digit Memory Task - Answer Correctly vs. Feign Memory 
// Impairment
// Lee T M C, 2002: Autobiographic Memory Task-Answer Correctly vs. Feign 
// Memory Impairment
// Subjects=6
21.89	-3.34	59.53
38.99	-4.3	59.41
45.29	5.54	48.48
27.18	13.78	60.26
54.71	22.21	29.13
34.37	34.94	30.52
28.98	46.46	28.5
41.53	62.45	0.25
8.49	62.06	11.82
34	50.89	-10.96
63.13	42.89	20.61
47.62	-62.72	46.37
65.24	-22.14	-8.54
16.19	-1.6	13.72
-41.23	6.51	54.97
-1.54	-5.97	68.94
-29.57	20.96	48.04
-42.56	31.31	31.71
-22.38	54.27	23.98
-60.78	30.6	24.17
-43.96	59.66	-.76
-5.38	66.54	16.06
-48.56	-64.44	46.5
-70.34	-41.39	2.44
-12.65	1.66	17.13
-.74	-38.37	21.46
15.39	24.28	59.52
37.84	16.84	57.65
57.02	0.96	43.15
36.4	50.3	22.52
52.39	35.71	11.29
49.79	-60.16	51.7
62.45	-49.65	35.07
66.68	-42.48	31.07
66.48	-55.54	-.17
17.26	-1.51	14.82
-44.48	11.52	51.24
-46.84	31.2	30.66
-23.69	63.84	-3.57
-38.55	49.46	4.49
-9.7	66.09	10.57
-25.73	68.11	10.59
-51.77	-53.54	50.09
-60.41	-42.47	42.57
-62.66	-37.08	29.87
-65.29	5.03	-17.12
-14.84	4.39	11.35
1.42	-24.98	29.24

// Sevostianov A, 2002: Pictures > Words
// Sevostianov A, 2002: Words > Pictures
// Sevostianov A, 2002: Mixed > (Pictures and Words)
// Subjects=14
-30.88	-77.04	-21.79
-28.81	-58	-23.41
-18	-17.12	8.73
-20.34	-69.72	-38.13
43.93	-69.91	-18.78
33.17	-48.82	-20.43
44.03	-66.76	-5.67
33.53	-89.06	9.71
-56.64	-14.67	-11.11
-45.89	-27.12	-7.96
-58.54	-21.08	16.22
63.12	-15.38	-3.5
-36.92	-.78	56.64
-41.44	27.43	36.49
1.39	37.34	50.77
-45.83	-70.44	-17.71
-48.09	-60.74	-29.65
31.48	1.92	57.86
52.41	-59.62	-24.2
63.13	-26.3	-7.05

// Tsukiura T, 2002: Story Recall - Visual Identification
// Tsukiura T, 2002: Picture Recognition - Visual Identification
// Tsukiura T, 2002: Story Recall - Picture Recognition
// Tsukiura T, 2002: Picture Recognition - Story Recall
// Tsukiura T, 2002: Story Recall - Visual Identification masked inclusively 
// by Story Recall - Picture Recognition
// Tsukiura T, 2002: Picture Recognition - Visual Identification masked 
// inclusively by Picture Recognition - Story Recall
// Subjects=16
56	24	28
41	0	56
19	-24	-16
44	-64	-31
34	-88	-22
-41	16	28
-41	8	53
-19	-24	-16
-47	-56	-28
-31	-32	-28
56	24	25
41	0	50
47	16	47
56	32	9
44	-64	-31
-41	8	53
-41	8	41
-47	-56	-28
-31	-32	-28
-19	-24	-19
-9	-56	6
47	48	-9
56	-64	34
-47	-24	-9
19	-24	-16
-19	-24	-16
56	24	22
56	32	9
31	8	59

// Wunderlich G, 2002: All Motion vs. Baseline
// Wunderlich G, 2002: Motion-in-Depth vs. Planar Motion
// Wunderlich G, 2002: Motion-in-Depth Towards vs. Away
// Subjects=12
48	-70	4
-42	-66	2
28	-58	54
-32	-48	52
-20	-68	56
34	-86	18
-22	-90	24
26	-88	32
-18	-90	32
8	-90	0
-12	-88	-2
20	-82	-14
-12	-78	-14
2	-92	-8
-52	-64	0
32	-88	-14
-40	-76	-14
40	-92	8

// Booth J R, 2002: Visual Meaning - Control
// Booth J R, 2002: Visual Rhyming - Control
// Booth J R, 2002: Auditory Meaning - Control
// Booth J R, 2002: Auditory Rhyming - Control
// Booth J R, 2002: Visual Meaning - Rhyming
// Booth J R, 2002: Visual Rhyming - Meaning
// Booth J R, 2002: Auditory Meaning - Rhyming
// Booth J R, 2002: Auditory Rhyming - Meaning
// Booth J R, 2002: Meaning - Rhyming
// Booth J R, 2002: Rhyming - Meaning
// Subjects=13
-3	36	36
-45	21	24
15	-72	15
21	-57	6
-15	15	3
-60	-51	0
21	-87	-3
-27	-90	-6
-27	-3	-6
42	21	-9
12	-54	-9
36	-69	-24
-36	-57	-27
15	-78	-30
0	-60	-33
-3	21	51
0	39	39
-27	-51	36
-45	30	12
12	-63	12
-18	-90	-3
-30	-6	-3
39	27	-9
30	-78	-9
-45	-60	-21
9	-75	-30
-48	18	18
-12	0	15
-9	-78	6
-51	-18	-6
63	-15	-6
33	-21	-9
-6	-33	-9
-45	36	-15
12	-81	-27
-6	36	36
-51	21	27
42	-27	12
60	-9	-3
-54	-18	-3
-45	-60	-18
15	-78	-24
-42	9	36
51	33	18
-51	-45	-3
12	-45	24
-51	21	18
-21	-93	3
-45	-33	-6
24	-72	-12
12	-81	-30
-3	-27	42
-6	18	42
-54	21	18
48	30	18
12	-81	12
-27	-63	0
18	-84	-3
-48	-33	-6
-48	21	-9
-6	-36	45
-57	-21	39
0	-39	24
-6	-63	24
-9	57	-12

// Pessoa L, 2002: Working Memory vs. Fixation
// Subjects=9
2.52	12.69	48.37
-1.97	29.18	28.08
-25.2	-4.4	50.12
28.22	-1.96	49.3
-45.71	4.34	27.32
48.37	5.33	31.73
-38.32	33.11	27.05
47.12	39.71	22.17
-32.06	22.8	3.31
35.27	23.29	3.61
-21.83	-59.79	49.15
20.95	-65.71	51.39
-39.04	-41.2	43.33
42.13	-34.63	38.5
-44.72	-63.49	-10.5
54.61	-54.52	-13.5
-32.73	-81.8	13.21
32.46	-84.67	11.58
-1.81	-91.1	0.25

// Pessoa L, 2002: Fearful > Neutral - Valence by Attention Interaction
// Pessoa L, 2002: Fearful > Happy - Valence by Attention Interaction
// Subjects=21
1.43	-77.54	10.22
-39.49	-52.52	-20.4
23.65	-60	-12.69
-54.4	-21.28	-.54
49.53	-44.24	23.61
-19.28	-6.15	-14.48
27.75	-6.84	-13.85
-8.57	-9.09	-12.13
12.72	9.98	-15.09
-53.32	-4.73	6.98
49.22	-3.49	0.12
0.93	57.9	-0.01
2.48	-76.65	7.91
-34.98	-87.41	-4.14
36.61	-86.98	-5
-44.5	-75.44	13.92
49.53	-67.22	15.5
19.36	-55.79	-12.99
-60.66	-38.44	12.12
49.54	-58.33	20.33
-20.42	-10.1	-24.17
10.6	36.46	-2.79
11.47	49.82	-22.87

// Pochon J B, 2002: Positive Reward Effect
// Pochon J B, 2002: Negative Reward Effect
// Subjects=6
3	-75	18
0	57	0
-15	63	9
-54	-57	-18
15	-63	27
57	-42	-12
15	3	24
-18	9	24
33	-27	-18
-3	24	33
-63	-9	12
-39	54	12
21	-66	39
48	-51	-21
-54	-60	-15
24	48	0
-48	42	15
-60	12	27
-3	27	33
-48	48	0
-33	51	27
-27	-24	-15
36	-6	18
-48	6	-24
-9	39	-9
45	-30	3
24	-27	-18
-18	45	-9
33	-54	24
-27	24	-6
0	9	-12
51	-3	-12
27	3	42
-12	39	6
-21	18	39
12	45	36
-12	45	-6
6	42	-3
-48	6	-27
-27	39	-12
42	6	-30
36	3	-18

// Reber P J, 2002: Categorization - Counting
// Reber P J, 2002: Recognition - Counting
// Reber P J, 2002: Counting - Categorization
// Reber P J, 2002: Recognition - Categorization
// Subjects=10
42	-69	38
-22	-98	13
18	-98	15
33	16	57
14	-60	26
45	-51	-12
44	43	7
-5	34	51
10	37	43
-51	39	-2
-27	61	5
-47	-2	-7
-51	-69	38
-47	-20	10
31	33	-7
15	-59	20
14	-62	32
3	-39	32
1	-74	43
-10	-67	35
37	-67	40
15	-83	-5
-19	-98	13
24	-46	-14
34	13	50
42	21	30
49	-46	-6
-8	0	61
-19	-55	62
18	-31	22
-34	36	33
16	-10	27
-1	17	8
-46	-5	50
-4	-73	43
4	-87	2
4	-71	22
9	-68	-28
-9	-68	4
13	-52	-11
17	-33	9

// Simon O, 2002: Calculation vs. Calculation Control
// Simon O, 2002: Language vs. Language Control
// Simon O, 2002: Saccades vs. Saccades Control
// Simon O, 2002: Grasping vs. Grasping Control
// Simon O, 2002: Pointing vs. Pointing Control
// Simon O, 2002: Attention vs. Attention Control
// Simon O, 2002: Calculation Only
// Simon O, 2002: Grasping Only
// Simon O, 2002: Saccades Only
// Simon O, 2002: Attention Only
// Simon O, 2002: Manual Tasks Only (Grasping and Pointing)
// Simon O, 2002: Visuospatial Tasks
// Simon O, 2002: Calculation, Saccades, and Language
// Subjects=10
-8	8	52
4	32	52
-28	-8	60
-36	-56	28
-28	0	56
-44	32	28
-44	56	12
-56	12	28
44	20	24
52	8	12
-8	24	28
4	24	32
-32	28	0
36	24	0
-48	-4	52
-32	-72	52
32	-60	44
-12	-72	48
-60	-32	44
-36	-64	36
-28	12	0
16	8	8
-40	16	0
-4	12	56
-56	20	32
-44	16	12
52	16	8
-52	0	48
-64	-36	36
-28	-80	40
-8	8	48
-24	-4	68
4	4	56
-36	0	56
28	-4	56
60	8	32
-16	-80	48
16	-72	56
40	-48	48
-4	-60	56
8	-80	44
-24	-84	40
20	-76	40
-8	-88	36
8	-84	32
20	8	4
-16	-24	12
-16	-4	68
24	0	60
-48	48	16
-28	-12	64
-64	8	16
60	12	32
52	8	12
-8	4	44
4	4	52
-40	-28	56
-44	-36	52
40	-44	52
-12	-68	56
16	-68	52
64	-32	28
-36	16	8
-12	-8	60
4	4	56
24	0	56
-8	4	44
-32	-12	64
-40	-28	56
-36	-44	56
-16	-76	48
16	-68	52
36	-48	56
40	-40	60
-8	-60	56
28	-76	32
-24	12	4
24	4	4
-12	-20	8
4	4	60
-36	44	32
-28	-8	64
24	64	28
40	16	36
48	36	0
44	-40	52
24	-64	60
-36	-60	60
56	-44	32
-4	-60	48
8	-64	52
-36	-60	36
-28	-44	68
-44	-36	40
-60	-32	36
-48	-40	60
36	-44	60
64	-32	24
-8	-88	36
-24	-84	24
28	-64	48
8	-84	36
28	-80	24
-4	-52	52
-40	-28	56
-36	-44	56
-32	-44	64
-12	-68	52
16	-68	52
-32	-72	44

// Skosnik P D, 2002: Grammatical - Nongrammatical
// Skosnik P D, 2002: AGL Correct - Incorrect
// Skosnik P D, 2002: AGL - Recognition
// Subjects=23
-32.54	-82.03	37.76
35.35	-51.64	-15.76
48.64	-57.77	41.48
-24.22	28.82	52.9
-51.83	-57.48	40.38
-43.2	-76.29	44.09
1.66	-63.08	45.81
-34.31	28.28	-8.28
-47.51	-64.6	44.27
15.21	20.2	34.21

// Arnow B A, 2002: Turgidity-Correlated Activations: Positive Correlations
// Subjects=11
-22.5	16.55	-.46
-29.22	12.19	-3.05
-20.58	27.53	-.24
-7.51	33.6	0.85
45.93	7.47	-8.35
37.67	11.81	-10.88
31.58	-7.2	15.76
42.08	-9.45	-8.85
29.46	-17.85	16.85
44.12	-8.14	-17.98
5.7	37.71	29.12
14.31	25.68	24.01
18.74	41.83	35.78
1.41	23.93	28.88
46.49	11.77	36.49
57.57	-.11	21.34
50.59	-67.22	11.07

// Bilecen D, 2002: 70 dB - Rest
// Bilecen D, 2002: 82 dB - Rest
// Bilecen D, 2002: 90 dB - Rest
// Subjects=9
51.47	-17.68	9.09
-51.13	-16.26	9.04
49.33	-21.04	7.17
-48.99	-17.31	9.1
49.33	-23.24	6.24
-46.84	-19.33	10.36

// Bunge S A, 2002: Incongruent vs. Neutral
// Subjects=10
-34	8	38
42	32	26
52	20	22
34	24	38
34	44	40
-14	18	52
14	22	48
-34	-60	34
-34	-40	54
40	-44	56
-52	-18	46
56	-22	44
50	-26	44
-16	-36	70
-22	-28	66
-18	-4	64
-12	-18	58
26	8	66
-4	-22	58
10	32	22
10	18	38
-8	12	38
-10	-34	36
16	-34	34
-16	-24	12
20	-18	10
46	-40	18

// Canli T, 2002: Female Subjects
// Subjects=12
-11.3	18.92	61.39
-40.21	4.94	48.39
-4.88	1.44	54.97
-1.72	18.55	55.73
40.57	-7.91	-15.02
-1.82	-8.88	31.27
-22.52	-8.63	-18.7
22.42	-16.56	-15.2
-23.49	-20.9	-12.08

// Canli T, 2002: Male Subjects
// Subjects=12
42.95	20.99	28.25
-6.04	-3.91	40.94

// Deuchert M, 2002: All 6 Subjects
// Subjects=6
-47.83	-24.02	18.57
52.61	-21.3	17.19
-49.96	-23.95	19.7
52.62	-21.22	18.3

// Deuchert M, 2002: Subject 1
// Subjects=1
-41.14	-28.81	52.35
-44.29	-28.23	60.14
-44.25	-41.01	60.1
-50	-22.17	15.09
46.15	-21.86	10.62
-37.93	-32.05	51.47
-44.31	-21.89	59.61
-44.25	-41.01	60.1
-52.14	-22.19	15.12

// Deuchert M, 2002: Subject 2
// Subjects=1
-41.11	-31.73	55.94
-41.04	-34.3	63.96
-51.79	-35.05	55.23
-46.79	-22.16	15.06
60.08	-18.09	16.83
-41.09	-34.9	56.21
-41.03	-34.22	65.07
-50.71	-34.96	56.32
-47.85	-22.08	16.18
60.08	-18.09	16.83

// Deuchert M, 2002: Subject 3
// Subjects=1
-50.75	-25.44	55.52
-57.17	-25.57	54.49
-47.52	-41.71	51.28
-47.83	-25.08	18.66
58.01	-24.01	22.93
-44.28	-34.75	58.46
-47.82	-24.99	19.77
58	-22.96	22.84

// Deuchert M, 2002: Subject 4
// Subjects=1
-37.92	-22.02	57.32
-28.19	-20.85	71.61
-47.84	-21.9	18.39
48.29	-18.5	12.54
-33.64	-25.25	56.43
-28.19	-20.85	71.61
-49.97	-21.83	19.53
48.28	-18.58	11.43

// Deuchert M, 2002: Subject 5
// Subjects=1
-44.37	-22.49	51.86
-51	-21.5	23.97
56.93	-20.76	23.78
-49.93	-21.4	25.07
54.8	-20.78	23.81

// Deuchert M, 2002: Subject 6
// Subjects=1
-44.58	-27.97	22.21
45.12	-24.78	14.22
-50.98	-31.18	22.55
44.05	-24.78	14.23

// Fincham J M, 2002: Planning
// Subjects=8
0.47	3.76	56.95
8.84	23.93	41.78
36.79	-2.71	52.61
-21.93	-14.69	54.29
49.28	43.32	27.42
-43.6	8.5	25.83
-5.75	-56.89	57.64
-1.62	-71.61	32.07
24.98	-68.17	19.21
-21.96	-78.68	25.09
20.52	8.88	25.06
2.32	-17.89	10.79
-6.43	37.05	6.28

// Gandour J, 2002: Thai subjects
// Subjects=10
-47.84	20.96	35.99
-44.78	32.56	20.48
-21.79	-69.22	51.06
-51.26	-6.55	-2.93
-58.64	-25.37	2.08
-42.54	-54.17	-.15
-2.8	17.31	53.62
-40.3	7.35	38.16
52.58	17.88	28.4
-1.7	18.72	57.95
-45.79	17.83	22.84
53.56	21.43	19.17
-27.21	-56.82	46.73
52.91	-31.34	52.6
-47.84	20.96	35.99
49.35	19.8	26.05
-41.05	-44.33	58.11
-45.84	30.52	21.78
-46.71	7.31	38.23
-42.54	-54.17	-.15

// Gandour J, 2002: Chinese subjects
// Subjects=10
-61.93	-3.18	0.26
-61.8	-20.56	9.52
70.55	-7.05	-6.52
-4.84	10.67	64.24
-41.43	9.91	30.15
51.52	14.7	28.68
-45.41	-38.7	48.77
51.9	-40.69	55.62
9.98	20.31	49.87
-42.51	13.08	29.9
56.85	17.9	28.35
-37.97	-40.14	43.23
40.13	-56.25	48.14
-47.84	20.96	35.99
49.35	19.8	26.05
-41.05	-44.33	58.11
-45.84	30.52	21.78
-46.71	7.31	38.23
-42.54	-54.17	-.15

// Gitelman D R, 2002: Explore - Saccade
// Gitelman D R, 2002: Saccade - Central
// Subjects=17
30	6	60
39	27	-9
-39	-24	-12
30	-60	45
18	-69	57
-12	-75	51
-18	-66	45
36	-78	21
-24	-99	15
30	-87	18
33	-78	-6
-24	-69	-12
12	-84	-15
-15	-84	-15
21	-93	6
-24	-93	15
-12	-99	3
0	-90	-9
42	-63	-9
-3	-27	-6
6	-21	9
-3	-24	3
48	-6	42
-33	-6	48
57	18	-6
-54	15	-9
3	-3	60
6	-60	51
-6	-63	54
-3	-75	36
-15	-78	48
6	-84	27
-18	-75	24
18	-54	-6
-15	-54	-6
0	-84	-12
-6	-72	-3
0	-90	15
-3	-66	-15

// Hasson U, 2002: Letters > Faces and Buildings
// Hasson U, 2002: Memory-Words > Blank
// Hasson U, 2002: Faces > Letters and Buildings
// Subjects=13
-27.51	-89.66	-6.27
-41.48	-69.65	-7.79
22.74	-89.1	-3.55
-18.98	-93.03	-9.43
-46.91	-53.02	-12.46
24.85	-93.74	-8.76
-48.91	-72.44	-1.89
-39.47	-52.26	-17.07
45.12	-67.64	-3.37
39.64	-50.38	-13.68

// Meyer M E, 2002: Normal Speech > Syntactic Speech
// Meyer M E, 2002: Syntactic Speech > Normal Speech
// Meyer M E, 2002: Normal Speech > Prosodic Speech
// Meyer M E, 2002: Prosodic Speech > Normal Speech
// Meyer M E, 2002: Syntactic Speech > Prosodic Speech
// Meyer M E, 2002: Prosodic Speech > Syntactic Speech
// Subjects=14
-47.65	-56.2	29.07
41.08	-64.04	29.83
-35.32	28.87	-.51
-52.31	-5.32	-.79
40.76	15.01	19.86
39.55	35.46	9.23
46.98	9.73	-7.65
48.29	-24.04	9.66
-51.27	28.4	8.64
-47.95	-19.76	4.83
-8.17	-52.16	22.7
-44.46	-57.49	25.8
-14.82	-28.36	0.71
53.47	-6.98	-4.1
-34.27	47.28	3.51
-35.26	19.53	2.51
-3.94	-16.38	30.81
-14.97	20.62	1.07
29.88	22.75	-2.97
47.05	12.7	3.25
53.73	-30.64	20.19
11.76	18.75	2.03
-51.23	29.97	15.2
-46.88	-19.75	4.82
-26.69	-6.49	-4.33
-5.21	-12.99	6
-13.74	-29.33	1.9
52.44	-8.84	-.58
12.83	-7.56	-8.04
-34.27	47.37	4.62
-35.26	19.53	2.51
-12.83	19.57	1.13
28.82	21.77	-1.76
44.95	13.03	7.71
59.12	-37.84	22.96

// Sadato N, 2002: Blind > Sighted (Tactile Discrimination)
// Sadato N, 2002: Sighted < Blind (Tactile Discrimination)
// Sadato N, 2002: Blind < Sighted (Tactile Non-Discrimination)
// Subjects=6
32	-88	2
-34	-78	-4
-42	-64	-16
48	-60	-14
-46	14	24
-44	-18	32
-20	-46	48
64	-16	30
-42	-4	18
52	6	10
-58	-22	28
-46	-30	24

// Vaidya C J, 2002: Encoding - Pictures vs. Words
// Vaidya C J, 2002: Recognition - Words Encoded as Pictures vs. Words Encoded 
// as Words
// Vaidya C J, 2002: Pictures vs. Words
// Subjects=8
-17	-66	-8
25	-54	-7
37	-85	17
-35	-51	-13
-41	-58	-13
42	-73	12

// Xu B, 2002: Rhyming Only
// Subjects=6
-38	46	24
-4	4	62
-54	28	24
-38	22	16
-52	14	20
-52	4	44
-52	-44	24
-2	10	58
-54	30	24
-54	14	20
-42	-4	54
-48	6	42
-56	12	-6
-56	-44	28

// Xu B, 2002: Category Only
// Subjects=6
-2	20	60
-46	24	20
-58	-34	-2
-62	-56	10
58	-32	0

// Xu B, 2002: Mixed
// Subjects=6
-18	52	14
32	46	22
-46	18	30
-38	28	-2
-32	-70	38
-44	-40	30
42	52	20
4	36	52
-46	12	28
-34	-64	46
34	48	22
18	18	50
-50	16	28
-58	-50	-4
58	-48	2
18	-40	52
28	20	50

// Seidler R D, 2002: Learning-Related Activation During Sequence Encoding
// Seidler R D, 2002: Areas Activated at Expression of Learning
// Seidler R D, 2002: Areas Correlated with Response Time Savings Across 
// Participants
// Subjects=6
-58	6	-18
-38	-16	50
46	8	36
8	30	24
-20	-48	44
-32	-36	56
48	-38	54
28	-32	2
20	-26	12
-28	-76	-22
20	-74	-26
-30	-76	-22
16	-76	-24

// Luke K, 2002: Chinese Syntax - Chinese Font
// Luke K, 2002: Chinese Semantic -  Chinese Font
// Luke K, 2002: English Syntax - English Font
// Luke K, 2002: English Semantic -  English Font
// Subjects=7
-46.89	30.69	24.01
-47.03	46.75	11.51
-58.98	38.11	-16.62
-52.16	13.82	26.6
-7.77	72.68	-14.53
-1.31	27.11	-26.4
-10.8	3.07	-19.81
36.08	62.37	-14.17
59.89	29.41	11.74
-47.33	20.6	-37.59
-65.21	-9.43	-11.45
46.77	15.25	-32.65
-21.04	-102.13	-3.07
33.37	-91.75	-11.25
-27.83	-52.33	-32.82
48.06	-47.3	-29.65
4.39	-83.35	-23.89
-48.97	23.53	27.98
-47.08	37.52	2.25
-52.16	13.82	26.6
0.33	40.77	53.85
-18.46	63.81	-18.13
-6.82	51.68	-38.43
64.02	45.5	-.81
37.12	57.71	-19.37
60.07	24.61	32.21
-53.59	18.85	-18.42
-64.01	-29	-3.13
-48.81	-60.41	16.06
69.53	-13.14	-2.65
54.22	17.15	-36.24
-23.22	-101.52	-8.67
32.31	-92.81	-11.15
-3.04	-12.63	10.41
11.95	-17.74	11.78
-10.79	9.76	-15.91
-36.4	-32.83	-27.66
-29.95	-58.77	-33.37
45.95	-51.37	-27.05
13.93	-75.34	-31.37
-53.25	24.56	27.94
-41.86	51.58	-9.03
-47.14	37.98	-5.6
-57.49	13.87	27.77
-20.49	13.24	-25.02
-5.97	5.58	53.52
54.48	35.21	4.62
55.67	22.24	15.73
53.83	-4.35	43.63
21.75	10.6	47.21
-60	7.89	-21.88
-45.92	-27.46	-12.39
-57.47	-33.05	12.75
50.25	-40.09	-19.13
-32.29	-.46	-36
-29.32	-62.12	47.2
-57.35	-35.19	26.31
-12.62	-15.61	14.11
-19.39	-.67	-26.09
24.4	-4.98	-30.7
-39.6	-36.11	-28.46
5.32	-55.13	-30.73
-31.9	24.52	25.47
-31.16	67.22	-.43
-52.42	21.02	-4.11
-57.46	12.02	31.27
-25.2	11.01	56.63
55.38	28.05	-19.32
54.61	22.32	16.85
16.81	62.97	-18.46
52.73	2.96	41.92
-55.21	-45.04	22.65
-51.39	0.88	-16.93
47.1	-47.25	-15.14
-30.38	-64.16	48.5
36.96	-69.13	47.03
-14.64	-82.46	3.02
-24.28	-77.32	1.58
32.29	-82.07	-9.82
-5.14	-13.36	14.96
-20.42	-.24	-20.54
0.28	23.71	39.66
21.4	-31.46	-15.06
-40.69	-33.03	-29.83
7.55	-54.18	-18.57

// Shergill S S, 2002: Fast > Slow
// Shergill S S, 2002: Slow > Fast
// Shergill S S, 2002: Greater Activation with Faster Rate
// Shergill S S, 2002: Greater Activation with Slower Rate
// Subjects=8
-52	30	20
-38	40	-8
-52	-8	8
64	-16	40
66	-12	22
50	-20	16
-2	60	36
54	-48	40
4	6	58
-38	-8	30
-54	32	22
58	-4	42
66	-50	12
-28	-16	-8
-26	-82	42
58	-42	50
-40	-10	50
50	28	-4
58	-24	0
16	-82	48
-28	-74	12

// Hunkin N M, 2002: Associative encoding of familiar associations vs. Single 
// item encoding of familiar associations
// Hunkin N M, 2002: Associative encoding of novel associations vs. 
// Associative encoding of familiar associations
// Subjects=8
4.72	-30.54	39.7
4.81	-41.74	46.22
4.73	-73.23	24.32
4.63	-56.74	17.37
-1.86	-50.95	10.26
1.32	-42.47	9.52
22.67	-36	8.73
-23.45	-41.33	-14.83
-23.41	-37.65	-8.45
7.94	-21.63	44.49
-4.93	-34.28	33.44
7.9	-73.64	18.75
1.48	-61.62	23.39
-5.05	-54.14	10.57

// Kircher T T J, 2002: Intentional Judgment of Personality Traits
// Kircher T T J, 2002: Incidental Judgment of Self Descriptors
// Subjects=6
-4.87	-52.26	34.94
8.01	-51.67	41.44
-26.12	-44.58	53.5
-20.35	0.44	-11.68
-17.06	1.4	0.47
-51.05	-15.41	20.11
-17.01	-25.55	-3.96
-23.16	-69.05	12.03
-11.4	-19.52	32.27
-39.36	2.64	18.47
-47.83	6.7	30.49
44.34	-41.5	45.74
-44.55	-50.69	17.42
59.96	-31.43	-4.35
-11.38	-86.33	7.76
-30.39	-47.78	53.82

// Rossell S L, 2002: Normal Males
// Subjects=6
-36.13	-67.33	-5.81
-39.39	-64.69	-12.69
-41.45	3.14	25.14
-23.19	-96.86	-3.48
-41.38	10.43	36.8
53.73	9.94	35.74
35.85	-56.36	47.09
-44.72	-55.75	-6.69
-47.85	-75.86	-4.96
35.85	-56.36	47.09

// Rossell S L, 2002: Normal Females
// Subjects=6
-23.25	-94.2	-10.4
-39.44	-53.06	-13.66
35.34	-46.27	-15.09
-36.07	3.6	30.62
-48.01	29.02	16.35
47.24	15.73	28.64
-44.69	-64.21	-5.98
66.32	-18.7	-5.49
53.58	23.8	22.32
44.05	12.54	28.95
69.51	-13.4	-5.97

// Peterson B S, 2002: Simon Incongruent vs. Congruent
// Peterson B S, 2002: Stroop Incongruent vs. Congruent
// Subjects=10
31	0	45
-32	-3	43
29	-75	10
-28	-77	9
11	17	21
-10	13	24
43	-49	-10
-46	-52	-10
45	-38	32
-45	-37	31
44	8	13
-44	5	14
40	32	9
-39	34	9
32	0	43
-35	0	43
23	-79	10
-26	-78	8
11	17	22
-10	15	24
44	-50	-10
-46	-51	-10
46	-37	29
-46	-35	28
44	8	13
-45	7	14
41	31	8
-41	30	8

// Podzebenko K, 2002: Mental Rotation
// Subjects=10
-30	-82	36
22	-78	54
-42	-54	46
36	-70	-32
34	-56	54
-36	-90	4
32	-12	56
44	12	8
-4	-64	64
28	-54	44
-44	-82	-14
42	-86	-10
24	-84	42
-36	20	4

// Horovitz S G, 2002: Oddball vs. Baseline
// Subjects=7
0.38	0.62	43.83
-47.59	-24.79	49.86
63.35	-34.99	18.21
-54.19	-26.8	24.45
-8.25	-24.41	23.72
35.34	0.92	3.26
34.18	25.31	2.34
-32.01	23.32	9.96
-45.87	-.63	4.32

// Koski L, 2002: Goals - No Goals
// Koski L, 2002: Contralateral - Ipsilateral
// Koski L, 2002: Goals x Direction
// Subjects=14
-15.49	6.55	66.93
15.5	2.33	64.7
-60.82	10.46	11.37
62.03	17.36	7.15
27.25	-96.53	23.79
-41.09	-19.5	62.72
38.03	-22.91	66.56
-17.63	6.54	66.96
-9.14	14.7	61.72
-28.31	-4.45	63.54
14.44	4.61	66.75
-41.1	-18.44	62.63
-17.63	6.54	66.96
17.62	6.58	64.32
28.33	-100.76	24.13

// Kroger J K, 2002: Linear Trend Analysis for Relational Complexity
// Kroger J K, 2002: Linear Trend Analysis for Distractor
// Kroger J K, 2002: Complexity levels 3-4 Minus Distractor levels 3-4
// Subjects=8
-52.22	26.34	23.32
46.2	10.52	30.21
-35.34	28.61	-3.83
42.35	-57.58	58.26
-34.57	-66.67	57.68
30.88	28.67	-9.06
-5.16	9.53	21.96
54.68	23.09	26.82
39.57	23.57	6.88
-35.4	21.41	-14.38
7.62	31.1	24.46
-13.44	3.42	53.79
-7.3	51.24	38.56
50.35	29.07	21.91
44.04	30.06	35.28
-3.14	41.27	19.27
-33.09	45.14	17.06
-28.62	-49.42	4.87
8.08	-60.75	47.77
-2.78	-73.62	19.98

// Olson I R, 2002: Synchronized Audio Visual - Static Visual
// Olson I R, 2002: Moving Visual - Static Visual
// Olson I R, 2002: Synchronized Audio Visual - Desynchronized Audio Visual
// Subjects=10
52.49	26.88	20.96
-54.46	15.44	6.42
-54.62	13.72	-15.74
52.23	14.28	-18.13
53.75	9.05	38.05
-58.47	8.21	37.18
-25.51	-2.11	10.9
-21.38	-12.34	-11.71
-6.3	-18.71	0.92
63.28	-37.87	8.42
-61.77	-38.88	6.59
45.06	17.49	24.06
-49.8	9.55	53.69
49.41	8.43	30.34
-4.92	9.81	53.16
-55.58	-3.83	-8.68
-26.63	-2.63	4.27
63.29	-37.79	9.53
-39.7	3.53	-25.1
-28.76	-19.02	-1.03

// Gauthier I, 2002: Small-Large Rotations
// Gauthier I, 2002: Large-Small Rotations
// Gauthier I, 2002: Task by Magnitude of Rotation Interaction
// Subjects=15
6	-48	45
44	-52	29
3	-44	24
42	14	46
33	-51	55
-43	-38	53
59	3	13
-36	-48	46
39	-72	26
-41	-34	44
35	-68	16
39	-60	11
-21	9	30
-15	-7	5

// Umetsu A, 2002: R-FP vs. Control
// Umetsu A, 2002: L-FP vs. Control
// Umetsu A, 2002: R-FEP vs. Control
// Umetsu A, 2002: L-FEP vs. Control
// Subjects=10
-56	-21	48
-46	-21	60
-35	-10	60
38	-24	54
32	-18	66
38	-7	54
-4	-18	54
-10	0	48
0	-7	48
-46	-14	54
-32	-14	60
-38	-35	54
28	-14	60
24	-46	-30
4	-7	66
-10	-10	54
0	4	54
38	-28	60
46	-24	54
32	-18	66
-42	-28	60
-38	-14	54
-32	-10	60
-46	-35	54
-32	-49	-30
-32	-60	-30
-10	-60	-18
-4	-10	66
0	0	48
4	-21	54

// Binkofski F, 2002: Conjunction of Active Conditions vs. Baseline
// Binkofski F, 2002: Motor-directed Attention
// Binkofski F, 2002: Visually-directed Attention
// Subjects=6
-48	-8	56
12	-56	-16
20	-96	12
-30	-92	8
20	60	1
56	16	8
36	-48	62
56	-28	24
28	-56	52
44	-60	16
44	40	28
-56	8	40
56	-52	44
4	-56	48
48	-86	-20
-52	-56	-12
32	-76	-16
-16	-84	-12
-8	-84	8

// Jessen F, 2002: Novel - Repeated Pictures, Fixed Effects Analysis
// Jessen F, 2002: Novel - Repeated Pictures, Random Effects Analysis
// Subjects=8
24	-8	-28
-20	-8	-24
32	-88	24
-32	-88	28
56	-88	8
-56	-84	8
28	-84	-24
-44	-88	-32
32	-44	-28
-32	-48	-24
24	-4	-28
-20	-8	-24
44	-72	8
-28	-88	32
-32	-84	-16
32	-40	-24
-28	-48	-16

// Karama S, 2002: Normal Males
// Subjects=20
-2	55	18
2	61	15
-48	21	-8
44	20	-20
-2	15	23
2	21	23
-2	-13	10
4	-13	10
-4	-5	-15
4	-5	-15
-40	9	-11
40	9	-14
-24	-4	-4
20	-4	-6
-18	-8	-16
14	-9	-18
-51	-54	16
50	-54	3

// Karama S, 2002: Normal Females
// Subjects=20
-4	53	3
2	58	-1
-36	18	-19
51	19	-12
-2	15	21
4	19	21
-32	9	-16
30	9	-18
-18	-5	-6
16	-5	-4
-18	-1	-22
18	-1	-20
-59	-55	23
61	-55	12

// Lanius R A, 2002: Memory Recall vs. Baseline (PTSD > Controls)
// Lanius R A, 2002: Memory Recall vs. Baseline (PTSD < Controls)
// Lanius R A, 2002: Memory Recall vs. Baseline (PTSD = Controls)
// Subjects=7
12	40	18
4	-4	36
52	24	-16
4	54	12
2	-66	46
50	-72	24
54	12	-16
-4	-76	34
-26	-84	36
-18	-34	-6
44	12	36
-42	-26	8
12	-18	2
18	-10	4
14	-6	16
0	-14	10
-14	-10	2
-6	-10	4
2	26	24
2	10	32
0	-4	32
14	-38	0
-14	-36	2
8	-44	8
-2	42	20

// Mead L A, 2002: Incongruent > Congruent
// Mead L A, 2002: Congruent > Incongruent
// Mead L A, 2002: Incongruent > Neutral
// Mead L A, 2002: Neutral > Incongruent
// Subjects=18
-45.7	6.63	29.36
4.73	-41.45	36.16
-16.16	32.53	-9.96
-45.72	7.6	28.16
-2.75	-43.7	35.32

// Watanabe J, 2002: Areas Activated During Preparation Phase
// Watanabe J, 2002: Areas Activated During GO Phase
// Watanabe J, 2002: Areas Activated During NO-GO Phase
// Watanabe J, 2002: Specific Activation Areas During GO Phase
// Watanabe J, 2002: Specific Activation Areas During NO-GO Phase
// Subjects=11
-44	-8	52
-24	-84	18
46	6	36
20	-74	-12
6	12	40
-34	-8	60
-12	-14	6
14	-52	-26
6	-10	4
4	18	26
-34	56	18
-44	-6	38
-30	-60	42
34	50	18
46	-72	-2
-32	-8	62
-16	-14	4
14	-52	-26
4	-10	6
2	22	24
-30	54	24
-28	-62	40
30	46	14
44	-74	2

// Wright C I, 2002: Emotional vs. Neutral
// Subjects=16
-24	-7	-14
-27	-26	-16
-6	38	-23
-11	55	1
11	66	-1
27	13	-37

// Cooke A, 2002: Subject-Relative Short - Baseline
// Cooke A, 2002: Subject-Relative Long - Baseline
// Cooke A, 2002: Object-Relative Short - Baseline
// Cooke A, 2002: Object-Relative Long -  Baseline
// Cooke A, 2002: Object-Relative Long - Subject-Relative Short
// Cooke A, 2002: Object-Relative Long - Object-Relative Short
// Cooke A, 2002: Subject-Relative Long - Object-Relative Short
// Cooke A, 2002: Subject-Relative Long - Subject-Relative Short
// Cooke A, 2002: Object-Relative Short - Subject-Relative Short
// Cooke A, 2002: Object-Relative Long - Subject-Relative Long
// Cooke A, 2002: Object-Relative Short - Subject-Relative Long
// Subjects=7
-68	-44	8
4	-84	-16
-68	-44	12
60	-24	-4
0	-88	-8
-64	-56	8
-64	-56	8
52	-68	16
60	-20	-8
-52	28	-8
-32	-20	-20
0	-92	-8
-52	28	-8
52	-68	16
0	-92	-8
-56	12	-4
48	-64	16
-56	-24	0
56	-24	0
-48	-68	-8
-4	-92	-8
28	-68	-20
-40	-76	-4
-32	-20	-20
36	-40	-12
16	-92	-12
-4	-56	-12
-8	-36	16

// Garavan H, 2002: Successful NoGos
// Garavan H, 2002: Errors
// Subjects=14
48.41	-18.36	28.14
40.98	9.58	45.96
54.68	-4.46	14.64
7.95	1.6	55.93
3.61	-14.51	40.6
11.07	-25.64	33.64
-5.04	-25.54	22.67
53.64	45.26	38.36
36.44	63.94	33.64
61.8	47.89	-11.02
8.54	16.45	0.03
-10.67	15.44	2.57
25.72	-5.74	0.58
-15.97	0.52	2.76
51.32	-11.56	-8.15
-28.75	-13.39	2.96
46.31	3.98	41.91
-46.74	1.42	30.92
-18.82	12.99	54.16
6.84	-5.43	47.61
55.75	46.16	36.03
-52.18	31.17	30.72
62.92	47.35	-4.3
-51.47	62.61	-3.15
-52.55	72.38	-.61
41.73	-11.28	-3.6
-33.01	-13.33	4.12
19.31	-6.84	0.74
-5.28	0.59	2.63
7.47	22.95	1.73
9.52	31.97	-5.74

// Miller M B, 2002: Episodic Retrieval - Nonretrieval
// Subjects=6
-8.27	31.86	33.86
-31.64	-61.96	-38.26
39.72	21.93	-17.52
43.97	-60.28	44.33
17.1	15.78	-13.16
-41.22	28.86	-7.86

// Staudt M, 2002: Controls
// Subjects=5
-50	34	22
-54	14	30
-62	20	8
-40	10	48
-24	6	60
-50	34	22
-52	44	4
-54	14	30
-24	-66	48
-10	-64	66
-44	-40	52
2	12	56
-2	26	40

// Staudt M, 2002: Patients with Lesions
// Subjects=5
54	26	22
32	6	52
40	46	18
38	50	-6
54	0	24
28	-64	54
38	-46	48
50	-30	44
6	12	52

// Tamm L, 2002: Go/NoGo  - Go, Developing Controls
// Subjects=19
48	12	2
-32	40	34
16	-2	66
48	-42	-2

// Milham M P, 2002: Young Subjects
// Subjects=12
-50.32	48.07	1.4
45.95	18.87	0.51
5.76	16.39	54.71
-17.42	-66.05	64.12
3.37	37.93	30.63
5.61	23.65	38.49
-43.65	33.25	29.33
-47.87	18.42	30.62
-41.3	9.08	46.94
-49.66	-32.92	55.02
-38.85	-42.58	66.86
46.4	-92.87	14.34
-2.57	-89	41.34
73.81	-19.72	-5.49

// Milham M P, 2002: Old Subjects
// Subjects=10
-46.03	43.87	1.7
48.07	21	0.31
3.6	18.32	52.34
-13.17	-66.2	61.86
-37.63	31.46	-21.89
-50.35	19.21	-14.02
43.59	25.43	-24.54
60.82	37.82	-3.48
-20.57	42.14	-22.98
-37.17	25.17	34.4
39.74	31.98	32.94
-49.8	-40.98	33.4
-30.38	-34.58	59.4
-.39	-53.43	60.64
5.6	-81.97	-6.18
-15.58	-88.84	16.94
43.98	-62.88	-10.45
-47.81	-60.11	5.98
-54.51	-8.14	-9.45
-52.05	-50.99	14.19

// Cansino S, 2002: Correct vs. Incorrect Source Memory During Encoding
// Cansino S, 2002: Correct vs. Incorrect Source Memory During Retrieval
// Cansino S, 2002: Incorrect vs. Correct Source Memory During Retrieval
// Subjects=17
-20	42	48
-4	30	62
-38	4	18
52	-6	54
-48	-4	54
-38	-10	60
0	-36	62
-44	-42	32
-58	-54	4
-42	-52	2
50	-70	0
28	-74	-10
38	-46	-12
-38	-54	-24
-14	16	-12
-10	-56	-18
-4	52	0
-10	58	32
46	-10	4
56	-8	-18
48	-26	-12
62	-34	24
60	-42	26
-14	-82	44
-30	-80	22
38	-86	0
4	-74	-6
-14	-44	-4
26	-16	-14
16	0	-18
-14	-2	20
20	-84	-32
-24	-60	-20
4	10	64
4	42	42
36	18	50
44	30	40
42	46	18
-22	18	54
-36	36	36
-38	54	14
48	8	28
42	28	10
-52	12	30
26	-14	54
-20	-8	48
28	-56	46
-24	-66	40
-52	-8	-14
-32	-72	-38

// Chen Y, 2002: Chinese Characters - Fixation
// Chen Y, 2002: Pinyin - Fixation
// Chen Y, 2002: Chinese Characters - Pinyin
// Chen Y, 2002: Pinyin - Chinese Characters
// Subjects=9
-4	10	48
6	10	52
-44	4	16
-40	20	10
45	25	16
-40	26	-9
-38	16	-5
39	13	5
-47	1	18
-43	0	33
-4	14	34
-60	-15	24
-38	-32	49
30	-55	46
-32	-46	46
-14	-86	-11
12	-82	-8
-29	-92	-13
26	-84	-12
-36	-90	-8
41	-84	-14
-44	-49	-3
-42	-54	-16
52	-63	-12
-31	-53	-32
36	-62	-28
36	-82	-21
-14	-19	2
23	-2	4
-3	9	52
4	10	52
-46	3	16
44	28	16
-32	16	-4
40	12	0
-42	0	27
-48	2	6
54	2	27
-4	12	40
8	12	41
-37	-29	50
-17	-67	52
24	66	53
-35	-46	45
33	-53	44
-17	-66	-5
19	-63	-5
-20	-63	-8
20	-62	-9
28	-84	-14
-38	-84	-14
-46	-52	-4
54	-62	-5
50	-66	-10
52	-72	-12
-20	-60	-26
30	-70	-28
-10	-20	-2
18	-16	2
-4	44	52
-24	-90	-17
-3	-90	10
-44	-66	28
-14	-87	-38
-17	9	-5
5	44	52
21	17	-17
16	-91	11
40	-55	-25
19	15	-10
-27	-5	56
-2	4	56
-36	10	-10
-20	-52	62
-39	-44	54
-16	-66	36
-44	9	-14
-63	-3	-9
-7	-29	-1
-6	-16	13
39	-1	55
52	4	30
8	-29	49
32	-32	65
25	-58	58
29	-60	44
35	-48	54
30	-61	41
52	12	-13
8	3	44
11	-21	0
13	-18	13

// Fu S, 2002: Chinese Readers
// Subjects=8
-4.89	16.67	59.27
7.53	8.24	4.08
-4.9	3.47	53.69
-46.02	30.84	-1.66
52.15	40.97	-17.02
-49.98	7.66	29.32
-33.14	20.51	1.28
37.4	16.7	0.79
-47.72	-10.85	37.54
56.97	-6.16	33.71
-62.87	-8.42	15.2
65.37	-7.65	13.67
-26.01	-62.05	61.66
40.23	-65.16	56.7
-23.97	-63.06	48.33
31.59	-60.61	47.49
-41.11	-50.48	47.48
40.14	-60.56	47.39
-13.58	-99	-4.53
16.34	-92.31	-3.21
-37.2	-82.74	-12.31
22.68	-82.04	-8.6
-24.26	-99.07	-4.4
27.03	-98.76	-5.02
-30.61	-98.42	4.54
35.54	-88.13	-6.01
-9.08	-98.86	24.4
18.7	-98.7	24.07
-65.08	-20.21	0.6
71.75	-23.27	3.75
-43.96	-22.65	-32.89
-35.33	-52.55	-34.94
39.47	-49.98	-36.02
-22.33	-2.35	7.54
26.82	0.06	6.77
-4.87	14.73	61.67
10.09	14.82	61.49
-4.89	10.16	57.59
-54.58	35.01	-1.92
-33.17	20.17	-3.15
-45.65	1.68	34.23
54.81	-1.94	33.38
-65.02	-4.2	14.87
63.21	-3.43	13.34
-17.55	-65.14	48.43
-13.58	-96.89	-4.71
-41.48	-80.65	-12.44
-24.24	-94.49	-.33
-65.1	-18.26	-1.79
-58.67	-46.57	-10.64
-43.97	-18.42	-33.24
-39.63	-44.11	-35.6
39.45	-45.75	-36.37
-26.6	-4.49	7.77
26.82	0.06	6.77
-.6	14.75	61.61
3.69	12.67	61.74
-4.89	10.16	57.59
-49.98	7.66	29.32
-49.85	-15.09	37.92
56.96	-4.05	33.53
-60.73	-8.41	15.18
-23.97	-63.06	48.33
-13.58	-99	-4.53
16.34	-92.31	-3.21
-37.2	-82.74	-12.31
22.68	-84.15	-8.42
-24.26	-99.07	-4.4
27.03	-98.76	-5.02
-30.61	-98.42	4.54
33.51	-98.04	3.77
-11.22	-98.88	24.43
-35.34	-50.43	-35.12
39.47	-49.98	-36.02
-22.33	-2.35	7.54

// Fu S, 2002: Pinyin Readers
// Subjects=7
-1.74	20.58	54.45
5.75	18.51	54.53
-.55	8.58	64.36
-26.26	-3.17	52.26
26.1	-1.8	51.54
-50.08	9.98	17.97
-49.98	7.66	29.32
50.38	9.52	16.86
-31.07	24.24	-5.74
35.19	22.52	-6.36
-53.02	-.5	47.88
53.83	3.31	46.34
-67.06	-25.19	18.89
-27.16	-56.39	52.27
30.55	-59.22	51.85
-23.97	-63.06	48.33
27.33	-64.87	47.9
-45.41	-35.35	50.72
49.69	-33.73	49.49
-17.87	-92.68	-5.01
22.73	-92.44	-5.5
-22.21	-88.99	-11.96
22.68	-90.84	-12.32
-24.26	-99.07	-4.4
27.02	-96.64	-5.19
-28.47	-89.61	8.23
31.36	-91.53	5.48
-.64	-78.01	18.09
-2.76	-82.25	18.47
-60.68	-38.7	8.8
-60.81	-28.98	-3.17
-49.95	-71.04	2.46
46.25	-76.81	1.84
-50.07	-65.73	-11.36
50.35	-67.58	-16.82
-39.52	-73.72	-33.12
37.38	-64.8	-34.75
-22.37	-.57	2.93
22.49	3.93	2.04
-2.81	20.57	54.46
3.61	20.61	54.38
-.55	8.58	64.36
-26.26	-3.17	52.26
29.31	-2.84	51.59
-50.08	11.03	17.89
-49.98	7.66	29.32
50.38	9.52	16.86
-31	5.21	-4.15
33.06	22.51	-6.34
-51.96	0.56	47.78
-49.83	2.69	47.58
-67.09	-23.25	16.5
-23.96	-56.37	52.23
31.62	-60.27	51.92
-23.97	-63.06	48.33
-23.96	-65.18	48.51
-45.4	-37.47	50.9
48.63	-34.79	49.59
-17.87	-92.68	-5.01
22.73	-92.44	-5.5
-22.19	-95.34	-11.43
22.69	-95.07	-11.97
-24.26	-99.07	-4.4
27.03	-98.76	-5.02
-30.61	-89.62	8.26
37.78	-82.69	9.12
-58.52	-45.03	9.3
-56.54	-26.84	-3.4
-49.95	-71.04	2.46
44.11	-74.71	1.69
-50.07	-65.73	-11.36
50.35	-65.47	-17
-39.53	-71.61	-33.29
37.39	-66.91	-34.57
-22.37	-.57	2.93
24.63	3.94	2.01
-2.81	20.57	54.46
5.82	12.68	61.71
-.55	8.58	64.36
-26.26	-3.17	52.26
29.31	-2.84	51.59
-51.42	36.81	-6.56
-49.98	7.66	29.32
52.6	10.39	27.91
-31.07	26.35	-5.92
-53.01	1.78	49.92
54.91	3.49	48.54
-69.21	-25.38	16.7
-23.89	-61.15	59.33
28.46	-56.6	58.34
-23.97	-63.06	48.33
27.32	-62.75	47.72
-32.47	-48.34	60.58
50.75	-30.55	49.21
-23.19	-95.72	-2.47
30.23	-93.28	-3.28
-23.25	-96.4	-11.33
25.89	-93.99	-12.1
-24.26	-99.07	-4.4
27.02	-96.64	-5.19
-30.59	-89.45	10.48
33.53	-89.06	9.71
-57.46	-42.91	9.11
-60.81	-28.98	-3.17
-48.88	-71.04	2.45
47.31	-72.57	1.48
-50.07	-65.73	-11.36
48.21	-65.48	-16.97
-41.64	-74.62	-30.79
39.6	-71.67	-27.51
-23.46	3.65	2.59
23.56	2.87	2.11

// Hautzel H, 2002: Conjunction Analysis
// Hautzel H, 2002: Real Object WM vs. Spatial WM
// Hautzel H, 2002: Spatial WM vs. Real Object WM
// Hautzel H, 2002: Spatial WM vs. Shape WM
// Hautzel H, 2002: Spatial WM vs. Verbal WM
// Hautzel H, 2002: Verbal WM vs. Spatial WM
// Subjects=17
-48	8	28
-48	32	20
-36	24	-8
28	0	60
32	60	4
28	8	48
32	24	-12
-36	60	0
0	20	36
-44	-44	40
8	-68	48
8	-68	48
8	-80	-28
-12	-80	-28
-36	-64	-48
32	-64	-36
-28	-92	-12
24	-92	-4
-4	-56	24
-12	-56	64
12	-60	60
-20	-64	0
-24	-72	-16
16	-60	0
24	-72	-16
-20	-60	60
12	-60	60
-16	-60	-4
12	-64	0
44	-64	12
45	-52	0
-4	-56	52
-16	-84	36
32	-80	32
44	-68	12
12	-92	0

// Suzuki M, 2002: Between Lists - Item Recognition
// Suzuki M, 2002: Within List - Item Recognition
// Suzuki M, 2002: Between Lists - Within List
// Suzuki M, 2002: Within List - Between List
// Subjects=21
-44	18	4
-54	16	28
-14	-10	8
-6	-42	12
-28	-88	-8
-30	-80	36
34	26	-4
56	38	20
12	-16	8
34	-80	32
34	-72	-16
0	14	56
-34	60	-4
-46	18	4
-56	16	28
-32	4	60
-12	-16	12
-34	-72	44
-6	-42	12
-18	-60	16
-38	-86	-4
-30	-80	36
-24	-72	-8
34	26	-8
54	34	16
24	6	60
36	-58	28
16	-74	36
34	-84	-8
34	-76	36
-2	16	56
-28	-2	-44
-6	-12	8
64	16	20
-28	22	40
-50	-42	20
-24	-48	48
-6	-12	40
68	-24	-16
34	22	-32
34	-42	36

// Bantick S J, 2002: Positive Interaction
// Bantick S J, 2002: Negative Interaction
// Subjects=8
18	44	2
-10	32	-2
-36	6	0
8	-78	-16
2	-14	12
-54	-10	0
-26	-34	6
-4	-20	32
0	-36	28
6	-2	50

// Ragland J D, 2002: Letter 1Back - 0Back
// Ragland J D, 2002: Fractal 1Back - 0Back
// Ragland J D, 2002: Letter 2Back - 0Back
// Ragland J D, 2002: Fractal 2Back - 0Back
// Ragland J D, 2002: 2Back - 0Back, Letter - Fractal
// Ragland J D, 2002: Letter 2Back - 1Back
// Ragland J D, 2002: Fractal 2Back - 1Back
// Subjects=11
39.59	26.03	11.14
39.71	22.83	24.79
31.32	-1.91	35.88
40.01	-39.93	38.97
-32.59	-48.48	44.98
-45.46	-35.87	44.07
-24.39	-56.43	-3.52
-41.57	30.46	20.62
-28.49	-1.93	41.03
39.9	-1.52	40.21
-36.8	-56.62	50.17
39.48	20.43	-6.23
52.6	-51.05	4.07
39.37	58.84	-4.99
48.19	39.8	23.27
-50.2	16.35	4.06
48.59	-39.53	43.3
-53.99	-40.15	44.53
-24.62	24.62	-1.39
35.22	24.98	-2.11
-33.22	46.06	1.37
43.9	35.2	19.24
-41.57	30.46	20.62
-45.7	9.97	31.31
1.31	32.09	37.83
44.35	-48.02	44.06
-28.3	-52.68	45.28
35.32	43.61	18.63
30.96	29.53	2.02
-50.2	16.35	4.06
39.53	51.75	13.44
-37.3	30.49	20.57
-45.67	10.31	35.74
44.13	11.2	39.09
-11.57	-8.11	14.59
5.56	27.54	33.71
48.61	-43.76	43.65
-24.01	-56.89	45.59
-33.18	46.4	5.8
48.18	35.23	19.19
44.03	27.77	33.24
-45.68	5.74	31.66
-3	31.72	33.45
-32.57	-52.71	45.33

// Hagen M C, 2002: Group 1
// Subjects=18
38.34	28.54	-11.36
42.6	42.66	-8.13
47.94	48.15	-6.43
36.06	43.53	-23.75
-34.49	56.06	-20.64

// Hagen M C, 2002: Group 2
// Subjects=13
45.91	23.99	-2.15
33.01	25.34	-11.03
23.27	21.79	-28.47
32.83	50.92	-24.33
-31.28	56.08	-20.68
23.25	31.48	-27.05

// Hagen M C, 2002: Group 3
// Subjects=12
45.85	25.59	-8.97
40.37	47.16	-18.52
-40.85	53.19	-15.87
32.93	57.4	-9.26

// Hagen M C, 2002: Group 4
// Subjects=23
18.94	40.97	-27.8
16.78	38.5	-32.02
30.7	48.79	-24.12
36.28	21.64	-4.07

// Honey G D, 2002: Normals
// Subjects=20
-35.81	-51.93	41.96
-44.72	21.1	23.67
38.42	52.38	7.83
1.44	13.74	48.29
-44.5	-1.85	43.44
35.74	-2.55	54.84
-19.8	-9.22	56.04
-36.15	-76.3	-11.75
-36.18	-67.84	-12.46
28.99	-73.17	-18.34

// Honey G D, 2002: Schizophrenic Patients
// Subjects=20
29.46	-62.74	47.69
-51.07	15.14	29.82
56.8	18.53	22.72
7.81	12.21	41.66
50.51	13.09	35.52
4.77	-69.55	30.71
38.6	-71	-18.63

// McGlone F, 2002: Subject 1
// Subjects=1
-49.79	-13.43	45.58
-50.84	-15.38	47.99
-45.44	-21.44	51.78
-43.3	-22.48	51.84

// McGlone F, 2002: Subject 2
// Subjects=1
-53.02	-14.77	42.39
-50.84	-15.38	47.99
-44.35	-18.97	56.02
-43.3	-22.48	51.84

// McGlone F, 2002: Subject 3
// Subjects=1
-49.78	-17.66	45.94
-50.84	-15.38	47.99
-42.22	-21.25	53.96
-43.3	-22.48	51.84

// McGlone F, 2002: Subject 4
// Subjects=1
-52.99	-16.62	45.89
-50.84	-15.38	47.99
-44.35	-24.43	54.25
-43.3	-22.48	51.84

// McGlone F, 2002: Subject 5
// Subjects=1
-48.66	-20.48	50.62
-50.84	-15.38	47.99
-40.14	-23.95	46.36
-43.3	-22.48	51.84

// McGlone F, 2002: Subject 6
// Subjects=1
-48.69	-13.08	50
-50.84	-15.38	47.99
-43.36	-21.94	45.11
-43.3	-22.48	51.84

// Wykes T, 2002: Load, Schizophrenics vs. Normals
// Wykes T, 2002: Cerebral Changes in Normals Who Improved On Memory Measures
// Subjects=6
46.87	27.28	-14.7
-39.67	47.79	-3.16
7.22	44.5	-22.38
10.4	49.81	-22.86
-8.8	53.38	-16.25
41.65	19.73	-1.74
41.75	17.5	10.71
14.14	-66.6	-.88
-11.5	-69.93	-.3
41.66	16.56	-1.47
43.75	16.06	-8.15
-54.58	8.69	-11.98
10.9	-44.96	4.04
19.59	-70.91	11.69
4.55	-59.8	5.36

// Sevostianov A, 2002: Deviant, Ignore vs. Standard, Ignore
// Sevostianov A, 2002: Deviant, Attend Left vs. Standard, Attend Left
// Sevostianov A, 2002: Deviant, Attend Right vs. Standard, Attend Right
// Subjects=18
-60.66	-20.92	18.46
-56.53	-20.15	0.5
-58.52	-60.35	3.9
-31.04	59.62	11.36
-45.97	-65.3	-33.75
-5.27	-83.92	-30.43
52.26	13.48	-14.72
63.26	-24.93	10.68
63.19	-21.21	3.68
63.24	-42.7	1.02
52.76	-1.1	44.49
5.91	2.62	69.25
42.11	5.87	52.95
42.31	-55.81	53.66
3.65	-95.42	12.81
48.06	-62.62	-35.05
-52.42	11.08	-8.86
-50.04	-28.06	7.78
-56.38	-42.73	11.32
1.56	-.38	58.4
-43.3	-18.08	53.71
-33.13	-58.54	-30
1.22	-12.78	8.14
52.34	14.34	-3.64
63.18	-16.98	3.32
61.12	-42.54	3.26
48.1	19.05	2.7
46.15	10.01	23.56
-50.21	-1.25	-3.39
-47.92	-23.82	7.4
-58.53	-38.52	10.99
-46.04	17.46	-9.46
-45.62	15.23	44.25
-.61	-.73	53.99
-54.36	8.72	15.9
-43.35	-31.8	41.47
-39.57	20.3	-.85
50.33	-15.11	1.08
61.14	-42.37	5.47
52.32	16.28	-6.03
16.52	6.23	59.9
54.69	16.58	25.14
59.05	-19.86	21.45

// Suzuki M, 2002: Right 115 dB vs. Silence
// Suzuki M, 2002: Left 115dB vs. Silence
// Subjects=11
-52	-20	6
-60	-28	8
-56	-24	6
52	-18	0
-38	-34	14
-42	-34	14
42	-30	8
-46	-32	12

// Chao L L, 2002: Naming Animals > Naming Tools
// Chao L L, 2002: Naming Tools > Naming Animals
// Chao L L, 2002: Naming, New > Naming, Old
// Chao L L, 2002: Naming, Old > Naming, New
// Subjects=7
-12.43	-91.62	8.22
21.77	-90.28	8.83
-38.15	-77.15	5.07
43.07	-75.52	5.12
-39.38	-61.26	-9.63
39.69	-59.73	-10.67
47.34	-39.23	19.87
-25.47	-59.86	-6.56
24.76	-56.22	-5.21
-45.71	-57.1	3.48
-31.5	-44.96	49.13
-45.7	11.03	31.22
-39.48	16.76	8.36
-47	33.97	11.47
-40.46	27.64	25.3
46.07	31.16	21.79
4.5	25.42	33.9
-30.06	48.82	-4.47
15.77	51.16	-19.69
-8.62	47.52	4.31
-33.09	11.08	3.19
39.63	3.4	7.46
-6.96	-64.96	36.03
6.92	-50.7	40.25
-28.75	-30.99	-4.48
26.75	-36.89	-16.89

// Konishi S, 2002: A Minus B
// Konishi S, 2002: B minus C
// Subjects=16
36	18	36
38	10	58
38	2	40
46	10	24
36	24	-6
-40	8	38
0	36	40
6	18	50
4	30	58
0	48	34
48	-24	-6
4	-74	40
60	-52	12
60	-22	-14
12	-32	46
-56	-48	42
-48	12	20
-40	42	14
-38	2	36
-48	-64	-10
-10	-70	60
14	-76	18
12	-58	62
-52	-36	42
-28	-78	34

// Bingel U, 2002: Main Effect of Pain
// Subjects=14
21	-21	-9
-21	-21	-12
18	-6	-18
-15	-6	-15
9	-12	3
-9	-15	3
39	-54	30
-39	-57	-27
21	9	-6
-27	9	-3
12	-12	-6
-6	-21	-6

// Bornhovd K, 2002: Stimulus Perception
// Bornhovd K, 2002: Stimulus Intensity
// Bornhovd K, 2002: Pain
// Subjects=9
54	30	21
-48	27	21
33	6	27
-48	9	21
45	-51	54
-36	-60	57
51	-27	45
-42	-21	54
-6	36	-12
42	-12	6
-45	-18	12
51	15	-9
-45	12	-9
36	9	0
-42	9	-6
24	0	-24
-27	0	-27
-6	54	12

// Smith K A, 2002: Noxious Pain vs. Non-Noxious Warm Stimulation
// Subjects=8
34	22	-2
-30	20	-2
58	8	-2
-52	-10	6
2	12	34
-56	-20	16
58	-18	14
40	42	18
-36	42	18
2	-72	2
28	-62	-32
-30	-76	-30
-38	-56	-30

// Derbyshire S W G, 2002: Males
// Subjects=11
50	-46	44
-40	-56	40
24	-6	66
-58	-28	22
40	42	20
-42	36	12
-32	52	-4
-2	30	40
-2	20	46
-10	34	40
14	-24	4
-24	-12	0
-32	-14	4
36	-6	-4
40	16	6
-42	4	14
48	-54	50
-42	-58	42
56	-42	42
42	10	46
-36	-2	54
52	10	4
-56	4	-12
-60	-26	22
42	44	18
-38	42	16
46	44	6
-32	52	-4
-2	30	36
-2	22	46
14	20	24
-10	32	38
16	-26	8
-24	-12	-2
-34	-12	2
36	-8	-4
40	12	2
-40	20	16
48	-46	44
-36	-52	40
-62	-28	14
-44	36	12
-52	-22	50
-44	-6	-2
-50	8	-14
10	40	-4

// Derbyshire S W G, 2002: Females
// Subjects=11
46	-64	40
58	-42	42
54	2	38
-30	2	52
56	8	8
46	46	-2
40	46	-12
0	30	30
8	26	42
-2	-10	-12
8	48	0
56	8	8
-28	10	-4
48	-54	50
-42	-58	42
56	-42	42
42	10	46
-36	-2	54
52	10	4
-56	4	-12
-60	-26	22
42	44	18
-38	42	16
46	44	6
-32	52	-4
-2	30	36
-2	22	46
14	20	24
-10	32	38
16	-26	8
-24	-12	-2
-34	-12	2
36	-8	-4
40	12	2
-40	20	16
48	-46	44
-36	-52	40
-62	-28	14
-44	36	12
-52	-22	50
-44	-6	-2
-50	8	-14
10	40	-4

// Veit R, 2002: Criminally Psychopathic Subjects
// Subjects=4
-60	-27	33
60	-30	45
-21	-3	-18

// Veit R, 2002: Socially Phobic Subjects
// Subjects=4
-39	48	-9
48	18	-9
-48	48	0
27	54	-12
27	57	30
-63	-30	24
63	-18	21
-39	36	36

// Veit R, 2002: Healthy Controls
// Subjects=7
57	12	-6
48	21	-12
-57	9	-3
0	9	33
45	48	0
-60	-24	15
63	-15	18
-6	3	66
18	-3	-21
3	9	33

// Tanabe J, 2002: Smooth-Pursuit Eye Movement vs. Fixate
// Subjects=15
42	-6	48
-48	-6	54
30	-39	48
-33	-57	57
6	3	60
-3	0	60
9	12	42
-12	-21	42
6	-72	15
6	-69	9
42	-87	-9
-30	-90	-15
12	-15	-3
21	-27	-3
42	-45	-36
-36	-36	-39
0	-60	-45

// Vingerhoets G, 2002: Rotated Hands > Non-Rotated Hands
// Vingerhoets G, 2002: Rotated Tools > Non-Rotated Tools
// Vingerhoets G, 2002: Non-Rotated Hands > Rotated Hands
// Vingerhoets G, 2002: Non-Rotated Tools > Rotated Tools
// Vingerhoets G, 2002: Rotated Hands > Rotated Tools
// Vingerhoets G, 2002: Rotated Tools > Rotated Hands
// Subjects=12
19.51	-95.11	-16.8
-25.34	-46.47	35.18
33.27	-46.42	55.47
-24.16	-3.01	52.15
29.89	-2.61	53.43
36.87	-90.07	-9.75
-3.5	-34.12	-29.16
1.91	-43.89	-30.53
-24.93	-74.41	-22.57
26.77	-65.59	-34.41
-29.32	-54.84	60.73
20.35	-64.75	55.26
-25.25	3.47	52.65
-22.1	-80.36	28.39
27.65	-82	31.07
64.8	-37.54	-12.06
7.96	51.78	39.46
-2.58	-68.83	35.89
-1.6	-33.41	35.73
0.44	-24.46	28.08
53.38	-63.7	18.74
-53.06	-2.65	-11.26
-7.63	63.61	6.06
5.89	45.91	45.68
-49.02	-59	40.19
12.13	-91.55	-1.34
50.04	-64.44	11.02
-41.88	-71.98	4.37
19.69	-64.21	3.67
-30.28	-57.64	-15.18
-29.3	-59.09	61.15

// Winterer G, 2002: Target Identification vs. Fixation
// Subjects=6
-11.63	-24.03	1.43
16.16	-16.12	4.9
-3.85	-85.69	15.43
2.59	-85.39	18.68
-39.22	-71.69	6.86
41.99	-70.15	5.79
-4.98	1.47	41.59
3.66	-7.4	50.04
-21.09	-22.55	21.48
60.18	-37.92	21.84
-37.43	-10.41	-12.8
39.58	-13.66	-6.72
-54.44	4.61	3.98
-23.44	0.56	3.96
32.11	6.18	2.85
-18.04	-65.79	-15.07
10.83	-62.19	-12.36
-2.7	-3.58	58.71
2.55	15.23	53.73
-35.81	-22.27	53.97
36.88	-27.12	53.54

// Cohen L G, 2002: Normals, Group 1
// Subjects=7
-39	-57	-9
-21	-3	60
-48	3	45
-30	21	9
18	45	33
51	9	30
33	-39	51
12	21	60

// Cohen L G, 2002: Normals, Group 2
// Subjects=9
-42	-57	-15
-42	-3	42
-45	12	12
45	18	0
39	6	51
-6	-3	48

// Fiebach C J, 2002: Words vs. Pseudowords
// Fiebach C J, 2002: Low vs. High Frequency Words
// Fiebach C J, 2002: Pseudowords vs. High Frequency Words
// Subjects=12
-28.81	-35.99	-14.1
36.42	-37.37	-10.27
-33	-47.22	-7.54
38.59	-50.22	-11.45
-29.55	-93.04	5.19
35.6	-85.33	2.68
-24.1	-93.04	18.51
34.68	-82.66	23.65
-17.69	-101.8	14.71
24.98	-98.97	6.18
-38.12	-70.2	12.29
42.02	-65.41	12.09
-54.19	-53.21	13.28
29.38	-60.25	38.56
-53.46	34.48	4.81
-43.67	3.41	15.11
-30.06	30.25	-10.72
36.23	26.59	-8.94
-9.51	-8.87	4.59
20.45	-2.8	11.55
-49.08	12.56	9.94
-38.52	17.85	-5.12
8.52	34.85	4.06
-2.02	-1	9.42

// Nakamura K, 2002: Kanji Writing (iWD) vs. Rest
// Nakamura K, 2002: Kana Writing (pWD) vs. Rest
// Nakamura K, 2002: Kanji Mental Recall (iMR) vs. Rest
// Nakamura K, 2002: Kana Mental Recall (pMR) vs. Rest
// Subjects=9
-49.69	39.96	7.99
-52.63	8.22	24.63
53.14	16.58	16.4
-11.43	24.81	39.1
3.79	12.42	43.43
-7.1	29.29	40.82
6.08	-.78	51.42
-21.89	-19.71	57.13
-59.31	-22.8	3.16
57.22	-6	-7.21
-45.3	-61.33	-7.83
-29.39	-46.64	56.56
36.52	-48.53	55.62
-27.63	-38.7	26.61
-24.78	-5.46	3.1
9.69	-73.98	-19.84
-50.46	5.04	24.91
-4.64	-7.85	56.78
10.35	1.05	47.8
-21.93	-24.38	53.11
-49.49	-36.28	7.69
55.06	-10.36	-7.86
-34.83	-38.15	55.81
-41.47	-32.83	44.19
-12.82	-20.2	5.48
12.86	-51.52	-21
-41.91	36.12	23.93
-41.74	7.82	31.21
53.13	14.35	15.5
0.56	9.21	43.8
4.91	9.44	45.94
-11.28	12.78	48.13
6.09	1.45	52.32
-54.99	-22.79	3.09
55.06	-10.36	-7.86
-47.46	-61.34	-7.79
35.34	-42.67	49.46
-39.32	-30.69	43.94
33.07	-47.87	39.93
9.68	-71.85	-20.05
-43.11	33.05	14.17
-52.63	8.22	24.63
-1.63	9	41.62
0.63	7.61	49.56
2.85	1.44	52.37
-55.02	-22.99	0.87
60.55	-18.44	-2.67
-49.72	-59.84	-14.63
-33.86	-43.33	46.22
31	-51.61	45.94
4.8	6.48	37.27

// Polk T A, 2002: Subject G.A.
// Subjects=1
-40.45	-51.41	-5.98

// Polk T A, 2002: Subject D.B.
// Subjects=1
-41.51	-60.05	-7.48

// Polk T A, 2002: Subject M.S.
// Subjects=1
-47.93	-55.85	-7.75

// Polk T A, 2002: Subject G.M.
// Subjects=1
-29.82	-42	-9.12
-46.85	-59.02	-7.5

// Polk T A, 2002: Subject T.P.
// Subjects=1
-41.5	-48.96	-1.72
-43.63	-51.17	-2.62

// Polk T A, 2002: Subject A.K.
// Subjects=1
-47.95	-54.97	-10.06

// Polk T A, 2002: Subject M.L.
// Subjects=1
-58.66	-43.14	-7.58

// Polk T A, 2002: Subject C.T.
// Subjects=1
-42.6	-47.11	-5.2

// Booth J R, 2002: Spelling, Vis - Aud
// Booth J R, 2002: Spelling, Aud - Vis
// Booth J R, 2002: Rhyming, Vis - Aud
// Booth J R, 2002: Rhyming, Aud - Vis
// Booth J R, 2002: Visual, Rh - Sp
// Booth J R, 2002: Auditory, Sp - Rh
// Booth J R, 2002: Auditory, Rh - Sp
// Booth J R, 2002: Independent of Modality, Sp - Rh
// Booth J R, 2002: Independent of Modality, Rh - Sp
// Subjects=13
27	-84	-6
-39	-60	-18
27	-45	63
27	-3	57
-24	-3	51
-63	-30	18
-39	-33	18
-45	-54	12
54	-54	3
-12	-72	3
-48	-21	-3
42	33	-6
24	-84	-12
-30	-84	-15
39	-63	-21
-30	-3	-36
51	-66	0
-60	-12	0
57	-12	-3
-3	-9	48
63	-24	24
48	-39	24
-57	-42	24
-63	-30	15
39	-30	15
54	-6	3
-42	6	-6
-18	6	51
30	-60	42
24	-48	42
21	18	39
-51	-30	33
30	9	33
-27	-12	30
-42	9	27
-42	30	18
-42	-42	9
-45	-57	-12
3	-42	36
-6	-54	9
0	57	-9
-30	-45	45
27	-48	42
30	-63	39
-42	9	27
48	30	21
45	12	15
-48	-57	-12
-48	-15	51
-6	-24	45
-3	-72	36
-42	-69	33
63	-21	27
-57	-21	21
-42	6	-9
0	57	-12

// Gold B T, 2002: Semantic Decision on Words
// Gold B T, 2002: Phonological Decision on Pseudowords
// Subjects=24
-47.18	37.55	-11.14
-49.02	20.9	21.51
-53.19	-57.14	3.57
-47.18	37.55	-11.14
-49.02	20.9	21.51
-57.46	2.16	27.64
-42.28	-41.65	37.83

// Jordan K, 2002: Women
// Subjects=14
32	-84	8
36	-76	-24
24	-64	52
24	-72	48
44	-64	-16
16	-84	40
-32	-72	-32
4	24	36
0	12	48
52	8	28
8	-20	8
-12	-24	8
-28	-88	12
-24	-72	48
32	-4	60
-36	-48	60
-56	4	28
20	-68	52
52	-60	-16
32	-88	0
-16	-76	52
-40	-48	44
-24	-76	32
28	-4	56
-48	-68	-12
-36	-76	-28
-28	-4	64
-4	16	48
4	12	52
52	8	24
20	-68	56
20	-60	48
36	-44	48
-48	-68	-8
-36	-4	52
-36	-48	48
-60	-28	36
52	-60	-4
48	-72	-16
32	0	52
-32	-20	68
-36	-72	40
16	-88	40
32	-24	52

// Jordan K, 2002: Men
// Subjects=10
32	-84	8
36	-76	-24
24	-64	52
24	-72	48
44	-64	-16
16	-84	40
-32	-72	-32
4	24	36
0	12	48
52	8	28
8	-20	8
-12	-24	8
-28	-88	12
-24	-72	48
32	-4	60
-36	-48	60
-56	4	28
12	-88	40
-36	-60	56
-28	-72	48
24	-8	56
-28	-20	56
0	12	48
20	-68	56
20	-60	48
36	-44	48
-48	-68	-8
-36	-4	52
-36	-48	48
-60	-28	36
52	-60	-4
48	-72	-16
32	0	52
-32	-20	68
-36	-72	40
16	-88	40
32	-24	52

// Vanrie J, 2002: Invariance - Control
// Vanrie J, 2002: Rotation - Control
// Vanrie J, 2002: Invariance - Rotation
// Vanrie J, 2002: Rotation - Invariance
// Subjects=6
12	-70	6
33	-87	-9
36	-67	22
28	-58	55
30	0	51
3	27	45
27	1	54
51	39	27
25	-57	57
37	-67	24
13	-60	4
39	-36	39
34	-78	16
3	30	45
-66	-6	-12
3	0	66
36	-21	66
60	9	3
-69	-36	0
21	-58	60
45	-42	54
42	-72	21
28	4	61
-54	-60	-6
33	45	-9

// Nakahara K, 2002: WCST
// Subjects=10
-52	14	20
46	16	24
30	26	0
-32	20	6
42	12	-2
34	2	38
-48	-4	50
-4	6	66
-10	12	50
8	28	52
32	-58	-10
-54	-34	46
-30	-72	12

// Norris D G, 2002: Incongruent vs. Neutral, GE-EPI, Activations
// Norris D G, 2002: Incongruent vs. Neutral, SE-EPI, Activations
// Norris D G, 2002: Incongruent vs. Neutral, SE-EPI, Deactivations
// Subjects=7
2.39	32.27	40.04
-39.3	8.78	29.1
48.33	20.39	33.81
-39.63	38.36	-1.25
34.12	58.69	7.35
-20.7	-76.7	50.56
28.43	-67.86	50.37
-39.24	-75.12	3.8
44.09	-75.94	-.44
0.27	31.28	41.26
-39.27	7.98	32.52
42.86	21.19	17.08
-45	44.59	-2.83
21.23	67.79	2.27
-26.09	-61.85	50.49
28.38	-70.58	42.79
-45.61	-80.28	6.53
42.04	-83.9	6.95
-10.83	73.06	4.43
-3.38	54.18	-6.34

// Brass M, 2002: Cue Only > Null
// Brass M, 2002: Cue Target > Cue Only
// Brass M, 2002: Cue Target > Null
// Brass M, 2002: Cue Target > No Cue Target
// Subjects=11
-41.4	2.6	31.88
-32.73	-2.67	45.6
-35.12	37.53	28.87
-34.68	-43.66	52.41
-26.13	-66.59	44.19
-38.31	-67.77	-11.33
-31.64	-94.74	10.93
-15.59	-100.99	11.27
48.41	3.65	37.45
37.79	0.93	44.49
40.74	37.81	25.75
2.56	11	54.09
38.55	17.48	10.75
34.79	-53.02	49.05
10.26	-65.86	50.41
64.57	-44.35	34.6
5.69	-32.7	25.37
60.14	-55.87	9.96
37.96	-73.06	37.31
40.91	-75.79	1.82
9.84	-83.34	-10.57
21.8	-97.59	10.56
-39.27	5.78	31.59
-54.27	5.26	26.22
-35.82	-18.04	53.62
-2.84	7.03	44.44
-38.28	-4.93	16.86
-54.2	-20.37	25.03
-41.48	-8.12	17.16
-37.88	-40.25	55.5
-34.6	-59.27	57.06
-26.08	-66.08	50.84
-10.49	-21.14	11.21
-26.65	13.66	8.48
-23.34	-61.08	-8.71
-32.71	-94.75	10.94
-39.26	-63.32	5.04
-25.25	-101.56	4.74
-23.33	-64.25	-8.45
35.8	-4.15	61.67
57.99	7.68	33.65
61.32	-25.08	36.36
11.98	-20.75	14.26
-41.41	5.77	31.61
-28.4	-2.13	52.2
-35.12	37.53	28.87
-.69	10.47	47.48
-29.87	16.81	8.25
51.55	9.5	30.23
37.81	1.18	47.81
41.81	37.82	25.74
43.83	39.98	12.15
35.32	17.2	7.47
-39.29	6.67	29.28
-29.49	4.21	51.68
-32.09	45.61	9.2
-35.24	16.53	4.99
50.44	15.66	27.5
26.04	7.46	47.42
6.74	16.6	43.53
37.37	46.02	8.37
34.26	20.63	10.54

// Dreher J C, 2002: Switching vs. Baseline
// Dreher J C, 2002: Main Effect of Regular Timing
// Dreher J C, 2002: Main Effect of Predictable Task Order
// Dreher J C, 2002: Main Effect of Unpredictable Task Order
// Dreher J C, 2002: Interaction Between Task Order and Timing
// Subjects=8
-28	4	56
-40	20	32
48	16	40
60	28	32
-36	-56	52
36	-60	44
-28	-68	-40
0	-68	-32
52	-56	-4
-28	0	72
-60	12	32
-36	60	-4
-48	-20	64
28	-24	76
-24	-32	80
20	-28	80
-60	0	-4
68	-40	8
40	28	0
-40	-80	12
0	64	8
28	-20	-8
0	-48	16
-44	16	32
36	24	20
-28	-16	60
20	-16	68
-32	-56	48
40	-48	48
-32	-68	-36
-52	-28	-12
52	-56	-4
-20	24	-4
28	28	4
-28	-88	4
28	-84	-8
52	-8	28
-44	-12	32
40	28	28
-36	28	24
-28	48	8
-4	12	56
4	28	16
40	-72	4
-52	-36	-8

// Dreher J C, 2002: ABA > ABC
// Dreher J C, 2002: First Task of Triplet > Second and Third Tasks Averaged 
// Together
// Subjects=14
38	19	11
27	27	27
-42	-53	-11
-27	-72	27
4	15	42
-42	-72	-8
38	-65	-15
-49	4	30
42	4	23
-34	-11	49
30	-27	49

// Gagnon D, 2002: CPT > Fixation
// Gagnon D, 2002: DPT > Fixation
// Gagnon D, 2002: TPT > Fixation
// Gagnon D, 2002: SCT > Fixation
// Gagnon D, 2002: CPT > SCT
// Gagnon D, 2002: TPT > SCT
// Gagnon D, 2002: DPT > SCT
// Subjects=7
-30	-8	52
-53	-10	55
46	-4	53
42	-3	58
2	-2	60
-30	-2	65
52	-2	43
-40	-44	58
36	-41	63
-24	-67	58
16	-64	59
-28	-2	1
24	0	9
-6	-76	-18
7	-70	-10
-30	-8	50
-54	-10	53
46	-6	54
34	-6	60
0	8	52
-30	-2	65
48	-2	42
-38	-46	58
36	-44	58
-23	-64	58
22	-64	57
-24	-4	2
24	-6	2
-6	-77	-19
-30	-10	48
-54	-10	54
46	-6	52
34	-5	60
-4	-6	67
-30	-2	65
52	-2	42
-36	-50	64
-24	-71	54
-22	-4	1
24	-6	4
-8	-78	-17
-30	-8	48
-54	-10	53
41	-2	52
3	-2	65
-30	-2	65
-46	-10	39
50	-4	36
-40	-44	58
16	-68	57
-24	-66	56
-44	-24	61
41	-16	56
-8	-14	60
-32	-11	60
54	-52	46
-20	-5	-7
16	-3	-7
24	10	-9
-32	-14	60
-12	10	6

// Luks T L, 2002: Informative Switch Cue > Baseline
// Luks T L, 2002: Informative Repeat Cue > Baseline
// Luks T L, 2002: Neutral Cue > Baseline
// Luks T L, 2002: Informative Cues > Neutral Cues
// Luks T L, 2002: Neutrally Cued Switch > Baseline
// Luks T L, 2002: Neutrally Cued Repeat > Baseline
// Luks T L, 2002: Neutrally Cued Switch > Repeat
// Luks T L, 2002: Switch > Repeat
// Subjects=11
-4.03	-.87	-63.82
1.65	16.97	46.37
6.01	15.07	48.73
1.65	16.97	46.37
-46.3	26.87	17.08
-33.34	46.58	20.51
33.52	39.29	7.76
-45.93	-1.04	40
49.14	0.36	38.24
53.64	1.72	52.6
-37.23	-23.55	39.84
-39.38	-34.4	38.71
-35.6	37.02	10.29
-9.15	14.81	46.77
-6.92	12.04	51.49
6.01	15.07	48.73
8.17	15.08	48.69
-41.98	29.01	16.79
46.49	37.21	7.75
59.6	33.94	17.93
-41.61	-5.38	39.24
51.44	-6.25	47.82
-32.94	-60.95	30.02
-39.87	33.07	14.11
-35.63	30.23	6.48
-54.91	37.99	21.72
-44.22	34.97	11.76
-45.87	-4.98	43.75
51.27	-3.14	35.19
53.62	-3.91	49.8
-46.48	46.25	6.2
-7.03	5.69	40.91
-4.83	23.54	48.07
-52.99	12.11	-2.64
-4.83	23.54	48.07
-48.38	31.84	24.46
-50.7	32.82	12.08
55.23	44.56	16.96
-52.24	-50.09	43.84
-53.2	-48.1	53.75
-52.25	-46.9	43.53
53.64	-44.19	43.7
-57.05	28.31	21.6
-35.46	38.06	21.39
-6.89	24.26	55.88
-44.25	12.87	4.98

// Rushworth M F S, 2002: Healty Controls: Response-switching (RS) Paradigm
// Subjects=10
-21.59	67.91	-6.17
-9.21	15.16	53.87
-7.24	26.58	36.16
-3.76	-13.36	56.2
-14.99	59.97	14.49
8.51	58.97	13.19
-7.64	52.04	-6.11
-18.32	46.61	-6.65
-15.22	50.97	-19.32

// Rushworth M F S, 2002: Healthy Controls: Visual-switching (VS) Paradigm
// Subjects=8
-6.99	9.43	62.13
-.84	26.53	34.98
3.15	56.48	9
-11.87	62.39	4.22
-8.8	52.24	-17.27
-8.23	39.49	51.82

// Heim S, 2002: BASE - NULL, Activations
// Heim S, 2002: BASE - NULL, Deactivations
// Heim S, 2002: NAME - BASE, Activations
// Heim S, 2002: GEN - NAME, Activations
// Heim S, 2002: GEN - NAME, Deactivations
// Subjects=12
-40.56	3.55	2.79
-53.37	2.41	3.03
-57.57	-15.5	5.7
-43.47	-8.79	36.2
-40.35	-31.63	15.78
-38.2	12.39	34.36
-45.79	21.09	23.68
-33.15	23.68	1.02
-51.31	19.26	0.48
-43.77	29.85	12.89
-38.24	9.85	29
-39.46	-46.71	-14.19
-48.91	-66.98	-.12
-43.68	19.7	19.32
-40.63	29.1	2.88
-50.17	5.69	3.84
-48.78	-5.22	41.54
-38.46	2.07	-2.68
-50.16	-13.94	-2.32
-42.43	-40.99	18.82
-54.37	-40.75	-4.49
-54.19	-62.01	9.56

// Szameitat A J, 2002: Auditory single task (AUD) > Baseline
// Szameitat A J, 2002: Visual single task (VIS) > Baseline
// Szameitat A J, 2002: Dual task (DT) fixed > Baseline
// Szameitat A J, 2002: DT random > Baseline
// Szameitat A J, 2002: DT random > DT fixed
// Subjects=11
28	42	32
-32	40	32
1	5	56
46	4	41
-47	2	32
-31	-10	53
34	-21	59
-26	23	13
43	12	6
47	-41	39
-47	-42	36
11	-64	59
-13	-66	53
-44	-26	11
53	-30	18
-47	-58	18
-16	-89	4
14	-94	8
-13	0	5
20	-4	10
10	-16	12
-11	-17	9
-14	-55	-9
26	-67	-9
-26	32	29
13	41	42
-7	-10	56
37	-4	52
46	4	41
-47	2	32
-31	-10	56
-35	-25	56
-38	-3	15
43	12	6
50	-44	27
-53	-26	23
34	-46	58
-16	-70	60
-20	-89	5
-20	-89	4
-14	-21	16
23	-52	-12
-44	16	38
-35	41	8
-38	33	16
-41	32	24
-38	24	32
-38	2	42
-20	-1	54
41	30	32
20	0	57
-10	-71	64
-32	-55	48
28	-66	50
-49	-55	3
-13	-55	-9
-41	14	42
-37	40	9
-38	33	16
-41	32	24
-38	24	32
-38	2	42
-20	-1	54
40	30	32
31	55	18
20	2	56
-4	19	50
29	19	7
-26	19	7
-8	-71	54
-31	-55	48
28	-54	51
-49	-55	3
46	-62	-1
1	-61	10
-11	-44	24
-13	-7	10
8	-18	19
7	-27	3
-5	-29	-5
-34	12	33
-35	45	13
-38	40	17
-41	29	25
-38	24	32
-41	5	39
-29	-7	53
35	12	33
25	53	20
-2	19	50
29	21	4
-29	16	11
-10	22	37
-8	-69	51
20	-68	44
41	-47	40
-50	-45	36
-46	-68	0
44	-62	-1
58	-25	2
1	-54	-6
-8	-45	21
-8	-8	7
5	-8	7
5	-27	3
-7	-27	3

// Henson R N A, 2002: Main Effect of Interference at Study
// Henson R N A, 2002: N3 > C, Study
// Henson R N A, 2002: C > P3, Study
// Henson R N A, 2002: P3 > C, Study
// Henson R N A, 2002: Main Effect of Interference at Test, Correct Trials 
// Only
// Henson R N A, 2002: N > C, Test, Correct Trials Only
// Henson R N A, 2002: C > P, Test, Correct Trials Only
// Henson R N A, 2002: Main Effect of Interference at Test, All Trials
// Henson R N A, 2002: N > C, Test, All Trials
// Henson R N A, 2002: C > P, Test, All Trials
// Henson R N A, 2002: Cue-Related Memory Effect, Memory > Repeat
// Henson R N A, 2002: Cue-Related Memory Effect, Repeat > Memory
// Henson R N A, 2002: Memory Effect During Delay Interval, Memory > Repeat
// Henson R N A, 2002: Memory Effect During Delay Interval, Repeat > Memory
// Subjects=12
-30	60	-3
33	63	3
-45	39	9
-39	30	-9
-45	24	12
-51	18	21
-42	-48	-21
54	-51	9
6	-60	45
-30	-81	12
-30	60	-3
33	63	3
6	-60	45
-45	39	9
-39	30	-9
-45	24	12
-51	18	21
33	63	3
54	-51	9
6	-60	45
-27	54	9
36	54	9
-39	36	-18
-42	30	0
0	15	45
18	21	0
15	6	0
-9	6	-3
-21	-9	21
9	-51	-12
36	-66	42
-3	-69	54
-27	54	9
36	54	9
18	21	0
-9	6	-3
-21	-9	21
9	-51	-12
36	-66	42
-3	-69	54
-39	36	-18
-42	30	0
30	45	27
-42	39	-18
-42	30	0
-27	30	6
30	24	-15
-3	24	39
15	21	3
-21	12	0
15	6	0
-15	6	3
-30	6	57
18	-18	-12
-6	-54	0
3	-48	-18
30	45	27
18	-18	-12
3	-48	-18
-42	39	-18
30	24	-15
-3	24	39
-51	27	-6
-27	21	-9
33	30	-6
-3	24	39
-45	21	21
-42	6	42
36	6	45
-15	-9	12
15	-3	18
-12	-12	-15
-18	-21	-12
24	-18	-18
-21	-66	48
33	-72	48
15	-69	42
-18	-81	6
-3	-90	0
9	-66	12
27	-93	-3
57	-60	18
60	-36	24
-42	27	27
-39	18	-15
33	21	-9
0	33	36
-39	-54	54
-9	48	-12
6	60	3
0	-57	18
-3	-57	45
54	-69	-9
36	-84	21
60	-57	15

// McDowell J E, 2002: Normals, Saccades
// McDowell J E, 2002: Schizophrenics, Saccades
// McDowell J E, 2002: Normals > Schizophrenics, AntiSaccades
// Subjects=14
45.29	3.34	47.55
-42.34	2.82	48.6
-1.63	5.23	62.42
19.97	-64.77	63.59
-16.36	-64.99	64.02
45.29	3.34	47.55
-42.34	2.82	48.6
-1.63	5.23	62.42
19.97	-64.77	63.59
-16.36	-64.99	64.02
25.79	48.81	31.69

// Barch D M, 2002: Controls > Schizophrenics, Encoding, 2-back, and 
// Recognition
// Barch D M, 2002: Schizophrenics > Controls, Encoding, 2-back, and 
// Recognition
// Barch D M, 2002: Schizophrenics > Controls, Encoding and Recognition
// Barch D M, 2002: Controls > Schizophrenics, Encoding and 2-back
// Barch D M, 2002: Controls > Schizophrenics, Recognition and 2-back
// Barch D M, 2002: Schizophrenics > Controls, Recognition and 2-back
// Subjects=38
-6.93	-35.06	-17.78
32.03	-62.7	34.28
-19.3	-60.09	31.3
41.45	11.09	38.02
3.28	-15.63	67.46
-12.89	-93.06	17.27
-32.54	-38.13	-13.88
5.88	-38.41	-20.99
-19.71	8.16	5.51
28.32	17.71	0.81
9.22	-4.1	9.55
-.25	30.39	43.57
-25.5	-34.84	69.4

// Riecker A, 2002: Isochronous Sequence vs. Isochronous Perceptual Baseline
// Riecker A, 2002: Rhythmic Sequence vs. Rhythmic Perceptual Baseline
// Riecker A, 2002: Rhythmic Sequence vs. Isochronous Sequence
// Subjects=12
-1.66	27.39	43.16
-62.4	4.58	20.68
65.1	-.29	18.99
-8.45	-15.41	10.53
14.23	-19.79	8.34
-50.42	-42.8	18.44
56.55	-45.61	16.89
-57.21	15.05	6.1
56.27	9.18	5.87
-28.18	20.71	-3.91
26.92	20.9	-4.87
-31.6	-55.05	-33.34
36.47	-54.81	-34.52
1.6	25.38	44.42
-59.09	-1.48	24.58
68.38	2.16	22.05
-31.22	3.55	7.92
30.36	3.77	6.85
-11.7	-13.3	10.38
14.26	-19.59	10.56
-50.48	-30.14	16.06
61.9	-32.83	15.54
-57.24	21.43	5.47
59.48	19.93	5.88
-31.42	20.7	-3.86
36.64	23.06	-5.25
-31.61	-52.93	-33.55
33.2	-49.51	-34.99
-27.93	-5.91	9.92
-8.47	-9.03	9.9
61.87	-36.33	12.52
46.85	-50.96	17.59
59.47	18.76	4.87

// Leung H C, 2002: Late Delay
// Leung H C, 2002: Main Task Effects
// Leung H C, 2002: Time Effects
// Leung H C, 2002: Interaction Between Task and Time
// Subjects=6
41.8	32.27	22.86
36.39	50.22	21.41
41.68	45.25	11.73
40.62	22.27	3.64
42.67	22.48	-7.56
18.7	6.75	66.52
-39.54	44.76	12.71
-8.07	0.54	57.32
49.46	5.6	35.04
50.45	5.89	24.97
22.12	-49.27	71.18
24.2	-55.32	61.63
42.2	-30.6	49.31
-26.22	-2.75	57.8
-50.07	2.4	16.38
41.8	32.27	22.86
36.39	50.22	21.41
41.68	45.25	11.73
40.51	49.76	1.33
40.62	22.27	3.64
42.67	22.48	-7.56
18.7	6.75	66.52
10.09	2.76	56.92
49.46	5.6	35.04
50.45	5.89	24.97
22.12	-49.27	71.18
24.2	-55.32	61.63
42.2	-30.6	49.31
-26.22	-2.75	57.8
-49.92	3.94	36.32
-20.67	-57.7	62.34
-42.22	-30.05	50.24
-39.54	44.76	12.71
41.8	32.27	22.86
7.83	14.66	45.91
10.09	2.76	56.92
-36.27	49.78	22.28
-6.16	19.01	34.56
-8.07	0.54	57.32
53.58	4.08	15.05
42.2	-30.6	49.31
-39.01	-11.28	58.66
-6.99	-87.22	23.4
42.2	-10.8	57.69
-36.27	49.78	22.28
42.2	-30.6	49.31

// Elliott R, 2002: Emotional vs. Neutral Targets, Normal Subjects > Depressed 
// Patients
// Elliott R, 2002: Emotional vs. Neutral Targets, Depressed Patients > Normal 
// Subjects
// Elliott R, 2002: Happy vs. Sad Targets, Normal Subjects > Depressed 
// Patients
// Elliott R, 2002: Emotional vs. Neutral Distractors, Depressed Patients > 
// Normal Subjects
// Elliott R, 2002: Sad vs. Happy Distractors, Depressed Patients > Normal 
// Subjects
// Subjects=10
-24	21	-21
12	42	3
12	-27	0
-6	-24	0
-66	-36	0
-12	-33	72
-48	-21	39
54	39	21
48	45	24
6	36	15
6	51	12
30	15	-24
-66	-33	-9
51	12	48
-45	15	45
36	27	-21
-30	27	-12
18	6	-21
45	0	-42
39	45	-21
36	27	-21
45	-6	-39
-30	0	-42

// Raemaekers M, 2002: Inhibition vs. Illness
// Subjects=16
-23.47	10.08	3.16
-9.53	3.02	6.94
28.82	5.31	-8.19
15.05	3.17	6.65

// Gurd J M, 2002: Switching > Non-Switching
// Gurd J M, 2002: Semantic Category Fluency > Overlearned Sequence Fluency
// Gurd J M, 2002: Interaction: SC, NS > OS, NS > SC, S > OC, S
// Subjects=11
-16	-68	60
28	-64	58
-4	18	40
8	20	34
-32	38	28
34	46	26
-36	22	-10
38	26	-10
-36	4	28
8	-80	-42
-24	38	-18

// Fu C H Y, 2002: Easy Letter Fluency vs. Repetition
// Fu C H Y, 2002: Difficult Letter Fluency vs. Repetition
// Fu C H Y, 2002: Difficult Letter Fluency vs. Easy Letter Fluency
// Subjects=11
-11.89	57.82	0.14
4.7	-72.52	19.8
-39.57	48.82	10.14
-34.08	47.05	28.06
46	36.99	14.61
49.33	30.63	28.48
-53.27	5.73	18.37
45.96	37.7	10.09
27.72	22.56	-5.16
38.45	37.31	5.74
-.98	53.59	27.14
7.64	42.27	31.33
-63.72	-55.67	23.64
-60.67	-58.33	2.64
-62.68	-57.06	19.28
50.38	-47.52	-5.12
-60.7	-60.88	-2.73
-67.98	-50.06	27.68
-55.18	3.63	46.45
16.15	6.86	13.01
28.82	22.83	-1.85
2.73	-74.08	41.15
-25.96	-82.48	58.91
-29.69	-86.75	-9.83
24.75	-79.37	-15.54
22.66	-82.21	-10.82
2.51	-86.25	7.6
24.73	-82.88	-19.71
-42.61	-76.94	-19.43
-11.5	27.78	38.34
-15.78	10.15	30.95
3.5	17.3	39.05
8.76	19.82	29.86
-.64	-46.14	31.04
-29.93	60.14	18
31.05	43.58	18.69
-38.25	25.08	33.3
-34.07	26.28	20.88
41.84	39.3	31.19
-51.4	23.77	-9.93
-50.23	22.69	3.53
51.29	23.3	2.31
27.79	-6.42	-8.31
63.24	-19.64	10.24
-65.99	-63.65	3.14
-63.8	-63.04	10.87
53.76	-65.51	9.73
-51.18	-55.16	-12.24
-43.21	-53.4	51.09
-47.67	6.21	51.72
50.65	5.75	50.63
30.17	-54.36	4.61
7.64	-35.72	-0.04
7.62	-34.83	-2.35
-22.44	2	-5.09
19.22	4.36	-5.77
-18.18	9.6	-3.55
17.19	7.58	8.48
-7.31	-31.32	3.1
9.8	-36.5	3.34
-14.26	-68.66	57.61
4.81	-59.26	39.88
-53.26	-69.98	-10.97
9.86	-96.38	-13.94
-6.16	-80.98	-6.13
8.87	-99.93	-4.71
27.89	-70.17	-20.81
-39.46	-73.03	-24.25
-7.24	27.72	37.18
14.16	-74.09	-1.36
13.19	-83.98	8.4
-1.75	-92.7	7.07
34.58	-93.63	5.62

// Smith C D, 2002: Letter Fluency vs. Baseline, Increases
// Smith C D, 2002: Letter Fluency vs. Baseline, Decreases
// Smith C D, 2002: Letter Fluency vs. Baseline, Increased Activation, 
// Subjects at Low-Risk vs. High-Risk for AD
// Smith C D, 2002: Letter Fluency vs. Baseline, Decreased Activation, 
// Subjects at Low-Risk vs. High-Risk for AD
// Smith C D, 2002: Letter Fluency vs. Baseline, Decreased Deactivation, 
// Subjects at Low-Risk vs. High-Risk for AD
// Subjects=12
-43.68	24.19	22.29
-40.34	6.83	31.51
-6.13	22.61	39.83
7.73	22.35	35.23
-28.25	-65.37	46.35
-40.08	-26.69	52.16
25.7	-66.3	-25.57
-43.68	-54.94	-10.11
-15.82	-69.32	-5.88
13.14	-75.78	4.37
32.65	-58.49	47.3
-52.01	-54.97	17.87
51.61	-51.34	14.14
-4.78	-57.92	44.34
11.27	-55.45	47.29
48.31	9.14	25.84
-33.67	-71.72	33.56
-38.32	-55.88	-8.98
-20.13	-62.12	-8.66
23.59	-52.85	-16.63
0.59	-66.43	43.87
-52.02	-53.91	17.78
49.51	-57.62	15.81

// Wildgruber D, 2002: Sentence 1 - Rest
// Wildgruber D, 2002: Sentence 2 - Rest
// Wildgruber D, 2002: Sentence 2 - Sentence 1
// Wildgruber D, 2002: Women - Men
// Wildgruber D, 2002: Men - Women
// Subjects=6
-45	33	15
45	21	24
-36	27	-3
36	21	-3
-60	-18	0
63	-24	3
-12	-15	3
9	-15	0
15	9	-6
9	-48	6
0	-60	12
-48	27	27
45	6	24
-36	27	-3
54	24	-6
-63	-15	0
66	-21	3
57	-39	45
18	6	-3
-3	6	57
-51	21	36
48	6	21
-54	21	-6
54	18	-12
57	-42	48
-3	12	51
-54	-48	6
48	27	36

// Trojano L, 2002: Coordinate Judgment vs. Syllable Counting
// Trojano L, 2002: Categorical Judgment vs. Syllable Counting
// Subjects=7
-16.37	-69.48	61.05
24.18	-65.43	54.67
-42.26	-35.93	42.92
41.17	-42.32	49.19
40.88	18.41	36.3
-14.27	-69.81	56.6
17.83	-69.27	60.64
-50.72	-46.05	50.56
50.78	-44.47	48.15

// Dupont S, 2002: Encoding vs. Fixation, Day 0
// Dupont S, 2002: Immediate Retrieval vs. Fixation, Day 0
// Dupont S, 2002: Delayed Retrieval vs. Fixation, Day 1
// Subjects=10
-15	-72	12
-18	-81	15
-27	-75	21
-33	-51	48
-33	-60	45
-30	-66	39
-57	-36	6
-54	24	6
-39	27	3
-6	-63	9
15	-66	12
18	-75	12
21	-84	15
42	27	9
9	-60	9
6	-60	3
15	-60	0
-18	-78	15
-18	-66	21
-42	-60	6
-51	-27	15
-45	-24	3
-36	-39	48
-30	-63	48
-66	-33	9
-63	-36	18
-57	-42	15
-57	-33	6
-45	-45	18
-54	24	6
-42	18	3
-42	27	3
-48	12	21
-45	21	18
-42	9	30
-21	36	18
-15	30	15
-30	-54	0
-12	-57	6
-12	-48	-6
-33	-39	-6
54	18	15
39	27	9
12	-42	3
27	-45	-3
21	-42	3
24	-54	3
-18	-78	18
-51	-36	27
-42	-36	36
-39	-36	45
-33	-51	48
-33	-60	48
-30	-33	48
-30	-45	42
-57	-33	9
-45	21	21
-39	24	12
-12	-57	3
-15	-42	0
42	-39	36
36	-39	45
36	-24	6
51	24	6
39	27	9
15	-42	3
24	-39	3

// Servos P, 2002: Biological Motion
// Servos P, 2002: Linear Motion
// Servos P, 2002: Common Object
// Servos P, 2002: Motor Imagery
// Subjects=12
6.76	-70.02	10.65
1.46	-82.74	11.78
-42.46	-72.06	2.46
45.17	-70.39	2.43
-33.09	-45.96	-18.79
33.16	-46.71	-20.61
-28.34	-5.93	58.09
-38.88	-46.18	61.59

// Ochsner K N, 2002: Reappraise > Attend
// Ochsner K N, 2002: Positive Correlation Between Activation and Drop in 
// Negative Affect When Reappraising
// Ochsner K N, 2002: Attend > Reappraise
// Subjects=15
-36	14	58
-24	6	64
-24	10	56
-40	2	60
-54	42	12
-48	46	4
-12	18	54
-4	20	54
8	28	40
-22	4	-26
-38	-74	40
54	-70	30
6	14	32
54	-48	34
-6	44	-22
-44	-16	2
38	-64	34
22	-76	40
16	-12	-20

// Johnson S H, 2002: Left Hand Preparation
// Johnson S H, 2002: Right Hand Preparation
// Johnson S H, 2002: Left Hand Grip Selection
// Johnson S H, 2002: Right Hand Grip Selection
// Subjects=8
-34.68	-22.8	60.69
-25.02	-15.63	70.02
-35.71	57.77	-39.73
-20.84	3.17	65.05
-21.51	61.02	1.1
1.56	-.38	58.4
-14.34	-63.98	49.42
-47.81	13.56	36.61
-20.71	-52.58	59.69
-34.71	-47.18	48.24
-37.85	-46.6	56.04
34.7	-3.35	58.27
-28.65	-3.56	19.98
-44.56	-18.91	29.26
-8.36	-20.07	11.09
47.05	-62.03	-27.29
-21.3	-1.62	3
20.23	-67.7	-43.23
31.12	-65.5	-15.66
37.21	54.26	-9.05
10.84	-65.36	-12.09
-1.6	-53.84	41.73
-41.26	14.97	54.26
-11.67	1.86	5.95
-4.59	-54.89	69.73
-17.66	-47.59	41.39
11.05	-28.1	29.39
1.39	22.03	45.37
-34.7	-19.63	60.43
-25.02	-15.63	70.02
-20.83	0	65.31
-34.73	-3.51	62.42
-44.3	-29.46	58.02
-21.65	56.31	-18.58
1.54	-.64	55.07
-34.74	-37.66	47.44
-14.34	-63.98	49.42
-20.71	-52.58	59.69
-5.16	-16.88	10.79
-41.43	9.91	30.15
-47.81	13.56	36.61
40.67	-61.72	-22.78
30.9	-71.07	-46.42
-21.3	-1.62	3
-17.94	-77.97	-7.36
20.25	-67.45	-39.91
-31.85	-3.58	20.02
10.82	-65.62	-15.42
-41.25	11.8	54.52
-34.57	-60.07	60.47
64.42	-18.52	24.63
-14.77	-33.31	5.59
1.41	18.86	45.63
4.71	-35.02	36.73
28.17	5.27	46.47
34.68	-3.61	54.94
-8.48	-55.42	-19.4
-5.13	-74.72	-7.78
-17.7	-.75	55.3
37.87	-.42	54.64
31.45	2.72	54.45
38.06	-42.46	61.51
37.64	-80.81	-7.76
41.2	-33.18	57.35
28.51	-54.95	66.01
-17.63	3.19	65.01
34.7	-3.35	58.27
-20.85	-6.86	59.2
-21.08	-80.64	-.41
-35.13	-65.89	-14.87
40.87	24.92	37.98
20.63	-90.97	-0.02
-41.03	-46.36	59.4
24.24	-54.97	66.06
-61.49	-20.65	49.67
-20.72	-49.41	59.42
28.07	-86.95	-3.79
-11.08	-55.7	59.84

// Langleben D D, 2002: Lie vs. Truth
// Subjects=18
0.3	21.48	25.78
4.76	35.72	39.98
1.66	32.38	50.45
-59.88	-18.96	44.25
-56.71	-10.75	40.03
-52.29	3.17	50.9

// Onozuka M, 2002: Increases in During Chewing Moderately Hard Gum
// Onozuka M, 2002: Increases in During Chewing Hard Gum
// Subjects=17
-48	-18	32
52	-14	30
-4	-8	56
8	-8	64
-40	-12	16
42	-6	12
-12	-20	0
14	-18	2
-8	-68	-22
20	-66	-28
-48	-20	38
56	-12	30
-2	-6	60
10	-6	58
-42	-14	16
40	-8	14
-10	-20	0
14	-20	2
-14	-66	-22
18	-66	-26

// Rotte M, 2002: Fingers
// Rotte M, 2002: Toes
// Rotte M, 2002: Tongue
// Rotte M, 2002: Eyes
// Rotte M, 2002: Lips
// Rotte M, 2002: Knee
// Rotte M, 2002: Diaphragm
// Subjects=9
-35.76	-13.04	63.23
41.24	-21.83	66.43
-.53	-3.22	63.12
-8.36	-20.07	11.09
-18.07	-5.75	4.43
-18.12	11.34	5.23
20.46	-5.98	11.81
34.69	-44.1	40.49
-47.74	-25.28	29.83
-24.51	-59.91	-21.07
-27.89	-62.79	-44.2
-33.26	-47.76	-42.06
-41.71	-51.18	-30.52
23.58	-55.22	-19.78
27.67	-63.68	-47
10.84	-65.36	-12.09
-1.5	-18.66	70
3.72	-1.25	60.68
-18.02	-6.29	11.16
-5.21	-17.39	4.14
-25.48	-20.43	7.97
30.06	-10.49	7.62
20.48	-1.4	15.89
13.98	-27.56	-5.26
61.27	-27.8	28.79
-55.22	-25.32	29.92
-28.74	-61.63	-15.3
-32.12	-71.19	-42.34
-35.07	-81.75	-13.54
34.27	-58.33	-19.64
21.56	-81.42	-14.22
17.13	-45.75	-20.5
-56.37	-7.52	26.21
66.56	-8.56	29.34
-4.9	6.73	54.53
-20.22	-6.99	2.33
26.81	-10.94	2.12
47.39	-24.45	32.01
-46.57	-39.56	37.7
-14.82	-68.94	-14.84
-36.27	-84.19	-31.16
27.9	-61.29	-15.98
47.21	-81.26	-14.52
46.98	-77.06	-42.75
-43.38	-6.79	48.3
41.1	-6.74	55.13
-.54	-0.05	62.85
-8.48	1.71	3.69
-18.09	-11.46	-.67
-18.03	-28.38	0.75
20.45	-16.01	5.96
34.27	-1.29	2.34
-47.91	-30.33	5.72
-24.19	-40.11	28.57
-27.67	-61.62	-15.31
-33.01	-61.65	-15.25
-41.76	-63.76	-41.73
23.68	-68.46	-11.98
27.92	-72.03	-17.31
10.56	-47.41	-41.48
-55.14	-11.35	45.47
58.09	-7.75	40.52
4.82	2.35	65.94
-21.33	0.32	0.61
-5.18	-20.3	7.73
-25.5	-26.14	2.88
29.01	-10.33	9.85
31.04	-1.57	-.95
20.35	-8.23	-3.61
64.48	-27.78	28.75
-46.6	-41.05	32.25
-14.82	-63.49	-13.07
-25.55	-59.58	-16.62
-32.13	-68.02	-42.6
23.62	-65.8	-18.89
7.71	-84.41	-10.46
34.14	-69.56	-41
1.7	-24.27	65.98
-1.65	-3.83	55.38
-1.95	-17.83	11.95
-14.91	-6.24	-2.26
-25.5	-20.68	4.65
23.6	-14.3	0.21
17.19	-3.34	4.94
20.49	-26.5	7.96
44.17	-27.9	28.99
-44.48	-39	30.94
-32.19	-60.87	-46.55
-28.9	-40.28	-28.24
-28.77	-58.71	-18.89
-7.53	-41.29	-29.51
34.16	-43.07	-28.73
27.67	-63.68	-47
31.11	-58.98	-13.98
3.79	-17.07	-75.17
-1.61	-6.66	60.08
-15.89	-.91	11.8
-25.5	-14.08	7.44
-2.02	-7.6	6.63
33.24	1.33	8.82
30.09	-13.49	10.1
15.13	-17.98	8.42
63.52	-58.45	31.33
-49.72	-67.59	33.4
-30.82	-70.98	-12.26
-21.32	-58.92	-22.3
-21.37	-40.78	-21.59
-32.13	-62.47	-39.72
30.01	-59.33	-18.4
7.68	-74.81	-10.15
17.03	-77.5	-45.72

// Critchley H D, 2002: Normals
// Subjects=9
16	2	-24
20	-8	-30
10	52	18
-6	-46	-8
58	8	10
62	-8	-12
62	-2	-8
42	-8	-8
36	-12	4
-24	40	-6
44	-2	2
38	-14	2
28	2	-14
-34	4	29
-30	-4	-24
26	-10	-26
42	-4	14

// Critchley H D, 2002: Pure Autonomic Failure (PAF) Patients
// Subjects=8
-24	40	-6
44	-2	2
38	-14	2
28	2	-14
-34	4	29
-30	-4	-24
26	-10	-26
42	-4	14

// Fraser C, 2002: Water Swallowing - Water Non-Swallowing, Pre-Stimulation
// Fraser C, 2002: Water Swallowing - Water Non-Swallowing, Post-Stimulation
// Subjects=8
58.98	-4.09	19.02
-56.43	-4.78	20.4
2.64	-3.54	58.65
1.55	-32.41	43.24
0.79	49.84	-21.64
63.02	3.4	-8.42
-52.38	2.79	-5.93
1.18	-19.72	0.92
58.98	-4.09	19.02
-56.43	-4.78	20.4
2.64	-3.54	58.65
1.55	-32.41	43.24
0.79	49.84	-21.64
63.02	3.4	-8.42
-52.38	2.79	-5.93
1.18	-19.72	0.92

// Turkeltaub P E, 2002: Locations of Significant Maxima for fMRI Study
// Subjects=32
-42	13	21
-50	4	42
-51	-3	22
-46	-8	32
-48	9	-11
-55	-12	-1
-40	-30	13
-59	-27	5
-63	-31	9
-46	-51	-13
-50	-57	-12
-36	-61	-19
-44	-74	-13
-16	-22	-6
-36	-52	-21
-12	-63	-14
4	11	55
-2	12	45
55	2	33
53	-1	18
48	-3	24
61	-4	0
67	-6	-8
63	-14	1
53	-16	1
55	-23	5
57	-50	-19
28	-57	-21

// Langheim F J, 2002: Instrument Performance (Covert) > Rest
// Langheim F J, 2002: Rest > Instrumental Performance (Covert)
// Langheim F J, 2002: Bilateral Finger Tapping > Rest
// Langheim F J, 2002: Passive Listening > Rest
// Subjects=6
22	-66	56
2	6	56
0	-16	8
-12	4	8
54	14	0
-26	-62	-29
36	-72	-28
4	-60	28
-26	-48	-24
54	-14	-8
-16	-60	-20
20	-52	-24
40	-14	56
50	-22	56
28	-2	0
-56	-6	-8
-54	-26	8
54	0	-8
52	10	-16

// Johnson S C, 2002: Self-Reflection > Factual Knowledge, All Subjects
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 1
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 2
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 3
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 4
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 5
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 6
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 7
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 8
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 9
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 10
// Johnson S C, 2002: Self-Reflection > Factual Knowledge, Subject 11
// Subjects=11
0	54	8
-2	-62	32
0	66	10
-4	-48	36
4	52	-4
-4	-74	38
0	54	18
-4	-46	-6
-10	64	26
0	-58	36
2	60	18
-4	-54	32
6	56	38
-8	-55	24
-6	60	32
-4	-52	30
2	62	20
10	-58	32
0	76	8
-4	-44	24
8	64	34
14	-54	20
-8	60	30
-4	-56	10

// Zysset S, 2002: Episodic Memory Retrieval vs. Semantic Memory Retrieval, 
// Activations
// Zysset S, 2002: Episodic Memory Retrieval vs. Semantic Memory Retrieval, 
// Deactivations
// Zysset S, 2002: Evaluative Judgment vs. Semantic Memory Retrieval, 
// Activations
// Zysset S, 2002: Evaluative Judgment vs. Semantic Memory Retrieval, 
// Deactivations
// Zysset S, 2002: Evaluative Judgment vs. Episodic Memory Retrieval, 
// Activations
// Zysset S, 2002: Evaluative Judgment vs. Episodic Memory Retrieval, 
// Deactivations
// Subjects=13
-5.44	60.4	5.43
-9.11	-49.74	40.36
-22.45	-21.15	-15.42
-56.15	-63.48	32.01
-39.52	29.53	8.41
-51.07	4.14	25.17
47.26	7.1	27.13
-33.56	-55.2	54.48
33.73	-76	40.95
43.15	-80.12	14.42
-48.85	-70.78	5.77
52.44	-35.16	-10.64
-5.44	60.4	5.43
-9.11	-49.74	40.36
-43.9	17.48	-9.49
-56.15	-63.48	32.01
51.39	34.28	20.35
-51.07	4.14	25.17
47.26	7.1	27.13
-33.56	-55.2	54.48
33.73	-76	40.95
-48.85	-70.78	5.77
52.44	-35.16	-10.64
-40.15	-9.86	49.63
-5.44	60.4	5.43
-43.9	17.48	-9.49
-9.11	-49.74	40.36
32.38	23.27	44.91
-25.3	20.98	47.99
-33.56	-55.2	54.48
33.73	-76	40.95
51.39	34.28	20.35

// Kelley W M, 2002: All Trials > Fixation
// Kelley W M, 2002: Fixation > All Trials
// Kelley W M, 2002: Self Relevance + Other Relevance > Case
// Kelley W M, 2002: Self Relevance > Other Relevance
// Subjects=21
-24	-94	-12
32	-92	-4
0	-70	-12
-4	-46	4
-2	-78	40
-32	-66	54
30	-64	50
-48	12	22
48	8	32
-42	16	-4
-32	26	-8
54	16	-6
42	0	58
0	14	42
-6	-20	8
-10	4	6
34	-62	-32
-28	-60	-32
10	52	2
-8	54	2
6	40	44
-4	4	-10
18	34	52
34	26	46
14	58	28
-14	50	26
-24	36	-10
12	-48	50
-56	-58	38
-34	-40	-12
-16	-84	18
-44	-76	30
24	-8	-18
56	-24	-14
-42	16	-4
0	14	42
10	52	2
12	-48	50

// Mathiak K, 2002: Closure Time - Voice Onset Time
// Mathiak K, 2002: Voice Onset Time - Closure Time
// Mathiak K, 2002: Voice Onset Time - Monosyllabic Control Condition
// Mathiak K, 2002: Monosyllabic Control Condition - Voice Onset Time
// Subjects=13
-46	40	-19
-51	-13	4
-22	-92	-9
28	-94	-5
-28	-58	51
40	-50	50
-53	-15	4
59	-12	-1
59	17	-4
0	61	17

// Adleman N E, 2002: Normal Children
// Subjects=8
-2.95	19.24	24.94
-26.57	-62.92	20.02
-5.33	30.75	10.39
-28.57	21.43	49.81
-13.84	-69	0.24
-13.48	-75.01	27.72

// Adleman N E, 2002: Normal Adolescents
// Subjects=11
-2.95	19.24	24.94
-26.57	-62.92	20.02
-28.54	19.51	52.24
-13.48	-75.01	27.72

// Adleman N E, 2002: Normal Adults
// Subjects=11
-2.95	19.24	24.94
-26.57	-62.92	20.02
-35.31	28.26	31.32
66.44	-44.33	30.04
-28.21	-65.57	60.65
-5.33	30.75	10.39
-28.57	21.43	49.81
-13.84	-69	0.24
-28.54	19.51	52.24

// Balsamo L M, 2002: Auditory Response Naming > Rest, Fixed Effects Analysis
// Balsamo L M, 2002: Auditory Response Naming vs. Rest, Multisubject 
// Conjunction Analysis
// Subjects=11
-50	-38	4
-60	-24	2
-60	-10	-4
62	-16	0
50	-38	6
58	-38	8
-8	-100	-4
-30	-98	2
-12	-104	14
14	-102	14
24	-102	2
32	-94	-8
-58	-56	-10
24	-82	-20
32	-72	-24
44	-62	-22
-8	-36	6
2	-76	-20
-36	-44	-24
6	60	-4
-4	60	-6
24	58	-6
-42	-68	-14
52	12	-22
-22	60	0
-50	14	36
-58	-20	0
-60	-12	-6
-54	-34	4
48	-38	6
66	-22	-4
60	-12	-2
58	-24	0

// Durston S, 2002: Go vs. No-Go
// Subjects=10
39.69	28.12	24.34
-30.89	29.38	19.47
8.65	42.82	24.58
10	-37.79	27.98
-10.3	-43.29	27.56
-16.48	-66.27	47.4
11.14	12.45	58.33
-10.45	44.08	42.54
-43.44	4.67	45.11
-43.22	-23.83	61.99

// Erk S, 2002: Sports Cars > Small Cars
// Erk S, 2002: Sports Cars > Limousines
// Erk S, 2002: Limousines > Sports Cars
// Erk S, 2002: Limousines > Small Cars
// Subjects=12
-48	-78	0
30	-54	-15
9	3	-6
-3	33	-18
-3	45	12
45	15	30
-45	3	36
-3	54	12
-42	-45	-6
33	-18	15
-6	-87	-6
-9	-96	-15
54	15	30

// Hutchinson S, 2002: Older Normals > Young Normals, Right Wrist Extension
// Hutchinson S, 2002: Older Normals > Young Normals, Right Index Finger 
// Abduction
// Hutchinson S, 2002: Older Normals > Young Normals, Left Wrist Extension
// Hutchinson S, 2002: Older Normals > Young Normals, Left Index Finger 
// Abduction
// Hutchinson S, 2002: Young Normals > Older Normals, Right Wrist Extension
// Hutchinson S, 2002: Young Normals > Older Normals, Right Index Finger 
// Abduction
// Hutchinson S, 2002: Young Normals > Older Normals, Left Wrist Extension
// Hutchinson S, 2002: Young Normals > Older Normals, Left Index Finger 
// Abduction
// Subjects=8
-4	-18	56
-20	-64	8
8	6	2
-24	-86	8
-4	-18	56
22	-34	56
-18	-72	42
-16	-82	26
12	14	0
16	-20	50
-24	-86	6
28	22	-8
6	-16	64
-4	-20	56
8	-16	58
-32	-22	54
4	6	4
-22	-64	52
-16	-84	26
-4	32	10
-14	-32	4
24	-30	-4
-2	-18	56
-2	9	2
4	30	12
-22	-16	60
-28	-26	54
16	-66	-24
-20	-64	-22
-4	-8	42
-24	-14	58
16	-66	-24
-30	-38	-20
-38	-16	50
-6	-84	16
28	-18	58
-20	-62	-22
44	-26	14
-48	2	14
-20	-14	58
42	-16	44
-22	-58	16
-54	2	12
48	-32	6

// Brooks J C W, 2002: Right Attend vs. Baseline
// Brooks J C W, 2002: Right Visual vs. Baseline Visual
// Brooks J C W, 2002: Left Attend vs. Baseline
// Brooks J C W, 2002: Left Visual vs. Baseline Visual
// Subjects=18
39.93	21.26	-1.77
-31.37	27.6	1.06
-40.74	-17.89	20.29
72.73	-12.92	21.23
-66.61	-19.79	24.28
62.57	10.08	-7.77
-60.53	-1.95	-3.36
7.9	21.82	28.98
-8.24	16.76	33.12
1.52	-15.74	29.44
26.84	-65.07	-28.86
-38.07	-65.92	-34.39
43.25	12.01	2.45
-57.18	-1.11	5.46
-43.98	-17.9	20.35
69.56	-28.78	23.97
-66.67	-23.5	19.05
59.3	10.92	-10.04
7.89	25.01	28.66
-4.94	10.7	37.02
23.75	-59.58	-15.9
46.25	22.27	-14.3
-38	25.37	-10.93
-37.88	14.29	-3.11
46.76	-14.39	18.45
62.61	11.45	-4.54
11.21	25.65	35.27
-1.79	25.29	32.16
-18.4	-74.07	-19.35
-57.15	-4.19	6.89
43.36	48.98	18.96
-28	41.72	14.17
39.95	14.88	-1.14
-37.78	11.72	3.86
49.92	-11.7	12.53
66.23	-19.63	18.64
62.58	7.95	-7.56
-60.55	4.43	-3.99
4.68	28.5	31.73
8.02	13.94	36.48
-1.7	10.71	36.96
-31.14	55.61	25.18

// Niddam D M, 2002: Nonpainful Activations
// Niddam D M, 2002: Painful Activations
// Niddam D M, 2002: Increases in Painful and Nonpainful
// Niddam D M, 2002: Increases in Painful, Decreases in Nonpainful
// Niddam D M, 2002: Decreases in Painful and Nonpainful
// Subjects=10
46	38	13
4	-11	48
51	15	36
51	14	7
40	-26	60
59	-11	16
65	-24	17
42	-22	58
26	-28	68
57	-21	47
46	-54	47
14	-66	42
57	2	5
65	-38	13
0	4	42
44	-13	15
37	-4	-7
14	-14	8
-61	-21	14
-6	-72	46
50	13	20
2	2	48
32	43	14
48	12	36
59	-16	14
65	-22	21
40	-28	60
63	-39	31
16	-62	40
55	2	4
51	10	0
0	15	23
6	12	38
4	-11	47
44	-13	17
38	18	5
40	2	7
38	-2	-8
14	-13	8
-55	4	9
-42	2	9
-59	-19	15
-59	-38	26
-10	-68	37
-50	7	-7
-2	-26	27
-38	-23	13
-42	-4	-6
-38	-18	-6
-13	-15	8
63	-22	22
63	-28	25
50	10	0
38	6	-7
46	-15	19
36	2	8
14	-9	10
12	-19	8
-57	-1	9
-8	-70	35
-50	5	-7
-38	-20	-6
-36	6	2
-16	-13	8
32	42	16
44	10	7
48	-8	-3
0	15	23
12	2	42
10	8	38
2	-30	24
34	16	10
38	-14	-8
-53	-15	14
-59	-37	28
-38	-45	34
-6	-26	29
-44	8	12
-40	1	15
-40	-17	19
-18	-27	11
-18	-1	17

// Munk M H J, 2002: What
// Munk M H J, 2002: Where
// Subjects=23
-38.24	-79.15	-7.03
34.4	-70.25	-8.61
-45.74	12.89	27.72
38.58	44.14	25.24
-52.15	-65.14	-3.58
47.23	-56.89	-2.07
-47.84	3.36	28.54
49.42	4.11	29.59

// Rivera S M, 2002: Fragile X Patients
// Subjects=16
2	14	64
-2	30	56
50	36	26
-36	-56	48
-32	-74	28
-44	18	30
-52	4	52
-50	44	-6
-54	36	16
-52	38	6
-50	-58	-16
-34	-48	-22
-42	-54	-34
30	12	-4
34	28	0
-38	-60	42
-32	-54	46
-20	2	68
-30	10	48
-10	26	50
-32	-60	-28
-40	12	28
-48	18	28
18	-28	72
28	-28	44
28	-42	36
-40	-52	2
-38	-62	2
-34	-40	-6
-20	-2	60
-42	-16	38
-22	-54	40
-10	-48	60
-36	-28	42
30	16	44
-6	62	-38
-16	-10	46
22	4	40
-20	-2	56
18	28	-18
14	24	-8
-18	-50	-36
-52	-10	42
-54	-2	34
-50	38	20
-50	40	-2
-42	38	-6
-20	2	26
0	2	28
8	-32	68
20	-2	50
28	-6	40
-48	-46	42

// Rivera S M, 2002: Unaffected Controls
// Subjects=16
-44	-44	44
-24	-80	42
30	-74	28
42	-56	52
-38	22	0
-46	28	26
8	14	46
-8	14	52
-46	-56	-14
-4	-90	-4
44	44	32
44	12	4
-24	-74	50
-42	-70	-18
-44	-60	-14
44	-46	46
-2	14	58
-42	0	40
26	-2	58
48	8	22
30	24	6
18	-28	72
28	-28	44
28	-42	36
-40	-52	2
-38	-62	2
-34	-40	-6
-20	-2	60
-42	-16	38
-22	-54	40
-10	-48	60
-36	-28	42
30	16	44
-6	62	-38
-16	-10	46
22	4	40
-20	-2	56
18	28	-18
14	24	-8
-18	-50	-36
-52	-10	42
-54	-2	34
-50	38	20
-50	40	-2
-42	38	-6
-20	2	26
0	2	28
8	-32	68
20	-2	50
28	-6	40
-48	-46	42

// Acuna B D, 2002: Transitive Inference - Visual Height Comparison
// Acuna B D, 2002: Visual Height Comparison - Passive Visual
// Subjects=15
-50.88	-20.21	40.59
-31.88	-20.38	9.16
32.22	-15.77	8.04
41.96	-4.48	29.28
53.84	-19.58	39.33
0.47	-6.19	52.21
30.39	16	61.15
-23.03	0.36	56.39
13.26	-4.17	49.66
-59.76	4.83	7.37
2.3	82.99	49.17
23.72	74.83	51.84
-28.7	70.57	42.76
-18.94	24.91	43.13
-2.06	13.98	10.4
17.29	8.61	21.78
23.51	35.28	8.32
4.71	11.1	55.17
-29.36	-27.34	56.55
-35.83	24.75	70.1
38.96	33.82	70.71
59.11	26.86	47.65
37.64	41.11	41.12
36.53	57.13	42.02
27.92	67.48	39.02
47.07	7.42	3.69
0.29	44.74	50.17
19.32	22.91	13.86
-6.35	18.18	10.09
27.82	2.73	-.16

// Shulman G L, 2002: Cue Period, Motion > Color Cues
// Shulman G L, 2002: Cue Period, Mixed > Blocked Cues
// Shulman G L, 2002: Test Period, Motion > Color Cues
// Shulman G L, 2002: Test Period, Mixed > Blocked Cues
// Subjects=19
-22.82	-65.54	57.45
-31.36	-54.51	63.31
-31.36	-63.31	59.59
-42.56	12.65	24.36
-48.88	15.75	37.55
49.68	-11.89	56.58
-14.26	-65.32	59.56
15.66	-63.03	59.03
-8.05	-69.62	30.86
2.77	-68.19	48.46
56.05	-27.69	44.45
41.13	-38.35	45.51
32.59	-42.63	45.97
45.5	-41.7	56.9
34.79	-77.14	39.92
34.73	-66.74	36.82
38.97	-78.14	26.57
-51.07	-70.51	-4.26
51.52	-61.09	-1.77
34.59	-.15	44.62
26.05	6.48	48.62
49.4	2.8	26.36
-35.63	-54.53	63.37
-44.55	-3.43	36.88
-44.46	-2.57	47.96
-17.15	-75.33	-42.16

// Shulman G L, 2002: Reactivation of BOLD Response
// Shulman G L, 2002: Delayed Activation of BOLD Response
// Subjects=22
-35.74	-53.44	49.89
36.99	-56.72	56.02
30.5	-59.73	45.2
32.55	-67.27	30.19
45.1	-67.81	-5.59
-44.69	-66.41	-6.91
36.64	-86.73	-1.68
38.87	-83.57	11.42
64.52	-39.41	29.72
58.05	-46.65	19.25
17.66	-64.38	41.28
11.36	-74.31	51.1
-36.36	14.86	-2.67
40.57	19.55	-3.94
36.32	24.27	2.4
40.81	8.92	23.71
8.88	16.61	43.51
47.39	1.87	42.07

// Luft A R, 2002: Extension/flexion of right knee vs rest
// Luft A R, 2002: Extension/flexion of left knee vs rest
// Luft A R, 2002: Flexion/extension of right elbow vs rest
// Luft A R, 2002: Flexion/extension of left elbow vs rest
// Luft A R, 2002: Sequential thumb-finger opposition of right hand vs rest
// Luft A R, 2002: Sequential thumb-finger opposition of left hand vs rest
// Luft A R, 2002: Passive extension/flexion of right knee vs rest
// Luft A R, 2002: Passive extension/flexion of left knee vs rest
// Subjects=11
-8.87	-26.39	80.77
-.34	-15.6	82
-2.58	-16.64	68.73
-42.1	-21.1	69.56
-11.1	7.77	82.39
-15.46	-28.32	56.48
-4.83	-24.37	51.56
-6.9	9.23	73.3
14.39	-13.51	52.66
10.34	-15.53	81.87
5.94	-12.53	66.06
12.45	-17.98	77.59
44.26	-18.24	43.79
10.25	-1.07	76.2
12.47	-13.41	81.67
1.69	-14.5	68.5
-41.2	3.59	58.56
-23.77	-39	84.23
-38.94	-28.11	61.19
-17.51	-7.58	77.06
-28.39	-.9	54.32
-32.59	-11.16	59.69
-26.07	-12.21	73.09
-32.5	-30.02	63.5
20.95	-16.33	70.66
21.04	-19.7	82.1
20.9	5.17	73.32
40.21	-13.75	74.69
46.68	-43.84	70.45
38.06	-35.77	65.41
27.38	-9.43	76.7
25.02	-22.76	42.16
-36.82	0.25	69.94
-25.95	-35.13	79.47
-45.39	-21.98	58.52
-36.87	-4.67	61.43
-47.6	-2.96	56.95
-47.42	-27.48	70.15
-41.03	-14.41	73.45
-21.8	1.02	78.62
-36.89	-9.24	57.35
40.06	-24.1	51.02
57.19	-14.85	58.97
37.97	-1.59	67
63.51	-13.55	47.64
46.63	-22.35	73.1
35.98	-17.67	79.53
40.18	-7.41	74.16
31.64	-5.17	76.3
-38.95	-15.08	64.56
-4.56	-32.54	83.47
1.61	4.54	66.91
-4.55	-23.74	87.19
10.33	-22.22	77.97
16.69	-7.38	76.65
3.91	-13.63	79.56
8.2	-13.43	81.72
12.5	-13.06	86.1
16.52	-9.09	54.5

// Castelli F, 2002: Activations Common To Autism Group and Healthy Controls, 
// ToM Animations vs. Rd Animations
// Castelli F, 2002: Healthy Controls > Autism Group, ToM Animations vs. Rd 
// Animations
// Subjects=10
-46	-60	-10
-38	-14	-30
42	6	-28
64	-48	16
-58	-52	4
22	-104	-8
-18	-106	-10
42	-82	-8
-26	-94	-12
10	54	30
-38	-14	-26
42	6	-28
52	-46	24
-66	-52	8
-4	56	22

// Gur R E, 2002: Schizophrenia patients
// Subjects=14
-36	22	4
40	-78	-4
-32	22	8
44	-58	-12
-16	-32	0
16	-12	-12
-12	0	-20
24	0	-4
-20	-32	0
-12	-4	-8
-16	-8	-8
20	-12	-8

// Gur R E, 2002: Healthy control subjects
// Subjects=14
-32	28	4
32	16	8
-20	-4	-12
20	-4	-4
-20	-8	-8
-40	-40	-12
-40	-76	8
32	-84	8
-32	20	8
44	20	0
-20	-4	-12
20	-4	-4
-20	-8	-8
-24	4	-12
-28	-88	12
40	-48	-8
-24	0	-12
20	-4	-4
24	-24	-4
-28	-8	-16
28	-12	-16
28	-36	4
-12	-4	-8
-16	-8	-8
20	-12	-8

// Kosaka H, 2002: Schizophrenia patients
// Subjects=12
-18	-4	-10
20	-6	-10
-20	-6	-14
20	-2	-12
22	-6	-12

// Kosaka H, 2002: Healthy controls
// Subjects=12
-22	-6	-8
20	0	-16
22	-2	-10
22	-6	-12

// Grossman E D, 2002: Frequency of activated regions during the point-light 
// biological motion localizer
// Grossman E D, 2002: Activation evoked by pictures of stationary headless 
// bodies minus stationary household objects
// Grossman E D, 2002: Activation during viewing texture patterns minus 
// viewing faces and objects
// Grossman E D, 2002: Activation during viewing pictures of faces vs objects
// Subjects=10
-42.75	-53.92	14.1
-44.65	-60.01	13.97
-48.82	-42.87	7.45
-42.15	-43.11	-15.47
50.64	-48.76	13.27
53.53	-53.95	11.89
54.67	-33.04	2.87
40.76	-37.71	-14.98
-40.53	-72.05	17.5
44.81	-67.14	12.87
-28.98	-81.49	0.31
37.59	-77.69	0.9
-28.98	-81.49	0.31
37.59	-77.69	0.9

// Gracely R H, 2002: Controls
// Subjects=16
54	-20	44
-52	-22	52
64	-26	22
54	-30	26
52	-52	48
48	-54	38
38	4	0
-48	12	-2
54	16	2
12	2	68
2	2	58
14	4	20
28	6	-2
-12	0	2
12	-8	12
6	-4	6
12	-14	2
-12	-12	6
60	12	-6
-24	-48	-30
-36	-44	-38
-50	-58	-36
28	-70	-32
-46	2	8
54	10	-4
-10	64	16
55	-18	29
52	-40	38
58	-28	28
36	4	6
-58	-24	14
46	-54	10
64	-52	18
-54	-2	0
1	8	30
12	-56	6
4	-46	40
18	-60	-32
-30	-62	-26

// Gracely R H, 2002: Patients
// Subjects=16
52	-16	44
52	-20	16
-58	-24	14
54	-20	30
64	-32	24
58	-38	36
36	6	6
26	2	4
62	10	2
-70	-28	16
-28	-60	-30
-20	-54	-32
-48	-24	52
-10	64	16
55	-18	29
52	-40	38
58	-28	28
36	4	6
-58	-24	14
46	-54	10
64	-52	18
-54	-2	0
1	8	30
12	-56	6
4	-46	40
18	-60	-32
-30	-62	-26

// Cools R, 2002: Final Reversal Errors - Correct Responses
// Cools R, 2002: Preceding Reversal Errors - Correct Responses
// Subjects=13
38	24	-2
8	32	52
42	-42	40
10	10	52

// Grossman M, 2002: All Verbs - Baseline
// Grossman M, 2002: [Motion Verbs - Baseline] - [Cognition Verbs - Baseline]
// Grossman M, 2002: [Cognition Verbs - Baseline] - [Motion Verbs - Baseline]
// Subjects=16
-67.74	-48.59	14.82
-3.61	42.74	-22.2
1.47	-95.98	9.37
-7.34	-66.64	2.13
13.69	38.55	-22.08
18.54	20.61	15.47
-59.07	-70.25	12.34

// Evans K C, 2002: Low Tidal Volume (VT) > High VT
// Subjects=6
-10	-66	54
-14	-76	46
-40	-52	-30
-38	-72	-42
-26	-68	-50
-28	-70	-28
-4	32	20
-4	24	24
-2	8	30
-4	10	42
-30	20	8
-46	18	-8
-28	-6	64
-40	54	6
-46	20	6
-30	62	-10
-20	2	-14
-38	-46	48
-54	8	16
-20	8	-4
-10	-80	6
-12	10	0
-18	-66	12
26	-70	52
2	36	34
4	18	44
12	18	28
4	30	24
2	18	32
4	8	48
4	12	56
34	16	8
46	14	-12
32	28	6
24	6	50
26	4	62
50	12	36
50	4	48
50	10	18
46	48	12
28	26	-14
24	4	-14
68	-28	38
50	-30	40
56	-40	52
4	-72	-12
2	-64	-22
2	-74	-32
8	-64	-48
50	10	18
24	10	-4
6	-78	34
10	-8	-4

// Rilling J K, 2002: Player A x Player B interaction (CC + DD) - (CD + DC), 
// Experiment 2
// Rilling J K, 2002: Both player cooperation (CC) versus all other choices, 
// Experiment 2
// Rilling J K, 2002: CC versus average of all other choices, Experiment 2
// Rilling J K, 2002: Competition following a cooperative choice (XC,CX) 
// versus all other conditions
// Subjects=19
6	18	0
-27	-39	60
18	-30	72
6	51	-18
-39	-30	60
3	48	-12
-3	51	6
-51	-30	12
18	-45	60
-39	-3	18
-3	36	-12
-27	9	6
-6	66	6
6	48	-18
3	36	-6
39	-45	-6
6	21	6

// Berthoz S, 2002: Violation of social norms > Normal behaviour
// Berthoz S, 2002: Embarrassing stories > Normal behaviour
// Berthoz S, 2002: Violation of social norms > Embarrassing stories
// Berthoz S, 2002: Embarrassing stories > Violation of social norms stories
// Berthoz S, 2002: Commonalities of violation of social norms and embarassing 
// stories
// Subjects=12
-12	58	8
-10	-18	66
-44	6	44
6	36	54
-6	14	60
-52	32	2
-36	28	-22
-50	-44	6
56	8	-28
-52	8	-38
-8	-98	8
18	-98	10
-34	-74	-16
-6	-28	-20
-8	52	18
10	54	24
-6	32	54
-20	-82	-10
4	54	36
2	36	52
-56	18	16
-54	24	8
-50	-38	-2
52	-16	-16
-54	2	-28
48	8	-28
-4	-80	-4
-8	-102	6
20	-96	10
-48	12	46
-42	26	-14
-50	12	-24
-30	-80	-12
-22	34	48
-10	58	8
-18	48	4
0	0	40
-32	-22	42
-44	-32	52
36	-6	-32
12	-50	52
-40	-72	32
-24	24	60
58	-18	-18
-8	52	18
-44	6	44
-38	4	38
6	38	52
-4	40	52
-4	18	62
-52	32	2
-56	24	16
-46	24	-16
-38	28	-12
-50	-44	6
-56	-34	0
54	0	-28
56	8	-28
-52	8	-38
18	-98	10
-8	-98	8
-20	-82	-10
8	-90	6
-36	-84	-16

// Janata P, 2002: Healthy Volunters, Experiment 1
// Subjects=12
-59.51	-3.53	-8.83
-63.65	-14.21	3.51
-54.98	-21.62	4.09
61.65	-9.51	0.91
66.01	-18	1.67
57.38	-21.22	2.14
1.84	16.2	61.01
50.28	6.3	44.36
46.2	-.66	61.93
50.4	11.6	55.04
-63.65	-14.21	3.51
-54.96	-25.87	4.51
-72.23	-30.19	5.23
65.86	1.69	-5.87
57.38	-21.22	2.14
-59.15	12.35	23.21
-47.25	27.8	27.09
1.86	11.94	61.43
50.03	16.44	26.55
45.89	5.77	38.88
34.18	-1.74	51.03
-34.86	-49.3	51.31
-51.16	-42.44	45.31
-19.19	-.79	18.23
17.16	5.25	-11
13.09	-5.97	6.99
-35.66	-43.32	-10.9
29.15	-59.56	-16
33.59	-54.25	-5.39
-7.29	-61.87	7.26
13.19	-50.1	5.75
-67.8	-41.35	11.87
-6.86	11.39	56.03
-54.58	5.41	40.63
-54.88	7.59	18.01
37.82	43.56	7.27
42.38	20.15	20.71
-58.77	-30.76	44.28
-59.01	-23.81	26.79
21.04	-29.73	-52.43

// Janata P, 2002: Healthy Volunteers, Experiment 2
// Subjects=8
-54.99	-18.43	3.78
-59.1	-37.61	16.95
61.65	-9.51	0.91
61.77	-20.69	7.61
74.75	-24.9	7.81
1.59	26.34	43.21
1.45	41.77	36.08
-40.02	22.04	-.48
-31.46	24.74	-6.5
-40.11	61.91	1.18
-31.5	53.98	-3.79
42.01	21.81	-7.46
37.82	26.02	3.4
34.23	3.03	56.16
38.66	12.59	66.35
-42.36	-45.62	56.68
43.16	-51.73	67.03
-7.31	36.45	25.55
1.58	-27.33	31.71
-15.23	17.35	-6.04
-22.61	6.67	6.35
-11.16	-83.03	-46.61
17.37	6.81	5.65
13.09	-5.97	6.99
13.05	-13.93	2.17
-59.46	1.24	-3.7
-59.23	-21.12	9.72
-63.42	-37.63	17.03
61.63	14.41	4.14
57.45	-20.7	7.69
1.65	10.39	44.78
1.59	26.34	43.21
-40.02	22.04	-.48
-34.75	-20.09	65.23
49.66	18.1	-1.62
-58.68	-16.96	54.12
46.33	-52.23	61.42
-22.87	-74.06	-30.49
21.77	4.15	11.44
-2.62	15.14	49.99
29.74	26.96	48.27
34.23	3.03	56.16
-34.93	-49.82	45.76
-30.55	-62.57	46.95
42.99	-45.32	55.19
38.71	-57.03	56.43
-7.4	40.19	19.58
-26.91	-72	-8.21
-14.93	-78.89	-2.13
17.44	-86.74	-7.51
45.59	-82.93	-2.76
17.56	-61.78	6.83

// Stein M B, 2002: Harsh > Accepting faces: Generalized Social Phobia > 
// Healthy controls
// Subjects=15
-.99	62.31	29.75
-46.04	33.92	-3.04
20.3	67.04	20.19
-20.13	8.21	20.01
-14.8	11.42	19.68
-17.97	8.48	23.31
24.82	6.97	27.4
-20.15	10.24	18.72

// Johansen-Berg H, 2002: Positive Correlation: Grip strength and Movement 
// task of the affected hand
// Johansen-Berg H, 2002: Negative Correlation: Grip strength and Movement 
// task of the affected hand
// Johansen-Berg H, 2002: Positive Correlation: Grip strength and Movement 
// task of the unaffected hand
// Johansen-Berg H, 2002: Negative Correlation: Grip strength and Movement 
// task of the unaffected hand
// Subjects=7
24.53	-65.96	-30.24
-21.96	-66.35	-29.94
-38.84	-3.95	61.33
-45.19	-34.02	19.03
-26.49	22.53	-24.9
-36.79	-58.21	-32.63
39.28	-57.57	-33.12
35.2	-19.73	68.64
-64.3	-22.65	0.61

// Hanakawa T, 2002: rCBF: Numeric mental-operation > Visual fixation
// Hanakawa T, 2002: rCBF: Verbal rehearsal > Visual fixation
// Hanakawa T, 2002: rCBF: Spatial mental-operation > Visual fixation
// Hanakawa T, 2002: Numeric mental-operation > Visual fixation
// Hanakawa T, 2002: Spatial mental-operation > Visual fixation
// Hanakawa T, 2002: Complex finger-tapping > Visual fixation
// Hanakawa T, 2002: Complex finger-tapping > Simple finger-tapping
// Hanakawa T, 2002: Oculomotor control > Visual fixation
// Subjects=10
-32.67	7.78	64.68
-6.92	17.46	52.07
-58.86	14.53	46.53
-46.19	16.75	23.68
-34.77	-44.32	58.66
22.21	-56.42	-50.93
22.88	1.07	12.85
-67.55	5.37	40.86
-46.65	-78.61	-31.87
46.17	-61.47	-37.39
22.2	-60.88	-52.73
-32.66	3.52	65.1
23.56	8.39	68.14
-7.01	18.97	45.2
-32.64	-44.52	56.4
38.8	-49.82	64.68
-8.63	-64.46	71.41
-42.2	-66.71	-19.68
44.06	-45.76	-29.94
24.35	-56.62	-53.19
-28.53	8.67	51.07
-59.14	14.58	24.11
61.95	13.5	28.88
-6.82	11.71	59.37
1.64	14.74	45.47
-44.35	42.75	3.14
-47.8	-27.35	57.2
-31.19	-89.24	-8.67
40.13	-86.66	-7.9
9.71	-72.7	-17.73
-27.04	12.41	-.87
-28.5	8.88	53.29
29.74	12.72	45.2
-61.19	15.4	33.03
64	21.4	21.34
-32.55	-46.03	63.27
36.52	-35.35	58.8
-25.91	-49.22	74.68
21.61	-53.51	72.06
-39.94	-61.62	-11.26
50.66	-44.91	-21.18
-39.2	-10.1	57.59
-56.7	1.36	43.31
-28.53	8.67	51.07
38.56	5.28	56.99
-2.57	8.97	52.84
8.3	13.89	58.89
-.27	3.43	62.31
-41.51	-15.6	44.73
-47.76	-31.4	59.85
20.35	-52.02	-26.68
-27.02	1.57	-2.04
-24.08	7.39	60.09
38.53	5.07	54.77
-26.17	-42.37	56.08
-28.14	-47.52	70.07
-1.21	-49.55	-22.07
-41.59	5.67	42.63
49.21	8.53	45.28
-28.53	8.67	51.07
-19.76	-60.41	46.55
-9.46	-84.94	1.74
9.94	-74.23	0.35
3.62	-77.47	11.98
24.86	-71.38	-15.88

// Wrase J, 2002: Abstinent Alcohol-Dependent Patients
// Subjects=44
-30.58	-77.02	41.66
-40.65	-87.3	12.59
-37.88	-47.03	-16.1
37.4	-67.52	36.2
46.78	-78.8	6.9
39.84	-41.75	-21.3
-44.63	33.02	-20.54
-8.48	25.94	16.52
-18.24	61.73	20.99
49.36	33.35	-22.17
7.27	47.76	-15.04
55.54	10.71	33.75

// Alkadhi H, 2002: Tongue Movements > Rest, Both Sessions
// Alkadhi H, 2002: Tongue Movements > Rest, Baseline
// Alkadhi H, 2002: Tongue Movements > Rest, Follow Up
// Subjects=12
-52	-5	29
56	-6	28
-52	-5	29
56	-6	28
-51	-6	33
56	-7	31

// Alkadhi H, 2002: Tongue Movements > Rest
// Subjects=12
61.17	-2.42	26.66

// Dupont S, 2002: Healthy Controls (HC)
// Subjects=10
-15	-72	12
-18	-81	15
-27	-75	21
-33	-51	48
-33	-60	45
-30	-66	39
-57	-36	6
-54	24	6
-39	27	3
-6	-63	9
15	-66	12
18	-75	12
21	-84	15
42	27	9
9	-60	9
-18	-78	15
-18	-66	21
-42	-60	6
-51	-27	15
-45	-24	3
-36	-39	48
-30	-63	48
-66	-33	9
-63	-36	18
-57	-42	15
-57	-33	6
-45	-45	18
-54	24	6
-42	18	3
-42	27	3
-48	12	21
-45	21	18
-42	9	30
-30	-54	0
-12	-57	6
-12	-48	-6
-33	-39	-6
54	18	15
39	27	9
6	-60	3
15	-60	0
12	-42	3
27	-45	-3
21	-42	3
24	-54	3
-18	-78	18
-51	-36	27
-42	-36	36
-39	-36	45
-33	-51	48
-33	-60	48
-30	-33	48
-30	-45	42
-57	-33	9
-45	21	21
-39	24	12
-12	-57	3
-15	-42	0
42	-39	36
36	-39	45
51	24	6
39	27	9
15	-42	3
24	-39	3

// Dupont S, 2002: Right Medial Temporal Lobe Epilepsy (RMTLE)
// Subjects=7
-57	6	39
-54	-6	45
-45	6	36
33	-45	45
39	-45	54
12	15	42
-15	-75	18
-12	-66	15
-42	-39	39
-54	-6	45
-54	3	30
-51	12	39
-51	21	42
-42	9	39
-57	18	33
-51	27	27
-42	21	33
-36	9	33
-18	-57	-3
-12	-63	6
-6	-81	6
-6	0	63
-3	15	54
9	-72	9
15	-57	0
9	-57	9
9	-63	0
3	-75	3
24	-51	6
9	9	51
-15	-75	12
-9	-78	6
-6	-81	24
-6	-69	12
-63	6	24
-45	33	0
-57	-3	45
-51	24	36
-42	12	36
-9	-60	6
-9	-66	0
-9	12	57
-6	21	48
-3	3	63
15	-66	15
12	-75	12
3	-63	15
21	-60	-3
12	-66	0
9	-60	6
3	-75	3
3	18	51

// Dupont S, 2002: Left Medial Temporal Lobe Epilepsy (LMTLE)
// Subjects=7
-33	-48	48
-45	-33	39
-63	-36	3
-54	-42	3
-54	27	9
-36	24	9
-36	48	12
-57	0	33
-57	27	24
-51	30	30
-42	48	24
-42	54	18
-48	21	30
-36	42	21
-33	60	12
-6	9	63
-3	33	48
-9	21	42
36	-42	48
30	-51	57
33	-54	48
42	30	30
27	57	27
33	51	30
36	45	21
6	3	63
-12	-66	15
-36	-45	42
-45	-66	24
-63	-45	21
-42	-36	15
-57	15	15
-54	21	3
-39	21	9
-42	36	0
-45	51	12
-57	27	24
-51	30	30
-48	33	21
-48	45	18
-39	51	24
-48	18	30
-42	6	30
-51	9	36
-45	33	36
-30	-54	3
-21	-54	3
-18	-45	3
-9	18	45
-3	6	66
36	24	36
45	21	42
48	0	39
9	-60	6
24	-60	15
21	-45	3
27	-54	3
3	30	51
6	18	48
-51	18	36
-42	12	39
-12	-66	15
-9	-60	6
-3	6	69
-3	15	60
3	-60	6

// Tamm L, 2002: Fragile X Syndrome
// Subjects=14
-57.17	35.03	13.09
-2.31	0	71.65
42.32	31.75	18.45
-29.12	-22.05	-1.91
35.24	7.6	-32.83
26.67	12.44	-26.44
-29.17	-18	-4.55
-48.38	-40.43	9.2

// Tamm L, 2002: Healthy Controls
// Subjects=14
38.74	-63.42	57.06
-21.73	-72.14	58.95
-55.21	11.69	-7.04
-2.68	-7.17	40.99
-10.17	39.97	-28.54
26.67	12.44	-26.44
-29.17	-18	-4.55
-48.38	-40.43	9.2

// Hashimoto R, 2002: Short-Term Memory for Sentences (STM-S) > Short-Term 
// Memory for Words (STM-W)
// Hashimoto R, 2002: STM-W > STM-S
// Hashimoto R, 2002: (Syntactic Decision 1 (SYN-1) + Syntactic Decision 2 
// (SYN-2)) > STM-W
// Hashimoto R, 2002: STM-W > (SYN-1+SYN-2)
// Hashimoto R, 2002: (SYN-1+SYN-2) > STM-S
// Hashimoto R, 2002: STM-S > (SYN-1+SYN-2)
// Subjects=16
-27	15	48
-39	6	36
-63	-3	15
-51	-15	15
12	33	21
-27	15	57
-39	3	42
-54	27	21
-6	-84	3
15	-78	0
9	-66	9
-36	6	36
-39	24	18
-9	-87	0
18	-78	-12
30	-75	42

// Formisano E, 2002: Mental Imagery Task > Baseline
// Subjects=6
-56.45	-21.5	10.65
53.6	-24.35	5.17
-44.64	15.35	31.96
44.04	11.4	27.93
-25.05	-65.35	46.31
1.46	9.51	48.65
-41.14	-9.01	60.73
38.99	-2.1	60.34
9.25	-60.78	61.14
-43.21	-23.74	63.1
43.36	-24.19	63.26

// Sack A T, 2002: Healthy Participants
// Subjects=6
32.68	-69.15	47.08
16.74	-74.99	55.56
-14.25	-67.43	59.74
-6.76	-66.25	60.67
38.55	44.94	21.83
24.2	-67.46	55.96
18.86	-70.75	55.18
-12.12	-65.31	59.54
0.7	-70.77	56.5
39.64	40.81	23.28
2.5	-77.53	10.21
3.58	-79.64	10.38
21.58	-59.24	-2.69
29.37	-73.54	31.87

// Sack A T, 2002: Right hand Responders
// Subjects=3
54.66	-17.83	6.84
-54.3	-23.6	10.8
1.5	5.54	52.33
-46.64	-1.87	43.46
-48.93	22.9	33.61
-29.34	-80.95	37.63
-19.13	84.46	42.6
37.98	-70.69	40.46
28.49	-69.46	57.19
51.54	23.76	35.73
50.79	-31.18	54.84
1.73	-76.65	49.18

// Sack A T, 2002: Left Hand Responders
// Subjects=3
63.18	-7.03	8.06
-58.51	-32.8	16.08
51.58	4.38	32.89
-7.86	-70.91	55.5
-25.02	-65.1	49.63
-1.76	4.92	44.61
-44.25	-41.01	60.1
10.32	-77.32	53.6
-30.45	-4.54	62.46
37.99	-24.48	60
39.14	-51.08	59.99

// Muller J L, 2002: Untreated Schizophrenics
// Subjects=10
39	-17.33	56.04
26.79	-9	-.28
-19.18	-54.51	-20.46

// Muller J L, 2002: Schizophrenics Treated with Olanzapine
// Subjects=10
42.15	-27.86	43.51
-18.22	-46.81	-31.16

// Muller J L, 2002: Schizophrenics Treated with Haloperidol
// Subjects=10
42.23	-36.86	50.95

// Muller J L, 2002: Healthy Subjects
// Subjects=10
35.78	-36.18	46.51
25.74	-11.03	1.02
-23.43	-5.95	2.28
-20.3	-62.69	-29.8

// Haslinger B, 2002: Activation During Performance of Finger Movements 
// Regardless of Complexity
// Haslinger B, 2002: Regions Showing Positive Correlation of BOLD-Contrast 
// Increases With Sequence Complexity
// Subjects=8
-12	-15	8
-26	-6	4
-8	-5	48
14	1	53
50	-27	40
44	-31	35
14	-15	10
-59	10	11
-57	9	33
-42	-19	56
-38	-3	54
28	-50	-24
6	-66	-34
51	9	-11
55	14	9
-28	-57	-22
-32	-48	52
46	-42	44
-42	-31	44
-28	-54	56
22	-53	63
14	-60	49
-32	-80	30
-46	5	20
-28	0	44
14	-56	-24

// Maddock R J, 2003: Unpleasant vs. Neutral Words
// Maddock R J, 2003: Pleasant vs. Neutral Words
// Subjects=8
-6.62	26.96	-7.14
0.62	58.5	-26.07
16.42	-38.18	6.76
-2.28	-28.28	67.73
-5.91	-16.96	39.77
-5.93	-1.76	41.63
-5.97	-54.57	27.81
-58.47	34.53	-3.65
-21.35	63.82	32.04
-51.05	-.49	-22.72
-61.72	-25.74	-16.68
-39.78	29.33	20.08
-32.62	56.96	-6.3
50.02	-29.58	16.54
52.94	-8.99	-4.6
41.77	-19.39	-34.76
37.98	10.8	12.75
52.51	-1.27	-36.73
-16.92	-26.21	21.83
23.85	-20.49	0.4
0.9	-52.09	-26.34
-9.64	-5.3	3.95
-17.18	-46.78	-3.03
-9.85	-2.5	-12.02
11.97	5.73	5.85
63.59	-59.31	-26.69
-24.94	-62.5	-21.51
26.9	-6.62	-12.23
-10	25.91	-18.18
8.15	65.97	-26.94
-2.3	64.17	0.31
5.1	18.54	62.97
8.88	34.17	23.26
-1.91	-48.88	8.13
1.76	-34.7	44.76
-35.56	43.92	15.21
-58.55	33.91	-10.31
-36.03	9.78	-28.47
-50.26	24.03	44.32
-50.43	-37.38	19.02
-2.13	-81.15	-15.57
4.03	-37.6	-32.31
1.03	-32.55	-12.59
16.13	-66.61	-21.8

// Calvert G A, 2003: Moving Speech vs. Closed Mouth
// Calvert G A, 2003: Stilled Speech vs. Closed Mouth
// Calvert G A, 2003: Moving > Stilled Speech
// Calvert G A, 2003: Stilled > Moving Speech
// Subjects=8
-44	-66	-10
48	-64	-10
-24	-96	-2
28	-88	0
-28	-74	18
30	-74	18
-44	-68	-6
46	-62	-4
-54	-14	10
-50	-38	12
58	-34	12
-48	-46	4
54	-50	4
-56	-44	2
52	-54	2
-32	-52	40
34	-48	40
-32	-58	46
28	-56	50
-48	26	6
44	12	22
-40	10	26
44	14	24
-2	22	48
4	6	56
-44	-4	42
46	2	44
-38	-70	-28
8	-80	-32
-12	-14	2
-16	-18	2
-44	-54	-14
46	-58	-12
-26	-94	0
24	-90	-2
-30	-82	6
26	-88	12
-48	-64	-8
54	-52	-4
-50	-42	4
-54	-46	-2
54	-52	-4
-32	-58	46
42	-46	46
-32	-58	54
40	-48	52
-46	28	6
38	26	-2
-42	10	28
44	12	20
4	24	46
2	22	46
-52	-8	42
46	0	44
-40	-70	-26
34	-54	-28
-30	-92	-4
24	-90	-4
-42	-68	-4
44	-62	-4
-48	-34	20
54	-36	16
-48	-50	4
58	-30	6
-54	-52	0
54	-48	0
-50	-38	26
-32	-48	56
-34	24	-6
40	28	-10
-40	10	26
-2	-2	58
-36	-2	52
-14	-80	-32
10	-80	-26
-12	-14	2
10	-14	2
-12	-66	2
8	-70	2
-40	-84	26
-44	-50	22
-48	-54	26
-10	52	-12
12	54	-8

// Moradi F, 2003: Normal Subject 1
// Subjects=1
12.13	-82.85	9.43
2.5	-85.19	7.51
2.52	-86.08	9.81

// Moradi F, 2003: Normal Subject 2
// Subjects=1
-8.17	-92.83	6.04
-7.11	-93.96	5.01
-9.25	-92.92	4.95

// Moradi F, 2003: Normal Subject 3
// Subjects=1
4.64	-85.18	7.48
6.78	-88.42	6.62
2.48	-88.79	2.23

// Moradi F, 2003: Normal Subject 4
// Subjects=1
-7.13	-86.56	4.39
-9.27	-85.43	5.43

// Siok W T, 2003: Homophone Decision vs. Font Size Judgment
// Siok W T, 2003: Initial Consonant Judgment vs. Font Size Judgment
// Subjects=11
-51	15	34
-32	7	59
-2	22	54
-4	31	30
-50	30	8
-48	11	18
-50	15	27
-46	12	42
-2	22	43
-2	39	33

// Tan L H, 2003: Chinese-English Bilinguals
// Subjects=12
-45.81	25.32	23.33
-28.2	-71.46	50.2
-46.35	-52.65	61.1
-.65	9.75	52
-45.76	22.58	29.14
-31.42	-68.31	49.98
-44.41	-40.43	39.98
0.42	9.85	53.09
-45.78	24.52	26.74
-29.27	-68.21	51.06

// Tan L H, 2003: Native English Speakers
// Subjects=12
-51.16	14.2	17.63
-36.3	23.12	7.79
-59.49	-41.81	23.54
-51.24	43.09	19.67
-45.78	24.52	26.74
-29.27	-68.21	51.06

// Kitada R, 2003: One-same vs. Baseline
// Kitada R, 2003: One-same vs. Two-opposite
// Subjects=5
-40	-18	58
-44	-24	22
-42	-50	34
-54	-58	28
20	-54	-20
-40	-48	32
-54	-58	24

// Li G, 2003: LED Stimulation > Rest
// Li G, 2003: Conventional Acupuncture > Rest, Activations
// Li G, 2003: Conventional Acupuncture > Rest, Deactivations
// Li G, 2003: Electro-Acupuncture 2 Hz > Rest
// Li G, 2003: Electro-Acupuncture 20 Hz > Rest
// Subjects=20
8	-78	6
-2	-80	0
-4	-85	16
4	-80	16
18	-64	10
50	20	10
3	-82	16
-2	-75	14
52	-18	12
-52	-15	12
-50	40	16
50	40	12
4	-80	18
-5	-70	16
-60	-65	16
55	20	16
-10	-80	10
-4	-90	10
-10	-92	16
4	-90	10

// Abel K M, 2003: Neutral Faces vs. Fixation, Placebo
// Abel K M, 2003: Neutral Faces vs. Fixation, Ketamine
// Abel K M, 2003: Placebo vs. Ketamine
// Subjects=8
35.49	-72.19	-6.23
13.14	-85.64	0.73
46.97	0.84	-12.48
-44.97	10.87	-12.27
5.82	-77.46	24.67
43.86	-48.76	-20.56
35.78	-62.59	35.34
47.28	-46.43	9.32
-41.85	-5.37	-29.9
-48.84	4.04	37.42
35.09	10.41	-25.42
-37.61	17.37	-25.17
47.27	8.33	29.26
-37.19	7.39	24.73
12.57	41.36	-22.18
-21.15	28.52	35.05
47.48	-34.51	39.54
-41.11	-36.21	52.97
47.03	9.19	-.92
-37.37	15.46	5.1
-3.08	-19.66	2.08
39.61	-71.5	-25.29
-37.23	-71.02	-12.18
19.74	-59.51	35.27
-5.88	-67.07	36.2
35.28	-41.41	-21.07
35.27	-12.97	-11.19
44.17	-45.5	21.54
9.06	-48.49	41.16
8.71	-30.17	2.82
43.96	-25.73	2.05
23.56	-38.93	-15.57
-38.2	-81	-3.53
-43.42	-3.88	44.71

// Abel K M, 2003: Fearful > Neutral Expression, Placebo
// Abel K M, 2003: Neutral > Fearful, Placebo
// Abel K M, 2003: Fearful > Neutral, Ketamine
// Abel K M, 2003: Neutral > Fearful Expression, With Ketamine
// Subjects=8
12.92	-38.49	-8.8
-44.45	-56.27	27.93
-44.81	-55.63	-18.96
-41.5	-58.9	-6.46
47.34	-35.97	20.71
23.97	-59.91	29.68
1.39	-36.24	21.26
-15.03	-7.44	-17.77
44.18	-23.41	31.96
-33.33	-23.18	-40.77
-28.34	-62.97	36.11
9.07	-76.92	31.27
-52.05	-46.51	17.16
-25.17	-63.38	30.53
-48.74	-37.72	34.23
1.29	-70.28	-6
-14.65	-57.37	10.95
-10.5	-25.62	8.24
-14.65	-57.37	10.95
8.72	2.93	17.89

// Fan J, 2003: Flanker Incongruent - Congruent
// Fan J, 2003: Stroop Incongruent - Congruent
// Fan J, 2003: Spatial Incongruent - Congruent
// Fan J, 2003: Conjunction Analysis Incongruent - Congruent
// Subjects=12
22	-38	68
-34	54	10
26	-64	6
-32	-16	54
62	-28	28
-8	28	24
-16	-58	0
-60	-16	30
-2	16	52
54	-54	-6
-36	-34	10
-40	-70	2
20	56	12
12	-46	54
-50	36	-8
-50	-40	48
-4	-58	50
-26	56	-2
64	-32	36
42	-22	2
50	-46	32
-38	28	14
-42	-24	0
-14	-80	34
40	20	44
4	-84	-6
42	-4	-18
-4	38	30
-38	-52	28
40	-16	-24
-16	32	-4
56	0	2
-42	2	-8
-50	-18	14
-12	64	12
62	-16	-12
-2	-72	40
-36	30	28
-6	46	12
50	6	0
66	-22	30
-60	-40	24
14	60	20
-4	-78	24
42	-18	-18
-30	54	-4
56	-50	-12
40	24	20
-30	34	32
-6	38	18
-36	-12	-24
50	14	32
30	38	30

// Gaillard W D, 2003: Children
// Subjects=16
-2	14	52
-44	10	34
-56	14	-6
-12	56	-8
34	22	-4
-18	-102	-2
-12	2	6
18	-98	0
-2	-24	16
10	0	6
-52	-74	52
-4	34	56
-54	36	0

// Gaillard W D, 2003: Adults
// Subjects=29
-6	-86	2
-52	10	34
-28	12	60
-48	22	-6
-2	18	52
-30	-70	40
-30	-42	-22
-26	-76	54
54	36	20
46	16	30
42	28	-18
-6	54	-14
30	20	56
-34	48	-12

// Gandour J, 2003: Chinese Speaking
// Subjects=10
-44.69	19.24	27.17
50.43	19.98	28.25
1.41	22.2	47.58
-35.81	-39.87	46.53
40.13	-49.65	50.93
-54.29	-46.49	3.8
52.49	-24.7	0.75
-.66	-84.78	13.09
-44.72	24.44	25.62
49.35	19.8	26.05
0.34	22.19	47.6
-34.72	-41.89	47.8
40.12	-50.87	48.81
-57.47	-48.45	6.23
52.5	-25.76	0.84
-29.49	5.35	52.7
-26.69	52.76	18.58
36.31	59.31	15.08
11.2	9.79	65.24
-60.51	-24.84	36.63
-47.79	-69.72	5.67
50.24	38.87	11.05

// Gandour J, 2003: English Speaking
// Subjects=10
-38.2	8.07	33.61
54.68	19.75	24.87
5.67	23.2	46.34
-29.38	-50.66	44.01
40.17	-56.96	52.66
-49.93	-47.81	13.9
51.49	-33.88	5.99
1.46	-84.94	10.85
-37.14	10.11	32.31
54.69	22.03	26.91
2.5	19.12	48.95
-28.32	-51.8	42.98
38.02	-53.8	52.42
51.52	-35.83	8.38
7.91	-80.16	17.06
56.87	24.68	33.36
-43.83	15.96	-1.56
45.94	22.13	1.36
10.9	38.49	37.19
59.15	-60.56	18.17
-43.47	-72.52	10.32
28.02	-58.94	0.55
-20.93	-92.22	15.06
38.8	-85.32	2.64
-9.26	-64.48	14.83

// Milham M P, 2003: Within-Region Analysis:  Interference vs. Control
// Milham M P, 2003: Region-Based Analysis:  Interference vs. Control
// Subjects=11
-32.94	-74.08	-10.86
52.47	-56.82	-15.52
31.11	-52.38	-11.18
41.93	-72.95	-2.89
-35.07	-65.29	-7.11
35.57	-81.28	0.11
-26.33	-80.79	11.93
-34.92	-83.47	5.56
-41.27	-82.82	14.5
-24.07	-90.5	23.87
10.05	-88.86	14.42
16.28	-77.5	-4.45
56.76	-25.82	-.32
63.23	-58.19	-6.61
-47.9	-56.57	-3.23
67.51	-51.48	-2.76
-45.69	-55.87	5.6
44.26	-73.17	21.63
52.46	-41.51	-10.11
-.59	8.24	59.93
7.59	35.16	21.89
3.39	35.99	33.02
1.38	26.26	45.01
1.47	16.2	52.55
-43.67	35.19	26.94
-41.41	32.17	42.78
-30.84	24.35	23.24
41.78	52.96	28.93
31.11	-52.38	-11.18
-22.32	-50.58	-10.72
-34.93	-76.95	7.25
46.19	-68.69	-3.3
16.3	-77.33	-2.23
10.05	-88.86	14.42
56.79	-27.76	2.07
42.12	-73.18	21.66
7.59	33.04	22.07
3.39	35.99	33.02
18.66	10.64	61.74
-.68	18.3	52.4
46.23	21.78	38.18
-41.46	20.57	30.37
-54.39	30.38	20.77
-49.97	31.95	40.67
-37.09	30.43	47.34

// Paller K A, 2003: fMRI Group
// Subjects=10
-33	13	4
-14	-18	-11
-50	-36	1
-46	-67	-29
16	-80	-26
39	28	26
32	23	-1
1	-25	-13
17	-66	35
36	-59	46
-10	-83	8
1	-83	8
-24	-92	-1
-9	53	21
-22	-13	70
1	-2	45
-61	-33	38
58	-40	36
11	-56	58
38	-42	-19

// Thierry G, 2003: Release Gender
// Thierry G, 2003: Hold Gender
// Thierry G, 2003: Release Semantic
// Thierry G, 2003: Hold Semantic
// Subjects=10
-42	-32	14
-48	-44	21
-50	-12	7
-10	-22	7
-12	-32	0
-12	-8	14
0	-78	7
-33	22	7
38	-36	14
48	-26	14
48	8	0
8	-20	7
12	-30	0
8	-68	7
41	15	7
-40	-32	14
-50	-44	21
-50	-12	7
-8	-22	7
-12	-30	0
-12	-8	14
-10	-82	21
-39	14	7
38	-36	14
48	-28	14
48	-40	21
8	-20	7
10	-30	0
4	-80	0
40	15	7
-42	-32	14
-48	-42	21
-48	-12	7
-40	12	7
-10	-22	7
-12	-10	14
-10	-32	0
-16	-72	0
-6	-82	21
-42	11	7
40	-36	14
50	-12	7
44	-38	21
8	-22	7
12	-28	0
18	-62	0
6	-80	0
39	18	7
-48	-22	14
-40	-34	14
-48	-44	21
-50	-12	7
-50	0	0
-38	14	7
-30	18	7
-10	-22	7
-8	-30	0
-12	-8	14
-6	-62	0
-39	16	7
-48	-22	14
42	-36	14
48	8	0
46	-20	7
10	-20	7
12	-10	14
16	-62	0
2	-76	7
43	10	7

// Ueda K, 2003: Expected vs. Unexpected, Pleasant
// Ueda K, 2003: Expected vs. Unexpected, Neutral
// Ueda K, 2003: Expected vs. Unexpected, Unpleasant
// Subjects=15
-43.88	13.44	34.05
19.22	-90.7	-38.52
-9.15	27.88	48.84
-27.22	-57.47	55.35
-47.34	29.3	20.21
-50.64	18.99	13.45
32.14	23.93	-18.71
32.22	-7.23	-18.99
42.48	-66.59	11.36
-39.62	-77.83	10.51
-7.7	45.55	-3.36
4.22	58.98	1.83
14.45	-85.94	12.64
-13.34	88.62	-13.13

// Yoo S S, 2003: Imagery > Rest
// Yoo S S, 2003: Stimulation > Rest
// Yoo S S, 2003: Imagery > Stimulation
// Yoo S S, 2003: Stimulation > Imagery
// Subjects=13
-57	-27	38
-55	-28	20
-34	-51	58
-34	-54	47
-50	-3	48
-8	3	55
-36	26	6
-48	34	12
-50	20	0
-17	-17	3
-30	-2	7
53	-24	34
-57	-24	34
51	-34	16
-50	-31	11
-30	-46	61
-50	5	32
-36	-12	6
-16	-21	3
-61	-47	28
-50	-3	47
-8	3	55
-46	22	19
-50	19	-3
-21	3	5
53	-24	29
-55	-24	34
50	-32	18
-48	-30	13
38	-11	4
-40	-11	4

// Devlin J T, 2003: Semantic + Phonological - Rest
// Devlin J T, 2003: Semantic > Phonological
// Devlin J T, 2003: Phonological > Semantic
// Subjects=12
-44	8	28
-50	16	22
-46	30	16
-42	24	0
-42	24	2
-36	26	-6
-42	48	-14
-46	20	-6
-6	-2	62
-28	-72	50
-52	-48	-2
-44	-54	-20
-34	-42	-36
-36	-44	-28
-34	-6	-40
24	-98	-4
18	-92	-10
34	-90	-14
-24	-94	-6
-36	-92	-10
-16	-92	-12
26	-50	-38
34	-46	-40
42	-46	-38
12	-78	-44
10	-62	-14
-10	52	-8
-14	44	-8
-20	30	48
-42	-66	28
-4	-56	28
-50	6	24
-42	0	28
-38	-2	44
44	36	26
46	42	14
42	2	28
46	28	-16
36	24	-8
-30	20	-8
-42	34	12
-38	34	20
-42	36	30
6	36	42
4	16	54
4	28	46
24	52	-8
46	-44	44
44	-56	52
52	-60	48
-42	-40	46
-56	-44	46
-52	-48	54
28	-68	44
34	-64	36
-20	-68	46
-24	-72	36
-10	-70	50
-48	-66	-20
-50	-54	-20
-50	-66	-10
52	-56	-16
52	-56	-26
42	-58	-10
-30	-60	-44

// Knecht S, 2003: Left Hemisphere Language Dominance
// Subjects=7
-50	6	26
-48	32	26
-58	4	30
-48	12	2
-50	14	-12
-2	10	44
38	16	-8
36	20	0
50	14	-10
-26	-64	34
-44	-40	34
-40	-44	42
-18	8	0
36	-78	-36
-6	-18	-16

// Knecht S, 2003: Right Hemisphere Language Dominance
// Subjects=7
52	10	16
50	4	38
56	10	8
36	16	-4
50	14	-12
4	6	46
-40	18	-8
-46	16	-8
42	-66	48
22	2	-4
-24	-66	-32

// Li G, 2003: Language - Rest
// Li G, 2003: Stimulation of SJ 8
// Li G, 2003: Stimulation of Du 15
// Subjects=18
55	18	16
-55	15	16
-64	-40	16
48	12	16
40	32	16
-62	-44	16
63	-30	16

// Wood J N, 2003: Social SEC vs. Control
// Wood J N, 2003: Nonsocial SEC vs. Control
// Wood J N, 2003: Social Semantic vs. Control
// Wood J N, 2003: Nonsocial Semantic vs. Control
// Subjects=20
-11.51	49.38	37.79
-7.37	55.7	24.77
-15.68	38.5	47.9
0.84	12.01	-18.12
-6.56	-17.04	73.41
18.9	38.62	47.3
-11.37	42.77	47.4
-2.94	53.25	32.78
-51.04	29.16	-15.57
-29.56	35.95	-24.45
1.81	-15.79	51.85
6.33	-13.15	68.32
-58.38	23.14	0.84
-51	29.47	-12.24

// Gruber O, 2003: Verbal Working Memory, Absence of Articulatory Suppression, 
// Verbal Rehearsal
// Gruber O, 2003: Verbal Working Memory, Absence of Articulatory Suppression, 
// Effects of Articulatory Suppression
// Gruber O, 2003: Verbal Working Memory, Absence of Articulatory Suppression, 
// Silent Articulations
// Gruber O, 2003: Verbal Working Memory, Absence of Articulatory Suppression, 
// Phonological Storage
// Gruber O, 2003: Verbal Working Memory, Under Articulatory Suppression, 
// Effects of Articulatory Suppression
// Gruber O, 2003: Verbal Working Memory, Independent of or Enhanced by 
// Articulatory Suppression, Verbal Rehearsal
// Gruber O, 2003: Verbal Working Memory, Independent of or Enhanced by 
// Articulatory Suppression, Phonological Storage
// Gruber O, 2003: Verbal Working Memory, Independent of or Enhanced by 
// Articulatory Suppression, Art. Suppression
// Gruber O, 2003: Verbal Working Memory, Independent of or Enhanced by 
// Articulatory Suppression, Silent Articulations
// Gruber O, 2003: Visuospatial Working Memory, Visuospatial Rehearsal
// Gruber O, 2003: Visuospatial Working Memory, Visual Pattern Storage
// Gruber O, 2003: Visuospatial Working Memory, Effects of Visuospatial 
// Suppression on Memory-Related Activations
// Gruber O, 2003: Visuospatial Working Memory, Eye Tracking
// Gruber O, 2003: Visuospatial Working Memory, Absence of Visuospatial 
// Suppression, Visuospatial Rehearsal
// Gruber O, 2003: Visuospatial Working Memory, Absence of Visuospatial 
// Suppression, Effects of Visuospatial Suppr.
// Gruber O, 2003: Visuospatial Working Memory, Absence of Visuospatial 
// Suppression, Eye Tracking
// Gruber O, 2003: Visuospatial Working Memory, Independent of Visuospatial 
// Suppression, Visuospatial Rehearsal
// Gruber O, 2003: Visuospatial Working Memory, Independent of Visuospatial 
// Suppression, Visual Pattern Storage
// Subjects=13
-42.44	10.51	37.92
-48.8	-.99	41.18
-42.46	16.94	38.49
-26.73	56.81	16.01
43.74	51.09	4.53
-51.94	-39.94	33.33
57.13	-47.31	38.28
-4.24	39.86	14.94
15.25	7.42	34.17
56.65	16.9	1.67
40.81	13.32	25.57
8.4	69.83	2.25
-23.49	54.98	19.47
27.75	60.23	13.98
-51.89	-53.68	34.49
53.84	-36.13	31.8
-13.79	31.68	20.2
2.29	41.1	30.38
56.62	18.76	-1.83
5.19	69.81	2.29
-58.66	16.18	16.44
-55.53	16.49	6.34
-42.52	14.14	29.81
-42.22	-32.16	50.41
34.74	-42.53	47.05
-33	-61.57	-14.14
34.3	-58.08	-16.32
-10.71	18.36	-1.02
8.53	26.22	2.56
40.65	47.87	18.22
-.74	18.76	44.55
-30.03	33.76	-6.55
34.11	34.4	-4
-42.71	36.28	13.45
-58.66	16.18	16.44
-42.51	10.96	30.07
-39.09	-35.2	38.37
41.07	-37.81	38.78
-39.49	-61.32	-24.12
40.68	-56.18	-19.9
-13.95	16.85	-6.44
11.75	23.07	2.78
43.83	50.98	16.8
2.48	20	46.64
-23.53	22.68	0.99
37.39	26.39	2.21
-42.72	31.8	10.48
-33.19	20	-5.36
43.69	29.72	-10.41
-42.73	30.57	8.36
-.65	15.3	54.88
-26.38	4.34	39.36
28.12	8.01	40.66
-32.58	-38.54	49.72
31.62	-46.01	57.42
-16.46	-64.96	50.64
22.02	-52.5	56.96
-26.2	-70.62	33.38
37.93	-72.35	32.79
-45.67	9.17	34.72
50.4	13.12	22.13
53.66	-56.68	0.07
-19.92	13.7	49.66
21.76	18.35	51.02
-35.78	-37.33	51.89
34.77	-39.99	52.42
-13.3	-43.36	54.37
15.62	-60.11	55.44
-26.22	-70.88	30.06
37.95	-72.09	36.11
-48.9	12.24	33.38
47.2	13.1	22.17
53.64	-53.59	-1.3
-23.15	-.84	40.88
28.14	4.93	42.03
-32.6	-35.45	48.35
34.72	-35.05	47.54
-19.64	-60.32	55.86
22.02	-52.5	56.96
-29.41	-73.98	31.47
34.71	-73.6	30.7
-42.46	12.53	36.63
53.6	11.91	19.97
50.45	-56.69	0.11
-23.09	11.82	53.2
24.91	7.99	40.7
-32.62	-32.28	48.08
34.69	-33.19	44.04
-22.9	-43.25	56.7
25.23	-48.08	58.78
-22.98	-72.71	33.52
34.69	-67.17	31.28
-48.87	12.5	36.71
56.87	11.56	28.88
40.91	-68.04	5.63
-48.9	-66.89	0.99
-23.37	-64.59	-12.88
34.5	-70.28	4.78
-.92	-75.38	-16.69
-39.28	-71.24	-.99
-29.74	-66.49	-9.3
34.42	-71.05	-5.2
-.98	-73.78	-23.52
-52.11	-66.91	1.03
-33.04	-55.31	-15.78
31.17	-66.13	-10.03
8.65	-70.37	-21.68
47	45.11	9.45
5.62	28.14	41.46
-29.98	28.82	-1.68
30.92	31.3	-2.59
57.13	-39.57	42.09
43.81	46.32	11.62
-.9	39.05	31.7
-26.8	26.38	-5.97
34.11	26.74	-6.7
53.93	-39.59	42.13

// Neumann K, 2003: Stuttering Patients Group 1 (PWS)
// Subjects=5
14	20	56
-30	0	40
42	8	54
-44	10	46
34	16	-18
48	14	4
42	-6	16
50	6	4
14	14	46
-10	26	26
66	-30	20
36	-42	48
-32	-46	54
50	2	6
40	4	56
-28	2	56
-12	4	60
62	12	18
52	18	-2
-42	-10	12
14	4	48
-60	-20	14
-46	2	-10
-48	-32	36
-62	-28	18
42	-38	48
-60	-32	38
24	6	0
-26	10	-2
12	12	52
36	10	52
-44	10	44
14	22	50
-34	-2	36
50	6	8
62	12	18
42	-2	16
-40	-6	12
-8	30	30
48	2	-4
52	-68	6
40	-48	60
-34	-48	58
-56	-26	16
32	-48	50
-24	-52	62
-46	-72	-10
-48	-4	32
10	-78	2
-6	-74	2
-52	-2	42
-6	-74	2
8	-78	2
-52	-2	42
-6	-76	4
8	-78	2
10	0	54
42	0	56
-8	2	50
60	4	2
54	14	-12
58	-20	8
66	-34	18
-60	2	0
-56	-32	12
48	-30	12
60	-10	20
26	8	-2
-26	10	-2
36	8	56
-46	-2	24
56	4	22
46	30	10
54	-2	-4
-56	-2	0
-58	-30	8
52	-68	6
54	10	-22
-64	-28	18
6	-22	-10
-6	-20	-10
36	10	56
46	14	48
-46	12	44
-52	18	32
50	0	20
4	14	44
-54	-12	-8
-58	-60	12
-48	-72	-6
34	-50	62
-44	10	46
-60	-58	10
32	-54	60
2	-74	8
0	-80	2
4	12	34
6	-78	-22
-44	-60	-26
58	-2	36
-38	24	-12
0	-76	10
10	0	56
0	-8	64
58	-10	30
54	-2	42
-52	-10	40
-44	-12	10
-38	10	-10
-8	4	48
14	6	38
56	0	4
-48	4	0
52	14	-10
66	-34	18
-54	-16	10
52	-28	10
-26	10	-2
-52	34	-14
-40	18	18
-6	20	44
-52	34	-14
-40	18	18
-6	20	44
-52	36	4
-52	34	-14
-40	18	18
-6	20	44
-52	34	-14
-36	18	18
-46	12	44
-52	14	36
-48	22	6
-48	-64	-20
-44	4	48
-28	-76	-28
-48	14	40
-46	30	2
-46	-68	-18
-46	4	46
-52	34	6
-28	-74	-28
-4	6	60
60	-6	30
50	0	30
-52	-2	28
10	6	58
-2	6	60
-58	12	20
34	16	-16
-42	14	16
-44	-30	0
8	4	46
10	18	44
50	-22	2
-62	-42	10
48	16	-18
-54	14	-8
-38	-30	6
64	-30	8
-60	-12	6
-62	-46	10
48	-8	16
12	-80	8
-2	-82	8
8	-18	-8
-10	-18	-10
14	-72	-26
-42	10	48
-54	22	22
-50	38	4
-48	38	8
-54	20	-8
-38	22	14
12	-84	4
14	-82	-12
-12	-90	-18
-40	-72	-24
-34	-82	-26

// Neumann K, 2003: Stuttering Patients Group 2 (PWS)
// Subjects=11
-4	6	60
60	-6	30
50	0	30
-52	-2	28
10	6	58
-2	6	60
-58	12	20
34	16	-16
-42	14	16
-44	-30	0
8	4	46
10	18	44
50	-22	2
-62	-42	10
48	16	-18
-54	14	-8
-38	-30	6
64	-30	8
-60	-12	6
-62	-46	10
48	-8	16
12	-80	8
-2	-82	8
8	-18	-8
-10	-18	-10
14	-72	-26
-42	10	48
-54	22	22
-50	38	4
-48	38	8
-54	20	-8
-38	22	14
12	-84	4
14	-82	-12
-12	-90	-18
-40	-72	-24
-34	-82	-26

// Neumann K, 2003: Controls (PWNS)
// Subjects=16
14	20	56
-30	0	40
42	8	54
-44	10	46
34	16	-18
48	14	4
42	-6	16
50	6	4
14	14	46
-10	26	26
66	-30	20
36	-42	48
-32	-46	54
50	2	6
40	4	56
-28	2	56
-12	4	60
62	12	18
52	18	-2
-42	-10	12
14	4	48
-60	-20	14
-46	2	-10
-48	-32	36
-62	-28	18
42	-38	48
-60	-32	38
24	6	0
-26	10	-2
12	12	52
36	10	52
-44	10	44
14	22	50
-34	-2	36
50	6	8
62	12	18
42	-2	16
-40	-6	12
-8	30	30
48	2	-4
52	-68	6
40	-48	60
-34	-48	58
-56	-26	16
32	-48	50
-24	-52	62
-46	-72	-10
-48	-4	32
10	-78	2
-6	-74	2
-52	-2	42
-6	-74	2
8	-78	2
-52	-2	42
-6	-76	4
8	-78	2
-52	34	-14
-40	18	18
-6	20	44
-52	34	-14
-40	18	18
-6	20	44
-52	36	4
-52	34	-14
-40	18	18
-6	20	44
-52	34	-14
-36	18	18
-46	12	44
-52	14	36
-48	22	6
-48	-64	-20

// Preibisch C, 2003: PDS > Controls, Random effects
// Preibisch C, 2003: PDS > Controls, Fixed effects masked inclusive by 
// conjunction of PDS
// Preibisch C, 2003: PDS > Controls, Fixed effects further masked exclusive 
// by conjunction of controls
// Preibisch C, 2003: PDS > Controls, Fixed effects further masked inclusive 
// by fixed effects difference Semantic Decision
// Preibisch C, 2003: Controls > PDS, Random effects
// Preibisch C, 2003: Controls > PDS, Fixed effects masked inclusive by 
// conjunction of controls
// Preibisch C, 2003: Controls > PDS, Fixed effects further masked inclusive 
// by fixed effects difference Semantic Decision
// Subjects=16
60	2	30
28	-12	64
18	24	52
28	8	42
36	12	48
36	54	14
36	18	-16
44	-8	16
-4	-6	30
54	4	2
36	-42	54
24	-42	58
-30	-42	60
58	-2	32
34	20	-16
54	10	-12
-42	18	-16
-54	-40	14
60	2	-10
54	-6	-12
32	22	-22
36	18	-16
0	-60	4
-10	-48	-6
-46	-2	32
-46	-2	32

// Remy F, 2003: Main effect of semantic task
// Remy F, 2003: Main effect of pain task
// Remy F, 2003: Positive modulation effect of pain on semantic
// Remy F, 2003: Negative modulation effect of pain on semantic
// Subjects=12
-18	-82	14
-2	-72	8
-6	-92	16
-2	22	52
4	22	40
-12	20	40
-46	22	18
-50	38	20
-48	18	4
10	30	24
-34	16	0
-38	20	-12
-32	32	-2
-30	4	42
-40	16	40
-60	12	26
-14	-74	26
-6	-72	22
-24	-78	30
-6	8	30
-50	-6	20
-52	-30	42
-54	-34	30
-14	-76	46
-14	-84	40
4	-68	30
2	60	22
8	62	2
12	4	34
4	-28	-6
-40	22	6
-32	44	-6
-32	24	8
-4	46	6

// Stippich C, 2003: Sentence Generation - Baseline
// Stippich C, 2003: Word Generation - Baseline
// Subjects=14
-49.14	16.27	2.94
47.04	21.33	4.75
61.19	-39.66	13.05
56.8	-26.53	4.2
-50.19	14.32	5.34
48.12	19.23	4.92
-57.45	-38.34	13.19
58.98	-29.44	7.76

// Veltman D J, 2003: Sternberg
// Veltman D J, 2003: n-Back
// Veltman D J, 2003: Sternberg and n-Back
// Veltman D J, 2003: n-Back > Sternberg
// Veltman D J, 2003: Sternberg > n-Back
// Veltman D J, 2003: Encoding
// Veltman D J, 2003: Responding
// Veltman D J, 2003: Encoding and Responding
// Veltman D J, 2003: Responding > Encoding
// Subjects=22
-51	12	36
-48	24	27
-51	12	3
54	12	36
45	33	33
-45	-42	54
6	18	60
21	-57	-42
-36	48	21
-48	24	30
-45	36	27
-51	12	9
54	15	36
45	36	36
54	12	18
-45	-39	51
-45	-54	-15
9	12	63
39	-57	-42
-42	39	30
-42	12	33
-51	12	36
-45	36	27
-51	12	3
30	48	15
33	51	30
42	42	30
45	33	33
48	18	33
-45	-42	54
36	-48	51
-42	-51	-12
6	18	60
21	-57	-42
36	-54	-42
-24	-54	-39
-51	9	36
36	42	42
54	9	18
-45	-39	51
36	-45	51
21	6	63
39	-57	-42
-18	-63	30
15	-63	30
-48	6	27
-51	15	0
36	-45	57
27	0	57
-45	3	36
-45	12	33
-51	15	0
45	33	33
48	18	36
-51	-36	42
42	-51	54
-42	-51	-12
24	15	60
-6	9	63
18	-63	-39
-48	6	27
-39	27	33
-51	15	0
42	42	30
54	12	39
-45	-45	57
-42	-36	39
42	-39	45
-9	9	63
24	-63	-36
-48	24	42
48	21	33
-60	-36	39
-6	-6	60

// Adcock J E, 2003: Normal Subjects
// Subjects=12
-56	10	24
-2	12	46
-42	28	16
-46	18	-6
-34	0	42
-32	22	4
-54	30	8
-12	14	42
-55	10	4
-22	-60	46
-10	-14	10
-48	10	6
-38	58	16
-10	-56	-28
26	-62	-34
12	14	42
-22	40	32
-38	24	44
-44	18	8
-50	26	6
-52	12	-1
-50	16	-10
-2	-58	20
-2	-66	30
-8	-38	38
-16	-68	20
-12	-24	48
44	-12	-20
2	-40	42
10	-48	42
50	-26	-24
56	-4	-12
4	-24	46
64	-56	-2
6	-10	42

// Adcock J E, 2003: Right TLE Patients
// Subjects=7
-22	40	32
-38	24	44

// Adcock J E, 2003: Left TLE Patients
// Subjects=12
-44	18	8
-50	26	6
-52	12	-1
-50	16	-10
-2	-58	20
-2	-66	30
-8	-38	38
-16	-68	20
-12	-24	48
44	-12	-20
2	-40	42
10	-48	42
50	-26	-24
56	-4	-12
4	-24	46
64	-56	-2
6	-10	42

// Desmond J E, 2003: Normal Subjects
// Subjects=13
-53.01	9.78	-4.65
28.96	-62.08	-31.43
-58.51	21.04	-10.15
-37.81	-73.83	-15.69
-43.87	9.19	34.47
-37.66	29.03	16.72
-36.17	8.74	-39.57
-29.65	-55.54	-50.13
-31.63	-21.36	-28.83
-2.9	29.44	30.65
46.39	-67.46	-21.11
11.89	-76.95	-17.34
50.53	-63.38	-35.03
1.9	15.55	65.56
31.01	-23.47	-31.93
39.46	-51.15	-52.86
39.62	-68.6	-44.42
53.37	-1.42	30.5
-41.44	-74.18	38.2
-35.33	-92.27	5.15
-30.43	-65.99	56.25
-24.54	-90.1	4.75
-34.89	-82.35	42.26
-20.09	-100.1	12.38
-50.89	11.7	-7.12
-59.11	14.79	26.33
-60.32	-48.54	3.49
-51.08	6.95	-23.45
-50.9	-77.04	-26.35
-44.68	-8.95	-33.19
-37.88	30.66	-.25
-11.38	27.36	43.33
-13.43	-73.54	32.05
-6.87	-78.42	36.91
10.23	34.02	44.54
8.28	26.86	59.85
28.5	58.1	-43.32
30.01	-70.66	48.96
42.48	-76.48	8.98
32.21	-55.03	55.22
31.18	-23.29	-18.5
37.94	40.03	15.46
36.35	14.74	54.97
44.54	9.21	18.4
57.91	5.34	-35.24
54.67	14.05	-33.8
52.94	15.13	0.86
-35.97	51.76	-15.82
9.37	62.66	-16.55
2.82	75.19	-19.92

// Desmond J E, 2003: Alcoholic Subjects
// Subjects=10
-53.01	9.78	-4.65
28.96	-62.08	-31.43
-42.09	-64.82	-10.9
-35.78	-64.98	-24.44
-48.15	7.25	36.98
-44.5	21.95	-12.72
1.55	24.96	39.98
-.5	19.2	47.31
8.25	26.65	57.63
37.98	44.7	19.48
-4.37	-35.42	71.83
-49	-8.97	-33.12
-38.19	-14.35	-33.89
-5.05	-86.43	8.53
-13.7	-91.98	6.99
42.28	-75.81	-6.77
12.28	-89.35	10.77
41.97	-62.78	-28.22
4.28	-57.18	68.23
-34.82	-46.87	54.43
-28.27	-63.86	56
-23.83	-65.14	65.02
5.11	-23.35	-29.26
0.95	-63.79	-25.18
26.62	-13.06	-35.12
43.67	12.55	-49.15
32.88	8.26	-48.55
26.77	67.91	-7.28
56.82	-27.16	41.96
-41.44	-74.18	38.2
-35.33	-92.27	5.15
-30.43	-65.99	56.25
-24.54	-90.1	4.75
-34.89	-82.35	42.26
-20.09	-100.1	12.38
-50.89	11.7	-7.12
-59.11	14.79	26.33
-60.32	-48.54	3.49
-51.08	6.95	-23.45
-50.9	-77.04	-26.35
-44.68	-8.95	-33.19
-37.88	30.66	-.25
-11.38	27.36	43.33
-13.43	-73.54	32.05
-6.87	-78.42	36.91
10.23	34.02	44.54
8.28	26.86	59.85
28.5	58.1	-43.32
30.01	-70.66	48.96
42.48	-76.48	8.98
32.21	-55.03	55.22
31.18	-23.29	-18.5
37.94	40.03	15.46
36.35	14.74	54.97
44.54	9.21	18.4
57.91	5.34	-35.24
54.67	14.05	-33.8
52.94	15.13	0.86
-35.97	51.76	-15.82
9.37	62.66	-16.55
2.82	75.19	-19.92

// Peng D L, 2003: High-Frequency Words, Short Exposure
// Peng D L, 2003: Low-Frequency Words, Short Exposure
// Peng D L, 2003: High vs. Low-Frequency Words, Short Exposure
// Peng D L, 2003: High-Frequency Words, Long Exposure
// Peng D L, 2003: Low-Frequency Words, Long Exposure
// Subjects=8
41.68	40.93	10.98
46.24	8.75	34.81
44.98	43.04	24.15
-20.23	-44.48	-14.6
36.48	-54.29	-8.86
52.49	-54.37	-11.26
35.85	-66.22	43.45
-22.94	-67.88	40.92
21.93	-66.64	39.19
-22.26	-63.1	-7.44
8.78	-60.2	-.24
34.69	-79.31	25.6
-6.03	-91.67	7.04
-27.69	-66.19	-19.39
28.97	-70.08	-19.71
-31.22	19.35	-27.64
-27	8.92	-39.08
40.86	-76.21	-3.72
49.24	-48.3	-15.08
49.29	-44.44	-6.48
-30.8	-72.93	-9.87
38.6	-63.25	-14.82
52.54	-58.25	-6.48
-31.92	-69.13	-15.75
-18.76	-86.4	21.24
-28.45	-87.23	11.38
-31.96	-67.27	-19.25
37.47	-55.14	-19.95
62.27	-47.22	11.44
-42.57	-65.51	-9.24
53.5	-52.84	-19.21
53.61	-58.25	-6.49
-38.28	-69.71	-8.93
-37.24	-86.43	-18.7
-38.35	-78.14	-21.61
40.46	-47.4	-44.05

// Perani D, 2003: Catalan and Spanish vs. Rest
// Perani D, 2003: Catalans > Spaniards
// Perani D, 2003: Spaniards > Catalans
// Perani D, 2003: Catalans Generating Spanish Words vs. Spaniards Generating 
// Catalan Words
// Subjects=5
-44	10	32
-54	12	24
-36	36	4
-30	24	4
-42	28	0
-36	36	20
-40	4	60
-46	12	52
-42	8	56
-2	8	56
-2	20	44
-42	-28	40
-32	-36	44
-32	-32	36
-54	-34	16
-48	-54	-8
-6	-10	8
46	24	-4
6	-46	-16
-28	16	8
-32	14	0
-36	18	28
-40	44	8
-46	40	16
-32	18	-4
-16	2	20
-40	4	60
-48	4	52
-44	-28	44
48	20	-8
-48	36	8
-40	44	8
-34	16	12
-40	46	4
-44	-28	40

// Xiang H, 2003: Activation Areas
// Subjects=6
11.23	83.6	-40.2
-42.44	-3.75	32.42
-38.4	-13.87	-2.46
6.85	-11.95	45.92
-33.5	86.01	-18.7
33.8	92.76	-20.04
-43.39	11.78	54.55
-29.75	66.34	43.13
-30.9	-15.77	-.16
4.13	42.43	-7.67
1.16	78.87	37.26
-59.82	36.1	12.55

// Kim J J, 2003: Normals
// Subjects=12
38	20	50
-28	62	-4
6	32	36
-24	-60	52
60	-38	44
-52	-62	48
-22	10	-4
-46	-82	-38

// Kim J J, 2003: Patients
// Subjects=12
66	28	22
-60	26	-6
-10	-74	34
20	-98	4
32	-64	-48
-20	-84	-34
-34	-48	-46

// Blankenburg F, 2003: Subject 1
// Subjects=1
-37.96	-22.45	51.78
-42.21	-18.96	56
-37.95	-19.02	54.84
-44.33	-17.66	59.26
-34.67	-21.57	62.82
-45.38	-18.55	61.58
-29.36	-27.34	56.55
-35.73	-30.21	61.33

// Blankenburg F, 2003: Subject 2
// Subjects=1
-41.16	-9.18	58.51
-42.21	-18.96	56
-42.21	-7.96	60.65
-44.33	-17.66	59.26
-42.19	-6.64	63.89
-45.38	-18.55	61.58

// Blankenburg F, 2003: Subject 3
// Subjects=1
-47.54	-19.96	57.26
-42.21	-18.96	56
-48.58	-18.57	61.61
-45.38	-18.55	61.58
-44.3	-21.72	61.83
-44.29	-20.49	63.96
-39.98	-31.12	63.68
-35.73	-30.21	61.33

// Blankenburg F, 2003: Subject 4
// Subjects=1
-41.21	-16.38	47.96
-42.21	-18.96	56
-44.31	-18.54	61.56
-44.33	-17.66	59.26
-44.29	-20.49	63.96
-45.38	-18.55	61.58
-44.27	-22.52	65.24
-44.29	-20.49	63.96

// Blankenburg F, 2003: Subject 5
// Subjects=1
-42.17	-18.53	61.54
-42.21	-18.96	56
-44.29	-17.23	64.8
-44.33	-17.66	59.26
-44.29	-18.29	64.89
-45.38	-18.55	61.58
-44.29	-18.37	63.78
-44.29	-20.49	63.96
-35.72	-30.12	62.44
-35.73	-30.21	61.33

// Blankenburg F, 2003: Subject 6
// Subjects=1
-41.12	-21.95	58.47
-42.21	-18.96	56
-42.16	-24.96	60.96
-44.33	-17.66	59.26
-46.41	-25.87	63.32
-45.38	-18.55	61.58
-38.93	-32.43	60.44
-35.73	-30.21	61.33

// Blankenburg F, 2003: Subject 7
// Subjects=1
-47.54	-24.28	56.5
-42.21	-18.96	56

// Blankenburg F, 2003: Subject 8
// Subjects=1
-52.96	-16.37	49.21
-44.33	-17.66	59.26
-54.01	-16.2	51.44
-45.38	-18.55	61.58

// Callicott J H, 2003: Schizophrenic Patients > Normals
// Callicott J H, 2003: Normals > Schizophrenic Patients
// Subjects=14
-43.36	44.26	-3.74
-55.22	17.11	-6.46
5.9	35.07	44.51
-10.31	40.44	45.38
28.97	7.34	68.15
-6.66	4.13	70.2
-30.52	6.62	63.63
-43.36	44.26	-3.74
33.28	23.28	-14.18
-22.31	14.37	31.35
-31.04	33.38	28.5
-39.81	44.43	20.83
42.41	37.9	26.8
-22.87	48.48	-5.63
29.64	-4.48	33.45
38.14	42.66	32
33.65	44.69	19.55
-31.06	37.64	28.08
37.75	39.75	0.92
-35.5	47.63	20.44
-35.64	43.3	8.55

// Mitterschiffthaler M T, 2003: Normals
// Subjects=7
8.37	46.51	-10.29
-6.61	39.65	-15.12
12.63	39.76	-15.35
28	-84.38	-11.81
-14.73	-86.75	-11.12
23.78	-83.89	-5.11
-6.47	28.96	-1.96
54.84	-28.01	26.65
-32.89	-76.83	-5.05

// Mitterschiffthaler M T, 2003: Depressed Patients
// Subjects=7
8.71	-4.9	12.97
16.89	17.7	-25.82
-44.54	-52.81	17.6
1.1	-45.84	-20.31
-52.03	-38.68	22.08
-55.28	-39.13	16.58
-41.4	-24.87	20.8
-2.86	-28.35	27.34
5.71	-23.64	32.42
1.33	-46.7	9.87
-17.19	11.03	-12.6
-21.28	-12.37	1.67
39.32	21	-26.35
43.69	35.18	-8.63
-55.48	-21.46	-2.75
-26.58	-17.52	4.4
-11.45	-2.43	33.07
52.45	44.06	22.86
-31.53	-20.04	54.85
-25.3	-96.53	0.97
21.03	-82.46	55.02
-10.27	6.44	51.27

// Okada G, 2003: Depressed Patients
// Subjects=10
-49.78	29.45	-1.05
-42.21	31.71	-.28
-47.39	11.46	13.02
-35.76	35.88	-1.92

// Okada G, 2003: Normals
// Subjects=10
-40.09	16.1	-6.62
-44.97	7.91	32.38
-39.73	4.56	19.17
-2.02	-20.16	5.29
-7.54	-29.83	-5.99
5.75	19.69	29.23
9.99	27.9	24.98
-5.17	29.76	22.81
-35.76	35.88	-1.92

// Yang T T, 2003: Happy vs. Neutral, Adolescent Subjects, Whole Brain 
// Analysis
// Subjects=12
28.95	-.86	-19.56
-20.72	-8.48	-17.96

// Vingerhoets G, 2003: Dutch:  Word Fluency - Control
// Vingerhoets G, 2003: English:  Word Fluency - Control
// Vingerhoets G, 2003: French:  Word Fluency - Control
// Vingerhoets G, 2003: Dutch:  Picture Naming - Control
// Vingerhoets G, 2003: English:  Picture Naming - Control
// Vingerhoets G, 2003: French:  Picture Naming - Control
// Vingerhoets G, 2003: Dutch:  Reading - Control
// Vingerhoets G, 2003: English:  Reading - Control
// Vingerhoets G, 2003: French:  Reading - Control
// Subjects=12
-54.25	38.18	-10.8
-46.18	20.05	24.47
-48.01	10.52	48.98
-48.5	41.86	16.75
3.73	31.66	42.64
-.64	28.04	38.59
41.78	15.69	-27.02
-46.25	21.76	19.82
-2.68	30.03	48.52
-26.12	-57.37	56.44
-39.2	-31.99	53.03
43.93	15.59	-28.17
-53.16	40.41	-9.92
-43.97	20.47	28.88
-35.04	10.57	48.75
-48.64	34.23	4.06
5.89	29.55	42.82
-5.19	40.5	22.87
39.6	27.59	-25.92
-46.33	35.38	16.23
-2.71	27.6	45.4
-30.39	-58.03	61.06
-37.14	-34.94	44.33
-44.19	-63.24	-5.42
-56.11	-60.3	-7.75
-50.97	39.56	-7.63
-55.13	21.03	1
-13.42	26.05	52.46
-48.64	34.23	4.06
5.85	32.53	40.28
-4.96	28.03	38.67
39.68	18.33	-21.64
-44.04	24.31	24.01
-6.98	28	49.91
-28.26	-57.17	58.7
-50.62	-57.43	-.28
-56.1	-55.84	-5.95
-45.76	3.5	54.12
-7.05	20.89	42.77
12.6	-84.73	37.2
35.63	-48.59	-13.83
55.39	-76.85	4.32
-16.06	-60.71	-2.79
5.69	-79.25	4.28
44.33	-68.98	-14.2
-22.6	-64.44	-7.91
-11.67	-75.48	-.28
-4.92	23.98	41.31
-4.79	21.62	50.51
-42.33	29.71	-10.17
-50.5	17.91	24.76
-47.96	5.41	51.72
-46.25	21.76	19.82
-28.3	-59.71	54.47
-48.61	-51.97	-10.94
12.58	-87.06	35.19
39.86	-51.43	-21.47
1.33	-81.71	1.23
44.44	-75.8	-6.81
-13.91	-69.52	-5.31
3.55	-81.29	5.64
42.19	-71.01	-12.85
-22.62	-60.18	-8.33
-24.63	-76.59	0.05
-52.83	-59.98	-4.47
-50.18	-.54	45.63
-4.92	25.05	41.2
-2.63	21.63	50.47
-31.5	22.3	-9.62
-44.04	17.72	22.43
-47.97	7.54	51.51
-48.41	30.47	21.24
-28.28	-59.5	56.69
14.72	-89.39	33.14
44.35	-64.41	-11.29
-24.66	-75.73	-2.28
3.54	-83.52	4.74
37.87	-73.15	-12.56
-33.38	-64.27	-5.5
-26.78	-79.78	0.4
-44.12	-73.67	-2.15
-58.46	-19.04	-14.03
-50.29	-57.17	25.46
14.27	-57.74	4.25
-11.74	-50.81	-.48
-7.22	-82.18	8.15
-37.14	12.14	54.24
-58.58	0.86	-19.36
-68.9	-42.63	9.77
7.88	-72.45	8.05
-13.82	-64.43	3.15
-7.21	-75.49	10.85
12.28	-66.39	15.22
-13.74	-63.81	9.81
-7.18	-86.23	10.79
5.83	-79.28	15.49
-43.67	6.28	49.32
-48.46	21.34	15.42
-60.27	-47.06	7.82
-60.27	-47.06	7.82
14.38	-81.04	7.67
-18.2	-71.45	-2.81
-5.18	-70.99	1.41
-22.18	-74.4	23.32
-33.15	-68.03	11.67
-15.8	-81.69	13.85
18.81	-94.44	13.4

// Coghill R C, 2003: High Sensitivity to Pain
// Subjects=6
-2	8	36
-4	18	24
-4	-34	58
30	64	0
32	62	-8
32	52	-18
-18	-20	14
-2	8	36
-4	18	24
-4	-34	58
30	64	0
32	62	-8
32	52	-18

// Coghill R C, 2003: Low Sensitivity to Pain
// Subjects=6
-4	18	24
-18	-20	14
-2	8	36
-4	18	24
-4	-34	58
30	64	0
32	62	-8
32	52	-18

// Kumari V, 2003: Normals
// Subjects=6
-58	-46	34
-66	-38	20
-66	-36	4
-2	58	2
-2	44	14
8	-64	4
-44	-20	56
-46	-30	56
-36	-38	62
46	-22	54
50	-14	52
32	-24	50
-62	-12	22
-58	-8	10
-60	-14	-8
58	-12	34
54	-4	34
60	-10	22
48	-54	18
56	-62	24
40	-56	18
-42	-68	16
-46	-74	-4
-4	-58	16
-2	-68	18
4	-60	18
38	40	-4
38	46	-14
30	48	2
12	-6	-6
16	-16	-2
20	-16	-10
-14	14	-6
-8	14	0
-12	-14	2
-26	-16	10
-14	-16	18
-42	-40	26
-60	-46	30
-44	-46	-4
56	-52	36
60	-46	28
60	-44	36
34	-36	28
30	-28	30
42	-24	12
34	-66	-24
40	-70	-28
-12	-88	18
4	-78	14
-2	-82	20

// Kumari V, 2003: Schizophrenic Patients
// Subjects=7
48	14	0
44	18	8
46	20	-8
34	34	30
28	38	30
28	46	16
-44	-54	28
-52	-50	28
-50	-50	40
-44	-2	-22
-30	-12	-30
-32	-12	-22
-34	42	28
-28	36	34
-36	34	32
38	4	36
32	-4	40
-42	6	28
-52	2	26
-30	-44	60
-20	-50	62
-56	-24	36
-54	-8	8
-60	-16	22
-30	-44	48
-2	-54	52
10	-62	48
16	-52	36
-2	58	24
2	64	4
2	62	16
-52	-58	26
-54	-60	18
-44	-62	36
2	-46	6
4	-60	20
0	-70	30

// Strigo I A, 2003: Painful Esophageal Distention
// Strigo I A, 2003: Painful Thermal Heat
// Subjects=7
52	-27	29
-52	-33	30
52	-18	25
-60	-16	25
30	20	6
34	0	2
-36	2	6
-26	-16	4
42	-10	36
-50	-10	34
2	10	48
-38	-58	52
-14	-68	38
-2	26	36
30	-56	-30
-24	-60	-22
-32	-56	-32
0	-50	-22
26	-12	4
-22	-2	4
-14	-14	6
32	12	8
32	24	6
-36	2	16
-36	12	10
36	-4	-6
-42	0	2
36	-20	14
-28	-22	6
54	-38	32
-56	-24	16
42	50	-2
38	-50	42
-34	-48	38
54	-36	44
-60	-38	38
-2	-26	28
-10	0	42
-16	-14	6
36	-56	-44
28	-56	-30
-40	-52	-44
-26	-66	-32
4	-58	-30
26	6	4
-30	-6	6

// Bingel U, 2003: Right Hand - Baseline
// Bingel U, 2003: Left Hand - Baseline
// Bingel U, 2003: Conjunction Analysis
// Subjects=14
27	-30	51
-36	-42	51
51	-24	21
-54	-24	24
39	0	9
-39	6	0
9	-3	39
-3	-6	51
12	-9	0
-12	-18	0
27	-30	51
-33	-51	51
54	-27	18
-57	-27	18
36	6	9
-36	0	12
3	-3	42
-9	-6	42
15	-18	9
-12	-15	3
33	-36	71
-33	-36	71
51	-27	24
-51	-27	24
38	-18	15
-38	-18	15
36	-18	9
-36	-18	9
12	-18	9
-12	-18	9

// Honey G D, 2003: Schizophrenic Patients
// Subjects=30
53.91	-27.7	44.47
-39.33	18.38	29.41
60.03	12.21	23.21
-44.85	16.47	5.1
50.28	10.69	4.49
7.77	22.78	40.77
-32.72	5.08	49.41
-39.4	-62.58	-12.86
41.83	-67.38	-13.4
-5.16	-76.12	-12.12
25.78	-61.13	-13.74
25.77	-59.01	-13.91
-35.77	-36.18	52.91
47.33	4.61	36.26
50.3	5.41	4.94
-39.48	8.04	5.75
56.83	12.19	23.25
-51.06	11.97	30.09
-20.13	41.22	33.97
43.91	36.43	21.37
33.2	48.17	22.74
-42.57	31.14	29.5
-44.42	-6.46	52.74
46.33	5.29	45.14

// Honey G D, 2003: Normals
// Subjects=27
-43.24	-53.66	47.77
-44.58	7.23	37.1
41.64	47.11	8.23
-33.16	21.4	-1.02
56.76	18.02	16.07
4.65	13.76	48.25
-44.51	1.32	43.17
-39.36	-73.15	-11.98
35.42	-67.41	-13.32
-11.58	-82.93	-17.05
32.17	-67.86	-18.82
19.35	-55.88	-14.1
-39.02	-24.57	51.97
47.57	-32.51	51.64
4.71	-3.16	49.67
33.2	48.17	22.74
-42.57	31.14	29.5
-44.42	-6.46	52.74
46.33	5.29	45.14

// van Turennout M, 2003: Overall Effects of Naming Novel and Repeated Objects
// van Turennout M, 2003: Main Effects of Naming Novel Objects
// van Turennout M, 2003: 30 s Delay (Deactivations)
// van Turennout M, 2003: 30 s Delay (Activations)
// van Turennout M, 2003: 1 h Delay (Deactivations)
// van Turennout M, 2003: 1 h Delay (Activations)
// van Turennout M, 2003: 6 h Delay (Deactivations)
// van Turennout M, 2003: 6 h Delay (Activations)
// van Turennout M, 2003: 3 Day Delay (Deactivations)
// van Turennout M, 2003: 3 Day Delay (Activations)
// van Turennout M, 2003: Short Delay (Deactivations)
// van Turennout M, 2003: Short Delay (Activations)
// van Turennout M, 2003: Long Delay (Deactivations)
// van Turennout M, 2003: Long Delay (Activations)
// Subjects=10
-42	-86	-6
-48	-68	-14
34	-92	-12
44	-68	-18
32	-46	-22
-52	10	4
-44	14	20
-54	30	10
-24	0	4
-16	-2	16
-16	12	4
-42	-88	-4
-48	-66	-16
44	-68	-18
32	-46	-22
-54	12	4
-42	14	24
-54	28	12
-46	-86	-2
-50	-64	-18
44	-66	-20
30	-42	-24
-56	16	8
-50	28	14
-34	8	0
-24	10	16
-46	-64	-16
40	-74	-6
46	-56	-22
-52	8	36
-56	16	8
-54	26	16
-32	6	-2
-22	6	-16
-22	6	14
-44	-86	-4
-44	-70	-16
-34	-60	-28
36	-88	4
-56	16	10
-54	26	14
-34	4	-2
-22	8	16
-52	-64	-18
-40	-56	-30
32	-68	-30
36	-46	-28
-54	10	36
-52	14	2
-56	26	14
-32	8	-2
-22	8	16
-46	-68	-16
34	-50	-24
-52	12	6
-44	14	24
-52	28	14
-32	6	-2
-24	10	16
-50	-62	-16
30	-42	-22
-52	10	34
-44	14	24
-50	28	14
-30	6	-2
-24	10	4

// Weiss E M, 2003: Rotated Images vs. Control, Men and Women
// Weiss E M, 2003: Rotated Images vs. Control, Men > Women
// Weiss E M, 2003: Rotated Images vs. Control, Women > Men
// Subjects=10
35.15	26.41	-11.15
-54.24	7.81	31.59
31.46	-2.66	53.78
-28.28	-1.99	67.8
1.35	21.51	38.72
40.05	-41.7	43.58
-41.08	-36.93	57.49
40.15	-49.47	53.15
-28.13	-70.69	60.17
-32.41	-40.08	71.04
39.94	-29.7	33.65
47.91	52.21	-9

// van Dijk P, 2003: Simultaneous Masking vs. Baseline
// van Dijk P, 2003: Backwards Masking vs. Baseline
// van Dijk P, 2003: Simultaneous Masking vs. Backwards Masking
// van Dijk P, 2003: Backwards Masking vs. Simultaneous Masking
// Subjects=8
-10	-30	6
-56	-22	10
-54	6	-4
-32	-60	50
50	-50	44
-48	12	38
38	20	6
26	52	8
8	-42	36
-8	34	26
16	-70	-42
30	2	0
-42	-26	8
-50	4	-10
34	14	-20
58	-44	46
-54	6	36
54	16	18
54	32	24
-6	36	30
28	6	-6
-54	-46	28
-34	22	8
-12	-52	18
-22	-52	-28
28	-40	-34
-50	4	-22
34	16	-3
2	54	28

// Astafiev S V, 2003: Attention vs. Fixation
// Astafiev S V, 2003: Saccade vs. Fixation
// Astafiev S V, 2003: Pointing vs. Fixation
// Astafiev S V, 2003: Attention > Saccade
// Astafiev S V, 2003: Pointing > Saccade
// Astafiev S V, 2003: Pointing > Attention
// Subjects=15
-25.02	-61.84	50.47
-29.24	-59.06	59.21
24.21	-62.97	58.93
28.39	-57.29	49.48
34.87	-56.57	58.27
-31.47	-49.02	51.7
43.41	-50	59.85
-16.43	-63.56	54.98
0.66	-52.54	58.32
4.9	-44.06	57.56
-29.45	-6.37	52.56
38.91	0.39	51.21
-33.49	-61.03	61.66
24.15	-61.37	52.1
-31.45	-48.85	53.92
-42.17	-40.45	53.34
34.8	-46.33	52.95
-25.08	-75.56	38.24
30.38	-74.14	24.1
9	-65.63	25.87
-33.71	-6.22	54.83
10.98	22.8	40.73
-25.01	-61.67	52.69
32.68	-57.09	51.64
-35.75	-46.93	51.58
39.09	-48.25	55.29
-37.97	-32.48	45.93
-9.99	-71.98	55.61
17.77	-65.47	54.75
0.61	-53.06	51.67
-27.24	-73.63	35.88
36.85	-75.7	30.85
2.63	-71.85	28.69
-23.05	-4.21	52.31
28.31	-12.02	56.84
-38.02	-6.59	50.45
38.92	-1.73	51.39
-38.21	2.44	29.62
-57.41	-1.73	32.42
36.67	1.46	37.77
53.72	5.45	32.77
-44.39	-17.2	51.41
-3.88	4.02	46.94
2.45	20.8	43.23
-31.91	36.49	28.93
25.76	27.69	20.08
40.8	17.55	25.22
-1.45	-47.81	64.64
-37.89	-46.94	51.6
-35.75	-55.73	47.86
-5.74	-78.81	49.45
2.75	-63.96	48.1
-42.33	-61.88	23.91
-57.32	-49.11	25.24
-55.4	-40.41	-0.04
26.23	-13.64	63.69
-10.04	-17.57	71.12
13.46	-24.12	66.94
-42.32	-64	24.09
-55.17	-46.81	27.26
-55.42	-40.58	-2.26
-46.63	-5.04	43.73

// Binder J R, 2003: Word > Nonword
// Binder J R, 2003: Nonword > Word
// Binder J R, 2003: Lo > Hi
// Binder J R, 2003: LoWord > HiWord
// Binder J R, 2003: LoNon > HiNon
// Subjects=24
-25.24	21.58	55.75
-15.74	36.9	46.55
-6.37	55.25	21.48
-35.97	14.49	47.54
-31.85	26.09	32.03
1	50.92	6.15
-.16	51.03	-6.12
-8.74	42.98	-13.15
1.94	29.75	-19.97
-39.72	40.68	-12.6
-51.88	-64.6	30.94
-38.91	-73.9	47.18
-42.21	-77.14	33
-52.88	-46.23	48.37
-51.98	-66.68	17.73
-38.85	-60.18	59.42
-61.82	-49.34	-4.8
-61.9	-52.31	-15.7
0.45	-36.02	37.98
-8.2	-61.31	14.55
-3.7	-56.68	46.45
-2.76	-53.64	30.57
2.57	-21.92	41.23
-5.67	-65.98	63.98
8.96	-96.78	8.41
-23.58	-10.75	-18.51
-44.67	1.89	23.05
-57.55	3.42	16.38
-53.03	-3.93	44.83
48.35	9.56	31.38
48.26	25.08	25.62
0.42	8.7	52.07
1.4	18.77	44.53
29.89	54.78	12.18
-41.72	19.06	-2.96
-23.24	33.34	42.47
-14.86	45.94	25.71
-13.97	59.46	7.83
-13.6	37	47.63
-15.72	23.95	44.29
-2.26	62.36	3
-2.02	43.99	26.84
-22.26	32.49	31.38
14.9	57.69	9.88
-0.03	46.86	8.73
0.9	47.69	-8.08
-6.59	31.02	-16.63
2.11	32.61	3.21
-4.24	2.54	0.23
-6.49	16.73	-8.74
8.58	6.93	0.83
-3.08	-5.32	8.68
49.67	-70.16	32.47
-43.24	-64.66	43.11
3.65	-34.94	37.85
5.66	-45.02	17.49
0.42	-50.62	28.05
-6.04	-55.58	19.62
4.86	-66.4	43.82
-2.47	-51.7	69.44
-36.31	-49.5	-22.92
-21.25	45.01	28.09
-26.44	32.35	43.71
-38.21	22.16	36.89
-30.64	14.43	46.37
-27.36	18.48	57.15
39.86	20.06	43.98
2.43	21.69	40.92
-44.27	-65.38	47.65
-51.85	-63.2	35.28
-49.76	-50.5	34.19
-60.91	-22.35	-13.76
-55.67	-14.63	-24.51
2.56	-38.47	33.7
2.61	-51.15	34.76
-6.6	30.93	-17.74
-52.98	-51.66	33.21
-8.18	-56.65	19.74
0.41	-50.71	26.95
4.72	-32.74	38.77
4.59	-47.23	16.57
7.75	-55.38	7.18

// Cabeza R, 2003: Regions Similarly Activated By VA and ER Tasks
// Cabeza R, 2003: ER > VA
// Cabeza R, 2003: VA > ER
// Subjects=20
5.67	33.31	25.64
49.96	21.45	22.7
49.47	19.94	-16.37
30.04	8.41	68.03
-2.6	5.47	49.83
-30.38	-52.5	62.76
30.12	-52.29	61.71
-30.49	-48.98	54.57
17.34	-29.54	-4.2
-15.08	-29.65	-3.64
-10.66	-16.9	6.23
9.85	-12.57	5.45
-15.08	-29.65	-3.64
17.35	-33.79	-3.78
-19.4	-29.67	-3.56
21.62	-29.83	-7.61
13	6.48	2.4
-10.82	5.98	-1.63
-31.38	-67.63	-18.65
33.39	-54.64	-21.04
-34.15	-90.37	13.9
-23.64	-86.03	-9.12
38.05	-88.27	-2.1
13.35	-82.86	11.23
-42.39	-16.28	60.5
-38.08	-13.07	60.11
-19.59	69.53	1.19
-47.84	46.4	-15.09
-51.8	34.84	10.78
-51.53	21.51	28.9
-47.32	29.51	22.43
-51.1	-54.03	47.57
-42.53	-70.99	37.9
50.31	-67.89	31.53
-58.29	-41.81	-5.06
-2.85	38.57	36.47
1.62	-28.09	35.14
1.66	-68.27	30.15
-2.52	-66.18	41.23
-2.66	-92.41	24.77
-14.98	-40.93	1.96
-30.41	-12.22	68.86
-34.83	-25.07	57.88
-43.34	9.39	-9.26
-47.58	1.29	-3.9
45.32	5.87	-5.94
60.53	-2.17	-.92
-51.9	1.27	-3.83
60.67	-55.87	-1.21
-51.51	-74.58	11.51
45.84	-77.76	18.02
-14.76	-99.53	6.63
42.36	-85.07	-2.49
57.67	-29.99	23.17
-66.56	-25.97	27.13
34.4	-43.87	59.68
29.23	55.96	14.03
49.53	41.19	-7.26
54.07	2.37	2.1
54.58	12.7	43.65
60.56	11.21	4.48
10.48	1.99	57.79
-62.53	8	11.37
-6.78	-26.35	54.17
-18.51	-40.56	63.61

// Cohen L G, 2003: Alphabetic Stimuli vs. Fixation
// Cohen L G, 2003: Alphabetic Stimuli vs. Checkerboards
// Cohen L G, 2003: Words vs. Consonant Strings
// Cohen L G, 2003: Consonant Strings vs. Words
// Subjects=9
36	-63	-18
48	-75	-12
-21	-90	-3
-42	-63	-15
-24	-18	3
-24	0	-3
-45	9	27
45	15	18
-48	39	15
24	18	-6
-51	-33	39
-36	-75	-12
-36	-45	-27
-36	12	18
-12	27	33
45	36	21
-18	-60	30
24	6	-3
-3	-33	33
-45	-63	27
-33	-87	12
-21	-51	63
27	-72	12
21	-60	63
48	-21	54
51	9	12

// Horn N R, 2003: Go/No-Go > Go
// Subjects=21
42	48	-6
-42	54	-12
3	60	27
-3	39	45
21	51	30
-24	39	39
57	21	12
42	24	-24
-45	27	-21
-6	-42	45
0	-93	21
42	18	-24
-36	9	-18
42	-60	45

// Konishi S, 2003: All Normal Subjects
// Subjects=36
-32	32	44
-42	16	32
44	18	38
-30	6	60
38	34	42
-42	36	12
-2	18	48
-28	-52	42
30	-64	54
34	-44	42
-28	-68	44
26	-56	68
4	-56	46
26	-50	0
30	-76	34
-10	8	8

// Konishi S, 2003: Subset of Normal Subjects With Additional Task Knowledge
// Subjects=16
-38	14	26
-38	24	-4
50	24	36
38	4	48
20	16	62
34	18	-12
-22	6	62
26	2	64
4	18	58
14	52	28
12	32	26
-40	-52	60
-26	-64	50
-44	-34	44
6	-68	48
-54	-54	38
30	-56	54
48	-36	54
-26	-80	28
36	-74	34
-20	-62	18

// Kuo W J, 2003: Low vs. High Frequency
// Kuo W J, 2003: High vs. Low Frequency
// Subjects=8
-8	8	52
-54	-12	48
-52	-2	28
-44	4	28
-38	20	0
-28	-60	48
-42	-56	0
-30	-64	6
10	10	52
42	8	24
38	26	-4
30	20	10
30	-56	6
-54	-48	36
-46	-62	22
-6	-64	40

// Lee H S, 2003: Japanese - Korean, Before Studying
// Lee H S, 2003: Korean - Japanese, Before Studying
// Lee H S, 2003: Korean - Japanese, After Studying
// Subjects=12
-56	-66	22
-32	-94	-6
28	-76	40
30	-78	40

// Maguire R P, 2003: Go vs. Fixation
// Maguire R P, 2003: Go/No-Go vs. Fixation
// Maguire R P, 2003: Go/No-Go vs. Go
// Subjects=6
0	-4	60
-10	-76	-24
50	-66	-6
-48	4	0
-16	-70	54
62	-22	18
0	-4	60
-14	-82	-24
66	-42	6
-48	8	-6
-34	-52	54
26	-80	18
-26	-80	18
38	42	30
-48	-70	0
26	-64	42
62	-34	-6
48	26	18
50	12	48
-48	30	24
30	-68	48
-16	-74	42

// Mostofsky S H, 2003: All Normal Subjects
// Subjects=48
26.87	-51.68	-23.46
-50.03	-13.64	54.76
-6.92	12.04	51.49
-33.6	-59.34	-21.67
-37.85	-58.84	-16.05
-2.55	14.6	55.64
35.52	-53.78	-23.4

// Mostofsky S H, 2003: Subset of Normals Subjects
// Subjects=28
25.31	-98.67	13.71
-5.33	-5.39	2.76
-39.27	-11.68	52.15
-2.58	14.39	53.42
48.83	42.93	22.83
55.34	28.91	21.87
16.96	23.9	62.24

// Delazer M, 2003: Fact Retrieval vs. Number Matching
// Delazer M, 2003: Untrained Multiplication Set vs. Number Matching
// Delazer M, 2003: Untrained vs. Trained Multiplication Set
// Delazer M, 2003: Trained vs. Untrained Multiplication Set
// Subjects=13
-34	-64	48
-26	6	60
-26	44	36
-46	24	32
-50	18	-12
-40	2	24
-32	20	-4
-2	26	40
-34	-72	-36
34	-70	40
38	28	28
38	48	-12
12	-82	-28
38	38	-36
-8	-76	44
-46	18	-8
-50	8	20
-26	2	60
-2	-78	12
-6	-82	-24
16	-70	60
50	16	24
30	22	-12
44	32	20
4	2	36
30	-92	-12
40	-72	-32
-20	-56	56
-64	-24	24
-50	6	20
-62	-36	20
-8	-84	0
-46	-60	24
-46	-12	-32
-12	-44	24
-22	-44	32
-24	-20	48
-22	-58	-32
14	-12	44
14	-52	-36

// Kringelbach M L, 2003: Main Reversal Task
// Kringelbach M L, 2003: Main Effects of Faces
// Kringelbach M L, 2003: Conjunction of Main Reversal Task and Control 
// Reversal Task
// Subjects=9
42	42	-8
-46	30	-8
38	20	16
-46	16	16
-10	-10	0
-16	8	4
-8	22	52
36	-60	-20
-30	-56	-16
32	-60	46
-32	-60	44
44	26	-12
-46	28	-8
-6	18	48
40	18	28
-46	10	36

// Milham M P, 2003: Oddball
// Milham M P, 2003: Incongruent, Eligible and Incongruent, Ineligible > 
// Neutral
// Milham M P, 2003: Incongruent, Eligible > Incongruent, Ineligible
// Subjects=16
-28.4	-95.44	15.41
-34.99	-84.16	-3.3
-17.67	-97.14	19.89
-32.59	-85.8	30.27
35.77	-94.54	21.29
27.22	-103.39	17.67
42.19	-92.21	23.25
-28.89	64.2	15.41
-41.54	22	21.33
-45.87	19.18	12.69
-45.61	13.11	44.43
-37.61	60.15	-8.68
46.23	12.98	34.46
5.53	40.4	34.86
-30.36	-58.53	52.49
38.02	-56	51.49
-35.16	17.3	14.96
35.34	19.66	11.72
-48.04	45.23	19.46
52.42	43.71	18.43
54.59	39.67	20.97
43.84	56.52	19.68
48.22	4.94	12.81
9.74	35.34	24.08
65.42	14.87	29.62
-11.19	-61.21	43.57
61.54	-53.58	53.25
-28.26	-47.94	51.58
40.25	-68.17	59.18
3.96	-70.16	64.22
-4.88	-84.21	20.89
-22.01	-71.45	22.25
-43.83	44.57	10.54
-37.36	25.4	9.84
-35	14.61	35.26
-39.36	29.04	29.64
-46.05	26.09	-7.96
-26.79	24.26	-5.79
45.91	31.73	1.67
43.89	41.72	20.92
48.06	47.23	9.26
56.74	17.85	13.86
37.31	28.88	-6.92
5.38	43.26	16.78
9.86	12.42	30.46
-7.2	-11.46	25.97
7.88	-25.49	35.9
-22.05	0.57	45.21
54.77	8.63	32.5
54.96	-50.93	33.03
61.44	-54.6	39.95
44.45	-69	48.05
50.76	-39.18	47.7
12.15	-65.07	19.09
-30.4	-58.87	48.06
1.78	-61.88	61.32
-43.53	-77.52	0.7

// Potenza M N, 2003: Normals Subjects
// Subjects=11
2.45	16.4	41.37
45.45	-54.27	45.68
47.29	11.84	33.43
-32.65	-49.17	36.12
42.78	46.74	17.17
3.28	35.93	18.53
12.98	-4.96	11.81
-28.84	13.05	0.75
39.54	15.57	-.25
17.05	6.12	-10.35
-1.26	43.02	-13.24
-20.48	38.68	-12.65

// Potenza M N, 2003: Pathological Gamblers
// Subjects=13
45.41	-42.64	44.71
-51.88	-39.25	42.2
-.84	19.93	32.19
46.19	9.29	28.08
-47.88	1.79	21.98
42.78	46.74	17.17
6.53	-17.4	2.89
36.3	14.15	-4.56
-39.56	9.38	-4.4
4.1	38.83	-12.95
-20.48	38.68	-12.65

// Swainson R, 2003: Wait vs. Go
// Swainson R, 2003: Switch vs. Nonswitch, Wait
// Swainson R, 2003: Switch vs. Nonswitch, Go
// Subjects=12
36	15	30
42	24	-6
0	9	51
3	33	24
9	15	30
21	-87	9

// Braver T S, 2003: Time
// Braver T S, 2003: Switch x Time
// Braver T S, 2003: Block x Time
// Braver T S, 2003: Mixed State vs. Fixation, Increases
// Braver T S, 2003: Mixed State vs. Fixation, Decreases
// Braver T S, 2003: Mixed vs. Single State, Increases
// Braver T S, 2003: Mixed vs. Single State, Decreases
// Braver T S, 2003: Block x Effect
// Subjects=13
-15.51	9.63	65.56
-28.21	-64.95	51.89
-41.78	32.63	-6.32
-47.96	18.53	18.35
18.01	-23.5	-35.76
-15.51	9.63	65.56
-28.21	-64.95	51.89
-41.78	32.63	-6.32
-47.96	18.53	18.35
18.01	-23.5	-35.76
-15.51	9.63	65.56
-28.21	-64.95	51.89
-41.78	32.63	-6.32
-47.96	18.53	18.35
18.01	-23.5	-35.76
24.58	44.09	12.03
37.37	53.68	11.07
5.39	31.29	13.32
-41.78	32.63	-6.32
24.58	44.09	12.03
37.37	53.68	11.07
5.39	31.29	13.32
-41.78	32.63	-6.32
-15.51	9.63	65.56
-28.21	-64.95	51.89
-41.78	32.63	-6.32
-47.96	18.53	18.35
18.01	-23.5	-35.76
24.58	44.09	12.03
37.37	53.68	11.07
5.39	31.29	13.32

// Dreher J C, 2003: Task Switching > Baseline
// Dreher J C, 2003: Dual Task > Baseline
// Dreher J C, 2003: Task Switching > Dual Task
// Dreher J C, 2003: Dual Task > Task Switching
// Subjects=8
-28.39	11.84	61.96
-54.69	17.76	34.93
40.73	16.33	60.34
53.39	22.81	37.07
53.1	51.35	20.8
5.97	36.65	49.96
-36.9	-52.84	59.54
40.84	-57.23	54.17
-25.17	-75.11	-41.55
35.29	-79.57	-46.62
-50.73	-50.61	-7.68
-33.27	-66.73	2.58
61.61	-45.96	-10.05
39.89	27.54	-3.51
-24.13	11.44	57.45
-37.56	29.75	24.49
-46.01	22.46	38.8
19.18	16.67	65.15
53.16	51.76	25.25
49.08	18.54	37.57
49.19	6.2	43.27
10.32	28.16	50.72
13.73	43.22	-18.06
14.28	34.19	23.16
-7.68	35.88	-3.52
14.54	9.91	39.01
-15.28	-13.23	68.7
19.35	-12.69	72.54
-32.68	-57.91	51.01
-41.38	-40.92	49.47
40.73	-58.06	45.29
-16.61	-66.99	-46.98
5.19	-74.17	-33.19
-68.1	-29.4	-9.48
-37.48	-65.92	11.54
44.14	31.39	-8.44
-7.03	-73.07	25.18
23.22	-72.97	24.65
13.94	18.52	-6.66
-63.39	17.32	30.64
65.92	15.28	1.74
-29.51	64.75	-14.97
52.68	56.95	-11.12
-36.83	-56.68	64.4
-10.75	-51.09	76.85
53.81	-44.01	57.12
-63.89	0.4	-12.5
-41.57	-81.7	26.62
1.06	40.99	4.79
5.52	33.33	14.43
9.84	63.96	20.29
-7.07	-47.13	27.09
-2.67	-68.39	29.12
-16.34	-47.48	-22.02
14.52	-42.8	26.3
-68.1	-29.4	-9.48
-63.42	-48.58	14.75

// Giesbrecht B, 2003: Foveal, Location
// Giesbrecht B, 2003: Foveal, Color
// Giesbrecht B, 2003: Peripheral, Location
// Giesbrecht B, 2003: Peripheral, Color
// Giesbrecht B, 2003: Conjunction of Location and Color, Foveal
// Giesbrecht B, 2003: Conjunction of Location and Color, Peripheral
// Giesbrecht B, 2003: Foveal, Location > Color
// Giesbrecht B, 2003: Foveal, Color > Location
// Giesbrecht B, 2003: Peripheral, Location > Color
// Giesbrecht B, 2003: Peripheral, Color > Location
// Subjects=10
-8	0	55
-49	-4	30
26	-8	50
-23	-71	50
-38	-45	40
26	-56	45
-49	-64	-10
-23	-94	-10
38	-79	30
34	-83	15
38	-86	-15
-38	15	5
-4	4	55
-34	-8	50
-53	0	30
45	8	25
-23	-68	45
30	-56	40
-26	-90	-5
-41	-68	-10
38	-83	-15
45	-60	-20
-34	19	10
-19	-38	-5
-11	0	55
-26	-11	50
-45	-8	35
-49	4	30
45	0	45
-23	-68	45
26	-64	35
-41	-68	-15
34	-83	15
49	-56	10
-34	15	5
34	23	5
-8	0	55
45	-4	45
-41	-8	40
-45	4	30
15	-68	50
26	-56	45
49	-49	15
53	-64	5
-53	-64	-10
41	-56	-20
-41	-53	-25
-38	15	10
-49	-4	30
-30	-11	45
-8	0	55
-30	26	-5
30	-56	45
-30	-56	45
-38	-45	40
-11	0	55
-34	-8	50
-45	-8	40
-49	4	30
45	0	45
-8	-56	45
26	-56	45
-26	-4	55
23	0	50
-30	-11	45
-45	-4	40
-15	-64	55
-34	-45	45
23	-56	45
34	-79	25
49	-71	-5
-34	-83	-15
-38	-68	-15
45	-79	-15
41	-64	-20
-34	26	0
-23	-8	50
23	-8	50
-15	-64	55
23	-60	50
38	-79	35
-45	-64	0
-45	-60	-15
-34	4	25
-38	11	5

// Mort D J, 2003: Reflexive > Voluntary
// Mort D J, 2003: Voluntary > Reflexive
// Subjects=12
-40	0	44
-30	-54	52
-44	-74	6
28	-6	50
36	-58	58
44	-74	-6
-46	-76	32
-6	-30	64
42	-66	30
20	-30	66
2	-44	34
10	38	58

// Sylvester C C, 2003: Normals, Group 1
// Subjects=14
15	-64	55
-22	-64	50
34	-45	35
-34	-49	55
26	-8	60
-34	0	55
45	26	25
-38	30	30
-26	-82	15
34	19	5
-26	26	10
-8	15	50
19	-8	20
-15	-8	15
11	-68	45
38	-56	50
-38	-41	45
26	0	55
-30	4	55
56	22	40
-49	26	40
-34	-75	20
-30	26	10
15	19	35
-8	11	50

// Sylvester C C, 2003: Normals, Group 2
// Subjects=14
-15	-56	55
-45	-41	50
-41	8	30
11	-60	0
-11	-64	0
0	11	50
11	30	-5
-15	-26	-10
22	-52	60
-22	-49	60
26	-45	50
-38	-38	40
30	0	50
-19	0	50
22	49	10
-26	49	15
-8	11	50
15	-15	25
-11	-4	25
-11	-19	20
-34	5	37
32	-41	47
-36	-41	47
0	10	49
-8	-64	55
-11	-64	0
22	64	0
-26	-86	25
19	-8	60
15	-56	60
22	52	10
8	11	10
-15	4	10

// Garavan H, 2003: Task-Related Performance
// Garavan H, 2003: Event-Related STOPS
// Garavan H, 2003: Event-Related ERRORS
// Subjects=16
-.66	9.67	50.89
46.05	-10.82	1.89
21.44	-35.43	-11.38
-7.2	-63.13	4.65
-51.91	-73.66	23.89
40.02	-18.98	48.36
1.58	-44.13	43.11
1.57	-68.42	31.76
18.39	-71.23	-6.11
15.65	-42.25	66.21
-2.68	-86.85	27.78
6.86	-96.37	13.97
43.92	33.17	20.53
27.88	50.6	27.06
42.22	-43.55	47.05
-43.32	-41.31	42.27
34.9	-65.03	58.98
53.59	-37.56	-.42
6.55	-66.7	-15.28
-2.08	37.93	17.31
10.77	29.46	16.76
10.86	20.54	25.31
3.56	17.98	47.91
-42.33	-64.08	22.98

// De Souza J F, 2003: Selectively Activated for Saccades (Both Pro and Anti)
// Subjects=10
37.54	48.88	31.55
38.94	-2.61	53.69
9.02	3.81	56.85
26.3	-60.13	54.2
11.09	-78.19	14.63
-32.64	-6.13	55.93
-1.67	2.6	55.95
-21.78	-58.13	56.82
-3.86	-79.26	16.01

// MacDonald III A W, 2003: Schizophrenic Patients
// Subjects=17
-37.95	-28.88	51.2
46.41	-29.06	41.33
41.75	41.62	19.84
-35.07	14.89	25.2
4.54	20.3	36.56

// MacDonald III A W, 2003: Normal Subjects
// Subjects=17
-42.31	-17.79	43.63
58.08	-18.84	34.76
43.01	13.93	33.3
38.44	25.17	0.07
-29.96	16.93	-4.03
17.18	-12.31	-1
5.74	-50.76	25.77

// Markowitsch H J, 2003: Sad > Happy
// Markowitsch H J, 2003: Happy > Sad
// Markowitsch H J, 2003: Sad > Fixation
// Markowitsch H J, 2003: Happy > Fixation
// Subjects=13
-52	24	-2
54	34	-6
64	-28	-12
-10	-60	-24
14	26	-10
-24	24	48
-30	-28	-16
-24	24	48
12	20	26
-44	44	10
28	10	2
4	-48	-18
32	-56	2
14	16	28
-16	20	48
-12	-45	4
-26	-58	16
-22	-4	-4

// Pelletier M, 2003: Sad - Neutral
// Pelletier M, 2003: Happy - Neutral
// Pelletier M, 2003: Sad - Happy
// Pelletier M, 2003: Happy - Sad
// Subjects=9
-38	50	-9
-50	34	-8
6	60	3
-6	60	2
36	52	-9
2	-33	-33
-4	-34	-29
-48	8	-30
-38	50	-10
34	50	-9
2	-30	-29
-6	61	1
-6	59	21
-53	13	-20
6	60	6
-53	30	2
-42	35	10
4	-26	-17
-2	-26	-17
24	7	-17
-24	56	-13
-6	61	10
2	58	7

// Winston J S, 2003: High vs. Low Intensity
// Winston J S, 2003: Effect of Highly Emotional Faces, Independent of SubType 
// of Emotion
// Winston J S, 2003: Effect of Highly Emotional Faces, Independent of SubType 
// of Emotion and Task
// Winston J S, 2003: Emotion Task vs. Gender Task
// Winston J S, 2003: Interaction Between Task and Intensity of Emotion
// Subjects=11
34	-72	-20
-36	-46	-24
34	0	-26
-24	-6	-18
30	-4	-22
-24	-2	-24
28	-66	-12
-30	-42	-20
-26	-2	-22
-38	-46	-18
46	-60	-22
44	-12	48
-8	-58	16
-16	42	-8
58	-34	8
40	-24	4
-40	-16	-8
-56	-12	12
10	4	48

// Gould R L, 2003: Positive zero-order relationship with task difficulty 
// during 100% successful attempts of encoding
// Gould R L, 2003: Positive zero-order relationship with task difficulty 
// during 100% successful attempts of retrieval
// Gould R L, 2003: Encoding - Retrieval
// Gould R L, 2003: Retrieval - Encoding
// Subjects=11
-28.58	8.26	46.63
15.02	-57.66	62.5
-7.15	23.45	35.8
-35.71	-60.1	-18.2
31.61	-85.75	2.24
-46.32	26.66	14.86
27.85	-72.79	49.21
50.99	-75.26	-1.37
34.14	-74.22	33.55
-11.82	-12	1.28
-41.46	1.18	52.03
31.9	12.72	45.16
31.3	-49.77	-14.76
-30.69	-78.91	32.88
-43.6	-7.44	51.8
-4.95	20.48	38.29
35.92	-92.43	-.53
9.77	-62.4	-10.9
-16.07	-15.85	6.22
-52.57	16.39	31.67
38.62	-64.25	48.18
25.74	-70.26	53.47
-38.21	27.1	-26.79
44.61	-52.66	11.07
30.91	35.96	-27.72
-3.7	57.42	-25.89
-51	27.24	-13.14
31.19	-12.34	-16.22
-60.22	-1.79	21.27
18.99	-85.43	29.32
57.47	-1.9	13.67
-31.05	-33.47	13.82
7.64	-66.56	-9.34
-39.19	-45.06	50.97
-39.23	-9.24	55.27

// Sperling R A, 2003: Attempted Encoding, All Face-Name Pairs vs. Fixation
// Sperling R A, 2003: Successful Encoding, High Confidence Correct vs. 
// Incorrect
// Subjects=16
-42	-48	-24
42	-39	-27
-24	-27	-6
21	-30	-3
-12	-12	-9
9	-9	0
-36	-3	57
-60	9	18
42	12	24
-9	15	42
6	18	45
-33	24	0
27	24	-6
-30	-21	-18
33	-15	-33
-36	0	12
-45	0	27
-51	21	6

// Hamzei F, 2003: Active vs. Passive
// Hamzei F, 2003: Verb vs. Rest
// Subjects=12
-51	9	-9
-39	-45	60
-57	-42	42
-57	9	27
-48	15	6
-51	24	-12
-42	3	33

// Laurens K R, 2003: Schizophrenics > Controls, Error of Commission
// Laurens K R, 2003: Schizophrenics > Controls, Correct Rejects
// Subjects=10
-24	-72	44
-36	-44	40
-28	-44	64
20	-64	52
28	-80	32
16	-72	60
24	-12	60
28	-4	48
40	8	40
40	-36	44
32	-40	52
20	-60	56
-28	-56	48
-20	-76	48
-24	-76	32
-44	-80	0
-16	-84	4
-20	-80	-4

// Weiss E M, 2003: Controls
// Subjects=13
-40	4	32
12	12	40
28	-56	44
-24	-64	36
28	-72	20
28	-84	4
-20	16	16
-28	20	-4
40	20	20
56	4	32
-56	4	36
0	-8	40
16	-76	36
56	-4	-8
-44	-72	8
-60	56	12
-40	-88	16
-4	44	36
20	48	28
-4	36	-8
-32	36	-8
28	-44	0
-36	-52	0
48	-8	4
-56	8	24
44	24	40
-40	-24	40
44	-52	52
-20	-60	24
-4	-88	16
8	-12	0
36	8	20
-36	-4	-4

// Weiss E M, 2003: Schizophrenia Patients
// Subjects=13
52	4	32
32	28	-8
28	44	16
-4	-8	56
-16	8	32
-56	-28	40
32	-68	28
-20	8	-8
-12	-12	-4
56	4	32
-56	4	36
0	-8	40
16	-76	36
56	-4	-8
-44	-72	8
-60	56	12
-40	-88	16
0	-52	28
-8	-24	28
-8	12	0
-20	-44	4
20	-40	4
-48	-40	48
-28	-68	48
40	-12	48

// Hofer A, 2003: Schizophrenic Subjects
// Subjects=10
-36	16	18
-30	26	4
-36	0	27
-24	-76	0
-24	-76	22
32	-84	-4
18	50	18
22	40	22
14	30	18
-46	-42	4
-34	18	14
-38	10	27
-44	-48	54
-36	-30	45
-44	-28	45
-42	26	18
-38	0	27
46	30	9
-54	-46	4
-62	-42	0
-40	-44	22
58	-40	0

// Hofer A, 2003: Comparison Subjects
// Subjects=10
-40	6	22
-40	38	0
42	4	27
34	38	-4
24	48	0
-22	42	4
-48	-48	9
18	50	18
22	40	22
14	30	18
-46	-42	4
-32	22	-4
-42	4	27
-42	24	18
-4	14	45
-2	-4	58
46	6	27
46	12	18
48	32	18
6	20	40
-32	-90	4
-26	-72	32
-24	-82	18
30	-86	4
30	-86	18
28	-76	22
-42	26	18
-38	0	27
46	30	9
-54	-46	4
-62	-42	0
-40	-44	22
58	-40	0

// Hofer A, 2003: Comparisons > Schizophrenics, Encoding
// Hofer A, 2003: Comparisons > Schizophrenics, Recognition
// Hofer A, 2003: Schizophrenics > Comparisons, Recognition
// Subjects=10
24	53	6
24	53	-3
-12	-31	35
20	-56	16
-10	-52	11
-16	-69	20
-44	26	15
-36	31	7
-38	8	33
-4	20	45
-30	-27	51
12	42	18
6	21	36
12	-50	19
-40	1	17
36	14	16
-34	-89	8
-20	-64	7
-16	-77	12
32	-84	21
44	-75	24
6	-69	16
8	-79	21
18	-91	13
20	-73	7
-8	51	1
-44	-5	25
12	51	6
16	47	-2

// Kumari V, 2003: Depressed Subjects
// Subjects=6
39.35	-24.86	-41.47
13.41	-80.7	37.12
-19.91	-41.14	28.61
-33.36	23.74	-25.75
-51.9	-60.37	30.59
-29.47	-30.74	40.11
-8.15	-82.71	13
25.61	48.07	8.33
23.33	46.6	-10.47
28.65	41.97	-15.72
54.59	13.35	10.91
16.96	35.99	-9.51
35.26	13.35	-1.13
16.07	-62.13	-25.81
-30	8.84	-12.27
-41.91	23.69	-25.65
-5.28	-68.6	-25.02
13.55	29.43	-39.03
39.49	37.06	2.41
35.39	31.09	21.91
1.32	8.05	29.81
5.32	19.51	-1.3
35.06	-22.77	-41.59
46.86	4.13	-25.03
27.77	15.42	-1.22
39.71	3.11	17.52
-49.05	20.56	17.08
-17.01	26.04	16.25
-3.33	21.69	-13.65
-3.02	13.94	23.79
-41.67	-26.64	-15.85
-11.81	-61.12	-37.84
-28.53	-85.89	1.23
9.01	-60	29.86
29.22	-58.71	17.25
47.31	-38.51	15.35
11.23	-56.93	41.84
16.04	-53.67	-26.52
-17.07	29.84	10.35
-13.69	-15.61	14.13
-18.89	-53.71	17.38
-39.68	-.62	-23.63
-19.77	-55.01	42.03
-23.45	-53.39	-19.39
35.49	-60.13	-1.66
54.69	-62.56	-7.26
62.28	-42.65	15.52
62.32	-42.22	21.06
31.99	-33.48	-28.39
30.98	-35.09	-21.55
35.24	-45.09	-27.46
-4.95	-31.11	33.17
-41.23	-56.08	30.1
-48.77	-64.46	18.63
-44.47	-60.84	23.85
-28.94	-28.56	-28.11
-1.67	-49.07	34.64
-16.63	-49.16	34.82
51.63	9.3	41.4
13.05	-47.06	4.19
35.45	-62.67	-7.03
31.26	-83.84	-5.2
25.74	-61.56	-19.27
-15.25	40.77	-27.39
-30.1	11.07	-24.72
-30.06	11.5	-19.18
-30.01	12.01	-12.54
-33.2	18.77	-7.49
-26.75	21.44	-1.1
-52.32	1.19	0.89
-26.62	-1.4	6.39
-32.99	2.25	12.85
-33.37	12.65	-31.51
-10.41	-86.21	-4.52
16.04	35.32	9.51
-2.81	-65.16	19.27
-37.39	8.68	0.09
5.48	-79.82	-19.74
54.74	-23.58	15.12
-48.04	-32.76	-11.92
-44.43	-64.81	27.53
-18.61	-55.2	53.19
-7.61	41.38	-6.34
61.32	-53.6	25.37
-8.15	-65.19	19.34
-23.36	-83.17	-19.13
25.45	10.18	-27.52
22.24	29.88	-20.21
4.16	15.31	-14.32
3.16	18.19	-4.51
-47.94	9.99	17.95
33.32	25.25	29.12
19.13	29.74	-7.9
-43.68	-34.08	-1.82
-40.09	-27.92	50.03
30.91	-20.46	-25.01
-2.09	-28.09	-10.61
-42.86	19.95	-11.94
-43.59	-73.19	-5.24
14.07	-35.42	3.2

// Kumari V, 2003: Control Subjects
// Subjects=6
17.08	41.67	8.97
27.93	35.71	27.19
5.22	32.74	-9.1
13.22	-56.26	22.8
19.38	-25.87	2.34
5.46	-44.87	-8.17
-2.85	-56.79	17.46
-2.78	-74.76	18.96
-10.19	-81.78	25.21
-44.83	23.33	11.22
-44.74	24.27	23.41
-20.84	-55.01	42.05
-49.25	-25.51	-28.13
25.76	-67.9	-18.74
-6.6	50.65	-10.47
-20.01	10.55	36.54
4.24	-66.31	-37.59
-55.17	-31.41	33.77
-23.3	-43.05	4.27
-8.49	-77.51	-29.81
4.27	40.54	9.21
7.48	48.39	14.09
4.36	40.42	21.49
4.39	45.08	26.67
8.73	39.28	33.8
19.09	-12.41	-30.01
1.25	-36.56	3.44
50.31	-34.03	-9.6
54.69	-37.29	2.89
44.07	-44.33	9.18
38.79	-47.02	16.16
47.37	-43.37	21.33
29.33	-39.91	40.2
4.75	-52.2	34.83
8.02	-54.84	41.7
-32.85	-62.14	5.98
-39.24	-54.35	10.98
-29.59	-50.6	17.24
-29.54	-53.35	23.05
10.47	19.77	-25.92
19.03	27.66	-21.1
24.35	24.09	-26.44
35.1	18.24	-20.5
31.94	18.73	-13.81
31.98	19.16	-8.27
32.12	20.61	10.56
32.17	21.04	16.1
14.22	11.19	41.67
1.29	15.46	29.19
44.09	-23.3	19.68
44.12	-17.5	25.89
58.05	-16.99	31.26
62.37	-16.45	37.86
57.79	2.28	5.11
41.91	-23.74	14.17
-11.87	42.67	-3.05
-5.03	16.36	41.46
-11.48	-47.84	10.11
-11.45	-44.15	16.49
-1.66	-12.72	50.55
-37.55	2.57	-23.93
-33.24	3.02	-18.44
-26.71	-26.55	-16.03
-29.88	-22.88	-9.61
-10.39	-90.44	-4.17
-13.88	-65.91	-30.72
-5.3	-62.26	-25.55
16.04	35.32	9.51
-2.81	-65.16	19.27
-37.39	8.68	0.09
5.48	-79.82	-19.74
54.74	-23.58	15.12
-48.04	-32.76	-11.92
-44.43	-64.81	27.53
-18.61	-55.2	53.19
-7.61	41.38	-6.34
61.32	-53.6	25.37
-8.15	-65.19	19.34
-23.36	-83.17	-19.13
25.45	10.18	-27.52
22.24	29.88	-20.21
4.16	15.31	-14.32
3.16	18.19	-4.51
-47.94	9.99	17.95
33.32	25.25	29.12
19.13	29.74	-7.9
-43.68	-34.08	-1.82
-40.09	-27.92	50.03
30.91	-20.46	-25.01
-2.09	-28.09	-10.61
-42.86	19.95	-11.94
-43.59	-73.19	-5.24
14.07	-35.42	3.2

// Perlstein W M, 2003: Schizophrenics
// Subjects=16
36.77	6.89	52.92
6.7	19.43	38.83
43.86	41.38	16.49
-38.42	41.94	17.39
48.15	18.51	9.44
-40.52	18.15	12.72
47.54	-53.63	40.03
-35.8	-50.79	42.98
2.19	15.95	7.95
36.77	6.89	52.92
6.7	19.43	38.83
48.15	18.51	9.44
-40.52	18.15	12.72
47.54	-53.63	40.03
-35.8	-50.79	42.98
47.14	32.22	21.68
47.14	32.22	21.68
47.14	32.22	21.68
47.05	45.62	16.1
-28.79	49.83	22.19
-40.49	29.5	21.8
2.38	27.78	37.07
-45.77	7	20.41
47.05	45.62	16.1
2.38	27.78	37.07
-45.77	7	20.41
47.05	45.62	16.1
-28.79	49.83	22.19
-40.49	29.5	21.8
2.38	27.78	37.07
-45.77	7	20.41
35.31	57.79	23.02
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
35.31	57.79	23.02
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
43.94	29.03	21.99
54.96	-44.33	35.82
43.94	29.03	21.99
54.96	-44.33	35.82
43.94	29.03	21.99
54.96	-44.33	35.82

// Perlstein W M, 2003: Normals
// Subjects=15
36.77	6.89	52.92
6.7	19.43	38.83
43.86	41.38	16.49
-38.42	41.94	17.39
48.15	18.51	9.44
-40.52	18.15	12.72
47.54	-53.63	40.03
-35.8	-50.79	42.98
2.19	15.95	7.95
36.77	6.89	52.92
6.7	19.43	38.83
43.86	41.38	16.49
-38.42	41.94	17.39
48.15	18.51	9.44
-40.52	18.15	12.72
47.54	-53.63	40.03
-35.8	-50.79	42.98
2.19	15.95	7.95
47.14	32.22	21.68
47.14	32.22	21.68
47.14	32.22	21.68
47.05	45.62	16.1
-28.79	49.83	22.19
-40.49	29.5	21.8
2.38	27.78	37.07
-45.77	7	20.41
47.05	45.62	16.1
2.38	27.78	37.07
-45.77	7	20.41
47.05	45.62	16.1
-28.79	49.83	22.19
-40.49	29.5	21.8
2.38	27.78	37.07
-45.77	7	20.41
35.31	57.79	23.02
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
35.31	57.79	23.02
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
52.51	28.19	24.19
3.22	45.19	14.41
-43.63	11.5	23.35
46.45	-48.44	38.49
-40.12	-49.04	38.42
43.94	29.03	21.99
54.96	-44.33	35.82
43.94	29.03	21.99
54.96	-44.33	35.82
43.94	29.03	21.99
54.96	-44.33	35.82

// Linden D E J, 2003: Encoding
// Linden D E J, 2003: Middle and Late Delay
// Subjects=12
-41.46	-67.28	-4.64
50.48	-62.95	1.75
-38.27	19.36	28.2
35.44	33.81	29.49
-25.17	-5.11	54.64
28.25	-6.02	51.87
-5.06	22.62	39.82
9.89	17.08	35.65
-4.92	3.21	50.36
12.13	0.6	42.58
-51.05	7.65	29.33
36.81	-31.15	42.73
-45.46	-42.47	41.28
-36.87	-45.25	45.87
-28.3	-63.69	40.63
36.87	-43.66	46.01
-17.6	-67.85	40.86

// Davidson R J, 2003: Prior to Drug Administration vs. 2 Weeks Venlafaxine
// Davidson R J, 2003: Prior to Drug Administration vs. 8 Weeks Venlafaxine
// Davidson R J, 2003: Negative Images vs. Neutral Images, Prior to Drug 
// Administration
// Davidson R J, 2003: Positive Images vs. Neutral Images, Prior to Drug 
// Administration
// Subjects=5
32	-4	20
36	-6	6
12	34	14
-34	-56	-16
43	10	24
-18	-6	-10
20	-4	-14
-44	-66	4

// Daselaar S M, 2003: Young Normals
// Subjects=26
-48	29	-6
3	5	49
12	9	63
-12	15	63
6	5	36
-56	-15	42
59	-10	42
-45	-17	1
50	-11	3
24	0	0
-12	-2	8
-12	9	2
15	-8	9
-24	-56	55
12	-55	58
15	-79	-6
-6	-85	-6
18	-78	-15
24	22	-19
48	-70	-2
-24	-99	8

// Daselaar S M, 2003: Old Normals
// Subjects=34
-59	10	24
36	-4	44
-36	6	52
-27	39	15
9	0	55
30	-17	62
-6	3	63
-3	2	39
-39	-29	54
36	-4	44
-50	-20	18
45	-29	54
59	-20	12
-48	6	-5
0	-90	5
-12	6	11
-18	-8	6
27	3	3
36	-33	38
-56	-28	24
3	-41	63
15	-95	19
-18	-73	-11
24	-50	-18
-9	23	-11
45	-67	-4
18	28	-14

// Lloyd D M, 2003: Normals, Group 1
// Subjects=10
26	-54	42
-46	-52	50
-46	-64	38
-46	-54	22
-46	8	46

// Lloyd D M, 2003: Normals, Group 2
// Subjects=7
24	4	58
24	-44	72
24	-54	58
24	-78	12
24	-66	-16

// Quintana J, 2003: Schizophrenic Patients
// Subjects=8
-49.87	0.06	41.11
37.53	37.79	25.79
-56.59	31.97	13.97
-60.73	6.91	20.58
-34.55	-57.7	63.62
44.35	-21.61	55.23
-41.19	-35.84	44.02
-52.37	5.08	-3.89
-41.47	27.09	32.05
44.01	16.51	25.27
-50.17	29.9	14.08
-1.09	-62.92	-34.47
23.11	-64.38	54.6
-47.55	-28.85	52.43
48.2	9.16	12.45
-32.45	-40.42	66.61
31.62	-58.16	51.75
-38.97	-28.46	56.76
-41.46	29.37	34.09
-58.6	6.92	20.56
-45.3	-49.64	58.61
-32.42	-70.89	58.01
42.29	-49.46	53.12
-32.58	-50.6	45.16
37.98	-54.23	46.88

// Quintana J, 2003: Normal Subjects
// Subjects=8
-41.71	22.4	-1.01
-52.41	15.65	-4.78
52.36	7.99	-3.11
48.39	11.05	36.83
-43.93	25.93	-10.2
52.49	24.68	20.02
-28.18	-62.4	57.25
-47.56	-26.74	52.25
-60.68	14.11	31.13
58.87	9.06	10.11
21.03	-57.19	65.17
-47.57	-29.02	50.21
44.37	-25.84	55.58
-52.4	13.54	-4.6
50.16	11.69	-10.09
-58.55	18.35	30.75
43.7	19.94	-12.93
-54.57	17.58	-7.15
-52.16	9.42	24.74
-32.48	-60.48	54.91
-51.85	-31.33	48.22
-43.2	-54.37	52.29
33.69	-50.03	46.58

// Stoesz M R, 2003: Macrospatial vs. Microspatial Form Discrimination
// Subjects=6
18	3	72
39	-42	42
39	36	30
18	-30	9
18	6	6
51	24	3
60	-57	3
-42	-63	3
-21	-39	2
24	-69	-45
-8	-66	-48

// Schlosser R, 2003: 2-Back vs. 0-Back, Schizophrenics and Normals
// Subjects=6
-43.8	9.71	40.02
59.81	15.83	30.93
-59.63	21.89	-12.46
46.29	18.22	-11.66
-36.99	-44.75	54.26
56.05	-41.25	63.53
-3.03	-20.71	10.96
-29.38	-65.58	-31.21
35.38	-72.35	-38.37

// Kotz S A, 2003: Normal Speech > Prosodic Speech
// Kotz S A, 2003: Prosodic Speech > Normal Speech
// Kotz S A, 2003: Prosodic Effects in Normal Speech, Positive > Neutral
// Kotz S A, 2003: Prosodic Effects in Normal Speech, Negative > Neutral
// Kotz S A, 2003: Prosodic Effects in Prosodic Speech, Positive > Neutral
// Kotz S A, 2003: Prosodic Effects in Prosodic Speech, Negative > Neutral
// Subjects=12
-3.32	63.59	5.14
-45.01	24.7	-12.31
-54.37	-16.63	4.64
-42.23	-59.8	37.12
-3.79	-49.96	36.97
-26.71	4.26	-3
-10.52	-30.2	4.16
59.92	-11	-1.6
24.57	1.14	-6.68
38	-56.26	48.17
-23.73	51.35	-13.68
-49.03	21.87	20.31
-33.01	-22.13	0.4
-10.69	15.27	0.35
27.56	51.66	-14.29
40.79	8.66	20.39
34.15	26.12	-1.07
11.77	16.72	3.32
-52.4	14.68	-3.58
-49.25	30.56	-4.95
-45.78	-21.61	8.31
-55.35	-29.95	11.35
-45.67	-50.16	10.7
-6.38	3.58	0.17
56.63	15.59	-1.56
50.54	-52.49	13.14
50.63	-44.95	28.12
6.41	9.83	-2.74
-42.68	4.76	4.94
-60.75	-11.92	11.01
35.43	-2.54	13.58
-28.93	24.25	-5.77
-55.6	21.26	-.75
-49.3	37.71	-8.89
-51.17	-13.35	5.45
-57.46	-34.11	12.84
-32.65	-44.76	37.98
-8.59	21.46	-2.42
48.12	24.77	7.8
30.9	42.04	-1.26
11.71	18.24	-4.62
-30	24.25	-5.76
-45.92	24.21	8.93
-54.55	23.3	-2.05
-49.3	37.71	-8.89
-46.01	35.32	1.3
-50.1	-13.34	5.43
-56.41	-32.07	11.54
-31.53	-46.36	44.79
-8.54	13.17	0.5
43.79	36.2	4.66
43.91	23.23	15.78
12.78	17.19	-4.54

// Mitchell R L C, 2003: Pure Congruent Prosody vs. Rest
// Mitchell R L C, 2003: Congruent Prosody vs. Neutral Prosody
// Mitchell R L C, 2003: Neutral Prosody vs. Congruent Prosody
// Mitchell R L C, 2003: Congruent Prosody vs. Rest
// Mitchell R L C, 2003: Incongruent Prosody vs. Rest
// Mitchell R L C, 2003: Congruent Prosody vs. Incongruent Prosody
// Mitchell R L C, 2003: Incongruent Prosody vs. Congruent Prosody
// Mitchell R L C, 2003: Semantics vs. Prosody
// Mitchell R L C, 2003: Prosody vs. Semantics
// Mitchell R L C, 2003: Attention to semantics induced activity positively 
// covarying with performance accuracy
// Subjects=13
62.57	-8.52	-11.53
-57.35	-8.94	-9.45
-37.02	7.55	62.53
65.96	-56.68	-10.19
46.22	39.59	-12.65
-24.61	62.54	29.99
17.92	-52.49	37.28
1.54	-27.65	28.38
52.7	6.78	-19.6
-54.04	40.8	5.74
-37.2	19.38	51.28
65.76	-5.63	-15.23
-47.41	-20.43	4.97
50.46	-41.56	49.09
62.87	26.5	18.61
52.9	44.37	3.57
56.14	-21.31	-10.16
-60.51	-18.22	-5.11
60.09	-16	46.4
-57.19	-27.46	-.89
-54.27	-.29	-20.44
72.63	-38.84	8.1
-11.73	-16.8	7.36
-31.27	18.54	7.56
-2.5	35.3	-21.48
-21.31	-74.89	6.55
52.87	8.02	-6.28
-49.9	-47.67	58.13
1.47	-87.26	10.75
-1.42	-91.16	38.08
-14.1	-30.03	72.58
-31.4	-25.12	-11.65
-40.3	7.23	59.26
-2.14	-4.62	-.73
-57.44	-29.33	-20.88
-23.86	-66.41	62.9
-50.43	23.85	30.89
-63.17	-13.86	41.56
2.1	-29.98	72.3
46.45	-40.8	-11.43
5.32	-13.7	74
-56.83	-54.31	21.93
66.32	-40.8	21.85
-11.92	44.14	4.7
-56.81	-37.73	27.01
59.71	-5.73	18.5
27.34	37.2	31.61
-37.75	41.48	12.12

// Hariri A R, 2003: Match Pictures vs. Match Forms
// Hariri A R, 2003: Label Pictures vs. Match Forms
// Hariri A R, 2003: Match Pictures > Label Pictures
// Hariri A R, 2003: Label Pictures > Match Pictures
// Hariri A R, 2003: Positively Correlated (with response to the left 
// amygdala)
// Hariri A R, 2003: Negatively Correlated (with response to the left 
// amygdala)
// Subjects=11
26	-5	-12
-22	-5	-12
-45	18	-5
45	18	-5
-45	23	17
23	48	-10
-23	48	-10
45	18	-5
-45	18	-5
-45	23	17
0	24	40
23	48	-10
-23	48	-10
26	-8	-12
-26	-8	-12
38	-41	-11
-38	22	-5
38	18	-5
-49	22	22
0	24	40
24	-6	-16
-40	18	12
-24	-70	-12
32	-52	-12
34	44	4
0	30	28

// Jensen J, 2003: Normals, Group 1
// Subjects=11
-15.78	3.64	-3.49
23.74	-4.34	4.58
-35.58	7.51	0.45
31.67	11.63	0.88
3.81	34.88	32.99
-8.13	10.42	-2.66
12.09	6.31	-4.71
-44.5	14.65	5.5

// Jensen J, 2003: Normals, Group 2
// Subjects=17
-11.8	3.71	-7.46
7.96	3.7	-3.35
-39.52	19.48	-3.37
55.43	7.77	-3.04
19.81	35.49	-2.8
-8.04	3.09	32.43
19.98	-47.45	-31.99
51.35	-28.41	24.3

// Durston S, 2003: Compatible Increased, Incompatible Decreased
// Durston S, 2003: Compatible Increased, Incompatible No Monotonic 
// Relationship
// Durston S, 2003: Compatible No Monotonic Relationship, Incompatible 
// Increased
// Durston S, 2003: Compatible Decreased, Incompatible No Monotonic 
// Relationship
// Subjects=9
-39.29	23.13	35.71
21.54	44.64	33.2
4.26	47.05	10.9
-32.49	-44.19	59.12
32.69	-52.61	54.61
35.8	-40.41	46.86
-40.36	-59.27	2.48

// Gusnard D A, 2003: Correlation between Personality Trait (Persistence) and 
// Percentage of Neutral Images in Image Set
// Subjects=24
4.23	39.05	3.76
-12.83	10.77	-2.59
-27.91	13.89	-16.06
49.07	16.97	-10.52
8.54	6.5	-4.71

// Hazeltine E, 2003: Incongruent - Neutral (Conjunction of Color and Letter)
// Hazeltine E, 2003: Incongruent - Neutral (Color > Letter)
// Hazeltine E, 2003: Incongruent - Neutral (Letter > Color)
// Subjects=10
48.87	29	23.09
16.66	31.5	40.2
-26.22	10.88	63.14
27.67	15.56	52.79
-34.9	-15.71	54.71
45.14	-35.53	56.43
48.95	8.79	25.09
-54.68	15.63	35.14
38.26	29.35	38.92
-43.66	-17.74	44.98
40.97	-23.46	70.99
-34.98	-58.95	39.94

// Volz K G, 2003: Prediction Under Uncertainty vs. Prediction Under Certainty
// Volz K G, 2003: Positive Covariation with Increasing Prediction Uncertainty
// Subjects=16
9.94	24.19	45.09
-11.82	13.52	-8.41
23.41	16.65	-12.42
-14.78	-16.93	10.9
9.74	-16.24	3.87
9.64	-17.27	-9.42
43.8	22.03	0.27
2.23	-72.7	-23.65
5.75	-72.68	17.57
5.61	36.86	44.08
9.74	-9.64	6.67
40.54	13.84	-9.04
-18.12	-76.51	-29.78
19.61	8.39	46.3
40.83	26.69	33.37
50.76	-51.32	42.03

// de Araujo I E T, 2003: MSGIMP + MSG + IMP vs. Tasteless Solution
// de Araujo I E T, 2003: MSGIMP vs. MSG + IMP
// Subjects=10
54	12	10
-58	18	2
-34	26	-6
-4	30	36
52	12	10
-44	34	-18

// Rubia K, 2003: NoGo, Successful Inhibition - NoGo, Unsuccessful Inhibition
// Rubia K, 2003: NoGo, Unsuccessful Inhibition - Go Response
// Subjects=20
44.78	27.69	-9.13
42.66	37.8	-2.15
0.98	62.73	7.39
4.28	38.51	10.5
52.38	55.34	17.45
-48.11	63.12	16.84

// Shapira N A, 2003: OCD Patients
// Subjects=8
-24.74	9.16	-22.4
-45.06	25.33	-17.94
45.79	22.7	-18.76
35.29	13.6	2.19
-2.26	17.38	-14.42
-42.46	-79.71	-.24

// Shapira N A, 2003: Normals
// Subjects=8
-35.12	-73.47	-16.46
25.78	-68.79	-16.44
-25.79	8.18	-21.19
23.34	14.82	-22.31
-42.93	26.31	-19.16
43.65	23.83	-17.72
-3.33	16.23	-15.43
-26.49	-71.5	-5.57
29.08	-70.03	-5.22
-41.39	-78.56	0.77
-19.27	14.88	-3.98
20.26	12.83	-6.49
-47.82	-71.12	1.33
-56.45	-43.5	1.34
-51.09	-45.5	2.57
-18.9	-78	6.04
-37.39	13.08	1.96
36.34	14.58	0.98
-5.43	46.31	2.15
-55.3	-31.64	17.06
62.26	-31.9	16.85
-42.66	44.54	23.91
42.85	43.11	25.28
57.02	-19.91	34.86
45.39	-39.55	43.34
-32.97	-79.88	-17.06
25.79	-73.1	-17.19
-26.85	1.75	-21.75
24.43	6.28	-22.72
-36.17	-63.36	-9.49
-7.62	21.58	-14.71
-24.35	-70.35	-4.58
30.15	-67.73	-3.19
-39.24	-80.67	0.92
39.83	-79.14	-.12
-22.46	2.97	-6.29
23.5	2.19	-6.75
-49.97	-69.1	0.07
-32.85	-73.14	1.33
41.95	-70.58	0.25
-52.17	-45.59	1.47
-48.93	-51.83	3.07
-17.82	-80.02	7.31
-3.29	45.18	1.1
-56.35	-31.47	19.29
63.33	-29.7	17.77
-40.5	41.47	25.26
41.78	40.82	23.25
44.35	-38.16	47.69
-25.04	-54.35	50.96
-39.09	3.26	54.1
-24.74	9.16	-22.4
-45.06	25.33	-17.94
45.79	22.7	-18.76
35.29	13.6	2.19
-2.26	17.38	-14.42
-42.46	-79.71	-.24

// Ursu S, 2003: OCD Patients > Normals, Error-Related Activation (Whole Brain 
// Analysis)
// Subjects=11
-56.39	10.97	31.35

// de Araujo I E T, 2003: Sucrose + Strawberry - Tasteless Solution
// de Araujo I E T, 2003: Sucrose - Tasteless Solution
// de Araujo I E T, 2003: Strawberry Odor - Tasteless Solution
// Subjects=11
14	26	-6
42	18	-6
-31	22	0
64	-4	20
64	14	16
8	8	-10
-18	-2	-24
20	-4	-24
8	11	49
-42	28	20
-32	50	-10
10	22	-12
45	15	-9
64	-4	20
-62	-10	14
8	8	-12
-18	0	-26
20	-4	-24
6	6	50
38	23	-7
45	15	-8
64	-4	20
8	8	-12
-20	-4	-24
18	-2	-26
6	10	52

// de Araujo I E, 2003: Water - Tasteless
// de Araujo I E, 2003: Water AND Salt AND Glucose
// de Araujo I E, 2003: Water - Tasteless, Pre- vs. Post-Satiety
// de Araujo I E, 2003: Water, Pre- vs. Post-Satiety
// de Araujo I E, 2003: Brain Activity Correlated with Pleasantness Ratings of 
// Water
// Subjects=11
37	22	3
-33	22	3
-60	-2	18
-1	35	-16
9	19	-16
1	24	39
37	6	-4
39	24	4
2	30	-18
2	40	16
-2	32	37
40	20	0
-40	20	0
6	22	-7
34	-4	-4
-3	45	-16
16	46	-16
-2	19	28
-2	-5	43
47	-1	6

// van der Wee N J A, 2003: OCD Patients
// Subjects=11
-1	24	44
43	31	30
26	13	61
-29	13	58
-33	24	1
-43	31	30
21	-74	53
-49	-49	53

// van der Wee N J A, 2003: Normals
// Subjects=11
1	24	47
47	41	19
33	13	54
-36	8	58
29	-66	54
-47	-52	51

// Rolls E T, 2003: Activations during Pleasant Stimulation
// Rolls E T, 2003: Activations during Painful Stimulation
// Rolls E T, 2003: Activations during Neutral Stimulation
// Subjects=8
36	-20	72
-22	52	-10
-8	58	-12
10	42	16
-8	12	22
0	-26	-16
36	4	-20
46	-28	66
-58	-14	8
56	-2	16
36	0	8
-44	-2	10
-60	-32	18
-6	-20	16
10	-22	-18
24	-6	66
22	10	-4
12	-6	4
-26	40	-20
16	32	-24
10	-6	34
8	4	52
42	-32	68
-60	-28	46
62	-22	14
-60	-24	8
12	-24	-8

// Rolls E T, 2003: Pleasant - Neutral
// Rolls E T, 2003: Unpleasant - Neutral
// Rolls E T, 2003: Pleasant vs. Unpleasant
// Rolls E T, 2003: Unpleasant vs. Pleasant
// Rolls E T, 2003: Activations Positively Correlated with Pleasantness 
// Ratings
// Rolls E T, 2003: Activations Positively Correlated with Unpleasantness 
// Ratings
// Rolls E T, 2003: Activations Positively Correlated with Intensity Ratings
// Subjects=11
0	54	-12
2	20	32
45	15	-9
-36	27	-8
0	18	36
45	15	-9
2	52	-18
26	28	-8
-2	52	-10
4	42	12
-20	54	-14
-16	28	-18
16	8	16
24	16	-29
20	6	-31
-17	-10	-29

// Ullsperger M, 2003: Normals 1
// Subjects=16
7.7	24.3	32.84
1.46	19.45	53.39
-38.52	11.25	-7.91
45.93	8.84	-5.34
52.56	24.31	28.98
58.96	14.32	23.05
17.19	46.04	24.21
-35.8	-44.18	45.77
56.04	-47.58	34.97
4.45	-24.56	6.86
-4.1	-24.61	6.97
-10.55	-8.53	9.04
14.06	-8.13	12.07
10.78	-8.92	2.13
-13.62	-20.39	21.22
-17.16	8.03	-10.12
-22.31	1.17	11.7
26.87	-18.08	6.06
-12.86	7.17	-7.87
-6.46	16.98	-5.42
9.57	9.42	-8.31
-29.37	-50.49	46.23
-13.64	-10.7	22.64
5.57	23.23	32.95
-38.54	16.54	-8.36
-12.86	7.17	-7.87
9.57	9.42	-8.31
-4.1	-24.61	6.97
7.65	-24.54	6.82

// Ullsperger M, 2003: Normals 2
// Subjects=16
5.57	23.23	32.95
5.73	21.6	53.16
-38.54	16.54	-8.36
42.95	14.48	26.57
-4.1	-24.61	6.97
7.65	-24.54	6.82
17.27	-11.28	12.29
-11.57	-14.63	12.9
-.6	-74.32	24.48
5.57	23.23	32.95
-38.54	16.54	-8.36
-12.86	7.17	-7.87
9.57	9.42	-8.31
-4.1	-24.61	6.97
7.65	-24.54	6.82

// Ding G S, 2003: Chinese Orthographic vs. Asterisks
// Ding G S, 2003: English Orthographic vs. Asterisks
// Ding G S, 2003: Chinese Orthographic vs. Asterisks - English Orthographic 
// vs. Asterisks
// Ding G S, 2003: English Orthographic vs. Asterisks - Chinese Orthographic 
// vs. Asterisks
// Ding G S, 2003: Chinese Semantic vs. Asterisks
// Ding G S, 2003: English Semantic vs. Asterisks
// Ding G S, 2003: Chinese Semantic vs. Asterisks - English Semantic vs. 
// Asterisks
// Ding G S, 2003: English Semantic vs. Asterisks - Chinese Semantic vs. 
// Asterisks
// Subjects=6
-50.52	55.88	-21.56
28.07	6.44	34.1
0.02	-26.22	-14.14
10.68	-29.67	-18.43
-41.46	40.38	38.75
36.08	46.96	-20.69
-26.02	88.17	-18.97
-47.23	64.5	-6.7
-16.16	17.21	-15.36
-51.03	33.17	42.81
64.38	27.26	38.63
-15.26	86.81	-10.06
-61.94	39.51	15.63
28.55	82.67	-12.44
32.5	34.41	65.16
-23.24	29.02	41.72
-28.11	93.08	-10.44
51.5	52.91	41.09
-55.68	9.49	-15.38
-49.12	57.11	21.82
-57.64	48.6	22.63
59.89	53.53	20.87
18.53	54.34	62.54
-6.03	57.7	67
-48.42	72.01	-19.59
-10.06	-36.4	61.55
-65.31	10.4	-16.46
-40.96	78.4	-20.21
-46.31	50.9	-31.22
62.23	39.14	41
-63.28	31.22	-22.69
56.97	-14.88	31.1
-31.8	54.06	49.75
-62.02	-6.32	-12.86
-35.79	-10.03	60.75
60.21	-22.26	31.68
61.18	0.92	28.61
64.45	-13.77	30.92

// Longcamp M, 2003: Reading, Letters - Reading, Lines
// Longcamp M, 2003: Reading, Pseudoletters - Reading, Lines
// Longcamp M, 2003: Reading, Letters - Reading, Pseudoletters
// Longcamp M, 2003: Writing, Letters - Writing, Lines
// Longcamp M, 2003: Writing, Pseudoletters - Writing, Lines
// Subjects=11
40	-49	-14
-30	-88	-6
32	-93	1
-51	-2	41
-10	9	66
-26	-49	39
-44	-35	40
53	-60	-2
-51	-76	4
22	-59	64
2	-92	29
8	-83	4
-53	-6	43
-53	11	29
-28	-1	65
-26	3	62
-32	6	49

// Maril A, 2003: Know > Feeling-of-Knowing > Don't Know
// Maril A, 2003: Know = Feeling-of-Knowing > Don't Know
// Maril A, 2003: Know > Feeling-of-Knowing = Don't Know
// Maril A, 2003: Encoding, Know = Feeling-of-Knowing = Correct Don't Know > 
// Incorrect Don't Know
// Subjects=17
-6	27	39
-51	24	30
-36	21	9
-42	18	27
-42	27	15
-45	30	6
-30	24	-6
-45	-54	45
-30	-60	36
-30	-69	51
-33	-48	36
-48	39	18
-18	-33	-6
-51	27	9
-48	33	15
-48	39	6
-45	21	9
-42	24	24
-48	18	30
-42	9	30
42	-36	-24
-36	-39	-24
-33	-15	-27

// Stewart L, 2003: Explicit Music Reading (Learners - Non-Learners), 
// Post-Training > Pre-Training
// Stewart L, 2003: Implicit Music Reading (Musical - Non-Musical), 
// Post-Training > Pre-Training
// Subjects=12
18	-72	57
15	-69	48
9	-66	57
-12	-66	60
-36	-69	-9
-63	-30	27
-48	-24	21
39	57	6
-57	12	30

// Wartenburger I, 2003: Early Acquisition High Proficiency (EAHP) 
// Italian-German Bilinguals
// Subjects=11
-48	0	28
48	12	28

// Wartenburger I, 2003: Late Acquisition High Proficiency (LAHP) 
// Italian-German Bilinguals
// Subjects=12
-48	0	28
48	12	28
-52	-64	11
24	-60	0
56	-32	33
-36	36	6
-28	44	11
16	-48	-6
-56	4	28
48	32	28
52	20	33
-48	4	33
-60	16	28
-56	8	17
-20	8	6
-32	20	-6
-20	0	17
0	40	44
-8	36	44
-32	-68	44
-44	-48	39
-28	-60	39
36	32	28
44	28	39
52	12	33
28	20	-6
20	4	0
44	16	0
-40	12	-6
-48	12	0
-56	8	-6
32	20	-6

// Wartenburger I, 2003: Late Acquisition Low Proficiency (LALP) 
// Italian-German Bilinguals
// Subjects=11
-52	-64	11
24	-60	0
56	-32	33
-36	36	6
-28	44	11
16	-48	-6
-56	4	28
48	32	28
52	20	33
-52	0	39
-56	4	22
-48	4	28
-16	-8	17
-44	-52	-17
-32	-68	44
-44	-52	44
-52	-44	50
-60	-40	50
40	4	28
56	12	33
44	32	28
4	-12	11
16	-16	22
8	0	6
-44	4	28
-56	4	28
-52	4	39
32	16	0
32	24	-11

// Kirsch P, 2003: Monetary Reward > No Reward
// Kirsch P, 2003: Monetary Reward > Verbal Reward
// Kirsch P, 2003: Verbal Reward > No Reward
// Kirsch P, 2003: (No Reward > Verbal Reward) + (Verbal Reward > Monetary 
// Reward)
// Subjects=27
-9	-15	1
18	-8	9
-9	-15	-12
9	-24	-9
-11	8	-5
13	8	-4
-21	6	-5
15	9	-3
-15	-9	-7
18	-12	1
-30	20	-14
27	14	-16
-9	8	44
6	16	35
-50	-22	20
36	20	2
0	84	10
-18	-97	-8
18	-70	-12
-27	-96	5
30	-85	-1
-36	-82	-6
-39	-15	57
48	-1	41
-9	-21	45
50	5	47
0	-5	9
6	-14	6
-9	-18	-7
12	8	-6
-18	8	-11
16	8	-3
-24	17	-11
-3	2	39
3	-4	39
33	20	2
15	-62	-17
50	2	44
-9	-12	-2
6	-3	0
-24	6	-3
21	6	0
15	5	0
-42	17	-8
36	20	-1
9	25	26
-42	12	-1
0	-84	10
6	-83	24
39	-85	-6
-36	-87	-1
45	-76	-9
18	-68	12
-36	-32	-6
30	-90	-3
24	-62	-10
6	-14	6
9	-21	-14
-10	6	-5
12	9	-6
-27	6	2
15	6	-3
-33	20	-1
53	20	-11
-3	2	39
6	16	35
33	20	2
-33	-79	-16
33	-59	-17
-15	-65	-9
15	-70	-4
-39	-12	53
-45	-6	53

// Matsuo K, 2003: Phonogram, Movement Allowed > Fixation
// Matsuo K, 2003: Phonogram, Movement Not Allowed > Fixation
// Matsuo K, 2003: Phonogram, Movement Allowed > Phonogram, Movement Not 
// Allowed
// Matsuo K, 2003: Phonogram, Movement Not Allowed > Phonogram, Movement 
// Allowed
// Matsuo K, 2003: Ideographic Character, Movement Allowed > Fixation
// Matsuo K, 2003: Ideographic Character, Movement Not Allowed > Fixation
// Matsuo K, 2003: Ideographic Character, Movement Allowed > Ideographic 
// Character, Movement Not Allowed
// Matsuo K, 2003: Ideographic Character, Movement Not Allowed > Ideographic 
// Character, Movement Allowed
// Subjects=12
-41.38	1.8	58.69
-34.76	-11.38	66.61
-45.57	-35.54	61.34
1.73	12.07	51.34
-2.46	-0.08	59.34
-45.76	3.5	54.12
-50.31	9.48	37.92
34.28	4.51	60.5
-45.73	-35.62	49.02
60.56	19.93	5.86
-.41	14.4	53.39
-39.14	-11.81	62.24
-43.31	-32.57	69.97
-38.95	-46.49	70.15
-6.78	-4.46	58.72
-45.92	3.42	41.8
-.44	10.9	50.37
6.14	10.58	58.13
-34.81	-6.27	63.86
-43.42	-13.74	64.75
-39.05	-48.38	61.38
32	3.57	50.54
52.82	16.43	-8.23
-28.4	1.95	59.58
-50.29	7.45	39.24
1.82	10.57	58.21
-.51	12.61	45.72
32.1	10.88	59.9
49.35	-35.28	47.37
23.56	-73.66	51.61
31.91	-71.46	28.83
-50.04	-37.76	49.31
-32.92	-80.51	27.47
-13.69	-79.87	10.27
-34.83	-16.25	60.37
14.49	22.67	37.75
-35.05	-36.52	38.84
-26.18	-79.68	47.45
-33.02	-83.46	18.8
21.48	-68.69	58.99
3.65	-75.03	15.1

// Ramnani N, 2003: Regions Activated in All Four Conditions
// Ramnani N, 2003: Main Effects of Motor Preparation
// Ramnani N, 2003: Main Effect of Reward Expectation
// Ramnani N, 2003: Interaction of Reward and Preparation Levels
// Subjects=8
-18	62	20
2	42	40
-40	32	24
-30	-2	50
-6	8	54
-34	12	6
-26	-60	44
30	-62	52
-46	-36	40
0	-56	42
12	-76	2
32	0	8
-28	-2	-8
24	-58	-30
-36	-58	-38
-2	-4	54
-36	-26	56
-58	-22	28
42	-26	64
-44	-4	6
-56	-26	40
32	-40	40
54	-32	40
-24	-10	0
22	-56	-30
-20	58	24
-22	18	48
-40	20	38
32	18	-20
-2	10	52
-2	-4	56
6	0	58
28	-54	70
-40	-74	40
-28	16	54
-64	-28	16
-60	-50	28
-60	-8	4
-4	-38	38
22	-26	-8
-16	-36	-2
-16	-12	-24
16	2	4
16	-72	-14
-18	-102	-12
12	-104	6
38	60	-2
-34	-2	64
-52	-24	54
30	-82	8
32	-90	-8
-6	-54	8

// Dilger S, 2003: Arachnophobics
// Subjects=9
-19.34	-.15	-19.45
40.65	18.21	6.21
-52.37	10.54	-2.12
37.27	21.93	-14.14
50.24	-51.18	-24.89
-39.59	-39.28	-28.2
-27	-5.34	-44.57
5.74	-47.51	26.62
-17.23	-3.74	-24.74
43.83	17.97	2.84
-52.36	13.97	0.94
-10.3	-67.49	17.32
-59.88	-9.57	-13.73
-17.26	-4	-28.07
-7.14	-14.12	32.88
37.34	10.56	-9.84
-52.37	10.54	-2.12
-39.74	28.36	-20.49
37.36	-41.99	-28.86
-30	-39.48	-31.64
-26.95	-11.43	-40.72
47.08	-61.77	-23.96
-39.53	-55.14	-26.87
-30.14	-16.82	-41.34
-32.01	-47.01	-18.72

// Dilger S, 2003: Normals
// Subjects=9
25.04	-100.57	13
-17.26	-4	-28.07
-7.14	-14.12	32.88
37.34	10.56	-9.84
-52.37	10.54	-2.12
-39.74	28.36	-20.49
37.36	-41.99	-28.86
-30	-39.48	-31.64
-26.95	-11.43	-40.72
47.08	-61.77	-23.96
-39.53	-55.14	-26.87
-30.14	-16.82	-41.34
-32.01	-47.01	-18.72

// Knutson B, 2003: Anticipation: Potential Gain vs. No Outcome
// Knutson B, 2003: Anticipation: Potential Loss vs. No Outcome
// Knutson B, 2003: Outcome: Gain vs. No Outcome
// Subjects=12
39.5	16.29	-4.77
12.79	13.93	-5.38
-8.58	11.68	-4.95
11.76	11.09	-.67
-7.42	2.77	3.59
-1.97	-11.48	11.42
4.47	32.74	32.17
1.5	1.14	50.46
-28.28	-53.57	47.59
1.14	-75.08	-26.78
38.43	16.28	-4.76
12.96	-.73	11.46
-15.94	-1.42	5.16
-7.38	-.14	7.18
5.54	38.29	35.04
-34.71	-8.8	62.87
1.17	-67.08	-19.64
1.89	56.7	-15.54
3.02	70.51	-2.21
6.8	-50.84	24.65
6.04	-59.83	59.99

// Akitsuki Y, 2003: Win 4 - Win 1
// Akitsuki Y, 2003: Loss 4 - Loss 1
// Akitsuki Y, 2003: Win 1 - Loss 1
// Akitsuki Y, 2003: Wins - Losses
// Akitsuki Y, 2003: Brain activities with modulation by the subjects' arousal 
// in the events of win
// Akitsuki Y, 2003: Brain activities with modulation by the subjects' arousal 
// in the events of loss
// Akitsuki Y, 2003: Sudden Win - Win 1
// Akitsuki Y, 2003: Sudden Loss - Loss 1
// Subjects=36
8	22	58
12	58	22
-2	58	10
-2	40	46
8	56	22
10	18	60
-8	22	58
-4	50	20
60	-12	-12
24	0	-8
-26	-2	-12
16	-68	-12
-16	-86	-2
40	-78	-12
-42	-62	-12
-10	-72	-20
-34	-64	-32
26	2	-10
-24	4	-12
38	-76	-28
-28	-78	-20
-22	-92	-6
-8	58	26
4	56	24
-4	46	10
-6	20	60
0	-24	38
4	52	24
58	-14	-22
-58	-14	-20
6	-62	-6
34	22	52
26	42	38
36	30	36
26	16	54

// Daumann J, 2003: Pure MDMA Users
// Subjects=8
37.43	13.68	55.05
-21.15	-83.52	17.49
28.03	-32.12	70.95
-1.76	-35.72	22.51
-59.43	-36.81	-8.9
55.04	-34.59	-14.43
55.67	-52.88	31.07
-46.89	-62.5	37.13
-33.57	-29.14	71.71
27.44	-76.97	16.01
-18	-90.73	9.18
27.63	-49.27	36.8
-14.73	-87.21	12.14

// Daumann J, 2003: Polyvalent MDMA Users
// Subjects=8
37.43	13.68	55.05
-21.15	-83.52	17.49
-33.57	-29.14	71.71
27.44	-76.97	16.01
-18	-90.73	9.18
27.63	-49.27	36.8

// Daumann J, 2003: Normals
// Subjects=8
28.03	-32.12	70.95
-1.76	-35.72	22.51
-59.43	-36.81	-8.9
55.04	-34.59	-14.43
55.67	-52.88	31.07
-46.89	-62.5	37.13
-14.73	-87.21	12.14

// Killgore W D S, 2003: Low Calorie Food + High Calorie Food
// Killgore W D S, 2003: High Calorie Food > Non-Food
// Killgore W D S, 2003: Low Calorie Food > Non-Food
// Killgore W D S, 2003: Food-Related Utensils > Non-Food
// Killgore W D S, 2003: High Calorie Food - Low Calorie Food
// Killgore W D S, 2003: Low Calorie Food - High Calorie Food
// Subjects=13
-38	1	-10
-22	-12	-15
-63	-23	16
-34	-36	-22
-44	-47	-16
-26	-86	-14
4	54	-8
22	-5	-17
61	-17	12
61	-48	10
4	-51	36
2	-60	14
-24	41	40
-20	-1	-20
-36	-3	-18
-4	-12	1
-63	-43	0
-48	-75	24
2	11	16
0	-77	-31
8	-29	-41
40	-42	-28
51	-66	-7
-61	-6	-1
-22	-17	-19
-63	-24	18
-38	-40	-22
-18	-72	-5
0	52	-16
65	-9	10
-42	50	-14
-46	-78	-1
12	60	-6
53	-66	-3
36	-70	-39
-26	52	29
-6	-16	1
-46	-76	24
2	-33	-40
32	-42	-33
50	-68	-7
2	-75	-33
-57	-2	-7
-18	-72	-5
4	52	-18

// Tapert S F, 2003: Alcohol Use Disorder (AUD) Adolescents
// Subjects=15
-3.64	-13.3	70.69
-.54	-17.65	55.41
-1.37	50.63	-25.03
-23.15	26.62	51.96
-26.88	13.46	-21.62
32.95	33.45	-16.17
-8.73	33.2	-15.67
-26.87	2.63	-24.05
21.19	-6.14	-31.68
-60.83	-42.44	-12.08
-64.02	-14.83	1.26
-1.13	-5.07	-15.9
-.73	-39.34	22.66
-26.17	-79.08	34.09
6.47	84.1	35.64
36.91	-70.7	40.47
40.64	43.39	15.25
58.69	42.3	-.48
-7.97	1.48	69.5
26.26	-8.89	69.98
36.99	-35.86	64.31
59.26	-22.12	47.29
3.82	-32.09	61.03
18.9	-58.18	66.39
-53.33	-57.54	-15.36
51.42	-64.32	-15.99
-11.54	-56.09	-.35
18.41	-86.38	-9.3
-1.11	37.96	3.91

// Tapert S F, 2003: Normals
// Subjects=15
-3.64	-13.3	70.69
-.54	-17.65	55.41
-1.37	50.63	-25.03
-23.15	26.62	51.96
-26.88	13.46	-21.62
32.95	33.45	-16.17
-8.73	33.2	-15.67
-26.87	2.63	-24.05
21.19	-6.14	-31.68
-60.83	-42.44	-12.08
-64.02	-14.83	1.26
-1.13	-5.07	-15.9
-.73	-39.34	22.66
-26.17	-79.08	34.09
6.47	84.1	35.64
36.91	-70.7	40.47
40.64	43.39	15.25
58.69	42.3	-.48

// Ehrsson H H, 2003: Imagined Finger - Imagined Toe Movement
// Ehrsson H H, 2003: Imagined Finger - Imagined Tongue Movement
// Ehrsson H H, 2003: (Imagined Finger - Imagined Toe Movement) + (Actual 
// Finger - Actual Toe Movement)
// Ehrsson H H, 2003: (Imagined Finger - Imagined Tongue Movement) + (Actual 
// Finger - Actual Tongue Movement)
// Ehrsson H H, 2003: Imagined Toe - Imagined Finger Movement
// Ehrsson H H, 2003: Imagined Toe - Imagined Tongue Movement
// Ehrsson H H, 2003: (Imagined Toe - Imagined Finger Movement) + (Actual Toe 
// - Actual Finger Movement)
// Ehrsson H H, 2003: (Imagined Toe - Imagined Tongue Movement) + (Actual Toe 
// - Actual Tongue Movement)
// Ehrsson H H, 2003: Imagined Tongue - Imagined Finger Movement
// Ehrsson H H, 2003: Imagined Tongue - Imagined Toe Movement
// Ehrsson H H, 2003: (Imagined Tongue - Imagined Finger Movement) + (Actual 
// Tongue - Actual Finger Movement)
// Ehrsson H H, 2003: (Imagined Tongue - Imagined Toe Movement) + (Actual 
// Tongue - Actual Toe Movement)
// Ehrsson H H, 2003: Imagined Finger Movement - (Imagined Toe + Imagined 
// Tongue Movement)
// Ehrsson H H, 2003: Imagined Toe Movement - (Imagined Finger + Imagined 
// Tongue Movement)
// Ehrsson H H, 2003: Imagined Tongue Movement - (Imagined Finger + Imagined 
// Toe Movement)
// Subjects=7
0	-24	48
-32	-24	68
-40	-28	64
-4	-24	52
-32	-24	68
-40	-28	64
-4	-24	48
-32	-24	68
-40	-28	64
-4	-24	52
-32	-12	68
-40	-28	64
-8	-28	64
-8	-20	72
-20	16	4
28	8	4
56	4	8
-8	-24	72
-8	-20	72
-28	12	-8
52	16	-8
-8	-28	64
-8	-20	72
-28	12	-8
32	8	4
56	8	4
-8	-24	72
-8	-20	72
-28	12	8
56	8	0
-56	-12	32
-64	0	24
56	-4	32
48	-12	56
32	-4	64
28	0	-8
-56	-12	32
-68	-4	24
56	-4	28
52	-12	52
32	-8	64
28	0	-8
-56	-12	32
-64	0	24
56	-4	32
48	-12	56
24	-20	72
28	4	-4
-56	-12	32
-64	-4	24
56	-4	28
52	-12	52
32	-8	64
28	-4	-4
0	-24	48
-32	-24	68
-40	-28	64
-8	-28	64
-8	-20	72
-56	-12	32
-64	0	24
56	-4	32

// Onozuka M, 2003: Young Adults
// Subjects=10
6	4	54
-48	-10	30
36	4	6
14	-16	4
-8	-64	-18
34	58	14

// Onozuka M, 2003: Middle-Aged Adults
// Subjects=8
-10	-6	64
-50	-10	42
-40	-12	14
22	-10	0
-10	-66	-2
30	60	22

// Onozuka M, 2003: Aged Adults
// Subjects=7
2	-8	70
62	-2	12
-36	-4	-2
-10	-20	6
24	-64	-22
40	54	18

// Gerardin E, 2003: Group Analysis for Right Hand Movement
// Gerardin E, 2003: Group Analysis for Left Hand Movement
// Gerardin E, 2003: Group Analysis for Right Foot Movement
// Gerardin E, 2003: Group Analysis for Lip Movement
// Gerardin E, 2003: Group Analysis for Saccadic Eye Movement
// Subjects=7
-36	-18	66
-39	-6	57
0	3	51
0	-3	54
66	-21	30
-54	-24	21
-27	9	0
-30	0	-3
-12	-15	6
18	-45	-18
54	12	0
39	-21	69
39	-6	66
6	6	54
3	0	66
63	-21	27
-51	-39	33
18	-3	21
30	3	3
-24	18	3
33	0	3
30	6	-9
15	-12	6
-15	-45	-18
-54	9	3
-3	-30	66
-3	-15	72
66	-21	30
-54	-24	21
-33	-9	18
-30	0	9
-6	-21	15
12	-57	-6
60	12	18
-51	6	3
60	-6	48
-57	-12	42
63	12	36
-57	6	30
6	6	66
3	-3	66
66	-21	27
-60	-15	36
15	3	15
30	3	0
-30	3	-3
-27	-3	3
27	15	-9
12	-9	9
-12	-12	12
15	-57	-12
-54	12	6
45	0	54
-45	-6	54
54	0	48
-57	9	36
3	0	66
0	6	54
15	6	15
-18	-6	18
24	6	9
12	-57	-12
-12	-39	-3

// Pihlajamaki M, 2003: Encoding - Tracking
// Pihlajamaki M, 2003: Retrieval - Tracking
// Subjects=12
38.55	19.68	11.68
-41.63	26.52	10.91
39.85	2.37	35.42
-46.67	1.13	40.98
-4.91	12.1	55.19
27.37	-62.24	54.37
-7.92	-61.65	51.38
30.91	-17.2	-24.17
26.69	-25.43	-20.09
33.21	-49.45	-14.8
-35.27	-40.94	-22.53
35.44	-71.56	-11.86
-41.49	-65.33	-7.03
36.69	-76.27	9.71
-25.22	-90.22	13.82
37.47	17.39	9.66
-35.23	16.61	6.1
-45.62	6.43	40.53
5.73	20.45	52.14
-4.93	18.53	55.77
25.24	-77.57	48.99
-34.71	-52.72	45.36
9.89	-83.89	-3.84
35.68	-88.88	11.9
-40.5	-51.92	-12.63

// Wild B, 2003: All Faces, No Movement
// Wild B, 2003: Effect of Photos with Happy Facial Expressions
// Wild B, 2003: Effect of Photos with Neutral Facial Expressions
// Wild B, 2003: Effect of Photos with Sad Facial Expressions
// Wild B, 2003: Movement - No Movement
// Wild B, 2003: No Movement - Movement
// Wild B, 2003: Effect of Congruent Stimuli
// Wild B, 2003: Effect of Dissonant Stimuli
// Wild B, 2003: Effect of Congruent - Dissonant Stimuli
// Wild B, 2003: Areas Where Activity Correlated with Reaction Time
// Subjects=10
39	-90	-9
-24	-84	-18
21	-66	48
39	-36	42
54	12	33
-51	12	6
48	21	-15
33	21	0
-3	15	45
3	12	51
39	-63	-27
-24	-84	-18
57	9	39
-54	-18	39
57	24	-12
24	3	-9
-24	3	9
-24	9	3
18	-84	-9
-24	-84	-21
21	-87	-6
-21	-87	-15
63	-6	39
-54	-21	39
69	-9	12
-57	0	6
45	-69	-18
-24	-87	-9
-24	-81	12
36	-72	36
21	-60	69
-42	-51	60
66	-12	-24
-69	-30	-3
-66	-6	-24
-39	21	-30
36	21	54
-45	21	42
24	36	-18
60	-45	36
-54	36	-6
21	-87	-3
-12	-90	-12
57	-6	36
-51	-21	39
39	-66	-24
-24	-84	-18
63	15	0
-57	3	6
-51	-9	42
63	-12	42
30	-9	-9
-12	-9	-9
27	-6	-18
-27	-18	-21
-42	0	-30
21	48	24

// Ganis G, 2003: Lie > Truth
// Ganis G, 2003: SI Lie > Truth
// Ganis G, 2003: MS Lie > Truth
// Ganis G, 2003: SI Lie > MS Lie
// Ganis G, 2003: MS Lie > SI Lie
// Subjects=10
34.2	57.35	17.49
-37.4	51.38	15.47
5.65	10.88	38.45
29.08	31.03	35.37
-40.22	-8.34	41.7
68.7	-14.01	27.54
25.76	-48.18	-11.47
-29.84	-41.11	-11.43
11.06	-67.54	14.85
14.46	-43.46	50.71
-3	-74.79	-8.91
32.96	57.75	-4.83
34.2	57.35	17.49
-37.4	51.38	15.47
5.65	10.88	38.45
29.08	31.03	35.37
-40.22	-8.34	41.7
68.7	-14.01	27.54
25.76	-48.18	-11.47
-29.84	-41.11	-11.43
11.06	-67.54	14.85
14.46	-43.46	50.71
-3	-74.79	-8.91
34.2	57.35	17.49
32.96	57.75	-4.83
-37.4	51.38	15.47
25.76	-48.18	-11.47
-29.84	-41.11	-11.43
14.46	-43.46	50.71
-3	-74.79	-8.91
5.65	10.88	38.45
68.7	-14.01	27.54
11.06	-67.54	14.85
-40.22	-8.34	41.7
32.96	57.75	-4.83

// Dobbins I G, 2003: Source > Recency
// Dobbins I G, 2003: Recency > Source
// Dobbins I G, 2003: Source, Hit > Source, Miss
// Dobbins I G, 2003: Source, Miss > Source, Hit
// Dobbins I G, 2003: Recency, Hit > Recency, Miss
// Dobbins I G, 2003: Recency, Miss > Recency, Hit
// Subjects=11
-9	33	57
-9	45	45
-3	60	30
-54	27	-3
-51	42	0
-45	45	-6
-45	21	33
-45	18	48
-27	-27	-21
-18	-36	-9
-15	-9	-15
-33	-18	-12
-12	-6	-24
-12	-12	12
12	9	9
-51	-66	39
-60	-48	30
-45	-57	45
-54	3	-33
-48	-51	-21
-48	15	-36
-33	21	-24
-24	15	-24
-57	-48	-9
-9	-75	33
-60	-15	12
45	-12	6
-39	-21	3
-45	-15	-3
-48	-24	3
-36	-12	21
9	-36	36
21	57	0
27	39	36
18	42	33
33	33	45
39	-27	39
33	-33	39
54	-33	51
-51	-30	15
-51	-6	0
36	-15	15
27	21	57
63	-21	27
63	-18	12
-57	-30	3
-54	-6	-3
-6	-36	6
-36	-15	-3
-36	3	0
-21	45	39
-15	54	36
-12	-81	30
3	-87	21
-6	-12	45
12	-27	45
-27	-30	54
27	-12	-27
-24	-18	-30
-15	-6	-21
-24	-18	-15
-33	-30	-15
54	-57	-3
45	-69	9
-54	-66	6
-27	-45	60
-36	-42	63
-42	21	-9
-30	24	-6
-39	33	-12
39	24	-15
33	24	-9
9	30	33
3	48	30
6	24	45
9	9	9
48	15	21
33	57	-6
-18	-21	75
-9	30	30
6	18	39
39	36	30
-57	3	-30
6	63	12
-6	24	51

// Elliott R, 2003: All-or-Nothing Response to Reward
// Elliott R, 2003: Activity Increasing Linearly with Reward Value
// Elliott R, 2003: Second-Order Relationship to Reward Value
// Subjects=12
39	-84	-12
-36	-90	-12
-52	-27	60
-27	0	3
27	0	6
24	-6	-18
-9	-12	-24
39	3	-39
-33	9	-27
45	-12	0
15	63	30
-33	42	-15
15	15	57
-6	42	51
-3	60	-9
-51	27	-12
48	33	-12

// Kubicki M, 2003: Normals
// Subjects=9
-52	26	16
42	22	-14
46	8	44
0	18	44
-22	-94	-4
36	-84	-6
-4	10	50
-26	-88	-14
30	-86	-8
-48	46	-8
40	22	-18
46	48	-10
-54	-22	8
52	28	-2
-52	28	6
0	10	36
-54	-6	18

// Kubicki M, 2003: Schizophrenic Patients
// Subjects=9
-52	14	-12
-46	12	32
56	18	28
-62	-16	22
-26	-68	48
0	18	48
-40	-70	-28
30	-66	-28
-52	14	-12
-46	12	32
56	18	28
-62	-16	22
-26	-68	48
0	18	48
-40	-70	-28
30	-66	-28
46	48	-10
-54	-22	8
52	28	-2
-52	28	6
0	10	36
-54	-6	18
52	22	12

// Ranganath C, 2003: Regions Exhibiting a Subsequent Familiarity Effect
// Ranganath C, 2003: Regions Exhibiting a Subsequent Recollection Effect
// Subjects=13
-18	6	-34
-50	12	38
-54	4	32
-20	60	-2
-16	26	-26
34	18	14
-50	-60	-16
-50	-54	-8
-34	0	44
-24	-8	54
0	24	46
-2	16	50
0	4	54
-44	-36	36
-46	-44	38
-56	-30	38
-44	-40	56
-22	-68	54
-28	-58	52
-10	-90	-16
-14	-78	-14
-26	-76	40
46	-38	52
44	-32	62
52	-22	54
-48	-24	54
16	-70	-18
8	4	-6
-6	-4	8
-4	-18	14
18	-4	8
26	-30	-4
30	-40	-16
-52	38	16
-48	0	28
48	16	30
-36	24	-12
50	-56	-12
44	-52	-20
-48	4	-10
-48	12	-14
-38	0	-12
64	6	-10
-32	18	-8
46	0	60
-40	-2	30
-52	-30	34
-40	-40	48
48	-38	40
36	-58	44
-4	-94	8
-16	-10	8

// McKay L C, 2003: Voluntary - Spontaneous Breathing
// Subjects=6
-2	-12	72
-22	-36	68
-22	-26	64
-22	-20	74
-52	-8	50
-64	-34	16
-10	-12	16
-44	-46	40
-22	-6	-2
-16	-64	-20
-26	-36	6
0	-38	-52
2	-10	60
20	-38	68
20	-28	62
24	-18	74
56	-4	36
44	0	60
4	-10	14
66	-32	28
24	-4	-2
12	-4	40
34	-62	-24
42	52	22
8	28	60
30	-34	2

// Fesl G, 2003: Tongue Movement vs. Rest
// Subjects=11
-62	-6	34
66	-6	30
-4	-2	60
6	2	70
-14	-60	-18
14	-60	-18
-8	-32	-32
8	-36	-32

// Suzuki M, 2003: Swallowing vs. No Swallowing
// Subjects=11
-56	-6	12
64	-20	16
-36	-56	-32
8	6	40
-12	-20	-6

// Lazeron R H C, 2003: Adding vs. Fixation
// Lazeron R H C, 2003: High vs. Low
// Subjects=9
-30	-60	48
63	-36	45
27	-60	45
30	6	60
-3	-3	63
-45	9	36
3	27	36
-33	21	3
-9	24	33
33	-60	-27
-36	-66	-36
-15	-51	57
24	-60	18
33	3	57
-12	15	48
45	9	18
12	33	-3
-24	-15	9
21	-6	18
-12	-42	-39
27	-66	-51

// Piefke M, 2003: (Childhood, Pos + Childhood, Neg + Recent, Pos + Recent, 
// Neg) > Baseline
// Piefke M, 2003: (Recent, Pos + Recent, Neg) > (Childhood, Pos + Childhood, 
// Neg)
// Piefke M, 2003: (Childhood, Pos + Recent, Positive) > (Childhood, Neg + 
// Recent, Neg)
// Piefke M, 2003: (Childhood, Neg + Recent, Neg) > (Childhood, Pos + 
// Childhood, Pos)
// Subjects=20
-10	62	28
40	18	20
-46	22	20
-42	6	52
-2	12	56
-50	32	-10
54	16	-32
-52	14	-34
60	0	-24
-56	2	-24
-24	-20	-18
-30	-54	48
-6	-56	4
36	-64	-24
-28	-66	-18
46	-82	2
-42	-78	4
14	-82	-42
-4	-46	24
30	-20	-20
-24	-22	-18
6	56	-12
34	8	-40
24	-10	-34
-22	-12	-32
50	-30	-6

// Wrase J, 2003: Men
// Subjects=10
-21	-9	-12
24	-4	-15
-45	28	-17
56	26	-1
-50	-69	20
59	-43	8
-21	-9	-7
-42	28	-14
33	28	-17
-9	56	14
12	56	11
-27	-39	-13
30	-50	-10
18	-9	-12
53	29	-4
-50	-61	11

// Wrase J, 2003: Women
// Subjects=10
-53	-66	12
62	-40	19
53	-64	6
-21	-9	-7
-42	28	-14
33	28	-17
-9	56	14
12	56	11
-27	-39	-13
30	-50	-10
24	-6	-10
-6	-7	31
3	18	18
50	21	7
-45	-69	12
56	43	5
45	-45	-18
48	-64	3

// Carr L, 2003: Face Imitation - Rest
// Carr L, 2003: Face Observation - Rest
// Carr L, 2003: Imitation - Observation
// Subjects=11
-54.21	-.65	32.3
48.43	-6.04	36.03
-41.19	-35.84	44.02
61.3	-18.65	36.94
-24	-59	45.76
-41.07	-43.45	55.81
33.66	-52.48	42.32
-30.56	3.14	51.78
-41.41	5.77	31.61
-54.31	13.64	24.41
52.57	12.33	25.52
44.05	10.34	28.02
10.08	12.53	59.45
1.49	9.85	53.08
-2.89	19.72	43.38
-7.37	35.07	22.07
-37.49	54.84	5.15
47.98	41.97	-3.68
37.29	46.31	-1.69
-41.52	17.77	21.68
54.58	17.66	11.67
-52.38	13.71	-2.39
54.48	14.35	-3.67
50.2	29.64	1.79
-37.43	20.31	-.88
39.48	33.63	-.65
-47.79	-48.85	13.96
42.89	-67.46	-14.52
-24.91	19.42	-41.1
26.74	10.3	1.45
24.5	0.45	-15.54
39.21	26.49	-37.97
-24	-59	45.76
-41.07	-43.45	55.81
33.66	-52.48	42.32
-41.41	5.77	31.61
1.49	9.85	53.08
-2.89	19.72	43.38
-7.37	35.07	22.07
7.56	61.22	28.63
47.98	41.97	-3.68
-41.52	17.77	21.68
54.48	14.35	-3.67
-48.12	39.97	6.52
50.2	29.64	1.79
39.48	33.63	-.65
-47.79	-48.85	13.96
50.51	-44.04	12.43
42.89	-67.46	-14.52
-44.05	20.33	-27.57
28.62	7.57	-34.03
-22.56	-.34	-21.62
24.5	0.45	-15.54
9.99	22.59	51.91
-54.21	-.65	32.3
48.43	-6.04	36.03
61.3	-18.65	36.94
-30.56	3.14	51.78
-41.41	5.77	31.61
-54.31	13.64	24.41
52.57	12.33	25.52
44.05	10.34	28.02
10.08	12.53	59.45
1.49	9.85	53.08
-2.89	19.72	43.38
-7.37	35.07	22.07
-37.49	54.84	5.15
47.98	41.97	-3.68
37.29	46.31	-1.69
-41.52	17.77	21.68
54.58	17.66	11.67
-52.38	13.71	-2.39
54.48	14.35	-3.67
50.2	29.64	1.79
-37.43	20.31	-.88
39.48	33.63	-.65
-47.79	-48.85	13.96
-24.91	19.42	-41.1
39.21	26.49	-37.97
26.74	10.3	1.45
24.5	0.45	-15.54

// Fossati P, 2003: Self Referential vs. Letter Recognition
// Fossati P, 2003: Self and Other Referential vs. Letter Recognition
// Fossati P, 2003: Self Referential vs. Letter Recognition, Positive vs. 
// Negative Words
// Subjects=10
11.7	54.42	9.08
-15.95	45.67	22.4
-13.47	-24.3	39.39
18.54	14.98	49.11
-21.92	-9.06	58.28
-21	28.92	53.97
11.31	-40.76	58.33
8.39	58.83	-2.41
-10.75	54.11	7.13
51.5	-10.74	16.31
-42.61	-16.47	5.61
-52.19	-35.9	2.89
-53.96	-72.81	35
-42.41	-63.8	12.92
19.59	-84.12	6.11
-13.63	-69.85	0.83

// Mller R A, 2003: Patients with Autism
// Subjects=8
-56.78	15.66	-18.11
-27.84	53.04	8.53
-40.76	51.93	-4.61
55.83	10.67	31.2
-27.24	-3.38	63.44
46.37	2.38	48.73
33.19	1.87	2.09
-36.73	-25.13	72.06
-27.08	-67.6	58.79
46.46	-36.2	45.27
40.07	-35.99	48.67
-27.24	-92.37	27.41
36.85	-79.04	28.9
23.63	-63.43	-15.75
49.39	-65.42	-2.49
-21.47	22.98	-9.09
1.27	-23.18	11.24
10.8	-27.32	-1.9
-40.4	9.58	25.7
-40.8	54.85	-8.2
-24.65	56.23	8.23
-8.3	39.86	42.87
-31.12	32.44	-9.78
55.72	26.01	23.22
49.13	30.78	2.82
-46.68	17.42	45.19
46.26	24.33	43.54
39.95	18.71	54.12
-30.3	-71.05	55.77
-39.96	-58.41	54.82
-36.86	-52.82	44.28
20.99	-77.34	52.36
36.96	-81.19	42.46
30.17	-75.31	-4.79
65.28	-27.25	-5.88
39.69	45.72	31.79
-17.76	-64.02	21.58
-20.57	-46.73	80.38
21.12	-56.25	77.36
53.06	-50.74	63.14
8.11	-61.56	51.19
11.02	-51.42	16.85
-8.17	-103.83	1.39
-17.65	-105.77	18.39
-11.57	-59.69	-5.62
7.9	-73.64	18.75
17.48	-70.67	15.04
-11.57	-59.69	-5.62
-27.22	-3.12	66.76
40.07	-6.41	59.58
36.75	8.92	51.64
-46.43	-29.39	59.15
-20.6	-50.41	74
-24.21	-61.14	18.07
37.1	-69.87	64.93
53.04	-47.57	62.88
71.97	-34.16	28.08
27.4	-90.5	46.7
-40.31	-62.01	8.29
71.93	-44.45	18.91
-8.35	-69.45	-8.18
-43.49	20.62	44.89
-21.45	52.82	5.13
-30.46	-6.83	60.42
49.55	2.14	45.37
11.31	-5.55	73.22
-27.04	-70.51	62.38
52.81	-33.51	38.28
-27.17	-71.8	45.76
-18.16	57.04	18.12
-8.25	40.37	49.52
-40.77	55.1	-4.87
-46.68	17.42	45.19
-49.66	-65.84	42.17
-39.92	-71.1	55.88
-8.07	-56.59	34.23
-36.74	-77.94	49.73
49.75	-71.59	41.51
65.28	-27.25	-5.88

// Mller R A, 2003: Normals
// Subjects=8
58.95	13.09	20.92
-27.27	2.96	62.91
36.86	0.17	62.41
58.95	13.09	20.92
-30.27	-57.59	64.68
-39.95	-35.18	66.25
43.43	-54.23	60.2
-30.5	-92.91	20.8
-11.39	-107.28	-1.63
42.88	-66.48	-15.71
17.45	-103.93	-2.24
20.5	-82.48	-14.11
29.98	-54.13	-19.95
-11.59	-20.34	7.81
-14.99	3.99	-7.58
20.22	13.46	-12.12
-21.32	-57.87	-22.39
-34.27	23.16	-5.62
-46.89	31.74	23.92
55.84	14.1	34.26
55.68	22.33	16.84
42.53	25.51	-23.42
-24.06	2.98	62.87
-1.69	8.95	55.42
-49.97	3.43	29.67
33.63	6.5	61.91
-27.13	-61.51	54.93
-20.8	-59.07	44.62
27.35	-48.24	56.54
-30.54	-96.59	14.42
-8.23	-101.17	-5.53
-30.78	-79.36	-10.44
7.86	-70.73	15.16
23.72	-85.63	-13.89
20.66	-90.71	3.3
65.28	-56.83	-16.78
-2.03	-30.83	-4.8
-14.71	-29.37	15.29
-8.34	-16.64	14.15
23.76	-29.13	14.83
7.58	-30.77	-4.92
7.56	-73.81	-24.73
39.69	45.72	31.79
-17.76	-64.02	21.58
-20.57	-46.73	80.38
21.12	-56.25	77.36
53.06	-50.74	63.14
8.11	-61.56	51.19
11.02	-51.42	16.85
-8.17	-103.83	1.39
-17.65	-105.77	18.39
-11.57	-59.69	-5.62
7.9	-73.64	18.75
17.48	-70.67	15.04
-11.57	-59.69	-5.62
-27.22	-3.12	66.76
40.07	-6.41	59.58
36.75	8.92	51.64
-46.43	-29.39	59.15
-20.6	-50.41	74
-24.21	-61.14	18.07
37.1	-69.87	64.93
53.04	-47.57	62.88
71.97	-34.16	28.08
27.4	-90.5	46.7
-40.31	-62.01	8.29
71.93	-44.45	18.91
-8.35	-69.45	-8.18
-43.49	20.62	44.89
-21.45	52.82	5.13
-30.46	-6.83	60.42
49.55	2.14	45.37
11.31	-5.55	73.22
-27.04	-70.51	62.38
52.81	-33.51	38.28
-27.17	-71.8	45.76
-18.16	57.04	18.12
-8.25	40.37	49.52
-40.77	55.1	-4.87
-46.68	17.42	45.19
-49.66	-65.84	42.17
-39.92	-71.1	55.88
-8.07	-56.59	34.23
-36.74	-77.94	49.73
49.75	-71.59	41.51
65.28	-27.25	-5.88

// O'Doherty J, 2003: High - Low Attractive Faces
// O'Doherty J, 2003: Low - High Attractive Faces
// O'Doherty J, 2003: Interaction Between Face Gender and Attractiveness
// O'Doherty J, 2003: Gender Differences in Responses to Attractive Faces, Men 
// > Women
// O'Doherty J, 2003: Gender Differences in Responses to Attractive Faces, 
// Women > Men
// O'Doherty J, 2003: Parametric Analysis of Attractiveness Responses Using 
// the Subject's Own Ratings
// Subjects=12
-3	36	-18
9	-48	33
-6	-45	42
-6	63	0
3	42	-12
-33	21	-3
45	30	9
45	30	9
-6	24	48
45	45	-9
66	-30	-9
18	42	0
48	-60	-27
-51	-75	0
48	42	-15

// Small D M, 2003: (IP + IUP) - (WP + WUP)
// Small D M, 2003: IP - WP
// Small D M, 2003: IUP - WUP
// Small D M, 2003: (IP + WP) - Tasteless Liquid
// Small D M, 2003: IP - IUP
// Small D M, 2003: IP - WUP
// Small D M, 2003: WP - WUP
// Small D M, 2003: (IUP +WUP) - Tasteless Liquid
// Small D M, 2003: IUP - IP
// Small D M, 2003: WUP - WP
// Subjects=9
-30	-48	-30
3	-45	-21
-18	-57	-21
-12	-27	-36
-9	-39	-27
9	-39	-36
9	-48	-30
9	-18	-21
6	-27	-39
15	-10	-15
-12	-12	-12
24	9	-12
39	6	-6
42	12	0
51	6	-3
-45	0	0
-33	3	12
-9	0	51
3	-54	-18
6	-27	-39
-12	-27	-33
-24	-6	-21
-12	-12	-21
21	-15	18
-45	9	6
36	9	-3
-39	-30	24
3	-12	45
15	15	33
-6	-3	39
-15	24	30
-51	15	-21
-21	-57	-21
-21	-66	-18
-33	-54	-30
3	-48	-12
27	-45	-27
18	-42	-30
24	-51	-33
3	-36	-36
-9	-24	-36
27	-9	-12
-12	-12	-12
-21	0	6
-30	0	-6
-21	12	0
-42	27	0
48	27	-12
-27	12	-12
27	9	-9
27	15	-15
-30	12	-3
-33	3	-3
0	-12	-12
12	-27	6
9	-24	9
36	21	-21
39	33	-18
-33	33	-21
-3	33	-6
0	39	6
3	42	-6
-15	33	33
-12	36	38
39	33	-15
12	-12	18
39	33	-9
27	9	-12
39	31	-15
-3	-27	-12
-9	-9	-6
0	-9	-12
-30	3	9
33	6	9
-39	6	-6
-54	9	9
-48	12	0
-45	18	-9
45	-3	-12
-39	27	-3
39	15	-15
-27	48	-18
-30	42	-15
6	54	21
3	45	-3
6	24	15
-6	21	30
-12	18	45
-15	48	24
9	39	36
6	30	-9
45	42	-6
39	27	-9
-48	36	-9
-24	51	0
-30	-51	-27
36	-9	15
-39	33	0
54	21	-9
42	0	21
-18	-6	39
15	6	38

// Wicker B, 2003: Olfactory, Disgusting vs. Rest
// Wicker B, 2003: Olfactory, Pleasant vs. Rest
// Wicker B, 2003: Visual, Disgusting vs. Neutral
// Wicker B, 2003: Visual, Pleasant vs. Neutral
// Wicker B, 2003: Overlap Between Observing and Feeling Disgust
// Subjects=14
-24	-2	-30
20	-4	-16
36	28	-2
36	10	4
-44	52	8
-36	22	8
50	26	14
46	16	18
44	36	22
4	26	26
-34	0	36
36	-70	56
-20	-54	-30
-18	-2	-28
2	-20	-24
26	0	-22
34	34	-12
-2	-42	-6
38	-2	2
26	28	10
48	42	24
-46	34	24
46	8	28
40	30	30
44	-62	48
34	-70	54
-30	-74	-20
44	-70	-14
-4	-26	-10
-38	26	-6
22	12	0
-24	30	4
62	-44	8
-24	8	12
64	12	14
-50	-14	18
-36	56	24
40	-50	28
4	24	30
54	8	40
-4	12	48
-52	-20	52
8	12	52
-2	-64	-24
-16	-10	-22
40	-74	-20
-50	-12	10
48	24	18
6	-70	44
-38	26	-6
-34	28	6
-34	10	16
4	24	30

// Ferrandez A M, 2003: Duration > Detect
// Ferrandez A M, 2003: Intensity > Detect
// Ferrandez A M, 2003: (Duration - Detect) - (Intensity - Detect)
// Ferrandez A M, 2003: (Intensity - Detect) - (Duration - Detect)
// Subjects=11
-48	6	48
9	27	48
-48	12	33
51	21	27
45	57	6
-39	9	30
45	9	36
-33	30	3
36	33	0
-9	33	27
-42	-36	42
39	-45	42
-51	-42	9
54	-39	6
-15	6	6
18	3	12
3	-51	-18
6	-18	-9
12	6	9
9	-3	6
-36	3	57
9	33	45
-42	27	27
45	12	33
-39	45	12
-42	9	33
-30	33	3
36	33	0
-12	36	24
-42	-36	42
36	-51	48
51	-24	-3
39	-72	-9
-21	3	9
21	3	9
0	-48	-18
6	-21	-9
-12	9	6
15	9	15
-18	-9	15
9	-12	12
-51	15	0
51	30	0
-54	12	18
-3	9	63
6	18	57
-48	3	48
36	21	6
-54	-48	9
57	-42	12
-60	-36	27
60	-33	30
-24	3	6
-27	-66	36
3	-66	33
-30	-42	-18
45	-54	-12
42	-69	30
-18	45	45
-6	57	6
-27	-21	-9
18	-27	6
0	-12	12
-24	-27	-3
27	-27	-6

// Grossman M, 2003: Alzheimer's Disease Patients
// Subjects=11
-37.87	-25.04	-10.43
-59.12	-57.48	11.07
-63.74	5.9	0.4
-7.18	9.01	30.5
48.93	-61.36	9.62
-63.36	-34.98	22.37
-46.21	16.55	21.46
-33.02	-73.58	21.19
44.26	-29	-11.43
22.74	6.62	3.34
-37.85	-29.29	-10.01
-16.2	-11.37	-3.19
35.62	27.94	1.01
5.42	15.07	2.8
18.42	37.21	9.35
-20.66	-3.7	-12.83
18.56	29.54	19.07
5.42	15.07	2.8
-54.68	-30.28	26.24
-29.1	-41.61	-4.46
-59.13	-40.05	13.83
-54.88	7.59	18.01
22.74	37.23	9.27
-20.52	-11.38	-3.11
-24.78	-41.59	-4.53
18.42	37.21	9.35
5.42	15.07	2.8

// Grossman M, 2003: Normals
// Subjects=16
-63.34	-39.24	22.79
53.33	-21.39	23.52
-63.36	-34.98	22.37
-46.21	16.55	21.46
-33.02	-73.58	21.19
44.26	-29	-11.43
22.74	6.62	3.34
-37.85	-29.29	-10.01
-16.2	-11.37	-3.19
35.62	27.94	1.01
5.42	15.07	2.8
18.42	37.21	9.35
-20.66	-3.7	-12.83
18.56	29.54	19.07
5.42	15.07	2.8
-54.68	-30.28	26.24
-29.1	-41.61	-4.46
-59.13	-40.05	13.83
-54.88	7.59	18.01
22.74	37.23	9.27
-20.52	-11.38	-3.11
-20.66	-3.7	-12.83

// Lanius R A, 2003: Trauma vs. Rest, Normals > PTSD Patients
// Lanius R A, 2003: Sad vs. Rest, Normals > PTSD Patients
// Lanius R A, 2003: Anxious vs. Rest, Normals > PTSD Patients
// Subjects=10
12	-12	2
-4	-8	6
-4	-14	18
0	36	-12
-6	7	25
-8	64	6
44	30	-12
-20	26	-8
24	-84	42
12	-8	10
-6	-16	14
-4	-6	10
10	14	26
-12	18	36
-2	-26	44
20	-30	-2
18	-28	-10
16	-48	-2
-28	-94	24
-14	-94	22
-6	-18	18
-16	-26	16
-8	32	4
-4	-2	32
-2	-28	24
-20	32	30
-38	34	14
-34	32	-2
-6	4	-10
16	-100	18

// Sonty S, 2003: Normals
// Subjects=14
-45	54	-9
-51	-45	0
-9	51	39
-45	39	-12
-6	21	39
-39	-60	24
-42	-69	30
42	33	-15
45	-9	15
-45	-27	0
51	-24	-3
30	-54	-21
-27	-57	51
39	-51	60
-54	3	15
51	3	21
27	-69	-18
-27	-60	54

// Sonty S, 2003: Primary Progressive Aphasia (PPA)
// Subjects=14
-48	42	-15
-42	6	36
-57	-45	-3
-3	27	36
-39	33	-15
-3	30	36
-42	-57	42
57	30	-6
39	-15	6
-57	-39	0
21	-78	-30
30	-54	-21
-27	-57	51
39	-51	60
-54	3	15
51	3	21
27	-69	-18
-27	-60	54

// Gizewski E R, 2003: Braille, Blind vs. Normals
// Gizewski E R, 2003: Finger Tapping, Blind vs. Normals
// Gizewski E R, 2003: Electrical Stimulation, Blind vs. Normals
// Subjects=12
-9	-99	10
27	-74	34
27	-97	-8
-6	-42	69
-6	-3	66
-36	-23	56
62	-1	33
-39	-23	56

// Sanfey A G, 2003: Unfair Proposals > Fair Proposals
// Subjects=19
-35.3	49.9	10
42.79	42.43	16.42
5.57	25.43	33.88
-7.35	29.78	22.51
36.53	29.67	30.94
-39.3	27.44	36.46
38.44	17.51	-2.63
-34.25	15.67	-6.1
-2.02	-3.2	8.49
-42.36	1.5	45.36
-41.2	-25.01	46.46
-2.05	-25.46	-4.14
33.6	-46.57	36.25
-30.45	-51.73	44.11
5.69	-76.63	7.87
-6.16	-74.38	-3.34
-2.01	-76.7	-19.92

// Seifritz E, 2003: Women Without Children
// Subjects=10
12.8	48.16	10.7
11.77	49.64	16.17
48.11	12.54	1.02
-41.67	15.17	1.83
35.19	-7.23	-19.48
45.96	10.24	-.99
-41.68	17.29	1.65
32	-13.68	-20.02

// Seifritz E, 2003: Men Without Children
// Subjects=10
12.8	48.16	10.7
11.77	49.64	16.17
48.11	12.54	1.02
-41.67	15.17	1.83
35.19	-7.23	-19.48
47.04	12.53	1.03
-39.53	15.19	1.8
29.89	-7.89	-13.79

// Seifritz E, 2003: Women With Children
// Subjects=10
12.8	48.16	10.7
7.39	55.1	4.61
48.11	12.54	1.02
-41.67	15.17	1.83
35.19	-7.23	-19.48
45.96	10.24	-.99
-41.68	17.29	1.65
32	-13.68	-20.02

// Seifritz E, 2003: Men With Children
// Subjects=10
12.8	48.16	10.7
7.39	55.1	4.61
48.11	12.54	1.02
-41.67	15.17	1.83
35.19	-7.23	-19.48
47.04	12.53	1.03
-39.53	15.19	1.8
29.89	-7.89	-13.79

// McClure S M, 2003: Juice Delivered (unexpected) > Juice Delivered 
// (expected)
// McClure S M, 2003: Juice Delivered (expected) > Juice Delivered 
// (unexpected)
// Subjects=18
-18	4	8
-18	1	8

// Kringelbach M L, 2003: Correlation of Pleasantness Ratings with Activation
// Kringelbach M L, 2003: (Chocolate Milk + Tomato Juice) > Neutral Solution
// Kringelbach M L, 2003: Satiation Effects of Food Type, Conjunction of 
// Chocolate Milk & Tomato Juice
// Kringelbach M L, 2003: Sensory-Specific Satiety-Related Change of 
// Activation for Chocolate Milk
// Subjects=10
-22	34	-8
26	26	14
16	38	-22
2	30	-22
16	20	36
16	8	58
-26	45	-8
-24	42	-12
-33	44	-12
48	-14	22
-30	-14	-6
24	16	-6
-24	10	0

// O'Doherty J P, 2003: Learning Rate and Signed PE Response, Responding to 
// delta t(cs) & Signed(delta t(ucs)
// O'Doherty J P, 2003: Significant Effects to Slower Learning Rate
// O'Doherty J P, 2003: Delta t(cs) & Delta t(ucs) Components, Delta t(cs) 
// Masked with Signed Delta t(cs)
// O'Doherty J P, 2003: Delta t(cs) & Delta t(ucs) Components, Delta t(cs) 
// Masked with Absolute Value of Delta t(cs)
// O'Doherty J P, 2003: TD Analysis of CSneut Condition, Less Stringent Test 
// of Conjunction Between the Two Regressors
// O'Doherty J P, 2003: TD Analysis of CSneut Condition, PE Responses in 
// Reward & Neutral Conditions
// Subjects=9
-27	3	-9
27	-9	-9
15	45	-18
-18	-60	-30
-33	0	-6
-27	3	-9
27	-9	-9
-27	15	-3
-21	45	-9
-24	54	-18
-12	-21	-6
24	-15	-6
-30	-51	-30
24	-60	-30
0	-54	51
-42	-33	33
-57	9	27
54	12	18
48	48	15
-33	21	57
39	18	54
3	9	51
42	3	30
45	15	30
54	15	18
-33	33	3
18	54	6
12	-45	-18
-18	0	-9
21	36	-9

// Elsinger C L, 2003: Healthy Controls
// Subjects=13
-43.29	-17.91	55.92
-51.1	-30.18	7.97
62.11	-21.39	1.47
17.11	-48.12	-23.65
-28.63	-36.31	9.34
-39.01	-21.14	55.03
-51.04	-30.73	14.71
6.93	-54.01	-16.35
-.54	-7.71	60.15
-27.55	-32.96	11.28

// Elsinger C L, 2003: Parkinson's Disease Patients
// Subjects=10
-36.8	-29.16	61.25
-53.21	-33.24	9.93
57.89	-27.41	6.49
32.3	-11.65	19.96
-53.92	-44.92	51.62
-57.49	-35.51	8.49
-2.05	54.73	28.17
-11.88	5.18	-19.98
-59.33	-45.64	42.82
-38.94	-30.32	60.26
-49.98	-28.6	14.52
54.86	-6.97	37.15
-48.63	-22.34	54.12
-4.81	-8.79	60.29
-29.84	-2.65	4.3
-13.8	-18.99	-1.98

// Specht K, 2003: Tones vs. Rest
// Specht K, 2003: Sounds vs. Rest
// Specht K, 2003: Words vs. Rest
// Specht K, 2003: Sounds vs. Tones
// Specht K, 2003: Words vs. Tones
// Specht K, 2003: Words vs. Sounds
// Subjects=12
56.22	-15.26	-2.91
-53.97	-18.84	-.68
69.27	-22.24	2.04
-71.18	-22.74	4.48
-62.43	-35.06	10.03
60.54	-15.25	-2.99
-58.29	-18.86	-.61
56.57	11.46	30.3
1.65	16.97	46.37
22.9	-86.3	-3.16
69.27	-22.24	2.04
-62.43	-35.06	10.03
-66.8	-48.56	3.6
27.25	-72.9	2.16
64.79	-11.39	-7.92
-67	-16.11	-5.21
-2.69	21.21	46.03
-28.97	-95.3	-4.75
-46.28	21.55	17.6
-7.85	-19.04	-28.34
-6.73	-40.18	55.53
56.63	11.88	34.74
-29.15	-67.11	-13.14
-57.79	-.88	42.43
64.65	-.42	-16.85
48.82	-39.23	5.19
-66.87	-31.55	1.92
-58.52	-.85	-14.71
-7.19	27.5	33.16
-41.95	-91.1	-4.94
5.17	-18.58	-24.13
-57.88	7.22	37.15
60.28	-.75	-20.11
-66.85	-35.8	2.34
-66.86	-22.73	4.4
1.72	13.14	51.23
69.18	-15.22	-3.14
69.06	-20.51	-13.82
-66.85	-48.87	0.27
-67.06	-12.17	-8.96
60.46	-20.23	-10.34
-50.95	21.07	-10.29
48.82	-39.23	5.19
-7.01	21.2	46.1
-46.75	37.68	-16.48
-53.77	17.69	22.59
-66.85	-35.8	2.34
-58.52	-.85	-14.71
64.65	-.42	-16.85
69.04	-16.25	-14.24
-6.92	13.11	51.38
65.08	-28.87	11.73
9.58	-38.67	-21.09
-66.92	-31.96	-2.52
64.84	-10.98	-3.48
-62.74	-12.15	-9.04
-53.91	-18.43	3.76
-46.63	21.08	-10.36

// Dhamala M, 2003: Brain Activity Correlated with Increased Rate of Finger 
// Tapping
// Dhamala M, 2003: Finger Tapping Correlations with Complexity (D1-D0)
// Dhamala M, 2003: Finger Tapping Correlations with Complexity (D2-D0)
// Dhamala M, 2003: Finger Tapping Correlations with Complexity (D3-D0)
// Subjects=13
16	-16	-12
24	-28	64
-4	-72	-20
-56	-72	-8
-36	-28	64
-4	-72	-20
-8.3	-28	-4
-4	-72	-24
44	-20	56
-4	-20	12

// Durston S, 2003: Healthy Controls
// Subjects=7
-35.86	-10.72	51.89
23.7	-47.34	-.37
-20.11	-48.66	0.24
58.06	-30.1	26.79
10.11	-47.6	38.84
-7	-44.53	38.78
-9.75	27.11	-11.81
12.78	63.31	13.9
-20.6	90.12	-8.04
15.69	93.17	-13.18
31.36	-41.01	25.78
7.03	-50.73	53.64
-1.51	-52.9	53.92
41.86	-35.26	2.87
44.98	35.29	20.34
21.78	-41.78	30.41
-5.99	-48.46	29.06
57.85	21.63	21.33
-25.28	28.9	54.02
65.52	-22.57	27.18
36.53	41.73	35.51
9.49	27.23	-12.04
-44.65	28.47	36.44
-14.83	6.67	13.39
27.77	-5.53	-10.61
-.86	5.41	23.37

// Durston S, 2003: ADHD Children
// Subjects=7
-35.86	-10.72	51.89
23.7	-47.34	-.37
-20.11	-48.66	0.24
58.06	-30.1	26.79
10.11	-47.6	38.84
-7	-44.53	38.78
-9.75	27.11	-11.81
12.78	63.31	13.9
-20.6	90.12	-8.04
15.69	93.17	-13.18
31.36	-41.01	25.78
7.03	-50.73	53.64
-1.51	-52.9	53.92
41.86	-35.26	2.87
44.98	35.29	20.34
21.78	-41.78	30.41
-5.99	-48.46	29.06
57.85	21.63	21.33
19.23	56.03	15.55
21.78	-33.06	33.03
-15.56	-41.4	38.62
-32.73	22.51	54.64
52.76	-43.97	26.89
20.63	-85.51	1.75
-13.09	88.31	-4.63
14.43	-37.2	49.07
-10.18	-35.49	45.86

// Peters S, 2003: Right Hand Movement > Rest, OFF Medication
// Peters S, 2003: Right Hand Movement > Rest, ON Medication
// Peters S, 2003: Left Hand Movement > Rest, OFF Medication
// Peters S, 2003: Left Hand Movement > Rest, ON Medication
// Subjects=7
-30	-12	66
-60	6	24
-63	-21	15
57	0	39
6	-66	-51
-30	-12	66
-36	-3	60
48	-6	54
57	-12	45
51	-27	57
-18	-48	-18
-24	-69	-24
-36	-75	-24
-63	-21	15
-60	-51	36
-63	-33	30
48	-6	54
54	-12	48

// Shikata E, 2003: Orientation Discrimination vs. Color Discrimination, 
// masked by Orientation Imagination and Movement
// Subjects=9
-36	-39	39
39	-39	39
-9	-75	54
21	-66	60
-30	-69	54
33	-69	51
-54	-42	45
51	-36	48
45	-24	36
-27	-75	33
36	-75	36
-54	-60	-18
51	-66	-12
-30	-12	57
36	0	60
51	9	27

// Taniwaki T, 2003: Self Initiated Movement Positive Linear Rates vs 
// Externally Triggered Movement Negative Linear Rates
// Taniwaki T, 2003: Self Initiated Movement vs. Rest, Categorical on-off 
// Responses
// Taniwaki T, 2003: Self Initiated Movement vs. Rest, First Order Term Linear 
// Effect
// Taniwaki T, 2003: Externally Triggered Movement vs. Rest, Categorical 
// on-off Responses
// Taniwaki T, 2003: Externally Triggered Movement vs. Rest, First Order Term 
// Linear Effect
// Subjects=10
26	-6	12
26	-2	-12
12	-16	6
-6	2	50
38	-14	62
56	6	36
28	-12	0
14	-18	4
6	-14	44
38	-40	64
34	-8	62
28	-4	-10
12	-20	4
-4	-2	48
42	-16	56
54	4	36
44	-20	56
40	-6	56

// Paulus M P, 2003: Risky - Safe
// Paulus M P, 2003: Risky - Punished
// Subjects=17
35.26	21.01	1.57
-5.84	-74.38	37.92
-16.48	-69.53	46.56
12.24	-65.19	31.37
40.86	11.63	31.29
52.5	7.25	14.8
-27.13	-43.99	61.27
-39.32	-20	14.79

// Perani D, 2003: Healthy Controls
// Subjects=10
-56	22	16
-44	26	20
-46	24	0
-34	10	40
-50	16	44
-32	38	32
-52	38	8
-20	8	0
-20	14	12
-10	2	12
-6	-10	4
-16	6	16
-42	-28	52
-44	-30	40
40	30	8
58	22	0
20	-6	12
-8	-76	8
2	-66	4
0	14	56
2	24	44
-34	26	32
-46	32	28
-44	36	16
-40	50	16
-26	38	4
-40	26	4
-44	-48	0
-50	-44	0
-26	-52	44
-30	-44	48
46	36	8
38	32	4
-20	-66	8
-4	-68	20
-2	-86	8
16	-78	8
-10	-90	12
-4	-8	12

// Perani D, 2003: Aphasic Patient 1
// Subjects=1
-52	14	16
-38	18	8
-32	20	16
-42	38	-4
-34	46	20
-38	24	4
-52	14	16
-44	40	0
54	14	12
-2	-54	8

// Perani D, 2003: Aphasic Patient 2
// Subjects=1
-58	10	8
-58	-8	8
-38	-60	-4
-4	-84	12
-14	-70	0
40	32	12
46	38	16
40	36	-4
50	51	12
64	-30	12
38	-56	0
66	8	4
14	-82	12
30	-72	8
-4	-48	12
-34	38	8
-34	42	0
-58	12	4
-32	60	-4
-36	52	-12
-30	-78	8
-20	-80	4
-18	58	0
42	36	-4
50	48	0
32	58	-4

// Perani D, 2003: Aphasic Patient 3
// Subjects=1
-20	62	16
-24	60	8
12	64	20
14	58	4
-8	54	-8
0	62	0
6	66	4

// Perani D, 2003: Aphasic Patient 4
// Subjects=1
-48	12	12
-14	-18	12
-6	-16	8
44	24	12
48	28	4
42	20	20
60	18	12
44	40	24
12	-20	8

// Perani D, 2003: Aphasic Patient 5
// Subjects=1
54	10	16
54	16	32
56	30	36
6	-86	0
54	10	16
40	22	0
58	16	-4
54	18	36
56	26	36
6	-86	0

// Ward N S, 2003: Aphasic Patients
// Subjects=8
44	-14	42
52	-10	36
50	-12	52
-42	-10	42
48	-6	50
-42	0	42
32	24	50
-20	20	50
-46	14	38
8	-22	66
6	12	66
4	-16	50
-24	42	32
-54	-22	44
30	-50	50
64	-24	8
-50	8	-34
6	-74	8
36	-84	6
-32	-78	4
8	-62	-36
-2	-6	12
24	-8	12
36	-26	64
-34	-26	70
-48	-16	54
32	-36	48
-36	-34	52
-48	-22	48
32	0	60
32	-16	68
-30	0	62
-26	-14	68
44	22	42
-2	-4	58
-4	28	56
-2	10	38
-28	-68	56
-28	-72	32
64	-16	18
34	60	-4
-42	46	-4
58	-48	14
-50	-44	10
-50	-64	-4
2	-84	14
-4	-96	14
-30	-76	-18
22	-62	-18
-24	-30	-34
48	-60	-28
-2	-68	-40
-4	-62	-22
2	-14	10
-4	-2	6
26	-16	8
48	18	-30
-50	-70	36
-10	8	18

// Tyler L K, 2003: Tools vs. Letter Strings
// Tyler L K, 2003: Animals vs. Letter Strings
// Tyler L K, 2003: Tool Actions vs. Letter Strings
// Tyler L K, 2003: Biological Actions vs. Letter Strings
// Tyler L K, 2003: Tool Actions vs. Tools
// Tyler L K, 2003: Biological Actions vs. Animals
// Subjects=12
-46	12	32
-50	20	12
-48	28	-10
-30	-34	-26
-20	-14	-14
-42	-42	-26
4	24	36
0	14	48
-6	28	54
0	-80	8
16	-82	10
10	-58	-2
-24	-12	-18
-42	-46	-28
-48	-40	-12
-28	24	-8
-30	28	-18
-44	18	4
-8	-20	20
-6	4	24
-4	-28	16
10	-72	-34
8	-64	-26
34	28	-10
42	18	6
18	26	24
16	-26	-22
10	-20	-20
38	-28	-22
4	20	44
-50	22	10
-32	22	-6
-46	32	-10
6	22	34
-4	14	46
-4	28	44
-44	-40	-24
-20	-12	-24
-18	-10	-14
-24	-58	2
-10	-78	6
-14	-66	2
36	24	-8
44	0	-14
46	20	6
10	-76	-34
6	-60	-22
10	-50	-16
-46	30	-12
-32	32	-18
-50	18	-6
-14	-36	-2
-8	-30	-2
-16	-48	0
-26	-16	-12
-34	-16	-26
-26	-22	-18
-54	-30	-6
-44	-42	-16
-52	-46	-8
-6	-68	-34
6	-36	-26
6	-62	-24
2	18	40
-4	32	40
-50	16	14
-44	32	-14
-38	12	6
-50	20	10
-36	28	-2
-42	24	18
-60	-50	2
-52	-32	-4

// Chee M W, 2003: Normals, Experiment 1
// Subjects=12
-41.49	16.97	25.1
38.63	20.54	22.76
35.25	25.32	2.33
-.67	6.24	47.83
-57.55	-45.97	-2.9
-44.75	-59.35	-11.96
-31.48	-64.51	44.08
-41.49	19.17	26.03
-48.04	30.88	12.85
35.25	25.32	2.33
-2.89	19.72	43.38

// Chee M W, 2003: Normals, Experiment 2
// Subjects=8
-47.86	10.85	29.03
40.84	10.32	28.05
-44.42	-28.46	43.44
-2.79	8.68	52.11
-26.1	-55.33	52.17
27.31	-63.98	45.59
-41.46	-73.88	-7.43
-43.63	19.16	26.05
-48.02	33.34	17.11

// Chee M W, 2003: Normals, Experiment 3
// Subjects=12
-38.28	15.93	25.15
41.88	18.79	27.33
30.98	26.44	3.4
38.72	5.02	28.52
-4.99	12.39	45.13
-46.89	-52.76	-9.14
-31.43	-62.94	50.64
31.59	-66.16	44.61
-28.64	-72.74	-7.68
-15.74	-64.15	5.95
-41.47	13.88	26.47
-32.07	31.52	5.92
36.39	15.1	7.63
-3.96	22.97	44.24
6.75	17.74	44.55

// Bullmore E, 2003: Load Response Following Placebo
// Bullmore E, 2003: Practice Effects Following Placebo
// Bullmore E, 2003: Treatment Effects On Periodic Activation
// Bullmore E, 2003: Treatment Effects On Load Response
// Subjects=12
35.14	8.8	-18.59
37.32	7.05	-14.01
35.23	-5.66	-12.92
22.51	-32.17	-10.55
24.67	-30.76	-6.23
-4.46	44.15	-12.18
-10.83	44.54	-6.56
-10.8	43.74	-3.15
-8.62	40.92	1.52
-4.32	44.46	5.64
-5.36	43.74	10.17
11.78	42.07	14.57
18.25	37.16	19.37
20.42	36.46	23.87
9.82	24.05	29.49
33.3	3.07	17.6
-39.45	24.84	16.61
20.28	19.6	-1.48
19.24	19.94	2.96
31.15	-12.43	10
23.52	-62.43	-30.33
23.54	-59.97	-26.07
-5.29	-56.63	-21.56
34.22	-40.19	-18.93
47.19	-70.43	-12.09
-17.91	-91.97	-9.53
-29.73	-57.52	-3.36
49.36	-70.08	-7.68
-17.94	-53.85	1.77
4.46	-35.48	3.32
-9.5	-8.78	5.7
-14.81	18.99	21.27
-13.72	21.45	25.52
-10.47	19.7	30.09
28.74	87.98	14.99
32.57	-69.21	32.59
31.53	-66.76	36.86
38.01	-66.03	45.64
34.85	-68.8	51.49
-39.42	-45.23	-8.74
-21.18	-66.27	-7.19
-23.3	-62.77	-3
-31.85	-53.04	-.37
19.31	19.57	11.91
26.92	12.18	25.83
32.3	13.61	30.11
-43.43	-43.57	26.85
-35.89	-51.64	31.9
-36.92	-52.36	36.43
-42.26	-46.85	39.38
19.77	-74.57	33.18
10.22	-82.75	38.44
11.3	-80.37	41.57
-39.22	-.31	35.44
-34.81	-14.23	47.71
-37.94	-22.28	54
1.44	-14.87	36.19
-1.73	-14.46	41.77
-1.69	-11.91	47.13
2.54	10.74	50.76
4.72	11.19	56.28
-7.93	-69.48	46.46
4.94	-70.03	51.93

// Luo Q, 2003: Semantic Jugdment > Fixation
// Luo Q, 2003: Analogy > Semantic Judgment
// Subjects=10
-38.21	-67.89	0.95
-30.85	-63.58	-12.88
-30.58	-86.02	13.53
-53.96	-22.2	56.4
-37.84	-37.63	61.97
-50.03	21.49	29.28
28.09	-81.32	0.2
43.92	-57.93	-15.33
-11.86	-2.31	-20.47
-55.24	-50.84	16.44
-43.79	28.45	8.55
-42.68	-52.36	-18.14
-27.96	-11.89	-32.86
-29.05	12.05	-25.93
31.3	-87.82	-1.52
2.03	40.56	-4.15
16	12.89	-5.33
42.53	30.97	-21.65
17.93	33.91	-22.73

// Downar J, 2003: Conjunction: Transient Response to Onset/Offset of 
// Non-Painful and Painful > Non-Painful
// Downar J, 2003: Conjunction: Sustained Response to Onset/Offset of 
// Non-Painful and Painful > Non-Painful
// Subjects=10
61.26	-40.03	22
61.06	4.13	14.96
-51.22	5.86	6.07
9.93	8.79	38.57
-2.99	14.29	28.22
0.41	-16.65	40.82
16.2	-15.69	10.44
-6.26	-22.68	4.6
-25.65	-1.36	-7
51.58	-24.22	20.79
-54.2	-28.03	22.32
44.84	15.18	-5.86
-32.02	22.09	7.83
44.92	-.43	-1.2
-38.46	1.99	-3.79
-41.17	-22.47	51.82
0.3	-34.31	18.88
0.41	-3.44	46.4
12.86	-53.43	-23.15

// Gray J R, 2003: Regions in which gF predicted neural activity on lure 
// trials
// Subjects=60
-33.13	46.92	12.45
43.8	47.38	11.53
-46.11	45.3	-7.34
-47.96	25.14	21.14
50.44	23.32	30.2
-41.48	12.74	25.45
48.23	12.77	17.73
-9.25	8.13	45.54
31.01	-57.81	-26.34
-47.95	21.96	21.41
63.48	-7.29	46
-39.03	-36.72	46.3
-58.32	-40.77	36.82
50.74	-29.58	48.01
22.79	-67.72	11.39
-58.45	-55.26	14.62
54.65	-29.98	1.16

// Luo J, 2003: Event A > Baseline
// Subjects=7
-20	39	44
-28	59	17
-22	63	12
-20	53	10
22	56	32
6	43	49
-34	33	39
-44	44	16
48	31	35
34	29	41
26	37	42
-4	60	1
-2	63	10
-4	50	-14
4	-20	67
0	15	-2
34	-23	53
32	-16	39
50	41	5
-50	41	7
2	-14	36
4	-23	40
6	0	30
-53	-16	1
67	-21	3
53	-15	6
61	-12	1
42	-27	11
36	-16	-14
24	-38	53
-20	-38	15
-53	-55	-12
-57	-45	-10
-48	-56	45
-36	-55	58
4	-64	47
6	-76	2
-8	-70	-8
-26	-51	-13

// Muller J L, 2003: Criminal Psychopaths > Healthy Controls, Positive 
// Emotional Load
// Muller J L, 2003: Healthy Controls > Criminal Psychopaths, Positive 
// Emotional Load
// Muller J L, 2003: Criminal Psychopaths > Healthy Controls, Negative 
// Emotional Load
// Muller J L, 2003: Healthy Controls > Criminal Psychopaths, Negative 
// Emotional Load
// Subjects=6
-46.67	-3.27	39.12
-45.74	10.6	25.68
41.94	0.72	27.73
-52.01	-52.68	19.91
62.24	-58.48	3.47
-51.11	-53.33	-2.35
34.64	-44.62	33.85
-38.99	-65.95	39.83
-17.96	-91.34	-15.16
18.39	-88.75	-12.45
-18.16	-49.47	-24.24
23.49	-49.48	-28.07
38.34	31.8	-10.52
47.4	-58.43	19.25
-21.13	-66.9	-1.56
26.91	-64.84	-6.75
-35.9	-10	47.37
45.17	-0.06	31.1
42.2	-6.39	59.55
5.78	-14.16	45.01
-50.07	-51.47	-5.87
-54.16	-50.66	18.65
58.95	-39.55	0.8
20.25	-9.26	-16.91
37.58	-11.16	12.05
-3.64	-59.43	52.26
42.28	-55.01	50.24
-19.12	-90.09	-26.4
31.12	-78.7	-21.24
-15.78	38.67	41.94
-5.41	37.68	0.64
5.38	31.11	11.1
-28.68	-51.17	-3.91
46.38	-73.33	19.39
-3.93	-63.48	13.57
26.93	-64.67	-4.53

// Hempel A, 2003: Discrimination Task (control vs patients, activation)
// Hempel A, 2003: Labeling Task (control vs patients, activation)
// Subjects=9
7.67	27.21	29.25
43.06	5.64	36.23
-34.99	6.95	32.55
5.65	-38.59	18.06
54.6	-23.89	-2.69
-45.87	-28.09	-6.76

// Hubl D, 2003: Autistic group
// Subjects=20
38.55	-50.65	-16.99
-39.44	-59.66	-16.45
45.11	-77.59	-8.12
-48.94	-73.92	-7.34
29.38	-68	34.75
-27.2	-68.8	43.28
40.87	10.58	31.38
-38.22	11.07	31.13
44.91	7.15	0.39
-36.33	16.26	1.68
48.21	23.51	19.06
47.37	-51.03	18.63

// Hubl D, 2003: Healthy controls
// Subjects=10
37.44	-47.74	-20.57
-40.54	-56.75	-20.03
41.9	-79.81	-9.01
-47.88	-75.06	-8.38
31.55	-67.64	39.16
-26.12	-68.7	44.37
45.16	4.26	31.86
-44.57	-1.48	34.49
43.89	13.11	8.83
-33.14	18.31	0.35
40.73	26.72	19.99
51.75	-53.23	31.03

// Beauchamp M S, 2003: Tool Video Clips > Human Video Clips
// Beauchamp M S, 2003: Human Video Clips > Tool Video Clips
// Subjects=9
49.34	-65.93	-9.14
-52.16	-65.23	-4.69
-21.34	-42.63	-18.09
30.97	-45.12	-27.4
-22.93	-33.73	55.9
28.48	-59.61	60.82
-50.05	4.77	19.53
45.06	-1.17	16.7
-40.24	-60.18	18.17
51.65	-56.46	16.8
-37.32	-44.42	-12.18
48.14	-44.25	-17.64

// Santi A, 2003: Regions of activation, visible speech
// Santi A, 2003: Regions of activation, walk/jump
// Subjects=10
-24.17	-94.78	9.73
25.97	-86.62	0.67
45.1	-60.07	-1.78
-63.97	-6.57	11.72
61.11	-28.37	7.65
-49.91	-24.49	26.44
62.31	-.67	35.42
-56.28	-1.04	41.27
-35.79	-7.83	61.68
-58.59	5.95	21.76
-46.96	25.51	12.18
-53.21	12.93	28.92
50.39	11.89	20.01
36.36	24.61	6.83
-4.79	-15.22	59.72
-.59	6.04	59
-22.37	-55.5	-19.23
6.53	-48.21	-10.14
40.94	-84.24	2.53
-8.2	-57.96	16.5
7.84	-67.64	13.78
-33.01	-57.25	-13.38
-38.45	-48.37	-21.87
43.93	-56.79	-14.31
39.35	-7.26	-34.02
68.59	-44.78	1.13
42.65	27.77	-8
3	67.08	-5.27
-22.67	60.07	-11.08
-24.78	67.97	-5.02
-2.4	63.11	-14.91
23.26	67.83	-11.14

// Mecklinger A, 2003: Interference > Control, Letter task
// Mecklinger A, 2003: Interference > Control, Object task
// Subjects=12
40.75	30.24	24.15
-32.9	14.19	29.69
42.22	-39.14	48.91
7.09	-63.25	56.92
44.37	-49.96	46.45

// Grezes J, 2003: Perception of one's own action > Perception of the action 
// of others
// Grezes J, 2003: False expectation > Correct expectation
// Subjects=6
-30.43	-4.77	68.12
36.34	-1.74	51
-43.51	-34.13	53.32
-48.67	3.41	-4.09
24.41	-43.03	-45.57
55.11	26.09	3.1
-59.6	37.41	-7.27
44.07	33.1	-13.09
-33.77	25.82	-17.77
-.51	34.5	50.28
18.42	13.19	5
-50.44	-46.2	16.53
66.07	-44.9	0.97
-57.1	-49.8	1.31
-23	-83.82	-42.96

// Li X, 2003: Tone > syllable
// Subjects=12
-40.43	16.89	23.98
4.57	28.31	43.69
-18.59	-68.15	50.93
-7.1	-84.02	9.75
2.19	-69.78	-27.24

// Abrahams S, 2003: Verbal Fluency
// Abrahams S, 2003: Confrontation Naming
// Abrahams S, 2003: Significant Correlation during Confrontation Naming, Age
// Abrahams S, 2003: Significant Correlation during Confrontation Naming, Task 
// Performance
// Subjects=18
-47.86	3.1	25.22
-47.85	10.93	30.14
-32.02	38.63	15.36
5.63	11.77	36.14
-39.24	8.32	36.95
-2.85	4.74	42.41
13.04	17.64	28.87
-2.8	5.25	49.05
-43.78	29.68	10.67
-35.96	0.31	43.16
-35.86	-12.92	50.96
-13.73	-5.04	13.24
-50.22	11.78	-0.02
-39.57	33.42	3.62
-6.28	27.67	22.68
-43.89	18.7	-7.36
-39.67	21.47	-13.22
34.3	35.32	21.57
-50.18	12.21	5.52
-2.98	-73.48	-5.68
-13.81	1.85	5.97
-19.77	-78.15	31.71
-47.9	13.68	24.33
-47.86	-62.74	-.49
-50.07	6.8	18.24
-36.04	-3.8	31.24
-31.72	-3.26	37.83
-35.95	-2.86	43.42
-43.64	-58.92	-6.43
38.82	-79.69	6.63
-39.24	-80.67	0.92
38.77	-80.2	-0.02
-48.11	19.19	-.66
-35.98	-80.13	7.53
5.52	33.71	30.96
31.26	30.41	40.98
-36.09	-75.7	-4
-35.18	-20.28	-3.08

// Audoin B, 2003: Clinically Isolated Syndrome Suggestive of Multiple 
// Sclerosis (CISSMS)
// Subjects=10
4.11	-5.92	65.41
1.75	10.05	52.66
-48.02	5	47.28
11.6	20.9	64.86
15.98	12.62	67.85
36.23	14.97	45.98
7.73	26	16.24
-.83	26.59	23.05
-45.36	52.09	11.2
-49.83	51.99	-1.04
-47.26	37.58	28.36
-42.85	9.84	29.91
64.78	37.82	1.77
-56.33	29.97	-6.59
58.05	22.75	-21.27
60.17	32.33	-22.26
-20.9	75.52	-15.06
36.74	62.16	11.05
-49.04	53.11	-23.57
2.08	-38.9	68.7
-4.4	-61.88	64.36
-69.89	-33.19	18.94
-71.28	-15.81	-1.81
-69.19	-1.02	-4.43
-48.96	-68.81	-41.77
-29.53	-55.77	-41.15
-29.44	-76.94	-37.93
11.8	-86.39	-26.49
21.49	69.89	2.7
-33.75	68.65	-7.44
-59.39	30.25	8
62.64	34.62	2.13
11.8	-86.39	-26.49

// Audoin B, 2003: Healthy Controls
// Subjects=10
10.57	8.14	66.15
-52.24	-1.94	53.65
49.14	5.88	39.94
31.81	14.23	38.29
54.34	7.64	23.99
-26.56	30.18	39.94
-48.16	30.21	41.43
6.83	15.33	28.52
-6.25	26.47	22.04
-51.77	37.28	13.9
47.72	36.13	19.04
-36.21	-63.4	26.96
-17.26	-49.09	75.64
24.54	-65.67	45.2
-73.28	-17.87	10.76
71.53	-25.87	9.08
-40.94	-78.54	-8.44
-55.16	-45.93	-14.79
65.76	-47.19	-23.45
-3.1	-.5	8.96
7.54	-26.8	-8.79
7.16	-35.12	-40.45
21.49	69.89	2.7
-33.75	68.65	-7.44
-59.39	30.25	8
62.64	34.62	2.13
11.8	-86.39	-26.49

// Eger E, 2003: Modality-related effects: AN>VN (fixed-effect)
// Eger E, 2003: Modality-related effects: AN>VN (random-effect)
// Eger E, 2003: Modality-related effects: VN>AN (fixed-effect)
// Eger E, 2003: Modality-related effects: VN>AN (random-effect)
// Eger E, 2003: N > L and C (fixed-effect)
// Eger E, 2003: N > L and C (random-effect)
// Eger E, 2003: N > L (fixed-effect)
// Eger E, 2003: N > L (random-effect)
// Eger E, 2003: N > C (fixed-effect)
// Eger E, 2003: N > C (random-effect)
// Subjects=9
56	-16	0
-54	-24	-2
44	-30	8
64	-12	2
-40	-36	12
-54	-32	4
-42	-68	-14
-32	-96	-2
44	-60	-18
44	-84	-6
38	-62	56
-40	-72	-14
-46	-74	-6
46	-76	-12
46	-82	-4
-28	-68	30
-32	-46	38
-24	-58	50
34	-60	34
-32	-48	32
32	-58	30
-24	-58	50
34	-60	34
-32	-48	32
32	-58	34
-28	-68	30
-32	-46	38
-20	-76	30
34	-60	34
-34	-50	28
-34	-46	40
32	-58	28

// Gandour J, 2003: Chinese
// Subjects=10
-38.26	19.45	29.31
-16.55	3.37	67.21
-56.33	-55.42	12.38
-47.52	-29.57	56.95
-16.34	-59.27	69.12
-38.4	51	24.44
-44.59	21.41	41.49
-18.68	3.36	67.24
-52.11	-55.99	4.57
-47.51	-33.88	56.19
-28.22	-63.97	50.69
-46.99	46.12	17.14
-41.48	17.14	27.31
-28.42	20.76	59.2
-56.36	-54.62	8.97
-47.48	-35.74	59.7
-26.08	-63.96	50.66
-39.47	50.99	24.45
37.26	64.63	1.24
-42.44	19.31	41.64
51.38	18.79	12.72
-21.02	21.09	49.05
3.54	14.47	43.75
-54.19	-59.72	11.6
-47.53	-29.65	55.84
-40.44	30.01	28.45
-56.34	-56.65	10.25
-44.26	-36.69	60.85
-43.82	43.59	11.74
-54.35	2.29	15.32
-16.55	4.43	67.12
-48.81	-67.01	13.26
-46.4	-36.7	60.88
-56.15	-27.22	46.81
-39.54	35.96	8.98
37.28	60.4	1.59
52.26	26.68	-9.14
-.58	13.78	62.81
-42.74	45.89	13.76
43.69	58.32	1.69
-44.73	14.49	20.88
60.03	20.92	25.83
-30.95	16.64	6.04
39.53	29.75	4.14
8.87	24.19	45.1
-52.93	-30.28	48.15
43.28	-39.22	47.79
-56.15	-27.22	46.81
-44.56	17.27	42.95
-44.71	13.52	22.08
37.35	28.25	-1.29
-23.92	-63.69	53.96

// Gandour J, 2003: English
// Subjects=10
-38.26	19.45	29.31
-16.55	3.37	67.21
-56.33	-55.42	12.38
-47.52	-29.57	56.95
-16.34	-59.27	69.12
-38.4	51	24.44
-44.59	21.41	41.49
-18.68	3.36	67.24
-52.11	-55.99	4.57
-47.51	-33.88	56.19
-28.22	-63.97	50.69
-46.99	46.12	17.14
-41.48	17.14	27.31
-28.42	20.76	59.2
-56.36	-54.62	8.97
-47.48	-35.74	59.7
-26.08	-63.96	50.66
-39.47	50.99	24.45
37.26	64.63	1.24
-42.44	19.31	41.64
51.38	18.79	12.72
-21.02	21.09	49.05
3.54	14.47	43.75
-54.19	-59.72	11.6
-47.53	-29.65	55.84
-40.44	30.01	28.45
-56.34	-56.65	10.25
-44.26	-36.69	60.85
-43.82	43.59	11.74
-54.35	2.29	15.32
-16.55	4.43	67.12
-48.81	-67.01	13.26
-46.4	-36.7	60.88
51.37	41.76	20.84
-40.4	12.83	26.55
54.75	24.83	35.6
37.37	28.42	0.93
9.82	34	34.23
-48.69	-38.35	39.85
55.03	-38.1	47.56
-45.63	14	42.12
44.22	13.19	51.19
-50.84	-41.79	36.82
55	-37.38	43.04
-31.88	41.15	34.11
33.64	12.04	64.79
-54.05	-41.81	36.86
53.97	-36.96	48.6

// Bentley P, 2003: Healthy Controls, Physostigmine
// Subjects=15
38	38	-12
-34	-68	-22

// Bentley P, 2003: Healthy Controls, Placebo
// Subjects=15
44	-50	-24
-42	-44	-28
16	-52	6
-24	-36	-14
-22	-32	-10
-40	-48	-24
10	-8	-16
40	-78	-18
32	-40	-22
-54	-40	34
12	-56	6
6	-86	14
-52	38	8
60	24	10
-6	14	50
58	16	30
54	-38	56
22	-68	32
-32	-56	30
8	-34	18
-54	0	-30
14	-8	68
-24	-16	44
-62	-36	12
-34	-80	16
22	8	0
-2	42	-22
40	-78	-16
32	-52	-22
-34	-84	16
-52	-42	34
-2	-86	6
-26	0	-26
58	12	30
-8	12	48
22	-68	32
6	-24	32
-22	-34	-10
-24	-16	42
-18	38	30
38	56	-10
-36	-90	-14
18	-10	-12
38	38	-14
40	46	-16
-34	-68	-22

// Gottfried J A, 2003: Main effect of olfaction
// Gottfried J A, 2003: Crossmodal semantic congruency, [OV-c] - [OV-i]
// Subjects=15
27	3	-27
21	-12	-21

// Royet J P, 2003: Subgroup of Healthy Controls, Right-handed women
// Subjects=7
46	18	-10
10	-6	-10
-40	14	0
-36	18	-6
-42	42	-12
40	28	-8
-10	-2	-10
-38	16	-6
-46	20	-6
-30	28	-16
38	16	-10
38	28	-8
30	10	-12
-22	-2	-12
-42	24	-4
-44	10	-2
-54	14	8
58	18	12
40	28	-8
48	22	-6
-42	46	-12
-30	4	-24
-22	2	-24
-12	-30	32
-44	-38	-2
36	12	14
-20	0	-24
-14	-8	-22
-44	-2	-8
-36	20	-10
-42	40	-6
-36	40	-14
38	16	-6
36	22	-16
40	28	-4
-34	28	-14
54	30	8
54	28	18
40	30	-6
-44	-28	-8
34	-14	0
-52	-4	-6
-44	-6	-4
-34	20	-10
-34	30	-14
-42	40	-8
-44	32	-6
36	6	-2
36	16	-6
-54	4	34
50	22	0
58	12	10
24	34	4
-20	28	8
-50	26	2
-46	20	6
-44	40	-2
-32	18	-4
-36	14	-6
-28	30	-16
-44	44	-10
-28	34	-14
-32	20	-4
-50	18	-4
44	22	-6
-38	4	-12
-40	16	-12
36	8	-12
-42	40	-2
-40	46	-14
-38	38	10
-6	-8	-16
-10	-2	-10

// Royet J P, 2003: Subgroup of Healthy Controls, Right-handed men
// Subjects=7
46	18	-10
10	-6	-10
-40	14	0
-36	18	-6
-42	42	-12
40	28	-8
-10	-2	-10
-38	16	-6
-46	20	-6
-30	28	-16
38	16	-10
38	28	-8
30	10	-12
-22	-2	-12
-42	24	-4
-44	10	-2
-54	14	8
58	18	12
40	28	-8
48	22	-6
-42	46	-12
-30	4	-24
-22	2	-24
-12	-30	32
-44	-38	-2
36	12	14
-20	0	-24
-14	-8	-22
-44	-2	-8
-36	20	-10
-42	40	-6
-36	40	-14
38	16	-6
36	22	-16
40	28	-4
-34	28	-14
54	30	8
54	28	18
40	30	-6
-44	-28	-8
34	-14	0
-52	-4	-6
-44	-6	-4
-34	20	-10
-34	30	-14
-42	40	-8
-44	32	-6
36	6	-2
36	16	-6
44	16	-2
42	4	0
56	12	16
-52	10	0
-40	16	-4
54	14	14
-38	12	-12
-40	4	-8
-40	20	-14
-56	10	26
-60	6	16
40	6	-12
-44	8	-4
-44	20	-12
-32	20	0
48	20	-8
38	24	-8
32	28	-14
-12	-6	-12
-50	12	-8
-42	20	-6
46	4	-10
38	22	-12
50	14	-10
-22	0	-18
-40	4	-6
-40	20	-4
-44	20	-12
38	24	-10
38	16	-6
48	20	-8
-20	0	-18
-12	-6	-12

// Royet J P, 2003: Subgroup of Healthy Controls, Left-handed women
// Subjects=7
44	18	-2
58	10	10
46	8	2
-42	8	-12
-26	38	-18
-34	20	0
-40	50	6
-36	42	14
-34	44	22
44	14	-10
-42	6	-8
-48	14	-8
40	8	-12
40	16	-4
-34	18	0
-40	4	-8
42	18	-4
38	8	-12
-40	50	6
-10	-6	-14
38	6	-16
-54	4	34
50	22	0
58	12	10
24	34	4
-20	28	8
-50	26	2
-46	20	6
-44	40	-2
-32	18	-4
-36	14	-6
-28	30	-16
-44	44	-10
-28	34	-14
-32	20	-4
-50	18	-4
44	22	-6
-38	4	-12
-40	16	-12
36	8	-12
-42	40	-2
-40	46	-14
-38	38	10
-6	-8	-16
-10	-2	-10

// Royet J P, 2003: Subgroup of Healthy Controls, Left-handed men
// Subjects=7
44	18	-2
58	10	10
46	8	2
-42	8	-12
-26	38	-18
-34	20	0
-40	50	6
-36	42	14
-34	44	22
44	14	-10
-42	6	-8
-48	14	-8
40	8	-12
40	16	-4
-34	18	0
-40	4	-8
42	18	-4
38	8	-12
-40	50	6
-10	-6	-14
38	6	-16
44	16	-2
42	4	0
56	12	16
-52	10	0
-40	16	-4
54	14	14
-38	12	-12
-40	4	-8
-40	20	-14
-56	10	26
-60	6	16
40	6	-12
-44	8	-4
-44	20	-12
-32	20	0
48	20	-8
38	24	-8
32	28	-14
-12	-6	-12
-50	12	-8
-42	20	-6
46	4	-10
38	22	-12
50	14	-10
-22	0	-18
-40	4	-6
-40	20	-4
-44	20	-12
38	24	-10
38	16	-6
48	20	-8
-20	0	-18
-12	-6	-12

// Booth J R, 2003: Visual Spelling - Visual Control
// Booth J R, 2003: Visual Rhyming - Visual Control
// Booth J R, 2003: Auditory Spelling - Auditory Control
// Booth J R, 2003: Auditory Rhyming - Auditory Control
// Booth J R, 2003: Positive Correlation between Visual Spelling Activation 
// and Accuracy
// Booth J R, 2003: Negative Correlation between Visual Spelling Activation 
// and Reaction Time
// Booth J R, 2003: Positive Correlation between Visual Spelling Activation 
// and Reaction Time
// Booth J R, 2003: Positive Correlation between Visual Rhyming Activation and 
// Accuracy
// Booth J R, 2003: Negative Correlation between Visual Rhyming Activation and 
// Accuracy
// Booth J R, 2003: Negative Correlation between Visual Rhyming Activation and 
// Reaction Time
// Booth J R, 2003: Positive Correlation between Visual Rhyming Activation and 
// Reaction Time
// Booth J R, 2003: Positive Correlation between Auditory Spelling Activation 
// and Accuracy
// Booth J R, 2003: Negative Correlation between Auditory Spelling Activation 
// and Accuracy
// Booth J R, 2003: Negative Correlation between Auditory Spelling Activation 
// and Reaction Time
// Booth J R, 2003: Positive Correlation between Auditory Rhyming Activation 
// and Accuracy
// Booth J R, 2003: Negative Correlation between Auditory Rhyming Activation 
// and Reaction Time
// Booth J R, 2003: Positive Correlation between Auditory Rhyming Activation 
// and Reaction Time
// Subjects=11
-45	18	21
48	30	12
-36	-78	-15
-42	-60	-18
-27	-51	36
-45	30	12
-18	-90	-3
39	27	-9
-30	-60	45
-48	18	18
-63	-12	-3
51	-12	-6
-51	-60	-15
-51	21	27
42	-27	12
60	-9	-3
-54	-18	-3
48	21	21
-45	48	3
-39	-57	-9
30	30	-15
63	-18	-3
-36	-42	36
-39	6	27
-39	3	36
-51	-45	24
39	-3	24
51	-39	9
-48	-6	6
51	-21	-3
-33	-60	-21
45	45	3
-45	-51	-18
-45	-48	30
-57	-36	18
-30	-48	42
-51	-63	12
-30	-51	-6
63	-15	12
-60	-21	9
66	-33	3
-51	-39	45
36	-63	39
-36	-30	36
-33	30	12
33	21	-6
-51	-48	-9
-51	-24	-3
45	-21	15
-39	-48	12
-51	24	9
-48	-36	3
51	3	-15

// Gaab N, 2003: Pitch Memory > Motor Control, ITP 0-2 Seconds After 
// Activation
// Gaab N, 2003: Pitch Memory > Motor Control, ITP 3-4 Seconds After 
// Activation
// Gaab N, 2003: ITP 0-2 Seconds vs. ITP 5-6 Seconds
// Gaab N, 2003: ITP 3-4 Seconds > ITP 5-6 Seconds
// Gaab N, 2003: Accuracy and Pitch memory task, Positive correlation
// Gaab N, 2003: Accuracy and Pitch memory task, Negative correlation
// Subjects=18
-43	-7.2	43.2
43.2	2.5	41.9
44.9	-44	43.1
-.8	4.4	45.5
-23.6	-67.3	-24.9
-51.8	6.4	24.5
-41.2	-7.2	44.9
-4.3	4.4	47.3
55.5	-31.5	7.1
-57.4	-36.8	6.8
-44.8	42.1	20.3
55.5	-34.3	13.6
53.7	-51.8	0.5
-28.9	-57.6	44.1

// Aasen I, 2003: Healthy Subjects, Experiment 1
// Subjects=15
-60	-30	21
-57	-33	33
-63	-18	24
60	-18	3
60	-30	27
66	-21	18
-60	-12	3
60	-12	-12
-30	18	6
-9	0	9
-21	45	24
-9	54	0
-12	66	6
-3	45	-6
6	57	-3
-45	-51	-21
36	-60	-15

// Aasen I, 2003: Healthy Subjects, Experiment 2
// Subjects=15
-60	-30	21
-57	-33	33
-63	-18	24
60	-18	3
60	-30	27
66	-21	18
66	-27	-6
-42	-72	33

// Nagai Y, 2003: Regional Brain Activity Associated with Contingent Negative 
// Variation (CNV)
// Subjects=12
-2	-6	50
-36	-14	60
42	6	0
42	54	18
2	-74	-20
-8	14	-2
-40	2	8
66	-24	26
22	48	-12
42	40	12

// Lewis P A, 2003: Time > Length 0.6s
// Lewis P A, 2003: Time > Length 3.0s
// Lewis P A, 2003: Time > Length (Mean of 0.6 and 3.0s)
// Lewis P A, 2003: Time > Length, 0.6 > 3.0s
// Lewis P A, 2003: Time > Length, 3.0 > 0.6s
// Subjects=8
50	24	0
48	39	24
62	21	0
42	53	-6
-45	50	12
-36	59	24
-48	39	36
36	24	-6
-42	21	0
0	15	54
3	27	48
48	9	42
48	9	54
-48	15	24
-56	15	42
53	-45	60
45	-45	42
-39	-42	48
-30	-65	-42
-53	-42	18
36	53	-6
45	53	12
42	27	48
48	42	18
48	39	30
-42	48	6
33	24	-6
-45	15	0
-30	21	-6
-53	15	0
3	27	42
48	-45	48
42	-50	66
48	-45	48
3	27	48
48	42	24
42	53	-6
-42	50	6
36	24	-6
-45	18	0
-42	15	24
56	15	6
-48	0	0
48	-33	-6
45	-59	12
-48	-42	18
-30	-65	-42
-36	-56	30
-12	-48	36

// Maddock R J, 2003: Threat-related words > Neutral words, Panic patients > 
// Controls
// Maddock R J, 2003: Threat-related words > Neutral words, Controls > Panic 
// patients
// Subjects=6
-47.09	45.09	3.84
-1.91	-49.35	3.44
16.21	-12.35	12.39
-13.88	-48.3	-23.28
-35.12	-42.66	-3.43
-39.17	-48.03	23.83
-13.88	-48.3	-23.28
56.85	-38.08	6.28
4.6	-66.94	9.3
57.18	-30.34	51.35

// Levitin D J, 2003: Normal > Scrambled
// Levitin D J, 2003: Scrambled > Normal
// Subjects=13
-50.97	17.67	-12.19
48.4	17.81	-16.14
12.2	28.22	28.27
-3.29	3.57	-4.88
-7.69	-27.68	-17.4
7.15	-51.6	-44.43
19.16	-66.65	46.51
-55.03	-63.59	-8.56
-34.88	-75.76	43.85
38.37	-88.01	23.64

// Tillmann B, 2003: Context - Rest
// Tillmann B, 2003: Consonant - Dissonant
// Tillmann B, 2003: Dissonant - Consonant
// Tillmann B, 2003: Related Consonant (RC) - Rest
// Tillmann B, 2003: Related Dissonant (RD) - Rest
// Tillmann B, 2003: Unrelated Consonant (UC) - Rest
// Tillmann B, 2003: Unrelated Dissonant (UD) - Rest
// Tillmann B, 2003: RC - UC
// Tillmann B, 2003: UC - RC
// Subjects=15
-4	52	45
15	49	45
-4	0	65
-52	-8	50
-49	-22	5
-56	-15	5
-60	-34	10
56	-19	5
68	-30	5
-4	-19	35
52	-60	35
4	-19	35
-45	-22	60
-52	-19	55
60	-49	-10
-15	-34	-5
26	-60	-20
8	-8	50
26	-11	60
34	-22	65
-64	-45	20
56	-22	50
38	-30	65
30	-49	55
49	-22	25
45	-4	15
11	-22	0
-8	-52	-10
-22	-52	-20
-41	26	5
56	11	5
-49	15	-5
45	11	-5
49	38	25
0	33	45
0	38	25
0	-34	30
-64	-26	35
-45	-49	60
68	-26	30
56	-38	55
52	-52	50
41	11	-15
-41	-8	10
-41	-8	-5
41	-11	0
-15	-15	15
-11	-4	15
11	-4	15
-15	-34	-10
0	-86	-5
-34	-68	-25
-19	-75	-20
4	-45	-15
45	-68	-30
52	15	5
-38	15	0
45	11	0
-45	41	15
49	41	5
38	38	25
38	49	20
0	26	45
4	34	25
0	0	40
0	-22	30
-64	-26	35
-49	-49	55
68	-26	30
45	-52	60
34	22	5
-41	0	-10
-41	-15	10
45	-11	0
-11	-11	15
-11	0	10
11	-4	10
11	-19	15
-8	-52	-5
-34	-60	-30
4	-75	-15
38	-68	-30
56	11	10
-38	15	0
49	15	-5
41	11	5
-41	38	15
49	38	10
49	38	25
52	22	35
0	30	50
8	30	35
0	15	35
-4	-26	30
4	-38	25
-49	-49	50
-64	-30	40
68	-26	30
49	-52	55
34	22	5
-45	-4	5
45	-8	-5
-19	-15	15
11	4	0
11	-4	19
-11	4	19
-19	-26	-10
0	-86	-5
-34	-60	-30
-8	-79	-35
22	-79	-20
34	-64	-30
56	11	5
-34	19	10
-38	15	0
41	15	-5
45	8	5
-41	38	15
49	38	25
49	41	10
0	26	45
0	15	60
-4	41	15
-4	-22	30
4	-11	30
64	-22	30
-64	-30	40
64	-34	40
45	-52	60
-41	-4	10
-45	-15	-5
45	-11	0
39	0	5
-11	-11	15
-11	0	10
8	4	0
15	-8	15
-8	8	0
-15	-26	-15
-8	-45	-15
-34	-60	-30
4	-45	-15
22	-68	-35
-8	64	5
-11	60	25
60	-19	35
-45	-75	30
52	-56	45
-11	-52	50
0	-45	55
-52	8	0
49	15	0
-38	19	5
34	22	0
45	26	20
41	34	25
-8	4	60
8	8	60
4	4	45
15	0	40
11	19	35
-4	-34	30
-34	-60	55
-15	-11	5
11	-15	5
-8	8	5
15	11	15
-19	-41	-20

// Montorsi F, 2003: Erectile Dysfunction (ED)
// Subjects=8
-26.53	-88.86	18.11
-41.87	-92.7	0.82
-50.72	-83.35	-13.4
-34.89	-43.03	49.57
-30.39	-61.32	60.27
36.17	-83.97	21.04
40.36	-80.53	11.66
62.03	-66.86	18.9
45.03	-36.36	47.55
28.01	-60.7	63.7
-56.88	10.96	31.16
-48.42	14	17.27
51.4	6.62	47.67
68.11	22.08	5.52
50.62	2.93	-14.7
-16.11	-4.15	5.06
16.35	-3.62	8.94
-5.55	72.88	1.74
3.21	73.74	10.47
-7.89	29.96	-20.86
11.55	32.16	-21.41
-1.28	28.69	-11.89
3.04	28.7	-11.96
35.65	-37.54	-10.44
-18.28	-2.03	4.89
22.79	-6.14	4.6
0.98	-12.14	-12.37
7.38	-36.76	-23.49
-33.28	-95.22	-3.56
-50.61	-82.51	-4.52
-50.61	-82.51	-4.52
-39.21	-45.17	49.86
-30.4	-57.07	59.85
38.21	-82.67	11.91
50.94	-82.16	-6.29
61.59	-70.19	-16.62
49.35	-36.35	47.48
38.78	-52.16	62.67
-56.88	10.96	31.16
-50.57	11.86	17.51
42.86	9.55	56.49
57.54	21.58	23.67
-57.6	18.73	-23.39
61.51	10.18	-6.64
-14.01	-2.43	0.38
3.38	-14.72	5.78
-14.01	-2.43	0.38
18.4	-2.32	-.19
14.01	-15.93	-7.73
-3.26	-20.24	-7.01
-7.72	2.72	-13.69
11.7	-36.74	-23.56
-19.63	-79.13	52.88
-33.28	-95.22	-3.56
-50.61	-82.51	-4.52
-32.71	-49.4	50.16
-2.23	-49.76	67.61
23.62	-74.31	56.15
7.65	-91.65	-13.58
49.51	-32.97	60.59
1.79	0.48	53.61
-52.97	42.93	5.52
47.12	11.27	51.77
61.78	27.56	18.53
59.43	-72.32	-16.37
-3.31	-20.66	-11.45
-5.61	-30.42	-23.89
-22.39	-87.97	4.5
-9.61	6.92	8.34
-7.41	-3.71	9.35
-18.04	54.47	35.15
-3.12	63.91	20.52
-16.41	28.63	-11.62
9.9	5.28	12.65
9.95	-9.61	14.12
13.7	51.72	-18.9
13.71	32.16	-21.45
-35.24	-41.26	22.51
42.41	-37.57	11.86
-37.77	-4.65	1
39.92	5.85	-5.84
-12.02	24.81	-6.84
11.75	24.89	-7.25
-28.74	-17.01	28.96
33.33	-40.92	-23.52
5.15	-2.32	-22.37

// Montorsi F, 2003: Healthy Controls (HC)
// Subjects=4
-22.08	-92.27	27.33
-46.27	-86.75	-4.18
-46.38	-87.58	-13.06
-50.11	-34.99	44.55
-30.4	-57.07	59.85
29.47	-26.56	15.47
38.21	-82.67	11.91
49.1	-75.42	19.97
51.45	-34.63	42.79
34.43	-61.1	59.14
-52.54	6.72	31.5
-61.44	13.53	13.05
64.18	9.67	33.7
61.67	11.43	6.68
-59.7	19.14	-18.91
48.35	-0.04	-23.34
13.88	-40.99	-23.18

// Puce A, 2003: (REAL FACE + LINE FACE) > (REAL CNTL + LINE CNTL)
// Subjects=10
48.28	-48.25	-.58
-30.69	-59.75	9.1
36.36	-62.18	-28.27
-34.17	-59.26	-25.47

// Grossman M, 2003: Alzheimer's patients
// Subjects=11
-50.51	-48.95	10.08
-24.79	-10.98	1.4
22.74	37.23	9.27
26.88	9.64	-10.48
-33.61	-8	-12.19

// Grossman M, 2003: Healthy Controls
// Subjects=16
-45.74	-32.43	48.71
9.49	35.11	-12.7
35.54	5.42	-10.21
23.1	-12.58	27.64
45.01	-32.11	47.13
-41.42	-32.41	48.63
-16.43	48.19	-9.07
39.9	10.1	-6.27
-20.77	-4.53	-21.71
-16.36	44.36	-4.21
-11.11	-62.5	46.61
-24.52	-4.65	23.19

// Potenza M N, 2003: Gambling Scenario, Healthy Controls (HC) > Pathological 
// Gamblers (PG)
// Potenza M N, 2003: Gambling Scenario, PG > HC
// Potenza M N, 2003: Happy Scenario, PG > HC
// Potenza M N, 2003: Sad Scenario, PG > HC
// Potenza M N, 2003: Sad Scenario, HC > PG
// Subjects=10
11.02	5.71	39.93
-3.86	-15.53	41.89
-17.67	-37.82	43.91
13.46	-73.58	46.56
-15.45	-60.01	45.75
-9.12	-55.37	36.37
47.46	-22.62	41.89
-30.62	-4.06	41.23
-34.82	-24.17	42.97
-42.4	-15.39	33.4
-42.49	-9.73	24
-25.57	55.56	27.25
17.25	35.73	28.42
36.23	23.24	-10.89
15.16	-20.98	10.9
-10.58	3.18	9.17
-19.24	15.14	-.66
-8.48	-4.89	0.9
4.12	36.8	-11.66
-20.85	-80.45	29.68
5.81	-94	17.13
-21.2	48.87	36.69
-36.47	32.32	-10.82
21.27	22.1	-10.63
13.68	68.2	-5.48
53.63	5.65	21.61

// Maguire E A, 2003: Younger Normals
// Subjects=12
-3	54	-3
-48	9	-30
48	18	-33
-28	-13	-18
21	-18	-15
-54	-6	-24
-21	-39	-15
-6	-63	24
-45	-63	21
30	-81	-36
54	36	0
-3	54	0
-36	15	-42
-21	-11	-20
-60	-3	-27
-30	-33	-21
-3	-51	12
-51	-69	24
21	-90	-36
-42	39	-21
-3	63	9
-42	9	-36
-22	-15	-18
-60	-12	-21
-33	-24	-24
-3	-57	12
-48	-60	18
24	-84	-39
-48	36	-15
-6	57	0
-39	12	-39
-22	-15	-19
-60	-3	-27
-2	-24	-24
-3	-54	6
-48	-63	18
18	-84	-39
-39	30	-21
-3	54	0
-33	-18	-15
-3	-60	27
0	-9	0
-3	51	-3
-27	-12	-24
-9	-60	24
-6	48	0
-24	-15	-15
-6	-57	18
-3	63	9
-3	63	9
-3	-45	21
0	-48	21
-48	21	21
-57	-3	-21
21	-15	-12
24	-15	-12
21	-18	-15
54	-15	-24
21	-6	-21

// Maguire E A, 2003: Older Normals
// Subjects=12
-3	63	9
-3	63	9
-3	-45	21
0	-48	21
-42	15	48
48	24	45
-3	54	0
-48	9	-24
42	15	-36
-18	-18	-21
21	-15	-12
-57	-3	-24
57	3	-15
-26	-28	-18
-3	-63	15
-42	-63	18
30	-78	-36
3	-6	-3
48	30	-9
-6	54	0
-45	9	-39
-21	-9	-21
-60	-9	-24
-24	-33	-21
-6	-57	6
-45	-63	21
24	-84	-39
-39	33	-18
-18	60	9
-42	15	-42
-26	-17	-17
-60	-12	-24
-27	-21	-21
3	-60	9
-39	-66	24
15	-84	-39
-3	60	9
-39	9	-45
-22	-21	-15
-60	-6	-24
-24	-21	-24
-6	-63	9
-45	-60	18
24	-84	-39
-48	36	-12
-6	51	0
-21	-15	-15
21	-15	-18
-51	-9	-12
57	-3	-18
-3	-54	3
-21	-12	-18
24	-12	-18
-60	-3	-24
57	-12	-24
-6	-57	24
-3	54	0
-21	-15	-15
21	-15	-15
-57	-3	-24
60	-12	-21
-6	-63	15
21	-15	-12
24	-15	-12
21	-18	-15
54	-15	-24
21	-6	-21

// Booth J R, 2003: Healthy Adults
// Subjects=12
-24	-72	33
-30	-54	-18
33	3	45
54	33	15
-27	3	48
48	12	21
18	-3	3
-15	-15	12
24	-27	-9
-24	-33	-6
6	33	36
21	18	-9
-3	-30	-9
-9	-30	-30
27	-57	48
30	-63	36
-30	-51	48
39	3	45
39	42	15
33	60	15
-24	3	48
38	15	21
30	27	0
-48	6	24
9	-27	24
-39	-81	3
9	30	33
6	-24	-12
21	39	39
3	54	30
3	60	0
45	0	12
-42	-30	15
-12	15	18
6	-9	36
-6	-42	9
24	-3	-15
-27	-9	-21
12	-27	-9
-3	-24	-21
6	42	12
-12	-27	12

// Booth J R, 2003: Healthy Children
// Subjects=12
27	0	45
30	27	-3
-30	24	-18
24	-30	-3
-21	-30	0
-33	-18	30
9	21	36
12	33	21
-18	9	36
-12	30	15
24	-60	15
12	-6	-3
30	-54	57
33	-33	36
-30	-45	57
27	0	42
42	24	15
-30	27	-12
-42	-30	0
48	-3	27
-42	0	33
-24	-78	12
3	18	54
15	57	21
-12	-3	18
-30	-24	-9
45	-12	-18
-21	-3	-18
21	39	39
3	54	30
3	60	0
45	0	12
-42	-30	15
-12	15	18
6	-9	36
-6	-42	9
24	-3	-15
-27	-9	-21
12	-27	-9
-3	-24	-21
6	42	12
-12	-27	12

// van den Heuvel O A, 2003: Planning > Baseline
// van den Heuvel O A, 2003: Positive Correlation between Planning > Baseline 
// and Task Load
// Subjects=22
50.98	42.83	21.68
44.55	36.63	24.65
-24.28	27.83	49.1
-26.35	13.14	52.83
-26.28	2.71	56.1
29.89	2.91	55.13
-4.89	27.48	44.32
-2.39	-53.13	54.5
8.45	-55.01	56.74
-39.22	-78.11	41.91
-63.02	-32.49	49.01
38.5	-84.84	34.53
32.14	-70.86	46.7
53.68	-38.46	47.61
44.88	-65.88	30.3
-7.64	9.94	-5.44
14.06	8.51	1.06
35.46	26.69	-12.31
-37.99	65.97	-1.5
-42.16	56.15	8.51
-46.3	37.82	19.35
-46.12	43.53	34.47
44.44	42.39	17.36
48.89	38.98	26.58
-24.18	24.2	56.18
-17.55	-5.35	61.24
-32.71	3.11	60.66
29.89	18.22	58.1
31.73	42.09	37.77
-4.81	23.64	49.19
-10.97	-52.75	59.09
8.43	-57.35	54.73
-43.67	-37.51	40.21
-50.01	-38.62	51.63
-41.38	-78.12	41.95
-42.16	56.15	8.51
-23.88	-74.27	59.2
42.86	-71.44	39.85
55.81	-38.66	45.35
53.76	-37.84	54.27
38.64	-61.91	50.19
20.71	9.78	14.26
14.04	6.17	-.95
-33.61	22.61	-6.25

// Tamm L, 2003: Turner Syndrome > Healthy Controls: NoGo > Go
// Subjects=11
-24.39	33.59	41.81
-19.93	34.64	52.84
-4.82	38.95	52.15
29.79	30.56	52.39
18.74	48.42	37.37
42.58	31.49	38.64

// Mackiewicz Seghete K L, 2003: Family History of Alcholism (FHP)
// Subjects=18
3.39	-59.01	63.85
3.39	-59.01	63.85
32.01	11.21	60.98
32.01	11.21	60.98
37.75	66.89	-3.98
-35.94	-41.84	-40.96
47.49	-63.55	-40.1
-23.25	68.93	-13.48
-45.19	-77.64	-7.63
3	-23.52	27.42
57.31	-54.82	-10.72
-.55	-7.33	-10.7
34.67	25.38	-3.81
-29.45	24.99	-3.04
-9.54	-93.12	36.75
-9.54	-93.12	36.75
-6.66	-53.67	9.99
-.67	67.17	3.13
-41.66	-8.27	63.46
-67.59	-21.28	21.35
60.23	14.73	-19.93
-48.82	26.76	-19.69
-32.74	7.57	-21.61
44.9	-7.75	62.42

// Mackiewicz Seghete K L, 2003: No Family History of Alcoholism (FHN)
// Subjects=16
2.4	26.3	-30.28
3.39	-65.61	61.06
37.65	59.26	-20.06
-28.92	7.41	58.65
-29.56	63.32	-2.9
-48.43	27.45	30.43
37.81	-31.36	-35.89
-38.58	-32.68	36.48
-3.17	-87	32.82
-13.13	-51.05	3.15

// Richeson J A, 2003: Black > White
// Subjects=15
7.82	46.39	27.67
14.13	35.28	11.85
7.86	23.74	26.55
43.35	55.46	19.44
36.71	64.08	8.62
-47.54	47.51	8.33
-40.91	42.09	18.84
29.91	68.25	-15.21
4.92	12.84	47.85
43.26	12.11	3.56

// Hanakawa T, 2003: Movement > Imagery
// Hanakawa T, 2003: Movement AND Imagery
// Hanakawa T, 2003: Imagery > Movement
// Hanakawa T, 2003: Activations In Relation To Response Movement
// Hanakawa T, 2003: Activations Associated With Task Performance
// Subjects=10
-37.08	-18.05	52.74
-47.87	-9.27	55.42
22.6	-56.81	-20.64
5.53	-69.45	-5.65
-53.76	-24.94	14.48
-29.39	-45.92	-27.56
-.47	1.97	46.77
-23.78	-41.77	73.91
59.14	-20.49	55.82
-45.53	-37.46	63.77
-39.33	-40.58	41.56
-39.25	5.96	57.12
-59.07	7.45	28.18
53.81	-35.29	58.5
41.8	8.58	57.73
-.47	15.05	48.84
33.41	-69.84	-22.9
-33.59	-72.42	-23.74
-44.13	44.41	20.91
-54.04	-18.3	-6.34
56.01	19.32	-11.93
-28.93	-94.99	-1.42
-24.85	-2.68	-1.66
-23.87	-66.52	61.79
25.83	-66.34	60.93
-49.09	10.52	49
-45.53	-37.46	63.77
53.85	-37.21	60.93
19.32	-68.7	59.03
-37.06	6.18	59.31
-39.17	-20.84	57.53
-55.83	7.46	28.12
38.56	8.57	57.78
1.71	4.32	48.75
40.15	51.4	22.14
5.69	33.51	27.86
6.07	19.95	54.97
-20.5	-82.38	-16.26
35.56	-58.99	-21.77
40.33	-90.62	7.06
-28.79	-97.25	8.89
14.44	-79.46	13.12
-7.15	-86.02	13.01
-31.4	-72.2	-21.56
35.52	-63.66	-25.79
-54.04	-18.3	-6.34
-41.61	-34.93	33.2
56.18	-17.7	-6.03
48.75	44.53	17.07
-24.84	-3.74	-1.55
-21.64	-12.76	-6.32
-39	-37.02	68.1
46.41	-63	-19.31
-41.42	4.79	56.16
-22.06	6.36	48.95
-45.76	-33.7	46.59
53.53	6.42	45.41

// Kuhtz-Buschbeck J P, 2003: Motor Execution, Simple, Right Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Execution, Complex, Right Hand vs. 
// Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Imagery, Simple, Right Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Imagery, Complex, Right Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Execution, Simple, Left Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Execution, Complex, Left Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Imagery, Simple, Left Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Motor Imagery, Complex, Left Hand vs. Baseline
// Kuhtz-Buschbeck J P, 2003: Execution > Imagery, Right Hand
// Kuhtz-Buschbeck J P, 2003: Imagery > Execution, Right Hand
// Kuhtz-Buschbeck J P, 2003: Execution > Imagery, Left Hand
// Kuhtz-Buschbeck J P, 2003: Imagery > Execution, Left Hand
// Subjects=12
-36	-24	52
-52	-20	48
-36	-12	68
12	-56	-24
-12	-4	56
-36	-24	52
-56	-20	44
-40	-16	68
36	-52	64
44	-40	48
16	-56	-24
-36	-56	-32
0	-8	64
-44	-8	56
-48	4	48
-60	8	12
-56	12	-4
-4	8	60
-8	8	48
-32	-12	60
-52	0	44
-52	0	32
-60	8	16
-60	8	0
-40	-44	56
40	-36	40
12	-68	48
44	-60	-32
-40	-68	-28
-8	-4	60
32	-24	56
32	-24	68
64	8	16
44	-24	20
16	-24	8
-56	-40	52
-60	-24	40
-20	-56	-20
-4	4	56
32	-24	64
40	-20	64
40	-40	44
56	8	32
12	-16	12
-52	4	40
-52	8	28
-16	-12	16
-48	-40	52
-20	-56	-24
20	-64	-24
4	-4	64
-40	-4	56
-52	8	36
-60	4	16
-40	-52	56
-52	-36	36
44	-68	-28
-4	4	64
36	-8	64
52	12	32
36	40	28
44	-40	52
-16	4	68
-48	4	40
-56	12	12
-16	-68	56
-44	-44	56
-48	-36	44
-40	-60	-36
36	-56	-32
-36	-20	64
-36	-24	56
-56	-20	48
16	-56	-20
-48	12	44
-56	24	16
-36	52	12
-48	-68	48
40	-20	52
44	-20	64
40	-16	16
4	-32	0
-20	-56	-24
-44	12	40

// Riecker A, 2003: Main Effect All Frequencies
// Riecker A, 2003: First Order Term, Positive Linear Effect
// Riecker A, 2003: First Order Term, Negative Linear Effect
// Riecker A, 2003: 2 Hz Tapping vs. Control
// Riecker A, 2003: 2.5 Hz Tapping vs. Control
// Riecker A, 2003: 3 Hz Tapping vs. Control
// Riecker A, 2003: 4 Hz Tapping vs. Control
// Riecker A, 2003: 5 Hz Tapping vs. Control
// Riecker A, 2003: 6 Hz Tapping vs. Control
// Subjects=8
3	3	54
-6	-15	54
-45	-24	60
-15	18	3
-12	-21	3
-21	6	-9
24	-51	-33
33	-51	-57
-3	12	54
-6	-6	60
-60	-24	60
-12	-18	6
24	-75	-48
-15	18	3
-21	6	-9
0	9	57
-6	-12	60
-45	-24	60
-9	12	3
-9	-24	3
-27	-6	-9
21	-57	-33
33	-69	-57
-6	9	60
-3	-12	54
-42	-27	63
-12	15	3
-12	-21	3
-27	-9	-6
21	-60	-30
27	-66	-57
-6	3	57
-6	-15	54
-45	-30	63
-12	12	0
-15	-24	0
-27	-6	-3
24	-57	-33
30	-66	-57
-3	3	57
-6	-12	57
-48	-30	60
-18	-24	3
-27	-3	-9
30	-57	-30
30	-66	-54
-6	6	54
-6	-15	54
-45	-24	57
-12	-24	3
24	-54	-33
30	-57	-54
-3	9	54
-3	-9	54
-45	-27	60
-12	-24	6
24	-57	-33
33	-54	-57

// Sperling R A, 2003: Young Controls
// Subjects=10
59.6	32.87	18.04
-43.64	13.08	53.13
-28.34	21.69	-16.33
-4.93	27.17	40.99
-5.21	10.85	15.72
-18.16	1.03	14.67
20.76	-15	13.35
-24.94	-25.3	-13.98
23.72	-31.3	-11.98
-41.25	-52.34	-26.72
46.22	-52.34	-31.57
46.26	-52.03	-28.24
-47.63	-66.94	-21.8
43.09	-70.12	-26.4
-21.38	-89.65	-2.07
29.89	33.08	-24.06
-4.93	27.17	40.99
46.68	21.13	19.42
-44.07	14.22	19.41
7.74	14.09	15.18
-41.44	13.4	56.43
-21.69	-28.48	-13.72
26.94	-31.5	-14.25
46.22	-52.34	-31.57
-41.29	-52.65	-30.05
43.89	-68.56	36.19
-18.39	59.52	8.89
20.56	69.96	15.04
-47.73	51.59	-5.52
-8.34	-66.02	8.81
36.91	-70.09	-2.76
-47.73	51.59	-5.52
-44.06	17.62	21.31
23.66	32.8	-3.75
10.7	14.15	-7.29
1.06	-18.1	-7.3
33.4	-25.1	-15
-14.86	-66.36	5.59
7.71	-73.7	-5.27
-8.64	34.58	5.59
14.39	18.65	29.18
4.84	1.27	38.91
27.38	15.61	30.38
66.14	11.42	17.81
27.6	11.75	46.45
61.26	14.9	-25.03
-47.59	-21.78	-9.46
-52.49	-19.12	30.7
46.96	-33.66	30.44
21.45	-62.41	57.25
-17.69	-70.9	37.47
-31.76	32.34	-28.54
39.73	31.82	-15.13
27.38	15.61	30.38
58.38	8.87	2.51
-30.75	21.32	48.74
1.03	11.24	-3.47
30.09	-19.04	-18.9
-11.22	-22.84	46.05
49.58	-31.73	-17.98
36.67	-41.25	-15.7
-52.76	-48.51	3.35
-33.73	-46.76	55.52
-50.72	-1.29	3.13
66.22	-7.62	20.81

// Sperling R A, 2003: Elderly Controls
// Subjects=10
56.11	43	0.29
-38.06	31.54	-13.78
-57.21	24.94	8.49
58.72	15.72	29.84
-1.98	14.06	15.35
-21.49	-6.2	6.48
-21.73	-28.79	-17.06
23.63	-25.44	-18.16
59.37	-59.66	-18.74
-47.65	-61.62	-22.33
-27.28	-56.83	50.81
-44.29	34.45	6.21
30.09	-19.04	-18.9
-27.39	-57.66	41.93
47.27	-46.68	51.89
-33.69	-46.45	58.85
-30.49	-73	50.22
-47.68	-58.54	-23.76
52.84	-57.87	-22.17
-34.04	-79.76	24.06
-1.94	14.37	18.68
-21.48	-9.39	6.79
-28.12	-24.79	-8.38
17.15	-25.46	-18.05
-41.27	-49.25	-28.14
-18.39	59.52	8.89
20.56	69.96	15.04
-47.73	51.59	-5.52
-8.34	-66.02	8.81
36.91	-70.09	-2.76
-47.73	51.59	-5.52
-44.06	17.62	21.31
23.66	32.8	-3.75
10.7	14.15	-7.29
1.06	-18.1	-7.3
33.4	-25.1	-15
-14.86	-66.36	5.59
7.71	-73.7	-5.27
-8.64	34.58	5.59
14.39	18.65	29.18
4.84	1.27	38.91
27.38	15.61	30.38
66.14	11.42	17.81
27.6	11.75	46.45
61.26	14.9	-25.03
-47.59	-21.78	-9.46
-52.49	-19.12	30.7
46.96	-33.66	30.44
21.45	-62.41	57.25
-17.69	-70.9	37.47
-31.76	32.34	-28.54
39.73	31.82	-15.13
27.38	15.61	30.38
58.38	8.87	2.51
-30.75	21.32	48.74
1.03	11.24	-3.47
30.09	-19.04	-18.9
-11.22	-22.84	46.05
49.58	-31.73	-17.98
36.67	-41.25	-15.7
-52.76	-48.51	3.35
-33.73	-46.76	55.52
-50.72	-1.29	3.13
66.22	-7.62	20.81
59.36	40.89	0.44
-31.33	-24.6	-6.1
13.96	-34.94	-15.93
-20.82	-58.07	48.58
29.86	44.88	-24.1
-30.79	21.01	45.41
-18.68	39.81	-18.29
-12.07	35.34	-9
27.01	8.45	-.28
30.09	-19.04	-18.9
-34.77	-29.36	-22.38
40.57	-52.72	33.56
-37.23	-76.06	29.35
33.86	-71.94	12.04
17.12	-25.67	-20.27
-24.7	55.33	21.74
-44.4	-15.59	-12.37
61.78	-23.88	7.93
14.45	-35.67	22.23
11.49	-60.92	39.35
-14.5	-69.08	33.87
-8	35	55.96
-27.94	55.31	21.79
-14.82	47.79	32.4
-21.78	38.71	-6.92
54.91	-3.85	-18.59
-50.99	-9.86	-19.55
14.69	-55.69	37.65
-38.01	-29.37	-22.32
-14.51	-65.89	33.56
-21.39	-79.87	-.8

// Sperling R A, 2003: Elderly Patients with Mild Alzheimer's Disease
// Subjects=7
-50.55	20.78	21.11
53.29	18.79	28.51
23.71	-28.11	-12.29
21.37	-53.15	52.98
-33.72	-56.54	54.25
-28.2	-48.38	-19.49
17.39	-70.68	-7.97
10.83	-46.14	-9.17
59.36	40.89	0.44
-31.33	-24.6	-6.1
13.96	-34.94	-15.93
-20.82	-58.07	48.58
29.86	44.88	-24.1
-30.79	21.01	45.41
-18.68	39.81	-18.29
-12.07	35.34	-9
27.01	8.45	-.28
30.09	-19.04	-18.9
-34.77	-29.36	-22.38
40.57	-52.72	33.56
-37.23	-76.06	29.35
33.86	-71.94	12.04
17.12	-25.67	-20.27
-24.7	55.33	21.74
-44.4	-15.59	-12.37
61.78	-23.88	7.93
14.45	-35.67	22.23
11.49	-60.92	39.35
-14.5	-69.08	33.87
-8	35	55.96
-27.94	55.31	21.79
-14.82	47.79	32.4
-21.78	38.71	-6.92
54.91	-3.85	-18.59
-50.99	-9.86	-19.55
14.69	-55.69	37.65
-38.01	-29.37	-22.32
-14.51	-65.89	33.56
-21.39	-79.87	-.8

// Jansma J M, 2004: Schizophrenic Patients vs. Normals
// Subjects=10
-47	-49	51
-50	13	33
-29	17	58
1	24	44
26	17	58
47	-45	54
5	-59	58

// Lee G P, 2004: Negative vs. Neutral
// Lee G P, 2004: Positive vs. Neutral
// Subjects=10
-4	54	12
-2	-12	38
2	8	64
-2	24	39
26	2	-22
-24	0	-27
24	-60	-34
-30	-60	-34
-4	-83	-26
-1	47	5
-22	47	37
22	46	47
-39	21	38
-49	32	3
-44	4	18

// Nelson A J, 2004: (Low + Medium + High) vs. Rest
// Subjects=6
-40.06	-20.98	57.26

// Hart H C, 2004: Stationary Unmodulated Tone vs. Baseline
// Hart H C, 2004: Stationary FM Tone vs. Baseline
// Hart H C, 2004: Moving Unmodulated Tone vs. Baseline
// Hart H C, 2004: Moving FM Tone vs. Baseline
// Subjects=12
0	-36	-8
0	-20	68
-12	-64	60
4	-72	-8
0	-36	-8
-56	-12	0
60	-8	0
-28	-16	68
-20	-68	56
20	-60	-16
-64	-36	8
60	-36	12
-28	-12	68
36	-24	60
-32	-64	52
-56	12	20
0	-40	-8
-56	-16	4
60	-12	4
-52	0	36
0	0	68
52	8	36

// Mathiak K, 2004: Discrimination vs. Identification
// Mathiak K, 2004: Identification vs. Discrimination
// Subjects=12
-40.9	54.88	-21.58
-49.6	-47.73	56.26
58.3	-43.99	53.6
49.55	17.54	51.88
-4.7	-60.4	53.47
40	-89.48	17.47
-30.5	-86.3	23.59

// Tyler L K, 2004: Basic-Level Naming - Baseline
// Tyler L K, 2004: Domain-Level Naming - Baseline
// Tyler L K, 2004: Basic-Level Naming - Domain-Level Naming
// Tyler L K, 2004: Domain-Level Naming - Basic-Level Naming
// Subjects=19
-34	-56	-24
-44	-60	-22
-26	-90	-2
42	-82	-12
-34	-48	-18
22	-98	-6
-22	-6	-20
-32	-90	-2
-30	-88	-12
-32	-70	-18
26	-58	-20
32	-40	-22
32	-90	6
-14	8	-18
-10	8	-18
40	18	40
30	10	38

// Giesecke T, 2004: CLBP Patients
// Subjects=11
57	-13	43
55	-22	18
-65	-15	12
46	-44	56
-32	-57	-21
57	-19	42
61	-15	14
51	-46	48
48	-24	20
2	12	42
-63	-17	12
-34	-59	-21

// Giesecke T, 2004: FMS Patients
// Subjects=16
59	-15	43
65	-28	16
-59	-17	10
40	-46	59
-30	-56	-22
57	-13	43
65	-22	18
42	-40	48
40	2	9
2	18	40
-67	-17	10
-34	-61	-22

// Giesecke T, 2004: Healthy Controls
// Subjects=11
61	-18	21
57	-27	46
55	-21	12
53	-44	50
50	-23	16
2	4	46
-69	-17	19
-36	-65	-22

// Ibinson J W, 2004: Tingling vs. Rest
// Ibinson J W, 2004: Pain vs. Rest
// Ibinson J W, 2004: Pain vs. Tingling (Main Effect)
// Subjects=6
-20	-32	-8
-30	-2	-12
-48	-28	14
-68	-24	36
38	-80	-32
-24	-22	8
-46	-10	-6
52	-24	12
-64	-30	8
-8	-10	46
-38	-30	50
12	-56	-28
-18	-24	0
-68	-28	26
-14	-4	38
-6	-20	50
-34	-28	52

// Numminen J, 2004: Compare + Control vs. Rest
// Numminen J, 2004: Compare vs. Control
// Subjects=11
65.17	-15.07	21.57
67.43	-14.34	29.3
36.42	-40.54	49.23
35.65	51.1	7.68
35.59	59.4	4.62
44.21	39.56	-1.41
5.98	14.86	46.51
39.8	23.62	-10.96
33.41	24.22	-4.19
-34.98	-38.23	43.49
-47.89	-37.86	48.16
-48.01	-25.61	41.35
-48.87	16.09	-17.67
-50.7	10.93	7.52
-37.98	18.99	-10.3
-28.56	10.59	48.64
-35.02	5.25	49.28
-43.77	5.56	41.55
29.18	12.92	1.48
25.07	-15.08	12.17
22.73	-4.43	-0.05
-24.93	5.41	-6.94
-5.35	-82.12	-14.3
-20.67	-72.68	-27.3
-11.91	-80.54	-19.95
60.73	24.47	19.97
46.78	14.2	25.71
56.21	26.3	5.3
53.56	-29.51	40
-2.5	10.55	58.29
-.49	8.35	46.14
3.88	13.14	51.2
7.78	42.78	23.55
5.53	39.92	16.02
7.72	51.08	20.48
-37.36	-27.78	29.05
-57.89	-19.14	30.79
-32.91	-30.13	38.18

// Yoo S S, 2004: Real Acupuncture vs. Rest
// Yoo S S, 2004: Sham Acupuncture vs. Rest
// Yoo S S, 2004: Tactile Stimulation vs. Rest
// Yoo S S, 2004: Real Acupuncture vs. Sham Acupuncture
// Yoo S S, 2004: Real Acupuncture vs. Tactile Stimulation
// Subjects=12
-55	-25	44
-40	-2	-8
48	7	-7
-3	24	43
-57	-11	13
51	-10	2
-57	-51	19
59	-52	19
-53	15	-7
57	4	-7
-46	-48	52
-57	-22	21
-55	-22	20
-12	-19	10
2	-70	-12
0	-51	-28
-22	-73	-18
24	-68	-15
-23	-61	-16
-24	-62	-17
-53	-32	41
-39	13	1
49	9	1
-57	15	3
55	-22	6
64	-40	8
-58	13	-6
-55	-58	-2
53	-53	-2
-53	-39	41
-65	-26	23
53	-34	24
-57	-27	43
-40	17	6
48	26	8
-55	-5	8
51	-15	10
-52	10	-6
58	6	-6
-50	-65	12
-60	-32	23
53	-34	16
-46	-18	22
-26	55	5
1	19	23
-11	-19	5
-1	-72	-10
2	-48	-29
-4	-62	-33
-6	-60	-37
-24	-74	-18
-18	-55	-19
-24	59	12
61	-48	13
-3	33	6
-3	-52	45
4	-52	45
-10	-23	3
-1	-69	-8
-2	-49	-28
-3	-65	-33
-5	-65	-36
-23	-73	-17
24	-67	-18
20	-59	-16

// Chen J K, 2004: Verbal Working Memory
// Chen J K, 2004: Visual Abstract Working Memory
// Subjects=8
-48	30	30
-56	20	30
-56	6	4
-50	0	32
-52	-36	2
-36	16	0
-20	-12	10
-2	-54	-18
-36	-60	-22
36	38	30
4	22	36
32	20	0
18	-12	10
8	-44	-22
24	-58	-22
2	-68	-24
10	-70	-18
-46	46	14
-52	18	28
-42	56	12
-50	0	32
-6	24	38
-42	-74	-8
-38	-74	-24
-34	-90	-6
-34	16	4
-18	0	22
-20	-16	22
-10	-12	4
-40	-64	-24
36	38	32
50	20	40
28	50	4
42	10	28
4	22	36
38	-2	32
40	-70	-4
26	-84	-8
30	22	4
16	-6	24
6	-16	4
8	-44	-22
0	-56	20
6	-70	-18

// Landau S M, 2004: Encoding:  Main Effect Only
// Landau S M, 2004: Encoding:  Main Effect and Practice Effect
// Landau S M, 2004: Encoding:  Practice by Load Interaction
// Landau S M, 2004: Delay: Main Effect Only
// Landau S M, 2004: Delay:  Practice by Load Interaction
// Landau S M, 2004: Retrieval:  Main Effect Only
// Landau S M, 2004: Retrieval:  Practice by Load Interaction
// Landau S M, 2004: Encoding:  Practice Effect Only
// Landau S M, 2004: Encoding:  Practice Effect and Load Effect
// Landau S M, 2004: Encoding:  Practice Effect and Practice by Load 
// Interaction
// Subjects=10
38	-56	20
45	-23	45
34	8	-10
49	-71	-14
-38	-4	35
-19	19	-5
-38	-83	10
-38	-64	-15
-45	26	20
45	24	-5
-30	24	1
19	0	50
53	15	-5
49	11	-5
-45	26	20
-45	26	25
-41	-71	-15
-30	-19	60
0	-64	-5
26	-23	10
8	4	35
45	-53	50
41	-19	60
-53	-49	25
-4	-86	45
-49	11	5
26	-71	45
53	-75	-5
45	11	-5
-34	-8	30
-23	-19	50
-45	-71	5
0	-4	10
41	-64	60
23	-4	-15
-30	11	-20
-34	-86	15
8	-45	-10

// Maguire E A, 2004: Facts vs. Baseline
// Maguire E A, 2004: Control vs. Baseline
// Maguire E A, 2004: Facts vs. Control
// Subjects=12
-30	-15	-18
-51	-9	-21
-51	-66	18
-54	-51	30
12	-87	-27
-42	27	-9
0	-12	12
-45	21	30
-39	30	6
-42	36	-12
-48	24	24
-54	3	36
-54	24	6
-48	30	-12
3	36	30
-6	-84	-24
0	-15	6
-51	-54	-21

// Noppeney U, 2004: Abstract Concepts > Sounds, Visual Attributes, and Hand 
// Movements
// Noppeney U, 2004: Effect of Task Difficulty
// Subjects=15
-54	21	-6
-51	18	-27
-51	9	-24
-60	-42	-6
-30	-18	-6
-6	24	48
-9	-6	3
-42	9	27
0	-57	-45

// Wheaton K J, 2004: Face Moving vs. Still
// Wheaton K J, 2004: Hand Moving vs. Still
// Wheaton K J, 2004: Leg Moving vs. Still
// Subjects=12
55.32	-62.06	1.73
67.21	-34.6	7.78
55.29	-43.67	3.28
50.7	-56.61	-20.02
51.17	21.33	32.77
53.11	-62.38	-1.56
-38.16	-37.72	49.1
38.47	-31.48	42.7
61	-11.82	33.64
47	12.57	42.67
46.65	-60.07	0.56
55.29	-43.67	3.28
22.86	-86.61	-6.49
44.21	-61.09	-21.71
45.04	-38.49	47.76
-26.31	-50	43.39
23.39	-50.89	42.63
23.59	-61.45	56
-35.17	-3.55	35.58
62.81	22.79	13.38
42.18	24.12	5.76
-58.04	9.27	24.62
31.83	5.61	38.02
-9.23	22.9	41.49

// Xue G, 2004: Chinese - Baseline
// Xue G, 2004: English - Baseline
// Xue G, 2004: English - Chinese
// Subjects=12
-42	21	18
-45	24	10
-24	-12	42
27	-12	42
-27	-53	42
-39	-33	35
-39	-56	-10
-36	-65	-12
36	-56	-17
-15	-91	-8
33	-79	-8
-6	28	26
9	22	35
45	-16	20
-18	-9	-2
21	-6	-2
-15	-15	1
18	-15	-2
-39	15	19
-45	32	7
-36	5	36
33	-6	50
-27	-53	44
-36	-33	32
-36	-50	-10
-35	-68	-12
39	-59	-12
-21	-88	-8
33	-82	-9
-6	28	26
9	33	26
33	27	12
-21	6	-3
21	3	5
-12	-14	3
15	-15	-2
-9	30	26
-3	-40	19
-27	-50	41

// Booth J R, 2004: Adults
// Subjects=16
-30	-66	42
30	-54	42
-3	33	42
51	30	21
-4	36	6
24	-90	-6
-36	-51	-21
-9	-81	-30
12	-78	-33
-30	-69	45
-48	15	39
-6	-36	36
-3	42	33
51	18	30
45	-54	30
-6	3	54
-21	-57	51
48	-24	45
-42	-3	24
-6	27	30
33	21	6
-6	-75	0
57	-54	-3
-6	33	42
-24	-54	39
54	33	12
-48	33	6
-48	-42	6
-63	-33	3
24	-90	-6
-39	-54	-21
12	-75	-30
-48	21	33
-51	-57	12
57	6	12
-6	24	42
33	-51	42
-30	-63	36
-45	12	21
54	33	18
-12	0	9
-60	-12	-3
60	-12	-6
33	27	-9
30	-66	-30
12	-81	-33
-45	-42	48
-45	12	42
-30	-63	36
48	12	27
-42	36	9
-45	36	9
42	36	6
-60	-9	0
54	-15	-12
-33	-54	-15
-54	-6	42
-48	36	6
-63	-12	-3
63	-9	-6
24	-63	-24
-42	-45	48
-48	-9	39
-45	36	9
-60	-9	-3

// Booth J R, 2004: Children
// Subjects=16
-6	15	45
-24	-57	39
-42	9	24
51	33	18
-51	-36	0
30	27	-3
-15	6	-3
-36	-72	-12
39	-69	-18
-30	-69	45
-48	15	39
-6	-36	36
-3	42	33
51	18	30
45	-54	30
-6	3	54
-21	-57	51
48	-24	45
-42	-3	24
-6	27	30
33	21	6
-6	-75	0
57	-54	-3
-51	-3	42
-51	30	9
21	-81	3
-51	-36	0
-24	-27	-12
-39	-48	-21
36	-63	-21
-48	21	33
-51	-57	12
57	6	12
-6	27	39
-48	12	21
-6	-78	6
-60	-18	-3
60	-12	-3
-30	21	-9
12	-75	-27
-45	-42	48
-45	12	42
-30	-63	36
48	12	27
-42	36	9
-45	36	9
42	36	6
-60	-9	0
54	-15	-12
-33	-54	-15
-54	27	3
-60	-18	-3
60	-9	-6
-42	-51	-15
-42	-45	48
-48	-9	39
-45	36	9
-60	-9	-3

// Calhoun V D, 2004: Figure Selection > Fixation, Sober
// Calhoun V D, 2004: Figure Selection > Fixation, Low Dose
// Calhoun V D, 2004: Figure Selection > Fixation, High Dose
// Calhoun V D, 2004: Dose-Dependent Deactivations
// Calhoun V D, 2004: Dose-Dependent Activations
// Subjects=10
-21.34	-66.38	5.71
24.02	-63.03	4.6
-11.51	-77.52	12.25
17.81	-79.57	23.15
-14.58	-69.7	27.21
27.66	-77.54	32.87
-21.46	-67.21	-3.17
27.16	-67.04	-4.02
-11.35	-96.05	20.8
30.54	-85.65	3.37
-24.67	-60.42	0.69
27.1	-55.44	-6.29
-14.81	-62.65	10.83
20.87	-68.9	10.84
-4.94	23.77	39.09
14.55	27.45	42.88
-4.81	21.52	49.4
8.25	16.76	55.25
-50.26	7.66	41.46
55.55	10.81	34.86
1.87	7.69	61.86
11.58	10.91	61.37
-50.4	9.92	31.15
39.87	29.56	-4.83
-5.22	-18.8	8.57
14.08	-29.65	-5.25
-30.56	-2.41	58.93
40.73	1.03	57.37
-33.79	-34.1	53.15
47.24	-33.81	51.74
-20.75	-66.27	52.75
27.79	-63.43	46.04
-43.7	-81.5	28.88
46.98	-79.47	22.65
-21.32	-72.76	6.34
30.52	-79.27	2.74
-14.69	-73.83	17.54
27.68	-83.92	33.5
-20.8	-69.98	47.52
30.99	-67.02	41.86
-21.48	-61.89	-3.7
40	-52.62	-11.27
-27.5	-81.45	28.59
30.82	-89.1	23.88
-15.08	-32.95	-4.43
33.6	-58.61	-6.08
-17.9	-67.04	21.4
27.33	-62.5	10.1
-11.45	26.84	37.78
14.56	24.26	43.19
-1.55	18.34	49.65
11.41	18.38	49.43
-27.41	3.46	52.69
34.16	6.87	51.3
-8.12	20.99	43.9
11.51	10.39	55.82
-50.47	11.52	25.39
49.99	15.07	23.33
-21.52	-29.36	-.19
14.07	-26.46	-5.57
-47.08	10.45	36.64
46.91	10.78	35.01
-33.79	-34.1	53.15
37.54	-40.23	52.54
-14.07	-50.55	71.25
27.87	-66.1	51.91
-40.53	-79.78	24.17
46.88	-70.42	16.15
36.64	26.36	-4.46
-17.28	-43.77	75.12
37.66	-39.29	62.53
-21.41	-63.6	0.95
24.01	-76.21	1.42
-11.53	-72.21	11.72
17.73	-76.9	17.29
-21.02	-66.12	31.45
21.16	-74.37	32.67
-28.12	-43.39	-12.14
30.35	-58.62	-6.03
-11.36	-92.86	20.48
27.53	-92.72	19.81
-28.01	-52.45	-5.64
27.14	-51.84	-2.16
-18.03	-65.85	11.2
24.09	-62.51	10.15
-8.26	25.37	33.39
14.63	8.41	45.88
-4.72	18.85	55.26
11.54	17.19	59.63
-44.11	23.79	18.46
34.16	6.87	51.3
-8.12	20.99	43.9
11.42	15.19	49.74
-41.07	24.48	2.66
55.42	8.71	23.86
-5.31	-29.3	-.48
14.14	-29.24	-.81
-50.25	4.47	41.77
58.8	7.63	35.12
-34.31	-21.57	14.94
46.43	-14.65	-7.29
-17.49	-56.27	56.19
34.15	-64.34	35.94
-20.77	-59.89	52.12
21.5	-47.76	64.77
-41.44	49.09	-21.06
30.85	5.27	45.91
-37.21	-69.37	32.05
49.92	-56.56	3.52
-34.06	-76.57	23.74
34.06	-89.09	23.82
-5.56	28.98	-8.48
0.96	32.61	-4.47
-1.68	-40.63	27.48
8.03	-38.47	27.1
-30.53	-53.65	50.55
37.47	-38.52	47.89
-38.2	49.1	-21.12
24.21	39.08	40.44
1.56	-40.62	27.42
14.53	-43.76	27.51
-21.12	17.34	40
17.97	16.8	55.08
-44.33	-40.26	-12.17
46.56	-58.57	-6.31
1.62	47.38	50.09
4.86	47.39	50.03
50.38	3.74	51.34
1.38	57.62	33.39
4.62	57.63	33.33
49.74	-16.35	-2.7
43.5	-26.62	14.12
-43.37	-52.76	60.76
-36.81	-41.16	69.59
50.49	-8.51	58.15
-46.68	-49.99	56.06
-1.56	5.16	46.48

// Jackson III O, 2004: Associative Encoding - Fixation
// Jackson III O, 2004: Successful Associative Binding - Unsuccessful 
// Associative Binding
// Subjects=12
6	12	63
9	30	30
9	21	39
36	-21	57
33	-12	66
51	-24	57
39	-30	66
57	-18	39
42	-27	36
27	-84	-30
42	-63	-33
45	-75	-18
27	-93	-3
42	-87	-12
18	-105	0
36	-81	-21
33	-57	-39
36	-42	-30
42	21	-21
-42	-72	-15
-21	-57	-27
-36	-84	-15
-45	-60	-33
-18	-102	3
-39	-48	-33
-24	-96	-6
-36	-93	-15
-12	-102	-9
-30	-99	9
-36	-27	-24
-15	-45	-24
-24	-39	-27
-21	-75	-30
-27	-18	-15
-36	21	-3
-51	15	0
-42	3	48
-21	3	48
-9	18	45
-48	33	0
-48	15	15
-51	24	27
-39	33	-18
-48	3	36
-42	24	-15
-9	15	57
-42	27	21
-42	6	24
-12	21	63
-21	-30	-3
39	21	-6
48	15	-3
21	-27	-3
12	-6	0
15	-21	-3
0	-27	12
-27	-63	48
-27	-78	39
-36	-75	24
-9	-18	15
42	21	-21
36	-21	39
21	42	0
12	-24	-15
21	0	-27
-27	0	-36
-33	6	-27
-39	15	-27
-18	-6	-21
-57	-12	-18
-45	33	-6

// Jacobsen L K, 2004: Diagnosis by Nicotine by Memory Load
// Jacobsen L K, 2004: Diagnosis by Nicotine by Attention Load
// Jacobsen L K, 2004: Schizophrenic Smokers > Healthy Smokers
// Subjects=13
-28.4	1	11.45
20.95	5.74	10.49
21.54	-9.91	11.79
52.86	-55.13	-6.07
19.31	0.18	-10.33
4.89	50.65	-3.24
-14.27	-26.34	3.44
19.35	-16.94	2.26
23.15	-31.4	3.43
27.72	-83.19	7.72
51.11	40.02	-14.03
25.11	-9.09	-9.62
33.28	-49.33	-6.34
-39.15	-55.05	-5.02
8.4	-53.39	-5.71
-41.3	-8.44	40.61
15.51	-63.42	40.11
8.66	46.25	27.64
-7.08	-46.44	27.79
57.04	-46.06	27.02
-25.15	-83.99	25.57
0.91	51.04	-6.13
-24.54	3.47	0.38
-20.13	-30.25	4.28
20.47	-27.9	3.61
-39.22	-69.49	7.79
16.38	-77.62	7.83

// Just M A, 2004: Normals (Visual)
// Subjects=12
-27.17	-61.94	49.39
-40.24	6.8	44.89
47.24	14.59	27.62
-55.39	-31.52	4.79
1.44	-71.99	13.11

// Just M A, 2004: Normals (Auditory)
// Subjects=10
-29.76	67.31	41.93
-14.26	-62.06	60.41
31.59	-50.75	51.13
17.8	-60.73	61.04
-42.4	8.73	42.53
-35.02	26.41	36.5
46.3	10.49	43.59
35.63	17.12	47.62
-53.24	-29.14	7.91
-51.12	-16.09	11.25
57.85	-19.04	4.67
53.63	-15.21	13.32
2.49	-68.9	11.72

// Kindermann S S, 2004: Working Memory > Active Viewing, Normals and Active 
// Viewing > Working Memory, Schizophrenics
// Kindermann S S, 2004: Working Memory > Active Viewing, Schizophrenics and 
// Active Viewing > Working Memory, Normals
// Subjects=10
-8.63	6.77	-13.46
-15.84	9.47	22.09
-45.41	-37.55	49.79
11.43	-76.8	60.23
-68.16	-40.86	9.06
-38.3	-67.68	-10.22
36.72	-92.47	6.61
33.12	-50.48	-28.09
-.61	-7.34	51.2
-33.67	-17.85	55.81
14.08	-56.2	-3.98
70.93	-22.91	36.07
-30.31	-16.29	75.71

// Thiel C M, 2004: Invalid - Valid Spatial Cues
// Thiel C M, 2004: Neutral Cues - No Cues
// Thiel C M, 2004: Valid Cues - Neutral Cues
// Subjects=15
27	-60	45
-12	-60	45
-36	-45	42
45	-69	15
27	9	45
-39	0	48
-36	24	33
36	-57	-18
-36	-75	-3
-9	15	33

// Vannini P, 2004: Detection vs. Control
// Subjects=10
27.36	-62.41	52.15
-20.73	-68.16	50.96
-43.29	-21.25	53.97
13.26	-85.5	16.33

// Asahi S, 2004: Response Inhibition
// Subjects=17
58	-42	18
60	-52	8
52	-60	10
26	4	50
44	12	38
40	34	30
48	30	18
52	26	26
24	-76	40
34	-74	34
10	-66	52

// Bellgrove M A, 2004: Response Inhibition
// Subjects=42
40.68	38.36	19.01
27.16	-1.88	50.42
-46.93	33.6	20.42
-34.04	28.82	26.25
50.35	19.12	17.17
-26.24	-5.2	53.55
-46.7	-.27	36.64
-53.32	4.07	10.7
0.48	4.9	57.97
-9.44	21.48	25.47
52.81	-41.17	35.58
-45.44	-41.16	44.51
-18.59	-61.54	53.72
20.9	-62.96	45.58
7.59	-13.17	2.53
21.43	-7	-1.5
39.64	7.89	10.43
-32.04	9.86	1.05
-55.23	-43.01	21.36

// Fassbender C, 2004: Tonic Activations for Fixed and Random SART
// Fassbender C, 2004: Activations For Correct Inhibitions
// Fassbender C, 2004: Activations For Commission Errors
// Subjects=21
-44.61	3.63	31.83
-41.19	-13.92	52.22
50.47	3.86	26.25
-.65	4.3	50.22
-44.9	9.44	-3.23
-1.81	-69.18	8.45
34.48	-83.65	-3.02
-30.67	-93.56	-1.45
-43.62	-67.46	-6.83
31.56	-51.1	46.69
-30.47	-44.24	44.6
21.03	-49.45	68.98
-33.55	-59.43	54.83
6.88	-23.67	45.79
-43.4	-37.77	33.05
-24.51	-40.11	-12.69
-11.17	-43.52	52.13
42.92	-19.93	8.26
24.65	1.91	3.3
-21.27	-6.83	4.56
7.54	-58.66	-21.54
-54.53	18.01	-1.61
38.3	53.38	-6.75
-43.61	29.28	33.01
-40.28	12.98	42.15
40.1	-45.59	48.36
48.59	-60.4	35.01
-48.91	-21.91	18.41
-22.41	13.34	3.99
2.28	30.01	24.62
10.66	39.26	5.9
-47.08	21.06	-4.18
36.2	17.53	-15.99
50.16	18.3	-7.29
-31.85	25.03	32.12
-64.94	-40.75	10.13
51.75	-41.09	36.7
-55.17	-43.47	29.21
-66.94	-37.11	29.92
-1.81	-20.77	28.92
33.39	-39.91	12.28

// Hester R L, 2004: Cued and Uncued Successful Response Inhibition
// Hester R L, 2004: Cued vs. Uncued, Increases
// Hester R L, 2004: Cued vs. Uncued, Decreases
// Subjects=15
42	-29.4	23.56
-41.37	-37.73	19.65
-50.95	-1.18	38.99
-30.57	9.57	52.36
-50.11	-42.03	-7.77
1.57	6.31	62.3
-38.06	-4.82	45.84
38.6	59.8	35.08
-40.46	58.36	37.23
-8.46	82.16	39.32
60.81	36.68	-4.5
-57.97	57.23	-17.12
18.94	21.17	-36.17
-55.57	50.13	14.67
16.11	6.34	6.37
19.33	17.54	13.2
59.9	36.1	15.64
48.12	40.17	14.31
-14.89	5.02	5.72
15.11	-8.29	9.84
38.43	82.12	20.94
45.17	-11.06	26.45
-28.47	12.5	48.74
3.63	-5.45	47.65
-25.54	72.28	37
32.17	72.71	37.42
2.19	40.07	17.08
61.83	49.37	-5.57
-43.07	63.32	-22.27
29.57	89.91	-15.29
-30.16	88.46	-1.1
-6.04	-53.29	21.66
-14.87	54.65	28.32
14.91	62.09	11.74
19.45	-.98	21.44
-37.48	17.6	-8.46
-46.99	17.6	6.15

// Jimura K, 2004: Negative - Neutral Feedback
// Subjects=21
54	26	30
44	16	26
36	2	44
-42	16	34
-42	4	48
30	18	-6
6	44	46
8	18	44
48	-44	38
30	-52	40
-34	-52	46
44	20	-12
54	-48	8
52	-20	-8
60	-36	-4

// Kelly A M, 2004: Fast and Slow Successful Response Inhibitions
// Kelly A M, 2004: Fast > Slow Stops
// Kelly A M, 2004: Slow > Fast Stops
// Subjects=15
56.74	24.45	16.65
42.82	38.37	18.99
34.01	59.78	-6.13
43.67	52.61	-3.41
38.66	31.8	30.74
50.42	23.15	27.98
-43.75	44.28	20.6
-35.35	52.73	5.3
20.33	58.58	20.9
56.66	12.59	0.92
1.3	27.69	35.97
-58.92	36.5	-9.8
-42.61	-62.59	-12.83
28.42	-64.69	50.1
51.77	-38.72	39.85
-51.86	-35.82	45.26
-46.43	-40.39	54.5
-60.52	-34.79	31.89
-20.72	-54.87	57.65
36.27	25.87	-4.42
-32.11	16.83	-5.11
-17.1	5.37	-3.21
23.45	13.73	-8.83
56.74	24.45	16.65
38.66	31.8	30.74
-42.61	-62.59	-12.83
-20.72	-54.87	57.65
36.27	25.87	-4.42
-32.11	16.83	-5.11
-17.1	5.37	-3.21
34.01	59.78	-6.13
20.33	58.58	20.9
-60.52	-34.79	31.89

// Konen C S, 2004: Predictable and Unpredictable Saccades vs. Fixation
// Konen C S, 2004: Oscillatory Saccades vs. Fixation
// Subjects=11
30.5	-53.13	47.99
-31.44	-55.36	52.24
53.9	-39.85	38.8
-48.6	-42.95	49.16
49.65	-37.41	43.11
2.54	7.4	48.81
0.45	1.3	52.69
45.26	0.88	43.29
-42.31	-5.73	48.2
51.51	9.07	24.69
-48.95	2.92	23.01
45.87	47.76	2.55
15.53	1.62	69.22
56.94	-41.62	15.5
-45.65	-48.84	13.94
49.2	15	5.26
-34.15	15.56	6.17
19.33	0.02	6.86
-22.32	-1.12	9.66
36.35	-53.46	-25.65
-35.25	-56.09	-25.72
-33.56	-55.12	55.58
0.46	2.53	54.82
45.34	-4.86	51.58
-47.65	-6.73	49.46
49.46	-1	32.25
37.29	48.43	-1.87
55.86	-38.46	15.24
21.44	1.89	3.33
-22.4	0.23	-.48
31.01	-58.95	-27.36
-35.24	-59.35	-26.57

// Matsuda T, 2004: Saccades vs. Rest
// Matsuda T, 2004: Anti-Saccades vs. Rest
// Matsuda T, 2004: Anti-Saccades > Saccades
// Subjects=21
46	6	50
-42	-4	58
6	4	62
-4	4	60
22	-68	60
-30	-56	56
-20	8	2
38	-90	-8
-22	-102	-8
-44	50	4
40	-2	50
-22	-2	68
8	8	52
-2	10	46
12	-64	64
-10	-72	56
22	8	-2
-20	6	0
26	-102	-6
-22	-102	-12
64	-36	28
-64	-40	34
8	8	52
-2	10	46
10	-14	8
-12	-16	2
42	46	18
-38	52	12
28	4	54
-28	4	48
16	-66	52
-26	-50	56
64	-20	24
-66	-36	28
10	18	36
-12	12	38
12	-14	-4
-12	-18	-2

// Monchi O, 2004: Normals
// Subjects=9
-42	32	28
48	26	32
-34	22	4
32	22	4
-8	20	46
6	28	46
-44	8	36
44	8	36
24	2	48
-44	-50	42
40	-42	42
28	-58	54
-28	-66	38
-26	-94	2
20	-76	40
-12	-2	2
-10	-6	2
2	58	12
34	8	12
-40	0	12
52	2	10
-2	-12	52
-34	-22	56
58	-24	26
6	-48	28
-44	26	38
-56	8	28
-48	-48	26
32	-66	52
-12	-92	-12
36	-84	-8
-24	-8	2
26	-4	4
6	-34	42
30	36	20
-46	10	36
-34	-60	36
28	-62	40
-14	-98	6
40	-78	-10
18	-72	8
20	-4	68
-54	6	28
10	-16	74
60	-38	38

// Monchi O, 2004: Parkinson's Disease Patients
// Subjects=8
-52	36	18
-6	30	42
6	26	40
-50	18	36
-28	10	52
34	14	56
-36	-54	42
-38	-76	40
34	-61	50
-10	-84	-4
8	-76	6
2	-12	62
10	-6	38
-44	-22	58
-62	-24	20
44	-32	24
62	-44	4
-30	4	14
32	-16	16
34	42	26
-6	24	44
32	20	2
28	-42	30
26	-64	36
-8	-82	42
-34	-64	46
2	-88	32
14	-92	-10
46	-70	6
-20	60	-6
-50	42	26
-6	30	42
-52	28	-8
-46	12	28
-34	-54	38
-18	-76	42
-10	-78	0
-16	-52	-4
6	-66	12
24	-68	-14
-16	-28	50
-26	32	-8
48	-42	38

// Peelen M V, 2004: Cue - Neutral
// Subjects=19
3.52	14.21	40.42
54.71	11.29	25.58
-24.07	-3.7	58.97
34.72	-6.44	59.64
-.51	-48.12	46.81
57.04	-42.71	28.97
-.48	-77.44	39.23
-3.19	-77.9	-35.41

// Kuo W J, 2004: Homophone Judgement > Character Form Judgement
// Kuo W J, 2004: Homophone Judgement > Pseudo-Character Form Judgement
// Kuo W J, 2004: Homophone Judgement > Figure Form Judgement
// Kuo W J, 2004: Character Form Judgement > Pseudo-Character Form Judgement
// Kuo W J, 2004: Character Form Judgement > Figure Form Judgement
// Kuo W J, 2004: Pseudo-Character Form Judgement > Character Form Judgement
// Kuo W J, 2004: Figure Form Judgement > Character Form Judgement
// Kuo W J, 2004: Figure Form Judgement > Pseudo-Character Form Judgement
// Subjects=10
-48	0	46
-4	14	52
-44	10	34
-50	24	26
-46	18	18
-42	6	18
-24	-62	44
-38	-46	52
-54	-42	14
-34	-84	4
-42	-62	2
-32	-78	-2
-36	-54	-8
8	28	36
42	14	26
32	-84	6
-46	2	44
-4	14	56
-40	14	30
-48	26	22
-46	16	22
-46	4	22
-48	16	2
-42	-54	42
-56	-44	16
-34	-72	8
-30	-78	-4
36	-62	-10
28	-70	-14
-2	30	36
-4	14	54
-50	26	26
-42	12	34
-42	4	8
-50	32	8
-42	32	2
-10	32	28
-64	-44	22
-36	-76	-10
-38	-62	-10
28	-70	-18
-54	2	22
-42	26	2
-44	28	2
44	6	22
-24	-62	48
-32	-48	60
-38	-38	42
-36	-74	20
-46	-58	4
48	18	22
46	6	22
32	-62	48
34	-50	62
40	-36	44
48	-48	-2
42	-74	16
-52	2	24
-26	-48	66
-50	-30	38
-50	-60	6
-38	-66	20
58	-16	38
54	12	22
26	-48	40
32	-62	48
30	-54	60
42	-34	36
32	-48	44
42	-76	10

// Siok W T, 2004: Normals
// Subjects=8
-43.94	19.62	31.2
-47.99	6.27	49.4
-50.54	15.36	20.53
41.91	18.85	-16.13
9.99	33.32	25.56
-.54	25.48	45.57
-35.57	-77.66	-10.86
-35.63	-58.41	-11.65
-26.68	-95.43	5.31
-26.44	-87.07	25.77
-29.01	-80.31	-5.11
35.56	-67.71	-23.14
-53.57	15.85	37.34
-46.11	7.49	27.95
-33.62	28.03	-5.67
58.58	33.28	22.5
44.96	3.61	50.32
51.05	13.8	21.19
37.63	23.51	-12.04
3.63	26.58	34.18
-.68	37.62	37.65
-48.53	-68.89	-8.15
-40.05	-56.93	-18.44
-28.86	-93.41	4.03
53.65	-24.43	48.46
-9.6	-18.16	4.1
7.68	-18.1	3.8
5.46	-8.75	0.67
-33.76	-81.31	-38.55
-52.55	16.5	32.78
-52.49	15.85	37.32
-46.11	7.49	27.95
55.35	35.61	24.57
48.92	9.64	22.76
-48.56	-69.1	-10.37
-56.09	27.38	11.59
29.41	-81.71	-.36

// Siok W T, 2004: Impaired Readers
// Subjects=8
-39.51	11.64	37.52
-53.99	30.27	7.91
-44.1	17.31	17.98
-31.54	27.41	-12.36
35.57	63.66	4.2
24.9	50.42	12.41
35.42	27.55	-14.64
37.79	25.82	1.18
-.64	25.81	37.69
12.03	31.33	15.64
-.54	25.48	45.57
-40.06	-54.8	-18.65
-5.31	-85.1	-11.76
-41.99	-76.1	-5.31
-15.81	-66.49	15.71
-11.42	-74.67	19.81
38.58	-60.2	45.54
35.89	-92.64	-2.75
33.69	-57.88	1.69
-30.56	-60.44	46.74
-28.3	-61.84	54.68
-11.75	-13.71	5.94
-7.58	-91.36	-21.19
-31.36	-65.3	-16.64
9.71	-82.59	-20.11
-43.97	16.11	28.19
-31.29	45.76	11.59
-53.83	31.41	20.12
-55.73	11.48	36.69
-33.62	21.44	-7.26
-37.02	-15.41	58.08
-52.22	-13.85	52.58
-34.72	-22.01	67.66
-33.09	2.43	30.48
41.97	58.7	-3.26
48.76	30.4	15.11
38.46	8.91	49.91
39.73	23.1	-16.51
5.74	29.47	30.5
-2.58	-3.14	49.56
-24.17	-69.86	37.48
-42.02	-80.67	-8.21
-24.51	-97.55	5.48
-39.76	-75.58	0.21
44.24	-58.65	-18.59
42.43	-83.38	4.06
40.37	-81.6	11.76
-26.23	-55.97	48.46
-34.7	-48.16	63.52
53.61	-26.97	44.23
-29.13	-31.93	-4.29
7.76	-15.35	10.25
-52.55	16.5	32.78
-52.49	15.85	37.32
-46.11	7.49	27.95
55.35	35.61	24.57
48.92	9.64	22.76
-48.56	-69.1	-10.37
-56.09	27.38	11.59
29.41	-81.71	-.36

// Seurinck R, 2004: Men
// Subjects=11
23.53	4.89	65.13
-28.4	1.95	59.58
30.05	-65.99	52.98
32.24	-46.01	59.93
-36.78	-47.55	70.22
-50.46	-77.01	8.38
-26.24	-71.38	44.38
5.71	-86.7	5.02
-30.57	10.66	60.99
37.64	20.32	-11.72
34.46	-46.65	64.44
-19.56	-53.43	63.79
-50.09	-35.95	45.77
-30.63	-69.68	39.81
32.09	-64.68	43.85
31.52	-66.71	-.76
37.99	-73.38	-3.58
42.28	-75.81	-6.77
33.87	-86.08	10.08
38.46	-74.21	33.48
-46.2	-79.64	2.96
-41.8	-82.3	8.75
-3	-75.24	1.79
12.13	-83.9	0.15
-41.8	11.76	27.46
10.01	-77.01	5.1
-50.45	-74.78	9.28
-35.58	-51.41	-5.62
31.48	-63.73	-3.3
33.69	-84.14	-3.56

// Seurinck R, 2004: Women
// Subjects=11
32.05	8.34	55.67
-19.76	4.11	59.22
-50.47	11.52	25.39
23.73	-50.52	69.48
-19.61	-46.19	60.83
-39.33	-31.86	42.94
38.13	-86.58	4.45
-44.17	-71.86	-5.69
-26.22	-70.1	46.5
-11.64	-94.93	-1.72
29.89	8.33	55.71
-19.79	3.9	57
-52.61	13.85	27.44
-15.1	-37.07	77.78
28.03	-50.72	67.19
45.08	-35.95	51.99
-19.47	-52.8	70.45
-45.84	-27.73	41.52
-24.09	-64.88	44.83
29.96	-66.61	46.32
42.25	-76.01	-8.99
40.17	-77.63	-3.19
31.98	-74.23	33.59
-39.83	-82.68	-6.93
-37.52	-79.3	6.14
-3	-75.24	1.79
12.13	-83.9	0.15
-41.8	11.76	27.46
51.08	-70.17	7.09
42.87	-39.66	46.79
-43.67	-29.85	41.69
25.73	-63.77	53.95
33.53	-51.48	-10.15

// Cools R, 2004: Object-Rule-Switch vs. Nonswitch
// Subjects=16
-30	27	6
-42	15	6
-42	9	21
-48	24	21
9	9	48
-27	-51	48
9	-3	-3
-45	0	33
24	0	54
-33	-87	0
15	-66	12

// Smith A B, 2004: Switch vs. Repeat
// Subjects=20
35.29	16.95	4.14
50.61	-15.46	37.91
50.47	-16.91	19.08
41.75	-6.71	0.48
4.75	-12.68	50.47
42.8	6.25	2.72
-39.26	-11.65	26.36
-43.43	-22.71	35.14
-44.74	-13.14	7.58
-28.89	52.14	10.85

// Brass M, 2004: Meaning Switch vs. Cue Switch
// Brass M, 2004: Cue Switch vs. Cue Repetition
// Brass M, 2004: Switch vs. Repetition, Single Cue
// Subjects=14
-38.22	8.96	31.31
59.92	24.21	13.29
39.07	-56.17	49.26
-41.26	0.71	48.76
53.58	-57.45	-9.9
-51.13	-61.25	-8.38
35.56	-82.42	-.91
-3.86	7.53	51.1
-23.05	-5.27	52.4
-38.2	12.39	34.36

// Koyama M, 2004: Serial Saccades > Fixation
// Subjects=20
-26	-12	54
18	-6	56
-14	-6	62
12	-2	62
-24	-8	64
20	-4	66
-40	-8	52
40	-4	50
36	-6	62
28	0	56
-18	-14	62
-6	-4	66
-22	-62	60
22	-62	60
-28	-58	54
34	-50	56
-22	-84	26
22	-78	28
44	-62	8
-52	-70	2
-28	-78	-10
28	-74	-8
-16	-76	-8
12	-74	-12
-12	-82	2
8	-84	2
-8	-72	0
16	-76	0
-12	-90	-2
-2	-84	6
-14	-24	12
-8	-76	-18
10	-72	-20
24	-74	-18
34	-64	-24

// Ischebeck A, 2004: Unfamiliar > Familiar, Silent Reading
// Ischebeck A, 2004: Pseudoword > Familiar, Silent Reading
// Ischebeck A, 2004: Familiar > Pseudoword, Silent Reading
// Ischebeck A, 2004: Unfamiliar > Familiar, Lexical Decision
// Ischebeck A, 2004: Pseudoword > Familiar, Lexical Decision
// Ischebeck A, 2004: Familiar > Pseudoword, Lexical Decision
// Ischebeck A, 2004: Unfamiliar > Pseudoword, Silent Reading
// Ischebeck A, 2004: Unfamiliar > Pseudoword, Lexical Decision
// Subjects=18
-52.7	14.29	20.67
49.37	34.52	-21.17
55.41	25.08	26.73
-52.17	-30.97	53.15
14.5	-83.4	16.87
-59.13	14.68	25.22
52.63	43.46	-17.63
61.89	25.1	26.61
8.04	33.81	42.36
-43.63	-32.84	44.23
-25.06	66.87	-4.05
-56.45	-14.65	-24.59
-52.39	-63.24	29.46
71.51	-15.02	10.25
-4.93	-57.11	23.56
-56.23	17.62	-.89
7.3	66.57	-9.06
24.42	-45.77	39.87
17.63	-68.91	10.9
-56.4	11.92	-16.01
42.98	28.64	-14.88
-1.59	-1.64	42.67
-46.84	-26.05	48.09
-2.69	50.32	-33.05
-59.78	-2.21	-29.12
-52.42	-53.67	28.51
58.92	-56.06	31.33
4.88	-49.86	31.64
-15.38	63.3	-8.35
-62.93	-14.67	-24.47
64.46	-1.77	-31.28
-41.25	-32.67	-23.06
46.34	-35.04	-18.72
-52.39	-63.24	29.46
53.49	-62.87	27.62
-4.88	-56.7	28
-21.55	-87.6	-14.6
-2.39	58.02	-8.05
-21.19	45.3	40.6
-56.64	5.79	-35.57
-52.3	-56.03	37.71
62.04	-53.68	22.08
1.51	-50.81	21.71

// Watanabe J, 2004: LEFT > REST
// Watanabe J, 2004: RIGHT > REST
// Watanabe J, 2004: RETR > REST
// Watanabe J, 2004: LEFT > RETR
// Watanabe J, 2004: RIGHT > RETR
// Watanabe J, 2004: (LEFT + RIGHT) > (2*RETR)
// Subjects=24
-56	2	28
-50	-8	46
-28	-58	64
-6	-2	58
-24	-6	70
-36	-42	46
-26	-2	-2
-12	-18	2
-16	-62	-24
-14	-70	-50
56	-6	30
62	4	22
42	-10	62
2	-6	70
26	2	2
14	-18	2
16	-64	-24
16	-72	-50
-58	2	30
-54	-6	28
-42	-12	52
-4	-2	54
-10	-8	70
-36	-42	46
-28	-4	-2
-14	-18	4
-14	-62	-24
54	-6	28
62	4	22
56	-24	36
40	-8	56
32	-2	-8
16	-18	2
18	-66	-26
14	-70	-50
-54	-2	26
-48	-10	44
-58	-4	10
-6	0	54
-14	-64	-20
54	-4	28
60	4	20
56	2	6
6	-2	72
26	-2	2
18	-66	-24
-20	-6	58
-38	6	44
-12	-68	60
-28	-60	62
-38	-40	46
30	2	56
14	-60	66
38	-44	54
-22	-2	64
-14	10	56
-24	-64	50
-32	-54	48
-36	-38	42
26	6	58
16	-66	60
42	-42	52
-22	-4	60
-36	6	40
-12	-64	58
-30	-58	62
-22	-66	54
-36	-40	42
28	6	60
14	-62	62
32	-58	64
40	-44	52

// Bestmann S, 2004: Supratheshold rTMS - Rest
// Bestmann S, 2004: Rest - Suprathreshold rTMS
// Bestmann S, 2004: Subthreshold rTMS - Rest
// Bestmann S, 2004: Rest - Subthreshold rTMS
// Bestmann S, 2004: Suprathreshold rTMS - Subthreshold rTMS
// Subjects=12
-36.84	-17.53	60.28
-28.25	-9.3	69.53
-54.35	2.29	15.32
-58.31	-21.94	46.4
-48.89	-28.34	17.83
-51.02	-52.47	8.73
-36.19	1.17	12.98
-10.53	-12.76	9.39
-27.65	-5.38	10.08
-5.25	-26.53	-4.01
2.68	-4.26	63.17
2.48	5.74	41.15
53.69	-27.81	15.49
12.96	-10.59	7.82
5.41	-26.81	-8.57
13.98	-48.42	-13.55
2.75	-32.09	61.04
43.31	-24.62	57.72
19.77	-84.43	29.55
32.5	-84.24	17.12
-26.14	-8.49	66.09
-47.88	-23.39	12.94
-9.46	-12.76	9.38
-54.37	-0.08	12.18
-4.19	-25.56	-5.22
6.93	0.97	61.57
3.53	13.24	41.62
53.64	-19.52	12.57
12.97	-9.45	8.84
1.67	-25.67	61.63
2.59	-84.33	18.59
39.04	-25.79	56.75
16.61	-85.08	35.22
33.52	-81.4	12.41
-36.81	-21.59	62.85
-28.25	-8.25	69.44
-52.92	-25.8	51.12
1.59	-5.58	59.95
-1.7	-4.34	48.73
12.9	-47.46	-14.73

// Christoff K, 2004: Rest vs. Arrows
// Christoff K, 2004: Arrows vs. Rest
// Subjects=12
40	12	-28
-38	8	-20
-14	-44	-16
12	-40	-12
24	-18	-36
-40	50	20
72	-24	28
-38	-26	8
24	-34	52
-16	-60	12
-4	-98	4
-40	-88	16
-6	-92	16
-10	-68	32
12	-98	8
-44	-18	48

// Daselaar S M, 2004: Remembered Items Elicit Greater Deactivation Than 
// Forgotten Items, Perceptual
// Daselaar S M, 2004: Remembered Items Elicit Greater Deactivation Than 
// Forgotten Items, Semantic
// Daselaar S M, 2004: Forgotten Items Elicit Greater Activation Than 
// Remembered Items, Perceptual
// Subjects=14
26.33	38.77	37.07
66.45	-40.93	31.95
-54.76	-60.45	13.53
-10.18	-43.98	38.04
-2.69	-8.33	39.99
66.22	-9.86	19.91
31.14	-24.32	62.28
30.4	48.93	19.19
54.84	-45.49	52.77
10.2	-44.94	26.58
6	-15.64	41.68
-44.27	10.53	2.97
-34.85	-18.59	58.36
9.6	-3.49	-12.25

// Ino T, 2004: Normals-All
// Subjects=28
-22	-20	-18
-10	-42	-6
12	-34	-8
-32	58	16
-6	-74	10
-18	-62	12
6	-66	6
-10	-70	52
4	-76	38
8	-86	6
6	-72	-2
12	-60	-10
4	-22	48
-8	-44	-6
12	-38	-8
-12	-68	-4
6	-70	-2
-22	-50	-10
8	-64	-8
14	-56	-10
44	-68	-18
-4	-70	54
4	-60	52
-4	-78	8
8	-80	8
-18	-66	6
42	6	22
-30	34	40
44	4	46
30	36	24
28	18	52
-12	44	32
22	48	24
10	42	38
-40	-46	26
60	-44	44
42	-72	28
64	-50	16
62	-54	12
14	34	50
16	42	4
30	28	42
14	58	20
44	16	16
-26	28	24
34	-4	38
26	22	34
-12	46	32
12	38	38
60	-56	24
-22	2	12
22	-8	8

// Ino T, 2004: Good Performance Group
// Subjects=13
-2	12	54
2	26	44
-50	18	6
-46	8	26
-42	28	2
42	20	-14
-42	4	46
-50	36	12
-34	58	14
-32	4	56
-28	-70	48
-46	-54	52
-20	-24	-14
16	-22	-18
10	-26	-14
-4	4	60
8	16	60
-6	12	50
-52	14	10
-44	26	4
-54	20	-2
42	20	-14
-48	12	36
-36	60	8
36	60	2
-34	2	52
-46	-4	52
-38	-70	50
-48	16	-14
-50	14	0
10	-86	8
-22	-22	-18
4	-30	-12
-4	12	54
8	12	60
-4	20	44
4	24	46
-50	14	8
-50	34	14
-42	26	2
38	22	-10
-40	4	44
-34	60	12
38	56	8
-32	2	54
-46	16	-8
46	16	-16
-30	-68	48
-4	-44	-4
-22	-24	-16
-4	-28	-12
4	-30	-12
-22	-22	-16
18	-16	-22
-32	58	16
-44	30	2
8	-16	-12
-10	-68	52
2	-74	46
12	-88	14
-18	-42	-8
30	-58	-6
-22	-22	-18
22	-20	-22
-12	-30	-12
12	-36	-8
-32	58	16
-20	-44	-8
-6	-70	52
2	-74	46
4	-68	4
46	4	22
44	0	44
32	16	50
26	20	36
-14	42	32
20	48	22
12	52	6
40	-72	26
-8	-8	16
62	-54	12
26	28	42
-20	2	60
14	60	18
44	16	18
44	0	44
24	22	38
18	32	50
12	38	38
62	-54	12
18	-8	12
18	-8	6

// Ino T, 2004: Poor Performance Group
// Subjects=13
-4	12	50
8	20	40
-44	24	24
44	30	10
-40	24	-16
-44	14	38
-52	32	12
-42	56	-2
32	8	50
-24	20	48
-48	10	-18
48	10	-22
54	-20	-10
-4	-24	-14
-2	6	54
10	14	40
-54	4	28
-46	16	20
34	20	-20
52	4	38
-32	-64	50
-32	-50	42
-10	-6	0
8	-18	-4
-6	-24	-14
4	-22	-16
-4	12	52
8	2	54
-8	26	34
10	24	40
-52	10	28
46	8	26
-46	20	18
-38	28	-10
54	8	38
-28	4	42
36	0	56
-44	26	-18
40	22	-16
-32	-62	56
32	-64	44
-34	-48	36
-38	-40	32
-14	-10	0
16	-4	4
-4	-24	-14
8	-20	-6
-22	-22	-16
18	-16	-22
-32	58	16
-44	30	2
8	-16	-12
-10	-68	52
2	-74	46
12	-88	14
-18	-42	-8
30	-58	-6
-22	-22	-18
22	-20	-22
-12	-30	-12
12	-36	-8
-32	58	16
-20	-44	-8
-6	-70	52
2	-74	46
4	-68	4
46	4	22
44	0	44
32	16	50
26	20	36
-14	42	32
20	48	22
12	52	6
40	-72	26
-8	-8	16
62	-54	12
26	28	42
-20	2	60
14	60	18
44	16	18
44	0	44
24	22	38
18	32	50
12	38	38
62	-54	12
18	-8	12
18	-8	6

// Peck K K, 2004: Sentence Generation vs. Viewing Nonsense Objects
// Peck K K, 2004: Sentence Generation vs. Object Naming
// Subjects=10
-59.91	17.55	-7.08
-48.04	30.97	13.96
-31.56	-76.37	28.35
-43.49	-74.98	6.07
9.26	-70.64	57.51
0.47	-91.83	18.13
14.29	-93.58	8.08
-61.71	-39.33	14.44
-60.54	-41.64	25.77
-40.54	-49.01	-16.22
-36.37	-11.63	-14.94
-27.45	-93.37	0.73
-14.03	-44.39	-41.45
-50.98	-64.11	9.7
-44.27	-65.38	47.65
36.96	-46.06	56.25
49.57	-65.73	20.95

// Salgado-Pineda P, 2004: CPT-IP, Controls > Schizophrenics
// Subjects=14
48	4	24
4	56	34
56	6	6
40	28	4
14	14	56
48	-6	56
-2	56	8
2	24	32
6	45	10
-8	-68	8
38	-73	20
54	-60	22
-40	-60	12
54	-38	-10
54	-64	2
64	-40	2
52	-24	12
-58	-34	0
-46	-24	-20
4	-14	8
4	-30	2
16	-4	12
-4	-10	8
10	8	14

// Rowan A, 2004: Verb Generation, Activations
// Rowan A, 2004: Verb Generation, Deactivations
// Subjects=10
-48	33	9
-51	21	-6
51	18	-6
-39	24	-3
39	24	-3
-57	21	18
-3	9	57
-48	-54	54
-39	-45	-24
-63	-36	3
54	-36	3
-24	12	0
30	-69	-21
48	-72	39
0	-51	24
-51	-69	30
0	30	-12

// Wilson S M, 2004: Listening to Speech
// Wilson S M, 2004: Producing Speech
// Wilson S M, 2004: Moving Fingers
// Subjects=10
-50	-6	47
55	-3	45
-54	-22	5
59	-19	5
53	-38	50
-51	-11	46
-45	-13	34
-56	-4	22
56	-8	44
48	-10	35
60	0	20
-38	-22	58
39	-21	59

// Heckers S, 2004: Schizophrenics
// Subjects=19
-48	8	28
-26	8	58
-38	40	24
-26	44	-20
38	38	22
48	12	32
-38	18	0
2	16	50
8	22	28

// Heckers S, 2004: Normals
// Subjects=15
-42	40	14
-44	8	30
0	18	46
36	12	22
-28	6	42
42	44	26
22	46	-22
28	14	46
40	20	-10

// Cairo T A, 2004: Encoding, Average Across All Loads
// Cairo T A, 2004: Encoding, Linear Regression with Load
// Cairo T A, 2004: Maintenance
// Cairo T A, 2004: Retrieval, Average Across All Loads
// Cairo T A, 2004: Retrieval, Linear Regression with Load
// Subjects=18
-12	2	56
-48	-10	38
36	-16	56
-52	4	18
52	6	26
32	44	28
-44	-40	42
32	-48	42
-24	-68	36
28	-68	40
-48	-62	-14
40	-62	4
-32	-92	8
24	-92	8
-24	4	0
20	12	0
-4	-30	-6
-12	-78	-16
28	-64	-18
-8	2	56
-44	-6	44
40	-2	48
-52	8	14
52	8	18
36	44	24
-28	-48	42
40	-36	42
-24	-64	36
8	-56	50
16	-68	52
-48	-62	-14
48	-54	-8
-16	-88	26
16	96	-4
-24	8	0
16	16	-4
-12	20	-8
12	16	-4
-12	0	0
16	0	4
-16	-16	-6
12	-8	12
-12	12	-8
12	-16	-2
-36	-64	-18
32	-60	-18
-4	10	48
-44	-6	52
-16	10	58
20	10	54
-48	32	20
36	48	24
-28	-60	40
-20	-94	-2
16	-90	4
-24	12	-8
32	24	-2
28	-64	-24
4	14	44
-40	-16	56
-48	-4	8
-36	20	-8
32	26	-4
-48	-34	38
32	-44	46
-40	-36	60
56	-18	34
12	-68	36
-56	-66	4
48	-58	0
-16	-12	-6
20	-56	-20
0	-58	-8
24	-64	-40
12	-70	-20
8	-80	-30
0	28	36
40	32	24
32	52	16
-4	-78	-16
44	-64	-28
36	-70	-20

// Canli T, 2004: Happy - Neutral, Controls > Depressed
// Canli T, 2004: Sad - Neutral, Controls > Depressed
// Canli T, 2004: Sad - Neutral, Depressed > Controls
// Canli T, 2004: Socially Threatening - Neutral, Depressed > Controls
// Canli T, 2004: Physically Threatening - Neutral, Controls > Depressed
// Canli T, 2004: Physically Threatening - Neutral, Depressed > Controls
// Subjects=15
-18.73	17.6	-26.18
-48.85	5.35	-17.73
-64.58	-49.2	8.11
24.65	-6.19	-18.96
46.35	9.92	-8.6
5.44	-40.63	-7.38
-60.64	7.1	-9.86
5.13	-50.57	-33.29
-55.4	-51.71	49.66
-37.28	18.76	44.62
2.9	8	-26.72
60.46	32.28	0.15
-7.17	34.19	35.86
-43.83	-63.84	22.65

// Mendrek A, 2004: Schizophrenic Patients
// Subjects=8
-4	12	56
-40	16	-8
52	12	16
44	-44	44
-40	-48	44
52	-48	0
4	-76	-40
-44	-6	40
-36	-44	48
48	-52	40
-28	-68	44
36	-64	44
-20	-4	52
32	-4	56
28	-64	-36
-32	-64	-36
20	-20	16
-32	-24	28
-12	-12	68
-4	-4	4
16	-16	8
-40	32	16
28	-56	-36
-40	-64	-20
44	44	24
12	-52	20
-52	32	16
48	28	12
-40	-64	-32
8	-52	20
8	4	8
-16	-4	4
28	-52	-36
-52	24	28
-52	32	12
-36	-64	-16
-8	-52	20
44	44	20
24	-4	16
-8	-52	24
-40	-68	-20
16	-4	0

// Mendrek A, 2004: Control Subjects
// Subjects=8
36	-48	40
48	8	32
-40	-52	44
-24	-4	52
-40	-60	-40
-16	-4	4
24	-64	-40
8	-24	8
-8	-8	56
8	-8	64
-28	-68	44
36	-64	44
-20	-4	52
-32	-56	-40
32	-4	56
40	-68	-36
-8	-24	12
8	-20	16
-8	-8	60
8	-4	64
-4	-4	4
16	-16	8
-40	32	16
28	-56	-36
-40	-64	-20
44	44	24
12	-52	20
-52	32	16
48	28	12
-40	-64	-32
8	-52	20
8	4	8
-16	-4	4
28	-52	-36
-52	24	28
-52	32	12

// Mendrek A, 2004: Control Subjects, Pilot Study
// Subjects=11
-48	34	20
52	34	20
-38	-60	-25
34	-60	-30
-12	-6	10
16	-4	10
-4	-54	20
-4	48	10

// Monks P J, 2004: Bipolar Patients
// Subjects=12
-10.34	-3.13	37.58
-32.69	-2.33	50.03
-41.43	7.8	30.33
35.69	-63.53	23.15
39.97	-1.89	49.16
-32.56	-62.48	42.81
-48.65	-22.51	51.91
-6.62	53.82	-10.74
51.81	-48.23	40.64
4.98	44.61	-34.63
-44.41	-51.44	35.33
-2.73	-12.72	50.56
1.24	-70.79	-12.64
57.97	-6.84	24.84
-28.45	-70.69	18.92
40.14	-61.62	47.48
5.54	36.09	34.1
39.35	23.55	-20.99
-21.81	-69.39	48.84
44.22	-59.25	22.7
35.53	28.23	39.99
-37.5	24.03	-7.88
47.06	38.05	14.5
-25.16	-6.08	55.84
9.01	1.52	54.81
-44.36	-50.92	41.97
4.89	-87.01	38.86
-53.14	-20.37	25.02
3.58	-99.36	3.11
3.35	-89.7	-23.35
2.56	-62.67	23.46
0.11	-89	-27.83
0.66	-70.06	51.98
4.71	-21.82	42.32
52.7	-67.63	9.92
-44.35	-64.04	37.5
14.17	-80.52	-1.94
1.13	-9.32	-2.18
-24.1	-77.64	25.02

// Monks P J, 2004: Controls
// Subjects=12
17.45	4.86	42.16
-25.09	-59.27	42.45
-10.24	-5.36	50.03
-51.98	-13.96	38.96
57.96	-3.67	24.57
40.03	-55.16	34.67
46.97	11.85	-7.83
-44.97	10.87	-12.27
-2.85	-45.78	22.11
-41.14	-18.87	57.09
-37.22	13.74	24.2
39.94	-68.16	17.92
12.53	53	-23.15
-41.36	4.08	37.33
5.72	12.71	48.33
12.44	39.99	-39.91
54.85	-5.92	37.06
5.54	36.09	34.1
39.35	23.55	-20.99
-21.81	-69.39	48.84
44.22	-59.25	22.7
35.53	28.23	39.99
-37.5	24.03	-7.88
47.06	38.05	14.5
-25.16	-6.08	55.84
9.01	1.52	54.81
-44.36	-50.92	41.97
4.4	-85.46	-23.72
35.79	-72.36	32.82
5.66	-78.03	3.53
-48.73	-18.97	42.69
-43.29	-70.72	33.59
61.29	-33.08	29.23
-19.16	-88.4	-32.12
40.89	0.97	31.07
45.09	21.09	29.33
-42.5	3.3	27.37
-45.52	-66.13	24.31
2.53	-64.07	19.12
0.37	7.13	45.51
54.5	12.41	-1.27
-33.61	-72.18	41.4
-27.73	-8.44	-1.93
43.54	-4.83	-44.31

// Salomons T V, 2004: Controllability Manipulation (UC - C)
// Salomons T V, 2004: Stimulus - Controllability Overlap [(UC and C) and (UC 
// - C)]
// Subjects=16
2	38	-2
-14	40	10
40	-16	12
-44	-16	12
56	-12	12
-64	-16	16
22	-6	-20
-24	-6	-18
-18	-8	-22
-22	-16	-22
-8	-12	4
2	-38	-16
26	52	0
-42	36	12
-28	34	42
-36	-28	58
0	-52	-20
-10	-52	-50
-22	-56	-34
-10	-48	-30
14	-62	-42
10	-54	-30
4	8	32
-10	6	34
40	8	-6
-36	6	8
-54	8	-2
8	10	58
-32	-56	-28

// Fu C H Y, 2004: Depressed Patients
// Subjects=19
-14.79	13.7	21.72
-14.83	15.47	17.11
-13.56	-5.44	35.58
-13.51	-42.33	26.4
27.07	-10.48	35.53
-25.16	-33.63	43.65
-22.01	-57.19	27.75
-17.78	-53.28	22.91
-17.81	-53.62	18.48
-41.14	-25.47	54.3
-54.13	-30.6	30.35
-46.55	-58.05	32.56
-56.32	-34.47	21.77
-41.68	-3.66	-7.74
-25.6	-37.03	-14.05
-25.62	-40.54	-18.22
-25.07	-37	55.08
-9.58	74.95	28.79
-28.69	4.82	18.16
-45.87	1.57	5.25
6.93	-20.95	53.37
44.27	-15.87	46.94
-29.79	4.47	13.74
-42.75	2.93	-4.94
-10.7	-10.16	-12.01
-10.74	-10.5	-16.45
-22.3	-30.61	-.13
-26.64	-33.52	-9.87
-25.53	0.98	9.53
-14.97	-3.5	-8.06
-20.23	20.39	12.3
-22.45	14.06	-.53
-9.42	-12.33	14.92
-19.08	-28.22	2.98
-3.2	41.72	11.43
10.68	-71.39	-35.01
-24.65	-64.63	-40.74
-25.54	30.56	20.43
-28.5	-10.82	36.2
-15.73	-21.2	24.66
29.17	-25.16	24.47
-25.26	-8.25	41.52
-29.59	-28.68	25.44
30.37	-24.84	42.27
19.54	-32.96	20.78
-6.05	10.27	45.32
42.04	-20.17	32.83
35.64	-40.98	25.72
-12.29	-35.24	49.21
-4.87	-42.4	38.58
11.18	-25.58	48.13
-11.09	-26.12	70.74
-24.15	-7.82	47.05
16.66	-15.38	69.52
32.53	-20.17	47.43
-33.86	-13.22	33.12
-37.13	-12.87	24.2
51.55	-10.22	22.96
54.74	-15.83	18.94
-27.62	5.88	18.06
-38.34	-21.99	2.68
-11.79	-4.88	-12.44
-10.75	-7.33	-16.71
-23.35	-10.64	10.48
-17.07	5.63	0.12
-22.26	-8.18	14.72
-38.34	-21.99	2.68
-26.62	15.06	12.82
-20.28	15.47	3.79
-8.55	5.43	-3.31
-8.56	5.25	-5.53
20.53	-11.81	18.99
-29.72	-12.45	15.16
-22.32	-9.92	5.94
20.41	-6.49	5.16
-23.36	28.8	25.01
-23.43	27.05	16.24
-16.88	38.32	37.52
-16.92	36.84	32.07
-36.04	18.12	39.43
-31.86	23.8	29.99
-42.55	14.94	26.39
-41.61	14.63	8.57
-52.19	-15.04	11.18
-55.41	-19.63	7.14
-48.91	-15.4	20.09
-40.41	-11.46	15.2
-20.21	14.04	12.83
-29.85	-6.08	1.25
-42.33	-52.02	27.55
-41.29	-53.42	23.19
-45.98	1.6	-8.13
-44.95	2.32	-12.67
-32.75	-68.85	15.47
-32.81	-72.71	6.87
-36.08	-61.36	2.61
-30.88	-51.86	-12.75
-29.9	-37.4	-18.43
-29.68	-96.61	-13.47
-39.29	-65.78	0.78
-38.28	-66.37	-6.98
-35.22	19.95	8.05
-36.34	4.03	-5.1
-20.1	-40.91	4.06
-25.58	-31.4	-10.06
-34.19	4.21	-2.91
-23.46	-10.7	-4.02
-18.12	17.94	8.02
-18.15	16.54	3.68
-27.47	-43.1	17.71
-23.28	-40.59	8.53
-1.78	-28.17	29.54
-7.07	-60.61	23.4
-35.72	-68.59	46.7
-35.76	-69.02	41.16
-45.46	-64.39	33.08
-41.26	-70.68	20.18
-35.78	-71.39	38.02
-12.48	-96.54	-.29
-17.68	-90.63	21.58
-10.37	-79.18	3.81
-7.22	-92.96	-9.57
5.65	-68.25	6.05
11.98	-75.59	-6.79
11.84	-20	-3.64
6.41	-14.29	-11.86
-9.43	-75	-11.05
-24.42	-75.43	-15.3
17.19	-2.28	4.85
17.2	-14.25	1.39
5.51	-13.64	10.4
15.05	-18.75	-1.55

// Fu C H Y, 2004: Healthy Subjects
// Subjects=19
-14.79	13.7	21.72
-14.83	15.47	17.11
-13.56	-5.44	35.58
-13.51	-42.33	26.4
27.07	-10.48	35.53
-25.16	-33.63	43.65
-22.01	-57.19	27.75
-17.78	-53.28	22.91
-17.81	-53.62	18.48
-41.14	-25.47	54.3
-54.13	-30.6	30.35
-46.55	-58.05	32.56
-56.32	-34.47	21.77
-41.68	-3.66	-7.74
-25.6	-37.03	-14.05
-25.62	-40.54	-18.22
-25.07	-37	55.08
-9.58	74.95	28.79
-28.69	4.82	18.16
-45.87	1.57	5.25
6.93	-20.95	53.37
44.27	-15.87	46.94
-29.79	4.47	13.74
-42.75	2.93	-4.94
-10.7	-10.16	-12.01
-10.74	-10.5	-16.45
-22.3	-30.61	-.13
-26.64	-33.52	-9.87
-25.53	0.98	9.53
-14.97	-3.5	-8.06
-20.23	20.39	12.3
-22.45	14.06	-.53
-9.42	-12.33	14.92
-19.08	-28.22	2.98
-3.2	41.72	11.43
10.68	-71.39	-35.01
-24.65	-64.63	-40.74
-25.54	30.56	20.43
-28.5	-10.82	36.2
-15.73	-21.2	24.66
29.17	-25.16	24.47
-25.26	-8.25	41.52
-29.59	-28.68	25.44
30.37	-24.84	42.27
19.54	-32.96	20.78
-6.05	10.27	45.32
42.04	-20.17	32.83
35.64	-40.98	25.72
-12.29	-35.24	49.21
-4.87	-42.4	38.58
11.18	-25.58	48.13
-11.09	-26.12	70.74
-24.15	-7.82	47.05
16.66	-15.38	69.52
32.53	-20.17	47.43
-33.86	-13.22	33.12
-37.13	-12.87	24.2
51.55	-10.22	22.96
54.74	-15.83	18.94
-27.62	5.88	18.06
-38.34	-21.99	2.68
-11.79	-4.88	-12.44
-10.75	-7.33	-16.71
-23.35	-10.64	10.48
-17.07	5.63	0.12
-22.26	-8.18	14.72
-38.34	-21.99	2.68
-26.62	15.06	12.82
-20.28	15.47	3.79
-8.55	5.43	-3.31
-8.56	5.25	-5.53
20.53	-11.81	18.99
-29.72	-12.45	15.16
-22.32	-9.92	5.94
20.41	-6.49	5.16
-23.36	28.8	25.01
-23.43	27.05	16.24
-16.88	38.32	37.52
-16.92	36.84	32.07
-36.04	18.12	39.43
-31.86	23.8	29.99
-42.55	14.94	26.39
-41.61	14.63	8.57
-52.19	-15.04	11.18
-55.41	-19.63	7.14
-48.91	-15.4	20.09
-40.41	-11.46	15.2
-20.21	14.04	12.83
-29.85	-6.08	1.25

// Hugdahl K, 2004: Major depressive disorder (MDD)
// Subjects=12
36	24	9
48	15	27
-36	42	36
30	-63	51
-33	-63	-24
-36	28	44
24	20	56
4	52	28
-20	0	56

// Hugdahl K, 2004: Schizophrenic Patients
// Subjects=12
-21	-72	45
24	-66	48
-45	12	27
-2	-45	24
-51	-18	-9
54	-15	-18
-55	-40	44
44	-52	44
4	24	40
60	4	8
48	-52	24
4	-44	8
4	52	28
-20	0	56

// Hugdahl K, 2004: Healthy Subjects
// Subjects=12
-39	18	18
45	15	39
-39	-36	39
27	-51	42
60	-12	12
-55	-40	44
44	-52	44
4	24	40
60	4	8
48	-52	24
4	-44	8
-36	28	44
24	20	56

// Eyler L T, 2004: Schizophrenia Patients
// Subjects=9
10.66	-61.79	-34.69
-.61	0.32	53.9
-37.96	-21.39	51.69
-38.33	-75.69	-17.35
48.29	13.37	25.48
-48.98	-67.75	-10.09
33.58	-29.22	40.37
-8.14	-18.9	39.99
3.31	-71.46	-21.53
33.05	30.17	-3.63
40.53	34.53	-2.97
51.78	-14.42	51.19
-15.98	-61.09	-23.3

// Eyler L T, 2004: Normal Subjects
// Subjects=10
-45.63	-73.85	7.11
-23.48	-61.39	-26.53
-45.65	2.83	35.25
37.05	-58.33	62.85
29.42	-36.76	53.32
-3.61	-28.36	68.61
32.85	-4.9	-44.18
-46.02	44.04	3.92
-30.51	-20.55	48.19
40.53	34.53	-2.97
51.78	-14.42	51.19
-15.98	-61.09	-23.3

// van der Graaf F H C E, 2004: Normals, Practice Group
// Subjects=6
-58	-24	36
-62	-18	16
-34	-36	60
-30	-40	64
-10	-46	68
50	-26	44
42	-28	48
42	-20	56
20	-50	64
60	-18	32
-34	-48	52
-16	-62	56
20	-62	56
-48	-30	48
-40	-34	40
-40	-36	56
46	-34	48
32	-42	60
-34	-10	56
-28	-2	52
32	-8	52
0	10	44
8	2	60
-12	6	60
-56	6	24
-58	8	20
-52	2	36
58	12	20
2	-66	-16
-18	-50	-28
16	-60	-20
20	-52	-24
-4	-74	-28
18	-70	-20
-16	-68	-20
22	-64	56
46	-4	48
30	-8	52
-26	-86	-12
-24	-72	-12
-16	-82	-12
-24	-2	60
-32	-14	60
6	6	52
-40	-8	-12
-36	-20	4
-38	18	-16
-8	-26	-4
12	-32	0
12	-24	-4
52	-8	0
44	-16	-4
54	-22	4
-6	48	28
28	-4	-12
-18	0	-8
-18	14	-8
26	-2	-4
24	10	-8
-6	-56	12
2	-50	12
4	-60	12
12	28	20
-4	34	20
-8	24	16
-28	-80	-12
-22	-86	-16
-22	-84	-24
22	0	-8
30	32	-20
46	30	12
-24	0	-12
-48	36	-4
-26	16	-12
-12	-10	68
0	2	56
6	-2	60
-52	-12	40
-40	44	12
-44	30	20
40	-16	44
54	-12	32
40	-4	52
24	-2	56
20	52	24
-2	36	36
8	34	44
34	-64	-48
-58	-18	44
-50	-14	52
-44	-32	56
38	-18	64
52	-24	56
40	-6	60

// van der Graaf F H C E, 2004: Normals, Control Group
// Subjects=6
-58	-24	36
-62	-18	16
-34	-36	60
-30	-40	64
-10	-46	68
50	-26	44
42	-28	48
42	-20	56
20	-50	64
60	-18	32
-34	-48	52
-16	-62	56
20	-62	56
-48	-30	48
-40	-34	40
-40	-36	56
46	-34	48
32	-42	60
-34	-10	56
-28	-2	52
32	-8	52
0	10	44
8	2	60
-12	6	60
-56	6	24
-58	8	20
-52	2	36
58	12	20
2	-66	-16
-18	-50	-28
16	-60	-20
20	-52	-24
-4	-74	-28
18	-70	-20
-16	-68	-20
22	-64	56
46	-4	48
30	-8	52
-26	-86	-12
-24	-72	-12
-16	-82	-12
-24	-2	60
-32	-14	60
6	6	52
-40	-8	-12
-36	-20	4
-38	18	-16
-8	-26	-4
12	-32	0
12	-24	-4
52	-8	0
44	-16	-4
54	-22	4
-6	48	28
28	-4	-12
22	0	-8
30	32	-20
46	30	12
-24	0	-12
-48	36	-4
-26	16	-12
-12	-10	68
0	2	56
6	-2	60
-52	-12	40
-40	44	12
-44	30	20
40	-16	44
54	-12	32
40	-4	52
24	-2	56
20	52	24
-2	36	36
8	34	44
34	-64	-48
-58	-18	44
-50	-14	52
-44	-32	56
38	-18	64
52	-24	56
40	-6	60

// Derbyshire S W G, 2004: Hypnotically-Induced Pain > Rest
// Derbyshire S W G, 2004: Physically-Induced Pain > Rest
// Derbyshire S W G, 2004: Imagined Pain > Rest
// Derbyshire S W G, 2004: Hypnotically-Induced Pain > Physically-Induced Pain
// Derbyshire S W G, 2004: Physically-Induced Pain > Hypnotically-Induced Pain
// Derbyshire S W G, 2004: Hypnotically-Induced Pain > Imagined Pain
// Derbyshire S W G, 2004: Physically-Induced Pain > Imagined Pain
// Subjects=8
0	-16	0
-4	4	48
6	8	34
-12	-40	-30
8	46	-10
-30	-16	60
-56	16	-2
-30	0	-6
28	10	4
40	18	16
-46	-48	60
56	-42	48
-50	42	24
60	14	20
40	60	4
-18	-14	10
8	0	4
-6	10	46
8	20	32
14	-72	-16
-58	-28	-12
-38	2	18
-34	12	8
38	14	6
-32	-52	40
30	-70	56
-44	34	34
-48	42	18
-40	54	-2
-56	8	14
-34	12	8
38	-2	16
50	-14	42
-42	34	-12
-14	-14	10
-4	26	34
-8	36	12
-42	30	34
32	-72	54
-16	-24	-2
14	-14	0
-4	10	0
-6	-46	-12
-68	-4	-4
-36	-26	8
-34	-28	60
-48	28	14
42	58	4
38	-56	42
-12	-10	14
-8	24	32
10	30	26
-26	-60	-24
18	-70	-22
-42	-12	18
-34	2	16
-36	16	12
38	14	6
-46	34	34
32	60	12
-28	-50	44
30	-50	44

// Pierce K, 2004: Autism Subjects
// Subjects=7
40.74	-61.04	-13.91
34.47	-88.14	-5.99
36.6	-87.07	-6.11
13.15	-91.01	0.07
14.12	-44.85	5.11
40.54	61.02	9.31
56.66	29.14	8.45
34.44	11.51	30.26
50.71	-17.77	49.25
41.11	-50.58	38.73
21.29	11.35	-11.96
8.85	3.15	34.6
-35.16	-55.15	-13.54
-35.03	-90.04	-10.61
-39.18	-85.53	6.9
-6.04	-84.1	8.63
-54.53	-17.2	-16.5
-37.92	-14.36	60.02
3.65	-40.4	36.08
2.65	-53.98	39.46
-.6	-41.31	38.44
0.52	-54	39.49
33.25	-56.77	-13.07
39.78	-80.79	-7.79
12.1	-91.91	2.39
47.49	-14.62	49.03
-30.85	-56.98	-10.09
-37.04	-86.57	6.96
-13.55	-83.34	5.31
-41.56	-74.91	-20.73

// Pierce K, 2004: Control Subjects
// Subjects=9
37.55	-58.69	-10.73
39.84	-86.79	-2.82
49.4	-76.25	-4.93
2.51	-98.31	3.03
3.02	48.59	-10.41
4.68	-51.83	25.87
50.19	39.5	5.43
2.06	57.36	6.71
47.01	38.59	7.77
2.69	-61.3	41.19
-40.44	-72.1	-12.05
-11.47	-95.99	-7.04
-38.25	-79.23	-8.14
-12.53	-99.25	-7.87
-12.86	-7.09	-13.36
-25.83	3.44	-27.48
-4.46	48.55	-10.32
0.42	-48.42	28.98
0.22	11.05	27.34
-37.9	-14.11	63.35
-19.27	62.06	14.37
-1.07	54.85	15.88
-41.12	-70.37	37.99
-41.63	2.4	1.79
0.52	-61.66	36.78
2.48	-49.18	18.99
2.07	60.79	9.77
1.98	51.04	-6.14
-.72	-49.2	19.03
-38.15	4.19	38.4
-0.01	52.57	13.83
-41.42	21.09	37.02
-19.01	37.34	38.74
-1.23	51.02	-6.1
40.76	-57.52	-9.75
44.02	-74.51	-9.48
21.6	-79.93	-8.76
46.23	-78.13	-1.39
-35.09	-65.47	-9.33
-35.03	-81.33	-8
-29.71	-74.95	-8.59
-44.73	-71.24	-14.31
-33.92	-77.55	-.52

// Weiss E M, 2004: Schizophrenia Patients
// Subjects=9
-46	10	27
34	20	0
10	16	40
-50	-46	54
-26	-58	40
-12	-18	4

// Weiss E M, 2004: Normal Subjects
// Subjects=9
-42	6	36
-22	12	54
52	20	4
46	10	32
44	44	27
-4	22	36
-26	-64	54
-8	-18	4

// Wang A T, 2004: Autistic Subjects
// Subjects=12
-30.83	-65.61	-11.59
39.62	-50.56	-15.9
-45.8	22.15	23.6
46.16	21.1	29.32
-45.9	32.04	13.85
-41.42	7.88	31.43
35.47	14.35	25.55
-35.45	16.5	-22.89
39.33	40.89	-16.87
-.44	-49.55	55.85
25.2	-47.28	55.37
-45.83	-57.24	-12.12
39.62	-50.56	-15.9
50.49	15.12	34.23
-45.81	21.98	21.38
48.14	34.89	14.76
-48.22	43.34	-4.92
54.56	28.41	13
-33.29	27.77	-14.94

// Wang A T, 2004: Controls
// Subjects=12
-37.27	-59.3	-12.05
41.77	-52.66	-15.74
-45.76	26.89	29.89
48.35	12.82	32.22
50.35	24.67	20.05
39.74	14.37	25.5
-48.01	27.96	16.44
-43.91	30.51	-6.12
52.32	20.68	-4.17
20.22	-1.86	-17.53
-37.27	-59.3	-12.05
39.64	-54.79	-15.54
-56.42	18.37	30.73
48.36	17.39	36.3
-50.1	24.06	21.25
41.8	24.62	20.15
-43.6	9.64	26.85
-54.48	31.64	9.52
-52.41	22.17	-3.09
41.51	21.53	-19.73

// Cato M A, 2004: Positive > Neutral
// Cato M A, 2004: Negative > Neutral
// Cato M A, 2004: Neutral vs. Emotional
// Subjects=26
-2.27	65.62	3.84
1.52	-47.02	33.31
-22.34	48.09	26.73
-59.43	-51.07	27.66
-49.83	-64.39	19.75
-52.26	-24.53	-1.41
-3.19	67.07	22.69
1.5	-46.05	32.12
-56.26	-43.73	25.9
-41.23	-55.02	30.02
-52.22	-30.79	0.23
-11.43	-56.04	14.15
-44.59	8.21	35.9
-61.85	-51.79	-9.05
-29.38	-68.18	37.67
-14.6	-76.58	10.33

// Abrahams S, 2004: Letter Fluency vs. Baseline 1, Normals > ALS Patients
// Abrahams S, 2004: Letter Fluency vs. Baseline 1, ALS Patients > Normals
// Abrahams S, 2004: Confrontation Naming vs. Baseline 2, Normals > ALS 
// Patients
// Abrahams S, 2004: Confrontation Naming vs. Baseline 2, ALS Patients > 
// Normals
// Subjects=18
-46.73	-58.88	8.1
-1.69	-66.84	24.98
-43.62	10.44	23.44
31.02	48.79	17.13
-29.89	46.22	16.93
-40.15	-32.92	40.42
4.43	27.99	25.87
42.67	-3.84	-17.62
-6.64	64.57	-9.41
51.26	20.85	-1.94
54.76	10.66	31.21
-54.32	-52.29	-2.4
-41.34	-75.85	8.34
-57.45	-30.68	15.89
49.15	32.09	6.06
6.85	-76.73	20.13
-45.96	21.58	2.46
-5.88	-71.47	34.33
4.67	4.07	46.84
31.18	-64.9	-7.9

// Schirmer A, 2004: Normal Males
// Subjects=12
-19.04	-14.59	14.1
-45.76	-27.95	8.84
-26.6	-68.21	-18.12
53.5	-8.84	-.6
16.11	-58.44	-19.43
-2.98	38.49	38.46
-49.11	23.21	10.16
47.03	20.19	3.74

// Schirmer A, 2004: Normal Females
// Subjects=12
-23.18	-3.38	35.51
-13.67	-14.3	17.36
-54.19	-36.75	19.71
51.49	-20.77	10.46
34.26	-55.16	-19.91
-45.89	14.6	8.62
50.11	28.7	-10.4
-2.98	38.49	38.46
-49.11	23.21	10.16
47.03	20.19	3.74

// Bischoff-Grethe A, 2004: Learning Related Increases, Low-Recall Subjects
// Bischoff-Grethe A, 2004: Learning Related Decreases, Low-Recall Subjects
// Bischoff-Grethe A, 2004: Compatible Mapping, Motor > Perceptual, Low-Recall 
// Subjects
// Subjects=7
6	56	26
-34	14	48
-14	28	52
0	12	48
2	36	42
-4	42	40
8	64	8
26	26	44
22	26	52
28	16	52
30	28	34
46	18	32
48	28	20
40	12	28
4	-48	24
30	-28	62
48	-14	30
8	-32	70
-40	0	56
-62	-12	26
-14	-44	66
50	-20	4
58	-14	2
-58	-22	-2
-62	-30	-8
-64	-14	-2
-48	-52	8
-48	-68	24
54	-58	32
-52	-38	38
14	-72	40
-34	-82	24
28	-86	18
-30	-82	10
-26	-86	4
-42	-68	-14
-50	-66	-14
20	-76	-12
-24	-70	-14
26	16	-16
22	-66	8
24	-76	16
-24	-70	10
44	12	-18
-44	6	-22
-38	6	-16
44	-66	2
-10	-64	46
-16	-14	-16
34	10	-4
0	-54	-24
2	-62	-22
8	-44	-24
36	-66	-36
4	8	54
-6	6	54
50	6	22
-10	18	44
-50	-36	34
-10	0	20

// Yang J C, 2004: Normals > Depressed Patients, Sexual Stimulation
// Yang J C, 2004: Depressed Patients > Normals, Sexual Stimulation
// Subjects=10
52	-56	-12
-62	-30	10
4	-24	18
-8	6	-4
20	-14	26
-34	60	-6
34	64	4

// Levine B, 2004: PE vs. PS,GS, and OE (Latent Variable 1)
// Levine B, 2004: PS vs. GS (Latent Variable 2)
// Subjects=5
-2.52	19.17	58.55
-16.23	66.12	10.44
53.29	18.79	28.51
-58.59	24.88	-15.01
22.29	27.32	-27.84
-15.15	-21.01	77.31
5.43	-2.37	0.04
-3.05	-26.34	8.16
5.16	-39.41	-28.79
-46.04	-54.38	20.63
56.77	-55.96	32.48
-62.7	1.23	-3.64
-58.02	-33.25	17.62
31.27	-37.97	-14.81
-33.62	-43.08	-19.92
5.61	-51.39	3.77
1.78	-46.61	43.7
-49.86	-35.35	63.63
-2.88	-88.55	8.71
-7.65	-94.11	-27.64
14.82	19.64	62.69
-10.94	-17.47	69.05
-28.57	34.61	52.99
-15.9	40.13	30.93
-2.77	38.13	43.23
-3.24	61.91	10.63
-11.71	59.94	24.42
56.4	26.58	19.84
-11.81	-14.13	1.5
14.36	-33	16.36
-53.38	-68.05	35.55
65.43	-60.18	32.75
65.03	-51.18	2.73
-29.44	-31.03	-29.03
-53.35	-38.29	43.81
-41.17	-55.73	63.26
-37.36	-96.76	14.59
5.85	-96.61	13.84
31.24	-51.36	-20.21
9.34	-62.33	-44.52

// Fiehler K, 2004: Incompatible Erroneous vs. Incompatible Correct
// Fiehler K, 2004: Corrected Incompatible Erroneous vs. Uncorrected 
// Incompatible Erroneous
// Subjects=13
-.57	12.81	64.01
-.68	21.56	53.24
8.99	28.73	62.56
2.49	37.69	55.19
2.38	26.64	36.05
-3.75	6.45	64.58
5.84	-.35	58.35
2.38	26.64	36.05
60.14	-21.8	23.83
66.71	-30.08	40.07
63.41	-11.32	35.19
-3.82	-89.83	16.89

// Mataix-Cols D, 2004: Contamination/Washing, OCD Patients > Normals
// Mataix-Cols D, 2004: Contamination/Washing, Normals > OCD Patients
// Mataix-Cols D, 2004: Aggressive/Checking, OCD Patients > Normals
// Mataix-Cols D, 2004: Aggressive/Checking, Normals > OCD Patients
// Mataix-Cols D, 2004: Hoarding, OCD Patients > Normals
// Mataix-Cols D, 2004: Hoarding,  Normals > OCD Patients
// Mataix-Cols D, 2004: Universally Aversive, OCD Patients > Normals
// Mataix-Cols D, 2004: Universally Aversive, Normals > OCD Patients
// Mataix-Cols D, 2004: Contamination/Washing, Pure OCD > Comorbid OCD
// Mataix-Cols D, 2004: Contamination/Washing, Comorbid OCD > Pure OCD
// Mataix-Cols D, 2004: Aggressive/Checking, Pure OCD > Comorbid OCD
// Mataix-Cols D, 2004: Aggressive/Checking, Comorbid OCD > Pure OCD
// Mataix-Cols D, 2004: Hoarding, Pure OCD > Comorbid OCD
// Mataix-Cols D, 2004: Hoarding, Comorbid OCD > Pure OCD
// Mataix-Cols D, 2004: Universally Aversive, Pure OCD > Comorbid OCD
// Mataix-Cols D, 2004: Universally Aversive, Comorbid OCD > Pure OCD
// Subjects=7
-18.35	35.35	-14.63
15.9	48.13	-3.83
-6.58	44.31	-9.94
12.65	44.42	-10.17
-14.11	31.69	-21.06
12.54	50.88	-22.98
-44.59	-65.38	6.39
15.86	7.12	-24.92
-25.6	49.76	21.05
12.78	24.84	-1.84
-29.83	25.96	16.4
-49.31	39.82	-9.07
1.45	-76.31	12.35
32.53	-75.18	24.17
-3.15	-14.89	-5.01
27.84	-14.7	-5.38
8.68	-21.71	2.11
-21.92	-50.79	41.71
27.76	-19.88	-17.22
51.47	15.33	23.05
8.7	35.59	27.42
-17.8	16.8	48.26
-32.81	-60.65	11.43
-14.11	19.63	-25.63
8.33	19.76	-25.89
-44.61	15.69	36.39
51.56	16.27	35.24
5.54	36.09	34.1
-6.39	58.34	20.11
-29.36	-9.82	62.89
5.52	-86	-16.99
-2.99	-82.45	-11.62
-41.64	-47.16	-19.71
47.28	-69.57	-1.01
-49	6.81	18.23
-17.63	-17.67	56.72
-44.87	-39.77	-20.29
24.31	34.66	-27.33
-5.8	-73.96	43.46
32.24	-61.63	-7.08
-29.39	-79.27	31.91
-41.37	-69.59	6.7
-49.12	-60.4	-25.2
16.62	-57.53	47.4
-13.46	-51.68	29.42
-37.48	20.86	-7.62
-44.96	7.7	-12
-8.57	-69.56	-37.17
-32.7	-51.79	29.65
-22.5	-47.98	-32.13
55.97	-42.8	27.87
1.47	-68.39	18.38
5.9	-74.4	36.68
5.68	-40.45	21.56
55.78	7.95	23.62
-41.16	-63.05	36.26
-60.69	-45.39	4.9
-17.54	-40.93	58.67
-10.5	-86.09	-16.8
-6.2	-82.47	-11.58
-25.44	-82.58	-11.35
-53.11	-36.57	21.91
43.75	-60.79	-38.5
5.72	12.71	48.33
20.83	-26.33	51.43
-13.37	-50.74	41.6
-37.02	-64.39	18.49

// Volz K G, 2004: Prediction Under Uncertainty vs. Prediction Under Certainty
// Volz K G, 2004: Positive Covariation with Increasing Prediction Uncertainty
// Volz K G, 2004: Group Difference Between Externally Attributed Uncertainty 
// and Internally Attributed Uncertainty
// Subjects=12
5.66	27.43	45.98
2.35	39.58	38.31
-39.3	13.18	30.96
44.04	17.91	29.61
-45.85	29.29	19.65
40.72	32.18	21.76
-26.75	26.89	0.68
30.99	25.38	3.48
-26.05	-60.27	57.05
34.8	-50.65	52.19
-4.15	-29.53	-1.54
5.46	-26.3	-1.92
-36.18	-56.93	-8.91
34.34	-52.19	-9.01
2.35	39.58	38.31
-45.67	16.83	37.42
44.02	29.8	31.96
-39	-39.72	48.78
44.44	-50.34	55.4
-.79	37.96	45.17
-42.52	22.94	33.53
44.04	17.91	29.61
-42.64	29.31	19.61
-29.25	-60.29	57.08
-48.56	-41.38	55.72
34.8	-50.65	52.19

// Valet M, 2004: No Distraction, Painful - No Distraction, Non-Painful
// Valet M, 2004: Distraction, Painful - Distraction, Nonpainful
// Valet M, 2004: (Distraction, Painful + Non-Painful) > (No Distraction, 
// Painful + Non-Painful)
// Valet M, 2004: (Distraction, Painful - Non-Painful) > (No Distraction, 
// Painful - Non-Painful)
// Valet M, 2004: Covariation of Cingulofrontal Cortex Only During 
// Distraction, Painful
// Subjects=7
-18	-14	8
12	-14	6
-30	-28	56
-60	-36	22
56	-26	24
-40	-16	14
34	-14	10
-58	-46	36
50	-56	46
-10	-2	46
-10	8	30
-6	-34	24
-36	50	12
36	52	14
-40	6	6
38	16	-4
-32	-30	58
-40	-16	16
10	-26	10
-2	-28	-18
-22	-70	28
42	-82	0
-4	58	-6
-2	-60	24
8	-22	12
-20	-32	6
2	-34	-16

// Vollm B A, 2004: Amphetamine - Saline
// Vollm B A, 2004: Activations correlating with "mind-racing" rating
// Vollm B A, 2004: Motor independent responses
// Subjects=7
16	38	-8
-2	24	-5
16	18	-9
13	19	0
-4	-12	68
5	15	1
39	44	-8
0	32	-1
11	38	-8

// Phelps E A, 2004: CS+ > CS-, Acquisition
// Phelps E A, 2004: CS- > CS+, Acquisition
// Phelps E A, 2004: CS+ > CS-, Extinction Day 1
// Phelps E A, 2004: CS- > CS+, Extinction Day 1
// Phelps E A, 2004: CS+ > CS-, Extinction Day 2
// Phelps E A, 2004: CS- > CS+, Extinction Day 2
// Subjects=11
1.3	18.8	31.14
-31.01	24.84	2.01
49.17	14.66	0.83
63.44	-37.3	29.56
-7.4	4	5.72
9.69	5.16	5.42
-1.28	38.45	-17.31
0.92	59.93	-1.3
-8.19	-58.93	17.7
16.37	-53.5	16.96
-45.41	-71.62	35.92
37.98	-76.15	38.68
-55.18	-38.1	29.87
47.45	-1.85	49.07
5.49	38.92	29.41
-36.35	16	-1.65
34.17	22.94	-.81
8.61	3.93	3.31
5.49	38.92	29.41
-36.35	16	-1.65
34.17	22.94	-.81
8.61	3.93	3.31
1.25	23.83	27.38
-28.9	23.45	-2.36
33.08	22.77	-3.01
10.73	5.97	2
-3.37	33.41	-13.52
-3.34	62.27	1.9
-10.45	-48.17	5.67
10.95	-53.25	6.96
-39	-73.78	34.91
40.04	-82.45	25.81
-51.88	-19.53	49.47
-55.27	-6.12	30.54
63.39	-9.29	33.9
-21.29	-37.8	-10.69
32.08	-30.34	-15.27

// Liu X, 2004: Simon Incongruent > Simon Congruent
// Liu X, 2004: Stroop Incongruent > Stroop Congruent
// Liu X, 2004: Simon Incongruent > Simon Congruent and Stroop Incongruent > 
// Stroop Congruent
// Subjects=11
-12	44	0
-34	36	10
32	60	26
30	42	44
12	32	62
26	18	36
-12	-66	74
-36	-44	70
22	-62	74
-46	-36	28
30	-80	-12
-16	-52	-6
-46	-78	34
48	-78	34
-14	-96	20
42	-10	-32
-36	-20	-20
32	-38	-2
-48	-54	-10
-64	-14	-26
58	-68	-2
-56	-26	-4
-44	-56	8
42	-60	8
44	-26	18
-38	22	-30
-32	0	-26
-36	-20	16
36	-10	-2
34	-12	16
-4	-30	72
-44	-32	68
40	-20	64
36	-18	50
-32	42	10
-32	12	52
-30	42	-4
-44	-32	50
-6	-4	72
-28	-38	54
-42	-88	30
46	-58	-30
-24	-2	-44
26	-38	-18
-44	-50	-20
-40	-60	-2
40	-56	2
-54	16	-28
30	-32	22
-6	-34	40
-36	10	52
-42	-84	36
46	-56	-28
32	-32	22

// Morris J S, 2004: Acquisition CS+ > Acquisition CS-
// Morris J S, 2004: (Acquisition CS+ > Acquisition CS-) x Time Interaction
// Morris J S, 2004: (Repeat CS+ and Reversal CS+) > (Repeat CS- and Reversal 
// CS-)
// Morris J S, 2004: (Repeat CS+ and Reversal CS-) > (Repeat CS- and Reversal 
// CS+)
// Subjects=12
-24	-10	-12
42	30	0
34	-28	0
-26	-22	8
30	0	-12
0	4	58
4	38	-14
42	44	-16
18	2	-24
12	4	56
28	-74	-8
-34	-72	-14
30	2	-26
18	0	40
28	-50	-12
20	-26	10
40	16	-12
38	-6	-6

// Kircher T T J, 2004: Speech Pauses > Fluent Speech
// Kircher T T J, 2004: Fluent Speech > Speech Pauses
// Kircher T T J, 2004: Pauses at Grammatical Junctions > Fluent Speech
// Kircher T T J, 2004: Pauses within Clauses > Fluent Speech
// Subjects=6
-33.81	-65.43	18.54
-47.69	-56.63	23.53
-5.04	-93.58	-3.97
-8.19	-96.34	1.88
-4.95	-92.64	8.22
-8.33	-85.65	-11.29
-1.87	-71.98	-.24
16.32	-90.28	-4.49
32.28	-85.41	-11.77
59.97	-21.4	1.5
38.47	-1.95	-6.58
-4.89	-97.5	14.2
-1.65	-91.68	20.37
-1.61	-67.04	36.14
11.18	-82.71	25.04
23.05	-74.84	43.21
4.87	-59.72	47.72
-13.26	-68.28	48.65
-8.43	-68.11	-18.33
29.03	-85.86	-17.27
-23.26	34.23	40.17
32.02	49.16	8.17
53.5	5.43	4.9
-36.42	36.18	-2.22
-54.47	16.41	5.22
-47.71	-1.87	43.48
22.52	-22.14	-4.7
-20.21	-25.57	-3.92
4.69	-10.02	43.56
1.4	1.17	37.08
14.1	-30.76	8.39
16.22	-13.32	13.59
-60.74	-33.75	3.92
56.7	21.82	10.18
60.11	-57.35	4.51
-41.56	-32.04	-3.13
-14.04	63.18	0.83
50.2	43.99	8.39
-53.97	-27.83	52.42
-32.51	-50.97	54.11
-25.8	54.22	-3.86
-47.91	-33.68	3.77
-41.39	-39.04	16.41
-67.13	-12.76	14.5
-32.76	-74.4	12.58

// Singer T, 2004: Pain - No Pain in Self
// Singer T, 2004: Pain - No Pain in Other
// Singer T, 2004: Pain - No Pain in Self and Others
// Singer T, 2004: Pain - No Pain in Self with Others
// Singer T, 2004: (Pain - No Pain in Self) - (Pain - No Pain in Others)
// Singer T, 2004: (Pain - No Pain in Others) - (Pain - No Pain in Self)
// Singer T, 2004: (Pain - No Pain in Others) correlated with BEES
// Singer T, 2004: (Pain - No Pain in Others) correlated with EC
// Subjects=16
6	3	45
33	9	12
-42	-21	21
-54	-24	27
-42	-9	-9
66	-33	36
-18	-33	75
6	-66	-30
0	12	36
51	9	-3
39	24	-3
-30	9	9
-39	9	-21
-39	-3	-9
45	-33	24
66	-36	15
-27	-39	60
-30	-30	72
27	-60	-18
15	-18	0
3	-6	6
-12	-21	12
-6	-42	-27
0	27	33
-3	12	42
60	15	3
-45	30	-3
-36	12	0
-18	-39	-39
-36	45	-9
42	42	-6
-33	-63	-24
-30	-54	-15
-15	-93	0
42	-63	-24
48	-63	-15
30	-72	-15
18	-93	0
39	-81	15
50	-51	12
-30	57	27
-60	-45	30
39	12	3
33	21	-9
-6	-39	-33
-9	-78	-42
-9	6	42
0	24	33
60	15	3
39	12	3
42	27	-6
-30	9	6
-39	0	18
-48	12	-3
-33	-66	-24
27	-66	-18
-6	-39	-30
-12	6	42
-3	24	33
60	15	6
39	12	3
33	24	-9
42	24	-3
-30	9	6
-39	0	18
-30	-63	-27
-6	-39	-30
6	6	42
12	0	48
-39	-27	24
-21	-33	75
-30	-24	72
-27	-36	60
0	-3	3
-21	-90	-3
-27	-90	15
-6	45	21
-3	21	39
-45	15	0
30	-63	-24
-9	6	39
-6	42	18
-33	9	6
30	-63	-27
-30	-63	-27
-15	-39	-48

// Elliott R, 2004: Movement vs. No Movement
// Elliott R, 2004: Reward vs. No Reward
// Elliott R, 2004: Reward vs. Reward and Movement
// Subjects=12
-51	-30	54
48	-27	45
-27	-72	-21
21	-54	-21
-6	-96	21
-57	12	-3
18	6	72
3	33	30
0	51	-6
9	57	36
45	36	30
54	24	-9
-45	51	-9
-57	18	-3
27	0	-21
33	3	0
3	-18	9
30	-6	-21
27	6	9
-24	-3	3
3	-15	-21

// Zink C F, 2004: Active Money > Passive Money
// Zink C F, 2004: Active Blob > Passive Blob
// Zink C F, 2004: (Active Money - Passive Money) > (Active Blob - Passive 
// Blob)
// Subjects=16
12	3	15
-12	-6	15
12	9	-6
-45	-36	63
27	-27	75
21	-57	-24
12	-90	-21
0	-9	54
-3	36	12
63	3	0
-48	15	-12
-57	12	27
66	-27	30
24	0	-15
-21	0	-15
-39	-36	66
9	-57	-12
0	-12	51
-39	-3	6
60	-30	36
6	-60	30
12	-3	12
-12	3	12
9	18	6
-33	-42	66
15	-87	-21
33	-84	-21
63	6	0
45	33	6
48	-51	-21

// German T P, 2004: Pretend > Real
// Subjects=16
6	31	32
-9	57	25
-3	52	-3
33	20	-11
56	18	10
-39	14	-13
-48	10	16
-30	53	6
-45	40	-12
-50	-52	3
59	-58	14
48	-70	-2
42	-53	-12
-18	-4	-12
21	-10	-22
21	-11	12
-3	9	9
12	-60	-40

// Grezes J, 2004: Observation of Faked Actions
// Grezes J, 2004: Actions Judged to Reflect Deceptive Intent
// Subjects=11
14	66	24
64	-44	22
54	14	8
50	-32	-6
52	-56	34
-42	-60	30
-8	42	20
52	32	6
50	46	-6
-46	34	-10
-26	-4	-20
26	0	-22
-46	-50	-22
-24	-80	-24
-42	8	-34

// Kozel F A, 2004: Lie - Truth
// Subjects=10
4	-28	34
-40	26	-8
4	20	20
-4	24	20
52	20	4
52	32	0
44	22	0
-60	-60	8
42	44	30
10	-78	20
-48	-8	54

// Lorberbaum J P, 2004: Social Phobics > Normals, Anticipation - Relaxation
// Lorberbaum J P, 2004: Normals > Social Phobics, Anticipation - Relaxation
// Subjects=6
-16.47	-.26	-22.21
-12.26	-1.08	-31.16
-46.68	4.3	-17.66
-24.66	29.38	19.82
-20.2	8.54	26.29
-7.13	26.85	37.7
-24.46	22.12	33.98
-7.3	56.22	30.32
-11.52	43.85	36.09

// Nitschke J B, 2004: Own Infant - Unfamiliar Infant
// Nitschke J B, 2004: Unfamiliar Infant - Own Infant
// Subjects=6
10.05	-86.58	6.05
40.57	-85.56	26.72
7.7	-75.93	-6.17
-42.49	33.99	-21.79
37.51	33.52	-19.75
48.24	34.1	-25.59
62.66	-34.15	-10.12
66.86	-18.6	-16.21
-60.42	-38.32	-2.01

// Bjork J M, 2004: Adolescents
// Subjects=12
42.75	13.48	-.11
12.76	12.61	-8.62
-6.45	9.41	-7.01
9.55	4.85	-12.39
6.53	-29.55	-2.78
-4.14	-8.58	7.85
-4.12	-14.93	8.38
-15.86	-3.82	15.39
35.09	51.07	-8.75
42.71	19.65	-2.86
11.88	2.43	11.2
34.4	-39.44	4.42
-30.76	-47.24	5.82
1.93	49.47	-12.7
-3.39	43.1	-12.1
45.93	32.96	3.79
-38.49	32.45	4.8
31.81	34.96	-24.09
12.74	18.96	-9.15
-6.47	17.96	-6.61
30.03	-6.43	5.05
-21.24	-8.68	8.06
12.74	4.7	-14.64
-13.96	2.42	-14.15
-23.43	-30.16	-7.96
24.69	-30.58	-4.02
21.52	1.6	13.39
-7.32	-1.74	14.01
-2.98	-18.55	16.48
-2.84	-52.3	20.42
9.59	7.39	-7.03
-5.32	7.82	-.2
-26.63	-13.63	-.39
8.68	-28.31	-.68

// Bjork J M, 2004: Young Adults
// Subjects=12
36.3	19.61	-2.78
13.81	20.02	-9.25
-11.83	17.75	-8.77
11.74	9.78	-3.91
-9.5	1.07	9.33
-10.72	9.47	-5.85
23.45	11.62	-8.66
-3.08	-27.32	-.63
9.79	-25.67	5.78
6.56	-8.35	9.94
-7.27	-19.89	13.3
-3.08	-21.78	2.25
2.53	-77.19	14.64
-4.47	57.26	-7.7
29.82	0.23	-18.93
8.56	12.22	0.39
-4.19	-27.76	-6.15
13.63	47.89	-20.51
-.24	43.57	-19.99
30.78	29.84	-21.42
-30.12	30.71	-18.56
8.5	17.07	-5.6
-8.6	16.97	-5.39
12.75	11.38	-10.74
-22.49	7.03	-8.86
-28.8	-11.79	-3.86
23.43	-.7	-16.55
-17.17	-3.06	-15.88
2.25	-3.26	7.33
25.7	-22.38	-8.06
-17.01	-27.75	-4.89
16.43	-56.24	22.76
3.6	-61.86	20.04
26.69	6.44	-7.14
-23.47	0.22	-.47
8.28	48.83	-21.64
-1.35	48.68	-22.63
2.54	-49.64	26.83
56.7	-1.24	0.96

// Cunningham W A, 2004: Good/Bad > Abstract/Concrete
// Cunningham W A, 2004: Abstract/Concrete > Good/Bad
// Cunningham W A, 2004: Good/Bad = Abstract/Concrete, Correlated with Rated 
// Emotional Intensity
// Cunningham W A, 2004: Good/Bad > Abstract/Concrete, Correlated with Rated 
// Emotional Intensity
// Cunningham W A, 2004: Good/Bad, Correlated with Rated Emotional Intensity
// Cunningham W A, 2004: Good/Bad = Abstract/Concrete, Correlated with Rated 
// Valence
// Cunningham W A, 2004: Good/Bad, Correlated with Rated Valence
// Cunningham W A, 2004: Good/Bad > Abstract/Concrete, Correlated with Rated 
// Control
// Cunningham W A, 2004: Good/Bad, Correlated with Rated Control
// Subjects=20
0	28	-8
-8	52	20
12	56	8
16	-8	-20
-4	-56	28
64	-12	-32
64	-16	-24
32	20	-24
-64	-8	-28
-48	16	-44
-52	-24	-20
20	36	44
-56	-60	24
-64	-60	4
48	40	16
44	56	12
52	16	32
-48	52	8
-44	52	20
-52	44	16
56	-56	-24
60	-60	-12
-12	-92	-8
-20	-72	8
32	-56	40
-20	-4	-16
-4	4	-4
12	32	-20
8	48	28
0	-24	-8
56	-72	8
-48	-64	28
-40	-88	32
0	-68	-40
40	-52	32
-32	-8	60
36	-8	52
-24	-44	56
36	24	-36
12	-52	28
-12	-56	-12
24	24	-16
-60	8	0
52	-32	-16
60	4	8
-44	36	8
-16	-60	36
-64	-48	36
36	20	0
52	20	4
4	20	40
-44	28	-12
32	60	8
-32	28	52
48	32	-4
16	32	60
48	16	48
48	4	-44
48	-60	28
40	56	4
-4	24	32
8	52	16
40	16	52
-52	28	-8
-12	-60	28
60	-24	-16
60	-44	-4
-52	-40	-4
36	-60	28
-28	-24	-24
-56	8	44

// Kozel F A, 2004: Lie - True
// Kozel F A, 2004: Electrodermal Activity Changes Correlated to BOLD fMRI 
// Changes during Deception
// Subjects=8
-64	-40	-4
56	12	8
44	44	-8
-36	-48	-32
-48	-24	4
-56	-56	-8
20	56	12
-28	-32	-28
56	8	20
12	52	0
36	32	-16
56	28	-8
56	32	16
12	36	24
-48	-48	40
12	8	12
48	32	36
64	-32	4
8	-4	-4
-4	-24	40
56	-40	-16

// Simon O, 2004: Calculation Only
// Simon O, 2004: Manual Tasks Only
// Simon O, 2004: Visuospatial Tasks Only
// Simon O, 2004: Saccades Only
// Simon O, 2004: Grasping Only
// Simon O, 2004: Calculation and Language
// Simon O, 2004: Attention Only
// Simon O, 2004: Saccades + Pointing + Attention
// Subjects=10
-8	16	36
-32	16	8
-36	48	24
-48	-4	40
-28	-8	68
-38	-56	47
-24	12	4
4	16	40
40	24	8
8	16	44
16	11	8
-4	6	44
-5	-4	60
-36	-44	56
-40	-26	56
-32	-44	64
8	3	56
36	-44	52
-3	7	52
-25	-4	68
-12	-68	52
28	0	68
7	5	60
16	-70	56
-24	-84	24
-8	-88	36
62	9	32
42	-3	56
28	-80	24
28	-64	48
8	-84	36
23	12	4
-44	12	12
-38	-14	56
-56	2	8
-6	-7	72
-20	-10	80
-28	-44	68
-46	-40	40
-60	-32	36
-48	-40	60
8	4	44
62	14	36
8	-4	56
14	1	72
34	-48	60
64	-32	24
-48	20	0
-58	6	20
-42	26	20
-50	18	28
-46	9	44
-2	-26	44
-28	-72	44
50	21	4
6	29	48
-32	43	36
-5	-62	52
52	37	4
45	8	52
30	38	36
54	20	36
44	-40	56
8	-62	52
60	-44	36
-20	-82	44
-16	-80	48
32	-72	36
8	-66	60
21	-78	48

// Knutson B, 2004: Gain vs. Nongain Anticipation, Placebo
// Knutson B, 2004: Gain vs. Nongain Anticipation, Amphetamine
// Knutson B, 2004: Loss vs. Nonloss Anticipation, Placebo
// Knutson B, 2004: Loss vs. Nonloss Anticipation (Deactivations), Amphetamine
// Knutson B, 2004: Loss vs. Nonloss Anticipation (Activations), Amphetamine
// Knutson B, 2004: Gain Hit vs. Miss Outcome, Placebo
// Knutson B, 2004: Gain Hit vs. Miss Outcome, Amphetamine
// Knutson B, 2004: Loss Hit vs. Miss Outcome, Placebo
// Subjects=8
-28.05	59.7	-15.44
33.07	21.54	-5.14
-14.99	12.7	-4.96
17.03	21.36	-6.05
-7.48	13.09	-.62
12.82	13.21	-.86
-14.88	9.5	8.69
21.34	8.52	-7.26
-45.96	32.58	7.11
-11.78	11.67	-4.91
-7.4	1.89	5.9
12.89	5.1	4.28
-22.42	7.71	0
29.88	7.43	-8.38
-7.69	47.13	-14.62
-2.75	-55.76	30.75
2.57	-55.98	27.36
0.81	65.41	-12.91
9.35	60.98	-15.98
1.5	-59.25	26.53
-30.95	21.04	7.91
-11.78	11.67	-4.91
-7.4	1.89	5.9
13.02	-2.34	18.28
-7.53	9.32	-8.11
9.56	18.14	-5.7
9.63	17.77	3.25
-10.73	0.5	-11.79
5.42	1.88	4.63
0.83	51.32	-16.19
-7.55	8	-11.34
-53.32	28.28	20.94
33.27	-16.99	5.9
-62.91	-14.39	6.78
62.07	-2.01	4.31

// Aron A R, 2004: Stimulus - Positive Feedback
// Aron A R, 2004: Negative Feedback - Positive Feedback
// Subjects=20
-6	9	51
-18	-39	-3
-36	-18	54
18	-57	-27
-6	-21	-9
39	-15	63
-15	-63	21
51	-15	48
-15	12	-6
3	-27	-21
-45	-6	45
0	30	48
51	27	15
-36	24	-9

// Leslie K R, 2004: Face Imitation
// Leslie K R, 2004: Face Viewing
// Subjects=15
55.68	15.04	45.64
53.19	14.77	19.94
58.46	19.28	10.44
64.99	17.48	13.87
-58.92	4.23	39.7
-62.47	10.65	16.71
-50.79	4.78	-.83
11.54	13.9	58.84
-7.84	7.76	63.13
58.83	-2.05	34.96
-43.81	-2.41	36.74
61.9	-26.24	17.13
68.46	-35.48	21.29
-59.08	-13.38	23.52
-59	-22.64	27.79
53.12	-63.44	-1.45
53.16	-63.13	1.88
-47.33	-70.18	0.92
33.77	-92.33	0.61
-21.33	-99.12	-0.02
46.35	-54.7	-22.37
-18.5	-67.15	-25.64
-41.08	-72.99	-17.96
55.68	15.04	45.64
53.19	14.77	19.94
58.46	19.28	10.44
64.99	17.48	13.87
-58.92	4.23	39.7
11.54	13.9	58.84
61.9	-26.24	17.13
68.46	-35.48	21.29
-59	-22.64	27.79
53.12	-63.44	-1.45
53.16	-63.13	1.88
-47.33	-70.18	0.92
33.77	-92.33	0.61
-21.33	-99.12	-0.02
46.35	-54.7	-22.37
-41.08	-72.99	-17.96

// Pelchat M L, 2004: Normal Diet Subjects
// Subjects=10
-37.32	-35.7	-9.57
-37.43	2.71	-8.33
18.38	-7.59	18.66

// Pelchat M L, 2004: Monotonous Diet Subjects
// Subjects=10
-37.34	-40.27	-13.64
-20.27	-31.71	-14.56
30.92	-6.02	-17.3
-3.09	8.86	13.07
26.68	11.9	-5.37
9.93	-41.82	17.17
-15.66	6.95	44.6
-37.32	-35.7	-9.57
-37.43	2.71	-8.33
18.38	-7.59	18.66

// Hesselmann V, 2004: Subject AM
// Subjects=1
-42.31	-18.85	43.72
58.21	-14.21	53.33
-42.32	-14.62	43.37
57.1	-13.59	47.72
-49.92	-11.46	29.81
64.4	-5.49	27.99
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Hesselmann V, 2004: Subject BS
// Subjects=1
-43.4	-25.71	37.62
51.63	-11.65	32
-42.32	-14.62	43.37
57.1	-13.59	47.72
-49.96	-6.34	27.15
64.33	-4.06	18.95
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Hesselmann V, 2004: Subject JK
// Subjects=1
-59.42	-12.52	44.5
54.87	-12.35	36.48
-42.32	-14.62	43.37
57.1	-13.59	47.72
-61.72	-8.7	25.25
63.27	-3.89	21.18
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Hesselmann V, 2004: Subject JS
// Subjects=1
-40.18	-15.57	44.54
60.31	-14.63	47.77
-42.32	-14.62	43.37
57.1	-13.59	47.72
-51	-5.03	30.4
62.29	-10.7	29.57
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Hesselmann V, 2004: Subject TK
// Subjects=1
-50.86	-4.64	49.32
54.96	-14.75	46.72
-42.32	-14.62	43.37
57.1	-13.59	47.72
-53.13	-4.96	31.53
68.68	-8.72	27.1
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Hesselmann V, 2004: Subject TV
// Subjects=1
-40.19	-19	41.48
56.03	-14.66	47.82
-42.32	-14.62	43.37
57.1	-13.59	47.72
-55.23	-10.09	34.21
62.3	-5.16	32.45
-56.38	-7.61	25.1
62.26	-7.7	27.09

// Martin R E, 2004: Voluntary Saliva Swallow
// Martin R E, 2004: Voluntary Tongue Elevation
// Martin R E, 2004: Voluntary Finger Opposition
// Martin R E, 2004: Voluntary Saliva Swallow + Voluntary Tongue Elevation
// Martin R E, 2004: Voluntary Saliva Swallow + Voluntary Finger Opposition
// Martin R E, 2004: Voluntary Tongue Elevation + Voluntary Finger Opposition
// Subjects=14
-59.61	-14.49	19.02
-61.62	-23.07	32.03
-.76	14.1	39.37
2.55	3.17	49.17
2.61	-2.83	54.13
3.93	-67.15	61.74
1.68	-84.91	38.72
40.76	-3.65	12.5
47.53	-7.68	56.25
-58.58	-.56	20.07
-55.26	-10.35	30.89
54.59	41.87	21.9
-52.27	41.23	23.19
62.25	-46.25	10.25
-59.72	-5.74	8.25
-47.87	-4.64	21.41
51.63	-1.71	36.74
51.74	-14.85	45.65
62.4	-17.25	41.27
5.72	3.38	44.65
3.68	2.72	57
23.52	7.9	-1.66
-15.99	3.61	1.39
10.8	-16.32	2.75
-8.4	-9.58	9.1
-3.54	-62.71	64.8
58.07	-28.87	28.91
-55.26	-30.15	22.51
65.29	2.49	7.24
-57.6	-2.64	6.85
52.44	1.1	4.16
-55.52	7.77	3.72
51.46	38.22	30.05
34.72	0.16	62.43
-38.3	36.62	31.22
14.41	-2.25	60.64
-25.16	-6.17	54.73
58.04	-47.88	17.12
1.56	-4.87	55.43
3.62	-2.28	47.38
24.68	3.39	8.75
-22.34	3.11	9.31
-41.12	-37.36	51.95
54.91	-43.78	29.08
-23.02	-11.61	52.93
-46.46	-20.84	59.55
11.34	-60.22	54.38
12.34	-72.96	40.94
64.36	-39.98	8.58
37.47	11.93	7.88
-35.19	11.5	8.75
-61.75	-16.7	18.12
-58.53	-6.65	23.93
-62.66	-27.14	34.61
-.58	-.48	57.32
3.54	10.02	41.33
65.41	-14.88	16.5
6.08	-60.45	65.61
1.52	-73.34	23.25
0.46	-.73	53.98
0.42	-1.16	48.44
2.61	-3.89	54.22
2.57	-2.12	49.61
64.36	-39.98	8.58

// Schoenfeld M A, 2004: Sweet vs. All Others
// Schoenfeld M A, 2004: Umami vs. All Others
// Schoenfeld M A, 2004: Salt vs. All Others
// Schoenfeld M A, 2004: Sour vs. All Others
// Schoenfeld M A, 2004: Bitter vs. All Others
// Subjects=6
54	8	4
34	10	-24
42	14	-16
40	18	6
48	8	-12
32	14	-16
38	14	-16
48	16	-10

// Takada T, 2004: Gum Chewing - Sham Chewing AND Gum Chewing - Rest
// Subjects=12
55.22	48.81	16.54
-46.54	64.43	5.52
-55.52	48.73	-24.15
47.38	-63.38	56.91
-41.34	-66.86	47.56
21.51	-78.37	58.83

// Kikyo H, 2004: Brain Regions Parametrically Modulated by the "Feeling of 
// Knowing"
// Kikyo H, 2004: Brain Regions Associated with Successful Name Recall from 
// Face Images
// Subjects=15
-6	15	48
0	45	30
-6	36	33
-33	18	-12
-54	24	30
-3	6	63
-39	6	57
-42	27	18
6	24	63
0	30	39
-33	30	0
-42	18	0
-48	9	42
-54	24	-3
-48	30	9
-45	18	-12
-42	21	39
-39	30	-9
-36	9	39
-15	15	69
-12	45	21
0	18	24
-27	6	66
39	24	-9
33	21	-18
33	60	21
48	42	27
45	42	18
-57	-42	18
-60	-24	0
60	-30	-6
42	12	-39
-30	-57	51
6	-12	33
-3	-9	33
-9	9	9
9	6	12
-3	-12	12
15	0	-6
-12	0	-6
0	45	30
0	30	39
0	18	24
-51	24	3
-6	27	51
-42	30	18
-48	36	21
-51	15	27
-3	15	57
-6	33	39
-45	36	-6
-54	27	24
-51	12	39
39	24	-12
-6	12	66
51	45	15
-42	24	-18
0	42	30
12	30	33
-39	6	45
-36	9	54
48	42	27
-27	18	-9
-57	-45	9
-54	-57	-15
-51	-54	-6
-51	-36	-9
-33	-57	51
-45	-42	39
0	-51	12
-3	-57	6
-3	-6	30
12	-6	6
-18	12	-3
-12	6	9
-3	-12	6
0	42	30
0	-51	12

// Haslinger B, 2004: Pianists
// Subjects=12
36.34	3.79	52.69
12.12	22.17	21.03
24.8	-58.72	-18.25
-24.98	-63.88	-24.73
60.38	-33.92	-19.07
7.83	-94.66	0.16
-.89	-88.72	-4.76
31.17	21.46	-10.6
10.66	-4.32	70.74
1.87	21.93	64.93
24.81	-62.97	-17.83
-24.99	-58.46	-24.15
9.78	-53.58	-8.42
-53.6	11.28	34.43
-53.58	7.03	34.85
53.06	37.86	14.3
-60.7	20.83	-12.34
33.31	25.72	-11.06
-54	-65.07	-12.92
60.38	-33.92	-19.07
5.94	-97.05	20.6
-.74	-95.23	5.97
-8.97	-93.31	38.42
27.13	10.45	9.61

// Haslinger B, 2004: Musically Naive Subjects
// Subjects=12
20.43	-61.28	-22.4
-50.36	15.65	35.06
-50.32	9.37	36.8
43.95	62.78	-17.15
55.18	39.78	11.83
49.57	-36.92	64.34
-49.99	-27.57	55.02
35.42	20.96	-16.23
7.65	-55.51	-5.95
-.76	-99.8	3.06
-54.04	-67.51	-16.04
29.34	13	13.8
36.34	3.79	52.69
12.12	22.17	21.03
24.8	-58.72	-18.25
-24.98	-63.88	-24.73
60.38	-33.92	-19.07
7.83	-94.66	0.16
-.89	-88.72	-4.76
31.17	21.46	-10.6
10.66	-4.32	70.74
1.87	21.93	64.93
24.81	-62.97	-17.83
-24.99	-58.46	-24.15
9.78	-53.58	-8.42
-53.6	11.28	34.43
-53.58	7.03	34.85
53.06	37.86	14.3
-60.7	20.83	-12.34
33.31	25.72	-11.06
-54	-65.07	-12.92
60.38	-33.92	-19.07
5.94	-97.05	20.6
-.74	-95.23	5.97
-8.97	-93.31	38.42
27.13	10.45	9.61

// Fahim C, 2004: (J - D), (Aversive - Neutral), Encoding
// Fahim C, 2004: (D - J), (Aversive - Neutral), Encoding
// Fahim C, 2004: (J - D), (Aversive - Neutral), Recognition
// Fahim C, 2004: (D - J), (Aversive - Neutral), Recognition
// Subjects=1
45	-50	-18
-42	55	-15
6	22	38
42	37	29
45	-54	-20

// Ernst M, 2004: Monetary Selection > Color Selection
// Ernst M, 2004: Monetary Anticipation > Color Anticipation
// Ernst M, 2004: Selection: High Risk/Reward > Low Risk/Reward
// Subjects=17
-24	4	50
-8	16	52
-38	2	34
-6	24	42
-8	28	36
0	22	42
-10	32	32
4	24	40
4	20	42
28	2	46
-48	24	32
-32	-54	44
44	-38	42
26	-60	42
34	-56	-10
-24	-96	-14
-34	-88	12
24	-94	-8
36	-82	12
0	20	50
-2	6	66
10	40	14
-32	-24	68
-24	-32	72
-20	-18	72
-24	-66	56
-42	-44	38
-50	-40	52
40	16	-30
-34	20	-4
-26	12	-20
8	6	-10
-10	6	-14
-4	-14	-20
28	14	58
4	20	-6
8	18	-8
12	32	-4
20	40	-2
18	52	4
-42	0	26
-46	40	2
-38	-70	42
52	-38	38
52	-48	52
58	-46	-16
-34	-74	26
-32	-88	6
-32	-82	-6
-40	-86	-10
-16	-84	-30
-42	-64	-34
8	6	-8
-12	0	-8

// de Araujo I E T, 2004: Correlation of the BOLD signal with Viscosity 
// (Activations)
// de Araujo I E T, 2004: (CMC at 1000 cP - Tasteless Solution) and (Sucrose - 
// Tasteless Solution) (Activations)
// de Araujo I E T, 2004: Vegetable Oil - Tasteless Solution (Activations)
// de Araujo I E T, 2004: (CMC at 50 cP - Tasteless Solution) and (Vegetable 
// Oil - Tasteless Solution) (Activations)
// de Araujo I E T, 2004: (Vegetable Oil - Tasteless Solution) and (Sucrose - 
// Tasteless Solution) (Activations)
// de Araujo I E T, 2004: Correlation of the BOLD signal with stimulus fat 
// content independent of viscosity (Activations)
// Subjects=12
-48	-12	6
-36	14	8
48	-8	12
36	10	10
-36	12	6
-36	0	-1
-36	18	4
-38	2	-6
-28	14	-6
28	30	-10
12	0	-4
4	-8	50
-6	40	10
-10	48	-2
-6	44	-2
-8	16	-2

// Haruno M, 2004: Activations correlated with Learning Rate
// Haruno M, 2004: Activations correlated with Learning Convergence Index
// Haruno M, 2004: Activations correlated with Short-term Reward
// Haruno M, 2004: Activations correlated with Accumulated Reward
// Subjects=8
23	-70	36
19	20	27
-30	43	7
31	49	13
-40	43	-6
30	43	-6
0	-3	0
12	3	10
-14	-9	2
12	-3	5
34	-73	-25
41	-32	-2
-25	-94	8
26	-85	-5
-11	-73	38
10	-73	38
-32	3	53
28	0	53
-6	-9	47
-30	-59	-35
-38	-79	30
34	-76	35
-16	-3	-18
-27	-64	2
26	-59	2
-22	-64	52
26	-64	47
-35	5	48
23	0	55
-3	-3	47
-37	-32	12
23	46	13
23	43	-1
52	-53	8
-19	-76	22
15	-70	23

// Ramnani N, 2004: Reward vs. Nonreward Outcome when Reward was Predicted
// Ramnani N, 2004: Reward vs. Nonreward Outcome when Nonreward was Predicted
// Subjects=6
-10	64	6
-68	-46	-2
-54	-4	-38
52	10	-40
16	62	-10
12	58	16
8	34	-24
44	20	22
18	-30	-14
-48	-56	-42

// Sharot T, 2004: Neutral, Remember > Emotional, Remember
// Sharot T, 2004: Emotional, Remember > Neutral, Remember
// Sharot T, 2004: Neutral, Know > Emotional, Know
// Sharot T, 2004: Emotional, Know > Neutral, Know
// Sharot T, 2004: Neutral, Remember > Neutral, Know
// Sharot T, 2004: Emotional, Remember > Emotional, Know
// Sharot T, 2004: Emotional, Know > Emotional, Remember
// Subjects=13
-13.51	-63.2	18.12
12.13	-5.92	40.9
50.69	-50.95	33.08
-46.81	-68.45	-5.6
54.72	-67.67	-4.6
14.03	-75.46	-19.09
5.62	44.6	47.89
60.22	-45.24	23.57
-7.08	-56.3	24.15
0.87	60.55	-6.93
14.03	-68.77	-15.19
51.62	-27.05	25.49
-39.37	-8.36	13.81
63.38	-15.98	30
-8.34	50.43	41.98
49.14	-27.32	-19.07
25.03	13.59	58.07
50.71	-55.1	34.54

// Weis S, 2004: Hit, Correct Source Judgment vs. Hit, Wrong Source Judgment
// Weis S, 2004: Hit, Wrong Source Judgment vs. Misses
// Subjects=12
-16	-5	-17
24	-1	-17
28	-17	-19

// Wheeler M E, 2004: Know > Remember
// Subjects=20
32.09	59.8	21.77

// Bartels A, 2004: Activations With Maternal Love
// Bartels A, 2004: Deactivations With Maternal Love
// Subjects=20
-42	8	-4
-10	26	30
-8	44	-6
-22	2	16
-30	2	-4
-28	-14	2
-18	-18	0
-52	36	12
-28	46	-14
-40	4	30
-38	-58	-24
-30	-90	2
-16	-88	34
46	12	-6
10	34	18
10	44	-6
14	-2	18
22	4	0
20	-18	-10
28	-20	-2
2	-32	-24
14	-22	-14
54	38	-2
26	54	-14
54	2	36
28	-48	-22
18	-98	-6
30	-74	30
-4	44	46
-30	40	42
-40	-52	26
-58	-40	10
-50	-26	-6
-50	-22	18
-62	-18	2
-38	-24	-26
-40	16	-42
-6	-46	6
-22	-60	16
-28	-14	-20
30	28	50
34	44	42
26	64	12
46	-74	36
46	-46	30
42	-54	6
66	-32	-16
44	-20	16
60	-6	8
56	-24	-22
42	14	-46
10	-44	8
22	-60	26
0	-74	46
22	-6	-34

// Fitzgerald D A, 2004: Disgust > Neutral
// Subjects=12
-12	-80	-10
-36	-20	-18
34	-34	0
-12	-30	12
-18	-18	8
-6	-6	4
16	-16	-2
-34	6	6
-42	-4	-6
40	-12	0
-6	-48	28
20	22	14
-8	18	10
16	36	24
34	-4	-2

// Nitschke M F, 2004: Triple-Step Saccades vs. Fixation
// Nitschke M F, 2004: Visually-Guided Saccades vs. Fixation
// Nitschke M F, 2004: Triple-Step Saccades vs. Visually-Guided Saccades
// Nitschke M F, 2004: Triple-Step Saccades vs. Visuospatial Working Memory
// Nitschke M F, 2004: Visuospatial Working Memory vs. Triple-Step Saccades
// Subjects=6
-27.14	-80.25	-27.56
-5.87	-49.93	-48.85
-5.54	-78.05	-28.15
-12.2	-83.78	-43.15
44.12	-75.96	-31.44
28.88	-37.51	-32.74
-27.18	-76.21	-30.2
-25.25	-82.32	-49.8
-3.45	-65.49	-31.66
9.44	-76.91	-39.72
26.87	-62.63	-25.74
-20.64	-75.77	-25.87
37.73	-90.66	-27.63
-38.21	-84.5	-49.36

// Kawabata H, 2004: Portraits vs. Non Portraits
// Kawabata H, 2004: Landscapes vs. Non Landscapes
// Kawabata H, 2004: Still Life vs. Non Still Life
// Kawabata H, 2004: Beautiful vs. Ugly
// Kawabata H, 2004: Beautiful vs. Neutral
// Kawabata H, 2004: Ugly vs. Beautiful
// Subjects=10
44	-48	-24
-34	-6	-36
38	-6	-36
30	-46	-4
18	-72	50
-26	-96	6
-2	36	-22
-2	50	-20
-4	48	14
-54	-68	26
-44	-26	60
28	-10	56

// Dolcos F, 2004: Positive > Negative + Neutral Pictures
// Dolcos F, 2004: Negative > Positive + Neutral Pictures
// Dolcos F, 2004: Positive + Negative > Neutral Pictures
// Dolcos F, 2004: (Remembered - Forgotten Pictures) x (Positive + Negative > 
// Neutral Pictures)
// Dolcos F, 2004: (Remembered - Forgotten Pictures) x (Positive > Negative + 
// Neutral Pictures)
// Subjects=16
-42.68	28.62	47.1
0.66	62.11	-21.95
0.86	63.56	-6.41
53.81	36.53	-11.36
54.27	13.71	20.03
-39.72	13.38	21.66
-3.23	58.72	10.95
33.14	18.95	-26.08
-52.03	32.01	-7.99
-39.59	6.66	30.17
-10.6	44.84	23.65
-51.95	24.98	-2.81

// Lennox B R, 2004: Normals
// Subjects=12
12.1	53.74	25.75
-1.4	21.27	-22.35
-3.06	-34.1	5.56
-11.7	-42.84	4.33
-9.56	16.05	14.16
-11.56	-26.5	18.4
-39.13	-20.52	60.86
33.77	-74.8	4.48
-30.53	-3.27	61.25
-58.85	-40.1	36.24
-38.08	1.79	-22.04
29.52	11.05	27.43
42.9	-82.08	40.9
-1.4	21.27	-22.35
-2.98	-33.47	12.22
-37.57	-20.62	13.78
-46.18	-66.36	7.25
-17.77	-83.54	28.64
-14.03	23.71	4.51

// Lennox B R, 2004: Bipolar Patients
// Subjects=10
-58.85	-40.1	36.24
-38.08	1.79	-22.04
29.52	11.05	27.43
42.9	-82.08	40.9
-1.4	21.27	-22.35
-2.98	-33.47	12.22
-37.57	-20.62	13.78
-46.18	-66.36	7.25
-17.77	-83.54	28.64
-14.03	23.71	4.51

// Elliott R, 2004: All Go/NoGo vs. Rest; Normals > Manic Patients
// Elliott R, 2004: All Go/NoGo vs. Rest; Manic Patients > Normals
// Elliott R, 2004: Semantic vs. Orthographic Conditions; Normals > Manic 
// Patients
// Elliott R, 2004: Semantic vs. Orthographic Targets; Manic Patients > 
// Normals
// Elliott R, 2004: Emotional Targets vs. Neutral Targets; Normals > Manic 
// Patients
// Elliott R, 2004: Emotional Targets vs. Neutral Targets; Manic Patients > 
// Normals
// Elliott R, 2004: Sad Distractors vs. Neutral Distractors; Manic Patients > 
// Normals
// Elliott R, 2004: Happy Distracters vs. Neutral Distracters; Manic Patients 
// > Normals
// Subjects=8
-45	6	36
-60	-12	6
63	-6	3
-54	-12	-21
45	-18	-30
33	-93	-6
-54	33	-6
51	30	-12
12	-66	54
51	48	6
24	60	3
12	-90	36
30	42	18
45	-81	-9
-42	42	-12
-60	6	-27
60	12	39
-24	51	42
30	42	33
60	12	0
33	36	36
-36	24	36
-3	30	-6
0	42	-9

// Kobayashi M, 2004: Gustatory Perception, Fruit Juice vs. No Gustatory 
// Perception
// Kobayashi M, 2004: Gustatory Perception, Distilled Water vs. No Gustatory 
// Perception
// Kobayashi M, 2004: Gustatory Imagery, Words, Recall Taste vs. Gustatory 
// Imagery, Words, Read Word
// Kobayashi M, 2004: Gustatory Imagery, Words, Recall Taste vs. Visual 
// Imagery, Words, Recall Image
// Kobayashi M, 2004: Gustatory Imagery, Voice, Recall Taste vs. Passive 
// Listening
// Kobayashi M, 2004: Gustatory Imagery, Voice, Recall Taste - Visual Imagery, 
// Voice, Recall Image
// Kobayashi M, 2004: Gustatory Imagery, Picture, Recall Taste vs. Gustatory 
// Imagery, Picture, Passive Viewing
// Kobayashi M, 2004: All Gustatory Imagery (Word + Voice + Picture) vs. No 
// Recall
// Kobayashi M, 2004: Gustatory Imagery (Words + Voice) vs. Visual Imagery 
// (Words + Voice)
// Kobayashi M, 2004: Gustatory Perception + Gustatory Imagery (Words + Voice 
// + Picture) vs. Control
// Kobayashi M, 2004: Gustatory Perception + Gustatory Imagery (Words + Voice) 
// vs. Visual Imagery (Words + Voice)
// Subjects=25
6	10	56
54	24	28
32	20	-6
56	10	8
-64	-18	26
36	20	0
-56	-38	26
-14	-58	-40
6	-30	2
14	12	-6
4	12	54
40	56	12
32	22	-6
56	10	8
-62	-16	24
46	12	-2
-54	-52	44
34	-64	-42
-40	2	6
-36	36	-12
64	0	30
-62	-14	32
-44	30	24
-8	14	66
-40	0	-6
54	-6	36
-60	2	20
-34	22	2
-25	36	-14
52	-6	36
-52	10	10
-52	4	46
4	6	66
-8	6	66
-64	-10	30
-38	-4	16
-26	40	-16
64	-2	32
-54	2	38
-46	36	18
-6	-2	68
-30	0	12
-40	36	-14
50	-6	32
-50	-4	34
-42	32	18
-4	4	66
-40	8	6
62	-4	28
-60	2	28
-36	24	2
-32	40	-16
66	6	10
-58	4	34
-52	20	40
46	6	0
-40	-2	4
64	-6	24
-60	0	26

// Mathews A, 2004: Fear > Neutral, View
// Mathews A, 2004: Fear > Neutral, View; Positively Correlated with BIS 
// Scores
// Mathews A, 2004: Fear > Neutral, Non-Emotional
// Mathews A, 2004: Fear > Neutral, Non-Emotional; Positively Correlated with 
// BIS Scores
// Mathews A, 2004: Fear > Neutral, Emotional
// Mathews A, 2004: Fear > Neutral, Emotional; Positively Correlated with BIS 
// Scores
// Subjects=22
16	-88	-8
-10	-98	-10
12	-96	-12
34	-88	-12
-44	-70	-70
20	-2	-24
-22	-10	-18
-42	-22	52
-46	-22	44
-20	-30	-12
-28	-26	-18
40	-16	-24
-6	-36	14
2	-26	14
-22	-34	6
8	-28	-12
-34	-2	14
-10	-34	-28
-12	50	2
-2	64	8
-2	-22	34
-12	46	24
40	-16	-12
16	-34	-8
14	2	-16
14	-6	-26
4	-34	12
-4	-36	-26
-16	52	-4
-16	-92	-6
-24	-90	-8
-38	-68	-16
-24	-8	-26
46	-6	-24
-24	-82	-14
-20	-96	-8
-30	-80	-8
-46	-72	-16
-20	-14	-12
18	8	-24
-22	-22	-12
-38	-12	-16
4	-32	-2
-34	4	6
-6	44	6
-4	56	0
-2	-18	40
-8	54	32
40	-16	-22
-2	-40	-24
-8	46	2
2	40	2
-16	52	4

// Driessen M, 2004: BPD Only Patients
// Subjects=6
39.6	42.89	-22.95
49.37	24.64	-23.55
46.54	25.51	8.91
-34.94	55.81	-18.48
-47.56	47.41	7.22
45.91	18.61	-41.95
-51.23	12.4	-34.08
-15.06	-93	-15.3
7.74	-89.86	-5.91
23.93	-83.42	-6.82
30.4	-80.21	-7.25
43.28	-78.55	-13.24
-28.38	-42.07	-32.44
-34.94	55.81	-18.48
49.82	19.24	10.59
36.31	52.35	-24.95
39.76	38.61	-11.32
36.72	37.93	4.48
36.62	44.85	-1.8

// Driessen M, 2004: BPD with PTSD Patients
// Subjects=6
39.6	42.89	-22.95
49.37	24.64	-23.55
46.54	25.51	8.91
-34.94	55.81	-18.48
-47.56	47.41	7.22
45.91	18.61	-41.95
-51.23	12.4	-34.08
-15.06	-93	-15.3
7.74	-89.86	-5.91
23.93	-83.42	-6.82
30.4	-80.21	-7.25
43.28	-78.55	-13.24
-28.38	-42.07	-32.44
36.21	12.19	-41.15
42.85	-15.02	-34.08
-44.83	15.1	-40.05
-35.01	0.55	-35.42
-59.72	-5.09	-25.48
1.52	-61.65	20.54
4.78	-47.3	24.67
52.56	36.35	-24.77
40.76	1.24	59.59
-1.34	-14.01	59.58
50.51	-11.7	58.46
-18.21	-90.16	-7.68
33.65	-83.38	-6.99
43.3	-75.15	-11.33
8.01	-99.89	13.01
-31.6	-43.04	-31.16

// Leibenluft E, 2004: Own Child vs. Familiar Children
// Leibenluft E, 2004: Familiar Children vs. Unfamiliar Children
// Leibenluft E, 2004: Unfamiliar Children vs. Unfamiliar Adults
// Leibenluft E, 2004: (Own Child vs. Familiar Children) + (Familiar Children 
// vs. Unfamiliar Children)
// Subjects=7
9.57	61.09	13
-4.22	51.03	21.81
-7.18	13.97	38.34
-33.97	2.13	25.14
15.39	23.14	58.5
-20.93	20.89	60.22
49.27	28.89	19.71
-41.26	9.51	52.48
-29.55	22.27	51.28
49.27	28.89	19.71
-37.11	26.91	43.17
-42.8	31.03	0.51
-4.61	59.07	-25.7
-56.16	-67.97	29.04
65.29	-2.96	5.47
56.58	-12.39	-19.29
-60.79	-27.75	-1.04
62.07	-45.94	-13.2
2.54	-50.78	25.81
10.06	-68.97	23.9
-49.74	-46.98	38.36
31.43	-68.84	23.65
50.2	-23.09	-19.44
-44.7	-79.7	-13.6
25.55	-7.46	-21.58
-42.92	29.74	-16.11
19.32	13.05	10.23
30.12	-29.7	7
-16.97	-17.46	4.28
-13.74	-5.12	12.13
-7.37	-10.97	4.74
24.6	-5.12	-5.04
-15	-.58	-11.65
15	6	1.95
37.4	-61.37	-31.69
-36.37	-62.15	-35.24
-2.28	53.39	-2.94
4.11	46.66	-8.03
6.64	27.63	34.8
18.36	30.62	31.07
36.32	53.85	13.3
-41.74	49.61	6.75
-29.91	52.65	17.51
46.15	30.87	31.85
36.24	33.27	-5.04
57.77	25.17	12.12
-52.37	18.28	1.69
-21.61	52.25	-16.01
-48.66	-63.27	34.14
66.33	-41.68	-13.6
-10.33	-53.57	18.39
66.4	34.88	26.82
-42.42	-27.7	25.51
34.73	-49.22	43.15
-39.98	-54.18	54.47
66.63	-26.45	31.96
-42.43	-26.65	25.42
46.44	-91.3	20.9
-22.18	-80.99	-4.83
42.86	-62.25	-16.07
-21.53	-6.22	-28.95
40.64	14.86	4.26
-40.62	18.27	0.44
27.96	-28.82	4.72
-12.68	-6.35	9.99
23.75	-.7	24.71
28.89	-56.59	-24.19
19.19	-58.56	-35.06
2.06	-56.89	-39.47
-34.15	-55.83	-22.41
-17.08	-51.58	-24.08
-8.53	-71.33	-32.56
-6.66	72.06	-8.92
54.41	39.98	-2.47
-20.57	50.94	-19.26
-16.19	0.41	-26.22
48.55	-56.42	31.33
-52.23	-38.53	-3.58
-17.75	-57.33	25.48
65.58	-31.83	31.3
33.65	-84.43	28.28
25.22	-54.77	54.88
-29.45	-79.87	24.16
-40.5	-65.04	-17.11
-44.95	-5.42	-16.48
23.62	-18.53	0.56
9.57	63.29	13.93
-4.24	53.06	20.53
-48.66	-63.27	34.14
2.54	-50.78	25.81
-38.57	19.54	-10.84
27.14	-67.98	21.4
30.1	-29.87	4.78

// Mainero C, 2004: Multiple Sclerosis Patients
// Subjects=22
37.52	24.91	-20.02
46.74	34.72	27.04
55.23	44.56	16.96
37.97	49.06	20.17
56.34	20.64	13.7
56.66	14.32	37.86
-46.29	33.46	18.66
46.78	7.61	24.12
36.33	18.99	54.55
34.05	8.27	43.32
3.92	21.11	56.01
10.14	23.52	35.5
-5.08	24.97	28.89
42.85	-42	44.78
47.04	-31.97	37
49.48	-39.77	56.78
-43.53	-38.59	51.52
-41.51	-34.2	40.97
-28.38	-47.15	50.99
-51.02	-41.84	-28.71
-57.77	-34.68	36.81
14.99	-64.46	58.69
60.55	-25.03	-4.26
64.83	-17.67	-6.18
50.8	-29.63	-7
-62.62	-23.33	-2.33
-62.75	-34.15	-14.71
-48.5	-29.25	2.5
37.71	21.9	-6.27
-35.59	-20.9	-.79
-46.44	-16.89	-3.24
-13.91	10.41	11.43
-14.03	-4.77	-1.63
-2.94	-47.4	12.48
5.7	-53.96	10.74
1.2	-66.27	-5.89
7.54	-24.67	-9
7.38	-32.4	-22.8
9.59	-25.49	-17.92
-46.47	19.03	2.17
-54.18	27.75	-7.53
-44.44	25.66	-7.49
55.23	44.56	16.96
44.83	-32.4	32.59
58.38	43.84	9.13
-46.41	45.7	11.85
-41.83	-28.94	16.92
3.76	34.1	45.76
1.78	23.44	58.06
9.08	30.2	38.21
-43.73	-34.63	36.56
-48.15	-29.95	29.45
60.43	-13.85	-10.97
60.51	-15.45	-5.21
56.24	-20.58	-2.39
52.95	-38.44	-9.53
48.69	-31.45	-3.42
48.8	-30.62	5.46
31.07	18.5	-19.27
58.14	21.24	-14.4
46.54	6.91	5.14
58.86	12.4	40.25
50.91	27	13.17
-35.78	28.02	-5.63
-46.28	23.68	17.39
-44.14	31.24	17.73
-55.97	32.67	22.27
36.29	13.26	50.63
-50.22	7.97	44.79
6.07	24.31	55.66
-2.82	32.29	38.21
44.95	-35.82	41.89
-33.12	52.6	38.96
60.53	-20.77	-4.68
66.99	-15.43	-5.32
69.18	-22.87	-4.62
-62.58	-27.38	0.31
-60.48	-18.01	-2.89
37.7	22.96	-6.38
21.71	3.74	7
18.36	10.55	-.34
-16.1	3.6	7.66
-14.05	13.73	1.02
-22.73	1.37	-4.33
66.99	-15.43	-5.32
56.08	-14.07	-13.11
62.78	-27.79	0.46
-20.59	18.71	-2.72
-31.3	-14.51	-1.5
-43.23	-2.85	-2.45
31.21	19.54	-8.17
26.7	21.47	-21.73
-22.81	19.35	-7.23
-40.12	24.61	-7.46
-24.97	14.99	-7.88
-44.18	-20.52	3.8
-39.88	32.96	13
-39.75	-26.26	11.02
61.01	7.95	38.41
51.16	2.62	27.9
44.83	8.1	40.91
-66.95	-25.58	-3.16
-60.34	-35.57	4.44
-54.13	-21.15	-13.9

// Mainero C, 2004: Normals
// Subjects=22
44.33	48.15	10.06
55.46	18.9	29.58
-44.24	39.22	11.34
-35.86	23.04	-12.98
48.96	9.96	26.09
-50.36	11.29	34.37
-41.64	7.48	39.09
-52.78	8.25	13.43
-32.81	16.62	55.96
-24.2	8.69	51
10.19	29.35	40.52
-6.82	17.13	59.95
55.83	-28.67	48.85
42.77	-38.16	39.92
47.19	-37.42	47.62
-50.15	-34.23	41.12
-34.96	-38.02	45.71
-44.57	-40.96	-31.15
71.49	-32.67	5.27
53.09	-30.81	3.16
52.98	-25.05	-4.13
64.8	-13.52	-7.71
-39.9	-31.76	-1.88
-66.71	-31.47	14.23
-55.78	-41.44	21.76
37.72	19.77	-6.06
46.32	17.36	-9.33
-35.65	19.18	3.09
26.88	20.59	-8.2
22.89	4.47	14.75
-4.19	3.85	9.67
-25.99	-11.92	-8.57
14.27	-4.18	14.63
-1.03	-27.37	-2.98
-1.08	-45.32	-11.29
16.13	-11.87	-10.41
11.88	-27.74	-7.65
-46.47	19.03	2.17
-54.18	27.75	-7.53
-44.44	25.66	-7.49
55.23	44.56	16.96
44.83	-32.4	32.59
58.38	43.84	9.13
-46.41	45.7	11.85
-41.83	-28.94	16.92
3.76	34.1	45.76
1.78	23.44	58.06
9.08	30.2	38.21
-43.73	-34.63	36.56
-48.15	-29.95	29.45
60.43	-13.85	-10.97
60.51	-15.45	-5.21
56.24	-20.58	-2.39
52.95	-38.44	-9.53
48.69	-31.45	-3.42
48.8	-30.62	5.46
37.49	22.47	-23.14
48.75	20.41	11.61
48.48	21.73	-8.68
-48.56	32.62	9.82
-37.84	26.61	2.39
-36.9	27.71	-8.94
-46.25	10.81	17.54
-52.48	13.72	37.53
-50.16	8.39	49.23
-26.34	12.18	54.05
-34.91	10.44	58.85
3.89	19.73	52.79
-11.35	25.44	45.76
12.33	28.09	38.37
-5.09	29.22	28.47
38.61	-55.63	48.45
-30.62	-49.91	44.58
-32.79	-60.97	41.23
67.04	-31.49	-4.85
64.89	-19.38	-1.53
55.22	-33.24	0
55.27	2.14	11.07
-64.44	-34.99	22.38
-52.78	-31.18	5
-66.82	-26.77	7.04
66.99	-15.43	-5.32
56.08	-14.07	-13.11
62.78	-27.79	0.46
-20.59	18.71	-2.72
-31.3	-14.51	-1.5
-43.23	-2.85	-2.45
31.21	19.54	-8.17
26.7	21.47	-21.73
-22.81	19.35	-7.23
-40.12	24.61	-7.46
-24.97	14.99	-7.88
-44.18	-20.52	3.8
-39.88	32.96	13
-39.75	-26.26	11.02
61.01	7.95	38.41
51.16	2.62	27.9
44.83	8.1	40.91
-66.95	-25.58	-3.16
-60.34	-35.57	4.44
-54.13	-21.15	-13.9

// Najib A, 2004: Ruminative vs. Neutral (Increases)
// Najib A, 2004: Ruminative vs. Neutral (Decreases)
// Subjects=9
-8.5	-73.19	-29.06
-16.02	-63.72	-29.77
-6.27	-82.1	-20.53
-11.68	-47.69	-15.55
-6.16	-78.78	-5.2
-15.86	-41.23	-.43
-23.21	-60.77	9.1
-11.41	-56.92	16.45
-6.05	-44.66	23.17
-.64	-61.55	24.52
-18.76	-43.54	38.83
-13.34	-62.54	40.36
-5.82	-73.07	41.16
-20.8	-67.87	40.9
1.61	-29.53	53.03
-28.22	-54.03	55.43
-26.35	-95.22	4.22
-8.21	-87.71	3.38
-15.62	-90.33	11.49
-18.79	-82.35	18.67
1.12	-57.73	-22.66
25.81	-87.19	-20.47
6.66	-63.3	1.16
3.12	-38.23	-32.12
44.2	-51.76	23.18
29.37	-70.29	32.71
57.07	-47.91	30.52
38.77	-60.4	8.36
18.65	-76.24	25.53
9.05	-34.31	45.54
14.44	-62.37	40.03
18.78	-80.32	41.48
24.16	-56.89	55.07
29.22	-94.89	3.55
21.65	-70.61	1.61
14.29	-86.98	10.87
44.04	-73.19	-6.24
21.74	-77.42	9.98
31.36	-79.47	10.04
40.98	-79.42	9.93
-6.52	-15.48	-26.11
-8.58	-4.78	-11.38
-15.85	-12.54	12.78
-16.12	13.16	-12.79
-28.88	-4.9	-11.13
-16.04	-9.05	-10.93
-19.41	1.36	-27.38
-47.26	3.77	-35.07
-36.6	11.23	-35.82
-56.76	-10.49	-25.95
-47.04	-7.12	-10.74
-49.07	-19.22	-1.89
-28.92	21.08	-5.5
-21.33	24.44	9.74
-26.64	14.89	10.6
-19.29	33.37	1.16
-26.81	46.01	0.19
-8.78	65.61	-9.47
-4.27	34.06	8.74
-23.29	-6.7	20.18
-4.06	10.94	26.29
-29.07	29.4	-21.81
-34.34	43.25	-7.3
-41.96	62.7	-16.65
-31	54.59	15.13
-41.79	49.1	0.1
-47.03	23.69	2.29
-46.93	27	17.63
-34.03	8.04	19.07
-41.55	17.51	18.36
-30.8	16.06	26.16
-26.5	26.21	33.07
-51.02	11.25	34.61
-51.25	6.74	3.76
-28.53	-3.41	35.58
-48.77	-2.94	43.58
-58.54	-10.08	20.87
16.08	11.55	4.82
23.58	17.31	9.82
3.28	17.18	10.07
6.63	57.21	45.7
8.74	49.22	38.54
1.38	81.18	67.17
14.02	33.25	24.21
13.97	19.53	11.98
31.15	41.35	31.14
6.66	65.21	52.84
21.51	35.58	26.16
23.73	57.31	45.5

// Phillips M L, 2004: Covert Fear vs. Neutral Face
// Phillips M L, 2004: Covert Fear vs. Overt Fear
// Phillips M L, 2004: Covert Fear vs. Covert Disgust
// Phillips M L, 2004: Overt Fear vs. Neutral Face
// Phillips M L, 2004: Overt Fear vs. Covert Fear
// Phillips M L, 2004: Overt Fear vs. Overt Disgust
// Phillips M L, 2004: Covert Disgust vs. Neutral Face
// Phillips M L, 2004: Covert Disgust vs. Overt Disgust
// Phillips M L, 2004: Covert Disgust vs. Covert Fear
// Phillips M L, 2004: Overt Disgust vs. Neutral Face
// Phillips M L, 2004: Overt Disgust vs. Covert Disgust
// Phillips M L, 2004: Overt Disgust vs. Overt Fear
// Subjects=8
31.1	-66.81	-18.9
-10.48	-80.38	-11.7
-32.52	-47.8	53.84
-41.41	3.57	30.68
-21.08	-28.98	20.91
46.95	5.07	-12.84
-52.13	-25.36	15.39
47.06	12.79	4.36
-41.34	-.15	37.68
5.65	18.54	41.15
-41.12	-48.36	47.3
51.47	-33.08	2.58
5.87	-26.42	51.61
-36.89	-48.76	41.71
31.1	-66.81	-18.9
-10.48	-80.38	-11.7
-41.41	3.57	30.68
-41.12	-48.36	47.3
31.1	-66.81	-18.9
-41.41	3.57	30.68
-41.12	-48.36	47.3
5.77	-63.71	23.51
-2.8	-70.53	18.61
-33.08	-12.95	-4.83
44.27	-22.47	44.15
30.99	-13	-11.14
30.93	-10.34	-18.05
5.2	50.18	-3.87
23.78	-71.83	-.55
35.4	27.92	22.18
9.01	-49	34.51
31.03	-48.84	-20.4
-41.63	26.52	10.91
51.25	11.87	-7.88
-33.16	-3.87	-11.17
44.26	-55.56	29.08
5.77	-63.71	23.51
-2.8	-70.53	18.61
-33.08	-12.95	-4.83
44.27	-22.47	44.15
30.99	-13	-11.14
5.2	50.18	-3.87
23.78	-71.83	-.55
35.4	27.92	22.18
9.01	-49	34.51
5.77	-63.71	23.51
-2.8	-70.53	18.61
-33.08	-12.95	-4.83
30.99	-13	-11.14
5.2	50.18	-3.87
23.78	-71.83	-.55
35.4	27.92	22.18
31.03	-48.84	-20.4
-41.63	26.52	10.91
5.56	-18.67	14.16
8.7	-15.99	7.21
5.82	-63.2	30.16
8.88	0.15	37.08
13.21	-64.09	17.88
35.32	-16.77	-5.3
27.91	-44.74	-8.44
-28.77	-48.77	-14.15
51.56	-57.4	4.61
5.56	-18.67	14.16
8.88	0.15	37.08
51.56	-57.4	4.61
5.56	-18.67	14.16
8.88	0.15	37.08
35.32	-16.77	-5.3
-28.43	-63.91	23.92
-41.28	-68.65	18.89
8.92	-49.94	22.32
-2.79	-35.33	33.5
13.38	-59.04	41.99
35.42	-66.36	-13.41
-16.98	-45.01	-7.9
-55.35	-19.03	14.89
-25.21	-27.54	39.79
43.89	-8.81	0.63
39.49	0.8	-12.39
-28.92	4.62	-11.93
8.37	46.51	-10.29
5.7	-83.06	7.29
-14.77	-51.97	-1.77
51.31	-6.1	-6.38
-41.5	-58.9	-6.46
-28.43	-63.91	23.92
-2.79	-35.33	33.5
-25.21	-27.54	39.79
43.89	-8.81	0.63
5.7	-83.06	7.29
51.31	-6.1	-6.38
-2.79	-35.33	33.5
-55.35	-19.03	14.89
-25.21	-27.54	39.79

// Ranote S, 2004: Own Infant + Unknown Infant - Traffic
// Ranote S, 2004: Own Infant - Unknown Infant
// Ranote S, 2004: Unknown Infant - Own Infant
// Subjects=10
-45	-72	-96
39	-54	-21
54	-69	-6
45	69	-6
-48	-81	6
-57	-66	9
-51	-69	21
-57	0	-21
-42	18	-24
45	15	-39
-18	-33	63
33	-30	63
33	18	-27
45	-81	15
-21	0	-18
-6	-96	-12
-33	60	12
-33	60	-9
39	39	42
33	45	33
15	48	48
-45	30	-12
51	48	-3
66	-27	-9
-6	-75	27
-3	-84	27
-9	-57	69
-21	-21	-9
-12	-36	-33
9	-60	-15

// Vartanian O, 2004: Representational - Abstract
// Vartanian O, 2004: Original - Altered
// Vartanian O, 2004: Original - Filtered
// Vartanian O, 2004: (Representational, Orig - Representational, Filt) - 
// (Abstract, Orig - Abstract, Filt)
// Vartanian O, 2004: Brain Areas that Decreased in Activation in Response to 
// Decreasing Preference
// Vartanian O, 2004: Brain Areas that Increased in Activation in Response to 
// Increasing Preference
// Subjects=12
-22	-102	-16
20	-100	-14
44	-60	8
4	-60	42
16	-50	6
16	-62	-20
42	-74	-16
-10	-44	-8
16	-38	-8
-14	-48	68
32	-90	18
6	10	8
-16	48	0
-24	-104	2
24	-104	2
46	-76	-20
-46	-76	-20
32	-71	-31
32	-71	-31
-12	-86	-28
-26	-94	-24

// Malhi G S, 2004: Bipolar Disorder Patients
// Subjects=10
37.3	72.72	9.48
28.75	72.67	9.58
37.39	67.06	18.87
28.78	73.01	14.01
45.75	16.81	-26.08
52.19	12.79	-23.58
20.18	4.31	-20.27
14.13	-95.29	-14.08
7.68	-25.43	9.13
3.12	0.15	-17.5
7.55	-42.12	-14
9.63	69.35	23.46
9.59	75.52	20.71
-9.11	-68.4	33
-20.34	73.06	19.03
-22.65	77.85	-1.41
-1.35	64.09	-16.12
0.78	75.02	-12.6
-14.06	8	-24.65
30.8	12.49	-25.54
-39.81	22.13	-32.23
43.59	12.23	-30.13
-14.04	-2.75	-25.98
-20.53	0.76	-35.12
-26.98	0.38	-39.48
17.98	3.62	-29.11
-20.43	-9.13	-25.37
-35.39	-13.62	-27.05
-26.85	-11.46	-27.33
3.38	-30.03	5.1
37.17	60.43	-11.79
22.82	40.27	59.2
69.65	27.58	28.51
-39.72	71.4	-.68
-41.85	62.76	-2.16
42.18	15.35	65.53
37.17	66.95	-10.11
67.57	15.05	31.81
-39.74	53.62	-10.34
-1.12	4.87	-11.15
9.84	-47.08	4.23
3.42	-40.6	5.99
29.53	-20.33	73.13
44.49	-39.96	65.68
29.6	-30.56	78.45
-40.98	-53.51	63.34
44.52	-46.31	66.22
9.83	-40.56	5.91
9.8	-40.91	1.48
-45.99	13.58	-4.68
11.7	0.55	-13.17
7.68	-25.43	9.13

// Malhi G S, 2004: Normals
// Subjects=10
27.04	39.78	52.51
20.7	31.63	57.72
3.55	39.82	55
3.6	27.13	56.07
14.22	39.71	52.66
-2.8	24.97	56.32
-.62	12.3	57.36
29.23	31.51	55.41
48.52	12.42	54.55
42.12	12.55	56.85
42.08	18.73	54.1
65.43	12.75	29.8
71.85	6.28	28.04
46.5	-10.51	60.96
74.02	-4.29	28.9
-53.98	-7.06	59.6
6.08	-65.91	63.84
35.97	-57.27	62.77
-36.72	-51.37	63.11
-2.46	-65.96	63.94
57.21	-58.52	44.79
-62.49	-52.89	45.69
-53.9	-59.01	48.34
-47.13	-55.2	97.01
-45.29	-38.56	64.37
67.82	-50.51	37.31
55.06	-71.9	37.02
-44.07	11.36	-33.51
-44.03	5.19	-30.76
-3.1	-39.55	-7.41
-7.39	-33.23	-7.89
1.72	-88.8	43.51
-26.06	-93.37	41.98
-26.07	-86.85	43.66
42.28	-75.87	41.96
42.31	-82.21	42.49
-2.5	-57.5	63.23
-23.88	-86.32	50.28
-.98	54.65	27.05
71.85	6.28	28.04
46.5	-10.51	60.96
74.02	-4.29	28.9
-53.98	-7.06	59.6
6.08	-65.91	63.84
35.97	-57.27	62.77
-36.72	-51.37	63.11
-2.46	-65.96	63.94
-56.03	-61.14	48.54
12.43	-95.08	43.91
1.79	-63.99	61.5
8.18	-86.13	49.9
16.74	-85.91	52.01
1.76	54.28	-33.17
56.86	25.73	33.27
76.01	13.9	16.2
3.4	20.67	27.62
-7.2	1.74	31.56
-2.81	-69.56	17.41
76.05	5.62	19.12
29.45	-62.91	45.48
61.35	-26.94	39.86
59.22	-33.47	38.21
-20.49	-20.73	-37.78

// Coull J T, 2004: Activations Due to Increased Attention to Time
// Coull J T, 2004: Activations Due to Increased Attention to Color
// Coull J T, 2004: Activations Due to Motor Response
// Subjects=12
6	3	54
60	24	12
21	36	33
27	3	63
-42	15	-12
63	-21	-21
66	-36	0
-51	-48	33
48	-45	33
-18	9	-6
66	-48	18
36	-54	-24
33	-72	-21
42	-81	-9
36	-90	-3
-30	-48	-24
-51	-21	54
-30	-3	63
-3	3	39
3	-27	24
-15	-21	3
-27	-9	-3
-51	18	-12

// Lanius R A, 2004: Subjects With Posttraumatic Stress Disorder (PTSD)
// Subjects=11
-39.64	26.13	-8.03
3.43	25.41	33.91
31.15	-47.64	-4.89
1.3	23.29	34.11
1.37	10.77	37.39
1.34	-46.62	10.98
0.44	-16.39	44.14
-2.83	-8.29	39.04
-5.2	37.71	28.52
28.61	60.21	-13.91
52.7	9.3	41.39
-29.1	51.06	-16.94
-26.96	55.47	-15.1
-18.49	67.87	-20.7
-52.05	3.93	36.35
63.58	-41.39	45.51
46.58	-49.26	55.29
-64.87	-31.18	23.83
-62.63	-47.74	29.65
10.03	-82.52	13.89

// Lanius R A, 2004: Subjects Without Posttraumatic Stress Disorder (PTSD)
// Subjects=13
-13.83	-9.32	-.9
45.9	16.24	-5.96
14.18	12.96	37.06
3.43	25.41	33.91
-7.03	-7.46	50.17
0.44	-16.39	44.14
-15.88	-37	-.78
50.54	11.23	39.02
12.02	30.21	40.1
-7.68	67.02	-5.14
-29.1	51.06	-16.94
-41.39	5.94	33.83
1.53	-13.92	48.38
29.52	-84.06	47.25
-37.04	-56.91	18.97
14.4	-68.26	32.72

// Mitchell R L C, 2004: Bipolar Patients
// Subjects=11
36	6	-27
-63	-12	-3
54	-12	-3
-54	24	18
-60	-15	-3
63	-15	-6
-36	15	12
36	3	-27
60	-30	9
3	3	30
-48	-45	27
36	-60	18
-30	9	-24
57	-27	3
-57	-48	3
-57	0	3
21	-33	6
-33	0	45
42	-6	42
57	-27	15
-51	-45	12
21	3	-18
-27	0	-24
30	21	-21
45	3	48
-57	-27	51
24	-33	-6
45	-48	36
-33	3	-21

// Mitchell R L C, 2004: Schizophrenic Patients
// Subjects=12
-63	-21	-6
66	-27	0
15	0	63
48	-30	33
-42	-27	15
-57	0	3
-48	-45	18
66	-12	0
54	-48	6
-36	-24	-12
48	9	30
66	-39	33
-36	33	21
48	30	12
45	12	-15
-27	-18	21
36	-18	3
15	30	54
-30	15	36
51	30	18
21	-24	63
15	-60	60
39	-45	57
-57	-27	24
-33	-45	-10
9	-69	-3
21	-27	3
-24	15	3
-60	-33	42
51	-3	18
-48	-54	-9
-36	-24	-15
39	3	12
-48	-21	9
3	-69	33
36	3	-27
60	-30	9
3	3	30
-48	-45	27
36	-60	18
-30	9	-24
57	-27	3
-57	-48	3
-57	0	3
21	-33	6
-33	0	45
42	-6	42

// Mitchell R L C, 2004: Normals
// Subjects=13
-36	33	21
48	30	12
-60	-33	42
51	-3	18
-48	-54	-9
-36	-24	-15
39	3	12
-48	-21	9
3	-69	33
57	-27	15
-51	-45	12
21	3	-18
-27	0	-24
30	21	-21
45	3	48
-57	-27	51
24	-33	-6
45	-48	36
-33	3	-21

// Rilling J K, 2004: Cooperate, Cooperate > Cooperate, Defect
// Subjects=19
29.82	62.81	5.93
30.78	60.56	-9.5
9.43	42.03	-13.28
11.66	18.87	-10.24
-27.45	12.08	43.19
-27.68	-8.98	4.81
-9.15	-5.1	53.34
-27.24	-23.1	56.17
-54.42	-32.54	-8.52
46.3	-52.18	17.62
-18.86	-70.97	14.37

// Chang K, 2004: Bipolar Patients
// Subjects=11
-29.26	-7.78	-10.04
-53.04	2.98	-8.46
-5.22	-5.62	11.75
26.79	33.04	-12.79
20.4	44.69	-2.63
-39.69	21.24	25.36
-11.29	-66.08	31.28
-16.4	41.81	-8.44
-16.21	65.16	11.65
-5.6	35.26	-10.22
7.45	-77.8	-26.15
-1.25	-60.81	-27.68
1.93	-53.12	54.42
-52.09	-35.87	58.12
5.93	23.27	44.56
39.71	21.83	-18.63
-38.01	26.43	-11.04
-31.62	58.57	-12.08
-37.59	36.14	23.85
14.07	-8.92	-1.7
-11.78	9.04	8.17
-48.9	6	-22.28
-33.78	21.36	-19.57
53.14	20.94	17.09
-50.48	16.95	25.97
61.27	4.06	-26.2
44.18	-1.14	-11.95
18.89	-42.37	30.66
-48.66	-64.4	-17.56
-54.83	-72.98	5.81
61.73	18.43	12.71
44.25	-64.07	-19.17
1.44	46.03	35.66
31.61	43.38	28.68
-42.45	-2.9	-25.99
-33.7	28.57	-11.32
-2.78	-91.11	15.68
-28.48	-76.36	37.07
-37.51	23.58	27.34
-48.19	6.94	33.65
-37.65	44.44	20.79
-13.6	37.88	41.2
-5.66	65.46	-8.73
-17.59	-34.04	52.87
-15.85	-26.31	20.7
23.03	-30.63	18.22
-3.34	16.33	-6.15
-24.24	-4.7	45.6
-13.56	-9.95	34.73
1.98	-41.86	60.03
-20.04	20.63	40.78
-37.41	11.23	33.04
51.08	-72.4	6.19
44.26	-66.2	-18.96
-7.79	65.66	-6.47
-1.37	49.96	-13.99
-28.8	-91.83	9.47

// Chang K, 2004: Normals
// Subjects=10
-29.26	-7.78	-10.04
-53.04	2.98	-8.46
-5.22	-5.62	11.75
26.79	33.04	-12.79
20.4	44.69	-2.63
-39.69	21.24	25.36
-11.29	-66.08	31.28
-16.4	41.81	-8.44
-16.21	65.16	11.65
-5.6	35.26	-10.22
7.45	-77.8	-26.15
-1.25	-60.81	-27.68
40.83	-68.29	50.78
6.29	-61.61	55.19
5.87	31.57	41.5
46.6	35.81	15.73
-33.71	32.83	-11.74
-24.18	8.89	53.22
-48.9	6	-22.28
-33.78	21.36	-19.57
53.14	20.94	17.09
-50.48	16.95	25.97
61.27	4.06	-26.2
44.18	-1.14	-11.95
18.89	-42.37	30.66
-57.04	-66.82	3
-11.73	40.07	18.54
-1.1	56.29	7.79
48.65	-63.43	-12.58
46.64	16.46	15.4
7.76	57.98	25.4
-54.55	-46.88	32.36
-5.66	65.46	-8.73
-17.59	-34.04	52.87
-15.85	-26.31	20.7
23.03	-30.63	18.22
-3.34	16.33	-6.15
-24.24	-4.7	45.6
-13.56	-9.95	34.73
1.98	-41.86	60.03
-20.04	20.63	40.78
-37.41	11.23	33.04
16.59	-102.51	7.52
53.14	-77.48	-2.31

// Critchley H D, 2004: Enhanced Activity During Heartbeat Detection
// Critchley H D, 2004: Decreased Activity During Heartbeat Detection
// Critchley H D, 2004: Heartbeat (Delay > No Delay) vs. Note (Delay > No 
// Delay)
// Subjects=17
-58	-32	38
54	-22	28
60	-18	32
32	16	10
62	18	6
-44	12	-4
56	14	4
-48	32	4
54	44	2
-10	-18	70
6	-2	48
-16	-66	2
10	-60	46
26	-50	58
-36	-64	42
38	18	10
48	2	-6
-36	40	36
36	26	26
-40	22	20
30	-80	22
-56	-48	0
58	-30	0
6	18	34

// Malhi G S, 2004: Bipolar Patients
// Subjects=10
17.91	68.77	-12.27
-7.28	-23.23	11.35
-3.21	9.77	-2.62
28.7	67.75	1.07
-31.23	59.85	-13.19
-26.93	66.73	-7.12
-35.37	63.48	6.63
-31.15	69.51	1.61
-31.13	63.16	2.14
37.15	57.97	-16.05
28.67	67.41	-3.36
-47.57	-33.42	48.35
-41.14	-33.21	50.49
-62.64	-54.43	25.75
-9.01	-67.37	46.29
-6.89	-61.02	45.74
-2.57	-51.67	56.06
-28.24	-63.09	48.39
-34.67	-63.3	46.25
-23.96	-47.57	55.96
1.67	-41.07	55.12
-7.58	70.33	10.19
13.76	70.12	5.51
20.18	70.16	5.43
22.5	61.14	26.23
-22.18	38.8	44.23
-37.47	63.81	11.09
13.9	67.09	21.37
33.01	63.72	3.59
32.97	63.38	-.84
-28.57	32.42	44.84
50.65	-9.57	45.22
50.63	-3.23	44.69
-43.36	-12.08	48.74
-43.34	-18.42	49.27
50.68	-15.92	45.75
-.5	-32.63	54.43
44.52	-46.31	66.22
48.63	-39.19	47.73
-49.73	-35.89	44.12
-41.14	-44.13	46.94
-49.76	-29.55	43.59
-43.34	-27.23	45.55
35.88	-53.9	51.34
37.99	-38.74	54.5
8.09	-89.28	36.78
7.98	-92.59	21.45
3.8	-49.86	51.37
5.98	-73.63	46.65
-28.24	-69.6	46.7
25.19	-67.17	45.88
-30.4	-63.27	46.2
3.82	-56.21	51.9

// Malhi G S, 2004: Normals
// Subjects=10
27.04	39.78	52.51
3.55	39.82	55
20.7	31.63	57.72
3.6	27.13	56.07
-.62	12.3	57.36
14.22	39.71	52.66
-2.8	24.97	56.32
-13.6	50.12	52.11
29.23	31.51	55.41
48.52	12.42	54.55
42.12	12.55	56.85
42.08	18.73	54.1
65.43	12.75	29.8
46.5	-10.51	60.96
71.85	6.28	28.04
74.02	-4.29	28.9
-53.98	-7.06	59.6
6.08	-65.91	63.84
35.97	-57.27	62.77
-2.46	-65.96	63.94
-36.72	-51.37	63.11
-45.29	-38.56	64.37
-62.49	-52.89	45.69
-53.9	-59.01	48.34
57.21	-58.52	44.79
-47.13	-55.2	97.01
67.82	-50.51	37.31
55.06	-71.9	37.02
-44.07	11.36	-33.51
-44.03	5.19	-30.76
-3.1	-39.55	-7.41
-7.39	-33.23	-7.89
1.72	-88.8	43.51
-26.06	-93.37	41.98
-26.07	-86.85	43.66
-23.88	-86.32	50.28
42.31	-82.21	42.49
42.28	-75.87	41.96
-2.5	-57.5	63.23
-.98	54.65	27.05
-9.63	75.58	23.16
-9.65	66.6	17.22
27	41.56	47.9
22.36	75.08	13.91
-2.96	34.35	39.92
-62.61	0.84	52.34
-64.83	4.37	43.15
-56.08	-30.85	54.92
-56.03	-61.14	48.54
-69.49	2.52	-7.94
12.43	-95.08	43.91
1.79	-63.99	61.5
16.74	-85.91	52.01
8.18	-86.13	49.9
1.76	54.28	-33.17
54.76	26.06	37.73
56.86	25.73	33.27
76.01	13.9	16.2
65.42	14.87	29.62
65.32	9.44	14.46
-7.2	1.74	31.56
3.4	20.67	27.62
1.47	-25.53	35.97
76.05	5.62	19.12
67.6	4.31	30.48
23.13	-33.4	69.84
50.64	-16.26	41.32
29.45	-62.91	45.48
61.35	-26.94	39.86
44.33	-37.27	45.39
44.42	-38.53	56.64
35.82	-43.5	48.24
24.44	-24.35	-33.53
-20.49	-20.73	-37.78
-33.32	-1.09	-30.36
-4.73	-67.35	46.24

// Kerr D L, 2004: Brain Activation During Read Task
// Kerr D L, 2004: Brain Deactivation During Read Task
// Subjects=14
-45.07	-23.17	-39.52
62.2	-3.98	20.09
-57.45	-5.42	26.04
-53	-4.73	48.24
61.03	-14.88	3.17
51.7	-9.82	41.89
5.86	2.1	62.6
55.71	-33.4	-1.91
-42.6	-62.51	-11.72
27.65	-76	-54.89
17.17	-69.52	-25.2
-1.74	8.43	48.77
-12.75	-69.62	-23.73
-39.3	-32.94	12.53
-8.64	-76.85	-48.82
11.69	-79.73	-46.58
-10.52	-7.13	13.38
-19.71	-28.09	59.85
-10.56	-20.77	2.26
17.26	-7.05	11.94
14.03	-19.39	4.09
30.01	-17.61	-1.82
-5.86	-53.69	44
10.2	-55.45	47.3
27.42	-45.27	67.44
-22.33	-48.47	-10.9
60.28	-25.89	39.79
-17.77	-64.11	20.47
15.39	-58.11	26.28
-22.27	-63.19	-8.55
-2.67	-90.11	26.94
-8.92	-58.77	61.18
-39.02	-79.5	29.81
15.68	-56.17	65.14
17.02	22.33	-7.25
48.63	-74.31	33.95
7.32	36.82	-11.7
-17.52	-86.8	43.56
-16.19	27.87	-15.14
24.16	-84.35	43.99
3.99	48.71	-22.7
3.13	11.33	-10.63
22.21	30.68	-23.62

// Adler C M, 2004: Regional Coordinates of Areas of Differential Activation
// Subjects=12
-26.87	68.48	1.65
37.32	60.83	7.13
-60.62	-50.16	11.99
50.41	-33	3.7
-14.29	85.87	-22.26
-43.47	-75.86	8.37
-17.95	-19.87	14.53
-13.77	16.54	17.01

// Strakowski S M, 2004: CPT-IP vs. Passive Viewing, Healthy Controls > 
// Bipolar Patients
// Strakowski S M, 2004: CPT-IP vs. Passive Viewing, Bipolar Patients > 
// Healthy Controls
// Subjects=10
-52.44	-31.96	-28.67
-5.64	49.54	-24.89
28.72	16.34	-16.92
-39.68	42.16	-7.15
37.23	37.97	-13.26
-9.73	-1.24	-20.58
3.19	-4.53	-9.3
42.07	-79.15	13.24
-30.52	-87.62	20.36
37.94	-38.11	48.88
29.48	-50.42	55.58
-65.03	-3.23	13.68

// Blonder L X, 2004: Human Faces vs. Fixation
// Blonder L X, 2004: Dog Faces vs. Fixation
// Blonder L X, 2004: House Images vs. Fixation
// Blonder L X, 2004: House Images vs. Human Faces
// Blonder L X, 2004: Dog Faces vs. Human Faces
// Blonder L X, 2004: Dog Faces vs. House Images
// Subjects=14
-18.19	-9.15	-12.01
18.14	-9.02	-13.56
-41.62	-55.7	-20.11
39.58	-49.93	-21.52
-44.55	-85.81	3.64
50.55	-75.47	5.03
-25.47	-69.72	-10.2
25.82	-67.3	-10.99
-41.62	-55.7	-20.11
39.58	-49.93	-21.52
-44.55	-85.81	3.64
50.55	-75.47	5.03
-14.59	-60.03	17.86
15.3	-54.65	15.95
-24.45	-46.11	-7.73
24.68	-42.73	-9.69
-25.47	-69.72	-10.2
25.82	-67.3	-10.99
-41.62	-55.7	-20.11
39.58	-49.93	-21.52
-29.35	-86.58	33.64
32.66	-84.73	38.35
-18.19	-9.15	-12.01
18.14	-9.02	-13.56
-14.59	-60.03	17.86
15.3	-54.65	15.95
-24.45	-46.11	-7.73
24.68	-42.73	-9.69
-25.47	-69.72	-10.2
25.82	-67.3	-10.99
-41.62	-55.7	-20.11
39.58	-49.93	-21.52
-44.55	-85.81	3.64
50.55	-75.47	5.03
-29.35	-86.58	33.64
32.66	-84.73	38.35
-25.47	-69.72	-10.2
25.82	-67.3	-10.99
-14.59	-60.03	17.86
15.3	-54.65	15.95
-24.45	-46.11	-7.73
24.68	-42.73	-9.69
-25.47	-69.72	-10.2
25.82	-67.3	-10.99
-41.62	-55.7	-20.11
39.58	-49.93	-21.52
-44.55	-85.81	3.64
50.55	-75.47	5.03
-29.35	-86.58	33.64
32.66	-84.73	38.35

// Matsumoto E, 2004: Uncrossed Incompatible > Uncrossed Compatible
// Matsumoto E, 2004: Crossed Incompatible > Crossed Compatible
// Matsumoto E, 2004: Incompatible > Compatible
// Matsumoto E, 2004: Crossed > Uncrossed
// Matsumoto E, 2004: (Incompatible vs. Compatible, Uncrossed) + (Incompatible 
// vs. Compatible, Crossed)
// Subjects=20
-26	-2	56
26	-2	62
-12	-60	50
14	-36	64
-48	-30	44
-6	-62	62
28	-52	62
-54	-14	-2
58	-32	8
-44	0	0
34	14	-4
60	-18	42
-28	-2	54
28	-6	54
-58	-26	42
54	-22	38
-42	-30	44
40	-28	38
-10	-62	50
22	-60	58
-16	-8	60
20	-2	60
-32	-38	44
32	-36	42
-14	-66	52
-46	-10	40
50	0	34
-2	12	64
26	-4	62
-8	-56	58
14	-42	58
-42	-26	2
58	8	-6
34	-24	10
28	4	8
24	-6	58
-18	-8	60
2	14	50
44	-28	40
-46	-30	44
-10	-58	54
22	-60	58
-6	16	30

// McClure S M, 2004: Brand-Cued Coke vs. Light-Cued Coke
// Subjects=16
20	-20	-16
-24	-24	-20
-20	-32	-8
-12	-20	-16
20	28	48
12	-8	4
-4	-60	12

// Schmithorst V J, 2004: Mental Addition/Subtraction, Musicians > 
// Non-Musicians
// Schmithorst V J, 2004: Mental Addition/Subtraction, Non-Musicians > 
// Musicians
// Subjects=7
-56.64	-40.01	-22.37
-35.25	57.02	19.44
33.39	-89.38	-8.11
-17.81	-79.94	8.42
20.53	-10.75	18.9
29.37	-77.94	30.01
-47.5	-38.2	55.44

// McClure S M, 2004: Delayed Discounting > Rest, Beta Analysis
// McClure S M, 2004: Delayed Discounting > Rest, Delta Analysis
// Subjects=14
-8	48	-4
6	8	-4
-26	-38	-8
0	44	12
-8	-28	32
-4	-80	0
0	12	56
4	30	40
40	-60	44
-32	-60	52
44	44	16
40	20	-8
24	50	-12

// Macrae C N, 2004: Remembered > Forgotten
// Macrae C N, 2004: Self Relevant > Not Self Relevant
// Macrae C N, 2004: Not Self Relevant > Self Relevant
// Subjects=22
0	50	8
-24	58	1
-26	-31	-16
27	-33	-8
-9	50	0
2	19	40

// Ochsner K N, 2004: Self Judgment > In-Out
// Ochsner K N, 2004: Other Judgment > In-Out
// Ochsner K N, 2004: Self Judgment + Other Judgment > In-Out
// Ochsner K N, 2004: Self Judgment > Other Judgment
// Ochsner K N, 2004: Other Judgment > Self Judgment
// Subjects=13
-6	52	32
0	56	36
-12	58	44
-12	36	52
0	56	36
-12	58	44
-26	58	30
-20	66	34
-28	50	32
16	34	52
-10	56	14
2	56	24
-2	56	8
-4	26	28
2	-18	40
-8	-48	34
-4	-56	22
-12	-54	26
-52	16	-10
-52	12	2
-52	22	12
-60	-34	-2
52	-38	0
46	-44	4
-54	-70	46
-2	8	8
-2	56	10
-2	56	22
6	54	26
-6	52	32
2	56	40
44	-42	6
52	-38	2
56	-70	6
-10	-58	32
-8	-52	24
-18	-56	30
28	-26	-10
2	56	40
-4	52	32
2	58	12
6	54	26
-2	54	24
-18	38	54
-10	38	56
-26	56	30
-52	22	12
-6	-60	30
-14	-58	32
-4	-54	24
46	-40	2
-60	-42	2
-64	-32	12
-2	58	38
-2	50	16
-62	-34	-6
-58	6	18
-58	12	24
2	-80	6
-2	-80	16

// Schmitz T W, 2004: Self Evaluation > Semantic Positivity Evaluation
// Schmitz T W, 2004: Significant Other Evaluation > Semantic Positivity 
// Evaluation
// Schmitz T W, 2004: Self Evaluation > Significant Other Evaluation
// Subjects=19
6	56	4
2	-60	16
2	-24	2
-4	18	-10
-4	58	4
2	-58	16
-2	-2	4
26	52	16
-28	46	16
30	-40	-14

// Decety J, 2004: Cooperation vs. Independent
// Decety J, 2004: Competition vs. Independent
// Decety J, 2004: Cooperation vs. Competition
// Decety J, 2004: Competition vs. Cooperation
// Subjects=12
30	2	66
-28	-2	56
32	-66	56
-24	-66	46
46	-34	42
-42	-36	42
38	20	2
-4	-80	-22
-16	-66	64
22	-74	58
50	-36	56
-28	4	56
26	4	52
-8	36	40
10	30	36
40	52	24
-32	18	4
42	24	-12
-18	-46	70
-4	-4	52
6	-20	48
0	-56	36
6	-50	24
-44	-2	14
32	-4	4
10	58	4
-12	36	-12
20	10	70
52	-48	46
-2	36	40
-42	-58	40
28	60	22

// Kanayama G, 2004: Cannabis Users
// Subjects=12
50	22	-12
14	-2	14
50	22	32
-48	36	28
-30	36	50
-2	22	42
2	52	50
54	22	32
-46	16	34
-2	18	46
12	-2	12
-42	20	-4
-26	10	60
32	-22	-4
34	12	-26
16	6	28
-18	16	34
36	26	8
42	32	4
14	24	12
-6	18	6
-22	38	14
16	38	-8
18	46	-12
54	6	18
26	8	18
-42	14	50
44	42	34

// Kanayama G, 2004: Healthy Controls
// Subjects=10
-62	12	12
46	12	22
46	16	36
-52	8	36
54	20	32
-48	8	36
-36	8	56
2	12	52
50	24	-14
12	-4	14
-12	-6	14
34	12	-26
16	6	28
-18	16	34
36	26	8
42	32	4
14	24	12
-6	18	6
-22	38	14
16	38	-8
18	46	-12
54	6	18
26	8	18
-42	14	50
44	42	34

// O'Doherty J, 2004: Reward Prediction Error, Fractals Chosen by Computer 
// (Reward > Control)
// O'Doherty J, 2004: Reward Prediction Error, Fractals with Reward 
// Probabilities > Fractals with Neutral Probabilities
// O'Doherty J, 2004: Reward Prediction Error, Fractals with Reward 
// Probabilities > Fractals with Reward Probabilities
// O'Doherty J, 2004: Correlation Reward Prediction Error with Neutral 
// Pavlovian Task
// O'Doherty J, 2004: Reward Prediction Error, Computer > Fractals 
// Probabilities (Reward)
// Subjects=12
-26	8	-4
26	6	-8
6	14	-2
-28	8	-6
20	12	-8
14	10	-10
-8	22	0
-6	22	2

// Seymour B, 2004: Temporal Difference Prediction Error
// Seymour B, 2004: Temporal Difference Value
// Subjects=14
32	0	-8
-30	-2	-4
18	20	6
-10	-10	-8
46	22	-4
28	-46	-30
-34	-52	-28
42	16	-14
0	-28	-18
8	12	32

// Herz R S, 2004: Experimental Odor vs. (Experimental Visual + Control Odor + 
// Control Visual)
// Herz R S, 2004: Experimental Odor vs. Experimental Visual
// Herz R S, 2004: Experimental Odor vs. Control Odor
// Herz R S, 2004: Control Odor vs. Control Visual
// Subjects=5
-7.21	-90.68	-7.53
-32.95	-65.45	-9.35
-29.69	-81.29	-8.06
-35.87	-92.14	17.45
-13.98	-8.75	-21.02
-32.88	-77.88	-4.96
-3.95	-93.32	-.66
32.47	-92.24	9.99
-13.97	-11.92	-20.75
-17.03	-36.81	-11.94
-1.06	-7.65	-7.88
-52.38	-14.81	-13.38
-4.1	-45.48	-1.32
44.65	14.35	-30.32
-26.89	7.83	-25.6
13.05	-94.24	-14.16

// Blackwood N, 2004: Uncertainty Probabilistic > Certainty Counting (Balls + 
// Survey)
// Blackwood N, 2004: Certainty Counting > Uncertainty Probabilistic (Balls + 
// Survey)
// Blackwood N, 2004: Uncertainty Probabilistic > Certainty Counting, Balls > 
// Survey
// Blackwood N, 2004: Uncertainty Probabilistic > Certainty Counting, Survey > 
// Balls
// Subjects=8
-33.67	-67.51	-28.71
-9.85	-79.13	-27.96
-48.08	7.77	42.53
-53.33	-31.6	46.51
-9.33	-99.31	8.76
-5.04	-88.55	8.74
-28.98	44.67	22.86
12.62	-40.84	47.42
-25.12	-5.82	-23.75
-39.78	-60.37	2.07
-54.59	-23.07	34.48
38.61	-38.1	52.31
44.93	-26.14	42.06
44.63	-74.34	8.73
53.36	7.3	31.88
29.95	-3.26	57.98
-46.8	20.9	-23.79
-36.92	-63.89	56.15
-68.09	-31.52	-9.27
18.8	-99.96	11.71

// Zahn R, 2004: [Sem-Lex] & [Sem-Pho] Conjunction Analysis, Activations, 
// Healthy Controls
// Zahn R, 2004: [Lex-Pho] & [Sem - Pho] Conjunction Analysis, Activations, 
// Healthy Controls
// Subjects=14
-40	20	28
-36	-64	42
-52	-16	-14
-56	-8	28
44	-8	42
8	-76	0
-48	16	-7
-60	-16	-14
60	-8	-14
28	-32	28
4	44	42
12	4	14

// Alkire M T, 2004: Stimulus Intensity Encoding
// Alkire M T, 2004: Pain Intensity Encoding
// Alkire M T, 2004: High-Pain Encoding
// Subjects=6
-40	-20	12
-52	-22	18
-44	-34	62
-54	-22	20
2	12	32
4	10	68

// Matthews S C, 2004: Safe - Risky Responses
// Matthews S C, 2004: Risky - Safe Responses
// Subjects=12
-48.71	-54.98	31.21
38.98	-60.45	35.13
-66.09	15.51	22.16
19.14	51.83	2.52
-13.95	9.2	-9.14
25.92	-35.47	15.34
-30.67	-86.96	1.35

// Bell-McGinty S, 2004: PRE > POST Sleep Deprivation
// Bell-McGinty S, 2004: POST > PRE Sleep Deprivation
// Subjects=19
28	-69	-12
22	-82	-11
42	-61	-14
-10	-78	-10
-14	-68	-5
-46	-61	-9
-34	-59	-11
-6	-64	5
-38	-10	-6
36	16	3
22	4	0
-51	-10	4

// Chee M W L, 2004: Rested Wakefulness, PLUS > LTR
// Chee M W L, 2004: Sleep Deprived, PLUS > LTR
// Chee M W L, 2004: Sleep Deprived, LTR < Rested Wakefulness, LTR
// Chee M W L, 2004: Sleep Deprived, PLUS < Rested Wakefulness, PLUS
// Chee M W L, 2004: Sleep Deprived, PLUS > Rested Wakefulness, PLUS 
// (Deactivation)
// Chee M W L, 2004: Sleep Deprived, PLUS > Rested Wakefulness, PLUS
// Subjects=14
-41.56	28.35	20.8
30.93	53.39	7.83
-48.88	8.01	33.74
-44.38	-43.44	42.46
35.82	-59.96	41.81
-50.02	-52.1	-.24
-10.61	13.84	9.39
11.96	-8.86	16.61
-39.44	32.59	20.42
50.47	14.86	30.91
-44.69	8.24	22.52
-41.1	-48.1	50.62
-46.9	-45.27	-8.65
-13.69	-10.07	17.01
11.95	-8.94	15.5
-23.03	-64.43	30.6
27.13	-64.72	22.24
-25.15	-52.21	37.4
-16.54	-64.67	40.58
26.17	-57.02	39.45
-42.58	15.74	22.98
-1.16	59.45	6.57
-7.04	-43.9	33.15

// Habeck C, 2004: Sleep Deprived Healthy Controls
// Subjects=18
-14	-62	10
-55	-58	12
-40	-77	13
2	-13	56
-59	-34	26
-51	-30	22
48	-68	7
50	-56	16
46	-5	48
10	-48	58
4	-42	48
40	-80	-3
-34	-83	8
-51	-62	-2
53	-66	9
16	-48	4
-42	41	9
32	-89	4
8	-78	35
59	-20	29
-4	-52	50
57	-21	12
-44	50	-1
6	6	37
-48	17	38
14	7	18
16	-13	12
-14	-13	8
10	-9	15
30	-36	-25
-40	-32	-20
4	7	-15
-4	25	30
4	21	27
-2	22	52
-8	8	1
-4	-66	-3
42	-54	-28
24	48	20
12	40	18
-48	-54	-23
-24	-65	-25
24	-69	-27
14	-69	-25
22	-77	-25
32	-14	-16
63	-55	-2
24	12	1
2	-52	-1
12	-50	-34
-22	10	-4
24	-32	-12
57	-53	-18
-46	-48	-23
-10	-73	-27
-42	-48	48
10	-64	-27
-65	-34	-10
-24	-44	-18
-48	-58	-24
20	12	51
-28	-81	-23

// Li P, 2004: Noun vs. Baseline
// Li P, 2004: Verb vs. Baseline
// Li P, 2004: Ambiguous vs. Baseline
// Subjects=8
-50	11	20
-48	28	12
-48	-23	45
-36	-15	54
42	-3	17
28	15	-4
34	25	4
63	-18	19
-51	8	-2
44	-8	-3
-44	-33	44
-32	-44	48
-50	-65	-9
-48	-59	-14
-16	-95	10
-12	10	38
14	12	38
4	-7	15
24	-7	10
16	-9	21
-22	-28	-9
-30	13	-2
12	-65	-20
-50	32	11
-50	-7	50
-51	-10	39
-38	15	-2
46	-13	56
36	15	-6
8	7	59
55	16	10
48	11	23
-40	-5	-20
36	-35	37
-48	-66	-8
-26	-64	31
-38	-28	-15
-18	-91	6
26	-82	-11
-18	-15	8
-40	-54	-24
26	-57	-22
-59	5	22
-40	-9	17
-28	-2	31
-46	-17	10
38	-12	34
40	-13	47
42	16	-1
50	11	23
-53	-26	14
44	-59	-9
40	-26	-12
-26	-37	41
36	-28	24
-40	-24	-17
-16	-93	8
-26	-57	-4
18	-89	4
2	-74	-8
8	8	42
30	-41	-6
-34	-24	-11
28	-57	-21
18	-47	-16

// Perlstein W M, 2004: Healthy Controls
// Subjects=7
-17.52	-71.48	48.97
-27.68	40.4	24.09
-36.17	31.09	28.31
36.4	51.45	23.54
34.28	16.4	10.89
-36.21	16.4	17.28
48.43	-.58	37.8
3.3	-15.57	-.57
28.95	-30.73	-6.28
-20.17	-35	-2.02
31.93	44.96	-4.86
40.73	39.93	25.57
-7.32	41.12	31.6
13.97	37.14	19.42
-42.53	14.05	28.7
-51.97	-35.79	31.87
-8.76	92.19	3.91
0.32	-79.12	3.68
46.31	-4.82	38.18
-34.98	15.84	37.38
56.87	1.61	24.14
-35.17	35.87	21.21
-55.33	-1.17	25.66
-36.18	18.86	21.53
41.8	18.01	17.36
-26.88	57.39	-4.11

// Perlstein W M, 2004: Traumatic Brain Injury Patients
// Subjects=7
-17.52	-71.48	48.97
-27.68	40.4	24.09
-36.17	31.09	28.31
36.4	51.45	23.54
34.28	16.4	10.89
-36.21	16.4	17.28
48.43	-.58	37.8
3.3	-15.57	-.57
28.95	-30.73	-6.28
-20.17	-35	-2.02
31.93	44.96	-4.86
40.73	39.93	25.57
-7.32	41.12	31.6
13.97	37.14	19.42
-42.53	14.05	28.7
-51.97	-35.79	31.87
-8.76	92.19	3.91
0.32	-79.12	3.68
-2.99	32.95	35.58
40.07	-59.05	39.46
35.35	46.07	22.89
42.81	15.13	7.55
32.03	29.53	2.01

// Myrick H, 2004: Alcoholism Patients
// Subjects=10
37	-5	-8
-1	17	31
-10	10	-8
13	5	-8
-45	13	-4
4	13	-7
-1	19	29
18	1	-3
43	20	-5
39	24	-15
25	-30	-9
-6	-58	20
-37	2	-3
-28	-26	-8
-6	13	50
-28	-23	-11
-10	14	-7
-7	42	2
-17	20	-16

// Myrick H, 2004: Healthy Controls
// Subjects=10
-3	-19	34
-1	34	24
28	-28	-13
-9	44	52
-2	42	21
-42	11	48
-23	-32	-11
40	21	48
-16	-104	-8
16	-104	-4

// Tyler L K, 2004: Words (Nouns + Verbs) - Letter Strings
// Tyler L K, 2004: Verb - Nouns
// Subjects=12
-20	-14	-14
-34	-26	-26
-42	-46	-28
38	-20	44
26	-22	42
-50	22	10
-28	24	-8
-50	18	-6
4	22	34
-2	14	48
-4	28	46
4	-62	-26
10	-76	-34
-8	-18	20
-18	-4	20
-2	-28	12
34	26	-12
12	-22	-22
-50	16	12
-38	22	0
-46	22	6

// Wright P, 2004: Fear > Neutral
// Wright P, 2004: Neutral > Fear
// Wright P, 2004: Contamination > Neutral
// Wright P, 2004: Mutilation > Neutral
// Wright P, 2004: Neutral > Mutilation
// Subjects=8
50.45	-64.44	-3.7
-43.57	-67.03	-1.29
-26.58	-40.49	-3.71
-26.58	-40.49	-3.71
34.14	22.69	-4.13
-39.64	29.47	-6.08
48.22	21.4	19.23
49.28	-51.21	-11.49
2.23	-77.01	-24.4
-34.26	24.31	-4.6
42.66	24.6	-7.74
6.56	46.58	32.1
1.42	-68.91	11.73
-39.37	-64.43	-9.36
46.14	-62.61	-7.15
21.59	-53.7	0.19
-19.04	-54.2	-2.65
49.47	1.28	34.29
-3.17	63.98	24.06
-10.3	31.36	56.99
-6.85	-90.17	40.37
28.39	-68.29	44.83
-22.93	-76.6	38.31
-30.45	-53.93	43.18
-5.17	-13.62	11.63
23.49	0.96	-8.88
36.27	51.13	5.73

// Rapp A, 2004: Metaphoric Sentences > Baseline
// Rapp A, 2004: Literal Sentences > Baseline
// Rapp A, 2004: Metaphoric Sentences > Literal Sentences
// Subjects=15
-24.6	-96.04	-1.39
43.57	-93.91	6.2
-52.77	-34.37	5.32
-53.3	39.37	-21.02
-58.87	-15.12	39.37
-21.94	24.39	-22.31
-55.84	21.6	30.09
7.98	22.44	35.64
-8.62	-29.84	-5.97
-15.14	-4.98	-3.84
-36.94	-43.27	58.59
-21.37	-92.84	-1.76
43.57	-93.91	6.2
-52.77	-35.44	5.42
39.75	25.43	-14.5
-43.62	0.11	52.17
-28.53	25.76	-30.18
-11.46	22.38	35.98
-8.63	-26.64	-6.28
17.19	4.39	-8.68
-33.87	-39.08	45.8
-56.44	18.19	-17.75
58.01	18.08	-25.29
-41.23	38.64	-6.59
-47.97	-9.27	-36.47
-56.01	-60.64	0.13

// Jung-Beeman M, 2004: Insight > Non-Insight
// Subjects=13
46.95	-7.07	-18.51
50.2	31.84	2.72
-48.06	28.51	9.71
-20.43	51.25	-1.44
-8.14	-57.36	24.26
-16.11	-11.94	-20.72
12.74	-11.76	-21.07

// Cahill L, 2004: Healthy Males
// Subjects=8
72.84	-18.68	28.52
20.55	-11.13	-2.71
-59.21	-11.13	13.21
41.76	6.76	-30.62
57.78	-.67	38.2
-16.24	-42.29	-12.45

// Cahill L, 2004: Healthy Females
// Subjects=7
-57.25	-41.06	-8.51
-1.15	-27.24	-13.08
-8.94	-47.09	50.65
-57.83	-38.39	31.57

// Kensinger E A, 2004: Regions Activated During Encoding > Control
// Subjects=28
-21	-102	0
27	-99	-3
33	-93	-6
-48	-42	54
54	-33	51
-54	24	-9
-51	36	15
-51	18	30
48	24	-15
-48	33	27
48	42	15
-3	27	42
-6	18	66
-30	9	60
0	18	51
27	6	-18
-30	-15	-12
-27	-3	-12
27	0	-18
30	3	-6
-24	-6	6

// Thomsen T, 2004: Young Subjects
// Subjects=13
28	-78	10
-8	25	28
55	-42	17
55	-8	-3
63	-16	-3
-63	-35	9
-51	-27	-5
32	23	-5
-32	23	-5
48	13	21
36	2	48
-44	13	18
-44	10	44
-40	32	9
24	-68	40
24	-77	22
-16	-93	8
-32	-60	-27
8	-71	-17
-44	30	-18
-44	10	40

// Thomsen T, 2004: Older Subjects
// Subjects=8
59	-42	6
59	-20	-2
-63	-8	-10
-36	-81	19
32	-85	4
32	-75	-20
44	5	26
-40	9	25
20	-68	40
-44	30	-18
-44	10	40

// Pinel P, 2004: Common Activations, Number+Size+Luminance
// Pinel P, 2004: Number Comparison vs. Size Comparison
// Pinel P, 2004: Size Comparison with numerical stimuli vs Numerical Task
// Pinel P, 2004: Size Comparison with numerical stimuli vs Luminance 
// comparison
// Pinel P, 2004: Size comparison with numerical stimuli vs size comparison 
// with letter stimuli
// Pinel P, 2004: Numerical and Size Distance Effects (Close - Far Trials)
// Pinel P, 2004: Size and Luminance Distance Effects (Close - Far Trials)
// Pinel P, 2004: Luminance, Numerical, and Size Distance Effects (Close - Far 
// Trials)
// Pinel P, 2004: Number Comparison Small Distance vs. Number Comparison Large 
// Distance
// Pinel P, 2004: Size Comparison (numbers) Small Distance vs Size Comparison 
// (numbers) Large Distance
// Pinel P, 2004: Luminance Comparison Small Distance vs Luminance Comparison 
// Large Distance
// Pinel P, 2004: Size comparison (letters) small distance vs Size comparison 
// (letters) large distance
// Pinel P, 2004: Size Comparison (all stimuli) small distance vs. Size 
// Comparison (all stimuli) large distance
// Pinel P, 2004: Incongruent vs. Congruent Trials: Physical Size Interference 
// (Numerical Comparison)
// Pinel P, 2004: Incongruent vs. Congruent Trials: Physical Size Interference 
// (Size Comparison, Number)
// Pinel P, 2004: Incongruent vs. Congruent Trials: Physical Size Interference 
// (Numerical and Size Comparison)
// Pinel P, 2004: Incongruent vs. Congruent Trials: Physical Size Interference 
// (Luminance Comparison)
// Subjects=15
-52	-32	46
47	-25	42
-42	-69	-16
32	-60	-19
-23	-57	-20
-64	-28	40
52	-28	48
-28	-48	48
-36	-48	40
-52	-52	-12
-12	16	4
32	-44	36
-44	-68	-4
32	-20	68
34	-43	41
-42	-45	42
28	-71	31
-28	-72	31
42	-63	-10
-44	-65	-10
43	-1	27
-51	4	30
-48	4	32
-44	-44	40
36	-44	40
44	8	24
28	-72	40
40	-40	44
-12	-80	-24
-20	-72	52
-32	-64	-24
44	28	16
-4	16	40
-28	-72	32
40	-56	-16
40	-4	28
-32	-44	-16
28	-72	28
48	-72	-8
-40	4	28
48	-68	-8
28	-72	36
44	0	24
-40	-64	-4
0	-84	-20
-40	-44	40
36	-40	36
-40	-72	-20
-8	-40	4
-48	-4	32
32	-72	36
40	-40	44
-8	-80	-20
40	0	28
-36	-68	-24
44	-72	-8
32	-64	-24
-36	-52	52
-52	-72	-8
16	-64	60
-48	0	28
-36	-48	48
-28	-4	60
28	-52	-28
-24	-52	52
8	-68	-8
36	-60	-28
4	8	28
-48	-40	52
-36	-16	48
-36	-36	44
32	-56	-28
-24	-8	52
-32	-52	-28
52	-32	48
-44	-76	0
4	0	20
-36	-80	8

// Gervais H, 2004: Autism Patients
// Subjects=5
48.29	-31.7	6.96
-45.75	-32.27	8.09
56.81	-23.19	6.15
60.98	-6.59	0.25
-62.85	-32.37	8.29
-58.72	-11.88	-2.4
-67.25	-7.36	1.78
48.29	-31.7	6.96
-45.71	-31.92	12.52
56.81	-23.19	6.15
60.98	-6.59	0.25
-58.72	-11.88	-2.4
-67.25	-7.36	1.78

// Gervais H, 2004: Healthy Controls
// Subjects=8
65.27	-10.79	0.55
60.97	-19.96	-7.55
-62.96	-11.56	2.09
-67.09	-40.85	9.05
-67.17	-28.51	3.56
56.76	-10.5	5.08
65.27	-10.79	0.55
65.29	-23.83	-2.82
-62.96	-11.56	2.09
44.07	-26.81	15.52
-41.41	-31.55	16.9
-50.1	-19.94	2.64
44.07	-26.81	15.52
-41.41	-31.55	16.9
-50.1	-19.94	2.64
61.03	-10.48	5.03
61.11	-22.82	10.53
-54.2	-31.29	21.48

// Just M A, 2004: High-Functioning Autism Patients
// Subjects=17
-55.28	-51.18	12.01
-33.24	31.54	-7.45
-55.46	23.78	17.99
-30.44	-59.38	41.41
-24.5	-27.96	-7.02
37.33	27.99	-4.61
40.08	-58.96	40.56
26.79	-25.46	-6.7
-2.88	19.8	44.49
-11.48	-88.42	-5.44

// Just M A, 2004: Healthy Controls
// Subjects=17
-59.71	-31.98	-.7
-50.35	26.87	-11.32
-52.01	10.96	44.68
-51.88	-28.33	45.74
37.27	27.39	-12.37
46.13	17.5	24.05
7.84	20.21	48.79
-35.04	-80.27	-8.09

// Calvo-Merino B, 2004: Expertise Effects in Action Observation (Predicted 
// Areas, Small-Volume Corrected)
// Calvo-Merino B, 2004: Expertise Effects in Action Observation 
// (Non-predicted Areas, Corrected P<0.05)
// Calvo-Merino B, 2004: Expertise Effects in Action Observation 
// (Non-predicted Areas, Uncorrected P<0.001)
// Subjects=10
-27	-6	72
30	-6	69
24	-69	63
-33	-45	54
33	-42	48
-54	0	45
-39	-66	36
0	-33	36
-3	-57	27
3	15	27
0	39	-15
33	-18	-21
-21	-57	69
-15	-54	51
57	-30	48
-48	3	27
21	-60	27
15	-9	18
54	36	3
9	12	-6
63	-48	-9
-51	-63	-9
-60	-39	-9
33	36	-18
-60	-12	-18
-27	24	-27
54	6	-30
54	-12	-36

// Mller R A, 2004: Autistic Patients
// Subjects=8
-22.03	-4.72	45.65
29.31	-7.16	50.84
-24.98	-62.47	56.1
37.89	-41.97	40.28
34.8	-44.05	54.99
26.21	-85.19	32.89
17.07	4.18	-7.96
-25.17	-4.05	54.55
-25.12	-13.4	57.57
34.66	-7.12	50.78
29.54	-69.63	54.96
60.17	-18.29	28
12.42	-75.45	50.07
0.34	-72.26	9.79
-18.65	-83.09	36.57
-30.67	-85.9	1.26
6.73	-85.68	0.81
-5.28	-28.02	-9.46
11.83	-24.49	-6.61
0.15	-62.17	-11.12
3.61	23.95	56.33
8.46	57.31	5.53
3.48	42.39	46.98
9.11	-22.71	57.95
22.97	-44.98	44.05
-4.92	-87.98	13.4
20.87	-92.88	30.25
14.29	-88.12	9.85
48.27	-31.87	4.74
45.14	-60.78	2.74
22.41	6.33	-8.2
51.69	-7.71	41.71
34.68	-26.67	45.72
-22.07	13.6	48.57
40.05	-16.44	53.73
-39.38	30.99	27.24
37.3	54.06	2.12
29.17	23.17	43.84
-22.1	-72.39	10.06
12.07	-72.44	6.33
-18.73	2.84	60.59
-35.78	-19.81	58.23
39.86	13.46	41.18
-39.42	37.16	24.49
-48.13	6.96	-7.44
-4.78	-63.46	41.46
-47.51	-41.54	53.49
43.36	-53.77	52.36
30.94	6.21	-10.52
31.41	14.35	53.47
25.47	56.47	-6.87
8.42	60.23	1.94
17.46	30.21	53.42
-32.48	-40.77	62.18
-10.15	-70.35	35.4
21.02	-68.28	59.41
43.35	-50.6	52.09
-25.22	-91.36	12.81
20.8	-70.59	29.49
14.29	-88.12	9.85
34.65	-84.14	18.2
17.23	5.81	13.09
25.61	6.35	-8.24
0.21	-67.03	-5.14
-44.49	-5.03	43.7
62.12	-.35	11.98
-39.17	1.35	43.11
45.21	1.43	36.56
-47.83	12.25	33.37
-5.42	54.06	5.96
0.03	42	14.71
53.57	14.91	17.49
26.23	-47.7	49.82
8.97	-20.91	39.96
34.63	-39.25	34.51
20.88	-96.06	30.51
26.27	-21.92	66.61
48.48	-4.47	42.59
-22.05	13.77	50.79
-18.88	-1.96	39.81
51.47	11.98	21.1
-1.79	-72.27	9.82
60.18	-28.06	25.47
-21.03	-72.39	10.05
12.06	-89.08	-2.31
26.09	-102.94	9.84
-36.04	-72.99	3.58

// Mller R A, 2004: Healthy Controls
// Subjects=8
-25.16	-.62	57.61
-44.79	-1.59	5.5
29.3	5.87	54.21
51.39	7.87	9.18
-50.26	5.89	-7.33
28.67	37.83	-14.26
-27.12	-62.48	56.13
-49.99	-19.89	17.13
29.47	-60.46	49.73
-25.16	-94.02	19.72
-13.54	-107.46	-3.82
5.52	-70.68	-11.59
-10.65	-21.71	-9.93
28.76	9.11	-14.08
17.28	-16.74	10.52
25.82	-83.76	-17.41
-21.98	-.86	54.25
-44.57	-2.54	34.57
31.44	2.63	53.34
59.95	11.35	12.14
38.02	-47.2	55.21
-10.36	-107.7	-7.18
-25.26	-100.5	4.65
-27.36	-91.37	12.83
17.39	-104.53	-10
-8.41	-23.92	2.5
20.48	-29.92	4.9
6.52	-62.56	-16.74
17.28	-86.99	-17.04
43.11	-11.36	36.54
-10.17	3.07	62.7
-27.37	8.45	51.3
-44.8	-1.68	4.39
3.65	5.72	54.52
44.68	37.67	-17.78
34.43	22.34	32.7
-30.3	-65.59	57.54
-32.63	-52.17	38.6
-51.09	-16.89	14.66
-48.19	8.48	-15.38
-44.49	-5.03	43.7
-44.56	-5.71	34.84
-47.79	9.33	36.96
8.44	63.66	4.99
-18.73	2.84	60.59
-35.78	-19.81	58.23
39.86	13.46	41.18
-39.42	37.16	24.49
-48.13	6.96	-7.44
-4.78	-63.46	41.46
-47.51	-41.54	53.49
43.36	-53.77	52.36
30.94	6.21	-10.52
31.41	14.35	53.47
25.47	56.47	-6.87
8.42	60.23	1.94
17.46	30.21	53.42
-32.48	-40.77	62.18
-10.15	-70.35	35.4
21.02	-68.28	59.41
43.35	-50.6	52.09
-25.22	-91.36	12.81
20.8	-70.59	29.49
14.29	-88.12	9.85
34.65	-84.14	18.2
17.23	5.81	13.09
25.61	6.35	-8.24
0.21	-67.03	-5.14
-44.49	-5.03	43.7
62.12	-.35	11.98
-39.17	1.35	43.11
45.21	1.43	36.56
-47.83	12.25	33.37
-5.42	54.06	5.96
0.03	42	14.71
53.57	14.91	17.49
26.23	-47.7	49.82
8.97	-20.91	39.96
34.63	-39.25	34.51
20.88	-96.06	30.51
26.27	-21.92	66.61
48.48	-4.47	42.59
-22.05	13.77	50.79
-18.88	-1.96	39.81
51.47	11.98	21.1
-1.79	-72.27	9.82
60.18	-28.06	25.47
-21.03	-72.39	10.05
12.06	-89.08	-2.31
26.09	-102.94	9.84
-36.04	-72.99	3.58

// Anderson M C, 2004: Suppression > Respond, Overall contrast, activation
// Anderson M C, 2004: Respond > Suppression, Overall contrast, activation
// Anderson M C, 2004: Suppression > Respond, Regression, Brain areas that 
// predict memory inhibition
// Subjects=24
-43.72	12.46	46.47
-44.16	33.26	16.41
-40.09	23.75	-5.13
53.49	10.46	42.77
34.06	12.73	45.12
62.74	33.22	10.11
41.98	25.96	-8.99
12.67	13.15	62.25
16.49	24.73	25.18
-19.71	-55.63	51.68
27.74	-58.32	43.29
17.04	-51.04	52.84
-56.36	-32.62	-21.69
54.72	-19.44	-36.09
-48.42	-71.35	-0.06
24.82	10.36	-2.67
18.62	-42.22	9.36
-24.74	65.96	20.68
20.72	58.03	25.18
16.19	66.24	9.88
16.71	48.29	47.5
-33.7	-9.79	-19.85
37.6	-9.54	-21.09
-39.91	-12.1	1.77
53.15	-12.86	11.47
46.43	-13.58	-7.39
-64.55	-21.57	16.58
-9.24	-96.45	16.32
-7.38	-80.03	-3.27
14.61	-103.4	21.08
-37.61	44.75	24.12
-32.84	-3.35	48.97
-26.14	-.61	66.52
-38.31	60.28	-27.83
-44.62	64.8	-13.6
-64.61	10.75	17.86
-42.16	25.53	2.57
35.76	44.28	15.08
32.2	-2.53	65.71
53.47	8.13	40.76
48.91	3.05	21.17
-9.44	15.92	24.25
-10.95	-4.39	71.11
3.88	10.91	50.3
-48.65	5.74	-2.08
52.9	12.59	-3.37
-15.26	-64.57	59.21
-30.28	-48.48	71.32
-52.41	-30.61	34.07
-70.85	-27.9	29.64
-43.46	-51.25	53.89
-53.52	-74.61	22.76
30.07	-61.42	55.89
10.73	-59.6	65
4.15	-43.98	60.21
-39.43	-80.74	25.36
-50.81	5.74	-2.05
54.84	14.23	-20.37
55.89	-7.87	-27.17
-39.43	-80.74	25.36
-41.98	-67.28	-2.82
-13.26	-82.17	42.99
-31.5	8.06	-12.69
29.38	-30.48	8.01
15.85	-34.78	-37.27
-27.05	-63.16	-16.93
39.88	-63.34	-22.53
31.07	-67.91	-36.5

// Nobre A C, 2004: Common Brain Activations to Precues and Retrocures
// Nobre A C, 2004: Precues > Retrocues, Differential Brain Activations
// Nobre A C, 2004: Retrocues > Precues, Differential Brain Activations
// Subjects=10
2	-57	54
-9	-51	51
-12	-54	48
9	-60	69
12	-63	60
18	-72	51
39	-42	51
27	-54	45
27	-57	60
15	-60	54
27	-66	39
24	-72	39
33	-81	24
-21	-63	54
-12	-72	45
-15	-60	54
-18	-75	42
-30	-78	30
-39	-75	27
-33	-81	27
-33	-84	21
-39	-48	33
30	6	57
-27	0	57
-42	-3	42
48	-69	-3
-45	-78	-3
-45	-69	-9
-48	-57	-9
0	-87	-3
-6	-21	-9
33	-87	15
33	-78	15
39	-72	18
3	-69	51
36	-57	42
33	-57	57
-36	-63	51
-3	24	39
36	24	-12
51	39	21
48	45	21
-54	21	33

// Gallagher H L, 2004: Expressive vs Instrumental
// Gallagher H L, 2004: Instrumental vs Expressive
// Gallagher H L, 2004: Recognize vs Observe
// Gallagher H L, 2004: Observe vs Recognize
// Gallagher H L, 2004: (RE-OE)-(RI-OI)
// Gallagher H L, 2004: RE-null
// Gallagher H L, 2004: OE-null
// Gallagher H L, 2004: OI-null
// Gallagher H L, 2004: Recognition of expressive vs instrumental
// Subjects=12
2.78	50.86	-27.59
24.53	-.54	-27.36
17.95	-5.64	-35.71
-14.37	-7.26	-28.28
53.02	-45.57	-5.46
27.56	-101.23	20.65
-24.4	-104.37	12.88
-44.04	14.43	21.63
-43.76	20.97	45.63
-9.07	35.1	57.09
-11.5	54.91	39.48
-44.71	37.92	-25.51
-55.11	29.95	4.59
-27.44	26.93	-29.2
52.45	20.21	-36.61
-49.09	17.73	-34.64
52.45	20.21	-36.61
41.51	3.83	-50.5
-49.09	17.73	-34.64
-40.6	-3.05	-50.66
59.58	-42.8	0.88
37.57	-87.44	-39.16
-5.7	52.07	-14.12
18.09	54.49	-12.53
12.52	-26.26	42.62
49.3	-67.37	37.1
-12.15	58.84	-10.2
-16.44	59.04	-7.91
16.09	57.86	0.62
14.51	33.73	41.14
-17.91	42.33	43.08
52.39	6.62	-44.23
-55.49	-12.28	-33.8
40.21	-11.63	13.81
-21.77	-17.71	67.01
57.46	-31.55	6.52
-54.84	-40.24	11.54
-5.28	63.9	20.56
43.71	-4.67	-49.69
-38.51	-5.79	-57.14
57.54	-59.41	7.04
61.78	-38.12	4.86
-59.11	-53.02	12.87
-37.03	-34.11	53.21
-13.74	-103.24	1.38
18.6	-99.29	-4.04
61.47	42.71	-3.14
-38.97	-39.04	69.42
59.66	-57.48	4.57
35.88	-97.1	-4.55
-29.02	-93.49	-8.29
35.3	-51.08	-40.47
-54.79	-22.4	18.73
-41.15	-41.39	67.44
38.04	-90.5	-3
-44.02	-88.25	2.65
26.88	-56.04	-24.15
3.13	64.4	2.44
-7.71	57.56	-1.19

// Prigatano G P, 2004: Right Hand Activations (HFTT vs. Rest), Healthy 
// Controls > TBI Patients
// Subjects=7
0	2	44
-58	10	12
48	14	8

// Saygin A P, 2004: Brain areas that preferred biological motion to 
// stationary point-lights
// Saygin A P, 2004: Brain areas that preferred stationary point-lights to 
// biological motion
// Saygin A P, 2004: Brain areas that preferred scrambled biological motion to 
// stationary point-lights
// Saygin A P, 2004: Brain areas that preferred stationary point-lights to 
// scrambled biological motion
// Saygin A P, 2004: Brain areas that preferred biological motion to scrambled 
// biological motion
// Subjects=12
-38.39	22.48	13.45
41.79	20.04	16.08
-42.51	8.76	29.14
48.32	12.56	28.89
-27.34	-0.01	52.01
39.97	1.37	50
-46.66	-59.16	18.16
52.68	-54.6	13.29
-44.52	-71.3	12.46
52.71	-69.74	10.1
-27.23	-45.02	47.97
31.59	-40.81	55.87
-43.47	-30.8	26.89
49.48	-24.95	25.34
-54.43	-43.63	-14.28
25.55	60.59	5.06
-33	-7.7	8.11
66.44	-17.5	10.02
51.56	11.78	32.27
-47.73	-61.46	16.13
56.97	-57.74	13.5
-44.52	-72.35	12.55
55.9	-65.41	10.81
-29.37	-46.18	46.98
33.76	-42.65	59.34
-43.47	-31.94	25.87
50.55	-23.8	26.34
35.13	52.64	-2.19
-36.19	-7.54	10.36
63.24	-18.49	11.25
-42.64	17.25	15.05
-38.27	8.36	23.55
37.61	11.1	24.68
-47.75	-55.03	16.71
58.05	-59.77	14.78
-43.46	-73.49	11.52
51.66	-75.04	10.55
-56.53	-52.02	-12.44

// Yang P, 2004: PTSD
// Subjects=5
-37.85	-77.44	-19.81
36.64	-74.3	-24.75
-21.34	-78.39	3.53
14.31	-88.15	0.53
66.58	-52.01	39.77
-50.99	29.58	-11.13
43.03	23.53	-12.13
-21.61	-83.66	-18.35
10.61	49.56	-7.43
-54.11	-64.73	-20.79
23.64	-64.77	-25.47
14.26	-88.46	-2.8
11.2	-90.42	10.89
-11.52	-94	8.27
-31.44	-26.49	-14.88
-30.62	-81.69	37.64
-31.45	-23.3	-15.19
30.16	-18.52	-13.35
-5.76	98.64	-9.77
14.25	-85.27	-3.12

// Yang P, 2004: Healthy Control
// Subjects=6
-37.86	-74.25	-20.13
20.43	-84.24	-26.85
-8.32	-94.3	4.89
14.4	-90.72	7.51
4.07	45.83	-12.55
-40.43	-82.35	31.14
47.03	-79.16	25.98
-8.64	67.42	12.42
33.55	64.69	15.34
-54.1	23.91	-2.67
43.12	27.44	-4.67
-50.99	29.58	-11.13
43.03	23.53	-12.13
-21.61	-83.66	-18.35
10.61	49.56	-7.43
-5.69	65.25	-10.95
10.66	17.13	-9.82
-31.45	-23.3	-15.19
30.16	-18.52	-13.35
-5.76	98.64	-9.77
14.25	-85.27	-3.12

// Platek S M, 2004: Self face > Famous face
// Platek S M, 2004: Mind in the eyes
// Subjects=5
46.98	29.9	44.32
43.76	30.09	46.6
46.76	12.93	23.59
46.98	29.9	44.32
43.76	30.09	46.6
46.76	12.93	23.59
7.09	43.56	54.86
-48.51	33.04	14.26
-48.99	20.68	-25.97

// Anders S, 2004: Brain Activations, Significant Peripheral Physiologic 
// Responses
// Subjects=16
-21	-6	-12
-24	3	-15
-18	-18	0
18	-18	45
33	-39	63
-57	-27	42
57	-33	24
-36	15	12
3	39	-24

// Gobel S M, 2004: NC vs. Rest
// Gobel S M, 2004: Reaction Time Effects vs. Rest
// Subjects=12
-43	-34.34	47.9
-30.27	-44.47	52.96
-45.15	-23.99	44.98
-49.4	-17.59	46.79
-43.13	-1	41.18
-47.39	0.53	32.22
-7.18	9.2	64.69
-13.61	16.06	39.84
-9.35	12.3	46.73
-26.18	-4.38	52.41
-24.09	-7.14	41.49
-58.08	11.15	0.48
-30.59	9.55	4.87
-20.01	10.04	11.43
-5.05	-66.08	-27.84
35.23	-48.94	39.56
43.67	-39.79	49.98
31.01	-53.18	39.88
37.41	-58.61	53.53
43.6	-27.72	40.28
49.91	-7.81	54.42
9.75	0.66	60.73
3.37	6.64	55.92
13.86	20.9	46
13.83	17.98	32.88
30.84	-2.35	43.06
54.06	-34.95	-10.34
49.89	-63.38	-26.13
62.31	22.26	-7.65
43.32	15.79	-7.09
28.52	20.01	-5.08
28.63	2.18	13.9
24.51	-22.8	20.08
9.71	-20.82	20.03
24.5	-59.8	-32.88
3.41	-59.02	-17.27
26.65	-68.05	-30.11
-57.76	-40.77	48.43
-53.58	-21.15	58.16
-28.09	-70.48	41.41
-26.02	-64.56	34.33
-32.38	-58.18	36.15
-34.48	-44.24	57.41
-21.81	-44.4	52.9
-47.26	-14.66	59.9
-49.45	-.37	52.27
-34.57	-18.89	57.89
-43.07	-8.59	55.02
-.8	-3.63	61.09
-2.89	-5.21	70.09
-5.13	14.57	48.77
-7.2	4.05	49.5
-7.25	9.81	40.23
56.12	14.27	35.11
56.14	14.81	43.95
51.93	15.05	48.4
58.15	21.47	14.63
47.6	12.71	10.85
7.67	-5.25	67.81
5.52	-1.75	56.48
11.82	8.95	57.93
9.61	27.16	45.6
55.99	34.2	15.99
41.22	25.4	12.24

// Piazza M, 2004: Regions Responding to Deviations in Number
// Piazza M, 2004: Regions Responding to Deviations in Item Shape
// Subjects=12
-36	-60	52
-28	-68	48
-28	-56	44
28	-56	52
28	-40	40
16	-56	44
24	-58	52
-48	28	12
-28	24	28
-40	24	24
48	8	36
48	8	12
20	32	24
-8	12	56
4	28	52
-4	8	44
44	-52	44
24	-48	40
32	-52	52
-40	-60	-4
-52	-60	-4
-60	-56	-8

// Shuman M, 2004: Healthy Controls Experiment 1
// Subjects=9
57	-60	-9
42	-84	21

// Bartels A, 2004: Color > Rest
// Bartels A, 2004: Faces > Rest
// Bartels A, 2004: Language > Rest
// Bartels A, 2004: Human Bodies > Rest
// Subjects=5
-32	-70	-10
26	-74	-10
-36	-44	-22
24	-54	-14
-44	-46	-24
44	-46	-26
-58	-58	16
56	-62	12
-66	-26	4
64	-24	0
-60	-12	-2
60	-2	-8
-44	-82	4
50	-74	2
-44	-46	-22
40	-44	-22

// Werring D J, 2004: Photic Stimulation: Patients > Controls
// Werring D J, 2004: Photic Stimulation: Controls > Patients
// Subjects=5
16.97	3.15	-21.25
8.46	-7.47	-20.27
-41.74	-2.06	-14.57
20.22	3.6	-15.75
36.24	5.81	-16.12
-19.3	10.13	-10.27
-45.05	36.42	-12.18
-19.27	12.68	-4.91
-46.02	23.09	-5.48
-40.61	4.09	-3.94
20.29	7.63	-4.94
1.19	-27.38	-1.78
-17.12	21.58	-.1
-33.1	7.74	1.24
-4.18	-11.12	2.49
-16.94	-27.06	3.97
-45.81	-21.95	3.88
-38.4	7.08	6.93
-5.06	-47.71	11.14
-15.87	-3.99	13.18
-5.98	-77.95	19.27
-4.96	-99.32	4.32
5.67	-82.34	2.77
-8.2	-78.82	8.21
12.11	-78.7	7.97
8.93	-74.06	13.19
-50.17	-34.89	-11.72
6.26	21.49	-17.09

// Deary I J, 2004: Signal Increase as a Function of Task Difficulty
// Deary I J, 2004: Signal Decrease as a Function of Task Difficulty
// Deary I J, 2004: Signal Increase as a Function of Task Difficulty 
// (Including Only 25, 37, 50, and 75 ms Duration)
// Deary I J, 2004: Signal Decrease as a Function of Task Difficulty 
// (Including Only 25, 37, 50, and 75 ms Duration)
// Subjects=20
-2	18	54
-42	12	-2
-30	48	8
56	12	10
50	4	34
48	-62	-2
-48	-78	-4
-28	20	54
-46	-72	22
0	-64	36
4	8	60
36	-82	30
-48	-26	56
52	-74	6

// Burton H, 2004: Early Blind
// Subjects=9
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
16.6	-91.77	31.32
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-1.73	-96.85	8.53
-3.79	-97.15	18.62
16.6	-91.77	31.32
36.28	23.84	-3.14
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
16.6	-91.77	31.32
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-34.02	-78.66	-14.92
-1.73	-96.85	8.53
-3.79	-97.15	18.62
16.6	-91.77	31.32
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
36.28	23.84	-3.14
-19.79	-90.38	24.93
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-15.79	26.53	36.27
-40.61	11.75	-1.24
-36.04	11.6	37.75
-3.99	11.71	36.26
-6.89	-12.61	66.21
-44.34	-25.49	54.34
-16.42	-29.32	71.07
-58.39	-15.05	39.13
-31.54	-34.39	48.25
-36.08	-26.15	17.5
-43.5	-39.94	18.74
-17.44	-44.22	71.21
-13.38	-25.56	50.64
4.79	-8.99	56.85
6.81	3.03	46.9
26.22	-10.38	64.53
39.07	-19.9	64.06
56.01	-13.77	45.51
52.56	-11.96	14.17
62.37	-43.91	26.78
34.82	-42.73	58.22
56.02	-27.94	41.13
52.91	-48.94	45.15
4.91	-34.11	62.3
16.34	-43.9	17.27
2.91	-57.93	71.01
1.8	-70.42	60.92

// Burton H, 2004: Late Blind
// Subjects=9
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
16.6	-91.77	31.32
32.27	-84.44	-12.97
-1.73	-96.85	8.53
-3.79	-97.15	18.62
16.6	-91.77	31.32
36.28	23.84	-3.14
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
16.6	-91.77	31.32
28.28	-89.21	22.05
42.05	-85.92	8.23
36.28	23.84	-3.14
-1.73	-96.85	8.53
-3.79	-97.15	18.62
16.6	-91.77	31.32
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
36.28	23.84	-3.14
-19.79	-90.38	24.93
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-15.79	26.53	36.27
-40.61	11.75	-1.24
-36.04	11.6	37.75
-3.99	11.71	36.26
-6.89	-12.61	66.21
-44.34	-25.49	54.34
-16.42	-29.32	71.07
-58.39	-15.05	39.13
-31.54	-34.39	48.25
-36.08	-26.15	17.5
-43.5	-39.94	18.74
-17.44	-44.22	71.21
-13.38	-25.56	50.64
4.79	-8.99	56.85
6.81	3.03	46.9
26.22	-10.38	64.53
39.07	-19.9	64.06
56.01	-13.77	45.51
52.56	-11.96	14.17
62.37	-43.91	26.78
34.82	-42.73	58.22
56.02	-27.94	41.13
52.91	-48.94	45.15
4.91	-34.11	62.3
16.34	-43.9	17.27
2.91	-57.93	71.01
1.8	-70.42	60.92

// Burton H, 2004: Healthy Controls
// Subjects=8
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.77	-98.42	1.98
22.79	-98.44	-.53
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
16.6	-91.77	31.32
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
16.6	-91.77	31.32
32.27	-84.44	-12.97
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
-41.39	-86.31	-3.05
16.6	-91.77	31.32
32.27	-84.44	-12.97
28.28	-89.21	22.05
42.05	-85.92	8.23
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
36.28	23.84	-3.14
-34.02	-78.66	-14.92
-41.39	-86.31	-3.05
-34.02	-78.66	-14.92
32.27	-84.44	-12.97
50.46	-75.27	-6.14
47.15	-62.06	-13.9
58.04	-1.67	36.67
-1.73	-96.85	8.53
-3.79	-97.15	18.62
-19.79	-90.38	24.93
16.6	-91.77	31.32
28.28	-89.21	22.05
42.05	-85.92	8.23
36.28	23.84	-3.14
-15.79	26.53	36.27
-40.61	11.75	-1.24
-36.04	11.6	37.75
-3.99	11.71	36.26
-6.89	-12.61	66.21
-44.34	-25.49	54.34
-16.42	-29.32	71.07
-58.39	-15.05	39.13
-31.54	-34.39	48.25
-36.08	-26.15	17.5
-43.5	-39.94	18.74
-17.44	-44.22	71.21
-13.38	-25.56	50.64
4.79	-8.99	56.85
6.81	3.03	46.9
26.22	-10.38	64.53
39.07	-19.9	64.06
56.01	-13.77	45.51
52.56	-11.96	14.17
62.37	-43.91	26.78
34.82	-42.73	58.22
56.02	-27.94	41.13
52.91	-48.94	45.15
4.91	-34.11	62.3
16.34	-43.9	17.27
2.91	-57.93	71.01
1.8	-70.42	60.92

// Doherty C P, 2004: Question with rising intonation (RQ) -  Statement with 
// falling intonation (FS)
// Doherty C P, 2004: RQ - Question with falling intonation and word order 
// change (FQ)
// Subjects=11
-63.99	-27.69	0.1
-40.87	-6.31	-42.1
52.81	-52.17	30.93
39.33	-7.43	-36.24
27.54	62.4	-12.96
36.12	32.07	-20.55
-54.55	29.81	-.37
9.46	43.43	-8.93
41.62	36.99	1.27
29.75	38.98	-13.25

// Han S, 2004: Global > Local
// Han S, 2004: Local > Global
// Subjects=10
-46.74	-2.71	-23.69
-42.07	-17.63	0.12
-54.91	-14.51	11.23
35.51	-25.4	-18.37
27.02	-41.82	-9.87
31.19	-38.59	-21.47
-13.34	-73.98	38.82
-30.45	-59.61	55.62
10.67	-69.9	58.18
25.65	-77.47	45.22
28.04	-60.5	65.92

// Meister I, 2004: Music performance vs. Baseline
// Meister I, 2004: Music imagery vs. Baseline
// Meister I, 2004: Music performance vs. Music imagery
// Meister I, 2004: Music imagery vs. Music performance
// Subjects=12
-55.62	-23.83	37.94
-40.24	-20.74	58.66
-52.29	-3.42	49.31
-11.15	-2.66	55.26
47.15	7.12	53.3
58.73	12.53	30.15
14.6	17.98	44.93
-33.65	-36.35	63.46
-25.48	-59.96	-63.21
-40.2	-30.31	59.61
24.75	-57.52	63.44
50.38	-25.81	45.29
-52.82	-65.4	-5.06
4.27	-59.86	-17.79
-24.93	-63.46	-20.29
-15.14	-20.29	-6.8
53.39	7.51	34.1
-52.54	10.01	32.3
53.53	11.84	46
-27.17	-52.7	60.48
-43.67	-29.85	41.69
28	-57.51	63.38
58.93	-26.4	38.48
-24.61	-92.85	-1.7
-34.35	-91.93	-2.75
33.82	-87.56	5.74
43.44	-82.83	-1.61
-24.96	-70.26	-24.1
-27.31	-22.06	55.21
-11.18	-6.16	52.24
-52.21	-19.27	52
-37.04	-22.1	55.38
-33.67	-33.16	63.14
40.88	-32.9	61.85
10.64	-51.95	-25.4
-18.31	-75.58	-12.48
-1.49	-93.91	31.63

// Moran J M, 2004: Healthy Controls, Seinfeld
// Subjects=12
-48	-38	-3
-48	-48	-14
-45	-5	-35
35	-5	-35
-33	-3	-20
47	-26	-6
24	-69	-34
-36	11	-3
36	5	-10
-21	-1	-17
21	-2	-16
-18	-21	7
-23	-38	57
53	12	2
39	-47	-14
6	-11	6
-33	-32	-7
-48	-38	-3
-48	26	-14
-36	11	-3
-21	-1	-17
21	-2	-16

// Moran J M, 2004: Healthy Controls, Simpsons
// Subjects=13
-48	-38	-3
-45	26	-11
-48	-3	-33
48	-22	-4
33	-71	-34
-33	14	-6
39	5	-8
-21	-1	-17
21	-1	-16
-18	-20	7
6	-11	6
-23	-38	57
53	9	8
-24	-27	-15
-48	-38	-3
-45	26	-11
-33	14	-6
39	5	-8
-21	-1	-17
21	-1	-16

// Osaka N, 2004: Pain > Control
// Subjects=20
0	18	46
-8	16	44
-54	18	10
-54	14	2
-42	8	52
-12	-12	10
-16	-66	50
-18	4	14
34	-74	-48
22	-76	-50
18	-80	-40
10	26	28
14	-10	14
-62	-28	30
-58	-36	36
24	10	-6
48	14	-4

// Giesbrecht B, 2004: Unrelated > Related
// Giesbrecht B, 2004: High Imageability > Low Imageability
// Subjects=10
-52	28	-18
-41	43	-6
-67	-37	-7
-59	-37	-15
-41	-53	39
-15	17	54
-15	31	40
-45	20	31
-56	33	3
-48	15	8
-59	-51	3
-4	38	35

// de Gelder B, 2004: Areas of activation observed in the comparison of 
// fearful bodily expressions with neutral ones
// de Gelder B, 2004: Areas of activation observed in the comparison of happy 
// bodily expressions with neutral ones
// Subjects=7
-5	-31	-2
4	-31	-3
-7	-25	5
6	-25	7
-8	-82	5
-20	-100	8
14	-100	10
-32	-51	-14
35	-60	-12
-9	-68	40
43	-78	-7
38	30	-12
-8	-49	27
-31	10	10
31	16	-4
13	-45	0
-5	10	-6
4	10	-3
24	0	-16
-43	14	10
44	17	23
-51	25	1
43	28	-2
-42	22	-9
-44	12	36
50	3	0
45	2	38
-5	-1	59
8	10	45
11	-7	66
-39	-55	50
27	-83	21
-33	-6	54
-44	-3	44
54	-3	35
15	6	15
-10	3	13
24	1	9
-25	-1	5
-13	-41	-3
24	-31	-8
-10	-95	20
-13	-84	-2
13	-98	18
11	-86	3

// Lindberg P, 2004: Patient 9
// Subjects=1
69.57	-53.87	19.73
8.23	-49.02	40.47
-11.66	32.93	22.61
31.2	-10.73	69.9
-30.83	15.28	41.49
-34.37	-46.11	5.04
-30.83	-17.56	34.66
33.11	-66.6	-45.62
40.58	-32.95	38.32
13.82	59.25	-7.32
36.57	33.49	-8.52
36.98	49.68	26.85
-41.38	41.85	-18.11
30.31	64.68	15.39
1.21	68.39	22.24
37.72	-20.28	70.74
59.64	-52.16	4.04
4.45	45.44	17.74
-40.48	9.17	45.62
-24.23	-3.53	46.6
30.83	29.19	49.15
-46.66	-37.78	60.46
-18.83	-44.45	-46.93
26.91	73.3	4.51
-18.21	38.98	18.76

// Wartenburger I, 2004: Main Effect of Canonicity: Non-Canonical (Non-CAN) > 
// Canonical (CAN)
// Wartenburger I, 2004: Main Effect of Canonicity: CAN > Non-CAN
// Wartenburger I, 2004: Main Effect of Grammaticality: Incorrect > Correct
// Wartenburger I, 2004: Main Effect of Grammaticality: Correct > Incorrect
// Wartenburger I, 2004: Conjunction Analysis: Activations During Processing 
// Canonical and Non-Canonical Sentences
// Subjects=13
-52	-28	-4
52	-28	0
-32	-36	-26
56	0	35
28	-76	-9
-60	16	18
-44	20	-13
-4	44	-9
-4	-60	13
0	-52	44
-44	-76	40
-60	4	26
-64	-20	9
-44	12	-40
60	8	26
64	-4	-13
52	-16	44
-24	4	0
28	4	0
16	-20	0
0	-24	-9
24	-104	0
4	-92	0
-8	-60	-13

// Gordon H L, 2004: Emotion > Fixation
// Gordon H L, 2004: Identity > Fixation
// Subjects=20
24.11	-97.37	4.64
43.01	28.84	-12.65
-5.42	66.16	10.25
58.8	24	37.98
29.94	5.01	-25.76
24.11	-97.37	4.64
43.01	28.84	-12.65
-5.42	66.16	10.25
58.8	24	37.98
29.94	5.01	-25.76

// Abo M, 2004: Healthy Controls
// Subjects=6
-57.29	-1.94	-3.42
-57.02	-49.18	7.97
-57.46	-3.18	-16.74
-7.84	4.46	62.34
-4.49	-1.28	69.58
-7.92	3.84	55.68
-53.5	21.89	44.58
-8.4	16.68	20.8
-5	8.05	31.68
-41.16	-15.58	-12.43
56.38	-39.2	5.06
56.03	7.41	-13
59.43	-34.06	-8.95
65.77	-8.82	-14.92
43.21	57.72	9.14
11.45	13.17	51.07
8.23	13.37	53.34
52.96	-4.43	-1.69
11.31	15.43	40.76
39.89	11.17	-6.37

// Abo M, 2004: Broca's Aphasia
// Subjects=1
59.42	-7.91	-4.82
52.9	1.64	-5.65
46.02	15.08	-33.76
36.3	15.04	-33.59
33.46	-1.62	-5
56.18	34.81	4.46
46.4	27.77	-1.4
46.39	40.84	0.67
33.17	19.16	-23.86
53.27	-5.44	21.94
46.89	-11.22	29.34

// Abo M, 2004: Wernicke's Aphasia
// Subjects=1
62.72	-13.97	-.91
69.42	-25.46	13.56
56.82	-42.47	38.99
53.7	-51.43	46.65

// Whalley H C, 2004: High risk Schizophrenia w/symptoms > High risk without 
// symptoms, Sentence completion > Rest, p<0.001
// Whalley H C, 2004: Healthy Controls > All high risk Schizophrenia, Sentence 
// completion > Rest
// Whalley H C, 2004: High risk Schizophrenia with symptoms > Healthy 
// Controls, Sentence completion > Rest
// Whalley H C, 2004: High risk Schizophrenia w/symptoms > High risk without 
// symptoms, Sentence completion > Rest, p<0.007
// Whalley H C, 2004: High risk with first degree relatives > Second degree 
// relatives, Sentence completion > Rest
// Subjects=10
-43.47	-44.77	54.37
-49.87	-45.23	61.25
-30.68	-43.84	40.62
15.96	51.4	-11.06
3.05	58.35	-4.81
-.96	-82.65	-8.72
-13.97	-83.11	-12.93
-22.67	-78.03	-15.53
9.82	-11.71	3.13
-5.22	-13.27	10.26
20.67	-9.13	7.17
-43.47	-46.9	54.58
-49.86	-44.06	62.25
-31.53	-31.13	61.78
-43.47	-44.77	54.37
-41.17	-59.03	62.47
-32.87	-44.06	38.43
-4.98	-103.44	10.22
12.42	-95.96	20.39
8.92	-74.88	4.91

// Gizewski E R, 2004: Sighted subjects
// Subjects=12
21	-58	-21
24	-63	-48
21	-48	-23
24	-63	-48
48	-64	-31
21	-58	-27
23	-65	-45
47	-65	-30
43	-74	-45

// Gizewski E R, 2004: Blind Subjects
// Subjects=12
48	-70	-26
21	-48	-21
24	-62	-46
21	-48	-21
24	-63	-48
21	-58	-27
23	-65	-45
47	-65	-30
47	-65	-30
-4	-81	-24

// Sweet L H, 2004: 2-back > 0-back, Multiple Sclerosis (MS) > Healthy 
// Controls (HC)
// Sweet L H, 2004: 2-back > 0-back, HC > MS
// Subjects=15
-36.83	-20.7	60.54
-.58	-3.74	56.47
-38.36	44.83	27.18
-8.22	6.65	40.08
-14.04	23.66	-14.81
37.44	-23.62	-11.44
3.12	-29.51	-29.51
24.64	-55.3	-20.9
26.99	-84.93	-5.06
-26.52	-81.62	-12.53
45.74	-.79	-33.52
-3.14	-63.13	-23.27
-44.95	29.79	-1.59
31.33	-19.35	30.65
-9.09	8.7	66.68
-15.8	-62.55	-.87
-36.06	-61.19	4.82

// Sidhu H, 2004: Irritable Bowel Syndrome (IBS)
// Subjects=8
-27.26	-9.1	58.34
-43.29	-6.99	59.47
58.2	-14.3	52.22
5.81	21.31	63.22
-52.92	-15.94	54.75
60.17	-16	30.04
-8.99	2.07	77.27
-3.14	41.27	19.27
-5.71	9.33	-49.39
-5.11	23.25	34.19
-2.13	37.33	9.55
0.08	37.05	19.59
-10.73	36.76	3.01
8.42	66.74	3.62
-24.32	43.11	45.01
28.69	61.06	-2.83
-24.77	56.09	-7.37
9.84	27.57	33.65
26.86	55.42	34.47
47.85	58.21	-13.96
11.42	-47.31	70.03
-11.27	-86.27	22.26
-1.51	-84.76	40.97
30.57	-74.45	47.55
-24.19	-96.1	6.5
-41.64	15.43	5.15
47.09	11.99	7.77
42.7	4.16	-10.48
37.34	11.62	-9.93
41.73	-6.88	-1.74
-38.47	9.65	-1.09
-46	5.75	-9.6
-29.37	-6.57	63.73
-43.29	-6.99	59.47
60.25	-8.63	42.8
5.81	21.31	63.22
-52.92	-15.94	54.75
60.17	-16	30.04
-8.99	2.07	77.27
-3.14	43.47	20.2
-5.71	9.33	-49.39
-5.17	23.7	26.34
-2.13	37.33	9.55
-3.17	38.81	15.02
0.08	37.05	19.59
-10.68	21.96	4.25
10.52	69.76	1.11
-24.32	43.11	45.01
28.69	61.06	-2.83
-26.88	59.59	-3.18
-24.77	56.09	-7.37
9.84	27.57	33.65
26.84	53.05	31.32
47.85	58.21	-13.96
12.46	-46.5	66.6
-11.27	-86.27	22.26
-1.51	-84.76	40.97
30.57	-74.45	47.55
-24.19	-96.1	6.5
-45.95	18.4	2.72
47.09	11.99	7.77
42.7	7.42	-9.64
37.34	11.62	-9.93
41.73	-6.88	-1.74
-38.47	9.65	-1.09
-46	5.75	-9.6
-26.17	-8.83	61.66
-49.77	-12.12	48.82
60.33	-7.77	53.88
11.16	19.23	63.33
-52.95	-21.74	48.55
60.17	-16	30.04
-9.02	4.99	73.68
-3.17	43.12	15.77
0.65	16.52	-53.41
-5.15	20.62	27.72
-5.36	42.6	9.15
-3.17	38.81	15.02
1.1	40.95	14.79
-10.72	43.54	8.02
9.51	64.81	6
-28.56	39.11	48.74
28.69	61.06	-2.83
-26.88	59.59	-3.18
-30.11	53.85	-8.24
5.51	29.14	26.88
26.84	53.05	31.32
47.88	58.55	-9.53
12.45	-43.24	67.44
-11.27	-86.27	22.26
-3.69	-83	36.39
30.57	-74.45	47.55
-24.22	-92.04	3.93
-45.92	18.66	6.05
51.35	15.19	7.45
42.7	5.3	-9.46
37.4	12.3	-1.07
38.54	-8.92	-.42
-38.52	9.05	-8.84
-41.61	12.51	8.74

// Sidhu H, 2004: Healthy Controls (HC)
// Subjects=8
48.41	-4.1	33.64
-49.64	-26.15	60.03
-50.83	-24.1	45.38
-15.39	-36.35	62.72
-40.12	-13.92	52.21
-33.82	14.59	48.63
43.26	-18.62	52.76
32.48	5.64	50.85
1.3	21	32.07
5.37	37.63	12.79
4.16	39.43	-5.19
-1.15	33.13	-3.49
3.4	20.67	27.62
9.84	22.11	31.88
-37.38	43.89	14.98
5.42	42.55	21.3
-27.95	60.72	-2.15
-2.14	41.64	10.31
26.97	36.81	41.6
3.39	31.59	31.16
15.45	-87.17	22.02
0.57	-47.94	49.01
18.62	-68.83	24.91
2.74	-91.51	35.92
5.72	-14.76	37.25
-42.59	6.76	17.04
-37.35	2.51	2.84
-43.76	11.27	6.64
39.49	1.94	-11.38
40.55	10.58	-9.88
48.14	-.32	-.13
-35.33	47.45	5.74
53.74	-4.24	31.36
-51.77	-22.73	63.12
-50.83	-24.1	45.38
-15.39	-36.35	62.72
-42.28	-16.3	49.08
-33.82	14.59	48.63
43.26	-18.62	52.76
32.48	5.64	50.85
1.26	23.91	28.48
1.09	34.26	10.89
5.37	37.63	12.79
4.16	39.43	-5.19
-2.22	33.13	-3.47
-4.33	37.77	1.74
3.4	20.67	27.62
11.96	20.81	28.62
-37.38	43.89	14.98
5.42	42.55	21.3
-30.07	55.34	-2.79
-2.14	41.64	10.31
26.97	36.81	41.6
3.39	31.59	31.16
15.45	-87.17	22.02
0.57	-47.94	49.01
18.62	-68.83	24.91
13.53	-51.95	64.82
2.74	-91.51	35.92
5.72	-14.76	37.25
-42.66	8.28	9.11
-37.35	2.51	2.84
-43.76	11.27	6.64
39.49	1.94	-11.38
40.55	10.58	-9.88
48.14	-.32	-.13
-35.33	47.45	5.74
53.74	-4.24	31.36
-51.77	-22.73	63.12
-51.91	-26.39	43.35
-19.66	-29.77	65.57
-42.28	-16.3	49.08
-33.89	16.1	40.69
43.34	-22.16	61.97
32.42	16.04	47.74
1.26	23.91	28.48
1.09	34.26	10.89
1.1	37.6	12.84
4.16	39.43	-5.19
0.96	31.83	-6.75
1.01	37.81	1.67
1.33	21.34	36.5
2.33	23.92	28.47
-41.64	45.09	17.16
1.19	35.29	24.18
-30.07	55.34	-2.79
-2.14	41.64	10.31
22.67	45.33	42.05
1.34	32.43	42.27
12.21	-79.79	21.44
1.68	-53.05	51.66
18.62	-68.83	24.91
11.45	-62.37	67.94
1.6	-90.08	26.89
1.38	-11.07	30.3
-42.67	12.51	8.76
-37.32	1.71	6.25
-38.43	13.33	5.29
39.49	1.94	-11.38
38.43	14.08	-5.69
43.87	-11.26	-3.63
-35.33	47.45	5.74

// Kim J, 2004: Huntington's Disease (HD)
// Subjects=8
-54	-30	-14
54	0	-14
-10	-18	14
52	32	6
16	-22	16
56	-30	50
16	14	8
16	46	42
50	39	-4
-24	-94	23
-4	-54	40
-36	44	27

// Kim J, 2004: Healthy Controls (HC)
// Subjects=12
50	39	-4
-24	-94	23
-4	-54	40
-36	44	27

// Yoo S S, 2004: Visual working memory (VW) > Rest
// Yoo S S, 2004: Auditory working memory (AW) > Rest
// Yoo S S, 2004: Dual working memory (DW) > Rest
// Yoo S S, 2004: Conjunction anaylsis AW + VW
// Yoo S S, 2004: DW > (AW + VW)
// Subjects=14
37.71	56.97	1.46
-40.02	50.52	5.66
60.84	20.94	28.16
-55.7	13.92	39.81
62.84	-49.17	1.45
56.16	-29.92	-10.43
-46.32	-60.81	-2.26
37.83	30.49	5.2
-40.14	23.34	-9.57
-.16	4.26	71.19
-47.9	-13.84	52.51
-2.81	25.8	37.73
38.58	-42.66	49.4
-36.99	-44.75	54.26
7.69	-80.39	-7.97
-33.5	-69.56	-16.18
33.17	56.36	-16.33
-44.63	54.92	-15.98
53.21	13.81	21.16
-44.06	15.39	20.42
52.89	14.72	-3.58
-50.66	11.24	10.85
60.27	49.53	-10.51
-64.95	41.1	-1.94
58.28	31.1	-.81
-55.15	30.7	1.16
44.16	21.71	-8.61
-40.13	19.08	-9.15
-4.54	7.12	67.62
-54.49	28.04	52.96
-.72	29.65	32.83
14.34	76.27	36.93
57.75	49.39	45.57
16.31	4.78	6.99
-13.96	5.63	6.3
11.94	2.49	2.81
-9.67	2.4	3.18
8.36	0.31	-23.81
-32.47	-73.16	-20.33
37.47	58.4	-17.73
-31.59	62.07	-9.07
61.8	14.59	17.57
-48.43	15.06	17.16
53.03	17.98	8.42
-50.81	14.45	-.67
68.39	-52.47	11.77
-61.39	-43.02	5.2
55.09	-28.75	-9.4
-55.12	-25.95	-7.8
53.08	-58.23	-3.09
-45.19	-58.27	1.95
56.32	-29.84	1.89
-50.64	-29.15	3.64
46.28	22.47	-12.08
-42.3	15.68	-11.02
-2.33	6.38	71.02
-34.65	-39.03	69.34
-52.26	-15.23	49.36
-4.93	24.94	40.09
14.88	-64.12	50.81
-13.17	-66.14	53.73
53.73	-38.04	52.05
-36.99	-44.75	54.26
27.08	-49.06	-6.92
-18.25	-51.04	-2.59
-14.99	0.52	9.06
16.32	2.65	7.2
9.82	-15.01	2.33
-10.68	-20.3	4.33
10.9	-78.46	-10.46
-32.65	-22.01	-24.26
35.42	57.09	-8.6
-35.82	52.9	-3.61
60.7	19.91	17.06
-56	13.86	16.29
64.65	54.32	-5.46
42.18	24.12	5.76
-40.02	25.33	0.31
-1.26	4.15	70.1
-52.39	26.46	47.48
-2.81	27.93	37.52
37.14	53.05	39.96
9.19	77.67	-28.12
-32.97	69.67	-31.09
-4.38	-30	72.41
-34.67	-39.13	68.23
-25.13	49.88	-13.58
52.15	-65.91	6.65
-10.84	-60.53	67.7
-18.25	-49.97	-2.69
26	-49.07	-6.9

// Derrfuss J, 2004: Common activations for task switching, the Stroop task, 
// and the n-back task
// Derrfuss J, 2004: Overlap of switch (switch > null) and stroop (incongruent 
// > neutral)
// Derrfuss J, 2004: Overlap of switch (switch > null) and n-back (2-back vs 
// 0-back)
// Derrfuss J, 2004: Overlap of stroop (incongruent > neutral) and n-back 
// (2-back > 0-back)
// Derrfuss J, 2004: Switch > Null
// Derrfuss J, 2004: Incongruent > Neutral
// Derrfuss J, 2004: 2-back > 0-back
// Subjects=19
-39.27	5.78	31.59
51.52	12.5	27.75
-2.83	17.06	50.29
-42.58	26.65	26.53
-28.35	4.99	61.64
-32.08	22.63	1.09
42.21	-41.43	46.88
-2.57	-59.33	53.35
-10.45	-24.05	14.8
45.97	13.67	2.06
-5.02	16.44	42.56
-43.67	27.53	24.24
54.75	9.52	30.19
-48.92	8.72	29.22
-26.22	4.91	60.5
2.48	20	46.64
31.43	8	54.01
-42.55	18.19	27.24
5.59	32.2	38.89
-42.61	38.46	27.77
48.11	37.89	12.28
-39.28	2.44	29.64
53.7	7.48	31.49
48.48	5.48	47.33
-26.36	-3.14	38.88
-28.32	-4.53	62.43
6.79	10.51	47.39
-48.99	21.16	24.83
-45.9	23.32	11.23
56.8	18.53	22.72
-.67	-12.34	41.58
2.72	-3.83	68.71
-36.43	49.21	1.15
-49	34.27	29.31
-48.9	15.5	34.23
-25.24	10.58	51.1
5.77	17.62	56.84
32.47	13.21	52.44
0.22	31.91	35.63

// Curtis C E, 2004: Match > Nonmatch (Stimulus cue period)
// Curtis C E, 2004: Nonmatch > Match (Stimulus cue period)
// Curtis C E, 2004: Match > Nonmatch (Early delay period)
// Curtis C E, 2004: Nonmatch > Match (Early delay period)
// Curtis C E, 2004: Match > Nonmatch (Late delay period)
// Curtis C E, 2004: Nonmatch > Match (Late delay period)
// Curtis C E, 2004: Match > Nonmatch (Memory-guided saccade period)
// Curtis C E, 2004: Nonmatch > Match (Memory-guided saccade period)
// Subjects=15
-43	24	46
64	-2	38
-54	-50	46
50	-46	40
8	-56	68
10	-34	68
5	6	56
48	0	54
42	23	56
50	-36	56
44	24	42
23	46	42
-32	14	38
-18	58	32
-30	48	32
-8	-50	30
14	-51	32
5	-88	31
0	-10	55
50	-40	64
17	-72	58
52	-50	52
-50	-52	54
46	22	28
-44	22	30
17	-72	58
-8	-8	58
52	-10	53
52	-33	58
6	0	46
-20	-94	35
18	-94	34
-58	2	27
52	2	28
6	-56	54
2	26	52
26	24	43
-40	22	40
28	40	36
46	-43	40
-42	-52	22

// Greicius M D, 2004: Fragile X Syndrome
// Subjects=12
-22	-84	-6
-26	11	-12
-24	-66	35
24	-68	37
24	-19	53

// Greicius M D, 2004: Healthy Controls
// Subjects=16
-2	-78	-1
-26	11	-12
-24	-66	35
24	-68	37
24	-19	53

// Menon V, 2004: Fragile X Syndrome
// Subjects=18
-3.43	-60.92	-28.76
7.52	-2.88	-5.55
-11.64	49.51	27.69
42.65	-69.71	24
5.01	51.38	-22.08

// Constable R T, 2004: Subject & Object Relatives, Auditory > Pitch Judgment
// Constable R T, 2004: Subject & Object Relatives, Visual > Orientation 
// Judgment
// Constable R T, 2004: Subject & Object Relatives, Visual- Subject & Object 
// Relatives, Auditory, Activations
// Constable R T, 2004: Subject & Object Relatives, Visual- Subject & Object 
// Relatives, Auditory, Deactivations
// Constable R T, 2004: Object Relative, Visual & Auditory > Subject Relative, 
// Visual & Auditory
// Subjects=20
-64.62	-42.93	6.36
-60.34	-21.33	7.52
-48.6	31.25	6.6
-37.16	-82.13	33.31
0.76	5.25	58.75
60.59	-18.12	0.66
35.71	23.14	7.08
2.92	5.25	58.72
-61.37	-48.34	5.72
-59.29	-32.48	3
-45.42	34.14	2.9
-56.88	-52.5	18.39
-5.9	-52.99	33.25
64.98	-50.43	-.7
60.63	-24.4	2.4
39.91	28.81	-1.39
58.75	-63.89	16.42
3.82	21.44	48.14
-61.3	-56.53	9.9
-53.92	30.79	13.46
-43.71	-75.02	29.35
-41.67	7.28	36.87
-9.15	-55.23	32.41
-42.16	-42.38	-12
-30.37	-12.35	-12.93
-5.13	-83.75	2.67
60.77	-56.21	6.66
54.47	-70.18	18.24
5.01	85.29	-15.35
-46.24	-31.81	9.43
-42.01	24.45	13.88
49.06	11.85	34.87
54.17	-23.15	4.63
49.11	11.1	38.3
-53.78	-60.11	5.64
-51.76	14.32	9.45
-37.16	-63.53	37.07
-37.23	10.35	46.57
-.69	11.26	31.29
-1.9	-22.52	14.48
48.58	8.21	-3.99
47.76	18.9	18.5

// Cunningham W A, 2004: Black faces 30-ms > White faces 30-ms
// Cunningham W A, 2004: Black faces 525-ms > White faces 525-ms
// Cunningham W A, 2004: White faces 525-ms > Black faces 525-ms
// Subjects=13
18	-6	-12
-21	30	39
30	-6	-33
-3	0	66
-48	-6	54
-6	36	24
-9	18	33
3	18	33
57	30	-12
27	48	24
33	48	36
24	60	27
0	0	72
-57	18	36
33	-24	-18

// Kim D, 2004: Right lift-abduction/fall-adduction (LAFA) > Rest, After > 
// Before Intervention
// Kim D, 2004: Left LAFA > Rest, After > Before Intervention
// Kim D, 2004: Right LAFA > Rest, Before > After Intervention
// Kim D, 2004: Left LAFA > Rest, Before > After Intervention
// Kim D, 2004: Right LAFA Fast > Slow, After intervention
// Kim D, 2004: Left LAFA Fast > Slow, After Intervention
// Kim D, 2004: Right Sensory Stimulation > Rest, After > Before Intervention
// Kim D, 2004: Left Sensory Stimulation > Rest, After > Before Intervention
// Subjects=8
69.37	-46.6	5.57
31.6	-98.93	-.94
60.35	5.19	-13.97
73.69	-12.68	12.22
-2.47	-49.4	48.53
-62.24	-41.26	24.09
60.53	-57.97	-12.21
-66.38	-25.68	41.67
48.83	-64.32	0.95
53.76	-26.89	56.55
-37.04	-62.59	47.06
-28.52	9.84	52.08
44.53	22.29	20.46
1.26	33.73	18.95
-11.36	-30.47	33.36
53.61	-16.02	46.51
22.58	52.46	-0.08
-54.33	-1.88	-25.89
14.09	-91.94	-17.02
22.69	-62.67	-14.46
48.34	20.69	-19.78
35.16	26.64	-35.83
13.91	-7.94	-14.12
-15.74	-27.6	29.79
-11.64	9.01	19.37
5.6	64.56	27.03
5.17	64.64	-6.59
44.05	-5.37	-22.73
44.72	-18.98	26.79
-45.68	-15.54	57.12
5.4	-71.55	-16.65
-7.4	-56.11	-0.03
-3.24	-71.58	-16.5
45.16	-1.42	65.38
-57.84	-1.29	37.99
1.56	3.17	36.53
-62.37	-15.94	19.34
22.46	-21.71	-24.11
0.92	60.78	-1.65
1.94	-9.33	63.54
27.19	-90.85	-6.14
27.74	-6.88	53.89

// Li X, 2004: Motor cortex TMS: 100% MT Placebo > Rest
// Li X, 2004: Motor cortex TMS: 120% MT Placebo > Rest
// Li X, 2004: Motor cortex TMS: 120% MT Placebo > 100% MT Placebo
// Li X, 2004: Motor cortex TMS: 100% MT Lamotrigine (LGT) > Rest
// Li X, 2004: Motor cortex TMS: 120% MT LTG > Rest
// Li X, 2004: Prefrontal cortex TMS: 100% MT Placebo > Rest
// Li X, 2004: Prefrontal cortex TMS: 120% MT Placebo > Rest
// Li X, 2004: Prefrontal cortex TMS: 100% MT LTG > Rest
// Li X, 2004: Prefrontal cortex TMS: 120% MT LTG > Rest
// Li X, 2004: Motor cortex TMS: 120% MT Placebo > 120% MT LTG
// Li X, 2004: Prefrontal cortex TMS: 100% MT LTG > 100% MT Placebo
// Subjects=8
10.03	-44.06	13.05
-2.95	34.55	27.9
53.57	-10.81	44.88
-63.39	-26.47	21.52
-42.07	19.57	7.64
44.37	15.62	6.56
-46.6	13.64	-9.62
5.23	66.12	-2.25
-24.73	-10.57	5.85
-50.82	1.27	-3.85
70.28	-23.82	-3.43
40.85	-13.44	63.28
-41.26	-13.73	64.71
-41.24	-48.6	59.19
10.03	-44.06	13.05
-2.95	34.55	27.9
53.57	-10.81	44.88
-63.39	-26.47	21.52
40.85	-13.44	63.28
-39.17	-18.6	58.43
70.28	-23.82	-3.43
-42.47	3.48	-26.62
22.48	0.29	-18.44
-46.57	5.13	-8.78
48.62	-11.14	-4.31
49.03	-56.27	18.08
-38.3	-2	-39.59
44.77	1.09	34.88
-36.98	-18.39	60.62
-46.33	46.33	18.51
36.3	15.49	51.53
-3.03	38.38	23.04
44.71	0.68	30.44
40.07	11.35	7.06
-37.77	23.84	7.15
57.84	-11.21	40.36
-63.77	27.59	2.74
44.07	4.62	-19.24
-33.32	-23.36	7.26
-37.87	5.57	-4.49
5.81	-12.64	27.94
53.35	18.14	33.05
-2.45	7.67	61.93
10.17	-43.02	24.15
-2.98	12.44	21.13
27.99	-25.84	69.21
-63.39	-26.47	21.52
-46.47	10.21	-.32
31.62	47.85	30.48
-28.79	-48.04	18.59
-50.77	19.12	3.35
62.05	-55.81	22.29
-63.6	-1.78	10.12
18.49	33.38	14.21
61.86	-22.19	14.49
66.03	2.93	7.45
-67.83	3.29	18.66
48.23	16.57	-29.46
-37.6	-36.14	8.59
22.63	-24.82	-11.48
-20.43	-50.09	-3.76
-32.72	11.82	62.04
44.28	54.32	7.21
-7.18	-4.17	27.33
40.34	0.25	26.08
57.61	-26.05	19.42
57.84	-11.21	40.36
22.46	-8.64	-22.04
-25.19	-9.63	-30.1
-63.86	5.07	-8.48
61.7	-10.26	4.34
-58.86	-20.54	38.79
-7.12	9.42	34.94
-51.05	47.66	-12.91
57.86	-2.28	43.96
-32.71	-18.79	56.1
0.76	-19.94	53.4
0.91	-59.29	57.29
14.95	-49.81	-25.69
-45.83	14.65	-33.27
-26.27	-12.93	-30.87
43.13	15.54	-5.74
33.92	32.42	37.57
58.98	-28.22	42.02

// Ganis G, 2004: Perception (P) >0, Imagery (I) >0, P-I=0
// Ganis G, 2004: P<0, I<0, P-I=0
// Ganis G, 2004: P>0, I=0, P-I>0
// Ganis G, 2004: P<0, I=0, P-I<0
// Subjects=20
-46.98	23.14	9.03
49.22	19.57	9.34
-38.3	26.76	27.58
40.79	26.27	27.83
-20.16	39.82	29.63
22.55	44.05	25.44
-7.14	15.55	44.89
9.95	17.76	44.51
-39.43	0.81	8.58
42.8	6.25	2.72
-44.55	-1.31	36.7
46.23	4.26	31.85
-8.48	32.43	15.61
9.72	29.62	18.99
-34.23	-65.4	-36.11
-48.7	-42.83	36.89
44.28	-41.05	37.9
-45.45	-37.98	44.25
44.35	-40.36	46.76
-28.18	-59.14	58.09
31.65	-58.87	56.27
-17.54	-65.05	49.54
18.8	-63.69	50.13
-50.87	-20.12	41.7
51.69	-20.91	36.12
-2.89	-35.21	21.22
4.6	-36.22	21.22
-6.13	9.41	34.25
8.82	10.56	33.98
-51.1	-21.38	11.69
51.5	-22.88	10.64
-57.52	-59.97	-5.07
56.73	-51.43	-14.9
-53.19	-53.89	4.41
55.74	-41.86	-1.2
-56.45	-24.84	8.7
56.8	-23.28	5.04
-16.95	-34.81	0.16
20.39	-28.67	-6.36
-53.32	-57.46	-14.25
50.34	-55.61	-13.36
-53.13	-65.35	7.6
53.73	-63.56	7.34
-32.57	-75.77	36.12
-2.9	-90.22	-2.04
7.79	-95.62	-3.94
-11.31	-83.36	18.67
6.84	-88.97	13.35
-23.47	-.84	-.38
24.61	2.62	-1.22
-30.97	6.52	-.91
30.97	18.61	-1.52
-9.47	-17.24	6.41
9.76	-16.07	6.09
-13.77	2.28	11.51
13.99	5.45	8.7
-6.13	9.41	34.25
8.82	10.56	33.98
-9.49	-51.48	-9.68
12.94	-55.83	-12.92
7.76	-89.36	-5.58
-4.9	-92.12	14.87
18.67	-85.84	25.22
-56.82	24.11	-18.82
-26.5	33.86	35.77
53.69	26.06	37.74
-16.96	50.75	33.13
17.25	51.05	33.83
-3.34	56.73	-.98
5.27	58.61	8.8
-5.39	36.8	2.95
20.34	40.01	14.65
55.01	-57.01	36.88
49.64	-52.99	34.38
52.71	-51.08	17.45
49.6	-55.53	29.01
27.3	-79.47	37.97
-47.8	-72.09	2.53
46.22	-67.29	1.04
44.2	-71.57	14.81
-27.6	-57.59	-4.5
25.83	-50.75	-3.45
-28.67	-63.14	-7.36
27.96	-65	-8.97
-43.52	-82.98	-1.07
41.95	-79.29	-2.36
-30.57	-89.19	13.8
36.74	-84.56	12.64
-18.95	-79.57	-.52
18.51	-79.89	5.77
-18.71	-91.35	26.11
20.83	-89.97	26.66
19.4	-30.1	2.69
-30.88	-51.86	-12.75
23.63	-50.31	-11.27
-4.9	-54.8	29.58
-2.83	-53.27	21.62
3.57	-53.32	20.44
-1.69	-52.49	31.58

// Handy T C, 2004: Picture recall > Rest
// Handy T C, 2004: Noun recall > Rest
// Handy T C, 2004: (Picture recall > Rest) > (Noun recall > Rest)
// Handy T C, 2004: Encoding > Encoding rest
// Subjects=15
53	41.8	10.55
-35.05	37.44	-31.23
-50.31	14.9	38.5
8.15	16.04	47.48
-31.47	26.87	-6.71
-37.63	32.53	19.73
-30.55	-67.99	46.36
-47.52	-57.39	-11.54
-46.82	-39.02	47.14
-17.68	13.38	54.9
46.38	21.07	-4.1
-37.82	47.55	8.16
-41.24	16.64	-12.25
-40.73	7.3	25.64
-50.05	-42.22	47.51
-44.28	-57.38	-11.6
-30.55	-67.99	46.36
30.82	9.43	44.38
33.31	49.74	-6.71
40.11	32.49	15.05
40.22	3.78	17.89
18.04	-71.32	42.5
40.79	-54.35	50.52
-37.64	-88.95	-5.23
37.05	-90.95	3.78
-30.41	-60.36	59.05

// Kawashima R, 2004: Adults
// Subjects=8
6.28	6.2	68.65
-21.98	0.39	54.02
-39.68	10.39	24.2
59.92	16.66	39.81
-40.04	1.11	-6.25
-32.57	-57.08	59.89
-44.39	-66.93	-21.86
44.11	-58.52	-28.68
-20.18	-98.59	5.51
31.67	-98.41	4.61
-4.43	4.66	75.71
-43.97	10.59	26.49
-30.47	-55.36	55.2
38.52	-43.18	43.85
-41.97	-82.48	-4.67
50.82	-65.55	-12.41
-35.29	-96.31	7.79
33.76	-94.56	-.29
-57.03	20.76	21.22
53.28	13.27	26.81
57.2	49.7	2.97
-22.85	24.56	-8.87
-32.72	-47.27	49.95
25.76	-61.33	57.07
-48.49	-80.59	-6.99
39.84	-62.58	-25.97
-18.14	-97.29	-3.62
35.91	-90.3	-.74

// Kawashima R, 2004: Children
// Subjects=8
1.63	19	45.05
-44.1	20.6	18.78
-50.82	-64.41	-17.52
50.46	-59.54	-39.9
-20.04	-106.27	15.24
27.46	-104.18	11.98
-48.29	17.16	28.16
43.04	-52.56	58.15
-55.09	-55.29	-11.62
40.61	-48.05	37.58
-17.91	-106.47	12.98
27.44	-97.8	11.35
-52.57	13.1	30.87
-37.93	35.77	-3
-39.55	-89.32	13.89
50.64	-62.55	-26.15
-35.22	-91.43	14.03
27.42	-102.26	9.55

// Mechelli A, 2004: Perception > Perception-Control (Participant 1)
// Mechelli A, 2004: Perception > Perception-Control (Participant 2)
// Mechelli A, 2004: Perception > Perception-Control (Participant 3)
// Mechelli A, 2004: Perception > Perception-Control (Participant 4)
// Mechelli A, 2004: Perception > Perception-Control (Participant 5)
// Mechelli A, 2004: Imagery > Imagery-Control (Participant 1)
// Mechelli A, 2004: Imagery > Imagery-Control (Participant 2)
// Mechelli A, 2004: Imagery > Imagery-Control (Participant 3)
// Mechelli A, 2004: Imagery > Imagery-Control (Participant 4)
// Mechelli A, 2004: Imagery > Imagery-Control (Participant 5)
// Mechelli A, 2004: (Category) Chairs > Faces and houses (Participant 1)
// Mechelli A, 2004: (Category) Chairs > Faces and houses (Participant 2)
// Mechelli A, 2004: (Category) Chairs > Faces and houses (Participant 3)
// Mechelli A, 2004: (Category) Chairs > Faces and houses (Participant 4)
// Mechelli A, 2004: (Category) Chairs > Faces and houses (Participant 5)
// Mechelli A, 2004: (Category) Faces > Houses and chairs (Participant 1)
// Mechelli A, 2004: (Category) Faces > Houses and chairs (Participant 2)
// Mechelli A, 2004: (Category) Faces > Houses and chairs (Participant 3)
// Mechelli A, 2004: (Category) Faces > Houses and chairs (Participant 4)
// Mechelli A, 2004: (Category) Faces > Houses and chairs (Participant 5)
// Mechelli A, 2004: (Category) Houses > Chairs and faces (Participant 1)
// Mechelli A, 2004: (Category) Houses > Chairs and faces (Participant 2)
// Mechelli A, 2004: (Category) Houses > Chairs and faces (Participant 4)
// Mechelli A, 2004: (Category) Houses > Chairs and faces (Participant 5)
// Subjects=5
-22.52	-91.13	-6.39
-28.09	-53.69	72.92
-39.9	-87.56	-13.17
-28.98	-88.82	-4.27
-41.23	-59.44	58.03
-46.36	-78.66	-9.46
-35.48	-91.18	-6.17
-32.54	-48.15	63.48
-44.2	-85.24	-11.09
-35.57	-76.49	-9.86
-19.52	-69.59	63.14
-46.39	-85.46	-13.27
-26.67	-98.62	5.63
-21.76	-57.04	59.7
-48.51	-80.79	-9.21
-9.22	-51.39	27.55
-15.42	-64.64	46.9
-38.09	63.01	-10.17
-20.03	-101.81	17.03
-15.09	-75.33	70.36
-24.75	68.09	20.47
-6.99	-61.81	30.78
-4.34	-77.83	65.94
-3.32	55.87	3.39
-6.97	-96.68	25.27
-15.17	-78.08	63.91
-35.94	49.84	-13.39
-19.88	-52.52	39.05
-8.84	-61.66	55.45
-27.07	51.53	4.22
-48.18	-84.89	15.84
-70.23	-37.91	-8.6
-48.5	-76.33	-7.41
-54.98	-69.77	-5.71
-48.5	-76.33	-7.41
-40.05	-79.88	-22.89
-39.98	-81.6	-18.24
-24.49	-87.56	8.98
-33.5	-59.68	-13.8
-31.37	-42.45	-13.3
-22.59	-78.58	-9.87
-35.59	-76.7	-12.08
-35.7	-70.94	-19.37
-37.83	-70.74	-17.11
-24.72	-65.2	-4.44

// Yomogida Y, 2004: Subgroup of Healthy Participants, Word Task
// Subjects=23
-43.94	10.79	28.71
-44.35	12.14	-2.79
-48.81	26.39	-10.85
-53.16	-70.12	-32.6
-16.05	-93.44	-8.51
10.26	21.16	44.69
44.01	-46.18	-34.38
48.48	-69.14	-27.71
11.9	-87.79	-18.51
-41.76	11.01	30.89
-50.8	34.22	4.1
-55.03	-63.59	-8.56
-26.25	-58.3	46.45
-16.32	-25.38	-15.24
24.69	-27.77	-20.19
18.51	-1.49	8.69
10.29	21.36	46.91
33.12	-38.12	-39.48
-50.54	9.94	19.94
-50.8	34.22	4.1
-57.17	-63.39	-6.3
18.52	2.97	10.49
-11.76	2.66	8.8
18.3	-88.39	-25.29
-26.16	14.59	68.37
-48.34	14.62	23.93
-51.07	51.91	-13.33
-37.02	-44.95	52.04
30.12	-63.24	59.43
-55.02	-65.72	-8.35
61.62	-63.39	-12.81
-30.62	-74.04	39.12

// Yomogida Y, 2004: Subgroup of Healthy Participants, Picture Task
// Subjects=20
-39.78	29.33	20.08
-33.52	58.3	8.15
-33.7	28.57	-11.32
-9.07	13.2	52.53
-42.31	-52.24	-25.59
41.83	-48.52	-36.36
-21.9	7.61	62.27
-50.55	20.78	21.11
-52.71	36.08	24.12
-48.9	49.79	-13.16
52.92	41.18	3.89
-32.72	-47.27	49.95
-52.92	-59.54	-11.24
18.5	0.64	8.48
8.05	27.32	41.88
39.63	-53.2	-40.34
-26.16	14.59	68.37
-48.34	14.62	23.93
-51.07	51.91	-13.33
-37.02	-44.95	52.04
30.12	-63.24	59.43
-55.02	-65.72	-8.35
61.62	-63.39	-12.81
-30.62	-74.04	39.12

// Johnston S, 2004: Different Orientation - Same Orientation
// Subjects=9
6	-62	58
2	14	54
-42	18	2

// Ragland J D, 2004: Schizophrenics
// Subjects=14
-49.97	9.95	31.36
-33.07	60.8	26.9
-28.87	64.37	17.63
-41.16	-4.86	59.26
-53.99	-22.55	51.97
61.19	-15.45	23.29
-2.71	-.4	58.45
1.3	23.29	34.11
-54.48	7.52	0.39
26.76	-26.86	-11.04
22.55	-26.2	-2.13
-66.96	-28.57	30.32
-41.54	-61.45	-11.82
43.8	42.98	9.67
-41.38	6.11	36.04
-33.11	25.25	7.58
22.41	20.67	-1.6
-32.41	-68.6	60.05
-28.19	-16.45	73.47
-45.84	-44.21	-8.76
56.78	-34.45	-1.83
-28.68	-52.22	-3.82
9.76	-43.53	-4.99
22.87	-93.19	12.41
44.12	-68.02	5.59
30.68	39.82	-30.06
30.69	57.42	-22.62
-28.37	-5.13	54.68
35.76	-26.58	46.82
-2.76	3.48	53.66
-33.5	3.54	-53.05
-41.21	-84.42	21.33
-11.59	-21.49	6.79
18.31	-17.08	6.08
-41.54	-61.45	-11.82
-2.99	-73.56	-6.79
5.56	-64.71	-3.17
-24.06	-88.21	25.91
31.45	-92.79	16.74
31.64	-51.3	57.86
-46.04	54.78	5.25
-33.05	47.77	23.53
-41.47	40.29	37.64
69.87	-14.03	40.91
57.18	-12.74	58.79
35.22	24.98	-2.11
-3.02	-8.06	14.49
5.51	-3.78	14.03
-23.79	-59.06	72.53
18.95	-58.81	72.02
30.68	39.82	-30.06
-41.15	-9.09	59.62
-28.16	-24.91	74.18
-11.21	-13.14	59.61
-33.49	-.69	-52.69
31.59	-47.41	53.08
-7.82	30.44	-37.76
39.28	35.98	-25.38
9.28	56.95	-26.79
-37.42	55.52	14.01
-28.23	-16.79	69.04
18.87	-20.05	77.69
73.94	-42.46	3.1
47.99	-23.87	-29.38
1.34	-51.02	9.12
-28.4	-97.72	13.38
-28.28	-48.11	49.36
44.48	-55.45	58.06
14.46	-65.46	41.4
44.05	23.54	33.6
9.28	56.95	-26.79
39.28	35.98	-25.38
-37.08	28.31	47.51
-11.64	-44	-9.17
65.42	-59.78	0.19
48.74	-51.2	57.66

// Ragland J D, 2004: Comparisons
// Subjects=15
-33.23	59.09	4.74
-28.78	47.8	23.48
-45.68	5.74	31.66
44.03	10.17	25.8
5.77	7.76	53.21
-11.35	-76.13	15.83
-41.52	-65.68	-11.47
44.1	-90.2	-5.93
43.8	42.98	9.67
-41.38	6.11	36.04
-33.11	25.25	7.58
22.41	20.67	-1.6
-32.41	-68.6	60.05
-28.19	-16.45	73.47
-45.84	-44.21	-8.76
56.78	-34.45	-1.83
-28.68	-52.22	-3.82
9.76	-43.53	-4.99
22.87	-93.19	12.41
44.12	-68.02	5.59
-37.46	55.18	9.58
-33.05	47.77	23.53
56.79	27.16	24.23
-45.68	5.74	31.66
44.06	10.51	30.23
-37.21	44.55	37.23
61.21	15.53	38.54
1.52	3.51	53.61
5.66	19.77	43.28
48.55	-.44	53.4
52.92	-16.99	59.2
-33.12	20.68	3.5
35.22	24.98	-2.11
-7.32	-12.66	10.46
9.78	-12.56	10.26
-28.18	-55.89	58.93
23.19	-59.12	67.54
-46.04	54.78	5.25
-33.05	47.77	23.53
-41.47	40.29	37.64
69.87	-14.03	40.91
57.18	-12.74	58.79
35.22	24.98	-2.11
-3.02	-8.06	14.49
5.51	-3.78	14.03
-23.79	-59.06	72.53
18.95	-58.81	72.02
30.68	39.82	-30.06
-41.15	-9.09	59.62
-28.16	-24.91	74.18
-11.21	-13.14	59.61
-33.49	-.69	-52.69
31.59	-47.41	53.08
-50.05	22.29	25.86
-58.33	-32.06	39.44
52.98	-33.91	60.62
-15.36	-64.61	55.06
23.16	-59.47	63.1
44.05	23.54	33.6
9.28	56.95	-26.79
39.28	35.98	-25.38
-37.08	28.31	47.51
-11.64	-44	-9.17
65.42	-59.78	0.19
48.74	-51.2	57.66

// Meister I, 2005: Musicians
// Subjects=12
-36	-23	59
-21	-6	61
-6	-3	55
24	3	61
3	0	61
-51	-27	48
-30	-33	49
-24	-52	58
-15	-58	53
-30	-35	57
-21	-43	66
39	-51	51
21	-61	56
12	-65	50
-9	2	41
-36	-4	42
-18	-3	61
6	-3	58
27	-4	53
6	11	44
-36	-26	40
-39	-26	54
-30	-41	63
-25	-53	47
-39	-47	44
39	-47	52
15	-49	61
36	-57	33
-33	0	58
-3	-3	55
-30	0	55
-6	-3	55

// Meister I, 2005: Non-Musicians
// Subjects=12
-36	-20	56
-30	-6	56
-27	0	55
-6	-9	47
24	-6	61
-33	-35	60
-33	-32	51
-24	-71	34
-24	-56	50
-30	-47	58
-33	-44	55
-33	-42	38
33	-47	49
21	-60	42
36	-42	44
-39	-18	53
-27	-3	53
-9	-3	53
0	8	47
24	-3	64
-36	-32	57
-33	-38	63
-39	-38	54
-30	-50	58
-9	-58	55
-24	-71	34
15	-58	61
12	-70	50
36	-41	49
-27	8	52
-3	6	60
3	6	60
-33	0	58
-3	-3	55
-30	0	55
-6	-3	55

// Milham M P, 2005: Congruent and Incongruent vs. Neutral
// Milham M P, 2005: Incongruent vs. Congruent
// Subjects=18
38	-68	-22
12	-28	-6
4	-12	-2
-14	-28	-2
14	6	-2
-22	-56	-6
-6	-86	0
-34	14	-14
-38	-72	0
-30	-80	8
38	-82	14
10	-78	10
66	-50	10
50	-50	22
18	-68	28
28	-62	46
-54	-48	22
-34	-54	22
-16	-68	28
-30	-62	40
-14	-68	54
-46	-30	40
-32	22	2
-44	46	22
-46	18	26
-30	26	54
-44	6	52
-28	42	2
30	22	2
34	18	18
32	38	20
36	58	30
28	46	44
44	24	48
-2	32	36
-2	14	38
0	14	54
12	22	36
34	-32	-24
-12	-24	16
8	-16	-4
-40	-50	-12
-26	-78	-12
-18	-54	-8
34	-78	-8
50	-50	-16
56	-38	-4
2	-70	2
24	-64	6
-26	-66	34
-32	-48	38
2	-54	36
54	-46	26
34	-50	36
-30	56	2
-36	16	6
-42	6	32
36	28	-6
40	14	26
6	20	28
-4	14	48

// Vink M, 2005: Go/Stop and Go Only
// Vink M, 2005: Go/Stop > Go Only
// Vink M, 2005: Parametric Analysis
// Vink M, 2005: Correct vs. Incorrect Stop
// Subjects=20
-22	5	-4
22	5	-4
42	-23	56
2	-3	56
-18	10	0
18	10	-4
-6	1	60
-42	18	-4
-18	10	0
18	10	-4
-6	10	48
-42	18	-4
-22	10	-4
22	10	-4

// Seurinck R, 2005: Hands, Fixed-Paced
// Seurinck R, 2005: Hands, Self-Paced
// Seurinck R, 2005: Tools, Fixed-Paced
// Seurinck R, 2005: Tools, Self-Paced
// Seurinck R, 2005: Tools, Fixed-Paced > Self-Paced
// Seurinck R, 2005: Tools, Self-Paced > Fixed-Paced
// Seurinck R, 2005: Fixed-Paced, Hands > Tools
// Seurinck R, 2005: Fixed-Paced, Tools > Hands
// Seurinck R, 2005: Self-Paced, Button Press Hand, Right > Left
// Seurinck R, 2005: Self-Paced, Button Press Hand, Left > Right
// Subjects=24
29.85	5.89	52.59
-19.76	4.11	59.22
-50.44	11.73	27.61
56.39	9.05	15.97
25.83	-48.8	64.8
40.63	-31.48	42.66
-19.62	-44.06	60.62
-39.33	-31.86	42.94
46.81	-74.23	9.81
-46.11	-72.43	11.21
46.81	-74.23	9.81
38.07	-85.94	-0.09
-44.08	-75.59	0.28
-35.4	-86.2	1.18
27.71	5.99	53.74
-19.89	3.18	49.23
12.93	-50.56	69.67
34.38	-39.62	59.26
-26	-48.78	67.92
-28.26	-44.09	60.77
-24.11	3.89	57.07
32.08	6.42	58.1
-23.85	-53.23	66.08
-47.94	-29.45	46.21
28.03	-50.72	67.19
40.79	-35.75	54.29
-41.92	-73.35	1.14
-29.06	-85.08	-10.24
31.45	-80.41	-9.49
42.31	-84.31	-5.93
-24.09	4.1	59.29
32.02	8.13	53.45
-10.87	-57.44	66.28
-50.06	-24.79	50.27
17.22	-56.28	65.68
40.66	-35.63	44.19
-24.68	-67.12	-2.01
-22.52	-67.11	-2.04
13.63	46.85	-25.14
4.03	35.74	-17.16
48.93	-65.72	8.93
51.12	-72.09	9.52
-48.29	-74.78	9.24
21.39	-63.89	52.92
29.3	-61.71	-4.58
32.46	-59.03	-10.5
-24.71	-62.97	-3.54
-26.98	-53.92	-10
-34.83	-16.25	60.37
47.24	-12.98	56.4
38.64	-16	59.09

// Wraga M, 2005: Object Task, Activations
// Wraga M, 2005: Object Task, Deactivations
// Wraga M, 2005: Self Task, Activations
// Wraga M, 2005: Self Task, Deactivations
// Wraga M, 2005: Object - Self
// Wraga M, 2005: Self - Object
// Subjects=11
-10.97	-57.11	58.4
-2.28	-55.6	62.59
27.93	-60.16	58.04
-37.2	8.43	49
-58.38	-50.19	-14.31
10.12	-70.76	14.57
-2.89	-97.37	6.22
-6.82	-20.07	52.42
-42.03	-18.38	3.55
-50.64	-5.03	9.1
-19.82	-93.66	35.27
-20	-100.54	19.15
14.25	64.59	26.88
-15.9	53.2	33
-20.18	44.78	35.03
4.92	35.35	-32.82
-7.93	40.6	-21.91
61.11	-60.2	32.83
66.42	-52.09	27.45
27.28	-98.95	-.86
-32.96	16.54	43.64
-50.47	18.11	26.98
28.01	-55.18	65.39
5.62	38.42	22.89
-2.92	35.92	31.13
-7.52	41.48	10.49
35.31	24.48	-24.42
-55.08	-54.12	-10.62
22.31	66.85	-18.3
44.08	-34.71	-26.56
-55.27	-34.75	-21.5
-28.86	-97.77	3.34
-11.36	-100.51	19
57.2	5.91	-6.15
-57.7	-7.9	47.6
-6.75	-2.02	61.84
-16.42	-14.09	-20.84
-33.81	-23.7	-30.8
-3.45	54.93	-6.6
-58.04	-29	17.2
-46.25	-30.75	9.33
40.6	-16.38	43.41
49.37	-11.05	53.94
40.68	-11.4	50.76
61.13	-64.45	33.25
-57.78	-61.03	30.45
-62.36	-50.91	12.72
26.68	-19.23	-32.27
64.59	-9.55	-22.67
-62.63	-2.61	1.22
-58.48	0.52	-11.49
-32.91	-.58	44.22
-55.08	10.5	3.16
61.25	-32.91	49.17
44.5	51.63	24.29
-45.82	-29.76	42.84
35.36	24.9	-19.98
10.42	-89.3	34.33
44.97	-29.13	44.59
-28.26	-44.09	60.77
1.91	-18.25	59.94
23.16	38.22	42.78
-58.03	-75.98	8.4
-46.35	-6.39	5.8
65.93	-36.06	-7.74

// Ford K A, 2005: Late preparatory period comparison: Anti vs. Pro
// Ford K A, 2005: Late preparatory period comparison: Correct Anti vs. Error 
// Anti
// Ford K A, 2005: Late preparatory period comparison: Error Anti vs. Correct 
// Anti
// Ford K A, 2005: Saccade period comparison: Pro vs. Anti
// Ford K A, 2005: Saccade period comparison: Error Anti vs. Correct Anti
// Subjects=10
-26.26	-2.03	53.28
23.99	-.42	55.91
-26.66	46.5	20.22
9.01	6.98	56.58
9.83	17.62	28.91
-26.18	-48.44	44.9
-18.63	-68.57	45.39
10.25	-65.94	49.3
27.82	56.51	20.98
9.85	22.19	32.99
3.64	12.15	55.09
-21.04	28.58	49.54
24.93	25.68	49.25
-3.7	-73.23	38.92
-40	-52.24	52.07
-2.71	-53.13	37.22
44.33	-64.74	34.31
5.78	-32.82	37.65
-14.59	23.5	52.12
-30.62	23.41	52.31
23.82	31.94	47.63
37.72	26.56	45.69
2.43	16.23	39.15

// MacDonald III A W, 2005: Patients with Schizophrenia
// Subjects=18
-43.66	16.7	21.8
45.11	12.46	27.83
35.29	59.73	20.63
-37.49	46.03	1.42
51.25	34.93	1.34
-45.94	21.75	4.67
24.65	57.98	26.47
-34.28	53.8	5.2
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// MacDonald III A W, 2005: Patients with Nonschizophrenia Psychosis
// Subjects=12
-25.68	41.25	7.27
33.21	27.39	15.56
56.66	14.88	2.96
24.65	57.98	26.47
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// MacDonald III A W, 2005: Normal Subjects
// Subjects=28
-27.69	57.92	30.42
46.1	27.01	23.25
-41.49	18.11	26.12
47.41	11.99	49.03
-41.43	14.31	32.01
24.65	57.98	26.47
-34.28	53.8	5.2
55.6	23.67	6.69
-8.62	60.64	8.79
33.14	60.69	19.46
54.51	23.49	4.49
-37.5	42.69	-.53

// Holmes A J, 2005: Schizophrenic Patients
// Subjects=7
42.91	49.17	34.81
48.34	29.2	37.54
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
-37.91	-62.52	42.87
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Holmes A J, 2005: Depressed Patients
// Subjects=10
42.91	49.17	34.81
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
-37.91	-62.52	42.87
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Holmes A J, 2005: Normal Subjects
// Subjects=9
42.91	49.17	34.81
48.34	29.2	37.54
-33.5	-68.86	56.74
4.46	56.86	41.3
42.93	32.88	30.6
69.65	-20.66	10.25
-63.86	-20.86	19.6
56.36	50.17	-22.31

// Habel U, 2005: Sadness - Gender Discrimination
// Habel U, 2005: Happiness - Gender Discrimination
// Habel U, 2005: Sadness - Happiness
// Habel U, 2005: Happiness - Sadness
// Subjects=26
-22.21	29.34	42.19
-42.55	40.06	-25.75
-12.04	61.8	-1.53
-9.61	63.89	20.63
-57.42	-6.17	-14.2
-57.23	-33.2	-4.81
-45.98	-58.32	24.38
-31.73	11.82	-29.87
-4.9	-64.56	24.3
-27.25	-19.86	-24.57
-35.87	-10.97	-20.82
-27.06	10.08	-2.88
27.36	-41.46	16.98
-39.93	-28.67	-3.31
-24.39	35.72	41.6
-3.53	36.77	-17.13
16.91	-36.67	45.82
-2.77	-49.45	25.01
-57.57	-11.67	-27.1
-45.74	-69.63	41.18
19.28	-39.46	61.74
-31.53	-32.64	-23.23
33.07	18.43	-31.63
-31.72	16.28	-28.07
-5.37	41.39	9.34
-37.6	-27.42	9.97
50.94	-23.06	5.79
-67.85	-20.94	12.09
25.22	28.68	32.49
-13.39	-15.3	46.46
44	-22.15	-30.04
15.92	-46.27	-33.9
-23	-40.03	-33.85

// Goldin P R, 2005: Sad > Neutral Film
// Goldin P R, 2005: Amusing > Neutral Film
// Goldin P R, 2005: Subject-Specific Regression Analysis Using Sadness Rating
// Goldin P R, 2005: Subject-Specific Regression Analysis Using Amusement 
// Rating
// Subjects=13
1.05	62.35	16.34
1.58	15.11	66.02
44.74	25.15	-14.5
-51.38	28.43	-4.75
49.1	-6.89	-16.32
57.93	-36.93	7.29
69.7	-49.89	3.78
-47	-11.09	-7.06
-5.93	-64.24	31.5
-2.87	-77.82	6.95
-10.44	-70.01	-1.42
-14.78	-58.66	-5.67
17.03	-3.91	-16.2
-16.09	-6.22	-15.63
-2.99	-25.32	11.47
-3.1	-5.57	5.36
-6.22	-62.92	-6.53
-2.93	41.29	47.15
-5.99	21.87	57.73
65.49	-40.43	16.41
69.75	-36.18	16.01
37.43	-19.3	-10.69
-14.89	-5.99	1.07
-6.45	58.79	12.26
57.76	27.2	10.83
-58.4	-69.01	15.77
65.53	-52.06	17.39
61.25	-44.43	20.14
-2.74	-59.99	31.1
29.1	-86.31	-9.43
-19.06	-58.77	-6.73
45.09	-83.3	-13.21
41.93	-69.69	-2.05
53.73	-82.31	-1.13
-22.49	-7.23	-14.35
-3.1	-6.63	5.45
-58.73	9.95	4.69
-46.83	14.82	25.34
-5.99	21.87	57.73
1.38	41.66	51.53
1.56	18.28	65.75
5.36	50.75	17.26
53.46	13.8	3.08
-18.8	-51.63	30.59
-58.28	-67.72	32.39
-58.76	-6.85	-6.16
53.68	-53.16	4.23
61.03	-25.88	-1.48
33.23	-30.62	-5.23
-6.25	-1.74	13.99
-3.03	-25.66	7.04
5.51	2.82	16.82

// Breitenstein C, 2005: Learning > Baseline, Activations
// Breitenstein C, 2005: Non-Learning > Baseline, Activations
// Breitenstein C, 2005: (Learning > Baseline) > (Non-Learning > Baseline), 
// Activations
// Breitenstein C, 2005: Learning > Baseline, Deactivations
// Breitenstein C, 2005: Non-Learning > Baseline, Deactivations
// Breitenstein C, 2005: (Learning > Baseline) > (Non-Learning > Baseline), 
// Deactivations
// Subjects=14
-63.68	-24.3	-1.1
-60.49	-11.52	-2.42
-63.84	-28.73	-14.1
69.15	-20.95	-7.05
62.57	-8.52	-11.53
56.2	-14.3	-4.13
-38.08	25.91	-16.59
-51.12	45.01	-18.25
-34.94	41.56	-21.55
-60.41	12.06	8.7
-11.44	31.3	39.58
39.74	29.69	-14.92
11.1	36.83	28.56
33.23	-62.48	-35.95
-63.69	-11.22	0.97
-37.89	33.85	-.57
-47.47	-27.43	-1.06
69.1	-8.19	-8.31
72.43	-20.63	-3.78
-47.78	19.5	-15.79
-54.09	20.72	-2.35
-1.7	38.03	42.11
-11.55	37.06	32.28
53.15	13.39	16.72
43.4	19.74	16.25
-18.41	-31.45	-11.25
-31.33	-31.19	-7.69
-28.3	-22.85	-22.01
11.03	-35.86	8.86
10.88	-30.41	-1.76
-14.57	35.41	49.31
-11.42	47.88	44.66
-14.37	-5.75	56.74
8.18	19.54	50.49
8.23	6.78	51.75
27.66	0.15	48.72
33.99	5.62	37.98
37.46	-9.07	52.82
-40.74	-35.42	16.42
-47.29	-39.26	10.19
-2.35	49.62	-6.09
52.96	-60.23	-12.98
50.23	-59.69	27.36
-31.44	-48.39	-19.43

// Denslow S, 2005: TMS
// Denslow S, 2005: Volitional Movement
// Subjects=11
-32	-20	68
-32	-34	68
-18	4	68
10	16	64
6	24	26
-28	-40	70
-50	-48	52
-20	-2	-10
8	-20	-6
4	-66	-18
-58	-28	14
64	-30	18
56	14	-14
-40	-12	62
-40	-34	62
-26	-12	70
-4	2	54
-30	-40	68
-50	-44	52
-40	36	28
-30	52	-10
32	52	-6
-46	48	2
50	46	4
-22	-8	-6
-6	-16	4
26	2	-20
8	-68	-14
-64	-30	6
64	-38	6
58	8	2

// Bonner-Jackson A, 2005: Schizophrenics Patients
// Subjects=17
-52.48	17.08	-13.82
-45.04	36.5	-11.07
-50.24	24.81	3.35
-54.39	27.13	19.93
46.95	22.59	-6.5
-50.01	10.66	26.84
-35.34	16.55	-8.4
-5.06	36.96	46.42
-45.96	44.64	11.68
-31.06	51.79	6.44
5.86	16.36	68.1
44.68	43.21	-14.9
45.17	19.66	38.37
-20.89	-95.13	18.65
-2.93	28.09	41.56
3.62	31.7	60.14
-45.58	8.97	45.89
39.46	19.12	-9.47
12.78	5.13	-9.11
19.24	56.12	16.65
-47.86	6.44	27.17
-3.82	-105.23	10.38
46.92	-20.53	-27.42
-35.74	-13.92	65.54
38.72	-85.11	-8.53
0.45	12.3	57.35
-20	-93.67	-3.79
-52.89	-26.6	54.53
20.64	-98.54	-1.62
41.63	19.56	-3.96
-48.9	4.49	29.57
-32.48	-56.17	55.66
47.27	20.47	34.93
-5.25	-27.68	-5.03
-42.7	-58.08	-23.24
25.55	-76.64	-49.23
-49.05	27.16	19.87
50.87	-45.81	58.3
-36.14	-83.96	-14.45
37.95	-4.05	62.75
40.66	-61.81	-23.89
-49.79	1.97	52.1
-32.08	20.43	0.16
33.04	-38.05	-32.48
-56.66	10.34	-4.28
3.73	-47.29	43.35
-42.19	-20.9	58.39
26.02	-91.56	5.54
1.52	7.91	55.47
32.13	-59.49	-20.64
-22.15	-91.65	-5.05
-39.37	-74.29	-13
1.11	-78.68	-32.05
-55.26	3.91	36.39
-33.56	-57.32	54.65
-34.2	-54.14	-28.13
31.5	-4.43	58.39
39.77	-75.42	-7.12
0.94	-45.27	-40.43
50.6	5.23	43.98
25.5	-68.36	-52.16
-17.02	-23.52	-5.25
-27.8	16.06	-1.75
-16.13	-70.38	-47.05
7.64	-64.24	-11.04
9.77	-20.39	5.34
60.98	14.19	7.42
31.56	-58.76	43.99
-45.44	-84.02	26.92
3.71	-42	42.91
17.4	-40.72	16.99
51.39	-11.93	0.8
-56.26	-65.65	17.7

// Bonner-Jackson A, 2005: Normals
// Subjects=26
-49.14	25.07	6.66
-12.35	20.14	63.53
-40.17	10.83	55.71
19.04	-34.93	-45.97
-64.85	-56.27	15.89
6.88	8.11	57.62
-50.46	34.56	-22
-55.31	-2.15	26.86
-46.72	23.6	42.44
-39.42	43.76	27.29
-40.68	28.67	-2.66
-27.8	-27.87	-19.25
-41.65	-45.04	-19.89
39.13	-28.11	68.1
30.66	6.64	-46.24
-25.79	-43.4	-41.39
-.61	6.92	56.69
-22.15	-95.97	-5.8
25.95	-90.14	-3.5
-51.11	13.66	24.37
-45.38	-30.61	57.01
-35.1	-79.81	-15.93
34.26	-63.96	-23.63
-43.81	28.28	6.33
-37.33	-57.7	-18.87
-25.59	8.04	4.47
-29.27	-61.61	53.85
-42.24	-3.81	59.19
48.24	35.91	28.05
35.26	19.86	0.55
-3.09	-26.35	-1.82
35.92	-57.87	55.02
13.9	-77.89	-36.73
-5.24	-80.32	-25.15
0.54	-44.94	46.53
5.84	-21.22	50.06
-46.95	-18.24	-3.11
-10.25	-63.63	25.92
12.09	-44.81	19.62
40.58	-6.68	-12.9
1.19	23.23	19.62
3.8	-81.73	38.43
-2.14	46.04	12.17
36.74	-61.49	21.86
-30.64	-47.09	21.42
-15.35	-40.32	66.4
52.72	-34.45	26.1
5.19	36.89	-10.57
55.72	-14.57	7.67
14.64	-50.37	71.36
24.16	-28.28	67.17
45.29	-13.12	41.12
-57.4	-33.51	20.59
-42.23	-75.2	30.6
-55.09	-53.62	35.63
18.23	52.4	23.67
-25.52	-48.32	-8.64
21.5	-46.89	-8.19
-40.25	-17.4	34.66
-32.15	-4.46	-18.94
22.74	26.3	43.65
-26.53	40.21	35.24
21.68	-91.22	-3.36
-44.32	-28.49	56.82
-24.3	-91.75	-6.13
-27.14	-57.28	54.58
-45.54	-4.86	45.93
-36.25	-63.07	-19.55
34.22	-56.73	-26.47
39.73	-74.71	-11.64
51.6	8.95	36.97
40.08	-40.3	47.92
-.65	7.64	52.17
-29.48	-81.35	18.71
-28.32	-3.47	62.35
12.91	-27.65	-6.36
22.32	-70.4	-50.83
37.89	1.95	57.78
-26.65	-8.26	0.28
5.37	-75.48	-32.37
-13.79	-27.64	-3.82
32.55	-68.32	30.28
-28.84	19.65	3.54
16.12	-3.43	3.84
36.34	18.9	1.74
17.64	2.43	65.78
26.32	-66.48	54.73
42.87	38.88	25.64
3.19	-37.54	-23.26
-44.75	28.5	23.05
-20.07	-22.97	15.93
56.06	-16.6	50.21
-49.16	-14.71	-12.31
48.13	-13.61	-6.82
14.49	-39.85	55.98
59.14	-51.93	19.68
-65.8	-45.13	36.16
55.93	-30.03	27.92
-51.8	-68.14	40.16
1.17	27.37	18.16
-5.93	-33.52	43.42
-1.54	-86.08	37.74
13.07	-38.09	10.13
-37.87	-86.29	38.18
-48.91	-34.06	12.73
-16.75	-51.41	19.39
-17.52	-42.88	61.07
7.38	34.16	-4.79
-61.62	-69.2	13.6
39.77	-21.55	15.13
1.43	-5.09	38.72
4.82	-19.65	56.63

// De Luca M, 2005: Multiple Sclerosis Patients
// Subjects=14
44	-3	52
-2	-3	53
-45	-34	55
-34	-27	49
-38	-14	56

// De Luca M, 2005: Control Subjects
// Subjects=7
-2	-7	52
-41	-18	56
-39	-24	54
-43	-9	48

// Rodriguez-Fornells A, 2005: Monolingual Subjects
// Subjects=11
36	-84	-16
-32	-28	-20
-28	-68	36
0	8	44
-56	12	36
-24	-52	-40
28	-68	-36

// Rodriguez-Fornells A, 2005: Bilingual Subjects
// Subjects=11
-36	-84	-8
32	-84	-16
-32	-60	42
4	4	48
-56	8	36
-36	-64	-28
36	-64	-36

// Kerns J G, 2005: Normal Subjects
// Subjects=13
3.5	19.5	39.98
-28.39	1.3	55.26
48.75	-46.71	60.63
-38.34	27.39	21.96
46.07	30.01	20.77
61.34	-47.97	29.36
-60.59	-46.47	18.37
42.64	51.89	1.13
19.42	-30.99	5
-59.58	-52.61	7.72
-15.93	-14.45	1.79
54.44	27.12	-3.62
-47.15	26.89	-11.36
1.36	19.48	40.01
-31.59	5.77	58.26
-26.12	-55.5	49.96
5.96	-59.54	49.93
55.08	-55.19	46.77
-43.49	6.36	39.39
54.72	14.72	28.64
-44.78	26.04	18.8
55.6	13.81	3.06
0.3	-60.63	8.82
52.29	20.42	-7.5
-38.56	19.62	-9.73
-56.45	-57.76	-4.15
5.56	23.14	31.84
-26.03	-53.5	62.05
49.81	-45.73	59.42
-63.9	-22.34	14.15
-6.22	-21.11	11.16
28.91	-3.61	0.36
40.46	7.52	-21.89
5.57	22.08	31.93
0.32	-67.06	8.24
19.2	5.25	-8.07
-56.46	-56.79	-5.35
24.48	12.26	-14.3
-.51	-18.45	58.82
36.86	-30.55	50.48

// Kerns J G, 2005: Schizophrenia Patients
// Subjects=13
-13.39	-34.45	45.81
-33.91	3.78	32.81
40.83	16.84	29.74
-38.39	28.02	16.33
40.67	29.38	13.07
44.86	30.75	2.87
24.7	-10.69	5.47
-10.58	-10.02	3.59
-57.47	-45.2	7.07
65.37	-31.77	4.54
-46.06	27.15	-8.05
44.74	31.75	-11.71
3.52	16.41	41.35
3.92	-65.13	60.45
36.71	10.69	47.03
9.92	27.28	43.71
62.4	-40.31	32.05
49.36	12.23	24.45
42.96	7.96	24.88
54.46	16.38	-4.95
5.56	23.14	31.84
-26.03	-53.5	62.05
49.81	-45.73	59.42
-63.9	-22.34	14.15
-6.22	-21.11	11.16
28.91	-3.61	0.36
40.46	7.52	-21.89
5.57	22.08	31.93
0.32	-67.06	8.24
19.2	5.25	-8.07
-56.46	-56.79	-5.35
24.48	12.26	-14.3
-.51	-18.45	58.82
36.86	-30.55	50.48

// Riecker A, 2005: Syllable Repetition vs. Passive Listening
// Subjects=8
-3	6	63
-54	-18	36
51	-15	33
-63	12	18
-39	12	0
-24	-3	3
27	-6	0
-12	-18	0
15	-21	3
-21	-60	-24
24	-60	-24
-21	-60	-57
18	-63	-57

// Jeong B S, 2005: Schizophrenic Patients
// Subjects=10
39.68	18.33	-21.64
-28	15.47	8.93
4.59	-76.07	3.98
37.51	-2.17	57.74
-23.81	-19.02	76.14
-17.32	-27.71	74.65
-17.84	17.66	43.28

// Jeong B S, 2005: Control Subjects
// Subjects=10
-2.32	44.3	-5.57
-17.83	14.47	43.59
-17.36	-64.05	64.8
-40.1	-42.65	65.31
-46.79	-25.64	52.53
-27.3	-15.37	57.91
-21.43	-63.71	-.16
-10.99	-56.15	57.19
54.86	5.62	-20.64
-17.84	17.66	43.28

// Caldwell J A, 2005: Pilots
// Subjects=8
-40	58	12
-48	20	0
-2	18	40
-38	-66	38
-18	0	10
-42	-64	-46
42	0	28
24	62	-10
28	8	64
28	-72	52
12	6	4

// Caldwell J A, 2005: Fatigue-Resistant Non-Pilots
// Subjects=10
-56	14	30
-52	-4	28
-12	-10	60
-20	-74	24
-30	-34	-20
34	36	24
32	28	4
28	-78	24
16	-20	10

// Caldwell J A, 2005: Fatigue-Vulnerable Non-Pilots
// Subjects=10
-42	-14	44
-44	34	0
-8	10	42
-28	-82	26
-28	-16	-24
48	24	20
36	6	-20
34	-76	26
20	-8	-4

// Gotlib I H, 2005: Sad - Neutral Faces, Depressed > Controls
// Gotlib I H, 2005: Sad - Neutral Faces, Controls > Depressed
// Gotlib I H, 2005: Happy - Neutral Faces, Depressed > Controls
// Gotlib I H, 2005: Happy - Neutral Faces, Controls > Depressed
// Subjects=18
-14.41	15.38	-27.15
50.5	-3.43	-25.28
60.4	20.92	-6.56
-7.83	33.67	-15.63
-27.42	42.34	-25.12
42.76	28.48	52.38
62.22	-6.76	-38.59
-42.01	11.27	10.7

// Keedwell P A, 2005: Depressed Subjects
// Subjects=12
11.6	55.5	-4.39
-37.59	46.06	-11.96
2.5	-24.81	31.44
-42.36	2.56	45.27
16.25	-86.65	-12.6
0.3	40.43	49.41
-27.5	-49.96	11.59
37.77	-13.59	35.67
-33.9	-8.19	29.35
-15.94	-89.27	-29.85
-26.26	-35.04	39.32
-.61	-29.34	41.89
51.3	4.73	-3.94
48.51	-27.19	37.8
37.44	-42.28	-18.8
46.29	9.26	41.46
62.17	-15.24	12.11
49.21	29.43	12.97
12.54	50.97	-21.87
-25.41	37.39	39.93
-41.84	46.29	-8.58
11.57	54.19	-7.63
51.3	18.99	1.56

// Keedwell P A, 2005: Control Subjects
// Subjects=12
11.6	55.5	-4.39
-37.59	46.06	-11.96
2.5	-24.81	31.44
-42.36	2.56	45.27
16.25	-86.65	-12.6
0.3	40.43	49.41
-27.5	-49.96	11.59
37.77	-13.59	35.67
-33.9	-8.19	29.35
-15.94	-89.27	-29.85
-26.26	-35.04	39.32
-.61	-29.34	41.89
51.3	4.73	-3.94
48.51	-27.19	37.8
37.44	-42.28	-18.8
46.29	9.26	41.46
62.17	-15.24	12.11
49.21	29.43	12.97
12.54	50.97	-21.87
-25.41	37.39	39.93
-41.84	46.29	-8.58
37.49	-31.82	-7.41
-42.94	33.97	-16.46
-4.49	64.75	-7.22

// Manoach D S, 2005: Spatial > Shape WM Conjunction
// Manoach D S, 2005: Spatial > Shape WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape > Spatial WM Conjunction
// Manoach D S, 2005: Shape > Spatial WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape > Spatial WM, Schizophrenics > Controls
// Manoach D S, 2005: Spatial WM Conjunction
// Manoach D S, 2005: Spatial WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape WM Conjunction
// Manoach D S, 2005: Shape WM, Controls > Schizophrenics
// Manoach D S, 2005: Shape WM, Schizophrenics > Controls
// Subjects=12
-10.88	-59.67	65.38
-27.09	-56.54	65.34
18.35	-62.45	68.51
30.96	7.17	54.69
47.01	-85.85	23.28
53.75	-41.23	52.37
56.27	12.47	6.67
-23.82	-66.1	66.23
-7.57	-65.73	69.28
59.49	-59.89	-9.76
11.89	-68.85	69.26
-40.87	19.44	17.72
-50.8	30.93	3.3
-44.35	-61.2	-17.95
-27.99	8.98	8.45
47.13	3.72	51.39
-31.6	25.93	-16.7
-17.46	-76.9	53.75
-40.36	-45.69	44.32
-27.41	-75.3	36.95
-27.41	3.46	52.69
-47.24	3.78	22.74
-44.11	32.51	19.84
31.06	-74.16	45.92
37.34	-78.88	29.48
36.43	25.86	-21.21
36.65	24.23	-4.25
34.24	7.49	57.96
8.13	22.42	46.84
59.59	13.11	13.27
53.09	39.23	17.52
49.65	47.55	3.31
-23.88	-60.03	62.27
18.07	-57.94	47.9
40.53	-30.08	34.68
63.02	21.06	29.24
53.22	-48.48	9.39
56.35	-52.59	-.34
-31.6	25.93	-16.7
-44.06	19.74	21.1
-50.32	5.01	36.12
-30.66	6.64	52.43
-1.54	19.51	50.66
-8.18	24.93	40.15
-30.62	-71.81	40.02
-30.73	-75.93	30.34
-30.64	-55.54	41.77
-47.6	-71.09	-20.27
-34.4	-98.83	-7.67
-11.83	-11.04	0.07
-44.48	49.47	-5.36
-30.92	-83.87	14.32
11.37	22.43	46.79
36.41	29.05	-21.53
49.95	13.69	20.1
49.73	38.28	7.59
43.27	54.84	12.78
37.46	-64.87	41.54
33.72	-101.47	-5.21
23.91	-102.12	-11.7
40.67	10.39	54.2
17.32	-7.75	-.75
49.62	-67.56	-22.28
37.33	-75.69	29.16
-24.92	30.71	-.48
-30.91	-18.19	28
-11.62	-45.51	10.2
-24.72	-43.3	0.12
-17.61	-28.72	52.34
-17.77	2.87	45.86
30.45	-39.3	5.51
33.66	3.13	11.34
20.79	0.52	18.54
33.94	8.5	34.34
34.13	-19.59	43.84
1.46	24.34	33.32
-51.09	15.67	-22.08
-43.59	6.91	55.98
59.21	23.38	-14.63
50.36	6.93	51.02

// Surguladze S, 2005: Happy Faces, Normals > Depressed
// Surguladze S, 2005: Sad Faces, Depressed > Normals
// Subjects=14
-31.84	-83.64	-10.63
37.58	-73.7	-12.26
24.53	12.77	-7.65
32.15	-62.58	-19.26
-25.67	5.07	-6.43
-25.83	-1	-29.89

// Yoo S S, 2005: Schizophrenics
// Subjects=10
6	14	49
46	36	15
-46	15	25
26	15	58
-26	16	53
40	51	1
8	26	23
34	-56	53
-34	-55	53
-28	-93	10
24	-83	-8
44	-55	-16
-44	-51	-16
32	23	-8
-34	15	-7
42	-57	-22
-40	-67	-17
6	31	44
-32	-1	53
24	17	36
-42	-73	13
-7	-72	42
-38	-48	-18
-22	-4	4
30	29	-1
-32	29	-3
12	-76	-15
-8	-78	-16
4	-58	-29
-4	-46	-31
14	-49	-31
-14	-48	-33
40	49	1
46	-34	57

// Yoo S S, 2005: Normals
// Subjects=10
4	31	44
6	14	48
26	14	38
48	15	18
-44	11	31
30	14	53
-32	8	51
12	26	23
34	-56	42
-34	-56	51
24	-91	3
-18	-97	3
48	-57	-16
-40	-51	-14
24	6	-4
-22	8	-4
36	21	-9
-30	27	-6
39	-57	-22
-38	-57	-21
2	-58	-29
0	-58	-31
6	31	44
-32	-1	53
24	17	36
-42	-73	13
-7	-72	42
-38	-48	-18
-22	-4	4
30	29	-1
-32	29	-3
12	-76	-15
-8	-78	-16
4	-58	-29
-4	-46	-31
14	-49	-31
-14	-48	-33
40	49	1
46	-34	57

// Audoin B, 2005: Multiple Sclerosis Patients
// Subjects=9
-43.14	32.85	11.95
-52.73	30.45	21.31
-54.99	24.3	13
-54.99	24.3	13
-54.16	34.44	-4.83
-1.99	51.15	21.76
-41.11	63.59	7.75
-.6	40.37	44.1
-2.61	38.21	55.55
-28.85	51.14	34.55
-61.17	1.37	32.18
-30.57	-22.18	54.16
8.55	70.05	5.15
63.81	24.4	7.6
61.6	32.8	5.69
68.17	15.91	8.37
20.76	-77.39	0.48
28.98	-81.64	-33.98
43.19	-91.29	-23.18

// Audoin B, 2005: Control Subjects
// Subjects=18
-18.65	18.56	64.49
-28.42	18.22	61.33
-37.3	3.24	39.43
-51.57	22.36	26.58
-37.03	5.32	61.63
-2.71	23.24	44.71
-45.12	6.77	20.17
-63.57	19.26	17
-62.71	18.67	-.88
-36.63	33.08	14.06
-59.37	30.35	9.11
-58.55	27.32	-11.89
-41.36	-27.64	53.76
-40.34	-42.29	46.23
-7.46	-48.53	81.02
-28.21	-42.61	65.1
-28.13	-49.64	70.28
-32.58	-56.12	58.67
-47.73	-10.8	-18.39
-43.49	-5.89	-23.43
-70.44	-15.45	-20.91
-49.75	-50.27	-15.57
-38	-71.99	-30.43
-27.14	-79.19	-27.66
15.46	22.91	28.74
2.55	9.04	30.33
52.15	7.42	21.81
62.43	38.59	-12.83
60.12	38.5	-25.11
50.3	59.64	-28.15
48.25	60.46	-19.23
41.79	65	-16.21
75.81	-30.52	4.99
78.07	-22.14	14.2
73.72	-37.66	9.09
40.69	0.27	-31.08
46.75	-59.34	8.33
59.29	-38.39	-20.85
74.27	-12.06	-27.07
47.43	-33.87	-17.73
42.87	-8.33	-31.39
6.77	-91.26	2.09
47.67	8.39	9.46
17.96	-74.07	36.05
37.64	-71.62	-30.64
-43.14	32.85	11.95
-52.73	30.45	21.31
-54.99	24.3	13
-54.99	24.3	13
-54.16	34.44	-4.83
-1.99	51.15	21.76
-41.11	63.59	7.75
-.6	40.37	44.1
-2.61	38.21	55.55
-28.85	51.14	34.55
-61.17	1.37	32.18
-30.57	-22.18	54.16
8.55	70.05	5.15
63.81	24.4	7.6
61.6	32.8	5.69
68.17	15.91	8.37
20.76	-77.39	0.48
28.98	-81.64	-33.98
43.19	-91.29	-23.18

// Mu Q, 2005: Sleep Deprivation-Resilient Subjects
// Subjects=10
-56	14	30
-30	26	-4
-12	10	60
-20	-74	24
34	36	24
40	12	-6
28	-78	24
-46	-64	-32
-60	14	22
-46	38	18
-12	0	40
-52	-46	18
-44	-2	54
26	-76	44
-52	-2	50
-2	32	22
-8	40	54
-18	-68	-38
-4	-72	46
-60	-64	23
-38	-62	-38
18	-8	62
32	-54	40
-44	14	16
-16	-12	68
-30	-8	-6
-32	-66	-28
10	30	6
28	-60	46
36	-60	2
30	-50	-38

// Mu Q, 2005: Sleep Deprivation-Vulnerable Subjects
// Subjects=10
-42	26	24
-32	46	-8
-28	-82	26
38	16	38
34	-76	26
-42	2	18
-44	-2	54
26	-76	44
-52	-2	50
-2	32	22
-8	40	54
-18	-68	-38
-4	-72	46
-56	4	36
-30	-80	24
42	24	38
32	16	2
4	12	54
38	-76	44
-44	14	16
-16	-12	68
-30	-8	-6
-32	-66	-28
10	30	6
28	-60	46
36	-60	2
30	-50	-38

// Napadow V, 2005: Manual, Increases
// Napadow V, 2005: Manual, Decreases
// Napadow V, 2005: Sensory Control, Increases
// Napadow V, 2005: 2-Hz Electroacupuncture, Increases
// Napadow V, 2005: 2-Hz Electroacupuncture, Decreases
// Napadow V, 2005: 100-Hz Electroacupuncture, Increases
// Napadow V, 2005: 100-Hz Electroacupuncture, Decreases
// Subjects=13
41.71	5.01	0.61
-38.5	10.36	-5.61
37.56	-20.13	6.11
-37.39	-2.32	-4.56
6.56	-11.69	7.99
-5.2	-15.02	7.29
33.06	64.32	11.35
-26.74	59.99	15.74
56.52	45.28	-2.94
-55.58	45.64	11.7
57.05	-32.77	33.71
-57.25	-33.02	40.62
56.93	-25.16	21.92
-55.24	-25.58	26.59
-17.21	-9.03	-24.3
19.18	-14.81	-19.77
-17.2	-13.26	-23.95
-4.41	29.26	-12.05
-5.49	68.69	2.5
2.98	50.37	-15.02
-2.37	50.25	-16.06
6.52	53.9	30.37
-4.31	52.29	10.55
32.89	19.65	-29.51
-52.5	13.57	-17.98
-10.41	45.56	47.99
-61.53	-37.45	38.81
56.86	-22.68	12.79
-64.91	-16.29	23.69
37.26	27.31	-13.48
6.69	19.34	37.73
-6.18	14.44	30.48
3.61	-3.51	45.25
36.35	15.73	2
-34.22	19.28	-.83
40.6	-.97	-7.8
-39.49	-4.19	-1.03
-21.3	1.72	4.95
4.4	-4.21	8.5
27.81	61.97	22.76
-20.28	61.6	22.23
5.49	59.69	36.59
-.79	31.36	42.38
63.18	19.29	18.12
-55.51	14.46	7.62
60.31	-42.01	37.79
-53.04	-42.4	29.09
3.11	-25.2	-28.76
-3.53	-37.36	76.06
53.74	-25.1	23.07
-46.71	-25.7	24.27
-16.14	-9.02	-24.31
28.84	-17.58	-15.19
4.2	22.25	-7.1
6.35	11.43	-9.56
5.04	63.87	-19.52
-1.22	66.51	1.52
3.01	34.25	-17.01
-1.26	34.22	-16.96
-25.92	15.61	-35.19
-2.94	15.86	34.78
37.4	15.56	-.23
-32.97	-16.16	8.82
29.92	61.64	18.3
-38.61	59.77	0.28
5.74	15.08	51.48
-.64	16.44	55.9
57.88	13.17	22.04
-41.43	30.86	39.54
50.73	-44.98	41.5
-55.15	-43.3	31.42
-8.88	-36.34	76.03
61.24	-24.8	26.3
-53.13	-25.82	23.24
-20.46	-2.87	-27.01
37.2	49.68	-13.12
-34.4	37.2	-16.83
2	30.44	-11.1
-2.82	-49.93	23.57
5.37	-10.69	-6.58
-1.35	64.09	-16.12
6.27	65.59	2.63
-1.23	65.29	-.61
2.97	41.48	-19.85
-1.3	41.45	-19.8
43.5	12.34	-42.4
-43	11.28	-34.63

// Nebel K, 2005: Event-Related Design with Continuous fMRI Acquisition
// Nebel K, 2005: Sparse fMRI
// Subjects=13
-4.98	-88.14	13.18
10.15	-96.8	11.54
1.5	-99.06	10.79
1.52	-94.5	13.7
-13.36	-82.9	35.22
-17.73	-85.46	31.07
-7.01	-101.35	21.25
-13.46	-94.57	25.17
12.35	-85.53	17.11
23.24	-93.59	22.21
21.13	-98.71	24.99
23.34	-82.98	32.36
-7.29	-61.87	7.26
-5.18	-92.89	-3.15
-9.53	-71.21	-.74
-11.82	-75.45	-11.49
-9.61	-80.55	-8.78
5.5	-82.84	-11.05
33.69	-92.96	-6.05
42.36	-90.49	-3.08
-13.5	-99.24	21.15
24.93	-53.32	-6.46
-20.37	-57.32	-.81
-11.82	-49.2	-6.24
8.26	-87.08	35.27
34.17	-82.73	34.39
19.03	-96.07	30.37
17.01	-81.86	44.69
21.3	-84.28	41.49
-6.8	-82.25	41.77
-19.82	-89.3	35.96
-9.01	-93.62	35.09
-11.16	-86.94	37.82
42.34	-73.16	-1.43
-2.86	-75.26	12.99
10.13	-72.88	14.78
-18.37	-27.85	-7.12
18.72	-67.74	11.88
-11.89	-38.77	-9.51
31.81	-67.83	21.75
18.98	-73.42	31.49
22.72	-36.21	-6.99
42.17	-60.16	-11.68
44.38	-64.2	-9.07
16.98	-73.35	43.84
16.88	-74.08	36.07
9.82	-33.61	-1.43
12.34	-90	15.31
5.78	-92.77	8.98
-4.93	-83.36	18.31
-15.8	-97	10.88
-11.43	-98.8	14.35
16.53	-74.55	8.11
1.27	-88.71	-4.79
1.32	-92.76	-2.15
-9.55	-88.85	-5.72
6.03	-87.61	29.75
10.29	-92.47	23.44
19	-87.56	29.53
-.64	-74.84	17.4
-9.2	-100.5	18.96
-18.25	-91.53	-10.91
25.01	-58.23	-1.49
22.8	-53.12	-4.2
22.89	-62.28	1.19
-20.31	-62.33	3.05
29.25	-77.43	-11.99
-29.04	-69.57	-5.05
-35.57	-68.84	-8.37
-19.82	-91.54	35.06
8.25	-84.95	35.06
-15.86	-65.74	12.27
-7.2	-69.96	12.54
8.13	-73.87	27.24
-33.53	-58.82	-16.12
-39.9	-66.73	-8.51
-35.65	-65.11	-14.35
-15.43	-80.05	42.82

// Volle E, 2005: MemG Delay One, 1 Square vs. Fixation
// Volle E, 2005: MemG Delay One, 3 Square vs. 1 Square
// Volle E, 2005: MemG Delay One, 5 Square vs. 3 Square
// Volle E, 2005: MemG Delay Two vs. MemG Delay One
// Volle E, 2005: MemG Delay Two vs. VisG Delay Two
// Subjects=11
-33	-3	60
-21	6	57
12	15	39
-45	-12	54
30	-6	63
-18	0	63
-27	-3	48
-9	12	51
15	-57	60
48	42	27
39	57	18
6	24	36
-3	27	33
-42	3	48
-21	3	54
-6	-3	63
-3	12	51
9	-66	54
-6	-66	57
-33	-39	45
-42	27	42
-51	15	36
-33	30	-3
0	39	42
-9	39	-3
-39	-24	63
39	-24	51
-12	-27	69
-6	-15	48
57	-30	27
-54	-36	42
-42	-18	15
57	-21	48
-51	-21	42
48	-12	9
-48	-6	9
-12	15	0
9	33	36
9	39	18

// Hui K K S, 2005: Normals Who Experienced Deqi Only
// Subjects=11
27.67	-7.62	-23.82
-24.72	-2.73	-24.74
37.42	-22.65	-12.64
-17.16	-17.23	-20.27
19.02	-3.24	-35.24
-26.92	-8.88	-35.35
3.31	-1.13	7.14
-.94	-2.05	9.5
3.29	3.1	6.79
-.98	3.07	6.84
9.55	8.11	-11.55
-4.31	10.57	-6.02
5.18	33.46	-13.62
-.12	31.66	-8.95
2.03	36.24	-4.9
-5.39	37.85	2.86
3.23	46.33	15.43
3.58	-12.57	38.21
-.69	-12.59	38.26
6.86	-38.18	36.97
-.64	-35.14	35.69
4.76	-40.05	40.5
8.88	-51.52	15.76
-3.88	-57.51	21.99
-3.89	-52.14	22.65
-40.68	8.86	-11.03
27.53	13.99	-33.44
-26.99	10.15	-36.95
2.88	69.06	-21.04
-21.51	57.68	-.85
5.11	32.77	-22.49
-2.36	41.53	-18.68
4.11	18.05	-20.13
-1.14	5.84	-12.35
16.05	15.69	3.35
-6.39	15.56	3.62
18.32	-29.14	1.51
-9.44	-31.25	4.24
61.35	-32.48	36.98
-37.91	-38.4	52
5.85	-8.98	56.84
-2.6	-13.55	67.36
12.83	-19.71	-13.71
-3.24	-21.29	-18.97
5.25	-33.9	-31.4
-4.41	-31.13	-35.98
6.26	-19.17	-33.76
-.13	-24.5	-33.24
1.12	-40.13	-15.21
-.85	-58.23	-1.4
3.38	-75.09	-13.42
-.9	-75.21	-14.48
5.34	-76.88	-36.71
3.18	-67.29	-36.38
10.57	-68.19	-48.65
2.05	-58.04	-40.49
-2.19	-51.12	-33.21
1	-47.93	-33.52
28.8	-34.47	-27.16
-7.4	-39.92	-11.79
17.2	-52.72	-14.34
-15.92	-52.83	-12.84
17.23	-88.64	-24.71
-14.78	-91.58	-18.52
20.35	-82.96	-34.15
-11.72	-76.64	-32.08
14.92	-83.85	-45.16
-9.59	-73.37	-31.26
11.7	-64.24	-38.96
-14.13	-56.42	-59.39
7.42	-70.95	-42.81
-5.54	-59.28	-55.91
-22.59	-42.41	-42.63
40.54	-41.09	-31.2
-28.91	-34.9	-27.57
38.4	-41.19	-32.28
-21.43	-46.92	-32.23
40.54	-47.69	-33.99
-37.52	-42.16	-38.02
-32.14	-72.5	-45.57
22.29	-68.46	-53.23
-37.57	-49.27	-47.46
30.83	-38.83	-42.43
-36.49	-52.44	-47.2
3.22	-53.75	-26.36
11.75	-60.38	-30.36
-19.26	-50.96	-29.68
6.03	-43.36	66.41
-5.77	-31.89	64.47
65.51	-20.46	27.01
-65	-12.83	13.37
3.25	-23.74	-9.92
-1.02	-22.62	-8.85
4.12	32.4	-13.52
-9.85	65.61	-9.46
6.25	18.06	-20.15
4.15	12.93	-17.47
3.21	-82.35	-38.46
15.94	11.23	-13
-19.3	-5.18	-15.68
-1.19	34.99	-6.99
-1.05	6.7	-1.27
3.5	0.84	32.62
3.52	-23.11	25.71
-1.71	-38.49	33.75
5.75	-60.62	22.14
-1.86	-48.75	11.19
37.36	20.68	-2.89
-33.11	16.45	3.85
53.33	14.63	-13.71
-54.56	11.07	-8.83
5.11	68.95	-8.79
-1.21	66.6	2.63
-.2	28.68	-19.85
-8.43	-10.98	4.76
-7.45	14.49	3.72
21.32	13.81	-7.7
-22.45	9.66	-2.39
-7.29	-8	15.65
7.62	-11.68	7.98
-5.19	-11.67	9.24
-10.48	-25.45	10.45
60.13	-23.03	21.71
-57.37	-19.96	30.61
58.2	-33.05	43.76
-48.8	-34	27.22
43.13	9.76	48.15
3.3	-75.95	-24.5
-.98	-75.98	-24.45
3.29	-72.78	-24.77
-.99	-72.8	-24.72
11.92	-61.93	-9.05
-8.4	-62.3	-12.13
9.8	-78.31	-14.34
-9.49	-78.94	-20.76
6.54	-84.39	-23.83
-6.27	-85.35	-21.37
9.77	-88.43	-21.3
-3.07	-88.76	-24.47
-16.07	-70.84	-39.21
10.62	-64.33	-40.06
-8.66	-51.76	-40.89
30.95	-40.89	-27.76
37.49	-66.94	-21.19
-24.46	-68.2	-18.14
41.76	-69.2	-23.28
-45.84	-76.07	-21.7
29.9	-75.85	-39.31
-30.94	-86.53	-34.37
33.06	-77.4	-45.91
-22.51	-77.73	-45.24
26.62	-61.32	-43.84
-25.74	-68.15	-44.9
-18.27	-59.47	-43.48
-13.88	-67.05	-31.74
-6.41	-80.29	-38.52

// Hui K K S, 2005: Normals Who Experienced Deqi and Pain
// Subjects=4
37.12	11.5	-38.91
-36.63	-0.02	-43.79
9.45	67.46	-.91
-4.43	64.21	-.48
3.03	14.61	-23.17
58.23	-55.77	38.97
41.53	-48.54	-45.08
27.67	-20.82	-29.4
2.25	26.41	19.34
2.38	11.32	30.64
-.77	-4.65	30.9
2.49	2.57	41.41
-.72	2.47	40.34
4.65	-43.37	25.17
0.35	-40.31	23.84
49.03	14.35	-16.99
9.61	65.83	19.3
-4.33	65.24	12.82
-3.43	22.86	-26.02
22.48	5.95	0.75
61.21	-22.94	22.8
-61.72	-18.56	21.62
52.88	-41.62	43.42
4.77	8.44	62.08
-2.64	-4.03	66.56
0.16	-65.34	-10.86
-14.51	-64.63	27.17
14.06	-88.32	-20.24
-11.6	-91.9	-22.99
-11.63	-84.5	-23.61
7.47	-77.04	-38.96
12.59	-59.52	-60.56
36.25	-34.77	-31.68
47.02	-48.02	-25.11
37.55	-78.49	-19.11
-42.68	-76.48	-27.27
-33.3	-49.25	-47.51
-30.14	-43.14	-51.4

// Miura N, 2005: Ancient vs. Rest
// Miura N, 2005: Modern vs. Rest
// Miura N, 2005: Ancient vs. Modern
// Miura N, 2005: Modern vs. Ancient
// Subjects=30
-54	-4	44
-44	2	38
-26	-68	46
-20	-100	0
-62	-26	0
-46	0	50
-30	-64	44
-22	-98	0
16	-90	-8
-44	0	30
-54	14	8
4	-78	6

// Mo L, 2005: Living Things vs. Baseline
// Mo L, 2005: Non-Living Things vs. Baseline
// Mo L, 2005: Non-Living - Living Things
// Subjects=8
-46.84	20.2	26
-44.9	40.16	8.69
-27.21	-68.97	41.06
-21.15	-89.07	-13.08
2.6	4.74	55.73
23.75	-89.69	-11.32
-45.51	2.08	53.16
-41.34	-2.26	37.86
1.51	6.77	54.45
-46.83	20.28	27.11
-46	39.81	4.27
-50.28	25.44	-2.28
-26.15	-69.05	39.94
-25.44	-86.98	-13.21
23.76	-91.81	-11.14
-9.38	-99.75	-14.55
2.01	52.44	-1.8

// Anand A, 2005: Depressed Patients
// Subjects=15
-29.44	-5.84	-23.68
33.21	-3.49	-24.98
-22.61	-8.64	3.38
27.18	3.11	11.45
-13.99	-8.82	1.01
16.26	-9.77	0.59
-46.04	-9.52	29.64
51.09	14.11	24.52
-7.2	54.82	38.3
16.59	53.94	39.1
-39.99	16.83	1.15
48.46	23.75	-10
-9.38	27.29	30.97
10.14	-6.03	29.46

// Anand A, 2005: Healthy Subjects
// Subjects=15
-25.14	-8.16	-25.76
28.95	-7.45	-21.15
-20.41	1.46	7.94
27.12	3.76	6.91
-9.69	-13.37	-1.98
11.91	-13.29	-2.35
-46.18	17.92	24.68
55.33	22.33	20.28
-5.26	64.11	22.78
5.55	64.15	22.59
-46.26	-8.96	12.78
50.93	-4.57	8.45
11.96	43.99	13.27
-.45	-25.24	42.74
16.77	8.21	43.62

// Harvey P O, 2005: Depressed Patients
// Subjects=10
42	-51	48
-36	-51	36
-6	24	39
-45	18	27
51	15	24
-36	48	15
33	6	48
39	45	21
-45	12	33
-36	42	12
-3	24	39

// Harvey P O, 2005: Healthy Subjects
// Subjects=10
-33	-45	42
-12	-69	48
15	-60	42
51	-30	36
42	-63	36
9	39	33
-45	18	21
-39	45	6
39	45	9
48	39	24
-45	12	33
-36	42	12
-3	24	39

// Tremblay L K, 2005: Interaction Between Mood and Drug, Depressed Patients 
// vs. Healthy Subjects, Decreases
// Tremblay L K, 2005: Interaction Between Mood and Drug, Depressed Patients 
// vs. Healthy Subjects, Increases
// Tremblay L K, 2005: Mood, Healthy Subjects > Depressed Patients
// Tremblay L K, 2005: Mood, Depressed Patients > Healthy Subjects
// Tremblay L K, 2005: Predrug > Postdrug
// Tremblay L K, 2005: Postdrug > Predrug
// Subjects=12
45.84	55.08	0.82
-12.87	14.75	-6.27
13.85	13.85	-6.5
18.1	13.62	-9.88
-22.68	42.38	-19.63
5.98	-19.76	68.89
-52.56	12.97	-25.74
38.32	4.17	-23.82
-8.7	71.93	3.38
-2.08	43.39	19.08
29.72	36.52	-17.51
27.6	34.48	-16.2
-33.75	-8.76	49.47
21.29	17.87	-10.27
-29.93	8.47	-3.32
-5.33	5.53	-2.24
15.99	4	-10.16
-33.21	14.28	-10.46
17.99	2.64	-27.92
4.25	-2.5	-10.6
-5.09	-86.43	-7.91
33.31	49.28	37.14
57.67	30.74	1.61
7.92	-31.66	38.64
14.56	-45.77	62.05
-9.25	19.13	50.19
-16.74	-15.15	34.2
-10.8	25.08	-10.51
12.71	17.56	-13.49
14.85	14.31	-14.36
9.58	21.57	-2.64
20.2	17.69	-12.47

// Vitali P, 2005: Tools vs. Rest
// Vitali P, 2005: Animals vs. Rest
// Vitali P, 2005: Tools > Animals
// Subjects=10
-28	2	52
-54	4	36
-44	32	12
-52	16	32
-38	18	28
-30	46	4
-30	24	-4
-48	28	16
-48	16	-8
-52	12	12
-32	8	12
-30	-46	44
-44	-54	0
-46	-56	-12
-42	-64	-8
-36	-68	-4
-24	-76	36
-8	18	44
-16	-18	-12
-16	-12	4
-12	20	16
28	-8	32
18	0	52
40	36	16
40	24	-12
30	20	8
14	30	24
0	16	4
-40	-6	32
-28	0	48
-12	22	44
-40	20	28
-30	22	-4
-40	36	0
-40	6	24
-38	-66	-8
-24	-48	-16
-28	-80	24
-28	-58	32
-32	-78	0
-22	-76	44
-26	-42	44
-6	10	36
-6	-24	4
-16	-6	20
36	44	24
40	36	16
42	30	-8
30	20	-8
26	-54	8
24	-52	4
12	22	28
22	-20	16
22	14	8
24	10	4
-34	4	40
-4	26	56
-10	30	48
-46	34	-4
-52	26	12
-40	-60	44
-50	0	8
-40	-62	0
-48	-56	-12
-36	-78	40
-22	-76	40
30	-6	32
10	30	48
50	34	-12
40	36	-8
30	-54	28
38	-52	8
22	-40	32
28	36	12
26	-26	28
26	-30	-8

// Floyer-Lea A, 2005: Normals, Short-Term Learning Group
// Subjects=15
42	18	44
-28	-44	70
-38	-22	58
34	-28	60
2	4	32
-34	-80	-34
28	-56	-34
26	2	6
14	-18	6
-34	-10	66
-42	-30	64
-16	-64	62

// Floyer-Lea A, 2005: Normals, Long-Term Learning Group
// Subjects=7
-20	-16	72
-32	-30	62
28	-10	16

// Kitada R, 2005: No-Estimation vs. Baseline
// Kitada R, 2005: Estimation vs. No-Estimation
// Kitada R, 2005: Negatively Graded Activity during Estimation within areas 
// activated by No-Estimation vs. Baseline
// Kitada R, 2005: More NGA in Estimation than No-Estimation within areas 
// activated by No-Estimation vs. Baseline
// Kitada R, 2005: NGA during Estimation within the areas activated by 
// Estimation vs. No-Estimation
// Kitada R, 2005: More NGA in Estimation than No-Estimation within areas 
// activated by Estimation vs. No-Estimation
// Subjects=14
-60	-22	44
-58	-20	18
58	-22	18
-58	10	-2
50	14	10
-34	52	20
36	54	10
-30	52	-14
44	48	-8
-2	-2	64
2	10	56
-46	-12	58
58	6	40
-44	-44	62
60	-32	50
-6	-76	52
16	-74	38
-20	2	0
18	0	20
-42	-72	-28
20	-72	-22
-64	-16	12
-32	20	-2
30	24	4
-44	28	28
44	34	22
36	58	-4
-4	18	46
6	24	44
-46	6	28
60	18	26
-44	-42	40
38	-66	52
10	-80	-48
-36	-10	10
58	-6	6
-34	-10	10
64	-6	4
50	36	12
52	38	12

// Mendrek A, 2005: Schizophrenia Patients
// Subjects=12
-44	24	24
40	32	28
28	0	52
-32	4	52
44	-44	44
-24	-68	40
28	-60	40
-52	-44	52
-68	-40	0
28	-68	-36
-36	-64	-36
-16	0	12
8	0	12
-4	48	-12
-8	-56	4
40	-28	8
-40	-28	16
-48	-36	60
-24	-76	-20
-4	-4	72
12	36	-8
32	-68	-28

// Mendrek A, 2005: Normal Subjects
// Subjects=12
-44	-4	36
44	28	24
32	-4	60
-40	48	20
40	-56	48
36	-68	40
-32	-72	44
-40	-52	44
-36	-60	-40
40	-64	-36
4	-16	12
-8	-20	12
-12	48	-12
-8	-48	20
-4	32	-4
52	-16	8
44	12	-40
-32	-36	-20
-48	-36	60
-24	-76	-20
-4	-4	72
12	36	-8
32	-68	-28

// Poldrack R A, 2005: Single-Task SRT vs. Rest, Pre-Training
// Poldrack R A, 2005: Single-Task SRT vs. Rest, Post-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Pre-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Post-Training
// Poldrack R A, 2005: Dual-Task SRT vs. Single-Task SRT, Pre-Training vs. 
// Post-Training
// Subjects=13
18	-54	15
-42	-81	0
-27	-48	48
-12	6	9
24	-54	-18
39	-42	36
60	3	15
-36	-27	51
-48	-30	42
0	-3	54
18	-48	-18
-12	-6	9
39	-45	51
60	-30	6
66	-30	12
-36	0	27
6	-36	-12
3	-78	-27
-42	-51	6
27	-84	6
-54	-33	12
63	-30	12
-42	9	30
33	-81	12
-27	-78	12
36	30	42
30	-78	45
-18	-75	51
6	-66	51

// Puttemans V, 2005: Exclusive Learning-Related Decreases (PRE > MID)
// Puttemans V, 2005: Exclusive Automatization-Related Decreases (MID > POST)
// Puttemans V, 2005: Learning- and Automatization-Related Decreases (PRE > 
// MID)
// Puttemans V, 2005: Learning- and Automatization-Related Decreases (MID > 
// POST)
// Puttemans V, 2005: Temporary Increased Activation (MID > PRE)
// Puttemans V, 2005: Temporary Increased Activation (MID > POST)
// Puttemans V, 2005: Sustained Increased Activation (MID > PRE)
// Subjects=11
48	40	4
-44	42	8
54	8	22
60	-40	40
0	-10	70
0	8	50
-48	16	-4
38	20	4
0	8	50
-48	16	-4
20	-32	76
-14	-32	76
28	-86	34
-10	-86	38
2	-24	44
-4	-22	46
20	-32	76
-14	-32	76
28	-86	34
-10	-86	38
2	-24	44
-4	-22	46
30	-2	-8
-28	-14	2
22	-24	-30
24	-42	-24

// Van Boven R W, 2005: Normals, Group 1 (Right Hand Test)
// Subjects=10
-39	-38.66	48.69
47.53	-34	46.19
0.37	16.99	49.15
-42.49	5.68	30.52
-38.96	-20.63	61.68
17.16	-59.66	-21.57
-50.89	-36.76	33.06
64.53	-29.38	35.57

// Van Boven R W, 2005: Normals, Group 1 (Left Hand Test)
// Subjects=10
-42.21	-38.68	48.73
53.96	-35.99	47.4
-.62	-.91	51.78
-38.19	2.62	31.84
49.74	-18.95	61.63
-18.1	-53.27	-18.35
-58.37	-33.54	33.99
65.64	-34.49	38.22

// Zhang M, 2005: Normals, Group 1
// Subjects=20
-52.89	-36.54	49.79
-62.86	-20.39	11.75
52.92	-35.65	51.84
-36.85	-0.01	66.61
-56.28	4.42	43.05
4.72	15.59	58.14
-63	11.07	5.76
65.2	14.76	0.64
65.33	19.47	20.31
52.23	19.74	-16.36
23.53	-64.45	-29.04

// Zhang M, 2005: Normals, Group 2
// Subjects=22
-21.95	-9.32	54.96
29.32	-7.07	51.95
-40.3	0.74	35.36
46.24	1.01	31
38.94	-29.02	42.53
-29.36	-40.55	50.97
-14.42	-70.29	36.56
44.41	-60.54	47.34

// Bedwell J S, 2005: Brain regions significantly active during encoding 
// period
// Bedwell J S, 2005: Brain regions significantly active during maintenance 
// period
// Bedwell J S, 2005: Brain regions significantly active during retrieval 
// period
// Subjects=14
34.01	-91.63	19.59
-29.05	-69.68	-6.16
33.7	-75.32	-1.07
-35.72	48.2	3.58
-31.53	42.82	-8.29
-21.8	-70.43	54.3
34.38	-57.15	55.39
-57.88	9.35	36.94
25.49	12.16	50.93
36.29	21.97	52.01
13.87	-23.56	-20.42
-2.91	33.79	31.34
16.62	23.54	35.38
-11.61	-10.44	17.94
11.77	5.33	-9.8
-16.27	7.78	-5.08
20.36	8.24	-13.59
12.04	-91.11	-8.1
-33.42	-83.18	-12.59
-13.77	-95.8	0.64
-46.14	-84.65	6.82
8.41	-87.1	46.47
-46.48	55.07	8.69
-58.17	24.7	17.49
55.27	36.05	17.8
-42.39	38.01	-13.23
-17.41	-62.24	61.26
-34.97	-33.77	45.29
-11.34	23.31	45.97
23.33	1.2	48.69
-20.03	38.27	45.76
-46.31	-65.17	-2.95
50.88	-57.49	-6.49
-20.85	-6.22	-28.27
18.13	-3.23	-21.38
-27	-27.77	-5.86
12.39	-7.53	36.29
-2.85	29.85	35.09
11.78	20.74	-5.72
-16.14	17.53	7.4
-20.62	19.57	-5.05
29.15	-67.21	-17.48
-39.89	-78.74	-10.68
41.87	56.8	-12.04
-50.55	17.49	20.32
37.64	21.38	-11.82
-33.71	25.17	-13.23
-5.07	40.38	32.97
3.64	38.69	37.47
-30.66	-49.16	41.14
1.18	39.7	13.88
-31.35	-20.34	-6.52
5.38	-13.73	-6.68

// Bristow D, 2005: Voluntary Blinking > Fixation
// Bristow D, 2005: Fixation > Voluntary Blinking
// Bristow D, 2005: (FV - FN) - (BV - BN), Interaction 1
// Bristow D, 2005: (BV - FV) - (BN - FN), Interaction 2
// Bristow D, 2005: Blinking, Visual Stimulation - External Darkenings, Visual 
// Stimulation
// Bristow D, 2005: External Darkenings, Visual Stimulation - Fixation, Visual 
// Stimulation
// Bristow D, 2005: Fixation, Visual Stimulation - External Darkenings, Visual 
// Stimulation
// Subjects=14
9	-66	-21
-9	-69	-21
3	-75	18
-6	-75	9
21	-69	12
-21	-63	0
51	-6	42
-51	-9	45
6	-9	72
-3	-6	63
63	3	15
-60	0	18
66	-30	9
24	3	6
-27	-9	6
30	-93	-3
-33	-87	-15
-45	-72	-9
48	-27	45
-42	-33	63
30	-72	18
-30	-87	12
48	-60	-15
45	-69	-9
-54	-48	-9
42	-27	42
-42	-39	36
33	-72	30
-27	-69	57
6	-75	24
-6	-75	9
9	-66	-21
-9	-66	-21
63	3	12
-60	3	9
45	-12	39
-48	-15	42
0	-6	63
-6	0	45
3	-75	18
-3	-75	12
45	6	0
24	3	3
-27	-9	6
6	-75	24
-21	-63	0
48	-48	33
-51	-60	33
-39	-48	-6
-45	-81	-9
48	-57	-15
33	-72	30
-18	-69	51
45	-27	42
-63	-27	30

// Dalton K M, 2005: Emotional Faces and Neutral Faces, Controls > Autistic 
// Subjects
// Dalton K M, 2005: Emotional Faces and Neutral Faces, Autistic Subjects > 
// Controls
// Dalton K M, 2005: Familiar Faces and Unfamiliar Faces, Controls > Autistic 
// Subjects
// Dalton K M, 2005: Familiar Faces and Unfamiliar Faces, Autistic Subjects > 
// Controls
// Dalton K M, 2005: Group x Familiarity Interaction, Controls > Autistic 
// Subjects
// Subjects=11
35.47	-59.16	-2.86
-40.42	-59.87	-5.27
16.48	-87.51	17.58
-5.99	-94.59	10.62
46.2	11.58	30.12
-24.79	38.22	-18.14
-22.55	-8.97	-23.13
52.49	-55.51	-12.28
-25.39	-67.81	0.8
-33.95	-76.75	-3.93
7.79	-81.36	1.55
23.36	-2.53	-26.43
31.22	-79.87	-8.88
20.56	-81.79	-5.25

// Fiebach C J, 2005: Long vs. Short Object
// Fiebach C J, 2005: Long vs. Short Subject
// Subjects=14
-45.93	24.03	6.71
49.16	24.52	4.46
-48.11	19.19	-.66
-56.42	10.62	26.92
-56.53	-27.81	-2.2
-54.26	-47.29	7.21
49.21	-17.83	-6.48
-17.99	-16.95	10.94
-19.91	-52.06	25.06
21.78	-59.38	22.97
-13.27	-63.97	49.4

// Katzir T, 2005: Blend > Plus-Minus
// Katzir T, 2005: Non-Blend > Plus-Minus
// Katzir T, 2005: Object Identity > Plus-Minus
// Katzir T, 2005: (Blend and Non-Blend) > Object Identity, with reaction time 
// as a covariate
// Subjects=12
-39	-69	-12
-51	15	33
33	-93	-3
33	30	-12
-3	36	45
-6	-21	-6
30	-33	0
-27	-60	42
12	3	0
45	24	27
42	3	27
33	-93	-3
12	18	45
-33	-84	-15
-45	21	24
33	21	0
-30	-60	45
-36	-12	-33
27	-33	-3
21	-6	15
0	-45	-21
-60	-45	-3
51	36	30
-42	-72	-12
21	-99	-3
-36	24	-9
27	-33	-3
42	36	-12
-3	39	45
57	33	18
-30	-27	-12
9	24	51
-57	9	9
0	18	45
-9	-9	12
-30	21	-3
33	27	-12

// Kemeny S, 2005: Syllable Generation vs. Rest, ASSIST
// Kemeny S, 2005: Sentence Construction vs. Rest, ASSIST
// Kemeny S, 2005: Sentence Construction vs. Syllable Generation, ASSIST
// Kemeny S, 2005: Syllable Generation vs. Rest, BOLD
// Kemeny S, 2005: Sentence Construction vs. Rest, BOLD
// Kemeny S, 2005: Sentence Construction vs. Syllable Generation, BOLD
// Subjects=6
50	-12	46
-48	-18	44
40	-30	18
-38	-30	18
66	-14	8
-64	-26	8
42	14	10
-40	14	10
-46	6	30
-48	28	-4
50	-14	46
-48	-18	46
38	-30	16
-38	-30	16
52	-34	6
-62	-38	14
-58	-48	22
-14	-16	10
38	18	-2
-50	16	8
-46	0	44
-48	34	4
-62	-52	22
-6	-18	6
54	9	-21
-51	6	-21
-39	6	-9
-39	33	-12
33	39	-3
-21	48	-9
-54	-3	-12
6	3	66
-42	-42	12
12	-63	-24
-15	-63	-24
51	12	-27
-57	-6	-24
-36	15	-6
-48	27	-12
-21	39	0
-51	0	12
-3	6	66
45	-33	-6
-45	-36	3
12	-63	-24
-15	-63	-21
33	24	-24
-48	21	-18
36	15	-3
-36	15	-3
-48	21	-12
-3	12	63
54	-39	-3
-54	-39	0
27	-81	-30
-6	-51	-36

// Lange G, 2005: CFS Patients - Study 1
// Subjects=6
-56.83	11.37	35.6
-48.57	23.8	7.33
-46.44	17.01	3.49
-32.78	13.53	57.39
-.42	13.23	52.38
-23.99	-68.51	51.91
-36.9	-52.84	59.54
-2.69	18.98	45.13
37.86	37.28	9.01
66.09	9.94	13.48
36.33	0.39	50.79
23.66	-8.42	72.04
27.94	-58.99	59.04
51.41	-32.71	40.36
6.02	8.59	48.25

// Lange G, 2005: Controls - Study 1
// Subjects=7
-45.99	11.62	37.63
-57.1	9.3	13.4
-43.59	6.91	55.98
-4.42	-63.15	62.25
32.17	-57.47	52.1

// Lange G, 2005: CFS Patients - Study 2
// Subjects=19
-50.65	35.36	16.31
-46.13	7.29	25.73
-41.89	39.52	25.83
-52.86	21.87	9.84
-26.3	18.98	57.86
-46.13	7.29	25.73
-26.43	10.39	46.38
-22.15	31.99	47.53
-21.83	-57.56	54.15
-32.66	-57.8	52.12
-21.83	-57.56	54.15
-.64	28.04	38.59
46.52	48.36	12.25
51.09	29.42	27.49
37.96	53.32	19.75
46.52	48.36	12.25
27.69	18.96	54.7
51.09	29.42	27.49
3.79	29.95	47.29
27.69	18.96	54.7
32.14	-53.32	50.57
38.61	-55.63	48.45
32.14	-53.32	50.57
5.86	24.88	38.8
9.85	39.93	15.95

// Lange G, 2005: Controls - Study 2
// Subjects=18
-48.22	11.09	32.12
-26.43	10.39	46.38
-.47	21.64	50.43
51.14	23.24	30.34
36.27	13.05	48.41
10.64	-59.16	58.24

// Bestmann S, 2005: Activity evoked by suprathreshold rTMS over the left PMd
// Bestmann S, 2005: Conjunction Analysis Finger Tapping Suprathreshold rTMS
// Bestmann S, 2005: Activity evoked by subthreshold rTMS over the left PMd
// Bestmann S, 2005: Differences in Activity between Supra- and Subthreshold 
// rTMS over left PMd
// Subjects=9
-40	-11	54
-49	2	17
-45	-25	15
-50	-52	3
-14	-17	8
-11	-4	18
-27	-11	3
-6	-59	-20
-3	-20	-2
3	-5	55
3	4	44
43	-3	49
42	7	26
54	0	13
50	-22	15
12	-14	8
12	0	14
6	-25	-6
5	55	-15
-50	0	12
-45	-27	16
-50	-53	3
-12	-17	5
-26	-11	3
-5	-19	-3
2	-5	53
3	5	44
53	1	14
53	-22	15
13	-2	15
5	-55	-15
-52	-3	15
-47	-23	14
-48	-53	4
-19	-15	4
-1	-6	52
3	6	43
53	-1	11
49	-26	16
12	-16	9
-37	-10	53
-51	5	12
-50	-51	3
-10	-5	19
-48	-24	16
3	-5	55
2	5	47
43	-8	52
41	7	26
13	0	15
51	-20	14
5	-55	-14

// Baciu M, 2005: Rhyme vs. Visual Detection
// Baciu M, 2005: Word Fluency vs. Fixation
// Subjects=10
-48	-59	-7
-48	-47	-12
-42	31	2
-51	13	21
-24	-60	36
-24	-58	44
-50	-33	20
-44	45	16
-36	-71	32
-51	6	37
-51	9	18
-48	24	17
-48	-52	-4
-35	-78	-3
-24	-64	33
-20	-72	44
-16	-85	12

// Fu C H Y, 2005: Schizophrenic Patients with Acute Psychosis
// Subjects=9
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-31	9.52	-3.39
-30.95	-8.63	-4.1
-29.77	-21.77	4.79
25.56	-10.63	-21.31
40.83	-56.84	-.89
-.78	-81.58	-.56
21.32	19.35	-4.82
14.01	10.02	12.77
13.89	59.34	17.56
9.78	51.17	36.14
60.29	-4.94	49.18
18.21	25.82	10.29
-7.07	-36.49	32.53
-19.93	-44.57	25.55
-23.04	-40.39	38.62
18.25	-24.36	-5.58
-12.96	31.41	-11.01
18.11	9.39	-9.52
13.92	23.42	7.19
-5.28	13.79	8.22
12.95	6.84	13.05
-11.62	3.52	13.61
3.47	-56.63	5.1
-27.54	11.14	31
-37.26	41.83	29.65
43.94	14.68	15.39
48.07	17.65	-1.64
-36.34	15.03	-.45
29.9	28.46	2.12
-27.71	19.28	12.48
-62.73	-30.11	23.71
-50.74	-34.16	52.91
27.85	9.59	5.96

// Fu C H Y, 2005: Schizophrenic Patients in Remission
// Subjects=10
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-11.43	14.21	41.71
-21.06	-49.67	14.84
53.55	26.8	19.83
56.8	25.05	24.4
52.42	23.99	11.16
-28.72	14.33	17.36
54.47	20.86	-1.98
-36.15	-2.8	16.66
-67.06	-59.26	5.02
-59.32	-31.21	50.53
15.12	-33.47	0.8
12.88	6.15	4.19
-6.34	2.87	4.69
-9.46	0.45	14.96
13.16	-76.67	6.67
-27.54	11.14	31
-37.26	41.83	29.65
43.94	14.68	15.39
48.07	17.65	-1.64
-36.34	15.03	-.45
29.9	28.46	2.12
-27.71	19.28	12.48
-62.73	-30.11	23.71
-50.74	-34.16	52.91
27.85	9.59	5.96

// Fu C H Y, 2005: Normal Subjects
// Subjects=11
-39.4	13.21	17.58
-24.38	24.9	29.81
10.86	31.46	28.86
-7.24	27.72	37.18
18.21	25.82	10.29
-7.07	-36.49	32.53
-19.93	-44.57	25.55
-23.04	-40.39	38.62
18.25	-24.36	-5.58
-12.96	31.41	-11.01
18.11	9.39	-9.52
13.92	23.42	7.19
-5.28	13.79	8.22
12.95	6.84	13.05
-11.62	3.52	13.61
3.47	-56.63	5.1
-11.43	14.21	41.71
-21.06	-49.67	14.84
53.55	26.8	19.83
56.8	25.05	24.4
52.42	23.99	11.16
-28.72	14.33	17.36
54.47	20.86	-1.98
-36.15	-2.8	16.66
-67.06	-59.26	5.02
-59.32	-31.21	50.53
15.12	-33.47	0.8
12.88	6.15	4.19
-6.34	2.87	4.69
-9.46	0.45	14.96
13.16	-76.67	6.67

// Reiss J P, 2005: Implicit Learners
// Subjects=8
-18.23	3.54	-13.08
-22.49	8.09	-8.95
-22.56	16.2	-14.09
24.53	8.37	-9.51

// Reiss J P, 2005: Implicit Non-Learners
// Subjects=7
-22.49	8.09	-8.95

// Grandjean D, 2005: Angry/Neutral + Neutral/Angry vs. Neutral/Neutral
// Grandjean D, 2005: Angry Speech vs. Neutral Speech
// Subjects=15
63	-30	6
-60	-24	0
27	-87	24
-33	-72	36
-54	24	21
-45	-15	-6
60	-15	0
18	45	6
6	12	21
-60	12	0
-51	-30	12
42	6	-18
63	-24	39
-27	42	27
-21	12	6

// Meyer M E, 2005: Laughter > Speech
// Meyer M E, 2005: Speech > Laughter
// Meyer M E, 2005: Laughter > Sounds
// Meyer M E, 2005: Sounds > Laughter
// Meyer M E, 2005: Laughter vs. Sounds and Speech vs. Sounds
// Subjects=12
-48.95	-24.54	11.93
31.45	-11.54	48.95
53.61	8.74	20.23
51.45	-11.25	9.67
60.2	-35.55	24.99
-44.72	21.18	24.78
-41.7	22.57	1.21
-61.87	-12.44	4.38
-48.81	-64.81	14.2
53.55	-21.52	0.47
56.78	-14.65	6.55
44.07	-36.67	11.88
40.8	-60.44	-6.16
-45.61	-33.01	25.99
-45.82	-63.76	-13.81
-28.99	34.57	-9.98
40.97	-32.23	28.28
-58.67	-4.76	7.04
-45.68	-75.5	-.56
-36.09	-82.3	-6.79
44.03	-32.7	8.21
63.12	-1.12	1.99
31.13	-53.35	-9.99

// Wildgruber D, 2005: Emotion Identification vs. Rest
// Wildgruber D, 2005: Vowel Identification vs. Rest
// Wildgruber D, 2005: Emotion Identification vs. Vowel Identification
// Wildgruber D, 2005: Vowel Identification vs. Emotion Identification
// Subjects=10
3	9	57
-48	9	30
51	33	15
-45	30	-12
48	36	-18
-45	-9	18
45	3	24
39	-51	48
-60	-45	9
48	-45	6
-36	-3	-15
45	15	-30
-6	-27	-3
6	-21	0
-30	-60	-27
42	-63	-33
-6	-72	-30
3	9	51
-54	6	30
42	0	33
-57	0	21
57	3	18
-21	-63	48
27	-54	57
-60	-30	9
51	-42	6
-39	-9	-18
54	3	-15
-6	-24	-3
9	-21	6
-33	-54	-33
48	-66	-33
-3	-72	-24
48	33	-15
48	-42	3
-54	6	33
-48	-39	54
27	-66	39

// Aron A, 2005: Picture of Beloved - Neutral Picture
// Aron A, 2005: Passionate Love Scale Correlation
// Aron A, 2005: Correlation with a Longer Relationship
// Aron A, 2005: Correlation with a Shorter Relationship
// Subjects=17
-16	1	22
12	11	14
18	-18	22
14	-4	22
30	-52	4
2	-15	-9
8	6	14
0	-1	17
-40	52	1
-51	-60	3
-28	-2	-7
42	-2	2
4	36	28
9	-50	15
18	-65	18
12	-70	40
-22	-38	9

// Strangman G, 2005: Implicit Learning, Increases
// Strangman G, 2005: Implicit Learning, Decreases
// Strangman G, 2005: Verbalizable Rule Learning, Increases
// Strangman G, 2005: Verbalizable Rule Learning, Decreases
// Strangman G, 2005: Implicit Learning vs. Verbalizable Rule Learning
// Strangman G, 2005: Verbalizable Rule Learning vs. Implicit Learning
// Subjects=9
-52.36	21.62	3.64
22.05	-77.5	50.13
4.79	-72.63	32.08
8.09	-84.79	39.75
68.41	-11.46	-8.35
14.91	14.91	-6.6
-19.3	-2.98	-14.75
-39.41	-70.32	-16.68
24.71	-69.94	-17.44
-35.26	-44.12	-22.27
42.52	40.74	-19.12
-35.49	46.88	-15.4
27.94	47.85	32.86
-25.39	34.3	41.3
-58.29	-28.29	46.93
-15.61	-104.5	7.11
-61.99	-16.98	-13.08
-15.79	-41.6	8.52
7.52	11.41	3.81
1.2	-76.68	-19.95
44.67	30.98	-21.68
-39.7	8.99	-23.32
14.67	59.61	-20.39
18.01	64.34	-.75
68.6	-17.23	13.32
-61.86	-1.35	10.14
68.6	-17.23	13.32
51.9	-60.41	48.36
-31.82	-88.97	-10.74
1.33	-75.31	-2.23
68.69	-47.1	12.48
-39.7	8.99	-23.32
54.33	-3.65	-30.03
-52.25	-56.31	-13.24
37.52	-58.94	-14.05
18.05	-9.96	-25.74
21.21	64.36	-.79
-22.62	63.84	-3.59
-35.45	13.24	-23.73
24.71	-69.94	-17.44
28.2	19.79	55.29
-5	32.02	51.29

// Fitzgerald K D, 2005: OCD Patients
// Subjects=8
-3	36	-6
3	24	-9
9	30	-9
-3	18	48
-21	6	57
-15	3	63
51	3	39
48	21	39
57	15	30
48	21	-21
57	18	-15
36	20	-21
-27	27	-6
-45	12	46
-51	24	-6
60	-45	-6
51	-54	3
-3	30	-6
3	9	48
-15	9	12
12	12	9
-3	15	12
12	18	9
-6	0	12
9	0	12
12	12	6
3	-3	15

// Fitzgerald K D, 2005: Normals
// Subjects=7
-3	18	33
9	33	36
9	12	45
6	9	48
15	3	69
-6	0	66
6	0	66
48	18	30
45	27	33
48	9	-24
36	15	-12
36	-9	-18
-42	24	-9
-3	30	-6
3	9	48
0	0	54
-6	-3	57
-6	0	12
9	0	12
12	12	6
3	-3	15

// Knutson B, 2005: Main Effect of Valence (Activations)
// Knutson B, 2005: Main Effect of Valence (Deactivations)
// Knutson B, 2005: Main Effect of Magnitude (Activations)
// Knutson B, 2005: Main Effect of Magnitude (Deactivations)
// Knutson B, 2005: Main Effect of Probability (Activations)
// Knutson B, 2005: Main Effect of Probability (Deactivations)
// Knutson B, 2005: Interaction of Valence by Magnitude
// Knutson B, 2005: Interaction of Valence by Magnitude and Probability
// Subjects=14
1.48	-3.44	46.39
-10.74	12.56	-7.23
12.77	12.7	-7.51
41.98	28.61	44.35
-22.68	43.44	-19.72
24.34	43.81	-19.17
-39.67	56.6	0.56
40.49	58.3	1.73
1.27	27.34	31.54
1.46	5.11	46.79
-31.05	21.15	-4.37
33.13	22.14	2.62
-10.72	12.73	-5.01
12.79	12.87	-5.29
-6.4	8.87	-.28
8.56	8.96	-.46
1.27	-12.26	14.79
1.07	-18.72	-13.66
-.26	48.86	-20.43
5.06	56.38	-20.01
-3.45	55.61	-15.38
5.06	55.32	-19.92
-22.47	-12.52	-13.91
2.54	-47.52	26.65
1.34	28.03	40.4
-.6	-7.25	52.31
-31.02	20.35	-.96
-10.67	9.99	0.79
17.1	14.38	0.11
21.32	9.41	-9.56
-43.98	49.63	-6.61
-3.41	51.64	-11.7
5.17	48.78	-8.22
-3.21	42.69	10.23
2.35	27.44	32.64
-2.85	4.74	42.41
-14.99	12.7	-4.96
15.98	16.06	-5.6
-11.55	-4.6	18.75
8.75	-4.48	18.51
-19.26	11.62	-4.82
18.12	16.07	-5.62
1.27	-13.32	14.88
-3.15	51.04	21.8
2.2	47.9	22
17.3	3.23	21.11

// Nakao T, 2005: OCD Patients
// Subjects=24
50	18	-6
42	48	18
46	12	26
44	38	22
-46	8	32
-42	26	18
-48	14	22
-6	18	44
-4	14	52
6	22	38
34	18	0
-10	-8	12
-12	-16	4
-14	-14	16
26	-60	42
34	-52	42
54	-40	44
-26	-66	44
-44	-38	44
-30	-82	20
36	-60	-26
28	-74	-24
-40	-60	-22
32	-10	56
8	28	30
-2	30	38
-8	28	32
12	-2	12
32	6	-40
-26	2	-28
4	-14	-14

// Nakao T, 2005: Normals
// Subjects=14
42	14	-8
34	20	-2
36	20	-10
52	14	34
44	16	28
42	6	52
36	56	14
38	42	30
-50	12	32
-44	28	16
-44	10	24
-2	26	40
-6	20	46
6	28	32
16	0	14
-16	-2	12
-8	-20	6
32	-64	50
34	-50	40
-26	-62	54
-20	-70	52
-34	-54	54
-34	-88	8
-28	-80	22
38	-54	-20
34	-68	-30
42	-58	-32
32	-10	56
8	28	30
-2	30	38
-8	28	32
12	-2	12
32	6	-40
-26	2	-28
4	-14	-14

// Schienle A, 2005: OCD-Relevant > Neutral, OCD Patients
// Schienle A, 2005: OCD-Relevant > Disgust, OCD Patients
// Schienle A, 2005: OCD-Relevant > Fear, OCD Patients
// Schienle A, 2005: Digust > Neutral, OCD Patients
// Schienle A, 2005: Fear > Neutral, OCD Patients
// Schienle A, 2005: OCD-Relevant > Neutral, OCD Patients > Normals
// Schienle A, 2005: Disgust > Neutral, OCD Patients > Normals
// Schienle A, 2005: Fear > Neutral, OCD Patients > Normals
// Schienle A, 2005: OCD-Relevant > Neutral, Unmedicated > Medicated OCD 
// Patients
// Subjects=5
-45	24	-21
-45	27	-21
48	21	-12
-21	3	48
15	66	27
42	15	-12
-30	18	-21
54	-33	48
-36	-69	39
30	-69	48
-9	6	3
-12	-6	3
3	-27	3
18	-66	51
-15	57	15
51	-33	48
-45	-66	51
45	-69	48
-15	8	12
-27	-63	54
21	-69	51
30	12	63
51	-33	45
-39	-69	45
30	-69	48
-15	9	12
-6	-9	12
21	-102	-3
30	-99	-3
-27	-102	-6
-39	36	-18
-33	-27	18
39	-3	3
-63	-24	27
27	-63	45
57	-69	6
42	-81	-3
-36	30	-9
-30	51	-12
48	24	-12
-27	6	66
54	-33	57
-18	24	0
18	-30	12
-39	18	-12
-51	-36	24
66	-27	18
-36	-27	21
39	-18	9
36	12	3
-18	9	24

// Viard A, 2005: OCD Patients
// Subjects=12
-28	60	4
-64	-40	16
8	-48	64
-28	-44	56
12	-84	28
28	24	-12
-48	-52	32
-16	-48	64
24	-56	32
12	-44	32
-8	-44	32
-20	-44	36
-8	-48	12
4	-40	24
20	-32	8
12	-24	4
-16	-32	8
-20	-32	60
-8	-24	56
12	-36	64
8	-32	60
12	-24	56
12	64	-4
-16	60	20
-52	28	4

// Viard A, 2005: Normals
// Subjects=15
-28	60	4
-64	-40	16
8	-48	64
-28	-44	56
12	-84	28
28	24	-12
-48	-52	32
-16	-48	64
24	-56	32

// Kuhtz-Buschbeck J P, 2005: Urge to Void vs. Withholding
// Kuhtz-Buschbeck J P, 2005: Contraction vs. Rest
// Subjects=22
-15	-3	66
0	3	51
0	-12	60
60	-42	48
63	-45	39
-54	9	0
-42	3	-6
-51	12	-6
63	9	12
42	15	-9
60	15	-3
-42	48	-6
-30	-72	-27
-3	-18	0
18	-24	9
3	-18	-30
3	-27	-12
6	-18	57
-6	-6	42
57	-39	21
45	9	-9
-9	-9	75
-12	-12	9

// van den Huevel O A, 2005: OCD Patients
// Subjects=22
-44	38	30
48	38	30
10	24	42
-24	12	52
24	6	54
-2	-56	54
8	-58	52
-30	-48	46
38	-42	44
-32	22	-4
-38	-78	32
32	42	14
24	-14	54
-14	20	34
-10	-64	22
10	-78	44
-52	-28	32
8	16	6
-26	16	-6
-36	52	8
38	54	8
-44	32	34
-42	32	28
38	40	34
-30	36	46
30	24	46
58	16	6
-6	34	28
6	34	24
-6	28	36
6	20	44
26	-2	50
-34	16	56
28	4	52
-24	16	50
-2	-62	52
2	-54	52
-50	-42	40
56	-40	40
-32	20	-4
34	20	-6
-16	-6	4
-26	-24	-22
-14	-4	-4
-8	-22	-26
-40	-72	38
-32	40	4
-2	18	32
9	26	26
-50	24	-10
-46	24	0
50	24	-2
58	20	8
-44	0	-32
-24	-24	-24
24	-18	-26
-4	-26	-20

// van den Huevel O A, 2005: Normals
// Subjects=22
-40	30	28
48	34	34
-20	-6	50
24	-12	52
-22	10	58
22	16	50
-22	20	48
8	24	48
-6	-54	48
-12	-62	22
10	-58	48
-26	-44	48
52	-40	46
-28	18	-2
28	26	0
12	12	0
-10	8	-2
-42	-76	30
38	-78	32
32	42	14
24	-14	54
-14	20	34
-10	-64	22
10	-78	44
-52	-28	32
8	16	6
-26	16	-6
-24	52	2
38	50	-4
34	62	4
32	52	6
-44	38	24
-30	42	4
44	32	32
-40	28	44
28	24	50
-10	22	34
6	22	40
18	-10	58
-22	6	58
26	8	50
-10	-54	48
8	-60	52
50	-42	54
-32	20	-4
34	22	-4
-18	4	16
-42	-70	36
-32	40	4
-2	18	32
9	26	26
-50	24	-10
-46	24	0
50	24	-2
58	20	8
-44	0	-32
-24	-24	-24
24	-18	-26
-4	-26	-20

// Phan K L, 2005: Suppress vs. Fixation
// Phan K L, 2005: Maintain vs. Fixation
// Phan K L, 2005: Conjunction Analysis (Maintain > Fixation) + (Suppress > 
// Fixation)
// Phan K L, 2005: Suppress > Maintain
// Phan K L, 2005: Maintain > Suppress
// Phan K L, 2005: Negative correlation with intensity of negative emotion
// Phan K L, 2005: Positive correlation with intensity of negative emotion
// Subjects=14
8	-84	-6
2	14	54
-14	62	32
42	34	2
-42	28	-6
38	28	0
-32	-4	-24
26	2	-24
42	28	-16
-40	54	16
-8	18	40
-10	52	18
12	58	2
10	-84	-2
8	62	34
54	38	8
38	26	6
-36	20	2
-28	0	-28
16	0	-28
2	6	-6
-48	20	28
-8	-2	-2
-38	54	20
8	64	8
-6	-90	-16
50	22	-12
52	44	14
8	64	30
-18	-4	-20
12	42	54
6	28	52
40	22	44
52	32	-10
52	30	-8
56	24	4
34	54	12
-8	20	44
6	36	36
0	12	-2
-42	20	28
-14	-6	-8
8	28	34
48	12	-10
-44	18	42
54	20	38
-43	50	10
36	52	12
48	-76	4
-40	34	42
42	28	14
-26	6	-26

// Tham W W P, 2005: English Homophone Matching vs. Fixation
// Tham W W P, 2005: Mandarin Homophone Matching vs. Fixation
// Subjects=6
-48	8	34
-40	28	24
-40	28	24
-30	-62	44
-28	-82	-14
-30	-90	-4
44	8	30
40	32	28
42	-54	44
14	-76	14
26	-88	-4
-44	10	36
-30	40	8
-42	32	38
-4	16	40
-46	-38	32
-44	-62	-14
-42	-84	2
44	4	34
12	10	50
36	38	12
12	18	38
40	-40	28
22	-92	-6
48	-70	-8

// Lee J H, 2005: 2D Smoking Images > 2D Non-Smoking Images
// Lee J H, 2005: 3D Smoking Images > 3D Non-Smoking Images
// Subjects=8
8.75	54.85	42.53
29.71	8.97	-29.7
-22.97	5.45	67.11
0.31	16.39	41.39
-23.76	47.75	-18.95
38.7	33.37	37.3
-38.65	-17.5	-35.61
-34.16	55	20.71
46.85	-5.9	-30.88
4.49	-90.06	-14.41
47.63	-68.09	45.7
-53.25	-16.11	11.28
17.12	66.22	23.64
-40.27	-91.25	1.82

// Xu J, 2005: Significant Load Sensitive Activity
// Subjects=8
-48.34	11.32	23.13
-24.17	7.83	53.32
-.44	8.77	50.58
-27.42	-67.75	37.32
51.4	-59.07	34

// Johnson-Frey S H, 2005: Tool, No Go, Right > Move, No Go, Right
// Johnson-Frey S H, 2005: Tool, Go, Right > Tool, No Go, Right
// Johnson-Frey S H, 2005: Tool, No Go, Left > Move, No Go, Left
// Johnson-Frey S H, 2005: Tool, Go, Left > Tool, No Go, Left
// Johnson-Frey S H, 2005: (Tool, No Go, Right > Move, No Go, Right) + (Tool, 
// No Go, Left > Move, No Go, Left)
// Subjects=13
-50.77	-51.98	-10.9
-39.02	-48.18	63.6
-52.91	19.32	5.61
-52.4	-26.15	35.87
-61.39	-22.19	9.86
-9.18	38.62	48.9
-9.64	-42.5	-3.58
-34.81	-14.36	-22.74
-39.98	-7.2	-3.19
-48.08	-74.28	25.99
-26.17	-4.11	63.5
-39.98	-7.2	-3.19
-11.58	52.16	33.03
-64.86	-9.72	-5.88
-65.34	-24.92	38.21
-50.39	-37.06	22.35
-35.16	-10.03	35.1
-26.29	-24.71	49.85
-50.39	-37.06	22.35
52.85	1.33	-8.98
24.75	-59.03	-21.58
31.15	1.59	-16.48
53.14	-39.22	5.11
42.26	-.45	7.06
59.28	34.84	-6.8
42.79	-5.22	47.87
-37.18	-25.37	43.38
-53.79	-64.53	4.28
69.56	-23.36	24.55
35.91	-46.51	8.37
50.51	-14.27	-26.45
65	-55.75	-.18
56.05	28.35	-7.22
-52.89	-51.68	-7.54
-46.8	36.21	-20.82
-62.5	-33.35	5.38
-11.58	48.86	32.24
-43.43	-48.81	57.01
-44.36	-1.04	-5.97
-61.99	-20.79	47.83
-34.77	-68.34	54.31
-56.24	18.58	-2.11
-24.33	34	46.25
-30.58	-38.65	50.19
67	-29.57	-7.28
46.17	45.77	-15.5
-46.52	41.58	2.18
-41.59	-28.24	35.9
-3.66	-48.45	-44.55
-46.55	-39.62	-16.68
-31.48	58.54	-.88
-67.82	-53.57	7.47
-6.67	-63.78	55.63
-46.71	53.3	-10.18
-53.93	-64.55	-7.37
-33.25	49.43	28.07
-31.26	52.55	15.4
44.11	-11.1	65.24
48.51	41.6	-2.81
-43.43	-47.75	56.91
-32.64	-67.48	51.95
-44.47	38.63	-6.53
-41.39	36.33	-19.8
-31.68	37.32	-21.19
-52.68	11.2	22.1
-9.42	52.16	32.99
-44.47	39.69	-6.64
-54.1	21.78	-2.46
-51.77	-55.72	-4.91
-62.54	-36.95	1.26
-33.4	-29.4	0.01
-42.16	-1.89	-3.68
71.38	-24.78	-2.23
30.34	4.73	5.64

// Amir N, 2005: Disgust - Neutral, Phobics > Normals
// Subjects=11
6	17	25
-8	42	16
12	39	13
-12	-9	23
-4	22	6
-30	-13	14
2	-60	12
38	37	9
-26	-39	-5
10	-32	26
8	-38	15
-42	-12	-4
44	-30	27
2	-58	-2
24	27	6
-20	32	15
-44	39	0
-36	35	4
-42	40	15
44	-61	29
-38	-61	21
28	-73	20
-44	-36	9
-34	-53	27
-12	33	-2
6	30	11
24	26	10
-50	9	24
34	19	-13
38	21	-6
18	43	-4
-34	-81	11
40	-60	7
14	-37	31
-18	-53	28
-18	-65	25
-22	-21	10
-14	-8	2
-22	-21	10
12	-10	0

// Creem-Regehr S H, 2005: Tools > Scrambled Tools, Viewing
// Creem-Regehr S H, 2005: Scrambled Tools > Tools, Viewing
// Creem-Regehr S H, 2005: Shapes > Scrambled Shapes, Viewing
// Creem-Regehr S H, 2005: Scrambled Shapes > Shapes, Viewing
// Creem-Regehr S H, 2005: Tools > Shapes, Viewing
// Creem-Regehr S H, 2005: Tools > Scrambled Tools, Imagined Grasping
// Creem-Regehr S H, 2005: Scrambled Tools > Tools, Imagined Grasping
// Creem-Regehr S H, 2005: Shapes > Scrambled Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Scrambled Shapes > Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Tools > Shapes, Imagined Grasping
// Creem-Regehr S H, 2005: Finger Clenching > Rest
// Subjects=12
-44	-50	-18
-34	-44	-22
52	-62	-2
44	-66	-4
38	-42	-22
48	-62	18
-42	-28	56
28	-46	60
-54	0	26
-8	20	48
20	-92	18
-20	-84	-12
-14	-96	10
28	-78	-14
-44	-68	-6
-16	-86	-14
16	-96	12
-28	-78	-16
-36	-48	-22
-42	-74	-6
-40	-34	-18
44	-62	2
44	-38	-18
46	-66	-6
40	-50	12
-40	-52	58
-20	-62	62
-26	-10	60
24	-8	60
-10	2	64
42	-40	64
-52	4	8
12	6	56
-16	10	4
-14	-84	-18
24	-84	24
12	-90	18
-14	-98	12
-10	-88	22
-42	-60	-6
48	-62	-6
-26	-10	62
-14	0	62
26	-10	56
-56	6	30
-44	-48	58
-34	-48	64
-56	-34	40
-46	-2	46
-8	20	42
12	12	44
-6	10	50
22	-94	18
26	-78	-12
-16	-86	-14
-24	-80	-10
-8	-64	36
-18	-96	16
-54	-10	-6
-46	-8	-24
56	-6	-6
-54	-66	20
20	-52	28
-60	-44	4
-42	-68	26
-38	-46	-20
12	-56	-16
-8	-62	-18
-52	-28	46
-36	-30	60
36	-24	64
44	-18	52
-4	-10	54
6	-6	48
-60	-32	24
22	-20	4

// Kozel F A, 2005: Normals, Model Building Group
// Subjects=30
-3	21	48
9	18	42
9	-3	66
36	27	0
48	15	-9
51	24	-6
-9	-3	6
12	0	9
12	3	-3
27	51	33
36	42	21
33	45	33
60	-45	21
66	-48	12
-57	-42	30
-57	-51	39
-30	12	9
-30	21	6

// Kozel F A, 2005: Normals, Model Testing Group
// Subjects=31
3	18	60
15	36	21
15	21	66
45	39	-6
42	24	-9
57	15	12
-45	36	-6
-36	42	-12
-51	21	-3
-57	-51	33
-48	-54	33
60	-54	33
-12	9	6
12	6	9

// Phan K L, 2005: Lie > Truth
// Phan K L, 2005: Lie > Recognition
// Subjects=14
-54	12	4
-48	16	-6
-52	16	16
60	14	-2
66	-44	-4
-58	-56	8
-6	40	50
56	18	36
-36	16	42
-44	-66	14
-44	-26	32
-42	22	-22
60	18	18
-54	-40	2
62	-34	-2
-48	-56	6
-2	20	50
-4	36	50
-40	4	44

// Schienle A, 2005: Spider Phobics
// Subjects=10
-18	102	9
24	3	-27
0	-9	12
-48	24	-9
15	6	69
-24	-78	-18
-27	0	-18
27	0	-21
-48	-63	9
21	0	-27
-54	33	-3
-30	-63	-15
-24	-6	-18
24	-3	-21
-51	-69	12
57	-66	9
-24	-9	-9
-24	-9	-12
21	-3	-18
60	0	3
3	12	66
-15	-105	-3
24	-105	0
-54	-27	27
3	27	33
3	6	66
18	-81	54
15	3	-27
51	-57	18
15	-18	-6
60	-66	3
-30	0	-12
-30	0	-18
27	3	-21
24	-9	69
27	-39	3
-27	-75	-12
42	-48	-21
-27	-6	-15
-27	-6	-15
21	0	-18
39	0	15
-30	-6	-21
-39	-18	-24
9	-54	30
51	-57	45

// Schienle A, 2005: Normals
// Subjects=13
-15	-105	-9
-51	-66	33
54	-57	42
12	-102	0
-18	-3	-21
54	-72	3
48	-45	-24
15	-18	-6
60	-66	3
-30	0	-12
-30	0	-18
27	3	-21
24	-9	69
27	-39	3
-27	-75	-12
42	-48	-21
-27	-6	-15
-27	-6	-15
21	0	-18
39	0	15
-30	-6	-21
-39	-18	-24
9	-54	30
51	-57	45

// Langleben D D, 2005: Lie > Repeat Distracter
// Langleben D D, 2005: Truth > Lie
// Langleben D D, 2005: Lie > Truth
// Subjects=26
34	22	-8
37	19	-11
56	26	17
56	12	3
37	19	-1
51	15	-14
8	34	40
12	31	35
16	18	51
7	21	36
56	-52	36
48	-48	50
59	-45	32
56	-50	17
42	-60	47
-30	14	-14
-26	11	-17
-38	16	3
-34	16	3
-42	-32	42
-37	-34	39
-37	-34	46
-24	-13	52
-26	-13	52
-26	-12	63
-12	-13	49
-4	-2	30
-24	-52	58
-12	-50	54
-12	20	21
63	-22	31
63	-22	27
63	-24	23
30	-50	58
24	-50	54
4	-2	44
4	-2	41
4	-60	-18
7	-63	-20
7	-59	-21
-15	-52	-24
-22	-49	-35
-56	6	26
-53	1	22
-53	-3	22
-26	-7	8
-30	-7	8
-12	-25	12
26	-4	66
30	-8	63
30	-13	56
37	-17	52
60	10	26
63	5	22
42	-7	8
63	1	22
34	-8	4
38	-11	8
-50	20	14
-4	34	44
-38	12	48
-38	34	-12

// Nunez J M, 2005: False > True
// Nunez J M, 2005: Autobiographical > Non-Autobiographical
// Nunez J M, 2005: False, Autobiographical > True, Autobiographical
// Subjects=20
-10	20	41
16	-5	19
-20	-1	26
-57	14	12
-20	11	16
-42	4	43
34	42	20
34	32	24
4	-51	27
22	45	37
57	-51	36
-42	-62	34
-2	12	51
-57	14	12
22	46	20
20	-3	22
50	19	32
52	14	9
-36	0	41

// Hennenlotter A, 2005: Smile Observation - Neutral Observation
// Hennenlotter A, 2005: Smile Execution - Fixation
// Hennenlotter A, 2005: (Smile Observation - Neutral Observation) + (Smile 
// Execution - Fixation)
// Subjects=12
56	8	40
-52	-26	32
-60	-18	24
58	-34	22
-42	-68	4
-34	-96	-2
60	8	6
48	-62	0
44	-74	-6
52	-40	-2
46	-26	-6
-52	26	-8
-38	16	-10
36	34	-12
-42	-52	-20
-24	-8	-22
22	-6	-26
-52	8	-36
-40	14	-36
36	14	-44
2	14	62
-4	4	52
-46	-2	56
-54	0	44
-44	-10	34
-58	6	8
46	-4	54
56	2	48
46	-10	36
62	8	12
68	-28	22
-60	-38	20
-22	0	18
20	-66	10
-10	-70	8
-46	-4	2
-12	-18	-2
10	-24	-2
20	-4	-10
-24	-4	-12
40	10	-12
-10	-60	-28
12	-56	-28
56	8	40
60	-32	18
60	8	6
-40	14	-10

// Holsen L M, 2005: Food > Non-Food, Pre-Meal
// Holsen L M, 2005: Food > Non-Food, Post-Meal
// Holsen L M, 2005: Stimulus x Motivational State Interaction
// Holsen L M, 2005: Non-Food > Food, Pre-Meal
// Holsen L M, 2005: Non-Food > Food, Post-Meal
// Subjects=9
5.11	57.95	-13.45
-1.32	61.08	-13.64
-30.07	35.53	-11.16
-7.55	67.33	12.68
25.31	-63.68	63.43
24.69	-56.9	-14.08
-23.41	-54.02	-13.77
63.12	-10.98	-1.64
27.92	-56.63	-10.79
-29.76	-56.72	-6.78
15.9	-2.4	-24.12
19.16	-11.64	-20.04
3.05	53.25	-5.22
-36.51	35.24	-14.41
27.63	35.88	-11.85
-7.48	63.62	19.68
-39.62	23.04	-6.66
43.66	22.77	-17.63
-39.69	22.27	-16.63
18.09	-12.79	-21.05
2.47	-11.95	32.59
-42.6	-63.65	-12.74
53.43	21.2	2.46
12.27	16.32	66.91
-20.16	51.88	34.19
56.83	-62.54	-7.28
11.72	4.06	-9
-13.29	-29.02	60.97
56.98	5.01	40.58
-3.6	-21.59	73.62
57.2	-32.28	53.74
-48.63	-36.6	48.63
21.43	-47.66	-18.16
37.35	-38.82	-29.12
44.1	-61.59	6.17
40.65	-44.38	-18.66
-39.5	-51.46	-20.49
2.52	24.83	54.04
-17.09	68.05	22.76
37.4	-44.91	-25.27
-39.47	-51.2	-17.16

// Simmons W K, 2005: Foods > Locations
// Simmons W K, 2005: Locations > Foods
// Subjects=9
36	-6	9
-21	33	-18
-18	45	-6
48	-45	-12
48	-66	-9
-48	-60	-18
-21	-39	-12
27	-42	-15

// Castriota-Scanderbeg A, 2005: Sommeliers
// Subjects=7
58	0	6
62	16	14
-34	12	-6
-32	28	-4
46	48	12
-34	40	32
-46	40	2
-28	0	2
-38	6	-6
-28	28	-6
-38	36	14
58	16	26
40	40	24
-28	4	12
44	24	-10
28	58	14
-28	-12	-16
-50	36	0

// Castriota-Scanderbeg A, 2005: Controls
// Subjects=7
52	10	2
58	18	2
44	24	-6
28	64	14
-50	36	6
-22	-8	-18
-38	6	-6
-28	28	-6
-38	36	14
58	16	26
40	40	24
-28	4	12
44	24	-10
28	58	14
-28	-12	-16
-50	36	0

// Goekoop R, 2005: Elderly Males, Placebo
// Subjects=14
42	-84	-8
-8	-88	-4
-14	-86	-10
-40	-56	-18
10	-96	-4
40	-54	-20
24	-30	-26
-32	-28	-6
26	-58	42
36	4	30
-38	42	28
-26	32	-6
16	-18	6
-18	-18	6
34	34	14
-28	-58	40
8	12	44
46	20	42
-30	-58	34
-36	12	42
2	46	44
-44	34	-2
-28	-64	0
46	-60	40
-34	18	4
30	4	56
-52	18	30
10	12	48
-38	-74	-4
44	18	42
-42	36	-4
36	40	-6
40	-58	46
44	18	42
-38	10	44
0	48	42
-42	36	-4

// Goekoop R, 2005: Elderly Males, Raloxifene
// Subjects=14
42	-84	-8
-8	-88	-4
-14	-86	-10
-40	-56	-18
10	-96	-4
40	-54	-20
24	-30	-26
-32	-28	-6
26	-58	42
36	4	30
-38	42	28
-26	32	-6
16	-18	6
-18	-18	6
34	34	14
-28	-58	40
8	12	44
46	20	42
-44	40	6
-30	-58	34
-48	-70	12
-4	44	44
46	20	42
-30	-58	34
-36	12	42
2	46	44
-44	34	-2
-28	-64	0
46	-60	40
30	40	-6
22	-82	-4
36	4	44
42	-42	68
-38	-74	-4
44	18	42
-42	36	-4
36	40	-6
40	-58	46
44	18	42
-38	10	44
0	48	42
-42	36	-4

// Kikuchi S, 2005: Pickled Plums > Red Balls
// Subjects=13
-48	18	-18
54	14	-16
44	10	2
-36	48	-10
36	48	-8
-54	10	22

// Achim A M, 2005: Encoding for Both Items and Associations Relative to 
// Baseline
// Achim A M, 2005: Both Item Recognition and Associative Recognition Relative 
// to Baseline
// Achim A M, 2005: Associative Encoding > Item Encoding
// Achim A M, 2005: Associative Recognition > Item Recognition
// Achim A M, 2005: Item Recognition > Associative Recognition
// Achim A M, 2005: New Item Recognition > Old Item Recognition
// Achim A M, 2005: (Associative > Item at Encoding) + (Associative > Item at 
// Recognition)
// Achim A M, 2005: (Item > Associative at Encoding) + (Item > Associative at 
// Recognition)
// Subjects=18
-38	24	20
-42	-4	12
-28	-6	-6
-30	-12	-28
-30	-14	-26
-12	-18	-20
-10	-20	10
-10	-24	46
-36	-28	56
-18	-30	-2
-28	-64	-14
34	38	36
46	30	26
34	24	4
54	6	30
2	2	52
8	2	4
52	0	42
42	-2	14
26	-2	-22
20	-4	-2
42	-10	-30
34	-14	64
10	-16	10
20	-16	-20
62	-30	26
22	-50	-20
-22	34	-16
-40	22	24
-10	4	0
-2	-4	56
-22	-12	4
-24	-12	-22
-36	-18	-24
-12	-20	10
-28	-20	72
-30	-24	6
-32	-24	-22
-46	-34	46
-32	-48	-20
-32	-52	48
32	62	0
30	58	-12
36	52	12
32	22	2
12	4	2
28	-2	-12
38	-4	60
38	-4	10
22	-28	0
46	-34	48
28	-56	-12
-24	36	52
24	58	-10
26	36	36
30	30	-4
6	8	40
6	2	54
14	-24	44
28	-26	-16
2	-58	42
-44	22	26
-32	-54	48
28	-62	46
-8	56	16
-22	12	32
-28	-10	-22
16	48	24
4	44	-18
32	20	38
16	2	30
28	-4	-24
20	-14	-30
56	-28	26
-26	-8	-8
-36	-24	-26
32	-2	-16
-6	12	46
-28	-10	56
30	24	-2
-16	-10	-18
-32	-14	-28
22	-8	-16
20	-10	-26

// Sadato N, 2005: Hearing Signers
// Subjects=9
-46	14	-4
-48	12	34
-44	8	48
-48	-2	42
-2	2	64
-4	16	64
-62	-16	6
-56	-4	-6
-60	-32	6
62	-24	2
42	10	32
42	0	56
-2	6	66
-4	20	52
-40	12	32
-28	4	62
-36	30	16
30	-62	48
38	-48	56
-30	-56	52
-46	-34	40
46	-60	-6
30	-74	24
-44	-66	-8
-54	-62	2
-62	-20	4
-58	-10	4
-54	-24	10

// Sadato N, 2005: Hearing Non Signers
// Subjects=10
-46	14	-4
-48	12	34
-44	8	48
-48	-2	42
-2	2	64
-4	16	64
-62	-16	6
-56	-4	-6
-60	-32	6
62	-24	2

// Sadato N, 2005: Deaf Subjects
// Subjects=7
0	6	66
8	24	46
-48	14	20
-36	0	50
-30	28	-2
48	32	2
46	46	16
36	-56	48
40	-46	56
-26	-62	54
-26	-48	48
-30	-54	52
-20	-76	40
54	-58	0
-60	-18	2
62	-10	0
-48	-70	4
-50	-56	6
-34	-64	-30
-62	-20	4
-58	-10	4
-54	-24	10

// Cox S M L, 2005: Reward vs. Negative Feedback
// Subjects=22
0	44	-8
-16	42	-18
-18	38	-20
-44	32	12
-26	34	44
-22	4	48
26	28	50
2	0	46
-4	-18	40
-16	8	-12
28	0	-10
-10	-10	18
-60	-12	2
62	2	-4
-54	-62	-20
0	-40	-34
-28	-54	-22
2	-50	16
-14	-66	-2
-26	-82	40
32	-74	32
28	-92	-18
-38	-16	50
24	-22	56
58	0	36
-46	-12	32
2	-36	52
-22	-60	42

// Ernst M, 2005: Adults
// Subjects=14
-14	-2	-10
20	-2	-14
-14	12	-8
10	16	-8
-46	-28	60
-34	-56	62
-14	10	-6
10	16	-8
2	10	0
26	-60	-22
18	-78	-14
10	-86	4
-20	-30	-16
50	-40	56
42	-46	52
-54	10	36
4	-10	10
0	-78	34
-10	-52	-4
2	-22	12
-16	20	-4
-26	-4	-14
-42	30	12
10	-64	12
-14	-4	-8
28	-2	-10
-2	6	-6
6	6	-8
-48	-28	58
-44	-50	56
8	-46	36
2	-28	36
-2	34	26
0	22	28
2	34	44
-6	-66	34
48	14	44
44	-72	34
-30	18	-8
26	24	-12
52	18	30
-8	-18	-4
2	-28	-4
32	0	-20
12	-82	-22
28	-84	0
26	-62	-24
-20	2	-12
26	-6	-14
-16	4	-12
16	8	-12
36	-12	-14
40	-26	-14
8	-64	60
-16	20	-4
-8	-60	66
-14	-66	62
-28	-4	-14
32	4	-16
32	-20	-22
-24	-4	-14
20	-4	-14
-16	4	-12
20	4	-8
10	-66	12
8	-86	4
6	-46	6
28	-62	-20
-26	-4	-14
-46	-28	60
-40	34	10
4	-6	8
20	-6	-16
-38	-74	-22
30	0	-12
24	-62	-20
-44	-48	58
-50	-30	56
10	-90	2
-22	-2	-12
26	-6	-14
18	8	-12
34	-12	-16
40	-26	-14
32	-20	-22

// Ernst M, 2005: Adolescents
// Subjects=16
-14	-2	-10
20	-2	-14
-14	12	-8
10	16	-8
-46	-28	60
-34	-56	62
-14	10	-6
10	16	-8
2	10	0
26	-60	-22
18	-78	-14
10	-86	4
-20	-30	-16
50	-40	56
42	-46	52
-54	10	36
4	-10	10
0	-78	34
-10	-52	-4
2	-22	12
-16	20	-4
-26	-4	-14
-42	30	12
10	-64	12
-14	-4	-8
28	-2	-10
-2	6	-6
6	6	-8
-48	-28	58
-44	-50	56
8	-46	36
2	-28	36
-2	34	26
0	22	28
2	34	44
-6	-66	34
48	14	44
44	-72	34
-30	18	-8
26	24	-12
52	18	30
-8	-18	-4
2	-28	-4
32	0	-20
12	-82	-22
28	-84	0
26	-62	-24
-20	2	-12
26	-6	-14
-16	4	-12
16	8	-12
36	-12	-14
40	-26	-14
8	-64	60
-16	20	-4
-8	-60	66
-14	-66	62
-28	-4	-14
32	4	-16
32	-20	-22
-14	-4	-8
20	-2	-14
-12	12	-6
10	4	-6
-46	-28	60
-36	-20	62
-26	-62	64
-14	12	-4
10	4	-6
10	14	-6
18	-78	-16
0	-40	22
42	-46	54
-6	-12	26
-16	-32	16
-4	32	28
0	-24	36
6	-42	36
-14	18	-6
14	6	-10
-6	-54	68
22	-66	60
-8	34	34

// Uncapher M R, 2005: Delay Invariant Memory Effects Associated with 
// Recollection
// Uncapher M R, 2005: Delay Selective Long Delay Memory Effects Associated 
// with Recollection
// Uncapher M R, 2005: Short Delay Memory Effects Associated with Recollection
// Uncapher M R, 2005: Delay Invariant Memory Effects Associated with 
// Familiarity
// Uncapher M R, 2005: Delay Selective Short Delay Memory Effects Associated 
// with Familiarity
// Subjects=18
-18	30	57
0	12	57
-45	3	54
-42	18	27
-45	33	6
57	15	30
57	21	15
39	-6	63
-48	-6	30
-21	-15	-15
-48	-63	-24
-60	-45	3
30	-63	57
-42	-69	36
-48	39	-3
45	45	-6
-6	15	54
-39	-63	-15
30	-24	-24
-60	-18	45
54	-6	48
48	-3	24
-48	-6	30

// Fenker D B, 2005: Emotional, Remember vs. Emotional, Know
// Fenker D B, 2005: Neutral, Remember vs. Neutral, Know
// Fenker D B, 2005: Emotional, Remember vs. Neutral, Remember
// Fenker D B, 2005: Emotional, Know vs. Neutral, Know
// Fenker D B, 2005: Remember vs. New
// Fenker D B, 2005: Know vs. New
// Subjects=20
15	12	-21
-27	12	-21
-9	42	54
-39	9	60
-33	33	12
-9	54	-9
63	-9	-21
-57	-54	0
66	-42	-12
51	-66	21
33	-27	9
-54	-15	-15
-66	-30	-12
-57	-39	12
54	3	9
42	-6	42
69	-18	21
-39	-69	36
-39	-72	51
6	-66	21
27	-93	21
36	-81	24
-24	-78	3
-33	-93	3
-36	-81	15
6	-93	27
-6	-96	21
18	-87	-24
-21	-96	-6
-12	-6	-18
33	-18	-12
33	6	-30
-33	-27	-15
-36	-18	-24
0	-39	39
24	-72	-39
45	18	27
9	51	-9
6	60	3
48	36	18
24	21	51
-60	6	9
-21	57	33
-6	51	-15
51	-6	-18
-45	9	-36
-42	-39	9
-54	-9	-18
33	-72	33
24	-54	39
-30	-84	42
-39	-81	18
6	48	6
-3	-12	45
-3	42	3
-3	-12	9
24	-9	-15
27	-48	-15
-36	-39	-21
27	-33	0
27	-21	-9
-9	-39	3
-33	-18	-11
36	-72	-51
24	-36	-33
15	-45	-51
27	-30	-27
15	-33	0
30	-78	-15
-24	-90	-12
-33	-69	-9
39	-18	69
-15	-84	15
30	6	-21
24	-93	-6
39	-9	27
-9	-9	9
45	51	15
-42	12	48
-15	18	-18
-21	60	6
39	-3	30
63	-48	-3
-63	-24	-3
-63	-48	-9
-36	-42	-21
9	-72	-15
-42	-63	33
39	-63	42
15	-84	39
-3	-78	30
18	-48	51
9	3	39
-9	-39	39
-21	-33	-3
30	0	-12
-18	3	-24
-9	-30	6
3	-18	9
36	9	3
-12	-57	-48
15	15	69
33	-33	42

// Ferretti A, 2005: Erotic > Sport Video Clips
// Ferretti A, 2005: Regression Analysis with Penile Turgidity (Video Clips)
// Ferretti A, 2005: Erotic > Sport Pictures
// Ferretti A, 2005: Onset of Erection > No Erection (Erotic Video Clips)
// Ferretti A, 2005: Sustained Erection > No Erection (Erotic Video Clips)
// Subjects=9
29.4	-52.42	43.48
-31.49	-51.47	47.45
58.1	-29.67	32.32
-46.58	-29.87	39.12
48.3	7.99	24.82
-48.93	7.5	27.09
53.68	-19.1	18.11
-52.13	-21.04	16.14
43.81	29.86	5.19
-40.58	29.61	9.53
42.82	-.1	3.26
-42.65	-.44	6.5
3.35	-12.77	8.12
0.12	-9.78	5.67
28.16	-89.35	6.45
-27.4	-92.86	7.38
5.21	27.2	-11.98
-1.2	23.9	-12.75
48.27	-61.54	-7.27
-47.89	-66.34	-5.76
4.23	-1.53	-11.79
-1.13	0.47	-13.02
19.24	-18.53	-12.77
-18.16	-17.61	-11.3
48.16	-53.93	-19.06
-46.96	-53.53	-19.11
23.39	-2.27	-23.1
-22.57	-1.49	-22.64
26.22	-54.3	47.02
-21.88	-56.96	44.45
54.9	-28.46	34.49
-54.12	-24.97	34.33
48.33	3.85	26.28
-48.91	5.47	28.38
54.76	-20.06	19.29
-54.27	-18.86	17.1
44.87	28.64	3.05
-43.79	30.65	9.48
44.95	0.97	3.14
-41.58	-2.63	5.55
2.3	-13.74	9.33
0.15	-11.64	9.17
29.24	-92.52	6.7
29.24	-91.37	7.72
6.28	26.06	-13.02
-3.36	25.84	-15.12
47.21	-67	-9.03
-50.02	-68.56	-6.67
3.16	1.72	-10.94
4.23	0.59	-11.97
20.32	-21.69	-12.52
-19.22	-20.87	-12.13
47.11	-62.49	-19.44
-45.9	-59.07	-22.01
22.33	-3.25	-21.9
-23.36	-1.92	13.09
26.25	-55.19	49.33
-25.05	-57.7	49.01
59.15	-29.84	30.1
-48.73	-29.97	38.04
52.62	7.39	30.39
-51.06	2.11	26.45
45.96	33.3	8.22
24.98	-89.11	9.81
-27.39	-92.77	8.49
47.2	-61.54	-7.26
-43.6	-65.09	-3.68
21.42	-24.69	-10.05
-23.41	-30.96	-4.55
41.74	-54.06	-20.09
-44.8	-54.41	-16.83
23.44	-6.16	-18.32
-24.62	-9.44	-15.26
57.97	-20.04	19.25
-52.1	-23.96	19.73
41.77	-3.19	4.64
-40.49	-1.23	9.88
5.22	26.14	-11.9
-2.28	27.07	-13
4.22	0.5	-13.08
-3.27	1.51	-13.08
21.24	-1.31	-24.28
-19.36	-3.67	-23.61
56.89	-21.19	18.24
-53.2	-22.11	16.24
41.77	-3.19	4.64
-41.56	-5.63	8.03
2.02	26.21	-10.75
-3.32	25.12	-10.6
22.31	-.16	-23.27
-21.49	-2.54	-22.57

// Nieuwenhuis S, 2005: Positive Feedback > Negative Feedback
// Subjects=14
4.25	48.03	9.7
0.9	43.29	-9.94
22.65	46.22	39.75
0.4	-27.73	35.06
-13.87	9.97	0.83
18.18	9.02	-.57
-31.95	-74.93	-21.95

// Nieuwenhuis S, 2005: Outcome, +60 Cents vs. -40 Cents
// Nieuwenhuis S, 2005: Outcome, +30 Cents vs. -20 Cents
// Nieuwenhuis S, 2005: Outcome, No Gain vs. No Loss
// Nieuwenhuis S, 2005: Expectation Related Activation, Win vs. Lose
// Nieuwenhuis S, 2005: Expectation Related Activation, Lose vs. Win
// Subjects=14
21.36	8.78	-3.93
-7.46	5.6	-1.11
-13.94	1.62	-10.73
-49.64	-50.27	50.9
-.68	-33.37	31.08
0.52	-27.59	50.65
-4.92	13.07	54
-18.75	10.33	61.08
11.91	-59.9	-10.33
-39.62	-56.09	-39.06
21.36	8.78	-3.93
-13.94	1.62	-10.73
21.36	8.78	-3.93
-7.46	5.6	-1.11
-13.94	1.62	-10.73
-49.64	-50.27	50.9
-.68	-33.37	31.08
0.52	-27.59	50.65
-18.75	10.33	61.08
-39.62	-56.09	-39.06
0.52	-27.59	50.65
16.58	-42.56	48.38
4.36	-43.02	-11.66
-36.45	16.12	-13.92
-.68	-33.37	31.08
-4.92	13.07	54

// Prince S E, 2005: Encoding > Retrieval
// Prince S E, 2005: Retrieval > Encoding
// Prince S E, 2005: Semantic, (Encoding + Retrieval) > Perceptual, (Encoding 
// + Retrieval)
// Prince S E, 2005: Perceptual, (Encoding + Retrieval) > Semantic (Encoding + 
// Retrieval)
// Subjects=14
-51.92	37.2	1.58
-59.43	17.92	2.5
-35.82	-11.62	-16.27
-2.88	35.07	33.45
-22.88	-61.71	55.7
-19.63	11.29	-13.21
-40.17	-66.58	-29.81
-31.71	54.65	-19.54
-48.41	33.76	22.03
-19.24	-41.6	6.58
-34.91	-71.61	42.31
-51.02	-38.1	57.2
-43.63	-67.81	37.6
-34.82	-70.89	50.09
30.93	-60.85	39.01
-43.84	-74.89	19.26
-27.93	-73.72	-3.54
-48.74	29.14	-4.4
-24.16	29.38	-26.13
-35.53	-21.55	3.75
-15.29	28.95	-8.31
-23.67	3.47	6.68
25.67	10.83	-20.66
-19.66	-1.03	-18.72
-19.56	-60.46	-22.92
-44.27	-75.88	-14.25
34.48	-47.61	65.65
-22.93	-70.84	49.88
17.3	-26.55	-6.74
0.92	49.84	-3.93

// Yonelinas A P, 2005: Remember Responses > High Confidence Familiarity 
// Responses
// Yonelinas A P, 2005: Familiarity Confidence, Increasing with Familiarity 1 
// to 4
// Yonelinas A P, 2005: Familiarity Confidence, Decreasing with Familiarity 4 
// to 1
// Subjects=16
-6	54	-6
9	63	21
-30	39	-12
24	30	-15
63	3	27
-3	-54	6
0	-45	30
60	-24	15
-54	-27	18
-21	-42	63
36	-36	60
-45	-21	39
54	-12	48
-42	-54	15
-54	-42	21
-45	-3	-3
54	-69	9
57	-48	3
-54	-63	0
66	-39	-3
-24	-21	-21
30	-21	-21
-15	-51	-15
15	-60	-15
-45	-6	12
18	-3	12
-36	57	-3
-48	24	21
-6	30	42
-33	-60	36
39	-51	36
36	-66	48
9	-72	36
-6	-24	24
-33	15	-6
9	15	3
21	15	6
27	9	39
6	51	-12
3	30	-9
6	0	39
-9	-96	6
-48	-69	0
-18	-18	-21
-45	-27	18
30	-51	-30

// Connolly J D, 2005: Prosaccade vs. Fixation
// Subjects=5
27.13	-4.34	46.17
-27.35	-9.95	47.27
4.76	-3.79	55.3
36.88	-45.78	46.19
-26.19	-51.87	41.85

// Dresel C, 2005: Whistling vs. Voluntary Breathing
// Dresel C, 2005: Early Activated Areas During Whistling
// Dresel C, 2005: Late Activated Areas During Whistling
// Subjects=15
-52.62	-5.92	22.67
-22.66	-71.44	-13.94
-60.32	-.39	13.29
-43.84	-8.14	32.82
-60.29	-2.31	15.72
-5.81	-43.99	-42.72
-11.87	-17.84	-3.74
-19.64	-17.91	64.76
-60.11	-6.49	28.46
-41.9	-30.52	11.47
-9.33	-103.67	8.07
-62.33	-6.91	24.05
-22.91	-1.04	-18.66
-35.5	-78.21	-5.21
-31.33	-18.01	-4.51
-22.73	-2.98	-5.02
1.47	11.27	31.25
-.36	3.87	55.55
20.5	-65.12	-17.54
58.5	-2.31	9.21
51.09	-1.19	21.56
58.53	-2.1	11.43
27.15	-71.5	-5.82
4.99	-39.59	-42.21
14.16	-34.55	-.29
23.3	-96.47	25.85
26.92	-5.35	-10.12
65.21	-6.05	26.28
35.68	-20.86	-4.25
28.97	-.75	-18.45
-2.51	12.68	58.07
3.95	27.9	59.82
-35.5	-78.21	-5.21
-.2	2.88	67.97
-22.8	0.85	-9.89
-41.67	-10.26	33
44.43	-80.26	-8.61
24.72	5.28	-11.13
-45.64	-13.1	60.24
-18.73	29.61	-24.01
-45.74	-60.91	42.56
-60.62	-23.4	-14.68
-55.44	-52.02	46.33
-26.49	34	46.29
-23.05	-60.11	-41.95
65.37	-51.88	29.69
22.54	-56.16	-25.19
1.74	-55.63	38.99
56.93	-44.93	47.07
29.88	-.49	53.22

// Dalton K M, 2005: Threat vs. Safety
// Dalton K M, 2005: Threat - Safety, Correlated with Self-Reported Anxiety
// Subjects=17
-29.12	48.6	-21.19
-39.47	27.93	15.23
-39.15	10.32	49.05
-19.1	41.85	28.33
-43.9	13.07	-11.35
36.4	22.84	11.44
29.66	38.04	-25.44
-25.87	32.67	-21.01
-38.32	38.65	29.93
-40.59	15.26	2.92
15.93	-5.31	-20.53
-18.59	-19.82	70.3

// Griffiths D, 2005: Bladder Infusion vs. Rest
// Subjects=6
34	10	16
-34	10	16
0	12	44
9	-6	5
-9	-6	5
0	-32	-10
-47	-32	30
52	-28	26
1	-48	-30
0	-54	0

// Ogawa H, 2005: 1 M NaCl - Deionized Water, Normals
// Subjects=11
-52	26	4
-60	-18	24
-44	2	36
46	-6	12
-38	-8	12
-48	-6	16
46	-6	12
-38	-8	12

// Botvinick M M, 2005: Painful - Non-Painful Facial Expressions
// Botvinick M M, 2005: Painful - Non-Painful Thermal Stimulation
// Subjects=12
0	4	19
-42	18	2
53	0	-5
-18	-2	8
18	-2	19
6	-5	14
68	-40	16
0	11	55
-18	-65	-17
45	-50	-18
-39	-75	7
50	-78	4
-45	-73	6
45	-50	-13
68	-40	13
-24	-6	-12
-27	11	-18
6	22	27
-30	-10	28
33	6	11
-24	-3	6
24	4	16
15	7	13
53	-34	24
12	3	58
-30	-74	-29
3	-22	29
42	36	23

// Hao J, 2005: Alzheimer's Disease Patients
// Subjects=13
-36	-42	62
-20	-104	0
32	-66	50
34	-94	6
38	-48	44
44	50	-4
-48	42	20
-36	60	12
44	-64	-14
30	26	2
30	-68	56
12	-66	60
56	-60	-14
34	4	60
46	8	28
56	14	34
-52	-68	-60
-60	-52	-14
-46	34	24
50	38	26
4	22	38
8	14	44

// Hao J, 2005: Normals
// Subjects=13
-26	-68	44
-32	-56	50
-50	-32	50
32	-60	48
32	-6	64
56	16	2
-16	-14	14
18	0	18
14	-6	12
42	56	8
50	46	14
32	-92	4
52	14	42
28	-56	50
-52	-66	-10
-44	-78	-4
-36	-58	-16
-18	-18	16
-14	-26	-4
-12	-16	6
-32	22	2
-40	14	6
28	-20	-6

// Jackson P L, 2005: Painful Stimuli vs. Neutral Stimuli
// Subjects=15
-42	-44	56
40	-50	56
8	26	40
-10	18	44
18	2	6
-18	2	4
-42	14	-4
32	18	6
-24	-72	-28
42	-66	-34
12	-70	58
-26	-72	38
58	16	24
-64	16	14
42	44	26
-44	42	10
8	18	52
56	-54	-14
-52	8	32
-28	0	52

// O'Boyle M W, 2005: Mathematically-Gifted Male Adolescents
// Subjects=6
33	-60	42
-36	-63	54
27	-12	54
-27	-12	51
18	-75	45
-18	-81	36
9	21	36
-12	15	48
-42	-63	-3
-12	21	-9
45	9	33
45	39	21
42	-60	-21
21	27	15
-33	-54	27
-36	-12	39

// O'Boyle M W, 2005: Control Male Adolescents
// Subjects=6
36	-57	51
-42	-48	42
21	-9	45
-21	3	45
54	9	30
18	-72	51
42	-60	-21
21	27	15
-33	-54	27
-36	-12	39

// Stark R, 2005: Sadomasochists (SM)
// Subjects=12
-15	-9	-21
33	-60	-15
-21	-3	-15
15	-30	0
-18	-27	-9
-21	-3	-18
30	-3	-15
12	3	-6
12	3	-6
9	-27	-3
-3	33	-24
-21	-3	-24
12	48	27
0	48	-18
33	0	51
36	-27	-9
-48	-75	12
36	-27	-9
-18	-6	-18
27	3	-27
6	0	-3
-15	-18	18
12	-18	15
6	-30	-15
-15	18	-12
12	48	30
-33	6	12
39	-72	-3
-15	21	-9
15	-18	18
9	-27	-12
-3	33	33
-33	6	12
-15	18	-12
-33	18	-21
-30	-39	-6
39	12	-15
9	3	-6

// Stark R, 2005: Non-Sadomasochists (NonSM)
// Subjects=12
3	-96	-6
30	-6	-15
54	-60	3
24	9	-12
24	6	-18
12	3	-6
9	-27	-3
0	-30	-6
6	-27	-3
12	3	-6
12	3	-6
9	-27	-3
21	6	-12
-6	0	-15
6	-27	-9
-21	-3	-24
12	48	27
54	-69	3
-15	18	-12
0	-54	27
9	30	21
-3	33	33
-33	6	12
-15	18	-12
21	15	-12
-33	18	-21
-30	-39	-6
39	12	-15
9	3	-6

// Bengtsson S L, 2005: Conjunction Analysis of Rhythmic Sequence - Rest
// Bengtsson S L, 2005: Conjunction Analysis of Isochronous Rhythym - Rest
// Bengtsson S L, 2005: Conjunction Analysis of Rhythmic Sequence - 
// Isochronous Rhythym
// Subjects=7
-8	-4	56
-60	-4	36
-56	-12	44
-56	4	0
-52	-44	16
-24	-4	-8
-8	-64	-24
-32	-64	-32
32	-60	-32
-16	-12	16
12	-12	16
-8	-4	56
-44	-12	52
-56	0	-4
-56	-28	16
-8	-64	-20
8	-72	-20
-32	-64	-28
32	-60	-32
-8	0	56
-52	-40	20
4	-64	-16
-36	-38	-32
28	-44	-40
40	-56	-32

// Garraux G, 2005: [Timing vs. Order Manipulation] - [Self-initiated vs. 
// Visually-triggered]
// Garraux G, 2005: [Order vs. Timing Manipulation] - [Visually-triggered vs. 
// Self-initiated]
// Garraux G, 2005: Second-level Conjunction Analysis of the PPI Results
// Subjects=11
34	0	-2
12	-82	-34
-30	-4	60
-30	-4	48
-58	10	10
-46	8	8
-34	44	12
-38	16	0
-58	-24	44
-46	-34	38
-40	-48	40
18	6	56
42	48	14
40	14	0
50	-24	36
50	-34	40
38	-54	44
2	8	60
-10	10	46
8	12	44
8	20	46
-16	-12	6
18	-54	-32
32	-66	-42

// Kuchinke L, 2005: Words > Nonwords
// Kuchinke L, 2005: Nonwords > Words
// Kuchinke L, 2005: Emotional > Neutral Words
// Kuchinke L, 2005: Neutral > Emotional Words
// Kuchinke L, 2005: Negative > Neutral Words
// Kuchinke L, 2005: Neutral > Negative Words
// Kuchinke L, 2005: Positive > Neutral Words
// Kuchinke L, 2005: Neutral > Positive Words
// Kuchinke L, 2005: Positive > Negative Words
// Subjects=20
-36	27	45
-15	57	9
-48	-69	30
-63	-21	-24
-63	-54	-9
-39	-69	42
-21	39	42
-39	-78	36
-12	57	39
-6	-30	33
-6	27	-18
54	-63	18
42	-69	33
12	-57	27
-42	27	0
-60	-9	-6
-9	3	60
-45	-51	-18
33	27	-6
51	24	21
24	-9	-21
27	15	15
-3	42	-24
-54	21	9
51	27	12
-18	42	9
33	63	0
39	-45	6
54	27	9
-24	-54	15
-27	-33	-21
-15	-3	-21
-18	42	9
15	39	21
39	-54	9
9	57	0
12	-57	3
27	-21	-12
27	-60	18
-3	42	-24
-45	6	-36
48	6	-30
12	48	51
39	57	9
-24	-63	18
0	39	-3
15	-54	0
30	-21	-12

// Lanius R A, 2005: Dissociative PTSD Patients
// Subjects=11
10	-18	0
-14	-16	4
-10	-2	0
0	-20	-6
0	24	22
2	10	32
3	16	30
2	-2	34
0	-48	4
-24	-86	38
4	-16	30
2	30	26
4	-46	4
-52	12	-6
10	8	38
12	22	34
58	-30	0
2	-4	32
4	10	26

// Lanius R A, 2005: Flashback PTSD Patients
// Subjects=11
-38	24	-2
2	20	36
28	-46	-4
0	18	36
3	16	30
0	6	38
0	-46	10
-1	-20	42
-4	-12	38
-6	32	32
26	56	-4
48	4	42
-28	48	-8
-26	52	-6
-18	64	-10
-50	0	36
58	-44	42
42	-52	50
-62	-32	22
-60	-48	26
8	-80	10

// Lanius R A, 2005: Normals
// Subjects=10
10	-18	0
-14	-16	4
-16	-10	0
40	-18	20
2	20	36
2	10	32
12	8	38
0	-18	46
-4	40	22
32	0	-20
-16	-36	0
30	40	-10
-16	62	-6
-8	62	4
-42	2	36
-42	10	30
-22	46	-10
-40	-10	46
24	-62	54
12	-68	28
-4	-38	48
40	-54	16
-38	-56	16
26	-84	40
4	-16	30
2	30	26
4	-46	4
-52	12	-6
10	8	38
12	22	34
58	-30	0
2	-4	32
4	10	26

// Strakowski S M, 2005: Bipolar
// Subjects=16
-26.25	-96.48	15.48
58.77	-17.32	-14.44
58.77	-17.32	-14.44

// Strakowski S M, 2005: Healthy Controls
// Subjects=16
-1.1	-57.46	-32.69
63.05	-30.41	-18.97
-60.8	-38.76	-5.7
-52.52	11.19	-21.13
-22.43	-0.03	-3.81
24.5	69.64	12.11
-17.68	-91.77	20.56
67.33	-21.5	-14.19
3.65	-92.07	14.76
67.08	-24.07	-47.43
-26.69	-4.29	-3.4

// Altshuler L L, 2005: Bipolar Disorder
// Subjects=11
39.49	40.32	3.25
-2.95	-.69	27.25
37.26	32.77	-11.7
-4.97	-17.11	35.34
24.69	-34.99	-5.88
39.49	40.32	3.25
-2.95	-.69	27.25

// Altshuler L L, 2005: Healthy Controls
// Subjects=13
39.4	30.66	-11.55
41.61	31.36	-2.71
-.72	-10.74	34.76
26.83	-30.57	-4.04
37.26	32.77	-11.7
-4.97	-17.11	35.34
24.69	-34.99	-5.88

// Liebenthal E, 2005: Phonemic - Nonphonemic
// Subjects=25
-63.03	-7.93	-6.02
-58.62	-31.71	2.61
-13.77	-15.33	4.07
19.35	-17.41	1.63
10.94	12.6	32.67
-.79	-47.69	11.09
16.15	-75.62	-21.33

// Bondi M W, 2005: APOE e4 Genotype Subjects
// Subjects=10
41.88	-68.01	-7.77
-.47	-64.15	45.93
-30.63	16.72	48.41
-48.08	39.25	11.04
3.44	33.16	37.72
3.28	-25.6	-6.42
-.43	-28.6	65.25
58.66	7.89	-18.79
12.13	-13.66	37.09
-26.38	-84.65	3.33
33.43	-67.03	5.63
-22.1	-40.61	21.9
-1.36	71.66	-14.52
41.58	38.76	-3.34
16.4	-40.04	25.87
-35.11	-38.17	-.46
24.85	-32.21	16.19
-48.03	-56.88	-21.05
37.55	-72.95	-16.22
8.21	-62.73	63.55
-5.26	-73.89	-24.58
-26.29	17.43	57.22
3.44	33.16	37.72

// Bondi M W, 2005: APOE e3 Genotype Subjects
// Subjects=10
-48.03	-56.88	-21.05
37.55	-72.95	-16.22
8.21	-62.73	63.55
-5.26	-73.89	-24.58
-26.29	17.43	57.22
3.44	33.16	37.72

// Canli T, 2005: (Negative - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Short Variant > 5-HTT Long Variant
// Canli T, 2005: (Positive - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Short Variant > 5-HTT Long Variant
// Canli T, 2005: (Positive - Neutral) Masked With (Neutral - Fixation), 5-HTT 
// Long Variant > 5-HTT Short Variant
// Subjects=13
-40	8	-14
-28	-32	18
30	-6	-8
36	-2	42
26	-8	48
52	-56	-8
32	-58	64
6	4	4
10	18	42
-8	48	30
-54	-56	38
-40	14	40
-34	12	54
-44	12	32
-44	18	14
-6	-50	40
-40	-46	62
8	46	34
16	-38	56

// Malisza K L, 2005: Fetal Alcohol Spectrum Disorders (FASD) Children
// Subjects=9
32	48	-16
24	58	-8
28	48	-16
-34	52	0
-54	22	32
-54	36	16
26	54	-8
-48	26	18
-58	24	18
-24	64	-10
24	56	-10
30	52	-16
-54	20	34
-36	32	22
-40	8	28
24	-68	44
28	-78	34
-66	-20	24
20	46	4
-42	12	28
22	-4	50
-28	4	26
10	4	66
-24	54	14
-32	0	58
30	-62	38
14	-24	64

// Malisza K L, 2005: Fetal Alcohol Spectrum Disorders (FASD) Adults
// Subjects=10
-24	54	22
34	48	32
12	-34	64
-6	16	40
44	-44	44
-50	-54	44
-46	-40	42
62	-30	2
-60	-54	0
-64	-32	18
-46	-14	10
38	62	-2
-28	66	0
-30	56	22
-42	50	10
42	56	2
-40	30	12
8	-6	62
-44	-40	44
62	-10	2
46	50	14
-18	6	58
-46	-4	54
-48	-6	34
22	-70	40
-14	-82	40
30	-84	22
-36	18	22
-16	8	56
-52	2	44
-42	0	36
-18	66	10
-16	62	-2
-24	-12	58
-30	50	34
24	-76	46

// Malisza K L, 2005: Healthy Children
// Subjects=14
62	14	-16
-50	-26	2
-40	-12	10
20	68	20
-22	-6	64
-40	-14	12
6	-6	56
40	-54	38
-32	-66	48
58	-54	-10
22	-88	34
44	-4	54
24	-22	28
24	0	52
-44	4	30
28	58	16
34	50	24
-30	52	30
12	-10	62
16	-78	46
-8	-60	48
40	-4	54
42	-4	34
-42	-6	54
-46	0	50

// Malisza K L, 2005: Healthy Adults
// Subjects=9
-22	18	58
54	-44	52
20	-72	48
-4	-32	44
12	8	62
-4	2	64
-40	48	22
26	0	44
-36	54	-18
54	42	10
48	4	36
-38	-52	52
-54	-54	42
-34	56	-2
-44	30	-8
-44	-44	22
-62	-52	14
-52	44	4
4	6	60
-8	8	60
-10	12	52
-28	34	34
-40	-46	10
-38	22	30
56	4	40
24	-78	34
38	6	34
-40	0	36
62	-56	18
32	-16	18

// Seung Y, 2005: Non-Musicians > Musicians
// Seung Y, 2005: Musicians > Non-Musicians
// Seung Y, 2005: Distorted Tunes Test > Music Listening
// Seung Y, 2005: Music Listening > Distorted Tunes Test
// Seung Y, 2005: (Musicians vs. Non-Musicians) x (LIS vs. DTT)
// Subjects=5
-2	-44	46
2	-62	4
14	-66	23
-50	-39	41
55	-47	0
51	9	10
-36	-1	5
48	-16	-15
24	-2	0
-4	21	44
-50	-16	46
-7	24	34
-46	-31	56
-41	-70	40
4	-58	12
-8	-32	69
-49	-16	50

// Ochsner K N, 2005: Normals, Experiment 1
// Subjects=17
-6	32	30
0	56	-4
-2	56	20
-8	40	34
2	52	-10
-8	52	16
2	48	4
0	-56	30

// Ochsner K N, 2005: Normals, Experiment 2
// Subjects=16
-12	48	36
-10	52	4
-12	28	52
18	38	44
-4	12	-16
-38	10	48
0	-54	24
-8	-52	28
-8	-64	14
-48	-68	22
-60	-56	20
-56	-48	-4
-66	-38	2
-60	-6	-18
-52	-8	-20
-62	-24	-10
-48	4	-36
-42	20	-30
52	-62	22
56	-70	26
60	-62	20
62	-10	-18
12	-76	-10
26	42	4
36	42	10
46	-54	44
-18	22	56
-12	40	42
8	32	32
-12	26	40
-8	20	36
18	24	28
-6	12	-16
34	26	-2
-12	-18	72
-36	-10	44
-10	2	66
-4	6	62
-6	16	50
-20	32	28
-38	0	24
-34	24	24
10	-22	66
22	18	40
46	18	22
34	22	20
42	26	18
-12	-64	62
-10	-48	66
-54	-34	48
-48	-44	44
24	-64	58
-32	-4	26
48	14	-30
40	10	-40
46	-16	-22
24	-4	-10
16	-56	14
-42	-8	22
-44	-12	24
18	-22	50
16	-34	50
-26	-34	44
20	16	-12
38	-22	12
-30	-4	-22
-8	-52	66
-20	-88	-6
-38	-46	-22
36	-50	-20
-54	0	-26
-54	-10	-20
46	0	-34
46	-16	-18
6	-32	-32

// Killgore W D, 2005: Adolescents
// Subjects=8
-36	-62	-16
40	-74	-10
-36	30	-16
-16	-18	-20
-52	10	8
-44	-32	32
-54	-48	8
42	4	20
2	-24	-12
30	-50	50
42	-28	22
42	22	12
54	-10	-4
28	-4	0
-50	-68	0
46	-66	-10
-28	-22	-12
-34	28	-18
30	-68	-44
-56	-30	2
8	-52	-38
-2	30	0
-16	-54	-24
8	-36	-28
26	-8	14
-18	30	18
18	48	-14
52	-58	28
64	-34	-8
-6	-56	22
8	32	20
2	-22	-28
-8	-12	20
-28	42	38
-48	-6	4
-14	24	28
10	-16	10
0	-56	-12
30	-50	-38
4	-60	48
2	28	60
-64	-20	20
58	-30	-14
0	-74	-48
-24	24	58
2	-42	28
-2	16	26
-46	24	30
28	-48	-12
-34	-62	-6
26	-42	18
12	28	10
44	-26	26
36	-66	18
-8	-50	-40
-32	-54	20
32	-6	6
-32	38	4
44	-4	12
-8	42	-2
-44	-4	0
-24	-28	8
28	32	10
-28	-24	-6
-40	-60	-18
44	-64	-26
48	-34	2
-22	-52	40
26	-48	52
66	-26	18
-56	12	-6
42	10	30
38	-66	14
-40	34	-16
2	-30	-14
-56	-30	8
58	-54	4
48	-70	32
42	-62	-30
2	-76	26
2	36	12
32	-2	-28
6	-2	56
-50	-64	-8
16	-54	-42
-44	-42	44
-18	-20	70
30	-64	50
6	18	-8
2	30	14
4	-64	-8
40	-58	-28
-34	-62	-14
30	-54	48
-24	42	-14
-42	-58	-30
60	-36	50
40	10	32
48	-64	-10
-42	-68	-6
36	-54	-24
-52	20	12
44	-58	16
-46	36	2
16	-12	0
-6	-70	-32
18	-72	-38
-14	48	42
32	14	-10
-12	38	10
50	-34	10
-8	64	20
-28	8	16
8	50	26
-10	-34	36
38	6	-50
48	-24	20
50	14	-38
-30	18	-20
10	-46	70
20	-52	-26
38	-60	60
-30	-88	-4
-6	-10	56
-12	16	22
-6	-38	8
22	-62	32
-46	-64	-36
-46	-68	-4
-52	16	32
0	-42	-10
-16	-60	30
10	10	66
10	-40	8
32	8	46
54	6	-26
36	-70	50
8	-30	2
-30	-78	30
-56	-68	-2
32	60	18
38	-22	-12
-54	10	2
-38	30	-18
28	6	50
36	-60	14
2	30	30
-12	-50	-20
4	26	10
-36	-66	0
2	38	14
18	-52	-24
-50	-66	4
-10	-50	-24
30	-70	-42
40	-18	66
-10	-16	42
34	-34	48
-44	-48	44

// Killgore W D, 2005: Adults
// Subjects=13
-36	-62	-16
40	-74	-10
-36	30	-16
-16	-18	-20
-52	10	8
-44	-32	32
-54	-48	8
42	4	20
2	-24	-12
30	-50	50
42	-28	22
42	22	12
54	-10	-4
28	-4	0
-50	-68	0
46	-66	-10
-28	-22	-12
-34	28	-18
30	-68	-44
-56	-30	2
8	-52	-38
-2	30	0
-16	-54	-24
8	-36	-28
26	-8	14
-18	30	18
4	-60	48
2	28	60
-64	-20	20
58	-30	-14
0	-74	-48
-24	24	58
2	-42	28
-2	16	26
-46	24	30
28	-48	-12
-34	-62	-6
26	-42	18
12	28	10
44	-26	26
36	-66	18
-8	-50	-40
-32	-54	20
32	-6	6
-32	38	4
44	-4	12
-8	42	-2
-44	-4	0
-24	-28	8
28	32	10
-28	-24	-6
-40	-60	-18
44	-64	-26
48	-34	2
-22	-52	40
26	-48	52
66	-26	18
-56	12	-6
42	10	30
38	-66	14
-40	34	-16
2	-30	-14
-56	-30	8
58	-54	4
48	-70	32
42	-62	-30
2	-76	26
2	36	12
32	-2	-28
6	-2	56
-50	-64	-8
16	-54	-42
-44	-42	44
-18	-20	70
30	-64	50
6	18	-8
2	30	14
4	-64	-8
40	-58	-28
-34	-62	-14
30	-54	48
-24	42	-14
-42	-58	-30
60	-36	50
40	10	32
48	-64	-10
-42	-68	-6
36	-54	-24
-52	20	12
44	-58	16
-46	36	2
16	-12	0
-6	-70	-32
18	-72	-38
-14	48	42
32	14	-10
-12	38	10
50	-34	10
-8	64	20
-28	8	16
8	50	26
-10	-34	36
38	6	-50
48	-24	20
50	14	-38
-30	18	-20
10	-46	70
20	-52	-26
38	-60	60
-30	-88	-4
-6	-10	56
-12	16	22
-6	-38	8
22	-62	32
-46	-64	-36
-46	-68	-4
-52	16	32
0	-42	-10
-16	-60	30
10	10	66
10	-40	8
32	8	46
54	6	-26
36	-70	50
8	-30	2
-30	-78	30
-56	-68	-2
32	60	18
38	-22	-12
-54	10	2
-38	30	-18
28	6	50
36	-60	14
2	30	30
-12	-50	-20
4	26	10
-36	-66	0

// Pariente J, 2005: Alzheimer's Disease (AD) Patients
// Subjects=12
30	-20	-12
-24	-32	0
16	-62	34
-12	-58	40
22	-62	62
-18	-60	58
46	16	46
46	48	-8
-24	58	-8
44	-66	42
-48	-58	48
-10	-80	-30
26	-16	-16
58	4	-22
38	22	-34
-32	12	-36
42	-56	-8
26	-18	-18
-58	18	0
-48	-56	44
44	-76	32

// Pariente J, 2005: Normals
// Subjects=17
32	-16	-10
8	-44	-16
-35	14	-28
-36	-60	-10
24	-16	-14
60	4	-20
54	-60	12
-10	-40	48
6	-78	2
30	-60	-20
30	-20	-12
-24	-32	0
16	-62	34
-12	-58	40
22	-62	62
-18	-60	58
46	16	46
46	48	-8
-24	58	-8
44	-66	42
-48	-58	48
-10	-80	-30
26	-16	-16
58	4	-22
38	22	-34
-32	12	-36
42	-56	-8
26	-18	-18
-58	18	0
-48	-56	44

// de Zubicaray G I, 2005: Correct Responses > Incorrect Responses
// de Zubicaray G I, 2005: Low Frequency > High Frequency, Correct Responses
// de Zubicaray G I, 2005: Second Presentation > First Presentation, Correct 
// Responses
// de Zubicaray G I, 2005: Second Presentation < First Presentation, Correct 
// Responses
// de Zubicaray G I, 2005: Unstudied Words > Studied Words, Correct Responses
// de Zubicaray G I, 2005: Studied Words > Second Presentation Words, Correct 
// Responses
// Subjects=14
-45	27	-12
-48	36	15
0	6	60
-48	-3	54
-51	-45	6
-48	-66	-12
-42	39	9
3	-78	42
39	-63	24
-45	24	-9
-57	15	21
-48	0	51
-3	6	57
-51	-45	6
-33	-60	45
-42	-3	54
-30	51	3
-48	18	36
-48	45	-3
-51	3	27
-3	9	57
-12	45	-15
33	-90	6
-30	-96	12
-36	27	-3
33	21	3
-30	-63	57
-36	24	-3
33	24	3
36	24	-9
-12	51	-15
-3	9	57
-30	-96	12
24	-102	3

// Kuhnen C M, 2005: Outcome Following Stock Choice, Gain vs. Loss, 
// Activations
// Kuhnen C M, 2005: Outcome Following Stock Choice, Gain vs. Loss, 
// Deactivations
// Kuhnen C M, 2005: Market Outcome, Chosent Stock vs. Unchosen Stock Value
// Kuhnen C M, 2005: Uncertainty Negative Correlation with Bilateral Anterior 
// Cingulate Foci
// Subjects=19
-2.32	60.71	-4.67
-2.32	52.96	-8.48
24.38	38.69	-16.51
12.76	13.67	-8.71
-12.88	9.2	-9.15
0.29	3.02	33.59
0.5	-30.05	46.4
-1.77	-32.49	28.79
-40.61	21.61	2.39
41.7	22.44	5.84
-2.28	61.05	-.24
-2.36	52.53	-14.02
-6.41	21.9	3.09
8.55	21.99	2.91
-20.35	10.39	-6.94
0.14	-5.21	9.75
5.66	21.97	44.21
-2.89	21.92	44.31

// Coricelli G, 2005: Choose Trials:  Financial Gain > Financial Loss
// Coricelli G, 2005: Unobtained Outcome vs Obtained Outcome, Partial Choose 
// Condition
// Coricelli G, 2005: Outcome of Unselectected Gamble vs Outcom of Selected 
// Gamble, Complete Choose Condition
// Coricelli G, 2005: Partial Choose Condition:  Actual Losses >  Unobtained 
// Outcome
// Coricelli G, 2005: mOFC Activity Correlating with Level of Experienced 
// Regret
// Coricelli G, 2005: Complete Choice Activity:  -50 and +50 Obtained > -200 
// or +200 Forgone
// Coricelli G, 2005: Choose Partial Feedback:  Minimizing Future 
// Disappointment vs Maximization of Expected Values
// Coricelli G, 2005: Activity Preceding Choice of Maximal Expected Values in 
// the Partial Choose Condition
// Coricelli G, 2005: Activity Preceding Choice of Maximal Expected Values in 
// the Complete Choose Condition
// Coricelli G, 2005: Influence of Cumulative Experience of Regret (CR) on 
// Choice-Related Activity
// Coricelli G, 2005: Influence of Immediately Prior Experience of Regret 
// (t-1) on Choice
// Coricelli G, 2005: Choose Complete Feedback:  Minimizing Future Regret vs 
// Maximization of Expected Values
// Subjects=15
8	18	0
6	18	12
12	24	8
2	-34	-20
-60	4	8
-4	0	-8
-42	0	-20
10	24	34
-14	0	6
42	42	-18
54	-50	36
-8	32	-14
-10	30	-12
8	32	24
30	-10	-12
18	-14	-6
-12	-16	-8
-12	-10	46
-34	-20	62
14	-28	54
18	36	8
42	-52	52
-38	-76	-6
-20	-31	6
-28	-28	-52
24	-56	50
32	2	-26
-6	-4	32
68	-12	20
-38	-42	40
-10	40	-24
-8	-4	-24
46	28	38
42	26	-16
54	-58	48
-2	32	28
-6	-16	-16

// Huettel S A, 2005: Task-Related Activation Increased Amplitude with 
// Increasing Uncertainty
// Huettel S A, 2005: Task-Related Activation that was Uncertainty Independent
// Huettel S A, 2005: Task-Related Activation without Significant Effects of 
// Uncertainty or Intercept
// Subjects=12
35	26	4
-30	20	5
61	13	16
55	10	35
-44	-4	36
17	-13	9
43	-50	46
-25	-64	50
29	-70	48
-16	-77	48
-5	9	40
1	0	56
-47	-3	9
42	-5	64
-25	-5	52
-41	-12	51
-30	-17	65
-12	-20	7
-59	-29	26
-54	-31	43
-40	-42	54
-56	-51	20
51	-67	-1
46	-77	-5
-38	-83	-6
-27	-92	25
35	-96	2
-25	-100	0
38	54	18
41	44	28
9	20	37
23	4	55
-61	3	30
37	0	51
53	-28	42
25	-54	-23
-33	-60	-18
-35	-71	-13
37	-81	28
30	-88	-15

// Specht K, 2005: One Frequency Component > Rest
// Specht K, 2005: Two Frequency Component > Rest
// Specht K, 2005: Three Frequency Component > Rest
// Specht K, 2005: Four Frequency Component > Rest
// Specht K, 2005: Four Frequency Component vs. One Frequency Component
// Subjects=5
69.35	-30.34	7.32
-71.03	-21.6	16.69
-66.86	-22.73	4.4
69.38	-25.77	10.23
-15.4	-71.03	47.53
-66.81	-22.31	8.84
64.87	-6.41	-.57
1.77	14.61	55.57
-66.88	-18.47	3.98
69.34	-26.08	6.9
6.04	13.15	51.16
-11.75	-13.71	5.94
31.27	-67.52	-20.85
-50.6	21.54	17.68
6.06	9.96	51.47
-62.67	-7.28	-2.8

// Protopopescu X, 2005: Differential BOLD activity in the luteal vs. 
// follicular phases for negative go vs. neutral go
// Protopopescu X, 2005: Differential BOLD activity in the luteal vs. 
// follicular phases for negative no-go vs. neutral no-go
// Subjects=12
3	51	-81
-45	36	-12
39	36	-18
0	3	39
-45	-3	3
-15	57	-15
-6	42	-18

// Crinion J, 2005: Healthy Controls
// Subjects=18
-60	-48	8
-54	-38	2
-60	-8	-14
-58	-6	-18
-58	8	-20
50	-34	-8
58	-4	22
54	10	-28
54	10	-24
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-42	28	-14
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-46	6	52
46	-18	64
-30	-36	-22
38	-38	-28
-60	-48	8
-54	-38	2
-60	-10	-14
-58	-6	-18
-54	8	-26
54	10	-28
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-42	8	20
16	-80	-40

// Crinion J, 2005: Temporal Aphasic Patients
// Subjects=8
-58	-6	-18
52	-32	-10
56	0	-22
54	10	-28
54	10	-28
-56	26	-2
-42	28	-14
-46	0	50
-60	-48	8
-54	-38	2
-60	-10	-14
-58	-6	-18
-54	8	-26
54	10	-28
-46	10	18
-56	20	16
-56	28	4
-56	26	-2
-46	0	50
56	-10	42
-36	-42	-28
-30	-36	-22
38	-38	-28
-60	-48	8
-50	-40	0
-62	-6	-16
-62	-6	-18
-58	10	-18
48	-36	-8
58	-4	22
-48	8	18
-56	20	16
-56	30	6
-36	-42	-28
62	-8	-16
-46	-56	6
-42	8	20
16	-80	-40
64	-10	-14
-50	-44	0
16	-80	-40
-42	8	20

// Crinion J, 2005: Control Aphasic Patients
// Subjects=9
-60	-48	8
-50	-40	-2
-60	-8	-14
-58	-6	-18
-58	8	-20
50	-32	-10
60	-2	-24
54	10	-28
56	12	-24
-46	8	18
-56	20	16
-56	30	6
-56	26	-2
-42	28	-14
-42	-6	46
-36	-42	-28
-46	6	52
46	-18	64
-30	-36	-22
38	-38	-28
-60	-48	8
-50	-40	0
-62	-6	-16
-62	-6	-18
-58	10	-18
48	-36	-8
58	-4	22
-48	8	18
-56	20	16
-56	30	6
-36	-42	-28
62	-8	-16
-46	-56	6
-42	8	20
16	-80	-40
64	-10	-14
-50	-44	0
16	-80	-40
-42	8	20

// Rinne T, 2005: (Sound Attention + Picture Attention) vs. Infrequent Tones 
// at Irregular Intervals
// Subjects=12
-56	-18	4
58	-18	4

// Remijnse P L, 2005: Reward Main Effect, Correct Response (CR) > Baseline 
// (BL)
// Remijnse P L, 2005: Main Effect of Punishment, PENS + PRE + FRE > Baseline 
// (BL)
// Remijnse P L, 2005: Main Effect of Punishment Excluding Reversal Events, 
// PENS + PRE > Baseline (BL)
// Remijnse P L, 2005: Conjunction Analysis of Reward (CR > BL) and Punishment 
// (PENS + PRE > BL)
// Remijnse P L, 2005: Interaction Analysis: Reward (CR > BL) > Punishment 
// (PENS + PRE > BL)
// Remijnse P L, 2005: Interaction Analysis: Punishment (PENS + PRE > BL) > 
// Reward (CR > BL)
// Remijnse P L, 2005: Main Effect of Affective Switching (FRE > BL)
// Remijnse P L, 2005: The Dissociation of Stimulus-Punishment Association and 
// Affective Switching (FRE > PENS + PRE)
// Subjects=27
-15	36	-15
-30	51	-15
-39	39	15
-45	3	27
-30	-60	48
-51	-39	51
-27	-93	-12
30	-96	-12
-6	15	3
6	18	6
12	6	-9
-18	42	-15
-33	54	-12
-27	24	-9
-24	-96	-15
-18	42	-15
-42	45	-18
-27	24	-6
-24	-96	-15
-18	39	-15
-36	54	-12
-27	-93	-12
-6	12	-6
-42	45	-18
-36	51	9
-30	51	-15
-48	18	6
-48	6	24
-30	24	-12
30	18	-9
-48	33	33
-33	51	30
-36	51	9
-3	30	48
-3	33	33
-27	-90	-9
-27	57	6
27	57	6
30	51	-3
-45	42	-9
18	15	-18
-48	3	18
60	9	33
57	15	12
-33	18	6
33	21	9
-33	45	33
-36	51	9
42	33	42
-3	27	42
0	30	30
-57	-42	27
-33	-24	12
-48	-63	-6
-6	3	54
15	-66	51
48	-36	39
-15	-48	-24

// Hsu M, 2005: Ambiguity > Risk
// Hsu M, 2005: Risk > Ambiguity
// Hsu M, 2005: Gamble > Certain
// Hsu M, 2005: Certain > Gamble
// Hsu M, 2005: Positive Correlation with Expected Value of Decisions in Risk 
// Condition of Card-Deck Treatment
// Hsu M, 2005: Positive Correlation with Expected Value of Decisions in 
// Knowledge Treatment
// Subjects=16
51	33	-6
54	18	-21
-54	-60	42
-45	-54	33
-9	48	39
-12	63	21
54	-54	36
54	-63	30
18	54	18
12	54	30
12	27	57
36	18	42
42	9	45
60	-36	-3
63	-27	-6
51	-24	-9
-39	-9	-15
39	6	-27
42	15	-24
54	27	6
-54	36	-6
-15	-15	-15
-21	-6	-18
33	-6	-27
0	-6	6
9	6	6
-12	6	0
12	-60	-3
9	-78	3
-12	-75	15
-15	-72	51
-3	9	45
12	-75	51
21	-84	39
-42	-75	30
18	-78	-12
0	-81	-3
-9	-21	48
-18	-12	51
-30	-27	54
-33	15	21
-6	15	-3
15	-90	12
33	6	21
27	12	21
-51	-66	6
-51	-57	3
42	-24	60
-15	-75	9
9	24	54
12	39	51
9	12	54
60	-33	3
57	-42	3
-51	-72	30
-42	-78	33
-66	-30	-9
-9	-18	18
-9	-3	18
15	6	3
48	24	-15
54	39	-3
39	24	-15
-9	45	9
-3	57	33
-9	39	30
-6	48	27
3	-42	-6
60	-57	30
60	-51	39
-6	27	42
-45	42	6
21	48	27
18	57	33
33	-87	15
39	-84	9
-9	12	3
-6	3	6
-24	-63	51

// Choo W C, 2005: Rested Wakefulness, 2-Back > 1-Back
// Choo W C, 2005: Rested Wakefulness, 2-Back > 1-Back (Deactivation)
// Choo W C, 2005: Sleep Deprivation Related Increase
// Choo W C, 2005: Sleep Deprivation Related Decrease
// Choo W C, 2005: State Effect: Sleep Deprivation Related Increase
// Choo W C, 2005: State Effect: Sleep Deprivation Related Decrease
// Choo W C, 2005: Load by State Interaction
// Subjects=12
-47.92	13.5	22.12
38.64	37.08	30.3
-.78	28.19	42.65
-32.63	-48.91	39.44
34.75	-62.17	40.89
6.02	-66.6	54.98
-15.79	-18.54	17.74
-6.38	55.16	20.37
-6.23	36.99	33.05
-29.41	-84.98	26.82
21.81	-79.9	19.11
-7.36	-18.63	2.04
-29.45	-82.15	22.12
32.52	-81.87	20.27
20.77	-78.51	23.47
21.85	-78.42	24.56
-62.97	-18.33	-2.92
-35.08	12.61	23.16
26.58	55.85	-1.25
33.04	28.94	-5.76

// Strangman G, 2005: Sleep Deprived > Normal Sleep, SpaceDock vs. Fixation
// Strangman G, 2005: Normal Sleep > Sleep Deprived, SpaceDock vs. Fixation
// Strangman G, 2005: Normal Sleep < Sleep Deprived, SpaceDock vs. Fixation
// Subjects=6
45.22	10.32	41.39
61.15	-54.26	3.13
38.99	-58.17	37.16
-39.15	-59.92	21.48
51.66	-59.63	17.07
9.56	-11.53	-17.71
26.1	-62.19	27.61
38.99	-58.17	37.16
9.56	-11.53	-17.71

// Tyler L K, 2005: (All Regulars - Baseline) - (All Irregulars - Baseline)
// Tyler L K, 2005: (Real Regulars - Baseline) - (Real Irregulars - Baseline)
// Tyler L K, 2005: (Regulars - Baseline) - (Additional Phonemes - Baseline)
// Subjects=18
-46	-26	8
-56	-24	10
-56	-48	8
58	-14	2
58	-28	4
62	-6	10
46	-42	34
38	-44	42
-48	-28	8
-56	-20	10
-66	-30	4
60	-18	4
60	-26	8
46	-28	-4
-4	18	34
-44	-32	6
-34	-28	10
-58	-28	2
38	-28	10
50	-16	4

// Crockford D N, 2005: Healthy Controls
// Subjects=10
-7.89	-61.39	54.7
7.05	-61.48	52.31
-41.06	-58.68	51.51
46.56	-58.24	49.35
-28.35	-90.52	23.92
35.79	-92.08	25.55
-15.63	-84.96	12.16
12.11	-78.62	9.08
-11.52	-64.64	-.74
12.04	-72.79	1.9
-37.08	-92.46	-.35
35.55	-85.85	-3.97
-20.15	-46.89	-4.37
-24.41	-65.4	-9.45

// Crockford D N, 2005: Pathological Gamblers
// Subjects=10
-7.89	-61.39	54.7
7.05	-61.48	52.31
-41.06	-58.68	51.51
46.56	-58.24	49.35
-52.21	16.65	21.9
-7.55	63.99	10.73
-28.35	-90.52	23.92
35.79	-92.08	25.55
-15.63	-84.96	12.16
12.11	-78.62	9.08
-11.52	-64.64	-.74
12.04	-72.79	1.9
-37.08	-92.46	-.35
35.55	-85.85	-3.97
-20.15	-46.89	-4.37
-24.41	-65.4	-9.45
22.61	-69.52	-11.88

// Brooks J C W, 2005: Face
// Brooks J C W, 2005: Hand
// Brooks J C W, 2005: Foot
// Subjects=14
-36	24	-6
38	16	2
-38	4	4
40	12	-4
-38	-10	10
-56	-18	14
62	-26	14
-26	4	-8
28	12	-8
44	20	-10
-12	-8	4
16	-10	4
4	-16	4
-14	-16	4
58	-32	20
-32	22	0
38	16	0
-36	12	0
38	12	2
-38	-16	8
64	-26	14
-22	8	-10
24	12	-6
46	24	-12
12	-8	4
6	-16	-2
-58	-28	14
56	-28	18
-34	22	-4
38	14	0
-40	8	-2
-38	-18	8
-56	-10	4
-22	14	-6
26	16	-2
46	22	-12

// Binder J R, 2005: Nonword > Fixation
// Binder J R, 2005: Fixation > Nonword
// Binder J R, 2005: Positive Correlation between Reading Activation and 
// Response Time
// Binder J R, 2005: Negative Correlation between Reading Activation and 
// Response Time
// Binder J R, 2005: Irregular > Regular
// Binder J R, 2005: Regular > Nonword
// Binder J R, 2005: Nonword > Regular
// Binder J R, 2005: Irregular > Nonword
// Binder J R, 2005: Nonword > Irregular
// Binder J R, 2005: Positive Correlation between Reading Activation and 
// Imageability Ratings
// Binder J R, 2005: Negative Correlation between Reading Activation and 
// Imageability Ratings
// Subjects=24
-3.77	2.93	60.41
-6.2	16.38	28.09
-8.19	-8.49	36.89
-6.13	1.75	31.54
17.33	14.58	30.2
6.63	9.94	26.25
11.86	23.12	17.28
-43.59	5.33	26.1
-22.01	-5.61	47.95
-50.25	9.32	-4.27
-51.24	26.55	12.14
-49.23	31.87	-1.71
-41.53	22.09	22.44
-52.42	45.14	5.02
59.04	-7.89	24.91
45.06	9.75	20.25
53.7	8.54	31.4
31.43	-3	49.35
50.19	14.15	-5.83
47.01	28.74	4.13
-36.37	24.64	-.14
29.93	12.34	0.13
-55.29	-8.49	27.39
-46.66	-14.18	35.57
-59.66	-13.86	13.39
-57.3	-8.27	44.12
-67.22	-11.5	3.25
-55.51	-8.6	-1.59
-31.88	-11.58	12.88
63.21	-5.63	12.41
55.95	-8.91	39.53
52.86	-15.39	52.38
37.97	-19.19	59.56
19.76	-27.39	51.53
-23.99	-64.38	45.1
-26.23	-80.82	25.32
-33.64	-50.52	46.28
-43.36	-39.54	37.66
-26	-64.16	61.83
-18.55	-79.78	51.9
-36.74	-54.97	57.84
28.44	-66.63	52.49
28.26	-71.78	27.28
33.72	-55.23	48.13
18.79	-75.84	44.45
-36.14	-25.69	9.65
-38.38	-21.27	-1.84
-47.82	-41.54	12.23
57.75	-11.27	-4.9
51.47	-29.74	4.53
-40.56	-53.58	-20.3
-27.47	-95.83	-3.52
-14.65	-101.21	-5.45
-37.17	-86.8	-9.74
-3.89	-86.11	9.89
-21.86	-79.85	37.45
-22.29	-71.1	-14.58
-16.88	-67.04	-3.83
-2.9	-106.77	-9.58
23.84	-97.55	-2.85
29.14	-88.09	-4.82
13.2	-76.24	12.21
43.05	-83.43	-.91
30.32	-82.48	12.54
37.63	-90.84	-13.61
20.83	-79.05	30.2
49.27	-55.7	-14.46
36.53	-62.58	-5.93
8.79	-66.72	-1.92
49.33	-75.88	-13.88
50.33	-44.78	-10.93
7.78	-100.19	-8.02
-42.55	-67.45	-6.84
-36.48	-8.34	-27.48
33.14	-12.9	-10.06
33.02	-3.1	-20.92
62.15	-67.08	-11.42
-15.91	-15.42	2.98
-19.09	-4.1	12.11
-26.65	10.4	7.63
-30.89	-1.43	6.44
16.13	-20.86	-1.39
19.34	-1.04	6.95
30.12	-26.35	8.95
24.78	-12.04	15.62
-17.04	-56.7	-21.42
-33.04	-72.91	-23.22
-28.96	-33.13	-32.18
-24.43	-89.86	-23.02
22.48	-51.09	-21.23
34.22	-57.79	-26.38
15.96	-65.44	-41.14
30.86	-26.43	-33.43
24.73	-74.08	-15.98
24.41	-56.56	-50.9
2.21	-57.47	-19.35
-6.36	-20.37	-6.75
-56.12	-66.4	35.6
-46.45	-72.43	39.34
49.59	-57.82	26.98
45.49	-74.79	41.83
61.41	-64.81	31.89
-25.35	24.87	43.21
-20.38	57.31	8.09
-36.03	18.29	41.65
-20.01	34.76	46.78
-29.01	52	-4.75
29.81	52.87	1.19
24.83	29.14	38.93
20.21	59.5	5.21
43.11	16.1	47.62
19.12	49.37	-1.74
36.73	25.21	55.85
-30.1	10.01	-24.64
-11.85	37.3	-3.71
-7.6	22.81	-12.58
36.17	44.65	-9.34
-5.9	-54.12	38.46
11.11	-58.22	25.22
6.9	-43.3	39.63
-30.85	-40.52	-3.66
-34.46	14.59	-33.89
-21.07	-21.23	24.72
-22.1	-38.41	22.83
-10.23	-67.86	26.28
-1.71	8.78	53.21
-8.26	15.03	38.26
-8.4	26.69	23.9
-2.87	26.49	48.39
15.45	16.16	64.66
8.85	18.56	41.11
11.88	25.49	20.42
-32.73	-2.75	44.49
-52.19	5.82	19.46
-56.57	13.48	8.83
-43.84	17.02	-1.65
-42.6	16.62	20.68
53.81	-8.92	39.56
29.28	-2.04	48.18
49.38	9.23	26.93
36.64	-.99	33.51
48.03	18.37	-6.16
62.01	14.91	2.89
50.25	23.64	6.76
44.74	26.21	-14.59
36.44	24.41	18
45.07	27.43	28.8
-34.17	13.19	3.03
32.07	15.7	2.05
-27.2	-62.28	44.96
-37.98	-44.63	40.26
-27.29	-46.76	39.2
-36.68	-66.43	61.03
-18.48	-80.23	59.75
-19.59	-87.27	51.43
-46.34	-53.71	61.19
-37.86	-54.34	52.22
-49.73	-38.09	43.19
-55.15	-30.1	37.01
44.29	-42.02	39.09
29.41	-75.4	35.37
28.47	-63.03	57.77
30.51	-60.79	45.29
40.22	-55.39	59.22
15.68	-81.43	55
27.43	-80.39	53.66
28.43	-87.67	41.99
19.9	-67.74	52.68
-30.53	-94.31	16.46
-37.16	-77.91	-4.91
-24.1	-79.84	24.09
-28.28	-94.24	30.92
-54.28	-78.27	-8.03
-23.97	-86.12	39.12
40	-88.34	18.49
-43.67	-58.11	-9.84
55.44	18.79	-15.2
-12.78	5.83	2.28
-7.39	-15.63	-.44
16.07	-.6	-.86
12.86	-11.62	-5.47
2.14	-25.23	-15.36
2.25	-23.06	-1.04
-42.5	1.19	27.55
30.37	-80.91	19.1
-9.21	-56.31	24.18
-16.8	-9.15	29.23
-31.72	-39.61	21.92
-19.94	-43.6	24.35
-32.95	-42.39	-.13
-29.62	-22.34	24.91
-17.96	4.17	22.55
14.11	1.19	22.44
23.81	-42.88	15.98
22.74	-15.42	27.07
-8.32	15.48	30.42
2.53	10.66	49.65
8.85	18.56	41.11
4.5	25.42	33.9
-42.36	0.36	44.34
-43.59	6.38	26.01
-52.21	10.05	19.11
-53.12	3.93	36.36
-49.17	13.81	-1.32
-54.5	27.07	5.44
-43.82	22.65	2.34
-51.27	36.15	12.45
-37.27	17.63	19.42
47.22	11.16	24.56
55.9	10.38	41.26
48.17	25.28	14.45
42.73	25.37	2.24
46.98	15.19	-5.88
53.58	28.2	24.18
35.18	24.55	-7.65
-28.89	20.28	-2.09
-30.93	12.49	7.51
32.02	14.04	-5.61
-24.01	-70.09	40
-40	-54.44	51.14
-51.85	-41.19	44.59
-34.79	-46.98	37.07
-28.15	-62.14	60.57
-5.28	-21.42	-6.67
4.37	-25.33	-3.11
1.01	-26.98	-24.12
-46.48	-70.57	35.84
-47.7	-64.46	18.61
-49.78	-57.27	29.19
-48.61	-84.76	31.48
-41.06	-83.94	41.36
52.78	-61.31	22.77
45.49	-75.85	41.92
56.13	-70.75	38.02
52.29	-11.44	-20.44
-24.32	29.99	40.53
-37.1	18.28	41.66
27	27.21	41.29
-7.57	26.41	-7.31
-2.29	22.5	-17.08
-13	49.64	-9.2
-11.85	49.45	1.96
-7.56	38.64	-.53
5.23	37.23	-6.13
9.51	15.34	-14.38
-31.99	-36.9	-11.76
-21.33	-34.89	-14.28
-11.41	-55.87	16.36
-3.73	-57.02	42.02
-15.57	-50.29	33.78
-8.08	-100.69	14.51
-6.89	-99.4	31.11
-.61	-72.21	24.3
2.55	-57.3	24.13
7.94	-35.89	39
14.2	-51.65	13.48
5.84	-47.54	40
16.58	-98.63	25.2
-7.26	17.6	30.23
3.69	6.06	58.95
6.7	20.57	39.85
-50.91	-7.35	41.74
-48.72	3.12	53.11
-32.7	-2.41	48.92
-44.66	5.32	26.11
-52.37	11.68	-1.1
-50.29	38.56	2.2
-51.25	36.32	14.66
-38.31	18.93	22.66
39.97	-15.09	43.58
43.06	-6.41	31.66
62.31	1.53	36.35
33.57	-1.84	50.35
47.21	10.99	22.35
48.03	16.17	-7.09
60.02	21.98	25.74
46.01	30.56	14.03
47.12	38.65	22.26
41.74	48.14	21.53
-27.82	19.14	-3.12
-35.22	22.15	8.98
33.13	17.74	0.76
-22.88	-69.4	48.85
-35.8	-48.59	43.91
-46.54	-39.3	41.03
-51.8	-38.48	52.17
45.37	-37.52	42.05
32.7	-61.32	52
19.9	-74.26	51
29.37	-72.49	31.78
32.56	-50.63	38.84
13.57	-63.58	65.79
26.24	-84.85	37.32
24.23	-59.46	63.09
46.61	-48.92	59.72
-26.4	-96.88	-3.45
-29.5	-89.27	12.68
-27.31	-82.06	23.2
-14.36	-79.55	40.69
-41.43	-76.79	-3.84
43.1	-89.43	4.05
34.67	-84.94	21.62
-51.12	-66.7	-10.15
67.29	2.28	-9.49
-8.43	-16.44	2.98
7.54	-13.68	-4.12
10.86	-14.66	10.42
-6.37	-19.4	-7.94
-0.01	-25.42	-17.55
-42.7	-54.74	-21.29
-44.33	-69.24	39.05
-48.77	-67.72	17.78
-50.79	-88.45	25.12
48.63	-66.57	37.76
48.5	-52.62	25.44
-15.71	30.64	48.19
-12.6	34.03	36.72
-39.2	15.35	45.28
-26.38	21.95	46.81
-40.77	26.58	-15.87
-8.66	28.43	-8.58
-12.96	43.55	-5.34
-20.27	-33.82	-14.38
-30.96	-35.03	-15.27
-10.34	-52.52	18.3
-5.98	-48.29	31.28
-5.94	3.72	57.02
5.8	8.02	56.53
-27.35	-6.7	48.11
-49.8	-8.06	46.25
-41.41	-9.64	25.1
-49.98	3.26	27.46
-53.32	4.07	10.7
-36.96	-37.47	36.3
-15.28	-69.21	64.36
-49.68	-39.7	50.02
35.85	-54.16	48.02
40.06	-43.82	43.75
25.23	-64.54	52.35
31.73	-63.56	64.46
28.31	-66.86	35.79
38.89	-38.33	32.16
-23.17	-98.8	-1.09
-36.04	-89.54	-3.95
-45.75	-60.87	-4.01
-21.81	-68.34	48.75
-33.66	-49.63	43.97
-59.36	-53.64	35.68
-49.76	-58.16	31.49
-48.6	-70.32	39.19
59.18	-56.96	23.45
47.41	-60.54	19.42
61.4	-46.23	38.14
42.3	-74.64	44.08
60.41	-68.44	40.01
46.61	-57.72	56
43.28	-57.89	40.44
43.44	-68.4	55.81
55.51	-16.79	-21.14
60.08	-51.01	3.98
54.34	-5.77	-29.86
51.58	-48.43	10.55
69.46	-20.51	-15.41
56.39	7.65	-35.47
-27.95	52.98	-5.96
-29.66	34.36	42.46
-41.38	23.63	42.38
40.88	26.15	40.11
32.34	36.04	44.95
40.8	36.3	33.68
26.99	23.87	39.34
20.35	46.69	18.55
23.33	55.4	-6.75
19.34	52.83	29.2
23.69	38.22	32.6
22.81	30.33	54.46
12.66	52.17	-6.36
-28.78	-38.99	-11.62
-7	-52.18	36.08
-7.07	-70.56	18.66
-3.69	-70.94	40.96
-15.64	-51.06	23.81
-.5	-51.29	47.08
9.02	-49.97	35.71
10.01	-53.02	23.68
-9.29	13.16	41.77
-3.84	7.71	53.32
-8.39	28.97	25.94
9.93	17.51	41.19
45.12	1.63	25.39
51.66	-.31	41.09
-55.43	13.12	17.77
-48.16	18.68	-7.31
-48.07	28.42	8.6
-43.66	13.36	19.85
-36.33	29.46	7.26

// Sabsevitz D S, 2005: Concrete > Abstract
// Sabsevitz D S, 2005: Abstract > Concrete
// Subjects=28
-27.85	-23.98	-24.04
-25.59	-39.14	-13.87
-59.75	-52.21	-14.62
-46.93	-55.39	-15.61
23.42	-5.18	-19.51
27.7	-15.02	-23.2
28.83	-27.53	-19.93
-28.23	-79.46	43.07
-31.53	-66.16	36.41
-38.9	-72.75	48.2
40.05	-59.3	36.13
46.49	-68.87	35.75
49.7	-44.64	45.94
-22.61	27.75	-16.17
-43.86	43.17	6.2
-38.41	31.11	14.95
-18.83	13.96	52.97
-10.85	19.1	-18.93
29.77	28.23	-14.58
40.41	37.73	-16.62
31.34	15.86	45.54
49.16	35.44	8.01
46.9	49.54	-2.07
-13.54	-54.74	17.41
7.77	-53.01	10.33
2.61	-62.16	30.11
-51.42	6	-19.59
-47.99	-30.05	-4.34
-65.94	-52.13	14.44
-61.76	-48.65	4.07
50.06	9.52	-24.4
51.28	-13.05	-13.6
51.17	-.96	-22.42
-45	23.73	-11.12
-52.34	17.48	5.1
-8.46	55.75	28.16

// van Veen V, 2005: Semantically Incongruent > Congruent
// van Veen V, 2005: Response-Incongruent > Semantically Incongruent
// Subjects=14
38.71	38.91	40.18
40.7	56.13	28.67
-35.02	31.96	39.38
8.83	23.84	40.67
55.1	-51.67	50.93
-46.4	-54.31	53.43
40.77	30.41	26.37
-35.2	27.87	14.07
-61.88	4.99	9.61
2.28	31.07	24.53
64.37	-53.01	5.21
-42.56	-14.81	13.28
-15.83	-10.17	15.93

// Koelsch S, 2005: Irregular Chords > Regular Chords, All Adults
// Koelsch S, 2005: Irregular Chords > Regular Chords, All Children
// Subjects=3
-58.33	12.61	3
-48.62	27.85	4.69
-43.41	17.7	-12.32
-52.66	4.72	21.62
-54.97	-34.69	2.02
-62.29	-49.32	18.16
57.33	12.37	5.54
48.62	33.72	4.7
51.65	21.22	-14.29
47.89	3.47	25.63
55.22	-32.18	-.1
63	-49.09	13.77
63	-49.09	13.77
-45.58	20.88	-12.6
58.4	13.33	4.31
57.24	21.53	0.15
48.41	21.21	-14.23
48.99	5.8	27.62
50.84	-30.38	-3.57
55.41	-41.67	13.16

// Kensinger E A, 2005: Accurate Emotional Word-Picture Identification > 
// Control
// Kensinger E A, 2005: Accurate Nuetral Word-Picture Identification > Control
// Kensinger E A, 2005: Accurate Emotional Word-Only Identification > Control
// Kensinger E A, 2005: Accurate Neutral Word-Only Identification > Control
// Kensinger E A, 2005: Accurate Retrieval of Emotional Items (Emotional 
// Corect Attributions > Emotional Misattributions)
// Kensinger E A, 2005: Accurate Retrieval of Neutral Items (Neutral Corect 
// Attributions > Emotional Misattributions)
// Subjects=16
-44	48	-13
-35	-26	59
-53	-20	18
-36	-65	42
-39	-41	57
18	-3	-17
-30	-9	61
-27	-37	-7
-9	-6	50
-35	-20	62
-48	-23	51
-33	-36	43
-35	-64	-2
18	-97	-1
-3	-31	24
-27	-6	-15
24	9	9
-12	34	-7
-30	37	42
45	-9	53
54	-18	51
-9	-50	44
62	-43	10
47	-49	0
62	0	-10
45	12	-33
50	-1	-22
-56	-6	-22
20	-18	-18
-27	-9	-22
21	-12	-22
29	33	29
47	-51	22
48	-22	29
-41	2	-10
-56	-21	-20
27	-5	8
-15	48	36
39	36	18
36	39	21
35	6	11
-32	-42	26
45	-39	32
18	-24	37
-59	-21	-16
50	-50	-5
-21	-6	-18
24	9	13
5	-3	-9
-35	43	-17
-35	13	-21
48	-50	0
-56	-54	25
-41	-61	-14
41	-70	-12
-41	-71	40
15	-2	-20

// Stephan T, 2005: Galvanic Vestibular Stimulation (GVS) > Rest, All 
// Stimulation Frequencies (Activations)
// Stephan T, 2005: GVS > Rest, All Stimulation Frequencies (Deactivations)
// Stephan T, 2005: Linear BOLD Increase with Frequency, Correlation
// Stephan T, 2005: Linear BOLD Increase with Frequency (Excluding 5.0 Hz), 
// Correlation
// Stephan T, 2005: Linear BOLD Decrease with Frequency, Correlation
// Stephan T, 2005: Linear BOLD Decrease with Frequency (Excluding 5.0 Hz), 
// Correlation
// Stephan T, 2005: Linear BOLD Increase with Stimulation Reciprocal (1/f), 
// Correlation
// Stephan T, 2005: Linear BOLD Decrease with Stimulation Reciprocal (1/f), 
// Correlation
// Subjects=10
56	-28	24
54	4	4
40	2	-6
42	40	0
52	2	44
-16	-14	6
-58	-22	22
-52	2	2
-36	0	-2
-46	4	36
-42	36	0
22	2	0
-30	-50	50
-18	-70	-28
30	-64	-28
56	-58	-2
-4	-2	62
6	6	56
-6	6	34
-10	-16	40
34	-50	46
12	-26	48
-54	-58	2
6	-34	-34
-50	-58	-28
6	-34	-34
6	-50	42
10	-58	56
-24	-90	22
8	-56	22
-16	-62	8
-24	-18	-24
62	-4	-20
48	0	-42
40	12	-40
44	-22	66
26	30	48
20	50	42
-4	60	-8
-42	-26	64
-32	-18	72
48	-64	26
24	-94	10
30	-32	-20
28	-22	-22
-40	16	-38
-62	-2	-20
-42	-36	24
18	-16	18
4	-46	-16
0	-66	-24
32	-26	10
-42	-38	22
-20	-18	2
10	-2	8
2	-32	46
34	-28	14
-18	2	-32
-32	-70	-16
-24	4	-38
-22	2	-38
34	-50	68
-34	-68	-16
-18	-20	4
20	-18	16
-44	-36	22
10	-80	10
0	-44	-6

// Birbaumer N, 2005: Healthy Controls
// Subjects=10
-36	3	-12
36	12	-15
-3	9	39
-3	33	-3
3	18	39
-24	30	-12
-60	-27	33
51	-42	24
12	3	69
-27	3	-18
27	3	-27
-36	57	-3
0	57	-9
21	6	-18
-51	-45	15
-18	6	-24
33	-6	15
3	30	3
15	24	-12

// Birbaumer N, 2005: Criminal Psychopaths
// Subjects=10
21	6	-18
-51	-45	15
-18	6	-24
33	-6	15
3	30	3
15	24	-12

// Kong J, 2005: Addition Without Carrying vs. Rest
// Kong J, 2005: Adding With Carrying vs. Rest
// Kong J, 2005: Subtraction Without Borrowing vs. Rest
// Kong J, 2005: Subtraction With Borrowing vs. Rest
// Kong J, 2005: Main Effect of Arithmetic Type (subtraction vs addition)
// Kong J, 2005: Main Effect of Procedure Complexity (with carrying/borrowing 
// vs. without carrying/borrowing)
// Subjects=16
-9	12	42
-21	-3	45
33	-93	-3
-30	-90	0
-27	12	0
-6	12	42
-42	9	30
48	12	27
-24	-3	45
-42	-78	0
-45	-66	-15
-15	-93	-12
15	-96	-6
-21	-33	-3
-27	24	3
33	21	0
-39	-51	-30
-30	-72	-21
-39	-54	-30
-9	12	42
-27	-60	-48
33	-60	42
-24	-72	30
-42	9	30
45	15	24
45	-75	-15
-12	-96	-15
-42	-72	-9
33	33	-6
-27	24	0
-6	12	42
-42	12	24
-24	-6	45
-27	-75	42
30	-54	45
-24	-69	36
-45	-69	-9
-30	24	0
30	24	0
-12	-9	0
-39	21	24
-24	-72	39
-27	-60	51
-12	-75	45
48	-39	51
-3	15	51
6	21	42
-45	9	27
-24	-78	36

// Rivera S M, 2005: Mental Arithmetic, Increases with Age
// Rivera S M, 2005: Mental Arithmetic, Decreases with Age
// Subjects=17
-53	-68	7
-51	-37	46
-16	59	19
-10	-4	-5
-32	-33	-2
-10	-20	-17
-32	1	-13

// Kadosh R C, 2005: Numerical vs. Size
// Kadosh R C, 2005: Numerical vs. Luminance
// Kadosh R C, 2005: Luminance vs. Numerical
// Kadosh R C, 2005: Size vs. Numerical
// Kadosh R C, 2005: Size vs. Luminance
// Kadosh R C, 2005: Luminance vs. size
// Kadosh R C, 2005: Numerical Distance
// Kadosh R C, 2005: Luminance Distance
// Kadosh R C, 2005: Size Distance
// Kadosh R C, 2005: Numerical Distance (IPS)
// Kadosh R C, 2005: Luminance Distance (IPS)
// Kadosh R C, 2005: Size Distance (IPS)
// Subjects=15
56.88	-43.28	7.83
29.45	-61.77	46.5
37.62	-55.71	0.17
40.88	5.2	30.71
-25.06	-56.72	47.82
-25.16	-12.68	53.05
-39.04	-41.29	42.22
55.82	-45.4	8.02
33.2	8.65	7.09
-25.06	-53.38	49.77
-26.35	-82.11	8.7
-52.18	3.7	19.64
-28.34	-16.85	54.55
-26.26	-4.23	52.35
-34.72	-39.61	49.84
-33.88	-2.47	34.45
44.17	-74.02	10.55
43.89	-45.16	-15.28
-40.32	-4.97	30.27
40.96	-70.87	10.33
48.18	-46.02	-13.03
-24.21	-86.49	6.81
-52.12	3.25	27.48
-37.35	14.57	7.41
25.72	-40.87	-13.2
29.44	-63	44.37
60.12	-39.66	13.07
39.77	-57.82	0.32
-24	-53.54	47.54
-37.13	1.48	30.81
41.74	-44.2	-16.45
38.74	-59.59	4.95
-44.52	-.97	41.13
26.24	-54.13	49.24
-24	-53.54	47.54
-22.99	-66.2	35.2
28.36	-55.43	45.98
-25.08	-51.44	47.37

// Nakao T, 2005: Obsessive Compulsive Disorder (OCD) Patients
// Subjects=10
48	26	26
-40	26	18
-36	2	44
-40	38	6
-40	12	-8
22	-60	42
40	-50	46
-20	-64	52
-48	-36	40
10	-76	-20
38	-60	-22
22	-74	-18
30	66	8
54	12	34
-50	4	36
6	24	42
-6	16	46
34	18	-2
58	-36	44
24	-58	58
-28	-58	52
-60	-28	34
-48	-40	46
-34	-86	14
26	-68	-24
-32	58	-4
-50	22	-4
-44	16	46
-54	-62	22
-66	-28	-8
-10	-70	52
28	-82	-30
-42	16	48
-34	58	-8
-44	28	-14
48	-66	40
-42	-72	36
-10	-60	26
22	-84	-34
8	-86	-26
44	46	-2
54	10	40
24	10	-8
-28	10	6
-30	4	-36
-58	-60	2
-64	-28	10
62	-44	30
-64	-32	34
-34	-60	48
-4	-70	50
-26	-86	32
22	-60	56
-44	-66	-38
-20	-70	-34
32	12	42
18	56	20
18	46	0
14	-42	34
-26	-40	36
-18	-6	40
24	-28	-18
64	-16	-14
26	-34	38
-18	-28	-16
54	-10	34
-36	48	18
-2	24	22
20	0	12
18	-30	-2
-12	-26	-2
-40	-10	-14
-64	-30	-2
-58	-42	0
32	-82	32
42	-82	4
16	-90	18
-16	-66	2
16	-58	-20
-42	-48	-24

// Nakao T, 2005: Healthy Controls
// Subjects=13
48	26	26
-40	26	18
-36	2	44
-40	38	6
-40	12	-8
22	-60	42
40	-50	46
-20	-64	52
-48	-36	40
10	-76	-20
38	-60	-22
22	-74	-18
-32	58	-4
-50	22	-4
-44	16	46
-54	-62	22
-66	-28	-8
-10	-70	52
28	-82	-30

// Pelphrey K A, 2005: Autism
// Subjects=10
49	-79	18
-38	-66	3
-42	19	-1
35	5	0

// Pelphrey K A, 2005: Healthy Controls
// Subjects=9
49	-51	11
63	-54	0
52	-37	37
-53	-40	42
46	23	32
56	16	11
7	26	35

// Peuskens H, 2005: biological motion - scrambled point light motion
// Peuskens H, 2005: localization of motion-sensitive regions
// Subjects=6
54	-69	6
-48	-69	3
45	-60	-18
-39	-69	-21
57	-48	12
45	-69	6
-48	-75	0

// Ansari D, 2005: Children
// Subjects=12
56.23	-47.72	60.62
9.93	26.31	44.91
44.08	9.62	32.54
-62.89	7.78	18.31
53.53	10.08	10.08
18.2	13.59	3.51
39.5	13.03	-5.61
30.9	23.38	-8.61

// Ansari D, 2005: Healthy Controls
// Subjects=12
-53.99	-11.54	56.63
36.84	-40.66	43.53
-32.61	-34.39	48.26
-52.04	9.56	40.34
-33	32.88	23.66
28.28	-71.61	29.49
-17.64	-71.54	34.48
-42.45	-33.5	19.3
63.32	-26.53	17.5
-38.45	28.48	8.48
50.24	12.55	0.99
-21.09	-68.67	3.05

// Kaufmann L, 2005: Numerical comparison > null events
// Kaufmann L, 2005: Physical comparison > null events
// Kaufmann L, 2005: Numerical comparison > physical comparison
// Kaufmann L, 2005: Both Tasks (Distance 1 > Distance 4, only neutral trials)
// Kaufmann L, 2005: Numerical comparison (Distance 1 > Distance 4, only 
// neutral trials)
// Kaufmann L, 2005: Physical comparison (Distance 1 > Distance 4, only 
// neutral trials)
// Kaufmann L, 2005: Both tasks (incongruent trials > congruent trials)
// Kaufmann L, 2005: Numerical comparison (incongruent trials > congruent 
// trials)
// Subjects=17
52	4	28
0	-4	60
32	-16	64
-56	0	24
-60	-16	24
-48	-20	60
24	-56	56
-24	-64	60
44	-32	44
20	4	28
-24	16	16
40	-80	-8
-44	-72	-8
8	-56	-4
36	-16	64
28	-60	56
-8	-4	68
-32	-52	52
-60	-24	48
36	-80	-8
-40	-84	-8
24	4	52
20	4	28
-48	-12	28
-24	-32	36
-36	-8	24
-4	8	48
12	-16	40
-24	-60	52
-48	-32	44
16	-44	52
28	-44	48
40	-36	40
-36	0	16
24	4	20
28	0	16
20	-48	52
32	-40	20
-28	-24	20
-28	-56	48
-36	-20	56
-48	-28	44
44	-32	56
40	-40	60
20	-80	40
44	8	28
44	36	16
-36	-84	20
-28	-68	36
0	28	36
-32	24	-4
-44	36	-4
36	-24	56
32	-48	56
24	-44	40
44	16	-4
28	24	0

// Venkatraman V, 2005: Symbolic Exact Addition > Control
// Venkatraman V, 2005: Symbolic Approximate Addition > Control
// Venkatraman V, 2005: Nonsymbolic Exact Addition > Control
// Venkatraman V, 2005: Nonsymbolic Approximate Addition > Control
// Venkatraman V, 2005: Conjunction (symbolic and nonsymbolic addition, exact 
// and approximate)
// Venkatraman V, 2005: Nonsymbolic-symbolic (collapsed across exact and 
// approximate addition)
// Subjects=10
-44.64	7.69	29.26
-50.76	-35.47	49.67
-28.28	-61.23	44.88
3.64	12.15	55.09
51.79	-38.54	42.06
-2.77	9.91	54.24
-44.62	3.46	29.61
-50.81	-35.99	43.03
-31.49	-58.08	44.66
-35.24	18.64	4.81
48.63	-38.05	48.75
29.94	19.03	4.03
-2.88	19.8	44.49
-42.49	4.53	29.5
-47.53	-35.2	52.96
-31.52	-58.33	41.33
-35.28	18.3	0.38
-44.78	30.44	20.66
-51.16	-56.04	-9.93
32.57	-51.6	40.03
32.03	18.53	-2.64
51.38	39.65	21.01
54.58	-46.07	-14.21
-6	11.84	51.88
-44.69	7.18	22.61
-54	-35.83	45.28
-28.33	-61.83	37.13
-28.81	19.99	7.97
-38.4	38.85	18.76
-52.25	-53.05	-12.4
38.65	10.85	21.34
51.79	-31.94	44.85
29.34	-58.48	33.96
32.1	22.56	8.17
44.94	42.61	18.61
54.55	-43.15	-17.8
-44.63	4.52	29.52
-50.76	-35.47	49.67
-28.28	-61.23	44.88
3.63	13.21	55
48.61	-38.31	45.42
0.27	28.02	40.42
-38.17	-1.53	33.3
-31.58	-62.28	31.63
-28.85	28.37	6.15
-38.3	20.16	24.79
35.48	8.97	24.88
42.26	-43.12	52.59
32.6	-64.55	37.77
34.25	29.34	13.15
51.51	21.21	30.36

// Costantini M, 2005: Possible hand movements vs possible scissors movements
// Costantini M, 2005: Impossible hand movements vs impossible scissors 
// movements
// Costantini M, 2005: Observation of impossible vs possible hand movements
// Subjects=13
-52	8	20
56	-24	48
52	-36	40
-40	-32	40
56	-36	48
-56	-48	0
56	-56	4
-12	-20	0
56	12	28
-28	-24	64
-60	4	24
-36	-36	64
44	-36	64
-64	-20	24
64	-16	20
-52	-40	28
56	-36	36
32	-44	56
-56	-28	16
52	-28	16
-52	-60	8
48	-56	8
48	-60	-12
-48	-80	8
-64	-20	28
60	-20	32
-52	-24	32
64	-28	40
32	-44	56
-60	-28	16
52	-68	4
48	-60	-12
40	-88	4

// Michels L, 2005: classic point-light walker
// Michels L, 2005: classic point-light walker static
// Michels L, 2005: sequential position walker
// Michels L, 2005: sequential position walker static
// Subjects=4
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6
44.13	-71.19	5.86
46.22	-63.95	2.99
32.42	-89.5	4.18
43.87	-43.13	-16.57
56.91	-41.88	12.17
35.39	-72.16	-19.61
45.93	36.3	5.74
35.68	11.11	52.58
18.51	-87.55	3.06
-42.44	-70.74	5.7
-43.54	-66.69	3.14
-27.42	-87.66	5.83
-35.21	-42.54	-15.71
-45.65	-51.04	13
-31.91	-76.71	-17.34
-42.75	27.14	5.3
-36.95	8.82	56.95
-11.4	-89.85	3.6

// Zentgraf K, 2005: Observation for motor imagery > rest
// Zentgraf K, 2005: Observation for evaluation > rest
// Zentgraf K, 2005: Observation for motor imagery > observation for 
// evaluation
// Zentgraf K, 2005: Observation for evaluation > Observation for motor 
// imagery
// Subjects=10
30	-6	57
48	30	15
-39	39	33
-36	-54	63
60	-30	33
33	-42	45
-45	-57	-30
-33	-75	27
-24	-63	-54
12	-60	-42
-21	0	9
21	21	-3
60	12	36
42	24	-3
-42	-3	60
-54	12	24
24	-57	60
-57	-33	27
42	-48	-30
-39	-87	-3
-21	-39	-45
-12	12	27
-33	42	21
-18	3	72
-54	12	0
-6	-3	60
-57	-39	42
-12	-60	-3
24	-36	18
-12	-36	18
0	24	66
0	24	66

// den Ouden H E M, 2005: IC (ICPM + ICnoPM) > PC (PCPM + PCnoPM)
// den Ouden H E M, 2005: PC (PCPM + PCnoPM) > IC (ICPM + ICnoPM)
// den Ouden H E M, 2005: PM (ICPM + PCPM) > noPM (ICnoPM + PCnoPM)
// den Ouden H E M, 2005: ICnoPM - PCnoPM
// den Ouden H E M, 2005: PC x PM
// Subjects=11
0	-48	33
-57	-57	18
51	-48	24
-9	63	12
-42	18	-39
39	21	-33
-42	-72	36
48	-75	36
-57	-30	36
-3	-60	51
48	-45	45
27	63	6
3	-42	24
-57	-57	21
57	-66	27
-9	69	15
-36	12	-30
30	18	-27
-45	-69	36
48	-72	39
-3	48	30

// Shin L M, 2005: PTSD
// Subjects=13
22	4	-14
18	-6	-20
-20	-8	-18
14	48	8
0	46	-10
4	-38	70
-12	52	-10
16	38	22
22	2	-14
22	0	-26
40	-72	-40
-12	-52	38
-10	38	-12
16	38	22
-12	52	-10
16	48	20

// Shin L M, 2005: Healthy Control
// Subjects=13
18	-6	-18
-16	-6	-18
-2	38	-10
-6	38	12
-6	24	20
14	48	20
-28	-8	-18
22	-8	-26
-38	-82	20
-58	-22	-18
20	-68	-46
10	-12	52
22	2	-14
22	0	-26
40	-72	-40
-12	-52	38
-10	38	-12
16	38	22
-12	52	-10
16	48	20

// Kim J, 2005: Appropriateness of facial affect > Gender matching task
// Kim J, 2005: Appropriateness of facial affect > Gender matching task + 
// Resting
// Subjects=14
-46.19	15.83	-30.51
-53.54	22.7	-9.82
-3.12	-4.69	3.05
-3.02	43.61	35.8
12	44.3	43.38
-.78	25.99	41.72
3.45	33.24	38.83

// Mitchell J P, 2005: Mentalizing > Nonmentalizing
// Mitchell J P, 2005: Nonmentalizing > Mentalizing
// Subjects=18
-9	51	36
-45	12	18
-36	6	51
-24	-3	-27
45	-6	-15
-30	-18	6
0	-21	48
-24	-42	69
24	-57	69
-51	-48	3
57	-51	9
-9	-102	12
9	-96	15
-39	-63	-3
51	-57	-12
-24	-69	39
-30	-87	6
36	-87	0

// Bryant R A, 2005: PTSD
// Subjects=14
51.66	-30.84	60.34
-47.7	-39.7	62.91
-56.79	-19.03	31.88
29.15	69.58	10.44
49.32	7.23	54.37
42.1	45.39	3.65
46	20.4	-34.28
61.6	-59.13	-13.23
-65.28	-52.89	37.62
-.32	0.88	58.08
26.84	-25.64	-20.44
-25.18	3.54	-26.92
7.38	0.44	-15.96
55.74	-12.93	45.05
-47.67	-32.9	66.72
-54.8	1.63	23.08
1.06	-55.3	-14.82
0.94	-38.7	-20.94

// Bryant R A, 2005: Controls
// Subjects=14
6.38	-78.42	59.09
3.6	-102.76	5.52
12.03	-99.93	-10.59
-52.03	-37.59	62.77
68.76	-25.64	46.09
13.97	25.32	-2.85
7.49	-86.31	-25.31
-24.95	16.26	-5.77
66.01	22.49	9.99
50.36	46.98	-25.78
22.98	63.12	33.6
72.49	-14.68	2.36
-7.46	0.34	6.71
0.85	28.49	-14.14
55.74	-12.93	45.05
-47.67	-32.9	66.72
-54.8	1.63	23.08
1.06	-55.3	-14.82
0.94	-38.7	-20.94

// Sakamoto H, 2005: PTSD
// Subjects=16
-13.75	-43.68	-4.71

// Sakamoto H, 2005: Healthy Control
// Subjects=16
48.71	-53.65	53.4
31.49	-11.12	54.49
-28.19	-75.78	49.45
-28.33	-13.42	57.6
-34.97	25.87	43.23
-15.86	18.1	23.59

// Allen P P, 2005: Activation Whilst Listening to and Evaluating the Source 
// of Speech
// Allen P P, 2005: Self > Alien
// Allen P P, 2005: Alien > Self
// Allen P P, 2005: Distorted > Undistorted
// Allen P P, 2005: Undistorted > Distorted
// Allen P P, 2005: Emotional > Neutral
// Allen P P, 2005: Source x Distortion Interaction
// Allen P P, 2005: Correct > Misattributions
// Allen P P, 2005: Distorted Self-Speech, Correct > Misattributions
// Subjects=11
50.29	-18.8	-5.3
-47.92	-21.62	8.33
-51.19	-28.92	-3.28
-36.22	-56.21	-13.44
38.41	28.17	-2.41
-41.62	22.29	11.27
4.44	18.22	23.35
7.84	-58.84	17.5
7.95	-61.07	29.96
0.11	-40.68	-8.46
-1.05	-18.48	-10.31
-37.49	21.91	-7.71
4.4	26.59	21.53
53.52	-26.27	-5.83
-46.9	-29.87	-2.14
-5.09	-69.97	-1.49
45.88	21.53	-6.4
-35.33	22.1	-5.52
5.5	26.86	24.84
-49.03	-34.2	-2.87
-53.27	-42.68	-2.11
-41.26	-35.56	33.96
-21.92	-74.99	31.47
-49.12	-23	-9.38
-49.16	-19.02	-13.06
54.45	-11.17	-17.14
17.26	-58.64	-8.27
44.93	20.52	8.19
8.77	15.5	29.1
-37.59	27.4	-19.32
5.24	40.66	-3.08
-33.38	31.14	-26.37

// Small D M, 2005: BR > BO
// Small D M, 2005: FR > FO
// Small D M, 2005: LO > LR
// Small D M, 2005: CR > CO
// Small D M, 2005: CO > CR
// Small D M, 2005: (CO > CR) vs. (LO > LR + BO > BR + FO > FR)
// Subjects=11
3	33	3
-3	27	21
18	12	9
57	-9	-6
-3	-27	51
-3	3	15
-6	0	-3
48	36	-18
24	-18	-12
-57	18	-3
54	15	-3
-45	-9	-3
51	-12	0
66	-24	15
-36	9	3
-30	24	-3
-3	-3	15
-6	0	-6
-36	12	0
-45	-9	-3
39	15	-18

// Stevens M C, 2005: Target Stimulus > Baseline, Placebo > E2
// Stevens M C, 2005: Distractor Stimulus > Baseline, Placebo > E2
// Stevens M C, 2005: Target Stimulus > Baseline, E2 > Placebo
// Stevens M C, 2005: Distractor Stimulus > Baseline, E2 > Placebo
// Stevens M C, 2005: Standard Stimulus > Baseline, E2 > Placebo
// Subjects=8
-16	-72	60
16	0	16
-60	-52	-6
36	-68	54
-48	-80	12
16	-4	-6
-52	-52	48
-20	-72	54
20	-84	30
-56	-16	48
-12	44	36
20	-84	42
20	44	30
-56	-64	12

// David S P, 2005: Smokers
// Subjects=9
1	44	-5
-14	56	28
14	-78	-17
8	56	-12
-6	50	0
-14	56	28
32	-86	-20
-6	-82	-12

// Canessa N, 2005: Descriptive Reasoning vs. Baseline
// Canessa N, 2005: Social-Exchange (SE) vs. Baseline
// Canessa N, 2005: Social-Exchange (SE) > Descriptive Reasoning (DES)
// Canessa N, 2005: Descriptive Reasoning (DES) > Social-Exchange (SE)
// Subjects=12
-10	32	32
2	36	32
-4	28	44
10	26	40
-4	16	56
-44	14	44
-42	18	32
-8	14	64
38	46	20
34	56	24
-54	-70	16
-38	-48	24
-48	-68	36
-46	-66	40
-46	-52	44
-6	-78	40
2	-68	36
-4	-80	36
-4	28	32
4	36	32
-4	40	36
4	42	44
-6	30	44
6	32	52
-6	14	68
10	16	56
-42	20	36
-28	18	44
-42	6	56
46	6	44
48	14	32
-40	36	12
-50	38	20
-52	-62	28
-46	-64	32
-44	-64	40
46	-64	28
46	-58	32
52	-56	36
46	-68	40
-14	8	12
-8	44	52
8	44	52
-8	40	56
8	38	56
-40	32	16
40	6	40
46	-60	32
50	-60	36
-16	10	12
4	38	32
-6	30	44
-6	34	56
-44	14	44
-42	18	32
-44	-58	32
-50	-66	36
-44	-64	40
-42	-66	44

// Dietz N A, 2005: All Conditions vs. Fixation
// Dietz N A, 2005: Main Effect of Word-Type: Pseudowords > Real Words
// Dietz N A, 2005: Main Effect of Response-Modality: Aloud > Silent
// Dietz N A, 2005: Aloud Real Word Reading > All Silent Reading and Aloud 
// Pseudoword Reading
// Subjects=16
-56.81	6.05	36.12
-41.19	-47.56	-21.59
-47.55	-61.96	-14.45
-39.87	-81.83	-9.26
-60.23	20	24.72
-46.19	11.23	21.98
-28.34	-51.2	53.63
10.46	21.55	60.34
-62.51	-.61	11.11
-53.65	-2.21	27.92
62.8	1.96	8.72
56.54	0.31	25.8
-54.27	16.07	-17.58
-65.84	-14.42	1.32
-64.66	-26.76	7.01
60.38	7.63	-10.85
62.77	-26.73	0.35
-18.84	-8.42	-40.41
-11.95	-29.41	-12.68
-35.7	-67.65	-18.58
18.42	-71.09	-12.43
5.52	-18.11	3.84
-20.63	9.68	-7.43
-22.61	-77.62	-11.09

// Grewe T, 2005: N-OS vs. N-SO
// Subjects=16
-33.17	22.37	-2.22
-54.42	16.92	11.87
-.94	37.56	26.25
-39.25	12.64	37.7
48.14	30.48	12.9
41.66	23.07	0.21
50.26	13.87	4.23

// Han S, 2005: Healthy Controls, Shape Experiment
// Subjects=16
16.76	-90.32	23.11
61.01	-22.66	32.48
-67.6	-33.31	29
55.04	5.9	-6.11
27.61	-83.38	27.85
-55.88	-57.47	11.02

// Han S, 2005: Healthy Controls, Vertical Lines Experiment
// Subjects=13
5.69	-81.38	4.49
-28.28	-59.5	56.69
3.72	-89.82	17.68

// Pouthas V, 2005: (Short Standard + Short Nonstandards + Long Standard + 
// Long Nonstandards) > Controls, p<0.01
// Pouthas V, 2005: (Short Standard + Short Nonstandards + Long Standard + 
// Long Nonstandards) > Controls, p<0.0001
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.01
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.0001
// Pouthas V, 2005: (Long Standard + Long Nonstandards) > (Short Standard + 
// Short Nonstandards), p<0.0003
// Subjects=6
-33	24	0
39	-42	39
3	6	60
3	24	48
33	18	0
39	33	15
-51	0	48
27	3	51
9	12	12
6	12	57
12	30	27
51	12	15
-51	-3	48
51	9	42
12	18	15
6	12	57
51	12	15
-51	-3	48
51	9	42
12	18	15

// Konishi S, 2005: Dimension change (DC) minus Dimension repeat (DR)
// Konishi S, 2005: Control minus release
// Subjects=31
8.42	19.18	69.57
-46.11	12.91	28.54
-19.67	5.9	66.88
-10.99	-79.1	52.73
-56.51	-3.78	57.26
-16.42	-87.43	-36
37.6	-50.04	-29.41
5.46	-32.77	-3.68
-43.3	-23.75	72.46
-30.42	-59.4	57.84
-31.33	56.39	10.54
62.06	-66.65	21.12
-18.52	-49.82	-23.99

// Meister I, 2005: Novel > Repeated 1-day (Activations)
// Meister I, 2005: Novel > Repeated 6-week (Activations)
// Meister I, 2005: Comparison of retention intervals for naming novel vs. 
// repeated pictures, 1-day > 6-week
// Subjects=10
30	-90	-3
48	-60	-15
-39	-75	-12
-48	-63	-15
-45	-84	0
-51	9	39
-36	30	12
39	-65	-9
45	-72	-9
-42	-72	-18
-56	26	-4
42	-69	-15
-27	-93	-9
-45	-72	-18
-33	-69	-15
-39	15	15
-36	6	24

// Mohanty A, 2005: Healthy Controls
// Subjects=17
-53.75	-36.8	-25.12
66.61	-8.2	-23.35
60.15	34.71	-10.71
-53.98	37.96	-10.26
0.97	38.55	-8.4
33.2	-99.58	5.31
43.74	-84.11	15.28
-57.85	-40.56	17.34
62.32	38.59	17.87
-32.72	25.19	19.35
55.98	24.59	-3.18
47.44	45.53	-4.53
30.78	-17.64	0.06
-20.03	5.07	-.96
-22.01	-28.57	1.37
-47.28	-51.91	2.74
-32.72	25.19	19.35
66.61	-8.2	-23.35
33.19	-97.48	5.16
43.74	-84.11	15.28
-57.84	-40.43	19.55

// Mohanty A, 2005: Schizotypy
// Subjects=17
-41.05	-42.99	-24.77
32.84	-21.09	-22.27
-20.06	4.22	-14.81
7.27	47.01	-9.02
-64.23	-39.33	3.97
-66.26	-57.85	11.91
-56.12	51.09	-2.27
43.23	45.75	-.27
53.93	28.42	25.27
-11.36	-33.33	25.45
-55.6	-57.83	45.14
55.98	24.59	-3.18
47.44	45.53	-4.53
30.78	-17.64	0.06
-20.03	5.07	-.96
-22.01	-28.57	1.37
-47.28	-51.91	2.74
-32.72	25.19	19.35
66.61	-8.2	-23.35
33.19	-97.48	5.16
43.74	-84.11	15.28
-57.84	-40.43	19.55

// Kimmerly D S, 2005: Increased activation during baroreceptor unloading 
// covarying with mild lower body negative pressure
// Kimmerly D S, 2005: Decreased activation during baroreceptor unloading 
// covarying with mild lower body pressure (LBNP)
// Kimmerly D S, 2005: Increased activation during higher heart rates 
// covarying with mild LBNP
// Kimmerly D S, 2005: Decreased activation during higher heart rates 
// covarying with mild LBNP
// Kimmerly D S, 2005: Increased activation during baroreceptor unloading 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Decreased activation during baroreceptor unloading 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Increased activation during higher heart rates 
// covarying with moderate LBNP
// Kimmerly D S, 2005: Decreased activation during higher heart rates 
// covarying with moderate LBNP
// Subjects=6
-42	36	20
44	0	54
52	18	28
6	-54	70
6	-78	52
-40	12	-6
-46	12	10
32	28	20
18	46	10
-8	24	24
44	48	-12
34	-22	13
40	-12	34
44	-22	60
-14	-52	-25
18	46	12
-22	0	-26
-12	-20	12
46	0	0
30	54	0
-42	38	24
48	4	50
58	20	26
-60	-16	42
8	-58	68
5	-78	50
-38	14	-6
30	22	12
16	54	6
13	-46	30
-26	-2	-18
6	-14	14
46	44	-10
36	-34	18
22	60	16
-8	-6	46
46	-6	54
44	-18	56
-28	-50	-36
44	-8	-2
4	44	2
-22	-6	-20
26	-2	-26
-6	-16	12
2	-32	-14

// Khalfa S, 2005: Minor - Major
// Khalfa S, 2005: Mode - Tempo
// Subjects=13
1.3	55.94	26.84
-15.24	53.39	0.48
-18.05	63.18	36.53
24.38	-.17	45.44
-60.03	11.67	38.98
31.06	-8.47	59.6

// Koelsch S, 2005: Unpleasant > Pleasant (Both Blocks)
// Koelsch S, 2005: Pleasant > Unpleasant (Both Blocks)
// Koelsch S, 2005: Unpleasant > Pleasant (2nd Block Only)
// Koelsch S, 2005: Pleasant > Unpleasant (2nd Block Only)
// Subjects=11
-28.9	-15.01	-18.09
-25.62	-27.43	-13.74
-49.36	11.84	-26.8
27.73	-14.67	-18.77
24.58	-27.3	-16.56
40.39	8.95	-30.93
-38.24	-25.36	14.11
-38.52	33.25	1.39
-29.92	20.7	3.46
50.39	-15.57	8.93
40.56	33.73	0.44
37.37	24.02	-.94
-19.32	-5.44	-19
16.99	-5.48	-22.76
-51.2	-2.69	5.67
-54.51	10.52	-2.09
-9.7	6.76	-13.45
53.53	2.42	7.38
53.49	5.34	3.79
11.71	7.23	-9.27

// Zambreanu L, 2005: Heat/Capsaicin > No Heat/Capsaicin
// Subjects=12
-18	-60	-28
-10	-28	-18
0	-34	-4
-46	-24	4
-10	-30	6
8	-28	8
38	-26	8
-64	-26	10
62	-40	10
2	44	14
-8	-40	36
4	-58	66
22	62	10
0	2	70
-2	-30	78

// Haist F, 2005: Autism Spectrum Disorders (ASD)
// Subjects=8
52.94	-25.62	57.69
44.34	-32.79	48.36
43.24	-43	40.3
38.6	-75.4	-20.49
38.57	-75.65	-23.82
34.39	-84.6	-15.21
44.34	-32.79	48.36
49.41	1.83	27.55
-42.51	5.42	27.19
-33.21	50.55	4.34
41.88	12.18	24.54
-54.25	-2.14	26.85
-32.02	16.63	6.06
38.98	-9.84	56.53
44.11	-4.38	30.36
-40.3	-1.54	33.33
32.47	-7.65	44.15
-5.91	-1.48	58.58
37.91	-36.26	45.38
27.31	-58.52	47.37
-24.98	-55.87	58.89
42.09	-36.11	33.05
22.99	-72.18	36.29
-19.75	-72.44	36.81
35.61	-85.16	4.9
-33.83	-75.55	11.58
50.43	-69.01	-7.78
42.92	-66.06	-10.17
-37.26	-58.08	-9.92
38.6	-75.4	-20.49
11.92	-18	8.46
-9.42	-26.59	9.42
-23.44	7.16	6.75
37.5	-74.6	-23.89
-42.4	18.68	47.27
-10.18	-5.82	57.87
31.15	27.09	25.64
6.83	-6.66	45.48
5.73	-7.01	41.06
-3.94	0.16	38.34
-42.87	4.99	-19.61
44.11	-4.38	30.36
-43.43	2.55	45.29
59.89	12.87	4.2
5.91	-84.17	34.15
-1.59	-78.93	33.8
-1.72	-80.3	16.07
37.82	-87.72	12.89
-20.91	-90.99	17.19
7.85	-92.82	4.74
-7.23	-75.44	-3.23
-32.79	-90.14	1.64
22.62	-68.38	-10.86
-15.84	-72.84	-10.04
50.28	-9.03	-2.77
50.18	10.81	-7.78
47.29	-70.55	0.19
16.13	-49.38	-12.38
-12.73	-46.38	-12.3
29.85	-14.92	-22.12
-25.73	-14.19	-21.54
25.56	-7.37	-20.47
-22.52	-8.63	-18.7
36.09	-1.19	-37.84
-31.24	1.58	-37.3
32.03	-49.51	-29.28
-27.73	-61.16	-23.15
-6.36	-46.77	-17.92
-42.75	53.46	15.36
-9.07	-93.24	28.39
-6	-89.21	11.29
59.05	-63.79	3.95
12.05	-94.71	-6.3
-9.24	-89.58	6.9
35.57	-85.59	-.64
40.85	-80.79	-7.8
30.06	-89.54	-23.67

// Haist F, 2005: Healthy Controls
// Subjects=8
52.94	-25.62	57.69
44.34	-32.79	48.36
43.24	-43	40.3
38.6	-75.4	-20.49
38.57	-75.65	-23.82
49.41	1.83	27.55
-42.51	5.42	27.19
42.26	-13.54	63.49
32.5	-5.19	48.41
-31.65	1.82	48.56
42.87	31.14	21.82
49.25	35.32	20.28
-33.21	50.55	4.34
-33.22	56.98	4.92
41.88	12.18	24.54
-54.25	-2.14	26.85
5.64	21.8	41.99
-2.9	20.69	42.18
-8.32	15.48	30.42
16.23	18.63	27.64
46.57	-24.09	64.33
-53.02	-20.31	39.51
-51.95	-41.08	32.31
27.37	-64.44	53.44
-28.19	-63.63	55.12
22.03	-69.93	51.73
-7.92	-60.59	51.29
-51.86	-44.62	41.53
61.22	-46.97	14.78
64.39	-47.3	10.31
-53.18	-41.66	11.19
38.87	-87.97	9.55
48.28	-68.05	-8.95
-39.39	-62.4	-10.65
-32.94	-69.68	-9
33.17	14.91	5.45
-32.02	16.63	6.06
16.19	-16.92	8.32
-12.72	-1.23	7.33
-16	19.9	5.6
23.62	-3.13	7.08
-.99	-55.2	-17.27
6.47	-75.22	-29.06
43.82	-63.36	-30.48
-25.64	-55.06	-27.04
44.34	-32.79	48.36
49.41	1.83	27.55
-42.51	5.42	27.19
-33.21	50.55	4.34
41.88	12.18	24.54
-54.25	-2.14	26.85
-32.02	16.63	6.06
38.98	-9.84	56.53
44.11	-4.38	30.36
-40.3	-1.54	33.33
32.47	-7.65	44.15
-5.91	-1.48	58.58
37.91	-36.26	45.38
27.31	-58.52	47.37
-24.98	-55.87	58.89
42.09	-36.11	33.05
22.99	-72.18	36.29
-19.75	-72.44	36.81
35.61	-85.16	4.9
-33.83	-75.55	11.58
50.43	-69.01	-7.78
42.92	-66.06	-10.17
-37.26	-58.08	-9.92
38.6	-75.4	-20.49
11.92	-18	8.46
-9.42	-26.59	9.42
-23.44	7.16	6.75
37.5	-74.6	-23.89
-26.26	-3.17	52.26
-43.43	2.55	45.29
-53.16	9.04	33.7
-34.27	49.48	4.44
56.85	8.04	24.72
-48.91	7.75	30.42
-51.03	8.97	32.57
3.65	-4.22	49.77
-3.9	12.65	48.45
11.14	-1.81	52.83
11.35	-22.73	71.31
-51.91	-20.93	45.12
48.65	-35.68	51.9
-6.87	-61.82	49.15
30.41	-75.02	26.41
65.47	-47.2	11.41
-42.44	-46.62	14.83
50.56	-73.18	7.07
32.12	15.07	7.68
-30.93	17.95	9.28
-40.52	5.03	8.24
-9.49	-13.01	6.05
25.69	9.4	3.77
7.56	-76.01	-25.66
44.11	-4.38	30.36
-43.43	2.55	45.29
59.89	12.87	4.2
5.91	-84.17	34.15
-1.59	-78.93	33.8
-1.72	-80.3	16.07
37.82	-87.72	12.89
-20.91	-90.99	17.19
7.85	-92.82	4.74
-7.23	-75.44	-3.23
-32.79	-90.14	1.64
22.62	-68.38	-10.86
-15.84	-72.84	-10.04
50.28	-9.03	-2.77
50.18	10.81	-7.78
47.29	-70.55	0.19
16.13	-49.38	-12.38
-12.73	-46.38	-12.3
29.85	-14.92	-22.12
-25.73	-14.19	-21.54
25.56	-7.37	-20.47
-22.52	-8.63	-18.7
36.09	-1.19	-37.84
-31.24	1.58	-37.3
32.03	-49.51	-29.28
-27.73	-61.16	-23.15
-6.36	-46.77	-17.92
47.31	21.96	40.39
-48.01	34.48	18.13
55.5	29.24	-3.81
-56.55	21.4	14.86
-51.35	26.49	-2.35
38.82	23.57	48.15
4.33	52.23	22.73
66.64	-15.45	36.61
-42.19	-19.76	59.41
-3.8	-64.31	30.36
51.72	-69.95	21.28
-45.55	-63.13	21.82
40.97	-58.64	17.11
-45.58	-60.22	18.23
67.31	-11.81	-12.77
-56.75	3.94	-18.24
25.68	-33.64	-16.04
-27.77	-40.73	-20.41
40.75	-64.21	-13.65
-27.72	-42.41	-14.69
-37.18	-22.18	13.83
0.08	-73.94	-25.75
2.09	-66.41	-38.67

// Valera E M, 2005: 2-back - X-task, ADHD
// Valera E M, 2005: 2-back - X-task, Healthy Controls
// Valera E M, 2005: 2-back - X-task, Healthy Controls > ADHD
// Valera E M, 2005: 2-back - X-task, Healthy Controls > ADHD, No LD subjects
// Subjects=15
-36	-60	54
39	21	-3
39	36	30
6	-78	-33
33	-57	-36
-12	-6	9
3	33	42
15	-12	6
-27	-69	-36
-33	27	-6
-27	-69	42
9	-75	-24
15	-81	12
57	-54	-18
-27	-66	-21
-33	-90	-3
-33	-57	-15

// Pantano P, 2005: Multiple Sclerosis (MS)
// Subjects=18
-45.82	-14.45	45.81
-47.8	-27.35	57.2
-36.44	-9.7	-64.64
-.35	6.1	56.45
-11.89	-11.45	-4.37
-11.7	-8.94	11.06
-58.39	14.32	-1.65
-18.42	-58.87	-17.5
47.14	7.02	52.19
36.56	-43.86	59.64
34.27	0.05	58.7
63.09	13.92	33.3
36.56	-43.86	59.64
14.21	-4.59	10.19
62.49	21.47	-12.26
51.79	5.79	-7.16
20.47	-58.74	-18.17
-.99	-70.85	-8.76
-39.28	-14.01	50.14
-55.76	-28.16	26.04
-51.08	-34.16	53.45
-62.28	10.94	31.25
-.39	8.02	54.02
-26.91	-.9	6.05
-16.14	-16.37	0.67
-51.6	-18.34	16.04
50.32	-22.93	41.65
44.94	-29.33	42.37
67.21	1.54	15.41
67.31	12.15	25.56
40.78	-4.08	60.12
40.92	-47.89	62.21
24.84	-.38	-2.73
14.21	-3.53	10.09
62.57	18.8	-6.39
20.45	-56.71	-19.49
3.36	-52.02	-2.86
56.63	9.75	34.95
69.64	-19.44	32.01
53.09	6.39	10.69
12.64	-16.61	53.99
60.98	-17.45	30.84
42.84	-16.91	49.02
60.96	-20.85	28.93
43.01	-37.46	58.9
-36.96	-9.47	64.21
60.98	-19.58	31.05
61.03	-13.74	36.07

// Pantano P, 2005: Healthy Controls (HC)
// Subjects=9
-33.82	-11.35	55.38
-27.27	-35.99	55.47
-41.25	-35.53	61.26
-62.29	-5.53	27.28
-49.12	8.08	45.88
-.29	7.68	61.89
33.17	-13.24	54.43
45.08	-31.59	52.68
5.04	7.18	56.25
17.34	-66.74	-11.72
7.55	-71.65	-17.8
9.6	-70.24	-25.81
-46.91	-4.68	47.1
-43.57	-12.65	53.44
-52.21	-31.28	49.82
-49.11	5.95	46.09
-1.44	8.22	56.26
39.66	-14.28	54.42
46.12	-35.19	48.54
10.48	1.99	57.79
31.35	-74.55	-15.67
6.53	-52.53	-8.46
9.77	-59.11	-10.11

// Mitchell R L C, 2005: Congruent > Neutral (Color Modality)
// Mitchell R L C, 2005: Congruent > Neutral (Number Modality)
// Mitchell R L C, 2005: Congruent > Neutral (Shape Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Color Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Number Modality)
// Mitchell R L C, 2005: Incongruent > Neutral (Shape Modality)
// Mitchell R L C, 2005: Congruent (number > color) > Neutral (number > 
// color), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (number > shape) > Neutral (number > 
// shape), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > color) > Neutral (shape > color), 
// Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > number) > Neutral (shape > 
// number), Before exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (number > shape) > Neutral (number > 
// shape), After exclusion of task difficulty effects
// Mitchell R L C, 2005: Congruent (shape > color) > Neutral (shape > color), 
// After exclusion of task difficulty effects
// Subjects=15
-10.91	-7.38	73.65
-7.54	-39.27	76.75
-24.35	-60.27	25.32
-17.94	-87.02	14.41
-8.42	-78.66	-0.02
0.97	-58.16	-22.38
-17.32	-13.47	77.72
-57.05	-19.84	11.8
50.44	-12.22	52.91
43.75	-36.76	31.92
52.65	-.23	-25.63
-44.74	-5.01	-36.95
21.39	-44.23	56.58
18.29	-36.61	69.32
-1.44	-51.94	44.28
26.83	-51.99	-26.79
-28.2	-35.3	-17.42
-28.04	-66.9	-10.94
39.82	-48.45	-24
-27.6	-80.05	20.61
36.32	-70.09	-48.69
-30.74	15.9	48.15
-17.74	6.37	48.87
-27.21	-60.66	55.67
-24.05	-71.16	46.57
-56.77	-24.35	32.41
-24.05	-84.23	44.5
-50.36	27.66	37.24
49.32	45.05	-23.33
29.8	51.05	-26.95
16.76	60.27	-31.01
-35.02	40.94	-28.21
40.85	-70.31	52.1
-27.77	-91.18	4.91
40.04	-82.92	-13.87
-40.95	-79.7	-9.45
-34.97	-40.7	-40.3
49.37	-79.31	-44.64
-22.07	-34.58	-44.49
40.85	-70.31	52.1
-56.77	-24.35	32.41
-24.05	-84.23	44.5
40.85	-70.31	52.1
-27.77	-91.18	4.91
40.04	-82.92	-13.87
-40.95	-79.7	-9.45
-34.97	-40.7	-40.3
49.37	-79.31	-44.64
-22.07	-34.58	-44.49
40.85	-70.31	52.1
44.14	-45.86	60.83
-68.9	-43.69	9.88
-44.2	-12.97	4.17
-55.97	-18.77	11.67
-14.19	-3.34	71.06
1.8	-50.86	44.12
30.14	-70.06	-25.06
24.05	-94.49	0.99
-55.97	-18.77	11.67
-14.19	-3.34	71.06
1.8	-50.86	44.12

// Chen S H A, 2005: Encoding > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Maintenance > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Retrieval > Finger Tapping (within telencephalon and 
// diencephalon)
// Chen S H A, 2005: Encoding > Finger Tapping (below diencephalon)
// Chen S H A, 2005: Maintenance > Finger Tapping (below diencephalon)
// Chen S H A, 2005: Retrieval > Finger Tapping (below diencephalon)
// Subjects=15
-48.49	-83.88	-7.79
-50.74	-62.72	-10.96
-56.1	-75.5	-9.61
-48.39	-84.22	0.09
-66.9	10.87	7.8
-53.45	5.83	45.05
-59.84	-5.58	49.65
-53.54	2.98	37.49
-20.45	-36.05	-2.91
-27	-38.72	-8.14
-22.76	-38.26	-14.98
-33.55	-31.61	-12.09
-29.11	-31.83	-3.18
-4.75	9.92	51.66
-.52	14.74	45.51
-8.83	11.67	70.61
-.32	10.77	60.47
27.07	-33.76	-3.95
29.15	-34.37	-10.65
20.48	-9.42	-7.36
47.22	-0.01	57.36
61.18	-.58	50.46
63.21	3.91	41.01
38.67	2.81	65.07
31.79	-103	12.91
27.56	-101.23	20.65
69.15	6.47	-.8
-11.28	10.65	48.34
-2.64	12.81	47.98
-64.62	12.87	17.65
-56.15	8.36	3.39
-58.06	11.29	23.3
-38.1	29	-18.01
-41.41	-44.42	46.46
-18.53	10.34	-12.02
-9.91	12.39	-13.49
-50.69	-64.54	-7.42
31.1	27.53	-14.56
13.87	14.71	-13
-3.02	37.32	23.15
-9.24	25.03	41.28
-4.78	6.42	48.65
-55.91	13.42	23.05
-64.57	13.29	22.09
-16.1	-13.93	3.79
-36.99	2.34	64.17
-46.63	14.49	-11.95
54.85	14.33	-19.26
48.51	12.05	-8.85
7.85	-16.86	17.12
-18.74	-30.65	-37.09
-10.12	-26.37	-37.66
-25.23	-37.26	-38.57
37.56	-70.01	-36.4
50.87	-91.5	-14.33
41.82	-61.7	-39.53
41.96	-72.67	-30.61
31	-45.47	-37.59
1.07	-84.75	-19.75
28.74	-80.11	-52.06
-16.45	-26.41	-26.34
20.16	-77.49	-46.57
-1.11	-87.09	-21.72

// Soeda A, 2005: Traumatic Brain Injury (TBI)
// Subjects=5
-59.42	21.22	3.29
-50.5	8.02	22.37
44.58	12.82	22.52
57.77	14.53	40.06
49.03	9.41	31.75
40.78	-62.11	47.93
12.58	11.36	54.59

// Soeda A, 2005: Healthy Controls
// Subjects=11
4.01	5.36	59.81
3.76	25.39	44.38
-24.3	-92.69	22.93
-32.56	-59.2	60.1
38.5	-76.13	35.91
51.68	-50.4	57.79
38.58	-66.79	43.95
-46.36	48.24	16.08
-46.21	23.13	23.05
-50.38	13.31	33.05
55.11	-70.21	-16.51
61.59	-57.01	-13.44
40.67	2.74	52.72
53.05	42.21	14.99
44.35	57.07	13.66
-28.39	-3.47	58.99

// Thomas R J, 2005: Pre-treatment: n-back > baseline
// Thomas R J, 2005: Post-treatment: n-back > baseline
// Thomas R J, 2005: Pre-treatment > Post-treatment: n-back > baseline
// Subjects=3
52.68	-1.87	34.52
39.01	-61.25	38.54
37.41	51.91	15.68
34.57	-4.72	40.54
2.53	7.32	47.7
-1.58	-4.2	64.33
-18.58	-70.26	51.11
-37.29	10.77	13.3
-46.58	-46.33	32.69
-42.6	26.48	24.31
-42.6	26.48	24.31
-45.85	-67.36	-19.08
-59.65	-33.58	6.12
34.73	-67.88	35.8
13.14	7.75	38.62
-4.88	0.3	53.95
-16.49	-71.82	44.52
-29.37	-17.57	59.08
-47.92	6.9	19.32
-60.02	31.84	-14.97
-63.94	-38.09	3.21
-42.6	26.48	24.31
49.38	4.74	23.96
51.39	-11.93	0.8
42.28	-60.55	47.36
39.56	19.09	3.91
18.77	-14.57	66.08
-27.09	-58.97	60.29
-46.79	-40.82	7.7
-56.2	-43.13	33.65

// Lieberman M D, 2005: In-Group > Out-Group
// Lieberman M D, 2005: Out-Group > In-Group
// Lieberman M D, 2005: African-American > Caucasian-American
// Lieberman M D, 2005: Perceptual Encoding > Verbal Encoding (African 
// American Targets)
// Lieberman M D, 2005: Verbal Encoding > Perceptual Encoding 
// (African-American Targets)
// Subjects=20
46.79	-52.44	13.25
61.73	-31.95	2.01
41.55	17.22	-45.1
35.08	19.53	-42.97
-35.71	-16.31	-9.09
37.62	26.7	-12.35
20.21	27.93	-21.14
41.96	-23.46	-20.91
11.65	-23.98	-24.82
18.08	-10.13	-26.3
57.24	25.89	0.84

// Amedi A, 2005: Negative Correlation between Visual Imagery (VI) and Visual 
// Imagery Questionnaire (VVIQ)
// Amedi A, 2005: Positive Correlation between VI and VVIQ
// Subjects=9
-61.89	-8.3	2.92
-38.3	-20.5	8.13
-51.21	-10.43	1.86
-48.06	-8.81	-5.01
56.66	-1.67	-4.58
55.53	13.13	-5.81
-64.12	-3.71	-6.37
66.49	-34.51	10.33
63.36	-38.16	18.48
-54.16	-52.86	17.72
42.93	-37.36	3.03
-44.54	-52.81	17.6
-5.04	-74.92	3.39
4.64	-91.78	4.69
-25.48	-74.21	-13.16
-50.05	-68.81	-9.99
-49.03	-59.46	-13.02
54.54	-37.69	-16.03
-13.61	-58.68	7.7
-3.83	-72.31	23.23
-30.97	-28.6	-14.7
32.1	-29.02	-12.04
51.18	30.99	-8.37
-31.08	35.07	-3.31

// Mazard A, 2005: Imagery - Baseline
// Mazard A, 2005: Perception - Baseline
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), p<0.001
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), p<0.05
// Mazard A, 2005: Perception (Objects) - Perception (Non-Objects)
// Mazard A, 2005: Perception (Non-Objects) - Perception (Objects)
// Mazard A, 2005: Imagery (Objects) - Imagery (Non-Objects), Left vs Right 
// Lateralization
// Mazard A, 2005: Perception (Objects) - Perception (Non-Objects), Left vs 
// Right Lateralization
// Subjects=15
-48	-58	-10
50	-58	-16
-6	-84	2
-16	-76	10
36	-50	38
36	-54	48
32	-68	46
-44	-46	42
-28	-74	28
-24	-76	42
-30	-66	52
-32	-52	40
32	0	52
-32	0	52
-54	28	28
-46	24	24
46	32	20
8	14	50
14	30	26
-10	26	38
-6	14	48
40	26	-4
-36	20	-4
-34	22	6
0	-36	-14
-14	-10	2
-14	-2	-4
-8	-10	10
16	-8	10
6	-26	-4
-18	2	14
16	0	-4
24	-96	-2
-8	-86	-2
10	-94	4
30	-74	40
34	-78	28
22	-30	-2
-20	-32	-4
-56	-48	-14
50	-56	-12
-46	-72	-10
-34	-74	-12
-18	-98	-2
-26	-82	20
34	-58	-18
-24	-92	10
34	-54	50
-40	-48	42
-30	-68	56
-32	0	54
6	18	44
-4	14	48
-50	4	36
54	10	24
32	-6	46
34	2	54
-56	14	22
10	-12	8
-10	-18	10
-52	8	16
-52	36	20
-54	6	36
64	4	36
-60	-14	18
-60	-28	48
-66	-28	30
-44	-38	36
6	-76	8
-16	-30	6
-50	-54	-14
6	-80	0
14	-94	4
4	-90	4
-12	-98	0
-28	-72	-12
-32	-58	-20
-50	-54	-14
-58	-60	-8
38	-68	-18
18	-86	26
-44	-76	20
8	-44	60
-46	30	16
-50	6	20
22	-64	50
-56	-22	30
-46	-50	50
-38	-50	38
-52	8	24
-46	4	30
-48	36	22
-24	2	42
-48	-54	-14
-46	-72	-8
-42	-62	-10
-62	-56	2
-52	-46	48
-26	-64	48
-50	6	24
-40	18	28
30	30	26
-62	12	8
2	-88	2
-34	-80	26
-48	-54	-14
-26	-88	-10

// Cannon T D, 2005: Maintenance and Manipulation
// Cannon T D, 2005: Memory Set
// Subjects=11
1.66	-59.82	46.65
52.45	24.25	14.48
46.91	45.23	-2.82
49.43	-14.46	23.34
2.48	7.94	42.08
20.3	15.46	-0.02
-17.09	15.32	1.54
-32.1	24.58	-1.3
29.3	-5.13	49.56
-31.65	-4.78	45.77
-46.78	3.28	27.42
-3.71	-53.51	46.19
50.36	21.41	19.21
-43.68	31.85	24.99
2.46	11.03	40.7
19.33	-1.12	5.84
-17.01	-8.03	2.38
29.27	0.07	48
-21.89	-37.33	50.61

// Laurens K R, 2005: Schizophrenic Subjects
// Subjects=29
-52	8	-20
52	12	-12
-36	24	0
48	20	-8
-36	20	4
36	20	0
8	28	32
-8	-4	48
-56	-40	16
60	-44	4
-60	-44	24
64	-32	32
-56	16	20
44	12	24
40	4	40
24	0	-24
20	-12	-16
44	16	-20
36	28	-16
44	0	0
8	48	8
0	-36	24
44	-64	12
-32	-68	52
40	-60	48
-4	-64	48
16	-76	52
-56	-48	48
42	-56	48
44	16	44
-12	44	32
16	56	28
-56	16	36
-44	20	48
-52	20	24
-64	-44	12
-68	-36	0
56	-36	4
56	-12	-8

// Laurens K R, 2005: Control Subjects
// Subjects=28
-24	-4	-24
20	-8	-16
-28	-20	-12
32	-20	-12
-52	12	-16
56	8	-12
-36	20	-12
36	16	-4
-36	16	-12
40	8	-12
0	32	28
4	28	36
-4	4	36
0	-36	28
-64	-36	20
56	-40	4
-60	-48	24
64	-28	32
64	-48	-8
-36	-64	52
36	-60	48
-4	-60	48
8	-76	36
-36	-56	40
36	-60	44
-48	4	36
52	16	28
48	4	48
16	52	28
24	0	-24
20	-12	-16
44	16	-20
36	28	-16
44	0	0
8	48	8
0	-36	24
44	-64	12
-32	-68	52
40	-60	48
-4	-64	48
16	-76	52
-56	-48	48
42	-56	48
44	16	44
-12	44	32
16	56	28

// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity on Day 
// 1, Decreased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity on Day 
// 1, Increased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity with 
// Extended Practice, Decreased Intensity
// Parsons M W, 2005: Learning Related Changes in MR Signal Intensity with 
// Extended Practice, Increased Intensity
// Parsons M W, 2005: Increased MR Signal Intensity for Transfer Conditions
// Parsons M W, 2005: Increased MR Signal Intensity in the New Sequence
// Parsons M W, 2005: Increased MR Signal Intensity in the New Map
// Subjects=12
-5.88	6.52	65.71
-22.01	2.05	50.66
-52.12	8.79	30.36
-43	47.55	-19.83
-38.28	7.22	22.53
-52.23	18.59	19.51
-46.75	-29.39	17.89
-40.09	-27.83	51.14
-54.08	-21.29	40.72
-20.72	-64.81	52.91
-41.24	-38.64	35.33
41.17	-13.72	61.29
20.9	-12.35	66.99
55.78	4.69	22.78
29.3	0.42	52.44
60.17	-18.29	28
13.57	-49.32	71.29
39.03	-36.88	50.99
43.22	-79.43	23.29
25.58	-39.06	-31.2
0.01	34.17	9.79
-4.4	38.15	-7.22
1.48	-30.9	35.31
0.28	-82.8	-2.7
-25.66	42.47	9.39
-16.49	-72.88	44.61
-40.04	-47.13	49.41
-61.77	-11.41	17.67
-28.51	-88.89	3.71
-11.69	4.95	4.57
-4.23	-65.51	-26.41
-20.27	-59.17	-25.64
-13.98	-47.22	-36.75
24.63	30.34	13.18
24.07	-66.55	40.27
38.96	-37.56	42.13
12.88	10.55	6.05
13	-14.57	11.5
-51.92	-58.34	29.3
-9.07	-98.78	25.51
48.52	-57.82	26.99
-37.02	1.53	45.3
-3.87	12.91	51.77
-46.81	17.2	28.48
-6.12	16.1	38.15
-29.28	-62.75	52.83
-38.99	-45.09	48.12
-12.75	-66.36	-22.89
38.86	5.33	46.34
6.81	14.03	51.55
41.92	18.16	32.96
25.67	36.61	11.53
7.8	13.26	41.57
20.94	-61.39	52.14
44.38	-40.02	51.19
31.47	-83.82	22.67
34.82	-75.74	44.26
12.17	-85.76	13.02
15	13.65	4.65
-11.28	-5.03	54.47
-22.98	-12.24	58.56
-32.06	48.07	13.46
-23.21	-93.77	-4.86
-38.15	-87	1.44
-14.85	-15.5	1.86
-8.46	10.77	10.74
21.87	0.89	59.17
54.65	12.8	17.65
13.19	-12.6	36.98
29.14	-88.09	-4.82
40.87	-70.67	-.84
53.81	-77.05	11.81
9.81	-19.96	10.88
40.62	-51.32	-25.88
24.45	-29.81	-35.3
-27.27	-75.11	30.42

// Piefke M, 2005: Increased Brain Activity Common to All Memory Conditions 
// Across Males and Females
// Piefke M, 2005: Males > Females, All Conditions
// Piefke M, 2005: Males > Females, CP + CN
// Piefke M, 2005: Males > Females, RP + RN
// Piefke M, 2005: Males > Females, RP + CP
// Piefke M, 2005: Males > Females, RN + CN
// Piefke M, 2005: Females > Males, All Conditions
// Piefke M, 2005: Females > Males, CP + CN
// Piefke M, 2005: Females > Males, RP + RN
// Piefke M, 2005: Females > Males, RP + CP
// Piefke M, 2005: Females > Males, RN + CN
// Subjects=10
-10	62	28
-50	32	-10
40	18	20
-46	22	20
-42	6	52
-2	12	56
54	16	-32
-52	14	-34
60	0	-24
-56	2	-24
-24	-20	-18
-30	-54	48
-6	-56	4
36	-64	-24
-28	-66	-18
46	-82	2
-42	-78	4
14	-82	-42
-12	-38	-14
-14	-36	-16
-14	-38	-14
-12	-38	-16
-14	-38	-14
48	44	8
44	2	4
48	44	8
44	2	4
48	42	6
46	44	10
48	44	8
44	2	4

// Ragland J D, 2005: Schizophrenics
// Subjects=14
-45.75	13.86	26.52
-37.36	-36.04	-14
-54.14	-54.89	19
22.73	-37.51	16.66
5.4	-66.42	-25.32
-7.32	-30.26	3.02
-32.98	-43.79	-4.48
-32.92	-60.71	-3.06
-2.7	-66.25	32.74
-33.14	6.25	-4.21
5.63	19.42	38.85
-32.76	-85.4	7.93
18.28	-17.42	1.64
-28.25	-56.57	50.07
31.55	-91.76	30.03
-20.21	-22.22	-1.97
39.76	-64.5	-3.58
-37.38	16.43	3.91
-62.98	12.39	9
22.79	-89.64	3.19
-7.27	-7.74	18.97
43.8	34.17	5.95
17.94	53.8	-13.25
-24.31	-86.38	-5.47
5.78	-31.67	38.67
5.6	45.49	45.58
31.06	48.16	22.76
57.12	-44.06	39.12
-49.86	-2.06	41.29
-2.91	15.14	39.3
5.68	15.54	43.63
-28.52	-85.72	3.45
-28.25	-56.57	50.07
39.73	-64.85	-8.01
-50.06	13.49	22.14
-7.35	-13	6.03
9.7	-9.01	1.04
39.54	21.12	2.63
-49.85	-23.89	34.19
56.89	10.59	30.08
48.53	-22.62	41.88
18.52	-89.67	3.24
-7.44	12.38	3.9
9.89	41.28	45.89
26.68	60.14	12.89
-24.8	53.54	-12.73
40.06	-61.42	36.31
5.73	-36.59	30.16
43.8	34.17	5.95
52.87	-48.31	39.52
-3.12	-9.09	1.19
-45.59	-2.03	41.23
-28.47	-89.61	8.23
27.2	-88.24	20.86
-36.92	3.62	58.5
35.87	-47.39	53.02
-49.78	-23.21	43.06
-11.13	0.91	76.28
-23.96	-43.17	57.82
-7.28	-3.51	18.61
1.53	-84.17	20.82
-15.58	-88.84	16.94
-32.78	-89.97	3.85
18.52	-89.67	3.24
-54.05	-14.43	46.83
31.5	-87.88	25.24
-32.61	-79.46	29.74
-49.96	5.72	31.71
65.16	20.93	-2.11
-23.93	-60.43	54.8
-15.72	-59.58	10.03
-33.17	-67.68	-38.16
48.21	35.57	23.62
18.62	-88.64	16.53
-28.23	-16.79	69.04
-62.91	-4.53	10.42
14.47	-30.25	56.29

// Ragland J D, 2005: Normals
// Subjects=14
-41.88	31.61	-19.62
-20.48	49.68	-8
-41.59	17.09	12.82
-7.32	-30.26	3.02
-32.98	-43.79	-4.48
-32.92	-60.71	-3.06
48.37	19.68	38.33
52.53	31.71	28.36
5.63	-90.43	-5.47
-33.14	6.25	-4.21
18.53	-93.9	3.59
14.01	-8.64	5.42
-24.02	-52.66	45.23
-11.62	-13.03	6.08
60.93	17.02	2.73
-49.97	9.95	31.36
31.53	-56.9	40.49
-50.14	25.84	16.65
10.02	16.25	52.45
1	-23.81	-24.39
22.79	-89.64	3.19
-7.27	-7.74	18.97
43.8	34.17	5.95
17.94	53.8	-13.25
-24.31	-86.38	-5.47
5.78	-31.67	38.67
5.6	45.49	45.58
31.06	48.16	22.76
57.12	-44.06	39.12
-49.86	-2.06	41.29
-2.91	15.14	39.3
18.52	-89.67	3.24
-46.09	49.87	-3.26
-24.01	-56.89	45.59
-7.43	-18.26	-6.91
56.87	14.82	29.72
5.74	16.22	52.5
-28.91	20.02	-5.41
-11.72	3.55	0.23
18.52	-89.67	3.24
-7.44	12.38	3.9
9.89	41.28	45.89
26.68	60.14	12.89
-24.8	53.54	-12.73
40.06	-61.42	36.31
5.73	-36.59	30.16
43.8	34.17	5.95
52.87	-48.31	39.52
-3.12	-9.09	1.19
-45.59	-2.03	41.23
-37.12	-81.88	-1.24
5.66	19.77	43.28
-41.44	5.43	27.18
-50.45	53.39	-12.43
-20.19	-26.45	-1.62
-28.33	-44.23	44.57
14.02	-12.87	5.77
52.48	26.79	19.85
31.57	-60.79	45.28
39.51	20.77	-1.8
31.49	8.6	61.76
-28.9	24.59	-1.34
35.24	-36.29	-23.73
52.69	7.02	39.35
-6.9	13.63	75.16
-7.28	-3.51	18.61
1.53	-84.17	20.82
-15.58	-88.84	16.94
39.87	-85.31	2.63
52.52	27.14	24.28
-11.61	-8.45	10.16
-54.39	30.38	20.77
-2.61	9.43	75.47
-32.47	-51.68	58.63
-33.17	-67.68	-38.16
48.21	35.57	23.62
18.62	-88.64	16.53
-28.23	-16.79	69.04
-62.91	-4.53	10.42
14.47	-30.25	56.29

// Tan H Y, 2005: Comparisons > Schizophrenics, Maintenance of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Maintenance of Letters
// Tan H Y, 2005: Comparisons > Schizophrenics, Manipulation Plus Maintenance 
// of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Manipulation Plus Maintenance 
// of Letters
// Tan H Y, 2005: Comparisons > Schizophrenics, Manipulation Plus Maintenance 
// > Maintenance of Letters
// Tan H Y, 2005: Schizophrenics > Comparisons, Manipulation Plus Maintenance 
// > Maintenance of Letters
// Subjects=11
-43.54	13.5	35.45
49.39	14.77	29.81
-14.74	-17.65	15.42
-57.56	14.33	19.93
58.9	16.97	16.14
-48.71	1.01	53.28
35.35	15.35	10.97
-46.43	-50.25	50.86
-48.57	-50.26	50.89
-43.69	39.42	26.58
44.93	40.32	16.57
-9.23	17.1	51.48
9.96	22.25	47.48
35.2	30.27	-2.55
-26.79	24.26	-5.79
-56.4	7.54	28.29
61.06	17.24	19.43
-0.04	63.23	14.05
-53.96	-42.01	48.03
57.22	-40.91	52.24
-44.74	38.53	28.9
-7.06	14.12	53.94
-56.4	7.54	28.29
-57.2	-39.11	44.48

// Tieleman A, 2005: Semantic Self-Paced vs. Perceptual Self-Paced
// Tieleman A, 2005: Semantic Fixed-Paced vs. Perceptual Fixed-Paced
// Tieleman A, 2005: Self-Paced > Fixed-Paced, Semantic vs. Perceptual
// Tieleman A, 2005: Greater Task-Related Deactivation During Fixed-Paced 
// Compared to Self-Paced, Semantic
// Subjects=22
-52.95	29.96	4.56
-38.24	33.49	-27.42
-54.92	22.58	17.65
-46.2	21.01	23.26
-.49	25.89	50.01
3.82	41.11	51.79
-.5	41.09	51.87
-.65	30.17	38.38
37.49	31.18	-21.76
35.26	36.18	-25.58
-51.05	9.39	-20.33
-37.74	24.05	9.37
-52.83	10.06	9.89
-52.78	-42.13	2.72
46.1	15.7	-27.1
-27.21	-17.32	-20.34
-24.96	-25.41	-15.09
-27.16	-32.31	-19.98
-18.58	-14.1	-20.8
-37.9	-47.14	-17.21
20.38	-14.61	-16.93
-9.26	-92.2	15.9
-12.08	93.27	2.08
-7.23	-81.12	8.05
-37.91	-47.24	-18.32
-2.77	-71.35	20.45
14.47	-90.2	13.06
14.55	-89.57	19.72
16.59	-67.54	14.14
-7.27	-61.76	8.37
-48.46	21.34	15.42
-40.22	24.94	-15.33
-54.9	23.86	19.76
-50.24	5.64	42.78
-.37	21.3	58.31
5.86	27.11	39.7
-6.99	23.53	48.11
38.26	30.41	38.82
50.56	24.41	-14.59
-48.91	18.01	-20.1
-39.9	15.32	8.02
-57.13	-36.83	2.27
-11.48	-94.85	10.6
-22.47	-92.95	-2.85
-20.29	-93.9	-1.67
-42.16	-52.16	-13.27
5.38	-51.99	-14.1
14.61	-92.45	23.36
9.64	-80.88	-24.76
37.6	-58.75	-30.79
-24.94	-27.43	-13.77
-20.77	-17.61	-23.78
-33.71	-21.91	-23.13
-50.21	-68.56	29.95
-42.51	10.82	-28.46
20.42	-14.3	-13.6
-.48	-75.82	29.82
-16	-47.11	4.83
14.43	-86.15	10.42
22.99	-57.19	9.65
-25.09	-28.57	-25.98
22.51	-21.4	-20.78
-56.74	-62.4	27.21
-52.36	-69.63	30.09
-50.23	-69.83	27.83
-20.06	40.19	43.33
-9.18	-69.68	27.12
18.9	-65.33	26.21
-9.29	-61.8	19.62
18.58	-51.24	4.65

// Lacourse M G, 2005: Novel, Move vs. Rest
// Lacourse M G, 2005: Novel, Image vs. Rest
// Lacourse M G, 2005: Skilled, Move vs. Rest
// Lacourse M G, 2005: Skilled, Image vs. Rest
// Lacourse M G, 2005: Novel, Image > Move
// Lacourse M G, 2005: Novel, Move > Image
// Lacourse M G, 2005: Skilled, Image > Move
// Lacourse M G, 2005: Skilled, Move > Image
// Lacourse M G, 2005: Novel > Skilled, Move
// Lacourse M G, 2005: Novel > Skilled, Image
// Subjects=54
-26	-4	58
-32	-18	48
40	32	26
34	-18	54
6	2	56
-6	-6	52
-42	-32	44
-24	-56	58
-36	-40	50
48	-34	44
20	-58	58
40	-44	52
-22	-56	-28
20	-56	-28
4	-62	-20
-32	-20	-6
-14	-20	8
10	-16	-8
-22	-4	58
-36	-20	52
34	24	-2
28	-8	52
4	0	58
2	-8	50
-50	-24	32
-42	-30	42
34	-50	42
-6	-50	-18
18	-56	-22
2	-62	-18
20	0	14
-24	-4	12
-14	-20	8
14	-20	8
-56	8	22
-26	-12	52
54	10	12
28	-10	54
2	-2	62
-10	-26	44
-38	-28	46
-32	-48	52
38	-54	48
-20	-56	-24
20	-56	-26
4	-62	-16
22	-8	22
-28	-2	-8
30	-4	8
-16	-22	6
18	-14	10
-46	12	6
-36	-20	52
38	36	20
32	-14	50
0	2	58
8	18	40
-52	-4	40
-18	-66	54
-42	-46	48
48	-38	40
-34	-52	-32
24	-64	-24
-2	-50	-10
20	-4	16
-28	-14	-2
-16	-10	8
-10	18	4
18	18	4
-38	12	12
-34	-24	54
-4	-18	46
-10	-14	58
6	0	44
6	-8	50
10	-10	58
-32	-38	48
-50	-26	30
50	-26	32
30	-26	44
-48	-22	12
6	-62	-20
-16	-22	2
10	-16	-10
-20	18	48
-52	22	22
-36	16	42
-50	-40	32
-48	-56	18
-32	-24	56
-6	-8	48
-8	-26	46
-46	-28	26
-12	-60	22
-42	0	14
52	-24	18
44	-14	0
-44	-12	2
54	-36	22
12	-36	14
-16	-22	4
2	-62	-16
-26	4	50
-42	8	42
-2	12	50
-40	32	22
-32	30	-8
32	-12	42
46	8	30
32	36	12
46	24	-6
-44	-34	32
10	-60	50
18	-32	34
32	-46	48
-44	-62	-6
16	-10	-2
-8	-24	0
-22	0	56
-4	8	52
26	-8	54
38	14	4
-34	-48	44
40	-40	44
54	-24	18
22	-36	4

// Ongur D, 2005: Recognition of Previously Seen Pairs
// Subjects=15
42	-24	-16
-46	-24	-18
8	46	-2
-18	28	-2
-8	44	-10
22	6	18
42	18	-40
-36	2	-6
42	-56	-2
56	-58	10
26	-52	14
4	22	30
30	26	36
-44	30	6
20	-46	26
8	-22	28
-6	-26	10

// Britton J C, 2006: Nonsocial (Positive + Negative) > Nonsocial Neutral
// Britton J C, 2006: Nonsocial Positive (Appetite) > Nonsocial Neutral
// Britton J C, 2006: Nonsocial Negative (Disgust) > Nonsocial Neutral
// Britton J C, 2006: Social (Positive + Negative) > Social Neutral
// Britton J C, 2006: Social Positive (Joy) > Social Neutral
// Britton J C, 2006: Social Negative (Sadness) > Social Neutral
// Britton J C, 2006: Social > Nonsocial, Emotion (Positive + Negative)
// Britton J C, 2006: Social > Nonsocial, Positive
// Britton J C, 2006: Social > Nonsocial, Negative
// Britton J C, 2006: Nonsocial > Social, Emotion (Positive + Negative)
// Britton J C, 2006: Nonsocial > Social, Positive
// Britton J C, 2006: Nonsocial > Social, Negative
// Britton J C, 2006: Positive > Neutral
// Britton J C, 2006: Negative > Neutral
// Subjects=12
18	-75	-15
18	-99	6
-36	-24	0
24	-9	15
24	-75	-18
-3	-81	-6
-36	-24	0
33	-15	6
-12	21	33
-9	-9	12
21	-99	3
33	-15	15
-18	-9	-21
-33	-87	-18
39	-87	-18
-48	-12	-12
45	-27	-9
15	-24	45
3	-3	3
-21	9	-15
21	-9	-6
33	-15	-18
-33	-12	-21
36	-90	-15
-33	-87	-15
42	6	-21
15	60	-12
15	-18	42
-9	6	0
0	-3	3
30	-6	-15
33	-18	-21
6	12	3
-48	-12	-9
9	18	33
15	-24	45
3	-3	3
-15	3	-12
39	-12	-27
57	-21	-15
15	-27	36
18	-12	-18
-9	3	-6
36	-87	-15
51	-57	-3
12	-24	36
30	-3	-15
-6	6	-6
24	-21	-24
-9	-81	-9
-9	30	21
-9	-18	36
15	-9	-18
-9	3	-6
18	-21	-21
-6	15	51
6	33	42
-36	-24	0
54	-18	12
15	-75	-15
15	-75	-15
-9	-90	-9
-18	-63	-9
-39	-9	12
54	-15	15
18	-102	-9
15	-99	6
-15	-66	-9
33	18	0
18	-93	9
-48	-3	-18
21	-24	48
3	-6	6
33	-6	15
-18	-84	9
6	-3	0
-21	-6	-21
-15	3	-12

// Cunnington R, 2006: Observation > Self-Selection Movements
// Cunnington R, 2006: Self-Selection > Observation Movements
// Cunnington R, 2006: Self-Selection and Observation Movements
// Subjects=14
58	-26	30
-52	-24	18
34	-50	56
-36	-34	66
48	-4	46
-46	-70	0
54	-72	6
34	-76	32
-14	-98	-2
26	-98	-4
38	32	30
-36	34	30
-20	60	6
44	20	52
-34	40	46
-4	26	54
-2	-22	20
-6	8	16
20	6	8
0	6	50
64	12	28
-44	6	30
-26	-4	52
14	-96	6
32	-68	44
-26	-70	54

// Hlushchuk Y, 2006: Normals, Group 1
// Subjects=10
54.96	-19.06	45.97
53.72	-26.33	20.94
-50.77	-21.3	54.06
-44.64	-20.83	18.27
-63.89	7.19	27.29
-8.85	-62.48	-14.34
-31.01	-46.55	-26.57
-21.9	-75.88	33.77
40.08	-18.3	57.23
20.98	-59.91	57.59
27.41	-49.84	63.36

// Hlushchuk Y, 2006: Normals, Group 2
// Subjects=10
43.3	-19.25	58.39
-44.33	-19.86	58.33
26.25	-23.32	62.27
-28.29	-20.73	59.33

// Soros P, 2006: Vowel Sound vs. Rest
// Soros P, 2006: Vowel Sound vs. Oral Movement
// Soros P, 2006: Consonant-Vowel Sound vs. Vowel Sound
// Soros P, 2006: Consonant-Vowel-Consonant-Vowel Sound vs. Consonant-Vowel 
// Sound
// Soros P, 2006: Consonant-Vowel-Consonant-Vowel Sound vs. Vowel Sound
// Subjects=9
-2	6	60
6	-2	66
-8	12	34
4	12	34
-2	0	34
4	8	34
60	-4	42
48	-12	44
-44	-6	0
44	2	-6
-24	6	-4
22	-2	2
-22	-6	-2
20	0	0
-12	-14	8
12	14	6
-10	-20	6
10	-20	8
-50	-18	-2
44	4	-14
-38	-26	10
-58	4	-10
-18	-66	-28
-12	-68	-22
-14	-68	-24
14	-68	-24
-8	-18	-6
8	-18	-6
-2	52	26
-4	62	14
2	54	8
-36	-30	14
48	-32	16
-46	-28	10
38	-30	12
-60	-34	4
70	24	0
28	-10	12
-52	-16	6
-50	28	-12
-38	-24	4
36	-24	14
-18	-26	20
-18	-20	24
-38	-24	8
36	-26	10
-64	-18	-8
64	-6	-8
-58	-8	-18
-22	-64	-28
22	-62	-28
-16	-64	-22
12	-72	-22
-18	-66	-24
16	-68	-24
-28	-62	-34
26	-62	-32
-22	-62	-26
26	-62	-26
-18	-56	-24
18	-62	-24

// Drobyshevsky A, 2006: Verb Generation
// Drobyshevsky A, 2006: Working Memory
// Drobyshevsky A, 2006: Emotional Pictures
// Subjects=31
53.48	17.31	7.25
57.9	-33.93	4.8
1.55	7.19	59.99
-41.14	-49.67	44.06
48.68	-43.08	52.52
-43.49	7.41	39.3
55.92	2.89	40.77
-48.02	14.68	9.75
51.35	16.24	7.36
-32.7	1.99	50.79
37.85	4.87	54.19
-29.98	57.34	9.31
37.3	62.86	5.85
2.56	10.92	52.98
-23.97	-62	48.25
22.01	-66.84	50.35
-37.94	-53	42.08
43.29	-50.14	44.25
-20.29	-32.94	-16.69
26.75	-34.69	-15.96
-35.22	-44.83	-17.75
37.43	-47.82	-21.68
-10.49	-83.72	-13.65
17.34	-83.13	-8.45
-44.65	-70.38	-3.23
51.5	-64.6	-5.93
-44.55	4.23	39.58
53.75	9.05	38.05
-43.78	19.82	7.04
50.24	29.01	7.42
-7.56	62.85	9.71
15.99	63.33	13.86

// Mechelli A, 2006: Naming > Fixation
// Mechelli A, 2006: Positive Linear Effect of Relevance, Artifacts
// Mechelli A, 2006: Positive Linear Effect of Relevance, Artifacts > Animals
// Mechelli A, 2006: Artifacts > Animals, Relevance Unmatched, Low, Medium, 
// and High
// Mechelli A, 2006: Artifacts > Animals, Relevance Matched, Low and Medium
// Mechelli A, 2006: Artifacts > Animals, Relevance Matched, Medium
// Subjects=12
-50	-8	46
50	-10	38
-54	-2	18
54	-4	24
-2	12	46
2	12	46
-54	-46	10
66	-34	8
-56	12	-8
-28	-96	2
18	-98	-4
-40	-62	-20
46	-62	-18
-44	-52	-18
44	-50	-20
-28	-74	26
30	-74	26
-28	-60	44
28	-68	44
-14	-26	-16
-40	-48	-28
38	-56	-32
-28	-52	-14
32	-50	-16
-29	-92	4
34	-82	10
6	-88	-16
18	-84	-24
-28	-52	-14
32	-50	-16
-28	-52	-14
-26	-36	-24
32	-50	-16
28	-42	-22
-28	-52	-16
30	-48	-18
28	-44	-22
-28	-52	-14
32	-50	-16
28	-42	-22

// Pierno A C, 2006: Action vs. No Action
// Pierno A C, 2006: Interaction Between Type of Observed Behaviour and 
// Distractor
// Subjects=14
-40	-12	62
-48	-10	36
42	-8	34
56	28	28
-54	-44	12
54	-32	8
-28	-44	64
26	-42	58
-48	-36	26
50	-27	26
-50	-74	6
48	-74	8
28	-82	30
-49	34	11
-47	7	25
54	-6	52
58	-7	27

// Saccuman M C, 2006: Verbs vs. Nouns
// Saccuman M C, 2006: Nouns vs. Verbs
// Saccuman M C, 2006: Manipulable vs. Non-Manipulable Items
// Saccuman M C, 2006: Non-Manipulable vs. Manipulable Items
// Saccuman M C, 2006: Interaction Between Word Class and Semantic Reference
// Saccuman M C, 2006: Manipulable Verbs vs. Manipulable Nouns
// Saccuman M C, 2006: Manipulable Nouns vs. Manipulable Verbs
// Saccuman M C, 2006: Non-Manipulable Verbs vs. Non-Manipulable Nouns
// Saccuman M C, 2006: Non-Manipulable Nouns vs. Non-Manipulable Verbs
// Saccuman M C, 2006: Manipulable Verbs vs. Non-Manipulable Verbs
// Saccuman M C, 2006: Non-Manipulable Verbs vs. Manipulable Verbs
// Saccuman M C, 2006: Manipulable Nouns vs. Non-Manipulable Nouns
// Saccuman M C, 2006: Non-Manipulable Nouns vs. Manipulable Nouns
// Saccuman M C, 2006: Positive Correlations with Increase in Response Time
// Subjects=13
-44	-46	44
-12	-78	-40
50	-54	-20
14	-80	16
10	-40	24
22	10	0
-56	-4	32
-56	6	24
-32	-58	60
-42	-40	56
-42	-38	36
-56	-16	28
-48	-54	-24
-44	-70	-16
40	-44	56
64	-24	0
60	-22	20
0	-38	16
-56	-4	32
-56	6	24
-32	-58	60
-42	-40	56
-42	-38	36
-56	-16	28
-48	-54	-24
-44	-70	-16
40	-44	56
64	-24	0
60	-22	20
0	-38	16
-32	-42	-24
-16	-64	4
-40	-86	20
24	-64	-24
20	-62	12
34	-90	12
10	-54	-8
-36	-22	44
-52	-68	0
-22	-90	-16
-26	-92	-4
-28	-86	4
-32	-74	-40
-12	-62	32
10	-64	32
6	-54	28
38	6	32
40	-10	44
50	-48	0
54	-68	8
34	-92	0
34	-86	8
26	-50	-24
24	-78	-20
28	-66	-35
-42	-44	44
-28	-88	4
-12	-78	-40
50	-54	-20
12	-82	20
10	-38	20
22	10	-4
-38	-54	44
56	-70	4
12	-80	20
22	4	-12
-32	-56	56
-42	-40	36
-32	-42	40
-44	-70	16
36	-44	56
-22	-56	-8
-16	-64	4
-14	-62	32
50	-44	0
14	-52	48
8	-66	36
52	-72	4
18	62	12
-28	-4	36
-26	-54	60
-52	-40	40
-30	-62	20
-62	-34	0
-50	-66	-4
-10	-70	32
54	-6	20
42	-22	36
50	-24	-8
4	-56	20
4	-36	20
-16	-60	4
-12	-40	-20
-30	-50	-24
-38	-80	8
36	-88	12
26	-80	-20
-44	20	-4
-42	-80	-4
-38	-82	-20
48	-70	-20

// de Diego Balaguer R, 2006: Regular Inflection > Regular Repetition
// de Diego Balaguer R, 2006: Irregular Inflection > Irregular Repetition
// de Diego Balaguer R, 2006: Nonce Inflection > Nonce Repetition
// de Diego Balaguer R, 2006: Irregular Inflection > Regular Inflection
// de Diego Balaguer R, 2006: Regular Inflection > Irregular Inflection
// de Diego Balaguer R, 2006: Regular Inflection > Nonce Inflection
// de Diego Balaguer R, 2006: Nonce Inflection > Regular Inflection
// de Diego Balaguer R, 2006: Irregular Inflection > Nonce Inflection
// de Diego Balaguer R, 2006: Nonce Inflection > Irregular Inflection
// Subjects=12
32	-48	0
36	-24	60
-48	8	0
-16	-52	-36
-48	36	12
-36	20	16
-24	-56	-44
20	-24	68
-48	16	12
-12	-52	-32
28	-24	56
-40	24	12
-56	24	16
-44	24	20
40	16	24
48	40	16
-28	-12	-20
-44	8	-4
-4	-36	44
-48	-24	12
-28	-28	-28
8	-56	8
48	-48	12
60	-48	4
0	44	-4
-48	16	24
-52	36	8
-48	48	4
-28	-68	32
-28	-60	-44
48	16	20
44	48	12
44	-36	52
-4	-36	44
-40	-24	8
8	-60	12
60	-48	8
64	32	8
28	-36	-32
0	60	-4
-48	12	8
-48	48	4
-36	-64	52
-40	-64	-40
48	16	20
40	-40	40

// Riecker A, 2006: Syllable Repetition vs. Passive Listening
// Subjects=8
3	6	63
-42	-15	36
36	-15	39
-12	-18	0
12	-21	6
-24	-3	3
27	-6	0
-12	18	9
-39	12	6
-24	-63	-21
21	-54	-24
-21	-67	-54
24	-60	-57

// Johnson M R, 2006: Controls
// Subjects=18
-47.31	14.21	19.47
1.67	18.25	48.49
18.28	-60.74	63.86
-18.3	2.22	4.47
-27.23	-66.29	52.86
54.82	21.78	-20
-38.08	59.82	-9.86
-65.84	-13.36	1.22
-18.52	0.56	-13.29
42.95	60.1	-11.26
36.69	53.03	5.23
43.52	11.86	23.76
-47.31	14.21	19.47
42.99	60.41	-7.93
-31.6	59.84	-9.97
-27.15	-74.49	57.03
54.78	21.47	-23.33
-18.3	2.22	4.47
-50.84	32.85	0.87
-40.62	10.37	35.42
-37.74	-46	-4.99
-62.52	13.53	13.07
23.55	-7.46	-21.06
49.7	44.67	6.96
-14.84	-79.33	4.64
-62.12	-11.94	39.11
-61.93	-29.09	50.89
46.65	-34.88	5.91
-40.11	-49.35	62.61
-41.01	28.19	7.89
-37.36	-12.48	32.02
7.51	-28.17	-12.01
-2.62	53.07	-26.6
58	45.39	-20.15
-47.35	13.9	16.14
-15.19	65.81	7.09
-2.61	52	-26.5
42.74	58.54	-27.92
-2.01	-15.7	7.09
20.31	-9.6	-20.79
-31.2	-42.26	0.13
-31.2	-42.26	0.13
20.31	-9.6	-20.79
-37.85	17.79	-.1
36.76	21.77	3.84
-58.64	-30.89	54.38
37.41	-52.11	40.27
-62.06	-10.36	44.56
-21.99	-2.28	-32
33.57	-32.57	-3.06
64.98	1.01	9.9
-31.1	1.19	17.12
20.89	8.9	27.8
-52.38	7.96	44.82
36.69	53.03	5.23
1.72	18.56	51.82
-27.29	-53.64	50.49
52.67	18.58	-19.65
-18.3	2.22	4.47
40.25	11.64	21.59
-18.49	-2.53	-11.86
55.64	14.73	42.31
-44.06	11.03	19.73
-30.46	-69.5	53.23
1.72	18.56	51.82
36.53	55.07	-7.3
-18.29	0.09	4.68
54.82	21.78	-20
40.25	11.64	21.59
-21.78	-.72	-15.35
55.64	14.73	42.31
33.04	-3.67	-38.4
-59.44	-53.28	-12.87
2.02	-74.39	56.53
-41.32	59.81	-9.8
-47.3	11.02	19.78
1.66	21.44	48.17
-34.8	60.14	-6.58
36.53	28.82	-12.54
-18.26	3.6	7.7
54.82	21.78	-20
-7.75	-74.73	53.37
39.75	60.4	-7.88
-47.31	14.21	19.47
-33.63	-67.92	58.74
1.66	21.44	48.17
36.47	60.08	-11.15
-34.87	56.33	-12.93
54.75	21.26	-25.55
-65.91	-8.35	-2.64
-18.26	3.6	7.7

// Johnson M R, 2006: Schizophrenics
// Subjects=18
-47.31	14.21	19.47
1.67	18.25	48.49
18.28	-60.74	63.86
-18.3	2.22	4.47
-27.23	-66.29	52.86
54.82	21.78	-20
-38.08	59.82	-9.86
-65.84	-13.36	1.22
-18.52	0.56	-13.29
42.95	60.1	-11.26
36.69	53.03	5.23
43.52	11.86	23.76
-47.31	14.21	19.47
42.99	60.41	-7.93
-31.6	59.84	-9.97
-27.15	-74.49	57.03
54.78	21.47	-23.33
-18.3	2.22	4.47
-50.84	32.85	0.87
-40.62	10.37	35.42
-37.74	-46	-4.99
-62.52	13.53	13.07
23.55	-7.46	-21.06
49.7	44.67	6.96
-14.84	-79.33	4.64
-62.12	-11.94	39.11
-61.93	-29.09	50.89
46.65	-34.88	5.91
-40.11	-49.35	62.61
-41.01	28.19	7.89
-37.36	-12.48	32.02
7.51	-28.17	-12.01
-2.62	53.07	-26.6
58	45.39	-20.15
-47.35	13.9	16.14
-15.19	65.81	7.09
-2.61	52	-26.5
42.74	58.54	-27.92
-2.01	-15.7	7.09
20.31	-9.6	-20.79
-31.2	-42.26	0.13
-31.2	-42.26	0.13
20.31	-9.6	-20.79
-37.85	17.79	-.1
36.76	21.77	3.84
-58.64	-30.89	54.38
37.41	-52.11	40.27
-62.06	-10.36	44.56
-21.99	-2.28	-32
33.57	-32.57	-3.06
64.98	1.01	9.9
-31.1	1.19	17.12
20.89	8.9	27.8
-50.02	-44.14	49.94
-8.09	17.9	45.33
-27.45	25.04	53.91
-47.19	5.26	27.07
37.53	-60	47.78
10.44	-15.14	-33.52
-40.27	-5.64	59.41
-31.32	24.72	4.71
-55.57	-1.52	46.94
-34.59	31.09	4.13
58.97	-32.68	40.23
-46.8	-47.63	46.87
33.33	35.71	-7.57
54.98	-38.3	-19.66
-31.32	24.72	4.71
-47.18	2.07	27.39
34.27	-56.82	47.52
-50.02	-44.14	49.94

// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, First Run
// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, Second Run
// Mochizuki-Kawai H, 2006: Mirror vs. Normal Reading, Third Run
// Subjects=15
34.17	8.04	52.31
56.46	11.69	21.31
48.71	-71.74	-9.52
34.19	-56.38	40.75
3.17	-76.44	-22.85
-2.73	20.9	42.7
-28.4	-60.44	46.7
-39.46	-67.87	25.21
53.13	19.78	16.08
29.7	5.82	40.28
50.85	-64.28	-10.3
35.81	-84.44	-6.93
32.11	-51.4	48.14
-7.04	18.76	42.98
-44.04	6.77	20.15
-28.39	-62.56	46.91
-41.93	-84.4	-2.24
46.58	11.58	9.16
48.62	26.06	3.21
44.38	-68.56	-9.76
23.52	-61.96	50.45
-28.63	3.48	41.5
-37.51	7.21	24.47
-44.11	-80.16	-2.63
-43.7	-34.42	38.78
-32.92	-76.15	28.16

// Shapiro K A, 2006: Nouns > Verbs
// Shapiro K A, 2006: Verbs > Nouns
// Subjects=10
-36	-42	-16
-22	59	23
24	-17	-19
-46	6	40
-32	-57	64
-57	-40	9
38	-48	48

// Hirshorn E A, 2006: Switch - Free Generation
// Hirshorn E A, 2006: Switch - Free Generation (Clustered Responses)
// Hirshorn E A, 2006: Free Generation - Switch
// Hirshorn E A, 2006: Free Generation (Clustered Responses) - Switch
// Subjects=10
-42	3	66
-18	48	-6
-39	24	18
-3	-57	63
-57	-57	54
-3	-66	60
-3	-72	0
48	24	54
48	24	42
48	42	30
3	51	-15
39	57	3
36	42	-9
12	-27	-27
42	-51	45
-12	21	63
-30	54	18
-51	45	9
-54	21	39
-33	18	51
-39	-3	51
15	54	-3
-33	27	6
-39	-24	33
-33	-63	21
-18	-21	15
-39	-39	36
-39	-66	39
-12	-66	51
39	45	39
36	51	15
15	33	48
66	-33	21
51	-30	-18
36	-54	42
48	-60	-33
-18	57	18
-6	57	0
-3	36	-3
-3	30	21
-39	-27	30
-57	-24	42
-57	-24	15
-45	0	-3
-63	-27	30
-36	-78	9
45	24	15
3	-15	12
54	-18	42
69	-15	12
48	-27	6
24	-102	9
-3	60	-12
-63	0	-12
-24	-36	18
-21	-24	-9
-27	-27	-18
-30	-42	-24
-36	-51	-15
-24	-54	-12
-15	-63	0
-6	-75	-9
-9	-90	3
-24	-90	27
27	-27	75
3	-33	30
18	-42	27
48	-21	63
45	-12	21
54	-3	-33
63	-3	9
30	-9	-30
30	-15	-12
30	-30	-15
39	-66	-12
12	-78	30
9	-96	3

// Tremblay P, 2006: Word Reading vs. Fixation
// Tremblay P, 2006: Word Generation, Subcategory vs. Fixation
// Tremblay P, 2006: Word Generation, Category vs. Fixation
// Subjects=12
-52	-8	25
-46	-17	39
47	-10	35
-1	-2	58
-55	-7	24
-48	-16	41
46	-11	35
-45	4	35
-2	-1	58
-2	4	57
-46	33	10
-56	-7	23
-47	-17	40
44	-13	35
-42	3	27
-2	-1	58
-2	4	57
-51	32	9

// Camchong J, 2006: Schizophrenic Patients
// Subjects=14
49.47	12.28	38.94
-48.84	11.7	40.12
29.28	5.7	51.99
-10.23	-78.87	21.62
17.77	-62.13	56.7
-9.95	-59.49	65.72

// Camchong J, 2006: Normals
// Subjects=14
0.4	10.73	50.79
49.47	12.28	38.94
-48.84	11.7	40.12
29.28	5.7	51.99
-26.3	5.2	50.44
-10.23	-78.87	21.62
17.77	-62.13	56.7
-9.95	-59.49	65.72
36.45	45.36	27.4
30.97	57.07	14.21
-38.54	56.14	8.39
23.6	7.62	8.4
37.43	20.22	4.96
-34.17	19.79	5.82
-11.57	-15.77	11.89

// Dalton K M, 2006: Controls > Autistic Subjects and Siblings, All Faces
// Dalton K M, 2006: Controls and Siblings > Autistic Subjects, All Faces
// Dalton K M, 2006: Autistic Subjects > Controls, All Faces
// Subjects=10
24.82	-81.94	-7.52
-34.02	-68.72	-10.18
21.22	-2.62	-27.51

// Meisenzahl E M, 2006: Schizophrenic Patients
// Subjects=12
-9.69	-11.14	-1.08
24.78	12.28	-5.1
31.11	25.4	-14.35
-31.59	27.1	-15.69
27.09	2.48	4.79
51.1	20.81	27.22
-31.41	54.7	3.98
-27.16	14.77	-10.07
44.97	-33.48	43.9
48.91	22.72	24.83
56.23	22.04	5.72
49.01	-36.71	20.62
39.72	16.41	-19.21
14.43	-23.76	23.29
-62.59	-5.59	3.76
-64.56	-19.45	16.37
-53.79	-24.08	12.16
56.24	-9.63	-.11
-29.3	32.4	-5.05
-11.65	-57.84	4.7
18.58	-60.06	2.16
34.25	-40.55	49.27

// Meisenzahl E M, 2006: Normals
// Subjects=12
-52.11	22.67	-16.03
-47.96	-39.44	42.72
-43.49	-40.51	53.95
53.17	15.73	18.73
56.26	26.61	8.63
-11.74	-9.25	7.73
-9.65	4.48	5.22
7.64	-18.42	0.47
-41.78	5.38	28.09
37.46	22.26	-25.36
-48.39	28.44	22.56
51.47	-37.72	44.21
-66.53	-38.83	27.28
36.54	-57.15	55.35
-37.95	52.04	-1.24
-35.66	47.56	8.12
-43.82	16.09	39.39
-1.02	41.61	11.48
-27.22	23.07	-13.13
3.46	38.41	22.93
-34.8	-48.89	55.75
-47.85	-38.61	51.6
-31.56	27.31	-13.47
-51.07	24.59	-18.48
-28.68	22.83	41.83
-43.88	15.67	34.95
50.94	27.21	15.39
34.27	-55.75	47.41
42.85	-49.65	43.3
-5.31	37.44	13.09
-3.07	24.89	16.54
7.98	-25.7	25.84
39.73	20.87	-17.41
9.96	33.11	23.34
-11.79	-3.07	4.88
7.63	-11.93	0.95
-44.33	18.83	-0.09
33.14	49.56	-20.14
-2.66	21.42	48.25
-11.04	-66.34	51.47
58.25	18.78	-6.32
-56.19	19	2.34
-2.84	29.96	36.2
-9.69	-11.14	-1.08
24.78	12.28	-5.1
31.11	25.4	-14.35
-31.59	27.1	-15.69
27.09	2.48	4.79
51.1	20.81	27.22
-31.41	54.7	3.98
-27.16	14.77	-10.07
44.97	-33.48	43.9
48.91	22.72	24.83
56.23	22.04	5.72
49.01	-36.71	20.62
39.72	16.41	-19.21
14.43	-23.76	23.29
-62.59	-5.59	3.76
-64.56	-19.45	16.37
-53.79	-24.08	12.16
56.24	-9.63	-.11

// Schaefer H S, 2006: Social Interaction Analysis
// Schaefer H S, 2006: Facial Stimuli Analysis
// Schaefer H S, 2006: Erotic Stimuli Analysis
// Subjects=9
-22.44	54.81	17.24
-11.44	32.87	49.07
-45.74	13.94	27.63
-40.38	0.95	24.2
-27.6	-3.81	16.64
-33.05	-13.75	-1.42
26.81	-6.54	3.98
21.59	-7.57	18.62
11.87	-10.86	4.51
-32.04	-18.66	-9.94
-29.81	-37.51	-6.16
66.46	-44.71	2.26
-56.26	-46.99	25.05
46.1	-55.29	-8.88
-5.01	-44.91	19.83
-49.71	-65.3	35.44
-1.97	46.7	34.42
-50.3	38.47	1.09
-6.13	30.27	42.53
-47.83	3.44	29.65
-37.4	20.66	3.55
42.69	6.28	-10.66
9.74	-20.64	2.01
21.56	-78.16	-13.37
-8.68	62.24	1.96
-23.48	60.52	22.35
35.13	50.44	-3.13
10.64	43.49	5.55
11.87	33.07	22.02
-27.59	39.14	35.34
-5.15	31.62	32.37
54.42	31.35	-3.98
42.02	12.58	43.46
61.01	5.73	8.13
2.5	-2.89	39.64
-45.59	26.49	52.22
38.47	23.31	3.57
-34.14	18.99	9.23
-6.39	-8.65	-6.61
-55.62	12.29	-6.69
-27.17	-38.88	58.61
-41.19	-44.64	40.3
41.06	-50.04	32
4.67	-48.66	25.61
2.67	-69.22	35.16
4.51	-76.69	-6.61

// Tan H Y, 2006: High-Performing Schizophrenics
// Subjects=8
-55	15	10
-45	37	-7

// Tan H Y, 2006: Low-Performing Schizophrenics
// Subjects=7
-55	15	10
-30	14	-2

// Tan H Y, 2006: High-Performing Normals
// Subjects=14
44	23	27
-45	37	-7

// Tan H Y, 2006: Low-Performing Normals
// Subjects=12
44	23	27
-30	14	-2

// Beauregard M, 2006: Depressed Patients
// Subjects=12
4	17	19
41	-9	-25
26	-6	-14
34	8	3
2	46	21
44	3	-27
-22	-12	-11

// Beauregard M, 2006: Normals
// Subjects=12
4	17	19
41	-9	-25
26	-6	-14
34	8	3
-6	49	10
-43	17	-13

// Voets N L, 2006: Left Temporal Lobe Epileptic (LTLE) Subjects
// Subjects=12
4	-56	52
-64	-36	22
62	-22	14
24	30	44
-8	58	32
2	58	32
12	-32	4
-10	-80	4
2	-86	-6
-34	18	-6
0	18	36
-44	36	8

// Voets N L, 2006: Normals
// Subjects=12
-40	0	26
-40	4	-12
-56	-4	36
-4	16	40
34	16	-2
14	-100	-8
-30	-84	-12
8	16	36
20	-94	2
-26	-64	42
-28	-10	4
30	-4	0
-10	6	42
-10	-96	-8
44	24	-12
-44	20	-12
16	-16	2
-14	-26	14
-38	48	14
-34	16	-8
34	16	-2
0	18	36

// Moriguchi Y, 2006: Main Effects of ToM Animated Stimuli, Conjunction of 
// Alexithmia Subjects and Normals
// Subjects=14
50	-31	0
42	-61	-9
53	-48	13
50	9	-24
40	4	-34
24	-5	-17
-24	-91	-2
-14	-79	-30
-57	-52	16
-65	-48	17
16	-81	-31
-53	24	14
8	-11	4
6	-52	43
-6	-50	41
-42	9	31
-44	4	44
12	63	17
10	62	30
6	49	44
-57	-6	-11
-49	-28	60
6	-23	-2
10	13	62
-42	-21	-24
69	-20	30
-4	30	-22
-34	-7	-30
-10	-15	4

// Porubska K, 2006: Food vs. Non-Food
// Porubska K, 2006: Activations Modulated by the Subjective Feeling of 
// Appetite
// Subjects=12
-30	30	-18
-48	-12	6
42	-12	12
39	6	-12
54	-6	18
-45	-3	9
39	-18	6
-48	-15	3
27	-12	-3
-30	-15	3

// Takahashi M, 2006: Normal Men
// Subjects=11
-4	-76	2
-44	-78	10
28	-22	-18
22	2	-14
-30	12	-8
0	-14	-10
-8	-90	10
-40	-8	48
-18	-10	38
-42	4	12
-32	-28	-4
-4	-26	6
12	2	18
-8	-14	-12
10	-64	-30
22	2	-14
-32	-6	30
-32	14	12
34	-18	-4
-4	-12	-12
10	-62	-30
30	-94	-16
-10	4	2
28	-92	-14
52	-62	34
-4	-28	2

// Takahashi M, 2006: Normal Women
// Subjects=11
28	-92	-16
-44	6	50
-8	2	0
6	-38	-6
-16	-92	-14
-48	4	50
-44	-66	34
-6	-30	0
-12	2	2
16	-82	-22
22	2	-14
-32	-6	30
-32	14	12
34	-18	-4
-4	-12	-12
10	-62	-30
30	-94	-16
-10	4	2
28	-92	-14
52	-62	34
-4	-28	2

// Allen P P, 2006: 2-Back > 0-Back, Sham Depletion
// Allen P P, 2006: 2-Back > 0-Back, Acute Tryptophan Depletion
// Allen P P, 2006: N-Back, Sham Depletion > Acute Tryptophan Depletion
// Allen P P, 2006: N-Back, Acute Tryptophan Depletion > Sham Depletion
// Allen P P, 2006: Letter Fluency > Baseline, Sham Depletion
// Allen P P, 2006: Letter Fluency > Baseline, Acute Tryptophan Depletion
// Allen P P, 2006: Letter Fluency, Sham Depletion > Acute Tryptophan 
// Depletion
// Subjects=10
47.52	-46.14	40.52
-41.57	34.86	22.48
43.92	35.37	21.46
-25.02	-66.24	48.61
0.36	16.91	48.04
5.58	24.45	35.08
-44.76	30.61	22.87
-44.84	13.3	5.37
35.73	1.68	54.49
-.48	-57.63	47.61
0.31	16.39	41.39
8.8	20.24	35.4
39.66	43.18	26.43
-6.02	-55.32	22.94
0.42	13.1	53.93
-37.36	37.55	15.52
-44.81	18.04	11.66
-53.46	8.07	-6.36
5.52	27.11	28.17
0.31	16.39	41.39
0.38	12.68	48.39
5.53	23.94	28.43
-41.53	10.03	17.87
-44.85	29.67	10.69
-22.05	21.43	53.49
0.33	12.16	41.75
-25.09	-9.8	62.84
0.56	-50.23	46.98
-2.83	12.66	48.43

// Bartolo A, 2006: Funny vs. Neutral Cartoons
// Bartolo A, 2006: Brain Regions in which Stimuli-Related BOLD Signal was 
// Significant for Humor Appreciation
// Subjects=21
-35.74	-52.66	-18.94
-33.97	11.19	-36.49
-33.42	-80.95	-11.7
-62.89	-12.23	-21.35
-58.67	2.36	-26.23
-54.23	16.39	-14.25
-42.32	-45.75	-25.11
-50.77	-73.88	-15.46
-50.9	-45.26	-19.41
7.52	-87.16	-22.98
31.27	-47.85	-17.19
37.28	21.97	-39.89
55.78	31.79	-27.73
33.48	-62.74	-15.76
52.87	-71.9	-23.02
56.21	-68.93	-14.41
-33.45	-80.09	-14.02
-53.23	24.59	-18.44
-56.15	-60.61	-11.08
-31.82	19.91	-35.15
-62.87	-10.96	-19.24
-50.77	-73.88	-15.46
-18.6	-5.49	-20.54
-58.42	-23.08	-11.39
-58.67	2.36	-26.23
-42.3	-45.55	-22.89
-54.41	6.32	-30.06
7.52	-87.16	-22.98
33.45	-47.64	-15.01
60.34	-18.93	-19.43
31.32	-62.74	-15.72
50.17	14.91	-47.26
55.84	27.85	-23.98
18.38	-34.2	-8.24

// Bird G, 2006: Autism Patients
// Subjects=16
46	-48	-20
44	-68	-14
62	-54	-4
-42	-78	-14
-50	-76	-2
28	-46	-12
2	-84	-6
16	-100	8
34	-82	20
-26	-46	-12
-10	-96	-2
-30	-88	22
30	-46	-16
-28	-42	-18
-44	-56	-16

// Bird G, 2006: Normals
// Subjects=16
44	-50	-20
46	-74	-10
-44	-54	-18
-42	-82	-10
-50	-70	2
28	-46	-10
28	-52	-8
2	-82	-6
20	-56	16
34	-88	24
-26	-48	-10
-30	-90	26
44	-46	-20
44	-78	-8
-44	-52	-20
30	-44	-12
-28	-46	-12
-44	-56	-16

// Dapretto M, 2006: Autism Patients
// Subjects=10
-52	-16	38
46	-6	20
-62	2	22
56	-2	14
-46	-16	30
-34	-38	52
-44	-50	-14
34	-50	-12
-8	-72	4
10	-80	2
-26	-66	-4
26	-66	0
-20	-12	-8
20	-4	-12
-34	-68	-16
28	-52	-20
54	8	6
12	20	34
-50	10	12
56	10	14
-36	-2	14
26	14	12
-22	-6	-8
30	-4	-16
-40	-14	-12
36	-18	-8
10	6	6
30	-24	0
-32	-32	6
-26	-10	-10
22	-10	-8
-48	-52	-14
36	-64	-12
-18	-80	-10
6	-76	2
-32	-62	-6
36	-74	-4
-22	-40	-2
30	-48	-16

// Dapretto M, 2006: Normals
// Subjects=10
-44	-6	44
42	-16	34
-42	-8	38
48	0	20
2	0	60
12	20	34
-36	40	26
50	0	40
-50	8	10
54	10	8
-40	20	2
42	36	8
-36	-4	10
36	2	4
-42	-18	38
58	-12	20
-52	4	2
48	12	-4
28	4	-24
-34	-62	-18
30	-62	-16
-18	-78	-12
6	-74	-4
-44	-64	-4
40	-70	-4
-18	-10	-8
18	-8	-8
-36	-12	-8
32	-12	-8
16	4	8
-28	-10	8
20	-4	8
-14	-24	14
4	-18	12
-30	-58	-22
26	-66	-20
54	8	6
12	20	34
-50	10	12
56	10	14
-36	-2	14
26	14	12
-22	-6	-8
30	-4	-16
-40	-14	-12
36	-18	-8
10	6	6
30	-24	0
-32	-32	6
-52	12	4
52	10	12
-52	36	2
42	26	2
30	34	2
-18	-8	-12
-38	-76	-12
32	-52	-12
-18	-78	-8
10	-82	-8
-34	-84	2
36	-70	-4
-42	-60	-14
30	-68	-14

// Ethofer T, 2006: Affective Prosody > Emotional Word Content
// Ethofer T, 2006: Emotional Word Content > Affective Prosody
// Subjects=24
-36	42	6
39	42	6
66	-42	3
-21	36	51
-48	9	-39
-48	30	-6

// Ethofer T, 2006: Happy and Angry > Neutral
// Subjects=24
60	-21	3
-54	-12	0

// Fliessbach K, 2006: Encoding, Abstract > Concrete
// Fliessbach K, 2006: Subsequent Memory Effect
// Fliessbach K, 2006: Recognition, Abstract > Concrete
// Fliessbach K, 2006: Recognition, Concrete > Abstract
// Fliessbach K, 2006: Recognition, Old/New Effect
// Fliessbach K, 2006: Old/New Effect for Concrete Words After Inclusive 
// Masking With Encoding, Concrete > Abstract
// Subjects=21
-52.97	24.33	1.75
55.29	29.67	18.43
-50.43	10.77	28.82
49.51	25.68	-12.45
-53.16	18.52	-14.48
-50.82	27.53	1.4
-36.98	-76.42	48.43
-52.17	-63.81	46.32
50.48	-67.71	44.96
47.13	-6.16	49.01
-2	74.11	26.21
-17.89	-50.57	25.37
-44.07	-12.03	14.16
-43.49	-63.47	49.5
-58.82	-43.19	37.67
7.31	41.48	-13.3
1.01	42.81	1.25
7.39	12.56	-12.68
-40.12	42.14	-3.59
17.27	-21.24	-7.26
-8.05	-59.48	32.81
8.21	-62.3	36.18
-18.47	-60.35	-21.83
-1.47	-35.77	44.92
5.05	-28.85	49.73
4.07	41.47	-13.24
-5.63	41.64	-10.85

// Kraut M A, 2006: Threatening - Non-Threatening
// Kraut M A, 2006: Non-Threatening - Threatening
// Kraut M A, 2006: Animal > Objects
// Subjects=18
44	-40	8
18	21	-8
26	25	-11
28	17	-9
32	-72	46
36	-52	-26
-32	9	35
-36	2	39
38	51	7
-57	-31	5
-34	44	-11
-30	44	-11
-32	23	23
-22	-83	41
57	-15	4
-65	-37	-2
-50	-39	0
-12	12	47
0	16	49
-63	-14	-3
-57	5	-9
-12	-5	9

// Mitchell R L C, 2006: Congruent Semantic vs. Prosody Only
// Mitchell R L C, 2006: Incongruent Semantic vs. Prosody Only
// Subjects=28
-53.18	31.49	-13.52
-65.53	-39.45	20.6
71.4	-19.15	0.57
-62.74	0.92	-6.97
-47.47	21.78	8.63
-53.1	35.41	-6.06
-47.88	27.49	-22.18
42.66	12.01	-43.48
-56.24	-18.62	-9.63
61.35	-4.14	-22.03
-34.85	-11.38	-25.28
-18.37	-14.77	-5.05

// Sacco K, 2006: Experimental Normals
// Subjects=6
50.45	9.15	25.81
61.28	-15.65	34.46
55.86	3.35	32.93
4.78	-4.68	57.61
7.81	13.35	42.68
42.9	1.82	14.25
61.23	-12.82	29.76
60.18	-15.91	31.15
4.92	-36.14	63.59
43.24	-30.94	44.87
-14.32	-41.8	60.94
17.49	-84.84	10.65
29.11	-77.34	-3.49
20.45	-64.33	-13.41
-53.22	5.1	24
-53.25	4.76	19.56
-53.03	-8.25	44.07
-56.37	2.42	30.95
-.55	-7.88	57.94
-1.74	4.12	48.02
-40.45	-1.94	14.4
-30.9	-31.17	-6.67
-52.99	-8.96	48.59
-40.14	-21.83	46.18
-7.93	-36.47	60.42
-30.35	-56.16	55.64
-52.98	-31.94	40.48
-7.05	-61.5	25.71
-11.57	-64.1	-7.48
4.87	-16.85	65.32
33.7	-10.33	64.44
-40.1	-11.46	56.46
0.6	-16.88	65.37
-52.04	2.96	37.54
-54.08	-22.43	39.7
-30.29	-51.16	65.25
-40.03	-37.18	54.16
-66.99	-43.08	21.5
17.48	-88.27	7.6
37.6	-73.57	-10.6
10.87	-57.36	-4.96
21.52	-67.58	-14.26

// Sacco K, 2006: Control Normals
// Subjects=6
50.45	9.15	25.81
61.28	-15.65	34.46
55.86	3.35	32.93
4.78	-4.68	57.61
7.81	13.35	42.68
42.9	1.82	14.25
61.23	-12.82	29.76
60.18	-15.91	31.15
4.92	-36.14	63.59
43.24	-30.94	44.87
-14.32	-41.8	60.94
17.49	-84.84	10.65
29.11	-77.34	-3.49
20.45	-64.33	-13.41
-53.22	5.1	24
-53.25	4.76	19.56
-53.03	-8.25	44.07
-56.37	2.42	30.95
-.55	-7.88	57.94
-1.74	4.12	48.02
-40.45	-1.94	14.4
-30.9	-31.17	-6.67
-52.99	-8.96	48.59
-40.14	-21.83	46.18
-7.93	-36.47	60.42
-30.35	-56.16	55.64
-52.98	-31.94	40.48
-7.05	-61.5	25.71
-11.57	-64.1	-7.48

// Smeets P A M, 2006: Men
// Subjects=12
-20	-8	-4
-16	-2	0
-35	-6	2
-34	-16	38
-14	12	66
22	32	-4
-6	26	-4
34	4	10
-24	6	8
-8	-80	20
-40	-8	36
-20	-90	16
-54	-34	54
-42	-46	62
0	26	46
-2	-4	-6
-14	-2	-2
6	26	46

// Smeets P A M, 2006: Women
// Subjects=12
44	-14	48
56	-2	32
66	-30	12
30	-16	-6
54	-10	8
-42	-16	48
2	-4	-4
-18	-6	-22
-2	-4	-6
-14	-2	-2
6	26	46

// Uher R, 2006: Food > Non-Food
// Uher R, 2006: Taste: Chocolate Milk
// Uher R, 2006: Taste: Chicken Broth
// Uher R, 2006: Taste: Both, Fasting vs. Satiation
// Uher R, 2006: Taste: Chocolate, Fasting vs. Satiation
// Uher R, 2006: Taste: Chicken, Fasting vs. Satiation
// Uher R, 2006: Food: Women > Men
// Uher R, 2006: Taste: Both, Women > Men
// Uher R, 2006: Taste: Chicken, Women > Men
// Subjects=8
-41.53	-66.9	-13.59
36.41	-55.06	-18.83
32.3	-77.49	-5.75
36.86	-54.75	40.25
-37.35	13.43	6.39
-41.4	-1.81	30.02
20.44	-62.22	-13.58
-6.32	18.44	13.42
20.27	-3.55	-11.81
8.63	-2.42	3.84
-34.17	13.19	3.03
-44.66	-17.74	16.89
-37.39	46	14.81
-48.93	10.84	29.04
-48.67	-42.57	40.21
44.24	-10.75	44.28
-41.62	17.89	9.41
51.4	14.56	13.08
-44.56	-12.4	30.94
8.88	28.76	49.18
32.27	-82.24	-12.04
-34.08	-67.2	-18.11
-49.29	23.53	-13.28
5.57	39.69	39.38
-39.59	13.44	-6.97

// Rektor I, 2006: Dots vs. Fixation
// Rektor I, 2006: Alphabet vs. Fixation
// Subjects=10
-51	-27	42
-54	9	15
-42	-30	39
-33	-36	60
-60	-24	30
-9	-30	45
-33	-27	57
-12	-15	0
0	-9	60
36	-93	-6
60	-27	33
-57	-21	36
-36	-24	57
-24	-18	60
-12	-21	6
-30	-39	57
-3	-15	51
42	-36	48
63	-12	30
21	-6	69

// Bohland J W, 2006: Simple Syllable, Go vs. Fixation
// Bohland J W, 2006: Simple Sequence, Go vs. Fixation
// Bohland J W, 2006: Complex Syllable, Go vs. Fixation
// Bohland J W, 2006: Complex Sequence, Go vs. Fixation
// Bohland J W, 2006: Go > NoGo
// Bohland J W, 2006: Complex Sequence > Simple Sequence
// Bohland J W, 2006: Complex Syllable > Simple Syllable
// Bohland J W, 2006: Syllable Complexity x Sequence Complexity
// Subjects=13
-46	-10	60
56	6	40
-54	-12	40
-62	-4	24
60	-4	30
-42	-24	12
66	-10	12
-32	20	0
40	10	6
38	24	2
38	-22	8
-62	-8	6
-54	-4	4
56	-26	8
-56	8	-6
64	6	2
50	4	-8
48	14	18
-34	36	12
-32	46	12
-2	-2	68
-2	6	50
4	4	70
-4	14	40
-12	2	10
-24	2	-10
-20	12	4
18	10	6
32	-6	-2
24	4	-4
-8	-20	-2
12	-22	0
14	-12	6
20	-16	10
8	-6	4
-26	-60	-22
40	-56	-26
34	-62	-24
24	-56	-20
36	-54	-54
-44	-60	-20
-44	-18	64
-34	-6	54
48	6	32
56	8	32
-54	-10	40
-62	-4	22
64	-10	14
66	-4	24
56	-6	34
-48	-26	14
-64	-12	12
-50	2	6
54	-14	12
38	-6	14
-34	8	8
-34	-4	8
42	8	-14
-66	-24	8
-40	-2	-14
70	-26	8
-54	10	-6
64	6	2
-46	6	28
-54	14	32
-38	24	2
40	26	4
50	20	0
-36	40	32
-26	46	20
56	-8	54
0	0	66
-6	10	52
-6	14	42
-8	-12	42
8	-12	40
-28	-52	52
-52	-36	50
40	-48	48
42	-44	46
-60	-40	30
-46	-30	32
-22	2	6
-30	-8	-4
-28	-16	10
32	-6	-2
24	4	6
-10	-16	0
14	-16	4
-20	-60	-22
20	-60	-20
40	-68	-22
44	-54	-28
36	-54	-54
16	-62	-44
38	-40	-50
56	6	40
50	-14	60
-52	-12	40
-62	-4	24
68	-6	26
56	-8	38
-42	-24	12
-52	0	4
68	-8	12
-44	4	0
36	-22	6
-64	-10	6
-66	-22	8
-64	-30	12
58	-12	6
66	-22	8
50	-24	12
70	-30	16
-52	8	-4
64	6	2
-36	26	2
-38	32	14
2	0	66
-2	14	42
-58	-38	28
-24	0	-8
-22	4	6
20	8	6
32	-16	-2
32	-4	-4
30	-4	8
24	2	-6
-10	-16	4
14	-16	2
-28	-60	-24
20	-56	-20
46	-56	-28
36	-52	-56
-46	-60	-20
-60	0	30
62	-4	42
56	8	40
-54	-10	44
60	-4	32
68	-4	22
-44	-24	14
-34	24	0
-40	14	4
40	24	0
-62	-12	8
-64	-30	12
52	-24	10
60	-14	8
64	-28	2
64	8	0
-54	12	0
-48	10	28
50	20	-6
-56	16	30
-46	28	24
-30	-6	50
-42	46	20
0	0	70
-2	18	38
-28	-52	50
-52	-38	54
-48	-36	46
34	-56	52
-12	0	10
12	2	8
-22	-2	6
32	-20	0
-10	-14	6
14	-12	6
8	-20	0
22	-22	-2
-28	-62	-28
-14	-62	-18
22	-62	-20
34	-62	-26
8	-68	-20
42	-54	-28
38	-52	-56
36	-40	-52
20	-64	-46
4	-46	-16
4	-56	-24
-46	-60	-20
-54	-12	40
-44	-24	12
-64	-8	20
-62	-6	4
-48	-16	2
-50	10	-6
-60	-30	12
-44	6	-2
-48	-14	60
60	-12	10
64	8	0
62	-4	28
50	-22	12
12	-16	4
46	-14	0
0	-6	12
10	0	10
68	-26	4
-10	-16	4
-24	0	-8
-20	4	2
30	0	-6
40	8	4
-10	-14	16
20	8	4
14	-16	16
34	-12	-2
48	2	-10
32	-66	-22
20	-58	-18
-26	-60	-22
-14	-60	-16
-8	-58	-2
0	0	68
2	-6	72
0	2	50
2	-4	52
2	18	40
-4	-14	78
38	-48	-56
22	-60	-20
32	-60	-26
-34	-56	-32
36	-54	-56
26	-32	-46
6	-74	-38
16	-70	-48
30	-62	-56
36	-44	-54
-44	-58	-10
6	-68	-18
30	-38	-50
4	-80	-18
-24	-64	-22
-48	-64	-22
22	-82	-18
-16	-62	-16
-30	-78	-22
-22	-84	-22
6	-88	-10
36	-38	-40
0	6	56
8	30	34
-2	18	46
0	2	68
0	-6	70
-2	22	36
-48	4	30
-56	-8	46
-50	28	24
-54	16	32
-50	-6	54
-54	6	42
-32	-4	64
-42	-2	44
-32	-4	52
-58	10	20
-26	-6	50
0	-6	12
-8	-2	10
18	-8	20
-32	22	4
-42	16	6
-48	14	2
-48	20	-6
40	22	2
50	20	-2
-30	-54	58
-26	-60	56
-30	-48	46
-48	-32	46
-26	-68	38
-52	-34	52
26	-64	64
32	-56	52
0	18	46
0	4	62
0	0	70
4	24	38
50	22	-6
42	20	-12
38	26	0
38	24	-6
-26	-62	52
-30	-54	52
-48	-40	52
-20	-66	66
-38	-44	44
-34	26	0
-34	22	4
-50	12	0
22	-76	-20
26	-62	-18
0	16	48
-8	8	62
2	34	36
8	26	34
0	16	66
2	14	32
-6	24	28
34	22	-8
38	44	24
52	20	-4
40	20	10
52	34	26
58	24	14
-42	30	24
-30	24	6
-42	46	22
-36	16	-8
-58	14	18
-52	16	14
-44	14	4
-62	6	28
-40	12	26
-52	10	44
-50	4	36
42	-50	-30
28	-52	-24
32	-52	-28
36	-56	-28
-2	-72	-8
14	-66	-12
42	-72	-28
2	-56	-32
14	-58	-20
14	-54	-14
16	-6	14
-10	0	10
10	-2	12
-4	-10	14
8	-8	2
-30	-52	50
-40	-44	54
-52	-40	56
-36	-48	42
-24	-72	46
-18	-68	64
34	2	58
34	2	38
34	4	44
44	12	38
34	0	48
-44	-58	-16
-32	0	52
-38	0	62
-38	-4	42

// Finger E C, 2006: Moral = Social with Audience > Social without Audience = 
// Neutral
// Finger E C, 2006: Moral > Social = Neutral
// Finger E C, 2006: Moral and Social > Neutral
// Finger E C, 2006: Audience > No Audience
// Subjects=16
-1.88	53.19	49.48
-44.93	24.41	-2.25
79.97	1.96	-28.57
-64.19	13.12	-8.89
-74.69	-53.1	-11.02
0.02	79.24	28.32
-9.02	3.93	73.77
-67.33	-62.08	-31.54
-74.5	-51.21	13.35
-21.52	1.61	-24.03

// Lepage M, 2006: Associative Encoding vs. Item Encoding, Conjunction 
// Analysis
// Lepage M, 2006: Associative Encoding vs. Item Encoding, Interaction, 
// Normals > Schizophrenia Patients
// Lepage M, 2006: Associative Recognition vs. Item Recognition, Conjunction 
// Analysis
// Lepage M, 2006: Associative Recognition vs. Item Recognition, Interaction, 
// Normals > Schizophrenia Patients
// Subjects=15
-26	26	10
-30	-8	58
-30	-52	-14
16	14	-2
4	-4	56
52	-66	12
-56	14	34
-2	12	32
-12	0	4
-4	-4	42
-30	-10	0
-30	-18	64
-2	-54	30
60	-18	26
24	-44	-22
60	-46	14
18	-52	-18
-38	22	24
-42	0	38
-18	-58	2
-42	-60	48
-18	-72	60
-10	-76	42
-10	-78	10
-10	-88	-4
32	24	-2
6	6	56
34	4	62
10	-58	8
24	-70	-12
14	-72	18
18	-72	48
34	-72	32
20	-76	-10
30	-76	44
-40	28	20
-30	-50	48
-28	-64	46
-44	-62	-8
28	26	-4
2	18	48
4	-38	26
30	-58	48
34	-74	52
4	-76	-16

// Ohnishi T, 2006: Maze vs. Control
// Ohnishi T, 2006: Good Navigators > Poor Navigators
// Ohnishi T, 2006: Poor Navigators > Good Navigators
// Ohnishi T, 2006: Positive Correlation between Task Performance and Brain 
// Activity
// Ohnishi T, 2006: Negative Correlation between Task Performance and Brain 
// Activity
// Ohnishi T, 2006: Positive Correlation with SDQ-S
// Ohnishi T, 2006: Negative Correlation with SDQ-S
// Subjects=28
-26	-30	-25
-20	-35	-4
-14	-58	7
-16	-65	51
-8	-91	3
-14	-61	53
-36	-39	41
-44	-63	-22
-44	-81	10
-3	-35	-3
34	-38	-27
21	-37	-5
20	-57	19
16	-65	53
16	-97	3
30	-56	53
36	-45	41
32	-59	-17
50	-68	-5
12	-80	-8
3	-22	-4
51	16	26
-16	-29	-5
16	-35	-3
-8	-54	52
10	-52	49
59	-48	45
-16	-30	-9
-20	-29	-4
44	-58	53
-17	-33	-6
-26	-32	-2
20	-31	-5
28	-32	-3
-40	-69	50
41	-50	48

// Ries M L, 2006: Normal Elderly Subjects
// Subjects=14
8	-74	32
10	-52	32
-8	-80	28
-56	-62	16
48	-54	28
58	-56	24
48	-58	14
8	-62	14
-8	-54	28
8	-58	24
10	58	24
-12	58	8
-10	48	42
8	-60	24
4	-66	22

// Ries M L, 2006: Mild Cognitive Impairment Patients
// Subjects=14
-52	-58	42
6	-74	36
46	-62	46
-10	44	4
-8	50	18
2	58	10
-6	-54	28
-10	-56	0
-28	16	-22
-24	4	-18
-4	-10	34

// Tang J, 2006: Numerical > Physical
// Tang J, 2006: Numerical Task Conflict Trials > Numerical Task Non-Conflict 
// Trials
// Tang J, 2006: Physical Task Conflict Trials > Physical Task Non-Conflict 
// Trials
// Tang J, 2006: Numerical Task Error Trials > Numerical Task Correct Trials
// Tang J, 2006: Physical Task Error Trials > Physical Task Correct Trials
// Tang J, 2006: Conjunction by Masking Across Tasks (Error Trials > Correct 
// Trials)
// Subjects=18
51.04	11.57	20.29
-37.97	19.09	-9.19
51.29	-78.5	21.36
45	-35.51	45.22
25.65	-62.16	48.19
36.46	-53.31	50.49
55.15	-55.66	-10.1
50.86	-64.18	-9.19
-21.82	-64.04	53.67
42.83	-37.75	44.36
36.47	-44.49	52.98
-9.11	19.48	50.79
16.34	-2.66	7.73
20.59	8.84	4.27
9.66	7.87	-5.53
18.94	23.62	47.66
-22.59	-16.19	3
39.52	55.45	-26.43
38.07	-79.35	1.5
-46.48	-52.17	-13.2
48.97	14.42	27.89
-42.19	34.04	1.73
4.6	-42.06	11.82
56.15	-26.73	-10.74
-33.76	18.27	-18.15
-33.98	8.96	-37.39
-53.69	-46.31	15.48
46.22	29.71	-15.04
60.54	24.19	5.44
37.3	15.59	-39.26
7.62	-14.16	0.05
-3.18	-14.2	0.23
-18.44	-83.1	-24.06
1.14	30.67	9.17
5.19	-23.9	-23.6
-52.54	2.36	30.81
39.7	-5.59	-24.88
-48.43	17.19	16.95
-26.85	37.89	19.02
-62.15	-28.52	34.03
58.65	-41.66	13.1
55.1	-27.59	-8.4
58.22	26.23	-7.05
35.41	20.85	-17.34
-35.92	18.27	-18.11
-16.3	-78.84	-24.52
5.02	-39.39	-39.99
58.62	-41.87	10.88
56.15	-26.73	-10.74
-33.76	18.27	-18.15
-53.69	-46.31	15.48
46.22	29.71	-15.04

// de Leeuw R, 2006: Painful Heat vs. Continuous Warm Stimulus
// Subjects=9
35.31	42.38	16.51
50.45	10.29	26.83
58.02	-23.84	25.15
51.27	11.07	-4.47
38.51	12.65	3.35
-35.24	12.12	3.13
2.5	5.92	43.36
5.39	37.8	15
0.04	37.77	15.07
7.58	-1.19	5.98
9.78	-14.76	9.32
-11.59	-14.88	9.58
-35.79	-19.89	57.12
-36.26	-66.5	-22.61
4.87	-71.86	42.05
13.21	-79.41	12.48

// Abler B, 2006: Increasing Probability at Expectation Phase
// Abler B, 2006: Reward Prediction Error at Outcome Phase
// Subjects=11
10.6	0.25	-18.24
-8.89	9.75	-18.85
10.77	-1.7	-4.6
-8.47	-19.98	7.62
4.13	-58.77	-29.1
14	14.58	-2.91
-5.59	6.88	-15.26
-63.7	-30.99	-3.8
-30.79	38.55	49.27

// Huettel S A, 2006: Decisions Involving Ambiguity > Decisions Involving Risk
// Subjects=13
39	16	33
51	16	45
40	6	44
41	19	9
-36	-57	50

// Preuschoff K, 2006: Win > Loss
// Preuschoff K, 2006: Activation for Expected Reward, Immediate
// Preuschoff K, 2006: Activation for Expected Reward, Delayed
// Preuschoff K, 2006: Activation for Reward Variance, Immediate
// Preuschoff K, 2006: Deactivation for Reward Variance, Immediate
// Preuschoff K, 2006: Activation for Reward Variance, Delayed
// Preuschoff K, 2006: Deactivation for Reward Variance, Delayed
// Subjects=19
-5.13	-18.73	14.29
14.08	-14.47	12.6
16.09	-17.95	-4.98
-22.42	-16.41	-9.13
-9.6	2.25	-3.03
13.9	5.65	-2.47
14	4.47	9.89
29.99	-17.86	-5.14
-2.19	-24.71	-22.04
-34.12	-37.88	-10.54
25.73	-33.04	-8.28
-6.32	-22.23	-3.25
2.54	-37.58	31.4
-.74	-20.77	28.91
-1.81	27.55	48.29
-45.9	25.52	12.16
50.36	22.55	20.23
-34.07	-4.45	8.96
-26.77	20.12	-4.33
52.6	4.93	26.14
-47.94	4.53	16.18
-54.23	-59.09	5.97
-33.81	-75.29	14.9
61.16	-42.11	8.8
41.81	-61.03	-13.93
21.82	-64.5	25.63
5.66	-88.94	-0.02
19.16	-44.65	-34
-3.14	-49.93	-17.69
-26.63	-8.09	2.49
25.77	-5.14	8.33
-11.78	4.01	-7.61
13.86	6.28	-8.1
18.23	-22.33	-6.86
3.08	-26.6	-33.1
-4.32	-20.33	-20.16
-1.2	34.82	-9.2
-46.54	-59.02	33.76
-33.83	12.38	47.7
20.63	32	48.77
-1.78	30.01	52.54
-11.76	42.73	11.44
-45.76	-37.89	4.1
25.14	-75.34	36.53
-13.97	-41.59	-32.76
-37.33	-70.91	-24.46
25.81	-87.19	-20.47
35.22	-34.35	-26.13
10.88	-84.74	-14.93
-46.17	7.29	-30.91
-24.75	23.34	-18.01
-4.45	24.51	-18.34
-16.04	-24.37	-16.34
-33.18	19.02	-4.17
37.37	15.22	-4.66
-17.11	-31.06	-20.22
20.28	-23.18	-17.97
62.12	-11.36	7.32
41.97	-23.05	23.03
-55.5	-7.37	0.53
10.72	-33.64	-14.75
3.08	23.93	-12.8
38.99	-32.82	48.42
44.33	-21.87	51.9
-8.04	-25.53	50.58
-1.2	23.9	-12.75
8.79	-65.57	-.9
-34.31	53.46	0.77
-30.99	23.95	4.32
34.18	27.52	3.27
-9.62	-2.32	-7.11
13.89	-2.18	-7.39
2.25	-15.32	2.77
2.13	-18.8	-14.78
-39.18	-6.39	39.3
-14.78	-30.14	5.32
0.11	-15.33	2.79
-0.01	-18.81	-14.76

// Yacubian J, 2006: Normals Group 1
// Subjects=42
-12	3	0
12	6	0
-33	21	-6
33	24	-6
-39	57	3
36	60	-3
-12	15	-3
15	15	-6
3	51	-6
12	9	-3
-12	6	-3
36	63	0
12	9	-3
-12	9	-3
48	39	-18
-45	45	-15
-12	6	-3
12	9	-3
-12	3	-3
12	9	-3
-27	-3	-18
30	-3	-12
-27	-3	-18
27	0	-18

// Yacubian J, 2006: Normals Group 2
// Subjects=24
12	9	-3
-12	6	-3
-12	6	-3
12	9	-3
-24	-3	-15
27	-3	-18

// Wagner G, 2006: Control Subjects
// Subjects=16
53.14	15.52	16.51
5.85	21.58	38
-48.74	19.26	-6.78
-12.08	48.42	-6.93

// Wagner G, 2006: Unipolar Depressed Patients
// Subjects=16
-56.01	23.64	17.56
-39.06	29.93	-8
-7.16	27.71	35.38
-48.74	19.26	-6.78
-12.08	48.42	-6.93

// Remijnse P L, 2006: OCD Patients
// Subjects=20
45	42	-18
27	-63	45
33	-93	0
-24	-99	-12
36	51	-12
15	36	-15
36	-93	-12
-36	-93	-3
6	18	3
39	51	-3
45	39	27
33	21	-3
27	-63	45
36	-96	0
30	51	-15
30	54	15
-30	54	6
-45	36	27
33	18	6
-18	18	-15
36	54	-3
-31	60	6
33	45	33
-42	33	42
36	27	3
-33	21	6

// Remijnse P L, 2006: Normals
// Subjects=27
36	54	-12
15	36	-15
45	42	21
30	-63	48
36	-93	-9
-33	-96	-12
6	18	6
-6	15	6
-12	6	-9
36	51	-12
15	36	-15
36	-93	-12
-36	-93	-3
6	18	3
33	54	-12
18	42	-15
30	24	-12
33	-93	-9
-33	-96	-12
-18	18	-15
36	51	9
-30	60	9
33	45	33
-42	33	42
33	18	6
-33	21	9
0	30	33
-18	18	-15
36	54	-3
-31	60	6
33	45	33
-42	33	42
36	27	3
-33	21	6

// Seseke S, 2006: Activations during Relaxation and Contraction
// Seseke S, 2006: Relaxation > Contraction
// Seseke S, 2006: Contraction > Relaxation
// Subjects=11
-1.22	-24.68	-35.44
7.52	-22.66	-10.06
-5.32	-23.96	-12.03
31.05	-53.06	-20.05
-25.6	-50.23	-19.63
7.53	-39.03	-15.38
9.74	-15.19	3.79
-8.44	-4.46	6.44
26.79	7.47	6.15
-23.43	6.11	6.84
53.53	7.88	9.15
-50.1	4.26	12.88
51.56	-51.86	7.5
1.46	-81.68	11.69
58.03	-31.42	23.55
-54.16	-29.8	26.93
0.33	12.16	41.75
-.61	-7.34	51.2
16.64	-23.3	63.49
-15.44	-23.66	61.66
1.49	16.45	55.87
2.27	35.38	25.28
17.2	54.93	29.04
45.09	25.49	31.19
43.78	19.66	-2.87
-34.2	20.59	2.4
42.12	2.61	52.1
53.95	-43.73	43.59
53.95	-43.73	43.59
-52.91	-48.77	43.01
2.74	-25.58	62.73
0.08	-49.74	-15.51
44.33	-70.2	32.54
-36.91	-69.88	30.1
-6.1	-41.83	18.47
33.34	-16.3	14.76
-29.74	-17.02	11.08

// Epstein J, 2006: Normals > Depressed, Positive
// Epstein J, 2006: Neutral > Positive, Depressed
// Epstein J, 2006: Positive > Neutral, Normals
// Epstein J, 2006: Normals > Depressed, Positive - Neutral
// Subjects=10
15	6	-3
-15	15	-6
15	6	-3
-15	15	-6
15	6	-3
-15	15	-6
15	9	-3
-18	9	-6

// Kerns J G, 2006: Incongruent, Activations
// Kerns J G, 2006: Regions on Conflict Trials Predicting Good Behavioral 
// Adjustments
// Kerns J G, 2006: Regions Active during Good Adjustment Trials for Both iI 
// and iC
// Subjects=26
-6.01	8.49	49.93
-45.34	-49.99	54.17
45.48	-34.21	57.38
-41.51	35.46	30.24
36.48	43.5	30.9
-1.82	13.12	40.58
-45.82	32.89	24.93
-54.21	9.21	35.93

// Meschyan G, 2006: Spanish vs. English
// Meschyan G, 2006: Spanish vs. Rest
// Meschyan G, 2006: English vs. Spanish
// Meschyan G, 2006: English vs. Rest
// Subjects=12
7.92	5.66	53.36
12.1	15.75	45.77
1.44	9.34	46.43
26.8	13.1	10.14
37.49	11.04	10.19
-58.67	-6.96	6.11
-54.39	-15.74	2.34
7.85	13.78	48.22
3.69	8.26	59.88
-.58	6.12	60.11
28.92	12.94	7.9
35.33	12.98	7.82
-58.75	7.5	0.44
-56.54	3.97	9.63
-56.58	5.74	5.02
46.56	-45.04	54.93
55.04	-50.07	44.11
-28.33	-75.03	31.55
-26.17	-72.56	35.77
46.52	-56.47	44.74
55.04	-52.36	42.07
-24.11	-71.12	26.71
-13.34	-79	33.94
52.99	-49.23	55.21
40.16	-47.19	55.19
-25.18	-66.72	28.58
-32.62	-66.43	33.1
-11.26	-68.59	30.81
-17.71	-73.37	24.59

// Rubia K, 2006: Adult Normals
// Subjects=23
34.91	57.99	-29.41
5.19	64.35	0.51
35.14	57.13	0.77
-48.01	29.02	16.35
-9.77	43.31	-8.7
-48.88	-24.91	20.89
28.07	-15.56	24.8
-9.29	-63.68	11.42
-22.53	12.06	-12.63
-37.25	-65.65	-11.52
12.31	-77.7	34.65
-51.32	27.97	3.1
-39.32	-35.4	8.27
33.94	50.21	-19.82
55.64	10.98	7.75
-38.5	35.71	5.65
-25.43	7.55	25.7
32.18	-4.05	8.17
8.7	-3.93	11.77
33.45	-52.51	14.45
29.92	49.58	13.73
48.34	-10.33	21.89
4.67	-3.59	44.13
-44.54	-22	30.63
22.57	2.58	12.18
4.67	-3.59	44.13
-10.37	-78.12	3.72
5.2	52.29	-4.05
-29.93	41.39	9.53
-33.16	8.19	-6.6
-52.02	-28.65	27.93
-18.03	26.54	22.91
27.79	-3.07	-6.36
4.88	-73.89	43.34
43.86	-63.02	-26.05
16.18	23.58	22.76
35.27	22.23	3.7
-41.1	-29.44	57.98
5.2	52.29	-4.05
43.56	55.81	-17.05
-37.55	52.04	-3.54
5.51	-82.83	-17.26
-37.05	-43.87	22.34
-62.93	-17.91	2.62
51.48	-1.05	17.73
-44.56	-24.46	26.38
47.03	22.31	3.56
-29.89	41.82	15.07
4.24	-13.59	-16.36
63.37	-35.87	20.52
35.78	-49.39	40.93
8.61	-43.25	-15.04
20.04	43.52	-22.45
47.1	-59.31	-19.71
-3.11	-88.05	-28.99
54.76	-20.06	19.29
55.91	9.32	41.35
44.01	-13.15	13.26
31.79	46.77	-22.85
-20.41	52.57	1.8
16.03	13.23	-.9
-9.3	-36.31	21.39
43.67	52.52	-4.51
-37.1	20.4	41.49
1.4	25.37	47.32
-48.83	-61.81	11.71
4.41	-24.99	1.32
-29.39	-67.21	36.48
31.96	-23.96	-29.19
39.56	-55.56	-25.51

// Rubia K, 2006: Adolescent Normals
// Subjects=29
39.36	23.63	-19.88
-26.53	-37.78	3.87
-9.4	-8.81	19.08
20.51	-4.41	18.37
-58.69	-16.02	-.93
8.77	-55.89	0.52
-53.05	-7.36	41.77
-.41	68.18	-32.08
32.39	-39.23	21.15
31.21	-56.84	0.01
52.6	-14.79	18.87
-54.26	-19.83	18.29
-32.54	-40.31	54.33
6.84	-12.03	44.82
5.2	52.29	-4.05
-29.93	41.39	9.53
-33.16	8.19	-6.6
-52.02	-28.65	27.93
-18.03	26.54	22.91
27.79	-3.07	-6.36
4.88	-73.89	43.34
43.86	-63.02	-26.05
16.18	23.58	22.76
35.27	22.23	3.7
-41.1	-29.44	57.98
5.2	52.29	-4.05
43.56	55.81	-17.05
-37.55	52.04	-3.54
5.51	-82.83	-17.26
-37.05	-43.87	22.34
-62.93	-17.91	2.62
51.48	-1.05	17.73
-44.56	-24.46	26.38
47.03	22.31	3.56
-29.89	41.82	15.07
4.24	-13.59	-16.36
63.37	-35.87	20.52
35.78	-49.39	40.93
8.61	-43.25	-15.04
20.04	43.52	-22.45
47.1	-59.31	-19.71
-3.11	-88.05	-28.99
54.76	-20.06	19.29
55.91	9.32	41.35
44.01	-13.15	13.26
31.79	46.77	-22.85
-20.41	52.57	1.8
16.03	13.23	-.9
-9.3	-36.31	21.39
43.67	52.52	-4.51
-37.1	20.4	41.49
1.4	25.37	47.32
-48.83	-61.81	11.71
4.41	-24.99	1.32
-29.39	-67.21	36.48
31.96	-23.96	-29.19
39.56	-55.56	-25.51

// Wittfoth M, 2006: Motion-Based: Incompatible > Compatible
// Wittfoth M, 2006: Location-Based: Incompatible > Compatible
// Wittfoth M, 2006: Motion-Based + Location-Based: Incompatible > Compatible
// Wittfoth M, 2006: Conflict-Based Activity of the Motion-Based Simon
// Wittfoth M, 2006: Conflict-Based Activity of the Location-Based Simon
// Subjects=20
1.92	6.94	65.29
3.91	14.41	53.31
-.6	20.7	40.44
-13.03	-57.45	66.31
1.41	-68.01	9.96
-5.06	-82.17	8.11
-61.94	-26.96	50.68
-68.93	-19.88	12
78.08	-17.67	16
10.08	-86.37	8.27
-37.8	-69.37	-13.89
-29.21	-63.16	-16.89
14.35	-85.61	4.76
-4.85	-89.33	23.39
34.25	2.07	57.38
27.85	-1.69	63.46
55.29	-66.63	-1.18
40.86	-35.24	59.84
-4.68	6.08	56.52
34.15	-76.35	33.76
10.08	-86.37	8.27
-.68	-83.87	12.69
5.72	-76.82	7.4
-2.52	8.22	56.28
3.9	15.48	53.21
-15.24	-53.41	63.71
1.41	-68.01	9.96
-61.94	-26.96	50.68
4.07	9.07	65.04
-68.93	-19.88	12
-.6	20.7	40.44
-37.8	-69.37	-13.89
-29.21	-63.16	-16.89
-4.85	-89.33	23.39
-24.01	-1.87	64.36
53.1	-66.84	-3.36
34.15	-76.35	33.76
44.26	-69.49	-19.75

// Knutson K M, 2006: Attitude Congruent - Attitude Incongruent
// Knutson K M, 2006: Attitude Congruent - Classification
// Knutson K M, 2006: Attitude Incongruent - Attitude Congruent
// Knutson K M, 2006: Attitude Incongruent - Classification
// Subjects=30
-20.85	11.32	-24.4
53.21	0.73	19.09
39.73	25.23	-16.72
-33.75	29.22	-15.87
-53.78	21.94	22.17
-7.15	27.81	36.49
-46.72	51.07	-11.08
5.88	25.08	41.02
-28.3	-61.84	54.68
-33.71	29.53	-12.54
-53.67	18.41	30.36
56.36	33.92	17.99

// Husain F T, 2006: Category - Auditory, Tones
// Husain F T, 2006: Category - Auditory, Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels
// Husain F T, 2006: Category - Auditory, Syllables
// Husain F T, 2006: Category - Auditory, All (Pooled)
// Husain F T, 2006: Category - Auditory, Tones + Vowels
// Husain F T, 2006: Category - Auditory, Tonal Contours + Syllables
// Husain F T, 2006: Category - Auditory, Tones + Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels + Syllables
// Subjects=12
-45	33	24
48	15	30
-27	-66	54
30	-63	45
33	48	18
6	-69	45
-54	-51	-12
0	18	57
-39	-57	51
6	-78	-15
-51	33	18
-27	-54	48
-24	18	0
-45	18	27
6	-27	0
9	33	42
12	-3	21
-42	-42	48
18	9	3
33	51	18
54	18	33
12	-45	-27
45	3	42
-3	-15	0
-48	-48	48
0	24	54
-30	27	0
-36	54	15
-51	33	15
-36	-63	45
39	51	12
-33	-60	48
-45	33	21
-30	27	0
36	51	15
-3	24	51
51	15	30
-48	18	24
54	15	33
-30	-57	48
33	51	18
42	3	54
30	-63	48
-36	3	54
-6	27	48
-45	-51	51
0	24	54
33	-93	-12
-51	33	15
39	51	12
-51	15	27
36	-72	51
-39	-57	51
-42	36	24
39	3	54
-33	30	-3
30	48	24
-27	12	54
-3	21	54
-39	39	0
42	-45	51
33	-63	42
-30	30	0
-6	-18	0
36	51	15
-45	-51	48
0	27	51
57	12	27
-51	15	27

// Husain F T, 2006: Category - Auditory, Tones
// Husain F T, 2006: Category - Auditory, Tonal Contours
// Husain F T, 2006: Category - Auditory, Vowels
// Husain F T, 2006: Category - Auditory, Syllables
// Subjects=12
-42	9	18
-54	-27	0
3	-21	-24
27	3	9
-21	-3	18
-48	12	-18
24	-30	48
57	6	3
60	-18	30
54	-39	30
-57	-21	9
-27	-24	60
48	12	33
63	-45	-9
-57	-3	45
36	-42	57
9	-24	-12
27	-60	54
24	45	36
33	-69	33
51	-51	45
51	-30	33
0	3	63
60	-24	6

// Smolka M N, 2006: Smoking-Related Pictures > Fixation, Correlated with FTND 
// Scores
// Smolka M N, 2006: Smoking-Related Pictures > Fixation Correlated with 
// Cue-Induced Craving Scores
// Subjects=10
48	0	39
33	-18	63
3	-6	42
-6	-12	45
-45	-12	39
-39	-9	39
-3	-87	12
9	-81	12
27	-21	-27
33	-36	-18
-60	-33	30
-30	-6	63
-27	-15	-30
-51	-30	51
3	-24	-18
-12	-18	-15
-30	-15	-18
-24	-6	-18
-45	-9	-30
-21	-18	-21
30	-63	12
27	-24	-24
30	-36	-15
27	-3	-15
45	-9	-33
27	-15	-21
-30	-42	-15
-24	-60	9
-33	-63	21
27	-57	-21
-18	-96	0
45	-69	21
-9	-72	-45
30	-63	-9
15	-84	9

// Golestani N, 2006: Read, English - Rest
// Golestani N, 2006: Read, French - Rest
// Golestani N, 2006: Sentences, English - Rest
// Golestani N, 2006: Sentences, French - Rest
// Golestani N, 2006: Sentences, English vs. Read, English
// Golestani N, 2006: Sentences, French vs. Read, French
// Golestani N, 2006: Sentences vs. Read, French - English
// Golestani N, 2006: Read, Five - Three
// Golestani N, 2006: Sentences, Five - Three
// Golestani N, 2006: Correlation between English Sentences - Read Subtraction 
// and Toefl Scores
// Subjects=12
-56	0	44
-28	-88	0
32	-84	4
-48	-64	-12
40	-72	-20
-24	-8	4
-48	-16	56
-32	-88	4
32	-84	4
-48	-64	-12
40	-76	-16
-48	12	20
-36	24	8
-48	24	24
-56	-4	36
-8	4	60
28	-60	48
-32	-84	0
32	-84	4
20	-60	-24
-44	-60	-12
40	-76	-12
-52	-36	52
-36	-56	52
-52	8	20
-52	-4	48
-12	4	60
28	-56	48
-28	-88	0
32	-84	4
36	-72	-20
-44	-60	-12
40	-76	-12
-52	8	16
-40	24	4
-44	28	24
-12	8	56
32	-52	44
-52	-44	56
-36	-52	48
36	-84	4
32	-60	-20
-52	8	16
-44	28	4
-52	32	20
-12	8	60
28	-52	36
-48	4	16
-20	-4	12
0	44	12
-20	-92	8
-44	-76	-12
-24	-92	16
32	-84	16
-8	12	-8
-28	-84	28

// Hoeft F, 2006: Dyslexic Participants
// Subjects=10
-4.75	17.58	53.15
-50.7	15.28	8.21
-47.96	-1.18	50.13
-56.04	3.67	10.57
-62.27	0.09	30.08
-28.72	-98.96	13.54
27.34	-101.82	2.78
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44
-39.62	25.05	31.71
23.01	49.09	32.75
-52.24	-46.8	44.64
-37.14	-46.95	42.15
45.12	-59.76	49.86
64.89	-48.93	-7.57

// Hoeft F, 2006: Age-Matched Participants
// Subjects=10
50.41	51.75	-20.65
-46.56	9.59	-6.98
-9.4	24.95	28.96
3.65	29.98	36.09
46.09	19.96	-27.52
-26.14	-64.06	53.74
40.87	-59.26	55.49
-33.1	-99.39	9.17
31.81	-100.67	14.92
-7.52	-87.65	-15.96
5.51	-53.18	-3.9
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44
-39.62	25.05	31.71
23.01	49.09	32.75
-52.24	-46.8	44.64
-37.14	-46.95	42.15
45.12	-59.76	49.86
64.89	-48.93	-7.57

// Hoeft F, 2006: Reading-Matched Participants
// Subjects=10
-.45	15.26	51.06
-54.11	28.27	-1.98
-64.54	6.91	22.72
-41.65	3.02	37.29
10.24	29.77	44.96
10.01	35.66	27.57
37.57	25.22	-16.69
42.06	21.06	-4.02
-46.63	10.14	-12.64
-46.45	-56.33	-11.67
48.63	-55.99	-13.32
-33.24	-97.14	-1.13
29.56	-99.17	8.08
-20.65	2.99	-10.13
33.42	12.31	-5.25
-9.61	-16.04	3.89
-11.97	-54.7	-19.14
46.45	-71.41	-17.36
-2.58	15.46	53.32
-42.29	19.07	-9.11
44.14	15.02	-11.31
69.36	2.5	14.16
-33.55	-20.66	-9.81
-28.75	-99.17	11.32
31.72	-99.16	8.05
16.32	-15.95	3.44

// Schmahl C, 2006: Borderline Personality Disorder (BPD) Patients
// Subjects=12
-5.26	-15.7	-1.58
10.76	-12.43	-2.03
1.49	10.91	52.99
-43.63	-21.42	10.5
55.74	-11.05	11.83
-30.95	16.64	6.04
-18.16	9.85	-.22
20.35	7.17	2.9
33.16	16.93	4.17
-46.54	-38.25	40.94
48.6	-47.19	40.59
-56.41	8.51	27.09
46.22	3.04	29.72
41.78	25.5	17.85
-30.96	56.07	20.58
41.73	46.91	19.4
-5.26	-15.7	-1.58
7.56	-15.63	-1.73
-43.33	-11.82	52.07
2.52	12.77	49.48
-46.83	-18.1	12.49
52.48	-8.33	6.06
-37.39	16.34	2.8
-24.53	0.3	0.65
20.36	7.26	4.01
36.35	15.73	2
-33.65	-63.8	39.59
46.43	-47.46	37.3
-51.1	1.68	20.91
42.97	2.59	24.22
-40.44	31.15	29.47
36.5	31.53	27.44

// Schmahl C, 2006: Normals
// Subjects=12
-5.26	-15.7	-1.58
-1.74	10.63	49.71
-53.19	-20.96	17.26
60.14	-19.6	24.77
-34.16	16.62	6.08
-11.67	7.41	8.83
20.31	10.09	-.69
36.38	20.47	8.3
-36.88	-50.88	41.89
53.93	-37.39	43.06
46.19	2.78	26.39
-37.34	43.26	20.61
39.71	34.98	30.46
-1.74	10.63	49.71
-52.12	-24.22	16.41
59.08	-19.61	24.78
-30.96	17.69	5.96
-20.26	6.84	2.28
23.52	10.1	-.72
36.37	18.1	5.15
-40.12	-41.38	41.13
34.74	-56.79	41.56
14.46	-64.32	42.42
-46.76	-.95	27.77
52.52	5.22	16.08
-34.2	49.11	13.4
42.72	52.74	12.21

// Yokoyama S, 2006: Japanese and English vs. Controls
// Yokoyama S, 2006: Japanese vs. Control
// Yokoyama S, 2006: English vs. Control
// Yokoyama S, 2006: English vs. Japanese
// Yokoyama S, 2006: Japanese, Active vs. Control
// Yokoyama S, 2006: Japanese, Passive vs. Control
// Yokoyama S, 2006: English, Active vs. Control
// Yokoyama S, 2006: English, Passive vs. Control
// Yokoyama S, 2006: Japanese, Passive vs. Active
// Yokoyama S, 2006: English, Passive vs. Active
// Subjects=36
-46	8	30
-6	8	56
-44	46	-10
-60	-38	-4
-34	-58	46
6	16	52
44	46	-18
34	-58	46
12	-80	-26
-42	24	-18
-56	26	-2
-42	24	18
-42	24	18
-56	-38	-2
-56	-38	-2
-48	-56	48
-40	-58	30
-12	-102	0
14	-84	-30
34	-78	-30
-50	26	20
-50	20	-4
-46	6	30
-48	4	50
-36	-60	48
-10	-92	-6
14	-80	-16
48	-68	-28
-28	-92	-8
-6	-82	-28
-32	-76	-22
-42	24	-18
-44	22	-32
-56	26	-2
-40	22	22
-48	4	50
-54	-38	-2
-58	-50	12
-38	-56	28
-40	-64	38
14	-84	-30
34	-78	30
-44	28	-18
-42	22	28
-54	30	10
-44	8	42
-38	12	52
-40	18	42
-6	6	68
-2	46	36
4	32	48
-62	-42	0
-56	-28	-10
-32	28	-12
-40	-56	-12
-42	-58	30
-38	-70	48
-48	-60	48
14	-82	-32
34	-82	-26
-50	22	-2
-50	8	46
-8	26	44
-36	0	40
-52	-40	-2
32	-74	-32
8	-82	-26
-4	-82	-24
-44	24	-6
-46	22	-18
-48	6	38
-4	6	68
-8	-88	-2
12	-84	-22
-28	-74	46
-52	34	14
-52	20	30
-32	18	-4
-50	20	-10
-6	-88	0

// Carlsson K, 2006: Uncorrelated > Correlated
// Carlsson K, 2006: Correlated > Uncorrelated
// Carlsson K, 2006: Uncorrelated High > Correlated High
// Carlsson K, 2006: Correlated High > Uncorrelated High
// Carlsson K, 2006: Uncorrelated Low > Correlated Low
// Carlsson K, 2006: Correlated Low > Uncorrelated Low
// Carlsson K, 2006: High > Low
// Carlsson K, 2006: Low > High
// Subjects=9
26	48	-4
36	24	2
-30	18	6
28	20	64
-34	8	58
52	18	48
58	18	16
42	12	22
-30	-54	40
46	-48	50
58	-54	18
42	-52	-44
6	52	-2
38	-22	-4
-40	-16	6
54	-14	14
-50	-20	18
-48	-24	62
-54	-36	56
36	-18	-20
-22	-10	-18
6	-86	20
6	-48	-8
26	46	-4
-30	26	10
-30	10	0
-36	10	60
24	-16	76
12	-12	54
-4	-26	60
-40	-80	40
-8	-18	-28
-36	56	-8
-50	46	-10
42	-2	-14
-44	-6	-12
44	-14	6
-44	-22	10
-16	-14	-20
-12	-80	14
-28	-64	-8
-10	-48	-12
50	14	52
42	10	24
22	20	60
44	6	40
32	22	-2
48	-54	58
38	-52	50
40	-52	-46
10	48	0
-60	0	26
-60	-6	24
52	-10	16
-64	-20	30
-52	-22	56
-34	-24	34
-38	-26	60
-40	-16	52
10	-100	22
10	-82	22
-28	-14	-20
38	-16	-18
-10	-52	-20
-34	24	-12
34	18	-16
-2	52	12
2	38	20
8	16	40
8	6	40
-10	0	42
-10	-16	44
50	26	-6
-50	30	0
36	12	6
-34	10	-4
46	-16	0
-40	-18	-6
42	-22	20
-42	-26	24
-28	-30	64
-42	-26	66
6	-32	-28
10	-24	-10
2	-86	10
-14	-58	-20
16	-46	-18
10	-64	-44
16	42	-20
-18	48	-18

// Diedrichsen J, 2006: Congruency Effect for Spatial Cues
// Diedrichsen J, 2006: Congruency Effect for Symbolic Cues
// Diedrichsen J, 2006: Symbolic > Spatial
// Subjects=15
-18	-80	54
10	-84	46
16	-72	62
28	-70	60
-6	-84	-28
-12	-78	-32
-16	-80	56
-8	-78	56
-16	-88	42
-26	-60	56
18	-78	54
12	-74	60
-10	22	46
0	28	46
-26	-70	40
-36	-50	38
-26	60	-6
-32	44	-12
-36	52	-6
-40	-2	32
-50	2	38
32	-90	-10
38	-78	-18
-22	-98	-10
-28	-88	-29

// Yoon H W, 2006: Picture > Fixation
// Yoon H W, 2006: Chinese Character > Fixation
// Yoon H W, 2006: Chinese Character > Picture
// Yoon H W, 2006: Picture > Chinese Character
// Subjects=14
-41.59	-55.44	-16.78
43.93	-69.91	-18.78
-47.87	22.82	32.49
-50.07	-61.33	-9.5
52.48	-63.34	-17.2
-22.34	-28.75	-3.63
-47.89	20.36	28.23
39.4	30.66	-11.55
44.42	-49.45	53.1
-2.89	30.63	46.93
22.61	-5.79	14
-7.09	-16.95	37.58
-43.43	-15.05	37.84
-4.9	18.79	59.09
41.81	-65.35	-14.68
-28.7	-67.88	-13.66

// Denkova E, 2006: Autobiographical vs. Semantic
// Denkova E, 2006: Autobiographical vs. Unknown
// Denkova E, 2006: Semantic vs. Unknown
// Denkova E, 2006: (Autobiographical, Faces vs. Semantic, Faces) vs. 
// (Autobiographical, Names vs. Semantic, Names)
// Denkova E, 2006: (Autobiographical, Names vs. Semantic, Names) vs. 
// (Autobiographical, Faces vs. Semantic, Faces)
// Denkova E, 2006: (Semantic, Faces vs. Unknown, Male Faces) vs. (Semantic, 
// Names vs. Unknown, Male Names)
// Denkova E, 2006: (Semantic, Names vs. Unknown, Male Names) vs. (Semantic, 
// Faces vs. Unknown, Male Faces)
// Subjects=12
-38	-84	28
-32	-82	38
-10	-58	8
-6	-52	0
-6	32	28
-26	12	58
-6	-64	44
-30	-34	-20
-20	-38	-18
-22	22	44
-40	50	16
-48	16	-2
-6	-40	36
-26	-18	-28
-46	28	2
-2	-52	10
-6	-52	2
-46	-72	28
-36	-78	40
-40	52	16
-6	28	46
-60	-38	-16
38	38	30
14	-2	-2
16	-2	12
2	66	20
-10	70	12
34	14	-6
-8	52	-18
-12	8	10
44	54	14
-26	-32	-22
24	-30	-22
-38	-78	44
-52	-68	34
32	44	0
-24	60	14
6	28	46
-2	-40	34
-36	24	-4
42	-72	44
-40	44	-10
-62	-28	-16
20	-14	66
-20	-30	-24
-46	-60	-16
-32	-34	16

// Eickhoff S B, 2006: Main Effect of Anal Canal Stimulation
// Eickhoff S B, 2006: Main Effect of Rectal Stimulation
// Subjects=8
-54	-12	18
6	-22	-6
-42	2	-6
-62	4	10
-2	-12	4
-6	-28	6
20	6	6
-44	-12	4

// Saito Y, 2006: Spontaneous Singing > Synchronized Singing
// Saito Y, 2006: Synchronized Singing > Spontaneous Singing
// Saito Y, 2006: Spontaneous Speaking > Synchronized Speaking
// Saito Y, 2006: Synchronized Speaking > Spontaneous Speaking
// Saito Y, 2006: Spontaneous Singing > Spontaneous Speaking
// Saito Y, 2006: Synchronized Singing > Synchronized Speaking
// Subjects=20
-33.75	40.17	-13.59
-46.18	-35.75	13.18
44.53	-32.45	9.07
-56.9	-25.28	22.42
55.47	-17.13	23.06
-44.43	27.99	-5.48
-50.66	-33.62	1.84
-58.91	-48.27	29.21
55.51	18.15	33.01
49.47	31.95	-14.19
3.6	29.67	32.76
57.39	-21.12	3.25
55.6	7.93	38.51
44.09	25.55	-13.47
3.6	23.08	31.17
66.13	-28.01	9.39
53.05	-1.57	5.87
50.69	3.45	-9.15
-52.53	-19.43	27.37

// Juckel G, 2006: Schizophrenic Patients
// Subjects=10
-15.25	10.66	-8.74
-18.5	7.25	-10.59

// Juckel G, 2006: Normals
// Subjects=10
-21.72	7.45	-8.31
10.67	7.35	-11.1
-24.91	7.75	-4.93
-11.96	10.98	-5.47
10.75	11.27	-3.64
-41	-1.26	2.96
-33.88	-54.49	41.72
-27.7	-77.48	13.64
7.49	-24.98	-12.33
-15.25	10.66	-8.74
-15.3	12.48	-12.28
10.67	7.35	-11.1
-15.3	12.48	-12.28
20.44	20.88	-4.76
-44.39	22.78	-3.84
-50.78	1.59	-.52
-52.71	-31.73	10.66
-50.56	-53.72	4.95
53.13	-60.05	0.45
-44.18	-16.16	4.49
-24.88	-24.78	-8.43
30.36	-48.74	-3.64
36.9	-45.01	1.48
-14.83	-62.85	8.61
24.07	-65.91	8.25
-17.92	-86.91	15.52
-18.13	-25.02	11.65
7.49	-15.2	-11.05
-18.5	7.25	-10.59

// Kumari V, 2006: Violent Schizophrenia
// Subjects=12
57.76	10.06	38.26
-50.53	7.81	20.15
-48.55	10.83	6.38
-50.69	19.75	10.01
43.98	58.63	-15.62
37.72	51.55	0.88
42.12	60.9	8.84
12.38	25.21	42.01
-30.45	-53.02	57.21
-43.53	-51.77	48.34
53.53	6.42	45.41
61.98	4.99	29.72
38.51	1.67	52.86
-43.59	-21.58	49.84
-23.85	-54.3	66.19
53.77	-33.37	56.07
-43.41	-37.76	60.4
38.75	-43.65	61.82
3.19	-77.4	-21.63
9.57	-58.44	-25.86
22.48	-58.81	-30.53
-30.71	15.04	50.48
44.87	12.77	44.93
8.41	-59.68	52.72
-30.75	16.96	48.05
31.9	21.44	46.54
8.44	-59.48	54.94
51.61	-46.56	52.93
60.21	-44.61	50.35
40.41	33.61	38.46
42.97	-48.72	53.29
48.62	47.96	7.77
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
16.13	-11.87	-10.41

// Kumari V, 2006: Non-violent Schizophrenia
// Subjects=13
-45.81	8.61	51.37
-34.97	13.32	55.2
55.23	16.07	10.81
23.68	-67.31	62.18
49.52	-43.82	59.42
-21.76	-65.76	58.32
-37.17	17.36	52.6
-48.06	16.7	46.13
35.95	39.15	29.03
50.93	46.88	19.04
-50.57	33.76	22.07
55.23	16.07	10.81
-50.35	28.83	38.24
-7.14	35.57	39.08
8.03	31.58	41.46
27.96	-69.83	57.88
34.32	-75.1	47.08
-49.91	-48.84	57.13
53.75	-42.3	52.47
-43.51	-49.44	50.35
-41.47	-48.13	41.22
36.32	2.52	50.57
49.3	4.9	52.36
-59.11	12.66	26.54
68.33	10.57	20.1
-49.95	-22.9	59.04
-43.51	-36.26	53.53
45.17	-44.04	57.27
51.47	-32.29	44.8
34.42	-50.25	60.31
37.58	-61.09	-32.8
12.75	-55.21	54.45
8.43	-57.35	54.73
60.21	-44.61	50.35
55.57	9.85	36.07
43.06	-56.81	58.57
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
-63.46	-37.94	13.7
16.13	-11.87	-10.41

// Kumari V, 2006: Violent Antisocial Personality Disorder
// Subjects=10
51.29	21.09	41.76
32.03	18.02	55.84
53.6	17.88	53.24
3.6	29.67	32.76
7.95	37.54	36.39
-65.27	-39.71	40.8
53.68	-45.05	46.02
-52.24	-41.38	45.22
55.85	-33.99	49.37
-47.74	-44.37	58.89
47.27	-51.04	51.21
6.34	-52.48	61.01
-2.33	-52.72	58.94
46.87	40.01	37.72
-22.13	29.97	48.85
-30.7	19.51	52.28
-17.73	26.14	53.64
46.95	18.74	39.82
49	17.92	30.91
39.53	17.63	51.27
-52.76	33.54	19.89
53.03	48.6	14.35
55.24	29.25	13.99
5.87	40.28	42.87
40.69	-60.61	41.06
58.07	-48.87	50.81
64.51	-38.21	49.64
-2.31	-56.97	59.36
-32.79	9.07	55.59
32.01	13.55	54.04
-61.13	-23.51	30.16
38.45	4.45	48.11
-39.12	-37.96	58.11
60.09	-19.29	45.6
-2.53	13.64	56.86
1.53	22.63	37.97
31.13	-60.9	-30.47
1.58	16.46	40.82
4.16	-63.54	57.66
-48.06	7.98	44.75
1.65	21.33	47.06
6.29	-61.61	55.19
-45.87	8.19	46.93
40.41	33.61	38.46
42.97	-48.72	53.29
48.62	47.96	7.77
55.57	9.85	36.07
43.06	-56.81	58.57
-65.57	-37.53	18.17
-46.44	1.71	0.52
29.12	3.68	-5.45
-50.61	-23.42	7.56
-48.59	-.43	0.77
16.13	-11.87	-10.41

// Kumari V, 2006: Healthy Controls
// Subjects=13
40.54	14.88	44.8
29.79	22.91	50.91
53.43	18.77	39.71
-50.19	8.18	47.01
-28.59	19.1	47.8
-34.99	12.05	53.09
40.31	37.24	31.38
48.74	48.79	16.65
-39.82	46.56	20.62
-46.33	39.74	16.92
-50.73	45.69	11.93
39.75	26.5	-14.61
52.7	22.08	-16.63
1.64	16.87	45.26
5.76	30.74	32.62
14.64	15	47.47
-45.66	-44.98	52.19
17.26	-66.91	66.73
21.48	-71.98	58.2
64.43	-38.84	42.98
57.49	-46.64	5.77
49.45	-46.57	52.97
39.8	66.24	-2.85
38.19	41.9	35.44
38.4	15.08	47.06
53.23	19.44	23.96
-44.5	50.43	-6.58
-50.61	22.5	16.46
41.93	28.84	-12.64
-2.88	30.71	32.77
5.75	32.86	32.4
3.79	25.59	46.6
-16.06	-1.61	9.29
-11.06	-52.31	52.32
10.57	-59.68	52.68
-43.49	-47.1	52.36
-3.44	-82.92	-34.42
44.02	-70.2	-38.73
-29.35	-80.68	-31.96
-31.65	-57.6	-37.57
49.24	6.61	47.71
34.18	4.85	52.62
-43.59	6.91	55.98
-36.1	-17.71	44.85
-54.35	-19.07	54.26
-48.57	1.91	2.78
-61.52	10.78	6.6
-52.62	12.68	26.43
8.2	10.93	50.22
-.41	-4.2	49.62
-6.91	13.21	52.49
59.51	-69.57	-9.92
-61.24	-39.64	18.31
9.53	-63.11	-29.88
24.59	-61.34	-34.79
5.37	-75.05	-19.66
-30.71	15.04	50.48
44.87	12.77	44.93
8.41	-59.68	52.72
-30.75	16.96	48.05
31.9	21.44	46.54
8.44	-59.48	54.94
51.61	-46.56	52.93
-63.46	-37.94	13.7
-50.61	-23.42	7.56
-48.59	-.43	0.77

// Adcock R A, 2006: MID Anticipation: Any Reward vs. +$0
// Adcock R A, 2006: MID Anticipation: +$5 vs. +$0
// Adcock R A, 2006: MID Anticipation: +$5 vs. +$1
// Adcock R A, 2006: MIE Anticipation: Main Effect of Reward Cue Value Across 
// Intervals
// Adcock R A, 2006: MIE Anticipation: Antecedent to Stimulus Onset (Cue)
// Adcock R A, 2006: MIE Anticipation: During Stimulus Presentation
// Adcock R A, 2006: Memory-Related Activation During High Value Cue
// Adcock R A, 2006: Memory-Related Activation During Low Value Cue
// Adcock R A, 2006: Memory-Related Activation During Low Value Stimulus
// Adcock R A, 2006: Memory-Related Activation Main Effect
// Adcock R A, 2006: Memory-Related Activation Antecedent to Stimulus Onset 
// (Cue)
// Adcock R A, 2006: Memory-Related Activation During Stimulus
// Subjects=12
6.41	-14.29	-11.86
-3.21	-15.49	-12.77
-11.76	5.32	-4.38
11.75	8.81	-2.71
9.67	0.59	1.35
-5.28	0.59	2.63
3.4	-22.2	10.02
-.88	-22.22	10.07
19.17	1.65	-13.35
-12.86	1.71	-9.64
-.97	32.82	19.96
31.1	44.1	25.33
33.01	20.94	-12.89
-34.27	13.22	-10.36
-33.11	23.05	6.65
19.6	-67.57	13.64
-21.43	-66.64	-39.5
6.41	-14.29	-11.86
-3.21	-15.49	-12.77
11.7	3.89	-11.22
-10.69	5.33	-4.39
39.72	-44.07	-.83
8.56	11.07	-.63
8.62	-.39	2.56
-5.28	1.64	2.55
3.41	-17.71	12.99
-.87	-19.94	12.11
19.18	0.59	-13.26
-12.86	0.57	-10.66
-44.94	19.93	-5.22
-1	39.08	18.32
33.02	19.88	-12.81
-35.33	12.24	-9.15
-21.43	-66.64	-39.5
-3.21	-13.29	-11.84
11.71	5.03	-10.2
36.45	-34.83	-4.91
-26.66	-21.63	-7.52
-4.31	16.03	-4.25
3.37	-13.65	10.42
49.14	20.92	-.81
-47.07	16.74	-4.93
0.05	40.06	17.11
7.31	66.39	-.8
-36.39	10.12	-8.96
19.59	-65.45	13.46
-9.61	-21.96	-13.27
-11.84	4.55	-14.35
21.35	-14.37	-14.26
35.21	-23.43	-22.58
35.46	-48.33	-.42
-36.17	-44.7	-2.13
18.21	-4.99	-2.74
23.53	17.85	3.09
42.66	-10.53	-21.52
39.62	-25.29	-5.75
-26.47	-28.46	14.24
-31.93	-31.81	-1.03
40.58	-30.8	-22.02
-64.01	9.46	12.6
-39.36	-35.74	3.84
5.62	-41.05	13.81
9.86	-78.77	-6.5
35.18	-39.18	-33.53
-13.91	-27.78	-19.42
-35.32	-37.06	-27.32
41.7	-77.55	-34.84
11.62	-55.15	-45.3
-8.53	-23.01	-13.19
-10.77	5.61	-14.45
26.67	-11.34	-16.81
34.14	-23.44	-22.57
34.39	-49.39	-.32
-37.23	-47.96	-2.96
-64.01	8.41	12.69
-39.35	-36.8	3.93
35.18	-39.18	-33.53
-35.32	-37.06	-27.32
10.8	-73.53	-21.44
-39.46	-59.83	-18.67
-32.98	-78.91	-18.26
-9.6	-20.81	-12.25
-9.7	5.62	-14.46
21.37	-16.4	-12.97
16.12	-5.54	4.02
25.7	16	6.56
15.01	-1.58	0.35
-14.97	-1.3	-7.13
41.78	-30.57	-5.33
-31.91	-32.7	1.27
-4.2	-33.39	-10.14
-5.16	-78.4	-14.16
-5.35	-13.3	-11.81
14.96	-16.44	-12.9
8.48	11.36	-10.69
23.42	-12.93	-23.33
-20.39	-12.05	-21.78
30.05	-33.64	-2.71
-8.54	9.91	-.34
-33.01	-1.18	9.79
39.39	44.75	-8.27
-53.51	37.22	-1
45.94	28.73	4.15
6.53	25.38	19.38
9.79	12.79	21.51
56.99	-13.65	33.22
-57.39	-12.48	31.09
-63.79	-38.75	22.22
8.85	-56.17	10.58
28.75	-48.19	-39.39
-8.55	-46.24	-24.63
23.35	-16.96	-34.14
8.7	14.81	20.24
-44.69	-8.22	16.09
-54.48	-36.4	-17.12
30.07	-46.67	-6.08
-35.13	-43.89	-5.56
8.47	11.27	-11.8
22.44	-10.93	-11.21
9.77	14.82	20.23
-61.72	6.7	31.77
48.39	-14.21	26.68
-4.28	-11.09	-10.89
8.48	11.36	-10.69
20.13	-12.66	-33.35
-11.77	11.84	-2.69
13.92	-9.5	-5.66
-29.87	-16.19	-5.71
9.77	14.82	20.23
-61.73	6.62	30.66
-47.89	-7.1	17.15
48.38	-14.3	25.57
-51.28	-33.12	-16.31
-33	-41.76	-5.76

// Chang L, 2006: THC+ Users
// Subjects=12
12	60	9
-27	-54	63
27	-54	-51
-39	-33	54
-21	-75	36
-15	-75	-6
-21	0	-24
24	-42	42
-12	60	9
6	12	51
6	-54	66
-18	-75	36
21	-66	-12
6	12	51
30	3	54
48	9	24
-27	0	57
33	-72	30
33	-48	60
-27	-42	66
12	-72	-3
-39	-66	-3
45	-63	-3
-30	-63	-27
9	-42	-48
42	-21	30
-42	15	-12
33	-72	30
-15	-75	-6
15	-78	-39
36	-36	27
15	54	36
-12	-75	-3

// Chang L, 2006: THC- Users
// Subjects=12
-21	-3	63
-36	21	-3
27	3	51
3	-48	69
30	-60	-18
-27	-6	30
30	-48	33
39	15	-27
-18	-78	-6
24	-42	42
-12	60	9
6	12	51
6	-54	66
-18	-75	36
21	-66	-12
12	18	54
45	-33	36
-33	-57	-39
24	-54	60
-39	-42	54
-6	60	12
39	-66	-33
45	-36	33
36	-36	27
15	54	36
-12	-75	-3

// Chang L, 2006: Normals
// Subjects=19
-21	-3	63
-36	21	-3
27	3	51
3	-48	69
30	-60	-18
-27	-6	30
30	-48	33
39	15	-27
-18	-78	-6
12	60	9
-27	-54	63
27	-54	-51
-39	-33	54
-21	-75	36
-15	-75	-6
-21	0	-24
27	-57	57
-24	-45	51
21	6	57
24	-54	60
-39	-42	54
-6	60	12
39	-66	-33
45	-36	33
42	-21	30
-42	15	-12
33	-72	30
-15	-75	-6
15	-78	-39

// Jager G, 2006: Novel Set > Contrasl Task, STERN
// Jager G, 2006: Tones, SAT > Rest
// Jager G, 2006: Tones, SAT - Dots, SAT
// Subjects=10
42	5	28
34	-59	44
6	5	56
-34	-63	44
42	-67	-12
-46	13	36
-2	13	48
-58	-31	4
58	-23	8
-46	21	-4
-58	-27	0
58	-31	8
-6	-67	8
-2	-83	32

// Deeley Q, 2006: Psychopathic Subjects
// Subjects=6
35.32	-67.3	-25.59
32.24	-85.84	-17.31
-41.6	-71.99	-24.32
-32.96	-83.06	-16.8
-41.18	-18.24	51.46
28.96	-78.97	-24.54
35.4	-74.19	-18.33
-41.23	-18.75	44.82
43.75	17.11	-8.24
28.27	-67.29	30.25
43.87	-67.25	-25.7
35.36	-62.56	-19.3
-37.25	-78.85	-17.1
-37.16	-77.91	-4.91
-36.93	-27.19	45.47
35.49	-85.39	-11.81
-6.2	-94.53	-16.14
-29.86	-67.69	-24.81
-32.7	-14.47	44.36
27.96	-73.8	-12.7
35.54	-84.88	-5.16
27.92	-74.23	-18.24
39.61	-71.5	-25.29
24.73	-78.48	-17.84
-41.46	-82.68	-11.16
35.87	-61.65	47.53
8.91	4.81	42.26
-21.82	-66.22	48.57

// Deeley Q, 2006: Normals
// Subjects=9
35.32	-67.3	-25.59
32.24	-85.84	-17.31
-41.6	-71.99	-24.32
-32.96	-83.06	-16.8
-41.18	-18.24	51.46
28.96	-78.97	-24.54
35.4	-74.19	-18.33
-41.23	-18.75	44.82
43.93	19	16.14
32.56	-58.38	35.03
-41.18	-18.24	51.46
35.32	-67.3	-25.59
-41.48	-78.45	-11.51
24.8	-85.45	-11.68
5.8	5.82	55.6
35.49	-85.39	-11.81
-6.2	-94.53	-16.14
-29.86	-67.69	-24.81
-32.7	-14.47	44.36
27.96	-73.8	-12.7
35.54	-84.88	-5.16
27.92	-74.23	-18.24
35.42	-78.42	-17.97
27.9	-83.21	-24.18
-21.99	-71.28	24.47
-32.63	-18.19	51.36
-37.47	-57.05	-37.89
-17.97	-90.37	-16.36
-29.89	-60.29	-25.43
-6.17	-77.72	-5.29
-22.43	8.77	-0.08

// Eickhoff S B, 2006: Left Anodal, Right Cathodal Stimulation > Rest
// Eickhoff S B, 2006: Right Anodal, Left Cathodal Stimulation > Rest
// Subjects=11
38	-26	20
60	-6	8
36	-4	-20
-46	-20	16
-38	-22	20
40	-26	22
-42	-6	-6
-48	-36	26

// McBride D, 2006: Expectant Smokers
// Subjects=10
-4	30	24
-4	40	8
0	56	22
-8	60	-14
-36	12	2
-2	-16	36
50	-34	2
-8	-58	36
4	-58	36
-2	-6	6
-56	2	34
56	6	35
-26	-14	54
26	-14	56
-38	-6	16
38	-2	15
-40	-45	58
36	-44	52
-57	-26	38
54	-27	42
-26	-58	55
27	-58	58
-22	-81	38
25	-80	41
-33	-85	10
35	-82	10
-26	-52	-13
30	-56	-13
-48	-68	-2
53	-61	-6
-16	-8	26
-4	30	12
-10	24	30
6	46	8
0	58	20
2	32	32
-8	60	-14
-30	36	42
20	58	34
-4	-24	26
58	-56	24
6	-74	32
-4	-74	26
-8	-58	36
-2	28	18
10	-20	26
18	-10	-10
-8	-58	36
50	-32	2

// McBride D, 2006: Non-Expectant Smokers
// Subjects=10
-4	30	24
-4	40	8
0	56	22
-8	60	-14
-36	12	2
-2	-16	36
50	-34	2
-8	-58	36
4	-58	36
-2	-6	6
-56	2	34
56	6	35
-26	-14	54
26	-14	56
-38	-6	16
38	-2	15
-40	-45	58
36	-44	52
-57	-26	38
54	-27	42
-26	-58	55
27	-58	58
-22	-81	38
25	-80	41
-33	-85	10
35	-82	10
-26	-52	-13
30	-56	-13
-48	-68	-2
53	-61	-6
54	-36	4
-2	28	18
10	-20	26
18	-10	-10
-8	-58	36
50	-32	2

// Mohamed F B, 2006: Guilty Subjects
// Subjects=6
-17	-83	-6
-35	-85	8
39	-9	19
28	-47	-10
-38	15	17
-52	-1	15
-52	-9	12
6	39	-5
-20	-18	23
36	-48	45
-56	15	25
-4	54	38
6	-5	13
0	-88	-4
-6	4	9
-14	-20	20

// Mohamed F B, 2006: Non-Guilty Subjects
// Subjects=5
30	-27	-2
-20	-56	56
46	-79	21
2	-44	56
50	-4	41
-14	-45	35
12	-59	62
0	-62	9
-16	17	-9
-22	19	-3
20	-50	54
-64	-22	-16
-48	-40	48
-4	-26	33
42	-1	37

// Goekoop R, 2006: Correct Recognition of Familiar Faces Averaged Across Pre- 
// and Post-Treatment of Both Groups
// Goekoop R, 2006: Interaction Between Activation Levels of Raloxifene and 
// Placebo Groups at Pre- and Post-Treatment
// Subjects=14
2	-82	4
-31	-73	-10
-30	-72	-12
25	-35	-2
-23	-38	2
50	8	-3
48	10	-2
-40	4	0
0	-40	60
36	-62	40
-38	-62	39
-35	10	55
40	0	0
43	28	40
-40	28	42
-39	-10	54
-42	-23	55
-26	-38	-2
52	22	16

// Jackson P L, 2006: Pain Related Sites of Activation
// Jackson P L, 2006: Self vs. Other
// Jackson P L, 2006: Others vs. Self
// Subjects=18
-6	24	39
6	21	42
33	21	0
-30	18	3
60	12	24
-48	9	3
-21	9	0
15	6	0
-12	-12	0
63	-18	36
-60	-21	33
42	-45	51
-30	-51	54
-36	-48	-39
42	3	-6
-42	3	-6
-42	-3	12
0	0	36
-21	-15	3
-63	-24	36
66	-27	42
63	-30	27
30	-36	63
-15	-54	66
51	18	48
48	-57	27
-45	-60	27
-51	-69	39
-12	-60	36
3	-66	39

// Mostofsky S H, 2006: Normal Children
// Subjects=11
51.56	-27.21	53.26
-43.43	-18.2	62.95
23.21	-48.94	29
43.02	-28.64	61.39
-49.94	-29.38	58.56
26.82	-63.05	-30.18
-27.11	-75.69	-24.65
12.39	14.37	40.85
47.34	-26.5	61.1
36.44	-27.26	53.52
27.96	-41.35	64.02

// Mostofsky S H, 2006: Children with Attention-Deficit / Hyperactivity 
// Disorder (ADHD)
// Subjects=11
-52.16	-15.56	57.23
12.02	-80.37	-8.04
-16.1	-85.04	-10.46
8.23	14.43	53.24
51.59	-12.76	58.55
-55.63	-.87	42.39
18.64	-95.68	0.08
-22.81	-60.47	-22.87
-16.1	-85.04	-10.46
8.15	8.39	45.99
47.34	-26.5	61.1
36.44	-27.26	53.52
27.96	-41.35	64.02

// Santel S, 2006: Anorexia Nervosa Patients
// Subjects=13
-50	-28	26
12	-82	-8
27	-91	-6
30	-77	-21
-18	-96	-3
-18	-86	-21
-24	-93	-2
24	-79	-14
18	-93	13

// Santel S, 2006: Normals
// Subjects=10
-50	-28	26
12	-82	-8
18	-93	0
30	-90	10
-12	-99	0
-12	-91	-8
21	-91	-3
33	-71	-17
-15	-96	-3
15	19	27
-33	40	-12
-48	-10	-15

// Xiao Z, 2006: Water-Related Images > Neutral Scene Images
// Xiao Z, 2006: Drug-Related Images > Neutral Scene Images
// Subjects=14
4.05	41.37	-14.35
-54.97	24.4	14.11
50.9	28.07	13.06
-28.63	-83.99	24.38
-46.38	-66.75	-8.4
41.16	-78.25	-9.87
-28.02	-76.57	-11.1
30.27	-70.19	-14.96
2.27	-82.74	-9.88

// Dimitrova A, 2006: Activation in Finger Movement
// Dimitrova A, 2006: Activation in Foot Movement
// Dimitrova A, 2006: Activation in Tongue Movement
// Subjects=12
6	-60	-24
8	-74	-44
14	-38	-24
28	-46	-30
24	-46	-20
40	-54	-26
-2	-72	-44
-6	-64	-20
-46	-60	-30
-28	-50	-24
-6	-38	-42
18	-34	-24
28	-34	-30
8	-66	-36
16	-60	-26

// Staresina B P, 2006: Increasing Activation Across Subsequent Memory 
// Conditions
// Staresina B P, 2006: Free Recall-Specific Network (Conjunction/Masking 
// Analysis)
// Staresina B P, 2006: Successful Word/Color Binding
// Subjects=16
-51	18	18
21	-21	-21
-66	-45	-9
-33	21	-3
42	-39	-27
-51	30	9
-24	-15	-18
-3	-51	18
-39	-54	57
-45	21	21
-51	21	30
-39	15	57
-30	30	48
-18	54	33
-30	21	-3
3	51	42
-39	-54	57
-57	-54	30
-36	-69	42
54	-60	39
39	-57	42
-3	-51	15
-60	-54	-3
-66	-48	-9
-48	-33	-18
42	-39	-30
-3	0	6
-15	0	18
-30	-6	-36

// Calhoun V D, 2006: Normals > Schizophrenic Patients
// Calhoun V D, 2006: Schizophrenic Patients > Normals
// Subjects=15
-56.42	18.4	-15.53
-56.37	18.71	-12.2
1.93	15.76	67.78
-56.16	-30	-5.14
-50.58	-24.28	9.88
-62.71	14.31	-1.57
-44.42	14.92	-7.55
1.89	11.09	63.76
-53.76	-23.87	14.38
-38.13	60.57	-13.29
-49.98	-60.3	49.3
1.25	-50.55	1.52
-2.94	24.77	26.63
-57.72	-45.21	38.97
-16.47	3.03	-21.41
-16.48	7.28	-21.83
-3.23	1.86	-.23
-3.09	-55.13	-1.32
-.98	-2.93	5.81
-7.34	28.59	21.84
-55.5	-59.03	40.3
64.7	7.65	-10.93
52.72	18.89	-16.32
8.48	11.94	72.53
64.67	3.08	-13.84
62.79	-13.45	4.64
58.4	-1.97	1.34
50.97	-15.2	9.5
17.07	11.56	67.94
56.39	-12.85	11.41
45.05	6.47	57.88
65.23	-32.19	22.14
1.27	-53.74	1.83
3.57	22.87	28.95
65.23	-45.27	20.07
20.35	-.58	-16.08
20.27	5.39	-21.15
22.54	-1.42	-13.79
3.34	-2.92	5.73
-15.3	-65.94	55.99
-28.51	-85.29	33.47
-23.93	-.18	70.92
-32.84	-81.05	33.13
-23.91	-4.44	71.34
-37.17	-78.94	32.99
-32.9	-81.46	28.69
-37.13	-74.27	37.01
-43.48	-14.16	60.31
-26.18	0.25	64.19
-4.41	-32.44	69.29
30	-79.48	46.47
27.82	-81.82	44.5
29.76	19.41	47.89
47.11	-76.31	33.54
47.1	-72.05	33.12
31.88	-93.56	22.06
44.97	-73.98	35.59
27.88	-72.59	51.43
34.1	15.17	48.24
4.18	-26.23	66.29

// Coan J A, 2006: Threatened - Safe, No Hand Holding
// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Spouse, 
// Threatened
// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Stranger, 
// Threatened
// Coan J A, 2006: Hand Holding with Stranger > Hand Holding with Spouse, 
// Threatened
// Coan J A, 2006: Negative Correlations between WDAS and Threat-Related 
// Activation during Hand Holding with Spouse
// Coan J A, 2006: Positive Correlation between Shock Pain Ratings and 
// Threat-Related Activation
// Subjects=16
5.71	11.48	46.2
-9.09	-2.3	62.03
11.26	-2.81	67.41
-11.91	42.24	-8.59
4.13	47.88	-5.9
35.39	39.89	25.64
-40.28	-.14	37.67
13.67	48.31	-14.97
-37.36	39.75	16.45
40.58	18.58	-2.75
-28.9	22.39	-2.27
9.67	9.31	3.96
-9.42	-.27	19.48
-7.47	5.52	-2.21
30.96	5.32	-8.22
-10.53	-12.76	9.39
2.16	-13	-8.58
4.38	-28.59	-3.95
11.07	-55.3	21.63
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
54.76	-26.66	16.5
-11.91	42.24	-8.59
-7.47	5.52	-2.21
4.38	-28.59	-3.95
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
-11.91	42.24	-8.59
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
35.39	39.89	25.64
-9.09	-2.3	62.03
40.58	18.58	-2.75
2.16	-13	-8.58
40.58	18.58	-2.75
2.16	-13	-8.58

// Assaf M, 2006: Schizophrenic Patients
// Subjects=16
11.32	7.88	40.39
8.33	23.98	63.5
-11.49	53.95	40.7
-8.91	59.92	-10.36
-43.56	-2.77	55.82
-51.12	36.19	-20.74
58.03	36.89	-19.31
-37.46	28.35	32.47
-49.88	-49.69	59.45
1.61	-53.38	28.68
-69.12	-36.64	-6.51
-31.84	8.76	-39.65
33.04	2.92	-36.81
-5.38	-4.63	-.67
4.35	-4.6	-.84
-11.88	18.2	2.78
17.22	14.49	-4.07
-21.83	-4.33	-19.47
30.11	-32.01	-19.86
-5.53	-9.07	-13.68
-14.41	0.52	55
14.59	11.39	43.34
4.13	16.8	-13.04
-32.59	-13.5	66.78
52.7	38.45	-13.77
33.8	28.29	27.9
-34.18	-84.09	12.16
54.83	63.44	-10.68
-48.01	9.01	-36.04
29.79	6.1	-37.07
-31.5	-9.47	-16.56
30.33	-42.36	-4.27
-39.27	-57.7	42.13
47.1	-54.51	36.98

// Assaf M, 2006: Normals
// Subjects=16
-1.86	37.95	29.79
-2.34	41.97	-7.58
-41.3	47.9	-10.86
61.49	29.74	-4.09
-43.75	11.19	44.36
53.08	39.13	16.41
-55.5	-52.44	41.89
47.08	-49.2	36.46
11.55	-57.21	44.58
-65.82	-49.29	-4.19
-30.69	9.28	-34.12
61.27	-11.25	-29.17
-5.38	-11.22	-2.26
10.74	7.87	-5.55
-2.12	-23.12	-3.38
-14.41	0.52	55
14.59	11.39	43.34
4.13	16.8	-13.04
-32.59	-13.5	66.78
52.7	38.45	-13.77
33.8	28.29	27.9
-34.18	-84.09	12.16
54.83	63.44	-10.68
-48.01	9.01	-36.04
29.79	6.1	-37.07
-31.5	-9.47	-16.56
30.33	-42.36	-4.27
-39.27	-57.7	42.13
47.1	-54.51	36.98

// Ongur D, 2006: Normals
// Subjects=15
20	-66	42
-38	-58	34
36	14	-6
-56	34	-14
4	26	56
52	18	2
-30	20	56
-6	-28	6
0	4	28
54	-38	-16
32	-22	-28
-38	-24	-22
36	-60	46
-10	18	38
32	-48	52
-30	-58	62
28	-50	52

// Ongur D, 2006: Schizophrenic Patients
// Subjects=15
32	40	-16
0	4	70
64	-12	-22
-58	-8	-4
36	-60	46
-10	18	38
22	-40	66
36	14	0
-34	30	-8
44	4	40
28	-50	52

// Ragland J D, 2006: Normals
// Subjects=13
-45	9	29
-45	22	17
-38	13	43
-22	7	55
30	-16	49
-4	21	43
-4	-36	27
-34	-52	47
-15	-44	-15
49	-26	-5
-55	12	25
-51	26	21
-34	11	55
-4	24	43
-41	-52	54
-15	-59	62
19	-56	36
-15	-88	-6
30	-80	1
-4	-52	-28
41	-64	-34
30	-29	5
22	-37	-5
-51	-19	-12
51	-26	-5
41	-58	10
-45	15	10
-49	13	40
-45	30	21
-38	10	51
38	21	43
-11	-3	19
-41	-56	50
26	-63	-20

// Ragland J D, 2006: Schizophrenic Patients
// Subjects=13
-30	17	47
-11	0	7
11	-8	0
49	-26	-5
-26	-64	44
49	-26	-5
-30	17	47
-19	2	48
41	20	36
-34	19	3
8	21	43
0	-32	27
-11	0	7
26	-25	1
22	-37	-2
-8	-60	40
-34	-75	37
-45	-56	43
45	-41	50
-8	-77	-13
30	-29	5
22	-37	-5
-51	-19	-12
51	-26	-5
41	-58	10
49	11	3
-49	4	3
19	-42	39
-55	-4	-3

// Weiss A P, 2006: Schizophrenia Patients
// Subjects=16
37.83	23.9	3.61
22.82	59.75	20.49
42	62.2	-.25
16.85	-56.85	36.61
57.91	-52.25	37.7
-30.82	-60.19	26.55
-28.69	-60.39	24.29
-36.1	-63.01	-49.28
-.42	-32.68	43.48
-31.84	10.99	-38.75
28.91	56.86	-10.7
-25.12	67.52	-8.6
61.37	24.45	-14.77
50.37	36.13	-26.95
-13.33	-47.62	45.18
4.2	-28.26	67.61
56.88	1.29	-32.58
70.23	-39.54	-10.83
-48.91	-66.27	-37.54
-9.59	0.54	8.97
-4.31	-11.94	81.83
4.05	-5.27	60.86
-36.29	14.4	-47.97
56.84	3.21	-35.01
-7.42	-1.58	9.14
3.76	25.39	44.38
48.7	28.81	9.66
-55.26	-4.03	-14.45
-49	44.71	-21.62
-29.6	13.75	-32.34
33.09	14.18	-31.21
31.56	56.15	27.42
15.14	-40.36	75.35
-6.83	15.96	58.94
-4.31	-11.94	81.83
-44.55	-68.17	-35.18
-11.86	12.88	3.31
-5.57	11.45	-12.35
48.7	28.81	9.66
-48.98	47.04	-19.61
35.34	12.68	-24.37
31.56	56.15	27.42
-4.76	24.06	53.63
-44.56	-66.05	-35.39
-9.71	10.55	1.26

// Weiss A P, 2006: Normals
// Subjects=16
3.53	41.16	29.38
42.13	21.58	1.53
24.98	68.47	21.83
44.46	51.32	20.96
44.18	57.95	0.13
24.63	61.52	-6.61
6.18	-55.85	47.9
16.85	-56.85	36.61
-2.43	-55.67	50.27
51.26	-53.51	24.49
57.86	-52.66	33.26
-67.53	-44.8	32.37
-65.49	-56.68	20.07
-59.06	-50.48	17.1
57.1	-18.94	-19.37
63.65	-29.35	-16.21
-61.69	-32.12	-16.04
37.83	23.9	3.61
22.82	59.75	20.49
42	62.2	-.25
16.85	-56.85	36.61
57.91	-52.25	37.7
-28.69	-60.39	24.29
9.98	21.21	22.28
-8.76	-30.43	68.05
56.95	-2.55	-27.72
-33.95	-60.87	-49.53
-35.83	15.6	-12.24
-36.1	-63.01	-49.28
-36.29	14.4	-47.97
56.84	3.21	-35.01
-7.42	-1.58	9.14
48.7	28.81	9.66
-48.98	47.04	-19.61
35.34	12.68	-24.37
31.56	56.15	27.42
-4.76	24.06	53.63
-44.56	-66.05	-35.39
-9.71	10.55	1.26

// Assaf M, 2006: Correct Recall
// Assaf M, 2006: Correct No Recall
// Assaf M, 2006: Correct Associated
// Assaf M, 2006: Correct Non Associated
// Assaf M, 2006: Correct Recall > No Recall
// Assaf M, 2006: Correct Associated > Non Associated
// Assaf M, 2006: Correct Non Associated > Associated
// Subjects=18
-1.63	23.24	44.69
-4.95	28.13	39.78
-37.06	-15.72	54.75
-44.03	10.17	22.05
-47.62	23.93	-2.78
36.52	23.3	-14.24
-46.78	-28.83	52.85
-30.54	-50.46	50.23
-59.35	-46.07	-4.62
-24.41	-96.82	13.25
33.78	-88.93	2.52
-8.62	-4.65	-.62
10.94	-10.34	6.34
-11.96	10.98	-5.47
17.32	11.92	2.9
-1.59	24.62	47.91
-37.11	-12.84	51.1
-44.06	6.67	19.04
-46.54	19.58	-3.49
46.32	22.79	-8.75
-43.66	-33.04	42.01
40.69	-44.13	45.03
-24	-56.5	54.08
37.6	-49.59	55.71
-24.36	-99.7	16.9
40.37	-93.61	9.59
-14.96	-18.94	7.63
14.21	-8.95	9.5
-11.88	8.31	0.4
8.05	22.96	41.19
-5.1	30.28	28.36
-42.51	-6.27	52.79
-39.68	14.75	24.89
-44.31	21.17	1.92
36.6	29.34	-6.99
-33.94	-33.01	41.84
40.75	-40.42	50.27
-27.36	-47.57	46.53
34.22	-47.35	45.46
-53.96	-49.45	-6.62
74.82	-33.09	11.98
-27.8	-94.68	1.89
46.8	-90.7	5.83
-15.07	-13.18	0.34
7.65	-16.18	1.37
13.94	14.16	-7.35
1.02	-18.41	-10.63
4.93	24.95	51.13
-1.65	27.5	44.27
-33.74	-5.3	62.63
-52.55	12.14	32.09
36.41	56.37	-16.39
-44.33	24.36	1.6
36.51	25.42	-14.45
-33.88	-35.89	45.49
37.51	-47.03	48.73
-30.6	-47.58	46.59
34.31	-46.72	52.12
-52.93	-56.35	-11.56
-37.41	-80.7	14.12
46.87	-90.19	11.38
-15.08	-9.99	0.02
7.6	-14.37	-2.17
17.17	10.78	-9.31
-1.74	37.72	38.78
-2.33	45.36	-5.67
-43.8	14.06	40.71
-44.57	34.6	-15.1
39.71	25.12	-17.83
-55.57	-46.37	37.93
-66.22	53.88	-14.39
-5.38	-4.63	-.67
17.32	11.92	2.9
-12.01	45.64	-2.17
-8.04	-36.42	38.37
-40.28	-47.3	50.09
-65.8	-54.6	-3.67
21.11	-4.75	42.59
20.92	18.99	32.4
-11.4	21.73	40.52

// Heinze S, 2006: Normals
// Subjects=15
31.55	37.44	22.55
16.6	40.87	37.03
-60.58	-38.4	-14.32
33.68	-37.16	5.24
-42.46	30.9	-20.37
29.45	35.72	27.24
29.99	-48.87	52.41
38.54	-37.55	46.66
-60.58	-38.4	-14.32
-42.46	30.9	-20.37
40.84	-70.41	50.99
34.48	-68.44	60.99
60.55	-62.23	-11.79
48.61	-58.32	-15.33
-60.47	-49.68	-8.73
55.32	-77.37	-1.23
40.84	-70.41	50.99
16.09	-34.08	-18.3
9.6	-87.78	-29.68

// Heinze S, 2006: Schizophrenic Patients
// Subjects=18
32.2	-59.5	53.42
49.28	-35.8	41.82
-.63	26.98	38.7
9.96	33.11	23.34
27.77	-88.72	39.58
-28.35	-60.02	51.14
33.68	-37.16	5.24
-42.46	30.9	-20.37
46.94	2.27	35.85
30.06	-59.3	55.68
-28.35	-60.02	51.14
-.63	26.98	38.7
-42.46	30.9	-20.37
-50.66	-66.46	-4.99
-64.87	-33.85	-11.34
14.06	70.9	13.93
-16.27	70.17	7.8
-28.43	10.46	58.74
62.97	-63.54	8.47
-17.43	-62.45	59.04
40.84	-70.41	50.99
16.09	-34.08	-18.3
9.6	-87.78	-29.68

// Kensinger E A, 2006: Pictures Corresponding with Subsequent Item-and-Source 
// Memory
// Kensinger E A, 2006: Words Corresponding with Subsequent Item-and-Source 
// Memory
// Kensinger E A, 2006: All Items Corresponding with Subsequent 
// Item-and-Source Memory
// Kensinger E A, 2006: Pictures Corresponding with Subsequent Item-Not-Source 
// Memory
// Kensinger E A, 2006: Words Corresponding with Subsequent Item-Not-Source 
// Memory
// Kensinger E A, 2006: All Items Corresponding with Item-Not-Source Memory
// Subjects=21
-30	11	51
45	46	-12
-24	26	-11
41	15	-23
45	-9	-9
-30	-12	-12
39	-21	-12
45	-24	-19
6	-17	12
22	-47	60
46	3	4
32	15	-21
-52	-35	-3
-30	-12	-15
-9	10	61
24	-47	55
39	13	-28
-36	-15	-14
15	-35	-6
-18	-6	-5
-15	48	31
-48	37	-13
-35	-65	7
42	-65	-8
30	-73	-11
-21	-10	-23
28	-1	-23
-40	-81	8
33	44	-2
17	-4	39
2	18	17
-36	-62	-20
35	-76	-10
-37	-12	-26
30	3	-20
35	-75	-20
-3	20	43
-42	31	29
33	35	1
-27	-63	28
45	-67	6
24	-79	-9
36	-76	-11
42	-64	-2
-27	-73	-1
-30	-82	-6
-36	-62	-17
-37	-10	-25
30	-4	-23
-42	-78	12
42	-78	7
15	-79	-6
18	-98	10
-6	-51	-25

// Blair K, 2006: Moderated by Decision Form:  RewRew > PunPun
// Blair K, 2006: Moderated by Decision Form:  RewRew> RewPun
// Blair K, 2006: Moderated by Decision Form:  RewPun > PunPun
// Blair K, 2006: Moderated by Decision Form:  PunPun > RewRew
// Blair K, 2006: Moderated by Decision Form:  PunPun > RewPun
// Blair K, 2006: Main Effect of Between-object Reinforcement Level 
// Difference, All Trials
// Blair K, 2006: Main Effect of Decision Form (Excluding RewPun):  RewRew > 
// PunPun
// Blair K, 2006: Main Effect of Decision Form (Excluding RewPun):  PunPun > 
// RewRew
// Blair K, 2006: Main Effect of Between-object Reinforcement Level Difference 
// (Excluding RewPun)
// Subjects=21
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
67.61	-63.65	4.95
-29.33	-62.21	46.09
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
67.61	-63.65	4.95
-29.33	-62.21	46.09
0.88	55.1	-8.7
28.77	-6.21	-19.49
-62.78	-28.42	18
-56.21	-76.14	19.69
-29.33	-62.21	46.09
4.6	22.05	45.33
53.72	28.51	41.99
-40.62	17.21	0.53
39.51	21.83	-1.89
47.66	-53.49	55.63
-48.93	-82.55	-8.85
4.6	22.05	45.33
53.72	28.51	41.99
-40.62	17.21	0.53
39.51	21.83	-1.89
47.66	-53.49	55.63
-48.93	-82.55	-8.85
2.3	15.92	21.34
-36.09	13.2	30.93
7.32	52.22	-5.19
34.13	-3.81	-16.41
33.03	-3.01	-19.81
-26.58	-40.49	-3.71
71.88	-30.7	17.76
-46.52	-79.71	27.69
20.88	-66.39	42.52
11.01	23.14	45.16
-54.23	-28.29	19
-40.45	-64.53	-10.46
-30.47	-51.98	40.79
-1.96	20.47	25.46
-35.02	12.15	31
48.34	-76.17	-3.81

// Daselaar S M, 2006: Oldness Related Increase, Recollection
// Daselaar S M, 2006: Oldness Related Increase, Familiarity
// Daselaar S M, 2006: Oldness Related Decrease, Familiarity
// Daselaar S M, 2006: Exponential > Linear, Recollection
// Daselaar S M, 2006: Linear > Exponential, Familiarity Related Increase
// Daselaar S M, 2006: Young > Old, Recollection
// Daselaar S M, 2006: Old > Young, Familiarity Related Decrease
// Daselaar S M, 2006: Young > Old, Familiarity Related Decrease
// Subjects=12
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-38	-76	28
4	-35	44
-26	-1	-26
49	-41	-17
-49	-19	-18
45	12	10
-19	12	13
-19	-27	4
-30	-80	8
34	-57	-35
-45	-6	35
53	5	28
-30	52	8
4	21	41
15	-67	56
-38	-29	15
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-38	-76	28
4	-35	44
-23	-26	-9
-53	-57	38
-4	-55	17
0	-2	35
0	49	19
-34	-23	57
4	-85	-2
30	-49	-20
-26	-1	-26
49	-41	-17
-49	-19	-18
-45	-6	35
53	5	28
-30	52	8
4	21	41
15	-67	56
-38	-29	15

// Daselaar S M, 2006: Brain Regions Associated with Recollection
// Daselaar S M, 2006: Brain Regions Associated with Familiarity
// Daselaar S M, 2006: Brain Regions Associated with Novelty
// Subjects=14
-26	-26	-11
30	-23	-11
-4	-43	20
0	-23	33
-45	-65	31
-27	14	-20
34	17	-20
0	-81	-2
-4	59	-3
-4	-43	20
-45	-65	31
-34	-41	-8
0	-31	44
-15	-68	34
-38	80	32
15	-58	17
0	30	12
-34	-41	-8
-38	80	32
15	-58	17
-19	-8	-16
27	-4	-27
30	15	-4
-64	-11	-3
-45	-23	-18
49	-22	5
-11	-52	62
4	17	41
-49	2	31
56	5	28
45	38	19
30	13	52
-11	-42	-23
27	-4	-27

// Montaldi D, 2006: Linear Increases in Familiarity F1 to F3
// Montaldi D, 2006: Linear Decreases in Familiarity F1 to F3
// Montaldi D, 2006: Linear Increases in Familiarity M to F3
// Montaldi D, 2006: Linear Decreases in Familiarity M to F3
// Montaldi D, 2006: Recollected > F3
// Montaldi D, 2006: F3 > Recollected
// Subjects=13
-51	18	-12
-36	24	-9
-54	18	21
-45	9	33
48	21	-12
3	48	6
-39	-72	39
-3	-81	45
-9	-12	6
0	-45	15
-63	-45	-3
66	-24	-15
-51	-60	21
-3	48	6
0	-45	15
-33	-3	-36
36	-9	-33
42	-36	24
42	-24	12
-33	-15	15
-39	3	18
24	15	30
-42	-45	12
42	-66	15
-57	-18	3
-30	-60	-6
33	-72	-6
-18	-90	0
-30	24	-12
-48	15	39
-30	63	6
-39	-51	48
-42	-66	42
9	-75	48
-15	-12	15
-3	-42	27
-12	9	0
15	9	3
-6	-18	-6
-63	-42	-3
-9	-75	48
-30	0	-33
30	-3	-36
-33	-12	24
48	-21	21
33	-30	24
36	-48	24
18	-48	12
-45	-3	-24
-60	-21	3
-45	-42	21
-48	27	-15
42	24	-21
-3	48	12
-42	-72	30
-12	-33	-3
21	-33	-3
-33	-12	0
-39	-75	-9

// Uncapher M R, 2006: Memory Effects for Items in which Once Source Feature 
// was Remembered (Location or Color)
// Uncapher M R, 2006: Memory Effects for Items in which Both Source Features 
// were Remembered (Location and Color)
// Uncapher M R, 2006: Items Remembered > Items Forgotten (Regardless of 
// Source Accuracy)
// Subjects=20
-45	21	-3
3	-60	15
-33	-54	18
-60	-45	15
-57	-36	-9
-45	24	-9
-48	27	9
-48	18	27
-48	-9	24
21	-42	48
24	-72	27
-48	6	33
-24	-3	-30
24	-93	30
-27	-96	15

// Gizewski E R, 2006: Men
// Subjects=22
-6	38	-12
30	32	-12
-30	-9	-20
27	-21	-18
-3	-17	9
3	-12	39
-42	-6	6
45	-7	-1
-9	36	-15
10	33	-17
-30	-9	-21
31	-16	-21
-6	-18	9
6	-6	36
-42	-3	3
43	-4	3

// Gizewski E R, 2006: Women
// Subjects=25
-6	38	-12
30	32	-12
-30	-9	-20
27	-21	-18
-3	-17	9
3	-12	39
-42	-6	6
45	-7	-1
-9	36	-15
10	33	-17
-30	-9	-21
31	-16	-21
-6	-18	9
6	-6	36
-42	-3	3
43	-4	3
2	1	31
-9	36	-21
-42	-3	-3
42	0	-1

// Kirsch P, 2006: Monetary > Verbal, All Subjects and Both Substances
// Subjects=8
-12	9	-15
12	9	-12
-9	-15	3
6	-21	3
-21	0	-12
27	-6	-12
-21	0	3
15	12	-6
-30	30	-9
51	21	-15
-6	12	36
6	24	27
-45	3	3
39	12	-6
12	-21	-9
-36	-18	51
51	-3	48
60	-15	27
-57	12	-3
54	-30	-6
-24	-51	60
-60	-21	24
-24	-66	3
42	-75	24
9	-72	51

// Bohlhalter S, 2006: Tic Generation > Baseline
// Bohlhalter S, 2006: Tic Imitation > Baseline
// Subjects=10
12.66	11.98	61.25
-8.91	16.58	65.64
10.22	9.9	39.08
-9.19	7.91	41.85
-30.72	-4.72	45.71
-26.44	34.41	50.73
42.63	3.42	36.93
47.18	-12.33	51.86
59.83	-25.62	23.82
-58.96	-32.22	28.74
48.63	2.04	-1.13
27.07	4.51	3.47
22.74	-21.86	-2.81
-40.01	-.81	-3.82
-37.84	-16.11	-6.83
-26.84	-10.16	10.32
-18.29	-21.8	0.12
-40.11	-56.28	-22.99
-33.55	-60.09	-18.24
6.19	16.42	63.16
8.15	8.39	45.99
-5	20.06	33.85
-42.49	31.76	-22.69
-42.09	39.13	10.19
-22.11	19.12	47.69
45.1	-9.59	58.35
47.19	-14.46	52.07
44.94	-21.68	43.86
32.35	-43.05	68.6
-39.11	-11.6	64.46
-67.68	-19.69	25.41
-25.98	-38.79	71.41
66.36	-25.19	28.15
-48.09	-27.3	34.79
44.12	7.16	-15.01
27.07	4.51	3.47
-46.48	12.34	-.53
-26.84	-10.16	10.32
13.94	-18.68	-14.18
-7.64	-18.55	-11.59
-1.06	-74.66	-15.11
31.21	-51.56	-22.43
-27.07	-53.48	-16.76

// Dresel C, 2006: Nomals
// Subjects=13
-48	-10	24
-56	-6	18
-16	-60	-24
-10	-18	-2
-16	10	-4
20	-60	-26
62	-6	14
48	-4	24
12	-14	0
26	-10	-2
-8	-22	74
-54	-34	54
-56	14	12
-14	-34	-20
8	-34	76
54	-32	52
-40	-62	-12
-24	-68	-22
-38	-34	64
38	-34	64
30	-58	-42
-64	-6	22
-42	-12	34
54	-2	26
44	-10	44

// Dresel C, 2006: Blepharospasm (BLEPH) Patients
// Subjects=13
-18	-60	-18
-50	-8	32
-52	-4	16
-18	10	-10
-10	-24	74
-2	8	34
-38	4	-4
-22	-12	-2
16	-60	-20
58	-4	34
38	10	0
12	-12	-6
58	0	12
24	2	-6
4	-14	60
-8	-22	74
-54	-34	54
-56	14	12
-14	-34	-20
8	-34	76
54	-32	52
-40	-62	-12
-24	-68	-22
-60	-4	14
-38	-16	14
56	-4	28

// Dresel C, 2006: Meige's Syndrome Patients
// Subjects=13
-54	-6	22
-46	-14	36
-16	-60	-50
-18	-14	-4
52	-10	36
24	-64	-24
54	-10	50
-38	-34	64
38	-34	64
30	-58	-42
-64	-6	22
-42	-12	34
54	-2	26
44	-10	44
-4	-6	70
-60	-58	-8
44	-42	62
62	-38	36

// Kim H, 2006: Reward Receipt
// Kim H, 2006: Successful Avoidance of a Monetary Loss
// Kim H, 2006: Reward Receipt > Successful Avoidance of a Monetary Loss
// Kim H, 2006: Reward Expectation: Expected Reward Increase
// Kim H, 2006: Reward Expectation: Expected Reward Decrease
// Kim H, 2006: Prediction Error on Reward Trials
// Kim H, 2006: Prediction Error on Avoidance Trials
// Kim H, 2006: Prediction Error on Reward Trials > Prediction Error on 
// Avoidance Trials
// Subjects=16
0	33	-18
0	33	-18
15	18	9
-6	30	-21
-36	27	-21
-42	21	33
48	33	33
6	27	36
-15	6	-15
15	6	-15
0	30	18
-24	30	48
-39	12	-9
39	15	-3
-3	-24	0
0	36	15
0	-27	-27
-12	6	-15
15	6	-15

// Little D M, 2006: Classification > Fixation
// Little D M, 2006: Feedback > Fixation
// Little D M, 2006: Classification > Feedback
// Little D M, 2006: Feedback > Classification
// Little D M, 2006: Classification: Early > Late
// Little D M, 2006: Feedback: Early > Late
// Little D M, 2006: Fixation: Early > Late
// Subjects=18
-44	10	0
30	28	-8
4	34	38
-48	6	36
26	6	48
24	-24	8
-16	-8	0
4	-18	12
44	-50	54
-28	-84	28
34	-70	28
-44	-60	-16
46	-62	-20
22	-66	22
48	40	14
-4	30	38
-56	4	34
32	4	44
-10	14	8
22	26	4
-24	-30	-6
34	-72	26
-24	-54	-22
-30	20	-2
30	44	24
-4	-8	48
8	4	32
-58	8	26
60	12	24
-20	12	-2
18	10	-2
-14	-14	0
6	-18	8
-42	-32	42
60	-18	44
-56	-66	22
-24	-10	-20
30	-12	-24
-50	-66	12
-26	56	22
-24	14	2
12	-74	-2
-34	27	4

// Brown M R G, 2006: Prosaccade Response > Fixation
// Brown M R G, 2006: Fixation > Prosaccade Response
// Brown M R G, 2006: Antisaccade Response > Fixation
// Brown M R G, 2006: Fixation > Antisaccade Response
// Brown M R G, 2006: Nogo Response > Fixation
// Brown M R G, 2006: Fixation > Nogo Response
// Brown M R G, 2006: Antisaccade Response > Prosaccade Response
// Brown M R G, 2006: Antisaccade Response > Nogo Response
// Brown M R G, 2006: Nogo Response > Antisaccade Response
// Brown M R G, 2006: Nogo Response > Prosaccade Response
// Brown M R G, 2006: Prosaccade Response > Nogo Response
// Brown M R G, 2006: Prosaccade Instruction > Fixation
// Brown M R G, 2006: Antisaccade Instruction > Fixation
// Brown M R G, 2006: Nogo Instruction > Fixation
// Brown M R G, 2006: Fixation > Nogo Instruction
// Brown M R G, 2006: Antisaccade Instuction > Nogo Instruction
// Brown M R G, 2006: Prosaccade Instruction > Nogo Instruction
// Subjects=10
39.98	0.39	51.2
-39.12	-1.39	48.91
37.52	48.62	28.23
-36.24	50.13	26.72
53.57	6.11	13.76
-37.3	6.28	10.33
1.56	1.74	58.22
1.36	13.94	37.13
40.12	-43.22	51.51
-36.84	-42.79	50.13
22.01	-64.73	50.18
-20.74	-64.99	50.69
62.47	-36.28	42.87
14.37	-28.99	45.04
3.81	-66.24	46.05
18.71	-83.3	30.58
-17.63	-82.46	30.93
-3.1	50.5	28.53
0.03	28.88	10.24
48.56	-60.74	30.58
-45.47	-62.36	31.79
8.17	-31.29	70.95
-2.79	-42.98	30.79
38.91	1.45	51.12
-34.83	-.14	50.99
34.27	53.72	25.6
-35.19	51.02	24.4
56.77	8.24	13.55
-44.78	9.49	11.26
2.62	6.06	58.96
1.32	18	34.55
41.16	-40.21	49.02
-37.92	-41.83	48.94
22.01	-65.79	50.27
-20.72	-64.81	52.91
63.49	-34.59	37.14
-58.5	-18.45	22.69
1.42	-23.84	30.26
1.7	-60.54	51.17
19.78	-83.2	31.68
-15.48	-83.41	32.1
20.45	1.6	13.41
-19.09	-1.9	13.04
-2	50.84	32.95
45.37	-61.73	31.81
-49.71	-67.5	34.5
-1.72	-48.44	29.01
36.75	4.52	49.78
-40.21	2.74	47.46
35.33	51.44	23.55
-35.22	49.62	20.06
46.1	3.95	14.03
-51.17	7.51	13.73
4.77	5.1	60.13
2.43	12.89	37.2
42.21	-39.23	47.81
-37.91	-42.8	50.14
24.16	-65.69	51.35
-22.88	-65.08	49.61
61.37	-33.37	39.29
-60.53	-20.61	36.27
5.73	-23.47	34.64
1.69	-58.42	51
28.32	-81.04	31.4
-21.88	-82.22	34.3
-13.7	2.96	20.38
2.18	53.19	21.56
26.12	0.65	55.8
-29.47	0.06	53.14
-2.75	10.17	57.56
-.83	18.87	32.28
34.76	-41.22	50.29
-29.31	-42.23	56.69
22.01	-64.73	50.18
-19.65	-59.26	55.77
33.66	-77.83	31.07
-6.96	-77.1	30.36
64.49	-19.95	33.67
-20.83	-27.55	53.13
-.7	-22.54	33.52
-.43	-53.86	55.1
-15.89	3.71	13.65
36.8	-.42	54.65
-28.39	0.16	54.24
35.36	54.96	27.72
-32.99	48.37	31.29
0.47	5.96	57.88
1.32	19.06	34.47
37.95	-40.23	49.05
-28.23	-49.8	55.08
18.82	-66.78	51.5
-19.64	-62.44	56.04
20.86	-84.17	32.86
-18.71	-80.35	30.77
-2.9	-19.98	25.52
4.91	-61.57	51.22
1.62	-82.17	32.92
-15.87	-3.99	13.18
9.93	37.31	49.56
43.23	-60.69	31.75
-49.72	-67.59	33.4
-.62	-53.63	30.55
27.02	24.21	43.78
-13.85	33.29	13.37
50.62	-51.64	24.22
36.86	-24.03	52.17
0.49	-33.39	44.45
0.74	-48.43	70.24
0.49	-53.2	36.07
-16.87	-1.03	24.09
15.52	-83.14	32.84
-13.36	-78.11	31.63
-27.76	39.55	13.01
27.67	68.17	6.63
32.53	-52.12	33.39
-30.55	-52.75	30.82
26.2	-62.22	41
-22.96	-62.6	40.48
29.32	-70.8	26.07
-48.6	-36.35	51.95
4.59	-27.51	23.84
0.64	-68.12	49.59
-27.48	3.99	34.95
-14.95	36.28	10.9
-22.31	23.17	21.01
7.49	33.07	8.69
25.04	-45.65	35.16
-31.54	-50.85	41.82
22.98	-58.01	40.68
-21.87	-59.08	44.63
-29.42	-74.07	30.36
3.52	-23.11	25.71
-3.61	-66.74	53.99
-2.59	-85.91	39.97
31.51	-46.07	42.93
24.08	-62.06	43.24
-15.53	-65.27	32.81
1.38	-24.27	24.72
3.76	-68.95	38.47
33.63	-3.36	58.28
-30.44	-3.32	64.59
-52.12	-25.27	16.49
28.15	3.95	43.23
-28.5	3.44	41.69
-10.03	-69.07	52.02
-4.67	-65.6	55.02

// Grimm S, 2006: unPV > unPJ
// Grimm S, 2006: unPJ > unPV
// Grimm S, 2006: exPV > exPJ
// Grimm S, 2006: exPJ > exPV
// Grimm S, 2006: Conjunction Analysis (unPV > unPJ) vs. (exPV > exPJ)
// Grimm S, 2006: Exclusive Masking Analysis (unPV > unPJ) vs. (exPV > exPJ)
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: unPV > unPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: exPV > exPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Valence: unPJ > unPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Intensity: unPJ > unPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Intensity: exPJ > exPV
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: unPV > unPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: exPV > exPJ
// Grimm S, 2006: Correlation Between Regional fMRI Signal Changes and Post 
// Scanning Ratings of Recog: exPJ > exPV
// Grimm S, 2006: Positive Valenced Pictures Showing Positive Correlation in 
// unPV > exPV
// Grimm S, 2006: Positive Valenced Pictures showing Positive Correlation in 
// exPV
// Grimm S, 2006: Negative Valenced Pictures Showing Positive Correlation in 
// unPV
// Grimm S, 2006: Positive Valenced Pictures Showing Negative Correlation in 
// unPJ
// Grimm S, 2006: Negative Valenced Pictures Showing Negative Correlation in 
// unPJ
// Subjects=29
12	64	16
10	46	48
46	14	48
-38	32	38
30	54	-6
-32	58	0
4	58	40
24	18	-24
-14	-8	-18
56	28	-6
44	-58	38
-44	-68	46
44	-10	44
-44	2	32
-6	8	48
30	-48	-10
-8	-58	4
-2	-10	56
12	-20	-10
-12	-18	8
0	-58	-30
36	26	48
-38	36	38
28	48	24
-30	56	8
4	26	20
0	-54	36
22	4	-24
60	-58	2
-56	-42	48
42	2	-30
-4	-4	-14
54	4	28
-42	10	32
30	34	-14
-48	32	-10
28	-62	-12
-30	-82	32
40	24	46
-40	34	38
26	46	30
4	-66	36
56	-56	28
-40	-60	36
6	66	16
12	60	2
6	46	52
50	26	36
-36	16	56
-38	54	4
16	2	-18
-14	-8	-16
54	26	-6
-58	-64	24
42	-62	-22
-18	14	14
-4	56	14
-28	36	20
46	26	14
-44	24	20
48	40	-10
4	30	52
46	4	14
12	44	10
26	20	42
46	-10	26
8	18	48
8	18	48
-24	48	16
-22	48	16
16	3	19
-36	-9	57
50	26	16

// Addis D R, 2006: Successful Encoding > Baseline Triad
// Addis D R, 2006: Zero Link > One Link > Two Link
// Addis D R, 2006: Two Link > One Link > Zero Link
// Addis D R, 2006: One Link + Two Link > Zero Link
// Subjects=12
-64.68	12.46	13.21
44.23	29.89	-1.57
50.88	33.39	12.53
-11.37	20.87	42.85
-7.16	27.71	35.38
5.85	27	38.59
-16.11	-16.16	2.89
11.94	-12.02	-.24
-16.15	-31.78	-3.41
-45.73	-33.49	48.81
38.58	-42.66	49.4
-44.37	-56.94	-18.37
-48.48	-69.64	-4.71
-37.88	-65.63	-19.86
20.31	-82.94	-35.95
-60.4	24.17	11.98
46.44	34.67	3.52
-52.44	9.68	40.17
33.34	58.77	-2
20.37	60.85	-1.99
-46.03	9.18	34.51
-4.95	-27.67	28.49
40.52	-69.51	26.25
-11.82	-80.98	-13.18
-13.78	44.18	28.26
-37.08	-11.46	54.33
-11.82	-4.35	2.77
-22.91	-9.86	-21.15
-42.32	12.28	-12.92
-39.33	-72.36	34.62
-13.5	-47.8	31.75
-2.54	-26.96	47.43
-47.82	-31.81	55.4
51.52	-30.81	49.13
-57.77	-39.03	36.12
61.13	-57.86	34.84
18.6	-83.98	-1.08
-1.02	-44.8	-5.74
11.89	-51.76	-11.99
46.81	25.36	30.21
5.62	-4.21	14.78
64.67	-5.74	-16.33
36.24	-51.67	33.53
-11.59	-92.39	2.51

// Britton J C, 2006: Faces - Fixation
// Britton J C, 2006: IAPS - Fixation
// Britton J C, 2006: Emotional Faces - Neutral Faces
// Britton J C, 2006: (Emotional Faces > Emotional IAPS) - Neutral
// Britton J C, 2006: Emotional IAPS - Neutral IAPS
// Britton J C, 2006: (Emotional IAPS > Emotional Faces) - Neutral
// Britton J C, 2006: Faces, Happy - Neutral
// Britton J C, 2006: Faces, Sad - Neutral
// Britton J C, 2006: Faces, Anger - Neutral
// Britton J C, 2006: Faces, Fear - Neutral
// Britton J C, 2006: Faces > IAPS, Happy - Neutral
// Britton J C, 2006: Faces > IAPS, Sad - Neutral
// Britton J C, 2006: Faces > IAPS, Anger - Neutral
// Britton J C, 2006: Faces > IAPS, Fear - Neutral
// Britton J C, 2006: IAPS, Happy - Neutral
// Britton J C, 2006: IAPS, Sad - Neutral
// Britton J C, 2006: IAPS, Anger - Neutral
// Britton J C, 2006: IAPS, Fear - Neutral
// Britton J C, 2006: IAPS > Faces, Sad - Neutral
// Britton J C, 2006: IAPS > Faces, Fear - Neutral
// Subjects=12
-21	-6	-18
24	-6	-15
-24	-30	-3
15	30	-3
0	45	-24
30	-78	-15
-21	-6	-15
24	-3	-15
15	30	-6
3	45	-21
-33	-60	-15
60	-39	6
-66	-6	9
-39	18	-9
0	30	30
69	-21	15
-66	-9	12
-27	6	12
-3	30	30
12	-75	12
30	-93	-15
36	-78	0
63	-18	9
-63	-15	6
-30	6	9
63	-27	12
51	12	-3
-42	21	-21
0	30	30
9	51	9
0	-72	24
33	-3	-24
-21	-21	-12
-63	-6	12
57	-24	12
-39	18	-9
-15	60	-12
-18	-27	-9
60	-33	0
-36	15	6
3	18	21
0	6	30
57	-18	3
-60	-15	6
-39	3	12
54	12	-6
-39	24	0
-3	36	30
0	30	-12
-60	-6	12
57	-15	6
3	27	-3
66	-33	9
-45	-9	0
-39	-9	9
0	30	30
54	-75	-3
-45	-72	-30
0	-90	0
-21	-12	-12
-42	24	6
-12	69	6
-18	-27	-3
9	-90	-3
30	-90	-15
9	-93	-3
0	-72	-15

// Dolcos F, 2006: Emotional - Scrambled Pictures
// Dolcos F, 2006: Neutral - Scrambled Pictures
// Dolcos F, 2006: Emotional - Neutral Pictures
// Subjects=15
50.27	43.53	16.24
-35.15	33.84	22.49
50.78	-52.21	44.34
-54.99	-52.59	48.93
5.76	-26.47	37.12
20.25	27	-2.1
57.7	32.14	5.96
-52.43	29.74	-1.5
3.03	13.56	-23.08
43.86	-11.35	-4.73
24.49	-.78	-17.67
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
1.02	0.57	-11.93
3.3	-14.42	0.45
50.27	43.53	16.24
-35.15	33.84	22.49
50.78	-52.21	44.34
-54.99	-52.59	48.93
5.76	-26.47	37.12
20.25	27	-2.1
57.7	32.14	5.96
-52.43	29.74	-1.5
3.03	13.56	-23.08
43.86	-11.35	-4.73
24.49	-.78	-17.67
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
1.02	0.57	-11.93
3.3	-14.42	0.45
50.27	43.53	16.24
50.78	-52.21	44.34
20.25	27	-2.1
57.7	32.14	5.96
-22.51	-4.23	-16.84
30.96	-14.4	-15.48
-24.59	-12.36	-11.67
24.49	-.78	-17.67

// Platek S M, 2006: Unfamiliar > Scrambled Faces
// Platek S M, 2006: Familiar > Unfamiliar Faces
// Platek S M, 2006: Self > Unfamiliar Faces
// Platek S M, 2006: Familiar > Self Faces
// Platek S M, 2006: Self > Familiar Faces
// Subjects=12
30	-84	-6
0	10	48
24	-34	0
26	-48	42
-8	-44	30
36	-4	56
42	-6	-14
-32	18	4
-20	-58	-36
50	-46	0
-50	-38	44
-40	-2	44
-34	40	22
54	-22	48
-22	-76	-26
58	-48	24
-12	8	-2
12	8	-2
16	-28	10
56	12	-6
-2	24	-2
-52	4	-16
26	34	34
6	48	-12
50	-62	40
-58	-6	-4
20	16	56
26	-12	46

// Garrett A S, 2006: Aversive vs. Neutral Pictures
// Garrett A S, 2006: Activation During Negative Emotion Ratings Following 
// Aversive Pictures vs. Neutral Pictures
// Garrett A S, 2006: Areas of Activation Significantly Correlated with 
// Ratings of Negative Emotions
// Subjects=9
-48	-77	15
-36	-72	-3
-40	-66	-8
-50	-62	-2
-48	-54	6
51	-64	3
42	-74	-8
30	-78	24
46	-67	-10
40	-44	-26
50	-56	1
55	-48	19
-22	3	-17
20	-2	-10
-14	-31	-5
-30	-16	-16
22	-10	-15
6	-32	-12
4	-15	4
2	-2	-5
26	13	-4
-24	11	-6
12	12	1
-16	17	-1
38	11	-4
40	29	-10
-34	25	-8
26	26	-15
-38	34	-15
4	-70	-32
-6	-78	-10
4	-82	-4
4	-29	1
-14	-22	-7
-2	-4	-7
50	36	-14
30	48	-6
48	36	-5
48	21	1
4	-71	-30
32	-42	-26
16	-20	-12
-14	-16	-9
8	-19	8
-6	-11	8
26	52	-18
50	32	-17
-36	-7	56
-32	-13	47
-28	9	59
-8	12	49
6	12	40
2	23	32
-8	9	33

// Beblo T, 2006: Borderline Personality Disorder (BPD) Patients
// Subjects=20
-23.41	-9.86	24.8
-33.47	11.64	2.68
-36.83	-17.69	-12.29
36.01	-9.65	23.77
26.08	-15.6	6.6
45.44	12.22	4.64
-1	-64.36	-8.29
-7.55	-56.19	-12.34
9.83	-64.12	-6.25
-36.97	43.66	-10.52
12.8	-19.1	-18.6
6.32	-25.71	-20.08
3.01	-26.24	-25.57
-16.94	-51.5	15.37
-23.35	-57.59	19.44
-26.53	-70.26	21.87
20.19	-75.78	40.67
-13.35	-31.35	46.93
29.01	-34.35	-21.85
32.65	-66.4	2.55
35.91	-56.4	5.99
4.36	-49.35	-8.74
71.69	-38.86	19.33
55.4	-32.96	14.54
40.27	-91.04	2.62
-50.73	8.49	4.4
-56.17	14.75	2.76
-33.5	11.43	0.46
52.7	45.04	-12.18
45.22	35.75	-7.77
48.21	44.84	-25.53
64.72	13.28	-8.12
46.49	12.02	2.4
55.14	25.23	5.43
14.51	-99.77	14
13.27	-91.13	3.08
-38.21	-5.74	-33.62
33.31	-6.06	-18
36.42	53.18	-16.07

// Beblo T, 2006: Normals
// Subjects=21
4.36	-49.35	-8.74
71.69	-38.86	19.33
55.4	-32.96	14.54
40.27	-91.04	2.62
-50.73	8.49	4.4
-56.17	14.75	2.76
-33.5	11.43	0.46
52.7	45.04	-12.18
45.22	35.75	-7.77
48.21	44.84	-25.53
64.72	13.28	-8.12
46.49	12.02	2.4
55.14	25.23	5.43
14.51	-99.77	14
13.27	-91.13	3.08
-38.21	-5.74	-33.62
33.31	-6.06	-18
36.42	53.18	-16.07

// Bermpohl F, 2006: Expected vs. Unexpected Picture
// Bermpohl F, 2006: Emotional vs. Neutral
// Bermpohl F, 2006: Expected Positive vs. Expected Neutral
// Bermpohl F, 2006: Expected Negative vs. Expected Neutral
// Bermpohl F, 2006: Expected Emotional vs. Unexpected Emotional
// Bermpohl F, 2006: Expected Neutral vs. Unexpected Neutral
// Subjects=17
12	64	20
-44	20	52
-28	-28	-8
32	-16	-20
-28	-20	0
-20	-28	-4
16	-4	12
-52	20	-16
-56	-56	-20
52	16	-20
40	-52	-24
-40	-60	-20
40	-52	-24
-60	-60	36
-40	-60	-24
12	-76	-20
-8	-88	-4
16	-84	-4
-4	56	20
48	8	20
-24	-8	-20
24	-4	-24
-28	-12	-20
28	-12	-20
16	-4	8
-8	-28	-12
44	12	12
-48	-80	12
56	-64	0
-52	-56	-24
44	-48	-24
-52	-60	-28
44	-56	-28
-4	-92	4
4	-68	-4
-8	64	24
-20	-8	-20
28	-4	-28
-4	-28	-12
40	56	8
-64	0	20
-68	-28	16
60	-28	0
-48	-40	36
48	-40	36
0	-28	36
-8	60	20
-56	32	-8
24	0	-28
-28	-32	-8
32	-16	-20
-28	-16	-8
-16	-12	8
24	-28	0
8	-36	-20
-52	16	-16
52	16	-16
-40	-56	-24
40	-52	-24
-36	-72	-24
12	-72	-20
-8	-76	-12
16	-84	-4
-48	52	-8
48	52	-4
-28	-24	-4
16	-4	12
-40	-60	-20
52	-52	-20
-60	-60	40
56	-60	44
-4	-84	16
4	-88	0

// Grosbras M H, 2006: Hand, Neutral > Concentric Circles
// Grosbras M H, 2006: Hand, Angry > Concentric Circles
// Grosbras M H, 2006: Face, Neutral > Concentric Circles
// Grosbras M H, 2006: Face, Angry > Concentric Circles
// Subjects=10
-24	-8	60
-48	8	28
44	4	36
52	20	24
48	24	20
-52	-28	40
-36	-52	64
-36	-44	52
-28	-52	44
32	-52	56
-12	-76	56
-8	-68	64
-52	-64	0
48	-64	0
60	-56	4
44	-56	8
-44	-80	12
40	-84	-4
-44	-52	-20
44	-48	-20
44	-60	-16
-12	-80	-44
-32	-68	-56
8	-76	-32
-16	-24	8
-24	-8	64
40	-4	64
-56	8	24
44	4	36
56	20	28
52	16	8
48	32	0
0	24	52
-52	-28	40
-36	-36	48
-40	-44	56
32	-60	48
-28	-80	28
-20	-80	44
-28	-60	52
20	-60	68
12	-68	64
-64	-20	32
-48	-64	4
52	-52	4
56	-68	12
56	-4	-12
-40	-80	12
48	-80	4
-44	-52	-20
44	-48	-20
-16	-80	48
-12	-80	-44
16	-48	-48
-16	-24	12
-16	-32	4
24	-8	-12
-44	-4	56
48	4	48
-48	20	24
36	12	32
52	24	28
-56	8	-12
4	44	44
4	12	60
52	-68	12
-48	-48	4
52	-56	8
52	-36	-4
-56	8	-12
56	-4	-12
-48	-80	-12
48	-84	-4
-44	-48	-16
-44	-60	-20
44	-56	-20
-8	-84	-44
-32	-68	-52
-4	-76	-24
8	-84	-40
-28	-4	-16
16	-20	-4
-20	-8	-12
20	-12	-12
-44	28	-4
-40	-4	44
44	4	48
-52	20	28
52	12	24
56	20	28
56	24	20
0	8	56
-52	-60	8
48	-56	8
56	-36	-4
-52	-44	4
52	-52	4
56	-40	0
56	4	-20
-48	-80	-12
48	-84	-4
-44	-56	-20
-40	-68	-24
44	-56	-20
-8	-80	-36
-32	-68	-52
-20	0	12
20	0	0
-20	-8	-12
20	-12	-12
24	-20	-12
-44	28	-8

// Holt D J, 2006: Schizophrenic Patients
// Subjects=15
-22	-8	-14
-22	-24	-14
26	-6	-16
-36	-36	-17
42	-42	-16
-22	-24	-14
-22	-16	-14
26	-6	-16
28	-16	-12
-40	-42	-20
40	-42	-16
-20	-8	-16
-22	-24	-14
-16	-4	-18
-22	-20	-10
30	-4	-16
24	-18	-12
-42	-44	-18
40	-40	-20
-22	-22	-12
30	-4	-26
28	0	-24
-30	-4	-26
28	2	-22
26	2	-24

// Holt D J, 2006: Normals
// Subjects=16
-34	-18	-22
24	-8	-20
-38	-47	-15
42	-42	-20
-22	-24	-14
22	-8	-20
22	-20	-12
-40	-46	-20
40	-46	-16
-24	-12	-16
-22	-24	-14
-28	-10	-18
-32	-20	-10
28	-8	-20
24	-22	-10
-40	-44	-20
38	-38	-17
-22	-22	-12
28	0	-24
-18	2	-18
24	0	-18
26	2	-24

// Ischebeck A, 2006: Multiplication Untrained vs. Number Matching
// Ischebeck A, 2006: Multiplication Trained vs. Number Matching
// Ischebeck A, 2006: Subtraction Untrained vs. Number Matching
// Ischebeck A, 2006: Subtraction Trained vs. Number Matching
// Ischebeck A, 2006: Multiplication Untrained vs. Trained
// Ischebeck A, 2006: Subtraction Untrained vs. Trained
// Ischebeck A, 2006: Multiplication Trained vs. Untrained
// Ischebeck A, 2006: Subtraction Trained vs. Multiplication Trained
// Ischebeck A, 2006: Subtraction Untrained vs. Multiplication Untrained
// Subjects=12
33	18	3
9	-6	63
57	3	21
-18	9	3
-30	24	6
54	-42	45
-33	-57	39
51	-57	-9
27	-96	3
-3	-57	-36
-21	-96	3
-3	-69	-6
-27	-60	-30
33	33	6
27	-3	21
51	3	33
18	-3	57
-15	3	18
-27	21	6
30	-51	45
-24	-60	54
57	-45	-9
36	-93	-3
27	-72	33
-24	-96	6
57	3	21
36	18	3
42	42	6
48	24	27
18	-15	0
27	3	57
9	0	60
21	9	9
-51	30	27
-45	15	3
-15	-3	3
-33	-6	54
33	-81	30
-33	-63	36
27	-90	-9
9	-81	15
33	-51	-33
-21	-96	3
-24	-75	12
-12	-75	-18
0	-48	-24
21	3	45
36	0	51
39	15	30
0	27	48
42	42	3
33	18	3
-42	30	33
-33	33	0
48	-57	39
-30	-63	36
45	-66	-21
6	-30	-6
18	-84	9
-27	-63	-24
-3	9	51
-51	6	-27
-18	-21	15
42	-45	45
-33	-66	39
-33	21	-3
48	6	33
24	-63	51
-42	-39	39
-48	-66	39
-12	-75	15
42	-69	-12
12	-69	45
-33	-78	24
-18	-81	-9

// Jacobsen T, 2006: Aesthetic vs. Symmetry
// Jacobsen T, 2006: Symmetry vs. Aesthetic
// Jacobsen T, 2006: Beautiful vs. Not Beautiful
// Jacobsen T, 2006: Parametric Effects of Complexity for Aesthetic Judgments
// Jacobsen T, 2006: Parametric Effects of Complexity for Symmetry Judgments
// Jacobsen T, 2006: Condition Specific Effects of Complexity for Aesthetic 
// Judgments
// Jacobsen T, 2006: Condition Specific Effects of Complexity for Symmetry 
// Judgments
// Subjects=15
2.32	28.24	29.22
2.15	60.5	19.83
24.62	51.12	20.36
2.56	-14.35	42.83
-2.75	-45.81	35.49
-48.14	18.85	-5.1
50.14	26.84	-6.89
-45.12	0.52	-35.93
50.72	-55.01	35.65
-42.21	-58.48	40.35
-18.55	-53.46	61.96
25.3	-56.11	65.03
-31.46	-84.05	39.03
-25.21	5.46	53.75
28.12	13.56	43.54
-51.03	6.77	31.64
-25.36	-74.07	2.44
-5.99	-82.53	15.19
3.23	59.54	21.01
-31.45	-86.17	39.21
-41.49	12.66	24.34
34.56	-82.8	8.05
15.37	-90.14	11.12
-22.14	-83.82	-.13
-25.44	-58.46	-2.22
28.03	-68.72	-1.97
37.68	-77.12	-1.38
-22.1	-93.34	0.67
-28.63	-61.66	-1.91
31.2	-52.58	-0.02
18.53	-92.84	3.51
34.02	37.86	-14.32
47.05	33.56	11.54
44.1	6.54	33.91

// Junghofer M, 2006: High > Low Arousal of Picture Presentation
// Junghofer M, 2006: Right > Left Side of Picture Presentation
// Junghofer M, 2006: Fast > Slow Rate of Picture Presentation
// Junghofer M, 2006: Slow > Fast Rate of Picture Presentation
// Subjects=18
-42	-72	-3
-28	-64	35
-46	-66	11
-44	-74	0
-46	-64	9
-26	-78	28
-14	-88	-2
46	-77	9
22	-66	38
46	-75	9
44	-78	1
48	-72	4
22	-76	30
18	-87	1
44	-76	4
20	-66	33
46	-66	0
-38	-57	32
50	-62	38
-40	-58	43
-28	-80	22
51	-58	38
34	-73	24
-26	-76	-6
24	-77	19
-6	-54	52
22	-58	49
-8	-72	28
24	-75	18
-2	-83	12
20	-75	15

// Kim S W, 2006: Erotic Scenes - Sports HIghlights
// Subjects=10
10	-60	58
-58	-42	36
10	-90	24
28	-6	68
60	24	14
38	57	-8
-34	50	-6
-3	-4	41
-12	8	6
10	8	6
60	12	0
4	24	6
38	-10	8

// Kranz F, 2006: Face-Responsive Regions
// Subjects=10
-37.2	-79.68	-11.34
40.49	-78.64	-11.65
-38.22	-49.29	-20.13
40.98	-50.56	-20.26
-51.04	-45.97	8.85
50.67	-41.41	6.41
-15.84	-7.87	-12.26
18.77	-7.22	-13.83
-31.93	-47.55	47.35
35.07	-49.16	45.26
2.3	-9.89	11.01
-11.5	1.35	14.46
14.8	1.15	15.07
-40.02	6.55	31.98
44.62	5.65	30.63
-20.71	6.4	-.69
23.86	6.2	-.29
1.94	19.62	45.9
-34.42	21.73	1.98
38.79	20.92	1.54
2.03	63.14	-8.05

// Lawrence E J, 2006: Social Perception > Non Social Labeling
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Personal 
// Distress, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Personal 
// Distress, Negative Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Social 
// Skills, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Reported Social 
// Skills, Negative Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Overlap on the 
// Trait Task, Positive Correlation
// Lawrence E J, 2006: Brain Activation Correlated with Self Overlap on the 
// Trait Task, Negative Correlation
// Subjects=12
-49.01	23.19	23.55
-48.99	-45.83	-1.89
55.69	31.21	21.67
1.45	12.68	48.38
39.36	-29.09	-41.11
27.61	44.51	-10.35
28.09	32.93	46.38
-6.38	29.9	10.23
-13.61	11.56	35.27
-18.17	13.03	-.49
-10.5	39.16	34.03
32.22	-4.76	12.69
66.27	-30.22	-16.79
55.64	30.7	15.02
40.03	-17.75	50.49
16.33	32.86	46.52
-37	17.11	54.03
-13.86	29.86	10.32
-30.07	39.94	-9.3
24.5	45.43	1.88
5.69	45.29	56.75
16.05	34.35	10.71
27.71	36.74	-.78
24.85	-57.48	6.04
-18.02	-1.89	13.03
-53.23	-25.79	9.86
-32.88	-40.56	9.75
-29.91	13.04	0.76
61.19	-36.31	15
51.34	26.02	9.89
-48.61	-46.29	47.21
-37.05	-56.99	17.87

// Ponseti J, 2006: (Preferred, Sexual Pictures + Non-Preferred, Sexual 
// Pictures) > Non-Sexual Pictures
// Ponseti J, 2006: Preferred Sexual Pictures > Non-Preferred Sexual Pictures
// Subjects=12
-48	-70	-6
-46	-36	60
-62	-24	40
-22	-66	60
64	-20	38
34	-54	62
24	-64	60
0	38	8
-8	54	0
4	56	8
0	-10	8
2	0	-2
4	-30	14
2	0	0
2	-26	2
0	-8	4
52	10	30
-46	6	32
26	-66	56
24	-68	60
16	-70	64
32	-80	30
-14	-66	64
-20	-80	48
-10	-82	50

// Ricciardi E, 2006: Tactile, 1-Back vs. Rest
// Ricciardi E, 2006: Visual, 1-Back vs. Rest
// Ricciardi E, 2006: Tactile Maintenance vs. Rest
// Ricciardi E, 2006: Visual Maintenance vs. Rest
// Ricciardi E, 2006: Overlapping
// Ricciardi E, 2006: Tactile Maintenance > Visual Maintenance, Interaction
// Ricciardi E, 2006: Visual Maintenance > Tactile Maintenance, Interaction
// Subjects=6
23.35	58.83	-3.69
13.66	78.95	-4.15
-21.52	53.19	-3.82
2.42	31.46	43.45
1.49	9.85	53.08
-25.07	-.83	68.78
-.5	-9.57	63.65
37.84	3.64	52.07
33.3	43.65	33.15
40.6	49.56	12.5
44.6	61.02	-18.62
-46.92	41.35	24.23
-25.71	69.42	13.82
-2.03	19.78	16.6
53.58	8.4	15.8
40.42	36.67	-16.53
-54.29	12.84	27.82
-43.98	53.94	-5.86
44.84	18.43	-5.01
-35.24	27.44	8.53
-39.44	2.92	8.41
39.05	-14.62	63.62
-36.79	-19.21	65.99
58.07	-19.01	32.55
-15.34	-30.38	71.14
-54.1	-18.2	39.34
9.3	-30.6	79.8
57.1	-40.97	37.74
-57.47	-22.13	16.29
18.81	-65.72	51.41
23.96	-72.15	22.9
6.05	-48.74	65.75
-20.81	-81.07	35.31
-7.82	-82.63	55.37
27.43	-48.52	66.6
-24.97	-63.53	56.19
-43.82	-21.28	-15.16
50.48	-64.1	0.73
46.91	-11.9	-25.91
-54.31	-59.95	-5.11
-42.31	-77.03	20.72
64.2	-8.69	0.38
41.45	18.73	-28.42
-50.35	18.15	-13.93
50.31	-46.09	-14.16
-41.62	-44.7	-15.45
20.67	-104.89	-1.09
-12.56	-88.59	-7.65
-22.13	-71.68	5.54
-28.46	-104.92	2.83
1.48	-92.43	10.36
0.51	-80.4	28.32
-42.29	-80.2	20.99
16.2	-22.38	6.54
-9.47	-22.7	4.64
10.82	1.45	12.41
-12.67	-1.77	14.07
16.95	-49.75	-44.7
37.53	-66.6	-16.76
20.43	-54.64	-11.99
-20.27	-44.83	-19.03
-37.47	-57.05	-37.89
8.05	12.49	72.86
0.39	14.96	50.43
32.55	-.19	58.03
46.1	33.61	26.04
52.64	9.76	33.54
37.25	54.68	-3.51
-46.11	54.1	-3.61
-35.92	-3.66	46.84
-53.16	11.24	34.63
-35.25	44.96	14.87
9.52	38.57	-2.95
-8.53	29.72	8.04
-16.23	52.71	-10.53
6.6	29.4	30.19
55.82	12.78	31.02
43.63	35.63	-16.48
-52.48	19.28	-12.89
-57.49	13.87	27.77
-29.89	22.1	7.8
58.79	11.46	-.13
-50.19	12.12	4.41
5.96	-22.13	65.75
42.15	-17.91	48.25
-58.54	-21	17.32
16.77	-74.65	59.99
30.38	-72.02	23.93
2.86	-57.3	65.39
-5.73	-83.04	49.8
-22.84	-63.51	56.17
34.78	-43.25	51.57
55.96	-27.49	33.28
-38.95	-44.75	52.55
43.03	-73.74	0.51
-46.76	-66.79	2.07
-34.93	-85.76	3.53
49.44	-49.5	10.67
31.05	-43.21	-16.41
-34.11	-60.86	-18.65
14.09	-80.23	-12
6.9	-101.48	16.63
16.41	-81.68	10.4
-4.91	-76.89	19.17
14	8.87	11.76
35.38	-82.1	-24.35
31.87	53.17	-8.89
13.72	76.21	1.65
-18.33	53.12	-4.97
10.5	56.3	-7.79
3.55	15.61	44.77
-25.08	-.91	67.67
-.52	-10.79	61.53
30.47	-1.89	63.77
40.6	48.5	12.59
-46.92	40.29	24.32
-25.71	69.42	13.82
37.54	0.56	12.18
-33.1	27.45	8.51
-42.63	6.33	11.5
57.79	7.74	6.89
21	-26.73	73.77
-38.93	-20.37	65
58.06	-19.1	31.44
-14.26	-31.34	72.33
-54.12	-16.17	38.06
-64.98	-9.32	17.53
57.12	-43	39.03
25.16	-59.77	45.26
0.69	-55.46	61.91
-20.81	-81.07	35.31
27.41	-45.44	65.22
18.94	-69.89	66.26
-34.55	-43.35	70.22
44.4	-34.3	56.29
-48.92	-63.81	-.39
53.67	-49.99	3.97
-45.53	-73.96	19.39
41.45	17.67	-28.33
-8.29	-84.17	-5.84
1.5	-94.37	12.75
-17.81	-72.28	11.12
29.3	-83.12	18.18
-31.78	-99.45	-8.74
16.2	-22.38	6.54
-5.22	-27.33	-.6
-12.67	-1.86	12.96
16.96	-50.8	-44.61
41.69	-49.11	-24.96
17.18	-48.49	-14.7
-20.24	-46.68	-15.53
-35.35	-56.06	-39.11
-12.97	55.44	-2.99
9.1	11.18	69.61
-.38	-21.48	74.69
33.64	1.04	60.14
45.01	35.64	24.77
51.56	9.67	32.45
35.11	55.73	-3.57
13.85	53.46	10.25
-37.54	55.47	-.48
-28.37	-.73	56.54
-32.87	17.79	34.96
14.98	29.94	8.86
-7.44	25.58	9.49
7.67	28.35	30.27
27.05	2.46	37.79
-39.72	31.88	-16.32
-54.33	12.41	22.28
-55.6	22.41	0.27
-29.89	26.42	8.56
54.53	8.35	1.3
-65.98	-16.3	23.71
15.7	-73.6	59.91
2.84	-49.81	65.87
-21.73	-67.48	59.83
6.03	-82.97	49.66
33.71	-44.31	51.68
56	-32.6	35.94
-36.82	-44.73	52.52
52.91	-62.14	39.57
45.16	-71.53	1.41
33.56	-71.12	21.58
-45.67	-63.36	5.12
65.35	-24.28	5.02
26.87	-59.81	-10.51
11.99	-83.16	-8.38
-17.94	-92.23	-12.86
5.83	-101.49	16.64
29.5	-84.32	43.93
-19.84	-75.49	24.8
20.46	-31.24	1.66
-2.99	-15.38	16.21
20.46	-31.24	1.66
26.69	-60.55	-33.87
-30.84	-66.75	-12.61
26.6	54.96	1.05
2.63	1.83	59.32
3.76	-20.63	57.84
29.35	-1.27	58.15
52.54	9.79	20.16
41.64	36.11	3.58
-40.71	49.19	1.2
-48.94	16.21	29.71
7.69	16.47	27.92
-5.24	31.74	20.1
-17.2	50.47	1.93
44.42	-27.53	61.3
44.42	-27.53	61.3
-47.52	-25.17	58.81
7.09	-66.59	54.97
6.07	-47.42	68.98
-13.2	-87.4	49.14
31.58	-46.44	51.88
27.25	-69.07	34.87
-33.5	-44.66	66.97
-39.04	-45.6	41.47
-12.74	-43.21	-12.56
-46.76	-66.88	0.96
32.26	-68.06	-7.65
-33.07	-51.25	-18.35
-22.26	-86.16	-16.66
1.33	-79.71	-4.09
-1.91	-58.15	-.28
9	-99.7	12
4.88	-95.9	34.03
-21.68	-71.37	64.62
-7.03	-86.59	17.77
5.78	-2.01	50.68
31.53	1.37	64.6
40.35	46.99	-20.74
-50.05	35.5	31.45
62.09	8.11	11.27
-57.54	7.9	19.35
-37.91	-14.19	62.24
47.59	-21.34	58.51
56.97	-20.42	28.22
-57.32	-21.65	36.32
-51.1	-14.86	13.38
6.06	-29.9	75.32
6.91	-25.61	48.18
26.17	-63.7	35.55
-19.71	-58.81	47.93
-2.5	-79.51	53.93
35.93	-42.38	62.64
12.62	-61.25	82.33
-31.38	-45.87	64.82
34.67	-34.5	40.81
24.54	-32.13	-23.96
-18.12	-42.53	-17.02
50.44	-53.52	-.16
-60.77	-58.22	-9.64
-59.87	8.12	-5.18
36.52	-68.21	-9.92
-24.26	-73.8	5.75
2.72	-101.62	28.96
-31.44	-86.08	40.31
-11.34	-96.82	9.76
-5.15	-54.11	-2.82
-25.38	-91.93	-8.33
-3.04	-21.44	6.69
-11.52	-2.05	24.12
-28.93	-69.14	-43.66
17.19	-49.46	-13.5
21.2	-44.52	-46.3
-27.93	-47.81	-43.23
15.32	33.46	54.29
14.96	50.55	13.83
-2.42	52.99	-21.87
-7.01	14.72	61.69
-32.71	17.22	55.08
-36.09	16.55	32.88
-11.83	50.76	5.19
1.97	33.35	-14.69
14.11	24.25	31.65
47.39	-44.26	23.63
51.43	-20.31	2.62
24.75	-47.5	-2.6

// Marjoram D, 2006: High Risk- (HR-)
// Subjects=12
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
12.74	-46.49	55.83
60.88	-67.39	13.37
-62.22	-57.52	22.34
36.29	-37.12	39.93
-13.38	-16.26	47.68
-20.19	11.84	27.08
29.63	18.47	37.9
-44.16	-24.77	4.22
12.14	46.4	27.59
33.65	-46.18	0.53
-13.75	33.44	28.2
-12.06	-71.8	-29.77
21.09	-21.32	37.51

// Marjoram D, 2006: High Risk+ (HR+)
// Subjects=12
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
67.27	-54.91	8.67
6.28	-55.12	55.67
-62.4	-59.93	8.01
36.29	-37.12	39.93
-13.38	-16.26	47.68
-20.19	11.84	27.08
29.63	18.47	37.9

// Marjoram D, 2006: High Risk+Ever (HR+Ever)
// Subjects=6
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
63.03	-60.89	13.81
-2.83	-64.11	17.49
37.82	54.51	9.55
38.11	31.5	27.51
39.94	-51.97	-15.81
29.53	23.17	30.72

// Marjoram D, 2006: High Risk+Now (HR+Now)
// Subjects=6
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
51.2	-40.86	22.12
-.24	-46.64	54.94
-65.7	-58.23	3.42
-37.16	-74.48	34.79
-50.26	-70.03	25.61
58.63	-72.48	4.95
37.82	54.51	9.55
38.11	31.5	27.51
39.94	-51.97	-15.81
-44.16	-24.77	4.22
12.14	46.4	27.59
33.65	-46.18	0.53
-13.75	33.44	28.2
-12.06	-71.8	-29.77

// Marjoram D, 2006: High Risk Ill (HRill)
// Subjects=5
56.63	-70.18	18.2
4.03	-53.63	48.84
-52.62	-77.02	8.41
1.07	64.05	10.35
69.28	-37.45	0.18
29.53	23.17	30.72
21.09	-21.32	37.51

// Marjoram D, 2006: Normals
// Subjects=13
-4.62	-44.94	50.37
56.72	-38.84	31.91
-62.36	-57.5	11.13

// Tanaka M, 2006: Chronic Fatigue Patients
// Subjects=6
9	-84	-3
-45	-9	54
-27	-57	57
24	-87	9
-21	-87	-9
57	-24	15
-39	-21	6
54	-21	12
-54	-33	18

// Tanaka M, 2006: Normals
// Subjects=7
9	-84	-3
-45	-9	54
-27	-57	57
24	-87	9
-21	-87	-9
57	-24	15
-39	-21	6
-54	-33	18

// Vollm B A, 2006: Theory of Mind (ToM) vs. Physical Causality (PC1) Strip 
// (processing ToM stimuli)
// Vollm B A, 2006: Empathy vs. Physical Causality 2 (PC2) Strip (processing 
// empathy stimuli)
// Vollm B A, 2006: Conjunction, ToM + Empathy (common activations associated 
// with processing ToM and empathy stimuli)
// Vollm B A, 2006: Interaction, (ToM-PC1 Strip) vs. (Empathy-PC2 Strip) (incr 
// activation processing ToM than empathy)
// Vollm B A, 2006: (Empathy- PC2 Strip) vs. (ToM- PC1 Strip) (areas more 
// activated in processing empathy than ToM)
// Subjects=13
-48	28	-17
-59	-57	22
-59	-21	-7
-50	-7	-27
0	-51	25
-36	-45	-18
-15	-102	0
-15	-89	-26
18	49	-8
45	-78	18
62	6	-5
62	-15	-17
39	-72	-32
-9	37	51
-50	-57	17
-45	10	-31
-12	-52	3
-30	-80	-26
48	4	-33
57	3	-21
27	-96	8
18	-83	-26
-21	35	51
-53	-57	19
-53	-9	-18
-50	-4	-30
-27	-96	10
-21	-102	-2
-9	-52	3
-30	-80	-26
15	37	51
6	8	-16
53	-60	17
59	-12	-15
18	-101	11
42	-87	4
21	-83	-26
-39	55	3
48	46	-7
62	3	-5
3	-89	29
-21	-1	-15
9	53	14
24	13	24
6	-22	34
42	-76	1

// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal (Lag=0)
// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal, (Lag=-20)
// Moulier V, 2006: BOLD Signal Correlated Negatively with Plethysmographic 
// Signal (Lag=0)
// Moulier V, 2006: (Women, Swimsuit - Women, Clothed) - (Children, Swimsuit - 
// Children, Clothed)
// Moulier V, 2006: (Women, Clothed - Women, Swimsuit) - (Children, Clothed - 
// Children, Swimsuit)
// Moulier V, 2006: BOLD Signal Correlated Positively with Plethysmographic 
// Signal, (Lag=+10)
// Subjects=10
15	63	-3
3	42	24
6	63	-3
27	57	-3
-27	63	21
12	-3	72
18	-15	57
42	30	42
36	45	33
30	33	48
27	-3	66
-33	30	45
-45	42	-9
36	18	-12
48	9	-6
-48	15	-6
-57	3	6
-9	-18	72
-33	-12	54
-36	18	0
-42	-15	-3
-45	-3	3
39	3	-9
3	18	36
3	30	33
0	-30	54
-54	-33	27
-63	-36	30
0	-69	51
60	-3	0
18	-15	12
-57	12	3
15	63	-3
-33	33	45
27	-3	69
3	21	63
45	15	-6
-45	-3	6
36	18	9
0	36	24
3	18	36
12	-9	48
-30	-84	15
39	-81	0
-36	-69	-18
36	-54	-15
39	-72	-15
-51	15	-6
-36	-42	60
3	-45	-21
-12	-12	15
3	-9	0
51	24	27
63	-6	36
0	48	-9
6	42	42
-30	39	-6
-6	-42	45
-3	-54	66
-6	42	-6
3	-45	21
18	-51	6
-9	-30	36
3	-72	3
27	-87	-3
-30	-21	18
-33	-21	-15
-27	-36	0
33	-33	-6
-24	-42	-15
-15	-51	-21
9	-63	-18
-9	-27	-15
42	-66	-15
48	-69	-9
-27	-84	6
-42	-63	-9
39	-81	-6
-36	-78	3
24	-63	48
39	-45	66
-27	-69	48
-18	-54	69
-45	-39	54
-39	-42	45
-51	-33	42
-57	-27	30
33	-48	54
-6	-81	39
33	6	30
39	21	0
30	24	9
-21	9	21
24	-30	15
0	-21	12
6	-9	-3
3	9	6
15	-63	21
-48	-69	24
-51	-33	3
0	-27	54
-9	-42	69
9	-39	72

// Perner J, 2006: False Belief > "False" Photo
// Perner J, 2006: False Belief > Temporal Change
// Perner J, 2006: False Sign > Temporal Change
// Subjects=19
54	-57	27
48	-21	-9
-48	-57	30
39	-30	12
9	-54	33
-15	54	36
51	-66	27
-45	-57	27
54	-18	-12
-60	-6	-18
-60	-36	-3
-18	30	54
54	18	15
-42	-63	36
-54	-42	-6

// Chen C H, 2006: Sadness, Manic > Depressed and Normals
// Chen C H, 2006: Fear, Manic and Depressed > Normals
// Chen C H, 2006: Happiness, Depressed > Manic and Normals
// Chen C H, 2006: Implicit, Sadness > Explicit, Sadness; Manic > Depressed 
// and Normals
// Chen C H, 2006: Implicit, Sadness > Explicit, Sadness
// Chen C H, 2006: Implicit, Fear > Explicit, Fear
// Chen C H, 2006: Implicit, Happiness > Explicit, Happiness
// Subjects=8
-28	-56	-8
-40	-2	32
-52	-8	38
-42	-38	4
20	-14	-22
-12	20	4
26	2	-4
-8	-24	4
-4	-28	-20
-14	38	46
58	-10	12
-32	-10	34
-20	30	-8
-52	-26	-8
-24	-58	14
16	-72	-8
12	10	40
-8	-36	36
-20	-4	12
10	-16	12
-12	28	46
-54	-16	-16
-58	-18	4
-6	2	44
-34	8	-4
-28	-34	-1
-28	-2	-16
56	-46	24
54	-44	20
8	-64	2
-6	24	0
20	-28	14
0	-48	-12
2	-20	-20
-34	-48	26
-28	-36	40
14	8	26
-28	-30	22
-8	2	18

// Roth R M, 2006: Bipolar Patients
// Subjects=11
34	-62	-27
44	28	8
10	3	50
18	-37	-32
-20	-63	14
-24	-26	-9
-30	-65	-9
-34	-77	6
-18	-66	9
14	-48	-25
16	-67	-19
-36	-13	23
-32	50	-3
63	-1	26
-46	-28	-14

// Roth R M, 2006: Normals
// Subjects=11
44	24	10
42	-58	-39
-46	-5	52
-22	-55	-12
44	28	8
10	3	50
18	-37	-32
-20	-63	14
-24	-26	-9
-30	-65	-9
-34	-77	6

// Kronhaus D M, 2006: Bipolar Disorder
// Subjects=10
27.73	-37.74	-27.99
56.59	10.85	-7.86
-20.56	42.22	-21.87
-12.06	29.7	-33.18
-2.33	25.41	-20.67
-20.5	40.62	-15.05
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-23.59	34.14	-2.2
-11.2	-47.12	46.85
-20.56	42.22	-21.87
-20.5	40.62	-15.05

// Kronhaus D M, 2006: Healthy Controls
// Subjects=11
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-34.49	41.71	-27.24
37.49	-36.22	-9.27
-23.59	34.14	-2.2
-11.2	-47.12	46.85
6.97	-74.39	36.66
7.74	-57.67	5.14
-31.59	-61.3	30.43
-30.79	-55.24	-1.31
-29.02	43.11	-9.58
-23.59	34.14	-2.2
-11.2	-47.12	46.85
-20.56	42.22	-21.87
-20.5	40.62	-15.05

// Baumgartner T, 2006: Pictures with Music > Fixation
// Baumgartner T, 2006: Pictures Without Music > Fixation
// Baumgartner T, 2006: Pictures Without Music > Pictures With Music
// Baumgartner T, 2006: Pictures With Music > Pictures Without Music
// Subjects=9
48	0	40
-44	12	-28
52	-20	-4
56	-4	-20
-32	4	-40
-40	-8	-36
-20	-4	-28
20	-24	-24
-24	-8	-24
32	-28	-12
-20	-4	-24
-28	-96	8
28	-92	16
12	-92	-16
-26	-100	0
-24	-88	-24
24	-87	-24
-4	-26	-8
40	-56	-36
8	-32	-32
52	8	32
-52	32	20
-20	-32	-8
20	-28	-12
-40	-80	0
28	-92	16
-12	-96	-16
12	-96	-16
-20	-100	0
-24	-88	-24
22	-86	-20
-48	-64	-28
24	-88	-28
52	24	28
48	44	8
-4	28	52
0	44	-16
52	0	44
56	-20	-4
60	-24	4
36	12	-32
56	-28	8
-64	-28	8
-56	-16	0
56	0	-20
64	-16	-12
40	12	-44
-52	8	-28
16	-8	-32
24	-16	-20
-26	-20	-28
-17	-4	-20
24	-8	-24
-24	-20	-16
-32	-20	-32
-40	-8	-32
35	-2	-36
-36	-8	12
8	-44	16
-8	16	0
-16	4	24
4	-24	-36
8	-40	-12

// Brambati S M, 2006: Dyslexic Patients
// Subjects=13
-46	18	10
-46	24	14
40	16	14
42	3	29
50	13	22
52	18	14
50	10	36
50	4	40
52	12	36
-50	16	7
-46	24	14
-38	-58	47
-59	-45	32
52	24	17
52	15	21
4	14	47
52	-45	2
22	-77	-26
14	-80	-23
12	-77	-30
-42	14	18
46	7	18
-46	19	6
-32	24	10
-51	-42	21
-30	-69	-13
-38	-49	-14
-42	-65	-10
34	51	5
26	49	1
14	-52	-21
-36	-69	-13
-46	20	6
-51	25	2
-16	-5	52
-16	4	47
-53	-40	20
-55	-55	18
-40	-26	-12
-37	-49	-14
-40	-57	-14
46	-35	-8
40	-27	-5

// Brambati S M, 2006: Healthy Controls
// Subjects=11
-54	8	7
-46	22	6
-44	13	18
-30	27	-4
-34	15	-7
-38	11	-7
-30	15	4
-2	3	62
-10	12	43
-4	8	51
-62	-44	13
-46	9	-7
-54	-46	6
-57	-29	-2
-55	-2	-10
-38	-49	-14
-40	-57	-14
-52	-40	24
40	17	25
32	24	6
44	32	10
36	21	-4
34	33	-8
48	25	25
48	36	24
36	46	16
36	39	-5
48	17	36
40	6	37
6	14	51
54	-35	2
-44	18	14
-48	16	4
-40	23	-8
-36	-2	7
-4	-1	63
-2	14	47
-57	-31	-2
-62	-39	6
-48	-41	2
-48	41	2
-54	-48	4
-38	-49	-14
36	13	22
40	15	25
38	33	6
42	32	10
34	35	-2
40	17	-11
34	47	5
36	51	1
-38	3	29
-48	5	33
-48	23	3
-36	24	13
-44	22	21
-40	16	18
-38	30	2
-30	4	4
-32	16	-1
-24	4	0
-4	5	58
-6	10	51
-52	-40	20
-62	-46	13
-38	-49	-14
-40	-60	-14
-24	-54	40
-30	-56	47
-44	-38	46
-50	-37	35
32	22	6
44	29	6
42	32	10
40	34	13
34	19	-4
38	17	-4
36	23	-11
46	17	-1
34	38	16
6	9	59
4	14	54
-46	19	6
-32	24	10
-51	-42	21
-30	-69	-13
-38	-49	-14
-42	-65	-10
34	51	5
26	49	1
14	-52	-21
-36	-69	-13
-46	20	6
-51	25	2
-16	-5	52
-16	4	47
-53	-40	20
-55	-55	18
-40	-26	-12
-37	-49	-14
-40	-57	-14
46	-35	-8
40	-27	-5

// Fu C H Y, 2006: Self Undistorted > Self Distorted Feedback
// Fu C H Y, 2006: Self Distorted > Self Undistorted Feedback
// Fu C H Y, 2006: Self Undistorted > Alien Undistorted Feedback
// Fu C H Y, 2006: Alien Undistorted > Self Undistorted Feedback
// Fu C H Y, 2006: Self Distorted > Alien Undistorted Feedback
// Fu C H Y, 2006: Alien Undistorted > Self Distorted Feedback
// Fu C H Y, 2006: Self Undistorted Feedback> Rest
// Fu C H Y, 2006: Self Distorted Feedback> Rest
// Fu C H Y, 2006: Alien Undistorted Feedback > Rest
// Fu C H Y, 2006: Alien Distorted Feedback > Rest
// Fu C H Y, 2006: Self Distorted Correct Responses > Self Distorted 
// Misattribution Responses
// Subjects=13
-37.58	9.97	-24.55
-37.54	10.4	-19.01
-55.56	-13.52	-10.1
-16.91	-25.66	8.32
57.84	-11.47	6.27
-33.34	31.57	-20.83
-29.02	32.11	-14.23
-55.51	-27.26	-8.95
-21.13	-76.76	-5.19
-10.78	25.25	-8.29
35.17	25.52	-8.84
-64.03	-23.71	-3.57
5.36	-6.38	-5.82
-2.91	-79.39	0.39
-59.78	-3.08	1.34
39.85	-69.1	5.73
-59.73	-16.83	2.49
-10.42	-57.77	5.36
-52.1	-58.02	5.86
-21.31	-2.85	0.88
-55.47	-2.63	6.83
13.17	-68.84	11.59
13.22	-68.32	18.24
-32.94	-11.5	14
-59.6	-15.46	20.22
-5.98	-51.63	29.33
62.04	-2.35	-.12
57.87	-18.87	6.89
12.87	-48.94	-20.18
-21.1	-84.16	-4.57
43.72	11.4	-13.33
-59.83	-3.6	-5.31
8.76	-58.17	-1.52
62.09	-30.36	-4.47
31.26	-71.78	-.64
-6.32	-26.54	-4
54.66	-29.89	2.27
-6.04	-85.24	7.61
27.97	-37.45	3.21
17.34	-51.26	4.49
1.45	-89.43	7.88
17.07	19.58	-1.45
-48.93	-47.43	4.93
-59.73	-16.83	2.49
-59.71	-12.17	7.68
-48.89	-47	10.47
13.13	-57.21	10.62
39.9	-70.79	11.45
17.13	15.78	4.45
1.39	-61.51	11.11
23.78	-46.57	9.6
-59.67	-8.49	14.06
-14.58	-64.26	18.22
17.18	16.3	11.1
1.29	-21.87	14.48
13.22	-68.32	18.24
-20.91	-84.39	19.98
17.27	-8.02	13.13
-59.6	-15.46	20.22
1.45	-52.1	22.59
19.53	-14.47	25.92
-59.54	-18.12	27.13
61.97	-9.64	-11.78
1.29	-72.39	-5.82
-55.46	-16.8	2.44
47.14	-19.36	1.48
62.14	-18.84	6.84
35.69	-74.53	18.5
62.19	-18.33	13.48
-55.71	-.71	-23.44
-55.59	-7.17	-10.63
-59.59	-18.63	20.48
-59.5	-28.69	28.02
12.92	-2.22	6.01
-6.65	12.81	-31.83
-49.37	6.21	-30.79
-52.5	-.69	-23.48
-17.17	-18.46	-22.4
-55.67	-.28	-17.9
8.28	45.57	-22.48
54.37	7.78	-19.84
8.33	31.82	-21.33
0.95	4.28	-18.94
-17.08	-31.78	-15.7
-59.74	-38.92	-7.92
-55.62	0.23	-11.25
61.95	-3.3	-12.31
62.06	-33.96	-9.74
-41.64	-20.84	-9.65
-3.23	-6.86	-11.26
1.35	-76.19	0.08
-59.72	-34.26	-2.74
-55.57	0.66	-5.71
-41.81	35.64	-8.81
62.09	-30.36	-4.47
66.3	-12.36	-6.02
43.82	-2.98	-6.55
8.57	1.38	-2.05
62.05	-5.53	0.14
-55.52	1.17	0.93
-10.6	-9.13	1.28
12.88	-2.65	0.47
-37.49	36.17	-2.21
-63.93	-38	4.31
66.42	-18.82	6.78
-59.72	-9	7.41
-63.89	-37.58	9.85
-41.56	-5.72	6.93
62.2	-21.5	13.75
-3.14	20.4	10.99
-52.21	-2.1	13.44
58.01	-42.68	15.57
13.23	-70.44	18.42
-59.56	-24.98	21.02
62.24	-21.07	19.29
-14.67	-14.68	26.33
5.69	-28.3	27.24
9.07	-76.92	31.27
-59.46	-38.21	28.81
-49.37	-20.11	-40.85
-37.48	-42.79	-32.39
46.8	-5.27	-36.5
57.51	-11.55	-36.1
-49.49	37.94	-33.45
43.64	-4.86	-30.93
-41.93	30.04	-26.18
46.78	27.39	-26.98
51.15	-0.07	-24.72
-44.92	-28.14	-21.27
61.91	-17.98	-23.34
62.08	-63.45	-19.53
-37.32	-59.82	-18.7
-10.81	7.39	-19.06
-60.04	27.18	-20.16
62.15	-70.43	-13.37
57.71	-27.1	-16.96
-33.13	-24.47	-16.13
-3.24	-3.69	-11.53
-6.64	49.16	-15.92
61.85	22.08	-14.44
-59.83	-3.6	-5.31
-3.08	-33.92	-3.42
-59.88	8.03	-6.28
-33.22	25.11	-8.02
-55.53	-9.92	-4.83
5.41	-5.87	0.82
-48.96	-40.03	4.31
-59.85	14.89	-.17
0.96	40.63	-3.03
-55.33	-51.7	5.36
19.29	-2.61	0.39
-14.8	-19.3	7.76
8.51	33.71	3.04
47.07	9.62	4.62
-52.15	-19.02	14.85
-55.5	20.09	11.61
-41.35	-36.5	21.77
8.71	7.16	17.54
-45.11	9.41	-31.1
34.98	38.96	-27.81
12.91	-59.52	-19.3
51.13	7.33	-25.34
-49.32	6.73	-24.14
57.71	-27.1	-16.96
-45.08	27.27	-20.33
-52.49	7.14	-18.56
8.63	-34.28	-9.1
-64.02	-38.95	-7.87
-48.95	-66.35	-5.75
35.05	46.24	-16.15
57.79	-33.99	-9.69
-55.6	-4	-10.9
-14.9	-17.08	-4.69
46.89	32.99	-9.6
-41.79	28.23	-8.19
57.7	1.34	-7.07
-55.57	0.66	-5.71
5.51	-44.45	-2.63
43.75	29.26	-2.56
57.85	-25.64	1.88
8.76	-43.91	3.98
-37.44	33.43	3.6
-55.4	-19.55	8.24
-21.21	-19.34	7.83
54.58	16.52	10.65
-52.14	-22.19	15.12
5.48	13.48	17.04
-14.72	-15.19	19.68
-59.56	-24.98	21.02
-59.51	-24.46	27.66
-45.11	9.41	-31.1
54.46	-27.55	-22.46
-49.32	6.73	-24.14
8.57	-31.62	-16.01
57.74	-34.5	-16.34
51.08	32.08	-21.84
8.63	-48.54	-14.59
-52.34	-31.99	-15.28
5.51	-70.77	-12.69
46.88	10.9	-20.02
-55.68	3.94	-18.26
-3.21	-10.03	-11
12.91	-34.26	-9.15
-59.76	-34.69	-8.28
-52.39	-3.98	-10.94
-55.37	-54.33	-1.11
51.17	33.02	-9.65
54.48	5.55	-7.39
62.09	-30.36	-4.47
1.33	-71.96	-.28
-59.82	-6.77	-5.04
8.62	-5.85	0.78
51.22	33.53	-3.01
-3.15	-2.74	0.66
62.18	-39.36	2.98
-59.78	-3.08	1.34
-6.3	-5.51	6.5
54.54	12.83	4.27
66.43	-21.99	7.05
-59.68	-19.57	8.3
8.61	20.47	10.84
54.59	13.35	10.91
-55.3	-32.78	16.04
35.44	3.09	17.57
5.65	-31.99	20.85
-55.24	-38.7	22.12
1.59	-76.97	31.36
9.07	-76.92	31.27
-55.19	-38.18	28.76
1.34	-86.14	-4.67
66.35	-26.11	-4.87
57.73	6.08	-.78
66.43	-32.99	2.4
5.67	-75.65	6.67
66.44	-25.16	7.32
-59.69	-16.4	8.03
62.27	-38.42	15.17
-55.24	-38.7	22.12
-59.58	-32.81	16.1
-59.51	-38.72	22.17
-59.47	-36.09	28.64

// Harenski C L, 2006: Watch, Moral > Number Discrimination
// Harenski C L, 2006: Watch, Non-moral > Number Discrimination
// Harenski C L, 2006: Watch, Moral > Watch, Non-moral
// Harenski C L, 2006: Watch, Non-moral > Watch, Moral
// Harenski C L, 2006: Decrease, Moral > Number Discrimination
// Harenski C L, 2006: Decrease, Non-moral > Number Discrimination
// Harenski C L, 2006: Decrease, Moral > Watch, Moral
// Harenski C L, 2006: Decrease, Moral > Decrease, Non-moral
// Harenski C L, 2006: Decrease, Non-moral > Decrease, Moral
// Subjects=10
63	27	9
-21	-6	-15
-12	39	54
-9	30	63
9	57	18
9	69	21
30	-45	-12
-15	54	39
3	-63	15
-6	51	21
-9	27	63
18	-3	-27
-51	-66	30
-15	-45	24
-39	39	39
42	30	-18
-54	27	0
60	36	15
12	66	30
-12	66	27
-18	54	39
-9	36	60
12	27	66
-30	-93	21
51	-66	15
-45	-81	18
15	-99	3
0	39	54
63	27	9
15	18	69
-24	0	-27
42	33	-18
33	-81	18
42	-48	-27
-45	-84	6
-12	-102	12
0	-87	-12
45	14	-3
3	17	-8
-39	17	-8
-30	47	17
-12	18	60
-12	23	49
-3	9	55
6	-72	33
-6	60	6
0	51	-3
-12	15	66
-21	48	21
42	33	30
-27	39	33
-36	15	48
3	36	-3
-51	-66	9
57	-66	9
39	-63	21
-45	33	-18
45	-33	45

// Lee T W, 2006: Imitation > View, Angry Faces
// Lee T W, 2006: Imitation >  View, Sad Faces
// Lee T W, 2006: Imitation > View, Happy Faces
// Lee T W, 2006: Imitation > View, Chewing Faces
// Lee T W, 2006: Imitation > View, Licking Faces
// Lee T W, 2006: Associated Conjunction of Imitation of Ingestive Expressions 
// > View
// Lee T W, 2006: Imitation > View, Angry Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: Imitation > View, Sad Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: Imitation > View, Happy Faces (Excluding Chew and Lick 
// Imitation)
// Lee T W, 2006: View, Angry Faces > View, Neutral Faces
// Lee T W, 2006: View, Sad Faces > View, Neutral Faces
// Lee T W, 2006: View, Happy Faces > View, Neutral Faces
// Lee T W, 2006: View, Chewing Faces > View, Neutral Faces
// Lee T W, 2006: View, Licking Faces > View, Neutral Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Chewing Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Licking Faces
// Lee T W, 2006: Activations Associated with Facial Movements, Conjunction of 
// Ingestive Expressions
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Angry Face
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Sad Face
// Lee T W, 2006: Selective Correlations with Facial Movements During 
// Imitation, Happy Face
// Subjects=18
-53	-7	36
53	-4	36
59	4	8
3	19	35
3	0	55
-53	-33	32
-18	-55	3
-39	-3	6
-48	-1	41
56	-10	39
50	13	35
59	7	13
0	8	44
6	9	60
-50	-7	36
45	-10	36
65	-25	21
59	12	8
0	-3	55
24	3	3
-50	-7	31
53	-2	25
59	3	8
59	-21	40
6	13	35
0	0	55
39	-5	14
-50	-7	28
56	-2	28
50	-8	11
53	-29	54
0	0	53
-42	-6	6
36	-5	11
-53	-7	31
53	-4	28
62	-21	37
6	3	55
39	16	-26
-42	-6	3
39	0	0
-45	-9	45
42	-13	39
-53	-11	12
-45	11	-4
56	9	11
56	8	36
3	19	35
3	0	55
-53	-33	32
-45	11	-6
-18	-55	3
-39	-3	6
36	9	8
-48	-1	41
56	-16	37
-50	7	7
59	9	13
50	13	35
0	8	44
6	9	60
-39	-41	55
-50	6	0
-45	-9	45
48	-4	42
65	-25	21
-48	16	-4
59	12	8
0	13	32
0	-3	55
-59	-31	24
-48	14	-6
24	3	3
-42	-7	31
12	-7	45
-3	58	-5
-33	22	-24
42	-19	-24
45	19	35
59	-54	19
56	-10	-17
67	1	19
-6	-64	58
-53	-48	30
-50	2	-28
-50	-7	28
56	-2	25
3	0	55
-18	-64	58
53	-28	26
59	-58	8
-39	-62	-12
-42	-50	-10
45	-56	-15
33	-76	-9
-42	-84	15
-45	-17	4
45	8	-5
-27	-3	3
-50	-7	25
53	-7	36
-18	-64	56
53	-28	24
39	19	-31
59	8	-5
53	-69	12
-45	-50	-15
36	-56	-15
24	-70	-4
-42	-87	7
-45	-76	-6
30	-81	18
48	-77	-1
-50	-37	18
45	-8	14
-56	-10	31
56	-2	28
-18	-61	53
-53	-52	8
59	11	-6
59	-64	9
-48	-47	-15
42	-50	-18
-48	-78	4
-30	-87	15
30	-81	18
-33	-82	-11
45	-79	-1
-48	-37	18
45	-8	14
-45	-12	45
45	-4	44
-53	-19	23
53	-28	21
-21	64	2
18	67	8
9	6	66
-57	6	5
56	7	13
3	55	-15
-3	0	53
-48	-65	36
-39	-56	-12
-37	3	5
47	8	-5
-24	0	-8
21	12	8
-56	-21	43
-12	-2	69
9	3	66
-30	20	-14
59	15	2
-3	46	-12
3	34	-9
3	0	58
6	-42	33
-45	-35	54
48	-62	34
42	16	-24
21	-13	-20
45	9	0
-45	-16	39
39	-16	37
42	-4	33
-53	-8	11
-59	-19	20
56	9	8
9	6	60
-6	-16	39
6	-36	40
50	-56	36
56	-28	26
-45	13	-26
39	16	-34
-65	-33	-11
-45	-67	9
53	-32	7
59	-36	-13
-39	-56	-12
42	-56	-12
-21	-95	13
-21	-82	-6
50	-69	9
42	0	6
-15	12	13
21	21	3
-24	6	5
27	0	0
-21	-4	-15

// Mathiak K, 2006: (Passive/Dead + Preparation/Search) > (Potential Danger + 
// Under Attack + Active Fighting)
// Mathiak K, 2006: (Potential Danger + Under Attack + Active Fighting) > 
// (Passive/Dead + Preparation/Search)
// Subjects=13
14	38	-2
-50	-60	54
44	-40	-6
36	-52	24
-26	56	-16
-38	-2	6
-40	-30	-18
54	-54	48
54	-58	-24
-2	-56	56
60	-32	18
-56	-38	36
-2	-12	40

// Petrella J R, 2006: Normals > MCI Patients, Encoding
// Petrella J R, 2006: Normals > MCI Patients, Retrieval
// Petrella J R, 2006: MCI Patients > Normals, Retrieval
// Subjects=20
-16	3	66
24	7	57
-44	18	19
-6	29	41
-22	-44	-16
40	13	29
-6	27	45
-46	12	36
32	23	-5
-48	15	-6
-34	-10	-13
34	-14	36
-26	5	18

// Aron A R, 2006: Go - Null Event
// Aron A R, 2006: Stop - Go
// Aron A R, 2006: Stop Inhibit - Stop Respond
// Subjects=5
24	-100	-6
-22	-102	-14
-42	-28	46
-14	-12	-6
-28	-10	0
-16	-14	6
-24	2	8
-26	-8	8
-18	-6	-4
-14	-20	-8
-10	-16	-12
-26	-20	4
-26	-18	10
20	10	-2
28	2	-4
30	14	-4
42	48	14
-34	-62	-36
-6	-6	58
-10	4	44
-20	-6	48
68	-44	8
34	26	0
36	22	0
44	22	-4
44	12	8
52	38	-6
54	14	0
42	20	-10
6	20	50
6	8	70
8	20	34
18	-104	4
-40	16	-6
-56	-28	8
-46	-38	18
22	-30	-6
12	-26	0
16	4	-6
6	-26	-2
6	-20	4
10	-14	-4
18	12	-8
12	-18	2
18	-22	-2
6	-20	-12
-6	-22	4
-8	-16	0
34	40	30
8	-20	30
-26	-98	-10
-20	-26	-10
48	2	50
14	-42	48
36	-48	46
10	-42	52
18	-104	2
-18	-108	0
-26	-10	2
-34	-16	-6
-34	-6	-18
-16	-54	14
-30	22	56
42	-22	52
22	-8	12
20	4	12
24	-2	2
-2	40	-18
-10	-28	70

// David N, 2006: 1PP > 3PP
// David N, 2006: 3PP > 1PP
// David N, 2006: ACT > PAS
// David N, 2006: PAS > ACT
// David N, 2006: ACT Using 1PP as a Search Volume
// David N, 2006: Common for ACT and 1PP
// David N, 2006: Common for PAS and 3PP
// Subjects=13
-2	44	-8
-62	-20	-14
-56	-64	30
-28	-4	-12
-4	-24	44
54	6	-32
-32	34	-12
20	36	52
-12	-50	8
6	-10	48
-8	-52	30
-6	-88	30
-48	-10	-8
-34	-56	56
-44	8	34
88	2	54
2	-36	-40
18	-26	14
34	22	2
-36	22	2
4	16	46
-18	-22	12
40	56	6
32	-64	-50
-14	46	10
-10	40	46
-8	58	20
4	-56	-50
14	46	22
50	-72	2
-50	-58	16
6	-54	50
28	-78	40
-38	-46	-18
44	4	50
-52	22	34
-36	0	62
28	-82	12
58	-38	54
44	-52	54
-14	46	10
-10	40	46
-14	-48	10
-14	-32	74
0	-28	46
10	56	32
-14	46	10
-10	40	46
-8	58	20
50	-72	2
-50	-58	16
6	-54	50
28	-78	40
44	4	50
16	-62	36
-52	22	34
46	18	36

// Daw N D, 2006: Activations Correlated to Number of Points Received
// Daw N D, 2006: Regions Correlated to Probability Assigned by Model
// Daw N D, 2006: Exploration > Exploit
// Daw N D, 2006: Prediction Error
// Subjects=14
3	30	-21
-3	45	-18
45	36	-15
-3	33	-6
27	57	6
-29	-33	45
39	-36	42
-57	3	36
3	9	51
21	-54	-30
18	-57	-51
9	12	-9
9	0	18

// Bingel U, 2006: Main Effect of Painful Laser-Stimulation
// Bingel U, 2006: Right Hand, Placebo > Nonplacebo
// Bingel U, 2006: Left Hand, Placebo > Nonplacebo
// Bingel U, 2006: Right Hand, Co-players of Placebo Analgesia
// Bingel U, 2006: Left Hand, Co-Players of Placebo Analgesia
// Subjects=19
42	-42	48
57	-21	21
63	-51	12
39	-6	0
3	30	39
6	39	9
9	-18	9
18	-3	-15
30	-63	-33
18	12	-3
-54	-42	48
-60	-15	15
-60	-36	12
-39	6	3
-3	18	48
-6	42	12
-12	-9	0
-18	-3	-15
-33	-72	-21
-15	15	0
3	42	-18
-3	39	-18
15	-6	-21
3	-21	-3
0	-12	-9
-18	-12	-21

// Fukui H, 2006: Human - Computer
// Subjects=16
-8	43	35
-57	-51	28

// Johnson S C, 2006: Activations in Novel Drawings Relative to Previously 
// Learned, Normals
// Johnson S C, 2006: Previously Learned vs. Novel Drawings, Normals
// Johnson S C, 2006: Elderly Normals vs. Mild Cognitive Impairment, Novel 
// Drawings
// Johnson S C, 2006: Elderly Normals vs. Mild Cognitive Impairment, 
// Previously Learned
// Subjects=14
-34	-44	-28
30	-44	-26
-44	34	8
24	-4	-24
-25	-8	-22
-12	22	46
58	-58	28
58	-18	-18
8	-76	36
2	-28	26
36	18	52
8	52	54
-36	-54	32
-54	22	30
40	-68	-24
22	-8	-26
24	-26	-10
16	-72	28
12	-52	16

// Smith Y R, 2006: Working Memory (4-sec Delay) - Working Memory (1-sec 
// Delay), Pre-Therapy
// Smith Y R, 2006: Working Memory (4-sec Delay) - Working Memory (1-sec 
// Delay), Post-Therapy, Hormone > Placebo
// Subjects=10
-42	6	29
-44	30	25
45	4	31
-5	14	47
-31	-70	43
27	-61	48
-12	-75	-14
25	-75	-17
-39	24	32
-44	20	15
40	11	18

// Becerra L R, 2006: Morphine > Saline
// Subjects=8
21.01	35.54	-26.07
-20.2	35.19	-25.81
7.45	19.08	17.31
33.83	36.86	28.14
-34.85	36.28	28.59
24.39	-22.28	-23.24
-16.82	-22.63	-22.98
22.53	-24.31	64.59
11.63	6.52	-16.26
-9.51	6.27	-17.23
21.19	-7.06	-15.39
-20.03	-7.68	-19.54
0.03	-3.37	-21.07
-17.88	-4.47	-2.02
28.61	-1.85	-.25
-12.58	-20.02	-15.41
9.67	-20.65	5.59
-5.12	-20.84	4.58
-1.97	-33.72	-16.76
14.97	-51.06	-26.77
-9.34	-49.3	-28.96

// Kong J, 2006: High Pain > Low Pain
// Kong J, 2006: Pain Intensity Evaluation > Target Matching
// Subjects=16
14	-42	72
66	-22	22
-66	-26	20
4	2	46
20	-70	-2
36	-20	16
-36	-16	14
-52	10	-4
-32	0	2
-14	-8	8
16	-14	8
0	-48	-26
-8	-78	18
-28	52	16
-30	20	8
-12	16	56
-14	74	52
-32	-80	34
42	14	2
36	32	4
14	-98	-6

// Maihofner C, 2006: Heat Pain Stimulation - Non Painful Stimulation
// Maihofner C, 2006: Impact Pain Stimulation - Non Painful Stimulation
// Maihofner C, 2006: Impact Pain Stimulation - Heat Pain Stimulation
// Subjects=14
-34.75	-20.14	53.78
-31.56	-17.04	52.37
-30.38	-58.7	50.27
38	-51.86	50.03
-43.6	-20.11	13.73
56.85	-20.56	12.62
-47.77	-24.48	26.41
52.89	-34.85	48.43
-41.4	11.4	35.6
48.35	7.36	30.45
-38.51	46.54	8.08
42.87	38.88	25.64
-2.73	14.74	61.64
8.88	30.96	50.11
-28.82	22.11	7.79
38.49	20.14	3.84
-2.9	15.23	40.41
5.63	12.91	37.16
-33.67	-18.91	55.9
-41.23	-5.55	50.4
51.68	3.21	45.25
-30.37	-59.67	51.47
36.95	-58.21	50.57
-54.27	-22.11	16.25
17.34	-20.46	17.52
-50.99	-24.67	24.24
59.27	-40.61	42.15
-50.17	15.64	8.58
52.54	9.79	20.16
-29.78	29.82	25
39.62	42.84	22
-4.95	25.93	55.15
8.92	25.84	52.77
-48.06	15.31	4.12
41.73	13.99	6.55
-48.06	15.31	4.12
40.83	-20.57	13.92
-.84	26.44	33.87
4.55	12.73	34.96
-54.27	-23.26	15.23
60.06	-18.26	14.62
-49.89	-31.98	25.95
52.68	-25.02	24.19
54.68	10.95	21.15
-31.83	-23.12	14.97
36.39	26.01	11.18

// Hampton A N, 2006: Prior Correct Activity
// Hampton A N, 2006: Posterior Correct - Prior Correct Activity
// Hampton A N, 2006: State-Based > Standard RL
// Hampton A N, 2006: Prior Incorrect Activity
// Hampton A N, 2006: Switch - Stay Activity
// Subjects=16
6	57	-6
33	-15	-18
-9	66	21
6	66	24
0	39	-6
0	33	-24
-9	-57	24
-6	54	24
-24	3	-9
18	3	-15
-12	51	-15
6	45	-9
39	36	33
48	15	9
6	21	45
-3	24	30
51	21	3
-39	18	-12

// Pessiglione M, 2006: Reward Prediction Error, Positive Correlations
// Pessiglione M, 2006: Punishment Prediction Error, Negative Correlations
// Pessiglione M, 2006: Stimulus Related Activity, Go/NoGo
// Pessiglione M, 2006: Stimulus Related Activity, (Go/NoGo Gain) - (Go/NoGo 
// Neutral)
// Pessiglione M, 2006: Stimulus Related Activity, (Go/NoGo Loss) - (Go/NoGo 
// Neutral)
// Subjects=39
-30	-10	-2
-10	12	-8
40	24	-8
-30	-6	0
26	-48	30
-12	-22	6
-38	-26	56
-6	-10	56
-42	-4	14
44	0	10
-12	10	-10
30	28	-6

// Cerasa A, 2006: Parkinson's Disease Patients
// Subjects=10
-30.4	-22	67.58
-62.56	-20.69	3.01
60.72	-21.55	9.96
-2.55	-7.29	51.09
-44.14	38.89	19.21
52.74	32.17	-12.03
-54.07	26.35	0.45
60.04	-2.17	45.03
-43.94	38.21	34.96
-11.79	-11.79	3.5
27	-73.71	-17.92
-22.62	-75.49	-11.3
-28.22	-26.24	67.97
-60.25	-23.89	14.49
57.48	-21.56	10.02
10.45	6.14	56.26
-28.97	28.31	20
62.56	20.92	-6.6
31.26	-73.04	-22.54
30.26	-62.64	-14.59
14.43	-68.61	14.28
-7.26	-70.38	8.1
34.01	-91.63	19.59
-7.18	-74.21	12.96
25.26	-62.95	16.9
4.03	10.99	62.61
54.88	27.72	-13.87
-62.59	-2.29	4.55
39.9	21.05	-3.99
-9.41	-74.74	7.45
26.99	14.83	-.91
12.08	-21.93	8.58
-13.96	-79.71	-11.03
18.6	-25.95	11.11
-7.52	-16.55	-1.7
31.28	-69.64	-20.64

// Cerasa A, 2006: Healthy Controls
// Subjects=11
-43.4	-22.35	64.48
71.57	-18.97	14
-13.38	10	52.92
25.59	-60.45	43.54
64.99	15.25	12.97
-11.59	22.5	25.88
20.42	-49.27	-20.23
-56.66	-16.93	42.88
9.68	-56.54	-17.09
20.76	-51.13	5.72
-22.27	-99.15	11.21
-7.21	-74.42	10.74
14.4	-78.7	9.68
4.03	10.99	62.61
54.88	27.72	-13.87
-62.59	-2.29	4.55
39.9	21.05	-3.99
-9.41	-74.74	7.45
26.99	14.83	-.91
12.08	-21.93	8.58
-13.96	-79.71	-11.03
18.6	-25.95	11.11
-7.52	-16.55	-1.7
31.28	-69.64	-20.64

// Eckert T, 2006: Parkinson's Disease Patients
// Subjects=9
-26	-28	60
-4	-12	60
-60	8	6
36	-12	60
56	16	-8
64	-24	20
48	-36	48
16	-56	-28
4	-68	-20
-28	-64	-32
-40	-28	60
0	-8	64
-60	4	6
32	-12	64
64	-28	24
48	-40	52
20	-56	-28
4	-68	-20
-24	-68	-32
24	0	64
32	4	56
40	0	40
-32	-52	60
-40	-20	56
-52	-24	36
0	4	60
36	-8	60
-60	-20	20
16	-72	56
-28	-64	-28
4	-68	-20
12	-60	-24
-40	-40	48
-40	-44	60
-36	-44	68
-48	-64	44
-40	-76	32
28	-32	64
12	-24	60
28	-44	72
16	-48	-48
-32	-16	64
0	4	64
4	-68	-16
16	-68	-24
-20	-72	-28
-36	-48	64
-40	-40	44
28	-28	68
16	-48	-48

// Eckert T, 2006: Healthy Controls
// Subjects=9
-40	-25	60
-4	-20	56
32	-24	68
-60	-20	40
-60	4	20
-56	-4	44
20	-52	-44
-40	-20	56
-52	-24	36
0	4	60
36	-8	60
-60	-20	20
16	-72	56
-28	-64	-28
4	-68	-20
12	-60	-24
-40	-40	48
-40	-44	60
-36	-44	68
-48	-64	44
-40	-76	32
28	-32	64
12	-24	60
28	-44	72
16	-48	-48
-32	-16	64
0	4	64
4	-68	-16
16	-68	-24
-20	-72	-28
-36	-48	64
-40	-40	44
28	-28	68
16	-48	-48

// Durston S, 2006: Healthy Controls
// Subjects=11
-57.54	-19.84	57.75
26.58	-50.57	-45.98
44.06	22.05	-16.48
-38.03	20.8	-13.84
5.42	45.68	8.73
-7.43	46.46	17.84
-37.85	48.4	5.84
49.02	19.19	33.02
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72
60.82	5.43	22.98
-16.3	-29.63	-14.82
-37.76	-31.86	-3.03
-38.03	20.8	-13.84
-7.43	46.46	17.84
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72
44.06	22.05	-16.48
49.02	19.19	33.02
-45.81	12.97	52.06
-63.18	-47.87	33.72

// Durston S, 2006: Unaffected Siblings
// Subjects=11
-57.77	-16.08	40.57
44.2	-51.31	-20.43
-58.33	1.66	0.73
48.7	20.1	8.28
5.42	45.68	8.73
-28.05	-23.21	-2.93
56.96	-53.44	47.92
48.15	0.64	-39.09
39.74	34.05	-14.23
-3.17	-14.1	1.34
44.06	22.05	-16.48
49.02	19.19	33.02
-45.81	12.97	52.06
-63.18	-47.87	33.72

// Durston S, 2006: Siblings with Attention Deficit/Hyperactivity Disorder
// Subjects=11
-57.6	-20.25	53.31
22.61	-54.58	-19.74
53.42	25.25	40.19
49.38	-36.14	49.7
-38.03	20.8	-13.84
-7.43	46.46	17.84
-45.81	12.97	52.06
31.17	60.89	-2.18
-63.18	-47.87	33.72

// Evers E A, 2006: NoGO Inhibition vs. Go, Experimental Session
// Subjects=13
48	-46	36
52	-52	42
52	-54	30
48	34	22
30	52	24
52	10	6
2	26	42
0	34	40
20	18	58
-34	-60	54
-58	-50	38
-28	-72	50
-30	26	-6
-48	10	42
-40	30	28
60	-36	-6
60	-26	-12

// Hermann D, 2006: Alcohol Dependent Subjects
// Subjects=10
-9	45	39
-54	21	21
-27	15	42
-39	48	-12
-6	-33	27
-21	-39	-3
33	-39	-3
-12	-60	30
12	-60	39
-9	-54	33
21	-27	3

// Hermann D, 2006: Healthy Controls
// Subjects=10
-9	45	39
-54	21	21
-27	15	42
-39	48	-12
-6	-33	27
-21	-39	-3
33	-39	-3
-12	-60	30
12	-60	39
-9	-54	33
42	54	6
-36	-3	30

// Passamonti L, 2006: MAO-A (+) Subjects
// Subjects=12
43	16	-10
33	20	-16
53	15	-5
49	-34	53
37	-55	58
61	-41	27
11	-8	18
-13	-8	18
3	-22	12
11	-66	-3
-17	-68	8
33	-55	47
53	20	19
37	19	-2

// Passamonti L, 2006: MAO-A (-) Subjects
// Subjects=12
11	-66	-3
-17	-68	8
33	-55	47
53	20	19
37	19	-2

// Peelen M V, 2006: Group-Average Activation for the Biological Motion 
// Display
// Subjects=17
48.31	-72.11	-6.38
56.87	-52.17	3
62.32	-40.02	21.99
39.55	-41.47	-22.23
37.53	-72.06	-18.53
16.39	-100.6	-.28
-43.56	-73.46	-1.87
-58.4	-38.29	27.69

// Saur D, 2006: Aphasic Patients
// Subjects=14
-51	36	-9
-48	27	18
36	24	-9
54	30	21
6	27	42
-51	30	-9
-48	24	18
-63	-39	0
-39	-63	24
-51	12	-21
48	18	-27
-51	27	-9
-48	27	18
-57	-45	0
-57	0	-15
-6	15	51
33	21	-9
51	30	21
33	21	-9
9	18	48
-33	24	-3
36	-84	9
36	30	-12
33	21	-9
-42	21	-6
-6	9	57
-48	-48	-12
-42	-45	-18
-42	12	24
33	24	-3
-63	-51	3
-57	-12	-12
-30	21	-3
36	30	-12
-9	33	42
-45	36	-9
-57	15	9
48	21	3
0	18	39
39	24	0

// Saur D, 2006: Healthy Controls
// Subjects=14
-60	-45	3
-42	12	24
-45	24	-6
33	24	-6
54	27	21
-57	-9	-15
-42	-45	-18
-36	-66	24
9	18	48
-42	-45	-18
-42	12	24
33	24	-3
-63	-51	3
-57	-12	-12
-30	21	-3
36	30	-12
-9	33	42
-45	36	-9

// Beaver J D, 2006: Appetizing - Bland
// Beaver J D, 2006: Appetizing - Disgusting
// Beaver J D, 2006: Appetizing - Nonfood
// Beaver J D, 2006: Disgusting - Bland
// Beaver J D, 2006: Disgusting - Appetizing
// Beaver J D, 2006: Disgusting - Nonfood
// Subjects=12
8	10	-12
-8	16	-12
52	-12	14
-24	-4	62
-34	-32	28
36	-30	30
24	-26	-20
14	-40	4
-58	-40	6
42	-30	-24
-32	22	36
16	-84	26
46	-70	40
-10	-20	32
14	-42	30
-10	-46	-16
-36	42	-10
-42	-4	44
40	-30	-26
-52	-40	10
58	-34	16
-42	-66	22
66	-46	-12
-30	26	40
-38	50	-8
40	-26	-8
34	10	46
-40	16	38
64	-28	18
32	-26	-26
-44	12	-32
-44	-54	10
-50	-32	6
-40	-28	-24
8	-90	8
8	-48	46
-14	52	8
18	52	6
-40	32	32
44	30	40
16	26	-14
12	12	-16
-38	-18	30
48	-20	42
50	-34	52
18	-18	-22
-18	-44	2
14	-40	4
-28	-60	36
36	26	-6
22	36	-14
20	0	-26
32	18	8
24	44	-8
52	-38	54
-8	-76	-2
16	-84	4

// Wiech K, 2006: Main Effect of Pain
// Wiech K, 2006: Externally-Controlled - Self-Controlled
// Wiech K, 2006: Self-Controlled - Externally-Controlled
// Wiech K, 2006: Self-Controlled - Externally-Controlled, Correlated with 
// Belief in Self-Control
// Subjects=12
57	0	3
-39	-18	15
-42	3	-9
-36	0	9
-54	-18	12
-15	6	0
15	6	-3
12	9	15
-51	-24	27
51	-45	33
51	42	-9
24	30	-15
-24	39	-9
-21	21	-6
-57	-42	36
0	31	2
27	30	-15
45	33	-12
27	45	0
-45	33	-15
-27	30	-15
-15	45	-15
-54	-21	-24
9	33	3
15	-87	-36
-3	45	36
9	12	54
-3	15	48
-9	12	42
33	33	39
30	42	42
39	39	39
27	51	33
45	45	30
48	51	12
-39	54	21
-12	-6	63
-48	-36	45
45	-36	54
54	-33	33
48	-33	45
-45	-27	21
51	6	12
-60	-30	21
-36	12	9
-12	27	51
15	-66	-12
27	-60	-24
36	48	21
33	57	15
24	18	60
-15	-96	0
-45	-72	-21
42	-72	9
-6	-18	69
27	-21	63
15	-66	66
-6	-24	33
-12	-27	9

// Desai R, 2006: Generate Regular Verbs - Read Regular Present Tense Verbs
// Desai R, 2006: Generate Regular Verbs - Read Regular Present Tense Verbs 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Read Irregular Present Tense 
// Verbs
// Desai R, 2006: Generate Irregular Verbs - Read Irregular Present Tense 
// Verbs (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Matched)
// Desai R, 2006: Areas Correlated with Response Time Across Conditions
// Desai R, 2006: Areas Correlated with Response Time Across Conditions 
// (Deactivations)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Mismatched)
// Desai R, 2006: Generate Irregular Verbs - Generate Regular Verbs 
// (Phonologically Mismatched) (Deactivations)
// Desai R, 2006: (Read Irregular - Read Regular) Past Tense Verbs 
// (Phonologically Mismatched) (Deactivations)
// Subjects=25
-51.09	3.97	22.95
3.58	12.69	48.36
-24.55	13.33	4.02
-51.16	-60.45	-11.79
-56.21	-31.07	38.22
47.33	-4.19	32.54
-33.68	-44.34	43.53
42.66	20.19	-9.6
-27.16	-65.11	49.66
46.02	-56.15	-19.96
-47.08	24.31	-3.34
48.62	-34.88	48.48
68.42	-7.06	-6.49
-45.82	-25.38	0.82
-4.1	18.25	24.56
-38.22	-96.49	-11.15
44.08	-29.98	15.78
27.41	-65.16	57.96
-21.19	-4.91	15.55
61.1	-36.11	3.83
51.32	34.56	10.29
-56.17	-62.51	30.81
49.63	-64.08	28.62
-5.85	-60.12	43.42
-4.5	47.06	-15.77
-32.05	-26.49	-14.86
-52.15	5.19	25.09
-32.04	15.32	2.82
-41.22	-43.84	36.88
-37.04	-6.38	39.27
-13.37	6.39	64.69
13.99	3.24	7.77
-6.18	0.18	24.98
-22.98	-72.71	33.52
48.06	15.37	-3.68
-12.8	0.11	-2.81
30.41	-65.08	31.15
-2.18	-20.31	-20.18
-16.82	-69.79	1.98
-64.7	-36.07	43.19
43.07	-5.19	33.79
-41.57	-56.33	-14.48
-47.97	-22.22	0.58
28.48	-64.09	57.86
50.32	29.87	18.5
-30.55	-93.42	14.15
-9	-89.21	39.2
45.39	-3.29	58.14
33.39	-87.18	-7.18
-5.04	-32.05	20.98
27.56	44	-17
3.58	12.61	47.25
-22.2	26.49	36.34
58.14	-54.51	27.72
-55.02	-66.13	38.91
8.6	4.9	2.11
-32.57	-54.91	44.4
-50.04	8.12	21.48
35.85	-62.96	44.29
38.44	26.23	-0.02
50.5	6.4	31.62
-29.45	-75.55	24.91
-44.7	-55.58	-4.47
-50.29	31.95	-.59
-46.65	-2.04	41.25
-11.58	-26.86	6.12
-56.49	-16.47	6.88
68.77	-36.3	28.3
6.48	2.86	3.42
-39.02	-50.89	41.91
38.03	-62.52	49.81
-46.72	2.74	34.16
46.9	14.42	-15.85
36.7	-3.65	40.43
50.37	28.18	24.22
-8.32	31.94	36.84
-29.46	-74.49	24.82
-6.32	-18.88	-1.3
-46.03	32.95	-1.84
-4.96	12.73	49.57
35.23	21.81	-1.84
-14.88	6.16	6.74
14.99	9.17	1.68
-42.39	0.1	41.02
5.44	-25.33	-3.12
0.22	26.37	32.75
14.43	5.67	66.66
-47.11	15.26	-10.38
-40.08	-50.81	43.03
19.42	-54.05	-4.22
49.43	5.25	30.61
-11.61	-56.78	-9.21
35.31	54.53	22.18
58.94	-23.26	5.01
43.29	-52.34	43.32
35.28	-63.41	-30.38
-60.72	-.66	18.99
-12.8	-82.28	-36.05
-46.91	24.97	18.91
2.48	-28.32	27.27
10.37	-43.8	74.2
-51.14	-59.13	-8.56
51.15	44.91	-7.31
-11.04	-50.87	67.24
25.45	49.7	-11.87
44.88	-16.26	-13.26
-31.18	56.05	-7.29
8.13	-87.7	43.34
-6.78	-24.69	75.03
-28.87	-34.48	-22.03
-42.57	-8.38	13.85
-41.7	-2.77	-10.05
-50.02	9.43	24.71
-33.64	-55.97	44.51
50.49	6.32	30.51
37.35	28.25	-1.29
-37.05	0.13	40.95
35.85	-64.02	44.38
11.88	10.09	13.91
-3.1	-19.83	-.14
-49.1	-55.75	-20.02
-30.53	-74.5	24.83
-9.38	30.97	38.05
3.57	14.72	47.07
-52.25	-17.84	2.49
-50.86	-7.89	48.48
-57.63	-10.56	0.83
58.76	-7.54	-11.92
-40.36	-36.21	11.7

// Dreher J C, 2006: Error Prediction at S1: P=0.5 $20 > P=0.25 $20
// Dreher J C, 2006: Error Prediction at S2: $20 in Slot A > $20 in Slot B
// Dreher J C, 2006: Reward Uncertainty During the Delay: P=0.5 $20 > P=0.25 
// $20
// Dreher J C, 2006: Conjunction Error Prediction at S1 and S2
// Dreher J C, 2006: Error Prediction at S2 (No Reward): P=0.75 $0 > P=0.5 $0
// Dreher J C, 2006: Error Prediction at S2 (No Reward): P=0.5 $0 > P=0.75 $0
// Subjects=31
-4	-23	-15
-46	19	30
-38	34	0
42	23	-19
-46	8	57
38	11	53
-11	27	19
4	15	27
-4	23	65
-42	-49	42
27	-61	42
8	-19	-15
-8	-15	-15
-34	27	34
-38	27	4
27	27	-15
-11	15	61
-53	15	8
-49	-42	57
-39	-20	59
-4	-19	-15
-4	-8	-11
23	8	-11
-30	0	-11
0	-23	-15
-42	23	34
-53	19	-8
42	23	-8
-11	8	65
-46	-27	38
30	-57	57
-38	27	0
-8	15	8
-11	-46	11
-30	-15	68
-4	-8	46
-30	15	46
-46	23	8
42	23	4
23	30	38
15	61	-8
46	-42	-4
-38	-46	-8
-57	-30	30
42	-38	30

// Grinband J, 2006: Unmodulated Regressor Activations
// Grinband J, 2006: Uncertainty Regressor Activations
// Subjects=10
2	38	38
-2	40	38
40	22	4
-36	24	4
14	10	8
-16	6	8
8	-12	-4
-2	-12	-2
28	10	58
-34	4	58
38	24	8
-40	24	10
46	16	26
-40	24	34
42	-62	4
-48	-68	-6
36	-28	46
-44	-40	48
2	38	40
-8	36	36
36	26	8
-30	22	12
12	4	-6
-16	6	-4
6	-14	10
-8	-16	10

// Huettel S A, 2006: Decision Phase Activity to Response Selection in the 
// Absence of Behavioral Risk
// Huettel S A, 2006: Decision Phase Activity Modulated by Behavioral Risk
// Huettel S A, 2006: Reward Phase Activity Modulated by Reward Delivery or 
// Omission w/in Behavioral Risk Condition
// Huettel S A, 2006: Reward Phase Activity Modulated by Reward Delivery or 
// Omission w/in Reward Risk Condition
// Subjects=11
-42	46	25
-25	11	4
0	7	46
0	7	46
25	7	7
53	4	7
-49	0	7
-21	0	11
-60	0	39
-46	-4	35
-28	-11	7
-35	-21	60
-53	-28	21
-53	-28	53
-39	-39	53
-56	-42	-21
35	-63	-21
-25	-67	53
-32	-67	-18
7	-70	53
0	-77	-21
0	-77	-21
28	60	7
-39	53	4
-4	28	39
4	28	39
42	28	39
39	21	0
-35	18	0
32	14	60
-21	14	63
18	0	4
14	-25	18
0	-28	32
0	-28	32
49	-56	46
-35	-63	46
-35	-70	-32
11	-77	49
-43	41	-7
-51	22	-15
1	7	-8
-1	7	-8
58	2	-5
62	-18	11
-63	-30	-11
-33	-38	70
7	-43	44
-7	-43	44
22	-61	-22
-48	-74	35
44	-83	-15
-33	-96	-14
11	-106	0
-6	57	1
6	57	1
21	38	49
-25	28	51
45	-41	-16
-8	-55	30
36	-89	-12
23	-101	-3

// Yoshida W, 2006: Goal-Search Task - Visuomotor Task, Activations
// Yoshida W, 2006: Correlation between Evoked Activity and Back-Track 
// Probability
// Yoshida W, 2006: Correlation between Evoked Activity and Expected Hidden 
// Current Position Entropy
// Subjects=13
34	55	5
40	52	-3
2	30	32
34	-51	55
32	-61	46
13	-46	55
3	-12	-10
16	-4	-6
2	31	33
26	-60	53
-24	-52	47
18	65	10
-8	42	29
-12	38	-7

// van Leijenhorst L, 2006: Healthy Young Adults
// Subjects=14
22	50	-14
8	14	56
34	28	0
42	30	18
-30	-2	38
-42	4	32
0	6	20
28	-74	34
26	-64	46
-22	-68	44
-20	-74	34
48	-40	52
-14	-104	6
-24	-86	8
-26	-84	-10
22	-98	2
16	58	20
-36	-28	16
-66	-32	28
58	-24	24
58	-64	8
-58	-68	8
-52	-72	32
12	46	-10
-24	-24	58
-46	-80	34
-34	20	-6
36	24	-10
48	24	36
-46	18	30
36	12	58
44	6	40
12	26	60
64	-46	-12
46	-56	48
-50	-46	48
-44	-58	50
4	50	-10
-4	50	-16
20	38	18
-20	12	-20
-34	-42	22
-22	6	68
-22	18	50
22	28	36
-12	22	4
48	-18	44
66	-4	26
54	-18	54
-26	-46	56
62	0	-8
68	-18	0
20	-8	-24
-12	-60	14
-48	-76	10
-60	-30	14
-22	0	-12
-44	-36	-24
-40	-84	36
-20	-90	40

// van Leijenhorst L, 2006: Healthy Children
// Subjects=12
2	14	44
-8	62	36
28	-34	12
6	-14	34
8	14	36
-2	8	24
18	-94	32
-2	-90	34
-44	-68	34
40	22	-12
-2	46	42
8	46	44
40	46	-12
-20	-2	38
-6	20	8
12	-40	44
-66	-26	32
-10	-82	20

// Yokoyama S, 2006: Passive vs. Active
// Yokoyama S, 2006: Passive vs. Nouns
// Subjects=28
-42	38	-4
-40	28	-2
-40	30	-12
-48	4	44
-10	-94	-2
-58	-38	4
-62	-28	0
-52	-2	40

// Feinstein J S, 2006: Action Selection: Uncertain > Certain
// Feinstein J S, 2006: Action Selection > Outcome
// Subjects=16
-46.91	37.03	23.48
45.01	36.69	24.68
35.3	18.18	6.27
-33.07	15.74	8.37

// Nakic M, 2006: High Negative > Neutral Words
// Nakic M, 2006: Low Frequency > High Frequency Words
// Nakic M, 2006: High Frequency Neutral Words > Low-Frequency Neutral Words
// Subjects=13
-60.92	-11.52	-11.32
-46.58	-66.05	25.43
49.02	-5.54	-26.47
11.63	45.99	-3.6
-1.74	-64.01	20.28
-32.1	30.12	1.58
28.77	28.91	-5.71
-7.07	0.83	47.24
47.56	-22.74	54.17
42.14	-34.54	39.61
41.27	-46.75	60.72
-44.33	-48.38	47.34

// Bedny M, 2006: Words (Nouns + Verbs) > Non-words
// Bedny M, 2006: Non-words > Words (Nouns + Verbs)
// Bedny M, 2006: Verbs > Nouns
// Bedny M, 2006: Positive Correlation between Imageability Ratings and Words 
// (Nouns + Verbs) Activations
// Bedny M, 2006: Negative Correlation between Imageability Ratings and Words 
// (Nouns + Verbs) Activations
// Bedny M, 2006: Interaction between Imageability and Grammatical Class
// Subjects=13
-57	-48	0
-48	33	3
3	21	54
27	-66	9
-15	-90	0
39	15	0
-60	-30	36
-39	33	39
9	-54	42
-60	-24	-24
-60	-30	39
33	-12	9
15	30	57
45	-66	48
-45	-66	-9
-24	-3	-24
-54	-6	6
-9	-36	21
-27	-78	39
-21	18	54
45	-69	24
-30	-99	-3
15	-90	-3
-54	15	-6
-60	-51	0

// Marangolo P, 2006: Noun-from-Verb Derivation > Verb Repetition
// Marangolo P, 2006: Noun-from-Adjective Derivation > Adjective Repetition
// Marangolo P, 2006: Verb-from-Noun Generation > Noun Repetition
// Marangolo P, 2006: Verb Inflection > Verb Repetition
// Marangolo P, 2006: Adjective Inflection > Adjective Repetition
// Marangolo P, 2006: Noun Inflection > Noun Repetition
// Marangolo P, 2006: Noun-from-Verb Derivation > Verb Inflection
// Marangolo P, 2006: Noun-from-Adjective Derivation > Adjective Inflection
// Marangolo P, 2006: Verb Inflection > Verb Derivation
// Marangolo P, 2006: Adjective Inflection > Adjective Derivation
// Marangolo P, 2006: Noun Inflection > Verb-from-Noun Generation
// Subjects=10
-53	28	24
-59	13	21
-44	55	3
-50	13	30
-32	22	3
-41	-48	42
-38	-63	39
-35	-69	54
-29	-63	51
66	22	18
50	13	24
41	34	18
35	-72	45
35	-72	51
20	4	24
-44	28	-1
-53	13	18
-35	25	-1
-38	10	36
-38	-54	51
-26	-69	54
-35	-63	39
-32	-60	45
35	-57	48
32	-54	45
-5	13	60
-59	-39	3
-56	-33	3
20	4	24
-20	7	3
-53	28	30
-53	16	21
-41	10	30
-50	43	6
-53	4	18
-59	13	21
-44	55	3
-35	10	36
-50	-3	48
-44	-42	48
-29	-69	51
-38	-72	45
-11	-18	69
-11	-9	78
-47	-57	-13
47	-6	57
-5	-27	57
-38	-72	24
-53	-69	27
32	-84	15
26	-96	15
-38	19	-1
8	25	27
2	7	42
52	4	-12
-41	34	3
-56	19	33
-50	10	30
-47	37	21
-32	-57	39
-32	-66	48
56	19	24
47	19	27
20	4	18
-47	31	21
-47	10	18
-38	4	30
-38	13	36
-44	43	18
-38	-54	54
-35	-63	39
-32	-63	45
38	-54	48
-5	13	60
-44	-72	24
-50	-72	26
-2	-2	42
-38	-72	20
-46	-74	20
2	10	42

// Stringaris A K, 2006: Literal Followed by Irrelevant (IRL) > Metaphoric 
// Followed by Irrelevant (IRM)
// Stringaris A K, 2006: Metaphoric Followed by Irrelevant (IRM) > Literal 
// Followed by Irrelevant (IRL)
// Stringaris A K, 2006: Literal Followed by Relevant (RL) > Metaphoric 
// Followed by Relevant (RM)
// Stringaris A K, 2006: Metaphoric Followed by Relevant (RM) > Literal 
// Followed by Relevant (RL)
// Subjects=12
-25.2	-80.18	19.67
24.75	-21.18	7.46
51.48	-61.52	-7.31
32.56	-70.44	30.46
-32.59	-55.08	42.19
-10.1	-57.69	47.72
1.62	-33.84	52.28
-29.4	-26.63	52.03
-29.96	-52.26	-31.68
-10.55	-74.46	-17.78
39.39	28.29	-14.7
-32.56	-50.42	47.37
55.35	-5.22	-36.61
44.03	-70.02	-6.51
31.95	28.68	-9.07
-53.16	-8.56	26.26
-2.87	-52.61	-38.65
-32.88	-77.88	-4.96
46.85	32.57	-15.14
-41.38	8.31	36.97

// Uchiyama H, 2006: Reading S1 > Baseline
// Uchiyama H, 2006: Sarcasm Detection: Sarcastic plus Non-Sarcastic Responses 
// minus Unconnected
// Subjects=20
-2	2	70
8	16	46
-6	18	38
2	-36	28
-46	0	48
34	8	58
-60	-12	40
-58	-14	14
-46	-18	44
46	40	32
38	48	22
-34	30	-24
26	36	-20
-42	6	30
-56	28	14
-58	0	-16
-54	-8	-20
-54	-38	0
58	12	-14
-16	-74	24
-38	-84	-6
28	-98	-12
40	-82	-4
-14	-94	-12
10	-94	-4
-40	-66	-30
36	-70	-26
0	-54	-38
-10	-28	-6
22	-28	-2
-22	-6	-2
20	-10	-2
12	-6	10
-10	-16	8
26	-2	-18
-34	-10	-20
-6	16	58
-6	44	42
-8	60	28
-60	22	12
-56	24	-6
-46	18	-10
-52	8	-30
-56	-10	-12
-56	-28	-2
28	-82	-34

// Aziz-Zadeh L, 2006: Metaphorical Phrases > Literal Phrases
// Aziz-Zadeh L, 2006: Observation > Rest
// Aziz-Zadeh L, 2006: Reading > Rest
// Aziz-Zadeh L, 2006: Observe Foot > Rest
// Aziz-Zadeh L, 2006: Observe Hand > Rest
// Aziz-Zadeh L, 2006: Observe Mouth > Rest
// Subjects=12
-48	18	-16
44	-82	16
6	-92	-2
-42	-58	-16
44	-52	-18
-34	-44	46
28	-56	48
-54	-32	30
52	0	48
54	4	28
-52	4	30
-36	-90	-8
28	-96	6
-40	6	32
-44	20	18
-54	32	-6
28	22	18
-26	-30	-8
6	-92	-4
-54	-32	30
-40	6	28
50	12	26
26	-90	16
-30	-6	46
54	2	38
-58	0	28
26	-84	18
-20	-30	-4
60	2	42
-54	4	26
-34	0	-34
-32	-56	-58

// Lee S S, 2006: Literal > Rest
// Lee S S, 2006: Nonliteral > Rest
// Lee S S, 2006: Nonliteral > Literal
// Subjects=12
-65.08	-20.21	0.6
-62.87	-30.42	5.9
-58.59	-21.6	9.57
-48.04	14.42	6.43
-52.14	-43.05	6.83
-43.98	25.42	-16.85
-48.2	19.39	-11.83
24.65	-52.93	-17.76
-3.11	-48.53	-13.34
-7.24	-77.82	-6.38
56.81	-18.79	8.01
50.41	-23.06	8.44
54.55	-20	-7.48
58.79	-5	-6.55
58.74	3.29	-9.48
-54.15	6.55	42.84
-56.43	11.68	26.83
-56.29	-2.27	39.15
-4.92	9.81	53.16
41.62	13.93	-7.94
48.03	24.88	-4.48
-62.89	-28.48	3.5
-60.7	-34.47	8.44
-50.04	-21.55	9.47
-43.77	-27.28	-10.2
58.84	-8.89	-1.77
44.02	-27.33	8.87
48.17	-21.98	-5.01
61.15	-31.28	11.24
-43.46	0.1	41.03
-54.33	22.27	25.91
-56.43	22.6	30.37
7.98	-92.59	21.45
-7.01	-81.93	22.96
-5.6	86.24	-4.54
7.17	94.6	-7.62
-43.51	36.9	49.1
-56.19	-34.16	39.59
-50.32	19.55	-9.59
-37.56	23.34	-16.75
-2.85	17.94	47.99
-52.2	24.39	25.71
-47.44	-58.46	54.91
-63.06	-8.19	-9.35

// Henderson L A, 2006: Superficial Pain vs Deep Pain
// Subjects=19
5	50	-4
6	-20	60
-6	-41	52
38	11	4

// Kounios J, 2006: Insight preparation> Noninsight preparation
// Kounios J, 2006: Noninsight preparation > Insight preparation
// Subjects=20
-50.91	-63.42	18.56
-3.29	45.18	1.1
-1.68	-45.81	35.48
56.97	-63.29	10.62
-25.68	-7.16	-13.21
-65.1	-33.58	-7.2
-30.58	-102.48	7.11

// Mackiewicz K L, 2006: Anticipation and Picture Periods: Aversive > Neutral
// Mackiewicz K L, 2006: Regression of delayed aversive memory (d') on 
// aversive-neutral contrast for picture period
// Mackiewicz K L, 2006: Regression of delayed aversive memory (Pr) on 
// aversive-neutral contrast for picture period
// Subjects=30
21.32	-2.65	-14.13
-19.29	-2.9	-13.64
31	-22.86	-14.77
-29.9	-23.05	-11.83
24.48	-6.41	-21.65
-21.5	-2.62	-23.67
23.41	-6.41	-21.64
-22.57	-2.63	-23.66

// Sergerie K, 2006: Encoding: Fearful Remembered vs. Forgotten
// Sergerie K, 2006: Encoding: Neutral Remembered > Forgotten
// Sergerie K, 2006: Encoding: Fearful Remembered > Neutral Remembered
// Sergerie K, 2006: Recognition: Fearful Remembered > Forgotten
// Sergerie K, 2006: Recognition: Neutral Remembered > Forgotten
// Sergerie K, 2006: Recognition: Fearful Remembered > Neutral Remembered
// Subjects=18
-34	-54	42
38	-56	50
34	-62	36
30	2	-34
-38	-90	0
-42	-76	-12
-36	-54	-18
-44	-56	-16
-14	14	-10
-14	-18	-14
36	-56	48
28	-92	10
46	-82	-6
48	-66	4
-32	34	10
-36	38	4
30	0	-34
42	-4	34
-4	-50	12
-38	-78	42
-38	-58	-20
-50	-58	-18
-38	-80	-16
-24	-8	-20
14	38	4
20	-44	28
20	-66	50
48	-38	32
56	-38	0
16	-48	-12
8	-4	10
20	-10	-14
-12	52	24
-36	14	24
-10	46	-14
-4	42	-10
-42	32	8
-22	-76	46
-64	-16	0
-48	12	-30
-28	-48	-18
-14	6	-8
42	46	-6
2	38	14
14	-68	10
36	-64	48
26	-16	-4
-40	8	-30
-20	-4	-12
-14	-8	-24
-16	-34	10

// Wagner G, 2006: Planning > CC1
// Wagner G, 2006: Planning > CC2
// Subjects=17
23.27	14.92	46.21
-24.24	10.61	48.56
3.67	30.19	38.31
10.68	-51.19	63.05
-6.62	-56.88	60.55
45.03	-37.43	47.66
-34.75	-44.11	60.88
55.15	41.7	9.4
-37.96	54.16	-1.45
33.2	24.89	-19.94
-9.18	-86.15	23.14
-22.1	8.28	46.52
8.05	31.68	42.57
36.53	-61.61	53.55
-34.77	-46.45	58.87
8.46	-59.37	56.05
-8.81	-57.1	58.36
-48.51	43.98	16.54
-44.37	50.3	3.52
35.32	30.01	-22.72
23.01	-19.79	19.39

// Kennedy D P, 2006: Autism (ASD)
// Subjects=12
-42.12	-37.74	60.92
-53.17	11.16	33.52
12.02	-93.9	-9.71
-30.71	-88.53	-5.21
28.87	-47.96	-22.68
-43.79	5.47	0.44
-4.11	-11.5	11.44
8.75	-10.02	15.63
17.73	-84.56	41.85
42.07	-74.75	15.1
47.51	-2.3	56.92
-34.58	-35.95	69.6
59.27	-19.75	50.44
12.42	-80.99	47.19
55.09	-45.16	52.62
-51.76	-30.39	60.41
59.27	-19.75	50.44
3.78	-41.32	51.77
46.58	-36.06	60.87
-59.46	-27.21	33.47
21.88	-6.69	57.58
-4.49	41.6	-17.54
16.93	21.38	-19.44
42.07	-73.69	15.01

// Kennedy D P, 2006: Healthy Controls
// Subjects=14
-46.41	-32.48	60.52
43.39	-50.17	57.63
54.78	8.72	33.6
-30.77	-85.79	-11.02
50.4	-80.27	-15.76
34.31	-64.59	-18
-.88	-9.11	14.55
34.23	19.23	6.19
0.34	-49.28	17.9
2.86	-36.44	73.67
-.17	55.35	-5.36
-0.07	13.51	-9.66
-42.22	-73.97	32.73
54.92	-64.56	21.9
58.86	-3.17	3.33
54.4	-.68	-19.13
-1.29	54.74	-13.1
-18.42	6.06	-35.59
38.3	12.71	-23.42
55.09	-45.24	51.51
59.27	-19.75	50.44
3.78	-41.32	51.77
46.58	-36.06	60.87
-59.46	-27.21	33.47
21.88	-6.69	57.58
-4.49	41.6	-17.54
16.93	21.38	-19.44
42.07	-73.69	15.01

// Schmitz N, 2006: Autism Group
// Subjects=10
-29.34	48.56	-4.41
37.87	43.87	10.6
-2.85	-6.29	27.46
3.15	42.71	0.1
-54.73	-52.59	17.24
-50.23	-46.87	32.28
-.58	16.45	40.86
3.47	27.56	21.76
-61.67	7.41	-6.51
59.25	13.8	-13.68
-26.3	-67.43	40.63
21.41	-60.49	54.82
-37.96	20.26	-8.19
54.8	39.11	-18.35
55.76	-25.9	44.09
36.37	-32.14	47.28
44.99	-19.14	48.09
36.49	-33.44	56.37
35.62	6.04	-3.55
-39.33	-13.26	46.7
-41.44	-26.03	48
-2.83	-6.08	29.68
-5.13	10.31	21.38
-2.84	4.77	30.85
-29.35	52.82	-4.83
-31.66	45.18	-17.48
-42.2	-7.62	-7.6
38.48	-19.37	45.98
-2.48	-29.73	52.19

// Schmitz N, 2006: Healthy Controls
// Subjects=12
-7.13	-91.34	13.54
-11.6	-96.85	0.71
-17.98	-96.04	9.71
5.97	-37.75	34.91
-43.55	-54.11	46.33
-50.09	-47.96	43.59
55.79	-40.99	43.34
60.03	-48.19	35.02
53.56	-52.47	35.55
42.7	14.89	44.76
44.58	21.54	23.9
40.68	-43.17	43.82
53.55	-28.45	39.9
9.71	1.7	-2.68
-1.11	5.91	-2.91
-5.5	1.02	-9.08
-26.77	-11.87	14.97
-18.17	-1.2	13.77
-27.06	3.49	-4.47
-24.87	-5.02	-3.67
57.5	-64.08	3.02
48.91	-70.28	6.02
-50.24	-22.85	36.63
-2.64	12.81	47.98
3.84	6.24	46.28
-29.35	52.82	-4.83
-31.66	45.18	-17.48
-42.2	-7.62	-7.6
38.48	-19.37	45.98
-2.48	-29.73	52.19

// Gomot M, 2006: Deviant > Standard, Activations common to both groups
// Gomot M, 2006: Novel > Standard, Activations common to both groups
// Gomot M, 2006: Deviant > Standard, Typically Developing Controls > 
// High-Functioning Autism (HFA) Patients
// Gomot M, 2006: Novel > Standard, Typically Developing Controls > HFA 
// Patients
// Subjects=12
62.63	-22.35	-10.17
52.05	-32.73	5.61
67.36	-32.39	19.88
-66.83	-22.52	6.62
-50.88	-16.68	-12.15
-48.02	-34.43	38.86
4.77	-25.51	28.11
7.69	-11.51	5.39
20.69	-2.44	9.87
6.26	-57.46	53.66
62.72	19.94	5.82
42.89	-66.88	42.76
20.27	1.03	-21.84
37.76	-69.62	-20.75
-29.02	-93.49	-8.29
-54.07	37.3	2.73
62.62	-20.22	-10.38
46.71	-35.53	10.46
71.72	-36.43	22.45
-66.82	-26.77	7.04
-39.61	-37.23	19.94
-52.51	-32.4	26.41
-60.74	11.8	-17.05
3.65	-23.59	25.7
48.44	36.72	-9.04
62.72	19.94	5.82
58.12	14.55	-17.1
12.82	12.78	-10.55
9.86	-15.76	5.77
-11.36	18.74	43.06
45.1	-40.2	52.41
-54.1	37.09	0.51
-11.32	36.59	50.26
-12.76	24	19.03
-27.41	53.39	-21.73
-32.6	27.62	-10.13
-44.97	-41.3	22.68
7.5	-52.3	-17.47
46.76	-39.57	13.1
30.88	33.52	-30.84
-14.92	21.87	19.28
22.69	56.58	9.6

// Wang A T, 2006: Autism Spectrum Disorders (ASD) Group
// Subjects=18
-38.93	-25.83	63.23
-30.4	-8.35	68.35
-54.49	20.55	3.76
-58.74	27.39	9.92
50.19	22.95	-2.11
37.27	26.25	-13.39
48.28	-20.79	10.5
-58.59	-26	7.71
61.12	-29.34	8.84
-62.85	-34.65	6.25
61.03	-19.28	1.31
-52.22	-28.59	1.16
61.07	-29.85	2.2
-69.31	-37.32	-.14
65.35	-34.23	0.28
-46.2	4.83	-35.17
43.6	1.31	-33.67
-46.2	11.35	-33.48
47.9	12.6	-25.75
-41.12	-15.44	60.15
43.8	25.37	2.22
-49.98	-25.26	16.47
-50.08	-30.69	1.31
43.74	-3.83	-17.63
47.87	1.34	-33.72
-7.48	62.56	19.77
-43.23	-19.51	62.75
54.52	21.38	4.67
-56.62	27.23	7.68
52.31	27.2	-2.49
-50.36	25.72	-12.34
47.93	41.46	-10.33
-49.99	-27.55	14.43
48.28	-20.79	10.5
-60.72	-23.72	9.77
46.11	-21.14	6.1
-67.12	-36.79	6.48
54.62	-19.32	1.39
-56.49	-26.33	3.25
54.64	-27.95	-.12
-58.58	-43.43	2.48
60.93	-24.71	-13.85
-67.02	-55.48	12.51
-61.04	-2.86	-23.2
-41.12	-19.84	58.29
-56.61	23	8.04
52.29	27.02	-4.7
47.93	41.46	-10.33
-36.9	-20.33	51.59
-49.69	-20.06	56.18
-60.91	16.11	1.97
-58.77	29.33	7.53
43.84	23.6	6.83
-50.36	25.72	-12.34
47.93	32.66	-14.05
46.15	-20.8	10.53
-62.92	-13.33	6.69
48.23	-14.78	5.54
-62.99	-11.9	-2.35
61.03	-19.28	1.31
-56.42	-40.96	6.71
63.2	-27.73	1.99
-65.16	-21.06	-10.47
52.39	-11.56	-8.16
-56.77	-7.24	-25.11
43.6	1.31	-33.67
-52.57	7.42	-28.62
47.9	12.6	-25.75
-2.89	24.12	45.24
-30.41	-8.52	66.14
-51.84	-20.25	53.99
43.84	23.6	6.83
-45.84	-20.09	0.37
-47.92	-32.62	3.68
-46.05	-6.83	-20.81
-4.93	22.85	56.52
-47.5	-23.94	60.94
-54.49	18.44	3.93
-39.48	19.04	10.4
-48.17	26.25	-5.72
35.15	26.41	-11.15
52.57	-22.87	10.63
-65.01	-19.52	9.47
65.36	-23.14	6.04
-65.1	-20.38	-1.61
54.6	-19.49	-.83
-60.81	-26.87	-3.35
-69.32	-33.09	-.5
54.55	-17.89	-7.65
41.43	0.96	-38.08
-48.31	11.68	-29.03
47.93	4.14	-25.04
-50.01	-38.81	6.45
39.31	1.11	-35.84
35.02	9.72	-34.28
47.92	3.97	-27.25
41.63	29.42	-.32
-58.33	-14.45	46.88
-65.13	-5.4	-.64
56.71	-11.02	-1.56
-67.26	-22.85	-5.84
50.2	-7.68	-12.92
-48.26	7.79	-24.24
52.25	11.19	-16.76

// Wang A T, 2006: Typically Developing (TD) Group
// Subjects=18
-5.45	68.06	8.13
-9.52	56.89	29.19
-5.02	26.39	47.31
-2.78	14.23	54.99
41.9	-24.88	13.15
-52.14	-32.13	10.38
52.48	-12.81	3.1
-62.88	-28.31	5.72
65.29	-15.02	0.9
-65.06	-24.44	0.96
56.85	-38.17	5.17
-65.06	-30.95	-.72
52.34	-12.07	-14.81
-50.45	-1.54	-34.58
-50.43	11.84	-26.79
52.25	11.19	-16.76
-41.12	-15.44	60.15
43.8	25.37	2.22
-49.98	-25.26	16.47
-50.08	-30.69	1.31
43.74	-3.83	-17.63
47.87	1.34	-33.72
-.98	56.94	29.09
1.06	60.32	17.63
-7	17	63.73
50.41	-23.06	8.44
56.8	-21.08	5.97
-60.78	-22.12	2.95
54.6	-12.97	0.85
-60.72	-32.53	6.05
-67.22	-29.02	-3.09
54.45	-10.11	-17.23
-50.45	-1.54	-34.58
-50.43	11.84	-26.79
-41.12	-19.84	58.29
-56.61	23	8.04
52.29	27.02	-4.7
47.93	41.46	-10.33
-.73	26.59	49.47
-15.93	54.73	29.44
-5.45	68.06	8.13
-.66	14.07	52.75
3.48	25.93	40.56
-45.41	-17.75	58.16
-52.26	21.59	17.03
-56.71	15.28	-9.16
-47.85	-31.94	12.54
52.48	-12.81	3.1
-65.09	-18.09	0.43
50.38	-23.4	4.01
-62.8	-45.06	9.35
63.09	-6.92	-4.21
-56.73	1.91	-16.96
60.93	-9.39	-8.44
-50.4	1.09	-28.11
-41.94	11.2	-35.75
50.1	11.01	-18.95
-2.89	24.12	45.24
-30.41	-8.52	66.14
-51.84	-20.25	53.99
43.84	23.6	6.83
-45.84	-20.09	0.37
-47.92	-32.62	3.68
-46.05	-6.83	-20.81
-9.3	37.28	50.9
-4.9	23.19	60.96
3.46	27.87	38.16
-43.69	21.82	19.14
56.62	27.56	1.89
-56.77	34.49	-8.54
54.44	20.52	-6.41
46.18	-29.26	11.24
-45.73	-32.09	10.3
48.23	-16.9	5.72
-58.65	-20	2.74
54.57	-11.03	-1.54
-65.07	-26.72	-1.08
56.87	-40.11	7.56
-56.58	-25.07	-8.01
52.34	-12.07	-14.81
-48.33	-1.7	-36.83
43.56	2.03	-38.19
-50.43	11.84	-26.79
47.91	10.48	-25.57
-50.01	-38.81	6.45
39.31	1.11	-35.84
35.02	9.72	-34.28

// Williams J H, 2006: ASD
// Subjects=16
41.8	-53.46	-12.33
27.02	-87.84	-1.47
50.86	-31.55	63.79
31.24	-68.61	-.9
54.83	-63.3	10.65
-55.01	-54.96	45.78
47.96	3.34	-21.63
22.37	-19.28	-22.78
22.52	30.59	16.53
-20.47	-1.9	-28.21
-41.74	-1	-14.66
-19.68	-16.74	68.94
-28.74	9.76	13.29
-30.57	13.98	54.22
-45.57	-79.85	12.07
66.65	-14.22	38.74
18.74	-3.91	66.3
-28.68	36.77	32.21
-46.01	45.18	4.94
20.81	-53.96	38.14
-55.01	-54.96	45.78
-7.63	37.95	-9.39
31.19	35.18	33.89
39.81	12.94	34.54
-22.03	10.68	52.16
-19.68	-16.74	68.94
-37.01	0.48	45.39
-45.5	-8.83	49.61
-28.29	-48.2	48.25

// Williams J H, 2006: Controls
// Subjects=15
41.8	-53.46	-12.33
27.02	-87.84	-1.47
50.86	-31.55	63.79
31.24	-68.61	-.9
54.83	-63.3	10.65
-55.01	-54.96	45.78
47.96	3.34	-21.63
22.37	-19.28	-22.78
22.52	30.59	16.53
-20.47	-1.9	-28.21
-41.74	-1	-14.66
-19.68	-16.74	68.94
-28.74	9.76	13.29
-30.57	13.98	54.22
-45.57	-79.85	12.07
64.45	-23.63	27.28
38.02	-31.8	61.73
64.56	-14.86	44.39
20.4	57.07	28.83
40.05	-25.24	50
60.3	-30.12	40.14
-22.27	49.92	36.61
20.81	-53.96	38.14
-55.01	-54.96	45.78
-7.63	37.95	-9.39
31.19	35.18	33.89
39.81	12.94	34.54
-22.03	10.68	52.16
-19.68	-16.74	68.94
-37.01	0.48	45.39
-45.5	-8.83	49.61
-28.29	-48.2	48.25

// Castelli F, 2006: Estimating Numerosity: In space and time
// Castelli F, 2006: Difficulty Effect While Estimating Numerosity: In Space
// Castelli F, 2006: Difficulty Effect While Estimating Numerosity: In Time
// Subjects=12
33	-78	24
24	-90	21
33	-78	15
-21	-90	27
-24	-48	48
-33	-51	54
33	-57	51
-57	-39	45
27	-42	48
21	-51	42
24	-42	42

// Cross E S, 2006: Observing and Simulating Rehearsed Movements > Observing 
// and Simulating Unrehearsed Movements
// Cross E S, 2006: Changes in BOLD Magnitude vs Dance Observation, 
// Uncorrected
// Cross E S, 2006: Simulation of Rehearsed Movements>Simulation of Control 
// Movements, Uncorrected
// Cross E S, 2006: Observation of Rehearsed Movements>Modulated Observation 
// of Control Movement, Uncorrected
// Subjects=10
30	-75	-21
21	-33	-9
-12	-30	24
0	-6	57
-3	6	54
-9	12	42
-36	0	45
-48	12	21
-54	6	33
27	-69	54
-33	-48	66
45	-48	18
66	-15	30
63	-18	39
-36	-36	42
36	24	0
33	-87	21
-18	-99	-3
-30	24	0
-18	12	0
-18	3	0
36	-75	-21
-18	-30	-3
57	-30	36
51	-45	9
57	-36	21
-48	-39	15
-48	-42	9
-42	18	15
-3	15	30
27	-54	33
-6	9	69
-51	9	36
-57	6	12
48	-51	21
-42	18	27
-54	12	33
-12	-87	-12
-9	-27	-18
-12	-96	-6
-9	-48	-3
18	-24	6
-18	-66	21
21	-60	24
-9	-18	33
36	-72	-6
21	0	9
24	-87	15
-6	-66	57
12	-75	-33
-42	-69	-24
30	-81	-24
60	-21	48
-9	-81	45
-51	6	30
-21	-33	-12
-57	-27	36

// Kana R K, 2006: High-Imagery - Fixation, Control > Autism
// Kana R K, 2006: High-Imagery - Fixation, Austism > Control
// Kana R K, 2006: Low-Imagery - Fixation, Control > Autism
// Kana R K, 2006: Low-Imagery - Fixation, Autism > Control
// Subjects=12
-34	20	-18
-42	24	-2
-52	16	2
48	18	2
-46	24	38
-48	12	46
24	46	-2
-8	8	58
14	18	66
-50	-54	28
-44	-74	36
0	28	30
-10	-8	8
-18	-84	-16
-4	28	32
-26	-2	54
44	-8	52
-20	-56	60
30	-48	60
0	-50	18
18	-60	24
-22	-56	22
18	-78	44
-18	-84	-16
20	-88	-10
26	-84	16

// Piazza M, 2006: Estimation > Matching
// Piazza M, 2006: Counting > Matching
// Piazza M, 2006: Counting > Estimation
// Subjects=10
48	42	14
50	8	34
54	14	12
52	-48	50
54	-36	50
50	-56	54
0	24	48
-2	30	42
4	14	54
-54	4	38
-52	-8	46
-60	6	16
32	-10	56
52	4	34
6	-8	66
52	-46	48
46	-50	52
60	-40	32
-40	-36	38
-38	-48	46
46	42	16
42	42	26
42	34	36
8	-8	66
-6	-4	62
-50	-10	48
-36	-10	42
26	-12	58
28	-14	48
40	-12	48

// Ansari D, 2006: Number Change Effect
// Ansari D, 2006: Area Change Effect
// Ansari D, 2006: Common Activation across Number and Area
// Subjects=16
33.78	-39.23	62.4
-26.04	-43.73	64.58
15.66	-58.62	60.89
-15.31	-57.5	64.5
-11.43	-68.18	8.47
26.24	-62.93	45.52
-31.93	19.77	19.18
28.06	-89.24	-5.83

// Ansari D, 2006: Children
// Subjects=9
47.08	31.62	13.93
-51.25	21	9.26
-26.17	-58.22	42.38
-35.82	-46.56	42.63

// Ansari D, 2006: Healthy Controls
// Subjects=9
-32.56	-48.14	49.41
35.85	-46.5	50.72
6.71	31.66	45.61
-.92	27.87	24.83
16.21	23.92	27.2
0.34	-17.42	30.85
-35.16	20.55	15.8
-35.82	-46.56	42.63

// Ansari D, 2006: Main effect of congruity (incongruent > congruent)
// Ansari D, 2006: Main effect of distance (small > large)
// Ansari D, 2006: Interaction of congruity and distance effects
// Ansari D, 2006: Main effect of distance in the neutral condition 
// (small>large)
// Subjects=14
11.22	-32.9	49.86
-20.86	-33.35	46.92
54.98	-36.5	40.74
6.85	-20.75	42.2
10.92	23.34	34
5.44	46.06	25.46
-23.44	46.69	22.4
26.75	51.05	19.22
42.8	34.85	14.82
-27.7	36.89	19.92
-12.44	-36.78	29.27
30.22	-21.98	24.19
22.67	-17.25	17.19
6.56	-6.15	10.87
-5.25	-9.02	2.32
34.19	13.34	-1.12
-32.02	1.31	0.65
34	45.35	-13.84
-22.57	14.97	-16.22
-24.65	-7.5	-17.65
-26.94	23.87	-24.72
31.53	-12.89	59.1
-11.11	-46.1	60.15
38.99	-26.22	51.21
2.49	15.69	45.89
-31.61	-34.01	39.3
13.06	28.81	35.74
31.34	0.46	39.03
21.34	45.93	8.56
-16.04	40.42	9.46
-32.05	15.23	1.71
13.2	8.35	46.38
56.78	0.67	11.95
-23.6	44.97	0.24
-35.74	-45.79	52.6
-11.15	-79.53	40.65
38.93	-42.22	36.94
5.67	14.39	42.61
29.38	-76.8	31.03
-47.84	-16.45	20.17
-16.8	-64.07	7.07

// Cantlon J F, 2006: Healthy Controls
// Subjects=12
43	-47	59
-31	-66	62
32	-70	-14
-34	-47	-19
-27	-72	-7
35	-79	38
-40	-60	60
18	-63	63
-10	-74	62

// Cantlon J F, 2006: Children
// Subjects=8
45	-44	62
18	-53	65
-56	2	62
-21	1	62
0	-14	57
-62	-28	25
46	28	20
-39	-78	4
-41	-88	13
45	-71	-11
17	39	11
15	28	62
37	-38	-1
35	-79	38
-40	-60	60
18	-63	63
-10	-74	62

// Liu X, 2006: All Number Comparison Tasks vs. Baseline
// Liu X, 2006: Incongruent vs. Congruent
// Liu X, 2006: DIstance of 18 vs. Distance of 27
// Subjects=12
-34	-48	44
26	-56	42
-44	-66	-16
44	-82	-10
24	-12	54
-48	4	38
-24	-8	58
28	-58	-30
2	-48	-34
-20	6	10
-16	-10	2
22	-12	18
8	-20	-14
44	34	22
-32	40	12
36	48	4
-40	-4	32
-44	30	20
48	12	8
12	20	30
12	6	54
40	-4	48
-22	-6	54
34	22	4
-24	-56	38
30	-58	44
-26	-86	2
34	-82	10
-28	-76	28
30	54	20
56	18	-4
12	14	38
-48	12	0
48	-54	38
8	-12	4

// Wiese H, 2006: Traumatic Brain Injury Patients
// Subjects=18
-37.18	-7.83	47.25
-43.58	-2.87	54.71
-21.89	-2.17	61
-.39	8.02	54.02
-4.98	11.45	33.59
14.53	12.04	38.8
10.09	16.61	30.58
-41.57	-25.9	37.91
-28.53	-20.88	45.03
49.14	-22.6	33.79
65.22	-12.53	25.8
-60.04	-21.27	31.04
-48.09	-25.07	35.69
59.06	-26.53	48.58
-46.4	-2.34	3.16
-31.32	3.89	0.05
33.54	4.43	2.25
-37.75	-23.04	-.54
-18.16	-17.57	10.91
25.03	-19.75	8.15
-20.42	-3	6.14
-60.11	12.11	32.22
55.11	13.01	1.03
64.77	14.76	-3.79
38.56	8.57	57.78
40.55	10.63	45.22
51.31	16.84	42.18
-62.39	13.4	23.16
54.99	16.43	-8.27
-9.21	14.29	41.22
-.49	8.35	46.14
12.28	11.3	31.07
-36.85	-32.76	67.64
56.73	-23.43	35.99
67.57	-20.95	38.92
-57.88	-21.27	31
-24.01	-33.65	57.42
59.07	-28.66	48.79
-35.73	25.14	-1.98
40	21.78	3.78
60.84	-34.86	16.88
53.12	-41.55	3.1
-29.2	16.76	-.14
37.87	8.9	3.97

// Wiese H, 2006: Healthy Controls
// Subjects=18
-41.3	-10.75	62.17
-34.85	-2.22	61.22
58.39	11.1	3.41
-24.21	-7.79	47.02
34.23	-.26	55.37
-11.02	7.1	67.74
1.59	14.33	41.03
12.69	8.89	62.67
-4.86	12.39	43.58
7.76	35.02	20.95
-58.09	-21.76	14.24
-52.2	-18.11	53
63.02	-28.15	19.54
69.66	-18.17	34.12
-60.07	-21.48	28.82
-48.47	-.56	10.86
56.62	-34.14	24.72
-39.97	-9.32	-2.98
42.19	2.33	2.31
-13.85	-22.02	9.03
-39.16	-2.13	62.41
-55.8	6.6	30.45
-52.61	0.78	25.37
55.16	8.96	3.67
47.13	8.08	52.08
46.5	24.14	5.68
-2.71	18.88	44.02
12.69	11.13	63.57
-11.42	11.74	37.03
-49.96	-14.18	60.42
67.51	-20.3	34.37
63.31	-22.68	43.64
-30.51	-36.01	55.53
30.18	-55.17	65.35
-42.13	19.15	3.2
-35.8	25.69	-7.64
46.34	1.1	-11.09
-53.03	7.44	-6.66
58.78	-40.73	23.1
-13.93	-20.41	3.27
-20.31	-13.12	12.75
-28.5	24.18	56.26
-39.38	25.75	50.69
7.49	20.94	-3.42

// Wiese H, 2006: Subgroup of Traumatic Brain Injury Patients, Right-Lesioned
// Subjects=9
7.49	20.94	-3.42

// Wiese H, 2006: Subgroup of raumatic Brain Injury Patients, Left-Lesioned
// Subjects=9
-28.5	24.18	56.26
-39.38	25.75	50.69

// Jatzko Alexander, 2006: PTSD >control, film - baseline
// Jatzko Alexander, 2006: Control >PTSD, film - baseline
// Subjects=10
33	-15	51
21	57	18
48	-51	3
-36	-33	-24
36	15	-27
-36	9	-24

// Williams L M, 2006: PTSD
// Subjects=13
-42	-56	62
38	-42	36
-56	-30	-26
44	-60	-14
-50	-36	-2
38	-60	0
-14	-62	60
24	-76	30
-6	-70	44
24	-56	54
-46	-34	6
48	-20	50
52	-8	52
-8	-76	12
-28	-90	22
24	-76	30

// Williams L M, 2006: Healthy Control
// Subjects=13
-46	8	46
40	14	30
-44	-38	-26
40	-78	42
-6	-70	44
24	-56	54
-46	-34	6
48	-20	50
52	-8	52
-8	-76	12
-28	-90	22
24	-76	30

// Kobayashi C, 2006: ToM > non ToM (monolingual)
// Kobayashi C, 2006: ToM versus non-ToM bilingual L1 (Japanese)
// Kobayashi C, 2006: ToM versus non-ToM bilingual L2 (English)
// Kobayashi C, 2006: Conjunction among three groups
// Kobayashi C, 2006: Conjunction between American and Japanese L1 (Japanese)
// Kobayashi C, 2006: Conjunction between American and Japanese L2 (English)
// Kobayashi C, 2006: Conjunction between Japanese L1 and L2
// Kobayashi C, 2006: Monolingual (English) minus bilingual L1(Japanese)
// Kobayashi C, 2006: Bilingual L1 (Japanese) minus monolingual (English)
// Kobayashi C, 2006: Monolingual (English) minus Bilingual L2 (English)
// Kobayashi C, 2006: Bilingual L2 (English) minus monolingual (English)
// Kobayashi C, 2006: Bilingual L1(Japanese) minus L2 (English)
// Kobayashi C, 2006: Bilingual L2 (English) minus L1 (Japanese)
// Subjects=32
42	5	55
50	-42	19
32	34	32
26	-61	18
18	30	24
-22	30	22
20	24	23
34	25	26
16	44	20
8	21	-4
2	-52	-26
18	44	16
16	28	23
22	40	20
18	28	24
34	28	24
-40	-14	-1
-12	-60	44
60	-44	20
-53	-40	21
-12	-54	41
32	-55	23
18	30	24
-48	-30	27
-40	-16	-1
-40	2	9
24	40	18
34	28	24
18	18	24
10	25	-3
18	42	20
18	27	26
57	-44	21
-34	6	13
-40	-16	-3
36	-7	8
53	-17	-23
14	-42	-25
51	-32	24
-48	-32	16
16	42	31
24	14	-23
12	-5	43
34	-5	11
14	-42	11
-22	-44	42
50	40	24
-44	44	20
16	40	38
-46	-7	-27
42	18	-36
12	13	-16
10	21	-3
2	-52	-28
53	34	-4
-6	11	-11
24	53	-1
-26	23	23
36	24	28
-59	-21	43
-8	3	16

// Astur R S, 2006: Controls > Patients
// Subjects=12
-65.82	-9.85	4.23
32.97	12.18	-41.09
29.78	2.7	-38.98
26.7	-11.37	-28.57
-66.05	-15.98	-15.33
36.16	-1.3	-47.66
-27.66	26.78	38.06
-56.41	34.87	-11.56
-14.77	54.69	37.32

// Liu L, 2006: Pinyin-naming (tone-change) > control
// Liu L, 2006: Pinyin-naming (vowel-change) > control
// Liu L, 2006: Character-naming (tone-change) > control
// Liu L, 2006: Character-naming (vowel-change) > control
// Liu L, 2006: Pinyin-naming (tone-change) > pinyin-naming (vowel-change)
// Liu L, 2006: Pinyin-naming (vowel-change) > pinyin-naming (tone-change)
// Liu L, 2006: Character-naming (tone-change) > character-naming 
// (vowel-change)
// Liu L, 2006: Character-naming (vowel-change) > character-naming 
// (tone-change)
// Subjects=10
-61.41	11.61	15.48
42.31	5.39	12.09
25.26	-62.95	16.9
-24.88	-24.78	-8.43
3.81	14.75	45.44
-43.83	-49.6	25.72
10.11	9.07	30.2
-48.57	-50.6	-7.72
-46.09	-21.95	23.02
29.11	-20.44	-10.9
40.22	1.55	16.99
-33.09	11.25	32.96
7.86	23.74	26.55
29.42	-88.2	-.84
-37.21	-9.21	44.02
16.87	-54.52	38.62
8.22	4.55	50.85
42.4	10.48	20.55
19.08	-60.68	41.43
29.49	-85.45	5.61
33.33	-19.03	-18.96
-35.51	4.91	11.22
-45.74	-54.32	44.15
9.84	35.47	14.15
8.01	-36.44	25.78
-40	42.97	5.29
42.5	6.85	27.63
-37.87	-25.04	-10.43
29.39	-88.41	-3.06
-39.45	-49.17	30.09
35.75	-34.58	-1.77
12.21	23.96	28.69
-65.71	7.35	15.98
-46.37	-67.82	-8.29
-13.84	33.88	21.43
45.35	26.91	0.94
9.96	-45.65	7.6
-11.51	8.89	29.47
-48.81	60.3	-4.12
-58.12	-44.93	7.57
-52.61	-63.84	11.59
50.6	29.08	-10.57
-24.8	-34.04	-4.16
-54.72	2.25	29.74
-43.73	5.87	44.88

// Xu Y, 2006: Chinese
// Subjects=20
-11.19	2.43	68.35
-48.69	1.18	55.5
28.31	-6.48	59.72
-14.21	-28.54	81.01
63.26	-11.72	16.26
-11.12	-64.93	50.57
21.01	-49.7	65.66
-54.27	-24.31	15.32
44.94	-55.18	-21.14

// Xu Y, 2006: Thai
// Subjects=20
-35.99	10.97	43.38
-41.69	10.51	-3.36
5.79	21.14	61.01
-21.93	-14.61	55.4
24.76	22.91	27.18
-4.96	-64.2	18.1
-44.71	-27.06	6.52
-45.67	-45.75	12.56
-13.26	-83.69	42.14
-31.71	-94.37	1.98
5.4	-71.88	-27.1

// Bangert M, 2006: (Acoustic vs. Rest, Pianists) > (Acoustic vs. Rest, 
// Non-Musicians)
// Bangert M, 2006: (Motion-Related vs. Rest, Pianists) > (Motion-Related vs. 
// Rest, Non-Musicians)
// Bangert M, 2006: Auditory-Motor Conjunction Analysis: Pianists > 
// Non-Musicians
// Subjects=7
68.05	-36.36	-11.11
8.47	3.12	70.04
26.85	61.94	-2.21
-50.7	-32.86	-1.59
-59.52	-2.47	-8.93
-47.48	-4.58	2.28
-55.77	6.81	32.67
-52.83	10.06	9.89
-43.64	-39.43	42.64
-55.65	-27.33	34.92
71.35	-32.64	-5.93
36.66	-24.88	-12.83
40.58	-10	42.78
53.59	-3.05	47.47
5.12	-8.67	58.94
58.54	34.14	20.17
53.51	-46.29	32.7
14.68	-6.59	46.24
8.02	-12.32	31.23
-59.09	-46.33	15.57
-52.85	8.79	7.77
-47.24	31.2	28.99
-52.42	1.06	39.9
-14.9	-50.19	6.24
71.35	-32.64	-5.93
53.54	-42.79	35.72
-55.88	-46.53	13.3
-59.29	-42.36	0.62
-50.7	-32.86	-1.59
-50.11	3.28	51.97
-52.48	3.94	36.26
-52.83	10.06	9.89
-43.69	-43.14	37.41

// Bense S, 2006: Leftward OKN vs. Rest
// Bense S, 2006: Rightward OKN vs. Rest
// Bense S, 2006: Leftward OKN vs. Rest, Deactivation
// Bense S, 2006: Rightward OKN vs. Rest, Deactivation
// Bense S, 2006: Rightward vs Leftward OKN
// Bense S, 2006: Leftward vs Rightward OKN
// Bense S, 2006: Laterality Effects
// Subjects=15
-6	-88	-10
20	-96	14
-42	-78	4
46	-66	-2
-60	-40	44
-30	-58	62
24	-54	54
38	-36	38
40	4	44
24	-4	50
-44	-2	56
-28	-6	48
8	8	54
-40	42	4
46	52	0
42	48	28
36	18	6
46	6	24
-44	6	20
-52	6	30
-30	18	3
-14	-20	42
-12	30	-2
-6	-90	-12
20	-94	14
-50	-74	-8
46	-68	-2
-44	-36	30
-30	-56	60
62	-32	42
36	-32	42
44	4	46
44	-6	52
-30	-4	50
-52	2	44
12	6	56
-10	14	46
-44	50	8
44	42	-4
40	48	20
62	16	2
62	16	8
-60	16	10
-44	4	20
-14	-20	46
58	-16	48
26	-60	20
-22	-50	8
0	-30	12
24	32	42
18	-46	72
18	-40	64
-20	-42	74
44	-2	-12
-38	-24	2
26	-44	22
-4	-6	22
26	32	36
20	-42	64
-22	-24	66
42	-14	0
-38	-20	4
17	18	31
14	-90	30
-28	-86	16
-22	-70	60
17	-19	31
-4	-74	14
32	-78	16
40	4	60
46	-58	-4

// Dehaene-Lambertz G, 2006: Healthy Controls, Experiment 1
// Subjects=10
48.69	-28.15	-2.63
66.01	-23.42	1.09
44.67	-47.78	17.31
-54.95	-32.36	4.03
-50.99	0.03	-17.17
-63.39	-57.08	15.59
-50.77	19.12	3.35
-15.94	-18.21	15.42
9.9	-10.03	9.68
53.04	-36.65	-1.86
39.9	-20.51	-12.2
-63.6	-32.39	4.18
-55.07	-15.76	-2.09
66.06	-36.19	2.35
53.2	-48.58	8.28
57.21	-11.52	-8.9
-55.06	-20.01	-1.67
-63.55	-45.15	5.45
-33.49	19.18	3.05
48.76	-31.99	2.23
52.96	-15.38	-3.97
-59.4	-15.77	-2.01
-63.48	-48.99	10.31
65.91	-11.08	-4.61
61.64	-23.85	-3.28
-59.43	-7.26	-2.86
-59.38	-20.03	-1.59

// Dehaene-Lambertz G, 2006: Healthy Controls, Experiment 2
// Subjects=15
-66.96	-14.74	-1.99
-60.37	-43.43	0.74
-57.13	-43.42	0.68
-63.76	17.81	1.46
-67.02	-11.86	-5.63
-63.61	-43.44	0.8
-60.37	-43.43	0.74
-67	-15.05	-5.32
-60.41	-10.9	4.24
-63.62	-40.25	0.48
-40.78	-35.73	13.09
-60.3	-39.62	7.08
-66.98	-44.39	-9.14
65.87	-11.39	-7.94
-63.58	-30.05	6.19

// Carreiras M, 2006: Lexical Decision, Low Frequency Words (LFW) > High 
// Frequency Words (HFW)
// Carreiras M, 2006: Interaction with Task, LFW > HFW
// Carreiras M, 2006: Lexical Decision-LFW, High Frequency Syllables (HFS) > 
// Low Frequency Syllables (LFS)
// Carreiras M, 2006: Reading Aloud-All words, LFS > HFS
// Carreiras M, 2006: Reading Aloud-HFW, LFS > HFS
// Subjects=16
-46	18	22
-4	22	42
-2	10	58
-46	18	22
-4	22	42
-2	10	58
-42	-12	-32
-40	-12	-32
-40	16	14

// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs1049353
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs806377
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs806380
// Chakrabarti B, 2006: Happy - Neutral, Polymorphism rs6454674
// Subjects=19
-36.4	-5.32	-2.09
-32.75	-2.39	0.97
-30.47	-31.86	7.88
-27.91	-20.71	11.37
-37.9	-35.37	12.72
-39.29	2.93	13.98
-31.19	-19.12	15.74
-39.04	-35.24	17.18
-2.38	-25.95	-6.33
28	1.03	-5.59
26.95	-.81	-3.19
19.43	-10.96	1.09
19.56	-6.71	5.19
20.66	-5.83	9.57
30.06	3.03	13.18
6.4	-19.92	-15.85
-10.27	-11.75	-11.89
6.21	-18.94	-11.47
-6.5	-9.16	-7.69
0.67	-5.05	-4.77
-17.27	-10.45	-4.11
0.79	-5.09	-2.53
-20.25	-7.33	-2.1
2.15	-18.57	1.93
4.42	-17.69	6.29
9.47	-14.99	10.46
5.52	-4.88	-12.64
1.68	-26.66	-6.31
4.48	4.38	-5.6
4.47	-22.05	-3.38
3.95	7.51	-3.63
4.34	-10.36	-2.13
5.98	13.38	-.8
-10.35	8.53	-.2
25.81	-30.91	2.69
10.29	13.86	3.57
20.6	-27.53	6.93
16.54	9.9	8.29
15.92	-24.36	11.18
14.35	-23.5	15.58

// Chou T L, 2006: Related Words > Baseline
// Chou T L, 2006: Unrelated Words > Baseline
// Chou T L, 2006: Related Words > Unrelated Words
// Chou T L, 2006: Correlation between Activation and Higher Semantic 
// Association in Related Word Pairs
// Chou T L, 2006: Correlation between Activation and Lower Semantic 
// Association in Related Word Pairs
// Chou T L, 2006: Correlation between Activation and Increasing Age in 
// Related Words
// Chou T L, 2006: Correlation between Activation and Increasing Age in 
// Unrelated Words
// Chou T L, 2006: Correlation between Deactivation and Age in Related Words
// Chou T L, 2006: Correlation between Deactivation and Age in Unrelated Words
// Chou T L, 2006: Correlation between Activation and Increasing Accuracy in 
// Related Words, p<0.001
// Chou T L, 2006: Correlation between Activation and Increasing Accuracy in 
// Related Words, p<0.005
// Chou T L, 2006: Correlation between Activation and Decreasing Accuracy in 
// Related Words
// Chou T L, 2006: Correlation between Activation and Longer Response Time in 
// Unrelated Words
// Subjects=35
-53.51	10.84	41.2
36.58	25.94	-8.9
-4.94	30.36	40.68
-41.17	-38.64	-17.99
4.73	-70.67	15.77
-21.54	-29.57	-2.41
-34.82	31.55	-13.84
36.53	28.82	-12.54
-4.92	23.98	41.31
-53.81	-41.72	7.18
17.69	-70.62	15.55
-22.87	-39.71	61.36
47.24	1.26	59.48
-56.92	-16.67	22.69
59.03	-2.72	50.71
-24.77	-26.18	-.45
10.71	-18.59	-13.01
-30.52	-63.43	49.27
-30.69	25.03	53.97
-4.9	-32.78	31.24
-17.5	-66.26	52.69
53.26	-52.52	12.03
50.44	-57.07	43.9
-34.76	61.52	-3.36
37.01	37.88	26.89
-41.36	-47.3	50.1
-55.97	-45.02	6.42
-56.22	18.79	0.11
-46.89	-29.66	43.97
-30.75	-4.93	43.49
-56.02	-51.92	1.51
-40.34	-16.04	51.48
27.78	14.16	60.77
1.91	56.77	-10.24
61.63	-19.5	-2.59
7.89	-46.09	14.41
58.45	-22.39	1.12
-59.44	-11.73	-4.65
-65.66	-25.08	13.58
14.66	-3.39	45.93
-8.03	-13.36	43.94
-63.03	-42.37	46.62
71.29	-24.34	-8.99
11.96	41.76	12.37

// de Zubicaray G I, 2006: Primed > Unprimed
// Subjects=13
-48	27	30
-21	57	18
-6	24	48

// Fassbender C, 2006: Cue-Related Activations
// Fassbender C, 2006: Cued and Un-cued Correct Responses to Incongruent 
// Stimuli
// Subjects=15
-55.38	16.97	26.37
-40.45	14.52	20.83
38.64	23.97	25.82
43.02	10.76	33.57
26.13	-.32	56.99
-42.43	5.13	37.25
34.79	-50.74	51.09
-34.64	-49.84	55.15
-49.69	-37.67	48.73
-21.85	-58.82	47.95
32.2	-48.86	-7.03
9.78	26.97	25.9
13.12	-13.37	27.01
-32.06	21.75	3.4
33.08	23.82	-3.1
32.4	12.52	43.58
-47.82	8.99	32.53
52.62	19.45	34.96
-50.03	25.81	30.03
53.55	24.6	18.9
-41.56	34.95	23.59
-32.63	2.67	59.65
44.94	37.07	15.73
-41.69	48.98	12.38
26.6	56.02	0.97
3.49	26.01	41.66
-1.91	35.24	37.61
-46.53	-24.87	48.74
37.98	-50.89	48.83
-35.72	-37.87	58.62
-36.82	-54.68	47.78
24.21	-57.43	61.81
54.92	-38.15	33.07
11.36	-57.76	58.64
25.16	-67.43	42.56
-8.97	-60.43	53.52
-.49	-54.46	47.34
32.19	-46.83	-8.32
-36.17	-52.44	-5.95
-47.86	-57.28	1.29
49.27	11.29	12.26
-35.2	13.61	8.58
30.96	19.67	-1.61
-27.83	23.46	-2.37
11.8	11.52	4.87
0.04	-17.16	-7.09

// Foerde K, 2006: ST correct > DT correct, Probe trials
// Foerde K, 2006: ST > DT, Training trials
// Foerde K, 2006: DT > ST, Training trials
// Foerde K, 2006: Bold activity vs. Accuracy, Probe task
// Foerde K, 2006: Bold activity vs. Declarative knowledge, Probe task
// Subjects=14
8	-66	0
-6	-72	4
-10	-70	10
-2	-64	38
4	-62	4
-4	-66	6
16	-8	26
6	14	-10
10	-22	14
10	6	-10
10	4	-2
24	-28	10
-6	-22	14
-16	-14	0
-18	-24	16
-14	-14	4
-18	-12	28
-16	-6	24
-12	32	58
-10	38	52
-14	62	28
-6	62	20
-22	64	20
-12	66	22
-6	8	52
42	0	36
-8	10	44
0	6	52
8	20	28
-54	-8	54
56	-42	20
54	-2	-4
70	-28	28
48	-48	8
54	-2	0
66	-38	14
-62	-2	4
-58	4	-6
-48	-6	2
-56	-54	8
-54	-50	10
-60	-6	-4
-6	-60	-6
6	-58	-14
14	-74	-18
10	-74	-16
8	-64	-14
-6	-72	10
36	46	32
36	50	32
30	48	22
40	52	24
36	52	24
34	52	12
-40	-30	44
-56	-32	46
-54	-32	50
-50	-36	52
-50	-32	52
-38	-34	44
28	-18	-18
-30	-18	0
22	-16	-20
-22	-16	-20

// Helmchen C, 2006: External vs. Internal, Activations
// Helmchen C, 2006: External = Internal, Activations
// Subjects=16
-30	-32	60
-34	-30	58
-60	-22	28
-62	-20	24
-40	-18	18
46	-14	18
54	-18	18
-32	6	6
-30	10	6
-32	14	4
-34	8	0
-32	32	-2
-36	8	-4
34	16	4
36	38	-4
40	30	0
-36	-14	10
38	-14	14

// Miotto E C, 2006: Related-Nonstructured Words, Post-Training > Pre-Training
// Miotto E C, 2006: Unrelated Words, Post-Training > Pre-Training
// Subjects=15
-46.91	22.77	17.98
-46.01	19.92	-5.21
-45.66	11.46	36.76
63.22	13.11	20.87
63.13	23.17	13.34
-.36	-65.24	59.4
-25.13	-93.67	24.15
-52.2	-67.85	-11.16
-48.08	-68.31	-31.24
-49.06	33.59	20.44
-32.16	59.1	4.73
-48.16	23.08	-5.45
63.22	13.11	20.87
47.34	11.3	40.16
19.72	-68.49	29.33
19.54	-81.37	0.3
-20.01	-78.44	0.51

// Paulus M P, 2006: High Probability Prospects > Low Probability Prospects
// Paulus M P, 2006: High Reward Prospects > Low Reward Prospects
// Subjects=16
16.7	-77.54	50.2
-.74	9.95	40.83
46	5.12	1.67
-40.49	36.1	24.6
39.96	-78.91	16.59
-22.85	-75.74	49.39
-26.02	-56.67	62.32
-41.68	9.54	-2.16
-2.09	1.49	0.29
59	-20.38	14.81
46.47	-53.64	40.04
-21.13	25.44	36.42
60.77	18.65	-17.48
-49.03	-7.79	8.3
-4.09	2.94	19.15
0.22	-19.67	15.42
40.12	-58.62	45
28.09	32.93	46.38
-58.25	-51.01	42.14
-37.06	26.37	49.91
-22.79	-68.54	59.93
-37.48	18.74	-7.44
-55.22	-50.59	19.77
-37.88	-71.06	42.47
-44.23	-52.9	57.75
32.57	5.44	62.01
3.08	45.93	-3.49
-49.23	26.33	-4.6

// Wood G, 2006: Small Decade Distance > Large Decade Distance, p<0.001
// Wood G, 2006: Small Decade Distance > Large Decade Distance, p<0.0001
// Wood G, 2006: Unit-Decade Compatibility
// Wood G, 2006: Decade Distance > Unit-Decade Compatibility, p<0.001
// Wood G, 2006: Decade Distance > Unit-Decade Compatibility, P<0.0001
// Wood G, 2006: Decade Distance < Unit-Decade Compatibility
// Wood G, 2006: Decade Distance and Unit-Decade Compatibility (conjunction)
// Subjects=14
10.71	-72.88	60.71
49.25	5.55	47.81
52.71	21.02	-16.53
40.87	-48.31	57.77
44.88	-35.27	36.24
-32.7	-44.94	51.96
-28.6	-87.08	25.81
-2.87	-19.57	23.17
-41.65	11.84	39.77
-24.2	1.03	49.51
53.01	24.37	7.79
49.31	-33.36	44.94
-20.1	-101.27	11.38
49.31	-33.36	44.94
-20.1	-101.27	11.38
32.09	-58.1	45.44
-37.05	-58.34	46.64
-38.04	20.7	-14.95
-6.78	-75.56	44.47
5.4	-71.55	-16.65
40.6	-85.36	28.94
52.93	19.38	0.44
18.79	2.82	31.79
-7.15	-54.24	19.95
6.28	-13.57	63.88
49.37	-32.95	49.38
45.27	-46.61	64.25

// Melcher T, 2006: Word-oddballs (Word-oddball vs. Oddball control condition)
// Melcher T, 2006: Stroop-incongruency (Stroop-incongruency vs. 
// Stroop-congruency)
// Melcher T, 2006: Word-oddball in contrast with stroop incongruency 
// (Word-oddball>Stroop-incongruency)
// Melcher T, 2006: Stroop-incongruency in contrast with word oddball (Stroop 
// incongruency>Word oddball)
// Melcher T, 2006: Color-oddballs (Color-oddballs vs. Oddball control)
// Melcher T, 2006: Color-oddball in contrast with Word-oddball 
// (Color-oddball>Word-oddball)
// Melcher T, 2006: Word-oddball in contrast with color-oddball 
// (Word-oddball>Color-oddball)
// Subjects=9
42	6	24
-36	12	27
54	30	15
54	36	3
39	3	-30
-33	3	-39
-42	-66	-15
24	-60	51
-21	-57	42
33	-72	24
-36	-75	18
36	-90	-6
-21	-93	-3
42	12	9
-42	-18	9
-54	9	33
-39	-3	27
-30	-15	45
-48	-24	36
15	9	42
-45	3	0
-42	-18	66
24	-21	12
6	-87	39
-6	-75	42
24	-42	-45
36	-63	18
42	6	3
-39	-15	6
-60	6	36
-51	0	36
-18	-24	57
-45	-21	42
42	6	27
-33	9	27
54	30	12
54	33	-6
42	0	-33
-30	3	-39
-42	-66	-15
24	-60	51
-30	-48	57
33	-69	24
-27	-66	24
36	-93	-9
-27	-87	-9
42	15	9
-39	-3	27
-51	9	33
-33	9	27
-42	-9	45
18	6	39
-51	-9	-9
-45	-21	51
21	-18	18
6	-87	42
-12	-87	39
18	-45	-42
36	-63	18
-39	-18	9
-24	-27	48
-45	-21	51
9	30	60
-9	39	48
-57	18	15
-42	33	-15
-12	36	21
-6	0	9
-39	12	-33
42	12	-33
-60	-48	0
57	-45	0
-9	-18	3
9	-12	9
9	-72	48
-18	-63	36
-9	-51	6
39	-57	-30
42	6	24
-39	6	21
60	21	6
-39	3	27
0	18	48
-51	-54	-15
-36	-75	-18
36	-54	45
-30	-69	45
-39	-69	27
48	-81	0
-30	-84	-9
12	-6	-3
9	27	54
-3	39	48
-36	36	18
-36	39	-24
-15	42	9
-33	27	-27
54	-9	-30
-54	-48	-9
54	-45	-3
-9	-18	-9
6	-15	18
9	-63	48
-3	-63	48
-18	-51	-6
24	-57	-42
-54	-48	-9
-21	-81	39
-36	-60	30
39	12	9
-33	3	-33
42	0	-33
-30	-18	48
-45	-18	15
48	-36	-27
-39	-3	24

// Kaufmann L, 2006: Numerical Comparison > Fixation
// Kaufmann L, 2006: Numerical Comparison Close Distance > Numerical 
// Comparison Far Distance
// Kaufmann L, 2006: Physical Comparison > Fixation
// Kaufmann L, 2006: Physical Comparison Close Distance > Physical Comparison 
// Far Distance
// Kaufmann L, 2006: Physical Comparison (maximal interference>minimal 
// interference)
// Subjects=17
-6.87	14.58	55.72
10.37	13.17	51.08
-28.16	-55.38	66.37
5.65	17.9	21.56
48.31	58.75	-14.58
-20.06	-40.8	26.69
73.51	-18.39	-2.9
45.18	-39.58	59.07
-61.9	-58.43	47.07
-53.63	-24	24.48
1.16	-70.94	-9.91
26.97	-58.61	-17.18
-37.93	-63.82	-23.4
48.66	54.75	11.58
1.63	21.23	45.95
-6.8	10.75	60.58
1.46	-23.81	23.52
23.15	-40.64	25.93
-46.29	46.64	21.84
45.27	-12.7	70.98
45	23.59	57.31
-32.6	-17.96	64.98
45.26	-43.42	63.93
-57.41	-39.63	64.19
-28.18	-51.12	65.95
5.52	-69.55	-6.76
-37.93	-63.82	-23.4
39.85	-63.54	-24.75
1.17	-1.97	4.55
48.88	13.79	21.23
-38.1	54.19	-12.66
-28.92	-64.28	5.63
-11.78	-78.43	-8.95

// Pekkola J, 2006: ATT_VOWELS vs. Baseline
// Pekkola J, 2006: ATT_CIRCLES vs. Baseline
// Pekkola J, 2006: ATT_CIRCLES > ATT_VOWELS
// Subjects=10
-13.58	-94.69	-3.78
37.34	28.16	-2.4
-37.4	20.66	3.55
-34.68	-43.58	53.51
50.8	-40.95	52.31
-9.24	11.56	48.6
67.63	-32.67	20.2
-59.52	-35.46	23.01
-41.33	-83.51	5.64
46.27	11.21	39.07
-51.85	-5.99	59.48
-23.79	-53.52	75.41
50.81	-43.07	52.49
-.63	15.47	57.09
64.43	-34.81	20.42
65.51	-36.92	20.58
14.65	-66.83	64.94
24.61	60.89	22.88
31.47	2.89	56.66

// Stevens M C, 2006: Single-tone > Two-tone
// Subjects=20
0	0	60
-52	-4	40
-48	-56	8
-56	-44	44
36	-20	-16
44	-36	-28
-28	-76	32
20	-76	36
-44	-88	8
44	-80	8
-24	12	8
24	-4	0
-24	-56	-20
28	-56	-20

// Lie C H, 2006: Original Wisconsin Sorting Test (A) - High level Baseline 
// (HLB)
// Lie C H, 2006: Non-Randomized Wisconsin Card Sorting Test (B) - HLB
// Lie C H, 2006: Pseudo-Randomized Wisconsin Card Sorting Task (C) - HLB
// Lie C H, 2006: Conjunction analysis [(A-HLB) * (B-HLB) * C-HLB)]
// Subjects=12
-40	-60	-12
46	-48	38
38	46	22
6	30	42
-26	32	-4
-2	-36	24
-44	-46	-2
-14	-2	20
38	24	-8
-42	-54	50
32	-64	52
32	-72	-30
-32	54	14
60	18	14
-12	-14	42
8	28	40
-2	-34	20
30	0	64
-38	16	-4
-24	-70	38
32	-68	54
38	-86	-8
26	-74	-48
-42	24	38
-28	-60	-38
50	12	22
12	16	46
8	-78	-40
-53	-54	18
32	-64	52
-28	-70	52
26	-74	-50
-52	10	34
50	12	24
-30	20	0
-4	18	50
32	26	-8

// Lotze M, 2006: Body referred movements - Isolated hand movements
// Lotze M, 2006: Expressive gestures - Body referred movements
// Lotze M, 2006: Main effect of isolated hand movement
// Lotze M, 2006: Main effect of body referred movement
// Lotze M, 2006: Main effect of expressive gestures
// Subjects=20
-48	-57	15
54	-57	9
60	-39	3
57	27	3
-45	-60	24
-60	-48	12
-51	-21	33
-54	21	-9
51	-63	0
-45	-72	0
39	-51	-21
-42	-48	-21
30	-78	-18
-30	-60	-21
48	12	30
-51	9	24
48	15	24
-48	12	24
42	0	48
36	-57	54
-21	-66	45
36	-45	54
-60	-30	42
-60	-30	33
51	-66	-3
-42	-75	3
39	-48	-24
-42	-48	-21
42	3	39
36	-48	-24
-39	-66	-21
-51	0	48
51	18	24
-45	9	27
51	18	24
-45	12	24
36	-51	57
-33	-45	60
-45	-33	45
36	-48	54
-45	-33	42
12	-27	-9
54	27	-9
51	-69	-3
45	-72	-9
-45	-78	-6
42	-66	-24
-39	-60	-30
-54	-51	6
42	-51	-21
-39	-48	-24
54	-42	6
51	21	24
-45	15	24
51	18	27
-48	12	27
-45	24	-12
51	36	-6
51	6	42
48	9	33
-48	0	48
-45	3	36
-63	-48	24
12	-30	-6
0	12	60
54	12	-27
-30	9	-24
30	-57	54
66	-33	21
-66	-39	18
21	-3	-18
-18	-3	-21

// Crone E A, 2006: Blocked Task: Bivalent - Univalent
// Crone E A, 2006: Mixed Task: Bivalent - Univalent
// Crone E A, 2006: Univalent Switching - Repetitions
// Crone E A, 2006: Bivalent Switches - Repetitions
// Subjects=21
18	28	30
-22	-28	22
-2	20	36
20	34	6
-38	16	30
-44	16	10
14	28	30
34	24	-2
-32	-4	54
-40	-8	40
24	2	64
26	-2	46
-36	52	12
-4	20	42
24	-48	22
-4	8	60
10	16	46
-30	-58	46
-40	-44	44
34	-56	40
-22	-2	42
38	-82	-10
-32	30	16
-14	48	34
-32	36	38
-28	-6	52
42	-8	32
-26	36	20
-12	8	60
4	2	62
-8	-16	66
-32	-52	52
18	-60	50
-24	-42	2
-6	-62	34
-42	-42	42
-62	-40	-16
-48	-32	-8
-38	8	-16
48	-34	-18
62	0	-12
-58	-22	42
26	-30	64
32	-30	54
-13	7	13

// Forstmann B U, 2006: (df2 U df3) > df1
// Subjects=22
10.28	-68.86	52.89
-4.04	28.71	35.95
34.78	-72.83	40.67

// Gruber O, 2006: Target with advance preparation vs Baseline
// Gruber O, 2006: Target with advance preparation vs Cue
// Subjects=12
-24.74	-98.14	-12.38
48.67	-67.69	-12.16
-45.68	-32.01	53.15
5.79	22.23	33.46
-23.95	-4.75	68.01
-21.86	-61.51	-33.99
18.17	-60.95	-30.24
-28.91	-105.84	-2.59
-36.87	-17.56	69.5
5.7	17.14	25
-36.87	-17.56	69.5
-20.56	-59.84	-16.24
14.01	-59.72	-16.84

// Liu X, 2006: Incongruent > Neutral trials
// Liu X, 2006: 1 word > 4 word blocks across incongruent and neutral trials
// Subjects=14
-54	22	30
34	64	12
-52	16	16
-40	-60	40
-40	-52	20
-60	-48	-8
-6	-100	-14
36	40	12
50	24	26
54	10	16
48	28	8
4	22	40
-8	4	36
36	-46	54
8	-62	54
0	-94	0
0	-94	28
28	-80	10
30	-70	-20
48	-38	16
-52	-36	16
48	-20	-6
-52	-40	-2
-50	-56	6
-32	-30	0
44	-54	2
40	0	-22
28	-40	-42
22	-54	-44
-22	-80	-38
-2	-22	-16

// Chen J L, 2006: 0 dB > Silence
// Chen J L, 2006: BOLD Covariation with parametric rhythm
// Subjects=12
63.19	-14.69	5.36
-65	-23.75	9.82
-71.39	-23.62	12.12
-58.72	-7.48	-.54
-18.33	-7.35	-30.01
22.45	-53.63	-26.59
-54.04	-3.34	52.59
-60.62	-33.61	19.52
69.68	-35.8	7.06
20.84	17.68	70.04
27.16	16.86	58.89
-24.13	16.56	59.5

// Ecker C, 2006: 0 degree angular disparity > Baseline
// Ecker C, 2006: 100 degree angular disparity > Baseline
// Ecker C, 2006: 100 degree angular disparity > 20 degree angular disparity
// Ecker C, 2006: 60 degree angular disparity > 0 degree angular disparity
// Subjects=10
-36.91	-18.21	51.41
-21.99	-6.49	50.26
5.73	9.54	48.6
27.7	21.25	-8.4
-18.1	-19.21	-4.48
-36.91	-18.21	51.41
47.15	-62.06	-13.9
-41.45	-73.71	-5.22
-21.99	-71.28	24.47
32.48	-63.55	23.19
-21.93	-62.93	36.03
32.55	-55.21	34.76
35.71	-6.15	49.57
55.76	11.12	23.35
-44.7	14.75	24.2

// Halari R, 2006: Subgroup of Normals, Men
// Subjects=9
44	-20	-6
0	-38	42
50	-10	2
-22	26	38
-36	12	42
4	12	48
54	-60	28
52	-58	38
60	-50	32
-40	-44	46
-30	-4	56
14	-88	-10
-16	-86	0
32	-52	52
4	12	54
-2	0	62
-34	-76	22
-32	-82	2
34	-70	22
-36	-4	52
32	-62	52
26	-54	62
-2	60	16
8	58	16
52	-40	12
54	-52	18
66	-38	22
-44	-58	24
-60	-36	0
4	-8	64
-2	14	54
10	14	58
6	28	30
-50	0	48
-52	8	34
-52	14	20
6	-32	8
-4	-36	0
2	-16	6
-4	-72	-10
6	-70	-8
-18	8	1
0	-58	30
-8	-48	38
10	-48	16
-16	56	-4
8	62	6
56	-58	8
46	-52	16
42	-74	2
-18	-32	-16
-22	-28	-4
-30	-38	-16
-52	-58	38
-42	-66	42
-56	-56	28

// Halari R, 2006: Subgroup of Normals, Women
// Subjects=10
16	-12	60
-20	34	40
-12	-44	44
40	-56	50
-32	-78	-12
18	-88	2
-46	-28	44
46	12	22
54	32	14
-28	-78	12
-38	-78	10
-34	-78	-2
-38	-40	56
12	-52	62
16	-58	58
-12	-48	34
-52	-10	28
-42	18	-6
-12	4	20
44	18	-12
-6	-48	32
10	-48	38
-44	-58	32
-40	-64	38
62	-18	18
52	-18	16
54	-6	8

// Hugdahl K, 2006: Normals
// Subjects=11
25.63	-72.15	44.7
-19.64	-47.46	58.71
40.29	13.01	24.82
-43.09	24.44	13.9

// Hugdahl K, 2006: Subgroup of Normals, Females
// Subjects=5
28.89	-60.03	47.93
40.16	25.15	16.89
25.65	-76.41	45.12
-39.79	24.87	18.28
44.46	29.42	16.4
-19.69	-55.53	52.79

// Hugdahl K, 2006: Subgroup of Normals, Males
// Subjects=6
28.89	-60.03	47.93
40.16	25.15	16.89
25.67	-67.48	48.72
-27.33	-47.36	48.75

// Keehner M, 2006: Mental rotation > 0 degrees rotation
// Keehner M, 2006: Mental rotation > Perspective taking
// Subjects=14
42	-44	57
30	-59	44
-42	-45	38
56	-21	45
-48	-33	49
-30	-58	61
53	-41	52
48	39	20
27	-73	56
50	13	32

// Ochsner K N, 2006: Pain > Warm
// Ochsner K N, 2006: Anxiety Sensitivity Index (ASI) Regression for (Pain > 
// Warm)
// Ochsner K N, 2006: Fear of Pain Questionnaire (FPQ) Regression for (Pain > 
// Warm)
// Subjects=13
0	-12	68
44	32	24
54	4	52
48	8	36
38	42	2
6	8	36
-2	-28	34
28	16	0
42	0	10
38	-22	12
44	-32	26
-70	2	2
54	-38	12
54	-36	32
66	-46	40
-42	-68	40
-20	0	14
-8	-2	6
16	-6	14
-10	48	0
-14	40	0
30	40	-8
38	42	-8
32	48	-10

// Song G H, 2006: Healthy Controls
// Subjects=12
-1.73	20.66	55.56
-8.26	19.34	39.01
55.66	15.55	11.83
-30.9	50.16	26.65
-38.59	51.23	-.11
36.25	28.96	-5.8
-8.43	-12.04	4.84
-24.51	-1.64	3.04
-49.81	-21.35	39.56
-59.55	-17.15	25.93
65.66	-30.97	42.38
-29.85	-67.6	-23.7
29.87	-14.66	-18.79
4.75	-54.4	33.9
3.03	43.22	-11.07
-5.03	25.16	45.18
55.68	17.93	14.98
-34.09	50.31	28.91
-40.64	54.27	11.92
39.51	19.72	-1.71
-5.23	-15.36	2.86
-18.07	0.85	7.22
-49.62	-43.5	55.91
2.21	-42.15	-13.94
29.86	-11.49	-19.06
7.97	-54.21	36.07
1.98	46.73	-6.89
10.97	23.86	40.64
58.88	19	14.85
49.25	42.98	22.99
36.3	47.08	8.3
36.36	20.21	4.97
26.82	0.06	6.77
62.51	-35.85	48.4
-23.52	-18.95	-14.48
-1.73	-48.52	27.9

// Song G H, 2006: IBS Patients
// Subjects=12
2.5	20.26	49.96
55.58	12.5	-.18
-32.04	21.92	5.61
-14.8	-11.65	10.46
-18.05	1.11	10.54
-46.53	-20.56	49.49
51.9	-46.15	53.85
-37.3	-65.11	-18.25
-24.58	-14.47	-11.49
1.57	-37.7	43.68
0.89	54.12	-7.5
1.41	16.74	45.81
52.32	19.62	-4.08
-37.4	19.51	2.53
-11.61	-11.8	8.21
69.71	-16.8	18.84
-1.92	-73.64	-7.91
29.97	-26.84	-11.08
6.93	-40.76	44.99
-2.33	44.07	-13.31
42.99	22.56	34.81
38.33	52.58	-3.34
39.48	20.52	-5.13
-46.52	-26.99	48.91
-36.76	-49.59	58.5

// Szaflarski J P, 2006: Healthy controls
// Subjects=10
-32.63	-20.3	51.54
34.7	-19.9	50.73
-32.62	-20.22	52.65
34.7	-19.9	50.73

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 1
// Subjects=1
34.68	-19.01	48.43
-34.97	1.66	33
37.82	-3.13	47.06
-38.1	0.3	43.18

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 2
// Subjects=1
-24.07	-32.23	47.98
-38.32	1.24	14.11

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 3
// Subjects=1
35.74	-24.55	45.53
-29.54	-9.42	40.55
-32.84	-20.33	23.66

// Szaflarski J P, 2006: Subgroup of stroke patients, Stroke patient 4
// Subjects=1
58.98	3.57	21.72
27.82	41.19	15.58

// Baliki M N, 2006: Healthy Controls
// Subjects=11
-2	-18	8
4	-20	10
16	12	8
24	8	-2
-24	14	-2
-12	16	8
46	-2	-14
46	-8	-2
-10	-94	-18
-32	-88	-20
0	18	34
2	12	46
18	28	58
-30	18	6
-48	22	-16
-46	4	-2

// Baliki M N, 2006: Subgroup of [Patients], Group 1
// Subjects=13
10	22	28
-12	40	0
18	60	12
26	42	22
54	16	-4
48	-2	16
56	-20	36
56	12	-8
56	-36	28
46	-20	28
-32	-18	58
-32	-26	52
-2	-70	-14
0	3	46
2	-2	54
4	-28	46
-14	58	28
-16	48	0
20	58	8
6	44	6
22	48	30
-28	32	26
18	-6	-30
-10	-2	-26
-10	-20	4
-14	-28	2
12	-28	4
6	4	-6
-22	4	-2
4	-2	50
4	18	28
10	-36	24
-30	-26	58
-28	-18	62
-46	-18	52
54	18	-8
54	-4	36
-12	-26	40
50	-30	44
62	-28	22
56	-40	24

// Baliki M N, 2006: Subgroup of [Patients], Group 2
// Subjects=11
-6	24	24
0	36	-12
0	32	-6
-12	58	20
12	60	22
-10	34	42
50	-64	30
-48	-70	-2
-32	-60	-38
-2	-90	-16
36	18	6
50	4	8
12	-60	28
62	-36	24
40	-58	54
34	40	32
4	4	48
-36	14	-4

// Tsukamoto T, 2006: True Feedback - Rest
// Tsukamoto T, 2006: False Feedback - Rest
// Tsukamoto T, 2006: True Feedback - False Feedback
// Subjects=20
9.82	-12.78	3.23
5.71	-30.9	16.3
-5.16	10.1	19.16
39.93	23.49	-.87
-2.37	1.71	67
57.3	17.58	3.9
-56.67	1.57	45.53
45.06	-60.18	45.42
-58.68	-32.27	51.15
-46.51	3.42	-4.13
-.18	1.92	69.18
-55	8.89	8.92
-22.64	15.18	5.5
11.96	8.92	5.53
-9.83	11.85	-7.83
9.9	-10.03	9.68
-9.54	-18.81	8.64
11.97	-1.93	4.37
52.72	11.24	-17.8
57.63	-32.43	20.05
59.92	16.66	39.81
-58.88	-.98	41.34
60.15	-27.59	48.67
-9.57	-27.74	5.04
12.16	-28.96	13.76

// Wang A T, 2006: Normal Adults
// Subjects=12
-50.5	-37.89	13.47
65.92	-21.92	-5.78
-12.27	53.55	-20.88
-37.64	-25.5	7.54
-44.08	-36.16	8.71
-26.93	-67.75	-8.63
35.71	-67.73	-11.94
-20.37	-80.28	-5.26
-52.65	-77.23	6.19
-48.37	-35.97	11
63.91	-38.32	2.6
-70	-44.97	7.78
63.7	-28.93	-11.77
-26.88	-65.21	-4.4
24.92	-65.44	-9.74
-5.05	-85.36	8.43
-16	-77.72	-1.11
-9.37	-94.09	7.12
-35.29	-96.31	7.79
40.23	-37.78	9.67
42.53	-45.45	19.36
-50.41	13.11	30.83
-61.62	14.42	-.48
-3.21	63.29	13.86
-14.1	64.75	7.18
-69.99	-40.51	9.58
-13.78	-86.02	1.92
-9.31	-93.68	11.57
-15.68	-92.87	20.56
46.82	-43.52	16.85
-52.88	19.53	7.83
40.15	18.56	15.3
31.61	21.49	24.13
-7.46	59.43	18.8
-46.17	-31.29	14.98
66.08	-11.96	8.92
48.99	-45.64	17.02
-9.76	58.39	7.73
-7.56	65.19	11.5
-50.69	19.75	10.01
46.82	-43.52	16.85
-29.06	-67.55	-6.37
33.53	-70.08	-13.91
-37.64	-25.5	7.54
27	-59.46	-14.85
-50.89	27.01	-4.15
-59.3	-17.28	4.86
59.55	-21.11	3.21
-65.95	-5.37	-5.17
55.21	-23.46	1.28
-70.13	-26.24	1.45
57.23	-9.19	-6.89
-65.94	-22.8	-7.93
59.34	-9.6	-11.37
-52.65	-77.23	6.19
51.03	-68.35	3.55
-48.89	17.05	-18.89
46.11	14.64	-26.99
-15.92	-90.28	2.38
9.94	-88.47	-2.72
-22.55	-82.62	-7.23
35.71	-67.73	-11.94
-44.22	-65.68	-8.54
46.45	-65.99	-16.78
-13.6	-95.61	14.07
12.27	-93.81	8.97
-13.55	-101.79	16.92
-24.27	-101.2	23.77
27.65	-94.01	28.9
-57.13	-21.52	5.24
48.76	-23.28	3.61
-70.11	-23.9	3.46
51.02	-42.21	7.69
-59.26	-30.04	6.12
61.73	-31.95	2.01
-63.74	-24.71	-5.54
52.9	-13.66	-8.62
-48.5	-63.15	-4.23
48.95	-74.33	8.66
-57.47	8.72	-15.68
46.11	14.64	-26.99
-13.76	-90.27	2.34
14.3	-83.79	1.22
-26.91	-65.41	-6.62
42.24	-67.3	-7.61
-31.28	-65.84	-10.99
46.47	-57.06	-13.18
-11.46	-97.94	12.02
10.08	-94.03	6.79
-26.51	-101.83	17.15
-37.39	-89.32	13.85
33.92	-84.6	14.41
53.04	22.45	10.22
57.21	19.09	-2.97
48.4	30.99	-12.96
55.57	9.85	36.07
-57.14	-19.4	5.03
48.78	-23.07	5.83
-56.97	-46.63	12.2
55.19	-17.08	0.65
-67.88	-43.04	5.31
59.6	-33.87	4.47
-61.51	-28.54	-.71
66.04	-36.39	0.13
-48.35	-70.83	5.49
42.4	-70.51	3.91
-59.6	6.8	-13.21
46.11	14.64	-26.99
-15.97	-86.23	-.26
5.51	-82.73	-9.94
-26.87	-82.64	-7.16
46.5	-56.85	-10.96
-31.34	-59.67	-13.84
50.84	-63.22	-10.4
-13.65	-98.16	9.84
10.08	-94.03	6.79
-22.17	-99.48	19.08
10.3	-98.95	22.96
-46.11	-85.51	9.14
25.54	-91.48	33.17
46.57	29.01	11.92
-48.83	24.06	-12.86
53.37	11.76	33.68
-54.83	25.44	25.21
-65.76	-17.09	7.19
44.48	-27.34	6.33
-70.08	-23.7	5.68
55.2	-21.33	1.07
-68	-26.44	-.81
57.4	-31.96	2.08
-65.74	-45.37	3.26
46.53	-36.88	-3.97
-50.53	-66.59	5.1
-46.8	5.59	-26.75
41.73	7.62	-32.94
-22.45	-79.66	1.44
20.72	-73.34	-2.16
-24.68	-89.01	-6.56
31.43	-80.51	-10.6
-46.5	-51.22	-14.41
46.47	-57.06	-13.18
-27.26	-2.43	-21.81
24.56	-2.45	-24.93
-5.02	-93.87	9.27
10.13	-93.61	11.23
-26.55	-99.91	14.72
25.36	-97.19	18.05
-43.93	-89.75	9.53
31.74	-84.82	12.23
57.22	23.55	-1.17
41.83	32.47	-19.72
55.58	7.72	36.29
22.91	-66.53	1.61
27.09	-67.56	-9.57
-20.73	-1.99	-17.48
-48.8	22.14	-10.43
-31.04	-85.87	4.44

// Wang A T, 2006: Normal Children
// Subjects=12
-37.64	-25.5	7.54
-44.08	-36.16	8.71
-26.93	-67.75	-8.63
35.71	-67.73	-11.94
-20.37	-80.28	-5.26
-52.65	-77.23	6.19
-48.37	-35.97	11
63.91	-38.32	2.6
-70	-44.97	7.78
63.7	-28.93	-11.77
-26.88	-65.21	-4.4
24.92	-65.44	-9.74
-5.05	-85.36	8.43
-16	-77.72	-1.11
-9.37	-94.09	7.12
-35.29	-96.31	7.79
40.23	-37.78	9.67
42.53	-45.45	19.36
-50.41	13.11	30.83
-61.62	14.42	-.48
-3.21	63.29	13.86
-14.1	64.75	7.18
-69.99	-40.51	9.58
-13.78	-86.02	1.92
-9.31	-93.68	11.57
-15.68	-92.87	20.56
46.82	-43.52	16.85
-52.88	19.53	7.83
40.15	18.56	15.3
31.61	21.49	24.13
-7.46	59.43	18.8
-46.17	-31.29	14.98
66.08	-11.96	8.92
48.99	-45.64	17.02
-9.76	58.39	7.73
-7.56	65.19	11.5
-50.69	19.75	10.01
46.82	-43.52	16.85
-29.06	-67.55	-6.37
33.53	-70.08	-13.91
-37.64	-25.5	7.54
27.01	-61.59	-14.64
-.86	51.57	26.18
-48.48	-21.49	5.09
48.78	-36.25	2.65
27	-59.46	-14.85
-50.89	27.01	-4.15
-61.4	-25.59	7.96
48.8	-18.61	7.63
-65.89	-11.54	-2.32
66	-19.17	0.67
-61.37	-42.81	7.42
59.59	-38.34	2.67
-57.17	-32.78	-.37
59.55	-34.29	0.03
48.87	-74.95	2
-57.48	10.85	-15.89
50.53	11.02	-19.98
-11.74	-84.71	-7.21
22.86	-84.38	-5.59
-37.7	-82.88	-9.19
46.5	-50.26	-9.37
-42.22	-53.74	-18.72
46.47	-57.06	-13.18
-11.45	-100.07	12.23
3.62	-85.12	10.5
-15.6	-100.96	25.84
16.72	-97.22	18.2
-50.51	-79.56	4.15
-61.59	23.34	3.12
-50.91	24.67	-6.16
59.37	-11.51	-8.94
-5.19	53.68	26.05
-9.74	69.44	11.12
-54.95	-19.18	7.21
46.68	-29.25	8.72
-61.5	-21.95	0.87
46.65	-38.17	5.12
-67.69	-54.76	17.67
63.87	-27.69	1.55
-63.58	-45.36	3.23
57.43	-38.34	2.71
-44.09	-69.11	0.76
48.85	-70.7	1.58
-55.53	7.07	-33.47
33.04	11.63	-35.43
-24.65	-90.93	-4.13
-15.91	-94.53	2.8
-44.27	-52.92	-9.8
42.18	-50.28	-9.29
-40.03	-53.53	-16.54
42.17	-54.74	-11.09
-4.94	-99.84	14.34
10.09	-96.15	7
-20.06	-102.02	14.81
10.34	-96.41	27.19
-52.8	-76.14	-5.12
42.52	-80.52	11.62
-59.07	-41.76	18.48
-61.42	22.46	16.65
3.57	54.54	34.78
-5.19	53.68	26.05
-7.54	67.53	13.51
-70.07	-27.95	6.1
46.75	-41.81	12.2
-65.9	-18.13	-3.91
59.68	-39.84	9.55
-63.36	-56.88	17.81
61.67	-23.65	-1.06
-52.76	-47.45	3.25
52.89	-11.54	-8.83
48.86	-72.82	1.79
-44.75	11.36	-34.08
-22.47	-88.59	-2.16
22.92	-83.97	-1.15
-35.53	-63.11	-4.46
37.93	-62.85	-5.74
-46.5	-51.22	-14.41
42.14	-48.36	-11.72
-11.42	-99.86	14.45
8.02	-97.66	13.91
-20	-101.6	19.25
16.68	-95.3	15.77
-41.97	-73.77	-3.3
42.45	-76.69	6.76
-55.04	19.52	7.87
52.99	28.62	7.37
-51.01	37.02	-11.86
-5.22	55.6	23.62
-9.73	65.18	11.54
9.65	69.09	6.34
-61.42	-21.33	7.54
66.06	-14.29	6.91
-63.54	-38.56	7.04
48.94	-41.59	14.38
53.05	-30.06	-.27
-61.73	0.41	-12.54
-58.99	-63.04	20.58
53.32	-63.05	14.19
48.85	-70.7	1.58
-44.05	-73.15	3.4
48.24	5.72	-30.63
-18.15	-88.57	-2.24
5.75	-85.32	8.24
-33.35	-82.66	-7.04
44.42	-62.83	-5.85
-42.17	-51.2	-14.49
40	-52.62	-11.27
-2.89	-94.07	7.01
20.95	-95.7	11.25
-9.17	-101.36	21.29
8.16	-96.63	25.01
31.71	-78.44	11.6
-56.79	9.45	38.03
-42.04	-63.34	-6.57
-48.27	-83.39	8.97
42.3	-66.88	-3.17
-50.51	-55.53	8.49
43.92	-.88	-32.14
48.86	-72.82	1.79
20.87	-89.73	6.18
10.17	-95.53	13.66
-28.86	-83.53	6.41
-35.27	-93.98	9.8
42.29	-64.75	-3.38
-48.8	22.14	-10.43
-31.04	-85.87	4.44

// Sweet L H, 2006: Relapse-remitting Multiple Sclerosis (RRMS)
// Subjects=15
1.53	-8.47	50.15
1.53	-8.47	50.15
32.48	7.84	51.78
-29.5	7.47	52.52
49.44	-6.72	27.15
-46.74	-7.3	28.31
39.66	61.93	34.89
-37.27	61.46	35.81
37.68	-47.46	10.63
-34.99	-47.89	11.5
12.87	22.53	9.51
-10.64	22.39	9.79
56.89	-6.93	23.74
18.86	52.18	-34.31
-17.48	51.96	-33.87
46.33	32.76	56.22
6.86	11.2	56.25
-22.99	-37.59	47.3
-49.81	-19.06	41.6
54.51	39.95	10.91
39.66	22.32	18.14
-3.83	11.13	56.38
1.32	-7.26	24.41
1.32	-7.26	24.41
-20.18	42.91	28.25
-34.37	17.73	-20.77
-3.83	11.13	56.38
47.16	35.74	25.85
1.06	-3.4	-8.26
1.06	-3.4	-8.26
51.32	4.9	-1.72
-49.13	4.3	-.52
12.86	-13.82	-6.4

// Sweet L H, 2006: Healthy Controls (HC)
// Subjects=15
1.53	-8.47	50.15
1.53	-8.47	50.15
32.48	7.84	51.78
-29.5	7.47	52.52
49.44	-6.72	27.15
-46.74	-7.3	28.31
39.66	61.93	34.89
-37.27	61.46	35.81
37.68	-47.46	10.63
-34.99	-47.89	11.5
12.87	22.53	9.51
-10.64	22.39	9.79
56.89	-6.93	23.74
18.86	52.18	-34.31
-17.48	51.96	-33.87
46.33	32.76	56.22
6.86	11.2	56.25
-22.99	-37.59	47.3
-49.81	-19.06	41.6
54.51	39.95	10.91
39.66	22.32	18.14
-3.83	11.13	56.38
1.32	-7.26	24.41
1.32	-7.26	24.41
-20.18	42.91	28.25
-34.37	17.73	-20.77
-3.83	11.13	56.38
1.49	-7.75	45.63
1.49	-7.75	45.63
32.48	7.84	51.78
-29.5	7.47	52.52
-46.8	45.89	41.69
47.16	35.74	25.85
1.06	-3.4	-8.26
1.06	-3.4	-8.26
-43.93	-33.39	-34.22
51.32	4.9	-1.72
-49.13	4.3	-.52
1.12	15.86	6.86
1.12	15.86	6.86
12.86	-13.82	-6.4
46.33	32.76	56.22
18.86	52.18	-34.31
-17.48	51.96	-33.87

// Albuquerque R, 2006: Burning Mouth Disorder (BMD)
// Subjects=8
3.92	28.73	28.61
-20.41	-66.55	23.49
11.66	-69.53	23.38
-13.17	-19.61	10.55
10.33	-16.3	10.01
41.32	28.96	28.16
40.37	8.23	35.48
-18.43	-67.11	2.33
6.94	-73.13	-36.49
5.62	29.52	27.63
47.25	10.51	-.36
2.82	1.61	55.09
41.57	-36.62	48.6

// Albuquerque R, 2006: Healthy Controls
// Subjects=8
3.92	28.73	28.61
-20.41	-66.55	23.49
11.66	-69.53	23.38
-13.17	-19.61	10.55
10.33	-16.3	10.01
41.32	28.96	28.16
40.37	8.23	35.48
-18.43	-67.11	2.33
6.94	-73.13	-36.49
16.47	-62.47	-28.91
5.99	57.31	-9.39
-26.99	-54.73	-34.97
-12.53	-16.25	12.61
31.41	6.01	8.9
1.39	43.62	25.94
11.6	-11.98	10.63
44.07	7.44	30.49
36.57	36.4	25.69
55.15	-40.12	33.79

// Roelofs A, 2006: Incongruent > Congruent
// Subjects=12
-8.03	19.62	70.21
-5.86	6.78	69.03
-19.89	-.22	48.59
-22.32	54.87	31.73
-48.03	16.71	8.47
58.83	33.89	14.72
-51.9	-37.31	39.8
48.64	-36.82	50.88
0.07	25.97	13.83
-3.02	35.95	33.1
-7.38	41.58	23.76

// Kesler S R, 2006: Turner Syndrome
// Subjects=15
-46.36	39.53	14.7
-23.96	-68.31	54.13
47.24	-46.89	49.67
18.41	4.37	2.51
-48.63	-58.67	-13.64
10.02	33.53	27.78
-43.56	-41.03	48.4
46.54	41.98	12.88
27.7	-54.27	40.65
-46.34	-76.33	-7.45
-23.94	-65.97	56.14
32.21	-65.98	52.94
-48.28	9.61	27.78
-21.78	-77.97	53.93
42.79	-46.77	39.65
-31.36	-49.99	-13.67
3.77	27.62	45.28
-4.83	6	44.21
-43.81	-5.7	35.94
-48.74	-3.7	-11.23
-45.98	-37.49	29.04
-5.5	39.28	-1.66
48.89	42.28	27.38
-43.88	15.67	34.95
8.07	-74.29	22.8
-35.68	-2.93	-3.69
26.76	25.18	-16.5
8.01	-5.83	31.71
-41.89	2.32	18.31
5.92	-22.75	34.54
32.05	-2.61	53.4
-11.62	33.24	25.94
28.91	28.38	-16.85

// Kesler S R, 2006: Healthy Controls
// Subjects=15
-4.83	6	44.21
-43.81	-5.7	35.94
-48.74	-3.7	-11.23
-45.98	-37.49	29.04
-5.5	39.28	-1.66
48.89	42.28	27.38
-43.88	15.67	34.95
8.07	-74.29	22.8
32.05	-2.61	53.4
-11.62	33.24	25.94
28.91	28.38	-16.85

// Knops A, 2006: (NL2 - NL1) and (LL2 - LL1)
// Knops A, 2006: LCL2 - LCL1
// Knops A, 2006: LIL2 - LIL1
// Knops A, 2006: NCL2 - NCL1
// Knops A, 2006: NIL2 - NIL1
// Subjects=13
-25.3	48.63	-26.9
-7.1	29.29	40.82
0.55	25.58	46.66
-46.25	30.48	21.2
-41.44	14.46	56.32
-46.6	47.54	-2.89
56.27	42.02	12.71
48.68	37.43	9.93
31.96	17.5	50.29
35.57	23.16	-4.12
40.67	-46.47	43.02
-37.13	-42.49	43.95
45.21	-56.91	57.42
-33.16	-81.21	8.5
0.99	-51.46	-19.68
-16.22	-80.45	-18.76
44.45	29.32	15.29
-53.79	35.01	24.24
5.85	32.53	40.28
-33.43	-84.35	-13.6
-28.54	-64.77	34.81
40.67	-46.47	43.02
5.22	-21.46	-20.48
-46.23	35.04	24.11
-53.47	12.21	44.42
32.01	18.98	54.62
56.39	38.59	22.01
48.53	57.11	2.38
30.91	62.21	-22.47
-24.07	-62.55	46.84
36.31	-46.8	39.77
-50.41	27.35	33.91
31.98	10.05	51.02
-42.32	47.25	-6.3
40.74	-49.24	47.78
-37.16	-33.98	43.11
-28.19	-59.94	63.46
31.9	17.08	45.85
53.03	42.01	12.77
35.51	64.31	-.35
-50.52	4.62	20.47
-2.79	32.5	40.43
-42.37	55.65	-8.25
40.61	-67.72	33.92
49.43	-57.62	49.58
-41.99	-60.8	-2.34
-20.55	-2.87	-3.95
5.33	-45.82	-16.95

// Wallentin M, 2006: Space > Nonspace
// Wallentin M, 2006: Nonspace > Space
// Wallentin M, 2006: Positive Correlation between Space and Nonspace > Rest 
// and Reaction Time
// Wallentin M, 2006: Negative Correlation between Space and Nonspace > Rest 
// and Reaction time
// Wallentin M, 2006: Positive Correlation between Space > Nonspace and 
// Reaction time
// Wallentin M, 2006: Positive Correlation between Nonspace > Space and 
// Reaction time
// Subjects=20
24	10	66
-56	-66	0
-42	-64	18
62	-58	-8
-16	-64	22
20	-64	22
-36	-82	32
40	-84	32
-38	-40	52
46	-40	60
26	-68	28
22	-74	58
-12	-68	62
-12	-60	50
10	-58	64
6	-74	56
2	36	-24
-6	56	38
4	60	28
-36	30	-18
-6	32	56
-58	-6	-34
-56	-12	-26
62	-16	-28
-46	6	-40
8	-46	30
54	-62	36
-32	-36	-28
-32	58	20
32	52	28
-36	38	36
-46	14	22
-42	18	-4
42	20	-6
46	8	46
0	36	36
-4	18	46
0	16	66
-34	26	0
-50	18	-14
-28	0	50
18	-64	22
6	-66	10
-34	-78	26
42	-76	22
-8	-78	44
2	-50	56
-2	-86	4
8	54	-8
-18	32	-8
18	38	-8
52	-12	36
30	-22	70
62	-12	-8
-56	-16	6
66	-22	6
-44	-32	16
-14	-46	74
18	-38	74
-28	0	-16
-28	-12	8
28	-8	2
-20	-60	16
-26	-74	20
30	-88	28
-26	10	-26

// Sol-Padulls C, 2006: Memory dysfunction patients
// Subjects=39
-37.59	20.83	20.89
-39.87	-80.76	-9.36
46.4	-53.22	-18.04
40.35	-10.59	24.91
-24.06	-64.67	47.05
-.52	14.74	45.51
40.2	21.1	19.53

// Sol-Padulls C, 2006: Subgroup of Memory dysfunction patients, Real rTMS
// Subjects=20
-5.09	36.87	29.95
46.9	16.2	35.59
-37.13	-61.09	40.19
42.86	-49.55	44.41
57.08	22.51	-12.27
46.44	45.61	5.8
40.34	44.04	35.19
8.02	35.83	41.04

// Sol-Padulls C, 2006: Subgroup of Memory dysfunction patients, Sham rTMS
// Subjects=19
-5.09	36.87	29.95
46.9	16.2	35.59

// Mitchell J P, 2006: Similar > dissimilar
// Mitchell J P, 2006: Dissimilar > similar
// Subjects=15
18	57	9
51	3	24
-3	3	36
12	-66	-6
9	-90	24
-24	-66	24
-9	45	42

// Callan D E, 2006: Conjunction: Passive Listening to singing of the song 
// lyrics and Covert singing of the song lyrics
// Subjects=16
-60.71	7.65	-15.51
55.94	18.8	-17.48
-53.07	7.13	-9.99
54.96	11.87	-11.18
67.18	-26.09	6.94
-57.98	-35.17	20.05
69.46	-35.03	14.51
51.61	-39.97	54.52
-33.68	16.67	-12.38
48.41	25.57	-13.54
-53.48	3.39	41.93
-39.52	-8.13	32.75
-.18	4.15	70.08
58.8	11.99	35.81
-35.59	-73.41	-11.28
29.19	-77.85	-16.43
-13.81	-95.04	-2.79
25.05	-95.11	-5.69
5.62	-77.54	-.37
-24.9	-65.48	-18.97
39.93	-69.51	-19.68
-18.72	-73.17	-44.09

// Chen F, 2006: Abacus Expert Group
// Subjects=7
17.06	14.75	67.62
70.36	-45.1	-1.32
66.04	-60.42	-4.22
55.35	-59.62	4.85
-70.37	-30.24	-18.32
-57.46	-24.02	-21.4
-67.72	-52.85	15.24
-65.71	-60.47	2.52
-57.35	-51.67	-18.67
27.71	9.28	54.53
21.39	12.64	67.76
21.65	-55.43	74.49
-28.07	-57.94	73.34
-28.33	10.13	66.61
-5.29	-38.98	-.64
27.71	9.28	54.53
23.83	-53.09	76.46
19.34	-69.66	60.25
22.96	-103.32	-1.48
27.12	-89.24	-11.91
-28.39	9.71	62.17
-15.23	-69.78	60.85
-19.48	-64.92	67.16
-22.47	-101.77	-5.34
-26.92	-91.77	-12.98
-2.69	-92.62	22.55

// Chen F, 2006: Non-expert control group
// Subjects=7
1.68	19.41	49.49
51.63	-31.05	58.12
-37.07	5.01	58.3
-45.58	-35.64	60.23
-56.53	-21.42	52.28
1.7	21.75	51.5
5.8	35.41	36.63
1.29	18.63	18.2
3.52	8.21	21.44
53.86	-32.75	62.73
62.3	-18.87	50.01
-30.56	11.83	62
-52.68	18.86	23.58
-33.63	26.86	-6.67
-48.57	45.69	11.89
-16.12	-54.53	-5.64
-49.99	-29.69	55.23
-32.63	-55.37	55.24
-32.75	-54.07	46.14
32.07	20.56	60.07
3.67	35.61	38.89
1.67	23.67	49.07
29.91	-60.44	43.47
-28.37	12.04	64.18
-57.02	16.51	21.65
-57.32	20.81	-1.19
-21.78	-59.37	57.69
-45.84	-28.8	41.63
-13.7	-107.29	4.02

// Peters L, 2006: Words-Digits
// Peters L, 2006: Dots-Digits
// Peters L, 2006: Dots-Words
// Peters L, 2006: Digits-Dots
// Peters L, 2006: Words-Dots
// Peters L, 2006: Digits-Fixation
// Peters L, 2006: Words-Fixation
// Peters L, 2006: Dots-Fixation
// Subjects=22
-20	-95	-8
24	-100	-6
14	-68	68
-26	-98	-2
-2	-76	-30
0	16	52
34	22	6
-40	14	2
30	-4	66
50	2	36
-24	-4	66
26	44	14
36	-86	28
-2	-78	-30
34	18	4
30	-2	62
-26	-66	-28
-38	16	4
30	-54	-36
-48	-82	4
-24	-6	64
8	16	52
-52	-70	40
60	-26	22
2	50	-10
60	-66	34
-4	-56	20
-4	-94	28
4	-76	34
2	50	-10
-68	-50	12
60	-64	34
60	-28	24
28	-54	-24
-8	14	46
-50	-38	56
-48	-78	-14
38	-48	56
-32	20	8
36	-66	-24
-50	-72	-16
-32	-66	66
0	12	52
-48	6	38
-28	32	8
48	8	24
34	24	4
38	-52	54
36	50	34
2	-72	-24
2	16	50
36	20	6
38	52	34
-30	22	8
50	6	36
-52	6	40
-38	56	22

// Kukolja J, 2006: (Right Imagined Stimuli (RI) + Left Imagined Stimuli (LI) 
// > Right Visual Stimuli (RV) + Left Visual Stimuli (LV))
// Kukolja J, 2006: (RV + LV > RI + LI)
// Kukolja J, 2006: (LV + RV > Catch Trials (2CT))
// Kukolja J, 2006: (RI + LI > 2CT)
// Kukolja J, 2006: (LV > CT)
// Kukolja J, 2006: (RV > CT)
// Kukolja J, 2006: (LV > CT), masked with (RV > CT)
// Kukolja J, 2006: (RV > CT), masked with (LV > CT)
// Kukolja J, 2006: (LI > CT)
// Kukolja J, 2006: (RI > CT)
// Kukolja J, 2006: (LI > CT), masked with (RI > CT)
// Kukolja J, 2006: (RI > CT) masked with (LI > CT)
// Kukolja J, 2006: (LV > RV)
// Kukolja J, 2006: (RV > LV)
// Kukolja J, 2006: (RI > LI)
// Subjects=20
-28	-60	46
-40	-48	48
46	-42	50
-26	-2	52
28	4	56
-50	4	30
52	10	26
-6	12	48
8	18	46
-30	20	2
43	22	-2
-16	-68	24
14	-62	26
-30	-64	-28
32	-64	-32
8	58	24
8	34	2
48	-76	6
-44	-72	4
38	-82	26
20	-64	62
-34	-62	54
-28	-58	48
32	-60	48
-26	0	56
28	4	58
-52	8	32
52	12	30
8	18	46
-28	18	2
34	22	-2
-16	-62	22
16	-62	26
-30	-64	-28
36	-68	-26
32	-74	34
18	-66	64
38	-82	24
14	-62	66
-30	-60	46
34	-76	34
22	-74	54
40	-84	14
14	-62	66
-30	-60	46
-26	-56	46
44	-44	48
-26	0	56
26	8	60
-46	4	34
48	6	32
10	18	46
-28	22	0
34	22	-2
-16	-62	22
16	-62	26
-28	-62	-28
36	-70	-26
-28	-58	50
24	-64	58
-26	6	48
28	0	56
-48	20	30
48	34	26
-38	56	12
8	18	46
34	22	-4
16	-62	26
-32	-64	-28
34	-66	-28
44	-40	50
-44	-38	46
-24	4	32
26	10	60
-2	20	42
10	24	46
-28	22	0
34	24	2
6	-64	56
-38	56	12
-38	4	32
-28	-54	54
24	-60	58
-24	-76	42
20	-74	-14
-18	-94	26
-34	-50	64
-28	-76	52
-58	-42	44
-46	-68	-6
22	-34	68
22	-16	-10
-14	-46	34
-12	44	48
12	60	32
-28	-64	-12
38	-88	-6
-26	-80	-32
38	-78	-32

// Suchan B, 2006: Simultaneous matrix rotation > Simultaneous 3-D cube 
// rotation
// Suchan B, 2006: Simultaneous 3-D cube rotation > Simultaneous matrix 
// rotation
// Suchan B, 2006: Successive matrix rotation > Successive 3-D cube rotation
// Subjects=11
58.17	38.99	-8.31
13.98	33.07	-.25
-8.64	27.99	4
-43.95	5.27	27.02
64.58	-.94	-22.4
54.92	-.45	-16.68
65.33	-14.99	33.88
53.71	-28.37	52.21
-46.74	-34.04	54.49
-52.18	-44.15	49.98
-27.08	-44.42	68.63
-14.05	-50.45	72.36
-34.42	55.29	21.91
-40.82	46.01	26.29
14.97	-19.71	66.58
-37.02	-8.82	59.67
17.48	-89.72	-4.97
11.08	-92.41	1.01
-1.75	-96.95	10.64

// Wilson K D, 2006: Object recognition > Baseline, p<0.001
// Wilson K D, 2006: Object recognition > Baseline, p<0.040
// Wilson K D, 2006: Object recognition > Baseline, p<0.003
// Wilson K D, 2006: Object recognition > Baseline, p<0.019
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.001
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.008
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.040
// Wilson K D, 2006: Letter mental rotation > Baseline, p<0.002
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.001
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.029
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.013
// Wilson K D, 2006: Object mental rotation > Baseline, p<0.002
// Subjects=7
41	-60	-30
-26	-98	-15
-30	-71	-30
19	-94	-20
38	-86	10
26	-86	-25
38	-52	55
19	-4	55
30	-94	10
19	-94	-10
-30	-90	15
34	-90	15
-38	-60	-30
-38	-64	55
26	-75	50
45	-68	-25

// Aramaki Y, 2006: Parallel
// Aramaki Y, 2006: Mirror
// Aramaki Y, 2006: Parallel - Mirror
// Aramaki Y, 2006: Phase Transition
// Aramaki Y, 2006: Asymmetric Activation, Phase Transition
// Aramaki Y, 2006: Asymmetric Activation, Parallel
// Aramaki Y, 2006: Asymmetric Activation, Mirror
// Subjects=15
32	-28	58
30	-16	68
-42	-28	58
-60	4	28
-58	-2	38
-48	-38	52
0	2	64
6	-8	66
-8	-4	72
56	12	14
42	16	6
24	-4	8
-26	-6	12
-18	-20	8
14	-18	10
22	-66	-20
-26	-54	-22
-2	-72	-18
34	-28	58
30	-14	68
-42	-26	58
-2	-10	56
-54	-26	12
-16	-54	-18
26	-58	-22
-4	2	60
6	4	60
8	-8	62
10	0	38
-30	-20	60
-30	-12	58
34	-14	54
32	-44	54
46	-2	12
-54	2	26
24	-10	0
24	10	2
10	-10	16
-22	-12	2
-22	0	2
-14	-16	18
4	-54	-18
28	-46	-30
-34	-52	-28
10	18	60
-8	14	58
24	12	58
44	2	44
10	36	26
-8	14	44
58	12	24
32	48	-4
30	18	-6
6	-24	26
-8	-34	24
-6	18	18
-40	16	0
-54	8	20
-40	-8	38
42	-44	54
-44	-46	46
-30	42	22
8	-8	0
-6	-12	-2
8	-18	-12
-18	-62	-40
28	4	62
28	2	50
54	10	22
48	-32	50
44	46	10
54	-42	46
22	58	14
32	-26	54
32	-12	62
-8	-4	70
-28	-56	-18
30	-28	62
-52	-40	16

// Lehericy S, 2006: Simple - Rest
// Lehericy S, 2006: Scale - Rest
// Lehericy S, 2006: Complex - Rest
// Lehericy S, 2006: Complex - Simple
// Lehericy S, 2006: Complex - Scale
// Lehericy S, 2006: Scale - Simple
// Subjects=12
-40	-14	50
-2	-4	56
-42	-26	22
-34	0	0
28	4	14
-18	-2	12
12	2	0
-14	-16	8
-44	-24	56
-2	-2	56
-6	2	46
-46	6	6
-48	-20	28
-22	16	4
22	18	6
-18	14	4
-20	2	0
-14	-16	-2
-14	-16	2
-36	-22	56
-6	-4	54
-2	0	52
-26	-8	52
28	-2	40
-10	6	42
16	8	38
-60	10	24
50	16	12
34	30	16
-52	-20	32
-46	-26	52
-20	-66	62
30	-64	52
-32	-40	46
40	-50	44
-10	-66	56
-24	-20	14
-24	4	0
26	10	16
-14	14	4
20	12	20
-18	-10	2
20	-6	0
-12	-12	-4
10	-12	-6
-14	-12	10
-36	-22	58
-2	-4	50
-4	2	48
-30	-10	58
34	0	62
-8	8	38
14	6	38
-56	8	32
54	-10	30
32	48	18
-52	-26	38
56	-20	36
-44	-30	50
46	-40	58
-14	-62	68
24	-64	56
-32	-38	48
34	-42	48
-8	-64	54
-28	20	8
-24	14	12
18	10	2
8	16	10
-12	-2	16
-14	4	4
16	6	4
-12	-12	-4
14	-12	-4
-10	-10	12
10	-2	10
0	6	52
-14	0	52
38	-4	46
38	28	16
-44	-36	48
34	-44	48
-28	-60	58
26	-66	56
-26	-54	48
-8	-64	54
26	12	14
-18	-24	22
10	-12	-6
-14	-14	12
8	-16	18
-34	-28	60
-4	-6	52
-24	-10	62
-36	-46	66
-30	8	4
14	12	2
14	12	2

// Rand-Giovannetti E, 2006: First Successful Encoding > Fixation
// Subjects=12
-39	21	27
-33	9	27
-45	36	3
-42	24	18
36	33	6
39	15	27
-12	-21	0
-21	-30	-9
9	-27	-6
-30	-54	39
-45	-30	48
36	-72	18
54	-18	24
48	-24	33
-33	-81	-6
42	-75	-3
9	-90	-12

// Riecker A, 2006: Younger Subjects
// Subjects=10
3	15	51
-36	-21	54
-9	18	9
-12	-21	6
-21	6	9
33	-51	-54
-3	12	54
-39	-24	57
-12	-18	6
30	-54	-51
-12	18	6
-21	6	3

// Riecker A, 2006: Older Subjects
// Subjects=10
3	12	51
-45	-21	51
39	-24	54
39	0	54
-15	21	6
-9	-18	6
-18	9	6
36	-54	-51
-3	15	51
-42	-24	54
-9	-18	9
27	-54	-51
-12	18	9
-18	6	6

// Ashwin C, 2007: Autistic Group
// Subjects=13
42	-48	14
-22	3	-17
2	18	-16
-8	26	-12
10	34	21
0	26	21
40	-48	14
65	-15	3
-54	-22	6
-46	-22	12

// Ashwin C, 2007: Control Group
// Subjects=13
36	-86	-18
-24	5	-15
-16	-6	-11
20	-8	-13
-4	54	38
-22	3	-17
2	18	-16
-8	26	-12
10	34	21
0	26	21
40	-48	14
65	-15	3
-54	-22	6
-46	-22	12
38	-68	-18
-36	-62	-22
54	-39	-2
-11	-4	-8
34	-4	-8
4	34	30

// Schneider F, 2007: 0-Back vs. Fixation, Normals > Schizophrenics
// Schneider F, 2007: 0-Back vs. Fixation, Schizophrenics > Normals
// Schneider F, 2007: 2-Back vs. 0-Back, Normals > Schizophrenics
// Schneider F, 2007: 2-Back vs. 0-Back, Schizophrenics > Normals
// Subjects=48
26	6	-8
-28	20	-12
50	-36	8
-28	-34	0
-6	-4	-6
-16	2	12
42	-26	48
-30	-42	66
34	-34	68
50	-6	34
6	-32	56
-8	-70	54
42	-28	46
40	14	-12
36	-24	10
44	-72	8

// Weiss E M, 2007: Schizophrenic Patients
// Subjects=8
-43.94	-2.28	26.64
-40.11	44.38	-2.69
48.49	22.9	-7.68
44.66	13.44	29.18
33.33	66.32	-1.63
48.5	38.31	-3.6
-26.69	-72.57	8.65
-34.99	-48.11	41.11
31.9	-72.62	27.83
-59.58	33.15	-6.85
-59.25	-54.06	1.77
61.79	-62.14	0.51
-28.56	-68.17	32.9
-30.95	-89.6	10.41
31.7	-87.26	9.11
31.99	-80.72	33.11
-44.37	9.81	-4.8
-35.12	5.59	41.4
-39.91	41.47	12.16
-44.06	14.32	20.52
37.96	38.01	16.78
3.43	27.25	18.43
46.96	-40.25	28.85
5.31	-3.3	-9.95
-54.73	-4.44	27.04
-5.14	-57.61	6.8
-50.82	1.27	-3.85
46.62	-34.02	3.59
55.08	-4.73	-5.06
-11.45	-89.12	14.51
-20.1	-87.02	14.45
12.36	-82.14	19.02
-42.09	-22.09	-1.68
35.71	-23.95	-2.82
9.67	23.28	-1.45
-18.37	58.56	10.1
-33.41	35.11	12.68
51.3	-11.65	36.03
59.61	-7.52	10.83
-11.72	33.58	18.06
-.76	8.51	24.84
9.95	31.95	22.34
14.38	4.31	25
7.95	-10.61	26.58
23.18	-36.08	28.84
-43.89	-47.88	21.07
-59.55	4.98	-9.67
53.35	-64.97	16.62
63.64	-.97	-11.18
-20.07	-95.53	15.29
-35.25	-12.88	27.54
-59.06	-35.17	20.07
-33.63	44.4	-2.8
7.48	31.78	-2.26
40.36	-91.48	9.38

// Weiss E M, 2007: Controls
// Subjects=8
-48.25	13.11	30.8
53.11	12.02	13.49
39.78	39.88	-9.21
48.98	28.76	32.07
-4.99	17.94	34.06
-2.97	38.8	27.48
-50.23	-33.69	35.46
64.21	-44.86	24.53
46.95	-38.12	28.64
-32.86	-54.9	37.26
-63.48	-44.63	11
-28.71	-95.56	15.44
36.28	-72.19	32.19
-33.62	24.73	-6.46
-35.12	5.59	41.4
-39.91	41.47	12.16
-44.06	14.32	20.52
37.96	38.01	16.78
3.43	27.25	18.43
46.96	-40.25	28.85
5.31	-3.3	-9.95
-54.73	-4.44	27.04
-5.14	-57.61	6.8
-50.82	1.27	-3.85
46.62	-34.02	3.59
55.08	-4.73	-5.06
-11.45	-89.12	14.51
-20.1	-87.02	14.45
12.36	-82.14	19.02
-42.09	-22.09	-1.68
35.71	-23.95	-2.82
9.67	23.28	-1.45
-50.67	15.49	10.43
-3.1	39.99	17.28
1.01	42.81	1.25
5.79	24.36	33.25
13.9	46.69	-3.84
-50.7	-30.63	-.69
-67.94	-41.33	0.66
-41.63	-55.87	27.42
70.33	-19.05	1.7
-43.75	-31.54	35.14
-11.21	-50.15	40.91
-16.22	12.55	0.05
-24.79	-6.62	2.09
20.55	17.35	3.43
-37.91	33.75	-1.68
-48.28	4.09	26.09
-20.33	57.88	25.89
53.04	31.16	11.6
53.2	-59.53	6
16.56	-50.21	15.79
8.15	-76.96	28.66
-29.06	28.75	13.23
48.47	9.61	-11.97
26.81	24.43	-13.06

// Basho S, 2007: Overall Effects for Category-Driven Word Generation
// Basho S, 2007: Factor-Specific Effects for Paced
// Basho S, 2007: Factor-Specific Effects for Unpaced
// Basho S, 2007: Factor-Specific Effects for Overt
// Basho S, 2007: Factor-Specific Effects for Covert
// Basho S, 2007: Paced > Unpaced
// Basho S, 2007: Covert > Overt
// Subjects=12
-13	-17	15
-16	-6	13
-34	17	17
-4	17	39
-24	2	52
-9	-58	-2
-14	-9	17
-5	15	37
2	-30	-8
-9	-54	7
-38	28	15
-40	13	15
-24	6	49
-34	-17	17
-43	30	15
-42	17	24
5	26	25
-38	24	22
-24	4	52
56	-34	17
7	15	-5
33	4	50
29	-90	0
-47	9	39
-27	0	10
51	-15	10
-7	6	66
-2	-64	-17
-9	-11	30
7	15	39
22	-52	66
-43	-21	-3
-14	-7	54
5	24	-10
14	54	-12
40	-58	47
33	-45	64
-27	-19	-18

// Chikazoe J, 2007: Antisaccade - Control Saccade
// Subjects=24
24	-6	54
36	18	-4
-34	18	-4
36	-2	50
52	16	20
-34	-6	50
-26	-6	60
38	36	26
-22	-2	46
-46	6	40
42	56	10
32	22	36
-4	36	28
-4	24	36
10	32	28
12	18	36
2	-10	40
0	2	56
14	36	4
8	20	60
8	-68	56
-28	-58	54
46	-46	46
-6	-56	50
-16	-46	50
-18	-68	52
54	-42	34
-54	-46	44
-62	-36	38
-4	-62	62
58	-30	52
20	-70	40
20	-52	50
-62	-24	36
-10	-78	40
44	-32	40
64	-22	32
-10	-34	0
58	-44	20
46	-54	16
56	-54	4
-40	-80	8
36	-76	26
-30	-76	24
-2	-20	10
26	-36	-42
-6	-2	0
4	-34	2
28	-60	-24
-6	-22	-18
10	0	-2
32	-50	-46
14	-26	-10
-36	-66	-20

// Dichter G S, 2007: Subjects with Autism Spectrum Disorder (ASD)
// Subjects=17
42	28	23
40	24	0
50	7	27
-31	26	5
10	22	41
29	-71	42
-23	-61	43
31	-78	-2
36	-39	42
-33	-65	-3
31	-79	25
-29	-85	-2

// Dichter G S, 2007: Neurotypical Controls
// Subjects=17
47	30	13
49	8	32
-43	0	33
35	1	53
3	21	44
7	18	30
33	-64	45
-29	-59	45
45	16	12
54	25	25
-38	27	21
17	-18	43
21	-98	17
-23	80	0
-29	-84	7
26	27	0

// Jardri R, 2007: Passive Speech Listening (UFV - GT)
// Jardri R, 2007: Voice Familiarity Processing (FV - UFV)
// Jardri R, 2007: Intelligible Speech (UFV - RTV)
// Jardri R, 2007: Self-Other Distinction (UFV - SGV)
// Subjects=12
-49.81	-13.6	43.37
-3.86	4.19	49.15
-55.47	-24.63	-2.48
-56.59	-10.89	-3.62
46.47	-31.72	48.24
-55.42	-25.18	4.26
-50.07	-16.34	7.91
52.78	-12.99	42.14
6.82	4.25	49.03
57.8	-23.96	-3.84
58.82	-10.2	-5
57.85	-24.5	2.9
52.21	5.31	-24.07
-48.74	-13.6	43.36
-1.66	2.69	57.06
-45.96	16.03	-.42
-49.05	-32.17	-4.15
0.17	31.4	28.98
46.46	-31.8	47.13
-48.02	22.34	12.45
51.71	-12.99	42.15
4.75	2.73	56.99
51.4	-31.57	-5.36
-60.61	-12.67	28.92
-59.62	-3.57	22.57
5.84	-2.55	57.42
-.89	53.39	38.3
-3.18	54.04	19.32
-33.19	39.72	1.9
-33.2	25.37	-4.7
0.38	-55.37	21.76
-2.18	36.9	4.01
25.58	-13.8	-21.05
1.5	-53.79	28.31
0.17	33.6	29.91
-46.6	-61.91	23.96
47.52	-29.68	46.94
-59.77	10.2	8.03
-10.7	-59.54	-31.29
-16.88	-1.2	21.88
-9.46	-17.16	7.52
63.35	-11.92	27.43
3.38	53.42	38.25
5.37	54.09	19.21
2.52	-55.36	21.73
4.24	36.94	3.94
2.31	33.61	29.89
49.57	-61.33	22.81
12.81	-59.4	-31.57
19.45	-.98	21.44
11.91	-17.03	7.26

// Parris B A, 2007: Normals, Group 1
// Subjects=22
-.69	25.5	34.36
-31.53	28.58	-11.36
-44.13	24.75	17.25
-26.47	3.49	41.46
-39.86	35.3	15.01
-59.61	11.05	-13.63
-34.99	-48.11	41.11
-.75	-81.09	7.93
0.39	-30.3	23.06
-36.06	-58.34	-45.26
-33.6	-74.65	-24.64
-9.55	-16.69	8.43
48.36	19.73	-18.57
58.42	22.26	7.9
37.55	29.47	-17.11
41.87	-54.8	-34.62
13.96	12.14	-6.03
18.26	21.83	-5.94
-16.35	13.74	-10.15
3.34	-6.21	4.94
-9.81	5.47	-7.2
-35.9	-60.39	-32.74
-.64	24.75	37.8
3.36	-11.53	5.46
18.29	10.03	-5.89

// Parris B A, 2007: Normals, Group 2
// Subjects=22
-9.81	5.47	-7.2
-35.9	-60.39	-32.74
-.64	24.75	37.8
3.36	-11.53	5.46
18.29	10.03	-5.89

// Aparicio M, 2007: Hearing Subjects
// Subjects=12
-52	20	18
44	26	6
-36	-20	60
-2	-2	68
-50	-22	-16
-62	-42	-2
-24	-94	-20
20	-86	30
62	-6	20
-4	-14	12
-50	14	-10
68	-16	30
56	-14	30
30	28	56
10	-40	16
-48	6	24
-56	-46	-4
-4	38	-10
66	-22	34
12	-26	74
26	-26	74
2	-92	10
8	-76	-2
-48	8	24
58	26	20
-26	64	43
10	24	46
30	-78	28
32	-70	40
28	-64	-32

// Aparicio M, 2007: Deaf Subjects
// Subjects=12
-46	36	6
10	12	-4
-6	6	54
18	32	26
-44	-50	-24
-24	-94	-16
14	-78	-42
32	-68	-44
-30	-72	-46
62	-6	20
-4	-14	12
-50	14	-10
68	-16	30
56	-14	30
30	28	56
10	-40	16
-48	38	10
64	20	16
52	26	-12
10	26	48
-48	-56	-24
-26	-66	42
26	-68	-36
-4	38	-10
66	-22	34
12	-26	74
26	-26	74
2	-92	10
8	-76	-2
-48	8	24
58	26	20
-26	64	43
10	24	46
30	-78	28
32	-70	40
28	-64	-32

// Caseras X, 2007: Women > Men, Disgusting vs. Neutral Pictures
// Subjects=17
-30.21	38.56	-27.03
-25.98	38.08	-33.73
-41.88	27.29	-20.37
-26.01	58.68	-28.76
-41.96	14.29	-37.12
-45.1	6.24	-30.84

// Habel U, 2007: Explicit Emotion Recognition
// Habel U, 2007: Implicit Face Processing
// Habel U, 2007: Explicit Emotion Recognition - Implicit Face Processing
// Subjects=14
-10	-54	-18
-4	-24	-10
4	-26	-10
14	-18	-8
-18	-26	-8
20	4	-14
-52	16	-24
-20	0	-20
40	20	-22
-44	20	-24
42	-58	-22
-10	-56	-18
-26	-56	-18
-12	-24	-10
20	-28	-8
-20	4	-18
18	4	-18
46	18	-18
38	28	-28
-28	-58	-16
38	-40	-20
-2	-24	-12
48	18	-20
-50	14	-24
-16	-2	-12
-40	20	-22

// Sommer M, 2007: Conjunction of True and False Belief
// Sommer M, 2007: False Belief > True Belief
// Sommer M, 2007: True Belief > False Belief
// Subjects=16
-22	8	66
-42	32	28
-52	14	0
-52	-50	48
56	-50	42
-6	-72	56
-2	-90	14
-8	16	46
42	4	58
46	28	40
34	64	6
34	-54	24
64	-54	-4
38	-64	46
4	-74	52
0	56	26

// Goldstein R Z, 2007: All Words > Fixation
// Goldstein R Z, 2007: Fixation > All Words
// Goldstein R Z, 2007: Positive Correlations Between Drug > Neutral Contrasts 
// With Drug > Neutral Percent Correct
// Goldstein R Z, 2007: Negative Correlations Between Drug Contrasts With Drug 
// Ratings
// Subjects=14
3	6	51
48	3	15
-33	42	15
-42	3	42
21	-63	48
-39	-36	48
24	-69	-9
21	-54	-21
9	0	15
9	-12	18
6	51	-9
3	36	6
3	54	0
33	-30	24
-33	-18	18
-18	-42	-3
-9	-78	24
6	51	-9
12	45	-6
-6	24	-3
-6	42	-12
0	39	-9
24	-45	-6
12	15	42
9	21	51
-15	15	27
21	-63	-24

// Gu X, 2007: Rating Painful Pictures vs. Counting Neutral Pictures
// Gu X, 2007: Rating Painful Cartoons vs. Counting Neutral Cartoons
// Gu X, 2007: Rating vs. Counting Painful Pictures
// Gu X, 2007: Rating vs. Counting Painful Cartoons
// Subjects=12
-5.12	29.01	26.25
-2.74	27.39	43.18
46.5	41.67	9.55
-48.83	49.25	-7.51
41.96	25.75	-11.21
19.31	21.63	-8.18
12.14	36.52	25.21
-.52	30.04	48.48
58.4	37.46	9.76
-53.75	-70.85	5.58
-47.97	-40.61	41.71
-21.78	-63.73	57
-64.21	-19.08	43.22
-5.22	31.58	19.27
8.2	26.23	53.19
42.34	45.03	22.73
39.73	20.87	-17.41
20.61	11.18	6.28
-.97	44.15	15.71
-2.65	36.83	52.33
-48.56	-53.79	-7.4
-64.24	-19.29	41

// Jobard G, 2007: Reading > Listening
// Jobard G, 2007: Listening > Reading
// Jobard G, 2007: Conjunction of Reading and Listening Irrespective of the 
// Linguistic Complexity
// Jobard G, 2007: Reading > Listening, Text - Words
// Jobard G, 2007: Listening > Reading, Text - Words
// Jobard G, 2007: Reading > Listening, Text - Sentences
// Jobard G, 2007: Reading > Listening, Sentences - Words
// Jobard G, 2007: Text - Words
// Jobard G, 2007: Text - Sentences
// Jobard G, 2007: Sentences - Words
// Subjects=10
-16	-94	-6
24	-90	-4
-40	-72	-18
-26	-84	20
32	-78	22
-48	-52	-12
38	-44	-22
-28	-62	52
28	-68	62
-52	0	34
-22	-32	-2
26	-30	0
-52	-20	6
-60	-36	16
-44	-4	-14
-24	-44	-12
56	-14	0
66	-18	0
58	0	-8
62	-40	6
-56	-74	16
24	-48	14
-40	-36	64
44	20	20
-14	-42	14
8	-44	-16
-56	-48	6
-50	-44	-10
-48	-56	-12
52	-42	14
-48	2	54
-58	30	2
-46	26	16
-42	6	28
46	28	-4
60	28	-2
58	-6	44
46	6	58
0	8	58
32	-62	-28
-26	-68	-26
0	-36	-4
-14	-30	-6
-2	-56	-36
-12	-98	-2
-24	-82	-14
16	-88	4
24	-94	8
16	-62	-8
24	-30	-2
44	-20	8
-14	100	0
-28	-90	0
28	-94	6
-10	-86	2
-14	-92	-8
14	-76	8
14	-70	-6
-42	4	50
-46	4	54
-48	-52	20
-58	-56	-2
-50	-66	20
-58	-8	-16
-56	-16	-12
-54	-36	-6
-22	-42	-12
56	12	-24
-48	-54	20
-18	-42	-18
-30	-40	-18
-24	-50	-16
-56	-8	-14
-58	-56	-2
54	12	-22
6	-36	-8

// Szameitat A J, 2007: Imagery > Fixation
// Szameitat A J, 2007: Whole Body Movements - Fixation
// Szameitat A J, 2007: Upper Extremity Movements - Fixation
// Szameitat A J, 2007: Whole Body - Upper Extremity Movements
// Szameitat A J, 2007: Upper Extremity - Whole Body Movements
// Subjects=15
6	6	49
-4	10	47
32	-7	50
-26	-7	63
-42	-45	61
-30	-47	67
-63	-43	39
18	-3	19
22	-4	4
-36	23	-5
-48	12	-1
10	-5	51
-6	-7	59
32	-7	50
-26	-7	63
-42	-49	60
-28	-47	67
-46	-40	54
22	-4	4
20	-3	17
-36	23	-3
-40	14	5
-48	12	-1
-4	10	47
12	3	66
32	-7	50
-26	-7	63
-42	-45	61
-32	-47	67
-63	-43	39
59	-36	50
63	-29	46
51	-23	40
20	-5	19
20	-2	4
-36	23	-6
-12	-30	53
-18	-30	60
-16	-43	63
-8	-48	10
4	-19	54
65	-14	30
53	-18	36
51	-25	53
-61	-14	34
-67	-14	27
40	-38	63
32	-40	50

// Wessa M, 2007: Emotional Go/NoGo vs. Control Go/NoGo, Bipolar Patients > 
// Healthy Subjects
// Wessa M, 2007: Emotional Distractors vs. Neutral Distractors (NoGo), 
// Bipolar Patients > Healthy Subjects
// Subjects=17
60	-60	8
64	-40	-12
52	-40	8
32	60	0
-20	60	0
-4	24	28
8	-44	44
-32	-24	24
-8	-4	20
-12	12	24

// Wong S W, 2007: 35% Maximum Contraction - 5% Maximum Contraction, 
// Deactivations
// Wong S W, 2007: Right and Left Hand, 35% Trials, Activations
// Wong S W, 2007: Right and Left Hand, 35% Trials, Deactivations
// Subjects=17
0	48	-2
-50	-62	40
-18	58	26
-42	4	8
38	2	14
32	14	2
-22	-14	6
14	-18	8
30	-2	0
4	-2	62
6	6	48
32	-2	64
-30	26	24
28	38	22
-54	4	8
50	6	14
-26	-58	44
34	-42	46
28	-54	42
-40	0	32
50	-28	48
60	-32	24
-28	-54	-26
16	-46	-28
-2	-62	-24
8	-26	-12
-26	-92	-6
34	-86	-4
0	46	-4
-2	58	-4
-10	40	54
-38	-74	44
42	-82	24
12	-40	62
36	12	-22
-8	-40	44
2	-52	34
8	-68	18
-4	-84	24
6	-78	30
-24	-82	42
42	-82	24
-10	-54	2
14	-48	0

// Engels A S, 2007: High Anxious Apprehension Subjects
// Subjects=11
-44	20	16
-50	-38	0
-30	-58	44

// Engels A S, 2007: High Anxious Arousal Subjects
// Subjects=13
54	-16	-18

// Engels A S, 2007: Normals
// Subjects=18
20	-82	-18
-46	28	-2
-2	54	10
-54	-52	22

// Toyomura A, 2007: TAF vs. Non-TAF
// Subjects=12
62	-22	22
56	14	32
36	30	-2
-52	8	38
52	-10	-2
32	-42	44

// Vance A, 2007: ADHD Children
// Subjects=12
-18	-92	38
-24	-74	50
-38	-56	48
24	-70	32
32	-90	28
36	-40	50
18	-12	22

// Vance A, 2007: Normal Children
// Subjects=12
24	-70	34
28	-84	42
32	-90	30
-16	-88	36
40	-88	-16
-28	-80	2
-26	-86	14
44	-54	-22
-44	-76	-18
48	-28	36
36	-42	50
-40	-46	48
-30	-60	50
36	0	32
54	8	16
40	0	48
48	30	16
54	24	30
-36	38	-14
42	-72	-34
42	-86	-34
44	-52	-40
56	-74	-22
24	-70	32
32	-90	28
36	-40	50
18	-12	22

// Begliomini C, 2007: Grasping Small > Reaching Small
// Begliomini C, 2007: Grasping Large > Reaching Large
// Begliomini C, 2007: Grasping Small > Grasping Large
// Subjects=12
-33.87	-12.83	51.05
-50.11	-16.39	48.31
-33.8	-31.97	52.94
-33.88	-29.3	47.07
23.66	-54.78	-21.98
17.27	-53.01	-14.2
-43.46	-15.12	61.52
-50.22	-10.63	41.02
23.67	-51.38	-20.08
-37.14	-42.59	42.84

// Creem-Regehr S H, 2007: Hand vs. Fixation
// Creem-Regehr S H, 2007: Viewer vs. Fixation
// Creem-Regehr S H, 2007: Hand Degree vs. Hand Zero
// Creem-Regehr S H, 2007: Viewer Degree vs. Viewer Zero
// Creem-Regehr S H, 2007: Hand Degree vs. Viewer Degree
// Creem-Regehr S H, 2007: Hand vs. Fixation, Event-Related Design
// Creem-Regehr S H, 2007: Viewer vs. Fixation, Event-Related Design
// Creem-Regehr S H, 2007: Hand Rotation, Right Hand vs. Left Hand
// Creem-Regehr S H, 2007: Hand Rotation, Left Hand vs. Right Hand
// Creem-Regehr S H, 2007: Hand vs. Viewer, Event-Related Design
// Creem-Regehr S H, 2007: Viewer vs. Hand, Event-Related Design
// Creem-Regehr S H, 2007: Effect of Degree on Hand
// Subjects=18
-38	-88	-4
30	-88	-6
-30	-6	62
-4	-80	-20
12	-80	-24
4	-74	-16
-38	-40	40
-34	30	0
-26	32	6
-54	2	30
-4	10	48
-20	-72	50
30	-32	-2
28	-64	52
32	-68	26
-40	-88	-4
30	-88	-10
8	-70	-24
-6	-24	-8
32	-54	56
28	-64	44
28	-34	0
-26	-32	-6
-36	-30	34
34	-74	26
-34	-78	14
-14	-62	54
38	-74	16
52	-72	16
-18	-76	30
-42	-82	16
-22	42	4
-28	-36	30
12	-48	50
16	-68	60
-22	-60	-28
-42	12	4
-28	-8	62
-26	-16	48
-26	-46	62
-14	-52	62
38	-52	-34
34	-88	-8
-32	-6	60
-38	-90	-4
-32	-54	-24
-4	10	48
-20	-74	50
-34	-58	56
-22	12	-4
-26	18	2
30	-64	50
-54	4	34
-14	-12	18
-20	-32	4
-22	-20	-8
34	-88	-10
-34	-62	52
-20	-72	50
-26	-76	18
-32	-6	60
28	-2	58
-6	10	46
-32	-52	-24
-20	-32	2
-30	-84	-22
22	-32	12
46	-60	-34
-40	-26	50
10	-60	-16
52	-12	50
-8	-66	-18
38	-20	14
10	-8	46
-36	-50	64
-42	-40	54
28	-50	-30
26	-74	-10
-24	2	62
-22	-68	54
-10	-72	44
24	-68	54
30	0	54
32	-68	28
44	-50	46

// Gowen E, 2007: Eye-Hand Tracing vs. Fixation
// Gowen E, 2007: Eye-Hand Drawing vs. Fixation
// Gowen E, 2007: All Eye Conditions vs. All Hand Conditions
// Gowen E, 2007: All Hand Conditions vs. All Eye Conditions
// Gowen E, 2007: All Tracing vs. Drawing Conditions
// Gowen E, 2007: Hand Tracing vs. Hand Drawing
// Gowen E, 2007: Eye Drawing vs. Eye Tracing
// Gowen E, 2007: Eye-Hand Drawing vs. Eye-Hand Tracing
// Gowen E, 2007: Independent Tracing vs. Coordinated Tracing
// Gowen E, 2007: Independent Drawing vs. Coordinated Drawing
// Subjects=10
4	-62	-16
2	-74	-36
-26	-18	58
-34	-28	62
52	6	-2
48	-2	2
4	-62	-16
4	-72	-38
-28	-26	70
12	-64	-50
-4	-22	48
-36	-30	50
-34	-28	62
-10	-80	10
-8	-92	12
-44	52	10
-52	36	18
-58	14	10
-44	40	26
-62	-50	44
-44	-68	30
50	8	40
46	-12	46
60	-30	8
56	-22	-2
26	14	0
-38	-30	60
50	-40	16
-26	-18	68
-44	-28	58
8	-74	-46
4	-70	-34
10	-72	-50
4	-68	-26
4	-66	-22
68	-14	30
-46	-70	6
-42	-82	20
14	-84	0
-8	-76	-8
24	-96	0
-34	-80	8
-40	-82	20
-26	-48	60
-60	-10	40
-54	-2	42
50	-64	-32
42	-72	-14
-2	14	48
8	12	44
22	-2	54
22	-2	54
-6	-70	58
18	-76	50
22	-72	32
42	36	34
30	24	-20
-32	38	38
60	-50	22
48	-76	32
-6	-96	28
-40	-72	-30
-2	8	56
-20	18	56
24	28	56
14	30	34
-38	34	28

// Koch K, 2007: Schizophrenia Patients
// Subjects=13
-38.15	-51.24	-38.09
-.69	29.86	35.05
-58.53	14.35	-12.85
-.41	24.28	55.77
48.23	23.15	-27.87
48.93	27.28	27.74
45.08	-46.89	49.71
-32.61	-55.26	56.35
14.82	-40.52	50.72
-9.45	-72.82	5.02
-26.33	-80.82	35.24
-1.4	40.93	-18.7
60.51	2.08	-1.34
51.39	-71.18	30.72
-24.42	43.16	40.86
44.81	-5.18	36.62
-54.36	-52.02	46.31
14.82	-40.52	50.72
-26.33	-80.82	35.24
-11.61	-72.83	5.06
20.77	-64.21	3.65
-1.4	40.93	-18.7
51.4	-70.01	31.72
60.56	2.39	1.99
-11.18	-29.12	47.79
-54.36	-52.02	46.31
14.63	1.82	44.29

// Koch K, 2007: Normals
// Subjects=13
14.04	-82.47	-19.08
-38.03	-67.84	-31.96
16.81	-98.72	25.07
46.78	31.74	29.58
46.93	16.41	37.81
-48.55	26.14	9.34
-.58	27.4	43.14
55.79	-44.29	42.55
-9.45	-72.82	5.02
-26.33	-80.82	35.24
-1.4	40.93	-18.7
60.51	2.08	-1.34
51.39	-71.18	30.72
-24.42	43.16	40.86
44.81	-5.18	36.62
-54.36	-52.02	46.31
14.82	-40.52	50.72
-26.33	-80.82	35.24
-11.61	-72.83	5.06
20.77	-64.21	3.65
-1.4	40.93	-18.7
51.4	-70.01	31.72
60.56	2.39	1.99
-11.18	-29.12	47.79
-54.36	-52.02	46.31
14.63	1.82	44.29

// Lagopoulos J, 2007: Bipolar Disorder Patients
// Subjects=10
-46	28	4
52	8	-18
-54	-36	4
38	-90	-2
10	14	4
-40	-84	-8
46	28	0
-44	24	0
-10	-98	6
-54	-8	0
4	52	0
14	16	6
-50	12	-2
-34	44	-2
12	20	10
14	-18	8
26	2	10
40	-14	46
-42	-10	46
44	24	6
8	-32	-12
40	26	6
38	42	32
20	-72	32
14	62	34
10	42	12
10	56	6

// Lagopoulos J, 2007: Healthy Controls
// Subjects=10
-24	-50	-18
-4	-80	-2
46	24	-2
-40	20	-2
48	30	4
34	46	36
12	-82	36
4	-40	-6
10	-96	-6
42	-70	-6
-18	-94	-6
44	26	0
56	-50	32
8	-98	0
-12	-98	0
26	-26	6
-52	-44	0
46	-52	6
-44	-30	6
36	-86	6
44	48	32
-6	-62	32
16	-78	32
6	4	-6
-55	-26	12
-32	45	12
9	40	12
12	60	36
-12	67	14
14	-20	14
22	2	16
14	-78	34
-8	-60	32
35	-14	48
-38	-12	46
44	24	6
8	-32	-12
40	26	6
38	42	32
20	-72	32
14	62	34
10	42	12
10	56	6

// Mallol R, 2007: Parkinson's Disease Patients
// Subjects=13
-41.46	-20.71	47.47
-24.1	-4.72	56.8
-37.08	-11.46	54.33
29.9	1.85	55.23
45.16	-41.91	57.06
44.95	-35.82	41.89
53.55	-27.38	39.79
22.71	-17.71	-4.34
30.17	0.19	-8.48
44.33	-10.94	-2.02
11.69	29.9	-11.11
-3.18	41.6	11.52
-41.93	-24.25	9.73
10.6	-72.65	51.73
-22.71	-18.19	-6.88
18.52	-.32	9.7
5.9	27.42	43.03
42.64	7.88	38.73
-.49	-43.09	35.54
7.63	-11.93	0.95

// Mallol R, 2007: Normals
// Subjects=11
-34.89	-24.43	53.33
-32.69	-31.76	55.14
-34.73	-41.78	62.89
8.19	5.4	48.53
-2.59	-1.02	49.35
-2.66	10.47	45.97
-29.01	-13.56	8.46
60.48	14.95	-1.49
55.19	-2.84	3.72
61.19	-31.2	44.52
53.56	-33.87	39.31
65.28	-20.83	28.86
58.76	5.09	30.89
-53.53	-39.64	29.38
-64.33	-39.68	29.57
32.26	-43.67	61.94
20.7	2.02	11.67
22.71	-17.71	-4.34
30.17	0.19	-8.48
44.33	-10.94	-2.02
11.69	29.9	-11.11
-3.18	41.6	11.52
-41.93	-24.25	9.73
10.6	-72.65	51.73
-22.71	-18.19	-6.88
18.52	-.32	9.7
5.9	27.42	43.03
42.64	7.88	38.73
-.49	-43.09	35.54
7.63	-11.93	0.95

// Milner T E, 2007: Simple Grip vs. Rest
// Milner T E, 2007: Complex Grip vs. Rest
// Milner T E, 2007: Complex Grip vs. Simple Grip
// Subjects=17
-42	-22	48
18	-54	-18
-36	-20	56
20	-56	-20
14	-62	-54
-14	-22	6
-44	0	4
-34	-32	60
-50	-26	14
-40	-42	60
68	-26	20

// Ogino Y, 2007: Pain vs. Rest
// Ogino Y, 2007: Fear vs. Rest
// Ogino Y, 2007: Pain vs. Fear
// Subjects=10
40	8	-8
36	-4	12
64	-32	36
52	6	8
8	10	52
4	14	32
8	-6	48
34	-52	60
-34	-50	52
-24	-62	-56
-12	-74	-48
4	-64	-48
48	-70	-4
-54	-66	-16
-20	4	-16
-4	8	40
2	-32	-4
-10	-74	-40
44	-80	-12
42	-60	-24
52	-78	0
58	-32	16
18	-48	72
-62	-26	20
-58	-48	48
-54	-34	52
42	-6	-12
8	-54	-56
-26	-50	-48
-14	-56	-48

// Sowell E R, 2007: Children with Heavy Prenatal Alcohol Exposure
// Subjects=11
-52	-22	0
62	-2	-8
-42	46	20
-68	-24	8
-66	-22	8

// Sowell E R, 2007: Control Children
// Subjects=16
-60	-24	6
-42	46	20
-68	-24	8
14	18	-22
36	-4	44
-40	48	20
-64	-22	8
-66	-22	8

// Sowell E R, 2007: IQ-Matched Control Children
// Subjects=11
14	18	-22
36	-4	44
-40	48	20
-64	-22	8

// Stoeter P, 2007: Somatoform Pain Disorder Patients
// Subjects=17
-34	12	6
-6	50	42
-60	-8	-4
-56	-40	16
-22	-28	-22
-4	-32	6
-26	-16	10
24	58	0
62	-6	-6
28	-2	-28
52	-68	30
-52	-2	48
0	60	36
-18	2	66
-30	-50	16
-31	-30	-24
-14	-56	-14
44	34	36
8	14	66
44	-22	46
6	-48	40
24	-74	10
-46	44	2
-34	-4	16
-8	10	4
18	-30	8
-22	6	34
-44	0	34
-38	2	-38
-10	2	38
-48	42	10
-46	-40	14
-44	-18	12
0	-56	20
2	64	6
-10	56	36
-62	-22	30
-24	-28	20
-28	16	-4
24	62	0
52	36	18
-52	-42	28
-20	96	24
-2	-64	48
-2	-14	12
30	-20	22
18	-36	6
34	-48	42
32	-76	42
16	-22	18
-38	-22	20
-42	-62	-8
-28	-54	66
22	56	-4
42	-70	-6
28	-48	68
-60	-8	-4
58	-14	0
-60	-6	-4

// Stoeter P, 2007: Normals
// Subjects=17
-34	12	6
-6	50	42
-60	-8	-4
-56	-40	16
-22	-28	-22
-4	-32	6
-26	-16	10
24	58	0
62	-6	-6
28	-2	-28
52	-68	30
-52	-2	48
0	60	36
-18	2	66
-30	-50	16
-31	-30	-24
-14	-56	-14
44	34	36
8	14	66
44	-22	46
6	-48	40
24	-74	10
-46	44	2
-34	-4	16
-8	10	4
18	-30	8
-22	6	34
-44	0	34
-38	2	-38
-10	52	24
-26	-46	-4
-4	-10	34
-24	-24	34
16	52	28
34	30	-14
56	34	8
30	-16	-10
12	-2	36
28	-20	38
-54	6	18
-14	-14	14
-36	-80	-42
48	42	-2
-52	-42	28
-20	96	24
-2	-64	48
-2	-14	12
30	-20	22
18	-36	6
34	-48	42
32	-76	42
16	-22	18
-38	-22	20
-42	-62	-8
-28	-54	66
22	56	-4
42	-70	-6
28	-48	68

// Wang Y, 2007: Language Switching vs. Language Non-Switching
// Wang Y, 2007: Forward Switching vs. L2 Non-Switching
// Wang Y, 2007: Backward Switching vs. L1 Non-Switching
// Wang Y, 2007: Forward Switching vs. Backward Switching
// Wang Y, 2007: Backward Switching vs. Forward Switching
// Subjects=12
-15	43	39
-18	51	25
18	45	34
15	-18	48
15	23	-4
0	25	43
0	47	14
0	40	-12
-12	-1	47
-42	-59	39
-65	-26	1
65	-16	20
27	-41	-3
-24	-66	-35
-3	-17	9
0	29	46
0	39	26
-62	-36	34
36	59	5
39	50	9
3	43	-12
-62	-29	1
18	-89	27
39	2	50
-24	-48	-23
33	-85	-3
3	-73	-4

// Wrase J, 2007: Alcoholic Subjects
// Subjects=16
-40	20	-4
4	-15	4
-16	12	-4
32	-23	-2
4	23	2
-40	19	-4
-4	-15	5
-16	12	-4
-36	51	1
20	4	0
-4	-19	1
32	-77	22
8	-50	10
-63	-31	-5
63	-38	13
4	-27	5
-36	-85	8
-21	-69	22
-36	-65	22

// Wrase J, 2007: Normals
// Subjects=16
-16	11	-7
12	8	-4
-16	12	-4
32	-23	-2
4	23	2
-20	15	-7
20	11	-7
-12	4	0
-16	12	-4
-36	51	1
4	-27	5
-36	-85	8
-21	-69	22
-36	-65	22

// Addis D R, 2007: Event Construction > Semantic Retrieval
// Addis D R, 2007: Event Elaboration > Visual Imagery
// Addis D R, 2007: Future Event Construction > Past Event Construction
// Addis D R, 2007: Future Event Elaboration > Past Event Elaboration
// Addis D R, 2007: Construction > Elaboration
// Addis D R, 2007: Elaboration > Construction
// Subjects=14
-22.81	-21.14	-15.55
61.1	-23.1	39.24
61.2	-39.81	44.25
-13.34	-69.62	39.51
40.31	-80.95	7.22
-1.32	67.81	-6.79
-5.18	55.91	26.95
25.27	41.11	39.1
-3.61	42.74	-22.2
-3.53	49.95	-13.95
-3.4	10.39	-12.28
3.02	36.25	-11.59
-2.68	-9.4	40.09
-22.84	-19.12	-16.87
-18.31	-36.15	-4.06
31.39	-35.97	-4.92
-36.11	13.52	-34.44
-56.39	-9.87	-19.46
73.28	-8.15	-19.6
-11.22	-38.14	43.08
3.64	-49.95	19.34
-7.05	-50.22	28.52
-11.21	-51.22	41.01
-47.96	-53.68	39.64
51.51	-51.65	44.47
-26.59	-99.16	11.28
-3.54	-57.39	-36.95
11.55	-55.42	-39.64
5.42	64.28	12.49
-43.88	11.31	34.26
56.21	39.37	7.37
39.8	54.23	-5.03
53.28	20.92	28.3
-41.79	7.51	27.88
-22.98	13.75	-21.24
55.09	41.29	4.96
62.43	32	-14.42
-18.52	49.77	-3.59
44.19	-22.93	-15.4
56.29	-37.7	-1.81
6.29	-50.66	57.47
-42.16	-60.98	-15.76
38.01	-55.74	1.4
-32.89	-77	30.49
-13.86	-91	-5.43
-16.1	-74.09	-8.19
48.79	-51.45	0.79
-39.96	-54.07	-10.88
42.42	-76.89	4.54
25.68	-57.6	51.1
23.62	-50.29	60.5
29.88	-65	40.56
-30.98	-84.39	8.77
42.29	-66.99	-4.28
-33.19	-90.23	3.79
35.93	-85.74	2.16
-15.94	-88.25	1.06
-13.42	-85.55	29.88
-22.89	64.75	-3.88
-35.28	31.76	34.33
-35.91	54.4	-10.48
58.12	29.86	-14.13
-6.74	-44.64	53.73
-57.68	-53.72	39.81
-33.8	-61.96	-38.22
39.58	-54.67	-44.67

// Ahrens K, 2007: Conventional Metaphor Sentences vs. Literal Sentences
// Ahrens K, 2007: Anomalous Metaphor Sentences vs. Literal Sentences
// Ahrens K, 2007: Anomalous Metaphor Sentences vs. Conventional Metaphor 
// Sentences
// Subjects=8
58.75	-25.23	-20.47
-2.81	11.77	50.74
3.53	32.96	48.89
-45.55	7.11	49.39
-52.11	18.74	35.11
-52.16	22.62	30.32
-44.02	35.99	-17.73
-50.08	24.24	23.47
54.77	19.55	36.04
43.6	36.52	-18.78
50.38	22.72	22.44
-54.57	30.79	-1.56
56.58	27.22	-2.54
54.41	22.47	-8.81
-34.72	-13.29	59.9
46.26	4.52	35.17
44.06	21.43	33.78
1.24	44.6	34.55
-2.84	11.43	46.31
9.71	57	28.96
-58.89	12.64	-15.6
56.56	15.96	-10.52
-60.73	-45.73	0.46
60.9	-25.05	-18.28
56.63	-27.19	-18.05
-45.92	-49.47	-21.7
-28.66	-93.78	-18.18
37.61	-88.81	-14.9
50.39	-76.04	-16.11
-2.82	7.2	46.66
-46.02	30.84	-1.66
37.31	24.48	-8.78
5.72	31.37	55.69
7.81	30.87	49.01
-49.96	16.63	35.26
-50.1	26.18	21.08
52.65	15.3	36.42
50.45	21.29	31.48
-52.22	24.22	23.5
-46	31.01	0.55
-50.09	13.15	17.71
-54.55	30.96	0.65
-52.47	32.57	-6.2
-36.9	-7.13	57.17
-45.54	5	49.57
48.4	2.42	35.32
-48.05	-51.6	-21.49
25.2	-75.8	44.38

// Altmann C F, 2007: Sheep vs. Barking Dog
// Altmann C F, 2007: Left vs. Right Sound Localization
// Altmann C F, 2007: Sound Pattern and Localization
// Altmann C F, 2007: Sound Pattern > Localization
// Altmann C F, 2007: Localization > Sound Pattern
// Subjects=17
-56.44	3.68	-12.28
-67.33	-22.95	10.04
56.84	5.56	-17.87
70.58	-20.92	3.45
-71.31	-20.24	11.74
68.38	-37.33	14.08
-63.41	-28.19	11.16
69.57	-25.08	8.48
-66	-1.38	-8.48
58.09	-1.38	-14.18
77.31	-25.18	-3.41
33.77	-47.79	34.98
38.88	36.99	-12.61
-45.3	-27.86	50.49
35.36	-24.97	45.92

// Dick F, 2007: Language vs. Tones
// Dick F, 2007: Environmental Sound vs. Tones
// Dick F, 2007: Language vs. Environmental Sound
// Dick F, 2007: Environmental Sound vs. Language
// Subjects=12
-56	22	26
-46	28	18
-44	18	26
-38	12	36
56	34	0
38	30	12
-28	-48	-10
-40	-74	14
-56	-12	6
-40	-60	12
-52	-60	-12
-46	-32	0
56	-12	-4
46	-48	-16
52	-18	-4
58	-6	-6
46	-72	20
38	-26	-18
64	-32	0
-46	30	12
-46	40	-12
-40	42	-12
44	12	30
52	40	8
56	36	6
50	42	-6
-50	-44	12
-40	-44	-16
-38	-42	-18
-46	-60	-12
-46	-68	-10
-38	-26	-22
-44	-72	18
-44	-14	-4
-28	6	-28
-52	-26	8
-58	-6	-12
-28	-2	-18
62	-6	0
50	-36	12
40	-36	8
38	-62	-18
56	6	-16
50	-66	-4
-64	-26	0
-32	-44	-10
-56	-38	6
46	-60	-12
46	-54	-12
56	-14	-6
40	-48	-18
38	-38	-24
50	-66	-16
58	6	-4
44	10	32
50	28	20
56	-30	14
58	-42	20
64	-20	14
64	-42	12

// Fusar-Poli P, 2007: N-Back, Positive Correlation
// Fusar-Poli P, 2007: Random Movement Generation, Positive Correlation
// Fusar-Poli P, 2007: Overt Letter Fluency, Positive Correlation
// Fusar-Poli P, 2007: Spatial Objects Location, Positive Correlation
// Fusar-Poli P, 2007: N-Back, Negative Correlation
// Fusar-Poli P, 2007: Random Movement Generation, Negative Correlation
// Fusar-Poli P, 2007: Overt Letter Fluency, Negative Correlation
// Fusar-Poli P, 2007: Spatial Objects Location, Negative Correlation
// Subjects=10
-53.14	-53.37	11.06
40	-10.35	49.87
5.68	9.02	41.95
-10.84	15.85	-19.77
-25.6	49.76	21.05
5.21	23.86	-13.93
-10.91	47.02	-15.69
8.67	6.73	12
-18.04	30.77	22.55
-17.93	24.31	35.36
-5.96	-46.98	34.51
-56.72	-45.19	-34.2
5.15	39.72	-15.26
43.9	-59.33	-19.67
39.81	-72.79	-.65
-32.91	-33.16	9.13
16.5	-75.28	24.36
63.37	-11.67	30.75
-6.18	-25.08	14.83
-32.77	-31.7	27.96
27.7	-44.68	-35.21
-48.8	-28.46	30.1
-41.23	-30.81	40.25
-10.54	-26.05	2.7
39.35	23.46	-22.1
8.75	-66	-6.44
-13.67	-70.37	-5.82
20.25	12.74	-7.6
24.87	-52.91	10.12
-36.85	-34.07	52.74
55.61	13.9	4.16
59	-36.84	8.38
63.28	-12.61	18.57

// Gur R C, 2007: Target Green Circles > Standard Red Circles
// Gur R C, 2007: Novel > Standard Red Circles
// Subjects=36
-54.12	-15.11	37.97
-45.43	-26.72	52.22
-45.46	-27.07	47.79
-3.04	-21.44	6.69
5.52	-16.81	10.66
-3.08	-30.58	-1.47
-11.6	0.35	13.88
57.11	-22.22	46.21
61.35	-13.74	45.45
40.05	-13.18	54.57
-.65	3.15	49.21
5.76	3.19	49.13
-.69	2.81	44.77
5.72	2.85	44.7
-54.3	5.01	22.9
-54.27	5.35	27.33
-67.24	-.67	5.68
-32.95	-8.24	14.84
-32.98	-8.58	10.41
-2.9	-68.3	6.15
-2.87	-67.96	10.59
18.62	-62.23	27.7
-23.94	-56.2	54.45
-28.22	-56.23	54.5
35.57	-50.47	13.14
43.96	0.68	13.21
31.57	-78.39	37.83
35.7	-84.31	15.97
31.56	-65.36	41.2
26.84	-48	-9.27
26.97	-64.24	1.01
-28.73	-48.34	-8.61
-28.71	-52.57	-8.25
-24.09	-79.75	25.2
-24.08	-83.98	25.56
10.02	-76	15.57
-7.09	-71.87	15.42
-7.35	-4.2	9.75
48.34	10.54	30.18
44.26	-70.88	23.67

// Kobayashi C, 2007: Adults
// Subjects=16
-59	-27	7
10	52	34
40	47	5
28	21	-8
6	-3	26
55	-8	-6
18	52	-6
28	15	25
-8	-80	22
-6	-22	58
17	-3	-12
60	24	21
62	-54	3
26	-95	-4
-12	-86	-6
4	56	23
-16	-4	-10
38	40	31
52	-30	32
14	-94	21
64	-49	26
-63	-47	23
61	8	1
36	5	-20
-2	-79	13
24	50	-13
-21	-11	-7
-61	-6	-3
50	-9	-12
-14	-2	-5
40	36	-15
42	11	-9
-65	-34	1
-42	-55	21
61	-52	17
-34	5	-17
-57	20	17

// Kobayashi C, 2007: Children
// Subjects=12
-59	-27	7
10	52	34
40	47	5
28	21	-8
6	-3	26
55	-8	-6
18	52	-6
28	15	25
-8	-80	22
-6	-22	58
17	-3	-12
60	24	21
62	-54	3
26	-95	-4
-12	-86	-6
4	56	23
-16	-4	-10
38	40	31
52	-30	32
14	-94	21
64	-49	26
-63	-47	23
61	8	1
36	5	-20
-2	-79	13
24	50	-13
-21	-11	-7
-61	-6	-3
50	-9	-12
-14	-2	-5
40	36	-15
42	11	-9
-44	14	12
-65	-34	1
-42	-55	21
61	-52	17
-34	5	-17
-57	20	17

// Malhi G S, 2007: Normals
// Subjects=10
-24.5	53.37	26.31
54.63	15.98	17.38
-43.8	28.36	7.44
-34.81	-21.89	45.01
-40.23	-27.09	33.24
-2.81	-6.89	43.38
66.55	-48.17	12.59
-59.85	-1.57	-6.59
-52.03	-58.4	14.81
-40.4	-24.49	11.83
-50.12	4	9.55
21.48	-58.15	-16.17
51.42	-64.32	-15.99
51.4	-70.03	-21.09
-13.7	-21.16	11.25
24.62	-54.33	-22.1
12.65	53.14	-7.55
-9.81	56.18	-7.55
-6.63	41.59	-17.52
-16.76	-49.38	18.11
41.09	-27.69	45.74
60.99	-4.3	2.28
-21.39	-21.23	-16.54
-24.76	-10.81	-32.99
-18.27	-12.21	-24.02
-18.1	-56.62	-20.3
-13.8	-51.85	-14.06
-38.57	49.2	1.17
-40.74	44.44	-5.1
37.65	11.53	30.22
41.04	-19.49	41.7
37.83	-36.05	34.21
29.93	5.74	-2.66
-20.17	-60.26	-12.16
-21.14	-85.64	-10.02
32.57	-40.69	43.58
30.46	-66.76	36.87
34.62	-73.4	19.53
-9.14	-88.46	21.3
-3.85	-91.23	12.55
5.8	-80.97	20.5
-21.32	-55.66	-21.46
-27.33	-82.23	20.99
-21.11	-87.5	-6.52
-4.95	-95.98	6.27
26.97	-84.04	-7.37
-56.41	4.19	26.34
-56.39	-28.56	15.7
-59.8	3.35	1.91
-20.28	-19.74	-11.1
24.55	-28.7	-20.9
-18.11	-36.9	-13.03
-57.36	-26.48	28.92
16.19	-64.19	-11.14
22.49	-58.66	-22.83
-34.11	-8.13	2.58

// Malhi G S, 2007: Bipolar Patients
// Subjects=10
-51.98	-24.96	34.31
-52.03	-25.47	27.66
-38.03	-19.88	43.76
-53.1	-60.69	12.78
-46.84	-52.25	-2.49
-45.67	-69.96	2.32
-40.58	-3.31	-3.32
-35.14	-7.71	8.13
-40.33	-78.64	-.35
-28.43	-85.92	14.62
-9.53	-32.19	-7.95
-32	-10.66	-2.81
-13.74	-35.93	-.9
-11.64	-33	-4.51
15.3	-53.59	15.86
-16.08	-21.54	-21.04
29.84	-21.52	-24.91
-36.57	4.98	-34.18
25.56	-22.77	-26.99
-21.46	-23.06	-26.42
42.84	-66.91	-21.25
42.86	-78.71	-22.49
-49.06	-72.92	-21.92
21.35	-37.43	-23.48
-46.91	-71.68	-19.82
38.62	-81.74	-19.96
48.11	-64.31	-29.34
-38.57	49.2	1.17
-40.74	44.44	-5.1
37.65	11.53	30.22
41.04	-19.49	41.7
37.83	-36.05	34.21
29.93	5.74	-2.66
-20.17	-60.26	-12.16
-21.14	-85.64	-10.02
32.57	-40.69	43.58
30.46	-66.76	36.87
34.62	-73.4	19.53
-9.14	-88.46	21.3
-3.85	-91.23	12.55
5.8	-80.97	20.5
-21.32	-55.66	-21.46
-27.33	-82.23	20.99
-21.11	-87.5	-6.52
-4.95	-95.98	6.27
26.97	-84.04	-7.37
-56.41	4.19	26.34
-56.39	-28.56	15.7
-59.8	3.35	1.91
-20.28	-19.74	-11.1
24.55	-28.7	-20.9
-18.11	-36.9	-13.03
-57.36	-26.48	28.92
16.19	-64.19	-11.14
22.49	-58.66	-22.83
-34.11	-8.13	2.58

// Soderlund H, 2007: Word Encoding, Alcohol = Placebo
// Soderlund H, 2007: Word Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Phrase-Word Pair Encoding, Alcohol = Placebo
// Soderlund H, 2007: Phrase-Word Pair Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Object Pair Encoding, Alcohol = Placebo
// Soderlund H, 2007: Object Pair Encoding, Alcohol NOT= Placebo
// Soderlund H, 2007: Face-Name Pair Encoding, Alcohol NOT= Placebo
// Subjects=12
-46.02	28.64	-2.6
-8.36	50.18	38.66
-3.91	25.68	51.81
-34.91	15.47	46.34
-50.16	26.72	14.34
52.53	-34.22	1.54
40.42	45.47	-12.81
4.72	21.13	61.02
-36.3	-55.93	-23.5
0.72	-59.6	63.37
-25.33	-94.67	-2.53
-18.95	-4.93	28.9
-43.43	-30.37	32.43
25.62	-45.15	-27.34
14.54	-92.07	41.4
-46.04	23.98	-7.78
-41.73	28.83	-.43
-37.21	-76.31	-11.74
-40.26	4.43	41.75
-3.89	20.39	52.26
-43.13	-47	65.05
10.19	-46.74	49.92
45.26	-38.72	26.54
-3.84	14.31	56.11
47.02	37.62	8.97
39.54	-45.87	-24.09
-37.28	-48.47	-9.61
32.19	-47.89	-8.23
-29.38	-59.46	40.29
-56.4	-68.25	-2.16
-29.69	-74.69	-5.27
16.35	-96.54	-2.85
57.67	8.74	-7.69
-46.74	-4.04	29.15
-17.72	-20.81	43.6
10.1	-25.76	45.93
-.75	-37.4	20.27
-14.57	10.47	48.75
52.27	17.97	-11.75
1.6	-39.56	47.19
61.2	-32.88	18.06
50.56	-43.44	20.18

// Wang A T, 2007: Autistic Subjects
// Subjects=18
-8	50	30
0	52	28
-64	-28	0
50	2	-4
-56	-36	0
40	-64	20
-66	-32	10
52	-26	10
-56	-30	2
56	-6	-2
-60	-54	10
54	-50	4
48	-62	6
-52	-64	18
52	-60	20
52	2	-8
-40	-62	-16
36	-46	-14
-34	-70	-14
36	-60	-8
-24	-82	-2
12	-86	0
-46	-84	10
34	-82	8
-30	-92	4
14	-90	-4
-18	-94	12
18	-88	10
-8	52	32
4	58	14
34	2	36
40	12	38
-50	14	26
52	16	16
-52	20	18
40	30	0
-40	-32	14
54	-24	6
-54	-20	4
50	-20	2
-56	-46	6
54	-2	-8
-46	-62	10
46	-62	6
-44	-60	20
-56	6	-10
40	10	-26
-40	-50	-10
40	-54	-10
-32	-78	-8
28	-76	-10
-22	-80	-8
16	-80	0
-46	-84	8
40	-74	4
-28	-86	-6
20	-88	2
-8	-92	10
16	-92	12
-30	-70	-26
2	50	20
-6	58	22
-52	-18	10
-60	-24	2
56	-8	-2
48	-10	-14
10	-78	-22
-52	-20	10
-60	-22	6
56	-8	-2
48	-12	-8
0	-90	20
0	-80	10
-10	-76	-22
10	-78	-28
10	42	36
-8	56	26
-4	58	18

// Wang A T, 2007: Controls
// Subjects=18
4	42	12
-6	64	12
14	50	-4
-58	-24	6
48	-21	10
-64	-20	2
56	-10	0
-8	50	30
0	52	28
-64	-28	0
50	2	-4
-56	-36	0
40	-64	20
-10	58	28
2	50	20
-2	62	18
48	2	34
-58	18	16
32	14	22
-56	22	20
50	24	10
-44	22	-10
-48	-30	8
48	-24	6
-60	-22	2
54	-8	-2
-58	-4	-8
46	-38	2
50	-60	10
-48	-66	14
38	-70	16
-42	16	-18
38	16	-20
-40	-44	-14
38	-48	-14
-32	-80	-8
26	-74	-10
-26	-78	-6
24	-80	0
-32	-88	8
28	-82	4
-36	-84	-4
38	-76	-2
-12	-94	20
10	-90	14
-28	-74	-28
12	-80	-20
-6	40	48
-6	52	30
0	62	20
-44	42	4
-56	16	14
50	18	24
-56	18	8
50	24	16
-48	30	-2
-52	-28	6
52	-20	10
-58	-22	4
50	-10	0
-66	-30	0
54	-6	-4
-54	-68	8
52	-58	10
-48	-66	12
38	-68	12
-46	10	-26
40	14	-20
-44	-48	-12
32	-46	-16
-32	-56	-10
40	-48	-8
-20	-82	-4
22	-78	-2
-32	-86	8
30	-84	8
-34	-82	-4
40	-74	0
-4	-92	12
16	-88	10
-26	-72	-32
16	-66	-20
2	50	20
-6	58	22
-52	-18	10
-60	-24	2
56	-8	-2
48	-10	-14
10	-78	-22
-52	-20	10
-60	-22	6
56	-8	-2
48	-12	-8
0	-90	20
0	-80	10
-10	-76	-22
10	-78	-28
10	42	36
-8	56	26
-4	58	18

// Lawrence N S, 2007: Disgust vs. Neutral, All Subjects
// Lawrence N S, 2007: Disgust vs. Neutral, OCD Patients > Normals
// Lawrence N S, 2007: Disgust vs. Neutral, Normals > OCD Patients
// Lawrence N S, 2007: Fear vs. Neutral, All Subjects
// Subjects=17
-42.52	-73.8	-6.31
51.55	-68.49	-1.15
45	-56.78	-14.32
-59.58	-43.81	11.44
-53.08	-63.78	14.16
-31.76	-85.02	-1.03
25.64	8.8	-3.99
-13.72	-13.75	10.63
-7.41	-5.94	0.98
-42.87	36.86	-6.67
-13.7	-15.7	13.02
36.35	31.13	8.52
-43.71	-55.29	-14.54
46.28	-40.29	19.97

// Roth R M, 2007: Medicated OCD Patients
// Subjects=6
32	31	6
28	26	52
30	-36	55
26	-35	0
24	-87	12
16	-2	4
8	-37	-30
-28	46	25
-10	35	44
-40	21	23
-32	21	-3
-34	15	36
-42	42	-7
-46	-33	-5
-14	-11	-20
-28	-11	-25
-20	-93	5
6	-13	56
42	13	-4
42	-14	62
46	-27	42
65	-35	7
48	-33	9
24	-48	-18
26	-85	10
-44	-4	-2
-12	-72	-3
-6	10	1.4
32	33	-8
-40	21	23
46	-18	60
12	-44	48
2	-76	0
42	-2	-35
42	-50	-26
-52	-31	35
-18	-54	50
-6	-17	14
-12	9	62
-24	-67	-15
-30	-50	-21
28	37	44
10	-16	36
42	-36	-14
59	0	-8
36	-5	-28
14	-23	7
-2	52	-8
-42	-6	-5
-2	-60	-34
-14	24	10

// Roth R M, 2007: Unmedicated OCD Patients
// Subjects=6
32	33	-8
-40	21	23
46	-18	60
12	-44	48
2	-76	0
42	-2	-35
42	-50	-26
-52	-31	35
-18	-54	50
-6	-17	14
-12	9	62
-24	-67	-15
-30	-50	-21
28	37	44
10	-16	36
42	-36	-14
59	0	-8
36	-5	-28
14	-23	7
-2	52	-8
-42	-6	-5
-2	-60	-34
-14	24	10

// Roth R M, 2007: Normals
// Subjects=14
61	19	27
12	2	40
44	-13	61
63	-33	5
46	6	-29
26	-77	13
50	-55	-7
6	-22	-7
-32	35	30
-30	41	-4
-63	-31	0
-48	-52	1
-46	-7	-27
6	-13	56
42	13	-4
42	-14	62
46	-27	42
65	-35	7
48	-33	9
24	-48	-18
26	-85	10
-44	-4	-2
-12	-72	-3
-6	10	1.4

// Tobler P N, 2007: Activations Correlated with Magnitude
// Tobler P N, 2007: Activations Correlated with Probability
// Tobler P N, 2007: Activations Correlated with Expected Value
// Subjects=16
-12	2	6
18	-6	2
12	36	36
50	16	6
-10	4	-4
18	-18	-12
-20	-16	-14
18	18	-14
-2	48	-12
8	58	10
-4	64	8
52	26	-2
28	42	26
-34	48	10
-8	12	6
16	-6	4
-30	34	0
14	46	18
52	28	8

// Yucel M, 2007: OCD Patients
// Subjects=19
2	0	52
4	4	52
-2	8	52
4	2	46
6	0	58
0	0	60
-12	10	40
20	-80	50
20	-10	60
-16	0	12
18	-4	12
34	14	2
22	8	12
48	-4	26
38	-22	56
-32	20	2
-42	-34	34
2	-10	52
-10	-86	40
-60	-6	12
24	-14	60
-34	30	26
-36	-12	4
2	40	26
-26	26	-14
54	-54	-14

// Yucel M, 2007: Normals
// Subjects=19
0	12	48
-8	16	46
4	10	48
-2	4	48
6	0	58
4	6	54
24	-76	32
28	-6	60
-28	0	56
20	-6	58
36	16	22
50	-4	34
36	-62	-26
-16	4	14
34	-58	-14
2	-10	52
-10	-86	40
-60	-6	12
24	-14	60
-34	30	26
-36	-12	4
2	40	26
-26	26	-14
54	-54	-14

// Mochizuki H, 2007: Itching
// Mochizuki H, 2007: Itching > Pain
// Mochizuki H, 2007: Pain
// Mochizuki H, 2007: Pain > Itching
// Subjects=14
-16	-4	64
48	8	8
-48	10	4
-38	-14	-4
8	16	36
2	-38	26
-16	4	6
-38	-14	-4
2	-38	26
-4	-2	58
36	10	6
-42	10	-4
-8	10	40
-18	6	4
50	-22	12
-2	-4	6
-2	-4	6

// Abler B, 2007: Depressed Patients > Normals, Negative - Neutral Picture 
// Expectation
// Abler B, 2007: Depressed Patients > Normals, Negative - Positive Picture 
// Expectation
// Abler B, 2007: Depressed Patients > Normals, Negative - Neutral Picture 
// Presentation
// Abler B, 2007: Depressed Patients > Normals, Positive - Neutral Picture 
// Presentation
// Subjects=12
-21	0	-9
27	-3	-9
-3	-6	69
-51	21	33
24	-3	-6
12	21	33
-3	24	-15

// Matsuo K, 2007: Depressed Patients
// Subjects=15
-30	0	48
40	0	42
-16	0	42
42	4	30
-26	0	48
-6	12	42
-32	34	26
-30	52	16
38	4	28
42	26	28
2	14	48
0	20	40
6	22	34
-34	32	28
-30	52	16

// Matsuo K, 2007: Normals
// Subjects=15
-30	0	46
-44	18	20
-24	10	44
44	54	6
44	34	20
-26	0	44
-34	32	28
-30	52	16

// Walter H, 2007: Depressed Patients
// Subjects=12
-42	-45	48
-18	-72	48
-45	-3	51
0	6	63
-45	27	24
33	-66	-27
-27	-75	30
30	24	3
-18	-72	48
-36	-3	57
0	12	57
33	-66	-30
30	-60	48
30	0	54
-18	6	3
33	21	3
-51	-60	-12
-18	-72	48
-45	27	24
30	-60	48
-51	-60	-12
30	-69	-27
27	0	54
30	21	0
-33	-66	-27
51	3	48
45	39	27
-9	-81	9

// Walter H, 2007: Normals
// Subjects=17
-36	-81	-12
42	-69	-24
-42	-42	45
-51	3	36
-24	69	54
33	-63	54
-51	3	36
21	-66	60
30	-66	-27
30	-3	66
-33	-69	-24
-39	24	0
33	24	3
-21	0	9
42	36	24
-42	24	27
12	-75	-21
-18	-69	57
-51	3	36
24	-66	60
39	39	24
54	12	30
24	-63	6
-39	-42	-36
-66	-15	18
-33	51	18
-33	-39	-42

// Georgiou-Karistianis N, 2007: Normals
// Subjects=17
-46	-44	50
34	-36	56
-4	2	56
10	4	58
-34	-16	56
50	-14	44
-26	4	8
22	12	4
-6	38	14
2	40	10
-4	-36	40
4	-42	28
-8	10	34
0	14	40
36	10	-2
36	20	-4
-36	0	6
48	-30	30
62	-38	14
-62	-38	26
-50	-42	18
-52	-20	42
-28	-10	64
20	-62	50

// Georgiou-Karistianis N, 2007: Huntington's Disease Patients
// Subjects=20
-44	-36	44
58	-36	22
-10	10	36
4	2	50
-54	-22	22
52	-16	24
-8	4	36
10	22	32
28	2	54
-36	-2	8
36	4	8
32	22	4
-30	-50	62
-42	26	38
-4	58	8
0	58	28
-4	-46	22
4	-52	22
-8	10	34
0	14	40
36	10	-2
36	20	-4
-36	0	6
48	-30	30
62	-38	14
-62	-38	26
-50	-42	18
-52	-20	42
-28	-10	64
20	-62	50

// Diamond E L, 2007: Novel vs. Repeated Correlated with AD Assessment Scale 
// Word Recognition
// Diamond E L, 2007: Novel vs. Repeated Correlated with AD Scale Assessment 
// Total Score
// Diamond E L, 2007: Novel vs. Repeated Correlated with Free and Cued 
// Selective Reminding Test-Cued Recall Assessment
// Subjects=29
-41.25	18.77	-12.46
-53.01	-8.82	-8.41
-41.15	-61.5	-21.33
54.79	5.1	-26.19
-56.15	-39.78	-6.42
-5.26	-32.18	3.17
-41.03	-64.92	-12.03
-8.53	-32.4	1.01
-41.26	-15.24	-20.3
-44.48	26.51	-9.81
54.86	3.49	-20.43
-4.92	23.98	41.31
-28.42	33.08	-20.82
-55.97	-38.43	8.01
27	-29.92	-8.81
-57.36	-9.05	-10.56
-40.81	-8.62	16.01
-56.29	-11.27	-11.48
-27.97	-6.22	6.59
-47.34	29.3	20.21
-47.57	-56.64	-14.98
54.93	4.01	-14.88
7.61	-9.91	-.37
-11.82	-36.12	-4.17
-24.44	25.52	35.89

// Fu C H Y, 2007: Differences in Dynamic Range, Normals > Depressed Patients
// Fu C H Y, 2007: Normals > Depressed Patients, Post- vs. Pre-Treatment
// Subjects=19
-18.91	-37.42	21.59
4.83	-52.49	44.89
-8.26	-70.71	3.07
-4.07	-40.82	3.86
-30.76	-49.44	4.89
3.36	-34.69	-0.08
11.92	-21.35	6.51
-6.26	-18.28	6.46
17.22	-18.48	1.75
8.67	-38.25	-5.42
2.23	-29.83	-6.05
2.53	-72.87	15.4
-4.88	-73.29	24.44
-2.62	-71.99	41.03
17.6	-74.93	28.78
-14.46	-75.12	29.16
18.44	-71.78	0.62
-10.37	-70.46	6.42
22.63	-66.01	-7.71

// Haller S, 2007: Simple - Fixation
// Haller S, 2007: Medium - Simple
// Haller S, 2007: Complex - Medium
// Subjects=16
28.06	-84.92	-5.07
28.06	-84.92	-5.07
-39.26	-81.98	-2.32
44.43	-23.04	64.27
-52.03	11.85	42.37
1.46	10.65	49.67
33.73	-49.6	52.12
36.34	25.5	4.53
-59.54	-12.66	28.9
56.94	-9.68	29.55
-23.95	-55.23	53.25
-31	31.53	5.91
-48.04	17.76	8.38
2.48	-28.32	27.27
-37.16	-65.91	-1.12
-43.94	104.98	21.09
49.53	6.79	44.98
4.57	3.89	62.47
27.07	-88.42	4.82
-29.35	-45.92	50.3
31.08	8.7	9.34
40.7	-48.26	-13.87
51.22	22.56	-7.34
49.35	-21.92	9.47
-1.82	-67.03	8.82
-41.33	8.61	43.64
-.27	9.72	59.8
-54.24	-39.46	12.13
34.7	-.31	59.13
46.2	20.38	33.84
-32.03	28.6	9.51
-57.7	-3.15	-5.26
35.28	31.12	8.53
33.66	-49.23	43.17

// Lagopoulos J, 2007: Bipolar Patients
// Subjects=10
-26.65	8.2	6.7
7.47	11.95	-2.93
-3.23	9.6	-4.84
-20.31	-18.85	-13.41
24.64	-31.1	-10.66
-16.02	-16.54	-11.42
13.78	2.16	-20.02
-16.13	2.15	-17.45
-5.52	40.97	-11.9
39.73	45.01	36.31
-26.71	-21	-13.15
11.64	2.15	-19.99

// Lagopoulos J, 2007: Normals
// Subjects=10
7.27	45.1	-14.62
-7.66	43.07	-12.05
39.64	46.26	25.05
-3.14	32.46	15.55
16.36	-48.13	17.62
-9.26	-50.22	20.32
-5.25	-11.22	1.39
-11.88	-.28	-21.75
42.16	-44.15	39.3
-41.19	-40.24	42.16
-5.52	40.97	-11.9
39.73	45.01	36.31
-26.71	-21	-13.15
11.64	2.15	-19.99

// Sheridan M A, 2007: ADHD Adolescent Girls
// Subjects=10
-22	-82	-8
18	-68	50
-22	-62	46
-10	-12	14
-44	28	10
-10	12	36
0	22	50
-42	12	30
-34	-52	-38
28	-50	-28
-14	-68	-16
22	-62	32
-16	-64	30
-10	-10	14
18	-12	18
8	18	44
-38	14	16
42	14	14
-38	14	58
36	-16	56
-24	56	36
38	26	4
48	-36	46

// Sheridan M A, 2007: Normal Adolescent Girls
// Subjects=10
12	-82	-10
-46	-56	-26
38	-42	44
-34	-60	34
16	16	22
30	38	16
-38	36	22
-8	32	16
36	-58	-20
-22	-46	-10
-18	12	14
-12	-18	4
6	-14	2
8	28	20
-32	16	6
38	12	-8
-54	-10	-4
32	42	16
-52	36	4
-48	-26	38
22	-72	-10
38	28	2
38	26	4
48	-36	46

// Koch K, 2007: Males
// Subjects=21
-6	30	56
32	28	-20
-44	14	20
-44	0	22
-60	-20	40
14	-12	40
-8	-50	28
54	2	-20
-58	6	-28
-56	-12	-28
-48	-66	30
54	20	16
-66	-22	4
-38	-22	-2
-26	30	36
34	10	28
-40	-22	62
-42	-10	62
12	38	28
-14	12	40
18	-10	40
16	14	42
-28	-46	6
42	-64	10
-34	-24	40
-26	-44	58
-32	-46	38
30	-40	44
12	-48	46
24	-80	36
-8	-56	-26
20	-26	14
36	-24	24
-4	6	16
46	-64	10
-32	-46	38
-22	-68	36
28	16	-22
-22	-2	-12

// Koch K, 2007: Females
// Subjects=19
-6	30	56
32	28	-20
-44	14	20
-44	0	22
-60	-20	40
14	-12	40
-8	-50	28
54	2	-20
-58	6	-28
-56	-12	-28
-48	-66	30
54	20	16
-66	-22	4
-38	-22	-2
46	-64	10
-32	-46	38
-22	-68	36
28	16	-22
-22	-2	-12

// Ortigue S, 2007: Love > Friend
// Ortigue S, 2007: Passion > Friend
// Ortigue S, 2007: Love > Passion
// Ortigue S, 2007: Passion > Love
// Subjects=36
6	12	0
6	-22	-22
-26	20	-4
36	-4	2
36	-88	-18
-48	-50	-24
34	-18	-28
-40	-8	-34
66	-44	32
-46	26	26
-44	-26	-20
-18	-96	-8
12	-48	-38
-36	-78	-52
6	12	0
-26	20	-4
36	-4	2
-48	-50	-24
64	-52	16
34	-18	-28
-40	-8	-34
66	-44	32
-18	-96	-8
18	-94	-8
-12	-68	-2
12	-48	-38
-36	-78	-52
-48	-50	-24
64	-52	16
-64	-50	22
66	-44	32
36	-88	-18
-56	-70	-2
-40	-8	-34
-44	-26	-20
-6	-42	8
64	2	24
-36	-78	-52

// Baumann O, 2007: Color-Coded Memory-Guided Saccades, 2.0s > 5.5s Retention
// Baumann O, 2007: Color-Coded Memory-Guided Saccades, Re-Ordering > Fixation
// Subjects=13
32.06	-86.79	37.07
56.83	-11.75	46.03
47.39	-39.26	62.36
-31.1	-34.95	9.49
1.53	26.99	38.66
-4.34	-61.47	68.8
-39.69	17.94	24.57

// Eddington K M, 2007: Self + Other Relevance vs. Syllable Counting
// Eddington K M, 2007: Self vs. Other Relevance
// Eddington K M, 2007: Promotion Goal Priming
// Eddington K M, 2007: Prevention Goal Priming
// Subjects=16
-2.12	34.16	9.82
-50.4	24.15	-18.9
4.33	60.94	25.34
-49.71	-59.84	37.21
46.44	-52.92	35.52
-17.86	-52.99	12.85
1.17	48.23	26.44
33.66	6.76	65.24
-50.1	-26.55	-.15
49.26	-23.92	-2.63
-34.24	6.96	-8.72
-37.69	41.78	-26.1
48.89	35.95	-26.6
29.86	-5.95	-16.18
10.57	31.81	-7.97

// Fehr T, 2007: Addition, Complex > Simple
// Fehr T, 2007: Subraction, Complex > Simple
// Fehr T, 2007: Multiplication, Complex > Simple
// Fehr T, 2007: Division, Complex > Simple
// Fehr T, 2007: Conjunction (All Conditions)
// Subjects=11
-2.57	24.28	55.81
10.39	22.09	54.68
8.12	27.84	47.43
-44.11	48.98	23.82
40.33	12.26	28.25
46.66	33.03	20.49
46.57	53.14	17.38
-43.52	-45.08	51.04
-17.45	-64.78	57.03
-28.63	-50.09	31.11
-33.24	-86.19	1.15
27.42	-74.95	14.69
20.89	-81.87	9.88
20.8	-94.61	-0.06
-33.08	-45.61	21.78
-50.74	-49.54	-7.78
55.16	-46.84	-7.61
-44.06	44.93	26.46
-.44	24.08	53.55
3.78	25.49	45.49
-41.84	37.7	29.37
-37.68	55.18	20.85
-28.45	14.72	58.32
48.83	33.04	20.45
48.73	53.15	17.34
46.82	12.28	28.14
42.09	23.5	-.9
-45.65	-44.88	53.3
36.44	-53.51	48.27
-10.95	-66.78	58.24
-30.53	-62.36	49.17
36.42	-71.15	43.3
32.04	-60.64	41.21
-9.94	-7.58	-20.47
-5.1	-10.21	20.04
3.78	25.49	45.49
-39.67	48.76	32.73
-41.84	37.7	29.37
48.83	33.04	20.45
48.93	16.34	25.46
31.35	-69.13	-15.09
-7.46	-35.8	-.92
-3.14	-5.17	4.94
-3.06	-19.85	8.64
3.78	25.49	45.49
-41.78	35.99	34.03
-48.94	51.71	-15.59
-44.09	34.84	21.85
48.82	35.17	20.24
51.08	18.47	25.21
38.57	13.03	59.58
60.78	24.89	24.41
-35.8	25.69	-7.64
-32.65	-73.01	50.26
-10.9	-70.83	60.88
36.44	-75.41	43.72
19.32	-68.7	59.03
3.34	-5.15	4.83
9.89	1.98	11.86
-2.57	24.28	55.81
10.39	22.09	54.68
8.12	27.84	47.43
-43.97	42.37	33.43
48.83	33.04	20.45
51.08	18.47	25.21
60.78	24.89	24.41
36.39	-71.36	41.08

// Milea D, 2007: Decision - Reference 1
// Milea D, 2007: Decision - Prepare
// Milea D, 2007: Prepare - Reference 1
// Milea D, 2007: Execution - Reference 2
// Subjects=12
-27	57	18
36	45	30
-36	0	54
45	9	48
-24	0	57
33	6	57
9	21	39
0	6	57
-39	39	30
30	45	39
27	9	57
48	12	39
-21	9	57
30	9	57
3	34	45
-36	-6	57
42	0	4
-24	0	57
33	0	51
9	6	57
-3	3	57
-24	3	51
27	0	4

// Woodard J L, 2007: Recent > Unfamiliar
// Woodard J L, 2007: Remote > Unfamiliar
// Woodard J L, 2007: Recent > Remote
// Subjects=15
-.7	-50.99	22.07
1.34	48.7	-6.16
-48.05	23.91	-4.41
-17.4	35.15	39.24
26.66	25.34	39.11
-59.3	-41.62	-7.14
-56.48	-13.34	-17.36
-45.48	-69.68	27.95
52.71	-61.75	14.33
26.49	-20.42	-15.93
17.88	8.36	15.77
-10.31	-49.23	51.26
1.53	-50.03	20.52
2.19	47.74	-7.65
-18.73	31.33	45.04
-29.39	16.48	56.22
-6	54.76	13.71
-8.63	47.51	30.3
-63.26	-41.46	-7.45
-46.99	-69.05	26.57
56.25	-61.98	15.2
29.19	-42.71	-20.89
15.01	6.31	17.09
-3.39	-54.83	31.8

// Stark R, 2007: Disgust > Neutral, Parametric Modulators
// Stark R, 2007: Fear > Neutral, Parametric Modulators
// Stark R, 2007: Disgust > Fear, Parametric Modulators
// Stark R, 2007: Fear > Disgust, Parametric Modulators
// Stark R, 2007: Disgust > Neutral
// Stark R, 2007: Disgust > Fear
// Stark R, 2007: Fear > Neutral
// Stark R, 2007: Fear > Disgust
// Subjects=66
18	30	-18
63	-18	27
-63	-24	30
45	-60	-9
-45	-66	-6
36	-87	12
-36	-93	12
39	3	-6
-39	0	-15
54	33	0
-9	-48	33
-42	-60	-18
-51	-69	12
45	-78	3
-15	-96	18
12	-99	18
-27	-45	-18
30	-51	-15
-45	-63	-6
-33	-96	15
21	-102	-6
39	-3	3
-39	-6	6
33	57	6
-48	42	-15
-39	48	-3
42	27	39
-42	27	39
36	15	54
42	-45	-30
63	-51	12
3	-60	42
-45	-72	12
-12	-99	15
-30	33	-15
48	9	24
-63	-24	33
24	-57	57
48	-63	-9
-45	-66	-9
-36	0	-12
33	0	-24
-27	-51	-15
30	-54	-12
-33	-93	12
39	-3	3
-39	-6	6
54	36	6
30	0	-30
48	-66	3
-48	-69	9
9	-93	3
3	48	-6
-48	42	-9
57	30	-6
27	27	48
0	27	-12
-39	12	45
57	-6	-24
57	-48	12
-45	-57	12
42	-48	-24
3	-57	39
-9	-99	12

// Gavazzi C, 2007: Huntington's Disease (HD) Patients
// Subjects=9
-32	-20	56
20	-66	-44
-36	16	8
-20	-16	20
-2	62	4
-4	60	-4
-20	-50	38
48	-40	40
18	-26	54

// Gavazzi C, 2007: Normals
// Subjects=11
-28	-18	54
18	-80	-10
-36	4	2
-20	-16	20
-2	62	4
-4	60	-4
-20	-50	38
48	-40	40
18	-26	54

// Herwig U, 2007: Expectation Negative > Presentation Negative in Conjunction 
// with Main Negative Expectation
// Herwig U, 2007: Expectation Negative > Neutral in Conjunction with 
// Expectation Negative > Positive
// Herwig U, 2007: (Exp Negative > Neutral) + (Exp Negative > Positive) + (Exp 
// Negative > Pres Disgusting)
// Subjects=12
4.35	33.74	17.59
1.39	17.63	43.51
2.52	-29.04	31.79
-28.81	48.51	18.96
31.09	42.96	24.31
-38.4	11.48	8.79
-1.03	-8.45	-4.46
-38.91	-55.32	53.43
15.52	-66.6	40.37
6.49	35.95	18.49
4.55	16.07	36.91
-24.44	44.11	30.43
40.54	10.49	-10.99
-6.37	-8.48	-4.4
-18.2	2.83	-8.56
-13.85	-20.58	-8.87
18.19	-19.42	-10.45
5.43	36.03	19.61
-4.23	-9.52	-4.34

// Hofer A, 2007: Encoding, Faces > Scrambled Faces
// Hofer A, 2007: Correct Recognition, Learned Faces > Scrambled Faces
// Hofer A, 2007: Correct Rejection, Distractor Faces > Scrambled Faces
// Hofer A, 2007: Failed Recognition, Learned Faces > Scrambled Faces
// Hofer A, 2007: False Recognition, Distractor Faces > Scrambled Faces
// Hofer A, 2007: Correct Recognition, Learned Faces > Correct Rejection, 
// Distractor Faces
// Subjects=21
-7.39	33.7	19.1
-7.2	30.69	32.84
5.82	31.15	37.06
-3.07	-23.25	6.73
-11.74	-1.6	9.22
31.3	-59.66	-17.15
40.04	-85.15	-14.77
27.07	-85.2	-14.55
35.37	34.78	-17.59
48.2	25.07	-30.3
57.02	22.1	-16.71
-46.36	-63.35	-6.49
-46.05	-69.79	16.55
-41.31	-.97	63.45
-32.7	7.57	62.46
-50.1	6.68	53.88
-2.73	36.21	45.67
-3.04	42.64	22.62
22.65	-59.69	-17
-41.33	3.28	63.03
5.82	44.33	40.23
1.65	36.64	50.03
48.22	34	-26.7
39.71	30.54	-17.25
18.5	-58.46	-3.6
48.67	-67.69	-12.16
-38.1	21.35	-19.5
-3.13	-23.67	2.29
5.56	-80.19	-5.71
1.35	-79.37	3.24
-41.33	3.28	63.03
-2.82	44.3	40.38
-7.29	38.78	27.56
1.12	-19.81	-2.64
-25.08	-8.8	-21.22
-7.24	39.2	32
5.42	45.68	8.73
-3.24	49.9	8.46
-32.65	-48.98	54.6
-32.82	-50.23	41.28
-46.33	33.15	15.33
-37.58	34.01	24.07

// Marchand W R, 2007: Bipolar Patients
// Subjects=14
-32	-24	46
-6	-8	40
16	18	8
-10	12	-2

// Marchand W R, 2007: Normals
// Subjects=15
-32	-32	62
-54	-26	54
10	-56	-22
22	-8	6
18	-18	6
42	38	24
34	-26	56
56	-16	52
54	-44	46
-28	-88	0
32	-82	14
-8	-54	-22
-32	-24	46
-6	-8	40
16	18	8
-10	12	-2

// Prado J, 2007: Verification: 2-Mismatch > 1-Mismatch > 0-Mismatch
// Prado J, 2007: Falsification: 2-Mismatch > 1-Mismatch > 0-Mismatch
// Prado J, 2007: Affirmative Throughout: 1-Mismatch > 0-Mismatch
// Prado J, 2007: Verification, Hits Only: 2-Mismatch > 1-Mismatch > 
// 0-Mismatch
// Subjects=20
49.96	21.45	22.7
11.4	18.28	48.32
34.23	-57.13	44.19
-8.21	-96.76	12.97
17.51	-89.51	-2.75
-52.61	34.68	32.1
-33.84	-47.59	46.64
49.96	21.45	22.7
11.4	18.28	48.32
34.23	-57.13	44.19
-8.23	-96.97	10.75
23.99	-89.49	-2.86
49.95	24.64	22.38
11.36	17.97	44.99
-30.58	10.56	59.88
34.22	-53.94	43.87
-44.14	35.59	18.42
-40.41	15.22	52.87
-17.71	6.58	51.09
-36.91	-59.43	57.95
-40.32	-29.01	50.52
-30.63	-57.67	41.98
58.66	25.19	27.78
53.39	7.51	34.1
53.11	24.03	15.66
14.56	20.96	42.4
1.6	27.51	44.21
11.19	38.62	36.23
27.74	-53.96	43.98
34.3	-56.61	49.74
34.47	-47.71	64.54
-21.83	25.22	-13.43
46.64	20.82	16.09
8.09	24.34	44.41
42.85	56.08	-19.83
24.14	-97.17	6.86
-24.64	-73.39	-.27
-1.46	-77.23	37.82
-44.09	33.78	21.96
-49.2	14.05	40.81
-43.87	28.85	38.13
-40.16	-49.66	59.28
-33.77	-51.43	51.5
-1.3	-59.61	54
37.56	-49.9	52.38
50.41	-37.61	45.34

// Rothemund Y, 2007: Normal weight subjects
// Subjects=13
-4	14	12
28	-22	-4
-38	18	0
-34	-20	-10
-28	-38	40
-4	44	50
-2	10	68
-2	2	72
32	50	4
54	26	2
-40	-76	2
-50	-32	14
-36	44	12
-32	52	-4
-30	-76	30
38	-54	46
26	-22	-4
-26	-22	-2
18	30	2
54	-70	-4
50	46	10
44	52	16
-44	48	10
34	-18	-8
-30	-22	-2
4	12	12
38	16	0
36	4	-10
2	-40	42
32	-32	42
24	-38	46
30	32	-8
-24	-16	-8
32	54	-6

// Rothemund Y, 2007: Obese subjects
// Subjects=13
-4	14	12
28	-22	-4
-38	18	0
-34	-20	-10
-28	-38	40
-4	44	50
-2	10	68
-2	2	72
32	50	4
54	26	2
-40	-76	2
-50	-32	14
-36	44	12
-32	52	-4
-30	-76	30
38	-54	46
26	-22	-4
-26	-22	-2
18	30	2
-46	-66	-16
46	-64	-14
44	-74	-16
30	-88	-4
34	-20	-8
-26	-30	-8
-24	34	-12
52	-60	-20
40	-82	-16
-44	-80	-14
-38	-86	4
40	-52	-24
-54	-58	-22
64	-44	2
50	24	-10
54	32	0
22	54	34
-40	-70	-8
-8	-94	-4
34	-18	-8
-30	-22	-2
4	12	12
38	16	0
36	4	-10
2	-40	42
32	-32	42
24	-38	46
30	32	-8
-24	-16	-8
32	54	-6

// Suh S, 2007: Embedded Korean vs. Rest
// Suh S, 2007: Embedded English vs. Rest
// Suh S, 2007: Conjoined Korean vs. Rest
// Suh S, 2007: Conjoined English vs. Rest
// Suh S, 2007: Embedded Korean vs. Conjoined Korean
// Suh S, 2007: Embedded Korean vs. Embedded English
// Suh S, 2007: Embedded English vs. Embedded Korean
// Suh S, 2007: Conjoined Korean vs. Conjoined English
// Subjects=16
-38	-50	46
-48	10	36
-6	16	48
20	-90	-12
-24	-92	-14
34	-64	46
-38	15	-4
-44	24	16
-6	24	40
-34	-60	46
-24	-94	-15
36	-58	52
-16	-90	-12
-34	-62	45
-2	10	50
-50	8	30
24	-90	-10
-2	10	60
34	-62	46
12	-90	-10
-38	-52	46
-8	-70	46
-46	16	46
-26	-80	2
8	-85	14
50	-34	46
-60	0	30
-16	-76	6
-34	45	8
4	30	48
-40	24	44
-42	23	-10
62	-10	-20
30	-80	30
-18	-34	50
-18	-70	24
-38	7	10
-30	-68	-2
-32	20	-18

// Carreiras M, 2007: (Lexical Decision + Read) > False Fonts
// Carreiras M, 2007: Lexical Decision > False Fonts
// Carreiras M, 2007: Read > False Fonts
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Lexical Decision > Read
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Lexical Decision > False Fonts
// Carreiras M, 2007: [Lexical Decision-False Fonts] > [Read-False Fonts], 
// Read > False Fonts
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Lexical Decision > Read
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Lexical Decision > False Fonts
// Carreiras M, 2007: [Read-False Fonts] > [Lexical Decision-False Fonts], 
// Read > False Fonts
// Carreiras M, 2007: Lexical Decision > Read, (Words + Pseudowords + False 
// Fonts)
// Carreiras M, 2007: Lexical Decision > Read, Words
// Carreiras M, 2007: Lexical Decision > Read, Pseudowords
// Carreiras M, 2007: Read > Lexical Decision, (Words + Pseudowords + False 
// Fonts)
// Carreiras M, 2007: Read > Lexical Decision, Words
// Carreiras M, 2007: Read > Lexical Decision, Pseudowords
// Carreiras M, 2007: Pseudowords > Words, (Lexical Decision + Read + False 
// Fonts)
// Carreiras M, 2007: Pseudowords > Words, Lexical Decision
// Carreiras M, 2007: Pseudowords > Words, Read
// Carreiras M, 2007: Pseudowords > False Fonts, (Lexical Decision + Read + 
// False Fonts)
// Carreiras M, 2007: Pseudowords > False Fonts, Lexical Decision
// Carreiras M, 2007: Pseudowords > False Fonts, Read
// Carreiras M, 2007: Words > Pseudowords, (Lexical Decision + Read + False 
// Fonts)
// Carreiras M, 2007: Words > Pseudowords, Lexical Decision
// Carreiras M, 2007: Words > Pseudowords, Read
// Carreiras M, 2007: False Fonts > Pseudowords, (Lexical Decision + Read + 
// False Fonts)
// Carreiras M, 2007: False Fonts > Pseudowords, Lexical Decision
// Carreiras M, 2007: False Fonts > Pseudowords, Read
// Subjects=36
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-28	-92	-4
14	-78	16
-40	-66	-12
-42	-42	-20
-52	-40	12
-62	-34	4
-62	-14	6
-52	10	-14
-44	24	-6
-54	12	0
-36	24	0
34	18	4
-44	-34	46
-24	-62	36
-20	-68	44
-26	-52	48
-60	-18	28
-48	6	32
-54	0	42
-46	-6	54
-26	-8	56
-4	4	58
8	6	56
8	18	44
-2	-78	-26
6	-74	-20
25	-68	-24
-28	-62	-24
-24	-6	6
-26	2	-4
-20	6	4
26	10	4
-50	-22	54
34	18	4
-50	-22	54
34	18	4
34	18	4
-62	-14	6
-62	-34	4
56	-28	0
-62	-14	6
-62	-34	4
-62	-14	6
-62	-34	4
56	-28	0
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
60	-20	46
-52	-28	48
-64	-26	28
-54	-22	18
-34	-32	52
24	-50	-26
2	-48	-32
-4	-12	54
30	-98	-10
6	8	-12
14	12	-16
-6	6	-12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
-66	-30	2
-54	-18	0
-52	-12	2
54	-36	6
50	-26	2
52	-12	0
56	12	-14
-58	-4	20
-44	-14	36
-52	-8	46
56	-4	24
46	-12	36
-12	-60	-20
16	-70	-16
-8	-94	0
0	-84	12
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
0	10	56
6	18	44
-2	-4	60
50	22	22
-50	-4	50
-56	0	34
-46	8	28
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4
54	-70	20
-46	-74	38
-52	-68	16
-6	-46	32
-2	58	4

// Curtis V A, 2007: Overall Task Effect, Bipolar Patients > Normals
// Curtis V A, 2007: Overall Task Effect, Normals > Bipolar Patients
// Curtis V A, 2007: Phonetic Tasks > Repetition + Word Form Analysis
// Curtis V A, 2007: Semantic Tasks > Repetition + Word Form Analysis
// Subjects=12
20.42	-83.25	-24.09
-41.3	0.28	43.22
5.66	16.42	41.33
-41.48	10.54	24.52
-44.64	10.95	30.1

// Deeley Q, 2007: Normals
// Subjects=9
39.75	-82.19	-12.13
35.54	-84.88	-5.16
32.09	-71.98	-30.74
32.48	-63.55	23.19
32.57	-62.61	35.38
-32.51	-16.9	67.98
-41.18	-18.24	51.46
43.93	19	16.14
43.89	18.57	10.6
35.49	-85.39	-11.81
-44.7	-74.24	-11.83
39.81	-84.85	-5.22
-17.84	-93.4	-.49
32.19	-86.35	-23.96
-28.95	-53.87	98.92
-36.94	-22.96	45.12
8.85	8.61	36.37
27.99	-82.26	-11.99
27.92	-86.38	-23.91
-36.92	-15.04	51.15
-32.68	-18.7	44.71
-33	-71.42	-17.77
-33	-71.42	-17.77
47.11	-62.49	-19.44
20.53	-85.48	-11.63
39.57	-71.93	-30.83
-37.32	-71.96	-24.37
-29.35	-26.2	57.57
-41.23	-18.75	44.82
51.44	10.58	16.76
47.15	14.79	16.45
32.23	-82.67	-17.58
-33.02	-67.2	-18.13
27.8	-67.77	-31.04
-37.4	-63.93	-30.62
-36.91	-18.21	51.41
-48.78	0.24	43.31
32.28	-85.41	-11.77
35.34	-71.53	-25.24
-41.19	-15.07	51.2
-41.15	-14.64	56.74
-10.47	-94.55	-16.09
-10.47	-94.55	-16.09
-25.51	-86.7	-23.27
-41.58	-63.02	-18.38
-41.46	-94.74	-15.72
-41.63	-63.53	-25.03
32.26	-90.07	-16.96
-33	-71.42	-17.77
-25.39	-94.21	-10.37
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
35.32	-67.3	-25.59
-37.37	-60.33	-25.34
27.94	-78.46	-17.88
32.3	-89.64	-11.42
35.32	-67.3	-25.59
39.68	-74.16	-18.38
32.3	-89.64	-11.42
35.28	-66.67	-31.22
32.26	-90.07	-16.96
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
-37.3	-79.37	-23.75
-22.29	-78.76	-17.28
-10.47	-94.55	-16.09
-37.37	-72.39	-29.91
24.12	85.42	-31.58
-29.74	-86.21	-16.57
-13.65	-89.91	-10.87
-33.11	-56.08	-25.75
-25.46	-86.18	-16.62
-13.62	-98.37	-10.16
47.15	-62.06	-13.9
35.49	-85.39	-11.81
-17.97	-90.37	-16.36
-44.61	-98.56	-9.79
-41.63	-63.53	-25.03
-29.72	-90.44	-16.22
-25.39	-94.21	-10.37
-22.19	-94.2	-10.41
32.3	-89.64	-11.42
20.48	-85.91	-17.17
35.32	-67.3	-25.59
27.95	-82.69	-17.53
-22.19	-94.2	-10.41
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
32.26	-90.07	-16.96
-17.95	-94.6	-16
35.54	-84.88	-5.16
-17.86	-93.66	-3.81
13.06	-69.95	-2.81
-13.62	-98.37	-10.16
39.56	-55.64	-26.62
-41.61	-67.76	-24.67
-37.3	-79.37	-23.75
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
32.26	-90.07	-16.96
-36.91	-18.21	51.41
35.28	-66.67	-31.22
32.3	-89.64	-11.42
39.68	-74.16	-18.38
-36.97	-15.56	44.5
35.32	-67.3	-25.59
32.3	-89.64	-11.42
27.94	-78.46	-17.88
-41.17	-18.15	52.57
-13.62	-98.37	-10.16
-25.46	-86.18	-16.62
47.15	-62.06	-13.9
43.94	-70.96	-18.69
28.3	-74.69	30.87
-33.11	-56.08	-25.75
-29.74	-86.21	-16.57
16.27	-89.74	-11.23
24.76	-85.88	-17.22
31.46	-75.19	24.18
-32.58	-21.99	57.26
-37.37	-72.39	-29.91
-10.47	-94.55	-16.09
-32.93	-78.4	-11.61
-41.63	-63.53	-25.03
-17.97	-90.37	-16.36
-13.62	-98.37	-10.16
55.83	8.47	30.27
-48.71	-18.8	44.91
35.49	-85.39	-11.81
16.27	-89.74	-11.23
27.95	-82.69	-17.53
-6.2	-94.53	-16.14
-22.19	-94.2	-10.41
-22.19	-94.2	-10.41
-37.29	-67.22	-18.08
35.32	-67.3	-25.59
32.3	-89.64	-11.42
20.48	-85.91	-17.17
-25.39	-94.21	-10.37
-29.72	-90.44	-16.22
-13.62	-98.37	-10.16
-17.95	-94.6	-16
-17.86	-93.66	-3.81
-41.61	-67.76	-24.67
32.26	-90.07	-16.96
35.54	-84.88	-5.16
13.13	-69.26	6.05
39.56	-55.64	-26.62
-36.92	-15.04	51.15

// Deeley Q, 2007: Asperger Syndrome (AS) Subjects
// Subjects=9
35.47	-82.22	-12.08
-29.83	-61.89	-18.61
39.78	-77.45	-5.84
32.04	-72.49	-37.39
-33.14	-72.88	-36.61
32.5	-67.78	23.55
39.75	7.86	23.81
58.89	19.09	15.96
51.31	9.21	-.97
35.4	-61.07	-13.85
39.78	-81.85	-7.7
-48.8	4.47	42.96
-44.37	-10.43	56.42
55.71	10.61	16.71
43.82	22.29	3.6
-33	-71.42	-17.77
-33	-71.42	-17.77
47.11	-62.49	-19.44
20.53	-85.48	-11.63
39.57	-71.93	-30.83
-37.32	-71.96	-24.37
-29.35	-26.2	57.57
-41.23	-18.75	44.82
51.44	10.58	16.76
47.15	14.79	16.45
32.23	-82.67	-17.58
-33.02	-67.2	-18.13
27.8	-67.77	-31.04
-37.4	-63.93	-30.62
-36.91	-18.21	51.41
-48.78	0.24	43.31
32.28	-85.41	-11.77
35.34	-71.53	-25.24
-41.19	-15.07	51.2
-41.15	-14.64	56.74
-10.47	-94.55	-16.09
-10.47	-94.55	-16.09
-25.51	-86.7	-23.27
-41.58	-63.02	-18.38
-41.46	-94.74	-15.72
-41.63	-63.53	-25.03
32.26	-90.07	-16.96
-33	-71.42	-17.77
-25.39	-94.21	-10.37
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
35.32	-67.3	-25.59
-37.37	-60.33	-25.34
27.94	-78.46	-17.88
32.3	-89.64	-11.42
35.32	-67.3	-25.59
39.68	-74.16	-18.38
32.3	-89.64	-11.42
35.28	-66.67	-31.22
32.26	-90.07	-16.96
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
-37.3	-79.37	-23.75
-22.29	-78.76	-17.28
-10.47	-94.55	-16.09
-37.37	-72.39	-29.91
24.12	85.42	-31.58
-29.74	-86.21	-16.57
-13.65	-89.91	-10.87
-33.11	-56.08	-25.75
-25.46	-86.18	-16.62
-13.62	-98.37	-10.16
47.15	-62.06	-13.9
35.49	-85.39	-11.81
-17.97	-90.37	-16.36
-44.61	-98.56	-9.79
-41.63	-63.53	-25.03
-29.72	-90.44	-16.22
-25.39	-94.21	-10.37
-22.19	-94.2	-10.41
32.3	-89.64	-11.42
20.48	-85.91	-17.17
35.32	-67.3	-25.59
27.95	-82.69	-17.53
-22.19	-94.2	-10.41
16.27	-89.74	-11.23
-6.2	-94.53	-16.14
32.26	-90.07	-16.96
-17.95	-94.6	-16
35.54	-84.88	-5.16
-17.86	-93.66	-3.81
13.06	-69.95	-2.81
-13.62	-98.37	-10.16
39.56	-55.64	-26.62
-41.61	-67.76	-24.67
-37.3	-79.37	-23.75
-32.96	-83.06	-16.8
39.53	-60.3	-31.81
32.26	-90.07	-16.96
-36.91	-18.21	51.41
35.28	-66.67	-31.22
32.3	-89.64	-11.42
39.68	-74.16	-18.38
-36.97	-15.56	44.5
35.32	-67.3	-25.59
32.3	-89.64	-11.42
27.94	-78.46	-17.88
-41.17	-18.15	52.57
-13.62	-98.37	-10.16
-25.46	-86.18	-16.62
47.15	-62.06	-13.9
43.94	-70.96	-18.69
28.3	-74.69	30.87
-33.11	-56.08	-25.75
-29.74	-86.21	-16.57
16.27	-89.74	-11.23
24.76	-85.88	-17.22
31.46	-75.19	24.18
-32.58	-21.99	57.26
-37.37	-72.39	-29.91
-10.47	-94.55	-16.09
-32.93	-78.4	-11.61
-41.63	-63.53	-25.03
-17.97	-90.37	-16.36
-13.62	-98.37	-10.16
55.83	8.47	30.27
-48.71	-18.8	44.91
35.49	-85.39	-11.81
16.27	-89.74	-11.23
27.95	-82.69	-17.53
-6.2	-94.53	-16.14
-22.19	-94.2	-10.41
-22.19	-94.2	-10.41
-37.29	-67.22	-18.08
35.32	-67.3	-25.59
32.3	-89.64	-11.42
20.48	-85.91	-17.17
-25.39	-94.21	-10.37
-29.72	-90.44	-16.22
-13.62	-98.37	-10.16
-17.95	-94.6	-16
-17.86	-93.66	-3.81
-41.61	-67.76	-24.67
32.26	-90.07	-16.96
35.54	-84.88	-5.16
13.13	-69.26	6.05
39.56	-55.64	-26.62
-36.92	-15.04	51.15

// Ferstl E C, 2007: Emotion > Time/Space
// Ferstl E C, 2007: Time/Space > Emotion
// Ferstl E C, 2007: Space > Emotion/Time
// Ferstl E C, 2007: Time > Emotion/Space
// Ferstl E C, 2007: Emotion/Space > Time
// Subjects=20
-55.57	4	-3.76
-38.95	-78.73	39.78
47.6	-68.43	41.27
15.39	-56.96	27.3
-48.91	13.21	32.19
47.19	26.22	26.65
-52.19	-50.16	-2.61
-55.48	-41.18	-10.01
-29.84	-37.86	-10.59
-35.74	-78.71	39.75
-13.51	-57.65	21
15.41	-60.14	27.56
-58.55	-56.29	1.33
-33.05	-37.87	-10.55
27.9	-40.42	-7.69
-42.9	38.72	-10.17
27.93	-43.34	-4.1

// Geuze E, 2007: Normals
// Subjects=12
12.76	38.93	1.44
9.9	24.91	40.57
-1.86	24.75	39.6
-10.74	37.73	1.81
-5.01	-46.05	18.81
-1.72	-46.24	29.94
-1.68	-45.81	35.48
4.61	-47.05	18.78
42.19	-52.69	38.9
-43.28	-46.43	44.93
49.56	-10.89	42
51.73	-11.68	45.39
50.41	17.61	25.1
-29.79	32.99	24.73
44.75	47.16	-5.19
53.4	17.6	-2.81
57.76	0.88	0.77
-49.9	-58.47	13.68
-41.72	16.86	-3.89
36.36	20.21	4.97
-29.94	18.24	-.79
25.6	-8.09	-15.95
-30.02	-12.28	-23.88
9.9	26.05	41.59
-.79	25.9	40.61
-3.92	-52.39	19.33
-4.93	-43	30.82
0.48	-52.23	34.88
8.9	-50.2	19
40.05	-51.65	38.84
-45.46	-45.73	40.44
51.7	-9.82	41.89
42.16	-16.77	49.27
46.18	19.15	31.71
31.89	49.99	-8.63
-30.86	31.92	24.84
45.81	47.16	-5.2
53.41	15.49	-2.63
57.77	-1.24	0.95
-51.23	-.75	3.27
-48.83	-56.26	14.59
-41.72	16.86	-3.89
41.63	17.36	-4.89
3.27	-14.77	-3.98
-17.07	5.63	0.12

// Geuze E, 2007: PTSD Patients
// Subjects=12
14.9	38.95	1.42
5.6	30.17	40.18
-5.07	30.19	41.41
-10.74	39.94	2.74
0.41	-53.97	26.1
0.41	-43.05	29.65
3.66	-46.92	34.4
-1.69	-45.89	34.37
5.73	-41.08	27.19
45.41	-54.7	40.15
-43.28	-48.63	44
52.8	-12.73	45.46
42.77	40.05	13.27
-36.18	27.66	25.25
46.88	49.37	-4.29
37.32	28.96	-5.81
56.69	-1.33	-.15
-53.36	-5.07	2.55
-49.86	-67.99	14.47
-30.99	23.95	4.32
40.57	18.49	-3.85
-29.95	18.16	-1.9
27.75	-11.25	-15.71
-25.75	-13.31	-23.84
20.35	3.91	2.06
7.77	23.84	40.68
-5.04	19.53	41.19
-.71	-51.23	20.31
-3.86	-42.99	30.81
5.8	-46.91	34.37
-8.1	-45.93	34.45
2.49	-50.15	20.18
42.19	-52.69	38.9
-41.16	-54.25	39.99
42.16	-18.88	49.45
51.48	17.61	25.09
-29.8	35.1	24.56
44.73	46.98	-7.41
53.42	16.63	-1.61
57.78	-1.15	2.06
-51.23	1.45	4.21
-41.71	14.74	-3.71
35.22	18.38	-4.9
-5.27	-14.73	-2.77
7.56	-14.57	-1.82
-28.88	17.11	-1.83
27.71	-10.53	-20.23
-27.88	-17.64	-24.57
-17.06	5.72	1.22
33.15	-7.27	-6.07

// Harrington G S, 2007: Write > Rest
// Harrington G S, 2007: Draw > Rest
// Harrington G S, 2007: Draw > Write
// Subjects=11
-53.23	8.36	24.84
-38.4	38.94	19.87
-20.86	-1.4	60.97
-43.44	-1.93	42.32
-52.15	-66.28	-4.6
-59.51	-20.06	29.52
-21.77	-62.45	56.06
-3.83	3.48	53.68
55.71	11.67	16.62
27.16	3.66	53.3
53.82	5.42	46.16
19.95	-52.97	64.83
36.8	-32.29	41.71
-52.12	6.59	29.43
-46.94	33.43	18.2
-28.02	40.23	-19.39
-24.18	1.78	47.36
-56.36	1.36	31.04
-50.04	-62.13	-6.09
-37.99	-37.05	41.85
-13.2	-58.88	60.13
-31	21.67	2.28
-19.16	6.13	6.79
-2.75	2.42	53.75
55.75	12.1	22.16
52.34	45.14	9.39
28.18	2.01	45.62
52.71	9.39	42.49
52.73	6.3	43.87
59.99	-57.41	-9.98
15.67	-60.74	61.07
36.75	-25.14	37.77
51.41	10.24	12.33
36.37	2.78	-.26
18.21	11.56	4.79
-44.9	37.96	7.76
-24.17	11.73	52.1
-50.01	-62.93	-2.68
-44.43	-29.69	41.31
-10	-54.55	60.84
-33.75	-89.04	16.05
-40.57	15.52	6.25
48.22	14.79	16.44
49.13	46.18	9.34
28.2	3.33	48.86
34.31	51.86	29.11
52.49	-59.91	-14.14
13.55	-58.38	64.24
42.14	-26.8	43.42
36.8	-78.5	22.17
14.03	-16.05	6.04

// Kensinger E A, 2007: Overall Recognition, Neutral + Negative
// Kensinger E A, 2007: Overall Recognition, Negative
// Kensinger E A, 2007: Overall Recognition, Neutral
// Kensinger E A, 2007: Successful Recognition, Negative
// Kensinger E A, 2007: False Recognition, Negative
// Kensinger E A, 2007: Successful Recognition + False Recognition, Neutral
// Kensinger E A, 2007: Successful Recognition, Neutral
// Kensinger E A, 2007: False Recognition, Neutral
// Kensinger E A, 2007: Visually Specific Recognition, Negative + Neutral
// Kensinger E A, 2007: Visually Specific Recognition, Negative
// Kensinger E A, 2007: Visually Specific Recognition, Neutral
// Subjects=19
-48.4	37.16	23.94
-44.14	26.88	17.04
-40.21	63.31	-6.8
-24.28	12.53	46.13
42.23	35.48	12.47
55.21	44.35	14.74
-7.06	27.37	43.25
-2.91	42.51	32.72
-44.44	23.53	-7.28
37.61	32.12	-11.77
-32.66	-51.22	53.7
40.93	-59.91	60.03
-6.61	-68.79	59.48
-4.53	-55.16	55.86
14.9	-57.43	53.51
-43.51	-36.26	53.53
-34.95	-40.15	45.93
38.61	-59.99	47.76
42.93	-49.03	49.96
42.87	-30.84	49.28
-53.86	-58.5	-.12
-48.49	-67.51	-4.92
-18.25	8.06	9.49
-53.64	25.21	34.17
-46.37	41.66	14.49
53.31	21.13	30.52
50.72	39.79	0.7
50.99	19.98	18.34
-34.83	-60.04	51.25
32.24	-56.95	57.65
1.79	-60.74	41.73
-24.03	-46.93	53.13
38.5	-60.82	38.88
42.89	-55.93	45.04
-44.36	-40.47	-14.39
33.79	-57.16	9.46
62.89	-57.57	3.4
-46.3	-53.06	0.33
1.36	0.55	19.99
18.92	-54.17	30.71
-37.89	25.13	-1.95
-18.6	-5.49	-20.54
-11.41	39.16	43.28
48.84	47.39	24.63
-52.16	47.44	-15.12
-46.31	22.41	15.28
-44.72	48.77	-24.34
-35.13	23.02	44.16
-28.72	13.81	37.12
48.68	54.96	13.8
-17.76	10.63	48.45
-44.04	4.65	20.36
-33.67	32.08	-8.31
35.66	36.96	5.72
-59.75	-26.74	52.87
-58.18	-58.52	-0.05
-54	-58.48	-11.33
60.65	-52.68	-1.53
-62.6	-45.02	-4.67
-60.44	-47.24	-5.61
-51.77	-66.67	-7.19
-39.85	-67.48	-5.07
14.26	-86.33	-3.01
1.5	-19.14	27.54
-11.41	27.15	41.11
-7.65	16.42	-4.96
-5.31	6.83	7.15
-50.61	35.67	19.64
-46.46	49.75	9.21
50.9	40.08	15.23
53.31	21.13	30.52
-4.86	25.46	45.64
-2.92	35.92	31.13
-56.31	27.95	-5.27
-46.16	13.67	25.1
37.65	28.07	-9.13
51.03	13.7	20.08
50.72	39.79	0.7
-34.78	-55.27	56.38
36.57	-59.06	57.78
36.36	-60.62	41.13
1.79	-60.74	41.73
-30.51	-46.95	53.25
-41.46	-29.43	46.1
40.59	-27.43	40.02
-42.21	-38.33	-14.64
-18.57	-26.11	-22.98
33.79	-57.16	9.46
62.89	-57.57	3.4
-51.68	-62.75	0.26
-48.52	-60.07	-5.66
31.77	-81.31	15.25
7.84	0.57	19.88
-7.09	-25.34	30.54
18.92	-54.17	30.71
-33.55	23.13	-.7
-18.62	-5.69	-22.76
5.09	33.41	-19.18
-17.92	22.56	38.31
-28.83	27.22	31.31
-64.18	-21	45.65
67.73	-21.94	51.34
67.74	-33.95	49.17
-44.25	-66.95	-10.65
-26.5	-56.88	27.27
53.07	-59.4	-4.1
-31.16	-82.45	-4.86
-39.71	-77.39	3.75
-15.92	-1.64	20.5
-13.83	15.39	18.78
14.1	21.89	6.45
23	-5.65	21.35
18.62	-23.62	13.12
33.88	-68.54	13.95
48.84	47.39	24.63
-52.16	47.44	-15.12
-48.4	37.16	23.94
-44.14	26.88	17.04
-24.28	12.53	46.13
55.21	44.35	14.74
-7.06	27.37	43.25
35.66	36.96	5.72
-32.66	-51.22	53.7
40.93	-59.91	60.03
-34.95	-40.15	45.93
-62.6	-45.02	-4.67
-56.02	-58.51	-0.08
60.65	-52.68	-1.53
14.26	-86.33	-3.01
-5.31	6.83	7.15
-20.2	35.86	31.43
2.88	36.28	-22.79
7.15	57.77	-22.75
7.51	63.77	6.91
33.96	-72.28	19.92
58.9	-32.14	34.57
38.18	-60.98	14.24
54.6	0.45	-41.42
32.02	-84.87	34.64
-43.94	-75.62	11.49
-31.08	-86.18	1.11
2.92	47.54	-17.18
-28.83	-72.37	10.91
14.42	-32.58	20.8
-39.73	-66.55	4.92
11.59	40.12	-16.6
-29.5	30.95	-20.59
-34.71	-68.99	58.86
44.82	-30.27	32.38
-64.75	-16.54	1.52
-41.68	-48.63	24.47
65.01	-21.74	7.66
73.66	-32.66	5.23
-22.79	-27.53	-14.92
-1.4	35.51	-19.28
20.87	-30.64	18.26
-16.48	-1.43	-23.21
-30.87	-80.26	18.45

// Lissek S, 2007: Simple + Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Simple + Complex 1 + Complex 2 > Rest, Non-Dominant Hand
// Lissek S, 2007: Simple > Rest, Dominant Hand
// Lissek S, 2007: Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Complex 1 + Complex 2 > Rest, Non-Dominant Hand
// Lissek S, 2007: Women > Men, Simple + Complex 1 + Complex 2 > Rest, 
// Dominant Hand
// Lissek S, 2007: Women > Men, Simple + Complex 1 + Complex 2 > Rest, 
// Non-Dominant Hand
// Lissek S, 2007: Men > Women, Simple + Complex 1 + Complex 2 > Rest, 
// Non-Dominant Hand
// Lissek S, 2007: Women > Men, Simple > Rest, Dominant Hand
// Lissek S, 2007: Men > Women, Simple > Rest, Dominant Hand
// Lissek S, 2007: Women > Men, Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Men > Women, Simple > Rest, Non-Dominant Hand
// Lissek S, 2007: Women > Men, Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Men > Women, Complex 1 + Complex 2 > Rest, Dominant Hand
// Lissek S, 2007: Women > Men, Complex 1 + Complex 2 > Rest, Non-Dominant 
// Hand
// Lissek S, 2007: Men > Women, Complex 1 + Complex 2 > Rest, Non-Dominant 
// Hand
// Lissek S, 2007: Men > Women, Complex 2 > Complex 1, Dominant Hand
// Lissek S, 2007: Women > Men, Complex 2 > Complex 1, Non-Dominant Hand
// Lissek S, 2007: Men > Women, Complex 2 > Complex 1, Non-Dominant Hand
// Subjects=16
-34	-28	56
56	-16	24
-34	-10	60
60	-18	44
0	-2	64
8	0	64
-24	14	62
52	4	50
54	6	44
58	8	38
-32	42	28
-56	4	36
60	10	20
-56	8	20
60	14	12
34	20	-2
0	4	54
32	42	30
-56	-22	48
62	-30	42
-54	-24	42
50	-24	38
-50	-24	18
54	-32	54
66	-20	20
-44	-38	60
42	-36	48
-46	2	2
42	10	-2
60	12	0
-52	6	2
50	8	4
62	-34	20
56	16	-8
-8	8	40
10	10	40
14	-104	6
-18	-16	20
-16	-20	8
14	-4	6
16	-8	6
16	-16	20
-18	-6	-2
16	-4	-6
-26	-2	8
22	8	4
-30	18	4
30	2	12
40	-22	62
-38	-10	60
32	6	66
58	12	4
0	-2	58
36	44	32
-60	8	24
60	10	24
62	10	16
-64	-20	28
54	-20	54
-56	-24	40
40	-22	50
-58	-22	20
62	-26	18
54	-18	18
-40	-40	50
-34	-40	46
-42	4	0
50	-22	22
-52	4	4
-52	-34	14
2	-54	0
-10	12	34
6	12	40
16	-18	6
24	-8	2
20	-6	-2
26	-2	6
-32	-28	56
-24	-22	74
-44	2	10
62	14	12
0	-2	64
-52	-22	52
-56	-22	50
-58	-18	26
-58	-22	18
-48	-24	18
-52	6	2
-4	-6	40
6	-94	-8
-16	-18	2
-28	0	-8
40	-18	60
34	-16	62
0	-2	62
6	0	68
44	-26	62
52	-18	14
-42	2	0
46	-22	18
-58	-22	20
-16	-104	8
18	-104	8
-26	-94	6
18	-18	4
28	-4	-2
-38	-26	58
60	-16	34
-34	-10	58
60	-18	42
52	8	10
0	0	62
10	0	64
-30	-12	68
32	-6	66
-58	6	34
60	10	22
-56	8	18
56	12	12
0	4	54
-58	-20	30
62	-30	42
-40	-28	54
58	-16	24
-38	-46	64
-58	-22	20
40	-40	58
64	-18	20
-44	-38	60
40	32	44
-42	10	-2
50	10	4
-50	-22	18
-52	6	4
62	-34	20
56	16	-8
14	-4	6
-14	-12	0
16	-16	20
-18	-6	-2
18	-2	-2
-26	-2	10
22	6	4
40	-22	62
-56	0	38
30	-14	60
-2	-2	64
8	0	64
-34	-8	62
32	-6	64
-58	6	34
-60	8	22
60	10	24
62	10	16
-64	-20	28
-62	-22	32
42	-36	66
-56	-24	38
40	-34	58
-58	-22	20
-34	-44	54
-24	-54	66
30	-50	64
-46	-38	24
50	-22	22
-52	36	14
2	-54	0
16	-16	8
14	-12	20
18	-4	-2
26	2	6
-34	-34	62
60	-2	10
-42	-26	46
-22	-38	70
-32	-46	64
-62	-48	24
48	-26	16
56	-34	18
-60	-12	12
-4	-46	8
8	-46	16
16	-30	40
-10	-100	6
-24	-98	18
52	0	26
26	-8	-12
-8	-26	0
14	-28	-2
38	-18	38
-44	-12	38
60	-6	34
52	0	10
46	-22	62
20	-38	58
48	-24	14
-44	-26	18
-60	-14	12
-60	-6	8
14	-20	46
-32	-54	28
-12	-30	18
12	-32	22
-18	-40	12
-50	-26	16
-38	-44	52
68	-38	24
-22	-46	54
56	-22	14
14	-28	42
18	-20	30
8	-4	28
60	-6	32
-60	-8	14
-26	-40	58
22	-40	58
-48	-28	18
50	-24	14
-16	2	38
-12	28	48
-20	-2	8
24	2	4
-44	-76	12
-40	-16	56
60	-2	10
62	10	16
-40	-28	46
-34	-34	62
60	-20	36
-36	-46	62
-40	-40	58
-48	-26	16
-62	-46	12
-40	-54	8
48	-70	8
-6	-92	32
20	-88	34
-6	-62	6
-40	-84	4
-42	-72	0
-32	44	38
52	0	26
-8	16	16
16	-14	20
42	-60	28
-22	-44	16
14	-22	30
38	-18	38
62	-10	36
46	-22	62
34	-40	60
-26	-60	18
16	-26	38
22	54	12
-4	-26	-2
4	-26	0
-60	-22	24
-54	2	-6
-32	-54	20
36	-58	20
-14	40	10
-6	-6	24
-32	34	28
-42	46	-14
-16	50	8
-10	-34	16
14	-32	20
-18	-38	12
-14	26	8
-8	2	26
16	-12	32
26	20	-4
18	-78	6
-66	-26	12
-48	-24	-4
52	-28	6
-16	-14	38
0	-18	-2
-34	-8	30
-24	-58	38
36	-70	46
-46	-38	44
22	-46	54
-22	-66	40
30	-74	36
34	-72	28
-22	44	4
-42	46	-6
52	30	20
-2	-4	-6
-12	-36	14

// Liu Y, 2007: English Words > Fixation
// Liu Y, 2007: English Pseudowords > Fixation
// Liu Y, 2007: Learned Chinese Characters > Fixation
// Liu Y, 2007: Novel Chinese Characters > Fixation
// Liu Y, 2007: Learned Chinese Characters > English Words
// Liu Y, 2007: English Words > Learned Chinese Characters
// Subjects=23
-54.1	1.6	47.72
11.81	56.67	24.5
-48.89	9.07	33.65
-52.29	29	16.41
56.57	27.05	-4.76
-62.87	-33.77	3.95
63.18	-26.84	-.31
-39.81	15.62	-33.92
36.09	3.21	-35.98
-58.39	-43.66	27.03
-32.83	-90.57	-3.9
33.43	-92.29	-4.52
-40.56	-46.98	-17.51
39.57	-41.21	-18.91
-51.02	6.85	32.75
59.14	4.14	42.86
-6.01	9.55	49.85
4.65	14.9	49.27
-46.94	29.03	16.34
54.67	25.12	25.54
-43.86	38.77	4.34
-61.78	-32.36	8.28
-36.85	-50.54	46.32
35.83	-52.21	45.62
-31.77	-90.65	-5.02
34.91	87.65	-17.4
-46.91	-54.16	-13.48
46.12	-64.98	-10.3
-51.95	-.5	47.87
44.25	0.42	51.15
-2.83	12.66	48.43
3.58	14.81	48.18
-51.06	16.37	31.95
48.31	19.08	30.58
-38.44	15.45	5.12
34.23	19.23	6.19
-33.57	-60.75	51.6
31.64	-60.1	54.14
-35.79	-52.81	44.27
33.7	-54.34	45.83
-31.73	-92.42	-.41
32.36	-91.15	-3.49
-47.93	-67.91	-12.32
46.09	-66.38	-14.64
-51.98	6.9	47.25
54.86	7.29	42.64
-6.03	10.52	48.65
2.51	14.8	48.19
-56.47	25.51	26.78
50.37	25.9	22.18
-32.07	23.77	2.11
33.11	23.02	0.31
-45.91	28.69	11.9
47.03	32.25	8.3
-30.35	-62.76	52.84
28.4	-61.6	48.73
-33.65	-52.8	44.24
39.03	-53.34	44.57
-31.77	-90.65	-5.02
33.45	-93.18	-2.21
-47.9	-70.91	-9.84
47.18	-61.8	-10.58
-54.2	4.98	36.28
-32.59	-3.41	63.5
44.08	1.88	28.72
-.7	13.64	47.21
3.56	14.64	45.96
-44.76	26.21	21.01
-35.29	51.13	12.12
42.9	32.62	27.27
48.22	24.74	21.18
-29.93	23.87	3.2
32.08	21.24	4.93
-21.71	-63.96	64
29.52	-57.74	57.31
-43.52	-80.78	-.14
-32.78	-91.12	2.83
43.15	-82.32	13.49
-50.08	-59.3	-10.79
50.38	-63.98	-11.55
-16.73	30.01	53.83
-13.7	53.49	40.67
9.67	58.77	24.35
7.74	45.5	45.56
-51.46	36.38	-12.1
45.81	26.22	-14.6
-58.34	-59.61	27.25
-64.95	-47.44	6.23
56	-62.27	23.93
57.97	-45.3	9.1
-48.35	12.31	-34.65
36.04	23.56	-34.34
-8.01	-91.2	27.09
5.88	-92.17	27.01

// Moriguchi Y, 2007: Alexithymia Patients
// Subjects=16
0	6	28
-8	24	40
6	24	16
6	8	52
6	16	48
0	-74	-38
12	-74	-44
-52	18	-6
-58	20	24
-46	34	12
-56	8	32
-56	8	20
-46	52	-12
-32	60	10
56	22	-6
54	28	6
56	8	32
34	40	24
38	28	20
-30	26	0
-38	-6	8
36	20	2
18	-18	-6
-30	-38	48
-42	-44	66
-60	-28	42
-68	-24	30
38	-34	42
34	-52	70
52	-28	44
-68	-26	30
-52	-26	20
62	-20	38
-14	-18	10
8	-26	-4
0	0	40
-8	24	40
2	18	48
-30	-36	-40
-48	44	-12
-56	8	22
-46	34	12
-56	8	32
-34	60	8
54	8	20
56	10	32
42	28	20
-42	-2	4
-32	16	10
-2	-36	-4
-14	-22	-8
-38	-28	58
-42	-46	62
-62	-24	36
-60	-28	42
38	-34	42
38	-48	60
52	-28	44
-54	-32	46
-62	-20	22
62	-20	38
-14	-18	10
4	-32	-4
-20	56	34
-12	60	32
-12	52	44
-14	-64	-32
-18	-50	-24
-10	-54	-28
-4	-70	-20
6	-76	-28
22	-70	-28
-32	-34	-40
-22	-32	-36
-2	-38	-42
-12	2	52
-14	4	56
32	2	-32
-20	12	46
-32	10	58
38	14	2
38	-30	18
48	-24	16
54	26	6
6	26	14
20	42	34
62	-6	-6
60	2	-8
62	-26	-2
-8	38	4

// Moriguchi Y, 2007: Normals
// Subjects=14
-10	2	52
-8	14	48
8	-2	36
12	16	42
-32	-34	-38
26	-64	-28
-54	10	32
-50	44	0
-56	14	2
-46	36	14
-42	36	40
-42	50	16
-44	54	-14
-20	56	34
-34	56	20
56	10	32
56	10	26
50	50	-16
54	32	30
52	48	-8
24	72	4
-30	16	8
-40	-10	0
44	24	12
0	-32	0
-10	-20	-16
6	-18	-22
-2	-38	-42
-40	-50	58
-34	-36	48
-60	-28	42
36	-46	58
52	-28	44
-62	-20	22
68	-36	36
62	-20	36
-14	-14	10
16	-6	12
0	0	40
-8	24	40
2	18	48
-30	-36	-40
-48	44	-12
-56	8	22
-46	34	12
-56	8	32
-34	60	8
54	8	20
56	10	32
42	28	20
-42	-2	4
-32	16	10
-2	-36	-4
-14	-22	-8
-38	-28	58
-42	-46	62
-62	-24	36
-60	-28	42
38	-34	42
38	-48	60
52	-28	44
-54	-32	46
-62	-20	22
62	-20	38
-14	-18	10
4	-32	-4
-20	56	34
-12	60	32
-12	52	44
-14	-64	-32
-18	-50	-24
-10	-54	-28
-4	-70	-20
6	-76	-28
22	-70	-28
-32	-34	-40
-22	-32	-36
-2	-38	-42
-12	2	52
-14	4	56
32	2	-32
-20	12	46
-32	10	58
38	14	2
38	-30	18
48	-24	16
54	26	6
6	26	14
20	42	34
62	-6	-6
60	2	-8
62	-26	-2
-8	38	4

// Scheres A, 2007: Normals
// Subjects=11
11.75	10.92	-2.89
-11.74	6.64	-1.14
33.71	-82.78	35.94
33.13	24.34	3.55
-35.23	21.01	7.96
12.81	10.93	-2.9
-13.87	9.97	0.83
12.88	9.41	5.03
-9.62	3.22	-4.23
-21.36	3.23	-2.98
-42.18	-40.62	51.12
-.2	-36.19	-46.75
7.89	-74.78	17.73
-28.39	-76.69	23.88
33.48	-84.03	5.94
-21.05	-90.25	-.72
33.71	-81.63	36.96
-23.99	-86.38	35.79
-30.04	-47.57	-39.88
-12.97	-47.72	-43.41
-8.46	-82.62	-27.15
1.28	-58.3	-2.54

// Scheres A, 2007: ADHD Patients
// Subjects=11
-23.99	-28.11	59.9
26.21	7.05	69.76
-45.46	-6.2	56.08
-46.48	-18.9	57.16
-12.71	-12.15	3.79
0.17	-12.53	11.48
10.71	-15.06	-8.5
-16.49	-18.04	65.66
17.72	-23.12	65.69
0.1	-29.76	-4.92
-24	-28.2	58.79
21.71	-44.75	19.51
10.34	-46.34	68.84
-7.84	-49.88	66
7.64	-57.64	-8.24
1.17	-64.88	-18.71

// Thompson C K, 2007: Pseudowords vs. Words
// Thompson C K, 2007: Verbs vs. Fixation
// Thompson C K, 2007: Nouns vs. Fixation
// Subjects=17
-47.35	13.9	16.14
65.17	12.24	26.71
-41.21	35.45	-6.27
-47.17	6.53	29.19
49.77	2.46	3.29
-55.71	-15.73	32.66
59.09	-15.38	53.08
47.21	-15.42	53.28
53.79	-20.09	60.36
-37.18	-33.02	41.9
-46.94	-26.78	40.32
-56.38	5.54	-15.38
-50.58	-41.81	6.02
-59.15	-50.04	10.34
-52.57	-71.18	13.44
-8.17	20.57	39.46
4.78	23.81	38.92
11.16	28.53	31.62
14.21	26.02	16.13
-40.89	-67.17	-1.73
-50.71	-72.29	-10.02
52.98	-65.55	-12.45
-11.84	-59.19	-9.73
-18.37	-62.92	-14.86
-34.73	-45.52	-23.02
-59.07	11.81	28.87
-62.12	-11.94	39.11
-31.38	21.01	-.53
-44.22	0	5.13
62.07	7.85	37.28
68.35	8.54	21.42
-55.61	-1.83	43.61
-4.81	11.63	47.01
8.14	14.87	46.47
43.88	3.61	50.34
58.5	-25.27	4.76
71.56	-21.2	13.1
-40.72	-62.63	12.39
-46.8	-29.03	50.63
44.02	-36.91	53.22
61.87	-17.73	16.28
-30.43	-49.63	59.11
17.67	-100.38	7.29
-24.49	-94.15	7.39
-27.56	-79.73	23.94
-31.23	-77.44	-8.72
-41	-75.66	-12.09
36.9	-86.56	-6.73
49.76	-78.53	-13.35
7.64	12.2	6.4
7.49	17.64	-4.22
-2.16	-24.49	-6.61
14.2	-15.64	6.81
36.64	23.06	-5.25
46.61	29.32	15.25
36.47	25.11	-17.78
50.34	-9.65	45.94
-31.36	17.82	-.21
-44.19	-3.09	6.56
-50.76	4.98	1.39
-52.41	-2.13	40.22
-59.1	8.3	25.85
40.23	24.61	22.55
47.2	-5.64	54.56
-4.81	11.63	47.01
40.23	24.61	22.55
58.66	-32.84	15.59
-43.63	-32.84	44.23
-40.21	-36.9	58.02
-33.7	-43.26	58.54
34.26	-63.51	44.82
-27.42	-67.75	37.32
-30.39	-49.31	62.44
-8.3	11.98	27.99
-40.92	-83.86	-7.92
30.56	-94.26	3.1
-21.24	-97.33	7.65
20.95	-100.06	10.56
-37.94	-51.81	-21.23
33.37	-44.97	-20.88
-18.48	0.87	-9.96
-28.21	4.03	-10.11
-5.47	-25.03	-12.1
14.1	-13.07	-.17

// Tunik E, 2007: Velocity-Dependent Perturbation - Null > Position-Dependent 
// Perturbation - Null
// Subjects=15
27	-3	-9
21	18	-3
21	12	-12
-33	-9	-3
-21	3	-3
-21	6	12
24	27	6
-3	-60	24
-3	-12	66
-18	15	-18
3	60	3
-9	57	-3
6	-48	15

// Abler B, 2007: Expectation, High > No Reward, Placebo
// Abler B, 2007: Expectation, High > Low Reward, Placebo
// Abler B, 2007: Outcome, Win > Omission, Placebo
// Abler B, 2007: Expectation, High > No Reward, Olanzapine
// Abler B, 2007: Expectation, High > Low Reward, Olanzapine
// Abler B, 2007: Outcome, Win > Omission, Olanzapine
// Abler B, 2007: Expectation, High > No Reward, Placebo > Olanzapine
// Abler B, 2007: Expectation, High > Low Reward, Placebo > Olanzapine
// Abler B, 2007: Outcome, Win > Omission, Placebo > Olanzapine
// Abler B, 2007: Breath-Holding vs. Normal Breathing, Placebo > Olanzapine
// Subjects=8
12	-24	-15
-12	-24	-21
-6	15	-3
9	15	0
-30	24	-9
-6	12	33
-48	-21	33
21	-45	-21
9	-15	-15
-15	-24	0
-27	27	-6
48	9	3
-33	3	3
-54	9	15
-12	6	42
15	45	15
51	-36	6
-6	-81	9
-21	-84	-9
9	3	-15
18	-15	6
-21	6	0
-21	-27	-9
0	18	33
-6	39	12
-24	36	42
57	-12	-9
9	-75	9
-21	-39	-27
9	12	-6
6	12	42
57	-24	24
18	-57	-27
-12	-3	-6
33	18	-12
-3	-39	30
-9	6	-9
15	-66	-3
15	-72	-27
-3	0	0
-30	27	0
3	15	36
21	-60	0
21	-72	15
-36	24	-15
-51	15	30
54	15	24
36	-12	9

// Cross E S, 2007: Activity during Movement Preparation (NoGo)
// Cross E S, 2007: Activity during Movement Execution (Go)
// Cross E S, 2007: Study Time: Random Increasing (Early > Late) > Block 
// Increasing (Early > Late)
// Cross E S, 2007: Study Time: Block Increasing (Early > Late) > Random 
// Increasing (Early > Late)
// Cross E S, 2007: Movement Time: Random Increasing (Early > Late) > Block 
// Increasing (Early > Late)
// Cross E S, 2007: Movement Time: Block Increasing (Early > Late) > Random 
// Increasing (Early > Late)
// Subjects=13
-34	-94	0
42	-18	68
-24	-60	48
38	-28	48
32	-96	-6
10	-22	0
44	-16	52
-10	-2	56
2	-2	62
-10	-20	8
6	-6	68
-38	-14	62
-56	-10	50
-18	-10	-2
18	2	0
38	18	6
22	-16	74
-44	-30	66
-12	-30	30
-12	-26	46
6	-14	46
-30	26	0
46	22	2
2	-28	-48
-54	-44	8
-4	-32	50
-12	-52	-22
-2	-56	-10
-34	-56	52
40	20	8
42	-44	46
14	-80	16
-14	4	2
-32	-10	60
38	-48	-36
34	-72	48
-42	-86	-8
32	-72	34
-30	24	2
-48	2	16
-40	14	4
58	10	40
-30	-12	50
64	10	12
-10	-24	32
6	20	50
-2	-6	64
-6	6	54
42	42	24
50	0	54
-34	38	24
18	-4	68
42	22	38
-32	-84	20
12	-26	30
52	32	26
-40	46	22
48	4	4
-8	-20	-10
24	-16	72
6	-44	64
46	-84	-4
52	-12	58
-22	-30	48
38	-54	-44
-32	-42	-4
-42	18	50
26	60	24
-40	-18	12
-16	-54	64
16	-48	50
-14	2	40
-60	-22	42
48	-14	12
-26	-4	56
-32	-48	26
30	-48	-10
-30	-68	22
14	-30	30
12	-44	-36
-48	-48	12
64	6	18
-42	-46	50
14	-38	-2
-12	-40	-2
46	-64	-4
-12	-22	50
30	-58	30
-10	-8	60
38	-10	-28
-26	6	20
54	-32	38
52	-68	16
-40	-4	-30
16	30	14
24	-66	-6
46	-8	40
-38	22	6
42	-54	-40
30	-46	66
-44	-70	-22
-22	-66	44
24	-30	-2
-32	-26	54
-32	-34	18
-60	-38	32
-38	-22	-22
46	-4	54
58	-22	54
14	-20	48
60	-32	52
50	-24	62
-46	-48	40
68	-36	34
58	-24	10
42	-62	12
34	-78	-8
-24	-34	-20
12	-54	2
24	6	-22
-56	-52	-14

// Rauch S L, 2007: Implicit Learning > Random, TTM Patients + Normals
// Subjects=10
12	18	10
-14	16	0
6	40	-14
-6	38	-12
10	-32	34
-4	-36	30
40	-14	18
2	-46	-14

// Gamer M, 2007: Regional Activity Differing Between Item Types
// Gamer M, 2007: Brain Activity Correlating with Reaction Time
// Gamer M, 2007: Brain Activity Correlating with Amplitude of the Skin 
// Conductance Responses
// Subjects=14
-48	-42	50
-36	-21	60
-48	-33	60
3	-27	35
45	24	-10
36	27	-5
45	18	0
-39	-51	55
-30	-72	55
-51	18	40
-42	18	-5
-42	51	10
-30	45	40
-33	36	45
-24	-9	65
-36	-9	65
-3	12	55
-3	27	40
6	30	40
51	-48	45
42	-48	60
51	24	-5
45	18	0
48	33	25
39	39	35
36	-69	55
60	-54	-5
66	-42	5
-9	-72	45
6	-75	55
15	-12	5
-39	-54	-30
-36	-60	-40
39	-54	-40
-51	-66	-10
-39	-75	-15
-3	15	45
6	6	55
48	18	-5
57	9	-5
-45	-66	-30
42	-54	-30

// Goossens L, 2007: Spiders vs. Neutral Pictures, Spider Phobics > Normals
// Goossens L, 2007: Spiders vs. Snakes, Spider Phobics > Normals
// Subjects=14
2	-29	1
-4	-15	10
14	-1	11
-2	-40	20
6	23	25
-4	26	24
-6	0	70
12	9	66
40	-67	-15
2	-86	-11
-18	-77	-16
-16	-90	-14
59	13	-7
-40	13	-4
-18	1	-12
-6	-57	64
24	-82	-11
20	-95	-5
32	-67	-12
12	-90	-9
-42	-59	-22
-40	-50	-26
-24	-90	-12
-2	-70	0
2	15	36
-4	23	28
6	19	62
0	6	49
61	10	-2
-51	13	-6
-32	52	25
20	-68	9
-2	-32	24
32	-46	-23
4	-15	10

// Liu X, 2007: Bet > Bank
// Liu X, 2007: Bank > Bet
// Liu X, 2007: Win > Loss
// Liu X, 2007: Loss > Win
// Liu X, 2007: Right > Wrong
// Liu X, 2007: Wrong > Right
// Subjects=15
-4	38	-12
6	16	-8
-26	-2	68
-14	20	8
8	18	6
56	20	0
-48	34	-6
-40	60	-2
20	62	18
32	-8	66
12	28	54
-40	-4	8
34	-18	4
34	30	26
-20	34	-16
-24	32	36
-16	6	52
18	16	4
-20	8	-4
-36	-18	8
36	-18	12
52	34	12
-60	20	20
2	54	30
42	14	-18
-40	16	-14
0	-30	2
40	34	24
-34	56	-12
42	56	-8
22	42	-14
-18	44	-18
24	56	-2
14	18	-2
-20	-4	22
6	52	24
4	20	24
-2	26	-10
54	26	8
0	56	-8
54	14	-14
-36	10	-22

// Mayer J S, 2007: Common Activation, WM Load
// Mayer J S, 2007: Common Activation, Attentional Demand
// Mayer J S, 2007: Common Activation, 2-Way Interaction
// Mayer J S, 2007: Common Activation, 3-Way Interaction
// Mayer J S, 2007: Working Memory Selective, WM Load
// Mayer J S, 2007: Working Memory Selective, 2-Way Interaction
// Mayer J S, 2007: Working Memory Selective, 3-Way Interaction
// Mayer J S, 2007: Attention Selective, Attentional Demand
// Subjects=18
48.38	13.16	36.65
49.26	37.61	22.32
42.79	33.62	12.69
57.89	13.25	23.15
-20.88	-7.11	55.87
32.57	-1.08	60.33
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
35.32	18.35	8.49
-29.94	25.9	1.91
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-7.37	-24.18	-.84
8.67	-20.74	0.92
48.38	13.16	36.65
49.26	37.61	22.32
42.79	33.62	12.69
57.89	13.25	23.15
-20.88	-7.11	55.87
32.57	-1.08	60.33
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
35.32	18.35	8.49
-29.94	25.9	1.91
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-7.37	-24.18	-.84
8.67	-20.74	0.92
-20.88	-7.11	55.87
-43.37	-5.56	50.43
44.3	0.85	56.69
-46.65	0.16	42.18
51.6	10.01	36.88
-3.85	10.96	54.16
5.78	13.31	56.09
-18.51	-62.89	63.87
31.65	-62.21	54.32
-39.04	-39	44.26
37.95	-52.29	44.49
-15.34	-64.35	58.38
-19.72	-72.09	41.24
28.33	-65.63	37.91
-24.18	-92.75	8.45
29.21	-90.66	3.2
-41.46	-78.19	-8.19
-41.49	-61.02	-6.28
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-46.65	0.16	42.18
-3.85	10.96	54.16
5.78	13.31	56.09
-19.72	-72.09	41.24
28.33	-65.63	37.91
43.96	-61.9	-11.65
-24.11	-82.12	22.05
37.87	-81.75	21.31
-20.78	-81.87	38.72
40.91	-77.9	2
12.07	-86.79	-.27
-41.59	36.81	20.09
-49	25.47	25.58
-54.51	21.53	2.56
-52.94	-34.86	44.07
-49.99	-63.81	-.37
57.78	-47.28	-16.38
-45.85	-51.95	-12.57
55.63	-48.43	-17.37
-52.23	-49.54	-8.24
53.63	-50.42	-1.57
-41.59	36.81	20.09
-49	25.47	25.58
-54.51	21.53	2.56
-52.94	-34.86	44.07
-49.99	-63.81	-.37
57.78	-47.28	-16.38
-45.85	-51.95	-12.57
55.63	-48.43	-17.37
-49	25.47	25.58
-49.99	-63.81	-.37
45.03	28.15	24.28
40.6	36.36	6.91
-21.21	-50.06	-4.09
21.6	-47.01	4.09
-14.74	-56.03	0.8
15.22	-59.82	4.12
19.59	-72.06	10.67

// Straube T, 2007: Spider Phobics
// Subjects=16
4.53	18.02	34.52
33.08	15.11	-5.71
-6.38	0.24	-1.78
32.28	-90.87	-13.55
-28.61	-94.32	-11.44
5.53	-14.53	12.7
-1.88	17.98	34.59
42.69	6.28	-10.66
-6.38	0.24	-1.78
34.41	-86.54	-12.82
-23.24	-92.97	-8.27
7.68	-25.34	10.24

// Straube T, 2007: Normals
// Subjects=15
-3.21	54.84	15.9
-1.88	17.98	34.59
42.69	6.28	-10.66
-6.38	0.24	-1.78
34.41	-86.54	-12.82
-23.24	-92.97	-8.27
7.68	-25.34	10.24

// Wrase J, 2007: Gain Cue > Neutral Cue
// Wrase J, 2007: Loss Cue > Neutral Cue
// Wrase J, 2007: Gain Cue and Gain Outcome > Gain Cue and Nongain Outcome 
// (GG>GN)
// Wrase J, 2007: GG > GN correlated with the probability of faster reaction 
// time in the next trial (pa(GG))
// Wrase J, 2007: GN > GG correlated with the probability of faster reaction 
// time in the next trial (pa(GN))
// Wrase J, 2007: LL > LN correlated with the probability of faster reaction 
// time in the next trial (pa(LL))
// Wrase J, 2007: LN > LL correlated with the probability of faster reaction 
// time in the next trial (pa(LN))
// Subjects=14
-15	6	0
18	6	0
27	-36	9
18	15	12
-21	42	9
24	42	5
39	21	9
-45	21	15
33	27	-6
-21	36	-3
-51	9	24
-30	18	12
30	21	9
-57	3	15
33	-69	27
-21	21	12
9	-30	6
9	-91	15
12	9	0
-12	12	0
-21	9	15
15	0	15
-15	0	15
15	-6	21
15	12	15
-21	18	21
-42	21	15
-45	6	24
36	24	9
-30	54	12
33	54	12
-27	27	14
33	-66	27
0	-6	6
9	-15	9
-27	-6	21
-15	18	18
18	15	18
-12	8	-5
6	42	0
39	54	0
-33	51	0
-39	-6	18
-33	-66	27
-48	-48	27
-30	-87	24
0	-12	12
-18	6	12
27	-12	12
42	-9	3
-15	-6	12
-9	9	-3
-42	33	-6
51	30	0
-12	-81	18
-12	42	9
6	33	9
-45	-6	9
45	-6	15
30	45	-3
6	-36	15
-6	-39	15
-42	-66	33
-48	-60	30
-33	-57	24
-12	3	-3

// Fischer H, 2007: Hits > Misses, Neutral
// Fischer H, 2007: Women > Men, Neutral
// Fischer H, 2007: Men > Women, Neutral
// Subjects=12
-33.22	32.1	26.42
4.13	-17.83	64.34
8.5	-62.35	58.59
16.38	-38.49	3.43
1.12	66.05	20.24

// Ilg R, 2007: (Coherent Explicit + Coherent Implicit + Incoherent) > 
// Pseudowords
// Ilg R, 2007: Coherent Implicit > Incoherent
// Ilg R, 2007: Coherent Implicit > Coherent Explicit
// Subjects=15
0	8	56
0	16	40
-8	26	38
-4	24	30
-52	10	24
54	18	-6
-46	10	32
-34	20	-4
40	20	-2
50	12	30
-28	-70	54
-52	-44	-6
-44	-62	-20
-14	-82	8
10	-70	12
16	-50	4
-2	-14	10
8	-2	6
6	-78	-16
-12	-84	-18
40	-68	-24
-6	4	64
4	2	66
-2	24	26
-52	16	-4
56	10	-8
-24	50	28
-2	-68	60
42	-66	-24
58	-40	24
-52	-56	40
46	-28	-10

// Kramer U M, 2007: High > Low Provocation
// Kramer U M, 2007: High > Low Provocation > (Computer Opponent, Win + 
// Computer Opponent, Loss)
// Kramer U M, 2007: High > Low Provocation, Low Selection
// Kramer U M, 2007: High > Low Selection, High Provocation
// Kramer U M, 2007: Win > Loss
// Kramer U M, 2007: Loss > Win
// Kramer U M, 2007: Win, High Provocation > Win, Low Provocation
// Subjects=15
-6.79	-50.04	63.77
-15.35	-63.38	57.18
0.44	-18.59	43.21
3.51	14.12	39.32
3.35	33.36	26.55
-5.14	19.65	28.91
3.45	7.98	28.68
2.49	-22.78	30.15
39.46	25.8	-5.57
-60.51	-39.1	31.13
26.86	41.16	28.97
-30.98	44.9	13.71
56.63	16.73	-.55
42.97	6.99	26.08
-47.08	19.91	-5.2
-55.32	-40.61	11.13
2.58	-78.88	20.36
-9.45	-18.13	8.71
-8.25	-73.88	3.34
-18.16	-73.68	-34.48
2.56	11	54.09
7.06	-55.93	55.19
3.6	6.26	47.78
-4.95	0.76	46.11
5.59	20.14	34.33
-.97	40.56	23.77
-9.45	-17.07	8.62
6.57	-14.86	8.26
25.67	8.09	0.54
41.58	25.56	-8.92
-29.99	24.33	-4.65
-42.81	18.8	-6.27
28.76	57.43	5.28
24.01	-71.63	29.54
-15.38	-48.32	59.27
8.18	-47.67	65.63
-5.8	-55.21	51.93
-33.61	-24.91	60.86
35.81	-12.86	59.05
-27.36	-4.58	47.93
35.85	-36.55	55.46
-5	14.5	44.96
7.82	4.63	40.06
-.81	25.73	38.39
-8.31	16.63	31.44
20.51	-6.61	17.44
13.97	8.53	7.32
-18.2	15.94	-4.08
-10.53	-11.62	10.41
15.1	-11.64	7.89
-38.39	-15.9	-1.18
-52.45	15.22	-10.32
-58.39	-45.86	26.1
7.57	-50.66	-14.4
-32.51	-19.1	67.05
-12.23	-10.44	67.21
-39	-44.12	46.92
45.41	-47.04	42.85
-12.46	21.23	50.06
40.88	23.86	38.07
-54.38	9.61	13.59
-.86	31.82	34.54
0.59	-57.63	47.6
14.96	4.42	-4.61
-7.44	4.72	1.2
-15.82	-8.94	18.05
-2.34	50.59	-11.63
40.79	-74.78	-12.76
35.28	-67.73	-31.13
-49.02	-18.71	4.76
57.81	-13.93	2.01
19.67	19.99	58.71
18.52	31.19	52.21
10.96	16.03	35.72
-.97	31.76	20.04
7.46	43.73	8.91
7.57	-2.34	4.96
46.98	17.39	-4.95
-24.55	-15.27	-8.08
-23.54	-7.07	-12.13
37.3	4.59	-18.26
-42.74	-56.22	-26.74

// Abutalebi J, 2007: Regular Switches into Italian
// Abutalebi J, 2007: Regular Switches into French
// Abutalebi J, 2007: Irregular Switches into Italian
// Abutalebi J, 2007: Irregular Switches into French
// Abutalebi J, 2007: Conjunction Analysis
// Abutalebi J, 2007: French to Italian > Italian to French, Regular Switches
// Abutalebi J, 2007: Italian to French > French to Italian, Regular Switches
// Abutalebi J, 2007: French to Italian > Italian to French, Irregular 
// Switches
// Abutalebi J, 2007: Italian to French > French to Italian, Irregular 
// Switches
// Subjects=12
-41.8	21.65	29.84
-5.11	56.43	32.5
-3.2	45.85	11.1
-16.21	49.86	8.69
-45.73	-65.17	42.98
-11.25	-48.24	38.48
-43.94	-57.02	15.25
-65.64	-49	10.34
-61.66	-25.33	-12.24
-40.05	-55.86	-18.55
-22.57	-25.86	2.84
-.97	13.54	9.78
-29.02	-10.37	8.14
61.53	25.69	-1.45
57.12	33.77	-6.66
59.63	25.43	18.78
52.99	-8.58	-.16
61.51	-20.43	-12.58
61.59	-32.99	-9.09
61.8	-51.09	3.9
16.16	-5.08	-6.6
31.42	-3.99	4.24
-41.81	17.18	28.04
-7.25	58.76	34.55
-63.54	-40.69	7.25
-55.18	-18.72	-10.76
-61.66	-25.33	-12.24
-44.26	-63.76	-10.97
61.53	25.69	-1.45
61.67	26.73	9.65
63.69	-18.09	-10.6
61.61	-32.78	-6.87
54.8	8.5	-24.29
-57.07	22.68	18.79
-50.8	18.92	1.13
-45.68	-47.32	50.18
-52.27	-41.58	43
-63.8	-23	-10.19
-63.73	-42.14	-8.3
61.77	23.1	16.73
49.25	11.07	49.51
59.89	16.45	37.59
39.76	24.37	-14.4
74.66	-47.41	-3.41
61.59	-32.99	-9.09
56.96	8.5	-24.33
-52.74	27.16	20.52
-52.91	19.32	5.61
-46.19	18.88	23.47
-.39	17.9	56.4
-39.22	-49.63	48.06
-61.66	-25.33	-12.24
-68.02	-35.36	-4.41
61.53	25.69	-1.45
57.18	40.78	-.63
59.63	25.43	18.78
46.85	13.66	31.36
57.76	16.65	39.85
74.66	-47.41	-3.41
70.26	-41.46	-8.4
63.75	-32.98	-9.13
56.96	8.5	-24.33
-50.6	24.83	18.47
-61.66	-25.33	-12.24
-63.77	-46.81	-12.31
61.49	-22.77	-14.59
72.5	-47.42	-3.37
61.62	24.19	5.42
59.52	37.77	13.07
-7.52	8.64	3.65
-5.26	29.04	15.04
14.09	45.92	10.8
-7.12	-56.26	21.27
20.92	-52.12	18.14
53.63	-54.18	40.2
-26.04	-61.1	62.41
-55	-13.01	4.36
54.9	4.86	-17.21
-20.63	18.4	-6.06
-5.08	26.03	28.78
9.75	34.85	7.49
-48.63	1.49	-1.66
-59.25	-32.17	6.33
40.24	-70.52	3.95
-22.84	68.35	0.25
-41.38	-27.74	52.65
-2.56	-52.25	40.97
64.27	-11.6	35.81

// Kroliczak G, 2007: Grasp - Reach
// Kroliczak G, 2007: Pantomimed Grasp - Pantomimed Reach
// Kroliczak G, 2007: Pantomimed Movement - Real Movement
// Subjects=10
-48.71	-31.91	40.43
-36.78	-25.64	65.42
-69.26	-25.8	11.16
-46.56	-23.01	45.24
-12.69	-15.23	5.16
47.52	-34.08	45.08
37.96	-40.14	50.16
17.15	-49.89	-19.04
59.03	13.94	32
44.26	-16.04	44.72
36.89	-29.15	54.83
10.82	-15.01	5.99
36.89	-42.35	49.24
30.07	2.8	14.31
24.05	-72.26	35.17
36.95	-52.75	52.35
6.85	4.6	53.46
46.49	-44.66	45.98
24.07	-84.15	32.82
26.28	-44.99	57.39
52.7	-33.56	23.79
-14.9	-47.88	-17.72
-51.83	-46.48	45.03
-15.88	-19.48	5.56
55.61	-38.83	-17.06
43.09	-62.06	14.02

// Nelson E E, 2007: Successful Change - Successful Go, Pediatric Bipolar 
// Disorder Patients - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Pediatric Bipolar 
// Disorder Patients with ADHD - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Unmedicated Pediatric 
// Bipolar Disorder Patients - Normals
// Nelson E E, 2007: Successful Change - Successful Go, Medicated Pediatric 
// Bipolar Disorder Patients - Normals
// Subjects=10
-32	20	46
36	12	54
-32	-4	60
-32	20	46
40	2	54
46	18	34
-30	-6	62
0	-66	46
-28	-72	40
-8	-8	44
-32	12	20
-28	20	38
-34	0	58
2	-34	66
-32	18	48
10	-66	56

// Ortigue S, 2007: All Primes > Rest
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Composite
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Ease
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Satisfaction
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Orgasm Frequency
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with PLS
// Ortigue S, 2007: Beloved's Name - Acquaintance's Name Correlated with 
// Emotional Closeness Satisfaction
// Subjects=29
6	-8	10
6	12	0
6	-22	-22
36	-4	2
-26	20	-4
-30	20	-4
-20	20	-4
36	-88	-18
-48	-50	-24
64	-52	16
56	-70	-2
34	-18	-28
-40	-8	-34
-64	-50	22
66	-44	32
-18	62	16
-46	26	26
52	38	22
66	-14	-8
-44	-26	-20
-64	-22	-10
-18	-96	-8
18	-94	-8
16	-76	20
-12	-68	-2
10	-40	20
-6	-42	8
64	2	24
12	-48	-38
-36	-78	-52
6	12	0
6	-22	-22
36	-4	2
-26	20	-4
36	-88	-18
-48	-50	-24
34	-18	-28
-40	-8	-34
-64	-50	22
66	-44	32
-18	62	16
-46	26	26
66	-14	-8
-44	-26	-20
-18	-96	-8
12	-48	-38
-36	-78	-52
-26	20	-4
-26	20	-4
-18	62	16
-26	20	-4
34	-18	-28
-18	62	16
66	-14	-8
-26	20	-4
34	-18	-28
-64	-50	22
-18	62	16
-46	26	26
-18	62	16

// Padula C B, 2007: Working Memory > Vigilance, Marijuana Users > Normals
// Padula C B, 2007: Main Effect for Performance, Positive Relationship
// Padula C B, 2007: Interaction of Group x Performance
// Subjects=17
35.44	-15.57	10.21
10.41	-48.91	76.86
-9.9	-62.24	71.52
67.46	-42.13	-5.77
9.37	-36.56	-52.41
45.52	-50.24	56.5
-58.61	-42.63	-.93
-52.16	-65.31	-5.8
51.52	19.1	30.54
-52.52	37.51	-11.07
-61.76	-42.05	6.86
34.98	0.58	-42.43
-1.13	28.99	-2.03
-23.7	-9.84	-34.2
25.82	-28.84	4.75

// Postle B R, 2007: Location Memory, Rest vs. Rest
// Postle B R, 2007: Object Memory, Rest vs. Rest
// Postle B R, 2007: No Memory, Saccades vs. Rest
// Postle B R, 2007: No Memory, Passive Listening vs. Rest
// Subjects=12
29	14	48
-20	-28	36
13	-29	30
13	36	22
-9	-17	11
-22	-57	3
42	-52	-4
39	-49	-8
-43	-49	-8
-44	-44	-36
-36	10	42
-5	-3	38
47	-7	38
-38	-10	38
31	-48	34
-9	1	26
13	18	26
42	6	26
23	-23	26
-31	-23	23
-47	11	24
38	22	23
54	14	19
-43	27	15
43	34	12
16	14	12
38	-3	7
-58	-26	1
-36	6	-4
46	24	-4
-9	-61	-8
-3	-7	-11
13	7	-12
-31	18	-12
-21	-56	-21
-43	-28	-21
42	14	-21
31	-11	-24
4	-21	-26
38	-26	-31
0	-49	53
21	6	53
39	-21	53
-20	-1	49
-2	-34	49
-2	6	46
-38	-11	42
6	-38	41
45	-9	39
12	-52	37
-6	-5	37
-15	-54	34
5	13	31
-8	-12	31
-12	-50	28
12	-69	24
9	25	24
-51	10	18
-4	-72	17
56	6	16
5	23	16
6	-60	12
-31	-61	6
-44	7	5
-13	-49	4
20	4	4
10	-60	2
42	-29	2
-13	-52	2
-20	15	2
-29	14	0
-6	-8	-1
34	28	-4
16	-9	-4
-14	-7	-4
-51	12	-8
21	-29	-12
-28	27	-12
20	20	-17
-55	-11	-23
20	-44	-26
-22	-48	-26
34	-7	53
-12	-6	49
36	-19	48
-1	20	46
11	2	44
40	1	43
42	-7	40
-47	-23	40
9	-33	37
-5	-7	34
35	-52	31
-20	-22	28
16	-30	27
21	-16	27
-39	0	27
-24	26	22
60	-19	19
47	26	18
-44	22	18
-45	-13	10
-16	2	10
39	-14	8
-16	19	1
-43	28	-1
14	-12	-1
54	-10	-5
-52	-11	-6
-21	-64	-6
37	38	-9
26	-7	-9
-9	-6	-12
9	-15	-15
45	-23	-18
54	3	-21
38	-33	-24
12	-29	-27
-21	-41	-32

// Vandewalle G, 2007: Light Condition Effects During the Performance of the 
// Task, Blue Light > Violet Light
// Vandewalle G, 2007: Light Condition Effects at Light Onset, Blue Light > 
// Green Light
// Vandewalle G, 2007: Light Condition Effects at Light Onset, Violet Light > 
// Green Light
// Subjects=15
-44	42	30
-18	-24	10
-6	-38	-20
6	-30	-16
-28	-38	2
-16	-24	18
16	-4	-18
-22	-22	-10

// Cornier M A, 2007: Eucaloric, Hedonic > Utilitarian
// Subjects=12
30	-3	48
-36	-63	-27
36	-63	-18
6	0	-12
21	-66	54
-27	-27	-9
24	-33	-6

// Filimon F, 2007: Actual Reaching > Passive Viewing
// Filimon F, 2007: Observed Reaching > Passive Viewing
// Filimon F, 2007: Imagined Reaching > Passive Viewing
// Filimon F, 2007: Actual Reaching + Observed Reaching + Imagined Reaching
// Subjects=15
-45	-41	14
-23	-14	14
-33	-18	14
-37	-30	14
-31	-28	14
-30	-37	14
-52	12	13
-21	-2	14
-31	3	6
-48	-47	9
-33	-46	14
-27	-55	14
-57	-38	14
-4	-60	11
-10	0	13
-5	-5	14
-14	-88	14
-45	-72	14
-3	-74	14
-2	-88	14
-11	-81	13
54	-35	13
37	-11	13
34	-38	7
29	-40	11
23	-5	12
26	-52	12
20	-59	14
60	-31	14
7	-64	12
7	2	14
15	-90	14
6	-76	13
5	-86	13
13	-79	13
-14	-92	26
-29	-52	47
-29	-57	64
-23	-6	60
-45	-76	3
-45	-58	12
-6	-62	52
-1	-89	10
20	-91	26
28	-52	49
21	-62	66
48	-72	4
51	-50	11
7	-65	52
-22	-65	62
-29	-51	45
-28	-40	55
-6	-63	57
-59	-37	41
-48	-44	26
-22	-3	61
-26	-12	55
-50	16	15
-5	-1	59
19	-66	61
59	-36	43
8	6	59
-22	-2	62
-24	-61	60
-30	-49	48

// Hassabis D, 2007: Real Memories > Real Objects
// Hassabis D, 2007: New Scene > New Object
// Hassabis D, 2007: Previously Imagined Scene > Previously Imagined Object
// Hassabis D, 2007: Conjunction Analysis (RM - RO + IS - IO + NS - NO)
// Hassabis D, 2007: Recall of Real Episodic Memories > Recall of Previously 
// Imagined Experiences, (RM - RO) > (IS - IO)
// Subjects=21
-3	51	24
3	42	-9
27	36	39
-57	-9	-21
57	-6	-24
-18	-21	-15
18	-24	-12
15	-18	9
-18	-36	-15
24	-33	-18
-3	-57	15
12	-60	12
-3	-54	33
3	-66	39
-48	-78	18
48	-72	27
3	-63	63
3	24	-9
27	27	45
57	-6	-24
21	-24	-12
-18	-36	-15
33	-42	-12
-12	-60	9
12	-57	15
9	-57	48
-48	-78	24
45	-66	24
9	-75	57
-3	45	36
-6	48	-9
-24	24	51
-63	-12	-18
24	-21	-15
-21	-39	-18
27	-36	-18
-9	-48	6
15	-57	9
-9	-42	36
-3	-60	54
-36	-75	30
45	-69	33
3	-66	60
-6	54	27
-3	48	-12
-24	24	51
24	24	48
-63	-9	-18
57	-3	-24
-21	-21	-21
24	-21	-15
-18	-33	-15
21	-33	-18
-6	-54	9
12	-54	9
-3	-39	42
-6	-63	51
6	-66	60
-33	-78	39
48	-72	27
-6	-78	54
-3	63	6
-3	-54	36
3	-63	39

// Jacobsen L K, 2007: Increases in Smokers During Smoking Relative to 
// Non-Smokers
// Jacobsen L K, 2007: Decreases in Smokers During Smoking Relative to 
// Non-Smokers
// Subjects=38
-38.17	-9.34	54.14
20.01	25.76	47.43
37.5	-42.67	49.42
13.8	11.34	65.77
49.75	-40.37	-7.04
50.12	0.7	30.35
-33.85	-33.45	48.61
61.91	12.13	25.66
-59.17	13.31	22
-5.66	2.45	63.62
22.12	12.27	40.89
40.61	5.18	-36.05
21.16	-3.71	-38.2

// Rilling J K, 2007: CC vs. (CD + DC + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: CC vs. (CD + DC + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: CD vs. (CC + DC + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: CD vs. (CD + DC + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: DC vs. (CC + CD + DD), Psychopathy Positive Correlation
// Rilling J K, 2007: DC vs. (CC + CD + DD), Psychopathy Negative Correlation
// Rilling J K, 2007: DD vs. (CC + CD + DC), Psychopathy Positive Correlation
// Rilling J K, 2007: Partner Cooperation - Defect, Psychopathy Positive 
// Correlation
// Rilling J K, 2007: Partner Cooperation - Defect, Psychopathy Negative 
// Correlation
// Rilling J K, 2007: Choice Cooperation - Choice Defect, Psychopathy Positive 
// Correlation
// Rilling J K, 2007: Choice Cooperation - Choice Defect, Psychopathy Negative 
// Correlation
// Subjects=22
5.1	60.07	-13.62
-62.96	-6.1	3.86
-66.01	-31.96	13.87
22.43	26.39	3.5
-34.09	16.25	15.04
-7.2	-3.8	28.67
45.37	-79.25	25.48
2.22	-17.86	-2.6
15.94	0.23	-17.65
41.5	40.11	-13.48
-12.83	23.98	2.99
-2.97	1.26	24.86
-9.37	-31.53	14.3
37.55	-42.22	-4.3
52.65	-68.14	3.27
16.45	-82.39	14.92
-19.96	-72.38	10.04
13.27	-87.61	16.51
-58.76	-30.97	-15.29
55.96	-51.69	23.04
-52	-73.46	12.73
18.37	-79.06	-11.03
18.55	-98.13	3.95
-61.91	-5.21	1.54
-17.11	25.01	2.95
-1.83	-59.5	9.86
26.91	-71.44	-9.54
27.3	-74.01	39.74
15.48	-93.43	23.66
-42.22	-5.84	60.47
7.29	46.33	-12.5
37.18	40.71	-19.06
68.47	-31.72	-8.89
46.03	-69.26	-24.44
13.27	-98.62	11.86

// Rolls E T, 2007: Chocolate Cravers
// Subjects=8
-30	12	0
32	22	0
-4	24	38
-20	42	-4
-12	6	4
-30	44	26
-6	32	-30
-8	22	28
4	30	8
-28	42	-10
-4	16	-12
-2	30	4
14	28	-18
-10	2	14
-8	28	30
34	14	-8
-2	40	2
8	36	-8
30	42	28
-8	28	-20
-6	56	16
-2	24	-28
0	40	-2
6	38	-10

// Rolls E T, 2007: Chocolate Non-Cravers
// Subjects=8
-30	12	0
32	22	0
-4	24	38
-20	42	-4
-12	6	4
-30	44	26
-6	32	-30
-8	22	28
4	30	8
-28	42	-10
-4	16	-12
-2	30	4
14	28	-18
-10	2	14
-8	28	30
34	14	-8
-2	40	2
8	36	-8
30	42	28
-8	28	-20
-6	56	16
-2	24	-28

// Safron A, 2007: Preferred Sexual > Non-Preferred Sexual
// Safron A, 2007: Non-Preferred Sexual > Preferred Sexual
// Safron A, 2007: Preferred Sexual > Sports
// Safron A, 2007: Sports > Preferred Sexual
// Safron A, 2007: Sports > Non-Preferred Sexual
// Safron A, 2007: Non-Preferred Sexual > Sports
// Subjects=11
-28	-85	-5
-32	-84	14
34	-82	-4
-18	-89	1
-21	-89	4
29	-85	24
-22	-83	35
-12	-53	22
12	-56	22
-9	-61	64
31	-41	-2
-27	-24	-1
-19	-15	-1
-19	-23	7
-24	-25	17
-14	7	14
-19	-18	27
9	9	16
18	-17	27
-33	2	18
-29	27	17
-1	26	21
10	20	21
-36	-32	52
-38	-17	58
-39	-43	65
-16	-36	66
-27	-38	65
26	-40	-34
26	-53	-24
-19	19	48
17	1	36
16	23	45
45	21	26
34	-30	63
-4	-90	-3
11	-90	-3
-31	-88	-4
-34	-88	9
27	-90	4
22	-89	9
27	-84	24
-38	-39	56
-1	21	15
-22	-26	5
-14	0	-6
-37	-3	4
-20	-62	7
16	-34	28
56	-26	38
29	-29	64
20	-47	-30
9	-52	11
-31	-32	65
-40	-30	20
40	-68	41
-54	-2	-16
-51	-21	45
-55	-47	11
-24	-34	-14
-12	-17	74
-10	-102	11
-41	-59	-40
-1	-69	39
-52	17	32
58	-43	0
-38	48	11
43	-32	54
-46	-70	-5
26	-85	26

// Stern E R, 2007: Position - Neutral
// Stern E R, 2007: Position - Word
// Stern E R, 2007: Position - Neutral, Positive Correlation with Behavioral 
// Cueing Effect
// Stern E R, 2007: Position - Neutral, Negative Correlation with Behavioral 
// Cueing Effect
// Subjects=14
32	46	-20
22	54	20
-2	6	48
38	-54	48
12	-72	48
-42	-40	48
12	-60	66
-32	-54	66
-36	-60	-30
26	-56	-26
-12	-62	-28
16	-12	16
16	-68	42
-54	-44	44
34	-50	42
52	-66	-10
36	46	40
-56	-64	22
64	-52	-4
12	-78	52
-22	-74	60
16	-62	70
36	-56	58
-42	-56	54
32	-64	32
28	-80	16
38	-92	-14
-22	-96	20
50	-8	34

// Baicy K, 2007: Leptin-Deficient Patients, High Calorie > Low Calorie
// Baicy K, 2007: Leptin Supplement, High Calorie > Low Calorie
// Subjects=3
-36	10	2
-56	-32	18
48	0	0
22	6	-32
-26	-24	-24
62	-24	20
-64	-48	26
-40	-52	-24
18	-66	16
-2	32	-12
-8	28	36
-14	14	48
10	56	12
10	44	46
24	54	-8
-28	44	38
-20	36	46
40	22	56
-2	-46	34
-30	-96	20
-14	-22	-14
6	-36	-32
-50	-52	-40
-32	-60	-38
-50	-64	-34
-2	-74	-46
-34	-80	-38
-20	-82	-32
-6	-82	-26
46	-48	-44
36	-68	-32
44	-76	-42
16	-84	-24

// Eschen A, 2007: Enact - Report
// Eschen A, 2007: Report - Abstract
// Subjects=10
-59.9	-25.66	41.55
-15.3	-50.64	58.95
-19.76	15.06	61.5
-58	-63.76	12.8
-49.87	-48.53	60.46
-26.5	-5.43	37.86
14.9	7.09	66.18

// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 1, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 1, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 2, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 2, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 3, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 3, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 4, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 4, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 5, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 5, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 6, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 6, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 7, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 7, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 8, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 8, 7T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 9, 1.5T 
// Scanner
// Gizewski E R, 2007: Signal Changes for Activated Regions, Subject 9, 7T 
// Scanner
// Subjects=9
-36	-28	70
-52	-20	20
-4	-6	60
16	-56	-24
-44	-30	62
-52	-20	20
-2	-10	62
-14	-20	0
14	-50	-28
-36	-26	70
-48	-24	28
-2	-10	62
-14	-20	8
16	-52	-18
-36	-30	62
-40	-24	19
-4	-4	52
-14	-24	0
22	-52	-28
-44	-24	56
-60	-16	28
-4	-2	58
26	-52	-24
-38	-24	70
-62	-14	28
-2	-2	58
-24	-10	6
18	-48	-22
-34	-18	68
-54	-20	20
-4	-2	56
18	-46	-24
-44	-24	58
-52	-24	22
-8	-4	56
-16	-24	4
14	-52	-18
-38	-32	64
-48	-30	20
-8	-6	52
20	-52	-24
-44	-18	60
-50	-28	20
-10	-2	54
-22	-20	-2
18	-46	-26
-44	-26	60
-58	-22	28
0	-4	58
18	-54	-26
-40	-26	64
-50	-26	18
-2	-4	54
-14	-20	6
18	-50	-28
-42	-20	64
-58	-20	22
-6	-8	52
22	-56	-24
-42	-24	66
-58	-18	18
-6	-10	50
-16	-22	8
24	-54	-28
-46	-12	56
-52	-18	12
20	-54	-20
-46	-18	54
-60	-18	8
-10	-8	52
-14	-22	0
18	-50	-28
-40	-32	64
-2	-2	-46
18	-50	-24
-38	-22	54
-54	-24	22
-6	2	48
-22	-26	6
16	-48	-22

// Herwig U, 2007: Expectation Unpleasant > Neutral
// Herwig U, 2007: Expectation Pleasant > Neutral
// Herwig U, 2007: Expectation Unknown > Neutral
// Herwig U, 2007: (Expectation Unknown + Unpleasant) > (Expectation Pleasant 
// + Neutral)
// Subjects=14
-32.03	22	6.72
-34.2	9.59	-2.25
-32.09	1.6	-9.41
2.24	20.78	15.35
-32.21	7	-22.13
-23.56	-2.92	-13.59
-11.62	-6.43	8.87
11.82	4.03	4.38
15.13	4.02	17.73
-12.72	2.03	8.18
25.66	-18.4	-11.74
-6.44	-16.82	-15.97
-60.55	-27.47	30.16
-32.95	-69.77	-10.11
51.55	-65.15	0.8
25.59	-2.63	-14.18
-23.49	-18.7	-11.15
8.52	-16.73	-16.14
-4.28	60.29	17.69
2.2	22.55	10.74
-1.1	9.53	-5.97
21.32	-2.65	-14.13
-19.23	-18.76	-12.31
-.91	-28.02	3.87
-10.68	-26.37	-15.12
38.65	-70.4	-10.88
51.55	-66.29	-.22
-19.29	-2.9	-13.64
21.38	-18.51	-12.8
5.51	24.83	26.13
7.62	44.3	30.05
49.17	27.86	6.41
-31.04	20.1	-4.28
-36.39	0.26	-12.59
-36.49	10.15	-22.34
21.33	-2.57	-13.02
-12.76	-1.66	1.79
10.76	4.11	5.5
-.96	-19.82	-.16
6.45	-24.86	-10.98
50.48	-63.04	0.64
37.29	6.7	-18.44
-34.07	-63.77	-15.06
51.37	20.82	11.44
40.5	23.27	-10.95
-29.92	21.76	3.37
-37.42	-1.52	-7.97
12.89	2.98	4.46
6.51	-13.26	1.43
8.57	-20.62	-11.36
-50.06	-65.64	-10.26

// Hummel C, 2007: Taste-Disorder Patients vs. Normals
// Hummel C, 2007: Normals vs. Taste-Disorder Patients
// Subjects=8
-3	36	-6
-6	-57	24
15	42	-12
48	-18	9
36	12	0
6	-15	33
39	-39	45
-36	-57	63
36	-81	24
12	-39	42

// Kleber B, 2007: Overt Singing - Imagined Singing
// Kleber B, 2007: Imagined Singing - Overt Singing
// Subjects=16
-57	-12	33
39	-24	39
-54	-9	33
48	-12	36
-39	-30	12
45	-21	12
-45	-21	3
66	-3	-6
-21	-75	9
-9	-42	-24
15	-63	-24
-63	-9	21
63	-6	12
6	-30	-45
18	-24	-3
-9	12	51
42	45	33
-36	30	-12
42	39	-9
9	42	9
-15	45	-6
-48	-57	48
60	-51	45
-33	-75	51
51	27	24
-50	9	42
-39	-69	45
57	-63	24

// Maihofner C, 2007: Acute Pain, Placebo
// Maihofner C, 2007: Acute Pain, ASA
// Maihofner C, 2007: Acute Pain, Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo
// Maihofner C, 2007: Mechanical Hyperalgesia, ASA
// Maihofner C, 2007: Mechanical Hyperalgesia, Parecoxib
// Maihofner C, 2007: Tactile Stimulation, Placebo
// Maihofner C, 2007: Tactile Stimulation, ASA
// Maihofner C, 2007: Tactile Stimulation, Parecoxib
// Maihofner C, 2007: Acute Pain, Placebo vs. ASA
// Maihofner C, 2007: Acute Pain, Placebo vs. Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo vs. ASA
// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo vs. Parecoxib
// Maihofner C, 2007: Acute Pain > Mechanical Hyperalgesia, Parecoxib
// Maihofner C, 2007: Mechanical Hyperalgesia > Acute Pain, Parecoxib
// Subjects=14
41.82	-26.18	56.98
53.37	-10.99	8.73
-54.57	-23.88	18.19
52.18	-45.83	48.25
-44.32	-42.73	50.21
40.26	17.94	-2.69
-45.69	15.81	7.73
13.94	26.95	25.3
50.14	5.18	40.64
44.89	46.67	27.08
22.1	53.07	-.97
-35.09	24.4	40.79
40.43	-25.36	58.04
49.64	-28.56	17.16
-54.66	-24.94	19.62
51.1	-45.06	47.3
-44.55	-39.53	50.28
34.88	17.65	6.43
-45.78	15.05	8.91
14.58	25.1	24.66
45.95	7.63	38.26
46.81	49.97	28.34
23.29	54.88	1.66
-46.36	17.82	46.16
39.88	-27.41	54.98
53.69	-27.25	15.89
34.85	-51.57	58.18
-43.26	17.89	4.07
12.22	23.76	22.68
44.46	12.79	41.75
38.58	43.79	26.16
3.5	59.13	0.64
-27.77	13.72	43.72
41.36	-29.86	52.05
30.67	-17.66	56.61
55.17	-24.98	14.79
-54.23	-23.4	20.26
51.57	-46.57	52.55
-43.27	-38.99	48.99
41.27	13.23	2.27
-41.95	13.26	6.01
10.3	22.39	21.7
-1.92	23.11	18.33
1.54	54.93	-5.46
58.65	-2.2	3.58
43.07	48.2	27.75
20.74	52.11	1.81
-35.49	43.24	24.27
40.52	-31.06	53.16
53.09	-15.4	12.23
-53.89	-23.56	22.28
52.43	-45.55	53.24
49.17	-39.28	49.29
39.98	16.33	2.58
-47.07	14.1	7.67
6.22	21.93	20.23
5.09	57.58	-1.71
29.5	12.63	41.04
38.22	45.23	21.36
21.71	52.22	3.24
-21.05	32.1	49.69
42.61	-30.64	47.42
55.31	-11.33	10.97
-55.95	-22.89	18.79
53.27	-44.59	51.81
45.76	-45.47	47.95
40.09	18.02	2.44
-45.39	13.54	3.12
4.71	22.61	18.18
6.15	58.88	-2.94
30.84	15.18	49.17
51.75	11.07	29.87
43.35	49.28	8.59
-35.94	43.81	49.66
42.71	-30.2	46.15
-53.29	-26.22	16.81
58.61	-23.87	17.89
52.92	-47.39	47.25
51.09	-39.21	48.6
50.08	15.11	7.92
5.9	17.14	31.34
10.07	50.19	45.47
46.39	46.37	27.2
55.83	16.66	6.83
7.71	12.22	57.05
42.92	-31.46	45.03
-51.45	-27.56	18.46
57.46	-25.11	21.24
52.16	-46.22	46.05
50.87	-35.28	48.6
-37.69	14.13	4.55
48.15	14.52	7.43
7.21	10.58	33.1
9.94	50.77	41.97
44.2	17.5	36.67
54.78	13.51	7.44
7.4	11.59	57.1
44.66	-29.78	50.11
-53.5	-25.95	17.57
58.18	-22.32	18.66
35.92	-52.6	57.14
43.98	-52.08	49.42
-35.04	19.34	4.19
49.86	14.53	7.3
5.08	16.97	36.05
8.96	49.19	39.44
41.07	38.35	27.15
53.69	15.95	6.13
8.26	4.51	55.01
49.7	-26.93	53.49
56.86	-24.13	13.25
-55.57	-20.37	14.11
51.2	-28.19	53.58
58.2	-25.51	20.04
-49.11	-26.53	17.9
52.85	-44.94	52.85
46.18	19.57	4.02
13.51	26.12	24.25
-4.04	21.48	19.49
39.22	45.41	26.47
42	-31.97	92.14
59.21	-21.19	13.98
-56.82	-24.02	16.67
52.18	-45.83	48.25
41.59	19.51	3.74
13.94	26.95	25.3
-4.39	22.15	15.76
40.97	49.71	18.5
43.14	48.49	9.44
41.37	-28.87	53.86
60.39	-19.62	14.84
-55	-24.53	16.69
53.72	-45.42	54.77
43.19	19.53	3.83
6.44	22.21	21.1
-4.14	19.33	19.23
40.93	49.9	27.97
22.75	54.15	0.5
43.08	-27.58	53.85
54.13	-10.33	10.34
-51.3	-20.24	14.05
40.46	47.31	35.77
42.06	-28.54	59.4
53.93	-45.14	54.3
39.72	48.02	23.01
23.72	53.02	0.92

// Rotshtein P, 2007: Main Effect of Feature Change: Features, Change - 
// Features, Repeat
// Rotshtein P, 2007: Main Effect of Second Order Configured Relations Change: 
// 2nd Change > 2nd Repeat
// Rotshtein P, 2007: Correlation of Behavior and fMRI:  Second-order 
// Configural Relations
// Subjects=14
39	-90	0
45	-75	9
-42	-60	3
42	-54	-21
30	-9	-21
-30	-6	-27
48	-39	36
33	-87	-18
-45	-75	-12
-45	-81	-6
42	-57	-21
45	-54	-21
-33	36	24
18	63	12
-18	18	42
-3	-9	36
33	33	-12
-24	-3	9

// Shibata M, 2007: Literal Sentence
// Shibata M, 2007: Metaphoric Sentence
// Shibata M, 2007: Anomalous Sentence
// Shibata M, 2007: Metaphoric Sentence vs. Literal Sentence
// Shibata M, 2007: Literal Sentence vs. Metaphoric Sentence
// Shibata M, 2007: Metaphoric Sentence vs. Anomalous Sentence
// Shibata M, 2007: Anomalous Sentence vs. Metaphoric Sentence
// Subjects=13
-32	-51	58
34	-59	56
-36	-38	57
12	-44	54
0	7	55
-55	11	20
53	14	18
0	23	36
20	-9	12
-2	-7	17
2	28	47
-8	57	8
-44	28	17
44	24	17
51	26	12
-51	8	9
4	-22	34
-2	23	32
-42	-9	15
-4	-11	13
10	-71	26
-2	8	49
-2	-1	52
55	21	32
-53	5	29
50	18	14
-50	4	7
51	8	1
4	23	30
-6	-23	12
-46	-50	39
-4	50	29
0	52	21
0	61	14
-42	24	14
10	-63	58
10	-46	50
-8	-53	58
-16	-51	65
22	48	34
26	35	41
2	54	23
0	61	12
-40	26	15
-34	-61	25
12	-37	44

// Szameitat A J, 2007: Right - Rest
// Szameitat A J, 2007: Left - Rest
// Subjects=17
-40	38	24
-36	31	30
-28	30	22
-4	-5	59
-12	-3	57
4	2	48
12	9	57
-55	10	0
-57	5	29
-53	5	13
-30	18	5
51	10	11
53	23	-6
46	14	3
-48	-34	55
-38	-38	55
53	-69	20
67	-39	33
67	-44	22
53	-27	40
34	-35	44
30	-43	67
-55	-65	14
-36	29	30
-4	-3	59
-12	3	57
2	2	48
12	7	59
-55	10	1
-57	7	29
-51	5	13
-30	22	4
55	10	5
55	21	-4
46	14	3
-50	-34	55
-38	-38	55
-40	-46	59
57	-63	20
67	-39	30
67	-44	22
51	-25	38
34	-31	42
30	-45	67
-57	-63	14
-50	-72	29
-61	-58	3

// Takahashi T, 2007: Brain Activations in Changing Gum Hardness
// Takahashi T, 2007: Brain Activations in Consistent Gum Hardness
// Takahashi T, 2007: Changing Gum Hardness - Consistent Gum Hardness
// Subjects=15
52	-8	38
-50	-10	32
50	-10	38
-52	-10	24
64	-26	28
50	10	54
-62	-42	8
0	-8	56
-46	40	0

// Neuner I, 2007: Encoding vs. Fixation
// Neuner I, 2007: Immediate Recall vs. Motor Baseline
// Neuner I, 2007: Delayed Recall vs. Motor Baseline
// Neuner I, 2007: Immediate Recall vs. Delayed Recall
// Subjects=15
-34	-62	-32
-46	-68	-10
-26	-62	52
-42	6	30
-2	24	40
-42	2	46
-36	30	-4
36	48	32
28	2	60
-16	-8	14
32	28	-6
16	6	6
-2	-28	-18
-24	-38	-50
22	-40	-50
-2	32	38
36	24	-12
-30	28	-4
26	-94	-6
36	-84	-10
46	-62	-16
0	-38	-46
36	26	-10
0	32	38
-38	-82	-6
-46	-66	-10
-26	-98	-4
40	-82	-10
-30	28	-6
32	12	56
8	-24	-16
16	2	8
-28	0	56
-16	-2	14
24	46	-18
-14	-24	8
10	-20	2
0	-26	64
-20	-16	70
14	-12	10

// Haase L, 2007: Sucrose - Water
// Haase L, 2007: Caffeine - Water
// Subjects=18
-55.35	-9.09	19.63
-55.34	-5.75	21.58
-33.13	17.34	1.55
-34.03	-5.16	13.48
-55.39	-11.72	13.16
-32.01	17.86	8.18
-42.77	35.69	5.7
-7.34	-13.97	7.23
-24.82	42.37	-19.6
-30.11	38.45	-14.75
-42.67	13.65	9.78
-35.34	11.01	-11.28
-60.74	-6.29	15
-55.5	13.49	8.82
-12.68	-16.21	6.36
-5.2	-15.1	6.18
-4.39	50.38	-.44
63.26	-1.86	19.9
42.93	-8.84	14.02
63.26	-1.86	19.9
41.64	21.84	-1.92
41.6	25.82	-5.6
13.9	15.51	1.16
36.17	39.1	-12.22
35.07	40.95	-15.71
43.73	8.14	-14.17
38.6	-2.87	9.11
67.52	-6.41	15.77
14.03	-16.05	6.04
12.97	-17.11	6.14
12.82	43.93	11.06
40.62	-24.91	-14.71
32.32	-23.54	17.61
35.27	-27.23	-16.69
34.36	-38.73	-.1
30.9	-7.34	-20.54
3.13	37.65	-.57
-19.31	-13.01	-20.6
-19.34	-7.81	-22.15
-56.44	-11.55	15.39

// Mobbs D, 2007: Cue, Predator vs. Cue, Yoked Control
// Mobbs D, 2007: Predator - Yoked Control
// Mobbs D, 2007: Yoked Control - Predator
// Mobbs D, 2007: Chase, Predator, High Correlated with a Distal Predator-Prey 
// Distance
// Mobbs D, 2007: Chase, Predator, Low Correlated with a Distal Predator-Prey 
// Distance
// Mobbs D, 2007: Chase, Predator, High Correlated with a Proximal 
// Predator-Prey Distance
// Mobbs D, 2007: Chase, Predator, Low Correlated with a Proximal 
// Predator-Prey Distance
// Mobbs D, 2007: Chase, Predator, High - Chase, Predator, Low
// Mobbs D, 2007: Chase, Predator, Low - Chase, Predator, HIgh
// Mobbs D, 2007: Chase, Predator, High Correlated with Increased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, Low Correlated with Increased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, High Correlated with Decreased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, Low Correlated with Decreased Dread of 
// Capture
// Mobbs D, 2007: Chase, Predator, High Correlated with Increased Confidence 
// of Escape
// Mobbs D, 2007: Chase, Predator, High Correlated with Decreased Confidence 
// of Escape
// Mobbs D, 2007: Chase, Predator, Low Correlated with Increased Confidence of 
// Escape
// Mobbs D, 2007: Chase, Predator, Low Correlated with Decreased Confidence of 
// Escape
// Subjects=14
13	32	-14
-6	41	22
-8	18	30
-29	48	-6
-4	39	-13
6	49	-19
3	54	-4
40	20	28
3	-25	-7
-2	-28	-8
-5	-63	-13
3	-22	11
-17	2	25
16	-13	20
-5	48	17
3	37	-9
22	-2	-18
28	-6	-27
-8	35	-13
-5	27	-14
32	-4	-24
16	16	2
45	34	-8
-10	38	-11
-31	-2	-25
2	42	6
-3	-33	-15
8	-32	-21
32	4	-13
60	18	8
2	-27	-28
7	20	30
6	-33	-14
5	28	17
8	59	-1
-10	16	13
20	7	10
30	47	27
37	33	9
38	-13	-17
-3	-32	-15
-23	0	-15
-1	51	-1
15	54	20
-35	39	8
31	-4	-23
-32	-73	-14
-1	-26	-19
7	-20	-15
18	58	7
5	42	15
5	42	-13
49	38	11
11	-32	-18
-3	61	12
0	-28	-19
-5	-32	-18
-9	-32	-32
-36	45	-2
-3	-61	-32
29	-57	-28
0	17	26
24	11	1
-45	-66	-8
-20	10	-11
34	-40	-6
-31	24	-4
3	38	-17
23	-2	16
57	-24	-11
42	-76	-13
-39	34	15
35	49	-1
-4	29	-8
-3	48	24
-3	-33	-5
27	7	-16
19	-7	-24
-11	16	-7
17	47	-4
-5	44	30
34	22	-10
2	-29	-19
6	24	28
7	54	28
6	-26	10
-8	-19	4
49	-7	7
-2	34	-20
28	9	-25
12	51	-8
-3	-37	-20
7	41	31

// Jager G, 2007: Associative Learning > Classification
// Subjects=20
-34	-51	-20
-34	-91	12
42	9	32
38	-51	-20
2	29	40
-46	29	24

// de Zubicaray G I, 2007: Hit > Correct Rejection
// de Zubicaray G I, 2007: Correct Rejection > Hit
// de Zubicaray G I, 2007: Hit > Miss
// de Zubicaray G I, 2007: Miss > Hit
// de Zubicaray G I, 2007: Miss > Correct Rejection
// de Zubicaray G I, 2007: Correct Rejection > Miss
// Subjects=16
-51	15	0
-45	33	15
0	42	6
0	3	63
-51	-6	48
51	-6	36
66	-9	-3
51	-18	3
60	6	-12
-57	-18	0
-18	-3	-12
21	-21	-21
-24	-24	-15
33	18	3
-39	-42	42
-6	-33	-6
36	-66	-30
27	30	-18
45	42	-9
24	33	36
27	60	3
24	-9	54
-21	27	42
-30	-12	54
33	-9	51
-9	-6	45
42	15	-36
-51	-3	-18
-51	-54	21
60	-18	-24
30	-3	-27
-30	-6	-27
-36	-24	-15
-33	-42	-6
-33	-15	12
-39	-21	48
-6	-30	57
12	-51	42
-15	-51	63
36	-72	-12
-39	-81	-9
-45	-66	-45
-54	9	12
-57	-3	21
0	15	30
3	42	3
-48	-12	15
-60	-12	-3
66	-6	0
-24	-3	-21
-24	-18	-21
66	-6	21
-42	-42	48
-15	-72	51
-24	-66	45
12	24	60
30	54	15
42	-60	-12
54	-72	-6
24	-87	-12
-30	-93	6
-27	-78	-21
-54	18	24
-42	9	36
39	6	57
3	12	48
-12	9	-3
15	9	-6
-33	-51	39
-33	-72	42
-3	-78	30
15	-72	27
-24	24	42
-30	-12	60
24	33	45
12	51	42
-45	-24	18
-39	0	9
-30	-6	-27
30	-6	-27
63	-9	27
-63	-15	21
-36	-78	-12

// Achim A M, 2007: Associative Encoding vs. Item Oriented Encoding, Normals > 
// FEP
// Achim A M, 2007: Associative Encoding vs. Item Oriented Encoding, FEP + 
// Normals
// Achim A M, 2007: Arbitrary vs. Related Pairs, Normals > FEP
// Achim A M, 2007: Arbitrary vs. Related Pairs, FEP + Normals
// Achim A M, 2007: Subsequent Memory Effect Contrast, FEP > Normals
// Achim A M, 2007: Subsequent Memory Effect Contrast, FEP + Normals
// Subjects=20
-42	16	-24
-50	6	28
50	8	30
-4	-58	14
26	-38	-16
-28	-46	-14
46	-74	22
30	-52	52
-28	-90	2
-32	-2	-36
-36	-10	-40
-30	-14	-32
-28	-28	-18
-18	-34	4
28	4	-38
30	-8	-26
36	-10	-40
-32	10	-28
50	10	-40
52	-4	-12
38	-16	-24
42	-60	4
48	-66	-2
-28	-10	-8
-42	-16	16
-38	-24	16
42	-12	12
38	-12	24
12	-50	-14
6	-64	-16
-40	-82	16
42	-42	-20
-42	-74	-8
-24	-96	8
52	-76	0
6	-18	-2
-48	-6	40
40	-2	-12
46	-12	24
16	-16	-2
-2	-20	22
-46	-24	38
-10	-66	18
-12	48	50
-52	34	16
-34	34	-22
-56	18	26
-40	16	22
-40	4	24
-26	-34	76
50	36	14
22	32	-20
60	14	36
42	12	24
-20	-2	-22
-22	-26	-10
-26	-32	-20
-10	-52	10
36	-12	-34
28	-30	-30
12	-36	-12
-42	-18	-26
-36	-8	20
-14	-30	24
28	-30	26
-28	-60	50
-44	-74	-2
30	-60	16
30	-74	34

// Bjork J M, 2007: Anticipation: No Response, Probability 1.0 vs. Probability 
// 0.5
// Bjork J M, 2007: Anticipation: Response, Probability 1.0 vs. Probability 0
// Bjork J M, 2007: Anticipation: Response, Probability 1.0 vs. Probability 
// 0.5
// Bjork J M, 2007: Anticipation: Response, Probability 0.5 vs. Probability 0
// Bjork J M, 2007: (Response, Probability 1.0 vs. Probability 0) vs. (No 
// Response, Probability 1.0 vs. Probability 0)
// Bjork J M, 2007: (Response, Probability 0.5 vs. Probability 0) vs. (No 
// Response, Probability 0.5 vs. Probability 0)
// Bjork J M, 2007: Reward Notification:  No Response, Probability 1.0 Wins 
// vs. Probability 0 Non-Wins
// Bjork J M, 2007: Reward Notification:  Response, Probability 1.0 Wins vs. 
// Probability 0 Non-Wins
// Bjork J M, 2007: Reward Notification:  Win vs. Non-Win Notifications in all 
// Probability 0.5 Trials
// Subjects=20
-2.37	49.19	-15.97
-26.18	-5.66	61.39
-30.46	-26.63	52.05
-7.03	-6.4	50.08
33.67	-30.48	51.63
49.56	-15.29	40.14
26.24	-9.15	66.66
-26.02	-36.96	69.59
-55.22	-33.07	26.1
-30.87	39.41	25.32
-35.2	-2.85	2.15
53.47	6.14	0.38
-10.74	9.21	-9.18
33.12	5.59	-4.92
28.94	-18.76	-2.83
-7.35	-18.55	3.15
1.24	-63.05	-8.83
-1.22	54.45	-3.04
52.52	-17.84	6.86
-34.77	-19.26	51.48
-10.47	12.04	27.38
29.38	-47.14	43.04
-46.51	-43.36	43.6
17.49	9.61	48.46
-30.93	10.29	6.58
17.06	12.81	-6.45
-14.99	9.45	-5.8
-3.14	-23.52	-6.52
5.46	-59.22	-14.78
-30.46	-26.63	52.05
-42.42	-16.7	30.16
-58.53	-17.65	19.27
13.3	-14.74	50.55
-2.84	-3.98	39.79
22.04	-20.46	72.11
29.42	-25.85	56.87
-21.77	-41.59	64.35
22.04	-41.32	63.83
-58.43	-33.09	26.14
-55.5	-2.97	2.4
61.06	-13.48	7.51
13.07	-71.01	-2.72
-18.75	18.07	64.89
-35.17	1.81	7.34
-26.63	-19.09	-2.16
28.98	-18.33	2.71
13	-62.98	-8.97
-34.79	-22.77	47.31
-14.93	-7.47	-4.38
21.42	-10.43	-4.55
25.68	5.97	0.71
-39.05	-92.96	20.9
-30.91	6.06	6.93
-14.35	-4.73	72.33
33.27	31.34	25.26
-26.51	-38.75	5.06
6.26	54.5	-3.13
-11.82	14.58	-8.5
11.71	12.78	-6.39
-61.83	-37.36	-1.34
66.36	-29.28	-4.61
-42.13	-53.23	53.29
47.61	-52.94	48.89
5.81	-29.34	-96.47
2.47	-4.29	35.3
-28.21	-18.82	70.32
31.63	-19.52	69.69
12.87	-50	-20.1
3.25	32.33	13.26
-2.76	-36.13	36.91
45.47	-62.9	44.18
5.37	31.03	10

// Samanez-Larkin G R, 2007: Younger Adults
// Subjects=12
-.18	59.66	-4.61
-12.98	42.15	-9.68
27.71	27.93	-4.5
-42.8	14.48	-7.02
53.36	14.89	-10.39
-12.82	13.06	-.55
-12.88	12.46	-8.31
8.61	13.87	8.05
25.7	2.89	2.09
-17.07	0.17	-1.66
10.63	-4.92	-14.93
10.77	-10.06	1.11
6.58	-9.23	12.24
-35.97	-7.43	39.35
-8.22	-9.89	32.54
15.18	-17.47	15.07
-16.86	-19.6	17.84
-4.24	-23.87	-10.94
4.48	-41.82	3.85
-1.94	-63.87	-5.38
26.03	-90.34	7.67
31.94	27.45	-11.2
0.26	24.68	38.47
23.38	20.71	-14.99
-36.32	19.61	3.63
-38.55	16.45	-9.47
44.8	16.95	-10.46
11.72	12.86	-5.28
-12.87	12.63	-6.09
-12.81	8.83	-.2
12.86	7.04	1.89
8.6	-19.22	-7.02
-6.26	-46.8	-4.53
42.71	21.85	-1.93
-16.07	13.75	-5.04
-40.64	27.95	1.86
42.68	20.45	-6.27
-18.2	13.74	-5.01
-6.38	15.64	4.73
34.08	29.75	-9.18
-26.76	29.01	0.5
-.14	50.15	-3.81
44.82	21.52	-6.39
16.02	9.8	-3.96
8.55	-2.13	-6.22

// Samanez-Larkin G R, 2007: Older Adults
// Subjects=12
-4.42	55.58	-1.99
31.87	55.28	-9.07
6.25	51.07	-6.19
40.47	49.33	-4.21
25.52	47.13	-3.85
21.56	37.15	32.72
-29.94	30.39	4.88
38.45	22	0.34
-49.07	13.7	10.96
-10.65	9.01	1.99
-12.41	12.94	52.98
17.09	6.55	-4.81
-12.69	3.51	13.63
-53.11	5.15	38.49
12.93	3.32	8.89
13.27	6.92	55.42
-38.08	-.59	45.49
-5.9	0.8	60.61
15.48	-1.18	60.54
17.23	-9.51	7.68
-25.08	-9.71	63.95
-10.49	-15.68	12.98
-8.09	-12.92	48.41
-40.14	-15.23	48.97
4.63	-18.28	33.1
25.69	-21.4	-9.26
-25	-22.06	69.44
21.75	-24.52	33.43
-16.59	-25.66	49.57
-35.81	-34.41	48.3
17.62	-34.09	47.66
38.91	-36.93	36.5
-8.24	-42.99	17.48
-8.15	-44.25	28.73
30.46	-42.64	46
-37.85	-46.6	56.04
-7.97	-46.76	51.24
-20.73	-52.84	56.36
60.11	-58.41	4.6
26.03	-57.41	20.52
17.75	-54.72	56.08
-25.19	-59.15	30.18
-7.89	-65.8	52.84
39.53	30.89	5.15
-32.07	26.06	4.15
45.17	-36.32	16.3
-12.5	-36.33	21.43
47.38	12.79	45.62
-3.41	56.04	-9.84
-8.62	13.46	-9.56
9.55	13.57	-9.78
-3.48	55.27	-19.81
-13.92	13.85	-3.95
12.78	11.64	-7.42
-6.38	15.64	4.73
34.08	29.75	-9.18
-26.76	29.01	0.5
-.14	50.15	-3.81
44.82	21.52	-6.39
16.02	9.8	-3.96
8.55	-2.13	-6.22

// Bonner-Jackson A, 2007: Siblings of Schizophrenic Patients (SIBs)
// Subjects=21
-2.92	30.38	43.6
-47.9	15.88	25.26
43.73	26.8	-6.82
35.25	-74.67	-38.36
-41.82	42.15	-7.12
47.93	45.86	-8.46

// Bonner-Jackson A, 2007: Siblings of Healthy Comparisons (SNCs)
// Subjects=38
-54.62	29.13	-9.23
-21.95	-106.06	15.12
-.61	18.98	61.26
29.33	-102.58	14.23
-46.03	46.07	2.63

// Budhani S, 2007: Punished Reversal Errors > Rewarded Correct Responses
// Budhani S, 2007: Rewarded Correct Responses > Punished Reversal Errors
// Subjects=21
11.17	8.31	59.79
48.36	14.05	34.35
-36.1	25.26	35.49
32.58	2.26	62.28
37.43	22.5	7
-28.81	17.79	7.04
10.73	-19.29	-8.15
-5.26	6.3	7.73
42.22	-45.75	46.12
-31.49	-52.53	47.54
-.21	54.92	-10.9
29.84	-11.66	-21.28
-30.96	-26.23	-11.55
-13.46	-51.68	29.42

// Galvan A, 2007: Greater Activation to Reward
// Galvan A, 2007: Greater Activation to Baseline
// Subjects=7
7.45	6.32	-6.91
-7.51	7.29	-6.82
50.12	34.33	-6.41
48.18	38.57	21.14
47.54	-47.11	41.72
27.8	10.22	0.33
3.53	-4.37	34.17
15.09	7.99	14.05
2.01	34.93	-8.14
-22.21	38.46	39.8
49.09	-4.77	-16.5
18.82	-45.92	59.79
6.58	34.69	29.75
7.39	-47.09	-37.01

// Johnson J D, 2007: Encoding, Scene > Encoding, Sentence
// Johnson J D, 2007: Encoding, Sentence > Encoding, Scene
// Johnson J D, 2007: Recognition, Scene > Fixation
// Johnson J D, 2007: Recognition, Sentence > Fixation
// Johnson J D, 2007: Content Independent Recollection Related Activity
// Subjects=16
24	-81	-12
-18	-72	48
51	-33	-18
51	6	33
-24	-12	57
24	-6	57
-6	54	-9
-60	-9	-21
-63	-24	-6
-3	-57	27
48	15	-12
-39	-3	0
6	-87	24
-54	6	0
-15	45	39
-9	-60	-18
-51	21	0
-51	-63	30
-30	-87	30
-48	-60	-9
-27	-42	-21
-6	60	-6
-21	-24	-21
-42	-78	30
-3	60	0
-42	-33	-21
-54	-57	-21
-36	-42	-30
15	-27	69
33	-24	57
51	-9	45
-24	-6	21
21	-3	24
-15	-39	60
3	-51	21
-9	57	-9
-6	-9	66
54	-72	18
57	-3	-18
-27	-60	15
0	-24	15
33	-93	-3
45	-78	12
57	-60	-18
0	-66	-27
36	-81	33

// Otten L J, 2007: Memory Effects for "Remember" Responses Irrespective of 
// the Probe
// Otten L J, 2007: Memory Effects for "Remember" Responses, Spoken Word Probe
// Otten L J, 2007: Memory Effects for "Remember" Responses, Picture Probe
// Otten L J, 2007: Memory Effects for "Know" Responses, Probe Independent
// Otten L J, 2007: Memory Effects for "Know" Responses, Spoken Word Probe
// Subjects=18
-48	39	-3
33	-39	-3
60	9	36
-6	-66	30
3	27	15
48	-54	27
-21	45	33
57	3	27
39	-84	3
-51	-60	-18
36	-48	54
-3	-45	24
-15	60	30
39	-24	30
-51	-60	18
-39	-57	24
-57	-30	51
30	-51	54
-39	-48	63
42	-42	48
-39	-60	33
-21	-54	51
63	-57	-3
-15	-57	0
39	-9	-27
27	21	27
-30	-72	24

// Flores-Gutierrez E O, 2007: Bach + Mahler - Prodromides
// Flores-Gutierrez E O, 2007: Bach - Prodromides
// Flores-Gutierrez E O, 2007: Mahler - Prodromides
// Flores-Gutierrez E O, 2007: Prodromides - Bach + Mahler
// Flores-Gutierrez E O, 2007: Prodromides - Bach
// Flores-Gutierrez E O, 2007: Prodromides - Mahler
// Flores-Gutierrez E O, 2007: Mahler - Bach (Excitement)
// Flores-Gutierrez E O, 2007: Bach - Mahler (Calmness)
// Flores-Gutierrez E O, 2007: Music - Noise
// Subjects=19
-55	-21	3
-61	-29	7
-42	-73	22
-12	-90	30
-46	-71	20
-34	54	-9
-42	-73	22
-55	-21	1
-61	-29	7
-12	-90	30
8	-6	-11
-34	4	9
-57	12	16
-38	31	4
-44	42	-11
34	31	-7
42	9	16
-50	-59	25
26	58	-1
-57	13	18
-40	29	4
-34	6	9
-30	16	8
-44	42	0.11
-40	21	-16
-50	35	2
-51	3	-10
34	33	-7
42	27	4
42	9	16
36	14	12
65	-34	18
-32	27	-11
-20	3	-15
24	5	-15
30	13	-19
12	-4	-10
36	32	-18
26	58	-1
46	26	-15
-42	29	6
-50	33	6
-32	16	10
-34	6	9
-57	13	18
34	35	-8
67	-43	24
34	29	6
-48	15	0
-32	27	-11
-55	-21	5
-44	13	21
55	-4	-7
63	-21	10
8	-6	-11

// Goldstein R Z, 2007: Normals
// Subjects=12
-41.35	12.51	-21.93
-37.92	7.39	-8.03
-28.33	-3.39	-20.58
42.87	35.46	-22.27
42.96	13.12	-20.06
46.25	43.1	-9.64
46.16	22.71	-21.07
-37.8	54.24	10.86
-18.16	59.06	26.86
33.64	52.24	19.93
4.39	51.51	13.77
4.56	62.64	29.48
7.75	65.53	25.78
-5.49	56.92	3.32
1.09	54.38	10.19
4.23	-18.61	-12.9
7.36	-22.72	-22.63
-11.89	-18.04	-5.96
-15.2	-11.99	-9.86
-5.32	-7.51	2.97
20.62	-10.61	2.84
-35.11	63.28	-30.42
-31.6	-49.63	-32.75
7.42	-71.52	-27.89
4.67	-87.56	7.36
-38.05	19.53	-15.96
33.43	27.72	-1.17
53.1	16.27	13.07
62.63	21.44	-1.05
36.78	21.97	6.06
46.41	14.69	-3.47
-27.96	45.33	18.3
53.38	8.57	34
47.23	1.16	58.37
-5.25	-3.7	9.32
-11.8	-30.49	-1.37
-28.25	-78.34	-29.97
-18.5	-74.8	-27.13
-24.74	-82.84	-9.42
-41.05	-67.25	-14.04
-24.22	-82.29	30.86
-24.31	-92.8	21.82
-27.5	-85.8	27.9
23.36	-60.26	-46.09
33.1	-63.41	-45.94
36.8	-82.93	-13.82
17.26	-90.32	-22.84
39.72	-55.76	-33.36
10.54	-75.63	-37.62
-21.35	56.17	30.56
46.11	35.47	-22.33

// Goldstein R Z, 2007: Cocaine Abusers
// Subjects=16
-41.35	12.51	-21.93
-37.92	7.39	-8.03
-28.33	-3.39	-20.58
42.87	35.46	-22.27
42.96	13.12	-20.06
46.25	43.1	-9.64
46.16	22.71	-21.07
-37.8	54.24	10.86
-18.16	59.06	26.86
33.64	52.24	19.93
4.39	51.51	13.77
4.56	62.64	29.48
7.75	65.53	25.78
-5.49	56.92	3.32
1.09	54.38	10.19
4.23	-18.61	-12.9
7.36	-22.72	-22.63
-11.89	-18.04	-5.96
-15.2	-11.99	-9.86
-5.32	-7.51	2.97
20.62	-10.61	2.84
-35.11	63.28	-30.42
-31.6	-49.63	-32.75
7.42	-71.52	-27.89
4.67	-87.56	7.36
-38.05	19.53	-15.96
33.43	27.72	-1.17
53.1	16.27	13.07
62.63	21.44	-1.05
36.78	21.97	6.06
46.41	14.69	-3.47
-27.96	45.33	18.3
53.38	8.57	34
47.23	1.16	58.37
-5.25	-3.7	9.32
-11.8	-30.49	-1.37
-28.25	-78.34	-29.97
-18.5	-74.8	-27.13
-24.74	-82.84	-9.42
-41.05	-67.25	-14.04
-24.22	-82.29	30.86
-24.31	-92.8	21.82
-27.5	-85.8	27.9
23.36	-60.26	-46.09
33.1	-63.41	-45.94
36.8	-82.93	-13.82
17.26	-90.32	-22.84
39.72	-55.76	-33.36
10.54	-75.63	-37.62
36.75	41.43	7.5
-21.6	67.37	12.65
36.85	48.75	16.86
4.55	65.83	29.16
14.09	67.81	15.36
36.75	41.43	7.5
33.47	64.07	8.68
20.5	64.02	8.9
-11.82	51.45	14.06

// Marsh A A, 2007: Activation Associated with Changes in the Number of 
// Response Options
// Marsh A A, 2007: Activation Associated with Reward Value
// Subjects=18
3.42	30.79	34.57
-36.06	3.69	31.72
42.01	4.75	38.54
-19.85	7.87	56.84
-.94	-3.1	9.59
-19.6	-68.61	58.79
29.51	-61.17	54.25
26.09	-88.68	15.34
-7.52	48.93	8.64
-.71	21.21	48.81
-23.05	1.25	54.08
-42.39	4.5	42.88
29.3	4.73	53.19
-39.36	23.59	27.86
28.74	-1.01	-21.04
-26.74	25.92	1.87
-45.49	-59.27	30.42
-58.32	-48.43	34.12
41.87	-65.89	-7.94

// Murray L J, 2007: Regions Active at the Target Word During Relational 
// Trials Relative to Item Specific Trials
// Subjects=17
-49	10	24
-10	14	56
-52	35	18
-56	-56	0
-32	24	0
-28	-28	-24
46	14	24
32	21	-4
-38	-35	-21
-14	10	7
-35	-52	46
-32	14	56
-52	49	-7
49	38	32
-38	4	56
-38	-42	42
-14	7	66
-14	28	28
-7	10	28
-46	-56	-10
-49	7	56

// Peters J, 2007: Correct > Incorrect Source Encoding, Auditory
// Peters J, 2007: Correct > Incorrect Source Encoding, Picture
// Peters J, 2007: Correct > Incorrect Source Encoding, Auditory Retrieval
// Peters J, 2007: Correct > Incorrect Source Encoding, Picture Retrieval
// Subjects=14
48.75	-51.76	-2.54
-24.82	12.83	3.53
-42.12	-57.37	-11.64
-33.4	-54.59	-5.34
35.89	-33.54	9.33
-55.06	-57.21	-9.19
-3.29	-40.22	-14
-31.07	-46.75	9.53
37.33	11.44	-37.73
20.43	-51.39	-20.02
63.79	-37.03	-6.49
13.86	-12.71	-19.25
-18.29	-52.41	-5.81
-20.59	-53.46	-16.88
39.66	-15.79	-30.59
-42.52	16.25	-27.88
-24.92	-49.22	-17.22
-31.48	-45.4	-21.97
31.29	-44.35	-14.18
54.95	-29.79	-20.5
-31.35	18.98	0.79
-20.95	-18.96	-38.21
70.37	-31.92	1.86
-12.08	-4.09	-17.42

// Sailer U, 2007: Wins vs. Losses, Exploratory Phase
// Sailer U, 2007: Correct vs. Wrong, Exploratory Phase
// Sailer U, 2007: Interaction of Utilitarian and Performance Feedback
// Sailer U, 2007: Wins vs. Losses, Exploratory vs. Proficiency Phase
// Sailer U, 2007: Interaction of Feedback and Learning Phase
// Subjects=38
-54	34	2
-12	68	-10
-6	12	6
-14	44	-12
4	68	0
18	32	-16
2	54	-14
-20	10	-20
-16	20	-10
-48	-6	48
-6	-68	46
-52	12	20
-32	12	68
-50	54	4
-38	-16	42
2	-24	38
0	6	28
60	-56	-20
-56	-6	-12
54	-46	58
12	-16	30
-48	-24	22
-42	30	24
-8	-46	64
28	-58	46
30	-68	62
-12	16	-22
-48	-52	18
-60	-50	0
66	-26	-8
66	-48	-2
66	-8	-6
-64	-42	-18
46	24	-20
-12	-48	18
-10	-2	12
-32	12	68
38	14	64
-54	16	40
-26	40	48
-24	24	34
-40	-62	-14
-52	-72	8
-14	-52	-8
42	-78	0
28	-96	14
36	-78	20
-2	-88	-12
38	-24	34
-26	-68	60
38	-62	58
-12	-70	56
4	-80	52
44	-44	14
-36	-30	-12
-22	-46	-16
18	-26	-12
-48	28	10
-54	32	2
22	38	-12
-14	16	-10
-14	40	-10

// Vilberg K L, 2007: Regions Selectively Sensitive to Familiarity
// Vilberg K L, 2007: Regions Selectively Sensitive to Recollection
// Vilberg K L, 2007: Recollection Sensitive Regions Which are Also Sensitive 
// to Amount of Information Recollected
// Subjects=14
-30	48	-12
-30	45	27
-45	39	12
-54	21	18
-48	3	39
24	3	51
27	6	18
-9	0	15
-27	-15	60
-66	-36	-3
-39	-30	45
-30	-63	45
42	-42	36
33	-54	45
15	-72	60
6	-66	30
-18	33	51
-48	27	33
-36	21	51
36	-27	69
6	9	-3
-15	-3	-15
-36	-9	-36
-51	-57	-21
-24	-87	-21
30	-33	-21
33	-60	57
-36	-78	33
-9	-78	33
33	-24	72
-54	-54	-24
-39	-81	39

// Blair K S, 2007: Negative > Neutral
// Blair K S, 2007: Negative, Incongruent = Congruent > View
// Blair K S, 2007: Negative, View > Congruent = Incongruent
// Blair K S, 2007: Negative, View > Congruent > Incongruent
// Blair K S, 2007: Interaction: Task * Negative Emotion
// Blair K S, 2007: Positive > Neutral
// Blair K S, 2007: Positive, Incongruent = Congruent > View
// Blair K S, 2007: Positive, View > Congruent = Incongruent
// Blair K S, 2007: Positive, View > Congruent > Incongruent
// Blair K S, 2007: Interaction: Task * Positive Emotion
// Subjects=22
-35.4	22.56	-13.36
5.5	52.12	34.99
-19.32	-6.5	-18.91
29.78	-5.74	-27.35
-40.34	-78.82	-2.57
49.43	-73.79	-.68
-32.02	54.04	21.88
43.94	44.43	28.5
21.11	53.39	-18.82
-20.55	49.97	-18.06
36.21	57.14	0.76
-7.3	20.43	25.53
-40.51	-.34	7.58
40.53	23.61	-6.51
-57.47	6.47	28.39
8.85	22.87	41.87
55.15	-37.95	63.16
11.78	-19.46	-10.38
36.21	57.14	0.76
-38.57	20.68	-9.82
-16.76	35.21	52.28
-46.41	-76.4	43.02
4.75	-48.94	35.67
22.36	-8.45	-20.34
-26.86	0.52	-23.88
40.46	60.16	-1.77
52.65	-84.6	-3.15
42.88	40.03	26.65
-28.81	55.11	21.75
34.06	55.89	-1.34
-21.62	47.76	-18.98
-14.92	33.28	13.39
-28.9	24.51	-2.45
38.39	24.66	-6.58
-58.68	7.21	10.5
40.82	7.86	23.8
66.52	-24.31	18.4
33.22	-63.71	-20.29
-15.69	34.16	52.35
1.54	-47.9	35.62
-48.54	-75.27	44.06
37.27	57.06	-.36

// Christoffels I K, 2007: PNvoice > PNnoise
// Christoffels I K, 2007: PNnoise > PNvoice
// Subjects=14
0	8	35
-1	-9	46
2	-17	-31
1	-15	9
37	7	11
49	-9	30
28	-34	-14
29	-54	-13
49	-25	-2
-40	2	9
-42	-21	41
-10	-68	7
-15	-53	-15
-27	-10	5
51	-18	8
57	-30	12
-41	-28	7

// Eippert F, 2007: Decrease - View
// Eippert F, 2007: Increase - View
// Subjects=24
0	18	54
6	24	36
-6	30	27
-45	15	3
-42	21	0
-30	3	57
-60	24	6
-6	30	27
-3	24	30
-45	18	-3
12	-48	9
0	15	57
-6	-39	-18
-24	-33	-6
-6	27	15
30	-63	-24
-6	-12	63
-9	-51	6
15	9	54
-21	-51	12
-27	-57	-24
9	-6	66
21	3	-18
-18	0	-12
-12	9	54
-15	9	60
-30	0	54
15	9	54
15	-3	75
51	9	6
-6	27	15
0	18	30
-6	30	30
-9	33	27
-45	18	-3
-18	12	-15

// Benuzzi F, 2007: Whole Faces vs. Masks
// Benuzzi F, 2007: Upper Faces vs. Masks
// Benuzzi F, 2007: Lower Faces vs. Masks
// Benuzzi F, 2007: Whole Faces vs. Parts of Faces
// Benuzzi F, 2007: Whole Faces vs. Upper Faces
// Benuzzi F, 2007: Whole Faces vs. Lower Faces
// Benuzzi F, 2007: Upper Faces vs. Whole Faces
// Benuzzi F, 2007: Lower Faces vs. Whole Faces
// Subjects=24
48.76	-82.37	-8.47
20.54	-31.96	-7.38
-46.46	-71.73	-15.75
29.57	-105.66	7.61
-46.28	23.68	17.39
20.3	-9.71	-21.9
-15.88	-101.98	3.53
7.63	-87.39	-14
34.26	-49.27	47.89
1.39	-74.7	7.26
-14.01	-88.84	-16.85
48.69	35.3	10.14
-16.37	-3.9	-15.13
-24.67	-88.91	-5.45
29.57	-105.66	7.61
-22.34	-106.25	4.07
3.2	-82.82	-22.22
34.13	-78.69	31.75
9.74	-32	-7.19
34.27	-51.39	48.1
46.49	-60.15	-11.75
-37.86	-72.02	-19.23
-33.67	21.13	-10.59
-26.15	-68.52	51.94
48.47	58.83	-2.27
-53.84	33.54	19.91
53.06	35.73	14.51
-1.31	-65.58	-32.81
56.52	20.93	28.24
39.74	20.97	-16.3
20.58	-31.65	-4.05
-9.77	-82.86	-21.99
10.1	36.38	35.34
-44.04	17.72	22.43
-.62	31.44	40.5
27.16	-73.63	-5.61
12.42	-103.61	18.9
20.24	-8	-26.55
48.04	15.11	-45
-25.18	-8.47	-29.09
-57.76	-67.41	31.08
-62.94	-12.54	-24.68
37.41	6.54	-32.76
5.71	-86.7	5.02
-9.46	-88.23	0.94
53.51	-64.89	28.94
18.13	-7.59	-22.07
12.42	-103.61	18.9
48.52	-51.3	-20.51
-25.02	-12.75	-17.47
-18.57	-5.28	-18.31
45.84	10.43	-48.98
52.82	-55.85	-23.49
12.41	-101.49	18.69
-62.88	-12.13	-20.24
20.24	-8	-26.55
-5.04	-52.42	16.37
-23.02	-8.46	-29.13
45.91	17.54	-41.84
-57.77	-65.29	30.87
-29.47	-16.99	-28.18
50.24	4.48	-43.98
44.5	-17.35	9.82
-7.83	63.22	-9.59
29.51	-103.94	2.96
40.39	-87.98	12.4
42.55	-87.97	12.36
33.52	-58.07	-11.74
-32.92	-87.09	25.88
-50.65	-69.65	-4.68
25.66	-57.7	49.99
50.65	56.81	-.98
7.76	42.68	22.44
56.18	-62.55	-15.04
35.52	21.68	-8.46
-24.06	-64.67	47.05
60.85	18.82	28.37

// Brown M R G, 2007: Preparation, Antisaccade > Preparation, Prosaccade
// Brown M R G, 2007: Preparation, Prosaccade > Preparation, Antisaccade
// Brown M R G, 2007: Response, Antisaccade - Preparation, Antisaccade
// Brown M R G, 2007: Response, Prosaccade - Preparation, Prosaccade
// Subjects=11
30.39	0.59	54.64
31.47	-.37	55.82
1.48	7.57	51.04
0.3	14.02	38.25
35.25	54.98	14.34
53.71	9.77	33.53
56.94	8.9	35.79
50.37	25.9	22.18
38.67	55.03	42.17
40.82	55.13	43.25
18.31	76.23	42.86
22.59	75.28	44
3.42	69.25	50.31
1.16	31.69	18.91
51.31	72.94	24.91
26.13	-2.52	56.06
29.32	-2.67	53.81
1.54	4.82	56.85
54.7	7.86	22.52
56.83	29.79	30.7
39.71	39.29	31.21
33.35	56.31	45.47
32.28	55.16	44.46
19.41	74.38	46.35
21.54	72.1	44.28
1.28	64.75	47.36
48.18	71.49	33.99
50.31	73.62	33.79
-3.9	40.11	59.53
17.53	45.16	67.78
35.69	38.66	64.77

// Burianova H, 2007: All Retrieval Conditions vs. Scrambled Pictures
// Burianova H, 2007: Semantic and Episodic Retrieval vs. Scrambled Picture
// Burianova H, 2007: Autobiographical and Episodic Retrieval vs. Scrambled 
// Picture
// Burianova H, 2007: Autobiographical Retrieval vs. Scrambled Pictures
// Burianova H, 2007: Episodic Retrieval vs. Scrambled Pictures
// Burianova H, 2007: Semantic Retrieval vs. Scrambled Pictures
// Subjects=12
-46.72	29.18	-15.64
52.71	21.02	-16.53
-41.56	16.82	47.12
13.89	17.04	-10.99
-7.43	-13.7	5.86
14.13	-1.92	4.33
-2.95	-72.7	6.02
5.68	48.71	29.72
56.81	48.92	-28.32
-55.11	-58.69	-13.53
65.48	-46.69	39.26
-57.66	-51.38	41.82
-2.98	26.69	24.2
5.45	41.53	10.26
1.47	-58.78	16.89
-42.28	12.59	-9.59
48.47	12.91	-11.17
-33.72	63.44	-5.81
35.68	57.9	11.49
5.21	69.31	-2.57
9.27	64.06	-24.53
39.67	58.72	-14.43
5.72	49.03	33.05
-45.52	-52.66	61.91
-6.65	-69.1	56.15
22.96	48.78	29.42
44.78	25.22	40.34
73.16	-14.5	-30.17

// Chua E F, 2007: Pair Remembered > Pair Forgotten
// Chua E F, 2007: Face Remembered/Pair Remembered > Face Remembered/Pair 
// Forgotten
// Chua E F, 2007: Face Remembered/Pair Remembered > Fixation
// Chua E F, 2007: Face Remembered/ Pair Forgotten > Face Forgotten/Pair 
// Forgotten
// Subjects=18
-22	-4	-18
20	-8	-16
-22	-12	-28
18	-6	-28
-28	-4	-24
-22	-4	-18
20	-8	-16
-22	-32	-6
24	-30	-4
-24	-14	-24

// Dickstein D P, 2007: Normals
// Subjects=22
36	52	-10
38	36	-12
38	36	-12
24	-24	64
22	-90	42
28	-24	46
12	-2	38
14	46	2
-16	-8	28
18	-12	28
34	-2	8
14	46	2
32	-52	22
-20	-12	30
-34	-54	-2
-16	-10	28
36	-66	30
-16	-8	2

// Dickstein D P, 2007: Pediatric Bipolar Patients (PBD Patients)
// Subjects=23
36	52	-10
38	36	-12
38	36	-12
24	-24	64
22	-90	42
28	-24	46
12	-2	38
14	46	2
-16	-8	28
18	-12	28
34	-2	8
14	46	2
32	-52	22
-20	-12	30
-34	-54	-2
-16	-10	28

// Feusner J D, 2007: NSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: LSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: HSF vs. Gray Ovals, Body Dysmorphic Disorder Patients > 
// Normals
// Feusner J D, 2007: LSF, Normals > Body Dysmorphic Disorder Patients
// Subjects=12
-62	8	2
-54	18	-2
-30	18	-6
-44	22	-20
-36	-36	54
-42	2	32
-60	8	0
56	-2	36
24	14	50
-56	10	-20
-60	-48	-16
-6	-74	16
22	-88	22
-24	-86	6

// Lee H J, 2007: Deaf Patients
// Subjects=9
-44	-38	14
-50	-4	-10
-54	-36	12
-64	-30	2
-52	-48	10
-52	-62	10
-46	-50	50
52	-10	-10
58	-42	10
52	-38	6
64	-24	-2
54	-28	-12
52	-54	2
52	-40	26
50	-44	36
40	-48	48
-50	-48	-16
-38	-68	-20
42	-50	-14
-12	46	-50
-26	20	4
-28	20	-4
-34	14	4
34	20	0
-40	20	30
-48	22	30
-56	10	16
-44	-4	42
50	26	-12
36	36	38
60	14	24
50	16	28
48	8	18
50	4	42
50	-2	56
42	0	46
-6	-4	60
8	12	50
6	-6	68
-24	-100	-2
-10	-92	-14
16	-104	8
14	-100	-8
22	-96	-6
20	-8	16
-20	2	12
-12	-8	6
24	-62	-28
8	-74	-11
-54	-38	12
-48	-66	6
-50	-64	8
-46	-50	52
58	-42	12
52	-54	0
62	-40	24
-40	-50	-16
-40	-66	-20
42	-50	-14
-38	12	4
34	20	2
-46	-2	42
36	36	38
48	8	16
50	4	42
-6	-6	60
-24	-100	-2
-44	-80	-2
14	-102	14
-20	2	12
-38	-36	10
-64	-30	2
-26	20	-6
-24	20	6
20	-8	16
-26	8	4
10	-64	-26
-42	-36	12
-60	-44	42
-64	-30	2
-38	-28	-4
-48	-6	-10
54	4	-12
58	-40	24
62	16	22
-26	32	-4
-32	30	54
-6	-92	-12
-16	-98	-6
14	-104	12
22	-78	4
-24	-22	22

// Lee H J, 2007: Normals
// Subjects=15
-62	-38	14
-50	-56	4
-42	-50	52
58	-42	10
52	-38	6
56	-26	-4
56	-26	-4
60	-48	0
48	-62	4
36	-56	56
-42	-64	-20
46	-52	-14
44	-56	-24
-46	18	-4
-26	20	2
-30	18	-6
32	20	0
34	26	-10
-36	52	8
-42	18	42
-60	6	10
-52	4	36
44	32	38
36	42	22
54	16	30
44	8	26
48	4	40
-6	-4	60
10	16	38
-24	-100	-2
30	-90	-10
24	6	2
6	-20	6
-24	0	6
-10	-14	4
12	-76	-18
46	-62	4
44	-52	-16
-40	12	2
-6	-6	60
-24	-99	0
-24	-92	-1
28	-88	-10
-62	-36	14
-46	18	-4
-30	18	-6
30	18	-14
-34	56	10
-38	16	28
-44	18	40
-6	4	58
-4	14	50
4	-20	6
-10	-14	6
-42	-36	12
-60	-44	42
-64	-30	2
-38	-28	-4
-48	-6	-10
54	4	-12
58	-40	24
62	16	22
-26	32	-4
-32	30	54
-6	-92	-12
-16	-98	-6
14	-104	12
22	-78	4
-24	-22	22

// Meister I, 2007: Video, Perception > Rest
// Meister I, 2007: Picture, Phonological > Rest
// Meister I, 2007: Picture, Conception > Rest
// Meister I, 2007: Video, Perception > Video, Phonological and Video, 
// Conception
// Subjects=14
30	8	62
44	8	32
46	12	22
34	26	-4
52	40	15
44	58	10
-28	-4	56
-38	18	30
-50	6	20
-60	20	16
-50	40	-16
-4	16	52
26	-58	50
32	-68	40
-30	-46	40
-26	-60	44
40	-44	-20
10	-98	16
44	-72	10
-50	-58	-14
10	-90	0
-12	-74	-50
12	-78	-50
26	-30	0
-16	-24	16
42	56	-10
-4	16	52
-46	6	34
-48	46	8
-48	28	38
-6	38	44
-32	22	-2
-50	-36	50
-52	-64	-16
34	-44	-22
14	-98	12
-32	-88	-18
42	54	-14
-50	-28	50
-50	14	34
-42	0	38
-4	42	58
-28	-50	42
-28	-68	36
-50	-64	-12
-32	-86	-12
16	-102	16
26	8	64
38	-2	48
58	16	14
58	18	6
42	14	24
36	62	12
6	12	52
-28	-4	50
-56	6	42
-52	4	12
-42	46	28
18	-74	58
24	-60	48
44	-76	26
-22	-60	64
-66	-32	32
-48	-46	52
50	-62	-10
-48	-74	-16
-40	-48	-50
16	-24	12
-10	-16	12

// Qin S, 2007: Hit Discontinuous Associations vs. Hit Simultaneous 
// Associations
// Qin S, 2007: Formation of New Memories Including Associations vs. Miss
// Subjects=6
15	39	33
33	30	39
15	48	30
-33	-39	-9
-18	9	12
-21	12	-3
-18	3	-6
21	6	6
27	9	15
15	-60	18
-39	-63	15
-42	-69	27
-33	-81	36
36	-72	-9
30	-90	15
30	-87	-9
-9	-99	3
-30	-93	-6
-24	-33	-3
-18	-36	3
24	-6	-18
21	-27	-9
0	45	-18
-6	60	-12
15	36	-15
-36	-51	-15
-21	-6	-18
0	6	-9
3	60	24
-9	54	24
42	30	12
-42	33	-9
36	33	-15

// Rektorova I, 2007: Normals
// Subjects=8
-6	0	64
-4	6	62
2	10	56
-26	20	2
-62	-10	0
-62	-30	2
-52	10	-4
-48	-10	48
-60	-14	22
-54	-6	16
-24	-94	8
62	-20	2
52	-10	4
58	-4	16
50	-14	40
4	18	38
4	-6	34
42	20	10
28	-74	46
-8	16	38
-10	-12	42
-54	-6	34
-38	-6	52
56	-4	36
44	-2	44
48	-72	-10
30	-6	48
-14	-64	52
16	-18	8
10	-18	6
-8	-18	6
-20	10	-10
6	-76	-6
-2	-78	6
-44	30	8
-50	-72	28
-10	-54	32
-48	-64	46
-52	-14	44
16	-12	10
-4	12	60
26	-62	40
-52	-14	44

// Rektorova I, 2007: Parkinson's Disease Patients
// Subjects=9
-4	12	60
4	8	62
-2	-28	-8
-30	6	4
-40	26	2
-28	18	-2
-46	-24	8
-50	6	-8
-64	-26	2
-52	-14	44
-58	-4	22
-56	-16	16
-18	-96	-2
50	-14	4
66	-12	4
42	-14	48
46	-14	36
8	6	46
6	20	40
4	-8	36
-2	-32	-4
46	8	-4
42	14	0
26	-62	40
-50	-40	2
-50	-66	28
-6	22	44
-12	-18	42
-46	-10	32
-42	-6	56
46	0	46
54	-6	34
26	-76	6
34	-4	46
26	6	0
-16	-56	56
16	-12	10
46	-70	20
48	-56	10
50	-64	28
0	-62	36
-58	-4	22
46	-14	36
-30	6	4
46	8	-4
-6	22	44
6	20	40
-42	-6	56
16	-12	10
26	6	0
50	-14	4
-58	-4	22
-18	-96	-2
-64	-26	2
66	-12	4
-38	-6	52
-44	30	8
-54	-6	16

// Schnell K, 2007: Borderline Personality Disorder (BPD) Patients
// Subjects=6
-39	-7	28
-15	6	63
-18	8	44
65	-38	7
59	-40	16
18	-14	62
6	-6	58
15	53	19
27	53	19
33	34	34
3	17	52
3	12	63
-62	-40	13
9	-45	41
21	-4	39
-15	-4	39
-56	-4	36
62	-10	36
9	-24	51
42	30	15
33	11	41
-30	-23	9
-33	-17	15
21	-16	-19
-59	-25	15
-59	6	-3
-50	-40	13
65	-14	6
56	-18	-9
50	-26	12
24	-66	12
12	-75	18
-6	-83	21
6	-60	20
33	-5	9
21	19	27
62	-24	-11
-45	-14	15
56	-57	22
3	-40	19
59	-39	32
50	-65	34
3	-50	44
15	-45	35
9	-57	30
-6	-80	29
3	-83	26
21	19	27
24	28	29
18	-6	53
53	24	15
-18	-4	-20
-36	-24	-16
-24	-13	-17
-12	-49	5
24	-24	-14
21	-15	-17
56	-57	22
21	-27	37
3	-40	19
21	-29	59
12	-53	47
42	-68	31
-3	-47	44
59	-42	33
50	-65	34
0	-86	26
0	-67	6
9	-83	35
9	-89	27
18	-73	-4
6	-60	17
27	23	23
21	22	22

// Schnell K, 2007: Normals
// Subjects=6
-39	-7	28
-15	6	63
-18	8	44
65	-38	7
59	-40	16
18	-14	62
6	-6	58
15	53	19
27	53	19
33	34	34
3	17	52
3	12	63
-62	-40	13
9	-45	41
-36	25	-16
50	7	30
18	-47	-8
-30	-53	-7
-36	-59	-12
48	-67	1
21	-73	48
36	-71	34
-36	-81	21
-6	-76	-4
45	-76	4
3	-86	24
18	-72	15
-6	-81	12
3	41	-2
39	-31	26

// Simmonds D J, 2007: Go Activations
// Simmonds D J, 2007: No-Go Activations
// Simmonds D J, 2007: Go Activations Negatively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: Go Activations Positively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: No-Go Activations Negatively Correlated with 
// Intraindividual Coefficient of Variability
// Simmonds D J, 2007: No-Go Activations Positively Correlated with 
// Intraindividual Coefficient of Variability
// Subjects=30
-5	-105.78	8.21
-41.35	-15.53	57.04
-6.91	7.68	50.8
13.75	-70.41	-39.31
3.4	-44.06	1.96
-18.03	-97.52	5.37
44.35	-57.82	-9.71
-2.58	15.46	53.32
11.86	-54.2	-15.11
29.07	-25.11	-14.92
62.89	-35.68	7.96
63.34	-50.96	39.72
-31.32	23.65	4.81
35.74	20.05	8.51
-58.13	-42.8	7.36
24.72	-42.87	-20.94
20.81	-1.51	19.86
20.75	53.88	26.71
-37.3	-20.78	35.08
20.52	-71.5	-16.91
51.63	-9.15	62.67
-18.44	-44.84	-16.64
-13.2	9.11	66.45
-66.53	-38.83	27.28
53.31	-12.78	23.78
22.53	69.58	-.65
14.1	2.23	2.8
18.54	2.01	11.71

// Smits M, 2007: (Lemon + Chocolate) vs. Sweetened Water
// Smits M, 2007: Lemon vs. Sweetened Water
// Smits M, 2007: Chocolate vs. Sweetened Water
// Subjects=7
32	-28	18
50	12	20
-26	-14	30
-62	2	6
-58	-10	8
58	-10	2
52	-52	-16
54	-44	-10
54	-56	-4
-18	-50	-8
28	-84	18
-12	-74	20
32	-28	18
-56	0	26
30	64	2
40	-76	18
46	-72	30
56	-44	-10
58	-10	4
-54	-62	36
46	-66	-8
30	-84	6
18	-80	40
-18	-82	42
40	-68	44
48	-60	42
50	12	20
-14	-74	-6
-16	-78	0
-2	-86	6
-6	-78	20

// David S P, 2007: Smoking-Related Pictures vs. Neutral Pictures, 
// Non-Abstinent
// David S P, 2007: Smoking-Related Pictures - Neutral Pictures, Abstinent
// Subjects=8
44.6	-72.2	-6.61
-44.5	-69.2	-10.4
45.3	-79.3	-11.8
-43.9	-69.5	-16.1

// Livesey A C, 2007: Duration Discrimination > Easy Color Discrimination
// Livesey A C, 2007: Duration Discrimination > Difficult Color Discrimination
// Subjects=10
45.19	50.85	-7.03
-50.96	48.38	-5.14
57.03	-28.9	57.81
2.79	28.34	53.07
0.63	28.33	53.11
38.8	26.36	-4.49
-19.61	7.04	-12.79
15.01	11.94	-8.26
-37.9	25.03	-3.06
-45.59	-68.93	-31.73
-64.18	-36.31	42.68
44.3	21.69	2.6
-45.31	21.79	8.6
-15.27	9.39	-10.86

// Gobbini M I, 2007: False Belief Stories vs. Physical Stories, Activations
// Gobbini M I, 2007: False Belief Stories vs. Physical Stories, Deactivations
// Gobbini M I, 2007: Intentional Movement Animation vs. Random Movement 
// Animation, Activations
// Gobbini M I, 2007: Intentional Movement Animation vs. Random Movement 
// Animation, Deactivations
// Gobbini M I, 2007: Point Light, Biological Motion vs. Point Light, 
// Scrambled Motion, Activations
// Gobbini M I, 2007: Point Light, Biological Motion vs. Point Light, 
// Scrambled Motion, Deactivations
// Subjects=12
-2.23	58.31	5.57
7.58	58.13	30
11.57	62.9	-5.02
-21.26	53.73	30.7
39.35	22.4	-22.01
11.06	29.2	54.69
-55.13	-59.5	28.32
38.17	13.54	-40.21
-52.61	11.31	-33.41
-35.28	-28.97	-19.08
6.76	-13.95	33.83
-10.21	-49.03	35.85
-43.75	35.48	16.88
-43.6	5.16	23.88
56.79	-48.63	-6.22
-50.11	-50.75	-10.39
-26.11	-71.88	44.64
-50.74	-39.62	51.14
-11.44	-93.53	-2.78
9.6	56.95	14.47
-50.18	27.61	12.04
54.47	31.87	2.67
4.71	20.96	58.8
-1.89	43.16	43.63
49.41	11.69	31.19
-48.1	-14.7	-12.32
-59.48	-58.18	18.22
51.6	-44.83	15.83
53.28	5.31	-24.08
-50.41	10.95	-24.48
46.14	-54.86	-3.34
-41.55	-56.07	-11.16
38.56	-56.02	-17.66
10.13	-48.48	41.14
-61.59	-31.53	32.74
49.48	-22.75	26.27
-24.62	24.62	-1.39
19.35	5.65	10.85
7.57	-22.14	-3.41
-28.82	-81.14	-33.73
15.9	-30.92	-35.11
-2.82	-22.38	35.76
46.97	31.56	-.56
40.81	14.38	25.48
49.32	39.35	31.1
64.44	-35.86	20.5
-54.18	-60.78	11.69
49.56	-75.76	15.1
47.28	-70.63	-.92
-45.61	-78.08	7.46
31.57	-64.13	43.33
-42.6	-68.05	-14.6
43.86	-44.36	-18.69
-14.73	-87.81	-11.03
-25.36	-100.47	-8.73
26.75	12.58	3.49
13.91	-71.2	-32.83
-57.38	-9.13	33.04
53.96	-20.58	53.91
-39.27	-30.48	16.78

// Malhi G S, 2007: Euthymic Bipolar Patients
// Subjects=10
50	26	4
-38	22	-4
-46	30	4
-6	-60	14
52	4	-8
-54	-4	-20
-56	-14	-4
-54	0	-10
26	-76	-10
30	-78	-18
22	-60	-38
42	24	-6
48	20	2
-44	20	2
10	50	2
8	48	-6
-6	42	-6
42	6	-24
46	12	-12
-38	-16	-6
18	-70	2
-22	-90	-6
22	-62	-38
28	28	36
-31	44	12
18	6	49
-10	5	49
34	-18	36
20	-24	49
3	21	36
-12	18	36
17	-22	36
-43	-33	33
-43	-30	36
17	-37	7
18	-15	4
21	-15	7
16	-36	14
21	-23	14
-20	7	15
11	43	19
-18	56	16
-19	59	27
27	47	16
27	54	13
-31	53	4
35	-16	61
48	-11	35
-46	-11	35
6	34	16
-7	-6	43
-61	-29	4
17	-54	6
16	-84	-6
12	-73	16
-13	-70	35
11	11	16
-13	17	-1
13	-26	-19
5	-39	-11
13	-33	-11

// Malhi G S, 2007: Normals
// Subjects=10
14	58	20
16	42	34
-12	48	34
-34	22	-6
-38	24	4
-44	20	12
-8	-54	20
40	10	-22
40	6	-12
-42	10	-22
-48	-2	-6
-44	6	-12
-42	-46	6
-38	-62	20
-40	-22	-4
12	2	-4
-8	4	4
14	-40	44
46	26	2
-36	24	6
-32	18	-8
-4	48	38
-2	56	20
60	-6	20
-2	-44	20
64	-30	6
-36	2	-20
-36	2	-30
-46	-60	20
46	-2	-30
-56	-20	-8
-52	-48	2
-40	20	2
-34	-72	-12
-14	-54	-42
32	-66	-30
28	28	36
-31	44	12
18	6	49
-10	5	49
34	-18	36
20	-24	49
3	21	36
-12	18	36
17	-22	36
-43	-33	33
-43	-30	36
17	-37	7
18	-15	4
21	-15	7
16	-36	14
21	-23	14
-20	7	15
11	43	19
-18	56	16
-19	59	27
27	47	16
27	54	13
-31	53	4
35	-16	61
48	-11	35
-46	-11	35
6	34	16
-7	-6	43
-61	-29	4
17	-54	6
16	-84	-6
12	-73	16
-13	-70	35
11	11	16
-13	17	-1
13	-26	-19
5	-39	-11
13	-33	-11

// Saarela M V, 2007: Provoked - Chronic Pain
// Saarela M V, 2007: Pain Intensity Ratings Correlated With Activations Due 
// To Face Stimuli
// Subjects=12
-41.68	20.55	2.49
46.97	24.96	-3.36
-5.14	25.1	30.69
3.65	12.32	57.31
-58.32	-47.29	35.14
-49.8	-1.46	49.04
-60.44	-58.13	32.73
40.52	19.04	-10.59
-8.28	29.11	41.54
-38.57	13.02	-12.52

// Schoning S, 2007: Males
// Subjects=12
-40	-54	62
-36	-50	46
-34	-40	44
36	-64	60
52	-44	58
10	-78	58
4	18	50
-22	-4	60
-20	-14	64
-50	10	28
-36	14	22
-54	10	38
-26	28	-4
-30	24	6
-46	30	32
-36	30	24
34	24	-6
40	34	20
52	30	34
30	-4	62
46	-52	-16
48	-62	-18
-38	-62	-22
-44	-76	-18
-32	-66	-10
30	-92	-4
-6	-80	-32
30	-68	-34
36	-48	-34
30	-42	-34
-28	-66	-12
-48	-42	26
-42	-34	40
-42	-50	58
-28	-66	-10
-38	-30	42
-28	-28	36
42	2	6
-8	-52	-42
-46	-16	58
-30	-30	70
40	20	50
-36	-52	10
-2	60	32
18	12	12

// Schoning S, 2007: Early Follicular Females
// Subjects=12
-42	-54	50
-36	-62	52
-46	-44	52
-44	-30	36
22	-76	54
10	-74	52
30	-60	32
58	-28	34
-30	-6	52
-12	-8	66
-22	-10	64
-24	26	-16
-48	10	22
-58	12	32
-30	26	10
56	10	20
20	2	60
32	-4	64
42	2	32
-36	-56	-24
52	-54	-22
42	-52	20
-40	-84	-10
-38	-70	-34
-44	-56	-34
36	-88	4
44	-82	-10
30	-78	0
-18	-8	0
-18	-30	10
-10	-76	-36
24	-68	-34
30	-62	-40
32	-48	4
-28	-66	-12
-48	-42	26
-42	-34	40
-42	-50	58
-8	-52	-42
-46	-16	58
-30	-30	70
40	20	50
-64	-36	22
-10	-12	62
-34	-48	8
-10	-16	-10
10	36	2
2	40	2
-6	4	32
-14	0	12
10	32	16
6	26	20
6	40	20
38	-72	20
34	-80	30
50	28	30
25	16	28

// Schoning S, 2007: Midluteal Females
// Subjects=12
-28	-80	28
-26	-70	34
-28	-48	34
28	-62	34
34	-52	40
28	-72	44
-8	2	58
-46	12	20
-40	2	44
-24	-4	54
-28	22	-12
-30	30	-12
40	20	4
34	30	0
50	6	48
32	-2	48
56	10	22
10	26	38
6	29	48
-8	2	58
-36	-88	-8
-38	-88	2
-32	-86	-20
32	-56	-36
44	-68	-12
42	-58	-28
-18	-2	8
-30	-60	-40
-42	-66	-32
-42	-58	-38
6	-68	-36
14	-68	-32
-28	-66	-10
-38	-30	42
-28	-28	36
42	2	6
-36	-52	10
-2	60	32
18	12	12
-64	-36	22
-10	-12	62
-34	-48	8
-10	-16	-10
10	36	2
2	40	2
-6	4	32
-14	0	12
10	32	16
6	26	20
6	40	20
38	-72	20
34	-80	30
50	28	30
25	16	28

// Butler T, 2007: Threat - Safety
// Butler T, 2007: Safety - Threat
// Subjects=42
12	12	9
33	27	9
-30	27	9
-15	6	9
48	21	-3
21	6	0
6	-18	9
-9	-9	6
3	30	39
51	-33	36
-69	-24	30
39	9	39
-57	15	3
0	-30	30
27	-99	-6
48	18	27
-30	-21	3
-39	-12	21
45	-66	33
-27	-18	-15
12	-48	3
48	-9	39
30	-15	-18
-3	75	3
-45	-12	36
-12	-81	30
-42	-66	39

// Cheng Y, 2007: Normals
// Subjects=14
-50	-66	-14
46	16	-2
2	-42	-2
46	26	22
-62	-26	28
48	8	40
-38	-4	60
-41	-43	60
-2	15	41
-28	-94	8
-60	-24	34
26	-70	56
-20	-66	60
-4	-34	-15
40	20	-9
-36	16	-1
4	18	45
6	2	54
-6	-12	73
48	8	42
-38	-4	59
32	-16	-30
-28	-30	-18
-34	-92	-12
4	62	6
-34	-12	12
-54	-4	26
50	-14	28
18	-28	30
-34	10	36
-4	-40	38
14	42	50
-14	30	48
36	-54	40
44	18	-12
-40	14	-8
24	-70	2
58	14	0
62	-54	0
-4	-86	18
-60	-26	20
-38	36	30
38	-2	60
48	8	42
2	10	42
12	-64	-40
-34	-92	-12
-20	-76	50
-30	4	64
-24	-78	-24
24	-70	2
58	-52	2
-38	-68	20
-4	-88	20
26	40	-8
-14	58	8
10	60	14
14	34	48
-12	24	52
-4	-36	-20
40	22	-14
-38	16	-8
0	24	30
38	-2	58
-6	-2	74
-38	10	-4
-44	20	4
46	6	38
4	8	44
-26	-52	68
-52	-38	16
46	6	38
4	6	46
-34	-30	66
0	62	4
-24	-84	-8
26	22	56
-26	-84	-8
16	38	46
-8	60	2
26	28	-8
-10	-78	8
38	-14	14
42	-2	42
-40	-22	60
-6	-76	12
-40	22	16
36	-16	18
-50	-18	32
-2	4	42
-42	-86	8
-30	-64	62
-2	-54	64
-42	-82	6
32	-86	10
-42	40	32
30	-60	58
-32	-62	62

// Cheng Y, 2007: Acupuncture Experts
// Subjects=14
-46	-76	-12
22	-26	-8
-22	-26	-12
44	6	30
-52	4	44
38	-52	52
-32	0	66
-14	-98	-10
-20	-28	-8
-54	6	42
-32	2	66
38	28	4
42	0	42
32	-16	-30
-28	-30	-18
-34	-92	-12
4	62	6
-34	-12	12
-54	-4	26
50	-14	28
18	-28	30
-34	10	36
-4	-40	38
14	42	50
-14	30	48
36	-54	40
44	18	-12
-40	14	-8
24	-70	2
58	14	0
62	-54	0
-4	-86	18
-60	-26	20
-38	36	30
38	-2	60
48	8	42
2	10	42
12	-64	-40
-34	-92	-12
-20	-76	50
-30	4	64
-24	-78	-24
24	-70	2
58	-52	2
-38	-68	20
-4	-88	20
26	40	-8
-14	58	8
10	60	14
14	34	48
-12	24	52
-4	-36	-20
40	22	-14
-38	16	-8
0	24	30
38	-2	58
-6	-2	74
-38	10	-4
-44	20	4
46	6	38
4	8	44
-26	-52	68
-52	-38	16
46	6	38
4	6	46
-34	-30	66
0	62	4
-24	-84	-8
26	22	56
-26	-84	-8
16	38	46
-8	60	2
-48	24	2
44	-16	18
-48	-20	20
40	-16	40
58	-22	54
-10	-90	22
16	-82	26
40	-16	40
56	-24	48
42	-88	4
-34	-84	12
16	60	6
-30	-56	56
22	-50	58
16	-30	-6
14	58	6
44	-66	4
18	50	42

// Lamm C, 2007: Observation of Patients Expressing Pain and the First-Hand 
// Experience of Pain
// Lamm C, 2007: Imagine Self > Imagine Other
// Lamm C, 2007: Imagine Other > Imagine Self
// Lamm C, 2007: Empathy Quotient, Other
// Lamm C, 2007: Empathic Concern Index, Other
// Lamm C, 2007: Emotional Contagion, Watching Pain
// Subjects=17
-52	-2	-16
-38	2	-20
-48	-8	-12
0	6	62
0	14	50
42	-2	-18
34	18	6
-38	18	4
-36	26	4
-32	26	-10
50	-44	18
40	-42	4
-10	12	40
44	20	-16
50	6	-14
22	10	-16
26	0	-22
-52	-26	26
-60	-34	24
42	8	-2
-16	-4	14
-30	2	8
-36	8	4
8	0	54
46	-14	56
22	-32	66
-38	-10	-12
-36	36	34
-60	8	2
26	-76	56
38	-68	56
24	-66	64
48	-64	44
26	0	10
-36	-2	12
0	-4	42
-22	-46	-24
14	16	28
30	16	12
44	18	8
-32	-10	10
16	-26	42
6	-4	52
50	-14	44
64	-38	34
-50	-42	36
-56	-44	56

// Martin R, 2007: Saliva Swallow vs. Rest
// Martin R, 2007: Water Swallow vs. Rest
// Martin R, 2007: Shifted Water Swallow vs. Rest
// Martin R, 2007: Water Swallow > Saliva Swallow
// Martin R, 2007: Saliva Swallow > Water Swallow
// Subjects=8
-54.23	-5.31	27.11
-56.26	-3.07	42.56
-54.33	-6.25	14.92
-62.87	-9.56	14.18
60.28	-9.43	46.21
65.46	6.49	31.44
7.9	6.55	51.05
8.04	-.8	66.16
-7.14	10	42.01
7.79	20.75	42.06
-41.32	25.37	51.15
43.13	16.28	49.83
50.88	-41.24	62.37
-61.45	-27.88	52.51
-42.68	2.56	4.01
-21.37	9.75	-1.29
-9.5	-17.59	1.98
5.48	-22.78	2.24
9.18	-74.75	45.59
7.84	-61.04	16.57
-21.97	-88.62	20.34
-33.78	-81.64	15.43
46.32	-81.58	8.93
44.48	-56.59	57.04
-27.07	-48.85	67.25
-3.58	-22.56	74.81
-2.54	-25.01	70.55
66.73	-48.57	34.93
9.98	-78.63	9.1
-18.96	-72	1.07
-25.45	-61.89	-5.28
-14.77	-54.17	-2.7
23.65	-47.85	-7.02
-54.23	-8.57	26.27
-40.08	-.29	63.33
-59.67	-5.23	14.9
53.87	-.66	50.01
-24.11	23.33	64.51
34.62	23.25	58.27
-3.81	3.65	55.89
12.24	5.06	58.93
-7.09	5.06	46.89
12.05	14.09	38.11
-41	-50.42	61.97
56.14	-62.92	42.94
62.55	-48.71	47.25
-12.71	-16.55	1.93
15.11	-4.95	11.79
45.91	15.18	-5.87
-5.74	-70.01	53.17
-31.39	-70.17	53.48
11.03	-69.99	10.6
7.1	-30.24	70.87
25.09	-89.06	24.3
-12.59	-60.33	0.02
16.32	-65.02	5.66
-20.18	-48.29	-8.71
-45.46	-4	57.01
-57.37	-5.7	36.1
-56.39	-8.84	22.97
-62.79	-18.57	21.63
59.12	-7.03	35.99
60.14	7.78	34.74
64.31	-2.03	17.67
-16.52	6.97	72.49
-41.54	42.86	29.62
28.25	24.7	63.79
48.46	18.42	49.59
-.43	-9.85	73.71
-7.05	-2.17	49.73
4.96	-20.39	74.53
-9.28	3.39	39.25
25.04	-29.19	41.59
4.48	26.31	31.59
-45.35	-33.61	59.49
49.79	-41.5	59.06
30.96	-2.34	-10.92
44.9	5.92	-1.73
28.29	-89.04	24.26
10.05	-81.2	17.12
9.12	-74.21	38.85
-1.77	-76.41	11.28
-7.03	-95.39	14.05
-1.46	-73.24	52.28
4.99	-29.91	75.33
26.16	-87.91	25.31
14.14	-56.74	2.76
-9.32	-76.09	2.42
-13.69	-57.34	-2.45
-36.11	39.35	38.77
-46.75	26.6	39.96
50.53	18.81	40.61
48.12	48.97	18.04
8.69	59.71	36.55
51.51	5.81	23.85
40.01	-28.93	43.62
-5.21	50.74	31.88
1.12	55.47	23.61
-43.61	9.47	24.63
-9.24	27.94	53.92
-19.2	14.51	4.97
-10.53	3.7	15.82
-16.76	-72.45	8.89
22.86	-75.75	17.64

// Sanjuan J, 2007: Schizophrenic Patients
// Subjects=10
-60	-24	-2
-54	-12	-12
-24	24	4
28	16	-12
16	-8	38
2	-52	28
4	-36	30
24	-4	-14
52	38	-8
-4	56	-8
38	38	-14
8	54	34

// Sanjuan J, 2007: Normals
// Subjects=10
-62	-16	6
48	0	-14
-60	-38	10
64	-48	12
-34	28	-12

// Sabatinelli D, 2007: Normals, Study 1
// Subjects=22
-4.39	44.92	-2.21
11.71	10.58	-7.32
25.6	-5.89	-15.02
42.93	-62.63	-7.12
51.51	-76.58	-9.39
48.34	3.93	27.39
35.96	-58.5	60.65
62.33	-26.82	27.58
-9.66	10.45	-7.06
-23.56	-6.18	-14.43
-40.42	-63.13	-6.12
-48.94	-77.18	-8.18
-45.7	3.37	28.52
-32.43	-58.91	61.47
-59.49	-27.55	29.04
9.82	21.94	29.67
0.58	-59.91	45.56
29.35	-.21	58.06
-32.11	25.63	-1.39
23.45	-5.98	-16.1
37.6	-72.43	-9.58
43.01	-81.57	-4.41
51.42	19.13	17.16
31.54	-72.13	36.19
19.54	-90.17	-3.42
-2.9	-3.43	33.06
58.11	-19.64	38.17
25.47	35.61	-15.15
-21.43	-6.25	-15.56
-35.06	-72.87	-8.71
-40.34	-82.07	-3.41
-49.03	18.53	18.36
-55.16	-20.32	39.53

// Sabatinelli D, 2007: Normals, Study 2
// Subjects=22
-3.32	42.72	-3.15
-3.23	3	-7.63
5.32	3.05	-7.73
-20.33	-8.1	-12.08
-43.75	-60.03	-20.84
46.02	-59.49	-21.91
-47.88	-71.8	-7.53
50.43	-71.21	-8.71
-23.63	16.11	-15.18
25.52	16.41	-15.77
6.89	-60.99	31.08
2.51	-10.46	38.04
33.8	-49.97	61.07
-28.4	-5.39	51.36
31.44	-5.03	50.64
-22.56	-5.8	-23.4
40.85	-71.98	-4.08
-38.23	-72.46	-3.13
39.76	-80.96	-10
-30.07	12.56	-19.27
9.95	-62.43	12.21
11.06	-9.27	38.96
5.84	-84.94	24.18
2.24	27.38	18.14

// Winston J S, 2007: Attractiveness Judgment > Age Judgment
// Winston J S, 2007: Age Judgment > Attractiveness Judgment
// Winston J S, 2007: Task x Attractiveness Interaction
// Winston J S, 2007: High Attractiveness + Low Attractiveness > Medium 
// Attractiveness
// Subjects=26
-60	-45	9
-48	-42	3
54	-48	27
51	-21	-6
-36	21	-24
-51	24	-6
0	51	18
-6	60	15
3	54	30
-9	27	60
-18	54	39
-18	45	42
3	36	9
0	-18	39
54	0	-36
-24	0	-24
12	-51	18
-9	-54	12
0	60	-6
27	0	-24
60	-42	0
-3	30	-27

// Jabbi M, 2007: Correlation, Personal Distress + Disgusted Faces
// Jabbi M, 2007: Correlation, Fantasy + Disgusted Faces
// Jabbi M, 2007: Correlation, Empathic Concern + Disgusted Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Disgusted Faces
// Jabbi M, 2007: Correlation, Personal Distress + Pleasant Faces
// Jabbi M, 2007: Correlation, Fantasy + Pleasant Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Pleasant Faces
// Jabbi M, 2007: Correlation, Personal Distress + Neutral Faces
// Jabbi M, 2007: Correlation, Fantasy + Neutral Faces
// Jabbi M, 2007: Correlation, Empathic Concern + Neutral Faces
// Jabbi M, 2007: Correlation, Perspective Taking + Neutral Faces
// Jabbi M, 2007: Unpleasant Taste - Neutral Taste + Disgusted Faces - Neutral 
// Faces
// Jabbi M, 2007: Pleasant Taste - Neutral Taste + Pleasant Faces - Neutral 
// Faces
// Subjects=18
20	4	2
-44	26	-10
0	-22	-22
46	38	-4
20	-46	0
-24	-60	2
-10	50	10
-4	32	10
40	34	16
50	2	18
42	-46	22
-60	-52	32
62	-42	36
8	12	26
-6	20	30
-48	10	32
-6	-12	38
-36	-2	42
42	12	38
-46	8	2
30	10	-10
48	22	-22
14	12	-4
-46	34	0
40	-32	2
-10	4	10
50	38	10
40	-50	16
-30	56	18
26	62	22
46	24	32
32	32	36
-12	28	26
0	-36	30
-10	54	32
58	-52	38
-44	14	42
-12	22	38
12	-34	-18
12	4	-16
-36	18	-4
10	-18	26
-32	14	-26
44	12	-18
-10	-2	-16
34	-28	-4
-20	58	-6
-44	16	-2
44	-50	10
-38	50	10
22	60	14
34	34	22
50	24	16
-14	40	22
6	-16	24
26	44	36
42	22	44
12	52	42
2	-38	-34
40	30	22
-38	20	-14
22	-6	0
-4	30	8
-28	0	16
48	-48	20
40	12	40
42	26	44
32	-6	-26
32	14	-18
-54	-10	-16
28	-26	-8
16	16	-14
-12	62	-8
24	48	-2
-30	56	10
-44	32	14
-6	48	8
40	-52	32
-32	28	16
10	-58	20
-10	-56	22
-16	28	24
-6	-30	26
-10	52	34
22	50	34
-44	14	44
40	24	46
10	32	50
-14	20	50
-30	6	50
48	8	-20
42	28	-18
-42	20	-20
-8	-4	-14
-14	60	-10
28	-28	-6
10	28	-4
38	22	48
30	-8	0
52	28	2
18	60	4
40	-48	12
14	28	26
-26	24	18
-18	38	18
10	-46	18
4	-36	32
12	28	50
26	-10	-24
-18	12	-8
24	0	2
46	16	-10
18	14	-10
2	-24	-2
-2	30	8
42	36	12
48	-4	26
32	-20	38
10	-16	44
-4	-16	50
32	16	-20
-24	8	-16
36	36	-14
16	18	-12
52	34	-4
32	34	2
-22	-22	2
40	-52	28
-52	20	12
-38	46	10
38	26	18
-12	24	26
-30	4	50
-38	-62	44
-10	30	46
26	-52	66
42	-48	14
-40	-52	28
-36	16	-24
22	-6	-26
40	30	-16
10	-24	-14
-14	-6	-14
30	-4	-10
-12	60	-6
36	-30	2
-30	18	22
18	56	6
38	-54	32
42	22	46
-14	38	18
-40	-66	42
6	36	50
52	18	-6
-38	24	-10
-44	30	0
-14	12	2
6	6	58
-34	8	-14
28	-18	42

// Keightley M L, 2007: Young Adults
// Subjects=10
12	32	-16
28	44	20
32	56	8
-24	40	44
0	68	4
-4	-4	56
8	24	-12
28	8	0
24	-72	8
-28	-88	28
-4	-52	36
20	-72	24
-20	-72	-12
60	-32	32
-60	-24	32
60	4	-4
-48	-20	4
-16	-44	36
-8	24	40

// Keightley M L, 2007: Older Adults
// Subjects=11
4	52	-4
4	-60	-4
56	-8	28
-60	0	12
-8	16	40
4	-8	40
12	60	12
-52	52	-8
40	28	-8
44	40	16
-48	8	36
24	-28	48
-28	-12	52
-32	8	48
40	-40	20
44	-36	0
-40	-44	4
36	-72	16
-20	-32	4

// Lanius R A, 2007: Post-traumatic Stress Disorder (PTSD) Subjects without 
// Major Depression
// Subjects=11
48	0	2
-32	14	6
16	48	10
36	30	30
-54	6	0
-56	4	22
0	55	-5
4	-54	26
2	32	16
46	42	-2
-46	12	-2
0	26	18
-6	-36	28

// Lanius R A, 2007: Post-traumatic Stress Disorder (PTSD) Subjects with Major 
// Depression
// Subjects=15
2	28	14
-2	-60	28
2	-44	28
50	38	0
-6	56	6
-12	-14	6
-6	52	4
46	40	-2
4	22	20
-2	-60	28
-46	12	-2
0	26	18
-6	-36	28

// Lanius R A, 2007: Control Subjects
// Subjects=16
40	18	6
16	-58	24
52	20	4
50	32	10
46	30	18
26	58	0
2	32	16
46	42	-2
-12	-14	6
-6	52	4
46	40	-2
4	22	20
-2	-60	28

// Pavuluri M N, 2007: Angry Faces vs. Neutral Faces, Pediatric Bipolar 
// Patients > Controls
// Pavuluri M N, 2007: Angry Faces vs. Neutral Faces, Controls > Pediatric 
// Bipolar Patients
// Pavuluri M N, 2007: Happy Faces vs. Neutral Faces, Pediatric Bipolar 
// Patients > Controls
// Pavuluri M N, 2007: Happy Faces vs. Neutral Faces, Controls > Pediatric 
// Bipolar Patients
// Subjects=10
16.24	20.92	29.68
14.97	-28.41	-16.35
36.77	-78.76	18.84
34.58	-74.88	14.08
-13.82	24.83	14.08
-14.62	-47.17	19.01
-36.48	-16.09	-31.29
-52.19	-47.96	-1.68
31.2	51.73	41.42
22.55	62.79	33.9
46.87	50.34	-5.48
10.7	38.63	11.53
14.35	-20.45	45.44
17.99	-12.76	-34.43
38.35	28.63	-10.25
8.77	-99.81	-16.99
14.5	-92.49	35.86
54.77	-41.98	11.09
-18.96	36.79	45.48
-38.7	50.03	-15.63
-32.98	-37.19	-1.69
-20.34	-29.14	-22.58
-23.23	-99.4	-8.85
-26.21	-96.05	21.02
-52.18	-34.76	3.91
-48.73	-80.5	17.74
33.37	32.37	38.56
1.18	27.46	19.27
9.93	-41.74	18.28
33.05	-6.1	-18.43
17.11	-28.31	-15.27
48.15	-14.5	-4.52
17.66	-84.19	32.9
-9.31	37.2	49.8
-27.9	39.23	-4.81
-9.68	44.26	3.48
-11.41	-51.47	18.22
-28.77	-29.05	-6.88
-24.77	-9.84	-34.18
-30.06	20.3	-15.46
-62.64	-62.09	23.05
25.74	62.56	30.54
25.74	62.56	30.54
40.38	53.85	-14.62
33.02	-3.1	-20.92
22.26	-13.88	-35.5
44.76	25.32	-12.28
4.55	-93.86	-8.52
28.29	-79.18	27.9
69.62	-45.2	-4.42
60.04	-63.5	-6.12
-25.21	15.32	57.39
0.06	63.2	27.43
-14.15	64.18	-13.75
-9.48	45.26	30.16
-34.24	-27.02	-21.48
-44.7	-9.45	13.97
-22.04	-101.46	5.81
-22.02	-101.28	8.02
-42.34	-62.05	21.7
-45.58	-83.28	9.02

// Hou C, 2007: PTSD Patients
// Subjects=10
-6	-48	6
-6	9	9
6	9	9
12	-9	0
9	33	30
-42	48	15
39	60	12
69	-18	9
-24	-51	-6
3	48	3
-57	21	24
42	57	15
-42	33	18
-42	48	15
51	-78	21
-54	-45	-15
-33	-36	69
66	-21	9
6	-51	15
28	-20	-18
-21	-24	-18
57	33	15
42	57	6
18	-33	-12

// Hou C, 2007: Normals
// Subjects=7
-15	-24	-6
21	-27	12
-9	-9	15
-33	-12	21
-3	60	24
-3	54	39
45	18	27
-42	33	18
57	-66	-15
-51	-69	6
48	-42	-24
54	-51	-15
51	12	-18
24	-21	-9
-24	-51	-6
3	48	3
-57	21	24
42	57	15
-42	33	18
-42	48	15
51	-78	21
-54	-45	-15
-33	-36	69
66	-21	9
3	-39	24
-3	60	-18
-3	33	39
-12	63	27
-21	63	15
48	39	33
-51	27	-12
15	-30	12
18	-15	18
-66	-42	-3
-24	-15	0
21	-6	3
9	9	6
-9	6	6
18	-99	-15
57	33	15
42	57	6
-3	-6	30
6	-36	24
3	27	60
-42	0	12
42	-33	6
69	-12	9
-12	-27	15
9	9	6
3	3	3
15	-90	9
12	-93	0

// Rauch S L, 2007: Implicit Learning vs. Random, All Subjects
// Rauch S L, 2007: Implicit Learning vs. Random, OCD Patients > Healthy 
// Controls
// Subjects=12
20	16	-6
14	38	-14
-16	38	-12
18	-10	10
20	-12	-16
26	22	-20

// Obleser J, 2007: Voiced and Voiceless Consonants > Spectrally Rotated 
// Analogues
// Obleser J, 2007: Voiced Consonants > Voiceless Consonants
// Obleser J, 2007: Spectrally Rotated Analogues > Voiced and Voiceless 
// Consonants
// Obleser J, 2007: Correlation with Spectral Peak of Consonantal Burst
// Subjects=13
-78	-18	0
26	2	2
0	50	-2
-68	-16	4
78	-4	-4
64	-26	8
-66	-34	22
-66	-50	16
60	14	-4

// Beneventi H, 2007: N-back Main Effect
// Beneventi H, 2007: Facial Expressions > Scrambled Drawings
// Subjects=12
-44	-55	-11
24	-52	43
0	21	43
-28	-56	51
40	40	20
28	24	0
28	7	55
-8	-79	-20
-44	6	44
-32	23	-1
40	-67	-17
-40	36	17
-44	9	25
4	11	62
48	-59	-7
-8	3	62
-32	-83	-16
4	-79	-16
-36	-75	-16
44	-55	-14
-40	39	9
-20	-86	-13
28	-92	4
-28	6	44
40	35	2

// Brown S, 2007: Melody Discrimination > Tone Discrimination
// Brown S, 2007: Harmony Discrimination > Tone Discrimination
// Brown S, 2007: Melody Listening > Rest
// Subjects=11
54.79	4.4	32.85
52.48	17.99	16.12
39.42	52.84	-0.03
43.85	39.09	14.45
48.08	34.2	5.89
-49.87	-4.34	39.25
-56.58	10.14	6.88
54.57	-19.83	-5.26
67.44	-19.24	1.23
63.15	-28.24	-4.66
65.36	-29.66	4.36
-60.8	-22.29	0.73
-54.25	-40.6	11.11
-56.59	-9.75	-2.6
-50.28	0.18	-12.43
-52.41	6.85	-8.5
-67.1	-32.22	10.56
-53.93	-57.07	45.95
5.74	7.42	48.77
52.31	13.99	-8.07
-30.96	-64.7	-27.28
54.79	4.4	32.85
3.65	3.52	53.59
52.46	17.82	13.91
48.22	9.34	14.67
39.44	53.01	2.19
43.84	41.2	14.28
47.94	48.15	-6.43
52.82	-2.7	51.31
50.21	40.73	7.55
44.3	-2.41	55.85
-45.61	-4.49	36.98
-52.27	10.51	11.26
-45.7	5.57	29.45
-43.6	7.36	24.81
-45.85	26.03	18.81
-.67	24.99	56.3
-35.44	53.99	-5.96
65.31	-19.25	1.26
65.37	-31.77	4.54
56.56	11.56	-12.38
-56.51	-22.1	2.9
-52.4	4.74	-8.32
-52.33	-9.9	-4.87
-67.1	-32.22	10.56
-67.04	-40.34	15.7
-52.09	-42.54	13.48
5.66	15.37	41.42
5.5	-23.67	4.55
-37.44	13.63	-4.78
61.06	-21.22	3.7
52.39	-7.16	-6.3
-50.15	-11.66	-.28
-50.06	-21.72	7.25
-58.6	-23.88	7.53
-52.13	-31.96	12.59
-56.31	-42.05	20.18

// Chen C H, 2007: fMRI Correlates of Depressive Symptom Severity at Baseline 
// (Pre-treatment)
// Chen C H, 2007: fMRI Predictors of Symptom Changes After Antidepressant 
// Treatment (Post-treatment)
// Subjects=17
-.14	56.81	-2.99
-1.11	43.89	10.11
-7.54	54.44	-6.11
6.18	48.29	-22.42
-20.25	47.87	-25.57
-10.6	27.1	-4.22
12.75	14.93	17.56
16.82	40.01	-4.16
11.58	25.97	-8.71
21.24	5.61	19.26

// Monterosso J, 2007: Hard Choice > No Choice
// Monterosso J, 2007: Easy Choice > No Choice
// Monterosso J, 2007: Hard Choice > Easy Choice
// Subjects=12
42	37	12
-47	15	33
34	-57	48
-41	39	-2
-34	-54	49
-3	26	42
-31	-55	48
-43	12	33
31	-62	44
43	42	19
-7	27	40

// Ramasubbu R, 2007: Mother > (Friend + Older Unknown Face + Younger Unknown 
// Face)
// Subjects=10
3	42	-6
12	36	-9
45	45	12
-3	-54	27
6	-60	30

// Wittmann M, 2007: Delay Reward vs. Immediate Reward
// Wittmann M, 2007: Delay < 1 Year vs. Delay >= 1 Year
// Subjects=13
-3.88	-53.11	23.85
-54.11	-63.35	19.71
45.04	-11.29	9.74
-41.58	-4.83	4.62
-41.23	-53.87	31.03
-51.78	-65.77	43.31
-.47	-76.21	41.36
-19.25	11.79	-2.61

// Yoo S S, 2007: Sleep Deprived Subjects
// Subjects=14
-3	-90	-9
-12	-87	-18
9	-81	-15
6	9	51
-6	9	48
33	27	0
-30	27	-3
-45	9	30
24	-30	-6
18	-6	-18

// Yoo S S, 2007: Sleep Privileged Subjects
// Subjects=14
-39	-81	-9
-9	-93	-3
-9	-78	-6
3	9	54
6	0	57
42	21	0
48	3	30
60	9	21
45	15	24
-42	3	30
-36	24	0
-33	24	-9
-36	33	-9
-45	18	15
-51	27	18
-33	-9	48
39	-24	51
-27	-66	51
-21	-30	-12
19	-7	-22

// Boettiger C A, 2007: Want/Dont Want - Sooner/Larger, Positive Correlations 
// with ICR
// Boettiger C A, 2007: Want/Dont Want - Sooner/Larger, Negative Correlations 
// with ICR
// Subjects=9
66	-42	44
36	-52	-62
56	-52	-2
68	-50	-12
18	-4	-28
-22	50	44
58	36	-10

// Johnstone T, 2007: Major Depressive Disorder Patients
// Subjects=21
-47	24	0
47	24	0
-42	10	44
44	14	-1
32	46	25
39	-55	41
-57	-18	7
32	46	25

// Johnstone T, 2007: Healthy Controls
// Subjects=18
-47	24	0
-42	10	44
44	14	-1
39	-55	41
-57	-18	7
32	46	25
32	46	25

// Chevrier A D, 2007: Cognitive Go-Phase Activities
// Chevrier A D, 2007: Successful Stop-Phase Activities
// Chevrier A D, 2007: Unsuccessful Stop-Phase Activities
// Subjects=14
-32.68	-0.04	52.07
0.4	15.05	51.54
36.44	45.19	25.18
24.37	58.41	-9.25
-1.22	65.37	0.5
0.81	48.95	-19.33
-35.76	-49.21	49.54
-2.57	-29.67	65.36
1.57	-44.3	40.89
-46.47	-69.34	37.97
47.09	-10.02	-1.54
31.34	-89.59	3.09
-28.49	-90.92	5
-7.33	-78.76	-18.57
24.46	-61.5	-46.03
49.31	15.06	19.75
6.5	4.17	6.66
-.66	-88.04	12.24
49.39	21.37	32.6
7.57	38.24	20.52
-42.17	-27.25	58.92
-58.3	-47.12	37.36
56.03	-45.46	34.79
-4.93	-27.59	37.34
-30.77	-24.35	12.83
0.38	-80.72	10.5
58.91	-31.27	-2.12
36.07	-.3	-40.14

// Devue C, 2007: Intact Own Face > Scrambled
// Devue C, 2007: Intact Own Body > Scrambled
// Devue C, 2007: Intact Faces > Intact Bodies
// Devue C, 2007: Intact Bodies > Intact Faces
// Devue C, 2007: Intact Own Face > Intact Colleague's Face
// Devue C, 2007: Intact Colleague's Face > Intact Own Face
// Devue C, 2007: Intact Own Body > Intact Colleague's Body
// Devue C, 2007: Intact Colleague's Body > Intact Own Body
// Devue C, 2007: Intact Self > Intact Colleague
// Subjects=28
-42	-54	-26
-46	-80	-14
40	-80	-16
42	-52	-22
42	34	6
44	24	0
46	8	44
40	-2	52
10	16	50
6	6	62
-40	-72	-6
-48	-76	2
-44	-68	-20
46	-78	-2
40	-54	-22
8	26	-16
52	-70	-2
42	-76	10
-42	-80	16
34	-54	-10
34	-52	-12
38	22	16
48	32	14
48	-28	18
40	-30	18
68	-22	12
-56	-48	16
-6	-42	56
26	52	2
32	18	-16
12	26	32
-36	36	16
-36	12	-14
43	-48	-10
48	-22	10
16	40	-10
8	32	26
32	14	-12

// Knutson B, 2007: Product + Price > Fixation
// Knutson B, 2007: Price > Fixation
// Knutson B, 2007: Choice > Fixation
// Subjects=26
9.69	38.17	19.38
-9.8	39.71	-13.98
40.58	37.24	4.61
-47.12	40.35	-2.45
-3.07	36.49	26.36
-21.04	31.84	50.38
31.98	23.47	-7.52
-27.88	22.94	-9.02
11.71	13.84	-6.48
-9.65	12.74	-5.02
8.58	6.93	0.83
-11.71	13.58	6.08
-7.49	3.15	-5.36
-1.74	-32.15	33.22
32.87	64.46	-14.31
-13.09	72.9	-11.15
-3.45	63.27	-12.68
5.12	49.32	-14.95
4.16	37.22	-6.12
-8.31	-48.16	5.64
-4.54	66.35	-14.04
-3.44	40.38	-19.68
-19.01	40.6	39.58
-45.8	18.8	21.65
32.95	31.25	-17.1
-35.47	34.99	-17.75
35.31	11.66	4.59
-31.99	11.43	7.61
-39.4	0.1	13.1
-39.3	-14.28	19.89
-51.03	-17.44	21.4
-25.02	-31.03	63.5
1.48	-27.64	36.15
60.21	-33.18	28.13
-50.93	-29.53	30.22
10.23	-37.59	58.07
-7.1	-52.15	22.69
-24.98	-68.01	53.22

// Petrella J R, 2007: Normals
// Subjects=28
-9.01	16.91	57.77
-43.95	16.22	29.3
-51.76	28.56	12.52
46.68	17.83	18.63
-37.01	-10.94	59.88
27.8	-60.03	47.94
-30.55	-51.62	49.23
-35.63	-58.41	-11.65
27.07	-57.88	-9.41
-20.54	-20.31	-6.71
-33.42	-16.43	0.97
-35.56	-29.41	0.05
18.48	-9.35	4.99
31.34	-19.91	-5.39
-11.78	-7.33	5.3
3.28	54.59	12.37
-7.51	63.38	15.04
18.31	63.8	6.72
7.67	33.23	13.29
-1.53	33.41	-30.28
55.06	-11.43	-7.76
-53.96	-12.25	0.91
64.91	-29.06	-1.7
8.27	-50.94	42.9
-6.9	-49.08	40.73
58.86	-47.75	28.27
-64.24	-30.24	38.72
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Petrella J R, 2007: Mild Cognitive Impairment (MCI) Patients
// Subjects=34
-27.06	-54.54	-16.66
23.09	-94.73	10
16.76	-93.61	22.32
27.41	-72.82	14.48
29.28	-73.93	-8.98
-15.94	-92.61	0.37
-44.27	-60.57	-11.29
-41.93	-73.46	0.03
-24.08	-49.47	48.9
-17.5	-48.72	56.56
-24.06	-17.59	56.95
29.92	-55.98	45.27
-16.14	-27.32	-1.61
5.44	-27.45	-4.2
31.31	-30.01	-9.99
-1.06	30.35	5.88
7.63	37.28	10.65
3.25	59.81	10.73
5.84	-12.43	30.16
60.51	15.16	0.73
-55.99	-13.45	11.15
-64.6	-21.99	12.14
55.04	-.69	-7.7
-62.48	-41.96	5.11
65.16	-32.71	16.59
58.83	-33.72	29.12
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Petrella J R, 2007: Alzheimers Disease (AD) Patients
// Subjects=13
29.9	-64.9	41.67
-13.27	-55.92	48.24
31.36	-58.07	-11.7
-39.77	-80.04	-1.59
48.76	20.51	12.72
50.81	15.33	3.12
-24.18	-89.63	32.71
-26.1	-63.75	57.07
-5.34	26.29	8.59
-7.42	35.62	16.67
-5.54	34.61	-5.68
13.98	39.66	1.34
-12.05	21.31	-9.85
-20.64	54.43	0.46
-9.71	12.78	2.16
-7.06	31.73	43.94
-11.3	23.62	49.3
18.12	-16.41	-24.56
-5.21	19.57	17.1
-27.17	-19.24	-17.91
-31.39	-54.56	-16.58
-18.55	38.61	-8.09
-48.74	5.02	-9.86
-9.13	-60.55	32.94
-6.78	-55.9	48.12
-.56	-52.32	28.61
14.59	-58.65	28.98
12.55	-63.25	37.32
50.82	19.79	4.92
44.73	16.09	34.52
-7.72	-16.94	-17.35
29.2	-13.23	-2.65
53.08	-28.68	2.95
-39.92	-55.99	-8.45
-29.26	-44.98	-17.57
-37.34	-83.48	18.88
-43.53	-17.87	55.07
-37.28	-43.63	31.74
31.89	-71.66	26.61
-52.48	13.72	37.53
6.3	-50.56	58.58
-8.81	-46.15	60.64
-.56	-47.96	29.3
-2.48	-69.16	43.76
-2.59	-63.41	36.47
12.59	-29.03	47.38

// Akine Y, 2007: Alcohol Dependent Subjects
// Subjects=9
-33	54	-6
36	54	-6
-51	12	21
51	12	24
-45	21	-6
36	21	0
-6	24	33
-12	-84	39
6	-78	38
-30	-66	36
36	-63	39
-15	-3	12
-18	-30	15
6	-24	15
18	-18	18
15	-3	15
51	30	33
6	24	27
-12	-30	6
-15	21	6
-36	42	3
33	54	0
-48	12	30
51	9	21
-51	24	-6
51	24	0
3	30	30
-6	-81	42
15	-72	39
-27	-72	39
30	-57	39
-18	-33	9
-12	-6	12
18	-3	15
-39	27	18
39	48	12
-33	-24	18
-6	30	18
-15	-24	19
18	3	3

// Akine Y, 2007: Healthy Controls
// Subjects=9
-48	39	-3
39	45	18
-54	9	33
54	27	33
-33	24	-3
60	21	6
-3	18	36
-6	-78	42
12	-72	45
-51	-39	39
-21	-3	6
-9	-12	6
15	0	15
51	30	33
6	24	27
-12	-30	6
-15	21	6
-39	45	15
36	60	0
-51	3	33
54	21	30
-57	9	3
60	18	6
0	21	39
-6	-81	42
3	-81	27
-30	-75	42
48	-36	36
-27	3	-3
-18	-6	21
-15	-6	12
15	-3	24
6	-27	3
27	3	0
-39	27	18
39	48	12
-33	-24	18
-6	30	18
-15	-24	19
18	3	3

// Altamura M, 2007: (3 Letter + 5 Letter + 8 Letter, Long and Short Delay) - 
// Arrow Task
// Altamura M, 2007: 3 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 3 Letters, Long Delay - Arrow Task
// Altamura M, 2007: 5 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 5 Letters, Long Delay - Arrow Task
// Altamura M, 2007: 8 Letters, Short Delay - Arrow Task
// Altamura M, 2007: 8 Letters, Long Delay - Arrow Task
// Altamura M, 2007: Load Effects
// Altamura M, 2007: Delay Effects
// Subjects=18
33	37	20
-41	38	24
-40	21	9
40	30	20
33	18	-1
-10	10	49
7	17	48
40	1	27
-29	10	60
-37	-55	47
44	44	51
21	-66	47
-48	-61	-12
-25	0.2	5
-18	-13	11
10	-3	5
3	-66	-11
-29	-67	-21
-10	-23	28
7	-23	28
-10	9	43
-33	-59	47
-10	10	49
-10	23	37
33	18	4
-51	1	27
-25	4	5
-7	-50	-7
-29	-66	42
-48	-62	-6
33	38	25
-3	-23	28
-10	10	49
-51	5	27
10	-62	-11
33	18	-1
7	-13	17
1	-63	-17
-37	-52	41
40	-47	57
-48	8	16
37	37	14
-48	-54	-7
-10	10	49
7	17	48
-40	-52	41
37	-48	46
-44	10	4
-40	-5	44
25	-7	55
37	14	-1
37	40	20
10	-3	5
44	26	15
21	-66	47
-3	-48	-12
-48	-62	-6
-51	4	21
33	2	27
-10	10	49
-44	10	4
7	34	31
-40	21	9
-44	34	20
40	30	26
44	12	27
-3	-55	-22
21	-59	-17
-55	-41	46
48	-41	46
21	-66	47
10	-18	6
-10	16	43
29	-1	53
-3	-1	60
-44	22	26
10	30	31
21	-66	47
14	-9	17
-14	-13	11
10	-3	5
-44	-45	35
33	-52	52
33	21	-1
37	37	20
44	1	33
-44	-62	-6
-40	-66	-17
-44	22	26
37	37	14
-51	5	27
33	18	-1
-44	-45	35
33	-48	46
1	20	48
-10	10	49
33	-1	55
-37	-5	50
-11	8	54
-52	-8	36
-51	4	21

// Hill S, 2007: Healthy Controls > Family History of Alcohol Dependence
// Subjects=8
63	-36	-6
21	57	9
-48	30	9

// Seymour B, 2007: Aversive Prediction Error
// Seymour B, 2007: Reward Prediction Error
// Seymour B, 2007: Aversive TD Error
// Seymour B, 2007: Appetitive TD Error
// Subjects=24
-16	0	-10
30	18	-12
-16	6	-6
-20	-4	6
10	6	-1
-12	6	-18

// Zaki J, 2007: Self Pain + Other Pain, Common Activations Assessed by Masked 
// Contrast Analysis
// Subjects=13
46	28	20
4	10	40
48	8	40
42	22	-12
28	28	2
28	16	6
30	20	-2
12	-2	10
20	-6	14
16	-10	20

// Hampton A N, 2007: Switch - Stay, Healthy Controls
// Hampton A N, 2007: Stay - Switch, Healthy Controls
// Hampton A N, 2007: Healthy Controls > Amygdala Lesion, Switch - Stay
// Hampton A N, 2007: Expected Reward, Healthy Controls
// Hampton A N, 2007: Expected Reward, Healthy Controls > Amygdala
// Hampton A N, 2007: High Probability Reward > High Probability Punishment, 
// Healthy Controls
// Hampton A N, 2007: High Probability Punishment > High Probability Reward, 
// Healthy Controls
// Subjects=1
-30	21	-9
33	21	-12
-9	21	33
0	18	51
-6	45	21
-30	21	-18
36	21	-18
-9	33	42
6	57	-6
-27	-6	-21
6	57	-3
-3	57	-9
27	52	6

// Kim H, 2007: Normals: Preference First
// Subjects=14
30	-21	-18
42	0	15
15	3	-12
9	6	-9
-60	-15	-27
-39	0	15
-15	27	-15
-18	-12	-6
12	39	21
12	3	-9
-18	27	-15
15	0	-6
-21	0	-9
9	-12	-15
-36	-6	0
-48	-21	21
-45	-27	15
-6	21	-9
-3	24	-21
12	3	-15
0	39	-27
12	15	-3
18	27	-15
9	6	-9
63	-36	-18
63	-33	-21
18	6	-15
-6	24	-12

// Kim H, 2007: Normals: Roundness First
// Subjects=11
-42	36	3
-42	15	0
-27	-39	-33
27	-33	-27
51	18	48
-54	-36	-6
-60	3	21
-45	-6	15
-42	15	0
-15	36	18
12	3	-9
-18	27	-15
12	3	-15
0	39	-27
9	6	-9
63	-36	-18
63	-33	-21
18	6	-15
-6	24	-12

// Langenecker S A, 2007: Major Depressive Disorder Patients
// Subjects=16
50	4	-4
-50	4	-4
54	4	-13
-54	4	-13
50	4	-4
-50	4	-4
3	47	23
-15	57	-4
-48	-27	49
48	-73	22
54	-30	10
-59	-13	6
-43	6	44
59	-15	6
-59	-15	8
-8	55	-1
50	3	37
50	-71	17
-61	-46	33
40	-83	8
-43	-75	-1
13	4	7
-13	24	-8
61	-13	10
45	-13	1
-66	-5	14
63	-30	3
-44	-54	-20
-17	61	-4
63	-50	18
31	-95	-16
-27	-102	-11
-45	-79	-27
-3	22	57
20	57	-3
56	20	27
48	4	26
-21	-1	-16
-4	-62	-7
-3	22	57

// Langenecker S A, 2007: Healthy Controls
// Subjects=17
50	4	-4
-50	4	-4
54	4	-13
-54	4	-13
50	4	-4
-50	4	-4
1	32	1
-50	18	24
40	-23	55
47	-71	0
57	-32	-13
-57	-26	-3
-50	-30	47
-52	-29	-23
-45	-79	-10
27	-96	23
50	12	37
-47	10	41
-45	-29	53
59	-29	-4
-45	-73	17
24	-91	23
41	-79	4
40	-85	-26
-13	24	-8
61	-13	10
45	-13	1
-66	-5	14
63	-30	3
-44	-54	-20
-6	43	0
-50	12	29
45	-71	3
-13	-102	16
20	-102	3
-3	22	57
20	57	-3

// Walsh N D, 2007: Major Depressive Disorder Patients
// Subjects=20
29.11	-62.02	1.91
1.28	-49.5	1.18
53.6	-23.21	6.18
64.5	-43.98	25.64
-44.86	16.38	4
4.71	-48.23	31.15
-41.34	-12.21	33.12
22.58	-41.34	-5.32
10.87	-27.7	7.05
2.16	-57.98	-25.99
-2.11	4.66	0.03
5.5	-9.41	10.04
24.96	-95.89	4.8
-44.55	-81.5	4.39
2.25	-82.3	-23.96
3.53	8.84	39.76
4.53	-27.05	15.99
-39.44	22.73	16.78
-36.11	17.43	30.57
-2.89	35.03	48.79
-31.54	-19.07	53.65
57.83	-32.42	-3.13
17.52	-76.84	17.79
8.02	70.38	-45.75

// Walsh N D, 2007: Healthy Controls
// Subjects=20
29.11	-62.02	1.91
1.28	-49.5	1.18
53.6	-23.21	6.18
64.5	-43.98	25.64
-44.86	16.38	4
4.71	-48.23	31.15
-41.34	-12.21	33.12
22.58	-41.34	-5.32
10.87	-27.7	7.05
2.16	-57.98	-25.99
-2.11	4.66	0.03
5.5	-9.41	10.04

// Bartres-Faz D, 2007: Parkinson's Disease Patients (A1/A2 heterozygous)
// Subjects=8
56	-28	-8
14	-54	-28
-40	-48	46
44	-42	40
22	-8	60
-22	-54	-28
34	-28	44
-24	-14	60
-46	-18	48
14	-16	64
4	-46	18
-34	-14	58

// Bartres-Faz D, 2007: Parkinson's Disease Patients (A2/A2 homozygous)
// Subjects=12
-34	-48	52
-50	-36	36
-34	-14	58
-4	6	52
36	-20	62
14	-16	64
4	-46	18
-34	-14	58

// Plassmann H, 2007: Positive Correlation with Willingness To Pay During 
// Free-Bid Trials
// Plassmann H, 2007: Areas with Increasing Activation with WTP in Free-Bid & 
// Free-Bid > Forced-Bid
// Plassmann H, 2007: Free-Bid > Forced-Bid, when Exposed to the Item
// Plassmann H, 2007: Forced-Bid > Free-Bid, when Exposed to the Item
// Plassmann H, 2007: Free-Bid > Forced-Bid, at Time of Bidding
// Plassmann H, 2007: Forced-Bid > Free-Bid, at Time of Bidding
// Subjects=19
6	30	-17
-4	34	-20
44	44	12
4	30	-18
44	44	18
6	23	-8
6	25	-11
4	38	-20
-26	30	-12
30	28	-15
16	-4	8
2	-14	-18
8	-52	17
3	39	15
-8	-4	-7
8	-6	-3
48	32	13
-12	18	5
-4	7	27
4	1	26
24	-89	-8
-62	-37	20
58	37	22
-10	-58	-1
10	-57	-1
-2	-26	33
6	-69	-20
26	-67	-19
-48	41	13
-32	60	16
22	4	-7
-4	32	22
4	32	24
-8	6	0
26	52	42
-4	-21	7
14	-2	2
-45	9	50
-8	-6	-5
-40	-6	-9

// Yu H, 2007: Parkinson's Disease Patients
// Subjects=8
-42.22	-17.9	55.91
-1.65	-10.34	53.69
4.79	-1.25	60.66
-57.59	6.33	12.79
60.36	-36.03	46.21
-55.36	-31.18	9.22
63.21	-24.3	5.05
-9.46	-16.02	8.54
5.49	-13.81	8.18
34.25	-73.99	-29.48
-23.44	-70.82	-24.62
-44.41	-16.31	49.11
-30.41	-27.18	58.78
57.01	-18.85	34.77
6.82	10.86	51.82
-1.63	-5.77	57.77
6.91	-1.4	58.42
-3.95	9.94	40.87
50.62	5.49	47.3
-56.5	6.51	14.99
57.78	12.05	7.64
-49.87	-36.21	26.31
50.69	-35.55	39.59
-56.41	-32.07	11.54
58.96	-28.47	6.56
47.05	11.56	2.23
-9.47	-18.3	6.5
16.18	-13.75	8.05
19.31	1.96	4.47
23.54	-61.11	-27.09
-24.57	-64.91	-30.68
1.16	-63.9	-19.91

// Yu H, 2007: Healthy Controls
// Subjects=8
-42.25	-11.64	54.27
-53.04	-22.68	36.36
-6.01	11.75	50.78
-4.83	-3.5	59.85
-1.76	2.72	43.68
-44.46	5.18	51.77
47.37	12.7	44.51
-50.88	-.49	47.86
-49.03	11.93	15.57
53.58	12.8	17.66
-50.82	-39.42	39.97
63.42	-30.96	29.03
-53.22	-31.08	10.3
60.02	-22.03	7.13
-39.39	-11.96	8.54
42.9	-16.84	6.89
-12.65	-17.01	9.77
14.05	-13.67	9.18
-26.64	-2.71	3.16
26.79	3.15	5.4
-14.78	2.87	19.28
18.33	3.96	16.58
-23.43	-7.1	1.26
15.08	-67.88	-17.51
-15.96	-65.32	-22.94
-45.46	-16.06	52.45
-3.88	10.62	49.73
8.96	12.01	52.81
-3.76	-3.5	59.84
6.94	-2.2	61.83
-2.86	7.91	42.14
7.8	11.06	40.64
53.81	8.59	45.89
-47.69	-1.7	45.69
54.89	1.03	44.28
40.73	49.79	29.21
-50.1	9.72	14.65
54.6	5.69	8.21
-54.05	-40.75	36.77
61.31	-32.83	32.55
-55.33	-34.18	11.7
62.21	-32.42	10.2
-42.69	7.94	4.68
43.83	16.91	2.93
-11.59	-19.29	7.72
-25.56	-3.68	4.34
-21.29	-3.74	3.18
24.6	-56.79	-26.35
-20.23	-69.66	-23.64
1.19	-60.3	-14.64

// Marco-Pallares J, 2007: Correct Responses > Incorrect Responses
// Subjects=12
36.38	-77.32	-31.46
18.36	-83.55	-14
21.32	7.29	-9.38
-2.83	-20.35	34.47
-5.27	33.59	16.59
-7.52	8.26	-8.02
-3	-29.81	8.5
-6.17	7.92	28.79
-12.85	5.14	-6.58
-47.98	-58.48	-14.22
-57.42	-53.48	10

// Schonberg T, 2007: Healthy Learners
// Subjects=17
18	15	15
18	12	15
18	15	15
18	12	15
-18	-24	39
-33	-18	-30
18	30	24
-3	60	-15
12	-3	36
30	-9	9
18	-30	39
33	-21	-12
36	3	-12
-12	63	-6
-48	3	24
-27	-9	-30
0	45	24
-3	-90	-6

// Schonberg T, 2007: Healthy Non-Learners
// Subjects=12
18	15	15
18	12	15
-18	-24	39
-33	-18	-30
18	30	24
-3	60	-15
12	-3	36
30	-9	9
18	-30	39
33	-21	-12
36	3	-12
-12	63	-6
-48	3	24
-27	-9	-30
0	45	24
-3	-90	-6

// Behrens T E J, 2007: Main Effects of Decide
// Behrens T E J, 2007: Main Effects of Monitor
// Subjects=18
38	-88	-12
-44	-72	-12
28	-96	-2
26	-90	-8
34	-44	-20
-44	-62	-18
-36	-50	-34
60	-40	20
66	-46	16
46	12	-4
42	18	-4
38	20	-14
42	18	-8
6	20	26
4	16	30
2	-8	48
-8	-8	52
2	6	60
4	16	56
0	-8	68
-44	-4	2
-38	-2	6
-34	18	6
-32	14	10
-46	8	0
-28	24	0
-20	2	-2
18	0	-2
-54	-24	14
-48	-26	12
-56	-22	20
-30	-56	52
-34	-54	54
-38	-34	42
8	-22	-4
-8	-18	-4
24	-34	-6
10	-20	2
-12	-20	0
34	28	26
30	30	24
36	46	34
32	48	22
28	54	12
-34	46	24
-32	56	20
6	-24	26
48	-24	16
20	-48	-14
46	-70	0
-4	-72	6
18	-74	-10
-20	-72	-10
36	-52	54
42	-52	40
6	-66	48
8	-46	44
-36	-54	54
50	-42	12
-10	6	-8
16	6	-4
10	-20	-10
12	-22	12
22	-26	-10
-20	-22	-10
44	-4	50
52	6	16
52	14	34
50	36	20
-4	34	6
6	36	10
4	32	24
6	34	44
-28	16	0
-32	14	-10
-32	14	-10
-58	-14	28
-54	2	42
8	-36	24
-56	-50	8

// Forn C, 2007: Healthy Controls
// Subjects=10
40.71	43.01	24.2
42.91	25.05	25.68
31.89	47.88	-8.45
5.73	13.94	50.46
-39.38	28.79	26.31
-24.79	61.37	-7.81
-41.37	6.2	37.15
32.66	-57.35	48.32
-27.19	-56.65	48.95
-35.73	-57.76	49.14

// Forn C, 2007: Relapsing-Remitting Multiple Sclerosis Patients
// Subjects=17
40.8	27.49	29.96
30.36	2.45	51.14
2.54	19.55	54.48
52.36	21.11	1.37
-41.52	23.32	24.56
-57.79	22.85	-7.55
-44.58	3.89	35.15
39.01	-46.91	45.14
0.18	-9.18	13.43
-6.19	25.27	32.92

// Opitz B, 2007: Local Violation Sentences vs. Correct Sentences
// Opitz B, 2007: Long-Distance Violation Sentences vs. Correct Sentences
// Subjects=24
-26.75	-22.49	-18.6
25.57	-10.54	-20.21
-58.39	-19.46	37.27
-55.21	-36.24	26.37
-64.94	-34.15	12.92
64.36	-26.78	14.17
37.23	8.3	-25.27
-36.33	-10.14	-9.49
41.66	-6.5	-10.69
28.81	9.54	-8.54
18.1	-26.96	-25.43
-0.05	-10.44	-16.57
8.9	-82.07	6.06

// Christmann C, 2007: Pain - Baseline
// Christmann C, 2007: Pain - Baseline, Correlation with Pain Intensity Rating
// Christmann C, 2007: Pain - Baseline, Positive Correlation with Pain 
// Unpleasantness Rating
// Christmann C, 2007: Pain - Baseline, Negative Correlation with Pain 
// Unpleasantness Rating
// Subjects=6
-50.07	-10.8	10.8
-54.26	-19.83	18.29
-44.8	-3.88	3.46
-41.47	-16.84	14.55
-32.02	19.97	8.01
-60.7	7.25	25.02
-43.29	-15.79	55.74
-51.86	-12.76	54.47
-31.54	-22.33	52.81
-47.53	-21.99	58.54
-33.63	-18.57	60.33
-13.44	-21.84	43.64
-15.58	-22.91	43.76
-8.2	-1.98	38.57
-9.29	-2.16	36.37
-2.71	-11.41	53.8
-2.74	-16.07	48.61
-.95	-55.92	-12.75
-2.87	-59.16	14.31
11.3	-5.72	71
10.2	-8.19	66.76
19.27	-51.19	-22.3
21.4	-51.26	-23.43
49.43	-27.67	17.76
53.7	-27.64	17.71
49.2	2.94	0.7
44.88	12.26	-2.27
44.87	6.72	-5.15
53.55	-6.21	5.87
-46.8	-16.7	16.83
-50.79	-13.81	54.55
-57.62	-1.67	5.66
-2.72	-14.84	50.74
-49.92	-37.78	19.75
-33.63	-18.57	60.33
-9.25	-2.87	40.89
25.62	-50.7	-30.22
32.07	-62.29	-29.32
-47.55	-21.11	56.24
0.54	-15.27	58.54
-30.41	-26.03	59.8
-9.29	-2.16	36.37
30.94	-45.38	-30.73
-61.77	8.39	26.05
-46.92	0.68	7.57
-67.11	-14.7	16.89
-14.5	-21.77	44.76
-48.92	-25.34	15.35
12.88	-57.57	-21.69
9.16	-10.14	69.17
60.99	6.61	5.83

// Freund W, 2007: Right weak - rest
// Freund W, 2007: Left weak - rest
// Freund W, 2007: Right moderate - rest
// Freund W, 2007: Left moderate - rest
// Freund W, 2007: Right pain - rest
// Freund W, 2007: Left pain - rest
// Freund W, 2007: Right increase
// Freund W, 2007: Left increase
// Freund W, 2007: Right tonic pain early - rest
// Freund W, 2007: Left tonic pain early - rest
// Freund W, 2007: Right tonic pain late - rest
// Freund W, 2007: Left tonic pain late - rest
// Freund W, 2007: Left tonic pain late - tonic pain early
// Freund W, 2007: Right tonic pain early - tonic pain late
// Freund W, 2007: Left tonic pain early - tonic pain late
// Subjects=15
-54	-16	18
52	30	22
62	-12	22
56	-52	46
-30	54	4
56	-18	12
38	-4	-8
42	0	8
-56	-16	36
14	-68	54
42	50	10
-40	40	-4
50	-42	52
-46	-56	48
0	38	36
44	52	12
56	-22	54
56	-20	14
56	-30	48
54	-54	48
-40	-16	16
38	44	-6
40	14	-6
-4	4	18
38	52	2
46	0	8
42	-28	10
-54	6	-2
36	6	38
-24	-42	2
54	-54	48
46	46	4
-2	-2	22
-4	8	12
-38	-12	6
-40	-16	14
42	50	-2
56	22	26
46	0	10
-52	18	-12
10	28	48
20	-34	12
32	-52	2
12	10	16
2	16	72
32	18	-2
-44	-4	8
40	52	20
14	-22	18
8	20	0
64	-18	20
-24	-48	6
-22	18	34
62	-18	18
54	-18	54
18	26	36
38	-10	14
-32	34	12
-6	18	6
8	-56	64
22	-34	12
6	28	-6
-4	12	4
26	-50	72
-16	-52	64

// Longe O A, 2007: Stems (Nouns + Verbs) vs. Baseline
// Longe O A, 2007: Inflections (Nouns + Verbs) vs. Baseline
// Longe O A, 2007: Stems + Inflections vs. Baseline
// Longe O A, 2007: Inflected vs. Stem
// Longe O A, 2007: Inflected Verbs vs. Verb Stems
// Longe O A, 2007: Inflected Nouns vs. Noun Stems
// Longe O A, 2007: Inflected Verbs vs. Inflected Nouns
// Longe O A, 2007: (Inflected Verbs vs. Verb Stems) vs. (Inflected Nouns vs. 
// Noun Stems)
// Subjects=12
-41.49	-19.86	45.15
-58.86	-18.31	39.69
-60.37	16.73	12.72
-46.2	27.6	24.85
7.57	-67.08	-14.89
22.49	-60.93	-30.32
-35.82	-49.98	-24.8
-44.39	-52.69	-18.79
-44.37	-50.35	-16.78
-46.5	-67.69	-18.39
-57.78	-15.01	40.47
-39.34	-18.79	45.01
-50.04	-29.05	50.69
-50.68	28.57	12.5
-41.86	11.35	23.02
-50.7	14.22	8.32
-53.03	30.4	-2.21
-37.99	36.42	-7.54
-33.82	32	-20.62
5.48	-51.26	-6.33
7.53	-76.11	-19.6
18.33	-58.64	-17.03
-57.78	-15.01	40.47
-41.5	-18.79	45.04
-47.9	-20.43	50.92
5.51	-51.06	-4.11
-44.39	-52.69	-18.79
-35.82	-49.98	-24.8
-48.64	-65.36	-16.34
-2.55	20.02	56.23
-41.84	13.68	25.03
-29.22	-11.83	-7.4
-50.7	15.28	8.21
-52.81	26.64	14.97
-60.37	15.67	12.82
-39.89	19.78	9.82
-46.28	10.6	15.32
-25.14	37.76	-16.86
-66.81	-39.85	4.98
-23	20.13	-21.87
-62.65	-22.48	-4.66
-15.48	-65.06	42.46
-13.47	-66.19	30.21
-26.34	-56.8	39.58
-51.58	-62.02	8.03
-42.04	11.06	8.48
-53.76	-42.47	10.62
-48.75	-25.7	-16.9
-23.01	23.32	-22.19

// Hermann D, 2007: Audiovisual Stimulation vs. Baseline, Healthy Controls > 
// Alcohol-Dependent Patients
// Subjects=9
6	-81	9

// Grahn J A, 2007: All Rhythms - Rest
// Grahn J A, 2007: Metric Simple - Metric Complex and Nonmetric
// Subjects=27
-9	6	60
3	6	66
-24	6	9
21	6	6
-54	0	51
54	0	45
30	-66	-27
-30	-66	-24
60	-33	6
-57	-15	9
-57	6	3
27	30	15
-51	3	3
-51	-9	-3
42	-36	18
45	6	-6
30	-21	12
-27	0	-9
-27	0	0
-27	-12	-6
24	0	-9
24	12	6
24	-3	9
-51	33	6
-12	69	18
21	9	-15

// Lamm C, 2007: Reaching Range Predictions/Averaged > Gender Matching
// Lamm C, 2007: Correlation between (Reaching Range Prediction > Baseline 
// Activation) and Visual Imagery Subscale
// Subjects=17
56	-26	50
62	-24	36
60	-26	26
32	-38	42
52	-30	60
-60	-8	22
-62	-30	28
-62	-32	44
14	-70	58
18	-62	60
18	-64	68
16	-54	70
6	-34	52
-6	-26	44
56	12	12
-40	4	2
44	-32	18
-36	-86	36
36	-80	46
46	-80	28
54	4	22
44	-50	44
35	-45	32
-50	-34	-12
-54	-42	6
10	-56	0

// Lieberman M D, 2007: Gender Labeling > Affect Labeling
// Lieberman M D, 2007: Affect Labeling > Gender Labeling
// Subjects=30
-24	0	-24
4	48	-16
6	8	-4
6	26	-8
2	18	32
44	-14	2
-40	-12	8
-8	-64	26
66	-42	14
-56	-22	12
40	6	-18
-40	8	-14
6	-26	-2
10	-54	-12
54	24	-10
48	46	-6
56	18	8

// Schaefer M, 2007: Familiar Brands > Unfamiliar Brands
// Schaefer M, 2007: Sport/Luxury Brands > Unfamiliar Brands
// Schaefer M, 2007: Value Brands > Unfamiliar Brands
// Schaefer M, 2007: Sport/Luxury Brands > Value Brands
// Subjects=14
14	8	50
-8	12	54
32	-36	-6
-8	-58	10
26	-34	34
-10	48	36
-6	10	56
2	30	2
-10	54	12
18	-92	-2
-14	-92	0
22	-58	62
38	-86	-4

// Kaladjian A, 2007: Healthy Controls
// Subjects=21
-8.38	56.21	30.34
-43.86	26.72	38.34
49.41	31.54	-18.63
0.71	55.93	-19.1
-62.6	-29.71	-1.7
58.24	-8.64	-12.57
-49.9	-53.09	57.55
55.68	-56.07	31.39
1.69	-56.05	34.55
-40.86	-66.97	0.49
30.79	-82.72	23.24
49.55	25.99	-9.12

// Kaladjian A, 2007: Schizophrenia Patients
// Subjects=21
-14.91	49.29	25.53
-37.29	17.59	43.61
33.9	32.32	36.46
-33.65	-70.26	56.73
31.1	-72.78	49.15
-1.3	-59.61	54
-27.49	-69.33	31.88
49.55	25.99	-9.12

// Mashal N, 2007: Novel Metaphors > Unrelated Words
// Mashal N, 2007: Conventional Metaphors > Unrelated Words
// Mashal N, 2007: Literal Expressions > Unrelated Words
// Mashal N, 2007: Novel Metaphors > Literal Expressions
// Mashal N, 2007: Conventional Metaphors > Literal Expressions
// Mashal N, 2007: Novel Metaphors > Conventional Metaphors
// Subjects=15
40.61	21.12	2.62
-5.18	-9.39	11.28
-38.51	49.89	10.03
43.72	54.18	3.15
-36.34	20.58	2.43
-48.09	36.97	9
-37.26	39.63	28.72
53.56	26.89	20.94
-41.12	-46.16	48.23
-4.16	36.31	24.16
-53.24	-47.8	0.55
-54.35	12.15	18.96
56.67	18.22	4.91
68.51	-30.24	-3.43
47.15	-21.48	1.65
-52.13	-53.97	3.29
-32.52	-69.71	45.65
45.84	50.68	-1.04
-38.49	48.91	11.23
-42.21	-48.62	43.99
43.71	55.15	1.96
-6.24	-9.31	12.4
-38.47	18.36	1.53
66.36	-31.48	-5.54
39.54	24.38	3.47
-36.21	43.87	28.36
-49.04	10.78	14.55
-43.88	39.65	2.03
56.67	18.22	4.91
-32.52	-69.71	45.65
-41.14	-46.33	46.01
43.78	56.98	11.84
-37.4	50.32	15.56
40.61	21.12	2.62
60	-40.86	-2.45
-54.31	-48.95	-.45
-4.17	-9.98	3.51
56.67	18.22	4.91
-47.94	12.19	18.88
-46.02	39.64	2.06
-35.26	15.21	1.75
-46.97	34.23	14.79
65.51	-50.12	15
43.82	32.15	7.23
-50.01	20.61	31.58
3.36	29.04	25.8
56.13	-23.57	56.37
-53	-57.37	28.12
-46.1	31.04	-12.83
53.59	-28.84	2.2
51.38	25.39	15.52
-46.95	36.6	17.94

// Stringaris A K, 2007: Metaphoric > Literal
// Stringaris A K, 2007: Metaphoric > Non-Meaningful
// Stringaris A K, 2007: Non-Meaningful > Metaphoric
// Stringaris A K, 2007: Literal > Metaphoric
// Stringaris A K, 2007: Literal > Non-Meaningful
// Stringaris A K, 2007: Non-Meaningful > Literal
// Subjects=11
-29.92	-63.89	-30.71
16.25	-85.51	-11.58
-6.31	-14.4	1.67
-45	31.39	-8.41
35.66	-68.19	17.97
-20.88	-82.9	25.43
28.26	-66.32	29.05
-53.08	-7.71	37.34
-29.33	-57.81	47.96
-6.31	-14.4	1.67
-25.41	-89.99	-10.73
-41.5	-74.22	-11.86
47.11	-62.49	-19.44
-33.28	27.86	-13.83
16.32	-52.96	10.22
-10.3	-79.55	12.76
51.45	7.41	17.02
-44.78	21.64	16.94
-13.33	-74.51	36.91
51.49	-65.75	-6.95
13.25	-63.66	23.42
-26.23	-42.35	41.05
35.83	-50.01	46.55
-2.67	-54.9	41.83
13.36	-29.54	51.79
1.5	-2.12	49.62
-41.22	-22.98	45.17
-33.02	-67.2	-18.13
-22.22	-82.48	-10.28
0.75	59.27	-23.54
51.49	-65.75	-6.95
-29.48	-80.21	19.73
9.07	-38.54	45.9
44.21	-6.61	42.82
-53.45	-7.16	-10.66
-22.01	-75.94	19.28
51.41	19.04	16.05
39.92	-2.41	42.51
-18.27	-61.59	-43.3
43.91	-62.5	-19.4
-33.2	19.83	-7.58
35.07	51.96	-11.06
-48.91	-53.78	5.46
-22.05	-80.68	12.99
16.47	-67.88	23.74
58.96	-1	17.64
-29.38	-55.06	42.15
32.65	-57.44	47.21
-2.77	-2.15	49.67
1.74	-53.51	59.51
-41.15	-26.7	52.17

// Vorhold V, 2007: Risk Rating > Letter Decision
// Subjects=13
-6	54	33
-42	33	-21
33	87	-42

// Walter H, 2007: Healthy Controls
// Subjects=17
-15	12	-3
21	18	3
30	-9	69
-39	-78	30
24	-66	60
39	-69	45
-39	-75	-24
33	-60	-48
-42	9	-27
36	18	-30
-9	-36	-9
15	-36	-12
48	0	53
-15	30	54
-39	9	-27

// Walter H, 2007: Schizophrenic Patients
// Subjects=15
-15	12	-3
21	18	3
30	-9	69
-39	-78	30
24	-66	60
39	-69	45
-39	-75	-24
33	-60	-48
-42	9	-27
36	18	-30
-9	-36	-9
15	-36	-12
48	0	53
-15	30	54
-39	9	-27
-45	18	-21
33	18	-24
-6	-45	-6
42	15	-18
-45	27	21
-39	27	18
27	39	-18
36	-63	-63

// Walter H, 2007: Depressed Patients
// Subjects=12
-45	18	-21
33	18	-24
-6	-45	-6
42	15	-18
-45	27	21
-39	27	18
27	39	-18
36	-63	-63

// Dougal S, 2007: Neutral > Control
// Dougal S, 2007: Emotional > Control
// Dougal S, 2007: Neutral > Emotional
// Dougal S, 2007: Emotional > Neutral
// Dougal S, 2007: Emotional and Neutral > Control
// Subjects=14
-17.12	-12.49	-13.98
-34.26	-8.62	-17.45
-33.19	-33.87	-27.61
-32.11	-12.83	-17.12
37.24	-20.13	-35.15
-32.09	-10.46	-13.97
19.23	-12.01	-11.09
-26.66	-34.75	-12
33.19	-36.51	-12.54
-24.62	-9.44	-15.26
-16.04	-10.11	-10.84
-35.34	-12.05	-20.49
-35.49	-5.85	-36.63
-29.95	-11.51	-13.91
-29.95	-11.51	-13.91
-35.34	-12.05	-20.49

// Harvey P O, 2007: Social Hits > Social Misses
// Harvey P O, 2007: Non-Social Hits > Non-Social Misses
// Harvey P O, 2007: Emotional Hits > Emotional Misses
// Harvey P O, 2007: Neutral Hits > Neutral Misses
// Subjects=17
-18	56	22
10	60	34
-44	38	-8
60	18	18
22	-6	-24
-22	-18	-22
-46	-72	-14
26	34	-16
46	12	30
-24	-16	-12
32	-24	-26
46	-62	-16
-32	36	-12
-46	18	26
20	-4	-20
30	-26	-24
-44	-52	-14
-16	58	22
58	6	4
-22	-6	-28
48	-60	-16

// Kensinger E A, 2007: Task-Correct Negative and Neutral > Control
// Kensinger E A, 2007: Task-Correct Negative > Task-Correct Neutral
// Subjects=20
30	56	17
-48	-59	-10
53	-64	-4
-48	-52	-5
27	-50	5
21	-32	-14
-18	-7	-22
-32	-8	-25
-30	-8	-35
36	-21	-20
36	-15	-17
-21	-9	-20
-18	3	-12
-21	5	-15
-12	29	46
-35	41	0
30	-6	28
30	-37	25
56	-61	-2
33	-2	-35
-50	-67	-7
-41	-56	-5
-29	-36	-13
-30	-5	-33
38	-21	-14
33	-4	-25
27	0	6
-3	7	16
6	-25	15
-32	-39	-21

// Miyamoto T, 2007: High-Intensity Clicks, Activations
// Subjects=12
-2	66	16
-6	58	24
28	26	48
-34	18	44
26	32	58
-48	-2	20
-28	2	50
-8	-42	54
36	-70	50
-32	-66	50
-40	-72	34
52	-56	26
-42	-58	34
-10	36	10
4	-42	38

// Anguera J A, 2007: Control group
// Subjects=9
-54	-61	5
53	-62	-4

// Anguera J A, 2007: fMRI group
// Subjects=11
50	25	1
48	13	23
6	5	61
26	3	55
-26	5	55
61	-32	29
-4	-57	54
4	-55	56
54	11	-4
-2	17	25
-24	-26	-12
2	27	-11
61	-8	-13
-38	-50	52
-57	-36	9
10	-74	35
20	-38	-20
24	-44	-12
-36	-14	14
20	-46	2
-54	-61	5
53	-62	-4
-38	-50	52

// Coccaro E F, 2007: Main Effect, Group
// Coccaro E F, 2007: Main Effect, Emotion
// Coccaro E F, 2007: IED (> HC) vs Rest, Angry
// Coccaro E F, 2007: IED (> HC) vs Rest, Disgusted
// Coccaro E F, 2007: IED (> HC) vs Rest, Fearful
// Coccaro E F, 2007: IED (> HC) vs Rest, Happy
// Coccaro E F, 2007: IED (> HC) vs Rest, Neutral
// Coccaro E F, 2007: IED (> HC) vs Rest, Surprised
// Coccaro E F, 2007: IED (> HC) vs Rest, Sad
// Coccaro E F, 2007: HC (> IED) vs Rest, Angry
// Coccaro E F, 2007: HC (> IED) vs Rest, Disgusted
// Coccaro E F, 2007: HC (>IED) vs Rest, Fearful
// Coccaro E F, 2007: HC (> IED) vs Rest, Happy
// Coccaro E F, 2007: HC (> IED) vs Rest, Neutral
// Coccaro E F, 2007: HC (>IED) vs Rest, Surprised
// Coccaro E F, 2007: HC (> IED) vs Rest, Sad
// Subjects=10
52	-80	14
-12	-96	-14
-26	50	26
-46	-84	-4
-36	-6	40
-4	-42	52
-8	0	76
-8	4	-22
36	-60	-44
-68	-44	14
-40	-48	-28
30	-82	26
40	20	50
-40	-74	-20
-8	-16	-34
-10	-98	24
24	-32	24
32	52	-16
-26	-48	62
26	-40	50
-10	10	24
-54	-18	-18
24	-10	-30
28	-62	10
-38	-56	34
10	-62	-6
-44	-58	54
52	26	2
42	-82	-28
46	-18	48
16	-56	34
-18	12	-22
-2	-30	-8
60	-34	12
6	-34	-22
40	-46	-26
-20	-102	2
-6	-16	-2
-22	-28	44
28	-72	-6
-12	-90	-12
26	-44	38
0	-40	-40
-40	-86	-14
6	-36	-14
48	-60	-14
-16	-12	24
-26	4	-10
10	0	-10
6	-12	-20
-44	-54	-16
-12	-36	-24
-10	-70	-2
-4	14	6
-24	-28	26
-32	-62	12
-24	14	14
-18	-106	-8
20	50	18
-34	64	0
-22	52	16
-56	-52	50
-42	26	44
-32	-78	-46
16	44	-4
-20	20	30
34	-6	42
-48	-78	12
10	2	-20
-16	38	40
14	-72	26
-46	-30	-4
20	26	36
-48	-84	16
-26	46	28
-4	-24	-50
18	-14	50
4	56	40
-10	-68	66
-44	-70	22
-16	52	12
-50	28	0
-48	-62	54
-50	-6	-38
16	28	38
-48	54	8
-38	-58	-42
-58	-48	24
4	-42	54
-30	-10	-30
20	12	-24
6	56	46
-46	56	-8
-52	16	12
-60	-50	38
42	-70	36
-10	60	12
-64	-48	2
-26	20	30
50	-4	-32
18	48	16
-54	-78	16
60	-60	14
-22	8	-22
-12	44	-18
34	36	-8
-64	-52	42
48	-80	-6
-6	-8	-4
-6	40	30
-52	20	-24
8	2	-24
-16	46	20
30	-22	-28
-50	-82	16
-20	24	60

// Grabner R H, 2007: Multi-Digit > Single-Digit
// Grabner R H, 2007: Single-Digit > Multi-Digit
// Grabner R H, 2007: Higher > Lower Mathematical Competence
// Subjects=12
36	-68	-26
-28	26	-4
30	30	-2
-36	-42	44
-46	8	30
-42	-66	-30
0	-74	-24
10	26	36
-26	-2	54
-10	16	44
0	-70	10
38	-46	42
24	-28	6
-48	36	28
-10	-22	12
-58	-64	32
-52	-64	28
-50	-54	16
-10	18	56
-6	54	34

// Nieuwland M S, 2007: Referential ambiguity > Referential coherence
// Nieuwland M S, 2007: Referential failure > Referential coherence
// Nieuwland M S, 2007: Semantic anomaly > Semantic coherence
// Nieuwland M S, 2007: Referential ambiguity > Referential failure
// Nieuwland M S, 2007: Referential ambiguity < Referential coherence
// Nieuwland M S, 2007: Referential failure < Referential coherence
// Nieuwland M S, 2007: Semantic anomaly < Semantic coherence
// Nieuwland M S, 2007: Referential ambiguity < Referential failure
// Subjects=22
-6	66	-2
2	64	20
28	28	44
-6	-62	30
-10	-64	44
-2	-64	48
-50	-68	30
50	-62	30
4	-64	46
-40	-60	50
-48	-52	48
-54	-54	42
52	-62	42
-42	10	54
-44	24	0
-46	32	8
-52	14	18
50	32	4
-2	62	24
-2	50	-6
-8	62	-2
-8	-66	22
-16	-68	22
-42	28	-2
-50	26	18
40	32	-8
40	22	12
50	18	18
-30	-12	-14
-44	-6	-20
4	60	-10
-4	18	-14
0	10	-10
6	22	-20
30	30	46
-8	-64	22
8	-56	18
-12	-62	34
-42	24	18
38	24	18

// Kalbfleisch M L, 2007: Areas modulated by task difficulty (Hard > Easy)
// Kalbfleisch M L, 2007: Areas modulated by response correctness (Correct > 
// Incorrect)
// Kalbfleisch M L, 2007: Areas modulated by task difficulty and correctness 
// interaction
// Subjects=14
-39.25	-4.99	54.85
10.38	12.21	52.3
-24.13	8.14	56.65
32.06	12.8	57.47
46.49	48.16	10.03
-48.36	6.76	20.22
-42.3	14.61	-10.91
56.11	16.75	-4.96
41.85	20.56	-20.78
14.96	-69.02	55.78
-17.52	-51.06	54.55
49.31	-42.08	43.56
-40.03	-34.93	-12.77
31.96	-67.85	32.96
-24.56	-102.32	0.35
-37.91	-85.51	-25.74
-5.34	-87.54	-14.88
-7.9	-65.37	-41.69
30.94	8.13	53.47
-46.2	6.77	20.18
58.69	7.86	26.13
-.15	-65.68	57.94
12.77	-75.83	52
6.39	-46.64	66.03
38.66	-50.86	53.58
-28.38	-58.1	48.71
33.98	-87.48	18.06
3.53	-84.68	3.73
-9.54	-64.73	-.26
33.52	-79.96	-16.29
11.6	16.1	-20.94

// Das P, 2007: Conscious, Schizophrenia patients < Control, Amygdala
// Das P, 2007: Conscious, Schizophrenia patients < Control, Medial prefrontal 
// cortices
// Das P, 2007: Conscious, Schizophrenia patients < Control, Thalamus
// Das P, 2007: Conscious, Schizophrenia patients > Control, Visual 
// association cortices
// Das P, 2007: Nonconscious, Schizophrenia patients < Control, Amygdala
// Das P, 2007: Nonconscious, Schizophrenia patients < Control, Medial 
// prefrontal cortices
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Thalamus
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Visual 
// association cortices
// Das P, 2007: Nonconscious, Schizophrenia patients > Control, Brainstem 
// (midbrain)
// Subjects=14
32	0	-16
8	54	-12
-6	50	6
-4	28	36
2	-12	4
-2	-10	12
-32	-50	-22
36	-48	-20
-32	-82	-18
30	-72	-14
36	-88	-2
-22	2	-18
22	4	-16
-14	44	12
18	-12	4
-40	-32	-20
48	-82	-2
-46	-82	-4
2	-16	-10

// Gaffrey M S, 2007: Autism Spectrum Disorders (ASD) Patients
// Subjects=10
-47.12	21.69	-9.81
-52.28	24.68	15.65
-48.07	21.82	5.81
-48.2	43.51	-2.7
-41.58	28.17	18.58
-3.87	16.16	52.61
0.53	-4.44	60.98
-9.23	-98.21	5.39
-14.68	-88.44	-5.4
-19.8	-96.01	20.94
9.01	-90.81	16.83
-21.39	-11.37	-12.91
11.94	-76.01	-12.33
-17.73	7.71	54.6
-58.92	0.33	-23.49
55.52	10.75	-8.95
-16.85	-84.39	-7.95
-24.15	-81.41	17.53
0.61	-78.32	41.53
22.66	-75.61	-8.02
30.29	-88.28	6.33
53.89	-15.81	46.82
3.51	-51.8	12.5
9.2	-78.9	47.05

// Gaffrey M S, 2007: Healthy Controls
// Subjects=10
-47.01	28.34	7.48
-4.98	31.13	53.6
-20.46	4.79	-24.31
-10.44	43.1	43.74
-2.91	25	42.94
-7.36	50.64	30.8
-45.65	1.68	34.23
36.22	36.36	-6.42
2.41	33.58	43.27
62.24	-5.76	24.7
13.34	-92.39	23.6
-11.65	0.98	8.25
-8.49	11.48	6.22
32.24	-5.65	14.99
-17.73	7.71	54.6
-58.92	0.33	-23.49
55.52	10.75	-8.95
-16.85	-84.39	-7.95
-24.15	-81.41	17.53
0.61	-78.32	41.53
22.66	-75.61	-8.02
30.29	-88.28	6.33
53.89	-15.81	46.82
3.51	-51.8	12.5
9.2	-78.9	47.05
-25.53	47.19	29.07
0.08	28.25	15.87
31.13	35.64	26.04
27.9	51.91	30.29
10.61	51.95	4.84
7.34	55.65	-2.13
-61.89	-31.36	-6.3
-27.58	-67.28	-5.92
53.68	-64.16	-.42
-31.59	-83.22	22.23
-40.36	-76.79	-3.86
-39.18	-69.06	13.33
-50.97	-70.62	8.02
36.77	-77.7	18.75
-4.81	-46.2	44.47
-52.99	-43.03	34.72
46.44	-44.12	39.25
59.22	-32.41	38.12

// Gur R E, 2007: Patients
// Subjects=16
26	-102	-2
16	-18	2
-6	-20	-14
24	-12	-28
-26	20	12
36	18	0
-36	4	26
50	56	10
28	-98	-4
50	-44	-18
10	-4	20
-10	-8	-26
18	-8	-24
34	-28	-18
-50	16	-18
48	20	-12
0	-27	-5
-51	13	-12
36	19	-18
4	-26	25
12	6	0
-6	2	-2
46	16	10
10	-1	-10
36	58	1
-10	11	-11
28	-6	-11
-24	-8	-13
6	-89	10
48	-67	12
-6	-85	41

// Gur R E, 2007: Healthy Controls
// Subjects=17
38	-82	-18
-46	-84	-20
42	-56	-28
12	-8	14
-12	-10	-26
20	-8	-26
30	-36	-6
-28	20	14
48	28	-2
-40	8	30
48	60	4
28	-98	-4
50	-44	-18
10	-4	20
-10	-8	-26
18	-8	-24
34	-28	-18
-50	16	-18
48	20	-12
0	-27	-5
-51	13	-12
36	19	-18
4	-26	25
12	6	0
-6	2	-2
46	16	10
10	-1	-10
36	58	1
-10	11	-11
28	-6	-11
-24	-8	-13
6	-89	10
48	-67	12
-6	-85	41

// Just M A, 2007: High-Functioning Autism Patients
// Subjects=18
-24	-96	10
30	-74	24
56	-24	52
42	-38	40
-38	-40	38
-58	-30	46
6	28	40
56	22	38
48	44	26
28	6	60
34	22	2
-48	10	32
-24	0	52
-58	14	10
-34	24	2
24	-24	-8
10	-14	10
-20	-28	-2
-12	-20	10

// Just M A, 2007: Healthy Controls
// Subjects=18
-28	-74	30
2	-64	44
4	-86	32
0	14	52
26	2	52
32	26	-2
-42	42	32
-24	-2	54
-32	64	8
-32	28	0
6	-42	0
20	-28	10
-20	-30	8

// Kana R K, 2007: Healthy Controls > Autism Patients, Simple Response 
// Inhibition-Fixation
// Kana R K, 2007: Healthy Controls > Autism Patients, 1-Back 
// Inhibition-Fixation
// Kana R K, 2007: Autism Patients > Healthy Controls, 1-Back 
// Inhibition-Fixation
// Subjects=12
-42	-46	-16
26	-34	-8
16	-48	8
24	0	60
14	-30	42
40	-30	46
-32	-44	56
40	14	10
38	14	-4
-12	-46	0
-4	38	4
-40	-80	34
-16	-54	12
16	-50	10
48	-72	32
-8	-64	32
-28	-4	66
56	8	38

// Manjaly Z M, 2007: Autistic patients
// Subjects=12
-45	-78	3
24	-93	-3
33	-84	12
30	-99	3
30	-66	42
-24	-78	33
39	-78	-12
39	-93	3
-12	-75	3
-24	-30	0
-27	-60	57
33	24	0
9	-72	6
6	-69	-33
39	-81	9
-27	-90	3

// Manjaly Z M, 2007: Control group
// Subjects=12
-45	-78	3
24	-93	-3
33	-84	12
30	-99	3
30	-66	42
-24	-78	33
39	-78	-12
39	-93	3
-12	-75	3
-24	-30	0
-27	-60	57
33	24	0
-12	-72	57
-24	-3	63

// Williams L M, 2007: Paranoid Schizophrenics
// Subjects=13
12.09	27.64	48.12
-25.71	-10.77	-18.48
20.55	19.09	33.13
8.9	27.87	51.48
-36.05	23.58	41.21
43.77	23.97	-2.12
-22.47	-30.12	-21.36
5.25	38.55	-2.9
-30.01	-4.45	-18.96
-6.26	37.7	28.53
12.65	34.48	-14.91
-41.62	5.74	3.74
43.88	2.02	3.06
-41.55	25.17	21.06
-38.17	11.59	37.78
-25.51	-32.83	-1.02
-32.81	23.94	45.6

// Williams L M, 2007: Nonparanoid Schizophrenics
// Subjects=14
5.76	20.79	56.57
-25.71	-10.77	-18.48
13.17	31.07	51.17
31.91	10.73	-20.95
-34.35	22.31	-16.7
-22.48	-25.89	-21.71
27.86	-39.71	-12.21
5.25	38.55	-2.9
-30.01	-4.45	-18.96
-6.26	37.7	28.53
12.65	34.48	-14.91
-41.62	5.74	3.74
43.88	2.02	3.06
-41.55	25.17	21.06
-38.17	11.59	37.78
-25.51	-32.83	-1.02
-32.81	23.94	45.6

// Williams L M, 2007: Healthy controls
// Subjects=13
12.09	27.64	48.12
-25.71	-10.77	-18.48
20.55	19.09	33.13
8.9	27.87	51.48
-36.05	23.58	41.21
43.77	23.97	-2.12
-22.47	-30.12	-21.36
5.76	20.79	56.57
-25.71	-10.77	-18.48
13.17	31.07	51.17
31.91	10.73	-20.95
-34.35	22.31	-16.7
-22.48	-25.89	-21.71
27.86	-39.71	-12.21

// Karunanayaka P R, 2007: Orthopedic Injury Patients > Traumatic Brain Injury 
// Patients
// Karunanayaka P R, 2007: Traumatic Brain Injury Patients > Orthopedic Injury 
// Patients
// Karunanayaka P R, 2007: Negative Correlation between BOLD Activation and 
// NEPSY Verbal-Fluency Scores in All Patients
// Karunanayaka P R, 2007: Correlation between BOLD Activation and DAS Verbal 
// IQ Scores in All Patients
// Subjects=8
-39.27	-23.88	19.58
63.36	-44.76	15.69
-39.06	-43.66	39.07
50.54	-27.23	23.29
24.83	-85.11	-7.25
-56.44	-42.27	3.47
-35.53	58.51	-16.37
-31.1	29.44	-7.29
50.25	13.69	2.01
-48.05	17.68	7.27
45.99	44.65	17.31
-56.54	-25.7	-2.38
46.22	-23.37	18.55
-13.72	36.86	32.03
11.93	37.01	31.72
50.16	8.44	-10.93
54.49	30.98	4.98
-43.64	-7.33	13.78
54.63	-15.89	4.44
-47.77	-27.82	24.46
12.15	-57.41	21.8

// Maruishi M, 2007: Diffuse Axonal Injury Patients
// Subjects=12
-55	18	19
-48	18	18
51	18	19
50	28	19

// Maruishi M, 2007: Healthy Controls
// Subjects=12
-46	1	48
-50	7	22
-46	26	19
-42	-38	39
-46	-35	46
-32	-49	60
48	-41	40

// Newsome M R, 2007: Traumatic Brain Injury Patients
// Subjects=10
24.22	-67	19.56
-8.31	-59.22	12.62
-4.14	-49.4	2.61
25.94	-79.03	-17.38
36.69	-66.23	-18.83
8.79	-47.44	-0.04
0.65	-74.34	34.13
11.02	-79.75	-1.36
-1.84	-48.36	13.68
2.35	-64.69	-.47
13.08	-76.12	-8.48
-3.8	-49.04	29.47
4.62	-41.95	12.93
4.84	-46.88	29.11
-10.16	-72.25	34.11
0.46	-69.21	20.18
2.52	-37.08	19.21
0.45	-60.49	21.56
-6.36	-34.52	1.18
19.48	-85.43	-16.63
0.18	-84.46	-5.2
2.3	-75.95	-6.08
-38.74	18.08	14.46
-31.66	-40.89	49.3
-27.97	17.91	12.05
-38.81	35.09	12.77
-53.64	4.38	29.51
-19.29	53.22	21.85
-32.43	16.85	1.02
-28.1	45.35	7.09
-47.25	5.91	22.53
-12.58	30.88	35.15
-47.25	5.91	22.53
-34.14	11.45	35.2
-53.76	12.26	22.01
-12.61	45.98	35.9
-38.97	31.72	-.34
-31.74	-19.62	47.2
-14.58	-2.95	40.78
-16.78	1.09	38.17
-14.66	11.73	37.08
-23.88	57.71	1.32
-16.63	-17.44	46.73
-20.97	-11.07	46.17
-20.85	-34.26	50.71
-21.6	56.43	10.37
-34.4	51.04	22.33
-60.09	-4.15	30.47
-32.09	-2.55	23.11
-19.25	29.4	19.73
-33.82	-27.72	52.52
-34.25	4.03	24.73
-17.18	65.99	20.55
-12.16	-31.69	54.79
-41.04	54.23	10.92
43.73	21.07	41.89
-19.14	45.54	31.57
-16.76	31.9	46.33
37.48	-3.44	55.63
38.94	37.29	8.99
49.8	24.56	10.06
-31.86	3.57	42.67
-25.27	13.14	52.81
43.34	31.34	13.99
28.77	0.36	50.92
11.38	25.83	48.69
13.66	9.24	54.78
13.53	21.37	46.86
-31.77	10.79	50.92
34.91	15.33	26.92
30.99	-1.34	55.53
52.39	16.84	42.16
-3.89	42.17	40.61
26.82	4.15	68.5
43.4	16.45	15.46
33.01	12.93	47.36
37.05	10.87	25.08
-20.95	26.34	55.92
20.35	-.13	69.04
47.94	4.95	29.97
-29.92	45.71	33.98
30.95	24.6	57.45
20.23	9.88	61.33
22.28	24.36	55.38
33.11	15.89	56.03
-14.68	22.57	38.25
-3.75	21.31	47.16
36.75	52.38	9.78
-29.44	9.91	64.41
43.89	9.13	52.03
50.35	6.82	49.91
32.94	32.08	45.47
-29.41	1.41	65.25
50	15.17	24.44
47.83	32.6	27.23
54.58	8.34	42.96
37.3	6.15	43.47
56.76	4.09	43.35
-19.1	34.9	32.63
-10.47	37.06	32.27
-8.3	43.66	33.82
39.46	-.43	41.85
41	49.64	3.25
34.53	30.06	0.82
56.32	20.54	12.59
41.17	20.28	10.64
56.39	18.83	17.24
25.8	62.14	0.03
43.41	-7.58	11.11
20.1	22.02	53.4
30.24	38.97	4.49
45.54	7.53	11.82
13.58	30.51	52.68
23.92	62.09	22.48
17.61	48	32.95
41.43	-17.18	23.3
63.07	-10.31	26.74
32.32	58.12	2.56
41.23	33.87	18.25
28.18	63.81	17.75
49.97	1.79	19.04
19.71	56.31	29.85
34.92	35.09	31.69
60.78	6.29	20.65
56.48	2.02	21.15
32.5	57.24	16.09
21.96	26.33	30.53
13.28	28.22	28.25
24.05	28.05	25.85
11.25	31.38	39.18
22	28.88	34.76
60.97	-20.74	30.05
11.81	-62.89	64.19
-49.06	-35.19	42.31
7.49	-56.31	65.85
-36.12	-48.53	36.69
29.02	-65.58	57.44
22.57	-67.52	59.98
37.35	-37.22	38.8
18.28	-67.33	62.28
17.93	-65.56	35.21
-5.55	-59.11	59.63
7.41	-56.94	59.19
-31.62	-51.52	50.36
-38.24	-39.41	42.55
-44.58	-60.29	49.2
-45.05	-48.51	14.43
-49.59	-52.32	-3.05
30.96	-82.54	36.67
30.95	-58.51	41.02
20.25	-62.18	48.29
-18.48	-61.07	62.28
37.68	-61.08	59.09
-3.72	-61.59	32.95
31.01	-79.99	40.9
-31.74	-72.12	36.71
39.56	-47.85	39.82
-14.4	-65.06	42.44
-40.42	-61.52	35.81
-42.38	-33.71	57.74
24.59	-75.14	47.25
50.28	-35.26	36.15
24.59	-75.14	47.25
50.28	-35.26	36.15
24.59	-75.14	47.25
35.4	-59.8	50.03
-44.95	-54.27	21.72
11.6	-81.98	43.67
15.95	-81.76	45.81
15.9	-84.3	41.58
-48.92	-34.15	53.41
39.73	-70.62	48.79
-33.61	-52.41	63.92
30.79	-75.07	24.73
48.39	-59.54	52.03

// Newsome M R, 2007: Orthopedic Injury Patients
// Subjects=6
-18.76	13.38	54.92
-18.69	16.13	61.37
-10.05	16.16	61.22
24.44	17.78	53.75
9.24	34.75	52.33
20.13	22.23	55.62
-38.61	34.42	28.52
2.84	22.17	55.92
-38.98	42.56	0.83
-38.4	3.14	38.34
-25.79	20.25	14.02
-27.36	9.3	57.71
-23.87	31.57	-2.82
-21.48	55.13	19.46
-36.66	52.53	15.49
-36.58	18.08	14.42
-23.82	25.39	0.03
-30.32	16.45	-3.46
-36.7	49.99	11.26
-23.59	55.54	23.94
-38.55	6.35	26.82
-25.64	49.77	31.27
-34.27	8.29	24.31
-10.84	21.18	0.23
-36.65	35.1	12.74
24.34	12.7	45.29
-39.01	35.77	-2.98
-15.15	25.63	2.1
-30.27	18.99	0.77
-45.15	20.8	21.02
-34.36	53.58	26.56
-23.73	47.91	11.25
9.09	29.25	39.43
15.76	32.85	54.65
-30.23	30.25	6.38
-31.76	15.25	52.72
-36.12	17.15	50.36
-51.51	10.77	28.84
24.22	-67	19.56
-8.31	-59.22	12.62
-4.14	-49.4	2.61
25.94	-79.03	-17.38
36.69	-66.23	-18.83
8.79	-47.44	-0.04
0.65	-74.34	34.13
11.02	-79.75	-1.36
-1.84	-48.36	13.68
2.35	-64.69	-.47
13.08	-76.12	-8.48
-3.8	-49.04	29.47
4.62	-41.95	12.93
4.84	-46.88	29.11
-10.16	-72.25	34.11
0.46	-69.21	20.18
2.52	-37.08	19.21
0.45	-60.49	21.56
-6.36	-34.52	1.18
19.48	-85.43	-16.63
0.18	-84.46	-5.2
2.3	-75.95	-6.08
-38.74	18.08	14.46
-31.66	-40.89	49.3
-27.97	17.91	12.05
-38.81	35.09	12.77
-53.64	4.38	29.51
-19.29	53.22	21.85
-32.43	16.85	1.02
-28.1	45.35	7.09
-47.25	5.91	22.53
-12.58	30.88	35.15
-47.25	5.91	22.53
-34.14	11.45	35.2
-53.76	12.26	22.01
-12.61	45.98	35.9
-38.97	31.72	-.34
-31.74	-19.62	47.2
-14.58	-2.95	40.78
-16.78	1.09	38.17
-14.66	11.73	37.08
-23.88	57.71	1.32
-16.63	-17.44	46.73
-20.97	-11.07	46.17
-20.85	-34.26	50.71
-21.6	56.43	10.37
-34.4	51.04	22.33
-60.09	-4.15	30.47
-32.09	-2.55	23.11
-19.25	29.4	19.73
-33.82	-27.72	52.52
-34.25	4.03	24.73
-17.18	65.99	20.55
-12.16	-31.69	54.79
-41.04	54.23	10.92
-49.52	40.14	21.42
-8.15	33.85	43.75
-25.29	26.12	53.77
-18.89	23.39	47.21
-36.46	29.97	26.69
-1.67	27.29	42.05
-29.86	22.1	34.08
-32.36	37.04	10.23
-27.34	18.22	61.31
2.86	24.5	57.93
-21.06	18.92	45.45
-30.28	49.6	6.71
-12.18	16.36	63.48
-27.55	14.43	43.76
-29.66	14.84	48.24
-28.21	29.22	-4.76
-36.05	13.31	55.22
-25.89	23.88	6.94
-34.52	50.21	13.45
-26	53.66	3.99
-36.63	52.74	17.71
-31.93	29.31	42.36
-31.76	15.25	52.72
-25.5	26.79	38.02
-42.72	9.71	40
-12.63	21.75	29.34
-25.95	32.18	3.88
-25.96	21.13	0.49
-16.67	15.09	50.23
-49.12	19.03	48.16
-23.61	16	14.4
-6.04	31.32	39.48
-30.08	35.75	19.28
-47.22	12.7	26.34
-49.37	17.16	28.17
-25.34	-7.04	43.61
-6.12	8.8	28.26
-53.65	19.68	32.48
-10.23	5.99	44.3
-27.83	49.56	29.08
-29.9	10.84	28.47
-27.7	15.52	32.45
-25.01	4.17	71.63
-10.44	15.38	29.93
-12.42	12.36	43.71
-36.37	8.69	28.79
-32.3	44.04	16.26
-51.82	41.22	10.15
-41.13	16.41	-3.27
-33.78	-1.15	61.1
-30.42	50.69	-4.6
-12.5	24.91	40.23
32.45	24.09	5.92
39.01	33.45	13.85
32.67	34.46	25.06
47.75	38.56	22.16
41.22	36	18.04
32.62	31.92	20.83
45.76	2.6	27.99
41.22	36	18.04
54.12	15.86	8.61
54.3	28.16	25.32
28.07	41.09	4.32
43.63	31.29	36.4
43.59	11.31	29.41
45.65	8.36	20.7
56.49	21.78	25.91
54.28	34.54	24.69
58.69	17.75	28.52
49.97	-6.93	17.66
19.4	32.13	0.87
17.23	27.66	-.89
41	49.64	3.25
34.53	30.06	0.82
56.32	20.54	12.59
41.17	20.28	10.64
56.39	18.83	17.24
25.8	62.14	0.03
43.41	-7.58	11.11
20.1	22.02	53.4
30.24	38.97	4.49
45.54	7.53	11.82
13.58	30.51	52.68
23.92	62.09	22.48
17.61	48	32.95
41.43	-17.18	23.3
63.07	-10.31	26.74
32.32	58.12	2.56
41.23	33.87	18.25
28.18	63.81	17.75
49.97	1.79	19.04
19.71	56.31	29.85
34.92	35.09	31.69
60.78	6.29	20.65
56.48	2.02	21.15
32.5	57.24	16.09
21.96	26.33	30.53
13.28	28.22	28.25
24.05	28.05	25.85
11.25	31.38	39.18
22	28.88	34.76
60.97	-20.74	30.05
-12.34	-59.29	35.11
-35.89	-57.71	53.28
-40.22	-49.01	54.74
-38.07	-53.47	52.9
-31.52	-63.87	56.06
-27.22	-64.06	53.76
5.22	-72.46	54.04
-1.49	-41.4	42.12
-42.4	-42.64	54.14
-40.46	-59.6	33.38
-10.09	-67.38	40.35
-35.95	-71.31	45.66
-25.01	-70.23	56.58
-42.4	-42.64	54.14
-40.46	-59.6	33.38
-10.09	-67.38	40.35
-35.95	-71.31	45.66
-25.01	-70.23	56.58
-42.83	-65.52	16.07
-3.52	-77.57	45.73
-12.23	-73.76	41.02
-9.94	-48.7	56.43
-51.21	-43.91	40.97
7.5	-65.03	64.47
-51.26	-46.46	36.74
-1.15	-62.93	64.41
-12.31	-39.32	42.1
39.79	-57.03	56.41
30.91	-54.47	38.38
-46.64	-42.03	60.88
-33.55	-45.41	69.95
-40.27	-27.53	54.85
-44.94	-71.7	18.96
15.88	-56.03	45.51
-1.2	-50.17	63.15
-40.66	-52.33	19.21
-34.06	-68.91	25.22
20.42	-69.65	60.23
22.57	-65.39	59.77
-33.98	-72.75	30.09
-42.83	-56.8	17.45
52.72	-46.35	55.13
-16.54	-47.42	47.45
-57.57	-47.36	50.39
-14.15	-63.19	62.42
26.88	-63.25	59.48
48.24	-43.15	43.68
28.77	-67.45	37.46
48.43	-48.28	57.64
-14.3	-53.38	52.49
50.59	-48.28	57.6
-37.99	-28.82	63.91
30.96	-75.95	38.26
-38.59	-66.13	9.34
52.57	-38.67	45.41
36.81	22.18	8.28
20.02	6.09	43.78
-10.55	-22.66	13.52
-6.16	-19.89	19.9
45.45	46.23	12.48
30.24	30.25	3.11
31.08	-2.84	62.4
38.88	39	4.34
15.1	-11.46	-5.95
-12.97	-7.1	-3.66
41.03	49.85	5.47
-8.6	-4.54	0.49
47.81	30.26	25.22
26.29	-21.7	21.77
17.88	-.3	44.44
41.79	0.83	55.13
2.2	-11.09	-1.28
50.07	13.46	29.09
-4.17	-12.41	7.92
-6.31	-16.67	8.38
43.58	6.85	27.61
22.29	6.93	52.62
22.35	5.22	57.27
13.06	-4.05	4.56
-10.7	9.04	8.15
45.75	-1.86	26.19
32.53	55.32	18.52
12.99	-.21	-.3
13.21	-20.44	12.9
6.83	-17.51	21.68
19.84	0.38	28.66
26.52	-.27	44.29
15.13	4.05	-.76
-19.28	-1.41	11.57
26.52	-.27	44.29
24.43	-4.11	49.19
34.95	26.59	32.53
30.86	-11.09	43.05
37.09	15.54	29.1
60.8	10.75	22.45
43.63	24.7	34.81
62.89	5.88	16.17
36.97	16.84	20.01
8.66	-13.41	-3.41
10.97	-14.49	7.87
51.86	41.38	6.12
56.7	10.27	40.5
43.84	-2.12	46.42
26.65	-10.28	52.01
21.93	2.1	23.97
21.96	-10.87	23.01
19.81	-6.41	24.85

// Takarae Y, 2007: Brain activation during visually guided saccades, 
// control>autism
// Takarae Y, 2007: Brain activation during visually guided saccades, 
// autism>control
// Takarae Y, 2007: Brain activation during visual pursuit, control>autism
// Takarae Y, 2007: Brain activation during visual pursuit, autism>control
// Subjects=13
26.17	-9.83	57.79
6.86	2.48	53.64
45.02	31.32	24.01
28.39	-74.89	42.03
4.77	-56.34	36.29
60.03	-65.78	-8.16
30.09	-90.42	-21.36
-38	-12.93	50.98
0.45	-6.36	49.99
-20.8	-49.12	49.36
-9	-66.14	48.42
-47.86	-70.49	-4.3
-14.85	-89.09	-27.65
51.57	16.36	36.35
4.77	18.3	65.72
36.28	63.36	12.51
12.94	45.22	27.68
8.96	-46.26	28.7
58.01	-62.48	7.2
2.25	-16.46	1.75
5.36	13.34	1.44
-42.53	15.11	28.61
-21.48	73.42	10.1
-.89	34.73	30.95
0.33	-25.16	27.03
0.09	-12.24	1.42
-4.26	13.28	1.56
-12.78	-64.5	-26.39
45.34	-12.6	47.77
3.69	24.81	67.41
38.76	28.42	42.17
49.69	-56.79	40.27
2.68	-69.05	37.38
4.56	18.36	38.95
21.49	-77.79	-22.33
-35.85	-6.23	54.86
-5.93	22.47	65.49
-36.09	39.61	42.09
-45.33	-52.1	54.35
0.65	-72.43	48.84
-0.03	48	9.75
0.3	14.11	39.35
0.47	-34.71	41.22
-53.25	-71.03	-10.88
-40.58	-68.1	-29.12
30.5	-53.22	46.88
47.39	-81.58	8.92
-48.92	-63.81	-.39
-8.4	10.23	17.48

// Ansari D, 2007: Small Nonsymbolic > Large Nonsymbolic
// Ansari D, 2007: Large Nonsymbolic > Small Nonsymbolic
// Ansari D, 2007: Conjunction of small nonsymbolic and large nonsymbolic
// Ansari D, 2007: Conjunction of Small and Large symbolic number
// Subjects=13
45.3	-55.81	25.74
11.07	-80.57	11.48
17.45	-58.87	16.28
-41.14	-34.27	50.58
33.69	-42.28	50.39
-16.45	-59.33	54.63
-24.01	-49.23	48.29
28.38	-48.66	50.99
6.78	17.03	49.07
-32.73	3.85	47.28
30.32	7.57	48.48
-41.43	9.91	30.15
48.29	14.42	25.39
30.93	25.92	-3.25

// Piazza M, 2007: Overall fMRI Adaptaion Effect (Activation decrease with 
// repetition of same approximate quantity)
// Piazza M, 2007: Distance-Dependent Recovery from Adaptation across 
// condtions (Far>Close)
// Piazza M, 2007: Notation Change > Number Change
// Piazza M, 2007: Mental Arithmetic > Sentence Comprehension
// Subjects=14
-34	-54	44
-20	-68	42
-32	-64	40
34	-64	54
34	-58	50
46	-46	40
-28	-64	-32
36	-72	-26
-34	-80	-2
24	-80	4
36	-46	-20
-36	-60	-14
-54	24	-30
38	26	20
-14	-2	2
14	-2	0
-34	-62	60
-26	-50	40
-24	-58	58
48	-44	38
54	-40	52
42	-44	52
-36	22	-4
-34	20	6
36	22	6
44	24	-4
-8	12	46
4	12	30
44	28	28
40	4	42
32	-2	60
-30	48	18
44	-52	-38
28	-60	-28
-38	-66	-38
-26	-68	-28
-4	-90	12
28	-42	-8
32	-56	-10
-32	-48	-8
-26	-36	-16
-14	-60	10
-16	-52	2
-45	-48	-48
-30	-39	-39
-21	-60	54
45	-45	45
33	-54	45
30	-72	42

// Baumgaertner A, 2007: sentences (intelligible > reversed)
// Baumgaertner A, 2007: videos (visible > scrambled)
// Baumgaertner A, 2007: sentences (action >  non-action)
// Baumgaertner A, 2007: videos (action > non-action)
// Baumgaertner A, 2007: conjunction (action sentences > non-action sentences 
// AND action videos > non-action videos)
// Subjects=19
-42	-45	-18
-3	9	54
-54	36	9
-45	6	33
48	-69	-3
-48	-72	0
48	15	21
-21	3	57
-48	9	24
-36	33	-15
39	36	-12
-6	-48	6
33	0	54
6	21	51
-51	36	6
-57	12	24
-39	-60	45
6	3	63
36	39	39
42	-33	33
30	-69	-27
-33	57	-6
-42	42	27
-42	-66	-15
-57	-24	36
-51	6	27
-51	9	24
-54	-21	30
-42	-48	54

// Herrington J D, 2007: Walker vs Fixation, Controls > ASD
// Herrington J D, 2007: Randomized walker vs fixation, Controls > ASD
// Subjects=10
40.83	-44.93	-23.07
55.71	-80.79	-20.24
-31.77	-81.61	-14.7
48.86	-67.8	-16.79
41.75	-71.94	-11.9
-31.74	-81.27	-10.27
53.86	-53.89	-13.55
43.65	-68.45	0.06
44.2	-33.31	-10.7
48.33	-49.78	-9.37
-52.21	-45.91	-4.08
-54.02	-41.33	-1.1
-54	-41.16	1.12
-56.66	-37.22	4.17
-39.53	-74.84	-6.26
45.77	-71.23	-3.08
32.32	-84.48	7.11
-40.51	-69.48	6.69
42.96	-82.57	15.75
30.43	-96.47	21.52
28.33	-95.19	25.89
-40.48	-69.14	11.12
51.12	-83.07	-6.61
37.6	-76.35	3.02
-56.63	-36.88	8.6
-58.41	-37.07	13.09
-57.36	-50.68	18.68
-55.19	-51.17	23.16
-40.77	-59.39	32.61
28.73	-87.02	11.82
21.76	-102.15	17.63
-5.44	-113.84	18.92
24.69	-85.67	29.6
-46.05	-57.76	28.07
-37.21	-58.92	36.99
-49.14	-63.39	40.84
-20.42	-55.39	39.84
-21.45	-54.02	45.32
-21.42	-50.95	50.63
-17.37	-38.12	55.09
-13.48	-38.52	60.65
-10.55	-37.33	66.1
54.46	-63.16	31.83
54.49	-62.81	36.26
58.04	-62.54	39.54

// Montgomery K J, 2007: activation evoked during all conditions, 
// communicative hand gestures vs rest
// Montgomery K J, 2007: activation evoked during all conditions, 
// object-directed hand gestures vs rest
// Subjects=14
-34.7	-15.23	62.29
-38.97	-29.52	56.85
58.06	5.11	41.68
-50.96	8.6	41.52
58.86	14.43	10.77
-55.39	-8.37	15.11
63.51	-28.96	41.12
-55.05	-46.67	42.86
50.49	-49.75	7.33
-54.21	-52.32	10.98
52.64	-62.77	3.94
-54.21	-67.64	5.57
41.71	4.93	-.5
-37.42	-3.72	-8.9
5.73	-93.8	5.96
-.71	-93.04	2.63
42.75	-55.71	-27.77
-24.57	-55.05	-27.05
-34.71	-15.4	60.07
-38.97	-29.52	56.85
59.12	5.03	40.55
-50.96	7.54	41.61
57.79	14.42	10.79
-55.39	-10.66	13.08
59.23	-28.98	41.18
-54	-43.49	42.58
50.49	-47.55	8.26
-56.35	-52.33	11.01
51.59	-62.6	6.17
-53.14	-67.63	5.56
41.7	3.78	-1.52
-35.24	-5.48	-4.32
6.85	-88.79	15.57
-3.79	-97.15	18.62
40.62	-55.64	-26.63
-24.55	-55.94	-24.74

// Jonas M, 2007: observation across all stimulus types
// Jonas M, 2007: observation of a color change
// Jonas M, 2007: observation of a moving dot
// Jonas M, 2007: observation of a moving finger
// Jonas M, 2007: observation of a moving finger and dot
// Jonas M, 2007: observation - execution across all stimulus types
// Jonas M, 2007: observation - execution of a color change
// Jonas M, 2007: observation - execution of a moving finger
// Jonas M, 2007: observation - execution of a moving dot
// Jonas M, 2007: observation - execution of a moving finger and dot
// Jonas M, 2007: response to imitation
// Jonas M, 2007: response to control cues
// Jonas M, 2007: finger movement vs color change
// Subjects=17
-51	15	9
48	15	6
-54	-36	48
60	-24	45
33	-36	39
45	-45	54
-39	-51	45
42	-45	54
-57	18	0
51	12	3
-54	-33	48
60	-27	42
-39	-39	36
45	-48	36
48	-42	54
-42	-39	39
-51	-33	48
-39	-48	48
-60	15	3
48	18	6
-57	-33	36
57	-33	39
-39	-42	42
-39	-51	51
39	-48	39
-39	0	12
57	15	3
-57	-21	21
60	-33	39
54	-39	42
-39	0	12
48	15	3
-57	-21	21
66	-33	27
-54	-36	48
54	-39	42
-39	0	9
60	15	3
-57	-24	21
69	-30	27
54	-36	51
-48	6	3
63	15	12
-57	-21	21
66	-18	30
-45	-30	54
51	-33	51
-39	3	9
60	15	3
-57	-24	21
66	-30	24
54	-36	51
54	-72	0
-36	18	9
36	27	0
-27	-57	48
30	-60	42
-54	-36	48
12	21	36
45	6	33
-66	-33	-27

// Kemp A H, 2007: PTSD-depression
// Subjects=8
-10	18	30
10	40	40
28	-2	-28
0	40	44
-2	38	12
14	58	4
-8	26	42
-4	40	8
26	4	-20
-20	2	-20
-10	52	40
30	4	-28
12	60	8
-20	2	-20
10	16	28
14	34	6
2	26	56
-10	52	-14

// Kemp A H, 2007: PTSD-alone
// Subjects=8
0	36	42
-2	52	-4
32	-2	-28
0	40	44
-2	38	12
14	58	4
-8	26	42
-4	40	8
26	4	-20
-20	2	-20
-10	52	40
30	4	-28
12	60	8
32	-4	-20
-10	52	50
10	16	28
14	58	4

// Kemp A H, 2007: Healthy Controls
// Subjects=32
8	26	56
-10	58	8
-26	4	-18
26	-6	-16
32	-4	-20
-10	52	50
10	16	28
-20	2	-20
10	16	28
14	34	6
14	58	4
2	26	56
-10	52	-14

// Scheibel R S, 2007: Traumatic Brain Injury (TBI) Patients
// Subjects=14
-51.38	16.06	39.52
-27.47	-.25	47.45
11.36	23.49	46.68
-8	17.46	52.09
-36.41	32.51	30.92
-6.15	23.9	29.01
-14.23	1.87	69.43
13.29	26.09	28.46
-33.8	-47.28	49.97
-16.43	-40	57.92
-9.92	-61.67	55.47
9.49	-57.55	52.49
44.04	-53.18	51.47
24.62	-66.22	50.85
18.18	-41.8	59.75
31.04	7.79	61.35
13.74	11.99	61.23
43.86	2.34	48.22
15.47	26.31	30.65
33.17	7.59	59.09
-12.39	19.16	47.52
-8.31	23.89	29.05
-51.43	13.52	35.29
-29.57	0.16	51.93
-49.04	-8.83	48.67
2.83	-6.32	49.78
15.72	6.28	46.07
0.57	21.33	47.08
-22.96	-25.14	56.56
-1.19	-39.12	66.54
-40.24	-27.32	57.07
0.55	3.69	42.1
4.61	34.57	27.77
0.8	-16.34	57.53
-3.46	-55.26	54.73
8.71	48.23	12.9
32.48	-26.08	-2.56
8.72	-15.12	1.24
-8.61	-54.92	-10.21
-6.52	-35.77	-12.14
-25.88	-30.75	-3.34
-21.74	-56.21	-23.31
-8.57	-13.05	1.33
-13.24	-70.4	-37.74
17.53	-27.02	11.24
6.58	9.1	7.85
10.89	28.68	10.32
30.31	35.13	9.35
23.78	17.26	2.27
34.79	-22.7	10.51

// Scheibel R S, 2007: Orthopedic Injury (OI) Patients
// Subjects=10
15.47	26.31	30.65
33.17	7.59	59.09
-12.39	19.16	47.52
-8.31	23.89	29.05
-51.43	13.52	35.29
-29.57	0.16	51.93
-49.04	-8.83	48.67
2.83	-6.32	49.78
15.72	6.28	46.07
-25.11	-29.4	57.02
-11.91	-53.84	70.42
-7.76	-24.46	62.96
35.47	-26.43	62.42
13.89	-19.71	66.6
24.75	-41.15	66.3
0.57	21.33	47.08
-22.96	-25.14	56.56
-1.19	-39.12	66.54
-40.24	-27.32	57.07
0.55	3.69	42.1
4.61	34.57	27.77
0.8	-16.34	57.53
-3.46	-55.26	54.73
8.71	48.23	12.9
32.48	-26.08	-2.56
8.72	-15.12	1.24
-8.61	-54.92	-10.21
-6.52	-35.77	-12.14
-25.88	-30.75	-3.34
-21.74	-56.21	-23.31
-8.57	-13.05	1.33
-13.24	-70.4	-37.74

// Thompson J C, 2007: face > radial
// Thompson J C, 2007: hand > radial
// Thompson J C, 2007: All conditions > fixation
// Thompson J C, 2007: Areas active to both Face > Radial and Hand > Radial
// Subjects=11
-16	2	16
-42	14	24
-44	2	8
2	32	48
8	14	56
-54	8	18
-20	-2	12
6	32	52
-46	-8	46
-49	8	2
2	29	52
-18	-2	14

// Wong P C M, 2007: Pre-training tone > pre-training sinewave, all subjects
// Wong P C M, 2007: Post-training tone > post-training sinewave, all subjects
// Wong P C M, 2007: Post-training tone > pre-training tone, all subjects
// Wong P C M, 2007: Successful vs less successful learners (Post-training 
// tone)
// Wong P C M, 2007: Less successful vs less successful learners 
// (post-training tone)
// Subjects=17
62.17	-24.05	8.39
-66.15	-15.81	2.48
46.08	-21.48	1.67
-46.92	-12.52	1.98
-40.46	21.04	22.51
-55.5	-45.84	-15.2
-63.03	22.79	5.9
-56.24	-32.47	33.87
71.64	-12.33	-6.09
68.48	-38.24	-10.57
42.65	-17.21	-25.42
52.5	-67.48	-15.74
50.53	0.15	33.26
39.66	27.86	21.02
14.4	-73.8	29.84
12.88	7.21	4.1
-24.41	-44.63	-2.28
-21.29	-2.6	4.2
-43.58	-1.19	24.41
-30.96	-36.17	-16.29
-56.47	-18.41	9.28
-33.61	-66.72	43.18
-39.95	-32.98	67.18
-50.04	-44.52	1.36
-53.38	13.33	6.58
-60.79	-52.93	-10.08
-62.82	-40.91	7.89
-40.38	-34.18	10.41
58.83	-28.78	-11.25
49.09	-23.52	-24.96
52.59	-.61	23.26
33.09	42.66	6.47
45.92	-6.65	-12.96
42.5	44.97	-19.48
42.54	11.34	-27.81
36.47	-44.52	-6.33
23.66	14.82	18.95
23.42	51.86	2.47
10.8	30.86	21.1
10.72	3.68	-0.04
10.79	53.84	29.21
-5.51	57.52	-4.37
4.83	-66.75	39.39
-21.31	43.36	20.42
-37.24	31.09	28.32
-32.77	0.16	40.9
-34.03	-44.68	-2.16
-40.43	8.18	21.36
-34.21	16.1	-.56
-40.48	-15.4	5.5
-50.38	-1.91	-25.63
-53.41	-33.14	-16.29
-56.16	-44.91	38.26
-53.09	-16.59	32.5
-54.32	-14.97	12.31

// Abutalebi J, 2007: Dialect vs. German
// Abutalebi J, 2007: Pseudowords vs. German
// Abutalebi J, 2007: 1st Run Dialect vs. 1st Run German
// Abutalebi J, 2007: 4th Dialect Run vs. 4th Run German
// Abutalebi J, 2007: 4th Run Pseudowords vs. 4th Run German
// Subjects=12
-38	8	28
-52	10	16
-40	30	12
-44	26	24
-32	30	0
-44	6	36
-24	-50	48
-28	-50	56
-16	-10	-12
-20	2	-16
-50	10	0
-54	-40	8
-42	-68	-4
-40	-62	-12
-18	8	0
-6	-10	12
-2	-18	12
48	34	20
34	-64	56
-4	20	52
-46	6	48
-46	8	36
-52	14	16
-42	18	20
-40	30	8
-30	30	4
-44	40	4
-24	-48	48
-46	-28	48
-44	-30	44
-50	8	4
-52	4	4
-62	-32	4
-34	-58	-12
-46	-52	-12
-40	-76	-4
-22	-74	28
54	22	32
50	26	32
46	34	24
50	26	8
42	32	4
30	-68	56
34	-54	52
40	-56	56
44	-62	-8
-48	2	44
-50	12	36
-46	22	28
-50	14	24
-52	12	20
-40	24	16
-44	28	8
-40	26	-4
-22	-54	44
-22	-64	56
-32	-54	44
-12	2	-12
-14	-4	-12
-24	6	-16
-62	-36	4
-34	-62	-8
-18	12	0
-18	8	12
-20	-6	12
-6	-12	16
-48	6	12
-48	10	20
-42	14	28
-50	8	-4
-4	18	48
-40	4	36
-42	14	28
-52	12	16
-32	32	4
-38	28	12
-44	30	4
-28	-42	48
-22	-54	44
-56	-22	40
-38	-62	-12
-14	-8	16
48	14	32
40	28	4
30	-60	56
-42	18	20
-44	32	4
-40	34	-4
-24	-50	52
-46	-30	44
-50	-50	-8
-20	-74	28
-22	-76	36
30	-70	56
40	-60	56
40	-60	-8

// Bahlmann J, 2007: All Conditions vs. Baseline
// Bahlmann J, 2007: Noncanonical vs. Canonical
// Bahlmann J, 2007: Noncanonical Unambiguous vs. Canonical Unambiguous
// Bahlmann J, 2007: Noncanonical Ambiguous vs. Canonical Ambiguous
// Subjects=12
-56	-32	-16
-48	-60	8
-44	12	20
-8	8	60
36	-80	-28
-40	-52	28
-44	24	28
-40	28	8
-40	-52	28

// Fias W, 2007: (Number comparison-number dimming) - (letter 
// comparison-letter dimming)
// Fias W, 2007: Conjunction of (number comparison-number dimming) and (letter 
// comparison-letter dimming)
// Fias W, 2007: Conjunction of (numcomp-numdim) and (lettercomp-letterdim) 
// and (squarecomp-squaredim)
// Subjects=17
6	-72	-6
-39	-87	-6
-24	-78	-9
-39	-39	36
45	-36	48
-27	-69	39
30	-69	42
-42	3	30
-24	-3	57
27	0	51
-18	-9	72
-6	3	53
12	3	45
-3	-75	10
10	-65	13
-7	-72	5
11	-68	11
-14	-48	-8
9	-56	-1
-24	-50	-16
29	-47	-17
-44	-68	-13
-27	-69	39
30	-69	42
-42	3	30
-3	-75	10
10	-65	13
-7	-72	5
11	-68	11
-14	-48	-8
9	-56	-1
-24	-50	-16
29	-47	-17
-44	-68	-13

// Kadosh R C, 2007: Notation Adaptation
// Kadosh R C, 2007: Quantity Adaptation
// Kadosh R C, 2007: Notation x Adaptation
// Subjects=12
-51.24	-53.64	-20.17
32.55	-59.52	34.01
-34.82	-54.98	29.94
21.96	-49.84	50.04

// Bitan T, 2007: All Spelling Conditions > Simple and Complex Control (Masked 
// by Spelling vs. Fixation)
// Bitan T, 2007: All Rhyming Conditions > Simple and Complex Control (Masked 
// by Rhyming vs. Fixation)
// Bitan T, 2007: Spelling vs. Fixation > Rhyming vs. Fixation
// Bitan T, 2007: Rhyming vs. Fixation > Spelling vs. Fixation
// Bitan T, 2007: Overlap of Language-Specific Activation between the Two 
// Tasks (Masked by Conditions vs. Fixation)
// Bitan T, 2007: Positive Correlation between Accuracy and Activations, 
// Rhyming Conditions vs. Fixation
// Bitan T, 2007: Spelling + Rhyming
// Bitan T, 2007: Spelling (Masked by Spelling > Rhyming)
// Bitan T, 2007: Spelling (Masked by Rhyming > Spelling)
// Bitan T, 2007: Rhyming (Masked by Spelling > Rhyming)
// Bitan T, 2007: Rhyming (Masked by Rhyming > Spelling)
// Bitan T, 2007: Rhyming, O+P- > O-P+
// Subjects=38
-48	36	6
-6	15	48
-54	-39	6
-6	-12	6
-6	-75	6
-57	-51	-12
-30	-57	39
-60	-42	12
-48	15	21
-6	9	60
-9	-87	12
-45	-33	-15
36	33	-6
27	-72	39
-21	-66	54
30	3	54
54	-48	-12
-39	-48	48
-24	3	60
-51	30	9
-45	30	-12
27	0	3
39	36	-9
-36	6	3
-54	-50	-12
-48	21	-15
-6	24	45
-42	6	30
-36	24	0
12	15	3
33	24	0
-6	36	24
-42	39	12
45	36	21
-12	3	12
-27	-60	42
33	-63	51
-30	-54	51
-48	33	9
-24	-63	45
30	-69	45
-39	-48	45
-45	30	12
36	33	-9
6	30	45
42	36	33
60	-12	3
51	6	9
-51	3	48
-51	-24	54
-33	21	6

// Grezes J, 2007: Body Expression vs Scrambled stimuli, Irrespective of 
// Static or Dynamic Stimuli
// Grezes J, 2007: Fearful Body Expressions vs Neutral Whole Body Actions, 
// Irrespective of Static or Dynamic
// Grezes J, 2007: Dynamic vs Static Body Expression, Irrespective of 
// Emotional Content
// Grezes J, 2007: Interaction, Fearful Body Expression and Dynamic 
// Information
// Subjects=16
4	54	28
-2	44	-14
36	32	-20
-46	34	-14
60	-46	16
-54	-50	16
13	-30	0
24	-24	-14
-22	-4	-32
54	14	-26
-32	12	-30
26	10	-28
28	0	-28
44	-52	-22
-40	-56	-18
52	-72	6
-44	-82	4
8	18	66
-12	-52	40
64	-46	24
-58	-54	14
52	-48	12
48	-66	8
50	30	-4
48	-20	-8
34	28	-16
34	4	-24
44	18	-32
-32	14	-32
10	0	70
22	-62	62
-22	-62	62
6	-56	66
34	-46	56
-34	-46	56
44	6	48
-44	6	48
30	-40	48
-30	-40	48
24	-84	28
-24	-84	28
60	-42	30
-60	-42	30
50	28	24
50	30	-12
-16	-24	10
60	-44	16
-60	-44	16
48	-66	8
-48	-66	8
30	-94	8
-30	-94	8
54	-16	-14
44	-50	-22
-44	-50	-22
24	10	-28
-10	-76	-42
54	4	40
60	-36	24
-52	-42	24
-52	-54	20
60	-44	18
50	-44	22

// Lotze M, 2007: Receiving aversive stimuli; parametric modulation
// Lotze M, 2007: Retaliation; parametric modulation
// Lotze M, 2007: Conjunction; retaliation and watching the opponent
// Subjects=14
12	-78	0
-42	-69	6
-15	-54	-15
60	-69	0
57	-29	12
-63	-12	12
66	6	3
-51	9	-3
12	3	39
-24	0	-12
36	0	-3
-33	0	-3
-54	6	-3
60	0	-3
12	-18	0
-6	-15	0
21	-45	-3
9	69	15
18	-84	18
-24	-90	6
12	48	33
54	27	6
-42	33	-9
48	-66	0
-48	-69	6
15	-96	9
-15	-99	15
27	-24	-18
-18	-6	-15

// Bar K J, 2007: Healthy Controls
// Subjects=13
-16.02	-8.95	11.14
58.33	23.76	1.03
48.48	41.39	-5.03
62.7	26.32	5.19
46.36	41.7	-1.66
-40.16	-1.96	-16.03
-55.85	-17.83	21.66
60.94	-16.59	28.51
71.7	-1.56	27.96
32.27	-15.19	68.08
29.77	28.23	50.38
44.36	41.77	10.7
-50.38	-54.5	19.59
-62.85	-23.93	-20.2
4.07	-27.06	57.41
10.05	-67.98	9.81
31.55	-73.09	-.13
3.93	-84.97	35.13
22.71	-18.78	-4.24
20.56	-36.22	-6.96
24.67	-74.96	-31.21
-35.96	-55.38	-36.59
11.91	-60.37	-12.26
-3.17	-62.24	-8.46
48.43	-78.27	-33.52

// Bar K J, 2007: Major depressive disorder
// Subjects=13
-16.02	-8.95	11.14
58.33	23.76	1.03
48.48	41.39	-5.03
62.7	26.32	5.19
46.36	41.7	-1.66
-40.16	-1.96	-16.03
-43.53	-30.94	53
-48.35	-9.51	18.47
-64.73	-1.03	6.7
-66.66	-15.75	21.64
-39.91	6.5	5.54
3.75	31.87	44.86
-11.35	18.85	44.17
-28.5	-5.36	50.22
29.81	19.82	52.33
33.22	35.94	-16.55
42.03	43.81	-1.79
55.33	-53.24	4.22
64.98	-30.77	2.95
50.67	-51.39	-21.65
-6.67	-39.76	59.97
10.57	-33.42	57.93
12.88	-42.16	67.72
-15.19	-50.87	67.94
45.13	-33.4	56.22
65.35	-20.31	34.41
27.09	-53.32	-6.5
27.07	-2.08	1.88
16.3	-16.05	2.33
-35.82	-54.34	-25.49
-44.25	-75.77	-13.14
48.43	-78.27	-33.52

// McCabe C, 2007: MSG > Odor tl
// McCabe C, 2007: NaCl > Odor tl
// McCabe C, 2007: MSGV > Odor tl
// McCabe C, 2007: NaClV > Odor tl
// McCabe C, 2007: Supralinear additivity, MSGV
// McCabe C, 2007: [MSGV - (MSG + V)] - [NaCIV - (NaCl + V)]
// McCabe C, 2007: MSG > Odor tl + NaCl > Odor tl + MSGV > Odot tl
// Subjects=12
34	24	-6
46	22	28
8	6	56
-38	20	20
-38	14	2
-40	22	24
10	6	54
-40	12	0
-2	8	54
-42	42	8
-6	52	-14
10	42	-22
-48	6	-18
-52	-10	42
-40	22	24

// Zhang Y, 2007: Effect of DRD2 rs1076560 genotype on brain activity during 
// working memory, GT > GG
// Zhang Y, 2007: Effect of DRD2 rs2283265 genotype on brain activity during 
// working memory, GT > GG
// Subjects=19
-19.63	24.37	-11.15
21.39	19.95	-14.77
-54.03	38.67	5.95
-31.56	43.68	-10.61
-53.39	8.48	50.39
-10.62	24.97	17.78
-7.55	-10.17	-2.33
-31.27	55.74	15.08
-10.46	-17.57	21.98
-22.53	-17.9	7.65
-54.05	42.93	5.53
12.25	-21.74	22.01
-9.35	-14.06	24.98
-35.31	-50.5	15.58
37.82	22.73	2.61

// Loucks T, 2007: Repetitive Vocalization > Continuous Vocalization
// Loucks T, 2007: Vocalization > Rest
// Loucks T, 2007: Exhalation > Rest
// Loucks T, 2007: Vocalization > Exhalation
// Subjects=12
-9.14	3.79	58.17
-61.71	-27.27	19
-45.58	-6.35	40.48
39.81	-4.66	27.09
61.43	-38.23	45.27
-3.84	-3.3	48.67
42.96	-75.57	-9.38
8.73	-74.98	-12.38
10.86	-1.46	16
-43.7	-2.47	7.79
-45.58	-8.55	39.55
61.42	-38.31	44.16
42.98	-73.11	-5.12
8.73	-73.92	-12.47
23.52	25.51	5.79
69.42	8.81	-7.83
-61.71	-27.27	19
-50.15	-8.31	1.67

// Holzel B K, 2007: Meditators
// Subjects=15
-51	-3	-42
-45	36	-21
36	-84	-42
15	21	-21
-24	-93	-36
-9	63	6
15	66	6
63	6	9
54	-6	-36
-18	-57	-54
-54	0	-39
-24	-30	72
-60	3	15
-27	-18	-30
-48	-21	-30

// Holzel B K, 2007: Non-meditators
// Subjects=15
-51	-3	-42
-45	36	-21
36	-84	-42
15	21	-21
-24	-93	-36
-9	63	6
15	66	6
63	6	9
54	-6	-36
-18	-57	-54
-54	0	-39
-24	-30	72
-60	3	15
-27	-18	-30
-51	-6	-39

// Di Russo F, 2007: Significant activation sites (Group Data)
// Di Russo F, 2007: Significant activation sites (Single Subject Data)
// Di Russo F, 2007: Unseeded source model (Group data)
// Di Russo F, 2007: Unseeded source model (Single subject)
// Subjects=5
11.04	-92.73	-2.32
48.87	-71.66	2.79
39.49	-75.68	29.12
30.35	-75.1	-10
14.5	-93.28	14.48
51.06	-71.44	4.97
32.92	-81.86	20.88
33.53	-74.44	-14.6
-6.2	-94.6	1.52
-44.05	-74.22	3.51
-32.85	-79.99	33.02
-23.59	-79.02	-3.09
-9.23	-91.99	18.12
-47.25	-72.85	6.79
-34.02	-88.37	23.79
-30.12	-82.75	-8.21
13.21	-91.55	-1.36
50.02	-70.07	8.22
34.17	-80.61	34.18
24.91	-74.26	-12.23
12.37	-95.21	16.95
47.79	-68.37	3.61
31.8	-72.29	19.95
24.95	-72.88	-9.01
-7.25	-96.63	2.86
-45.09	-68.49	7.44
-28.59	-86.98	26.92
-42.1	-62.69	-11.11
-6.01	-89.96	16.74
-45.1	-68.59	6.33
-28.63	-90.58	22.79
-38.8	-58.97	-5.93
15.34	-97.28	-5.31
40.17	-74.33	-2.4
6.77	-77.02	5.16
42.36	-67.53	1.37
-8.43	-90.77	-3.31
-36.54	-76.84	-1.96
-5.07	-83.34	7.11
-32.08	-65.9	11.45
5.61	-86.36	-2.86
39.21	-81.06	6.13
9.09	-85.65	16.06
43.41	-71.03	-1.66
-15.91	-89.11	3.38
-38.64	-82.91	2.03
-9.36	-84.21	9.51
-41.79	-76.78	10.45

// Gaab N, 2007: Words with Silence > Silence
// Gaab N, 2007: Words with Recorded Scanner Background Noise (RecSBN) > 
// RecSBN
// Gaab N, 2007: Words with RecSBN > Words with Silence
// Gaab N, 2007: RecSBN > Silence
// Gaab N, 2007: Words with Silence > RecSBN
// Gaab N, 2007: Words with RecSBN > Silence
// Subjects=10
64	-14	10
-60	-18	12
-4	12	44
-2	-28	32
-46	-6	48
62	-26	6
-20	8	4
-64	-42	16
-60	14	8
-66	-24	14
36	-52	-20
-56	-16	8
-42	-34	16
54	-22	14
54	-20	14
-42	-26	16
-18	8	4
26	2	2
62	-14	10
-58	-18	10
2	12	40
-2	88	6

// Gothelf D, 2007: Significant Activations During the Response Inhibition 
// Task in All Subjects
// Gothelf D, 2007: 22q11.2DS Patients > TD and DD Subjects, Go/NoGo vs. Go
// Subjects=9
-7.16	27.71	35.38
35.68	62.26	12.18
31.6	-94.57	-.25
-37.98	29.93	-8.02
65.33	-36.89	29.33
-20.16	-101.68	6.94
-26.72	62.95	34.46
-28.26	-46.22	60.98
-37.08	-47.6	46.7

// Gu X, 2007: Rating Painful Words > Counting Neutral Words
// Gu X, 2007: Rating Painful Words > Counting Painful Words
// Gu X, 2007: Conj. Analysis: (Rating Painful vs. Counting Neutral) vs. 
// (Rating Painful vs. Counting Painful)
// Subjects=10
37.74	12.33	-5.33
50.99	28.69	19.72
-40.04	37.24	1.38
-43.93	-30.66	21.61
-60.13	-8.82	26.45
-28.85	-76.94	8
24.92	-5.28	2.24
42.24	-7.14	4.37
50.97	26.36	17.71
-48.37	-44.68	9.62
-15.58	-16.58	44.38
-52.48	-10.3	33.19
53.28	-12.99	21.56
-64.57	-12.96	16.85
-28.79	-75.35	13.45
37.76	12.43	-4.22
50.96	28.48	17.5
-46.18	-44.47	11.81
-52.48	-10.3	33.19
53.28	-12.99	21.56
-28.85	-76.94	8

// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Happy 
// Music, Happy > Neutral
// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Sad 
// Music, Sad > Neutral
// Mitterschiffthaler M T, 2007: Conjunction Analysis: Main Effect of Neutral 
// Music, Neutral > Sad and Happy
// Subjects=16
-57.05	-34.08	8.72
50.8	-15.38	-3.93
-20.06	40.19	43.33
-9.73	43.29	6.98
-2.71	-7.37	38.77
-2.64	-24.39	40.45
-11.76	17.96	11.77
9.58	5.12	-11.98
-13.87	-47.31	2.57
-6.61	-19.58	69.18
-11.12	-45.07	49.37
-41.93	-31.9	8.25
53.03	-19.22	0.89
65.81	7.86	-8.73
22.43	-16.5	-25.75
-13.4	-28.48	43.28
-11.21	22.12	56.17
-14.1	-55.56	-16.78
-59.18	-36.01	11.19
-37.48	-28.72	19.06

// Chen C, 2007: Unmatched Numbers > Matched Numbers
// Subjects=20
-29.22	-60.7	66.91
-35.77	-54.65	63.06
-39.09	-45.4	58.84
-55.98	22.79	19.89
-49.53	38.97	20.42
-20.48	-54.86	-8.89
-26.89	-74.03	-6.89
-20.31	-76.57	-0.03

// Kadosh R C, 2007: Main effect of size congruity (incongruent vs. congruent 
// or neutral) for number and size comparisons
// Subjects=14
28.36	-64.15	43.36
-26.12	-53.39	49.78
42.23	-41.26	49.09
-37.96	-34.51	47.22
31.53	-6.37	60.79
-26.2	-4.69	60.19
-3.95	9.94	40.87
3.54	-18.54	29.79
33.24	46.4	27.35
-28.74	46.03	28.09
53.61	8.74	20.23
-48.92	4.32	27.36
37.44	15.99	5.31
-36.26	7.09	6.91
37.44	15.99	5.31
-36.26	7.09	6.91
37.51	-51.45	-13.57
-39.39	-59.15	-9.81
6.81	12.97	51.64

// Price G R, 2007: Group (dyscalculic vs. control) x Distance (close vs. far) 
// Interaction
// Subjects=8
36.97	-47.04	57.44
-37.29	-57.28	-13.33
-13.04	58.01	-11.01

// Cavina-Pratesi C, 2007: Grasp > Reach
// Cavina-Pratesi C, 2007: Size > Pattern
// Subjects=9
-34.71	-24.2	56.35
-36.87	-36.45	49.6
-29.35	-51.38	48.53
43.22	-36.57	40.88
-38	-40.4	39.9
-21.87	-67.88	40.91
-11.25	-86.02	25.58
1.46	-81.68	11.69
6.82	5.31	48.94
50.76	-40.32	46.68
-29.51	-91.56	10.64
-51.1	-68.65	-7.76

// Kadosh R C, 2007: Numerical comparison task for I.S.: Incongruent vs. 
// Congruent
// Kadosh R C, 2007: Triangle comparison task for I.S.: Incongruent vs. 
// Congruent
// Subjects=1
-32.57	-64.77	40.77
-30.54	-58.13	30.15
-42.59	-71.23	-14.33

// Robertson B, 2007: Decreased activation post-treatment, Sad vs. Neutral
// Robertson B, 2007: Decreased activation post-treatment, Attentional targets
// Robertson B, 2007: Increased activation post-treatment, Sad vs. Neutral
// Robertson B, 2007: Increased activation post-treatment, Attentional targets
// Subjects=10
34.23	39.79	-21.43
-2.05	59.45	18.7
8.38	35.96	-15.01
4.29	39.84	3.73
46.39	27.66	-2.51
27.13	-39.93	-1.1
16.22	20.53	3.19
-6.64	-50.84	-24.1
31.48	-60.43	-2.5
31.43	-8.34	3.55
-57.89	-48.69	24.75
34.77	-60.11	0.77
-51.81	32.61	9.88
-32.21	-60.35	1.93
38.83	58.35	4.67
60.76	15.96	20.81
19.73	1.78	20.67
12.78	-71.37	53.8
-1.26	-71.42	54.05

// Zysset S, 2007: Interference-related changes: Incongruent > Neutral
// Zysset S, 2007: Age-related changes: Incongruent > Neutal
// Zysset S, 2007: Reaction time-related changes: Incongruent > Neutral
// Subjects=23
-3.94	19.88	45.61
-23.08	7.59	53.55
-45.78	21.26	25.9
-45.98	35.58	4.63
-32.52	-53.25	52.07
-6.76	-68.45	59.74
-36.36	25.86	1.99
-45.72	-70.39	-3.22
-29.58	-85.64	4.57
-16.97	-21.86	2.42
-10.52	1.67	17.1
-10.47	-80.21	-9.49
-7.07	-55.16	25.17
2.48	23.35	48.59
31.37	7.4	46.25
44.07	12.8	32.27
47.17	28.16	24.25
34.74	-43.59	47.14
12.43	-65.42	55.92
11.95	28.47	31.32
43.8	16.57	-1.5
40.83	-66.7	-4.52
34.52	-88.68	0.74
11.91	-77.41	-16.67
5.79	-51.39	31.4
-7.16	29.63	48.17
-45.67	12.52	36.67
-49.15	26.04	5.46
-16.76	-69.19	9.73
-26.66	-16.09	-4.64
50.52	16.52	38.57
18.41	-53.37	4.66
-32.85	-83	-2.31
56.76	21.36	18.02
37.69	-79.15	-0.09

// Moll J, 2007: Neutral agency > No agency
// Moll J, 2007: Guilt > Neutral agency
// Moll J, 2007: Embarrassment > Neutral agency
// Moll J, 2007: Compassion > Neutral agency
// Moll J, 2007: Disgust > Neutral agency
// Moll J, 2007: Indignation self > Neutral agency
// Moll J, 2007: Indignation other > Neutral agency
// Subjects=12
7.32	12.04	-18.23
24.87	62.22	12.37
58.13	-12.76	-22.24
39.75	19.91	-16.2
-29.47	20.21	-20.65
-2.9	14.13	27.68
13.68	45.03	-21.6
-48.5	9.01	9.92
3.11	69.72	1.91
48.24	56	-21.03
3.17	-11.92	-10.18
69.39	-46.5	6.68
-54.26	7.46	-17.85
-57.93	-34.76	24.49
-60.16	-46.23	16.7
5.28	67.6	2.08
-7.2	18.68	30.67
-48.49	5.82	10.23
-43.94	-61.37	14.56
7.39	71.65	-.6
24.66	-19.26	-21.03
-11.35	-3.05	39.61
13.95	3.32	-8.51
-60.14	-43.89	18.71
56.38	-51.21	2.88
-26.9	55.01	18.44
5.28	-12.22	-13.55
-67.16	-15.13	-17.63
46.37	-78.62	-25.61
-50.36	-25.91	26.85
-43.92	-32.79	21.82
26.84	-5.97	-16.78
-46.26	-60.4	2.18
41.92	36.39	-12.26
-9.29	15.9	35.46
-1.04	34.92	8.79
46.22	1.23	-21.18
55.24	-59.39	-4.13
48.41	47.46	-8.99
7.84	11.52	22.15
31.03	-21.14	-29.92
3.06	14.67	-12.81
5.51	35.46	14.22
0.96	67.58	2.16
24.77	-27.15	-13.53
59.24	37.82	-9.34
56.33	-66.94	-4.53

// Bengtsson S L, 2007: Improvise - Reproduce
// Bengtsson S L, 2007: FreeImp - Rest
// Subjects=11
36.91	45.87	20.5
-24.27	19.11	47.72
-27.33	17.16	61.42
-33.77	4.37	62.79
30.83	19.31	46.77
11.46	19.86	53.76
-34.04	8.88	42.18
-37.22	2.8	46.2
-63.42	-38.69	17.13
49.7	-53.86	-13.55
-37.28	-79.77	24.11
-27.82	-91.49	1.58
43.58	-80.73	9.38
43.5	-84.54	3.04
36.91	45.87	20.5
-27.33	17.16	61.42
-33.77	4.37	62.79
30.83	19.31	46.77
11.46	19.86	53.76
-34.04	8.88	42.18
-37.22	2.8	46.2
49.7	-53.86	-13.55
-37.28	-79.77	24.11
-27.82	-91.49	1.58
43.58	-80.73	9.38
43.5	-84.54	3.04

// Baumann S B, 2007: All motor > Off
// Baumann S B, 2007: All auditory > Off
// Baumann S B, 2007: Involuntary (Motor and auditory condition > Baseline)
// Baumann S B, 2007: Voluntary (Motor and auditory condition > Baseline)
// Baumann S B, 2007: Voluntary (Pianists > Non-musicians)
// Subjects=7
-40	-38	54
-16	-54	-32
24	-8	-8
-26	-8	-10
14	-22	-10
18	-54	66
8	22	30
-34	44	26
50	-12	6
-58	-26	2
-36	-44	36
42	-2	60
54	4	48
22	0	-6
16	-6	74
-32	-56	62
-42	16	22
58	12	12
-52	-8	48
24	-70	-34
-24	-8	48
58	8	-10
-56	12	-10
-46	-30	10
64	-32	8
54	0	48
-54	8	36
-54	10	-6
-56	8	32
34	4	60
61	7	13
8	4	56
24	0	-6
48	8	-12
64	-38	10
62	-35	18
-60	-24	24
54	2	48
-20	8	-6
-34	-14	62
-58	-26	12
46	-40	50
-52	-6	48
22	-68	-34
34	-4	60
-2	6	46

// Mizuno T, 2007: MAJOR - NEUTRAL
// Mizuno T, 2007: MINOR - NEUTRAL
// Mizuno T, 2007: MAJOR - MINOR
// Mizuno T, 2007: MINOR - MAJOR
// Subjects=18
39.75	26.5	-14.61
-34.8	26.23	-13.31
11.3	28.5	42.83
1.64	22.4	46.96
7.84	40.01	28.3
-54.16	16.91	-8.7
-5.38	-14.52	-3.06
49.64	37.66	0.93
-5.38	-14.52	-3.06
11.3	28.5	42.83
-38.04	26.22	-13.26
52.73	23.35	-14.52
4.88	22.41	46.9
-37.04	-22.1	55.38
-27.24	-8.37	63.94
-33.65	-37.42	63.56
7.54	-70.58	-17.9
-4.82	-16.85	40.87
-11.88	-21.23	-5.64
47.29	-24.68	57.56
-8.73	-64.57	-21.58
28.01	-46.46	66.77

// Kawamichi H, 2007: 3D rotation with large angular difference (3DL) > Rest
// Kawamichi H, 2007: 3D rotation with small angular difference (3DS) > Rest
// Kawamichi H, 2007: 2D rotation with large angular difference (2DL) > Rest
// Kawamichi H, 2007: 2D rotation with small angular rotation (2DS) > Rest
// Kawamichi H, 2007: (3DS + 3DL) - (2DS + 2DL)
// Kawamichi H, 2007: 3DL - 3DS
// Kawamichi H, 2007: 2DL - 2DS
// Subjects=12
10	-86	46
-14	-84	44
28	-4	58
-24	-8	50
-42	-74	-32
50	42	24
42	-62	-34
56	10	36
-48	10	24
8	12	48
-50	-48	42
32	-58	34
-30	-66	54
44	-62	-32
-24	-92	20
58	-22	36
-42	-74	-32
34	8	60
42	-38	30
44	-46	62
-30	-70	56
8	-80	52
44	-62	-30
-38	56	22
-42	-74	-32
34	62	14
54	10	34
-44	6	24
32	-68	-32
-24	-8	62
10	-86	46
40	-62	-34
-32	-68	58
-28	-86	12
34	-56	30
42	-42	36
-42	-74	-32
28	-64	36
38	58	10
-24	-10	54
38	12	-4
30	-72	38
30	-82	32
-28	-74	44
28	-12	70
2	-7	72
24	-86	32
14	-88	46
24	-80	52
10	-60	48
56	-54	40
-22	-82	48
-46	-72	-30
22	-12	78
44	-52	42
58	-38	28
46	-50	44

// Kucian K, 2007: Healthy Children
// Subjects=20
21.36	-69.62	49
40.12	-80.17	-7.42
-14.35	-66.87	45.98
21.36	-69.62	49
15.04	-60.75	63.92
40.12	-80.17	-7.42
-14.35	-66.87	45.98
43.8	-39.64	35.57
-40.33	-44.42	46.44
14.17	-25.73	2.2
7.6	-16.5	-1.96
-15	-25.84	2.71
-8.53	-16.03	3.87
31.01	7.58	59.13
4.99	22.07	54.78
-24.64	-86.47	-2.33
-11.66	-96.2	-3.83
-20.69	-.17	70.86
-27.41	0.17	51.89
26.81	28.79	-12.37
-44.52	18.55	-14.63
-38.03	25.16	-13.15
55.02	17.81	-5.04
46.73	37.91	26.73
11.28	-50.46	24.87
11.4	-59.41	32.47
14.63	-49.62	33.69
-8.05	-59.48	32.81
-4.71	-35.79	44.98
-43.64	-39.43	42.64

// Kucian K, 2007: Healthy Adults
// Subjects=20
-46.83	-37.96	47.03
-40.94	-80.66	-8.23
40.69	-44.13	45.03
34.04	-85.9	23.5
23.79	-85.52	-17.82
-34.83	24.86	-16.54
43.45	11.34	18.2
55.37	21.47	22.6
43.31	32.19	11.66
36.49	31.8	-15.08
-44.01	8.15	23.37
24.2	-96.65	12.41
-34.71	-58.49	-23.98
11.28	-50.46	24.87
11.4	-59.41	32.47
14.63	-49.62	33.69
-8.05	-59.48	32.81
-4.71	-35.79	44.98
-43.64	-39.43	42.64

// Schendan H E, 2007: Saccade task: Saccade > Fixation
// Schendan H E, 2007: Object decision task: Intact object > Scrambled
// Schendan H E, 2007: Mental rotation task: Rotation > Control
// Subjects=13
-42	-12	54
48	0	54
30	-54	51
-18	-78	48
-27	-72	24
-15	-93	0
21	-93	12
-30	-78	3
-39	-78	-12
-21	-57	-15
18	-48	0
9	-30	-24
6	-81	-36
-21	-24	-6
-45	30	12
54	33	21
-42	15	30
-45	-6	45
51	-9	42
-24	-21	66
21	-27	66
-30	33	-12
30	42	-12
-30	-3	15
33	-63	60
-12	-36	57
-42	-66	-21
-33	-63	-18
36	-66	-15
18	18	42
-9	-75	-36
6	-60	-39
-30	24	0
36	33	3
-45	6	27
-48	33	27
-27	3	63
24	9	57
9	36	42
-6	18	24
9	6	30
-24	-66	60
33	-75	30
-36	-78	18
-39	-54	-3
-33	-54	-15
-27	-48	-6
30	-42	-9
-42	-33	3
-54	9	-18
24	-21	6
-33	-30	3
18	0	3
3	-24	-12
0	-33	-33
6	-81	-33
30	-72	-33
6	-63	-39

// Hermann A, 2007: Blood-injection-injury (BII) Phobia Patients
// Subjects=9
-15	-30	-6
0	-21	6
3	-21	6
27	-63	54
18	0	-18
-6	-21	6
12	-21	18
-6	48	-15
-9	45	-21
-21	-63	54
27	-63	54
-9	-3	63
-12	15	42
3	57	30
6	57	30
-3	36	-21
12	48	-9
54	24	53

// Hermann A, 2007: Healthy Controls
// Subjects=10
-57	-24	42
18	-81	54
18	-12	-3
-27	39	-21
51	36	-18
30	33	-15
-3	63	24
-24	0	-15
-15	-30	0
6	-24	12
-9	-3	63
-12	15	42
3	57	30
6	57	30
-3	36	-21
12	48	-9
54	24	53

// McClure E B, 2007: General Anxiety Disorder Patients > Healthy Controls: 
// Fearful faces > Happy faces
// Subjects=15
18	-3	-13
30	-6	-8
-12	-6	-8
-8	-5	-12
-16	-8	-6
38	31	-3
36	35	-7
8	5	31
4	49	12
4	6	40
2	6	44

// Meseguer V, 2007: Positive > Neutral (Activations)
// Meseguer V, 2007: Negative > Neutral (Activations)
// Subjects=14
-41.92	24.66	-26.84
-22.61	17.89	-19.81
-30.12	16.36	-25.17
-35.97	15.54	47.46
-38.45	31.82	10.43
32.51	-14.97	45.88
-49.85	-8.57	39.6
36.21	3.27	-21.49
-31.24	12.58	-32.64
61.89	1.56	-18.29
45.27	-57.3	20.29
16.58	-50.22	45.68
-10.32	-74.26	12.32
43.87	-40.93	-15.64
40.78	-73.81	-13.96
-36.29	-40.44	-15.87
-.1	31.91	-5.63
-2.85	-42.53	22.95
32.99	3.16	-22.56
-39.38	-44.8	-3.2
-36.3	29.72	10.58
-24.78	4.33	-29.8
-4.32	18.14	-4.42
18.3	-8.45	7.58
-20.15	-27.17	2.9
-20.14	-7.28	12.39
27.91	6.93	12.87
-6.35	-49.95	-17.65
52.41	21.62	8.01
-42.5	7.71	29.23
-42.79	37.71	4.41
-25.86	15.16	-27.35
-3.88	13.96	51.68
42	5.81	38.46
-28.68	38.88	32.03
41.5	2.78	-28.2
-33.31	4.45	-27.48
-53.07	-44.94	23.73
60.81	2.61	-18.37
48.39	-55.94	10.1
-43.51	-57.54	11.29
-10.4	-70.72	3.1
18.39	-56.89	0.49
-12.36	-45.87	35.61
11.1	-82.42	14.98
44.93	-41.01	-16.76
40.79	-71.53	-11.92
-38.38	-47.68	-13.01
5.19	33.55	-12.52
-7.28	14.09	26.06
-3.92	-37.07	24.74
20.5	-47.27	0.78
14.88	-15.09	-23.05
-37.26	-47.16	-6.38
-16.91	-47.67	-.99
34.51	-30.59	22.64
-46.96	-6.35	-.77
29.84	-.66	-16.62
-30.04	-2.59	-22.46
18.31	-6.16	9.62
-23.38	-23.04	1.48
32.04	3.3	-6.94
5.44	-44.07	-11.59

// Tracy J, 2007: Internal Heartbeat - External Heartbeat
// Tracy J, 2007: Internal Heartbeat - Rest
// Tracy J, 2007: Internal Heartbeat - Rhythmic Neutral Tone
// Tracy J, 2007: Internal Heartbeat - White Noise
// Tracy J, 2007: Internal Heartbeat - Silent Counting
// Subjects=17
51.94	-27.45	40.28
40.36	-57.6	50.29
51.93	-41.59	37.19
54.72	-42.06	43.47
58.73	37.72	35.5
42.25	-26.17	35.05
-22.91	-47.88	39.43

// Wise R G, 2007: Saline: Pain > Warm
// Wise R G, 2007: Midazolam: Pain > Warm
// Wise R G, 2007: Saline: Pain Anticipation > Warm Anticipation
// Subjects=8
2	16	34
10	-2	48
48	4	-10
-2	-2	60
36	8	8
-34	4	4
38	-16	12
-32	-24	6
16	-18	4
-12	-18	2
24	-22	64
26	-32	64
6	-40	-48
-18	-44	-36
-2	2	40
-6	-24	44
6	-26	50
-54	-8	8
56	4	-4
6	-6	70
-26	48	8
38	2	4
-40	-4	-12
-36	-20	10
38	-22	14
10	-16	2
-4	-18	4
34	-26	52
-50	-24	10
54	-18	10
-2	-34	26
18	-42	52
-6	-32	-12
-12	-40	-32
12	-96	-10
2	20	26
-2	-20	44
44	20	-14
56	18	-12
4	0	58
-8	-2	50
48	8	-10
-38	-36	18
-52	-38	16
-66	-34	24
8	-54	64

// Walter M, 2007: Pedophiles
// Subjects=13
-3	-3	-15
3	-30	-18
-27	42	36
60	-51	6
57	27	0
24	-78	6
-33	12	-3
-30	57	24
30	39	51
42	-3	42
-21	-66	15
-6	66	24
12	-45	3
-21	-21	-15

// Walter M, 2007: Controls
// Subjects=14
-3	-3	-15
3	-30	-18
-27	42	36
60	-51	6
57	27	0
24	-78	6
-33	12	-3
-6	66	24
12	-45	3
-21	-21	-15

// Aron A R, 2007: Noncritical Stop > Noncritical Go
// Aron A R, 2007: Critical Stop > Critical Go
// Subjects=15
-40	-44	46
-44	-46	34
-54	-28	0
46	10	-6
52	-24	-4
50	-50	42
-48	36	26
-44	46	24
-50	42	10
-34	-70	-60
-20	-80	-58
-14	-78	-46
14	-8	6
10	-16	-6
8	-22	-12
6	-38	24
-2	-24	30
10	-26	36
-26	-70	-36
-40	-64	-36
-34	-76	-32
38	58	-10
28	52	-12
22	52	-22
-12	-84	-30
-16	-92	-32
42	20	0
56	-30	2
38	-44	46
-2	-20	24
6	-18	28
4	-20	42
-32	22	2
-38	18	-4
-44	16	-10
8	-18	-6
14	4	-4
16	10	8
-14	10	-4
-14	4	8
-14	18	-2
-62	-40	30
-52	-40	14
-68	-34	4
28	-96	0
20	-102	-4
22	-104	10
14	-62	30
6	-78	54
10	-46	46
-32	-70	-56
-34	-72	-64
-16	-14	62
-12	-8	-2
-8	-16	-4
-42	-82	-6
-24	-102	6
-22	-98	-14
-44	44	24
-36	36	24
-42	36	30
-18	-72	-38
-42	-62	-42
-32	-64	-38

// Rubia K, 2007: Adults
// Subjects=26
44.88	29.87	5.18
-46.01	32.07	0.46
10.72	45.41	16.54
-46.83	-62.11	-6.13
36.54	-76.75	-10.32
-22.43	-42.9	-21.4
-9.32	-54.17	10.62
46.97	37.11	2.32
2.08	57.62	10.03
-51.36	31.95	-.58
52.43	-7.78	-.67
-50.93	-27.33	31.15
-59.56	-27.09	21.19
3.63	-47.26	29.96
3.53	-15.37	29.52
1.17	35.12	21.97
46.93	29.02	-5.93
-41.75	45.04	2.67
-3.09	42.92	26.94
-60.87	1.14	1
47.39	-23.39	31.92
24.8	-20.67	14.11
-6.24	-45.57	-2.4
47.39	-23.39	31.92
-10.52	-30.28	3.05
-15.04	20.99	-7.89
33.36	-73.26	-6.11
1.14	-70.68	-24.92
-25.49	-66.72	-12.68
-10.12	-76.61	37.04
43.87	-2.46	0.1
65.2	-2.76	-5.7
-28.67	-25.73	8.46
-28.77	1.76	6.15
9.05	-70.58	30.74
44.24	-51.33	28.72
-36.96	-30.79	40.2
0.98	61.67	7.48
1.18	34.06	22.06
50.41	0	17.66
4.7	-39.51	33.76
4.53	-68.77	-.58
42.99	-77.43	-5.87
-26.68	-22.86	-9.65
-25.61	-22.85	-9.66
-22.31	-9.83	7.05
-22.25	-37.75	3.81
-25.34	-57.44	11.08
23.59	-10.07	-.15
23.79	-12.33	25.69
47.31	-27.51	20
24.88	-57.13	10.47

// Rubia K, 2007: Children
// Subjects=26
50.14	16.98	-10.53
31.92	59.14	-.47
-22.15	18.2	39.27
-41.33	5.48	41.67
40.98	-4.69	40.46
-45.92	5.46	0.46
40.37	4.29	-36.12
5.95	-54.08	51.7
20.44	-84.14	-21.78
46.97	37.11	2.32
-4.18	50.32	26.33
-56.55	-26.93	-4.51
-41.25	-60.73	24.92
51.37	-17.65	-4.29
46.39	-58.89	27.1
3.59	-54.21	22.74
1.17	35.12	21.97
46.93	29.02	-5.93
-41.75	45.04	2.67
-3.09	42.92	26.94
-60.87	1.14	1
47.39	-23.39	31.92
24.8	-20.67	14.11
-6.24	-45.57	-2.4
47.39	-23.39	31.92
-10.52	-30.28	3.05
-15.04	20.99	-7.89
33.36	-73.26	-6.11
1.14	-70.68	-24.92
-25.49	-66.72	-12.68
-10.12	-76.61	37.04
43.87	-2.46	0.1
65.2	-2.76	-5.7
-28.67	-25.73	8.46
-28.77	1.76	6.15
9.05	-70.58	30.74
44.24	-51.33	28.72
-36.96	-30.79	40.2
0.98	61.67	7.48
1.18	34.06	22.06
50.41	0	17.66
4.7	-39.51	33.76
4.53	-68.77	-.58
42.99	-77.43	-5.87
-26.68	-22.86	-9.65
-25.61	-22.85	-9.66
-22.31	-9.83	7.05
-22.25	-37.75	3.81
-25.34	-57.44	11.08
23.59	-10.07	-.15
23.79	-12.33	25.69
47.31	-27.51	20
24.88	-57.13	10.47

// Ertelt D, 2007: Subgroup of stroke patients, Control group
// Subjects=8
-40	-34	32
-6	-10	58
-18	54	22
-34	-14	66
-46	24	-4
-56	12	24
-42	-46	64
12	-48	-14
50	-64	2
62	6	24
-28	4	42
-28	-64	-16
14	6	48
46	-30	-6
38	-24	36
-24	8	-16
-54	-16	16
-6	-6	46
-40	14	28
56	-32	28
60	14	22
52	-24	6
58	16	-4

// Ertelt D, 2007: Subgroup of stroke patients, Experimental group
// Subjects=8
-4	-46	-4
-62	6	12
-24	-38	56
-10	-36	38
-30	-64	38
-26	-38	-34
-40	26	-8
-30	-6	40
-18	-18	-20
-38	-54	-14
-40	6	-12
-14	-54	-42
-10	4	44
-34	-68	-26
54	-36	24
6	-66	2
10	-54	56
14	-52	-50
50	-40	0
30	-42	-28
56	20	-8
-56	-26	52
-34	-52	58
-42	-52	-26
-12	-50	-20
50	10	12
28	-62	-36
-24	8	-16
-54	-16	16
-6	-6	46
-40	14	28
56	-32	28
60	14	22
52	-24	6
58	16	-4

// Lindberg P G, 2007: Stroke patients
// Subjects=5
44.2	-30.14	68.24
60.18	-18.57	53.38
17.16	-22.07	-16.14
-8.68	-21.53	-9.03
14.03	-27.84	-8.79
-18.18	-3.43	12.87
10.92	-7.15	6.02
46.06	15.39	-30.43
-7.73	-1.29	69.63
-31.51	-52.2	-25.78
21.6	-9.83	80.06
31.29	-23.18	74.49
1.69	-.25	45.84
5.05	0.7	55.77
-44.57	29.08	-16.79
47.4	-43.51	62.78
1.76	26.52	56.63
18.16	8.37	68.23
-44.49	-58.94	-28.25
-34.72	-71.67	-27.16
-37.65	48.79	21.48
43.03	39.89	-9.27
-50.36	-18.26	28.33
-37.15	19.69	54.61
56.8	-3.25	45.19
-49.8	-40.35	67.49
-59.79	-25.99	49.43
33.42	-57.73	-19.61
-9.04	-73.45	-47.59
37.13	44.23	37.47
1.74	29.71	56.32
-4.56	17.86	67.68

// Lindberg P G, 2007: Healthy controls
// Subjects=6
63.03	-28.05	20.65
18.26	-7.27	73.14
57.15	-26.9	67.7
21.43	11.88	71.19
14.15	-13.83	3.26
-37.95	-61.8	-24.72
45.99	21.46	-34.39
-53.59	-21.46	28.71
-54.21	29.67	-9.96
-31.51	-52.2	-25.78
21.6	-9.83	80.06
31.29	-23.18	74.49
1.69	-.25	45.84
5.05	0.7	55.77

// Kapreli E, 2007: Fingers > Rest
// Kapreli E, 2007: Knee > Rest
// Kapreli E, 2007: Ankle > Rest
// Kapreli E, 2007: Toes > Rest
// Subjects=18
-38	-26	52
-4	-8	54
-46	-28	18
-28	-2	8
-18	-22	10
38	-24	50
28	-4	10
16	-18	4
22	-52	-24
8	-66	-22
24	-50	-24
16	-68	-48
-40	-28	48
-2	-6	64
-4	-54	-8
-10	-52	-20
-20	-66	-50
-16	-40	64
-2	-24	66
-12	-6	44
-24	-26	64
-40	-28	20
-32	-16	8
-18	-22	10
12	-38	64
0	-24	68
10	-6	42
12	-22	72
30	-26	20
28	-10	16
20	-18	-2
22	-38	-20
20	-32	70
36	-28	24
4	-50	-16
14	-40	-22
20	-50	-50
-12	-34	66
-12	-6	44
-44	-28	20
-32	-14	8
-26	-24	20
-2	-48	-8
-14	-38	-18
-22	-60	-40
-8	-42	66
-4	-26	62
-8	-8	46
-12	-28	76
-34	-24	16
-30	-14	6
6	-38	66
2	-24	68
8	-12	52
10	-24	72
40	-30	20
32	-14	8
18	-22	12
22	-42	-24
52	-28	20
4	-70	-42
12	-40	-22
24	-50	-50
-12	-40	76
-8	-8	48
-46	-28	20
-28	-8	-12
0	-48	-8
-16	-36	-22
-6	-42	68
-4	-18	74
-4	-8	52
-4	-18	74
-56	-34	20
-28	-10	10
-22	-22	22
4	-38	70
0	-26	70
8	-4	44
12	-22	72
34	-24	18
32	-2	6
44	-32	22
4	-46	-8
14	-40	-24
-12	-6	58
-52	-32	20
-28	-10	10
0	-44	-8
-14	-38	-24

// Picchioni M, 2007: Common Activations Associated with Correct Answers
// Picchioni M, 2007: Increased Neural Response Associated with Correct 
// Answers
// Picchioni M, 2007: Decreased Neural Response Associated with Correct 
// Answers
// Picchioni M, 2007: WM Simultaneous > WM 4
// Picchioni M, 2007: WM Simultanous < WM 4
// Picchioni M, 2007: WM Simultaneous > WM 12
// Picchioni M, 2007: WM Simultaneous < WM 12
// Picchioni M, 2007: WM 4 < WM 12
// Picchioni M, 2007: WM 12, Correct > Incorrect
// Subjects=14
-29.75	-83.04	-16.84
27.94	-78.46	-17.88
-22.23	-82.56	-11.39
32.21	-66.38	-13.37
32.33	-84.9	-5.13
-22.21	-73.59	-5.45
8.6	-26.88	-9.72
-30.07	27.88	-13.87
43.69	20.92	-14.13
35.17	24.46	-8.75
-30.01	24.07	-7.97
16.35	-72.42	6.28
12.84	8.98	-.51
-6.29	-18.62	2.03
12.98	-18.08	7.34
20.39	2.05	5.56
16.39	-71.99	11.82
47.23	7.9	23.72
-48.95	7.32	24.88
44.21	-30.81	32.58
-44.57	4.06	37.37
-25.13	-50.81	41.74
32.67	-73.72	43
5.6	20.22	35.43
51.65	5.07	41.75
1.4	12.17	41.73
32.51	-6.17	49.61
-32.6	-14.59	56.64
12.77	-47.77	-32.55
5.23	-20.95	-29.14
-6.36	-51.17	-19.78
-25.67	-32.26	-21.14
-10.44	-77.75	-5.23
20.67	-84.02	7.2
-10.27	-88.01	13.47
20.7	-68.28	18.15
16.51	-79.51	24.71
12.9	42.59	21.21
-10.45	24.36	35.27
-25.17	-27.12	45.33
-2.89	28.52	47.1
-17.54	-40.93	58.67
-13.33	-26.1	57.38
39.54	-63.47	-31.54
-32.99	-74.6	-17.51
-44.71	-71.07	-12.09
47.14	-58.88	-14.17
39.73	-77.96	-12.48
-32.95	-58.85	-6.56
51.48	-61.52	-7.31
-32.79	-76.94	7.22
8.72	-21.28	7.65
27.93	-1.62	12.48
35.69	-39.33	33.39
28.39	-61.69	47.62
35.27	-63.5	-31.49
-41.64	-60.36	-25.29
32.23	-82.67	-17.58
-32.9	-85.8	-10.99
28.06	-84.92	-5.07
-6.27	-38.17	-3.02
-41.34	-76.99	7.32
13.03	-41.77	3.75
8.72	-21.28	7.65
16.28	-41.32	9.25
-17.65	-87.11	25.74
28.36	-78.49	36.76
32.6	-70.01	36
1.16	-62.76	-18.89
-3.07	-62.36	-13.3
12.93	-54.86	-14.11
-10.5	-61.89	-6.56
16.17	-50.1	-7.86
-25.45	-90.41	-16.27
32.23	-82.67	-17.58
-44.71	-71.07	-12.09
47.24	-70	-6.55
-41.41	-73.28	0.32
39.87	-76.51	6.35
24.59	9.05	-.65
8.72	-21.28	7.65
13.12	-40.83	15.93
1.1	62.87	22.99
5.4	-67.48	-25.24
-10.53	-78.69	-17.42
-13.84	-39.16	-15.12
-10.41	-85.15	-4.61
-2.83	-76.33	12.4
-6.41	37.3	9.61
16.02	41.67	8.98
20.3	49.52	13.85
-17.68	-30.24	45.51
-25.09	-34	52.6
20.38	-71.62	-25.06
-18.06	-67.11	-18.31
5.37	-19.5	-10.3
12.67	28.13	-14.38
1	16.86	-7.72
-22.11	-89.02	1.42
13.11	-77.18	0.02
-2.89	-72.53	6.51
55.8	-48.92	3.85
59.05	-48.47	9.36
-10.32	-72.15	12.14
20.7	-68.28	18.15
20.82	-74.74	30.96
5.42	54.6	25.86
5.91	-62.25	42.35
-14.04	-48.87	-44.42
39.56	-55.64	-26.62
43.95	-62.08	-13.86
16.26	-73.36	-5.91
-25.74	24.1	-8.02
-3.33	32.69	-9
5.28	29.03	-2.1
-33.2	33.03	-2
32.07	22.22	3.74
20.72	-87.83	13.1
-5.99	-75.84	19.09
39.58	25.95	10.03
32.1	37.96	14.68
28.36	-78.49	36.76
-17.51	-61.45	54.82
1.72	-61.34	54.59

// Vohn R, 2007: Within-Modal Divided Auditory Attention - Within-Modal 
// Selective Auditory Attention
// Vohn R, 2007: Auditory/Visual Divided Attention (A/V DAC) - Auditory/Visual 
// Selective Attention (A/V SAC)
// Vohn R, 2007: Conjuntion Analysis for Cross-Modal DAC-SAC and Within-modal 
// DAC-SAC
// Vohn R, 2007: Cross-Modal DAC-SAC - Within-Modal DAC-SAC
// Subjects=16
49.03	28.01	35.51
48.83	38.57	22.14
40.12	42.38	17.43
40.69	-49.66	43.34
35.6	14.65	-3.28
35.52	9.67	-10.63
60.58	11.32	5.59
48.57	14.7	-3.51
39.71	29.48	-17.14
31.49	38.09	18
40	57.91	11.41
-24.12	6.01	56.86
-19.74	15.27	63.72
40.74	-49.24	47.78
40.84	-48.52	55.55
5.67	-8.25	17.42
27.08	-13.99	0.82
27.67	22.15	54.38
23.55	11.58	67.82
-15.28	-60.31	58.79
-45.68	-40.73	51.77
14.51	29.37	40.45
-50.84	-3.29	-6.76
-41.83	40.04	31.38
48.88	26.87	23.3
49.03	28.01	35.51
45.16	-48.5	55.47
36.55	-52.68	57.15
35.6	14.65	-3.28
40.17	42.79	21.87
1.77	14.61	55.57
-2.7	25.47	45.61
35.8	42.36	17.51
-49.89	-39.91	60.72
-46.44	45.49	9.63

// Wakusawa K, 2007: (Situational_Irony + Situational_Metaphor) - 
// (Literal_Irony + Literal_Metaphor)
// Wakusawa K, 2007: Situational_Irony - Situational_IronyControl
// Wakusawa K, 2007: Literal_Irony - LIteral_IronyCon
// Subjects=31
-10	58	24
2	46	-14
52	12	-32
52	12	-32
2	46	-14

// Woo S H, 2007: All Conditions > Rest
// Woo S H, 2007: Areas Positively Correlated with Response time change
// Woo S H, 2007: Areas Negatively Correlated with Response Time Increase
// Subjects=10
1.25	-83.39	-5.32
57.9	-41.4	38.87
45.24	51.27	-2.59
-47.89	-30.21	49.64
-44.59	-14.37	58.11
2.35	29.48	19.35
2.17	-30.96	-7.16
2.86	-72.86	38.43
2.16	-4.82	-3.03
1.5	-58.57	19.11
-22.56	49.7	18.89
55.62	4.74	38.82
8.1	-4.04	39.38
-29.42	-.21	-20.87
32.26	-13.5	-17.25
7.15	-.88	50.29
-11.17	-71.74	39.68
-43.87	-68.51	18.63
61.14	-38.1	39.6
-54.43	-31.71	45.42
58.57	-43.35	6.55
10.36	28.47	54.05
49.54	48.95	-4.67

// Kimmerly D S, 2007: BOLD signal changes that corresponded with sex-specific 
// heart rate responses (Activations)
// Kimmerly D S, 2007: BOLD signal changes that corresponded with sex-specific 
// heart rate responses (Deactivations)
// Kimmerly D S, 2007: BOLD signal changes that correspond with sex-specific 
// total muscle sympathetic nerve activity (act)
// Kimmerly D S, 2007: BOLD signal changes that correspond with sex-specific 
// total muscle sympathetic nerve activity(deact)
// Subjects=16
4	18	26
24	0	-22
-2	46	-2
40	14	-2
32	-36	18
-36	8	-6
-4	46	-14

// Kimmerly D S, 2007: 15 and 35 mmHg > 5 mmHg
// Kimmerly D S, 2007: 15 and 35 mmHg < 5 mmHg
// Subjects=11
38	-22	22
4	44	10
-8	40	-6
14	44	-6
2	-16	4
-4	-18	6

// Hale T S, 2007: Forward Digit Span - Baseline, ADHD - Healthy Controls
// Hale T S, 2007: Backward Digit Span - Baseline, Healthy Controls - ADHD
// Hale T S, 2007: Backward Digit Span - Baseline, ADHD - Healthy Controls
// Subjects=10
-39.47	-66.81	25.11
-13.48	-81.6	26.13
-2.9	-2.24	24.82
12.3	-49.81	20.3
24.94	48.5	14.84
57.49	12.45	17.86
17.16	-50.11	62.83
-23.9	-70.02	58.78
-47.79	-31.61	57.62
-30.87	-69.32	20.73
53.37	-25.44	26.16
25.82	-39.02	66.07
-50.08	-65.39	40.84
-44.22	-28.48	-1.01
1.65	-15.87	39.54

// Elzinga B M, 2007: Healthy Controls
// Subjects=14
-40.73	40.15	32.48
-31.51	26.56	-10.04
-47.69	30	-6.74
-53.88	9.2	12.23
-24.59	13.43	21.4
39.7	62.22	-11.42
56.48	33.8	28.09
56.73	15.9	43.3
33.31	26.79	-11.17
46.26	30.02	-11.71
53.18	16.9	19.73
8.05	31.68	42.57
-40.26	-38.38	53.68
47.36	-43.83	59.45
-34.11	14.95	38.22
-30.69	13.02	51.8
-37.56	-55.59	7.16
-47.36	-36.48	5.43
52.99	-66.61	-12.34
37.01	-61.71	6.49
46.67	-45.72	4.75

// Elzinga B M, 2007: Dissociative Patients
// Subjects=13
-37.78	60.93	13.56
-47.25	39.81	29.26
-47.38	48.76	21.65
-34.78	23.04	-13
46.36	60.3	2.11
53.06	48.8	16.58
56.53	21.03	29.35
66.44	6.05	40.75
30.89	13.24	50.73
33.3	29.98	-11.48
36.65	24.23	-4.25
11.34	28.81	46.16
-37.06	-48.56	47.91
-53.28	-45.43	47.88
-53.16	-44.49	57.87
63.5	-37.7	55.21
37.38	-42.54	39.33
50.52	-44.44	52.74
-37.17	22.88	54.29
-20.91	10.18	55.27
-10.78	-62.24	72.35
-4.44	-59.96	61.93
-7.74	-66.98	55.96
21.56	-65.94	65.44
31.24	-66.22	61.94
-5.01	34.2	35.82
1.43	43.8	34.76
56.2	-60.22	-13.03
49.95	-51.99	6.43

// de Lange F P, 2007: Affected & Unaffected > Fixation
// de Lange F P, 2007: Affected > Unaffected
// de Lange F P, 2007: Left Hand > Right Hand
// de Lange F P, 2007: Right Hand > Left Hand
// Subjects=8
38	-36	38
-28	-4	46
-26	4	62
28	0	60
8	44	-24
-12	62	32
-36	48	34
-58	-6	10
-52	-36	-4
68	-28	10
16	-40	70
32	-10	68
-6	-36	64

// Nebel K, 2007: Patients < Controls, Focused Attention
// Nebel K, 2007: Patients < Controls, Divided Attention
// Subjects=6
31.85	40.79	46.86
-40.29	24.42	-20.88
-41.94	29.32	20.12
-50.64	22.29	14.24
31.3	2.73	-4.27
-60.88	-39.62	-38.85
50.29	-52.07	-51.84
48.16	-47.41	-47.78
68.82	-32.16	-35.07
-34.25	-83.89	-77.5
-27.82	-90.87	-83.65

// Kobayashi C, 2007: Bilinguals
// Subjects=12
5.51	24.51	11.94
-53.17	-19.85	-23.01
33.13	62.64	-18.07
35.94	-97.75	-0.01
7.62	71.19	17.38
29.03	71.94	1.25
59.39	28.02	0.59
14.06	73.02	13.72
-25.02	71.54	-0.03
1.87	-57.99	48.18
-46.41	23.81	7.3
-51.18	42.36	-23.59
31.38	-89.64	-16.42
30.98	62.73	-16.92
1.95	-72.68	51.88
71.48	13.15	13.07
-20.92	40.34	-23.91
64.75	25.5	-3.73
33.37	69.93	2.49
5.81	54.11	41.51
41.77	4.64	-30.41
33.08	57.86	-23.2
-53.16	-21.98	-22.8
-.25	-79.58	47
30.91	57.85	-23.16
-20.9	57.98	-18.93
-23.1	55.54	-22.01
1.98	-73.53	54.2
39.63	4.84	-28.15
28.73	55.51	-25.14
37.69	67.71	1.52
-44.44	-8.25	-14.22
-53.15	-24.1	-22.59
48.16	11.69	-35.7
48.59	27.98	0.78
22.52	73.94	0.04
-58.35	18.99	2.37
0.88	34.22	-10.23
63.68	19.01	-4.19
67.36	-54.29	15.33
-67.01	-13.98	-5.42
24.5	15.63	-26.72
71.48	11.02	13.28
-40.32	8.91	-26.07
41.8	7.07	-27.29
65.2	-56.42	15.57
-51.18	16.11	-28.84

// Kobayashi C, 2007: Monolinguals
// Subjects=12
-64.9	-1.21	-6.72
46.15	18.24	-22.87
26.58	53.38	-24.89
69.13	12.85	-1.43
-11.03	-82.71	48.61
39.93	53.04	5.17
3.66	15.84	34.12
64.75	25.5	-3.73
33.37	69.93	2.49
5.81	54.11	41.51
41.77	4.64	-30.41
33.08	57.86	-23.2
-44.44	-8.25	-14.22
-53.15	-24.1	-22.59
48.16	11.69	-35.7
48.59	27.98	0.78
22.52	73.94	0.04
-58.35	18.99	2.37
0.88	34.22	-10.23
67.36	-54.29	15.33
-67.01	-13.98	-5.42
24.5	15.63	-26.72
-58.34	19.1	3.48
-64.91	-5.68	-8.52
52.61	4.99	-27.27

// Wolf R C, 2007: Healthy Controls
// Subjects=16
-36	30	33
-36	30	36
-36	33	33
-36	33	33
-36	27	33
-36	27	33
-39	-42	39
-36	-42	36
-36	-42	36
36	21	48

// Wolf R C, 2007: Pre-Huntington's Disease
// Subjects=16
-36	30	33
-36	30	36

// Wolf R C, 2007: Subgroup of Pre-Huntington's Disease, Far pre-HD
// Subjects=8
-36	33	33
-36	33	33
-39	-42	39
-36	-45	36
39	18	48

// Wolf R C, 2007: Subgroup of Pre-Huntington's Disease, Close pre-HD
// Subjects=8
-36	27	33
-36	27	33
-39	-42	39
-36	-42	36
-36	-42	36
36	21	48
-39	-42	39
-36	-45	36
39	18	48

// Powell H W R, 2007: Healthy Controls (HC)
// Subjects=10
34	-26	-28
26	-22	-20
-28	-28	-16
38	-20	-30
-26	-30	-18
44	-36	-18
-18	-14	-28
-28	-6	-30
-40	-18	-26
-40	-16	-30

// Powell H W R, 2007: Subgroup of Temporal Lobe Epilepsy, Right TLE (RTLE)
// Subjects=10
-30	-10	-36
-34	-34	-18
-40	-20	-26
16	-18	-26
-18	-14	-28
-28	-6	-30
-40	-18	-26
-40	-16	-30

// Powell H W R, 2007: Subgroup of Temporal Lobe Epilepsy, Left TLE (LTLE)
// Subjects=4
34	-24	-16
22	-14	-32
40	-20	-30
40	-32	-24
38	-36	-24
38	-30	-30
34	-26	-28
26	-22	-20
-28	-28	-16
38	-20	-30
-26	-30	-18
44	-36	-18

// Powell H W R, 2007: Healthy Controls (HC)
// Subjects=10
-44	2	24
-40	20	0
-44	-56	12
-52	-26	-6
48	-26	-4
-44	10	20
-50	-34	-6
52	-26	-6
50	22	40
42	12	38

// Powell H W R, 2007: Subgroup of TLE, Right Temporal Lobe Epilepsy (RTLE)
// Subjects=7
-42	14	22
-46	28	-2
-52	-52	6
-56	-30	-12
54	-28	-12
-44	10	20
-50	-34	-6
52	-26	-6
42	12	38
46	-8	14

// Powell H W R, 2007: Subgroup of TLE, Left Temporal Lobe Epilepsy (LTLE)
// Subjects=7
-40	10	12
38	6	18
-44	10	20
-50	-34	-6
52	-26	-6
50	22	40
46	-8	14

// Fan J, 2007: Ready > Relax
// Fan J, 2007: Incongruent > Congruent
// Fan J, 2007: Uncued > Cued
// Fan J, 2007: Response anticipation and response conflict > Baseline
// Subjects=20
32	-78	30
-42	6	32
38	4	34
4	6	6
6	-26	0
4	-4	8
-24	-62	36
-30	36	24
4	62	28
-26	6	50
6	12	52
8	16	38
-52	24	26
22	34	42
-8	24	38
-38	-72	44
-32	42	32
8	-44	50
10	-16	48
6	-30	48
-40	2	32
-40	42	4
-32	36	30
-28	-86	28
-22	-44	-2
30	-78	24
8	24	40
-8	18	38
42	6	34
14	-24	8
26	-60	-2
-22	14	-52
-30	-56	48
56	-42	16
-40	0	36
34	-78	30
42	2	44
4	8	6
-4	14	48
-30	-56	52
-32	44	22
6	-26	2
22	-48	52
20	46	24

// Hessl D, 2007: Fragile X Premutation
// Subjects=12
59.92	-57.74	24.76
1.55	-56.02	23.34
-54.81	-77.24	6.23
1.55	-56.02	23.34
50.92	-82.36	-8.51
-44.15	-91.42	-8.24
53.66	-12.31	51.75
57.28	43.73	8.04
15.99	-4.2	-20.13
-50.12	-8.84	48.69
-28.47	2.5	53.92
-30.62	-45.55	45.27
18.62	36.54	25.1
-48.7	5.33	-6.52
28.86	41.14	-18.11
42.91	-53.6	47.05
-50.66	-23.84	3.12
8.16	-52.84	34.12
59.95	-57.53	26.98
-38	-65.4	-28.84
-39.95	14.91	3.58
-46.23	-53.6	5.99
-33.43	-26.32	-1.41
12.26	-47.89	17.87
55.19	-78.3	-11.23

// Hessl D, 2007: Healthy Controls
// Subjects=13
-40.04	36.18	1.48
65.86	-35.51	-13.4
-44.11	-58.26	1.93
-37.72	-91.81	-12.79
-50.01	-1.42	59.16
55.87	-1.04	57.32
-20.23	-107.73	-.31
48.47	-51.71	-24.95
46.75	26	25.66
15.89	6.02	-25.62
-30.62	-45.55	45.27
18.62	36.54	25.1
-48.7	5.33	-6.52
28.86	41.14	-18.11
42.91	-53.6	47.05
-50.66	-23.84	3.12
8.16	-52.84	34.12
59.95	-57.53	26.98
-38	-65.4	-28.84
-39.95	14.91	3.58
-46.23	-53.6	5.99
-33.43	-26.32	-1.41
12.26	-47.89	17.87
55.19	-78.3	-11.23

// Almor A, 2007: Repeated Name> Pronoun
// Subjects=16
32	-72	44
26	-70	46
38	-72	38
-26	-60	54
-20	-58	50
30	-64	42
-56	-34	-10
-62	-42	2
-50	-36	-18
-50	-38	-14
-54	-34	-14
-62	-36	4

// Santi A, 2007: MOV > BIND, Linear Effect
// Santi A, 2007: MOV, Positive Linear Effect
// Santi A, 2007: BIND, Negative Linear Effect
// Santi A, 2007: MOV & BIND, Postive Linear Effect
// Santi A, 2007: BIND > MOV, Linear Effect
// Santi A, 2007: BIND, Positive Linear Effect
// Santi A, 2007: BIND > MOV
// Santi A, 2007: MOV > BIND
// Subjects=11
-50	32	6
-50	33	8
-39	19	10
-40	-28	-22
44	-22	-26
48	-16	-32
46	-18	-29
42	58	-8
-62	-40	0
-52	14	28
70	-42	0
48	-28	-16
44	-20	24
-34	28	42
6	58	2
59	-3	-14
36	3	-32

// Hoeft F, 2007: NoGo > Go, Healthy Controls (HC) > Fragile X and 
// Developmental Delay > Fragile X
// Hoeft F, 2007: NoGo > Go, Fragile X > HC and Fragile X > DD
// Subjects=10
-24.78	54.7	15.08
48.36	16.44	-19.36
20.46	12.27	-5.03
-52.55	11.08	32.19
40.44	7.56	35.44
9.56	2.78	-13.99
-37.39	2.62	32.77
62.61	-7.15	-8.31
48.65	-13.16	-2.99
-37.91	-18.76	-12.17
33.59	-24.71	0.65
-41.62	-27.38	33.57
40.08	-35.63	-1.74
58.74	-43.16	19.98
18.68	-46.16	13.11
29.38	-60.03	1.97
53	48.39	12.13
-22.31	49.34	37.98
-2.63	39.17	54.34
14.58	7.99	41.44
36.01	36.27	32.67
-45.57	-50.85	58.37
-7.52	-31.85	-4.67
-39.94	25.96	6.97
-.43	-74.35	34.15

// Kaplan J T, 2007: Normals
// Subjects=20
-60	8	20
44	36	10
-44	36	34
46	36	26
6	-2	62
-2	14	32
60	4	28
-54	-32	48
32	-56	42
-60	8	-4
64	4	0
-4	-86	34
36	-4	-4
-36	14	2
-44	6	-4
42	6	-2
24	10	4
-22	14	2

// Fitzgerald P B, 2007: Schizophrenia
// Subjects=3
48.85	-83.88	-1.6
-37.93	20.46	-5.96
-48.24	17.58	32.6
-50.09	4.55	54.09
-43.56	-58.57	44.53
-34.75	-57.29	57.7
-50.06	-47.75	45.81
-7.23	30.48	30.62
12.3	22.46	35.56
-3.04	36.05	21.03
-46.65	17.68	-12.26
-55.22	7.23	-8.84
-20.59	5.64	-4.79
-57.02	16.51	21.65
-37	3.3	62.95
-41.55	10.34	46.65
-54.6	-42.84	29.72
39.86	20.74	-7.32
-41.6	-.92	41.04
-7.09	31.52	41.72
10.17	22.66	37.82
-39.48	11.85	39.74
-33.71	17.52	-14.71
-57.38	7.22	-8.81
-61.27	12.65	26.58
-47.93	-32.64	46.52
-58.96	-40.93	27.36
-43.75	-3.06	41.28
-41.33	-55.81	50.95
-34.95	-58.75	42.16
-46.49	21.06	0.85

// Fitzgerald P B, 2007: Controls
// Subjects=4
-7.23	30.48	30.62
12.3	22.46	35.56
-3.04	36.05	21.03
-46.65	17.68	-12.26
-55.22	7.23	-8.84
-20.59	5.64	-4.79
-57.02	16.51	21.65
-37	3.3	62.95
-41.55	10.34	46.65
-54.6	-42.84	29.72
39.86	20.74	-7.32
-41.6	-.92	41.04
-7.09	31.52	41.72
10.17	22.66	37.82
-39.48	11.85	39.74
-33.71	17.52	-14.71
-57.38	7.22	-8.81
-61.27	12.65	26.58
-47.93	-32.64	46.52
-58.96	-40.93	27.36
-43.75	-3.06	41.28
-41.33	-55.81	50.95
-34.95	-58.75	42.16
-46.49	21.06	0.85

// Ronquillo J, 2007: Dark > Light
// Ronquillo J, 2007: Light > Dark
// Ronquillo J, 2007: Black > White
// Ronquillo J, 2007: (White dark-White light) > (Black dark-Black light)
// Subjects=11
-27.61	-62.08	-7.47
-20.34	-.53	-10.48
11.7	-15.91	-19.6
7.38	22.01	-10.46
-25.75	19.61	-10.99
-29.99	-36.05	-28.58
36.38	-44.32	-17.5
52.36	25.51	3.23
-28.94	20.82	-8.83
12.79	3.01	-8.93
59.77	-13.6	-21.46
-30.02	-14.48	-24.81
-49.24	14.19	-10.27
14.98	-28.33	-15.25
56.75	-36.99	-7.19
23.53	-31.53	-16.19
55.63	-4.59	-.98

// Koshino H, 2008: Autistic Patients
// Subjects=11
-50	22	26
42	8	36
4	8	62
6	22	44
-38	-54	50
52	-44	44
52	-50	-16
-36	-54	-28
-34	-70	-28
-50	12	36
42	42	0
-24	8	-14
42	28	-6
-6	20	48
6	12	24
-4	26	34
-42	-38	26
-58	-38	22
42	-28	24
52	10	-4
46	-26	-6
44	-66	20
-26	-60	-12
-22	-20	-20
-42	-42	-6
-18	-14	26
16	-10	28
4	-14	-12
-2	-22	8
34	28	44
32	-12	56
28	-70	48

// Koshino H, 2008: Controls
// Subjects=11
-34	54	14
-32	2	58
38	24	-12
-2	20	50
-8	-6	62
-36	4	30
6	10	26
-32	-58	42
36	-64	42
58	-44	8
-44	-62	-24
42	-50	-26
-34	-88	-6
-24	6	-14
20	-12	8
-50	12	36
42	42	0
-24	8	-14
42	28	-6
-6	20	48
6	12	24
-4	26	34
-42	-38	26
-58	-38	22
42	-28	24
52	10	-4
46	-26	-6
44	-66	20
-26	-60	-12
-22	-20	-20
-42	-42	-6
-18	-14	26
16	-10	28
4	-14	-12
-2	-22	8
34	28	44
32	-12	56
28	-70	48

// Seghier M L, 2008: Semantic Categorization vs. Perceptual Categorization
// Subjects=50
-50	14	-13
-48	27	15
-45	15	22
-50	-38	3
-30	-65	42
-48	5	47
-3	20	46
42	20	-9
39	54	22
50	-32	2

// Fitzgerald P B, 2008: MDD Patients
// Subjects=13
30	30	2
48	20	36
32	48	18
44	20	34
42	-52	36
-22	-36	-6
20	-36	-6
-40	2	-6
-38	22	-16
30	0	-6
20	-40	50
50	0	22
-44	4	48
28	18	54
50	12	16
6	10	4
6	12	42
34	-8	54
-4	2	60
-2	8	46
-28	-54	48
-28	20	52
-52	24	16
50	-38	34
52	-52	28
18	-66	42
36	-80	24
-38	-62	36
-52	-46	32
-46	-54	28
-58	50	6
18	-10	10
-18	-14	12
42	8	-16
50	-58	20
44	24	48
-42	-32	22

// Fitzgerald P B, 2008: Controls
// Subjects=13
30	30	2
48	20	36
32	48	18
44	20	34
42	-52	36
-44	6	26
-42	38	20
44	36	28
28	18	54
50	12	16
6	10	4
6	12	42
34	-8	54
-4	2	60
-2	8	46
-28	-54	48
-28	20	52
-52	24	16
50	-38	34
52	-52	28
18	-66	42
36	-80	24
-38	-62	36
-52	-46	32
-46	-54	28
-58	50	6
18	-10	10
-18	-14	12
42	8	-16
50	-58	20
44	24	48
-42	-32	22

// Mitterschiffthaler M T, 2008: Depressed Patients
// Subjects=17
-10	32	28
6	-60	42
-52	-72	24
-26	32	4
8	-46	-6
-26	10	58
-5	30	24
2	-60	44

// Mitterschiffthaler M T, 2008: Normals
// Subjects=17
-30	62	14
-5	30	24
2	-60	44

// Dillon D G, 2008: Anticipation; (Reward - No Incentive ) masked with 
// (Reward - Loss)
// Dillon D G, 2008: (Anticipation; Reward - No Incentive) masked with (Reward 
// Anticipation - Reward Outcome Gain)
// Dillon D G, 2008: (Anticipation; Loss - No Incentive) masked with (Loss 
// Anticipation - Loss Outcome Penalty)
// Dillon D G, 2008: Outcome; (Reward - No Incentive) masked with (Reward - 
// Loss)
// Dillon D G, 2008: (Outcome; Reward - No Incentive) masked with (Reward 
// Outcome Gain - Reward Anticipation)
// Dillon D G, 2008: Outcome; (Loss - No Incentive) masked with (Loss - 
// Reward)
// Dillon D G, 2008: (Outcome; Loss - No Incentive) masked with (Loss Outcome 
// - Loss Anticipation)
// Subjects=8
3.66	14.78	34.23
19.22	5.59	-18.91
-28.07	-3.65	-.38
-55.24	22.43	-6.98
66.32	-31.02	23.13
-44.47	-50.02	-24.65
-23.71	-75.6	-12.39
9.83	-93.66	-12.29
13.32	-86.36	8.21
35.63	-84.73	-21.46
6.81	20.65	27.99
-55.24	22.43	-6.98
48.69	11.28	5.8
62.53	3.18	-12.69
49.08	-11	31.53
-64.42	-25	25.88
66.32	-31.02	23.13
6.67	-8.87	10.75
-41.25	-50.21	-26.93
-10.38	24.61	36.86
45.41	22.96	4.69
-.6	21.77	40.33
-23.86	-59.2	-20.73
3.15	-55.81	-20.41
41.87	36.08	-15.59
69.07	-20.4	-12.71
-37.77	-72.46	-12.46
-24.02	-55.99	-32.25
42.02	-67.89	-25.48
-7.62	49.47	4.1
3.74	-30.62	30.88
6.35	52.19	-2.01
-28.39	27.87	-19.19
-50.78	25.61	3.83
38.52	28.65	-26.01
48.32	47.9	-15.75
-41.34	54.18	-12.6
41.97	61.99	-2.47
45.8	24.81	35.88
22.91	56.01	26.46
9.94	63.62	28.17
6.93	33.6	40.16
-68.15	-42.89	-15.99
69.1	-23.49	-11.28
55.78	12.13	-31.39
69.31	-40.53	1.61
52.3	-53.82	21.14
-3.94	-92.8	9.15
-20.77	-62.46	-32.79
19.23	-39.15	-26.81
-61.11	-50.72	26.13
-28.09	-84.74	-18.13
-1.09	52.04	8.21
-58.18	23.53	16.49
49.45	31.85	-15.3
-20.89	48.2	-20.21
-41.35	57.37	-12.92
-40.48	19.06	48.01
-17.32	69.31	10.14
-7.32	56.11	29.21
-6.94	25.01	52.45
56.72	12.6	42.51
-64.89	-47.13	-15.63
59.52	-67.34	-9.02
65.87	-25.63	-11.02
-61.11	-50.72	26.13
-28.07	-87.93	-17.82
-13.77	-77.2	4.41
23.04	-77.61	9.42

// Cooper J C, 2008: Valence Effect
// Cooper J C, 2008: Salience Effect
// Cooper J C, 2008: Interaction Effect of Valence and Salience
// Subjects=12
-10	34	10
-4	28	8
36	-74	36
-22	8	44
-2	-24	2
-34	42	18
38	36	-20
48	40	2
44	-50	38
-10	34	-22
-18	12	-18
-26	-8	62
6	-66	-24
50	-68	-20
-28	14	-4
34	-52	-30
-18	-66	54
-20	-18	66
-30	-58	46
-48	-48	40
-52	-58	42
24	-62	20
-22	-8	-10
-18	-6	-4
56	-28	36
-18	52	0
28	56	-6
18	-18	-2
18	10	18
26	-82	32
-50	6	-24
-20	-64	26
-12	6	8
-54	-46	26
-24	20	36
-10	4	18
-12	-58	26
-32	4	18
38	-30	36
-38	12	16
-6	-22	12
-6	26	14
-26	34	28
-22	-46	-8
10	14	-4
36	10	16
32	-6	48
-26	2	-30
26	-52	-22
42	-50	-26
-20	-76	18
6	-84	6
-42	-76	18
30	16	36
0	-72	18
40	-50	-2
34	34	26
6	-8	64
-34	-92	24
6	-56	14
-10	-72	8
-6	6	-4

// Strohle A, 2008: Normals
// Subjects=10
-18.39	-24.76	-8.55
4.36	-16.51	-1.91
-50.42	-62.46	14.78
-52.66	-69.68	6.57
4.35	51.2	10.44
20.3	39.5	-12.2
-50.91	38.92	-3.09
-44.29	18.08	3.34
54.9	45.36	-8.89
49.62	36.39	-1.19
43.01	55.1	-7.41
14.1	5.53	3.59
20.51	14.81	-.8

// Strohle A, 2008: ADHD Patients
// Subjects=10
46.37	39.57	-1.45
58.14	45.37	-8.95
20.25	63.21	-11.19
-50.91	38.92	-3.09
-44.29	18.08	3.34
54.9	45.36	-8.89
49.62	36.39	-1.19
43.01	55.1	-7.41
14.1	5.53	3.59
20.51	14.81	-.8

// Guroglu B, 2008: Peer vs. Celebrity + Positive vs. Non-Positive
// Subjects=28
6	32	-2
4	20	-4
-2	32	4
-8	6	-6
-6	-10	0
34	2	-34
30	-4	-22
38	8	-22
-28	-4	-26
-28	-12	-8
-32	-4	-12
52	-8	8
58	2	6
32	-22	-4
-44	-26	2
-44	-76	28
-40	-62	20
-50	-64	18

// Payer D E, 2008: Methamphetamine (MA) Dependent Subjects
// Subjects=12
-22	-6	-16
28	28	-6
38	50	0
-56	22	28
-6	18	46
32	-58	44
16	-64	-6
-8	-70	40
-20	-100	18
2	-76	-4
-22	-30	-4
18	-24	-10
18	-14	-10
-16	-10	4
-58	-52	8
38	-50	-22
-42	-46	-26
48	38	-6
64	-48	14
42	-36	38
40	10	-20
54	-66	-2
58	-54	-16
-16	-88	26
-2	16	20

// Payer D E, 2008: Normals
// Subjects=12
-22	-4	18
44	4	26
-46	46	-6
-38	-4	50
0	28	46
-8	12	46
42	-42	24
50	-74	2
-28	-68	40
22	-4	-16
40	-4	50
-48	-46	8
62	-50	14
48	38	-6
64	-48	14
42	-36	38
40	10	-20
54	-66	-2
58	-54	-16
-16	-88	26
-2	16	20

// Brown S, 2008: Glottal Stops > Fixation
// Brown S, 2008: Phonation > Fixation
// Brown S, 2008: Lips > Fixation
// Brown S, 2008: Tongue Movement > Fixation
// Subjects=16
49.09	-5.48	33.22
64.9	11.33	5.51
58.86	10.28	40.46
-2.51	12.68	58.07
-39.51	-10.25	32.96
-55.64	5.62	42.87
-58.16	10.56	15.53
-60.32	-9.11	11.91
-48.31	-33.32	16.34
26.92	-66.68	-23.1
39.72	-61.29	-35.06
-25.05	-67.69	-31.08
-42.41	-63.91	-35.64
-23.12	-82.52	-52.06
49.08	-3.35	33.01
10.42	14.65	55.42
67.03	11.13	3.26
55.58	3.36	35.6
-2.52	14.81	57.86
-41.72	-6.21	30.36
-53.45	5.83	45.05
-62.57	8.76	7.94
56.21	-8.78	-2.43
55.19	-29.09	-1.53
60.5	-8.97	-4.73
58.24	-.99	-11.08
-43.94	-37.35	18.91
-52.86	-18.63	1.52
-58.07	-31.44	14.08
-66.7	-22.65	16.72
-58.43	-3.53	-8.84
26.54	-73.84	-53.76
29.02	-67.08	-27.58
37.63	-65.13	-30.16
14.04	-74.82	-17.59
-27.19	-65.36	-29.03
-7.55	-72.56	-15.21
-37.94	-71.58	-25.99
-23.13	-80.4	-52.27
-36.17	-61.3	-53.93
24.81	-11.53	-7.23
-18.45	-5.51	-9.33
62.94	-12.31	16.85
63.1	-5.64	30.76
69.23	13.58	6.34
67.37	11.5	30.11
-53.54	-7.97	35.21
-60.07	9.13	34.75
-63.47	-10.62	18.84
-4.79	8.55	48.44
-46.42	6.27	3.43
24.75	-3.23	-10.29
27.06	4.4	2.36
-22.63	-2.26	2.75
-20.57	-2.98	-5.06
26.88	-64.76	-25.53
-22.82	-64.93	-24.67
71.58	-3.56	18.08
63.11	-7.76	30.97
67.05	13.47	5.27
-66.59	-6.51	28.57
-55.9	6.94	22.57
-66.78	-6.8	14.03
-2.54	5.88	54.27
-22.65	2	2.33
-20.62	3.2	-7.91
20.42	-71.16	-24.79
-20.64	-69.18	-24.28

// Eyler L T, 2008: Normals
// Subjects=14
-5.05	-34.34	18.94
10.02	-72.66	17.52
-35.21	17.93	9.33
-45.82	-50.64	-9.33
-2.82	24.8	54.11

// Eyler L T, 2008: Schizophrenia/Schizoaffective Disorder Patients
// Subjects=17
-10.37	-45.11	17.68
35.85	-38.75	54.53
35.52	-3.72	25.95
2.66	-53.9	40.57
4.98	49.01	-32.77
52.79	-59.03	24.81
10.02	-72.66	17.52
-35.21	17.93	9.33
-45.82	-50.64	-9.33
-2.82	24.8	54.11

// Koppelstaetter F, 2008: 2 Back - 0 Back, Caffeine
// Koppelstaetter F, 2008: 2 Back - 0 Back, Placebo
// Subjects=15
-7.36	30.61	20.52
-46.34	24.33	12.85
-33.49	49.79	8.99
-53.97	15.06	6.05
-32.87	8.45	48.93
-53.82	17.27	18.15
-19.7	-62.12	51.2
-37.08	-41.01	48.29
-24.59	-77.34	3.49
-33.66	-65.28	-27.81
-3.38	-29.9	-18.38
10.06	22.89	28.84
52.96	32.77	5.84
44.05	59.15	-10.07
52.86	23.22	-4.42
31.95	8.68	47.8
53.16	13.5	17.83
23.59	-65.8	55.31
49.23	-38.35	37.59
35.85	-82	-3.81
44.12	-65.01	-29.16
9.63	-29.54	-15.27
-2.8	24.74	37.84
-42.07	37.11	11.51
-28.57	12.72	48.43
-28.35	-57.89	50.93
-50.03	-33.3	51.11
-6.71	-57.51	53.89
-15.8	-97	10.88
-33.61	-68.16	-24.16
5.84	24.77	37.69
52.96	32.77	5.84
31.89	8.26	43.36
27.77	-58.11	45.51
53.61	-37.92	41.95
23.56	-61.65	53.78
23.1	-96.86	10.21
31.11	-69.83	-34.07

// Noriuchi M, 2008: Own Child vs. Other Child
// Noriuchi M, 2008: Other Child vs. Own Child
// Noriuchi M, 2008: Own Child vs. Other Child, Separation Situation
// Noriuchi M, 2008: Own Child vs. Other Child, Play Situation
// Noriuchi M, 2008: Separation Situation vs. Play Situation, Own Child
// Noriuchi M, 2008: Play Situation vs. Separation Situation, Own Child
// Subjects=13
-30	24	-24
28	22	-24
54	6	28
2	18	62
52	10	48
-38	2	28
58	-66	8
36	24	6
-16	-56	14
-20	6	0
-16	-8	10
-12	-16	6
0	-28	-12
6	-8	-4
22	56	26
32	48	24
32	34	16
68	-14	6
-46	-36	52
-34	-42	68
30	-32	48
-22	-58	50
-26	-34	-22
-22	-44	-8
-14	6	-12
12	8	-12
32	32	-18
-42	14	46
56	28	26
-26	26	52
-20	0	70
26	54	42
0	28	66
58	-64	12
-36	-76	30
44	-70	34
2	-76	56
36	-66	-8
-4	-60	26
2	-34	36
22	6	-10
-26	22	-24
26	26	-22
54	10	46
44	-58	-8
60	-54	-4
62	-40	20
50	-76	-14
-22	12	4
4	-10	-12
-32	24	0
-16	12	56
18	0	78
-4	2	70
4	32	66
56	24	26
-50	56	22
-42	12	42
-32	6	44
-38	22	56
32	52	40
50	24	48
-18	-34	54
64	-8	-12
-52	-34	-2
48	-32	-6
46	-22	-6
54	-16	-8
-60	-62	24
-52	8	0
62	-26	8
-52	-56	-14
61	-60	30
-42	-70	52
-38	-32	38
54	-54	50
-40	-80	42
-6	-78	12
-14	-72	26
-4	-78	52
6	-64	62
2	24	30
12	-44	38
-2	-18	-10
-14	-22	-6
-18	-2	20
-13	-21	-12
-30	-26	54
32	-38	12
34	-58	18
-28	-76	8
-46	-40	30
-6	4	-12

// Watanabe T, 2008: Hits - Correct Rejection (Retrieval Success)
// Subjects=18
-45	27	24
-48	27	6
36	-12	-30
57	0	-24
-36	-3	-18
-51	6	-24
-18	-60	39

// Iaria G, 2008: Emotional Processing - Orientation Discrimination
// Iaria G, 2008: Orientation Discrimination, Positive and Negative - 
// Orientation Discrimination, Neutral
// Subjects=10
-6	34	56
8	36	56
-12	56	34
-14	58	18
-48	46	-12
-40	34	2
40	28	-22
-40	34	2
-4	50	-20
56	-70	18
-24	-34	-22
38	-74	24
-36	-84	26
-26	-10	-14
10	-86	-26
-6	24	64
-44	34	-20
-46	-52	26
46	-48	-22
-60	-56	14
54	-70	-2

// Spence S A, 2008: Lie - Truth
// Spence S A, 2008: Comply - Defy
// Spence S A, 2008: [(Lie - Truth) - (Defy - Comply)]
// Subjects=17
-34	34	6
-30	-86	16
-10	-96	16
-4	-46	-18
32	36	6
60	10	18
20	10	-10
-26	28	4
-46	26	0
-20	-14	-22
2	56	6
2	44	-18
18	-24	-20
-28	44	-16
-58	-26	-4
-8	-98	24
-20	-106	4
-20	-24	6
38	46	-18
62	8	18
38	-86	22
14	-26	8
-42	30	-4
-26	28	4

// Abe N, 2008: Effect of Making Deceptive Responses:  (LT - TR) + (LN - CR)
// Abe N, 2008: True Recognition to True Targets (TR) > False Recognition to 
// False Targets (FR)
// Abe N, 2008: Lie to New Targets (LN) > Correct Rejection to New Targets 
// (CR)
// Abe N, 2008: False Recognition to False Targets > Correct Rejection to New 
// Targets (CR)
// Subjects=20
12	57	-6
33	21	15
24	15	60
42	6	51
24	-3	57
15	-27	0
24	-69	-12
18	-75	39
-45	48	-15
-12	21	57
-30	21	9
-48	9	6
-27	3	60
-54	-6	39
-42	-27	3
-30	-42	45
-27	-57	54
-51	-60	36
-30	-69	30
-9	-78	45
66	-21	-3
0	60	24
0	-45	-42
-48	-9	-15
-60	-18	-12
-51	-54	36
24	15	39
18	-27	3
-12	21	54
-27	21	12
-42	18	39
-27	9	42
-51	-57	36
-33	-69	33
9	6	-9
36	-9	-15
-9	33	-18
-21	27	-24
-42	27	0
-24	18	39
-27	18	12
-12	3	9
-27	-63	54
-18	-63	21

// Suchan B, 2008: Recollection vs. Correct Rejection
// Suchan B, 2008: Familiarity vs. Correct Rejection
// Subjects=10
31.2	-18.83	-16.7
22.34	-7.34	-31.13
-33.78	-9.25	-25.51

// Dunsmoor J E, 2008: Unconditioned Response Diminution
// Subjects=18
0.28	30.69	29.49
54.58	46.58	8.57
-6.5	-69.17	-30.87
19.83	-82.41	-31.06
22.11	-44.18	-25.49
-31.09	36.39	-31.63
-46.18	-25.03	10.83
48.5	-22.5	10.31
-3.43	-16.46	-.53

// Galati G, 2008: Sound > No Sound
// Galati G, 2008: Action vs. Non Action Related Sounds
// Galati G, 2008: Non Action vs. Action Related Sounds
// Galati G, 2008: Mouth > Hand Sounds
// Galati G, 2008: Hand > Mouth Sounds
// Subjects=11
-52	-22	2
-44	-28	4
-58	-18	0
-60	-46	10
-36	-32	42
-58	-20	24
-56	-38	24
-40	-14	56
-4	8	52
60	-14	0
66	-32	10
68	-34	4
56	-40	4
34	-48	46
62	10	20
42	40	26
32	8	58
44	26	14
46	16	30
12	42	54
24	40	52
2	58	12
4	50	8
18	-70	8
8	-68	-12
8	-78	18
-48	34	-10
-54	36	-4
-46	38	-2
-56	10	12
-50	20	20
-60	22	6
-54	-48	4
-54	-42	-2
-64	-30	-12
52	-42	4
56	-30	-2
68	-32	-2
-38	-28	16
-46	-28	18
-50	-12	0
46	-20	6
44	-10	-6
34	-22	16
28	48	44
28	48	22
30	54	34
8	-46	54
14	-48	62
16	-42	48
16	-74	48
24	-72	40
-42	-24	12
-50	-6	0
-40	-30	12
-62	-6	-8
68	-24	-6
62	-28	-8
64	-12	-8
58	-4	-16
-50	38	16
-50	38	24
-42	32	20

// Goldin P R, 2008: Watch, Negative > Watch, Neutral
// Goldin P R, 2008: Reappraise > Watch, Negative
// Goldin P R, 2008: Suppress > Watch, Negative
// Goldin P R, 2008: Watch, Negative > Suppress
// Goldin P R, 2008: Reappraise > Suppress
// Goldin P R, 2008: Suppress > Reappraise
// Subjects=17
-42.99	24.66	-26.83
-36.41	25.35	-4.66
1.07	61.47	18.65
56.96	16.82	41.82
4.75	29.13	68.15
-54.25	10.98	31.32
53.51	32.97	17.09
-50.24	20.32	0.38
56.62	20.96	-.9
-42.23	2.87	63.09
-13.82	66.55	30.66
-54.42	32.33	18.38
8.9	46.53	58.84
-49.93	-78.62	0.87
44.61	24.84	-32.31
38.39	22.45	-7.51
38.11	-39.74	69.09
-46.59	-21.16	41.73
-6.19	-91.18	-14.19
19.19	-5.84	-13.84
-17.15	-2.88	-13.67
-9.52	6.36	8.89
11.88	3.57	12.22
1.24	-30.13	4.02
-3.25	-5.97	-13.57
19.41	-23.42	6.59
-10.79	73.49	9.97
52.21	45.97	-7.41
-53.57	44.37	-4.94
-38.15	11.85	41.1
-29.06	44.89	-14.19
-39.79	47.65	-18.76
-36.52	40.61	-13.75
-39.84	9.73	-41.23
-60.98	7.68	-10.7
-54.73	21.41	-26.42
-65.3	-3.77	-20.84
-60.72	-34.73	5.12
-60.77	-38.5	-2.37
-47.26	-.63	-36.93
-30.55	-62.7	26.08
-42.34	-54.31	25.51
-49.65	-67.96	42.35
8.78	-67.86	-2.94
1.45	24.83	54.05
42.97	15.79	29.8
52.47	25.57	17.72
54.48	42.95	8.43
57.73	23.6	5.56
32.93	51.94	-11.03
-35.47	60.25	-7.6
-47.15	48.89	-2.05
-35.27	20.58	2.42
57.03	-65.95	17.54
67.59	-55.11	5.35
56.94	-74.55	2.65
-60.57	-70.42	11.46
-46.9	-61.73	-15.08
-38.95	-64.47	45.28
-31.39	-77.91	49.67
39	-72.26	33.88
-1.57	-94.08	30.6
0.29	-77.26	0.18
-6.09	-85.76	0.96
-14.04	78.5	6.24
-6.28	67.19	38.32
-50.25	27.98	3.08
-39.3	-15.42	18.87
-39.83	28.56	-31.66
-57.47	-41.85	9.02
-42.87	-7.07	-24.17
-57.97	5.65	-37.33
41.46	18.82	-27.31
4.69	-73.66	18.78
-16.65	-98.71	13.32
19.76	-102.12	21
1.47	-5.72	44.35
1.4	4.51	39.03
1.38	19.66	42.22
-2.3	48.82	-7.02
52.37	35.54	9.08
52.51	14.99	18.61
-6.71	62.74	-19.29
-35.38	53.45	0.78
49.26	25.55	17.76
56.72	9.93	7.83
-46.88	-61.48	-11.76
-64.87	-22.38	27.55
49.46	-74.59	2.73
-38.95	-79.87	38.76
1.17	-19.89	-1.3

// Huh J, 2008: Perfume > Rest
// Subjects=8
10	-2	-6
-36	38	-2
22	-6	-30
-16	0	-14
-38	14	4
58	-46	26
8	-84	16
-24	56	20
8	22	64
0	-28	24
-14	-20	-12
52	-46	10
-22	-64	64
-14	36	56
-56	-36	42
10	18	28
46	-52	8
32	-40	-42
48	-60	26
0	-72	2
8	-24	0
52	-10	20

// Reiss A L, 2008: Normals
// Subjects=12
-42.57	24.65	-29.83
-1.23	-12.46	-15.66
-1.13	-18.32	-9.48
48.26	13.48	-28.03
-16.33	7.36	-9.52
44.04	-9.83	-24.53

// Reiss A L, 2008: Narcoleptic Patients
// Subjects=10
7.59	-8.95	-1.59
55.85	-5.95	-29.6
-51.13	-2.18	-29.27
-16.33	7.36	-9.52
44.04	-9.83	-24.53

// Rosenbaum M, 2008: Placebo Treatment > Initial Weight
// Rosenbaum M, 2008: Initial Weight > Placebo Treatment
// Rosenbaum M, 2008: Leptin Treatment > Placebo Treatment
// Rosenbaum M, 2008: Placebo Treatment > Leptin Treatment
// Subjects=6
8	-14	-18
-10	-54	-4
-18	-10	0
-46	28	-4
18	-84	-4
38	22	34
-52	22	38
58	-2	-18
-32	-24	-12
32	-26	-12
-20	-4	-18
-6	20	-4
-22	38	2
6	26	2
10	-14	34
-6	-24	34
-48	-36	-18
12	6	-12
-40	-58	40
-24	50	-12
-26	-48	2
36	-2	34
-36	-10	36
40	-56	34
14	36	0
-14	36	0
-16	18	38
-6	-46	-14
-22	-2	-12
12	14	-2
52	30	-6
36	-4	34
-34	-52	-2
6	26	40
26	34	-18
-26	44	-12
-38	6	42
-54	-32	-18
-48	-28	44
42	-76	40
-12	6	-10
2	2	4
-2	2	4
-6	-14	-20
-18	-20	34
26	-4	40
12	-44	-22
-14	-40	-20
-26	18	-8
-36	6	-10
20	-84	-4
-6	64	0
-36	58	-6
-28	12	32
32	-74	0
42	-38	0
-42	-26	-18
38	-30	-16
28	-64	28
-20	-50	30
-12	40	38
-44	-4	-10

// Schwartz S, 2008: Humor > Neutral, Normals + Narcoleptic Patients
// Schwartz S, 2008: Humor > Neutral, Normals > Narcoleptic Patients
// Schwartz S, 2008: Humor > Neutral, Narcoleptic Patients > Normals
// Subjects=12
-45	-51	-18
48	-63	-15
-42	18	-3
-39	-87	6
-12	39	45
18	6	-18
-21	-6	-21
12	3	-18
-9	45	15
27	12	-21
42	-78	-6
-27	24	-18
-48	18	15
0	18	36
45	18	-12
12	60	3
57	-33	27
-36	3	-6
-9	-45	33
51	30	3
33	-57	-15
-39	-60	-12
-15	9	-3
33	3	-21

// Bueti D, 2008: Action - Control Action
// Bueti D, 2008: Perception - Control Perception
// Bueti D, 2008: (Action - Control Action) vs. (Perception - Control 
// Perception)
// Bueti D, 2008: Control Perception - Perception
// Subjects=14
-48	45	9
-33	36	27
42	51	6
12	0	60
-3	15	51
45	-39	48
-30	12	-3
24	9	9
24	-9	0
-30	-69	-45
30	-66	-24
-57	12	24
-27	12	-3
21	-6	-9
27	-15	24
42	-60	-36
-48	27	39
12	24	60
-45	12	51
48	-39	45
-36	-54	51
54	-66	-9
-30	-63	-9
24	-66	-9
0	-78	-24
12	-63	-36
-30	-66	-45
12	-93	-33
-51	-66	39
15	30	60
-12	-54	36
21	-69	60

// Ettinger U, 2008: Standard Antisaccade
// Ettinger U, 2008: Standard Saccades
// Ettinger U, 2008: Delayed Saccades
// Ettinger U, 2008: Saccade-by-Delay Interaction
// Subjects=17
-11.02	-70.6	51.89
8.26	14.64	55.46
14.93	-68.17	53.45
16.5	-94.42	2.23
-13.93	8.07	9.42
32.1	10.88	59.9
58.23	16.45	-8.33
32.36	-54.95	67.53
63.25	-38.5	35.13
48.74	46.66	16.86
16.37	-6.81	9.26
49.27	5.75	50.03
-32.59	-50.7	59.26
-11.49	-89.43	11.18
-26.28	6.01	56.9
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18
63.25	-38.5	35.13
32.1	10.88	59.9
-26.28	6.01	56.9
49.27	5.75	50.03
32.36	-54.95	67.53
-32.59	-50.7	59.26
14.93	-68.17	53.45
-11.02	-70.6	51.89
48.74	46.66	16.86
58.23	16.45	-8.33
16.37	-6.81	9.26
8.26	14.64	55.46
-13.93	8.07	9.42
16.5	-94.42	2.23
-11.49	-89.43	11.18

// Calder A J, 2008: Disgusting - Non-Foods
// Calder A J, 2008: Disgusting - Bland Foods
// Calder A J, 2008: Disgusting - Appetizing Foods
// Calder A J, 2008: Appetizing - Non-Foods
// Calder A J, 2008: Appetizing - Bland Foods
// Calder A J, 2008: Bland - Non-Foods
// Subjects=12
48	10	-10
-14	-2	-6
22	10	44
-14	-2	-8
44	-34	42
-46	4	-26
-52	-10	43
62	-2	24
-46	-12	24
30	0	12
48	-42	36
26	6	60
-42	24	24
20	-80	24
22	30	24

// Driessen M, 2008: T1 vs.T2, ULE vs. RLE
// Subjects=13
9	-49	8
-27	-70	-9
6	-76	-13
42	-29	7
15	-75	12
-47	-12	-2
36	18	13
-3	-93	7
30	41	-2
18	30	30
-27	19	32
-9	19	32
21	2	41
-33	17	49
-24	-50	50
27	17	41
6	-24	-16
-3	-21	-16
39	-74	34
-9	-33	46
9	11	41
-3	10	38
-18	-8	14
57	6	3

// Hanakawa T, 2008: Instructional Cue
// Hanakawa T, 2008: Finger Tapping, Imagery
// Hanakawa T, 2008: Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Imagery + Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Movement > Finger Tapping, Imagery
// Hanakawa T, 2008: Finger Tapping, Imagery > Finger Tapping, Movement
// Hanakawa T, 2008: Finger Tapping, Imagery > Instructional Cue
// Hanakawa T, 2008: Delay 1 vs. Delay 2
// Subjects=13
-40	-72	-28
52	14	26
-28	0	62
-32	-56	44
42	-56	58
28	-76	44
-54	10	30
-50	6	42
-2	12	42
-4	10	52
58	-44	34
-56	10	26
-44	-70	-28
6	14	40
-2	2	58
-40	-52	58
-20	4	60
-38	-4	58
-44	14	-12
34	-2	56
56	14	-14
12	-74	50
18	-52	-32
6	-64	-32
-48	-30	46
-36	-26	56
-36	-8	62
-2	2	50
-28	-62	-42
66	-22	12
-26	-10	-2
-28	8	-6
32	-68	56
52	8	-4
-10	-24	-6
-44	-70	-28
6	12	44
-2	-2	54
56	16	-14
32	-68	-36
-46	14	-10
-24	-4	-2
-54	12	26
-56	6	38
-40	-52	58
-28	-66	58
-62	-38	22
20	2	4
14	-76	52
64	-42	28
-36	-6	60
-4	-88	2
34	0	60
-34	-28	64
-48	-28	46
-38	-18	60
-34	-46	64
14	-52	-32
6	-64	-40
56	-26	48
66	-24	10
-2	-10	44
-58	-22	8
-10	-22	4
0	10	58
-16	6	58
42	0	40
30	-60	-18
56	14	-12
-46	14	-16
0	-2	60
6	18	32
46	0	44
32	-6	60
-12	-76	-12
-28	-64	-36
16	-78	-12
-64	-30	26
10	-28	36
-4	-8	58
-8	12	38

// Iseki K, 2008: Gait Observation > Scrambled Gait Observation
// Iseki K, 2008: Stepping Observation > Scrambled Gait Observation
// Iseki K, 2008: Gait Observation > Stepping Observation
// Iseki K, 2008: Virtual Walking > Scrambled Virtual Walking
// Iseki K, 2008: Gait Observation > Scrambled Gait Observation and Virtual 
// Walking > Scrambled Virtual Walking
// Subjects=16
18	-12	64
-8	-10	68
-24	-2	64
-12	-56	64
-50	-34	30
-56	20	6
46	-62	0
30	-94	-2
-46	-78	0
26	-4	-38
-26	-10	-26
48	2	44
-44	0	56
48	8	26
-40	14	28
-36	-54	58
50	-70	-2
-48	-68	8
-38	-44	-26
26	-90	-14
-30	-88	-6
22	-6	58
-24	-8	68
32	-4	46
-30	-6	42
12	-66	64
-16	-62	22
-16	-16	46
38	-80	18
-38	-82	24
-18	-4	-22
6	20	0
-10	22	-2
8	-20	6
32	-6	48
-14	-16	48
-34	-8	52
14	-64	66
-10	-62	62
38	-56	-12
-34	-42	-16
26	-86	-6
-24	-90	-6
-20	-28	-2

// Liu C, 2008: Real Characters > Checkerboard
// Liu C, 2008: Pseudo Characters > Checkerboard
// Liu C, 2008: Artificial Characters > Checkerboard
// Liu C, 2008: Real > Artificial Characters
// Liu C, 2008: Pseudo > Artificial Characters
// Liu C, 2008: Pseudo > Real Characters
// Liu C, 2008: Artificial > Real Characters
// Subjects=14
-46.27	-80.16	-2.59
-47.81	-62.42	49.47
-33.82	-8.5	-28.94
-41.82	16.02	27.04
53.17	-81.63	-.78
-44.09	-84.41	-2.21
-26.26	-62.76	44.65
-52.63	22.46	27.7
-37.96	36.63	-5.32
-22.48	-17.59	10.98
51.01	-81.64	-.74
36.32	-59.87	37.7
22.59	39.38	-2.14
18.57	11.04	16.42
25.04	-15.29	9.95
-43.98	-83.58	6.67
55.34	-75.03	0.78
34.19	-69.45	38.68
15.98	27.48	-14.3
-50.45	24.81	29.68
-60.26	21.92	22.29
-53.61	-12.85	28.97
-64.3	-30.65	34.28
-62.54	-55.55	-2.51
-52.94	-43.27	-9.49
-55.92	-53.43	8.38
-55.72	7.23	37.11
-50.48	20.24	26.77
-46.51	-54.61	-16.32
3.33	-3.02	4.62
14.25	4.44	14.9
37.75	-.75	-7.4
31.1	19.88	-16.05
-46.45	-62.91	-13.26
-50.54	-86.35	0.34
-22.93	35.95	-13.36
-11.82	-4.35	2.77
-26.96	-6.73	1.02
-11.74	35.6	16.74
26.84	19.21	-11.43
28.95	18.81	-15.9
7.62	-8.74	0.63
16.34	15.94	11.49
24.7	54.38	-2.54
14.09	41.56	10.11
34.22	-45.22	45.25
32.2	-48.55	55.7
46.73	-21.18	14.64
24.95	57.32	17.33
27.29	48.79	29.34
56.23	-62.24	-11.71
25.91	-56.28	-15.15
-41.69	-88.06	16.04
-46.1	-79.98	10.84
-29.08	-70.95	-8.28
-35.57	-64.48	-7.68
-20.31	-77.63	0.08
-21.84	-83.92	47.79
-53.78	-75.42	2.67
38.31	-83	19.78
33.53	-60.19	-11.53
37.85	-51.46	-10.22
31.21	-44.97	-20.84
60.53	-57.97	-12.21
42.7	-23.37	37.34
25.91	-61.36	68.28
36.32	-67.52	36.21

// Mehnert U, 2008: Bladder Filling vs. Rest
// Mehnert U, 2008: Combined vs. Rest
// Mehnert U, 2008: Bladder Filling vs. Combined
// Subjects=8
47	12	15
42	35	13
27	12	-13
-50	20	20
-41	37	15
5	29	44
43	10	2
-39	14	-2
-8	-64	29
58	-42	0
58	-41	33
-51	1	7
-54	-28	22
-58	-42	22
13	-73	-25
-5	-75	-23
-20	-65	-26
35	41	26
0	51	5
-34	30	33
-35	-51	31
3	-58	17
49	7	11
45	-23	46
26	-29	61
-32	-29	56
2	-36	55
56	-37	24
51	-48	45
-55	-29	23
-51	-41	36
-35	-51	31
-52	-4	6.8
-10	-53	3
-25	-66	-26
49	29	12
-48	19	19
56	-34	20
7	19	24
8	37	24
28	3	7

// Munzert J, 2008: Motor Imagery > Gymnastic Film
// Munzert J, 2008: Gymnastic Film > Motor Imagery
// Munzert J, 2008: Gymnastic Film and Motor Imagery > Fixation
// Subjects=10
5.57	14.42	29.23
-42.66	-13.73	-.2
43.78	4.25	-9.39
-48.08	4.13	-2.75
-.91	-8.31	11.14
-28.22	-52.97	55.34
27.36	-52.55	55.79
24.61	-19.3	-9.42
3.14	-50.12	-34.47
-24.2	17.99	50.46
26.17	-4.29	60.67
-50.05	6.98	20.46
52.5	5.05	13.86
2.61	0.51	56.08
-18.1	-2.75	1.95
20.35	7.17	2.9
-24.66	-48.25	-35.42
-21.42	-56.69	-34.75
20.18	-60.47	-46.07
-27.29	-37.87	44.03
40.05	-34.04	46.28

// Dannhauser T M, 2008: Amnestic Mild Cognitive Impairment (aMCI) Patients
// Subjects=10
-52.25	18.42	17.29
55.86	-3.25	30.13
-3.13	-46.5	-14.63
-41.63	25.46	11

// Dannhauser T M, 2008: Normals
// Subjects=10
-37.22	26.86	28.68
8.58	-84.26	-36.13
-41.63	25.46	11

// Dohnel K, 2008: Amnestic Mild Cognitive Impairment (aMCI) Patients
// Subjects=16
10	30	22
18	37	33
32	51	16
50	-52	36
6	-35	44

// Dohnel K, 2008: Normals
// Subjects=16
9	38	31
44	-64	42
-14	-74	35

// Foland L C, 2008: Emotion Perception vs. Shape Perception, BD Patients vs. 
// Normals
// Foland L C, 2008: Emotion Labeling vs. Shape Perception, BD Patients vs. 
// Normals
// Foland L C, 2008: Emotion Perception vs. Shape Perception, Normals vs. BD 
// Patients
// Foland L C, 2008: Emotion Labeling vs. Shape Perception, Normals vs. BD 
// Patients
// Subjects=9
-18	-4	-12
-18	-28	-16
-4	-28	6
-16	42	2
8	24	24
-18	-12	-12
-26	-6	-8
-4	-12	10
-32	30	14
-34	28	-8
34	34	-4
36	24	-4
-14	34	18
-34	26	-8
36	30	-10
44	24	-8
-6	34	4
-46	26	28

// Sanchez-Carrion R, 2008: Traumatic Brain Injury Patients
// Subjects=18
34	-6	56
-28	2	54
-50	12	30
-34	-52	42
-28	-68	46
44	-48	44
34	-62	44
32	-6	56
46	2	54
-52	12	38
-50	-2	48
-60	8	16
-34	-56	46
-24	-80	46
-28	-76	40
44	-52	48
34	-66	44
44	-44	38
22	-74	36
-22	-28	-8

// Sanchez-Carrion R, 2008: Healthy Controls
// Subjects=14
24	4	62
-4	6	60
-52	12	26
-34	24	2
-36	44	24
-40	50	8
34	22	4
-42	-46	46
-22	-66	42
-32	-56	48
40	-54	52
44	-46	44
16	-68	56
8	-76	-26
32	-56	-38
-34	-56	-38
-52	10	24
-30	-2	46
-32	-2	56
24	2	62
4	20	44
-34	26	6
42	32	34
40	46	20
52	10	30
-42	50	10
-34	42	20
34	22	4
-20	-68	40
-38	-48	44
44	-46	46
34	-74	36
14	-82	-26
38	-66	-32

// Brune M, 2008: Schizophrenics
// Subjects=9
-46	-44	18
48	-42	20
54	-48	10
46	-64	18
-44	-36	8
-50	-40	12
50	-14	-12
62	-40	4
-60	-40	4
-10	-52	46
14	-54	48
-42	18	24
-16	28	42
6	-30	62
44	-22	20
14	34	-2
12	-28	22
14	-36	24
-20	40	-16
24	-16	20
-16	-20	0
38	12	28
22	24	40
0	-28	54
4	-34	60
46	-24	6
56	-36	-4
-48	-42	34
14	-70	46

// Brune M, 2008: Normals
// Subjects=13
-2	6	20
38	-22	24
-58	-40	16
-56	-68	18
-50	-32	0
62	-6	-16
60	-64	6
46	-70	10
-6	-54	36
34	10	34
40	20	-20
-10	18	16
24	-26	26
4	-28	0
44	-22	20
14	34	-2
12	-28	22
14	-36	24
-20	40	-16
24	-16	20
-16	-20	0
38	12	28
22	24	40
0	-28	54
4	-34	60
46	-24	6
56	-36	-4
-48	-42	34
14	-70	46

// Ghosh S S, 2008: Monosyllables > Passive Viewing
// Ghosh S S, 2008: Bisyllables > Monosyllables
// Subjects=10
-54	2	20
54	-8	48
20	-28	66
-50	14	0
-50	30	18
-40	-28	12
-40	-30	16
60	-2	16
2	18	50
-2	8	62
2	0	76
-32	-20	4
48	12	-2
-4	-42	12
2	-42	10
-50	-10	20
-58	-14	26
-66	-30	20
-4	-56	72
-4	-50	76
2	-56	74
46	-18	4
46	-22	6
-58	-22	12
68	-18	4
64	-26	12
-36	6	-20
-24	6	-20
-52	-54	-28
-8	-64	2
0	-66	8
14	-28	-8
10	-46	4
-12	-2	14
-16	-2	16
10	2	8
-26	-6	-6
-18	0	10
24	4	-6
-16	0	6
18	2	6
-12	-20	-2
-10	-8	6
14	-28	0
6	-8	8
-42	-62	-28
42	-56	-30
30	-78	-26
44	-36	-38
-30	-56	-28
-18	-60	-20
28	-58	-30
8	-66	-20
-28	-38	-54
40	-40	-52
-16	-32	-44
28	-36	-48
24	-34	-46
4	-58	-6
-4	-80	34
2	-84	36
-52	-6	30
-46	-8	54
50	-4	38
-56	16	20
-60	16	32
-6	4	68
8	16	44
54	-2	32
-24	-70	42
-20	-70	48
24	-68	50
-32	-52	50
-62	-2	-10
-66	-18	2
70	-2	-6
70	-28	4
-58	6	-12
-42	-64	-10
18	-92	-12
-38	-50	-24
-40	-44	-24
-22	4	4
26	4	0
22	8	4
-22	0	-4
-30	-84	-20
-8	-80	-32
-30	-60	-28
-32	-56	-26
28	-62	-26
2	-102	-6
14	-66	10
-46	-84	-2
-28	-82	16
-16	-92	-10
34	-88	20
34	-80	-16

// Gomot M, 2008: Novel > Standard Tones, All Subjects
// Gomot M, 2008: Novel > Standard Tones, ASC Patients > Normals
// Gomot M, 2008: Novel > Standard Tones, Normals > ASC Patients
// Gomot M, 2008: Novel > Standard Tones, Positive Correlation Between Signal 
// Change and AQ-Adol Scores
// Subjects=12
-13.94	-13.93	3.75
-47.33	-26.39	10.04
-49.48	-21.94	11.87
65.01	-19.61	7.45
58.69	-36.99	17.12
-58.11	-24.09	12.23
-62.43	-29.53	11.73
-42	-26.89	4.39
44.53	-29.15	9.87
52.28	-29.9	24.38
7.9	33.83	31.15
-37.74	-2.21	4.12
67.43	-47.18	22.47
18.54	-17.65	8.05
-2.72	10.06	41.53
52.86	-22.69	-13.33
10.15	-27.82	26.01
3.73	31.66	42.64
50.88	-18.06	1.94
-2.64	-4.73	44.11
-5.04	23.05	31.32
-31.21	-11.65	6.06
23.02	-70.06	9.8
-58.39	-18.52	-8.48
6.52	-16.5	-1.94
-.43	11	51.48
-41.42	-9.46	53.08
-30.56	-19.95	55.06
-26.29	8.13	56.69
-35.56	52.64	16.58
-40.34	51.43	-19.07
-42.35	51.4	-7.83
-48.67	-54.62	-16.28
-44.38	-47.16	-17.09
32.06	6.21	55.88
23.42	4.06	56.25
36.41	-4.51	55.75
42.9	-0.03	57.44
34.11	1.03	46.28
49.31	-13.7	48.6
65.09	9.49	20.26
-32.84	-59.15	37.68
-34.98	-51.3	41.43
-19.88	7.64	51.03
5.41	19.32	2.37
32.07	6.32	56.99
62.95	9.59	21.41
-.55	7.94	41.7
-18.53	-47.25	60.92
-51.71	-50.95	0.22

// Jogia J, 2008: Bipolar Patients
// Subjects=8
-44	24	24
-38	8	34
40	16	32
-50	-80	2
-32	-54	62
34	-54	48
-54	-40	34
20	-24	0
-36	-54	-24
40	-64	-28
4	6	64
34	58	-8
-42	42	2
4	-18	68
54	-72	0
-28	-28	64
-50	-80	8
-2	-18	10
2	-24	4
12	-4	68
-42	2	50
30	30	-18
28	-24	72
6	-36	28
-26	-22	-20
60	-16	36
-58	-12	-20
4	-16	70
-28	-14	68
2	-34	76
42	32	0
-42	40	0
14	-20	8

// Jogia J, 2008: Normals
// Subjects=12
48	40	14
6	16	44
68	-44	16
-48	44	6
66	-34	-14
-42	-50	-28
12	-4	68
-42	2	50
30	30	-18
28	-24	72
6	-36	28
-26	-22	-20

// Lowell S Y, 2008: Overt Swallowing vs. Rest
// Lowell S Y, 2008: Oral Sensory Stimulation vs. Rest
// Lowell S Y, 2008: Covert Swallowing vs. Rest
// Lowell S Y, 2008: Breath Holding vs. Rest
// Subjects=14
62.2	-3.98	20.09
62.2	4.82	23.81
47.07	5.13	1.65
59.94	5.72	8.15
62.25	-16.67	21.15
15	-19.35	-9.31
15.08	-16.3	2.7
16.09	-.43	1.36
32.08	-9.48	-6.99
-10.59	-17.76	-.23
-20.27	-5.3	-3.39
-23.52	-.29	-7.12
-57.35	-5.45	39.43
-53.11	-8.05	32.9
-53.29	-5.53	10.39
10.64	-53.16	-33.19
8.54	-55.03	-29.66
-13.83	-57.73	-21.37
2.58	0.17	51.65
-4.93	0.93	48.33
-1.83	11.89	38.45
6.76	9.11	43.04
-23.47	-48.1	-19.84
15.03	-1.41	2.57
25.94	-84.68	-1.73
40.72	-49.15	-11.57
-31.98	11.51	8.72
-25.29	-95.39	1.99
10.62	-66.53	-40.99
2.41	-65.27	3.61
55.86	-36.26	16.17
15.51	-.84	64.97
44.92	-56.5	-24.38
-3.09	-34.01	-4.53
-36.31	-2.23	-3.46
-59.66	-13.86	13.39
-46.84	-16.07	11.2
-57.38	-27.79	25.69
-50.88	-7.01	46.17
-50.97	0.77	36.6
-42.52	-15.53	17.8
62.28	-27.25	22.04
64.3	-13.12	11.91
42.9	-6.9	11.63
64.39	-18.77	21.3
61.22	-12.91	28.65
25.75	-64.73	-19.01
42.76	-8.44	-8.31
-21.29	-63.07	-20.84
-31.98	-49.93	-15.13
-42.47	-32.62	17
47.11	-53.68	-15.72
-57.34	-38.37	26.57
-31.65	-92.63	10.75
40.63	-47.89	-22.82
21.51	-29.2	0.36
34.55	-81.83	6.86
-19.17	-19.22	-4.47
-10.27	-19.97	40.1
42.85	-66.74	-19.04
57.99	1.08	30.86
30.03	-16.29	1.41
-31.53	-45.3	44.7
-44.8	-45.6	-13.11
43	-82.8	-6.54
-10.58	-25.34	-1.82
-55.26	-60.87	10.59
51.54	-71.83	-3.1
38.77	-80.2	-0.02
32.19	-62.23	-14.83
36.44	-71.18	-20.82
36.69	-81.81	6.83
-27.74	-45.84	-17.75
-38.37	-69.51	-20.1
-44.66	-68.35	-4.51
0.56	-3.04	65.32
5.9	-5.21	64.33
8.86	12.04	39.43
29.99	3.08	4.25
42.78	9.33	1.35
57.75	16.11	5.07
58.79	2.66	-3.85
-34.08	0.93	9.63
-51.24	11.23	6.73
-29.53	-88.38	10.37
62.27	-38.34	16.28
-6.08	12.12	41.82
-23.34	-84.06	-16.82
26.25	-79.31	40.2
6.86	-15.12	46.19
-53.08	-36.23	26.34
45.31	-10.66	45.37
28.39	-30.88	60.65
-27.45	-89.06	1.49
-27.49	-87.2	-2.02
64.44	-31.46	22.37
4.75	4.93	57.92
-3.77	-3.67	57.62
47.03	4.79	-2.78
60.97	10.84	5.47
54.57	6.49	4.8
28.08	-84.66	-1.75
36.61	-80.47	-3.32
-36.18	-68.99	-13.48
58.19	-34.19	42.74
40.64	-45.61	-20.78
36.34	-45.89	-24.06
49.49	-2.86	35.75

// Redcay E, 2008: Toddlers
// Subjects=10
3.46	8.15	30.9
-47.53	-61.6	41.79
-9.34	-51.08	9.25
12.06	-49.55	13.33
-.52	-69.06	37.42
43.2	-84	19.21
2.32	-46.41	-.2
-40.71	-5.74	-20.96
7.4	34.33	-2.57
3.47	7.09	30.98
-56.5	14.17	17.7
-48.05	13.19	4.3
41.87	11.04	23.52
61.03	22.44	17.88
-14.05	55.35	-4.09
20.15	64.36	-.77
3.3	40.5	22.61
6.15	54.44	-17.63
-31.03	52.04	9.77
28.64	50.69	-13.11
-22.6	28.89	-15.15
41.65	48.25	9.25
16.08	53.35	22.5
16.35	-44.95	17.36
-9.04	-68.77	41.95
-9.08	-102.21	22.45
-17.9	-94.08	-9.35
33.34	-81.09	-11.03
9.55	21.31	-5.96
-27.75	-61.33	-25.37
16.2	-68.5	-11.89
25.6	-.34	-12.14
-30.66	25.18	47.7
29.41	-11.67	61.26
-18.02	36.57	28.76
12.13	3.94	44.53
-35.26	-24.4	-15
-39.67	-6.08	-25.41
-52.09	-59.08	5.95
67.46	-33.33	-2.05
-22.22	-55.02	0.8
24.78	-50.5	-.12
-56.61	-4.46	-3.04
-43.64	-33.65	3.72
67.46	-15.73	5.4
-56.58	-21.73	-6.06
63.06	-8.32	-8.56
-43.77	-8.62	-2.84
54.69	-19.69	10.34
-17.79	-22.64	33.72
-69.19	-32.78	17.32
-9	-33.22	61.27
12.28	-25.32	51.44
42.23	-16	59.24
-21.81	-37.53	61.78
-43.51	-76.29	2.83
-39.27	-32.6	16.96
45.94	-3.14	-8.79
29.07	-72.31	-7.26
-16.92	-77.42	-14.11
-22.09	-89.91	3.73
-16.92	-77.42	-14.11
16.38	-88.62	3.18
-27.76	-57.1	-25.72
12.1	3.6	40.1
-9.12	-18.05	51.08
-9.08	-38.48	48.33
-7.56	48.5	3.1
-39.6	46.28	4.77
50.22	35.36	6.89
-32.08	25.89	1.94
40.77	11.75	19.01
58.81	18.23	4.88
44.8	31.3	-3.86
-26.87	50.96	-4.69
-53.44	-35.59	-20.54
-50.19	-1.08	-1.17
62.04	-16.61	-5.62
50.3	14.21	8.66
-52.24	-12.3	5.37
-34.74	-59.58	39.24
55.02	-64.59	35.29
-45.34	-59.93	49.43
-13.6	-45.48	13.28
-10.27	-92.41	11.61
20.72	-92.23	11.24
-17.86	-89.25	-1.95
19.47	-82.06	-8.56
11.81	12.66	5.89
-32.03	-61.44	-26.43
20.42	-59.13	-14.96
-32.04	4.4	-.72
-18.08	-6.89	3.41
-17.54	-38.65	60.71
-35.77	-29.58	55.7
62.16	6.59	19.2
53.59	5.22	16.07
-40.63	43.44	9.48
41.74	36.08	16.96
41.02	13.26	52.34
-22.51	55.18	8.29
33.31	-67.17	-9.97
-56.68	-21.7	-19.44
62.18	-45.88	1.3
-53.32	-12.39	4.28
50.19	-3.37	-12.17
54.46	-0.08	-11.38
-52.24	-12.3	5.37
60.47	-45.92	55.96
-22.1	-93.34	0.67
-27.52	-85.34	-5.52
36.67	-87.44	2.84
-31.59	-51.45	34.07
38.6	1.53	10.97
14.24	0.36	39.23
-9.03	-19.22	63.44
-9.19	-12.13	45.01
3.8	-29	59.66
-25.11	-19.92	55.88
-4.73	-40.94	57.41
-5.23	-47.22	-10.08
-14.83	-16.3	5.28
20.45	-20.32	5.21

// Redcay E, 2008: 3 Year Olds
// Subjects=10
-17.93	-68.02	-2.62
-26.54	-51.15	-3.93
-48.01	-8.3	1.64
-48.03	-12.87	-2.44
62.12	-15.76	5.46
50.4	-16.54	10.12
-38.19	-34.71	17.12
-20.81	-64.61	41.74
20.72	-51.65	26.79
21.73	-82.96	7.1
-17.79	-69.82	15.37
-27.62	-49.05	-4.1
-21.02	-90.96	3.8
-26.77	46.44	5.73
33.03	56.23	3.1
7.4	34.33	-2.57
3.47	7.09	30.98
-56.5	14.17	17.7
-48.05	13.19	4.3
41.87	11.04	23.52
61.03	22.44	17.88
-14.05	55.35	-4.09
20.15	64.36	-.77
3.3	40.5	22.61
6.15	54.44	-17.63
-31.03	52.04	9.77
28.64	50.69	-13.11
-22.6	28.89	-15.15
41.65	48.25	9.25
16.08	53.35	22.5
16.35	-44.95	17.36
-9.04	-68.77	41.95
-9.08	-102.21	22.45
-17.9	-94.08	-9.35
33.34	-81.09	-11.03
9.55	21.31	-5.96
-27.75	-61.33	-25.37
16.2	-68.5	-11.89
25.6	-.34	-12.14
-30.66	25.18	47.7
29.41	-11.67	61.26
-18.02	36.57	28.76
12.13	3.94	44.53
-35.26	-24.4	-15
-39.67	-6.08	-25.41
-52.09	-59.08	5.95
67.46	-33.33	-2.05
-22.22	-55.02	0.8
24.78	-50.5	-.12
-56.61	-4.46	-3.04
-43.64	-33.65	3.72
67.46	-15.73	5.4
-56.58	-21.73	-6.06
63.06	-8.32	-8.56
-43.77	-8.62	-2.84
54.69	-19.69	10.34
-17.79	-22.64	33.72
-69.19	-32.78	17.32
-9	-33.22	61.27
12.28	-25.32	51.44
42.23	-16	59.24
-21.81	-37.53	61.78
-43.51	-76.29	2.83
-39.27	-32.6	16.96
45.94	-3.14	-8.79
29.07	-72.31	-7.26
-16.92	-77.42	-14.11
-22.09	-89.91	3.73
-16.92	-77.42	-14.11
16.38	-88.62	3.18
-27.76	-57.1	-25.72
12.1	3.6	40.1
-9.12	-18.05	51.08
-9.08	-38.48	48.33
-28.53	24.05	46.66
33.15	-40.28	-20.03
-39.67	-7.13	-25.32
-47.84	-54.91	4.43
66.21	-8.9	-16.35
-23.39	-51.65	-10.62
33.08	-22.3	-21.54
-57.67	-8.79	-3.78
-42.45	-41.16	16.6
63.17	-13.72	4.16
-53.2	-41.91	7.86
53.39	-8.89	-15.09
-43.65	-22.82	6.15
50.41	-19.8	9.28
-17.79	-23.7	33.81
23.8	-56.17	9.29
-25.07	-71.16	40.1
-14.48	-53.37	35.15
-23.29	-67.08	-3.75
16.2	-55.3	-6.31
-40.32	-22.57	22.82
49.43	-6.8	26.05
27.65	61.4	1.62
-9.5	-17.59	1.98
16.19	-20.26	6.37
3.21	29.7	6.79
-15.01	38.94	3.99
-26.93	49.21	-13.46
48.45	10.59	44.67
48.2	35.49	22.51
20.57	41.26	44.65
55.86	-54.92	8.82
29.92	-35.01	-20.43
-59.81	-9.94	-4.78
-59.65	-29.18	7.99
-46.82	-25.76	9.78
-44.35	-65.1	37.59
-25.71	31.04	-.8
-27.54	-81.2	-6.98
-27.42	-84.31	7.78
-13.72	-20.27	8.94
16.25	-20.72	14.21

// Sachdev P, 2008: Anorexia Nervosa Patients
// Subjects=10
8	-68	48
10	-94	-14
-8	-94	-14
-50	14	46
-46	6	30
-42	4	22
54	30	12
-30	-64	48
42	-62	-8
-36	-86	-4
-20	-28	14
18	-80	26
14	-76	0
46	20	20
-36	10	20

// Sachdev P, 2008: Normals
// Subjects=10
56	10	8
62	-20	36
26	-2	48
-32	-54	54
36	-96	-2
-42	-90	-4
12	-22	8
-34	6	20
46	10	24
48	38	16
38	-70	44
-22	-68	56
52	-34	50
-40	-90	-4
44	-64	-16
8	-18	6
-10	50	-4
-22	28	40
18	-80	26
14	-76	0
46	20	20
-36	10	20

// Wong P C M, 2008: Speech in Moderately Loud Noise vs. Quiet
// Wong P C M, 2008: Speech in Loud Noise vs. Quiet
// Wong P C M, 2008: Speech in Loud Noise> Speech in Moderately Loud Noise
// Wong P C M, 2008: Speech in Moderately Loud Noise > Speech in Loud Noise
// Subjects=11
-59.71	-15.52	5.73
-46.74	-40.3	14.35
-46.65	-45.88	24.85
-30.58	0.69	47.53
-34.11	-45.45	-12.13
-21.04	-89.02	1.41
-18.14	39.69	14
-11.38	-65.47	16.05
-5.01	-88.92	1.22
-2.01	21.01	18.73
-18.1	-12.61	-1.69
55.69	-18.25	1.28
65.44	-39.89	9.68
10.95	-43.39	10.6
13.98	-18.76	-1.54
20.36	-2.6	0.38
17.43	-6.4	34.19
23.75	-79.75	-6.57
26.96	9.26	29.42
49.06	-23.78	-28.29
-69.34	-19	2.78
-33.65	-50.6	45.17
-50.01	10.66	26.84
-1.75	20.41	52.23
-46.94	33.43	18.2
-34.17	19.79	5.82
-30.67	-3.51	34.5
-40.58	-42.83	-18.97
-27.28	-60.85	35.92
-11.66	-12.31	1.56
55.69	-18.25	1.28
42.97	-46.88	3.83
39.57	33.43	10.52
49.28	14.72	15.32
46.28	0.38	36.63
30.29	3.97	43.21
11.13	4.62	53.41
20.8	-63.99	32.29
17.25	-14.8	8.13
26.96	-86.33	-9.4
-56.43	-34.53	7.28
-30.95	23.24	8.84
-49.73	-71.02	30.34
-21.49	-4.65	-22.39
-56.78	-11.72	-28.08
-66.36	-8.09	-21.59
-8.23	-52.76	14.95

// Yassa M A, 2008: At-risk Alzheimer's
// Subjects=18
33.58	13.45	6.96
51.53	-55.9	44.89
56.61	-42.96	22.23
62.85	-43.64	3.14
41.87	54.68	-11.83
24.75	-16.41	-13.47
-41.86	-83.88	3.31
23.58	11.79	70.05
-21.7	-10.6	74.15
54.89	25.59	-13.66
46.34	-31.74	-17.92
25.78	-32.75	64.33
-31.1	15.43	20.19
41.97	-8.05	-16.83
31.2	-74.63	-27.99
-24.56	-35.57	13.92
60.68	-8.68	9.81

// Yassa M A, 2008: Healthy Controls
// Subjects=15
35.61	-2.78	-6.04
-6.66	8.49	70.89
-35.16	0.92	37.38
53.16	11.27	16.93
-21.96	-24.59	50.89
58.17	30.27	-9.69
33.59	17.92	8.76
41.89	57.01	-9.82
48.45	52.13	-4.97
32.26	-54.62	59.66
25.87	-63.8	65.16
28.02	-59.54	64.7

// Altshuler L, 2008: Healthy Controls
// Subjects=17
-26.79	0.15	-14.92
24.5	-1.83	-17.58
-52.46	19.54	-9.56
50.13	20.15	-10.79
52.52	20.62	22.59
-26.56	-65.59	-11.64
39.68	-60.96	-12.79
-50.25	13.72	-2.41
48.01	24.71	-6.69
52.55	18.68	24.99
-37.43	44.43	8.25

// Altshuler L, 2008: Bipolar I Depressed
// Subjects=11
-43.94	52.17	-1.25
46.12	27.27	26.57
-39.41	-61.6	-14.06
37.54	-60.97	-12.77
-50.25	13.72	-2.41
48.01	24.71	-6.69
52.55	18.68	24.99
-37.43	44.43	8.25

// Forstmann B U, 2008: Incongruent vs. Neutral
// Forstmann B U, 2008: Congruent vs. Neutral
// Subjects=24
-30	-82	18
-38	-66	46
22	-78	56
54	12	32
66	-56	16
10	-80	4
-30	-84	18
32	-86	18

// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Overall Interference
// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Highest 20% Interference
// Lee T W, 2008: Activation Associated with Interference Effect of Emotion 
// Expression, Lowest 20% Interference
// Lee T W, 2008: Discordant > Concordant
// Lee T W, 2008: Activation Associated with Interference Effect of the Simon 
// Task
// Subjects=14
45	-24	48
50	17	-11
-3	9	55
-53	-29	10
65	-40	8
50	-24	-9
-21	-76	-11
-9	-71	31
36	12	-1
6	-32	4
24	-75	-37
39	-29	51
50	26	4
-3	17	52
-65	-43	15
62	-46	8
62	-35	-1
-24	-79	-14
6	-68	42
36	29	-4
12	-29	1
27	-75	-34
53	-12	48
50	20	-11
53	-60	22
56	-43	2
-30	-88	-5
6	-68	31
50	9	-3
8	-20	4
28	-60	-27
-53	13	24
-42	26	-4
48	23	-11
-30	25	37
45	25	26
42	14	55
9	-23	56
27	43	-15
-53	-38	7
-48	-44	-3
39	17	-11
-33	-83	-29
-3	-65	-27
-12	48	22
42	16	38
50	-6	-2
30	-35	-8
45	-53	-20
-9	-71	42
-45	0	-3
-15	17	-6
27	17	-6
-33	-72	-39

// Lissek S, 2008: Deception > Cooperation
// Lissek S, 2008: Deception > Cooperation/Deception
// Lissek S, 2008: Cooperation/Deception > Deception
// Lissek S, 2008: Cooperation/Deception > Cooperation
// Lissek S, 2008: Cooperation > Deception
// Lissek S, 2008: Cooperation > Cooperation/Deception
// Subjects=13
-38.29	26.48	-33.45
-40.24	30.26	-15.86
-44.69	27.08	-26.67
-18.27	54.93	17.18
-20.57	53.89	6.12
-1.11	65.01	9.17
-7.33	18.81	20.57
12.1	23.13	19.81
3.54	8.42	23.66
-4.72	-45.67	42.59
10.34	-57.08	34.5
-41.63	-44.92	29.7
-37.37	-56.37	21.8
42.54	-56.3	18.19
51.13	-63.27	12.01
-41.91	-44.87	7.29
57.07	-3.84	-18.62
61.44	-16.59	-17.44
-15.44	-60.39	46.48
-20.24	65.1	34.14
-13.9	57.49	21.34
-7.45	50.72	17.42
12.05	22.72	15.37
-6.97	-44.17	35.76
-9.43	17.09	25.26
7.85	19.28	24.75
-33.14	-35.08	19.62
-59.35	-43.84	-3.72
-39.68	-42.11	13.7
-50.58	-31.93	8.4
50.44	10.4	-26.64
-11.2	-67.59	38.15
-48.92	32.15	-18.14
-36	20.94	-23.97
-9.16	23.42	47.04
12.58	-41.15	44.09
-48.24	-48.11	18.92
-52.67	-48.95	10.12
51.1	-54.76	11.17
61.72	-51.71	-2.76
61.94	-58.77	13.62
-41.56	-77.24	28.42
-41.89	-57.84	6.33
57.77	-75.18	22.04
52.43	17.88	-38.62
59.16	-8.71	-24.9
-.31	-53.75	47.8
6.2	-46.93	51.5
-40.22	32.6	-13.85
-44.77	30.92	-31.54
-11.28	19.37	49.72
-2.51	-43.12	46.79
-50.42	-43.86	18.54
-57.02	-42.59	9.56
-43.69	-61.74	33.64
46.65	-60.07	0.56
-48.2	-71.92	16.8
51.15	-76.24	11.05
59.89	-57.95	22.54
65.69	-12.74	-22.37
57.18	-18.32	-12.71
-.19	-63.76	55.51
8.42	-61.81	52.93
-16.2	71.75	13.24
12.63	-47.32	46.95
-56.82	-41.13	25.1
-50.61	-38.73	4.59
-50.36	-58.75	20.01
-67.92	-54.3	-.3
59.55	-49.6	-2.93
-48.28	-59.37	13.32
57.77	-75.18	22.04
-61.08	-51.58	28.45
-54.79	-31.11	17.35
1.89	-42.48	53.37
-5.31	63.7	18.34
-32.04	-73.24	13.29
-46.19	-27.04	14.56
-52.34	-59.64	33.58
-39.77	-31.89	8.21
-11.81	67.93	18.03
-61.21	-30.72	21.91
-67.56	-29.7	33.12

// McKay L C, 2008: Breath Holding vs. Rest
// Subjects=8
-42	2	2
-22	8	-4
-32	-18	-2
-8	-20	-16
-4	10	42
-8	20	28
-58	14	16
-48	42	6
-30	50	20
-40	46	24
-4	10	42
-56	-2	40
-64	-40	36
-16	-16	6
-22	-8	-22
-62	2	-8
-66	-24	4
-2	-30	-24
-2	-28	-40
44	20	8
44	4	0
40	-10	-8
26	6	4
32	-14	2
10	-20	-14
8	26	30
2	8	28
58	14	16
46	48	8
44	42	20
4	8	48
58	-2	42
56	-46	54
14	-16	6
22	-8	-20
62	-2	4
62	-22	6
4	-24	-24
2	-22	-42

// Sommer M, 2008: Incompatible > Compatible
// Sommer M, 2008: Cognition Emotion Integration, Emotion x Compatibility
// Subjects=12
-33.63	-10.82	64.14
33.32	37.31	33.68
-7.07	7.43	50.04
50.47	-60.92	0.46
-36.15	-65.39	-8.21
38.53	11.77	5.66
7.49	24.27	4.96
-14.76	-15.62	14.14
50.66	-32.55	37.11
-33.68	-54.2	39.9
18.78	-67.12	47.07
39.76	11.28	26.87
-20.2	45.99	26.88
35.25	46.18	10.61
1.46	7.31	47.72

// Tourville J A, 2008: No Formant Shift vs. Passive Viewing
// Tourville J A, 2008: Formant Shift vs. Passive Viewing
// Tourville J A, 2008: Formant Shift vs. No Formant Shift
// Subjects=11
-48	-8	60
-48	0	30
-56	-10	42
-62	-6	12
48	8	4
54	-8	30
-48	10	-2
-2	8	62
4	20	36
-44	-34	24
46	-26	18
-58	-10	10
-64	-30	14
-52	-34	16
72	-24	6
58	-28	12
-44	6	2
-16	-62	-20
-30	-86	-24
26	-58	-24
-26	-4	4
-24	-6	-4
-8	-14	6
30	8	4
26	-2	-4
14	-12	10
6	-18	8
-44	-8	64
-60	4	8
-52	-14	38
-60	-8	12
44	-18	70
56	-10	30
-60	8	2
-48	10	-2
0	72	72
48	12	2
-40	-30	18
44	-24	18
72	-24	32
-62	-30	14
-62	-22	4
68	-16	8
58	-28	6
64	-10	10
-34	-4	10
-34	-20	8
-18	-62	-20
-2	-78	-14
8	-64	-10
24	-56	-22
28	-58	-54
-30	-6	4
-22	-2	-2
-10	2	10
-8	-14	6
22	2	-2
14	4	10
4	-22	6
-2	-70	16
-22	-42	70
48	-10	44
60	14	34
70	-2	20
58	14	28
56	32	24
-54	-24	14
-66	-38	22
-60	-30	10
-62	-24	10
-60	-62	10
68	-36	18
72	-40	12
68	-16	8
48	-8	-8
56	-10	-4
26	-62	-54
12	-84	40

// Vanderwal T, 2008: (Self-Concept vs. Letter) > (Mother-Concept vs. Letter)
// Vanderwal T, 2008: Self-Concept > Mother-Concept
// Vanderwal T, 2008: Mother-Concept > Self-Concept
// Vanderwal T, 2008: Friends vs. Bumper Cars
// Subjects=17
-8.36	51.32	39.68
-5.28	56.66	25.81
-53.37	23.36	12.43
-47.12	25.03	-7.86
-47.29	23.23	-31.12
-4.92	-51.71	28.21
-50.06	-38.18	0.82
17.41	32.95	47.61
45.71	14.27	-31.44
-14.7	-56.74	5.32
14.24	-72.17	9.63
-18.11	33.35	14.53
13.87	39.37	6.97
7.58	40.61	23.66
-37.29	-45.22	-8.77
27.52	13.9	-34.55
-31.16	4.64	-25.29
-2.3	27.96	-15.31
49.42	-43.16	10.14
61.93	-6.81	-16.48
-49.88	-52.75	18.77
58.68	-3.91	-20.03
55.71	-31.2	-.98
-40.25	-69.07	13.34
-53.16	-53.54	8.84
36.36	-39.12	-19.05
49.13	26.38	0.96
12.85	59.68	22.01
-47.15	34.55	-8.65
-34.11	-38.85	-9.34
7.98	-57.47	35.23
26.59	-1.19	-23.23
-11.6	47.61	33.33

// Wittfoth M, 2008: Incompatible > Compatible
// Wittfoth M, 2008: Error, Compatible > Compatible
// Wittfoth M, 2008: Error, Incompatible > Incompatible
// Wittfoth M, 2008: (Error, Compatible > Compatible) > (Error, Incompatible > 
// Incompatible)
// Wittfoth M, 2008: (Error, Incompatible > Incompatible) > (Error, Compatible 
// > Compatible)
// Wittfoth M, 2008: (Error, Compatible > Compatible) + (Error, Incompatible > 
// Incompatible)
// Wittfoth M, 2008: (Error, Compatible > Compatible) + (Incompatible > 
// Compatible)
// Wittfoth M, 2008: (Error, Incompatible > Incompatible) + (Incompatible > 
// Compatible)
// Subjects=15
55.36	15.94	20.91
58.46	31.29	12.61
56.33	40.31	17.36
64.62	16.91	-15.2
71.2	14.36	-8.34
50.7	-47.89	-18.64
52.95	-58.1	-13.19
-15.17	-55.12	68.36
-41.25	-39.88	60.57
-50.94	-39.71	62.96
-61.9	-26.65	54.01
49.43	-35.72	54.14
-37.66	-78.21	-5.17
-44.09	-82.18	-1.31
60.82	16.38	25.25
35.47	27.86	-11.31
46.35	21.93	-6.42
8.05	31.68	42.57
-.68	32.09	35.95
7.86	24.8	26.44
17.05	15.81	67.52
71.87	-34.22	34.55
-1.1	43.22	5.72
-.86	30.74	21.52
3.43	38.2	20.71
1.53	-14.57	30.45
35.35	18.21	-22.68
-42.3	10.25	-11.6
-9.01	-65.14	41.23
12.6	-65.06	40.86
6.38	-59.82	62.86
0.92	-14.78	-17.71
3.08	-14.77	-17.74
-7.49	-5.39	2.8
-3.12	-22.5	3.3
7.68	-22.46	3.11
60.78	18.3	22.82
62.81	22.79	13.38
58.99	-22.69	43.72
65.43	-22.98	40.28
53.63	-35.58	43.96
51.69	-28.4	63.46
-61.91	-34.41	51.42
-53.34	-29.47	46.3
-66.66	-15.75	21.64
-60.15	-22.1	22.16
-60.42	-64.57	-7.25
-41.94	-82.28	-2.45
58.55	-64.28	0.78
-48.67	-43.67	-14
-42.33	-52.34	-26.7
1.01	-76.44	-22.81
-13.77	48.65	30.06
-14.19	43.3	-4.15
-5.43	38.74	4
-35.14	12.07	41.88
14.34	55.44	32.27
25.05	42.74	22.13
-5.72	35.49	-19.21
5.05	36.39	-21.72
-69.34	-13.11	-18.92
66.62	2.6	-30.63
66.62	2.6	-30.63
-25.05	-15.19	-20.59
14.66	-49.41	35.91
-11.34	-50.03	30.81
-2.68	-43.3	33.36
-41.41	-63.02	42.7
3.8	32.18	48.19
35.41	23.08	-16.44
-46.62	10.24	-11.53
6.04	17.51	51.85
61.91	15.42	26.45
-60.73	-38.03	58.48
64.41	-34.58	42.56
6.04	17.51	51.85
61.43	22.73	-10.12
-46.65	17.68	-12.26

// Cao Q, 2008: Intrinsic Alerting vs. Fixation, Normals > ADHD Children
// Cao Q, 2008: Phasic Alerting vs. Fixation, Normals > ADHD Children
// Cao Q, 2008: Alerting Effect, Normals > ADHD Children
// Subjects=12
11.67	-49.68	56.16
27.35	31.77	31.02
-58.73	-35.98	45.92
27.57	8.25	43.43
26.65	46.24	-20.82
-34.37	27.22	20.2
-18.13	37.37	24.52
21.4	-23.4	61.24
14.78	13.91	58.78
-21.62	4.88	-1.34

// Capek C M, 2008: SR > BP
// Capek C M, 2008: Man > BP
// Capek C M, 2008: DM > BP
// Capek C M, 2008: EP > BP
// Capek C M, 2008: (SR + Man + DM + EP) > BP
// Capek C M, 2008: (Man + DM + EP) > SR
// Capek C M, 2008: SR > (Man + DM + EP)
// Capek C M, 2008: (DM + EP) > Man
// Capek C M, 2008: Man > (DM + EP)
// Capek C M, 2008: DM > EP
// Capek C M, 2008: EP > DM
// Subjects=13
55.58	-6.16	-7.53
-56.46	-21.58	9.54
51.65	0.67	39.89
-2.9	20.69	42.18
47.26	-60.94	0.5
-48.95	-66.35	-5.75
55.91	4.92	39.49
-44.72	18.98	23.85
47.26	-60.94	0.5
-48.95	-66.35	-5.75
-44.48	0.6	47.69
47.19	-58.37	-7.52
-56.45	-38.04	3.12
51.64	9.38	42.51
-41.52	14.51	20.84
1.57	6.22	61.19
47.15	-30.28	-2.07
-56.45	-38.04	3.12
51.66	5.15	42.86
-44.74	26.38	23.23
47.28	-65.17	0.85
-48.95	-66.35	-5.75
-56.51	-14.44	5.6
58.78	-14.95	-11.3
-56.46	-21.58	9.54
-41.52	14.51	20.84
47.15	-54.4	-11.2
-56.58	-10.81	-2.51
51.51	-37.06	6.25
-49	-62.38	-9.43

// Capek C M, 2008: Normals
// Subjects=13
47.15	-30.28	-2.07
-44.62	-65.72	1.96
-33.62	-50.34	48.49
40.07	-45.93	43.93
-48.76	-2.85	44.69
43.99	15.28	23.14
5.75	9.71	50.81
36.41	-46.26	-15.1
13.1	-85.01	-4.9
1.4	-31.76	24.23
-2.9	-7.92	30.09
55.88	-11.8	29.74

// Capek C M, 2008: Deaf Patients
// Subjects=13
55.58	-6.16	-7.53
-56.46	-21.58	9.54
51.65	0.67	39.89
-2.9	20.69	42.18
-10.75	-48	-33.37
51.38	-26.28	-5.8
39.55	17.86	1.79
51.48	-17.51	11.31
-56.42	-25.56	13.22
51.43	26.96	22.08
1.29	19.86	31.05
32.51	-1.76	51.47
-29.46	1.29	55.27
36.78	5.92	54.12

// Falconer E, 2008: PTSD Patients
// Subjects=23
-42	56	4
64	-52	-10
62	-60	18

// Falconer E, 2008: Trauma-Exposed Patients
// Subjects=17
42	14	36
32	-60	46
10	-72	42
42	-60	54
36	4	-20
-36	4	-24
62	-50	-10

// Falconer E, 2008: Normals
// Subjects=23
30	56	-14
44	16	34
-38	58	2
6	32	26
32	-60	46
-32	0	-24

// Gundersen H, 2008: 3-Back, Control Group > 0.08% BAC Group
// Gundersen H, 2008: 2-Back, 0.08% BAC Group > Control Group
// Gundersen H, 2008: 3-Back, 0.02% BAC Group > Control Group
// Gundersen H, 2008: 2-Back, 0.02% BAC Group > Control Group
// Subjects=12
1.37	34.56	27.83
11.24	26.92	37.38
-17.77	-33.26	38.23
7.6	-55.93	-10.39
50.02	-85.38	5.25
46.9	-86.68	14.4
14.61	-97.87	22.78
-1.48	-97.1	31.94
-5.53	19.41	-7.53
7.45	17.33	-7.55
-27.39	-77.32	38.27
-24.02	-69.78	49.79

// Herpertz S C, 2008: Adolescents with Conduct Disorder
// Subjects=22
48	-78	0
-30	-96	3
-30	0	-18
-39	27	-6
30	3	-21
33	27	0
-45	24	-21
45	24	-21
57	33	0
39	33	-6
-42	-18	-21
-30	15	-18
6	54	18
-12	66	21
39	6	30
0	42	-18
-3	51	-9
-3	33	-6
63	-24	33
27	-60	57
-48	24	18
-60	-30	33
-51	-33	42
39	-84	6
-45	-72	-3
24	0	-9
33	-12	-12
33	-18	0
0	57	30

// Herpertz S C, 2008: Healthy Controls
// Subjects=22
-18	-99	-12
39	-72	-12
-21	-3	-15
18	-3	-12
27	0	-27
42	6	33
48	21	21
51	33	-6
3	54	27
-39	36	12
-24	36	-12
-30	33	-6
-54	9	33
-39	6	24
-3	48	-12
-9	57	0
27	-54	54
24	-72	54
-60	-33	30
63	-30	36
-27	24	-9
48	-75	-9
-48	-81	3
45	-3	48
-36	30	-3
-39	27	0
54	30	12
-21	3	-24
-21	-3	-15

// Olsson C J, 2008: Active High Jumpers
// Subjects=12
2	14	66
-2	-6	68
-2	0	60
-30	0	70
-34	-64	-30
-50	-2	54
-40	-2	60
-16	-10	78
52	10	52

// Olsson C J, 2008: Novice High Jumpers
// Subjects=12
-38	-44	50
-8	-90	-6
-6	-90	8
4	-86	18
-12	-100	16
14	-70	-4
14	-80	-6
-64	-28	24
-52	8	16

// Suskauer S J, 2008: Go - Fixation, Between Group Differences in Correlation 
// Between Activation and CV
// Suskauer S J, 2008: No Go - Fixation, Between Group Differences in 
// Correlation Between Activation and CV
// Subjects=25
-61.98	-20.68	48.94
-61.98	-20.68	48.94
55.92	-24.75	56.3
69.57	3	30.91
-11.03	13.58	68.22
16.37	8.49	12.22
65.34	-22.54	33.51
21	33.85	42.13

// Suskauer S J, 2008: Normals (Typically Developing Children)
// Subjects=25
-37.64	-75.88	-3.16
3.72	25.08	41.05
51.07	-81.22	3.7
42.25	50.89	16.55
53.26	-37.22	15
7.63	-64.44	-9.55
26.9	11.98	-8.47
65.14	-35.05	14.58
-9.97	-61.36	-33.08
-26.87	-62.97	-3.5
-24.03	-14.09	59.97
33.63	-64.89	-4.34
1.69	21.64	50.39
-22.9	-39.3	-26.08
12.32	24.79	37.57
56.54	-36.89	18.27
-2.85	-37.96	21.63
-32.75	-13.58	54.46
-24.65	2.07	14.68
-15.75	-48.54	24.02
8.6	-25.49	73.99

// Suskauer S J, 2008: ADHD Patients
// Subjects=25
8.1	18.92	43.83
65.14	-35.05	14.58
-9.97	-61.36	-33.08
-26.87	-62.97	-3.5
-24.03	-14.09	59.97
33.63	-64.89	-4.34
1.69	21.64	50.39
-22.9	-39.3	-26.08
12.32	24.79	37.57
56.54	-36.89	18.27
-2.85	-37.96	21.63
-32.75	-13.58	54.46
-24.65	2.07	14.68
-15.75	-48.54	24.02
8.6	-25.49	73.99

// Morey R A, 2008: Executive Shapes, Activations
// Morey R A, 2008: Emotional > Neutral Pictures, Activations
// Morey R A, 2008: Executive Shapes, Deactivations
// Morey R A, 2008: Emotional > Neutral Pictures, Deactivations
// Morey R A, 2008: Emotional > Neutral Pictures Positively Correlated with 
// Symptom Severity (DTS)
// Morey R A, 2008: Emotional > Neutral Pictures Negatively Correlated with 
// Symptom Severity (DTS)
// Subjects=39
-6	8	40
-50	6	26
48	-32	54
30	-54	54
34	-10	64
-40	-40	58
6	8	48
-40	40	22
-34	20	0
-20	-52	-18
-18	0	8
-16	-8	12
4	58	6
-46	-60	26
-2	-54	42
34	-46	50
-10	2	12
54	20	20
-42	-4	34
2	-44	24
30	-12	-20
4	40	-22
4	62	4
26	26	40
4	8	-12
54	28	2
2	-48	32
54	-50	30
-40	-18	16
58	-18	-12
28	-30	-12
4	8	0
58	2	-6
38	-18	18
4	-16	58
4	2	40
64	-10	28
-58	-8	20
-10	50	0
-4	50	12
-2	36	-2
-50	36	2
10	2	12
-60	-36	42
-36	8	2
-50	-60	26
36	40	22
26	46	-6
-2	36	30
2	30	20
-2	34	16
-24	50	0
-54	12	12
20	-18	6
30	-86	-4
30	-52	60
46	-46	40
6	-66	-28
38	16	2

// Paine P A, 2008: Saline Infusion - Rest
// Paine P A, 2008: Hydrochloric Acid Infusion - Rest
// Paine P A, 2008: Saline Infusion - Hydrochloric Acid
// Subjects=7
-56.45	-9.44	15.22
63.13	-2.09	3.19
63.17	-5.01	6.78
63.22	3.25	17.24
51.65	-15.79	33.47
-53.24	-18.14	12.56
47.37	-7.1	36.13
47	8.85	-5.35
-48.9	3.44	29.66
59.07	-16.35	25.62
-29.89	1.24	-.48
47.38	5.13	42.91
58.95	-13.23	10.86
51.77	-17.85	48.13
59	-3.92	21.23
-53.18	-4.33	25.9
-33.03	-5.84	4.61
39.74	-13.09	14.42
55.85	-3.34	29.03
55.8	-20.4	14.85
51.71	-15.2	41.22
59.01	-12.63	18.62
63.27	-3.89	21.18
63.29	-.46	24.24
59.03	4.08	28.37
59.07	-16.35	25.62
39.86	-60.13	11.67
-56.45	-9.44	15.22
-17.78	-64.19	19.36
-13.4	-67.54	30.75
-17.73	-68.08	24.15
-56.45	-1.69	19.03
-53.18	-4.33	25.9
-48.93	-4.56	22.53

// Sommer I E C, 2008: Attention to Hallucination - Rest
// Sommer I E C, 2008: Silent Word Generation - Rest
// Sommer I E C, 2008: Attention to Hallucination - Silent Word Generation
// Subjects=24
40	-4	4
48	21	28
28	27	-5
44	16	10
51	11	-4
-44	-17	45
-20	-8	67
-55	-37	39
-44	0	4
-32	-4	0
-55	4	11
-12	2	44
8	3	62
-4	-9	48
24	-52	-21
20	-64	-30
-55	-19	16
-20	-59	-24
48	-46	13
51	-37	30
-51	6	33
-56	12	16
36	24	-8
-28	-4	52
36	-4	60
-24	-4	56
32	-4	60
-48	4	32
48	4	32
-36	20	0
36	24	-4
-12	-8	12
12	-8	8
4	8	28
-44	-56	-16
44	-56	-20
-44	-64	-4
52	-36	4
-44	4	-12
52	-36	8
-28	-60	48
32	-64	52
-28	-56	44
48	-44	52
-28	-68	36
28	-92	0
-32	-60	-28
23	-76	-24
51	9	29
40	23	-8
55	12	14
44	1	29
44	2	44
44	12	12
36	16	7
0	3	59
0	26	50
-28	23	-1
-36	4	0
-36	-1	55
44	32	21
-48	-33	42
28	-63	-20

// Haldane M, 2008: 3, 2, 1-back > 0-back, Pre-Treatment
// Haldane M, 2008: Angry vs. Neutral Faces, Pre-Treatment
// Haldane M, 2008: 3, 2, 1-back > 0-back, Post-Lamotrigine Monotherapy > 
// Pre-Treatment
// Haldane M, 2008: Angry Faces, Pre-Treatment > Post-Lamotrigine Monotherapy
// Haldane M, 2008: Angry Faces, Post-Lamotrigine Monotherapy > Pre-Treatment
// Subjects=8
46	8	34
48	-50	52
-36	-56	62
-6	8	52
46	30	40
-4	-82	-16
8	-82	-20
46	-56	-48
-60	8	6
4	26	48
32	-78	-30
-12	50	42
-4	62	22
-6	44	32
-16	44	8
22	22	46
8	62	22
0	38	18
28	42	46
8	-22	16
-4	46	10
-44	-14	34
-60	-38	24
-8	-54	-8
10	36	6
50	-12	-8

// Hassel S, 2008: Happy Faces, Group-by-Condition Interaction
// Hassel S, 2008: Happy Faces, Main Effect of Group
// Hassel S, 2008: Fearful Faces, Main Effect of Group
// Subjects=19
10	20	11
-17	20	14
-46	-56	36
20	14	35
18	-91	-10
49	-53	2
20	-56	42
-14	-96	-11
39	-62	31
36	-64	39
36	-64	36
-30	5	42

// Vinogradov S, 2008: Healthy Controls
// Subjects=8
-9.71	54.34	10.37
-3.25	64.04	10.42
-3.32	54.8	3.49
3.31	46.09	13.21
9.7	66.21	9.99
7.6	58.97	12.98
-6.87	-54.39	41.25
7.59	57.8	11.98
7.52	66	7.81
21.06	27.68	44.98
-2.36	-7.01	65.62
-2.54	-5.06	51.99
1.86	-15.37	56.29
24.64	10.18	-16.1
16.4	-77.71	-2.78
-.67	17.95	33.99
-16.31	9.7	-7.51
-14.02	-.31	0.17
65.35	-20.31	34.41
42.33	-23.95	8.27
44.46	-26.38	5.11
-5.65	36.01	-13.66
5.21	34.24	-10.3
-60.15	7.44	28.2
-53.58	7.03	34.85
48.55	-22.6	-12.14
-53.63	0.12	29.93
-1.04	2.07	1.95

// Vinogradov S, 2008: Schizophrenic Patients
// Subjects=8
22.52	12.61	-12.94
1.73	-33.84	42.44
7.59	57.8	11.98
7.52	66	7.81
21.06	27.68	44.98
-2.36	-7.01	65.62
-2.54	-5.06	51.99
1.86	-15.37	56.29
24.64	10.18	-16.1
16.4	-77.71	-2.78
-.67	17.95	33.99
-16.31	9.7	-7.51
-14.02	-.31	0.17
-41.48	-72.26	35.77
-39.45	-63.41	27.01
-45.88	-69.6	29.98
65.35	-20.31	34.41
42.33	-23.95	8.27
44.46	-26.38	5.11
-7.75	47.37	-6.9
-53.63	0.12	29.93
-1.04	2.07	1.95

// Schnell K, 2008: Interrupted > Uninterrupted Control, Schizophrenia 
// Patients
// Schnell K, 2008: Interrupted Control Correlated with AMDP score, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted Control Correlated with SAPS score, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted > Uninterrupted Control Correlated with AMDP, 
// Schizophrenia Patients
// Schnell K, 2008: Interrupted > Uninterrupted Control Correlated with SAPS, 
// Schizophrenia Patients
// Subjects=20
36	24	-9
36	42	27
39	33	33
3	24	48
3	30	42
-33	54	18
-30	63	-3
-27	42	27
-33	27	-9
-33	18	-6
-3	33	27
-6	18	24
12	27	21
-42	0	36
63	-48	21
51	-51	33
51	-45	54
-57	-51	36
-54	-51	48
-63	-54	18
-3	-78	48
15	-75	39
6	-75	42
12	-45	36
-51	-18	42
-57	-15	30
-42	-21	57
51	-48	48
42	-54	42
-45	-51	42
-33	-54	39
45	-69	-18
-57	-12	33
-54	-24	48
-51	-15	39
57	-15	39
-42	-12	-6
-39	-54	40
-45	-54	48
42	-54	42
51	-48	48
48	-69	-15
-6	-27	39
-3	-30	39

// Hutchison E R, 2008: Syllables (30 ms Between + 15 ms Between + 15 ms 
// Within) > Tones
// Hutchison E R, 2008: Tone Different > Syllables (30 ms Between + 15 ms 
// Between + 15 ms Within)
// Hutchison E R, 2008: 30 ms Between > Tone Different
// Hutchison E R, 2008: Tone Different > 30 ms Between
// Hutchison E R, 2008: 15 ms Between > Tone Different
// Hutchison E R, 2008: Tone Different > 15 ms Between
// Hutchison E R, 2008: 15 ms Within > Tone Different
// Hutchison E R, 2008: Tone Different > 15 ms Within
// Hutchison E R, 2008: 15 ms Between > 30 ms Between
// Hutchison E R, 2008: Condition vs. RT Regression
// Subjects=14
-5.09	3.22	14.68
-60.98	-19.36	5.62
31.43	24.46	-8.49
33.04	-45.88	5.31
6.72	-78.04	44.55
55.88	-25.25	23.73
-58.36	-38.24	33.82
1.24	-28.63	46.83
-42.03	-3.28	2.71
44.69	-57.91	15.22
-54.79	-7.91	23.88
0.05	-33.62	1.54
-61.95	-21.69	4.49
-2.33	-6.19	-5.42
61.89	-37.1	22.64
52.97	1.83	17.59
62.92	-41.05	29.32
30.86	-39.21	44.92
-55.05	-12.34	29.94
-.18	4.05	0.17
0.44	19.86	44.89
31.64	25.32	-8.45
-36.23	20.64	1.87
0.82	-29.83	5.12
-61.41	-18.64	5.45
35.45	9.81	49.46
61.89	-31.63	24.64
44.59	-57.55	15.75
-1.14	-20.02	46.81
1.79	20.4	40.82
6.17	-34.85	4.47
-.84	-1.88	8.92
-22.02	25.44	3.53
-10.96	-35.14	-.55
-61.52	-18.07	5.85
4.49	-74.74	47.54
60.61	-37.83	22.94
-59.74	-36.26	34.79
-51.16	-10.52	21.38
-46.66	-4.01	-2.19
49.86	-.88	0.79
-.37	-21.86	47.84
50.27	16.65	19.61
47.01	-46.1	43.87
3.95	-16.65	41.78
-1.8	-45.32	33.54
-5.55	41.76	-1.6

// Drapier D, 2008: Bipolar Patients
// Subjects=20
-25.02	-66.24	48.61
-41.44	10.97	30.06
43.8	41.83	8.65
35.76	-58.36	34.99
-37.6	51.52	-10.19
-29.37	-59.29	42.5
51.17	19.9	-14.13
-37.16	11	30.01
47.12	35.39	21.42
-37.58	47.29	-9.83
-44.84	37.5	15.61
-33.63	-50.43	47.39
43.72	24.52	-8.86
-41.55	30.63	22.84
-32.85	-85.29	-4.34
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-30.27	66.49	-23.79
27.44	66.83	-24.49

// Drapier D, 2008: Healthy Relatives
// Subjects=20
-41.58	38.03	22.22
47.07	34.88	14.77
-37.3	34.89	22.43
47.07	34.88	14.77
-21.82	-66.22	48.57
-41.86	47.27	-9.78
8.66	-5.42	6.32
-13.77	6.59	12.27
1.45	12.68	48.38
-34.37	60.51	-4.29
-33.69	-46.63	41.49
44.32	-46.16	40.56
-30.06	60.97	1.2
47.07	34.88	14.77
-30.09	63.97	-1.28

// Drapier D, 2008: Healthy Controls
// Subjects=20
-41.57	9.6	12.33
-29.32	-49.98	52.87
47.12	35.39	21.42
44.36	-45.73	46.1
-33.63	-50.43	47.39
47.11	38.57	21.15
-33.16	21.4	-1.02
1.42	21.14	47.67
-33.38	55.35	-16.13
-37.44	48.75	9
39.4	24.06	-14.34
-33.63	-50.43	47.39
-37.38	-68.16	-30.26
-29.95	21.42	-1.06
5.63	23.83	40.71
47.14	31.16	21.77
-33.17	48.77	8.95
-30.09	63.97	-1.28
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-22.75	46.01	-27.74
16.68	-73.39	48.73
-17.52	-73.6	49.14
-30.27	66.49	-23.79
27.44	66.83	-24.49

// Aleman A, 2008: Men
// Subjects=8
-46.76	5.65	30.57
26.77	40.22	16.79
-11.62	30.98	24.69
-53.42	3.04	-2.59
-37.57	17.71	-20.73
-11.91	54.3	-4.02
-33.75	14.21	57.58
40.14	-23.24	62.1
7.48	69.16	21.27
20.64	36.49	51.74
65.23	-12.37	-6.01
23.72	-57.03	-1.79
-21.24	-35.09	-3.11
33.35	-27.13	12.32
-30.71	-13.8	25.32
67.39	-7.69	-.85
47.26	12.64	30.02
31.46	7.2	57.42
32.02	57.97	11.89
8.65	35.16	21.88
-12.29	-3.38	62.15
-12.38	12.14	56.39
-15.04	69.32	11.48
-27.24	-8.84	61.67
-27.66	48.32	30.11
-41.33	-8.78	36.18
-58.72	-2.02	1.24
-27.87	18.63	-9.77

// Aleman A, 2008: Women
// Subjects=8
-46.76	5.65	30.57
26.77	40.22	16.79
-11.62	30.98	24.69
-53.42	3.04	-2.59
-37.57	17.71	-20.73
-11.91	54.3	-4.02
-33.75	14.21	57.58
40.14	-23.24	62.1
7.48	69.16	21.27
20.64	36.49	51.74
65.23	-12.37	-6.01
23.72	-57.03	-1.79
-21.24	-35.09	-3.11
33.35	-27.13	12.32
-30.71	-13.8	25.32
67.39	-7.69	-.85
47.26	12.64	30.02
31.46	7.2	57.42
32.02	57.97	11.89
8.65	35.16	21.88
-12.29	-3.38	62.15
-12.38	12.14	56.39
-15.04	69.32	11.48
-27.24	-8.84	61.67
-27.66	48.32	30.11
-41.33	-8.78	36.18
-58.72	-2.02	1.24
31.1	43.04	25.42
-48.87	-21.48	23.94
34.17	21.89	-.72

// Baliki M N, 2008: Chronic Low Back Pain (CBP) Patients
// Subjects=7
2	48	2
-2	38	20
-16	32	46
16	22	52
6	12	-10
-56	-8	-32
-48	-72	38
-64	-44	-10
6	52	-8
-2	38	20
-16	30	44
-46	-74	44

// Baliki M N, 2008: Knee Osteoarthritis (OA) Patients
// Subjects=5
-36	42	6
-36	28	-8
-8	22	28
50	14	48
2	8	62
-36	6	4
42	6	-4
26	6	-2
-20	-6	-18
14	-18	2
-8	-22	0
-54	-26	24
52	-28	24
44	42	-14
-40	36	32
-4	38	22
6	30	26
40	18	52
-22	14	-2
10	16	62
-40	8	-6
38	18	-8
-18	14	-2
16	-18	4
-16	-16	4
-38	-24	56
-58	-28	26
54	-24	26
0	-52	68
-28	-52	54
-56	-64	4
22	-76	48
-12	-80	-12
-38	52	12
-36	28	-8
-4	24	28
12	-18	0
-6	-22	0

// Bragulat V, 2008: Alcoholic Odor > Non Appetitive Odors
// Bragulat V, 2008: Alcohol Odors > Appetitive Odors
// Subjects=10
6	0	-10
4	12	-18
-4	68	-2
-2	62	0
8	70	2
0	-68	24
-44	-78	40
0	-40	32
-4	-50	20
0	48	-6
34	34	-14
34	36	-20
-10	64	10
0	-40	30
-2	-66	20

// Brewer J A, 2008: Incongruent vs. Congruent Stroop
// Brewer J A, 2008: Stroop Main Effect Correlation with Percent 
// Cocaine-Negative Urine Toxicology
// Brewer J A, 2008: Stroop Main Effect Correlation with Longest Duration of 
// Cocaine Abstinence
// Brewer J A, 2008: Stroop Main Effect Correlation with Weeks in Treatment
// Subjects=20
36	28	-8
-40	8	32
-4	12	52
-16	4	0
12	0	-4
-32	-60	44
52	-48	48
24	0	-4
-24	-36	40
-12	48	-8
24	0	12
-28	40	48

// Chandrasekhar P V, 2008: Activations in Response to Regret
// Chandrasekhar P V, 2008: Activations in Response to Rejoice
// Chandrasekhar P V, 2008: Activations in Response to Regret and Rejoice
// Chandrasekhar P V, 2008: Regions Activated with the Linear Increase of 
// Probability of Shock in the Anticipation Phase
// Subjects=30
9	-81	51
-6	-63	66
-30	-81	39
45	-72	36
-6	-27	12
-54	-66	-18
-21	6	66
3	54	-24
-9	60	-6
0	60	-9
3	-21	72
21	-18	75
45	15	-12
39	-15	-6
-45	6	-6
-30	-12	15
15	-84	3
-18	9	-9
18	9	-9
63	-27	42
-12	-87	0
3	36	3
-21	-27	-3
12	15	0
-9	36	48
3	-15	-12
33	-60	-12
48	45	24
48	21	-18
51	39	-15
-48	18	-12
-6	-75	45
3	-30	27
42	-54	57
-42	-54	57
-3	24	36
63	-39	-6
6	24	63
24	6	-15
51	12	42
9	-3	12
-42	-66	-27
-3	9	39
9	-9	75
15	-48	72
60	3	0
-57	3	0
57	-27	27
-63	-24	21
9	-21	3
-6	-24	-9
45	-3	45
-51	-3	45
-36	48	36
27	36	24
33	24	6
45	6	6
-39	18	6
-21	-60	-27
-9	-42	-30
15	-30	42
-18	-45	72

// Coderre E L, 2008: Kana Words > Kanji Words
// Coderre E L, 2008: Kana Incongruent > Kana Congruent
// Coderre E L, 2008: Kanji Incongruent > Kanji Congruent
// Coderre E L, 2008: (Kana Incongruent > Kana Congruent) > (Kanji Incongruent 
// > Kanji congruent)
// Coderre E L, 2008: Kana Incongruent > Kana Words
// Coderre E L, 2008: Kanji Incongruent > Kanji Words
// Subjects=9
-30.56	-32.06	36.89
-20.65	-55.33	65.49
-19.3	45.26	3.51
49.47	-16.24	27.95
17.78	-65.38	55.86
7.62	37.7	27.25
-14.87	50.25	26.46
14.23	-83.26	3.87
-11.41	-78.93	7.14
-21.21	-61.07	-8.74
10.92	18.94	32.14
-5.06	25.96	41.77
-5.49	51.08	-4.94
42.95	5.67	22.84
-46.5	-44.33	44.79
-5.11	25.45	35.12
10.91	28.72	34.66
-6.51	38.48	-2.76
-4.91	7.7	53.33
-49.98	8.8	30.34
13.97	32.74	17.56
-17.97	28.29	31.68
4.35	27.14	14.8
-37.2	28.17	31.91
46.18	-.65	23.34
13.82	65.26	11.49
-43.63	-57.69	-4.3
8.84	22.79	40.76
39.87	3.68	38.66
-46.47	-50.68	45.32
-46.75	15.68	36.42
-2.86	23.32	48.65
43.18	-48	30.69
14.28	-91.46	7.9
-14.66	6.27	35.72
10.93	9.17	29.61
-9.21	14.02	52.85
47.38	-45.48	21.51
-8.31	-86.54	-8.98
14.23	-85.38	4.04

// Frangou S, 2008: Healthy Controls
// Subjects=7
-52	6	40
-28	-66	56
-30	-66	44
-54	-46	12
-14	-4	16
4	18	54
52	12	40
48	38	24
38	-62	52
42	-50	38
8	-2	12
-50	2	42
36	20	54
36	12	56
8	40	32
36	62	-2
-20	10	68
-34	58	14
-54	8	40
-44	46	16
-54	18	-6
-2	-84	-28
2	30	46
20	62	-6
28	58	-10
50	10	36
34	24	-10
38	-66	56
28	-78	-22
6	-16	8

// Frangou S, 2008: Bipolar Disorder Patients
// Subjects=7
-24	4	60
-40	54	-4
-46	46	16
-42	6	28
-40	22	-8
-44	-56	54
44	-48	42
-58	-60	12
36	2	60
2	14	58
50	10	36
50	38	26
48	20	-4
52	-46	56
58	-46	-14
54	-40	48
-26	-8	70
-64	-20	2
-54	16	-12
-62	-50	8
-30	-66	56
34	0	64
58	-64	-4
28	-76	50
6	-96	16
36	-72	-26
2	-26	10

// Hoeft F, 2008: (Unfixed + Fixed Wall) > Rest, Males + Females
// Subjects=11
0	-11	52
36	37	31
26	7	53
36	42	15
-55	5	22
-51	2	37
44	-7	50
-32	-40	61
-55	-19	40
20	-59	55
-50	-28	27
-16	-59	55
-46	-74	-1
-40	-75	-15
44	-74	-6
46	-59	-7
-22	2	-3
-12	-3	11
-12	-18	-1
18	-13	12

// Hoffman W F, 2008: Delay Discounting vs. Magnitude Estimation, 
// Methamphetamine Users + Healthy Controls
// Hoffman W F, 2008: Significant Clusters for Second Level Linear Regression
// Hoffman W F, 2008: Significant Clusters for Second Level Linear Regression: 
// Effect of Group
// Subjects=20
2.14	-17.55	42.77
-45.96	-61.04	37.93
0.67	34.59	26.26
-33.83	53.35	7.57
49.15	-56.86	39.39
-39.56	-17.26	-.72
-3.52	77.5	26.83
-44.18	-10.59	40.6
-30.01	-51.52	17.77
-36.47	47.94	-4.32
-42.25	-45.86	12.31
-21.85	-.97	-11.88
-42.8	74.02	16.98
-18.52	-53.98	23.53
8.86	63.77	-8.74
-24.44	7.93	1.57
16.69	44.46	0.93
-14.58	12.22	34.22
-12.66	80.88	20.41
-58.18	-12.31	-2.48
-33.11	75.43	27.46
29.18	74.2	23.95
-19.68	3.65	21.5
-10.34	-11.7	34.17
7.79	80.5	-2.88
-11.01	81.79	-.99
-34.58	81.21	4.57
-18.12	16.85	35.21
-8.7	80.55	35.11
-35.34	89.76	-7.29
-25.51	14.32	59.59
-25.76	80.83	-14.9
35.37	20.01	43.81
48.5	76.54	-19.18
-40.1	4.35	35.17
-23.04	96.48	-16.47
-48.52	7.77	25.06

// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, All Participants
// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, Attend Subjects
// Hutcherson C A, 2008: Extraversion and Response to Amusing vs. Neutral 
// Films, Watch Subjects
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// (Attend vs. Watch Subjects)
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// Attend Subjects
// Hutcherson C A, 2008: Extraversion and Response to Sad vs. Neutral Films, 
// Watch Subjects
// Subjects=14
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
21.23	69.99	3.2
41.67	42.96	9.69
17.83	-36.26	74.6
12.77	21.42	-4.9
-19.29	12.42	-8.23
-19.35	8.56	-16.83
-19.35	8.56	-16.83
-19.35	8.56	-16.83

// Ino T, 2008: Kanji > Kana, Word Recognition
// Ino T, 2008: Word Recognition > Reading Aloud, Kanji
// Ino T, 2008: Word Recognition > Reading Aloud, Kana
// Ino T, 2008: Reading Aloud > Word Recognition, Kanji
// Ino T, 2008: Reading Aloud > Word Recognition, Kana
// Ino T, 2008: Word Recognition (Kanji vs. Kana) > Reading (Kanji vs. Kana)
// Subjects=14
-36	-44	-16
36	-48	-18
32	24	4
-28	22	0
44	6	32
-50	4	36
48	24	30
10	26	38
-4	14	48
2	4	34
24	2	48
36	4	60
32	-76	34
-38	-82	24
42	-76	18
-34	-78	8
34	-60	52
-26	-66	48
34	-54	46
-50	-42	50
-28	-52	38
24	-34	-24
-52	-54	-10
40	-62	-12
56	-46	-12
36	46	30
-44	32	40
-20	-2	0
-18	-78	8
8	-80	6
-36	-64	-30
36	-48	-46
38	-72	-14
10	-6	4
-6	-24	-4
-2	-26	-26
8	-28	-18
14	-50	-20
-24	-36	-40
-30	-12	62
24	-8	60
22	2	48
-42	-24	62
-36	-34	40
54	-20	36
-48	-26	38
36	-42	40
-8	-22	-6
44	-48	62
-16	-64	60
42	30	26
10	-62	54
-10	-4	58
10	-4	48
32	24	4
-26	22	2
2	-24	-32
-6	-24	-28
-30	-4	0
14	6	-6
16	16	-4
-16	22	10
-42	-54	-18
-44	-58	-16
14	-52	-18
-32	-12	60
-40	-28	54
-46	-12	34
44	-12	36
54	-6	46
66	-8	-2
-60	-12	2
-10	-62	-24
-46	-14	36
44	-12	36
56	-4	46
64	-10	0
-58	-12	6
-10	-62	-20
28	24	6
-32	22	2
10	32	28
-2	6	32
32	4	56
-20	-2	58
12	-66	54
-20	0	4
52	-42	58
-46	-44	46
44	30	26
50	40	8
52	-36	60
-50	-46	56
-20	-76	10
8	-74	10
34	-56	64
-26	-66	48
36	-78	36
-24	-64	42
10	-6	0
-30	-56	-36
4	-50	-20
-8	-40	-34
56	-52	-14
16	14	-4

// Ino T, 2008: Word > Color
// Ino T, 2008: Color > Word
// Subjects=18
-42	-86	-8
42	-80	-6
-28	-88	-10
32	-92	-6
-48	-68	-12
46	-80	-10
-24	-94	-2
30	-96	2
-44	-50	-22
50	-60	-16
-54	-58	-12
50	10	26

// Knaus T A, 2008: Autism Spectrum Disorder (ASD) Adolescents
// Subjects=12
-48	23	-10
-62	-47	8
-8	-17	12
-4	7	60
36	-81	-26
-8	-21	-10
-32	-39	-17
62	31	18
62	31	20
72	-57	-6
-54	19	18
-62	-65	-8
-34	3	34
-58	-69	12
-2	5	60
-36	17	-.25
38	13	24
38	39	-14
42	-71	56

// Knaus T A, 2008: Typically Developing Adolescents
// Subjects=12
-50	25	14
-54	-11	-12
-58	-37	6
-32	-37	-16
-32	33	-12
-36	-13	-40
-44	-.5	50
62	31	20
72	-57	-6
-54	19	18
-62	-65	-8
-34	3	34
-58	-69	12
-2	5	60
-36	17	-.25
38	13	24
38	39	-14
42	-71	56

// Knutson B, 2008: Major Depressive Disorder (MDD)
// Subjects=14
-10.44	15.64	32.66
-53.21	-.27	23.33
47.35	-11.68	32.05
-31.7	23.23	50.11
9.5	43.86	-3.39
-32.2	26.89	-12.64
15	11.45	3.72
-19.2	6.85	2.27
-16.59	9.54	64.46
-42.5	-24.16	16.29
-33.58	-28.97	63.43
-48.74	-37.8	33.12
-39.38	-46.92	-3.03
41.79	44.25	26.31
12.76	14.73	-8.79
17.07	12.98	-4.24
18.11	11.59	-8.59
-10.77	8.96	-12.5
-19.07	11.48	20.84
57.69	10.05	-4.46
1.31	11.23	29.55
-23.55	8.17	-7.83
-10.62	7.16	5.49
1.41	9	42
53.7	8.62	32.51
17.6	10.72	62.86
45.22	9.26	41.47
37.86	1.7	54.46
26.2	2.57	66.79
26.2	-5.09	64.09
4.44	-13.65	10.41
-3.03	-15.81	10.67
21.45	-23.29	-5.71
26.2	-21.64	56.55
61.29	-27.54	32.11
-42.16	-30.51	58.08
26.29	-37.16	62.31
-10.04	-46.17	59.03
5.76	-64.85	22.49
-18.57	-62.43	56.03
12.82	67	20.28
32.9	48.34	-16.31
1.06	50.38	12.88
9.61	42.77	10.08
33.04	21.19	-9.57
-42.78	21.34	-.91
5.66	25.23	45.05
-23.56	9.22	-7.92
26.06	14.31	53.54
-9.47	-.78	12.83
-10.53	-1.76	14.04
-3.1	-23.09	-.98
12.94	-26.17	-.91
49.72	-34.53	52.9
0.88	48.49	-11.49
8.52	20.59	-1.43
-19.04	3.02	21.55
-18.96	-8.27	26.95
17.36	-4.88	26.25
-2.97	-41.53	8.37
21.64	3.95	29.92

// Knutson B, 2008: Healthy Controls
// Subjects=12
-10.44	15.64	32.66
-53.21	-.27	23.33
47.35	-11.68	32.05
-31.7	23.23	50.11
9.5	43.86	-3.39
-32.2	26.89	-12.64
15	11.45	3.72
-19.2	6.85	2.27
-16.59	9.54	64.46
-42.5	-24.16	16.29
-33.58	-28.97	63.43
-48.74	-37.8	33.12
-39.38	-46.92	-3.03
9.56	45.6	5.38
-10.74	12.47	-8.34
21.28	12.32	-13.15
7.44	12.75	-6.34
-9.68	11.34	-9.37
8.58	5.79	-.19
-16.08	1.52	-11.82
1.21	-6.26	9.83
21.05	63.79	-21.93
1.09	59.52	21.04
-19.58	55.55	-28.57
41.47	52.97	-12.33
41.72	43.56	17.45
1.39	29.69	48.07
28.73	20.83	-13.95
-35.31	16.9	-3.96
53.41	17.69	-1.7
-58.85	16.41	-8.11
12.75	16.84	-8.97
33.51	14.02	49.02
9.63	10.02	-.56
-9.47	-.78	12.83
1.55	-2.75	55.25
1.22	-9.44	10.09
-42.24	-10.42	56.4
-46.44	-38.28	54.32
49.71	-37.96	49.84
33.79	-41.34	62.58
29.51	-50.17	58.91
29.5	-62.4	52.13
13.48	-66.72	52.67
-22.87	-70.46	48.94
-3.46	64.33	-12.77
-15.02	28.91	-1.86
9.58	21.65	-1.53
-23.55	16.97	-4.1
1.33	12.54	32.78
-15.04	0.13	-16.17
65.31	-1.65	8.7
17.34	-8.4	22.09
-14.7	-12.82	22.83
-26.67	-15.12	-5.84
21.45	-23.29	-5.71
-34.66	-25.89	62.07
-50.77	-31.16	50.43
49.75	-34.18	57.33
-2.45	-57.08	68.77
29.57	-57.23	63.96
32.95	60.92	-5.09
-35.5	59.91	-12.03
-26.75	-3.83	-11.25
-26.57	-6.43	10.16
28.91	-10.21	-2.43
61	-9.76	0.51
1.61	-9.81	60.3
49.55	-15.38	39.03
-62.85	-22.51	11.92
49.66	-18.67	51.57
57.9	-21.78	10.48
65.5	-28.2	23.19
49.51	-27.95	27.82
-51.19	-39.93	-7.94
-38.94	-51.18	51.97
17.85	-56.95	68.53
-25.98	-61.79	64.98
6.05	-78.4	53.74

// Koeneke S, 2008: Anticipation Effect of Losing Trials (Increasing Linearly 
// with Subjective Preference)
// Koeneke S, 2008: Anticipation Effect of Losing Trials (Decreasing Linearly 
// with Subjective Preference)
// Koeneke S, 2008: Outcome of Lost Losing Trials (Increasing Linearly with 
// Subjective Preference)
// Koeneke S, 2008: Outcome of Lost Losing Trials (Decreasing Linearly with 
// Subjective Preference)
// Koeneke S, 2008: Main Effects of the Anticipation Phase of Winning Trials 
// (WA)
// Koeneke S, 2008: Main Effect of the Outcome Phase of Won Winning Trials 
// (WOW)
// Koeneke S, 2008: Preference-Dependent Activation during WA, Increasing 
// Linearly with Subjective Preference
// Koeneke S, 2008: Preference-Dependent Activation during WA, Decreasing 
// Linearly with Subjective Preference
// Koeneke S, 2008: Preference-Dependent Activation during WOW, Increasing 
// Linearly with Subjective Preference
// Subjects=19
10	24	10
-12	18	16
0	-90	14
-10	-100	24
-6	-100	16
12	-62	-2
2	-68	-6
16	-54	-8
60	8	-10
24	8	14
-18	-42	20
-28	22	44
26	-94	-10
-30	-96	8
-24	-30	-4
22	-28	-2
-16	28	-4
-22	-8	32
4	24	2
16	-28	-30
32	22	-26
48	46	-16
-58	16	4
60	22	26
30	4	68
44	-6	22
-22	-8	60
-40	-4	48
38	-10	36
-60	-6	38
12	-78	-46
2	-34	-32
-28	-30	28
-8	-86	-12
-48	-60	30
2	-62	62
-14	0	28
-12	14	22
14	14	20
28	-32	8
-34	-12	-24
-38	8	44
40	26	24
-50	28	0
2	28	62
44	52	-10
42	18	48
-2	62	26
-34	22	-26
-6	64	-2
18	48	48
-10	14	68
38	-20	68
4	-46	34
68	-32	-8
52	16	-22
-54	4	-26
62	-4	-26
-40	16	-34
38	18	-42
-44	-40	-22
64	-2	10
10	-38	74
-12	-42	74
46	-8	18
-26	-30	20
40	-26	26
28	-76	-50
0	-72	-46
10	-56	-36
32	-2	24
-2	24	8
24	-54	36
24	-22	44
6	-30	16
-16	-8	62
16	4	68
44	28	-12
42	-48	14
10	-18	-6
-36	12	60
-4	-30	40
-16	-50	36
-4	-50	8
6	-52	14
-2	-58	26
-2	-72	34
-4	-70	16
-42	-76	34
-52	-74	26
-8	-80	-8
-16	-82	-6
-26	-42	-14
28	-36	-40
18	8	18
16	2	26
24	2	-8
6	-46	6
-2	-42	8
0	-54	-4
16	-60	40
-20	-72	-4
-14	-82	-12
-12	-80	-2
-14	-96	20
-14	-56	0
-6	-66	4
22	-90	-16
34	-22	-16
22	-52	-2
14	-50	-4
16	-82	-28
6	-20	-22
-22	-66	-34
52	-26	16
42	-42	22
46	-28	28
-38	-56	16
-42	-52	22
38	-30	54
28	16	20
18	28	40

// Leff A P, 2008: (Idioms + Rearranged Idioms + Time Reversed Idioms) vs. 
// Fixation
// Leff A P, 2008: (Idioms + Rearranged Idioms) - Time Reversed Idioms
// Subjects=26
-44	-24	8
50	-26	6
-62	-32	14
68	-32	2
-58	0	-8
56	0	-8
40	-18	54
-4	-86	2
8	-86	2
-20	-48	-22
28	-62	-24
-26	-4	8
24	-6	8
-52	-48	8
-54	10	-16
-48	28	-6

// LoPresti M L, 2008: Active Maintenance Analysis, DMS vs. Number 
// Discrimination, Delay
// LoPresti M L, 2008: Face Processing Analysis, DMS vs. Number 
// Discrimination, Stimuli
// Subjects=19
-46	26	-6
-40	56	14
-44	30	8
-26	32	8
54	6	46
-40	2	32
0	20	48
-18	-16	-20
-18	-4	-20
-32	-30	-8
34	-46	-4
-50	-50	52
-42	-54	-28
-2	-82	-30
50	-74	-14
58	-62	-10
28	-82	18
24	-80	-14
50	-36	0
-40	-74	-14
-40	-60	-18
-52	-46	4
40	30	-8
50	38	6
34	28	2
-50	22	-6
-46	16	22
-32	26	0
2	30	44
10	20	36
6	38	18
-16	-36	-6
16	-36	-6
-18	-4	-16
20	2	-20
-36	-52	42
40	-52	48
0	-52	-44
-6	-80	-38

// Merabet L B, 2008: Blindfold > Non Blindfold, Day 5
// Merabet L B, 2008: Non Blindfold > Blindfold, Day 5
// Subjects=16
8.91	-100.55	0.92
57.01	4.21	43.99
40.8	-5.51	16
-28.25	-76.38	41.69
-37.15	-9.78	22.83

// Pierno A C, 2008: Main Effect of Type of Observed Behavior [(GT + GTD) - 
// (GAT + GATD)]
// Pierno A C, 2008: Interaction [(GT - GTD) - (GAT - GATD)]
// Subjects=12
-36	0	45
48	-3	51
27	-6	51
-27	-12	60
60	-36	15
36	-42	51
-30	-42	60
-24	-51	51
42	-48	-18
6	-63	3
-39	-69	9
54	-66	3
50	24	21
9	-78	-3
-3	-75	-3

// Schiller D, 2008: Shock > No Shock
// Subjects=17
-9.55	4.96	4.55
13.96	6.25	5.28
-26.64	-1.57	4.18
26.7	4.32	-6.97
-45.91	7.74	2.5
49.18	9.29	0.16
10.77	-11.21	0.09
6.59	-11.35	12.42
-6.41	-12.17	-10.78
-6.39	-24.05	-13.13
3.53	8.84	39.76
1.6	-2.24	61.9
-9.09	-37.51	47.14
5.97	-54.97	54
16.08	-44.44	-17.25

// Seseke S, 2008: Normal Males
// Subjects=12
7.46	-18.85	-15.95
-4.28	-15.5	-12.76
34.24	-52.07	-21.28
-30.88	-58.38	-14.43
12.94	-11.91	4.59
-11.63	-13.11	4.97
26.75	8.18	1.63
-24.47	-1.3	7.47
61.04	8.27	13.5
-54.38	6.35	12.75
63.4	-34.47	24.86
-47.71	-27.14	33.33
34.24	10.51	3.58
-32.04	17.52	3.75
18.79	-26.45	63.73
-14.35	-24.54	63.95
-1.24	-20.45	-35.79
1.18	-43.93	-9.32
0.34	7.93	42.1
1.57	-2.49	58.57
-8	1.22	66.18
37.36	20.68	-2.89
-34.23	19.19	-1.94
-21.28	5.15	8.01
-.11	-34.1	-33.55
9.61	-18.76	-14.87
-6.41	-17.62	-12.55
15.07	-19.64	0.75
-13.77	-21.93	1.27
8.11	-27.49	65.06
-5.79	-26.6	64.03
21.45	-57.27	-18.47
-13.8	-51.93	-15.17
27.14	-85.5	15.06
-15.57	-83.3	19.82
-6.31	56.99	30.26
-43.45	-60.2	18.21
5.18	-21.47	-35.78
3.26	-52.17	-19.8
2.6	-47.98	34.5
22.48	-75.29	-31.47
17.47	-44.43	23.99
42.2	-38.26	46.61
-46.56	-28.47	43.46
28.87	57.4	18.67
-24.43	49.65	33.31
26.73	14.61	2.21
26.85	-40.26	-5.46
3.74	-63.67	38.03
-24.43	49.65	33.31
48.4	-49.25	14
-46.72	-45.59	14.79

// Seseke S, 2008: Normal Females
// Subjects=11
22.48	-75.29	-31.47
17.47	-44.43	23.99
42.2	-38.26	46.61
-46.56	-28.47	43.46
28.87	57.4	18.67
-24.43	49.65	33.31
26.73	14.61	2.21
26.85	-40.26	-5.46
3.74	-63.67	38.03
-24.43	49.65	33.31
48.4	-49.25	14
-46.72	-45.59	14.79

// Strathearn L, 2008: Own Infant Face vs. Unknown Infant Face
// Subjects=26
2.65	4.2	62.46
4.29	66.06	22.68
52.57	12.33	25.52
49.54	-13.35	37.75
22.98	-22.88	54.46
52.25	3.53	-19.46
43.02	-40.91	12.25
41.84	-55.23	-7.72
24.6	6.94	-.47
26.87	-15.88	6.99
10.77	7.46	7.45
8.65	-19.76	-.28
5.41	-5.87	0.82
16.14	-8.63	5.39
4.27	-7.79	-10.15
46.03	-38.46	-11.41
35.23	-2.4	-12.08
43.84	4.94	-.52
45.99	-19.17	-9.68
2.5	2.66	42.52
2.09	-17.03	-19.39
4.31	-21.62	-10.11
41.67	-51.49	-28.11
-6.35	44.5	20.15
-44.95	25.3	-4.56
-24.49	54.51	27.33
-47.7	-13.93	38.91
-14.75	-58.31	-1.24
-58.65	-39.8	-5.63
-49.26	3.01	-17.14
-40.45	-28.35	3.23
-42.7	-47.08	-18.59
-12.8	7.77	-.11
-23.47	3.48	0.37
-29.86	-11.71	-2.74
-26.58	-8.72	8.12
-13.76	4.56	13.55
-8.47	-8.06	1.17
-10.58	-15.48	1.81
-4.29	-7.92	-11.16
-27.86	-6.46	-17.7
-32.01	-4.15	-1.12
-1.1	41.39	6.97
-1.91	17.64	30.16
-3.91	-53.45	19.42
-7.13	-65.7	12.68
-7.45	-23.97	-12.01
-2.11	-21.74	-11.14
-35.34	-41.63	-31.4
-1.2	-49.77	-43.37

// Thaut M H, 2008: Polyrhythmic vs. No Movement
// Thaut M H, 2008: Isorhythmic vs. No Movement
// Thaut M H, 2008: 3 Hz vs. 2 Hz
// Thaut M H, 2008: Polyrhythmic vs. Isorhythmic
// Thaut M H, 2008: Isorhythmic vs. Polyrhythmic
// Subjects=12
-32	-26	68
-48	-30	62
-30	-20	66
-48	-28	52
-58	-18	50
-56	-12	40
-42	-10	48
-52	8	44
-8	-8	68
2	-6	70
-6	2	68
2	2	68
-8	-4	56
-50	-22	16
-56	-26	24
-56	-16	22
-24	-8	-2
-36	4	0
-52	10	-4
-32	-30	10
16	-24	8
-6	-24	0
16	-48	-22
28	-62	-24
16	-50	-18
30	-62	-24
-28	-28	62
-44	-24	52
-40	-20	62
-34	-12	-6
-28	-4	6
-32	-26	10
-52	-22	16
-16	-28	0
4	-66	-16
30	-42	56
44	-24	10
46	-16	-2
-20	-66	-18
-4	-6	70
4	-4	72
52	-32	50
38	-48	46
-20	-66	-18
-28	-42	-34
18	26	-4
18	14	-4

// Wu Y, 2008: Cerebral Palsy Patients
// Subjects=11
20.26	53.43	-12.46
-28.29	54.84	-6.17
39.56	-5.57	-36.09
-8.1	30.97	47.4
3.86	-3.43	46.11
-17.52	-10.56	62.87
-41.06	37.65	5.83
30.11	-38.6	-21.45
46.83	-55.42	15.79
-37.97	0.49	-12.95
-27.99	-39.16	-1.35
14.39	-75.51	9.36
-11.51	-74.23	13.04

// Wu Y, 2008: Healthy Subjects
// Subjects=10
7.5	14.45	-3.9
-5.55	19.2	-9.75
49.96	-29.99	12.1
-2.11	-19.72	-1.48
14.11	-29.44	-3.03
7.65	-58.81	-6.74
-31.12	-38.35	7.58

// Li C S, 2008: Stop Errors > Stop Successes
// Li C S, 2008: Post-Stop Successes Go > Post-Stop Errors Go
// Subjects=40
-4	16	44
4	8	64
-8	20	36
16	-64	8
28	-48	0
-4	-24	8
-48	8	-8
-44	4	4
-32	24	8
-36	-8	52
-48	-28	24
44	16	0
-4	-8	56
-16	-36	52
-36	-12	52
16	-68	12
24	-64	4
16	-56	-4
-12	12	-8
8	12	-8
12	28	-8
-16	-32	0
-12	-28	8
16	-20	-12
20	12	-16
-16	-52	-4
40	4	12
28	-20	-28
16	-28	8

// Shamosh N A, 2008: 3-Back vs. Fixation, Activations
// Shamosh N A, 2008: 3-Back vs. Fixation, Deactivations
// Shamosh N A, 2008: 3-Back Correlated with Accuracy
// Shamosh N A, 2008: 3-Back Inverse Correlated with Accuracy
// Shamosh N A, 2008: 3-Back Correlated with Intelligence
// Shamosh N A, 2008: 3-Back Inverse Correlated with Intelligence
// Shamosh N A, 2008: 3-Back Inverse Correlated with Delayed Discounting
// Shamosh N A, 2008: 3-Back Correlated with Delayed Discounting
// Subjects=103
10	-70	54
-3	40	7
39	-9	-11
-9	-62	12
-22	61	8
10	-70	54
-3	40	7
-59	-32	22
39	-9	-11
-9	-62	12
-22	61	8
10	-70	54
-3	40	7
-59	-32	22
39	-9	-11
-9	-62	12
-22	61	8
-3	40	7
39	-9	-11

// Deckersbach T, 2008: Bipolar Disorder Patients
// Subjects=9
-10	22	40
12	18	38
-58	10	6
50	6	16
-56	14	18
-32	26	4
36	28	24
32	34	28
-40	-4	52
-26	-2	44
30	2	48
-22	0	-14
-42	4	34
-56	-16	36
-60	0	10
-60	-10	20
20	2	14
-66	-14	-2
60	-16	-2
-62	-18	4
60	12	-12
30	14	6
-12	32	22
-12	20	40
6	20	42
-48	10	14
-30	26	6
42	20	6
36	22	-10
32	36	28
-40	-4	52
-20	-2	-14
-56	-16	36
20	4	14
60	-12	-2
62	-22	0
-62	-20	2
60	10	-12
-38	12	-4
-52	34	16
-50	16	28
50	8	16
32	34	26
28	6	44
-56	-12	34
32	34	26
28	6	44

// Deckersbach T, 2008: Healthy Controls
// Subjects=17
-8	4	-56
-58	6	22
36	18	-6
26	-8	46
12	-6	12
-46	-4	42
-56	-16	28
24	-10	-2
-8	-20	-12
68	-12	-6
-58	-10	-8
-32	18	2
14	8	38
-6	16	44
10	8	58
-2	10	62
60	8	30
48	18	2
36	18	-8
28	14	-18
-48	22	25
-46	-2	42
-24	-10	-18
24	-12	-16
-12	-16	6
-32	-6	50
-56	-16	28
24	-12	-2
-8	-20	-12
60	-16	-10
-56	-14	-12
52	-8	-28
44	14	-38
38	10	-20
14	46	6
38	24	14
-32	24	38
42	4	40
-2	2	8
50	8	16
32	34	26
28	6	44
-56	-12	34
32	34	26
28	6	44

// Fales C L, 2008: Major Depression Patients
// Subjects=27
-18.29	-5.86	-24.55
39.68	32.43	25.1
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34
-21.45	-6.51	-18.89
23.44	-6.07	-17.21
43.97	24.89	23.45
20.4	46.15	25.28
-39.38	20.07	23.7
4.51	26.65	36.02
5.62	22.68	39.69
-40.34	27.78	40.9
-2.31	43.19	-11.01
12.84	44.19	14.38
-20.06	36.45	41.06
-24.3	30.16	42.75
22.68	34.42	38.51
5.42	32.6	16.56
1.36	18.34	38.99
46.07	31.16	21.79
-41.53	28.69	25.23
-0.08	39.74	-.71
-34.25	40.94	4.04
-23.32	41.29	35.12
22.63	40.5	34.65
-39.38	36.53	30.12
40.89	25.09	40.2
-.11	28.48	-8.69
-4.17	43.89	25.76
34.19	35.26	7.08
-26.58	39.69	28.6
30.08	34.75	28.36

// Fales C L, 2008: Healthy Controls
// Subjects=24
-18.29	-5.86	-24.55
39.68	32.43	25.1
-9.76	37.94	-9.37
5.62	22.68	39.69
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34
-21.45	-6.51	-18.89
23.44	-6.07	-17.21
43.97	24.89	23.45
20.4	46.15	25.28
-39.38	20.07	23.7
4.51	26.65	36.02
5.62	22.68	39.69
-40.34	27.78	40.9
-2.31	43.19	-11.01
12.84	44.19	14.38
-20.06	36.45	41.06
-24.3	30.16	42.75
22.68	34.42	38.51
5.42	32.6	16.56
-7.71	38.16	-20.56
1.36	18.34	38.99
46.07	31.16	21.79
-41.53	28.69	25.23
-0.08	39.74	-.71
-34.25	40.94	4.04
-23.32	41.29	35.12
22.63	40.5	34.65
-.11	28.48	-8.69
-4.17	43.89	25.76
34.19	35.26	7.08
-26.58	39.69	28.6
30.08	34.75	28.36

// Fu C H Y, 2008: Patients with Major Depression
// Subjects=19
-18	58	-10
36	54	8
-63	-12	-2
63	-30	26
-48	-74	-16
8	-84	-18
-14	-102	-12
-42	-90	4
38	-82	34
16	-92	16
14	-42	-10
-28	-4	-24
10	-32	4

// Fu C H Y, 2008: Healthy Controls
// Subjects=19
14	36	12
26	52	0
50	20	38
-60	-4	12
42	-4	0
40	-84	-10
-18	-88	-22
26	-80	26
-53	-72	-6
-20	-20	-16
2	2	4
29	-52	-26

// Fu C H Y, 2008: Major Depressed Patients
// Subjects=16
29.83	-7.43	-21.63
14.92	-4.72	-12.76
-11.79	32.44	2.27
-10.45	32.02	37.98
-13.68	1.02	22.77
-12.58	2.43	27.1
24.91	-5.21	35.12
23.94	-8.59	46.56
19.71	-31.25	42.93
-25.41	31.93	38.15
-25.37	32.36	43.69
4.54	36.76	42.98
1.38	36.12	48.65
-10.42	34.56	43.34
-15.72	34.96	48.94
32.59	-45.98	44.02
26.18	-36.07	48.84
12.3	-51.38	44.71
19.8	-32.51	54.19
34.21	18.97	2.87
-19.15	-4.78	3.24
-49.08	20.21	12.64
3.4	38.27	35.06
39.72	27.4	28.86
36.31	8.7	-6.33
34.23	13.68	3.31
-8.24	-60.59	10.03
-.58	-63.06	32.45
-2.89	-25.35	24.86
-4.15	34.2	24.34
-58.58	-56.63	-3.11
-58.54	-57.26	2.52
-49.93	-55.55	10.09
-51.12	-24.9	7.53
-52.04	-37.62	21.99
-45.6	-36.18	26.26
-37.87	-42.37	55.68
0.49	-54.25	36.16
7.01	-53.1	50.49
-14.71	-60.17	2.26
-9.35	-58.83	5.43
-34.27	-62.48	-39.7
-38.32	-82.2	-19.04
37.32	-56.68	-39.89
38.58	-62.37	-17.12
-7.34	-97.51	-27.03
-9.41	-97.89	-18.05
14	-62.51	-16.83
16.19	-66.39	-12.07
-29.71	-89.21	-14.09
-31.81	-89.94	-9.54
35.47	-86.7	-15.05
36.59	-91.64	-10.18
-26.42	-94.85	-4.73
-37.05	-93.26	3.06
30.23	-96.63	-5.23
30.32	-92.43	7.8

// Fu C H Y, 2008: Healthy Controls
// Subjects=16
29.83	-7.43	-21.63
14.92	-4.72	-12.76
-11.79	32.44	2.27
-10.45	32.02	37.98
-13.68	1.02	22.77
-12.58	2.43	27.1
24.91	-5.21	35.12
23.94	-8.59	46.56
19.71	-31.25	42.93
-25.41	31.93	38.15
-25.37	32.36	43.69
4.54	36.76	42.98
1.38	36.12	48.65
-10.42	34.56	43.34
-15.72	34.96	48.94
32.59	-45.98	44.02
26.18	-36.07	48.84
12.3	-51.38	44.71
19.8	-32.51	54.19
-8.24	-60.59	10.03
-.58	-63.06	32.45
-2.89	-25.35	24.86
-4.15	34.2	24.34
-58.58	-56.63	-3.11
-58.54	-57.26	2.52
-49.93	-55.55	10.09
-51.12	-24.9	7.53
-52.04	-37.62	21.99
-45.6	-36.18	26.26
-37.87	-42.37	55.68
0.49	-54.25	36.16
7.01	-53.1	50.49
-14.71	-60.17	2.26
-9.35	-58.83	5.43
-34.27	-62.48	-39.7
-38.32	-82.2	-19.04
37.32	-56.68	-39.89
38.58	-62.37	-17.12
-7.34	-97.51	-27.03
-9.41	-97.89	-18.05
14	-62.51	-16.83
16.19	-66.39	-12.07
-29.71	-89.21	-14.09
-31.81	-89.94	-9.54
35.47	-86.7	-15.05
36.59	-91.64	-10.18
-26.42	-94.85	-4.73
-37.05	-93.26	3.06
30.23	-96.63	-5.23
30.32	-92.43	7.8

// Grimm S, 2008: Major Depressive Disorder Patients
// Subjects=19
-42	10	30
-2	-12	56
28	-78	22
-26	-78	30
-38	-30	50
40	24	42
48	28	0
0	-72	38
56	-56	30
-40	6	30
40	12	10
-2	-12	54
28	-68	24
-26	-74	28
-38	-22	54
-40	10	34
2	-6	58
46	16	48
6	-68	36
56	-54	32
22	12	50
24	10	-12
-26	14	-12
48	-4	44
-38	22	28
36	8	38

// Grimm S, 2008: Healthy Controls
// Subjects=29
-42	10	30
-2	-12	56
28	-78	22
-26	-78	30
-38	-30	50
40	24	42
48	28	0
0	-72	38
56	-56	30
-40	6	30
40	12	10
-2	-12	54
28	-68	24
-26	-74	28
-38	-22	54
-40	10	34
2	-6	58
46	16	48
6	-68	36
56	-54	32
22	12	50
24	10	-12
-26	14	-12
48	-4	44
-38	22	28
-40	6	40

// Taylor Tavares J V, 2008: Major Depressive Disorder (MDD) Patients
// Subjects=13
48.62	50.08	7.56
44.26	30.09	0.65
-50.53	8.88	20.05
-50.4	14.27	31.84
20.58	50.4	12.49
65.09	-48.54	8.07
56.6	-47.43	20.43
-50.53	8.88	20.05
-52.72	8.66	17.87
-15.51	14.55	55.87
-7.43	-44.31	-0.08
-9.47	-57.62	6.88
-22.5	-53.83	2.24
24.95	-50.99	-4.45
48.62	47.96	7.77
50.92	35.83	15.65
21.03	34.06	44.35
63.18	-52.1	27.51
42.7	-38.68	34.37
42.91	-44.78	49.54
48.62	47.96	7.77
50.9	35.72	14.54
40.14	46.94	20.34
48.62	47.96	7.77

// Taylor Tavares J V, 2008: Bipolar Disorder Patients
// Subjects=12
-7.43	-44.31	-0.08
-9.47	-57.62	6.88
-22.5	-53.83	2.24
24.95	-50.99	-4.45
48.62	47.96	7.77
50.92	35.83	15.65
21.03	34.06	44.35
63.18	-52.1	27.51
42.7	-38.68	34.37
42.91	-44.78	49.54
48.62	47.96	7.77
50.9	35.72	14.54
40.14	46.94	20.34
48.62	47.96	7.77

// Taylor Tavares J V, 2008: Healthy Controls
// Subjects=15
48.62	50.08	7.56
44.26	30.09	0.65
-50.53	8.88	20.05
-50.4	14.27	31.84
20.58	50.4	12.49
65.09	-48.54	8.07
56.6	-47.43	20.43
-50.53	8.88	20.05
-52.72	8.66	17.87
-15.51	14.55	55.87

// Wang L, 2008: Attentional Targets, Major Depression Disorder < Healthy 
// Controls
// Wang L, 2008: Sad Distractors vs. Neutral Distractors, Deactivations, Major 
// Depression > Healthy Controls
// Wang L, 2008: Target-After-Neutral > Target-After-Sad, Healthy Controls > 
// Major Depression Disorder
// Wang L, 2008: Target-After-Sad > Target-After-Neutral, Healthy Controls > 
// Major Depression Disorder
// Subjects=19
-42	53	0
46	42	4
49	25	-11
32	14	25
-28	4	39
-42	11	-11
49	11	-11
-7	-67	60
-28	4	-4
25	-11	18
-32	-77	21
-25	-81	-35
-28	28	35
56	-32	25
-7	-63	46
-49	-18	21
-35	-32	11
-39	42	14
35	42	28
39	18	35
49	14	18
-28	18	14
-11	35	11

// D'Ardenne K, 2008: Response to Positive and Negative Reward Prediction 
// Errors from Delivery of Primary Rewards
// Subjects=18
20.37	5.14	4.19
-13.95	2.59	-11.93

// Bjork J M, 2008: Children of Alcoholics
// Subjects=13
8.56	11.07	-.63
8.49	12.59	-8.57
2.24	-6.6	5.38
5.37	-20.64	-11.32
-7.56	10.12	-11.52
11.67	10.15	-12.86
-16.07	-9.39	-15.36
18.11	-7.07	-15.95
0.13	-10.76	6.87
2.97	49.14	-17.14
41.48	53.14	-10.12
-46.1	42.04	-8.18
53.6	-62.73	-9.46
-42.55	-63.05	-4.98
3.51	-54	11.57
11.04	-69.91	11.7
-14.62	-66.89	11.75
-8.49	9.28	5.29
11.84	7.46	7.44
-30.04	19.42	-13.16
40.52	16.84	-11.52
-.94	-27.31	-.65
8.47	45.34	2.07
7.2	49.79	-22.82
-28.85	-3.5	-6.79
28.95	-6.52	3.95

// Bjork J M, 2008: Adolescent Controls
// Subjects=13
-9.68	9.14	-10.3
-17.18	9.98	-12.51
11.69	10.32	-10.64
-18.23	-9.58	-17.55
20.23	-9.43	-19.12
-8.37	-9.24	13.53
2.99	48.25	-14.84
45.94	33.04	4.9
-42.75	28.2	5.21
52.6	-63.2	-1.6
-43.61	-60.86	-4.04
1.43	-36.96	25.78
7.85	-56.55	19.54
-7.13	-59.01	16.58
-8.48	6.11	5.55
12.84	11.18	0.42
-38.53	12.31	-8
36.29	12.93	-6.68
8.67	-27.25	-.77
1.1	-19.52	-10.25
7.39	39.7	-1.91
19.62	-65.11	17.9
-39.77	51.17	-14.59
32.88	59.09	-14.98
-27.71	-5.98	2.33
28.94	-6.61	2.85

// Bokde A L W, 2008: Healthy Controls
// Subjects=19
39.4	-74.21	-12.01
31.05	-59.21	44.73
41.55	-41.19	44.54
47.61	18.57	20.44
51.81	27.15	22.04
9.57	25.17	30.2
-30.23	-96.45	-3.42
-49.28	-90.51	-7.04
-47.34	-54.33	-19.52
-45.31	7.83	30.6
35.28	-83.26	13.05
16.28	-70.18	40.02
18.4	-58.5	58.07
31.05	-56.97	46.8
45.53	14.83	28.47
-36.61	-88.3	-7.27
-32.33	-83.49	19.02
-11.19	-61.19	52.88
-17.54	-70.86	33.6
-38.79	-38.34	33.72
22.57	-77.2	10.49
16.18	-65.77	8.64
18.24	-60.19	-3.96
24.75	-105.38	-2.02
39.41	-72.82	-6.55
41.58	-85.21	-2.39
43.53	-51.34	-18.04
32.73	-7.74	-45.38
34.87	-9.48	-39.72
33.81	-5.94	-33.3
47.49	0.86	-44.94
24.26	8.89	-30.93
1.15	33.8	51.85
9.47	46.69	19.85
7.46	27.38	32.28
40.1	20.28	-19.59
11.55	64.19	29.73
11.52	65.88	22.96
7.53	-16.73	0.89
-11.35	-59.52	-6.06
-15.79	-10.66	-17.14
-20.05	1.07	-14.59
-54.99	28.9	-2.97
-45.45	33.15	13.33
-57.11	37.76	4.2
-41.29	30.3	-16.47
-57.03	30.57	24.67
-49.74	52.09	13.16
-22.28	61.2	20.15
-13.68	24.84	28.14
31.08	-76.83	32.62
12.04	-44.29	67.13
16.31	-67.13	55.35
-9.06	-63.27	53.01
-6.96	-68.07	43.34
-4.8	-66.9	62.11
3.17	51	39.57
0.96	63.63	22.07
5.14	65.93	7.45
-47.61	50.14	15.51
-37.03	50.7	23.17
-34.79	33.16	46.56
-24.4	63.28	20.02
-17.98	50.55	35.28
-9.42	33.71	51.92
-59.11	26.83	32.71
-43.44	59.22	8.2
-39.27	68.17	-1.32
-37.1	50.13	-3.42
-7.35	36.14	39.53
-7.41	47.15	29.9
-7.54	59.05	0.23

// Bokde A L W, 2008: Mild Cognitive Impairment (MCI) Patients
// Subjects=16
37.44	-94.67	16.04
43.64	-78.45	-12.85
54.24	-76.5	0.27
43.75	-51.72	61.9
41.17	33.26	2.82
51.88	15.15	32.85
-36.57	-96.5	-3.37
-47.2	-79.72	-3.35
-51.47	-73.92	-11.49
-47.48	17.91	23.26
58.37	-61.58	-15.2
47.98	-87.02	18.79
37.42	-76.64	34.79
35.29	-51.92	59.74
49.6	41.94	5.51
-17.46	-76.93	55.11
-17.53	-55.58	59.19
-32.28	-85.76	33.6
-17.87	-23.82	-25.11
-32.3	-57.47	64.96
-51.82	28.72	-6.31
-56.05	18.29	-21.11
-32.56	11.93	61.32
3.17	51	39.57
0.96	63.63	22.07
5.14	65.93	7.45
-47.61	50.14	15.51
-37.03	50.7	23.17
-34.79	33.16	46.56
-24.4	63.28	20.02
-17.98	50.55	35.28
-9.42	33.71	51.92
-59.11	26.83	32.71
-43.44	59.22	8.2
-39.27	68.17	-1.32
-37.1	50.13	-3.42
-7.35	36.14	39.53
-7.41	47.15	29.9
-7.54	59.05	0.23

// Bray S, 2008: Pavlovian Training > Transfer Trials
// Subjects=23
27	-3	-3
24	-18	0
-27	-15	-3

// Harenski C L, 2008: Normal Males
// Subjects=14
12	45	-12
-6	-54	9
12	-48	3
-51	-72	24
54	-66	33
21	-33	-18
-24	36	51
-12	-72	60
-21	6	69
0	-12	-15
-6	54	6
-9	-54	9
9	-48	6
-6	-60	36
-3	-36	36
-54	-60	27
21	-36	51
-24	-30	-18
-6	-66	57
-21	6	72
9	-24	-15
0	-15	-15
54	-72	12
-9	-33	-36
6	-51	27
0	51	-15
-45	-75	36
-21	-3	-27
-42	-78	36
-18	-63	33
-33	6	15
-39	-81	33
36	21	3
42	9	27
0	-36	-42
-45	-72	15
36	21	3

// Harenski C L, 2008: Normal Females
// Subjects=14
12	45	-12
-6	-54	9
12	-48	3
-51	-72	24
54	-66	33
21	-33	-18
-24	36	51
-12	-72	60
-21	6	69
0	-12	-15
12	45	-9
-6	-57	24
3	60	6
-51	-72	24
51	-69	36
-24	-36	-18
-12	-72	60
6	-51	27
0	51	-15
-45	-75	36
-21	-3	-27
-3	-57	21
-12	-57	30
-30	6	12
-18	-63	33
-33	6	15
-39	-81	33
36	21	3
42	9	27
0	-36	-42
-45	-72	15
3	18	51

// Hu S H, 2008: Healthy heterosexual males
// Subjects=10
-2	2	26
-30	-90	-26
40	-60	-32
20	-36	-2
-32	-56	48
48	-72	-10
-54	12	24
54	20	10
54	32	30
-54	-70	-8
-40	0	-4
38	6	-10
2	-80	-2
6	-70	2
8	40	-6
-38	58	16
52	42	20
-52	-74	0
28	-92	2
62	-6	-26
14	-14	-20
-60	-16	40
-20	-16	62
48	10	36
-12	-40	4
-20	70	8
32	64	16
28	-66	50
-18	-52	66
-16	-18	12
0	-26	-24
-6	-44	-30

// Hu S H, 2008: Healthy homosexual males
// Subjects=10
-42	-68	48
-8	0	24
-12	-86	-28
-6	-78	-48
60	20	4
54	30	20
44	12	18
-52	-68	-10
56	-66	-6
-50	-62	-18
64	-30	-18
-38	0	6
8	72	12
2	-6	38
4	20	32
-42	56	6
-36	52	2
52	44	16
-28	-84	32
-64	-12	-18
14	0	6
32	-36	66
-64	-10	20
12	-36	6
54	2	30
-22	-42	18
-16	72	6
-26	-78	54
-8	-32	6
12	-10	8
-2	-50	-30

// Jager G, 2008: Recognition, Novel - Recognition, Practiced
// Jager G, 2008: Oddball Detection - Rest
// Jager G, 2008: Associative Learning - Classification
// Subjects=33
34	-63	48
46	5	32
6	6	56
46	-39	-12
-30	-67	44
-46	21	-4
-58	-31	4
60	-23	8
-2	21	44
-26	-47	-16
34	-47	-20
-34	-87	8
50	17	28
-46	29	24
-42	21	-4
2	29	40
30	-91	8
50	21	-4

// Lim H K, 2008: Alzheimer's Disease
// Subjects=12
-21.91	-51.59	49.08
-46.61	48.61	-3
-57.42	24.44	-8.27
-46.43	-24.44	-3.62
25.68	-9.45	60.91
-24.12	-49.78	45.57
-17.55	-57.86	50.74

// Lim H K, 2008: Elderly Normals
// Subjects=12
-2.47	-75.65	43.28
60.84	20.94	28.16
-41.26	-20.32	63.12
-37.33	-29.81	30.38
14.96	-8.87	67.75
-46.61	48.61	-3
-57.42	24.44	-8.27
-46.43	-24.44	-3.62
25.68	-9.45	60.91
-24.12	-49.78	45.57
-17.55	-57.86	50.74

// McClernon F J, 2008: Smoking Cues vs. Control Cues, FTND-Positive 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, FTND-Negative 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Craving-Negative 
// Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Negative 
// Affect-Positive Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Negative 
// Affect-Negative Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Sex-Female Correlations
// McClernon F J, 2008: Smoking Cues vs. Control Cues, Sex-Male Correlations
// McClernon F J, 2008: Smoking Cues > Control Cues
// McClernon F J, 2008: Control Cues > Smoking Cues
// Subjects=12
9	42	-6
6	39	-18
-42	-75	-18
-48	-78	-12
-15	-6	0
9	12	9
-36	-45	45
-27	-51	51
21	-12	-21
-33	-48	-6
60	-3	0
-12	21	-6
-51	-78	9
15	3	0
-30	-12	-18
-12	33	-18
-15	-6	78
-15	-3	66
-51	-45	54
-42	24	-9
27	12	3
12	-84	33
-42	15	-27
-45	0	-27
-18	-102	9
-15	-9	75
-30	-12	-18
-12	33	-18
-9	48	-3
18	54	12
-6	-84	36
9	-48	30
12	36	-15
6	-48	-21
21	27	66
18	-69	54
-15	51	30
-15	-72	9
-12	-39	-33
-9	-48	45
42	-30	-3
-6	-33	30
39	-15	60
-15	-69	-12
9	39	12
-45	-66	57
-39	-87	21
45	-75	24

// Piblajamaki M, 2008: AD Patients > Healthy Controls, Repeated Face/Name 
// Pairs vs. Fixation (Activations)
// Piblajamaki M, 2008: AD Patients > Healthy Controls, Repeated Face/Name 
// Pairs vs. Fixation (Deactivations)
// Subjects=15
42	36	26
38	16	28
-36	-50	40
-46	-44	36
-24	-62	42
-22	-4	-26
16	-50	24
6	-68	40
-4	-72	40
-36	-70	36

// Shimomura T, 2008: Nenbutsu > Rest
// Shimomura T, 2008: Sutra > Rest
// Shimomura T, 2008: Shiritori > Rest
// Subjects=8
1.88	13.21	63.55
-6.73	9.03	65.23
-2.32	-.11	70.54
-.5	21.43	48.21
-.44	13.13	51.27
1.5	34.43	37.92
-45.97	20.54	41.23
-58.06	24.47	26.48
-52.39	12.22	44.4
56.85	-50.98	39.83
49.28	-59.82	37.47
67.58	-40.62	35.26
3.79	21.24	45.91
-33.58	39.29	-0.06
-46.7	46.82	-10.66
-36.79	27.47	0.05
-41.52	19.36	51.35
-32.82	19.81	55.64
-28.47	12.38	56.31

// Vannini P, 2008: Normals
// Subjects=13
26.28	-70.25	47.24
-22.92	-62.17	46.02
-20.75	-79.42	42.98
34.73	-47.02	44.08
-32.61	-48.65	42.76
49.41	8.34	29.24
-45.7	8.91	31.4
49.41	8.34	29.24
-32.7	-10.07	46.22
10.05	14.63	42.54
-7.85	10.74	47.54
24.07	-85.29	31.8
-32.74	-85.25	9.93
-22	-95.53	13.68
31.42	-85.47	15.01
-30.49	-86.22	24.7
-46.7	-78.26	5.15
-32.01	21.12	9.03
7.38	-19.74	0.18
1.92	-18.68	0.6
-18.07	4.22	8.05
22.06	-78.48	51.33
-14.27	-79.75	51.85
56	-34.72	36.12
44.27	-47.73	34
31.46	-87.25	19.62
-34.8	-85.53	20.23
-15.65	-81.93	10.01
-45.65	-74.11	3.68
23.67	-31.19	2.07
0.01	-14.21	3.48
-21.76	-73.28	53.63
40.85	-2.59	23.56
-48.9	-.75	27.78
22.81	-15.8	36.03
-25.23	-13.46	43.07
-30.65	-93.36	1.21
30.39	-80.65	22.42
-6.69	-89.62	33.64
29.21	-38.99	24.52
28.99	-24.83	1.14
-.52	-15.24	4.02
28.19	-94.51	8.55
57.95	-54.27	3.27

// Vannini P, 2008: Alzheimer's Disease Patients
// Subjects=13
28.29	-63.86	33.3
-23.93	-78.04	47.36
-22.93	-54.6	47.61
40.04	-36.33	44.24
-36.89	-42.16	44.5
48.35	7.15	30.46
-42.46	3.52	32.93
26.07	-81.19	15.82
-28.45	-80.63	14.17
44.14	-71.12	6.85
38.52	21.62	9.29
14.06	-18.02	7.99
-16.93	-17.12	8.71
-19.13	5.23	10.21
22.06	-78.48	51.33
-14.27	-79.75	51.85
56	-34.72	36.12
44.27	-47.73	34
31.46	-87.25	19.62
-34.8	-85.53	20.23
-15.65	-81.93	10.01
-45.65	-74.11	3.68
23.67	-31.19	2.07
0.01	-14.21	3.48
-21.76	-73.28	53.63
40.85	-2.59	23.56
-48.9	-.75	27.78
22.81	-15.8	36.03
-25.23	-13.46	43.07
-30.65	-93.36	1.21
30.39	-80.65	22.42
-6.69	-89.62	33.64
29.21	-38.99	24.52
28.99	-24.83	1.14
-.52	-15.24	4.02
28.19	-94.51	8.55
57.95	-54.27	3.27

// Vossel S, 2008: Invalid Responses > Valid Responses, Nicotine vs. Placebo
// Subjects=12
15	54	-15
51	15	45
36	60	3
51	0	24
-51	-18	-21
42	-42	15
18	-60	63
54	-54	36
24	-48	3
-15	30	-6
33	-12	-18
30	-27	3
3	9	15

// Wiech K, 2008: Catholics
// Subjects=12
51	-21	27
48	-33	27
36	6	18
39	-21	3
-54	-33	24
18	-102	15
48	-81	-9
24	-9	-9
-27	3	-12
21	0	-15
39	3	-6
-54	-3	12
57	0	9
33	-30	75
9	-15	54
-18	-45	-27
33	9	-21
48	30	6
-6	-21	-27
0	-15	75
18	-12	75
51	-75	9
-15	-24	78

// Wiech K, 2008: Atheists and Agnostics
// Subjects=12
45	-24	21
-60	-24	21
-48	-33	21
57	6	0
48	30	6
-6	-21	-27
0	-15	75
18	-12	75
51	-75	9
-15	-24	78

// Zheng D, 2008: No-Go - Go (Go/No-Go)
// Zheng D, 2008: Stop - Go (Stop Signal)
// Subjects=18
1.4	51.24	34.02
42.9	21.42	-23.12
64.51	5.13	-26.36
-37.88	59.14	5.9
-8.88	-52.54	-30.61
40.37	35.53	36.03
53.22	24.86	24.54
55.27	-76.62	-4.67
50.01	21.76	26.03
67.93	-46.01	-22.48
58.92	-49.47	32.92
-68.9	-28.39	12.84
55.25	-75.66	-5.89
-24.33	-63.35	26.75
-49.94	-33.74	57.87
68.14	-32.44	-3.66
61.63	25.36	6.42
-8.54	38.6	14.15

// Chan S W Y, 2008: Negative Words vs. Control Words
// Chan S W Y, 2008: Positive Words vs. Control Words
// Chan S W Y, 2008: Positive Words vs. Negative Words
// Chan S W Y, 2008: Negative Words vs. Positive Words
// Chan S W Y, 2008: Negative Words > Positive Words, High N Scores vs. Low N 
// Scores
// Chan S W Y, 2008: Positive Correlations with N, Negative Words
// Chan S W Y, 2008: Positive Correlations with N, Positive Words
// Chan S W Y, 2008: Negative Correlations with N, Positive Remembered
// Chan S W Y, 2008: Negative Correlations with N, Negative Remembered
// Chan S W Y, 2008: Correlations with Categorization and Recognition of 
// Negative Words
// Subjects=10
14	-84	6
-4	56	24
-44	28	-10
-2	18	42
14	-82	4
-56	28	-2
66	-18	30
-24	14	66
20	-64	64
-8	-8	52
-20	-28	66
-46	26	-6
48	0	12
-10	8	54
-10	26	46

// Helmchen C, 2008: Thermal Pain > Laser Pain
// Helmchen C, 2008: Thermal Pain = Laser Pain
// Subjects=14
8	-4	42
58	-18	14
48	-22	16
-56	-12	26
-48	-12	12
50	4	4
-54	-20	6
-36	-16	10
0	56	-16
-4	64	4
-4	58	-10
8	-12	54
20	-14	76
26	-44	72
18	-46	66
6	16	36
0	10	48
-8	8	46
32	20	4
34	18	6
40	18	-2
46	8	14
-32	10	8
-38	26	-2
-36	0	0
36	4	4
40	-2	-10
40	0	-10
36	8	-16
32	6	-12
46	-18	20
38	-14	18
62	-30	18
50	-14	22
52	-18	18
52	-20	32
50	-24	22
54	-14	14
34	-16	16
-4	-10	-2
-8	-20	6
6	-10	0
10	-10	-4
10	-20	8
10	-22	10
10	6	2
20	10	-12
18	6	2
-12	6	-4
-18	12	-8
-20	8	0
-20	6	-10
28	-2	52
28	-2	54
-28	-6	50
-30	-2	58
44	-2	56
-50	4	46
36	0	60
-40	48	22
54	6	26
-56	6	38
-60	12	30
-58	8	18
48	-32	48
34	-40	46
36	-48	54
-56	-38	24
22	-52	0
16	-38	-6
-6	-28	-8
-4	-30	-26
8	-30	-6
6	-36	-36
4	-28	-26
-4	-42	-18
14	-78	-24
-10	-70	-24
-44	-50	-38
-36	-50	-36
-36	-46	-44
-20	-38	-30
-14	-46	-24
-28	-56	-32
-58	-18	30
-22	-10	62

// Mohr C, 2008: Pain vs. High Level Baseline
// Mohr C, 2008: Self Administrated Thermal Stimulation vs. Externally 
// Administrated Thermal Stimulation
// Mohr C, 2008: Externally Administrated Thermal Stimulation vs. Self 
// Administrated Thermal Stimulation
// Mohr C, 2008: Externally Administered Thermal Stimulation = Self 
// Administered Thermal Stimulation
// Subjects=17
2	16	56
6	22	40
-4	22	40
40	46	6
-38	36	14
-38	32	24
-42	50	20
36	46	-16
46	-44	48
54	-42	54
42	-48	40
-38	-54	46
-20	-42	76
-60	-24	22
-54	-18	10
-64	-16	12
-44	-22	12
52	-4	8
-52	-4	4
-32	20	-4
34	24	-8
32	16	8
-38	-18	14
14	14	-2
-14	14	-4
-40	-58	-34
-44	-74	-30
38	-74	-28
-8	-80	-32
-10	-74	-46
-20	-72	-46
52	-4	8
-38	-2	-14
60	2	8
36	-20	56
28	-14	60
32	56	30
42	52	8
4	-58	-32
0	-48	-18
0	-46	-6
-6	-62	-32
-8	-50	-16
0	16	44
8	14	44
4	10	54
36	18	4
42	12	-4
38	10	-6
-32	14	6
6	-66	-16
8	-76	-18
-4	-58	-12
26	-60	-24
22	-52	-24
-28	-50	-30
-28	-60	-28
-22	-66	-24

// Plassmann H, 2008: Wine 1 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 1 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine 1 Low vs. High Price, Sampling
// Plassmann H, 2008: Wine 1 Low vs. High Price, Swallowing
// Plassmann H, 2008: Wine 2 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 2 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine 2 Low vs. High Price, Sampling
// Plassmann H, 2008: Wine 2 Low vs. High Price, Swallowing
// Plassmann H, 2008: Wine 1 and 2 High vs. Low Price, Sampling
// Plassmann H, 2008: Wine 1 and 2 High vs. Low Price, Swallowing
// Plassmann H, 2008: Wine vs. Neutral Solution, Tasting
// Plassmann H, 2008: Wine vs. Neutral Solution, Swallowing
// Plassmann H, 2008: [Wine 1, High Price - Low Price] - [Wine 2, High Price - 
// Low Price]
// Plassmann H, 2008: [Wine 2, High Price - Low Price] - [Wine 1, High Price - 
// Low Price]
// Plassmann H, 2008: Sampling is Modulated by the Liking Ratings
// Subjects=20
-12	-90	-6
30	30	24
-6	0	39
-12	36	-9
15	-93	-3
-42	-24	-6
-18	42	6
-24	30	-4
-4	-10	-9
9	-60	-42
9	-60	15
4	27	-4
21	42	54
-2	27	-2
3	-40	-33
3	-27	-12
9	-42	-1
-6	-49	16
57	18	3
57	12	24
54	12	45
57	16	3
-43	50	3
63	-9	-21
-30	-24	-6
-2	48	-20
3	48	-19
21	0	-18
6	-57	24
39	27	-21
9	39	-9
57	21	33
9	54	-3
-50	2	-27
15	30	57
-54	3	-27
3	33	-21
9	51	-6
3	-24	-21
33	-18	-21
9	-48	12
-1	-45	-12
-27	31	24
24	33	30
36	42	42
51	-27	6
14	-22	38
18	49	-9
-48	25	0
-51	-27	0
52	26	0
-9	3	43
38	-23	19
-60	-39	-3
33	-66	0
-4	43	-16
4	33	-13
-6	-15	-12
5	38	-9
-3	45	-18
4	-39	-38
9	-51	15
-33	-93	-3
-32	24	3
32	24	3
12	24	30
5	24	48
-3	24	47
21	45	36
-27	-51	-33
24	45	15
-6	12	6
10	15	10
-18	-84	0
18	-84	-3
33	30	21
-27	-45	-33
-27	54	30
-54	3	-15
-2	18	-17
-18	5	57
48	27	9
-3	48	-18
1	-39	-33

// Hampton A N, 2008: Expected Reward Signals at the Time of Choice
// Hampton A N, 2008: Influence Signals, Influence Update of Inferred 
// Opponent's Strategy
// Hampton A N, 2008: Influence Signals, Influence On Opponent
// Hampton A N, 2008: Prediction Error signals
// Subjects=30
0	36	-21
-3	63	15
42	15	-39
-3	57	12
-57	-54	0
60	-54	9
-3	51	24
9	6	-18
-9	9	-18
-9	57	6
12	36	18

// Tobler P N, 2008: Covariation Between Modeled and Actual Brain Activation 
// with an Inverted S-Shaped Function
// Tobler P N, 2008: Activations Covarying with an Inverted S-Shaped Function
// Tobler P N, 2008: Independence of Neuronal Probability Coding in Striatum 
// from Behavioral Probability Distortion
// Subjects=16
-32	16	34
54	32	14
-10	4	-4

// Knutson B, 2008: Positive Pictures > Negative Pictures
// Knutson B, 2008: High > Low-Risk Shift
// Knutson B, 2008: Gain vs Loss Outcome
// Subjects=15
-7.71	40.36	-19.63
12.65	24.62	-18.54
-26.87	20.15	-17.72
-3.25	17.09	-4.35
-11.82	12.38	-9.43
8.48	9.16	-11.62
21.3	9.24	-11.78
36.69	4.98	41.93
53.74	8.97	36.94
-58.48	-57.72	10.37
-51.04	-54.85	5.58
-2.84	-56.7	18.56
42.08	-60.41	21.7
-43.34	-85.49	21.44
36.35	25.58	5.64
-7.56	24.38	-6.03
5.34	14.23	-.86
-11.81	4.81	-11.03
13.83	7.08	-11.51
0.87	67.16	-4.13
-14.93	14.45	3.81
20.26	9.49	-8.44
-18.21	9.26	-7.98
49.36	12.23	24.45
-58.73	1.15	0.97
1.41	-53.59	17.14
24.83	-78.51	-4.46

// Hare T, 2008: Parametric Regressor for Goal Values
// Hare T, 2008: Parametric Regressor for Decision Values
// Hare T, 2008: Parametric Regressor for Prediction Errors
// Subjects=16
33	-81	-9
30	27	-12
-24	30	-18
-1	27	-18
1	39	6
51	24	21
45	33	9
21	9	-21
21	-30	-3
6	51	0
-15	-9	-15
-27	36	-6
15	21	-6

// Henderson L A, 2008: Male > Female, Intramuscular Pain
// Henderson L A, 2008: Female > Male, Intramuscular Pain
// Henderson L A, 2008: Male > Female, Subcutaneous Pain
// Henderson L A, 2008: Female > Male, Subcutaneous Pain
// Subjects=11
-24	-50	-48
-24	-60	-20
33	-11	-24
-24	-30	-20
8	8	56
3	-2	40
36	51	20
-33	50	16
-24	-66	-48
9	-47	-48
-18	-33	-20
0	17	44
0	3	28
35	41	24

// Hooker C I, 2008: Fear Learning > Neutral Learning
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlations 
// with Neuroticism
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlations with Neuroticism
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Extraversion
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Extraversion
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Agreeableness
// Hooker C I, 2008: Negative Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Agreeableness
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Conscientiousness
// Hooker C I, 2008: Fear Learning > Neutral Learning, Positive Correlation 
// with Openness
// Hooker C I, 2008: Happy Learning > Neutral Learning
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Extraversion
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation wtih Extraversion
// Hooker C I, 2008: Happy Learning > Neutral Learning, Negative Correlation 
// with Extraversion
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Negative Correlation wtih Extraversion
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Neuroticism
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Neuroticism
// Hooker C I, 2008: Happy Learning > Neutral Learning, Positive Correlation 
// with Conscientiousness
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Conscientiousnes
// Hooker C I, 2008: Positive Object Recognition > Neutral Object Recognition, 
// Positive Correlation with Openness
// Subjects=12
28	8	-24
42	-20	-18
50	32	16
-52	32	4
-56	18	26
-26	-76	46
66	-52	2
-62	-54	4
38	-84	-20
44	-46	-26
30	2	-16
26	-20	-20
-26	-24	-20
24	-2	62
-30	-38	64
-54	-26	44
-46	-68	6
44	-60	-18
-8	-50	22
20	-6	-16
32	-18	-20
-26	-10	-20
38	-52	60
44	-70	28
-36	-76	42
26	62	-6
52	50	10
-36	50	32
6	20	40
60	-46	30
44	-44	58
18	-4	8
-14	0	-8
-44	-6	-18
-40	34	36
16	-78	40
8	-44	44
6	18	50
-22	-86	30
38	-86	20
-36	-50	36
-10	-44	4
52	-30	4
-52	-42	-20
58	-42	-22
36	-10	12
-8	20	68
-12	12	44
-40	-76	12
-54	-34	4
-16	-22	4
-34	-30	12
26	-54	42
22	-20	-2
-36	6	58
-52	-62	2
-52	0	28
36	-50	48
26	32	42
-46	-36	12
-36	-80	-28
46	-50	34
-56	-62	0
30	34	-22
-20	60	-8
36	44	4
8	32	48
26	26	-14
12	-54	40
-12	-64	28
2	-44	-10
46	-56	16
10	56	-8
58	-16	-6
-44	2	-10
-36	-46	-44
28	-22	-14
2	66	2
-10	66	-4
0	58	-8
20	32	32
-28	24	46
44	-18	18
-32	-26	20
8	-22	52
32	-26	52
-46	-12	22
-10	-30	70
54	-22	-6
60	-38	18
-44	-54	-2
-40	-64	24
-18	-36	-16
-10	-56	22
-18	-14	-22
-22	2	-16
24	-12	-14
-16	-40	64
6	-40	58
48	-10	-10
-40	-18	-6
-54	4	-18
6	-10	-10
16	-16	36
40	-70	14
46	-44	-32
-14	-30	-12
18	-28	-6
36	-40	-38
2	-42	34
26	0	-20
22	-6	-10
14	28	62
56	-6	42
60	-34	-4
60	-46	-2
28	16	-36
-14	14	8
-20	-82	22
-14	-92	-4
26	-86	20
28	0	-10
-40	8	14
-56	4	4
28	12	-14
-20	28	-14
-32	40	22
14	-16	48
-14	-2	46
34	-6	42
36	-20	4
-30	-26	18
-52	-28	24
-46	-14	-10
-60	-34	20
44	-66	-4
-44	-66	-8
-28	-44	62
16	-66	10
-20	-76	26
12	-48	66
-26	30	56
32	-36	60
-26	-72	52
-22	-72	-14
-12	-52	4
-12	-2	2
18	-4	64
-34	-40	-34
-46	-64	24
-6	-46	38
28	16	48
10	-58	46
-40	-72	16
-56	-56	0
-48	-38	-20
-30	-22	-20
-48	-48	-40

// McNab F, 2008: Flanker Task, Incongruent > Congruent
// McNab F, 2008: No-Go > Oddball (Go/No-Go)
// McNab F, 2008: No-Go > Go
// McNab F, 2008: Stop > Oddball (Stop Task)
// McNab F, 2008: Stop > Go
// McNab F, 2008: Spatial Working Memory > Spatial Working Memory Control
// McNab F, 2008: Verbal Working Memory > Verbal Working Memory Control
// McNab F, 2008: Spatial and Verbal Working Memory Tasks
// McNab F, 2008: Go/No-Go and Stop Tasks w/ Oddball
// McNab F, 2008: Go/No-Go and Stop Tasks
// McNab F, 2008: Flanker Task and both Working Memory Tasks
// McNab F, 2008: Go/No-Go and both Memory Working Tasks
// McNab F, 2008: Stop Task and both Working Memory Tasks
// McNab F, 2008: Go/No-Go, stop Task and both Working Memory Tasks w/ Oddball
// McNab F, 2008: Go/No-Go, Stop Task and both Working Memory Tasks
// Subjects=11
30	-54	45
39	-45	51
-3	27	18
-24	27	9
-15	27	9
-42	12	-3
45	15	-3
33	24	-6
27	15	-15
12	-75	48
-42	36	36
33	51	33
24	48	33
45	42	30
63	-45	33
51	-42	36
54	-36	42
-45	-45	39
-42	-51	48
-33	-90	-6
6	-36	27
0	-30	30
33	24	-6
33	24	-6
48	15	-9
33	12	3
27	51	30
36	42	27
48	39	27
45	15	-6
36	15	3
36	18	-18
-45	15	-9
-36	21	6
-36	12	12
30	45	36
30	42	24
42	42	27
15	9	69
15	-9	72
12	15	60
9	18	45
9	6	48
6	24	30
54	-45	36
63	-54	30
9	-18	9
9	-24	-6
15	-9	-3
24	-87	-15
42	-84	-9
39	-78	-15
27	-54	51
39	-39	51
48	15	-6
6	9	48
33	24	-6
-45	15	-9
-33	21	6
-30	6	15
-63	-57	6
-45	-81	-12
-57	-54	18
12	-72	45
51	-72	-6
51	-57	12
9	-18	9
6	-24	-6
-3	-18	-6
-3	-27	30
27	-69	51
21	-78	51
39	-42	42
27	-6	60
-24	-6	57
6	15	54
-42	-51	51
-24	-69	54
-33	-54	45
36	21	-6
45	15	-3
-33	21	3
-42	15	-6
48	6	27
48	21	33
57	6	36
-42	3	30
-3	-3	63
-42	-6	51
-30	-60	42
-27	-69	45
-42	-45	42
36	21	-6
30	-69	48
39	-48	48
33	-66	36
45	3	30
51	24	30
45	42	30
33	-3	66
27	-6	60
-48	-51	6
-15	-3	15
-15	9	3
-3	-18	15
-42	-51	51
-33	-54	42
-42	-45	42
-42	-6	51
-6	12	51
6	12	54
30	-69	48
39	-48	48
36	-57	51
36	21	-6
45	15	-3
-33	21	3
-42	15	-6
45	3	30
51	27	33
42	39	21
33	-3	66
27	-6	60
45	15	-3
33	24	-6
36	21	-15
-42	12	-3
24	48	33
45	42	30
39	33	39
33	24	-6
48	15	-9
33	12	3
27	51	30
36	52	27
48	39	27
30	-54	45
39	-45	51
33	24	-6
45	15	-3
33	24	-9
36	18	-3
45	15	-3
6	6	51
9	18	45
12	21	36
-33	24	3
-42	15	-6
-36	21	-6
27	-54	48
33	-57	54
39	-42	48
33	24	-6
45	15	-3
33	24	-6
45	15	-3

// Mulder M J, 2008: Attention Deficit/ Hyperactivity Disorder Patients
// Subjects=12
-37.92	52.24	0.98
23	27.19	28.19
-16.59	-62.42	-44.07

// Mulder M J, 2008: Healthy Siblings
// Subjects=12
27.31	31.46	27.69
35.38	-52.69	-34.71

// Mulder M J, 2008: Healthy Controls
// Subjects=12
44.06	20.99	-16.38
10.1	27.56	32.86
44.28	53.26	7.32
-37.6	51.34	25.71
48.64	-44.94	-9.93
64.87	-18.42	-2.75
-20.96	-59.56	-47.64
39.82	25.95	-8.95
48.64	-23.04	-5.38
1.44	-88.53	8.63
35.38	31.59	-17.28
5.78	36.37	35.42
10.11	45.2	37.83
40.57	26.04	49.3
-57.79	-47.96	32.52
69.67	-43.25	29.88
-37.92	52.24	0.98
27.31	31.46	27.69
-16.59	-62.42	-44.07
35.38	-52.69	-34.71

// Protopopescu X, 2008: Premenstrual vs. Postmenstrual Phases, Negative Go 
// vs. Neutral Go
// Protopopescu X, 2008: Premenstrual vs. Postmenstrual Phases, Positive Go 
// vs. Neutral Go
// Subjects=8
24	3	-27
-21	51	-3
-45	36	-12
30	42	-12
-6	48	-15
9	6	-9

// Shane M S, 2008: Errors > Correct Responses, Performance Go and NoGo
// Shane M S, 2008: Errors > Successful Inhibitions
// Shane M S, 2008: Observed Errors > Observed Correct Responses
// Shane M S, 2008: Observed Errors > Observed Correct Inhibitions
// Shane M S, 2008: Observed Errors vs. Performed Errors
// Subjects=21
-39	15	-15
-63	-45	36
9	21	63
3	-72	45
-39	-51	-27
6	30	33
0	-24	6
45	21	-9
48	12	45
18	-33	-3
9	-3	6
3	-21	-33
-9	39	12
-45	3	-12
3	-93	30
3	-36	0
-15	-24	-39
-57	-21	15
-3	24	27
9	21	66
0	24	30
51	-36	48
-54	-27	51
-39	-54	60
-45	-81	0
39	-42	-36
-39	-57	-36
45	39	30
21	42	-21
54	-63	3
-12	-6	12
57	18	24
-63	-24	18
27	-24	3
12	-69	6
39	6	60
3	27	45
0	15	33
-9	36	18
12	21	-9
6	30	-12
12	57	6
-6	42	-6
3	3	-15
-45	-39	60
-33	-45	-51
0	-81	21
-66	-24	18
12	-66	9
-60	-21	42
-18	-48	63
-54	-27	51
-54	-72	12
-15	-51	-3
6	66	3
63	-18	36
45	-45	60
-9	0	60

// Simmons W K, 2008: Word association > Situation generation
// Simmons W K, 2008: Situation generation > Word association
// Simmons W K, 2008: Early property generation > Late property generation
// Simmons W K, 2008: Late property generation > Early property generation
// Simmons W K, 2008: Early property generation > Late masked by Word 
// association > Situation generation
// Simmons W K, 2008: Late property generation > Early masked by Situation 
// Generation > Word association
// Simmons W K, 2008: Late property generation > Early masked by Word 
// association > Situation generation
// Subjects=10
-39	24	-12
-48	36	-6
-51	18	-3
-51	39	6
-57	12	12
54	12	18
-42	3	30
-9	-69	-42
-27	-60	-30
-9	-54	-12
15	-87	-33
27	-69	-30
-45	-48	-18
-18	15	-15
-33	33	24
21	18	-15
-24	0	9
24	3	9
-15	-9	3
-12	-18	12
18	-15	-3
-24	-96	0
-24	-69	48
-54	6	-6
-9	-15	-18
0	0	69
15	6	72
48	18	-3
12	18	-3
0	-93	6
12	21	39
-9	18	42
-12	-72	24
-21	-69	18
-6	-57	54
-12	-42	57
3	-69	27
39	-12	42
-9	-30	51
-9	-45	21
48	-72	33
48	-60	12
-45	-3	-21
-51	0	-15
-42	-21	-3
-54	-15	9
-54	-30	15
51	-18	9
0	54	-6
-24	51	-3
18	36	39
-24	45	27
-27	27	45
-63	-9	-30
42	-6	-9
-45	36	6
-54	27	12
-39	27	15
-45	33	24
-3	45	-18
-21	30	-18
6	57	3
-15	57	27
-3	42	30
-3	45	51
-18	33	54
6	63	3
-54	-6	42
-30	-15	54
-30	-6	54
27	-72	-33
6	-57	-39
0	-45	-21
-54	-39	-9
-51	-48	-3
-3	-57	18
-12	-51	3
-15	15	0
-3	9	60
-12	33	-15
6	30	-12
-12	-72	33
54	24	-6
54	18	6
45	18	39
33	63	12
18	54	39
3	36	45
27	18	63
24	6	66
27	54	-6
51	-18	9
39	9	-36
-21	-48	-9
-39	-15	-18
-30	-60	-12
-42	-84	12
-24	-84	18
-60	-51	33
-39	-48	42
-51	-48	51
-39	9	-12
6	3	9
27	15	-6
33	6	-6
-15	-27	12
12	-15	18
-45	36	6
-48	6	33
27	-72	-33
-6	-54	54
9	-72	27
6	-69	42
9	-54	51
51	-54	18
9	-15	12

// Tanaka S C, 2008: Contrast of High vs. Low Objective Contingency
// Tanaka S C, 2008: Contrast of Sessions with High vs. Low Causality 
// Judgments
// Subjects=13
6	10	20
-6	52	-10
-2	30	-20
26	-36	-8
-48	14	-18
-10	50	-10
-42	32	-8
-2	18	-18
-12	36	42

// Walter M, 2008: Bodily-Emotional Positive Pictures > Non-Bodily-Emotional 
// Positive Pictures
// Walter M, 2008: (Positive Bodily > Positive Non-Bodily) ^ (Positive > 
// Negative Bodily)
// Walter M, 2008: Signal Correlation with Sexual Intensity
// Walter M, 2008: (Positive Bodily > Positive Non-Bodily) ^ (Negative Bodily 
// > Negative Non-Bodily)
// Walter M, 2008: (Bodily-Emotional > Non-Bodily-Emotional) ^ 
// (Non-Bodily-Emotional > Non-Bodily Neutral)
// Subjects=21
-9	9	3
9	6	6
-3	12	-9
6	0	-12
0	39	6
3	57	3
6	51	30
-51	-78	0
54	-72	0
-36	-60	57
27	-60	60
3	-66	36
42	-45	24
-3	-6	-9
18	-3	-15
0	12	-3
-2	11	-11
0	39	6
3	57	3
54	-72	-6
3	-66	48
-3	15	-3
-6	48	-9
33	-39	48
-9	9	6
9	9	3
-9	3	-13
-6	51	27
-51	-75	-6
54	-66	0
-33	-57	54
33	-57	57
9	-63	39
45	-42	-24
-15	3	-18
18	0	-18
9	0	0
3	-24	0
-48	-81	0
51	-69	0
42	-45	-24
39	33	-9
-6	54	30

// Preuschoff K, 2008: Activation During 1s Epoch After Display of Card 1
// Preuschoff K, 2008: Deactivation During 1s Epoch After Display of Card 1
// Preuschoff K, 2008: Activation During Second, Remaining Epoch Between Cards 
// 1 and 2
// Subjects=19
35.19	16.95	-9.57
-32.12	15.57	-7.68
58.13	-51.34	27.45
52.44	20.82	11.43
-44.35	-59.64	39.36
43.92	-9.68	3.04
62.33	-24.62	28.51
-39.25	-25.83	21.97
-58.68	-10.43	2.61
36.32	24.27	2.4
-9.38	-25.1	14.87
-13.71	-30.1	5.75
-32.07	24.89	2.8
-39.23	-5.64	32.54
-41.27	-8.18	43.93

// Rao H, 2008: Activations Covaried with Voluntary Risk
// Rao H, 2008: Activations Covaried with Involuntary Risk
// Rao H, 2008: Activations Differed Between Voluntary and Involuntary Risk
// Rao H, 2008: Active Inflation vs. Passive Inflation
// Rao H, 2008: Active Loss vs. Passive Loss
// Rao H, 2008: Active Win vs. Passive Win
// Rao H, 2008: Active Loss vs. Active Win
// Subjects=14
38	10	-2
-34	18	-6
0	12	42
-10	2	4
14	2	-2
6	-16	-2
-6	-12	-4
-22	-54	-4
30	-76	24
30	-52	-16
-28	-80	20
30	-46	46
-34	46	16
-52	-36	38
30	36	20
-42	-80	4
28	-50	-10
10	-68	6
30	-50	48
-28	-48	50
12	18	38
-8	0	4
36	16	0
-28	18	6
12	4	4
32	46	26
-32	46	22
30	50	32
-14	10	67
30	54	26
30	22	-6
-8	2	0
8	4	2
32	52	32
10	12	70
-32	18	-6
32	20	-2
4	22	52
-8	2	2
10	4	0

// Kinno R, 2008: Sentence Control > Fixation
// Kinno R, 2008: Canonical/Subject-Initial Active Sentence > Fixation
// Kinno R, 2008: Noncanonical/Subject-Inital Passive Sentence > Fixation
// Kinno R, 2008: Noncanonical/Object-Initial Scrambled Sentence > Fixation
// Kinno R, 2008: Canonical/Subject-Initial Active Sentence - Sentence Control
// Kinno R, 2008: Noncanonical/Object-Initial Scrambled Sentence - 
// Canonical/Subject-Initial Active Sentence
// Kinno R, 2008: (Scrambled Sentence - Active Sentence) vs. (Active Sentence 
// - Sentence Control)
// Kinno R, 2008: Noncanonical/Subject-Initial Passive Sentence  - 
// Canonical/Subject-Initial Active Sentence
// Subjects=14
-36	12	51
45	15	36
-54	18	12
-45	39	9
-3	24	48
-54	-51	6
-48	-60	51
42	-63	36
-45	6	48
48	21	33
-51	18	27
-51	27	6
-3	18	51
-6	3	3
9	3	0
-54	-54	6
51	-54	6
-24	-78	33
45	-78	6
-39	-3	45
45	18	36
-51	21	24
-54	27	3
3	18	51
9	3	3
-54	-54	6
51	-60	9
-39	-57	54
-30	-81	30
42	-78	6
-42	3	48
48	21	33
-51	21	18
-48	18	0
42	21	-6
-3	18	48
-9	0	3
-60	-48	9
54	-36	3
-36	-57	51
-30	-84	30
45	-75	6
-39	0	54
-57	-60	0
54	-60	0
-51	-75	6
-39	0	45
-52	21	21
-54	-54	3
-51	21	18
-51	-51	3
-48	24	21

// Shikata E, 2008: Color Discrimination > Orientation Judgment
// Subjects=11
-39.6	-40.1	44.7
41.2	-40.6	50.2
-15.5	-66.3	58.4
21	-65.7	55.9
-25.6	-57	58.4
26.1	-59.4	57.6

// van Duinen H, 2008: Right Index Finger Abduction > Rest
// van Duinen H, 2008: Left Index Finger Abduction > Rest
// van Duinen H, 2008: Right Finger MVC vs. Right Finger Submaximum
// van Duinen H, 2008: Left Finger MVC vs Left Finger Submaximum
// van Duinen H, 2008: Activity Correlating with "Activation Per Se", Right 
// Contractions
// van Duinen H, 2008: Activity Correlating with "Activation Per Se", Left 
// Contractions
// Subjects=10
-34	-40	56
-40	-28	52
-24	-26	56
-60	2	34
-20	-20	76
22	-10	68
66	-16	32
40	2	16
-10	-10	54
14	-12	48
-12	-26	44
56	12	14
-42	-36	24
52	-36	26
-54	-30	22
66	-34	22
-40	-2	12
40	2	10
34	28	8
30	4	12
-14	10	22
-14	-22	6
-22	0	-10
12	-56	-12
-34	-58	-28
22	-52	-24
-18	-72	-50
18	-66	-44
-44	-60	-30
40	-56	-32
-34	-46	56
-38	-12	66
-26	-30	48
-46	-12	60
-42	-12	44
-48	-8	48
-20	-18	70
54	-16	54
38	-24	64
32	-26	50
40	-12	62
18	-22	74
42	-22	48
-44	-2	2
-6	-6	54
8	-4	50
12	-14	76
-12	-26	44
12	0	44
56	12	20
58	10	32
-50	-42	24
-52	-26	20
54	-22	18
-64	-20	28
56	-20	20
-30	-54	56
38	-48	64
-48	-40	14
66	-30	18
44	2	10
-16	-2	6
26	-2	2
-24	6	0
32	-8	4
-12	2	16
18	0	24
26	0	10
-40	-18	-18
-28	-42	2
12	-34	16
-22	-48	10
-4	-62	-16
-20	-52	-26
30	-54	-26
-20	-64	-50
-44	-26	56
-40	-28	50
-30	-26	64
-38	-24	62
38	-22	64
24	-14	64
-44	-4	10
42	4	12
-10	-12	56
12	-2	52
16	-22	48
16	-30	50
-34	-28	24
-44	-24	18
50	-26	18
58	-30	20
-32	-16	8
-38	6	6
-26	-10	-10
-16	-4	-18
-16	-2	-24
-18	-26	-20
16	-36	-10
-10	-34	-12
8	-64	-8
2	-62	-14
-24	-52	-24
22	-52	-24
-24	-62	-48
18	-56	-46
4	-70	-34
-36	-60	-28
40	-58	-30
-32	-28	60
44	-16	48
42	-22	52
30	-24	48
-46	-10	50
-28	-28	72
-30	-26	72
38	-24	64
50	0	6
-6	-6	56
-4	2	46
8	-20	48
10	0	42
14	38	2
10	14	-14
48	-34	26
-44	-24	16
36	-26	22
52	-28	18
46	-34	16
36	-18	10
28	-6	-2
30	-8	0
30	-20	6
-12	10	20
18	0	24
18	-16	8
-30	-40	0
38	-28	-10
-20	-54	-24
30	-52	-26
-16	-66	-46
-6	-42	-42
6	-44	-48
-40	-38	66
62	-16	30
-38	-30	54
-38	-30	68
-46	-14	60
-36	-16	56
-48	4	8
-14	-8	50
14	0	62
58	10	28
52	12	4
36	30	8
-60	-24	34
58	-40	34
62	-24	46
64	-28	38
-38	-40	42
38	-44	46
-44	-76	-6
-52	-74	-2
36	22	-2
-38	0	4
42	6	0
-26	4	0
-30	-8	0
26	8	0
26	-6	4
16	-52	-26
18	-66	-50
42	-22	46
66	-14	28
34	-26	52
38	-24	58
36	-22	60
-62	6	20
-56	4	32
-56	2	40
4	-8	52
62	12	24
-60	-24	32
-36	-56	62
-34	-54	54
36	-46	50
42	-70	-6
-32	-92	-8
44	-78	-6
-40	-86	0
40	-64	2
-40	0	10
40	2	12
-26	-6	10
32	-4	2
-18	-52	-24
-26	-66	-50

// Cohen M X, 2008: Reward > Loss (p <. 001)
// Cohen M X, 2008: Reward > Loss (FWE p < .05)
// Cohen M X, 2008: Loss > Reward
// Cohen M X, 2008: Loss Switch > Loss Stay
// Cohen M X, 2008: Loss Stay > Loss Switch
// Subjects=15
60	8	-7
63	5	0
65	-30	25
65	-15	8
30	-2	-7
30	8	10
8	-52	23
68	0	20
33	35	-10
8	28	-10
60	-5	-17
48	-55	5
38	5	8
68	-47	-10
50	-47	-15
53	40	10
3	-17	40
13	-35	35
10	-12	45
25	-2	-15
-60	-35	38
-57	-27	10
-12	-87	33
-12	33	55
-17	23	60
-30	-12	10
-2	-55	20
-60	8	38
-47	-17	40
-30	-22	-20
-30	30	-10
-47	-62	23
-47	-5	-22
-52	-60	0
-60	-7	-7
-35	0	10
-40	-40	-15
-45	30	18
-42	33	5
-30	-10	-17
-10	48	48
-5	-35	45
-2	-37	38
-2	33	13
-45	-70	35
-22	0	-12
-22	0	-14
-23	0	-13
25	-3	-15
-45	-70	35
-20	0	-15
40	28	33
35	18	8
45	18	3
10	23	30
10	15	45
-5	3	53
-40	15	8
-27	28	3
-7	10	43
-10	23	33
-17	-7	-2
-15	-20	8
-30	20	-10
38	53	5
-18	-5	-8
35	-12	-17
-7	-25	45
35	-13	-18

// Finger E C, 2008: Successful Extinction > Successful Baseline (Control)
// Finger E C, 2008: Successful Extinction < Successful Baseline (Control)
// Finger E C, 2008: Correct Hits > Correct Avoidance
// Finger E C, 2008: Early Extinction Phase > Late Extinction Phase
// Finger E C, 2008: Extinction > Baseline (Control)
// Finger E C, 2008: Response Type x Phase
// Finger E C, 2008: Response x Pair
// Finger E C, 2008: Response x Phase x Pair
// Subjects=19
15	69	-5
-16	62	-9
-30	42	-11
14	35	-5
12	36	-12
37	-66	58
-27	-70	58
47	4	30
32	40	-19
-32	-28	72
15	5	-17
4	34	42
-35	20	29
42	13	43
-27	20	4
40	-70	47
-41	-62	45
52	18	-7
3	-75	34
9	70	-1
35	33	-17
-37	-2	-10
-51	20	12
-62	-10	7
-43	-6	0

// Mitchell D G V, 2008: Reversal Errors > Constant Reinforcement
// Subjects=13
-47	22	-1
5	27	60
49	18	51
-25	58	28
-6	1	13
13	6	16
2	-22	5

// Xue G, 2008: Regions Activated in the Learning Task
// Xue G, 2008: Full Reversal Learning - No-Reversal Learning
// Xue G, 2008: Outcome Reversal Learning - No-Reversal Learning
// Xue G, 2008: Response Reversal Learning - No-Reversal Learning
// Xue G, 2008: Outcome Reversal Learning > Response Reversal Learning
// Subjects=17
6	18	40
-2	10	50
-28	-10	46
-48	0	30
-34	14	24
40	42	16
40	4	30
46	32	26
-30	-54	50
30	-66	54
-24	2	0
24	2	0
8	-18	10
-14	-8	10
-38	-44	-20
38	-44	-22
8	-74	8
-32	-90	4
12	-94	-6
38	-62	-24
-40	-60	-28
-4	16	46
-2	10	56
-26	6	64
-46	30	16
-50	2	34
-38	14	26
38	8	26
-24	-74	48
18	-70	54
-30	-56	42
-40	-68	-16
34	-60	-18
-6	-96	-14
-28	-78	30
36	-90	0
0	-68	16
34	-66	-26
-4	12	44
0	14	62
-30	-2	66
-48	14	2
-54	14	0
-64	-14	32
36	4	24
58	10	6
34	26	-2
-56	-22	24
-20	-72	50
18	-74	48
-58	-36	0
-24	-30	-6
24	0	-18
-14	4	14
-24	8	2
18	12	-6
-8	-16	12
8	-14	10
2	-72	18
-38	-68	-18
40	-62	-16
-32	-86	20
38	-90	14
-8	-98	-8
40	-82	4
-34	-42	-26
-4	10	40
-4	12	68
-36	54	12
-32	44	14
-30	-2	54
-46	10	22
-54	8	6
46	18	24
-24	-72	54
24	-68	42
-26	-52	38
14	-76	12
-38	-64	-14
30	-48	-14
-30	-88	22
-48	-74	-8
36	-90	2
52	-70	-14
-6	-74	-28
12	-72	-28
18	8	-4
-28	-8	4
20	22	12
18	10	-12
60	8	6

// Fuhrer D, 2008: Hunger > Satiety
// Fuhrer D, 2008: Satiety > Hunger
// Fuhrer D, 2008: Food > Nonfood
// Fuhrer D, 2008: Nonfood > Food
// Fuhrer D, 2008: Increased Interaction between the State of Satiation and 
// the Quaility of Visual Stimulation
// Fuhrer D, 2008: Decreased Interaction between the State of Satiation and 
// the Quality of Visual Stimulation
// Subjects=12
41.13	-67.93	34.61
-16.72	-96.22	4.19
21.16	52.85	-12.09
-26.91	49.39	-11.25
-61.64	-60.57	15.1
-7.45	65.02	24.02
-45.49	-49.41	34.05
63.36	-4.09	32.35
-3.89	-10.33	40.34
-10.19	-52.12	37.22
-4.04	17.71	31.3
-39.59	4.64	-10.69
-16.75	-96.48	0.87
37.58	-8.96	12.98
-4.18	26.2	17.2
-7.22	-31.44	15.38
-32.96	-88.6	-19.68
24.99	9.91	51.69
63.54	-25.27	47.51
34.81	-43.96	56.09
37.95	-80.89	32.39
-48.81	-67.09	12.16
27.59	62.91	-6.32
44.13	-80	2.13
2.01	17.32	-15.58
-13.67	20.82	31.14
28.28	-94.67	20.27
-10.8	40.48	-3.99
18.03	-8.99	-26.94
30.79	-12.85	-36.8
5.21	17.34	-15.62
-20.48	23.28	-19.17

// Malik S, 2008: Male Healthy Controls Who Received Ghrelin (Experiment 1)
// Subjects=12
-36	30	-6
50	6	30
-52	2	32
-50	4	4
20	-10	-8
-18	-10	-16
32	-10	-30
42	8	-6
-34	16	10
42	-6	10
-36	-12	14
-8	-2	12
20	-100	4
42	-70	-12
-50	-66	-10
-16	-36	2
18	-98	-4
-10	-96	-12
-42	-48	58
32	-90	6
-26	-92	14
-26	-76	30
28	-58	56
-20	-66	48
-52	34	18
54	30	18
-28	30	-10
25	28	-12
-34	20	8
48	8	30
0	8	54
34	6	-14
0	4	40
-46	4	32
42	-6	10
-56	-6	42
18	-10	-8
-24	-12	-10
36	-28	-22
-46	-38	50
32	-44	44
-32	-60	58
28	-60	56
-22	-66	50
38	-68	-14
-50	-70	-10
44	-74	-10
-28	-74	28
30	-80	26
40	-82	-8
-40	-86	-8
32	-90	0
-28	-92	12
-34	-94	0
24	-98	2
-16	-98	-8
16	-98	-2
-18	-100	-2
-36	36	-2
-28	16	16
34	8	18
-30	-4	-16
-36	-14	14
10	-26	-14
-14	-38	6
44	-60	-20
-18	-72	-14

// Malik S, 2008: Male Healthy Controls Who Did Not Receive Ghrelin 
// (Experiment 1)
// Subjects=8
48	10	30
-44	4	32
-34	20	8
-16	-100	-2
46	-72	-12
-34	-80	-14
-46	-38	50
38	-84	2
-48	-74	-6
32	-62	56
-32	-58	56
-52	34	18
54	30	18
-28	30	-10
25	28	-12
-34	20	8
48	8	30
0	8	54
34	6	-14
0	4	40
-46	4	32
42	-6	10
-56	-6	42
18	-10	-8
-24	-12	-10
36	-28	-22
-46	-38	50
32	-44	44
-32	-60	58
28	-60	56
-22	-66	50
38	-68	-14
-50	-70	-10
44	-74	-10
-28	-74	28
30	-80	26
40	-82	-8
-40	-86	-8
32	-90	0
-28	-92	12
-34	-94	0
24	-98	2
-16	-98	-8
16	-98	-2
-18	-100	-2
40	-68	-16
-32	-56	-18
-52	8	26
48	-80	-4
-42	-74	-12
-46	-38	48
40	-62	-2
16	-86	-12
48	-64	-8
-30	-60	60
-36	36	-2
-28	16	16
34	8	18
-30	-4	-16
-36	-14	14
10	-26	-14
-14	-38	6
44	-60	-20
-18	-72	-14

// Malik S, 2008: Male Healthy Controls (Experiment 2)
// Subjects=20
-22	30	-14
-46	26	20
50	4	30
38	4	-8
-36	-6	-8
-32	-6	-28
-62	-22	32
-46	-38	42
34	-56	-18
-36	-56	-14
28	-58	50
-24	-60	48
40	-76	-8
-42	-72	-8
42	-82	-4
-24	-86	-4
18	-94	2
-14	-98	2
-20	-30	0
-24	32	-12
-44	22	26
46	2	28
36	4	-10
-38	0	-4
-32	-32	-24
-58	-20	26
-2	-32	30
-44	-40	46
34	-48	-18
-34	-56	-14
30	-58	56
-26	-62	54
44	-68	-10
-40	-74	-8
38	-84	0
-26	-86	-8
16	-94	0
-18	-100	-4
-20	-10	-8
-34	-20	-22
-20	-30	0
20	-30	-4

// Davis M H, 2008: All Words vs. Letter Strings
// Davis M H, 2008: (Complex Noun vs. Simple Noun) vs. (Complex Verb vs. 
// Simple Verb)
// Davis M H, 2008: Verbs (Simple/Complex) vs. Nouns (Simple/Complex)
// Subjects=12
-63	-42	-3
-45	-42	-12
-6	27	-42
-48	30	-15
-33	27	-12
-48	24	18
-18	-9	-15
9	27	42
33	-12	60
-30	-6	18
-27	48	-12
-54	-48	-6
-54	-36	21
-21	-36	3
-3	9	-6

// Knutson B, 2008: Sell vs Buy - Product Preference (Product + Price)
// Knutson B, 2008: Sell vs Buy - Price Percent (Price) - Deactivations
// Knutson B, 2008: Sell vs Buy - Price Percent X Condition (Price) - 
// Activations
// Knutson B, 2008: Sell vs Buy - Price Percent X Condition (Price) - 
// Deactivations
// Knutson B, 2008: Sell vs Buy - Product Choice (Choice)
// Knutson B, 2008: Sell vs Buy - Product Choice X Condition (Choice) - 
// Deactivations
// Knutson B, 2008: Period Regressor - Product Period - Activations
// Knutson B, 2008: Period Regressor - Product Period - Deactivations
// Knutson B, 2008: Period Regressor - Price Period - Activations
// Knutson B, 2008: Period Regressor - Price Period - Deactivations
// Knutson B, 2008: Period Regressor - Price Period X Condition - 
// Deactivations
// Knutson B, 2008: Period Regressor - Choice Period - Activations
// Knutson B, 2008: Period Regressor - Choice Period - Deactivations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict (Price) - 
// Activations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict (Price) - 
// Deactivations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Conflict X 
// Condition (Price)
// Knutson B, 2008: Conflict and Reaction Time Regressor - Reaction Time 
// (Price) - Activations
// Knutson B, 2008: Conflict and Reaction Time Regressor - Reaction Time 
// (Price) - Deactivations
// Knutson B, 2008: Sell vs Choose - Product Preference (Product + Price) - 
// Activations
// Knutson B, 2008: Sell vs Choose - Product Preference (Product + Price) - 
// Deactivations
// Knutson B, 2008: Sell vs Choose - Price Percent (Price) - Deactivations
// Knutson B, 2008: Sell vs Choose - Price Percent X Condition (Price)
// Knutson B, 2008: Sell vs Choose - Product Choice (Choice)
// Subjects=24
28.77	28.91	-5.71
-6.97	-104.65	18.17
37.69	32.82	44.05
-39.22	24.96	45.59
49.3	19.29	19.4
-55.46	18.32	16.22
65.34	-17.85	5.6
-7.61	41.38	-6.34
28.63	31.86	-22.68
-7.35	30.92	23.53
-10.6	18.33	12.36
-15.01	0.47	-11.74
1.2	-14.01	6.01
1.07	-27.52	-17.38
-7.12	-49.07	21.32
-23.18	-82.43	4.23
-55.44	-2.37	10.15
37.86	-6.05	50.65
61.27	-48.66	20.5
33.08	-24.5	-22.47
32.96	57.75	-4.83
12.81	17.44	-1.22
-26.4	-87.02	0.19
45.23	-86.25	3.76
-39.19	-86.75	4.77
33.02	25.42	-9.92
-31	25.98	3.03
-7.29	23.86	28.59
3.55	16.75	45.79
-.73	16.64	44.73
41.91	12.53	28.97
-39.21	4.18	38.41
33.54	5.56	49.73
-26.28	0.97	50.8
5.67	-20.81	27.72
-19.11	-26.36	-.52
21.49	-26.12	-1.01
-3.26	54.33	9.26
-3.31	32.95	-5.68
17.38	-28.83	19.34
21.65	-33.29	16.32
33.35	-38.14	7.67
-18.94	-37.76	17.16
-26.48	-41.67	8.65
-2.75	-48.01	34.56
-42.2	-71.51	36.99
-39.61	58.34	9.34
45.01	31.24	22.91
-10.56	30.9	23.57
33.02	25.42	-9.92
5.67	21	45.41
-1.81	20.95	45.5
-42.79	16.85	-3.87
37.59	15.33	24.33
-42.54	11.68	25.55
29.23	13.99	49.07
12.9	1.92	4.54
-23.09	-3.5	47.79
12.9	-6.88	0.82
-7.31	-13.72	10.55
9.82	-13.27	14.78
1.39	-20.84	27.77
21.52	-25.86	2.31
9.74	-26.19	-.87
-3.09	-26.26	-.71
-19.1	-30.59	-.17
-7.75	59.73	-16.79
-15.01	54.26	9.4
-7.6	28.35	-9.7
33.24	11.19	12.46
17.3	3.23	21.11
53.36	-3.69	-16.64
-23.26	-.9	26.39
-63.14	-4.64	-18.57
-23.49	-7.7	-6.5
-23.56	-8.38	-15.36
9.97	-3.98	38.53
-46.87	-9.72	10.67
-39.34	-13.57	15.37
37.48	-14.39	-2.18
-19.28	-16.01	-18.12
17.05	-15.8	-18.55
-10.3	-11.51	39.39
61.18	-16.59	22.27
-58.75	-19.88	-9.53
21.65	-16.83	22.74
-10.27	-19.97	40.1
-39.24	-33.4	20.37
-23.67	65.15	-.34
1.44	-23.67	32.47
-7.13	-53.55	18.35
32.87	64.55	-13.2
37.11	56.49	-21.5
-26.73	9.55	-3.45
-46.69	12.94	42.22
25.74	6.57	8.47
5.63	-12.35	27.01
-10.55	-14.08	6.16
25.82	-25.49	6.7
-19.09	-26.1	2.8
-26.12	-51.1	51.82
26.28	-53.7	54.78
-18.66	-63.37	43.84
53.99	-67.51	38.89
-7.32	31.27	27.97
-7.09	-56.47	21.94
45.21	-82.02	3.41
48.99	32.58	-15.17
37.51	11.22	12.4
-30.82	2.6	17.26
-2.88	4.4	37.97
42.09	5.61	49.62
13.29	1.55	54.76
-42.96	-5.81	-35.43
-14.54	-11.19	43.88
53.54	-22.75	-1.66
53.73	-24.04	22.98
-42.61	-30.73	0.11
61.21	-40.46	16.47
-58.55	-46.43	4.96
-55.25	-45.38	18.22
-58.29	-48.09	38.55
-55.17	-49.01	26.33
5.89	-47.02	46.65
-25.98	-52.99	68.7
-31.11	53.47	0.73
-35.4	48.88	-3.3
-39.57	54.37	13.02
33.17	55.49	21.01
-26.55	47.61	34.62
28.93	43.83	22.03
-30.86	39.58	27.54
33.04	28.94	-5.76
-42.55	14.85	25.29
37.59	15.33	24.33
37.77	9.56	46
-14.85	2.1	9.31
-10.64	-7.28	-2.22
1.04	-20.12	-18
5.68	-16.24	31.8
42.17	-22.14	48.6
-42.24	-26.88	49.97
1.21	-51.24	-7.59
29.46	-46.28	54.12
17.36	-57.61	5.02
26.24	-58.53	47.38
-2.84	-65.5	14.84
-22.87	-62.71	52.75
29.4	-71.09	36.13
-18.89	-86.63	4.53
25.99	-86.36	3.99
-26.22	-85.14	24.56
-26.12	-84.11	37.86
-14.51	-97.64	13.21
41.8	-1.79	8.98
25.57	-8.34	-19.27
-18.93	-5.81	31.21
-19.27	-20.24	-17.76
69.61	-17.83	5.55
33.08	50.23	8.07
56.98	-52.2	16.38
45.36	-71.67	27.07
56.98	-52.2	16.38
36.55	32.13	35.2
-38.16	23.82	44.56
49.3	19.29	19.4
-54.39	18.32	16.21
65.33	-16.8	5.51
33.41	-61.74	5.19
-6.28	38.59	26.22
0.98	36.41	-2.67
-6.45	17.07	-4.31
-22.14	-73.96	3.5
-33.96	-65.92	-1.5
-14.44	-92.47	25.04
-14.9	42.25	19.32

// Labudda K, 2008: Incentives Presented (Activation) > No Incentives 
// Presented (High-Level Control)
// Labudda K, 2008: Incentives Presented (Activation) > Blank Die (Low-Level 
// Control)
// Subjects=12
2	28	36
50	32	24
-34	10	46
-48	-58	42
6	-90	-14
4	-74	54
46	34	24
-52	18	26
42	-46	38
2	-72	-29

// Lee T M C, 2008: Younger Healthy Control Males
// Subjects=12
-40	-6	-14
-26	-28	-20
-28	-44	-8
16	-26	-24
-30	50	20
38	12	-12
20	-76	6
-16	-24	20

// Lee T M C, 2008: Older Healthy Control Males
// Subjects=8
42	0	-12
52	4	-14
12	-62	10
4	-48	50
-8	-40	18
14	-10	16
-30	50	20
38	12	-12
20	-76	6
-16	-24	20

// Samanez-Larkin G R, 2008: Association between Activation During Loss 
// Anticipation and Subsequent Loss-Avoidance Learning
// Subjects=11
33.08	22.77	-3.01

// Schlagenhauf F, 2008: Healthy Controls
// Subjects=10
-18	6	-9
18	6	-3
18	6	3
24	-3	-18
-24	-60	12
0	-72	0
-27	-90	6
3	-81	-15
9	-93	-9
0	-15	-18
6	-57	-18
-6	-60	-18
-15	6	-3
15	15	-3
-33	-6	-6
-21	-3	6
18	15	0
21	-3	0
-51	-36	15
63	0	12
36	0	3
-15	12	-6
15	9	-3
-12	-3	6
-27	21	0
21	6	3
18	-12	6
18	3	-18
66	-33	9
54	-51	-18
57	0	3
-48	-75	-15
-42	15	-3
-30	-84	12
-51	-30	6
36	-93	-9
6	-42	-6
-6	-60	-18
-15	9	-3
18	6	-3
-6	3	18
-18	-6	3
-30	-3	3

// Schlagenhauf F, 2008: Schizophrenia Patients
// Subjects=10
15	6	-12
-21	9	-6

// Weber B J, 2008: Healthy Controls
// Subjects=23
-20	-90	-7
-56	-67	-8
-28	-57	47
-28	4	52
-45	8	30
-50	33	17
-3	29	35
22	35	-23
26	3	51
28	-54	50
30	-37	-7
31	19	-10
41	51	-10
44	35	17
49	8	25
49	-59	-6
-40	6	6
-8	-56	18
2	32	10
2	34	0
10	60	14
10	8	-2
38	-46	64
50	8	-6
58	38	0
36	6	52

// Weber B J, 2008: Subgroup of Healthy Controls Who Exhibited Consistent 
// Delay Discounting
// Subjects=7
-30	34	40
-23	31	39
-18	-41	7
-9	-62	32
-4	-46	21
18	1	23

// Liljestrom M, 2008: ACT vs. Rest
// Liljestrom M, 2008: OBJACT vs. Rest
// Liljestrom M, 2008: OBJ vs. Rest
// Liljestrom M, 2008: OBJACT vs. ACT
// Liljestrom M, 2008: OBJACT vs. OBJ
// Liljestrom M, 2008: ACT vs. OBJ
// Subjects=15
-34	-50	-26
-28	-34	-28
-34	-20	-24
-48	-72	-2
-46	-62	-12
-50	-22	40
-40	-48	58
-58	-36	18
-66	-38	6
-50	-42	6
-46	14	14
-46	32	-2
-44	34	-16
-30	28	0
-48	4	44
-40	-4	56
-36	6	-4
-36	-14	-14
42	-76	-8
36	-80	6
50	-68	0
50	-74	10
64	-48	8
44	-52	-20
40	-58	-30
50	-6	50
2	6	62
-4	18	46
36	-18	-12
36	-6	-24
-32	-62	48
-48	-72	-2
-34	-50	-26
-46	-64	-12
-48	-34	38
-44	-48	-22
-42	-46	-24
-44	-50	4
-48	34	8
-46	14	12
-56	16	2
-44	12	26
-34	30	-8
-50	4	46
-6	16	50
-8	6	60
40	-74	-4
36	-86	6
50	-74	10
28	-60	50
18	-66	60
38	-48	-20
46	-64	-10
40	-58	-28
-48	-72	-2
-32	-50	-24
-34	-40	-28
-30	-62	46
-48	-36	42
-42	12	12
-34	32	-4
38	-48	-20
40	-84	4
20	-70	46
28	-58	48
34	-88	8
-50	-38	38
-50	-54	48
-30	-66	52
-12	-66	44
42	34	30
48	20	42
34	-64	56
46	-48	54
-44	6	38
-30	8	26
-10	18	50
-44	22	26
10	30	36
-12	2	68
-54	26	2
-30	36	10
-30	26	0
-20	12	8
-14	-74	48
-50	-50	42
-36	-52	42
-26	-76	38
-56	-40	30
-46	-50	6
-62	-48	6
34	56	8
46	30	30
32	0	50
52	14	8
54	28	-10
26	-46	42
40	-50	50
26	-60	60
34	-72	46
62	-52	10
48	-68	0
42	-50	-22
32	-66	-38
-56	-42	26
-62	-50	8
-46	18	-22
-4	18	42
-52	6	44
60	-48	12
54	-66	-4
36	-58	-42
46	8	-8
50	-2	-14

// Siri S, 2008: Main Effect: Infinitive Verb + Inflected Verb + Action Noun
// Siri S, 2008: Action Noun vs. Infinitive Verb
// Siri S, 2008: Action Noun vs. Inflected Verb
// Siri S, 2008: Inflected Verb vs. Infinitive Verb
// Subjects=12
-46	10	24
-54	4	38
-52	-14	-6
-44	2	-10
44	2	-14
26	-34	2
-46	16	26
-48	24	-4
-46	16	26
-48	24	-4
-48	24	-4

// Tyler L K, 2008: Stems (Nouns + Verbs) vs. Baseline
// Tyler L K, 2008: Phrases (Nouns + Verbs) vs. Baseline
// Tyler L K, 2008: Noun Phrases vs. Baseline
// Tyler L K, 2008: Verb Phrases vs. Baseline
// Tyler L K, 2008: [Phrases (Nouns + Verbs) - Baseline] vs. [Stems (Nouns + 
// Verbs) - Baseline]
// Tyler L K, 2008: [Noun Phrases- Baseline] vs. [Stems (Nouns + Verbs) - 
// Baseline]
// Tyler L K, 2008: [Verb Phrases - Baseline] vs. [Stems (Nouns + Verbs) - 
// Baseline]
// Tyler L K, 2008: Verb Phrases vs. Noun Phrases
// Subjects=15
-48	22	28
20	-52	-32
-30	-8	-4
-52	20	28
-28	-2	-6
-52	-44	-4
-50	30	12
-54	-44	-2
-32	4	-4
-52	20	28
-30	-6	-6
-52	-42	-4
18	-54	-28
-46	-36	-6
32	-82	4
-50	-32	-6
30	-88	6
-46	-36	-6
-52	18	28
-12	-48	40
-2	-76	22
-52	-58	6

// Berlingeri M, 2008: Noun vs. Baseline (GCST)
// Berlingeri M, 2008: Verb vs. Baseline (GCST)
// Berlingeri M, 2008: Nouns vs. Verbs (GCST)
// Berlingeri M, 2008: Verbs vs. Noun (GCST)
// Berlingeri M, 2008: Noun vs. Baseline (PNT)
// Berlingeri M, 2008: Verbs vs. Baseline (PNT)
// Berlingeri M, 2008: Verbs vs. Noun (PNT)
// Berlingeri M, 2008: Verb vs. Noun (PNT + GCST) (Inclusive Mask of Baseline)
// Berlingeri M, 2008: Verbs vs. Noun (PNT) + Nouns vs. Verb (GCST) (Inclusive 
// Mask of Baseline)
// Subjects=12
-46	26	32
-48	26	32
-48	28	0
-48	16	30
-46	20	-6
-44	28	-2
-48	4	50
-52	14	-16
-54	-48	-18
-52	-54	-20
-28	-68	42
-22	-78	40
-24	-80	32
-22	-88	18
-24	-86	22
-26	-96	10
-12	-96	-6
-14	-92	-4
-8	-74	-20
56	-40	-18
24	-80	26
36	-86	-12
24	-100	0
24	-90	12
28	-92	-12
24	-100	0
38	-76	-32
-44	4	36
-50	-2	50
-46	-4	38
-8	8	50
-2	-40	56
-4	-8	38
-50	-46	24
-60	-4	-12
-58	-52	-2
-60	-54	-10
-58	-54	-18
-58	-46	26
-42	-48	30
-36	-50	34
-22	-100	-14
-40	-54	-32
-38	-82	-22
-32	-24	-10
-32	-18	-16
34	-14	56
48	8	-22
54	-6	-18
58	0	-14
56	-42	-16
36	-90	-10
26	-94	-14
26	-88	-16
44	-86	-12
24	-102	2
36	-72	-30
34	-68	-28
-52	24	2
-38	36	18
-44	28	-14
-46	-46	62
-8	-72	62
-24	-88	16
-18	-80	42
-38	-72	-28
36	-74	-30
-12	12	54
-26	-18	62
-6	-12	64
-4	-38	46
-2	-40	50
18	-30	66
16	-26	64
4	-20	58
12	-8	54
2	-34	52
16	-34	64
20	-40	64
6	-32	56
4	-38	56
2	-42	56
16	-2	-16
22	-4	4
-32	-24	58
-22	-92	34
-44	-78	-8
-38	-54	-28
50	-64	-18
36	-92	0
48	-82	-2
44	-50	-26
40	-50	-32
-54	30	20
-50	26	32
-24	-88	28
-26	-88	24
-32	-90	16
-34	-94	8
-10	-78	6
-46	-74	-8
-52	-72	-2
-24	-74	-8
-8	-74	6
-12	-62	-2
-42	-62	-22
-44	-54	-26
-18	-34	-8
52	-66	-12
16	-86	46
28	-88	28
36	-92	4
34	-88	16
48	-80	-2
52	-66	-12
10	-58	0
38	-46	-32
40	-64	-22
22	-32	-4
-36	22	2
-32	22	2
-10	-38	72
-12	-46	74
-58	-50	6
-20	-80	28
-50	-72	6
-10	-100	-12
-12	-82	-6
-6	70	6
-34	-36	-32
-46	-54	-26
-28	14	-2
-14	-2	-14
-40	-24	60
-22	-18	62
-32	-24	46
-38	-34	58
-14	-34	74
-8	-22	58
-18	-56	60
-14	-44	66
-12	-40	66
-14	-4	-16
-18	-28	10
38	-26	58
4	-8	58
26	-46	64
16	-30	60
10	-36	64
18	-44	70
16	-42	64
10	-42	64
6	-40	60
32	-46	56
18	0	-14
-52	32	14
-48	24	22
-30	22	-2
-54	-56	-16
-48	-50	-18
-24	-86	28
-26	-88	20
-28	-94	10
-12	-78	-16
-38	-74	-18
26	-80	30
32	-88	14
38	-74	10
10	-70	-34
10	-78	-18

// Filbey F M, 2008: Alcohol Cue > Rest
// Filbey F M, 2008: Control Cue > Rest
// Filbey F M, 2008: Alcohol Cue > Control Cue
// Subjects=37
-26	-28	50
46	10	-12
68	6	-2
74	-24	-4
-22	-58	34
52	28	6
64	30	6
-58	24	12
-5	-22	0
-68	-40	-18
-54	-40	14
-6	30	14
40	2	-40
-36	34	-20
-50	-62	44
-38	2	52
-10	-48	14
-20	-12	-20
48	-18	-24
62	28	10
-18	-50	-2
24	-26	18
-22	-26	16
-40	-38	-14
0	10	-16
-2	-38	-8
30	-40	16
-44	-88	-4

// Gilman J M, 2008: Alcoholism Patients
// Subjects=12
-42.71	-24.1	-10.48
44.75	20.84	-15.25
-19.06	-46.71	-2.16
49.39	-50.01	4.02
44.93	-14.6	-5.59
25.77	-34.81	-3.68
21.7	-73.44	6.3
-35.41	24.59	-14.64
-39.51	-36.23	-16.19
9.64	-7.41	-5.79
-46.77	-66.97	-.14
25.94	-78.16	-0.04
-46.85	-59.02	-7.5
49.31	-55.27	-8.92
-19.06	-46.71	-2.16
-23.13	-89.57	8.17
42.01	-77.55	6.41
12.94	-30.65	-3.88
33.4	-87.09	-6.07
-26.41	-82.7	0.94
37.68	-73.86	-.54
41.78	-55.83	-15.48
-39.44	-39.94	-9.19
49.28	-46.81	-9.63
13.13	-82.47	0.47
-42.48	-71.17	0.16
-35.2	-31.46	-9.95
21.68	-82.42	0.36
-39.51	-36.23	-16.19
21.52	-25.86	2.31
25.9	-82.9	-6.33
37.71	-82.32	0.17
69.54	-35.06	-10.85
-7.19	-78.36	0.36
44.94	-43.12	-16.58
65.3	-30.34	-4.5
32.95	20.25	-21.76
-42.74	-15.64	-11.19
12.83	-3.16	-6.18
-23.67	15.68	-20.72
-42.85	-.29	-19.16
57.85	-38.85	-3.7
9.6	-11.1	-12.17
28.85	-27.36	-17.72

// Gilman J M, 2008: Healthy Controls
// Subjects=12
-30.61	-89.62	8.26
-35.2	-31.46	-9.95
21.68	-82.42	0.36
-39.51	-36.23	-16.19
21.52	-25.86	2.31
25.9	-82.9	-6.33
37.71	-82.32	0.17
69.54	-35.06	-10.85
-7.19	-78.36	0.36
44.94	-43.12	-16.58
65.3	-30.34	-4.5
32.95	20.25	-21.76
-42.74	-15.64	-11.19
12.83	-3.16	-6.18
-23.67	15.68	-20.72
-42.85	-.29	-19.16
57.85	-38.85	-3.7
9.6	-11.1	-12.17
28.85	-27.36	-17.72

// Gilman J M, 2008: Main Effect of Alcohol
// Gilman J M, 2008: Main Effect of Emotion
// Gilman J M, 2008: Interaction between Main Effects of Alcohol and Emotion
// Gilman J M, 2008: Neutral Faces: Alcohol > Placebo
// Gilman J M, 2008: Fearful Faces: Alcohol > Placebo
// Gilman J M, 2008: Fearful Faces: Placebo > Alcohol
// Gilman J M, 2008: Placebo: Fearful > Neutral
// Gilman J M, 2008: Alcohol: Neutral > Fearful
// Subjects=12
25.69	7.12	1.73
-23.5	-0.04	-3.79
25.75	-47.12	-11.56
-14.45	-40.97	44.14
-16.99	29.55	20.41
-59.78	-4.14	1.43
-23.19	-80.4	2.94
19.26	-8.41	-5.81
-12.65	47.87	36.67
19.55	-88.95	-1.29
15.09	51.92	31.55
4.14	33.8	-9.18
-42.64	-29.93	-3.3
32.35	-82.52	-1.98
-29.87	39.88	17.47
21.76	-63.96	18.89
66.42	15.25	20.66
49.24	-18.63	-3.07
34.21	46.43	13.95
-10.35	-58.15	14.31
-8.44	-25.32	-1.85
-29.87	39.88	17.47
-8.64	9.94	-13.72
-23.39	-5.52	7.82
25.64	4.49	-4.74
25.78	41.07	27.88
11.09	-48.53	26.64
-25.43	-68.24	-4.74
-16.95	27.78	25.02
-21.41	3.86	-8.61
53.37	-2.55	-15.62
-12.62	-83.65	-12.52
-42.64	-34.33	-5.16
-21.44	-9.68	-18.62
62.08	27.74	17.43
-21.29	-27.86	-5.95
15.38	-94.46	10.37
-18.87	-88.66	5.81
-38.4	-43.45	-13.37
10.58	14.29	-14.31
44.97	-25.18	-4.7
49.38	0.34	22.1
-21.31	42.21	19.4
-48.87	24.56	41.27
-19.08	-13.96	8.47

// Kemmerer H, 2008: Running Verbs > Wingdings
// Kemmerer H, 2008: Speaking Verbs > Wingdings
// Kemmerer H, 2008: Hitting Verbs > Wingdings
// Kemmerer H, 2008: Cutting Verbs > Wingdings
// Kemmerer H, 2008: Change of State Verbs > Wingdings
// Subjects=16
-28	-32	60
24	-32	62
-60	-36	0
-54	24	28
-54	32	16
-46	16	36
-44	30	-16
-6	44	46
-60	-42	22
-58	-52	18
-60	-4	-12
-50	-22	-10
-46	-14	-30
46	12	-18
58	-6	-12
60	2	-10
24	-48	72
14	-84	26
12	-70	20
10	-40	22
-34	-30	-6
-30	-42	2
-36	-20	24
-54	-38	2
-48	-30	-8
-50	18	20
-50	24	-12
-46	34	-2
-4	56	36
-2	48	-14
34	-40	2
-28	-30	62
14	-26	62
10	-34	68
-54	-38	2
-66	-36	2
-58	-34	-10
-46	40	4
-32	40	-14
-42	46	-14
-58	-4	-14
60	4	-8
24	-48	72
14	-58	32
0	28	-20
-46	28	24
-46	10	40
-54	-40	2
-60	-42	16
60	-58	-8
-44	-60	12
-46	-14	-30
-36	-68	42
-38	-60	38
-52	36	18
-58	16	-12
-28	38	-12
-50	38	-2
-54	26	-4
-4	48	-18
-36	40	18
70	-8	16
54	-72	26
24	-50	72
10	-58	30
16	-66	12
10	-70	20
44	-16	4
-56	-38	0
-44	-16	-28
-52	-26	-22
-46	18	22
-38	30	22
-4	46	50
-58	-6	-14
-58	-44	18
10	-68	18

// Onoda K, 2008: Conjunction Analysis: Anticipation of Affective Pictures
// Onoda K, 2008: Anticipation of Certain Negative > Anticipation of Certain 
// Positive and Uncertain Positive/Negative
// Onoda K, 2008: Conjunction Analysis: Perception of Affective Pictures
// Onoda K, 2008: Positive Pictures > Negative Pictures
// Subjects=18
-4	14	54
-44	8	34
46	10	26
-40	-4	50
-32	22	-2
34	22	-2
-26	-60	44
14	70	-10
-14	-70	44
14	-82	-10
4	22	24
0	16	50
44	14	22
-46	8	32
-34	20	-2
-40	-2	58
-24	-62	46
8	-90	-2
58	-2	26

// De Nil L F, 2008: Stuttering Patients
// Subjects=15
-58	-14	-4
-52	-8	30
2	12	40
6	6	58
-46	-30	18
62	-18	0
-14	0	34
38	-24	22
-32	4	12
-52	-4	6
30	-4	20
58	-30	32
62	-6	-4
-12	-14	16
0	52	38
6	-40	-10
28	-34	18
-64	-22	0
42	2	14
32	22	-2
48	-36	20
54	-2	-14
10	-12	-16
-34	2	-18
0	-20	-22
54	6	24

// De Nil L F, 2008: Healthy Controls
// Subjects=15
-58	-20	4
-54	-16	2
-46	-2	-10
-6	-34	-8
0	16	42
-62	-36	14
-10	-22	-18
-4	-80	-12
24	-18	-18
-12	-14	16
0	52	38
6	-40	-10
28	-34	18
-64	-22	0
42	2	14
32	22	-2
48	-36	20
54	-2	-14
10	-12	-16
-34	2	-18
0	-20	-22
54	6	24

// Giraud A L, 2008: Stuttering Patients, Pre-Therapy
// Subjects=16
-16	18	4
-16	10	16
-8	4	-2
12	20	6
8	26	10
14	36	6
-4	-38	72
-12	-48	72
-32	-42	64
58	-10	-32
-58	-8	-30

// Giraud A L, 2008: Stuttering Patients, Post-Therapy
// Subjects=9
6	16	12
36	-26	-24
8	-60	26
-6	-10	12

// Watkins K E, 2008: Speech Activation Across Feedback Types, Healthy 
// Controls > Stuttering Patients
// Watkins K E, 2008: Speech Activation Across Feedback Types, Stuttering 
// Patients > Healthy Controls
// Subjects=10
-54	2	24
66	2	16
-48	-16	46
44	-10	44
-48	-10	6
-10	28	26
30	16	10
-34	12	14
32	14	-14
-8	-20	-10
6	-18	-12
-6	-68	-48
8	-68	-48

// Strakowski S M, 2008: Correct Stops > Non Targets, Healthy Controls
// Strakowski S M, 2008: Non Targets > Correct Stops, Healthy Controls
// Strakowski S M, 2008: Correct Stops > Non Targets, Bipolar Disorder 
// Patients
// Strakowski S M, 2008: Non Targets > Correct Stops, Bipolar Disorder 
// Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Healthy Controls > 
// Bipolar Disorder Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Unmedicated > Medicated 
// Bipolar Disorder Patients
// Strakowski S M, 2008: Correct Stops > Non Targets, Medicated > Unmedicated 
// Bipolar Disorder Patients
// Subjects=8
49.42	7.37	30.43
48.4	5.68	36.16
-4.04	29.85	36.97
7.73	23.5	36.25
0.3	-19.96	25.48
8.88	-23.97	27.95
-2.05	-9	2.29
8.88	-23.97	27.95
-2.05	-9	2.29
8.65	-9.9	3.35
-39.55	16.07	-.5
43.84	13.74	3.2
-57.46	-51.63	6.5
59.69	54.82	-3.77
-31.49	-61.33	43.82
30.5	-65.28	42.32
-2.86	-58.02	15.33
7.81	-55.84	15.02
-48.68	-66.78	29.97
-32.14	49.5	4.42
-26.17	-51.61	45.17
23.02	-72.98	39.71
-6.03	-53.21	22.77
5.74	-44.25	27.46
-48.7	-67.04	26.65
-1.92	29.7	34.73
-.65	-47.37	28.91
3.62	-47.35	28.86
-2.08	-8.28	-2.23
4.36	-7.9	2.12
-12.22	-78.48	40.57
9.17	-77.04	43.55
-54.28	-58.47	0.34
35.17	-6.26	-20.68
43.9	1.14	5.37
-59.44	-29.15	35.86
-34.78	-71.01	29.05
-21.9	-79.14	32.93
28.27	-83.75	23.82

// Lauro L J, 2008: Conjunction Among All Conditions
// Lauro L J, 2008: Idiomatic > Literal
// Lauro L J, 2008: Literal > Idiomatic
// Subjects=22
-46	28	16
-52	16	28
-44	-12	60
-56	2	32
-32	20	0
-34	-30	52
-44	-42	48
-48	-24	16
-34	-52	0
-38	-52	-24
-34	-84	16
-46	-78	-4
-14	-22	8
-32	-68	-20
-4	56	4
-2	-2	56
-2	42	-4
38	-6	64
50	28	16
50	8	28
32	22	-4
10	-50	32
62	-4	0
54	-68	0
44	-52	-20
22	-76	36
44	-70	8
46	-76	-12
10	8	8
12	-16	4
34	-46	-28
-4	54	32
-10	48	48
-50	26	0
-50	-58	24
-52	4	-32
-52	6	-40
52	32	-8
46	12	-36
54	0	-24
52	-48	12
-58	-32	40
42	-46	60
58	-36	52
62	-28	36

// Elliott R, 2008: Responses to B Cue Greater after AB than after BC
// Elliott R, 2008: Responses to B Cue Greater after BC than after AB
// Subjects=12
6	48	-12
15	-6	-15
-24	6	6
-9	9	-6
42	42	-18

// Izuma K, 2008: High Monetary Reward vs. No Monetary Reward
// Izuma K, 2008: Interaction: (Self - Other) x (HSR - NoSR)
// Izuma K, 2008: Main Effect: Self > Other
// Izuma K, 2008: Main Effect: Other > Self
// Subjects=19
50	38	22
-20	36	-18
22	32	-24
10	30	36
-28	18	2
24	12	4
12	10	-4
-14	10	-4
10	10	2
-12	8	2
-24	4	12
16	-2	-6
-20	-6	18
22	-14	18
-14	-14	14
10	-20	16
4	-26	-14
30	-60	-32
-32	-62	-34
50	-34	44
-42	-46	40
14	-66	42
-14	-68	42
-14	52	8
-36	50	10
-6	40	18
-14	24	54
-8	24	32
-52	20	14
-22	20	-2
22	16	-4
-4	-22	30
-44	-32	-8
-62	-18	-10
16	-48	-38
-6	-58	-12
12	2	-2
-6	2	6
-46	-54	-12
-34	-94	-10
50	-56	-16
40	-84	-6
34	28	38
36	-4	-46
28	-24	-26
-32	-6	-42
-20	-14	-22
-36	-16	16
-50	-38	20
10	-72	-4
-6	-88	-12
4	-30	62
6	-56	50
10	-102	16

// Krueger F, 2008: Integration Verification - Font Verification
// Subjects=18
-45.67	-53.8	49.7
-41.64	20.66	42.26
-28.56	21.54	50.92
-50.52	26.52	25.03
-6.49	-67.96	68.36
-36.9	-69.21	56.68
-6.8	-71.31	44.05
45.06	-71.12	43.15
-32.64	-79.49	49.78
1.66	-30	37.57
-2.85	-36.9	21.52
-2.83	-27.97	25.12

// Uddin L Q, 2008: ASD Patients
// Subjects=12
40	-72	-8
30	-82	-14
36	-82	-2
42	-54	-8
38	-50	-14
38	-54	-18
-32	-86	-8
-40	-82	-12
-14	-100	2
-20	-94	2
-38	-64	-18
-34	-48	-20
50	6	26
40	34	14
34	24	0
32	16	8
48	4	40
40	0	40
28	-84	-16
-30	-84	-10
42	-76	-14
-32	-48	-22
40	-74	-8
-18	-88	-14

// Uddin L Q, 2008: Typically Developing Controls
// Subjects=12
40	-72	-10
-30	-86	-14
-42	-82	-12
46	-62	-16
28	-76	26
38	-42	-22
50	6	26
40	34	12
32	18	-8
38	48	10
42	48	10
34	28	4
30	-84	-16
42	-72	-14
-30	-84	-16
-42	-66	-24
22	-88	-12
-36	-58	-18
52	14	30
48	6	28
42	32	10
32	26	6
40	12	6
30	16	2

// Kensinger E A, 2008: Healthy Young Subjects
// Subjects=17
30	54	10
-38	-32	-14
-34	-80	-2
-20	-91	10
14	-67	13
15	-5	-18
30	14	-14
46	-38	36
20	-64	-3
20	66	7
-28	59	21
-52	30	8
16	-47	32
-63	-54	6
-57	-36	11
-21	-18	-11
14	-32	25
-28	-18	-13
26	-14	-12

// Kensinger E A, 2008: Healthy Old Subjects
// Subjects=17
30	54	10
-38	-32	-14
-34	-80	-2
-20	-91	10
14	-67	13
15	-5	-18
30	14	-14
46	-38	36
20	-64	-3
20	66	7
-28	59	21
-52	30	8
16	-47	32
-63	-54	6
-57	-36	11
-21	-18	-11
14	-32	25
-16	64	4
-6	52	20
-2	65	17
8	56	3
-38	54	1
52	25	1
58	-33	5
44	-17	4
0	43	-7
0	33	-10
-8	26	10
10	11	25
-8	-45	26

// Mickley K R, 2008: All Valence Types, Recognized > Forgotten
// Mickley K R, 2008: Positive and Negative Items, Recognized > Forgotten
// Mickley K R, 2008: Negative Items, Remembered > Known
// Mickley K R, 2008: Negative and Positive Items, Remembered > Known
// Mickley K R, 2008: Positive Items,  Known > Remembered
// Mickley K R, 2008: Negative Items, Known > Remembered
// Mickley K R, 2008: Negative and Positive Items, Known > Remembered
// Subjects=20
-13.42	12.98	50.39
43.9	25.27	-28
18	-25	-36.04
59.68	19.25	21.63
-31.7	27.33	-24.68
-48.86	45.74	-10.52
-3.35	3.15	-9.32
14.15	28.9	12.48
18.52	-42.94	1.59
59.43	-57.02	-13.4
-39.52	-51.92	23.64
-50.93	-36.76	-20.25
46.54	-67.49	-9.91
52.87	-44.48	-16.77
34.34	-37.7	56.83
23.43	-75.77	40.61
21.24	-45.37	44.36
22.47	-12.89	-21.62
27.41	-23.61	24.18
57.06	-60.81	-30.92
50.76	-79.15	-20.03
-46.55	-73.53	-23.41
-29.42	41.35	-12.66
-40.01	-35.89	-11.56
46.45	-37.5	-10.63
-12.11	-2.17	-19.85
25.23	-4.06	26.76
24.91	-23.98	-2.64
-7.26	-22.23	17.91
9.52	-39.08	-25.53
40.05	-65.38	-10
-29.37	-30.51	-23.48
50.97	-60.05	0.49
-48.48	-60.82	-2.22
-44.07	-68.9	2.98
-56.03	-62.97	-1.88
25.69	46.01	-11.82
34.09	17.3	48.03
-16.47	29.28	-16.17
6.03	-1.19	46.98
12.36	-31.86	28.61
-55.86	-5.93	22.73
-34.87	-45.05	50.89
-47.87	-33.29	51.07
-62.73	1.03	-5.86
29.26	6.95	6.55
-12.07	23.33	-11.17
27.64	15.35	50.57
1.49	-14.88	27.12
9.63	-18.59	-13
-4.85	51.82	52
34.12	15.38	50.46
27.49	-16.4	32.43
-39.58	-21.72	25.13

// Ritchey M, 2008: Encoding Success Activity (ESA) Emotional > ESA Neutral
// Ritchey M, 2008: ESA Neutral > ESA Emotional
// Ritchey M, 2008: Recollection Persistence for Emotional Stimuli
// Ritchey M, 2008: Recollection Persistence for Emotional and Neutral Stimuli
// Ritchey M, 2008: Emotional > Neutral Encoding (long- vs. short-delay hits)
// Ritchey M, 2008: Emotional > Neutral Encoding (short- vs. long-delay hits)
// Subjects=13
26	3	-23
-19	3	-19
-48	29	6
-56	-48	-17
37	-64	35
30	-33	-2
4	22	-4
-19	-13	39
-11	18	3
15	12	17
-26	-18	4
63	-33	5
45	-54	3
-37	-51	-7
33	-52	-23
-37	-59	-16
30	-76	11
-22	-4	-13
-37	-77	-9
-45	2	35
-37	-77	-9
30	-1	-26
-19	-8	-22
7	38	37
59	-24	36
56	-38	37
-19	44	15

// Sommer T, 2008: Encoding: Arousing > Non and Slightly Arousing
// Sommer T, 2008: Arousal-Dependent Memory Effects
// Subjects=17
-33	-3	-21
30	-6	-12
-30	-18	-27
-24	-39	3
30	-15	-27
-24	-12	-33
27	-12	-33
-15	36	39
15	-12	36
12	18	19
12	-48	63
-45	-39	-6
-33	-3	-15
30	-33	63

// Talmi D, 2008: High Attention (HA) > Low Attention (LA): Scrambled Pictures
// Talmi D, 2008: HA > LA: Neutral Pictures
// Talmi D, 2008: HA > LA: Emotional Pictures
// Talmi D, 2008: Emotional Pictures > Neutral Pictures: LA
// Talmi D, 2008: Spatial Overlap: Content-Indepenent Attention and Emotion
// Talmi D, 2008: Spatial Overlap: Content-Dependent Attention and Emotion
// Talmi D, 2008: Spatial Overlap: HA > LA Neutral Pictures vs Scrambled 
// Pictures
// Talmi D, 2008: Differences due to memory (Dm) Emotional > Dm Neutral: EEM
// Subjects=11
31.61	-56.04	51.57
-26.16	-80.13	34.18
-28.39	-88.83	18.21
-32.02	-48.16	-19.74
50.34	-57.81	-14.3
30.97	-34.12	-22.75
51.48	6.61	20.44
-51.04	5.54	29.51
-26.17	-1.17	64.36
-32.08	14.89	-2.72
38.43	15.14	-5.78
-1.84	23.87	41.91
37.84	-84.21	17.06
31.46	-46.58	36.28
23.56	19.33	8.54
32.48	-5.37	46.19
49.44	3.23	31.9
-27.33	-6.52	50.32
47.29	-42.03	11.18
33.01	-14.27	-27.78
18.69	-58.2	38.52
-30.54	-81.27	19.83
49.35	6.68	21.57
33.57	-4.04	49.42
-47.85	3.19	26.33
-26.15	-6.38	65.91
-6.12	18.3	39.08
-.94	29.82	22.44
20.59	-23.35	21.07
-5.09	-19.36	19.92
10.76	-1.43	2.62
19.42	-29.85	6.02
35.25	21.98	0.38
-36.34	17.23	0.48
2.26	-27.29	-.69
-23.44	20.28	11.23
28.03	2.67	26.61
-47.88	-78.32	-9.22
36.67	-91.84	0.98
-26.21	-83.91	26.69
-19.3	2.48	-12.98
27.4	-81.79	49.31
-57.73	-9.47	-12.65
-38.47	-23.36	-15.05
-39.67	32.39	-9.67
-7.19	-47.55	13.39
25.19	-64.97	46.81
-27.27	-78.37	29.58
-40.33	-83.04	-2.22
-34.86	-87.27	11.46
37.82	-83.32	14.75
42.91	-61.74	-9.42
-34.13	-52.31	-18.25
-44.49	-78.61	14.19
-27.28	-79.6	27.46
-42.49	-59.2	3.62
49.48	-74.33	6.06
37.82	-83.32	14.75
51.38	-50.49	-16.04
25.18	-63.91	46.73
-56.07	-50.48	48.76
51.8	-46.12	40.47
-8.25	-49.76	12.47
36.78	-84.13	18.18
-27.25	-78.2	31.8
-40.16	-82.47	18.92
-33.08	-49.22	-19.63
-40.33	-83.04	-2.22
40.78	-65.01	-10.24
29.96	-45.58	-19.55
-38.96	-47.03	50.51
50.44	6.86	23.77
-27.33	-4.32	51.25
-50.06	-72.24	-13.05
-46.91	-55.22	-13.4
-36.48	1.52	-23.85
39.37	-8.14	-31.72
-22.58	-5.97	-25.61
-64.19	0.98	-14.56

// Janzen J, 2008: Right Ear Vestibular Evoked Myogenic Potential (VEMP) 
// Stimulation > Rest, Deactivations
// Janzen J, 2008: Left Ear VEMP Stimulation > Rest, Deactivations
// Janzen J, 2008: Acoustic Short Tone Bursts (STB) Control Stimulation > 
// Rest, Right Ear (Deactivations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Left Ear 
// (Deactivations)
// Janzen J, 2008: Acoustic Loudness Control Stimulation > Rest, Right Ear 
// (Deactivations)
// Janzen J, 2008: Acoustic Loudness Control Stimulation > Rest, Left Ear 
// (Deactivations)
// Janzen J, 2008: VEMP Stimulation > Rest, Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Rest, Left Ear (Activations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Right Ear 
// (Activations)
// Janzen J, 2008: Acoustic STB Control Stimulation > Rest, Left Ear 
// (Activations)
// Janzen J, 2008: Right Ear > Left Ear, VEMP Stimulation-Rest (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB Control Stimulation, Right 
// Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB Control Stimulation, Left 
// Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic Loudness Control Stimulation, 
// Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic Loudness Control Stimulation, 
// Left Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB + Acoustic Loudness Control 
// Stimulations, Right Ear (Activations)
// Janzen J, 2008: VEMP Stimulation > Acoustic STB + Acoustic Loudness Control 
// Stimulations, Left Ear (Activations)
// Subjects=16
-12	-52	66
-6	36	10
-14	16	22
-6	-10	64
-8	-36	48
14	-52	72
4	-12	64
-36	-46	38
-20	-44	50
-10	10	40
-20	-2	54
-18	40	-14
36	-30	40
10	-64	56
6	34	-4
40	-74	28
12	50	-8
22	-40	64
-2	10	34
64	-56	16
44	-2	56
-2	22	24
44	-2	56
6	26	22
16	-32	44
-42	-30	10
-36	-30	18
-58	-24	14
-30	2	-18
-32	-16	6
-42	-8	52
-14	-24	-8
-12	-36	-20
42	-30	10
54	-22	2
58	-24	14
34	-20	-14
32	-22	-4
50	-6	52
52	22	14
-38	-26	8
-48	-26	0
-46	-34	22
-30	-20	8
42	-20	2
42	-26	2
52	-26	20
32	-22	2
-48	-28	4
44	-22	2
-44	-34	20
48	-28	4
44	-22	2
-34	-30	22
-36	-32	24
40	-24	4
36	-26	6
40	-36	30
-32	-12	48
-32	-46	52
-38	-46	38
-26	-16	16
-44	-62	2
-14	-70	38
-4	12	46
40	-46	38
14	-70	-50
16	-70	-26
-36	-30	20
-58	10	14
-44	-34	24
-32	-20	0
-28	2	-20
-34	-6	42
-14	-24	-8
38	-28	10
52	-24	0
48	-28	20
32	-20	0
48	-2	50
46	12	16
-42	32	12
-46	-14	-8
-44	32	20
-32	-22	2
48	-34	10
46	-14	-8
50	-28	20
30	-22	2
-38	-26	-2
-38	-34	20
-48	-34	24
-30	-22	-2
-40	-2	62
42	-20	-4
44	-20	-8
40	-34	22
30	-22	-2
56	2	48
50	20	20
-34	-30	16
-44	-30	6
-40	-28	22
32	-20	2
42	-28	6
68	-20	8
48	-28	24
32	-20	-2
-40	-36	18
-44	-36	24
-54	-10	14
-42	-2	60
38	-34	16
44	-22	-8
40	-34	24
46	2	50
48	6	16
-42	-32	8
-34	-30	16
-38	-30	22
48	-18	-10
44	-12	14
50	-32	20

// Schlindwein P, 2008: Right-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Right-Sided 102 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Right-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 dB STB) > Rest, 
// Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 dB STB) > Rest, 
// Deactivations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Activations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Deactivations
// Schlindwein P, 2008: Right-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Activations
// Schlindwein P, 2008: Left-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Left-Sided 102 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Left-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 dB STB) > Rest, 
// Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 dB STB) > Rest, 
// Deactivations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 102 dB White Noise Signal) > 
// Rest, Deactivations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Activations
// Schlindwein P, 2008: Left-Sided (102 dB STB - 65 db STB - 102 dB White 
// Noise Signal) > Rest, Deactivations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 65 dB STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 65 dB STB > Rest, Deactivations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 65 dB 
// STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 102 dB 
// STB > Rest, Activations
// Schlindwein P, 2008: Right vs. Left-Sided 102 dB STB - Ipsilateral 102 dB 
// STB > Rest, Deactivations
// Subjects=21
50	-24	4
50	4	50
14	-24	-6
8	-74	-24
4	-50	-28
-50	-26	2
-18	-2	42
-50	-2	48
-38	34	-18
8	54	0
36	20	44
66	-10	32
54	-20	48
42	-86	20
18	-36	6
20	-46	-52
-40	-80	30
-52	-12	30
-16	-36	4
-28	-42	-14
58	-26	4
48	2	38
4	-28	-42
-46	-24	2
-36	-28	44
-12	-16	40
42	-34	12
2	-48	-26
-38	-40	12
-48	-14	12
22	38	42
28	50	4
8	12	44
24	-12	60
10	-54	60
34	-46	-32
18	-50	-54
-10	-54	72
-46	-16	30
-40	-34	48
-8	-42	44
-16	-36	4
50	-14	-4
52	2	50
54	40	-6
-56	-28	6
-46	-8	48
-58	32	-2
46	-82	18
50	-12	-6
-44	-36	24
52	-12	-4
-50	-24	-2
-18	-62	62
56	-26	2
-46	-34	6
38	-32	12
-34	-30	8
2	-40	42
42	-76	-28
-10	20	42
46	-28	12
-38	-28	12
40	46	24
36	-76	40
2	26	44
-4	-18	76
-34	-26	10
40	-68	52
2	22	48
-2	22	48
-6	6	12
-14	-38	-48
12	-12	60
4	-80	-34
18	-52	-34
-64	12	10
-46	-12	54
26	44	10
42	-44	28
-8	-22	-12
-58	-12	-6
52	-28	2
58	-20	0
-58	32	8
8	-88	-40
4	-16	28
12	-10	68
44	-86	18

// Wang Z, 2008: Vestibular Vertigo (Activations)
// Wang Z, 2008: Vestibular Vertigo (Deactivations)
// Subjects=17
0	-24	52
42	-62	4
22	-60	-4
10	-48	54
0	0	46
44	-32	14
46	-58	-38
34	-20	4
8	-46	74
2	-16	6
4	-62	6
0	-24	54
44	-70	2
38	28	-22
-16	-36	-2
-6	-72	18

// Brookheimer S Y, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=12
-35.59	-61.4	-9.11
-44.39	-51.62	-18.89
33.46	-46.47	-14
27.13	-54.17	-4.17
-24.71	-73.91	-5.82
22.87	-71.2	-2.41
-39.88	-63.33	-6.6
42.17	-48.15	-9.5
35.59	-44.54	-16.47
-32.86	-83.38	31.12
22.87	-71.2	-2.41
35.68	21.76	3.86
33.32	57.5	-4.12
-28.44	-65.11	42.68

// Brookheimer S Y, 2008: Typically Developing (TD) Controls
// Subjects=12
-42.07	-54.83	-7.41
42.18	-59	-10.67
24.9	-52.47	-8.78
-11.69	-75.58	-1.39
29.5	-65.68	10.37
42.48	4.51	25.62
44.42	31.34	13.97
35.53	51.33	-1.31
22.5	2.62	-16.43
-22.83	-10.3	-14.38
-37.84	-53.31	-14.35
-42.07	-63.55	-8.79
42.18	-59	-10.67
33.48	-57.31	-15.17
-24.67	-77.96	-3.18
31.46	-71.59	-7
-48.25	15.24	30.59
38.17	15.55	29.08
50.95	33.91	18.08

// Ischebeck A, 2008: Multiplication, Untrained > Trained
// Ischebeck A, 2008: Multiplication, Trained > Untrained
// Ischebeck A, 2008: Differences, Division > Multiplication
// Subjects=17
-44.04	13.36	21.74
-24.92	20.82	-2.86
-4.67	-9.22	53.56
-30.61	13.64	58.46
33.41	34.1	-1.81
49.7	44.67	6.96
34.2	17.06	57.02
-18.15	0.07	15.89
20.76	6.9	17.91
27.17	-29.73	4.62
-23.95	-53.96	58.31
53.74	-28.16	54.43
28.1	-58.91	71.36
21.48	-66.56	58.78
-21.25	-90.84	8.13
-30.67	-68.93	36.37
-34.41	-72.68	-3.53
-46.67	-67.43	53.31
-8.03	-46.2	37.1
62.69	-50.31	-10.76
-33.75	-77.58	47.37

// Kleinhans N, 2008: Patients with Autism Spectrum Disorder (ASD)
// Subjects=19
-44	-48	-22
42	-54	-22
46	-42	-22
-28	-48	-8
28	-54	-8

// Kleinhans N, 2008: Healthy Controls
// Subjects=21
-42	-50	-24
-28	-66	-12
30	-44	-14

// Kroger J K, 2008: Normals Group 1
// Subjects=16
40.86	26.95	36.7
-52.82	-59.89	50.63
9.74	48.54	29.67
-24.2	10.33	47.76
31.39	5.37	47.54
-38.01	-11.96	49.79
-20.68	-65.53	57.43
-41.62	45.35	20.49
-52.86	-51.6	47.71
-47.82	-15.13	23.4
60.92	30.13	7.2
-20.29	17.59	3.61
-40.73	23.75	-11.17
20.19	17.6	-13.58
-62.85	-25.85	9.97
-19.75	-94.36	28.61
-38	-8.53	52.84
49.22	40.52	18.73
-.67	-35.48	31.26
-48.93	-14.42	18.89

// Kroger J K, 2008: Normals Group 2
// Subjects=12
35.94	-52.16	60.11
-32.45	-52.57	60.93
52.56	-28.42	7.75
32.88	67.89	-11.25

// Marquand A F, 2008: Depressed Patients
// Subjects=20
26.69	67.28	-13.94
-46.56	55.51	1.92
-30.65	28.64	58.1
28.91	43.68	-13.88
-47.8	-5.46	61.76
-63.85	2.94	-8.27
44.08	-6.23	-20.41
-32.39	-42.65	76.39
-19.47	-75.76	65.99
55.03	-66.37	-21.37
3.47	-90.62	-2.4
49.09	-86.47	16.58
40.16	-95.16	-7.06
-16.59	7.62	-29.71
-20.79	-22.17	-26.69
-9.87	22.48	-8.88
7.24	-22.49	-31.62
-37.83	-86.05	-20.08
9.33	49.17	-23.06
44.02	63.3	-11.6
-47.12	-7.74	-54.56
-34.06	-48.53	-55.23
28.67	61.58	-29.1
2.01	8.73	72.96
44.02	63.3	-11.6
52.56	51.65	-21.8
-33.89	57.73	-20.93
-69.86	-30.75	22.06
-70.23	-31.32	-7.01
70.03	2.79	-17.26
-23.89	-72.14	58.99
7.69	-93.57	-11.15
4.89	-17.36	-45.53
-42.08	-89.9	-15.14

// Marquand A F, 2008: Healthy Controls
// Subjects=20
18.87	53.72	48.05
3.28	61.18	13.96
-27.42	44.57	-24.22
-27.28	52.2	-11.53
39.75	57.11	-8.67
44.68	46.39	37.13
61.83	21.39	21.38
60.06	8.98	49.53
68.46	-51.95	17.32
-55.37	-4.86	-23.33
61.23	1.51	-30.43
74.53	-28.69	-9.74
60.07	-58.83	36.07
1.29	-40.46	6.12
6.45	-73.54	65.33
-.63	-104.28	12.47
5.72	-70.23	8.99
38.64	-83.81	45.63
1.1	-87.83	-18.33

// Shafritz K M, 2008: High-Functioning Autism vs Control Group, All Target 
// Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, Target-Shift 
// Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, 
// Target-Maintain Trials
// Shafritz K M, 2008: High-Functioning Autism vs Control Group, All Novel 
// Trials
// Subjects=15
54.31	23.8	24.63
-30.58	-47.47	47.7
-19.49	12.33	-2.11
-43.03	-9.05	11.61
-19.49	-54.41	-15.68
-39.72	35.27	26.22
-1.96	36.05	21.01
-37.05	-45.16	49.82
-23.87	14.03	-6.69
-41.96	-10.21	10.59
52.09	26.67	21.02
47.08	10.96	48.44
-39.16	-38.27	54.78
-21.64	11.26	-1.97
-39.82	-11.47	8.43
-41.88	-8.52	17.14

// Fakra E, 2008: Schizophrenic patients
// Subjects=14
22.33	-4.3	-21.81
-16.14	-2.42	-21.52
-26.51	9.57	24.43
27.92	0.41	11.19
56.89	-42.05	9.96
-30.74	5.66	29.27
-41.41	5.77	31.61
52.44	24.17	13.38
41.43	42.68	-21.51
-3.21	-2.29	-7.18
-43.78	-42.77	-17.82
-36.75	-40.79	62.23
-56.12	-28.02	50.23
-26.03	-40.3	67.64
46.53	-32.18	56.09
28.41	-36.17	61.09
-25.33	34.9	49.06
-22.27	40.06	32.98
-26.72	55.76	16.1
-3.27	66.3	12.71
-11.24	-4.69	58.91
-50.33	-.34	-19.07
3.89	-37.92	68.21

// Fakra E, 2008: Healthy controls
// Subjects=14
22.33	-4.3	-21.81
-16.14	-2.42	-21.52
-26.51	9.57	24.43
27.92	0.41	11.19
56.89	-42.05	9.96
-30.74	5.66	29.27
-41.41	5.77	31.61
52.44	24.17	13.38
41.43	42.68	-21.51
-3.21	-2.29	-7.18
-43.78	-42.77	-17.82
-36.75	-40.79	62.23
-56.12	-28.02	50.23
-26.03	-40.3	67.64
46.53	-32.18	56.09
28.41	-36.17	61.09
-25.33	34.9	49.06
-22.27	40.06	32.98
-26.72	55.76	16.1
-3.27	66.3	12.71
-11.24	-4.69	58.91
-50.33	-.34	-19.07
3.89	-37.92	68.21
22.36	39.88	-.98
26.75	-24.74	-11.22
46.37	-86.53	13.81
-36.87	-61.71	39.45
31.54	4.72	66.55
54.71	-46.98	1.47
50.51	-57.24	6.84
-15.92	26.21	18.45
-28.27	-91.95	32.96
10.08	16.93	61.31
18.76	-71.78	41.88

// Gilbert S J, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=15
-38	54	16
48	48	16
-44	42	28
36	26	0
-38	26	2
-6	20	40
-48	16	-6
50	14	10
-52	12	18
56	12	44
30	0	58
60	-24	46
44	-40	60
-46	-42	44
38	-46	-38
-34	-56	-32
16	-58	70
-14	-58	64
20	-66	42
-8	-74	44
6	50	-8
-14	32	6
26	-32	-20
-18	-40	28
-38	-52	26
0	-52	24
-12	-62	30
36	-92	2
-24	-46	-30
-42	-58	-18
-50	44	6
38	42	26
-2	24	50
-36	22	0
30	20	-8
-44	12	26
-36	8	54
-34	6	34
-26	-50	34
-36	-60	54
10	-64	52
-28	-44	-30
20	60	2
12	52	34
10	56	36
-6	56	18
-12	50	0
-14	38	36
52	12	-26
-50	2	-30
2	-2	36
32	-12	-18
-64	-14	-24
-6	-18	44
66	-26	24
-38	-30	62
32	-44	60
20	-44	-20
22	-52	-22
-28	-62	-50
48	-64	-38
34	-72	-40
10	54	36
0	48	2
-16	44	24
-12	36	38
10	30	26
36	22	-32
26	8	-22
-58	4	-24
26	-6	-16
-22	-8	48
8	-28	46
14	-34	66
40	-40	6
28	-42	60
2	-46	16
18	-48	-20
-38	-56	4
12	-62	46
16	-96	16

// Gilbert S J, 2008: Healthy Controls
// Subjects=18
46	54	-4
36	32	24
32	30	-2
-22	28	-6
-32	18	10
-46	6	28
24	-4	42
-24	-8	42
14	-8	-2
24	-38	66
-46	-38	50
16	-44	72
46	-46	40
-40	-48	-46
-26	-48	40
-10	-66	60
14	-72	56
0	50	50
18	48	46
4	46	-10
-32	30	52
2	24	-2
-36	22	-32
38	-10	-36
20	-16	-34
48	-20	-18
-52	-24	-12
40	-32	-26
-32	-32	-26
-12	-40	-26
-6	-54	6
10	-60	14
-42	-62	-16
60	-62	26
-10	-68	18
-52	-70	34
50	-78	20
-24	-46	-30
-42	-58	-18
24	56	4
34	48	22
-36	44	0
-26	38	40
44	38	26
-4	38	38
34	24	-4
2	22	36
28	20	50
-52	18	16
40	6	46
-40	4	42
0	-8	4
-50	-36	50
52	-36	46
38	-56	46
10	-56	-2
-10	-68	54
-28	-70	54
8	-84	-4
-28	-44	-30
20	60	2
12	52	34
4	64	30
-64	-8	26
66	-16	28
26	-92	6
-22	-100	14
10	54	36
0	48	2
-16	44	24
-12	36	38
10	30	26
36	22	-32
26	8	-22
-58	4	-24
26	-6	-16
-22	-8	48
8	-28	46
14	-34	66
40	-40	6
28	-42	60
2	-46	16
18	-48	-20
-38	-56	4
12	-62	46
16	-96	16

// Hall J, 2008: Fear vs Neutral facial expression in control > patients
// Hall J, 2008: Neutral facial expression vs Baseline in control > patients
// Subjects=19
14	-55	-2
33	-39	-11
-22	-1	-12
10	-53	-10
10	-76	-7
-17	-2	-15
10	-53	-10
10	-76	-7
-17	-2	-15

// Kennedy D P, 2008: Autism
// Subjects=13
-4.87	13.67	61.75
-5.34	57.11	17.97
-4.83	-60.63	36.76
-39.54	21.7	3.49
-4.75	-99.38	31.09
-43.45	7.84	44.84
-60.46	-61.65	28.56
-52.3	-21.7	-6.11
13.06	-50.23	4.46
-21.07	29.38	46.12
0.39	-38.82	29.29
-25.61	-26.2	-11.61
-30.53	-74.5	24.83
25.95	29.66	45.56
46.55	-75.93	40.8
0.01	-20.76	-12.36
25.88	-22.69	15.38
16.43	-79.22	14.65
28.94	-29.76	-7.48
-3.9	-79.68	10.47
-39.03	-78.53	28.62
20.68	22.66	51.79
0.02	-21.81	-12.28
24.7	-11.75	5.56
-25.37	-79.7	-1.55
13.15	-83.35	2.77
4.79	-59.52	36.55
16.3	-23.46	20.02

// Kennedy D P, 2008: Healthy Controls
// Subjects=12
-5.09	46.48	45.62
-1.03	57.48	22.35
3.64	-48.23	31.16
-43.75	22.36	12.4
-1.55	-99.36	31.05
-43.42	8.18	49.27
-51.8	-64.8	42.11
-1.18	33.94	-6.9
-44.05	1.67	-34.93
63.55	-64.79	31.86
-52.19	-33.7	3.82
-39.64	30.53	-6.17
3.54	-13	32.67
0.01	57.15	17.9
-.97	24.02	16.23
-4.01	-48.93	9
-21.05	26.29	47.5
4.74	-30.37	41.92
-18.13	-34.87	-14.32
-39	-73.78	34.91
42.04	27.01	51.17
51.77	-68.38	27.84
-39.03	-78.53	28.62
20.68	22.66	51.79
0.02	-21.81	-12.28
24.7	-11.75	5.56
-5.04	-76.06	2.37
24.89	-70.25	6
9.01	-56.75	30.7
-17.95	-46.19	4.47
24.82	-45.67	7.28
20.55	-23.7	16.64

// Killgore W D S, 2008: Bipolar Patients
// Subjects=14
40	-18	-8
-14	-62	-24
-52	-8	22
-8	-46	-6
-14	-64	44
34	28	46
20	-52	18
-18	-30	-18
-40	-8	-22
-34	-36	-6
36	32	8
10	-60	-18
-28	-66	4
-28	-88	14
-6	-70	20
54	14	-18
-16	12	-4
-20	-6	22
-8	34	12
42	24	36
34	14	-32
26	28	-6
-12	48	-6

// Killgore W D S, 2008: Healthy controls
// Subjects=13
-22	14	-18
-10	-2	22
-34	42	-4
-4	-30	24
16	-4	-4
16	-6	-30
20	42	-12
-6	-70	20
54	14	-18
-16	12	-4
-20	-6	22
-8	34	12
42	24	36
34	14	-32
26	28	-6
-12	48	-6

// Michalopoulou P G, 2008: Schizophrenia patients
// Subjects=11
-32.59	-55.08	42.19
-17.72	-18.61	44.54
-13.26	-54.02	54.14
-5.9	-10.2	55.96
27.99	-81.21	-12.08
-48.98	-21.62	8.35
24.51	-7.21	-18.24
27.84	-26.76	-9.95
-52.89	-29.94	52.58
31.9	16.1	-20.28

// Michalopoulou P G, 2008: Control group
// Subjects=9
35.46	-77.99	-12.43
39.78	-77.45	-5.84
46.9	4.56	-19.49
55.4	7.35	-25.39
43.79	5.48	-7.26
-13.96	-7.44	-17.78
27.76	-6.67	-11.63
27.65	-16.59	-29.76
27.99	-81.21	-12.08
-48.98	-21.62	8.35
24.51	-7.21	-18.24
27.84	-26.76	-9.95
-52.89	-29.94	52.58
31.9	16.1	-20.28

// Schmitz N, 2008: Healthy Controls
// Subjects=10
33.76	-20.16	14.76
3.47	19.91	20.28
-3.11	24.58	13.2
28.46	35.28	34.02
-29.91	50.17	35.78
-5.21	38.17	20.86
-24.13	47.13	-20.04

// Schmitz N, 2008: Autism Patients
// Subjects=10
-2.22	47.26	3.1
-23.96	58.26	-4.34
-31.32	55.33	10.64
38.84	-53.87	67.32
-5.21	38.17	20.86
-24.13	47.13	-20.04

// Silani G, 2008: High Functioning Autism and Asperger Syndrome (HFA/AS) 
// Group
// Subjects=15
-4	42	-16
8	56	16
-44	10	48
8	-56	40
36	26	-22
46	10	-42
58	-60	28
24	-94	-18
-12	38	-14
-14	56	32
-12	56	14
-36	28	24
10	38	32
-6	-22	50
-10	-54	38
-50	-2	-34
-56	4	-30
62	-8	34
-6	-50	-30
6	-54	-34
-30	-10	68
10	-58	48
-30	-50	50
8	-40	-6
-20	-78	30
26	-82	30
-26	-96	2
38	-80	32
-2	54	-16
-8	-60	52
58	20	30
-44	48	-12
-42	18	-10
-62	-58	14
-18	-2	-18
-42	-54	38
-22	-80	-10
16	-84	-8
34	-86	10
-44	-74	-6
-12	-86	-20
-28	34	-14
6	-84	-40
34	-88	10
2	-80	-6
-2	24	8
-40	4	0
-18	-8	-20
-32	20	2
44	20	-2
-44	4	-4
-36	14	0
48	0	10
-16	-6	-16
-32	10	2
-20	-10	-16

// Silani G, 2008: Healthy Controls
// Subjects=15
-4	36	-14
-14	54	32
-6	56	16
4	52	28
-24	50	26
-12	40	26
8	42	28
-4	8	70
-4	-46	34
-36	16	-18
30	20	-20
-58	-4	-22
60	-6	-24
-46	8	-38
34	8	-18
-40	14	-36
44	14	-36
-34	6	-36
-36	8	-6
-40	-60	20
30	-8	-28
-26	-30	-24
-22	-76	-32
18	-80	-34
-12	38	-14
-14	56	32
-12	56	14
-36	28	24
10	38	32
-6	-22	50
-10	-54	38
-50	-2	-34
-56	4	-30
62	-8	34
-6	-50	-30
6	-54	-34
-30	-10	68
10	-58	48
-30	-50	50
8	-40	-6
-20	-78	30
26	-82	30
-26	-96	2
38	-80	32
-28	34	-14
-46	-40	-20
-32	-4	-14
-28	34	-14
6	-84	-40
34	-88	10
2	-80	-6
-2	24	8
-34	28	0
-32	20	2
44	20	-2
-32	20	2

// Kramer M E, 2008: Children with Traumatic Brain Injuries
// Subjects=5
46.09	36.87	26.88
-47.96	31.74	23.93
41.73	31.59	13.99
-39.45	31.45	19.4
33.03	56.23	3.1
-39.23	11.67	38.9
3.55	-27.17	28.28
-.8	-6.05	26.56
-21.85	-65.42	45.16
33.82	-45.4	65.15
-21.88	-47.1	48.09
29.41	-46.79	47.47
37.86	-82.98	19.18
-34.81	-83.41	20.06
28.98	-51.25	-10.14
20.37	-51.99	-18.9
-47.52	-20.85	59.56
-47.49	-29.31	60.27
3.22	52.85	17.11
-.98	31.68	18.94
2.89	49.42	-27.2
-1.34	45.51	-22.37
2.94	54.34	-18.7
-1.34	54.31	-18.64
54.43	30.3	-3.89
54.39	29.95	-8.32
-56.37	-6.38	27.23
-56.35	-1.81	31.3
3	46.22	-13.55
-1.27	46.2	-13.5
45.69	15.16	-33.74
-47.63	-57.09	31.38
-47.71	-53.54	22.16
38.06	-45.72	60.66
-17.48	-45.71	65.76
-47.5	-55.71	49.1
20.99	-80.68	50.41
-8.93	-80.86	50.77
20.91	-85.94	37.47
-13.27	-90.38	38.24
25.11	-86.6	28.56
-26.18	-86.91	29.17
29.1	-54.45	3.51
16.03	-35.09	-20.27

// Kramer M E, 2008: Children with Orthopedic Injuries
// Subjects=8
46.09	36.87	26.88
-47.96	31.74	23.93
41.73	31.59	13.99
-39.45	31.45	19.4
33.03	56.23	3.1
-39.23	11.67	38.9
3.55	-27.17	28.28
-.8	-6.05	26.56
-21.85	-65.42	45.16
33.82	-45.4	65.15
-21.88	-47.1	48.09
29.41	-46.79	47.47
37.86	-82.98	19.18
-34.81	-83.41	20.06
28.98	-51.25	-10.14
20.37	-51.99	-18.9
-47.52	-20.85	59.56
-47.49	-29.31	60.27

// Kramer M E, 2008: Children with Orthopedic Injuries with Behavioral Data 
// Available
// Subjects=6
3.22	52.85	17.11
-.98	31.68	18.94
2.89	49.42	-27.2
-1.34	45.51	-22.37
2.94	54.34	-18.7
-1.34	54.31	-18.64
54.43	30.3	-3.89
54.39	29.95	-8.32
-56.37	-6.38	27.23
-56.35	-1.81	31.3
3	46.22	-13.55
-1.27	46.2	-13.5
45.69	15.16	-33.74
-47.63	-57.09	31.38
-47.71	-53.54	22.16
38.06	-45.72	60.66
-17.48	-45.71	65.76
-47.5	-55.71	49.1
20.99	-80.68	50.41
-8.93	-80.86	50.77
20.91	-85.94	37.47
-13.27	-90.38	38.24
25.11	-86.6	28.56
-26.18	-86.91	29.17
29.1	-54.45	3.51
16.03	-35.09	-20.27

// Dichter G S, 2008: Healthy Controls
// Subjects=22
3.57	-28.14	29.48
36.35	-38.06	-19.14
-41.68	33.75	8.08
39.76	11.28	26.87
59.04	-67.22	0.89
-8.27	-94.91	-7.17
-4.5	53.58	-14.09
-16.09	48.71	6.53
51.47	22.99	25.75
-41.4	-52.33	9.72
40.02	-68.45	27.98
-48.62	-10.11	60.91
-18.64	-47.8	52.57
32.59	-59.09	39.55
-29.84	58.79	28.15
31.81	64.54	-13.19

// Dichter G S, 2008: Autistic Patients
// Subjects=12
-56.27	-66.88	15.57
-56.66	33.4	4.93
62	35.68	10.07

// Freitag C M, 2008: Typical Developing (TD) Controls
// Subjects=15
54	-20	30
24	-68	18
64	-20	-20
52	-4	2
42	2	6
4	12	-2
22	12	2
44	30	-10
-56	-26	28
-46	-46	38
-18	-44	34
-32	-10	-38
-40	0	-6
-16	12	8
-28	-8	-2
-8	-2	64
16	-84	10
22	-64	18
38	-16	42
54	-20	30
32	-36	44
62	-26	24
54	-64	6
44	0	4
10	0	46
10	-6	60
28	34	48
-20	-30	70
-54	-26	24
-32	-10	-36
-58	2	2
-38	-12	18
-6	2	48

// Freitag C M, 2008: ASD
// Subjects=15
14	-30	-14
4	-8	2
30	-12	-20
-32	-22	44
-4	-64	36
-12	-38	4
-16	-30	-10
-10	-4	22
-8	64	28
16	-84	10
22	-64	18
38	-16	42
54	-20	30
32	-36	44
62	-26	24
54	-64	6
44	0	4
10	0	46
10	-6	60
28	34	48
-20	-30	70
-54	-26	24
-32	-10	-36
-58	2	2
-38	-12	18
-6	2	48

// Loveland K A, 2008: Healthy Controls
// Subjects=3
32.92	51.86	-12.14
23.27	48.12	-18.41
4.8	-75.81	32.34
4.74	-92.95	17.06
-30.72	-55.61	7.64
-24.35	-49.48	3.71
-5.1	-75.52	-4.37
-11.36	-87.22	10.07
39.41	52.67	-2.25
36.13	51.88	-12.18
-50.17	-18.43	-5.29
20.59	-71.68	1.71
-14.66	-68.46	5.19
26.92	-36.23	5.35
33.33	-42.79	2.48
-33.96	-52.71	4.09
-24.38	-43.14	3.18
11.3	-2.38	72.95
8.06	7.12	72.19
8.01	-75.79	32.31

// Loveland K A, 2008: Autism Spectrum Disorder (ASD) Patients
// Subjects=5
32.92	51.86	-12.14
23.27	48.12	-18.41
4.8	-75.81	32.34
4.74	-92.95	17.06
-30.72	-55.61	7.64
-24.35	-49.48	3.71
-5.1	-75.52	-4.37
-11.36	-87.22	10.07
0.75	67.01	-19.73
10.4	67.33	-16.52
14.15	-78.57	-4.33
-5.12	-75.77	-7.69

// Wicker B, 2008: Emotion vs Age, Controls>ASD
// Subjects=12
73.88	-32.06	23.1
58.32	24.83	0.93
14.16	63.97	20.22

// Pichon S, 2008: Effects of observing body expressions vs scrambled stimuli
// Pichon S, 2008: Main effect of anger vs neutral expressions
// Pichon S, 2008: Brain regions involved during the observation of dynamic 
// expressions, (Ad-As)
// Pichon S, 2008: Brain regions involved during the observatioin of dynamic 
// expressions, (Nd-Ns)
// Pichon S, 2008: Brain regions involved during observation of dynamic anger 
// expressions (Ad-As)-(Nd-Ns)
// Subjects=16
56	30	-8
-34	2	-24
20	-2	-14
24	-24	-6
12	-32	-4
42	-52	-20
-40	-42	-22
50	-76	0
44	-86	0
-44	-86	0
26	-100	-4
-26	-100	-4
10	60	40
60	32	0
-42	30	-8
-54	22	32
-46	10	54
42	2	44
28	0	-26
10	-12	6
-12	-6	42
54	-18	-14
66	-34	36
66	-40	20
-66	-40	20
56	-42	4
-56	-42	4
44	-44	-18
-44	-44	-18
46	-74	0
-46	-74	0
12	-102	2
-12	-102	2
38	30	0
-38	30	0
28	12	-30
-28	12	-30
54	8	-22
-6	0	-14
50	2	48
54	-2	-24
68	-38	22
42	-42	-20
-42	-42	-20
54	-44	12
-54	-44	12
48	-68	4
-48	-68	4
-12	-80	-46
52	16	32
42	-46	62
-42	-46	62
62	-44	16
-62	-44	16
8	-74	56
-8	-74	56
8	-50	50
-34	-62	52
26	-66	66
42	-56	-18
48	-70	2
-48	-70	2
24	-94	24
-24	-94	24
46	-76	-14
-46	-76	-14
6	56	48
2	48	-26
56	-4	52
-6	0	-12
48	-42	8
54	-22	-6
54	-6	-20
54	14	-26
-54	14	-26
-32	12	-30

// Lui F, 2008: conjunction analysis: observation and imagery for all stimuli, 
// MNI coordinates
// Lui F, 2008: conjunction analysis: observation and imagery for all stimuli, 
// Talairach coordinates
// Lui F, 2008: observation > motor imagery for all stimuli, MNI coordinates
// Lui F, 2008: observation > motor imagery for all stimuli, Talairach 
// coordinates
// Lui F, 2008: motor imagery > observation for all stimuli, MNI coordinates
// Lui F, 2008: motor imagery > observation for all stimuli, Talairach 
// coordinates
// Subjects=13
-28	-72	36
-56	8	20
-40	-8	44
-8	4	56
-52	36	20
-56	4	40
-60	-48	12
44	-48	44
56	32	12
44	8	20
52	0	44
60	-52	-12
64	-44	8
-28	-68	36
-55	9	18
-40	-6	41
-8	6	51
-51	36	17
-55	6	37
-59	-46	13
44	-44	43
55	32	9
44	9	18
51	2	40
59	-51	-8
63	-42	9
-64	-16	16
-48	-56	0
40	-72	36
56	-12	20
60	-20	40
48	-40	0
60	-48	-4
-63	-15	15
-48	-54	3
40	-68	37
55	-11	19
59	-18	38
48	-39	2
59	-47	-1
-68	-36	20
-48	8	4
-44	12	-8
-36	40	20
-8	4	48
-12	0	-8
60	-44	28
36	28	-8
44	20	-20
28	44	24
8	12	60
4	16	32
64	-44	20
16	-8	4
-67	-34	20
-48	8	3
-44	11	-7
-36	40	16
-8	6	44
-12	0	-7
59	-41	28
36	27	-8
44	19	-18
28	44	20
8	14	55
4	17	29
63	-42	21
16	-8	4

// Villarreal M, 2008: [(tv > rest) AND (iv > rest) AND (cv > rest)]
// Villarreal M, 2008: (tv > rest)
// Villarreal M, 2008: (iv > rest)
// Villarreal M, 2008: (cv > rest)
// Villarreal M, 2008: [(iv - cv) - (tv - cv)]
// Subjects=17
55.25	-71.3	-5.2
42.52	-87.11	10.03
39.94	-68.34	-18.67
36.46	-77.43	45.04
38.66	-50.86	53.58
-50.61	-75.93	-2.93
-44.27	-68.22	-12.77
-26.61	-98.2	10.07
-26.24	-69.14	45.28
-28.15	-58.57	66.68
-43.5	-38.39	53.74
12.51	21.79	51.32
64.01	-41.95	9.68
40.42	-88.83	14.72
57.44	-71.08	-3.01
40.03	-67.72	-12.01
38.77	-56.62	60.87
59.63	-40.26	5.1
57.44	-49.19	1.54
19.31	-69.87	58.03
-50.57	-77.84	-.5
-37.62	-82.26	-2.53
-41.34	-38.38	53.7
-42.08	-68.01	-10.59
-10.93	-78.69	57.17
-56.92	-68.11	12.09
-34.74	-52.83	59.5
-28.8	-83.11	10.85
-56.95	-44.3	14.21
38.39	10.62	45.26
45.01	5.09	54.65
-28.44	9.29	57.73
-24.03	1.22	62.94
12.58	17.95	56.18
1.69	26	51.08
55.27	42.64	19.39
44.28	32.43	2.66
55.31	-70.88	-.76
50.82	-72.14	-14
-50.61	-75.93	-2.93
-26.19	-73.19	47.93
-26.17	-64.27	51.52
38.35	-88.22	21.42
17.16	-72	58.27
-37.75	-76.71	-12.04
-39.14	-49.01	54.72
-37.63	-80.13	-2.74
32.18	-66.19	50.72
-61.3	-68.54	7.72
38.63	-51.07	51.36
42.86	9.55	56.49
-30.82	-97.39	19.02
59.74	-39.43	13.99
-59.18	-42.59	9.6
-32.89	12.7	48.5
57.41	40.31	17.34
-31.32	47.68	9.16
46.43	41.15	4
5.95	25.6	46.57
-52.38	7.96	44.82
-23.03	20.98	-24.2
-23.02	25.45	-22.4
-35.76	27.06	-4.41
-52.73	31.62	22.32
44.6	21.74	26.12
35.67	23.89	3.65
53.11	-68.97	-3.15
38.28	-86.51	16.77
-44.22	-65.68	-8.54
40.96	-56.4	63.05
35.74	-69.65	-9.51
61.88	-41.75	11.94
36.42	-66.8	43.98
-48.45	-73.79	-3.18
-37.63	-80.13	-2.74
-39.3	-34.95	44.36
-30.85	-97.59	16.8
-26.32	-69.77	38.62
-34.77	-53.04	57.28
12.6	20.28	58.19
-28.48	4.62	53.71
-9.08	17.46	52.11
35.92	3.86	19.07
38.44	6.57	47.9
39.94	27.95	0.93
-50.87	29.34	-2.14
-54.99	22.07	12.1
-52.71	27.37	22.74
44.43	37.93	15.56

// Kim M J, 2008: PTSD
// Subjects=12
-40	18	50
-50	16	44
58	-56	-12
-64	-28	-8
58	-48	-14
40	-58	-20
-50	-50	-22
-46	-50	-24
10	-82	52
-8	64	32
-10	66	26
-6	66	26
-68	-28	-8
-58	-52	2
-38	14	50
6	64	32
12	64	32
32	-84	-20
30	-82	-22
24	-20	-8
-14	44	4
-8	40	6
-10	40	0
12	50	2
16	60	-2
24	-76	48
-50	10	42
54	-40	-18
54	-36	-16
60	-48	-14
56	-38	-14
-66	-48	22

// Kim M J, 2008: Healthy Control
// Subjects=12
-40	26	-26
48	-60	-42
50	-64	-44
-6	64	14
20	62	-2
24	-20	-8
-14	44	4
-8	40	6
-10	40	0
12	50	2
16	60	-2
24	-76	48
-50	10	42
54	-40	-18
54	-36	-16
60	-48	-14
56	-38	-14
-66	-48	22

// Sailer U, 2008: PTSD
// Subjects=13
-38	50	-10
-50	30	36
-48	42	24
-38	26	54
24	-74	52
28	-68	34
-38	-42	46
30	-94	14
38	-94	2
24	-72	-12
0	-98	-8
0	-94	6
-12	-76	-8
46	-72	-6
40	-56	-14
52	-44	-20
60	30	-4
-48	0	2
-61	-18	19
-24	28	60
-54	-54	28
-4	10	-6
6	12	-2
-8	62	-12
-8	-10	2
4	64	-14
-4	10	-4
6	62	-16
4	52	-22
-6	10	-8
16	10	-30
-12	38	34

// Sailer U, 2008: Healthy control
// Subjects=13
-38	50	-10
-50	30	36
-48	42	24
-38	26	54
24	-74	52
28	-68	34
-38	-42	46
30	-94	14
38	-94	2
24	-72	-12
0	-98	-8
0	-94	6
-12	-76	-8
46	-72	-6
40	-56	-14
52	-44	-20
60	30	-4
-48	0	2
-24	24	60
-54	-54	26
-56	-24	16
-18	-44	32
-24	28	60
-54	-54	28
-4	10	-6
6	12	-2
-8	62	-12
-8	-10	2
4	64	-14
-4	10	-4
6	62	-16
4	52	-22
-6	10	-8
16	10	-30
-12	38	34

// Sanchez-Carrion R, 2008: Traumatic Brain Injury Patients
// Subjects=12
36	46	24
6	62	-4
-22	56	-2
32	48	22
6	62	-2
40	44	30
-14	14	18
-34	36	22
-16	58	18
-34	34	18
-18	30	-4
10	50	38
22	52	36
12	48	40
10	42	52

// Sanchez-Carrion R, 2008: Healthy Controls
// Subjects=10
36	46	24
6	62	-4
-22	56	-2
32	48	22
6	62	-2
40	44	30
22	52	36
12	48	40
10	42	52

// Yi D J, 2008: Refresh > Repeat
// Yi D J, 2008: [Novel + Skip] > Repeat
// Yi D J, 2008: Conjunction of [Novel > Repeat] and [Novel > Refresh]
// Subjects=9
-40.36	3.52	54.02
-52.54	10.01	32.3
-62.39	-50.05	10.39
-62.53	-42.37	0.67
-59.3	-65.42	-4.95
-65.39	-50.42	29.53
34.03	14.65	42.69
8.09	24.34	44.41
46.52	48.36	12.25
39.96	56.54	8.19
43.96	-40.62	47.99
-27.42	-94	32.08
21.06	-98.16	19.34
37.31	-91.2	23.97
36.64	-51.34	-20.3
-40.38	-77.57	36.27
27.37	-52.3	15.81
47.09	-84.17	29.83
26.91	-35	-17.27
33.47	-52.96	-14.48

// Abraham A, 2008: Mental state or intentional relations (M) > 
// Non-intentional relations (PO)
// Abraham A, 2008: M > Person-spatial (P) relations
// Abraham A, 2008: P > Object-spatial (O) relations
// Subjects=17
-10.59	53.62	28.36
2.09	58.76	11.05
-43.01	0.19	-40.39
-43	9.17	-34.45
-55.73	-2.03	-26.68
56.47	21.62	-19.91
43.6	4.66	-31.72
63.24	-27.3	7.53
-58.7	-16.11	-2.04
37.87	-80.61	22.33
28.27	-90.44	19.92
47.34	-75.49	5.06
28	-73.46	-8.27
24.73	-57.62	-9.56
37.53	-57.8	-13.03
-39.29	-70.18	-1.08
60.11	-13.34	23.13
-55.37	-8.2	17.33
-45.69	-4.2	26.92
-.55	-11.14	57.09
2.63	-50.98	36.98
-14.02	44.69	-4.31
-10.59	53.62	28.36
2.11	59.02	14.38
-43.01	0.19	-40.39
-49.36	10.7	-27.82
40.4	-1.97	-34.48
63.24	-27.3	7.53
37.88	-83.78	22.6
31.21	-70.01	-5.25
2.46	-95.56	-2.77
66.46	-4.04	18.93
-48.81	-13.22	34.4
-48.92	-4.48	23.63
-39.2	-32.97	25.91
-10.27	-5.62	46.71
47.15	-4.93	9.19
-13.24	-82.29	46.48
44.18	-45.42	22.65
-42.36	-52.28	24.22
-3.89	-52.05	23.76
-.57	-54.18	37.28
-55.6	-7.34	-12.85

// Montojo C A, 2008: NMBR, RULE, BOTH > HOLD
// Montojo C A, 2008: Main effect of Condition (NMBR, RULE, BOTH)
// Montojo C A, 2008: Main effect of Event (CUE, CALC, ANSW)
// Montojo C A, 2008: Interaction of Condition x Event
// Montojo C A, 2008: RULE > NMBR
// Montojo C A, 2008: NMBR > RULE
// Montojo C A, 2008: BOTH > NMBR
// Montojo C A, 2008: BOTH > RULE
// Subjects=16
44.24	3.14	36.76
-47.57	-13.19	29.26
34.04	-8.73	39.65
-10.46	67.03	36.6
-11.6	69.81	1.03
4.02	28.6	14.45
-34.39	54.22	32.71
37.37	62.03	41.94
-12.91	78.11	42.39
-50.23	39.64	38.24
14.21	75.53	38.28
2.23	-.67	61.43
-8.1	-5.38	51.01
-27.25	68.55	35.77
-44.93	-3.77	42.15
2.96	35.86	17.65
-43.42	-45.76	13.65
43.54	60.06	38.01
38.84	44.2	31.48
-2.25	1.23	49.27
-13.57	6.2	66.38
-11.26	65.25	42.56
-25.7	67.49	42.54
2.45	5.53	64.58
-27.24	62.28	34.4
-47.84	0.53	27.77
-17.76	79.75	37.96
37.27	63.63	43.36
3.37	1.54	58.33
-3.99	-12.7	39.98
9.2	83.24	42.15
-8.8	77.83	48.17
-42.88	-35.31	31.73
-39.18	-6.39	39.3
-28.64	60.76	32.76
23.78	77.48	32.43
-36.34	57.26	44.74
-31.11	49.59	26.26
2.81	2.24	55.04
6.04	-9.62	52.76
6.72	83.72	40.36
32.21	61.19	38.5
14.03	85.52	46.37
-45.59	2.93	28.33
-34.4	57.29	32.56
36.08	63.52	42.05
-42.6	2.06	27.81
2.63	-3.77	57.11
-21.91	81.96	40.72
10.79	82.95	41.04
8.29	20.75	37.81
-41.93	-35.53	30.28

// Bryant R, 2008: PTSD (Post traumatic stress disorder)
// Subjects=15
24	2	-12
-26	-2	-12
-8	60	36
-28	-2	-26
26	4	-28
0	36	36
0	50	-12

// Bryant R, 2008: Healthy Controls
// Subjects=15
-16	2	-16
18	4	-16
8	58	-12
-28	-2	-26
26	4	-28
0	36	36
0	50	-12

// Carrion V G, 2008: PTSS/early life trauma
// Subjects=16
39.83	43.49	-5.09
-29.45	22.54	-18.64
22.66	68.39	9.55
44.29	51.13	7.53
7.53	50.8	5.95
24.51	29.97	-22.54
-33.78	24.66	-18.78
52.84	18.76	-6.22
-33.65	21.23	-9.48
33.49	-.35	-2.88
-18.28	13.27	7.86
50.76	-29.94	-10.33
66.95	-33.28	-12.52
46.5	-51.33	-9.26
-42	-63.03	-3.24
-35.25	-90.58	11.7
-35.61	43.51	10.77
-11.4	-78.92	20.23
-48.48	-69.64	-4.71
-46.2	-75.29	3.65
7.68	31.11	13.5
-9.7	39.14	8.52
5.48	33.02	11.1
-5.33	35.11	11.08
31.03	32.43	-19.53
33.34	25.93	-8.84
35.59	16.78	-3.49
35.48	10.42	-14.07

// Carrion V G, 2008: Healthy Controls
// Subjects=14
39.87	32.85	-4.03
-31.59	27.1	-15.69
28.84	32.22	-21.71
-27.3	29.04	-18.2
10	40.01	28.26
10.14	52	41.64
33.59	39.81	13.31
10.28	16.9	45.11
48.48	21.73	-8.68
-42.37	22.81	-15.09
13.94	20.75	-5.76
-16.3	16.29	-5.92
-5.48	12.07	-5.69
24.6	14.23	-18.74
-26.99	10.59	2.67
7.66	-24.8	1.1
7.58	-6.82	-1.8
34.16	14.52	52.79
55.21	-54.07	-4.66
50.64	-25.35	-18.63
60.36	-3.42	-14.24
46.53	-64.3	-10.22
-46.37	-75.47	-9.78
-20.44	-46.89	-4.08
-19.61	-70.21	56.48
51.48	-35.48	45.11
10.46	-58.38	43.59
-5.46	-31.51	-12.58
-22.51	-50.64	1.93
48.78	-69.09	-4.18
-44.17	-78.44	-7.28
-35.61	43.51	10.77
-11.4	-78.92	20.23
-48.48	-69.64	-4.71
-46.2	-75.29	3.65
7.68	31.11	13.5
-9.7	39.14	8.52
5.48	33.02	11.1
-5.33	35.11	11.08

// Geuze E, 2008: PTSD > control, encoding
// Geuze E, 2008: Control > PTSD, encoding
// Geuze E, 2008: Control > PTSD, retrieval
// Subjects=12
49.43	11.94	34.51
13.01	-46.34	-.33
-45.66	-69.79	4.54
46.31	-67.41	13.32
-47.96	-22.05	2.79
-54.46	-1.11	-1.12
60.94	3.9	-1.75
-39.72	49.48	-8.88
54.45	37.15	2.23
-33.76	6.47	53.77
-8.16	29.17	56.03
-37.97	-67.6	32.15
-9.07	-64.71	39.38
66.38	14.9	16.22
64.2	1.17	4.02
-52.14	-11.27	18.67
-10.45	-48.17	5.67
-59.66	-35.86	4.09
48.38	-54.96	8.91
-65.12	-21.69	-4.85
11.02	-94.28	-.75

// Simmons A N, 2008: Negative - positive anticipation, PTSD> control, whole 
// brain
// Subjects=15
39.77	21.32	32.72
46.46	-41.66	43.5
-40.09	-37.78	46.4
7.59	9.98	12.85
35.21	28.15	-2.37
13.17	17.87	45.58
-12.39	2.2	51.65
-32.1	24.58	-1.3
-42.63	17.34	16.16
-14.54	19.62	56.91
55.59	15.93	2.88
11.98	36.47	38.46

// B?lte S, 2008: Healthy Controls
// Subjects=7
23	-72	-7

// Kadosh R C, 2008: Size Congruity Effect
// Kadosh R C, 2008: Comparison X Congruity Interaction
// Kadosh R C, 2008: ComparisonXCongruity - Beta weights of Congruity Effect
// Subjects=16
38.94	-41.08	37.96
37.64	18.04	31.9
35.81	-51.33	43.32
49.65	-30.81	45.9
41.04	-33.75	36.21

// Kleinhans N M, 2008: Autism (ASD) Group
// Subjects=14
-42.59	18.91	22.72
53.44	16.89	1.71
52.33	28.51	0.75
58.79	9.26	-1.06
54.5	13.46	-1.36
50.23	27.78	5.29
-30.96	22.01	6.71
-52.15	13.91	27.71
-2.77	6.65	53.4
-43.53	28.99	43.07
56.55	21.33	-9.85
-57.57	5.44	15.1
-9.13	-10.39	53.78
-43.53	28.99	43.07

// Kleinhans N M, 2008: Typically-Developing (Control) Group
// Subjects=14
-43.58	13.07	29.91
53.44	16.89	1.71
52.33	28.51	0.75
58.79	9.26	-1.06
54.5	13.46	-1.36
50.23	27.78	5.29
-45.79	21.09	23.68
-38.52	28.85	-.47
-4.9	8.93	55.46
-43.53	28.99	43.07
56.55	21.33	-9.85
-57.57	5.44	15.1
-9.13	-10.39	53.78
-43.53	28.99	43.07
-9.38	-92.09	-11.85
-.64	-97.73	10.83
-8.68	57.84	0.1
39.71	-39.75	-0.07
48.32	-47.91	3.86

// Ramirez-Ruiz B, 2008: Parkinson's Disease Patients Without Halluncinations
// Subjects=10
49	7	33
44	-73	9
-49	-66	7
54	28	15
50	25	2
20	18	51
12	-4	46
40	21	36
-16	22	19
-10	23	41
-10	-6	47
-24	9	42
-22	6	53
16	12	44

// Ramirez-Ruiz B, 2008: Parkinson's Disease Patients With Visual 
// Hallucinations
// Subjects=10
51	-60	7
-36	-69	-13
54	28	15
50	25	2
20	18	51
12	-4	46
40	21	36
-16	22	19
-10	23	41
-10	-6	47
-24	9	42
-22	6	53

// Ramirez-Ruiz B, 2008: Healthy Controls
// Subjects=10
-10	45	0
48	-61	25
-49	-57	16
44	-67	-12
16	12	44

// Hooker C I, 2008: Emotion Inference (EI): False Belief (FB) > EI: True 
// Belief (TB)
// Hooker C I, 2008: EI: FB > Emotion Recognition (ER): FB
// Hooker C I, 2008: (EI: FB - ER: FB) > (EI: TB - ER: TB)
// Hooker C I, 2008: ER: TB > ER: FB
// Hooker C I, 2008: ER: FB > ER: TB
// Hooker C I, 2008: EI: FB > EI: TB (correlated with overall empathy)
// Hooker C I, 2008: EI: FB vs. ER: FB (correlated with overall empathy)
// Hooker C I, 2008: ER: TB > ER: FB (correlated with overall empathy)
// Hooker C I, 2008: Personal Distress (PD): EI: FB vs. EI: TB
// Hooker C I, 2008: PD: ER: TB vs. ER: FB
// Hooker C I, 2008: PD: EI: FB vs. ER: FB
// Subjects=22
-44	18	22
-38	32	22
-4	40	16
-10	8	56
-50	-68	14
-60	-46	-2
-48	24	-20
-22	-68	-4
-12	-10	0
-22	-28	-2
-20	6	-10
62	-42	-4
14	-2	10
10	-30	2
22	-64	6
46	24	22
46	-16	42
-42	4	36
-42	24	-10
54	54	8
-42	-2	58
-18	50	38
-10	18	54
2	56	18
-54	-58	16
-58	-14	-16
-12	-54	30
-18	-72	-4
18	-52	8
-8	-18	12
-10	12	-12
38	18	24
32	22	-6
6	-12	12
-40	26	12
-46	14	8
-6	16	46
-4	42	18
-52	-46	-8
-50	24	-22
-24	-62	-6
26	-58	-16
-10	-14	0
-28	14	-4
-12	2	14
42	26	18
14	14	-2
48	-16	48
-42	26	14
0	50	20
4	20	44
-14	58	38
-52	-40	48
20	-52	6
-8	-18	4
-28	6	4
14	12	4
-48	-16	54
-26	52	-4
-44	-80	22
10	-46	36
22	12	54
28	58	2
50	-54	22
-16	-12	4
56	-26	22
64	0	4
4	-32	46
8	22	38
48	-36	46
22	-28	-2
-46	4	4
6	6	40
20	-22	6
54	-32	18
56	-30	30
26	-2	72
-28	-10	14
-46	18	4
-38	-62	-14
-16	-56	62
38	-28	40
48	-24	22
20	-10	56
52	-36	60
32	-58	-20
28	-8	-14
18	-24	4
54	-18	12
-10	-8	0
-8	-74	14
42	-50	8
24	24	38

// Malhi G S, 2008: Healthy controls
// Subjects=20
56.6	51.51	8.81
-56.67	49.78	10.25
52.38	27.88	6.37
-54.33	-19.46	9.34
39.53	23.23	2.45
-34.17	18.73	5.91
65.7	-50.35	39.55
-60.36	-48.48	47.53
52.91	-64.34	38.64
-47.54	-64.95	39.84
63.03	-9.72	-12.9
-56.65	-10.44	-11.46
33.17	-29.02	-12.05
14.09	-16.59	12.77
-7.3	-13.63	11.66
18.23	4.07	4.3

// Wagner G, 2008: MDD Patients
// Subjects=16
-10	-51	22
-12	-59	30

// Wagner G, 2008: Healthy Controls
// Subjects=16
4	-54	19
-8	48	-6
-14	55	32

// Frewen P A, 2008: PTSD
// Subjects=25
4	48	6
2	50	6

// Frewen P A, 2008: Healthy control
// Subjects=15
8	54	2
2	50	6

// Bensafi M, 2008: CO2 > Baseline
// Bensafi M, 2008: H2S > Baseline
// Bensafi M, 2008: CO2 High > CO2 Low
// Bensafi M, 2008: H2S High > H2S Low
// Subjects=8
6	39	15
24	-69	-30
69	-21	6
66	-51	12
3	-63	-27
-51	-12	9
-60	-36	36
-66	-39	15
57	-24	27
57	-42	48
45	33	27
36	-9	21
18	-3	12
36	-27	-9
-9	15	21
-15	-48	9
-3	-21	51
6	-51	-27
0	-87	3
3	0	57
39	-72	48
-39	45	27
-30	9	-33
-12	-66	48
-33	6	57

// Blondin F, 2008: Low Discriminability vs High Discriminability
// Blondin F, 2008: High Discriminability vs Low Discriminability
// Subjects=24
-40	-8	24
-56	-24	48
-36	-30	40
-38	-32	66
-30	-34	52
-16	-54	54
-44	62	-4
-22	-62	52
-44	-66	-18
-22	-66	-26
-12	-70	62
-4	-82	-14
-12	-86	42
-22	-92	0
-22	-96	16
38	32	14
2	-12	40
34	-42	38
44	-50	52
32	-50	-32
34	-64	-18
18	-72	-18
38	-72	-26
18	-74	-6
30	-86	-4
32	-86	-18
6	-86	42
12	-98	6
0	-46	-26
0	-68	-26
0	-68	-6
2	-26	52
-6	60	24
-18	60	16
-38	6	-36
-22	-6	-38
-20	-12	-22
-36	-12	-36
-12	-60	16
8	46	2
4	42	-10
60	24	8
36	8	-40
20	-64	-32

// Gundel H, 2008: Somatoform Disorder Pain Patients
// Subjects=12
30	9	-15
-39	-45	18
33	-27	66
-27	-48	57
21	0	-15
-36	-45	-6
6	54	-15
12	-3	6
-12	-3	6
39	6	9
-42	3	-3
9	3	39
39	-12	6
-36	-18	12
51	-36	18
-42	-39	21
36	-30	66
15	-33	30
51	-45	45
-48	-45	42
-9	18	30
6	-9	39

// Gundel H, 2008: Healthy Volunteers
// Subjects=13
30	9	-15
-39	-45	18
33	-27	66
-27	-48	57
21	0	-15
-36	-45	-6
6	54	-15
21	-21	15
-12	-9	6
27	15	-3
-27	18	9
9	-18	33
-6	-21	30
39	-18	15
57	-36	24
3	24	51
39	39	0
-45	45	-9
45	-48	51
-57	-48	30

// Bolger D J, 2008: Spelling and Rhyming Tasks, Orthographic and Phonological 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling and Rhyming Tasks, Orthographic and Phonological 
// Consistency, Consistent Words
// Bolger D J, 2008: Spelling, Orthographic Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling, Phonological Consistency, Inconsistent Words
// Bolger D J, 2008: Rhyming, Orthographic Consistency, Inconsistent Words
// Bolger D J, 2008: Rhyming, Phonological Consistency, Inconsistent Words
// Bolger D J, 2008: Spelling, Orthographic Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Orthographic Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Phonological Consistency, Consistent Words
// Bolger D J, 2008: Rhyming, Inconsistent Words >Spelling, Orthographic And 
// Phonological Consistency
// Bolger D J, 2008: Rhyming, Inconsistent Words > Spelling, Orthographic 
// Consistency
// Bolger D J, 2008: Rhyming, Inconsistent Words > Spelling, Phonological 
// Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Orthographic and 
// Phonological Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Orthographic 
// Consistency
// Bolger D J, 2008: Rhyming, Consistent Words > Spelling, Phonological 
// Consistency
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Orthographic 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Phonological 
// Consistency, Inconsistent Words
// Bolger D J, 2008: Correlation of Rhyming Accuracy With Phonological 
// Consistency, Consistent Words
// Subjects=46
-6	19	38
6	22	35
-33	23	-1
-50	12	16
46	27	24
45	7	28
-27	-56	42
-36	-45	41
-50	-33	46
-48	-56	-7
-9	-75	12
18	-66	12
18	-55	0
30	-56	44
27	-65	36
-50	-40	8
15	-32	-6
45	-36	46
-9	-22	20
6	-60	27
3	-57	45
-15	-57	27
-48	-63	21
9	-54	69
45	-54	24
60	-54	21
51	-54	12
-3	22	38
-3	30	18
-33	20	-1
-45	41	3
-42	36	15
36	20	-1
45	36	18
30	2	47
11	-8	15
-21	-56	44
24	-59	39
33	-44	44
50	-38	49
6	-22	26
-33	23	-1
-27	23	-11
-12	-38	-1
-48	-53	-5
-27	-59	44
-30	-60	33
-27	-65	39
21	-66	25
27	-60	31
21	-59	44
-6	19	38
6	17	43
9	28	35
-36	23	-1
-50	10	19
-45	4	30
33	26	1
50	27	24
42	2	39
53	-7	42
-24	-52	3
-33	-21	40
-33	-45	41
-39	-36	38
42	-53	44
-3	-22	23
-6	20	43
6	20	40
-3	11	49
-36	26	1
-50	9	11
-45	35	-2
39	20	-1
39	21	13
42	24	21
45	42	23
53	7	30
53	5	38
0	46	-15
6	-57	25
9	-49	63
6	-50	49
-45	-63	20
45	-1	-28
53	-57	17
9	-54	33
3	-51	38
-3	-56	42
-6	22	38
6	37	40
6	25	43
-53	15	19
-56	10	24
-45	26	-1
53	10	27
50	21	18
42	8	38
6	-4	31
56	-10	39
-53	18	13
-56	7	25
-45	21	21
-6	22	38
9	17	43
6	11	49
-56	10	24
-56	18	13
39	14	38
53	10	27
53	5	36
6	-1	33
-45	-24	48
18	-4	3
15	-64	53
9	-63	25
3	-36	40
3	-40	13
48	-69	20
50	11	-21
42	13	-28
15	-64	53
9	-63	28
15	-67	56
0	-50	41
-33	-54	-9
-33	-54	-3
0	-54	42

// Mouras H, 2008: Positive Correlations with Penile Tumescence (Time Lag = 
// 0s) (Activations)
// Mouras H, 2008: Negative Correlations with Penile Tumescence (Time Lag = 
// 0s) (Deactivations)
// Mouras H, 2008: Positive Correlations with Penile Tumescene (Time Lag = 
// -20s) (Activations)
// Mouras H, 2008: Negative Correlations with Penile Tumescence (Time Lag = 
// -20s) (Deactivations)
// Mouras H, 2008: Sexual (Block) > Neutral (Block)
// Mouras H, 2008: Sexual (Onset) > Neutral (Onset)
// Subjects=8
18	9	60
-12	24	45
39	33	36
6	-6	60
0	30	36
27	6	63
36	30	48
-30	36	36
39	33	36
42	48	12
-30	24	-15
36	24	-15
54	9	0
48	3	0
63	6	18
-3	-9	33
3	12	33
0	33	21
12	45	6
-15	-30	36
-33	-18	15
18	-54	18
-15	-30	36
9	-30	39
-51	-27	21
-54	-18	21
66	-12	21
-60	-27	21
57	-39	51
-54	-45	33
-42	3	6
-33	18	0
42	-12	3
63	-18	12
-54	-3	0
60	-6	0
48	15	-9
60	-33	12
6	-78	21
-9	-66	39
15	-51	51
15	-63	30
15	-9	12
18	21	-6
27	3	-9
-36	-12	-6
33	3	9
6	-51	-21
3	-48	18
-45	-12	21
-24	-63	21
-18	-9	60
18	-9	66
9	-9	63
-9	39	45
-30	0	51
33	0	48
39	9	30
42	48	12
48	39	3
-51	12	15
39	9	30
-48	3	3
57	9	39
3	9	30
51	-27	57
-60	-21	27
60	-24	24
60	-12	21
60	-12	21
-21	-60	45
33	-45	66
36	39	69
-51	-33	48
57	-27	48
-39	12	-9
42	6	-6
-42	-6	-6
42	0	9
57	-9	0
-51	-57	-3
51	-63	-6
51	-63	-6
-36	-39	-3
-18	-36	3
-36	-60	-12
21	-72	39
42	-78	-6
15	-81	-3
12	-6	12
-21	-6	24
21	-27	18
-33	0	12
0	15	-6
18	60	24
9	33	57
-9	12	51
51	18	9
-48	27	-3
48	-66	45
-9	36	33
6	-48	12
-42	-72	36
-57	-57	27
60	-57	36
60	-33	0
-57	-39	0
-48	-69	-3
-39	-45	-15
45	-57	-18
45	-72	-9
-24	-3	69
-30	-9	-60
30	-6	57
45	9	24
0	3	33
-33	-51	51
-39	-45	57
-30	15	6
48	-63	-6
48	-60	9
-24	-57	51
-21	-75	33
30	-81	33
-9	-36	-6
-6	-6	9
-6	9	-3
3	-48	-3
33	-51	60

// Paul T, 2008: Healthy heterosexual males
// Subjects=12
18	42	-3
-18	3	30
-15	6	18
36	15	-3
24	51	12
-9	36	-15
36	-81	3
-51	-63	-6
60	-27	24
-69	-30	21
42	-48	-15
-42	-51	-21
21	-66	-51
-12	-72	-48
6	-27	-15
21	0	-18
9	6	0
45	3	0
-36	3	6
-12	9	-3
45	39	9
36	0	60
-54	18	12
-51	6	42
48	-75	-12
45	-75	-9
66	-30	33
-33	-48	57
42	3	-12
-39	9	-18
3	-27	-6
-6	-21	-9

// Paul T, 2008: Healthy homosexual males
// Subjects=12
6	48	-15
-24	33	-9
42	-81	0
-39	-75	3
60	-24	27
-24	-48	39
42	-51	-12
-48	-42	-18
24	-51	-48
-21	-60	-48
-9	15	6
9	57	3
15	57	27
24	27	-15
39	15	-12
-39	15	-12
45	84	6
-54	-72	-6
63	-24	21
-66	-30	24

// Strigo I A, 2008: Pain anticipation; MDD > CON
// Strigo I A, 2008: Pain anticipation; CON > MDD
// Strigo I A, 2008: Pain stimulation; MDD > CON
// Strigo I A, 2008: Pain stimulation; CON > MDD
// Subjects=15
48.08	25.48	3.28
-33.06	23.48	12.19
12.04	22.72	39.61
-17.8	2.54	42.76
49.43	17.4	36.28
-35.09	4.86	19.35
-26.62	38.12	22.04
-34.27	31.96	-1.89
-48.2	18.25	-12.85
-35.86	-26.12	45.37
-55.16	-12.66	42.24
-27.32	-16.3	47.8
48.37	-40.79	13.3
56.79	-39.82	-2.5
27.64	-2.5	-26.48
20.46	-57.56	-8.4
7.44	24.81	-1.77
2.67	-60.41	38.89
-2.76	-71.25	23.13
-29.42	-69.67	32.22
5.26	-14.01	-21.91
-2.82	-49.93	23.57
30.77	-2.11	-35.47
-41.76	-11.03	-20.51
-53.39	-53.74	-21.25
5.22	41.55	-5.38
12.79	45.79	7.56
36.69	17.04	46.5
-45.6	12.14	45.62
-49.24	38.3	-1.14
-17.83	31.86	50.34
-22.12	24	45.47
-56.47	-43.67	-.87
-34.65	-69.73	45.67
-48.66	-50.06	39.72
11.8	-35.75	-14.59
13.85	-40.99	-27.55

// Landgrebe M, 2008: Electrosensitive Patients
// Subjects=15
36	18	0
-33	15	6
-3	21	51
-24	48	9
-27	-66	-33
48	45	21
48	-51	48
57	-39	48
3	15	57
-42	-30	57
51	21	3
-33	27	-3
9	24	39
-3	15	57
42	24	-6
-42	21	-6
54	24	3
-3	21	51
33	30	-3
0	-78	39
36	-42	-18
60	-54	18
39	-51	-18

// Landgrebe M, 2008: Controls
// Subjects=15
36	18	0
-33	15	6
-3	21	51
-24	48	9
36	21	3
-33	15	6
-57	3	42
66	-21	24
48	30	33
48	3	36
6	21	48
42	-48	45
30	6	57
-48	-36	48
54	24	3
-3	21	51
33	30	-3
-18	-66	-24
-54	-57	-3
57	-63	-3
57	-54	6

// Bertolino A, 2008: 2-back, Main effect of diagnosis (controls > patients)
// Subjects=46
-49	21	44
19	13	51
-34	58	1
0	-33	-2
-11	-7	0
8	-67	48
-11	-74	45

// Campbell-Meiklejohn D K, 2008: Chase > Quit
// Campbell-Meiklejohn D K, 2008: Quit > Chase
// Campbell-Meiklejohn D K, 2008: Quit > Ctrl
// Campbell-Meiklejohn D K, 2008: Ctrl > Quit
// Campbell-Meiklejohn D K, 2008: Ctrl > Chase
// Subjects=23
-6	50	-16
-6	38	-18
-2	6	-12
-54	-70	26
-4	22	38
36	18	0
38	30	36
40	8	52
-32	20	2
0	-30	26
-18	18	-4
18	18	-6
44	-52	52
-42	-44	48
8	-74	6
4	-74	44
-2	26	36
-42	-48	52
42	-52	52
-8	-18	6
-30	20	4
0	-30	26
-6	-88	-8
-6	50	-16
4	20	-10
4	-84	-14
36	18	2
52	40	4
12	18	42
10	50	14

// Chen E, 2008: Predicate Metaphors > Literal Motion Sentences
// Chen E, 2008: Literal Motion Sentences < Non-Motive Sentences
// Chen E, 2008: Predicate Metaphors > Non-Motive Sentences
// Chen E, 2008: Positive Correlation between Figurativeness Ratings and 
// Activations Across All Sentences
// Subjects=14
-56.2	21.13	2.12
-53.37	6.01	-33.41
-56.39	-9.87	-19.46
-65.69	-38.47	8.18
-43.64	-55.9	38.67
57.95	-2	-33.39
-56.42	-1.37	-20.3
-24.7	-55.21	-.94
-8.2	-86.88	15.36
58.04	8.51	-24.35
27.12	-48.75	-3.59
11.19	-77.34	12.96
-59.11	-49.73	13.67
-59.53	32.5	-2.31
-53.37	6.01	-33.41
-56.39	-9.87	-19.46
-55.95	-40.46	9.33
-43.61	-54.52	41.89
54.8	1.91	-25.88

// Chen J L, 2008: Experiment 1 Non-musicians
// Subjects=12
-43.61	-32.25	8.06
58.94	-21.06	5.94
48.3	-29.42	9
-6.93	2.37	67.19
-49.77	-3.32	52.54
57.02	3.16	44.08
-52.16	5.02	22.88
54.72	10.23	25.67
50.45	8.09	25.9
-33.06	-68.77	-24.69
13.99	-76.94	-24.54
33.16	-68.71	-29.91
-26.86	-73.07	-53.39
28.71	-77.14	-55.92
-13.75	-1.95	11.87
16.06	5.83	-.28
14.07	2.96	17.83
-30.39	-54.47	49.92
-54.22	-29.34	19.09
-32.94	-27.96	7.58
73.99	-28.75	15.34
44.06	-35.61	11.8
-41.14	-11.21	59.8
-2.67	-2.18	63.06
57.07	1.55	50.91
-60.69	5.14	25.19
63.21	9.77	18.92
50.29	4.26	3.92
-28.79	-68.74	-24.74
13.99	-63.74	-18.96
24.63	-64.19	-25.73
-29	-70.97	-53.54
-31.16	-66.75	-53.87
24.44	-74.88	-53.83
-22.35	-2.52	5.32
22.53	2.15	6.64
-51.86	-33.62	46.19
-41.43	-34.01	12.64
71.81	-24.87	10.58
44.06	-35.61	11.8
-6.93	2.37	67.19
-49.77	-3.32	52.54
57.02	3.16	44.08
-52.16	5.02	22.88
52.55	7.76	21.44
-33.06	-68.77	-24.69
13.99	-76.94	-24.54
33.16	-68.71	-29.91
-26.86	-73.07	-53.39
28.71	-77.14	-55.92

// Chen J L, 2008: Experiment 2 Non-musicians
// Subjects=12
-39.28	-33.83	14.83
48.29	-27.3	8.82
63.25	-22.81	10.5
1.67	0.73	72.8
-51.91	-3.33	52.57
59.2	-.72	48.84
-35.16	-70.55	-20.05
-41.57	-66.19	-18.11
37.49	-65.89	-21.28
-41.42	-36.13	12.82
-62.91	-19.85	5.01
-56.48	-19.64	7.15
52.56	-27.28	8.77
-.55	6.47	64.54
-49.77	1.09	54.4
59.19	3.51	48.49
-56.65	11.57	-2.16
-47.9	13.68	24.33
-41.38	1.71	34.18
-30.93	-66.64	-24.89
-48.02	-68.86	-24.51
37.47	-70.46	-25.35
11.89	-78.73	-19.91
-29.04	-69.2	-58.15
-24.71	-75.17	-53.24
26.6	-79.09	-53.5
-43.55	-33.85	14.88
-58.45	-42.06	20.2
69.7	-28.94	13.17
-.52	0.12	65.07
-43.29	-9.11	59.64
57.08	3.84	52.94
-52.35	9.65	0.19
58.73	11.92	-7.97
-30.96	-62.58	-27.46
33.15	-62.2	-28.23
7.63	-67.67	-14.09
-22.57	-75.16	-53.27
22.32	-74.72	-51.59
-11.62	-17.43	4.22
-15.87	-10.6	10.39
18.29	-1.93	9.27
-41.42	-36.13	12.82
-62.88	-21.79	7.4
-56.48	-19.64	7.15
69.7	-28.94	13.17
1.58	-.21	60.61
-51.9	-1.04	54.61
59.19	3.51	48.49
-35.16	-70.55	-20.05
-30.88	-66.12	-18.24
37.49	-65.89	-21.28

// de Rover M, 2008: Healthy Controls, Experiment 1
// Subjects=6
8.23	-85.16	32.83
-2.78	-93.24	15.89
-4.87	-88.37	22.17
-7	-81.58	26.02
12.14	-75.08	2.64
12.2	-76.79	7.29
16.37	-73.56	-4.31
5.77	-74.27	11.63
-7.14	-73.9	16.29
29.35	-64.59	-.94
27.21	-68.85	-.48
22.93	-64.2	3.62
-9.71	-13.47	-3.09
-9.71	-20.06	-4.68
-7.56	-9.21	-3.55
-5.33	-13.04	1.28
9.77	-6.6	0.38
11.99	-6.18	4.79
7.67	-8.32	5.07
-14.06	-4.98	-3.85
14.07	-.21	-.32
-18.39	-2.87	-3.99
-18.32	-6.7	0.87
31.43	-21.42	1.48
37.91	-19.27	1.16

// de Rover M, 2008: Healthy Controls, Experiment 2
// Subjects=20
16.47	-11.51	16.44
18.52	-3.62	8.9
-15.98	-7.58	14.37
-11.75	-14.77	6.04
22.73	8.75	3.13
-20.48	8.59	3.88
-18.27	2.43	6.69
-22.62	-4.38	2.96
16.45	-13.84	14.43
-11.73	-12.44	8.05
20.54	8.53	0.94
-18.34	6.27	1.83
-13.91	0.52	9.05

// Evans K C, 2008: Angry Faces > Neutral Faces, Social Anxiety Disorder 
// Patients > Healthy Controls
// Evans K C, 2008: Angry Faces > Neutral Faces, Healthy Controls > Social 
// Anxiety Disorder Patients
// Evans K C, 2008: Angry Faces > Happy Faces, Social Anxiety Disorder 
// Patients > Healthy Controls
// Evans K C, 2008: Angry Faces > Happy Faces, Healthy Controls > Social 
// Anxiety Disorder Patients
// Subjects=11
-60	-55	28
-10	0	66
18	26	24
-24	-82	-2
-24	-68	6
-40	-64	0
34	-64	-6
34	-12	48
14	-76	-36
44	-12	14
-16	-26	44
58	-22	-14
44	42	30

// Gentili C, 2008: Emotional Faces > Scrambled Pictures, Social Phobia 
// Patients > Healthy Controls
// Gentili C, 2008: Emotional Faces > Scrambled Pictures, Healthy Controls > 
// Social Phobia Patients
// Subjects=7
0.42	-86.8	14.36
27.13	-40.6	31.37
37.67	-44.28	10.37
-42.53	-34.28	9.33
-26.8	-5.48	-18.91
-33.27	4.88	-21.94
39.08	-50.62	52.14
-35.74	-54.5	49.98
-38.37	-43.19	-10.04
-42.6	31.94	26.08

// Mohr C, 2008: Common Activity During Thermal Stimulation
// Mohr C, 2008: Capsaicin-Treated 43 C vs. Untreated 43 C
// Mohr C, 2008: Capsaicin-Treated 0 C > Untreated 0 C
// Subjects=15
26	-40	76
-46	-40	62
-66	-22	22
40	-12	66
-34	-4	66
-42	-2	60
-50	-2	52
-4	10	34
-58	14	32
-26	-52	72
38	-4	12
58	-14	8
22	16	-22
-50	-24	20
56	6	6
-18	10	-4
28	10	52
12	-26	-22

// Gandini D, 2008: Healthy Young Adults
// Subjects=13
-30.77	-69.65	28.6
-30.3	-60.7	66.93
-34.63	30.78	0.8
43.3	35.38	11.35
36.64	23.06	-5.25
53.69	-25.28	50.79
53.22	-79.09	3.45
-1.34	11.18	64.93
31.26	-59.52	64.64
13.89	25.86	-8.5
-18.32	8.6	3.84
-11.31	-72.78	28.58
33.27	58.25	-7.56
-1.09	-50.4	72.14
-58.87	-33.72	35.61
-24.53	-7.94	22.39
-62.52	-32.39	4.17
-50.21	-53.25	32.91
-53.22	31.18	-16.85
-8.07	-46.51	33.77
21.47	-6.41	70.76
-52.05	-46.51	59.17
14.78	-80.26	38.96
69.14	2.01	-2.6
-52.5	-25.81	28
26.96	4.74	-5.51
-44.08	-21.92	11.78
68.28	-21.52	9.83
11.13	-87.64	6.14
-59.28	-32.37	4.11

// Gandini D, 2008: Healthy Older Adults
// Subjects=12
-62.52	-32.39	4.17
-50.21	-53.25	32.91
-53.22	31.18	-16.85
-8.07	-46.51	33.77
21.47	-6.41	70.76
-52.05	-46.51	59.17
14.78	-80.26	38.96
69.14	2.01	-2.6
-52.5	-25.81	28
26.96	4.74	-5.51
-44.08	-21.92	11.78
68.28	-21.52	9.83
11.13	-87.64	6.14
-59.28	-32.37	4.11

// Kaufmann L, 2008: Healthy Control Adults
// Subjects=12
41.02	-53.76	68.39
37.47	-57.12	44.13
31.05	-53.43	49.48
-30.35	-47.94	65.67
-49.91	-17.06	64.07
53.89	-32.54	64.95
50.38	-25.81	45.29
50.63	-22.78	66.28
43.45	-66.36	2.36
-40.8	-86.21	1.28
53.56	-22.92	41.59
41.02	-53.76	68.39
24.78	-57.32	65.66
65.6	-30.45	52.22
55.91	-11.68	58.37
34.38	-10.07	65.3
14.61	-53.02	31.79
-1.49	-42.47	42.22
-11.2	-70.88	37.36
14.72	-77.38	35.32
21.53	-28.95	70.75
62.42	-26.75	57.51
68.32	-1.55	16.81
71.93	-29.45	39.68

// Kaufmann L, 2008: Healthy Control Children
// Subjects=12
53.75	-20.4	57.03
43.96	-31.9	49.37
43.45	-66.36	2.36
-40.8	-86.21	1.28
53.56	-22.92	41.59
65.6	-30.45	52.22
55.91	-11.68	58.37
34.38	-10.07	65.3
14.61	-53.02	31.79
-1.49	-42.47	42.22
-11.2	-70.88	37.36
14.72	-77.38	35.32
21.53	-28.95	70.75
62.42	-26.75	57.51
68.32	-1.55	16.81
71.93	-29.45	39.68

// Kaufmann L, 2008: MCI > Elderly Controls Congruity effects (collapsed over 
// numerical and physical)
// Kaufmann L, 2008: MCI > Elderly Controls Distance effects (collapsed over 
// numerical and physical)
// Subjects=6
30.22	-43.19	-13.15
39.82	-55.04	-25.59
49.59	-56.82	-22.22
-40.82	-66.66	3.83
49.78	-35.7	-3.02
49.38	46.64	-17.89
47.43	-38.95	65.69
56	-32.85	61.58
-21.28	-19.94	20.16
-50.55	20.78	21.11
53.3	25.48	31.2
1.77	-2.92	51.7
-8.63	-26.64	-6.28
7.62	-36.06	-4.51
49.57	45.86	-3.24
68.48	-22.19	25.58
-50.17	-10.32	44.35
62.1	-43.39	28.9
30.89	-52.44	37.06
11.3	-5.4	36.1
-62.07	-40.01	37.41
-68.88	-30.41	14.16
-7.72	-64.64	57.97
-34.83	1.9	-20.99

// Kucian K, 2008: Children-Adults (Approximate Calculation)
// Kucian K, 2008: Children-Adults (Exact Calculation)
// Kucian K, 2008: Children-Adults (Magnitude Comparison)
// Kucian K, 2008: Adults-Children (Exact Calculation)
// Kucian K, 2008: Adults-Children (Magnitude Comparison)
// Kucian K, 2008: Children-Adults (Approximate Calculation) (ANCOVA with 
// Number of Trials as Covariate)
// Kucian K, 2008: Adults-Children (Approximate Calculation) (ANCOVA with 
// Number of Trials as Covariate)
// Kucian K, 2008: Adults-Children (Exact Calculation) (ANCOVA with Number of 
// Trials as Covariate)
// Kucian K, 2008: Adults-Children (Magnitude Comparison) (ANCOVA with Number 
// of Trials as Covariate)
// Subjects=10
11.46	-64.42	36.33
-8.01	-77.77	32.38
-50.68	-39.24	-.96
58.24	4.54	-9.39
28.05	-27.55	73.86
40.12	-5.77	7.63
-8	-71.18	33.97
1.99	-23.15	64.91
-63.57	-2.63	12.45
-59.48	-2.15	-5.6
-20.6	-37.81	70.1
-14.43	-39.01	45.46
-4.66	-58.33	44.97
65.16	-3.17	22.63
20.59	-84.16	-14.54
14.28	44.08	25.55
14.36	28.23	28.23
-43.62	-39.32	43.75
-46.89	-36.25	42.38
-27.43	-74.34	35.73
-50.47	11.52	25.39
-27.59	-89.83	19.34
20.96	-96.66	12.46
34.26	-53.63	47.2
43.61	-77.23	12.4
46.41	-59.71	-18.52
59.02	-25.78	45.14
40.09	-80.38	-9.64

// Kadosh R C, 2008: Main effect: Inteference
// Kadosh R C, 2008: Main Effect: Interference and Facilitation, Numerical 
// comparison > Physical comparison
// Kadosh R C, 2008: Size congruity effect
// Kadosh R C, 2008: Interference under physical task
// Subjects=14
42.23	-41.26	49.09
-37.96	-34.51	47.22
8.84	13.98	37.04
-3.95	9.94	40.87
31.53	-6.37	60.79
-28.74	46.03	28.09
-48.92	4.32	27.36
37.44	15.99	5.31
28.36	-64.15	43.36
-26.12	-53.39	49.78
37.5	-50.4	-13.65
-39.39	-59.15	-9.81
-26.2	-4.69	60.19
33.24	46.4	27.35
53.61	8.74	20.23
6.81	12.97	51.64
3.54	-18.54	29.79
-36.26	7.09	6.91

// Zarate J M, 2008: Healthy experienced singers
// Subjects=12
-40	-24	0
-40	-36	12
-42	-22	36
-58	4	4
-42	-20	42
58	2	2
40	-34	16
2	-6	58
42	-14	36
62	6	28
38	-2	0
6	-4	4
22	-2	-6
2	-54	-26
-42	-28	6
-60	-16	8
-42	-34	12
-2	0	46
0	-4	58
-44	-14	44
-40	-20	40
-2	-26	8
-26	-64	-24
62	-12	8
40	-34	16
2	-2	52
46	-12	36
54	4	30
38	-2	2
4	-6	4
-10	-62	-20
2	-56	-24
-52	-18	4
-62	-30	10
-50	-32	6
-42	4	24
-54	-36	50
-46	-40	42
-38	-54	50
50	-4	-6
64	-34	8
50	-44	0
38	-4	56
48	8	22
40	20	0
-44	-44	58
-38	-38	22
62	-30	46
-48	-50	54
-62	-44	26
40	-4	54
36	20	-2
52	-46	50
-56	-32	4
-4	24	30
-2	6	52
-44	-4	54
-40	4	26
-36	22	2
-46	16	32
-56	-42	50
-28	2	6
48	-34	0
10	8	60
52	2	46
40	10	28
30	16	6
28	-6	52
46	6	24
42	-50	60
58	-30	42
10	-22	18
26	8	4
20	-4	8
-46	-3	54
-54	-44	54
-60	-40	50
8	6	48
46	-50	62
-56	-28	6
-24	-14	10
54	-20	4
48	-42	0
-42	-10	46
-54	-32	24
-10	20	38
-22	-2	8
50	-38	0
16	-26	66
-34	-14	70
-12	-52	32
-20	-86	40

// Zarate J M, 2008: Healthy non-musicians
// Subjects=12
-54	-18	8
-54	8	0
-38	-34	16
-2	4	42
0	-4	58
-44	-14	44
-38	-20	40
-24	-60	-22
60	-22	10
60	8	-2
54	-30	18
4	-2	52
48	-10	42
48	4	26
38	-16	-6
20	-32	58
0	-22	14
10	-74	-16
0	-48	-4
-42	-28	6
-60	-16	8
-42	-34	12
-2	0	46
0	-4	58
-44	-14	44
-40	-20	40
-2	-26	8
-26	-64	-24
62	-12	8
40	-34	16
2	-2	52
46	-12	36
54	4	30
38	-2	2
4	-6	4
-10	-62	-20
2	-56	-24
-44	26	28
-54	12	28
-48	-50	56
-52	-34	30
8	18	40
42	-4	52
36	20	-2
-48	-50	54
-62	-44	26
40	-4	54
36	20	-2
52	-46	50
-62	-44	20
-34	-14	70
-34	-2	64
-50	-48	58
-54	-40	26
8	6	46
-46	-3	54
-54	-44	54
-60	-40	50
8	6	48
46	-50	62
-56	-28	6
-24	-14	10
54	-20	4
48	-42	0
-42	-10	46
-54	-32	24
-10	20	38
-22	-2	8
50	-38	0
16	-26	66
-34	-14	70
-12	-52	32
-20	-86	40

// Nagano-Saito A, 2008: Balanced Drink (BAL): Receive negative feedback (RNF) 
// > Receive control feedback (RCF), p<.05
// Nagano-Saito A, 2008: Amino Acid deficient drink (APTD): RNF > RCF, p<.05
// Nagano-Saito A, 2008: BAL: RNF < RCF, p<.05
// Nagano-Saito A, 2008: APTD: RNF < RCF, p<.05
// Nagano-Saito A, 2008: BAL: Matching after negative feedback (MNF) > 
// Matching after control feedback (MCF), p<.05
// Nagano-Saito A, 2008: APTD: MNF > MCF, p<.05
// Nagano-Saito A, 2008: BAL: MNF < MCF, p<.05
// Nagano-Saito A, 2008: APTD: MNF < MCF, p<.05
// Nagano-Saito A, 2008: BAL: Positive feedback (RPF) > RCF, p<.05
// Nagano-Saito A, 2008: APTD: RPF > RCF, p<.05
// Nagano-Saito A, 2008: BAL: Matching after positive feedback (MPF) > 
// Matching after control feedback (MCF), p<.05
// Nagano-Saito A, 2008: APTD: MPF > MCF, p<.05
// Nagano-Saito A, 2008: BAL: MPF < MCF, p<.05
// Nagano-Saito A, 2008: Balanced Drink (BAL): Receive negative feedback (RNF) 
// > Receive control feedback (RCF), p<.001
// Nagano-Saito A, 2008: Amino Acid deficient drink (APTD): RNF > RCF, p<.001
// Nagano-Saito A, 2008: BAL: RNF < RCF, p<.001
// Nagano-Saito A, 2008: APTD: RNF < RCF, p<.001
// Nagano-Saito A, 2008: BAL: Matching after negative feedback (MNF) > 
// Matching after control feeback (MCF), p<.001
// Nagano-Saito A, 2008: APTD: MNF > MCF, p<.001
// Nagano-Saito A, 2008: BAL: MNF < MCF, p<.001
// Nagano-Saito A, 2008: BAL: RPF > RCF, p<.001
// Subjects=19
3.52	28.56	47.03
-39.48	34.36	15.81
-47.93	26.54	25.48
37.82	7.78	50.61
-47.85	14.19	30.98
44.04	12.45	27.84
-31.07	28.64	-3.88
37.32	26.76	-6.74
-17.85	-68.22	8.55
14.24	-72.09	10.74
-28.64	-71.6	-6.66
22.68	-79.75	-6.56
-34.85	-89.3	12.74
37.83	-90.98	12.05
-24.01	-74.49	38.14
31.58	-71.7	41.73
-30.35	-56.24	54.53
31.66	-59.93	56.35
-13.91	7.42	-4.53
3.52	28.56	47.03
-41.63	36.46	15.66
-54.35	28.61	25.38
43.86	36.97	14.63
37.84	14.64	56.72
-45.72	14.2	30.95
46.16	12.29	25.6
-31.08	28.47	-6.1
37.32	26.76	-6.74
-11.39	-69.96	13.08
14.24	-69.97	10.56
-32.94	-69.68	-9
26.95	-82.01	-8.65
-32.67	-91.06	17.33
42.05	-87.07	7.21
-28.26	-72.06	42.45
-28.2	-64.86	52.99
46.51	-41.15	50.15
16.01	7.6	-4.89
-7.38	-8.94	3.46
11.84	-11.11	1.19
5.06	57.44	-20.09
-.61	-49.15	33.52
-58.71	-5.19	1.5
-48.4	4.13	-44.01
49.9	8.95	-45.54
-24.69	-15.67	-27
30.82	-4.94	-30.77
39.63	6.66	8.3
2.91	59.54	-20.25
24.47	-17.49	-27.42
3.52	30.67	46.85
-45.88	38.89	19.96
-43.67	37.48	28.98
-30.52	14.58	61.97
46.06	42.07	25.33
-31.1	28.3	-8.31
39.44	26.61	-8.98
-39.68	56.42	-1.65
35.15	61.62	3.74
39.27	57.81	-18.29
-28.26	-72.06	42.45
3.88	-66.61	55
-30.34	-64.87	53.02
3.88	-66.61	55
35.88	-60.42	49.66
-24.26	-100.12	-4.31
35.51	-88.48	-10.44
41.86	-82.44	-15.48
-9.59	-77.77	-33.12
-31.01	-69.61	-35.79
9.72	-83.49	-26.17
43.85	-75.16	-31.72
3.37	42.33	32.49
-48.01	38.88	19.99
-50.02	27.04	32.16
-30.51	16.86	64.01
48.15	41.57	18.66
37.84	14.64	56.72
-45.69	7.86	31.48
-31.09	26.18	-8.14
37.27	28.54	-11.35
-39.59	55.17	9.6
37.31	59.69	6.11
-7.11	-80.85	9.49
-4.64	-70.72	57.68
-30.32	-64.7	55.24
-4.64	-70.72	57.68
33.81	-64.15	56.68
43.98	-82.6	-17.72
-3.09	-83.39	-23.8
-52.23	-68.2	-15.59
9.72	-83.49	-26.17
43.99	-80.31	-15.68
0.77	59.53	-20.22
78.23	-22.55	12.54
-22.51	-15.15	-20.38
28.79	-16.95	-20.82
-5.58	53.49	-15.18
3.75	-21.86	55.71
9.98	-74.23	10.96
46.16	-84.35	-13.14
40.18	-57.93	53.86
16.43	-102.37	4.33
9.99	-74.06	13.18
-26.09	-67.3	48.71
-39.35	-78.52	-12.64
1.43	22.37	49.8
-41.59	36.81	20.09
-28.35	10.53	64.52
-31.03	24.58	-1.31
-9.25	-80.86	9.51
10.34	-70.46	59.71
-6.77	-70.73	57.7
-30.28	-66.47	59.85
-6.77	-70.73	57.7
35.96	-63.96	58.87
44	-78.02	-13.64
-71.38	-21.33	14.15
-26.27	16.54	59.53
50.32	37.53	21.2
16.02	9.89	-2.85
-7.37	-11.06	3.64
11.88	-10.77	5.62
-30.51	16.86	64.01
-13.9	16.22	-.81
-4.91	-3.22	49.79
14.4	-26.54	49.29
-6.99	-44.44	39.89
35.7	21.15	58.43
-45.7	9.97	31.31
-2.83	-78.53	11.47
-28.82	3.45	0.44
35.29	1.54	-2.37
-16	-3.16	-3.62
16.06	-.69	-1.96
50.44	10.21	25.72
-31.01	5.03	-6.36
-11.62	-8.63	7.94
16.1	-2.46	2.64
3.7	-13.57	52.79
-41.38	6.11	36.04
-26.14	-67.82	42.07

// Konishi S, 2008: 1st shift - 2nd shift during the WCST
// Subjects=176
42	-34	34
-48	-30	16
44	-66	36

// Specht K, 2008: Working memory-Rest
// Specht K, 2008: WCST-Rest
// Specht K, 2008: WCST-Working memory
// Subjects=14
33	24	6
-3	3	54
-48	-39	48
45	30	18
45	-45	51
-33	-9	63
-33	-63	-9
30	-3	63
-39	3	33
36	-69	-9
-30	24	3
-6	-75	-21
3	3	54
-48	-39	51
6	27	39
30	21	0
42	-57	45
51	9	33
36	-60	-27
-33	27	-3
-33	-57	-24
-30	-9	54
-36	48	12
9	-12	9
-9	3	9
-6	27	39
42	-60	45
-45	-57	48
30	12	57
-51	18	30
-30	54	-3
42	21	-9
-21	-75	-24
-33	24	-9
-60	-39	-3
9	-6	9
-36	-57	33

// Stice E, 2008: Food reward anticipation: Obese > Lean adolescents
// Stice E, 2008: Food reward consumption: Obese > Lean adolescents
// Stice E, 2008: Positive relationship between Food reward anticipation and 
// BMI: All Participants
// Stice E, 2008: Positive relationship between Food reward consumption and 
// BMI: All Participants
// Stice E, 2008: Negative relationship between Food consumption reward and 
// BMI: All Participants
// Subjects=7
54	-3	27
-54	-9	30
-29	-18	39
51	-12	33
-48	-6	3
51	3	18
-54	-3	18
-60	-42	30
60	-36	42
-36	6	6
-39	-15	18
-6	3	45
54	-6	27
54	-12	33
-48	-12	33
-48	-12	12
51	3	18
45	45	0
-39	30	36
-45	33	30
-54	-3	3
-57	-6	6
-54	-9	12
63	-12	12
-12	3	27

// Rilling J K, 2008: Experiment 1 Participants
// Subjects=30
38.45	13.2	-3.39
-33.22	15.25	-11.66
-15.79	-64.66	-.69
14.01	-10.84	4.49
-10.58	-12.13	3.76
55.73	27.24	25.35
40.53	24.67	-6.6
12.93	-12.08	2.37
-9.52	-12.21	2.64
-21.15	-63.81	-2.93
-33.22	18.6	-9.71

// Rilling J K, 2008: Experiment 2 Participants
// Subjects=20
54.42	13.75	-11.42
41.95	7.41	31.63
29.87	16.06	-6.87
19.71	-63.11	29.99
15.18	-71.25	-6.07
6.36	31.32	-0.08
-8.27	-72.99	1.03
-40.34	7.98	32.53
-30.92	-43.41	-13.45
36.61	-29.94	16.98
31.82	-11.08	-41.42
-8.44	47.21	27.76
-13.7	-31.1	6.5
-36.04	-32.32	20.25
-43.71	31.51	20.56

// Jensen J, 2008: Neutral comparators (CS-), Schizophrenia > Healthy controls
// Subjects=13
-6	-36	39
12	-30	3
36	45	-3
15	-21	-15

// Gu B M, 2008: OCD
// Subjects=21
39.97	57.71	9.19
-37.29	-7.6	38.26
27.54	18.99	43.49
-54.26	22.77	-14.88
21.35	-8.4	60.88
-4.87	-24.92	34.94
21.06	-32.48	33.01
24.49	2.45	-29.9
46.49	-25.18	-5.13
-21.84	-35.77	57.59
27.86	-33.36	57.63
42.64	-65.45	23.58
52.6	7.11	-27.48
1.86	-86.48	42.04
20.93	-81.56	13.21
-21.36	0.26	18.16
-31.08	-33.68	11.6

// Gu B M, 2008: Healthy Controls
// Subjects=21
42.17	59.09	12.38
-30.73	3.99	47.09
32.02	16.85	54.83
-58.46	19.23	-6.61
1.64	19.1	46.16
6.4	-12.63	73.87
20.75	17.74	19.08
-.56	-28.3	32.96
23.18	-39.37	28.05
-41.35	-45.07	51
47.08	-42.61	38.05
34.08	-53.91	32.66
-22.25	-94.58	14.12
16.66	-96.57	13.65
20.34	23.45	-11.73
-19.21	2.4	17.92
39.97	57.71	9.19
-37.29	-7.6	38.26
27.54	18.99	43.49
-54.26	22.77	-14.88
21.35	-8.4	60.88
-4.87	-24.92	34.94
21.06	-32.48	33.01
24.49	2.45	-29.9
46.49	-25.18	-5.13
-21.84	-35.77	57.59
27.86	-33.36	57.63
42.64	-65.45	23.58
52.6	7.11	-27.48
1.86	-86.48	42.04
20.93	-81.56	13.21
-21.36	0.26	18.16
-31.08	-33.68	11.6

// Pessoa L, 2008: Color-cue > Pop-out
// Pessoa L, 2008: Switch > Non-switch
// Pessoa L, 2008: Color-cue (Switch > Non-switch)
// Pessoa L, 2008: Pop-out (Switch > Non-switch)
// Pessoa L, 2008: Pop-out (Non-switch > Switch)
// Subjects=20
-21.01	-98.53	2.21
-42.47	-75.4	0.51
-48.83	-60.66	12.73
-53.15	-41.4	14.51
55.85	-36.34	15.07
-52.02	-33.05	26.07
-48.8	-30.74	28.07
47.43	-37.23	31.97
-38.09	1.44	44.2
38.76	6.51	33.97
-37.04	0.22	42.06
44.21	1.05	45.52
-52.23	10.93	16.8
50.22	30.96	5.03
-18.01	11.31	18.61
17.23	11.35	15.97
-16.86	-22.95	15.89
-37.16	-81.25	-6.86
35.56	-82.42	-.91
-29.77	-59.09	-9.92
-60.78	-46.33	-7.29
-26.17	-67.02	38.65
33.69	-57.69	43.88
-36.11	14.17	29.73
-20.89	5.92	59.24
-35.89	-73.65	22.59
36.63	-87.87	-2.7
-38.25	-83.72	-11.11
38.53	-57.42	-22
-25.08	-66.84	40.86
32.59	-66.84	35.73
-37.18	15.22	29.65
37.79	-4.53	42.72
-23.08	8.65	53.46
24.91	10.19	41.63
-28.31	-67.12	37.57
-43.51	3.9	35.14
-4.33	56.52	10.2
12.69	65.71	3.66
49.09	-2.57	-15.57

// Murray G K, 2008: Psychosis
// Subjects=13
-16	6	-12
12	10	-12
10	-8	-6
-4	-16	-6
8	-22	-8
-10	-22	2
-18	-2	6
-14	-24	4
52	-2	-8
-36	-12	2
2	22	32
-10	-34	42
36	-8	-18
-36	-10	-14
-48	-26	6
50	-16	0
-58	-6	-18
52	-58	4
26	14	-20
10	46	30
36	44	14
-26	40	28
64	-34	38
14	-84	48
6	-48	-20
-20	-64	10
30	-94	14
-44	-80	10

// Murray G K, 2008: Healthy controls
// Subjects=12
-16	6	-12
12	10	-12
10	-8	-6
-4	-16	-6
-8	-20	-8
14	-16	-6
16	18	-10
-20	10	-12
-16	6	-2
-36	10	-4
-10	-42	44
-12	-10	36
42	-76	24
24	-26	72
-20	-16	72
10	46	-8
-10	54	-4
28	38	28
-8	-54	-22
32	-98	-10
-28	-98	-12
8	-22	-8
-10	-22	2
-18	-2	6
-14	-24	4
52	-2	-8
-36	-12	2
2	22	32
-10	-34	42
36	-8	-18
-36	-10	-14
-48	-26	6
50	-16	0
-58	-6	-18
52	-58	4
26	14	-20
10	46	30
36	44	14
-26	40	28
64	-34	38
14	-84	48
6	-48	-20
-20	-64	10
30	-94	14
-44	-80	10

// Park I H, 2008: Schizophrenia patients
// Subjects=14
52	16	38
22	-6	-26
20	-36	6
-12	-34	4
-10	-54	18
36	8	-32
-10	-18	-8
-28	-34	-18
-24	-42	12
14	-46	-42

// Park I H, 2008: Healthy Controls
// Subjects=14
30	-74	32
2	-40	-2
-10	50	0
0	18	-4
-50	0	0
-34	-12	-18
32	-18	-18
10	-38	6
-10	-42	6
-18	14	-6
50	-4	6
-58	-10	36
46	-10	-6
-52	-12	50
20	-32	58
-62	-22	22
-44	-62	14

// Kdia G, 2008: Emotional > Neutral conditions, p<0.05
// Kdia G, 2008: Emotional > Neutral conditions, p<0.001
// Kdia G, 2008: Other agent > Self agent
// Kdia G, 2008: Interaction [(guilt + other-anger) - (self-anger + 
// compassion)]
// Kdia G, 2008: Guilt > Self-anger
// Kdia G, 2008: Other-anger > Self-anger
// Kdia G, 2008: Compassion > Self-anger, p<0.001
// Kdia G, 2008: Compassion > Self-anger, p<0.05
// Kdia G, 2008: Conjunction: (Guilt > Self-anger) + (Other-anger > 
// Self-anger) + (Compassion > Self-anger), p<0.001
// Kdia G, 2008: Conjunction: (Guilt > Self-anger) + (Other-anger > 
// Self-anger) + (Compassion > Self-anger), p<0.05
// Subjects=29
4	44	31
12	23	62
-59	-37	31
-48	4	0
-4	51	20
0	-56	36
-48	-61	29
10	43	13
6	1	7
-22	4	-11
-1	-62	32
-50	-69	10
52	-58	14
6	39	37
24	12	-21
20	1	-14
-15	-3	3
-8	1	7
-47	-69	21
12	23	62
0	-56	36
59	-53	21
-48	-57	21
-4	51	20
0	-56	36
51	-57	21
-48	-57	25
0	51	20
48	-57	21
0	-56	36
-48	-57	25
0	51	20
48	-57	21
0	-57	35
-48	-57	25

// Brunetti M, 2008: Erotic > Sport
// Subjects=18
31.58	-50.84	50.02
-24.06	-46.4	43.59
58.12	-25.02	37.51
-57.28	-27.82	39.07
51.5	8.98	23.58
-47.85	7.59	28.19
53.7	-18.92	20.32
-54.41	26.87	16.61
41.7	31.25	9.56
43.86	0.71	-.17
-42.69	1.33	1.89
1.22	-12.78	8.14
0.12	-10.84	5.76
27.08	-89.44	5.35
-27.41	-92.94	6.27
4.2	27.79	-4.22
-1.13	23.53	-3.8
-51	-59.96	8.24
11.71	-4.83	-13.83
-2.17	-4.82	-12.56
17.12	-20.57	-11.46
-17.09	-17.6	-11.32
48.16	-53.93	-19.06
-45.88	-49.04	-16.16
26.6	-1.11	-22.12
-22.56	-1.4	-21.53

// Buehler M, 2008: Erotic > Neutral, Blocked Design (Activations)
// Buehler M, 2008: Erotic > Neutral, Blocked Design (Deactivations)
// Buehler M, 2008: Erotic > Neutral, Event-Related Design (Activations)
// Buehler M, 2008: Blocked Design > Event-Related Design: Erotic >Neutral 
// (Activations)
// Buehler M, 2008: Blocked Design > Event-Related Design: Erotic > Neutral 
// (Deactivations)
// Subjects=10
33	-3	51
42	15	27
-24	-9	51
36	-48	54
-21	-54	54
54	-63	0
42	-75	-15
-51	-66	3
-3	-72	-27
63	0	6
48	15	33
-9	-15	57
36	18	-15
39	42	-3
-39	18	-12
-27	-18	42
-39	-18	-21
48	-57	-3
48	-72	-3
-54	-66	3
-39	-75	-9
-9	-24	6
6	12	42
-9	-24	6
36	3	51
27	-39	42
-21	-54	54
39	-63	9
-51	-66	3
6	-15	66
-3	-18	63
60	3	0
-42	-15	15

// Morita T, 2008: Self > Other
// Subjects=19
36	10	-4
48	36	4
-38	24	0
52	6	26
8	4	30
48	-70	-8
46	-52	-14
24	-72	42
-42	-74	-2

// Polk T A, 2008: Stroop > Neutral
// Subjects=14
-48.12	44.37	8.38
-52.09	14.51	35.46
-47.96	34.99	24.77
28.93	41.63	21.1
31.62	-58.16	51.75
-38.8	-64.07	64.2
-35.4	30.22	-10.66
41.55	28.56	-11.4
-30.42	-52.53	47.53
-9.12	12.76	64.11

// Berkowitz A L, 2008: Melodic Improvisation > Patterns, Activations
// Berkowitz A L, 2008: Melodic Improvisation > Patterns, Deactivations
// Berkowitz A L, 2008: Rhythmic Improvisation > Metronome
// Subjects=13
0.21	26.28	31.64
0.38	10.48	47.46
-48.98	10.24	21.29
-19.9	7.35	50.19
26.04	0.94	45.74
66.21	47.17	6.83
-19.07	-64.4	-10.72
39.44	49.67	0.24
16.96	68.91	3.34
-4.9	-36.14	36.94
13.3	-33.49	42.08
-60.49	-44.39	31.58
49.57	-44.87	29.24
-1.91	24.24	32.95
-8.22	3.31	38.13
-35.22	33.16	13.63
-16.74	6.86	43.5
-25.22	-10.03	46.13
-19.67	-58.38	53.47
-36.91	-38.02	43.04

// Limb C J, 2008: Improv > Ctrl, Activations
// Limb C J, 2008: Improv > Ctrl, Deactivations
// Subjects=6
-28.38	57.52	-12.03
-28.18	69.92	5.78
13.69	61.5	-17.63
8.39	66.67	-7.96
4.19	69.72	1.89
-54.15	36.67	-3.93
-54.94	11.53	14.26
-56.88	4.37	29.57
-30.42	-7.96	68.44
-1.33	7.99	65.24
-27.32	-8.99	57.28
-67.04	-28.43	-10.72
-54.33	-17.18	-28.85
-50.84	-71.1	-20.22
-55.48	-38.09	46.07
-43.53	-41.89	50.73
-17.39	-73.08	60.09
-37.55	-94.92	-.16
-27.55	-97.17	21.19
-20.86	-95.59	37.72
-3.72	15.04	48.9
56.49	10.84	23.63
34.35	1.73	65.25
5.24	4.28	71.1
30.95	-2.71	52.3
69.36	-32.47	7.53
62.58	-21.59	-13.6
49.47	-16.19	-24
53.63	-37.71	44.17
50.54	-37.74	55.44
24.81	-74.64	64.01
40.49	-76.3	22.44
39.54	-84.09	31.08
23.57	-68.58	-31.82
4.06	-85.54	-39.89
7.56	-71.54	-16.69
-11.62	56.2	30.39
-31.07	48.48	29.25
-43.88	27.68	37.12
-37.22	25.76	50.65
-47.96	44.4	-24.97
14.25	59.17	26.3
56.39	36.36	21.11
43.62	31.18	35.29
46	25.2	51.53
36.27	21.43	-34.22
36.32	41.5	-26.12
-10.95	-5.9	-13.9
-25.14	-.5	-24.28
-24.78	-37.23	-3.84
-38.04	-29.58	-24.54
-1.66	-50.3	27.31
-31.72	2.04	-31.14
-31.45	-12.35	-12.91
-11.83	18.51	6.11
-30.2	-1.22	2.77
-34.83	16.14	-17.92
-34.45	6.94	9.88
-34.39	-23.26	8.39
-53.58	-57.49	22.19
-46.88	-68.98	36.66
10.7	-5.51	-10.95
31.07	-1.16	-22.93
30.06	-25.83	-22.71
17.46	-42.84	2.72
26.74	-29.66	-29
4.93	-56.04	34.49
36.15	-2.47	-48.66
30.06	7.01	-15.88
10.74	17.76	-3.16
30.35	-13.77	2.98
36.8	18.78	6.38
36.86	2.83	7.95
46.56	-9.35	3.39
56.69	-53.29	26.61

// Ettlin D A, 2008: Pain > Baseline
// Ettlin D A, 2008: Pain > Baseline, Correlations with Intensity Rating
// Ettlin D A, 2008: Pain > Baseline, Correlations with Unpleasantness Rating
// Subjects=17
26	-74	-28
-16	-80	-36
-48	16	-6
0	-74	-2
42	38	28
0	24	26
2	-48	44
6	-86	-8
-44	8	26
-26	-68	52
-48	8	-10
62	-54	-8
26	-74	-28
-16	-80	-36
0	-74	-2
0	24	26
16	0	14
8	-84	-8
-26	-68	52
-48	8	-10
62	-54	-8
26	-74	-28
-16	-80	-36
0	-74	-2
0	24	26
16	0	14
8	-84	-8

// Green A C, 2008: Minor - Major
// Subjects=21
-18.12	-44.58	9.1
9.63	37.21	-1.71
-1.19	41.43	-1.94
-14.24	51.7	-6.1

// Iannilli E, 2008: Chemical Stimulation > Baseline
// Iannilli E, 2008: Electrical Stimulation > Baseline
// Iannilli E, 2008: Mechanical Stimulation > Baseline
// Iannilli E, 2008: Positive Effect of Chemical Stimulus on the Electrical
// Iannilli E, 2008: Positive Effect of Chemical Sitmulus on the Mechanical
// Iannilli E, 2008: Positive Effect of the Electrical Stimulus on the 
// Mechanical
// Iannilli E, 2008: Positive Effect of the Mechanical Stimulus on the 
// Electrical
// Iannilli E, 2008: Conjunction Analysis: Chemical and Electrical
// Iannilli E, 2008: Conjunction Analysis: Chemical and Mechanical
// Iannilli E, 2008: Conjunction Analysis: Electrical and Mechanical
// Subjects=18
-44.39	49.03	1.4
49.72	48.06	8.86
43.19	41.14	4.05
-31.62	31.25	-17.23
58.22	17.51	-8.43
-12.2	54.07	-15.33
-27.81	11.4	22.77
43.29	-6.28	2.02
43.2	5.11	-2.47
-41.08	-18.25	-6.56
44.33	17.54	4.13
36.96	-5.16	14.34
-44.26	-14.55	-1.27
-31.25	0.05	4.91
-27.92	-2.51	11.83
17.43	-12.44	6.43
42.95	11.96	-21.07
36.49	5.55	-20.32
-11.63	24.42	23.45
14.24	36.11	20.73
23.64	45.77	-2.79
49.43	51.41	-12.76
-44.59	56.29	-12.76
46.36	29.69	-3.83
49.31	46.12	-23.44
52.96	41.49	7.22
-1.77	38.57	36.45
-43.65	15.21	52.92
47.17	10.52	55.2
43.76	11.49	42.84
58.86	8.05	39.56
58.86	8.05	39.56
58.96	-39.38	37.53
-41.58	-26.01	36.8
-39.27	-20.5	49.66
25.83	-30.2	68.56
59.78	-25.94	20.49
-42.52	-42.4	45.16
55.91	-56.53	49.36
-33.9	-42.58	42.79
-14.63	-30.69	31.2
-11.85	11.82	3.41
10.94	7.2	10.2
51.67	16.97	-13.87
-41.29	11.87	-17.38
-11.65	-24.99	11.53
36.32	31.62	-28.5
-38.05	11.88	-17.44
-53.29	36.18	-20.71
36.79	58.11	13.69
-31.4	59.17	5.78
7.75	55.75	24.5
1.23	48.83	19.7
39.58	62.45	-20.4
46.36	55.94	1.42
55.04	49.69	3.01
-44.43	48.72	-1.93
-44.47	58.29	-2.87
7.78	-2.07	14.54
17.38	5.85	6.87
-11.62	0.4	19.1
-15.24	20.54	-6.36
-8.5	-5.94	8.47
-44.41	17.15	-6.65
46.27	15.88	-13.67
43.17	-11.57	-8.66
36.96	1.43	15.93
36.74	24.96	3.52
44.21	1.3	-8.83
46.36	-5.39	-11.57
-18.25	0.4	8.01
-11.56	17.29	27.52
18.68	20.59	26.68
-13.84	34.95	21.33
7.7	32.38	15.61
-48.05	1.05	-40.85
52.41	4.59	-42.91
-57.66	-4.74	-33.39
43.29	-7.34	2.13
46.2	8.78	-20.81
52.83	52.56	-.6
-44.29	50.92	10.18
-8.32	18.37	27.36
-34.48	-.92	6.18
43.33	38.89	14.36
49.82	32.42	13.77
23.68	51.5	1.12
2	61.85	-1.78
-27.97	55.11	19.57
11.51	58.1	-19.5
3.85	58.41	-27.24
-34.78	-9.8	-19.83
4.49	25.99	16.3
24.81	19.08	-1.29
48.33	9.64	-23.17
-37.95	23.55	-7.39
48.42	51.92	-7.19
-44.43	48.72	-1.93
42.97	5.57	-20.44
50.7	54.99	2.56
50.51	51.41	-12.77
-38.01	12.19	-14.11
46.27	15.88	-13.67

// Schiffer B, 2008: Heterosexual pedophile forensic patients
// Subjects=4
54	15	18
51	39	3
-48	15	45
-36	21	0
-21	9	3
48	-45	-18
39	-48	-18
-42	-54	-21
57	-63	-12
66	-18	24
-57	-27	42
-24	-78	33
-51	-33	60
-24	-3	6
-39	-90	3
-48	-60	-6
45	-81	-9
-36	-87	-15
48	21	27
9	57	12
-12	6	48
33	18	9
48	12	33
15	3	21
30	-3	-12
-3	-6	6
-9	-21	-9
-48	-57	-15
51	-51	-18
-57	-60	-15
-45	-72	9
-60	-60	0
42	-78	9
-21	-39	-12
30	-78	42
33	-57	60
24	-69	48
39	-84	3
45	-75	9
-33	-84	-12
57	21	24
-42	18	15
33	33	42
-3	-21	3
-27	-36	-6
-33	-36	-21
30	-48	-9
-36	-51	54
-45	-84	3
-48	-63	-6
-51	-69	-12
39	-78	-12
48	-45	-18
49	-50	-18
-33	-36	-23
8	55	10
-12	6	48
16	4	19
-48	-57	-19
-3	-21	3
-42	36	-15
-6	24	-15
-21	60	21
18	54	39
-21	60	30
33	18	9
-3	-6	6
39	-84	3
-33	-84	-12
33	33	42
-27	-36	-6
-45	-84	3
-9	12	33
3	36	9
3	15	27
6	21	21
-6	-54	3
-48	15	-9
54	-3	-12
21	-81	30
9	-75	30
-9	-66	30
-12	-57	30
-6	-63	0
24	-78	-18
-33	-27	-12
30	24	-9
-36	-39	-12
51	-60	-21
18	-24	15
-27	-36	-6
30	21	-24
45	33	-12
-30	15	-30
6	57	3
3	-15	39
6	3	42
-3	6	39
-3	38	0
3	42	3
42	-18	63
-30	-15	69
-3	-24	48
48	18	27

// Schiffer B, 2008: Healthy heterosexual volunteers
// Subjects=10
-30	21	-24
36	39	-12
51	39	3
-3	-9	72
-9	21	0
24	3	-18
-24	-3	-27
21	-27	-3
-30	-45	-18
30	-75	-21
-48	-66	0
27	-93	3
-36	-81	-9
45	-75	-12
-21	-99	6
36	-75	27
51	39	-9
-39	0	42
45	-18	63
-3	39	0
-6	6	51
3	39	6
-3	6	39
-3	6	42
6	9	-6
-3	-12	9
6	-15	9
15	-21	-6
32	-36	-10
48	-60	-6
-48	15	-9
51	21	-18
48	-33	39
-45	-30	42
18	-27	-12
-30	-45	-15
30	-78	33
-9	-66	63
-36	-48	54
24	-69	45
-27	-87	-3
42	15	39
24	-3	-3
-6	-15	-9
-24	-99	12
39	-78	-12
-9	-90	3
30	24	-18
51	30	18
48	18	45
12	21	39
-18	-3	0
30	-45	-18
33	-72	-12
-21	-84	-21
-24	-99	12
39	-78	-12
-36	-84	-18
-9	-90	3
35	-31	-11
-11	-62	61
-34	-45	52
32	36	-13
-32	20	-21
-11	23	2
-32	-44	-16
-3	38	0
-44	-30	42
-30	-44	-13
-9	-66	65
21	-2	-5
-9	12	33
3	36	9
3	15	27
6	21	21
-6	-54	3
-48	15	-9
54	-3	-12
21	-81	30
9	-75	30
-9	-66	30
-12	-57	30
-6	-63	0
24	-78	-18
-33	-27	-12
30	24	-9
-36	-39	-12
51	-60	-21
18	-24	15
-27	-36	-6
30	21	-24
45	33	-12
-30	15	-30
6	57	3
3	-15	39
6	3	42
-3	6	39
-3	38	0
3	42	3
42	-18	63
-30	-15	69
-3	-24	48
48	18	27

// Dechaumont-Palacin S, 2008: Subgroup of Ischemic Stroke Patients, Trained 
// group
// Subjects=7
-45.8	-13.18	47.92
-2.55	-21.54	48.01
49.12	-29.29	31.09
-43.84	-34.39	27.58
3.9	4.53	50.93
-20.32	49.17	24.51
57.56	4.25	22.03
62.05	-18.61	29.82
60.04	-41.5	37.72

// Dechaumont-Palacin S, 2008: Subgroup of Ischemic Stroke Patients, Control 
// group
// Subjects=6
-32.79	-25.9	48.96
3.93	-3.98	51.77
47.16	-5.95	51.23
62.07	-44.66	26.79
-48.21	-41.31	22.73
35.98	54.66	34.22

// Li C S, 2008: Stop Success > Stop Error, Long > Short SSRT
// Li C S, 2008: Stop Success > Stop Error, Short > Long SSRT
// Subjects=15
3	-66	-21
9	-48	-24
18	-24	12
-6	-21	-3
-18	-63	-45
12	-33	39
-27	27	27
12	0	48
3	-21	57
30	-69	39
60	6	18
12	-45	69
-9	-42	27
-3	36	51
-9	51	6

// Abler B, 2008: Healthy Controls > Bipolar Manic Disorder (Win > Omission of 
// reward)
// Subjects=12
-3	12	-9

// Tsukiura T, 2008: Face and Name (HSFN) > Face (HSF) and Non-retrieval of 
// Face or Name (HS)
// Tsukiura T, 2008: HSFN and HSF > HS
// Subjects=10
-60.7	-6.49	-17.48
-7.06	-43.73	29
-13.77	-61.89	7.38
-22.94	3.11	-20.19
-3.16	-66.6	-9.15
22.35	9.13	-27.16
2.96	67.51	-10.2
8	31.99	-45.99
44.89	-62.59	31.1
61.03	-34.57	31.41
12.39	-43.66	28.66
10.37	-31.69	42.07
12.17	-74.87	4.86
9.97	-55.43	6.33
1	56.95	3.21
-9.39	-48.28	14.92
-9.73	10.45	0.15
-5.52	-60.41	-23.17
44.6	31.52	27.39
48.84	13.48	17.9
37.36	11.65	-35.51
34.22	-64.88	41.59
49.25	-42.6	38.01
8.25	-76.23	36.43
12.21	-90.93	5.32
37.71	20.84	-6.17
20.29	-7.58	-22.11
26.94	-29.27	-13.35
5.52	-9.4	5.21
7.53	-33.49	-11.49
3.66	-19.13	27.5

// Browndyke J N, 2008: Normal Hits (NH) > Malingered Target Miss (MM)
// Browndyke J N, 2008: MM > NH
// Browndyke J N, 2008: Normal Correct Rejection (NCR) > Malingered False 
// Alarm (MFA)
// Browndyke J N, 2008: MFA > NCR
// Subjects=7
2	-72	-6
26	-48	6
-2	-74	46
-16	-84	34
50	-50	30
46	-44	0
10	-28	34
-4	14	38
-32	-2	-22
-34	-40	32
-34	30	36
28	-78	-4
-26	-76	-10
-16	-84	34
-34	-58	18
-12	-62	14
58	-58	8
46	14	-4
48	-68	28
40	-76	-16
-42	18	-6

// Muller J L, 2008: Controls
// Subjects=12
12.81	58.11	15.45
-58.63	14.33	19.94
-45.98	39.98	6.49
37.17	13.16	-31.25
12.81	58.11	15.45
-58.63	14.33	19.94
-24.67	43.91	0.34
37.17	13.16	-31.25
-45.48	-47.04	37.2
-16.46	-61.62	52.59

// Muller J L, 2008: Criminal Psychopaths
// Subjects=10
12.81	58.11	15.45
-58.63	14.33	19.94
-45.98	39.98	6.49
37.17	13.16	-31.25
33.04	27.8	-6.78
30.94	24.95	-2.05

// Schiffer B, 2008: Pedophiles
// Subjects=11
51	39	15
57	33	12
36	27	-18
-51	15	33
48	-45	-15
-54	-72	9
30	-51	51
33	-54	60
54	-24	54
-42	-87	9
-36	-87	18
48	-72	6
36	-90	0
51	39	6
24	33	-6
51	15	27
24	42	-15
-42	33	18
57	9	42
51	12	36
3	15	-6
-3	12	-6
3	30	-9
6	18	0
18	-6	-9
27	-18	-3
27	3	-6
-9	-21	-12
12	-21	12
30	15	-33
-39	18	-36
51	6	-21
-48	42	12
48	18	27
3	12	-6
-3	12	-6
48	-42	-15
-36	-57	-18
-36	-84	15
39	-60	57
-30	-66	57
-36	-36	-18
-39	-78	6
-36	-87	9
-36	-81	-9
-42	-87	-6

// Schiffer B, 2008: Healthy Controls
// Subjects=12
48	-48	-15
-45	-60	-21
-45	-72	-3
27	-51	48
-21	-60	57
33	-51	54
51	-75	-3
45	-81	3
-39	-90	0
-45	-84	3
42	-75	-9
-36	-87	-9
-45	-84	-6
48	51	12
54	42	12
45	-67	-18
48	-48	-15
-45	-78	-12
-48	-48	-21
36	-81	33
27	-57	54
15	-66	63
21	-69	57
33	-84	15
42	-84	3
-45	-78	-12
-33	-90	3
42	-75	-12
36	-75	27

// Shimada T, 2008: Pre-improvement: Motor task > Rest
// Shimada T, 2008: Post-improvement: Motor task > Rest
// Subjects=1
8	-14	76
-14	-72	-16
16	-70	-16
-2	-12	66

// Lloyd D, 2008: Subgroup of cLBP, High Pain Levels (WS-H)
// Subjects=15
4	-54	18
22	-66	10
14	-76	24
-46	-50	42
-38	-66	38
50	10	6
46	12	2
58	4	4
15	46	65

// Lloyd D, 2008: Subgroup of cLBP, Low Pain Levels (WS-L)
// Subjects=13
-30	-72	42
-40	-80	-16
-40	-60	-10
4	-54	18
22	-66	10
14	-76	24
-46	-50	42
-38	-66	38
52	8	10
60	-30	36
-42	-48	40
48	30	26
46	-34	16
-40	-42	38
-50	-58	42
34	6	-2
-24	-2	4
-6	38	42
4	28	50
-62	-20	18
62	-20	18
40	-2	-2
-12	24	34
30	22	-2
62	-18	24
-62	-18	24

// Lloyd D, 2008: Healthy Controls
// Subjects=17
-30	-72	42
-40	-80	-16
-40	-60	-10
62	-32	38
34	6	4
44	10	-6
54	2	2
62	-20	18
40	-16	-10
62	-18	24
12	-20	-24
4	-34	-30
-20	43	64
18	44	64

// MacSweeney M, 2008: Deaf group: Location task > Baseline
// MacSweeney M, 2008: Deaf group: Rhyme task > Baseline
// MacSweeney M, 2008: Hearing group: Rhyme task > Baseline
// MacSweeney M, 2008: Deaf group: Conjunction of rhyme and location tasks
// MacSweeney M, 2008: Deaf group: Rhyme > Location
// MacSweeney M, 2008: Deaf group: Location > Rhyme
// MacSweeney M, 2008: Native signers > Non-native signers: Rhyme > Location
// MacSweeney M, 2008: Non-native signers > Native signers: Location & Rhyme > 
// Baseline
// MacSweeney M, 2008: Deaf group x Task Interaction
// MacSweeney M, 2008: Native signers > Non-native signers: Rhyme > Baseline
// MacSweeney M, 2008: All groups: Location & Rhyme > Baseline
// MacSweeney M, 2008: Deaf group > Hearing: Location & Rhyme > Baseline
// Subjects=11
-44.68	19.32	28.28
-29.36	-62.55	41.66
5.69	16.77	45.76
-41.41	7.97	32.54
-25.04	-66.41	46.4
1.46	12.85	50.6
-41.48	10.54	24.52
-25.07	-57.95	45.69
1.38	25.2	45.1
44.06	-77.42	-5.89
-41.64	34.09	12.51
-29.32	-66.44	46.45
1.49	6.51	51.13
-53.07	0.04	41.15
1.56	-5.92	55.52
-2.56	-69.19	49.72
-41.49	23.57	27.89
-41.48	19.34	28.24
-41.5	10.28	21.2
-44.7	23.55	27.93
-48.85	3.95	36.31
1.47	17.34	53.57
-41.42	11.14	32.28
-29.28	-61.69	52.74
1.45	17.08	50.24
-41.39	3.74	32.9
-2.8	9.66	50.91

// Redgrave G W, 2008: Patient - Control, Thin - XXXX
// Redgrave G W, 2008: Control - Patient, Fat - XXXX
// Subjects=6
-52	-12	12
-46	-16	16
-18	10	56
-24	14	52
-12	12	52
-50	26	6
-52	26	14
-48	20	34
30	-58	46
20	-58	42

// DeLuca J, 2008: Group x Within-run fatigue
// DeLuca J, 2008: Group x Across-run fatigue
// DeLuca J, 2008: Group x Across x Within-run fatigue
// Subjects=15
-4	31	-19
0	1	65
-36	17	47
-32	53	19
-50	29	17
-40	25	-25
-24	-81	25
0	11	-9
40	31	35
2	-55	59
4	-85	-21
-18	53	27
-58	19	9

// Rubia K, 2008: Healthy Controls (HC) & Conduct Disorder (CD) > ADHD, 
// Successful stop > Failed stop
// Rubia K, 2008: HC > CD & ADHD, Failed stop > Go
// Rubia K, 2008: HC & ADHD > CD, Failed stop > Go
// Subjects=13
-26	65.67	6.17
13.48	-46.85	28.96
-41.53	-29.95	40.55
64.06	-16.45	18.36

// Vasic N, 2008: Developmental Dyslexia
// Subjects=12
-48	3	39
-6	-93	0
-42	-69	48
21	-78	-3
-45	3	39
-33	-60	60
-27	27	51
-42	12	15
57	18	12
-45	33	27
39	21	24
9	30	54

// Vasic N, 2008: Healthy Controls
// Subjects=13
-48	3	39
-6	-93	0
-42	-69	48
21	-78	-3
-45	3	39
-33	-60	60
-27	27	51
-42	12	15
57	18	12

// Conway T, 2008: Healthy controls
// Subjects=11
-44.75	-17.63	4.62
56.76	-19.3	1.36
61.12	-20.54	12.57
4.73	13.47	58.31
-45.67	-33.61	18.23
53.38	5.28	-10.7
53.42	-3.09	-8.88
-65.05	-17.75	4.86
4.55	26.99	40.45
45.12	19.23	32.83
-3.74	-43.91	46.5
-51.2	-7.09	3.81
11.61	42.47	-7.76
-59.51	-38.72	22.17
-59.65	-25.83	9.94
-60.59	-37.67	22.09
-53.22	-28.97	10.12

// Conway T, 2008: Developmental dyslexia
// Subjects=11
-59.51	-38.72	22.17
-59.65	-25.83	9.94
-60.59	-37.67	22.09
-53.22	-28.97	10.12

// Fehr T, 2008: addition (complex > simple)
// Fehr T, 2008: subtraction (complex > simple)
// Fehr T, 2008: division (complex > simple)
// Fehr T, 2008: multiplication (complex > simple)
// Fehr T, 2008: complex > simple
// Subjects=11
8.21	19.75	52.71
23.39	19.15	56.99
-28.43	10.46	58.74
-32.85	3.13	49.45
-33.03	29.2	41.27
44.65	14.4	27.97
51.07	33.67	27.07
32.02	16.85	54.83
29.86	8.12	53.49
-39.25	-44.42	46.42
-34.88	-51.64	49.3
-32.68	-71.09	47.83
34.26	-60.21	45.61
34.25	-69.03	43.12
44.94	-38.15	39.88
17.42	-2.66	7.71
12	16.88	10.35
10.01	-17.91	17.19
-11.85	-2.43	0.34
-1.29	-9.68	-20.41
9.69	-15.94	-7.66
8.2	21.88	52.5
-37.55	51.75	30.15
51.02	37.72	24.43
53.39	31.63	39.56
40.58	4.25	45.85
53.24	11.89	23.59
-37.03	-53.77	49.55
-39.25	-44.42	46.42
42.86	-45.19	45.1
-30.53	-68.95	47.58
34.26	-60.21	45.61
19.27	-65.82	55.39
-9.77	21.08	-.9
14.22	-.13	11.99
-7.65	3.24	-8.14
6.02	19.53	50.53
55.3	35.19	20.12
60.88	14.67	29.9
35.45	25.52	-13.32
-35.79	21.43	-7.22
30.62	-77.82	-73.61
-9.6	-93.63	-10.85
-7.36	-6.59	13
12.02	-4.81	8.01
6.01	21.66	50.32
49.39	0.1	58.44
64.67	19.45	-10.97
-30.36	-57.82	63.28
-13.06	-68.6	61.81
-21.74	-68.95	58.64
32.16	-68.52	48.71
53.04	-61.84	-7.21
-7.28	-63.99	7.47
29.33	-80.11	-6.12
-50.75	-60.59	-11.17
69.1	12.65	-3.65
5.6	-4.41	12.56
-5.3	4.7	7.37
8.21	19.75	52.71
34.3	-62.13	48.04
12.02	-2.68	7.8

// Ragland J D, 2008: Schizophrenia
// Subjects=13
48	4	20
-50	24	23
39	31	36
36	6	55
0	3	59
3	17	44
-53	-11	21
-59	-37	9
-56	3	4
-50	-33	47
53	-35	49
-9	12	62
3	14	44
-12	-14	14
15	-6	0
-50	-52	10
48	-35	5
56	-41	-5
-53	-41	47
-50	-56	-7
-12	-90	-2
15	-84	4
-33	-65	-22
3	-74	-22
45	-60	-26
9	9	13
-42	30	26
-24	0	51
-53	-4	31
-42	-3	52
-42	15	7
3	16	34
-36	-39	26
39	12	7
24	6	0
-45	-50	-7
50	-44	-7
50	-40	12
-45	-21	-6
-53	-52	10
48	-35	5
-53	-41	47
-12	-64	58
-15	-58	-4
-9	-73	4
-15	-90	4
-6	-59	48
0	-74	-22
-45	24	19
0	11	44
-24	2	45
30	-13	38
53	10	34
-48	8	-10
-6	32	-5
18	7	17
-45	-21	-6
50	-40	12
24	-30	-14
-18	-90	4
24	-20	1
15	-76	-15
-24	-59	34
24	-6	52
-15	-28	29
-30	-32	2
18	-23	5
-30	-52	16
50	-41	-5
-42	-40	9
30	-56	40
27	-53	44
24	-67	51
-15	-12	59
12	27	19
9	-90	4
3	32	54
-15	-87	1
21	-79	-15
-30	-55	58

// Ragland J D, 2008: Normals
// Subjects=14
-27	35	2
50	22	34
33	17	41
-53	-42	37
53	-35	49
33	-62	51
-15	-71	-25
-27	47	15
42	34	30
-3	6	59
36	5	35
-33	18	3
33	14	-4
36	-48	-30
9	9	13
-42	30	26
-24	0	51
-53	-4	31
-42	-3	52
-42	15	7
3	16	34
-36	-39	26
39	12	7
24	6	0
-45	-50	-7
50	-44	-7
50	-40	12
-45	-21	-6
-53	-52	10
48	-35	5
-53	-41	47
-12	-64	58
-15	-58	-4
-9	-73	4
-15	-90	4
-6	-59	48
0	-74	-22
-36	17	-8
-39	21	16
-6	22	37
-12	-11	21
21	-2	20
-45	-21	-6
50	-40	12
24	-30	-14
-18	-90	4
24	-6	52
-15	-28	29
-30	-32	2
18	-23	5
-30	-52	16
50	-41	-5
-42	-40	9
30	-56	40
3	-64	55
-15	-12	59

// Wood G, 2008: large range > small range
// Wood G, 2008: small range > large range
// Wood G, 2008: decade crossing > no decade crossing
// Wood G, 2008: no decade crossing > decade crossing
// Wood G, 2008: large sum > small sum
// Wood G, 2008: small sum > large sum
// Wood G, 2008: small distance to the mean > large distance to the mean
// Wood G, 2008: large distance to the mean > small distance to the mean
// Wood G, 2008: multiplicative >non-multiplicative
// Wood G, 2008: non-multiplicative > multiplicative
// Wood G, 2008: impossible > possible
// Subjects=17
55.87	-28.36	52.18
39.8	-51.5	58.1
-7.72	-71.23	56.38
-52.19	-32.24	51.04
34.28	-69.89	45.45
43.57	-93.91	6.2
-27.3	-70.11	46.52
-40.89	-95.66	-7.87
-37.72	-75.34	-8.82
8.4	-66.38	50.02
-1.19	-80.68	58.32
33.98	27.41	41.43
-24.27	24.64	49.42
55.47	20.07	30.58
-47.25	16.85	24.81
46.31	34.8	-6.58
43.07	5.24	-12.56
-31.51	22.2	-10.73
-2.53	49.33	-20.63
21.06	40.86	48.16
-1.56	-42.99	36.67
37.6	-49.59	55.71
37.54	-56.6	49.68
-40.4	-29.63	43.86
-30.41	-62.6	58.15
37.55	-72.97	46.82
-27.31	-73.51	44.61
46.53	-71.95	-11.71
-47.49	-65.9	-10.7
65.06	27.89	21.8
-47.18	8.66	28.98
-47.41	35.37	16.25
7.94	51.68	38.35
-1.59	24.62	47.91
34.02	17.84	42.37
-36.08	-3.37	49.03
43.02	19.06	-13.93
-31.58	21.68	-16.28
62.23	-62.11	35.24
-55.59	-59.65	33.64
65.24	-22.21	25.63
-65.59	-23.5	19.03
24	56.12	27.55
-11.7	58.87	24.53
11.33	-46.76	30.1
0.7	45.95	-22.59
37.02	-94.45	0.77
-8.27	-84.1	10.6
-19.11	-97.53	5.39
4.14	92.37	3.01
-44.4	-57.15	-20.59
-5.4	-79.24	-17.94
-50.42	72.1	41.81
58.9	-69.34	27.04
-40.31	-38.79	49.24
-20.73	-52.99	57.04
18.27	-50.96	65.14
-52.65	14.71	25.11
1.67	18.25	48.49
34.31	8.01	63.51
-40.44	5.13	48.26
-31.52	29.75	-10.35
36.62	26.25	-5.57
-40.8	-78.56	2.76
-46.9	-52.72	38.41
50.4	-57.38	40.57
-14.95	58.86	24.58
21.05	44.05	47.85
71.43	-41.9	-1.66
-52.39	-59.95	30.25
-14.86	56.19	30.45
-50.07	-32.55	47.67
47.32	-39.78	56.81
-33.99	-76.05	29.29
21.54	-63.92	64.12
-47.28	17.71	22.48
61.82	17.99	19.47
-1.69	27.18	40.94
-28.16	24.11	-2.01
42.93	24.93	-20.11
-47.41	-67.51	-4.94
44.12	22.47	-12.04

// Moores K A, 2008: PTSD patients
// Subjects=13
-25	45	15
30	40	25
35	35	20
-40	20	30
45	25	35
0	30	20
-10	25	30
-35	20	15
35	20	15
-45	15	10
35	30	5
-40	-5	40
50	0	30
-60	-25	25
-40	-30	50
50	-25	45
-30	-55	35
30	-50	40
-10	-30	35
5	-35	30
-15	-75	35
15	-70	35
-55	-25	0
40	-30	0
-50	-50	20
45	-40	15
50	-65	10
-40	-65	-5
-35	-80	0
35	-75	10
-30	-15	-10
-30	-25	15
-35	-15	0
-15	-70	0
20	-85	0
-25	-55	-10
40	-55	-10
-30	-40	-25
40	-40	-30
-25	-5	15
25	5	10
-20	5	20
20	0	20
-25	-15	25
25	-10	20
-10	-90	30
15	-80	20
-20	-70	10
0	-20	-30
-40	45	5
35	45	5
-45	30	30
-40	25	25
35	25	30
-35	15	10
35	20	5
-50	10	5
40	20	15
-55	10	30
45	0	40
-5	10	50
5	10	55
-40	-60	45
35	-55	45
-50	-50	50
50	-50	50
-45	-50	35
-55	-25	0
45	-30	0
-55	-50	10
45	-50	10
-55	-45	20
-50	-50	-5
-15	-85	5
-35	-55	-25
30	-45	-25
15	0	20

// Moores K A, 2008: Healthy Controls
// Subjects=12
-25	30	30
35	5	60
-30	45	25
35	40	25
-40	20	30
40	30	35
-45	15	5
-30	20	15
10	25	40
-10	20	40
10	25	40
-5	10	50
-45	0	40
50	0	35
-45	-50	30
55	-35	50
-30	-55	35
35	-50	45
5	-35	25
-10	-65	45
15	-70	35
40	-75	30
-40	-65	-5
50	-50	-5
-15	-70	0
25	-55	-5
40	-55	-10
-10	-60	-10
15	-50	-20
-25	-5	20
20	0	20
0	-20	-30
-25	45	15
30	40	25
35	35	20
-40	20	30
45	25	35
0	30	20
-10	25	30
-35	20	15
35	20	15
-45	15	10
35	30	5
-40	-5	40
50	0	30
-60	-25	25
-40	-30	50
50	-25	45
-30	-55	35
30	-50	40
-10	-30	35
5	-35	30
-15	-75	35
15	-70	35
-55	-25	0
40	-30	0
-50	-50	20
45	-40	15
50	-65	10
-40	-65	-5
-35	-80	0
35	-75	10
-30	-15	-10
-30	-25	15
-35	-15	0
-15	-70	0
20	-85	0
-25	-55	-10
40	-55	-10
-30	-40	-25
40	-40	-30
-25	-5	15
25	5	10
-20	5	20
20	0	20
-25	-15	25
25	-10	20
-10	-90	30
15	-80	20
-20	-70	10
0	-20	-30
40	25	0
-45	0	35
40	0	55
5	10	55
-5	-5	60
35	-55	45

// Spalek K, 2008: Object and Color tasks > Baseline
// Subjects=17
17.21	-86.27	-25.48
39.96	-75.89	-19.05
-34.64	-47.02	-16.15
-59.69	34.55	-14.83
-50.84	40.5	2.36
-27.3	-51.51	50.28
-1.54	22.8	51.45

// Schon K, 2008: Object delay match to sample (ODMS) > Location delay match 
// to sample (LDMS)
// Schon K, 2008: ODMS > OCON, familiar objects
// Schon K, 2008: Saccadic eye movements > Fixation
// Subjects=17
24	34	-16
-2	50	-6
18	16	-12
-34	42	-14
-26	36	-14
-18	20	-6
34	-48	-32
-14	58	4
-34	-36	-32
-2	-54	-12
24	-28	70
-26	58	-4
-38	-88	10
-10	-6	-18
-30	-10	-26
-40	-12	-32
-10	-2	16
-22	50	20
-40	32	2
34	10	-24
12	-34	10
40	-56	-32
-38	-88	10
24	34	-16
-34	42	-14
-2	50	-6
34	-48	-32
48	-62	-30
-34	-36	-32
-32	-48	-28
-40	-52	-28
-2	-54	-12
24	-28	70
-10	-6	-18
-30	-10	-26
-40	-12	-32
-10	-2	16
-40	32	2
34	10	-24
12	-34	10
24	-24	74
26	-32	70
42	-26	64
-32	-48	-26
-40	-60	-16
-46	-66	-20
10	16	42
-4	14	42
4	12	52
24	14	-26
32	26	-26
20	30	-2
-12	28	62
-16	-70	42
-18	-76	52
-28	-74	46
-32	-4	52
50	0	-12
-16	-60	26
-10	0	16
-44	0	30
-40	-4	-24
48	-24	34
42	34	8
-52	36	2
-6	34	58
60	-46	-6
48	-10	12
30	-76	50
34	-2	-18
38	-62	-28
10	-42	54
-6	-74	-40
12	-80	-14
10	-74	-6
-12	-80	-16
22	-2	54
28	-6	50
36	-2	38
-36	-4	42
-56	0	38
-26	-8	54
-24	-30	-4
-4	-28	-18
6	-28	-16
-22	-6	6
-18	-10	-4
-26	-56	46
24	-30	-4
26	18	4
22	4	6
-38	26	-10

// Holsen L M, 2008: Fragile X Syndrome
// Subjects=11
27.72	-20.3	-22.76
-36.33	-33.21	-18.71
-42.74	30.48	7.25
-27.94	13.54	-20.5
-18.21	-9.41	-15.34
41.79	-49.14	-11.58
-38.46	-44.14	-22.23
-46.79	-19.95	15.99
-3.9	-64.28	16.98
15.17	-83.48	-12.85
-38.46	-44.14	-22.23
-4.08	-81.48	-12.8
-20.36	53.08	8.44
-10.54	51.94	34.08
-52.87	-64.81	42.12
-29.84	22.62	14.45
-14.7	-52.34	7.18
-40.34	4.72	31.69
12.58	50.25	-17.35
27.64	55.77	-2.37
-27.64	-40.41	-2.59

// Holsen L M, 2008: Healthy Controls
// Subjects=11
23.61	-36.22	-7.99
-53.5	36.25	0.2
17.28	48.04	36.31
-20.36	53.08	8.44
-10.54	51.94	34.08
-23.39	-11.07	4.94
41.23	-65.84	47.82
30.37	-89.63	16.48
25.87	-54.73	0.22
-16.74	-86.53	5.61
-20.36	53.08	8.44
-10.54	51.94	34.08
-52.87	-64.81	42.12
-29.84	22.62	14.45
-14.7	-52.34	7.18
-40.34	4.72	31.69
12.58	50.25	-17.35
27.64	55.77	-2.37
-27.64	-40.41	-2.59

// Watson C, 2008: Typically Developing (TD)
// Subjects=13
16.41	-39.34	5.75
-3.01	64.74	29.4
42.73	10.74	46.29
18.14	-48.7	54.83
-2.42	-38.03	55.25
18.41	6.5	2.3

// Watson C, 2008: Developmental Delay (DD)
// Subjects=10
44.51	28.67	19.83
37.98	35.99	18.1
28.9	-16.58	-26.97
-2.39	-42.18	56.78
-9.28	26.95	38.85

// Watson C, 2008: Fragile X Syndrome (FraX)
// Subjects=13
-35.68	10.15	-1.62
18.41	6.5	2.3
-9.52	-17.54	10.76

// Cardoso E F, 2008: Subgroup of Parkinson's disease, Active rTMS (+placebo)
// Subjects=9
39.58	-58.73	-25.25
50.43	18.92	28.34
-44.8	13.72	10.91
1.48	2.02	48.16
-2.38	5.17	47.94

// Cardoso E F, 2008: Subgroup of Parkinson's disease, Sham rTMS (+fluoxetine)
// Subjects=9
20.79	-5.81	55.29
47.28	4.1	29.62
-2.38	5.17	47.94

// Andersson F, 2008: 22q11.2 Deletion Syndrome
// Subjects=15
6	39	-3
-33	-45	-27
-57	-21	36
-45	21	-9
-36	-87	9
-36	-33	42
-36	-27	57
-30	-45	-27
-24	-42	51
-24	-39	63
-24	-15	57
-21	-96	3
0	-9	51
6	-30	30
27	-39	-21
30	-9	63
33	-39	57
36	-84	6
36	-84	21
36	-42	42
36	-30	66
39	-60	24
48	-30	42
57	-18	27
63	-36	21
0	-9	51
27	-60	-6
-27	18	57
51	24	0
15	30	0
27	6	60
-6	-6	33
18	-18	36
24	21	24
24	42	27
-36	33	42
-33	0	-45
33	3	-33

// Andersson F, 2008: Healthy Controls
// Subjects=16
-39	-36	-27
-33	-75	6
3	-81	3
48	-75	3
48	-39	-24
-33	-45	-27
-33	-93	9
-24	-45	-12
15	-51	12
24	-51	-12
33	-90	24
33	-78	9
36	-78	18
27	-60	-6
-51	-12	-6
15	30	0
-54	18	0
-39	-66	-21
36	-48	-30
-51	12	-12
-48	-66	24
33	3	-30
-36	33	42
-33	0	-45
33	3	-33

// Chiao J Y, 2008: Own-culture Fear > Other-culture Fear
// Subjects=10
-24	-12	-16
50	18	-18
24	6	22
-4	10	64
12	-36	-8
18	-6	-12
38	36	-16
-30	-8	-20

// Lee K, 2008: Happy > Neutral (Own-race faces), p=0
// Lee K, 2008: Happy > Neutral (Own-race faces), p=0.001
// Lee K, 2008: Neutral > Happy (Own-race faces)
// Lee K, 2008: Sad > Neutral (Own-race faces), p=0
// Lee K, 2008: Sad > Neutral (Own-race faces), p=0.001
// Lee K, 2008: Neutral > Sad (Own-race faces)
// Lee K, 2008: Happy > Neutral (Other-race faces), p=0
// Lee K, 2008: Happy > Neutral (Other-race faces), p=0.001
// Lee K, 2008: Neutral > Happy (Other-race faces), p=0
// Lee K, 2008: Neutral > Happy (Other-race faces), p=0.001
// Lee K, 2008: Sad > Neutral (Other-race faces), p=0
// Lee K, 2008: Sad > Neutral (Other-race faces), p=0.001
// Lee K, 2008: Neutral > Sad (Other-race faces), p=0
// Lee K, 2008: Neutral > Sad (Other-race faces), p=0.001
// Lee K, 2008: Own-race > Other-race neutral face, p=0
// Lee K, 2008: Own-race > Other-race neutral face, p=0.001
// Lee K, 2008: Other-race > Own-race neutral face, p=0
// Lee K, 2008: Other-race > Own-race neutral face, p=0.001
// Lee K, 2008: Own-race > Other-race emotional face (happy and sad), p=0
// Lee K, 2008: Own-race > Other-race emotional face (happy and sad), p=0.001
// Lee K, 2008: Other-race > Own-race emotional face (happy and sad), p=0
// Lee K, 2008: Other-race > Own-race emotional face (happy and sad), p=0.001
// Subjects=13
14	16	-2
42	44	14
6	22	44
-34	-56	48
-12	16	-10
-4	10	52
36	16	-42
6	54	-12
22	34	46
48	-8	32
-44	-8	6
44	-12	2
-24	-56	56
50	-56	32
-58	-56	-8
-22	-10	-16
-6	-76	22
-20	-32	70
10	20	0
-48	-28	58
-42	-14	56
42	-12	50
-8	-38	52
-10	-90	18
46	8	-26
52	-32	-16
-44	-12	-2
0	-72	-32
20	-8	-6
-44	-60	20
6	-42	-26
56	-36	50
52	10	20
6	24	44
36	58	-8
48	36	14
-64	-24	28
12	-44	72
56	-48	-8
8	34	40
54	32	24
0	2	26
-34	24	-4
44	24	0
36	58	-2
-46	28	22
-62	-6	30
6	-70	22
-10	-66	8
38	58	-4
52	2	46
6	26	42
-34	-52	40
34	28	-4
38	-10	66
-26	-86	-14
-30	22	6
-22	-10	-16
-40	32	-14
38	4	-20
-66	-44	2
-42	-28	8
10	-48	56
-28	-80	-16
40	30	30
-52	-32	52
-28	-56	-18
40	-48	52

// Van Bavel J J, 2008: In-group > Out-group
// Van Bavel J J, 2008: Black > White
// Subjects=17
-24	3	-15
-30	39	-6
39	-48	-15
-36	-42	-24
27	-6	15
-54	-57	-6
-36	-54	30
-48	-78	-6
42	-75	-6
33	-93	-9
-30	-96	-9

// Guillot A, 2009: Physical Execution vs. Passive Listening
// Guillot A, 2009: Visual Imagery vs. Passive Listening
// Guillot A, 2009: Kinesthetic Imagery vs. Passive Listening
// Guillot A, 2009: Visual Imagery vs. Kinesthetic Imagery
// Guillot A, 2009: Kinesthetic Imagery vs. Visual Imagery
// Subjects=50
-36	-40	47
62	-22	20
-50	-30	51
46	-29	46
-45	-27	39
39	-21	51
47	-24	43
38	-44	63
41	-17	56
-39	-9	57
27	-12	59
-27	-8	50
-8	-6	61
8	-6	61
-3	-3	53
5	1	55
-5	1	55
-46	-1	8
57	4	19
-2	0	37
18	-24	18
-24	-10	-2
24	-15	4
-25	5	10
23	6	13
-26	-2	-5
30	-14	8
-12	-47	-15
-21	-44	-21
8	-57	-2
-5	-55	-2
-12	-49	-8
-35	-52	-18
35	-51	-20
-5	-59	-15
-20	-67	-14
24	-61	-15
-14	-67	-12
44	-55	-2
-11	-24	2
16	-65	42
-14	-68	-4
20	-72	-9
-12	-62	-6
36	-69	-14
8	-72	23
-51	-30	32
34	-36	49
21	-59	58
36	-15	52
-36	-11	43
24	-11	54
-9	-9	61
9	-6	59
-3	-3	66
5	-3	66
-40	33	12
39	44	26
22	-13	3
-20	-11	3
-20	3	5
20	5	9
-27	-9	12
27	-9	12
-26	-30	-24
-4	-48	0
-28	-36	-26
-34	-46	-25
40	-51	-20
-4	-62	-25
-24	-57	-17
7	-70	-17
-36	-59	-17
-39	-41	41
46	-29	46
-60	-22	26
40	-40	57
-61	0	6
60	-27	40
39	-40	60
-30	-48	49
18	-44	52
36	-15	52
-28	-7	56
27	-8	61
42	-6	57
-9	-9	61
9	-2	63
-4	-5	64
-45	2	8
46	2	9
-61	11	19
-57	4	22
60	7	25
-42	46	23
-40	9	11
-39	12	8
-13	11	-1
20	-26	18
-21	-2	0
24	-9	1
-27	9	12
20	5	9
-28	-5	11
22	-3	0
-11	-49	-18
-4	-49	-5
-10	-55	-2
-15	-51	-20
-15	-66	-8
38	-50	-23
-3	-68	-9
-32	-55	-17
6	-69	-17
-18	-67	-14
-42	-55	-20
38	-63	-36
15	-77	12
8	-72	21
-38	-77	9
27	-80	40
3	-40	57
-18	-54	55
27	-76	45
-32	-7	50
26	-9	53
-63	-30	29
59	-41	32
-53	-5	9
56	1	17
4	9	58
11	-6	67
-58	6	19
56	6	17
-47	21	36
10	5	36
20	-24	21
-29	-12	1
29	-8	11
-32	-51	-20
-23	-65	-17
22	-61	-20
-42	-55	-20
38	-63	-36

// Wilson S M, 2009: Semantic Dementia Patients
// Subjects=5
-52	-6	28
62	2	16
42	-32	6
-38	-90	-6
38	-86	2
-36	-14	38
46	-10	42
-38	-90	-2
38	-84	-4
-50	-6	28
62	-6	18
-40	-84	0
46	-82	0
-38	-14	38
-38	-36	32
-38	-84	-8
18	-100	-2
-36	-14	36
62	0	18
-40	-84	-10
20	-98	-6
-26	-58	44

// Wilson S M, 2009: Normals
// Subjects=9
-54	-8	30
-60	-26	14
60	-2	44
68	-26	18
-32	-94	-6
-28	-62	-18
26	-92	-4
36	-60	-16
-56	-8	28
-50	-28	10
-46	-40	28
56	-8	44
66	-24	18
-30	-94	-8
-36	-50	-16
22	-94	-2
34	-60	-18
-4	-2	38
-62	-4	24
-50	-24	8
58	-10	20
60	-28	12
-28	-96	-8
-36	-46	-18
28	-92	-4
32	-58	-18
-52	-10	28
-40	-36	10
60	-2	44
64	-24	14
-28	-96	-8
-34	-48	-18
28	-94	-4
44	-70	-12
-48	4	20
-68	-30	8
56	-10	20
60	-30	12
-32	-94	-6
-34	-48	-16
22	-94	-4
40	-56	-16
-36	-50	34
-26	-60	48
-48	30	-8
-46	36	12
-32	34	6
-18	8	6

// Ewbank M P, 2009: Attended Anger > Attended Neutral, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Neutral, (State Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Fear, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Attended Fear, (State Anxiety)
// Ewbank M P, 2009: Attended Anger > Unattended Anger, (Trait Anxiety)
// Ewbank M P, 2009: Attended Anger > Unattended Anger, (State Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Neutral, (Trait Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Anger, (Trait Anxiety)
// Ewbank M P, 2009: Unattended Fear > Unattended Anger, (State Anxiety)
// Subjects=24
14	-38	76
-48	-12	-18
-2	20	-8
52	-42	-12
26	-4	-20
26	-2	-20
-50	-44	-8
-46	-28	-10
16	-4	-26
60	-38	8
18	-80	-34
44	36	2
-28	-28	72
-18	30	-6
28	-8	-22
50	6	-2
16	-2	-24
44	-42	38
-28	0	-24
38	-44	30
38	2	-16
-28	-2	-20
52	-44	6
-12	-82	-44
30	28	-12
-24	-2	-22
42	-86	-6
40	4	-16
-40	0	-14

// Ballard K, 2009: Magnitude
// Ballard K, 2009: Delay
// Ballard K, 2009: Magnitude x Delay Interaction
// Subjects=16
10.64	6.17	-9.17
-10.9	43.77	-16.53
0.33	-51.57	15.87
-19.38	59.89	0.05
-48.71	-57.18	30.28
34.74	-73.25	35.13
60.02	2.18	17.36

// Bickel W K, 2009: Hypothetical Money Gains + Hypothetical Money Losses > 
// Real Money Gains
// Bickel W K, 2009: Real Money Gains - Random Effects
// Bickel W K, 2009: Hypothetical Money Gains - Random Effects
// Bickel W K, 2009: Hypothetical Money Losses - Random Effects
// Bickel W K, 2009: Real Money Gains > Hypothetical Money Gains
// Bickel W K, 2009: Real Money Gains > Hypothetical Money Losses
// Bickel W K, 2009: Hypothetical Money Gains > Real Money Gains
// Bickel W K, 2009: Hypothetical Money Losses > Hypothetical Money Gains
// Bickel W K, 2009: Hypothetical Money Losses > Real Money Gains
// Subjects=30
1.22	-70.53	-5.47
36.95	49.47	24.63
1.68	-79.11	28.99
-15.19	59.22	5.5
-5.47	-73.17	-21.91
-15.03	-87.27	-11.38
-11.52	-97.29	7.48
53.63	-48.65	41.9
46.59	42.3	16.21
30.77	27.61	43.7
-11.74	3.93	10.91
-15.1	14.99	3.15
1.6	-25	33.72
17.39	3.72	7.08
14.02	-1.69	-4.66
23.73	1.54	-5.14
36.75	-29.68	-6.76
30.29	-23.01	-3.95
20.12	-44.96	-43.06
1.33	-36.86	10.24
-21.49	64.91	20.73
-56.1	-32.88	-1.5
-62.72	-35.01	-12.38
-21.28	51.16	34.42
-28.04	-26.4	-2.62
71.1	-19.2	-22.95
-43.85	16.94	37.07
49.83	42.31	16.15
-38	61.5	-3.3
-41.26	-75.4	-32.28
10.83	-85.57	-17.59
14.09	15.3	4.87
17.45	7.43	12.31
4.89	-26.8	37.2
1.4	-42.93	14.2
26.98	-24.6	-9.34
-15.01	10.2	9.23
-18.13	-8.54	15.62
0.9	-61.97	-28.73
7.28	-65.97	-37.4
-24.8	-26.39	-2.67
20.76	-24.88	10.97
30.6	-65.57	11.47
-11.65	-24.99	11.53
7.92	2.26	26.43
23.38	-41.55	-41.21
53.71	-53.56	46.86
39.77	-75.11	-33.69
46.79	35.03	30.37
-37.16	13.1	53.02
-59.7	-18.06	-26.44
-65.78	-42.38	0.73
-52.74	-41.82	6.05
64.6	-22.63	-24.74
-14.98	3.92	10.97
-11.69	-15.42	10.59
1.61	-27.13	33.93
0.83	-55.9	-32.69
-2.55	-41.64	-40.76
17.2	1.2	-8.36
14.27	-11.83	13.15
4.09	-26.24	-25.59
-12.12	-19.71	-23.72
17.43	-55.06	-1.68
-2.22	-41.38	-15.02
-24.77	-26.18	-.45
-27.86	-50.24	6.46
64.89	-45.63	-6.78
-52.93	-56.35	-11.56
-5.64	-36.16	-27.81
-25.15	-69.48	-38.74
40.11	32.49	15.05
-41.44	45.8	-21.86
44.1	-46.17	57.5
-1.39	23.94	63.66
-51.11	11.1	-24.98
17.82	-72.98	24.74
-17.69	-97.16	32.22
-51.08	43.09	-15.82
-27.81	-53.12	10.11
24.13	-70.91	12.1
43.58	32.04	32.96
-8.31	48.02	34.51

// Broome M R, 2009: 1-Back, Healthy Controls > At-risk > Psychosis
// Broome M R, 2009: 2-Back, Healthy Controls > At-risk > Psychosis
// Broome M R, 2009: 'Easy' Verbal Fluency, Psychosis > At-risk > Healthy 
// Controls
// Broome M R, 2009: 'Hard' Verbal Fluency, Healthy Controls > At-risk > 
// Psychosis
// Broome M R, 2009: 'Hard' Verbal Fluency,  Psychosis > At-risk > Healthy 
// Controls
// Subjects=10
35.65	-59.56	19.48
-41.17	-46.67	41.58
32.57	-62.61	35.38
44.36	-45.73	46.1
-21.98	-59.13	30.14
44.34	-41.5	45.74
-21.81	-69.39	48.84
-41.2	-39.27	40.96
32.56	-58.38	35.03
-17.72	-75.74	21.45
35.17	24.46	-8.75
-41.49	14.77	24.17
5.71	16.94	47.98
40.17	-53.7	53.5
1.37	20.63	41.03
-22.02	0.91	49.64
-37.39	33.94	10.24
-41.53	10.03	17.87
-49.12	13.27	5.42
-44.79	13.81	12.02
-33.19	16.65	-7.31

// Camara E, 2009: Gain, Boost Unexpected Trial vs. Fixation
// Camara E, 2009: Loss, Boost Unexpected Trial vs. Fixation
// Camara E, 2009: Gain, Standard Trial vs. Fixation
// Camara E, 2009: Loss, Standard Trial vs. Fixation
// Camara E, 2009: Gain, Standard Trial vs. Loss, Standard Trial
// Camara E, 2009: Gain, Boost Unexpected Trial vs. Loss, Boost Unexpected 
// Trial
// Subjects=17
8	8	4
-4	16	8
20	-72	-28
-24	-72	-24
-4	-50	-4
44	36	28
-36	-56	-12
4	24	52
36	20	-8
36	-56	48
-36	-52	52
-4	-28	-4
4	-16	8
-4	-12	8
8	4	-8
-16	12	-12
8	8	4
-4	16	8
20	-72	-28
-24	-72	-24
-4	-50	-4
44	36	28
4	24	52
-36	-56	-12
36	-56	48
-36	-52	52
36	20	-8
0	-28	-8
4	-16	8
-4	-12	8
8	4	-8
-16	12	-12
8	36	24
8	16	8
-8	8	8
32	-72	-32
-32	-68	-36
12	-88	4
44	36	28
-24	-40	12
-8	-80	-4
32	-56	48
-32	-56	52
36	24	-8
-28	20	4
8	40	40
8	-24	12
-12	-28	12
-16	12	-12
16	12	-8
4	20	52
4	4	12
-4	4	12
12	-68	-28
-28	-64	-36
12	-88	8
-12	-84	12
28	-56	52
-44	-44	52
4	-20	4
36	24	-8
16	12	-12
-16	12	-12
-16	4	-12
16	8	-12
-16	4	-4
16	8	-16

// Clark L, 2009: Winning Outcomes minus Non-Win Outcomes
// Clark L, 2009: Near-Miss Outcome minus Full-Miss Outcome
// Clark L, 2009: Selection Phase Contrast (Participant-Chosen Trials minus 
// Computer-Chosen Trials)
// Subjects=15
28	16	-10
-36	18	-4
16	4	-12
16	6	-4
-14	10	-2
-10	-2	-6
-4	32	6
6	28	20
10	40	2
-6	-20	-14
8	-20	-12
-8	-12	-8
-2	-34	28
2	-14	32
4	-4	34
4	-20	32
30	-66	-26
2	-16	2
-8	4	-2
12	2	-2
32	18	0
18	-44	-24
8	-60	-40
4	-62	-14
-26	-50	-26
-34	-32	52
-30	-46	60
-48	-32	40
48	-30	54
-22	-4	58
-4	-4	54
38	-10	52
-12	-18	4
10	-12	-2
6	22	30
32	14	2
-32	16	4
-38	0	6
44	10	-4
-18	2	12
18	12	0
-56	6	30
24	-10	2

// Engelmann J B, 2009: Expert Message > No Message
// Engelmann J B, 2009: No Message > Expert Message
// Engelmann J B, 2009: Followed Advice > Ignored Advice
// Engelmann J B, 2009: Ignored Advice > Followed Advice
// Engelmann J B, 2009: Correlations with Weighted Value of Lotteries, No 
// Message
// Engelmann J B, 2009: Correlations with Magnitude of Sure Win During No 
// Message
// Engelmann J B, 2009: Correlations with Magnitude of Sure Win During Message
// Subjects=24
3.5	38.4	51.2
-51.7	-57	31.2
50.9	-50.2	31.6
-29.4	18.2	-11.9
35.7	25	-11.3
55.5	25.5	7.5
7.9	9.5	11.4
9	8.4	1.2
-51.6	25.8	9
1.2	-81.6	-3.2
-9	-66	4
10.6	6.7	36.3
-19.7	-69.9	-9.4
12.4	-50.9	10.3
58.5	-35.5	-3.5
-41.4	-13.8	-1.8
49.8	-31.5	28.4
49.2	-7.4	48.7
17.6	-35.1	50.3
8.4	-7.8	60
14.5	-2	69.5
-30.3	20.5	-9
15.5	2	-5.1
-31.4	20.8	-2.1
-6.2	27.7	42.9
-.7	-13	0.6
-37.7	23.6	41.2
28.1	-89.5	-3.5
31.3	-48.5	44.2
-23.9	-95.4	-8.3
32	-92	-1.1
29.7	-64.8	40.5
-11.3	-73	6.4
19.6	-68.8	4.4
59.5	-49.3	-12
-27	-60.6	1.1
28.8	-65.4	7.2
40.8	7.2	30
-9	7.5	-6
-27	-20.1	52.7
-58.4	-35.1	-5.5

// Flaisch T, 2009: Insult > Neutral
// Flaisch T, 2009: OK > Neutral
// Subjects=30
27	-53	55
62	-22	26
62	-10	34
39	-44	57
30	-65	31
-9	-95	24
21	-95	24
30	-71	28
-45	-76	-4
48	-67	-7
-45	-79	-6
45	-76	-6
-48	-78	12
53	-59	-7
-48	-76	-1
48	-73	-1
-48	-68	-12
48	-65	-12
-9	-95	25
6	-89	21
-9	-101	16
9	-95	13

// Goldstein R Z, 2009: Cocaine Use Disorders (CUDs)
// Subjects=15
6	-12	-9
-6	-15	-12
3	-15	-12
-6	-15	-18
3	-18	-21
3	-15	-12
-21	-24	-12
-15	42	-9
0	36	12
3	15	-3

// Goldstein R Z, 2009: Normals
// Subjects=15
3	-15	-12
-6	-15	-18
3	-18	-21
3	-15	-12
-21	-24	-12
-15	42	-9
0	36	12
3	15	-3

// Hauk O, 2009: All Words > Hash Marks
// Hauk O, 2009: Positive Correlation with Imageability
// Hauk O, 2009: Positive Correlation with Action Relatedness
// Hauk O, 2009: Frequency - Action Related Words Only
// Hauk O, 2009: Frequency - Visually Related Words Only
// Hauk O, 2009: Frequency - All Words
// Subjects=21
-42	-46	-22
-56	-50	-4
-54	12	32
-44	24	16
-54	24	0
-36	-24	50
-32	30	-14
-2	18	48
-42	-42	56
-34	-44	-22
28	-44	-22
0	-22	6
2	-12	2
4	58	-4
-62	-52	4
-62	-48	16
-26	-14	64
40	-38	10
4	-14	6
16	-28	12
-12	14	48
-60	-60	10
-46	-56	40
-28	28	-14
8	24	48
-38	-38	-24
18	30	40
-36	-32	-18
-28	-36	-22
-18	-36	-26
-30	28	-12
-20	26	4
-32	24	8
-38	14	30
32	28	-6
30	26	10

// Husain F T, 2009: Identity Discrimination > Category Discrimination
// Husain F T, 2009: Category Discrimination > Identity Discrimination
// Husain F T, 2009: Meaningful (ASL, EMB) > Non-meaningful (pASL, NLNM)
// Husain F T, 2009: Linguistic + Meaningful (ASL) > Nonlinguistic + 
// Non-meaningful (NLNM)
// Subjects=12
-36	-58	56
-34	-52	42
-36	-22	62
24	-74	58
24	-60	44
40	-52	54
-44	-56	-18
-48	-72	-18
-48	-80	-4
-22	-78	2
12	-80	0
-14	-62	-8
10	-46	58
-4	-20	40
0	-34	62
34	18	-26
48	30	-16
46	-20	-6
48	6	48
42	4	58
-56	-66	18
-44	-56	22
48	-66	22
40	-66	16
54	-56	18
-34	56	2
-14	62	18
40	-82	26
56	-56	46
52	-68	24
-58	-64	16
-46	-56	20
-2	-70	-28
16	-66	-36
6	-62	-16
38	-28	66
44	-28	52
40	-26	40
48	-32	-18
42	-38	-20
40	-14	-32

// Janata P, 2009: Summary of Significant Activations Associated with the 
// MusPlay Regressor
// Janata P, 2009: Summary of Loci at which BOLD Signal Correlated Positively 
// with Familiarity
// Janata P, 2009: Loci in which Activity was Positively Correlated with the 
// Degree of Autobiographical Salience
// Janata P, 2009: Loci at which Changes in BOLD Signal were Pos. Correlated 
// w/ the Degree of Postive Affect
// Janata P, 2009: Summary of Tonality Tracking Activation Clusters
// Subjects=13
-40	22	2
-60	-28	16
-46	-2	-10
-66	-34	4
-18	-14	-10
-6	-36	-4
-20	-56	-36
62	-22	6
58	0	-2
28	-56	-22
-44	14	12
-50	12	32
-32	10	58
-48	42	12
-2	34	48
-6	44	36
-4	56	2
0	28	32
-30	18	8
-50	-44	18
-54	-44	26
-52	-24	-12
-4	-50	10
-12	-12	10
-42	-52	-26
2	12	54
50	12	32
56	26	32
56	26	32
10	54	28
58	-62	24
16	-10	22
8	-28	2
20	-76	-28
40	-52	-26
32	-60	-20
34	-72	-36
4	-56	-34
-16	48	40
-4	48	40
-10	32	44
-12	44	30
-32	18	42
-50	20	6
8	52	30
8	50	-16
62	-18	-22
-22	40	22
-2	26	10
-6	34	-6
-2	-20	-6
-14	-12	12
56	-32	22
-10	52	32
-4	28	34
-8	32	48
-8	42	8
-16	62	22
-4	42	50
2	40	32
-46	42	-2
-42	38	6
-40	32	14
-42	42	18
16	48	34
-18	-86	-4
-10	-82	10
42	-62	22
18	32	52
8	-2	50
26	-68	-48

// Keedy S K, 2009: Schizophrenia Patients
// Subjects=9
-44.41	-8.57	52.92
2.61	7.03	57.76
0.43	9.93	54.2
8.47	-50.25	-36.75
-9.71	-53.79	-39.59
2.04	-73.53	-48.11
11.66	21.07	-9.31
-9.65	11.68	-4.94
25.16	-43.31	51.69
-18.61	-43.05	58.86
11.98	-96.53	-16.18
-9.3	-56.11	13.01
60.14	-16.34	25.61
-54.04	-31.86	41.6
21.29	17.95	-9.16
-12.85	5.06	-7.69
47.02	22.22	2.45
-63.93	-14.94	13.53
21.21	40.16	-11.02
-16.16	17.21	-15.36
11.57	46.44	-11.44
-0.09	21	-9.17
40.7	-15.34	-1.02
2.6	1.49	54.88
63.52	-40.93	37.67
-54.04	-45.06	36.02
12.05	18.49	39.97
-6.15	8.09	31.01
15	12.51	3.63
-3.14	12.66	7.17
27.9	-21.76	-.33
-22.46	1.83	-7.31
-2.8	9.66	50.91
50.2	21.98	-.91
-25.71	24.44	-3.59
8.87	25.33	46.12
-2.81	12.83	50.65
24.56	54.84	13.36
-25.51	39.7	28.58
11.99	21.15	33.05
-9.49	23.17	19.75
8.61	-12.53	-3.12
8.57	-3.02	-3.91
34.31	-41.44	-7.68
-18.87	-82.06	8.61
53.48	0.85	0.82
-28.35	-1.62	58.84
-25.8	-64.43	-51.9
24.51	-40.13	-31.09
2.09	-59.81	-35.88
-6.05	22.33	49.89
14.94	48.18	10.68
37.29	-.96	-21.14
-48.22	17.02	-14.98
24.34	52.61	-15.45
-22.62	56.18	-6.29
43.78	31.72	1.69
-44.78	0.78	8.65
44.41	-39.76	54.52
-28.3	-43.88	49.01
60.18	-62.04	12.71
-18.77	-87.63	19.11
60.18	-25.86	26.4
-54.21	-27.06	21.13
-15.72	8.55	37.77
-9.51	6.53	11.11
27.86	-12.25	-1.13
-31.92	39.66	28.66
11.81	35.73	15.1

// Keedy S K, 2009: Normals
// Subjects=9
-44.41	-8.57	52.92
2.61	7.03	57.76
0.43	9.93	54.2
8.47	-50.25	-36.75
-9.71	-53.79	-39.59
2.04	-73.53	-48.11
11.66	21.07	-9.31
-9.65	11.68	-4.94
25.16	-43.31	51.69
-18.61	-43.05	58.86
11.98	-96.53	-16.18
-9.3	-56.11	13.01
60.14	-16.34	25.61
-54.04	-31.86	41.6
21.29	17.95	-9.16
-12.85	5.06	-7.69
47.02	22.22	2.45
-63.93	-14.94	13.53
21.21	40.16	-11.02
-16.16	17.21	-15.36
11.57	46.44	-11.44
-0.09	21	-9.17
40.7	-15.34	-1.02
2.6	1.49	54.88
63.52	-40.93	37.67
-54.04	-45.06	36.02
12.05	18.49	39.97
-6.15	8.09	31.01
15	12.51	3.63
-3.14	12.66	7.17
27.9	-21.76	-.33
-22.46	1.83	-7.31
-2.8	9.66	50.91
50.2	21.98	-.91
-25.71	24.44	-3.59
8.87	25.33	46.12
-2.81	12.83	50.65
24.56	54.84	13.36
-25.51	39.7	28.58
11.99	21.15	33.05
-9.49	23.17	19.75
8.61	-12.53	-3.12
8.57	-3.02	-3.91
34.31	-41.44	-7.68
-18.87	-82.06	8.61
53.48	0.85	0.82

// Nakao T, 2009: Patients with Obsessive-Compulsive Disorder
// Subjects=40
42	18	14
-42	-50	20
-32	-14	18
14	-86	18
40	28	-18
14	-18	10
-24	-34	68

// Nakao T, 2009: Normals
// Subjects=25
42	18	14
-42	-50	20
-32	-14	18
14	-86	18

// Nelles G, 2009: Young Healthy Adults
// Subjects=11
48	2	50
-42	-3	53
3	3	58
0	-52	58
-27	-50	55
15	-88	-6
-12	-90	-1
15	-61	-4
-9	-73	-11
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4

// Nelles G, 2009: Older Healthy Adults
// Subjects=11
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4
39	2	47
-33	5	47
0	3	61
24	-56	55
-30	-50	52
9	-87	4
-6	-93	2
39	-81	7
-30	-87	4

// Salo R, 2009: Group Differences Associated w/ Trial to Trial Adjustments in 
// MA Dependent and Normals
// Subjects=12
8	14	44
18	0	72
44	0	46
-14	-6	72
14	44	42
62	12	10
-52	-2	40

// Seifert F, 2009: Normal Pin-prick Pain, Placebo Administration
// Seifert F, 2009: Pin-prick Hyperalgesia, Placebo Administration
// Seifert F, 2009: Normal Pin-prick Pain, Lidocaine Administration
// Seifert F, 2009: Pin-prick Hyperalgesia, Lidocaine Administration
// Seifert F, 2009: Main Effect of Sensitization Across Both Pharmacological 
// Treatments (Hyperalgesia > Normal Pain)
// Seifert F, 2009: Placebo > Lidocaine Administration, Averaged Across Both 
// Sensitization States
// Seifert F, 2009: Interaction of Sensitization and Pharmacological Treatment
// Subjects=12
-56.37	-20.73	20.62
54.77	-25.43	18.62
-42.47	-24.96	19.7
35.26	11.15	-2.06
-53.23	-.45	21.12
56.84	5.67	21.57
-53.18	-18.68	19.3
52.62	-16.82	20.16
-41.57	4.05	9.45
41.76	7.64	7.08
-7.32	26.86	26.1
5.54	22.88	28.52
-10.48	39.42	37.35
7.7	37.41	37.31
-23.32	34.77	33.43
43.95	29.12	23.1
-19.81	-10.45	53.91
36.66	0.32	36.75
-26.14	-56.82	46.72
37.94	-42.6	45.91
-8.44	-12.12	3.74
11.86	-9.89	3.32
-8.49	-18.18	-5.79
-5.03	-41.82	18.46
8.89	-43.69	20.68
-51.01	-25.98	21
16.67	-28.41	66.15
-48.86	-28	22.26
50.54	-26.09	24.3
-41.53	-4.32	11.27
-48.81	-25.28	29.84
51.66	-21.17	32.8
-42.67	-1.75	3.26
44.98	-5.29	4.78
-29.92	27.3	6.25
34.2	21.09	2.69
-4.17	39.49	23.89
7.57	38.33	21.63
-5.23	42.82	25.86
9.87	38.91	42.74
-4.02	43.23	44.77
-34	21.59	29.08
37.64	16.9	30.88
-16.61	-6.12	54.63
17.6	-20	50.94
-26.12	-58.84	48.01
32.66	-55.15	49.25
-10.58	-12.22	2.65
9.71	-9.98	2.23
-10.63	-15.99	-4.83
2.52	-39.95	28.25
-54.2	-17.03	26.98
54.73	-13.8	17.65
-43.82	12.79	-1.29
40.64	6.06	0.53
44.02	-20.64	12.77
-3.03	22.66	26.41
6.63	22	30.81
-12.7	51.67	30.78
12.04	31.52	43.33
-22.29	44.21	31.51
-43.52	2.75	34.12
50.56	-6.11	34.9
-25.03	-56.38	52.25
25.26	-55.39	60.51
15.02	-11.44	-3.28
-9.59	-18.53	-10.21
18.2	-14.93	-7.49
-4.42	50.03	-4.87
18.12	53.4	9.09
3.25	64.11	25.09
-2.86	-49.21	19.05
3.56	-49.09	20.08
-2.94	-48.93	8.99
17.07	22.84	-.6

// Spreckelmeyer K N, 2009: MID, Normal Males and Females, Triangle < One Bar 
// < Two Bars < Three Bars
// Spreckelmeyer K N, 2009: SID, Normal Males and Females, Triangle < One Bar 
// < Two Bars < Three Bars
// Spreckelmeyer K N, 2009: MID, Normal Males > Normal Females
// Spreckelmeyer K N, 2009: SID, Normal Males > Normal Females
// Spreckelmeyer K N, 2009: MID, Normal Females > Normal Males
// Spreckelmeyer K N, 2009: SID, Normal Females > Normal Males
// Subjects=16
9	15	-1
3	-17	12
-9	9	0
24	-89	18
-21	-90	10
33	26	-9
-12	-65	34
27	-90	13
-18	12	-1
-9	6	5
21	9	8
-24	-90	10
30	32	-2
24	-90	16
9	15	-1
15	32	-4
15	-2	17
-9	12	-1
12	-69	15
39	-77	26
-21	2	-10
24	-90	10
-18	12	-1
21	9	8
-3	32	2
3	-17	12
-21	11	-6
-21	-90	10
-6	28	26
0	19	32
15	9	5
18	-2	11
21	-90	10
12	-72	15
3	49	-13
21	-52	5
-18	5	-8
-9	6	5
0	-17	9
27	-87	13
15	-92	16
-24	-90	10
42	-57	25
24	18	2
0	24	18
-6	25	26
6	0	3

// Xu G, 2009: Previously Viewed > Novel Faces, Family History, APOE4
// Xu G, 2009: -APOE4 > APOE4, Previously Viewed vs. Fixation
// Xu G, 2009: -APOE4 > APOE4, Novel Faces vs. Fixation
// Xu G, 2009: No Family History > Family History, Previously Viewed vs. 
// Fixation
// Xu G, 2009: No Family History > Family History, Novel Faces vs. Fixation
// Xu G, 2009: Family History and APOE4 Interaction, Previously Viewed > 
// Fixation
// Xu G, 2009: Family History and APOE4 Interaction, Novel Faces > Fixation
// Xu G, 2009: d' and Previously Viewed > Novel Faces Interaction
// Subjects=15
-16	-46	50
-14	-76	50
-12	42	16
-14	40	16
-8	24	50
44	-60	18
-10	26	46
-10	-82	22
42	-60	-18
30	-8	-42
28	-12	40
-18	-46	2
28	-12	40
-18	-46	2
-24	-38	-2
-24	20	62

// Yoon H W, 2009: Word Encoding > Fixation, Alcoholic Patients > Normals
// Yoon H W, 2009: Word Encoding > Fixation, Normals > Alcoholic Patients
// Yoon H W, 2009: Face Encoding > Fixation, Alcoholic Patients > Normals
// Yoon H W, 2009: Face Encoding > Fixation, Normals > Alcoholic Patients
// Subjects=12
-50	-4	-20
-28	-50	50
-2	46	-8
-30	-52	-8
44	-58	-14
16	-74	2
-12	-76	3
-28	-46	62
28	-35	64
-44	-32	18
-8	36	-8
10	-78	2
-8	-78	2

// Beck A, 2009: Healthy Controls
// Subjects=19
-15	6	-3
15	12	-6
24	-39	12
-6	-24	6
6	-24	6
33	24	3
-18	9	-3
18	12	-6
0	-18	9
21	0	9
-24	0	0
-24	3	-12
15	-12	-15
36	-90	12
27	-27	15
-6	-69	9
60	12	-3
3	-87	15
21	12	-6
-15	-66	21
-12	-78	24
24	-60	24
15	-78	21
36	-45	6
42	-54	9
-51	-30	15
69	-27	9
57	-27	9
66	-27	0
-15	15	-3
-15	-63	21
39	-39	3
36	-24	0
-48	-75	18
69	-27	9
66	-24	0
-30	54	-6
-48	-42	15
-24	3	6
54	-18	12
15	9	3
0	33	-3
12	9	3
0	33	-3
15	9	3
36	-84	27
45	-78	27
-24	-78	24
-3	33	0

// Beck A, 2009: Alcoholics
// Subjects=19
-15	6	-3
18	6	-5
18	3	-6
-33	54	-3
36	51	12
9	-24	3
-51	6	-12
-15	6	-3
18	6	-6
33	45	3
36	33	9
-15	15	-3
-15	-63	21
39	-39	3
36	-24	0
-48	-75	18
69	-27	9
66	-24	0
-30	54	-6
-48	-42	15
-24	3	6
54	-18	12
15	9	3
0	33	-3
12	9	3
0	33	-3
15	9	3
36	-84	27
45	-78	27
-24	-78	24
12	9	3
0	33	-3
12	9	3
0	33	-3
21	15	0
12	0	3
12	0	3

// Xu L, 2009: Loss > Gain
// Xu L, 2009: Gain > Fixation
// Xu L, 2009: Immediate Reward > Delayed Reward, Gain
// Xu L, 2009: Loss > Fixation
// Xu L, 2009: Immediate Loss > Delayed Loss, Loss
// Subjects=20
48	51	21
54	39	21
12	33	-24
54	48	0
-42	33	18
-51	27	27
24	12	51
42	9	57
33	39	24
12	-9	12
30	-18	-6
27	18	-3
-24	-27	3
-12	15	-3
-33	-18	6
54	-42	48
42	-57	45
-24	-72	60
6	-66	0
15	-81	45
54	-60	-12
-51	-63	0
45	57	-9
27	69	-6
51	24	-12
-42	57	-9
-45	48	-15
-60	24	3
21	45	-21
9	57	39
-12	27	57
-6	45	45
33	24	48
-33	24	51
54	-42	48
-51	-57	45
-3	-99	18
15	-108	-3
6	-105	3
60	-36	-18
-60	-36	-18
21	-54	30
3	-42	36
-9	-60	33
6	57	9
-3	57	-6
-3	45	-9
3	48	-15
-6	9	-6
42	-63	42
54	-24	-15
51	0	-30
-54	6	-24
30	66	-6
39	33	27
-57	21	-6
-45	54	-3
6	21	66
-3	27	54
-42	12	48
24	-27	12
21	0	24
-21	-33	9
-12	-6	-6
6	-99	24
54	-45	48
-51	-54	30
63	-27	-18
-63	-33	-24
-45	-36	-6
-54	-63	-21
3	36	15
-6	30	15
9	42	-6
-6	-15	42
9	-21	33
-18	54	27
-27	51	30
-21	30	45
-30	24	60
42	-15	9
42	-21	-6
-36	-24	6
12	-51	36
-3	-54	42
-60	-15	-21
-57	-18	-12
-57	-51	36
-57	-57	21
-63	-48	15
66	-51	21
69	-45	15

// Hamilton L S, 2009: Schizophrenic Patients
// Subjects=20
-30	18	-4
-42	16	-8
-48	18	-16
-46	20	28
-58	14	12
-50	-22	52
-6	-10	52
-42	-18	62
6	-12	52
-16	-14	70

// Hamilton L S, 2009: Bipolar Patients
// Subjects=21
-8	-70	32
10	-76	10
8	-82	2
10	-72	-12
28	-86	-6
-50	-22	52
-6	-10	52
-42	-18	62
6	-12	52
-16	-14	70

// Hamilton L S, 2009: Healthy Controls
// Subjects=38
-30	18	-4
-42	16	-8
-48	18	-16
-46	20	28
-58	14	12
-8	-70	32
10	-76	10
8	-82	2
10	-72	-12
28	-86	-6

// Robinson J L, 2009: Familiarity > Fixation, Bipolar Patients + Healthy 
// Controls
// Robinson J L, 2009: Novelty > Fixation, Bipolar Patients + Healthy Controls
// Robinson J L, 2009: Healthy Controls > Bipolar Patients, Familiarity
// Robinson J L, 2009: Healthy Controls > Bipolar Patients, Novelty
// Robinson J L, 2009: Bipolar Patients > Healthy Controls, Familiarity
// Robinson J L, 2009: Bipolar Patients > Healthy Controls, Novelty
// Subjects=15
37.29	19.91	-12.86
46.06	33.27	21.61
-2.84	11.43	46.31
45.96	36.64	10.17
35.34	34.98	17.13
-39.64	56.94	4.99
-39.32	5.27	24.94
26.78	-59.61	-21.68
35.28	18.98	2.86
37.36	18.48	-3.82
22.59	-30.25	0.44
16.18	-14.8	8.14
16.11	-17.78	-2.76
22.63	-32.03	5.05
24.76	0.91	17.88
22.57	0.38	11.25
9.63	-22.9	-13.41
7.7	27.55	33.68
35.25	34.12	6.05
-41.82	52.01	-3.49
5.68	17.82	45.67
35.67	1.08	46.73
33.61	1.93	57.84
27.13	-5.48	45.15
54.81	6.86	37.11
46.06	33.27	21.61
-2.87	19.89	45.6
-.56	1.89	60.46
1.62	2.42	67.08
45.98	36.82	12.39
-39.65	56.77	2.78
41.89	5.75	23.96
46.28	-1.82	35.7
41.77	43.99	22.99
1.49	9.85	53.08
-35.37	59.08	4.77
20.42	-32.72	-3.79
-22.33	-30.87	-3.45
-33.07	-53.45	-19.28
-7.43	-29.18	-10.46
11.73	-25.52	-19.91
31.61	-64.84	47.85
31.65	-62.21	54.32
33.32	-84.6	-15.2
9.91	-92.52	-5.34
-45.75	-76.27	-10.53
35.21	22.69	-4.14
37.43	19.16	5.05
22.65	-9.85	16.57
22.62	-34.31	3.01
-22.26	-30.18	5.41
-11.58	-19.2	8.83
-15.86	-14.82	10.74
-11.63	-19.71	2.18
24.67	-26.35	-4.37
-18.03	-4.26	9.88
9.64	-25.01	-13.23
-7.45	-22.83	-10.99
-24.65	-32.76	-27.8
-9.55	-18.1	-4.67
37.61	-73.49	-9.49
16.35	-96.54	-2.85
-19.94	-94.13	4.06
20.64	-89.82	1
-11.51	-75.56	-4.29
37.65	-70.86	-3.02
-17.7	-101.89	13.6
27.06	-87.5	2.96
18.78	-58.4	49.68
38.09	-55.32	60.35
-37.27	-63.71	-13.91
35.46	-84.59	-15.22
-15.93	4.21	9.14
-18.04	-30.67	-1.29
-37.28	-55.08	-12.4
44	-64.82	-8.06
-39.54	-36.57	-20.62
-62.96	-51.17	-14.67
-67.18	-52.8	-7.79
-69.34	-33.26	-2.71
-37.37	-45.02	-19.94
-17.69	-95.2	17.5
33.37	-92.89	-12.27
16.35	-96.54	-2.85
-19.95	-92.01	3.88
20.64	-89.82	1
-11.47	-90.53	-5.27
18.44	-83.84	-3.94
-17.73	-99.94	11.21
27.05	-85.39	2.78
-35.33	-30.54	-25.64
31.42	-60.21	25.16
42.24	-49.98	46.48
33.66	-45.97	44.01
-43.76	-42.6	-15.61
59.07	6.71	34.84
59.02	10.6	30.05
-3.25	53.27	9.35
-5.57	36.05	-20.41
-5.56	51.54	-12.79
52.71	7.19	41.56
59.06	0.03	30.94
-1.1	35.85	4.09
-9.66	42.31	5.88

// Kaladjian A, 2009: Bipolar Disorder Patients
// Subjects=10
0	40	45
-6	54	28
-48	20	43
27	10	33
-45	-32	2
57	-4	-15
-24	-10	-15
-42	-57	30
48	-54	22
9	46	39
-23	37	31
-42	14	49
-33	-13	23
-42	-63	28
50	-57	19
-15	-51	36
9	-57	30
-21	-71	45
27	-55	57
-27	-9	-14
25	5	-4
-24	6	-3
15	-51	27
-6	-57	19

// Kaladjian A, 2009: Healthy Controls
// Subjects=10
24	56	14
27	37	40
-45	16	30
48	-1	34
56	0	-5
-27	-6	-18
27	-11	10
27	-33	-18
-42	-62	50
15	-42	38
-42	-70	1
24	-65	47
-12	46	39
-45	19	21
54	-4	-12
-54	-20	-1
-27	-6	-12
21	-32	-6
21	-54	28
27	-72	48
25	5	-4
-24	6	-3
15	-51	27
-6	-57	19

// Kaladjian A, 2009: Bipolar Disorder Patients
// Subjects=20
-40.39	9.9	53.39
4.73	51.88	40.63
-43.73	-63.11	30.42
59.85	-50.61	20.69
47.24	-56.77	47.29
5.18	-66.18	52.3
-21.78	64.96	-1.68
-28.23	-9.26	-14.4
30.06	-3.94	-18.16

// Kaladjian A, 2009: Healthy Controls
// Subjects=20
-40.66	28.65	35.85
30.68	20.4	35.45
-21.77	61.77	-1.36
26.91	56.93	1.65
-44.59	34.4	-17.32
52.59	36.56	-22.55
7.28	44.57	-14.72
-57.17	-42.67	-2.75
54.72	4.58	-31.74
-25.02	-10.52	-16.57
26.87	-9.06	-15.35
-43.58	-60.9	42.52
53.48	-49.8	29.69
4.96	-52.54	37.51
-40.85	-70.16	0.81
18.04	-80.04	41.13
-21.78	64.96	-1.68
-28.23	-9.26	-14.4
30.06	-3.94	-18.16

// Lee T M C, 2009: Intentional Faked Responses > Truthful Accurate Responses
// Lee T M C, 2009: Truthful Accurate Responses > Intentional Faked Responses
// Lee T M C, 2009: Intentional Faked Responses > Truthful Error Responses
// Subjects=10
-26	14	40
8	10	42
40	6	-14
4	-66	46
-42	-60	10
-8	-68	6
10	-56	6
8	-22	-4
-44	20	-4
-34	44	6
8	-40	28
-12	-56	46

// Chikazoe J, 2009: Stop vs. Uncertain-Go
// Chikazoe J, 2009: Uncertain-Go vs. Certain-Go
// Chikazoe J, 2009: Conjunction Analysis, Stop vs. Uncertain-Go + 
// Uncertain-Go vs. Certain-Go
// Chikazoe J, 2009: Disjunction Analysis, Stop vs. Uncertain-Go but not 
// Uncertain-Go vs. Certain-Go
// Subjects=22
38	16	-6
-32	18	2
54	14	26
48	16	18
42	6	32
34	18	14
26	52	26
-44	16	-6
46	36	16
-44	10	32
34	8	58
-40	56	18
-32	36	18
32	-4	50
18	16	58
4	24	36
2	14	46
0	-22	32
6	42	14
6	6	62
-4	4	60
18	-6	68
-8	0	68
64	-40	30
-42	-52	50
52	-38	48
64	-30	38
36	-58	48
-58	-36	36
-50	-42	48
12	-70	38
44	-46	40
24	-62	42
64	-26	24
-26	-66	50
-26	-60	38
14	-36	42
-14	-96	6
64	-40	16
60	-48	8
52	-50	16
52	-20	-6
-54	-40	20
38	-52	-14
50	-30	-2
36	-12	-8
54	-10	-10
10	-10	2
16	2	10
-10	-2	6
12	-18	14
-26	16	-6
6	-28	-22
2	-50	-40
-30	-58	-32
-12	-22	18
10	-56	-36
30	28	2
42	18	4
42	6	40
-40	16	0
-26	26	-6
4	12	52
20	-10	56
-14	-20	8
40	24	4
46	10	44
-32	20	4
-42	6	38
34	58	20
6	22	52
2	-22	32
58	-40	40
-62	-24	34
16	-66	40
30	-56	48
12	-90	4
-16	-92	-2
56	-20	-2
-8	-4	10
14	-14	16
-32	-56	-30
14	2	0
0	-52	-36
46	16	16
28	52	28
-42	12	28
-24	16	2
-34	20	18
-36	16	-10
56	-43	24
-44	-44	52
-54	-36	38
54	-46	56
4	36	26
-2	-24	36
20	4	6
-14	4	6
8	-6	6
-4	0	6

// Fales C L, 2009: Depressed Patients
// Subjects=23
39.68	32.43	25.1
-18.29	-5.86	-24.55
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34

// Fales C L, 2009: Healthy Controls
// Subjects=18
39.68	32.43	25.1
-18.29	-5.86	-24.55
-9.76	37.94	-9.37
5.62	22.68	39.69
-5.49	13.76	-19.66
1.27	17.4	26.8
1.31	17.83	32.34

// Baillieux H, 2009: Activations in Controls, Absent in Dyslexics
// Baillieux H, 2009: Activations in Dyslexics, Absent in Controls
// Subjects=7
-44.86	29.58	9.58
-30.08	-15.08	-32.57
4.68	29.5	59.2
40.21	-39.02	64.54
-38.45	40.54	13.05
-53.35	-51.11	-14.78
-46.6	-43.25	31.32
-39.36	-79.75	-14.77
-20.42	-12.39	-26.21
68.57	1.17	17.35
20.51	-76.85	-10.13
19.51	-97.03	-9.54

// Bokde A L W, 2009: Face Matching > Control, Before Treatment
// Bokde A L W, 2009: Location Matching > Control, Before Treatment
// Bokde A L W, 2009: Before Treatment > After Treatment, Location Matching
// Subjects=5
-24.35	-102.12	-16.41
-70.55	-34.73	-21.53
-30.41	-52.44	48.63
-42.58	10.19	20.1
-32.89	39.54	40.95
-30.63	26.58	52.05
-9.39	28.68	36.01
-13.78	37.31	24.19
-13.86	-94.26	-39.5
-11.63	-104.22	-30.88
31.39	-107.74	2.38
46.29	-90.73	0.78
48.33	-86.2	-9.66
1.31	39.83	41.65
10.06	11.22	56.21
9.57	54.4	9.1
11.82	58.96	26.54
5.79	22.19	60.92
8.05	1.49	68.2
3.27	41.3	19.2
50.33	23.35	16.81
58.82	30.46	11.66
54.7	22.12	28.02
50.62	-3.31	43.58
58.82	30.46	11.66
43.85	-58.7	-25.3
48.09	-68.88	-33.41
-24.35	-102.12	-16.41
-41.68	-34.38	-19.66
-43.38	-101.24	10.5
-39.33	-73.95	-8.57
-36.88	-76.14	31.74
-34.88	-92.9	7.47
-24.26	-91.32	-.59
-19.76	-65.92	38.49
-54.62	2.72	-20.4
-56.82	19.71	-20.68
-46.17	21.55	-25.42
-24.61	-32.42	-23.37
-21.8	-78.11	46.23
-15.72	-73.84	4.54
-45.6	-30.72	28.03
-36.84	-43.85	50.22
-54.65	31.07	-11.62
-41.58	30.37	19.51
-52.48	46.74	-1.81
-15.65	24.64	53.15
-5.02	17.59	43.58
-.97	41.62	23.68
-4.93	15.19	53.82
-3.18	58.44	21.18
-3.01	37.09	34.12
-34.86	0.66	47.58
-24.01	-19.57	60.3
-21.84	-14.81	66.57
-52.31	-65.71	-24.72
-37.53	-41.18	-39.21
-35.33	-39.43	-30.47
-28.81	-48.14	-19.77
-9.48	-46.99	-6.71
20.61	-102.14	-6.89
25.06	-86.06	21.82
41.97	-73.66	1.63
46.14	-68.07	-8.93
33.74	-71.52	43.92
31.12	-55.64	-12.03
48.27	-73.68	-12.94
52.41	-42.11	-17.87
73.78	-41.98	-18.12
65.33	-56.32	-10.13
41.52	5.24	-23.94
48.37	-57.25	6.87
58.79	-29.12	-15.68
52.84	-60.71	30.53
60.95	6.18	0.29
61.22	-43.71	15.62
35.2	-6	-17.35
44.42	-38.53	56.64
48.63	-47.91	45.11
61.26	-32.28	25.82
12.27	-45.13	43.07
16.73	-65.22	58.08
40.15	-25.27	63.39
42.15	-53.12	33.36
46.4	-43.4	34.73
57.07	-43.51	32.38
1.43	4.85	43.46
20.53	26.57	33.62
50.16	36.96	0.06
58.86	18.75	11.53
39.67	33.4	23.9
43.01	20.53	36.09
41.71	38.99	13.37
41.77	30.87	18.51
35.39	42.1	26.57
3.12	51.82	3.82
12.13	16	49.1
14.22	24.3	46.15
14.1	41.77	37.99
10.27	-22.91	69.11
46.29	-6.14	34.95
11.8	-7.23	-3.6
16.2	-15.69	10.44
13.96	-.36	2.49
33.2	-7.9	-.44
5.29	-32.41	-25.94
26.85	-64.38	-14.59
18.29	-86.52	-24.9
52.43	-71.51	-26.55
65.13	-36.46	-28.52
-19.68	-100.27	34.68
-11.24	-73.87	31.25
-32.63	-78.57	27.43
-41.07	-80.77	41.09
-28.26	-74.26	41.52
-19.58	-69.58	59.98
-15.36	-76.67	50.49
-52.23	-62.74	-13.82
-41.59	-56.5	-16.69
-26.77	-30.4	-24.63
-39.16	-73.21	14.79
-39.74	34.96	-17.7
-39.73	24.13	-20.13
-17.56	-21.3	64.83
-3.13	43.55	21.31
-54.45	-72.32	-27.49
-43.84	-45.65	-27.62
-3.32	-47.32	-39.09
7.75	-79.58	-3.06
31.23	-70.98	-4.05
31.46	-79.59	22.32
65.32	-58.69	-13.28
45.97	-46.8	-22.97
56.7	-53.97	-20.27
20.29	-12.09	-12.21
46.2	-68.52	-1.08
44.31	-62.71	33.02
8.19	-80.5	53.89
14.5	-73.83	43.22
42.16	-52.95	35.57
35.08	28.98	-19.17
37.22	35.68	-15.29
35.32	17.2	7.47
49.22	15.17	7.48
18.2	-.67	-1.99
9.51	-48.3	-39.16
26.87	-64.21	-12.37
39.47	-43.3	-32.12

// Chae Y, 2009: Verum Acupuncture > Sham Acupuncture
// Subjects=10
20	33	30
-20	-1	24
-24	18	18
-18	-57	19
-8	-50	6
30	-49	-8
-30	-38	-15
-4	-64	31
8	-61	27
-10	-67	-12

// Davis N, 2009: Normal Adults
// Subjects=10
52.79	-38.17	33.1
46.06	-57.92	-15.35
46.18	-63.24	-1.53
36.8	-57.55	31.56
47.56	-56.72	41.4
33.71	-53.11	47.95
30.53	-66.08	45.73
-44.26	-49.89	55.27
-36.74	-53.82	58.86
43	6.19	29.49
26.98	2.92	29.95
33.67	-50.2	44.36
30.42	-57.33	34.96
-43.3	-41.14	44.49
-43.54	9.1	33.59
33.29	38.11	30.27
39.72	-70.39	-10.89
-30.43	-10.89	62.99
39.76	9.08	25.94
30.39	-1.61	53.71
43.09	3.79	39.73
46.4	-31.35	39.29
57.09	-24.68	41.95
-40.36	8.86	30.22
-30.76	12.09	29.84
-46.7	9.59	40.27
33.62	-57.31	34.92
30.6	-68.65	53.75
33.64	-70.26	32.66
30.52	-43.1	53.84
4.65	17.02	49.1
14.55	-65.66	52.57
-30.96	52.82	19.74
-24.5	53.37	26.31
-46.56	-41.68	37.88
-39.95	-49.53	59.65
42.98	12.53	28.96
46.29	3.81	39.69
29.96	57.67	21.98
30.45	-1.01	61.46
30.45	-60.25	38.55
43.19	-31.36	39.33
36.87	-53.61	41.27
37	-65.44	53.41
43.2	-41.14	36.8
52.81	-24.71	42.01
-43.47	3.27	40.77
-43.3	-41.14	44.49
-43.38	-35.31	37.31
-27.22	-47.13	48.15
-24.05	-1.33	62.12
-14.32	-69.26	49.86
-46.59	-25.56	39.87
-27.3	-61.11	32.6
4.62	16.76	45.77
46.11	-57.41	-8.7
30.14	-73.36	-7.18
-49.94	-69.9	3.48
-40.33	-80.93	-2.39
-27.55	-76.88	-6.23

// Davis N, 2009: Normal Children
// Subjects=27
36.34	16.78	1.91
33.15	26.79	7.8
4.56	26.02	41.65
7.79	13.09	39.35
-8.28	15.91	35.96
-20.72	-79.07	47.41
4.86	-82.86	37.4
-7.81	-68.2	63.08
-30.47	-50.84	41.81
14.49	-63	45.66
1.43	20.17	48.87
-1.88	25.72	38.4
-17.76	7.37	50.16
27.13	4.46	49.89
7.86	-94.93	4.92
7.94	-97.33	15.16
-14.68	-96.09	-8.11
-1.83	-75.96	3.44
-1.52	-62.84	49.17
8.18	-71.79	56.5
30.56	-68.99	49.32
1.42	23.34	48.6
-5.11	32.05	37.91
4.49	38.45	37.26
-20.94	7.6	53.53
-24.01	-83.29	34.42
-30.46	-54.01	42.07
-24	-73.26	40.27
-36.81	-50.11	51.86
27.42	-78.27	53.48
33.83	-71.63	56.2
27.13	11.06	52.68
23.83	10.02	39.43
-20.68	-75.39	53.79
-30.47	-70.64	33.43
33.67	-63.4	38.78
1.43	20.17	48.87
4.56	26.02	41.65
-1.92	31.81	34.55
-30.42	-63.53	42.87
-27.13	-72.51	50.28
-33.64	-53.77	45.44
43.25	-40.62	43.45
-43.57	2.24	27.47
52.79	-38.17	33.1
46.06	-57.92	-15.35
46.18	-63.24	-1.53
36.8	-57.55	31.56
47.56	-56.72	41.4
33.71	-53.11	47.95
30.53	-66.08	45.73
-44.26	-49.89	55.27
-36.74	-53.82	58.86
43	6.19	29.49
26.98	2.92	29.95
33.67	-50.2	44.36
30.42	-57.33	34.96
-43.3	-41.14	44.49
-43.54	9.1	33.59
33.29	38.11	30.27
39.72	-70.39	-10.89
-30.43	-10.89	62.99
39.76	9.08	25.94
30.39	-1.61	53.71
43.09	3.79	39.73
46.4	-31.35	39.29
57.09	-24.68	41.95
-40.36	8.86	30.22
-30.76	12.09	29.84
-46.7	9.59	40.27
33.62	-57.31	34.92
30.6	-68.65	53.75
33.64	-70.26	32.66
30.52	-43.1	53.84
4.65	17.02	49.1
14.55	-65.66	52.57
-30.96	52.82	19.74
-24.5	53.37	26.31
-46.56	-41.68	37.88
-39.95	-49.53	59.65
42.98	12.53	28.96
46.29	3.81	39.69
29.96	57.67	21.98
30.45	-1.01	61.46
30.45	-60.25	38.55
43.19	-31.36	39.33
36.87	-53.61	41.27
37	-65.44	53.41
43.2	-41.14	36.8
52.81	-24.71	42.01
-43.47	3.27	40.77
-43.3	-41.14	44.49
-43.38	-35.31	37.31
-27.22	-47.13	48.15
-24.05	-1.33	62.12
-14.32	-69.26	49.86
-46.59	-25.56	39.87
-27.3	-61.11	32.6
4.62	16.76	45.77
46.11	-57.41	-8.7
30.14	-73.36	-7.18
-49.94	-69.9	3.48
-40.33	-80.93	-2.39
-27.55	-76.88	-6.23

// Fullam R S, 2009: Lie - Truth
// Fullam R S, 2009: Truth - Lie
// Subjects=24
-30	24	-12
51	24	-15
-6	48	-6
3	48	-3
-9	54	0
6	51	0

// Harada T, 2009: Lie Judgement - Gender Judgment (masked with Lie Judgement)
// Harada T, 2009: Moral Judgement - Gender Judgment (masked with Moral 
// Judgement)
// Harada T, 2009: Lie Judgement - Moral Judgement (masked with the Lie 
// Judgement)
// Subjects=18
-6	46	40
-52	18	14
-48	28	-10
-48	18	38
-54	4	-30
52	18	46
60	30	16
52	30	18
44	30	-12
-50	-60	46
-58	-52	26
-4	-78	40
50	-54	28
-56	-42	0
52	-30	-10
46	6	-44
-28	26	0
-10	8	14
-16	4	0
10	0	18
16	0	0
6	-18	-4
28	-82	-40
-8	44	46
-48	16	-34
-50	16	16
-52	26	-10
-46	6	50
-36	24	44
-56	-42	0
32	-86	-36
14	8	0
-48	-58	40
-50	-54	24
-38	-58	20
54	-52	28
50	-52	40
-46	26	44
54	-28	-12

// Hester R L, 2009: Aware Errors - Unaware Errors, Healthy Controls and 
// Cannabis Users
// Hester R L, 2009: Cannabis Users > Healthy Controls, All Errors
// Subjects=16
2	21	36
41	15	-1
-41	-25	54
47	-34	48
28	-8	57
28	-10	5
29	-92	14
13	-80	-21
-29	44	24
41	15	-1
49	-41	42
-35	15	-6
2	-18	33
5	36	22
58	-28	-1
-39	-51	56
19	6	-4
-29	20	5
6	-19	-2
3	-14	49
1	-27	28
39	49	18
39	40	30

// Janse Van Rensburg K, 2009: Post Sitting > Fixation
// Janse Van Rensburg K, 2009: Post Exercise > Fixation
// Subjects=10
34	-28	72
56	36	4
54	42	-2
-32	38	-20
-64	-36	-14
-12	-16	52
-40	-46	44
40	-54	48
-34	-44	50
-48	-38	32
-38	-60	56
36	-58	60
64	-24	2
58	-30	0
64	-8	12
-38	-20	-12
-12	-16	68
-34	-42	-38
-44	-44	2
18	-4	18
18	-64	-28
-52	-56	-18
-34	32	50
0	48	14
10	46	18
2	62	12
-10	-78	26
48	-20	-16
38	-70	22
2	-62	26
2	16	36
0	46	-2
-2	-54	-44
0	-42	46

// Kato J, 2009: Negative Political Advertisements, Unchanged > Changed
// Kato J, 2009: Negative Political Advertisements, Changed > Unchanged
// Kato J, 2009: Positive Political Advertisements, Unchanged > Changed
// Kato J, 2009: Positive Political Advertisements, Changed > Unchanged
// Kato J, 2009: Negative Cola Advertisements, Unchanged > Changed
// Kato J, 2009: Negative Cola Advertisements, Changed > Unchanged
// Kato J, 2009: Positive Cola Advertisements, Unchanged > Changed
// Kato J, 2009: Positive Cola Advertisements, Changed > Unchanged
// Subjects=40
-43.96	-52.76	14.83
-69.15	-36.85	-8.73
-7.3	-66.33	5.46
32.04	-49.69	43.49
7.98	56.35	42.37
25.58	-75.86	39.46
51.14	-52.22	15.4
-15.8	47.45	40.29
-5.34	-42.69	-5.87
46.69	-35.74	8.24
40.89	-64.58	56.02
-13.42	-85.55	29.88
71.36	-1.93	1.11
-35.58	-87.55	-13.25
44.63	-80.93	7.14
-43.85	22.47	38.76
16.08	-27.6	-17.82
-53.33	13.98	-28.59
58.33	34.71	3.31
-30.62	-89.34	36.15
-23.84	-68.43	64.22
-48.6	34.54	7.39
-66.59	-6.51	28.57
46.05	29.53	-28.46
16.92	-95.66	34.85
58.32	-62.75	-17.3
-38.22	4.04	-32.35
-56	-41.93	5
19.32	-59.98	60.41
14.1	-71.11	-12.36
-15.29	-75.72	54.71
12.13	-42.34	8.36
5.55	-89.01	-8.2
-22.61	-62.31	-8.12
0.78	26.9	-19.59
27.1	-57.67	-7.18
-69.14	-38.97	-8.52
50.78	-62.57	-14.95
48.16	9.46	-36.6
-46.35	-78.56	-8.35
-35.89	-37.33	-27.18
50.67	-14.19	-14.13
53.03	-29.1	-1.49
-31.46	-16.82	-14.71
29.32	-77.98	-6.33
63.09	-49.53	20.53
-41.61	-72.13	25.67
-28.44	-69.46	41.99
-60.69	3.39	-15.09
18.16	67.02	-4.8
-44.06	-26.17	12.2
-33.13	12	29.53
43.07	-52.35	60.37
-50.6	-58.39	0.93
56.28	-15.91	1.63
37.64	-65.03	-29.05
56.12	46.4	2.19
-32.55	-6.6	71.7
22.34	-12.76	-31.72
-28.42	-45.23	48.56
38.23	-77.04	14.71
73.7	-30.12	9.46
-27.3	-48.66	-34.04
46.78	14.2	25.71
25.54	-54.28	40.69
26.68	28.92	-22.47
-16.51	28.97	-19.5
-19.86	-55.71	39.36
8.02	-38.57	25.99
56.37	-43.67	3.26
62.99	23.08	27.92
48.37	-1	-22.12
14.43	53.93	39.14
-48.18	-45.46	24.26
49.12	5.68	37.72
60.4	-16.28	-14.09
-56.23	36.22	2.87
-3.1	66.25	22.53
-48.06	-82.89	25.73
-18.37	-34.44	-8.71
7.82	-90.4	-.26
-41.54	-.51	45.48
24.72	-16.62	-15.69
-7.04	47.24	49.13
17.33	-52.15	75.36
32.1	19.7	62.39
-60.11	12.11	32.22
16.61	-103.47	8.73
18.51	-17.86	5.83
33.77	11.61	21.7
37.67	-60.46	-26.14
-11.39	-105.07	16.09
-22.5	-19.92	8.97
-35.77	-72.53	-24.81
1.41	-50.47	13.83
40.11	26.97	13.35
-68.67	-32.15	30.02
55.71	5.02	-38.53
-8.84	-78.14	51.48
51.05	2.85	18.91
42.53	43.19	37.48
48.82	-79.72	-3.13
-41.61	29.59	45.86
-25.04	14.47	-13.43
-52.57	9.8	30.08
-43.74	-41.32	33.86
-32.81	-20.58	48.43
-33.75	38.04	-13.38
29.9	-69.26	40.98
25.3	-54.98	21.71
55.06	-51.92	-16.07
-6.92	-9.85	46.93
-48.59	-19.03	-3
20.53	-25.48	-6.9
33.11	18.74	-28.3
50.76	25.86	0.96
-7.05	-98.37	18.71
42.89	2.1	57.23
58.15	-3.84	-18.64
-50.95	23.3	-9.39
-50.44	-35.25	18.81
-21.73	-39.3	65.79
-69.17	-16.22	-6.28
40.6	-22.97	41.82

// Langleben D D, 2009: Public Service Announcements (hiMSV + loMSV) > Neutral 
// Video Clips
// Langleben D D, 2009: Neutral Video Clips < Public Service Announcements 
// (hiMSV + loMSV)
// Langleben D D, 2009: High Message Sensation Value > Low Message Sensation 
// Value, Public Service Announcements
// Langleben D D, 2009: Low Message Sensation Value > High Low Message 
// Sensation Value, Public Service Announcements
// Langleben D D, 2009: Positive Correlation Between Frame Recognition Test 
// and Public Service Announcements
// Langleben D D, 2009: Negative Correlation Between Frame Recognition Test 
// and Public Service Announcements
// Subjects=18
-52	-58	16
56	-36	8
-8	44	40
10	-30	-10
-6	-52	32
4	46	-18
46	2	42
24	-96	-6
10	0	10
-18	-78	-34
26	-80	-30
18	-64	54
-30	12	8
40	-2	-2
-30	38	-14
40	28	34
54	-60	-6
-44	-72	10
60	-24	12
-30	-4	46
14	-46	-43
-64	-40	2
48	-36	2
-50	-62	40
50	-62	40
8	24	58
44	12	46
-6	38	46
16	44	42
6	42	-20
-28	-14	66
-46	-24	58
-24	-98	-8
-18	-82	-36
32	-80	-28
-40	20	-28
-60	-46	10
50	-34	0
6	52	-12
-54	-16	-6
2	48	38
56	-18	-10
42	-38	-18
-26	-84	8
38	-56	2
0	-88	-4
-32	-86	0
-32	-64	-12

// Leaver A M, 2009: Musically Trained Subjects
// Subjects=11
59.96	-11.63	4.02
-52.22	-18.64	5.9
4.69	10.93	52.95
34.18	-54.96	-31.08
1.15	-72.79	-24.74
-5.02	-78	4.76
-14.62	-97.61	-.17
-2.1	-24.91	-10.88
-34.21	-55.28	-29.15
-8.18	12.54	47.39
-40.09	-43.24	44.63
-56.53	7.31	11.58
25.66	6.84	-1.81
-49.05	1.9	9.72

// Leaver A M, 2009: Musically Untrained Subjects
// Subjects=9
57.85	-13.61	6.11
-52.2	-20.6	8.18
27.73	-12.47	-17.84
-1.09	-56.26	24.08
-35.24	-30.74	-14.47
55.97	5.45	47.25
6.7	9.28	63.1
53.53	22.14	14.65
37.18	51.71	-14.41
-1.59	-.94	65.17
1.51	8.97	55.38
0.34	-30.53	26.37
-19.15	-3.64	4.26
-14.84	-13.13	5.01
-1.92	-18.63	15.36
-35.82	-50.96	40.76
30.96	-57.26	-33.08

// Liu P, 2009: GB37 Acupuncture vs. Rest
// Liu P, 2009: GB37 Acupuncture vs. Rest (Deactivations)
// Liu P, 2009: KI8 Acupuncture vs. Rest
// Liu P, 2009: KI8 Acupuncture vs. Rest (Deactivations)
// Liu P, 2009: GB37 Acupuncture vs. K18 Acupuncture
// Liu P, 2009: K18 Acupuncture vs. GB37 Acupuncture
// Subjects=28
-15	28	32
6	56	19
-42	-12	-4
42	-12	-4
-27	-10	-20
-50	11	-3
-18	-72	12
3	-78	12
-12	-80	26
21	-55	3
-30	-83	26
12	-86	35
-45	-57	17
56	-57	17
31	-84	4
-3	-80	26
12	-90	16
-42	-60	14
6	-77	37
-3	55	0
3	-18	48
9	41	3
23	26	-10
-3	53	14
6	42	23
-3	-51	30
3	-63	17
-12	-55	3
42	-67	9
-42	-15	-4
42	-14	12
-33	-15	-7
30	-12	-15

// Mazzola-Pomietto P, 2009: Manic Patients
// Subjects=16
27.57	27.91	47.09
-40.45	-56.2	35.28
8.27	-42.12	45.38
46.22	28.65	-14.93
-41.31	24.84	-16.43

// Mazzola-Pomietto P, 2009: Healthy Controls
// Subjects=16
46.17	31.53	-18.58
-38.13	33.15	-19.54
-21.82	64.65	-5.01
64.86	-16.29	-2.96
53.48	-56.39	28.1
-36.89	-60.39	59.17
-1.46	-38.97	45.24
46.22	28.65	-14.93
-41.31	24.84	-16.43

// McCabe C, 2009: Subjects Receiving Aprepitant
// Subjects=12
32	-60	-20
-36	-48	-28
36	-52	-22
-38	-48	-22
0	54	24
-38	-48	-20
58	-64	-10
46	40	24
2	46	0
24	6	0
-18	-100	0
12	-18	6
-22	4	2
14	-96	-2
12	-2	12
-20	-98	0
14	26	-18
2	-72	30

// McCabe C, 2009: Subjects Receiving Placebo
// Subjects=12
30	-58	-20
-38	-20	52
34	-56	-18
2	46	0
24	6	0
-18	-100	0
12	-18	6
-22	4	2
14	-96	-2
12	-2	12
-20	-98	0
14	26	-18
2	-72	30

// Mensebach C, 2009: Borderline Personality Disorder (BPD)
// Subjects=18
43.12	23.09	-5.36
-1.66	30.69	43.95
-37.84	49.57	6.84
-59.54	17.09	-6.38
-30.65	-45.76	43.05
-27.31	-57.03	48.59
-37.2	-39.71	39.2
49.84	49	18.85
36.31	52.35	-24.95
33.17	56.36	-16.33
34.22	-53.94	43.87
21.33	-63.24	48.37
-5.59	-22.67	-21.3
4.7	-22.73	23.36
-5	-9.48	27.81
-62.41	-37.08	11.35
-8.44	-18.6	10.85
24	1.38	16.16
17.45	3.07	11.62
55.35	24.66	22.29
4.24	-54.64	-19.42
-8.12	24.28	44.7
1.47	29.87	35.02
-49.46	17.6	21.41
43.12	23.09	-5.36
49.49	15.69	-15.95
-27.32	-53.84	48.27
-43.65	-36.23	42.32
-37.14	-42.59	42.84
-5.18	-11.9	13.49
-18.24	-9.38	6.74
-12.03	-22.38	-17.86
-50.86	-53.77	-18.57
-44.13	-51.88	1.3
20.81	-8.1	18.27
17.28	-8.06	-4.08
4.39	-45.85	-5.73
1.04	-46.69	-14.55
7.67	-70.71	-7.81
49.84	49	18.85
49.65	46.48	3.42
43.39	-48.17	1.68
36.96	-56.6	3.75
-56.13	-33.09	-3.72
-59.27	-42.15	2.84
-15.15	-59.72	-15.23
11.36	-23.59	36.77
11.23	-42.06	22.92
1.53	-12.34	31.35
-59.68	1.81	-20.56
-62.37	-36.77	14.68
52.87	24.39	-3.42
47.09	-58.98	35.19
4.95	-23.09	42.44
43.4	-50.3	1.89
-33.62	-26.26	68.06
0.27	21.28	23.56

// Mensebach C, 2009: Healthy Controls
// Subjects=18
-1.58	21.43	48.23
-40.78	1.47	20.62
-55.73	13.71	37.59
40	48.03	9.03
-27.46	-49.46	37.75
-14.21	-62.54	57.87
-27.35	-57.35	45.26
11.76	-67.66	59.06
46.27	15.88	-13.67
47.05	-33.04	37.1
4.12	-35.81	-24.65
-34.65	52.46	3.14
-1.58	21.43	48.23
-37.78	18.31	5.45
-44.29	34.45	6.21
4.44	-80.5	-9.02
7.47	-44.85	-18.2
-5.49	-18.64	-12.73
-5.58	-42.23	-23.85
24.02	-11.59	15.2
-27.42	-49.15	41.08
-52.99	-60.06	-16.79
11.36	-23.59	36.77
11.23	-42.06	22.92
1.53	-12.34	31.35
-59.68	1.81	-20.56
-62.37	-36.77	14.68
52.87	24.39	-3.42
47.09	-58.98	35.19
4.95	-23.09	42.44
43.4	-50.3	1.89
-33.62	-26.26	68.06
0.27	21.28	23.56

// Mostofsky S H, 2009: High Functioning Autism (HFA) Patients
// Subjects=13
-53.33	-14.06	50.38
24.86	-56.07	-12.91
-13.95	-22.75	1.26
-31.37	-3.01	-4.87
-6.95	8.54	48.47
12.16	-85.82	2.58
42.95	-12.79	58.7
1.2	-66.27	-5.89
-.3	6.51	60.89
9.82	-16.07	2.44

// Mostofsky S H, 2009: Healthy Controls
// Subjects=13
-39.25	-22.52	50.98
18.27	-54.7	-20.78
-18.13	-26.08	11.75
-9.22	16.42	41.01
22.36	-68.46	-41.9
-22.86	-60.89	-27.31
-.81	-99.04	-.38
55.66	-13.55	38.39
-20.39	-86.97	-7.96
51.53	-11.05	53.9
-16.26	-54.51	-16.85
-4.89	14.31	41.15
-34.81	-1.91	64.55
-41.46	-29.43	46.1
26.99	-62.86	-16.75
14.22	-11.08	9.71
-62.09	-17.16	40.75

// Obermann M, 2009: Pain-Related Responses Using Train Pulse and Single Pulse 
// Stimulation
// Obermann M, 2009: Stimulation Level by Condition Interaction
// Subjects=11
1.41	15.21	27.5
-.57	-27.24	32.86
46.32	0.89	-13.31
51.76	-54.13	63.76
53.78	-32.21	57.08
9.93	-14.18	11.22
57.59	28.48	28.59
5.97	23.58	47.89
22.81	7.14	8.89
-37.92	-73.6	-24.67
7.39	-27.94	-21
1.41	15.21	27.5
10.53	-24.3	-28.13
26.94	-18.32	-11.08

// Onur O A, 2009: (Fear > Neutral) Reboxetine > (Fear > Neutral) Placebo
// Onur O A, 2009: (Happy > Neutral) Reboxetine > (Happy > Neutral) Placebo
// Onur O A, 2009: (Fear > Neutral) Placebo > (Fear > Neutral) Reboxetine
// Onur O A, 2009: (Happy > Neutral) Placebo > (Happy > Neutral) Reboxetine
// Subjects=9
50	-16	8
42	42	-10
32	-60	-14
20	-54	44
18	-86	-4
-36	-56	-8
-22	30	-12
54	-50	30
-48	-44	32
26	6	-32
60	-24	22
-46	-40	30
-18	-4	26
16	-64	-34
14	28	-20
-12	38	28
-8	48	6
12	-16	34
-32	-74	14
12	-56	42
-28	14	-10
-28	-86	42
4	-68	-20
-40	-74	24
-26	-14	16
-12	-28	-6
56	-58	-34
48	-56	-16
-18	54	-10
18	-44	6

// Ramaekers J G, 2009: Effect of MDMA in Go Trials
// Ramaekers J G, 2009: Effect of MDMA in No-Go Trials
// Subjects=12
-7.41	-5.94	0.98
-11.72	7.95	2.09
-20.76	-66.3	47.45
-33.58	-45.52	55.9
61.32	-27.28	35.43
-40.05	-43.95	49.15
36.91	-53.09	47.91

// Schienle A, 2009: Spider-Phobic
// Subjects=10
-39	9	-12
45	15	-12
-24	0	-15
-48	15	-9
48	18	-9
-9	48	-21
0	42	-27
6	51	-6
45	6	-6
-36	30	-18
48	51	-6
0	42	-27
3	42	-21
-33	3	6
0	42	-27
9	39	-9
-15	48	-18
-39	-3	18
-36	30	-15
21	24	-18
-36	-12	12
45	9	-6

// Schienle A, 2009: Healthy Controls
// Subjects=8
-9	45	-6
12	42	-6
-15	18	-12
15	42	-12
-3	57	-15
-33	3	6
0	42	-27
9	39	-9
-30	24	-3
-24	36	-9
36	51	-12
-33	21	-9
33	15	-12

// Small G W, 2009: Internet-Naive Subjects
// Subjects=12
-56	26	-4
-46	18	18
-54	28	14
-38	-2	32
-46	10	44
-56	0	-20
-60	-16	-16
-60	-44	0
60	-4	-20
-44	-66	34
-36	-46	-20
-44	-70	-12
-14	-102	6
26	-90	-6
-20	-24	-20
-2	-60	14
8	-34	66
-54	28	4
-56	20	22
-48	6	38
-46	10	48
-56	10	-26
-56	-16	-12
-56	-44	-2
48	-54	12
-44	-50	-18
-52	-56	-14
-14	-102	4
-28	-74	48
18	-102	10
-2	-54	12

// Small G W, 2009: Internet-Savvy Subjects
// Subjects=12
-54	30	-6
-50	12	20
-46	28	12
-46	0	32
-42	2	42
50	30	14
-52	-8	-26
-62	-28	-6
-56	-38	-4
-34	-74	32
-38	-50	-18
-44	-64	-18
-22	-102	-2
26	-100	4
-22	-30	-6
-4	-56	16
-52	26	-6
-56	20	20
-46	8	22
-42	2	40
-4	44	38
-10	14	64
46	12	28
-56	0	-20
-56	-20	-8
-56	-38	-2
60	-6	-18
-48	-70	20
-28	-36	-22
-34	-54	-18
38	-48	-22
-18	-102	-6
-22	-80	48
16	-92	-6
26	-86	40
-26	-24	-16
24	-18	-18
-4	-56	10
-4	-54	38
-6	26	34
12	-28	66

// Sripada C S, 2009: Social Anxiety Disorder Patients
// Subjects=26
0	-82	-2
48	-76	-8
42	-48	-24
-46	-78	-4
-16	-14	-12
52	-14	24
-24	-86	12
10	50	22
-12	-84	28
48	6	16
52	14	22
-8	18	74
-62	-52	32
44	44	32

// Sripada C S, 2009: Healthy Controls
// Subjects=26
0	-80	0
-46	-80	-6
46	-80	-4
50	26	28
48	-70	8
-14	10	-8
-64	-2	20
-24	-86	12
8	52	24
52	-14	24
-24	-86	12
10	50	22
-12	-84	28
48	6	16
52	14	22
-8	18	74
-62	-52	32
44	44	32

// Summerfield J J, 2009: Brain Regions Activated By All Conditions
// Summerfield J J, 2009: Recall of Real Autobiographical Events > Recall of 
// Imagined Autobiographical Events
// Summerfield J J, 2009: Recall of Autobiographical Events > Recall of Film 
// and News Events
// Summerfield J J, 2009: Recall of Previously Viewed Events > Recall of 
// Previously Imagined Events
// Summerfield J J, 2009: Recall of Film Events > Recall of News Events
// Subjects=18
-9	63	24
0	48	-12
-3	18	-15
-3	6	69
-21	39	48
-36	6	57
-54	21	15
-51	30	0
57	30	9
-15	-15	9
45	15	-33
-57	-3	-21
-51	-42	-3
48	-36	-3
18	-30	-9
-24	-36	-15
30	-36	-18
-3	-54	36
-6	-42	39
12	-54	30
-9	-54	3
-12	-60	12
21	-60	21
-48	-69	30
42	-63	27
0	-69	-3
6	-87	-18
9	-48	-48
-27	-81	-36
27	-84	-33
-9	42	-9
3	33	-3
-21	24	45
39	12	0
30	-33	54
-3	-12	30
12	-66	27
-48	-66	33
42	-72	36
-21	-36	-42
-18	-51	-30
27	-51	-33
-12	54	33
-27	51	27
-18	39	33
-33	36	-12
-6	33	-12
6	33	24
3	18	24
-24	6	60
-51	9	33
-36	-24	39
18	6	21
-9	-15	12
6	-30	36
-6	-54	6
-9	-72	54
-39	-81	27
-6	-96	0
18	-84	-36
-3	-3	63
-3	18	-6
48	-9	54
60	3	-18
-9	-45	0
9	-51	6
3	-51	45
-15	-57	18
-9	-96	6
0	54	27
3	45	-21
48	12	-33
60	-9	-18
48	-33	-6
-57	-60	30
57	-57	24
0	-60	42

// Watson A, 2009: Not Informed Low Intensity (Conditioning-Preconditioning) - 
// Informed (Conditioning-Preconditioning)
// Watson A, 2009: Not Informed (Post Conditioning - Preconditioning) - 
// Informed (Post Conditioning - Preconditioning)
// Subjects=11
4	-22	42
-6	32	24
-26	52	18
-6	44	34
-2	-32	32
-20	-62	2
-8	-48	16
-8	-58	36
12	38	-12
-24	52	18
-6	44	34
-8	42	-10
-6	32	24
-10	40	-12

// Welander-Vatn A S, 2009: Bipolar II Disorder
// Subjects=27
12	0	58
28	-66	44
-10	-76	-26
38	-66	-22
22	2	0
10	-104	8
-34	-58	58
40	16	0
-38	22	-2
-56	2	40
50	14	18
8	-76	-20
-26	6	-8

// Welander-Vatn A S, 2009: Healthy Controls
// Subjects=28
-4	6	50
-48	-68	-8
-26	-64	50
-24	2	-2
12	-98	8
46	4	22
46	-52	50
-50	-2	52
4	-30	-14
44	38	22
-22	-92	18
10	-100	8

// Baglio F, 2009: Healthy Controls
// Subjects=11
-26.25	-21.1	53.98
-50.13	-13.3	46.89
-39.26	-17.1	51.56
18.26	-62.45	-23.37
-41.98	-78.23	-5.1
-46.53	-58.01	-18.22
1.73	0.06	49.17
-.24	2.57	64.64
28.94	-.52	64.45
47.46	-25.56	71.09
31.48	-84.56	-7.96
37.4	82	-17.82
42.14	-54.95	-13.31
-21.78	-59.37	57.69
53.57	-26.11	41.91
10.18	-82.35	16.84
70.59	-30.26	19.62
-11.82	-19.65	-.2
-59.01	9.03	33.63
63.97	12.47	17.74
55.42	-78.77	6.75
-59.6	6.8	-13.21
-48.41	-84.43	-2.13
-44.36	-66.72	-19.64
58.12	-39.74	56.63
-21.9	-58.08	48.6
39	-82.61	-10.52
47.45	-23.43	70.88
-19.58	-61.29	60.08
-28.13	-34.34	73.25
43.88	-4.49	-36.27
9.68	10.2	-3.52
-28.46	-23.65	49.79
40.99	-27.71	71.42
-48.41	-84.43	-2.13
-5.23	-16.67	8.36
7.48	-18.49	-11.85
-59	-43.48	23.13
5.58	3.13	12.94
-31.58	32.63	-14

// Baglio F, 2009: Parkinson's Disease Patients
// Subjects=15
-54.94	-14.72	9.01
-13.45	-68.22	31.53
-34.93	-12.62	53.29
-7.6	-13.88	-7.57
-28.78	-96.08	9.89
11.84	-13.81	-7.9
16.74	-29.2	33.88
22.98	41.23	29.04
-52.29	-13.31	46.93
42.95	-66.36	48.31
51.03	14.76	19.98
48.79	42.61	19.5
6.01	26.02	51.01
-33.06	-88.13	14.78
37.18	-87.78	14.67
47.45	-23.43	70.88
-19.58	-61.29	60.08
-28.13	-34.34	73.25
43.88	-4.49	-36.27
9.68	10.2	-3.52
-28.46	-23.65	49.79
40.99	-27.71	71.42
-48.41	-84.43	-2.13
-5.23	-16.67	8.36
7.48	-18.49	-11.85
-59	-43.48	23.13
5.58	3.13	12.94
-31.58	32.63	-14

// Bennett D S, 2009: Prenatal Tobacco Exposed Subjects
// Subjects=7
-8	26	54
-38	22	49
4	26	52
14	54	36
-30	42	26
-34	57	19
14	13	58
36	5	53
30	39	40
44	10	36
51	0	42
-55	-22	-6
-59	-18	-14
50	-49	-16
20	-54	45
-4	-74	26
-16	-96	23
8	-88	34
-10	-96	25
10	-13	4
6	-41	-6
-6	-51	-3
0	-64	0
-8	-29	-7
-2	-72	-3
-44	18	47
-10	60	28
-12	63	19
-32	18	43
-36	17	25
-54	-59	26
32	-57	27
-53	-59	25
32	-57	30
-50	-51	-15
-50	-51	-13
32	-57	25
-36	-73	46
-40	-74	35
10	-51	34
20	-78	28
20	-78	32

// Bennett D S, 2009: Non-Exposed Subjects
// Subjects=11
2	8	53
0	20	47
18	11	57
18	-5	61
2	8	38
32	-43	63
50	-40	54
-32	-69	-23
6	-41	-6
-6	-51	-3
0	-64	0
-8	-29	-7
-2	-72	-3
-44	18	47
-10	60	28
-12	63	19
-32	18	43
-36	17	25
-54	-59	26
32	-57	27
-53	-59	25
32	-57	30
-50	-51	-15
-50	-51	-13
32	-57	25
-36	-73	46
-40	-74	35
10	-51	34
20	-78	28
20	-78	32

// Lau J Y F, 2009: Fearful Faces > Passive Viewing
// Subjects=31
26	2	-16
22	16	56
26	30	48
-16	-4	-10
36	-68	-22
-6	42	42
4	-20	-14

// Dichter G S, 2009: Healthy Controls
// Subjects=15
6	-76	10
18	-2	66
2	-8	56
-6	52	-4
2	54	22
20	10	18
-44	34	4
48	20	81
-30	34	30
-44	22	38
48	77	55
16	-32	8
-40	-60	-8
38	-66	-10
32	28	-18
-42	40	8
45	97	38
18	-12	24
34	14	8
-40	-8	64
34	40	32
-8	50	20
-42	38	30
0	-56	22
-18	-32	2

// Dichter G S, 2009: Unipolar Major Depressive Disorder Patients
// Subjects=14
6	-76	6
16	20	-2
-18	-18	74
4	22	44
-12	18	2
48	14	30
14	-2	66
-36	22	-14
-44	22	38
48	77	55
16	-32	8
-40	-60	-8
38	-66	-10
32	28	-18
-42	40	8
45	97	38
18	-12	24
34	14	8
-40	-8	64
34	40	32
-8	50	20
-42	38	30
0	-56	22
-18	-32	2
32	63	25

// Glascher J, 2009: Conjunction of Vchosen for Action Response and Stimulus 
// Response
// Glascher J, 2009: Action Response Vchosen > Stimulus Response Vchosen
// Glascher J, 2009: Conjunction of Prediction Error for Action Response and 
// Stimulus Response
// Glascher J, 2009: Action Response Prediction Error > Stimulus Response 
// Prediction Error
// Glascher J, 2009: Conjunction of Action Response Switch > Stay and Stimulus 
// Response Switch > Stay
// Glascher J, 2009: Conjunction of Action Response Stay > Switch and Stimulus 
// Response Stay > Switch
// Glascher J, 2009: (Action Response Switch > Stay) - (Stimulus Response 
// Switch > Stay)
// Subjects=20
-6	24	-21
6	30	-9
9	27	-12
3	54	-3
-27	-18	-18
24	-9	-18
9	-30	51
-3	-9	51
3	-6	51
-36	-60	24
-21	-63	-18
21	-66	-18
-51	-18	54
51	-15	54
-57	-3	-15
63	-15	3
-57	-30	39
63	-30	48
-6	6	45
12	6	36
-18	-6	57
0	3	57
-33	-6	42
48	-3	39
-42	-21	42
-39	-15	15
57	3	12
-15	3	-15
9	9	-12
-24	6	6
24	3	15
30	-6	9
0	33	-12
3	36	21
-42	33	-9
-18	3	-15
18	6	-15
57	-33	33
27	27	-3
24	48	-6
-33	48	21
36	45	30
-3	39	-12
3	-15	42
-33	-30	45

// Hooley J M, 2009: Healthy Controls
// Subjects=12
-18	-2	4
-36	-84	0
46	20	42
-18	-82	16
-22	-50	-12
-14	-66	-8
4	-76	22
24	-46	-6
56	-52	30
-38	12	-2
48	-64	42
12	-62	4
0	50	-6
-4	-60	4
58	16	24
-34	8	-28
-42	-4	6
50	56	14
42	-4	-16
46	22	-6
-52	-24	6
62	-2	-10
16	-80	-44
2	58	18
-18	-78	-30
-16	-48	-10
-52	28	-12
0	-14	0
-2	-50	2
-50	-28	2
6	-78	20
60	-4	-8
26	-84	-36
-26	-80	-34
0	58	8
-58	-20	-4
62	-12	-10
2	-78	-14
-26	-82	-36
-2	-60	8

// Hooley J M, 2009: Recovered Depressed Patients
// Subjects=11
-18	-2	4
-36	-84	0
46	20	42
-18	-82	16
-22	-50	-12
-14	-66	-8
4	-76	22
24	-46	-6
56	-52	30
-38	12	-2
48	-64	42
12	-62	4
0	50	-6
-4	-60	4
58	16	24
-34	8	-28
-42	-4	6
50	56	14
42	-4	-16
46	22	-6
-64	-26	-2
46	14	-46
26	-86	-38
4	-60	-46
-22	-74	-38
62	-24	-12
-64	-26	-2
6	-4	2
-26	-18	-18
4	-72	-20
4	-32	-6
-62	-28	-2
64	-18	-14
54	18	18

// Matthews S C, 2009: Errors - Correct Responses, Healthy Controls > Major 
// Depressive Disorder Patients
// Matthews S C, 2009: Hard - Easy Trials, Major Depressive Disorder Patients 
// > Healthy Controls
// Subjects=15
32.06	29.79	5.33
-12.82	27.41	6.05
-6.33	43.62	22.46
1.97	34.5	-13.67

// Remijnse P L, 2009: Major Depressive Disorder Patients
// Subjects=20
39	15	-30
-36	-15	48
30	-90	15
-27	15	0
12	33	-12
39	15	-30
-27	-87	0
24	0	12
-39	21	3
18	-69	51
-33	18	3
36	-93	3
39	-72	39
-21	-42	54
39	15	-24
-48	15	-18
-21	-45	54
-33	24	9
-18	51	0
45	42	6
33	21	6
-33	48	-6
-24	57	9
48	3	18
-3	36	18
-48	-33	36
9	-15	6

// Remijnse P L, 2009: Obsessive Compulsive Disorder Patients
// Subjects=20
12	33	-12
39	15	-30
-27	-87	0
24	0	12
-33	18	3
39	15	-24
-48	15	-18
-21	-45	54
-33	24	9
-18	51	0
45	42	6

// Remijnse P L, 2009: Healthy Controls
// Subjects=27
39	15	-30
-36	-15	48
30	-90	15
-27	15	0
-39	21	3
18	-69	51
36	-93	3
39	-72	39
-21	-42	54
33	21	6
-33	48	-6
-24	57	9
48	3	18
-3	36	18
-48	-33	36
9	-15	6

// Valentin V V, 2009: Average Prediction Errors, (Juice - Neutral Solution) 
// and (Money - Scrambled Money)
// Valentin V V, 2009: Conjunction Prediction Errors, (Juice - Neutral 
// Solution) and (Money - Scrambled Money)
// Valentin V V, 2009: (Money - Scrambled Money) - (Juice - Neutral Solution), 
// Prediction Errors
// Valentin V V, 2009: Juice > Money, Prediction Errors
// Subjects=17
-9	3	15
15	12	-6
-9	0	6
15	9	-6
-39	-66	-3

// Smoski M, 2009: Selection Phase > Control Wheel, Depressed Patients > 
// Healthy Controls
// Smoski M, 2009: Selection Phase > Control Wheel, Healthy Controls > 
// Depressed Patients
// Smoski M, 2009: Anticipation Phase > Control Wheel, Depressed Patients > 
// Healthy Controls
// Smoski M, 2009: Anticipation Phase > Control Wheel, Healthy Controls > 
// Depressed Patients
// Smoski M, 2009: Feedback > Control Wheel, Depressed Patients > Healthy 
// Controls, Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Healthy Controls > Depressed 
// Patients, Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Depressed Patients > Healthy 
// Controls, Non-Winning Trials
// Smoski M, 2009: Feedback > Control Wheel, Healthy Controls > Depressed 
// Patients, Non-Winning Trials
// Subjects=14
48	-10	8
8	-86	26
-34	36	20
24	24	52
26	30	-16
22	48	-20
-16	34	-12
22	-6	-28
56	-72	-8
-4	-62	4
52	-72	14
-40	-64	6
14	-70	56
-14	-72	58
8	-90	14
-8	-90	30
-38	-12	-22
44	-36	32
64	-18	8
6	-50	76
6	-28	80
8	-50	58
-16	-50	54
-50	-28	34
50	-42	44
-44	-24	-14
48	-56	-6
-46	-56	-10
44	-22	-32
-60	-8	0
-52	-54	28
-8	6	6
-48	26	38
-18	26	60
-14	44	48
0	48	2
52	-2	52
-62	-52	38
-70	-14	-22
-52	-28	24
-18	-16	22
-16	36	14
10	-44	12
-10	-30	-38
-28	24	26
34	12	30
-32	12	52
-34	34	12
-34	-26	-14
-10	-76	-4
22	-74	36
-32	-66	46
-34	-80	22
-32	-70	-2
42	-22	48
24	-10	72
-40	-4	54
16	-66	42
-22	-54	22
-2	12	2
-58	-28	-22
-70	-22	-20
-54	14	-34
18	-22	14
-12	-10	14
48	-58	20
6	-88	24
58	14	22
30	-76	2
8	-56	18
-30	10	-24
18	-30	-4
-22	-30	0
-2	-88	42
44	22	42
-18	-66	-8
24	-70	32
-30	-72	34
60	14	22
52	34	22
-24	22	-24
24	2	-18
-16	2	20
-42	-16	12
-6	-34	18
-30	12	16
-16	38	-20
52	-20	6
-28	-18	-18
-32	12	-8
-10	-74	2
-30	-72	6
-34	-72	20
-24	-48	48
36	-36	14
-2	-42	66
20	-56	8
26	-2	-4
-6	6	-12
56	-20	-6
-54	8	-32
18	-18	16

// Werner N S, 2009: Depressed Patients > Healthy Controls, Encoding
// Werner N S, 2009: Healthy Controls > Depressed Patients, Encoding
// Werner N S, 2009: Depressed Patients > Healthy Controls, Retrieval
// Werner N S, 2009: Healthy Controls > Depressed Patients, Retrieval
// Subjects=11
0.42	11.96	52.91
1.38	24.06	44.08
-22.41	-17.38	-7.93
38.53	-45.36	-17.43
40.74	-62.1	-13.83
-42.61	-61.54	-12.92
19.48	-90.77	-11.18
38.65	-74.8	-12.74
-39.34	-78.44	-11.54
1.07	-68.1	-32.94
-14.69	-96.18	-9.22
1.09	-61.33	-27.93
31.23	-88.5	-10.39
-25.38	-94.13	-9.26
1.07	54.95	16.96
0.93	54.55	-1.96
-39.48	-12.82	-2.54
1.05	38.23	7.21
1.01	44.41	4.46
2.5	-1.74	40.66
1.21	26.74	23.79
20.36	-37.73	-13.41
44.79	2.6	-17.07
3.51	-50.66	13.52
0.3	-38.71	17.02
2.58	-15.23	45.13
7.72	-11.8	20.25
2.6	-29.24	42.96
1.46	-48.67	25.65
0.64	-64.77	51.54
1.53	-65.59	27.07
1.54	-80.82	22.77
3.49	-66.24	4.79
-11.55	-74.93	-9.92
0.4	15.13	52.65
29.08	-88.69	-12.58
-1.06	35.22	9.72
-1.21	51.2	-3.89
47.54	-9.71	57.54
-.34	-36.37	74.82
1.61	-25.13	54.9
1.79	-60.65	63.45
0.72	-46.4	68.96

// Cooper J C, 2009: UNC-Only, High Gain > UNC-Only, Low Gain
// Cooper J C, 2009: UNC-Only, High Loss > UNC-Only, Low Loss
// Cooper J C, 2009: UNC-Only, High Gain > UNC-Only, High Loss
// Cooper J C, 2009: CERT/UNC, UNC High Gain > CERT/UNC, UNC Low Gain
// Cooper J C, 2009: CERT/UNC, UNC High Loss > CERT/UNC, UNC Low Loss
// Cooper J C, 2009: CERT/UNC, UNC High Gain >CERT/UNC, UNC High Loss
// Cooper J C, 2009: CERT/UNC, UNC High Loss >CERT/UNC, UNC High Gain
// Cooper J C, 2009: UNC-Only, High Gain > CERT/UNC, UNC High Gain
// Cooper J C, 2009: CERT/UNC, UNC High Gain > UNC-Only, High Gain
// Subjects=12
6	20	30
2	6	48
4	-26	38
-40	-30	66
-8	12	-2
-40	26	0
-30	28	-6
8	-64	26
-40	8	14
-6	-44	18
38	12	-6
-24	44	34
-40	-14	52
8	40	-14
10	-16	10
-28	46	26
-38	2	58
-34	50	14
-18	16	8
-2	-36	60
-30	-44	70
8	-76	48
-4	54	-8
-8	-18	28
14	-10	24
18	-70	38
56	8	-10
14	-38	52
12	10	44
-4	8	50
-6	-20	48
-16	6	4
-34	-44	66
38	-50	20
6	44	10
-4	-10	56
-4	4	66
-58	12	6
28	-58	6
24	-4	8
10	-66	24
-24	-16	54
44	-50	-4
-26	-20	-2
10	6	10
30	34	18
-10	-10	38
14	14	-12
-40	-10	60
-34	-38	66
-32	38	40
52	-8	54
-14	-84	32
-4	14	-14
42	2	52
-28	2	48
14	-48	-4
-44	-50	20
4	-84	32
-4	-8	16
58	-28	30
-16	-54	-2
34	22	2
26	-72	24
30	36	-6
-16	-68	28
36	-4	-22
-10	-38	6
-38	-16	52
34	4	60
50	-36	0
-30	-76	28
12	-20	0
-16	-14	22
-34	2	-8
-2	8	36
22	-52	8
14	2	-2
-46	10	54
4	-34	42
-8	-24	-8
-42	44	0
-28	-70	56
-38	6	40
6	-72	44
-38	-62	56
6	-76	34
12	10	-4
-20	0	6
-10	42	12
-6	-4	60
-2	36	-18
34	-8	-26
24	-20	62
-30	-68	52
-32	28	14
54	30	22
-54	16	26
28	52	18
54	2	-22
30	32	-8

// Bach D R, 2009: Noisy, Ambiguity > Clear, Risk
// Bach D R, 2009: Noisy, Ambiguity > Noisy, Ignorance
// Bach D R, 2009: Conjunction:  (Noisy, Ambiguity > Clear, Risk) & (Noisy, 
// Ambiguity > Noisy, Ignorance)
// Bach D R, 2009: Risky Cues as Opposed to Ignorance Cues
// Subjects=20
32	-56	-8
30	-68	-10
44	-54	-4
-44	-58	0
-52	-60	2
-28	-68	-10
-30	-82	-8
32	-46	-14
10	-88	6
-34	-82	20
-28	-76	38
28	-70	-14
38	-52	-14
30	-56	-8
-28	-68	-10
-20	-74	-12
-26	-80	-8
8	-86	2
-10	-94	2

// Blasi G, 2009: Schizophrenia Patients
// Subjects=12
45	34	16
45	26	26
-4	14	38
-53	15	9
45	23	9
-11	-5	-16
-27	14	-17
45	15	-1
41	32	-18
-11	-5	-16
-11	-3	-16
41	32	-17
41	32	-17
45	22	-14

// Blasi G, 2009: Healthy Controls
// Subjects=12
45	34	16
45	26	26
-4	14	38
-53	15	9
45	23	9
-11	-5	-16
-27	14	-17
45	15	-1
41	32	-18
-11	-5	-16
-11	-3	-16
41	32	-17
41	32	-17
45	22	-14
48	-15	4

// Chae Y, 2009: Verum Acupuncture vs. Covert Placebo
// Chae Y, 2009: Covert Placebo vs. Overt Placebo
// Chae Y, 2009: Vernum Acupuncture vs. Overt Placebo
// Subjects=10
-34	32	21
28	-62	33
26	-15	49
-28	-25	-2
20	0	39
20	13	34
-51	-51	30
-50	-53	19
-46	1	-14
-4	12	49
28	38	26
4	-9	19
36	-12	39
26	-61	27
14	-6	35
-14	6	40
40	-35	4
44	-62	-5
18	18	41
36	-30	18

// Chan S W, 2009: High Neuroticism Score > Low Neuroticism Score, Medium 
// Fearful Face vs. Medium Happy Face
// Chan S W, 2009: High Neuroticism Score > Low Neuroticism Score, Positive 
// Correlation with Fearful Faces
// Subjects=12
0	-64	-26
-30	58	2
-18	-66	60
4	-48	68
26	-66	-14
-56	-32	0

// Chikazoe J, 2009: No-Go vs. Frequent-Go
// Chikazoe J, 2009: No-Go vs. Infrequent-Go
// Chikazoe J, 2009: Infrequent-Go vs. Frequent-Go
// Subjects=25
26	-4	62
42	42	18
48	4	38
40	18	-2
50	10	26
-52	8	20
42	-2	56
32	46	0
40	56	6
56	16	16
-22	-4	58
32	58	-2
-30	58	14
-26	56	24
44	32	32
30	22	-6
-36	-6	58
-40	38	22
-52	6	38
32	18	12
-8	2	58
-2	-4	64
6	10	60
10	20	56
8	0	60
6	30	36
36	-44	42
24	-68	48
66	-14	32
64	-38	28
14	-68	54
-24	-66	48
-20	-62	60
56	-42	48
16	-68	64
40	-62	56
-48	-36	40
-42	-48	52
30	-68	30
52	-22	-2
66	-32	20
52	-46	14
-30	-58	-30
-32	-62	-16
-36	-50	-34
-14	-64	-32
24	4	0
-30	16	8
-18	12	10
18	10	6
-26	2	4
-32	26	-2
42	16	-2
36	40	20
24	-4	62
-24	-4	58
30	24	-6
58	14	16
44	0	56
-50	10	18
38	56	10
-50	6	4
48	10	26
60	10	28
-58	12	10
44	2	44
-46	14	-8
6	-12	32
2	2	50
2	30	36
4	34	26
4	-28	32
12	-32	44
-4	6	36
2	0	62
-6	-6	64
0	12	44
10	16	60
54	-42	48
44	-46	46
38	-56	48
62	-44	36
64	-28	28
12	-70	52
32	-64	50
-14	-66	54
-22	-60	64
-48	-32	40
30	-68	38
62	-40	24
52	-26	0
-60	-34	22
58	-50	-2
60	-18	-2
28	-54	-32
-30	-62	-28
-20	2	-4
22	6	-6
-14	4	12
32	12	-10
-24	10	4
26	0	4
16	4	12
-30	16	-4
32	52	-2
30	52	14
26	-4	64
-50	10	34
42	-4	40
52	0	40
-50	6	46
-4	12	60
-24	-68	46
22	-64	46
28	-74	22
-32	-64	-14
-36	-54	-22

// De Ruiter M B, 2009: Problem Gamblers
// Subjects=19
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	42	6
27	-78	36
39	42	3
-30	-66	-30
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
3	-42	-15
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21

// De Ruiter M B, 2009: Smokers
// Subjects=18
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	24	6
54	21	39
27	21	48
12	-18	60
-30	-33	51
33	-57	57
36	42	6
48	3	21
36	39	9
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21
30	-48	39

// De Ruiter M B, 2009: Healthy Controls
// Subjects=19
45	39	3
51	9	18
51	-36	54
30	-90	-6
-3	12	6
3	12	6
-3	-15	-6
33	21	9
48	15	6
-3	-15	-6
39	54	3
36	18	-3
48	12	15
39	36	30
21	9	66
9	36	33
-42	-45	39
48	-42	45
-3	-18	-6
33	42	6
27	-78	36
33	24	6
54	21	39
27	21	48
12	-18	60
-30	-33	51
33	-57	57
39	42	3
36	42	6
48	3	21
-30	-66	-30
36	39	9
33	30	-3
54	21	15
-39	33	36
45	36	30
-6	21	48
-12	-63	60
9	-63	51
-39	-45	45
45	-39	45
-9	15	6
18	18	6
3	-42	-15
-42	33	33
39	42	30
0	30	42
-9	-63	57
9	-54	54
-54	-45	48
48	-57	48
-18	3	15
18	6	21
30	-48	39

// Hsu M, 2009: Regions Significantly Correlated with Probability (p) Term
// Hsu M, 2009: Regions Significantly Correlated with Nonlinear Deviation Term
// Subjects=21
-12	15	60
-15	9	48
-12	-3	-6
30	-51	-27
-9	57	24
12	0	-3
30	-87	-9
6	24	-12
-15	-48	24
-24	-48	27
-9	-75	-24
-9	-66	-27
-42	9	21
51	18	24
18	21	18
27	24	18
21	-45	15
18	-48	24
-18	-6	3
-24	-6	12
-27	3	9
-33	9	-9
-9	9	-3
-21	18	-12
-18	18	-3
33	3	24
15	24	30
27	18	30
3	-3	0
0	-6	-9
0	-15	-3
18	-21	39
-18	-72	-33
-12	12	21
24	-9	18
-30	-9	39
-30	6	39
-15	-3	48
-24	27	48
-18	36	48

// Li C S, 2009: Alcohol Dependence > Healthy Controls, During Stop Error > 
// Stop Success
// Li C S, 2009: Healthy Controls > Alcohol Dependence, Risk-Taking Decisions
// Subjects=24
-56	-72	12
20	-64	36
12	28	56
-4	28	60
36	-84	20
-36	12	44
40	12	44
44	4	20
-12	36	20
-28	44	32
28	-84	-12
52	-52	4
-20	-76	28
-8	-28	32
12	-40	72
40	-60	0
32	40	24
24	12	-12
40	-8	-16
28	36	-12
44	-12	64
4	-88	4
-52	-52	-20
-52	-24	44
68	-20	12
-28	24	-12
-44	-16	60
32	-68	36
-4	16	40

// Li C S, 2009: Increased Reaction Time vs. Decreased Reaction Time, Go-Trial
// Subjects=33
28	-96	-8
-28	-100	-8
-52	16	40
-20	20	48
-4	-44	44
-32	-72	48
-40	-60	40
-60	-48	-12
56	0	-32
56	-8	-16
16	-84	-36
44	-64	-44
48	-72	40
-12	-32	-32
36	36	-16
-56	-24	-28
48	20	48
24	32	48
32	-16	16
0	-8	36

// Mak A K Y, 2009: Males
// Subjects=12
-8	48	24
-40	28	-4
-16	52	32
4	40	4
-36	-4	16
-4	44	36
-40	24	-12
-36	-12	-20

// Mak A K Y, 2009: Females
// Subjects=12
-8	48	24
-16	20	-16
-4	44	36
-36	-12	-20

// Mandzia J, 2009: Healthy Controls > Mild Cognitive Impairment, Encoding 
// Tasks
// Mandzia J, 2009: Healthy Controls > Mild Cognitive Impairment, Deep 
// Retrieval
// Mandzia J, 2009: Mild Cognitive Impairment > Healthy Controls, Shallow 
// Retrieval
// Subjects=14
-44	5.44	-27.44
-27.87	5.51	-14.25
46.71	1.45	-45.99
1.49	28.51	60.44
-19.97	31.84	50.37
-48.22	17.02	-14.98
-35.45	36.22	-15.62
-15.57	-45.89	35.65
11.18	-48.65	38.92
0.5	-90.43	22.47
-11.68	23.7	13.04
29.82	8.94	-16.31
12.78	11.73	-6.31
-34.18	-24.22	-12.8
-54.21	11.41	36.86
-34.37	38.6	-12.49
-17.85	35.03	50.07
23.9	23.9	53.87
4.43	43.4	32.39
31.75	59.63	-21.7
52.37	30	6.2
-42.24	-80.74	27.72
15.24	-5.87	27.47
-11.44	-10	31.47
-20.07	-20.77	16.86
-17.19	4.43	-15.39
-22.28	-58.96	-8.9
-40.6	53.64	17.55
-11.41	22.12	47.74
22.85	-2.25	46.04
-18.1	-36.81	-11.92
-48.99	-67.83	-11.2
57.49	3.6	-32.91
48.15	18.51	9.44
48.06	34.03	3.68
51.72	-27.17	37.76
-30.49	-92.82	21.91
-17.73	-85.68	16.7
-1.15	-59.11	-40.36
27	-18.91	22.86

// Schmidt H, 2009: Males
// Subjects=25
26	12	54
-6	22	46
42	36	32
32	64	8
-34	22	-4
14	-68	52
-28	0	58
-48	-48	50

// Schmidt H, 2009: Females
// Subjects=21
34	4	56
-4	14	54
54	22	30
-56	20	32
-41	32	-8
44	-54	58

// Tricomi E, 2009: Normals, 1-Day Group
// Subjects=16
-12	3	-3
12	3	69
-33	-6	51
39	0	51
6	12	51
-45	-36	39
-45	-3	36
-27	-75	30
6	3	27
3	-24	24
63	-45	15
54	12	9
12	3	6
-27	30	3
24	24	-3
9	-9	-6
45	-54	-18
-30	9	-24
0	-57	-36
-42	-84	30
36	-24	21
45	-84	21
-12	-51	12
-3	-27	-9
-54	-6	-18
-3	45	-18

// Tricomi E, 2009: Normals, 3-Day Group
// Subjects=15
33	-24	0
-66	-45	24
33	-24	0
60	-36	-6
-45	-15	-15
12	15	48
-12	-24	39
42	6	36
12	15	48
9	-24	27
63	-18	27
-63	-18	21
-63	-42	18
-36	-84	6
-27	-24	0
12	-24	-3
-6	6	-6
42	-45	-18
-42	-84	30
36	-24	21
45	-84	21
-12	-51	12
-3	-27	-9
-54	-6	-18
-3	45	-18

// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts- Vhand
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Veye
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Vchosen
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Vunchosen - Vchosen
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Hand Bias
// Wunderlich K, 2009: Location of Significant Correlation with Parametric 
// Contrasts - Eye Bias
// Subjects=23
-21	-90	-18
57	-54	-9
-30	-24	75
39	-78	39
27	15	-3
-39	-36	69
21	-48	60
36	-21	39
-15	-36	45
-48	-15	51
-60	-9	-6
-54	-30	3
-27	24	0
36	24	6
-33	-54	42
-48	12	36
-39	-21	51
21	-45	-30
6	21	66
-39	-66	-39
66	-27	-21
21	-39	60
-39	-66	57
48	-51	54
30	15	45
33	-27	69
-12	-42	30
45	-72	-33
12	-72	12
-27	12	0
24	-42	45

// Yang T T, 2009: Stop - Go, Depressed Adolescents > Healthy Adolescents
// Yang T T, 2009: Stop - Go, Depressed Adolescents < Healthy Adolescents
// Subjects=13
-11.71	37.64	-13.11
0.4	56.34	-.77
-1.05	-73.57	8.03

// Ye Z, 2009: Effects of Plausibility in Sentence Comprehension
// Ye Z, 2009: Effects of Syntax in Sentence Comprehension
// Ye Z, 2009: Effects of Interaction in Sentence Comprehension
// Ye Z, 2009: Effects of Congruency in Stroop Task
// Ye Z, 2009: Effects of Congruency in Flanker Task
// Ye Z, 2009: Plausibility, Stroop Congruency and Flanker Congruency
// Ye Z, 2009: Plausibility, and Stroop Congruency
// Ye Z, 2009: Plausibility vs. Stroop Congruency and Flanker Congruency
// Subjects=19
-6	46	32
-40	22	24
-52	32	-4
-44	-60	30
-12	8	60
-54	22	14
-32	30	-4
34	-88	-10
22	-50	-4
-30	-92	-12
-24	-96	-8
36	-94	-6
0	16	50
-38	28	0
-44	14	22
-40	-46	52
-40	-86	-6
-42	-56	-32
-50	-54	-20
40	22	8
32	30	-14
50	14	2
38	-86	-6
34	-86	4
44	-50	-28
54	-50	-22
-38	-42	46
-46	-58	-10
-44	-68	-8
54	-64	-12
42	-86	-2
28	-56	-32
8	34	42
-44	20	28
-36	26	-14
-32	16	8
-44	-46	46
56	26	14
-8	28	42
10	32	44
-38	22	26
-46	-48	44
-58	-30	-18
46	24	28
40	36	-10
38	-52	28
-8	56	18
-40	-60	28

// van Broeckhoven P C A, 2009: No-Step vs. Dot
// van Broeckhoven P C A, 2009: Random-Step vs. Dot
// Subjects=17
-14	-76	-2
-42	36	-14
-48	-10	42
52	-6	38
20	4	4
42	-64	10
58	-50	38
32	-64	56
-20	16	4
-26	-6	8
50	40	-14
62	-42	10
40	-10	48
18	-44	0
-34	-58	60
12	-16	0
-24	-74	24
22	-84	52
46	-36	34
-56	-8	-28
-50	4	-2
32	-80	10
10	-78	-12
-20	-64	60
68	-36	14
28	-62	54
-48	-2	40
26	6	6
56	-54	42
-64	-34	0
60	-6	46
-30	-4	42
48	-42	30
20	-28	-4
36	-6	-14
50	12	2
-14	4	12
-60	-32	-10
50	2	16
-24	-2	6

// Christopoulos G I, 2009: Normals (Point Gamble)
// Subjects=13
8	30	34
48	32	14

// Hare T, 2009: Food Decision > Taste Rating
// Hare T, 2009: Successful Self-Control Trials:  Successful Self-Controllers 
// > Non-Self-Controllers
// Hare T, 2009: Task Related Functional Connectivity with the Left IFG/BA9
// Hare T, 2009: Positive Task Related Functional Connectivity with the Left 
// IFG/BA46 Region
// Subjects=18
3	51	3
-3	45	6
3	36	-12
-30	42	18
-3	39	21
27	-27	66
60	-36	18
-48	-12	48
12	-18	42
-60	-33	21
-21	-3	-3
-12	-42	60
-21	-21	66
18	0	0
42	-12	45
-27	-60	51
54	30	30
42	-48	-30
9	-90	-3
-45	42	12
-3	-42	-15
-42	-51	-24
3	-54	-33
9	-84	-24
-12	-27	-15
33	-78	-21
-3	24	45
33	-66	45
-54	15	36
-9	-96	-3
-9	-63	6
-3	-27	33
-48	-69	-6
-3	48	12
12	51	0

// Lawrence N S, 2009: Decision Making per SE
// Lawrence N S, 2009: Choices from Risky vs Safe Decks
// Lawrence N S, 2009: Positive Correlation with Score
// Lawrence N S, 2009: Decreases in Activation Over Time (Linear)
// Lawrence N S, 2009: Significant Activation in Response to Wins vs Losses 
// (All Decks)
// Subjects=15
10.57	39.47	-12.03
7.43	23.82	-7.07
-2.39	39.42	-11.81
-66.57	-5.24	30.68
-66.71	-2.98	20.38
-30.82	-96.32	18.92
-2.21	47.36	4.21
4.27	47.39	4.1
-2.37	56	-6.72
-8.63	54.34	10.35
-51.03	22.68	-16.05
-28.47	21.82	-26.43
-37.96	7.08	-11.36
-31.59	12.86	-18.77
56.11	21.11	-4.27
39.86	30.62	-4.93
-2.26	73.2	5.02
4.22	73.22	4.91
7.38	72.61	-1.81
0.71	64.65	-17.72
-1.58	29.08	49.71
-4.65	17.24	61.02
-4.6	27.43	66.74
-57.14	-7.39	7.2
-44.55	22.7	-16.16
-38	16.65	-12.31
-28.3	23.07	-13.11
-44.44	16.94	-8.87
-1.58	29.08	49.71
27.46	-47.32	23.16
4.54	-9.74	13.11
39.61	-82.85	-47.49
-21.19	-18.15	27.83
-18.32	21.78	7.02
13.51	-48.15	-53.84
-24.36	-47.19	27.39
30.67	-8.09	29.31
60.25	-34.52	54.95
-28.46	-70.01	-44.24
-20.85	27.07	63.69
20.4	33.75	-4.91
-27.12	-60.04	62.33

// Xue G, 2009: Foci of Regions Modulated by the Experienced Risk in the 
// Parametric Analysis
// Xue G, 2009: Foci of Regions Modulated by the Experienced Reward in the 
// Parametric Analysis
// Xue G, 2009: Risky Minus Safe Choices Across both Gain and Loss Domains
// Xue G, 2009: Win Minus Loss Domains Across both Risky and Safe Choices
// Xue G, 2009: Negative Correlation Between Individual Risk Preference 
// Activation in Risky vs Safe Contrast
// Xue G, 2009: Positive Correlation Between Individual Risk Preference and 
// Activation in Win vs Loss Contrast
// Subjects=13
4	48	26
2	52	30
4	50	12
-2	-2	4
54	-42	34
54	-50	46
0	58	-6
-34	56	-14
-2	42	8
0	-36	26
-20	12	-12
-16	6	-18
-52	-64	20
-30	-78	44
-26	32	48
-18	28	58
8	18	-4
6	40	38
4	52	28
6	50	48
-4	-2	2
2	-12	10
4	-90	-4
-10	-84	-38
-22	-78	-20
66	-32	-4
-2	40	8
0	48	-14
0	58	-4
-52	42	-4
-22	32	44
-16	54	34
-14	20	54
-20	12	-12
-10	16	-6
8	18	-4
20	12	-10
-44	-78	34
-46	-66	24
-18	-54	68
-46	-56	58
-76	32	44
32	-62	36
-6	-46	30
6	-46	68
4	58	18
-20	-68	40
2	-24	14
-28	-70	-10
-40	-74	6
-30	-86	6
16	-92	6
-52	-32	28
-14	50	-2
-46	-74	32
-40	-60	40
-44	-66	18
26	28	38
-56	-54	46
-50	-54	56

// Ghahremani D G, 2009: 1st Post-Reversal Trial vs 2nd Acquisition Trial, 
// Correct Responses Only
// Ghahremani D G, 2009: 2nd Acquisition Trial vs 1st Post-Reversal Trial, 
// Correct Responses Only
// Ghahremani D G, 2009: 1st Reversal Trial Errors vs 1st Acquisition Trial 
// Errors
// Ghahremani D G, 2009: 1st Acquisition Trial Errors vs 1st Reversal Trial 
// Errors
// Subjects=16
48	36	-18
50	-18	-12
54	-48	28
60	-44	2
46	2	-18
10	-56	22
24	-40	-20
30	-62	-22
28	-60	-30
50	34	-18
34	16	-20
44	30	-6
46	12	44
50	0	-34
8	8	14
-10	0	16
10	-14	10
-14	-28	10
20	-26	10
2	-12	-14
44	-52	34
14	-62	24
36	-42	-22
32	-86	2
56	-76	-6
36	70	-24
-46	-82	0
-50	-70	-30
-40	-88	-2
-56	-58	-28

// Mitchell D G V, 2009: Reward Differential x Block ANOVA
// Mitchell D G V, 2009: Reversal Errors vs. Correct Control Condition 
// Selections
// Subjects=16
-44.59	17.01	39.63
-26.74	53.38	12.95
9.99	22.59	51.91
-6.35	15.98	9.16
-28.3	5.5	68.28
34.89	-64.05	57.78
14.71	-69.49	71.85
-29.31	-67.49	46.54
16.11	11.89	9.25
7.93	22.21	60.89
-37.24	20.08	23.67
53.35	30.2	-4.98
-48.19	29.34	-7.09
-27.79	18.43	1.4
-22.87	-3.47	75.67
-6.62	20.82	-24.7
20.12	46.49	-11.54
65.22	-21.25	-10.84
59.13	-53.07	18.66
-1.81	-80.1	4.9
-35.18	-69.67	-22.36
4.33	-21.36	-6.79
22.67	-79.92	-8.78
-45.52	-58.47	27.01
33.79	-75.32	49.81
-5.3	9.22	4.14
18.23	8.47	6.16
35.51	-43.41	8.09
5.42	-65.11	-22.09

// Peters J, 2009: Positive Correlation with Subjective Value of Delayed 
// Reward, Delay Discounting
// Peters J, 2009: Positive Correlation with Subjective Value of Delayed 
// Reward, Delay > Probabilistic Discounting
// Peters J, 2009: Subjective Valuation during Probabilistic Discounting
// Peters J, 2009: Subjective Valuation during Probabilistic Discounting, 
// Probabilistic Discounting > Delay Discounting
// Peters J, 2009: Correlation between Subjective Value and both Delay 
// Discounting and Probabilistic Discounting
// Peters J, 2009: Correlation with Inverse Delay-to-Reward, Orthogonalized 
// with Respect to Subjective Value
// Peters J, 2009: Correlation with Reward Probability, Orthogonalized with 
// Respect to Subjective Value
// Peters J, 2009: Subjective Value Correlation Delay Discounting
// Peters J, 2009: Correlation with Inverse Delay-to-Reward
// Peters J, 2009: Correlation with Reward Probability
// Peters J, 2009: Correlation with Reward Magnitude, Delay Discounting
// Peters J, 2009: Correlation with Reward Magnitude, Probability Discounting
// Subjects=22
-58	-46	36
-54	-56	46
-50	-54	36
-8	4	-8
-18	-6	-12
54	-42	26
54	40	-4
48	36	-12
70	-36	2
66	-30	-2
58	-40	-2
12	46	6
28	16	-18
-2	-46	32
50	-22	-20
-8	52	16
-2	58	24
-34	32	12
-44	14	12
-52	14	8
36	30	-16
-18	16	12
-66	-30	-6
-64	-32	2
54	6	42
-58	-50	34
12	42	4
64	-42	28
54	-40	26
-10	54	16
-62	-14	-10
-4	-48	32
52	38	-6
42	-38	44
40	-46	42
-36	-52	46
-8	4	-8
-6	-20	10
6	-12	6
-48	-62	-10
-58	-48	-10
-52	-44	-14
0	-34	42
-4	-34	26
6	-20	32
44	8	26
36	4	30
52	10	18
-12	-96	-6
-16	-92	0
-24	-72	-8
-42	-2	30
-48	6	28
-50	6	42
46	36	10
42	30	20
56	-54	-10
48	-56	-10
46	-56	-20
-26	18	0
-18	60	4
-24	56	0
-4	38	-8
4	40	-2
22	-50	-24
-44	42	8
-40	36	14
-38	24	20
-12	-76	-24
26	34	-14
30	18	-6
24	24	-10
-22	34	-18
-14	40	-16
-20	26	-18
-6	-30	-8
10	-80	-26
-14	-38	-2
18	-18	14
12	-80	6
6	-80	18
0	-76	8
26	18	-16
38	-82	-4
54	30	18
4	-28	-16
28	18	44
6	28	-10
48	20	-18
-10	28	30
-26	10	-18
2	2	38
-16	-92	0
-4	-86	-6
42	-38	44
32	-48	44
32	-60	54
38	2	30
44	6	26
-48	-64	-10
-14	-38	-2
22	-56	-2
12	-70	10
16	-60	6
56	-54	-10
48	-56	-10
-26	18	0
-22	-72	50
-32	-76	34
-28	-84	32
24	-50	-26
-18	-56	12
-14	-54	4
8	-72	46
16	-96	8
14	-94	18
-42	-2	30
-20	-26	-2
2	-34	42
44	36	8
48	42	14
-22	-68	-2
44	-78	16
40	-72	20
48	-68	20
-8	28	32
-4	-30	10
-12	-18	12
40	-64	-12
-2	-78	6
-24	34	-18
-4	-74	44
-42	-50	48
-32	-54	48
-14	-64	22
-18	-80	16
-12	-64	54
-8	4	-8
26	18	-16
-50	-52	44
-4	34	-6
-20	38	0
-48	28	-8
44	32	40
52	-60	-14
54	-48	-16
-6	30	34
-4	20	54
6	22	48
44	42	22
52	34	26
44	-52	42
42	-42	50
54	-34	48
-6	-28	60
-12	-34	76
26	-64	42
34	-58	52
22	-56	40
56	-32	-18
-16	30	60
30	-34	52
28	-34	60
60	12	28
38	-12	-30
8	22	34
-22	-66	-34
-28	-60	-34
-46	-38	40
-42	-44	44
48	-16	58
-38	44	2
62	-20	42
20	28	56
32	16	56
20	-16	44
-46	10	-34
-64	-36	40
-58	-42	40
-60	-54	34
60	-40	42
-62	-54	0
52	30	-4
50	38	-16
46	-44	30
52	-56	24
56	-44	26
56	-36	-10
58	-28	-14
46	-6	-36
54	-12	-8
-60	-62	6
64	-22	-24
-34	16	28
24	-8	16
-18	-4	12
-48	26	-10
-50	38	-6
-46	4	46
-30	-18	8
-20	38	0
-58	-62	2
34	-50	18
-64	-30	-4
-64	-20	0
-20	16	10
-54	20	18
44	-50	60
34	-60	58
36	-86	0
-48	-62	-8
-40	-56	-12
-32	-58	-8
-44	-46	50
-36	-52	50
-40	-44	42
56	-56	-12
44	-56	-8
38	-40	-20
46	6	28
46	14	30
36	4	30
44	42	22
48	46	16
52	34	26
-40	-42	-38
-54	8	34
-46	4	46
-42	-2	32
-40	44	4
-44	48	-14
24	36	-14
-18	36	-20
-22	-74	-4
-10	-34	0
-8	-20	-12
-6	-30	-8
-6	30	34
-8	-78	-24
42	32	42
22	2	50
28	20	44
32	12	56
10	-10	10
-30	56	-4
-26	6	60
6	22	48
52	24	14
-2	6	26
-6	12	22
-10	-14	2
-42	34	18
14	12	2
22	-94	-2
8	-40	44
32	16	-2
48	20	-14
-38	-72	-26
-42	-72	-34
0	-32	28
-50	28	26
-16	-6	-8
-8	0	-10
8	8	-6
30	-28	-12
30	18	-14
8	46	8
52	44	-4
56	36	2
10	-26	-20
-14	-92	2
-10	-100	4
-24	-78	-12
-30	-68	-14
28	-58	38
-54	-56	32
-14	-94	-2
-16	-98	8
4	-50	6
-14	-70	24
8	-76	22
0	-78	26
-8	-74	54
0	-94	14
-2	-86	20
8	4	-4
2	-22	12
4	-18	4
-6	4	4
6	-78	48
14	-76	52
-14	-86	18
8	-18	30
-28	22	2
-20	22	6

// Jocham G, 2009: FINREVERR (Final Reversal Errors) - ALLPOS (Positive 
// Feedback), High Probability
// Jocham G, 2009: FINREVERR (Final Reversal Errors) - ALLPOS (Positive 
// Feedback), Low Probability
// Jocham G, 2009: REVERR (Reversal Errors) - ALLPOS (Positive Feedback), High 
// Probability
// Jocham G, 2009: REVERR (Reversal Errors) - ALLPOS (Positive Feedback), Low 
// Probability
// Subjects=21
1	33	29
-52	-37	35
46	-51	35
34	18	28
-55	6	28
-12	50	6
-41	42	27
24	-40	59
-13	-70	33
8	-17	30
-5	-39	63
-2	36	28
46	38	26
-37	33	24
-1	-24	27
-39	4	24
43	-42	29
48	14	33
-39	36	28
3	36	31
47	-42	35
-35	-36	36
14	-57	18
1	-24	33
4	-29	-21
-32	-24	14
24	-35	71
23	37	-19
-34	9	27
-46	8	36
-51	30	7
31	-17	14
28	-80	16
-11	-69	12
9	-76	-19
-4	-23	62
46	-36	35
-39	-40	42
44	9	36
-42	34	32
2	34	31
21	52	32
57	-41	-8
-58	-33	-16
30	17	50
31	-29	52
4	-50	-15

// Mobascher A, 2009: Activation in Response to Laser Stimulation
// Mobascher A, 2009: Electrodermal Activity High vs. Low
// Subjects=12
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
24	0	20
46	44	2
28	-6	70
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36
12	-14	8
-8	-12	0
-8	-20	-16
0	-30	-48
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
46	44	2
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36

// Vanhaudenhuyse A, 2009: Wakefulness, Non-Painful > Rest
// Vanhaudenhuyse A, 2009: Non-Painful, Wakefulness > Hypnosis
// Vanhaudenhuyse A, 2009: Wakefulness, Painful > Rest
// Vanhaudenhuyse A, 2009: Painful, Wakefulness > Hypnosis
// Vanhaudenhuyse A, 2009: Wakefulness > Hypnosis, Painful > Non-Painful
// Subjects=13
-6	-22	-12
-58	-34	12
46	-16	-4
46	-38	52
0	-22	-16
-54	-42	8
46	-14	-6
48	-36	52
0	-22	-14
6	-18	16
-14	10	8
16	6	-2
-60	-34	10
40	-14	14
48	-34	52
-6	18	44
34	48	12
36	14	60
8	-18	14
10	-18	14
-14	12	10
18	8	2
-54	-40	6
34	-14	12
46	-40	52
-4	24	46
36	50	12
36	6	54
4	-10	12
24	2	-6
-20	8	6
4	12	58

// Freund W, 2009: Right weak - rest
// Freund W, 2009: Left weak - rest
// Freund W, 2009: Right moderate - rest
// Freund W, 2009: Left moderate - rest
// Freund W, 2009: Right pain - rest
// Freund W, 2009: Left pain - rest
// Freund W, 2009: Right increase
// Freund W, 2009: Left increase
// Freund W, 2009: Right tonic pain early - rest
// Freund W, 2009: Left tonic pain early - rest
// Freund W, 2009: Right tonic pain late - rest
// Freund W, 2009: Left tonic pain late - rest
// Freund W, 2009: Right tonic pain early - tonic pain late
// Freund W, 2009: Left tonic pain early - tonic pain late
// Freund W, 2009: Right tonic pain late - tonic pain early
// Freund W, 2009: Left tonic pain late - tonic pain early
// Subjects=15
0	-64	-34
26	-12	70
-14	-78	-26
8	-20	6
26	22	-12
40	50	-10
26	-34	58
34	-24	42
10	8	30
12	4	62
36	18	-12
28	-18	-8
-36	18	-8
18	4	52
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
54	-52	4
-24	-64	48
16	-72	42
-34	-32	50
-38	-22	64
34	-70	40
28	-12	66
46	36	34
36	60	-4
34	24	-6
42	-60	46
2	22	50
-30	18	0
58	12	26
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
16	-66	64
54	-52	4
-24	-64	48
-34	-32	50
14	30	26
-18	-86	18
66	-30	6
14	-78	22
14	-86	10
-36	54	-4
46	-40	46
12	24	58
26	10	-8
-34	26	0
12	24	46
-12	-80	-36
22	-12	68
-10	-8	-10
54	16	0
20	8	58
0	-2	12
-60	10	10
36	48	28
38	54	-2
44	24	-4
50	24	28
42	-62	54
12	24	48
56	-36	44
-36	38	22
-34	-20	64
-32	-44	36
-22	-84	-50
-40	-2	8
-40	52	-6
-38	-68	-50
-52	-24	20
-60	6	4
-8	-82	-34
56	-46	0
12	10	66
42	36	36
36	46	22
22	56	20
-42	-36	38
-32	24	12
18	-10	62
-32	26	-2
34	24	-4
-4	26	42
52	14	-2
-60	10	10
-12	2	8
48	40	18
16	2	6
26	10	-8
44	-62	52
52	24	28
44	24	-4
-20	-86	-48
36	46	22
-28	20	58
-8	-4	0
-42	52	-6
56	-36	46
8	26	54
-14	-82	-28
-44	10	-6
40	36	36
-38	38	26
-36	-68	-48
22	10	-8
44	52	-8
-34	-52	48
12	12	68
-16	22	-14
-30	30	2
-60	-24	8
-46	-34	34
20	6	48
-2	10	52
62	-18	14
10	-20	16
-2	-72	-2
42	2	30
52	24	0
46	16	24
-20	-42	70
2	24	44
-32	42	28
40	16	2
52	20	22
-62	-18	22
10	0	10
-56	-36	46
2	8	-2
38	20	-2
12	2	62
44	-62	-38
32	-10	34
-12	-94	16
10	-64	-34
-20	24	24
-28	14	12
-26	42	12
34	20	-22
-34	36	-4
14	6	44
10	4	64
-2	-74	-42
-26	-54	-44
-52	8	4
38	16	2
-12	10	60
52	20	-6
42	42	-12
58	2	8
-44	-26	-8
6	4	14
-54	-62	-16
-8	22	2
-18	-42	74
-28	-66	48
10	-20	18
-6	12	-12
58	-14	4
-26	-54	46
-8	-70	52
-34	6	-38
-18	-8	70
-12	-34	76
56	-16	2
-50	-24	4
2	12	2
38	-38	54
-26	-68	48
-4	-70	50
-42	-24	-24
0	-48	62
-56	-68	-6
0	-10	58
-4	-30	52
-18	30	32
8	-58	-32
26	18	20
-18	-52	-46
30	16	-30
40	42	-16
-30	-16	26
-34	-56	22
36	-12	18
-8	20	54
14	-74	-38
36	-40	-14
34	-82	-46
30	-10	24
12	-46	-40
-24	-28	-6
32	-26	-14
26	-40	26
-16	-52	-42
-10	-44	24
-20	44	34
14	-72	-42

// Schienle A, 2009: Female Binge-Eating Disorder Patients
// Subjects=17
-15	-96	0
-24	30	-21
-45	-42	-24
36	3	-12

// Schienle A, 2009: Normal Weight Healthy Control Females
// Subjects=19
9	-93	-6
27	27	-18
-36	-6	6
-9	-90	-12
-15	-105	-6
-30	30	-12

// Schienle A, 2009: Female Bulimia Nervosa Patients
// Subjects=14
15	-84	-9
-39	6	-9
-27	-66	-12
30	24	-18

// Schienle A, 2009: Overweight Healthy Control Females
// Subjects=17
-39	-57	-12
-24	3	-24

// Boorman E D, 2009: Relative Chosen Value During the Decide Phase (Chosen - 
// Unchosen Subjective Action Value)
// Boorman E D, 2009: Relative Unchosen Probability During the Entire Trial 
// (Log Unchosen - Log Chosen Action Probability)
// Subjects=18
-6	48	-8
-34	56	-8
36	54	0
42	34	28
50	-46	46
-32	-60	40

// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Money Category
// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Trinkets Category
// Chib V S, 2009: Common Representation of Decision Value (Willingness to 
// Pay) for Snacks Category
// Chib V S, 2009: Conjuction Analysis Across All Categories
// Subjects=19
-3	42	-6
6	39	12
3	30	12
-3	42	-6

// Engelmann J B, 2009: Activations During Risky Choice
// Engelmann J B, 2009: Correlations Between Risk Preference and Activations 
// During Risky Choice
// Engelmann J B, 2009: Correlations Between Risk Preference and Deactivations 
// During Risky Choice
// Engelmann J B, 2009: Activations During Anticipation Period After Risky 
// Choice
// Engelmann J B, 2009: Activations During the Outcome Period After (Won vs. 
// Lost)
// Subjects=10
27.66	54.88	27.37
22.48	41.03	42.86
13.34	36.62	-7.85
32.58	34.55	-21.28
14.04	34.03	27.38
-3.17	31.92	25.07
-12.56	12.31	6.2
28.19	8.19	-19.02
-7.11	10.88	18.97
11.96	12.34	67.81
2.29	6.41	71.76
2.23	-10.54	16.31
2.71	-17.31	-7.89
3.38	-22.33	35.91
-17.02	-35.69	3.92
21.46	-36.62	4.89
20.97	-50.81	-23.02
27.23	-50.31	-15.77
-39.54	-59.71	-1.95
-16.93	-64.93	45.51
46.22	-73.01	-1.26
-16.12	-72.96	22.87
-26.54	-75.69	42.17
36.56	-85.21	16.6
-32.37	-86.42	16.71
13.11	47.48	-18.79
6.61	40.28	-19.12
-45.59	33.98	-14.76
46.45	27.85	-14.19
24.64	31.84	55.99
21.88	17.93	-16.42
-49.52	11.76	21.72
27.96	-20.62	-19.95
-34.88	-23.37	-21
-15.52	-27.45	-6.72
35.78	-32.41	-8.01
31.77	-78.91	-6.07
13.18	-83.54	-6.58
-35.29	-83.42	-.57
1.88	-86.61	-5.3
0.81	-86.62	-5.29
2.35	-99.43	-4.57
0.43	-99.44	-4.54
16.34	12.82	11.62
33.62	48.74	-5.75
10.9	36.83	22.61
-2.84	36.01	28.41
21.49	0.46	-4.13
58.23	-26.2	-17.82
-.98	-30.07	35.27
51.33	-61.17	42.63
-10.6	39.07	-7.11
0.22	32.35	22.1
8.91	24.53	-4.22
-17.22	6.39	-5.19
-61.02	-5.37	20.06
62.1	-7.83	19.85
-50.6	-9.58	39.03
-15.99	-15.94	21.1
-34.79	-16.95	49.72
51.62	-18.2	28.54
0.44	-18.22	43.85
2.58	-18.21	43.82
20.62	-21.38	25.93
36.58	-29.76	41.39
4.18	-28.53	67.08
-32.97	-37.54	55.78
-4.59	-40	33.8
-44	-48.65	-34.72
-1.58	-46.17	5.96
4.19	-46.14	5.89
-14.87	-51.82	-42.49
46.38	-51.96	-41.51
-29.82	-56.75	-56.73
34.13	-51.91	62.12
12.85	-54.92	44.33
48.83	-62.83	-46.09
22.55	-61.81	-30.48
-38.62	-64.33	-37.04
-27.26	-58.42	38.39
-40.3	-63.2	-18.15
-28.13	-69.1	-22.6
-2.41	-70.49	-41.51
4.43	-70.45	-41.59
-18.26	-65.43	25.38
39.67	-66.52	25.48
-28.46	-66.42	46.55
-15.7	-73.95	-6.5
49.58	-73.89	-8.81
1.21	-69.93	53.64
2.28	-69.92	53.63
-3.42	-71.89	34.23
-35.85	-85.36	22.46
12.55	-85.3	35.51
26.44	-86.78	34.35
31	-93.81	-.57

// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Main Effect of Person, Self > Other
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Main Effect of Time, Current > Future
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Valence, Positive > Negative (Activations)
// Ersner-Hershfield H, 2009: Regions Correlated with the Full Factorial 
// Model:  Valence, Positive > Negative (Deactivations)
// Ersner-Hershfield H, 2009: Person x Valence (Deactivations)
// Ersner-Hershfield H, 2009: Time x Valence
// Ersner-Hershfield H, 2009: Person x Time x Valence (Deactivations)
// Subjects=18
-15.17	69.09	-5.23
28.77	54.18	4.44
-3.24	50.1	9.61
4.08	47.46	-11.44
-3.37	41.07	-10.82
-23.34	44.46	34.85
-46.73	12.59	37.79
-3.05	23.55	24.1
9.62	22	2.9
-7.51	17.24	-2.08
7.4	18.93	-9.09
-7.11	16.95	49.24
12.92	6.5	8.62
13	-5.85	14.12
-10.54	2.47	13.69
-3.05	-9.46	10.14
-2.86	-11.81	34.87
-23.43	-23.56	-5.17
-51.17	-26.55	-.14
-7.24	-33.81	12.23
33.72	-34.28	57.53
33.63	-35.22	45.34
-46.78	-41.79	8.9
-2.94	-49.99	9.08
-22.9	-46.59	54.75
-2.57	-53.87	55.12
-18.63	-79.58	40.74
13.49	-53.44	59.36
29.4	-63.43	38.83
33.75	-74.69	44.19
26.22	-79.56	36.87
-51.35	12.23	-7.85
49.55	-15.38	39.03
-39.06	-27.2	45.5
-7.44	-31.55	-13.6
-18.64	-42.34	54.34
5.63	-54.16	9.33
29.5	-62.4	52.13
-39.58	58.6	12.66
-51.18	1.88	9.74
-42.43	-8.07	31.67
69.84	-19.83	34.71
5.75	-69.34	19.52
10.06	-76.72	20.09
-15.01	45.45	5.68
13.24	-81.27	15.98
28.88	-10.55	-6.86
-46.8	7.42	25.96
-35.02	-.97	26.53
33.75	-41.68	58.15
10.32	-53.11	63.83
-14.4	-67.92	39.71
45.42	-67.82	35.67

// Palminteri S, 2009: Correlation with State Value (Expected Reward, Given 
// Displayed Cues, Regardless of Upcoming Action)
// Palminteri S, 2009: Activity Correlated with Reward Prediction Errors at 
// Outcome
// Palminteri S, 2009: Activity Correlated with Right Hand Movement
// Palminteri S, 2009: Activity Correlated with Left Hand Movement
// Palminteri S, 2009: Activity Correlated with the Right Option Value
// Palminteri S, 2009: Activity Correlated with the Left Option Value
// Palminteri S, 2009: Activity Correlated with Prediction Error Following the 
// Chosen Response (Right Symbol)
// Palminteri S, 2009: Activity Correlated with Prediction Error Following the 
// Chosen Response (Left Symbol)
// Subjects=20
-54	32	-4
-12	8	-10
-50	-20	48
38	-18	46
-54	34	0
-28	36	-10
-8	20	-12
6	26	-8
28	36	-12
54	32	-4
-16	8	-10
10	8	-8

// Smith B W, 2009: Greater BOLD for High-Magnitude Rather than Low-Magnitude 
// Selections
// Smith B W, 2009: Greater BOLD for Low vs. High-Probability Selections
// Smith B W, 2009: Greater BOLD for Risky vs. Safe Selections
// Subjects=25
-3.85	-51.71	28.19
0.42	-8.82	45.74
8.48	59.68	8.67
-59.59	-53.84	5.59
-28.64	0.84	21.84
41.67	-6.42	-9.58
25.63	-14.34	-14.31
24.48	-5.26	-20.64
-16.01	-18.57	-10.13
-23.58	-6.44	-17.75
2.44	27.24	43.8
-35.02	35.21	40.22
-2.92	28.17	42.67
-57.18	-44.4	44.92

// Venkatraman V, 2009: Activation Modulated by the Decision:  Magnitude 
// Sensitive > Probability Maximizing
// Venkatraman V, 2009: Activation Modulated by the Decision:  Probability 
// Maximizing > Magnitude Sensitive
// Venkatraman V, 2009: Activation Modulated by the Decision:  Strategy 
// Preference (Mag. Sen. - Prob. Max.)
// Venkatraman V, 2009: Increased Activations to Anticipation and Resolved 
// Gains, Deactivations to Resolved Losses
// Subjects=20
38	28	0
16	21	-23
20	-76	57
3	-72	57
44	44	27
47	42	8
42	25	22
10	22	45
10	42	29
14	16	-10

// Weber B, 2009: High-Price Income Feedback > Low-Price Income Feedback
// Weber B, 2009: Random-Effect Results for Model 1 @ Outcome High > Low
// Weber B, 2009: Random-Effect Results for Model 1 @ Outcome Modulated by 
// Real Income, High > Low
// Subjects=24
12	47	0
12	47	0
27	-6	-12
21	10	1
16	4	14
-31	-7	-3

// Smits M, 2009: 0-Back > Rest
// Smits M, 2009: 0-Back > Rest, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: 2-Back > 0-Back
// Smits M, 2009: 2-Back > 0-Back, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: 2-Back > 1-Back
// Smits M, 2009: 2-Back > 1-Back, Regression Analysis, Increased Activation 
// with Increased Severity of PCS
// Smits M, 2009: Stroop Interference > Stroop Neutral
// Smits M, 2009: Stroop Interference > Stroop Neutral, Regression Analysis, 
// Increased Activation with Increased PCS
// Subjects=11
6	8	62
42	14	6
-34	22	12
58	-24	-6
-66	-30	10
42	6	48
8	24	56
6	8	62
30	50	4
20	50	32
12	-12	66
34	38	36
38	30	16
-38	14	24
-10	24	42
-8	38	34
58	-48	-4
50	-32	48
-34	-44	46
-30	-56	62
-42	-48	62
28	0	62
-46	12	34
2	18	52
32	22	4
-34	24	0
46	-44	46
4	-68	50
-32	-64	42
-6	62	24
16	-36	-4
-6	-48	4
12	-68	18
24	-4	54
-4	16	54
30	-54	38
32	-72	38
-36	-56	40
-26	-68	42
40	-24	6
56	-34	16
-58	-30	-6
-54	32	10
-44	-22	4
-54	8	4
6	-50	54
20	-74	22
52	-44	28
6	-56	62
-52	-20	20
18	-16	-12
6	-40	8
42	18	-6
54	20	30
42	16	36
-44	16	32
-8	10	58
30	-66	46
2	-70	54
-30	-78	24
-28	-66	32
-38	8	18
-56	-10	18
-4	44	10
4	32	26
-4	-26	24
-12	-60	-18
10	-80	20
-20	-58	22

// Tomasi D, 2009: Rested Wakefulness, Main Effect
// Tomasi D, 2009: Rested Wakefulness, Main Effect (Deactivations)
// Tomasi D, 2009: Rested Wakefulness, Load, 2 Ball to 4 Ball-Tracking
// Tomasi D, 2009: Rested Wakefulness, Load, 2 Ball to 4 Ball-Tracking 
// (Deactivations)
// Tomasi D, 2009: Sleep Deprived, Main Effect
// Tomasi D, 2009: Sleep Deprived, Main Effect (Deactivations)
// Tomasi D, 2009: Sleep Deprived, Load, 2 Ball to 4 Ball-Tracking
// Tomasi D, 2009: Sleep Deprived, Load, 2 Ball to 4 Ball-Tracking 
// (Deactivations)
// Tomasi D, 2009: Sleep Deprived > Rested Wakefulness, Main Effect
// Tomasi D, 2009: Sleep Deprived > Rested Wakefulness, Main Effect 
// (Deactivations)
// Subjects=14
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
-15	-15	12
15	-18	15
-36	15	9
27	18	9
0	-21	-9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
3	-45	-9
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
-12	-45	-3
18	-45	-3
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
36	6	33
-15	-15	12
15	-18	15
0	-21	-9
-30	-51	54
-12	-69	57
3	-45	-9
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
-15	-15	12
15	-18	15
-36	15	9
27	18	9
0	-21	-9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
12	-57	-30
-3	33	12
-36	-21	18
30	-12	15
-12	-45	-3
18	-45	-3
3	-63	21
-6	-81	18
-6	-9	39
-9	-36	60
0	12	51
-27	-3	60
21	0	57
-51	6	39
36	6	33
0	-21	-9
-30	-51	54
21	-69	54
12	-57	-30
-36	-21	18
30	-12	15
-6	-81	18
-15	-15	12
15	-18	15
30	-12	15
3	-63	21
-6	-81	18
-9	-36	60
0	12	51
-27	-3	60
21	0	57
27	18	9
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
-33	-72	-12
33	-72	-12
3	-45	-9

// Volkow N D, 2009: Rested Wakefulness, Main Effect
// Volkow N D, 2009: Rested Wakefulness, Main Effect (Deactivations)
// Volkow N D, 2009: Rested Wakefulness, Load, 4 Ball Tracking > 2 Ball 
// Tracking
// Volkow N D, 2009: Rested Wakefulness, Load, 4 Ball Tracking > 2 Ball 
// Tracking (Deactivations)
// Volkow N D, 2009: Sleep Deprived, Main Effect
// Volkow N D, 2009: Sleep Deprived, Main Effect (Deactivations)
// Volkow N D, 2009: Sleep Deprived, Load, 4 Ball Tracking > 2 Ball Tracking
// Volkow N D, 2009: Sleep Deprived Main > Rested Wakefulness, Main Effect
// Volkow N D, 2009: Sleep Deprived, Positive Correlation between BOLD 
// Activations and Accuracy
// Volkow N D, 2009: Sleep Deprived, Negative Corrrelation between BOLD 
// Activations and Accuracy
// Volkow N D, 2009: Rested Wakefulness, Positive Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Rested Wakefulness, Negative Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Sleep Deprived, Positive Correlation between BOLD 
// Activations and Main Effect
// Volkow N D, 2009: Sleep Deprived, Negative Correlation between BOLD 
// Activations and Main Effect
// Subjects=14
-27	-3	60
21	0	57
-51	6	39
36	6	33
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
-15	-15	12
15	-18	15
3	-45	-9
12	-57	-30
-3	33	12
-6	-9	39
-36	-21	18
30	-12	15
3	-63	21
12	-81	12
12	-57	-30
-6	-9	39
30	-12	15
-27	-3	60
21	0	57
-51	6	39
36	6	33
-30	-51	54
33	-54	60
-12	-69	57
21	-69	54
-3	-81	-9
12	-72	-15
-33	-72	-12
33	-72	-12
-15	-15	12
15	-18	15
12	-57	-30
-3	33	12
-6	-9	39
-36	-21	18
30	-12	15
3	-63	21
21	-69	54
-15	-15	12
15	-18	15
3	-81	-6
27	-72	-18
-12	-72	-18
-12	12	36
42	-21	21
-3	-66	42
3	-81	-6
27	-72	-18
-12	-72	-18
42	-21	21
-3	-66	42
3	-81	-6
27	-72	-18
-12	-72	-18
-12	12	36
42	-21	21
-3	-66	42

// Koenigsberg H W, 2009: Borderline Personality Disorder (BPD) Patients
// Subjects=18
26	-80	-2
-26	-64	-8
-58	-24	-16
40	-16	-22
-50	28	16
10	44	36
-18	54	28
-4	-68	-18
56	-34	22
4	-20	46
0	8	46
-6	-56	42
-54	-50	46
-38	-36	22
52	-28	-6
-50	-12	2
-24	-12	-22
8	-8	-22
-8	6	-4
-36	12	-38
-36	30	30
44	30	2
14	64	20
-8	-98	16
-56	-22	44
62	-12	34
42	8	26
-56	4	34
-54	-50	46
46	-52	46
6	-66	44
-62	-38	14
18	-6	-24
38	56	4
26	20	60
-18	58	10
44	12	50
-30	28	52
34	-16	18
14	-96	14
-28	-48	54
-4	-6	54
58	-10	32
40	-76	4
30	-70	20
28	-54	-16
30	-52	44
-40	-50	54
-4	30	36
42	-20	6
50	-18	-14
30	6	-22
26	28	50
16	-16	18
-32	-26	8
54	8	0
-38	12	-2
-16	54	14
32	54	24

// Koenigsberg H W, 2009: Healthy Controls
// Subjects=16
26	-80	-2
-26	-64	-8
-58	-24	-16
40	-16	-22
-50	28	16
10	44	36
-18	54	28
-4	-68	-18
56	-34	22
4	-20	46
0	8	46
-40	-56	38
50	-56	40
-58	-52	-6
62	-36	2
4	-24	36
36	56	4
2	-86	0
-40	-78	14
44	-72	-6
-50	-32	56
-40	-12	62
-54	-50	46
46	-52	46
6	-66	44
-62	-38	14
18	-6	-24
38	56	4
26	20	60
-18	58	10
44	12	50
-30	28	52
34	-16	18
14	-96	14
-28	-48	54
-4	-6	54
58	-10	32
40	-76	4
30	-70	20
28	-54	-16
30	-52	44
-40	-50	54
-4	30	36
42	-20	6
50	-18	-14
30	6	-22
26	28	50
16	-16	18
-32	-26	8
54	8	0
-38	12	-2
-16	54	14
32	54	24

// Koenigsberg H W, 2009: Negative - Rest (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Negative - Rest (Handedness as a Covariate), HC > 
// BPD Patients
// Koenigsberg H W, 2009: Positive-rest (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Positive - Rest (Handedness as a Covariate), HC > 
// BPD Patients
// Koenigsberg H W, 2009: Negative - Positive (Handedness as a Covariate), BPD 
// Patients > HC
// Koenigsberg H W, 2009: Negative - Positive (Handedness as a Covariate), HC 
// > BPD Patients
// Subjects=17
16	-92	10
32	-86	28
48	-74	-12
30	-76	18
-46	-42	16
18	-68	0
6	-66	18
16	-48	0
46	-44	14
36	-2	48
-44	-28	-10
48	-10	22
40	44	10
16	-76	-28
48	-70	-14
-54	-64	22
4	6	64
-54	22	6
-16	-12	4
0	-62	14
-40	24	2
18	-50	0
48	-40	16
18	28	4
-20	34	6
16	-94	12
-34	-88	14
-26	-84	-2
26	-90	-2
6	-88	22
-38	-54	-18
30	-60	24
30	-48	-22
18	-42	42
44	20	22
-44	-26	-8
30	-20	40
42	-12	16

// McClernon F J, 2009: Smoke > Control, Abstinent
// McClernon F J, 2009: Smoke > Control, Abstinent > Satiated
// McClernon F J, 2009: Positive Correlation between Pre-Scan Craving and 
// Smoking > Control Activation, Abstinent
// McClernon F J, 2009: Smoke > Control
// Subjects=18
-10	-60	18
-6	-34	34
-14	-56	70
20	-62	46
0	-46	56
-28	-26	14
-32	0	-12
32	-4	-4
-14	58	20
-26	40	44
-8	48	26
-22	-60	6
-30	-80	36
-16	-86	40
32	-24	48
0	-32	60
10	-82	-20
-40	-68	-20
12	-18	22
-20	26	60
18	-54	48
8	-38	32
30	-76	22
26	-58	8
-22	-52	10
26	-34	72
20	16	20
20	30	54
4	44	8
12	58	18
14	10	62
-44	-28	42
46	-42	50
20	-76	-12
36	-68	-20
4	-56	-2
4	-34	54
12	-82	36
2	0	-10
-28	-74	30
20	-12	68
26	-8	48
-44	-4	6

// Goldstone A P, 2009: High-Calorie > Low-Calorie, Fasted
// Goldstone A P, 2009: High-Calorie > Low-Calorie, Fed
// Subjects=20
-36	-46	-32
28	-40	-30
-8	-24	50
-36	10	-16
34	2	-24
38	-10	-14
-26	48	34
2	2	70
-24	36	54
-46	4	54
54	-44	12
-38	18	-28
-16	-8	54
-20	-38	2
-34	-40	64
18	-74	-24
-8	-78	0
30	34	-16
62	-4	0
-20	66	6
42	40	-2
54	-24	44
-14	-46	-4
40	16	-36
-14	56	-8
26	34	54
-54	-72	18
-64	-56	16
56	-10	24
12	-54	-52
8	20	30
58	14	34
10	28	62
60	10	-16
-20	-8	74
-32	-20	68
-50	-24	24
-10	14	36
36	-8	18
50	-62	-12
-38	-50	-14
-48	-66	-2

// Janes A C, 2009: Smoking-Related > Neutral Images, Prequit
// Janes A C, 2009: Neutral > Smoking-Related Images, Prequit
// Janes A C, 2009: Smoking-Related > Neutral Images, Smoking Abstinence
// Janes A C, 2009: Neutral > Smoking-Related Images, Smoking Abstinence
// Janes A C, 2009: Smoking-Related > Neutral Images, Smoking Abstinence > 
// Prequit
// Janes A C, 2009: Smoking-Related > Neutral Images, Prequit > Smoking 
// Abstinence
// Subjects=13
-17.94	41.75	40.59
1.65	-3.92	67.62
7.83	39.84	54.95
-27.24	5.42	67.16
10.87	25.03	28.28
20.79	-34.41	43.19
4.62	-45.83	20.91
1.42	-12.84	34.91
49.36	-33.9	6.01
-50	-40.84	7.74
-18.19	-23.41	-17.51
-40.77	-5.28	-28.81
59.16	-28.61	32.22
14.61	-48.51	67.86
8.09	-46.41	54.38
4.96	-32.45	69.97
-30.42	-30.52	56.83
36.52	-77.01	-13.64
-40.47	-71.38	-16.57
27.13	-84.53	13.86
14.32	-94.38	11.49
17.69	-82.79	37.24
8	-77.01	30.18
-40.26	-65.9	13.07
42.76	-52.37	-25.82
-53.31	-55.09	-11.1
-27.35	-68.22	23.16
-33.69	-60.89	36
46.32	-2.54	40.22
-53.29	-5.45	11.5
30.1	41.52	33.37
23.5	42.85	9.91
-4.82	-17.68	55.46
-36.98	10.68	53.45
16.91	70.6	-2.38
-8.09	14.54	59.49
-11.56	51.3	39.72
13.8	38.6	-3
4.58	6.47	36.6
11.1	-2.24	47.29
7.65	21.58	25.26
20.4	27.49	17.93
-30.81	41.15	34.1
4.69	-22.08	38.99
-8.14	-28.76	36.35
-24.12	-28.34	43.19
1.68	-33.24	60.04
45.97	7.07	-.73
-27.87	15.37	-10.61
-30.8	-18	12.29
-34.13	10.27	6.61
39.6	23.92	11.31
-37.49	28.52	-4.91
46.21	-36.57	12.97
-33.87	-33.11	23.63
-43.54	-40.28	14.31
45.77	-1.59	-30.11
-21.21	-51.21	-5.11
63.5	-24.64	41.88
30.57	-49.19	57.7
-7.89	-59.19	55.63
56.05	-60.61	31.6
27.33	-33.09	59.73
-56.3	-43.02	21.38
-59.58	-24	19.82
20.77	-84.05	20.59
-8.05	-87.14	24.52
17.3	-60.49	-4.77
-8.32	-70.16	-3.66
-14.72	-79.98	-6.11
10.77	-15.61	-1.77
7.56	4.18	6.65
-27.59	-11.38	15.05
7.33	11.64	-20.74
33.14	-32.62	-17.33
-24.65	-23.96	-24.08
-43.82	-39.94	-22.52
-17.86	-95.86	-4.75
23.55	49.97	19.35
-1.7	14.41	57.19
20.73	7.85	53.03
-17.69	-11.67	51.76
-43.68	17.59	19.49
-17.76	-61.82	22.51
-30.6	-42.35	27.72
46.44	-27.66	45.67
20.82	-27.56	49.3
17.51	-84.59	13.98
-20.97	-81.64	14.17
-15.04	35.25	-2.39
-14.98	-23.39	-17.55

// Coletta M, 2009: Highly - Moderately Palatable Food, Unrestrained > 
// Restrained Eaters, Fasted
// Coletta M, 2009: Highly - Moderately Palatable Food, Unrestrained > 
// Restrained Eaters, Fed
// Coletta M, 2009: Highly - Moderately Palatable Food, Restrained > 
// Unrestrained Eaters, Fasted
// Coletta M, 2009: Highly - Moderately Palatable Food, Restrained > 
// Unrestrained Eaters, Fed
// Subjects=9
52.85	-1.97	-9.77
-15.46	-21.61	-32.44
-21.67	-.96	-6.36
-44	21.33	26.55
-8.1	-34.71	33.72
43.57	12.27	28.2
14.62	-43.14	34.17
-18.24	-53.16	-2.38
-2.21	-43.51	-14.81
20.41	-86.57	-28.86
-50.82	65.79	8.82
-34.41	58.69	23.81
-31.21	26.61	13.48
-38.32	25.21	-35.56
-43.89	8.98	32.25

// Grahn J A, 2009: Exp. 1: Beat - No Beat
// Grahn J A, 2009: Exp. 2: Beat - No Beat
// Grahn J A, 2009: Exp. 1: All Rhythms - Rest
// Grahn J A, 2009: Exp. 1: Volume Conditions - Duration Conditions
// Grahn J A, 2009: Exp. 1: Volume Nonbeat - Volume Beat
// Grahn J A, 2009: Exp. 1: Beat x Accent Interaction
// Subjects=36
-26	2	6
26	8	8
-32	-18	0
30	-16	8
-8	20	-8
-18	12	-12
0	28	-12
-50	-24	-20
-18	-26	66
-22	6	8
-20	8	-4
-24	-2	8
-18	10	-8
26	8	0
22	6	12
-30	-14	-2
-26	-12	14
30	-12	4
42	38	28
44	22	8
34	28	2
-34	20	2
6	0	66
-6	-4	66
54	0	48
-52	-10	50
-48	-8	54
-50	-20	4
-42	-34	10
56	-14	4
56	-24	6
62	-42	32
46	-50	46
-30	-64	-28
-28	-62	-50
28	-60	-28
24	2	8
20	8	68
-2	24	54
-6	32	46
46	16	42
36	4	62
44	44	18
40	26	26
48	38	28
42	34	40
30	56	30
42	46	-6
-42	22	42
-44	18	44
-50	12	42
-40	46	-2
10	34	36
8	20	66
-44	-6	36
50	28	32
42	22	36
32	14	34
34	8	38
28	12	32
38	6	40
48	46	2
-50	8	32
-38	6	32
-48	38	16
-54	30	16
-48	36	20
64	-14	4
-40	-34	14
-56	-22	6
-66	-36	-4
-52	-60	4
-56	-50	-10
70	-32	2
64	-50	-2
68	-40	-6
62	-34	-16
56	-50	46
42	-50	46
52	-42	54
42	-56	50
34	-62	48
-48	-48	42
-50	-54	50
-42	-62	54
62	-38	42
60	-40	44
56	-44	42
-64	-42	36
-32	-70	-48
-12	-78	-32
-38	-64	-40
10	-78	-32
18	-26	22
22	-32	16
-12	-22	22
-18	-24	-2
-8	24	44
48	44	14
-46	12	26
-46	16	2
-40	26	22
52	10	20
40	12	26
60	18	28
32	26	-6
44	22	12
46	24	24
56	26	26
54	28	24
50	40	14
-34	24	4
34	24	-4
-52	-6	48
54	2	44
40	2	38
56	8	40
-6	14	54
-2	0	66
6	18	48
8	12	60
10	4	70
-54	-40	12
-66	-36	10
-54	-2	-8
-48	-16	-6
56	-24	0
56	-6	-4
-58	-38	10
-66	-26	4
-52	-22	0
-44	-2	-16
70	-36	6
40	-52	44
12	-12	4
-14	-10	0
12	-18	-8
-8	-10	-6
0	-58	-20
-12	-74	-28
-20	-70	-36
-8	-36	-12
-24	-64	-28
-12	-76	-20
-38	-68	-22
20	-70	-26
28	-64	-28
36	-68	-24
16	-58	-28
-16	-74	-40
-28	-62	-50
14	-76	-34
-50	38	6
-46	14	2
-44	14	22
-32	24	4
54	20	28
44	22	12
50	12	16
44	14	26
50	16	2
30	26	-8
42	20	22
-52	-8	48
-46	2	36
54	0	46
40	0	38
38	2	36
-2	0	66
-8	16	52
8	2	66
-54	-2	-8
-54	-6	-6
-44	-10	-10
-36	-34	10
-50	-44	18
-56	-38	12
-42	0	-16
58	-4	-2
56	-34	4
70	-34	4
52	-40	12
56	-26	0
70	-24	0
-66	-26	4
56	4	-6
42	-50	46
-26	-62	-26
-14	-74	-16
30	-62	-26
26	-74	-24
24	4	4
24	2	8
-22	2	4
12	-12	2

// Grahn J A, 2009: All Stimuli - Rest
// Subjects=35
-22	46	-4
-18	42	-12
24	44	-6
-28	48	-6
-22	44	-10
-32	42	26
34	40	20
40	48	10
32	-8	58
-54	4	12
58	6	20
-50	28	30
-42	32	26
42	16	10
40	38	30
12	14	38
-4	-4	68
-6	0	60
6	0	70
-50	-8	54
-28	-10	54
34	-26	56
52	-2	50
26	-6	48
16	-38	78
-36	-30	60
-10	-40	76
-8	-36	68
-12	-30	72
12	-34	72
8	-42	76
-28	22	4
-30	18	10
34	26	6
-54	4	8
-62	-34	14
-62	-28	10
-52	-16	2
-54	-42	20
-42	-34	14
66	-20	6
58	-16	2
68	-32	12
-42	-4	-22
-38	0	-28
-42	-46	44
42	-44	46
32	-8	-22
-22	-40	12
24	-14	-18
22	0	26
-22	4	6
-22	10	6
22	12	6
24	10	16
24	-6	16
-14	-16	6
-4	-14	24
-2	-10	8
16	-14	6
0	-56	-8
2	-62	-20
2	-68	-44
-8	-50	-26
-10	-78	-32
-30	-82	-34
-4	-52	-14
-28	-62	-26
-12	-78	-36
-24	-64	-50
-34	-56	-50
6	-82	-26
20	-82	-38
32	-58	-30
8	-80	-38
6	-78	-36
32	-56	-50
20	-66	-50
8	-76	-34

// Garn C L, 2009: Male Healthy Controls
// Subjects=13
31	-79	-15
-24	-92	-6
12	-88	-6
-8	5	54
-40	-85	-15
-30	-69	55
-7	-26	10
1	2	33
-14	-94	-6
16	-94	-4
-24	-78	50
-66	-42	26
-54	20	22
22	-99	-2
-18	-72	53
-33	-61	51
-29	42	28
-17	-31	-17
-1	27	15
-46	-63	24
50	-24	-4
-59	-23	-2
50	-24	-4
50	-26	6

// Garn C L, 2009: Female Healthy Controls
// Subjects=13
31	-79	-15
-24	-92	-6
12	-88	-6
-8	5	54
-40	-85	-15
-30	-69	55
-7	-26	10
1	2	33
-14	-94	-6
16	-94	-4
-24	-78	50
-66	-42	26
-54	20	22
-27	-95	1
-39	-61	54
-62	-42	28
-44	16	24
-17	-31	-17
-1	27	15
-46	-63	24
50	-24	-4
-59	-23	-2
50	-24	-4
50	-26	6

// Hsieh L, 2009: No Conversation > Fixation
// Hsieh L, 2009: Long Conversation > No Conversation
// Subjects=10
50.42	-26.23	8.7
42.97	9.19	27.01
40.85	-38.98	9.88
35.44	-57.3	-6.36
29.43	-69.69	40.47
28.9	17.08	6.44
27.11	-73.78	15.19
25.76	-7.52	5.19
24.74	-26.73	4.58
20.68	-5.86	40.79
3.4	-61.72	-5.62
-5.97	7.78	54.45
-12.48	4.51	40.31
-19	-71.29	-3.45
-22.03	-75.05	16.98
-22.29	-23.92	3.77
-24	-67.81	42.04
-24.53	18.96	8.01
-26.61	-3.51	6.57
-32.18	32.61	-7.55
-33.89	8.44	37.99
-38.21	-39.28	13.05
-47.93	-20.65	7.14
54.69	-22.95	9.5
50.41	19.72	24.92
43.72	26.72	-7.93
41.73	24.99	11.2
37.94	-40.4	46.84
21.74	-57.61	18.36
15.53	-53.31	47.06
11.13	-73.37	22.03
8	-38.55	45.91
4.65	-26.91	31.59
1.39	-17.58	28.62
-1.84	21.75	42.08
-27.19	-44.59	53.51
-28.91	22.31	-3.38
-44.89	9.52	-2.12
-32.96	13.59	21.94
-39.01	-35.4	49.53
-45.64	8.37	38.13
-50.02	-21.29	12.79

// Meriau K, 2009: Healthy Controls
// Subjects=23
2	58	40
-2	62	24
-16	-4	-14
16	-4	-16
-14	-92	42
10	-88	42
30	-56	58
52	-74	0
-40	0	-4

// Meriau K, 2009: Healthy Controls, Skin Conductance
// Subjects=18
50	52	-4
-36	54	2
42	18	-6
40	24	-18
-12	-32	2
-34	-36	2
38	-70	32
4	-92	22

// Modinos G, 2009: Main Effect of Task: Self > Semantic and Other > Semantic
// Modinos G, 2009: (Self > Semantic) > (Other > Semantic)
// Modinos G, 2009: (Other > Semantic) > (Self > Semantic)
// Subjects=16
-8	28	28
6	28	28
26	54	30
-24	52	32
20	52	36
-24	50	22
4	-62	32
14	-88	0
66	-40	18
8	10	62
-36	20	4
-8	28	28
6	28	28
26	54	30
-24	52	32
20	52	36
66	-40	18
8	10	62
-36	20	4
-24	50	22
4	-62	32
20	-68	50

// Chang S E, 2009: Speech Perception, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Non-Speech Perception, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Speech Planning, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Non-Speech Planning, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Speech Production, Healthy Controls > Stuttering Patients
// Chang S E, 2009: Speech Production, Stuttering Patients > Healthy Controls
// Chang S E, 2009: Non-Speech Production, Healthy Controls > Stuttering 
// Patients
// Chang S E, 2009: Non-Speech Production, Stuttering Patients > Healthy 
// Controls
// Subjects=20
-33.87	-5.65	34.71
45.39	-7.69	56.28
4.91	-6.56	74.49
-38.22	-39.45	10.83
46.2	-36.74	10.75
-47.72	-64.63	16.4
64.28	-42.95	-2.32
49.73	-66.31	41.07
34.77	-79.6	35.66
4.41	-9.59	7.84
17.2	-60.38	-17.04
53.77	8.25	41.46
-31.73	-5.63	34.69
13.5	-12.68	77.14
-38.22	-39.45	10.83
43	-36.68	11.9
-49.85	-63.5	17.44
64.3	-43.92	-1.12
49.73	-66.31	41.07
4.39	-9.76	5.62
20.39	-59.39	-18.28
-36.01	-5.66	34.74
41.11	-7.72	56.33
0.3	5.3	35.63
43.38	-61.26	51.87
-31.44	-68.56	46.65
6.63	-30.72	9.58
23.59	-75.91	-25.85
-12.74	-65.13	-20.76
-18.86	3.76	44.9
43.38	-59.14	51.69
-33.57	-70.69	46.85
51.61	-16.22	27.93
4.41	-9.59	7.84
23.59	-74.86	-25.94
-23.46	-63.42	-25.24
-33.89	-5.82	32.5
30.55	-21.9	66.56
10.99	5.37	35.5
-57.49	-31.11	10.35
-63.98	-33.06	-.56
-40.26	-23.03	30.67
-48.77	-50.12	25.23
19.47	-89.8	-12.37
19.09	-45.33	-42.86
4.41	-55.71	-10.6
-42.35	-13.81	39.95
52.65	-5.47	29.24
-10.4	14.93	37.18
-5.96	2.41	53.79
48.02	16	-9.31
-45.84	-13.49	3.17
40.77	-5.77	12.68
-36.13	-28.86	9.92
47.23	-26.08	10.96
60	-26.6	3.05
55.73	-33.14	1.42
55.88	-29.4	22.29
-8.18	-66.59	14.99
26.79	2.01	4.38
-30.92	-57.75	-20.06
-36.01	-5.66	34.74
9.23	-25.91	71.6
-27.82	54.35	11.77
-33.92	-41.37	13.17
-39.18	-26.2	30.92
49.73	-48.7	48.51
-50.91	-49.07	25.17
-23.21	-80.57	0.73
19.48	-89.63	-10.16
4.41	-9.59	7.84
0.13	-53.62	-10.72
-19.17	-78.54	-28.49
-21.3	-74.15	-26.6
-42.35	-13.81	39.95
65.38	-3.08	17.74
-8.26	18.28	39.1
-40.48	-20.94	2.61
-40.48	-20.94	2.61
68.56	-26.46	4.06
55.74	-35.26	1.59
56.94	-29.48	21.17
49.73	-48.7	48.51
-23.45	2.68	3.78
27.84	4.04	3.08
-31.68	-54.5	22.06

// Kell C A, 2009: Healthy Controls
// Subjects=13
50	26	38
30	20	56
44	16	48
20	34	52
4	46	26
4	32	50
-2	40	8
18	12	-16
-14	6	-18
46	22	10
42	-14	-4
34	-30	12
50	-22	20
0	-32	38
56	-42	30
46	-54	50
46	-52	-36
34	-62	-28
18	12	-16
-14	6	-18
46	-52	-36
34	-62	-28
2	44	26
2	30	48
-6	60	8
32	18	-18
-20	16	-14
46	22	10
40	-14	-8
-44	-32	16
0	-32	38
2	-58	22
-4	-48	24
2	-40	-10
-2	-60	-16
38	-62	-22
-20	16	-14
-2	-60	-16
38	-62	-22
-30	54	10
-44	-16	52
-30	14	-28
48	-28	12
22	-70	-18
28	-64	-28
-24	-74	-22
22	-70	-18
28	-64	-28
-24	-74	-22

// Kell C A, 2009: Recovered Stutterers (RS)
// Subjects=13
-30	54	10
-44	-16	52
-30	14	-28
48	-28	12
22	-70	-18
28	-64	-28
-24	-74	-22
22	-70	-18
28	-64	-28
-24	-74	-22

// Kell C A, 2009: Persistent Stutterers (PS)
// Subjects=13
50	26	38
30	20	56
44	16	48
20	34	52
4	46	26
4	32	50
-2	40	8
18	12	-16
-14	6	-18
46	22	10
42	-14	-4
34	-30	12
50	-22	20
0	-32	38
56	-42	30
46	-54	50
46	-52	-36
34	-62	-28
18	12	-16
-14	6	-18
46	-52	-36
34	-62	-28
2	44	26
2	30	48
-6	60	8
32	18	-18
-20	16	-14
46	22	10
40	-14	-8
-44	-32	16
0	-32	38
2	-58	22
-4	-48	24
2	-40	-10
-2	-60	-16
38	-62	-22
-20	16	-14
-2	-60	-16
38	-62	-22
-26	4	-4
14	8	-4
-34	4	12
-44	-12	-4
46	-12	-6
-44	0	10
-44	0	10
-44	28	32
44	24	36
-50	-40	48
40	-54	50
32	12	-18
32	12	-18

// Lu C, 2009: Healthy Controls
// Subjects=9
-42.58	31.05	28.39
-52.22	6.62	16.05
-48.13	22.28	-2.04
-32.68	-2.16	52.25
-44.36	-35.52	48.49
44.29	-40.96	39.01
32.67	-80.24	41.32
-35.18	-49.86	-13.98
35.56	-78.02	0.95
0.3	17.36	40.2
-32.02	21.03	7.92
44.93	12.86	5.49
-18.1	9.31	6.51
-26.74	66.59	18.54
28.82	52.57	11.27
36.71	1.89	43.31
6.7	31.58	44.51
61.97	32.08	4.8
36.88	-50.18	44.32
-46.7	-44.28	18.03
37.42	23.48	5.8
-24.48	-1.39	6.37
-45.79	38.69	31.13
-51.22	-16.06	-2.13

// Lu C, 2009: Stuttering Patients
// Subjects=10
33.14	54.09	16.67
-49.08	23.56	14.59
-36.02	-.29	35.4
37.76	-4.88	38.29
-31.45	-53.25	52.06
-30.43	-36.15	52.84
39.05	-49.82	48.73
-62.76	-38.11	16.58
44.04	-70.99	-5.31
-33.8	-88.41	10.43
-2.84	8.08	44.36
-38.34	4.42	13.85
34.23	22.49	7.04
-23.39	3.28	11.54
14.95	-76.99	-39.04
-27.75	-44.87	-18.94
26.77	-56.43	-21.95
-10.49	-16.74	13.07
16.19	-7.06	11.95
-26.74	66.59	18.54
28.82	52.57	11.27
36.71	1.89	43.31
6.7	31.58	44.51
61.97	32.08	4.8
36.88	-50.18	44.32
-46.7	-44.28	18.03
37.42	23.48	5.8
-24.48	-1.39	6.37
-45.79	38.69	31.13
-51.22	-16.06	-2.13

// Corbett B A, 2009: Autism Patients
// Subjects=12
-38.21	5.65	53.78
-65.76	-32.4	4.22
-60.16	-58.24	14.53
26.93	-40.32	-16.74
-65.79	-30.48	1.79
-33.73	-5.2	63.74
-64.37	-11.51	32.39
-35.83	-61.65	57.03
-52.48	13.72	37.53
-57.53	-57.38	-33.79
39.91	48.47	2.26
-37.69	11.28	10.63
38.05	-90.4	-1.89

// Corbett B A, 2009: Healthy Controls
// Subjects=15
54.39	17.83	29.7
39.85	-52.6	-22.47
-18.44	-12	-9.81
-21.65	-38.05	-12.78
-18.46	-36.23	-16.38
-49.62	-63.47	-7.55
26.93	-40.32	-16.74
-65.79	-30.48	1.79
-33.73	-5.2	63.74
-64.37	-11.51	32.39
-35.83	-61.65	57.03
-52.48	13.72	37.53
-57.53	-57.38	-33.79
40.43	-55.99	21.56
21.53	-7.5	-9.81
-31.33	-83.69	-18.18
25.96	-92	-18.34

// Mashal N, 2009: Novel Metaphoric Sentences > Nonsensical Sentences
// Mashal N, 2009: Novel Metaphoric Sentences > Literal Sentences
// Subjects=15
-48.71	-59.38	29.35
-48.14	-6.33	-14.14
-56.47	-42.62	-.96
-9.17	-49.28	32.51
-45.76	22.49	28.03

// Freyer T, 2009: Main Effect of Last Reversal Error (Final Reversal Errors 
// vs. Correct Responses), First Visit
// Freyer T, 2009: Main Effect of Last Reversal Error (Final Reversal Errors 
// vs. Correct Responses), Second Visit
// Subjects=10
6	24	29
30	21	0
36	33	33
-34	24	33
39	-48	38
6	24	39
30	21	-6
-33	21	-6
36	30	36
-39	27	33
-36	-54	42

// Schmidt G, 2009: All Sentences (Literal, Easy-Familiar, Easy-Unfamiliar, 
// Difficult-Unfamiliar) > Non-Word Sentences
// Schmidt G, 2009: Metaphors (Easy-Familiar, Easy-Unfamiliar, 
// Difficult-Unfamiliar) > Literal Sentences
// Schmidt G, 2009: Easy-Familiar Metaphors > Literal Sentences
// Schmidt G, 2009: Familiar Metaphors (Easy-Familiar) > Unfamiliar Metaphors 
// (Easy-Unfamiliar)
// Schmidt G, 2009: Unfamiliar Metaphors (Easy-Unfamiliar) > Familiar 
// Metaphors (Easy-Familiar)
// Schmidt G, 2009: Easy Metaphors (Easy-Unfamiliar) > Difficult Metaphors 
// (Difficult-Unfamiliar)
// Schmidt G, 2009: Difficult Metaphors (Difficult-Unfamiliar) > Easy 
// Metaphors (Easy-Unfamiliar)
// Subjects=10
-35.22	21.1	9.07
30.14	0.22	22.33
-35.32	-10.74	-17.26
-67.06	-5.39	27.26
39.63	-2.15	4.58
-59.99	22.24	-15.28
-43.43	-36.97	29.64
15.5	-49.25	44.49
-17.88	-75.17	1.33
8.03	-64.61	39.18
-67.08	-6.7	24.03
-12.32	-79.51	27.28
17.63	-86.73	27.54
-24.2	-66.6	16.29
-31.67	-83.02	11.07
-27.48	-76.11	3.75
65.05	30.82	-11.86
-29.7	-63.86	-2.83
-14.91	-33.62	-12.23
15.78	11.72	-34.23
53.68	23.77	35.7
-29.46	-103.1	12.72
-24.2	-92.92	6.23
28.01	-53.57	1.22
-11.45	-7.97	30.19
-29.79	-37.26	-2.83
-23.95	-51.89	55.2
-48.04	41.88	17.51
2.22	23.86	13.98
-4.24	34.31	12.06
-9.74	43.66	-4.27
-14.98	21.59	-.13
19.12	37.31	-6.3
-28.89	0.47	-10.47
-33.52	-72.29	53.68
-68.14	15.3	33.35

// Aziz-Zadeh L, 2009: Aha Solutions > Search Solutions
// Subjects=12
-54	20	0
40	44	0
-6	26	44
38	12	-14
-48	-52	24
58	-52	36
42	6	-40
-6	-20	-26

// Fink A, 2009: AU > Fixation
// Fink A, 2009: OC > Fixation
// Fink A, 2009: NI > Fixation
// Fink A, 2009: WE > Fixation
// Fink A, 2009: AU > OC
// Fink A, 2009: OC > AU
// Fink A, 2009: NI > WE
// Subjects=68
-20	32	22
36	-66	-26
22	-94	-8
-50	-48	-18
36	-40	0
-20	-94	-12
-24	-68	46
-42	-38	44
28	-70	4
-10	-22	20
-4	16	46
24	-94	-8
-16	-94	-10
-26	-66	44
34	-36	2
-34	-30	-4
-46	16	24
34	-64	-26
26	-92	-8
-38	-88	-6
26	-54	34
-26	-66	46
-44	-40	44
32	44	30
-6	16	46
-52	14	12
50	-8	34
40	-66	-26
-28	-64	46
-42	-88	-8
-28	-34	8
40	-88	-12
-46	-40	44
28	-56	36
-36	-4	60
-48	-74	30
36	-58	48
50	-74	-4

// Kleinhans N, 2009: Healthy Controls
// Subjects=20
22	-6	-14
-22	-10	-14
42	-46	-24
-42	-48	-22
-20	-10	-12
16	-6	-16
-24	-2	-22
42	-52	-22
-44	-70	-16
-22	-4	-28
44	-60	-18
24	-74	-16
22	0	-18
-26	-2	-22

// Kleinhans N, 2009: Patients with Autism Spectrum Disorder
// Subjects=19
24	10	-18
-26	-10	-16
44	-56	-22
24	0	-16
-24	-6	-10
-28	-6	-26
-16	-8	-18
42	-56	-18
-42	-58	-20
16	-6	-16
-22	-4	-28
44	-60	-18
24	-74	-16
22	0	-18
-26	-2	-22

// Mickley K R, 2009: Emotional Items > Neutral Items
// Mickley K R, 2009: Arousing (Remembered - Forgotten) > Non-Arousing 
// (Remembered - Forgotten)
// Mickley K R, 2009: Non-Arousing (Remembered - Forgotten) > Arousing 
// (Remembered - Forgotten)
// Mickley K R, 2009: Negative (Remembered - Forgotten) > Positive (Remembered 
// - Forgotten)
// Mickley K R, 2009: Positive (Remembered - Forgotten) > Negative (Remembered 
// - Forgotten)
// Subjects=19
55	29	6
-4	63	17
8	59	19
40	-82	23
-36	-91	14
-53	-70	7
-22	-91	16
-22	-99	9
-38	-91	3
28	-93	8
22	-99	3
44	-70	-5
30	-90	23
36	-42	11
40	-60	-4
46	-49	-4
40	-73	24
48	-64	0
-55	-68	0
36	-34	-17
48	-45	-11
42	-40	17
-22	-5	-15
32	-13	-18
34	-8	-10
36	-16	-8
-8	8	-4
-30	-44	-16
-28	-34	-18
-55	-35	39
-26	-71	9
36	-3	26
-16	-22	-19
48	5	26
2	-32	59
44	2	44
-36	22	21
-26	-88	34
32	-28	59
55	-31	-3
-28	-51	-3
-24	-58	1
-14	-33	7
-26	56	-11
-40	11	31
24	9	27
38	47	11
34	53	7
50	-52	52
-24	-21	5

// Rasch B, 2009: Negative > Neutral Pictures, Genotype-Independent (G-I)
// Rasch B, 2009: Positive > Neutral Pictures, G-I
// Rasch B, 2009: Neutral > Positive Pictures, G-I
// Rasch B, 2009: Negative > Positive Pictures, G-I
// Rasch B, 2009: Emotional Subsequent Memory (ESM) Analysis, Difference Due 
// to Memory (Dm) Negative > Neutral, G-I
// Rasch B, 2009: ESM Analysis, Dm Positive > Neutral, G-I
// Rasch B, 2009: ADRA2B Deletion (Negative > Neutral) > Non-ADRA2B Deletion 
// (Negative > Neutral)
// Rasch B, 2009: ADRA2B Deletion > Non-ADRA2B Deletion for (Dm Negative > Dm 
// Neutral)
// Rasch B, 2009: Non-ADRA2B Deletion > ADRA2B Deletion for (Dm Negative > Dm 
// Neutral)
// Rasch B, 2009: ADRA2B Deletion > Non-ADRA2B Deletion for (Dm Positive > Dm 
// Neutral)
// Subjects=8
-22	-6	-20
19	0	-20
-52	-69	4
44	-52	-16
-63	-22	28
69	-25	28
39	0	-20
-22	-6	-20
28	-52	60
-6	52	20
52	-17	-24
-8	-17	36
-19	-3	-16
19	-3	-20
-14	-72	-4
-52	-72	8
52	-69	8
-3	47	-20
0	61	16
3	44	0
-33	19	-20
28	-41	-12
39	-83	24
-30	-41	-20
-22	-6	-20
22	0	-20
36	-52	-16
58	-22	40
44	-63	0
-14	-17	-24
-50	-74	-4
66	-14	24
-61	-22	36
-33	19	12
19	0	-20
30	0	-20
19	0	-20
-28	-8	-24
-25	-3	-24
-25	3	-20
-19	-3	-24
22	-3	-24
-22	0	-20
-30	-41	48
39	17	-20
-47	-6	-8
-52	-11	16
-44	-6	12
-19	-102	-8
-47	-6	16

// St. Jacques P, 2009: Subsequent-Memory Activity for Negative > Neutral: 
// Younger > Older
// St. Jacques P, 2009: Subsequent-Memory Activity for Negative > Neutral: 
// Older > Younger
// St. Jacques P, 2009: Functional Connectivity with Amygdala for Subsequent 
// Memory of Negative > Neutral: Younger > Older
// St. Jacques P, 2009: Functional Connectivity with Amygdala for Subsequent 
// Memory of Negative > Neutral: Older > Younger
// Subjects=15
-26.33	3.8	46.1
-14.89	43.48	21.45
13.16	30.99	50.06
17.61	2.09	61.35
40.89	14.18	36.65
21.94	-34.61	54.34
49.39	-11.55	19.75
36.2	15.33	-16.92
-26.67	13.49	6.26
-38.66	-2.27	-31.31
-54.08	-33.35	36.15
49.59	-35.9	35.17
57.07	-49.06	29.5
36.85	-55.98	38.12
-26.67	-27.18	-10.4
-22.48	-12.69	-16.13
-26.52	-57.5	-3.4
8.96	-16.59	40.71
-26.39	-95.65	-1.32
33.4	-68.43	1.29
-19.24	5.28	-4.29
-46.87	39.66	29.95
28.69	2.88	-25.83
-2.5	-72.91	56.72
37.03	-48.64	64.27
-2.97	-81.05	-7.27
-26.58	-86.7	-23.26
-42.81	24.34	-3.39
36.26	29.04	-4.69
-34.23	-15.93	-15.72
-54.37	15.24	17.58
-47.07	36.55	3.44
56.59	37.17	2.2
-34.05	-50.4	-7.26
-53.9	-46.87	54.01
8.64	-71.52	-22.7

// Gentili C, 2009: Normals
// Subjects=7
-42.04	-71.03	57.02
1.56	-39.99	41.65
-25.51	-40.49	-3.72
-32.08	-20.23	-16.5
-43.71	-14.62	2.12
67.29	-15.32	-16.94
50.19	-9.97	-14.96
-3.27	0.37	-14.1
3.06	50.08	-4.96
-22.43	57.1	19.28
59.91	2.12	2.87
21.99	-73.7	44.24
-1.42	-77.22	55.95

// Gentili C, 2009: Social Phobics
// Subjects=8
-8.07	-56.59	34.23
57.05	-52.57	25.34
28.62	-3.35	-37.57
-38.41	-12.81	-2.55
-53.65	22.65	-24.31
33.94	21.69	-30.81
43	-18.02	19.25
11.5	21.55	-30.54
-15.8	45.1	42.52
34.05	20.6	-17.34
21.99	-73.7	44.24
-1.42	-77.22	55.95

// Grabner R H, 2009: Retrieval > Procedural
// Grabner R H, 2009: Procedural > Retrieval
// Subjects=28
-54	-66	36
12	3	0
-9	-72	51
9	15	51
36	-3	63
45	9	27
30	-66	45
-3	-75	12
-51	-63	-12
-15	-42	-3

// Perfetti B, 2009: Activations
// Subjects=8
0.37	16.99	49.15
-29.43	-9.37	55.05
27.2	-5.86	54.1
-47.8	1.59	33.15
49.38	12.49	27.77
-30.99	20.69	3.47
36.34	21.1	2.67
-47.9	-65.37	-6.96
53.53	-55.76	-15.62
-33.62	-51.4	48.58
32.69	-60.26	51.91

// Solomon M, 2009: ASDs
// Subjects=22
55.89	3.08	-24.89
-54.16	11.48	-9.28
-53.27	2.38	-26.33
5.85	-25.5	28.09
27.72	-42.05	45.05
-33.1	-66.55	16.01
-53.23	-25.35	55.98
-29.47	54.11	-13.92
31.09	55.91	-9.53
-24.3	-89.4	23.72
-15.38	-57.74	51.82
24.89	-86.48	-16.62
-20.38	53.11	20.76
26.89	-67.95	-25.21
-58.13	-41.73	7.26
-62.11	-41.38	34.18
-22.53	-84.65	-5.91
-52.32	-32.11	40.94
-28.4	1.95	59.58
27.45	-83.46	15.53
29.82	-40.33	40.36
-52.29	-34.03	43.37
-26.23	-.17	59.75
-6.47	-43.73	74.93
37.77	-31.25	-12.22
44.48	-49.23	1.77
-60.2	13.62	25.35
23.7	-59.55	64.78
-13.12	-59.24	58.65
-22.54	53.1	20.8
-30.94	-68.77	15.07
-46.18	-70.72	6.56
40.33	-34.82	18.34
-15.45	17.2	61.21
19.21	-64.11	50.74
20.98	-79.02	17.44
-39.91	-73.42	-11.21
44.29	-71.41	-17.32
25.91	-26.29	76.01
-46.03	13.54	35.2
-26.87	-87	-7.85
-.21	9.37	68.45
6.42	-32.19	71.33

// Solomon M, 2009: Normals
// Subjects=23
-20.16	-92.96	8.32
-57.69	-40.64	41.88
29.59	-88.02	12.58
60.57	-35.77	-4.32
-31.72	51.25	-21.44
14.42	27.58	32.78
3.91	12.29	53.52
-51.02	13.96	-17.42
31.05	58.89	-12.06
38.68	7.27	66.87
-46.02	7.05	34.72
1.45	-12.96	24.69
-22.53	50.98	21.01
-37.56	37.41	25.97
25.69	17.97	67.16
35.49	28.07	-9.09
27.72	-42.05	45.05
-33.1	-66.55	16.01
-53.23	-25.35	55.98
-29.47	54.11	-13.92
31.09	55.91	-9.53
-24.3	-89.4	23.72
-15.38	-57.74	51.82
24.89	-86.48	-16.62
-20.38	53.11	20.76
26.89	-67.95	-25.21
-58.13	-41.73	7.26
-62.11	-41.38	34.18
-22.53	-84.65	-5.91
-52.32	-32.11	40.94
-28.4	1.95	59.58
27.45	-83.46	15.53
29.82	-40.33	40.36
-52.29	-34.03	43.37
-26.23	-.17	59.75
-6.47	-43.73	74.93
37.77	-31.25	-12.22
44.48	-49.23	1.77
-60.2	13.62	25.35
23.7	-59.55	64.78
-13.12	-59.24	58.65
-22.54	53.1	20.8
-30.94	-68.77	15.07
-46.18	-70.72	6.56
40.33	-34.82	18.34
-15.45	17.2	61.21
19.21	-64.11	50.74
20.98	-79.02	17.44
-39.91	-73.42	-11.21
44.29	-71.41	-17.32
25.91	-26.29	76.01
-46.03	13.54	35.2
-26.87	-87	-7.85
-.21	9.37	68.45
6.42	-32.19	71.33

// Wu S S, 2009: Mental Arithmetic, Roman, Calculation - Identification
// Wu S S, 2009: Mental Arithmetic, Roman, Identification - Calculation
// Wu S S, 2009: Mental Arithmetic, Arabic, Calculation - Identification
// Wu S S, 2009: Mental Arithmetic, Arabic, Identification - Calculation
// Wu S S, 2009: Mental Arithmetic, Arabic - Roman
// Wu S S, 2009: Mental Arithmetic, Roman - Arabic
// Subjects=18
36	-50	42
54	-54	-18
2	-64	-30
36	-88	4
-14	52	34
-54	-66	28
48	-70	28
-52	14	30
-22	-70	42
34	-52	44
-2	54	8
56	-58	12
-46	-72	42
-46	-72	20
-4	56	24
-54	10	8
-26	32	-4
-22	8	58
-2	6	60
38	20	-6
-24	-58	-42

// Kana R K, 2009: Autism Patients
// Subjects=12
52	30	0
-48	38	-14
42	-54	-24
46	8	24
58	-52	6
56	-28	18

// Kana R K, 2009: Healthy Controls
// Subjects=12
-10	56	42
-50	-72	28
-54	20	8
44	-48	18
0	-62	32
-42	18	48
60	-10	-18
44	-46	-22
-54	-12	-24
-42	-56	-14
-54	-34	-10
60	24	22
56	-28	18

// Kraus A, 2009: BPD+PTSD Patients > BPD Only Patients, Deactivations
// Subjects=12
24.5	-6.23	-19.44

// Reske M, 2009: Schizophrenia patients
// Subjects=18
-10	-48	42
-10	-58	22
-32	-78	48
14	-54	16
54	-46	40
-44	-40	48
-28	36	44
36	34	42
-54	-8	44
44	-12	54
20	-32	56
0	-32	42
-52	-56	22
-48	-30	14
66	-14	-2
58	-52	14
-48	-66	-8
40	-12	4
-32	-84	16
-18	-70	6
26	-84	16
10	-46	-2
-4	-64	24
-52	-42	46
-34	28	42
-38	32	-4
12	-54	-6
0	-38	40

// Reske M, 2009: Healthy subjects
// Subjects=18
-14	104	10
40	-50	60
-32	-52	38
16	20	60
-34	10	60
-26	42	24
44	12	54
-42	10	28
-40	30	26
40	42	-2
-28	28	-14
-46	38	-2
52	18	-2
-52	-14	26
6	24	40
54	-68	8
-56	-64	10
46	-60	-20
32	-72	-14
22	-88	38
38	-72	22
6	-64	14
14	10	0
-12	8	0
-4	-64	24
-52	-42	46
-34	28	42
-38	32	-4
12	-54	-6
0	-38	40

// Soulieres I, 2009: Autism (AUT) Group
// Subjects=15
-32	-84	-10
-22	-92	16
-36	-76	-10
-12	-98	2
-46	-28	46
-56	2	32
-38	-4	12
-28	20	4
-32	-4	-4
-14	-18	6
-2	-40	-42
-20	-58	-54
-26	-50	-54
-34	-54	-54
30	-84	16
34	-76	-12
32	-42	46
32	-52	50
24	-60	56
56	6	30
2	4	18
54	8	12
12	-14	0
-36	-58	24
-44	-68	38
-24	-84	-10
-26	-92	16
-30	-76	-10
-28	-66	-14
-12	-98	2
-44	-30	46
-36	-34	50
-32	-44	50
-28	-58	54
-54	4	34
-38	-4	12
-28	20	4
-34	-2	2
-12	-14	6
-28	-2	-4
-8	-14	-4
32	-88	12
30	-68	-12
34	-48	54
28	-56	50
48	8	28
58	8	30
60	8	22
30	-4	52
32	20	4
28	26	0
12	-10	2
8	-18	-4
2	-36	-42
-20	-16	58
-44	-14	42
-32	-14	42
-56	0	20
-50	-6	-34
28	-14	46
42	-16	40
46	-18	32
22	-18	50
22	-16	64
30	-12	70
-28	-88	-4
-38	-82	-6
-24	-92	18
-32	-88	12
-26	-74	32
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
36	-76	-10
-24	-64	52
-24	-4	56
-42	28	26
-46	2	34
34	-50	50
54	10	30
28	-6	52
44	36	20
-54	-22	-16
-44	-64	28
-56	-60	12
-52	-62	20
-56	-34	16
-64	-44	16
-60	0	0
-48	-64	38
-60	-46	30
-22	-6	32
-20	42	42
-8	-36	10
-8	46	2
60	-14	-20
62	-6	-12
62	-46	20
62	4	-2
40	-36	-6
36	-46	0
2	-66	36
2	-84	36
58	-48	32
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
4	34	14
12	34	-2
22	-18	-18
-28	-88	-4
-32	-88	12
-26	-92	16
-26	-74	32
-22	-64	52
-30	-50	50
-24	-2	56
-42	28	26
-46	2	34
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
32	-74	30
22	-64	58
52	10	28
28	-6	52
44	36	20
-44	-64	28
-60	0	0
-52	-62	20
-58	-32	18
-60	-42	24
-46	-68	38
-22	-6	32
-20	42	42
-6	-44	12
-8	46	2
-10	-36	6
60	-14	-20
58	-8	-14
62	2	2
36	-46	0
40	-38	-6
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
2	34	16
12	34	-2
22	-18	-18
40	-30	-12
14	-38	10
-2	-60	40
-42	22	36
-36	34	38
2	-58	54
36	42	34
-22	-92	18
-18	-82	24

// Soulieres I, 2009: Non-Autistic (Non-AUT) Controls
// Subjects=18
-12	-98	4
-14	-92	-2
-20	-86	-8
-28	-70	-12
-36	-38	48
-42	-30	46
-28	-50	54
-18	-66	50
-58	8	30
-50	2	36
-38	-2	12
-28	20	4
-12	-14	6
-8	-14	-4
-24	0	2
-26	-14	0
26	-80	-10
28	-70	-12
26	-62	50
28	-62	38
58	8	30
60	8	22
46	8	26
32	26	-2
38	0	14
32	24	8
12	-10	2
22	-24	-4
8	-18	-4
2	-36	-42
22	4	0
26	-4	0
30	6	-8
-24	-84	-10
-26	-92	16
-30	-76	-10
-28	-66	-14
-12	-98	2
-44	-30	46
-36	-34	50
-32	-44	50
-28	-58	54
-54	4	34
-38	-4	12
-28	20	4
-34	-2	2
-12	-14	6
-28	-2	-4
-8	-14	-4
32	-88	12
30	-68	-12
34	-48	54
28	-56	50
48	8	28
58	8	30
60	8	22
30	-4	52
32	20	4
28	26	0
12	-10	2
8	-18	-4
2	-36	-42
-20	-16	58
-44	-14	42
-32	-14	42
-56	0	20
-50	-6	-34
28	-14	46
42	-16	40
46	-18	32
22	-18	50
22	-16	64
30	-12	70
-30	-88	-8
-30	-92	4
-18	-94	-4
-18	-66	52
-34	-42	46
-26	-74	32
-24	-2	54
-44	14	30
-48	24	28
-6	8	56
-8	18	48
-42	44	-2
-30	24	-2
-4	-74	-24
30	-92	-4
38	-86	-4
32	-74	28
18	-64	58
28	-62	40
26	-62	52
28	-2	54
46	8	26
50	20	36
42	26	24
48	38	16
6	16	52
32	24	-2
8	-74	-24
0	-52	-40
2	-38	-42
-58	-30	20
-58	2	4
-42	6	-12
-50	-12	14
-6	-44	32
-6	-66	-8
2	-82	40
4	-42	26
4	48	0
10	38	-4
0	-22	42
6	-66	-6
-28	-88	-4
-32	-88	12
-26	-92	16
-26	-74	32
-22	-64	52
-30	-50	50
-24	-2	56
-42	28	26
-46	2	34
28	-92	-4
38	-84	-4
34	-88	2
32	-88	10
32	-74	30
22	-64	58
52	10	28
28	-6	52
44	36	20
-44	-64	28
-60	0	0
-52	-62	20
-58	-32	18
-60	-42	24
-46	-68	38
-22	-6	32
-20	42	42
-6	-44	12
-8	46	2
-10	-36	6
60	-14	-20
58	-8	-14
62	2	2
36	-46	0
40	-38	-6
22	-2	26
4	52	8
2	-28	42
2	-42	28
6	44	-4
2	34	16
12	34	-2
22	-18	-18
40	-30	-12
14	-38	10
-2	-60	40
-42	22	36
-36	34	38
2	-58	54
36	42	34
-22	-92	18
-18	-82	24

// Kim Y H, 2009: MPP, Healthy Controls > Traumatic Brain Injury Patients, 
// Activations
// Kim Y H, 2009: MPP, Healthy Controls < Traumatic Brain Injury Patients, 
// Activations
// Kim Y H, 2009: MPP, Posttraining > Pretraining, Subgroup of Traumatic Brain 
// Injury Patients, Training Completion
// Subjects=10
6	2	66
-2	-4	66
0	-12	32
0	14	32
22	28	38
28	8	36
42	40	-8
-26	-10	-28
38	-10	-4
6	24	18
-2	28	18
8	-58	40
-2	-52	48
46	-58	6
4	-58	-6

// Kohl A D, 2009: Group x Within-Run Fatigue
// Kohl A D, 2009: Group x Across-Run Fatigue x Within-Run Fatigue
// Kohl A D, 2009: Fatigue-Interaction Analysis: Group x Within-Run Fatigue
// Kohl A D, 2009: Fatigue-Interaction Analysis: Group x Across-Run Fatigue x 
// Within-Run Fatigue
// Subjects=11
0.6	-7.02	69
-41.72	47.58	8.03
0.12	23.22	19.63
-18.6	-85.83	42.38
-63.9	-21.29	14.06
-57.67	-0.07	-1.17
53.44	19.09	2.64
34.8	-69.4	43.73
2.46	-49.44	15.66
-21.93	1.85	61.83
-12.19	-72.59	47.88
-57.77	-1.01	-13.36
-19.23	-26.42	-15.01
-38.34	-38.45	-3.75
40.7	46.19	23.93
59.92	16.47	9.48
53.95	-40.47	44.43
53.41	-46.04	-27.58
0.6	-7.02	69
-41.72	47.58	8.03
0.12	23.22	19.63
-18.6	-85.83	42.38
-63.9	-21.29	14.06
-57.67	-0.07	-1.17
53.44	19.09	2.64
2.46	-49.44	15.66
-25.59	55.31	23.93
-44.44	-74.84	21.68
-41.54	-38.47	-3.71
-12.8	2.31	-1.88
5.86	-73.77	31.05
15.11	3.77	14.4

// Lee P S, 2009: Regional activation for the NoGo vs Go trials
// Subjects=12
6.74	11.14	41.76
-33.27	19.14	-16.44
34.04	15.06	-20.22
-27.81	39.12	7.47
32.13	31.62	15.22
-12.72	18.57	15.71
-7.4	4	5.72
59.15	-45.24	23.58
-55.13	-23.32	42.01
46.41	-23.52	44.21

// Dormal V, 2009: Numerosity Processing vs. Ref for N
// Dormal V, 2009: Discrete Length vs. Ref for DL
// Dormal V, 2009: Continuous Length vs. Ref for CL
// Dormal V, 2009: Conjunction of Discrete Length and Continuous Length
// Dormal V, 2009: Conjunction of 3 Experimental Tasks (N, DL, CL)
// Dormal V, 2009: Conjunction of N and DL tasks masked exclusively by CL
// Dormal V, 2009: Conjunction of 3 Reference Tasks
// Subjects=14
48	6	26
-48	4	26
30	-2	64
42	32	28
46	-38	50
-32	-52	52
-44	-74	-8
6	16	46
32	26	0
44	-40	50
-38	-46	50
-22	-64	52
48	6	28
34	28	0
-44	-76	-6
-34	-84	14
6	16	46
30	0	60
50	4	26
40	-42	48
-40	-50	64
28	-40	44
50	4	26
40	-42	48
-40	-50	64
-30	-80	24
46	-60	-10
-42	-40	42
58	-66	28
12	-54	36
-52	-62	20
-58	-46	0
-50	-20	18
54	-14	-20
-12	46	34
-16	68	16
-4	62	-8

// Cantlon J F, 2009: Healthy Controls
// Subjects=14
44	-68	8
-48	-68	-4
-24	-60	48
-28	-8	52
-40	-12	68
40	8	16
-32	12	16
-40	-52	-64

// Cantlon J F, 2009: Children
// Subjects=14
-24	-60	-8
16	-52	-12
-20	-48	-4
-47	-72	0
-24	20	12
-32	12	16
48	16	12
40	12	16
40	0	32
-8	0	52
-24	-12	56
-8	-4	64
-40	0	36
8	-16	16
-12	-20	16
-20	-56	48
40	8	16
-32	12	16
-40	-52	-64

// Leroux G, 2009: (INT-REfint) AND (COV-REFcov)
// Leroux G, 2009: (INT-REfint) - (COV-REFcov)
// Leroux G, 2009: (COV-REFcov) - (INT-REfint)
// Subjects=9
60	-50	-10
48	-40	46
62	-28	46
20	-70	54
18	-62	58
6	22	46
6	36	30
54	14	26
44	46	14
38	24	-2
34	-90	-10
-30	-62	52
22	-70	54
34	-66	50
12	-64	60
-12	-64	52
-26	-66	38
34	-64	38
8	22	46
-6	36	42
4	32	50
54	38	30
6	12	26
38	4	14

// Bledowski C, 2009: Selection
// Bledowski C, 2009: Updating
// Subjects=17
-21	-6	51
24	-3	51
-18	-66	57
18	-60	57
42	-36	42
-24	30	36
-21	-30	39
-9	-48	36
6	-45	33
-3	54	-6
18	57	24
18	51	-3
-51	-66	36
-27	0	-21
-24	-3	57
27	-3	54
-18	-66	54
18	-60	57
-33	-39	42
42	-39	54
27	63	12
-21	12	-6

// Nee D E, 2009: Perceptual Selection
// Nee D E, 2009: Memorial selection
// Nee D E, 2009: Perceptual and Memorial Selection
// Nee D E, 2009: Perceptual Selection Unique
// Nee D E, 2009: Memory Selection Unique
// Nee D E, 2009: Forget vs Remember Cues, Memory updates
// Subjects=18
-28	4	56
-42	-4	44
-48	0	56
-46	30	30
14	0	68
48	4	38
24	-2	52
4	20	44
42	46	26
34	46	24
52	-48	26
58	-48	8
-26	-66	56
-14	-66	54
-32	-84	26
22	-66	58
34	-52	46
26	-60	54
50	-34	2
56	-44	2
-52	-36	0
-60	-52	4
20	-100	-8
28	-98	-14
-16	-102	-6
-20	-96	-12
6	-8	0
18	-82	-30
26	-74	-32
20	-14	-14
18	-2	16
-52	20	28
-54	14	22
-48	26	34
-56	10	38
-50	-4	39
-2	18	50
6	28	32
6	8	68
50	8	40
36	4	56
50	36	30
40	46	28
60	14	32
34	26	2
48	14	-4
46	28	2
-30	8	60
-28	8	66
-24	-66	42
-34	-66	50
-36	-50	42
34	-60	42
32	-62	34
36	-44	44
-52	-46	4
-60	-38	0
48	-42	2
52	-34	2
16	-76	-34
-16	-2	4
-40	-70	-36
4	12	20
-6	-84	-26
-25	5	52
-44	32	30
-48	0	48
2	18	44
2	6	60
44	6	44
38	44	26
-56	14	2
-36	28	-4
-38	22	16
36	28	-8
14	30	20
-6	-64	52
-22	-66	52
24	-66	52
-50	-38	42
52	-40	4
-54	-46	2
52	14	-4
-56	16	-14
28	-76	-32
20	2	12
8	-6	2
-14	0	14
-34	-60	-32
-8	-12	0
-18	6	8
16	-2	64
50	-6	54
18	-60	64
-22	-58	66
54	-44	22
-10	-50	54
-20	-98	-10
22	-98	-8
-32	-84	22
-22	6	0
-6	-34	-46
-48	26	12
46	38	18
-2	28	42
38	12	56
34	30	0
10	42	16
-38	-56	44
44	-52	44
0	-74	46
-42	-68	-38
58	-64	-38
46	-58	-38
4	-88	-34
46	-82	-30
6	-30	-22
2	8	20
58	6	36
-50	12	50
-36	28	26
-44	22	36
-8	26	52
-16	6	70
-8	14	66
-4	40	36
-8	42	28
50	26	26
46	10	48
50	16	32
52	16	42
30	56	2
28	60	10
10	10	68
32	34	-4
50	38	8
12	16	36
-46	-58	56
-42	-66	50
-22	-72	50
-50	-48	52
-36	-52	54
28	-64	58
36	-66	54
44	-60	52
54	-36	42
-24	-60	49

// Grezes J, 2009: Dynamic > Static, Controls and ASD
// Grezes J, 2009: Dynamic > Static, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, Controls and ASD
// Grezes J, 2009: Fearful > Neutral, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, ASD > Controls
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, Controls and ASD
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, Controls > ASD
// Grezes J, 2009: Fearful > Neutral, Dynamic > Static, ASD > Controls
// Subjects=12
-50	-76	0
-28	-88	24
-52	-56	2
-24	-94	8
-24	-94	30
50	-76	6
48	-58	0
56	-40	16
56	-46	10
44	-68	-16
28	-96	4
32	-50	50
36	-78	24
44	4	54
44	18	24
-68	-46	16
54	-36	18
46	-74	-6
-52	-54	0
14	48	54
48	-32	0
44	-4	50
-64	16	12
10	-68	56
54	14	50
-54	-72	6
42	-42	-26
-48	-76	4
54	-44	10
48	-64	6
-24	-100	-10
-46	-52	10
52	22	0
44	-6	56
46	-16	-24
22	-16	74
36	-4	-20
58	-44	-6
-6	62	10
60	-48	10
18	-54	48
44	-60	20
62	28	20
12	-42	44
16	-60	8
44	0	-20
-34	10	-16
-36	-38	20

// Jung W H, 2009: Activation associated with biological motion vs scrambled 
// motion in OCD and control groups
// Jung W H, 2009: Increases in BOLD response associated with biological 
// motion vs scrambled motion, Control>OCD
// Jung W H, 2009: Increases in BOLD response associated with biological 
// motion vs scrambled motion, OCD>Control
// Subjects=15
60.84	-52.39	13.01
-58.88	-60.08	29.26
-60.08	-47.84	22.46
69.29	-28.63	2.67
-58.07	-27.08	14.77
-41.62	-56.93	27.53
60.68	-51.41	0.59
42.47	-80.94	7.18
58.8	-27.44	27.38
53.76	-67.38	48.23
-62.26	-32.64	24.36
-39.21	-60.47	46.89
-39.38	17.04	49.31
-4.98	54.18	42.81
4.92	46.3	-30.54
-5.86	50.82	-27.44
-14.42	42.7	-22.01
-37.53	-24.67	16.42
-46.29	-9.16	10.56
14.64	-.31	44.5
5.94	-16.06	37.24
-.48	-27.68	39.62
-56.32	34.43	-4.79
-50.81	27.63	2.51
59.68	-35.48	10.23
-58.21	-42.36	0.6
55.37	-50.7	8.45
62.79	-41.93	-1.51
-52.74	-47.24	5.47
65.16	-63.32	10.65
35.97	-99.67	2.42
-54.04	34.21	4.16
-53.94	26.22	10.55
60.33	30.28	-9.73
58.26	33.13	-2.13
51.15	21.12	30.55
48.88	26.87	23.3
55.31	33.07	20.34
-48.42	23.88	19.65
-42.13	-56.31	-11.74
46.37	-46.84	-18.67
-50.88	-34.21	-16.02
56.54	-21.59	21.24
60.62	-44.17	-2.37
56.45	-48.57	8.22
-46.43	-56.22	-10.56
-44.3	-47.71	-11.44
-50.88	-34.21	-16.02
16.08	-65.86	-25.24

// New A S, 2009: PTSD
// Subjects=14
-6	-42	10
14	-42	38
-32	38	-8
20	20	50
-38	2	36
-4	40	44
-36	30	-12
-36	-6	36
-42	-60	40
54	8	2
-52	-58	0
-56	-8	10
54	-2	10
0	-60	2
-18	46	32
-22	32	42
-12	38	40
10	22	50
44	14	36
-42	-62	52
14	-66	60
-58	-30	18
20	-68	-8
-6	12	60
44	16	38
-40	10	44
30	6	-30
32	-22	-18

// New A S, 2009: Non-PTSD
// Subjects=14
4	-24	26
-22	12	48
14	26	48
-34	16	56
-34	-66	48
10	6	16
50	-66	2
56	10	0
18	-84	40
38	-82	-4
0	-60	2
-18	46	32
-22	32	42
-4	2	42
-6	12	60
44	16	38
-40	10	44
30	6	-30
32	-22	-18

// New A S, 2009: Healthy Controls
// Subjects=14
-6	-42	10
14	-42	38
-32	38	-8
20	20	50
-38	2	36
-4	40	44
-36	30	-12
-36	-6	36
-42	-60	40
54	8	2
-52	-58	0
-56	-8	10
54	-2	10
4	-24	26
-22	12	48
14	26	48
-34	16	56
-34	-66	48
10	6	16
50	-66	2
56	10	0
18	-84	40
38	-82	-4
-12	38	40
10	22	50
44	14	36
-42	-62	52
14	-66	60
-58	-30	18
20	-68	-8
-4	2	42

// Strangman G E, 2009: Group (Simple Effect), Directed - Spontaneous, Healthy 
// Controls > TBI Patients
// Strangman G E, 2009: Group x Condition
// Strangman G E, 2009: Group x LBCsem
// Strangman G E, 2009: Condition x LBCsem
// Subjects=20
-52	-61	43
-32	29	29
4	-14	29
-52	-58	39
-14	31	43
29	-8	16
-30	-15	21
-24	-2	5
13	-13	37
29	-5	16
26	-5	-12
6	-19	66
-23	29	30
-33	32	30
26	59	1
-1	-88	21
-52	-61	39

// Chen S, 2009: Post-traumatic stress disorder (PTSD)
// Subjects=12
8.26	24.52	57.84
33.59	57.35	17.18
42.7	19.25	45.45
58.7	29.86	31.8
53.23	33.68	27.03
-52.72	30.56	22.42
-43.97	35.78	31.84
-29.13	-31.93	-4.29
-24.94	-29.66	-14.67
26.96	-34.59	-12.83
-42.18	12.25	-1.72
25.37	23.23	43.11
40.54	19.24	45.49
-53.81	21.73	19.95
58.15	41.01	-9.63
-5.11	2.86	22.11
3.16	1.15	-8.12
6.12	-44.26	45.63
-20.51	-29.88	-5.76
14.23	-41.69	3.78
-18.16	-47.12	4.87
-41.84	-20.22	18.3
12.71	20.05	67.17
-11.85	47.95	11.04
9.35	59.15	-19.56
-62.55	19.91	12.44
18.38	-34.2	-8.24
10.4	19.96	54.89
-39.34	21.71	53.33
26.79	69.18	-5.16
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
-31.52	-23.82	-20.74
35.42	-19.54	-24.55
-43.95	-32.99	19.6
46.75	-30.86	14.48

// Chen S, 2009: Healthy Controls
// Subjects=12
-64.47	10.72	29.07
58.73	0.52	27.98
35.28	58.18	-19.91
-58.24	35.13	14.22
-56.39	38.27	-9.65
24.46	13.19	-29.84
7.47	3.3	-8.4
-5.11	2.86	22.11
6.12	-44.26	45.63
-29.15	-29.91	-5.61
14.23	-41.69	3.78
-18.16	-47.12	4.87
-46.54	16.28	-4.28
48.54	10.13	-6.42
25.37	23.23	43.11
40.54	19.24	45.49
-53.81	21.73	19.95
58.15	41.01	-9.63
-5.11	2.86	22.11
3.16	1.15	-8.12
6.12	-44.26	45.63
-20.51	-29.88	-5.76
14.23	-41.69	3.78
-18.16	-47.12	4.87
-41.84	-20.22	18.3
29.05	69.91	2.57
-48.85	18.43	-15.66
10.4	19.96	54.89
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
35.42	-19.54	-24.55
-31.52	-23.82	-20.74
-43.95	-32.99	19.6
46.75	-30.86	14.48
10.4	19.96	54.89
-39.34	21.71	53.33
26.79	69.18	-5.16
-13.56	-5.6	35.42
25.28	-40.84	23.68
-42.21	-33.98	-13.95
-31.52	-23.82	-20.74
35.42	-19.54	-24.55
-43.95	-32.99	19.6
46.75	-30.86	14.48

// Elman I, 2009: PTSD
// Subjects=20
25	2	-1
-2	8	11

// Elman I, 2009: Healthy Controls
// Subjects=26
16	13	-2
25	2	-1
-2	8	11
26	7	-8

// Felmingham K L, 2009: Posttraumatic stress disorder (PTSD)
// Subjects=11
16	40	18
26	-12	-22
-34	-22	-10
64	-20	38
22	18	40
30	-30	-22
-2	-18	2
36	20	38
28	-12	-24
10	-20	54
-8	8	42
44	22	14
8	24	18
50	-24	24
-44	30	42
36	12	28
4	34	-8
-52	12	2
30	6	32
-36	34	26
-46	-38	28

// Felmingham K L, 2009: Healthy Controls
// Subjects=11
16	40	18
26	-12	-22
-34	-22	-10
64	-20	38
22	18	40
30	-30	-22
-2	-18	2
36	20	38
28	-12	-24
10	-20	54
-8	8	42
44	22	14
4	34	-8
-62	-32	42
-52	10	4
4	34	-8
-52	12	2
30	6	32
-36	34	26
-46	-38	28

// Shaw M E, 2009: PTSD
// Subjects=13
-40	-50	61
35	-54	52
50	-38	55
-38	54	-1
27	56	4
-27	31	-24
-38	41	-20
-57	11	29
48	20	29
42	33	12
-37	18	-7
-57	12	-7
-17	7	70
13	17	64
-37	0	60
33	7	60
-2	19	43
-55	-39	-16
-50	-30	-22
-44	-65	-23
12	-78	-26
32	-70	-47
-2	2	70
-13	26	58
-3	32	17
-3	39	-4
17	57	9
49	-70	-23

// Shaw M E, 2009: Healthy Control
// Subjects=12
-29	-61	52
31	-59	52
-45	-41	55
50	-33	55
42	48	16
-52	11	29
48	15	29
-37	0	60
33	7	60
-2	15	49
-1	-7	-14
-5	-37	-16
-2	15	-1
14	-19	13
-34	-61	57
-2	24	43
48	25	-12

// Thomaes K, 2009: PTSD
// Subjects=9
-18	-12	-18
-36	-27	-21
-42	-30	-21
-45	-36	-15
-42	-42	-21
-36	-15	-18
-39	-27	-24
-42	-39	-15
-21	-12	-15
-36	-9	-33
-30	-18	-9
-36	-9	-33
-33	-9	-18
-30	-9	-12

// Thomaes K, 2009: Healthy Control
// Subjects=9
-36	-24	-21
-39	-27	-24
-42	-39	-15
-30	-18	-9
-36	-9	-33

// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Happy
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Sad
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Angry
// Seiferth N Y, 2009: Healthy Controls > Schizophrenia, Fearful
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Happy
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Angry
// Seiferth N Y, 2009: Schizophrenia > Healthy Controls, Fearful
// Seiferth N Y, 2009: Conjunction Analysis: Healthy Controls > Schizophrenia, 
// All emotions
// Seiferth N Y, 2009: Conjunction Analysis: Schizophrenia > Healthy Controls, 
// All emotions
// Subjects=12
-36	-70	-10
32	-78	-6
0	-16	2
-34	-72	-8
-2	-22	-18
-14	-14	22
60	-44	20
0	-36	24
16	-34	16
48	-78	18
22	-80	30
44	-62	14
60	-20	16
40	-8	-14
30	-18	20
-16	-40	-20
-38	-38	12
66	-22	-4
20	-36	-20
62	-48	40
50	-24	-6
-36	-70	-10
32	-78	-6
-2	-18	2
-26	-78	-8
32	-78	-8
46	-38	6
8	-82	18
8	-82	18
-4	-54	8
-56	10	32
-8	-66	22
8	-82	14
-36	-70	-10
32	-78	-6
8	-82	14

// Mak A K Y, 2009: Control > Depressed, Gray Matter Concentration
// Mak A K Y, 2009: Control > Depressed, Gray Matter Volume
// Subjects=17
18	42	15
20	5	56
7	28	41
-23	54	15
34	29	-23
70	9	45
31	21	-31
57	-15	-8
-52	-45	-5
24	-41	-16
-1	-71	61
19	43	13
66	11	44
13	-18	59
31	21	-31
-51	-46	-4
-50	-60	36
-1	-67	60

// Milad M R, 2009: TENC > PTSD, extinction learning, blue > yellow
// Milad M R, 2009: PTSD > TENC, extinction learning, blue > yellow
// Milad M R, 2009: TENC > PTSD, extinction recall, blue > red
// Milad M R, 2009: PTSD > TENC, extinction recall, blue > red
// Subjects=15
-15.26	35.23	-30.27
27.62	-7.07	-30.56
-9.87	45.63	-20.05
2.94	47.74	-21.49
35.09	-10.46	-33.7
-1.06	41.82	12.51

// Werner N S, 2009: Encoding test > encoding control, PTSD > control
// Werner N S, 2009: Encoding test > encoding control, control > PTSD
// Werner N S, 2009: Retrieval test > retrieval control, PTSD > control
// Werner N S, 2009: Retrieval test > retrieval control, control > PTSD
// Subjects=12
-47.09	25.29	-4.53
11.06	17.05	49.02
-46.77	22.03	35.88
33.19	17.28	8.6
39.68	24.69	21.29
-1.84	29.41	44.79
-21.1	-10.57	24.94
-14.79	-4.96	14.36
7.8	16.52	42.41
33.67	-63.4	38.78
-37.33	-68.71	-23.53
-45.93	-49.55	-22.8
42.93	-70.37	-10.93
40.63	-42.35	-19.94
20.3	-13.15	-12.12
33.27	-31.33	-.71
-30.95	-19.54	-7.65
-27.2	-60.08	45.89
-66.11	-35.19	-.36
-30.52	-51.35	35.16
-17.86	-95.86	-4.75
-21.15	-93.39	-13.84
10.73	-75.28	-30.22
7.4	61.79	8.51
1.23	24.71	25.07
-24.31	22.42	38.94
-7.95	-49.93	51.51
-62.71	-29.85	27.04
59.03	-26.72	15.34
62.3	-45.74	16.9
58.6	11.69	-24.68
-27.62	-44.64	-2.24
-43.34	-71.23	26.94
20.37	-38.78	-13.32
-54.54	1.44	-9.44
-51.33	1.48	-9.2
-37.46	22.17	-4.38
-5.05	22.79	42.03
36.29	16.27	-4.73
-39.47	-68.72	-23.5
1.73	-19.53	72.27
-2.21	51.96	6.1
-2.07	59.93	26.62
9.72	12.11	12.65
1.79	-61.79	62.43
-23.85	-42.06	72.22
59.19	-34.95	32.76
4.78	-47.46	41.12
49.38	-66.65	-4.62
-1.8	-69.1	9.55
-21.16	-57.29	-1.25
69.63	-11.05	10.56
52.54	-20.93	8.24
7.78	-59.52	8.64
17.6	-86.99	24.21
-17.7	-84.28	21.05
-4.83	-83.69	27.54

// Whalley M G, 2009: Emotional hits > Neutral hits, (PTSD, Depressed, 
// Control)
// Whalley M G, 2009: Negative hits > Neutral hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Positive hits > Neutral hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Negative hits > Positive hits (PTSD, Depressed, Control)
// Whalley M G, 2009: Positive hits > Negative hits (PTSD, Depressed, Control)
// Whalley M G, 2009: PTSD > depressed/control, old > new
// Whalley M G, 2009: PTSD < depressed/control, old > new
// Whalley M G, 2009: PTSD > depressed/control, Emotional > Neutral
// Whalley M G, 2009: PTSD > depressed/control, Negative hits > Neutral hits
// Whalley M G, 2009: PTSD < depressed/control, Negative hits > Neutral hits
// Whalley M G, 2009: PTSD > depressed/control, Positive hits > Neutral hits
// Whalley M G, 2009: PTSD > depressed/control, Postive hits > Negative hits
// Whalley M G, 2009: PTSD < depressed/control, Positive hits > Negative hits
// Subjects=16
-14	46	4
8	28	20
-38	30	28
-30	24	40
-12	48	2
16	-12	38
-30	26	42
-22	-82	-4
42	-54	38
-40	8	8
-30	6	10
-32	10	-12
-14	-50	-14
-18	0	-12
42	-74	6
38	-82	0
40	38	10
14	-4	36
20	-50	14
30	-68	16
-30	0	2
-18	-44	10
20	-50	12
-26	8	40
-22	6	60
-60	-4	-4
44	-64	4
14	-6	38
44	0	4
-26	-16	54
58	4	26
-38	-18	20
-40	-8	-8
30	-70	16
-44	-14	20
-12	-14	-8
-64	-36	22
-20	-64	20

// Albrecht J, 2009: Nicotine Stimulation vs. Audition and Rest
// Subjects=19
8	28	38
10	20	44
-8	16	50
46	38	0
22	4	-16
-30	-60	-30
-54	12	4
-40	16	-8
-62	-28	20
42	36	30
50	4	44
-4	-34	24
24	-64	28
-6	-80	42
20	-26	2
4	-30	-6
-22	-18	56
58	-30	38
58	-12	10
-34	-4	0
-58	-50	-4
-8	-76	-34
-38	-52	52
52	-38	22
2	-92	6
-30	-40	-40
30	-38	38
66	-32	14
26	-72	-32
-10	-12	4
50	-46	58
-12	-76	28
34	-6	12
30	50	-8
12	8	70
-10	-14	62

// Bai L, 2009: Visual, V1 vs BL
// Bai L, 2009: Visual, R1 vs BL
// Bai L, 2009: Visual, V2 vs BL
// Bai L, 2009: Visual, R2 vs BL
// Bai L, 2009: Acupuncture, A1 vs BL
// Bai L, 2009: Acupuncture, A2 vs BL
// Bai L, 2009: Sham, S1 vs BL
// Bai L, 2009: Sham, S2 vs BL
// Subjects=26
-8.23	-96.97	10.75
17.9	-97.55	26.05
-5.03	-97.27	7.37
4.65	-87.66	6.25
-17.78	-101.18	23.66
33.83	-90.75	6.06
-47.11	-42.27	23.93
52.64	8.49	-24.25
-27.22	-49.82	56.84
-40.35	-22.63	49.89
46.11	12.51	-26.78
-1.7	-73.57	19.53
7.96	-93.72	10.15
-44.09	-76.76	-.72
4.66	-90.85	6.57
-44.23	-78.86	-11.72
68.07	-11.07	-4.65
-20.83	-47.23	49.75
46.98	14.59	41.35
69.19	-20.64	-3.72
14.66	-72.37	31.46
20.34	-6.1	-17.78
-29.38	-28.38	-23.69
-5.23	32.54	18.06
5.53	37.79	16.23
-1.62	-15.02	37.27
5.91	-43.69	28.77
-2.32	-2.68	-14.37
5.29	-5.64	-11.96
-41.15	22.79	-3.9
39.89	23.18	-4.2
-44.4	-1.35	-9.3
46.4	-13.79	-9.61
-8.47	-28.69	6.24
7.7	-12.47	6.6
-2.18	-18.11	-7.24
4.3	-18.09	-7.35
-14.05	-26.32	77.82
-52.41	-27.32	34.87
58.86	-24.8	32.72
6.21	-11.86	59.23
-3.57	46.35	-18.08
6.08	43.63	-24.69
-30.54	31.26	-17.24
61.75	17.47	13.92
-57.23	-60.62	-11.06
-58.95	-21.17	32.13
65.34	-22.54	33.51
-1.84	-69.19	9.01
8.24	-70.81	37.02
-2.39	-62.29	-32
7.46	-61.32	-22.18
-15.17	-64.28	-18.14
20.59	-69.92	-11.47
-29.44	-5.84	-23.68
29.94	-7	-27.94
-31.57	-13.29	-22.9
29.02	-28.82	-20.16
7.37	48.49	-7.27
-2.29	-5.77	-12.94
4.17	-3.72	-14.37
-37.9	23.97	-2.95
43.09	21.81	-7.48
-45.41	-.83	-3.73
-44.22	-20.83	0.47
49.75	-12.95	-.79
13.96	-21.77	-12.76
-3.33	-30.65	-14.94
4.28	-29.14	-10.74
-1.56	-37.91	-46.75
2.79	-40.98	-45.4
-65.44	-22.36	31.24
57.59	-25.09	18.21
5.04	-14.71	51.69
-59.33	15.36	9.47
61.78	17.68	16.14
-59.43	-58.71	-13.45
59.46	-56.81	-11.18
-24.1	-71.47	43.24
27.8	-68.85	45.46
-27.97	-74.03	-6.87
20.98	-83.38	16.75
-2.3	-51.79	-22.95
5.18	-62.27	-32.13
-34.61	-67.54	-17.48
23.75	-60.64	-15.8
-28.31	-14.24	-21.74
-31.53	18.8	-12.63
36.79	25.27	6.85
-52.56	-29.52	22.76
44.21	-23.45	70.94
-55.81	-26.34	22.5
67.96	-5.14	242.41
-51	22.88	-13.83
5	43.63	-24.68
-47.24	14.73	25.02
42.98	51.59	-10.42
-52.53	-26.02	25.78
-56.12	-29.69	-1.81
68.04	-24.45	-10.05
-28.19	-41.79	-17.9
13.97	-79.69	-23.83
-24.92	-38.27	-14.94
30.06	-29.13	-23.51
-31.53	18.8	-12.63
40.16	-5.46	10.96
50.51	-23.71	56.29
-62.3	-26.37	22.62
49.68	21.5	0.28
-1.65	20.91	42.68
15.41	34.61	27.59
-31.58	21.68	-16.28
34.36	-43.01	57.35
-31.43	-41.8	-17.84
36.6	-41.76	-21.25
-24.98	-41.98	-20.18
23.71	-43.42	-15.26
-11.89	-62.9	-14.97

// Eger E, 2009: Number Comparison Same List
// Eger E, 2009: Number Comparison Different List
// Subjects=10
32	-75	36
-20	-63	57
-39	-47	57
-33	-42	66
15	-72	39
-8	-69	47
-48	2	51
-5	8	42
32	-63	45
30	-72	50
23	-65	53
-24	-59	47
-42	-53	54
-17	-63	44
-24	-62	60
-5	-68	56
33	-3	65
6	11	57

// Franklin M S, 2009: Magnitude Near>Far (common regions with Order Near>Far)
// Franklin M S, 2009: Order Far>Near (common regions with Magnitude Near>Far)
// Franklin M S, 2009: Magnitude Near>Far (Unique regions)
// Franklin M S, 2009: Order Far>Near (Unique regions)
// Subjects=17
-40	-52	52
-40	-52	52
-42	-44	46
-58	-42	48
-34	-64	52
2	-74	-26

// Roebling R, 2009: JME patients
// Subjects=19
-3	3	66
-51	-3	54
-45	3	27
-30	24	0
36	21	0
-15	-3	15
12	3	0
-27	-63	51
-45	-66	-15
-30	-63	-30
36	-66	-33
30	-3	60
51	36	33
51	9	27
-51	0	42
39	-45	51
-21	-69	60
63	-57	-15
-54	-63	-24
-42	-69	-27
48	-69	-30

// Roebling R, 2009: Healthy controls
// Subjects=20
-3	6	57
-45	-3	54
-51	12	15
-45	39	0
36	27	-3
-18	6	-3
12	6	3
-21	-66	48
-48	-39	-24
-39	-66	-24
39	-57	-33
27	3	60
45	36	30
51	9	30
-48	6	36
45	-42	57
-24	-66	57
60	-45	-18
-51	-63	-15
-42	-42	-33
57	-57	-21

// Costafreda S G, 2009: Patients in clinical remission after CBT-Low 
// intensity
// Costafreda S G, 2009: Patients in clinical remission after CBT- High 
// intensity
// Costafreda S G, 2009: Patients not in clinical remission after CBT-Low 
// intensity
// Costafreda S G, 2009: Patients not in clinical remission after CBT- High 
// intensity
// Subjects=16
-9.35	13.25	30.12
25.48	-10.91	45.36
-24.31	-7.45	39.15
-20.64	64.31	2.85
18.49	55.27	18.77
-6.82	27.01	62.33
37.94	31.32	14.08
-4.55	-22.53	60.47
31.65	-61.42	9.92
-11.11	-53.79	47.99
25.83	-47.74	64.69
38.35	-53.15	29.15
11.58	-4.84	-26.72
-1.27	-41.25	-25.14
9.54	-65.23	-29.67
8.03	18.4	38.28
-11.74	57.5	21.3
-8.98	27	62.37
8.46	-11.22	65.86
-34.68	-32.65	68.71
38.35	-53.15	29.15
43.17	-62.57	65.86
-19.8	-49.77	45.5
46.31	-29.82	-20.35
18.57	-99.5	-6.26
-33.23	-70.78	5.22
16.05	-65	-27.56
16.73	-33.66	32.08
11.7	-36.74	-23.56
7.32	54.66	-10.12
29.09	55.98	2.83
-24.21	2.1	49.41
49.46	1.68	63.88
19.24	-20.11	62.07
-28.72	-58.47	21.86
-65.56	-30.94	19.76
-39.6	-24.05	23.12
50.81	-39.41	-8.28
-15.23	-69.78	60.85
10.02	60.95	34.04
33.85	-96.07	6.58
-48.68	-51.43	-16.6
46.02	-45.08	-45.73
-20.71	-36.86	-23
22.23	-45.37	-47.54
9.3	55.55	-23.69
-26.38	4.22	49.23
46.08	64.81	-18.51
-35.46	0.86	13.86
-63.49	-29.43	12.85
57.83	-74.76	26.48
50.81	-39.41	-8.28
49.33	-45.27	43.88
29.96	-51.31	49.29
-46.52	-51.42	-16.63
29.49	-85.45	5.61
16.22	23.82	3.99
-13.97	22	9.16
-5.62	-41.47	-27.28

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Contralateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Ipsilateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Contralateral
// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Ipsilateral
// Subjects=15
-4.75	-7.13	67.96
-43.24	-24	59.78
-30.35	-19.98	69.33
-27.3	-28.1	46.56
-27.12	-39.5	64.24
1.54	-1.78	54.05
-49.91	-30.03	23.56
-53.32	-2.53	7.91
-27.7	-2.63	4.28
-1.91	-60.35	-1.21
4.83	-4.16	64.25
4.66	7.24	46.57
49.56	1.17	46.56
62.45	-24.39	45.21
36.83	-44.09	40.47
62.33	-32.28	25.8
52.43	1.02	3.05
58.91	5	12.68
42.79	0.7	-.16
39.55	16.8	1.88
49.11	39.32	3.22
14.02	-8.47	7.63
13.95	-52.02	-18.82
-21.29	-65.18	-20.66
-4.72	-10.05	71.55
-23.89	-32.63	70.32
-23.92	-19.68	72.58
-23.93	-42.91	61.14
-52.89	-21.14	56.3
-33.67	-31.05	50.22
-1.73	0.86	47.18
-4.88	-8.42	51.34
-11.17	-40.18	54.08
-53.16	-23.97	19.74
-43.68	-2.22	11.12
-40.56	-13	-4.74
-50.23	6.23	-2.9
-14.81	-21.59	5.72
-27.68	-8.98	4.81
1.27	-60.59	-4.58
11.29	-3.61	70.82
4.5	22.08	31.95
7.79	13.09	39.35
59.15	-32.04	29.17
33.22	7.76	9.4
36.48	-18.11	4.84
55.68	-1.88	6.6
7.64	-14.86	8.24
13.95	-52.02	-18.82

// Kumari V, 2009: Healthy Controls (HC)
// Subjects=14
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
42	-52	-16
28	-44	-6
30	-58	-12
26	-74	18
-20	-78	20
-20	-70	6
24	-66	2
28	-58	-2
26	-74	20
46	16	-2
52	18	6
42	20	-8
60	-46	16
64	-54	8
60	-32	2
64	-2	30
56	-6	32
48	-16	52
-38	-40	68
-42	-80	26
-54	-24	8
38	-82	40
36	-86	24
32	-70	56
-4	-30	8
10	-36	46
52	-16	-4
48	16	0
48	22	-8
-6	50	0
-2	22	40
6	12	54
-62	-52	4
-56	-52	30
-56	-60	32
10	-68	-2
22	-72	12
12	-38	4
-10	-62	60
-26	-46	70
-4	-38	64
0	-54	-10
-8	-40	8
4	-34	-10
-40	-74	30
-46	-82	14
-28	-88	40
44	-16	42
56	-4	36
46	-24	-8
-16	44	46
-26	34	46
-6	44	32
-44	-16	56
-50	-2	54
-38	-22	44

// Kumari V, 2009: Nonviolent Schizophrenia Patients (SZ)
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
26	-74	18
-20	-78	20
-20	-70	6
20	32	-14
-6	24	-2
-16	26	-8
42	-60	16
50	-12	-2
26	-74	14
-44	-34	-14
-36	-26	-6
-28	-84	10
-32	-76	24
-20	-66	6
-38	20	-6
-34	22	2
-42	16	-18
38	22	-4
56	14	-14
58	10	0
-46	-76	12
-40	-86	6
-50	-64	26
-2	-26	60
-2	-28	70
0	-38	60

// Kumari V, 2009: Violent Schizophrenia (VSZ) Patients
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
42	-52	-16
28	-44	-6
30	-58	-12
26	-74	18
-20	-78	20
-20	-70	6
24	-66	2
28	-58	-2
26	-74	20
20	32	-14
-6	24	-2
-16	26	-8
42	-60	16
50	-12	-2
26	-74	14
-44	-34	-14
-36	-26	-6
-28	-84	10
-32	-76	24
-20	-66	6
16	-10	8
12	20	0
-4	18	60
-2	42	32
4	26	54
40	24	-12
50	22	-18
54	20	-8
-38	-32	54
-42	-26	66
-38	-40	68
52	-76	26
44	-52	16
12	-64	8
-22	-42	-6
-34	-30	-20
-20	-34	-2
30	36	-10
56	22	-6
58	22	-4
66	-46	26
56	-44	16
62	-54	38
-8	50	0
-6	40	28
0	28	48
0	38	44
44	-64	6
50	-64	28
48	-56	-6
-20	-78	20
-22	-76	34
-32	-78	22
-38	-28	-20
-36	-38	-22
-54	-44	-14

// Kumari V, 2009: Antisocial Personality Disorder (APD) Patients
// Subjects=13
38	24	-8
50	18	-8
50	18	26
2	28	38
6	16	60
2	30	48
-40	20	-2
-46	24	-18
-60	-50	38
-60	-32	28
40	50	20
40	58	4
32	42	34
12	-2	6
-10	-4	6
4	-12	14
62	-32	26
58	-44	34
58	-52	44
20	-82	-8
28	-72	-26
18	-100	-2
-30	-76	-26
-16	-82	-26
46	22	-8
54	16	14
58	20	26
2	24	58
0	40	50
2	34	40
56	-52	46
58	-36	24
62	-54	36
-58	-50	38
-62	-56	24
-62	-54	14
-60	-26	-6
-66	-38	-6
-64	-52	-6
-40	22	-6
-50	20	4
-44	-24	66
-38	-30	56
-8	-38	64
-24	-42	-16
12	-56	20
30	-36	-22
46	-68	0
48	-68	24
38	-84	26
32	-54	62
26	-68	60
26	-54	46
-14	-44	4
-24	-54	-2
10	-68	0
14	-50	8
18	-36	4
-6	46	-2
4	48	-6
14	40	-2
-44	-26	66
-36	-36	70
16	-78	54
20	-74	38
-58	-18	48
-52	-14	30
-40	-10	16
-8	-52	68
-14	-72	48
-8	-62	56
44	26	-2
52	16	-6
-52	12	-2
-42	18	-2
-4	-20	22
4	22	36
4	32	30
-6	-30	64
4	-30	64
-42	-22	60
50	-68	4
50	-68	28
32	-76	34
10	-54	26
-2	-62	28
-2	-48	38
-42	-80	12
-28	-80	34
-48	-62	28
26	-74	18
-20	-78	20
-20	-70	6
16	-10	8
12	20	0
38	24	-8
52	12	-4
58	22	2
-20	-40	66
-10	-44	68
16	-34	70
48	-64	-8
40	-74	6
48	-72	4
50	-18	52
66	-4	28
44	-8	32
-22	-76	6
-38	-76	0
-32	-70	4
-8	-94	-2
-16	-100	2
-28	-92	12
40	-48	-16
16	-48	6
26	-62	6
-30	-36	-4
-10	-46	8
-18	-40	0
-8	-38	54
-28	-34	68
-14	-38	68
-6	-30	64
10	-32	66
18	-38	70

// Bonnet M, 2009: Healthy Controls
// Subjects=20
-30	-85	-17
-30	-44	-27
41	20	22
22	-85	32
29	-71	42
-42	-67	-20
41	6	28
32	-85	-11
-33	-92	-5
-27	20	34
-20	-75	-23
21	-24	-14
13	-37	-8
-15	-75	-20
4	-51	-6
-24	-17	-26
47	-64	27
4	34	38

// Bonnet M, 2009: Subgroup of Healthy Controls, Performance Data Available
// Subjects=19
38	3	-9
-40	-3	-16
34	-37	44
29	-27	17
-24	24	32
-52	-24	14
22	-10	40
-27	1	3
-42	-27	11
-40	-24	17
7	-89	-23
-20	-58	-19

// Brem S, 2009: Children
// Subjects=19
-63.52	-46.01	7.77
-53.94	25.16	10.65
-8.34	-55.07	11.09
-63.71	5.04	2.72
62.73	-27.04	-2.98
-38.01	-35.96	-23.91
-60.21	-6.15	20.58

// Brem S, 2009: Adolescents
// Subjects=13
-63.56	-46.32	4.44
-50.92	26.8	-6.37
-17.83	28.71	46.66
-57.53	-7	-23.08
52.92	-37.58	-11.85
-46.7	-70.93	50.29
-56.68	-3.96	43.84

// Brem S, 2009: Adults
// Subjects=18
26.68	-13.71	-30.58
62.66	1.99	-2.49
59.23	-15.85	-20.84
-36.88	-73.46	57.1
-60.84	-10.82	-29.37
-1.49	-62.13	38.57
50.32	-59.07	34.02
49.32	31.98	-25.4
66.02	-49.68	-4.16

// Pizzagalli D A, 2009: Healthy controls > MDD; Reward-No incentive
// Pizzagalli D A, 2009: MDD > Healthy controls;  Reward-No incentive
// Pizzagalli D A, 2009: Healthy controls > MDD; Loss-No incentive
// Pizzagalli D A, 2009: MDD > Healthy controls; Loss-No incentive
// Pizzagalli D A, 2009: Healthy controls > MDD; Gain-No change
// Pizzagalli D A, 2009: MDD > Healthy controls; Gain-No change
// Pizzagalli D A, 2009: Healthy controls > MDD; Penalty-No change
// Pizzagalli D A, 2009: MDD > Healthy controls; Penalty-No change
// Subjects=30
-28.81	-12.93	-4.88
33.54	-31.85	33.9
41.95	-67.23	2.2
37.19	-3.13	-35.46
59.69	37.22	-11.22
-47.91	20.19	26.01
26.97	28.01	37.88
33.27	31.34	25.26
-28.61	29.79	38.37
13.7	34.31	-17.14
62.07	-8.61	1.52
-24.68	32.82	-5.42
-24.18	-34.48	32.56
14.14	-52.25	5.73
35.27	-76.62	-35.96
22.53	-59.37	-18.31
-39.55	-6.99	-9.72
3.43	36.33	37.45
-41.34	-14.41	32.19
3.26	26.87	11.48
7.91	-16.43	42.94
-34.9	-66.75	15.31
-28.61	-63.6	0.48
16.07	18.06	6.5
18.33	2.9	16.67
-11.56	-1.34	19.6
-20.03	-25.88	19.52
-7.58	11.01	-13.83
35.22	19.52	-3.88
-32.94	-1.55	18.74
54.61	28.92	19.64
22.33	52.74	0.17
55.81	23.7	34.57
31.34	21.32	47.31
5.41	53.46	24.84
-53.15	0.33	31.09
7.45	32.64	3.15
11.94	22.84	27.34
-.71	-27.11	29.44
55.8	-58.78	0.22
-7.39	-66.16	-20.74
-15.92	-81.35	-23.83
-41.82	-16.03	-30.12
16.04	26.52	5.79
-7.36	0.03	9.4
-17.93	-24.1	14.89
48.15	33.83	14.85
33.43	20.9	41.75
-55.29	0.31	31.11
-.78	-10.28	26.91
54.38	11.12	-17.89
72.86	-40.44	1.83
-63.85	-52.55	8.88
-34.99	-85.3	-4.32
-15.62	-54.15	25.19
33.22	-81.23	-26.63

// Seo Y, 2009: ERO vs. HA
// Seo Y, 2009: Positive association of basal plasma prolactin concentration 
// with brain activity
// Seo Y, 2009: Positive association of basal plasma testosterone 
// concentration with brain activity
// Seo Y, 2009: Correlation between subjective feeling for erotic pictures and 
// brain activation
// Subjects=12
48	12	34
32	-4	60
40	26	42
-28	2	58
-4	36	54
4	42	48
10	24	48
-8	46	50
32	46	-18
30	32	-14
28	-8	46
-24	-10	48
-56	4	36
-36	-6	66
-42	-50	54
24	-60	58
-30	-58	56
54	-30	56
-52	-62	2
-50	-76	4
-38	-78	6
-46	0	-44
48	8	-44
-24	-4	-34
-24	-12	-26
-22	-10	-22
30	-6	-36
24	10	-36
-32	10	-40
-14	2	-4
10	6	10
-16	-8	16
20	-10	0
14	10	-6
34	24	0
8	-18	-14
-6	-80	-30
6	-20	-34
-8	-22	-32
-38	16	54
-6	32	34
40	-54	54
12	-64	40
-4	-56	64
-24	-60	56
38	-72	-38
4	2	48
-38	16	54
-22	20	64
32	14	56
24	10	66
-6	32	34
20	-74	50

// Osuch E A, 2009: Major depressive disorder
// Subjects=16
-14	64	14
56	-54	-10
16	-6	2
-36	-14	-20
-14	64	14
16	-6	2

// Persad C C, 2009: Deep Processing > Shallow Processing, Postmenopausal 
// Subjects
// Persad C C, 2009: Deep Processing > Shallow Processing, Hormones > Placebo
// Subjects=10
-48	24	16
8	14	28
42	22	0
-32	-70	32
-42	-36	48
30	-70	32
50	-36	-6
30	-90	2
-34	-88	-2
-22	4	6
-2	-58	-44
-24	16	50
10	12	48
6	-18	60
-48	-32	22

// Braskie M N, 2009: Encoding > Control
// Braskie M N, 2009: Retrieval > Control
// Braskie M N, 2009: Positive Correlation between Left ERC Thickness and 
// Retrieval Activation
// Subjects=32
-6	18	40
-2	-34	28
-24	-74	34
-28	-56	42
-26	-62	46
-64	-22	2
-64	-32	8
-30	-30	-22
-30	-22	-16
-44	6	34
-46	32	0
-50	-6	50
0	-76	8
-4	18	40
-2	-32	26
-28	-64	36
-28	-60	34
-30	-64	48
60	-18	2
-62	-32	0
-28	-28	-28
-18	-28	-10
-46	12	22
-34	26	-4
-50	-8	52
2	-84	32
-8	-26	-14
-10	0	18
-6	-20	12
-8	-60	-14
6	26	30
-10	66	14

// Mechelli A, 2009: Go/Nogo > Fixation
// Mechelli A, 2009: Nogo > Go
// Mechelli A, 2009: Go > Nogo
// Mechelli A, 2009: Go/Nogo, CT and TT Variants > CC Variant
// Mechelli A, 2009: Go/Nogo, TT Variant > CC Variant
// Mechelli A, 2009: Go/Nogo, CT and TT Variants > CC Variant (Controlling for 
// Teacher Rated Hyperactivity)
// Mechelli A, 2009: Go/Nogo, TT Variant > CC Variant (Controlling for Teacher 
// Rated Hyperactivity)
// Mechelli A, 2009: Effect of twin pairs: Go/Nogo, CT and TT Variants > CC 
// Variant
// Mechelli A, 2009: Effect of twin pairs: Go/Nogo, TT Variants > CC Variants
// Subjects=7
-36	50	28
38	50	32
-46	46	8
38	54	8
50	22	40
50	16	-4
62	-40	-2
4	-26	34
-42	-64	50
36	-60	46
-34	-60	-20
34	-58	-20
-42	-82	-10
38	-84	-12
6	-88	-6
-4	-88	-6
42	22	42
26	-2	48
42	0	38
62	-48	16
48	-30	-8
40	-40	44
28	-64	48
8	-62	50
20	-52	-22
-26	-64	-14
28	-56	-10
-26	-64	-14
6	28	-6
-28	-42	-12
28	-44	-12
-44	-18	14
44	24	-14
44	24	-14
44	24	-14
44	24	-14
44	24	-14
44	24	-14

// Jensen K B, 2009: FMS Patients and Healthy Controls: Painful Stimuli - 
// Sensory Stimuli
// Jensen K B, 2009: Healthy Controls > FMS Patients: Painful Stimuli - 
// Sensory Stimuli
// Subjects=16
48	10	-2
-2	-24	16
-38	-2	-16
-52	-2	2
40	36	32
22	-56	-24
8	46	4
-14	-34	12

// Bertolino A, 2009: Subgroup of Healthy Controls; Working Memory Sample, 
// DRD2
// Subjects=142
59	23	6
30	52	-3
26	7	-6
15	26	19
-38	6	51
-38	26	26
-8	0	7
11	-6	18
26	-72	21
-34	49	33
-38	52	11
-11	24	34
38	-53	24
-45	22	-7
-63	-35	16

// Bertolino A, 2009: Subgroup of Healthy Controls; Working Memory Sample, DAT
// Subjects=142
-41	6	51
-49	20	37
-45	22	-7
-38	6	51
-38	26	26
-8	0	7
11	-6	18
26	-72	21
-34	49	33
-38	52	11
-11	24	34
38	-53	24
-45	22	-7
-63	-35	16

// Bertolino A, 2009: Subgroup of Healthy Controls; Recognition Memory Sample, 
// DRD2
// Subjects=102
-22	5	14
48	22	-1
49	13	41
11	7	17
-8	8	15
-22	10	-16
26	-78	35
-41	-5	42
59	-19	42
4	-21	8
49	19	9
30	14	-10

// Bertolino A, 2009: Subgroup of Healthy Controls; Recognition Memory Sample, 
// DAT
// Subjects=102
-8	-18	11
-55	-2	42
-19	10	-16
41	-46	34
4	-4	8
30	18	-1
49	13	41
11	7	17
-8	8	15
-22	10	-16
26	-78	35
-41	-5	42
59	-19	42
4	-21	8
49	19	9
30	14	-10

// Peck K K, 2009: Comfortable Pitch > Rest
// Peck K K, 2009: High Pitch > Rest
// Peck K K, 2009: Low Pitch > Rest
// Subjects=12
33.47	-54.45	16.84
-20.23	-63.15	-21.96
50.45	-39.09	7.55
-57.47	-39.74	8.85
-29.75	-.65	16.4
40.78	-2.34	15.73
32.01	35.88	1.48
63.34	-5.41	29.11
-47.8	-11.62	27.57
67.52	-6.32	16.88
-54.26	-12.17	21
46.3	-31.23	27.01
-47.71	-38.14	28.67
11.03	-65.59	12.46
-16.74	-67.87	12.97
44.24	-38.13	34.31
-45.53	-36.64	34.1
39.41	53.81	-1.23
32.15	-54.92	-16.56
-10.68	-47.23	-23.4
52.54	-26.39	6.46
-60.68	-39.76	8.89
-32.93	-8.07	17.06
49.33	-.17	15.45
48.07	26.46	2.08
-47.98	9.56	12.41
57.96	5.13	28.29
-49.95	-7.4	27.24
59.07	-26.29	20.88
-53.17	-9.71	25.24
61.26	-29.03	26.66
-46.63	-40.25	28.84
30.31	-55.19	21.4
-22.1	-60.33	14.63
-41.25	-36.53	35.16
34.35	-72.88	-15.08
-7.47	-47.21	-23.44
45.05	-22.2	6.2
-62.74	-35.65	20.83
-37.17	-16.55	17.82
39.74	-22.95	10.78
30.93	37.98	1.31
-52.24	6.36	12.73
63.33	-2.23	28.85
-46.73	-10.55	27.46
60.06	-6.2	19.18
-49.98	-14.26	21.12
64.46	-29.01	26.62
-57.34	-35.02	28.52
17.19	-6.68	2.99
21.63	-4.94	25.09
-17.82	-64.62	13.82
-22.34	1.97	8.29
-3.82	-.84	52.92
-49.79	-39.75	35.52
45.84	48.56	-.86

// Crinion J T, 2009: Native Chinese
// Subjects=31
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
52	14	-20
46	-4	-16
44	-14	-12
-34	-16	0
-46	-10	16

// Crinion J T, 2009: Europeans
// Subjects=21
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
52	14	-20
46	-4	-16
44	-14	-12
-34	-16	0
-46	-10	16
54	16	-18
46	2	-20
44	-16	-4
-38	-16	4
-50	-16	18

// Crinion J T, 2009: English-Chinese
// Subjects=7
54	14	-18
46	-2	-16
44	-16	-6
-36	-16	2
-48	-12	16
54	16	-18
46	2	-20
44	-16	-4
-38	-16	4
-50	-16	18

// Crossley N A, 2009: Working Memory, All Groups
// Subjects=10
32	0	56
46	4	38
40	32	40
38	50	38
-36	-50	50
-14	-72	56
38	-42	44
28	-64	58
36	-56	54
-26	0	56
-46	26	38
-40	2	34
-44	44	26
0	14	52
8	20	42
6	4	56
-34	18	2
38	24	-4
-32	-60	-32
16	-4	20
30	-66	-30
-36	56	14
-36	46	30

// Dagher A, 2009: Deactivations during stress
// Dagher A, 2009: Cue-reactivity, stress
// Dagher A, 2009: Cue-reactivity, non-stress
// Dagher A, 2009: Stress response predicts craving response
// Dagher A, 2009: Deactivations due to the stressful MIST
// Dagher A, 2009: Deactivations due to the non-stressful MIST
// Subjects=15
0	60	0
2	40	2
-44	38	-8
-24	42	-20
-46	32	8
-6	18	-6
12	14	-14
-14	14	-12
36	8	-26
-24	-8	-16
-32	-16	4
40	-20	4
-28	-24	-20
32	-24	-16
0	-32	32
-54	-36	4
-8	-58	16
2	-66	28
-46	-74	30
4	-84	28
10	53	20
16	0	18
2	-6	2
18	-34	-12
58	-40	6
-18	-48	-6
2	-58	44
0	-82	0
54	-40	6
-24	-54	2
16	-80	8
10	50	22
-20	36	-2
16	34	38
14	32	4
-16	24	40
20	20	44
18	8	18
14	-6	-26
-2	-8	4
-4	-26	32
-4	-28	60
18	-34	-12
-22	-34	-10
-12	-38	48
58	-44	10
16	-58	14
-28	-60	10
0	-86	0
-8	46	44
-44	42	-14
4	38	-2
20	36	46
-24	36	-20
28	34	-16
54	34	-12
12	14	-14
-12	14	-12
36	6	-20
-46	4	-38
44	2	-34
-12	-6	-24
20	-8	-18
4	-10	42
-40	-10	2
42	-14	-4
-30	-14	2
28	-18	-24
-26	-18	-24
18	-26	70
-42	-30	8
-4	-30	42
-4	-50	28
14	-52	0
-12	-52	0
-52	-62	26
54	-62	28
0	58	-4
-2	66	-2
10	52	40
12	28	56
52	30	-8
-2	-10	48
-50	-8	4
40	-8	-16
-34	-24	12
22	-14	24
-22	-16	-22
-38	-24	54
4	-24	42
8	-52	32
-54	-62	30
52	-58	34

// de Greck M, 2009: Win > Lose
// Subjects=10
18	20	-6
-18	16	-2
6	-28	-32
-4	48	-6
-38	34	-18
12	6	-6
22	-2	16
-58	-54	-8
-42	-16	46
-18	-38	18
6	26	22
-40	-28	36
-28	-38	18
-42	-26	-20
38	-28	10
-64	-40	18
-6	-44	44
68	-30	0
50	-42	-22
-46	34	18
0	18	26
-58	-6	-8
50	-30	-20
52	-38	-14
-18	-42	48
-38	-66	36
-40	52	-4
56	6	-30
26	-40	20
-24	-78	14

// Callan A M, 2009: Driver Occluded View (DO) > Driver Occluded View with 
// Camera (DOC)
// Callan A M, 2009: DOC > DO
// Callan A M, 2009: Driver Non-Occluded View with Camera (DNC) > Driver 
// Non-Occluded View (DN)
// Subjects=14
-13.7	-83.27	8.37
-68.62	-29.6	34.25
-42.08	-9.98	1.6
41.88	5.47	-21.53
-24.94	37.09	-1.11
53.18	-2.77	16.07
-52.68	-6.33	18.23
14.61	-2.75	41.38
-11.59	22.5	25.88
29	-76.01	-31.18
-56.24	-16.38	-8.73
-9.9	56.18	-4.37
-31.51	-10.64	-17.56
41.98	-16.76	-18.21
-26.8	-19.73	11.27
-25.16	0.46	-25.49
26.84	30.16	-9.15
-22.47	15.36	18.93
-29.18	-65.19	-15.57
33.57	-55.52	-7.51
-32.77	5.98	57.01
40.56	-80.14	27.31
-50.42	-75.64	11.6
36.58	-50.24	60.27
-31.98	68.32	46.35
-15.27	-62.44	59
17.16	-68.71	59.07
-28.43	-78.18	40.61
37.45	-73.69	39.05
10.17	-96.59	13.76
-9.41	-74.74	7.45
12.19	-63.72	9.35
48.88	15.92	21.02
14.11	-75.36	-11.94
1.1	-77.95	-15.94
48.84	-77.39	-1.12
40.62	-80.79	31.85
-30.78	-80.71	25.21
10.28	-94.7	22.54
-11.6	-72.73	6.17
33.59	-61.91	-6.88
-20.4	-69.54	-5.2
23.52	-72.91	48.17
44.51	-77.41	-1.05
16.34	-48.58	-1.18
38.68	-48.53	55.59
-.18	-65.89	55.72

// Cao F, 2009: Meaning - Lines, Adults
// Cao F, 2009: Meaning - Lines, Children
// Cao F, 2009: Rhyming - Lines, Adults
// Cao F, 2009: Rhyming - Lines, Children
// Cao F, 2009: Meaning - Lines, Adults - Children
// Cao F, 2009: Rhyming - Lines, Adults - Children
// Cao F, 2009: Rhyming - Meaning, Adults - Children
// Cao F, 2009: Rhyming - Lines, Children - Adults
// Cao F, 2009: Positive Correlation between Differences in Accuracy and 
// Activations, Rhyming - Lines, Children
// Cao F, 2009: Negative Correlation between Differences in Accuracy and 
// Activations, Rhyming - Lines, Children
// Cao F, 2009: Positive Correlation between Differences in Accuracy and 
// Activation, Meaning - Lines, Children
// Cao F, 2009: Meaning - Lines, Adult Accuracy Subgroup > Child Accuracy 
// Subgroup
// Cao F, 2009: Rhyming - Lines, Adult Accuracy Subgroup > Child Accuracy 
// Subgroup
// Cao F, 2009: Meaning - Lines (Accuracy as Covariate), Adults > Children
// Cao F, 2009: Rhyming - Lines (Accuracy as Covariate), Adults > Children
// Cao F, 2009: Rhyming - Meaning (Accuracy as Covariate), Adults > Children
// Subjects=5
27	-90	6
-3	-96	15
-24	-90	-9
-45	27	21
6	-63	-30
-60	-45	0
-3	33	39
-36	-3	-33
30	-69	-36
33	-24	-24
39	30	-3
-39	24	24
-39	-66	-18
33	-84	-12
-57	-39	6
24	-99	0
-6	21	54
-36	-6	-33
21	-69	6
36	27	-6
33	-87	0
-39	27	-12
-54	18	9
-24	-90	-9
-3	30	33
-30	-84	-6
30	-90	-12
-42	36	3
-3	15	57
-48	15	30
27	-90	6
27	-90	9
-45	-36	51
57	-9	21
9	18	24
24	18	6
15	-63	33
-12	-57	42
-39	21	36
-30	-63	-15
27	-84	3
-27	-72	-9
30	-81	3
-36	-51	57
27	-87	6
27	-90	6
-18	-66	60

// Carreiras M, 2009: Low Frequency - High Frequency
// Carreiras M, 2009: Incongruent - Congruent
// Subjects=20
-1.82	22.98	44.21
11.24	-53.51	44.9
-38.54	30.88	-1.75
45.93	19.76	-1.79
4.9	-44.06	57.56
-6.23	-21.28	8.94
11.93	-21.17	8.72
4.18	50.68	2.79

// Chiao J Y, 2009: Individualism > Collectivism
// Chiao J Y, 2009: Collectivism > Individualism
// Chiao J Y, 2009: General Self-description > Contextual Self-description
// Chiao J Y, 2009: Contextual Self-description > General Self-description
// Chiao J Y, 2009: (IND General + COL Contextual) - (IND Contextual + COL 
// General)
// Chiao J Y, 2009: Correlation Analysis [Contextual - General] and [COL score 
// - IND score]
// Subjects=10
10.97	-8.96	9.56
33.45	-5.02	-6.9
-14.89	-15.12	13.97
-1.85	-49.53	12.67
27.1	9.07	6.38
17.73	-86.79	14.9
-37.8	-75.96	-15.48
33.54	-81.98	-14.97
17.13	71.79	0.35
-47.75	-9.84	-19.61
-53.61	-10	-55.35
62.33	-15.37	53.02
-58.83	-13.75	42.6
-12.02	-41.94	-20.4
0.73	36.37	-21.64
61.6	-29.59	-7.19
17.55	-21.39	14.04
-56.48	1.51	-23.94
-18.13	-25.02	11.65
40.04	54.93	13.95
4.82	30.71	43.84
-34.71	15.91	-8.93
8.05	-35.07	29
55.06	27.9	-.44
36.61	-76.73	-27.87
4.53	42.77	23.6
4.63	-75.76	7.31
4.57	14.6	20.79
23.37	55.8	-21.71
46.72	-39.89	9.77
43.7	-2.1	35.22
27.66	13.33	51.89
58.33	-27.68	-9.56
-33.94	-83.39	31.14
-25.06	-26.13	-22.86
4.18	48.89	-2.77
20.3	-29.37	-25.56
4.22	50.26	0.45
-62.33	-36.46	18.01
0.94	48.88	-2.71
-33.93	-87.64	31.56
-25.06	-26.13	-22.86
36.8	-87.29	-14.5
17.54	-46.58	8.69
67.84	-.72	-20.24
17.02	-29.69	-28.83
-40.69	-26.29	22.24

// Clement F, 2009: Mild Cognitive Impairment Patients
// Subjects=10
-36	51	-9
-21	-69	-39

// Clement F, 2009: Healthy Controls
// Subjects=10
18	0	6
-24	0	21
-57	-9	-18
-24	0	21

// Costafreda S G, 2009: Schizophrenia Patients
// Subjects=39
-54	14	0
-56	22	16
56	14	0
-56	32	8
56	28	16

// Costafreda S G, 2009: Unaffected Twins of Schizophrenia Patients
// Subjects=10
56	22	8
56	28	8

// Costafreda S G, 2009: Bipolar Disorder Patients
// Subjects=28
-56	32	8
56	28	16
56	28	8

// Costafreda S G, 2009: Healthy Controls
// Subjects=48
-58	16	8
-54	14	0
-56	22	16
56	14	0
56	22	8

// Dibbets P, 2009: Correct NoGo Trials - Correct Go Trials in All Subjects
// Dibbets P, 2009: Negative - Positive Feedback in All Subjects
// Dibbets P, 2009: ADHD > Healthy Controls (Overall)
// Dibbets P, 2009: Activation During Response Inhibition (NoGo - Go) That 
// Positively Correlates with Number of Errors
// Subjects=13
61	-42	6
50	-51	32
57	-45	32
46	34	19
53	12	12
53	18	19
-63	-33	37
-40	-52	49
-28	-69	57
26	-71	51
44	-52	54
50	-48	50
6	33	43
14	37	48
-34	21	-3
-46	20	21
-46	32	17
18	11	64
16	-2	68
10	21	62
-32	3	55
-50	4	40
-44	-1	48
-46	-26	57
-53	-23	47
-57	-39	41
53	21	-9
57	17	-4
50	41	9
46	-60	51
59	-37	39
61	-48	4
-51	12	5
-48	11	-14
-4	-24	-17
8	-24	-14
38	23	38
-53	35	-7
-57	16	3
55	27	-1
51	14	10
51	33	8

// Diekhof E K, 2009: Regions showing a positive interaction with pOFC during 
// processing of infrequent deviants
// Subjects=10
-56	-60	44
44	-48	56
-8	-28	8
-4	-20	-20
52	-64	-12

// Fang J, 2009: LV3
// Fang J, 2009: LV2
// Fang J, 2009: ST44
// Fang J, 2009: Sham
// Fang J, 2009: LV3, Deactivations
// Fang J, 2009: LV2, Deactivations
// Fang J, 2009: ST44, Deactivations
// Fang J, 2009: Sham, Deactivations
// Fang J, 2009: LV2 vs. Sham
// Fang J, 2009: ST44 vs. Sham
// Subjects=10
-3	7	33
3	9	33
-3	21	45
3	12	48
-9	-12	6
12	-15	6
-42	18	-9
36	12	-9
-59	-14	17
60	-15	15
-63	-24	24
53	-25	29
-54	-18	30
-3	-3	36
6	6	33
-3	12	42
6	12	57
-9	-14	3
9	-14	6
-42	15	-9
36	21	-9
-59	-14	17
54	-12	15
-60	-18	18
63	-27	21
-57	-21	24
-3	30	27
6	24	30
-3	12	48
3	12	48
-9	-15	3
9	-14	2
-34	24	-7
39	24	-3
-60	-12	15
54	-12	12
-60	-18	15
63	-24	24
-3	27	27
3	33	24
-3	6	45
3	6	42
-9	-12	0
9	-12	0
-36	18	-9
33	21	-9
-59	-9	6
51	-9	12
-51	-18	15
63	-24	24
-3	60	0
6	57	-3
-27	-36	-12
30	-39	-9
-24	-42	-15
30	-45	-12
-45	12	-30
48	6	-30
-3	-45	48
6	-39	51
-9	-60	27
6	-54	39
-6	-51	9
12	-51	9
6	-78	33
-6	54	-9
6	51	-12
-6	36	0
9	36	-3
-24	-9	-15
-24	-33	-9
27	-39	-9
-24	-45	-6
24	-45	-9
-6	-58	30
6	-48	30
-12	-50	10
9	-45	9
-9	-84	33
9	-78	21
-9	54	0
6	54	-12
-33	-6	-30
-39	-21	-21
48	9	-24
-6	-60	33
-6	57	24
9	-42	33
-6	-84	27
6	-84	27
-6	45	-6
15	57	-3
-3	39	0
6	36	0
-30	-3	-27
-35	-12	25
33	-33	-15
-27	-36	-18
30	-36	-18
-48	12	-30
45	9	-30
-9	-36	60
9	-36	54
-6	-33	45
6	-54	30
-9	-48	9
12	-48	3
-9	-75	30
9	-72	33
-39	6	-24
-9	30	45
9	-36	39
51	-33	42
-9	-30	45
-9	-33	-3

// Fridriksson J, 2009: Correct Naming > Baseline
// Fridriksson J, 2009: Phonemic Errors > Correct Naming
// Fridriksson J, 2009: Semantic Errors > Correct Naming
// Subjects=11
58	0	40
57	1	32
6	8	68
64	6	-3
57	-31	0
53	-37	45
49	33	9
70	-21	6
-20	-86	42
-24	-90	38
-31	-64	42
-22	-82	46
-26	-73	45
-44	-61	-4
20	-98	6
18	-96	10
40	-80	4
32	-86	6
58	-62	-6

// Friedman D, 2009: Target Tones > Baseline, p<0.001
// Friedman D, 2009: Target Tones > Baseline, p<0.0001
// Friedman D, 2009: Target Tones > Baseline, p<0.00001
// Friedman D, 2009: Target Tones > Baseline, p<0.000001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.0001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.00001
// Friedman D, 2009: Novel Sounds > Baseline, p<0.000001
// Friedman D, 2009: Target Tones > Novel Sounds
// Friedman D, 2009: Environmental Sounds > Target Tones
// Friedman D, 2009: Novel Sounds > Target Tones
// Subjects=15
53	-19	38
12	-39	35
-12	-31	36
-12	-43	37
-40	-34	49
2	-29	-7
-20	-2	-7
14	-19	5
-28	45	13
40	-11	54
-55	-6	-6
53	-17	47
32	24	-4
34	26	8
6	-6	64
-44	-11	48
50	-10	8
2	20	38
58	-44	12
-55	-19	45
-51	-27	36
48	-20	18
32	18	6
-54	4	18
4	-10	66
-52	2	10
-10	-2	42
10	4	36
54	-26	-4
-48	-12	-8
68	-40	20
52	-22	4
-14	-16	-2
-32	2	10
-38	12	2
2	4	48
-42	-25	14
-63	-35	9
-32	23	3
63	-38	11
-48	-34	13
63	-12	-3
65	-27	10
53	-17	3
-55	-18	-1
-57	-30	27
42	-29	38
50	-26	23
-49	26	8
55	-18	-3

// Ge J, 2009: Nonreligious Healthy Controls
// Subjects=14
12.62	-28.82	49.6
40.49	-58.77	26.31
-41.43	-63.13	41.59
31.95	30.57	52.36
-13.65	-50.01	19.64
47.07	-62.38	33.28
-34.83	-64.4	50.56
29.82	30.77	54.61
-11.16	-34.43	48.32
19.44	-42.68	73.26
43.06	-60.11	57.78
29.74	36.74	49.54

// Ge J, 2009: Christian Healthy Controls
// Subjects=14
-2.42	-65.45	49
34.48	-17	71.59
-15.49	-31.26	48.08
40.77	-74.23	44.65
-39.21	-76.95	42.92
-67.86	-25.4	10.29
65.97	-10.66	-.17

// Goldin P R, 2009: Social Anxiety Disorder Patients
// Subjects=15
-7.74	52.16	-18.39
-13.01	26.49	-19.52
-21.31	-28.03	-8.16
21.47	-28.57	-5.26
-57.14	-19.76	60.7
-44.4	-12.89	52.17
-20.59	-51.38	75.2
-41.22	-75.79	22.84
27.04	-93.22	-2.14
11.97	-57.1	-1.65
22.99	-79.84	33.59
9.06	-52.89	39.3
-50.67	-53.19	54.5
65.65	-53.06	31.97
8.42	55.83	0.08
12.14	-1.43	43.87
-24.15	-5.62	47.98
45.01	-19.29	2.61
45.47	-14.58	63.54
-5.79	-90.24	39.25
12.16	-92.45	9.12
-21.11	-63.38	2.61
49.68	-15.15	55.74
16.33	-59.39	9.65
24.3	-62.03	71.11
34.92	-43.99	69.48
-42.17	-33.94	55.02
19.6	-58.77	17.36
-20.59	-43.73	77.9
44.95	-58.35	-20.88
-60.73	-16.15	11.37
67.52	-15.13	13.15
-24.46	-72.52	-18.89
70.63	-11.73	1.68
23.56	55.6	23.34
11.7	4.95	-11.31
-9.64	-3.64	-10.34
63.34	8.85	34.61
-65.05	-19.95	3.93
-54.28	-26.69	12.18
44.94	55.73	23.08
1.06	65.78	19.4
37.56	18.33	21.84
49.44	-85.76	-4.13
-42.57	-79.77	-14.73
60.14	-74.53	2.61
1.4	-17.5	29.72
1.54	-56.71	31.9
45.41	-49.16	43.03
-42.68	-51.22	-17.13
52.68	-62.34	9.48
-17.15	-2.88	-13.67
19.21	-9.01	-13.57
-2	-45.89	-6.89
-34.66	-90.67	36.28
-16.39	-86.19	51.3
-20.78	-87.42	35.84
-20.81	-72.36	37.93
-31.42	-93.57	39.83
16.38	-55.61	17.14
9	-28.23	41.69
-24.48	-43.11	-10.21
30.96	-25.4	-20.14
41.88	15.53	26.49
1.11	58.64	23.34
45.01	30.09	21.89
-57.41	-78.66	0.96
52.64	-74.83	-.63
16.3	-82.79	-4
27.33	-86.87	38.59
-28.29	-80.06	35.31
-16.87	-83.5	-10.25
1.53	-53.45	32.74
-34.51	-44.07	74.74
-42.73	-44.08	-21.07
41.76	-46.14	-14.06
56.57	-5.87	-17.61
-20.35	-3.96	-13.54
16.15	-27.21	-.86
-16.97	-27.4	-.46
44.96	-4.49	1.37
37.61	-7.56	17.32
45.15	-25.49	18.74
37.51	3.47	8.59
-60.76	-8.75	10.75
-68.2	-19.37	11.72
-28.74	-45.16	-8.87
-57.81	33.68	-5.11
59.75	31.21	-6.26
9.02	21.41	64.29
-57.17	-57.43	41.55
-5.82	-64.27	44.88
63.47	-50.16	28.41
-53.87	-59.73	52.86
-60.77	-31.9	0.42
56.74	-27.22	-4.67
67.53	-41.36	4.2
-17.15	4.78	-10.96
37.56	-19.08	6.02
-42.79	1.45	-10.39
24.24	-62.63	63.36
49.71	-22.55	56.36
-38.95	-38.15	55.34
34.87	-40.02	65.8
16.75	-44.1	69.7
-49.63	-27.12	61.23
52.99	-26.16	64.43
-60.75	-11.92	11.01
60.26	-73.33	18.12
-49.97	-68.04	-0.02

// Goldin P R, 2009: Healthy Controls
// Subjects=17
-7.74	52.16	-18.39
-13.01	26.49	-19.52
-21.31	-28.03	-8.16
21.47	-28.57	-5.26
-57.14	-19.76	60.7
-44.4	-12.89	52.17
-20.59	-51.38	75.2
-41.22	-75.79	22.84
27.04	-93.22	-2.14
11.97	-57.1	-1.65
22.99	-79.84	33.59
9.06	-52.89	39.3
-50.67	-53.19	54.5
65.65	-53.06	31.97
8.42	55.83	0.08
12.14	-1.43	43.87
-24.15	-5.62	47.98
45.01	-19.29	2.61
45.47	-14.58	63.54
-5.79	-90.24	39.25
12.16	-92.45	9.12
-21.11	-63.38	2.61
49.68	-15.15	55.74
16.33	-59.39	9.65
24.3	-62.03	71.11
34.92	-43.99	69.48
-42.17	-33.94	55.02
19.6	-58.77	17.36
-20.59	-43.73	77.9
44.95	-58.35	-20.88
-60.73	-16.15	11.37
67.52	-15.13	13.15
-24.46	-72.52	-18.89
70.63	-11.73	1.68
23.56	55.6	23.34
11.7	4.95	-11.31
-9.64	-3.64	-10.34
63.34	8.85	34.61
-65.05	-19.95	3.93
-54.28	-26.69	12.18
49.38	-75.45	-8.34
-46.73	-86.34	-2.98
1.4	-25.15	27.02
52.91	-53.34	43.29
63.56	-60.22	35.94
-46.41	-37.93	58.75
-13.83	5.99	4.51
-17.15	-3.94	-13.58
20.25	-2.66	-14.11
-16.38	-81.71	54.27
27.39	-63.13	56.67
-57.57	-53.88	-8.92
-23.43	-41.07	-11.51
23.62	-45.99	-10.52
4.26	58.06	15.55
4.54	31.31	41.21
4.67	20.53	53.26
49.33	22.97	25.78
59.99	30.44	25.03
-31.66	1.74	47.45
34.11	27.89	-5.68
-32.12	31.01	-.72
52.58	-75.43	-8.38
42.81	-50.71	-18.15
-46.75	-83.17	-3.25
-41.58	-47.61	-11.86
-13.51	-103.78	2.56
31.54	-83.13	31.54
1.45	-47.7	24.45
-28.08	-65.77	68.68
-38.83	-40.2	70.01
44.65	22.01	-27.62
56.5	4.36	-22.93
1.23	-26.95	3.75
16.14	-24.03	-1.12
-20.36	-2.9	-13.63
19.17	-.55	-14.28
-35.15	6.47	12.52
-39.26	-26	19.75
-39.36	-16.02	11.11
-9.04	-11.73	63.93
-42.44	-33.42	20.41
57.04	-5.39	43.68
63.02	13.26	-4.79
-68.23	-11.97	11.1
-31.92	-38.33	-2.72
-46.96	-9.61	-1.61
-60.8	-54.16	-12.21
9.03	13.75	61.59
-1.57	11.38	73.06
-49.85	16.78	50.86
-34.83	-22.14	41.68
-57.76	19.94	-3.96
-54.33	-12.94	11.02
-8.3	19	34.58
52.76	2.24	46.44
-54.05	-1.23	52.42
-64.66	-54.3	41.38
-64.65	-42.07	48.16
-60.76	-35.07	0.69
49.3	-31.24	-.9
-57.91	21.65	-23.06
44.95	-58.35	-20.88

// Grabner R H, 2009: Conjunction (Multiplication, Figural-spatial), Untrained
// Grabner R H, 2009: Multiplication > Figural-spatial, Untrained
// Grabner R H, 2009: Figural-spatial > Multiplication, Untrained
// Grabner R H, 2009: Conjunction (Multiplication, Figural-spatial), Trained
// Grabner R H, 2009: Multiplication > Figural-spatial, Trained
// Grabner R H, 2009: Figural-spatial > Multiplication, Trained
// Grabner R H, 2009: Untrained > Trained, Multiplication
// Grabner R H, 2009: Trained > Untrained, Multiplication
// Grabner R H, 2009: Untrained > Trained, Figural-spatial
// Grabner R H, 2009: Trained > Untrained, Figural-spatial
// Subjects=14
14.29	-84.96	0.21
-43.93	7.6	29.03
27.08	-27.17	-2.36
53.28	14.33	26.71
43.85	3.4	48.12
24.07	-97.69	1.31
-24.45	-100.42	9.13
28	-66.23	62
33.4	-41.46	-17.86
-28.25	-45.5	-23.14
-20.54	-52.7	71.57
31.05	4.6	61.66
63	14.36	26.54
-60.35	-69.58	-3.4
-59.9	-20.23	42.14
14.29	-84.96	0.21
27.08	-27.17	-2.36
8.19	16.35	50.81
-21.53	-30.53	-1.2
-43.93	7.6	29.03
53.29	11.14	27.02
-27.36	0.58	56.33
43.1	20.75	-7.37
23.84	5.66	4.53
37.47	0.81	55.21
-34.56	21.41	3.97
-14.87	-98.13	-1.35
27.44	-99.93	11.56
33.33	-68.24	-28.66
33.32	-42.09	-24.52
59.51	-66.28	-9.13
36.23	-11.73	-44.38
-24.98	-41.98	-20.18
-4.83	19.18	47.39
-47.23	10.47	25.44
-28.19	27.19	-3.43
-5.55	-81.45	-30.05
10.6	-22.71	-22.69
31.24	-66.22	61.94
-28.4	-63.01	-38.21
-27.23	-54.28	55.04
33.39	27.41	-4.51
56.48	14.03	23.32
49.81	38.91	14.25
-37.95	-74.87	-26.79
-57.22	-63.81	-10.74
-21.13	-89.91	18.12
34.31	11.31	64.31
-63.04	-45.77	44.72
63.19	-56.46	26.82
-1.53	-39.48	39.69
47.14	-32.31	44.87
-53.81	35.97	23.03
56.49	10.84	23.63
-8.07	19.17	47.44
53.18	39.85	24.18
27.73	3.97	55.06
33.41	24.22	-4.19
-27.34	7.27	59.03
-28.13	24.31	0.21
59.95	-56.47	26.87
-56.57	-65.52	39.84
-1.61	-63.07	28.58

// Green A, 2009: German, Unrelated > German, Iconic
// Green A, 2009: German, Iconic > Russian, Iconic
// Green A, 2009: German, Unrelated > Russian, Unrelated
// Green A, 2009: German, Iconic > German, No Gestures
// Green A, 2009: German, Unrelated > German, No Gestures
// Green A, 2009: German, Iconic > Russian, Iconic and German, Iconic > 
// German, No Gestures
// Green A, 2009: German, Unrelated > Russian, Unrelated and German, Unrelated 
// > German, No Gestures
// Green A, 2009: [GI > RI and GI > G] and [GU > RU and GU > G]
// Green A, 2009: [GI > RI and GI > G] masked by [GU > RU and GU > G]
// Green A, 2009: [GU > RU and GU > G] masked by [GI > RI and GI > G]
// Subjects=16
-44	-36	40
-60	16	24
52	-36	36
48	32	12
8	20	56
8	-36	56
-60	-60	-4
44	12	48
-20	-12	-16
-40	-72	8
44	12	-28
60	-44	-8
-60	-20	36
12	-8	-16
-56	-8	-20
-44	28	0
56	-52	-8
-32	-44	44
-44	4	48
56	0	-24
36	-52	48
60	-4	36
-48	-76	-4
52	-72	-4
68	-24	8
-20	-28	-8
-48	-76	-4
44	-68	-4
32	-56	44
-48	-68	4
-56	-68	0
56	-64	-4
-32	-44	44
32	-52	44
-52	-68	0
-40	-76	8
-56	-56	0
56	-64	-4
-32	-44	44
32	-52	44

// Habermeyer B, 2009: Deviant Pattern > Silence
// Habermeyer B, 2009: Standard Pattern > Silence
// Habermeyer B, 2009: Musicians vs. Non-musicians, Deviant Pattern > Silence
// Subjects=8
55.69	-13.77	4.25
38.4	-8.18	-18.32
-2.99	6.54	24.41
-12.39	-50.53	30.42
-31.01	42.36	8.35
-45.78	-24.95	6.36
-38.37	24.94	17.7
-44.35	-77.16	33.02
51.28	-5.3	-9.79
-30.48	-71.87	31.31
-49.06	-13.59	2.1
19.08	30.28	-14.63
-43.98	30.88	-15.07
-55.6	-15	-15.55
-60.71	-17.04	13.67

// Haupt S, 2009: Incongruent Phonetic > Congruent Phonetic
// Haupt S, 2009: Incongruent Semantic > Congruent Semantic
// Haupt S, 2009: Incongruent Phonetic > Incongruent Semantic
// Subjects=29
40	16	32
-48	18	10
2	18	46
2	-56	26
-44	4	20
28	8	28
-34	16	14
-6	-6	26
-18	12	0
-6	32	38
48	14	30
-6	-16	8
-2	32	18
-18	-6	46
0	14	48
-18	-8	16
-18	-8	62
0	30	48

// Heim S, 2009: Congruent > Null
// Heim S, 2009: Incongruent > Null
// Heim S, 2009: Incongruent > Congruent
// Heim S, 2009: Congruent > Incongruent
// Heim S, 2009: Onset Latency Difference for 1st Temporal Derivative of the 
// HRF: Congruent > Incongruent
// Subjects=16
-32	-14	-6
26	-4	6
-14	-24	2
10	-14	0
-54	-2	16
-60	-8	2
-36	-20	4
-50	6	2
4	-38	-6
-30	-60	-10
-40	-40	-14
-42	-82	-8
-34	-92	-2
-20	-68	-12
20	-62	0
22	-48	-12
-16	-66	12
6	-64	16
-6	-76	24
20	-64	20
10	14	58
-6	32	32
6	28	32
-18	-76	48
-28	-86	36
-20	-88	26
28	-52	64
28	-40	64
10	-68	-14
22	-82	36
18	-80	26
14	-30	56
12	-26	50
-30	26	6
-12	2	66
10	4	70
-42	4	36
-62	10	14
46	14	14
48	-28	58
-12	-22	2
10	-12	0
-50	4	4
-62	-2	4
-44	4	38
-54	-2	16
-36	10	8
-66	-28	12
-30	-4	-12
2	-40	-2
-34	-60	-10
-26	-92	-12
-38	-86	22
-22	-82	24
22	-80	38
-14	-68	12
6	-66	16
-6	-76	22
6	-82	32
-18	-76	48
-24	-62	-2
10	-86	-4
24	-72	-6
26	-42	-22
10	14	58
-12	4	68
2	24	38
8	-70	-16
-2	-60	2
32	-46	60
22	2	4
28	-88	30
32	-86	30
-40	-44	-14
26	-92	2
24	-94	4
-38	-56	-46
-40	14	30
26	-70	50
-50	-8	46
14	-40	-48
-32	36	38
6	56	-4
-50	-8	46
-46	-32	26
-34	-22	22

// Meehan S K, 2009: Low Synchrony > High Synchrony
// Meehan S K, 2009: High Synchrony > Low Synchrony
// Meehan S K, 2009: High Synchrony > Low Synchrony, Vibrotactile Tracking
// Meehan S K, 2009: Low Synchrony > High Synchrony, Vibrotactile Tracking
// Meehan S K, 2009: High Synchrony > Low Synchrony, Visuospatial Tracking
// Meehan S K, 2009: Low Synchrony > High Synchrony, Visuospatial Tracking
// Subjects=10
-5.86	-.97	65.22
52.51	16.13	19.63
-32.1	27.92	0.65
33.07	29.28	-1.33
-68.15	-37.52	11.01
64.38	-34.26	13.68
37.41	55.25	17.63
19.54	-93.43	-4.26
-23.33	-73.05	-12.17
54.48	-26.23	-19.22
40.67	-70.53	-26.5
29.8	-45.1	-40.78
-36.37	-68.76	-38.03
20.38	-57.36	-19.57
-15.78	39.82	42.96
-1.22	74.17	4.22
-47.64	-71.43	24.77
-44.78	-54.15	-13.51
-44.51	-60.21	18.22
-67.11	-16.9	15.96
-55.15	-29.04	36.92
-65.23	3.52	-9.19
28.48	-35.49	69.95
15.7	-53.8	68.29
56.96	-44.71	16.87

// Nahab F B, 2009: Control vs. Baseline
// Nahab F B, 2009: Cough vs. Baseline
// Nahab F B, 2009: Gape vs. Baseline
// Nahab F B, 2009: Yawn vs. Baseline
// Nahab F B, 2009: Gape vs. Yawn
// Nahab F B, 2009: Yawn vs. Gape
// Subjects=18
-19.4	-95.75	3.63
25.48	-88.88	5.88
-16.69	70.51	6.38
28.18	60.75	-0.01
6.11	8.48	28.05
50.76	29.41	5.71
57.45	-36.91	14.54
-57.9	-40.26	22.83
-38.67	-86.35	3.06
-61.34	23.17	17.56
47.91	-72.37	10.93
53.74	7.32	-32.62
28.71	-95.21	6.37
31.19	29.13	-37.54
2.44	-32.6	-48.76
38.1	-61.28	-9.96
-45.02	-69.24	18.43
47.95	-68.69	17.31
-38.66	-82.92	6.12
54.3	3.2	37.98
63.91	-42.96	18.32
-38.68	-.79	36.03
2.85	-38.26	1.9
-10.17	-13.99	-13.37
9.46	13.22	47.69
47.59	26.48	9.34
60.74	-19.48	33.11
-15.87	-10	80.04
28.91	-53.54	49.72
-38.85	-51.97	-6.51
57.26	-48.74	-14.58
47.9	-75.8	7.87
-41.86	-82.94	6.16
57.54	6.9	44.32
-.37	-35.11	1.67
2.49	30.5	-17.25
-31.91	-29.9	71.85
73.34	-41.52	-5.33
-61.26	-61.62	-5.45
-10.2	-11.07	-16.96
-6.52	-35.75	35.25
15.32	-54.98	-50.37
0.06	-86.72	36.1
-6.45	-67.98	31.26
57.56	-19.25	36.47
-61.05	-19.96	37.9
12.73	-38.81	35.28
-25.7	4.26	58.88
-41.95	-11.35	23.57
-67.78	-33.11	-7.76
-13.42	61.27	10.46
35.01	32.15	42.46
2.72	9.84	4.56
18.92	-83.86	-11.19
2.5	27.33	-16.98

// O'Hare E D, 2009: Healthy Controls
// Subjects=20
32.76	20.59	3.74
49.87	-63.92	-34.97
43.53	-20.4	22.02
-42.93	-64.84	32.23

// O'Hare E D, 2009: Fetal alcohol syndrome (FASDs)
// Subjects=20
1.24	10.83	55.65
30.86	-66.05	-32.49
-47.32	-68.8	-31.85
43.53	-20.4	22.02
-42.93	-64.84	32.23

// Natale E, 2009: Main Effect of Endogenous Invalidity, Invalid > Valid
// Natale E, 2009: Simple Main Effect of Valid Exogenous Cues
// Natale E, 2009: Simple Main Effect of Invalid Exogenous Cues
// Natale E, 2009: Orienting of Endogenous Spatial Attention, Valid > Neutral
// Subjects=14
6	10	68
-10	16	66
24	8	56
-8	-68	54
8	-64	54
56	-42	36
58	-44	20
44	12	32
54	18	2
-58	-48	34
-36	-46	44
0	12	66
-8	14	68
18	16	60
-6	-62	52
8	-62	54
56	-44	34
54	-46	18
42	12	32
54	20	0
-58	-48	32
-38	-46	42
6	8	68
-10	18	64
24	8	56
-10	-68	52
10	-70	54
54	-44	40
58	-44	22
44	10	22
58	20	4
-58	-50	36
-32	-46	46
-2	-2	62
-28	-4	56
-20	-64	60
-30	-52	56
-32	-38	44
28	-2	54
26	-62	64
32	-36	40

// Kaufmann L, 2009: Nonsymbolic Numerical Judgment > Rest (Healthy 
// Dyscalculics > Healthy Controls)
// Kaufmann L, 2009: Spatial Judgment > Rest (Healthy Dyscalculics > Healthy 
// Controls)
// Kaufmann L, 2009: Nonsymbolic Numerical Judgment > Spatial Judgment 
// (Healthy Dyscalculics > Healthy Controls)
// Subjects=9
-40.02	-46.95	51.63
49.3	8.37	15.85
42.77	53.26	18.85
30.52	-36.5	56.63
33.75	-36.22	59.92
-40.01	-56.73	49.1
-1.4	-38.58	73.9
7.99	-21.03	52.25
2.38	38.78	41.72

// Kovas Y, 2009: Nonsymbolic Number Comparison High Ability > Nonsymbolic 
// Number Comparsion Low Ability
// Kovas Y, 2009: Nonsymbolic Number Comparison Low Ability > Nonsymbolic 
// Number Comparsion High Ability
// Subjects=13
1.24	-66.31	-9.67
-34.4	-17.73	-38.99
28.12	-68.92	9.2
-2.93	-85.11	-4.7
20.35	13.77	5.7

// Wood G, 2009: Conjunction all age groups: Interference Control
// Subjects=9
-23.99	3.76	67.17
-27.45	6.44	50.15
-33.85	-42.17	47.23
52.85	-63.29	-22.76

// Chouinard P A, 2009: Object lifting vs. Rest
// Chouinard P A, 2009: Different size > Same size
// Chouinard P A, 2009: Different weight > Same weight
// Chouinard P A, 2009: Different density > Same density
// Chouinard P A, 2009: Same density>Different density
// Chouinard P A, 2009: Different size/same weight/different density (SW 
// illusion) > Same size/weight/density (SS-SW)
// Chouinard P A, 2009: SW illusion>SS-SW in conjunction with effect of 
// density
// Subjects=12
-34	-22	56
-50	-22	54
-48	-20	48
-42	-32	58
-60	10	20
-14	-22	-2
-28	-52	-28
22	-50	-24
4	-56	-18
10	-70	-46
-58	-24	48
-40	-24	42
-42	-32	60
-22	-62	-20
26	-52	-22
-38	-14	50
-58	12	18
-38	-12	50
-34	-20	46
-38	-26	42
-60	8	22
-58	16	20

// Tesink C, 2009: Autism Spectrum Disorder ASD patients
// Subjects=24
-62	-24	8
-56	-32	20
-42	-28	14
-38	-18	54
-46	-28	54
-56	-26	48
56	-22	8
66	-12	4
66	-32	12

// Tesink C, 2009: Healthy controls
// Subjects=24
-36	-38	10
-46	0	28
-42	-28	6
34	-26	14
46	-14	26
42	-22	30
8	-66	26
36	-50	-10
46	-42	-16
2	26	4
16	28	-10
14	46	-2
4	-30	-6
6	-20	4

// Peran P, 2009: Object Naming, Manipulable Biological Objects - Fixation
// Peran P, 2009: Object Naming, Man-Made Objects - Fixation
// Peran P, 2009: Generation of Action Words, Manipulable Biological Objects - 
// Fixation
// Peran P, 2009: Generation of Action Words, Man-Made Objects - Fixation
// Peran P, 2009: [Generation of Action Words - Fixation] > [Object Naming - 
// Fixation]
// Peran P, 2009: Interaction between Task and Object Category
// Peran P, 2009: [GenA, MBO - Fixation] > [ON, MBO - Fixation]
// Peran P, 2009: [GenA, MMO - Fixation] > [ON, MMO - Fixation]
// Peran P, 2009: [GenA, MBO - Fixation] > [ON, MMO - Fixation]
// Peran P, 2009: [ON, MMO - Fixation] > [GenA, MBO - Fixation]
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and ON, MBO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and ON, MMO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and GenA, MBO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between UPDRS Motor Score and GenA, MMO 
// BOLD Responses
// Peran P, 2009: Positive Correlation between Endogenous Repitition and GenA, 
// MBO BOLD Responses
// Subjects=14
-48	-8	50
-46	-74	-12
-2	-2	62
46	-12	26
34	-96	-2
-40	26	-4
-52	-10	48
-46	-72	-12
-2	0	60
48	-10	26
36	-94	-4
-40	26	-4
-12	-18	0
-2	0	60
-50	-10	36
50	-10	28
38	-68	-28
-46	-74	-10
30	24	0
-24	-68	40
-2	-2	62
-50	-10	36
50	-74	28
-46	-66	-10
40	-50	-28
-40	-44	58
-46	52	-4
32	26	-4
-48	-78	22
-66	-28	22
-2	36	34
-26	8	54
-16	-52	28
-44	54	-2
-2	36	34
-48	-78	22
-16	-52	28
-64	-28	22
-2	38	32
-46	52	-4
32	26	-4
-2	36	34
32	28	-4
-48	-78	22
-44	54	-2
18	42	28
-62	-54	28
-62	8	18
-4	-32	22
-18	-52	30
-30	58	18
-34	18	30
16	-72	30
6	-62	46
-32	-42	70
-58	-26	48
-42	-4	52
-2	-2	58
-44	4	28
50	-24	-8
-42	-6	54
4	0	60
0	6	56
50	-16	-8
-44	16	22
-38	0	52
56	2	30
10	14	32
-40	-2	58
44	10	28
-40	22	-6
-4	12	52
-44	2	38
38	-44	-28
28	-100	8
58	-24	-6
-28	-90	-10
10	10	68
30	24	2
58	6	-10
-52	-60	-16
-56	6	-10
-56	-18	22

// Kim J H, 2009: Healthy Controls
// Subjects=12
-40	38	14
-43	-54	3
-37	-77	36
-1	7	46
53	30	0
34	17	14

// Kim J H, 2009: Subgroup of mTLE patients, Left mTLE
// Subjects=12
-38	18	29
-53	-45	-4
-29	-64	29
51	12	30
8	-2	61
-43	18	29
-66	-36	-2
-29	-63	36
-34	53	19
-31	-3	48
-1	6	53
51	16	26
56	-53	-11
31	-68	32
38	0	42
-42	14	30
-27	-54	33
-19	-97	-3
53	18	22
48	11	30
29	-69	40
35	19	6

// Kim J H, 2009: Subgroup of mTLE, Right mTLE
// Subjects=7
-40	32	8
-63	-51	-7
58	24	17
-47	13	26
-44	-33	-2
-1	5	55
-46	14	30
6	-52	42

// Schlagenhauf F, 2009: Healthy controls
// Subjects=15
15	-6	-18
12	6	-3
-6	-54	-6
9	-21	-12
-24	-6	6
9	-24	12
27	-3	3
12	6	0
27	-63	12

// Page L, 2009: Control > OCD: No-Go > Go
// Page L, 2009: OCD > Control: No-Go > Go
// Page L, 2009: Control > OCD: Incongruent > Congruent
// Page L, 2009: OCD > Control: Incongruent > Congruent
// Page L, 2009: Control > OCD: Switch > Repeat
// Subjects=10
-3.56	42.44	-34.35
-3.28	7.94	-12.5
39.58	-22.46	-10.44
28.07	-52.89	10.08
-17.84	-36.36	21.49
-44.82	-67.78	-24.63
31.93	48.22	-4.02
51.21	-3.87	-18.83
32.51	-6.17	49.61
32.52	-58.81	29.49
55.87	-56.95	10.1
-41.33	-28.58	27.8
-10.14	-70.27	36.51
-22.33	-67.13	-18.25
-33.87	11.96	42.16
-5.83	-41.29	52.99

// Chiu C Y, 2009: Sustained effects of attention: Left-Mag + Left-Par > 
// Right-Mag + Right-Par
// Chiu C Y, 2009: Attention shift (attSh) > Attention hold (attHd)
// Chiu C Y, 2009: Categorization rule switch (rulSw) > Categorization rule 
// hold (rulHd)
// Chiu C Y, 2009: Conjunction: attsh>attHd + rulSw>rulHd
// Subjects=16
29.44	-58.6	46.23
-23.98	-64.29	46.21
37.66	-72.92	-2.07
-33.95	-74.56	-3.11
28.28	0.84	57.99
37.52	42.11	26.54
52.62	11.79	32.26
61.3	-41.71	27.72
10.24	-60.57	49.96
-10.05	-68.18	49.72
-.46	-65.12	47.12
-3.67	-66.28	46.14
4.86	-64.29	43.65
-3.63	-67	50.66
9.16	-59.61	48.78

// Yoshida W, 2009: Rule Switch > Exploitation
// Yoshida W, 2009: Meta-rule Switch > Exploitation
// Yoshida W, 2009: Rule Switch > Meta-switch
// Yoshida W, 2009: Meta-rule Switch > Rule Switch
// Subjects=16
-42.26	18.22	-6.79
7.73	44.6	20
35.42	20.96	-16.23
33.31	60.69	-4.44
-12.02	-14.62	-15.26
7.65	1.35	5.24
1.26	33.73	18.95
-33.6	63.21	3.18
-56.06	37.47	16.19
37.58	61.46	-7.95
-32.72	-62.58	46.99
-5.37	-33.01	-5.71
-57.16	24.19	11.92

// Jamadar S, 2009: Schizophrenia
// Subjects=12
-50.39	11.08	32.15
2.08	-64.09	63.35
-3.27	-76.15	-19.41
-16.01	55.67	24.92
-28.73	24.65	38.29
-15.77	40	41.03
-15.61	-12.43	42.85
-15.62	-43.14	35.81
-11.43	-48.52	23.94
-63.86	-12.47	-12.35
53.4	-61.37	20.75
18.65	57.58	31.98
5.54	59.69	20.79
40.16	-13.11	9.47
53.29	-15.11	21.78
44.02	-1.22	-24.27
48.96	-72.1	9.56
27.14	-23.46	2.88
-16.03	59.92	24.5
-28.85	27.01	29.09
-15.84	40.55	35.37
-3.01	35.19	23.36
-24.76	-47.97	-3.9
-33.35	-60.77	-2.49
-3.27	-24.71	-8.81
14.35	40.24	30.41
5.69	22.57	25.58
5.41	-20.01	-4.94

// Jamadar S, 2009: Healthy Controls
// Subjects=12
-6.55	-8.22	75.9
-33.25	47.2	27.17
-6.73	-62.07	50.98
14.96	-78.91	53.39
-11.66	-77.6	-0.07
-42.2	-67.78	-19.57
-29.3	-63.89	-24.66
18.63	-92.49	-.23
5.36	-71.86	-19.98
44.15	-60.44	-26.25
53.4	-61.37	20.75
-16.03	59.92	24.5
-28.85	27.01	29.09
-15.84	40.55	35.37
-3.01	35.19	23.36
-24.76	-47.97	-3.9
-33.35	-60.77	-2.49
-3.27	-24.71	-8.81
14.35	40.24	30.41
5.69	22.57	25.58
5.41	-20.01	-4.94

// Chechko N, 2009: Healthy Controls
// Subjects=18
-16	-4	34
16	6	-20
2	-28	-14
0	28	20
-46	6	38
38	2	34
-2	8	56
-24	-56	44
-14	-78	-6
-10	48	-8
-14	42	14
-8	-58	2
2	30	22
-8	-36	-24
56	-6	-8
-14	44	24
-28	-24	58
28	-34	-6
-40	12	-20

// Chechko N, 2009: Panic Disorder
// Subjects=18
-34	-10	-22
22	-34	-26
48	-2	-26
34	8	60
46	-50	46
36	50	26
10	-60	42
16	6	-20
2	-28	-14
0	28	20
2	30	22
-8	-36	-24
56	-6	-8
-14	44	24
-26	-12	-18
22	-6	-20
28	-34	-6
-40	12	-20

// Arnow B A, 2009: Healthy Controls
// Subjects=20
-27.57	-84.2	22.14
-53.9	-74.12	-6.42
-46.04	-83.92	14.59
-48.44	-61.68	0.1
-36.24	-86.56	20.28
-49.64	-68.04	-10.46
-26.25	-58.3	46.45
-62.15	-26.39	33.82
-26.28	-68.39	41.85
-64.48	-27.64	20.54
-29.62	-80.08	31.86
-66.36	-22.28	43.57
-40.41	-40.58	41.58
-.16	-68.35	-28.08
-0.06	38.55	1.69
-31.57	30.5	-13.79
-2.2	46.3	4.32
-30.42	-72.48	55.77
-9.95	-86	47.8
-2.03	-20.27	4.18
-14.15	-.18	-9.93
-18.59	53.61	-8.45
-16.31	57.84	2.29
-51.74	7.94	10.08
0.32	21.69	28
-2.09	-28.33	-1.75
-28.5	33.62	-26.48
-39.86	-88.31	-9.74
-39.93	50.08	12.43
-24	-4.44	-20.55
-11.92	10.23	-2.03
-9.86	-25.56	-17.58
-50.36	1.41	31.99
-28.53	1.64	-35.64
-44.32	-32.5	-9.58
26.57	-86.37	30.4
25.6	-62.58	43.75
52.04	-67.81	-2.12
25.57	-70.44	40.05
36.59	-52.37	60.48
23.78	-72.45	-15.75
50.02	-82.08	6.05
32	-79.55	34.12
31.83	-84.09	20
23.54	-63.99	51.77
13.87	-52.04	-26.57
27.93	-56.24	-26.39
37.75	36.45	0.13
4.4	36.31	11.92
21.67	19.79	6.53
16.01	-6.22	-18.81
31.99	-6.32	48.16
20.41	-74.12	58.43
33.57	-35.86	-3.85
28.39	-34.22	14
51.71	-41.82	-22.62
14.27	-16.19	12.46
50.05	7.83	26.28
34.35	-1.56	64.46
16.35	-25.52	4.38
24.47	0.11	-31.91
-3.98	-58.04	13.55
44.58	-15.66	16.37
57.92	-54.37	37.91
-16.58	2.2	-30.29
22.31	0.11	-31.87
-30.37	1.89	-9.86
37.61	22.24	-14.15
6.24	72.19	-6.23
25.91	-.48	-3.86
-51.54	-80.31	7.6
-53.86	-76.04	-3.99
-48.4	-79.96	-.33
-28.36	-96.26	42.4
-15.63	-100.11	23.51
4.22	-81.72	58.34
-38.08	-51.78	-32.43
-19.82	-74.44	-46.19
-4.19	34.46	15.61
-.45	-96.34	28.49
-39.5	-97.73	15.84
-18.42	-71.61	64.44
-7.74	-84.51	52.09
-48.52	58.12	18.5
-23.98	-2.11	-18.54
-19.54	-4.45	-9.42
-9.53	-73.45	-1.64
-47.59	-43.67	-14.02
-64.35	-1.52	35.88
-28.14	-54.1	68.48
-15.87	-14.4	21.76
54.17	-68.01	-4.38
42.31	-77.72	-4.34
37.89	-76.34	-12.25
16.27	-74.29	-12.08
17.94	-98.3	29.49
20.24	-88.54	41.93
46.28	10.46	-14.25
41.98	-53.96	-25.73
32.23	34.44	-9.66
29.8	6.2	-35.96
28.09	30.35	4.26
19.79	-2.16	24.43

// Arnow B A, 2009: Women with Hypoactive Sexual Desire Disorder
// Subjects=16
-52.4	-26.15	35.87
-43.72	-28.04	38.15
-64.43	-19.58	26.46
-54.46	-22.13	44.48
-39.85	-76.2	-6.45
-41.96	-84.61	-4.46
-49.84	-39.94	-19.96
-54.03	-61.98	-14.34
-58.23	-60	-4.38
-44.38	-43.87	-16.3
-22.15	-81.84	24.06
-14.4	-85.89	37.77
-15.61	-85.76	27.7
-29.84	-81.74	14.1
-48.36	5.69	20.33
-32.19	-40.48	7.81
-2.11	-17.59	-1.69
-21.97	-66.25	41.56
-33.86	26.26	-24.54
-52.47	-.42	35.57
-5.65	-75.59	-36.23
-32.41	22.48	3.83
-11.98	-74.47	-23.91
-6.11	-28.29	21.85
-12.27	26.58	57.99
-37.99	-69.76	-29.53
-34.01	-70.11	-56.46
-27.94	47.66	20.31
-24.01	2.04	-20.07
-22.25	-27.83	27.68
-19.87	-17.89	-38.34
-23.92	3.83	-12.4
-8.39	-18.29	14.18
47.61	-64.29	-10.24
42.26	-68.26	-6.4
28.14	-67.76	-11.81
23.54	-76.44	-35.52
35.94	-80.21	3.86
9.63	-4.35	-9.92
23.62	-.36	-13.92
37.6	24.36	-14.36
39.69	11.84	-22.12
-12.03	-3.78	-14.09
62.01	-17.76	27.49
54.54	-18.22	34.39
29.68	-79.64	21.84
30.06	-56	56.47
29.68	-79.64	21.84
24.34	-83.6	25.68
2.3	35.65	16.5
24.15	-28.08	22.43
57.58	7.65	23.93
31.52	48.18	22.61
32.45	48.11	10.27
41.81	-59.57	-39.74
1.92	-65.68	-33.98
25.51	-75.66	-50.2
35.52	-47.91	62.3
7.84	-18.03	16.11
-16.58	2.2	-30.29
22.31	0.11	-31.87
-30.37	1.89	-9.86
37.61	22.24	-14.15
6.24	72.19	-6.23
25.91	-.48	-3.86
22.37	-87.68	39.57
40.16	-89.74	-6.48
44.48	-86.43	-5.76
-31.81	8.35	47.8
-.36	-3.78	54.06
-12.05	-39.57	62.29
-10.17	-9.97	45.88
-29.79	16.03	38.04
-11.69	-48.26	3.75
-17.99	-57.88	16.02
-4.56	21.88	-15.64
-28.36	-19.63	58.35
52.43	-10.16	40.35
20.16	8.3	55.88
52.56	-20.17	48.06
36.34	13.57	53.96
35.91	8.22	19.76
24.38	2.06	46.34
33.98	2.22	36.08
3.92	-13.96	48.28
43.61	-11.54	26.07
16.38	-46.14	1.94
6	-15.64	41.68
-51.57	-66.28	8.45
-50.51	-79.56	4.15
-53.77	-55.65	7.44
-44.01	-64.12	8.11
-39.74	-84.19	-0.06
-60.47	-58.4	-10.1
-43.95	-80.08	9.69
-46.16	-71.68	7.78
-37.61	-74.5	0.06
-49.79	-48.35	-18
-65.48	-21.6	27.8
-53.76	-28.23	13.69
-64.4	-30.32	26.4
0.05	-19.71	-1.52
-26.12	-69.82	-30.85
-4.51	-74.1	-31.91
-31.57	26.14	-14.48
-16.33	-3.58	-11.8
-23.96	2.46	-15.63
-7.6	-74.04	-19.54
-19.66	-67.78	-32.28
-62.44	7.56	18.14
-10.12	-91.6	33.79
-19.47	-58.22	69.86
-17.8	-85.98	25.52
-18.26	22.2	11.46
0.1	37.57	14.11
-62.42	-43.67	9.76
-.2	-67.6	-31.51
-5.46	2.39	-5.85
-25.72	-38.33	7.49
47.76	-81.75	-1.79
49.89	-69.94	-1.88
46.4	-47.7	-16.35
56.36	-75.44	-3.68
54.34	-70.05	8.14
42.22	-69.63	-9.62
47.6	-62.17	-10.45
42.3	-75.6	-4.55
47.7	-87.69	-7.93
10.32	-94.39	25.87
10.2	-89.8	17.57
56.43	6.06	18.51
11.78	-7.74	-11.86
27.77	-87.66	39.47
22.27	-88.4	31.8
32.31	21.88	-6.18
19.7	-27.97	12.41
27.83	2.12	-22.08
26.17	-81.72	-.31
20.29	-86	46.16
38.13	-38.44	14.26
19.61	-10.1	8.41
37.59	12.25	-17.64
60.51	-41.71	-10.45
26.34	-30.1	23.72
28.45	-40.29	17.97
14.34	-15.67	18.01
19.77	-19.8	19.45

// Burnett S, 2009: Adolescents
// Subjects=19
-42	-68	44
-52	-58	34
-10	52	18
-18	42	16
-4	52	-8
-16	48	34
-4	-56	28
-4	-62	40
-38	-66	42
44	-48	28
-40	-6	-26
-16	42	20
-24	-40	52
14	38	44

// Burnett S, 2009: Adults
// Subjects=10
-42	-68	44
-52	-58	34
-14	44	2
4	48	18
-56	-62	28
-36	-30	28
-40	-6	-26
-16	42	20
-42	-66	40
14	42	36

// Bengtsson S L, 2009: Isochronous rhythm sequence (ISO) > Random intervals 
// (RAN)
// Bengtsson S L, 2009: METRIC > RAN
// Bengtsson S L, 2009: NON-METRIC > RAN
// Bengtsson S L, 2009: ISO > METRIC
// Bengtsson S L, 2009: ISO > NON-METRIC
// Bengtsson S L, 2009: METRIC > ISO
// Bengtsson S L, 2009: NON-METRIC > ISO
// Bengtsson S L, 2009: METRIC > NON-METRIC
// Subjects=17
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-31.29	57.77	13.76
-24.99	59.73	0.01
-21.2	50.72	41.18
-50.72	31.55	9.96
-40.47	15.87	48.32
-1.5	19.82	53.99
-11.43	18.23	37.51
-1.4	-5.71	56.51
17.61	-81.13	6.5
20.93	-70.61	15.49
21.23	-81.51	36.73
18.3	-51.19	-17.76
-37.72	54.86	17.52
43.27	54.84	12.78
-34.42	38.92	19.04
-47.66	33.5	-3.73
46.45	37.96	4.31
66.06	6.44	10.46
24.55	20.84	63.53
8.21	23.04	53.51
-1.92	16.7	20.69
14.33	26.95	26.12
-25.31	21.21	-33.15
43.09	10.87	-9.76
43.49	-25.55	14.01
-44.37	10.87	-4.91
-40.98	-17.52	1.21
-53.92	-14.07	4.45
56.28	-13.68	2.53
-63.3	-34.57	26.81
-31.76	-54.07	-45.76
-37.72	54.86	17.52
43.27	54.84	12.78
-34.42	38.92	19.04
-47.66	33.5	-3.73
46.45	37.96	4.31
66.06	6.44	10.46
24.55	20.84	63.53
8.21	23.04	53.51
-1.92	16.7	20.69
14.33	26.95	26.12
-25.31	21.21	-33.15
43.09	10.87	-9.76
43.49	-25.55	14.01
-44.37	10.87	-4.91
-40.98	-17.52	1.21
-53.92	-14.07	4.45
56.28	-13.68	2.53
-63.3	-34.57	26.81
-31.76	-54.07	-45.76
-18.01	53.61	37.48
17.73	54.36	43.52
72.51	-29.89	0.5
52.31	10.35	-50.2
30.84	-85.6	26.89
17.41	-76	-7.45
36.87	-66.04	-5.4
-18.01	53.61	37.48
17.73	54.36	43.52
72.51	-29.89	0.5
52.31	10.35	-50.2
30.84	-85.6	26.89
17.41	-76	-7.45
36.87	-66.04	-5.4
1.22	65.2	22.56

// Dube A A, 2009: Pain > Warm
// Dube A A, 2009: Regression Analysis: SCRwarm and Brain Activation
// Dube A A, 2009: Regression Analysis: SCRpain and Brain Activation
// Dube A A, 2009: Regression Analysis: SCRpain-warm and Brain Activation
// Subjects=12
8	20	68
4	16	56
8	24	60
-56	8	12
52	0	52
-52	16	-12
52	16	-12
52	-48	-4
16	8	20
8	16	8
-20	24	8
-20	12	12
32	8	-8
28	-4	8
28	16	-8
-24	20	-4
-24	-76	-48
-44	-52	-36
-28	-72	-28
-32	-56	-52
20	-72	-24
16	-80	-28
28	-68	-28
-28	-40	-48
36	32	36
52	28	0
52	4	36
32	0	64
52	-40	20
68	-28	4
-48	4	-8
16	-60	4
8	-72	4
44	-56	-32
8	-64	0
-36	-88	-16
8	-76	-4
8	16	60
52	8	48
-16	28	-4
-24	20	-4

// Peretz I, 2009: Familiar - Unfamiliar
// Peretz I, 2009: Familiar - Random
// Subjects=9
48	-24	-10
-48	-18	-16
-24	2	-8
16	4	-8
-8	-72	46
4	-70	46
-60	-40	24
60	-30	10
-56	13	-2
-4	-4	66
-24	2	-5
20	6	0
-8	-72	46
8	-72	36

// Lu H, 2009: Control > Baseline
// Lu H, 2009: Placebo > Baseline
// Lu H, 2009: Control > Placebo
// Subjects=14
-42.47	17.72	-23.55
-4.64	4.16	58.95
-66.53	-27.89	29.56
-62.28	-24.03	24.63
-52.97	-11.81	-5.88
-53.94	-7.69	3.82
-46.78	4.63	-25.54
-37.82	19.06	2.02
-.6	29.42	41.82
-11.83	-9.87	1.07
-18.32	-6.7	0.87
-31.48	-1.61	-12.85
67.03	15.49	3.95
62.93	9.49	20.3
46.57	42.19	15.1
71.92	-38.27	37.2
65.13	-11.03	18.93
76.02	-30.03	21.74
62.7	-4.29	-.75
54.86	18.79	-17.47
39.89	16.59	-5.79
44.22	-7.42	-10.21
14.56	12.25	41.02
16.26	-9.77	0.59
33.43	5.83	-5.73
18.31	10.13	-4.78
13.86	-36.73	-23.6
-54.18	29.88	-7.74
-56.32	8.18	-10.04
-13.99	-8.82	1.01
-22.64	-6.72	0.95
52.98	35.11	7.85
8.2	26.23	53.19
42.17	6.58	1.89
16.26	-8.71	0.48
31.35	4.21	0.07
13.93	-57.05	-22.71
-35.26	0.19	29.61
-41.86	41.96	28.95
-60.01	7.42	39.4
-22.89	5.65	-15.96
-35.9	20.6	-16.1
-60.1	-21.69	26.6
-11	-57.31	56.18
-68.84	-11.5	21.26
-70.94	-11.09	25.73
-52.94	-13.73	-3.45
-51.08	6.95	-23.45
-46.06	-77.54	13.96
-48.44	-6.94	11.49
-16.23	-30.17	-9.17
-29	-9.1	10.26
67.07	9.21	5.69
35.89	33.2	22.89
69.6	-20.82	28.78
53.72	-12.96	56.29
60.29	8.07	-17.62
53.27	-61.24	10.65
40.06	9.12	6.16
14.61	14.79	45.25
14.15	31.03	12.27
18.5	-21.26	3.93
29.01	5.08	-13.43
33.42	12.31	-5.25

// Stankewitz A, 2009: Ammonia > Air Puffs
// Stankewitz A, 2009: Odour > Air Puffs
// Subjects=23
36	18	-9
6	12	42
24	-57	6
42	-12	39
57	-21	27
9	-12	0
9	6	-3
12	-63	-21
51	-48	6
3	-36	-45
24	-3	-12
-39	0	-3
0	-3	42
-15	-66	9
-60	-18	30
-57	3	31
-9	-15	0
-9	-63	-21
-12	0	-3
-51	-60	6
-6	-39	-51
-18	0	-15
-6	36	6
63	12	12
24	-63	-42
12	3	-3
21	6	-9
18	9	15
27	3	-18
69	-18	21
33	15	12
54	3	51
-24	30	-9
-15	-75	-36
-15	6	0
-66	-18	21
-21	-3	-18
-27	18	12
-45	33	36

// Ponseti J, 2009: Pedophiles < Controls (boys <men)
// Ponseti J, 2009: Pedophiles <Controls (girls <women)
// Subjects=24
-38	-62	-24
40	-64	-22
-12	-40	-2
-2	-6	4
22	-32	-4
-34	-76	0
14	-34	0
-38	-74	-16
46	-44	-12
38	-66	44
12	18	-8
-8	14	-8
32	-62	52
-42	-44	-10
-38	-46	-10
-2	4	28
-38	-78	0
-18	0	-12
-26	-56	46
44	-42	-14
54	-56	-8
-32	12	-10
44	24	22
-16	-8	10
28	-48	-30

// Veldhuijzen D S, 2009: Pricking > Burning
// Veldhuijzen D S, 2009: Burning > Pricking
// Subjects=10
-29.93	-16.79	-13.47
-10.57	-35.2	-5.46
22.58	-34.74	-2.53
-37.3	-45.3	-9.88
33.2	-41.96	-14.31
9.68	-70.71	-26.13
9.02	-81.92	21.66
-35.08	32.41	31.53

// Kobayashi Y, 2009: Healthy Controls
// Subjects=8
48.49	12.08	50.12
2.49	-40.29	23.82
2.55	9.77	51.96
33.21	47.11	22.83
39.58	11.6	3.43

// Kobayashi Y, 2009: Patients
// Subjects=8
2.45	-46.18	16.51
2.48	17.8	45.71
51.3	14.67	0.8
36.25	27.9	-5.71
20.93	-28.56	63.88
3.51	-46.26	15.38
3.45	-48	6.61
3.54	18.78	44.5
51.31	13.61	0.89
-52.37	19.34	1.6
35.2	29.12	-3.57
49.4	29.12	36.42
-6.35	19.24	10

// Schiffer B, 2009: Girls > Neutral
// Schiffer B, 2009: Girls > Women
// Subjects=1
-38	49	1
-2	17	-3
-2	5	-7
-26	14	-28
-34	18	-24
28	54	38
30	40	36
32	-64	64
30	-62	48
-36	-52	63
-36	-52	-36

// Chau A C M, 2009: Subgroup of Ischemic Stroke Patients, Treatment Group
// Subjects=10
-50	-32	64
-4	4	74
4	4	74
68	-40	20
42	30	44
48	20	-16
-56	8	-4
-2	-58	70
2	-58	70

// Chau A C M, 2009: Subgroup of Ischemic Stroke Patients, Control Group
// Subjects=8
-4	4	74
4	4	74
68	-40	20
42	30	44
48	20	-16
-56	8	-4
-2	-58	70
2	-58	70

// Chao H H, 2009: Short SSRT > Long SSRT (Within Subjects)
// Subjects=65
28	-4	0
-4	-44	-12
8	-12	40

// Page S J, 2009: Post-testing > Pre-testing: Wrist flexion/extension of the 
// affected hand > Rest
// Subjects=10
47.31	-3.92	44.23
28.48	-61.65	59.1
-30.36	-13.94	70.27
35.48	-45.44	72.72
23.37	-74.83	43.31

// Adamovich S V, 2009: OTI > REST
// Adamovich S V, 2009: WATCH_e > REST
// Adamovich S V, 2009: MOVE_h > REST
// Adamovich S V, 2009: MOVE_e > REST
// Adamovich S V, 2009: OTI > WATCH_e
// Adamovich S V, 2009: MOVE_h > MOVE_e
// Adamovich S V, 2009: WATCH_e > OTI
// Adamovich S V, 2009: MOVE_e > MOVE_h
// Adamovich S V, 2009: OTI block 4>3>2>1
// Subjects=13
34	20	-4
-34	20	2
-44	-32	44
-66	-16	20
14	-76	56
-24	2	50
-52	12	38
46	50	-10
-46	46	-16
-36	64	4
-48	28	12
66	-12	34
52	18	22
-54	18	4
26	-16	-28
38	-24	-12
18	22	42
-8	30	38
-8	12	60
-24	16	12
24	-60	-38
-26	-72	22
46	-68	2
-26	-102	-4
48	-68	2
-44	-70	-16
20	-96	10
-8	-104	-4
-22	-96	6
36	-44	54
-36	-46	38
-34	-44	48
-38	-48	-28
-54	-66	16
-44	-14	52
-8	40	40
28	-38	-50
-22	-4	74
16	2	58
44	-66	-10
-44	-8	4
50	6	4
-6	4	48
46	-26	32
16	-70	52
-46	-74	-20
32	-70	22
24	-2	6
56	6	42
-26	-86	-4
-58	-2	2
56	-20	44
54	16	-6
44	-64	0
-38	-76	-18
44	-56	-40
-27	-70	-38
-14	-54	54
-56	2	44
-32	18	4
18	2	12
22	50	20
16	-68	50
66	-14	24
-34	-80	18
44	-74	12
-32	14	10
-40	18	0
38	18	2
-28	64	6
-20	-4	62
34	4	56
-58	10	34
46	44	26
-44	52	14
-62	4	18
46	20	26
-26	-104	-2
26	-32	2
38	-20	-10
-64	-34	22
-50	-36	26
6	-62	-34
-20	-74	-48
-34	-62	-34
40	-58	-44
20	0	20
-14	20	-4
-26	-70	32
38	-68	38
18	-62	46
-26	-86	-4
26	-86	-6
58	-54	-14
40	-68	-12
-12	-94	20
18	-80	24
6	-62	0
-10	-16	32
-10	-88	34
-16	58	14
62	4	-6
-20	20	50
22	46	16
34	-6	38
-36	56	-4
-46	-16	14

// Pujol J, 2009: Subgroup of [Healthy Controls], Group 1
// Subjects=9
-51	-27	48
-54	-28	26
56	-17	17
-59	-23	15
-36	15	2
36	15	-1
-45	-15	42
-45	-36	30
-59	-28	18
-45	18	7
0	14	38
3	2	44
-27	6	-3
15	14	-6
48	29	4
-51	-44	49
36	20	-4
-27	-39	46
-56	-46	22
-45	18	7
51	29	4

// Pujol J, 2009: Subgroup of [Healthy Controls], Group 2
// Subjects=9
-54	-15	48
-33	-29	62
54	-21	48
-60	-22	26
56	-16	23
-48	-20	18
-33	-2	11
39	-3	-2
-6	-1	36
0	0	55
54	13	35
-30	-62	-17
-42	12	5
38	18	-1
0	-4	44
-27	3	8
30	12	-3

// Pujol J, 2009: Patients
// Subjects=9
-36	-17	59
-48	-28	26
59	-37	21
-59	-28	18
56	-17	17
-39	15	5
36	15	-1
0	14	38
3	2	44
0	0	53
-27	6	-3
15	14	-6
54	-64	6
21	18	18
-45	-15	42
-45	-36	30
-59	-28	18
-45	18	7
0	14	38
3	2	44
-27	6	-3
15	14	-6
48	29	4
-54	-33	43
-45	-25	23
59	-17	20
-39	18	5
36	15	0
-27	-39	46
-56	-46	22
-45	18	7
51	29	4
-45	-15	42
-59	-28	18
-39	15	5
33	12	-1
3	11	38
6	2	44
3	0	55
-33	9	5
18	12	-1
54	-61	3
56	6	3
-51	-27	43
54	-15	48
-48	-20	18
56	-16	23
-33	-3	8
-45	-8	6
39	17	-1
0	-1	44
0	0	55
-27	3	-3
15	12	-1
56	10	16
-42	12	5
38	18	-1
0	-4	44
-27	3	8
30	12	-3

// Whalley H C, 2009: Healthy Controls
// Subjects=14
26	-43	30
-28	-51	23
-40	-7	50
32	-2	-10
-28	-4	-12
-34	-59	20
18	-85	-3
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48

// Whalley H C, 2009: Schizophrenia
// Subjects=15
-28	-46	16
42	-53	32
-20	-10	35
32	-2	-10
-28	-4	-12
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48
12	26	10
-44	40	24
-46	-47	39
57	-18	36

// Whalley H C, 2009: Bipolar Disorder
// Subjects=14
26	-43	30
-28	-51	23
-40	-7	50
-28	-46	16
42	-53	32
-20	-10	35
-34	-59	20
18	-85	-3
-26	-30	-10
19	-57	-6
12	17	43
-30	4	48
12	26	10
-44	40	24
-46	-47	39
57	-18	36

// Scheibel R S, 2009: Moderate Traumatic Brain Injury (mTBI)
// Subjects=9
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
1.45	-23.91	22.41
-18.14	-46.91	7.09
16.36	-24.35	5.39
-5.25	-17.94	6.24
3.5	-64.16	5.06
3.61	-23.9	22.37
5.55	-.37	9.92
-7.44	11.39	10.1
14.23	-24.15	7.65
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Severe TBI (sTBI)
// Subjects=8
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
-7.19	-23.94	22.56
12.29	-32.38	23.06
-26.63	-21.78	23.8
60.73	-28.03	9.48
-7.39	-50.58	1.67
46.53	-18.28	-.21
48.86	-39.98	8.62
-24.6	-51.19	7.62
33.91	-36.56	23.11
20.82	-48.49	11.06
1.33	-64.17	5.1
1.45	-23.91	22.41
-18.14	-46.91	7.09
16.36	-24.35	5.39
-5.25	-17.94	6.24
3.5	-64.16	5.06
-32.79	1.42	54.1
-26.47	-37	33.14
-55.49	-31.61	46.55
-41.7	7.07	34.64
-34.93	-44.4	46.35
-35.18	-54.99	24.99
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Very Severe TBI (vsTBI)
// Subjects=13
7.74	-.15	12.11
-7.44	10.33	10.21
-15.85	14.19	29.02
36.04	0.44	28.37
18.67	11.77	24.19
7.75	4.31	13.91
-15.85	14.19	29.02
-11.73	-.43	10.22
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
21.11	-8.04	41.79
-30.94	-36.99	22.01
-33.05	-53.06	22.52
-26.56	-70.47	19.65
-22.33	-88.61	9.04
-11.51	-23.96	22.63
31.74	-3.83	28.87
10.12	-19.31	25.17
58.5	8.64	11.49
23.5	-33.69	54.38
7.72	-2.49	10.1
25.15	-30.93	14.86
21.22	-13.8	49.09
-53.54	-37.52	29.17
-35.18	-54.99	24.99
-13.59	-32.06	27.95
16.75	-38.98	32.6
46.55	-33.48	-2.07
29.77	-53.82	33.85
-26.41	-76.98	30.37
10.68	-43.54	64.53
-41.93	-73.46	0.03
-39.57	-79.65	14.05
36.09	-63.76	19.04
19.19	-66.44	48.73
40.47	-34.85	29.55
-14.01	47.94	11.08
-1	26.41	9.63
16.19	23.61	1.77
3.31	46.09	13.21
-5.1	-28.81	16.28
-11.76	-11.58	5.72
5.5	-5.14	4.79
20.88	7.73	26.79
14.39	-35.02	17.68
-24.42	-43.25	23.64
10.09	-8.57	25.23
7.73	6.33	12.58
-15.85	14.19	29.02
-9.56	4.04	11.99
24.92	28.63	8.97
27.16	10.66	11.83
38.2	0.45	28.34
-30.8	-35.96	33.11
-26.56	-70.47	19.65
-33.05	-53.06	22.52
-22.33	-88.61	9.04
-48.54	4.34	5.9
-50.28	-35.17	31.13
-50.07	-29.25	48.47
-50.43	-13.35	23.37
-9.34	-26.08	22.81
-8.22	-22.47	26.91
-23.48	-27.92	15.38
-53.54	-37.52	29.17
-37.35	-50.74	24.6
-13.59	-32.06	27.95
-26.38	-76.77	32.59
-7.19	-23.94	22.56
7.74	-.15	12.11
-22.23	-38.68	26.51
-26.63	-21.78	23.8
38.5	5.92	52.44
21.14	-9.96	44.22
-32.72	0.87	59.76
-15.59	15.1	50.21
-44.87	0.99	38.66
46.69	-37.86	8.45
12.78	-41.82	59.85
-32.79	1.42	54.1
-26.47	-37	33.14
-55.49	-31.61	46.55
-41.7	7.07	34.64
-34.93	-44.4	46.35
-35.18	-54.99	24.99
3.61	-23.9	22.37
5.55	-.37	9.92
-7.44	11.39	10.1
14.23	-24.15	7.65
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Scheibel R S, 2009: Orthopedic Controls (OI)
// Subjects=10
-7.19	-23.94	22.56
12.29	-32.38	23.06
-26.63	-21.78	23.8
60.73	-28.03	9.48
-7.39	-50.58	1.67
46.53	-18.28	-.21
48.86	-39.98	8.62
-24.6	-51.19	7.62
33.91	-36.56	23.11
20.82	-48.49	11.06
1.33	-64.17	5.1
-7.19	-23.94	22.56
7.74	-.15	12.11
-22.23	-38.68	26.51
-26.63	-21.78	23.8
38.5	5.92	52.44
21.14	-9.96	44.22
-32.72	0.87	59.76
-15.59	15.1	50.21
-44.87	0.99	38.66
46.69	-37.86	8.45
12.78	-41.82	59.85
3.61	-23.9	22.37
-35.27	-52.42	18.01
-28.91	-66.41	5.84
-28.81	-35.07	19.54
-52.71	-53.62	6.1
-34.96	3.54	53.93
-32.6	-48.57	59.04
-53.37	-29.68	44.08
-43.92	4.41	29.34
-52.61	20.44	29.03
10.12	-19.31	25.17
-9.38	-21.92	21.28
9.85	-2.69	7.84
-24.54	-28.88	16.62
-17.39	-46.83	65.34
14.55	-37.07	30.21
-13.57	-31.95	29.06
10.68	-43.54	64.53
-13.91	-2.77	8.25
29.81	-55.74	36.28
-39.22	-33.26	50.92
30.1	-50.27	60.39
-13.15	-9.07	67.13
-22.06	-5.65	46.77
14.91	-63.91	53.03
56.86	-22.49	45.98
47.24	-35.94	51.95
-34.9	1.83	58.58

// Pollok B, 2009: Auditory Pacing > Rest
// Pollok B, 2009: Visual Pacing > Rest
// Subjects=10
-36.93	-15.85	64.85
-32.81	22.04	56.54
8.44	14.92	69.99
-45.46	-36.94	69.32
-16.01	-16.5	10.77
35.31	-90.41	-47.79
-54.83	-11.76	17.68
66.15	-13.67	13.57
-39.06	-15.65	67.1
-58.97	13.7	37.64
12.8	19.61	73.94
-45.46	-39.07	69.53
-5.23	-10.08	9.95
41.73	-88.68	-52.55
-17.88	-99.67	16.79

// Posner J, 2009: Positive Correlation between Unadjusted Valence and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Unadjusted Valence and BOLD 
// activity
// Posner J, 2009: Positive Correlation between Unadjusted Arousal and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Unadjusted Arousal and BOLD 
// activity
// Posner J, 2009: Positive Correlation between Valence Extremes and BOLD 
// activity
// Posner J, 2009: Inverse Correlation between Valence Extremes and BOLD 
// activity
// Subjects=10
-40	3	-15
32	50	25
14	-46	56
-32	-22	-16
2	45	9
-32	5	57
-6	-74	-6
-33	51	1
-10	59	8
5	40	9
-2	-49	39
34	49	18
-61	-33	2
35	1	-20

// Post M, 2009: All Conditions > Rest
// Post M, 2009: Sustained MVC > Brief Maximal Voluntary Isometric 
// Contractions (MVC)
// Subjects=12
-38	-20	62
-30	-22	70
-22	-24	72
-32	-28	56
-24	-26	60
-60	-22	14
-36	-28	48
-36	-32	58
-26	-30	72
-34	-40	60
-50	-24	50
-50	-18	52
-52	-18	16
-4	-12	56
-2	-22	48
4	-14	54
12	-52	-12
20	-54	-22
16	-58	-18
12	-60	-16
30	-58	-26
26	-62	-24
30	-68	-26
16	-74	-20
12	-70	-44
6	-62	-46
6	-58	-12
6	-64	-24
0	-60	-20
4	-72	-32
6	-68	-44
4	-72	-34
-16	-72	-28
-4	-56	-12
-12	-56	-20
-20	-64	-38
-8	-62	-46
28	-6	6
-16	-30	12
-14	-30	6
-12	-26	8
-20	-24	72
-28	-22	70
-38	-22	60
-18	-30	68
-36	-32	58
-28	-42	58
-32	-40	56
-18	-30	64
-52	-20	20
-46	-10	32
-50	-8	22
-2	-16	56
-4	0	44
2	14	34
-58	-22	14
-40	-20	8

// Pulvermuller F, 2009: Normals, Experiment 1
// Subjects=12
-47	22	15
-42	-44	-19
-45	20	8
-53	-49	-1
-49	11	16
-32	-38	58
-44	-29	40
-51	-50	-3
48	22	10
-32	-5	52
-49	-51	-9
27	-17	56
37	21	13
-19	-29	61
0	3	56
-29	-7	-15
-12	-43	-6
28	-19	60
-36	21	8
-46	6	42
-4	20	52
1	-10	61
-32	-28	-17
-33	-67	22
32	-26	53

// Pulvermuller F, 2009: Normals, Experiment 2
// Subjects=9
-49	22	16
-45	-46	-14
-46	18	13
-50	-50	-6
-50	9	10
-38	-34	51
-49	-50	-4
49	21	8
-34	-10	50
-52	-52	-9
36	-8	48
7	-8	58
38	19	12
-20	-26	57
0	2	58
-4	20	48
-35	-8	-11
-11	-38	-10
38	-17	53
-39	26	2
-50	-3	38
-2	20	56
0	-14	61
-28	-19	-16
-28	-66	38
38	-31	52

// Qin J, 2009: Risky Social Situation > Safe Social Situation, Risk 
// Identification
// Qin J, 2009: Risky Physical Situation > Safe Physical Situation, Risk 
// Identification
// Qin J, 2009: Social Risk Identification > Autobiographical Response
// Qin J, 2009: Physical Risk Identification > Autobiographical Response
// Qin J, 2009: Social Risk Identification > Physical Risk Identification
// Subjects=14
-13.93	61.64	19.81
-5.35	63.38	15.01
-2.79	-55.08	22.2
-6.99	-47.57	33.86
-58.58	7.45	-17.77
-47.95	-60.17	39.16
-13.49	-30.27	35.62
-4.99	-54.23	19.91
-5.58	47.48	-5.83
-7.47	65.92	19.27
-50.71	-12.14	1.96
-4.85	-11.64	39.23
-9.24	25.03	41.28
-37.49	-88.98	5.98
-7.5	-20.8	-1.28
9.75	-18.82	-4.01
-41.33	-10.96	59.95
29.05	-55.93	-23.08
27.29	-74.82	4.59
16.84	-76.62	31.84
-35.25	-21.6	26.17
51.02	-10.43	14.63
50.72	-20.37	-11.28
-35.74	-16.52	-11.31
10	37.78	27.36
-9.27	24.82	39.06
-58.27	-34.06	-2.46

// Vilberg K L, 2009: Familiarity > Recollection
// Vilberg K L, 2009: Recollection > Familiarity
// Subjects=20
-6	33	39
-36	51	9
-48	27	33
-54	9	36
-39	21	-12
-27	-3	60
-33	15	0
12	12	0
-12	3	12
-15	3	-3
9	0	9
0	-18	27
48	-30	42
-48	-48	51
45	-48	51
42	-72	45
12	-66	33
-3	-81	42
36	-63	-36
-36	30	-21
-27	27	54
39	-21	57
21	-15	-36
-24	-24	-30
24	-27	-30
-63	-51	-12
-6	-54	18
-51	-75	21

// Wilson S M, 2009: Viewing Pictures or Scrambled Pictures > Fixation
// Wilson S M, 2009: Naming Pictures > Fixation
// Wilson S M, 2009: Positive Correlation between Word Familiarity and 
// Activations
// Wilson S M, 2009: Negative Correlation between Word Frequency and 
// Activations
// Wilson S M, 2009: Positive Correlation between Word Length and Activations
// Wilson S M, 2009: Positive Correlation between Reaction Time and 
// Activations
// Subjects=12
-6	-96	-6
-40	-8	26
-54	12	20
-56	-28	0
-16	-4	14
-4	-12	6
40	-8	30
66	-24	6
-6	6	56
-10	-52	-8
-12	-64	-22
-50	-56	-18
40	-58	-26
36	-46	-28
22	-92	-2
-50	-80	4
-14	-54	-32
-38	-54	-22
-64	-34	24
-44	-68	-10
12	-70	-10
-54	-2	-16
-38	-68	50
-6	2	46
-26	10	60
58	-10	-4
-4	-80	-12
-28	-54	-22
26	-52	-22
-44	-58	-18
-44	-64	-36
28	-66	-32
-56	8	2
-58	18	22
-44	34	-8
-42	4	28
-44	4	48
-6	14	40
-2	14	58
38	18	-2
-32	-86	14
38	-80	8
-2	-6	2
-58	-28	-4
-56	-32	-4

// Dichter G S, 2009: Target Face > Novel, Healthy Controls > Autism
// Dichter G S, 2009: (Target Shape > Novel) > (Target Face > Novel), Healthy 
// Controls > Autism
// Dichter G S, 2009: (Target Face > Novel) > (Target Shape > Novel), Healthy 
// Controls > Autism
// Dichter G S, 2009: Target Shape > Novel, Autism > Healthy Controls
// Dichter G S, 2009: Target Face > Novel, Autism > Healthy Controls
// Dichter G S, 2009: (Target Shape > Novel) > (Target Face > Novel), Autism > 
// Healthy Controls
// Dichter G S, 2009: (Target Face > Novel) > (Target Shape > Novel), Autism > 
// Healthy Controls
// Subjects=15
-12	-56	62
-54	32	18
-6	26	48
-40	26	-10
18	64	4
40	-76	14
-20	2	-18
-4	24	28
-10	4	2
-16	-8	20
-56	-12	12
-12	-20	32
-6	-24	46
-14	4	70
-22	26	-16
-26	48	14
-36	-26	4
-38	6	0
16	-46	-12
10	52	0
0	24	36
50	2	38
24	-18	60
-48	44	10
-12	-56	10
-20	14	-4
4	-12	50
-46	-50	10
-12	-16	-4
-24	-8	-18
44	6	12
-14	34	12
44	22	28
-44	16	36
-36	6	48
-4	26	54
-10	56	-10
-44	12	0
24	22	-8
40	44	12
28	14	10
14	-68	12
6	-78	-12
20	-54	4
-14	-78	-12
-10	46	20
34	-42	40
-52	-20	24
-44	2	30
12	-74	44
-20	-60	14
-46	-46	52
-50	-42	38
-50	-24	-8
-12	-16	0
18	64	4
40	-76	14
-6	26	48
-40	26	-10
-54	32	18

// Baumgartner T, 2009: Promise Stage: Dishonest (D) > Honest (H), (Promise - 
// No Promise)^D - Promise - No Promise)^H
// Baumgartner T, 2009: Anticipation Stage: D>H, (Promise (P) - No Promise 
// (NoP))^D - (P-NoP)^H
// Baumgartner T, 2009: Anticipation Stage: H>D, ((P-NoP)^H - (P-NoP)^D)
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.0001
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.0005
// Baumgartner T, 2009: Anticipation Stage: D>H, ((NoP-P)^D - (NoP-P)^H), 
// p<0.005
// Baumgartner T, 2009: Decision Stage A: D>H, ((P-NoP)^D - (P-NoP)^H), 
// p<0.001
// Baumgartner T, 2009: Decision Stage A: D>H, ((P-NoP)^D - (P-NoP)^H), 
// p<0.005
// Baumgartner T, 2009: Decision Stage B: D>H, ((P-NoP)^D - (P-NoP)^H)
// Subjects=26
33	-72	3
-45	-66	36
51	-57	-3
-36	66	6
9	-30	21
21	-72	60
24	-72	52
-33	3	54
6	-6	63
-36	-42	15
21	18	63
24	-33	45

// Greene J D, 2009: Subgroup of Normals, Honest
// Subjects=14
34.18	-20.9	-17.21
-29.96	-14.93	-16.97
-42.17	-25.13	58.75
-13.27	-37.65	59.46
26.18	-15.21	57.13

// Greene J D, 2009: Subgroup of Normals, Dishonest
// Subjects=14
38.91	-45.74	32.78
-29.49	-49.57	30.54
-6.97	-18.92	53.36
-35.93	-30.15	34.56
50.57	-36.75	24.08
8.98	-46	32.03
-39.43	75.54	39.12
43.83	-23.75	-13.73
-45.87	-20.35	-2.95

// Kozel F A, 2009: Subgroup of Normals, Mock-Crime Group
// Subjects=22
-45	30	-9
-42	12	45
-54	30	-3
54	15	-12
33	18	-15
36	27	-6
-42	-51	48
-60	-51	33
-33	-42	51
9	-3	6
15	0	18
9	18	54
-3	18	48
-6	15	57
9	-105	6
6	-93	3
27	-87	-9
12	-84	-18
-6	-81	-18
39	54	12
33	51	21
-27	51	24
-33	60	15
-45	51	6
-18	-102	12
-9	-27	18
-24	-63	60
-15	-69	60
-60	-36	-12
-51	-42	-6

// Kozel F A, 2009: Subgroup of Normals, No Crime Group
// Subjects=26
-3	-24	48
-12	-18	42
9	-54	33
12	54	0
-12	42	-15
-3	48	-18
-45	-78	36
45	-27	63
42	-18	45
30	-30	54
57	-66	18
42	-51	21
30	-12	9
21	-18	-27
27	-12	-27

// Bhatt S, 2009: Unfamiliar: Lie > Truth
// Bhatt S, 2009: Familiar: Lie > Truth
// Bhatt S, 2009: Familiar (Lie > Truth) > Unfamilar (Lie > Truth)
// Subjects=18
-13.16	-46.37	58.5
29.82	15.47	51.65
3.2	-20.43	-9.34
57.19	16.75	-4.98
60.04	-37.14	38.41
3.79	25.59	46.6
38.11	39.15	28.99
8.61	-58.23	68.26
10.63	-43.95	60.09
8.62	-60.36	68.47
-13.16	-46.37	58.5
53.21	45.59	28.1
52.78	16.12	-11.56
26.73	-78.97	-39.81
66.52	-59.01	33.74
29.1	60.44	4.63
45.73	0.89	-59.24

// Antonova E, 2009: Older Normals
// Subjects=10
55.78	7.95	23.62
-32.83	-29.05	21.05
51.38	9.98	9
51.53	8.27	28.1
-25.16	-6.08	55.84
-41.13	-22.04	57.36
28.2	-2.13	47.09
59.06	-12.12	25.27
44.11	-69.16	4.57
-41.38	-69.68	5.6
27.86	-46.31	-15
-48.78	-28.28	32.32
63.3	-16.84	18.92
51.62	-60.06	11.53
-25.25	-71.9	16.75
12.92	-22.02	-2.37
25.15	-66.45	41.36
-5.75	-73.44	50.11
25.15	-74.11	38.66
-25.27	-80.87	10.81
-25.33	-89.13	0.35
32.48	-80.01	16.77
20.58	-93.68	-7.6
-13.55	-93.29	0.57
5.38	-22.67	-10.03
-22.22	-85.74	-11.12
8.45	-69.09	-46.32
-13.74	-13.93	8.41
16.16	-9.52	7.7
-25.51	-2.11	10.9
-13.66	-13.07	19.49
-32.92	7.42	24.68
-32.93	-33.33	6.91
47.24	-17.28	14.68
-2.75	-18.44	45.46
2.57	-6.52	47.75
1.55	-10.41	52.55
-2.68	-14.41	56.28
-29.34	-29.37	57.84
35.77	-38.55	43.36
-29.41	-26.8	49.82
51.43	-54.37	-11.25
-41.36	-72.85	5.86
51.57	-24.31	19.68
35.65	-68.36	15.75
-37.14	-29.41	16.67
-29.3	-33.34	61.52
44.38	-41.16	50.17
40.03	-50.76	36.53
-21.93	-50.87	40.6
1.29	7.71	25.38
16.64	-61.68	48.87
-2.57	-73.68	46.75
-6.55	56.71	-.94
1.37	-52.96	11.51
1.43	-56.68	18.51
39.88	-72.02	9.32
-17.61	-70.14	38.82
-22	-83.51	17.69
20.64	-93.08	0.16
20.58	-93.68	-7.6
-10.3	-92.75	7.17
-17.95	-90.2	-14.14
24.78	-85.71	-15.01
-10.52	-18.14	8.73
32.52	-67.52	26.87
32.49	-51.4	28.87
28.32	-62.46	37.65
32.56	-62.69	34.27
32.51	-70.95	23.81
28.23	-79.78	20.14
32.55	-67.27	30.19
28.27	-67.29	30.25
28.29	-79.18	27.9
32.45	-71.55	16.06
24.99	-75.83	16.5
-25.23	-71.64	20.07
-25.2	-63.64	27.21
-17.57	-74.11	42.5
16.15	76.04	40.67
-13.26	-66.08	49.58
-13.27	-69.51	46.52
-13.22	-61.25	56.98
-13.34	-66.94	38.5
-17.62	-74.63	35.85
-21.88	-70.16	38.87
-17.68	-67.57	30.8
-17.69	-71	27.74
-21.96	-79.74	25.18
-29.51	-76.15	17.16

// Antonova E, 2009: Younger Normals
// Subjects=10
27.8	46.4	14.03
39.61	38.26	17.92
39.63	47.32	24.96
58.86	18.75	11.53
-44.76	2.01	10.78
47.09	14.19	8.7
55.71	10.61	16.71
-21.94	-1.58	58.77
28.25	-6.02	51.87
-41.42	3.48	29.57
27.89	-30.65	-5.16
-37.19	-54.05	0.89
-18.11	-27.04	-9.4
-37.04	-48.1	22.7
47.26	-60.94	0.5
35.36	-46.01	-11.77
-53.09	-40.8	22.27
-60.58	-24.47	27.68
16.54	-41.84	43.86
24.62	-8.21	-3.66
-22.43	1.03	-3.9
-17.52	-69.28	49.9
25.24	-68.77	52.71
-13.28	-78.32	42.8
16.68	-77.79	46.87
-25.33	-89.13	0.35
32.38	-88.78	-.34
-17.85	-97.89	-3.46
-10.46	-94.38	-13.88
20.46	-82.91	-19.65
-17.94	-20.84	15.73
24.73	-30.16	1.52
-22.37	-14.83	-2.57
-13.83	-19.27	-5.64
51.42	38.93	25.53
58.86	18.75	11.53
47.03	17.9	1.7
55.71	10.61	16.71
-25.1	-14.29	59.87
28.25	-6.02	51.87
-36.89	-42.16	44.5
44.31	-38.5	43.26
35.4	-38.01	-4.63
47.18	-45.34	-4.15
-18.11	-27.04	-9.4
35.41	-49.98	-8.09
-53.22	-58.63	-1.89
35.36	-46.01	-11.77
-25.53	-42.95	-7.98
59.19	-30.55	34.62
-32.59	-41.88	47.77
35.74	-70.68	27.1
-32.71	-32.16	35.81
13.34	-41.86	43.9
16.38	-43.55	21.7
-22.36	-19.06	-2.21
25.24	-73.26	49.74
-13.2	-61	60.3
-13.28	-78.32	42.8
28.33	-74.35	35.3
16.38	-97.34	0.56
-25.28	-88.61	7
-10.42	-98.35	-10.2
-10.46	-94.38	-13.88
20.47	-86.08	-19.39
-6.28	-14.14	5
12.97	-18.25	5.12
24.7	-21.7	0.81
32.52	-67.52	26.87
32.49	-51.4	28.87
28.32	-62.46	37.65
32.56	-62.69	34.27
32.51	-70.95	23.81
28.23	-79.78	20.14
32.55	-67.27	30.19
28.27	-67.29	30.25
28.29	-79.18	27.9
32.45	-71.55	16.06
24.99	-75.83	16.5
-25.23	-71.64	20.07
-25.2	-63.64	27.21
-17.57	-74.11	42.5
16.15	76.04	40.67
-13.26	-66.08	49.58
-13.27	-69.51	46.52
-13.22	-61.25	56.98
-13.34	-66.94	38.5
-17.62	-74.63	35.85
-21.88	-70.16	38.87
-17.68	-67.57	30.8
-17.69	-71	27.74
-21.96	-79.74	25.18
-29.51	-76.15	17.16

// Wolf R C, 2009: Attention-Deficit/Hyperactivity Disorder (ADHD)
// Subjects=12
-41.24	26.52	-9.87
43.21	14.99	-0.08
20.96	-99.95	11.67
11.58	10.91	61.37
39.77	-68.53	-32.1
7.21	-63.19	-42.16
43.61	11.42	30.52
-1.54	29.39	53.04
-12.04	-91.35	-32.32
-34.51	-93.07	-14.96
17.42	-10.31	6.22
-25.18	32.03	-20.77
-7.99	-68.85	35.98
-23.87	-63.22	62.59
-40.08	-16.3	71.67
-57.25	44.29	8.82
3.98	-20.48	-32.88
-40.18	-47.64	57.96
-57	-42.48	10.67
-60.27	-46	7.72
-31.24	45	15.03
-53.9	15.58	11.6
-8.39	36.45	25.57
-11.5	24.3	33.55
-18.26	18.9	10.66
-37.82	24.59	3.71
15.22	-58.34	78.25
4.88	35.48	48.97
34.3	-41.3	52.7
26.81	-68.57	-31.88
17.42	-10.31	6.22
8.13	22.42	46.84
53.5	-33.22	34.77
47.04	-39.62	35.51
50.09	10.37	30.51
50.11	5.06	31.04
49.88	32.84	18.21
30.14	30.59	-4.76
34.15	10.06	50.99
24.72	-56.67	61.11
46.7	26.76	22.23
34.29	-70.95	45.55
39.81	33.5	-8.58
11.75	-76.48	56.57
62.94	-58.33	6.84
20.59	8.84	4.27
30.42	-98.6	-8.8
62.49	13.81	-13.74
65.93	-27.34	-6.37

// Wolf R C, 2009: Healthy Controls
// Subjects=12
-41.24	26.52	-9.87
43.21	14.99	-0.08
20.96	-99.95	11.67
11.58	10.91	61.37
39.77	-68.53	-32.1
-21.17	-90.22	14.79
-24.31	-92.8	21.82
-60.2	13.62	25.35
-43.27	-53.09	68.64
-21.21	-67.57	15.91
-31.42	23.99	-3.06
-53.97	-66.99	-10.49
-24.41	-67.27	19.29
-34.37	39.23	22.37
-34.69	20.48	-6.02
-11.52	17.6	30.85
-27.9	-101.99	-7.47
-18.67	58.51	-13.42
-31.48	-71.66	-27.22
-53.22	-28.54	56.29
-60.47	-17.9	-1.78
-47.27	43	28.94
-18.35	-1.49	-.76
-36.86	-1.09	73.47
-63.64	-37.06	0.16
-15.08	-11.05	0.13
-12.17	-23.42	-28.96
27.54	-92.61	20.92
46.35	14.28	-7.91
46.98	-.71	38.39
36.59	-71.42	-28.4
18.17	-72.52	52.71
14.33	26.95	26.12
49.56	-74.56	-28.31
24.41	-75.43	32.72
50.38	-31.23	44.71
59.9	-10.86	32.45
39.89	24.24	-4.3
33.35	27.1	-7.84
24	-12.86	13.09
56.48	14.03	23.32
46.64	42.71	20.65
65.96	-23.84	-3.35
14.77	13.8	57.67
44.11	-53.72	57.13
20.59	8.84	4.27
30.48	52.85	26.64

// Banich M T, 2009: Neutral > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Neutral > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Congruent > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Congruent > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Fixation, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Fixation, ADHD > Healthy Controls
// Banich M T, 2009: Congruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Incongruent > Neutral, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Congruent, ADHD > Healthy Controls
// Banich M T, 2009: Incongruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Congruent > Neutral, Healthy Controls > ADHD
// Banich M T, 2009: Neutral Frequent (inc) > Neutral Frequent (neut), Healthy 
// Controls > ADHD
// Banich M T, 2009: Neutral Frequent (inc) > Neutral Frequent (cong), Healthy 
// Controls > ADHD
// Banich M T, 2009: Incongruent > Congruent, Healthy Controls > ADHD
// Subjects=23
-42	30	24
-50	4	36
8	-46	20
34	-26	12
60	-10	2
42	-58	12
-46	-26	4
-14	46	46
-2	-94	-4
-34	-82	38
6	54	14
26	16	-28
-46	32	28
-48	6	40
60	-4	-2
-40	-34	8
4	-48	30
-46	32	30
44	-14	6
-40	-22	6
6	-48	6
42	-60	12
-34	0	-28
0	-92	-2
16	-90	-6
-6	-60	32
-58	-50	34
2	-76	30
48	40	20
54	34	18
6	-22	0
-38	-58	46
24	-50	8
-34	-18	-16
14	-14	-12
10	-28	-16

// Lehtonen M, 2009: Finnish inflected real & pseudo words > Swedish inflected 
// real & pseudo words
// Lehtonen M, 2009: Finnish inflected real & pseudo words > Finnish 
// monomorphemic real & pseudo words
// Subjects=16
-54	12	27
-57	9	15
-48	0	36
-33	-90	-12
-36	-75	-21
-51	9	24

// Gougoux F, 2009: Sighted Group
// Subjects=14
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
67.43	-21.53	-.81
61.14	-37.97	7.34
-60.82	-20.35	-1.66
-65.01	-34.84	4.06
65.28	-27.17	-4.77
-65.07	-31.12	-2.94
37.48	-54.97	-17.73
39.69	-73.99	-16.16
-48.02	-51.25	-17.06

// Gougoux F, 2009: Congenitally Blind Group
// Subjects=5
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
65.35	-31.94	2.32
-67.18	-28.68	1.34
-48.03	-49.14	-17.24
65.28	-27.17	-4.77
-65.07	-31.12	-2.94
37.48	-54.97	-17.73
39.69	-73.99	-16.16
-48.02	-51.25	-17.06
54.76	-71.64	-.92
63.22	-33.01	2.44
-73.61	-35.4	-2.48
-67.18	-28.68	1.34
37.48	-54.97	-17.73
38.58	-72.22	-20.76
-48.02	-51.25	-17.06
65.38	-44.8	1.17
65.23	-11.31	-6.1
-57.51	-52.23	-1.26

// Gougoux F, 2009: Acquired Blind Group
// Subjects=10
63.24	-14.18	12.01
-54.31	-14.88	13.42
37.6	-77.89	-11.35
14.31	-75.8	17.74
48.46	-76.11	10.68
-49.89	-81.45	5.57
-37.27	-72.51	-17.63
69.5	-11.28	-6.15
58.81	-20.15	-9.74
-60.8	-20.18	0.55
-58.64	-33.03	-.62
54.76	-71.64	-.92
63.22	-33.01	2.44
-73.61	-35.4	-2.48
-67.18	-28.68	1.34
37.48	-54.97	-17.73
38.58	-72.22	-20.76
-48.02	-51.25	-17.06
65.38	-44.8	1.17
65.23	-11.31	-6.1
-57.51	-52.23	-1.26

// Bohon C, 2009: Anticipatory reward: Main effect of mood condition
// Bohon C, 2009: Anticipatory reward: Interaction between emotional eating 
// and mood condition
// Bohon C, 2009: Consummatory reward: Main effect of emotional eating status
// Bohon C, 2009: Consummatory reward: Main effect of mood condition
// Bohon C, 2009: Consummatory reward: Interaction between emotional eating 
// and mood condition
// Subjects=10
-2.35	29.85	-10.86
-14.95	-33.07	5.66
-31.3	-40.76	-6.74
13.98	63.68	5.68
-5.37	47.97	10.93
27.04	-40.55	-7.76
7.62	31.75	8.95
-11.88	11.61	1.19
4.3	41	4.73
-2.02	42.23	18.16
20.5	-1.66	-4.77
-18.2	-20.01	7.79
-24.8	-11.08	0.29
-14.84	-5.99	19.79
4.41	-10.67	3.12
7.66	41.95	14.66

// Frodl T, 2009: Emotional processing, Major Depression>Healthy Controls
// Frodl T, 2009: Explicit Processing, Healthy Controls>Major Depression
// Frodl T, 2009: Implicit Processing, Major Depression>Healthy Controls
// Frodl T, 2009: Implicit>Explicit
// Frodl T, 2009: Explicit>Implicit
// Subjects=12
-6	-4	36
26	-28	42
30	56	18
28	48	22
-24	-68	-44
-8	-76	-32
-42	6	38
-32	58	14
-60	-14	10
-22	-66	-42
30	-58	-24

// Rubia K, 2009: Healthy Controls
// Subjects=16
47.61	-13.92	0.46
47.59	-12.96	-.75
4.46	-51.92	-1.77
20.9	9	28.91
21.07	-13.78	37.88
11.61	35.87	-16.18
-29.89	-48.15	17.5
-29.89	-48.15	17.5
-37.22	-67.24	31.84
-57.19	-34.05	-2.48
-18.08	11.53	23.72
-20.94	-26.17	45.42
-3.46	40.59	-10.78
-3.46	40.59	-10.78
42.9	47.68	-17.88
8.48	65.17	-1.09
-41.84	27.92	28.1
-57.08	-1.44	13.34
-41.5	-58.23	36.62
-41.5	-58.23	36.62
-32.81	-29.4	45.95
1.42	-24.12	20.19
-5.88	-70.32	31.61
-25.69	3.44	17.92
4.78	-54.95	23.18
36.27	-14.27	43.27
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: ADHD
// Subjects=18
20.65	-66.21	-6.23
44.29	-55.05	-14.46
-6.37	-86.07	-10.53
20.65	-66.21	-6.23
-30.05	-70.12	0.62
-6.24	-56.65	5.61
-45.12	-41.38	10.36
21.37	-32.32	57.64
20.89	-47.97	16.61
21.01	-18.65	31.64
16.39	39.31	20.38
24.9	50.42	12.41
25.34	17.6	40.3
-10.35	9.51	36.11
32.78	33.06	33.05
32.78	33.06	33.05
20.49	34.37	1.75
39.8	29.04	-10.38
-42.23	49.04	1.37
-42.23	49.04	1.37
-42.31	28.75	-8.95
63.84	-1.64	4.57
63.84	-1.64	4.57
16.2	6.18	-.99
44.52	-11.72	12.62
-45.24	-70.69	-4.66
-37.08	-21.35	51.95
-37.54	-24.77	15.31
-28.71	9.45	36.43
-52.3	-38.5	41.58
-40.4	18.51	53.66
-29.68	-42.23	34.84
-56.39	-16.02	64.07
-21.63	-10.53	-5.42
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: Conduct Disorder
// Subjects=14
-3.13	-45.56	-2.27
-2.48	-69.16	43.76
-6.51	-91.46	-22.32
-50.1	46.73	-22.92
47.15	43.88	-24.3
39.81	-15.71	-18.28
29.01	-15.75	-18.09
35.44	21.06	-15.12
-2.78	26.01	39.95
39.8	-51.95	-27.02
39.8	-51.95	-27.02
35.55	-71.11	-25.05
-18.47	-66.94	-23.42
20.62	-78.42	-10.62
-45.4	-46.75	-12.63
-10.54	-61.98	6.21
-13.66	-76.36	13.29
-17.49	-39.9	59.05
35.43	40.72	-11.46
-2.86	-52.31	17.45

// Rubia K, 2009: Healthy Controls (HC) > ADHD & Conduct Disorder (CD), 
// Incongruent > Oddball
// Rubia K, 2009: HC & CD > ADHD, Oddball > Congruent
// Rubia K, 2009: HC > ADHD & CD, Oddball > Congruent
// Subjects=13
59.23	-7.13	-19.46
16.93	-64.95	41.89
-33.77	56.43	-11.84
31.82	41.65	44.54

// Wolf R C, 2009: Healthy Controls (HC) > Huntington's Disease (HD), Load 
// level 2
// Wolf R C, 2009: HC > HD, Load level 3
// Subjects=12
27	-63	-30
-30	33	36
-51	0	39
-51	-45	51
-9	-69	48
3	-53	54
-27	-50	48
-18	9	-3
30	-63	-33
12	-33	-48

// Aarts E, 2009: Incongruent > Congruent + Congruent > Neutral
// Aarts E, 2009: Congruent > Neutral
// Aarts E, 2009: Incongruent > Congruent
// Subjects=12
-6	38	28
-2	26	44
-32	26	-14
36	24	-18
-44	22	24
-36	10	28
44	6	44
-32	-54	44
-6	34	10
-2	26	44
36	24	8
-34	8	30
58	16	28
-40	60	2
32	58	4
26	16	42
38	2	48
-60	-50	8
-32	-54	44
36	-48	44
32	-68	52
12	-64	58
-8	0	4
14	2	6
-8	-14	10
34	-64	-36
-10	42	26
2	30	46
-40	22	-14
34	24	-14
-42	28	6
-42	20	14
-54	4	38
-46	4	30
-28	-60	36
-36	-38	40
-48	-52	30
-32	-64	54
-26	-66	46
-8	10	-2
10	12	6

// Schoning S, 2009: Healthy controls (HC)
// Subjects=28
-2	8	58
-30	26	-2
-32	26	-6
-36	-56	38
-34	-64	38
-30	-64	16
-4	-54	-24
0	-58	-40
-6	-74	-36
-16	0	22
-16	0	10
14	4	-2
16	-2	20
12	-6	0
2	-28	10
38	-66	-36
-12	-8	6
-4	-10	8
-50	-62	-22
-42	-68	-36
-32	-58	38
-26	-68	38
30	-48	24
26	-46	32
-34	-44	0
-50	8	38
-26	0	72
-8	-38	72
8	-24	72
8	-16	74
54	-4	-14
16	-52	70
-4	40	6
0	-20	44
-24	-10	-28
-2	20	36
-12	-26	42
-4	-6	34
-12	-14	46
-42	-24	38
-22	-8	18
-10	-2	2
-14	2	14
34	-20	48
38	-16	40
-6	-24	68
0	-18	62
6	-18	70
-58	-54	34
-58	-44	32
-46	-66	20
46	20	20
12	-48	32

// Schoning S, 2009: Major depressive disorder (MDD) patients
// Subjects=28
4	8	56
-48	8	46
-6	-8	4
36	-56	32
-38	-58	36
-34	-68	36
58	-46	-16
60	-26	-18
24	-36	50
-38	-24	34
4	-74	-6
-28	-18	-28
22	-30	-10
-10	2	62
-6	-2	56
-48	8	20
34	-56	32
-30	-52	30
-28	-62	34
40	-68	-34
30	-70	-30
-38	-26	-38
8	-40	-38
-8	-40	-36
54	-46	-20
-4	-32	14
6	-28	16
-60	-30	-6
-28	46	-4
-28	54	-6
-24	48	-12
32	-54	-40
-12	-80	-34
-12	-70	-36
22	44	-2
-32	-16	-22
-30	-70	-34
36	-72	14
-54	-50	8
0	-32	-22
12	-76	-28
-8	-38	72
8	-24	72
8	-16	74
54	-4	-14
16	-52	70
-4	40	6
0	-20	44
-24	-10	-28
-2	20	36
-12	-26	42
-4	-6	34
-12	-14	46
-42	-24	38
-22	-8	18
-10	-2	2
-14	2	14
34	-20	48
38	-16	40
-6	-24	68
0	-18	62
6	-18	70
-58	-54	34
-58	-44	32
-46	-66	20
46	20	20
12	-48	32

// Rodriguez-Jimenez R, 2009: Conjunction, Auditory and Visual > Control
// Rodriguez-Jimenez R, 2009: Auditory > Visual
// Rodriguez-Jimenez R, 2009: Visual > Auditory
// Subjects=13
-1.48	13.44	54.62
-1.37	7.68	61.91
7.99	34.56	38.92
-53.57	8.19	35.86
-47.27	33.12	26.56
-43.94	10.79	28.71
-27.33	4.08	59.35
-24.2	-0.03	49.62
-43.61	-42.51	44.07
-27.31	-67.98	46.31
-27.37	-52.03	44.73
1.08	-54.03	-12.71
43.44	43.01	24.04
63.02	21.06	29.24
49.94	26.77	22.17
37.43	10.38	54.26
27.72	7.16	54.74
18.22	-63.38	58.52
47.31	-40.95	55.81
50.34	-32.61	41.49
-1.97	62.31	26.26
11.03	65.85	29.05
-54.25	29.36	-13.29
-44.07	-22.98	11.89
65.87	-1.5	-5.56
56.37	-26.13	7.12
-50.54	-81.99	1.03
-44.03	-88.35	1.54
-40.83	-78.77	0.54
-11.57	20.48	27.2
-21.22	-54.5	17.98
-44.33	-67.58	-17.31
-31.48	-58.58	-25.15
-37.71	-46.85	-2.67
7.28	9.49	-22.46
52.93	-63.73	-15.99
43.22	-66.96	-15.51
49.73	-73.31	-14.99
27.65	-42.57	39.5
14.37	-38.42	15.78

// Melcher T, 2009: Response Incongruent (RI) - Semantic Incongruent (SI)
// Melcher T, 2009: RI - Congruent (CO), p<0.005
// Melcher T, 2009: RI - Congruent (CO), p<0.001
// Melcher T, 2009: SI - CO, p<0.005
// Melcher T, 2009: SI - CO, p<0.001
// Melcher T, 2009: RI-CO+RI-SI
// Melcher T, 2009: RI-CO+SI-CO, p<0.005
// Melcher T, 2009: RI-CO+SI-CO, p<0.001
// Subjects=12
-60	3	33
-60	6	36
15	9	42
-45	-21	42
-45	-15	18
-45	3	0
6	-87	39
-39	-15	6
42	6	3
24	-21	12
24	-42	-45
-39	-12	12
42	6	3
30	-66	-21
-15	-6	45
-12	6	42
-51	-21	45
-51	-12	24
-39	15	6
18	-75	42
6	-84	36
21	-21	9
-60	6	36
12	6	42
-36	-12	9
-42	3	0
42	6	3
6	-87	39
24	-21	12
24	-42	-45
-48	-12	45
24	-21	12

// Morey R A, 2009: Main Effect Combat > Scrambled
// Morey R A, 2009: Main Effect of Scrambled > Combat
// Subjects=20
-32.53	-52.75	-13.05
37.19	-49.08	-14.82
-21.09	-6.63	-19.61
25.39	-4.21	-21.16
-43.3	23.64	12.86
50.78	19.72	21.45
2	63.23	15.43
2.44	-48.77	29.75
-41.3	23.19	-29.3
59.21	-8.33	-24.4
-33.93	53.51	-.34
33.69	51.84	-2.85
-49.32	-34.13	52.36
52.13	-40.83	48.9

// Acheson A, 2009: Iowa Gambling Task > Rest, All Participants
// Subjects=15
51.88	2.38	13.75
-34.67	-57.92	-28.23
28.61	-30.48	-37.14
-53.56	-34.3	50.18
-47.23	-36.89	41.44
-28.14	-53.4	44.68
-28.09	-61.4	51.89
-26.01	-64.43	36.54
-26	-61.92	43.03
62.55	-22.48	19.83
-24.14	-29.03	-5.85
-36.98	12.89	-8.64
-30.61	11.38	0.3
34.9	12.06	2.09
37.01	11.81	-2.35
-26.38	9.31	0.42
-23.89	-98.5	-3.31
-11.25	-94.73	-12.52
14.15	-100.55	-7.83
20.49	-100.5	-7.88
-5.02	-76.85	-31.54
24.38	-35.12	-43.45
32.85	-36.88	-38.94

// Hall S S, 2009: Fragile X Syndrome
// Subjects=10
-37.49	2.96	24.89
71.33	17.53	2.55
-41.53	12.67	48.66
-7.1	-21.09	30.12
7.85	35.65	27.61
-53.3	17.48	-25.58
48.25	19.96	-27.55
53.02	-29.2	-2.6
-1.08	-49.68	-11.98
-15.99	2.2	15.64
12.08	2.2	14.04
-5.05	36.12	33.39
-46.69	-5.59	-20.05
-20.62	-56.96	-19.89
-3.56	-27.95	-32.02

// Hall S S, 2009: Healthy Controls
// Subjects=10
-45.81	-29.65	43.95
-9.41	-86.75	5.28
31.09	-65.57	-34.49
11.77	14.05	-8.42
-5.05	36.12	33.39
-46.69	-5.59	-20.05
-20.62	-56.96	-19.89
-3.56	-27.95	-32.02

// Krendl A C, 2009: All Participants: Stigma face > Control
// Krendl A C, 2009: High-Functioning Older Adults > Low-Functioning Older 
// Adults and Young Adults: Stigma face > Control
// Subjects=17
-48	-57	-24
30	24	-6
6	15	48
-57	15	-9
-30	0	51
-21	-42	-51
21	0	-21
-18	0	-21
-54	33	15
30	21	-27
-39	42	0
-33	27	-12
36	24	9
21	-66	-45
-39	-48	-39
24	15	0
-18	-12	12
-48	9	27

// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p<0.001
// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p=0.004
// Newman-Norlund R D, 2009: Miss (All) > Goal (All), p=0.001
// Newman-Norlund R D, 2009: [Miss (Friend) > Goal (Friend)] > [Miss (Foe) > 
// Goal (Foe)]
// Newman-Norlund R D, 2009: Friend (All) > Foe (All)
// Subjects=22
69.66	-36.77	30.36
-45.76	41.42	-22.47
39.64	6	-27.15
-5.48	-11.95	-10.03
12.96	-9.14	-3.9
-5.02	36.33	35.61
11.64	36.07	-13.96
-3.25	-7.07	-3.83
-44.57	-14.71	-25.9
-12.96	38.92	6.35
23.66	-28.53	-16.73
-39.84	-78.33	-6.24
45.43	-57.82	-9.72
44.51	13.36	16.87

// Volz K G, 2009: Mixed trials > in- and out-group trials
// Volz K G, 2009: Mixed trials > in-group trials
// Volz K G, 2009: Mixed trials > out-group trials
// Volz K G, 2009: In-group > out-group trials
// Volz K G, 2009: In-group bias > fair behavior (pooled across strategies)
// Volz K G, 2009: Inter-group behavior (mixed trials > in-group trials)
// Volz K G, 2009: Fair behavior (mixed trials > in-group trials)
// Subjects=20
2.12	56.9	14.56
2.09	43.44	5.65
5.84	-53.08	37.12
-55.14	-54.13	28.99
47.51	-59.43	33.83
-55.44	-30.89	-.84
8.55	57.2	17.8
-1.09	43.68	9.01
5.85	-49.65	40.18
-45.52	-57.33	28.03
57.1	-51.97	33.09
5.32	56.92	14.52
2.16	37.61	12.83
2.73	-58.67	47.66
-61.56	-47.65	30.75
57.13	-52.77	36.5
-29.91	20.79	4.57
27.77	20.88	0.55
-20.01	-55.29	10.84
-10.66	50.74	18.56
2.13	33.92	6.45
8.91	24.62	50.64
-61.61	-48.17	24.1
9.27	-57.35	64.2
-36.32	27.35	7.44
9.68	58.86	25.46
-4.32	50	8.52
5.82	-46.73	36.59
-51.92	-58.43	28.19
9.06	-85.81	26.44
8.88	-84.44	2.91
-7.17	17.4	41.39
-36.06	-75.45	-.67
44.1	-81.4	-2.21

// Xu X, 2009: Chinese Participants
// Subjects=17
-2	28	20
0	20	38
-48	34	-2
-4	38	40

// Xu X, 2009: American Participants
// Subjects=16
2	34	38
-40	42	4
34	46	14
-48	-50	52
4	28	42

// Davis N, 2009: Children with Mathematical calculation difficulties (MD)
// Subjects=24
-40.58	39.56	14.27
-1.69	11.15	56.35
-5.08	25.7	38.44
30.35	7.91	52.91
49.26	34.26	20.37
30.35	7.91	52.91
33.11	16.51	-1.37
1.66	-63.08	45.81
-27.24	-63.77	39.51
43.31	-49.88	47.57
33.71	-66.32	42.37
-14.79	1.64	17.15
-34.02	21.33	25.76
-31.02	48.87	10.03
-24.59	22.76	2.11
-40.69	41.7	0.71
26.55	44.5	-10.34
-1.66	8.23	59.94
-46.66	0.08	41.07
46.06	-1.94	6.72
36.86	-17.43	54.96
-2.22	48.53	3.04
-1.72	-28.72	36.28
-1.88	-50.06	7.96
-21.46	28.61	-5.11
40.09	-66.53	38.97
23.46	32.57	0.74
-46.88	17.57	19.53
33.09	9.65	-7.49

// Davis N, 2009: Typically developing control (TD)
// Subjects=24
33.15	26.79	7.8
10.96	22.63	38.52
20.74	14.45	55.82
1.38	26.26	45.01
8.11	-65.96	49.32
-24.13	11.01	56.62
-27.26	-87	28.08
33.72	-82.69	37.05
39.79	29.15	37.64
-46.66	0.08	41.07
46.06	-1.94	6.72
36.86	-17.43	54.96
-2.22	48.53	3.04
-1.72	-28.72	36.28
-1.88	-50.06	7.96
-21.46	28.61	-5.11
40.09	-66.53	38.97
23.46	32.57	0.74
-46.88	17.57	19.53
33.09	9.65	-7.49

// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract), 
// p=0.609
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract), 
// p=0.039
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract)
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.339
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.009
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract), 
// p=0.042
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract), p=0
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract), 
// p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid)
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.901
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.909
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.367
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.288
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.975
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.948
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.936
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0.017
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid), p=0
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (High-vivid with respect to Low-vivid)
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.042
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Visual) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.032
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.77
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.78
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.131
// Olivetti Belardinelli M, 2009: Imagery (Auditory) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.085
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.005
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.001
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0
// Olivetti Belardinelli M, 2009: Imagery (Tactile) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.035
// Olivetti Belardinelli M, 2009: Imagery (Olfactory) > Control (Abstract) 
// (Regressed onto the vividness ratings)
// Olivetti Belardinelli M, 2009: Imagery (Gustatory) > Control (Abstract) 
// (Regressed onto the vividness ratings)
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.049
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.05
// Olivetti Belardinelli M, 2009: Imagery (Kinaesthetic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.095
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.002
// Olivetti Belardinelli M, 2009: Imagery (Somatic) > Control (Abstract) 
// (Regressed onto the vividness ratings), p=0.004
// Subjects=9
-50.74	-68.14	-11.55
-42.02	-61	-4.56
-47.44	-61.13	-5.57
-58.16	-60.54	1.27
-37.68	-35.7	1.83
-46.36	-27.22	1.14
-37.67	-39.95	2.25
-15.26	-68.92	58.52
-19.75	-62.53	46.76
-15.32	-57.33	56.26
-33.26	-42.61	8.04
-37.79	-27.71	-4.56
-23.83	-30.07	72.75
-36.81	-39.04	69.38
-45.54	-35.33	63.56
-15.54	-7.55	49.09
-25.09	-61.41	-32.82
44.38	-79.51	-12.04
31.21	-34.03	-18.56
44.25	-49.83	-16.1
-42.09	-84.48	-14.56
-54	-67.2	-12.71
-46.54	52.42	3.35
-29.32	69.5	1.36
-37.94	65.21	1.93
31.32	53.21	7.54
31.32	53.21	7.54
-16.39	-47.79	-25.35
-33.84	53.79	-17.18
-33.47	45.54	9.41
53.8	-35.4	57.39
-46.54	52.42	3.35
-33.73	3.18	-18.89
-32.83	-20.79	46.21
-12.2	-45.52	-35.73
18.13	-48.08	-30.39
45.21	-64.56	55.94
32.23	-57.06	56.54
44.87	12.77	44.93
40.23	-90.29	-.82
49.14	21.19	42.91
-28.62	3.59	42.61
-24.85	49.83	8.84
18.54	-86.63	-6.42
53.28	-76.44	8.79
-3.14	39.68	13.95
10.11	-50.03	18.12
18.9	-52.15	29.39
44.84	-38.88	32.11
-41.46	-42.61	42.92
18.39	58.9	11.68
27.06	54.78	13.06
39.76	56.15	-7.46
44.37	19.98	7.25
-28.92	-77.46	2.45
5.76	-28.36	20.53
50.36	-67.47	35.97
73.64	-17.46	7.09
-53.81	4.2	16.09
55.95	42.92	-12.03
36.58	-39.3	62.55
40.25	-24.5	13.96
55.86	20.41	-23.24
-53.72	-15.91	19.19
31.13	-56.55	-29.78
49.3	53.67	-23.06
31.34	62.14	11.14
44.32	58.99	11.23
-41.99	3.82	11.44
-37.63	-4.67	12.21
14.86	-13.95	59.29
-41.61	7.69	41.31
27.63	-85.4	29.17
-57.73	-25.65	41.52
-62.18	-27.66	31.71
27.87	-22.31	61.02
-2.59	-3.25	48.45
14.88	-18.21	59.71
-66.65	-50.71	15.01
-62.59	19.6	9.11

// Gardini S, 2009: General image > Baseline
// Gardini S, 2009: Specific image > Baseline
// Gardini S, 2009: Image generated as first > Image generated as second
// Gardini S, 2009: Image generated as second > Image generated as first
// Gardini S, 2009: Interaction: Image Type x Position
// Subjects=13
21.17	-67.78	34.26
53.31	27.71	32.1
51.4	6.62	47.67
-4.97	-21.29	27.86
-5.6	60.45	-4.87
-5.3	68.16	20.14
1.14	-9.83	0.85
-2.79	-55.08	22.2
-.74	-48.25	14.77
7.97	-56.42	18.79
-16.26	-16.24	-9.43
-22.98	-19.1	-28.08
-35.84	-30.42	-22.26
-22.63	-89.84	-15.48
-46.47	-69.61	-15.96
29.68	-98.24	18.08
33.73	-97	-3.41
22.92	-94.91	-3.43
64.75	1.47	-8.08
58.44	-15.9	1.59
-8.88	-75.15	48.94
21.19	-65.45	36.27
44.61	33.86	29.4

// Kumari V, 2010: Self Undistorted, All Subjects, Increases
// Kumari V, 2010: Self Distorted, All Subjects, Increases
// Kumari V, 2010: Other Undistorted, All Subjects, Increases
// Kumari V, 2010: Other Distorted, All Subjects, Increases
// Kumari V, 2010: Self Undistorted, All Subjects, Decreases
// Kumari V, 2010: Self Distorted, All Subjects, Decreases
// Kumari V, 2010: Other Undistorted, All Subjects, Decreases
// Kumari V, 2010: Other Distorted, All Subjects, Decreases
// Kumari V, 2010: Self > Other, All Subjects
// Kumari V, 2010: Other > Self, All Subjects
// Kumari V, 2010: Undistorted > Distorted, All Subjects
// Kumari V, 2010: Good Performers > Poor Performers, Self Undistorted
// Kumari V, 2010: Good Performers > Poor Performers, Self Distorted
// Kumari V, 2010: Good Performers > Poor Performers, Other Undistorted
// Kumari V, 2010: Good Performers > Poor Performers, Other Distorted
// Kumari V, 2010: Poor Performers > Good Performers, Self Undistorted
// Kumari V, 2010: Poor Performers > Good Performers, Other Undistorted
// Kumari V, 2010: Poor Performers > Good Performers, Other Distorted
// Kumari V, 2010: Self > Other, Good and Poor Performers
// Kumari V, 2010: Healthy Controls > Schizophrenia, Self Undistorted
// Kumari V, 2010: Schizophrenia > Healthy Controls, Self Undistorted
// Kumari V, 2010: Schizophrenia > Healthy Controls, Other Distorted
// Kumari V, 2010: Other > Self, Healthy Controls and Schizophrenia
// Kumari V, 2010: Undistorted > Distorted, Healthy Controls and Schizophrenia
// Subjects=20
56	-24	4
-50	-36	16
56	-34	16
18	-66	6
-14	-76	12
-18	-78	22
58	-26	4
58	-36	14
60	-22	20
-54	-36	14
-58	-24	4
10	-16	4
-20	-80	34
-14	-76	12
30	-78	26
16	-78	26
44	-70	2
56	-26	0
62	-36	8
46	-30	14
-54	-38	14
-34	22	8
-58	2	-2
-2	-30	-8
12	-16	8
-6	-20	4
-52	-32	10
10	-18	4
-56	-12	12
62	-16	4
64	-36	14
60	-4	12
-22	-36	16
22	-40	12
32	-46	2
6	32	-4
6	24	0
4	14	6
-32	-50	0
-26	-46	10
32	-44	6
-2	18	4
-16	28	2
10	26	2
-30	-48	4
-46	-66	28
32	-44	16
-2	34	2
20	32	-4
10	38	-2
22	-52	18
16	-50	26
34	-50	16
-8	26	10
-12	46	-8
-22	42	0
44	-42	22
-34	-48	20
16	-52	24
-2	10	8
0	0	-8
38	-22	22
32	30	0
20	-4	-2
54	-24	0
34	6	-2
-52	-36	10
-14	-82	14
-10	-96	22
-24	-90	28
16	-70	10
24	-60	4
16	-78	14
56	-26	2
46	-30	12
56	-6	18
-44	-38	14
-54	-26	18
-54	-34	16
-52	-40	14
-52	-36	26
56	-28	0
62	-34	6
52	-36	16
-58	-6	10
-38	14	-2
-58	-24	6
60	-26	0
62	-12	0
54	-22	6
2	32	4
-22	-28	-14
-14	40	6
-24	42	6
-4	28	6
30	-52	16
36	-52	8
28	-52	24
-12	-52	22
-44	-66	28
20	32	6
-6	26	6
-18	32	4
28	34	4
-28	-30	-8
-38	-34	-8
8	-30	14
-4	-30	14
-14	-36	12
-48	-36	18
-56	-28	0
50	-32	20
58	-28	8
64	-38	8
-54	-32	10
-56	-42	16
-50	-40	-2
-16	-38	0
4	-6	4
-6	10	6
40	-24	18
36	-22	-10
42	30	12

// Righi G, 2010: Competitor > No Competitor
// Righi G, 2010: No Competitor > Competitor
// Righi G, 2010: First Run > Second Run
// Righi G, 2010: Second Run > First Run
// Subjects=18
63.7	53.75	30.28
54.14	-1.77	14.98
2.98	9.23	38.06
51.04	-43.55	11.82
-51.57	51.17	48.55
34.71	-13.72	-13.91
5.74	100.22	17.01
21.48	103.83	-20.27
-10.52	87.78	-18.56
2.29	77.83	-24.56
-35.46	55.47	61.39
-55.27	65.82	-9.51
34.99	64.9	53.1
28.07	95.9	0.39
63.78	31.55	32.14
2.63	55.02	10.8
41.31	73.94	45.57

// Sergerie K, 2010: Happy Faces, Conjunction Analysis, Patients + Controls
// Sergerie K, 2010: Sad Faces, Conjunction Analysis, Patients + Controls
// Sergerie K, 2010: Happy Faces, Controls > Patients
// Sergerie K, 2010: Correlation, Happy Faces, Controls
// Sergerie K, 2010: Correlation, Happy Faces, Patients
// Sergerie K, 2010: Happy Faces, Patients > Controls
// Sergerie K, 2010: Correlation, Happy Faces, Controls
// Sergerie K, 2010: Correlation, Happy Faces, Patients
// Sergerie K, 2010: Sad Faces, Patients > Controls
// Sergerie K, 2010: Correlation, Sad Faces, Controls
// Sergerie K, 2010: Correlation, Sad Faces, Patients
// Subjects=20
-12	-26	24
24	-30	20
-34	-26	-18
28	-58	20
46	-66	20
22	-36	-6
-32	-36	-12
24	-6	-26
-26	62	16
-4	26	60
-36	0	46
-20	36	-8
-44	28	-8
-32	22	-16
-32	4	32
-28	-22	24
-30	-60	54
-54	-4	-18
-64	-36	-2
-54	-70	8
-48	-54	-16
-40	-60	-18
-30	-16	-34
-54	-70	-8
-38	-84	-10
-28	-14	-24
-28	0	-26
36	36	-12
54	32	20
46	28	-10
56	22	20
48	-40	36
52	0	-20
42	-70	18
48	-8	-22
62	-14	-22
10	-54	26
22	-36	-6
24	-2	-26
32	-4	-14
-26	62	16
-4	26	60
54	32	20
-36	0	46
56	22	20
-32	22	-16
-32	4	32
-28	-22	24
-30	-60	54
48	-40	36
52	0	-20
-54	-4	-18
-64	-36	-2
-54	-70	8
48	-8	-22
62	-14	-22
-48	-54	-16
-40	-60	-18
-30	-16	-34
10	-54	26
-54	-70	-8
-38	-84	-10
-28	-14	-24
-28	0	-26
-26	62	16
-4	26	60
54	32	20
-36	0	46
56	22	20
-32	22	-16
-32	4	32
-28	-22	24
-30	-60	54
48	-40	36
52	0	-20
-54	-4	-18
-64	-36	-2
-54	-70	8
48	-8	-22
62	-14	-22
-48	-54	-16
-40	-60	-18
-30	-16	-34
10	-54	26
-54	-70	-8
-38	-84	-10
-28	-14	-24
-28	0	-26
-30	-50	8
-30	-50	8
-30	-50	8
26	26	-22
40	-22	26
-36	-26	34
-50	-34	42
10	-30	22
26	26	-22
40	-22	26
-36	-26	34
-50	-34	42
10	-30	22
26	26	-22
40	-22	26
-36	-26	34
-50	-34	42
10	-30	22

// Mobascher A, 2010: Activation in Response to Laser Stimulation
// Subjects=20
52	-24	22
60	-44	34
38	22	-2
30	-38	62
26	0	-22
32	-12	62
36	48	18
-64	-20	20
-36	22	0
-64	-24	22
6	12	36
14	-70	38
-14	-46	-34
10	-4	0
-10	-10	4
-6	-14	-20
-6	-20	-28

// Benoit M M, 2010: Incongruent Non-McGurk - Congruent Pa
// Benoit M M, 2010: Incongruent McGurk Fusion - Congruent Pa
// Benoit M M, 2010: Incongruent Non-McGurk - Incongruent McGurk Fusion
// Subjects=16
-65.95	-21.44	-1.51
-28.75	-2.68	47.9
-29.43	19.94	-17.45
-50.45	-38.54	47.14
-3.15	22.86	38.66
-8.7	-81.51	-3.04
-13.14	-101.1	-4.14
55.07	-33.7	-1.54
38.3	25.92	-4
10.9	21.25	30.27
44.49	9.18	29.56
47.96	-43.58	43.31
13.25	-91.69	-1.77
16.01	-95.82	7.8
-27.16	-2.31	46.96
-41	-78.28	-5.17
-61.31	-36.03	-2.01
-29.18	25.84	-10.03
-67.88	-17.18	-1.29
-44.79	-42.03	45.58
-41.06	9.04	36.69
39.28	22.14	-3.36
58.59	-42.22	7.61
10.29	15.79	46.46
44.09	20.48	-3.28
72.38	-39.38	23.94
27.46	-92.28	-2.44
34.61	-63.23	35.41
-32.13	55.81	-6.15
-33.48	4.44	-22.12
-65.64	-30.35	34.69
-18.9	-52.57	3.23
51.98	-55.21	-8.4
23.66	-69.13	55.1
4.29	-69.84	8.99
26.7	-57	10.67
38.21	7.82	46.92
9.79	-88.96	8.97
36.76	23.68	3
14.61	-105.97	17.14

// Davey C G, 2010: Positive Feedback Faces > Control Feedback Faces
// Subjects=19
0	60	-4
-4	68	10
8	36	4
2	-10	22
0	-32	28
-6	-46	14
2	-66	20
-24	42	40
-24	28	48
-22	44	26
-62	-10	-22
-42	-60	44
-22	-78	-20
-18	-100	0
22	60	26
38	14	-18
64	-12	-24
16	-96	-2
4	6	-4
-24	-10	-24
30	-8	-22
0	-20	-18
26	-48	-24

// Domes G, 2010: Negative Pictures > Neutral Pictures, Males and Females
// Domes G, 2010: Neutral Pictures > Negative Pictures, Males and Females
// Domes G, 2010: Females > Males, Negative Pictures > Neutral Pictures
// Domes G, 2010: Decrease Emotions > Maintain Emotions, Females and Males
// Domes G, 2010: Increase Emotions > Maintain Emotions, Females and Males
// Domes G, 2010: Males > Females, Decrease Emotions > Maintain Emotions
// Domes G, 2010: Males > Females, Increase Emotions > Maintain Emotions
// Subjects=16
51	-63	0
48	-39	-21
45	-51	-12
-54	-69	6
-45	-39	-21
-66	-27	33
-33	-45	48
-45	-33	39
6	60	27
6	54	39
54	-27	36
3	15	27
-6	18	27
-9	27	30
-21	-3	-12
21	15	3
12	-9	6
51	15	21
36	-45	57
54	0	48
-24	-9	48
-3	-66	36
54	36	6
42	36	9
30	-42	-6
-30	-45	-6
21	-57	15
27	3	30
24	3	48
15	21	48
-51	-69	6
-3	12	60
12	3	66
-45	0	51
-54	21	-3
-60	15	24
-36	15	3
54	27	-6
60	24	6
60	15	-3
57	-42	27
33	42	27
33	30	33
-63	-51	21
-63	-33	0
-66	-48	6
-30	48	27
51	3	48
0	6	63
-3	18	39
-6	12	24
-51	12	0
-60	15	24
-12	-33	3
6	-45	3
-18	-12	-12
45	12	6
48	-54	-36
36	-51	-33
-57	-42	24
-6	-66	63
-6	-75	57
57	0	48
-3	-63	-15
9	0	-6
-12	57	36
-33	48	30
21	-24	-9
-60	-21	3
-57	6	0
36	21	-21
6	42	12
18	-15	57
-18	-33	72
9	-36	75
-6	-9	72
-57	-6	24
-63	12	9
-39	15	-6
-18	-6	-15
-24	-69	51
-12	-75	51
-27	36	24
-33	45	18
15	-48	0
6	-60	6
30	18	21
30	-36	-36
63	-51	-3
27	-21	-9
27	30	39
36	36	36
57	-39	18
60	27	6
-45	-54	-9
-54	-18	-3
-12	-15	9
-18	-12	15
-30	-33	-27
-57	-60	0
63	-9	-6
-45	3	39
-36	0	45
12	-81	48
24	-72	45

// Linke J, 2010: Correct Responses - Incorrect Responses
// Linke J, 2010: Incorrect Responses - Correct Responses
// Linke J, 2010: Behavioural Switching
// Linke J, 2010: Positve Correlation with Extrinsic Motivation
// Linke J, 2010: Negataive Correlation with Intrinsic Motivation
// Subjects=33
-15	36	51
-9	33	-9
6	33	-15
6	45	-6
-33	33	-15
-6	-54	15
6	-48	18
-6	-42	33
-51	-3	-6
-54	-54	-9
-45	-78	33
30	-9	-24
24	-3	-18
30	-9	-6
9	-9	-9
-15	6	-12
21	6	63
-30	48	18
-30	-3	60
-3	12	54
6	18	45
-33	24	3
30	24	0
-27	0	63
-24	-3	51
6	21	45
36	39	33
36	51	18
33	60	0
3	30	36
-12	27	30
51	21	0
48	-45	45
30	-48	45
-24	-45	42
-48	-36	48
12	-60	54
-12	-60	54
30	21	-9
-39	15	-6
-33	21	3
45	-30	-9
-36	-60	-33
-27	-69	-30
-15	-75	-30
-18	36	42
30	45	39
18	-9	54
-15	-6	54
12	-30	33
-12	-57	24
-6	-36	78
42	-66	45
-39	-60	27
57	-24	3
51	-30	-24
24	0	21
-15	-3	27
-24	12	9
27	0	-15
-15	36	42
33	39	45
18	-9	54
-39	-60	27
57	-24	3
48	-27	-24
21	30	6
-24	12	12
24	-27	-15

// Markov V, 2010: At Risk Patients > Healthy Controls, 2-Back > 0-Back
// Subjects=22
29.49	27.22	28.08
-33.23	40.82	27.8

// Notebaert K, 2010: Number Identification Trials - Null Events
// Subjects=13
34	-50	46
28	-62	50
-28	-60	46
-32	-62	56
42	-58	-6
34	-92	-8
36	-46	-18
-36	-58	-14
-34	-74	-10
-36	-84	0
-2	10	46
6	14	46
2	20	34
32	40	20
50	10	34
16	-22	12
10	-12	14
36	26	0
48	12	4
30	20	4
-30	26	4
-40	18	-8

// Simoes-Franklin C, 2010: Punishment Go-NoGo > Neutral Go-NoGo
// Simoes-Franklin C, 2010: Neutral Go-NoGo vs. Punishment Go-NoGo, Errors
// Simoes-Franklin C, 2010: Nuetral Go-NoGo vs. Punishment Go-NoGo, Successful 
// Inhibitions
// Subjects=16
25.07	4.08	58.87
-19.8	-5.88	57.99
37.64	7.04	27.25
-37.18	8.62	26.86
4.67	4.07	46.84
3.47	17.04	35.73
28.39	-60.63	47.53
-28.29	-47.05	49.27
-14.8	-1.79	14.1
16.09	1.77	2.29
-22.43	4.29	-3.05
34.12	24.63	-6.53
-28.92	23.28	-4.57
-48.75	-12.62	42.16
34.51	17.74	42
46.39	-.71	50.1
-29.73	29.19	30.63
37.5	41.85	23.22
43.75	44.66	3.95
-31	50.19	13.27
23.41	57.32	4.24
-6.34	31.47	16.78
3.49	19.41	38.87
11.25	-68.82	39.49
53.96	-33.79	48.33
-35.79	-42.96	47.9
-56.14	-47.99	39.63
-53.17	-17.45	21.43
50.33	-41.52	-10.09
-45.57	-58.99	20.36
59.06	-56.04	7.76
53.66	-34.67	9.38
-10.21	-76.49	24.77
15.33	-69.71	13.87
-17.07	13.38	3.93
17.08	13.07	-3.13
42.77	16.99	4.05
-41.62	12.34	6.53
-16.07	8.21	-7.92
6.59	-31.15	4.05
-4.11	-14.84	9.49
4.79	-3.45	59.73
47.2	10.9	21.24
33.2	38.22	17.99
42.67	48.89	3.61
26.58	60.25	0.61
-1.94	20.64	27.68
8.7	29.08	25.73
4.63	12.44	45.02
-47.83	-8.62	25.08
-47.75	-64.97	11.97
24.54	3	-10.18
-19.2	7.91	2.18
57.06	-38.14	33.05
36.29	17.33	-4.82
-30	26.45	-4.83
14.96	12.08	-1.91
8.69	-4.02	10.67

// Thimm M, 2010: At Risk Patients > Healthy Controls, Face Encoding
// Thimm M, 2010: At Risk Patients > Healthy Controls, Face Retrieval
// Subjects=29
-26	37	-4
-8	-95	7
24	-83	10
2	-72	33
14	29	32
59	5	22
50	-43	39

// Tseng M T, 2010: Innocuous Heat vs. Reference Temperature
// Tseng M T, 2010: Noxious Heat vs. Reference Temperature
// Tseng M T, 2010: Innocuous Heat > Noxious Heat
// Tseng M T, 2010: Noxious Heat > Innocuous Heat
// Subjects=12
-52	-40	40
58	-34	40
-64	-26	18
58	-24	22
-36	-20	6
38	-2	6
-14	-44	64
48	2	48
10	-18	-12
-34	46	10
-38	26	26
40	36	18
-46	16	-6
-44	10	20
32	20	-4
42	36	8
48	12	18
-32	18	-2
34	16	0
-32	-56	-50
40	-54	-38
-2	26	48
4	14	52
-6	-20	70
-14	-18	18
6	-18	12
-6	20	28
-10	28	22
2	18	32
-14	-2	10
14	4	-4
-6	-20	-22
-30	34	10
40	54	14
48	18	30
-40	14	-8
-52	8	22
26	10	-20
50	12	22
54	18	18
-34	16	6
36	16	2
-18	-62	-26
36	-52	-38
-14	-6	72
10	16	56
-4	-30	70
-14	-8	6
10	-6	8
-6	2	40
-4	4	42
2	2	44
2	20	32
-30	-18	8
20	10	-10
-6	-18	-14

// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued)
// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued), Pain Expectancy 
// Sensitivity as Covariate
// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued), Harm Avoidance 
// as Covariate
// Subjects=10
58.15	-33.48	38.22
-59.5	-25.43	28.86
57	6.33	43.82
-37.03	-4.09	41.31
-3.88	8.42	48.8
6.83	8.74	52
4.57	6.39	35.49
-3.91	10.28	45.3
41.72	16.1	6.37
-37.33	20.28	12.5
25.7	8.35	3.86
-23.5	13.08	0.68
15.1	-8.38	8.73
-10.58	-9.93	4.69
-67.2	-10.19	6.48
36.38	51.19	20.22
9.01	-8.34	51.17
55.05	-14.86	59
2.39	-79.79	-5.21
28.63	3.34	-33.67
-30.13	2.01	-31.77
27.77	-16.53	-15.27
-27.72	-30.27	-9.02
0.93	-27.84	-35.2
36.34	-65.61	-31.32
3.51	18.53	41.18
-.77	20.61	41.05
-8.31	18.91	33.47
3.79	0.58	70.56
-.48	0.55	70.61
42.29	-22	64.2
11.15	-53.39	32.62
-4.92	-40.71	32.86
-44.45	-71.67	21.41
-37.66	-1.8	-39.17
7.61	-5.25	8.55
25.74	-18.69	-1.68
29.83	-8.49	-21.54
-24.66	-7.67	-19.87

// Grabenhorst F, 2010: Negative Correlation with Pleasantness of Texture
// Grabenhorst F, 2010: Positive Correlation with Pleasantness of Flavor
// Grabenhorst F, 2010: Correlation with Fattiness
// Subjects=14
-16	0	4
-2	-8	12
32	46	22
24	6	42
-36	50	-4
46	42	24
40	56	10
56	-8	18
14	-14	-4
42	10	46
-6	52	46
38	56	26
28	-14	0
28	6	22
-34	-20	-10

// Alexander W H, 2010: Main Effects of Error Likelihood in the Anterior 
// Cingulate Cortex (High - Low Error Likelihood)
// Alexander W H, 2010: Main Effects of Error Likelihood for Low Reward 
// Magnitude (High RM/High EL - High RM/Low EL)
// Alexander W H, 2010: Main Effects of Error Likelihood for High Reward 
// Magnitude (High RM/High EL - High RM/Low EL)
// Alexander W H, 2010: Main Effects of Reward Magnitude (High - Low Reward 
// Magnitude)
// Subjects=24
4	-4	52
6	-4	46
6	-4	46
-26	-18	-20
8	2	-6
-54	30	6

// Burke C J, 2010: Value-Preference Contrast
// Burke C J, 2010: High Variance > Low Variance
// Burke C J, 2010: Effect of Chimpanzee Social Information
// Subjects=17
-9	-51	0
-12	33	-12
-63	-12	6
33	-12	-21
3	-66	-3
-42	6	6
36	0	12
24	-24	-21
-18	36	27
6	63	24
-51	21	0
45	33	-9
-30	24	0
12	42	18
-45	39	3

// Daniel R, 2010: Effect of Entropy
// Daniel R, 2010: Effect of Training
// Daniel R, 2010: Negative > Positive Feedback
// Daniel R, 2010: Positive > Negative Feedback
// Subjects=27
18	55	-13
45	49	-10
6	25	37
-6	25	37
-30	23	-4
30	23	-9
33	8	38
-42	4	27
-24	-1	44
15	-5	20
-9	-9	3
24	-27	-6
-30	-42	41
30	-42	41
54	-53	-5
-45	-53	-7
-12	-71	-17
12	-71	-17
24	46	-7
-36	27	13
33	23	-4
54	10	24
-6	23	43
6	23	43
-59	10	27
-9	9	13
12	-8	9
33	9	60
33	-87	7
33	59	16
36	58	0
39	33	18
48	25	32
45	14	44
-33	53	17
30	46	-10
3	29	54
-3	29	54
42	20	-16
-33	14	-11
-59	-24	-6
62	-33	-11
36	-42	41
-36	-45	35
-3	-25	29
3	-25	29
12	-62	42
-12	-80	-16
21	-52	69
15	-7	-22
12	11	-13
54	-6	50
27	-33	-14
24	-83	26
30	-16	-19
-24	-16	-22
42	-72	9

// Fleming S M, 2010: Cost > Neutral, Activations
// Fleming S M, 2010: Greater Criterion Shifts in the House Value Condition > 
// Lesser Criterion Shifts in the HV Condition
// Fleming S M, 2010: Effects Of Categorical Uncertainty: Positive Correlation 
// with Uncertainty
// Fleming S M, 2010: Negative Correlation with Categorical Uncertainty 
// (Greater Activation in Easy Certain Decisions)
// Fleming S M, 2010: Activity Under Conditions of Asymmetric Cost, 
// Independent of Changes in Categorical Uncertainty
// Fleming S M, 2010: Activity Under Conditions of Categorical Uncertainty, 
// Independent of Changes in Category Value
// Fleming S M, 2010: Activations Correlated with Increasing Wins
// Subjects=15
-36	3	24
-27	-3	54
-15	-18	0
26	-9	54
-36	-39	45
-45	21	0
36	15	-6
-36	-72	21
6	36	30
6	12	51
42	24	-3
9	33	-6
6	36	30
-27	-3	54
15	-18	0
27	-9	54
-36	-72	21
36	15	-6
9	12	48
-9	12	48
-3	42	30
-9	9	-3
30	-81	-30

// Grabenhorst F, 2010: Healthy Controls - Thermal Stimulus Only
// Subjects=12
-28	52	-2
2	44	-2
-6	8	-16
-32	56	-6
4	38	-2
-2	20	-4

// Grabenhorst F, 2010: Healthy Controls - Taste Stimulus Only
// Subjects=12
-28	52	-2
2	44	-2
-6	8	-16
-28	52	-2
4	44	-2
-6	10	-16

// Grabenhorst F, 2010: Healthy Controls - Thermal and Taste Stimuli
// Subjects=14
-28	52	-2
2	44	-2
-6	8	-16
-32	56	-6
4	38	-2
-2	20	-4
-28	52	-2
4	44	-2
-6	10	-16
52	-20	-28
44	-12	58
-26	48	2
-10	-2	0
64	-14	22
4	4	48
-30	46	4
-28	52	2
46	42	24
12	50	-8
8	30	16
56	-8	18
22	36	-10
14	-14	-5
42	10	46
50	28	30
40	16	18
10	6	20
18	16	-6
-18	4	14
32	48	-8
-40	44	28
50	26	30
44	18	34
-8	6	48
36	56	28
-12	10	-6
-34	56	20
-46	18	40
12	14	-2
-16	4	14

// Guitart-Masip M, 2010: (Sure/CSwin + Gamble/CSlose) - (Gamble/CSwin + 
// SureCSlose)
// Subjects=21
-6	-6	52
8	-10	54
-16	-34	42
-12	-34	50
38	-16	-8
12	22	0
-22	6	-18
-6	-40	-18
36	8	-30
-32	-74	8
-10	-22	56
16	-8	-2
24	-6	-28
-8	32	28
-6	-64	-28
-8	-60	-20
14	36	30
8	32	22
16	34	20
50	12	-8
4	4	46
10	-22	12
34	-50	-38
-26	-52	-38
2	-72	4
50	2	0
-2	-50	-50

// Han S, 2010: HITs > CRs No-Incentive Condition, Activations
// Han S, 2010: HITs > CRs F-Map All Conditions, Activations
// Subjects=20
-6	26	46
-42	50	4
-4	-44	40
10	-44	40
-18	-78	-6
-6	-72	32
-44	-60	50
-34	-80	46
-8	-2	22
-6	4	14
-6	8	4
8	-2	20
8	12	22
-56	-38	-20
-20	-82	-14
16	-70	-6
-8	4	6
-10	6	18
8	4	8
8	12	22
12	8	16
14	-6	22
-8	-26	20
6	-6	2
-2	-28	2
-34	18	2
-6	26	44
-42	44	4
-44	32	20
-28	22	-6
32	26	-8
-30	-68	48
-50	-58	50
-6	-72	36
14	-62	20
-44	-76	40
52	-22	12
-64	-42	-10
-4	-34	30
-6	12	24

// Hartstra E, 2010: First Phase > Third Phase Contrast
// Hartstra E, 2010: Third Phase > First Phase Contrast
// Hartstra E, 2010: First Phase > Third Phase (Reward Trials Only)
// Hartstra E, 2010: Third Phase > First Phase (Reward Trials Only)
// Hartstra E, 2010: Third Phase > First Phase (Punishment Trials Only)
// Subjects=20
-6	12	54
-42	3	36
30	6	57
-27	0	54
30	54	0
39	36	39
45	42	21
48	-42	54
33	-69	36
3	-75	54
-42	-42	45
-24	-60	42
-45	-39	57
-18	-81	3
-24	-78	-9
30	24	0
30	24	12
-6	51	9
9	54	-3
0	57	-9
-57	-12	12
-48	-72	30
-60	-30	18
-9	-63	21
-12	-45	30
3	39	6
-3	-24	45
-36	3	-12
-12	-66	-6
-6	12	54
-9	18	48
24	6	54
33	6	54
21	15	66
42	36	36
39	33	45
-42	3	30
-27	0	54
30	54	0
45	-39	45
48	-42	54
42	-60	51
-27	-60	42
-45	-42	48
-24	-72	33
6	-72	57
-9	-78	3
-24	-69	-3
-21	-81	0
-6	57	6
-3	60	-9
-9	63	-3
-57	-6	12
-45	-9	6
-57	-6	3
-51	24	-3
-39	33	-12
-45	21	-12
-12	-39	45
-9	-48	36
-9	-60	24
12	-69	-6
-48	-72	30
-39	-78	33
3	3	45
-24	36	48
-21	42	42
6	54	18
-3	57	9
3	42	3
-6	-63	27
-9	-54	9
-42	-75	30

// Kahnt T, 2010: Regions Where the Variability of Reward Predictions of 
// Individual Attributes is Encoded
// Kahnt T, 2010: Regions Where the Combind Value of Multi-Attribute Objects 
// is Encoded
// Subjects=16
-33	24	24
3	-36	69
-39	-57	-36
36	-63	-27
-6	51	-6

// Kahnt T, 2010: Value of Anticipated Outcomes Independent of the Sensory 
// Properties of the Cues
// Kahnt T, 2010: Value During Both Anticipation and Receipt of Reward
// Subjects=16
3	33	-6
6	6	-6
3	54	-15

// Norbury R, 2010: Group x Emotion Interaction in Regions of Increased 
// Activation to Fear in Recovered Depression Group
// Subjects=16
-36	14	36
26	16	52
16	8	8

// Peters J, 2010: Activity for Presentation of Delayed Reward: Episodic > 
// Control
// Peters J, 2010: Correlation between Subjective Value and BOLD Responses in 
// Control and Episodic Conditions
// Peters J, 2010: Correlation between Subjective Value and BOLD Responses: 
// Episodic > Control
// Peters J, 2010: Correlation b/t Sub. Value and BOLD Responses in both 
// Episodic and Control and Episodic > Control
// Peters J, 2010: Positive Correlation between Neural Tag-Effect and 
// Behavioral Tag-Effect
// Peters J, 2010: Negative Correlation between the Neural Tag-Effect and the 
// Behavioral Tag-Effect
// Subjects=30
-6	-54	14
-6	-60	24
6	-52	16
-44	22	22
-38	-54	-16
-30	-76	-10
-8	34	-12
-56	-44	6
-44	-66	32
-52	-68	24
-30	18	-20
-42	16	-24
-52	-10	-16
-36	50	-10
10	8	0
-2	-28	24
-4	-42	28
-18	12	-14
-10	8	-6
-50	-38	-2
-46	-36	34
-46	-44	30
-36	30	0
6	26	16
6	34	14
56	-38	-6
-44	2	56
-48	10	50
-66	-42	32
-58	-46	42
-56	-36	32
-38	36	36
-30	32	40
-42	50	20
-2	16	36
-4	6	46
0	0	54
42	48	26
38	42	36
50	4	8
-16	12	56
-12	0	64
18	-40	-16
-30	-8	20
-24	-2	20
-60	-22	-6
-12	58	34
-14	64	24
-26	10	-28
-34	14	-24
-50	8	-8
-66	-24	22
40	-18	-24
24	2	-24
-10	-52	40
-18	-54	58
-24	-60	50
-18	-50	66
52	10	46
54	0	46
58	-8	46
-20	-60	-8
2	-8	38
16	-20	60
10	-26	62
-36	-72	30
-44	-76	22
-14	-34	40
-54	2	38
38	14	-20
-18	-42	52
-32	-40	-8
62	6	34
36	-82	34
26	-86	36
-22	-8	58
10	-44	54
-66	-46	-2
64	-34	28
66	-28	34
-30	-44	48
8	-78	-12
16	8	54
-22	-34	58
-66	-42	30
18	34	18
16	32	26
-30	2	30
-20	34	22
-32	32	24
-34	40	20
-66	-20	-8
-58	-28	-8

// Smith D V, 2010: Monetary Rewards (Regardless of Value) > Photographs of 
// Faces
// Smith D V, 2010: Photographs of Faces (Regardless of Attractiveness) > 
// Monetary Rewards
// Smith D V, 2010: Sensitivity to Monetary Value:  Large Gains (+$5 & +$2) > 
// Large Losses (-$5 & -$2)
// Smith D V, 2010: Increasing Activation with Increasing Monetary Reward Size
// Smith D V, 2010: Sensitivity to Social Value:  Attractive Faces (4-Star) > 
// Unattractive Faces (1-Star)
// Smith D V, 2010: Increasing Activation with Increasing Social Reward Size
// Subjects=23
4	-72	34
40	-40	44
32	4	64
62	-46	-8
-24	6	62
-52	-56	-14
48	-62	6
-42	-78	0
6	40	-22
12	58	2
-2	68	-2
10	64	0
0	44	-10
-2	62	-2
-18	32	34
-14	40	6
-26	20	44
-24	24	52
-18	46	10
0	68	-2
12	60	0
8	68	0
-6	72	-4
4	52	-10
0	48	-8
-8	18	-6
0	38	-12
0	42	-6
-18	18	0
50	-76	-2
34	-92	-6
40	-82	8
54	-72	10
48	-74	6
40	-84	-2
50	-76	-2
36	-84	16
40	-82	6
4	-80	16
12	-86	10
34	28	-6
0	48	-8
-8	16	-6
14	-16	-2
-16	16	2
-18	-62	48
-26	-50	48
-10	-64	60
-20	-54	34
-20	-90	24
-26	-82	36
-26	-68	24
-28	-70	20
-34	-86	24

// Zheng H, 2010: Large Group Context:  Positive Frame Activations > Negative 
// Frame Activations
// Zheng H, 2010: Small Group Context:  Positive Frame Activations > Negative 
// Frame Activations
// Zheng H, 2010: Activations Across Both Positive and Negative Frames:  Large 
// Group > Small Group
// Subjects=22
33	29	-8
33	-13	13
33	-31	52
24	32	-8

// Kasahara M, 2011: Healthy Controls
// Subjects=9
-54	-36	-26
-44	-52	54
-20	-10	46
10	-56	-30
-10	-54	-32
-20	-56	-38
44	30	30
52	30	34
44	44	28
-54	-36	-26
-44	-52	54
28	6	56
10	-56	-30
-10	-54	-32
-20	-56	-38
42	30	28
52	30	34
44	44	28
-54	-36	-26
-66	-34	-12
-8	0	28
6	10	24
-10	-30	26
-34	-26	38
-56	-24	32
-54	-30	38
-32	-68	46
-10	-68	58
-22	-70	60
6	-44	-36
8	-60	-20
12	-58	-30
40	-32	36
44	-48	40
44	-42	52
26	-12	50
28	6	54
24	0	50
-26	12	-30
-28	22	-26
-46	-6	-36
52	44	2
46	48	-6
58	28	14
-28	-92	-10
-12	-90	-18
-6	-98	-12

// Kasahara M, 2011: Traumatic Brain Injury (TBI) Patients
// Subjects=9
-52	-42	44
-36	-26	48
-34	-34	66
44	-40	34
52	-42	42
32	-42	34
18	-46	8
32	-62	-6
26	-56	-4
38	2	56
34	2	48
24	8	60
-52	-42	44
-36	-26	48
-34	-34	66
44	-40	34
52	-42	42
32	-42	34
42	34	38
38	2	56
12	14	58
34	2	48
-58	6	20
-62	6	22
-40	-4	26
-54	-36	-26
-66	-34	-12
-8	0	28
6	10	24
-10	-30	26
-34	-26	38
-56	-24	32
-54	-30	38
-32	-68	46
-10	-68	58
-22	-70	60
6	-44	-36
8	-60	-20
12	-58	-30
40	-32	36
44	-48	40
44	-42	52
26	-12	50
28	6	54
24	0	50
-26	12	-30
-28	22	-26
-46	-6	-36
52	44	2
46	48	-6
58	28	14
-28	-92	-10
-12	-90	-18
-6	-98	-12

// Medaglia J D, 2011: Main Effect of Group
// Medaglia J D, 2011: Main Effect of Practice
// Medaglia J D, 2011: TBI Patients > Healthy Controls, 2-Back
// Medaglia J D, 2011: Healthy Controls > TBI Patients, 1-Back
// Medaglia J D, 2011: Healthy Controls > TBI Patients, 2-Back
// Medaglia J D, 2011: Main Effect of Load
// Medaglia J D, 2011: TBI Patients > Healthy Controls, 1-Back
// Subjects=12
60	-4	22
40	4	50
0	-18	66
2	-76	40
32	-78	32
8	-8	44
2	-34	48
-18	-30	70
-22	-84	28
-48	-32	34
62	-20	30
42	0	50
20	14	58
54	10	34
38	58	2
20	64	8
44	4	-8
50	-36	-8
2	-2	36
8	-40	36
10	42	10
50	14	-8
42	-52	46
54	10	16
40	26	6
44	24	22
36	34	-2
18	22	2
-54	-26	38
-18	0	58
-30	-4	54
-42	-8	48
-20	-80	38
-34	-64	50
-36	36	28
-52	-38	22
-34	-74	-14
-8	20	40
-46	-52	-22
-42	-50	42
-44	-28	14
-44	24	22
-48	18	-2
-22	18	14
-24	-20	18
-28	-20	4
-4	0	0
56	-2	24
-40	-40	16
-34	0	-32
-10	20	20
24	-14	34
-10	20	20
34	8	30
26	4	56
10	-54	44
0	-80	0
20	-58	30
20	12	-10
12	10	-2
10	-4	-8
8	-18	2
-30	6	56
-44	-6	44
-12	-62	46
-42	24	32
-8	10	52
-10	16	46
-48	-54	-12
-36	-76	26
-44	20	22
-12	2	2
-16	16	2
-22	8	-8
-6	-18	0
60	-4	22
52	-10	36
18	20	60
44	2	54
2	-76	42
40	14	50
4	52	46
50	8	36
12	72	14
26	66	12
30	-80	32
52	-44	0
8	-8	42
4	-38	6
4	-64	10
18	-40	42
30	-62	26
40	-40	50
54	-14	12
46	22	8
46	36	20
40	20	-16
-50	-28	38
-18	-30	70
-4	2	66
-28	14	48
-4	-22	56
-38	28	34
-38	44	26
-40	-26	14
-4	-80	16
-20	-82	36
-38	-82	28
-20	-68	-2
-22	-58	-6
-40	4	-32
-2	-44	14
-6	-40	6
-18	-74	28
-12	8	38
-42	-56	-16
-42	22	-22
-38	-62	38
-48	-74	24
-40	-52	50
-58	-12	14
-42	40	24

// Venkatraman V, 2011: Rested Wakeful Session, Decision Phase
// Venkatraman V, 2011: Sleep Deprived Session, Decision Phase
// Venkatraman V, 2011: Rested Wakeful > Sleep Deprivation, Decision Phase
// Venkatraman V, 2011: Sleep Deprived > Rested Wakeful, Decision Phase
// Venkatraman V, 2011: Rested Wakeful > Sleep Deprived, Loss Focus
// Subjects=29
8	-70	43
-26	61	43
24	-94	-10
-30	-90	-10
-42	-63	-20
32	2	49
-31	1	49
-48	9	29
48	14	29
1	18	46
32	24	-2
-30	21	-2
45	31	18
30	-65	44
-28	59	42
23	-92	-12
-30	-90	-9
-41	-67	-17
34	-1	49
-26	-4	48
-50	12	29
46	12	25
-6	19	44
31	20	0
-30	22	-4
45	31	19
20	-74	50
-14	-73	50
14	-8	-3
45	-70	-15
-45	-50	-18
-1	18	-14
-3	33	-24
-36	40	-10
37	37	-16
39	19	2
-34	19	2
1	33	48

// Cowdrey F A, 2011: Chocolate in the Mouth: Recovered Anorexia Nervosa 
// Subjects > Healthy Controls
// Cowdrey F A, 2011: Sight of Chocolate: Recovered Anorexia Nervosa Subjects 
// > Healthy Controls
// Cowdrey F A, 2011: Chocolate in Mouth with Sight of Chocolate: Recovered 
// Anorexia Nervosa > Healthy Controls
// Cowdrey F A, 2011: Strawberry in Mouth - Rinse, Recovered Anorexia Nervosa 
// Subjects > Healthy Controls
// Cowdrey F A, 2011: Strawberry in Mouth with Sight of Strawberry: Recovered 
// Anorexia Nervosa > Healthy Controls
// Cowdrey F A, 2011: Main Effect of Chocolate in the Mouth
// Cowdrey F A, 2011: Main Effect of Sight of Chocolate
// Cowdrey F A, 2011: Main Effect of Strawberry in the Mouth
// Cowdrey F A, 2011: Main Effect of Sight of Moldy Strawberries
// Subjects=15
12	8	0
-20	2	8
0	-36	20
38	-80	-10
12	66	12
-1	28	-12
14	10	-4
42	-14	4
24	4	14
10	6	34
42	-14	20
14	12	12
8	46	22
-32	20	2
36	18	2
10	8	-4
-2	34	20
18	20	-14
14	-96	-4
-26	-92	-6
10	6	-4
8	18	38
40	44	34
32	48	18
30	24	-2
-32	20	8
16	12	-2
10	-96	-2
-18	-90	-8
-30	20	8
38	-4	10
38	22	-16

// Ihssen N, 2011: Alcohol - Neutral, Group Interaction between Heavy and 
// Light Nonalcoholic Drinkers
// Ihssen N, 2011: Concern - Neutral, Group Interaction between Heavy and 
// Light Nonalcoholic Drinkers
// Ihssen N, 2011: Alcohol - Concern, Group Interaction between Heavy and 
// Light Nonalcoholic Drinkers
// Ihssen N, 2011: Positive - Neutral, Group Interaction between Heavy and 
// Light Nonalcoholic Drinkers
// Ihssen N, 2011: Negative - Neutral, Group Interaction between Heavy and 
// Light Nonalcoholic Drinkers
// Subjects=11
-18.21	8.2	-7.89
-40.58	3.29	-.53
49.21	-4.72	-2.01
49.27	19.03	16.07
34.5	1.11	33.36
-40.51	-4.74	5.72
48.27	9.85	21.32
55.97	-28.46	34.48
10.01	-13.5	39.33
10.75	-55.3	-19.63
-7.49	-33.12	-20.16
13.09	-35.63	14.38
28.91	31.51	14.15

// Lang S, 2012: Borderline Personality Disorder (BPD) Patients, 
// Trauma-Exposed
// Subjects=14
3	56	1
-3	53	-2
-3	44	-2
-3	35	10
-3	-52	22
3	47	10
-3	56	-5
-9	38	-14
-3	44	-8
0	38	7
-9	44	-2
3	-73	34
-60	-16	-5
-51	-19	-11
-21	-1	1
48	-43	13
48	-46	16
-66	-37	7

// Lang S, 2012: Healthy Controls, Non-Traumatized
// Subjects=15
3	56	1
-3	53	-2
-3	44	-2
-3	35	10
-3	-52	22
-6	44	46
-39	14	31
-45	41	7
-36	50	13
-36	14	34
3	47	10
-51	-61	34
-27	-55	37
-15	41	31
-21	41	31
-27	-7	-17
9	38	-2
-48	-28	-2
-24	41	31
-18	44	28
36	-4	46
-54	-31	-2
-24	-58	43
-63	-49	28
39	-37	46
21	-22	1
-24	-7	-2
-9	-49	37
-9	62	25
-54	-16	-14
18	-4	-23

// Lang S, 2012: Healthy Controls, Non-PTSD
// Subjects=14
-6	44	46
-39	14	31
-45	41	7
-36	50	13
-36	14	34
-51	-61	34
-27	-55	37
-42	41	7
36	50	7
-42	20	43
-33	-58	46
-3	-73	37
-3	-31	28
60	-28	22
-63	-31	22
24	-49	58
-51	-64	4
-63	-31	22
24	-76	22
-54	-55	13
-21	-82	43

// Niedtfeld I, 2010: (Early, Negative vs Rest), BPD Patients > Healthy 
// Controls
// Niedtfeld I, 2010: (Early, Neutral vs Rest), BPD Patients > Healthy 
// Controls
// Niedtfeld I, 2010: (Late, Neutral, Hot vs Rest), BPD Patients > Healthy 
// Controls
// Niedtfeld I, 2010: (Late, Neutral, Hot vs Rest), Healthy Controls > BPD 
// Patients
// Niedtfeld I, 2010: (Late, Neutral, Warm vs Rest), BPD Patients > Healthy 
// Controls
// Niedtfeld I, 2010: (Late, Negative, Hot vs Rest), BPD Patients > Healthy 
// Controls
// Niedtfeld I, 2010: (Early, Negative > Early, Neutral), Whole Group
// Niedtfeld I, 2010: (Late, Neutral, Hot > Late, Neutral, Warm), Whole Group
// Niedtfeld I, 2010: (Late, Negative, Hot > Late, Negative, Warm), Whole 
// Group
// Subjects=20
21	48	12
-18	63	15
0	42	6
-33	30	48
-45	15	-18
36	-78	-18
9	-12	48
27	-45	42
42	-9	0
36	36	42
24	-69	42
45	0	33
-12	-60	24
-12	-27	30
24	-6	-21
-15	-87	36
-24	-3	-21
-39	3	-12
21	-3	-21
-24	-6	-21
-36	27	48
9	-15	48
-12	-6	30
36	36	42
-15	-27	33
-3	-30	18
42	42	-3
21	-63	36
42	-9	60
39	-33	48
-12	66	12
15	30	60
9	-12	51
-42	6	-12
-15	-18	-12
-42	6	-12
-12	-90	12
48	27	27
-39	0	-12
-42	-9	-3
18	-6	-12
-42	-9	-3
42	0	-9
-45	12	-18
24	-6	-21
-24	36	48
-9	66	12
6	-15	48
42	-3	0
-42	0	-8
-27	-3	-21
-48	-72	9
-60	-6	-15
0	3	30
0	-3	72
3	18	18
-21	-6	-15
21	-6	-15
39	15	21
-42	6	21
6	36	3
-9	-63	24
-3	-27	24
-45	-72	45
39	-21	21
-39	3	-12
48	-72	0
24	-30	3
30	0	51

// Schulze L, 2011: Borderline Personality Disorder (BPD) Patients
// Subjects=15
52	-64	-2
42	-52	-14
44	-44	-18
-52	-66	8
-44	-46	-20
28	-54	54
38	-48	62
10	-20	-12
-62	-26	34
66	-20	30
52	-20	32
16	-70	-26
-42	-42	52
30	-36	40
-2	-48	28
6	56	30
8	56	38
26	-80	38
-42	-32	40
44	20	26
-22	-2	-14
8	2	-2
38	-10	-8
44	-8	-2
22	-2	30
30	2	28
26	-16	68
-50	-24	0
4	-64	-40
2	0	30
56	-14	-8
-54	-42	6
-42	-58	34
-50	-52	36
48	-6	-26
24	16	50
-6	-20	44
46	4	-26
-24	-42	66
36	-40	52
58	-46	22
-50	-56	22
-52	20	-6
-2	14	56
-8	20	64
-2	22	44
-44	8	48
-34	8	42
-34	4	54
-34	-56	-30
-52	20	26
-58	-46	26
36	-56	-30
36	-68	-28
-14	22	46
50	30	-10
-2	36	32
56	20	-4
-52	16	-4
-40	6	2
-38	26	0
0	10	62
2	16	40
-6	22	66
-54	-44	26
46	14	-2
56	12	0
34	-54	-30
30	-76	-24
40	-62	-28
0	4	20
10	-8	-12
4	2	-6
-44	8	48
-60	14	18
-4	-30	6
0	-38	0
-10	-36	10
0	20	10
30	-42	4
-32	-56	-28
62	-44	-14
40	-48	56
44	-34	58
24	0	-2
-48	28	-6
50	-54	22
-36	16	52
-2	-74	38
-50	-46	-2
-28	-12	16
-18	-38	-40
30	-16	68
34	-24	20
-4	-78	-28
-28	-22	72
16	10	42
38	12	10
2	-76	46
-8	-10	32
18	-32	2
-10	-28	-2
-50	-28	50
-52	-36	56
-28	-74	2
-44	-6	-30
48	-66	0
42	-52	-14
44	-64	12
-46	-48	-20
-48	-72	14
-48	-70	0
-52	-66	6
-22	-4	-14
22	-4	-12
30	0	-28
-28	-42	-10
-16	-62	20
30	-44	-8
20	-54	16
-36	-48	-42
-32	-54	-30
56	22	-4
-44	22	-12
-50	18	-4
-54	20	-4
30	-76	-26
-52	14	-2
6	14	36
2	14	48
-30	16	8
-44	22	-14
-50	18	-4
-54	20	-4
48	6	4
-44	6	2
56	20	-4

// Schulze L, 2011: Healthy Controls
// Subjects=15
52	-64	-2
42	-52	-14
44	-44	-18
-52	-66	8
-44	-46	-20
28	-54	54
38	-48	62
10	-20	-12
-62	-26	34
66	-20	30
52	-20	32
16	-70	-26
-42	-42	52
30	-36	40
-2	-48	28
6	56	30
8	56	38
26	-80	38
-42	-32	40
44	20	26
-22	-2	-14
8	2	-2
38	-10	-8
44	-8	-2
22	-2	30
30	2	28
26	-16	68
-50	-24	0
4	-64	-40
2	0	30
56	-14	-8
-54	-42	6
-42	-58	34
-50	-52	36
48	-6	-26
24	16	50
-6	-20	44
46	4	-26
-24	-42	66
36	-40	52
58	-46	22
-50	-56	22
-52	20	-6
-2	14	56
-8	20	64
-2	22	44
-44	8	48
-34	8	42
-34	4	54
-34	-56	-30
-52	20	26
-58	-46	26
36	-56	-30
36	-68	-28
-14	22	46
50	30	-10
-2	36	32
56	20	-4
-52	16	-4
-40	6	2
-38	26	0
0	10	62
2	16	40
-6	22	66
-54	-44	26
46	14	-2
56	12	0
34	-54	-30
30	-76	-24
40	-62	-28
0	4	20
10	-8	-12
4	2	-6
-44	8	48
-60	14	18
-4	-30	6
0	-38	0
-10	-36	10
0	20	10
30	-42	4
-32	-56	-28
62	-44	-14
40	-48	56
44	-34	58
24	0	-2
-48	28	-6
50	-54	22
-36	16	52
-2	-74	38
-50	-46	-2
-28	-12	16
-18	-38	-40
30	-16	68
34	-24	20
-4	-78	-28
-28	-22	72
16	10	42
38	12	10
2	-76	46
-8	-10	32
18	-32	2
-10	-28	-2
-50	-28	50
-52	-36	56
-28	-74	2
-44	-6	-30
-54	-66	8
-44	-74	-6
50	-64	-2
48	-66	-12
42	-48	-14
-44	-58	-18
-42	-46	-20
36	-42	54
30	-48	52
26	-56	56
52	-20	32
-2	-48	28
6	58	28
-28	18	-20
-32	22	-2
-26	16	-22
-34	24	-16
-36	30	-2
40	-10	-10
38	30	4
44	22	-8
34	10	-16
46	22	-8
-28	2	-22
-20	-2	-12
-22	2	-16
18	-4	-12
30	-42	-8
20	-54	16
-18	-58	16
-26	-44	-8
-48	24	-4
-56	28	4
-34	48	-14
-2	14	56
-44	8	46
-34	8	42
-54	-44	2
-14	18	50
-32	50	22
50	30	-10
50	18	-6
34	-26	18
-2	14	58
-52	16	-4
-44	22	-2
-40	6	2
-48	16	-4
-34	30	-2
-40	22	-16
46	16	-4
-54	-42	26
40	-62	-28
0	18	40
-2	22	30
-8	-34	8
48	18	-6
-4	6	18
-44	4	48
-20	18	-16
46	-30	60

// Victor T A, 2010: Masked Sad Faces vs. Masked Happy Faces, MDD Patients > 
// Healthy Controls
// Victor T A, 2010: Masked Sad Faces vs. Masked Happy Faces, Healthy Controls 
// > MDD Patients
// Victor T A, 2010: Unmasked Sad Faces vs. Unmasked Happy Faces, MDD Patients 
// > Healthy Controls
// Victor T A, 2010: Unmasked Sad Faces vs. Unmasked Happy Faces, Healthy 
// Controls > MDD Patients
// Subjects=22
-28	-18	-14
-8	-29	5
-38	13	-21
4	-17	49
38	-13	47
50	-15	49
26	-23	53
-44	-5	48
-51	-4	41
61	-9	10
58	-10	-15
50	-21	16

// Vollstadt-Klein S, 2011: Alcohol Cues > Neutral Cues, Abstinent 
// Alcohol-Dependent Patients
// Vollstadt-Klein S, 2011: Positive Correlation between BOLD Response and 
// Attentional Bias Score
// Subjects=38
-20	-100	-6
32	-94	-8
-12	-6	10
0	-40	28
-6	8	60
-58	-16	-26
0	-20	10
-36	-4	44
-12	60	2
32	-64	46
-30	-66	40
-14	52	-8
-16	2	-14
34	22	-14
-52	14	-16
-6	54	8
42	18	12
-16	-34	4
-42	2	10
-38	-62	28
36	-2	0
-26	22	-18
-32	16	8

// Grabski K, 2011: Tongue - Rest
// Grabski K, 2011: Vowel Vocalization - Rest
// Grabski K, 2011: Jaw - Rest
// Grabski K, 2011: Lips - Rest
// Grabski K, 2011: Conjunction
// Grabski K, 2011: Main Effect
// Subjects=13
-20	-28	58
56	-4	30
-52	-8	32
0	-6	58
-62	0	26
-58	8	30
58	8	28
-38	-44	54
-62	-6	18
-20	-52	64
14	-64	56
36	16	8
-26	-2	-4
24	8	6
18	-8	-4
18	4	20
16	-20	-2
-16	-62	-20
18	-60	-20
10	-58	-14
-60	-4	18
52	-6	32
-52	-8	32
44	-8	30
-4	-4	62
8	-4	60
-60	-4	36
54	-6	38
-42	-24	8
50	-16	6
52	-20	0
58	-26	24
-58	-6	10
60	-4	6
46	8	2
10	14	34
26	-2	-8
-26	-8	-6
24	-4	-2
22	-10	-4
32	-8	12
-14	-20	0
14	-18	4
-12	-64	-16
20	-60	-20
18	-62	10
-48	-12	34
54	-6	32
-52	-8	32
60	-10	34
-18	-4	68
2	-6	58
-44	-12	60
54	-6	38
58	8	28
-40	-26	12
-62	-30	34
64	-26	22
-46	-28	20
52	-28	20
-62	-6	18
-38	-12	18
-6	8	38
26	6	-6
16	-20	-2
-16	-62	-18
20	-60	-20
-48	-12	36
-54	-16	42
-22	-2	66
-10	-2	70
2	-6	58
-44	-12	60
54	-6	40
-58	8	30
58	8	30
-48	-26	38
-48	-28	20
60	-16	22
-20	-52	64
-38	-14	20
-6	8	38
-26	-2	-4
-24	0	-4
-14	-20	2
-16	-62	-18
18	-58	-20
-48	-12	36
40	-12	46
-50	-16	40
-4	-4	62
-56	-4	40
54	-6	40
58	6	30
-48	-28	20
-26	-2	-4
-16	-62	-18
18	-58	-20
-60	-4	18
-52	-8	32
-52	-16	4
44	-22	4

// Ogura E, 2012: Lip-Pursing/Lip-Stretching - Rest
// Ogura E, 2012: Tongue Protrusion - Rest
// Ogura E, 2012: Lateral Tongue - Rest
// Ogura E, 2012: Oral Ball-Rolling - Rest
// Subjects=8
11	-58	-15
22	-58	-21
-18	-58	-24
43	-11	36
54	-14	45
58	-14	36
29	-11	-3
54	-7	30
65	-4	15
-50	-11	30
-58	-7	27
14	-61	-15
47	-14	36
54	-11	33
54	-11	48
-54	-14	36
-61	-14	30
-43	-14	36
14	-61	-18
-11	-54	-21
-11	-65	-18
25	0	-3
29	-14	6
-4	0	54
-4	-4	63
14	-61	-18
-58	-11	24
-61	-22	21
-58	-18	42
-14	-58	-18
-29	-54	-24
50	-14	39
54	-7	27
43	-7	57
14	-18	0
4	0	60
-4	-7	54
-14	-22	3
-25	-7	0
-29	-14	-3

// Wong D, 2011: Tooth Grinding Patients
// Subjects=10
-54	-6	44
-48	-10	50
-48	-14	32
56	-2	36
54	0	48
52	-8	32
-24	8	2
-26	-4	12
26	2	2
26	0	-12
-56	-16	32
-58	-10	38
-64	-16	26
52	-8	30
58	-2	38
62	-20	36
8	-2	62
-6	-2	58
-46	-44	56
-46	-42	46
24	10	0
26	0	8
24	2	-2
-20	-50	44
-32	-42	42
-46	-52	46
-50	-62	-2
-32	-60	-14
-40	-70	-10
0	12	46
-4	0	54
24	-62	-8
-16	-66	-4
-22	-74	6

// Wong D, 2011: Healthy Controls
// Subjects=9
-46	-12	34
-56	-8	44
-60	-2	32
54	-2	38
46	-8	36
54	-4	46
-2	-2	58
-8	-8	66
6	0	64
-56	-46	40
-48	-54	46
-20	-46	40
-50	-60	-4
-58	-52	0
-52	-66	-12
-36	-84	-8
-38	-72	-10
-32	-60	-14
-30	-32	14
-26	-14	4
-32	-24	6
26	0	2
20	0	12
26	-12	6
16	-56	-20
16	-46	-22
6	-54	-14
-56	-12	40
50	-6	34
58	-6	48
68	-14	24
-4	0	54
6	-2	64
-22	-74	6
-18	-86	8
-28	-84	8
-24	-10	4
-26	-6	-14
28	-2	-10
26	10	2
26	-2	2
-8	-20	4
10	-18	4
-20	-50	44
-32	-42	42
-46	-52	46
-50	-62	-2
-32	-60	-14
-40	-70	-10
0	12	46
-4	0	54
24	-62	-8
-16	-66	-4
-22	-74	6

// Duka T, 2011: A+ or B+ vs. C- or D-, Reward vs. Non Reward
// Duka T, 2011: (AB-) - (CD-), Incentive Conflict
// Duka T, 2011: (A-) - (A+), Reversal
// Duka T, 2011: (A+) - (A-), Reversal
// Subjects=8
-16	-42	-48
-6	-52	10
-22	-14	-18
-4	52	-12
-16	32	52
14	-6	44
-8	-10	48
-48	-14	54
32	-14	16
32	14	-40
-48	-64	22
-34	-8	0
-16	52	-4
-6	38	-24
8	10	68
42	-16	-26
-12	48	36
-26	56	-2
-6	66	18
-22	-66	28

// Goudriaan A E, 2010: Problem Gamblers
// Subjects=17
-42	9	33
42	15	30
-30	33	-9
36	36	-6
-33	-18	-21
33	-15	-15
-27	-33	-21
27	-48	-15
-27	-84	-9
-39	-78	9
36	-45	-15
27	-84	-9
24	-81	12
-18	-30	-3
18	-30	-3
-42	12	33
54	24	30
-33	33	12
36	33	-6
-30	-21	-21
30	-21	-21
-33	-48	-18
33	-48	-18
-21	-6	-18
24	-6	-18
-24	-84	-6
-33	-72	21
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
42	15	33
36	33	-6
-30	-15	-15
33	-15	-15
-24	-33	-18
36	-48	-24
-21	-6	-15
21	-6	-15
-30	-84	-9
-36	-81	12
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
-9	27	57
-27	-45	-15
33	-45	-12
-36	-66	27
45	-63	30
60	-54	12
-3	54	36
-33	48	6
3	54	0
-39	6	-15
-45	-63	33
45	-63	39
60	-36	-3
39	7	30
-18	-24	-21
21	-27	-21
15	0	-15
-33	-78	12
-39	-72	12
-48	9	33
45	0	42
-42	24	3
-27	-45	-15
27	-36	-21
30	-60	-15
-21	9	-18
15	5	-10
57	-60	3
-33	-78	12
27	-72	33
-6	66	15
9	60	15
15	51	3
-6	48	3
6	45	6
-3	-48	33
-39	45	-3
-6	27	39
-48	21	-3
-15	15	6

// Goudriaan A E, 2010: FTND-High Heavy Smokers
// Subjects=10
-42	9	33
42	15	30
-30	33	-9
36	36	-6
-33	-18	-21
33	-15	-15
-27	-33	-21
27	-48	-15
-27	-84	-9
-39	-78	9
36	-45	-15
27	-84	-9
24	-81	12
-18	-30	-3
18	-30	-3
-42	12	33
54	24	30
-33	33	12
36	33	-6
-30	-21	-21
30	-21	-21
-33	-48	-18
33	-48	-18
-21	-6	-18
24	-6	-18
-24	-84	-6
-33	-72	21
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
42	15	33
36	33	-6
-30	-15	-15
33	-15	-15
-24	-33	-18
36	-48	-24
-21	-6	-15
21	-6	-15
-30	-84	-9
-36	-81	12
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
-9	27	57
-27	-45	-15
33	-45	-12
-36	-66	27
45	-63	30
60	-54	12
-3	54	36
-33	48	6
3	54	0
-39	6	-15
-45	-63	33
45	-63	39
60	-36	-3
-48	9	33
45	0	42
-42	24	3
-27	-45	-15
27	-36	-21
30	-60	-15
-21	9	-18
15	5	-10
57	-60	3
-33	-78	12
27	-72	33
-12	54	-3
12	51	0
-33	51	6
-6	42	9
-3	48	6
6	42	9
-9	-60	36
-12	51	-3
9	51	6
33	42	42
-6	42	9
9	42	6
-51	6	-21
-45	9	-15
36	9	-9
-6	-54	36
-6	66	15
9	60	15
15	51	3
-6	48	3
6	45	6
-3	-48	33
-36	6	60
-18	3	-21

// Goudriaan A E, 2010: FTND-Low Heavy Smokers
// Subjects=8
-42	9	33
42	15	30
-30	33	-9
36	36	-6
-33	-18	-21
33	-15	-15
-27	-33	-21
27	-48	-15
-27	-84	-9
-39	-78	9
36	-45	-15
27	-84	-9
24	-81	12
-18	-30	-3
18	-30	-3
-42	12	33
54	24	30
-33	33	12
36	33	-6
-30	-21	-21
30	-21	-21
-33	-48	-18
33	-48	-18
-21	-6	-18
24	-6	-18
-24	-84	-6
-33	-72	21
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
42	15	33
36	33	-6
-30	-15	-15
33	-15	-15
-24	-33	-18
36	-48	-24
-21	-6	-15
21	-6	-15
-30	-84	-9
-36	-81	12
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
-9	27	57
-27	-45	-15
33	-45	-12
-36	-66	27
45	-63	30
60	-54	12
-3	54	36
-33	48	6
3	54	0
-39	6	-15
-45	-63	33
45	-63	39
60	-36	-3
-48	9	33
45	0	42
-42	24	3
-27	-45	-15
27	-36	-21
30	-60	-15
-21	9	-18
15	5	-10
57	-60	3
-33	-78	12
27	-72	33
-12	51	-3
9	51	6
33	42	42
-6	42	9
9	42	6
-51	6	-21
-45	9	-15
36	9	-9
-6	-54	36
-36	6	60
-18	3	-21

// Goudriaan A E, 2010: Healthy Controls
// Subjects=17
-42	9	33
42	15	30
-30	33	-9
36	36	-6
-33	-18	-21
33	-15	-15
-27	-33	-21
27	-48	-15
-27	-84	-9
-39	-78	9
36	-45	-15
27	-84	-9
24	-81	12
-18	-30	-3
18	-30	-3
-42	12	33
54	24	30
-33	33	12
36	33	-6
-30	-21	-21
30	-21	-21
-33	-48	-18
33	-48	-18
-21	-6	-18
24	-6	-18
-24	-84	-6
-33	-72	21
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
42	15	33
36	33	-6
-30	-15	-15
33	-15	-15
-24	-33	-18
36	-48	-24
-21	-6	-15
21	-6	-15
-30	-84	-9
-36	-81	12
39	-63	-15
24	-84	-15
24	-90	12
-21	-30	-3
21	-30	-3
-9	27	57
-27	-45	-15
33	-45	-12
-36	-66	27
45	-63	30
60	-54	12
-3	54	36
-33	48	6
3	54	0
-39	6	-15
-45	-63	33
45	-63	39
60	-36	-3
39	7	30
-18	-24	-21
21	-27	-21
15	0	-15
-33	-78	12
-39	-72	12
-12	54	-3
12	51	0
-33	51	6
-6	42	9
-3	48	6
6	42	9
-9	-60	36

// Versace F, 2011: Cigarette > Neutral Cues
// Subjects=35
-48.86	-66.46	6.53
55.83	-60.72	2.61
-41.14	-41.93	47.87
36.94	-41.83	55.89
-25.08	-83.3	34.43
25.17	-77.2	40.03
-2.68	-60.53	37.84
-46.98	34.14	13.68
-50.03	8.29	23.69
-38.35	-6.76	6.98
0.94	41.52	-5.33
-.7	-24.74	32.59
10.72	4.74	-.13

// Addicott M A, 2012: Selection Phase, Money > Control, Abstinent > Satiated
// Addicott M A, 2012: Anticipation Phase, Money > Control, Abstinent > 
// Satiated
// Addicott M A, 2012: Anticipation Phase, Money > Control, Satiated > 
// Abstinent
// Addicott M A, 2012: Outcome Phase, Win > No Win, Satiated > Abstinent
// Subjects=13
-26	-32	60
44	-8	-12
-16	-56	-4
52	-26	22
34	-30	54
-2	-54	-16
-60	4	4
36	-8	-8
-34	52	8
34	-8	46
-40	-70	6
14	-2	68
22	-66	16
-30	22	58
52	36	-14
-2	-60	12
-12	16	36
12	-14	48
4	54	-24
26	46	20
-38	6	-2
14	40	-6
-2	-28	56
28	-14	-2
-2	48	-6

// Burger K S, 2012: Reduced Responsivity to Milkshake Receipt as a Function 
// of the Frequency of Ice Cream Consumption
// Burger K S, 2012: Milkshake Receipt > Tasteless Solution Receipt
// Subjects=151
33	35	37
-6	38	16
9	29	31
33	5	13
39	11	13
18	5	22
-33	14	-14
-24	11	1
-21	8	-14
24	8	-8
-33	32	37
-21	32	40
45	-13	37
-51	-13	28
-48	-16	31
39	41	31
42	44	22
30	53	25
-12	-16	40
-18	-31	-40

// Park S Q, 2010: Correlation between BOLD Activity and Prediction-Errors in 
// All Subjects
// Subjects=16
-38	28	42
44	20	38
-28	24	-10
36	22	-8
-8	-10	-16
14	-2	-14
14	6	-12
-8	8	-4
8	6	-4
2	32	56
-6	34	30
-48	-48	36
48	-50	36
-30	54	0
22	52	20

// Bragulat V, 2010: Preferred Food-Related Odors > Nonappetitive Odors, All 
// Participants (Pleasantness Rating Covariate)
// Bragulat V, 2010: Preferred Food-Related Odors > Nonappetitive Odors, Obese 
// > Lean (Pleasantness Rating Covariate)
// Bragulat V, 2010: Preferred Food-Related Odors > Nonappetitive Odors, Lean 
// > Obese (Pleasantness Rating Covariate)
// Subjects=5
-4	-88	2
22	28	46
-32	0	62
60	-6	6
-34	14	38
50	10	42
22	-16	20
-56	-8	6
2	40	-8
-60	-56	16
-56	-16	20
-6	-6	60
44	-12	-2
46	-68	34
-42	26	-4
-8	-64	42
16	-28	-8
4	22	30
-10	-78	50
40	-12	40
-48	-64	-12
-36	44	6
66	-40	2
54	-4	26
62	-10	-10
32	-82	28
-12	-34	-2
36	32	36
-14	-16	-20
-26	-62	-4
26	-14	-12
-24	-48	52
22	-48	-4
20	-16	-8
58	32	8
-30	34	28
-32	-12	12
-56	-58	6
6	8	40
-22	28	38
-8	30	52
34	42	22
42	42	4

// Brooks S J, 2011: Healthy Controls
// Subjects=24
-3.11	-67.19	-20.7
55.56	-10.74	-11.61
55.78	-37.03	6.2
-3.03	2.86	18.03
58.83	-26.58	-10.32
-53.36	-15.02	-2.2
48.58	-67.17	30

// Brooks S J, 2011: Restricting Type Anorexia Nervosa Patients
// Subjects=11
-18.05	-79.17	-22.87
51.52	11.44	27.84
44.34	-62.37	37.45
-25.56	-71.81	-23.4
-13.65	-89.91	-10.87
44.02	7.88	23.76
1.3	48.46	43.15
58.6	-28.98	-41.34
-10.09	-49.95	51.54
47.4	0.9	43.27
43.95	-1.69	10.07
16.18	10.46	18.29
-44.53	8.81	43.66
-60.97	-4.29	-14.16
-3.01	-70.56	-9.27
1.35	-41.07	13.86
51.75	-34.57	38.38
-2.61	-49.9	51.45

// Brooks S J, 2011: Binge Purging Type Anorexia Nervosa Patients
// Subjects=7
-18.05	-79.17	-22.87
51.52	11.44	27.84
44.34	-62.37	37.45
-3.27	-61.16	-39.05
27.88	-67	-21.07
25.04	1.62	54.61
58.6	-28.98	-41.34
-10.09	-49.95	51.54
-37.31	-59.73	-17.59
43.95	-1.69	10.07
16.18	10.46	18.29
-44.53	8.81	43.66
-18.24	-68.99	-42.68
-22.66	3.03	-33.06
-2.72	-67.48	30.62
28.2	13.27	53.6

// Brooks S J, 2011: Bulimia Nervosa Patients
// Subjects=8
13.12	-84.75	-1.57
-33.84	-28.37	29.93
-48.15	11.11	-8.91
-56.34	-12.64	28.87
58.6	-28.98	-41.34
-10.09	-49.95	51.54
47.4	0.9	43.27
-37.31	-59.73	-17.59
43.95	-1.69	10.07
16.18	10.46	18.29
-44.53	8.81	43.66
-60.97	-4.29	-14.16
-3.01	-70.56	-9.27
1.35	-41.07	13.86
51.75	-34.57	38.38
-2.61	-49.9	51.45
-18.24	-68.99	-42.68
-22.66	3.03	-33.06
-2.72	-67.48	30.62
28.2	13.27	53.6
58.83	-26.58	-10.32
-53.36	-15.02	-2.2
48.58	-67.17	30

// Frank S, 2010: Healthy Control Males
// Subjects=6
21	36	-12
-15	-87	-12
-30	15	-21
-3	-42	12
-24	-39	45
0	-15	9
21	60	12
-9	33	33
15	39	15
-39	-39	48
-54	3	45
24	-15	63
15	-63	60
24	-48	-24
-15	-18	6
9	51	9
0	-48	33
-45	-69	33
51	-75	36
63	-12	-12
-6	33	63
-54	33	3
48	21	-30
-15	-87	-3
0	-48	33
-45	-75	45
-15	54	6
-9	27	-9
51	-75	36
-30	18	-18
60	-63	36
-63	-36	3
-30	21	-18
15	30	-15
27	18	-18
54	39	-3
-51	-72	36
6	54	6
0	-51	33
-6	42	-3
-6	-69	27
48	21	-24
60	-63	36
-21	30	45
-66	-15	-9

// Frank S, 2010: Healthy Control Females
// Subjects=6
21	36	-12
-15	-87	-12
-30	15	-21
-3	-42	12
-24	-39	45
0	-15	9
21	60	12
-9	33	33
15	39	15
-3	45	54
24	-72	-6
-15	48	-6
-24	18	60
9	21	-12
-24	-72	-3
-39	-39	48
-54	3	45
24	-15	63
15	-63	60
24	-48	-24
-15	-18	6
9	51	9
0	-48	33
-45	-69	33
51	-75	36
63	-12	-12
-6	33	63
-54	33	3
48	21	-30
-15	-87	-3
0	-48	33
-45	-75	45
-15	54	6
-9	27	-9
51	-75	36
-30	18	-18
60	-63	36
-63	-36	3
-30	21	-18
15	30	-15
27	18	-18
54	39	-3
-51	-72	36
6	54	6
0	-51	33
-6	42	-3
-6	-69	27
48	21	-24
60	-63	36
-21	30	45
-66	-15	-9

// Schacht J P, 2011: Alcohol > Neutral Beverages, Scan 1
// Schacht J P, 2011: Alcohol > Neutral Beverages, Scan 2
// Schacht J P, 2011: Alcohol > Neutral Beverages, Scan 2 > Scan 1
// Subjects=9
-18	15	12
12	9	-3
18	12	12
27	-9	0

// Demos K E, 2011: Main Effect of Dietary Status, Dieters > Non-Dieters
// Demos K E, 2011: Main Effect of Dietary Status, Non-Dieters > Dieters
// Demos K E, 2011: Main Effect of Preload, Milkshake > Water
// Demos K E, 2011: Main Effect of Preload, Water > Milkshake
// Demos K E, 2011: Restraint x Preload Interaction
// Subjects=25
-54	-72	23
-48	41	-2
36	-50	49
-15	18	60
-54	19	7
36	4	14
29	-86	-7
36	19	27
15	60	21
9	-96	2
15	26	-9
-42	-18	45
74	-41	-6
42	58	-5
-24	-15	48
6	34	34
12	9	-3
-18	6	8
-15	3	-8
-12	15	16
-27	-4	-20

// Dimitropoulos A, 2012: Food > Object, Obesity Patients > Healthy Controls, 
// Pre-Meal
// Dimitropoulos A, 2012: High-Calorie Food > Object, Obesity Patients > 
// Healthy Controls, Pre-Meal
// Dimitropoulos A, 2012: Low-Calorie Food > Object, Obesity Patients > 
// Healthy Controls, Pre-Meal
// Dimitropoulos A, 2012: Food > Object, Healthy Controls > Obesity Patients, 
// Pre-Meal
// Dimitropoulos A, 2012: High-Calorie > Low-Calorie Food, Healthy Controls > 
// Obesity Patients, Pre-Meal
// Dimitropoulos A, 2012: High-Calorie Food > Object, Healthy Controls > 
// Obesity Patients, Pre-Meal
// Dimitropoulos A, 2012: Food > Object, Obesity Patients > Healthy Controls, 
// Post-Meal
// Dimitropoulos A, 2012: High-Calorie Food > Object, Obesity Patients > 
// Healthy Controls, Post-Meal
// Dimitropoulos A, 2012: Low-Calorie Food > Object, Obesity Patients > 
// Healthy Controls, Post-Meal
// Subjects=16
25.43	62.65	-9.61
-35.49	67.74	-7.11
-34.44	67.57	-9.34
45.82	64.85	3.35
-37.59	64.81	-3.5
-1.68	17.92	61.36
51.24	-56.34	-36.73
-29.73	33.59	32.49
-48.02	1.47	4.17
-23.03	-22.7	47.17
-57.52	-10.59	14.21
-41.53	0.08	13.13
-23.58	-12.95	-19.44
49.08	-54.33	-37.99
-15.92	-69.29	-19.26
-31.85	36.03	36.77
-41.58	0.71	7.5
-13.5	-4.84	43.33
-35.48	-2.51	-34.68
-44.61	-29.37	17.87
-56.41	-16.75	16.94
1.04	59.01	14.39
31.89	27.02	-16.74
19.58	21.25	47.45
20.5	-47.36	-.33
31.97	6.93	-15.05
47.97	8.97	-17.64
-9.52	-46.28	-11.23
5.68	29.88	50.24
3.33	54.05	32.62
35.13	31.78	-10.48
-3.38	16.78	-22.16
9.71	9.82	10.61
30.05	-35.84	-3.64
-16.23	63.71	-5.88
22.78	21.18	46.31
1.07	58.21	17.8
23.73	-49.2	3.13
-1.12	24.68	-2.78
49.04	4.57	-19.51
-52.53	18.77	-19.54
-59.47	-50.35	23.14
58.16	-63.05	27.32

// Khader P H, 2010: Noun Generation > Rhyme Generation
// Khader P H, 2010: Verb Generation > Rhyme Generation
// Khader P H, 2010: Noun Generation > Letter-Search
// Khader P H, 2010: Verb Generation > Letter-Search
// Khader P H, 2010: Nouns > Verbs
// Khader P H, 2010: Verbs > Nouns
// Subjects=17
-65.39	50.13	-11.98
-41.79	61.15	4.67
-52.5	71.84	6.12
-6.52	62.51	5.26
46.86	65.57	-1.18
55.33	59.4	-13.03
57.52	52.18	-10.22
63.2	30.46	24.99
-41.31	-66.79	15.39
-53.05	-67.83	16.73
-3.23	56.78	13.51
-47.06	26.69	-.19
0.16	23.57	24.06
7.81	-58.12	12.98
-3.25	57.67	11.21
-47.04	23.6	1.18
0.15	22.42	23.05
-64.92	-51.5	8.8
-50.83	-77.88	24.24
62.23	-44.31	7.85
-64.83	-43.96	23.78
25.14	-84.14	32.81
-56.49	11	17.96

// Leidy H J, 2011: Food > Non-Food, Breakfast Skipping > Normal Protein
// Leidy H J, 2011: Food > Non-Food, Normal Protein > High Protein
// Subjects=10
-19.27	-21.39	-18.78
22.4	-4.76	-13.96
-3.37	26.81	-16.31
-3.38	43.18	-11
28.82	-14.5	-16.57
-16.15	0.84	-20.68
-28.8	-37.05	-14.01
-29.03	3.42	-27.44
35.31	19.32	7.29
-31.99	12.57	8.63
32.11	45.71	18.5
-38.26	37.05	36.76

// Miedl S F, 2010: Problem Gamblers (PG)
// Subjects=12
50.49	45.78	-15.58
73.54	-24.77	-2.27
12.02	-33.29	1.86
73.62	-19.79	5.08
58.43	-11.54	2.28
65	-30.56	5.17
48.78	-26.36	5.04
-.89	-24.2	7.91
-14.3	5.27	-20.55
18.11	5.38	-21.12
-28.33	6.83	65.82
-17.39	-55.55	63.96
-22.41	-100.18	0.11
-9.48	-83.98	0.52
-7.17	-81.76	12.59
-18	-103.9	6
-11.55	-61.47	11.78
-7.74	10.27	-13.31
11.68	10.13	-15.87
3.7	-21.05	29.93
-9.56	-13.5	8.12
-15.96	-15.02	15.1
-3.26	-78.28	-19.2
3.2	-82.82	-22.22
11.91	-82.27	-16.82
3.39	-78.07	-5.88
27.68	23.32	55.39
-32.7	-52.59	50.48
-28.24	-46.12	62.09
-9.1	39.25	55.56
52.63	47.81	-16.94
73.5	-25.08	-5.6
-46.85	24.95	-26.43
49.53	-45.94	59.63
61.13	-53.51	35.53
53.74	-51.12	49.98
-18.74	-15.35	-34.12
9.84	-33.4	0.79
-30.52	0.03	62.05
38.52	10.49	55.35
34.3	6.84	62.51
47.08	6.6	47.75
-55.77	6.81	32.67
51.3	-11.65	36.03
20.26	7.52	-21.36
27.71	23.53	57.61
-44.16	-24.77	4.22
53.02	-18.26	-.32
63.32	-18.22	45.44
49.49	-33.08	59.48
51.41	-25.06	41.84
-30.45	-44.31	58.59
30.07	-65.78	55.2
-15.94	-59.77	7.2
-9.47	-86.1	0.73
3.39	-78.07	-5.88
-20.16	-103.91	6.04
-7.17	-81.76	12.59
19.04	-98.2	30.58
29.25	-55.54	-7.43
-31.3	-11.21	-.7
29.26	9.08	6.34
35.69	-15.33	-2.56
29.1	12.3	-5.18
-37.75	-25.27	-1.44
18.81	-65.95	19.55
-7.74	10.27	-13.31
11.69	8.01	-15.66
-.55	-24.9	34.87
-7.52	-16.55	-1.7
-11.65	-19.47	13.23
-20.45	-25.1	-.63
11.94	-20.74	-1.62
18.48	-15.94	3.4
3.2	-82.82	-22.22
11.91	-82.27	-16.82

// Miedl S F, 2010: Occasional Gamblers (OG)
// Subjects=12
50.49	45.78	-15.58
73.54	-24.77	-2.27
12.02	-33.29	1.86
73.62	-19.79	5.08
58.43	-11.54	2.28
65	-30.56	5.17
48.78	-26.36	5.04
-.89	-24.2	7.91
-14.3	5.27	-20.55
18.11	5.38	-21.12
-28.33	6.83	65.82
-17.39	-55.55	63.96
-22.41	-100.18	0.11
-9.48	-83.98	0.52
-7.17	-81.76	12.59
-18	-103.9	6
-11.55	-61.47	11.78
-7.74	10.27	-13.31
11.68	10.13	-15.87
3.7	-21.05	29.93
-9.56	-13.5	8.12
-15.96	-15.02	15.1
-3.26	-78.28	-19.2
3.2	-82.82	-22.22
11.91	-82.27	-16.82
3.39	-78.07	-5.88
27.68	23.32	55.39
-32.7	-52.59	50.48
-28.24	-46.12	62.09
-.36	14.82	57.83
23.59	-8.94	66.49
46.83	-14.93	24.11
73.62	-19.79	5.08
58.43	-11.54	2.28
65.03	-30.35	7.39
48.82	-28.28	7.47
31.43	-46.61	-3.87
-5.21	-21.99	8.88
7.75	-21.94	8.66
46.78	-26.29	17.39
49.05	-10.15	29.2
-14.3	5.27	-20.55
18.11	5.38	-21.12
-28.33	6.83	65.82
-17.39	-55.55	63.96
-22.41	-100.18	0.11
-9.52	-79.93	-2.12
-7.17	-81.76	12.59
-2.73	-89.63	20.02
-11.55	-61.47	11.78
14.45	-92.53	11.05
14.74	-95.88	32.66
18.84	-72.33	20.18
8.06	-94.06	18.03
25.16	-63.67	9.13
20.94	-64.02	17.08
-7.74	10.27	-13.31
11.68	10.13	-15.87
3.7	-21.05	29.93
-9.56	-13.5	8.12
-15.98	-13	13.78
20.75	-26.05	9.96
-3.12	-78.3	-7.99
27.06	-66.7	-11.89

// Murdaugh D L, 2012: Healthy Controls (n=13)
// Subjects=13
20	-32	14
-46	-64	-14
40	-88	10
-46	30	10
48	34	-2
34	-56	56
-36	10	-18
-26	-70	32
-54	-24	26
48	14	8
-8	-28	0

// Murdaugh D L, 2012: Healthy Controls (n=11)
// Subjects=11
58	-58	32
10	-60	20

// Murdaugh D L, 2012: Obesity Patients (n=25)
// Subjects=25
-36	-2	-2
38	4	-18
-20	-2	-22
2	36	14
-6	-6	28
-52	-32	42
-26	-86	14
-50	-70	-8
-36	4	-20
-26	12	18
-50	36	4
26	-22	24
52	-28	42
66	-20	34
62	-18	42
4	22	42
-6	30	40
54	-38	40
18	-72	46
22	-50	48
-2	-32	28
6	-34	40
44	4	42
40	-74	30
44	12	-16
46	18	6
-2	10	42
4	4	42
-8	18	28
-20	-56	56
18	-58	54
-46	-36	42
44	10	52
2	-68	16
-12	-64	-4
-24	-76	26
-6	-28	-30
60	-44	-2

// Murdaugh D L, 2012: Obesity Patients (n=22)
// Subjects=22
34	-18	-2
32	-20	18
32	-24	-8
30	-80	-4
36	-86	26
28	-86	26
-44	-36	36
6	-80	-22
28	-80	-20
-8	-10	-10
-48	26	14
38	-74	22
12	-24	-6
-30	-12	-6
-18	18	-6
-42	26	14

// Nummenmaa L, 2012: Appetizing > Bland Foods, All Subjects
// Nummenmaa L, 2012: Appetizing and Bland Foods, Obesity Patients > Healthy 
// Controls
// Nummenmaa L, 2012: Appetizing and Bland Foods, Healthy Controls > Obesity 
// Patients
// Nummenmaa L, 2012: Appetizing > Bland Foods, Obesity Patients > Healthy 
// Controls
// Nummenmaa L, 2012: Appetizing > Bland Foods, Healthy Controls > Obesity 
// Patients
// Subjects=15
26	-48	-20
-16	-100	-6
6	-50	24
50	-6	4
28	-96	-12
-10	60	18
44	-40	2
-48	-28	14
-52	-14	12
14	-48	62
-44	-26	54
-34	-20	2
10	22	6
8	-10	66
-24	-42	56
2	-28	34
-24	26	40
-46	-68	20
-26	-52	-16
2	-14	38
-30	-10	-26
8	-38	18
56	-16	30
-40	-58	-10
-42	4	10
18	30	4
-42	4	10
20	34	-8
38	32	-8
46	12	-26
52	-38	18
20	40	38
38	-38	38
-38	34	10
30	6	54
36	-76	30
-22	-38	46
60	-24	-10
48	-32	40
26	28	54
8	-14	36
-30	-74	22
-20	-64	44
-62	-28	0
-8	-80	0

// Rubinstein M L, 2011: Smoking-Related > Neutral
// Subjects=12
-10	38	-10
46	-68	-2
38	-68	-10
46	-66	-10

// Willms J L, 2011: Verbs > Nouns
// Subjects=16
-50	-42	4
-2	14	64
-2	20	56
-46	6	42
-48	20	26
-34	6	58
34	-86	0

// Yu X, 2011: (Nouns - Fixation) > (Verbs - Fixation)
// Yu X, 2011: (Verbs - Fixation) > (Nouns - Fixation)
// Yu X, 2011: High-Imageability Nouns > High-Imageability Verbs
// Yu X, 2011: High-Imageability Verbs > High-Imageability Nouns
// Yu X, 2011: Low-Imageability Verbs > Low-Imageability Nouns
// Subjects=20
-42	33	-18
-12	42	42
-3	36	-24
-54	3	-33
-30	-33	-21
33	-30	-21
-33	-72	39
45	-75	45
-51	9	6
-45	-51	9
51	-39	9
21	-63	9
24	-69	-48
-30	24	60
-45	39	-18
-33	15	-21
36	39	-18
-54	3	-36
-33	-36	-18
36	-33	-18
-33	-72	39
-6	-57	12
-51	9	6
39	18	12
12	-33	63
60	0	45
-57	-39	21
-36	-96	9
18	-90	18
24	-69	-48
-30	-54	-48
-60	3	36
36	0	30
-12	15	51
18	36	27
-66	-48	9
54	-36	9
30	-57	3
-9	-75	-39

// DeWall C N, 2012: Exclusion > Inclusion
// Subjects=25
-36	24	-3
33	15	-12
42	30	-3
48	27	6
-48	36	-9
-6	-15	-15
3	42	48
-9	-93	3
3	-51	-36
-15	-75	-33
24	-69	-3
-36	-69	-15
48	-15	-18
54	-45	15
-12	-63	33

// Han S, 2010: Death-Related > Neutral-Valence Words
// Han S, 2010: Negative-Valence > Neutral-Valence Words
// Han S, 2010: Neutral-Valence > Death-Related Words
// Han S, 2010: Negative-Valence > Death-Related Words
// Subjects=20
-4	48	36
-6	-58	38
-32	-66	40
40	-64	28
44	16	38
-48	24	20
-6	42	22
-8	60	18
-12	-74	14
-8	-58	46
30	24	46
24	48	30
42	-30	12
-40	-4	2
48	-8	10
0	14	28
-40	-14	12
42	-8	8

// Herwig U, 2011: High Risk > Low Risk, Whole Evaluation Period
// Herwig U, 2011: High Risk > Low Risk, First Volume
// Herwig U, 2011: High Risk > Low Risk, First Two Volumes
// Subjects=18
39.44	18.95	-11.69
4.3	-6.39	-5.81
-4.97	-32.42	29.93
-5.29	13.62	6
-4.79	-73.41	36.71
13.91	-6.33	-5.93
-8.49	-9.38	-2.07
49.56	-68.02	18.91
-43.37	-71.49	23.61
-7.98	-70	39.81
-56.57	-42.5	-13.24
39.43	15.52	-14.74
-5.3	-6.19	-2.37
-11.68	13.84	9.4
7.5	36.41	10.64
-8.4	27.83	24.92
-33.78	4.1	50.62
49.54	0.91	43.24
-4.86	8.21	59.98
1.47	-38.73	30.39
-40.14	-71.22	26.9
49.65	-70.42	29.15
-7.98	-70	39.81
-53.4	-39.57	-16.86

// Pereira M G, 2010: Detection Only vs. Baseline
// Pereira M G, 2010: Unpleasent Viewing vs. Neutral Viewing
// Pereira M G, 2010: Detection after Unpleasant vs Detection after Neutral
// Subjects=11
24	-88	-10
-34	-84	2
30	-80	10
-54	-2	46
-24	8	40
30	20	40
-24	2	4
24	-4	4
-38	-84	8
-32	-14	16
-40	-40	52
-26	-20	68
-58	-4	42
-18	-2	56
-4	8	46
-18	4	12

// Yoshino A, 2010: Pain > No Pain
// Subjects=15
-2	8	32
40	-12	8
-38	-12	6
10	-16	10
-8	-20	0
30	-4	-14
60	-20	20
-60	-20	12
34	52	24

// Toyomura A, 2011: Healthy Controls
// Subjects=12
-62	-10	6
68	-30	8
14	-60	40
-52	-24	4
64	-32	8
8	-58	38
-64	-10	4
66	-30	8
-46	-26	16
64	-20	0
14	10	2
40	20	24
40	-42	42
-62	-34	22
66	-22	2
48	-16	16
-10	20	36
40	18	38
-50	-38	16
64	-20	2
42	22	18

// Toyomura A, 2011: Stuttering Patients
// Subjects=12
-50	-34	18
66	-20	2
-12	2	4
-50	6	26
46	22	20
-10	-44	8
-30	-2	50
36	-42	44
-62	-28	12
66	-24	2
-58	-48	22
48	-54	24
-10	-54	38
8	-48	42
-26	26	42
40	20	38
-18	-48	-2
-58	-32	12
66	-20	2
40	-38	20
-46	-26	16
64	-20	0
14	10	2
40	20	24
40	-42	42
-62	-34	22
66	-22	2
48	-16	16
-10	20	36
40	18	38
-50	-38	16
64	-20	2
42	22	18

// Pavuluri M N, 2010: Adolescent Bipolar Disorder Patients
// Subjects=13
16.35	-14.15	30.39
-11.47	-7	28.99
54.72	-14.95	16.63
-17	4.2	9.16
19.12	74.64	8.41
-10.8	74.54	9.88
9.57	58.8	10.96
-55.56	29.35	7.49
-5.88	-30.8	51
28.96	-21.84	-1.45
-23.45	-20.47	-6.54
29.03	-22.21	7.5
-.94	-16.31	4
-9.75	71.03	5.7
-32.14	2.23	-15.04
-44.99	51.28	1.07
6.36	55.53	10.16
-45.16	19.9	-33.1
51.79	-70.32	30.23
22.48	7.1	1.77
25.82	-17.83	9.4
-19.15	-22.3	-3.09
-5.56	52.6	-12.88
12.6	53.77	-13.18
-7.64	44.39	-8.82
3	54.94	-10.94
7.38	11.01	-15.11
6.72	-50.64	13.48
-3.88	-59.71	21.06
-60.65	-27.35	17.88
12.72	8.84	-16.11
-16.13	6.55	-15.58

// Pavuluri M N, 2010: Healthy Controls
// Subjects=13
16.35	-14.15	30.39
-11.47	-7	28.99
54.72	-14.95	16.63
-17	4.2	9.16
19.12	74.64	8.41
-10.8	74.54	9.88
9.57	58.8	10.96
-55.56	29.35	7.49
-5.88	-30.8	51
28.96	-21.84	-1.45
-23.45	-20.47	-6.54
29.03	-22.21	7.5
-.94	-16.31	4
-9.75	71.03	5.7
-32.14	2.23	-15.04
-44.99	51.28	1.07
6.36	55.53	10.16
-45.16	19.9	-33.1
51.79	-70.32	30.23
22.48	7.1	1.77
25.82	-17.83	9.4
-19.15	-22.3	-3.09
-46.08	51.1	-1.13
25.44	67.13	-6.64
-.75	36.19	49.78
16.42	3	45.68
-10.27	-3.51	46.53
29.02	-19.04	7.23
-23.36	-9.58	10.39
12.85	16.81	4.41
-12.82	16.4	1.4

// Pompei F, 2011: Bipolar Disorder Patients
// Subjects=39
36.45	-55.64	48.48
-19.66	-70.63	52.04
38.54	-45.21	45.17
-43.51	-27.54	54.91
-1.15	12.19	-4.65
37.55	28.41	-17
-28.89	48.59	30.32
-2.44	48.89	-13.86
-48.15	7.25	36.98
-62.03	-36.4	41.53
-17.38	-68.62	61.89
-4.45	21.54	-7.76

// Pompei F, 2011: Healthy Controls
// Subjects=48
36.45	-55.64	48.48
-19.66	-70.63	52.04
38.54	-45.21	45.17
-43.51	-27.54	54.91
-1.15	12.19	-4.65
37.55	28.41	-17
-53.64	18.62	32.58
37.56	27.35	-16.9
-18.26	33.14	13.74
-33.01	3.05	37.14
-17.95	-36.74	24.01
38.63	-53.3	50.46
40.68	-47.53	43.13
-30.6	-65.11	42.72
-.12	17.3	-7.42

// Pompei F, 2011: Healthy Controls, Relatives of Bipolar Disorder Patients
// Subjects=25
36.45	-55.64	48.48
-19.66	-70.63	52.04
38.54	-45.21	45.17
-43.51	-27.54	54.91
-1.15	12.19	-4.65
37.55	28.41	-17
-39.34	23.83	53.12
-44.01	24.52	26.23
35.45	25.52	-13.32
-16.42	46.07	-8.86
-43.94	5.37	28.13
-22.18	-37.2	30.85
-36.93	-59.64	55.73
-45.67	-47.21	51.29
-12.01	20.45	-7.53

// Pompei F, 2011: Major Depressive Disorder Patients, Relatives of Bipolar 
// Disorder Patients
// Subjects=14
36.45	-55.64	48.48
-19.66	-70.63	52.04
38.54	-45.21	45.17
-43.51	-27.54	54.91
-1.15	12.19	-4.65
37.55	28.41	-17
-43.95	34.82	33.06
30.91	46.91	-25.44
-14.24	46.18	-7.79
-45.85	19.25	50.32
25.36	-37.03	30.02
-24.12	-56.37	43.98
-45.61	-40.21	57.32
-9.83	21.73	-5.45

// Singh M K, 2010: Pediatric Bipolar Disorder Patients
// Subjects=26
4	16	-8
-14	-102	-10
8	18	42
34	24	34

// Singh M K, 2010: Healthy Controls
// Subjects=22
52	6	30
10	10	46
34	24	34

// Townsend J D, 2012: Bipolar Disorder Patients
// Subjects=32
-34	36	30
24	44	16
-36	46	20
34	58	14
-44	16	-10
-32	24	-6
40	20	0
-34	16	4
14	12	34
52	-32	-6
44	-50	40
26	-70	50
60	-48	28
-30	-94	-6
-38	-78	-8
38	-62	-10
24	-94	0
8	-88	4
16	-4	20
16	6	8

// Townsend J D, 2012: Healthy Controls
// Subjects=30
-36	38	36
-36	48	20
32	58	16
-28	-4	48
-34	20	2
36	20	2
-42	14	2
2	16	38
-58	-46	20
-58	-40	42
-36	-46	44
46	-44	38
-58	-48	28
62	-44	30
-36	-90	-6
30	-60	36
-16	10	8
24	10	14
-22	10	8
20	10	0
-14	-10	8
16	-10	8
-8	-16	-8
10	-14	-10

// Zandbelt B B, 2011: Schizophrenia Patients
// Subjects=22
32	-76	20
12	16	-12
16	8	-12
28	0	-4
-20	12	-12
-16	8	-16
-12	12	-12
-12	12	0
-20	8	8
-24	4	-4
-56	-20	44
-44	-28	48
-36	-28	64
-28	-24	68
-40	-20	40
-40	-40	60
-36	-44	64
-28	-44	68
-52	-44	0
-52	-52	4
40	0	36
44	16	32
-12	-4	64
32	28	-4
40	8	28
56	16	16
16	0	64
48	4	36
4	12	48
-4	8	52
44	0	44
32	40	24
40	0	52
36	28	28
48	36	24
4	16	56
40	24	32
20	8	0
12	32	24
44	16	-8
-8	12	44
40	8	-4
4	24	44
-32	-8	52
32	56	12
24	-4	48
4	32	36
-36	16	0
64	-36	12
32	-60	40
28	-68	36
56	-40	24
52	-44	36
52	-48	4
44	-56	0
48	-40	48
28	56	-4
32	64	0
-32	-60	44
-48	-40	36
-56	-32	28
-40	-56	44
-24	-60	32
-60	-24	20
-36	-48	32
52	-28	-8
-36	36	32
-28	36	20
-36	-32	56
-36	-28	64
-36	-20	40
-48	-16	48
-16	-32	72
-16	-32	56
36	-24	12
44	12	-32
20	20	20
24	-16	28
60	-4	-4
56	4	-28
40	-8	12
48	-24	4
60	0	-16
52	-8	-24
32	-12	28
24	8	32
0	-64	24
-4	-52	8
-8	-48	-4
16	-48	-4
-56	-12	-20
-12	-68	16
8	-52	12
0	-52	24
-8	-56	-12
-48	-8	-20
-8	-60	0
-16	-64	12
-40	-72	24
-20	-16	-24
-20	-56	12
28	-60	4
-60	-8	-8
16	-52	-16
-52	-68	20
-44	-4	-28
-52	-12	0
-48	4	-28
-36	-8	-24
20	-68	12
-32	-16	16
-24	-24	-20
32	-48	8
-32	-32	16
-24	-36	-20
-28	-28	16
12	-44	-12
-56	-8	12
28	-52	12
-36	-52	12
-28	-36	-12
-4	-36	40
36	-40	24
32	-48	20
-12	-80	20
-44	20	-28
-20	-84	36
36	-32	-12
-52	-24	4
-40	12	-36
32	-40	0
-40	-16	8
-40	-40	4
-36	-36	12
-36	-48	0
-16	-44	-24
-12	36	44
-8	60	20
4	56	-12
0	68	0
-24	28	48
-28	24	52
-8	52	40
-8	48	48
4	68	8
-36	12	48
8	56	28
8	56	44
44	-16	36
4	-28	68
64	-4	28
40	-28	60
16	-32	68
24	-28	64
4	-20	56
48	-12	52
44	-24	56
60	-4	16
-48	28	12
-36	36	-12
-52	40	4
24	-16	-24
32	-4	-24
0	28	-4
0	20	-8
-12	36	-4

// Zandbelt B B, 2011: Healthy Control Siblings of Schizophrenia Patients
// Subjects=22
52	4	48
48	0	44
40	-4	44
40	20	-4
48	12	0
-16	-72	28
-24	-68	28
-16	-76	40
-40	-80	8
-44	-36	40
-52	-28	36
0	16	32
0	24	36
28	-68	32
32	-68	24
4	20	52
4	8	48
0	4	56
20	12	-12
-24	12	-12
-20	8	-8
-12	16	-12
-20	8	48
-48	-20	52
-52	-20	44
-44	-24	40
48	16	-4
40	20	0
32	24	8
4	8	44
24	12	-8
8	16	36
36	36	36
28	-4	64
40	8	32
32	36	28
0	28	32
32	48	32
4	24	36
0	32	24
48	8	24
36	-4	56
48	4	48
12	0	68
8	-4	64
16	8	4
36	20	24
48	32	32
28	-8	44
32	4	44
28	0	48
12	-8	4
-12	-4	60
12	-8	56
28	-64	32
64	-44	24
60	-40	16
24	-64	40
60	-44	8
32	-52	40
60	-40	40
16	-72	40
28	-68	20
32	-60	40
48	-76	4
28	-48	36
52	-48	32
52	-36	24
52	-24	-16
36	-72	16
52	-48	0
56	-32	36
48	-52	40
48	-32	-4
52	-64	-4
52	-48	-12
8	-68	56
40	-52	56
32	-80	4
36	-84	8
-28	-24	4
-36	20	-4
-36	40	32
-40	32	40
-28	48	20
-32	52	24
-32	-8	44
-40	0	32
-56	-48	4
-56	-48	32
-44	-40	40
-56	-44	44
-56	-36	24
-64	-28	24
-24	-72	20
-28	-76	16
-40	-80	0
-36	-84	4
-52	-60	-8
-48	-68	-4
-40	-72	0
-28	-52	36
-12	-72	36
-20	-72	40
-24	-64	36
36	60	-4
28	64	0
-4	60	0
0	24	-8
-20	24	44
-8	56	36
-4	68	16
-16	68	20
-4	48	44
-16	36	44
0	12	-12
-12	40	52
-8	24	4
8	40	-12
12	-56	4
-12	-60	8
-8	-48	28
-4	-64	20
32	-52	4
20	-44	16
-24	-16	-24
-20	-8	-20
-28	-28	-20
-40	-16	-24
-44	-72	24
-40	-80	28
24	-12	-24
12	-4	-24
64	-4	24
64	-12	36
-36	-32	64
-20	-36	68
-56	-20	44
-40	-24	48
-40	12	-36
-44	0	-36
40	-16	12
-52	28	12

// Zandbelt B B, 2011: Healthy Controls
// Subjects=22
-56	-44	28
-56	-44	36
-52	-28	40
-56	-32	32
-36	-24	32
-48	-36	32
-44	-60	36
-12	-20	4
-12	0	4
12	0	4
12	-20	8
8	-8	8
16	8	0
-12	-32	4
16	-32	8
20	-12	8
24	-20	8
32	-64	44
60	-36	28
16	-80	44
40	-36	36
-8	-80	40
-16	-84	40
-4	-64	56
-24	-52	60
-20	-76	36
64	-44	12
32	-44	44
52	-32	32
-20	-72	44
12	-88	32
56	-32	-12
48	-32	-8
-24	-64	56
52	-32	44
64	-48	32
52	-44	0
68	-20	-12
60	-24	28
-40	-8	48
-24	-4	52
-24	0	64
-24	-12	64
-20	-4	68
-16	-20	68
52	16	-4
36	24	-4
52	8	12
4	16	44
4	8	52
4	32	40
44	24	36
20	44	32
52	4	44
40	0	48
32	32	36
16	4	64
-8	36	36
52	4	36
52	8	28
16	-20	64
4	16	60
4	0	68
4	-12	64
40	20	48
16	-20	72
36	-4	60
32	48	24
4	16	28
8	-16	68
36	20	4
44	-76	4
36	-80	24
28	-76	16
52	-60	0
52	-56	-16
48	-48	-12
-28	40	36
-32	28	40
-40	40	24
-48	12	-8
12	-44	36
12	-28	36
16	-44	24
-24	-76	16
-36	-52	48
28	-4	8
24	0	4
28	8	0
16	8	12
28	-8	-8
32	-12	-4
44	16	48
24	24	56
24	32	52
32	32	44
28	12	64
24	12	52
-28	-4	4
-24	-8	12
48	28	24
56	24	28
40	56	8
16	-28	-12
-4	-32	-4
-44	-16	56
-52	-16	48
32	20	0
40	52	20
48	16	8
36	44	28
36	-4	48
40	0	44
24	-4	60
40	0	32
52	16	28
48	8	28
28	52	24
40	-4	60
52	20	20
20	0	8
16	8	8
44	0	56
20	4	68
12	12	4
40	16	48
48	28	28
40	32	32
36	24	36
-28	24	-8
-40	16	4
36	-52	36
56	-40	28
20	-72	36
48	-40	4
44	-52	36
56	-48	28
48	-60	0
56	-44	36
64	-44	16
52	-56	40
60	-4	8
52	-44	48
32	-72	20
44	-72	8
28	-68	56
4	28	36
-40	0	32
4	12	48
-4	8	48
-20	-8	60
8	16	40
-8	28	20
4	28	52
-44	-4	44
-44	4	20
8	32	24
-28	-64	36
-20	-68	40
-12	-72	36
8	-16	8
48	-24	-12
56	-28	-16
60	-24	-12
-56	-44	20
-60	-52	32
-56	-44	36
-64	-52	20
-56	-48	8
0	-20	-12
-32	52	28
-36	36	36
-40	48	16
-8	-56	8
12	-56	8
-4	-60	24
20	-48	8
-16	-52	0
36	-16	-20
8	-48	-4
16	-48	-4
28	-24	-16
-20	-28	-20
-24	-20	-24
20	-36	-16
-20	-4	-16
20	-16	-24
36	-40	-4
-24	-36	-16
32	-52	4
36	-32	-16
-20	-44	-8
20	-24	-24
-4	64	-8
-12	56	32
-16	32	44
0	48	-16
-12	68	8
-20	16	48
-4	64	24
0	44	-8
-4	52	44
0	68	8
12	40	-12
0	40	4
12	36	0
0	48	0
-40	-72	24
-48	-72	20
-40	-80	28
-28	-84	36
60	-8	-20
48	-4	4
52	-8	8
48	-12	12
68	-12	-4
-56	-8	-20
-44	0	-32
-48	12	28
-44	8	-36
64	-4	32
52	-12	36
-36	-12	12
48	-72	24
48	-64	20
-8	-36	64
8	-36	60
-52	-16	44
-40	-20	48
-44	-16	56

// Diaz M T, 2011: All Valid Sentences > Nonword Sentences
// Diaz M T, 2011: Metaphor > Literal
// Diaz M T, 2011: Congruent > Incongruent
// Diaz M T, 2011: Incongruent > Congruent
// Subjects=16
-54	28	2
34	26	-6
-38	20	14
28	20	-4
-10	58	24
-60	-32	2
50	-18	-8
-34	16	-18
-8	56	32
-58	-18	-14
-58	-42	4
-8	-12	42
30	-98	12
-46	34	-8
52	26	10
36	2	46
-6	34	46
6	52	-24
44	22	-22
-60	-40	-8
-40	-52	28
30	-92	8
0	-28	-10
-60	-4	-4
-46	-22	24
-38	-26	68

// Strother L, 2012: Finger vs. Rest
// Strother L, 2012: Wrist vs. Rest
// Strother L, 2012: Elbow vs. Rest
// Subjects=13
-48.6	-28.6	55.76
-41.15	-14.64	56.74
-39.96	-25.41	68.78
-45.43	-32.27	49.34
-50.74	-26.5	55.61
-40.09	-20.18	53.84
-35.79	-16.64	57.96
-34.69	-19.54	61.54
-47.59	-18.28	51.54
-42.23	-15.79	55.73
-39.98	-26.72	65.54
-50.78	-15.92	54.73
-42.22	-23.45	53.03
-37.92	-26.42	55.46
-35.74	-38.04	56.41
-38.97	-24.06	58.62
-33.57	-27.83	64.45
-38.96	-37.09	55.25
-47.49	-38.11	56.55
-29.38	-26.46	54.25
-32.56	-18.47	61.42
-29.34	-28.23	58.86
-34.67	-38.03	56.4
-39.03	-27.91	50.02
-36.79	-34.62	59.48
-44.34	-32	52.66
-37.93	-31.97	52.58
-35.75	-34.87	56.14
-29.27	-40.75	62.14
-32.55	-27.19	58.81
-29.28	-38.63	61.96
-25.08	-33.83	54.82
-28.3	-32.97	52.55
-26.13	-24.87	60.77
-25.1	-19.74	58.1
-22.92	-22.65	61.66
-30.37	-37.75	59.67
-29.34	-28.23	58.86
-31.48	-34.84	56.09
-34.69	-31.69	55.86
-25.11	-28.72	52.16
-28.25	-32.45	59.2

// Chevrier A, 2010: Post-Error Slowing Activations
// Chevrier A, 2010: Post-Error Slowing Deactivations
// Subjects=14
-8.64	31.95	-4.42
21.49	46.33	27.49
32.28	39.76	37.95
20.07	41.58	-20.05
12.41	-12.95	73.82
57.78	2.19	4.01
-59.75	3.86	8.56
-47.52	-53.77	46.71
67.52	-16.27	12.13
58.77	-5.26	-9.88
-58.79	-1.65	-7.72
48.98	1.77	-28.2
-47.21	4.28	-28.42
46.97	-76	-42.84
8.55	-15.33	-11.8
-7.47	-16.49	-11.52
-17.98	44.58	35.89
28.66	20.14	-22.81
-18.34	17.83	-20.97
7.05	-35.16	62.37
-10.03	-38.34	63.94
-44.38	-67.55	33.33
17.55	-100.7	11.98
-18.15	6.6	-1.07
23.43	1.5	-15.61
-27.84	3.57	-11.85
-12.79	-.86	-1.62
17.08	-13.25	-13.19
-19.26	-12.5	-13.95

// Georgiadis J R, 2010: Stimulation > Non-Stimulation Without Erection 
// (Activations)
// Georgiadis J R, 2010: Stimulation < Non-Stimulation Without Erection 
// (Deactivations)
// Georgiadis J R, 2010: Stimulation > Non-Stimulation With Erection 
// (Activations)
// Georgiadis J R, 2010: Stimulation < Non-Stimulation With Erection 
// (Deactivations)
// Georgiadis J R, 2010: Correlation between Regional Cerebral Blood Flow 
// (rCBF) and Penile Circumference (Activations)
// Georgiadis J R, 2010: Correlation between rCBF and Penile Circumference 
// (Deactivations)
// Georgiadis J R, 2010: Correlation between rCBF and Rate of Circumferential 
// Change (Activations)
// Georgiadis J R, 2010: Correlation between rCBF and Rate of Circumferential 
// Change (Deactivations)
// Georgiadis J R, 2010: Correlation between rCBF and Subjective Sexual 
// Arousal (Activations)
// Georgiadis J R, 2010: Correlation between rCBF and Subjective Sexual 
// Arousal (Deactivations)
// Subjects=16
20	-42	64
-6	-16	62
34	-20	44
-24	-4	58
50	-32	16
-48	-38	26
-8	2	36
-18	-52	6
48	24	-2
-48	2	2
-44	-62	8
32	24	8
30	14	0
-30	-20	10
-30	6	-4
32	0	-6
12	-4	12
-56	30	18
38	64	0
-44	52	-14
8	64	10
6	48	-16
-48	0	58
-2	-58	42
42	-86	26
26	-92	28
70	-22	10
-60	-2	-20
20	-38	64
-16	-34	60
-6	-16	60
22	-8	58
18	32	38
-32	32	-8
48	-38	16
-50	-22	22
2	0	44
54	0	4
-48	-4	10
46	-70	8
-44	-64	6
16	-80	6
-26	-68	4
34	18	8
32	-4	6
-22	4	6
16	-2	-6
-20	8	-12
-2	4	68
-42	30	-20
4	44	-14
2	40	4
-2	22	-18
-18	-20	-16
-2	0	-12
8	-38	72
4	-10	60
40	-6	54
16	12	60
42	-34	22
-4	16	24
50	0	8
-50	-2	-2
-22	-44	4
-36	6	0
34	-14	18
34	-26	20
-34	-14	-2
-30	0	2
32	0	-6
12	-4	-6
56	36	20
-54	32	20
40	62	6
-44	56	-10
14	72	0
42	-86	26
-30	-98	12
66	-8	-8
-62	-8	-16
-28	-40	-6
20	-42	68
-18	-40	58
36	26	26
52	-26	-2
-52	-22	14
2	2	44
4	-34	24
56	0	4
58	-58	8
-54	-62	10
32	28	-2
-34	30	-4
-18	10	-8
16	-2	-6
-4	24	54
-2	28	-12
-30	-2	-16
-4	2	-10
6	-42	64
-20	-42	60
8	-10	60
-4	-12	64
26	-26	54
-24	-28	54
-10	16	46
-34	48	16
-44	-22	24
16	-48	64
-10	2	38
48	-2	8
-50	-4	6
32	22	2
32	16	-6
-38	2	-10
30	0	-8
10	34	-22

// Johnstone T, 2012: 49 > 44 C; Modulated by Fit to Pain-Experience Function
// Subjects=14
45.94	13.33	-2.37
-4.26	-14.18	-9.52
6.82	11.91	51.73
4.61	-27.25	27.16
-32.08	16.03	-1.7
60.25	-39.35	30.88
4.58	0.93	33.72
18.16	5.5	-4.74
19.39	-10.38	9.96
27.87	-27.56	-6.54
47.24	-16.13	15.7
-15.91	-12.08	4.93
58.85	-32.92	-9.79

// Dichter G S, 2012: Anticipation, Controls > ASD (Money Trials)
// Dichter G S, 2012: Anticipation, ASD > Controls (Money Trials)
// Dichter G S, 2012: Outcome, ASD > Controls (Money Trials)
// Dichter G S, 2012: Anticipation, ASD > Control (Face Trials)
// Dichter G S, 2012: Outcome, ASD > Controls (Face Trials)
// Subjects=16
-4	6	-4
24	4	-20
0	-2	24
-30	38	-2
30	58	16
-26	38	-14
20	50	-16
40	-68	24
54	-30	16
38	2	40
10	12	-14
-4	22	-8
64	-28	40
58	-42	32
-62	-44	40
46	-22	-14
-48	-36	-6
24	-12	-30
-8	-20	54
46	6	-28
54	12	4
-48	14	6
-24	2	52
14	-10	72
-40	46	18
44	10	-6
26	-62	4
-10	-76	4
8	-62	4
50	-76	30
26	-64	34
18	-80	42
46	-8	12
-46	16	-4
40	22	2
56	2	44
24	10	-6
22	-4	-32
-26	-4	-30
4	-36	4
-20	54	28
-14	-40	4
32	-66	8
-36	-66	8
36	-58	-6
-34	-2	18
-36	-32	28
-34	-38	10
24	-52	24
-28	-62	14
-56	-54	-14
42	-58	16
44	6	52
0	18	60
-26	4	60
38	14	-6
-30	12	-12
-42	14	-4
-8	-76	4
10	-56	-2
18	-82	42
-20	2	-4
-10	-34	-16
-18	-62	16
32	-2	4
-28	-4	8
-46	-58	8
52	6	-20

// Fernandez-Corcuera P, 2013: Depressive Bipolar Patients
// Subjects=41
-44	4	28
-42	-44	42
36	-54	44
32	-62	-32
-22	-4	8
-6	-50	10
2	54	-8
44	-12	8
-30	-56	-34
-34	-2	50
10	-64	64
-4	38	-10

// Fernandez-Corcuera P, 2013: Healthy Controls
// Subjects=41
-42	14	28
46	-44	44
-6	52	-8
0	-46	30
46	-8	-6
-44	-78	34
38	-26	70
-30	-56	-34
-34	-2	50
10	-64	64
-4	38	-10

// Garrett A, 2011: Healthy Controls
// Subjects=19
62.67	37.06	5.25
60.54	37.26	7.5
40.58	15.19	48.13
-43.58	-42.3	46.29
-43.65	-40.59	41.64
57.01	-31.24	55.8
47.33	-54.98	54.96
55.9	-27.09	54.29
-30.67	21.95	55.4
-60.2	22.44	27.84
-32.88	21.52	50.99
-60.21	22.33	26.73
-45.75	-40.19	46.11
-43.65	-38.47	41.42
40.55	12.75	45.01
-53.67	18.41	30.36
3.83	25.91	49.93
-.45	23.97	52.44
16.64	-81.37	15.51
29.49	-65.78	9.26
-60.53	-54.46	-13.85
-56.23	-54.65	-16.15
-58.25	-68.92	-7.98

// Garrett A, 2011: Psychotic Major Depression Group
// Subjects=16
61.02	12.41	40.21
61	16.67	39.79
58.54	13.31	15.51
-43.65	-40.59	41.64
-43.62	-40.39	43.86
36.4	-62.54	43.56
38.55	-60.41	43.32
49.38	-40.5	49.01
-50.57	21.74	19.9
-55.84	18.3	29.29
-53.51	20.72	43.58
10.13	36.59	37.56
10.13	36.59	37.56
62.78	20.35	10.26
62.84	17.58	15.02
31.81	20.82	39.88
34.01	18.9	42.27
33.32	19.24	-11.54
38.52	-58.49	40.89
40.71	-60.4	43.28
40.71	-60.4	43.28
-43.57	-35.61	48.98
-28.34	-73.09	49.07
36.36	-58.5	40.92
8	36.79	39.82
7.89	42.55	32.53
7.99	38.92	39.61
-52.65	15.77	25.01

// Garrett A, 2011: Nonpsychotic Major Depression Group
// Subjects=15
56.13	44.27	2.4
62.8	35.87	15.45
38.44	6.57	47.9
45.08	-46.89	49.71
-37.2	12.79	49.69
-46.32	33.25	16.44
12.28	38.72	37.32
10.15	38.92	39.57
-48.47	31.12	16.69
-52.25	-35.95	45.8
-45.82	-38.47	41.46
-20.27	-102.51	-1.94
-20.23	-104.43	0.49
-22.43	-102.52	-1.9
-60.54	-52.33	-14.07
-52.86	-73.37	-9.87
-58.39	-54.66	-16.11
-52.84	-71.03	-7.86
64.78	-49.76	-16.45
60.44	-52.11	-18.39
64.86	-51.37	-10.69
53.67	-40.69	46.71
49.27	-42.39	40.23
-11.73	10.52	12.5
14.17	10.4	9.83
16.18	14.79	-.72

// Kleinhans N, 2010: Autism Spectrum Disorder (ASD) Patients
// Subjects=29
-28	-92	-6
34	-70	-16
-36	-62	-18
24	0	-16
-20	-6	-16
44	20	22
-38	6	28
40	-62	18
-16	-64	12
-44	20	20
48	-48	-18
22	-2	-16
-58	-32	-2

// Kleinhans N, 2010: Healthy Controls
// Subjects=25
22	-92	-10
-40	-60	-14
38	-52	-22
18	-10	-12
-18	-8	-14
52	24	26
-44	20	24
52	-44	10
-16	-64	12
-44	20	20

// Lee T W, 2013: Healthy Controls
// Subjects=14
16.46	6.77	53.17
-23.05	4.59	56.03
37.8	-2.25	44.76
36.46	46.59	29.52
-42.32	4.13	51.83
-32.66	13.42	60.98
-38.58	49.11	0.06
63.29	13.8	29.73
-39.71	50.71	-6.75
50.42	11.09	23.42
-45.81	13.26	18.77
49.52	1.88	42.04
-48.94	4.15	25.14
-34.8	-5.34	52.54
14.34	6.93	55.41
-6.09	21.9	44.35
8.82	24.82	39.47
5.73	5.13	46.74
-1.81	9.95	40.84
9.91	21.74	40.83
-7.14	13.35	43.96
29.41	-55.6	43.75
-22.93	-67.8	42.03
38.99	-63.63	35.39
-36.79	-54.34	52.21
35.52	-56.53	3.61
-35.82	-49.9	40.68
8.13	-70.19	49.68
-7.88	-67.82	54.13
52.45	-36.13	-9.45
-44.68	-55.32	-1.15
-68.33	-21.8	-5.92
52.46	-51.45	-14.85
-48.88	-68.84	3.38
25.92	-60.73	5.19
-14.64	-69.26	8.6
46.02	-46.29	-16.33
-43.64	-62.17	-7.27
-28.39	-72.29	25.74
54.69	-65.81	-8.1
3.72	-95.7	22.87
-34.95	-77.21	3.92
2.45	-96.71	-3.79
1.34	-92.74	-7.46
34.13	21.46	-6.26
27.78	20.96	1.66
24.68	-8.67	4.18
-17.04	-8.37	-2.05
17.26	0.69	15.75
-14.82	-.82	12.9
19.39	-13.64	9.12
-14.85	-8.82	5.76
9.56	-30.19	-25.07
-13.92	-22.41	-18.76
10.71	-18.41	-10.45
-8.51	-20.55	-8.94
7.46	-60.58	-32.53
-38.49	-58.74	-32.16
10.72	66.27	24.82
-15.79	49.59	45.48
1.94	47.36	-12.52
-0.03	56.8	13.47
22.74	-46.23	14.05
69.7	-41.09	7.5
-52.39	-6.18	-11.87
51.19	-6.33	-23.08
-51.42	-7.12	-24.07
44.63	2.03	-38.21
-31.24	-5.02	-40.09
21.25	-11.08	-26.8
-36.62	9.92	-39.05
8.46	13.39	-11.98
-15.06	23.02	-9.17
27.52	3.96	-39.29
-33.39	-2.92	-40.24
39.77	-18.29	15.97
-37.88	-86.46	35.96
-14.68	-94.95	-7.09
9.61	21.91	1.79
-5.3	16.88	6.85
-25.79	-7.14	-26.59
-31.39	-63.65	55.16
-33.6	-53.43	49.87
-58.51	14.47	35.54
71.85	-43.11	8.76
28.57	7.14	-39.57
-30.26	8.3	-46.79
-22.6	-4.03	-28
42.68	61.12	10.39
23.29	60.43	-10.52
29.9	69.13	18.79
-49.07	41.16	22.04
-56.53	-48.67	-10.49
48.46	-85.97	7.05

// Lee T W, 2013: Depressive Patients
// Subjects=14
-31.39	-63.65	55.16
-33.6	-53.43	49.87
-58.51	14.47	35.54
71.85	-43.11	8.76
28.57	7.14	-39.57
-30.26	8.3	-46.79
-22.6	-4.03	-28
42.68	61.12	10.39
23.29	60.43	-10.52
29.9	69.13	18.79
-49.07	41.16	22.04
-56.53	-48.67	-10.49
48.46	-85.97	7.05

// Newman S D, 2011: Number Easy vs. Fixation
// Newman S D, 2011: Number Hard vs. Fixation
// Newman S D, 2011: Word Easy vs. Fixation
// Newman S D, 2011: Word Hard vs. Fixation
// Newman S D, 2011: Word > Number
// Newman S D, 2011: Number > Word
// Newman S D, 2011: Hard > Easy
// Newman S D, 2011: Interaction
// Newman S D, 2011: Number Easy Correlation With Reading Span
// Newman S D, 2011: Number Hard Correlation With Reading Span
// Newman S D, 2011: Word Easy Correlation With Reading Span
// Newman S D, 2011: Word Hard Correlation With Reading Span
// Subjects=15
32	-50	44
-38	-46	48
-28	-64	46
-4	16	46
-8	4	14
26	-62	-30
12	8	12
-32	2	54
-48	2	36
-38	-46	48
-30	-60	42
-14	-2	0
-4	18	48
32	-50	42
-4	-24	-10
10	6	12
-48	2	36
-30	4	54
28	-2	58
-2	10	46
-18	-10	2
24	-28	-2
12	-76	-14
-12	-90	-4
34	-50	46
34	-54	-28
-44	-44	50
-28	-64	50
2	-70	52
-34	-52	-28
-24	-30	8
-46	2	32
-32	2	56
-4	10	48
-32	2	54
-46	-42	46
-32	-58	42
-36	-56	-16
34	-54	50
32	-56	-28
12	-74	-16
-54	12	26
-14	-90	-4
30	18	0
-16	2	2
4	-72	52
-28	18	0
12	-8	-2
8	-48	-12
26	-2	58
-4	6	58
-30	30	2
-36	10	32
24	-68	-6
-14	-76	-10
6	-86	2
2	-52	-28
8	-8	-6
46	-32	2
22	10	8
-24	-42	6
-54	-30	40
-42	-4	20
22	-42	12
-12	36	8
36	-40	50
-20	6	64
-30	2	66
-4	12	52
-32	-52	36
-46	-50	44
-52	-46	50
30	10	62
20	6	60
24	4	68
-10	-64	48
-30	50	8
-36	58	12
-2	-30	-22
38	32	46
46	38	30
30	-54	-30
10	-70	-26
-40	-68	50
18	-94	4
-24	-52	36
-22	-96	2
8	8	52
-34	-68	6
16	-92	0
8	8	52
-12	-16	8
-12	-10	18
44	10	20
-24	-98	0
-34	-70	6
34	-76	-4
-52	14	40
-42	26	-6
-48	10	12
24	-76	6
8	52	52
-24	-98	0
0	0	72
-48	8	30
26	-100	2
24	-78	4
40	8	24
44	-30	46

// Preusse F, 2011: Task Difficulty (Diagonal > Horizontal > Vertical > 
// Identity)
// Preusse F, 2011: HI-FluIQ > AVE-FluIQ
// Preusse F, 2011: AVE-FluIQ > HI-FluIQ
// Preusse F, 2011: Task Difficulty * Fluid Intelligence
// Subjects=18
-36	-44	40
38	-78	36
-28	-4	62
28	12	52
-52	8	26
-52	-68	0
-28	-58	56
22	-66	46
6	50	6
52	-70	28
-10	-80	48
-48	-70	2
54	-64	0

// Vizueta N, 2012: Healthy Controls > Depressed Bipolar II Patients, Match 
// Emotions vs. Match Forms
// Subjects=21
-32	40	-8
26	16	-20
-2	42	-16
-26	48	-12
-42	0	40
38	-12	6
-36	-14	16
-2	44	-8
2	44	-8
-2	30	18
26	-2	-16
-36	-14	-16
34	-20	-12
26	8	-8
-56	-22	-12
60	-10	-10
60	-40	20
64	-38	14
52	-58	22
-52	-52	40
-50	-54	32
60	-52	24
-4	-82	-8

// Contreras J M, 2012: Categorical Knowledge (Non-Social > Social)
// Contreras J M, 2012: Feature Verification (Object > Person)
// Contreras J M, 2012: Categorical Knowledge (Social > Non-Social)
// Contreras J M, 2012: Feature Verification (Person > Object)
// Subjects=19
-46	-36	44
-58	-60	-4
6	12	22
-48	6	18
14	-18	68
42	-10	24
-44	38	12
-24	10	56
-48	-52	-12
-40	32	14
-4	-58	28
-8	56	34
-4	48	-8
-50	-10	-22
60	-2	-22
-56	-60	24
56	-56	18
-12	-96	-4
-26	-74	-16
-10	38	50
-2	58	22
-56	-4	-24
38	22	-22
-56	-64	26
54	-12	-32
-40	20	-16
-4	0	6
44	30	-8
62	18	16

// Ebisch S J, 2012: High-GF > Low-GF
// Ebisch S J, 2012: Induction Conjunction Analysis
// Ebisch S J, 2012: Visualization Conjunction Analysis
// Subjects=10
24.98	8.68	49.56
47.02	20.02	1.52
-43.71	30.45	20.65
-26.2	-64.02	36.17
-27.34	-76.94	20.54
-29.79	-56	-11.3
31.08	-46.12	-12.82
-49.71	-42.24	44.65
48.55	-42.16	36.83
4.49	24.19	31.77

// Greimel E, 2010: Other > Control, Correlations with Age
// Greimel E, 2010: Self > Control, Correlation with Age
// Greimel E, 2010: Self vs. Other, Correlations with Age
// Greimel E, 2010: Other > Control
// Greimel E, 2010: Self > Control
// Greimel E, 2010: Self > Other
// Greimel E, 2010: Other > Self
// Subjects=15
28	-68	48
42	-48	54
8	-38	14
-6	64	-4
4	54	-14
-32	-4	66
-36	8	60
-12	22	64
-34	2	64
-46	-20	60
-2	-48	34
12	-50	32
-62	-40	32
-48	-68	24
64	-58	18
-52	-56	8
68	-46	2
-52	-24	-28
48	-20	-32
50	12	-36
22	-12	-24
-6	-60	34
10	-52	34
40	-78	-36
-2	62	10
-14	48	36
54	30	-6
0	-18	38
-48	-66	28
64	-46	20
-56	-64	22
54	-36	-4
52	8	-36
44	18	-34
-2	-50	30
-2	-58	34
12	-50	28
-4	-68	20
-6	-62	2
10	-62	0
34	-78	-38
-30	-84	-36
-4	54	10
-14	48	38
-42	12	46
-48	22	12
-52	-50	48
-56	-64	30
-60	-40	-8
28	-80	-38
-38	-24	-28
-26	-52	-10
-30	-30	-24
-28	-86	-16
-28	-94	-4

// Hampshire A, 2011: Normals (Experiment 1)
// Subjects=16
-30	24	-2
30	28	0
-28	-2	60
-44	48	16
26	4	54
48	44	22
-4	16	48
-28	-48	48
30	-68	36
-10	4	2
12	4	0
-30	52	-2
36	60	16
-32	54	20
-44	28	38
44	46	20
50	24	32
8	-56	58
-26	-56	56
22	-60	46
-46	40	0
-46	30	16
-40	40	-16
-44	-50	-8
-28	-66	32
-22	18	60
-32	60	16
16	64	-2
-26	44	36
36	58	-2
42	22	38
44	46	20
14	-68	44
-16	-54	44
44	-48	48
-46	40	0
-40	40	-10
-62	-52	-8

// Hampshire A, 2011: Normals (Experiment 2)
// Subjects=21
26	-54	50
-28	-54	48
-16	48	4
30	30	42
26	60	2
-28	-46	-18
-40	36	-12
-48	36	8
-48	46	4
-10	50	22

// Hasenkamp W, 2012: Aware > MW
// Hasenkamp W, 2012: Shift > MW
// Hasenkamp W, 2012: Focus > MW
// Hasenkamp W, 2012: MW > Shift
// Hasenkamp W, 2012: Positive correlation between practice time and aware 
// phase
// Hasenkamp W, 2012: Negative correlation between practice time and shift 
// phase
// Hasenkamp W, 2012: Positive correlation between practice time and focus 
// phase
// Subjects=14
-44.44	-27.57	41.13
41.68	1.33	-5.77
-8.3	9.05	29.84
-33.2	22.03	-6.65
-5.4	-20.42	-21.25
-29.21	-50.01	66.26
-28.83	53.8	18.52
45.86	59.74	6.01
-12.56	-6.2	25.59
26.84	-11.74	5.53
60.38	-38.06	47.5
-46.32	-53.45	64.51
45.07	41.78	35.4
46.11	38.19	30.12
52.67	-28.36	22.24
-17.79	-58.91	18.92
-51.86	-13.82	54.56
27.2	-95.9	18.16
16.4	13.83	48.11
-36.91	-83.08	24.51
53.88	-77.42	20.76
1.94	34.16	-18.11
28.87	-29.39	-16.43
-52.35	-10.07	-7.08
-26.89	-9.68	-31.94
-46.21	-8.46	-41.86
4.7	-5.45	47.63
17.96	57.23	-10.19
-61.92	-14.08	-3.03
-20.34	-.53	-10.48
36.29	-45.26	-29.68
46.17	-42.55	4.55
-48.89	-20.68	20.53
32.99	14.08	-19.01
-11.69	-59.84	-21.22
-61.9	24.62	15.77
-9.04	-5.04	67.83
36.42	-0.05	4.44
8.56	-61.37	-29.13

// Jack A I, 2013: Social > Rest, Mechanical < Rest
// Jack A I, 2013: Mechanical > Rest, Social < Rest
// Jack A I, 2013: Social > Mechanical
// Jack A I, 2013: Mechanical > Social
// Subjects=45
-.58	-55.4	35.16
-0.02	51.34	11.7
-53.99	-36.81	46.48
-37.96	-44.37	43.58
-40.57	36.38	14.54
14.43	-98.72	24.12
28.89	-82.91	-34.25
-22.41	-78.99	-33.99
-53.99	-65.41	34.38
-60.51	-59.96	22.84
56.02	-56.55	29.03
3.46	-57.78	4.08
2.61	-54.41	33.92
4.17	-54.94	-41.89
-5.07	-46.65	11.06
65.45	-44.12	10.03
7.67	-38.63	3.54
-54.34	-39.35	-.14
-36.04	-31.27	20.16
-8.46	-32.1	-6.85
19.29	-27.87	-9.76
56.71	-27.48	-7.99
-60.85	-27.21	-7.78
2.56	-18.66	42.08
-20.31	-18.85	-13.41
57.69	-16.27	-14.52
3.37	-14.8	9.4
72.63	-13.09	-16.07
23.5	-12.07	-12.25
-54.58	-6.71	-18.49
52.18	1.71	-29.34
-50.43	3.03	-30.51
35.12	14.09	-19.04
-37.57	13.4	-21.49
40.3	13.47	-41.35
4.76	24.82	67.4
3.12	18.81	-10.14
57.76	23.94	9.99
53.39	25.09	-2.32
-46.06	26.01	-9.07
19.48	36.68	40.59
15.29	41.91	53.58
2.97	42.54	-19.94
-1.06	53.88	17.08
20.46	55.55	36.76
5.53	55.72	40.26
-14.88	58.88	27.97
43.28	-78.83	31.04
-23.96	-68.43	47.67
36.96	-67.98	48.05
19.91	-65.46	54.72
-11.05	-64.16	60.55
38.42	-68.39	-40.04
-54.31	-62.07	-4.93
62.12	-57.48	-11.11
-18.64	-46.74	52.48
40.37	-51.69	-58.19
-30.86	-46.15	-7.65
-46.46	-41.79	50.15
44.37	-40.1	50.09
33.24	-43.65	-8.6
59.28	-33.93	46.05
16.53	-33.21	45.37
-62.6	-32	40.6
-12.36	-30.47	42.12
-23.02	-10.47	53.95
-38.39	-9.3	1.61
43.88	-5.63	0.36
-.78	0.72	31.57
-23.05	5.73	57.05
26.1	5.94	55.36
-50	4.23	26.26
52.54	5.39	18.3
-29.9	15.33	2.8
-3.95	26.4	47.29
-43.74	35.65	19.09
45.99	40.25	15.45
-47.05	42.18	7.43
44.76	51.73	-1.11

// Luo J, 2013: Experiment 1 Normals
// Subjects=19
1.38	-75.94	3.4
55.83	-49.72	7.27
-2.28	57.79	-1.08
1.41	-29.47	26.27
4.47	-17.79	11.87
-56.32	-43.28	18.05

// Mannie Z N, 2010: Load Response Activity, FH Participants > Healthy 
// Controls
// Mannie Z N, 2010: Quadratic Load Response Activity, FH Participants > 
// Healthy Controls
// Subjects=15
-50	-78	4
52	0	0
-6	-68	54

// Oei N Y L, 2012: Emotional > Neutral Distractors
// Oei N Y L, 2012: Neutral > Emotional Distractors
// Subjects=40
42	-62	-12
-52	-70	12
-36	30	-2
52	30	4
22	-4	-18
-30	-10	-36
54	8	-32
38	0	-16
62	-4	-4
-66	-28	8
24	-26	70
-24	-30	66
42	52	-10
0	-70	22
30	-94	-10
-30	22	54
24	38	46
50	28	32
-36	-60	38
46	44	16
54	-38	52
52	-22	56
36	-24	48
-24	34	34
46	-42	38

// Perlman S B, 2011: Controls > Autistic Subjects, Free Viewing
// Subjects=7
30.06	-57.76	-11.84
20.27	-6.8	-12.65
-24.68	-1.24	-19.29

// Sebastian C L, 2012: Affective ToM > PC
// Sebastian C L, 2012: Cognitive ToM > PC
// Sebastian C L, 2012: Affective ToM > Cognitive ToM
// Sebastian C L, 2012: Cognitive ToM > Affective ToM
// Subjects=15
8	-54	26
-6	-46	26
-54	-50	18
10	50	22
-8	54	0
50	8	-24
52	-48	20
-62	-10	-14
8	-60	26
-40	-80	22
50	-48	20
56	-6	-16
-62	-12	-12
-6	-52	26
4	-54	28
50	10	-24
-46	-54	-6
30	-44	-10
-20	-76	50
-22	8	52
24	8	52
-40	-8	30
-46	4	36

// Soto D, 2012: Cue-type effects - Verbal > Visual
// Soto D, 2012: Cue-type effects - Visual > Verbal
// Soto D, 2012: Cue repetition effects: (Valid + Invalid)/2 vs Neutral - 
// Conjunction Visual and Vebal
// Soto D, 2012: Cue repetition effects: (Valid + Invalid)/2 vs Neutral - 
// Verbal
// Soto D, 2012: Cue repetition effects: (Valid + Invalid)/2 vs Neutral - 
// Visual
// Soto D, 2012: Cue-validity effects: Valid > Neutral > Invalid - Conjuction 
// Visual and Verbal
// Soto D, 2012: Cue-validity effects: Valid > Neutral > Invalid - Verbal
// Soto D, 2012: Cue-validity effects: Valid > Neutral > Invalid - Visual
// Subjects=10
24	-96	2
-16	-98	4
-38	-44	-24
38	-78	6
-42	-72	6
30	-66	-14
-12	-40	-16
10	46	32
22	6	36
-8	-44	22
6	56	34
-40	-16	18
-14	32	56
-22	54	32
14	34	56
-50	22	2
-54	-8	-34
50	10	-20
-58	-30	-10
66	-32	-2
-28	-20	-24
30	-26	-24
-14	-56	32
-12	-20	-18
-12	-62	-32
-34	-40	18
22	22	24
28	-54	62
-36	-22	32
38	-22	14
-32	-80	-6
-50	-56	-8
34	-20	-12
-40	-74	2
-48	-76	18
48	-26	40
8	16	28
-14	50	-2
32	58	6
46	-4	-4
-32	8	14
-26	-34	-2
28	-24	4
-26	-16	-14
-28	-8	8
-10	20	-6
22	22	-2
16	-18	-22
-16	-26	-24
-16	-8	54
12	28	56
50	-34	14
34	-16	-12

// Tamm L, 2012: Fluid Reasoning, Controls > ADHD
// Subjects=10
33	-73	14
-8	-78	-31

// Tian F, 2011: Successful > Unsuccessful Preparation
// Subjects=16
-21.21	42.18	32.79
-52.98	-60.55	28.38
14.06	-76.17	-14.57
36.49	-10.28	9.76
-34.09	-11.22	3.96
-36.92	-20.59	48.27
1.58	-16.67	54.19

// Zarnhofer S, 2013: Story, Visualization
// Zarnhofer S, 2013: Formulation, Visualization
// Zarnhofer S, 2013: Story, Verbalization
// Zarnhofer S, 2013: Formulation, Verbalization
// Subjects=36
-12	-85	19
51	-73	1
-6	-67	7
36	-58	-5
-27	-37	4
36	-58	-5
-9	-55	67
27	-31	13
9	2	-14

// Osumi T, 2012: Negative Correlation: Psychopathy vs. [UG (unfair-fair)+DG 
// (unfair-fair)]
// Osumi T, 2012: Negative Correlation: Psychopathy vs. [UG (unfair-fair)-DG 
// (unfair-fair)]
// Subjects=20
-30	-58	54
-8	-8	0
28	2	-16
-36	-36	12
26	-16	-6
54	-12	-12

// Veit R, 2010: Anticipation of pain (High + Low Punishment)
// Veit R, 2010: Anticipation of pain, High > Low Punishment
// Veit R, 2010: Observation of opponent pain (High + Low Punishment)
// Veit R, 2010: Observation of opponent pain, High > Low Punishment
// Veit R, 2010: Retaliation of pain (High + Low Punishment)
// Veit R, 2010: Retaliation of pain, High > Low Punishment
// Subjects=10
69	-42	21
60	-18	30
-48	-63	0
51	27	9
12	-84	-12
-48	-87	-6
60	21	-6
-33	24	-21
-57	12	45
-9	-9	6
-45	0	54
51	-6	48
0	15	60
66	-24	30
-60	12	6
-39	24	9
15	3	3
-12	3	3
45	-63	-15
15	-99	18
-66	-12	-24
69	-18	-18
45	-45	-15
21	-33	-18
66	-42	12
12	-57	27
45	-45	27
60	27	-9
39	0	39
51	30	21
42	18	-6
9	42	51
-33	15	-12
63	-9	-15
-54	-69	15
-42	21	-9
66	-48	12
-63	-51	12
51	-48	-18
-3	69	-6
30	-6	-15
42	-75	6
66	-36	18
51	-51	-21
57	-36	45
-45	-54	42
27	-42	12
-30	-36	-18
66	-33	30
-21	-21	-18
45	-60	45
9	-12	-18
-42	24	9
-57	21	18
0	-21	39
-21	-6	-12

// Terasawa Y, 2013: Body Now > Possession Now
// Terasawa Y, 2013: Emotion Now > Possession Now
// Terasawa Y, 2013: Body Usual > Possession Usual
// Terasawa Y, 2013: Emotion Usual > Possession Usual
// Terasawa Y, 2013: Common Activations, Emotion Now and Body Now
// Terasawa Y, 2013: Coactivated Areas for Body Now and Emotion Now 
// (Conjunction Analysis)
// Terasawa Y, 2013: Coactivated Areas for Body Usual and Emotion Usual 
// (Conjunction Analysis)
// Terasawa Y, 2013: Emotion Now > Body Now
// Terasawa Y, 2013: Body Now > Emotion Now
// Subjects=18
-12	-72	-12
39	21	6
3	-48	-9
15	-72	-39
-24	12	24
-3	-18	33
51	45	-3
-9	-84	-18
-57	12	-12
-51	33	-3
51	18	-15
21	-84	-15
-60	-48	9
2	-60	-18
-9	75	-9
-18	-84	15
42	-75	12
39	-18	54
-36	-15	51
-18	-54	60
15	-51	54
-9	-72	-6
9	-84	-6
60	-27	36
-63	-9	27
27	-60	-15
-42	-63	-15
-18	-84	12
-39	-3	21
36	-39	69
54	15	-9
-51	-15	45
-54	-27	45
-60	-39	24
-20	36	-12
36	18	6
-3	-75	-3
-48	6	36
-33	-3	63
-6	9	57
-51	18	-12
-57	-42	6
54	18	-6
-51	-21	30
54	18	-6
-51	-27	3
36	18	6
-33	18	6
-9	-81	0
9	-87	3
-42	-27	57
-3	-3	57
-48	6	42
-24	-66	51
42	-87	3
-48	21	-9
-48	-57	26
-51	33	-3
-54	18	-14
-42	18	54
-1	-49	28
-1	58	21
-1	39	-1
57	30	10
-35	-14	52

// Fan L Y, 2014: Healthy Controls
// Subjects=23
24	45	-12
33	18	12
-9	21	24
12	30	18

// Fan L Y, 2014: Attention Deficit Hyperactivity Disorder (ADHD) Patients
// Subjects=25
30	15	12
-3	30	0
3	30	0
33	18	12
-9	21	24
12	30	18

// Rahm C, 2014: Affective Stroop (aStroop), Control
// Rahm C, 2014: aStroop, SSRI
// Rahm C, 2014: Counting Stroop (cStroop), Control
// Rahm C, 2014: cStroop, SSRI
// Subjects=11
-56	-70	22
-2	-60	10
-62	-54	-2
-24	-54	36
-44	24	40
-2	-60	10
-6	-50	28
-20	-12	-16
-26	-72	-16
-54	-16	56
-42	32	-2
0	6	46
36	14	38
-32	18	-2
42	-46	36
4	40	36
48	20	42
36	32	2
-32	18	-8
-48	14	6
-54	16	28
62	-54	-4
44	20	-12
-58	-46	-8
-14	-74	-46

// Adank P, 2012: Noise > Clear
// Adank P, 2012: Clear > Noise
// Adank P, 2012: Accent > Clear
// Adank P, 2012: Clear > Accent
// Adank P, 2012: Noise > Accent
// Adank P, 2012: Accent > Noise
// Adank P, 2012: Clear < [Noise + Accent]
// Adank P, 2012: [Noise + Accent] < Clear
// Subjects=26
32	28	10
-32	24	8
6	-14	28
-24	-40	-2
-12	10	-2
12	20	36
30	40	24
8	22	18
-40	-22	12
-40	-20	54
34	-22	10
-36	22	-26
34	42	-14
-54	-44	-6
14	-50	-20
-8	50	40
66	-42	-8
-54	-44	-6
-60	-12	-6
-14	56	40
14	46	16
-52	-56	46
32	28	8
30	42	28
-34	18	0
10	22	40
-8	34	24
-40	-20	8
46	-14	4
12	-72	6
32	36	10
-12	10	-2
-42	-24	16
-40	-20	54
-36	22	-24
-10	52	42
-62	-50	-6
-34	-68	36
62	-42	-8
-44	16	46
16	50	50

// Gillath O, 2012: Normals
// Subjects=39
10	12	0
-4	14	26
4	-16	42
-42	20	10
-34	18	-16
-38	28	-4
40	22	10
28	28	-10
-30	18	52
-56	-62	6
-54	-64	20
-58	-54	38
64	-48	32
-6	20	24
-32	18	-14
42	20	14
-36	20	12
50	-66	-6
-62	-40	-8
-54	-66	8
-8	-72	38
6	-58	48
12	-72	38
66	-46	30
-28	20	-10
-40	-40	42
6	66	12
60	12	36
58	6	42
34	4	52
38	-86	2
38	-60	28
20	-34	-6
52	-26	50
4	-44	18
12	-74	42
30	-68	40
26	44	36
-30	-66	52
34	-54	48
-10	-6	4
-8	22	32
14	-40	-4
-22	-98	12
50	10	32
36	32	-8
42	-78	-2
-36	16	12
4	18	46
-30	-8	58
-32	38	-10
-26	-90	8
-54	-68	8
30	-92	6
-18	-36	-6
6	-38	24
-44	-2	36
54	-2	52
48	16	8
-2	-66	46
-32	48	34
24	48	22

// Gillath O, 2012: Subgroup of Normals, Healthy heterosexual males
// Subjects=19
-56	-14	-6
-6	44	-8
34	-80	10
-40	-56	16
-6	-66	18
-22	14	-4
-2	34	16
4	10	2
10	12	-6
-4	20	26
2	-26	30
2	-18	34
2	-48	0
20	-2	-4
42	18	14
28	30	-10
36	16	0
42	48	28
46	12	34
32	44	24
-14	12	-6
66	-44	26
26	48	18
6	50	30
2	-18	10

// Gillath O, 2012: Subgroup of Normals, Healthy heterosexual females
// Subjects=20
-56	-14	-6
-6	44	-8
34	-80	10
-40	-56	16
-6	-66	18
-22	14	-4
0	20	22
8	8	8
12	2	16
-14	-4	20
4	-4	30
10	0	-2
-42	24	6
-48	14	16
-32	18	-14
58	20	16
44	-76	-4
-48	-58	46
-44	2	52
-34	-6	46
50	12	48
54	-64	4
-24	42	46
-28	52	32
6	16	52
10	48	40
12	58	28
-54	-52	10
-52	-56	34
64	-48	30
-8	-28	38
10	18	38
-10	-72	32
-18	-44	-10
-50	6	30
38	-84	-2
-42	-30	36
-30	22	4
-4	60	12
10	10	-18
-20	2	-14
18	2	-16
54	-26	52
-4	-58	18
6	-48	14
-34	-8	50
-46	-4	58
-24	-56	44
-10	-80	40
14	-48	48
10	-60	62
-18	14	-6
-20	48	34
-26	-68	52
30	12	-24

// Herrmann B, 2012: Univariate Analysis, grammaticality and perceptual 
// markedness contrast
// Subjects=25
-54	8	10
-60	-22	-2
-54	5	-14
57	-28	1
60	-4	-8
-45	-22	1
48	-22	7

// Huang C M, 2012: Incongruent vs. Congruent - Physical Size Task
// Huang C M, 2012: Incongruent vs. Congruent - Numerical Magnitude Task
// Huang C M, 2012: Older > Young - Physical Size Task
// Huang C M, 2012: Older > Young - Numerical Magnitude Task
// Huang C M, 2012: Older > Young - Physical Size Task and Numerical Magnitude 
// Task
// Subjects=15
44	24	2
-54	12	18
32	44	10
-38	8	34
10	20	42
14	8	42
-30	10	12
-48	6	44
-32	-50	48
38	-48	46
60	-32	50
12	-66	64
34	-56	60
-8	-46	-18
16	-48	-44
46	-28	6
-52	-50	14
-6	-22	6
52	20	14
-36	28	8
28	58	32
8	22	20
-32	50	36
40	56	8
16	-68	48
16	-68	50
-48	-38	44
-12	-70	42
62	-36	34
-30	-58	-36
36	-50	-32
-24	-72	32
-14	-24	10
-28	-18	72
32	-32	74
38	-6	66
6	-2	70
-4	30	-10
-24	12	-26
34	62	8
36	-44	54
-22	-44	-24
20	-68	-20
46	-28	14
-30	-62	42
38	-50	44
-32	-54	34
-12	-72	40
58	-32	0
-52	-6	52
-36	52	22
34	60	22
-10	-10	62
-60	-36	12
-20	-34	-26
12	-54	-22

// Isenberg A L, 2012: Sensory motor integration contrast
// Isenberg A L, 2012: Spatial hearing contrast
// Subjects=17
-58	6	20
-7	8	37
-41	-44	57
-31	30	0
-53	32	17
-52	22	12
-33	-19	35
-21	-13	7
-31	28	10
-50	-34	12
-37	-9	67
-25	11	-25
-35	20	-25
47	-12	45
49	5	2
22	12	2
62	11	7
26	-5	7
65	2	20
11	1	10
14	-18	10
34	-7	0
28	-3	-10
65	3	30
6	-5	12
55	-34	25
2	42	20
28	-21	7
61	-27	12
-45	-1	-5
-29	-27	15
-54	-1	-3
-52	-29	5
-17	-25	7
-58	3	32
-9	-17	2
-47	-11	12
-43	12	32
-17	-15	67
45	-33	72
22	3	56
51	-9	32
12	-60	20
38	-15	20

// Masten C L, 2012: Social Exclusion vs Control
// Subjects=21
42	27	-9
-45	18	-15
0	15	27
54	-69	3
63	-42	24
39	-51	-15
9	-54	60
-48	-72	12
-57	-48	27
42	3	54
0	54	15
45	24	24
3	54	39
6	6	9
-3	-30	-3
-15	-78	-30
-30	9	-24
-24	0	69
-39	-60	-12
6	-42	-36
-24	-72	36
-42	15	24
15	-3	-15
27	54	9
12	27	21

// Minamoto T, 2012: Distractors Forgotten - Remembered
// Minamoto T, 2012: Distractors Remembered - Forgotten
// Minamoto T, 2012: Memorandum Remembered - Forgotten
// Minamoto T, 2012: Functional Connectivity Contrast: Distractors Forgotten - 
// Remembered
// Minamoto T, 2012: Functional Connectivity Contrast: Distractors Remembered 
// - Forgotten
// Subjects=29
16.76	27.87	47.28
-17.8	29.98	48.78
-22.73	61.53	7.64
26.97	63.94	7.68
-6.55	-8.22	75.9
56.85	-59.8	37.34
3.97	-45.33	45.77
1.92	-70.76	49.45
10.75	-41.96	69.98
-66.56	-30.32	26.44
65.32	-52.3	25.25
-48.13	-61.52	24.73
-64.46	-50.5	17.2
-17.73	-67.92	34.93
3.85	-7.9	44.31
-2.72	-41.38	30.93
-20.55	-29.13	-9.2
22.67	-89.13	-21.93
-29.21	-85.06	-21.45
-39.79	-69.19	-.42
-29.36	62.6	-3.56
34.12	15.38	50.46
58.54	24.26	17.79
51.09	5.4	23.14
-4.65	6.29	58.74
30.07	-54.83	57.48
38.74	-50.24	60.24
-26.19	-44.71	54.07
50.75	-54.06	-15.79
-46.28	-58.37	0.86
42.74	-71.21	30.87
-41.56	-80.54	27.62
38.21	-90.32	10.42
20.94	-94.64	11.14
-22.64	-40.62	-5.78
-22.78	3.19	-7.88
13.86	-36.73	-23.6
14.01	-71.73	-19.02
31.36	-62.43	-12.39
-44.49	47.24	-6.26
-40.06	34.91	-.63
14.93	11.76	70.2
17.12	-6.63	68.62
-35.1	3.56	42.72
-10.94	-6.52	71.32
-10.88	-17.05	73.49
-15.21	-34.6	69.69
6.04	-16.4	45.12
42.28	-28.72	3.14
7.77	-38.21	6.91
-11.8	13.29	7.75
-22.65	17.3	5.29
29.22	-33.85	-5.1
50.35	16.26	-32.83
-7.65	-36.08	-15.45

// Bzdok D, 2012: (TR--AG) and (AT--AG) and (TR--HA) and (AT--HA)
// Bzdok D, 2012: (TR--AG) and (AT--AG)
// Bzdok D, 2012: (TR--HA) and (AT--HA)
// Bzdok D, 2012: (TR--AG) and (AT--AG) and (HA--AG)
// Bzdok D, 2012: (TR--HA) and (AT--HA) and (AG--HA)
// Bzdok D, 2012: AT--TR
// Bzdok D, 2012: TR--AT
// Bzdok D, 2012: TR and AT and HA and AG
// Bzdok D, 2012: Male AT- female AT
// Subjects=44
-2	57	17
-17	58	23
-54	24	6
35	-81	-38
-3	60	15
-3	39	-17
-50	27	0
-45	12	-41
-3	38	11
-2	-20	38
-3	-48	29
-24	-23	-18
-33	-12	-23
-29	-6	-21
-33	-6	-29
-27	-81	-39
-35	-80	-35
33	-81	-36
-2	57	17
-48	20	6
45	26	-8
-38	24	-20
29	18	-20
-5	-2	3
2	-17	5
-45	12	44
42	23	23
-45	12	-39
50	-62	38
33	-75	50
-44	-69	-42
-29	-81	-36
35	-81	-38
-11	51	-11
-41	24	-11
33	24	-6
41	21	-6
-53	32	15
42	23	23
33	47	11
33	-75	50
-41	-65	-41
33	-39	-12
-24	-44	-11
-12	-78	-9
-41	-78	15
-66	-39	-5
57	-51	15
57	-8	-17
-33	-8	50
29	-6	48
45	6	29
-5	8	48
5	9	48
-41	5	29
56	17	32
-32	-47	45
29	-57	42
-30	-50	48
29	-63	50
-20	12	-5
18	12	-3
-24	-92	-14
27	-86	-12
-8	-26	-6
8	-26	-8
-23	-26	-6
24	-27	-5
0	-23	11
5	-6	8
5	-20	12

// Gutchess A H, 2012: False Alarms: Positive Modulations (Lrg>Med>Small)
// Gutchess A H, 2012: False Alarms: Negative Modulations (Small>Med>Lrg)
// Gutchess A H, 2012: Hits: Positive Modulations (Lrg>Med>Small)
// Gutchess A H, 2012: Hits: Negative Modulations (Small>Med>Lrg)
// Gutchess A H, 2012: False alarms > hits
// Gutchess A H, 2012: Hits > false alarms
// Gutchess A H, 2012: Hits-Novel and False alarms-Novel
// Gutchess A H, 2012: All Hits - All False Alarms
// Gutchess A H, 2012: All False Alarms - All Hits
// Subjects=16
36	-38	-26
38	-10	-18
2	-64	10
16	-70	12
34	-24	58
14	24	0
-26	-48	58
58	-56	30
-60	-54	30
-54	-76	12
-48	-58	50
38	-90	-2
32	-76	32
-30	-92	10
38	-60	-14
-16	12	0
-28	-12	12
-24	14	12
36	-52	-24
-18	40	14
0	-42	-16
-14	-32	52
28	38	4
34	-38	-26
44	-74	-12
34	-52	-24
38	-16	-24
42	-18	-16
-34	-70	-16
-28	-92	8
-28	-86	2
10	-10	32
-4	-20	-8
-14	-34	26
-24	-28	24
-44	20	-12
-34	22	-12
-16	60	20
34	-24	56
64	-58	24
64	-54	34
-44	-66	6
-54	-72	14
46	-66	20
52	-68	14
-26	10	44
-20	18	48
28	-50	48
36	-60	44
12	-72	52
26	-52	-24
32	-44	-22
44	-52	-16
-22	-32	-32
-20	-48	-24
-30	-40	-30
24	-38	-20
26	-26	-10
-20	-92	10
54	10	44
58	2	34
42	4	22
8	26	48
14	0	54
-8	14	42
-42	24	30
-54	22	32
42	30	20
42	48	28
34	32	26
38	-6	50
30	-10	48
42	6	52
-14	-12	34
-4	0	6
4	-2	6
-12	4	6
64	-22	38
64	-20	28
64	-30	42
-50	-26	36
-56	-20	46
-28	-46	48
-44	-42	38
-26	-56	32
-42	12	40
-42	0	40
-50	10	36
10	-56	-22
2	-62	-20
12	-70	-18
42	24	40
38	24	48
46	18	50
-24	-58	-10
-24	-52	4
-14	-62	-20
-14	-64	-12
-18	-76	36
28	-8	-4
24	-8	-14
30	-62	-20
50	-18	32
48	-30	28
-14	-76	60
-8	-68	58
-14	-60	60
-28	-90	24
-20	-92	32
-16	-42	-26
4	-20	46
-10	-18	50
-16	-20	40
-26	-40	16
-26	-48	24
-22	-38	24
-26	-40	-6
32	-80	26
-50	-10	-8
-36	-16	-8
-44	-16	-6
30	40	-4
16	20	34
10	18	24
36	52	18
34	48	10
28	42	6
40	-16	30
28	-12	34
46	-10	26

// Hargreaves I S, 2012: Animal SCT > Concrete SCT
// Hargreaves I S, 2012: Concrete SCT > Animal SCT
// Subjects=15
-2.18	20.84	-21.6
-5.47	56.73	-20.71
-47.32	-34.44	12.42
-66.46	-23.89	-19.27
-48.22	-76.61	13.09
-59.96	-61.11	-7.88
-31.55	-36.34	-20.84
-2.85	-58.17	14.89
7.22	52.64	-20.5
24.66	-19.28	77.55
19.99	22.65	-29.62
71.04	-28.44	24.63
27.39	10.28	-43.25
67.85	-34.67	9.53
67.7	-10.81	-14.3
32.93	-39.6	-14.34
-1.01	37.31	40.53
-66.39	-6.07	30.56
59.3	4.3	26.89

// Kalm K, 2012: Encoding > Unmodelled Rest
// Kalm K, 2012: Load: Supraspan > Subspan
// Kalm K, 2012: Load: Subspan > Supraspan
// Kalm K, 2012: Ungrouped > Grouped
// Kalm K, 2012: Supraspan: Grouped > Ungrouped
// Kalm K, 2012: Subspan: Ungrouped > Grouped
// Subjects=23
-62	-26	2
-36	20	-2
-32	36	-8
-46	38	28
-54	4	32
-52	-38	36
52	14	-26
34	20	10
32	-40	-38
28	16	14
44	44	28
22	44	40
54	-20	38
-44	-20	6
50	-12	8
18	-104	2
-56	-6	-4
-42	22	-30
-42	-8	38
-34	38	-14
-34	44	20
58	12	-30
40	20	8
54	10	28
46	36	-6
-54	2	-2
62	-2	-6
52	8	-24
-56	-22	36
-48	2	26
-56	-30	16
-36	20	-2
-28	-2	-58
-38	54	14
60	-22	20

// Kalpouzos G, 2012: Encoding vs. Control, Young > Older, ANOVA
// Kalpouzos G, 2012: Encoding vs. Control, Young > Older, ANCOVA
// Kalpouzos G, 2012: Encoding vs. Control, Older > Young, ANOVA
// Kalpouzos G, 2012: Encoding vs. Control, Older > Young, ANCOVA
// Kalpouzos G, 2012: Retrieval vs. Control, Young > Older, ANOVA
// Kalpouzos G, 2012: Retrieval vs. Control, Young > Older, ANCOVA
// Kalpouzos G, 2012: Retrieval vs. Control, Older > Young, ANOVA
// Kalpouzos G, 2012: Retrieval vs. Control, Older > Young, ANCOVA
// Subjects=16
-10	58	14
36	32	-22
-10	-32	70
36	-26	68
16	-62	52
44	-26	58
64	0	20
-42	6	-26
-62	-52	12
52	14	-16
-18	-2	-26
22	6	-26
-12	-44	-6
-14	-94	14
-42	-74	12
34	-78	0
28	-50	-14
-16	-64	-48
-32	-60	-24
6	-62	-46
-10	12	-12
36	-12	12
-10	58	12
-10	-30	68
32	-26	68
44	-26	60
-42	6	-24
-52	-4	-10
48	12	-16
24	12	-26
-16	-90	14
14	-68	14
6	-92	0
22	-56	14
-12	-70	8
6	-78	6
-46	-74	12
34	-80	0
30	-46	-16
-16	-64	-48
6	-62	-46
-10	10	-10
34	-12	12
-18	-84	-34
-18	-82	-32
-32	-82	-4
34	-80	-4
16	-94	2
-32	-82	-4
34	-80	-2
-14	28	56
-28	30	40
-42	-12	56
38	-20	68
-62	4	16
-44	-64	52
-52	-30	36
-56	-36	52
52	-72	30
62	-28	40
60	-52	-8
62	2	-6
28	-76	42
38	-80	-26
8	-86	-28
-36	-70	-30
20	-74	-32
-16	28	58
-44	-66	50
-50	-28	36
52	-72	30
58	-50	-10
30	-86	-28
34	-82	-26
8	-86	-30

// Marvel C L, 2012: Manipulation (2 target -1 target) vs Storage (2 target -1 
// target) during delay
// Marvel C L, 2012: Manipulation (2 target -1 target) vs Storage (2 target -1 
// target) during delay, Deactivations
// Marvel C L, 2012: Manipulation (2 target - 1 target) vs Storage (2 target - 
// 1 target) during encoding
// Marvel C L, 2012: Manipulation (2 target - 1 target) vs Storage (2 target - 
// 1 target) during encoding, Deactivations
// Marvel C L, 2012: Negative correlation between BOLD and accuracy scores 
// during 2 target manipulation
// Subjects=16
-4	22	12
-42	10	30
-40	40	38
-30	26	-2
-36	18	2
-46	4	40
-4	8	66
-8	20	52
-10	18	42
10	18	52
-14	0	26
-14	-12	14
-44	-44	44
-38	-60	-32
-28	-72	38
-10	-70	52
38	42	26
48	34	38
14	26	26
6	24	10
52	24	28
26	18	26
64	14	-38
18	6	27
12	8	18
0	-2	8
0	-28	14
20	-30	2
36	-54	54
36	-46	46
28	-66	38
32	-60	-30
32	-70	-54
0	-76	4
-30	-46	76
-52	-72	42
44	-24	16
30	-32	66
58	-64	24
-18	46	-6
0	58	-8
-16	54	12
-12	38	2
-32	42	-34
-24	6	-4
-8	-48	36
-12	-60	10
-8	-62	28
-16	-88	14
20	46	-6
22	60	-14
20	44	-18
14	38	4
16	36	-12
32	40	-32
30	32	-18
24	16	0
36	12	-36
46	-54	12
8	-54	26
-46	4	-2
46	64	-18
-34	16	6
-40	6	28
-48	-46	-42
-26	-52	-34
-6	-56	-34
-42	-66	-40
-14	-74	-28
22	-62	-32

// Aue T, 2012: Favorite team vs. baseline, whole brain analyses
// Aue T, 2012: Least favorite team vs. baseline, whole brain analyses
// Aue T, 2012: Favorite team vs. least favorite team
// Subjects=13
0.38	-30.11	31.91
2.12	47.04	10.92
61.31	-49.37	25.02
-44.97	6.47	-14.13
-54.11	-57.89	21.48
-10.32	-89.67	5.8
-1.69	-50.38	31.4
52.32	-8.9	-15.07
46.1	33.61	26.04
57.93	6.99	24.79
50.1	30.81	-10.57
21.71	-93.08	0.14
-25.29	-29.46	28.8
-24.27	-67.29	7.43
29.78	11.86	-19.9
-4.89	-28.31	41.86
2.17	46.41	16.55
-7.42	-12.63	-2.92
54.69	-25.15	8.57
-53.11	-46.51	17.17
-10.34	-88.78	3.5
-1.69	-50.38	31.4
32.11	16.04	6.49
-39.67	29.13	-10.52
3.6	-16.8	38.56
57.93	6.99	24.79
3.2	-53.92	-28.58
44	-71.42	-10.85
34.16	-52.93	-32.36
41.85	34.99	30.43
-23.44	-37.9	-11.77
20.6	-90.25	-4.54
-34.38	52.77	-8.1
1.13	-70.76	-26.03
-40.42	23.58	27.88
-23.2	-67.28	7.42
29.45	-58.43	48.45
-35.06	-65.12	-4.89
-1.09	60.14	15.44

// Moseley R, 2012: All emotion words > Baseline
// Moseley R, 2012: Abstract emotion words > Baseline
// Moseley R, 2012: Experimental words
// Moseley R, 2012: Face words
// Moseley R, 2012: Arm words
// Subjects=18
-56	4	24
-50	-10	44
-44	26	-2
60	2	38
8	22	52
-8	22	38
6	40	10
-10	54	12
-28	34	-5
-56	-34	2
-38	-44	-14
-40	-62	-12
-48	-34	38
-52	-38	30
8	-62	2
-2	-70	2
-56	4	24
-48	-12	40
-56	-8	44
56	0	40
60	2	24
-10	56	12
8	52	8
-60	-34	2
-40	-40	-14
-44	-74	-8
-48	16	-26
50	-32	24
36	-64	2
16	-50	64
28	24	6
34	-16	22
-54	-8	42
-56	4	20
-34	0	32
-30	26	10
-42	28	-4
-42	28	6
-6	18	40
-4	-2	60
60	2	38
12	18	44
-56	-34	2
-40	-40	-18
-60	-36	24
-62	-18	20
-56	-22	32
66	-36	30
-50	-2	42
-56	4	12
-54	6	34
-30	28	0
-28	22	8
-6	14	40
6	12	34
62	10	12
30	30	4
30	22	6
-64	-20	-18
-52	-56	2
-40	-42	-18
-44	-50	-28
-56	-38	26
62	-36	30
-44	-80	-8
-54	-8	42
-62	-36	22
-46	24	16
-8	20	38
-8	0	62
-28	-6	52
58	2	38
64	2	12
40	22	-4
-52	6	-8
-46	14	0
-34	-18	12
-46	-38	2
-40	-42	-20
-44	-60	-12
-48	-32	40
68	-40	28
4	-44	-34

// Greck M D, 2012: Intentional empathy for familiar angry > baseline - 
// transcultural constants
// Greck M D, 2012: Intentional empathy for familiar angry > baseline, Chinese 
// > Germans
// Greck M D, 2012: Intentional empathy for familiar angry > baseline, Chinese 
// > Germans
// Greck M D, 2012: Intentional empathy for familiar neutral > baseline - 
// transcultural constants
// Greck M D, 2012: Intentional empathy for familiar neutral > baseline, 
// Chinese > Germans
// Greck M D, 2012: Intentional empathy for familiar neutral > baseline, 
// Germans > Chinese
// Subjects=16
-43.59	-.22	23.22
-40.35	-22.92	18.39
30.34	15.48	54.51
-4.89	2.41	53.78
11.09	-1.26	46.09
-28.75	-26.59	-2.62
-18.16	-12.15	-9.53
35.86	88.66	-31.99
39.53	-61.44	-32.82
-15.46	94.7	-31.91
-41.07	52.02	-44.76
-30.93	57.47	24.92
-24.66	79.2	16.34
-5.36	83.26	25.81
42.98	-2.87	22.44
33.23	-24.02	-2.44
23.57	-11.39	-3.38
26.64	66.31	10.14
33.22	74.75	36.12
-2.41	34.5	-27.01
8.29	34.65	-26.03
26.49	35.19	-20.71
-50.44	47.93	-14.2
-21.62	34.64	-23.45
-5.33	34.14	9.86
-45.64	-4.83	32.55
59.93	51.76	25.47
61.78	16.91	-26.27
57.7	-11.78	-11.55
-42.8	-.92	-13.54
-43.59	-.22	23.22
-40.35	-22.92	18.39
49.4	-6	22.63
26.89	-43.09	-.76
-4.88	2.58	55.99
11.1	-1.18	47.2
-27.67	-27.55	-1.44
33.21	-24.27	-5.76
-21.35	-8.74	-6.44
35.86	88.66	-31.99
39.07	59.1	-42.93
-18.64	94.93	-28.54
-41.06	55.45	-41.7
-37.95	80.85	-43.87
-30.95	60.65	24.66
-8.5	80.58	32.76
26.61	72.65	9.61
17.16	77.57	32.72
-2.38	34.76	-23.68
8.25	36.51	-29.53
-24.53	37.71	16.47
26.51	32.02	-20.44
-21.62	34.64	-23.45
-46.7	-5.81	33.76
-40.63	-2.77	-10.06
58.56	19.01	-26.41

// Uchiyama H, 2012: Metaphor effect [(Mc-Cm)+(Mi-Im)]
// Uchiyama H, 2012: Metaphor-specific effect 
// [(Mc-Cm)+(Mi-Im)]-[(Sc-Cs)-(Si-Is)]
// Uchiyama H, 2012: Sarcasm effect [(Sc-Cs)+(Si-Is)]
// Uchiyama H, 2012: Coherence effect [(Mc-Cm)-(Mi-Im)]+[(Sc-Cs)-(Si-Is)]
// Uchiyama H, 2012: Sarcasm and metaphor effects by the conjunction analysis
// Subjects=20
-12	34	46
-14	56	30
-8	46	12
-4	28	12
10	-4	12
-8	-4	2
10	16	10
-8	12	8
-16	6	-12
-18	-2	-12
-2	-18	-20
18	28	8
-6	22	8
2	56	24
-10	52	16
-6	46	-6
-18	2	-10
-26	0	-20
-28	14	-24
-8	48	-4
-2	52	-14
-14	56	28
-10	48	12
-6	40	-4

// Almeida J R C, 2010: Happy, main effect of group
// Almeida J R C, 2010: Sad, main effect of group
// Almeida J R C, 2010: Fear, main effect of group
// Subjects=15
33	-36	3
27	-51	6
3	33	9
36	-33	12
-18	-33	39
12	-90	18
36	-72	45
-9	-84	6
-39	-54	45
-12	-3	-15
6	-42	-6
12	-90	21
-27	-51	-12
39	33	-18
21	-3	9

// Dowd E C, 2010: Valence Contrast, Total Sample
// Dowd E C, 2010: Arousal Contrast, Total Sample
// Dowd E C, 2010: Valence x Arousal Contrast, Total Sample
// Subjects=32
2.23	-27.63	-5.12
42.84	-52.57	-14.65
49.02	30.72	-11.67
49.35	19.8	26.05
-48.98	16.84	24.08
-56.34	-22.59	24.12
55.69	-2.85	7.8
64.49	-26.55	30.87
49.74	-39.81	53.34
18.93	-56.78	70.73
-17.41	-51.62	71.83
-0.06	34.46	-.27
58.03	-65.57	8.57
4.47	-81.43	-12.9
6.86	-93.11	14.81
-.87	-44.14	1.87
-56.32	-68.45	9.01
50.33	36.56	22.4
-0.03	60.06	14.31
-.58	-24.6	48.19
0.63	-52.8	55
-40.48	-65.93	-14.8

// Foland-Ross L C, 2012: Label emotion vs Match forms (activation, between 
// group differences)
// Subjects=24
42	40	-8
34	30	-5
30	28	-4
6	-75	6
36	14	44
32	15	2
21	3	5
9	-7	5
7	8	-3

// Groen W B, 2010: High functioning Autism adolescents
// Subjects=16
-42	18	-10
50	22	2
-48	22	14
-60	-12	2
62	0	-6
-58	12	26
-36	-74	6

// Groen W B, 2010: Control group
// Subjects=26
-6	-82	24
52	-34	42
52	-14	-12
18	50	10
32	-18	42
12	22	-14
32	-70	-40
-56	-42	-2
-52	26	-6
-54	-2	-14
-42	24	-4
16	-82	-32
-62	-6	-6
-36	-40	-22
-8	8	42
62	2	-10
26	-4	-42
-16	-96	4
26	-82	-36

// Habel U, 2010: Discrimination of Happy faces, Patients<Controls
// Habel U, 2010: Discrimination of Happy faces, Patients>Controls
// Habel U, 2010: Discrimination of Sad faces, Patients<Controls
// Habel U, 2010: Discrimination of Sad faces, Patients>Controls
// Habel U, 2010: Discrimination of Fearful faces, Patients<Controls
// Habel U, 2010: Discrimination of Fearful faces, Patients>Controls
// Habel U, 2010: Discrimination of Angry faces, Patients<Controls
// Habel U, 2010: Discrimination of Angry faces, Patients>Controls
// Habel U, 2010: Discrimination of Neutral faces, Patients<Controls
// Habel U, 2010: Discrimination of Neutral faces, Patients>Controls
// Subjects=17
-6	-102	-2
12	34	18
-30	-38	-4
32	-78	-4
58	-52	6
0	30	48
50	-64	-8
-12	32	18
0	-46	0
44	-16	-2
-34	-94	2
-36	14	-6
-46	44	10
-8	56	16
40	-52	-14
14	-10	16
-6	-44	14
-6	-94	26
12	-90	28
10	34	20
0	30	10
-4	-102	-4
44	6	18
12	-6	16
46	-18	-2
42	-52	-14
66	-54	10
14	-98	0
-44	40	8
-8	50	16
10	34	20
0	30	10
-4	-102	-4
44	6	18
12	-6	16
46	-18	-2
42	-52	-14
66	-54	10
14	-98	0
-44	40	8
-8	50	16
-4	-94	24
28	-66	38
48	0	36
12	-90	26
24	0	6
-4	-102	-2
12	36	22
46	8	18
24	2	4
-30	-90	26
-4	-94	26
50	0	38
48	8	18
-24	-44	-2
0	-100	-6
16	42	8
66	-52	4
68	-40	8
26	-64	38
-30	-90	26
54	4	34
-6	-94	26
-6	28	-14
4	-96	-6
42	-50	-16
34	-64	-14
46	-16	0
26	-66	38
48	0	36
-6	-94	28
28	-4	4
-28	-92	28
-50	-20	40
-36	-38	40
-24	-2	4
0	36	-14

// Hesling I, 2010: High Functioning Autism (HFA) participants
// Subjects=8
-48	-24	4
-24	-70	-34
42	-32	2
0	-6	14
-56	-26	0
56	-6	-14
46	14	-22
-44	-52	22

// Hesling I, 2010: Healthy controls
// Subjects=8
-48	-30	-4
-10	-82	-34
52	-18	-22
-56	-26	0
56	-6	-14
46	14	-22
-44	-52	22
-10	-60	24
-32	30	44
4	26	18

// Hulvershorn L A, 2012: Healthy Controls (HC)
// Subjects=30
-30	24	-2
12	-16	10
-22	-28	-4
34	24	-2
24	-24	-6
6	18	44
-28	-4	-16
44	38	34
-10	-18	8
-24	22	-24

// Hulvershorn L A, 2012: Unmedicated Bipolar depressed (BPD)
// Subjects=30
20	-6	-16
34	24	-2
-32	24	-2
-22	-4	-16
-18	-30	-4
10	-16	10
-10	-18	8
6	18	44
50	46	14

// Hulvershorn L A, 2012: Bipolar hypomania or mania (BPM)
// Subjects=30
34	22	-2
-32	24	-2
22	-28	-4
10	20	44
-10	-18	8
10	-16	8
-18	-30	-4
-42	34	38
14	10	8
-4	8	26
26	46	-16

// Hulvershorn L A, 2012: Bipolar euthymic (BPE)
// Subjects=30
18	-6	-14
-32	24	-4
-18	-30	-4
12	-16	10
-12	-22	14
6	20	36
-42	34	40
14	8	10
-28	-18	8
4	2	28
6	60	-12
8	22	4

// Kaiser M D, 2010: State activity, Coherent biological motion vs. Scrambled 
// biological motion
// Kaiser M D, 2010: Trait activity, Coherent biological motion vs. Scrambled 
// biological motion
// Kaiser M D, 2010: Compensatory activity, Coherent biological motion vs. 
// Scrambled biological motion
// Subjects=17
-43.95	44.42	-5.06
-3.42	35.09	-19.24
49.32	-30.98	2.42
26.66	-11.42	-17.91
47.09	-55.08	-20.06
-43.71	-51.94	-12.59
29.67	0.8	-39.05
-44.76	28.41	21.94
51.29	-38.23	-22.64
-49.1	-44.83	-16.47
51.6	-52.57	12.02
-1.34	43.31	-23.3

// Keehn B, 2014: Autism (ASD) Patients
// Subjects=9
60.81	28.93	-8.31
38.31	79.78	4.41
-26.89	83.62	4.84
38.52	17.22	7.43
10.09	8.22	58.69
-23.36	-29.39	2.01
22.68	-5.11	22.86
-20.03	-28.08	18.59
38.94	-5.87	52.85
6.6	-68.39	-9.56
-38.96	-28.29	58.97
39.02	-67.68	37.96
10.25	-40.68	59.45
-10.19	-19.11	51.18
38.49	19.08	3.93
-32.46	-63.66	55.17
54.7	5.66	21.59
-6.93	-5.37	63.37
-48.85	-1.59	33.43
54.6	24.44	16.68
48.55	-78.43	22.03
22.89	0.38	52.51
-29.68	-71.26	-2.21
-3.91	10.28	45.3
51.34	40.28	15.38
-22.86	-60.43	54.79
-10.15	-8.82	60.36
-16.87	5.49	25.78
35.7	-2.97	49.3
48.28	8.79	21.41
-35.83	-48.84	40.59
-45.44	-35.7	46.29
39.02	-67.68	37.96
26.08	-9.63	46.62
-6.94	-8.8	60.32
6.84	14.29	54.88
25.48	18.18	-20.38
-42.2	-45.19	47.05
-10.3	2.84	46
-.45	-44.17	56.52
54.54	40.3	15.35
-38.85	-56.84	61.37
26.14	8.57	61.83
26.3	-66.73	51.41
35.64	-89.31	6.36
22.9	-2.79	52.78
48.21	4.85	11.7
51.48	-48.31	-1.72
35.82	-67.7	38

// Keehn B, 2014: Typically Developing (TD) Controls
// Subjects=13
32.01	85.34	21.86
28.84	-50.5	-28.04
60.81	28.93	-8.31
29.23	-82.74	9.23
19.35	-29.47	-2.93
39.02	-67.68	37.96
10.25	-40.68	59.45
-10.19	-19.11	51.18
38.49	19.08	3.93
-32.46	-63.66	55.17
54.7	5.66	21.59
-6.93	-5.37	63.37
-48.85	-1.59	33.43
54.6	24.44	16.68
48.55	-78.43	22.03
22.89	0.38	52.51
29.23	-82.74	9.23
-29.53	-79.67	12.99
39.02	-67.68	37.96
26.08	-9.63	46.62
-6.94	-8.8	60.32
6.84	14.29	54.88
25.48	18.18	-20.38
-42.2	-45.19	47.05
-10.3	2.84	46
-.45	-44.17	56.52
54.54	40.3	15.35
-38.85	-56.84	61.37
26.14	8.57	61.83
-29.74	-75.21	-11.92
32.6	-71.15	34.98
37.39	26.48	3.32
22.9	-2.79	52.78
48.21	4.85	11.7
51.48	-48.31	-1.72
35.82	-67.7	38
60.94	3.9	-1.75
-17.14	-1.66	-11.54
38.48	-14.01	-11.14
-58.46	-24.63	25.43
3.59	17.18	51.33
22.66	-77.81	-8.95
-13.53	-73.23	12.27

// Lepage M, 2011: Schizophrenia-Control (Conjunction, Activation)
// Lepage M, 2011: Control > Schizophrenia (Group Comparison, Activation)
// Lepage M, 2011: Schizophrenia>Control (Positive Correlation with flat 
// affect, Activation)
// Lepage M, 2011: Schizophrenia>Control (Negative Correlation with flat 
// affect, Activation)
// Subjects=26
-.66	-89.19	13.21
-55.11	23.36	3.01
63.96	29.9	20.5
24.6	-4.37	-22.5
-33.58	29.4	-2.44
16.65	-5.8	31.56
-37.59	29.55	22.27
-59.19	27.34	22.85
-41.86	23.36	25.19
17.02	23.26	66.78
-5.36	30.54	8.17
-5.28	-19.21	4.13
18.71	-98.46	4.84
15.78	-40.72	-43.41
52.74	11.45	-15.58
5.57	-7.92	9.55
16.35	-38.7	1.21
-4.69	-82.66	37.29
-9.43	-92.38	2.47
-44.47	35.33	-7.32
-35.11	12.28	44.1
-31.1	20.85	20.77
-22.97	-9.21	-25.69
-27.3	-.51	-24.24
37.46	-20.46	-34.58
30.93	-9.85	-35.51
28.74	-1.35	-36.32
43.82	18.05	-36.25
53.6	-39.08	40.95
-15.76	-49.7	23.01
44.93	-17.43	43.44

// Li H, 2012: Schizophrenia patients
// Subjects=12
27	36	30
-36	9	42
3	-6	66
-54	-27	-9
-45	12	-6
6	9	66
-36	42	18
-39	12	39
57	12	24
54	21	9
-39	15	30
6	3	54
-3	21	54
-54	3	-3
-54	-3	12
39	3	18
-45	-18	21
24	-48	66
-15	-45	63
15	-33	63
-39	42	18
39	54	9
42	54	-3
-57	-63	15

// Li H, 2012: Nonpsychotic siblings
// Subjects=12
15	12	51
33	-3	42
-39	12	39
57	12	24
54	21	9
-39	15	30
6	3	54
-3	21	54
-54	3	-3
-54	-3	12
39	3	18
-45	-18	21
24	-48	66
-15	-45	63
15	-33	63
-39	42	18
39	54	9
42	54	-3
-57	-63	15

// Li H, 2012: Healthy controls
// Subjects=12
27	36	30
-36	9	42
3	-6	66
-54	-27	-9
-45	12	-6
6	9	66
-36	42	18
15	12	51
33	-3	42

// Lombardo M V, 2010: Healthy Controls
// Subjects=33
-6	50	-6
-4	62	2
22	-82	-24

// Mickleborough M J, 2011: Post-Traumatic Stress Disorder (PTSD) Patients
// Subjects=17
4	16	0
-8	22	0
-6	18	2
-34	-20	12
-34	18	18
38	-2	20
-4	14	4
-14	24	-2
-18	-16	4
-26	-20	8
-18	-24	10
-14	-24	8
28	38	22
24	-4	-22
-26	12	0
-26	10	-6
20	46	6
-20	56	2
-10	58	28

// Mickleborough M J, 2011: Healthy Controls
// Subjects=26
4	16	0

// Rauch A V, 2013: Sad > Neutral, Schizophrenia > Control
// Rauch A V, 2013: Happy > Neutral, Schizophrenia>Control
// Rauch A V, 2013: Sad > Erased, Schizophrenia > Control
// Rauch A V, 2013: Happy > Erased, Schizophrenia > Control
// Rauch A V, 2013: Neutral > Erased, Control > Schizophrenia
// Subjects=12
-28	-5	-13
34	-3	-23
-18	-3	-15
-26	-5	-15
34	-3	-23
34	-3	-23
-16	-7	-15

// Spengler S, 2010: Correlation: Performance in Imitation-Inhibition Control 
// vs. Neural Activity During ToM
// Subjects=18
15	54	-3
-51	-63	24
60	39	6

// Strigo I A, 2010: PTSD-IPV > Healthy Controls, Warm-Non-Painful Temperature 
// (Run 2 - Run 1)
// Strigo I A, 2010: Healthy Controls > PTSD-IPV, Warm-Non-Painful Temperature 
// (Run 2 - Run 1)
// Strigo I A, 2010: PTSD-IPV > Healthy Controls, Moderately Painful 
// Temperature (Run 2 - Run 1)
// Strigo I A, 2010: PTSD-IPV > Healthy Controls, All Temperatures (Run 2 - 
// Run 1)
// Strigo I A, 2010: Healthy Controls > PTSD-IPV, All Temperatures (Run 2 - 
// Run 1)
// Strigo I A, 2010: PTSD-IPV > Healthy Controls, Run 1: All Temperatures
// Strigo I A, 2010: Healthy Controls > PTSD-IPV, Run 1: All Temperatures
// Strigo I A, 2010: PTSD-IPV > Healthy Controls, Run 2: All Temperatures
// Strigo I A, 2010: Healthy Controls > PTSD-IPV, Run 2: All Temperatures
// Subjects=15
29.33	-49.85	35.46
35.78	-69.19	32.55
-43.57	-40.63	9.88
37.67	13.99	34.47
-51.16	15.34	18.65
-31.96	43.64	24.98
-42.39	15.42	46.43
12.13	-8.2	38.86
35.45	-23.15	8.62
-34.05	-20.73	4.75
51.26	-2.3	-12.27
17.79	-37.84	68.04
46.44	-11.2	52.1
-23.91	-38.26	66.33
-47.68	-19.13	40.46
11.36	-79.77	49.33
62.11	-12.59	5.2
-32.59	-81.49	31.02
-58.55	-44.23	5.89
-4.81	-81.32	30.69
-47.88	-65.2	-4.74
-3.01	9.63	23.04
-24.17	-63	21.57
-31.89	-15.01	9.82
-49.91	-64.1	9.69
44.1	-72.59	1.51
4.72	-81.06	19.4
-14.42	-57.09	42.15
38.64	-46.36	-2.85
-42.56	-46.68	0.34
8.69	-83.15	-21.73
36.3	18.47	-3.8
45.1	21.18	30.44
45.89	-.39	-14.6
2.83	-79.65	51.65
32.65	-84.9	36.13
-43.77	-64.69	-26.02
-54.38	-39.77	-5.68
6.82	-82.54	13.93
7.62	-85.27	-21.54
-31.92	-15.26	6.5
8.92	-67.55	14.88
31.61	-49.44	54.36
-23.99	-55.57	48.82
-14.46	-77.32	28.23
36.8	-79.56	22.26
-42.5	-66.94	-.2
-27.61	-75.28	-13.05
-11.57	-69.55	-9.25
5.22	-46.3	-40.39

// Vaidya C J, 2011: Neutral > Fixation contrast, Gaze task > Arrow task
// Vaidya C J, 2011: Neutral > Fixation contrast, Arrow task > Gaze task
// Vaidya C J, 2011: Congruent > Neutral, Facilitation
// Vaidya C J, 2011: Incongruent > Congruent, Interference
// Subjects=15
12	-97	3
-39	-45	-15
-51	-6	7
53	-18	18
-33	-42	58
30	-39	53
-6	-25	46
18	-7	57
0	29	12
-33	34	4
30	21	33
-15	24	32
48	-12	4
-42	-15	9
24	-45	-12
27	-65	-6
0	32	14
-39	35	29
12	14	8

// Scott-Van Zeeland A A, 2010: Autism Group (ASD)
// Subjects=16
14	12	6
-40	36	8
48	32	16
-40	12	40
50	8	40
-44	4	32
48	6	32
-28	58	-6
28	54	-2
22	-30	-4
4	24	44
-32	16	4
36	16	-4
-30	-68	-16
40	-60	-14
10	-98	16
-48	-52	50
48	-44	54
52	26	34
52	0	48
-40	-70	-18
30	-80	-20
12	-100	16
34	-60	54
40	-52	42
14	52	-14
14	50	-14
-6	38	-16
-2	26	-18
-10	22	0
-26	24	-18
-30	8	42
-38	0	30
28	54	-12
2	42	-4
-2	-34	34
-8	36	-12
30	-72	38
52	26	14
-42	16	36
-44	8	34
48	2	30
44	50	2
30	-20	-14
-38	-68	-18
26	-70	-16
34	-66	46
-46	-52	50
-44	-52	50
50	-46	50
32	-16	2
-8	10	-8
-24	10	-18
38	24	-18
34	-24	42
24	-6	-26
6	44	24
2	-22	46
-20	-74	-10
34	-68	-14
2	-92	6
-18	18	6
16	4	12
-26	14	0
20	10	-2
30	50	-6
-4	36	12
-26	18	-10

// Scott-Van Zeeland A A, 2010: Typically-Developing Controls (TD)
// Subjects=16
12	10	6
-40	38	-10
24	42	-14
28	18	-18
42	38	18
-44	4	32
42	50	4
-16	-36	-4
18	-32	-8
8	30	20
-28	18	-8
34	20	2
-32	-76	-20
37	-72	-16
7	-60	52
40	-52	48
16	4	14
18	4	6
20	4	-2
-46	24	20
-26	14	-20
-48	24	34
44	26	32
-40	2	34
46	4	34
-42	52	-6
-18	-32	-6
-30	16	-8
-28	-70	-18
32	-60	-20
32	-90	-6
-16	10	-2
-12	4	-10
12	6	-8
14	52	-14
14	50	-14
-6	38	-16
-2	26	-18
-12	14	3.18
16	14	2.46
-20	4	2.55
26	6	2.36
-10	14	3.44
6	14	3.37
0	60	3.02
32	32	2.72
-28	26	3.01
-40	-8	3.08
30	64	2.99
0	-48	3.26
24	-56	3.4
36	60	3.26
58	20	3.1
32	-16	2
-8	10	-8
-24	10	-18
38	24	-18
34	-24	42
24	-6	-26
6	44	24
2	-22	46
-20	-74	-10
34	-68	-14
2	-92	6
-8	16	0
8	18	0
-16	66	20
-2	38	6
-2	24	-12
-42	-50	-20
42	-52	-18
-18	18	6
16	4	12
-26	14	0
20	10	-2
30	50	-6
-4	36	12
-26	18	-10

// Scott-Van Zeeland A A, 2010: Autism (ASD) Group
// Subjects=18
-62	-22	6
-50	-30	14
-42	-32	10
52	-20	6
54	-6	0
-50	-32	8
-50	-18	14
-40	-34	10
-66	-30	0
58	-32	8
46	-12	4
46	-26	12
-52	-40	14
-52	-18	0
-50	-28	16
-66	-28	-2
-64	-22	28
46	-10	2
58	-12	12
44	-24	12
52	-8	10
42	8	10
58	-10	26
-14	64	2
-22	60	6
32	50	8
-62	-10	8
-42	-20	46
-50	-22	46
-36	44	12
-14	64	2
30	48	12
44	10	10
34	14	8
-50	-38	18
-52	-42	32
-54	-50	38
24	-52	54
12	0	12
-36	-32	42
-48	-38	40
-22	12	8

// Scott-Van Zeeland A A, 2010: Typically-Developing (TD) Group
// Subjects=18
-58	-22	6
-54	-14	4
-44	-34	10
-20	54	24
-24	50	26
-26	-4	62
-58	12	6
-34	26	32
-48	2	40
-28	52	20
-4	40	22
-52	0	28
-52	-8	44
-56	-38	30
-2	54	6
-8	46	28
58	-20	6
54	-22	8
48	-14	6
-22	24	36
26	6	52
10	38	34
34	32	32
28	12	52
4	42	38
-8	60	12
8	46	26
58	-6	16
10	44	12
-60	-16	10
-56	-10	6
-18	62	8
-26	-6	64
-36	52	4
-42	38	2
-44	34	8
-40	22	12
-62	-26	28
-32	-34	62
-42	-44	56
-18	-26	66
-54	-18	16
-38	-28	54
-34	-28	62
-44	-22	58
-50	-28	52
54	-22	8
60	-18	6
34	-22	14
52	-20	0
52	6	10
32	36	-8
42	40	8
18	56	4
30	52	14
52	-20	34
26	-26	50
32	-44	58
36	-32	56
-56	-24	-24
-52	-22	-22
-64	-16	-16
-56	-4	-4
-50	-20	-20
-58	-2	-2
56	-24	-24
46	-18	-18
40	-22	-22
58	-34	-34
-26	50	26
-8	38	24
26	44	0
-40	40	14
-62	-10	8
-42	-20	46
-50	-22	46
-36	44	12
-14	64	2
30	48	12
44	10	10
34	14	8
-52	-44	30
-54	-50	38
-8	4	4
14	2	6
-50	-38	18
-52	-42	32
-54	-50	38
24	-52	54
12	0	12

// Lockwood P L, 2013: Pain>No Pain
// Lockwood P L, 2013: No Pain>Pain
// Lockwood P L, 2013: Control>CP (for Pain>No Pain)
// Lockwood P L, 2013: CP>Control (for Pain>No Pain)
// Subjects=18
-48	-62	0
-34	-86	-2
-46	-48	-16
-60	-30	34
-52	-26	36
-60	-30	24
46	-56	-8
52	-62	-6
36	-80	8
-52	6	34
-36	-4	14
62	-22	30
36	-34	38
52	40	4
52	8	26
-50	38	10
-30	-6	48
-32	-2	-38
-58	-34	-10
14	24	4
-42	-66	-38
12	-74	-4
-44	-16	-6
0	-48	-20
44	6	-36
10	10	10
-10	12	52
-22	10	-20
-32	12	-16
-36	34	20
-4	-14	20
28	-58	-30
-28	-30	14
14	-72	-32
22	48	22
-16	-8	-4
10	-20	-16
54	38	0
-30	16	2
0	20	24
-4	-62	28
-18	-20	-16
-2	-48	-4

// Schiffer B, 2014: Conflict-related activity (Incongruent-Congruent)
// Schiffer B, 2014: Error-related activity (All error trials- accurate 
// Congruent trials)
// Schiffer B, 2014: Conflict-related activity (Non-Offenders>Offenders)
// Schiffer B, 2014: Conflict-related activity (Offenders>Non-Offenders)
// Schiffer B, 2014: Error-related activity (Non-Offenders>Offenders)
// Subjects=21
-36	-52	40
54	18	-12
48	-50	56
-34	-2	64
32	-68	-30
-34	-68	-30
-14	-6	10
20	-12	22
-44	50	-12
16	10	52
-4	20	48
-40	20	-10
8	20	62
-4	26	42
46	-52	32
38	20	48
64	-32	-12
6	-24	-24
-64	-48	30
-8	4	34
-10	16	38
-52	-2	22
-44	-10	42
-50	-26	2
52	-8	16
46	6	50
-16	0	-26
-12	-6	-8
40	-2	50
52	-12	22
-28	-38	62
24	0	64
30	-6	-12
-22	12	8
-10	12	34
-46	42	14

// Guo X, 2013: (Painful for Violent + Nonviolent) - (Nonpainful for Violent + 
// Nonviolent)
// Guo X, 2013: Correlation of self-rating score and painful-nonpainful 
// activation
// Guo X, 2013: (Painful - Nonpainful for Nonviolent) - (Painful - Nonpainful 
// for Violent)
// Guo X, 2013: (Painful - Nonpainful for Violent) - (Painful and Nonpainful 
// for Nonviolent)
// Subjects=20
-54	8	18
34	20	6
-6	10	40
-34	20	6
4	20	24
-58	-26	40
-36	-40	66
68	-22	32
30	-92	-4
-30	-96	-8
24	2	14
-8	8	48
6	22	24
8	20	30
54	2	12
-22	10	8
-42	10	-12
52	26	-4
6	2	66
-6	10	38
-8	30	24
-44	-2	-16
-34	6	2
-54	-34	22
16	-10	0
24	4	12
36	20	14
54	4	14
20	0	-14
-6	-66	52
-18	6	54
-54	-8	-32
56	-54	16

// Harenski C L, 2010: Psychopaths
// Subjects=16
57	-9	-18
12	39	-9
-48	-72	15
57	-6	-18
9	54	-12
48	-63	27
-60	-9	-21
-27	-77	43
-24	-27	-9
-21	26	46
18	-33	-16
45	-54	-28
-36	49	-5
36	36	26
21	12	5
30	14	55
-59	-7	-17
-45	-69	18
57	-6	-21
56	-63	39
-60	-12	-18
-15	-6	-21
33	-9	-21
12	51	-6
-18	-72	57
-36	-48	-6
27	-30	-9
-3	54	33
-33	18	-21
48	30	-6
-6	-54	-21
-15	-33	-24
3	-3	-12
-15	-87	-3
51	-57	-3
-42	42	-12
-45	18	-24
36	-72	18
33	0	-21
57	-51	27
51	-60	27
45	9	42
-3	18	60

// Harenski C L, 2010: Non-Psychopaths
// Subjects=16
57	-9	-18
12	39	-9
-48	-72	15
57	-6	-18
9	54	-12
48	-63	27
-60	-9	-21
-27	-77	43
-24	-27	-9
-21	26	46
18	-33	-16
45	-54	-28
-36	49	-5
36	36	26
21	12	5
30	14	55
-59	-7	-17
-45	-69	18
57	-6	-21
56	-63	39
-60	-12	-18
-15	-6	-21
33	-9	-21
12	51	-6
-18	-72	57
-36	-48	-6
27	-30	-9
-3	54	33
-33	18	-21
48	30	-6
-6	-54	-21
-15	-33	-24
3	-3	-12
-15	-87	-3
51	-57	-3
-42	42	-12
-45	18	-24
36	-72	18
33	0	-21
57	-51	27
33	0	-21

// Cappelletti M, 2010: Common Conceptual - Fixation
// Cappelletti M, 2010: Conceptual Quantity - Fixation
// Cappelletti M, 2010: Nonquantity Conceptual - Fixation
// Cappelletti M, 2010: Number Conceptual - Fixation
// Cappelletti M, 2010: Object Conceptual - Fixation
// Cappelletti M, 2010: Conceptual Only: Number vs. Object (RT Effects)
// Cappelletti M, 2010: Conceptual vs. Perceptual  (RT Effects)
// Cappelletti M, 2010: Quantity Only (RT Effects)
// Cappelletti M, 2010: Nonquantity Only (RT Effects)
// Cappelletti M, 2010: Conceptual Only (RT Effects)
// Cappelletti M, 2010: Numbers and Object Names (RT Effects)
// Cappelletti M, 2010: Numbers > Words (RT Effects)
// Cappelletti M, 2010: Numbers and Object Names (RT Effects)
// Subjects=22
24	-104	2
28	-92	-4
14	-106	6
14	-106	16
-18	-102	0
-32	-96	-2
-24	-88	-10
30	-58	56
-26	-64	54
46	26	22
38	-76	-20
22	-78	-20
24	-104	2
28	-92	-4
14	-106	6
14	-106	16
-18	-102	0
-32	-96	-2
-24	-88	-10
30	-58	56
-26	-64	54
46	26	22
38	-76	-20
22	-78	-20
24	-104	2
28	-92	-4
14	-106	6
14	-106	16
-18	-102	0
-32	-96	-2
-24	-88	-10
30	-58	56
-26	-64	54
46	26	22
38	-76	-20
22	-78	-20
24	-104	2
28	-92	-4
14	-106	6
14	-106	16
-18	-102	0
-32	-96	-2
-24	-88	-10
30	-58	56
-26	-64	54
46	26	22
38	-76	-20
22	-78	-20
24	-104	2
28	-92	-4
14	-106	6
14	-106	16
-18	-102	0
-32	-96	-2
-24	-88	-10
30	-58	56
-26	-64	54
46	26	22
38	-76	-20
22	-78	-20
28	-70	32
32	-66	32
32	-80	34
42	-78	34
38	-78	30
32	-76	42
30	-62	46
32	-56	42
22	-68	56
18	-70	56
32	-64	54
48	-48	40
44	-44	48
-40	-44	40
-52	-44	46
28	-70	32
32	-66	32
32	-80	34
42	-78	34
38	-78	30
32	-76	42
30	-62	46
32	-56	42
22	-68	56
18	-70	56
32	-64	54
48	-48	40
44	-44	48
-40	-44	40
-52	-44	46
28	-70	32
32	-66	32
32	-80	34
42	-78	34
38	-78	30
32	-76	42
30	-62	46
32	-56	42
22	-68	56
18	-70	56
32	-64	54
48	-48	40
44	-44	48
-40	-44	40
-52	-44	46
28	-70	32
32	-66	32
32	-80	34
42	-78	34
38	-78	30
32	-76	42
30	-62	46
32	-56	42
22	-68	56
18	-70	56
32	-64	54
48	-48	40
44	-44	48
-40	-44	40
-52	-44	46
28	-70	32
32	-66	32
32	-80	34
42	-78	34
38	-78	30
32	-76	42
30	-62	46
32	-56	42
22	-68	56
18	-70	56
32	-64	54
48	-48	40
44	-44	48
-40	-44	40
-52	-44	46
26	-70	60
28	-72	50
34	-63	60
16	-80	54
34	-70	50
40	-64	52
36	-62	52
40	-56	54
50	-44	54
30	-70	32
-24	-60	64
-34	-56	50
-30	-52	46
-40	-52	56
-34	-60	46
-48	-36	56
44	-8	28
-48	-28	20
26	-70	60
28	-72	50
34	-63	60
16	-80	54
34	-70	50
40	-64	52
36	-62	52
40	-56	54
50	-44	54
30	-70	32
-24	-60	64
-34	-56	50
-30	-52	46
-40	-52	56
-34	-60	46
-48	-36	56
44	-8	28
-48	-28	20
26	-70	60
28	-72	50
34	-63	60
16	-80	54
34	-70	50
40	-64	52
36	-62	52
40	-56	54
50	-44	54
30	-70	32
-24	-60	64
-34	-56	50
-30	-52	46
-40	-52	56
-34	-60	46
-48	-36	56
44	-8	28
-48	-28	20

// Kasahara M, 2010: Traumatic Brain Injury Patients
// Subjects=12
-32	-16	56
-44	-6	58
-30	-16	66
-42	-18	30
-46	-12	24
-4	62	0
-32	0	18
-2	-68	-18
-38	-28	38
0	-54	-22
18	-12	24
-52	-20	38
-48	-8	36
-54	-12	44

// Kasahara M, 2010: Healthy Controls
// Subjects=9
-40	-14	64
-46	-12	50
-38	-16	50
20	-54	-30
2	-60	-14
2	-62	-30
-2	-14	52
0	-6	62
8	-12	62
-10	-20	2
-40	-54	36
-28	-4	-8

// Cohn M D, 2013: Persistent Disruptive Behavior Disorders (DBD-p)
// Subjects=25
36	-10	4
40	-6	2
34	-16	10
-30	-6	-12
-24	-6	-10
-16	18	38
-16	10	38
-14	6	38
36	-18	14
34	-14	10
50	-2	8
34	-8	12
38	-8	4
-8	0	42
-6	0	46
8	6	36
12	32	18
20	0	-10
-36	4	-12
-34	8	-12
32	-12	12
32	-16	14
34	-8	12
-30	4	-16
6	6	36

// Cohn M D, 2013: Desistent Disruptive Behavior Disorder (DBD-d)
// Subjects=25
-38	-20	24
42	-4	6
36	-18	14
-14	10	40
-12	16	40
36	-18	14
34	-14	10
50	-2	8
34	-8	12
38	-8	4
-8	0	42
-6	0	46
8	6	36
12	32	18
20	0	-10
-36	4	-12
-34	8	-12
32	-12	12
32	-16	14
34	-8	12
-30	4	-16
6	6	36

// Cohn M D, 2013: Healthy Controls
// Subjects=26
-38	-20	24
42	-4	6
36	-18	14
-14	10	40
-12	16	40
36	-10	4
40	-6	2
34	-16	10
-30	-6	-12
-24	-6	-10
-16	18	38
-16	10	38
-14	6	38
36	-18	14
34	-14	10
50	-2	8
34	-8	12
38	-8	4
-8	0	42
-6	0	46
8	6	36
12	32	18
20	0	-10
-36	4	-12
-34	8	-12
32	-12	12
32	-16	14
34	-8	12
-30	4	-16
6	6	36

// Pawliczek C, 2013: Group by condition interaction p<.001 uncorr., k=20
// Pawliczek C, 2013: Main effect of condition, p<.001 uncorr., k=20
// Pawliczek C, 2013: Main effect of group, p<.001 uncorr., k=20
// Subjects=19
-8	10	26
0	-68	-24
4	-6	0
-22	-6	-12
-34	-44	28
-24	-18	-2
10	-6	-18
34	36	10
-26	-12	22
-12	-10	32
2	30	10
0	12	-6
4	-4	36
16	-34	28
-2	2	64
10	32	64
-22	16	34
-54	-2	48
-62	0	30
36	-24	56
-46	-70	38
50	-74	34
-26	-56	46
32	-44	46
22	-68	40
-28	-34	-14
26	-6	-20
28	-84	-34
6	-50	-46
-26	-82	-30
0	-10	8
-52	26	32
44	52	18
48	20	28
-40	2	58
-6	22	44
10	30	30
24	24	4
38	22	-4
-54	-42	4
-16	16	8
-20	0	18
12	4	0
16	-82	-18
-28	-68	-12
20	-92	30
14	-88	12
34	-86	-8
-24	-92	6

// Pujol J F, 2012: Psychopathic Individuals
// Subjects=22
-12	46	42
-4	-58	36
56	-64	34
-48	-64	32
-60	-10	-8
42	-84	-8
-28	-96	-8
-40	26	-22
4	20	50
8	-32	40
26	-30	-12
-28	-22	-16
10	-26	-18
-8	-24	46
48	-46	12
-60	-34	20
12	-20	2
36	-6	10
-40	0	8
52	-34	56
-38	-34	64
22	-38	-20
-2	54	12

// Pujol J F, 2012: Nonoffender Control Subjects
// Subjects=22
-16	46	44
-2	-60	36
46	-58	30
-50	-66	30
28	-28	-14
-28	-24	-16
0	-32	-12
-12	6	4
54	-20	0
-54	-16	-4
34	-90	0
-12	-104	0
42	32	-20
-46	40	-16
4	20	50
8	-32	40
26	-30	-12
-28	-22	-16
10	-26	-18
0	52	-12
-8	-26	48
62	-50	16
-48	-40	18
12	-18	-4
52	-18	8
-52	-10	2
50	-34	56
-38	-36	60
24	-44	-16
-2	54	12

// Chassy P, 2012: Disk vs. Rest Activation
// Chassy P, 2012: Disk vs. Rest Deactivation
// Chassy P, 2012: Dots vs. Rest Activation
// Chassy P, 2012: Dots vs. Rest Deactivation
// Chassy P, 2012: Positive Integers vs. Rest Activation
// Chassy P, 2012: Positive Integers vs. Rest Deactivation
// Chassy P, 2012: Negative Integers vs. Rest Activation
// Chassy P, 2012: Negative Integers vs. Rest Deactivation
// Chassy P, 2012: Disk (Positive contrast of the time derivative)
// Chassy P, 2012: Disk (Negative contrast of the time derivative)
// Chassy P, 2012: Dots (Positive contrast of the time derivative)
// Chassy P, 2012: Dots (Negative contrast of the time derivative)
// Chassy P, 2012: Positive Integers (Positive contrast of the time 
// derivative)
// Chassy P, 2012: Positive Integers (Negative contrast of the time 
// derivative)
// Chassy P, 2012: Negative Integers (Positive contrast of the time 
// derivative)
// Chassy P, 2012: Negative Integers (Negative contrast of the time 
// derivative)
// Chassy P, 2012: Conjunction Disk^Dots^PI^NI
// Chassy P, 2012: Disk > Dots
// Chassy P, 2012: PI < NI
// Chassy P, 2012: Analogue Routes (Disk and Dots Common Activation)
// Subjects=16
39	-75	3
30	-60	54
-39	-72	0
54	9	33
-36	-15	60
-24	-60	54
42	-21	63
39	-15	21
-45	-78	30
-3	-39	39
-9	-72	30
27	-60	51
51	9	33
33	21	3
-18	-63	48
45	-21	60
51	-69	36
39	-15	21
9	-15	51
-45	-78	33
-9	-60	27
-36	-15	60
-27	-57	57
33	-63	57
42	-24	63
39	-15	21
54	6	-12
51	-72	27
60	0	6
-42	-78	30
-57	0	-15
27	-63	54
39	-75	-3
-27	-60	57
-39	-72	3
54	-6	-15
12	-63	24
51	-72	30
0	33	-12
-39	-78	39
-60	-3	-15
-30	-27	-18
-63	-36	6
18	-90	-3
51	9	33
-15	-93	-3
-9	0	54
-54	6	33
-6	-93	12
-42	-78	36
33	-21	48
36	-78	-6
51	6	30
36	-3	48
30	27	6
-6	0	54
-45	0	33
36	-21	48
51	-69	36
39	-21	9
-6	-93	15
-48	-66	27
18	-93	3
30	-60	39
48	6	33
-36	-69	-15
-39	-21	54
33	-24	54
36	-15	18
54	-69	24
-42	-24	0
54	-3	-9
-6	-93	15
-42	-78	33
-27	-33	-15
-51	-9	27
-6	33	-3
15	-90	-3
48	6	33
30	27	6
3	-24	27
15	-90	24
-6	-93	15
30	-51	48
45	-39	45
30	-60	54
24	-63	51
-24	-60	51
45	-39	45
30	-51	48

// Dormal V, 2012: Numerosity vs. Ref for Numerosity
// Dormal V, 2012: Duration vs. Ref for Duration
// Dormal V, 2012: N vs RefN compared to D vs RefD
// Dormal V, 2012: N vs RefN and D vs RefD
// Subjects=15
50	38	34
10	22	52
44	-46	50
40	24	4
-40	-52	68
50	38	34
10	26	48
44	-46	52
-38	-64	-32
-46	-42	54
36	-62	52
50	38	34
8	26	48
44	-46	52
-40	-48	48

// Clapp W C, 2010: IS interruptor > DS distractor
// Clapp W C, 2010: DS distractor > IS interruptor
// Subjects=22
-41	-13	-30
37	42	20
28	-55	13
-26	-56	-8
43	-47	-11
-23	-91	2
-11	12	6
31	28	3
18	-100	10
6	6	11
25	56	9
-35	-73	9
-12	-8	8
4	46	15
-12	-79	9
40	-63	10
26	5	16
-1	26	19
47	34	27
-42	24	26
6	34	27
40	10	38
13	-69	36
38	-55	34
-39	4	38
1	32	45
36	-51	46
6	51	51
44	-59	53
-2	17	57
4	34	58
-27	-2	71
-41	-66	23
-33	-81	42

// Gazzaley A, 2014: Remember Scenes and Remember Faces > Passive View, 
// Univariate activity contrast
// Subjects=18
-29	-2	59
-32	43	51
-46	-60	-11
-22	-30	-23
-2	13	54
-38	32	31
-30	20	14
-58	10	-6
2	-51	67
22	-66	61
29	-5	52
-20	-32	-23
14	22	8
32	2	66

// Han T, 2012: Fear (eyes-removed>eyes-only)
// Han T, 2012: Happy (eyes-only>eyes-removed)
// Subjects=16
7.63	60.05	-4.4
-40.2	-28.88	50
-43.35	41.6	29.97
51.47	-22.81	48.78
-27.02	36.55	38.9
26.97	37.01	41.36
2.9	-15.05	46.12
24.2	50.43	34.92
-24.68	-.87	-18.65
-32.66	-50.26	-20.78
-51.08	-79.19	18.33
21.07	-1.09	-32.43
-27.42	4.33	-25.42

// Redcay E, 2014: ASD Patients
// Subjects=12
-5.43	34.17	-3.53
15.9	37.12	-8.48
-10.79	50.42	0.75
3.26	41.22	18.09
32.15	43.93	23.1
-28.8	48.68	21.18
20.78	2.82	56.79
20.18	68.04	5.61
3.44	11.24	29.52
-19.45	24	-23.7
24.33	28.32	-26.8
41.63	52.48	8.9
54.46	38.38	4.36
45.12	2.69	25.3
-44.69	-3.82	17.96
-34.17	3.33	-.61
36.33	-25.11	-16.88
-22.27	-43.47	-1.28
-48.11	-35.73	-22.82
-8.02	-39.62	47.3
11.21	-38.44	46.98
-35.72	-72.99	44.84
-6.94	-61.44	40.2
17.71	-89.13	37.77
20.88	-90.6	32.29
-3.88	-70.63	17.51
-14.65	-90.29	-1.9
-38.35	-74.8	-19.66
37.37	-55.03	-32.22
14.89	21.26	-7.14
42.26	-24.46	59.95
-38.97	-28.46	56.76
-9.77	30.2	-13.18
-30.04	42.48	-3.94
-31.03	13.67	-4.86
-44.74	-30.66	1.25
-52.11	-57.05	4.66
-43.76	-40.4	-14.67
-28.64	-46.34	3.49
47.06	-34.48	-15.1
-47.37	59.78	-26.38
28.4	-72.52	45.18
-28.27	-55.69	47.77
-22.08	-66.76	14.05
36.88	-44.64	47.21
-10.2	-25.8	47.28
19.45	-55.91	-.72
-9.15	-84.23	20.94
-9	-81.55	41.91
36.38	-57.52	-23.08
-34.06	-69.15	-15.72
3.19	50.39	12.86
53.64	20	28.21
40.78	-6.83	12.76
45.19	-15.2	27.91
-39.58	-6.19	-13.13
-51.83	-22.28	55.27
-32.08	-57.56	-31.21
-26.72	48.1	13.39
-9.25	2.59	42.66
-32.26	27.35	-20.49
-46.87	-13.07	8.72
-34	-7.02	16.99
-44.73	-33.92	0.41
-44.7	-47.83	-.66
-48.14	-31.68	-25.39
-40.65	-27.06	-21.41
-43.49	-77.09	6.24
-35.85	-53.5	35.4
-17.57	-29.13	59.91
-5.27	15.02	10.35
-56.62	-4.64	-5.26
69.61	-20.03	4.62
54.58	-4.34	2.36
33.53	-41.8	29.16
33.28	13.82	18.93
62.15	8.7	19.02
54.63	-1.63	9.94
55.78	-27.17	9.84
-52.28	-4.98	3.64
-29.86	48.76	22.3
33.02	-52.56	-41.3
-39.26	-70.98	2.34
41.91	20.27	32.78
12.6	60.37	-10.39
-22	17.63	59.39
58.84	-24.29	-8.28
-57.67	-27.45	-11.14
-64.03	-15.97	0.24
56.13	-42.23	49.01
11.74	52.56	12.58
55.69	24.61	18.88
51.43	-24.71	0.76
6.85	-50.41	30.19
7.01	-60.76	47.79
-10.35	-44.94	19.89
-19.9	-88.24	11.37

// Redcay E, 2014: Mental age-matched controls
// Subjects=11
-5.43	34.17	-3.53
15.9	37.12	-8.48
-10.79	50.42	0.75
3.26	41.22	18.09
32.15	43.93	23.1
-28.8	48.68	21.18
20.78	2.82	56.79
20.18	68.04	5.61
3.44	11.24	29.52
-19.45	24	-23.7
24.33	28.32	-26.8
41.63	52.48	8.9
54.46	38.38	4.36
45.12	2.69	25.3
-44.69	-3.82	17.96
-34.17	3.33	-.61
36.33	-25.11	-16.88
-22.27	-43.47	-1.28
-48.11	-35.73	-22.82
-8.02	-39.62	47.3
11.21	-38.44	46.98
-35.72	-72.99	44.84
-6.94	-61.44	40.2
17.71	-89.13	37.77
20.88	-90.6	32.29
-3.88	-70.63	17.51
-14.65	-90.29	-1.9
-38.35	-74.8	-19.66
37.37	-55.03	-32.22
14.89	21.26	-7.14
42.26	-24.46	59.95
-38.97	-28.46	56.76
-9.74	50.26	-1.48
-32.24	58.33	-5.24
-45.35	-60.02	48.32
-13.45	-104.32	9.3
21.94	-90.68	31.16
21.76	-80.42	12.46
-30.3	-36.98	69.64
33.28	13.82	18.93
62.15	8.7	19.02
-16.5	-15.92	65.48
24.14	-28.54	63.85
3.79	-29.09	58.55
-35.2	0.41	2.99
-22.72	46.35	-23.31
-5.59	50.06	-18.24
11.48	47.7	-22.7
-2.11	38.73	13.9
2.4	10.43	32.95
-49.06	-16.94	0.15
23.46	-13.56	-17.7
-13.86	-26.13	-11.75
-1.61	-38.52	47.13
-43.21	-59.92	49.41
-17.59	-89.69	33.77
-17.75	-101.26	7.97
12.32	-95.14	29.42
20.28	-.2	-9.86
-18.11	12.48	6.25
66.41	-3.5	12.19
-39.53	-9.02	-8.43

// Redcay E, 2014: Chronological age-matched controls
// Subjects=12
-9.77	30.2	-13.18
-30.04	42.48	-3.94
-31.03	13.67	-4.86
-44.74	-30.66	1.25
-52.11	-57.05	4.66
-43.76	-40.4	-14.67
-28.64	-46.34	3.49
47.06	-34.48	-15.1
-47.37	59.78	-26.38
28.4	-72.52	45.18
-28.27	-55.69	47.77
-22.08	-66.76	14.05
36.88	-44.64	47.21
-10.2	-25.8	47.28
19.45	-55.91	-.72
-9.15	-84.23	20.94
-9	-81.55	41.91
36.38	-57.52	-23.08
-34.06	-69.15	-15.72
3.19	50.39	12.86
53.64	20	28.21
40.78	-6.83	12.76
45.19	-15.2	27.91
-42.71	18.77	7.12
-58.43	2.04	39.93
-31.16	47.42	-8.8
-3.24	43.58	7.93
-3.33	23.89	-12.72
-.93	49.71	31.92
-39.37	-24.91	6.28
-46.77	-37.3	11.86
-25.39	-57.95	4.43
-61.55	-19.05	42.84
-17.82	-18.5	32.26
-38.36	30.48	20.58
-57.8	-9.1	-21.6
-40.03	-64.56	44.18
-13.8	-70.59	-22.52
-66.15	-18.01	1.55
-47.98	-21.16	0.49
-65.17	-14.55	-8.79
53.58	-20.12	4.81
70.65	-14.82	3.05
-26.42	-58.67	8.96
15.29	12.25	41.57
-9.4	-20.87	14.52
10.91	-20.67	15.38
-27.81	24.77	0.87
-43.55	5.67	30.53
62.08	-17.33	-1.1
64.14	-3.83	-5.6
-60.8	-21.24	0.64
-44.76	-13.31	5.37
-60.74	-52.5	-4.54
54.68	-18.72	9.14
72.78	-17.09	0.99
66.16	-10.47	-22.91
48.96	-1.74	-32.36
-27.49	-58.68	8.98
-21.93	-61.88	35.94
15.52	-65.54	40.28
-3.76	-28.76	49.69
0.62	-55.17	51.85
54.79	7.66	33.69
-14.24	-43.23	69.98
-6.32	-4.62	4.2

// Redcay E, 2014: Subgroup of Participants, males only
// Subjects=26
-5.43	34.17	-3.53
15.84	42.07	-13.35
-8.71	50.98	-6.01
24.62	52.18	20.27
-28.8	48.68	21.18
20.77	4.94	56.62
22.35	65.05	8.06
2.39	5.95	29.98
-19.45	24	-23.7
-18.21	60.92	13.34
33.23	46.23	25.13
-47.67	4.01	50.79
45.12	2.69	25.3
-35.25	13.1	1.93
23.5	-29.68	-19.69
-22.27	-43.47	-1.28
-48.11	-35.73	-22.82
-8.01	-41.73	47.48
13.02	49.33	39.6
-35.72	-72.99	44.84
-12.27	-64.65	40.53
20.88	-90.6	32.29
-3.88	-70.63	17.51
-38.35	-74.8	-19.66
24.61	-45.7	-20.59
13.82	21.25	-7.12
-35.38	-4.74	-22.22
37.99	-27.74	59.16
-35.75	-25.01	59.78
-39.55	-4.79	-8.79
48.05	-.12	-11.3
-43.77	14.44	6.38
-9.32	7.36	35.57
-31.03	13.67	-4.86
-48.05	-9.79	-3.81
-52.11	-57.05	4.66
-34.1	-51.97	-13.82
-28.64	-46.34	3.49
29.47	-71.46	45.08
-26.13	-55.67	47.74
-22.08	-66.76	14.05
-10.27	-18.82	41.12
19.45	-55.91	-.72
-9.15	-84.23	20.94
-9	-81.55	41.91
36.38	-57.52	-23.08
-34.05	-74.52	-16.39
7.55	30.41	15.6
7.48	47.25	13.07
53.64	20	28.21
11.98	1.26	23.57
-19.95	16.7	47.18

// Attout L, 2014: Order STM retrieval
// Attout L, 2014: Alphabetical Order Judgment
// Attout L, 2014: Numerical order judgment
// Attout L, 2014: Conjunction Alphabetical order and Order STM
// Attout L, 2014: Conjunction Order STM and Numerical order judgment
// Attout L, 2014: Distance effect of order STM
// Attout L, 2014: Distance effect of Alphabetical order judgment
// Attout L, 2014: Distance effect of numerical order judgment
// Attout L, 2014: Conjunction of distance effect for alphabeticala andorder 
// STM and numerical vs. luminance
// Attout L, 2014: Conjunction of distance effect for alphabetical order 
// judgment and order STM vs. luminance
// Attout L, 2014: Conjunction of distance effect for order stm and numerical 
// order judgment vs. luminance
// Attout L, 2014: Conjunction of distance effect for alphabetical order 
// judgment and numerical order judgment vs. lum.
// Attout L, 2014: Order STM: Encoding-maintenance phase
// Attout L, 2014: E-M phase inclusive mask over neural substrates associated 
// with 3 distance effects
// Attout L, 2014: E-M phase inclusive mask over neural substrates associated 
// w/ distance effect in STM and num. condit
// Subjects=26
-50	0	46
-28	6	70
-36	18	26
-24	-70	42
-34	-46	38
14	-88	2
-14	-92	-10
30	-68	-28
14	-88	2
-14	-84	-22
16	0	26
-52	-20	16
-50	-34	52
36	-56	-36
-40	-6	10
-22	-4	10
14	-88	2
12	-80	-18
-14	-92	-10
32	-68	-30
-34	-48	40
44	-34	38
38	-40	42
40	-48	48
-28	-54	42
-26	-60	42
24	-62	44
34	-52	44
-2	14	44
4	18	52
-38	-50	36
46	-40	36
30	22	-6
-34	-52	40
40	-48	42
-34	-58	44
-30	-66	54
22	-66	44
34	-62	46
-36	-50	40
-36	-50	40
-34	-48	40
44	-36	38
38	-48	44
-30	-54	42
24	-62	42
34	-52	42
-38	-50	38
46	-40	36
-2	-2	74
-56	-2	20
-4	-48	-22
42	36	30
-36	-42	32
-24	-70	44
32	-70	50
-66	-28	2
-50	-64	-14
-24	-18	-12
24	-94	-10
28	-70	-30
-42	8	26
-44	20	24
-36	-46	34
-42	8	26
-44	20	24
-36	-44	34
-24	-68	44
22	-66	48

// Damarla S R, 2013: Stable Parietal lobe voxels in Pictoral Mode
// Damarla S R, 2013: Stable Parietal lobe voxels in Digit-object mode
// Subjects=10
-11	-53	16
-25	-77	37
27	-77	37
40	-42	53
-29	-45	53
22	-61	57
-37	-52	46
43	-40	51

// Hayashi M J, 2013: Main Effect of Duration Task
// Hayashi M J, 2013: Main Effect of Numerosity Task
// Hayashi M J, 2013: Duration AND Numerosity
// Hayashi M J, 2013: Congruent - Incongruent Contrast (Masked by Duration AND 
// Numerosity)
// Subjects=26
34	20	2
-6	18	48
-34	18	0
48	10	26
48	34	18
-12	6	0
28	-88	18
28	-72	-8
48	-74	10
24	68	-4
-22	-90	10
-26	-76	-8
-22	-93	24
-16	-80	-8
-10	-96	20
40	-80	12
-28	-90	22
22	-90	20
48	6	26
30	-58	-8
-4	36	18
10	28	38
26	-28	60
24	-26	64
50	-32	50
24	-46	54
12	-42	64
-42	-24	8
48	6	26
38	-22	22
28	-88	18
28	-72	-8
48	-74	10
24	-68	-4
28	-74	26
46	34	16
36	12	-8
26	12	-8
0	-52	-34
-4	-58	-16
-22	-90	10
-26	-76	-8
-22	-92	24
-16	-80	-8
-8	30	22
28	-28	62
24	-26	64
50	-32	50
4	-12	4
-4	-12	4
18	-40	4
54	12	28
52	8	30

// He L, 2013: Large > Small
// He L, 2013: Small > Large
// He L, 2013: Nonsymbolic > Symbolic
// He L, 2013: Symbolic > Nonsymbolic
// He L, 2013: Dot-dot > cross-notation trials
// He L, 2013: Digit-digit > cross notation trials
// He L, 2013: Cross-notation > digit-digit trials
// He L, 2013: Overlap between (nonsymbolic>symbolic) and (large>small)
// He L, 2013: Overlap between (Symbolic>nonsymbolic) and (small>large)
// Subjects=20
-23	-62	51
-30	-49	45
-26	-67	35
27	-60	51
28	-67	38
51	-34	49
49	-63	28
26	-60	51
31	-70	28
35	-81	19
-22	-62	51
-33	-41	41
-25	-69	31
-35	-87	14
51	-34	52
55	-56	26
48	-63	30
31	-69	30
-22	-62	44
31	-57	52
-30	-41	40
51	-53	27
30	-55	44
-23	-62	51
-33	-41	41
-26	-67	35
27	-60	51
28	-67	38
51	-34	51
48	-63	30
49	-57	29

// Holloway I D, 2010: Greater Conjunction related activation for Symbolic and 
// Non-symbolic in Adults compared to Children
// Holloway I D, 2010: Greater Conjunction related activation for symbolic and 
// nonsymbolic in children compared to adults
// Subjects=19
44.41	-40.82	54.61
35.76	-46.3	39.55
33.8	-62.03	56.51
39.54	19.97	1.61
-34.68	-11.8	65.35
-24.74	16.82	-19.69
51.5	-15.14	14.45
-46.1	2.52	-23.82
-45.15	12.24	-35.8
5.7	-54.54	18.28
3.08	14.07	-16.44

// Jacob S N, 2014: Line Proportion full brain analysis
// Jacob S N, 2014: Dot Proportion full brain analysis
// Jacob S N, 2014: Line Control (Colour) full brain analysis
// Jacob S N, 2014: Dot Control (Shape) full brain analysis
// Jacob S N, 2014: Adaptation to Line Proportion
// Jacob S N, 2014: Adaptation to Dot Proportion
// Jacob S N, 2014: Numerosity full brain analysis
// Jacob S N, 2014: Overlap of distance effect for proportions and 
// numerosities
// Subjects=15
46	31	46
44	41	52
35	-61	-14
-51	-65	-14
24	-93	6
-18	-96	-3
30	-87	-3
-48	-72	-9
-27	-87	-9
21	-90	-9
-30	-51	48
-30	-54	63
-18	-72	57
24	-63	48
30	-54	48
39	-39	45
-36	-6	57
-45	0	39
48	6	36
-24	-6	51
33	-3	54
42	0	54
-9	6	57
-6	15	45
3	15	42
-33	24	6
-30	27	-6
36	21	0
-21	6	12
27	-75	-15
-21	-93	6
-33	-75	-3
42	-72	9
24	-63	42
27	-51	51
-21	-63	42
-30	-54	54
42	3	30
-48	0	33
6	12	45
12	-27	36
3	-30	42
-6	12	48
3	6	54
36	36	24
-39	39	3
33	27	6
-36	-6	12
-33	18	-9
15	-9	12
9	-21	0
-9	-27	6
-6	-9	15
-24	6	9
-15	6	0
21	0	0
-37	28	50
48	36	45

// Lyons I M, 2013: Whole Brain Conjunction of [NumCard>LumCardNum and 
// DotCard>LumCardDot]
// Lyons I M, 2013: Whole Brain Conjunction of [NumOrd>LumOrdNum and 
// DotOrd>LumOrdDot]
// Lyons I M, 2013: Symbolic: NumOrd>LumSymbolicOrd
// Lyons I M, 2013: Nonsymbolic: Numord>LumNonsymbolicORD
// Lyons I M, 2013: DotOrd>LumOrd(dot) and DotCard>LumCard(Dot)
// Lyons I M, 2013: SymOrd>LumOrd(sym) and SymCard>LumCard(Sym)
// Subjects=33
41.04	-32.61	37.23
1.42	-84.31	5.22
0.31	18.59	42.32
0.37	14.79	48.22
-48.84	7.38	39.37
-56.53	7.31	11.58
43.25	-36.31	44.2
2.41	24.78	39.55
48.24	23.85	23.49
43.67	43.81	-7.13
-45.01	41.25	-4.78
34.15	21.71	-2.94
-33.17	21.31	-2.13
44.31	-34.19	44.01
30.43	-72.56	30.66
3.49	24.87	40.65
42.82	35.02	17.04
49.37	8	24.8
42.6	48.12	-6.36
34.17	20.74	-1.74
-33.16	20.34	-.93
-44.64	-71.44	-3.14
-8.18	-76.45	11.36
44.31	-34.19	44.01
30.43	-72.56	30.66
3.49	24.87	40.65
42.82	35.02	17.04
49.37	8	24.8
42.6	48.12	-6.36
34.17	20.74	-1.74
-33.16	20.34	-.93
-44.64	-71.44	-3.14
-8.18	-76.45	11.36

// Vogel S E, 2013: Number > Control
// Vogel S E, 2013: Brightness > Control
// Vogel S E, 2013: Conjunction of [Number>Control and Brightness>control]
// Vogel S E, 2013: Number Specific Activation
// Subjects=14
10.33	-76.09	55.72
32.61	-61.12	40.83
38.96	-78.23	25.46
35.69	6.8	51.83
9.98	15.91	48.01
44.97	42.87	21.93
-15.57	-98.62	14.42
-12.1	-79.4	56.26
-31.43	-67.34	48.78
51.52	18.04	30.63
35.82	-54.5	43.58
32.51	7.04	55.19
10.34	-79.26	55.99
-34.72	-58.35	41.37
-2.9	25.09	44.05
16.39	-92.85	3.53
52.5	36.83	25.7
35.82	-54.5	43.58
32.51	7.04	55.19
10.34	-79.26	55.99
51.4	36.56	22.39
6.72	25.15	43.93
42.13	-35.69	38.59
-49.72	-42.32	43.55
38.88	-72.4	18.29
26.07	0.14	49.15
-8.87	-80.18	59.63

// Decety J, 2013: Imagine-self perspective
// Decety J, 2013: Imagine-other perspective
// Decety J, 2013: Imagine-self (Controls>psychopaths)
// Decety J, 2013: Imagine-self (Psychopaths > Controls)
// Decety J, 2013: Imagine-other (Controls>psychopaths)
// Decety J, 2013: Imagine-other (Psychopaths>controls)
// Subjects=37
-34	20	2
44	14	0
-58	-28	32
58	-24	34
-4	12	60
6	10	60
-6	20	38
4	18	40
-8	54	14
4	56	18
44	30	-4
-38	28	4
54	12	8
-44	-54	38
46	-66	-12
20	-4	-14
-46	6	-6
34	28	8
-56	-36	36
58	-28	28
-4	12	58
6	10	58
-4	24	26
-6	14	38
0	-10	34
-42	40	10
48	30	0
-8	56	26
8	54	2
-52	8	6
50	12	4
-48	-44	10
50	-36	2
-44	-34	34
-12	0	4
14	58	-2
-12	52	8
0	-28	-14
50	26	8
-4	8	34
4	10	32
-10	2	50
38	20	12
44	-48	14
44	26	2
6	18	34
16	32	12
-44	14	4
34	30	4
-6	16	54
8	24	46
50	-52	22
44	-32	22
-48	-36	22
30	8	2
-14	10	-2
28	48	14
-50	-38	-18
10	16	-6

// Biagi L, 2010: observation of object-related hand actions vs static control 
// conditions
// Subjects=12
-42.49	-69.05	-0.02
45.13	-67.47	-1.16
-52.07	-39.11	16.54
59.07	-38.35	16.31
-58.39	-28.26	33.54
55.98	-31.63	34.74
-35.67	-50.47	60.8
34.87	-44.51	62.83
-28.19	-60.37	55.96
28.41	-61.52	49.83
-30.47	-10.26	57.36
36.84	-6.68	56.29
-47.78	2.9	36.39
51.6	5.61	35.02
56.77	11.59	15.5
57.06	-14.02	42.18
-38.44	-52.68	-22.63
-15.69	-89.96	2.54
21.73	-86.3	5.15
-.37	-47.72	65.74
-39.51	-58.23	-25.5
40.67	-58.47	-21.94

// Bodden M E, 2013: aff-phy
// Bodden M E, 2013: cog-phy
// Bodden M E, 2013: aff-cog
// Subjects=30
46	-54	-16
-38	-4	34
42	4	-24
36	4	52
14	16	-8
38	-40	50
8	-72	46
-4	-28	32
58	-32	38
30	30	-16
-10	-70	-24
36	4	52
40	2	-26
24	-64	50
-48	-50	8
62	-34	38
-16	0	66
2	-14	34
2	22	28
-34	-30	64

// Pardini J E, 2010: Positive Associations between Concussion Symptom 
// Severity and 2-Back vs. 0-Back Contrast
// Pardini J E, 2010: Negative Associations between Concussion Symptom 
// Severity and 2-Back vs. 0-Back Contrast
// Subjects=14
-45.55	8.26	50.41
-20.74	-70.53	47.81
-28.44	1.84	48.52
-33.06	-22.64	-6.25
-29.47	-61.46	28.19
-4.85	-40.03	41.72
21.73	10.35	43.88
39.9	7.2	42.82
37.96	-74.21	36.29
-45.8	-3.12	13.45
-54.43	-9.57	-.41
-50.39	30.93	-13.89
-40.56	-8.6	-2.88
-23.09	-95.75	10.92
-31.71	-75.71	9.34
-34.73	-16.63	57.95
-28.56	-78.49	0.61
-17.51	-48.25	60.4
-20.32	43.65	10.35
-20.41	43.76	-1.93
-12.77	52.04	21.83
-10.4	-55.32	9.61
-11.7	24.67	11.84
2.6	-7.32	51.16
3.52	-84.64	0.76
2.15	19.84	3.17
9.14	-39.97	54.94
9.82	-41.79	3.79
15.61	-44.79	60.85
23.95	-97.49	11.64
17.22	-26.14	-.96
15.21	12.54	31.51
19.43	-42.96	1.54
18.7	-75.64	33.29
25.03	-76.45	22.13
31.6	-29.81	60.52
49.34	-6.6	14.88
43.85	-2.63	-2.12
40.08	-17.24	57.14
42.84	-14.19	-0.02
41.91	-6.13	21.61
48.44	-27.96	27.83
59.28	-15.27	53.41
66.58	-10.5	31.73

// Toepper M, 2010: CBT related activity
// Toepper M, 2010: BST related activity
// Subjects=20
21	-63	66
-39	-45	60
24	-3	57
-27	-3	57
6	-54	54

// Thompson J C, 2014: Intact > Apart
// Thompson J C, 2014: Apart > Intact
// Thompson J C, 2014: Unoccluded > Occluded
// Thompson J C, 2014: Occluded > Unoccluded
// Thompson J C, 2014: Intactness x Occlusion
// Thompson J C, 2014: Upright > Inverted
// Thompson J C, 2014: Unoccluded > Occluded
// Subjects=10
-64	-52	14
-40	-52	22
-40	-40	32
46	-50	-6
44	-40	16
34	-34	34
42	-38	36
-54	-58	6
-26	-80	22
-22	-74	36
30	-66	56
34	-52	64
-38	-52	-22
-30	-48	62
38	-64	-6
-36	-48	22
-20	-62	34
-38	-66	10
64	40	10
-48	-48	-14
-46	-70	6
40	-30	-8
36	-62	6
20	-60	64
-40	-76	-6
-44	-70	4
-46	-46	50
38	-38	-24

// Castelli I, 2010: Healthy Controls Young
// Subjects=12
48	2	54
-42	-4	54
52	24	26
-4	32	56
-26	-50	45
-34	-50	43
-42	22	-20
40	10	-38
50	-36	-6
30	-88	28
12	-80	-6
-4	-84	-12
-4	26	24
-14	4	0
-26	-6	-22
6	-20	-2
2	-38	-8
-18	-46	-26
26	18	32
14	-80	-6
-4	-84	-12
-2	28	12
-48	-8	52
40	-16	66
-46	16	16
-64	-32	18
-24	-20	16
26	-24	18
40	-52	45
55	-1	24
18	38	35
46	30	13
46	-14	-3
-40	-74	41

// Castelli I, 2010: Healthy Controls Old
// Subjects=12
26	18	32
14	-80	-6
-4	-84	-12
-2	28	12
38	-8	50
-40	-4	54
8	10	50
58	24	6
-16	50	30
-50	34	0
-24	-58	52
-32	-50	43
-62	-32	14
58	4	-14
-50	-46	-20
32	-74	22
-26	-98	-4
10	-6	4
26	-24	20
-24	-20	16
-10	-10	12
20	-72	-34
-2	-52	-42
-48	-8	52
40	-16	66
-46	16	16
-64	-32	18
-24	-20	16
26	-24	18
4	62	-3
-47	9	-9
30	13	-17
-32	19	-14
42	30	15

// Corradi-Dell'Acqua C, 2014: Attribution of Beliefs
// Corradi-Dell'Acqua C, 2014: Attribution of Emotions
// Corradi-Dell'Acqua C, 2014: Attribution of Pain
// Corradi-Dell'Acqua C, 2014: Beliefs > Photos
// Corradi-Dell'Acqua C, 2014: Emotions > Photos
// Corradi-Dell'Acqua C, 2014: Pain > Photos
// Corradi-Dell'Acqua C, 2014: Belief > Emotions
// Corradi-Dell'Acqua C, 2014: Emotions > Belief
// Corradi-Dell'Acqua C, 2014: Belief > Pain
// Corradi-Dell'Acqua C, 2014: Pain > Belief
// Corradi-Dell'Acqua C, 2014: Emotion > Pain
// Corradi-Dell'Acqua C, 2014: Pain > Emotion
// Subjects=46
8	58	12
6	54	-6
4	-52	28
60	-58	28
54	8	-26
48	30	-8
24	-10	-16
-52	-58	26
-64	-16	-14
-48	30	-8
-22	-10	-14
-4	44	-10
-2	-18	36
8	-82	28
66	-22	30
-58	-32	32
-4	-28	26
-10	-70	34
64	-32	36
46	42	6
-58	-36	34
-42	42	10
-28	34	-14
-40	-4	-6
8	56	12
-4	44	-14
6	-54	30
58	-46	22
66	-24	-4
26	-22	-16
-48	-58	24
-64	-20	-12
-20	-28	-12
8	56	10
-4	44	-14
0	-14	38
8	-52	28
16	10	-8
62	-8	-12
-12	12	-8
-30	10	-22
66	-40	22
18	-72	2
16	-72	46
12	4	-8
-14	8	-12
-56	-34	36
-38	-8	-6
-6	-60	44
-38	-74	34
-14	-56	16
-6	-60	18
12	2	0
-14	8	4
-2	-56	36
62	-54	26
52	2	-28
24	32	50
-52	-56	30
-64	-14	-12
-28	30	48
-26	-34	-16
6	60	16
2	54	-16
-53	-36	36
-50	8	18
-6	-62	18
-2	48	-18
-4	-52	30
60	-56	28
58	-2	-26
40	-28	64
-54	-60	32
-60	-10	-14
-48	28	8
-58	-34	36
-46	6	16
-40	-12	4

// Das P, 2012: Schizophrenia
// Subjects=20
42	8	30
28	-98	0
40	-80	-8
32	-90	-6
58	-38	14
54	-56	2
44	-60	-6
32	-56	-12
-30	-94	-8
-48	-68	-4
-52	-56	4
-60	-60	-2
-48	-62	-12
60	-26	48
64	-16	36
-18	-78	-40
-32	42	24
-30	56	16
38	32	36
-8	30	28
-8	-100	4
16	-90	24
-10	-90	24
0	-22	32
54	16	2
-52	24	4
46	16	20
68	-34	10

// Das P, 2012: Healthy Control
// Subjects=19
50	18	20
40	12	32
42	8	44
-44	12	24
-38	2	46
-40	-2	34
16	8	66
62	-42	18
44	-78	28
50	-62	-6
38	-64	-10
32	-90	-4
40	-82	18
32	-70	32
32	-58	48
56	-20	24
58	-18	50
14	-74	-38
-30	-92	-8
-36	-88	18
-36	-84	34
-58	-46	14
-60	-58	10
-42	-58	-8
-28	-44	-16
-16	-72	-40
4	-26	-4
-20	36	6
-22	16	54
-14	-102	14
16	-84	24
16	-70	-6
-18	-58	64
20	-52	62
52	-62	46
54	16	2
-52	24	4
46	16	20
68	-34	10

// Dohnel K, 2012: FB > Control FB
// Dohnel K, 2012: TB > Control TB
// Dohnel K, 2012: (FB > Control FB) + (TB > Control TB)
// Dohnel K, 2012: FB > TB
// Dohnel K, 2012: TB > FB
// Dohnel K, 2012: B (FB, TB) > Control (Control FB, Control TB)
// Subjects=18
-31	16	1
51	-43	14
-60	-29	-4
52	31	14
57	-38	4
-52	-66	22
41	-47	-10
55	-47	15
-3	27	52
47	31	30
-49	11	43
34	16	0
-33	28	0
-45	-33	-2
-42	-52	55
12	-60	48
-13	-3	18
-10	54	9
1	37	-14
65	-23	26
0	27	51
47	11	34
-56	17	27
49	-65	10
-52	-66	22
-3	-54	50
41	-49	-7
-39	-49	-9

// Martineau J, 2010: Autism Group (ASD)
// Subjects=7
-32	-34	66
-58	-22	48
20	-42	-32
60	-18	42
30	-42	54
-50	-30	36
44	-26	22
-38	-74	-8
26	-90	14
-26	-84	24
38	-62	2
-56	20	20
52	12	12
22	-44	-32
-32	-26	52

// Martineau J, 2010: Healthy Controls (TD)
// Subjects=8
-36	-28	70
-34	-50	54
-48	-70	-8
46	-68	2
-56	20	20
52	12	12
42	-80	-4
36	-68	8
54	-60	0
4	-72	48
28	-82	38

// Kim J W, 2010: Attitude attribution > Control
// Subjects=24
-52	26	2
-52	26	8
-54	18	4
-50	30	2
-60	-42	4
-52	-48	48

// Spreng R N, 2010: Past, Future, Other > Control
// Spreng R N, 2010: Control > Past, Future, Other
// Spreng R N, 2010: Other > Past, Future
// Spreng R N, 2010: Past, Future > Other
// Subjects=16
-68	-36	-4
-4	20	52
-12	32	20
-8	-44	4
-12	56	44
-44	16	52
-44	36	-12
20	-88	-36
32	-60	4
20	8	12
-20	4	8
-48	28	4
-4	-48	24
-52	24	36
-64	-12	-16
-60	-12	-28
-40	-76	40
-12	64	24
28	-60	-16
-48	-80	8
-48	0	-4
20	-28	0
-16	-40	48
-8	-72	-44
52	0	28
-32	-32	72
48	-36	-4
48	-48	20
-52	-48	12
-4	-36	40
-8	-60	24
-8	-44	8
-24	-40	-20
-32	-80	44
8	-40	4
-20	-20	-24
-4	40	4
-16	64	12
16	-44	-52
-24	16	52
4	-8	12
44	-72	-44
-32	24	-8
28	-40	-12
-12	12	-4
-4	-20	-28

// van der Meer L, 2011: High-inhibition (HI) > Low-inhibition (LI)
// van der Meer L, 2011: HI > Fixation
// van der Meer L, 2011: LI > Fixation
// van der Meer L, 2011: Baseline > Fixation
// van der Meer L, 2011: NoGo > Go
// Subjects=19
-24	-76	-8
10	-84	-2
18	-76	-12
-38	0	42
-40	10	28
-52	16	18
-56	-38	0
-56	-10	-12
-56	-54	16
-18	-94	20
-32	-84	14
-6	16	46
-4	6	60
-2	16	56
-2	-28	-4
-28	-56	44
-10	-86	44
-6	-52	46
-4	-80	44
32	22	6
34	26	-2
30	-86	20
36	-88	14
-26	24	4
-35	22	12
-52	18	18
-30	-2	54
-42	2	44
-8	18	36
-44	-52	42
-56	-42	-2
14	-68	46
-8	-82	-10
24	-78	-10
-56	-54	18
8	-68	-22
34	-58	42
38	-8	54
32	-54	-30
-8	-20	-2
-30	-58	42
36	-58	46
-54	-48	-2
-6	-4	54
10	-16	-4
-32	20	2
-52	4	14
-34	-12	62
44	-24	44
44	-16	58
-28	-52	-34
32	-52	-30
-6	-70	-26
8	-66	-26
-42	-44	40
-58	-36	0
-30	-2	50
-4	-70	42
14	-70	46
-8	12	36
-26	26	2
38	10	0
44	2	8
34	28	-2
-8	-78	-10
16	-76	-10
-36	-10	60
54	-16	42
-30	-52	-32
40	-58	-34
-4	-16	-12
-48	20	-8
58	6	0
16	60	26
38	58	2
16	34	42
-6	42	12
-48	-30	54
-60	-56	2
-44	-76	-12
44	-34	16
56	-54	34
32	-42	66
-60	-52	38

// Abraham A, 2010: (Belief question > Control) + (Desire question > Control)
// Abraham A, 2010: Belief scenario > Desire scenario
// Abraham A, 2010: Belief Question > Desire Question
// Abraham A, 2010: Desire scenario > Belief scenario
// Abraham A, 2010: Desire Question > Belief Question
// Abraham A, 2010: Incongruent > Congruent
// Abraham A, 2010: False beliefs > True beliefs
// Subjects=22
-4	11.62	35.15
8.52	38.19	6.01
-23.46	45.37	19.16
24.63	45.66	18.58
9.03	-29.03	45.1
63.38	-36.84	21.71
60.26	-26.06	37.57
46.99	31.82	2.76
47.11	0.1	5.42
-49.05	-3.65	6.84
-36.2	3.29	12.8
-52.03	-30.93	25.89
-17.15	11.38	-8.17
14.91	18.17	-5.76
-45.89	35.47	16.9
-26.76	64.13	14.28
24.57	61.52	17.26
24.68	52.78	28.02
40.52	47.64	1.51
27.76	58.11	14.16
37.52	46.51	28.4
-45.86	35.72	20.23
-29.78	49.53	32.27
53.8	-72.82	11.46
53.67	-67.51	-2.37
47.31	-80.23	-1.23
44.24	-82.14	15.7
-35.96	-53.56	20.91
-32.65	-68.88	28.85
-45.96	-14.69	-12.34
-1.19	37.11	-7.17
43.77	-11.24	-17.01
47.37	-49.88	19.65
-45.9	-17.35	-5.43
53.47	-6.98	-4.1
-48.76	-46.77	27.18
-58.55	-28.83	12.4
53.82	-72.57	14.78
-33.26	10.51	-17.95
27.69	-5.24	-20.67
27.77	-20.85	-16.02
40.41	-19.4	-39.71
37.96	-21.48	57.52
28.4	-30.8	61.76
12.36	-96.91	34.03
-4.8	-100.95	24.53
-52.1	-31.7	15.92
-4.25	-10.75	-6.46
-10.75	54.2	8.24
8.41	53.54	-1.96
-7.49	67.93	20.43
-.63	-65.78	24.87
-16.69	-62.96	21.48
-1.12	64.28	13.97
-4.42	50.03	-4.87
-.63	-65.78	24.87
-16.78	-47.35	16.82
21.68	-50.55	13.31
-16.83	-47.87	10.18
31.02	-23.74	-12.47
21.32	-1.6	-14.22
31.02	-23.74	-12.47
-29.89	-17.51	-8.95
-48.93	-8.97	20.67
-52.32	-7.61	-2.83
-20.36	11.36	-8.13
-22.8	-26.91	75.4
-29.36	-15.28	61.12
-48.51	-31	66
47.03	28.91	6.35

// Dodell-Feder D, 2010: (Subject-wise) BELIEF > PHOTO
// Dodell-Feder D, 2010: (Item-wise) BELIEF > PHOTO
// Subjects=62
-2	-54	38
52	-52	22
58	-20	-14
-50	-58	20
-60	-24	-8
50	6	-34
2	60	18
10	34	62
0	56	26
-52	4	-28
-20	60	30
46	8	48
2	-92	0
2	-22	42
52	30	-6
2	48	-18
62	-32	0
56	-48	24
58	-22	-10
-50	-50	24
8	-58	40
0	60	18
-18	60	28
12	34	62
2	58	30
62	-24	-10
52	2	-36

// Lee J, 2011: Healthy Controls
// Subjects=14
42	-54	24
-40	-54	24
14	26	42
40	10	42
60	-26	-8
-52	-60	14
-64	-18	-8
38	22	34
-8	-54	40
4	-56	34
10	40	42
-44	-54	24
50	-56	26
-52	-58	34
-58	-58	16
-56	-48	18
52	-50	30
56	-54	26
-56	-56	26
44	-66	38
-50	-70	40
-48	-70	44
4	-64	38
22	28	36
-44	-68	26
62	-8	-14
18	-42	32
12	-52	34
14	38	40
54	-62	28
42	-52	22
-38	-54	26
46	12	-30
56	-54	24
-60	-58	26

// Prochnow D, 2014: Face Affect (Emotional Facial Expessions) > Control, 
// Stimulus Presentation
// Prochnow D, 2014: Face Affect (Emotional Facial Expessions) > Control, 
// Empathic Reasoning Decision
// Subjects=26
48.37	5.33	31.73
-48.03	-63.4	-22.73
-57.22	-16.22	51.48
-47.44	-37.6	63.2
45.25	-53.07	19.94
-47.86	-71.54	-4.21
35.65	-72.67	15
48.34	-77.31	-4.83
-41.14	-15.61	57.93
-50.67	-37.87	59.91
38.64	-68.37	-12.16
51.57	5.35	31.69
-60.44	-13.07	51.25
-51.05	-68.13	-1.11
44.95	-56.15	-19.95
48.35	-80.48	-4.56
-51.18	-76.11	-21.63
-48.27	59.29	-5.14
-47.89	26.96	31.02
-6.08	25.33	47.41
75.12	0.46	35.18
-60.55	2.28	43.27
-32.13	30.83	-2.94
-47.5	-15.13	64.66
-31.49	-51.47	47.45
-12.45	-76.39	12.52
-22.3	-55.79	-9.17
9.83	-81.23	-10.75
-6.17	-81.07	-7.24
-45.07	46.1	-10.76
65.33	33.73	25.81
-47.9	23.53	27.96
-6.09	28.5	47.14
-9.18	23.16	61.01
-47.57	3.9	63.06
-51.25	28.66	11.96
-6.27	-75.49	-17.74
-57.45	30.85	40.84
-48.05	35.2	13.61
-6.15	37.76	43.02
-54.66	33.1	-12.91

// Rothmayr C, 2010: False belief > True belief
// Rothmayr C, 2010: No go > Go
// Rothmayr C, 2010: Conjunction for False belief > True belief and No go > Go
// Rothmayr C, 2010: Masking False belief > True belief with No go > Go
// Subjects=12
-42	22	42
32	4	52
52	-50	38
6	66	22
66	-36	-2
-52	-50	32
-40	52	-4
-64	-38	-10
-18	4	14
-2	-62	44
10	34	46
52	28	30
30	58	10
48	20	-4
-62	-56	36
64	-46	30
6	24	62
-44	20	48
56	-50	36
66	-36	-2
54	26	30
-60	-58	32
10	36	44
-50	-50	30
-4	24	62
-46	26	26
-18	4	14
0	-64	50
-36	56	-6
-32	4	54
-2	50	20
-64	-38	-8
-28	50	28

// Saft C, 2013: pre-HD
// Subjects=30
-8	14	62
-2	6	72
-10	30	54
-10	46	44
-16	52	46
-38	14	48
-42	32	-6
-50	34	-8
-54	26	8
-4	54	-14
-6	52	48
-12	-48	38
2	-50	28
8	-54	40
-44	-60	24
44	-60	24
44	-66	14
52	-50	14
-50	-50	14

// Saft C, 2013: Healthy controls
// Subjects=26
-14	54	34
0	48	-20
6	50	30
6	42	-16
-2	-56	36
18	-66	14
22	-62	6
-60	-6	-12
58	-12	-16
52	-64	2
-54	-54	6
-44	-52	16

// Schlaffke L, 2014: Affective ToM > Control
// Schlaffke L, 2014: Cognitive ToM > Control
// Schlaffke L, 2014: Affective ToM > Cognitive ToM
// Schlaffke L, 2014: Cognitive ToM > Affective ToM
// Subjects=39
-4	12	55
-4	16	49
-8	56	34
-44	18	49
-52	22	10
-58	-60	19
-52	-36	-5
60	-8	-20
52	-76	1
30	-98	4
14	-106	10
42	-76	-8
-4	-54	37
-4	14	58
-46	12	52
-52	-64	19
52	-48	16
-60	-38	-2
50	-64	13
52	-14	20
-56	-6	-23
-48	-80	1
-2	-58	40
-2	30	40
-2	42	49
-52	18	4
-46	32	-5
32	12	-14
8	-68	7
18	-4	16
-12	-6	16
38	-60	25
-36	-82	28
-18	-90	19
-4	-94	16
2	-52	49

// Schnell K, 2010: Affective > Visuospatial
// Schnell K, 2010: 3pp > 1pp
// Schnell K, 2010: (3 pp visuospatial > 1 pp visuospatial) > (3 pp affective 
// > 1 pp affective)
// Schnell K, 2010: (3 pp affective > 1 pp affective) > (3 pp visuospatial > 1 
// pp visuospatial)
// Schnell K, 2010: 3 pp affective > 3 pp visuospatial
// Schnell K, 2010: 3 pp visuospatial > 1 pp visuospatial
// Schnell K, 2010: 1 pp affective > 1 pp visuospatial
// Schnell K, 2010: Conjunction Affective > Visuospatial
// Subjects=21
-6	54	30
6	54	24
-3	45	-15
6	6	9
-3	0	-3
-48	27	-9
-39	21	-15
-45	12	-39
-45	-57	21
-54	-21	-12
-27	0	-24
-18	-9	-24
45	9	-42
66	-51	21
57	30	3
-6	-48	30
-15	-30	27
21	-30	24
-21	15	3
27	-84	-39
-30	-81	-36
30	9	57
27	21	45
-27	9	54
-54	-51	21
-51	-39	6
63	-48	18
57	-54	15
57	-54	24
9	-54	54
-9	-45	48
-33	-36	51
42	-78	33
-39	-75	36
66	-45	30
66	-45	18
51	-18	45
39	-21	42
39	-27	57
-15	-3	42
-12	6	36
42	-48	-6
36	-63	39
-15	-12	24
30	-15	0
36	-9	0
27	-3	21
21	-12	24
30	-33	3
-6	54	36
-6	51	12
9	51	27
-3	45	-15
42	-18	48
42	-9	39
39	-12	69
-42	-12	42
57	30	3
48	33	-3
-45	27	-6
-39	27	-15
-48	3	-30
51	-30	-3
48	-36	3
48	9	-42
48	0	-27
57	3	-24
-57	-66	24
-45	-57	27
-18	-12	-21
-30	-15	-21
-27	0	-24
-54	-51	27
12	-18	48
0	-12	42
21	-30	24
12	-18	24
-12	-27	24
-12	-15	24
-15	-45	27
30	-84	-39
-27	-81	-36
-48	-51	18
-63	-45	18
-54	-54	36
66	-45	18
60	-57	24
66	-42	33
-3	-54	57
6	-48	51
-6	-42	48
-9	51	30
6	54	24
-15	48	39
-48	27	-9
-45	12	-39
-42	21	-12
45	9	-42
57	30	0
45	18	-36
66	-48	21
63	-57	24
27	-84	-39
-30	-81	-36
-6	51	33
9	51	27
57	30	3
51	30	-3
0	45	-15
-9	15	69
-9	21	63
3	9	66
-57	18	15
-45	27	-6
-39	24	-15
-45	9	-36
-60	-21	-18
-54	-24	-3
48	9	-42
45	15	-36
45	-30	-3
45	-42	6
30	-84	-39
-30	-81	-36

// Spunt R P, 2014: (Study 1) Healthy controls
// Subjects=29
-6	58	18
-6	56	40
-6	24	64
8	52	40
-2	44	-18
-46	24	-12
-48	-66	28
-2	-48	30
46	14	-34
-54	-8	-18
60	-8	-22
54	-2	-22
-58	-36	0
34	-80	-34
-30	-82	-32
-42	-42	40
-46	-42	58
40	-42	48
56	-32	50
50	-42	40
60	-24	24
-56	-36	40
-8	-62	58
10	-68	52
-26	-62	58
-24	-70	32

// Spunt R P, 2014: (Study 2) Healthy controls
// Subjects=10
-48	-66	26
-6	-56	28
-42	36	-18
-8	38	-16
-6	54	16
2	-58	22
-8	-62	46
46	-50	24
-44	-50	34
20	10	56
-8	62	22
-20	34	44
-6	48	0
8	58	28
14	50	40
-2	46	-18
-42	30	-14
-48	22	-2
-46	-62	32
56	-62	24
-4	-50	32
-46	6	-34
-60	-12	-16
54	0	-28

// Li X, 2010: Consonant (random) > consonant (fixed)
// Li X, 2010: Rhyme (random) > rhyme (fixed)
// Li X, 2010: Tone (random) > tone (fixed)
// Subjects=12
-36	8	24
-32	-56	34
4	20	44
34	30	6
32	-2	44
30	-56	40
-36	22	26
-26	-66	44
-4	22	42
32	26	-4
10	-78	-28
36	-54	40
28	-4	38
-44	8	30
-28	-64	38
-2	-78	-30
30	30	-4
40	-60	48
36	-4	48
0	18	50

// Nan Y, 2013: Language phrase pitch processing > music phrase pitch 
// processing
// Subjects=18
63	-6	-5
57	-30	5
63	-24	0
-54	-12	-5
-60	-18	5
-54	27	0

// Chang H C, 2014: Tone sandhi sequence > baseline
// Chang H C, 2014: Mixed tone sequence > baseline
// Subjects=15
-31.48	56.31	-1.78
-46.39	48.04	13.86
-44.51	49.26	-7.58
-55.92	15.55	22.84
-37.96	25.68	-7.6
1.94	11.5	68.2
-52.38	7.96	44.82
-66.84	-16.03	7.1
-26.14	-64.06	53.74
-45.62	-40.31	56.21
-.23	-75.02	49.9
-24.54	-97.75	3.26
-44.21	-75.46	-9.81
-5.09	-97.68	2.93
1.17	-3.03	4.66
46.52	54.95	13.84
62.75	20.15	8.04
62.54	18.59	-8.61
46.29	21.51	-10.87
51.59	-6.17	60.14
69.15	-2.35	-3.29
32.3	-57.6	62.19
40.71	-40.74	46.94
3.63	-79.6	12.19
18.63	-55.29	7.29
29.35	-88.72	-6.39
11.83	14.57	-2.87
-48.53	39.42	13.63
-33.64	25.69	-7.68
-.42	15.46	53.28
-32.75	8.32	59.02
-53.66	11.93	29.89
-64.42	-12.99	28.05
-66.87	-16.24	4.88
-30.4	-54.84	60.75
1.99	-64.71	56.69
-11.45	-74.88	17.59
-44.21	-75.46	-9.81
-31.03	-95.65	3.17
-7.24	-99.82	3.17
1.21	-7.08	7.3
-20.57	7.97	-2.78
-11.78	3.62	7.58
1.05	-49.88	-14.24
38.55	10.7	57.57
35.52	21.68	-8.46
6.4	-12.63	73.87
51.57	-6.38	57.92
36.59	-10.81	68.7
53.26	14.22	25.6
53.62	-22.51	46.03
32.3	-57.6	62.19
5.76	-88.51	8.56
12.05	-84.52	-6.51
14.34	-55.1	9.59
20.76	4.67	17.01
11.87	6.06	-2.03

// Alluri V, 2011: Fullness, Positive correlation
// Alluri V, 2011: Fullness, Negative correlation
// Alluri V, 2011: Brightness, Positive correlation
// Alluri V, 2011: Brightness, Negative correlation
// Alluri V, 2011: Activity, Positive correlation
// Alluri V, 2011: Activity, Negative correlation
// Alluri V, 2011: Timbral Complexity, Positive correlation
// Alluri V, 2011: Key Clarity, Negative correlation
// Alluri V, 2011: Pulse Clarity, Negative correlation
// Subjects=11
56.21	-13.13	-3.12
56.21	-13.13	-3.12
55.17	-13.89	0.33
55.07	-2.61	-5.27
69.36	-12.8	11.19
44.59	-26.51	15.21
55.53	-32.02	24.53
58.22	3.27	-11.5
33.28	-85.02	-35.96
28.95	-85.14	-37
33.28	-85.02	-35.96
35.63	-67.19	-17.59
35.63	-67.19	-17.59
7.18	-50.33	-42.31
17.96	-52.62	-44.51
-52.85	-20.76	1.73
-52.85	-20.76	1.73
-56.05	-13.87	6.71
-52.89	-18.84	-.7
-46.19	-27.04	14.56
-53.76	-23.87	14.38
-13.97	-77.59	-11.24
-13.97	-77.59	-11.24
-29.29	-68.15	-24.24
-29.29	-66.02	-24.45
-29.29	-68.15	-24.24
-7.73	-77.2	-30.43
-7.74	-75.07	-30.64
-29.4	-74.5	-34.81
-29.4	-74.5	-34.81
-27.25	-72.37	-35.06
-31.56	-76.64	-34.57
-20.66	-90.11	-30.06
-20.66	-90.11	-30.06
49.35	-17.75	51.24
49.35	-17.75	51.24
45.17	-33.09	59.55
45.13	-33.4	56.22
45.14	-33.3	57.33
45.17	-33.09	59.55
-37.06	-26.66	52.47
-37.06	-26.66	52.47
-32.77	-37.8	47.9
-27.47	39.8	-29.35
-31.78	44.25	-27.47
-17.38	-57.67	64.17
-17.38	-57.67	64.17
-23.94	-37.49	62.28
-15.19	-57.46	66.35
55.18	-18.25	-.36
55.18	-18.25	-.36
53.01	-13.9	0.37
55.07	-2.61	-5.27
69.36	-12.8	11.19
44.59	-26.51	15.21
53.37	-32.03	24.57
50.91	-33.15	1.19
56.03	3.05	-13.69
61.03	5.93	39.73
61.03	5.93	39.73
56.84	5.78	49.9
26.84	12.63	-13.02
26.84	12.63	-13.02
16.14	12.25	-4.95
16.08	7.48	-10.08
24.83	14.82	-.87
-33.58	-67.95	-21.94
-29.28	-63.68	-22.44
-33.58	-67.95	-21.94
-58.28	-14.39	1.19
-58.28	-14.39	1.19
-56.05	-13.87	6.71
-48.64	-7.33	-4.15
-66.72	-19.46	16.4
-48.35	-27.04	14.6
-66.74	-21.79	14.39
-62.7	-11.84	-5.71
-60.69	5.62	-14.19
-57.8	5.61	42.91
-57.8	5.61	42.91
-57.81	5.51	41.8
-20.53	47.61	7.86
-20.55	48.57	6.65
-20.49	47.92	11.19
-5.12	-44.32	11.09
-5.15	-44.53	8.87
56.21	-13.13	-3.12
56.21	-13.13	-3.12
55.17	-13.89	0.33
44.59	-26.51	15.21
55.53	-32.02	24.53
56.06	3.26	-11.47
55.07	-2.61	-5.27
69.36	-12.8	11.19
9.22	64.81	-27.96
9.22	64.81	-27.96
33.29	-86.08	-35.86
28.95	-85.14	-37
33.29	-86.08	-35.86
35.66	-66.98	-15.37
35.66	-66.98	-15.37
-5.17	-40.28	8.45
-5.12	-44.32	11.09
-52.85	-20.76	1.73
-52.85	-20.76	1.73
-56.05	-13.87	6.71
-46.19	-27.04	14.56
-55.92	-23.88	14.42
-60.7	7.75	-14.4
-52.89	-18.84	-.7
-31.45	-68.15	-24.2
-29.29	-66.02	-24.45
-31.45	-68.15	-24.2
-33.69	-76.44	-32.31
-29.4	-74.5	-34.81
-27.25	-72.37	-35.06
-33.69	-76.44	-32.31
-16.13	-77.59	-11.2
-16.12	-78.66	-11.1
47.2	-19.88	51.49
47.2	-19.88	51.49
-37.06	-26.66	52.47
-37.06	-26.66	52.47
-39.26	-31.34	48.49
-17.39	-48.96	65.55
-17.39	-48.96	65.55
-23.94	-37.49	62.28
-15.22	-48.95	65.51
-32.93	14.62	46.07
-32.93	14.62	46.07
-32.95	12.29	44.06
-20.43	59.28	17.91
-20.43	59.28	17.91
-22.57	59.48	20.17
58.32	-6.95	-6.01
58.32	-6.95	-6.01
56.25	-11.76	0.1
71.39	-2.78	3.44
75.69	-24.87	-3.41
55.07	-2.61	-5.27
71.49	-8.64	9.62
58.19	3.06	-13.72
-58.35	-11.62	-3.56
-58.35	-11.62	-3.56
-52.8	-15.98	6.86
-44.03	-27.03	14.53
-60.5	-13.75	-3.32
-27.11	-65.8	-22.27
-27.11	-65.8	-22.27
-31.42	-67.95	-21.98
65.19	0.34	25.65
65.19	0.34	25.65
69.39	7.17	18.17
67.13	-.15	8.85
60.87	-8.4	24.34
53.76	-8.29	60.31
55.9	-8.49	58.05
53.76	-8.29	60.31
55.41	-11.06	19.1
38.08	-14.73	15.27
55.41	-11.06	19.1
14.98	-4.3	70.66
17.14	-4.29	70.63
10.71	-10.49	73.59
17.15	-6.42	70.84
14.98	-4.3	70.66
-45.62	-11.83	62.35
-45.62	-11.83	62.35
-43.46	-10.76	62.21
-48.39	-6.52	15.93
-48.47	-9.38	8.37
-55.88	-10.39	20.93
-48.39	-6.52	15.93
-7.39	59.95	24.35
-9.55	59.94	24.38
-7.39	59.95	24.35
-35.59	-9.96	1.49
-37.75	-12.09	1.74
16.8	-.3	44.46
16.8	-.3	44.46
16.79	1.83	44.25
-33.43	-9.95	1.45
3.73	12	38.99
3.73	12	38.99
5.92	12.22	41.17
15.02	-43.42	65.57
15.02	-43.42	65.57
17.18	-43.41	65.53
42.18	13.17	3.48
42.18	13.17	3.48
44.36	13.39	5.66
52.84	-51.28	-20.58
48.55	-50.02	-18.39
52.84	-51.28	-20.58
-33.61	-8	-12.19
-29.32	-8.2	-14.48
-31.47	-10.33	-14.23
-37.93	-8.02	-12.11
-31.41	-9.92	-9.79
-.59	11.99	39.06
-.59	11.99	39.06
-.6	14.11	38.85
-39.99	14.6	0.25
-39.99	14.6	0.25

// Atzil S, 2011: Own Infant > Unfamiliar Infant
// Subjects=23
64.5	-36.32	28.35
45.14	-70.73	-2
42.22	-5.08	62.79
32.07	22.22	3.74
26.32	-53.27	60.32
7.15	-75.85	59.09
16	18.43	-2.45
15.97	-1.63	-14.15
3.69	-15.86	50.75
6.85	16.66	58.02
6.59	23.86	27.31
-3.08	46.27	28.89
0.79	-48.97	76.98
-9.5	6.62	12.21
-41.41	-74.42	-.7
-19.02	-12.22	17.25
-38.49	14.93	-1.53
-54.07	-49.72	30.83
-66.94	-37.11	29.92
-9.69	-5.21	-16.9
31.91	0.87	-24.58

// Bulthe J, 2014: Subtraction - Fixation
// Subjects=16
-8	8	60
-50	5	28
-22	-55	40
-44	-86	-8
24	-55	50
-22	66	44
42	-84	-8
32	-52	46
44	-76	-18
-44	-44	42
-46	-62	-20
32	4	64
48	10	28
-26	24	2
44	0	54
-20	8	70
-32	28	-4
-42	38	28
42	2	40

// Demeyere N, 2014: Adaptation to categories (repeated categories pairs vs. 
// different categories pairs)
// Demeyere N, 2014: Repetition of small category versus large category (large 
// < small)
// Demeyere N, 2014: Repetition of small cateogry versus large category (small 
// < large)
// Demeyere N, 2014: Numerosity specific repetition [Rep-Cat > (Rep-num + 
// Rep-Exact)]
// Demeyere N, 2014: Interaction S/L with Cat/Num/Ex
// Demeyere N, 2014: Small num < Small cat
// Demeyere N, 2014: Small exact < Small cat
// Subjects=12
-16	4	54
-10	6	60
-28	12	48
-26	-54	32
-14	4	30
12	38	4
-12	42	20
-14	-40	26
-8	-50	32
-44	-62	24
-36	-52	24
54	-56	20
54	-64	36
-16	32	50
-18	2	44
-8	10	46
44	26	6
16	-40	54
-16	-42	60
-34	-38	44
-36	-60	-2
30	-62	0
24	-50	28
-42	-30	18
26	-14	16
-10	32	24
12	42	18
-12	-42	24
-54	-18	30
-36	-62	4
24	18	2
-38	-60	0
16	16	48
-54	-18	30
26	20	0
-36	-60	-2
-12	10	46
10	4	48
-60	-14	24
24	-46	32
38	24	24

// Garbin G, 2012: Object Noun, Event Noun, and Verb > Object Pseudonoun, 
// Event Pseudonoun, and Pseudoverb
// Garbin G, 2012: Object Noun > Object Pseudonoun
// Garbin G, 2012: Event Noun > Event Pseudonoun
// Garbin G, 2012: Verb > Pseudoverb
// Garbin G, 2012: Object Noun > Event Noun
// Garbin G, 2012: Event Noun > Object Noun
// Garbin G, 2012: Object Noun > Verb
// Garbin G, 2012: Verb > Object Noun
// Garbin G, 2012: Event Noun > Verb
// Garbin G, 2012: Verb > Event Noun
// Garbin G, 2012: Object Noun and Event Noun > Verb
// Garbin G, 2012: Verb > Object Noun and Event Noun
// Garbin G, 2012: Object Noun > Event Noun and Verb
// Garbin G, 2012: Event Noun and Verb > Object Noun
// Garbin G, 2012: Object Pseudonoun > Object Noun
// Garbin G, 2012: Event Pseudonoun > Event Noun
// Garbin G, 2012: Pseudoverb > Verb
// Subjects=12
-46	12	10
-48	-54	14
-54	-36	12
-56	-14	18
48	-2	54
52	14	-12
56	-56	12
62	-44	42
66	-20	22
-60	-32	32
-28	32	22
-44	14	16
-26	10	48
-62	-20	12
46	-34	10
56	-58	14
60	-28	16
-42	18	6
-18	44	12
-58	-4	4
-48	-32	22
-56	-6	16
66	-52	10
50	-40	10
40	-54	6
-46	2	8
-36	-6	14
-34	-4	52
-46	-60	46
-16	-56	66
-24	-16	16
48	0	34
68	-36	-6
68	-32	34
6	-78	42
4	-6	42
-38	14	12
-28	30	14
-32	-36	18
-48	34	34
-30	-4	68
-56	6	-4
-34	-32	4
-56	-18	12
-32	-38	66
-10	-38	0
40	10	10
54	42	2
64	14	22
16	20	56
28	-16	66
44	-14	-8
64	-32	12
48	-66	10
48	-30	28
40	-34	60
10	-10	-4
-36	-8	16
-46	2	8
-34	-4	52
-42	-32	48
-16	-56	66
48	0	34
8	-12	54
68	-32	34
6	-78	42
-32	26	-6
-52	10	2
-42	42	6
-20	48	8
-8	66	8
-38	16	14
-48	26	14
-22	8	64
-60	-2	6
-58	-46	8
-46	-50	22
-46	-34	24
-58	-16	18
-18	80	28
-10	28	20
-8	-10	-4
38	20	-10
28	56	-4
4	0	64
48	-26	-8
64	-28	-2
48	-50	6
52	-62	36
20	-46	32
-38	12	10
-28	30	14
-32	-36	18
-34	2	28
-48	34	34
-34	-32	4
-56	-24	10
-12	-62	48
-10	-38	0
40	10	10
54	42	2
64	14	22
12	36	48
26	-12	62
44	-14	-8
64	-32	12
50	-64	10
40	-34	60
10	-10	-4
-32	26	-6
-42	18	2
-42	42	6
-20	48	8
-8	66	8
-22	8	64
-58	-46	8
-52	-58	30
-58	-16	20
-18	-80	28
-28	-50	50
-10	28	20
38	20	-10
28	56	-4
10	-6	66
48	-26	-10
64	-28	-2
50	-50	8
52	-60	36
6	-72	22
-34	-8	6
-48	4	14
-36	4	26
-34	-2	46
-42	-32	46
-20	18	32
46	0	26
40	-82	8
-32	26	-6
-44	18	0
-42	42	6
-20	48	8
-8	66	88
-38	16	16
-48	26	14
-22	8	64
-60	-2	6
-50	-58	30
-66	-42	10
-58	-16	18
-46	-34	24
-48	-52	22
-12	-56	38
-8	-10	-4
-6	-32	6
38	20	-10
28	56	-4
10	-4	66
50	-28	-10
64	-28	-2
52	-62	36
2	-74	30
-36	-6	14
-34	-4	52
-10	-26	54
-46	-26	38
-48	-58	48
-24	-16	16
48	0	34
4	-6	44
8	-12	52
68	-32	34
6	-78	42
60	-38	50
-38	14	10
-46	8	30
-2	20	40
-54	16	4
-42	42	6
-38	24	18
-58	-46	8
-26	-26	2
-12	-64	50
-34	-50	48
-6	-10	-2
40	4	16
62	6	22
18	22	42
62	10	22
58	6	-12
56	-12	-10
64	-28	18
48	-64	8
32	-86	10
54	-62	30
34	-60	50
32	-30	-6
-36	4	16
-22	-12	50
-28	-28	58
-2	-36	42
-18	-18	6
10	16	34
52	-6	48
42	-32	12
52	-62	38
30	-66	50
6	-52	24
6	-10	4
-26	10	64
-8	-4	-4
32	22	14
46	-74	22
-44	8	32
-48	-4	52
-2	4	58
-26	-58	50
-28	-60	60
16	20	40
30	-72	24
44	-66	42

// Haist F, 2014: Adult Healthy Controls
// Subjects=16
-35	-68	39
-46	-68	39
-48	-46	34
-20	-80	30
-14	-73	22
-3	-46	11
32	-67	24
49	-67	28
44	-52	23
10	-84	23
5	-44	11
-40	40	9
-40	31	19
43	-3	35
3	-59	-35
49	15	-4
62	4	22
31	-2	-19
48	-3	-12
16	-61	-15
-39	-43	48
-30	-66	51
-49	-36	47
-13	-69	45
-25	29	35
-32	9	50
-12	71	2
-60	-43	-28
-12	-73	2
-17	-70	15
-43	-75	25
-44	13	-40
-42	1	-37
22	-65	2
14	-72	12
-44	-62	-40
-12	-75	-18
-25	64	18
-16	66	18
-10	-43	-18
13	-49	50
59	-33	22
53	8	18
10	36	-6
33	6	4
-19	-71	-5
-62	-53	-12
-51	-34	0
-55	-34	7
-12	-70	29
-12	-70	11
2	-73	-1
-55	-28	-1
-64	-32	0
40	-21	7
16	-76	12
14	18	10
20	-8	6
-6	-33	61
-6	-46	63
-5	34	-19
-29	-17	-17
23	-11	-21
3	-62	-16

// Haist F, 2014: Adolescents
// Subjects=14
-35	-68	39
-46	-68	39
-48	-46	34
-20	-80	30
-14	-73	22
-3	-46	11
32	-67	24
49	-67	28
44	-52	23
10	-84	23
5	-44	11
-40	40	9
-40	31	19
43	-3	35
3	-59	-35
49	15	-4
62	4	22
31	-2	-19
48	-3	-12
16	-61	-15
-39	-43	48
-30	-66	51
-49	-36	47
-13	-69	45
-25	29	35
-32	9	50
-12	71	2
-60	-43	-28
-12	-73	2
-17	-70	15
-43	-75	25
-44	13	-40
-42	1	-37
22	-65	2
14	-72	12
-44	-62	-40
-12	-75	-18
-25	64	18
-16	66	18
-10	-43	-18
-5	22	-14
-11	-16	64
29	15	28
23	60	24
26	10	42
14	66	18
3	18	-13
7	-20	65
62	-21	-15
53	-64	12
-10	-15	-1
-25	-75	-24
21	-81	-16

// Haist F, 2014: Children
// Subjects=14
-35	-68	39
-46	-68	39
-48	-46	34
-20	-80	30
-14	-73	22
-3	-46	11
32	-67	24
49	-67	28
44	-52	23
10	-84	23
5	-44	11
-40	40	9
-40	31	19
43	-3	35
3	-59	-35
49	15	-4
62	4	22
31	-2	-19
48	-3	-12
16	-61	-15
-39	-43	48
-30	-66	51
-49	-36	47
-13	-69	45
-25	29	35
-32	9	50
-12	71	2
-60	-43	-28
-12	-73	2
-17	-70	15
-43	-75	25
-44	13	-40
-42	1	-37
22	-65	2
14	-72	12
-44	-62	-40
-12	-75	-18
-25	64	18
-16	66	18
-10	-43	-18
-30	-56	50
-26	-66	51
-56	-28	33
-6	-62	31
-58	-21	44
26	-56	48
33	-55	57
45	-59	54
48	-41	54
7	-42	62
-25	28	48
-26	-8	58
-43	-27	60
-10	-9	45
-29	60	-24
29	62	3
22	-15	53
7	-5	39
-12	-86	-1
-32	-84	-4
-36	-89	17
-17	-65	15
-17	-88	26
-44	-43	-21
-55	-63	14
7	-86	-3
14	-70	12
55	-39	20
40	-38	16
-38	-63	-30
36	55	-9
47	-9	-21
-12	-39	19
10	-43	-18

// Hernandez M, 2014: Verbs > Pseudoverbs
// Subjects=14
-48	-70	34
-42	-58	31
-15	38	46
-6	62	7
-6	56	25

// Holloway I D, 2013: Healthy Controls Bilingual (English + Chinese)
// Subjects=13
-31.49	-64.68	41.87
-47.99	-49.85	-12.72
29.41	-54.54	43.66
29.41	-54.54	43.66
32.59	-54.78	40.3
38.61	47.83	31.62
22.37	-67.6	-42.15
-21.91	-48.5	43.74
6.75	15.63	44.73
35.27	22.23	3.7
45.1	7.97	24.86

// Holloway I D, 2013: Healthy Controls Bilingual (English + non-East-Asian)
// Subjects=13
-31.49	-64.68	41.87
-47.99	-49.85	-12.72
32.59	-54.78	40.3
38.61	47.83	31.62
22.37	-67.6	-42.15
-21.91	-48.5	43.74
6.75	15.63	44.73
35.27	22.23	3.7
45.1	7.97	24.86

// Kadosh R C, 2011: Magnitude Change Dots
// Kadosh R C, 2011: Magnitude Change Digits
// Kadosh R C, 2011: Magnitude Change Dots>Digits
// Kadosh R C, 2011: Magnitude Change Digits>Dots
// Kadosh R C, 2011: Magnitude Change Digits&Dots
// Kadosh R C, 2011: Notation Change Dots
// Kadosh R C, 2011: Notation Change Digits
// Kadosh R C, 2011: Notation Change Dots>Digits
// Kadosh R C, 2011: Notation Change Digits>Dots
// Kadosh R C, 2011: Notation change Digits&Dots
// Kadosh R C, 2011: Visuomotor Change Dots
// Kadosh R C, 2011: Visuomotor Change Digits
// Kadosh R C, 2011: Visuomotor Change Digits&Dots
// Subjects=19
-27	-75	27
-30	-90	18
24	-78	39
27	-51	51
-27	-72	-9
21	-78	-9
-42	-69	-9
-27	-90	-3
-39	-87	-6
33	-87	-3
-27	-75	27
-30	-90	18
24	-78	39
27	-51	51
-27	-72	-9
21	-78	-9
-42	-69	-9
-27	-90	-3
-39	-87	-6
-9	-78	21
-27	-75	27
-30	-90	18
24	-78	39
27	-51	51
-27	-72	-9
21	-78	-9
-27	-90	-3
33	-87	-3
-9	-78	21
27	-51	51
-30	-87	9
-9	-69	6
9	-75	30
15	-63	12
9	-63	15
-27	-75	39
45	-78	-12
-33	-51	45
27	-63	30
6	-87	-3
-6	-87	-6
21	-78	-12
-27	-87	21
12	-93	3
-6	-99	6
-24	-72	-9
21	-90	21
-12	-81	-9
30	-69	-3
9	-96	15
-15	-96	15
30	-81	30
-24	-72	45
30	-75	21
27	-78	39
-27	-79	27
-27	-75	36
30	-54	51
-30	-69	45
-30	-66	57
-30	-54	51
21	-69	42
-42	6	36
39	-90	-6
21	-99	-6
42	-57	-15
3	-81	21
-30	-93	-3
-36	-84	-9
-45	-72	-9
-42	-66	-9
-33	-51	45
27	-63	30
-24	-72	45
30	-75	21
27	-78	39
-27	-79	27
-27	-75	36
30	-54	51
-30	-69	45
-30	-66	57
-30	-54	51
21	-69	42
-42	6	36
6	-87	-3
-6	-87	-6
21	-78	-12
-27	-87	21
12	-93	3
-6	-99	6
-24	-72	-9
21	-90	21
-12	-81	-9
30	-69	-3
9	-96	15
-15	-96	15
30	-81	30
39	-90	-6
21	-99	-6
42	-57	-15
3	-81	21
-30	-93	-3
-36	-84	-9
-45	-72	-9
-42	-66	-9
-27	-72	33
-30	-69	54
-33	-51	45
-30	-69	45
-12	-72	51
30	-63	33
27	-78	39
12	-72	45
33	-60	42
45	-57	-3
-42	6	36
-36	-24	63
-24	-21	75
-30	-33	72
-51	-30	54
-45	-36	63
0	-3	60
3	12	42
-60	-21	15
-51	-24	18
-57	-45	30
-54	-39	24
60	-36	27
57	-30	54
60	-21	21
57	-33	42
42	-42	39
45	-45	48
60	-42	39
33	-48	36
57	18	-3
48	3	6
45	6	3
60	9	15
51	18	-12
12	0	9
0	-9	12
3	-6	9
3	-15	15
3	-27	12
-12	-12	15
6	-63	-12
-18	-24	21
3	-45	6
-3	-36	6
18	-15	24
-12	-18	9
0	-51	0
3	-54	-3
27	-33	9
6	-36	6
-12	0	12
9	-54	-12
3	-75	-12
-48	0	6
-57	6	-3
42	0	57
48	3	39
54	9	39
3	-30	27
36	45	33
39	42	30
36	39	27
9	-66	48
-27	-3	-15
-39	42	27
-36	-24	63
-24	-21	75
-30	-33	72
-51	-30	54
-45	-36	63
0	-3	60
3	12	42
-60	-21	15
-51	-24	18
-57	-45	30
-54	-39	24
60	-36	27
57	-30	54
60	-21	21
57	-33	42
42	-42	39
45	-45	48
60	-42	39
33	-48	36
57	18	-3
48	3	6
45	6	3
60	9	15
51	18	-12
12	0	9
0	-9	12
3	-6	9
3	-15	15
3	-27	12
-12	-12	15
6	-63	-12
-18	-24	21
3	-45	6
-3	-36	6
18	-15	24
-12	-18	9
0	-51	0
3	-54	-3
27	-33	9
6	-36	6
-12	0	12
9	-54	-12
3	-75	-12
-48	0	6
-57	6	-3
42	0	57
48	3	39
54	9	39
3	-30	27
36	45	33
39	42	30
36	39	27
9	-66	48
-27	-3	-15
-39	42	27
-36	-24	63
-24	-21	75
-30	-33	72
-51	-30	54
-45	-36	63
0	-3	60
3	12	42
-60	-21	15
-51	-24	18
-57	-45	30
-54	-39	24
60	-36	27
57	-30	54
60	-21	21
57	-33	42
42	-42	39
45	-45	48
60	-42	39
33	-48	36
57	18	-3
48	3	6
45	6	3
60	9	15
51	18	-12
12	0	9
0	-9	12
3	-6	9
3	-15	15
3	-27	12
-12	-12	15
6	-63	-12
-18	-24	21
3	-45	6
-3	-36	6
18	-15	24
-12	-18	9
0	-51	0
3	-54	-3
27	-33	9
6	-36	6
-12	0	12
9	-54	-12
3	-75	-12
-48	0	6
-57	6	-3
42	0	57
48	3	39
54	9	39
3	-30	27
36	45	33
39	42	30
36	39	27
9	-66	48
-27	-3	-15
-39	42	27

// Notebaert K, 2011: Ratio 1.25 Below > Ratio 1 (Habituation)
// Notebaert K, 2011: Ratio 1.5 Below > Ratio 1 (Habituation)
// Notebaert K, 2011: Ratio 2 Below > Ratio 1 (Habituation)
// Notebaert K, 2011: Ratio 2 Below > Ratio 1.25 Below
// Notebaert K, 2011: Ratio 1.5 Above > Ratio 1 (Habituation)
// Notebaert K, 2011: Ratio 2 Above > Ratio 1 (Habituation)
// Notebaert K, 2011: Ratio 2 Above > Ratio 1.25 Above
// Subjects=13
-42	-50	46
-42	-50	46
-42	-50	46
-42	-50	46
-42	-50	46
-42	-50	46
-42	-50	46

// Price G R, 2011: (conjunction) Arabic digits>Scrambled digits and 
// Letters>Scrambled letters
// Price G R, 2011: (conjunction) Arabic digits>Letters and Arabic 
// digits>Scrambled digits
// Subjects=19
-37.86	-63.14	48.5
-46.53	-61.14	33.93

// Roggeman C, 2011: Different vs. Same Location Deviants
// Roggeman C, 2011: Large vs. Small Numerical Deviants
// Roggeman C, 2011: Far vs. Close Numerical Deviants
// Subjects=23
35	-84	-12
25	-98	9
-25	-97	3
39	-63	45

// Peelen M V, 2012: Action Verbs > Object Nouns
// Peelen M V, 2012: Object Nouns > Action Verbs
// Peelen M V, 2012: State Verbs > State Nouns
// Subjects=27
-53.27	-30.54	3.57
-50.97	-54.16	14.44
-59.45	-45.78	27.22
35.55	-83.65	-3.04
-26.72	-35.35	-19.75
-63.98	-25.4	2.14

// Balodis I M, 2012: Healthy Controls
// Subjects=14
-9	45	24
-51	27	-6
3	-54	54
3	-54	54
-12	45	21
-51	30	-6
-18	18	-6
3	24	-15
9	33	-3
-18	-51	9
48	-9	-9
24	-81	-9
27	-57	54
-60	0	39
-42	-60	3
-18	18	45
-6	48	48
21	60	12
-9	-27	-18
-39	-72	18
-39	-72	18
-51	21	18
-57	-42	-6
-9	-30	-15
27	48	21
-36	42	-21
-42	-72	8
-18	0	36
3	-87	-27
-45	27	-21
-15	-63	18
-45	-69	33
-27	30	51
54	-66	24
-33	-51	3
-30	-93	-27
-3	-60	30
-27	24	48
-21	-18	-18
66	-9	30
54	-69	24
-54	9	-18
-54	-9	36
24	-48	9
0	33	-15
24	-78	-9
-48	12	33
54	12	30
9	42	6
33	-57	15

// Balodis I M, 2012: Pathological Gamblers
// Subjects=14
-9	45	24
-51	27	-6
3	-54	54
3	-54	54
-12	45	21
-51	30	-6
-18	18	-6
3	24	-15
9	33	-3
-18	-51	9
48	-9	-9
24	-81	-9
27	-57	54
-60	0	39
-42	-60	3
-18	18	45
-6	48	48
21	60	12
-6	18	-21
-36	12	60
-63	-33	-15
27	-18	-33
18	-87	-45
-9	72	0
-39	-96	-9
-9	72	0
45	21	-27
6	-60	-3
-18	12	54
-30	-30	-9
54	-3	45
9	-6	12
-15	72	3
-30	-87	12
36	-78	0
12	-36	12
-63	-9	6
9	-63	0
45	-15	6
45	-36	9
-30	-21	-18
18	3	72
3	15	24
24	18	57
3	15	24

// Ritchey M, 2011: Negative, Neutral, & Positive: Control > MDD
// Ritchey M, 2011: Negative & Positive > Neutral: Control > MDD
// Ritchey M, 2011: Negative > Positive: MDD > Control
// Subjects=14
4.98	45.65	-26
29.3	-61.71	-4.58
26.83	-60.37	55.84
-22.6	-65.5	-7.81
-6.14	-83.24	8.24
21.42	-3.97	-18
21.77	16.16	13.61
-26.99	-26.61	-4.86
29.21	-29.6	-5.52
34.12	13.15	49.56
-33.86	10.23	56.61
-2.75	-0.03	36.93
-54.74	-59.18	15.65
9.54	-31.95	62.29
18.37	-57.88	71.42
-47.9	17.5	-25.67
69.6	-4.45	31.65
-2.99	40.82	26.16
52.72	27.71	-13.83
-31.04	29.03	27.81
-2.52	6.09	56.49
-46.99	3.52	42.93
-34.59	10.26	-.53
-21.8	-12.5	65.38
-5.49	-22.56	71.7
-19.48	-26.99	-9.43
-50.75	-26.69	-4.44
-47.45	-53.58	-5.2
-54.74	-59.18	15.65
65.52	-30.01	45.45
13.72	-41.79	48.62
-42.9	-75.92	8.14
-31.1	-84.16	-.21

// Samson A, 2011: Healthy Controls
// Subjects=12
20	-100	8
-8	8	56
-12	-98	-10
6	-34	46
-24	-44	-16
38	-82	32
-26	-88	30
8	14	70

// Samson A, 2011: Major depressive disorder (MDD) group
// Subjects=21
20	-100	8
-8	8	56
-12	-98	-10
6	-34	46
-24	-44	-16
38	-82	32
-26	-88	30
8	14	70
-12	34	38
26	16	40
-12	-48	16
18	-78	14
22	-74	2
-6	76	18

// Samson A, 2011: Subgroup of MDD, Responders
// Subjects=10
-26	-20	20
48	-26	14

// Samson A, 2011: Subgroup of MDD, Non-responders
// Subjects=11
-26	-20	20

// Barrett J, 2011: Own Positive > Unfamiliar Positive
// Barrett J, 2011: Own Negative > Unfamiliar Negative
// Barrett J, 2011: Own Positive > Own Negative
// Subjects=22
52.26	-56.76	-42.29
-53.6	17.62	-20.54
-63.05	-7.05	-8.33
-34.3	-4.64	-21.13
52.23	21.94	-15.43
36.04	23.47	-35.45
-9.52	-5.7	4.33
-15.05	15.45	-10.77
20.18	11.97	-17.57
27.23	-27.52	49.23
49.57	-15.21	41.25
-40.72	1.83	-19.37
17.33	-96.42	-15.14
39.52	52.72	12.25
-33.66	-47.43	44.9
65.41	-13.74	17.52
33.39	-43.25	10.33
39.36	54.35	-7.96
23.94	14.47	55.78
-2.18	72.02	17.8
-11.57	34.75	32.18
17.39	-16.68	25.01
20.7	-74.88	15.36
-22.18	19	35.86
46.11	-8.02	10.57
36.58	-33.46	12.82
23.64	8.05	13.94
49.66	-24.21	48.69
-14.96	26.25	5.05
-1.83	19.64	42.26
10.88	-67.13	-7.48
14.09	-80.32	-13.11

// Billot P E, 2011: Isoamyl Acetate, 1 - Phenyl Ethyl Alcohol, 1
// Billot P E, 2011: Isoamyl Acetate, 3 - Phenyl Ethyl Alcohol, 3
// Billot P E, 2011: Isoamyl Acetate, 6 - Phenyl Ethyl Alcohol, 6
// Subjects=17
7.51	1.46	-.93
11.96	-4.46	18.47
-10.5	-3.7	16.44
-54.46	30.76	11.82
1.02	8.23	-9.23
-25.77	15.04	-15.07
-26.85	-6	-25.56
-3.04	-49.96	-4.3
-15.1	-31.19	-35.85
9.07	11.98	66.2
11.04	37.75	55.09
-37.03	14.57	48.67
43.15	4.39	47.48
12.96	49.79	31.76
-56.49	27.54	25.5
33.04	49.8	2.53
-22.56	56.78	1.47
59.15	-52.9	20.88
-51.92	-58.34	29.3
17.21	0.18	9.1
49.23	21.86	11.38
51.37	-28.57	-7.84
55.62	-37.6	-14.94
63.1	-52.96	-21.54
15.34	-77.28	12.27
26.88	-88.24	-20.4
6.55	-83.16	-21.7
34.25	-83.85	-33.12
6.93	-6.69	58.87
-3.75	-7.81	59.08
-2.82	6.14	46.75
-66.95	-20.74	35.24
-55.37	-21.41	11.75
-51.14	-10.81	10.81
51.44	-5.88	10.33
47.23	-16.22	14.59
41.64	-2.36	-12.15
-39.59	-48	-30.81
-7.49	-86.99	-42.41
-19.42	-21.87	-38.81

// Frodl T, 2011: Subgroup of MDD, Mitrtazapine
// Subjects=11
48	-24	20
4	-10	50
12	0	48
30	-10	62

// Frodl T, 2011: Subgroup of MDD, Venlafaxine
// Subjects=13
-42	-52	-16
-4	-54	6
-8	-44	-24
6	-52	-2
8	52	38

// Zanto T P, 2011: V4 connectivity, Attend > Ignore
// Zanto T P, 2011: V5 connectivity: attend > Ignore
// Subjects=20
-38	30	8
-4	20	40
46	18	4
32	56	14
18	36	40
20	48	-10
44	20	24
38	8	58
-36	4	54
-26	52	-14
-36	-52	42
44	-50	36
36	-70	52
-22	-62	66
8	-60	46
14	-70	62
-50	-22	48
30	-28	48
-36	50	12
-22	0	60
-32	32	16
2	-2	60
58	12	24
4	14	54
-56	8	36
10	10	70
34	-42	38
-8	-66	62
-34	-38	42
-30	-48	60
-44	-42	58
56	-30	52
30	-50	58
18	-62	22

// Aybek S, 2014: (Patient > Healthy Controls) x (Escape > Severe Event)
// Aybek S, 2014: (Patient > Healthy Controls) x (Escape < Severe Event)
// Subjects=12
12	8	68
30	42	72
28	34	54
52	44	20
40	58	24
42	54	30
26	46	-4
22	44	0
28	42	2

// Yoshino A, 2013: MP x LP
// Yoshino A, 2013: (Patient > Healthy Controls) x MP x Neutral
// Yoshino A, 2013: (Patient > Healthy Controls) x LP x Sad
// Yoshino A, 2013: (Patient < Healthy Controls) x MP x Sad
// Subjects=11
8	34	24
6	20	30
-8	6	32
42	0	-4
-40	-8	-6
6	-4	12
-8	-4	14
-18	54	26
-34	24	48
-56	8	8
-16	14	8
-66	-24	34
60	-24	20
-60	-24	20
-2	12	58
50	2	44
-38	-8	62
-56	-62	6
-56	4	10
28	22	-16
50	2	-4
38	-10	-24
28	22	-16
50	2	-4
38	-10	-24
28	22	-16
50	2	-4
38	-10	-24

// Roy M, 2010: Positive vs. Neutral
// Roy M, 2010: Negative vs. Neutral
// Roy M, 2010: All Pictures
// Roy M, 2010: All pictures-positive correlation with symptomatic improvement
// Roy M, 2010: Contrast of positive pictures hits minus positive pictures 
// misses
// Roy M, 2010: Contrast of negative pictures hits minus negative pictures 
// misses
// Roy M, 2010: Contrast of neutral pictures hits minus neutral misses 
// revealed
// Subjects=20
55.53	-68.16	16.9
-43.93	-93.05	8.73
-17.57	-79.85	45.08
20.84	35.9	29.61
-14.41	51.52	-19.52
46.56	-50.91	-4.82
9.39	51.81	-17.72
33.39	-22.97	-15.21
-26.55	-98.85	14.61
-32.73	-64.91	44.98
44.78	-89.67	16.97
52.92	-53.95	-14.72
-37.5	-85.79	5.66
-41.92	-75.58	0.24
46.75	3.05	21.21
-13.56	20.66	40.67
-43.75	3.53	42.87
-18.54	-22.61	-19.96
-1.01	-11.96	1.1
20.71	-30.72	5.94
28.84	-1.69	-28.44
-18.28	52.7	16.28
-12.2	49.71	-16.02
18.44	35.19	10.67
14.8	17.31	60.68
-59.12	-72.79	8.11
55.47	-69.64	12.57
-22.18	20.83	43.04
-12.27	53.55	-20.88
50.8	-67.89	-14.42
-41.77	-89.75	9.49
-26.57	-100.12	12.5
39.9	-27.1	-13.79
-20.68	44.34	-4.14
44.74	7.48	34.25
-56.86	-2.01	30.2
57.52	-17.95	14.14
-39.81	0.64	11.72

// Voon V, 2011: Internal-Fixation vs. External-Fixation
// Voon V, 2011: External-Fixation vs. Internal-Fixation
// Voon V, 2011: External + Internal (CD) vs. External + Internal (HV)
// Voon V, 2011: External + Internal (HV) vs. External + Internal (CD)
// Subjects=11
-8	-4	74
-44	20	0
-36	-56	38
2	14	54
36	0	62
42	48	-4
-6	-56	18
6	-48	24
10	-50	10
10	-48	24
-6	-52	8
-34	22	-4
54	-46	10
-62	-50	4
20	-2	-14
-20	-20	0
-8	-4	74

// Contreras-Rodriguez O, 2014: Criminal Psychopaths
// Subjects=22
32	-86	-8
-22	-92	-8
40	-50	-24
-36	-62	-20
32	-64	46
-30	-48	42
18	-30	-4
-22	-30	-6
-6	-28	-10
12	-18	6
52	14	34
-48	6	38
-2	22	46
24	-62	12
-18	-88	12
-32	2	46
-52	20	14
-2	24	44
32	-86	-10
-20	-94	-6
40	-50	-22
-38	-62	-20
36	-60	48
-32	-52	44
18	-32	-4
-22	-30	-10
-4	-28	-20
10	-16	8
44	12	30
-48	24	24
4	20	48
12	-64	8
-32	2	46
18	-98	0
-24	-96	-6
38	-50	-22
-38	-62	-18
34	-66	52
-28	-48	42
22	-30	-4
-24	-28	-6
10	-24	-10
38	22	24
-50	18	22
-4	20	46
-18	-88	14
-28	-2	50
0	36	40
48	34	16
-44	8	14
-26	6	62
54	42	4
-16	-54	44
20	-92	14
4	-22	-2

// Contreras-Rodriguez O, 2014: Controls
// Subjects=22
32	-88	-8
-22	-94	-8
40	-54	-22
-40	-56	-26
34	-56	46
-30	-50	40
22	-4	-20
22	-30	-4
-22	-30	-2
-6	-26	-10
42	14	26
-44	20	24
-4	18	50
24	-62	12
-18	-88	12
-32	2	46
-52	20	14
-2	24	44
36	-82	-14
-20	-92	-8
40	-54	-22
-38	-62	-22
32	-54	50
-30	-56	44
20	-14	-18
20	-30	-4
-20	-30	-2
6	-30	-6
10	-14	6
42	14	28
-44	22	24
-2	18	50
12	-64	8
-32	2	46
18	-96	-2
-24	-94	-8
38	-54	-22
-38	-52	-26
34	-56	38
24	-30	-4
42	14	22
-44	18	24
-18	-88	14
-28	-2	50

// Jiang W, 2013: Lie-rest>True-Rest
// Jiang W, 2013: True>Rest
// Jiang W, 2013: Lie>True
// Subjects=10
-6	24	42
3	30	39
38	18	57
-51	-45	48
-45	-51	39
-45	12	27
39	9	42
-45	24	30
-42	51	3
-33	54	3
3	30	39
-39	9	42
-45	-51	39
-45	24	30
30	18	57
-51	-45	48
-6	24	42
-45	12	27
-42	51	3
-33	54	3
3	30	39
-39	9	42
-45	-51	39
-45	24	30
30	18	57
-51	-45	48
-6	24	42
-45	12	27
-42	51	3
-33	54	3

// Larson C L, 2013: Early Alternative Focus, Psychopaths > Nonpsychopaths
// Subjects=24
-51.34	15.66	-4.79
-51.46	38.58	-11.17
-23.71	51.52	-11.46

// Prehn K, 2013: Antisocial offenders with hypo-reactivity (EHO group)
// Subjects=11
-36	-3	51
-33	-9	45
9	42	-6
9	33	-9
-27	-84	-33
-30	-78	30
-42	-75	36
54	36	3
42	-75	-15
-18	-27	27
-24	-33	24
36	-27	-3
30	0	21
24	9	39
-21	-42	21

// Prehn K, 2013: Antisocial offenders with emotional hyper-reactivity (EHE 
// group)
// Subjects=12
-31	-29	-24
-27	-84	-33
-30	-78	30
-42	-75	36
42	-75	-15
-18	-27	27
-24	-33	24
36	-27	-3
-21	-42	21
-24	-54	15

// Prehn K, 2013: Healthy Controls
// Subjects=13
-36	-3	51
-33	-9	45
9	42	-6
9	33	-9
-31	-29	-24
54	36	3
-18	-27	27
-24	-33	24
36	-27	-3
30	0	21
24	9	39
-21	-42	21
-24	-54	15

// Pujara M, 2014: Gain x loss
// Subjects=18
-21	9	-9
-12	-66	60
-36	42	39
-39	57	15
-45	-66	6

// Reniers R L E P, 2012: Moral > Non-Moral
// Reniers R L E P, 2012: Non-Moral > Moral
// Reniers R L E P, 2012: Moral > Baseline
// Reniers R L E P, 2012: Non-Moral > Baseline
// Reniers R L E P, 2012: Baseline > Moral
// Reniers R L E P, 2012: Baseline > Non-Moral
// Subjects=24
-28.84	35.83	31.58
-3.25	53.09	8.15
-7.74	56.19	-4.41
-57.62	-37.89	48.33
-2.49	-33.13	50.28
-53.39	-42.96	39.79
-29.05	-78.39	-7.54
0.91	-65.16	-28.41
14.06	-75.78	-16.38
-7.51	63.38	15.04
-2.87	49.41	37.64
9.72	61.96	10.41
-46.8	36.21	-20.82
-46.76	28.86	-18.97
56.38	30.84	19.42
-3.07	27.13	17.43
-42.12	8.31	2.03
-50.76	8.28	2.18
-7.75	-16.08	-19.67
-54.62	-65.28	-61.07
-63.19	-57.14	-53.88
-54.35	2.38	-26.31
55.78	6.6	-33.08
-28.42	-45.23	48.56
-33.13	-88.65	9.23
36.24	-81.22	27.49
-28.94	-90.74	-1.84
-33.36	-69.59	-4.98
-42.03	-62.17	-5.56
-7.35	-86.41	-2.63
14.42	-92.74	8.83
27.15	-82.45	-8.1
5.16	-61.31	-33.35
35.54	-67.92	-25.36
9.77	-79.94	-14.77
-7.35	60.26	27.68
-7.19	49.4	37.71
14.56	42.86	46.95
14.47	49.89	41.78
9.77	63.44	14.74
-54.22	25.21	-11.76
-53.7	26.92	29.52
56.42	31.15	22.75
48.84	26.56	19.97
-2.7	25.47	45.61
-41.52	8.42	49.08
40.55	4.04	43.63
-50.39	11.08	32.15
-37.06	-11.36	55.44
-16.26	5.65	-4.87
-7.45	-9.44	5.44
-53.53	-57.18	25.52
-38.25	13.72	-32.19
-66.7	-46.67	12.37
-51.16	1.97	-30.8
-28.42	-45.23	48.56
-28.82	-84.38	8.74
-28.63	-78.57	24.97
36.24	-81.22	27.49
-29.05	-78.39	-7.54
-46.38	-66.75	-8.4
-2.99	-86.08	0.62
14.42	-92.74	8.83
27.15	-82.45	-8.1
22.33	-45.71	-39.66
5.13	-65.87	-36.26
9.77	-79.94	-14.77
5.07	54.03	-16.74
48.4	51.72	-9.41
0.91	43.14	-6.63
-2.83	7	31.75
10.33	-25.41	40.33
-20.04	-57.06	24.93
22.68	-36.52	-10.32
-46.52	-3.28	-6.83
44.18	5.45	-10.36
-37.89	-12.07	-9.47
-50.67	-18.41	3.7
-53.71	-28.98	17.13
64.9	-13.86	0.16
53.13	-60.05	0.45
60.64	-60.43	-4.12
-62.39	-21.57	16.54
-19.54	-39.08	67.97
60.97	-31.69	27.77
-11.26	-64.71	34.5
18.85	-56.92	24.26
14.97	-39.37	62.93
14.68	-67.81	34.37
5.07	54.03	-16.74
27.28	39.97	26.85
15.03	-38.96	67.37
0.95	43.46	-3.3
5.34	39.63	1.49
-7.06	-14.19	35.04
6.01	-25.42	40.41
5.9	-22.96	32.32
18.78	-54.15	19.5
5.78	-32.61	20.95
22.69	-40.78	-9.9
-46.52	-3.28	-6.83
44.28	-15.72	-7.15
44.13	-3.68	-16.18
-46.33	-22.65	4.05
56.44	-28.9	11.88
-58.14	-60.44	2.38
53.18	-59.73	3.78
60.63	-57.24	-4.44
-19.54	-39.08	67.97
-66.54	-23.63	29.14
65.39	-25.53	36.05
-11	-39.78	60.05
-6.91	-72.14	35.17
10.38	-72.08	34.87
19.25	-39.67	59.52

// Sadeh N, 2013: Fearless-dominance, Positive vs. Neutral
// Sadeh N, 2013: Implusive-Antisociality, Positive vs. Neutral
// Sadeh N, 2013: Impulsive-Antisociality, Negative vs. Neutral
// Sadeh N, 2013: Fearless-dominance x impulsive-antisociality, Negative vs. 
// Neutral
// Subjects=49
11	18	66
-65	-46	32
-45	8	-24
-59	-31	-12
-47	-63	35
-5	65	-5
-15	29	53
-27	-8	-23
-5	-80	28
41	-21	50
-20	-23	67
-1	-10	51
36	-17	7
30	19	-17
-61	-21	-10
-53	-44	3
-41	-53	42
58	-7	21
-51	-9	30
-3	35	33
-2	64	-20

// van Beilen M, 2011: Healthy Controls
// Subjects=21
-38	-34	60
-36	-20	16
14	-54	-18
38	-28	58
18	-20	2
-12	-54	-22
-8	20	42
-56	-42	38
54	42	46
62	-18	28
28	64	2
50	38	14
-10	-66	34
28	-42	-24
52	4	26
56	-46	28
52	6	-8
-48	14	-10
-10	20	40
6	14	34
-52	16	8
-28	-36	71
10	-58	2
-16	-13	-12
22	-32	-24
-8	10	60
40	10	46
-48	14	10
-6	18	40
-34	46	24
-54	12	30
-56	-26	28
-22	-70	50
-8	4	10
32	38	28
54	8	0
60	-40	36
6	-70	40
-20	-54	8
-48	-42	26
26	-76	-4
-16	-48	-26
54	4	16
-10	20	40
-8	-62	-48
16	-60	42
46	-8	50
0	8	62
6	14	32
-8	16	42
52	-42	50
-44	18	4
44	2	-4
-36	50	12
-50	-38	26
-8	-14	58
12	-8	60
52	-32	36
44	-76	-12
30	44	36
36	16	46
52	2	4
-58	-24	28
-36	-44	64
-46	-34	26
52	-2	4
-46	-40	58
26	36	24
26	24	52
-54	-38	-6
32	-32	8
52	-32	36
-2	-42	12
48	38	14
40	-10	46
56	-46	28
-10	20	10
-48	14	-10
-46	-34	28

// van Beilen M, 2011: Conversion Patients
// Subjects=9
-10	-8	52
-30	-30	54
28	-68	2
4	-20	52
38	-28	58
48	40	8
38	22	8
8	60	34
38	-6	-4
-2	-52	-44
-34	-22	52
12	-56	-20
36	-26	60
38	4	14
-22	52	-26
-8	20	42
44	40	22
54	-40	46
28	64	2
50	38	14
-10	-66	34
28	-42	-24
52	4	26
56	-46	28
52	6	-8
-48	14	-10
-10	20	40
6	14	34
-52	16	8
-12	8	70
4	8	66
-36	54	0
28	62	2
42	38	16
46	46	-2
-52	-44	48
52	-48	46
-10	-66	36
8	-66	36
-32	-74	44
-8	34	36
10	40	46
-20	-54	8
-48	-42	26
26	-76	-4
-16	-48	-26
54	4	16
-10	20	40
34	-10	60
-10	-8	64
8	-4	72
-32	-44	40
34	-40	52
10	-22	76
30	-30	48
56	-46	14
58	-34	26
-8	8	42
6	-2	44
-46	-66	4
-12	-26	38
-6	60	2
-6	-64	10
-24	-46	-8
-50	-38	26
52	0	6
12	4	68
-14	8	70
-38	-44	64
-34	-76	32
62	-42	18
-46	-34	26
-10	-4	64
56	8	0
36	40	28
-20	-82	-14
-46	-34	-28
40	-12	-12
48	38	14
40	-10	46
56	-46	28
-10	20	10
-48	14	-10
-46	-34	28

// van Beilen M, 2011: Feigners
// Subjects=13
-34	-22	52
12	-56	-20
36	-26	60
38	4	14
-22	52	-26
-56	-42	38
54	42	46
44	40	22
54	-40	46
62	-18	28
-28	-36	71
10	-58	2
-16	-13	-12
22	-32	-24
-8	10	60
40	10	46
-48	14	10
-6	18	40
-34	46	24
-54	12	30
-56	-26	28
-22	-70	50
-8	4	10
32	38	28
54	8	0
60	-40	36
6	-70	40
-12	8	70
4	8	66
-36	54	0
28	62	2
42	38	16
46	46	-2
-52	-44	48
52	-48	46
-10	-66	36
8	-66	36
-32	-74	44
-8	34	36
10	40	46
-8	-62	-48
16	-60	42
46	-8	50
0	8	62
6	14	32
-8	16	42
52	-42	50
-44	18	4
44	2	-4
-36	50	12
34	-10	60
-10	-8	64
8	-4	72
-32	-44	40
34	-40	52
10	-22	76
30	-30	48
56	-46	14
58	-34	26
-8	8	42
6	-2	44
-46	-66	4
-12	-26	38
-6	60	2
-6	-64	10
-24	-46	-8
-8	-14	58
12	-8	60
52	-32	36
44	-76	-12
30	44	36
36	16	46
52	2	4
-58	-24	28
-36	-44	64
52	0	6
12	4	68
-14	8	70
-38	-44	64
-34	-76	32
62	-42	18
52	-2	4
-46	-40	58
26	36	24
26	24	52
-54	-38	-6
32	-32	8
52	-32	36
-2	-42	12
-10	-4	64
56	8	0
36	40	28
-20	-82	-14
-46	-34	-28
40	-12	-12
48	38	14
40	-10	46
56	-46	28
-10	20	10
-48	14	-10
-46	-34	28

// Bruhl A B, 2011: Reboxetine > Placebo: Negative vs. Neutral
// Bruhl A B, 2011: Citalopram > Placebo: Negative vs. Neutral
// Bruhl A B, 2011: Reboxetine > Citalopram: Negative vs. Neutral
// Bruhl A B, 2011: Reboxetine > Citalopram: Positive vs. Neutral
// Bruhl A B, 2011: Citalopram > Reboxetine: Positive vs. Neutral
// Subjects=16
22.04	-10.6	75.75
10.96	-20.15	22.03
-5.03	-23.16	25.81
-30.74	-33.86	13.62
-69.38	-2.97	3.67
68.45	-45.1	-16.68
-53.38	-62.46	-23.87
46.32	-91.53	4.19
-40.23	-101.82	2.7
24.13	-96.75	34.99
8.1	-75.99	43.47
4.28	-82.35	-38.47
4.42	2.56	13.51
-5.37	19.45	-1.18
14.07	-27.76	5.91
-34.17	-82.4	-35.8
45.77	47.79	-10.83
59.78	42.56	2.83
68.72	-62.07	11.5
27.24	-103.22	19.89
14.24	36.62	54.03
6.92	0.75	-78.93
-1.9	51.87	46.25
42.84	27.62	17.66
7.63	47.73	33.1
-1.5	-13.2	71.78
26.54	37.9	-13.13
-56.27	-3.15	41.45
62.38	-5.36	43.62
36.8	-57.55	31.56
-27.31	-57.94	32.33
-37.13	-53.45	8.65
17.06	-10.25	-15.67
-47.84	-93.38	-11.3
13.81	22.22	-8.32
4.26	22.94	1.77
-5.35	-12.24	-11.9
-29.93	-11.33	-11.69
-21.34	-21.77	-9.8
20.48	6.34	19.7
-14.78	3.93	19.19
1.22	-16.04	7.3
-21.16	-17.69	15.5
20.52	-20.69	14.16
41.68	-56.86	-28.77
26.75	-40.14	-17.74
-27.76	-44.96	-20.05
-41.68	-64.04	-31.67
-21.33	10.18	4.25
2.39	26.72	37.16
-2.13	-72.44	-33.65
-18.13	-59.07	-24.55
-34.27	-63.63	-40.72
29.91	16.49	-1.33
-17.72	31.91	64.83
-66.27	-7.15	-9.4

// Cooney R E, 2010: Major depressive disorder
// Subjects=14
1.12	43.32	17.94
58.37	-53.17	58.83
-35.25	9.75	-0.02
-26.47	15.55	32.85
37.82	-72.32	19.41
61.06	-9.08	9.37
1.57	-51.96	38.19
-71.53	-31.59	-8.4
12.93	-30.74	-4.98
-7.17	16.35	41.48
-10.26	-72.61	19.98
28.64	27.63	-22.33
42.18	-42.92	41.42
5.13	52.75	-11.9
-26.2	-97.02	22.21
-67.28	-24.16	-9.08

// Cooney R E, 2010: Healthy Controls
// Subjects=14
37.57	-58.43	-7.41
-42.07	-70.23	53.6
-39.16	-89.67	8.36
-51.11	-9.41	15.15
57.86	-1.35	13.22
13.53	-73.87	56.62
22	-8.75	72.25
29.6	-65.69	64.67
-14.44	-92.47	25.04
1.01	62.01	11.91
10.29	-69.92	52.98
28.95	63.8	32.63

// Herwig U, 2010: Major depressive disorder
// Subjects=14
-40.48	36.18	25.7
-47.8	9.24	35.85
-49.21	22.19	-3.13
44.78	26.64	-9.05
-32.19	18.17	-15.26
1.29	38.52	38.41
2.57	13.2	55.02
-10.58	2.13	9.26
43.83	21.31	4.79
2.24	-13.2	2.59
9.63	-21.84	-13.5

// Seo Y, 2010: Positive correlation between age and sexual brain, ERO vs. HA
// Seo Y, 2010: Negative correlation between age and sexual brain, ERO vs. HA
// Seo Y, 2010: ERO vs. HA
// Seo Y, 2010: Food vs. Nature
// Subjects=21
26	-78	-16
22	-2	-22
4	4	12
44	44	12
12	12	6
24	4	52
32	18	36
-24	32	28
-24	-8	48
-26	4	62
-52	6	32
-24	30	-8
-34	18	-12
40	20	-6
-4	38	52
-38	-8	42
-2	22	22
0	40	16
6	44	20
12	0	14
-32	-56	48
-48	-70	-6
40	-76	8
50	-78	-20
-46	-70	20
68	-52	14
-4	-10	-16
22	-32	4
26	2	-14
2	-52	-36
28	-62	-48
36	-70	-12
-44	-60	-20
38	-82	-6
-26	-90	4
42	-64	-18
-22	-76	-12
-34	4	-18
-28	2	-22

// Plailly J, 2011: Familiar - Unfamiliar: Olfaction and Music
// Plailly J, 2011: Familiar - Unfamiliar: Olfaction
// Plailly J, 2011: Familiar - Unfamiliar: Music
// Plailly J, 2011: Unfamiliar - Familiar: Olfaction and Music
// Plailly J, 2011: Unfamiliar - Familiar: Olfaction
// Plailly J, 2011: Unfamiliar - Familiar: Music
// Subjects=13
-6	54	-4
-21	21	56
-6	48	39
-6	36	39
-3	39	35
-39	9	35
-51	30	0
-51	27	11
-39	-39	39
-39	-39	25
-51	-51	21
-48	-48	18
-3	-3	28
12	39	7
-36	-15	14
-3	60	60
-33	12	12
-27	6	6
-33	-3	-3
-45	-75	-75
-54	-21	-21
-51	-57	-57
-3	-39	-39
-60	-45	-45
-45	-48	-48
48	-60	-60
30	24	7
27	21	46
60	-39	32
63	-51	25
12	24	35
-48	-24	46
-27	-18	56
-39	-21	18
39	-39	32

// Reske M, 2010: Correlation analysis: BOLD signal for Rotten yeast vs. 
// Vanilla stimulation and Age
// Reske M, 2010: Rotten yeast vs. Vanilla
// Reske M, 2010: Rotten yeast vs. Ambient air
// Reske M, 2010: Vanilla vs. Ambient air
// Subjects=15
-46	18	30
-4	4	12
44	-34	10
-38	-42	10
52	-16	8
-46	-6	38
56	4	40
-12	14	46
-62	6	18
-4	58	-16
-34	32	-18
32	48	-8
-48	8	12
-28	22	8
-42	36	26
12	50	40
6	28	44
20	2	68
-12	14	44
-46	-6	38
58	6	40
64	10	26
42	-12	38
50	-4	20
-62	0	26
-54	-14	24
-2	58	-16
64	-26	-24
-64	-54	-10
-36	-80	44
54	-40	46
-26	-4	-28
-22	16	18
-10	10	4
-42	-72	32
32	62	20
-28	60	20
54	-46	32

// Burgmer M, 2011: Pain anticipation (with information on pain intensity): 
// FMS Patients > Healthy Controls
// Subjects=12
38	18	40
-24	-58	42
-6	-40	-2

// de Greck M, 2013: Somatoform Patients
// Subjects=20
32.9	58.2	-12.67
-24.75	-4.21	-30.19
-14.56	47.96	65.68
-34.35	-17.22	-32.34
-34.46	17.93	-31.94
20.11	22.2	-22.89
-37.4	37.12	9.98
-21.52	-3.94	-26.91
-37.91	84.53	-37.49
32.9	58.2	-12.67
35.79	87.89	-41.96
22.93	90.73	-45.4
-34.35	-17.22	-32.34
-14.56	47.96	65.68
-34.35	-17.22	-32.34
-34.46	17.93	-31.94
20.11	22.2	-22.89
-37.4	37.12	9.98
-21.52	-3.94	-26.91
-37.91	84.53	-37.49
32.9	58.2	-12.67
35.79	87.89	-41.96
22.93	90.73	-45.4

// de Greck M, 2013: Healthy Subjects
// Subjects=20
-46.76	-9.75	24.05
49.31	-3.6	12.4
7.88	-54.09	23.8
49.01	42.7	-8.21
-49.85	14.49	48.82
55.88	11.18	37.85
7.99	6.35	62.22
23.89	54.54	64.69
-11.94	12.24	-25.03
23.35	6.11	-24.92
17.15	-11.42	-3.31
-24.02	95.62	-33
33.7	91.73	-33.34
-29.38	91.01	-37.01
-41.02	48.13	-39.97
47.61	78.79	-36.87
49.81	53.08	-39.2
-49.97	-22.97	18.51
49.34	-3.35	15.72
7.97	9.52	61.95
55.9	11.44	41.17
-49.84	11.32	49.09
20.69	57.95	67.78
-18.31	-.49	-23.89
23.35	6.11	-24.92
-41.09	84.77	-34.12
35.8	91.32	-38.9
42.28	52.52	-45.76
-46.9	-27.67	-1.21
-2.72	10.43	60.89
4.7	7.67	52.11
-41.09	84.77	-34.12
29.41	91.54	-35.5
42.33	46.43	-41.9
30.86	-5.57	-25.14
11.19	6.37	62.18
-24.78	15.33	-25.14
21.19	10.24	-26.36
-37.89	84.79	-34.16
32.61	88.13	-38.6
-37.8	49.38	-37.89
-50.03	-20.32	11.59
4.78	6.33	62.26
23.36	8.48	-21.77
-41.09	84.77	-34.12
42.26	78.67	-37.92
32.9	58.2	-12.67
-24.75	-4.21	-30.19
-14.56	47.96	65.68
-34.35	-17.22	-32.34
-34.46	17.93	-31.94
20.11	22.2	-22.89
-37.4	37.12	9.98
-21.52	-3.94	-26.91
-37.91	84.53	-37.49
32.9	58.2	-12.67
35.79	87.89	-41.96
22.93	90.73	-45.4

// Karama S, 2011: Amusement - Neutral
// Karama S, 2011: Disgust - Neutral
// Karama S, 2011: Sexual Arousal - Neutral
// Karama S, 2011: Conjunction Analysis: Amusement - Neutral / Disgust - 
// Neutral / Sexual Arousal - Neutral
// Karama S, 2011: Amusement > Disgust and Sexual Arousal
// Karama S, 2011: Disgust > Amusement and Sexual Arousal
// Karama S, 2011: Sexual Arousal > Amusement and Disgust
// Subjects=18
-45	10	30
-44	0	40
12	2	72
44	0	54
-60	-44	2
-58	-48	8
-52	-28	-12
-52	-12	-20
54	-48	4
52	0	-24
-62	-44	26
-30	-48	62
56	-36	20
34	-42	6
38	-84	-14
4	-94	8
-52	-58	8
-6	-52	42
8	-56	50
-2	-4	-4
-22	-18	-16
-6	-38	-42
4	-4	-6
8	-36	-42
-20	-86	-27
18	-80	-42
0	-62	-26
-10	66	18
-46	8	28
14	64	20
54	22	32
-54	-44	6
-54	-18	-18
-52	-34	-6
58	-12	-22
-36	-50	62
-60	-36	20
38	-44	48
62	-38	14
-26	-88	4
-54	-48	4
-12	2	14
16	10	14
8	-32	-20
2	-62	-38
-40	12	28
-40	4	40
48	4	52
54	14	30
-62	-44	14
-62	-30	20
-28	-54	62
62	-28	38
36	-54	58
52	-68	-12
2	-78	0
-40	6	-4
-2	-54	56
4	-54	58
-16	-16	-18
-10	14	2
-4	-32	-40
14	12	4
4	-30	-32
-44	-54	-30
0	-68	-36
-6	14	52
-48	12	28
-44	4	42
40	28	-18
2	14	48
50	6	30
44	4	48
-50	-40	2
-48	-30	24
60	-30	26
44	-50	-24
-50	-54	-4
12	-18	38
-2	-4	-4
-20	-14	-18
0	-62	-36
-60	-46	2
-52	-28	-12
-54	4	-24
68	-40	-2
34	8	-40
0	-56	54
4	-92	10
-52	-44	8
64	-56	18
-36	30	4
68	-24	30
-28	-60	-10
32	-62	-8
-26	-88	6
-26	-94	24
32	-90	12
40	8	-14
0	-16	-18
0	-30	-20
-8	-6	-10
-26	-6	-16
-7	-6	-12
0	-70	-10
-4	40	-16
0	38	-16
4	38	-16
-56	-62	-12
42	-74	-10
-22	-54	68
-26	-74	52
28	-50	70
36	-54	56
-4	36	-14
-4	-38	32
-8	-78	44
-2	-76	48
4	36	-12
2	-38	32
6	-78	50
8	-70	38
-28	-60	-30

// Lee S J, 2013: FM Patients
// Subjects=23
-51	6	27
54	8	27
-36	-9	63
36	-9	63
-51	-29	51
51	-29	51
-36	-48	57
40	-36	57
-3	0	57
3	0	57
-24	-3	0
-30	-54	-27
30	-54	-27
-3	12	30
3	12	30
-54	6	29
54	6	29
-27	-15	57
27	-15	63
-45	-30	45
50	-27	45
-6	6	51
-15	-21	13
15	-21	13
-15	-71	-12
15	-71	-12
-51	6	27
54	8	27
-36	-9	63
36	-9	63
-51	-29	51
51	-29	51
-3	0	57
3	0	57
-36	-48	57
36	-48	57
-33	15	3
-24	-3	0
-30	-54	-27
30	-54	-27
-51	6	27
54	8	27
-36	-9	63
36	-9	63
-51	-29	51
51	-29	51
-36	-48	57
36	-48	57
-3	0	57
3	0	57
-24	-3	0
-30	-54	-27
30	-54	-27
-7	18	36
-54	10	32
54	10	32
-36	-9	63
36	-9	63
-45	-36	52
45	-36	52
-42	-48	57
42	-48	57
-6	0	57
-37	14	9
-18	5	3
18	5	3
-15	-16	9
15	-16	9
-27	-23	-12
-9	-18	-12
9	-18	-12
-33	-52	-24
33	-52	-24
54	8	27
-36	-48	57
-3	0	57
30	-54	-27

// Lee S J, 2013: Healthy Controls
// Subjects=24
-3	12	33
3	12	33
-54	10	32
54	10	32
-36	-9	63
36	-9	63
-45	-36	52
45	-36	52
-36	-48	57
36	-48	57
-6	0	57
6	0	57
-33	18	0
33	18	0
-21	9	0
21	9	0
-9	-16	9
9	-16	9
-30	-18	-15
-30	-18	-15
-9	-18	-12
9	-18	-12
-33	-52	-24
33	-52	-24
-3	12	30
3	12	30
-54	6	29
54	6	29
-27	-15	57
27	-15	63
-45	-30	45
50	-27	45
-6	6	51
-15	-21	13
15	-21	13
-15	-71	-12
15	-71	-12
-51	6	27
54	8	27
-36	-9	63
36	-9	63
-51	-29	51
51	-29	51
-3	0	57
3	0	57
-36	-48	57
36	-48	57
-33	15	3
-24	-3	0
-30	-54	-27
30	-54	-27
-3	12	33
3	12	33
-54	10	32
54	10	32
-36	-9	63
36	-9	63
-45	-36	52
45	-36	52
-36	-48	57
36	-48	57
-6	0	57
6	0	57
-33	18	0
33	18	0
-21	9	0
21	9	0
-9	-16	9
9	-16	9
-30	-18	-15
-30	-18	-15
-9	-18	-12
9	-18	-12
-33	-52	-24
33	-52	-24
-51	6	27
54	8	27
-36	-9	63
36	-9	63
-51	-29	51
51	-29	51
-36	-48	57
36	-48	57
-3	0	57
3	0	57
-24	-3	0
-30	-54	-27
30	-54	-27
-7	18	36
-54	10	32
54	10	32
-36	-9	63
36	-9	63
-45	-36	52
45	-36	52
-42	-48	57
42	-48	57
-6	0	57
-37	14	9
-18	5	3
18	5	3
-15	-16	9
15	-16	9
-27	-23	-12
-9	-18	-12
9	-18	-12
-33	-52	-24
33	-52	-24
-45	-36	52

// Lopez-Sola M, 2014: Healthy Controls
// Subjects=25
-52	-14	-6
-70	-30	6
48	-24	-4
74	-24	-2
22	-88	-20
0	-100	-14
46	-8	0
20	-54	-12
62	-18	2
-64	-32	12
28	-28	-4
-30	-30	-3
4	-88	-8
16	-56	-26
-44	-32	54
66	-14	22
-54	-40	22
42	0	2
-40	0	2
24	2	0
-24	-2	0
12	-20	8
-12	-22	2
-10	-22	-4
54	10	12
-56	8	14
54	10	32
-58	6	28
-4	-2	50
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
-52	-14	-6
-70	-32	6
72	-24	0
50	-18	-10
2	-96	-12
-32	-20	6
44	-24	-10
46	-8	0
20	-56	-12
-28	-78	-2

// Lopez-Sola M, 2014: FM Patients
// Subjects=35
-52	-14	-6
-70	-30	6
48	-24	-4
74	-24	-2
22	-88	-20
0	-100	-14
46	-8	0
20	-54	-12
54	-16	4
-50	-20	10
36	-8	-14
-18	-30	-2
6	-90	-6
22	-56	-24
-44	-26	52
58	-28	20
-56	-36	22
42	0	2
-38	4	2
26	6	0
-20	-2	-2
14	-22	8
-12	-22	8
-8	-26	-4
52	10	6
-52	4	6
58	10	32
-58	6	28
-4	-2	52
2	-86	-12
62	-24	4
-54	-12	0
40	-88	-20
-6	-92	-22
-10	-92	-23
62	-24	2
-56	-16	0
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
16	-104	-6
74	-26	-4
-68	-10	-4
20	-54	-30
-52	-14	-6
-70	-32	6
72	-24	0
50	-18	-10
2	-96	-12
-32	-20	6
44	-24	-10
46	-8	0
20	-56	-12
-28	-78	-2
68	-16	-2
-70	-30	12

// Berent-Spillson A, 2012: Deep Processing vs. Shallow Processing
// Berent-Spillson A, 2012: 4-Second Delayed Match vs. 1-Second Delayed Match
// Subjects=56
-56	24	-10
38	26	4
-4	26	50
52	22	30
-54	22	20
-38	22	-40
-56	-16	-34
-34	-66	44
-2	16	52
-52	10	28
26	-74	56
-24	-74	54

// Berent-Spillson A, 2010: Post-Menopausal Women
// Subjects=55
50	32	2
6	24	42
54	20	8
-40	14	6
-26	-54	46
20	-58	52
40	-40	38
4	-28	0

// Berent-Spillson A, 2010: Subgroup of Post-Menopausal Women, Estrogen 
// Therapy
// Subjects=17
54	20	6
8	60	0
12	30	36
-40	14	12
58	-62	28
-26	-60	52
-18	-30	-14
2	-36	32
2	-28	-2
24	26	48
-30	20	42
-44	4	-16
46	-16	-2
-44	-28	12
60	-62	28
-50	-72	18
2	-20	44
54	-8	52

// Berent-Spillson A, 2010: Subgroup of Post-Menopausal Women, Estrogen Plus 
// Progestin Therapy
// Subjects=20
54	20	6
8	60	0
12	30	36
-40	14	12
58	-62	28
-26	-60	52
-18	-30	-14
2	-36	32
2	-28	-2
-12	14	62
-28	8	10
56	18	4
-44	6	-16
-42	-30	16
60	-54	38
-20	-42	4
0	-28	-4
54	-8	52

// Berent-Spillson A, 2010: Subgroup of Post-Menopausal Women, Never Treated
// Subjects=28
54	20	6
8	60	0
12	30	36
-40	14	12
58	-62	28
-26	-60	52
-18	-30	-14
2	-36	32
2	-28	-2
24	26	48
-30	20	42
-44	4	-16
46	-16	-2
-44	-28	12
60	-62	28
-50	-72	18
2	-20	44
-12	14	62
-28	8	10
56	18	4
-44	6	-16
-42	-30	16
60	-54	38
-20	-42	4
0	-28	-4

// Burgmer M, 2012: Secondary hyperalgesia: FMS > HC
// Burgmer M, 2012: Secondary hyperalgesia: FMS < HC
// Subjects=17
-44	38	-2
12	-28	72
-16	-48	68

// Loggia M L, 2014: Healthy Controls
// Subjects=14
-36	-4	48
-30	-60	-22
48	-28	16
-2	-4	68
52	-60	12
-62	-38	20
4	-28	-4
12	-18	38
34	-78	-10
-10	-8	66
16	-4	66
-10	-20	12
-52	-64	8
-4	-78	-2
-10	-68	8
56	-50	20
12	2	16
-10	2	8
18	-38	64
32	-26	14
20	-76	-40
4	-4	42
-12	-44	64
40	24	4
20	-62	10
12	-16	14
14	-22	70
42	-2	46
-16	2	0
-16	-18	70
6	-14	-10
-4	28	54
22	-52	52
-30	-46	44
-44	8	-6
26	-30	-24
-38	-22	0
-60	-36	36
-4	18	-12
-10	-58	4
20	-62	10
-10	-56	26
20	-58	-6
-18	-62	6
4	-6	68
8	-12	44
-22	-6	64
48	-28	16
40	-14	4
-6	-4	8
0	-28	-4
-16	2	4
6	-20	6
-8	18	4
6	-12	-12
16	-98	-4
-14	-98	2
10	-72	18
22	-82	16
56	-24	20
8	-72	-24
-8	-68	-4
-26	-72	34
-30	-62	-22
-8	-86	0
-54	-26	20
-18	-10	-2
-34	-24	4
6	-14	-12
-12	-18	-2
-24	-2	0
-34	2	2
6	-26	-2
38	22	14
38	8	-12
60	8	16
42	-10	4
46	20	-2
26	-2	2
-28	30	52
-20	-30	78
-4	68	4
-18	0	22
-30	-46	70
12	64	8
-10	58	38
40	-24	64
28	-48	68
-38	34	40
-16	-44	74
14	-44	74
-14	-50	74
6	-36	56
-28	2	68
-26	48	-8
-40	-90	-6
52	12	44
-42	-14	64
-62	-56	-10
24	36	32
-44	-22	-20
-8	-42	72
6	-42	56
-34	26	8
18	20	64
4	36	-2
-56	-44	50
-4	34	0
-4	32	20
-30	24	8
8	8	54
26	-46	70
2	32	46
-18	20	2
0	14	48
14	-28	76
6	44	16
-22	16	4
-16	-44	74
-14	-50	74
-60	-28	48
-46	-12	58
-50	42	-2
-36	30	48
-8	42	56
-44	18	10
-43	18	8

// Loggia M L, 2014: FM Patients
// Subjects=31
-10	-34	68
34	-88	-12
-10	-32	68
52	-42	14
30	-50	44
-36	-24	2
40	2	56
52	-34	24
-42	-68	4
-42	-2	52
6	14	30
-16	-72	-38
32	-60	-14
-10	-10	68
-60	-38	20
-30	-46	44
-8	-8	68
32	26	0
4	-28	-4
30	-78	-22
-8	-70	-2
12	0	68
16	-28	40
10	-42	66
-38	0	4
50	-8	42
-6	-84	0
6	-84	2
22	-34	-20
-2	16	52
-60	-28	32
34	-26	14
-10	8	6
8	8	8
-10	-28	-2
-10	20	-14
-18	2	-4
12	-8	16
18	2	2
-10	-58	4
20	-62	10
-10	-56	26
20	-58	-6
-18	-62	6
4	-6	68
8	-12	44
-22	-6	64
48	-28	16
40	-14	4
-6	-4	8
0	-28	-4
-16	2	4
6	-20	6
-8	18	4
6	-12	-12
52	10	42
60	6	20
46	20	-2
52	-32	28
-38	-90	-2
46	-48	42
32	22	2
-32	-64	56
18	12	9
-32	-56	46
30	-56	48
14	14	0
-32	-70	-26
22	0	0
38	-62	46
-40	-50	38
30	-64	-24
40	-14	4
6	-34	-14
-24	-2	0
-36	-24	2
-10	-20	-2
-34	18	0
-40	-38	16
-40	16	-2
-16	-2	-2
10	-14	-2
-52	6	34
-14	14	2
-8	54	-12
-2	64	30
2	58	-4
2	60	38
44	32	20
30	32	6
24	2	70
2	32	50
16	50	-14
32	-90	-4
50	-60	-18
46	-82	-2
46	-28	26
56	-44	10
2	-44	72
14	-34	74
6	-44	48
32	-50	42
22	-26	72
-22	-100	-8
-16	-44	74
-14	-50	74
-60	-28	48
-46	-12	58
-50	42	-2
-36	30	48
-8	42	56
-44	18	10
-43	18	8

// Martinsen S, 2014: FM patients + HC: Incongruent > Congruent
// Martinsen S, 2014: HC > FM: Incongruent > Congruent
// Subjects=23
-36	-52	46
30	-52	-24
6	18	42
30	22	-8
-44	-52	-18
38	-2	64
-4	-20	32
24	46	38
40	38	34
-8	-18	4
12	-70	8
22	-14	24
42	-2	-16
26	-14	-16
44	-40	24
6	-56	0
-38	-24	-8
-14	6	22

// Seo J, 2012: FM Patients
// Subjects=19
-48	15	24
51	9	21
-33	25	-6
33	26	-8
-6	20	47
6	27	42
-6	3	66
3	12	57
-18	6	-3
15	0	-3
-27	-72	54
21	-78	54
-30	-63	42
51	-45	45
-33	21	-21
-42	18	48
27	18	57
9	42	15
-6	-24	3
6	-24	0
51	-45	18
-42	-69	42
45	-45	21
-17	-39	68
18	-39	69
-9	63	2
6	57	3
-24	-3	-24
36	0	-24
-24	-7	-24
39	-12	-18
-24	-12	-27
23	-12	-31
-36	-14	2
36	0	12
-3	-48	21
9	-48	21
-33	9	-31
-33	9	-27
33	9	-27
-12	-38	72
9	-42	69
33	26	-8
-48	15	24
51	-45	45
33	26	-8
-48	15	24
51	9	21
51	-45	45
51	-45	45
51	-45	45

// Seo J, 2012: Healthy Controls
// Subjects=22
-42	9	30
30	9	57
-33	24	-6
33	26	-6
-6	24	45
9	27	45
-3	15	54
6	18	54
-15	3	0
15	3	0
-12	9	0
15	9	6
-54	-51	-15
-27	-66	45
39	-66	51
-39	-60	48
42	-45	42
-9	-78	-34
35	-63	-39
-33	21	-21
-42	18	48
27	18	57
9	42	15
-6	-24	3
6	-24	0
51	-45	18
-42	-69	42
45	-45	21
-27	-39	63
30	-36	63
-6	54	0
3	57	0
-24	1	-27
24	-4	-19
-23	-6	-24
24	-3	-21
-23	-12	-27
27	-9	-30
-37	-18	18
39	-12	15
-6	-48	33
9	-60	21
-42	12	-29
54	2	-15
-42	0	-15
58	6	-13
-6	-26	50
9	-34	55

// Bertolino A, 2010: Healthy Controls
// Subjects=37
-29	13	54
-51	15	19
40	40	15

// Bertolino A, 2010: Subgroup of Healthy Controls, GG Genotype (rs1076560)
// Subjects=26
4	-2	35
-41	31	30
33	-1	45
63	8	7
10	16	40

// Bertolino A, 2010: Subgroup of Healthy Controls, GT Genotype (rs1076560)
// Subjects=11
45	36	-14
45	-68	45
8	66	4
-38	43	-6
33	-1	45
63	8	7
10	16	40

// Brendel B, 2011: Four Syllable Categories > Baseline, Healthy Volunteers
// Subjects=20
-3	0	63
3	15	36
-60	-3	21
-63	-9	15
-57	-3	27
-45	-15	39
-48	-12	42
-51	-6	45
-54	-9	48
48	-9	39
63	-6	15
60	0	21
60	-3	24
54	3	48
-57	6	6
-36	18	6
-39	6	6
42	9	3
36	21	3
-39	-33	15
-48	6	0
60	-9	9
54	9	3
-27	-3	-6
-21	6	6
24	6	0
24	-3	6
24	0	-6
-12	18	6
15	-15	6
18	-12	3
-54	12	-3
-57	-21	3
-57	-30	6
-51	-18	0
-51	-42	18
-48	-39	15
54	-30	3
60	-6	3
66	-15	6
48	-18	6
-42	-42	-15
-30	-57	48
-21	-87	-9
-42	-78	-9
-42	-66	-12
42	-66	-15
39	-84	-6
-15	-90	-9
15	-87	-3
24	-87	-3
-18	-63	-18
-12	-63	-18
-27	-57	-27
-27	-66	-18
12	-63	-18
18	-60	-21
-30	-63	-54
15	-69	-48
33	-57	-51

// Brendel B, 2010: Motor prepareness (NCT>BL)
// Brendel B, 2010: Overall network (LCT>BL)
// Brendel B, 2010: Overall network (LCT>BL), Faster > Slower Syllable 
// Repetitions
// Subjects=16
-3	6	51
-3	-3	60
3	6	51
12	0	66
6	-18	30
-63	3	24
-54	-9	15
-51	-9	42
66	3	15
51	3	42
57	0	30
33	48	30
-57	6	9
57	12	0
48	21	-6
-42	12	0
-39	18	-6
39	24	3
-6	-24	6
-15	-12	3
-18	-9	6
18	-9	0
9	-12	6
6	-18	9
-21	6	-3
24	6	12
30	0	-9
21	3	9
-24	-12	-9
-63	-18	0
-51	-24	9
-54	6	-6
-51	-36	18
63	-21	9
51	-15	6
57	-39	24
-42	-57	-30
-15	-21	-9
-9	-21	-18
15	-18	-6
9	-21	-12
6	3	60
9	15	33
-57	-6	36
-51	-6	42
-57	-3	44
51	-6	33
60	0	18
48	0	48
51	9	6
-45	6	0
-15	-18	0
15	-18	0
-24	-15	-3
24	-12	-3
-45	-21	6
-57	-24	12
-48	-12	0
66	-21	9
51	-12	3
-21	-60	-24
15	-60	-21
-12	-24	-9
12	-21	-6
-57	-9	33
54	-6	33
60	0	21
-45	-21	6
51	-12	3
66	-21	9
63	-15	6

// Parkinson A L, 2012: Shifted Vocalization > Rest
// Parkinson A L, 2012: Unshifted Vocalization > Rest
// Parkinson A L, 2012: Shifted Vocalization > Unshifted Vocalization
// Subjects=12
60	-12	-1
66	-17	13
68	-23	3
-56	-2	-1
-61	-16	6
-56	-24	9
-66	-31	9
63	-29	3
-1	-1	65
-47	-11	43
-21	-29	62
50	-9	32
-47	-14	42
-35	-55	59
-36	34	7
43	23	11
-32	24	9
37	15	19
22	6	6
-23	8	6
-10	-18	1
61	-5	5
60	-12	-1
-61	-14	9
-61	-7	6
-59	-5	9
1	0	66
-49	-7	32
50	-10	39
15	-29	66
-52	-7	21
-33	15	-10
49	14	9
-38	5	0
41	19	6
22	3	6
-23	-4	6
63	-17	9
66	-19	13
66	-29	9
51	-28	9
-57	-29	9
-52	-28	6

// Fonzo G A, 2013: Negative Functional Activation Correlates of CM (childhood 
// maltreatment), Angry faces vs. Shapes
// Fonzo G A, 2013: Negative Functional Activation Correlates of CM, Fearful 
// faces vs. Shapes
// Fonzo G A, 2013: Positive Functional Activation Correlates of CM, Angry 
// face vs. Shapes
// Fonzo G A, 2013: Positive Functional Activation Correlates of CM, Fearful 
// face vs. Shapes
// Fonzo G A, 2013: Task-evoked activation, Angry faces vs. Shapes
// Fonzo G A, 2013: Task-evoked activation, Fearful faces vs. Shapes
// Fonzo G A, 2013: Task-evoked activation, Happy faces vs. Shapes
// Fonzo G A, 2013: Task-evoked connectivity, Angry faces vs. Shapes
// Fonzo G A, 2013: Task-evoked connectivity, Fearful faces vs. Shapes
// Subjects=33
-11.56	16.18	25.93
14.09	16.33	25.63
4.24	45.74	7.66
-2.17	45.7	7.74
-10.57	-49.46	-10.95
20.48	-65.05	-8.88
0.48	-10.42	52.56
2.62	-10.4	52.53
35.54	-69.47	1.35
-28.57	-78.57	-.5
-45.69	-41.52	12.21
-44.66	14.12	29.83
52.49	23.54	19.01
8.8	-57.83	2.91
47.22	15.47	25.32
-44.7	15.89	25.22
1.39	23.08	45.28
6.65	-57.93	1.83
47.22	15.56	26.43
45.42	-34.81	49.63
-46.55	-31.73	42.62
1.61	-32.87	51.08
2.63	-46.58	38.84
0.49	-46.6	38.87
30.18	-71.88	-1.73
-37.14	-70.08	0.01
49.18	-3.92	-5.42
-37.97	-28.08	47.79
34.74	-43.59	47.14
47.01	-3.13	-8.81
17.22	-56.86	-12.88
-14.84	-57.06	-12.49
-6.89	-28.01	59.7
10.21	-27.91	59.49
21.92	-16.2	58.38
-3.06	-60.07	-11.26
5.49	-60.02	-11.36
-14.4	-21.79	58.15
-2.93	25.89	40.63
5.62	25.94	40.53
21.51	-51.21	-8.94
-14.82	-52.48	-8.42
1.48	-7.84	44.53
-8.33	-65.93	-4.02
10.9	-65.82	-4.25
44.96	-15.4	-2.18
-52	-41.68	24.56
58.13	-41.39	32.19
11.02	-3.09	36.21
-8.21	-3.21	36.44
14.13	-68.89	-2.91
-11.52	-69.04	-2.61
-52.09	-29.42	17.96
2.64	-68.42	31.75
0.5	-68.43	31.78
5.57	-67.97	-4.01
-2.98	-68.02	-3.91
5.88	-22.99	54.67
-2.67	-23.04	54.77
14.02	-1.87	10.43
-11.62	-2.02	10.73
-13.7	31.57	32.47
32.09	-18.19	-9.6

// White S F, 2014: Positive PCL(Post-Traumatic Stress Disorder Checklist) 
// Score Association, Task trials > View trials
// White S F, 2014: Positive PCL Score Association, Negative and Positive > 
// Neutral
// Subjects=57
25.4	28.92	42.84
-.11	7.07	51.66
54.08	27.29	19.23
44.29	45.24	4.45
51.21	-41.75	35.09
28.43	13.93	13.95
-19.69	9.96	8.15
67.08	-53.22	9.1
-12.87	-94.43	20.17
-38.65	-86.09	6.38
35.16	-91.48	12.68
60.48	-58.49	-17.14
-16.49	-16.43	-3.06
15.78	-60.13	6.93
67.06	-7.27	25.32
34.83	-58.64	-16.84

// Cubillo A, 2010: ADHD Patients
// Subjects=11
-29.97	24.59	-1.32
39.55	21.2	3.74
-17.64	-1.29	62.04
8.6	-14.82	-5.15
27.8	21.13	3.88
-37.12	-24.84	20.75

// Cubillo A, 2010: Healthy Controls for Stop Task
// Subjects=14
-29.97	24.59	-1.32
39.55	21.2	3.74
-17.64	-1.29	62.04
8.6	-14.82	-5.15

// Cubillo A, 2010: Healthy Controls for Switch Task
// Subjects=13
27.8	21.13	3.88
-37.12	-24.84	20.75

// Davanger S, 2010: Continuous Meditation > All Control Tasks
// Davanger S, 2010: Continuous Meditation > Pseudoword Repetition
// Davanger S, 2010: Continuous Meditation > Physical Relaxation
// Davanger S, 2010: Continuous Meditation > Word Sequence Generation
// Davanger S, 2010: Continuous Meditation > Rest After Meditation
// Davanger S, 2010: Control Tasks > Rest After Control Tasks
// Davanger S, 2010: Word Sequence Generation > Rest After Control Tasks
// Subjects=4
-38.16	24.22	-23.14
-25.13	33.51	-16.44
-38.16	24.22	-23.14
-25.13	33.51	-16.44
-38.16	24.22	-23.14
-25.13	33.51	-16.44
-38.16	24.22	-23.14
-20.87	36.3	-21.27
-62.64	-11.43	-1.27
-53.88	-26.93	4.6
-50.22	7.97	44.79
49.92	-23.71	10.36
49.88	36.13	19
-2.7	-17.15	37.5
56.73	-42.03	32.22

// Fairhall S L, 2014: Healthy Controls Experiment 1
// Subjects=16
42	-46	-23
-42	-46	-26
48	-58	16
51	-76	-5
3	-58	34
-51	-46	13
60	-4	-26
21	-7	-17
-21	-4	-17
30	-43	-11
30	-61	-8
39	-82	19
18	-55	13
-33	-88	19
-27	-64	-8
-27	-43	-17
-15	-58	10
6	-58	40
30	-34	-17
36	-79	37
18	-55	22
-30	-85	37

// Fairhall S L, 2014: Healhty Controls Experiment 2
// Subjects=17
45	-55	19
3	-49	28
3	53	-14
24	-1	-23
45	-46	-23
42	-79	-14
-42	-82	-14
-24	-4	-20
51	-7	-26
30	-43	-11
30	-61	-8
39	-82	19
18	-55	13
-33	-88	19
-27	-64	-8
-27	-43	-17
-15	-58	10
3	-49	28
3	53	-14
-39	-79	34
-27	-32	-20
-15	-55	16
30	-31	-20
18	-52	16

// Ross L A, 2011: Fame > No fame
// Ross L A, 2011: No fame > Fame
// Subjects=11
-4.26	58.35	20.08
-2.3	59.73	-3.47
-4.43	41.15	-9.7
-3.22	6.43	-4.57
-21.43	-7.4	-16.58
-59.83	-11.26	-8.01
-39.77	20.36	-27.62
-35.29	-34.6	-23.06
5.2	47.98	-4.81
5.19	48.95	-6
-37.51	54.66	2.93
62.07	-37.13	-9.47
9.11	-68.84	39.52
4.63	24.59	50.69
42.9	57.89	37.42
0.37	-25.88	31.55
-4.76	-72.01	41.06

// de Greck M, 2010: Win > Lose
// Subjects=12
-12	10	4
14	12	2
-18	6	-4

// Allen M, 2012: Mindfulness Training
// Subjects=19
-32	-24	28
-32	-20	40
-38	-14	20
-24	44	26
-32	42	26
-12	30	32
24	24	-22
28	22	-14
36	18	-14
6	46	30
20	38	30
2	44	12
-30	26	22
-40	38	24
-28	36	20
30	16	50
24	-2	56
-12	12	48

// Allen M, 2012: Control
// Subjects=19
-30	26	22
-40	38	24
-28	36	20
30	16	50
24	-2	56
-12	12	48

// Dickenson J, 2012: Focused breath > Mindwandering
// Dickenson J, 2012: Mindwandering > Focused Breath
// Subjects=31
39	-7	22
18	26	3
42	-58	25
24	2	52
-36	-19	25
-45	5	10
12	26	40
-30	-40	-10
42	-79	31
30	-25	-5
9	38	43
36	-52	43
21	38	34
-3	50	-8
-3	50	7
-48	14	-8
-42	11	52
-6	38	-8
-39	-61	58
-6	-67	64
0	-46	61
0	8	64
-9	-46	1
-30	-64	58
-27	-73	49
51	17	-2
-33	59	7
0	-22	55
-42	-4	58
-12	-37	-2
-3	23	37
60	-13	10
3	-76	46
-3	26	43

// Farb N A S, 2012: Waitlist controls
// Subjects=16
27	-51	12
15	-12	51
-30	-42	-6
45	-24	24
-24	-51	6
-9	-24	21
-33	-6	15
-12	-60	15
-9	-48	-45
3	-81	-27
-42	-54	48
-48	15	21
45	-48	54
36	57	18
0	18	63
39	24	0

// Farb N A S, 2012: Training Group
// Subjects=20
33	-6	15
15	-21	51
-21	-18	21
-12	-54	21
27	-51	9
33	-36	-3
-30	-18	36
18	-60	-48
0	-42	-45
-3	27	51
-45	-54	51
-51	12	30
33	-57	54
57	0	-39

// Gard T, 2012: Practitioners
// Subjects=17
49.35	-17.52	11.33
46.38	-47.98	30.65
36.21	-43.91	-39.83
29.81	48.47	-.67
17.08	16.41	-1.18
-1.68	-34.81	40.13
-1.51	-36.44	60.34
-14.95	16.48	2.53
-37.44	-73.16	-39.88
-34.35	54.17	-3.76
-31.11	-31.12	-33.44
-30.55	-28.63	39.95
-53.01	-38.8	34.37
1.51	17.77	59.11
10.6	48.61	2.89
-47.29	16.63	-33.91
71.9	-32.73	19.04
58.81	-32.21	-14.31
13.99	-74.74	-23.61
-21.6	4.09	-33.16
-30.59	-58.73	22.4
-46.96	-22.81	-7.19
-46.87	-48.19	-5.06
45.89	2.87	-13.76
62.22	-3.73	23.41
42.98	12.53	28.96
17.18	-15.57	-1.84
17.08	16.41	-1.18
4.78	8.53	63.19
1.45	-12.58	38.23
-37.36	-6.38	-1.99
-24.54	49.68	19.93
-43.54	22.3	39.17
-46.75	2.48	30.83
-56.28	-19.78	32.81

// Gard T, 2012: Controls
// Subjects=17
49.35	-17.52	11.33
46.38	-47.98	30.65
36.21	-43.91	-39.83
29.81	48.47	-.67
17.08	16.41	-1.18
-1.68	-34.81	40.13
-1.51	-36.44	60.34
-14.95	16.48	2.53
-37.44	-73.16	-39.88
-34.35	54.17	-3.76
-31.11	-31.12	-33.44
-30.55	-28.63	39.95
-53.01	-38.8	34.37
1.51	17.77	59.11
10.6	48.61	2.89
-47.29	16.63	-33.91
71.9	-32.73	19.04
58.81	-32.21	-14.31
13.99	-74.74	-23.61
-21.6	4.09	-33.16
-30.59	-58.73	22.4
-46.96	-22.81	-7.19
-46.87	-48.19	-5.06
36.48	-18.11	4.84
55.62	-28.8	-11.21
43.14	4.3	46.38
43.24	-44.05	40.39
40.15	-26.41	62.37
20.95	-42.65	60.6
10.78	-18.78	-1.5
13.9	3.45	-3.4
11.26	-23.67	59.12
7.76	12.84	36.03
1.42	-26.04	29.33
-14.94	0.1	-2.79
-40.62	-3.74	-8.86
-49.8	-32.18	37.12
-46.5	-44.33	44.79

// Guleria A, 2013: Meditation > Control
// Guleria A, 2013: Control > Meditation
// Subjects=14
-41	32	38
-46	8	18
-32	4	60
-6	-52	58
-52	-50	12
-54	-24	8
-54	-44	44
-52	-16	32

// Ives-Deliperi V L, 2011: Meditation vs. Control, Activations
// Ives-Deliperi V L, 2011: Meditation vs. Control, Deactivations
// Subjects=10
11.13	-40.41	21.5
-15.08	49.16	-1.44
21.28	52.99	3.51
36.41	29.53	15.34
-37.41	13.94	-.68
27.14	-35.06	34.25
-13.4	-56.54	35.4
16.56	-60.33	38.72

// Kilpatrick L A, 2011: Mindfulness-based Stress Reduction (MBSR) 
// Participants > Controls, Auditory/Salience
// Kilpatrick L A, 2011: MBSR Participants > Controls, Medial Visual
// Kilpatrick L A, 2011: MBSR Participants > Controls, Lateral Visual
// Kilpatrick L A, 2011: MBSR Participants > Controls, Sensori-motor
// Kilpatrick L A, 2011: MBSR Participants > Controls, Executive Control
// Subjects=15
12	42	18
-50	-20	16
0	-74	18
-24	-96	20
-20	-68	4
20	-72	12
6	38	10
2	-26	32
10	-46	70
6	-42	56
0	-74	22
20	-50	6
-50	-50	32

// Lee T M C, 2012: Experts, Focused Attention Meditators (FAM)
// Subjects=11
44	-58	20
2	-12	-4
4	-66	24
-34	22	-6
-4	34	16
-26	-60	20
-10	40	42
28	-24	46
2	8	32
18	-26	-10
-40	-78	0
18	-86	30
-22	-80	10
-22	-70	8

// Lee T M C, 2012: Novices, FAM
// Subjects=11
44	-58	20
2	-12	-4
4	-66	24
-10	40	42
38	34	12
28	-24	46
50	-68	-4
40	-68	-20
18	-26	-10
-40	-78	0
18	-86	30
-22	-70	8
-22	-80	10
34	-76	8
-8	-82	10

// Lee T M C, 2012: Novices, LKM
// Subjects=11
-4	34	16
42	34	14
-34	46	18
-12	6	20
14	-4	22
-22	0	-6
28	20	30
-14	42	26
18	46	30
-10	30	48
-16	24	48

// Lee T M C, 2012: Experts, Loving-Kindness Meditators (LKM)
// Subjects=11
-4	34	16
42	34	14
-34	46	18
-12	6	20
-22	0	-6
-14	42	26
18	46	30
-10	30	48
-16	24	48

// Lutz J, 2014: Perception negative vs. Perception neutral, Mindfulness > 
// Basic
// Lutz J, 2014: Expectation negative vs. Expectation neutral, Mindfulness > 
// Basic
// Lutz J, 2014: Expectation unknown vs. Expectation neutral, Mindfulness > 
// Basic
// Subjects=22
-49.11	44.08	18.45
-41.21	10.02	59.13
-50.93	15.54	48.74
27.71	-15.99	-22
-40.47	-10.91	8.46
-51.25	18.8	8.33
-48.31	49	-14.31
-44.58	18.24	41.75
-5.98	13.15	55.12
-64.02	-43.35	-9.73
-57.36	-53.94	17.84
-60.47	-46.33	33.97
-54.49	28.3	7.57
-38.13	2.16	39.68
-2.78	13.17	55.08
-60.82	6.05	9.51
41.72	6.16	1.63
-44.87	8.55	-.92
-6.16	24.56	37.44
58.09	-36.36	28.42
-16.02	21.93	4.31

// Manna A, 2010: Monk Group
// Subjects=8
-8.51	29.97	11.36
13.89	36.28	8.34
13.81	55.23	5.64
1.76	-68.65	56.31
58.82	20.6	8.03
-9.71	72.52	11.15
-50.26	43.21	7.38
-49.04	37.1	24.61
62.3	-51.28	14.01
-43.81	9.62	-1.03
52.32	46.03	7.08
-42.55	-24.67	9.64
-42.64	-9.07	4.99
-30.26	-51.96	68.66
-27.71	54.41	26.26
-26.83	64.5	5.33
-50.23	35.81	8
26.74	46.56	16.25
55.58	33.36	8.11
-50.05	-31.49	4.72
-40.37	-30.75	13.47
-4.66	-72.12	53.33
-33.17	25.71	-.27
-2.04	43.81	24.62
58.81	23.78	7.76
13.9	34.17	8.52
17	52.88	2.45
-2.25	58.05	2.24
-56.42	-37.7	7.55
-17.55	-62.94	49.37

// Manna A, 2010: Novice Group
// Subjects=8
-23.1	-22.24	39.33
-11.64	24.12	18.58
13.71	42.14	-12.22
17	61.68	6.18
23.47	26.05	-.95

// Taylor V A, 2011: Experienced
// Subjects=12
-28.35	28.18	-15.86
-11.58	-48.5	12.74
14.56	-53.44	27.35
27	-32.15	-9.71
-5.29	-22.61	2.22
19.58	-29.97	2.53
19.65	-21.8	9.56
-28.38	-1.58	-24.12
-37.77	34.79	9.42
12.86	59.01	1.68
12.28	-47.79	18.98
15.01	54.56	-.15

// Taylor V A, 2011: Beginners
// Subjects=10
32.77	-24.97	20.86
-20.73	3.43	-16.9
20.41	7.49	-10.16
-28.35	28.18	-15.86
-11.58	-48.5	12.74
14.56	-53.44	27.35
27	-32.15	-9.71
-5.29	-22.61	2.22
19.58	-29.97	2.53
19.65	-21.8	9.56
-28.38	-1.58	-24.12
-28.38	-1.58	-24.12
29.99	-1.16	-22.91
12.86	59.01	1.68
12.28	-47.79	18.98
32.84	26.99	37.01
-26.54	29.22	41.16
13.43	-49.39	24.73
42.7	-63.87	29.02
-29.65	-69.34	31.91

// Wang D, 2011: Meditation 1 vs Control, Activations
// Wang D, 2011: Meditation 1 vs Control, Deactivations
// Wang D, 2011: Meditation 2 vs Control, Activations
// Wang D, 2011: Meditation 2 vs Control, Deactivations
// Wang D, 2011: Meditation 2 vs Meditation 1, Activations
// Wang D, 2011: Meditation 2 vs Meditation 1, Deactivations
// Wang D, 2011: Post-meditation Baseline 2 vs Pre-meditation Baseline 1, 
// Activations
// Subjects=10
0	64	18
-18	14	10
54	-68	-12
-28	-62	34
-30	10	-22
44	-4	-4
-18	-34	-6
18	-24	-22
-50	-2	-4
-24	-58	46
40	-78	2
26	-57	63
-44	-18	46
-12	16	-28
-34	12	20
-18	-32	-22
-2	-48	-32
44	16	-24
-40	-22	52
-52	-44	54
14	44	14
-14	40	-12
38	-24	48
-28	36	8
38	0	56
4	-48	64

// Xu J, 2014: Nondirective Meditation vs. Rest
// Xu J, 2014: Concentrative practicing vs. Rest
// Xu J, 2014: Nondirective meditation vs. Concentrative practicing
// Subjects=14
22	36	-21
24	-86	27
36	-83	0
30	-86	20
7	-74	-14
-56	5	17
-14	-56	55
-61	-15	14
-19	-60	47
44	-26	-27
27	-17	-6
-37	-2	-7
-20	-74	-12
38	-27	-32
8	37	10
8	6	31
-3	42	-3
-27	-2	-8
-7	10	-9
-24	-11	2
-11	15	3
23	-5	-21
-16	-15	15
22	-5	-2
25	4	-5
-13	-89	24
-36	5	49
-6	-3	61
-39	-14	41
-34	7	55
-48	-20	37
17	-74	5
-37	6	58
15	-87	19
4	11	31
-1	13	34
-21	-75	-11
7	6	53
52	-6	-22
28	-24	-32
36	-2	-20
47	-29	-19
31	2	-19

// Buhler M, 2010: Anticipatory brain activity to monetary reward, Occasional 
// smokers > Dependent smokers
// Buhler M, 2010: Anticipatory brain activity in the motivation task, All 
// smokers
// Subjects=21
20	18	-6
-6	12	-6
12	-2	16
18	26	-16
6	58	8
-10	34	6
8	6	-14
-10	-2	16
-32	4	6
26	-8	0
12	40	30
-10	64	8
-16	16	-4
20	16	-6
10	10	-6
-12	-4	14
14	-18	10
14	-12	-8
-6	-24	-6
6	-26	-6
-38	-16	62
-38	-28	46
36	-22	58
50	-22	44
34	54	8
8	40	32
10	38	24
-16	-92	-18
14	-88	-18
-12	-98	-8
6	-92	14

// Callan D E, 2010: Spaced Condition > Verbal Working Memory of Spaced 
// Condition, P<0.005
// Callan D E, 2010: Spaced Condition > Verbal Working Memory of Spaced 
// Condition, P<0.05
// Callan D E, 2010: Massed Condition > Verbal Working Memory of Massed 
// Condition
// Callan D E, 2010: Massed Condition Correlated with Behavioral Performance, 
// 10-min Recall
// Callan D E, 2010: Massed Condition Correlated with Behavioral Performance, 
// 1-day Recall
// Callan D E, 2010: Spaced Condition Correlated with Behavioral Performance, 
// 10-min Recall
// Callan D E, 2010: Spaced Condition Correlated with Behavioral Performance, 
// 1-day Recall
// Callan D E, 2010: Massed vs. Spaced Decreasing Activity Trend Relative to 
// Verbal Working Memory Conditions, P<0.005
// Callan D E, 2010: Massed vs. Spaced Decreasing Activity Trend Relative to 
// Verbal Working Memory Conditions, P<0.05
// Subjects=13
53.19	13.71	20.05
33.35	27.1	-7.84
-56.69	5.82	45.11
-4.86	28.76	46.44
-1.91	13.51	21
-33.77	-54.72	50.71
34.32	-60.86	50.16
-31.11	-95.21	-3.6
33.73	-101.36	-4.1
-53.81	9.72	17.78
-57.15	22.06	12.13
-28.22	23.69	-6.45
-40.34	13.51	57.52
-1.43	23.63	60.33
-23.94	-67.03	56.24
-24.7	-3.77	9.65
-50.58	12.92	17.41
49.98	7.31	20.73
-47.48	21.68	7.52
-43.67	6.28	49.32
40.35	-1.88	26.29
-8.02	22.78	51.57
-1.57	29.18	50.82
-50.7	-43.81	-3.87
-50.01	-45.21	50.04
-33.65	-57.08	59.9
-18.17	-.14	13.67
30.51	-32.29	11.54
-5.61	-29.36	-24
42.8	-63.59	-48.33
-47.34	12.94	17.35
-43.98	13.78	26.18
-60.28	22.88	21.07
-34.75	23.25	-10.78
-66.69	-55.38	10.99
-20.6	-63	64.75
-47.23	13.77	26.23
-47.37	22.51	16.41
-31.45	20.49	-6.08
-66.69	-55.38	10.99
-46.78	-42	49.67
-30.47	-70.66	52.23
53.17	11.37	18.04
-56.92	7.35	27.03
-28.09	21.33	2.75
-60.11	7.75	31.53
1.67	45.56	53.63
-47.69	46.37	-3.88
-37.09	-48.77	45.69
-28.06	-1.42	0.51
53.15	11.16	15.82
-60.18	10.53	26.77
-28.09	21.33	2.75
-40.47	15.87	48.32
56.62	8.58	33.94
1.67	45.56	53.63
-47.82	48.73	-13.08
-31.36	-1.85	-3.87
-1.51	29.6	55.26
-50.58	12.92	17.41
-34.63	20.89	-1.58
33.33	33.48	-8.47
-37.48	7.42	26.69
8.03	31.58	41.46

// Chapin H, 2010: Expressive > Mechanical
// Chapin H, 2010: Mechanical > Expressive
// Chapin H, 2010: Experienced > Inexperienced
// Chapin H, 2010: Inexperienced > Experienced
// Subjects=7
20.44	-42.41	-5.21
46.09	-59.86	-12.96
42.23	-33.6	51.79
50.13	30.01	-7.16
15.91	-1.17	-22
-1.29	72.34	-5.66
7.32	37.87	-11.79
-30.39	-46.72	53.73
3.34	58.54	35.59
-13.66	50.66	45.37
-60.49	-44.39	31.58
15.93	12.2	-14.2
-14	42.66	-3.02
-1.17	12.1	-13.99
-22.48	-22.55	-19.76

// Chen J L, 2012: Listening to melodies at pre-training
// Chen J L, 2012: Early > Late learning (melody training)
// Chen J L, 2012: Late > Early learning (melody training)
// Chen J L, 2012: Early > Late learning (random training)
// Chen J L, 2012: Late > Early learning (random training)
// Subjects=16
54	-10	-2
-46	-24	8
52	2	42
-48	-6	44
36	-2	52
-24	-6	48
52	-6	42
-54	4	26
-26	-4	54
2	-52	22
-4	40	-26
-40	48	-10
-26	-4	52
4	-10	70
2	0	42
26	-28	70
18	8	50
6	-30	42
46	-78	16
-26	52	-12

// Dennis N A, 2011: Younger Healthy Controls
// Subjects=12
-51.6	13.34	21.87
-27.11	-36.26	-16.22
-23.03	-38.73	48.94
-59.39	-55.1	-9.33
-22.97	-71.16	46.55
29.57	-95.77	9.99
-19.21	-89.54	-1
-23.64	52.99	19.71
-9.84	-11.83	71.83
34.29	-5.27	59.22
12.82	12.78	-10.55
33.58	-17.16	1.02
-23.45	-11.23	21.58
-3.27	10.26	-2.18
13.24	-35.54	12.15
9.84	-54.23	-3.87
-23.84	-31.68	-13.37
25.86	-31.5	-14.24
21.85	4.77	18.1
29.29	-.49	7.29

// Dennis N A, 2011: Older Healthy Controls
// Subjects=12
-43.25	34.14	2.86
-27.15	-36.57	-19.56
-24.12	30.76	-22.91
-51.48	18.63	32.55
-59.2	-44.93	7.59
-40.1	-20.14	-15.36
41.93	-12.72	-20.85
-19.45	46.55	7.95
-23.84	-31.68	-13.37
25.86	-31.5	-14.24
21.85	4.77	18.1
29.29	-.49	7.29

// Dillo W, 2010: Healthy Controls
// Subjects=15
10.36	10.94	50.18
8.35	7.71	61.74

// Dillo W, 2010: ADHD Patients
// Subjects=15
25.65	-68.75	46.6
34.42	-65.56	57.34
-2.6	8.76	50.62
55.5	11.56	31.42
33.74	-96.9	-2.3

// Escoffier N, 2012: Conjunction: Voice > Rest and Music > Rest
// Escoffier N, 2012: Voice > Music
// Escoffier N, 2012: Music > Voice
// Escoffier N, 2012: Conjunction: Emotion Tracking > Pitch Tracking (Music 
// and Voice)
// Subjects=16
-60	-23	15
60	-19	12
-54	-16	12
54	14	-24
64	-4	-7
-1	-80	37
9	-69	45
-51	-35	13
43	-13	-2
-4	57	8
11	45	0

// Fan J, 2011: All Prime and Target Events in Common
// Fan J, 2011: All Face Primes
// Fan J, 2011: Fear Prime
// Fan J, 2011: Fear Target
// Fan J, 2011: Fearful Targets Primed by Fearful Primes
// Subjects=25
-32	-56	-24
6	-82	-10
34	-48	-24
-44	-36	48
-32	-42	42
-4	2	50
42	8	30
36	2	48
34	2	62
2	-28	28
-12	-16	8
10	-14	10
-38	-4	16
-44	0	6
-34	20	6
-14	-30	-2
-8	-22	-10
32	24	2
-16	-88	-14
-38	-86	-8
-26	-92	-4
42	0	56
50	18	22
42	2	26
34	-60	-12
46	-76	-8
22	-56	-4
-16	-70	8
-12	-64	4
4	20	38
4	16	48
-8	8	38
-30	-28	60
-32	-26	52
-34	-14	64
-54	6	-10
-64	-14	-6
-54	-42	2
-12	54	-2
-20	54	6
-16	36	10
62	-22	0
66	-38	12
52	-36	6
44	16	-2
36	20	-6
46	8	2
-56	-58	18
48	-52	24
58	-56	30
50	-38	26
22	-10	20
38	-26	16
36	-14	16
12	-14	70
-2	-6	70
22	-12	70
-14	-62	24
0	-60	30
-12	-58	32
-6	-38	8
-20	-18	70
-60	-30	14
46	-6	8
44	4	2
58	0	6
-8	16	2
-10	14	12
-20	-48	-26
-32	-42	-24
42	-80	-10
-42	2	30
42	4	26
40	18	20
38	12	38
-36	-18	62
-38	-28	52
-30	-26	54
8	14	46
2	40	36
2	32	40

// Friederici A D, 2010: Correct-Intelligible > Correct-Rotated
// Friederici A D, 2010: Incorrect-Intelligible > Correct Intelligible
// Subjects=17
-58	-4	4
62	-4	-14
-54	-16	4
-60	-42	6
-62	18	16
-12	-28	2
44	-20	6

// Glahn D C, 2010: Bipolar Disorder Patients
// Subjects=15
-26.25	-31.28	-7.9
-26.23	-33.11	-3.34
20.24	-32.99	-8.06
-45.37	21.15	24.14
-49.59	16.64	20.03
-45.26	5.42	42.97
-47.66	44.45	-8.52
47.53	36.09	13.69
49.78	9.61	28.81
39.2	9.25	24.45
-5.16	20.6	43.92
-7.25	23.63	59.26
-34.43	-68.3	43.52
-36.56	-63.98	45.45
34.55	102.14	-8.52
1.41	-79.24	-2.56
24.67	-92.33	-12.9
-28.24	-76.5	-22.55
-60.03	-37.6	-2.83
-24.16	-27.2	-10.41
24.48	-32.82	-5.87
-30.69	23.31	-11.61
-51.66	10.86	29.32
-45.35	17.08	26.63
-45.28	2.65	32.06
34.82	23.86	-12.04
43.34	32.4	22.84
39.11	32.23	20.66
47.72	-2.88	31.89
-.96	22.33	37.11
-3.07	22.58	41.55
-25.99	-68.5	39.04
-32.34	-57.23	51.63
-34.46	-59.89	42.94
-55.71	-23.81	49.47
35.28	-68.25	34.22
45.73	-31.91	40.55
33.18	-81.69	21.84
1.48	-98.15	-1.27
14.21	-106.04	5.86
-45.17	-67.97	-18.6
-15.73	-7	8.13
-24.22	-3.41	-.94
18.07	-4.62	7.77
22.22	7.21	-6.38
-47.49	30.21	34.63
-11.51	18.18	39.68
-23.82	-76.34	48.44
39.22	-1.66	18.54
-22.12	3.18	3.03
24.38	1.47	2.88
-28.13	-101.31	-14.19
33.16	-100.53	-10.17
-.99	33.24	43.03
-15.44	-73.29	28.21
16.22	-64.75	25.22
-70.63	-34.02	-11.89
-32.68	-17.44	-22.13
-30.57	-17.56	-24.35
-24.02	-74.23	-20.51
20.34	-69.66	-21.09
-22	10.63	55.8
22.38	8.9	55.65

// Glahn D C, 2010: Healthy Controls
// Subjects=24
-24.15	-29.3	-10.27
-34.79	-19.69	-24.18
-32.72	-4.7	-20.78
26.58	-30.84	-8.24
28.57	-10.76	-25.17
26.44	-6.57	-25.44
-47.54	31.23	16.8
-38.98	6.49	25.1
-49.49	7.76	47.28
-51.86	38.11	-8.06
45.42	31.6	9.57
45.51	19.94	25.9
41.3	9	20.02
-7.33	28.45	34.51
-5.15	18.64	46.27
-30.2	-72.6	41.57
-28.13	-69.19	28
37.41	-63.22	47.19
35.27	-61.68	38.21
33.12	-90.16	-13.1
-17.54	-107.53	-13.83
28.93	-100.7	-12.35
37.31	-88.56	-22.11
-22.04	-29.28	-10.28
22.34	-28.91	-10.57
-34.92	20.9	-15.86
-51.66	8.63	27.25
-49.6	23.49	28.44
-26.08	-20.11	71.24
36.97	22.45	-.85
49.7	28.38	25.3
45.42	38.58	20.19
43.45	7.59	31.2
3.28	18.3	39.58
1.18	18.42	41.81
-23.85	-70.17	45.8
-36.58	-50.83	53.43
-32.36	-60.01	40.72
-53.6	-26.3	42.97
22.66	-71.48	52.28
33.16	-52.48	50.91
-34.5	-92.82	-12.52
-9.06	-106.78	-2.83
14.21	-106.04	5.86
-5.14	-31.65	-16.88
-13.57	-21.82	6.91
-22.11	-1.16	1.11
15.96	-4.63	7.78
15.92	3.64	5
-47.49	30.21	34.63
-11.51	18.18	39.68
-23.82	-76.34	48.44
39.22	-1.66	18.54
-22.12	3.18	3.03
24.38	1.47	2.88
-28.13	-101.31	-14.19
33.16	-100.53	-10.17
-.99	33.24	43.03
-15.44	-73.29	28.21
16.22	-64.75	25.22
-70.63	-34.02	-11.89
-32.68	-17.44	-22.13
-30.57	-17.56	-24.35
-24.02	-74.23	-20.51
20.34	-69.66	-21.09
-22	10.63	55.8
22.38	8.9	55.65

// Greening S G, 2011: Main Effect of Condition: OA > IR, RR, and CTL
// Greening S G, 2011: Main Effect of Condition: OA, RR, CTL > IR
// Greening S G, 2011: Interaction of Condition and Relearning Stage
// Greening S G, 2011: OA Error Feedback > IR Error Feedback
// Greening S G, 2011: Conjunction Analysis (OA, RR, IR): Error Feedback >/= 
// Correct Feedback
// Greening S G, 2011: Conjuction Analysis (OA, RR, IR): Correct Feedback > 
// Error Feedback
// Greening S G, 2011: OA Error Feedback > OA Correct Feedback
// Greening S G, 2011: OA Correct Feedback > OA Error Feedback
// Greening S G, 2011: IR Error Feedback > IR Correct Feedback
// Greening S G, 2011: IR Correct Feedback > IR Error Feedback
// Subjects=21
-32.54	-56.77	47.91
14.34	-87.61	16.5
-15.46	-75.5	38.13
-19.17	-73.08	-26.71
19.63	-70.48	17.23
37.3	65.06	6.78
-41.51	36.6	31.26
-10.56	56.08	32.61
-46.52	-66.6	32.16
-1.61	-63.78	36.99
-68.19	-42.34	3.61
33.08	59.03	11.79
-33.16	56.52	12.76
44.16	19.2	46.23
-44.64	16.49	32.98
35.22	20.58	-3.97
-34.24	21.3	-2.12
2.44	29.44	44.73
-40.11	0.43	58.81
40.16	-61.45	49.69
-33.6	-63.29	46.23
4.88	-67.38	45.02
-9.27	-79.97	7.21
3.56	-74.35	9.93
9.98	-74.23	10.96
-26.55	-87.42	-18.74
-41.58	-68.48	-20.15
39.62	-69.22	-23.25
23.84	-97.55	-2.85
4.61	-88.78	2.21
30.14	-86.57	-12.77
9.79	-13.61	10.34
-9.45	-14.79	10.66
-1.25	54.11	-7.48
32.04	59.28	15.13
-33.2	58.29	8.15
42.01	19.01	44.04
-43.51	13.84	39.88
42.71	19.65	-2.86
-38.52	21.19	-3.17
1.35	30.4	43.55
-22.9	-66.31	47.48
39.06	-65.06	44.43
25.97	-97.54	-2.88
-28.7	-84.26	-18.98
11.03	-74.39	8.74
62.1	-39.08	-7.08
-60.81	-35.58	-5.96
-1.98	-11.57	10.31
-32.08	-21.29	-16.41
35.19	58.7	7.33
-35.31	58.62	12.61
-43.94	49.97	-2.18
42.03	18.13	46.34
-44.63	15.44	33.07
34.16	20.66	-2.85
-33.17	21.31	-2.13
2.44	29.44	44.73
-37.97	0.53	59.89
43.33	-61.86	44.12
-34.67	-63.3	46.25
33.1	-40.79	-26.68
-26.53	-89.45	-17.45
-34.22	-47.71	-27.55
-9.28	-79	6.01
4.88	-67.38	45.02
26.97	-87.3	-8.21
-64.03	-32.52	-7.3
63.15	-35.9	-7.36
9.79	-13.61	10.34
-4.43	56.55	-3.18
-60.55	-29.58	30.33
64.45	-28.03	25.42
-37.3	1.88	8.47
-9.19	-53.85	28.43
60.35	-20.72	51.62

// Haase L, 2011: Male Healthy Controls
// Subjects=9
44.93	-5.8	-1.87
-38.49	25.94	3.12
16.12	-15.49	-.72
61.1	-.99	17.62
-51.08	-14.61	16.7
15.15	-67.19	-8.64
-1.19	50.31	-1.58
41.59	52.05	3.36
-4.27	9.85	-1.5
-.72	-27.2	28.33
-37.39	44.86	13.79
-4.16	-13.15	3.77
9.99	-82.86	9.46
-36.17	-12.83	10.81
51.43	-55.43	-11.16
30.85	30.53	-12.56
15.35	-50.79	24.55
51.69	-54.97	22.25
50.47	-53.18	4.27
10.09	-68.63	28.34
54.37	15.44	-17.14
35.34	-33.06	-9.51
6.47	-42.21	-15.1
31.95	-6.45	-22.85
25.99	-62.24	13.12
-22.54	-7.75	-21
32.07	-29.37	-16.47
-1.16	55.05	4.71
-16.82	-25.78	20.59
20.57	-23.52	18.86
-16.19	44.33	-8.71
38.59	-31.56	-4.09
6.78	-48.9	22.26
46.87	-8.99	-29.5
-48.96	5.04	22.84
29.38	-75.66	32.05
-50	-18.92	15.94
16.5	-58.82	30.79
-26.66	3.63	2.63
-23.05	-75.6	23.73
35.7	-68.9	22.49
22.61	-64.06	-10.11
-14.77	-35.51	4.66
51.52	-28.17	11.09
54.79	-18.66	23.63
9.78	-68.63	-12.92
28.3	-59.37	36.27
28.81	12.88	-6.59
10.08	-72.06	25.28
-23.48	9.99	2.06
19.52	-59.54	7.39
42	-63.38	10.8
22.81	-66.41	14.62
6.62	-48.33	2.14
-.8	-60.97	4.4
-.71	-50.17	20.22
-.91	-14.91	8.34
9.85	-69	-3.97
-17.01	-49.75	-14.2
42.13	-68.69	24.63
36.28	15.04	-6.86
3.35	21.21	20.88
-39.2	-78.04	7.39
-10.88	76.94	-.36
36.07	66.68	-13.42
-39.19	-47.23	20.42
-1.28	66.97	-6.32
70.61	-19.65	-4.35
67.56	-18.04	16.74
22.63	-14.42	12.49
-68.33	-29.45	-8.62
-39.29	-21.85	18.29
-2.83	-71.93	14.26
26.23	-77.28	38.91
12.66	67.57	0.16
48.69	-67.11	44.49
38.5	3.76	-1.48
35.21	-24.57	-23.6
41.57	9.01	-16.45
-46.08	44.5	-3.92
35.22	22.78	-3.04
25.68	-79.76	-34.48
-36.37	-64.36	-36.17
35.11	28.27	-14.65
41.69	-9.51	-8.21
-3.45	65.56	-10.64
4.21	52.08	7.13
-48.88	-34.86	16.15
48.65	-70.8	38.11
16.12	-15.49	-.72
-37.27	-46.1	-6.46
-45.94	42.61	12.96
-23.02	-58.8	34.58
44.27	-43.33	35.86
-58.3	-32.86	42.85
-21.53	-11.68	-30.72
-7.44	-37.01	-15.38
-4.24	-56.79	-23.79
27.56	73.57	-6.09
23.35	-12.56	-32.28
28.67	1.56	-29.06
-52.27	-7.1	3.82
22.51	33.76	16.26
-57.39	-67.4	8.94
-46.83	9.28	22.46
-.8	-60.97	4.4
25.49	-5.86	-28.4
64.19	4.43	4.86
51.69	-54.97	22.25
57.87	-41.93	-2.33
-32.99	-61.48	-13.03
51.55	-10.22	22.96
35.34	-33.06	-9.51
49.39	-31.35	11.38
32.04	-20.91	-17.18
45.37	-84.79	22.6
-12.35	-69.91	27.59
57.82	-55.65	-14.56
3.19	55.85	14.63
47.9	31.26	-18.39
-23.59	-25.18	-26.22
19.3	40.34	19.09
-67.21	-27.88	-2.07
7.53	3.84	2.22
-15.93	17.33	13.62
38.59	-31.56	-4.09
41.74	40.48	18.82
-20.46	8.13	-22.36
13.39	-85.27	33.04

// Haase L, 2011: Female Healthy Controls
// Subjects=12
-9.49	-18.56	3.17
41.84	-7.96	11.73
57.93	-1.72	22.18
38.5	13.71	3.26
-10.88	76.94	-.36
12.97	-15.97	7.16
-4.23	-17.18	-7.04
-54.3	-37.86	5.31
64.03	55.44	3.93
-35.16	0.84	8.53
12.88	-12.59	-4.27
44.85	3.2	-9.31
-2.83	-71.93	14.26
-20.43	67.71	4.99
19.29	7.25	4.02
-25.59	-49	-17.51
12.93	-3.28	6.1
63.16	0.45	8.55
19.31	-18.9	-3.82
-15.84	-34.46	4.58
19.63	-61.77	19.85
22.58	-64.32	-13.43
-10.53	-68.75	-12.68
-51.13	4.68	18.43
44.9	10.32	0.13
-38.55	35.2	-1
29.01	-47.65	-4.87
9.81	-57.28	-3.84
9.64	10.11	0.55
61.16	-10.25	21.74
-51.09	-18.04	13.64
38.45	26.4	2.2
41.69	-2.9	-5.42
-54.47	13.15	4.38
22.62	-35.37	3.1
-16.71	-63.13	19.26
28.74	54.98	1.03
50.38	13.92	18.72
41.7	16.9	2.96
57.91	-4.18	17.92
-1.1	2.93	-8.76
-42.73	32.86	10.4
41.67	46.31	11.64
45.1	1.37	22.06
-48.91	5.55	29.48
23.79	-29.93	18.24
38.59	-31.47	-2.99
35.51	-6.09	22.8
-48.96	5.04	22.84
29.38	-75.66	32.05
-50	-18.92	15.94
16.5	-58.82	30.79
-26.66	3.63	2.63
-23.05	-75.6	23.73
35.7	-68.9	22.49
22.61	-64.06	-10.11
-14.77	-35.51	4.66
51.52	-28.17	11.09
54.79	-18.66	23.63
9.78	-68.63	-12.92
28.3	-59.37	36.27
28.81	12.88	-6.59
10.08	-72.06	25.28
-23.48	9.99	2.06
19.52	-59.54	7.39
42	-63.38	10.8
22.81	-66.41	14.62
6.62	-48.33	2.14
-.8	-60.97	4.4
-.71	-50.17	20.22
-.91	-14.91	8.34
9.85	-69	-3.97
-17.01	-49.75	-14.2
42.13	-68.69	24.63
36.28	15.04	-6.86
3.35	21.21	20.88
-39.2	-78.04	7.39
-10.88	76.94	-.36
36.07	66.68	-13.42
-39.19	-47.23	20.42
-1.28	66.97	-6.32
70.61	-19.65	-4.35
67.56	-18.04	16.74
22.63	-14.42	12.49
-68.33	-29.45	-8.62
-39.29	-21.85	18.29
-2.83	-71.93	14.26
26.23	-77.28	38.91
12.66	67.57	0.16
48.69	-67.11	44.49
38.5	3.76	-1.48
35.21	-24.57	-23.6
41.57	9.01	-16.45
-46.08	44.5	-3.92
35.22	22.78	-3.04
25.68	-79.76	-34.48
-36.37	-64.36	-36.17
35.11	28.27	-14.65
41.69	-9.51	-8.21
-3.45	65.56	-10.64
4.21	52.08	7.13
-48.88	-34.86	16.15
48.65	-70.8	38.11
16.12	-15.49	-.72
-37.27	-46.1	-6.46
-45.94	42.61	12.96
-23.02	-58.8	34.58
44.27	-43.33	35.86
-58.3	-32.86	42.85
-21.53	-11.68	-30.72
-7.44	-37.01	-15.38
-4.24	-56.79	-23.79
27.56	73.57	-6.09
23.35	-12.56	-32.28
28.67	1.56	-29.06
-52.27	-7.1	3.82
22.51	33.76	16.26
-57.39	-67.4	8.94
-46.83	9.28	22.46
-.8	-60.97	4.4
25.49	-5.86	-28.4
64.19	4.43	4.86
51.69	-54.97	22.25
57.87	-41.93	-2.33
-32.99	-61.48	-13.03
51.55	-10.22	22.96
35.34	-33.06	-9.51
49.39	-31.35	11.38
32.04	-20.91	-17.18
45.37	-84.79	22.6
-12.35	-69.91	27.59
57.82	-55.65	-14.56
3.19	55.85	14.63
47.9	31.26	-18.39
-23.59	-25.18	-26.22
19.3	40.34	19.09
-67.21	-27.88	-2.07
7.53	3.84	2.22
-15.93	17.33	13.62
38.59	-31.56	-4.09
41.74	40.48	18.82
-20.46	8.13	-22.36
13.39	-85.27	33.04

// Habib R, 2010: Pathological Gamblers
// Subjects=11
-11.93	-20.48	-9.08
13.84	10.14	-15.91
35.22	24.92	-31.18
55.22	-39.83	-1.59
-56.11	-45	-4.78
-55.45	-47.66	47.02
-.56	-7.47	37.62
29.48	-97.56	2.32
-45.54	-17.8	67.43
41.79	-1.75	-29.78
28.82	-4.02	-30.45
-20.86	2.5	-26.89
62.86	-44.71	3.25
-26.72	-102.33	0.39
-64.3	-23	35.76
3.34	-51.06	-4.07
-9.94	-19.59	-22.65
10.5	-84.32	41.68
64.73	26.46	-4.94
63.23	-45.2	32.43
-18.53	-30.16	-20.34
33.8	-97.55	2.25
37.42	0.05	-33.24
7.5	-.85	-6.87
1.04	-47.75	-14.45
23.75	-50.42	70.59
48.23	38.46	-24.9
-5.7	31.24	-18.79
-1.09	-.47	-2.28
-24.51	-104.13	3.89
27.35	-103.95	2.99
-10.91	-55.52	63.85
21.58	-59.25	68.14
-26.44	-87.07	25.77
40.68	-80.37	36.29
-26.4	12.83	49.5
34.19	15.9	56.01
31.66	-101.81	2.71
-20.23	-104.43	0.49
37.42	0.05	-33.24
7.5	-.85	-6.87
-22.76	-1.06	-7.45
1.04	-47.75	-14.45
-63.69	-45.13	-5.76
-9.91	-19.39	-20.43
-32.58	-57.18	58.78
21.58	-63.61	67.45
34.11	19.63	50.04
-28.64	18.79	44.47
9.17	-64.74	-58.85
34.45	-50.04	62.53
42.81	-80.57	34.03

// Habib R, 2010: Healthy Controls
// Subjects=11
-11.93	-20.48	-9.08
-.7	58.24	40.09
-56.52	-2.09	-28.07
7.83	-94.66	0.16
27.77	-0.08	57.7
-17.42	-24.08	67.57
51.38	23.95	49.32
42.6	39.35	42.34
-17.82	-80.66	24.99
-34.79	-18.17	62.8
29.66	23.04	40.81
55.47	-60.92	13.94
-37.39	-59.77	19.89
67.09	26.85	10.66
-33.08	25.49	36.04
27.32	35.92	29.49
71.26	-13.6	-8.94
-22.97	60.83	-11.33
-31.54	-87.48	-35.73
31.74	27.95	35.81
-37.74	26.28	10.27
-.84	39.66	25.12
65.19	-30.27	19.71
-55.33	-44.6	56.8
10.59	-59.57	53.79
44.95	-33.69	41.68
-34.81	-53.35	53.95
-48.94	51.71	-15.59
58.39	-62.23	-11.75
38.35	25.61	44.89
33.95	-57.08	21.77
-37.82	-71.7	-15.9
-.52	30.04	48.48
38.28	-81.08	17.35
51.75	-34.57	66.31
-26.78	-84.14	-.29
-45.84	12.76	49.84
56.52	16.57	27.55
-24.51	-104.13	3.89
27.35	-103.95	2.99
-10.91	-55.52	63.85
21.58	-59.25	68.14
-26.44	-87.07	25.77
40.68	-80.37	36.29
-26.4	12.83	49.5
34.19	15.9	56.01
27.35	-105.02	3.1
44.97	-36.78	43.11
-28.41	-44.07	49.56
-3.4	-65.79	56.89
-51.09	49.58	-15.34
38.35	25.61	44.89
48.7	44.12	12.63
-32.85	23.96	54.11
-50.58	35.88	21.86
-2.69	29.93	47.41
33.37	-67.93	-25.33
5.45	-82.08	-14.49
-39.93	-75.76	-13.22
-18.11	-101.44	-2.08
64.83	-55.93	-13.6
7.93	-30.48	20.71

// Mies G W, 2011: Positive Feedback > Negative Feedback
// Mies G W, 2011: Invalid Feedback > Valid Feedback
// Subjects=29
-52	-46	42
54	-38	36
-48	-58	48
8	42	18
12	44	18
-18	-50	36
-22	24	48
-28	22	42
-30	8	0
-56	-58	-8
-34	-16	42
58	4	12
10	-38	44

// Nakamura Y, 2011: Umami
// Nakamura Y, 2011: Salty
// Subjects=20
40	-4	15
52	-2	15

// Kucian K, 2011: Developmental dyscalculia (DD) children
// Subjects=16
-12	30	42
3	21	57
-39	21	3
39	24	42
-12	-18	36
-63	-39	57
18	-63	48
63	-54	0
-15	-3	9
-24	-33	75
-36	-84	36
30	-42	51
21	-36	75
-36	-27	15
-12	-33	-27
-45	9	30
9	18	39
39	21	45
-9	30	42
9	36	54
-33	27	27
-39	-15	45
-36	-48	48
-24	3	66
-42	15	0
-27	-18	42
-39	-66	6
-12	39	39
-36	3	39
-51	-27	12
-18	3	54
-36	-63	30
9	12	60
24	48	24
63	-66	21
-48	-45	54

// Kucian K, 2011: Healthy control children (CC)
// Subjects=16
42	-45	60
-3	18	60
-42	-63	-30
-30	-48	48
3	-18	30
-9	-75	-24
-45	3	45
33	21	21
-36	15	9
24	0	69
51	6	36
-12	-18	36
-63	-39	57
18	-63	48
63	-54	0
-15	-3	9
-24	-33	75
-36	-84	36
30	-42	51
21	-36	75
-36	-27	15
-12	-33	-27
-45	9	30
9	18	39
39	21	45
-9	30	42
9	36	54
-33	27	27
-39	-15	45
-36	-48	48
-24	3	66
-42	15	0
-27	-18	42
-39	-66	6
-12	39	39
-36	3	39
-51	-27	12
-18	3	54
-36	-63	30
9	12	60
24	48	24
63	-66	21
-48	-45	54

// Meusel L C, 2013: PRE, Recollection memory task (Recollect-encode), Healthy 
// controls > Patients (Hypoactivity)
// Meusel L C, 2013: PRE, Recollection memory task (Recollect-encode), 
// Patients > Healthy controls
// Meusel L C, 2013: POST > PRE, n-back (2-back - 0-back)
// Meusel L C, 2013: POST > PRE, Recollection memory task (Recollect-encode)
// Meusel L C, 2013: PRE, n-back (2-back - 0-back) , Healthy controls > 
// Patients (Hypoactivity)
// Subjects=13
10.55	-9.03	-26.85
-9.75	-8.1	-26.7
22.44	-17.45	-12.9
-19.09	-35.96	-.83
-37.37	-32.87	-14.26
19.58	22.31	47.37
-9.36	44.34	45.85
41.58	44.22	-1.56
32.01	31.48	-.38
-54.29	10.55	25.78
9.73	49.51	28.47
3.18	51.36	11.66
45.15	-34.29	15.02
-54.68	9.87	-24.34
38.94	-38.88	38.89
23.03	-57.49	47.33
-41.23	-26.41	42.11
32.02	-21.08	-19.4
-25.55	-36.52	-7.4
35.14	70.33	6.36

// Penades P, 2013: Healthy Control (HC)
// Subjects=15
-26	-66	52
42	38	24
-2	18	44
22	-34	72
6	46	-12
-30	-98	-5
30	-94	-4

// Penades P, 2013: Subgroup of schizophrenia patients, cognitive remediation 
// therapy (SZ-CRT)
// Subjects=17
-26	-66	52
42	38	24
-2	18	44
22	-34	72
6	46	-12
-30	-98	-5
30	-94	-4
10	-66	28
-30	-98	0
26	-98	-4
-46	-38	56
46	-42	52
30	2	60
-26	-62	52
-34	50	16
42	42	20
0	-57	16
2	38	-20
-30	-98	-4
-2	-56	36
-46	-70	28
-3	-88	0
-38	-18	60
22	-66	60
30	-2	48

// Penades P, 2013: Subgroup of patients, social skills training (SZ-SST)
// Subjects=18
10	-66	28
-30	-98	0
26	-98	-4
-46	-38	56
46	-42	52
30	2	60

// Rowland L M, 2010: Schizophrenia
// Subjects=17
48	14	16
38	10	26
50	30	10
34	30	10
20	-18	46
28	-62	36
-54	-32	-16
38	-72	50
24	12	-18
-44	-22	3
-52	2	-20
-8	-100	12
10	-6	36
-8	-54	60
30	-70	-14
56	-56	-12

// Rowland L M, 2010: Healthy Controls
// Subjects=17
50	4	40
20	-18	52
50	38	6
40	10	26
-6	4	28
32	30	4
-12	-44	-2
12	-42	-2
8	-52	12
8	-58	38
-8	-52	12
-38	-70	34
-10	-36	28
14	-88	2
34	-82	2
38	10	26
50	30	10
34	30	10
20	-18	46
28	-62	36
-54	-32	-16
26	34	-6
10	-22	44
-8	-52	58
32	-72	-16
10	-6	36
-8	-54	60
30	-70	-14
56	-56	-12

// Subramaniam K, 2014: 2-back > 0-back
// Subjects=16
48.91	41.32	28.59
-43.92	32.9	35.49
39.81	26.91	-10.17
-33.61	22.61	-6.25

// Vianin P, 2014: RECOS vs. TAU at T2
// Vianin P, 2014: T2 vs. T1 in RECOS
// Subjects=8
50	-56	44
52	8	42
-48	34	30
-32	-96	2
-2	-36	50
-20	-74	54
52	6	42
-30	-62	56
38	-64	58
36	-88	-8
-32	-94	0
60	-28	40
-6	2	74
-6	-20	76

// Bugden S, 2012: Large Ratio > Small Ratio
// Subjects=17
-29.37	-66.95	39.8
-13.96	-5.24	-16.85
14.02	-39.28	-5.4
-13.71	-46.59	-1.12
7.58	-72.58	-22.6
0.35	-79.92	7.09

// Meintjes E M, 2010: Proximity Judgment (PJ)  > Proximity Judgment Control 
// (PJCTL)
// Meintjes E M, 2010: Exact Addition (EA) > Exact Addition Control (EACTL)
// Subjects=16
43.29	-44.6	47.13
34.75	-67.71	38.01
-9.1	-68.32	34.11
-3.72	-64.6	40.42
-29.36	-65.81	40.82
4.74	-87.49	18.83
33.33	25.34	30.23
40.7	36.33	20.3
-21.29	30.33	17.05
6.68	24.8	39.5
-44.66	18.44	30.59
13.3	-66.41	29.23
13.21	-75.01	14.34
29.91	22.03	1.55
-26.74	21.52	0.01
34.51	-44.93	16.03
-18	1.62	17.19
36.82	-57.38	33.78
-33.71	-53.4	36.48
-40.16	-44.01	34.66
-29.39	-62.81	38.34
4.75	-59.86	32.12
-9.13	-63.11	32.56
28.2	-18.59	40.66
41.86	25.22	27.91
33.13	54	15.56
-18.18	51.32	13.03
-26.34	9.17	46.76
2.36	25.41	33.92
3.47	25.76	38.34
-6.33	24.96	15.1
-8.33	21.91	30.99
0.28	-3.76	28.58
-43.66	22.16	23.57
-35.03	10.92	28.87
34.18	19.77	-.54
35.21	-63.04	-39.33
4.22	-47.82	-32.45
17.16	7.32	5.16
-14.87	4.13	8.02
32.38	-41.52	19.12
22.6	-15.82	8.15

// Mussolin C, 2010: Number Comparison vs. Fixation (Developmental Dyscalculia 
// (DD) Children > Control Children))
// Mussolin C, 2010: Small Numerical Distance vs. Large Numerical Distance 
// (Control Children > DD Children)
// Mussolin C, 2010: Close Color Distance vs. Far Color Distance (Control 
// Children > DD Children)
// Subjects=15
28	-30	42
46	-32	34
-2	-20	-12
30	36	36
-18	-64	52
42	-46	54
-12	-28	46
-10	-76	-6
16	-64	0
-2	-80	30

// Park J, 2012: Letter > Number
// Park J, 2012: Number > Letter
// Subjects=20
-57	-28	28
-36	-37	-23
24	-43	58
51	-25	34
3	20	34
48	-73	-2

// Kedia G, 2014: Distance effect in the beauty conditions
// Kedia G, 2014: Distance effect in height conditions
// Kedia G, 2014: Distance effect in the women conditions
// Kedia G, 2014: Distance effect in the dog conditions
// Kedia G, 2014: Main effect of judgment: Beauty>Height comparisons
// Kedia G, 2014: Main effect of judgment: Height>Beauty comparison
// Kedia G, 2014: Main effect of judgment: Height>Control condition
// Kedia G, 2014: Main effect of target: Women>dogs
// Kedia G, 2014: Main effect of target: Dogs>Women
// Kedia G, 2014: Conjunction analyses of the beauty and height distance 
// effects
// Kedia G, 2014: Conjunction analyses of the beauty and height distance 
// effects (reaction time as a covariate)
// Kedia G, 2014: Conjunction analyses of the women and dog distance effects
// Kedia G, 2014: Conjunction analyses of the women and dog distance effects 
// (reaction time as a covariate)
// Kedia G, 2014: Distance and judgment interactions, Deactivations
// Subjects=25
49.89	44.95	21.49
4.87	31.02	47.17
-34.75	18.89	-11.47
-40.69	9.85	29.87
-33.78	-55.89	49.7
31.04	-55.66	48.58
43.22	-61.53	-14.92
-28.31	-70.04	-33.03
-5.61	-86.22	-35.18
-1.81	36.13	33.33
-40.8	28.68	24.65
55.99	22.4	-13.36
-54.23	15.32	-14.14
-40.15	-51.79	59.49
31.18	-57.92	58.88
-44.74	-68.46	-49.72
39.75	-69.8	-34.22
7.43	-72.48	-26.68
-37.6	28.38	21.26
1.62	31.01	47.23
-31.52	22.1	-11.84
-33.89	-50.13	42.41
27.93	-54.74	58.62
49.7	-61.51	-15.03
-28.31	-70.04	-33.03
-37.68	-83.84	-7.97
49.75	47.21	11.19
4.81	33.9	43.52
-50.99	15.33	-14.2
33.24	25.2	-16.61
-40.69	9.85	29.87
-36.89	-54.97	59.75
34.43	-61.1	59.14
33.03	-74.88	-53.77
-5.52	-85.6	-28.52
36.57	-52.92	-25.75
-34.72	-56.36	-24.19
27.68	9.08	52.31
-59.85	-30.77	44.3
24.77	-54.13	65.34
-14.14	-60.96	63.32
37.6	-74.78	50.36
27.68	9.08	52.31
24.77	-54.13	65.34
-17.39	-57.78	63.06
53.16	25.51	20
46.3	-43	-23.53
53.29	-62.2	11.87
-47.11	-71.81	17.89
11.43	-89.82	28.76
-56.69	-31.38	37.58
-27.95	-87	-7.83
30.48	-86.17	-2.18
1.53	33.58	40.25
-36.89	-54.97	59.75
31.18	-57.92	58.88
-41.28	-70.08	-32.81
1.53	33.58	40.25
-36.89	-54.97	59.75
31.18	-57.92	58.88
-41.28	-70.08	-32.81
56.46	32.52	25.97
4.81	33.9	43.52
-36.95	-52.09	56.11
31.14	-58.23	55.55
-34.81	-66.87	-33.24
56.46	32.52	25.97
4.77	33.59	40.19
-36.95	-52.09	56.11
31.14	-58.23	55.55
-34.81	-66.87	-33.24
4.14	51.87	-5.31
-60.04	-58.47	23.51
-17.92	-55.13	22.47

// Mier D, 2014: Healthy Controls
// Subjects=18
-63	-48	3
-54	-48	3
-48	-54	12
54	-51	12
54	36	-3
51	-3	-24
-48	-6	-21
-51	9	-33
-48	33	-3
-45	-42	-18
-15	-81	-39
24	-54	-12
-45	-51	12
-51	-45	6
-60	-39	-9
57	-48	12
36	-66	45
-30	-66	39
60	21	3
-12	51	39
45	24	30
-3	-81	42
-45	36	18
27	18	21
-36	21	21
-54	21	12
24	-54	-12
30	-63	-15
24	-57	-15
-9	15	66
9	18	63
12	-48	-36
18	-42	-33
24	-21	-27
-12	-45	-36
12	-48	-36
30	-9	45
18	-39	-30
21	-51	-39
12	-48	-36

// Mier D, 2014: Psychopaths
// Subjects=11
24	-54	-12
-45	-51	12
-51	-45	6
-60	-39	-9
57	-48	12
36	-66	45
-30	-66	39
60	21	3
-12	51	39
45	24	30
-3	-81	42
-45	36	18
27	18	21
-36	21	21
-54	21	12
24	-54	-12
30	-63	-15
24	-57	-15
-9	15	66
9	18	63
-15	-6	-24
18	-39	-30
21	-51	-39
12	-48	-36

// Bolling D Z, 2011: Healthy Controls
// Subjects=24
46.09	-11.45	7.52
10.96	-53.16	8.07
-8.25	-59.62	8.83
-11.85	45.04	0.1
-53.56	19.19	-13.98
-47.05	-7.21	-11.84
-46.81	-21.27	12.75
-43.96	-44.65	-42.2
30.64	-55.02	64.88
43.26	5.59	62.99
65.36	-47.26	-3.09
43.37	-42.77	57.01
-39.99	-69.67	46.84
-18.38	63.53	-8.07
52.16	-1.81	-33.51
36.68	16.95	45.39
-30.7	19.21	39.28
4.55	35.79	44.18
23.42	-23.93	-27.98
36.61	-13.4	24.52
20.92	-42.9	57.28
4.39	-51.57	-12.06
-8.76	-18.81	-41.42
-14.54	-78.18	17.15
-36.86	-21.04	56.11
42.8	-2.47	0.11
23.81	-46.22	14.03
33.34	-30.56	9.26
-27.6	-1.61	17.57
-34.09	-35.42	-6.28
-14.75	-44.05	4.26
-14.66	-13.45	28.45

// Bolling D Z, 2011: Autism spectrum disorder (ASD) patients
// Subjects=24
-8.37	-34.5	3.38
-56.24	-9.5	41.98
-59.72	-5.74	8.25
40.13	-43.04	53.73
36.46	34.44	23.85
36.31	26.3	1.12
39.58	50.07	19.16
23.99	14.99	62.43
17.1	59.45	18.63
-21.54	57.42	-4.17
-33.76	-48.46	31.61
-40.74	-41.2	-39.18
49.76	-39.56	56.67
62.02	-18.99	-8.76
36.35	-81.98	-36.64
43.21	-83.92	20.32
13.95	3.96	3.25
-4.81	-53.86	41.77
-14.88	-2.56	4.12
-46.61	-42.19	31.23
42.78	23.68	7.95
-37.51	21.66	-11.03
39.92	14.06	48.94
4.24	16.08	-4.35
-5.5	41.14	-9.69
-66.31	-7.58	-14.94
11.27	-20.24	62.18
42.97	-7.27	20.58
20.57	-36.73	13.27
-37.36	-26.18	-10.36
-24.39	-31.17	6.63

// DeRamus T P, 2014: Healthy Controls
// Subjects=19
-4	-68	54
66	-44	24
62	-40	40
54	-42	22
38	-92	6
-40	-48	-12
-54	22	10
38	-50	-22
-46	36	12
-6	54	30
-36	-90	2
-42	-82	-2
-12	40	50

// DeRamus T P, 2014: Autism Spectrum Disorder ASD patients
// Subjects=17
44	-64	6
62	-40	4
-4	-40	30
-10	-34	32
14	-48	34
-40	-60	36
-50	-60	44
-44	-50	46
32	18	44
26	16	54
24	-94	-10
24	-98	0

// Brieber S, 2010: Coherent Motion (CM) > Random Motion (RM)
// Brieber S, 2010: Interaction (Controls > ASD Patients x CM > RM)
// Subjects=15
-14	-34	61
16	-54	55

// Delmonte S, 2012: Reward anticipation: Monetary incentive delay> Social 
// incentive delay
// Delmonte S, 2012: Reward feedback: Monetary incentive delay (MID) > Social 
// incentive delay (SID)
// Subjects=21
44	-6	58
-36	34	-6
0	10	64
-44	34	14
42	26	-10
56	-26	-2
-50	-58	-2
-56	-24	-12
-34	-6	-23
-46	-24	48
8	-52	44
-28	-50	44
14	-28	64
-20	-66	38
24	-74	44
36	-90	6
-32	-90	12
-34	-6	-28
32	-76	-30
8	-86	-38
-34	-46	-24
-24	-82	-32
42	22	-12
10	-28	64
-54	14	32
-4	46	30
4	34	20
4	-30	34
-32	24	4
66	-24	6
54	-14	4
-40	-32	10
52	-62	-12
-32	-94	6
-16	-74	8
16	-70	10
30	-66	-4
42	-46	-16
-28	-64	-12
62	-14	30
-46	-24	44
-34	-50	56
-54	-30	38
-20	-48	46
16	12	0
-28	-34	2
42	-74	-38

// Cascio C J, 2012: Healthy Controls
// Subjects=18
-20	-3	-20
-30	3	-18
25	3	-28
23	-5	-18
8	15	-13
-33	-23	23
-30	-25	15
-35	33	-20
48	-3	3
43	5	5
40	20	8
-45	5	3
-38	13	-3
8	35	20

// Cascio C J, 2012: Autism Spectrum Disorder ASD patients
// Subjects=17
-23	-8	-15
25	-5	-18
-13	25	-8
-38	-15	23
43	-5	3
45	10	-13
40	3	-13
15	28	-13
48	-3	3
43	5	5
40	20	8
-45	5	3
-38	13	-3
8	35	20

// Carter E J, 2012: Healthy controls
// Subjects=13
-62	-6	28
56	30	4
-28	22	-6
26	20	0
40	4	58
52	16	46
4	-98	-2
-36	-2	64
-40	-14	64
2	18	50
12	10	72
42	20	32
-46	6	28
-58	24	22
40	26	20
-26	26	0
32	-24	24
-48	32	36
40	2	58
-58	-50	2
2	-98	4
12	-36	68
-38	-36	44
-34	-4	66
-22	-14	72
-58	10	34
28	22	0
30	0	6
-42	-4	14
24	2	72
-16	22	28
-10	6	10
-42	4	26
36	26	-18
-54	26	30
-30	20	-8
40	6	54
52	16	46
-64	-8	-28
2	-98	-2
-44	6	48
34	0	68
-12	26	34
10	24	38
-12	-14	14
-54	-50	52
-42	-36	38
-18	-6	44
18	-34	36
-8	-30	44
-46	48	10
-26	-30	62
44	-14	46
-50	0	2
44	2	10
-12	-12	64
16	-12	66
-6	6	6
12	32	32
-40	-44	-24
44	-46	-22
-28	-28	-6
28	-28	-6
34	16	-18
-30	18	-8
42	6	52
52	-2	-26
52	-56	10
-60	-12	-20
-50	-44	2
-62	-56	16
-52	-76	14
28	-56	-10
34	-94	14
36	-94	-2
28	-86	40
-18	-96	-4
-26	-96	20
40	4	30
2	-54	26
-4	46	16
6	30	64
8	64	6
-48	12	4
44	42	-12
-46	36	-2
-28	24	-2
42	4	58
30	48	-12
-26	-88	-4
6	-36	48
22	-84	14
18	-100	18
-14	-98	26
46	-46	0
44	44	-10
-22	-52	48
22	-16	68
-22	-2	-24
4	24	-6
-36	34	-6
-38	10	52
-60	-4	-22
22	-86	16
-14	-98	26
-12	-6	24
-32	-16	-16
-32	16	-22
-52	18	-2
44	28	4
30	14	-18
-28	20	-6
42	4	58
-64	-50	-4
-68	-42	-2
-14	4	2
-44	10	-24
-26	-88	-4
6	-36	48
32	26	42
28	-26	56
22	-84	14
18	-100	18
46	-14	0
-28	-86	-2
-40	-36	40
44	-58	-6
34	30	40
18	-18	68
32	-24	66
16	-4	62
-52	20	2
52	-2	-26
4	40	10
30	12	-18
-28	-14	-16
-28	14	-10
-30	-26	-10
-32	14	-22
-8	8	-2
-58	-14	-20
-46	8	-22
-32	34	30
-10	-90	30
2	-54	22

// Carter E J, 2012: Autism Spectrum Disorder ASD patients
// Subjects=12
-20	-2	-22
-12	24	0
40	6	34
-36	2	50
-62	-6	24
36	-72	-26
-40	-14	66
-52	14	36
0	-52	52
30	-8	70
30	-62	50
-10	14	48
-20	-4	-24
2	6	-14
14	18	42
-48	6	52
38	46	38
-62	-6	-24
20	-104	8
24	-16	-20
-38	-18	68
48	-18	62
42	6	34
2	-56	24
-32	-2	-6
-44	-20	22
30	-10	72
-30	-70	46
26	-58	48
2	0	72
-10	14	48
20	-10	-2
20	-8	-16
-16	-6	-14
-34	16	32
40	6	36
-30	20	-6
38	-52	-20
-52	10	42
-30	-10	70
-36	2	50
0	-52	52
26	24	0
38	-10	68
20	-64	60
-8	16	48
-42	20	-20
14	2	40
-6	12	38
-52	-22	40
-38	-18	16
44	2	-4
-42	52	14
-18	-38	66
-34	-22	58
26	-32	70
48	-18	46
-14	-4	44
50	-26	38
-54	-30	24
-28	-48	-12
34	20	18
-26	24	0
40	10	40
44	-56	16
-52	-58	18
46	-56	-10
-28	-92	-4
-26	-72	26
-48	-64	-18
30	-68	32
-22	-62	56
28	-54	54
-42	20	-18
-48	12	4
44	42	-12
-46	36	-2
-28	24	-2
42	4	58
30	48	-12
-26	-88	-4
6	-36	48
22	-84	14
18	-100	18
-14	-98	26
46	-46	0
44	44	-10
-22	-52	48
22	-16	68
-22	-2	-24
4	24	-6
-36	34	-6
-38	10	52
-60	-4	-22
22	-86	16
-14	-98	26
-12	-6	24
-32	-16	-16
-32	16	-22
-52	18	-2
44	28	4
30	14	-18
-28	20	-6
42	4	58
-64	-50	-4
-68	-42	-2
-14	4	2
-44	10	-24
-26	-88	-4
6	-36	48
32	26	42
28	-26	56
22	-84	14
18	-100	18
46	-14	0
-28	-86	-2
-40	-36	40
44	-58	-6
34	30	40
18	-18	68
32	-24	66
16	-4	62
-52	20	2
52	-2	-26
4	40	10
30	12	-18
-28	-14	-16
-28	14	-10
-30	-26	-10
-32	14	-22
-8	8	-2
-58	-14	-20
-46	8	-22
-32	34	30
-10	-90	30
2	-54	22

// Sabatino A, 2013: Face targets: ASD > Controls
// Sabatino A, 2013: High autism interest (HAI) targets: ASD < Controls
// Sabatino A, 2013: Group (ASD, Controls) X Target (Face, HAI) Interactions
// Subjects=15
40	8	-8
-6	52	18
-6	56	28
-26	-2	-20
-6	14	0
-48	-10	8
-58	10	14
-34	-76	24
2	6	30
62	-8	10
10	-82	-4
26	20	42
28	-66	-18
50	2	26
30	-56	-12
-16	-60	-6
22	-50	-2
0	-50	4
0	0	-4
26	-2	48

// Sato W, 2012: Healthy Controls
// Subjects=13
34	-84	8
52	-62	0
40	-60	-12
50	-36	6
54	6	-12
54	-28	28
40	-2	50
56	28	10
52	8	36
32	-10	-16
28	-8	-12
6	64	22
-14	50	18
-48	-78	0
-56	-50	10
-52	-18	0
-62	-32	20
-42	-58	-16
-46	-32	22
-26	-6	-16

// Sato W, 2012: Autism Spectrum Disorder ASD Patients
// Subjects=12
46	-78	0
52	-64	-2
48	-48	6
60	-24	38
48	-6	46
46	8	36
-52	-72	2
-58	-54	2

// Tully L M, 2014: Healthy Controls
// Subjects=24
3	-67	-35
-18	-67	-44
36	14	19
6	11	52
-6	11	46
-42	2	31
-27	-49	-50
6	-28	28
-36	-19	64
39	-88	-8
-36	17	4
-27	-7	43
42	20	-8
-39	-46	10
21	-46	46
-42	-34	-14
6	-61	-35
-21	-70	7
-15	-70	-38
21	-64	7
12	-10	13
12	-25	73
-15	14	34
48	26	-17

// Tully L M, 2014: Schizophrenia
// Subjects=23
33	20	7
-24	-61	49
-21	-49	-32
24	-52	-20
-30	-88	-11
24	-61	-47
45	-40	61
24	-64	52
48	-46	-2
-12	-16	10
-33	17	10
21	-64	4
69	-34	22
-39	-43	64
-33	-16	64
-15	14	34
48	26	-17

// Morita T, 2012: Autistic Subjects (ASD)
// Subjects=15
-24	-42	34
4	-38	32
-28	-34	28
44	40	-10
36	46	0
36	18	-8

// Morita T, 2012: Healthy Controls (HC)
// Subjects=15
38	8	-8
48	6	26
48	34	4
-40	20	-8
-4	24	28
60	-22	28
52	14	-8
10	8	-8
28	-78	32
-36	14	-6
-44	16	-12
-6	8	32
4	-28	26
-24	-78	22
46	-62	-4
8	20	32
-44	-62	-12
-26	-84	34
54	-22	42
6	-12	6
-4	-10	6
46	4	42
2	6	38
38	-84	-6
-46	-68	-4
32	16	4
-4	-12	40
-34	26	0
-14	48	32
-46	36	12
-46	18	-16
2	28	20
32	20	2
46	16	-10
48	32	12
-20	-26	-14
-10	-28	4
6	-12	10
-24	-42	34
4	-38	32
-28	-34	28
44	40	-10
36	46	0
36	18	-8

// Rahko J S, 2012: ASD vs. Controls, Happy expressions
// Rahko J S, 2012: ASD vs. Controls, Fearful expressions
// Rahko J S, 2012: Happy vs. Fear, Group differences
// Subjects=25
-40	-12	-14
24	16	-6
-42	42	24
40	48	26
-50	-68	8
-58	-36	46
50	0	12
-54	6	-28
66	-36	14
-46	-8	58
28	64	12
-50	-2	-36
36	10	-22
-58	-16	-8
-28	-18	0
66	0	20
-56	-54	-22
68	-6	22
46	52	8
54	12	12
54	14	14
-60	-42	44
-56	-8	-30
-56	-52	-24
22	6	-14
30	66	-6
6	70	-2
14	72	-2
-30	-20	2
66	-30	10
64	-28	10
64	4	24
64	6	26
2	36	32
-20	-2	54
-50	-22	58
18	-76	-4
12	-66	-16
-36	4	8
66	-10	0
62	-10	28
-48	42	0
-36	26	-6
64	-12	32
56	14	36
-42	10	8
-56	28	0
-62	-40	42
-60	-38	42
-42	-28	2
-34	22	4
-48	12	20
-48	14	22
44	6	30
68	-34	38
-62	-26	42
62	-18	48

// Schneider K, 2013: Autistic Subjects (ASD)
// Subjects=28
-45	26	4
60	20	19
-45	-4	52
57	2	46
-12	53	28
51	-19	-11
45	-31	7
15	2	13
54	-67	4
24	-79	-35

// Schneider K, 2013: Subgroup of Autistic Subjects, Males
// Subjects=15
-21	35	28
24	35	31

// Schneider K, 2013: Subgroup of Autistic Subjects, Females
// Subjects=13
-21	35	28
24	35	31
3	-28	-5

// Schneider K, 2013: Healthy Controls (CON)
// Subjects=28
-3	-13	40
54	29	-5
63	11	25
42	-1	43
-3	53	31
0	-28	-5
-18	-97	13

// Schneider K, 2013: Subgroup of Healthy Controls, Females
// Subjects=13
3	-28	-5

// Schulte-Ruther M, 2011: Autistic Patients (ASD)
// Subjects=14
0	-58	34
-6	-48	26
2	48	-16
-8	56	-14
4	62	18
-8	56	34
-16	34	52
-38	20	44
-46	36	-8
-48	22	6
50	26	-12
0	-58	34
-2	-54	34
-50	-62	34
50	-54	30
60	-36	-4
-56	-14	-18
50	6	-30
48	4	-40
-54	-30	-18
28	-80	-36
-24	-86	-42
12	62	30
50	16	46
40	26	-12
50	-50	30
0	-58	34
-6	-48	26

// Schulte-Ruther M, 2011: Control Subjects (CS)
// Subjects=14
8	56	-10
-8	58	-18
12	-50	28
0	-48	26
-16	-58	-2
54	-38	-4
-60	-60	16
2	48	-16
-8	56	-14
-2	56	8
-4	56	26
8	56	28
-4	54	-16
8	58	-6
-40	30	-14
-52	30	-4
12	-50	30
-6	-52	28
-4	-64	32
-52	-58	24
54	-36	-4
-58	-40	-6
34	-76	-36
12	62	30
50	16	46
40	26	-12
50	-50	30
-6	56	-14
8	58	-6
12	-50	30
-2	-48	28
-58	-62	14
54	-36	-4

// Han D H, 2014: Emotional word > Neutral word, ASD patients > Healthy 
// controls
// Han D H, 2014: Facial emoticons > Neutral faces, ASD patients < Healthy 
// controls
// Subjects=10
35.45	-84.68	-16.33
59.93	-40.49	-11.4
66.38	-40.02	-5.93
34.36	-87.05	-19.47

// Koldewyn K, 2011: Biological motion > Coherent motion, Healthy controls > 
// ASD patients
// Koldewyn K, 2011: Biological motion > Coherent motion, ASD patients > 
// Healthy controls
// Subjects=16
30	18	0
14	-62	50
30	34	30
-40	-58	46
4	38	16
42	-76	-4
-40	-78	-4

// Masten C L, 2011: Autism Spectrum Disorder ASD patients
// Subjects=19
6	33	-4
-48	15	4
42	30	0
57	30	12
6	12	-4
33	-87	24
-51	-24	-12
60	-3	-16
-21	-81	-20
15	-84	-16
-9	-51	48
42	0	52
-48	18	20
42	-15	12
-45	12	-8
45	36	-12
21	3	-12
36	-84	-12
51	-18	-16
57	-60	16
-36	6	-20
0	-42	4
21	-54	-12
6	-42	44
33	-81	44
27	-3	-8
0	24	20
3	0	48
-60	-18	16

// Masten C L, 2011: Healthy Controls
// Subjects=17
0	36	-16
36	18	-24
-45	15	-12
39	36	-16
54	39	8
-42	27	-12
6	3	4
-3	-99	20
42	-63	24
-63	-33	0
63	-12	-12
6	-57	-48
30	-78	-32
3	-42	40
21	3	-12
0	60	36
-18	-21	-12
24	-18	-8
-60	-30	-20
42	-15	12
-45	12	-8
45	36	-12
21	3	-12
36	-84	-12
51	-18	-16
57	-60	16
-36	6	-20
0	-42	4
21	-54	-12
6	-42	44
33	-81	44
27	-3	-8
0	24	20
3	0	48
-60	-18	16

// Pfeifer J H, 2013: Group x target interaction: Healthy Controls > ASD 
// patients for Self > Other (age covariate)
// Pfeifer J H, 2013: Healthy controls > ASD patients, Self > Other (age 
// covariate)
// Pfeifer J H, 2013: ASD patients > Healthy controls, Other > Self (age 
// covariate)
// Subjects=18
36.14	-3.08	47.51
-30.53	11.11	30.29
-33.61	6.4	57.26
-1.97	1.69	27.43
19.93	70.6	12.6
-2.17	58.82	30.18
0.97	51.33	10.7
-2.25	46.52	-15.59
23.18	48.56	14.09
48.66	17.26	16.08
29.6	23	9.14
-30.6	12.84	6.86
-30.51	11.51	36.92
36.14	-3.08	47.51
-24.31	32.21	12.16
0.93	43.4	-15.4
-11.56	16.96	19.79
-30.51	11.51	36.92
-36.78	6.37	57.28
36.14	-3.08	47.51
-24.31	32.21	12.16
45.48	17.03	12.79
-11.56	16.96	19.79
29.59	26.15	8.93
23.19	45.41	14.3
29.61	40.38	34.59
-2.18	58.62	26.87

// Watanabe T, 2012: Autism Spectrum Disorder ASD patients
// Subjects=15
-26	-4	-18
60	4	0
2	34	8
0	30	52
54	28	22
38	42	-4
-38	16	-8
-26	-6	-20
56	2	0

// Watanabe T, 2012: Healthy Controls
// Subjects=17
32	24	2
-26	22	-2
50	28	22
-54	18	20
-4	20	50
40	-54	56
-30	-64	48
-44	-44	52
2	34	8
0	30	52
54	28	22
38	42	-4
-38	16	-8
-26	-6	-20
56	2	0

// Daly E, 2014: Healthy Controls
// Subjects=14
66.14	28.88	-9.48
51.13	56.8	-4.96
24.64	58.95	25.28
70.63	10.27	10.99
-33.33	67.92	-4.92
-56.85	43.58	-14.88
-64.15	21.21	-.65
-37.18	-8.98	19.42
58.74	-3.32	-12.27
-63.75	-60.32	18.45
-60.56	-69.28	12.47
5.65	-93.52	-4.1
-5.96	-108.5	9.56
-48.78	-88.67	8.39
-32.79	-101.15	-3.01
-29.82	9.67	12.19
-41.48	-90.51	-16.07
5.24	52.72	1.49
32.14	42.71	20.98
43.92	47.43	26.02
35.49	3.6	24.22
-3.1	47.15	26.58
13.03	19.76	28.7
-13.6	11.65	36.37
24.56	17.51	-1.36
20.4	23.09	16.07
-13.68	7.54	24.45
-25.5	10.12	17.68

// Daly E, 2014: Autistic Subjects
// Subjects=14
8.28	19.25	-32.54
46.95	17.13	-8.27
20.5	36.18	33.93
9.04	18.33	65.66
5.88	-17.53	56.44
58.86	2.28	5.1
15.87	16.01	-20.09
-64.21	23.87	-7.56
-22.64	39.55	-14.93
-10.27	13.04	54.06
51	26.91	-33.67
20.08	-17.58	-41.86
-45.17	26.33	-32.52
-18.41	2.8	-36.43
1.06	1	-6.39
5.72	-11.5	38.09
8.84	11.78	36.1
-6.22	23.87	28.57
43.8	17.63	-1.59
-29.86	22.36	11.13
8.59	1.56	0.16
32.07	9.1	-.74
-3.14	6.14	5.49
58.51	43.75	-22.91
43.97	47.95	32.67
20.84	6.77	66.5
20.78	10.57	60.6
-60.76	23.11	23.69
-37.7	66.95	-17.06
-33.33	67.92	-4.92
-10.85	6.96	-24.6
-25	-8.86	75.03
62.85	15.86	-26.19
1.22	23.49	22.94
-3.02	23.89	28.53
-33.04	13.88	11.88
-10.78	24.19	-8.2
-10.64	1.44	0.39
-29.88	13.39	5.19

// Diehl J J, 2014: Typically developing (TD) vs Reading difficulty (RD) by 
// task (figures vs lexical decision)
// Subjects=10
-26	-86	-38
54	-69	30
-51	0	44
54	-72	-34
-6	-6	58
-60	-44	40
10	8	-16
34	-66	-9
-42	-84	-12
34	-6	44
30	-84	18
-38	-68	9
-40	-22	-12
-30	20	7
62	-26	-13
26	-98	4
2	41	38
4	58	30
-32	32	16
66	-36	10
-22	-52	46
12	20	62
48	-2	-24
36	2	22
-48	36	-6
46	34	34
30	22	54
-36	-12	-20
34	16	4
62	24	0
12	8	70
30	-8	-4
64	18	14
62	-26	47
-58	26	2
46	38	-16
-30	-4	10
34	16	-36
-34	18	60
24	-24	74
-64	-57	-6
62	4	-16

// Hale T S, 2014: Healthy Controls
// Subjects=21
-10	2	50
-40	-12	66
-44	-2	28
-24	-12	50
-38	-36	38
-36	-94	-4
-10	2	50
-40	-12	66
-44	-2	28
-24	-12	50
-38	-36	38
-36	-94	-4
-12	2	46
-40	-12	66
-46	-2	26
-24	-12	50
-36	-36	36
-32	-92	-4
-18	54	40
-6	28	-12
4	26	-14
0	42	8
-14	38	18
2	54	-24
-10	6	-20
10	42	-16
-6	28	-12
4	26	-14
0	42	8
-26	-100	-16
-12	-80	-48
6	-86	-42
14	36	-26
22	44	38
-8	64	-2
-22	58	24
10	30	-22
8	26	-22
-34	24	44
-18	26	52
-2	52	-26
0	28	14
2	36	20
12	38	24
2	20	48
14	36	-26
-8	64	-2
-12	22	-24
10	30	-22
8	26	-22
-2	52	-26

// Hale T S, 2014: Attention Deficit Hyperactivity Disorder patients (ADHD)
// Subjects=21
-10	2	50
-40	-12	66
-24	-12	50
-38	-36	38
40	-82	-4
-4	-22	-16
0	-38	-24
26	-46	-28
-40	-12	66
-24	-12	50
-38	-36	38
-18	20	6
-40	-12	66
-24	-12	50
-36	-36	36
34	-86	-4
2	-26	-18
0	-34	-24
24	-48	-28
-32	-26	-14
32	-34	-4
-28	52	34
46	34	-8
-10	72	6
12	64	20
4	50	36
48	16	16
58	34	10
44	16	8
46	0	14
-2	48	14
8	48	14
64	-10	24
58	-10	48
46	8	-40
48	-2	-28
56	-28	-14
52	-28	-22
64	-22	-8
60	-44	6
-64	-10	6
62	-30	2
-60	-40	10
44	-34	4
-62	-58	30
62	-50	28
-28	52	34
46	34	-8
-10	72	6
12	64	20
-20	16	46
4	50	36
48	16	16
58	34	10
44	16	8
46	0	14
-2	48	14
8	48	14
62	4	14
64	-10	24
58	-10	48
46	8	-40
48	-2	-28
56	-28	-14
52	-28	-22
64	-22	-8
60	-44	6
-64	-10	6
62	-30	2
-60	-40	10
44	-34	4
-62	-58	30
62	-50	28
-6	-52	46
4	-52	48
-6	-56	66
4	-56	62
-14	56	8
-4	62	8
8	58	10
2	48	14
-16	46	-2
0	46	8
16	54	2
-14	56	10
-4	64	10
14	60	4
10	62	30
-18	48	-4
-8	36	6
2	54	-24
-10	6	-20
10	42	-16
-6	28	-12
4	26	-14
0	42	8
-26	-100	-16
-12	-80	-48
6	-86	-42
14	36	-26
-8	64	-2
-12	22	-24
10	30	-22
8	26	-22
-2	52	-26

// Hart H, 2013: Univariate analysis of STOP task, ADHD < Controls
// Hart H, 2013: Univariate analysis for STOP task, ADHD > Controls
// Subjects=30
30.79	26.67	-21.16
-37.56	26.6	-15.9
-2.34	14.33	-26.43
-44.66	-40.89	6.57
42.88	-62.08	-13.85
-51.96	-43.45	29.17
-5.79	-73.78	45.68
23.97	-58.86	29.59
-25.43	-69.29	-4.66

// Hernandez N, 2013: Healthy Controls
// Subjects=16
-50	18	12
-42	24	28
-28	34	-12
-44	4	36
16	-100	-8
32	-66	-30
-14	-92	-10
-4	14	58
-56	-48	-14
32	26	8
-24	-78	42
26	-56	-22
44	-18	44
-40	-10	54
2	-2	70
48	-52	-16
-50	-52	-16
-44	-2	46
-50	12	18
-42	36	8
50	12	16
44	-2	46
42	34	8
46	-42	30
24	-78	40
-44	-42	32
-24	-78	40

// Hernandez N, 2013: Developmental Dyslexia (DD)
// Subjects=15
-22	-92	-2
-24	-74	44
-18	-94	-18
-10	-90	-4
-18	-88	-18
-30	-68	52
-42	-44	44
18	-90	-18
22	-94	12
22	-88	0
14	-102	2
44	24	6
30	20	6
48	22	-8
-4	8	60
42	52	26
-42	-6	52
-40	30	2
-48	16	34
-64	0	14
-38	18	8
-56	14	-10
-38	48	30
-32	32	-12
28	-72	44
34	-64	50
12	-76	52
26	-56	-22
44	-18	44
-40	-10	54
2	-2	70
48	-52	-16
-50	-52	-16
-44	-2	46
-50	12	18
-42	36	8
50	12	16
44	-2	46
42	34	8
46	-42	30
24	-78	40
-44	-42	32
-24	-78	40

// Liu L, 2012: Control > Reading Disabled, All tasks
// Liu L, 2012: Semantic > Rhyming, All subjects
// Subjects=16
-58	14	20
16	-92	18
-40	34	-12
-64	-50	0
-44	-64	20
34	36	-14

// Olulade O A, 2012: Healthy Controls
// Subjects=9
-50	4	46
-46	34	12
-48	24	22
-44	-58	-26
-52	-64	-16
-38	-44	-28
-26	-102	-8
-34	-92	-10
-34	22	-6
22	-96	12
36	-92	10
10	-8	30
36	-92	10
-50	4	46
-40	10	26
-46	34	12
-42	-60	-24
-24	-94	-8
-36	-90	-10
-6	16	52
-4	26	38
10	28	40
46	32	38
48	32	24
38	24	22
38	-50	-34
12	-82	-32
42	-74	-32
-10	20	58
-14	32	50
-60	-52	4
-54	-44	34
-44	-4	0
-44	0	-12
44	-26	40
-58	-22	26
-48	32	14
-50	-74	-4
-36	-36	34
-44	-56	-26
44	28	28
38	24	24
50	-60	46
46	-60	36
-44	-58	-2
24	-96	10
36	-92	12
42	-84	4
42	-78	14
30	-44	46
28	-2	50
50	6	24
32	20	-8
-32	-66	-14
-30	-88	4
-22	-64	54
-50	8	28
-44	4	50
8	16	50
8	30	38
10	24	30
42	30	20
52	36	14
18	-78	54
28	-82	48
32	2	54
-32	-68	-12
-36	0	58
-22	-64	52
-20	-76	56
-6	-52	56
44	-86	6
-30	-90	6
42	30	22
-36	-40	48
-10	-80	-46
2	-36	66
36	-44	12
42	-84	4
40	-74	10
44	-82	12
-30	-88	4
-32	-66	-14
-48	-82	6
-38	-40	50
-36	-50	58
-38	-58	60
24	-60	58
24	-60	58
38	-40	40
-10	-28	62
-14	-24	54
-10	-24	10
-10	-24	10
-4	-30	10
-18	-106	2
26	-32	6
20	-18	10
52	-70	-8
8	52	10
-40	-52	34
56	-60	2
10	50	46

// Olulade O A, 2012: Reading disabled (RD)
// Subjects=6
-34	22	-6
-38	22	-16
-38	30	0
-34	22	-6
22	-96	12
36	-92	10
10	-8	30
36	-92	10
-10	20	58
-14	32	50
-60	-52	4
-54	-44	34
-44	-4	0
-44	0	-12
44	-26	40
-58	-22	26
-48	32	14
-50	-74	-4
-36	-36	34
-44	-56	-26
44	28	28
38	24	24
50	-60	46
46	-60	36
-44	-58	-2
-28	-96	-12
-42	0	32
-50	0	46
-46	6	16
24	-96	10
36	-92	12
-32	-90	-2
-48	-80	-8
-48	-72	-12
40	-82	4
22	-64	60
50	-70	-8
36	-42	46
56	-40	54
52	-30	52
18	-78	54
28	-82	48
32	2	54
-32	-68	-12
-36	0	58
-22	-64	52
-20	-76	56
-6	-52	56
44	-86	6
-30	-90	6
42	30	22
-36	-40	48
-10	-80	-46
2	-36	66
36	-44	12
-10	-28	62
-14	-24	54
-10	-24	10
-10	-24	10
-4	-30	10
-18	-106	2
26	-32	6
20	-18	10
40	-82	4
52	-70	-8
38	-72	8
-32	-90	-2
-48	-80	-8
-40	-52	36
-46	-32	44
-46	-46	44
52	-70	-8
8	52	10
-40	-52	34
56	-60	2
10	50	46

// Reilhac C, 2012: Healthy Controls
// Subjects=12
-48	25	1
-44	-41	30
-40	-50	54
-22	-63	53
-50	-35	48
30	-47	32
30	-48	50
26	-71	50
38	-38	48
-63	-18	23
51	5	-9
-46	13	-6
-48	-22	-16
-48	-37	-2
-55	-49	-16
53	18	40
53	32	15
42	55	8
-51	12	40
-36	36	13
-59	16	18
36	-2	44
34	-63	-19
-38	-63	-19
24	-71	48
32	-60	49
63	-32	20
-20	-64	49
-30	-47	32
-40	-55	34
-22	-62	34
-36	-11	-21
-38	32	11
-36	47	-2
22	35	0
48	47	7
53	19	38
-26	-38	-32
-28	52	-4
-26	-84	-4
30	-93	6
-18	-50	-31
20	-77	-16
32	-81	-20
-20	-66	49
-44	7	-5
53	3	-9
-46	-66	2
-26	-80	-9
28	-91	1
-57	18	19
-40	40	18
-38	-1	50
44	11	22

// Reilhac C, 2012: Developmental Dyslexia (DD)
// Subjects=12
-46	-46	45
32	-65	51
-42	-52	54
39	-59	58
53	-37	46
44	50	-6
-42	-32	26
-28	52	-4
-26	-84	-4
30	-93	6
-18	-50	-31
20	-77	-16
32	-81	-20
-20	-66	49
-44	7	-5
53	3	-9
-46	-66	2
-26	-80	-9
28	-91	1
-57	18	19
-40	40	18
-38	-1	50
44	11	22

// Steinbrink C, 2012: Healthy Controls
// Subjects=16
-51	-21	3
54	-18	3
-45	36	0
-36	15	3
36	18	3
-48	-21	3
51	-21	3

// Steinbrink C, 2012: Developmental Dyslexia (DD)
// Subjects=17
-51	-18	0
54	-21	3
-36	18	3
42	18	3
-48	-21	0
54	-21	0

// Wimmer H, 2010: Words > Baseline: Controls > Dyslexics, p < 0.005
// Wimmer H, 2010: Words > Baseline: Dyslexic > Controls, p < 0.005
// Wimmer H, 2010: Pseudohomophones > Baseline: Controls > Dyslexics, p < 0.05
// Wimmer H, 2010: Pseudohomophones > Baseline: Dyslexics > Controls, p < 0.05
// Wimmer H, 2010: Non-words > Baseline: Controls > Dyslexics, p < 0.005
// Wimmer H, 2010: Non-words > Baseline: Controls > Dyslexics, p < 0.05
// Wimmer H, 2010: Non-words > Baseline: Dyslexics > Controls, p < 0.005
// Wimmer H, 2010: Pseudohomophones > Words: Controls > Dyslexics, p < 0.005
// Wimmer H, 2010: Pseudohomophones > Words: Dyslexics > Controls, p < 0.005
// Wimmer H, 2010: Non-words > Pseudohomophones: Controls > Dyslexics, p < 
// 0.005
// Wimmer H, 2010: Non-words > Pseudohomophones: Dyslexics > Controls, p < 
// 0.005
// Subjects=20
-45	-48	-15
-33	-33	63
-24	-3	45
-12	-3	21
-30	9	24
-6	24	21
12	-72	12
15	12	72
15	24	33
-45	-48	-15
-33	-36	63
-48	-12	51
-24	-3	42
-12	-6	18
-9	0	3
-18	6	24
-18	15	3
-12	21	36
-27	24	18
12	-72	12
15	9	72
33	27	0
27	42	21
-57	12	12
-45	-48	-15
-51	-45	54
-33	-36	63
-48	-12	51
-18	3	21
-18	12	3
-6	24	21
-15	24	33
12	-72	12
15	12	6
12	24	33
27	39	21
-45	-51	-18
-9	12	45
-21	-87	-18
-45	6	36
-48	27	33
-21	0	-9
-21	15	0

// Arnone D, 2012: Currently Depressed in Longitudinal Analysis
// Subjects=32
21	-32	-10
-25	-25	-15
21	-25	-20
-28	-91	0
32	-91	5
-42	-46	-20
42	-49	-15
-60	-56	5
60	-56	5
-21	-4	-15
28	-7	-15
-53	14	30
56	21	25
18	4	-15
-11	-77	-5
4	42	30
-11	-53	60
-21	-81	-15
18	-88	-10
-4	-74	45
56	-32	-10
35	-7	-20
49	0	-15
56	-7	30
46	-4	-10
28	-88	25
67	-42	30
-11	-81	5
32	-70	-10
-14	-53	50
18	-56	-30
11	4	65
-35	0	-25
35	-7	-20
-63	0	15
-42	4	-25
49	0	-15
-39	-7	-5
39	7	-5
28	18	-15
-21	-81	-15
18	-88	-10
-4	-74	45
-18	-88	25
-60	-21	-5
67	-42	5
14	-88	-5
-25	-84	30
32	-88	10
-42	7	45
39	-4	55
56	-32	-10
53	-70	0
35	-7	60
-11	-74	45

// Arnone D, 2012: Depressed Patients in Remission
// Subjects=24
-28	-91	0
32	-91	5
-42	-46	-20
42	-49	-15
-60	-56	5
60	-56	5
-21	-4	-15
28	-7	-15
-53	14	30
56	21	25
18	4	-15
-11	-77	-5
4	42	30
-11	-53	60
-21	-81	-15
18	-88	-10
-4	-74	45
56	-32	-10
35	-7	-20
49	0	-15
56	-7	30
46	-4	-10
28	-88	25
67	-42	30
32	-70	-10
-14	-53	50
18	-56	-30
11	4	65
-35	0	-25
35	-7	-20
-63	0	15
-42	4	-25
49	0	-15
-39	-7	-5
39	7	-5
28	18	-15
-21	-81	-15
18	-88	-10
-4	-74	45
-18	-88	25
-60	-21	-5
67	-42	5
11	-95	0
-42	-4	35

// Arnone D, 2012: Healthy Comparison
// Subjects=54
-28	-91	0
32	-91	5
-42	-46	-20
42	-49	-15
-60	-56	5
60	-56	5
-21	-4	-15
28	-7	-15
-53	14	30
56	21	25
18	4	-15
-11	-77	-5
4	42	30
-11	-53	60
-21	-81	-15
18	-88	-10
-4	-74	45
56	-32	-10
35	-7	-20
49	0	-15
56	-7	30
28	-88	25
-11	-81	5
32	-70	-10
-14	-53	50
18	-56	-30
11	4	65
14	-88	-5
-25	-84	30
32	-88	10
-42	7	45
39	-4	55
56	-32	-10
53	-70	0
35	-7	60
-11	-74	45
11	-95	0
-42	-4	35

// Aupperle R L, 2013: Increased activation for negative & positive image 
// anticipation (ANI-API) from pre to post-treatment
// Aupperle R L, 2013: Decreased activation (ANI-API) from pre to 
// post-treatment
// Aupperle R L, 2013: Increased activation for negative and positive images 
// (NI-PI) from pre to post-treatment
// Aupperle R L, 2013: Decreased activation (NI-PI) from pre to post-treatment
// Aupperle R L, 2013: Greater Activation (ANI-API) pre-treatment=better 
// treatment response
// Aupperle R L, 2013: Greater activation (NI-PI) pre-treatment = better 
// treatment response
// Aupperle R L, 2013: Greater activation (NI-PI) from pre to post-treatment= 
// better treatment response
// Aupperle R L, 2013: ANI > API, Pre-treatment
// Aupperle R L, 2013: API > ANI, Pre-treatment
// Aupperle R L, 2013: ANI > API, Post-treatment
// Aupperle R L, 2013: API > ANI, Post-treatment
// Aupperle R L, 2013: NI > PI, Pre-treatment
// Aupperle R L, 2013: PI > NI, Pre-treatment
// Aupperle R L, 2013: NI > PI, Post-treatment
// Aupperle R L, 2013: PI > NI, Post-treatment
// Subjects=14
-3.97	-37.59	18.09
28.84	-62.56	-32.61
66.32	-15.45	-4.65
-15.97	42.25	19.34
-7.47	-65.87	-30.8
31.97	60.71	6.09
37.38	5.44	-7.18
29.48	-42.77	58.29
-17.73	-52.76	29.56
20.77	-53.33	32.51
-45.74	9.54	25.77
10.8	37.46	23.89
56.97	-20.42	28.22
31.53	-64.56	37.79
-6	-78.21	15.94
9.14	-75.09	41.16
11.12	-26.27	39.27
11.03	-79.94	5.86
21.55	-55.18	-5.26
60.77	-12.16	-30.51
44.26	-9.44	47.51
29.38	-58.05	39.5
38.93	-.5	53.52
-21.8	-64.91	51.81
61.22	-54.63	12.08
-41.27	-2.72	45.7
41.67	15.59	-.28
-35.84	-39.07	43.11
11.32	-55.99	54.03
-60.47	-35.33	38.62
40.95	-77.47	7.53
59.98	-14.71	5.4
-51.1	-19.18	12.63
-15.97	34.5	15.53
1.98	65.39	0.46
-10.35	-57	15.33
-30.93	-53.44	-19.3
-56.29	-12.21	34.4
-32.57	-52.71	45.33
34.78	-55.31	47.01
-.81	-29.2	16.23
51.52	9.24	26.91
50.54	-52.49	13.14
-38.39	45.63	23.77
-41.64	-65.82	-27.06
40.03	0.91	57.85
-21.93	-69.54	33.24
-48.96	-21.37	11.67
57.85	-11.38	7.37
50.6	-12.29	37.64
-6.55	49.05	-3.65
2.28	58.61	36.71
-12.91	27.52	-6.23
-41.18	-66.56	32.1
-.7	-53.35	20.49
-44.88	28.27	6.34
51.43	21.42	19.2
47.45	-65.57	23.19
-1.9	46.33	43.37
-34.12	-44.48	-13.33
-44.66	14.12	29.83
22.42	-14.36	-14.27
-28.91	-54.62	-34.84
-39.14	11.55	51.17
-4.25	59.49	21.1
-44.04	-5.9	-36.52
0.44	25.42	61.82
-4.82	-6.76	59.01
44.34	-33.84	48.45
48.18	-3.15	4.56
24.84	-64.16	2.14
-.72	-76.58	9.05
-48.99	-7.45	12.73
15.49	-70.28	33.99
37.63	37.76	39.17
-31.91	2.43	15.05
63.25	-23.95	9.48
-20.09	-93.47	-14.96
-49.91	-37.69	20.86
8.98	-55.95	27.29
-44.44	-63.84	26.33
6.66	-29.32	13.93
-49.18	24.64	1.12
59.9	-19.97	-7.54
-59.85	-13.63	-11.16
0.82	68.76	-10.96
-53.21	21.73	32.64
-1.11	-59.74	-34.73
-46.63	-14.98	38.99
32.5	-12.85	45.71
6.76	-78.82	6.93
-19.09	-11.84	8.3
12.35	-76.13	41.21
-12.67	-69.9	-13.67
18.15	17.47	-1.28
28.87	8.02	-.61
26.31	-11.72	74.68
-17.05	13.55	6.14
-35.1	36.56	30.07

// Buchheim A, 2012: Relevant vs. Irrelvant, Group x Time Interaction
// Buchheim A, 2012: Patients > Controls, Baseline
// Subjects=16
-34.34	-15.99	-30.21
1.02	25.83	-1.78
4.51	51.91	46.17
-34.34	-12.73	-29.37
-34.34	-15.99	-30.21

// Falconer E, 2013: No-Go > Go, Improved Treatment Response
// Falconer E, 2013: No-Go > Go, Poorer Treatment Response
// Subjects=13
-18	8	4
-28	22	-20
0	62	14
8	56	26
42	-28	-4
52	-34	42
2	-22	46
-24	-4	10
-22	-10	-2
14	-30	-6
-22	-68	-26
-2	-52	-6
46	40	-2
44	10	-2
36	-14	6
-54	-62	8
-22	-50	8
10	-42	14
40	-6	-38
-4	42	-12
2	0	50
-32	-60	48
28	10	-4
36	-4	0
-56	-26	0
0	-66	58

// Fonzo G A, 2014: Generalized Anxiety Disorder (GAD)
// Subjects=21
-2.84	-54.5	19.49
-26.37	17.63	46.06
29.22	17.16	48.8
46.44	-23.26	47.53
51.32	-21.42	-11.78
-32.11	50.9	8.76
8.14	-29.43	67.45
-54.41	-26.91	-4.53
16.24	43.98	38.9
-20.38	-15.22	-21.52
-16.56	-16.52	57.73
-0.07	-31.56	-28.19
20.67	-90.63	4.41
27.97	41.59	34.5
-23.4	-85.8	-25.6
38.82	7.1	41.73
34.72	-62.51	36.46
-31.52	-52.88	43.11
-30.98	19.64	3.56
48.25	30.46	26.28
-41.42	11.14	32.28
-34.83	-1.2	51.08
-7.1	20.29	51.19
-37.35	-45.9	-17.63
34.2	21.09	2.69
-42.7	36.37	14.56
13.08	-21.45	18.77
8.9	26.73	50.46
41.74	-45.26	-16.36
54.77	-65.04	1.87
-40.24	-73.39	12.59
53.58	-51.99	-8.13
7.61	-14.05	4.83
-11.54	-4.51	19.86
12.44	-65.33	57.03
-28.39	-71.23	25.65
41.85	-67.2	-11.18
-16.57	-17.75	55.6
8.65	-70.37	-21.68
-9.37	-89.8	-9.81
-10.65	22.22	7.57
-1.99	-.74	12.75
-19.93	5.95	45.85
0.13	-49.22	-8.86
-15.76	-22.6	20.31
-12.42	-14.61	40.79
7.93	11.29	57.35

// Fonzo G A, 2014: Healthy Controls (HC)
// Subjects=12
-2.84	-54.5	19.49
-26.37	17.63	46.06
29.22	17.16	48.8
46.44	-23.26	47.53
51.32	-21.42	-11.78
-32.11	50.9	8.76
8.14	-29.43	67.45
-54.41	-26.91	-4.53
16.24	43.98	38.9
-20.38	-15.22	-21.52
-16.56	-16.52	57.73
38.82	7.1	41.73
34.72	-62.51	36.46
-31.52	-52.88	43.11
-30.98	19.64	3.56
48.25	30.46	26.28
-41.42	11.14	32.28
-34.83	-1.2	51.08
-7.1	20.29	51.19
-37.35	-45.9	-17.63
34.2	21.09	2.69
-42.7	36.37	14.56
13.08	-21.45	18.77
8.9	26.73	50.46
41.74	-45.26	-16.36
54.77	-65.04	1.87
-40.24	-73.39	12.59
53.58	-51.99	-8.13
7.61	-14.05	4.83
-11.54	-4.51	19.86
12.44	-65.33	57.03
-28.39	-71.23	25.65
41.85	-67.2	-11.18
-16.57	-17.75	55.6
8.65	-70.37	-21.68
-9.37	-89.8	-9.81
-10.65	22.22	7.57
-1.99	-.74	12.75
-19.93	5.95	45.85
0.13	-49.22	-8.86
-15.76	-22.6	20.31
-12.42	-14.61	40.79
7.93	11.29	57.35

// Godlewska B R, 2012: Group x Condition Interaction
// Subjects=17
6	-48	14

// Lopez-Sola M, 2010: MDD Patients
// Subjects=13
-42	-10	0
50	-8	4
-58	-2	42
54	0	56
-30	6	0
28	14	2
-8	-12	44
4	-46	-24
-68	-42	-8
-4	-4	-14
-46	-26	-10
40	-14	-6
-24	24	6
-4	16	-16
-62	-42	4
4	18	-18
-40	8	14
48	-10	-6
-12	8	22
12	4	22
6	-2	-16
-66	-36	0
-6	50	-10
-36	22	34
20	34	26
-46	20	-2
-44	-24	-6
44	-16	-6
4	-2	-16
-60	-42	4
2	22	-24
-30	48	14
34	26	34
2	-38	-36
0	-20	-24
4	42	-6
36	8	32
28	38	32
-46	12	0
-2	-24	-26

// Lopez-Sola M, 2010: Controls
// Subjects=20
-36	0	-8
40	34	2
-36	32	12
46	34	36
-30	-8	-6
30	6	6
6	20	36
4	-50	-18
-2	46	-14
-46	-26	-10
40	-14	-6
-24	24	6
-4	16	-16
-62	-42	4
4	18	-18
-40	8	14
48	-10	-6
-12	8	22
12	4	22
6	-2	-16
-66	-36	0
-6	50	-10
-36	22	34
20	34	26
-46	20	-2
-44	-24	-6
44	-16	-6
4	-2	-16
-60	-42	4
2	22	-24
-30	48	14
34	26	34
2	-38	-36
0	-20	-24

// Olatunji B O, 2014: Positive Correlation: Symptom Improvement & 
// Contamination Early Phase > Neutral
// Olatunji B O, 2014: Positive Correlation: Symptom Improvement & 
// Contamination Late Phase > Neutral
// Olatunji B O, 2014: Negative Correlation: Symptom Improvement & 
// Contamination Early Phase > Neutral
// Olatunji B O, 2014: Negative Correlation: Symptom Improvement & 
// Contamination Late Phase > Neutral
// Subjects=12
39.29	-9	-42.8
43.55	6.34	-37.44
-18.1	-79.68	-29.52
-44.89	-35.54	-20.64
-25.92	34.36	-26.73
24.42	16.06	-20.19
15.73	55.13	-23.37
-53.26	-58.97	-6.32
-44.53	-69.18	12.28
47.35	-64.4	10.83
5.48	2.48	12.39
-41.31	-48.13	22.75
-2.96	-17.23	19.72
-60.68	-13.35	20.05
-68.11	-12.88	26.79
-22.02	-63.88	23.85
32.54	-38.83	40.08
20.93	-78.02	43.5
44.28	-22.38	45.25
1.16	-86.97	-29.13
-22.64	-8.86	-35.41
31.89	-4.93	-30.79
46.74	10.59	-37.83
-13.77	-83.46	-23.68
-37.42	-32.33	-21
39.31	23.12	-26.53
-13.8	-50.79	-14.15
-49.18	-20.34	-16.29
-56.71	-7.69	-17.27
-30.21	26.42	-32.7
54.36	24.15	-14.52
-41.71	-3.92	-11.07
-10.35	-64.75	11.52
8.83	-24.57	20.2
-53.16	-8.56	26.26
40.01	-50.93	34.32
-13.37	-50.74	41.6
8.92	-23.62	32.38
20.94	-81.2	43.76
-6.03	-76.35	12.44
-41.33	-43.9	22.39
32.54	-38.83	40.08
-52.83	-45.8	53.91
-2.92	49.04	50.96
24.46	-57.1	-44.17
-18.28	-57.36	-43.66
43.83	-67.68	-31.24
8.38	-5.07	-30.5
70.47	-11.16	-18.44
58.94	-70.45	-13.33
8.4	64.37	0.47
13.34	-98.99	20.81
8.49	41.11	2.42
-22.23	19.54	29.12
24.48	-61.33	-43.81
5.09	67.64	-12.03
35.19	45.5	1.75
5.28	41.09	2.46
23.36	52.4	-4.27
16.47	-92.08	13.5
-44.6	-36.95	16.27
-29.89	29.76	10.51
24.81	-24.9	14.46
-22.13	-20.01	26.86
63.44	-15.38	37.76
51.65	-6.99	37.19
16.25	56.21	45.68
-41.18	-6.18	56.03

// Ruhe H G, 2012: MDD > Controls, All Faces, Study-Entry
// Ruhe H G, 2012: MDD > Controls. Negative Faces, Study-entry
// Ruhe H G, 2012: MDD > Controls, Happy Faces, Study-entry
// Ruhe H G, 2012: Controls > MDD, All Faces, Study-entry
// Ruhe H G, 2012: Controls > MDD, Negative Faces, Study-entry
// Ruhe H G, 2012: Controls > MDD, Happy Faces, Study-entry
// Ruhe H G, 2012: Study-entry > T0, All Faces, Patients
// Ruhe H G, 2012: Study-entry > T0, Negative Faces, Patients
// Ruhe H G, 2012: Study-entry > T0, Happy faces, Patients
// Ruhe H G, 2012: T0 > Study-entry, All Faces, Patients
// Ruhe H G, 2012: T0 > Study-entry, Negative Faces, Patients
// Ruhe H G, 2012: T0 > Study-entry, Happy Faces, Patients
// Ruhe H G, 2012: Study-entry > T1, All Faces, Patients
// Ruhe H G, 2012: Study-entry > T1, Happy Faces, Patients
// Ruhe H G, 2012: T1 > Study-entry, All Faces, Patients
// Ruhe H G, 2012: T1 > Study-entry, Negative Faces, Patients
// Ruhe H G, 2012: T1 > Study-entry, Happy faces, Patients
// Ruhe H G, 2012: Study-entry > T1, Non-Responders > Responders, Negative 
// Faces
// Subjects=7
-26	4	12
-28	6	15
-12	-6	-6
50	20	-6
-34	22	-6
42	16	27
48	-2	51
-54	16	0
-4	10	63
-42	-54	-21
-8	26	42
-6	-20	51
-4	10	63
50	20	-6
-34	22	-6
42	16	27
-42	-54	-21
46	-40	-24
-16	-38	-21
58	-6	-12
-12	-22	48
54	32	3
44	2	48
54	-48	12
48	-36	6
-40	-54	-18
0	-66	12
28	-36	0
-2	-66	12
-48	-46	6
-36	16	-18
-12	-18	48
2	4	33
4	36	3
28	-28	-12
-10	22	60
-44	-4	-39
-4	22	60
2	30	33
2	2	36
-24	58	30
-50	26	-3
-28	44	42
-30	22	54
32	-2	54
24	42	48
30	-28	-9
-22	-34	-27
-24	-32	-24
50	-48	18
22	-36	0
-34	30	-9
20	-36	0
36	12	-3
28	6	48
10	-12	63
-48	22	18
-28	4	51
-4	0	60
-38	2	48
28	6	48
12	-4	66
-28	4	51
-46	20	24
42	20	21
60	-20	30
-46	8	30
-26	-16	57
6	-12	30
-26	-6	51
24	-16	-18
0	26	-3

// Wagner G, 2010: Incongruent > Congruent, All Major Depressive Disorder 
// (MDD) > Controls
// Wagner G, 2010: Baseline > Week-6, Incongruent condition, All MDD
// Wagner G, 2010: Incongruent, Baseline > Week-6, Citalopram
// Wagner G, 2010: Incongruent, Baseline > Week-6, Reboxetine
// Wagner G, 2010: Incongruent, Non-remitters > Remitters, Baseline
// Wagner G, 2010: Incongruent, Non-Remitters > Remitters, Week-6
// Wagner G, 2010: Incongruent, Remitters > Non-Remitters, Week-6
// Wagner G, 2010: Negative Correlation between Symptom Improvement & Signal 
// Change, All MDD, Baseline > Week-6
// Wagner G, 2010: Group (Citalopram & Reboxetine) x Time (Baseline & Week-6) 
// Interaction
// Subjects=8
53.85	-28.39	63.42
-50.93	19.04	-8.96
51.63	-9.15	62.67
-47.69	-37.47	63.81
40.95	-59.7	62.25
8.26	-5.03	51.8
-64.64	-48.55	3.56
-50.63	-65.19	-2.88
-9.82	41.5	-.68
-50.78	-24.67	-5.76
71.4	-33.39	-2.5
48.69	-27.09	-2.73
26.67	20.1	-24.96
43.12	-50.87	64.71
-11.05	-51.14	53.33
-15.11	-56.83	73.01
53.51	-36.41	35.08
57.06	-37.41	58.65
-3.22	-49.48	-9.72
20.41	-12.17	-13.81
-18.49	-7.95	-12.45
26.67	20.1	-24.96
51.31	14.71	42.39
-43.68	8.41	49.11
12.67	24.1	64.53
16.82	12.98	48.75
-62.59	-38.43	-3.08
52.88	-20.36	-11.32
-48.59	-23.39	-3.69
25.87	-63.8	65.16
16.82	12.98	48.75
30.04	-48.56	55.74
-15.11	-56.83	73.01
57.05	-35.28	58.44
-39.07	-44.13	60.96
-3.22	-49.48	-9.72
-39.72	-53.37	8.09
-53.99	-25.53	-3.38
-22.58	-37.98	-.44
-9.11	-83.4	29.59
29.81	-71.05	33.31
-13.46	-32.19	38.05
8.02	-92.14	15.6
-42.11	-.41	0.65
48.78	-4.47	9.59
-9.64	-57.8	-6.55
-24.79	-25.22	-1.67
37.52	-6.87	-26.96
-37.92	29.29	-3.48
-12.05	-16.61	66.74
18.21	-10.26	-16.21

// Wang Y, 2012: Positive > Neutral, Major Depressive Disorder (MDD) < 
// Controls, Pre-treatment
// Wang Y, 2012: Positive > Neutral, MDD > Controls, Post-treatment
// Wang Y, 2012: Positive > Neutral, MDD < Controls, Post-treatment
// Wang Y, 2012: Negative > Neutral, MDD > Controls, Pre-treatment
// Wang Y, 2012: Negative > Neutral, MDD > Controls, Post-treatment
// Wang Y, 2012: Negative > Neutral, Post > Pre-treatment (MDD)
// Subjects=18
-9	18	3
45	-36	12
3	24	57
33	-15	21
-12	21	0
-6	39	3
48	-39	57
39	18	57
45	24	45
60	-21	-18
42	-72	36
36	-63	48
54	30	33

// Schneider M F, 2010: Attention Deficit-Hyperactivity Disorder
// Subjects=19
-20.36	-86.77	-5.74
3.56	-91.06	4.36
14.34	-94.43	2.27
23	-96.52	2.33
-24.49	-97.44	6.59
-50.7	-62.41	-7.63

// Schneider M F, 2010: Healthy Controls
// Subjects=17
42.7	29.13	47.83
5.86	49	44.25
-15.48	2.75	55.92
15.05	17.67	-4.35
62.87	-29.3	7.33
56.66	-66.67	21.22
60.07	-48.94	38.45
-26.09	-59.29	58.87
-20.36	-86.77	-5.74
3.56	-91.06	4.36
14.34	-94.43	2.27
23	-96.52	2.33
-24.49	-97.44	6.59
-50.7	-62.41	-7.63

// Sabri M, 2013: Deviant > Standard
// Sabri M, 2013: Detected deviant > Standard
// Sabri M, 2013: Undetected deviant > Standard
// Sabri M, 2013: Detected > Undetected
// Subjects=22
8.83	-16.82	24.01
2.49	17.89	46.82
-24.05	-51.86	41.82
-10.58	-10.02	3.59
48.16	-37.47	-12.63
-29.08	38.03	-20.31
12.24	-1.54	56.14
-9.76	8.36	-20.27
45.86	3.67	-17.17
-11.39	-79.81	9.45
-55.54	10.86	2.35
-40.61	-4.71	-7.67
-26.69	47.3	16.81
-42.18	-32.88	54.93
-12.53	-32.27	18.86
-49.8	-40.98	33.4
20.44	8.11	15.09
1.84	56.19	-22.18
-48.65	-76.38	29.66
12.72	57.17	3.26
-4.99	-19.48	32.19
-32.65	-41.42	39.93
20.42	-5.26	7.29
-47.93	-14.05	9.93
-9.51	-10.01	3.57
7.97	-2.63	56.28
41.04	-39.21	34.44
29.33	-5.93	52.97
48.14	-14.58	-5.63
-28.23	-64.06	49.58
-48.74	-24.6	38.7
-29.08	36.97	-20.22
51.32	-29.08	-14.49
0.11	-6.61	5.41
-7.3	-26.75	7.18
-22.29	-9.58	10.37
26.88	-2.59	13.68
-44.59	-22.51	23.98
-33.63	-50.43	47.39
-47.51	-36.08	55.26
-38	-19.53	48.19
-1.77	-54.49	19.48
-45.5	-68.16	25.59
-5.08	46.57	46.73
52.81	-66.51	24.32
3.16	47.85	7.5

// Choi S, 2014: Hedonic block, Healthy controls > Schizophrenia
// Subjects=15
-4.36	58.38	6.7
-2.22	43.07	1.27

// Dowd E C, 2012: Effect of cue, Healthy controls > Schizophrenia
// Dowd E C, 2012: Effect of receipt, Money > No money
// Dowd E C, 2012: Effect of receipt, Healthy controls > Schizophrenia
// Dowd E C, 2012: Effect of receipt, Schizophrenia > Healthy controls
// Dowd E C, 2012: Effect of cue x receipt, Unexpected > Expected reward
// Dowd E C, 2012: Effect of receipt x group, Control no money > Money - 
// Schizophrenia money > No money
// Dowd E C, 2012: Cue Money - No Money, Correlated with physical anhedonia
// Dowd E C, 2012: Receipt Money - No money, Correlated with physical 
// anhedonia
// Dowd E C, 2012: Receipt money - No money, Correlated with social anhedonia
// Subjects=20
15.88	-62.95	-50.27
2.03	51.56	0.51
-11.92	47.62	-7.92
-.63	-36.11	36.88
1.92	-31.94	-47.13
-9.76	-50.96	-44.29
12.64	-44.74	-48.41
-36.28	-66.67	-24.82
57.77	-67.16	-25.86
38.55	-69.31	-24.35
14.06	-83.92	-18.38
-48.97	-65.38	-6.94
-38.23	-89	-10.66
-25.37	-97.3	-9
13.22	-100.19	5.3
-11.55	-4.6	18.75
15.06	3.25	7.75
47.05	45.62	16.1
-43.6	7.36	24.81
1.42	-24.98	29.24
-37.92	-56.09	43.45
-11.17	-74.24	40.2
-.7	14.78	48.23
-45.54	-9.26	44.07
47.19	34.94	29.26
-34.61	-23.17	69.65
-8.93	-26.99	73.02
44.84	23.98	-2.13
-41.73	18.89	-5.17
-32	53.07	23.08
0.35	-29.39	27.39
46.26	16.67	40.84
-45.75	23.72	30.16
-40.33	8.06	33.64
48.63	-50.11	44.18
-40.01	-58.93	48.17
0.68	-68.74	55.22
55.88	-72.27	4.7
-1.19	36.05	-7.08
-53.26	3.61	18.55
-30.75	25.38	36.53
-10.29	31.44	58.1
-15.2	-9.24	-41.03
2.11	-50.84	-29.94

// Ren T, 2012: Systemic Lupus Erythematosus Patients (SLE)
// Subjects=14
-32.14	60.41	7.96
35.66	16.32	51.03
31.9	53.42	-5.57
-51.16	29.6	24.15
-31.36	-66.57	58.75
48.69	-53.91	50.08
-37.92	-48.34	47.26
-57.15	-48.46	47.49
-15.94	-6.88	3.38
32.01	24.87	-3.18
38.55	-65.97	-22.4
6.57	-78.59	-17.63
-6.04	-46.78	23.34
25.59	-14.77	-19.85
31.97	54.19	4.4
45	39.95	25.52
-32.23	62.81	-2.27
-47.98	29.36	20.79
-3.03	33.58	29.95
-37.78	-56.83	61.35
45.47	-50.76	49.85
31.99	21.44	-6.23
54.57	-.11	2.01
-18.63	-34.51	59.26
-6.6	33.13	-16.81
32.07	-27.17	-15.54

// Ren T, 2012: Healthy Controls
// Subjects=14
45.04	30.44	26.32
-35.4	54.33	-1.53
0.31	25.11	44.01
35.82	-54.5	43.58
-37.89	-54.69	47.79
33.44	-86.66	-.53
54.63	-32.35	-1.98
-38.31	-59.05	-8.71
16.07	-.6	-.86
14	-5.39	6.26
-9.5	-6.58	6.63
31.99	21.44	-6.23
-44.63	4.52	29.52
31.9	53.42	-5.57
-38.63	54.06	-4.81
0.31	25.11	44.01
39.05	-54.22	46.87
-44.35	-42.04	46.81
35.86	-24.41	61.13
-6.62	46.08	-14.55
6.77	-50.13	20.13
-9.21	-16.7	40.93
16.63	-40.9	56.05
-50.96	-24.33	28.67
61.18	-20.99	20.41
-54.56	-2.05	-13.31
-47.77	-60.74	11.61
32.11	-30.08	-11.95
-27.73	-30.44	-11.23
-19.29	-11.7	-17.36

// Sato Y, 2013: Anorexia Nervosa (AN)
// Subjects=15
-17	3	4
34	17	7
11	0	3
-34	-92	8
-7	18	44
29	-89	3
27	-50	0
-9	-40	0
48	38	-13

// Sato Y, 2013: Subgroup of AN, Restrictive (ANR)
// Subjects=9
-30	21	-1
-16	8	0
36	20	3
8	4	3
-8	23	34
-16	8	0
38	19	-1

// Sato Y, 2013: Subgroup of AN, Binge-Purge (ANBP)
// Subjects=6
-8	23	34
-16	8	0
38	19	-1
48	38	-15

// Sato Y, 2013: Healthy Controls (HC)
// Subjects=15
-35	14	-5
-17	-48	-4
-9	22	33
34	18	0
21	45	-3
27	-50	0
-9	-40	0
48	38	-13
-8	23	34
-16	8	0
38	19	-1
48	38	-15

// Simard F, 2013: Matching according to semantic minus control matching
// Simard F, 2013: Matching according to syllable rhyme minus control matching
// Simard F, 2013: Matching according to syllable onset (attack) minus control 
// matching
// Simard F, 2013: Matching according to semantic minus matching according to 
// syllable rhyme
// Simard F, 2013: Matching according to syllable rhyme minus matching 
// according to semantic
// Simard F, 2013: Matching according to semantic minus matching according to 
// syllable onset (attack)
// Simard F, 2013: Matching according to syllable onset (attack) minus 
// matching according to semantic
// Simard F, 2013: Matching according to syllable onset (attack) minus 
// matching according to syllable rhyme
// Simard F, 2013: Matching according to syllable rhyme minus matching 
// according to syllable onset (attack)
// Subjects=14
-42.98	57.66	-12.87
-7.38	41.58	23.76
11.85	41.7	23.52
-31.07	33.04	-2.02
39.6	41.52	18.76
-50.16	32.18	16.11
-54.37	32.84	25.03
39.6	41.52	18.76
-50.16	32.18	16.11
-2.86	26.57	49.5
-49.88	13.09	44.48
-.71	-32.57	27.67
-47.88	-65.2	-4.74
-26.11	-60.96	48.18
31.7	-66.1	59.1
-30.79	-73.9	-8.67
24.79	-71.28	-7.3
-39.28	-84.35	-5.46
33.44	-89.92	-1.37
-7.11	-87.36	7.8
10.03	-86.92	12.03
-5.2	-12.82	8.22
-26.52	-34.44	5.82
24.7	-28.3	-1.98
9.76	-12.73	8.04
-11.6	0.35	13.88
13.89	9.88	-2.82
-39.51	-67.03	-29.22
37.55	-78.4	-18
-26.8	59.3	6.88
-47.92	28.82	27.52
-31.07	30.75	-4.06
35.16	30.98	-7.07
-50.16	32.18	16.11
-35.05	16.21	28.43
-7.29	35.92	33.15
9.73	41.86	25.77
-2.79	20.74	56.68
12.04	28.26	42.49
-52.01	10.96	44.68
-28.3	-48.28	47.14
-23.98	-60.95	48.16
31.61	-64.84	47.85
-43.66	-65.69	-11.44
35.36	-57.1	-17.53
-7.07	-87.02	12.23
20.86	-89.71	29.98
-17.87	-61.88	8.02
12.18	-73.53	19.8
-11.37	-71.9	15.47
14.27	-89.35	7.72
-3.12	-70.53	-22.65
7.58	-81.38	-26.32
-7.34	-10.72	8.07
-22.27	-32.47	3.37
20.48	-12.32	12.34
24.7	-28.3	-1.98
13.91	-.87	-4.15
-39.71	67.17	-.32
-.94	48.48	29.79
9.76	39.91	28.16
-31.07	30.75	-4.06
35.16	30.98	-7.07
-50.16	32.18	16.11
-54.37	32.84	25.03
-.75	28.53	47.08
-49.89	10.8	42.44
-50.05	-65.55	-9.15
-34.71	-43.92	49.08
-26.12	-58.84	48.01
33.8	-62.03	56.51
-21.89	-92.25	28.45
25.17	-91.46	34.54
-20.04	-90.75	-7.38
9.98	-85.15	7.42
-15.71	-94.61	-2.64
20.62	-98.8	-4.94
-28.83	-71.37	-31.21
37.55	-78.4	-18
-22.27	-32.47	3.37
-5.2	-12.82	8.22
22.68	-29.23	13.74
-15.95	1.75	4.89
16.07	1.6	0.07
-58.92	32.19	-10.55
-60.99	34.98	-1.84
-56.56	38.83	20.09
-30.93	-40.23	-13.72
-39.66	-18.05	-28.86
-13.51	-98.32	4.33
18.14	16.25	-3.41
-42.58	5.79	18.24
52.04	-1.95	-49.11
-47.83	-69.09	0.05
20.72	-93.37	10.22
-30.96	27.55	9.59
-39.61	30.87	-1.74
-20.15	-50.23	-6.32
-43.85	-32.54	-23.14
5.7	-74.25	11.02
20.8	-96.91	19.43
7.22	73.11	-10.28
-62.48	-28.6	57.04
48.67	-32.16	56.06
-54.25	-67.01	-0.06
37.97	-36.8	52.11
-15.72	-92.5	-2.82
13.92	43.14	14.46
-7.04	-73.47	22.25
12.02	-70.84	-.5
-11.45	-63.95	8.12
20.64	-89.82	1
-17.99	-56.56	-5.81

// Essingler C, 2012: Monetary > Control
// Essingler C, 2012: Control > Monetary
// Essingler C, 2012: Famous > Non-famous
// Essingler C, 2012: Non-famous > Famous
// Essingler C, 2012: Dull > Bright
// Subjects=27
9	0	63
0	30	-15
-33	-6	54
-54	6	9
-33	-27	54
42	-6	51
33	27	-3
39	54	18
-12	-27	42
-18	3	-12
-12	-15	-3
-30	18	6
18	6	-9
-6	-21	-12
6	-15	-12
-54	-39	27
-57	-15	18
-9	-57	63
54	-42	36
-45	12	0
36	21	9
-42	-57	9
-51	9	-6
-42	-51	-36
0	-60	-33
36	-54	-33
27	-57	-24
12	-90	6
-9	-90	3
-42	-45	-18
-60	-9	-21
42	-48	-21
-3	45	-15
0	-57	24
-24	6	57
33	54	-12
-9	-69	48
-60	-45	48
15	-66	51
45	-48	60
48	-33	54
48	9	24
6	18	48
-45	-72	-3
-36	-84	12
18	-66	3
39	-86	0
27	-81	24
-15	-75	48
-12	-66	57
-39	-39	45
21	-66	48
33	-54	54
-30	-57	-33
-3	-78	-24
42	-54	-36
-33	21	3
33	21	0
-42	-60	0
36	-84	21

// Harvey P O, 2010: Positive vs Neutral pictures
// Subjects=26
7.35	38.5	-10.76
-7.83	56.63	-11.18
-3.56	38.8	-18.45
18.9	-105.82	17.89
-13.56	-109.54	14.33
-.44	-49.26	38.4
-62.33	-9.14	23.15
-11.75	-2.76	8.21
24.71	11.76	-10.65
-11.79	6.81	7.27
-5.57	12.51	-12.45
-4.81	-23.33	40.39
-64.34	-27.67	31.74
-16.06	64.07	22.96

// Jogia J, 2012: Euthymic Bipolar
// Subjects=36
-17.95	-36.74	24.01
-16.42	46.07	-8.86
-16.53	51.83	-16.16
-22.7	-44.33	-11.02
51.15	13.47	29.07
49.18	23.63	46.03
57.44	31.8	18.18
-16.41	59.25	-5.69
-3.51	36.98	-14.91
-55.02	-30.65	-.62
-65.69	-34.11	8.87
-36.93	-59.64	55.73
12.71	-75.18	47.46
-42.29	-65.21	-26.55
-16.02	-36.27	6
9.89	-14.49	7.89
11.93	-35.08	-5.8
-42.31	-74.13	-30.15
64.05	-43.87	12.11
65.77	-3.4	-14.33
46.08	58.22	-20.1
-48.35	40.77	28.06
-50.27	7.56	40.35
-33.68	24.32	-10.9
57.53	-50.69	8.41
45.1	-46.79	50.82

// Jogia J, 2012: Healthy controls
// Subjects=37
-17.95	-36.74	24.01
-16.42	46.07	-8.86
-16.53	51.83	-16.16
-22.7	-44.33	-11.02
48.8	47.08	21.3
-48.41	40.35	23.62
5.89	42.62	44.88
4.02	25.13	64.58
-46.1	8.66	28.96
55.38	14.98	22.12
-59.32	-19.61	2.85
41.95	24.59	-12.22
-48.72	46.78	0.58
8.07	29.66	43.89
72.38	-22.1	-8.11
-67.91	-19.23	7.44
45.15	-52.96	53.67
7.74	-18.75	8.34
55.62	-64.14	25.47
-40.19	-72.21	-32.62
64.05	-43.87	12.11
65.77	-3.4	-14.33
46.08	58.22	-20.1
50.99	38.58	22.1
36.39	13.98	58.4
35.33	67.31	-14.09
39.83	20.53	-9.54
-39.17	-53.68	50.7

// Carnell S, 2014: High energy-density vs. Low energy-density in Obese vs. 
// Lean for visual cues
// Carnell S, 2014: High energy-density vs. Low energy-density in Obese vs. 
// Lean for auditory cues
// Carnell S, 2014: Conjunction of visual and auditory cues (high energy 
// density vs low energy density)x(obese vs lean)
// Subjects=10
-44	-36	10
58	-34	12
-26	-6	-6
26	34	-10
-58	-50	28
-16	-40	-8
14	-30	-32
44	8	10
0	-12	-8
-32	-6	-6
28	-12	-22
-16	-32	32
58	-30	12

// Oltmanns K M, 2012: Obese > Healthy
// Oltmanns K M, 2012: Healthy > Obese
// Subjects=10
32	-52	56
-6	-32	-6
32	18	4
28	-80	2
18	-94	14
-14	-78	-2
-30	-88	28
38	-58	-20
16	2	60
-22	-16	0
12	16	36
16	-4	8
26	-6	-18
-14	4	-10
-8	-92	14
-12	-84	-16
46	-8	56
54	-36	-3

// Christodoulou J A, 2014: Typical Readers
// Subjects=12
-.18	17.23	72.15
33.34	29.22	-8.05
-52.68	-46.83	9.91
59.76	-45.81	14.62
-35.44	-79.92	-.56
40.54	-90.13	23.81
53.27	-80.9	6.99
-40.35	-51.56	-41.38
-7.81	-85.48	-38.58
-7.48	-15.17	1.53
14.06	15.1	2.65
4.86	-39.47	-52.31
-.32	16.19	61.05
53.15	31.99	20.48
37.61	35.41	-10.97
42.64	1.29	37.14
55.3	-40.27	5.18
-41.41	-19.24	51.81
40.81	-42.14	54.92
34.23	-67.01	41.8
20.79	-83.77	1.11

// Christodoulou J A, 2014: Dyslexic Readers
// Subjects=12
8.15	23.69	48.96
40.25	52.13	29.91
31.91	10.6	45.37
-37.88	14.29	-3.11
33.38	27.31	-5.62
-65.64	-46.87	10.13
52.98	-34.94	-6.51
-37.01	-25.19	56.81
-30.44	-48.56	59.01
-56.89	-17.53	25.01
51.66	-46.14	57.37
30.1	-65.57	57.42
0.84	-59.09	-32.37
-9.68	-19.85	-2.46
10.13	-19.21	26.28
8.18	23.9	51.18
53.34	13.68	31.25
37.64	35.62	-8.75
-48.42	14	17.27
-52.73	-49.37	5.68
-50.45	-20.05	20.67
-39.2	-16.68	56
-30.36	-45.81	65.46
10.14	-80.43	14.41
-22.13	-94.81	23.1
29.64	-93.13	15.33
-7.63	-29.39	-12.75

// Cliff M, 2012: Younger Participants
// Subjects=11
63.12	-18.72	-5.45
-56.53	-14.7	2.27
13.11	-89.24	-4.54
-56.57	-6.24	1.57
63.12	-18.72	-5.45
13.11	-89.24	-4.54

// Cliff M, 2012: Older Participants
// Subjects=10
58.94	-20.98	7.05
-59.74	-17.97	1.47
16.28	-89.65	-10.12
-13.64	-89.83	-9.76
-56.57	-6.24	1.57
63.12	-18.72	-5.45
13.11	-89.24	-4.54

// Congdon E, 2014: Attention Deficit Hyperactivity Disorder
// Subjects=35
64	-16	2
-42	-28	6
-10	8	-4

// Congdon E, 2014: Healthy Controls
// Subjects=62
64	-16	2
-32	20	4
12	8	4
-8	2	-6

// Cubillo A, 2014: Controls > ADHD Placebo, Successful inhibition - Go trials
// Cubillo A, 2014: ADHD Placebo > Controls, Successful inhibition - Go trials
// Cubillo A, 2014: Controls > ADHD MPX (Methylphenidate), Successful 
// inhibition - Go trials
// Cubillo A, 2014: ADHD MPX > Controls, Successful inhibition - Go trials
// Cubillo A, 2014: Controls > ADHD ATX (Atomoxetine), Successful inhibition - 
// Go trials
// Subjects=19
35.07	32.24	-18.33
-22.67	34.81	-21.22
-44.67	-54.09	0.98
39.7	-61.84	-10.49
-25.49	-74.38	-15.38
51.42	-13.79	4.3
-41.46	-61.73	-1.76
-29.98	-40.37	-29.33
-32.62	-70.74	32.35
-10.5	-54.14	-2.75
-41.5	-58.9	-6.46

// Gilger J W, 2013: (G) nonverbally gifted normal readers
// Subjects=5
0	-82	2
-38	-62	38
-40	-62	-34
-50	14	28
-4	18	46
32	-64	-48
-22	-88	-4
-4	-46	34
-52	-18	-2
18	-100	4
58	-24	-2
-4	-98	-6
-54	26	14
-38	-50	32
-24	-14	60
26	-78	10
32	-8	62
-24	-88	-2
-40	-52	42
-24	-14	60
-46	6	22
36	-82	0
48	-38	50
32	-8	60
54	26	30

// Gilger J W, 2013: (GRD) nonverbally gifted reading disorder
// Subjects=9
-32	-80	-18
-24	-64	52
-64	-32	-2
-2	18	46
-40	8	24
58	-24	-2
6	-20	60
58	0	38
-22	-88	-4
-4	-46	34
-52	-18	-2
18	-100	4
58	-24	-2
-4	-98	-6
-54	26	14
-38	-70	-16
-36	-50	62
-22	6	52
38	-82	-2
20	-74	50
28	10	50
54	10	26
-38	-50	32
-24	-14	60
26	-78	10
32	-8	62

// Chung S C, 2014: Driving only (DO) - Driving with task (DWT)
// Chung S C, 2014: DWT - DO
// Subjects=16
11	-75	50
51	8	35
64	-31	40
58	14	30
55	11	0
27	-7	65
56	-26	50
19	-26	5
17	3	65
-22	-84	30
-55	-36	45
-56	-37	30
-28	-50	40
-55	0	35
-55	10	35
-51	7	20
-22	-37	70
-12	-6	-15
31	-68	-15
14	-59	-45
-20	-48	-15
-37	-46	-40
25	-36	25
20	-1	-5
17	-29	30
39	-26	-10
5	-28	15
-5	-26	15
-23	-6	-5
-11	-34	20

// King G R, 2011: Cannabis users < Controls, 2 Hz
// King G R, 2011: Cannabis users < Controls, 4 Hz
// King G R, 2011: Cannabis users > Controls, 2 Hz
// King G R, 2011: Cannabis users > Controls, 4 Hz
// King G R, 2011: Females > Males, 2 Hz
// King G R, 2011: Females > Males, 2 Hz
// King G R, 2011: Males > Females, 2 Hz
// King G R, 2011: Males > Females, 4 Hz
// King G R, 2011: Male cannabis users < Male controls, 2 Hz
// King G R, 2011: Male cannabis users < Male controls, 4 Hz
// King G R, 2011: Male cannabis users > Male controls, 2 Hz
// King G R, 2011: Male cannabis users > Male controls, 4 Hz
// King G R, 2011: Female cannabis users < Female controls, 2 Hz
// King G R, 2011: Female cannabis users < Female controls, 4 Hz
// King G R, 2011: Female cannabis users > Female controls, 4 Hz
// Subjects=14
-12	-104	-1
6	-96	8
50	-12	64
36	-18	54
46	-24	70
-16	-108	-6
-12	-104	0
2	18	50
-62	-26	-6
-38	10	44
46	48	-6
32	-46	64
26	62	-26
10	-108	4
40	-18	44
50	-20	52
34	-20	56
0	-108	6
20	-100	-4
-18	-90	-6
-18	-90	-6
-34	-84	-10
36	-16	50
32	-6	60
-60	0	34
-12	-104	-10
-12	-108	4
-60	-14	30
36	-18	54
2	18	50
-48	14	-12
2	22	54
-54	-32	64
22	-98	-14
56	-66	8
50	-14	66
-48	4	62
26	-94	-14
-58	16	4
48	52	-2
-36	44	12
52	20	-24

// Bartolo A, 2014: Reachability task > Color discrimination and Left-right 
// discrimination tasks
// Bartolo A, 2014: Reachable > Scrambled image
// Bartolo A, 2014: Unreachable > Scrambled image
// Bartolo A, 2014: Reachable > Unreachable, p < 0.001
// Bartolo A, 2014: Reachable > Unreachable, p < 0.01
// Bartolo A, 2014: Unreachable > Reachable
// Bartolo A, 2014: Brain areas where BOLD signal was significant for an 
// increase of reaction time (parametric analysis)
// Subjects=14
14.97	-71.15	55.99
49.67	49.88	5.32
-5.45	-92.73	-24.45
8.13	-97.9	22.89
-47.89	45.98	-19.53
-50.4	15.34	31.73
4.62	37.97	29.68
43.88	-74.09	34.49
-28.45	-50.24	-39.47
-50.35	-67.47	18.64
-11.39	-56.93	25.89
23.48	-72.5	-39.27
-27.45	-16.51	45.7
4.42	-62.01	-6.37
33.85	0.23	26.19
29.87	-44.72	-41.01
-24.07	-73.49	44.56
23.48	-24.35	-29.47
4.29	-35.63	-11.22
-27.74	-59.19	14.07
17.73	-53.94	21.74
40.42	-28.68	26.7
-11.34	-56.61	29.22
53.44	-66.48	23.49
-37.14	-77.56	36.22
17.71	-55.22	19.63
-27.73	-62.38	14.38
-44.03	-5.13	19.08
-24.62	-11.97	13.83
-18.53	61.78	-1.42
-21.73	45.61	-2.01
10.84	11.9	3.02
27.64	-94.12	27.79
37.21	17.54	38.99
-8.8	35.56	-6.83
24.29	7.92	40.16
1.14	48.2	13.04
10.55	2.06	-21.78
-15.12	-17.95	-4.79
-27.78	-94.47	4.11
30.33	-32.58	-3
-2.29	-2.47	-12.15
4.65	-6.67	22.89
-40.56	-63.62	24.81
-30.62	-9.42	52.9
-37.2	-20.05	42.85
26.75	-46.03	-31.86
-21.82	-72.14	-32.93
-4.63	-86.6	41.04
-3.81	-86.34	20.83
40.71	14	58.33
49.45	-55.73	-33.53
7.85	34.58	27.72
55.37	21.47	22.6
21.2	-6.25	49.46
-34.71	-65.08	-25.57
-4.52	-71.53	52.99
-5.45	-92.73	-24.45
14.89	-62.95	51.82
36.47	18.52	-19.37
37.54	-63.19	48.09
-33.93	8.65	51.16
14.81	14.12	61
7.55	-92.37	-21.35
-33.94	-42.89	39.46
36.52	64.85	-6.02
42.85	56.08	-19.83
61.43	19.44	-10.92
20.42	-15.36	-13.5
-52.39	-33.7	35.5
-33.72	-56.54	54.25
68.61	-33.27	33.4
50.27	-72.56	27.51
-31.59	24.87	-16.59
-1.79	-19.56	23.15

// Deprez S, 2013: Dual task (DT) > Visual task (VT) & Auditory task (AT)
// Deprez S, 2013: Multitask (MT) > VTAT
// Deprez S, 2013: MT > DT
// Subjects=33
-24	-4	50
-26	-6	30
30	0	50
-10	-70	54
22	-56	42
34	-60	-36
-40	2	30
-34	-2	62
-50	22	32
-6	12	52
34	2	50
48	30	26
-8	-72	54
14	-72	54
32	-60	-36
26	-74	-50
-50	38	16
-36	-78	8
-46	-60	-12
-4	22	44

// Njiboer M, 2014: 2-Back > Baseline
// Njiboer M, 2014: Tone-counting > Baseline
// Njiboer M, 2014: Tracking > Baseline
// Njiboer M, 2014: 2-Back and Tone-counting > Baseline
// Njiboer M, 2014: 2-Back and Tracking > Baseline
// Njiboer M, 2014: Tone-counting and Tracking > Baseline
// Njiboer M, 2014: (2-Back and Tone counting) - (2-Back + Tone-counting)
// Njiboer M, 2014: (2-Back and Tracking) - (2-Back + Tracking)
// Njiboer M, 2014: (Tone-counting and Tracking) - (Tone-counting + Tracking)
// Subjects=19
-42	2	28
-30	-52	46
0	2	58
-33	20	-2
-48	-7	52
-54	2	19
54	-1	43
66	-28	10
-60	-31	10
-3	-4	61
18	-58	-23
-48	-73	-2
48	-58	-2
39	-10	52
-54	-22	43
66	-28	25
18	-55	61
-15	-19	7
-39	50	22
39	44	31
-60	-31	10
63	-28	7
-3	8	52
-33	-43	40
-33	20	4
39	20	1
0	-67	-20
-51	2	31
36	38	31
45	2	34
-48	-73	-2
0	-1	52
-12	-19	7
15	-19	7
18	-55	-23
33	-91	-8
-48	-73	-2
54	-70	-2
-45	-19	55
-45	-37	13
-48	-1	7
66	-28	10
-21	-55	61
-9	-82	1
33	-34	-2
0	-37	22
-12	-49	46
6	-79	4
48	-1	-14
30	14	-5
-36	50	22
33	56	16
-30	2	22
33	11	25
12	8	31
45	-25	49
15	-82	7

// Ohrmann P, 2010: Women > Men, Angry faces p < 0.001 uncorrected
// Ohrmann P, 2010: Women > Men, Angry faces p < 0.001 corrected
// Ohrmann P, 2010: Women > Men, Angry faces p < 0.05 corrected
// Ohrmann P, 2010: Women > Men, Angry faces p < 0.01 corrected
// Ohrmann P, 2010: Women > Men, Fearful faces p < 0.001 uncorrected
// Ohrmann P, 2010: Women > Men, Fearful faces p < 0.01 corrected
// Ohrmann P, 2010: Women > Men, Fearful faces p < 0.05 corrected
// Ohrmann P, 2010: Women > Men, Happy faces p < 0.001 uncorrected
// Ohrmann P, 2010: Women > Men, Neutral faces p < 0.001 uncorrected
// Ohrmann P, 2010: Women > Men, Neutral faces p < 0.001 corrected
// Ohrmann P, 2010: Women > Men, Neutral faces p < 0.05 corrected
// Ohrmann P, 2010: Women > Men, Neutral faces p < 0.01 corrected
// Ohrmann P, 2010: Men > Women, Angry faces
// Subjects=8
-31.14	29.01	-12.83
-53.49	37.48	2.33
-52.22	18.68	20.62
33.66	-78.89	31.16
35	42.47	-23.64
-49.94	-42.44	14.56
50.36	-20.31	2.63
-47.7	-68.77	17.86
55.75	-52.69	-3.63
-45.81	-62.53	-11.68
-15.83	-6.82	17.88
33.27	-22.53	3.02
31.09	-1.05	5.7
-24.48	-10.1	3.75
-22.36	-16.86	-1.28
3.35	-5.11	10.82
33.12	-14.21	-13.29
-43.8	38.31	12.18
-37.5	49.29	2.27
-41.53	27.55	24.21
64.19	24.15	12.13
-41.55	9.77	14.55
33.64	-67	33.51
18.31	-.62	12.5
-28.94	18.62	-9.76
5.52	30.37	29.01
-47.72	-56.88	20.21
-17.68	-104.97	14.98
37.7	-6.62	29.51
-9.55	6.1	5.57
27.07	-88.47	4.16
7.47	5.44	-4.61
-41.67	9.63	-1.05
27.07	-88.47	4.16
27.07	-88.47	4.16
7.47	5.44	-4.61
7.68	13.04	24.86
9.73	18.79	16.55
16.25	-17.46	15.05
26.92	-13.08	15.68
16.08	-4.92	-1.61
9.69	-17.9	-3.79
18.3	3.61	12.15
-33.06	-18.24	-4.39
-45.81	-60.41	-11.86
31.34	-86.33	3.93
-4.98	-97.38	1.93
-50.03	-24.72	9.73
-43.55	-49.17	9.48
-17.77	-94.91	7.44
39.47	17.09	-8.18
-33.19	-17.41	-21.18
30.9	-.74	-17.74
1.17	-38.56	-8.65
5.65	-17.64	27.46
37.47	-9.02	-1.51
-24.43	-9.59	10.4
-33.08	1.31	0.66
24.68	-14.21	1.3
-15.9	10.01	15.35
-55.38	-7.23	16.13
33.14	12.36	0.09
-13.85	-7.38	-3.29
-20.2	-47.4	-11.01
11.8	19.18	7.57
-11.26	-63.04	33.69

// Kast M, 2011: audiovisual words and nonwords: control > dyslexic
// Kast M, 2011: audiovisual words and nonwords: dyslexic > controls
// Kast M, 2011: main effect (all stimuli) controls > dyslexic
// Kast M, 2011: stimuli overall effect: nonword > word
// Subjects=12
-52	-44	36
-12	-60	46
-36	-60	30
32	80	36
18	-66	40
56	-18	-12
34	-64	44
36	-48	32
-42	16	-2
-34	4	30
-6	10	36
-14	-46	0
36	22	0
6	18	30
28	-8	42
-52	-46	34
54	-20	-12
-52	10	2
-2	4	62

// Siniatchkin M, 2012: ADHD
// Subjects=17
4	20	36
46	42	20
9	15	4
2	20	48
-38	20	2
40	20	6

// Siniatchkin M, 2012: healthy controls
// Subjects=14
2	18	34
-42	6	-2
50	18	-2
-30	52	10
28	60	10
-4	14	2
12	6	10
4	20	36
46	42	20
9	15	4

// Vasic N, 2014: Incorrect - Correct Response Inhibition, All subjects
// Vasic N, 2014: Incorrect - Correct Response Inhibition, ADHD > Controls
// Subjects=12
-30	22	-6
34	18	-16
-2	20	38
6	30	22
10	12	58
-44	22	-4

// Carmona S, 2012: Controls > ADHD for No-Go > Go
// Carmona S, 2012: Win > Control for Controls > ADHD
// Subjects=23
63.65	-16.17	-13.03
47.07	-35.06	38.42
16.65	22.68	37.71
-52.7	-5.37	17.01
-54.86	-5.38	17.05
24.98	44.45	17.48
-7.91	-68.67	-42.48
-10.07	-59.96	-41.06
-14.31	-52.76	-32.74
-33.04	-14.69	31.05
-33.31	-42.92	4.71
-48.5	19.96	12.19
-45.64	-51.37	52.82
-45.73	-43.27	47.54
-49.94	-42.46	56.49

// Desroches A S, 2010: typical readers (TR)
// Subjects=12
-63	-24	15
-63	-27	3
-54	-15	-3
66	-12	3
60	-24	12
57	-30	-3
0	12	54
-48	-63	-24
-48	-54	-18
-48	-51	-15

// Desroches A S, 2010: reading diffuculty (RD)
// Subjects=12
57	-12	-3
57	-27	6
-60	-21	9
-63	-12	-3
-66	-33	9
-6	6	42
3	24	30
-3	18	36
-48	-51	-15

// Hu W, 2010: control English speakers
// Subjects=10
-46	6	30
-56	-38	6
-48	6	32
-48	6	32
-54	-38	4

// Hu W, 2010: dyslexic English speakers
// Subjects=11
-48	6	32
-48	6	32
-54	-38	4

// Hu W, 2010: control Chinese readers
// Subjects=14
-46	6	30
-56	-38	6
-54	-38	4
-48	6	32

// Hu W, 2010: dyslexic Chinese speakers
// Subjects=11
-54	-38	4
-48	6	32
-54	-38	4

// Waldie K, 2013: Control > Dyslexic for Regular word versus Fixation
// Waldie K, 2013: Dyslexic > Control for Regular word versus Fixation
// Waldie K, 2013: Control > Dyslexic for Pseudoword versus Fixation
// Waldie K, 2013: Dyslexic > Control for Pseudoword versus Fixation
// Subjects=12
-27	-96	-6
-3	-9	18
-12	6	3
-6	21	45
-3	36	33
-3	24	36
-42	42	36
-39	33	24
51	-9	45
-3	15	57
6	6	54
33	0	12
-51	21	9
-21	60	21
-27	57	15
39	-84	9
-15	18	-12
-12	12	-5
45	-9	39
-51	-12	24
30	-21	12
36	-69	-12
-6	24	33
54	12	0

// Gradin VB, 2011: Major-depressive disorder (MDD)
// Subjects=15
8	2	-8
-6	2	16
8	-6	16
2	-24	-4

// Gradin VB, 2011: Schizophrenia (SZ)
// Subjects=14
-26	-14	-24
32	-20	-12
-26	-38	-18
28	-48	-2
32	6	4
26	-4	-10
-6	-16	-16

// Juckel G, 2012: Prodromal Schizophrenia (UHR)
// Subjects=13
9	-81	3
-12	48	-15
21	33	-18
-12	48	-15

// Juckel G, 2012: Healthy controls
// Subjects=13
-6	-57	-6
-51	-72	6
27	-93	0
63	6	18
-15	-6	12
-36	12	9
-45	-33	21
63	-60	-3
-27	-99	6
-39	-90	9
6	-69	0
-3	-21	-15
-51	-69	-6
15	-6	-15
54	30	18
-15	-9	-15
-12	48	-15
-12	-87	12
18	-6	-12
-48	-69	-6
-9	-3	6

// Koch K, 2010: Schizophrenia
// Subjects=19
-16.43	40.54	-10.56
37.93	37.8	14.56
22.7	43.51	7.53
10.29	36.67	49.88
10.12	49.66	39.63
-19.82	19	57.74
-26.63	36.25	35.98
36.27	19.64	50
-.97	-9.42	5.33
27.12	-76.07	-8.73
39.9	-50.05	-18.24
14.07	50.17	10.38
-20.42	11.24	9.22
7.24	49.68	-17.47
63.88	-37.47	0.27
39.99	-31.89	-7.71
42.38	0.49	17.06
14.07	50.17	10.38
-22.6	13.26	7.93
-26.83	51.17	23.3

// Koch K, 2010: Healthy controls
// Subjects=20
44.42	40.06	15.35
35.36	56.57	-14.15
60.15	-47.26	45.01
-16.43	40.54	-10.56
37.93	37.8	14.56
22.7	43.51	7.53
10.29	36.67	49.88
10.12	49.66	39.63
-19.82	19	57.74
-26.63	36.25	35.98
36.27	19.64	50
-.97	-9.42	5.33
27.12	-76.07	-8.73
39.9	-50.05	-18.24
14.07	50.17	10.38
-20.42	11.24	9.22
7.24	49.68	-17.47
63.88	-37.47	0.27
39.99	-31.89	-7.71
42.38	0.49	17.06
14.07	50.17	10.38
-22.6	13.26	7.93
-26.83	51.17	23.3

// Hedden T, 2010: Incongruent Shifting (IS) > Neutral non-shifting (NN)
// Hedden T, 2010: Incongruent non-shifting (IN) > Neutral shifting (NS)
// Hedden T, 2010: NS > IN
// Subjects=17
-32	2	60
-10	0	64
28	-4	56
-44	10	30
52	8	28
-12	30	28
10	30	28
-42	34	22
48	36	24
-34	22	4
34	26	2
-8	18	50
6	12	54
-28	-78	38
30	-68	42
-46	-44	46
40	-52	48
-20	-2	22
22	-8	20
-30	-56	-34
26	-62	-34
-52	12	-8
54	20	6
52	10	12
58	18	6
32	6	44
6	16	66
6	44	52
42	10	38
52	44	-12
54	24	30
28	66	20
-68	-34	26
-62	-38	20
60	-34	50
58	-60	8
64	-50	18
-60	-36	52
64	-50	18
-60	-36	52
-56	-2	2
54	-44	4
10	4	12
12	16	8
-16	8	2
-10	16	6
-16	20	-4
-22	-70	-34
-26	-56	40

// Braem S, 2013: Task-switch cost (Task-switch > Task repetition)
// Braem S, 2013: Goschke effect (Task-switch cost after incongruent trials > 
// Task-switch cost after congruent trials)
// Braem S, 2013: Modulation of the Goschke effect
// Braem S, 2013: Picture Presentation
// Subjects=35
-2	14	54
6	-26	28
-32	44	6
-46	4	40
40	54	6
-30	-72	50
22	-32	2
14	4	8
-44	20	26
46	24	22
44	2	50
-44	-30	44
64	-50	24
-2	50	-2
-4	-40	-12
56	-70	20
-16	-20	60
36	-53	46

// Corradi-Dell'Acqua C, 2014: High-functioning Autistic Males (ASD)
// Subjects=10
-48	-21	30
-60	-33	30
57	-9	39
-3	-96	0
12	-75	-3
-15	-84	0
18	18	0
-48	-69	-15
45	-63	33
-45	-66	27
-24	21	45
-6	-57	48

// Corradi-Dell'Acqua C, 2014: Controls
// Subjects=10
36	-54	-21
45	-57	27
12	-54	9
9	-69	18
-9	-48	33
-12	-54	15
6	57	-3
6	12	-3
-15	18	-3
-21	-93	6
-6	-96	-6
30	-69	-3
9	-75	-3
-3	-96	0
12	-75	-3
-15	-84	0
18	18	0
-48	-69	-15
-27	-36	-18
-15	-39	-6
-27	27	12

// De Baene W, 2011: Task-switch > Cue-repeat contrast
// Subjects=20
-8	-77	48
-32	-4	58
-4	7	58
10	-80	6
-40	35	27

// Jack A, 2014: Autistic Subjects (ASD)
// Subjects=15
60	-34	10
52	-30	16
20	-76	-14
52	-64	-12
-24	-86	14
8	-84	-10
-32	-48	52
50	-32	22
-48	-38	24
-64	-26	30
38	-6	42
22	-88	38
0	-76	4
6	-86	42
14	-74	60
-6	-62	40
-48	-74	-12
-48	-70	2
48	18	18
50	18	34
52	12	32
-20	-64	-32
-6	-64	-34
2	-58	-32
-14	-56	-24
42	-58	-28
42	-56	-52
42	-58	-46
-46	-32	40
-32	-10	62
40	-2	36
-36	-50	68
30	-54	-26
46	-62	2
20	-46	-28
-30	-90	2
-22	-102	-6
-44	-72	0
-38	-70	-10
-50	2	2
-18	-24	2
-28	-6	2
46	-28	36
40	-44	54
40	-42	42
20	-78	44
42	-64	-2
-12	-100	8
-18	-78	34
-38	-80	6
-6	50	0
-4	32	-10
-22	54	28
-44	-18	34
12	-68	-14
22	-60	28
22	-72	-48
-12	-64	-24
-6	-64	-34
4	-68	-12
-48	-10	48
-66	-16	6
-56	-68	-2
-46	-38	36
42	4	-8
46	0	6
52	-10	50
6	-62	52
-18	-56	66
16	-58	60
54	-32	32
66	-20	20
68	-16	36
-38	-2	12
-58	10	-16
-52	14	12
6	-4	38
-36	30	-4
-22	16	-2
-14	-6	-14
-12	-60	-28

// Jack A, 2014: Healthy Controls
// Subjects=15
46	-70	-6
20	-78	-16
-50	-76	-6
46	-78	-10
-18	-86	30
-34	-52	56
42	-2	54
-56	-2	42
40	12	18
16	-30	-4
-18	-30	-4
6	-28	-14
22	-88	38
0	-76	4
6	-86	42
14	-74	60
-6	-62	40
-48	-74	-12
-48	-70	2
48	18	18
50	18	34
52	12	32
-20	-64	-32
-6	-64	-34
2	-58	-32
-14	-56	-24
42	-58	-28
42	-56	-52
42	-58	-46
-46	-32	40
-8	-2	54
-44	-6	8
28	-50	-34
-48	-80	2
-50	-68	0
28	-84	32
-8	42	-8
8	40	-20
-6	56	-8
34	-30	56
30	-26	64
12	-68	-14
22	-60	28
22	-72	-48
-12	-64	-24
-6	-64	-34
4	-68	-12
-48	-10	48
-66	-16	6
-56	-68	-2
-46	-38	36
42	4	-8
46	0	6
52	-10	50
6	-62	52
-18	-56	66
16	-58	60
54	-32	32
66	-20	20
68	-16	36
-38	-2	12
-58	10	-16
-52	14	12
6	-4	38
-36	30	-4
-22	16	-2
-14	-6	-14
-12	-60	-28

// Weisberg J, 2014: People > Tools, All Participants
// Weisberg J, 2014: Tools > People, All Participants
// Weisberg J, 2014: Localizer faces > Localizer tools, All Participants
// Weisberg J, 2014: Localizer tools > Localizer faces, All Participants
// Subjects=17
22.8	-56.55	18.26
52.71	-74.06	9.34
56.93	-54.83	9.91
18.62	-90.75	16.71
-42.35	-70.86	17.97
18.28	-32.82	-4.87
49.12	-46.24	-29.75
-8.43	-32.9	-3.44
24.49	-7.38	-20.46
-43.82	-43.2	-23.36
-2.25	-1.19	-20.67
-35.72	-41.13	57.78
-29.85	-55.46	-18.03
35.43	-63.99	-10.26
-46.81	-67.31	-4.58
-43.74	31.16	16.13
-33.33	40.46	-16
-36.42	-26.4	-27.08
-60.79	6.31	12.83
-18.77	-98.64	14.46
26.98	-85.01	-6.17
48.13	-53.13	-22.47
54.65	22.75	22.39
-19.33	-8.87	-22.06
22.31	3.1	-22.43
9.04	-59.75	33.18
59.2	-67.7	22.12
45.16	6.37	31.68
-47.8	-72.09	2.53
-29.97	-32.62	-25.52
40.51	-26.03	-29.12
42.98	-63.26	-1.49
-64.85	-25.47	28.92
29.48	-48.22	56.51
-21.82	-73.97	44.76
-20.76	-48.78	53.79
-37.23	-.69	16.49
-57.46	12.02	31.27
-6.66	-62.93	76

// Scherf K S, 2010: High-functioning Autism (HFA) Group
// Subjects=10
54.44	-5.8	-16.47
-47.86	-78.15	-7
15.26	-90.2	-3.37
-3.95	-95.6	-2.7
34.59	-83.6	11.47
-23.11	-88.26	11.41
26.27	-74.73	44.28
-17.54	-77.11	44.98
-24.17	-93.72	9.65
6.89	-36.78	41.32
-9.12	-37.77	43.81
18.49	-57	12.77
-1.12	36.74	1.79
54.65	33.67	25.94
36.72	20.72	52.88
27.89	-59.17	-16.15
-24.45	-63.71	-15.17
26.06	-87.88	11.92
-22.04	-89.4	10.37
29.48	-77.89	44.5
-19.69	-80.55	41.95
29.5	-61.26	53.14
-21.75	-66.59	57.53
37.96	-40.14	50.16
-32.56	-44.88	50.25
63.45	-19.61	38.11
2.49	-5.17	37.6
46.15	35.27	33.71
-59.48	1.14	42.24
33.47	24.59	48.13

// Scherf K S, 2010: Typically-developing (TD) Controls
// Subjects=10
43.79	-43.9	-26.54
-40.55	-54.64	-20.21
53.77	-58.82	13.63
-66.18	-31.56	-8.47
-43.07	20.46	-39.86
-40.05	-59.27	43.74
0.02	63.83	21.8
-5.53	45.2	-12.26
9.89	51.23	50.63
23.84	26.65	48.07
6.59	61.18	42.02
1.38	42.72	51.44
34.05	63.47	0.26
-15.68	35.38	54.48
-17.94	41.75	40.59
-1.24	68.46	-.87
36.61	7.46	32.8
-46.61	11.59	52.37
-50.37	30.04	-11.58
-35.3	-79.75	-42.7
18.45	-88.15	-4.69
-35.3	-79.75	-42.7
18.45	-88.15	-4.69
-3.95	-91.12	0.27
33.61	-77.2	25.44
-21.96	-84.14	23.31
23.19	-64.58	65.76
-7.81	-66	64.01
67.6	-12.15	24.06
63.24	10.03	22.25
-32	15.74	8.36
-40.6	34.98	10.19
-40.6	34.98	10.19
25.8	-65.27	-12.27
-24.42	-66.63	-11.58
8.88	-84.44	2.91
34.58	-82.63	10.27
-22.04	-88.25	11.39
38.05	-44.66	60.58
-30.33	-51.58	59.71
-57.27	-27.74	40.18
64.42	-15.17	26.58
-46.71	-30.1	22.41
-45.92	34.07	12.56

// Hakun J G, 2012: Perceptual-catch > Baseline
// Hakun J G, 2012: Rule-catch > Baseline
// Hakun J G, 2012: Rule-catch switch > Repeat
// Subjects=20
42	8	34
8	-104	2
36	-58	40
60	-48	6
-26	-56	34
12	14	44
8	-24	24
-26	-26	26
30	56	16
-12	-102	2
8	-104	2
2	-26	22
34	-58	38
10	14	48
58	-48	6
-12	-102	2
-30	28	-2
28	56	16
-40	30	18
-44	8	18
-4	22	40

// Kim C, 2012: Significant areas of activation for the main effect of 
// switching
// Kim C, 2012: Significant areas of activation for the main effect of 
// conflict
// Kim C, 2012: Conjunction analysis: Common areas of activation for both 
// switching and conflict
// Subjects=16
-25	34	-2
21	32	-3
-22	-4	45
-50	-3	37
-13	-5	54
4	29	20
-16	0	40
-22	-68	7
26	-24	40
41	-42	32
-20	-67	41
19	-68	45
18	-56	59
-38	-34	-9
45	-59	-4
-33	12	19
34	2	19
-22	12	18
25	0	19
18	-66	-31
49	14	2
-32	26	6
42	9	32
39	29	36
8	9	48
-15	-12	70
-44	-1	34
6	11	41
28	-53	43
-41	-43	46
-31	-52	38
-57	-42	35
48	-48	29
26	-69	32
52	-53	6
34	10	2
-32	12	1
-8	1	10
8	3	10
-20	1	13
12	2	3
12	-8	6
-50	-3	37
-1	13	42

// Philipp A M, 2012: Stimulus-categorization switch > Stimulus-categorization 
// repeat
// Philipp A M, 2012: Response-modality switch > Response-modality repetition
// Philipp A M, 2012: Conjunction of Stimulus-categorization switch > 
// Repetition and Response modality switch > Repetition
// Philipp A M, 2012: Interaction: Stimulus-categorization vs 
// Response-modality (switch minus repetition)
// Philipp A M, 2012: Interaction: Response-modality vs 
// Stimulus-categorization (switch minus repetition)
// Subjects=23
-44	4	30
-14	-66	46
-30	-46	44
-44	-38	46
-40	-50	46
30	-56	52
-46	24	34
-58	-50	26
56	-52	30
-12	-8	32
26	-16	18
-14	-12	48

// Piguet C, 2013: Switch > Repeat
// Piguet C, 2013: Repeat > Switch
// Piguet C, 2013: DoubleSwitch > Inhibition
// Piguet C, 2013: (Switch > Repeat) > (Color > Others)
// Piguet C, 2013: (Switch > Repeat) > (Gender > Others)
// Piguet C, 2013: (Switch > Repeat) > (Emo > Others)
// Piguet C, 2013: (DoubleSwitch > Inhibition) > (Color > Others)
// Piguet C, 2013: (DoubleSwitch > Inhibition) > (Gender > Others)
// Piguet C, 2013: (Doubleswitch > Inhibition) > (Emo > Others)
// Subjects=20
-9	-72	42
-30	-51	39
-3	-27	27
-39	-51	-24
-51	-60	-15
45	39	-6
-12	54	27
6	45	36
-12	15	12
60	-24	30
-6	-72	39
-15	-45	30
-51	-21	45
-57	-18	21
36	-75	-3
-45	-60	-9
12	-93	6
33	15	48
-30	18	51
9	30	48
-12	48	30
15	15	3
24	9	-12
-6	-45	63
45	36	-6
45	12	-12
24	-3	-3
21	6	0
-45	-24	63
12	-93	6
-33	-87	15
-15	-93	6
27	12	-3
-27	9	-15
36	-6	-6
24	-33	-9
-48	-24	-9
54	-15	-6
-63	-51	-6
42	-12	36

// Reeck C, 2014: Gender > Emotion expression task
// Reeck C, 2014: Switch > Stay trial transition
// Reeck C, 2014: 3 way interaction (Task x Trial x Congruence)
// Subjects=10
48	21	21
-33	-45	39
-30	0	63
3	-66	-12
30	-30	0
30	9	54
-6	-30	21
57	36	-3
3	-24	33
-54	36	-6
-9	-87	36
42	33	36
18	-3	27
18	-90	30
12	21	3

// Rodriguez-Pujadas A, 2013: Monolinguals
// Subjects=18
-25.11	24.89	-16.71
-1.48	-25.99	46.2
-27.45	-71.25	34.31
-7.88	-70.25	43.96
-7.71	-55.82	60.46
-52.29	-29.68	44.06
-50.7	-49.23	-4.45
-52.85	-59.02	-5.69
-27.53	-79.53	26.16
-5.45	11.21	-3.36
-15.1	-4.67	-.51
14.94	-56.05	56.73
14.06	5.21	0.26
17.48	4.34	13.74

// Rodriguez-Pujadas A, 2013: Bilinguals
// Subjects=18
-20.97	18.48	52.21
-17.63	13.79	59.34
-27.83	49.56	29.08
-24.56	41.06	29.87
-34.42	48.7	20.32
-44.43	48.72	-1.93
-11.05	-17.23	60.06
-4.47	-3.31	70.9
-53	39.43	2.5
-43.68	5.12	48.32
-14.24	-10.24	66.15
-47.03	-47.17	28.9
-43.8	-57.04	26.46
-52.39	-66.54	28.66
-46.91	-74.72	32.74
-59.3	-52.25	-1.77
-4.98	28.99	37.45
-5.42	14.72	-.35
21.31	14.24	62
21.25	-63.87	41.71
21.04	-60	25.65
40.81	-69.56	48.67
53.26	-78.78	6.78
53.14	-76.42	-2.41
4.46	38.96	17.26
17.73	17.16	36
4.73	-45.48	21.12
7.51	11.26	-3.59
13.92	10.76	-9.25

// Whitmer A J, 2012: Switch trials > Repeat trials
// Whitmer A J, 2012: Switch > Repeat correlated with behavioral inhibition
// Subjects=27
-28	-70	38
-8	8	50
26	-10	46
-6	-36	20
12	-20	-10
-30	24	2
-22	-4	64
18	-10	60
30	4	-8
-24	2	-12

// Bruffaerts R, 2013: Main Effect of Task: [Property verification - Control]
// Subjects=19
-36	-43	-23
-36	-22	-23
-9	-58	10
-36	-10	-35
-30	-37	-5
-45	-55	-20
-15	-37	1
-30	-1	-23
-3	-46	25
9	-49	1
27	-16	-17
15	-28	-11
36	-37	-20
6	2	-5
-39	32	10
-30	35	-17
-45	29	-14
-9	17	49
0	17	64
-48	-73	28
39	32	-17
-9	50	46
-12	32	49

// Gruber O, 2010: Activations due to saliency per se, Session 1
// Gruber O, 2010: Activations due to saliency per se, Session 2
// Gruber O, 2010: Activations due to behavioural relevance per se, Session 2
// Gruber O, 2010: Activations due to behavioural relevance per se, Session 3
// Gruber O, 2010: Session 2 > Session 1
// Gruber O, 2010: Session 2 > Session 3
// Subjects=11
8	-52	20
36	-80	32
44	-60	16
-4	-76	28
-32	-76	32
8	-44	24
44	-72	40
48	-56	16
-32	-76	32
-40	-20	60
-36	20	-12
32	28	-12
-40	12	-12
52	16	-16
4	28	40
-60	-56	36
64	-48	28
-28	40	32
8	-12	-12
8	-28	-16
-28	16	-16
-36	12	0
36	28	-20
40	20	-4
0	28	28
-56	-52	12
-64	-48	16
-24	44	28
8	-12	-12
8	-28	-16
32	24	-16
-32	24	-4
-4	24	56
-60	-44	28
60	-48	40

// Ruge H, 2010: Switch > Repetition for effect feedback
// Ruge H, 2010: Switch > Repetition irrespective of feedback type
// Subjects=18
-30	39	30
-6	18	45
-39	-6	52
-51	-27	45
48	-27	54
-36	-63	-12
-24	-87	-9
39	-60	-9
33	-75	27
-36	48	12
-9	0	60
-15	-72	39
-6	-60	66
24	-63	57
-6	-75	-6

// Wende K, 2012: Causal Verbal Fluency (CVF) > Baseline
// Wende K, 2012: Free Association (FA) > Baseline
// Wende K, 2012: Phonological Verbal Fluency (PVF) > Baseline
// Wende K, 2012: Conjunction: CVF, FA, PVF
// Wende K, 2012: Conjunction: (FA > PVF), (CVF > PVF)
// Subjects=18
32	-60	-30
0	8	72
12	-18	-22
32	-60	-30
0	8	72
26	-64	-24
-62	-16	2
58	-28	2
2	-34	0
4	4	72
28	-64	-24
58	-28	2
-62	-16	2
2	-34	0
4	4	72
-38	14	54
-46	-66	30
26	-80	-28
-52	26	10
-54	-10	-26
64	-12	0
30	-22	30
-2	50	-14
-26	-16	28
-54	-20	2

// Braet W, 2011: Successful inhibitions, High risk (HR) > Low risk (LR), 
// p<0.05
// Braet W, 2011: Successful inhibitions, High risk (HR) > Low risk (LR), 
// p<0.001
// Braet W, 2011: Successful inhibitions, Control > ADHD
// Braet W, 2011: Commission errors, Controls > ADHD
// Braet W, 2011: Commission errros, LR > HR
// Subjects=9
3	9	45
36	39	34
-34	44	34
45	2	42
-28	-8	46
46	15	31
48	-9	60
-25	-25	70
-15	-21	37
0	-29	25
34	14	-1
-33	18	1
8	-22	8
-18	-26	6
3	0	9
-12	5	5
0	-11	-8
2	-27	-25
51	-47	32
-54	-49	23
8	-77	34
13	-38	40
50	-74	-17
50	-25	-15
11	-72	-5
-33	-61	34
30	-66	33
-58	-46	20
-50	-45	43
0	14	43
-33	41	31
31	42	37
40	39	22
45	-15	8
0	-24	29
42	10	7
-37	13	0
-12	-19	6
10	5	6
-9	4	1
3	-24	-18
-20	-40	-6
-21	-36	-21
-49	-55	-25
-58	-44	27
56	-49	34
-39	-54	36
-12	-78	32
10	-76	19
12	-78	39
-46	-77	33
-53	-26	42
57	-26	32
53	-47	12
-54	-22	13
51	-21	-22

// Maurer U, 2011: Control > Dyslexic for Word > Symbol
// Subjects=11
54	-30	-12
-60	-63	12
-63	-27	-9

// Norton E, 2014: Whole brain phonological gradient analysis (Control > 
// PHONOdef > DOUBLEdef)
// Norton E, 2014: Whole brain rapid naming gradient analysis (Control > 
// RANdef > DOUBLEdef)
// Subjects=10
-37.84	38.62	4.56
-35.77	34.71	-2.93
-41.54	-.51	45.48
-39.21	-40.81	50.55
-66.48	-25.34	33.79
-39.61	9.85	29.85
-64.28	-25.02	37.08
-57.68	-29.59	45.27
39.75	-47.9	-29.66

// Orinstein A J, 2014: Controls > ADHD-I: Target > Baseline
// Orinstein A J, 2014: Controls > ADHD-I: Novel > Baseline
// Orinstein A J, 2014: Controls > ADHD-I: Target > Novel
// Subjects=18
33	39	24
-3	3	51
3	-3	63
6	21	33
-12	27	24
0	-6	39
-42	9	-3
36	15	-12
-36	-36	51
48	-39	48
-54	0	-6
-48	-12	0
-63	-30	-3
63	-27	-3
60	-39	15
-3	-6	6
-3	-24	6
0	-75	-18
3	-78	-36
-12	-24	-15
12	-27	-12
-60	-24	6
-42	-33	9
63	-27	3
66	-18	3
-6	-3	72
0	-6	39
3	18	33
-39	6	3
45	15	-3
-42	-27	60
-66	-27	24
45	-42	45
-12	0	0
12	0	-6
-9	-24	3
0	-42	-3
21	-54	-27
3	-69	-18
-12	-24	-15
12	-24	-12

// Dickie E, 2011: Negative correlation: [Rembered - Forgotten faces] and 
// change in CAPS score
// Dickie E, 2011: Negative correlation: [Memory x Emotion Interaction] and 
// change in CAPS score
// Subjects=18
62	-6	20
28	-40	74
-22	-40	-26
32	-12	-18
46	-24	34
-2	-44	30
36	-12	8
-16	-14	72
-4	26	-8

// Peyrin C, 2011: Dyslexic
// Subjects=12
-11.39	-73.4	21.92
4.25	93.2	11.89
17.64	-87.41	8.24
-44.03	29.84	25.71
37.24	4.57	38.03
11.27	20.64	39.12
40.2	-86.14	-2.35
-24.58	-92.64	0.52
-34.38	-70.24	-.41

// Peyrin C, 2011: Typical
// Subjects=12
-37.85	-46.83	-13.88
46.45	-52.81	-13.6
31.1	-53.01	53.92
-24.02	-69.78	49.79
-37.08	-35.59	48.87
50.38	-35.59	44.02
-18.14	-86.34	-1.34
-31.1	-69.92	2.86
4.7	-70.88	13.55
-11.51	-68.81	13.62
17.64	-87.41	8.24
-40.81	30.81	24.44
53.36	10.59	32.68
37.34	21.77	49.77
18.05	17.42	61.74
1.48	28.8	35.12
26.84	-71.66	-30.45
-11.87	-75.87	-15.93
49.89	-69.94	-1.88
-44.08	-73.36	1.18
-27.79	-82.56	5.18
-14.27	-53.17	54.71

// Doyle-Thomas K A, 2013: Autism Spectrum Disorder Participants (ASD)
// Subjects=18
-28.53	28.36	47.41
-32.48	-93.49	40.95
-50.78	-85.11	27.07
-71.36	-38.68	10.03
25.53	63.67	3.68
48.45	2.93	41.97
12.99	20.47	24.18
48.43	-53.31	16.57
22.61	-35.46	1.99
38.69	-74.45	-8.3
-2.89	-17.69	27.56
19.53	-34.19	18.65
3.37	-32.4	1.96
-19.06	-35.71	2.49
-22.75	58.16	-22.07
-41.96	48.44	-22.15
-6.68	42.13	-24.25
-3.33	56.9	1.24
-25.19	19.89	61.47
38.92	-25.93	41.15
-44.37	-71.87	32.58
51.81	-77.9	28.63
-54.51	-34.54	-20.62
-32.44	-89.81	47.33
0.54	-105.41	21.49
16.56	-97.65	24.01
20.22	73.93	12.92
-16.2	6.93	-24.54
-54.34	-26.14	5.44
38.24	9.91	-32.1
-45.05	-19.65	-35.36
19.2	-7.95	-13.66
0.04	55.29	21.41
-38.41	35.51	16.81
-29.11	38.83	-23.72
25.84	34.01	32.93
-47.66	-69.49	22.38
-9.11	-48.68	40.27
-70.44	-33.61	-7.13
57.56	-5.58	-27.68
32.2	20.33	20.62
16.78	68.17	-20.01
-41.8	56.67	1.7
-32.19	67.56	4.02
35.23	64.59	14.65
-54.45	46.24	19.44
3.63	6.61	52.21
25.48	20.38	-19.45
44.7	23.67	-19.95
9.71	32.88	19.83
45.02	7.2	14.88
-44.66	27.24	34.31
-34.97	-4.94	30.2
0.31	-34.13	21.1
9.93	-14.36	28.25
54.54	-20.17	-9.69
-64.19	2.12	-13.55
-19.03	-38.62	6.08
41.64	-27.62	-22.3
-38.21	-92.09	-9.29
38.39	-8.35	-20.54

// Doyle-Thomas K A, 2013: Typically Developing Controls (TD)
// Subjects=16
-34.42	76.55	-3.4
-45.04	66.17	0.94
-71.41	-25.99	8.97
74.84	-13.45	-7.14
-60.94	-1.83	-9.91
-63.92	-62.12	-4.81
-63.66	-75.93	23.1
-38.4	45.54	22.66
32.21	53.34	34.58
51.58	2.18	31.96
45.27	-29.84	31.37
-41.78	-15.69	-25.69
35.11	-15.74	-33.26
35.11	-15.74	-33.26
-32.19	-15.89	-29.13
-38.62	49.83	-4.46
18.96	42.29	-24.56
26	25.78	50.35
-22.07	15.71	48.4
-2.74	-45.73	36.6
-31.96	-43.15	-10.12
48.64	-87.43	29.47
35.42	-45.41	-4.01
-37.9	-81.09	36.62
6.78	-102.68	1.12
-21.67	-65.74	68.61
57.82	-19.38	0.24
44.67	-9.6	-37.23
0.04	55.29	21.41
-38.41	35.51	16.81
-29.11	38.83	-23.72
25.84	34.01	32.93
-47.66	-69.49	22.38
-9.11	-48.68	40.27
-70.44	-33.61	-7.13
57.56	-5.58	-27.68
32.2	20.33	20.62
16.78	68.17	-20.01
-41.8	56.67	1.7
-32.19	67.56	4.02
35.23	64.59	14.65
-54.45	46.24	19.44
3.63	6.61	52.21
25.48	20.38	-19.45
44.7	23.67	-19.95
9.71	32.88	19.83
45.02	7.2	14.88
-44.66	27.24	34.31
-34.97	-4.94	30.2
0.31	-34.13	21.1
9.93	-14.36	28.25
54.54	-20.17	-9.69
-64.19	2.12	-13.55
-19.03	-38.62	6.08
41.64	-27.62	-22.3
-38.21	-92.09	-9.29
38.39	-8.35	-20.54

// Eyler L T, 2012: Toddlers at risk for Austism Spectrum Disorders
// Subjects=40
63.1	7.51	3.5
-69.45	19.41	4.02
-48.3	87.55	2.53
-56.61	6.45	0.5

// Eyler L T, 2012: Typically developing Toddlers
// Subjects=40
-56.61	15.25	4.22
63.02	19.86	-2
-5.24	69.06	34.81

// Greimel E, 2012: Controls
// Subjects=13
58	22	28
50	44	18
-6	14	38
0	6	56
46	10	32
-54	-18	22
34	-88	-10
-32	-92	0
-38	32	22
48	44	22
-46	30	32
40	-70	-18
-32	-92	0
32	-90	-10
58	22	28
50	44	18
2	24	36
-8	8	40
-2	4	58
52	12	38
40	-70	-16
-40	-74	-14
32	-90	-10
32	52	30
-34	48	18
40	-70	-16
-40	-74	-14
-22	-64	32
34	-88	-10
32	52	30
-34	48	18
40	-70	-16
-40	-74	-14
-22	-64	32
34	-88	-10

// Greimel E, 2012: Autistic Spectrum Disorder patients (ASD)
// Subjects=13
-52	24	34
-30	-8	68
-48	-18	20
-40	-22	64
-40	-76	-14
40	-72	-16
42	-86	-4
48	38	28
30	54	28
-32	-6	66
42	16	-2
-32	22	6
2	24	40
16	18	62
-38	-24	66
54	-42	38
-38	-24	66
46	-54	30
34	-80	-16
-40	-78	-14
36	26	-14
-58	12	22
48	16	-4
-40	-22	64
-62	-20	38
18	-4	-20
42	-72	-16
-40	-74	-14
44	-86	-6
8	-70	12
-4	-72	8
48	38	30
2	20	40
-4	14	40
2	16	50
-38	-24	66
-60	-20	38
-56	-22	50
42	-72	-16
-40	-76	-14
44	-86	-6
48	38	30
2	20	40
-4	14	40
2	16	50
-38	-24	66
-60	-20	38
-56	-22	50
42	-72	-16
-40	-76	-14
44	-86	-6

// Hummel T, 2013: All odors - Baseline, All subjects
// Hummel T, 2013: Ambroxan stimulation, Sensitive > Insensitive
// Subjects=10
-36	2	-35
-27	8	10
39	-25	46
-39	-13	16
-24	-4	-23
21	-25	37
-33	-7	13
30	-4	-14
-24	26	7
33	-7	10
-3	-1	37
-36	17	10
-24	-10	-11

// Ishitobi M, 2011: Healthy Controls
// Subjects=24
20	-2	-2
-2	-8	-1
52	18	28
-3	4	30
4	16	54
44	-4	-2
-4	-5	-2
42	-8	-1
-3	-8	-1
38	-5	44
-3	-5	44
40	8	30
-3	12	28
2	24	56
48	-5	-1
-4	-6	-8
32	-8	-8
-3	-8	-1
30	-6	46
-3	-5	50
54	20	44
-4	26	20
2	16	60
44	-4	-2
-4	-6	-1
42	-8	-1
-4	-8	-1
32	-6	46
-3	-5	42
20	-10	-24
-32	-8	-20
-6	-52	14

// Ishitobi M, 2011: Autism Spectrum Disorder (ASD)
// Subjects=9
-3	8	32
2	22	42
42	-5	-2
-4	-3	-2
34	-9	4
-4	-7	-1
32	-6	34
-2	-6	38
48	24	32
-2	50	6
40	-6	-2
-4	-5	-1
32	-8	4
-4	-7	-1
28	-6	44
18	6	-1
-2	4	-2
56	28	30
-5	26	26
-4	8	60
46	-5	-2
-4	-5	-2
36	-8	6
-4	-7	-1
20	-10	-24
-32	-8	-20
-6	-52	14

// Liu L, 2013: Typically-developing controls (TD)
// Subjects=14
-38	8	28
-34	30	-10
-36	8	26
-36	32	-8

// Liu L, 2013: Reading disability (RD)
// Subjects=14
-36	8	26
-36	32	-8

// Rudie J D, 2012: Children with Autistic Spectrum Disorders (ASD)
// Subjects=23
14	-4	-18
-18	-10	-16
28	-16	-18
-24	-12	-26
30	-6	-8
-20	2	-8
22	-12	6
-16	0	-8
6	6	-6
-6	6	-6
8	-30	2
-24	-26	2
-4	-10	2
22	-32	-20
-20	-14	-26
30	10	-16
-38	2	-18
0	18	-8
4	68	-6
-2	40	-20
44	38	-18
-46	22	-10
28	12	-36
-24	4	-40
38	-44	-16
62	-4	-14
-62	-18	-18
48	-18	-28
-44	-26	-22
8	-86	-4
-28	-42	-8
24	-44	-14
-32	-88	-14
-26	-54	-26
-12	-62	42
8	-40	44
64	-36	32
-62	-50	34
58	-52	46
-44	-54	56
32	-46	54
42	-72	38
-38	-76	48
20	56	22
32	60	6
50	20	36
54	-20	24
40	-44	-6
50	-68	4
-32	-78	2
-6	-92	22
-10	32	26
18	8	62
28	22	38
-32	28	44
10	26	22
56	14	16
50	8	4
50	6	40
-40	0	30
50	30	-6
50	32	26
-42	40	20
36	14	6
-32	22	2
-2	16	50
16	4	62
10	18	32
44	-42	44
30	-56	44
30	-68	36
32	-62	46
48	-32	2
64	-48	-6
30	52	-10
16	2	14
22	10	-8
12	12	-8
6	-18	10
-6	-66	14
-4	-40	34
-44	-60	34
-24	-26	-26
-50	-12	-22
-14	-58	-18
20	-58	-28
-62	-32	42
-30	-48	54
-14	-62	46
0	30	4
-4	60	14
6	54	-4
30	24	-16
22	36	40
4	28	2
36	46	-4
20	10	-2
12	14	-6

// Rudie J D, 2012: Typically Developing Controls
// Subjects=25
30	-8	-16
-16	-10	-16
26	-14	-18
-20	-18	-18
30	-14	-8
-32	-12	-10
22	-10	-6
-16	-8	-8
6	8	-4
-8	10	-4
24	-30	0
-22	-34	-2
4	-6	-4
18	-16	-22
-16	-14	-24
34	8	-16
-38	0	-14
4	60	-14
0	34	-18
38	26	-14
-44	20	-18
54	10	-34
-32	26	-34
28	4	-38
-34	-50	-12
66	-12	-22
48	-46	-26
-48	-44	-26
26	-48	-12
-16	-70	-10
40	-68	-10
-32	-78	2
8	-98	0
-14	-98	16
-4	-52	-18
0	-52	56
6	-34	46
66	-34	42
-48	-52	36
44	-46	38
-42	-56	56
44	-48	58
-24	-46	46
50	-70	36
-40	-84	32
-2	32	36
18	8	58
-18	10	62
20	60	0
-22	64	-4
34	24	38
-38	34	36
10	34	16
36	4	36
-50	0	36
40	-44	-6
50	-68	4
-32	-78	2
-6	-92	22
-10	32	26
18	8	62
28	22	38
-32	28	44
10	26	22
58	16	14
-56	10	18
50	4	42
-52	4	42
46	44	-4
-44	40	18
38	40	28
-26	-2	54
38	20	-2
-32	22	2
4	14	50
10	18	30
64	-32	30
-50	-42	52
26	-52	50
-30	-48	42
34	-80	24
-36	-88	20
16	-78	54
-22	-60	46
54	-44	10
48	-24	-6
44	-50	-10
16	42	-18
18	0	14
20	2	8
-18	-2	6
-4	-54	10
-2	-48	32
-42	-64	32
-22	-26	-26
-56	-14	-18
-32	24	52
-42	20	-36
-20	-52	-30
-2	32	-4
-24	60	4
0	60	-2
-62	-32	42
-30	-48	54
-14	-62	46
0	30	4
-4	60	14
6	54	-4
30	24	-16
22	36	40
4	28	2
36	46	-4
20	10	-2
12	14	-6

// Lehn H, 2012: Odors > Rest
// Lehn H, 2012: Objects > Rest
// Lehn H, 2012: Odors > Objects
// Lehn H, 2012: Objects > Odors
// Subjects=19
36	-86	-12
-4	24	42
-8	-16	-12
-40	2	30
-30	26	-6
22	4	2
32	24	-8
-32	-14	-18
-36	56	8
0	-60	-36
36	26	22
26	-28	-6
-42	-52	40
-52	-34	-10
48	16	46
-20	-30	-4
24	-28	-4
-30	-8	-34
-36	6	-16
-36	6	-16
-48	46	8
32	-80	-44
14	-82	-32
-30	-36	-2
36	-26	-10
-28	-30	-22
26	-32	-18

// Sezille C, 2013: All odors > Baseline
// Subjects=11
-23	32	-9
25	39	-6
-33	8	14
-37	8	-9
18	1	-9
18	-12	-6
-43	32	4

// Wintermann G B, 2013: Patients with Panic Disorder (PD)
// Subjects=13
-50	30	16
-50	22	34
-42	6	46
-2	28	42
-10	20	46
8	-34	2
8	-28	4
10	-38	8
0	22	-8
-48	14	0
48	-10	0
52	-32	16
52	-30	24
-4	-42	54
48	-26	34

// Wintermann G B, 2013: Healthy Controls
// Subjects=13
0	6	16
-6	-6	22
6	-4	20
18	16	18
-6	-6	22
10	-36	0
4	-6	-12
-44	42	12
-42	46	24
60	-42	-10
64	-42	-14
-24	-52	10
-26	-60	10
8	-34	2
8	-28	4
10	-38	8
0	22	-8
32	-46	10
-18	-38	16
-10	-30	22
-12	-22	24
52	-32	16
52	-30	24
-4	-42	54
48	-26	34

// Ursu S, 2014: Schizophrenia
// Subjects=20
46	28	12
36	30	-10
-38	30	4
-48	2	36
-20	-83	-13
-44	-58	-16
28	-48	-12
26	-62	-8
26	-82	-8
46	26	14
42	-4	46
48	12	20
-2	24	-16
2	18	-10
32	-10	56
-4	8	-4
-34	28	0
-38	10	-4
8	16	52
-48	6	32
-12	66	-8
-2	12	26
36	-20	-24
30	-46	-12
20	-34	-2
-30	-56	-6
28	-84	-8
42	-46	-12
28	-12	-14
-4	-16	-2
60	26	20
50	24	18
2	8	26
-46	4	34
-34	-32	-12
-30	-58	-6
-22	-86	-10
-42	-56	-12
30	-44	-14
28	-50	-12
18	-42	-4
32	-14	-28
28	-82	-8
20	-28	2
-4	-12	-2
54	34	8
-12	-6	70
52	14	38
32	6	56
34	-6	54
34	-18	44
-28	-32	-18
-30	-18	-20
-8	62	14
20	-34	-2
8	-18	0
-32	26	-2
-18	22	8
10	-38	50
-2	44	-16
-10	16	38
-14	-32	46
42	-18	-24
-24	-78	-8
42	-46	-16
32	-20	0
24	-4	-32
42	-46	-18
34	-4	48
56	6	32
6	-4	38
-36	52	0
46	34	14
54	26	-4
50	22	34
18	-14	76
26	58	2
-4	-12	78
48	-14	58
-4	26	-20
2	24	-14
-12	22	-12
16	28	-18
-10	56	30
-18	52	34
-4	34	56
6	36	34
-2	48	12
6	34	2
34	38	-10
38	28	2
-58	26	14
-30	26	-6
48	16	34
-40	-14	64
26	-30	-16
4	-50	32
26	20	-4
30	-14	0
20	-12	20
16	-14	12
6	-10	4
22	-36	4
-16	-10	0
46	-10	0
0	-12	54
-4	-12	34
-14	-42	36
-14	16	-8
28	14	-14

// Ursu S, 2014: Healthy controls
// Subjects=20
-10	62	24
-8	14	58
8	12	62
2	38	-20
-40	34	-10
-44	20	-4
58	30	6
52	26	18
48	-8	52
-46	0	36
24	2	-22
-20	-34	-4
-32	-36	-16
38	-12	-28
30	-80	-12
44	-50	-18
-20	-86	-6
18	-30	0
-46	18	22
-44	22	18
-50	14	28
-40	34	-6
-42	28	8
-54	34	-4
-42	4	28
-46	-4	44
-30	4	-18
-26	10	-18
-10	0	-6
-2	6	-6
0	54	-14
4	14	60
28	-38	-16
-36	-42	-18
40	-48	-18
28	-84	-12
24	-74	-6
28	-84	-12
28	-54	-8
32	-82	-4
30	-34	-14
-26	2	-18
-20	-42	-4
-2	-12	-2
-20	0	-12
52	34	2
46	10	26
38	28	-2
38	26	-6
2	36	-16
24	-2	-24
-8	2	-6
-26	8	-16
0	4	32
20	18	-18
-30	32	-16
-30	36	-20
38	0	48
42	18	38
34	12	30
28	28	-24
-8	44	30
6	56	8
0	54	-16
24	2	56
28	-16	-22
28	-86	-10
-44	-60	42
42	-4	42
44	-34	-24
46	-32	-18
-44	-52	-16
-18	12	-16
-20	2	-10
-10	4	-6
-36	52	0
46	34	14
54	26	-4
50	22	34
18	-14	76
26	58	2
-4	-12	78
48	-14	58
-4	26	-20
2	24	-14
-12	22	-12
16	28	-18
-10	56	30
-18	52	34
-4	34	56
6	36	34
-2	48	12
6	34	2
34	38	-10
38	28	2
-58	26	14
-30	26	-6
48	16	34
-40	-14	64
26	-30	-16
4	-50	32
26	20	-4
30	-14	0
20	-12	20
16	-14	12
6	-10	4
22	-36	4
-16	-10	0
46	-10	0
0	-12	54
-4	-12	34
-14	-42	36
-14	16	-8
28	14	-14
-34	36	32
-50	18	42
-46	28	32
-40	6	32
-8	28	50
8	4	66
26	-8	54
38	-12	56
-10	14	54
-40	-26	60
-10	32	-8
-12	46	42
-4	20	64
-50	24	34
-52	14	40
42	10	42
-26	26	-16
-46	26	36
6	34	-4
12	32	-16
32	-32	-24
36	-14	-32
16	24	-8
18	-22	-2
22	-38	4
8	-26	12
12	-16	18
36	38	-14
-4	38	48
18	34	48
-48	34	20
-30	16	52
-18	36	40
-6	14	50
-52	32	18
-14	32	26
42	2	-14
-10	54	-18
6	38	-18
12	36	4
28	12	-22
16	-2	-22
-8	18	26
-6	-14	32
-10	16	-6
-20	8	-4
-36	4	-14
-20	-4	-24
-14	-6	-14
-2	-10	8

// Chechko N, 2012: Incongruent emotional > Congruent non-emotional
// Chechko N, 2012: Incongruent > Congruent
// Chechko N, 2012: Positive BOLD response, Incongruent > Congruent
// Chechko N, 2012: Negative BOLD response, Incongruent > Congruent
// Chechko N, 2012: Incongruent non-emotional > Congruent non-emotional
// Chechko N, 2012: Positive BOLD response, Incongruent emotional > Congruent 
// emotional
// Chechko N, 2012: Negative BOLD response, Incongruent emotional > Congruent 
// emotional
// Chechko N, 2012: Areas that positively correlated with conflict-related 
// slowing during incongruent emotional trials
// Chechko N, 2012: Areas that pos. correlated with conflict-related slowing 
// during incongruent non-emotional trials
// Subjects=24
-8	12	54
4	14	50
-44	-72	-10
-32	-56	-28
-42	52	-18
8	-70	-40
34	-48	26
36	-44	-22
-38	4	-2
-48	8	0
44	-68	-10
44	-72	-10
-22	-72	60
-42	-6	62
-48	30	16
-32	-50	46
-4	26	34
6	24	30
-44	-8	6
-43	6	5
8	16	66
-2	12	54
34	32	0
34	20	-12
34	28	-12
-18	-18	10
-4	26	34
6	24	30
-44	-8	6
-43	6	5
8	16	66
-2	12	54
34	32	0
34	20	-12
34	28	-12
-18	-18	10
50	-70	40
50	-70	40
10	44	48
34	30	30
-8	10	56
-8	18	34
12	16	38
-44	-72	-8
-46	-60	-16
-46	-48	-18
-38	-62	0
34	-52	-15
34	-48	-15
-54	0	38
-60	8	32
-44	6	4
-40	24	-8
38	-48	52
46	-66	-8
42	-78	-6
38	-84	2
38	18	-14
36	32	-8
-16	0	0
-46	-34	64
12	-12	0
-30	34	24
56	32	10
-12	-8	80
-36	-4	-12
50	-40	6
48	-72	42
48	12	18
54	22	20
46	20	-18
42	18	-14
34	24	-2
-48	40	14
-36	40	12
38	-14	50
40	-4	48
-24	-18	72
-12	-8	74
48	-38	32
-60	-38	24
-56	-34	14
-62	2	20
-60	2	32
46	36	-8
44	52	6
22	-54	10
28	-64	2
28	-76	-10
-48	-12	54
-36	-10	52
-10	12	48
6	10	46
36	40	12
38	36	10
-44	6	24
54	-42	2
-44	-16	32
50	-12	40
-32	-2	-24
18	-14	8
-44	26	24
-50	-20	36

// Hart S J, 2010: Incongruent > Congruent
// Hart S J, 2010: Congruent > Incongruent
// Hart S J, 2010: Aversive stars > Neutral stars
// Hart S J, 2010: Neutral stars > Aversive stars
// Hart S J, 2010: Neutral congruent > Aversive congruent
// Hart S J, 2010: Aversive incongruent > Neutral incongruent
// Hart S J, 2010: Aversive incongruent > Neutral incongruent, Negative 
// correlation with reaction time (RT)
// Hart S J, 2010: Neutral incongruent > Aversive incongruent, Positive 
// correlation with RT
// Subjects=14
-42.31	36.83	4.18
-48.26	-39.71	47.19
2.36	-30	26.25
13.86	-7.67	10.22
13.08	-93.92	-2.73
25.82	-97	14.05
-55.87	-24.38	-11.53
20.44	-38.53	56.69
22.12	16.23	-31.42
-5.99	-44.95	41.75
53.04	-50.14	-17.07
43.59	-78.48	-30.61
-36.56	-88.07	13.81
39.03	9.6	-38.83
-34.8	28.35	36.9
4.62	-43.84	58.26
-28.27	-53.16	-3.06
59.16	14.54	-12.65
7.35	56.93	32.47
-49.51	-13.45	10.99
-56.78	-40.35	20.65
30.93	-20.71	53.19
-38.67	-88.22	11.61
-32.5	-56.62	-7.24
14.23	-83.58	45.39
9.88	-80.87	4.16
26.65	-56.53	-14.25
-31.73	30.55	3.43
-60.98	-53.4	14.91
32.95	1.09	47.25
-28.62	27.9	-23.04
-2.82	-23	72.41
24.15	39.5	-30.8
-6.54	51.85	-31.47
5.35	27.37	32.29
-24.99	-70.96	15.9
-13.41	-29.42	55.16
-61.07	-33.71	9.12
0.1	-16.56	-12.39
30.89	-59.64	-14.06
-56.71	-72.95	5.12
-60.15	20.31	29.83
-28.62	31.26	-19.94
-52.57	-38.22	20.48
-7.07	-22.66	61.32
-24.44	65.75	8.75
-5.49	52.84	-32.65
5.36	26.59	36.78
-50.6	-9.53	6.29
67.92	-57.07	5.52
-49.69	10.78	-23.96
30.88	-61.1	-20.62
0.09	-17.81	-15.64

// Melcher T, 2011: Negative arousal > Neutral arousal
// Melcher T, 2011: Neutral arousal > Negative arousal
// Melcher T, 2011: Neutral incongruent > Baseline
// Melcher T, 2011: Negative incongruent > Baseline
// Melcher T, 2011: Neutral oddball > Baseline
// Melcher T, 2011: Negative oddball > Baseline
// Subjects=14
24	-4	-12
32	4	-24
-36	0	-24
-20	0	-28
28	28	-20
-36	28	-20
44	16	24
48	40	12
48	-20	40
-60	-20	32
-12	-20	48
28	-60	48
-20	-72	52
32	-84	4
52	-52	-4
-32	-96	0
-40	-68	-12
32	-56	-28
-40	-44	-32
-24	-44	-8
-44	0	40
-36	4	28
-36	24	20
-8	4	56
-20	-76	56
-44	-40	56
-24	-96	-8
28	-96	0
-40	-68	-28
-28	-100	16
-48	-68	-4
-32	4	32
-48	-44	16
-32	-96	-4
24	-100	-4
52	-56	-4

// Mulligan R, 2011: No go > Go (no go trials), Healthy Controls > ADHD
// Subjects=12
41.14	-56.93	39.27

// Veroude K, 2013: Incongruent - Neutral, All subjects
// Veroude K, 2013: Incongruent - Neutral, Young adults > Late adolescents
// Veroude K, 2013: Negative - Neutral, All Subjects
// Veroude K, 2013: Negative - Neutral, Young adults > Late adolescents
// Subjects=17
-28	-70	42
-35	-53	42
-7	-74	48
-42	25	30
-53	11	39
-42	-4	60
-32	-4	69
-35	-18	69
35	-56	45
32	-67	42
42	7	30
46	25	30
46	32	39
39	4	57
-4	11	57
32	25	3
-35	18	0
-14	28	42
-63	-39	-6
-39	18	-15
-4	-21	48
-39	-21	66
-35	-25	54
21	-56	-27
7	-67	-24
-7	-14	57
-18	28	42
-18	-60	24

// Wang S, 2013: ADHD
// Subjects=28
33	-27	-14
15	34	-9
-30	8	-11
-30	26	-1
42	12	-1
5	-50	5
-3	7	25
33	-10	36
-53	-26	-4
-30	-9	-15
30	-27	-14
24	-7	-15
-50	22	29
-42	-61	3
-45	-79	-6
-21	9	0
-9	-46	11
-12	-67	50
12	-53	-5
-18	21	21
-42	-58	6
21	-44	44
-27	-33	29
18	-77	-16
-45	10	30
-56	-32	2
-42	-62	42
48	-56	42
-6	-50	41

// Wang S, 2013: Healthy controls
// Subjects=31
33	-27	-14
15	34	-9
-30	8	-11
-30	26	-1
42	12	-1
5	-50	5
-3	7	25
33	-10	36
-53	-26	-4
-30	-9	-15
30	-27	-14
24	-7	-15
-50	22	29
-42	-61	3
-45	-79	-6
-21	9	0
-9	-46	11
-12	-67	50
12	-53	-5
-18	21	21
-42	-58	6
21	-44	44
-27	-33	29
18	-77	-16
0	-56	36

// Barros-Loscertales A, 2011: Cocaine-dependent subjects
// Subjects=16
-42	25	29
42	2	47
53	10	24
-48	12	27
45	-48	27
-15	-35	54
50	-53	41
-36	-48	38
45	17	-8
53	-39	38
53	-41	2

// Barros-Loscertales A, 2011: Healthy Controls
// Subjects=16
15	14	52
15	9	55
-45	22	32
42	-1	36
59	21	7
-45	22	29
53	-26	-1
45	-64	-2
33	-53	52
-30	-64	53
50	-42	38
-36	-45	38
-15	-11	6
15	-5	11
45	17	-8
53	-39	38
53	-41	2

// Krach S, 2011: Common neural activations in response to vicarious 
// embarrassing situations
// Subjects=32
-6	20	44
-4	14	54
-10	28	28
-32	24	0
-36	22	-16
-48	30	10
-4	-6	6
30	-68	-28
-2	-20	-22

// Mercadillo R E, 2012: Activated regions for all participants during 
// execution of Counting Stroop Task
// Subjects=8
32	-58	36
24	0	62
38	32	36
46	-38	-14
16	0	-6
40	22	6
-38	-2	26
-16	-62	44
-56	-52	10
-24	44	18

// Michl P, 2014: Normals
// Subjects=14
-27.33	-87.77	18.1
4.69	-84.66	14.13
7.58	-74.78	-23.53
-5.19	-34.74	0.02
-43.99	17.68	-20.66
-7.99	9.05	71.1
39.35	21.35	-21.92
-56.6	23.08	9.14
4.55	49	49.76
1.11	70.7	27.91
-1.69	-93.16	14.92
-11.48	-100.56	-11.12
-14.67	-92.66	-5.05
4.63	-80.95	7.13
4.59	-79.09	3.63
-24.29	-97.21	-7.9
26.74	-82.04	-36.53
-31.99	-81.88	-29.17
-56.3	-56.22	15.79
-53.34	-19.16	-.73
-62.89	-35.08	0.71
-63.06	-10.48	-11.39
58.67	5.86	-17.5
-46.93	12.65	11.02
-56.51	20.68	19.38
-46.56	1.19	55.47
-53.35	7.07	8.22
-5.19	61.91	38.75
20.48	54.67	39.07
1.17	33.97	20.95
4.66	-35.54	30.08
-21.31	-39.03	-12.82
10.89	-34.13	6.48
13.79	-7.61	-22.55
23.42	58.46	5.26
33	18.65	-14.93
36.42	-58.23	-18.56
-64	-32.17	-2.86
18.26	-5.53	3.99
-30.76	-94.5	-13.63
14.05	-84	-19.49
29.92	-55.87	-28.72
45.98	-42.32	-20.01
0.93	-17.98	-31.57
17.17	-5.79	0.68
-8.7	67.53	1.52
7.41	65.22	11.57

// Michl P, 2014: Subgroup of Normals, Females
// Subjects=7
33.69	-69.75	39.31
4.77	-44.28	40.85
52.86	-44	40.28
44.28	-77.31	23.1
1.49	-38.47	33.71
10.84	-28.04	2.62
39.8	6.17	29.53
32.97	46.91	-7.27
-32.2	57.61	-.72
-40.28	-52.95	15.33
-62.93	-32.17	-2.88

// Michl P, 2014: Subgroup of Normals, Males
// Subjects=7
53.5	-61.56	-21.82
-11.7	-35.8	-13.2
-37.42	-30.13	-20.07
-2.04	33.96	20.99
7.3	39.9	-13.07
20.41	34.18	21.83

// Roth L, 2014: pride > shame/guilt
// Roth L, 2014: pride > neutral
// Roth L, 2014: shame/guilt > neutral
// Roth L, 2014: neutral > shame/guilt
// Roth L, 2014: conjunction analysis (shame/guilt > neutral) & (pride > 
// neutral)
// Subjects=25
-18.79	23.1	61.12
-3.36	59.81	-2.35
-2.81	-33.3	32.21
32.45	-26.48	34.58
-57.67	-47.25	-19.52
-34.74	-68.38	35.52
-9.37	-8.47	23.52
-22.38	-20.38	-5.45
-9.12	0.7	59.54
-41.16	-2.66	60.19
-41.62	9.08	5.69
-18.92	-53.97	14.06
-9.17	-69	25.24
-16.04	-1.31	-7.12
-28.54	-17.85	27.87
-5.96	6.81	55.65
-19.25	54.66	14.99
-37.99	0.27	56.57
-60.9	21.66	4.85
51.3	15.73	0.72
-18.95	-51.05	10.47
-9.51	-59.4	-15.71
-19.24	5.28	-4.29
-22.26	3.88	19.28
48.54	-35.65	38.51
32.67	-63.78	47.74
-6	9.72	52.06
-12.51	-60.53	11.19
-44.81	12.49	8.78
-37.96	-2.65	60.16

// Wagner U, 2011: guilt > shame + sadness
// Wagner U, 2011: common network activations for guilt/shame/sadness (guilt > 
// neutral)
// Wagner U, 2011: common network activations for guilt/shame/sadness (shame > 
// neutral)
// Wagner U, 2011: common network activations for guilt/shame/sadness (sadness 
// > neutral)
// Wagner U, 2011: common network activations for guilt/sadness (guilt > 
// neutral)
// Wagner U, 2011: common network activations for guilt/sadness (sadness > 
// neutral)
// Wagner U, 2011: guilt > neutral
// Wagner U, 2011: sadness > neutral
// Wagner U, 2011: guilt > shame
// Wagner U, 2011: guilt > sadness
// Wagner U, 2011: sadness > guilt
// Wagner U, 2011: shame > sadness
// Wagner U, 2011: sadness > shame
// Subjects=18
36	32	-4
-10	42	34
0	-62	30
-16	58	24
-36	12	-22
-48	-60	26
-66	-14	-14
42	6	-42
-46	8	-40
2	-84	-2
0	-48	-6
0	60	16
0	-60	30
-14	54	26
-38	18	-20
-52	-62	30
-66	-16	-14
44	2	-42
-54	2	-30
10	-80	-6
-2	-48	-4
2	64	22
-4	-56	28
0	62	18
-30	16	-16
-60	-58	28
-56	-20	-14
46	2	-38
-48	-2	-28
4	-78	-4
-2	-48	2
-16	62	24
6	52	8
38	-24	24
54	-26	20
52	-46	26
56	-34	8
-34	-32	-4
-26	10	8
14	48	14
36	-24	24
56	-20	14
58	-36	20
46	-26	2
-32	-32	-8
-28	12	12
34	26	-16
0	50	34
-14	-10	68
24	14	40
-34	10	38
30	-44	-4
30	0	12
-26	46	30
-48	-4	50
18	14	24
-6	-2	68
-46	-18	38
-50	2	-14
-42	-22	-26
-26	-12	-28
36	-32	-6
38	-80	-10
46	-74	-20
-44	-70	-12
10	-6	-2
-10	44	36
22	36	44
10	38	14
38	30	-4
-38	24	4
-34	6	-24
-50	-4	-20
24	-6	-12
12	4	2
-16	12	14
-32	-10	-2
-20	-4	8
46	-56	-30
36	36	-2
34	18	58
34	-62	30
14	-100	6
-28	-56	-28
20	-16	68
34	42	16
14	38	16
12	16	44
-38	24	4
48	-26	36
30	-58	30
14	-66	50
-16	-66	52
-50	-6	-12
58	-56	-4
-52	-58	20
36	-14	-34
-34	-14	-32
-30	-30	-8
24	-56	-26
-30	-60	-28
8	-6	-2
-14	-10	-4

// Azevedo R T, 2014: Pain stimuli > Touch stimuli
// Azevedo R T, 2014: Pain NW (normal weight) > Pain Ob (all obese)
// Azevedo R T, 2014: Pain NW > Pain UnkOb (unknown obesity cause)
// Azevedo R T, 2014: Pain NW > Pain HormOb (hormonal obesity)
// Azevedo R T, 2014: Pain UnkOb > Pain HormOb
// Azevedo R T, 2014: Faces > Places
// Subjects=12
56	10	30
40	-2	-10
-58	10	28
-42	-4	7
-58	-22	22
-60	-36	46
34	-36	54
68	-22	32
44	-62	-10
52	-68	-14
-42	-52	-20
-44	-68	-8
54	-20	34
56	-22	20
-62	-14	14
-38	-2	4
40	4	-2
-44	-56	-22
50	-68	-12
-6	-92	-12
-4	-10	-4
-60	-24	22
54	-62	-8
-20	-88	-14
56	-20	32
-44	-56	-22
50	-70	-10
-8	-4	-2
46	20	8
48	24	6
46	-56	-22
48	-84	-2
-44	-80	-16

// Frank S, 2014: Entire cohort: Activation in response to all pictures
// Frank S, 2014: (Obese > Controls) x (N-back vs. Control)
// Subjects=11
24	-78	-30
33	-51	-18
30	-30	-6
21	-72	-36

// Geliebter A, 2013: Visual, Fed: (Males > Females) X (High ED > Low ED)
// Geliebter A, 2013: Visual, Fasted: (Females > Males) X (High ED > Low ED)
// Geliebter A, 2013: Audio, Fed: (Males > Females) X (High ED > Low ED)
// Geliebter A, 2013: Audio, Fasted: (Females > Males) X (High ED > Low ED)
// Subjects=14
-56	-50	-22
22	-46	14
-46	6	20
42	34	16
30	22	34
-22	-56	52
14	40	30
16	56	32
-32	-34	20
30	40	34
12	-64	44
42	-36	44
42	24	28
10	-28	46
-20	-12	70
36	-54	4
-24	-36	16
22	12	22
6	12	14
-10	16	14
-28	0	30
16	48	10
-34	38	32
16	16	40
-14	-6	54
28	-10	62
-4	22	54
-34	-2	60
8	-68	16
8	58	20
-18	-32	-6
-10	-98	2
-28	44	14
-12	56	14
6	30	22
-2	-52	54
14	48	22
-22	26	38
-8	-68	-26
38	-40	-6
-2	-34	-28

// Grabenhorst F, 2013: Health label > Taste label, Correlated with health 
// cost rating
// Grabenhorst F, 2013: Taste label > Health label, Correlated with taste 
// pleasantness rating
// Grabenhorst F, 2013: Health label > Taste label Correlated with difference 
// in health cost rating between successive foods
// Grabenhorst F, 2013: Taste label > Health label, Correlated with difference 
// in taste rating between successive foods
// Grabenhorst F, 2013: Brain activity (food choice task), Negative 
// correlation with confidence rating
// Grabenhorst F, 2013: Brain activity (food choice task), Correlations with 
// cost benefit
// Subjects=13
18	-6	-22
-40	12	12
12	-10	-22
40	10	-6
-42	8	6
0	10	24
-28	24	14
18	-4	-14
-8	44	-18
64	-4	6

// Grimm O, 2012: Food - Neutral stimuli correlated with TCI subscale, 
// self-directedness
// Grimm O, 2012: Food - Neutral stimuli correlated with TCI subscale, 
// self-transcendence
// Grimm O, 2012: Food - Neutral stimuli correlated with TCI subscale, 
// persistence
// Grimm O, 2012: Food - Neutral stimuli correlated with TCI subscale, harm 
// avoidance
// Subjects=27
24	-80	4
-22	-70	0
4	-40	-28
48	-36	46
-10	26	-16
4	-62	26
42	4	-6
28	-26	34

// Grosshans M, 2012: Main effect of task in all participants
// Subjects=21
12	-90	-2
-24	30	-14
-26	-70	46
0	-34	32

// Kishinevsky F I, 2012: Hard DD task > Easy DD task
// Kishinevsky F I, 2012: Hard DD task > Easy DD task, Correlations with rate 
// of weight gain between first and second weighing
// Subjects=24
-42	2	40
-8	24	38
-24	60	12
-22	50	10
-42	-78	30
-10	-54	28
4	-46	-8
16	-42	-12
-18	-46	-8
14	-54	8

// Kroemer N B, 2012: Food - Control (Sex/BMI covariates): Correlated with 
// plasma fasting ghrelin levels
// Kroemer N B, 2012: Food - Control: Correlated with plasma fasting ghrelin 
// levels
// Subjects=26
-32	-68	20
-48	-54	-22
14	44	38
34	-62	26
-32	4	24
-52	-18	24
-4	-14	-12
8	-12	-4
8	-4	0
8	-6	-4
-32	-84	32
48	30	30
-20	0	-8
54	12	14
-40	-60	-2
12	2	20
-6	-6	14
-24	10	58
-4	46	22
-48	26	12
14	44	38
34	-62	26
-32	4	24
-52	-18	24
48	30	30
54	12	14
-40	-60	-2
-24	10	58
-4	46	22
-48	26	12

// Miyake Y, 2010: Healthy Controls
// Subjects=11
46	-44	-20
30	-4	-8
34	0	-12
-10	40	34
-32	22	40
48	-52	34
-16	-32	8
52	24	-18
44	-16	50
52	12	30
44	-56	-22
-40	-48	-14
34	-54	40

// Miyake Y, 2010: Bulimia nervosa (BN) Patients
// Subjects=11
2	-74	-8
38	-32	34
50	26	16
36	-56	38

// Miyake Y, 2010: Binging-purging type anorexia nervosa (AN-BP) Patients
// Subjects=11
24	26	34
-42	36	32
-34	20	-8
8	-30	-6
22	-6	-20
48	-50	-20
48	8	28
46	-48	-16
34	-50	42

// Miyake Y, 2010: Restricting-type anorexia nervosa (AN-R) Patients
// Subjects=11
26	-10	-10
44	-58	-16
52	14	26
42	-60	-14
-44	-50	-14
50	-48	46

// Ocher C N, 2012: Post (Roux-en-Y gastric bypass) RYGB fasted: Low Calorie > 
// High Calorie
// Ocher C N, 2012: Pre RYGB fasted > Post RYGB fed: (High Calorie > Low 
// Calorie)
// Subjects=5
-44	-50	10
30	-4	44
-26	-10	66
-40	-76	14
8	-68	-16
36	8	-8
10	60	20
-10	-4	-4
-12	-56	58
30	-12	44
-22	28	48

// Owens T E, 2010: Lean Males
// Subjects=9
52	-2	45
52	35	10
0	68	60
-33	51	23
36	51	24
-8	52	28
-18	-19	78
22	-1	73
2	-58	2
1	-89	-6
3	-77	53

// Owens T E, 2010: Lean Females
// Subjects=10
45	21	33
-50	30	33
-10	56	29
13	47	24
53	13	4
53	23	9
-33	51	23
36	51	24
-8	52	28
-18	-19	78
22	-1	73
2	-58	2
1	-89	-6
3	-77	53

// Page K A, 2011: Complete Subject Cohort
// Subjects=14
-56	7	6
39	26	9
-29	-7	48
54	3	20
-40	11	-3
38	12	1
-22	7	2
25	5	1
3	-12	8
-8	-4	-6
55	-44	12
-44	-39	39
38	-49	43
-7	54	12
-3	44	9

// Page K A, 2011: Subgroup of Complete Subject Cohort, Lean Participants
// Subjects=9
37	8	2
29	1	-1
39	-49	44
-2	56	12
-4	45	8
-28	-20	-15
32	-18	-18
-7	-19	-14
-40	-14	-22
41	3	-29

// Page K A, 2011: Subgroup of Complete Subject Cohort, Obese Participants
// Subjects=5
-45	24	7
43	23	11
-25	-2	52
29	-3	50
1	21	26
-37	14	-5
39	17	-3
-18	-12	2
23	4	1
1	-14	8
-8	-3	-7
5	-5	-6
-10	-15	-12
-55	-4	-3
41	-24	-7
-40	-43	42
36	-49	45

// Simon J J, 2014: Food Incentive Delay (FID): Anticipation of high reward > 
// Anticipation of no reward, p<0.001
// Simon J J, 2014: FID: Anticipation of high reward > Anticipation of no 
// reward, p<0.05
// Simon J J, 2014: FID: Receipt of high reward > Receipt of no reward, 
// p<0.001
// Simon J J, 2014: FID: Receipt of high reward > Receipt of no reward, p<0.05
// Simon J J, 2014: Monetary Incentive Delay (MID): Anticipation of high 
// reward > Anticipation of no reward, p<0.001
// Simon J J, 2014: MID: Anticipation of high reward > Anticipation of no 
// reward, p<0.05
// Simon J J, 2014: MID: Receipt of high reward > Receipt of no reward
// Simon J J, 2014: (FID > MID) X (Anticipation of high reward > Anticipation 
// of no reward), p<0.001
// Simon J J, 2014: (FID > MID) X (Anticipation of high reward > Anticipation 
// of no reward), p<0.05
// Simon J J, 2014: (FID > MID) X (Receipt of high reward > Receipt of no 
// reward)
// Subjects=27
12	2	2
-6	5	2
6	-13	2
36	17	-6
-36	17	-6
24	-85	-2
-15	-91	2
-6	32	-2
42	41	-14
-39	47	-6
51	41	18
-51	35	18
-45	11	30
24	-91	-2
-21	-91	2
-51	-58	-10
30	-61	46
-27	-61	42
-9	2	-2
30	20	-2
27	-91	-2
-30	-79	-6
3	-13	-6
-9	-22	-2
-3	-31	-6
6	35	-6
45	38	18
-45	20	26
33	17	-10
3	-37	34
36	-64	42
-30	-64	42
60	-43	-2
-54	-58	-10
-3	56	6
-54	20	10
0	-49	26
-45	-58	30
66	-10	-14
-27	32	-14
21	-91	6
-15	-91	-2

// Stoeckel L E, 2013: Whole brain correlation between Difficult > Easy and 
// ln(K)
// Subjects=19
-20	18	64
4	22	66
0	-60	46
14	-62	50
-6	-30	42
10	-20	38
-44	-54	18
-42	-58	36
-22	-64	-34
-34	-60	-30

// Wang G J, 2013: Subgroup of Obese Females- NB32 Treatment Group
// Subjects=20
-12	39	39
-9	30	33
36	-27	-12
36	-27	-12
18	-45	66
42	-30	18
-12	39	39
-9	30	33
36	-27	-12
18	-45	66
42	-30	18
-12	39	39
-9	30	33
36	-27	-12
18	-45	66
42	-30	18
33	-6	-27

// Wang G J, 2013: Subgroup of Obese Females- Placebo Group
// Subjects=20
36	-27	-12
18	-45	66
42	-30	18
18	-45	66
-12	39	39
-9	30	33
33	-6	-27
-12	39	39
-9	30	33
36	-27	-12
18	-45	66
42	-30	18
-12	39	39
-9	30	33
36	-27	-12
18	-45	66
42	-30	18
33	-6	-27

// Abler B, 2011: Erotic - Neutral (videos): Placebo > Paroxetine
// Abler B, 2011: Erotic - Neutral (videos), Placebo > Bupropion
// Abler B, 2011: Erotic - Neutral (videos): Bupropion > Placebo
// Abler B, 2011: Erotic - Neutral (videos): Bupropion > Paroxetine
// Abler B, 2011: Erotic - Neutral (videos): Placebo
// Abler B, 2011: Erotic - Neutral (images): Placebo
// Subjects=18
-12	32	-6
14	46	4
14	32	32
-4	-24	-14
6	14	-6
16	34	30
16	20	34
-22	0	-10
26	-8	-12
18	-14	6
-22	-14	14
-6	-12	8
-36	40	-8
52	0	30
38	-56	30
-34	-62	-4
-22	-34	-6
42	-20	-14
36	-38	-12
-42	-56	-24
2	-74	-28
22	-48	-18
-14	32	-6
12	44	6
16	24	36
-4	-24	-14
10	12	-6
-18	12	-6
-22	0	-10
26	-6	-10
12	-14	2
-22	-14	14
-4	-10	6
-34	36	-6
56	6	34
36	-58	28
-36	-62	-6
38	-40	-12
-20	-34	-6
40	-22	-10
-42	-56	-24
-8	-70	-18
18	-50	-18
-6	36	-2
2	34	10
-4	26	24
-2	-12	34
-6	-24	-12
6	-26	-14
-14	20	-10
8	16	-4
-2	18	2
12	-4	-6
-6	-2	-12
-42	38	10
48	38	6
-52	4	24
50	6	18
-42	4	-4
44	8	-8
-34	18	10
38	26	8
-54	-30	30
58	-32	22
-44	-66	-4
50	-68	-10
-36	-16	-8
24	-68	-26
-22	-68	-24
0	38	6
4	28	18
12	2	24
-4	-8	28
0	-36	24
0	-12	-14
-10	8	-6
10	12	-4
14	0	4
-16	-4	-10
14	-4	-8
2	-6	4
12	2	24
0	-8	-12
30	-28	-6
-24	28	-16
34	22	-4
-18	28	-2
22	30	-12
-28	6	30
48	8	28
-42	-2	32
42	2	34
-36	14	-10
32	14	-12
-34	-38	34
32	-40	36
-44	-44	-14
42	-48	-16
30	-36	2
-34	-34	-2
-22	-72	-30
16	-76	-22

// Abler B, 2013: Females taking Oral Contraceptives
// Subjects=12
62	6	18
-58	8	16
48	44	6
60	-48	6
46	14	12
-46	-2	14
-40	6	12
36	4	16
10	48	30
-8	-6	34
-56	-38	30
12	46	22
-16	40	16
-14	18	32
6	8	28
16	46	36
32	42	22
-20	38	-8
-54	6	22
48	6	24
54	4	34
-38	-12	-6
38	-4	-12
36	30	6
-36	22	4
2	10	28
-4	-4	36
-44	36	12
50	42	6
58	-32	20
-60	-34	28
46	-58	-12
-40	-68	-8
8	-18	8
-8	-20	-12
-14	-8	-8
22	-2	-14
-22	-4	-16
-30	-60	-26
24	-66	-26
-6	-4	-6
18	-12	12
-4	-12	0
-46	0	28
44	6	28
48	16	24
34	18	-8
-32	20	8
2	30	-10
2	32	6
0	28	16
2	14	34
2	-10	34
6	50	12
52	40	2
-54	-24	34
58	-22	34
38	-66	-6
-50	-64	2
4	-16	14
4	2	-2
-10	6	-6
8	-20	-10
8	-4	-4
-6	-6	-2
-8	-8	-12
14	-16	-12
22	-6	-14
-24	-6	-16
-12	-76	-36
16	48	34

// Abler B, 2013: Healthy Control Females
// Subjects=12
48	44	6

// Abler B, 2013: Subgroup of Healthy Control Females, Unmedicated Follicular 
// Phase
// Subjects=12
62	6	18
-58	8	16
14	38	-2
-8	32	32
16	44	38
30	58	0
-20	40	-8
24	-20	-22
46	14	12
-46	-2	14
-40	6	12
36	4	16
10	48	30
-8	-6	34
-56	-38	30
-56	6	16
52	4	12
56	8	32
-40	-2	10
42	8	-8
30	20	8
-34	22	8
2	14	28
6	-2	34
-46	38	18
50	38	14
60	-32	20
-60	-34	28
46	-58	-12
-40	-68	-8
-6	-12	2
8	-18	8
14	4	-2
-8	4	-4
-6	-28	-14
-14	-10	-8
14	-10	-8
-26	-70	-26
-28	-62	-28
24	-66	-28
-46	0	28
42	8	22
42	12	-8
40	26	-16
36	32	4
-24	32	-12
-30	24	12
4	30	-12
-6	36	4
-6	24	22
0	12	38
-10	-46	18
4	-18	34
2	-2	32
4	50	38
-2	54	-2
-46	-70	18
-56	-22	34
48	-70	-12
-48	-64	2
-2	-6	8
4	-16	12
8	14	-6
-6	8	-6
6	-26	-18
6	-8	-6
-8	-8	-12
16	-16	-12
-24	-4	-18
-42	-56	-22
-34	-78	-38
-10	-76	-38
44	16	12
-46	-2	16
-28	26	-2
8	48	30
0	-10	0
8	-26	-10
14	-78	-3
-18	-46	-30

// Abler B, 2013: Subgroup of Healthy Control Females, Unmedicated Luteal 
// Phase
// Subjects=12
60	-48	6
14	38	-2
-8	32	32
16	44	38
30	58	0
-20	40	-8
24	-20	-22
12	46	22
-16	40	16
-14	18	32
6	8	28
16	46	36
32	42	22
-20	38	-8
-56	6	18
48	2	14
54	8	26
-36	-4	12
40	6	-10
38	22	8
-30	16	12
-4	18	30
2	4	32
-36	40	28
42	44	18
62	-30	22
-60	-36	-28
46	-58	-10
-44	-70	-8
0	-14	8
8	-22	-14
-16	-8	-8
-28	-70	-26
26	-66	-28
12	-4	-8
-54	6	26
50	12	28
38	30	8
4	34	-10
-2	38	12
-4	26	24
0	56	0
-56	-24	34
60	-20	34
44	-76	0
-52	-68	-6
-2	-14	4
8	16	-4
-8	16	-4
8	-24	-20
6	-6	-6
-8	-8	-12
-12	-18	-12
16	-18	-12
-26	-62	-34
46	-54	-34
20	-70	-26
12	34	-6
-16	38	18
-16	18	28
4	-40	16
12	44	38
32	34	24
10	52	14
-22	42	-8
-16	-82	-38
-38	-64	-36

// Barros-Loscertales A, 2010: Erotic > Neutral
// Barros-Loscertales A, 2010: Aversive > Neutral
// Barros-Loscertales A, 2010: Erotic > Neutral, Positive Correlations with 
// Sensitivity to Reward
// Barros-Loscertales A, 2010: Erotic > Neutral, Negative Correlations with 
// Sensitivity to Reward
// Barros-Loscertales A, 2010: Aversive > Neutral, Positive Correlations with 
// Sensitivity to Reward
// Barros-Loscertales A, 2010: Aversive > Neutral, Negative Correlations with 
// Sensitivity to Reward
// Subjects=45
4	10	-6
-2	48	0
2	12	-8
4	-22	4
-2	-16	2
-26	-2	-16
2	50	36
-2	54	30
48	18	24
-42	26	2
-38	-4	56
0	10	62
-32	20	-18
-12	-62	-10
0	-56	46
46	-70	0
-46	-72	8
40	-60	-22
-36	-76	-22
8	-60	4
-28	2	-18
28	-8	-14
30	-8	-16
-24	-18	-12
-2	-14	0
18	-10	18
42	16	24
-34	-4	50
-2	64	24
-2	64	24
18	-10	52
-30	28	6
4	8	64
-30	-56	54
-2	-88	4
2	-86	2
-38	-58	-22
36	-52	-24
-50	12	14
0	42	20
24	-68	22
-20	8	42
36	-14	2
50	12	38
52	30	26
-12	-88	14
40	-58	42

// Bianchi-Demicheli F, 2011: Healthy Controls
// Subjects=15
-27	3	-30
-3	-15	36
48	9	15
-45	3	27
-39	30	6
-12	51	6
33	0	42
45	-60	-6
-33	-66	-15
36	-69	-12
33	-60	60
-48	-72	-9
24	-54	36
12	12	27
12	-3	42
-24	3	-27
-57	-45	42
54	15	45
-18	105	6
18	-105	-3

// Bianchi-Demicheli F, 2011: Heterosexual females with Hypoactive Sexual 
// Desire Disorder (HSDD)
// Subjects=13
27	-66	-12
36	-48	57
-54	-27	36
45	-33	36
39	-42	51
48	6	27
-48	6	27
-39	27	6
-24	27	-18
42	30	-3
39	-84	6
-42	-72	-3
-36	-96	9
24	-54	36
12	12	27
12	-3	42
-24	3	-27
-57	-45	42
54	15	45
-18	105	6
18	-105	-3

// Borg C, 2014: Women with Vaginismus
// Subjects=20
-50	-62	-10
50	-56	-12
-60	-30	34
58	-26	36
24	-66	44
-46	2	28
50	6	26
-24	-6	46
32	-4	50
42	-4	-4
-6	0	-8
-18	-30	2
22	-30	0
2	-16	-12
-4	-24	-14
-44	-64	-12
50	-56	-12
-34	-86	-6
40	-78	2
-60	-32	36
-38	-46	46
34	-42	46
-28	-60	54
50	6	26
-44	-64	-10
50	-56	-12
-32	-88	-6
42	-80	4
56	-24	32
-26	-70	28
-24	-64	54
-40	-36	34
44	8	32
-50	4	30
-46	-54	-16
40	-48	-16
36	-86	-6
-20	-70	38
-50	4	30
46	2	28

// Borg C, 2014: Healthy Controls
// Subjects=21
-50	-62	-10
50	-56	-12
-60	-30	34
58	-26	36
24	-66	44
-46	2	28
50	6	26
-24	-6	46
32	-4	50
42	-4	-4
-6	0	-8
-18	-30	2
22	-30	0
2	-16	-12
-4	-24	-14
-52	-60	-10
48	-58	-12
38	-86	-6
0	-52	54
-60	-26	34
-22	-66	48
28	-78	26
-46	2	28
50	4	24
-28	-8	46
-4	-4	2
-16	-26	6
20	-24	4
-8	-22	-12
10	-20	-14
44	-64	-28
-52	-60	-10
50	-60	-12
-32	-88	-4
42	-88	-4
-60	-26	32
-20	-68	48
-44	-38	40
48	-36	38
40	-2	30
-48	2	30
-4	-10	4
-4	0	-2
-16	-26	6
20	-24	4
-8	-22	-12
4	-30	-24
12	-20	-14
-32	-48	-18
34	-50	-16
-44	4	22
-36	2	26
-16	-4	-12
22	-6	-16
8	-8	18
10	-8	20

// Borg C, 2014: Women with Dyspareunia
// Subjects=21
-50	-62	-10
50	-56	-12
-60	-30	34
58	-26	36
24	-66	44
-46	2	28
50	6	26
-24	-6	46
32	-4	50
42	-4	-4
-6	0	-8
-18	-30	2
22	-30	0
2	-16	-12
-4	-24	-14
-46	-64	-10
42	-64	-14
-34	-88	-4
40	-82	12
-58	-30	36
58	-24	36
-38	-38	38
34	-38	40
-28	-68	24
22	-64	46
54	6	28
-8	2	-6
-46	-66	-10
44	-66	-12
-34	-88	-4
42	-80	10
-62	-26	30
56	-26	40
-28	-68	24
20	-66	56
-38	-38	38
10	0	-6
-42	-46	-18
38	-62	-22
34	-90	0
-62	-26	28
-8	2	-6

// Borg C, 2014: Neutral Bodies > Neutral Objects
// Borg C, 2014: Sexual Penetration > Neutral Objects
// Borg C, 2014: Sexual Penetration > Core Disgust
// Borg C, 2014: Sexual Penetration > Core Disgust
// Borg C, 2014: Sexual Penetration > Neutral Bodies / Core Disgust > Neutral 
// Bodies, Conjunction
// Borg C, 2014: Sexual Penetration > Neutral Objects, Positive Correlations 
// with Subjective Disgust
// Borg C, 2014: Sexual Penetration > Neutral Objects, Positive Correlations 
// with Subjective Pleasure
// Borg C, 2014: Sexual Penetration > Neutral Objects, Positive Correlations 
// with Negative Associations
// Subjects=20
48	-74	0
44	-42	-10
48	-72	-2
44	8	28
10	-26	-14
24	-42	-42
4	8	28
16	-2	-10
36	-2	50
-18	-44	-42
-26	-2	50
-48	8	30
-24	8	-16
-8	-4	-10
50	-60	-6
50	-26	44
-48	-72	-4
-32	-50	56
-52	-28	40
-42	-16	54
46	-74	-2
28	-52	48
22	-28	2
20	-4	-12
-40	-74	-10
-8	-28	-2
26	-76	10
50	-68	-14
22	-16	-24
58	4	-12
-36	-70	48
-28	32	46
-46	-50	-14
28	-74	8
30	-52	34
-46	-50	-14
28	-76	42
8	-24	-16
28	-6	-20
-6	4	-6

// Cera N, 2012: Erotic > Dance: Controls > Patients
// Cera N, 2012: Erotic > Dance: Patients > Controls
// Subjects=17
41.69	10.21	-.94
3.48	11.67	35.06
38.44	-23.16	-19.3
3.07	54.57	-1.99
-13.92	21.51	-1.25
3.66	-37.06	38.03
-29.24	-53.52	62.09

// Basile B, 2011: Emotional faces > Neutral faces
// Basile B, 2011: Guilt > Anger and Sadness (sentences)
// Subjects=22
-48	32	0
-58	18	26
-48	18	-14
46	24	-14
36	28	-4
46	14	0
12	28	60
0	50	-2
-12	40	12
-4	-52	40

// Morey R A, 2012: Positive correlation between guilt and guilt ratings, 
// regardless of social consequence
// Morey R A, 2012: Negative correlation between guilt and guilt ratings, 
// regardless of social consequence
// Morey R A, 2012: Other > Self
// Morey R A, 2012: Interaction: Guilt x Social consequence
// Subjects=16
-50	46	-2
0	50	38
-2	48	26
-48	-38	34
-6	68	16
-46	38	-12
30	22	44
12	-12	44
6	-44	50
36	-34	52
8	-48	50
36	-34	52
-20	-68	24
50	20	18
40	-22	20
-46	38	-12
42	-62	8
24	-70	48
26	-6	36
-20	-68	24
26	-72	8
44	-62	24
6	-44	50
8	-48	50
24	14	50
-50	46	-2
-22	60	14
-44	36	-12
-54	-36	40

// Morita T, 2014: Self > Other
// Morita T, 2014: Partner > Other
// Subjects=32
34	-88	-8
46	-60	-16
24	-62	54
50	10	34
40	2	6
48	42	10
8	-32	-4
6	-22	4
-36	20	-6
-42	32	12
-36	-90	-10
-44	-62	-14
-48	-72	-16
6	-4	30
6	14	58
-22	-68	52
-20	-70	42
-8	-66	34
-48	-58	26
16	-62	32
-2	40	4
8	58	4
-6	56	20
44	20	24
34	4	42
-42	14	36
-34	8	46
38	-88	-14
44	-58	-12
28	-92	0

// Costumero V, 2013: Erotic > Neutral
// Subjects=45
42	-46	-17
54	-64	7
30	-52	55
36	-79	22
-21	-67	49
-33	-49	52
9	-79	16
-6	-49	19
54	32	7
45	2	52
36	32	-17
-3	56	1
-24	14	-20
-30	29	-20
-18	-4	-14
-36	20	-26
3	8	-8
-42	14	25
-42	-1	55
-42	-37	-20
12	-28	-5
0	14	55
63	-19	37

// Graf H, 2013: Erotic Expectancy > Neutral Expectancy, Placebo > Paroxetine
// Graf H, 2013: Erotic Expectancy > Neutral Expectancy, Placebo > Bupropion
// Graf H, 2013: Erotic Expectancy > Neutral Expectancy, Bupropion > 
// Paroxetine
// Graf H, 2013: Erotic Expectancy > Neutral Expectancy, Paroxetine > 
// Bupropion
// Graf H, 2013: Erotic Expectancy > Neutral Expectancy, Placebo
// Graf H, 2013: Erotic > Neutral, Placebo
// Subjects=18
-4	40	-6
-12	26	24
8	24	24
-10	-50	22
6	-26	-26
-8	-10	2
58	2	14
-24	46	38
28	24	38
40	50	14
-28	18	10
38	10	-6
36	-14	12
46	-28	26
-50	-36	16
56	-16	0
-50	-16	-2
14	-36	28
-12	26	24
8	26	26
-6	-46	20
4	-26	-26
-12	-12	6
-18	8	46
-24	46	38
32	26	38
36	48	10
38	14	-8
48	-24	26
-44	-38	26
-24	-40	-26
14	-46	-16
60	2	16
38	-12	12
54	-16	0
-22	6	44
34	26	36
28	52	12
44	-36	36
-22	-40	-24
16	-46	-16
-4	36	0
10	36	-2
-10	26	22
8	24	24
-8	12	36
8	16	28
-10	-26	36
16	-20	36
-10	-50	22
4	-44	14
-4	-30	-24
6	-30	-24
-16	0	4
14	6	-2
-10	-14	4
8	-16	0
-6	0	-8
6	0	-6
-24	-28	-8
-44	28	36
26	22	36
-26	50	10
38	50	10
-32	36	16
34	46	22
-30	18	4
30	18	2
-34	-2	6
38	-6	2
-32	-12	2
34	-10	8
-50	-14	0
50	-20	4
-54	-56	6
46	-56	6
-52	-36	18
48	-26	26
12	-56	8
-22	-66	-18
14	-70	-32
0	38	6
4	28	18
12	2	24
-4	-8	28
0	-36	24
0	-12	-14
-10	8	-6
10	12	-4
14	0	4
-16	-4	-10
14	-4	-8
2	-6	4
12	2	24
0	-8	-12
30	-28	-6
-24	28	-16
34	22	-4
-18	28	-2
22	30	-12
-28	6	30
48	8	28
-42	-2	32
42	2	34
-36	14	-10
32	14	-12
-34	-38	34
32	-40	36
-44	-44	-14
42	-48	-16
30	-36	2
-34	-34	-2
-22	-72	-30
16	-76	-22

// Habermeyer B, 2013: Females > Males, All Participants
// Habermeyer B, 2013: Boys and Girls > Men and Women, All Participants
// Habermeyer B, 2013: Girls > Women, Heterosexual Pedophilic Men > 
// Heterosexual Healthy Men
// Subjects=8
55.67	-34.89	-7.36
49.13	-17.55	-16.54
45.34	-40.07	36.69
45.11	-81.99	-9.98
35.68	-87.82	11.81
11	-98.86	-4.83
6.92	86.49	-43.74
-33.95	-95.49	-12.4
-20.12	-91.61	-18.46
-25.56	-91.61	-31.78
12.84	63.91	21.65
31.89	58.8	-4.9

// Habermeyer B, 2013: No-Go > Go, All Participants
// Habermeyer B, 2013: Interaction: Task x Group
// Habermeyer B, 2013: Go > No-Go, All Participants
// Subjects=7
58.07	-39.79	25.37
42.25	-47.6	49.62
35.27	22.23	3.7
38.65	43.86	35.3
26.08	-3.03	49.42
-9.58	-40.36	-17.3
-38.4	12.53	8.7
-25.08	-51.44	47.37
-22.21	-31.78	12.24
-41.46	27.26	34.27
-38.28	-38.99	2.99
-47.57	-65.29	35.41
-5.97	-32.8	38.9
-41.02	-60.54	55.01
-47.57	-65.29	35.41
-54.06	-46.29	33.89
-.17	36.6	-13.83
-5.91	-55.26	37.44
-47.57	-65.29	35.41

// Hamann S, 2014: Women
// Subjects=13
27	-1	-11
-21	-58	-8
45	-19	-14
9	-82	-2
-30	11	31
15	-97	10
51	44	19
-21	-1	-20
21	2	-20
-9	-64	31
60	-34	-5
-54	-34	40
-39	-64	7
-60	17	16
-27	2	67
27	-7	46
3	35	52
45	-58	16
18	29	61
-24	47	25
39	-52	52
57	23	4
21	2	-20
24	-25	49
24	44	4
-6	-13	10
15	11	16
18	38	-17
54	23	-5
-45	5	-6
-24	-25	49
-12	2	70
-27	41	16
24	14	52
24	-34	52
-54	-34	40
9	-73	49
-18	-40	43
-30	35	28

// Hamann S, 2014: Men
// Subjects=13
27	-1	-11
-21	-58	-8
45	-19	-14
9	-82	-2
-30	11	31
15	-97	10
51	44	19
-30	-1	-14
24	-1	-11
42	2	19
24	-1	-8
-24	-49	-11
-39	2	-29
-60	-4	-14
12	56	-5
-12	-73	-8
-51	-34	-11
-42	53	-14
15	26	49
-15	38	37
21	47	-17
51	-34	-11
42	53	-14
24	-25	49
24	44	4
-6	-13	10
15	11	16
18	38	-17
54	23	-5
-45	5	-6
-24	-25	49
-12	59	19
36	32	-17
-42	56	-11
-57	-37	-14
33	-70	1
-33	-73	-29
3	56	-11
-33	-73	40
-42	-13	40
54	23	34
-45	-13	16
-42	29	16
-12	88	-2
-6	-49	34
12	59	19

// Hamann S, 2014: Women with Complete Androgen Insensitivity Syndrome (CAIS)
// Subjects=13
-30	-1	-14
24	-1	-11
42	2	19
24	-1	-8
-24	-49	-11
-39	2	-29
-60	-4	-14
12	56	-5
-12	-73	-8
-18	5	-20
-33	29	-20
51	44	-17
-18	5	-20
12	-76	1
30	38	28
-12	59	19
36	32	-17
-42	56	-11
-57	-37	-14
33	-70	1
-33	-73	-29
3	56	-11
-33	-73	40
-42	-13	40
54	23	34
-45	-13	16
-42	29	16
-12	88	-2
-6	-49	34
12	59	19
-12	2	70
-27	41	16
24	14	52
24	-34	52
-54	-34	40
9	-73	49
-18	-40	43
-30	35	28

// Hu S H, 2011: Lesbian-Erotic > Neutral, Homosexual > Heterosexual Men
// Hu S H, 2011: Lesbian-Erotic > Neutral, Heterosexual > Homosexual Men
// Hu S H, 2011: Hetero-Erotic > Neutral, Homosexual > Heterosexual Men
// Hu S H, 2011: Hetero-Erotic > Neutral, Heterosexual > Homosexual Men
// Hu S H, 2011: Gay-Erotic > Neutral, Homosexual > Heterosexual Men
// Hu S H, 2011: Gay-Erotic > Neutral, Heterosexual > Homosexual Men
// Subjects=14
9	3	-15
-30	-60	-21
12	48	0
9	-42	9
12	-51	6
0	-21	-30
-30	-78	-6
12	-48	-6
21	-54	2
6	3	-15
0	-54	-42
33	-3	42
42	0	39
15	-21	45
39	-57	27
33	-63	33
51	-6	-18
-45	-45	-9
24	-87	-9
-12	42	0
-18	51	6
18	-51	-36
-12	0	27
15	-72	-39
3	-45	15
3	-48	69
3	-99	3
-42	-54	-39
-39	-51	-30
-24	33	-21
-33	-72	-12
-18	36	12
9	36	15
15	48	15
36	-54	-12
-6	-69	33

// Mason L, 2014: Anticipation of reward: High probabiltiy > Low probabiltiy, 
// All groups
// Mason L, 2014: Anticipation of reward: Large > Small, All participants
// Mason L, 2014: Gain > Loss, All participants
// Mason L, 2014: Probability of reward: High > Low, All participants
// Mason L, 2014: Large > Small reward, All participants
// Subjects=20
30	-66	38
46	10	32
46	40	20
32	10	60
44	12	32
44	26	0
-34	22	-2
4	32	48
-50	16	28
-10	12	-10
10	14	-8
-8	44	-2
-40	46	0
44	42	-2
52	12	20
-24	32	42
-16	32	52
62	-50	16
-40	22	-6
-4	-40	10
44	26	0
46	14	34
-34	20	-2
32	-62	44
-48	14	28

// Chen Z, 2013: (Semantically Incongruent (SI) - Congruent (CO)) late stage - 
// (SI-CO) early stage
// Chen Z, 2013: (Response Incongruent (RI) - SI) late stage - (RI-SI) early 
// stage
// Subjects=25
-8.06	21.4	48.34
-60.12	16.47	32.91
-47.72	18.85	-11.24
30.09	25.82	-9.89
-34.32	-36.98	10.86
4.46	-86.89	-8.39
-33.51	-47.33	72.38
-1.51	-96.24	29.62
33.47	-22.35	-8.55
-2.07	-51.19	-5.09
-34.68	-65.93	-23.24
33.27	-59.94	-31.72
-40.89	-37.63	4.32
-27.1	-51.12	65.93
27.43	-48.59	21.05
-37.92	-65.95	-23.19

// Poser B, 2011: Detected clusters of activation in the Vascular Space 
// Occupancy (VASO) data, Fixed Effect Analysis
// Poser B, 2011: Detected clusters of activation in the BOLD data, Fixed 
// Effect Analysis
// Poser B, 2011: Detected clusters of activation in the VASO data, Random 
// Effect Analysis
// Poser B, 2011: Detected clusters of activation in the BOLD data, Random 
// Effect Analysis
// Subjects=12
-28	-70	48
32	-66	54
-32	-14	58
38	-6	52
-32	20	6
34	24	2
-24	-98	2
30	-94	4
-34	-92	-5
24	-78	-12
-5	5	50
-12	54	32
14	48	38
-10	56	-14
10	50	-12
-50	-60	28
-10	-48	34
48	-24	54
-28	-66	52
32	-58	52
-36	-10	62
36	-8	52
-30	26	4
34	25	3
-22	-98	6
22	-84	-10
-42	-80	-10
36	-86	-2
-4	4	54
-12	42	40
22	36	40
18	64	6
-42	-84	32
48	-78	32
-20	-62	14
46	-24	58
-22	-72	52
24	-60	48
-34	-10	46
32	-8	45
-18	-96	-8
16	-92	-10
-48	-74	-14
28	-62	-20
-4	4	48
-12	8	28
18	42	40
-10	58	-10
1	-54	-10
-46	-74	38
-8	-56	34
44	-22	52
-32	-60	52
32	-60	46
-44	0	36
44	0	42
-28	22	6
40	12	6
-16	-92	-14
14	-90	-10
-32	-52	-18
38	-46	-20
-4	6	50
-14	36	54
-18	64	4
-44	-78	26
44	-80	34
-6	-62	16
52	-22	60

// Silton R L, 2010: Incongruent > Congruent
// Subjects=89
-31	19	-8
36	21	-6
-53	-56	-15
-8	-79	2
0	-16	7
11	11	7
-23	-2	9
41	35	13
-40	11	34
7	21	27
-35	-57	44
-5	-63	45
0	14	51
39	-50	48

// Caseras X, 2013: Healthy Controls
// Subjects=20
-52	-20	8
-44	28	4
-44	-14	12
-32	24	8
-44	34	-4

// Caseras X, 2013: Bipolar I
// Subjects=17
-30	28	-20
-44	-14	12
-36	-12	-10
-30	38	-16

// Caseras X, 2013: Bipolar II
// Subjects=15
-52	-20	8
-44	28	4
-44	-14	12
-32	24	8
-44	34	-4
-30	28	-20
-44	-14	12
-36	-12	-10
-30	38	-16

// Hooker C I, 2014: Low Social Anhedonia
// Subjects=15
24	-97	10
45	-70	4
36	-70	-5
45	-37	22
-21	-100	10
-15	-91	28
-30	-91	7
-33	-73	-11
-48	-73	10
-54	-64	13
-54	-43	25
-54	-46	7
33	8	10
21	-10	-11
-21	-7	-11
-24	-28	-8
-24	2	-17
3	29	4
-57	-7	-11
51	-1	52
18	-31	1
9	-25	4
27	-28	-5
-9	56	13
-9	-19	43
45	-13	-5
-54	11	-20
21	-97	16
15	-79	-14
30	-70	-8
-18	35	49
-18	-97	-2
-24	-97	10
-12	47	-2
-24	53	-5
-9	41	10
-9	14	-8
15	44	4
3	47	4
12	53	1
3	56	1
48	-67	4
48	-55	1
57	-37	19
45	-40	10
-39	-82	-5
-51	-73	7
-48	-58	7
-57	-46	10
9	-28	-2
-9	-34	4
54	-1	49
-18	-97	13
24	-4	-11
-21	-10	-14
-27	2	-20
48	-22	-2
-15	-79	-11
-39	-46	-14
30	-88	22
45	-4	10
-45	-10	1
-21	50	-2
-33	41	13
39	14	-8
-48	-1	-2
27	47	22
48	-7	4
-3	-7	37
-6	38	7

// Hooker C I, 2014: High Anhedonia
// Subjects=15
30	-91	10
48	-67	4
45	-79	4
54	-37	10
48	-28	1
54	-19	-5
-24	-94	-2
-36	-73	1
-33	-85	-8
-60	-46	19
-51	-46	10
9	-28	-2
-39	17	-29
-39	20	-20
-21	-7	-14
-27	-1	-17
-30	8	-20
-57	2	-20
-48	-13	-11
-51	11	-20
-33	-49	-20
-36	-55	-14
0	-55	31
-3	47	-14
3	47	-14
-9	-28	-2
45	-46	7
51	-67	4
57	-37	13
-36	-73	1
-54	-64	13
-60	-55	16
-51	-46	10
39	-49	-14
-18	-7	-11
-21	-94	10
-51	-19	-8
57	32	4
21	-91	13
-60	-7	-17
3	-58	25
63	-7	28
42	-16	49
45	-4	10
-45	-10	1
-21	50	-2
-33	41	13
39	14	-8
-48	-1	-2
27	47	22
48	-7	4
-3	-7	37
-6	38	7

// Wolf D H, 2014: Healthy Controls
// Subjects=37
16	6	-12
-16	4	-16
0	-60	18
0	-36	34
-16	-24	70
34	-20	58
0	42	-12
4	42	14
38	48	-8
-20	48	-16
20	30	44
-24	28	56
-18	-102	8
30	-96	-2
52	-20	12
-48	-60	52
-58	-16	2
-62	-30	-24
50	-74	32

// Wolf D H, 2014: Schizophrenia
// Subjects=41
16	6	-12
-16	4	-16
0	-60	18
0	-36	34
-16	-24	70
34	-20	58
0	42	-12
4	42	14
38	48	-8
-20	48	-16
20	30	44
-24	28	56
-18	-102	8
30	-96	-2
52	-20	12
-48	-60	52
-58	-16	2
-62	-30	-24
50	-74	32
-44	-66	16
-8	4	-6
8	4	-8
-40	-70	22
-52	8	32
44	22	24
-38	32	36

// Goswami R, 2012: Increased brain activation in response to somatosensory 
// stimulation
// Goswami R, 2012: Decreased brain activation in response to somatosensory 
// stimulation
// Goswami R, 2012: Increased brain activation during Lower-body Negative 
// Pressure (LBNP)
// Goswami R, 2012: Decreased brain activation during Lower-body Negative 
// Pressure (LBNP)
// Goswami R, 2012: Increased activation during Lower-body Negative Pressure 
// with Somatosensory Stimulation (LBNPSS)
// Goswami R, 2012: Decreased activation during Lower-body Negative Pressure 
// with Somatosensory Stimulation (LBNPSS)
// Goswami R, 2012: Increased activation during Apnea
// Goswami R, 2012: Decreased activation during Apnea
// Goswami R, 2012: Increased activation during Apnea with Somatosensory 
// Stimulation (ApneaSS)
// Goswami R, 2012: Decreased activation during Apnea with Somatosensory 
// Stimulation (ApneaSS)
// Subjects=15
-38	-20	18
-38	0	14
-4	48	-12
-12	-46	22
-8	10	62
-44	-34	46
38	-30	42
-28	-6	54
30	-8	50
-54	-20	0
54	-20	-4
8	-44	-46
12	-20	-20
32	12	14
16	40	20
28	-2	-26
-32	50	-36
44	-58	-36
0	-36	-34
-4	22	-14
8	34	-10
-2	-46	18
2	-44	18
-10	-18	0
30	-4	-22
-36	-54	-40
42	-56	-38
8	-10	-22
-30	-30	54
-40	-28	66
-4	22	-14
8	32	-10
-2	-46	18
2	-44	18
-10	-20	6
12	-20	6
34	-26	16
-38	16	-4
40	20	-6
-4	30	34
4	32	32
-20	-52	-28
-22	-78	-50
-10	-16	6
12	-16	6
-26	-10	4
28	-8	4
-2	22	56
4	22	54
-44	4	50
58	8	40
58	-24	46
42	-8	14
34	-38	-28
44	-60	-26
-22	-16	-14
28	-18	-14
-54	-2	-4
64	-2	-8
-36	-94	-2
34	-90	-4
38	20	-10
6	30	30
-16	-52	-32
-10	-16	6
10	-16	8
-28	-10	2
28	-8	4
-4	14	54
6	12	50
-42	2	50
46	2	46
58	-24	44
42	-8	14
38	-68	-26
48	-60	-32
-22	-16	-14
28	-18	-14
-52	-2	-4
-48	-72	8
42	-82	2
34	-90	-8

// Donnay G F, 2014: ScaleImprov > Control
// Donnay G F, 2014: JazzImprov > Control
// Donnay G F, 2014: Rest > ScaleImprov
// Donnay G F, 2014: Rest > JazzImprov
// Subjects=11
-44	29	8
-60	8	14
-56	-6	-2
-6	18	48
-56	-62	-10
-54	-42	2
-42	-36	40
-24	-70	48
-2	22	40
-26	-72	24
52	22	2
56	16	0
66	-46	20
6	22	58
58	-58	-10
58	-38	2
58	-36	50
20	-72	50
12	60	32
44	-72	-16
-54	34	12
-60	12	24
-56	-46	12
0	16	54
-46	-24	-2
-48	-42	58
-12	-80	50
-50	-38	28
50	24	0
50	14	4
64	-24	2
8	24	54
52	-52	-24
42	-52	18
58	-36	54
62	-26	46
42	-74	22
-46	28	36
-18	6	52
-22	-18	74
-48	-52	26
-8	-56	18
24	48	6
18	46	36
44	-10	56
50	-52	34
18	-64	26
-38	20	52
-18	58	20
-22	-18	64
-44	-60	26
-14	-54	68
40	38	32
26	-8	68
54	6	18
62	-58	26
6	-58	46

// Liu S, 2012: Improvised > Conventional
// Liu S, 2012: Conventional > Improvised
// Subjects=12
-6	57	18
-9	57	33
-15	48	42
-6	15	66
-8	18	47
-39	0	54
-48	30	3
-54	15	18
-48	-45	3
-45	-39	6
-45	-57	-24
-12	-3	21
-18	0	3
-6	-66	-3
-33	-90	0
15	-75	0
33	-84	3
27	-75	-33
39	48	9
34	29	37
35	-65	42
33	-66	48
3	-69	42
6	-39	24
36	-57	42
51	-42	42
-32	-65	40
-15	-75	45
-6	-69	39
0	-33	27
-36	-48	39

// Villarreal M, 2013: Subgroup of Healthy Musicians, Less Creative Group 
// (LCG)
// Subjects=6
-2	-4	78
-28	4	50
-50	32	30
38	0	20

// Villarreal M, 2013: Subgroup of Healthy Musicians, Higher Creative Group 
// (HCG)
// Subjects=6
-81	16	50
-50	32	30
50	26	8
52	19	0
-50	32	30
38	0	20

// de Manzano O, 2012: Improvise/Random - Notes
// de Manzano O, 2012: Random - Improvise
// Subjects=18
10	26	34
-42	26	26
54	14	10
-44	14	-2
48	16	-2
-2	8	58
-42	-66	-36
28	-68	-32
-16	52	34
-36	42	14
-34	26	46
24	22	56
36	-6	52
-34	12	14
-14	-28	38
-10	-24	68
-38	8	42
-62	2	24
-28	-12	66
-38	-14	50
2	-26	64
-20	-36	68
-40	-40	60
54	-46	36
-48	-54	30
4	-66	36
-60	-26	16
-28	-52	56
-44	-52	-20
32	-54	-18
-18	-66	-4
-14	-72	0
22	-62	-10
2	-78	6
-26	-32	-14
-28	-52	-20
-10	-60	-42
-14	-62	-56
-10	-80	-30
16	-64	-56
12	-70	-28

// Scheef L, 2012: preWalk: Pain > Heat (Activations)
// Scheef L, 2012: preWalk: Pain > Heat (Deactivations)
// Scheef L, 2012: postWalk: Pain > Heat (Activations)
// Scheef L, 2012: preRun: Pain > Heat
// Scheef L, 2012: postRun: Pain > Heat
// Scheef L, 2012: (preRun-postRun) > (preWalk-postWalk)
// Subjects=20
20.71	-11.05	9.6
53.5	8.34	42.98
-64.52	-18.07	19.59
-64.44	-26.27	23.76
60.9	-21.26	24.49
67.28	-15.48	17.09
60.38	14.22	-9.26
37.88	6.78	4.18
62.67	6.45	-.69
-56.2	5.82	-.84
-42.21	9.81	-4.84
42.33	-15.23	9.65
35.76	-15.88	3.1
10.13	17.99	33.8
11.87	-20.19	-7.27
-9.78	-16.22	-9.54
-27.06	-65.49	-18.94
-23.01	-72.98	-41.8
-7.81	-74.53	-36.3
-11.95	-48.01	-16.44
-1.14	-52.33	-17.32
1.02	-65.39	-19.42
26.95	-65.3	-19.87
31.21	-60.28	-23.81
37.61	-54.29	-28.99
10.13	17.99	33.8
12.61	12.73	57.81
8.17	21.67	50.28
-4.82	-38.74	36.31
67.28	-15.48	17.09
56.52	-19.57	19.92
40.03	8.91	3.94
62.68	4.32	-.48
55.06	8.24	-4.1
-40.06	11.95	-5.09
-56.13	4.11	3.81
-60.59	5.29	-6.32
9.83	-15.97	3.55
11.8	-16.35	-12.13
-11.68	-17.55	10.8
33.63	-20.04	4.67
18.57	-10.85	11.86
7.91	18.63	29.29
5.89	12.01	38.95
-5.07	18.48	28.41
5.24	-27.84	-19.85
-29.26	-63.58	-21.33
1.19	-76.16	-8.28
-9.67	-71.19	-11.94
-18.72	-68.81	-43.4
39.8	-85.85	-33.75
9.38	-43.42	-37.43
-9.78	-16.22	-9.54
6.18	6.54	60.78
32.12	-13.03	56.67
27.94	-32.74	64.29
-64.48	-19.99	22.02
-55.96	-13.24	13.37
63.07	-23.38	24.67
53.24	-17.66	17.55
44.52	-15.02	11.83
40.03	8.91	3.94
60.4	14.33	-8.15
60.54	6.65	1.57
25.05	-17.42	10.16
18.57	-10.85	11.86
-20.51	-6.92	-1.31
-11.83	-8.81	0.97
11.87	-20.19	-7.27
8.11	12.43	43.35
7.97	19.05	33.73
35.77	48.74	16.88
-33.42	52.54	15.44
58.79	11.88	34.7
16.81	-16.67	41.6
-27.07	-63.37	-19.15
-31.52	-56.66	-27.58
-29.54	-58	-42.05
-44.29	8.2	0.96
-51.82	1.89	2.83
-9.78	-16.22	-9.54
-3.61	-43.67	-39.42
33.59	-15.99	2.03
-35.64	-20.15	-4.23
60.9	-21.26	24.49
63.31	-33.63	41.37
-.64	16.03	36.42
5.95	12.42	43.39
7.94	18.84	31.51
37.88	6.78	4.18
37.78	21.35	-.62
18.57	-10.85	11.86
25.02	-15.5	7.73
-53.98	1.89	2.87
-46.49	7.88	-2.33
-66.68	-18.08	19.63
14.12	-14.03	1.04
-29.26	-63.58	-21.33
-7.54	-77.98	-15.79
-9.73	-58.53	-14.32
-27.39	-66.82	-44.57
56.23	2.38	2.06
56.12	10.26	-5.44
3.07	-27.95	-20.92
-11.44	-5.9	32.05
0.92	27.94	-8.49
-37.69	10.22	10.73

// Shukla S, 2011: Heat Pain > Baseline (Activation)
// Shukla S, 2011: Heat Pain > Baseline (Deactivation)
// Shukla S, 2011: Minimal Intensity Acupuncture (MI-EA) > Baseline 
// (Activation)
// Shukla S, 2011: MI-EA > Baseline (Deactivation)
// Shukla S, 2011: Optimal Intensity Electroacupuncture (OI-EA) > Baseline 
// (Deactivation)
// Shukla S, 2011: MI-EA, Heat Pain > Baseline (Activation)
// Shukla S, 2011: OI-EA, Heat Pain > Baseline (Activation)
// Shukla S, 2011: OI-EA, Heat Pain > Baseline (Deactivation)
// Subjects=10
51.76	-45.4	35.95
48.19	3.54	8.46
41.96	18.5	37.39
28.92	55.72	24.38
-22.31	-16.43	4.26
6.66	21.2	34.22
-44.74	49.45	32.45
-66.94	-50.31	24.34
2.96	55.65	-15.46
-48.38	12.05	-37.98
-67.38	-2.13	-13.15
-50.87	-82.71	16.84
51.27	12.13	-4.56
49.29	17	17.36
19.23	4.45	-4.66
-32.04	25.26	7.56
32.6	-31.54	51.73
19.83	-38.77	55.83
5.45	-1.12	7.12
-12.35	-45.79	36.72
12.96	62.99	37.34
-5.95	-71.1	25.38
16.57	-56.99	40.67
6.38	74.36	19.73
-3.39	72.76	-0.09
-5.76	-61.38	54.68
-9.52	63.49	31.98
42.42	-65.61	64.51
-9.58	32.17	12.3
-12.56	37.72	43.1
-25.22	19.64	58.14
-0.04	-21.27	-19.01
-57.11	-44.77	53.87
-71.17	-77.29	19.96
-45.13	-13.82	-42.54
-34.24	64.09	14.37
9.73	8.85	11.81
31.03	55.47	21.03
44.69	33.44	-17.42
54.8	-63.56	7.32
-59.38	-59.27	31.7
6.45	-27.06	-11.91
51.24	11.79	-8.99
61.29	-42.94	25.59
61.09	-45	-1
29.14	-100.15	-9.39
-2.69	-78.22	29.29
-19.05	30.31	30.41
-22.14	11.77	38.69
-28.38	-12.88	50.87
-38.04	-36.42	36.23

// Smith J K, 2011: Pain Block > Baseline
// Smith J K, 2011: Pain Ramp ON > Baseline
// Smith J K, 2011: Pain Ramp OFF > Baseline
// Subjects=14
10	-72	42
-8	-14	-6
-34	8	4
62	-44	36
46	14	6
-2	-58	-34
-58	-44	42
-38	-6	-16
-34	46	30
6	-28	26
-4	-22	28
6	14	34
18	-10	8
-12	-10	6
12	-10	-12
54	14	-8
52	34	-6
32	22	6
64	-46	36
-38	42	26
-24	14	-2
-54	10	-10
-58	-22	12
56	6	2
64	-28	18
38	2	-10
12	-4	12
-8	-2	8
-34	-22	2
8	-2	42
-10	-28	-4
28	-40	72
-38	0	-14
38	18	4

// Altenmuller E, 2014: Stimuli>Silence
// Altenmuller E, 2014: Old>New Pieces
// Altenmuller E, 2014: New>Old Pieces
// Altenmuller E, 2014: Recognized>Not Recognized Target Pieces
// Altenmuller E, 2014: Positive Pieces>Less Positive Pieces
// Altenmuller E, 2014: Recognized Positive>Recognized Less Positive Target 
// Pieces
// Subjects=18
1.52	7.99	56.58
42	8.01	39.39
37.42	21.28	4.87
53.6	-17.75	7.96
56.8	-15.62	7.74
-28.86	-54.11	-28.19
-6.27	-10.71	8.05
-1.03	-23.85	-10.98
44.74	63.62	1.24
30	22.89	12.63
-27.83	-57.79	-34.59
0.11	45.06	26.72
1.47	-32.13	33.18
-4.83	-61.77	35.74
32.01	48.02	7.15
-18	-10.52	11.52
-61.82	-37.19	0.88
60.85	-11.3	-19.43
-2.23	-54.81	-39.59
36.25	-62.15	-41.65
-25.32	15.27	42.9
-47.81	8.02	33.73
-2.85	-23.87	30.31
-12.4	-57.22	26.52
8.48	58.63	8.76
-55.26	-41.15	17.86
-18.01	-9.46	11.43
-9.31	-55.14	11.82
-2.03	-5.48	6.45
23.6	-18.7	-1.66
1.27	-53.99	-1.79
55.51	15.07	-8.2
60.94	-9.22	-6.23
22.37	-56.69	-38.6

// Coen S J, 2011: Positive Correlation between brain activity during 
// Anticipation and Neuroticism scores
// Coen S J, 2011: Negative Correlation between brain activity during 
// Anticipation and Neuroticism scores
// Coen S J, 2011: Positive Correlation between brain activity during Pain and 
// Neuroticism scores
// Coen S J, 2011: Negative Correlation between brain activity during Pain and 
// Neuroticism scores
// Subjects=31
24.48	18.86	-11.51
9.72	31.83	19.92
-49.9	-27.75	25.6
12.97	-18.25	5.12
44.83	9.63	-8.74
-35.29	7.21	-5.38
19.17	-2.84	-16.32
-6.4	46.19	14.44
5.63	24.97	41.73
8.48	-68.83	-43
-5.31	-6.27	-3.48
-58.71	-21.65	-4.92
-38.13	-56.03	16.68
47.36	-55.51	15.66
-11.29	-36.98	40.43
53.5	-39.64	-13.62
29.4	-65.54	39.01
7.79	-59.44	9.75
-42.19	-60.43	42.75
-31.85	33.83	35.84
-10.6	-55.26	-17.16
44.06	-24.7	15.34
26.61	-9.74	-23.63
47.48	-14.71	47.92
-47.83	-61.34	3.86
5.33	37.2	7.25
16.22	-25.38	9.03
-46.75	-20.58	21.61
21.5	-33.69	-2.6
-21.32	-26	-9.45
-10.51	-21.31	8.99
-15.47	3.46	68.31
36.36	26.81	7.76
-7.51	40.3	7.14
-31.95	-21.06	0.3

// Farmer A D, 2013: Subgroup of [Healthy Controls], Pain Cluster (PC) 1
// Subjects=12
35.29	-10.52	-6.94
-29.81	-18.85	1.2
-6.34	-14.74	-2.76
8.58	-19.48	-10.34
-13.38	-34.36	46.92
-14	-4.52	-21.37
-10.66	-55.86	-24.91
39.67	-9.38	7.41
-53.23	-21.31	12.83
13.24	-15.43	41.68
-6.09	-7.68	33.45
63.32	-31.98	15.73
59.15	-27.64	31.03
44.18	5.11	42.95
59.1	-23.75	26.24
63.42	-18.9	33.59
8.72	-70.75	-12.73
-53.07	-16.42	34.72
29.83	-13.95	-23.31
-25.61	1.27	-.53
-56.54	10.48	11.32
-48.96	2.84	21.91
41.68	44.19	11.82
32.22	35.9	29.35
18.23	44.65	19.86
35.27	25.49	4.54
17.09	25.3	3.65
55.74	4.27	17.24

// Farmer A D, 2013: Subgroup of [Healthy Controls], Pain Cluster (PC) 2
// Subjects=17
51.79	-29.74	45.79
-18.06	-55.05	-13.74
-33.61	-30.45	57.98
56.99	-19.11	31.45
56.78	-8.13	8.23
61.21	-33.94	18.15
24.46	-0.06	-22.19
5.87	-9.87	59.14
-31.63	-12.27	45.28
12.9	-10.14	-0.02
27.81	-63.29	-28.08
12.87	-14.88	-6.31
-33.18	22.28	-3.32
9.89	9.42	32.95
-30.96	-.97	-1.4
0.17	20.39	24.33
-22.25	-1.49	18.62
39.69	39.12	29
-25.61	1.27	-.53
-56.54	10.48	11.32
-48.96	2.84	21.91
41.68	44.19	11.82
32.22	35.9	29.35
18.23	44.65	19.86
35.27	25.49	4.54
17.09	25.3	3.65
55.74	4.27	17.24

// Foster N E V, 2013: Reversed > Control
// Subjects=12
44	-42	52
-4	20	56

// Groussard M, 2010: Conjuntion Musical Familiarity
// Groussard M, 2010: Musicians > Nonmusicians, p<0.001
// Groussard M, 2010: Musicians > Nonmusicians, p<0.002
// Groussard M, 2010: Musicians > Nonmusicians, p<0.02
// Subjects=20
-46	-26	58
-44	30	4
18	-52	-22
34	32	-10
-52	-18	22
54	-26	-4
-32	-66	44
-12	-14	-14
40	-26	-18
20	90	-8
-10	-52	2
-56	-6	10
42	-32	14
-12	-38	-12
-8	58	-10
8	62	-6
0	-22	56

// Angulo-Perkins A, 2014: Human vocalizations + music > Non-vocal sounds
// Angulo-Perkins A, 2014: Human vocalizations + music > Monkey vocalizations
// Angulo-Perkins A, 2014: Music > Human vocalizations
// Angulo-Perkins A, 2014: Human vocalizations > Music
// Angulo-Perkins A, 2014: Speech > Music
// Angulo-Perkins A, 2014: Music > Non-linguistic
// Angulo-Perkins A, 2014: Violin > Speech
// Angulo-Perkins A, 2014: Speech > Violin
// Angulo-Perkins A, 2014: Music > Human|musicians > Non-musicians
// Subjects=23
-64	-14	-4
62	-15	-4
54	-12	2
-54	4	-14
50	-2	-8
-48	-4	-8
-32	-32	48
-58	-8	12
58	-6	14
-52	20	-2
-8	62	24
-20	-6	-20
22	-2	-18
-64	-14	-4
56	-18	8
-52	22	-8
52	28	14
-4	40	42
-50	-4	46
20	-8	-20
22	-2	-18
-50	-6	-4
50	-4	-4
-32	-32	48
42	-12	-10
-58	-18	-8
58	-8	-10
-52	22	-4
52	30	8
-4	40	42
-50	0	44
-20	-10	-20
22	-6	-18
58	-14	4

// Benson S, 2012: Healthy Controls
// Subjects=30
34	12	8
58	14	6
-30	18	6
64	-22	38
-56	-24	22
-60	-42	38
8	18	36
8	14	48
18	-10	8
44	48	6
-50	42	10

// Benson S, 2012: Subgroup of Healthy Controls, Males
// Subjects=15
-2	22	-8
-32	42	-10
-18	-72	-44
8	18	36
-4	-26	-4
-26	34	24
-38	6	-38
38	-66	-36
12	60	4

// Benson S, 2012: Subgorup of Healthy Controls, Females
// Subjects=15
52	18	6
-66	-28	24
-22	-76	-24
10	18	52
-26	34	24
-38	6	-38
38	-66	-36
12	60	4

// Brattico E, 2011: Sad > Happy
// Brattico E, 2011: Happy > Sad, p < 0.001
// Brattico E, 2011: Happy > Sad, p < 0.05
// Brattico E, 2011: Lyrics > No lyrics, p < 0.001
// Brattico E, 2011: Lyrics > No lyrics, p < 0.05
// Brattico E, 2011: No lyrics > Lyrics, p < 0.001
// Brattico E, 2011: No lyrics > Lyrics, p < 0.05
// Brattico E, 2011: Sad with lyrics > Sad without lyrics, p < 0.001
// Brattico E, 2011: Sad with lyrics > Sad without lyrics, p < 0.05
// Brattico E, 2011: Happy with lyrics > Happy without lyrics, p < 0.001
// Brattico E, 2011: Happy with lyrics > Happy without lyrics, p < 0.05
// Brattico E, 2011: Happy without lyrics > Happy with lyrics
// Brattico E, 2011: Sad lyrics > Happy lyrics
// Subjects=15
-4	-30	0
10	16	-4
2	10	0
-64	-8	8
-66	-30	14
-52	-2	0
-26	-10	-6
-6	-82	20
-32	-58	-12
42	-26	10
-62	-8	-18
28	24	30
16	8	44
54	6	20
6	-46	-48
-4	18	24
-26	0	-22
8	60	20
30	-4	18
24	10	-22
18	-6	-22
-28	18	-14
-28	-14	-6
50	6	-22
-50	8	-18
56	-16	-2
-56	-14	-6
40	10	2
50	8	14
-22	4	64
-34	44	32
0	32	30
-46	16	8
-34	22	-16
-66	-10	6
46	14	-14
36	0	14
30	18	-18
62	-40	32
42	0	6

// Danielson A L, 2014: Transitions > Continuous
// Subjects=19
6	-70	-24
-48	-36	12
62	-36	6
46	8	24

// Gopinath K, 2012: Healthy Controls
// Subjects=14
45.27	31.69	56.32
-53.16	29.9	41.99
41.79	2.53	9.74
25.68	71.9	27.52
11.14	3.65	54.6
22.89	33.3	65.36
6.68	-11.46	24.7
54.55	53.5	20.93
53.26	29.26	-17.17
51.3	-13.93	-11.29
8.48	20.16	-6.97
21.36	-3.28	-8.5
37.67	-32.14	16.04
12.21	-34.81	38.86
5.71	-47.85	22.18
-53.16	29.9	41.99
-36.2	14.29	17.45
-31.93	-6.55	9.12
-9.42	64.6	46.38
-5.98	10.95	54.19
-36.04	11.52	36.64
-.83	-9.65	21.29
-63.94	39.81	33.48
-48.04	21.02	9.22
-32.25	-9.89	-34.09
-37.38	26.29	7.54
-17.11	17.35	0.25
-13.75	10.11	16.43
-26.64	-6.06	1.21
-31.49	56.14	-47.45
-39.26	-32.51	18.07
-22.96	-25.19	56.3
41.86	40.62	34.42
-48.9	41.82	44.29
50.25	7.09	-.78
-42.75	34.8	8
40.67	-10.14	-2.57
-35.11	0.29	15.27
7.69	61.53	46.44
-18.08	60.09	30.13
2.47	23.18	46.37
-2.81	13.97	51.67
25.03	31.2	65.52
-31.71	31.95	52.72
37.57	45.88	34.03
-45.69	40.78	44.34
16.92	0.44	-28.83
-20.57	-1.87	-41.59
29.95	-7.29	-6.03
18.73	-22.65	57.84
-32.61	-25.68	50.87
-2.75	-45.9	34.38
6.43	-18.43	-10.4
35.48	38.64	36.89
-20.01	33.62	45.76
50.23	9.12	-2.06
-67.23	30.22	19.82
37.55	-5.96	10.5
-36.22	-3.49	7.79
24.61	72.95	27.45
-16.78	61.36	60.12
12.14	22.69	53
-3.88	39.23	61.83
19.69	28.97	64.65
-21.99	28.72	65.15
-35.54	13.36	-36.01
-25.79	14.78	-18.39
-16.89	-8.94	18.07
-30.92	3.78	4.89
51.6	-41.57	16.67
-54.28	-35.49	8.45
3.54	-42.66	20.66
10.82	-45.81	-7.04
60.02	20.84	24.72
47.1	17.62	11.76
38.5	-17.1	-9.77
26.74	66.28	23.52
5.78	29.77	62.51
30.31	20.68	52.96
5.65	-11.13	29.14
38.75	47	48.42
51.27	-6.53	-11.92
21.23	8.46	-21.75
25.42	13.18	-30
9.58	22.71	-1.62
18.14	19.59	-1.46
19.32	-19.96	-3.73
21.36	-7.77	-11.47
12.52	48.51	-26.12
5.72	-45.48	25.33
-56.42	24.97	33.52
-54.39	26.07	20.02
-33	-25.3	0.66
-4.1	74.24	46.63
-8.08	14.62	60.6
-18.8	17.56	58.24
-10.4	8.33	34.39
-65.09	43.35	24.27
-41.83	-23.86	-35.04
-29.09	32.48	-23.19
-6.43	26.13	2.74
-18.22	26.77	-1.64
-19.09	-16.24	6.44
-20.23	-14.74	-1.48
-26.07	61.34	-35.68
-2.51	31.19	-42.34
31.3	46.24	53.03
-38.22	32.02	40.52
51.36	22.93	11.26
-39.45	30.3	18.38
40.68	3.15	4.12
-39.43	-5.79	5.79
12.88	69.8	28.96
-16.91	55.58	40.53
3.6	34.79	58.77
-2.64	-5.18	65.54
27.14	29.81	61.15
-26.33	27.92	55.23
6.73	1.11	35.91
-7.25	28.69	35.99
43.95	67.58	38.83
-45.75	51.18	41.23
27.64	0.84	-24.53
-25.78	3.95	-20.83
46.96	-6.99	-17.4
-48.12	-14.96	-15.64
21.15	23.1	-25.21
-26.94	32.67	-21
18.11	24.7	-4.12
-15.85	-15.88	10.83
-22.42	2.26	-1.77
48.74	47.61	-40.96
-20.7	48.43	-38
-4.59	32.92	-33.54
32.33	42.56	46.64
-31.93	34.03	24.67
56.7	31.68	13.81
-60.8	16.17	16.46
45	10.2	12.4
-42.73	42.71	14.03
22.76	54.99	56.86
-21.18	53.44	40.76
8.99	-12.99	45.99
-4.92	32.88	62.37
28.19	29.65	58.92
-41.34	19.66	46.06
7.77	21.64	39.75
-6.21	25.1	30.7
59.98	40.21	27.56
-36.23	63.41	33.41
-25.79	0.52	-23.89
44.72	-9.17	-31.69
-56.69	-7.52	-15.05
-21.54	28.81	-16.27
41.27	47.65	-39.76
-26.19	79.86	-43.92
-3.44	28.32	-24.25

// Gopinath K, 2012: Sydrome 1 (Syn 1)
// Subjects=11
41.86	40.62	34.42
-48.9	41.82	44.29
50.25	7.09	-.78
-42.75	34.8	8
40.67	-10.14	-2.57
-35.11	0.29	15.27
7.69	61.53	46.44
-18.08	60.09	30.13
2.47	23.18	46.37
-2.81	13.97	51.67
25.03	31.2	65.52
-31.71	31.95	52.72
37.57	45.88	34.03
-45.69	40.78	44.34
16.92	0.44	-28.83
-20.57	-1.87	-41.59
29.95	-7.29	-6.03
18.73	-22.65	57.84
-32.61	-25.68	50.87
-2.75	-45.9	34.38
6.43	-18.43	-10.4
31.3	46.24	53.03
-38.22	32.02	40.52
51.36	22.93	11.26
-39.45	30.3	18.38
40.68	3.15	4.12
-39.43	-5.79	5.79
12.88	69.8	28.96
-16.91	55.58	40.53
3.6	34.79	58.77
-2.64	-5.18	65.54
27.14	29.81	61.15
-26.33	27.92	55.23
6.73	1.11	35.91
-7.25	28.69	35.99
43.95	67.58	38.83
-45.75	51.18	41.23
27.64	0.84	-24.53
-25.78	3.95	-20.83
46.96	-6.99	-17.4
-48.12	-14.96	-15.64
21.15	23.1	-25.21
-26.94	32.67	-21
18.11	24.7	-4.12
-15.85	-15.88	10.83
-22.42	2.26	-1.77
48.74	47.61	-40.96
-20.7	48.43	-38
-4.59	32.92	-33.54

// Gopinath K, 2012: Syndrome 2 (Syn 2)
// Subjects=16
35.48	38.64	36.89
-20.01	33.62	45.76
50.23	9.12	-2.06
-67.23	30.22	19.82
37.55	-5.96	10.5
-36.22	-3.49	7.79
24.61	72.95	27.45
-16.78	61.36	60.12
12.14	22.69	53
-3.88	39.23	61.83
19.69	28.97	64.65
-21.99	28.72	65.15
-35.54	13.36	-36.01
-25.79	14.78	-18.39
-16.89	-8.94	18.07
-30.92	3.78	4.89
51.6	-41.57	16.67
-54.28	-35.49	8.45
3.54	-42.66	20.66
10.82	-45.81	-7.04
32.33	42.56	46.64
-31.93	34.03	24.67
56.7	31.68	13.81
-60.8	16.17	16.46
45	10.2	12.4
-42.73	42.71	14.03
22.76	54.99	56.86
-21.18	53.44	40.76
8.99	-12.99	45.99
-4.92	32.88	62.37
28.19	29.65	58.92
-41.34	19.66	46.06
7.77	21.64	39.75
-6.21	25.1	30.7
59.98	40.21	27.56
-36.23	63.41	33.41
-25.79	0.52	-23.89
44.72	-9.17	-31.69
-56.69	-7.52	-15.05
-21.54	28.81	-16.27
41.27	47.65	-39.76
-26.19	79.86	-43.92
-3.44	28.32	-24.25

// Engel A, 2012: VpresAtrain > VpresUntrain
// Engel A, 2012: VpresAtrain > VpresVtrain
// Engel A, 2012: Finger Movements > Eye Movements
// Subjects=22
-45	-1	7
-9	38	22
-21	8	-11
12	47	13
-12	26	49
-33	29	40
36	-4	10
24	-55	-23
-9	59	16
-27	-19	-5
9	20	4
-18	-43	40
21	-25	-11
-30	47	28
-18	2	61
30	-43	-2
-21	56	10
63	-22	40
30	32	-5
-63	-25	31
12	-70	46
18	2	55
6	14	49
12	20	37
-57	5	34
-48	2	19
54	11	19
-18	2	58
45	-37	37
33	-1	55
-3	-25	-2
-36	-31	49
-39	-28	49
-39	-34	34
-24	-49	61
-45	-25	13
-27	-13	61
-60	8	7
-45	2	4
-54	5	4
21	-55	-23
39	-37	43
51	-25	43
57	-16	40
57	14	34
12	-67	46
-30	32	31
48	-67	-17
39	50	22

// Herholz S C, 2012: Listen > Baseline
// Herholz S C, 2012: Imagine > Baseline
// Herholz S C, 2012: Conjuntion of (Listen > Baseline and Imagine > Baseline)
// Herholz S C, 2012: Listen > Imagine
// Herholz S C, 2012: Imagine > Listen
// Herholz S C, 2012: Previously Listened > Baseline
// Herholz S C, 2012: Previously Imagined > Baseline
// Herholz S C, 2012: Conjunction of (Previously Listened > Baseline and 
// Previously Imagined > Baseline)
// Subjects=10
-62	-16	4
46	-16	0
-58	0	44
-6	-78	10
-8	4	58
54	0	48
-46	-64	-18
-56	2	42
-2	10	58
54	-14	-10
-36	-60	58
54	0	48
56	16	-18
-16	-76	-12
-56	2	42
54	-14	-10
-52	8	-12
-8	4	58
54	0	48
52	6	-14
-8	-80	10
-40	-26	4
52	-12	2
2	-62	20
2	12	48
46	14	-4
34	-50	50
-56	-54	30
-32	44	28
-34	-54	-32
-36	16	-2
-6	-92	2
-32	20	-6
-4	32	36
46	20	20
30	20	-10
34	-70	-50
-56	-34	2
-38	-58	44
-6	-96	4
-40	8	28
-8	20	40
32	22	-4
46	20	20
-6	-92	2
-38	10	26
-8	20	40
30	20	-10
46	20	20
32	-66	-52
-38	-56	44
-2	-50	10
8	-60	0

// Kung S, 2013: Find Beat > Silence
// Kung S, 2013: Find Beat > Listen Iso
// Kung S, 2013: Tap Beat > Tap Iso
// Kung S, 2013: Listen Iso > Silence
// Kung S, 2013: Tap Iso > Silence
// Kung S, 2013: (Find Beat > Listen Iso) AND (Tap Beat > Tap Iso)
// Subjects=11
-64	-40	16
-38	-34	14
-48	-20	2
-48	-34	12
-62	-28	8
62	-34	10
62	-26	6
54	-22	6
42	-36	14
-30	22	-2
32	22	0
34	20	8
-14	10	-2
18	14	8
-46	8	20
-54	12	6
50	14	24
50	12	20
-30	-62	-50
-24	-68	-46
30	-64	-50
-28	-64	-26
-32	-58	-28
42	-58	-30
36	-64	-26
-12	-76	-34
-4	4	60
-4	16	44
4	12	52
-30	-50	40
-44	-10	-8
-52	-2	-2
-64	-10	4
-28	22	-2
34	22	-2
50	20	-4
-14	8	0
18	10	0
56	12	4
-2	22	42
4	14	48
12	32	22
54	-22	6
50	-30	8
-32	22	-2
34	22	-2
40	16	-2
54	18	-6
40	26	22
34	20	16
-42	6	26
48	8	22
54	12	6
-54	12	-6
-28	-66	-50
-32	-60	-40
30	-62	-56
-12	-2	12
8	-6	12
-64	-40	16
-52	-40	20
-40	-36	14
62	-34	12
42	-40	12
-28	-62	-50
26	-64	-50
42	-54	-32
-10	-74	-36
10	-78	-78
-40	-36	16
62	-34	12
42	-36	14
-38	-22	52
-46	-16	54
52	-2	52
-4	0	62
-26	-58	-24
24	-62	-52
12	-54	-18
6	-66	-16
-20	-8	-2
16	20	4
-30	22	-2
34	22	-2
50	18	-6

// Park M, 2014: Music >  Baseline
// Park M, 2014: Musicians > Non-musicians (Sadness)
// Park M, 2014: Musicians > Non-musicians (scary)
// Subjects=12
60	-18	10
-50	-24	2
22	4	34
44	-32	46

// Petrini K, 2011: Audio > Baseline
// Petrini K, 2011: Visual > Baseline
// Petrini K, 2011: Audiovisual > Baseline
// Subjects=16
54.56	-4.51	0.14
36.35	23.47	5.81
6.67	-80.82	-5.17
9.04	-99.27	17.54
-10.58	-16.62	0.79
-17.01	6.23	7.87
-25.51	-72.35	-16.67
-29.35	-61.32	43.79
-34.15	19.96	8.03
-31.53	-14.5	57.73
-36.83	-36.1	54.03
-43.81	5.21	-2.89
42.97	-72.14	-6.32
38.51	-43.33	-18.72
36.34	25.5	4.53
20.72	-96.63	9.37
5.54	-83.63	-13.85
-10.57	-13.19	3.85
-22.03	-93.71	9.62
-22.96	-78	33.96
-26.59	-71.39	-17.85
-41.46	-76.08	-8.36
-37.92	-34.08	52.76
-31.53	-14.5	57.73
-29.35	-61.32	43.79
-57.41	6.01	36.23
56.78	-20.19	3.66
18.35	-80.38	-14.27
35.32	-46.52	-18.41
20.71	-95.66	8.18
13.97	-11.27	-1.05
-11.64	-16.54	1.91
-18.8	-99.95	11.22
-24.21	-86.41	7.92
-30.42	-61.33	43.8
-31.54	-12.38	57.55
-41.48	-78.45	-11.51
-37.92	-38.48	50.89
-36.28	-1.89	0.97
-37.9	-26.25	57.67

// Schon D, 2010: Speech > Noise
// Schon D, 2010: Vocalise > Noise
// Schon D, 2010: Song > Noise
// Schon D, 2010: Song > Speech
// Schon D, 2010: Song > Vocalise
// Schon D, 2010: Vocalise > Speech
// Subjects=10
-57.39	-2.67	-11.19
-62.81	-14.86	-15.02
-65.98	-26.41	-12.06
53.76	10.93	-21.15
62.59	-2.89	-8.73
-57.43	-2.98	-14.52
-51.09	9.08	-23.66
-59.42	-8.33	-2.75
57.12	8.58	-12.01
45.05	9.32	-26.45
57.16	-6.41	-11.65
56.48	14.03	23.32
-47.9	-5.12	53.89
-56.11	16.33	8.2
50.53	5.6	-20.57
59.28	8.59	-12.05
53.84	-2.69	-17.56
-41.44	6.37	-30.28
-56.36	0.22	-14.85
-53.76	24.28	24.18
53.22	18.27	22.96
65.8	-20.62	-14.87
65.91	-14.37	-5.41
55.96	11.25	-17.86
15.12	-14.65	-5.63
-62.82	-9.48	-14.9
-53.12	0.23	-14.91
-56.2	-15.01	-5.51
-65.87	-35.46	-5.56
-62.74	-8.86	-8.24
-65.84	-23.14	-0.05
53.88	-17.68	-17.2
62.5	2.97	-14.91
-41.83	14.85	26.03
-47.09	8.22	35.74
-20.78	-11.12	-23.3
-42.47	33.03	-20.58
-44.28	26.9	5.83
20.72	-59.1	0.91
17.6	-53.82	11.64
6.24	-5.06	63.04
-8.89	-2.98	63.1
50.35	-1.89	48.53
-50.09	0.19	53.4
38.61	-5.26	59.15
-41.44	0.22	53.25
-41.84	6.03	23.54
-59.37	11.75	5.35

// Schulze K, 2011: Healthy Musicians
// Subjects=16
46.85	29.22	-17.09
47.41	8.73	48.19

// Schulze K, 2011: Healthy Volunteers
// Subjects=17
-.76	25.1	44.02
-.6	10.27	58.64
-45.77	30.15	30.73
-52.44	17.51	-8.28
-45.89	35.47	16.9
-33.19	27.66	-2.66
-32.65	0.3	56.5
-52.16	10.56	25.76
-51.94	-6.93	47.29
-42.13	-37.82	59.81
-35.85	-35.9	42.85
-26.17	-51.7	44.06
-7.36	-49.35	-9.88
-17.05	-50.18	-19.74
-36.21	-69.33	-17.91
37.91	-8.79	56.45
37.72	2.35	35.45
50.6	-.23	42.21
44.26	-25.9	41.09
24.7	-68.96	-18.64
18.18	-76.63	-34.65
11.7	-37.83	-27.79
-7.27	24.03	30.8
-3.81	10.25	58.68
-42.87	30.26	-9.46
-52.45	40.49	-.17
-48.71	-6.65	50.58
-39.21	-1.28	36.64
-58.52	4.44	29.69
-61.84	6.56	16.17
-48.62	-28.86	52.44
-35.86	-32.72	42.58

// Schulze K, 2011: Healthy Musicians
// Subjects=16
-52.28	9.28	9.14
-29.94	21.59	1.16
-26.17	-12.09	60.81
-26.25	3.51	56.16
-48.86	8.18	35.95
-32.85	4.85	32.7
-55.01	-35.24	53.05
-48.5	-40.78	63.48
-35.73	-47.81	53.88
-29.29	-60.72	51.55
-19.57	-62.81	64.99
-20.16	-6.39	10.08
15.17	17.57	27.74
5.78	10.05	55.24
34.15	21.71	-2.94
31.42	0.17	49.09
9.19	-24.05	68.1
34.86	-23.64	71.12
34.72	-25.19	51.18
27.93	-68.69	-15.36
-16.89	23.98	30.92
-26.76	44.33	5.9
-58.72	8.98	5.89
-29.97	24.5	-2.43
-36.3	15.46	5.09
-45.82	29.63	24.08
-46.05	50.3	2.28
-52.13	17.42	31.87
-26.28	3.26	52.84
-48.76	-7.17	43.93
-48.85	5.01	36.22
-32.87	4.59	29.38
-35.68	-47.3	60.53
-19.59	-63.07	61.67
-26.39	-70.39	8.83
-26.57	-6.43	10.16
-20.1	-71.63	-7.87
-17.04	-40.15	-13.89
-16.98	-56.01	-12.56
-23.5	-47.3	-23.25
2.59	6.86	55.55
28.33	-5.16	62.95
37.92	-11.96	56.72
60.18	2.75	38.5
2.74	-27.78	61.8
21.41	-7.17	-3.71
18.36	0.95	19.06
5.59	-84.17	-7.11
31.18	-74.76	-11.54
47.14	-68.83	-18.91

// Spada D, 2014: Melody as the upper voice minus melody as the lower voice 
// (cMcA_S - cMcA_B)
// Spada D, 2014: Melody as the lower voice minus melody as the upper voice 
// (cMcA_B - cMcA_S)
// Spada D, 2014: Correct melody minus altered melody
// Spada D, 2014: Altered melody minus correct melody
// Spada D, 2014: Correct melody/Correct accompaniment minus Altered 
// melody/Altered accompaniment (cMcA - aMaA)
// Spada D, 2014: Correct melody/Altered accompaniment minus Altered 
// melody/Correct accompaniment (cMaA - aMcA)
// Spada D, 2014: 2x2 interaction between violations in melody and violations 
// in accompaniment
// Subjects=20
14	-48	24
-12	-54	28
10	-40	16
6	-46	36
24	50	8
24	58	20
2	42	0
-24	46	16
66	-16	4
14	-42	8
20	-64	20
22	-52	8
14	-56	-4
-20	-48	4
-10	-54	8
54	34	0
-36	-20	56
-26	-18	64
-32	-22	52
8	-2	52
-10	-6	60
16	-46	8
22	-52	8
12	-48	32

// Trost W, 2014: Consonant > Dissonant
// Trost W, 2014: Visual cues during consonant > Dissonant music
// Trost W, 2014: Visual cues during dissonant > Consonant music
// Trost W, 2014: Visual cues during strong > Weak beats
// Trost W, 2014: Visual cues during strong > Weak beats in consonant music
// Trost W, 2014: Visual cues during weak > Strong beats in consonant music
// Trost W, 2014: Visual cues during strong > Weak beats in dissonant music
// Trost W, 2014: Interaction between Strong/Weak Beat in Consonant/Dissonant 
// Music
// Subjects=18
8	8	4
-6	-40	76
-28	-34	70
-26	-24	70
-8	-20	62
-22	-16	56
-10	-12	60
-40	-4	32
38	-58	46
28	-2	-32
-28	-86	20
42	-74	18
-10	16	6
14	16	6
12	-56	26
12	-56	26
56	-18	-12
46	20	20
-38	20	24
-12	16	4
14	16	8
-46	-28	-4
-42	-22	-2
-14	16	6
16	16	8
34	28	6
38	18	8
-46	-30	-4
-14	-16	-4
-52	-24	18
18	-68	42

// Vuust P, 2011: Tap Counter Meter (TapC) > Tap Main Meter (TapM)
// Vuust P, 2011: Tap > Listen
// Vuust P, 2011: Listen > Tap
// Subjects=18
-42	42	-4
12	10	38
8	22	32
34	-56	-40
0	-64	-22
22	-58	-34
-14	-8	14
-4	-10	62
-52	-8	44
-58	-22	44
-46	-22	50
-48	8	0
-38	16	-10
16	-2	10
-2	4	46
8	-46	28
22	-64	64
8	-68	44
10	-60	46
-2	-58	46
36	-84	22

// Logie R H, 2011: Mental rotation > Control
// Logie R H, 2011: High imagers > Low imagers
// Logie R H, 2011: Low imagers > High imagers
// Logie R H, 2011: Control > Mental rotation
// Subjects=10
-26	0	62
26	0	64
-40	10	-4
42	-18	20
4	-86	12
-10	-64	-4
56	-28	30
60	0	-8
60	-46	-16
26	14	-18
0	-4	66
6	-18	34
18	-42	-6
-52	-50	0
-2	-22	-16
36	-54	22
16	2	58
-20	10	44
40	-64	-36
-32	-42	46
-44	-56	-6
24	38	18
42	-6	44
-20	6	68
-6	-80	18
16	-78	22
58	-30	-8

// Manber T, 2012: Maintain > Reappraise: Healthy Controls > Generalized 
// Anxiety Disorder (GAD) and Panic Disorder (PD)
// Manber T, 2012: Maintain > Baseline: Healthy Controls (HC) > PD = GAD
// Manber T, 2012: Maintain > Baseline: HC > PD > GAD
// Manber T, 2012: Maintain > Baseline: HC = PD > GAD
// Manber T, 2012: Maintain > Baseline: HC > GAD > PD
// Manber T, 2012: Reappraise > Baseline: HC > PD = GAD
// Manber T, 2012: Reappraise > Baseline: HC > PD > GAD
// Subjects=18
-43.29	-25.65	52.11
-9.27	38.68	55.25
12	20.18	34.25
-43.37	4.3	54.06
-30.82	23.47	25.54
46.47	1.29	62.2
-43.71	22.7	16.83
67.39	14.22	7.35
50.09	3.26	-22.76
-56.45	-46.76	0.5
-4.99	-44.74	22.05
-30.84	-64.55	-11.68
-31.07	25.3	-5.83
-35.26	-44.12	-22.27
37.44	-60.94	-26.15
20.31	-61.39	-30.38
-5.29	35.62	15.31
45.74	41.99	-17.04
42.13	-34.63	38.5
24.92	-88.57	3.07
-26.66	-74.36	-28.75
67.54	-45.68	3.45
-52.04	-45.36	18.18
-51.7	-54.97	59.13
-47.87	-63.97	-2.61
-39.28	6.84	31.5
63.23	19.8	24.77
37.61	11.19	25.79
-9.25	34.45	55.6
-35.23	-52.58	-21.56
33.57	-87.49	16.27
-22.34	-78.22	-24.02

// Blair K S, 2011: Diagnosis-by-emotion interaction, (Patients > Controls: 
// Angry = Fearful > Neutral)
// Blair K S, 2011: Diagnosis main effect, Controls > Patients
// Blair K S, 2011: Emotion main effect, (Angry = Fearful > Neutral)
// Blair K S, 2011: Age main effect, Adults > Adolescents
// Subjects=14
8.33	47.22	-14.82
-28.98	-2.67	-23.58
12.17	-98.96	7.44
62.27	14.31	36.4
6.8	11.74	49.51
-17.17	0.2	-15.04
28.74	1.19	-20.11
18.29	-28.34	-1.9
49.43	-85.85	-5.24
-32.81	-91.46	-1.6
30.45	-63.59	36.6
-6.61	25.3	-21.73
-51.36	37.41	1.19
-56.35	6.99	35.03
65.39	13.47	25.28
1.37	8.57	36.46
57.11	-10.16	50.77
54.85	-82.85	5.6
-65.95	-70.88	5.98
-14.85	-52.83	-12.85

// Bruhl A B, 2011: Expectation Negative > Expectation Neutral, Social Anxiety 
// Disorder (SAD) > Healthy Controls (HC)
// Bruhl A B, 2011: Expectation Unknown > Expectation Neutral, SAD > HC
// Bruhl A B, 2011: Expectation Negative > Expectation Neutral, HC > SAD
// Bruhl A B, 2011: Expectation Unknown > Expectation Neutral, HC > SAD
// Subjects=14
7.61	40.87	26.99
-11.44	26.18	45.17
-17.74	-31.99	36.74
-53.24	-31.34	6.98
55.81	-59.75	1.42
52.24	12.16	-17.96
-52.91	-50.97	42.08
14.26	-98.32	1.78
7.58	-81.38	-26.32
-4.95	-98.18	5.34
-43.69	-81.43	-22.39
-27.55	-70.28	-3.43
4.46	-30.99	6.29
4.36	-9.04	1.1
-40.58	-36.23	-16.18
-17.94	-7.64	21.31
-18.23	-4.12	-15.78
55.84	-66.09	1.95
33.31	-70.43	-10.81
-27.57	-70.54	-6.76
-43.77	-32.82	-13.08
-40.81	47.02	-13.12
-21.53	54.25	-3.91

// Gorka S M, 2014: Group x Valence Interaction: Unpredictable (U) Conditions
// Gorka S M, 2014: Group x Valence Interaction: Predictable (P) Conditions
// Gorka S M, 2014: Main Effect of Group: U Conditions
// Gorka S M, 2014: Main Effect of Group: P Conditions
// Gorka S M, 2014: Main Effect of Valence: U Conditions
// Gorka S M, 2014: Main Effect of Valence: P Conditions
// Subjects=9
14	-16	58
-36	-2	18
34	-20	20
-16	-4	54
2	0	-18
-28	-42	42
-46	-54	-10
-8	-40	34
-20	-84	-32
-18	-80	-4
54	18	40
36	22	-18
-42	6	58
6	44	42
4	-98	6
22	-4	28
24	-50	-38

// Klumpp H, 2013: Main effect of group: Generalized Social Anxiety Disorder 
// Patients (gSAD) > Healthy Controls
// Klumpp H, 2013: Main effect of emotion: Match Faces > Match Shapes
// Klumpp H, 2013: Group X Emotion Interaction
// Subjects=27
-30	-98	-4
28	-86	4
-64	-42	32
8	-16	52
-34	-14	-12
-36	10	26
-18	32	54
16	-16	24
22	0	24
40	-2	62

// Klumpp H, 2012: Generalied Social Anxiety Disorder Patients > Healthy 
// Controls: Fearful > Happy faces, p<0.005
// Klumpp H, 2012: Generalied Social Anxiety Disorder Patients > Healthy 
// Controls: Fearful > Happy faces, p<0.05
// Subjects=26
58	10	36
-54	16	32
-40	20	-4
38	24	-4
-28	-68	52
-4	0	10
-52	-22	36
-2	24	46
24	-54	-8
48	-48	-30
-22	-12	-12
14	2	-20

// Aue T, 2013: Correlations between gaze duration and BOLD contrast, Spider 
// pictures > Bird pictures
// Subjects=17
-12	41	-2
15	32	-5
-3	-76	28
-13	18	12
0	-49	64
-45	-61	10

// Caseras X, 2010: Spider Phobics
// Subjects=14
36	-50	46
44	-66	-28
8	12	28
-16	-62	48
-4	18	24
-54	8	26
-20	4	-24
46	-2	48
14	-10	-22
62	20	12
-46	-12	52
-42	-10	38
6	12	38
-42	-14	20
-30	-2	48

// Caseras X, 2010: Blood Injection Injury (BII) Phobics
// Subjects=15
-50	12	-12
48	12	-6
-2	30	22
-2	36	18
10	34	14
-36	16	-16
-8	-72	24
-64	-52	34
-8	-78	36
52	-50	30
16	-68	30
10	-74	22
12	-78	34
-38	-58	34

// Caseras X, 2010: Healthy Controls
// Subjects=17
36	-50	46
44	-66	-28
8	12	28
-16	-62	48
-4	18	24
-54	8	26
-20	4	-24
46	-2	48
14	-10	-22
62	20	12
-46	-12	52
-42	-10	38
6	12	38
-42	-14	20
-30	-2	48
-50	12	-12
48	12	-6
-2	30	22
-2	36	18
10	34	14
-36	16	-16
-8	-72	24
-64	-52	34
-8	-78	36
52	-50	30
16	-68	30
10	-74	22
12	-78	34
-38	-58	34

// Gaebler M, 2014: Aversive pictures > Neutral pictures, Social Anxiety 
// Disorder (SAD) > Healthy Controls (HC)
// Subjects=21
-54	-39	27
-63	-48	24
-63	-30	18
-15	-18	42
-12	-30	39
57	-30	21
39	-33	21
57	-30	3

// Palm M E, 2011: Generalized Anxiety Disorder (GAD) Patients
// Subjects=15
10.73	69.1	6.32
7.51	49.52	3.83
49.89	-15.21	9.52
-37.51	-13.62	19.81
33.14	29.9	-23.8
-47.83	34.39	-17.26
-8.96	46.43	-16.87
16.91	65.77	-18.11
-15.43	69.47	-11.2
-31.37	52.79	6.41
17.32	63.36	13.5
39.73	31.82	-15.13
-50.72	31.55	9.96
4.29	49.72	6.11

// Palm M E, 2011: Healthy Controls
// Subjects=16
46.21	38.43	-13.66
-47.83	34.39	-17.26
46.09	26.55	-25.93
-47.69	25.64	-7.43
4.86	14.55	43.2
39.81	61.99	-2.43
-34.47	48.39	16.99
-8.36	24.64	25.61
46.29	12.69	-13.35
-41.13	-8.78	-8.62
36.5	-4.23	-21.6
-31.47	-9.27	-14.34
33.14	29.9	-23.8
-47.83	34.39	-17.26
-8.96	46.43	-16.87
16.91	65.77	-18.11
-15.43	69.47	-11.2
-31.37	52.79	6.41
17.32	63.36	13.5
39.73	31.82	-15.13
-50.72	31.55	9.96
4.29	49.72	6.11

// Schlund M W, 2012: Angry sentences: Major depressive disorder with comorbid 
// anxiety (MDD/GAD) > Healthy Controls (HC)
// Schlund M W, 2012: Angry sentences: HC > MDD/GAD
// Schlund M W, 2012: Happy sentences: MDD/GAD > HC
// Schlund M W, 2012: Happy sentences: HC > MDD/GAD
// Schlund M W, 2012: Sad sentences: MDD/GAD > HC
// Schlund M W, 2012: Sad sentences: HC > MDD/GAD
// Schlund M W, 2012: Angry faces: HC > MDD/GAD
// Schlund M W, 2012: Happy faces: MDD/GAD > HC
// Schlund M W, 2012: Happy faces: HC > MDD/GAD
// Schlund M W, 2012: Sad faces: HC > MDD/GAD
// Subjects=10
-16.29	-54.71	-19.07
-27.13	-34.23	-17.55
-35.33	-19.99	20.41
-39.73	-28.28	12.34
-22.84	25.73	-7.86
-48.86	-35.24	-27.16
-11.78	4.68	7.48
27.04	37.14	8.09
24.74	43.75	-1.49
-22.42	31.08	26.34
-1	-42.47	-3.73
-.91	-28.67	6.11
27.27	33.38	25.26
-2.84	29.96	36.2
-33.68	-4.16	-17.05
-11.6	-72.73	6.17
23.25	-67.23	28.56
29.66	-61.24	23.38
34	-56.66	26.21
22.7	-19.95	-5.24
29.23	-20.67	-1.92
7.64	-35.95	-3.4
-22.75	39.53	1.97
27.3	33.59	27.48
27.11	35.43	12.74
-15.63	12.56	45.98
-24.34	7.65	39.89
-9.59	3.83	9.77
-41.81	7.3	25.66
46.57	-26.79	0.63
24.8	36.51	1.46
26.97	30.03	0.95
25.14	33.58	27.52
-39.46	-28.44	33.64
38	-24.07	7.23
-31.1	35.1	23.85
-35.56	30.75	12.03
21.11	-.39	43.28
-9.4	-44.03	14.5
-14.19	50.95	-2.66
-28.56	-49.57	36.66
5.7	-83.51	4.7
14.48	-85.73	14.86
7.82	-57.56	6.58
16.48	-72.73	4.57
10.29	-23.49	37.9
35.93	18.21	23.26
-41.62	-28.45	33.68
38.43	-27.44	40.06
-31.35	28.87	3.18
-35.42	35.08	23.92
18.45	30.94	11.09
21.11	-.39	43.28

// Ziv M, 2013: Social Anxiety Disorder (SAD) patients
// Subjects=12
-35.23	28.67	10.66
1.28	23.03	30.79
-32.3	55.44	-15.04
4.92	-82.26	45.15
-50.48	28.84	-27.1
-68.32	-20.57	-3.79
-1.65	18.18	64.68
-54.24	0.15	28.88
59.79	-2.42	-14.59
-21.34	5.69	1.28
48.95	22.29	-24.34
-57.75	34.28	2.64
-68.35	-13.17	-4.41
-13.9	-13.35	-11.71
16.19	-11.46	10.09
41.56	7.79	-18.58
-57.73	-10.53	-12.56
-24.4	-71.92	-11.14
4.48	-71.49	-8.16
26.92	-79.01	-11.13
-28.84	-13.27	-9.31
-6.2	-79.21	-10.74
26.79	-53.98	-17.69
19.37	-61.08	-12.55
-1.68	17.92	61.36
-49.83	12.55	51.21
19.98	-51.48	70.28
26.85	-45.72	-7.23
-60.75	-11.92	11.01
-1.66	13.69	61.72
-57.73	27.94	3.17
-42.35	12.59	51.12

// Ziv M, 2013: Healthy Controls
// Subjects=13
-35.23	28.67	10.66
1.28	23.03	30.79
-32.3	55.44	-15.04
-1.86	-59.75	6.54
-1.62	10.78	65.3
-57.27	1.93	52.19
-68.03	-48.38	21.96
-57.64	-17.33	-4.18
-54.64	26.76	-12.38
-64.94	-34.15	12.92
44.99	-23.86	-1.47
-54.62	14.87	-14.72
67.47	7.42	15.72
-57.72	-6.04	-9.59
-24.4	-71.92	-11.14
4.48	-71.49	-8.16
26.92	-79.01	-11.13
-28.84	-13.27	-9.31
-6.2	-79.21	-10.74
26.79	-53.98	-17.69
19.37	-61.08	-12.55
-1.86	-59.75	6.54
31.59	-11.23	66.77
-1.62	18.52	69.12
-54.09	9.35	51.53
-64.82	-59.27	18.38
-46.85	25.57	26.67
27.44	-51.7	66.86
-23.83	-73.75	61.5
-57.81	27.08	-7.91
-1.8	12.23	42.88
31.47	-72.9	26.22
-67.71	-183.41	9.86
-32.14	53.81	5.17
-31.54	-91.51	25.16
-50.22	12.92	1
-24.01	-19.57	60.3
-2.02	-1	9.42
-49.68	-60.56	41.73
-39.07	-54.75	33.31
-32.03	-9.78	-5.11
-54.31	-34.69	5.04
-60.75	-11.92	11.01
-1.65	18.18	64.68

// Kattoor J, 2013: Pain > Baseline
// Kattoor J, 2013: CS+ > CS- (Early Acquisition, Anticipatory)
// Kattoor J, 2013: CS+ > CS- (Late Acquisition, Anticipatory)
// Kattoor J, 2013: CS+> CS- (Extinction)
// Kattoor J, 2013: CS- > CS+ (Extinction)
// Subjects=21
-34	0	12
-32	8	2
42	10	-6
32	8	8
-62	-34	32
-62	-24	26
62	-28	40
-50	-32	26
60	-38	48
62	-24	30
-48	0	10
-24	34	12
-38	44	32
44	50	14
4	-52	70
2	30	-2
-2	28	-2
4	-54	18
4	-90	16
-32	12	-28
50	-14	6
42	-6	-20
44	-28	-14
28	6	-12
-28	-24	6
26	8	-10
22	-70	-12
-40	-46	-24
-28	-62	-16
20	-70	-12
16	-68	-12
32	-66	-18
-18	-50	-16
-20	-76	-20
-38	-50	-26
6	-72	-10
-22	-50	-26
24	2	-22
12	24	26
26	-66	26
-18	-80	50
-26	-70	40
-48	-46	6
-28	-36	0
-22	12	10
-40	-24	22
32	6	46
-20	36	-16
-6	-58	34
26	12	46
-6	58	40
-10	48	22
4	54	46
4	42	24

// Balodis I M, 2013: Binge Eating Disorder (BED)
// Subjects=19
45	30	9
-30	-99	12
9	6	24
-18	-18	39
33	-45	9
-9	-93	33
3	0	63
39	-87	30
-12	-72	12
36	-54	-15
24	24	21
-39	-57	-9
63	-30	24
-69	-33	30
0	21	24
-6	54	12
21	3	-12
-33	-90	-9
27	-84	-12
-21	-21	54
54	36	21
-42	-6	0
-24	-57	9
-48	-75	36
15	-27	-15
-42	12	15
39	21	15
39	-12	45
3	-84	-12
-45	12	15
30	-81	-15
-18	-66	3
27	12	-3
48	-78	33
33	-96	6
15	-21	48
45	-30	18
-33	-96	6
-60	3	30
-42	-12	63
45	-51	-15
-15	-69	-6
3	-15	-21
39	-48	54
51	-30	12
-36	-54	48
12	51	-24
-63	6	21
9	-9	51
-33	-96	0
-45	-3	57
-24	-72	15
45	12	-6
33	-72	-3
-36	-84	0
-57	-48	3
-24	-51	0
6	15	36
-39	6	33
-54	-36	-6
-39	-63	54
-33	-21	57
-24	-48	18
42	15	-6
-24	6	-15
12	-78	-27
-15	-39	12
-6	-90	-30
15	-51	3
-66	-12	-12
42	-87	21
-54	-6	15
-9	-60	-24
-63	-6	-15
24	-21	33
-24	-33	9
-57	33	-6
3	51	21
42	-84	18
-30	15	-15
33	15	-9
-63	-60	27
3	-57	-36
45	27	45
-27	-78	-39
66	-54	30
9	-51	36
66	-54	30
51	-24	-12
3	-63	3
24	-24	33
-27	-57	3
-6	63	30
-39	-15	15
-27	-54	-3
-51	-78	-6
-18	-12	66
-57	9	36
21	-51	-15
54	-69	30
-12	-82	43
3	-63	24
-51	-38	21
-24	-21	66
-36	-15	15
-54	12	30
-42	-84	-6
-45	9	30
-18	-42	9
3	-66	-15
42	6	-12
-42	-84	-9
21	-42	63
3	-66	-15

// Balodis I M, 2013: Obese
// Subjects=19
-54	-36	-24
45	-6	60
-3	-69	-39
-39	-15	33
9	-72	-3
-51	-81	21
-3	-9	51
27	42	-21
-39	-18	-27
54	-12	21
-18	-51	-27
-57	-42	21
0	-72	-18
-6	0	54
-39	-15	36
21	33	-24
-42	30	12
-18	-21	42
9	-3	-3
-24	-42	21
-24	33	-27
24	45	-15
15	36	21
12	-33	-24
-48	-84	24
-33	-15	51
0	-57	21
0	-60	24
-51	-81	21
-27	-9	60
27	-9	60
-42	12	15
39	21	15
39	-12	45
3	-84	-12
-45	12	15
30	-81	-15
-18	-66	3
27	12	-3
48	-78	33
33	-96	6
15	-21	48
45	-30	18
-33	-96	6
-60	3	30
-42	-12	63
45	-51	-15
-15	-69	-6
3	-15	-21
39	-48	54
51	-30	12
-36	-54	48
12	51	-24
-63	6	21
9	-9	51
-33	-96	0
-45	-3	57
-24	-72	15
45	12	-6
33	-72	-3
-36	-84	0
-57	-48	3
-24	-51	0
6	15	36
-39	6	33
-54	-36	-6
-39	-63	54
-33	-21	57
-24	-48	18
42	15	-6
-24	6	-15
12	-78	-27
-15	-39	12
-6	-90	-30
15	-51	3
-66	-12	-12
42	-87	21
-54	-6	15
-9	-60	-24
-63	-6	-15
24	-21	33
-24	-33	9
-57	33	-6
3	51	21
42	-84	18
-30	15	-15
33	15	-9
-63	-60	27
3	-57	-36
45	27	45
-27	-78	-39
66	-54	30
9	-51	36
66	-54	30
51	-24	-12
3	-63	3
24	-24	33
-27	-57	3
-6	63	30
-39	-15	15
-27	-54	-3
-51	-78	-6
-18	-12	66
-57	9	36
21	-51	-15
54	-69	30
-12	-82	43
3	-63	24
-51	-38	21
-24	-21	66
-36	-15	15
-54	12	30
-42	-84	-6
-45	9	30
-18	-42	9
3	-66	-15
42	6	-12
-42	-84	-9
21	-42	63
3	-66	-15

// Balodis I M, 2013: Low Weight Controls
// Subjects=19
-54	-36	-24
45	-6	60
-3	-69	-39
-39	-15	33
9	-72	-3
-51	-81	21
-3	-9	51
27	42	-21
-39	-18	-27
54	-12	21
-18	-51	-27
-57	-42	21
0	-72	-18
-6	0	54
-39	-15	36
21	33	-24
-42	30	12
-18	-21	42
9	-3	-3
-24	-42	21
-24	33	-27
24	45	-15
15	36	21
12	-33	-24
-48	-84	24
-33	-15	51
0	-57	21
0	-60	24
-51	-81	21
-27	-9	60
27	-9	60
45	30	9
-30	-99	12
9	6	24
-18	-18	39
33	-45	9
-9	-93	33
3	0	63
39	-87	30
-12	-72	12
36	-54	-15
24	24	21
-39	-57	-9
63	-30	24
-69	-33	30
0	21	24
-6	54	12
21	3	-12
-33	-90	-9
27	-84	-12
-21	-21	54
54	36	21
-42	-6	0
-24	-57	9
-48	-75	36
15	-27	-15
6	15	36
-39	6	33
-54	-36	-6
-39	-63	54
-33	-21	57
-24	-48	18
42	15	-6
-24	6	-15
12	-78	-27
-15	-39	12
-6	-90	-30
15	-51	3
-66	-12	-12
42	-87	21
-54	-6	15
-9	-60	-24
-63	-6	-15
24	-21	33
-24	-33	9
-57	33	-6
3	51	21
42	-84	18
-30	15	-15
33	15	-9
-63	-60	27
3	-57	-36
45	27	45
-27	-78	-39
66	-54	30
9	-51	36
66	-54	30
51	-24	-12
3	-63	3
24	-24	33

// Kong J, 2013: Anticipation: Low cue, high pain (LC) > High cue, high pain 
// (HC)
// Kong J, 2013: Pain: LC > HC
// Subjects=48
-20	24	50
-48	-60	46
10	-82	-34
-4	36	54
-2	58	20
-20	60	8
-44	38	-10
-34	22	-2
14	64	10
26	60	6
38	16	34
-38	-72	32
-36	-68	50
-52	-66	30
34	-68	30
30	-64	56
8	-80	-34

// Longo M R, 2012: Laser Stimulation > Baseline
// Longo M R, 2012: Object > Hand
// Longo M R, 2012: Hand > Object
// Subjects=14
-46	-12	36
-58	-6	26
58	-6	24
52	-10	42
44	-12	36
-2	-2	58
-4	12	42
-64	-6	14
48	12	-6
-48	10	-6
-2	20	32
2	20	30
10	2	72
-2	-92	22
-6	-82	-10
54	-36	56
-48	-4	0
18	-30	62
-18	-30	62
12	-76	48
-14	-4	16
-46	-10	8
24	-98	6
-16	18	2
34	-12	16
46	-8	6
42	-14	14
32	-18	6
32	-24	12
40	-12	-6
-16	-74	-8
50	0	-40
8	-86	20
-30	-28	56
46	-66	-42
32	-20	48
-42	-20	24
-68	-18	-6
-18	-62	66
-26	-84	38
24	-100	6
16	-68	64
-48	-72	-4
28	-80	42
-34	-94	10
16	-102	8
-16	-78	50
-24	-102	6
44	-74	-8
48	-64	-2
8	60	-18
38	-86	28
16	12	-10
-12	22	6
-4	16	4
24	16	-6

// Moulier V, 2012: Pedophilic Male
// Subjects=1
-12	-96	-3
-9	-84	-24
0	3	36

// Perini I, 2013: All Painful > All Nonpainful
// Perini I, 2013: All Nonpainful > All Painful
// Perini I, 2013: All Press > All No-press
// Perini I, 2013: All Heat > All Cold
// Perini I, 2013: All Painful Press > All Painful No-press
// Perini I, 2013: All Nonpainful Press > All Nonpainful No-press
// Perini I, 2013: Conjunction: Painful Press and Nonpainful press
// Subjects=18
45.93	51.62	11.15
-38.51	41.08	6.31
38.48	15.65	0.87
-35.18	9.38	8.93
41.75	24.1	13.51
60.93	9.36	0.02
-51.24	9.03	5.8
6.23	49.76	-9.43
-14	46	-1.07
-24.17	13.93	53.03
29.27	9.93	51.64
-30.48	-19.15	52.53
-56.37	1.28	29.93
38.95	-15.73	49.22
47.45	-13.91	44.51
-.46	-39.86	57.27
-55.2	-14.15	36.78
-1.53	-32.21	59.99
-55.56	-9.12	-8.24
57.64	-5.86	-17.62
-43.52	-33.51	19.32
-20.82	-77.9	35.05
48.52	-69.97	21.32
27.27	-73.21	36.33
-29.79	-45	-6.64
-.69	9.33	46.46
-2.83	6.05	45.64
-37.93	-15.59	57.9
-37.85	-31.2	62.55
51.29	12.3	-2.34
-41.57	-3.6	6.75
-47.86	-22.16	15.07
0.06	-59.85	-22.47
19.24	-53.65	-26.55
-12.68	-68.93	-14.87
-12.67	-16.12	7.47
12.93	-9.88	3.3
-19.3	21.14	-5.62
19.46	-1.95	22.64
9.61	48.23	11.85
3.6	29.33	57
6.67	47.69	46.5
44.76	43.98	-4.92
58.79	12.6	0.89
3.65	-12.94	47.16
-12.31	-22.3	51.47
6.74	-7.6	33.29
-3.26	18.06	-5.54
48.22	3.79	11.79
35.88	-37.35	58.87
-37.89	-34.88	56.17
16.72	-43.3	66.28
-37.85	-51	54.17
-5.72	-63.24	58.18
-28.62	-25.22	15.1
32.28	-21.68	14.11
48.22	3.79	11.79
-25.35	-60.86	8.02
29.13	-57.37	7.1
-15.65	-83.01	9.77
19.5	-14.73	22.59
3.31	-72.52	-21.44
3.41	17.5	27.88
-35.74	-18.24	64.78
-31.4	-27.47	68.85
-54.04	-29.66	42.53
35.32	16.15	7.55
0.17	-68.6	-11.7
16.06	-66.61	-28.78
-3.04	-71.96	-13.61
-9.5	0.02	9.42
6.59	-15.75	10.56
-25.56	-13.54	0.71
25.66	5.8	-1.5
-3.34	18.35	-15.6
0.3	11.9	38.42
-50.8	-25.96	48.88
-37.87	-24.85	62.02
-44.81	-.71	3.2
4.32	-49	-20.08
16.04	-53.67	-26.52
0.14	-19.47	4.25
-15.8	-8.77	20.27
9.68	22.6	10.65
-28.82	-4.3	-3.38
0.27	14.82	34.83
-38.06	27.05	58.78
-37.85	-31.2	62.55
-48.08	8.53	-.89
0.06	-59.85	-22.47
19.24	-53.65	-26.55
-9.45	-19.27	7.69
-15.79	-18.54	17.74
-3.18	-23.95	-12.06

// Pfleiderer B, 2014: Anxiety-Sensitive Females
// Subjects=27
-7.98	62.08	-21.8
7.57	69.71	13.04
-9.27	-53.94	23.32
-2.55	-54.38	41.18
12.41	-55.57	27.6
-22.08	41.22	54.46
-20.01	49.32	49.14
-35.12	38.43	48.24
-22.92	-0.08	-19.88
-20.74	-21.76	-22.25
22.41	-4.59	-24.68
-44.86	19.25	-41.58
61.29	-6.79	-27.37
13.75	60.86	-13.08
3.05	61.65	-4.01
-2.55	-54.38	41.18
5.54	-8.12	7.33
-11.8	-2.01	4.78
-22.58	15.59	9.94
-61.13	13.69	37.68
-46.03	-17.07	29.26
53.38	3.04	32.3
25.71	-9.24	63.13
44.7	-3.78	28.64
-30.77	-51.05	32.37
20.33	48.53	-7.49
11.63	48.09	-11.78
24.52	47.51	-18.67
22.82	22.55	12.96
16.62	2.71	30.72
1.22	-8.14	7.4
24.95	15.76	9.12
1.22	-8.14	7.4
-13.93	-1.81	7.04
-48.19	-1.78	32.27
-48.63	-5.1	-3.25
-48.2	-14.95	29.09
-9.81	71.15	6.47
-13.99	58.99	14.47
13.87	-14.84	-19.04
26.77	0.1	-20.74
-20.7	-17.09	-18.23
-18.56	-4.11	-17.31
7.7	-8.12	7.29
-5.34	-4.32	2.66
-13.91	-6.07	7.46
1.49	-27.96	25.05
14.31	-42.13	10.54
10.1	-39.18	19.29
-58.94	13.91	39.86
-47.92	9.02	55.85
-13.61	11.52	34.85
-9.13	21.5	49.47
-9.34	24.3	33.51
-20.59	-1.48	-6.33
57.58	-32.84	15.61
-65.59	-31.15	17.54
61.77	-29.4	6.24
46.74	-30.96	13.37
-61.31	7.98	22.56
-56.66	6.03	47.33
-20.71	-21.55	-20.03
-56.58	0.06	52.4
-68.05	-13.68	-2.07
-65.6	-35.61	15.74
59.29	9.76	-11.04
61.73	11.84	11.12
55.13	13.11	2.14
-.23	5.97	66.54
9.78	-2.14	2.18
63.97	-31.32	8.63
52.68	41.64	-14.09
50.69	42.88	-.73
-31.37	29.83	1.96

// Pfleiderer B, 2014: Healthy Controls
// Subjects=27
-7.98	62.08	-21.8
7.57	69.71	13.04
-9.27	-53.94	23.32
-2.55	-54.38	41.18
12.41	-55.57	27.6
-22.08	41.22	54.46
-20.01	49.32	49.14
-35.12	38.43	48.24
-22.92	-0.08	-19.88
-20.74	-21.76	-22.25
22.41	-4.59	-24.68
-44.86	19.25	-41.58
61.29	-6.79	-27.37
13.75	60.86	-13.08
3.05	61.65	-4.01
-2.55	-54.38	41.18
5.54	-8.12	7.33
-11.8	-2.01	4.78
-22.58	15.59	9.94
-61.13	13.69	37.68
-46.03	-17.07	29.26
53.38	3.04	32.3
25.71	-9.24	63.13
44.7	-3.78	28.64
-30.77	-51.05	32.37
20.33	48.53	-7.49
11.63	48.09	-11.78
24.52	47.51	-18.67
22.82	22.55	12.96
16.62	2.71	30.72
1.22	-8.14	7.4
24.95	15.76	9.12
1.22	-8.14	7.4
-13.93	-1.81	7.04
-48.19	-1.78	32.27
-48.63	-5.1	-3.25
-48.2	-14.95	29.09
-9.81	71.15	6.47
-13.99	58.99	14.47
13.87	-14.84	-19.04
26.77	0.1	-20.74
-20.7	-17.09	-18.23
-18.56	-4.11	-17.31
7.7	-8.12	7.29
-5.34	-4.32	2.66
-13.91	-6.07	7.46
1.49	-27.96	25.05
14.31	-42.13	10.54
10.1	-39.18	19.29
-58.94	13.91	39.86
-47.92	9.02	55.85
-13.61	11.52	34.85
-9.13	21.5	49.47
-9.34	24.3	33.51
-67.87	-23.27	10.08
-67.9	-36.66	4.68
-63.73	-20.25	-3.74
74.66	-23.39	0.94
74.73	-33.82	4.21
72.25	-12.09	-15.83
-50.08	-4.17	52.71
1.97	4.06	68.94
36.01	-6.36	24.56
39.67	-63.83	-39.29
-14.38	-55.51	-39.19
2.89	-73.09	-44.47
-70	-31.79	10.96
-54.94	-27.9	5.83
57.05	9.13	-17.67
74.81	-17.89	13.84
74.69	-25.31	3.37
4.16	4.27	71.12
-11.39	11.95	39.25
39.93	23.49	-.87
40.07	9.22	7.27

// Ponseti J, 2012: Nude Boys < Nude Men, Pedophiles < Teleiophiles
// Ponseti J, 2012: Nude Girls < Nude Women, Pedophiles < Teleiophiles
// Subjects=11
-38	-62	-24
40	-64	-22
-12	-40	-2
-2	-6	4
22	-32	-4
-34	-76	0
14	-34	0
-38	-74	-16
46	-44	-12
38	-66	44
12	18	-8
-8	14	-8
32	-62	52
-42	-44	-10
-38	-46	-10
-2	4	28
-38	-78	0
-18	0	-12
-26	-56	46
44	-42	-14
54	-56	-8
-32	12	-10
44	24	22
-16	-8	10
28	-48	-30

// Russo A, 2012: Healthy Controls
// Subjects=16
54.63	-9.37	6.13
-54.36	-13.2	7.7
38.44	31.77	2.86
-32.1	27.92	0.65
3.55	9.01	41.97
57.9	-21.78	10.48
35.28	19.06	3.97
-38.51	1.47	-10.44
48.37	2.08	30.89
-34.88	-10.51	40.71
28.78	57.6	7.5
-25.68	47.76	8.95
35.31	19.32	7.29
-35.3	27.9	0.69
6.67	11.43	31.7
57.9	-21.78	10.48
61.37	-35.57	38.36
-57.31	-40.22	30.07
38.65	-15.56	10.18
12.97	-22.57	4.37
51.51	-41.37	5.5
-31.73	-77.02	6.1
-25.75	-68.23	-46
58.08	-.18	42.12
-47.65	-10.08	47.51
32.14	42.79	22.08
-28.72	42.94	29.46
41.65	31.79	2.82
-35.3	27.9	0.69
3.55	9.01	41.97
57.9	-21.78	10.48
57.8	40.83	21.95
-63.83	-24.92	22.17
38.66	-18.73	10.44
12.97	-22.57	4.37
48.32	-37.96	8.6
-25.04	-60.87	49.28
-1.05	29.76	7.95
53.64	-11.87	15.27
-60.71	-14.75	15.71
-5.47	-14.59	-28.43

// Russo A, 2012: Migraine Patients without Aura (MwoA)
// Subjects=16
53.47	-.38	-1.3
-44.7	-17.11	11.26
4.54	17.05	35.71
42.7	31.62	0.6
6.68	14.86	34.76
58.94	-18.86	6.87
42.89	-12.53	7.64
-40.52	7.23	9.17
43.21	-1.53	53.55
23.31	68.35	-4.49
-23.66	56.43	-2.95
40.58	31.78	2.84
-35.31	28.96	0.6
3.46	14.75	33.69
34.69	-37.59	42.18
-58.39	-40.4	27.87
14.52	-47.26	56.6
38.61	-13.7	6.67
-43.85	-.67	-10.2
12.9	-5.73	1.84
-12.72	-10.03	3.61
52.58	-40.31	5.4
51.29	-71.15	-35.49
-37.41	-70.62	-34.52
-3.31	-24.18	-28.77
54.65	-15.72	6.66
54.64	-14.74	5.46
41.65	31.79	2.82
-35.32	31.07	0.42
6.65	15.66	31.34
54.64	-14.74	5.46
56.09	-38.26	45.34
41.75	-3.45	1.32
-41.7	-1.63	-9.03
14.03	-20.45	4.18
-12.75	-16.98	-3.61
55.77	-64.58	-5.98
-54.16	-66.07	12.13
1.2	-56.87	-11.58
-12.71	-69.27	-19.3
-6.41	-37.43	-20.93
-1.05	29.76	7.95
53.64	-11.87	15.27
-60.71	-14.75	15.71
-5.47	-14.59	-28.43

// Strigo I A, 2013: Healthy Controls
// Subjects=22
35.21	31.49	-.42
-36.29	24.35	9.92
52.51	19.39	20.47
45.12	17.03	31.9
58.16	-44.39	34.67
0.36	-36.96	25.79
58.96	-38.41	1.82
52.4	-19.04	-8.65
12.89	11.7	7.07
-2.11	-30.54	-14.86
-39.65	-50.89	-40.61
28.87	-31.5	-16.26
-50.98	-10.24	31.95
43.82	8.03	-1.9
-17.97	37.09	35.41
-19.96	-35.06	24.75
-54.51	-.48	-6.75
35.11	40.33	-10.08
47.26	17.04	31.88

// Strigo I A, 2013: MDD Patients
// Subjects=31
40.59	18.75	-.53
-39.52	20.81	5.79
-38.55	28.6	-3.79
59.98	-10.31	7.26
-59.76	-3.97	3.64
4.48	-8.9	16.7
49.27	-29.29	-3.29
-56.56	-17.15	-1.98
-8.47	-33.33	-8.98
42.67	-26.9	-26.84
43.82	8.03	-1.9
-17.97	37.09	35.41
-19.96	-35.06	24.75
-54.51	-.48	-6.75
35.11	40.33	-10.08
47.26	17.04	31.88

// Poeppl T B, 2011: Pedophiles
// Subjects=9
42	16	24
52	-74	-6
4	-38	26
-44	-78	0
34	-16	-18
46	-22	48
-4	-54	24
48	-4	52
-18	-16	-18
32	-68	34
-20	-24	32
22	-94	-4
-30	-48	-16
-28	-92	4
-40	-44	-24
-40	26	-10
56	-72	4
-34	-80	20
66	-20	6
42	-26	-16
16	-32	-16
-32	50	-2
22	-56	50
24	38	-6
-18	12	-2
26	-30	10
18	8	4
0	-22	-12
4	58	-2
24	-64	-20
42	-58	0
38	-66	-20
-42	-24	10
-40	-70	-2
30	-74	22
28	-48	-20
-16	-62	2
6	-86	22
8	-42	64
2	-2	8
38	-24	28
-20	12	-2
16	10	0
64	-44	32
-38	56	6
-20	-6	16
-54	-18	44
-2	-22	24
-60	-2	-24
16	10	28
-36	0	-26
42	-42	2
26	-82	42
-30	-52	36
18	-68	10
16	-46	-30
20	-44	28
44	-40	-2
12	-42	30
-8	-16	14
22	12	26
34	-20	-16
42	-4	-24
28	-44	-24
32	12	16
48	-22	48
8	-12	36
-40	-44	22
42	8	16
46	-42	-2

// Poeppl T B, 2011: Controls
// Subjects=11
-28	6	-6
64	-46	40
46	-80	-6
-42	-82	-6
40	-42	-14
2	-2	8
38	-24	28
-20	12	-2
16	10	0
64	-44	32
44	-40	-2
12	-42	30
-8	-16	14
22	12	26
34	-20	-16
42	-4	-24
28	-44	-24
32	12	16
48	-22	48
8	-12	36
-40	-44	22
42	8	16
46	-42	-2
42	-74	-10
-44	-72	-4
-2	-62	24
30	32	-8
-30	16	32
46	18	-24
-38	8	32
20	-2	-10
-8	64	28
-40	26	-18
-2	-54	-10
-46	-8	-26

// Stoleru S, 2013: Children - Fixation, Pedophilic - Healthy Men
// Subjects=5
-36	-63	-27
42	-63	-33
36	-69	-33
27	-78	-30
-45	36	24
36	21	27
45	42	24
-33	12	36
-30	60	15
45	48	12
48	6	48
-6	45	51
42	3	42
27	48	36
-24	9	69
-24	-12	51
30	48	-12
-36	21	-6
48	18	-6
54	18	27
-6	-69	-9
27	-90	-3
-57	-63	-3
-39	-33	-21
-3	27	39
-3	-51	6
-33	21	9
39	21	0
-27	-48	39
-27	-69	36
-42	-45	24
-39	-33	-21
-3	-75	27

// Sundaram T, 2010: Erotic (Early Stage) > Rest
// Sundaram T, 2010: Erotic (Mid Stage) > Rest
// Sundaram T, 2010: Erotic (Late Stage) > Rest
// Subjects=14
34	-84	24
-36	-89	1
-36	-89	-1
-34	-57	-7
-22	-86	-4
-22	-93	1
-28	-58	-4
-2	2	-3
-2	-42	8
20	10	9
-10	0	2
10	1	13
-4	-4	4
-57	-36	20
-2	-8	-1
6	-43	-40
18	-27	-26
-38	-77	-23
2	-63	-10
-28	-80	26
-34	-87	3
-36	-82	-11
-38	-80	-11
22	-87	3
26	-83	12
-28	-20	-12
-32	-47	-6
-24	1	-17
6	17	25
-26	-71	13
30	-8	-6
-8	14	7
-18	-17	17
-4	-4	-7
-57	-34	20
-16	-18	-8
-49	-62	-31
-2	-72	-32
36	-84	24
-46	-70	-3
-34	-72	-3
32	-68	-8
-32	-72	-3
-26	-81	10
-30	-53	-6
30	-1	-15
6	26	15
22	17	-6
-24	-10	0
10	21	1
6	-17	16
-8	-6	-5
-57	-36	18
-10	-18	-11
-8	-41	-38
-18	-38	-30
-36	-51	-18
-2	-60	0

// Sylva D, 2013: Heterosexual Women
// Subjects=11
-15.92	4.29	10.25
-2.72	1.71	58.27
26.69	-42.94	-26.42
-48.63	-26.74	52.26
22.6	-66.35	-12.15
15.07	-.98	8.11
4.35	41.4	20.29
-25.65	-.22	-5.98
-18.07	-18.95	-1.16
-13.7	-16.76	13.11
-40.09	-54.24	39.97
64.2	-42.75	-13.49
3.47	-78.55	-3.1
-37.91	-21.94	58.43
-43.57	-23.02	17.32
-2.52	-27.04	71.83
-18.67	-41.54	50.93
-24.1	-67.78	28.66
30.03	-39.35	-7.8
-12.6	-48.36	3.48
-36.08	-77.82	-3.82
44.35	-19.5	55.05
25.83	-71.53	-10.63
-23.02	-87.4	22.48
5.7	-66.6	13.72
-19.09	-10.7	9.32
-28.26	-24.79	61.9
19.48	-14.99	19.27
44.84	-43.01	-28.86
16.08	-48.84	-19.12
-23.5	6.48	-2.11
28.69	72.9	-25.9
-21.98	72.39	-27.95
-5.96	91.52	-21.49
37.62	29.04	61.31
-27.22	95.43	-4.84
-8.72	97.22	-16.36
26.7	56.88	42.38
37.47	57.8	53.33
55.76	24.44	0.16
-8.84	60.39	-46.72
-24.41	70.52	16.84
48.2	28.05	47.45
7.53	66.68	0.07
-18.76	-22.51	19
42.6	28.19	14.04
-24.49	33.9	-7.97
-13.51	-20.58	7.63
5.03	83.81	15.39
45.17	-2.06	2.5
29.02	70.84	16.2
-29.73	70.69	19.56
31.55	51.77	-24.16
7.78	-10.31	0.95
55.91	17.9	17.43
34.19	52.64	-13.11
58.62	8.82	4.33
0.11	41.51	52.45
-13.34	-2.38	36.66
-16.8	51.45	-57.04
18.14	98.89	2.82
24.11	47.8	62.8
20.9	98.68	-0.09
-29.52	-14.96	12.92
-21.39	-1.17	19.92
-10.99	86.66	18.01
16.12	0.13	33.43
18.57	29.33	30.95
61.37	27.27	36.21
-13.46	51.35	43.3
18.75	44.79	60.21
-34.53	15.93	68.82
-21.01	13.69	74.43

// Sylva D, 2013: Homosexual Women
// Subjects=11
-15.92	4.29	10.25
-2.72	1.71	58.27
26.69	-42.94	-26.42
-48.63	-26.74	52.26
22.6	-66.35	-12.15
15.07	-.98	8.11
4.35	41.4	20.29
-25.65	-.22	-5.98
-18.07	-18.95	-1.16
-13.7	-16.76	13.11
-40.09	-54.24	39.97
64.2	-42.75	-13.49
3.47	-78.55	-3.1
-37.91	-21.94	58.43
-43.57	-23.02	17.32
-2.52	-27.04	71.83
-18.67	-41.54	50.93
-24.1	-67.78	28.66
30.03	-39.35	-7.8
-12.6	-48.36	3.48
-36.08	-77.82	-3.82
44.35	-19.5	55.05
25.83	-71.53	-10.63
-23.02	-87.4	22.48
5.7	-66.6	13.72
-19.09	-10.7	9.32
-28.26	-24.79	61.9
19.48	-14.99	19.27
44.84	-43.01	-28.86
16.08	-48.84	-19.12
-23.5	6.48	-2.11

// Sylva D, 2013: Heterosexual Men
// Subjects=12
3.47	-78.55	-3.1
-37.91	-21.94	58.43
-43.57	-23.02	17.32
-2.52	-27.04	71.83
-18.67	-41.54	50.93
-24.1	-67.78	28.66
30.03	-39.35	-7.8
-12.6	-48.36	3.48
-36.08	-77.82	-3.82
44.35	-19.5	55.05
25.83	-71.53	-10.63
-23.02	-87.4	22.48
5.7	-66.6	13.72
-19.09	-10.7	9.32
-28.26	-24.79	61.9
19.48	-14.99	19.27
44.84	-43.01	-28.86
16.08	-48.84	-19.12
-23.5	6.48	-2.11
28.69	72.9	-25.9
-21.98	72.39	-27.95
-5.96	91.52	-21.49
37.62	29.04	61.31
-27.22	95.43	-4.84
-8.72	97.22	-16.36
26.7	56.88	42.38
37.47	57.8	53.33
55.76	24.44	0.16
-8.84	60.39	-46.72
-24.41	70.52	16.84
48.2	28.05	47.45
7.53	66.68	0.07
-18.76	-22.51	19
42.6	28.19	14.04
-24.49	33.9	-7.97
-13.51	-20.58	7.63
5.03	83.81	15.39
45.17	-2.06	2.5
29.02	70.84	16.2
-29.73	70.69	19.56
31.55	51.77	-24.16
7.78	-10.31	0.95
55.91	17.9	17.43
34.19	52.64	-13.11
58.62	8.82	4.33
0.11	41.51	52.45
-13.34	-2.38	36.66
-16.8	51.45	-57.04
18.14	98.89	2.82
24.11	47.8	62.8
20.9	98.68	-0.09
-29.52	-14.96	12.92
-21.39	-1.17	19.92
-10.99	86.66	18.01
16.12	0.13	33.43
18.57	29.33	30.95
61.37	27.27	36.21
-13.46	51.35	43.3
18.75	44.79	60.21
-34.53	15.93	68.82
-21.01	13.69	74.43

// Sylva D, 2013: Homosexual Men
// Subjects=12
3.47	-78.55	-3.1
-37.91	-21.94	58.43
-43.57	-23.02	17.32
-2.52	-27.04	71.83
-18.67	-41.54	50.93
-24.1	-67.78	28.66
30.03	-39.35	-7.8
-12.6	-48.36	3.48
-36.08	-77.82	-3.82
44.35	-19.5	55.05
25.83	-71.53	-10.63
-23.02	-87.4	22.48
5.7	-66.6	13.72
-19.09	-10.7	9.32
-28.26	-24.79	61.9
19.48	-14.99	19.27
44.84	-43.01	-28.86
16.08	-48.84	-19.12
-23.5	6.48	-2.11

// Versace F, 2013: All Participants: Emotional > Neutral
// Versace F, 2013: Sexual desire x Picture category
// Subjects=11
-39.11	-71.64	21.35
33.6	-68.57	26.95
-59.46	-30.46	32.63
57.04	-33.91	32.69
-1.11	42.36	5.77
48.36	3.05	29.69
14.2	-92.32	-3.18
41.08	-57.53	31.51
4.23	38	3.85
28.8	39.11	2.36
50.55	20.12	43.85
-28.55	-31.13	21.18

// Wehrum S, 2013: Sexual - Neutral, Men and Women (Conjunction)
// Wehrum S, 2013: Sexual - Positive, Men and Women (Conjunction)
// Wehrum S, 2013: Sexual - Negative, Men and Women (Conjunction)
// Wehrum S, 2013: Sexual - Neutral / Sexual - Positive / Sexual - Negative 
// (Conjunction), Men and Women (Conjunction)
// Wehrum S, 2013: Sexual - Positive, Men - Women
// Wehrum S, 2013: Sexual - Negative, Men - Women
// Subjects=48
48	-67	-8
51	8	28
-6	47	1
15	-52	-50
-51	5	28
-27	-4	49
-6	-28	-11
54	41	7
-33	-16	-8
48	-67	-5
-12	-73	-41
39	-1	46
0	38	4
-30	-4	49
-51	5	31
27	17	-17
-6	2	-5
6	-31	-5
-15	-52	-47
0	23	25
3	-58	31
48	-70	-2
30	-52	58
-51	-73	4
0	38	-5
0	-28	28
-27	-4	49
30	-49	61
-51	-70	1
51	-73	4
-3	38	1
-24	-4	49
27	-7	49
45	-40	-23
-18	-100	4
18	-100	16
18	-31	13
-18	-100	4
-12	26	4

// Woodard T L, 2013: Women with Hypoactive Sexual Desire Disorder (HSDD)
// Subjects=10
10	-23	9
10	46	12
27	-61	-24
51	-60	1
45	-64	-14
1	-19	6
-18	-13	21
-23	-71	-23
1	-81	-12
-25	-53	-25
0	-75	44
0	-60	42
-42	-52	-23
-1	21	24
-3	44	17
-27	2	-10
-37	-85	6
14	-11	2
-57	-33	22
-36	-69	-1
-50	-5	37
-53	9	26
-49	4	20
-15	-46	37
-14	-39	-3
-48	-72	8
-44	-42	34
6	45	28
-18	-71	39

// Woodard T L, 2013: Healthy Controls
// Subjects=6
14	-70	-8
34	1	-2
38	-1	10
48	-33	34
17	-11	5
49	-31	17
43	-8	8
-3	-64	2
1	-67	-4
-12	-37	-5
-36	-1	0
-34	-29	-8
-55	-37	21
-48	-3	41
14	-11	2
-57	-33	22
-36	-69	-1
-50	-5	37
-53	9	26
-49	4	20
-15	-46	37
-14	-39	-3
-48	-72	8
-44	-42	34
6	45	28
-18	-71	39

// Cai W, 2011: Not-Stop Task (NST) > Stop-signal Task (SST)
// Cai W, 2011: Color > Motion
// Cai W, 2011: Motion > Color
// Cai W, 2011: SST: All Stop > Go
// Cai W, 2011: SST: Stop > Go, Successful trials
// Cai W, 2011: NST: Not Stop > Go
// Cai W, 2011: SST: Successful Stop > Unsuccessful Stop
// Cai W, 2011: SST Unsuccessful Stop > NST Not Stop
// Cai W, 2011: Conjunction: (SST Stop - SST Go) and (NST Not Stop - NST Go)
// Subjects=23
-60	-51	-3
-33	-66	-18
48	-63	-3
-48	69	0
-27	-90	-12
-39	-63	-9
-33	-90	9
45	-66	-15
45	-54	-18
33	-84	-9
-30	18	-15
-51	39	12
-45	12	-30
-12	27	27
9	33	24
6	45	3
-24	39	36
-27	42	21
-27	51	30
18	-3	-21
-24	-15	-33
-3	-24	-3
-18	-9	-21
9	-63	6
18	-57	9
-51	39	12
48	45	3
-42	12	-9
36	12	-6
51	15	3
-48	9	27
48	8	30
33	42	30
-36	-69	-9
39	-72	12
-30	-90	-12
-15	-60	-39
24	-3	60
21	6	55
24	9	48
33	21	51
33	39	39
12	54	36
48	9	30
12	33	48
27	6	51
-51	39	12
-48	39	0
57	21	6
51	39	0
9	-6	6
-3	-24	-3
9	-9	51
9	0	42
-45	-69	-6
-27	-84	-12
-39	-78	-12
-21	-6	48
-51	3	27
-42	-3	42
-48	-6	36
-30	-3	63
-12	-3	69
33	-84	-6
42	-63	-15
48	9	33
45	-54	-18
39	18	18
48	27	12
21	-6	69
21	3	63
30	-57	45
-6	-30	-12
-21	-27	-6
-33	24	6
3	30	3
-48	6	-21
-12	-72	6
24	42	18
30	36	21
-48	-42	12
-21	-3	-3
-27	-15	-18
-15	6	-15
33	-6	24
39	-15	21
30	-21	-3
-9	-54	15
0	-60	21
15	-45	21
-48	-75	18
12	-30	63
21	-18	66
-33	-39	24
-36	-48	9
-24	-48	30
12	-9	51
51	-51	12
21	12	0
-15	30	48
-24	30	48
21	15	27
51	-3	15
12	9	-15
-6	-57	42
-12	-48	0
39	9	-24
33	27	0
33	18	6
-24	-69	24
-18	-69	39
-12	-75	51
0	0	54
-6	12	42
9	9	48
30	-3	51
18	-3	69
33	42	24
-54	-30	24
-60	-24	33
-57	-42	15
-21	-72	6
-27	39	21
-24	-3	45
-39	12	0
-54	12	-6
-48	0	-6
-39	-54	-21
-33	-57	-15
-30	27	-3
9	12	3
-30	-78	-12
-30	-87	-15
-42	-69	-6
33	-84	-9
42	-66	-15
45	-54	-18
-21	-60	45
48	9	30
-51	6	27

// Ghahremani D G, 2012: Stop > Go
// Ghahremani D G, 2012: Negative Correlation of Stop Signal Reaction Time and 
// Successful Stop > Go
// Subjects=18
36	20	-10
48	10	16
46	4	42
-32	18	-6
4	14	48
32	50	22
-34	46	22
64	-34	8
-62	-42	16
-16	-100	0
32	50	22
4	58	32
18	62	16
2	40	6
-40	46	6
-20	54	-12
20	14	-2
12	10	10
10	-4	8
-50	-60	40
-50	-72	18
8	-84	-30

// Jimura K, 2014: Stop > Go, Negative Correlation w/ Stop Signal Reaction 
// Time (SSRT) (Runs 3-12)
// Jimura K, 2014: Stop > Go, Negative Correlation w/ SSRT (Runs 8-12)
// Jimura K, 2014: Stop > Go, Negative Correlation w/ SSRT (Runs3-7 > Runs 
// 8-12)
// Subjects=46
10	-64	-24
-2	-84	6
-12	-66	-46
-12	-64	-46

// Bhasin A, 2012: 8 Weeks: Fist clenching/extension > Rest, Right hemispheric 
// stroke
// Bhasin A, 2012: 24 Weeks: Fist clenching/extension > Rest at 24 weeks, 
// Right hemispheric stroke
// Bhasin A, 2012: BOLD activation: Left hemispheric stroke patients > Healthy 
// controls
// Subjects=8
2	-36	0
-22	-30	-4
2	-74	0
30	-30	20
30	-38	18
-24	-24	22
2	-82	-22
40	-46	-10
24	2	62
18	32	6
4	18	10
-8	8	38
48	18	40

// Diserens K, 2010: Passive extension-flexion movements of the affected arm > 
// Rest
// Diserens K, 2010: Passive extension-flexion movements of the unaffected arm 
// > Rest
// Subjects=8
-27.19	-25.93	60.87
-38.96	-34.89	56.18
3.73	-9.97	58.06
1.69	-28.76	63.01
5.63	-29.96	19.57
-27.19	-25.93	60.87
-38.96	-34.89	56.18
3.73	-9.97	58.06
1.69	-28.76	63.01
5.63	-29.96	19.57

// Hendrick O M, 2010: Stop > Go
// Hendrick O M, 2010: Post stop- stop success > Post go - stop success
// Subjects=60
4	-20	-4
4	-24	-20
4	-24	32
8	28	32
8	20	56
-4	40	32
12	8	8
32	24	-4
44	12	36
48	12	52
32	-92	-8
44	-80	-8
60	-44	36
-12	4	8
-28	-96	-8
-60	-48	36
-40	-64	-12
-40	16	-4
4	-100	0
12	36	60
8	48	52
16	52	32
12	64	8
36	56	-4
44	28	28
48	20	48
40	20	56
-48	-68	-36
36	-84	-32
48	-60	52
52	-48	56
60	-56	32

// Page S J, 2010: Post-testing > Pre-testing: Wrist flexion/extension of the 
// affected hand > Rest
// Subjects=8
3.92	-38.25	1.88
41.21	-9.48	-.96
-13.27	0.22	5.55
38.22	15.79	37.1
12.58	-33.75	18.13
-29	-46.17	26.34
-35.7	-29.49	-5.09
-45.54	-12.05	-26.51
37.87	41.77	1.47
51.22	-25.12	43.73
19.17	-12.1	49.7
19.2	-67.83	30.95
-16.75	3.98	-28.19
-48.74	20.93	-12.51
-.54	25.68	3.26
47.68	-18.7	3.09
12.46	-21.83	7.1
-13.19	-15.38	10.2
-35.32	-84.79	22.96
-19.91	-21.93	-32.67
21.72	4.21	-28.65
12.9	-70.01	44.59

// Spunt R P, 2012: Stop Failure > Stop Success
// Spunt R P, 2012: Stop Success > Stop Failure
// Spunt R P, 2012: Stop Failure > Rest, Positive Correlation with Frustration
// Spunt R P, 2012: Stop Success > Stop Failure, Correlation with Frustration
// Spunt R P, 2012: Stop Failure > Rest, Negative Correlation with Frustration
// Spunt R P, 2012: Stop Failure > Rest, Positive Correlation with Response 
// Latency
// Spunt R P, 2012: Stop Failure > Rest, Negative Correlation with Frustration
// Subjects=15
-12	24	30
-12	48	6
-15	51	27
15	-57	-18
-3	15	57
6	-24	-12
-33	-90	15
42	-72	-12
27	12	-6
-6	27	27
-33	-30	54
-33	-36	57
33	24	6
-36	30	-3
12	9	66
-45	-9	-9
39	45	9
-30	-36	57
3	-15	57

// Veverka T, 2012: W0 > W4: Imaginary finger movement with the impaired hand 
// > Rest
// Veverka T, 2012: W4 > W11: Imaginary finger movement with the impaired hand 
// > Rest
// Veverka T, 2012: W0 > W11: Imaginary finger movement with the impaired hand 
// > Rest
// Subjects=14
-24	-74	58
-48	-44	58
-16	-64	38
-26	18	12
-20	64	18
12	50	42
4	34	58
-24	-74	58
6	52	32
-20	64	18
22	38	-24
48	-32	62

// Veverka T, 2014: Subgroup of stroke patients, Group A
// Subjects=7
-22	-78	-8
48	-62	-14
-20	-74	22
16	-84	44
-8	-98	-2
-10	-74	16
-32	-86	-2

// Veverka T, 2014: Subgroup of stroke patients, Group B
// Subjects=7
-14	-82	44
-26	-100	-4
-12	-28	52
18	-88	-32
30	-94	-4
28	-78	-20
34	28	-6
24	42	-20
36	20	12
56	14	-12
-52	16	12
-44	22	-6
-28	42	-10
2	-76	2
-6	-102	2
-46	-56	24
-50	-46	18
-44	-64	30
-58	-54	6
36	-78	-22
24	-82	-40
-8	22	50
-4	-10	30
-8	18	48
-58	-18	-20
-48	2	-32
-66	-24	-2
-48	-2	-28

// Wilbertz T, 2014: Stop > Go
// Wilbertz T, 2014: Main Effect of Reward: Rewarded stop > Nonrewarded stop
// Wilbertz T, 2014: Main Effect of Success: Successful stop trials > 
// Unsuccessful stop trials
// Wilbertz T, 2014: Reward x Success: Successful stop > Unrewarded stop
// Wilbertz T, 2014: Stop Success (Reward) > Stop Success (Nonreward), Stop 
// Fail (Reward) > Stop Fail (Nonreward)
// Subjects=24
30	20	-14
32	20	0
50	20	4
46	-28	-4
32	52	-4
34	-56	44
56	-44	28
36	-44	-20
24	-58	4
14	-64	8
6	26	36
0	-30	28
2	16	46
24	56	28
10	-8	6
6	-26	-2
18	-34	0
6	-14	-6
16	-40	-6
10	-14	14
8	-22	10
-30	22	0
-32	16	-10
-44	6	30
-50	28	32
-46	36	28
-28	56	24
-44	52	-8
-44	48	2
-24	42	-16
-24	46	-14
-30	-4	46
-26	2	50
-28	48	16
-40	-62	-14
-32	-50	44
-36	-54	-18
18	-68	6
-54	-50	10
-62	-34	-14
-8	-72	12
-32	-58	-34
-26	-70	-30
-14	-40	-2
0	-22	-20
30	18	-12
-4	42	8
-46	48	-6
-40	38	-16
-30	16	-14
-34	14	-2
-2	-22	-18
-26	2	8
-38	-4	16
-48	2	6
-56	-20	18
-44	-24	20
-58	-20	48
-32	18	12
-44	-36	24
-62	-22	26
58	-14	20
58	-4	-6
-8	10	-10
10	12	14
6	14	-6
-8	4	16
-6	15	8
-10	-18	4
-12	-8	22
-8	40	-12
-2	50	-10
0	60	-12
-40	40	-12
-20	68	10
-28	60	2
-4	68	14
-4	14	36
-24	20	60
-26	28	54
-32	16	60
30	30	54
-22	30	-18
-22	22	-20
26	30	-20
-38	-78	40
-44	-78	30
48	-74	32
-32	-84	34
24	-58	-22
20	-66	-20
4	-46	36
-10	-54	10
10	6	-12
-12	4	-12
36	14	-8
-2	42	6
8	36	22
-32	16	-12
-34	14	-2

// Andres M, 2012: Arithmetic > Letter reading
// Andres M, 2012: Multiplicaton > Subtraction
// Andres M, 2012: Finger task > Colour task
// Andres M, 2012: Right hand > Left hand
// Andres M, 2012: Left hand > Right hand
// Subjects=18
-28	-72	42
-32	-58	42
32	-70	42
42	20	-2
48	-40	48
-60	14	0
60	-2	-2
-20	-68	62
-38	-44	50
-48	-69	-2
44	-40	52
30	-72	40
54	-60	-8
-28	-4	50
38	26	-4
26	-2	56
50	32	30
-46	4	34
-46	-22	62
42	-20	62

// Watanabe R, 2011: Third-person > First-person
// Watanabe R, 2011: First-person anatomical > Motor control
// Watanabe R, 2011: First-person specular > Motor control
// Watanabe R, 2011: Third-person anatomical > Motor control
// Watanabe R, 2011: Third-person specular > Motor control
// Subjects=15
-36	-8	64
38	-64	22
52	-56	26
52	-72	24
-22	8	46
24	-32	-14
38	-28	14
-56	-68	24
30	-52	4
-12	-64	24
46	-16	18
-54	-16	14
-48	8	12
-10	-66	20
8	-78	18
34	-20	12
-46	14	12
52	-70	30
-56	-66	36
-50	-76	22
-54	-14	18
-26	-46	6
-30	-54	-4
-12	-64	24
-52	16	8

// Bouhassira D, 2013: Healthy Controls
// Subjects=11
-54	-18	18
48	-4	32
16	-10	-4
-36	18	0
-4	36	24
0	-20	34
32	42	32
-32	32	34
-36	-74	-38
-36	-29	48
-24	-32	68
64	-34	24
-46	-40	40
-38	-24	62
-12	14	60
-14	-14	10
-38	8	16
-36	-14	2
-14	32	26
-28	52	28
52	12	10
-22	24	54
-20	-78	-20
28	-10	8
14	26	-2
28	-28	-20
-34	17	-7
0	-26	36
-48	22	16
32	50	11
-22	62	14

// Bouhassira D, 2013: Patients
// Subjects=10
60	-10	16
-54	-20	26
2	-14	48
-36	20	-12
-8	32	18
-42	32	20
-12	-68	-16
20	6	-8
-37	-38	61
52	-19	31
52	-16	16
-47	-26	19
-54	-46	52
48	-8	44
-8	-16	54
18	-20	2
-34	16	-10
38	-17	3
6	14	26
0	-28	36
-40	48	8
30	54	22
44	42	22
26	26	56
10	-68	-10
26	4	4
-34	17	-7
0	-26	36
-48	22	16
32	50	11
-22	62	14

// Hall G B C, 2010: Healthy Controls
// Subjects=6
11.83	-.28	3.63
-6.34	1.72	3.67
-60.68	-46.36	6.09
-60.92	6.08	-3.88
35.32	-12.37	-3.44
-41.56	-12.23	5.24
-38.06	7.24	50.41
-3.28	38.75	0.53
-3.93	26.57	49.51
-3.39	26.64	-18.53
37.41	58.51	18.48
-25.57	57.68	27.08
8.6	42.31	17.94
22.93	-45.4	38.51
17.37	4.01	31.08
-5.14	21.76	28.74
16.47	-1.95	50.55
-35.83	-31.32	46.92
5.5	-19.27	6.41
-4.29	-27.73	-19.54
-21.42	-17.17	-19.11
-24.47	-47.43	-10.96
-26.9	-2.11	-30.35
-50.13	-63.07	-18.28
-2.64	-73.31	37.8
11.52	14.07	-31.03
-52.37	31.4	6.17
51.6	-28.37	22.25
51.72	-52.43	27.62
45.27	-66.02	17.68
22.97	-52.63	41.34
12.22	-68.7	27.2
16.09	51.24	22.68
-37.35	48.63	21.28
27.81	16.9	4.23
10.75	13.89	8.03
7.48	23.13	3.94
61.18	-16.59	22.27
-43.6	9.64	26.85
-4.29	-26.58	-18.52
-37.38	-50.56	-22.82
-26.61	2.03	9.45

// Hall G B C, 2010: Patients
// Subjects=7
-11.84	-60.32	-41.25
27.28	-74.18	37.53
-23.96	-73.98	44.79
-25.12	-58.47	39.04
3.53	-74.7	5.5
13.98	-2.38	3.78
-5.24	-2.33	6.22
-32.65	-13.96	51.01
-31.01	3.98	-6.28
6.74	17.66	43.44
-1.3	29.39	-24.36
13.73	23.65	-17.36
10.47	48.3	-14.93
22.56	61.74	33.99
8.6	42.31	17.94
22.93	-45.4	38.51
17.37	4.01	31.08
-5.14	21.76	28.74
16.47	-1.95	50.55
-35.83	-31.32	46.92
5.5	-19.27	6.41
-4.29	-27.73	-19.54
-21.42	-17.17	-19.11
-24.47	-47.43	-10.96
-26.9	-2.11	-30.35
-50.13	-63.07	-18.28
-2.64	-73.31	37.8
11.52	14.07	-31.03
-52.37	31.4	6.17
51.6	-28.37	22.25
51.72	-52.43	27.62
45.27	-66.02	17.68
22.97	-52.63	41.34
12.22	-68.7	27.2
16.09	51.24	22.68
-37.35	48.63	21.28
27.81	16.9	4.23
10.75	13.89	8.03
7.48	23.13	3.94
61.18	-16.59	22.27
-43.6	9.64	26.85
-4.29	-26.58	-18.52
-37.38	-50.56	-22.82
-26.61	2.03	9.45

// Jensen K B, 2010: Painful > Non-painful
// Subjects=83
10	-24	-12
-24	0	-8
-28	-24	70
-40	-18	16
2	20	32
-54	0	0
56	-16	8
26	-56	-24
38	6	2
10	-4	2

// Jack A, 2011: Conjunction Analysis: IMI & OBS & EXE
// Subjects=15
-34	-40	42
38	-84	8
-58	10	22

// Langner R, 2014: Conjunction: Encoding and Recall Epochs for both 
// hands/delays
// Langner R, 2014: Left > Right-hand sequences
// Langner R, 2014: Right > Left-hand sequences
// Langner R, 2014: Delayed > Immediate recall
// Subjects=36
-1	-2	56
-44	-42	50
-54	5	33
-33	-9	62
-51	-36	21
-35	23	0
-1	15	42
-51	8	18
-30	-56	65
-15	8	-3
-39	-56	-30
-18	8	-1
-38	27	27
-17	-69	-24
-32	-60	42
-56	-54	2
-60	-15	23
-17	-12	9
47	-39	47
3	-2	54
40	-36	44
33	-60	-27
44	-45	48
51	8	21
30	-6	62
57	8	33
33	23	-1
15	-74	59
21	6	0
9	-68	48
51	-33	-3
8	14	33
20	9	6
41	30	24
60	-56	-8
5	-72	-20
18	-15	14
-33	-48	-26
45	-35	51
30	-12	60
38	-28	42
39	-28	42
30	-53	59
34	-27	50
8	-6	54
36	-26	57
45	-34	57
20	-62	68
17	-20	2
-41	-35	51
-41	-32	50
-32	-18	57
-32	-33	48
-36	-47	66
-36	-23	57
-37	-28	53
-8	-8	53
-28	-53	67
-17	-21	5
-51	-18	47
33	-50	29
-57	-15	29
-60	-15	15
-29	6	-5
-44	-23	36
-57	3	30
-51	-23	36
-36	-48	60
-11	14	32
-30	-54	65
-9	-14	69
-38	-17	51
-35	3	5
-56	2	20
-62	-3	8
3	-5	59
51	-17	39
24	5	-6
8	6	41
62	-32	17
23	5	2
41	-32	42
59	5	17
39	-12	51
62	-17	20
41	3	3

// Rusconi E, 2014: IIBT > IINT
// Rusconi E, 2014: IINT > IIBT
// Subjects=13
-25.22	-2.27	56.85
27.59	-1.74	54.55
-52.05	7.05	28.51
-55.66	-27.27	36.32
-36.45	-35.32	43.7
-17.47	-61.88	55.24
20.59	-59.86	49.7
47.08	-29.22	-2.43
-3.04	-43.55	22.76

// Zhao Y, 2011: Healthy Controls
// Subjects=14
-56.27	22.73	-3.64
46.32	29.37	-7.16
-52.83	3.47	8.3
46.57	0.63	6.88
33.08	26.19	-29.03
58.4	-12.92	-.94
-56.25	17.42	-3.11
-44.42	12.69	-8.45
-52.68	4.62	20.51
-50.84	7.66	-4.48

// Zhao Y, 2011: Subgroup of Patients, Contralateral Pain
// Subjects=8
64.89	-4.08	1.44
4.56	27.67	22.85
4.64	18.41	27.13
36.34	55.85	-21.94
-50.61	17.07	15.88

// Zhao Y, 2011: Subgroup of Patients, Ipsilateral Pain
// Subjects=6
17.71	-22.37	26.46
-59.55	19.22	-6.59
53.07	16.07	10.85
-55.99	10.67	16.6
-41.31	1.88	-20.88
36.41	31.18	-21.74
-47.37	7.2	13.44

// McKenna B S, 2014: Bipolar Disorder < Healthy Controls, Encode Interval
// McKenna B S, 2014: Bipolar Disorder > Healthy Controls, Maintenance 
// Interval
// Subjects=23
3.46	-61.09	0.62
-51.48	-47.86	17.8
-.99	52.73	68.33
-1.18	84.72	39.5
53.72	61.19	-8.04
-51.71	29.13	34.73
-56.18	69.22	0.93
-5.52	91.19	8.01

// Pomarol-Clotet E, 2012: Manic Patients
// Subjects=29
-42	16	26
44	-2	36
-26	-62	38
34	-58	38
-46	-76	-8
-24	-6	4
16	-2	6
-8	-52	26
-2	62	4
-32	-2	54
12	-72	56
22	-6	58
-2	42	-2
34	18	-36
-28	12	-24
-2	42	-2

// Pomarol-Clotet E, 2012: Healthy Controls
// Subjects=46
2	20	44
-38	60	18
0	50	-10
4	-52	26
24	-42	74
-32	-32	72
-48	-76	30
-32	-2	54
12	-72	56
22	-6	58
-2	42	-2
34	18	-36
-28	12	-24
-2	42	-2

// Wu G, 2014: 2-Back, Deactivation across all groups
// Subjects=20
0	-49	28
-3	56	22
51	-70	19

// Pereira C S, 2011: Familiar > Unfamiliar
// Pereira C S, 2011: Unfamiliar > Familiar
// Pereira C S, 2011: Like > Dislike
// Pereira C S, 2011: Dislike > Like
// Subjects=14
-20	-2	-18
-54	16	-10
4	-6	56
2	14	-8
22	-2	-18
0	0	66
12	-16	16
-10	-6	10
-2	14	-8
-16	8	-12
26	8	-4
2	12	40
-14	-8	-20
-44	22	-10
0	8	48
8	10	-8
-38	-32	62
-38	-26	16
-42	-78	-4
16	-92	20
6	-6	60
14	44	8
-2	58	-6
-2	-8	62
-28	20	48
58	10	10
-52	18	14
-22	28	50
-48	-12	-2
-60	-22	2

// Morris R W, 2012: Healthy Controls
// Subjects=15
43.94	45.24	-21.02
55.03	29.92	-1.76
-22.21	38.06	43.57
-49	0.92	-30.74
-11.88	71.77	13.17
50.51	15.28	-20.4
11.9	52.29	10.21
43.95	43.11	-20.81
43.94	45.24	-21.02
9.76	48.03	10.67
-16.02	60.03	25.61
52.85	29.71	-3.94
-13.27	18.48	63.29
-48.87	34.69	-13.91
-44.28	45.5	9.6

// Morris R W, 2012: Bipolar-I Disorder
// Subjects=13
43.94	45.24	-21.02
55.03	32.05	-1.97
28.75	25.01	-29.96
50.51	15.28	-20.4
11.9	52.29	10.21
43.95	43.11	-20.81
-53.16	26.17	-12.99
54.73	40.82	-23
7.81	51.81	28.25
-45.84	17.12	50.53
-3.17	67.96	17.88
57.11	29.31	-8.46

// Morris R W, 2012: Schizophrenia
// Subjects=12
55.03	29.92	-1.76
-22.21	38.06	43.57
-49	0.92	-30.74
-11.88	71.77	13.17
55.03	32.05	-1.97
28.75	25.01	-29.96
43.94	45.24	-21.02
9.76	48.03	10.67
-43.78	-1.14	38.85

// Duerden E G, 2013: Healthy Controls
// Subjects=20
24	38	31
21	17	49
36	17	46
-48	23	28
30	14	28
0	-28	34
30	17	-11
-15	-40	46
9	-43	61
42	-70	34
51	-49	43
54	-55	1
42	-52	-17
27	-49	-20
36	17	46
24	17	49
45	23	19
33	-73	-8
21	17	49
48	23	19
33	-73	-5

// Duerden E G, 2013: Autism Spectrum Disorder (ASD)
// Subjects=19
48	23	19
-33	26	-14
48	26	4
3	32	13
-33	5	7
48	-46	1
36	-73	-8
27	-46	-26
-36	-67	-26
-6	-49	-2
36	17	46
24	17	49
45	23	19
33	-73	-8

// Duerden E G, 2013: Subgroup of ASD, Autism Diagnostic Observation 
// Schedule-Generic (ADOS-G) Cutoff Participants
// Subjects=13
33	23	-17
-33	23	11
48	23	19
36	-73	-8
-30	-73	13
-45	-49	34
33	14	-35
3	32	10
21	17	49
48	23	19
33	-73	-5

// Fan J, 2012: Alerting, Healthy Controls (HC) > Autism Spectrum Disorders 
// (ASD)
// Fan J, 2012: Validity, HC > ASD
// Fan J, 2012: ((Moving+Engaging), HC > ASD
// Fan J, 2012: Disengaging, HC > ASD
// Fan J, 2012: Orienting, HC > ASD
// Fan J, 2012: Flanker (incongruent-congruent), HC > ASD
// Fan J, 2012: Alerting for Flanker, HC > ASD
// Fan J, 2012: Orienting for Flanker, HC > ASD
// Fan J, 2012: Validity for Flanker, HC > ASD
// Subjects=12
-38	36	28
-36	28	40
-46	16	44
6	6	2
-12	18	14
12	48	-12
12	22	-8
18	34	-14
-36	44	14
-24	46	4
-46	-52	48
22	52	26
26	44	20
0	36	26
4	34	12
-8	36	22
48	-46	48
54	-46	38
52	-54	40
8	-16	38
0	-14	38
4	-2	38
-18	-56	-26
-34	-38	-10
-38	-70	-8
-26	-40	-12
32	8	-30
32	16	-18
-38	28	38
-6	30	18
-2	34	10
10	40	8
48	-40	36
46	-46	44
56	-50	30
-26	-24	-20
-34	-38	-10
30	8	-14
32	8	-28
-2	34	24
0	28	32
2	2	36
20	50	14
-32	-60	30
-38	-68	28
-6	-74	-18
4	14	46
-6	16	40

// Nelissen N, 2011: Primary Progressive Aphasia (PPA)
// Subjects=19
45	6	-33

// Nelissen N, 2011: Alzheimer's Disease
// Subjects=15
54	9	-6
63	-21	15

// Nelissen N, 2011: Control Group
// Subjects=37
54	9	-6
63	-21	15
45	6	-33

// Wierenga C E, 2011: Probable Alzheimer's Disease
// Subjects=10
41.77	5.61	8.36
41.82	10.53	16.87
16.42	37.06	59.55
54.46	32.84	1.47
7.3	70.62	-1.15
63.22	13.11	20.87
45.92	76.8	20.19
11.72	39.27	5.89
50.16	30.36	-2.73
33.07	47.86	4.92
11.72	39.27	5.89
50.16	30.36	-2.73
54.52	7.12	-.83
16.08	35.75	15.05
37.43	22.5	7
41.51	48.99	-8.65
12.07	20.86	43.11
45.98	13.75	3.17
58.83	42.69	18.44
33.34	39.68	36.83
41.58	47.57	0.39
37.44	29.19	10.9
20.62	18.8	43.19

// Wierenga C E, 2011: Healthy Controls
// Subjects=22
50.48	18.29	33.97
46.17	17.92	29.59
28.98	60.8	35.11
41.48	75.06	-1.92
12.15	45.84	63.32
33.13	68.26	21.05
24.94	45.57	58.74
3.22	63.85	21.77
41.76	27.45	15.46
24.65	38.26	19.21
12.01	22.46	36.29
7.62	21.24	20.83
11.72	39.27	5.89
50.16	30.36	-2.73
33.07	47.86	4.92
11.72	39.27	5.89
50.16	30.36	-2.73
54.52	7.12	-.83
16.08	35.75	15.05
37.43	22.5	7
41.51	48.99	-8.65
12.07	20.86	43.11
45.98	13.75	3.17
58.83	42.69	18.44
33.34	39.68	36.83
41.58	47.57	0.39
37.44	29.19	10.9
20.62	18.8	43.19

// Frings L, 2010: Controls > Patients, Naming Task
// Frings L, 2010: Patients > Controls, Naming Task
// Subjects=6
-54	-12	39
-48	-72	0
54	-6	30
-48	-24	9
-39	-48	-18
48	-63	-15
63	-3	18
-18	-30	60
-60	3	3
33	-27	-21
-6	-57	33
63	-12	-18
-3	-66	51

// Fonzo G A, 2010: Intimate-Partner Violence with PTSD (IPV-PTSD) > Controls, 
// Fearful > Happy
// Fonzo G A, 2010: Controls > IPV-PTSD, Fearful > Happy
// Fonzo G A, 2010: IPV-PTSD > Controls, Angry > Happy
// Fonzo G A, 2010: Controls > IPV-PTSD, Angry > Happy
// Fonzo G A, 2010: IPV-PTSD > Controls, Male > Female faces
// Fonzo G A, 2010: Controls > IPV-PTSD, Males > Females faces
// Subjects=12
-2.82	-38.33	-41.19
-46.51	21.31	28.02
-45.81	-3.38	39.01
50.31	-72.4	17.26
46.69	6.76	8.99
32.04	64.8	3.85
-10.43	-49.52	48.83
-4.44	6.53	31.23
-58.91	-6.19	-11.46
-33.76	-6.38	34.88
-47.3	11.72	-9.3
-25.29	-18.74	47.64
-36.95	-44.86	-34.45
4.83	49.34	17.05
1	37.8	-13.49
44.19	-47.79	37.46
20.2	-61.98	39.04
-45.11	-61.61	23.59
-50.02	-5.46	33.1

// Ham T E, 2014: Controls for Stop Signal Task
// Subjects=25
62	-6	26
60	-4	6
46	6	-2
-34	2	6
-46	16	6
-60	-10	32
-14	6	14
-28	0	10
26	8	10
28	24	42

// Ham T E, 2014: Low-Performance Monitoring (PM)
// Subjects=18
62	-6	26
60	-4	6
46	6	-2
-34	2	6
-46	16	6
-60	-10	32
-36	-18	40
-44	16	6
-46	-16	14

// Ham T E, 2014: High-Performance Monitoring (PM)
// Subjects=30
-36	-18	40
-44	16	6
-46	-16	14
-14	6	14
-28	0	10
26	8	10
28	24	42

// Landr L, 2012: PTSD patients
// Subjects=17
-25.7	-2.6	43.4
35.6	-76	13.9
-17.8	-60.5	51.8
-31.7	21	51.4
-7.9	-45.7	36.3
63.4	-16.2	5.4
43.6	-46.8	53
35.6	20.3	-1.8
-47.5	-10.2	8.8
-9.9	57.1	34.9
-25.7	-83.3	-15.2
-41.6	20.1	-5.2
-7.9	57	33.1
-11.8	38.3	46.9
-23.7	-80.8	34.4
0	-47.6	38.3
-3.9	-49.4	42.1

// Landr L, 2012: Controls
// Subjects=17
25.7	-72.3	10.1
25.7	-72.3	10.1
-27.7	-4.7	41.7
21.8	5.9	61.4
5.9	14.7	42.5
45.5	8	24.5
3.9	28	36.4
-35.6	-60.6	50
33.6	-74.8	-39.1
-5.9	-81.8	-23.6
-47.5	-10.2	8.8
-15.8	57.1	34.9
-29.7	-82.9	-6.8
-11.8	38.3	46.9
-23.7	-80.8	34.4
0	-47.6	38.3
-3.9	-49.4	42.1

// Linnman C, 2011: PTSD > Trauma-exposed Non-combat Controls, Unconditioned 
// Stimulus
// Subjects=19
-22	0	-6
18	10	-12
-22	-4	48
-18	-38	-4

// Mazza M, 2012: PTSD > Healthy Controls
// Mazza M, 2012: Healthy Controls > PTSD
// Mazza M, 2012: Main Effect of Priming, All Subjects
// Subjects=10
49.2	-5.86	-3.03
-18.25	-14.15	-21.63
-11.46	-99.25	-7.88
-27.62	31.14	28.21
20.66	20.28	48.64
-46.81	-1.46	21.13
55.64	-5.56	0.22
43.23	-34.28	42.92
17.57	-57.67	31.79
-27.42	-30.44	30.03
-24.08	-44.46	41.2
58.96	-30.67	5.63
-47.02	-62.93	-30.59
-24.2	-88.52	8.09

// Moser D A, 2013: PTSD patients
// Subjects=11
-30	-28	-18
-28	-36	-18
-16	-24	-22
-22	-18	-26
-6	-24	38
-44	-32	22
56	-6	-18
54	2	0
-32	-22	60
-42	-16	58
-54	-20	54
-18	-12	66
-48	4	20
-56	14	12
20	-18	-12
-22	-20	-22
-14	-26	-20
-26	-20	64
-12	-18	46
-14	-20	70
6	-38	-22
-10	-46	-18
-16	-46	-26
48	26	28
-20	-12	62
-20	-10	70
50	20	-6
44	26	-14
-14	-42	44
-8	-38	52
-2	-24	38
0	-16	34
32	-14	-28
20	-20	-22
-34	-46	-24
-40	-36	-16
-24	-34	-16
56	6	0
44	-8	-22
46	-20	-14
54	-8	-22
-62	-46	6
-58	-52	0
-2	-42	48

// Sozda C N, 2011: Severe Traumatic Brain Injury (sTBI)
// Subjects=10
-2.13	-16.45	-11.58
26.77	-22.37	-8.08
33.13	19.94	1.69
-47.04	25.8	2.12
-11.6	34.41	27.75
4.14	-40.93	-39.71
-37.28	-54.99	-11.3
-47.12	5.22	-16.23
26.78	-18.94	-5.02
10.87	-7.98	14.32
-11.56	-4.68	17.65
26.73	56.33	18.78
-20.85	-63.98	36.11
24.08	-69.8	39.43
4.65	-19.16	35.4
-30.81	41.15	34.1
-43.33	-5.13	55.97
-17.7	11.31	59.87
10.97	-82.74	-2.83
-17.85	-79.22	3.9
62.09	-8.44	3.73
7.81	-55.84	15.02
-43.57	-10.96	21.89
-36.88	-77.28	30.72
17.3	21.9	28.47
17.44	-16.17	31.66
-46.75	15.68	36.42
43.21	-27.94	42.39
46.27	10.15	39.16
-27.31	-18.33	49.08
-33.51	-46.94	64.94
17.78	-19.17	75.4
20.51	18.74	28.7
-11.84	-53.72	-38.46
33.13	19.94	1.69
-50.21	22.87	5.74
14.1	18.7	28.77
-11.58	34.67	31.07

// Sozda C N, 2011: Healthy Controls
// Subjects=12
-2.13	-16.45	-11.58
26.77	-22.37	-8.08
33.13	19.94	1.69
-47.04	25.8	2.12
-11.6	34.41	27.75
4.14	-40.93	-39.71
-37.28	-54.99	-11.3
-47.12	5.22	-16.23
26.78	-18.94	-5.02
10.87	-7.98	14.32
-11.56	-4.68	17.65
26.73	56.33	18.78
-20.85	-63.98	36.11
24.08	-69.8	39.43
4.65	-19.16	35.4
-30.81	41.15	34.1
-43.33	-5.13	55.97
-17.7	11.31	59.87
10.97	-82.74	-2.83
-17.85	-79.22	3.9
62.09	-8.44	3.73
7.81	-55.84	15.02
-43.57	-10.96	21.89
-36.88	-77.28	30.72
17.3	21.9	28.47
17.44	-16.17	31.66
-46.75	15.68	36.42
43.21	-27.94	42.39
46.27	10.15	39.16
-27.31	-18.33	49.08
-33.51	-46.94	64.94
17.78	-19.17	75.4
20.51	18.74	28.7
-11.84	-53.72	-38.46
-15.03	-50.31	-35.36
-8.57	-10.15	-12.04
33.04	15.74	-11.34
-47.04	25.8	2.12
50.66	-67.76	22.22
-11.59	31.24	28.02
-4.78	-47	47.88
-11.32	14.26	56.2

// Terry D P, 2012: Mild Traumatic Brain Injury (mTBI), Athletes
// Subjects=20
-2	0	58
-44	-4	13
39	-27	60
-57	-21	18
22	-57	-23
-20	-54	-23
-44	-13	54
58	-15	19
-56	-22	39
57	11	25
-58	6	22
-8	9	55
-48	26	25
-26	-70	36
-33	-87	6
39	-87	-3
34	-64	-30
44	15	-9
-46	9	0
28	-90	7
54	8	39
-4	-60	40
-2	5	57
-33	36	27
44	-37	4
18	-49	28
-48	-3	45
-48	-46	18
-8	-67	39
-22	3	13
46	0	49
-30	-21	46

// Terry D P, 2012: Control, Athletes
// Subjects=20
-51	-22	45
48	-22	51
42	-3	12
-2	-1	54
62	11	25
51	-21	18
-30	-63	42
26	-57	40
30	-81	15
-3	-61	39
36	-82	-3
-4	0	59
-8	18	36
-46	-9	42
36	39	37
-56	-1	15
21	0	63
54	0	49
-24	-88	4
-58	-16	16

// Bogg T, 2012: Decision Period < Fixation
// Bogg T, 2012: Inflation Choice > Fixation
// Bogg T, 2012: Explosions > Fixation
// Subjects=27
-2	-86	6
8	-30	58
-12	38	-18
-32	-16	16
4	40	-22
4	-76	-4

// Chanraud S, 2013: Analysis of Variance (Group x Condition x Load)
// Subjects=15
48	47	7
-27	-70	-17
-42	-25	-43
-6	-40	37
-33	50	25
45	-19	46
18	-70	-11

// Chaunrad S, 2011: Alcoholics > Controls
// Chaunrad S, 2011: Controls > Alcoholics
// Subjects=15
42	-1	-14
-42	11	-14
45	-19	46
48	41	13
-33	50	25
-30	-67	-14
18	-70	-11

// Weiland B J, 2012: Negative Correlation with Resiliency for Entire Sample
// Weiland B J, 2012: 2-back > 0-back
// Weiland B J, 2012: 2-back < 0-back
// Subjects=34
20	-2	6
10	-14	-8
30	64	-6
26	48	-16
-46	28	28
44	26	32
30	24	-2
4	22	42
-34	20	0
30	6	54
42	-52	40
6	-62	48
-6	60	-3
14	40	46
-40	34	-14
50	-2	-26
36	-2	14
-40	-20	54
38	-30	64
-6	-46	24
-52	-64	30

// Gradin V B, 2013: Schizophrenia
// Subjects=14
-62.37	-8.29	20.83
-52.7	-8.67	16.22
-46.35	-3.09	6.59
60.71	0.24	13.41
58.61	-8.07	16.5
44.34	0.11	1.37
1.47	29.87	35.02
3.36	-22.48	3.18
-29.33	4.88	-12.41
26.97	1.55	-5.2
-57.66	-29.49	46.38
24.66	-52.11	-27.86
27.5	-80.91	19.76

// Gradin V B, 2013: Healthy Controls
// Subjects=18
-25	2.77	-12.28
-22.95	-3.58	-22.89
-35.53	-5.08	7.73
-66.74	-8.72	16.46
-22.73	-67.6	-18.8
33.49	-.35	-2.88
26.8	-2.99	-19.31
40.06	2.53	4.57
62.93	-8.05	16.43
22.68	-69.36	-17.16
-.6	20.7	40.44
5.37	-15.96	-7.58
-4.88	-91.77	20.27
7.12	46.62	-27.25
-1.23	65.24	0.19
-11.57	-52.85	12.05
-28.77	31.99	36.44
31.73	38.79	36.98
56.64	-74.43	18.62
-47.93	-76.43	37.41
14.38	29.5	30.35
-29.33	4.88	-12.41
26.97	1.55	-5.2
-57.66	-29.49	46.38
24.66	-52.11	-27.86
27.5	-80.91	19.76

// Grimm O, 2012: Food Images > Scrambled Control Images
// Subjects=23
30	-62	-12
-38	4	-12
46	16	-8
26	-42	-46
48	38	14
46	6	28
-24	-14	-20
-30	30	12
24	28	-16
0	2	28
-32	-54	-14

// Rausch F, 2014: Reasoning > Control
// Subjects=23
51	-43	46
30	-70	49
30	-76	31
36	20	-2
39	53	-5
30	26	-11
3	29	43
-30	20	-5
-42	44	-5
-21	47	-14
-45	26	31
-45	8	34
-42	2	58
63	-28	-20
-12	-4	-5
-18	17	61

// da Silva Alves F, 2013: Healthy Controls
// Subjects=12
37.98	-29.7	4.43
-.82	-46.64	9.01
41.83	17.17	-22.69
-16.37	18	-10.57
-2.49	24.9	62.47
-5.11	32.41	28.15
-15.98	29.62	21.89
-3.08	29.25	17.22
42.16	28.37	5.34
35.63	47.7	5.77

// da Silva Alves F, 2013: Schizophrenia
// Subjects=10
52.89	25.66	-1.3
35.63	47.7	5.77
39.88	14.36	-6.69
48.74	24.77	12.3
-5.29	35.42	14.41
52.91	28	0.71
37.68	18.4	-9.29
37.98	-29.7	4.43
-.82	-46.64	9.01
41.83	17.17	-22.69
-16.37	18	-10.57
-2.49	24.9	62.47
-5.11	32.41	28.15
-15.98	29.62	21.89
-3.08	29.25	17.22
42.16	28.37	5.34
35.63	47.7	5.77

// Polosan M, 2011: Incongruent (Human + Machine) > Congruent (Human + 
// Machine)
// Polosan M, 2011: Human (Incongruent + Congruent) > Machine (Incongruent + 
// Congruent)
// Polosan M, 2011: [Human (Incongruent > Congruent)] > [Machine (Incongruent 
// > Congruent)]
// Subjects=14
14.91	14.84	68.77
36.75	60.03	11.26
8.11	14.66	44.25
-40.43	6.29	49.27
52.91	21.41	-.88
17.37	35.29	11.8
36.75	31.55	5.11
40.8	-56.48	50.73
-27.08	-44.42	68.63
49.77	-68.65	-10.97
-10.95	-71.14	57.55
-1.28	-49.63	57.5
14.51	-99.77	14
-5.6	56.09	-5.56
-5.26	58.58	21.08
56.06	37.17	-4.74
-5.54	56.51	-1.12
-47.36	12.73	15.13
69.46	-25.15	16.89
36.46	-16.55	-27.1
33.7	-88.49	-4.25
-31.23	-73.08	-8.03
-28.06	-44.04	-7.59
60.14	-2.51	52.91
30.31	64.68	15.39
14.21	35.9	18.51
39.8	20.32	-11.76
-57.26	-60.83	-13.28
72.46	-49.97	-7.6
33.37	-44.97	-20.88

// Raboyeau G, 2010: Cognates > Baba, Early Learning Phase (T1)
// Raboyeau G, 2010: Non-cognates > Baba, T1
// Raboyeau G, 2010: Cognates > Baba, Consolidation Phase (T2)
// Raboyeau G, 2010: Non-cognates > Baba, (T2)
// Raboyeau G, 2010: [(Spanish Naming > Baba, T1 > T2]) masked by [(French 
// Naming > Baba, T1 > T2)]
// Raboyeau G, 2010: [(Spanish Naming > Baba, T2 > T1)] masked by [(French 
// Naming > Baba, T2 > T1)]
// Raboyeau G, 2010: Non-cognates > Cognates, T1
// Raboyeau G, 2010: Cognates > Non-cognates, T2
// Raboyeau G, 2010: Non-cognates > Cognates, T2
// Subjects=10
-48.53	-61.24	-6.67
-35.59	32.77	10.71
-52.71	12.06	19.77
-39.87	46.14	16.18
-26.21	-1.13	60.97
-7.05	20.89	42.77
-28.43	-51.93	45.86
-54.97	-71.89	-5.5
-9.21	-75.41	23.2
-31.52	39.63	-7.97
-19.87	6.57	51.13
-24.03	-66.59	49.48
-19.64	-61.7	55.64
37.58	28.62	-14.78
12.39	23.08	42.22
-52.68	-77.44	3.97
-50.42	2.06	27.45
-6.71	14.66	68.04
-13.77	30.05	26.29
-41.41	-25.82	50.22
-48.78	-69.69	-28.24
50.99	-64.31	0.91
14.48	5.03	32.77
26.69	-37.73	-34.92
-52.58	-72.35	12.43
-35.47	9.58	15.24
-27.11	46.86	0.2
-11.62	34.31	25.83
-43.6	-26.04	48.04
-19.47	-53.87	70.55
51.03	-68.35	3.55
22.87	-27.41	6.7
7.76	-53.62	2.83
13.77	-48.41	-33.65
-33.67	37.5	-7.72
-41.91	36.12	23.93
-43.93	21.85	32.1
-13.83	38.35	23.23
33.2	43.49	-16.18
-54.79	-.5	23.29
-31.15	-18.89	9.02
21.61	-9.72	81.17
9.46	-43.96	-31.77
-49.13	-2.25	-41.63
-17.83	7.88	42
-10.25	-59.08	-54.59
43.67	3.84	-50.53
54.88	-25.95	-25.36
29.6	-106.51	9.93
44.11	-27.91	-22.75
12.28	-1.77	29
50.84	26.49	7.62
27.13	55.3	18.61
38.25	9.58	34.16
30.02	-.51	64.43
43.01	-44.05	57.31
33.52	13.04	2.52
18.14	-10.78	-21.76
-33	-71.24	23.2
-50.52	-62.12	6.9
-15.8	17.9	34.25
-17.59	18.46	63.36
-24.14	-30.23	48.12

// Jurjanz L, 2011: Amnestic Mild Cognitive Impairment (aMCI) group
// Subjects=12
-9	-54	30
-9	45	15
57	-36	48
6	-60	21
-3	30	15
6	30	15
48	6	18
60	-57	-9
18	-60	-51
-39	-45	63
39	-21	51
39	-24	60
45	-24	21
57	-63	9
54	-27	24
57	-57	36
-54	-57	12
0	-63	33
30	9	-24
-27	-45	15
-36	-87	21
36	84	21
30	-39	-15
18	-75	-6
30	-3	51
30	15	63
-6	-61	35
6	-61	29
45	20	8
39	53	8

// Jurjanz L, 2011: Healthy Controls
// Subjects=12
-9	-54	30
-9	45	15
57	-36	48
6	-60	21
-3	30	15
6	30	15
48	6	18
60	-57	-9
18	-60	-51
-39	-45	63
39	-21	51
39	-24	60
45	-24	21
57	-63	9
54	-27	24
57	-57	36
-54	-57	12
0	-63	33
30	9	-24
-27	-45	15
-36	-87	21
36	84	21
30	-39	-15
18	-75	-6
30	-3	51
30	15	63
-9	45	17
-12	-51	30
-24	30	39
-30	24	-18
-51	6	12
-33	-12	51
-36	-42	45
33	-54	-51
51	-51	3
45	20	8
39	53	8

// Lenzi D, 2011: Single Domain Amnestic Mild Cognitive Impairment (sd-a-MCI)
// Subjects=15
-50	14	-18
62	-4	-8
-50	-62	-12
-38	30	-16
-8	50	44
36	30	-18
-24	-14	-16
22	-8	-20
-6	-62	14
-58	-16	0
62	-4	-8
-54	-42	0
-34	22	-6
-56	28	8
54	-36	44
54	-36	44
40	-62	48
4	18	46
56	16	8
26	22	-14
42	-2	44
38	-2	52
-28	-8	60
16	-10	72
32	-76	-20
44	-60	-18
-52	10	40
44	4	48
-44	20	30
50	26	14
-2	4	60
-34	-44	-24
34	-56	-28
-8	22	40
-26	-100	10
-38	-64	-24
40	-84	-12

// Lenzi D, 2011: Healthy Controls
// Subjects=14
-58	-20	-2
64	-6	-6
-56	-54	-16
-50	30	8
-8	56	32
-38	30	-14
-24	-14	-18
24	-8	-22
-8	-56	-2
-56	-16	2
62	-6	-8
-64	-34	-2
36	22	-8
-50	26	6
50	-34	46
-30	-56	54
-16	-66	52
48	18	-18
48	38	18
32	22	-8
42	4	32
36	0	54
-22	-6	48
4	32	46
24	-72	38
56	-54	-18
-44	6	36
54	4	44
-50	24	2
56	38	12
-6	10	56
-38	-54	-24
44	-52	-16
-16	8	42
-28	-98	12
-38	-68	-30
38	-68	-30

// Viinikainen M, 2010: Positive Linear Correlation between Negative Valence 
// and BOLD Activity
// Viinikainen M, 2010: Negative Linear Correlation between Negative Valence 
// and BOLD Activity
// Viinikainen M, 2010: Positive Linear Correlation between Positive Valence 
// and BOLD Activity
// Viinikainen M, 2010: Negative Linear Correlation between Positive Valence 
// and BOLD Activity
// Viinikainen M, 2010: Second-order Positive Correlation Across all Pictures
// Viinikainen M, 2010: Second-order Negative Correlation Across all Pictures
// Subjects=17
46.09	24.73	21.21
-31.09	25.13	-8.05
33.05	25.77	-5.49
-47.21	50.41	-9.98
23.33	54.26	-7.77
-15.18	56.94	-10.9
36.13	17.9	-24.94
20.18	-1.23	-23.15
-65.8	-38.62	37.84
-59.28	-40.72	51.33
46.1	21.55	21.48
-34.28	21.93	-7.74
45.89	29.27	-2.59
-4.92	17.47	55.86
14.19	29.51	44.59
14.09	21.88	28.51
-33.91	12.59	36.53
-46.89	20.74	19.27
-8.49	10.43	6.31
-14.74	-4.45	21.01
14.04	8.16	16.28
-33.79	-81.72	14.33
39.92	-74.94	12.91
-62.88	-38.25	0.98
4.38	-15.39	1.63
1.1	-22.78	-11.09
39.64	-48.18	-12.75
-27.71	-48.84	-15.27
-59.32	-37.81	47.74
65.71	-23.86	51.82
52.53	-4.56	13.55
49.31	28.18	24.23
-43.8	16.3	2.87
33.07	22.59	-5.23
-1.8	19.89	45.58
10.97	26.06	41.57
-59.79	26.49	12.24
-11.69	17.01	9.14
-33.78	-84.89	14.59
36.73	-78.13	13.21
33.19	-45.31	-16.26
-21.15	-60.47	-.98
43.04	3.27	33.08
14.09	-47.31	0.85
-27.72	-45.67	-15.53

// Vollstadt-Klein S, 2010: Spatial Working Memory > Control, Alcohol 
// Dependent > Heavy and Light Social Drinkers
// Vollstadt-Klein S, 2010: Positive Association between OCDS and Activations 
// During Spatial Working Memory Task in All Subjects
// Subjects=7
-12	42	26
-28	-28	-10
18	-12	-2

// Witt S T, 2010: Mild Traumatic brain injury (TBI)
// Subjects=33
39	42	18
-12	-15	3
-9	-18	-6
3	-24	-18
-63	51	24
-42	-36	63
6	18	45
-3	9	48
-48	12	9
-30	-12	69
57	-33	48
-33	-51	-36
-30	-57	-33
42	18	-12
-39	-18	66
-36	-24	69
-48	-27	27
-63	-39	24
-63	-21	18
-54	-25	48
-57	-21	45
66	-30	18
-51	-12	6
63	-12	3
63	-15	9
57	-21	-3
57	-36	9
-54	-36	9
-51	-93	12
-45	0	-3
-63	-30	6
-60	-21	12
24	-54	-30
-54	0	-9
-60	-36	15
-63	-15	0
60	-36	6
63	-12	0
57	-27	3
-60	-36	15
-63	-15	0
60	-36	6
63	-12	0
57	-27	3
33	15	-18
-15	15	-18
-24	-24	75
-48	12	9
-12	24	66
-63	-42	30
-39	-36	-27
-48	-60	-6
3	6	-15
-54	-72	-9
-15	-42	-30
-30	-39	-30
-3	-51	-21
0	-18	-6
39	-57	-42
-18	3	-27
-66	-18	27
66	-27	36
63	-30	45
24	-3	-36
12	51	6
48	21	30
18	-63	45
30	-69	60
33	24	24
-27	0	36
60	-63	24
0	27	0
27	33	45
-60	6	30
33	-51	66
33	-60	-45
63	-45	36
60	-3	18
-63	-3	18
-15	27	54
-30	24	54
-45	-15	27
-6	-6	36
45	-18	12
30	-3	-24
42	12	-21
-18	9	9
-9	-60	-48
21	-21	-24
60	-36	-15
-30	-96	15
-15	-63	21
9	-42	39
45	-72	24
-48	-60	15
-42	-45	9
39	-39	3
-30	-96	15
3	30	3
6	45	9
6	36	-9
6	-66	15
-12	-66	6
-3	-72	12

// Witt S T, 2010: Healthy controls
// Subjects=33
45	-27	18
-27	42	12
12	15	6
9	21	27
6	15	39
-6	6	39
30	21	-9
-42	0	3
39	9	-3
-6	-3	54
39	36	27
-36	-12	63
6	6	54
54	-42	45
-51	-36	36
-51	-24	51
-33	-24	48
54	-27	-3
-51	-15	3
63	-33	9
-45	-30	15
54	18	-12
-57	-30	15
-15	-18	12
15	-54	-21
-30	-57	-39
3	-69	-18
12	-57	-18
39	30	9
57	-12	-6
57	-30	0
-57	-12	-3
-63	-33	3
33	15	-18
-15	15	-18
-24	-24	75
-48	12	9
-12	24	66
-63	-42	30
-39	-36	-27
-48	-60	-6
3	6	-15
-54	-72	-9
-15	-42	-30
-30	-39	-30
-3	-51	-21
0	-18	-6
39	-57	-42
-18	3	-27
-66	-18	27
66	-27	36
63	-30	45
24	-3	-36
12	51	6
48	21	30
18	-63	45
30	-69	60
33	24	24
-27	0	36
60	-63	24
0	27	0
27	33	45
-60	6	30
33	-51	66
33	-60	-45
63	-45	36
60	-3	18
-63	-3	18
-15	27	54
-30	24	54
-45	-15	27
-6	-6	36
45	-18	12
30	-3	-24
42	12	-21
-18	9	9
-9	-60	-48
21	-21	-24
60	-36	-15
-30	-96	15
-15	-63	21
9	-42	39
45	-72	24
-48	-60	15
-42	-45	9
39	-39	3
-30	-96	15
3	30	3
6	45	9
6	36	-9
6	-66	15
-12	-66	6
-3	-72	12

// Van Hell H H, 2010: Non-users > Cannabis Users
// Van Hell H H, 2010: Cannabis Users > Non-users
// Van Hell H H, 2010: Cigarette Smokers > Cannabis Users
// Van Hell H H, 2010: Cannabis Users > Cigarette Smokers
// Van Hell H H, 2010: Non-users > Cannabis Users, Reward Outcome Activations
// Van Hell H H, 2010: Cannabis Users > Non-users, Reward Outcome Activations
// Van Hell H H, 2010: Cigarette Smokers > Cannabis Users, Reward Outcome 
// Activations
// Van Hell H H, 2010: Cannabis Users > Cigarette Smokers, Reward Outcome 
// Activations
// Subjects=13
-16	14	-10
16	13	-6
-12	8	3
12	8	3
-28	0	-3
32	23	-11
4	37	35
20	59	15
-28	52	27
-4	2	33
-20	-94	-5
-24	-93	5
-48	-68	20
40	-64	20
12	-76	24
24	-16	-24
-8	8	8
16	-4	20
-24	0	-8
-16	-8	16
48	20	-4
20	60	12
-24	56	28
-48	-68	20
-44	-28	-12
-36	-62	10
-12	-68	3
1	-62	10
20	17	30
28	33	40
33	-83	-6
36	0	-9
43	34	-14
53	-1	-13
55	-18	22
63	-30	31
62	-43	14
-51	-65	22
-55	-26	20
-27	-39	-8
-38	27	-4
-20	4	8
-8	-65	26
-14	-25	38
6	58	1
8	32	24
4	-18	29
12	4	7
19	8	-11
24	-72	30
22	-10	35
48	-6	34
48	10	32
43	78	15
-44	-40	-8
4	-60	14
28	49	-2
55	-6	-16
-55	-25	9
-24	14	8
0	59	15
1	2	34
25	0	18

// Gebauer L, 2014: Happy > Sad, ASD > Healthy Controls
// Gebauer L, 2014: (Happy & Sad) > Neutral, All Participants
// Gebauer L, 2014: Happy > Sad, All Participants
// Subjects=19
-24	34	42
-50	-2	8
-26	52	32
54	-14	6
-48	-16	4
54	-4	46
-6	42	-14
-6	-24	-6
-26	28	-14
-42	-18	54
10	0	58
-18	-10	-16
2	6	-6
46	28	-4
-36	26	2
38	34	-16
-56	-10	2
56	-12	4
-24	34	42
-8	46	0
-14	24	-10
24	2	-10
36	10	-22
-4	50	26
-52	-10	52
-58	-60	16
0	-22	42

// Kana R K, 2014: Autism Spectrum Disorder (ASD)
// Subjects=15
32	-52	42
54	38	2
22	-76	46
-30	-70	46
54	-64	12
4	-56	34
-48	-70	14
6	52	18
50	-62	18
-54	-66	16
4	-56	46
34	24	-12
-38	8	46
-32	24	-6
4	54	28
52	-30	48
27	-76	46
42	2	10
-22	-50	64
-60	-24	40
56	-26	48
-42	-4	0
46	48	-2
-4	-90	-6

// Kana R K, 2014: Healthy Controls
// Subjects=15
32	-52	42
54	38	2
22	-76	46
-30	-70	46
-60	-64	14
62	-52	16
-40	8	48
6	-54	48
40	-42	-22
46	10	44
34	20	-12
50	-62	18
-54	-66	16
4	-56	46
34	24	-12
-38	8	46
-32	24	-6
4	54	28
44	-40	62
-46	-40	54
-52	-2	2
44	2	-8
6	-24	56
56	-26	48
-42	-4	0
46	48	-2
-4	-90	-6

// Alaerts K, 2014: Emotion > Fixation, Healthy Controls > ASD
// Subjects=15
-45	-32	24
-17	-94	12

// Beacher F D C C, 2012: Asperger Syndrome (AS) > Healthy Controls, Verbal 
// Fluency
// Beacher F D C C, 2012: Males > Females, Verbal Fluency
// Beacher F D C C, 2012: Males > Females, Mental Rotation
// Beacher F D C C, 2012: Sex x Diagnosis Interaction, Mental Rotation
// Beacher F D C C, 2012: AS males > AS females >= Healthy Controls males > 
// Healthy Controls females, Verbal Fluency
// Beacher F D C C, 2012: AS males > AS females >= Healthy Controls males > 
// Healthy Controls females, Mental Rotation
// Subjects=14
-54	-62	-14
-48	22	-14
-42	-40	44
-24	-34	13
22	-16	-16
-20	-80	-22
-34	-90	16
-20	-88	-14
30	-90	16
46	-82	-4
-34	-48	50
32	-60	48
-26	-70	34
-22	-60	46
-50	-54	-18
-30	-2	56
-12	10	56
0	-88	-8

// Bird G, 2010: Other Pain - Other No Pain masked on Self Pain - Self No 
// Pain, Low Alexithymic
// Bird G, 2010: Other Pain - Other No Pain masked on Self Pain - Self No 
// Pain, High Alexithymic
// Bird G, 2010: Other Pain - Other No Pain masked on Self Pain - Self No 
// Pain, Low > High Alexithymic
// Bird G, 2010: Other Pain - Other No Pain masked on Self Pain - Self No 
// Pain, High > Low Alexithymic
// Bird G, 2010: Other Pain - Other No Pain masked on Self Pain - Self No 
// Pain, Healthy Controls > Autism
// Subjects=18
-12	12	36
-9	-30	42
-27	-18	-9
-9	6	0
57	-45	18
66	-3	-9
15	15	-3
21	-3	6
-3	27	48
0	-6	42
-57	-21	24
-12	-102	-6
57	21	0
42	3	36
54	-45	18
60	-27	-9
36	-63	-30
-21	-15	-9
-3	9	3
15	-12	-12
24	-6	0
21	-48	21
-39	24	24
24	-81	-9

// Gadgil M, 2013: Autism Spectrum Disorders (ASD)
// Subjects=16
42	-70	7
-42	-82	-5
39	2	55
-42	11	28
33	20	-5
-33	20	7
-33	44	13
48	-64	1
30	-91	-2
-36	-85	-5
-39	-79	4
30	-1	61
-33	-7	58
-42	50	4
-35	38	16
-39	23	4
15	-4	16
12	-16	10
27	-91	25
15	-91	16
45	-10	58
-51	-61	52
-39	-13	49
48	-73	-8
42	-64	-11
21	14	55
3	38	46
-3	38	37

// Gadgil M, 2013: Healthy Controls
// Subjects=15
-33	-85	-8
27	-58	52
39	20	4
-33	17	7
-54	8	40
48	11	25
-3	11	46
6	5	64
42	-82	-2
39	-55	55
33	23	1
-33	20	1
-48	11	25
39	38	25
-48	2	43
-30	47	25
9	-19	16
18	5	16
30	-91	-2
-51	20	25
45	-61	25
6	-28	52
-3	-28	52
-18	11	10
-51	26	7
6	50	43
-3	41	34
48	-73	-8
42	-64	-11
21	14	55
3	38	46
-3	38	37

// Georgescu A L, 2013: High-Functioning Autism (HFA)
// Subjects=13
66	-45	6
11	-60	23
45	-63	23
-32	-33	-18
-26	-36	-12
-38	23	48
-59	-12	-15
-47	-6	-33
-9	35	-29
24	-33	-14
32	-41	-9
-45	-66	21
56	-14	-27
51	-9	-20
-44	-65	20
0	15	-18
-2	48	-21
12	-60	21
-60	-12	-20
11	-50	60
57	-14	-18
48	-68	14
-9	33	15
5	27	18
11	38	-17
-38	-9	-6
-6	-80	38
3	-72	38

// Georgescu A L, 2013: Healthy Controls
// Subjects=13
47	-68	-2
-45	-72	2
48	2	6
41	8	3
12	-51	66
-5	-35	60
-51	-32	8
57	-41	12
47	-36	23
65	-47	15
-44	-65	20
0	15	-18
-2	48	-21
12	-60	21
-60	-12	-20
11	-50	60
57	-14	-18
48	-68	14
-9	33	15
5	30	18
-50	-62	23
-9	33	15
5	27	18
11	38	-17
-38	-9	-6

// Marsh L E, 2011: Autistic Spectrum Conditions (ASC)
// Subjects=18
44	-84	-14
32	-92	-4
36	-88	-12
-22	-102	-12
-52	-78	2
-30	-102	-8
-10	10	40
-8	0	46
-12	-4	70
-22	-74	0
-6	-90	-16
-26	-68	-4
-24	-10	38
-35	5	24
-25	-10	48
-56	-28	36
-35	-38	72
-60	-16	20
20	-50	40
30	-56	62
22	-70	54
-22	-100	-12
-36	-92	-12
-44	-86	-12
46	-84	-14
32	-94	0
34	-88	-12
-46	-10	18
-52	-24	18
-30	-26	18
18	12	34
-16	0	76
-12	-6	70
-14	-58	-12
-12	-88	-14
-6	-52	-20
-14	-102	-8
12	-102	-2
16	-88	-4
-22	-76	-12

// Marsh L E, 2011: Healthy Controls
// Subjects=19
48	-70	-2
-48	-76	-2
-44	-82	-10
-38	-48	64
-16	-50	76
-12	10	38
-24	-6	74
-6	0	44
22	-30	-2
6	-14	-12
8	-22	-16
-10	10	40
-8	0	46
-12	-4	70
-22	-74	0
-6	-90	-16
-26	-68	-4
8	60	6
-4	60	14
0	48	-6
38	-40	50
28	-64	54
22	-70	46
48	-72	-4
26	-96	-6
26	-92	-16
-44	-82	-12
-48	-76	-2
-50	-80	6
-6	-1	62
-10	10	36
-24	-6	74
64	-38	20
52	-35	24
48	-52	36
-36	-42	60
-32	-48	70
-52	-32	56
6	-22	0
6	-24	22
22	-30	-4
-46	-10	18
-52	-24	18
-30	-26	18
18	12	34
-16	0	76
-12	-6	70
-14	-58	-12
-12	-88	-14
-6	-52	-20
-16	-94	-20
0	-96	-16
-5	-92	-26
22	-88	-16
42	18	-16
34	12	4
36	-16	-20
56	-74	0
40	-62	-20
-48	-82	6
-28	-70	-8
-16	-78	-10

// Ohta H, 2012: Autism Spectrum Conditions (ASC)
// Subjects=24
16	-92	-6
-26	-28	-6
26	-26	-6
-22	-76	40
-46	36	34
-18	-76	40
-50	-46	58
-4	-62	58
30	4	56
-28	-62	40
24	-52	40
-42	16	28
-44	-72	8
-60	-2	-20
26	-18	-18
58	-4	4
48	2	-24
40	-10	12
-6	-62	24
-4	54	-4
-30	-90	2

// Ohta H, 2012: Healthy Controls
// Subjects=25
24	-102	4
-18	-76	40
-50	-46	58
-4	-62	58
-38	-52	50
32	-2	50
32	-70	36
-2	14	54
-2	-46	-18
-48	-56	-12
50	-10	12
-50	-76	30
-14	54	38
-6	-54	26
54	-14	58
-28	-102	-4
10	-16	48
-22	6	-24
16	-88	30
-40	-4	-14
-64	-26	14
-30	-90	2

// Redcay E, 2013: Autism Spectrum Disorders (ASD)
// Subjects=13
42	14	28
-20	-60	-24
-18	-90	28
-14	-74	-12
34	-74	20
-48	8	32
58	-38	18
6	-76	38
54	6	44
30	-20	44
-58	-8	18
14	-50	10
-28	-18	12
-22	-32	-16
10	30	-10
46	-42	6
6	62	18
28	8	4
32	-46	-6
30	-94	14
50	-4	14
-12	-28	64
-36	-14	14
38	54	18
-42	50	12
18	-90	26
-14	-82	4
-58	-34	24
0	20	52
8	-80	40
-56	-48	40
-50	12	-6
-20	-60	-14
-4	-54	60
-2	8	40
22	-58	-16

// Redcay E, 2013: Healthy Controls
// Subjects=13
0	-54	24
-54	-72	6
-10	-100	6
-42	-66	48
-62	-32	-8
44	-64	14
46	-42	6
2	58	32
6	-86	-12
-12	-82	16
-10	20	28
28	-52	52
28	8	8
58	-50	50
2	34	56
60	16	4
-28	48	24
-46	-48	42
-4	-42	48
64	-30	26
46	-46	14
2	-74	42
48	12	46
-48	20	0
2	8	56
50	26	-10
50	-64	12
-30	-28	-14
40	-16	12
2	-28	68
42	-80	-4
34	-10	-30
-30	-26	52
-26	-96	4
22	-34	-16
-60	-14	42
-20	-84	-4
-8	-14	54
26	-96	-8
-34	32	-16
10	-14	48
46	-42	6
6	62	18
28	8	4
32	-46	-6
30	-94	14
-10	-102	8
-2	-54	22
28	0	-22
14	-100	6
-48	-60	20
-28	0	-22
-4	-26	72
8	-88	30
8	-68	-14
14	0	6
-32	-84	16
32	-86	14
4	0	60
42	44	6
-56	-42	42
4	36	24
38	14	-4
60	14	4
-42	10	-4
-46	32	34
2	32	54
34	50	32

// Tanabe H C, 2012: (ES' + EN') - (BS' + BN'), Healthy Controls (3T) > ASD 
// (3T)
// Tanabe H C, 2012: (ES' + EN') - (BS' + BN'), Healthy Controls paired with 
// ASD (1.5T) > Healthy Controls (1.5T)
// Subjects=19
-22	-100	-6
32	-86	8
46	-62	2
-24	-86	8
-46	-68	2
58	10	26
50	24	24

// Yamada T, 2012: Autism Spectrum Condition (ASC)
// Subjects=25
-60	-32	-14
-48	-66	42
54	-54	50
-44	14	54
-42	50	-6
-52	-30	-14
-46	-70	48
56	-58	48
-20	20	62
32	26	52
32	52	-14

// Yamada T, 2012: Healthy Controls
// Subjects=26
-52	-30	-14
-58	-56	42
52	-74	32
-42	48	-8
22	60	20
24	24	62
-6	-62	34

// Caria A, 2011: Asperger Syndrome (AS)
// Subjects=8
-51	-39	27
69	-30	18
54	3	-9
-27	-72	-39
69	-33	3
45	-54	-45
-69	-36	21
63	12	21
57	30	-6
36	18	24
-39	15	21
24	9	12
18	6	15
15	57	30
33	33	51
-3	-81	-27
69	-18	-21
-3	48	45
6	-27	36
6	-48	24
-9	-51	18
-33	-33	21
3	-18	48
-3	48	-15
0	57	-6
6	-84	-6
3	-15	9
-3	63	63
-42	-42	12
51	-54	-39
69	-30	3
57	6	-9
-63	-42	15
63	-42	15
69	-27	21
54	30	15
60	15	9
36	-39	-33
45	12	54
69	-33	30
-51	15	-3
-18	-93	-21
12	-21	-9
-24	-81	51
6	21	70
21	-27	-12
36	60	12
-45	-18	0
0	15	69
27	-15	75
6	-15	60
36	-84	-27
0	-87	-33
-12	12	70
-39	6	15
-39	24	-6
39	-60	31
48	-60	-9
27	-15	75
-15	-3	63
-54	18	15
33	-87	-30
-21	3	60
21	-6	57

// Caria A, 2011: Healthy Controls
// Subjects=14
54	0	48
-6	3	75
6	9	72
-27	-60	-27
45	30	0
-51	-36	21
30	-57	-30
-24	6	9
48	-33	0
24	9	12
69	-33	24
48	-42	6
-36	12	3
-36	33	6
51	15	0
-12	-12	6
27	48	42
33	33	51
39	-27	12
33	33	0
-9	-24	-42
3	27	39
-30	18	-9
-36	-30	15
-15	-54	39
-63	-45	18
-9	42	21
-15	-9	6
-18	12	12
6	-30	-18
0	-24	42
-27	3	9
6	9	9
33	-39	-39
12	66	3
12	-6	0
54	3	48
-39	21	0
42	30	0
-54	21	-3
27	-15	75
6	-15	60
36	-84	-27
0	-87	-33
-12	12	70
-39	6	15
-39	24	-6
39	-60	31
48	-60	-9
27	-15	75
-15	-3	63
-54	18	15
33	-87	-30
-21	3	60
21	-6	57

// Damarla S R, 2010: Embedded Figures Task (EFT) - Fixation, Autism > Healthy 
// Controls
// Damarla S R, 2010: EFT - Fixation, Autism < Healthy Controls
// Subjects=13
-44	-38	64
20	-50	54
28	-40	56
-18	-56	58
26	-100	12
-8	42	38
-30	14	46
-20	-12	2
-62	-34	40
-42	-48	46

// Dichter G S, 2012: Monetary Anticipation, Healthy Controls > ASD
// Dichter G S, 2012: Monetary Anticipation, ASD > Healthy Controls
// Dichter G S, 2012: Monetary Outcome, Healthy Controls > ASD
// Dichter G S, 2012: Monetary Outcome, ASD > Healthy Controls
// Dichter G S, 2012: Object Anticipation, Healthy Controls > ASD
// Dichter G S, 2012: Object Anticipation, ASD > Healthy Controls
// Dichter G S, 2012: Object Outcome, Healthy Controls > ASD
// Dichter G S, 2012: Object Outcome, ASD > Healthy Controls
// Dichter G S, 2012: Anticipation, Group x Reward Type Interactions
// Dichter G S, 2012: Outcome, Group x Reward Type Interactions
// Subjects=15
-6	6	-4
-4	18	26
-36	-60	-26
8	-44	-28
40	20	4
-22	8	-20
-38	14	-12
40	6	-2
-8	-58	-8
14	-92	-6
44	-14	-6
-30	-16	70
30	-14	-10
38	18	-24
-50	-52	24
-20	56	30
26	-14	-26
-36	22	44
-64	-50	0
50	-20	60
-4	-60	46
-12	26	52
-58	-30	-2
66	-16	-4
-8	8	-10
48	34	-12
44	6	-10
-44	46	12
26	-10	-26
-44	28	6
0	6	62
40	-64	0
-32	-76	48
30	-66	28
-36	38	38
-64	-24	-10
-64	-50	-4
-44	-26	54
42	-24	52
-34	-4	56
30	-16	58
-14	28	58
4	20	58
-36	-52	64
-68	-36	8
-4	12	32
54	-56	20
-46	36	-2
26	40	44
-40	-64	14
-26	36	36
62	-22	-6
-4	54	8
6	54	6
-34	-34	42
44	-30	56
48	-10	56
-6	-72	30
60	-22	2
-40	16	22
-36	-84	24
-18	-80	-6
-24	-94	2
18	-52	72
-26	-52	-12
-58	-56	12
10	-44	28
-26	16	-26
6	56	-10
28	38	42
-24	62	-8
-38	-64	16
-58	-14	-14
66	-46	2
-62	-24	10
10	-66	28
6	30	36
-6	18	-14
0	2	-6
-18	22	10
-16	12	16
28	-52	-30
4	-66	-14
-32	24	-22
-2	-84	-18
12	-92	-6
-42	-40	12
-534	12	-12
-14	-8	10
8	8	-8
56	-42	38
4	-60	-20
-14	-66	-28
12	-68	22
36	28	4
50	34	-12
-28	-60	12
8	56	-14
26	38	42
-40	-22	6
-36	16	-10
42	16	-8
2	-82	-24
34	18	54
62	-52	4
8	30	40
0	42	-6
-44	8	-20
-16	-68	24
6	-80	46
60	-36	18
42	18	-20
2	-16	10

// Fan Y T, 2014: Autism Spectrum Disorder (ASD)
// Subjects=24
54	-30	58
-60	-28	46
-48	-14	8
-46	0	6
-2	-68	32
-14	52	30
10	-18	60
20	52	36
32	-26	-8
-46	-58	22
-16	-8	-12
-8	-52	20
-14	-68	6
34	-44	-14
-44	-10	26
10	-44	6
-6	-42	16
14	32	40
4	-20	18
48	-32	12
-58	-46	20
34	-22	-16
6	8	-2
4	-2	-6
-24	-30	36
16	-6	32
26	-30	26

// Fan Y T, 2014: Healthy Controls
// Subjects=21
8	-52	70
-58	-26	38
-48	-4	48
8	-20	-10
-28	8	40
-34	-48	56
-28	-42	46
-60	10	26
-14	-12	-14
-20	-6	-6
-4	-46	22
18	-82	-8
32	-28	-8
-20	-22	0
-16	8	30
-40	4	16
-2	-68	32
-14	52	30
10	-18	60
20	52	36
32	-26	-8
-46	-58	22
-16	-8	-12
-8	-52	20
-2	-76	-2
50	-8	58
-38	-16	40
30	-14	-6
-40	-24	-10
-6	-58	18
48	-32	12
-58	-50	16
6	-58	44
-26	-76	20
62	2	-12
22	10	-14
22	24	40
-6	64	26
6	44	-10
-8	48	-10
-2	22	-12
40	-22	22
-40	4	16
10	-44	6
-6	-42	16
14	32	40
4	-20	18
48	-32	12
-58	-46	20
-2	-28	-16
26	-28	24
-2	-32	2
20	-40	12
-24	-30	36
16	-6	32
26	-30	26

// Hadjikhani N, 2014: Autism Spectrum Disorders (ASD)
// Subjects=36
46	-40	6
50	-64	-2
48	-74	12
60	-38	18
30	-90	2
42	-62	-2
50	-26	-8
46	-58	6
46	-50	-22
62	-30	22
26	-2	-24
22	6	-36
54	-54	16
-52	-48	12
-46	-62	4
-38	-82	-12
-54	-52	16
-32	-94	-8
-46	-46	-24
-36	-88	-8
-52	-40	26
-38	-58	-26
-60	-34	-2
-38	34	-12
-46	10	26
-34	6	32
-44	26	-12
-48	-2	46
-38	40	4
-52	6	4
-50	34	4
-44	12	-10
58	28	-8
38	28	-18
38	32	-16
44	8	10
0	-32	-10
-40	34	20
-34	46	4
-14	24	24
-60	-46	48
-30	-42	40
-42	-64	40
30	-50	-56
-30	40	-16
24	-98	26
-54	-72	-2
-40	10	-26
-46	26	2
-24	14	8
30	-14	12
10	14	10
-10	20	4
4	32	10
-16	42	14
-22	34	-16
36	24	-18
6	0	54
-10	0	42
48	16	-28
-14	24	26
6	16	48
-18	-24	16
2	-16	0
-30	12	14
36	12	-18
-16	38	42
-34	14	32
-20	50	22
2	34	-12
-10	-52	-34
6	-36	-34
0	-62	-36
10	-56	-58
-14	-56	-46
-2	-66	-30
-32	8	-18
-30	4	-16
-34	-18	-18
-54	-16	-16
-44	10	0
-44	-12	-34
-40	8	-42

// Hadjikhani N, 2014: Healthy Controls
// Subjects=31
62	-52	12
48	-66	-4
38	-84	-20
60	-40	12
30	-90	-12
50	-64	-2
56	-24	-10
60	-58	8
42	-60	-22
64	-32	22
16	-8	-16
56	10	-24
64	-50	18
64	2	-18
-66	-42	16
-50	-50	6
-46	-78	0
-50	-50	20
-28	-92	-2
-36	-86	-4
-48	-34	22
56	-50	-38
-48	-16	-14
-58	2	-20
-34	6	-24
-22	0	28
-40	30	-16
-56	26	6
-42	22	-12
-52	30	0
-32	6	-18
-14	54	28
-8	62	34
58	28	-4
22	14	-26
48	32	-10
40	-6	-14
2	50	28
0	52	-18
8	52	10
0	-32	-6
-40	34	20
-34	46	4
-14	24	24
-60	-46	48
-30	-42	40
-42	-64	40
30	-50	-56
-30	40	-16
24	-98	26
-54	-72	-2
-40	10	-26

// Kana R K, 2012: Pun > Fixation, Autism > Healthy Controls
// Subjects=16
28	-40	-2
56	-30	30
30	32	50
-56	-38	38

// Lee T M C, 2013: Main Effect of Familiarity, Familiar > Unfamiliar
// Lee T M C, 2013: Main effect of Cue, Lie > Truth
// Subjects=13
-6	-54	18
-52	22	2
-54	-54	36

// Wu D, 2011: Bad Lie (BL) > Bad Truth (BT)
// Wu D, 2011: Bad Lie (BL) > Good Lie (GL)
// Wu D, 2011: GL > BL
// Subjects=20
9	-87	-6
-36	-45	63
30	-72	39
-36	-60	45
39	-51	54
-48	-42	54
36	-54	45
42	-60	48
-39	39	36
-51	-45	42
-6	-93	6
6	-78	18
-6	90	15
6	-87	12
18	54	24
-21	57	24

// Aoki Y, 2014: Social - Belief, Healthy Controls > ASD
// Aoki Y, 2014: Belief - Control, Healthy Controls > ASD
// Aoki Y, 2014: Social - Belief, Oxytocin > Placebo, ASD
// Subjects=17
48	20	-14
56	-64	36
0	18	20
4	-86	40
60	0	-22
60	18	-2
46	24	-18

// Kleinhans N M, 2011: Autism Spectrum Disorders (ASD)
// Subjects=28
44	-76	-14
-38	-50	-20
34	-46	-24
50	-24	50
-46	26	4
26	28	48
46	36	-16

// Kleinhans N M, 2011: Healthy Controls
// Subjects=25
38	-48	-22
-36	-48	-22
34	-62	42
2	-72	-34
34	-46	-24
50	-24	50
-42	-74	-10
36	-46	-18
38	-78	0
-46	26	4
26	28	48
46	36	-16

// Mizuno A, 2011: Autism
// Subjects=15
-34	-56	-32
-34	6	64
34	4	66
-2	-36	24
40	60	2
56	32	28
-20	60	0
4	-54	-26
36	26	-4
32	34	24
14	16	20
34	50	16
-10	12	24
-54	-18	22
44	-18	60
44	-44	60
22	-86	38
-6	-36	28
58	-48	-8
38	10	36

// Mizuno A, 2011: Healthy Controls
// Subjects=15
-26	-62	42
50	34	36
12	22	38
20	30	6
40	60	-2
36	4	62
30	0	-12
34	58	26
24	-12	40
44	-18	60
44	-44	60
22	-86	38
-6	-36	28
58	-48	-8
38	10	36

// Murphy C M, 2014: Autism Spectrum Disorder (ASD)
// Subjects=46
30.85	-.19	-24.48
-33.33	30.6	-19.63
-25.43	27.35	34.08
20.39	-13.26	0.16
0.93	-24.58	-34.36
-26.03	28.76	-44.1
-40.89	13.24	-37.05
-28.93	-3.21	-16.85
28.27	-29.97	44.96
-5.97	-30.69	38.72
8.95	-22.14	37.83
27.41	62.17	-29.67
-45.04	51.91	-4.56
-52.26	21.59	17.03
-1.91	-49.35	3.44
20.3	-47.21	-25.99
8.58	66.26	24.85
8.17	78.43	-24.12
-44.29	-8.43	68.52
4.94	-16.16	74.18
-25.93	1.27	-41.79
66.26	9.22	-2.26
54.66	-33.15	1.43
-47.64	-59.37	29.34
-13.2	-73.14	54.63
50.62	-18.72	37.07
35.7	-90.91	13.18
-20.92	-95.48	14.22
-9.82	-20.84	-40.12
8.43	-56.14	-44.06
-37.07	-27.59	26.55
8.35	-8.67	-35.78
40.43	9.38	-25.39
-33.33	30.6	-19.63
-45.04	51.91	-4.56
20.39	-13.26	0.16
20.3	-47.21	-25.99

// Murphy C M, 2014: Healthy Controls
// Subjects=44
30.85	-.19	-24.48
-33.33	30.6	-19.63
-25.43	27.35	34.08
20.39	-13.26	0.16
0.93	-24.58	-34.36
-26.03	28.76	-44.1
-40.89	13.24	-37.05
-28.93	-3.21	-16.85
28.27	-29.97	44.96
-5.97	-30.69	38.72
8.95	-22.14	37.83
20.3	-47.21	-25.99
27.41	62.17	-29.67
-45.04	51.91	-4.56
-52.26	21.59	17.03
-1.91	-49.35	3.44
8.58	66.26	24.85
8.17	78.43	-24.12
-44.29	-8.43	68.52
4.94	-16.16	74.18
-25.93	1.27	-41.79
66.26	9.22	-2.26
54.66	-33.15	1.43
-47.64	-59.37	29.34
-13.2	-73.14	54.63
50.62	-18.72	37.07
35.7	-90.91	13.18
-20.92	-95.48	14.22
-9.82	-20.84	-40.12
8.43	-56.14	-44.06
-37.07	-27.59	26.55
8.35	-8.67	-35.78
40.43	9.38	-25.39
-33.33	30.6	-19.63
-45.04	51.91	-4.56
20.39	-13.26	0.16
20.3	-47.21	-25.99

// Poulin-Lord M P, 2014: Autistics
// Subjects=23
-34	-84	-10
-30	-88	-2
-18	-62	-52
-28	-58	-52
-14	-72	-48
-18	28	-4
28	-86	-8
22	-64	-52
14	-76	-46
42	46	32
36	38	28
2	-56	-34
-40	-86	-4
-30	-84	4
-44	-76	14
44	-74	0
54	-72	10
58	-62	4
44	-74	0
54	-72	10
-30	-84	4
-38	-86	6
-46	-76	14
-32	-84	18
-20	-76	20
-2	-86	18
-20	-70	-6
-22	-74	50
-32	-28	38
-18	28	-4
38	-92	10
14	-94	14
26	-78	22
30	-88	24
18	-72	-8
20	-78	-16
28	-70	52
26	34	52
6	-20	70
-24	-68	-8

// Poulin-Lord M P, 2014: Healthy Controls
// Subjects=22
-36	-86	-8
-28	-86	4
-26	-62	-52
-20	-70	-50
-42	42	32
-34	54	32
28	-86	-8
30	-60	-52
20	-72	-48
52	40	12
42	40	8
38	48	34
-40	-86	-4
-30	-84	4
-44	-76	14
44	-74	0
54	-72	10
58	-62	4
44	-74	0
54	-72	10
-30	-84	4
-38	-86	6
-46	-76	14
-32	-84	18
-20	-76	20
-2	-86	18
-20	-70	-6
-22	-74	50
-32	-28	38
-18	28	-4
38	-92	10
14	-94	14
26	-78	22
30	-88	24
18	-72	-8
20	-78	-16
28	-70	52
26	34	52
6	-20	70
-24	-68	-8

// Samson F, 2012: Autism Spectrum-Speech Onset Delay (AS-SOD)
// Subjects=13
-66	-16	8
-60	-2	2
-52	-32	16
-40	-22	56
-30	-26	68
-30	-14	68
0	6	48
-10	-76	20
-22	-94	4
68	-14	10
64	-2	2
2	-2	56
32	52	22
42	46	16
26	38	14
6	-76	24
18	-76	18
-34	-26	64
-50	-22	56
-54	-22	26
-4	-12	48
0	24	42
-42	38	4
-40	48	10
-10	-26	48
-10	18	36
-22	-36	-40
-12	-16	12
60	8	-10
68	-16	22
52	-22	52
56	-32	26
6	-8	64
22	-10	72
48	42	14
44	46	22
36	44	30
52	8	42
30	-16	66
52	6	26
16	-56	-16
4	-60	-8
12	-68	-16
22	-12	16
-30	-24	16
-32	-30	22
60	-18	6
56	-12	-2
46	-14	-2
60	-14	6
-56	2	-10
-36	-46	58
-54	-30	36
-34	-20	62
-6	-10	54
-54	2	22
-42	32	14
-42	36	22
-34	42	18
-8	-24	46
-22	-54	-18
-16	-4	10
-18	2	4
-22	-20	-16
64	-22	-4
60	8	-10
64	-14	22
48	-24	42
34	-50	50
56	-32	26
32	-4	66
28	-14	62
4	-6	64
62	12	8
36	38	14
36	40	28
28	42	22
14	-98	10
24	-66	-20
22	-56	-16
24	-18	14
16	-12	6

// Samson F, 2012: Autism Spectrum-No Speech Onset Delay (AS-NoSOD)
// Subjects=14
-62	-18	16
-60	2	-2
-46	-28	50
-34	-46	56
-36	-20	62
-4	-6	56
0	-4	60
-38	-4	14
-48	-4	2
62	-16	20
62	10	6
26	-60	-20
22	-52	-20
24	-56	-20
-40	-32	8
-32	-30	68
-50	-22	52
-16	-28	54
-50	-22	26
-18	-12	70
-46	4	30
-56	6	38
-42	-16	20
-2	-8	42
-12	-4	42
-38	-40	-32
-42	-52	-30
-48	-60	-30
56	-18	52
44	-30	24
46	42	16
6	14	30
4	24	38
34	-42	-24
-56	-22	4
-52	6	2
-68	-34	4
-64	-14	16
-58	-2	20
-18	-64	54
-32	-46	52
-42	-42	30
-32	-34	20
-54	18	0
-62	6	10
-38	36	24
-6	-14	58
-2	6	66
-24	-12	56
-30	-16	66
-28	-10	42
-16	-28	4
60	-22	-1
56	-6	-8
48	-26	42
58	-14	24
34	-42	46
62	12	10
64	10	14
58	18	-2
6	-4	62
32	-8	62
38	-2	54
26	-66	-18
28	-28	14
60	-14	6
-56	2	-10
-36	-46	58
-54	-30	36
-34	-20	62
-6	-10	54
-54	2	22
-42	32	14
-42	36	22
-34	42	18
-8	-24	46
-22	-54	-18
-16	-4	10
-18	2	4
-22	-20	-16
64	-22	-4
60	8	-10
64	-14	22
48	-24	42
34	-50	50
56	-32	26
32	-4	66
28	-14	62
4	-6	64
62	12	8
36	38	14
36	40	28
28	42	22
14	-98	10
24	-66	-20
22	-56	-16
24	-18	14
16	-12	6

// Samson F, 2012: Healthy Controls
// Subjects=13
-58	-6	2
-50	-36	16
-54	-22	22
-40	-22	60
-56	4	34
-4	4	56
58	4	-4
64	-20	20
18	50	-12
28	-50	-24
18	-54	-18
-34	-26	64
-50	-22	56
-54	-22	26
-4	-12	48
0	24	42
-42	38	4
-40	48	10
-10	-26	48
-10	18	36
-22	-36	-40
-12	-16	12
60	8	-10
68	-16	22
52	-22	52
56	-32	26
6	-8	64
22	-10	72
48	42	14
44	46	22
36	44	30
52	8	42
30	-16	66
52	6	26
16	-56	-16
4	-60	-8
12	-68	-16
22	-12	16
-30	-24	16
-32	-30	22
60	-18	6
56	-12	-2
46	-14	-2
-40	-32	8
-32	-30	68
-50	-22	52
-16	-28	54
-50	-22	26
-18	-12	70
-46	4	30
-56	6	38
-42	-16	20
-2	-8	42
-12	-4	42
-38	-40	-32
-42	-52	-30
-48	-60	-30
56	-18	52
44	-30	24
46	42	16
6	14	30
4	24	38
34	-42	-24
-56	-22	4
-52	6	2
-68	-34	4
-64	-14	16
-58	-2	20
-18	-64	54
-32	-46	52
-42	-42	30
-32	-34	20
-54	18	0
-62	6	10
-38	36	24
-6	-14	58
-2	6	66
-24	-12	56
-30	-16	66
-28	-10	42
-16	-28	4
60	-22	-1
56	-6	-8
48	-26	42
58	-14	24
34	-42	46
62	12	10
64	10	14
58	18	-2
6	-4	62
32	-8	62
38	-2	54
26	-66	-18
28	-28	14

// Zurcher N R, 2013: Autism Spectrum Disorder (ASD)
// Subjects=22
30	-42	-26
40	-34	-20
36	40	32
26	-86	-8
2	24	28
-2	-22	2
14	-58	30
30	30	-6
-10	8	10
6	-36	-8
14	-42	32
48	-6	-16
-58	-8	-2
18	-66	64
-16	-70	54
24	-4	66
-26	-6	64
20	-46	68
-24	-52	66
60	-32	46
-56	-26	28
54	20	14
40	48	30
-62	-60	10
42	16	-4
-42	10	-6
6	18	38
-6	2	38
66	-16	28
-12	-40	50
24	-22	-12
-34	-18	-14
70	-36	4
68	-8	0
66	-30	28
38	8	-24
-52	14	-18
8	-38	46
10	-18	8
8	-30	-8
42	-60	-16
38	-36	-20
-42	-32	-22
30	-88	-8
8	-54	-2
16	-82	36
-40	-82	10
-36	-58	-40

// Zurcher N R, 2013: Healthy Controls
// Subjects=22
58	-64	-16
-54	-62	-12
14	-54	52
-18	-72	54
24	-10	48
-26	-10	50
9	-52	55
-10	-52	54
-40	-78	12
42	-76	18
66	-10	0
-58	-10	-2
-26	-54	62
30	-46	64
42	-60	-16
-42	60	-20
-62	-42	14
66	-32	18
24	-61	22
-18	-74	24
60	-32	44
-56	-32	44
-8	0	42
8	18	38
38	-12	-6
-42	-2	2
20	-32	-6
-56	2	6
48	-6	-16
-58	-8	-2
18	-66	64
-16	-70	54
24	-4	66
-26	-6	64
20	-46	68
-24	-52	66
60	-32	46
-56	-26	28
54	20	14
40	48	30
-62	-60	10
42	16	-4
-42	10	-6
6	18	38
-6	2	38
66	-16	28
-12	-40	50
24	-22	-12
-34	-18	-14
70	-36	4
68	-8	0
66	-30	28
38	8	-24
-52	14	-18
8	-38	46
10	-18	8
8	-30	-8
42	-60	-16
38	-36	-20
-42	-32	-22
30	-88	-8
8	-54	-2
16	-82	36
-40	-82	10
-36	-58	-40

// Zurcher N R, 2013: Autism Spectrum Disorders (ASD)
// Subjects=16
-24	-4	-24
12	-30	6
-10	-30	6
-6	-32	-2
4	44	-2
-2	44	-2
-30	-14	-18
2	36	-16
-6	36	-16
2	22	-8
-8	30	-22
-32	28	-18
4	-46	34
-2	-46	34
-6	-52	16
6	-52	18
50	-14	-20
-58	-4	-34
-60	-36	0
54	-58	16
-52	-52	20
40	-12	6
-40	-10	-2
28	-12	-32
-32	-38	-12
16	-34	76
-20	-44	66
34	-92	22
-32	-92	26
36	-82	-16
-36	-84	-12
34	-54	-18
-28	-62	-14
38	-92	12
-38	-86	-8
54	-60	-14
26	-70	46
-32	-46	42
26	4	64
50	2	28
-42	-4	40
48	8	20
-52	22	20
54	36	8
-50	32	20
30	26	-6
-26	24	-4
4	18	48
-2	14	46
48	30	32
-50	32	20
40	-64	-26
-28	-64	-36
38	-92	12
-36	-94	8
50	-70	-14
-40	-90	-10
30	-44	-20
-32	-54	-14
40	-86	18
-40	-90	16
58	-54	-16
-56	-42	-28
24	-76	40
-22	-84	38
34	6	60
52	6	36
-38	-2	36
36	24	8
-46	12	10
52	28	4
-48	24	-2
32	18	-2
-38	18	0
10	26	44
-8	34	36
-40	0	48
18	-24	2
-12	-16	2
-14	10	-4
50	-46	-40
36	-60	-44
-6	-74	-34
-8	-70	-28
36	-62	-52
-10	-72	-46
-22	-68	-58
8	10	12
-18	20	4
-14	-28	14
54	16	-6
36	18	0
-32	22	-4
16	2	-4
10	18	38
-4	22	42
46	-4	60
-44	-10	64
40	32	30
38	2	60
8	0	70
-20	14	68
8	6	68
18	-24	14
2	-46	-6
0	-48	-22
20	-66	-52
-20	-64	-25
-2	-68	-42
26	-68	-52
-28	-68	-56
2	-56	-32
-24	-40	-46
-32	-52	-30

// Zurcher N R, 2013: Healthy Controls
// Subjects=18
4	36	-16
-4	36	-16
6	12	-10
0	8	-10
-28	32	-20
2	-30	36
-6	-32	40
10	-56	26
-2	-58	36
62	4	-26
-64	-14	-24
68	-28	2
-66	-32	2
52	-2	-16
-56	-2	-12
60	-62	24
-62	-60	26
36	-14	12
-40	-18	0
30	-16	-28
-32	-30	-18
46	-26	64
-20	-46	70
22	-82	-42
36	-92	-4
-34	-90	8
42	-82	-4
-34	-82	-14
30	-52	-16
-30	-58	-18
40	-82	4
-38	-80	-2
54	-60	-12
-48	-54	-20
30	-44	46
-32	-44	42
34	-2	54
54	8	8
-44	-2	32
56	14	4
-34	10	26
-40	26	22
36	18	-6
-40	18	0
4	20	54
-2	16	52
48	28	30
-46	34	30
10	-14	6
-14	-20	8
18	0	-4
40	-56	-36
-42	-66	-34
-6	-76	-44
18	-50	-52
-4	-60	-40
-30	-2	-20
28	-6	-16
22	-10	-24
-24	-12	-20
2	46	-16
-4	38	-24
2	30	-18
-2	30	-18
-28	30	-18
4	-26	40
-2	-52	24
0	-58	22
0	-58	22
64	-10	-28
-62	-16	-18
62	0	-24
-64	-8	-26
48	-62	28
-40	-74	36
38	-20	4
-38	-6	-12
18	-8	-28
-24	-16	-28
22	-42	62
-64	-16	16
12	-26	44
-4	-24	58
18	4	22
-14	-2	18
26	-82	-46
34	-92	-6
-16	-92	0
34	-88	0
-44	-80	-6
30	-60	-10
-30	-62	-20
38	-86	12
-46	-82	-6
56	-30	-22
-44	-62	-22
26	-76	38
-28	-46	42
28	4	62
44	0	38
-50	2	38
52	16	2
-50	20	34
54	24	20
38	20	0
-32	16	2
12	26	26
-10	22	30
-48	30	22
8	-16	12
18	-12	-2
-14	-4	-6
-30	-74	-28
-4	-76	-34
-34	-64	-24
-6	-74	-46
28	-70	-60
8	10	12
-18	20	4
-14	-28	14
54	16	-6
36	18	0
-32	22	-4
16	2	-4
10	18	38
-4	22	42
46	-4	60
-44	-10	64
40	32	30
38	2	60
8	0	70
-20	14	68
8	6	68
18	-24	14
2	-46	-6
0	-48	-22
20	-66	-52
-20	-64	-25
-2	-68	-42
26	-68	-52
-28	-68	-56
2	-56	-32
-24	-40	-46
-32	-52	-30

// Abe N, 2014: Dishonest + Honest > Control
// Abe N, 2014: (Honest/harmful + honest/helpful) > (dishonest/harmful + 
// dishonest/helpful)
// Abe N, 2014: (Dishonest/harmful + honest/harmful) > (dishonest/helpful + 
// honest/helpful)
// Abe N, 2014: (Dishonest/helpful + honest/helpful) > (dishonest/harmful + 
// honest/harmful)
// Abe N, 2014: Dishonest/harmful > honest/harmful
// Abe N, 2014: Honest/harmful > dishonest/harmful
// Subjects=25
52	10	-28
18	8	70
6	-4	48
32	-56	-2
6	-60	0
-34	46	30
-24	-20	76
-2	-24	26
-2	-76	30
-22	-78	-36
40	0	4
60	-26	30
-40	0	8
-48	-16	48
-64	-32	20
42	24	54
14	-102	4
-28	-38	-16
-38	-82	36
14	0	60
32	-40	44
-38	-48	54
10	52	20
10	40	48
54	-56	24
40	0	4
62	-22	32
-48	-16	48
-24	-40	68

// Abe N, 2014: Subgroup of Normals, Honest
// Subjects=13
-24	-66	-10
-30	-32	-22
-4	-52	-24

// Abe N, 2014: Subgroup of Normals, Dishonest
// Subjects=8
46	22	4
-4	32	0
-14	-16	-14
42	34	32
-8	20	38
16	14	38
-32	26	-12
-40	52	10
-6	34	14
-38	6	0
-6	30	36
-38	36	12

// Abe N, 2014: Subgroup of Normals, Ambiguous
// Subjects=7
-26	-50	44
-36	-10	52
62	12	24
-52	-28	38
-8	20	38
16	14	38
-32	26	-12
-40	52	10
-6	34	14
-38	6	0
-6	30	36
-38	36	12

// Cui Q, 2014: Subgroup of Normals, MUD (Assigned Murderer) group
// Subjects=16
-60	-45	36
45	21	3
57	-45	33
15	6	0
33	27	-6
15	9	3
42	0	54
6	21	60
-60	15	3
-12	6	3
57	-42	33
51	30	39
-57	-51	33
-27	-81	-27
-48	39	-15
66	-27	-3
36	57	-9
39	-63	57
-63	-48	-9
9	48	42
21	57	15
-12	54	36
54	-54	33
63	-21	-9
-48	-54	27
-33	21	42
48	33	39
39	51	-9
48	6	-42
-48	36	-9
-48	-30	-6

// Cui Q, 2014: Subgroup of Normals, INC (Assigned Innocent) group
// Subjects=16
33	27	-6
15	9	3
42	0	54
6	21	60
-60	15	3
-12	6	3
57	-42	33
9	48	42
21	57	15
-12	54	36
54	-54	33
63	-21	-9
-48	-54	27
-33	21	42
48	33	39
39	51	-9
48	6	-42
-48	36	-9
-48	-30	-6

// Ding X P, 2012: Identity concealment > Control
// Ding X P, 2012: Identity faking > Control
// Subjects=12
-38	26	-6
54	24	2
38	8	-10
-46	30	-14
-34	18	-8
56	14	2
50	12	12
22	58	32
-4	-86	2
18	2	18
30	52	16
26	50	24
-22	-88	0
-14	-86	0
6	-14	8
16	24	16

// Hayashi A, 2014: Harmful/ Dishonest > Harmful/ Honest
// Hayashi A, 2014: Harmful/ Honest > Harmful Dishonest
// Hayashi A, 2014: Helpful/ Dishonest > Helpful/ Honest
// Hayashi A, 2014: Helpful/ Honest > Helpful Dishonest
// Subjects=37
6	35	-8
27	20	52
3	-58	34
45	-64	25
-9	-55	10
-39	-76	37
36	-73	-8
9	-85	-5
-54	-16	52
63	-25	37
42	-61	10
-9	-28	46
57	26	25
54	26	1
30	11	-8
48	-25	-5
18	-88	4
-6	59	34
-48	29	7
-30	17	-14
-39	11	25
-57	2	-14
-63	-19	-5
-33	-88	-8

// Ito A, 2012: Execution: (Certain/Lie + Uncertain/Lie) > (Certain/Truth + 
// Uncertain/Truth)
// Ito A, 2012: Execution: (Uncertain/Truth + Uncertain/Lie) > (Certain/Truth 
// + Certain/Lie)
// Ito A, 2012: Preparation: (Certain/Truth cue + Certain/Lie cue) > Uncertain 
// cue
// Subjects=16
-33	56	19
-9	17	58
-51	-46	37
42	17	4
21	-19	-8
12	-91	25
42	14	28
-39	47	1
-9	20	37
-18	5	70
-12	-70	-26
15	11	70

// Ito A, 2011: Main effect of 'Lie' (Neutral/Lie+Negative/Lie) > 
// (Neutral/Truth+Negative/Truth)
// Ito A, 2011: Main effect of 'Negative' (Negative/Lie+Negative/Truth) > 
// (Neutral/Lie+Neutral/Truth)
// Ito A, 2011: Main effect of 'Neutral' (Neutral/Lie+Neutral/Truth)  > 
// (Negative/Lie+Negative/Truth)
// Ito A, 2011: Neutral/Lie > Neutral/Truth
// Ito A, 2011: Negative/Lie > Negative/Truth
// Ito A, 2011: Conjunction analysis: Neutral/Lie > Neutral/Truth + 
// Negative/Lie > Negative/Truth
// Subjects=32
-42	26	30
-8	10	56
-58	-38	2
-42	-44	44
-30	-58	-32
38	28	34
40	14	0
48	-28	-6
42	-42	38
-44	28	10
-6	-26	-10
-52	-62	0
46	4	26
4	-2	36
66	-28	34
24	-56	54
-56	-62	38
38	54	-4
52	-60	48
-46	50	-10
-50	18	10
-10	12	60
-20	4	10
-58	-36	0
-46	-42	42
48	24	34
48	-46	48
-36	28	30
-28	18	6
-6	6	58
-8	-66	50
34	32	32
40	14	0
50	-36	-2
42	-42	38
-40	26	30
-10	10	60
-42	-44	44
38	28	34
48	-44	46

// Kireev M, 2013: Deceptive Claim (DecClm) > Catch
// Kireev M, 2013: Honest Claim (HonClm) > Catch
// Kireev M, 2013: (Conjunction) DecClm > Catch + HonClm > Catch
// Kireev M, 2013: DecClm > HonClm
// Kireev M, 2013: rCBF: DecClm > Catch
// Kireev M, 2013: Catch > DecClm
// Subjects=36
-45	-1	49
-51	14	22
-54	17	4
9	8	7
-33	20	1
48	20	40
42	23	28
33	23	-5
45	8	52
39	2	52
6	29	46
3	32	43
-3	17	61
3	41	22
-42	-46	37
-33	-61	52
-30	-70	28
-33	-58	40
42	-55	46
36	-49	40
33	-70	28
54	-52	34
-39	53	-2
-39	47	1
-48	41	-8
-45	41	-2
-45	50	-8
3	35	43
3	26	52
12	14	58
-36	61	52
-39	-68	46
-42	-49	40
-51	14	22
-39	-1	40
-45	5	34
-36	23	22
45	23	34
48	20	40
42	-2	39
39	-52	43
-6	8	1
-6	-10	-2
-36	20	1
3	23	55
6	38	40
-42	-1	52
-45	5	34
-45	17	22
-39	-58	49
-45	-49	46
45	20	37
42	2	34
45	11	49
39	-52	46
54	-52	34
-9	5	1
-9	-13	4
-33	23	-2
-48	14	7
42	20	10
33	23	-2
-39	53	1
15	-10	19
9	-13	16
-6	-22	1
-33	-67	28
-39	-37	37
-45	-46	34
-36	-55	34
-9	8	-5
-12	11	16
-27	13	-3
0	-64	-8
12	-61	-11
-36	-1	58
-33	8	52
-27	-4	64
36	5	55
33	-4	58
45	-4	49
42	-43	34
39	-49	49
54	-40	37
38	54	8
50	-46	40
-2	32	26
8	40	32
-40	12	26
-40	-64	46
-8	-74	22
-54	-26	26
54	-14	-4

// Lee T M C, 2010: True: Positive > Negative
// Lee T M C, 2010: True: Negative > Positive
// Lee T M C, 2010: Lie > True
// Lee T M C, 2010: True > Lie
// Lee T M C, 2010: Positive: Lie > True
// Lee T M C, 2010: Negative: Lie > True
// Lee T M C, 2010: Lie: Positive > Negative
// Lee T M C, 2010: Lie: Negative > Positive
// Lee T M C, 2010: Conjunction Analysis (Lie > True, Positive + Negative)
// Subjects=14
18	44	32
-16	38	26
-10	-46	36
34	36	10
34	-48	-12
-30	-18	10
32	0	64
6	48	34
54	22	26
32	26	-2
8	14	24
10	30	36
-36	6	44
-10	6	50
-38	-40	48
-4	-70	44
18	-38	0
50	-70	8
6	-10	20
54	24	0
44	-54	48
24	-56	4
46	-48	12
-2	56	34
-42	32	16
-36	26	38
-16	-4	44
-30	30	4
-38	10	44
-40	-46	50
-22	-42	-2
18	-26	8
46	4	-4
58	-48	42
-16	4	52
56	10	18
22	-46	66
18	-78	10
36	-70	34
46	-18	38
-42	30	14
34	24	-4
50	42	18
-2	-16	28
18	-16	74
50	-46	40
-20	-64	2
8	-62	46
-48	-52	24
-20	-64	28
16	-68	8
-22	-30	0
-14	8	14
6	-6	16
36	2	60
16	-42	-8
54	-38	0
-14	56	30
-8	34	48
-32	24	-10
-22	-44	0
46	44	20
-32	22	8
-12	-44	10
32	-40	-20
-22	-20	0
-28	-62	-2
-10	-86	4
44	6	16
-20	-72	34
-18	-26	24
-32	44	24
16	-76	-2
-40	-68	12
44	30	32
-4	-16	20
-46	-50	28
6	-46	10
-18	-26	-10
32	-52	10
50	-70	14
10	-16	16
-14	56	30
-32	24	-10
-38	-56	26
-6	34	48

// Liu J, 2012: Falsification card > BL
// Liu J, 2012: Non-Falsification card > BL
// Liu J, 2012: Falsification > Non-Falsification
// Liu J, 2012: MT > Non-Falsification
// Subjects=14
-50.54	29.6	23.6
-44.12	22.62	17.46
-1.37	7.68	61.91
14.78	10.61	57.98
-47.26	6.97	22.42
-37.06	-48.56	47.91
37.35	-46.04	36.31
-24.08	-64.78	45.94
-7.72	-70.17	56.28
44.1	-50.53	56.81
31.04	-48.01	50.06
-12	-2.4	-10.87
20.55	-14.43	-3.51
23.83	8.85	4.22
30.2	14.64	-3.19
30.89	13.24	50.73
-33.96	9.51	48.84
-30.74	-7.06	43.7
-30.83	5.39	39.11
-37.06	-48.56	47.91
40.85	-47.35	56.55
-20.66	-66.71	59.52
-7.72	-70.17	56.28
40.53	-43.15	32.61
47.2	-25.3	50.9
-53.7	30.22	30.32
-40.79	23.26	24.06
-44.13	48.77	21.6
-27.25	-70.86	49.95
-50.01	-51.8	48.45
-43.63	-48.14	41.26
39.67	-85.73	-43.84
42.93	-69.14	-38.82
52.47	-66.09	-52.73
-40.81	26.45	23.75
-44.12	45.58	21.91
8.27	7.09	55.08
-8.31	37.07	32.23
-4.9	28.44	43.11
-27.32	-64.79	45.99
-17.43	-73.39	56.76
-33.89	-52.36	41.51
42.92	-65.95	-39.13
29.9	-73	-44.94
20.29	-68.91	-35.09
4.29	-90.36	-22.61
-5.63	-62.3	-31.94
-2.27	-58.17	-22.32

// Marchewka A, 2012: Normals
// Subjects=29
-33	24	0
-3	18	51
48	21	-3
39	18	-3
30	-63	-27
-24	-102	0
6	-57	-12
36	51	9
-60	-39	-3
51	-36	-3
33	-6	63
-54	-51	27
-60	-54	18
-3	-72	-27
9	-72	-36
9	6	15
15	-15	0
-39	27	0
-33	21	-9
48	21	0
33	15	36
6	12	57
-3	18	51
-15	-96	-3
30	-63	-27
-30	-63	-30
3	-63	-15
-36	21	-9
-30	24	3
-33	-54	-33
-15	-6	21
-12	-6	9
15	-9	21
21	-3	36
-6	-63	54
6	-60	60
15	-48	72
36	33	0
39	18	-6
-9	15	50
9	9	63
-3	-54	36
3	-51	27
0	57	21
12	48	12
60	-9	-21
-54	-63	27
57	-63	30
57	-54	18
-57	0	-18

// Marchewka A, 2012: Subgroup of Normals, Females
// Subjects=15
-33	24	0
33	30	0
15	-9	21
-9	21	60
-3	18	51
-12	-3	12
-15	3	18
3	-60	-9
48	27	27
-3	-75	-27
-15	-72	-33
9	12	66
-3	18	60
-39	27	-3
-30	18	-12
-12	-96	-6
48	27	30
-3	27	45
6	21	39
-39	12	24
9	9	63
-6	12	51
-36	39	18
-51	15	3
39	33	0
39	18	-3
6	-5	-12
-21	-9	27
30	39	21
-27	-3	66
-36	-3	66
-3	-2	12
-12	-7	9
36	33	0
27	24	-3
-36	24	-12

// Marchewka A, 2012: Subgroup of Normals, Males
// Subjects=14
3	12	60
-39	27	0
33	-57	-33
-18	-96	0
39	18	-3
-57	-39	-6
-39	-45	-3
15	-12	15
21	-15	27
-54	-48	27
-6	-69	48
6	-75	57
-15	-6	21
-30	-6	24
-3	-12	15
3	-18	12
-36	21	3
-42	12	9
0	12	57
-3	30	33
-9	21	42
42	18	0
-36	0	51
33	-54	-33
-45	18	36
-45	6	24
-27	-99	-3

// McPherson B, 2012: Tones: Feigned > Correct
// McPherson B, 2012: Tones: Feigned > Incorrect
// McPherson B, 2012: Words: Feigned > Correct
// McPherson B, 2012: Words: Random > Correct
// McPherson B, 2012: Words: Feigned > Incorrect
// Subjects=15
0	39	33
51	-45	42
-42	21	36
-54	-54	48
-57	-36	-6
-36	-72	-39
30	-75	-42
-42	45	-15
36	36	39
-36	-72	-42
39	21	-15
54	-45	39
-36	18	39
-51	-54	45
-42	21	-12
-63	-33	-9
-51	-48	54
42	36	27
48	-48	36
-39	-78	-33
-36	27	42
24	57	27
54	-48	45
24	15	57
54	15	6
-36	-81	-27
18	60	24
36	36	42
-51	-51	51
51	-48	42
-42	15	48

// Vartanian O, 2012: Mismatched > Matched
// Vartanian O, 2012: Lying > Truthful
// Vartanian O, 2012: Matched: Lying > Truthful
// Vartanian O, 2012: Mismatched: Lying > Truthful
// Subjects=15
20	16	36
-28	10	20
-36	0	46
-12	16	46
42	-44	38
18	-56	40
-8	0	4
10	-76	-30
36	52	12
48	30	24
32	28	6
-58	12	26
-44	-34	-14
-34	-58	42
38	-48	34
-20	-4	22
10	-14	-10
2	-54	-30
24	-70	-42
14	-38	-50
-30	0	46
40	-42	46
4	18	48
0	-8	8
4	-80	-26

// Cascio C J, 2012: Autism Spectrum Disorders (ASD)
// Subjects=13
-22	-38	62
-12	-4	72
-48	-14	14
-18	-36	64
-32	-34	62
-24	-20	74
-36	-14	16
50	-30	24
36	-36	56
56	-10	42
-36	-8	58
-44	-26	54
24	-58	62
-4	0	50
12	50	-2
38	48	20
34	-2	46
60	-22	2
0	-46	-46
34	-34	48
36	46	22
28	42	32
26	58	16
-26	-2	62
50	2	24
6	-50	52
28	6	4
-16	-26	58
-6	-48	62
-2	2	48
32	-36	58
-46	-30	52
-32	-10	54
12	-38	52
8	30	44
-2	2	48
-34	30	34
2	16	48
36	50	22
-14	24	-2
-20	-28	4
-38	-36	22
-2	-28	-14
-14	-68	14
-20	-26	6

// Cascio C J, 2012: Healthy Controls
// Subjects=14
-34	-36	66
-54	-26	16
-44	-38	54
-38	-46	52
-54	-46	48
-46	44	0
-46	12	24
-36	46	-4
-44	-62	8
-34	-44	62
34	-48	44
-38	-40	50
-46	-56	52
44	48	-4
36	58	0
30	58	-8
48	40	-10
-54	-66	6
64	-22	16
-34	-34	70
-44	-4	56
-34	-42	54
56	20	16
-52	-72	10
36	-36	56
56	-10	42
-36	-8	58
-44	-26	54
24	-58	62
-4	0	50
12	50	-2
38	48	20
34	-2	46
60	-22	2
0	-46	-46
34	-34	48
36	46	22
28	42	32
26	58	16
-26	-2	62
50	2	24
6	-50	52
28	6	4
-16	-26	58
-6	-48	62
-2	2	48
32	-36	58
-46	-30	52
-32	-10	54
12	-38	52
8	30	44
-2	2	48
-34	30	34
2	16	48
36	50	22
-14	24	-2
-20	-28	4
-38	-36	22
-2	-28	-14
-14	-68	14
-20	-26	6

// Schneider K, 2013: Autism Spectrum Disorder (ASD)
// Subjects=28
3	53	25
-24	29	40
30	29	46
-3	-55	37
-45	-61	25
-54	-4	-35
60	-55	28
-3	-55	34
-9	50	19
-24	29	40
-42	-61	25
-57	-7	-29
3	53	25
-27	29	43
30	29	43
60	-19	-14
-45	-61	25
60	-55	28
-3	-55	37
30	-82	-35
-24	-82	-32
-3	-52	28
6	41	-8
9	-61	22
-12	-61	13
-3	29	-8
0	41	4
-18	-58	22
12	-67	31
45	-46	31
-15	-13	-20
-39	35	10
-24	-4	-23
-39	5	4
-9	-25	25
12	-67	31
-15	-61	10
9	35	-8
6	41	-8
9	-61	22
45	-46	34
45	11	34

// Schneider K, 2013: Subgroup of ASD, Non-Medicated
// Subjects=23
-39	38	10
-18	-55	22
42	-40	28
-15	-13	-20
-39	35	10
54	8	7
6	41	-8
6	-61	19
12	62	19
-3	29	10

// Schneider K, 2013: Healthy Controls
// Subjects=28
-3	-55	34
-48	-64	22
48	-58	22
0	50	22
-3	-55	34
-48	-64	25
-6	50	25
-3	56	5
-27	29	25
27	-79	-35
3	50	22
-48	-64	22
60	-49	28
-3	-55	34
0	-58	28
-57	-43	31
51	35	-5
12	-73	-2
57	-25	-14
-21	-79	-22
6	41	-8
9	-61	22
-12	-61	13
-3	29	-8
0	41	4
-18	-58	22
12	-67	31
45	-46	31
-15	-13	-20
-39	35	10
-24	-4	-23
-39	5	4
-9	-25	25
12	-67	31
-15	-61	10
9	35	-8
-39	38	10
6	41	-8
9	-61	22
45	-46	34
-18	-55	22
42	-40	28
-15	-13	-20
-39	35	10
54	8	7
6	41	-8
6	-61	19
12	62	19
45	11	34
-3	29	10

// Scheibel R S, 2012: Mild Traumatic Brain Injury (TBI) in Blast-Exposed 
// Veterans
// Subjects=15
-6	-68	32
28	-38	-14
-58	-42	12
8	-80	22
-26	-52	-26
18	20	46
-38	-26	40
-28	-58	56
24	-78	-24
56	-28	6
0	38	20
-50	-26	4
24	-30	66
20	-66	46
-26	-52	-26
38	-32	4
18	20	46
-50	-28	4
-4	-86	-8
6	-66	36
-14	-34	-4

// Scheibel R S, 2012: Control Veterans, no Traumatic Brain Injury (TBI)
// Subjects=15
8	-80	22
-26	-52	-26
18	20	46
-38	-26	40
-28	-58	56
24	-78	-24
56	-28	6
0	38	20
-50	-26	4
24	-30	66
20	-66	46
-26	-52	-26
38	-32	4
18	20	46
-50	-28	4
-4	-86	-8
6	-66	36
-14	-34	-4

// Liu Z, 2014: Controls
// Subjects=12
-6	-24	54
12	12	48
54	-9	54
-3	18	0
34	-15	16
39	-54	6
-27	-63	57
-39	-51	30
45	39	21
-24	-24	75
0	-99	0
-3	-60	-6
-42	36	0
6	54	30
-39	-39	-30
-24	-15	-30
-57	-20	-24
-39	33	-15

// Liu Z, 2014: Patients with Mild Cognitive Impairment (MCI)
// Subjects=12
21	-33	36
21	-57	45
-6	-24	54
12	12	48
54	-9	54
-3	18	0
34	-15	16
39	-54	6
-27	-63	57
-39	-51	30
45	39	21
-24	-24	75
0	-99	0
-3	-60	-6
-42	36	0
6	54	30
-39	-39	-30
-24	-15	-30
-57	-20	-24
-39	33	-15

// Berlingeri M, 2010: Picture Naming Task, Elderly Normals < Younger Normals
// Berlingeri M, 2010: Picture Naming Task, Elderly Normals > Younger Normals
// Berlingeri M, 2010: Sentence Judgement Task, Elderly Normals < Younger 
// Normals
// Berlingeri M, 2010: Sentence Judgement Task, Elderly Normals > Younger 
// Normals
// Berlingeri M, 2010: Picture Recognition Task, Elderly Normals < Younger 
// Normals
// Berlingeri M, 2010: Picture Recognition Task, Elderly Normals > Younger 
// Normals
// Berlingeri M, 2010: Sentence Recognition Tak, Elderly Normals < Younger 
// Normals
// Berlingeri M, 2010: Sentence Recognition Tak, Elderly Normals > Younger 
// Normals
// Berlingeri M, 2010: Main Effect of Picture Naming Task
// Berlingeri M, 2010: Main Effect of Sentence Judgement Task
// Berlingeri M, 2010: Main Effect of Picture Recognition Task
// Berlingeri M, 2010: Picture Naming Task > Picture Recognition Task
// Berlingeri M, 2010: Sentence Judgement Task > Sentence Recognition Task
// Berlingeri M, 2010: Picture Recognition Task > Picture Naming Task
// Berlingeri M, 2010: Sentence Recognition Task > Sentence Judgement Task
// Subjects=24
-52	-2	46
-44	-64	-4
-38	-50	-16
-34	-52	-16
-32	-86	6
-30	-86	12
-28	-48	-26
-26	-62	-18
28	-58	-12
30	-68	-10
20	-56	4
32	-84	-6
34	-84	4
36	-84	18
6	-72	12
26	-44	-22
28	-50	-18
-40	44	20
-14	-84	38
-48	42	-14
-50	36	-12
-52	22	-12
-62	-30	10
-16	-40	-10
-44	-80	28
-50	-76	16
-22	-86	42
66	-24	12
22	-34	-10
26	-28	-14
-40	-46	-14
-44	-64	-2
-30	-64	-6
-24	-50	-16
-22	-62	4
-46	-80	0
-44	-84	0
34	-52	52
38	-44	-22
40	-46	-18
16	-52	4
20	-54	4
8	-72	16
34	-42	-24
24	-42	-20
-42	44	16
-42	36	24
-40	20	44
-38	20	38
-38	10	44
36	26	46
42	6	48
-40	-60	42
-42	-56	42
48	-66	44
50	-58	44
-38	28	-8
-38	-52	56
32	24	-6
46	24	-16
40	24	28
44	36	34
44	-52	50
38	-56	46
-40	-6	52
-48	-76	28
-38	-82	36
-28	-86	40
-50	22	26
-4	12	50
-44	6	32
-50	-6	48
-38	26	-24
-14	-34	-8
-10	-42	-2
-44	-54	-22
-44	-72	-14
-42	-86	-2
-10	-78	8
32	-92	16
12	-80	12
22	-90	34
36	-42	-24
26	-52	-18
-46	24	-12
-50	20	18
-2	20	48
-62	-20	-6
-20	-22	-16
-8	-36	-4
-4	-16	10
60	-22	-8
62	-10	-10
4	-76	-14
-48	18	36
-48	26	32
-44	8	34
-34	22	-4
-42	-58	-20
50	36	20
42	42	32
2	24	48
36	22	-6
-44	-72	-14
34	-90	12
-50	-6	50
-10	-38	-10
54	-4	-24
-34	20	-6
-26	-78	-14
-22	-68	-12
-30	-66	-18
50	36	22
2	26	48
28	-76	44
34	-70	38
14	-38	-10
-44	46	-6
-34	-72	54

// Bayerl M, 2010: 2-back vs 0-back, ADHD < Healthy Controls
// Subjects=30
52	-72	24

// Cubillo A, 2012: Attention Deficit Hyperactivity Disorder (ADHD)
// Subjects=11
-49.23	19.73	-7.39
-41.2	-14.01	51.11
44.05	11.48	29.03
46.98	49.25	7.99
1.4	12.17	41.73
12.69	23.9	-14.02
8.71	-30.17	2.82
1.51	-18.5	44.3
13.22	-68.32	18.24
-18.25	-16.35	-22.56
20.16	-12.4	-30.02
55.81	-41.09	8.77
-52.1	-44.91	10.33
51.75	-34.49	39.49
-44.38	-34.63	46.18
-5.84	-78.7	37.17
20.9	-69.57	42.79
39.92	-76.08	11.89
-41.3	-76.57	12.86
-25.49	-66.72	-12.68
32.11	-50.94	-20.24
46.85	32.57	-15.14
1.16	38.29	21.7
47.27	8.33	29.26
47.21	-13.13	13.22
-13.92	-3.75	-11.4
-10.29	-31.14	33.23
-44.73	-17.37	7.94
-32.55	-54.65	47.73
-52.16	-54.31	-1.14
40.07	-78.85	31.08
13.15	-88.81	1
-32.81	-84.86	1.2
-33.09	-60.31	-25.39
-29.71	7.44	24.64
63.2	-1.41	12.05
13.13	-31.94	20.76
-44.38	-34.63	46.18
51.81	-38.29	45.39
-5.89	-74.9	31.28
5.51	-70.77	-12.69
-25.49	-66.72	-12.68
39.47	57.67	7.37
27.5	50.97	-23.16

// Cubillo A, 2012: Healthy Controls
// Subjects=15
-36.87	-17.79	56.95
-52.23	-10.01	7.41
51.7	-18.62	38.16
5.82	-13.73	50.55
-22.42	-6.55	-5.49
-10.56	-9.76	6.91
24.93	-19.3	31.84
-10.26	-39.6	33.94
27.82	-34.68	-15.98
-18.18	-23.32	-16.4
28.21	-75.63	18.68
66.11	0.02	-24.9
-56.76	-4.95	-23.07
-37.05	-81.2	7.63
8.6	-39.02	-15.39
35.28	46.44	13.94
-3.14	-18.06	-4.75
27.71	-7.19	-18.28
5.53	39.26	33.84
5.79	-6.33	49.93
63.1	-38.7	-16.04
13.41	-78.5	38.05
-17.98	-61.93	-6.47
-29.71	7.44	24.64
63.2	-1.41	12.05
13.13	-31.94	20.76
-44.38	-34.63	46.18
51.81	-38.29	45.39
-5.89	-74.9	31.28
5.51	-70.77	-12.69
-25.49	-66.72	-12.68
39.47	57.67	7.37
27.5	50.97	-23.16

// Cubillo A, 2011: Attention Deficit Hyperactivity Disorder (ADHD)
// Subjects=11
-30.06	60.97	1.2
-44.94	52.93	8.74
-49.34	23.02	-19.93
-37.33	-19.32	-4.25
46.8	6.79	-31.94
55.66	-26.17	-4.74
-60.97	4.43	-11.54
5.89	-45.96	46.56
-13.75	-50.28	-7.5
43.92	-66.73	-19.05
27.7	-40.28	-33.35
-25.56	-87.13	-28.81
47.31	12.01	35.64
-3.36	15.89	-19.86
1.32	20.2	35.49
-3.17	-34.87	-15.6
-49.5	30.11	-38.36
40.04	-46.19	40.61
27.68	-36.05	-33.7

// Cubillo A, 2011: Healthy Controls
// Subjects=15
-30.06	60.97	1.2
-44.94	52.93	8.74

// Dibbets P, 2010: Switch > NonSwitch
// Dibbets P, 2010: Switch > Baseline, ADHD > Healthy Controls
// Dibbets P, 2010: Switch > Baseline, Healthy Controls > ADHD
// Subjects=14
15.45	22.68	66.34
-21.94	-56.5	36.61
-26.8	27.44	-6.06
42.06	-57.32	20.33
24.66	36.14	19.38
16.5	-53.27	33.67
21.71	-85.42	2.85
-36	-8.92	33.9
-29.58	-38.46	22.92
25.65	7.83	-2.79
22.93	-26.66	46.97
-9.13	2.73	58.26
4.42	-10.56	9.03
-28.92	12.28	-9.23
-35.93	-27.95	35.49

// Karch S, 2010: Attention-Deficit/Hyperactivity Disorder (ADHD)
// Subjects=8
0.39	25.96	55.09
-46.77	15.42	33.09
-47.56	-42.14	45.74
1.14	45.78	22.19
5.19	64.27	-.6
18.45	49.16	50.7
-42.42	25.02	46.74
-7	14.8	62.8
10.05	22.13	59.76
-48.76	13.61	51.11
-37.36	44.06	17.2

// Karch S, 2010: Healthy Controls
// Subjects=8
2.52	25.89	53.95
-45.64	22.72	44.74
55.89	21.21	43.7
-44.28	-55.61	50.17
54	-45.42	49.3
1.14	45.78	22.19
5.19	64.27	-.6
18.45	49.16	50.7
-42.42	25.02	46.74
-7	14.8	62.8
10.05	22.13	59.76
-48.76	13.61	51.11
-37.36	44.06	17.2

// Valera E M, 2010: Attention-Deficit/Hyperactivity Disorder (ADHD)
// Subjects=21
-45	30	0
-51	36	3
-51	18	30
-48	45	-6
-42	-3	48
-48	6	54
-54	-18	27
-45	-15	33
-48	-6	36
-63	-42	30
-66	-30	33
-54	-42	0
-57	-54	6
-51	9	-12
-51	-39	24
-45	12	9
30	-69	-18
18	-57	-15
36	-24	69
21	-27	54
15	-30	66
51	-9	42
54	-36	24
39	-33	18
-6	-42	-24
-15	-48	-36
-60	15	3
-54	-18	27
-48	12	6
-36	-27	0
-51	-39	24
-24	-15	12
-27	-3	-6
-30	-21	0
-30	-15	-9
6	-54	-27
6	-48	-21
48	27	0
39	27	-9
42	33	-3
24	-3	-12
-36	-21	51
-42	-21	63
-33	-21	72
-27	-48	3
-48	0	0
-39	-33	9
-45	-27	6
-54	-24	12
-33	-39	24
-39	-33	18
-18	-39	9
15	-51	-21
6	-63	-15
30	36	15
21	48	18
66	-39	39
57	-51	51
36	-42	3
69	-21	3
21	-39	12
-6	-3	63
-9	-24	51
-27	-24	75
-36	-21	51
-42	-21	63
-60	0	9
-60	0	27
-12	-15	78
-3	9	21
-54	-15	48
-57	-15	18
-12	-21	24
-39	-21	18
-45	3	0
-30	-9	9
-6	-12	21
15	-51	-18
6	-63	-15
6	-54	-6
30	36	15
9	-15	51
12	24	45
57	6	45
45	0	60
66	-3	12
63	6	12
6	3	66
21	51	18
66	-42	36
63	-42	45
57	-51	51
33	-45	3
6	0	18
24	-45	12
21	-36	18
45	9	-3
36	21	6

// Valera E M, 2010: Healthy Controls
// Subjects=19
-45	30	0
-51	36	3
-51	18	30
-48	45	-6
-42	-3	48
-48	6	54
-54	-18	27
-45	-15	33
-48	-6	36
-63	-42	30
-66	-30	33
-54	-42	0
-57	-54	6
-51	9	-12
-51	-39	24
-45	12	9
30	-69	-18
18	-57	-15
36	-24	69
21	-27	54
15	-30	66
51	-9	42
54	-36	24
39	-33	18
-6	-42	-24
-15	-48	-36
-60	15	3
-54	-18	27
-48	12	6
-36	-27	0
-51	-39	24
-24	-15	12
-27	-3	-6
-30	-21	0
-30	-15	-9
6	-54	-27
6	-48	-21
48	27	0
39	27	-9
42	33	-3
24	-3	-12
-63	6	18
-6	0	63
-45	24	42
-33	-27	72
-39	-21	54
-51	-9	12
-48	-45	60
-57	-51	48
-60	-39	48
-51	-15	0
-63	-30	15
-60	-21	9
-36	3	3
-30	21	9
-39	-27	3
-42	3	-3
-48	9	3
-51	-39	24
-27	-18	3
-27	-12	-3
-15	-18	0
18	-54	-18
12	-63	-48
54	15	3
45	27	0
42	42	30
48	45	-6
54	3	48
60	-54	42
60	-39	51
54	-33	21
60	-27	15
63	-15	0
51	-9	-3
48	6	0
69	-30	6
48	-24	9
42	-36	21
-63	6	18
-6	0	63
-12	-27	63
-18	-21	78
-36	-12	63
-33	-27	72
-39	-21	54
-51	-15	45
-51	-9	12
-24	45	27
-9	-15	45
-15	-9	-24
-54	-21	21
-27	21	9
-42	3	-3
-45	6	6
-48	9	3
-51	-39	24
-27	-15	6
-30	-6	-3
-15	-18	3
15	-54	-18
12	-66	-51
6	-66	-36
63	6	21
42	24	-6
45	48	-3
42	45	-6
54	3	45
39	42	30
63	3	9
60	-3	45
57	-6	42
27	54	30
15	54	30
60	-54	42
57	-39	51
54	-54	51
48	-36	27
48	6	0

// Maier S J, 2014: IF-Test: CS+ > CS-, Healthy Controls > ADHD
// Maier S J, 2014: UF-Test: CS+ > CS-, ADHD > Healthy Controls
// Subjects=13
-51	0	-6
-45	-7	-26
57	-7	-29

// Wilbertz G, 2013: Attention-Deficit Hyperactivity Disorder (ADHD)
// Subjects=12
-42	14	-20
12	38	-17

// Wilbertz G, 2013: Healthy Controls
// Subjects=12
-6	50	31
-9	-97	19
48	-70	1
12	38	-17

// Vieira J B, 2014: Subgroup of Normals, High Psychopathy
// Subjects=26
3.12	46.28	0.94
3.45	37.64	40.69

// Vieira J B, 2014: Subgroup of Normals, Low Psychopathy
// Subjects=35
39.22	-46.97	71.91
17.26	-44.38	-2.77
-51.11	20.26	27.16
-2.87	51.75	58.54
48.74	-69.86	50.3
-2.87	51.75	58.54

// Cope L M, 2014: Psychopaths
// Subjects=137
15	30	57
-39	21	48
45	30	0
-15	39	12
-6	33	21
-6	-12	36
9	-33	33
18	-48	39
15	0	0
-18	-3	6
-9	-3	66
-39	36	27
30	42	42
-57	9	30
-48	12	27
-42	3	42
45	-6	24
3	-21	36
-39	-60	42
-51	-42	36
-48	-39	45
48	-51	12
54	-36	-6
-6	3	6
-18	15	6
39	-12	45
-39	-9	3
15	-102	12
-21	-12	-9
18	-33	-21
-24	-39	-24
-12	-12	63
15	-18	69
15	24	57
-12	21	54
-18	48	18
18	36	48
-6	27	57
-18	15	45
-30	18	51
27	36	39
-39	9	36
-39	15	24
-36	-3	48
45	36	3
-27	-21	63
-24	-21	72
-60	-30	45
15	-42	72
27	-27	-18
27	-39	-6
-30	0	-27
-18	39	12
-9	9	36
-3	27	18
-6	-12	39
9	-12	36
12	-42	39
3	-45	33
-39	-57	42
42	-36	30
54	-57	12
45	0	-3
54	-63	3
-39	-33	9
-39	-12	6
-39	-3	0
-9	-93	12
-3	-93	0
-21	-15	-9
-15	-3	0
-33	-15	-12
12	12	6
9	3	6
36	-21	3
36	-3	3
-36	-21	0
51	-24	51
36	-18	63
60	0	-3
-57	-6	3
45	-9	9
-27	-39	-9
-33	-6	-33
-24	-3	-36
-27	-15	-6
21	-30	9
-24	-36	-21
-30	-51	-30
18	-33	-18
18	-78	21
21	-6	-6
21	51	3
21	42	3
45	12	-27
-57	-54	6
-54	-45	0
-36	9	-42
-42	0	-42
36	-12	-27
-21	-21	18
12	39	36
-27	42	-9
-45	21	-3
6	12	15
-3	-33	-21
-12	-3	66
-6	-15	63
-36	-3	48
-30	-36	66
-36	-27	45
-42	-24	33
39	-9	45
-15	33	18
-9	6	39
-9	-12	39
12	-42	42
0	-45	45
6	-69	51
-45	-36	-12
-39	-30	-21
-54	-36	-12
-33	-33	9
-39	-30	3
-60	-27	33
3	-84	21
-15	-54	-6
-9	-69	0
-33	-21	0
-18	-18	-9
-24	-51	-18
-30	-12	21
-39	21	-21
-39	18	-6
-42	33	-6
48	36	3
57	27	15
42	18	-12
3	57	9
-9	24	54
15	30	48
3	45	18
-42	9	39
30	18	36
-45	21	30
-45	30	18
-3	27	27
-21	42	12
9	-9	33
6	-45	30
-6	-51	9
9	-51	12
27	-3	-24
24	-27	-21
18	-9	-21
21	-33	-6
45	-36	9
-51	-48	30
27	-84	27
27	-87	18
15	18	18
12	12	9
15	-15	24
0	-12	3
18	-27	3
-33	-6	3
12	-33	-18

// Cope L M, 2014: Subgroup of Psychopaths, Negative Urinalysis
// Subjects=115
15	27	57
-24	48	18
30	45	36
27	54	24
39	30	48
-42	33	30
-36	12	36
-42	6	42
21	33	48
-42	33	-3
30	-21	48
-15	39	12
-9	36	21
3	-21	36
-6	-12	36
9	-33	30
3	-51	30
18	-48	39
48	-51	9
48	-39	0
54	-39	-9
51	-18	-18
-63	-36	-12
-60	-24	-18
-51	-33	-12
-42	-48	36
-39	-39	30
-48	-39	45
-39	-60	39
15	0	0
-3	3	6
-21	-3	3

// Harenski C L, 2014: Incarcerated
// Subjects=157
33	0	-18
6	27	18
-57	-45	9
42	-57	-24
-57	-45	9
33	0	-18
6	27	18
-57	-45	9
42	-57	-24
-57	-45	9
60	-54	15
30	-90	-12
-39	-69	-12
-33	-30	-21
60	-30	18
-21	-54	-12

// Kielar A, 2011: Main effect of verb stems, covert production
// Kielar A, 2011: Main effect of past tense verbs, covert production
// Kielar A, 2011: Main effect of present tense verbs, covert production
// Kielar A, 2011: (Past tense verbs + Present tense verbs) > Baseline, covert 
// production
// Kielar A, 2011: Past tense verbs > Verb stems, covert production
// Kielar A, 2011: Present tense verbs > Verb stems, covert production
// Kielar A, 2011: Past tense verbs > Present tense verbs, covert production
// Kielar A, 2011: Main effect of verb stems, overt production
// Kielar A, 2011: Main effect of past tense verbs, overt production
// Kielar A, 2011: Main effect of present tense verbs, overt production
// Kielar A, 2011: (Past tense verbs + Present tense verbs) > Verb stems, 
// overt production
// Kielar A, 2011: Past tense verbs > Verb stems, overt production
// Kielar A, 2011: Present tense verbs > Verb stems, overt production
// Kielar A, 2011: Past tense verbs > Present tense verbs, overt production
// Kielar A, 2011: Present tense verbs > Past tense verbs, overt production
// Subjects=13
33	-70	22
-42	-4	46
-51	2	37
-3	8	52
30	-70	25
-27	-70	31
-21	-55	46
-27	-73	22
-6	5	52
6	-1	58
-48	-1	46
-51	2	34
-27	-70	31
-21	-52	43
30	-70	28
-42	-4	52
-9	8	52
-21	-55	43
-27	-70	34
-42	-4	52
-21	-55	43
-27	-70	34
-39	-4	55
-21	-55	43
-27	-73	34
-24	2	34
-9	-70	22
-51	-10	31
-54	-7	22
-33	-25	10
0	5	55
54	-7	40
57	-7	19
-18	-28	58
18	-25	58
21	2	1
33	8	4
-12	-19	4
15	-16	4
-51	-10	31
54	-7	40
-54	7	22
0	5	55
-6	20	25
18	-28	58
-21	-28	55
-3	-76	34
12	-67	10
-51	-10	31
-54	-7	22
-45	-16	37
0	5	55
54	-7	40
51	-4	49
57	-7	19
-18	-28	58
18	-28	58
12	-67	10
33	-70	25
-51	2	25
0	8	55
-6	11	40
6	17	37
-39	-4	55
51	-4	49
-33	23	1
-33	14	7
-12	-4	1
-24	-58	43
-18	-58	49
-51	5	19
-45	5	13
-51	2	31
0	8	55
6	17	34
-39	-4	55
45	2	52
51	-4	49
-33	14	7
-33	23	1
-12	-4	7
-21	-61	46
-6	11	40
3	8	55
-42	-7	49
-51	2	25
-24	-58	43
-18	-58	49
-9	26	55
21	32	46
30	26	43
24	23	37
-15	47	31
-21	26	34
-30	26	37
-15	50	13
15	44	16
15	-43	13
0	-19	13
-15	-28	49
21	-43	49
30	-58	31

// Meffert H, 2013: Main effect of hand interaction type (Love and Pain > 
// Baseline) during Experience
// Meffert H, 2013: Experience: Love > Pain
// Meffert H, 2013: Experience: Pain > Love
// Meffert H, 2013: Main effect of movie type (Love and Pain > Baseline) 
// during Observation
// Meffert H, 2013: Observation: Love > Pain
// Meffert H, 2013: Observation: Pain > Love
// Subjects=18
-45	-21	51
51	-18	48
-3	57	-3
-6	6	48
-21	-51	-27
24	-51	-30
3	-51	21
-33	-69	42
-3	-33	57
-24	-3	3
24	3	0
-39	48	-3
51	-51	-9
-36	27	39
18	-27	57
-3	-39	-12
51	12	-24
57	9	30
6	6	-3
51	36	9
6	33	39
33	24	48
-24	0	-15
-45	-21	51
51	-18	48
24	-51	-30
-21	-51	-27
-6	6	48
-9	45	-3
57	9	30
24	3	0
-30	42	27
51	-60	0
-18	9	3
3	6	-3
-60	-36	9
66	-24	3
54	-51	42
-48	-51	42
6	33	39
42	-33	57
-57	-48	18
45	-66	-9
30	3	57
-33	-39	57
-24	-12	60
18	-90	0
-45	21	21
-6	30	54
-6	57	12
3	-75	-3
-21	-90	-3
12	-27	42
-3	54	30
27	-84	6
-33	24	-18
60	-48	-12
9	-30	-3
18	-57	21
3	60	-3
-36	-78	-6
-33	-39	54
-24	-12	60
21	21	60
24	24	51
-3	-3	-6
3	-78	0
-57	-48	27
-51	18	0
3	-33	-6
-33	24	-18

// Oh T, 2011: Main effect of phonological complexity
// Oh T, 2011: Regular > Irregular
// Oh T, 2011: Irregular > Regular
// Subjects=19
-11.38	16.92	49.29
-49.08	-11.65	-.3
8.04	-53.52	44.94
-46.94	36.77	20.15
54.64	29.26	24.08
-32.12	26.6	-2.58
36.26	25.79	-5.53
-57.68	21.85	7.03
-8.44	10.94	12.95
-50.22	-16.74	-11.01
-33.64	-53.77	45.44
14.81	54.46	-4.34
23.66	47.83	32.91
39.74	35.23	33.78
14.19	22.9	41.8
42.43	0.28	-46.96
4.71	-15.22	45.11
-24.62	-23.7	-20.76
10.64	-36.7	-26.76
-18.28	-47.41	-38.91
7.02	-42.01	56.25
-24.45	-48.31	-8.66
4.41	-51.31	-8.74
61.36	-51.06	30.74
59.09	-52.44	13.03
15.32	-53.33	19.19
-49.8	-65.19	23.16

// Pliatsikas C, 2014: Regular morphology > Irregular morphology
// Pliatsikas C, 2014: Irregular morphology > Regular morphology
// Pliatsikas C, 2014: Regular morphology > Regular unrelated
// Pliatsikas C, 2014: Irregular morphology > Irregular unrelated
// Subjects=17
46	-70	8
48	2	46
16	0	16
8	2	50
34	-52	58
-46	-70	2
-38	-72	-44
-50	8	-4
-22	8	24
-40	6	26
14	20	32
12	-80	-10
40	-78	6
46	6	22
-40	24	16
-40	-70	2
8	-8	8
14	-84	-10

// Slioussar N, 2014: Real verbs (RV) + IV) > Nonce verbs (RNV + INV)
// Slioussar N, 2014: Nonce verbs (RNV + INV) > Real verbs (RV + IV)
// Slioussar N, 2014: Regular verbs (RV) > Irregular verbs (IV)
// Slioussar N, 2014: Irregular verbs (IV) > Regular verbs (RV)
// Slioussar N, 2014: Real nouns (RN + IN) > Nonce nouns (RNN + INN)
// Slioussar N, 2014: Nonce nouns (INN + RNN) > Real nouns (RN + IN)
// Slioussar N, 2014: Parametric contrast (RV > B) < (IV > B) < (RNV > B) < 
// (INV > B)
// Slioussar N, 2014: Parametric contrast (RN > B) < (IN > B) < (RNN > B) < 
// (INN > B)
// Slioussar N, 2014: Conjunction of (Regular verbs > Irregular verbs) AND (RV 
// > B) < (IV > B) < (RNV > B) < (INV > B)
// Subjects=21
-51	-64	28
-30	29	49
-9	-49	37
51	-58	22
-30	-52	46
-45	5	31
27	-64	46
42	-37	40
39	-61	-29
-6	11	52
51	-61	25
-45	5	31
-45	23	34
-45	50	1
-30	-52	43
-30	23	-2
33	-64	-29
-6	11	52
-6	-52	31
-48	-64	25
51	-58	25
-45	5	31
-33	17	4
-42	29	22
-39	-49	46
-27	-67	46
-6	11	52
27	-67	46
-12	-73	7
45	-34	49
30	-64	-26
48	29	25
48	5	28
-45	5	31
-48	20	31
-30	-52	43
-24	-61	43
-6	11	52
9	20	43
27	-64	46
30	-55	55
42	-37	40
36	-61	-29
-30	23	-2
45	35	22
-24	-4	55
-48	8	31
-33	17	4
-39	-49	46
-27	-67	46
-6	11	52
27	-67	46
33	-61	49
48	29	25
45	-34	49
48	5	28
-12	-73	7
-9	-1	-1
30	-61	29
-45	5	31
-48	8	16
-30	-52	43
-30	23	-2
-6	11	52
33	-64	-29
51	-61	25

// Wright P, 2011: Words > Baseline (MuR)
// Wright P, 2011: Main effect of task
// Wright P, 2011: Main effect of Complexity
// Wright P, 2011: Task x Complexity interaction
// Subjects=14
-60	-3	-6
-60	-30	3
-63	-18	-3
63	-18	-3
60	-6	-3
54	-27	3
-36	-51	48
-45	-51	48
-42	-57	-3
-48	-57	-12
-39	-45	-15
-36	33	-12
-48	27	-6
39	-54	48
45	-45	54
51	-39	51
66	-36	6
69	-30	-9
54	-42	15
-54	12	9
51	-27	9
60	-18	12
42	-15	6
-48	-36	18
-54	-33	-9
-51	-33	9

// Dresler T, 2012: Panic Disorder
// Subjects=20
-40	24	-18
-36	10	42
56	28	0
-48	-54	22
-2	-38	30
-42	-60	52
-2	-64	34
56	26	16
44	-38	0
60	-36	-10
-40	24	-18

// Dresler T, 2012: Healthy Controls
// Subjects=23
-46	30	-6
-40	24	-18

// Heath S, 2012: Healthy Controls
// Subjects=18
9	-42	6
-39	-69	-9
-30	-9	42
30	-42	69
57	-12	45

// Heath S, 2012: Aphasia Patient P02
// Subjects=1
-45	12	-39
42	33	12
42	-36	60
36	6	-39
9	18	30
-60	-33	51
-45	33	-9
12	72	21
-18	-81	-3
21	60	-9
39	-3	-45
-48	-45	48
-27	-60	57
42	42	-9
39	-21	-15
48	-33	39
30	-33	42
15	-36	33
3	9	54
-66	-30	0
-21	-24	-12
-57	-9	48
48	3	57
-60	-27	48
-36	3	-9
-57	-3	33
-42	3	42
-27	-78	3

// Heath S, 2012: Aphasia Patient P03
// Subjects=1
39	27	21
36	6	-24
57	0	-12
0	-18	-45
-27	-63	-39
-9	-18	51

// Heath S, 2012: Aphasia Patient P05
// Subjects=1
21	51	27
-6	39	30
-3	-3	54
60	-6	-24
36	-72	42
27	-75	12
51	-48	54
24	51	27
-42	27	-9
-15	51	30
-3	-66	57
36	-72	42
24	-75	9
12	-69	24
60	-57	30
39	-54	-3
39	-78	-18

// Heath S, 2012: Aphasia Patient P06
// Subjects=1
-45	27	21
45	36	12
21	-96	0
42	-66	-18
-54	-69	18
-42	-6	57
15	-39	75
30	-66	36
-36	-90	6
45	6	27
60	-39	39
-18	-57	30
-21	18	33
15	-54	30
-30	-3	6
30	21	-12
42	-54	-3
30	-51	42
-51	36	6
-54	-72	18
33	21	-9
60	-12	15
-42	27	21
36	-75	-27
-12	-87	3
-15	-72	-21
-21	-63	30
18	-45	-36
-21	18	30
18	-30	60
-12	66	12

// Heath S, 2012: Aphasia Patient P07
// Subjects=1
-36	51	0
36	21	-27
54	6	-30
-21	-27	24
27	-21	66
-12	-18	72
-57	-48	-6
-33	45	-12
39	-42	-48
39	33	12
39	48	30
-18	36	15
57	-51	-9
45	9	15
18	42	21
-6	-93	33
-48	-45	-3
51	18	24
39	36	12
57	-39	0
3	-87	30
45	-6	-33
36	21	-27
57	-6	6
-36	-3	-36
24	-87	0

// Heath S, 2012: Aphasia Patient P08
// Subjects=1
63	-36	27
57	18	-3
-3	33	-9
33	-66	12
-36	-48	18
-18	30	12
18	-21	-36
-21	-3	12
-48	30	-12
-3	30	-9
57	21	-3
-39	9	33
45	15	27
24	-84	-6
33	-60	51
-21	9	3
-39	3	48
57	-30	-6
-24	-63	-12
69	-42	9
-27	57	18
-39	-36	12
12	63	6
39	48	30
33	-66	12
-12	-27	-42
-33	42	39

// Rochon E, 2010: Treated Aphasia (ATr1)
// Subjects=1
-48	20	8
-36	-76	24
-8	-12	64
-8	-76	36
-12	-48	-16
12	-64	52
56	8	0
4	-60	20
-44	-76	-24
-28	60	20
-64	-48	40
-56	-20	-20
24	44	12
44	-48	-32
28	36	-12
12	-96	-4

// Rochon E, 2010: Treated Aphasia (ATr2)
// Subjects=1
-16	20	8
-8	72	8
-52	-12	-32
-56	36	8
-64	4	16
-60	-68	32
-48	-40	56
-44	60	0
-36	20	-28
44	-40	56
24	64	8
64	-8	28
24	20	52
-48	4	-24
-20	0	-28
-44	-4	20
-52	-28	12
-48	-20	-16
-24	-72	40
-24	56	-20
-8	16	40
-56	-32	48
16	0	-4
40	0	0
20	0	-28

// Rochon E, 2010: Aphasia Untreated (AUn1)
// Subjects=1
-44	-72	16
-4	-16	4
64	-4	0
4	-44	40
52	-76	20
44	-72	12
60	-32	32
52	-28	-20
20	-88	32
0	12	-8
-44	36	-12
-28	-68	44
-28	44	24
-56	16	-8
24	-72	56
0	52	16

// Rochon E, 2010: Aphasia Untreated (AUn2)
// Subjects=1
-40	20	4
-12	-44	32
-36	48	8
-36	-76	32
-48	-84	8
-36	48	8
-24	68	12
36	-84	40
48	-8	56
4	40	40
28	44	40
20	-12	16
16	28	24
44	24	4
40	44	28
28	48	-4
0	-60	24

// Rochon E, 2010: Healthy Controls
// Subjects=10
-48	20	-4
-64	-28	16
-8	-88	16
-48	8	16
52	16	-8
8	-92	-4
60	-32	8
60	-40	40
0	-84	24
-52	-80	-8
-12	-68	48
48	-80	-12
32	36	8

// Sandberg C, 2014: Aphasia Patient 1 (AP1)
// Subjects=1
-3	-21	42
-3	39	45
-24	45	45
-48	30	33
-45	30	-3
-51	27	3
-36	-15	21
0	21	54
-36	-15	57
6	63	18
30	9	66
33	57	21
48	39	-12
45	39	24
57	18	0
45	18	-3
24	-24	66
-39	24	-21
-66	-27	-3
-42	-63	-9
-33	-48	69
-51	-54	48
-60	-51	30
-48	-54	30
-15	-93	24
-21	-93	15
-48	-66	-12
-12	-93	-3
-12	-66	36
-9	-93	24
-21	-66	3
-12	-78	-15
63	-48	18
54	-42	-3
24	-90	21
48	-78	3
42	-81	-12
15	-93	6
18	-90	15
9	-90	-9
-3	-36	36
-12	63	18
-24	21	54
-42	6	57
-45	21	-9
-45	30	15
-39	51	-9
-30	24	-3
-30	6	0
-9	6	-6
0	21	54
-39	-9	60
3	-3	39
9	60	24
15	33	54
45	42	27
39	39	-18
45	24	12
54	18	0
45	9	-6
54	-15	3
6	-27	66
39	-27	63
-33	-27	45
-42	18	-15
-45	-15	-6
-60	-45	0
-54	-57	-12
-42	-48	-24
-33	-51	69
-48	-57	57
-60	-48	33
-57	-57	24
-3	-51	24
-15	-93	24
-9	-93	3
-9	-54	27
3	-81	0
-9	-84	-24
24	-30	63
66	-48	21
51	-9	6
51	-39	0
39	-24	-15
69	-39	24
27	-93	15
15	-93	6
15	-87	21
-3	-36	39
-6	45	42
-18	27	42
-42	6	57
-45	33	-15
-42	21	21
-45	48	-6
-27	24	0
45	24	15
9	12	3
36	-27	63
-54	-57	21
-54	-39	-15
-54	-30	48
-57	-48	30
-54	-63	30
54	-6	6
6	-87	12
0	30	27
-12	63	21
-12	18	51
-42	6	57
-24	27	-15
-45	39	6
-54	15	12
-36	54	-3
-30	21	-3
-15	6	6
-3	15	48
-39	6	45
12	12	45
9	60	27
33	54	12
45	42	24
57	24	15
45	18	-3
45	-3	12
30	-9	12
12	6	6
33	0	51
-48	-39	57
-48	-18	0
-60	-48	3
-48	-39	-21
-33	-9	-27
-30	-66	42
-48	-45	30
-3	-33	33
-24	-69	33
-27	-75	39
-24	-27	-18
57	-36	51
-12	33	54
-24	42	18
-42	36	-12
-45	39	6
-30	21	-3
-57	0	36
57	24	15
45	18	-3
33	-15	66
-48	21	-12
-57	-45	0
-48	-39	-18
-42	-51	-12
-30	-66	45
-57	-57	24
-24	-72	30
-48	-60	-18
21	-3	6

// Sandberg C, 2014: Aphasia Patient 2 (AP2)
// Subjects=1
0	-12	39
-9	57	36
6	48	18
3	-27	30
24	51	33
-51	-63	21
-3	-57	30
63	-51	0
9	-57	39
-9	39	21
-3	-45	36
-3	51	30
-12	57	27
-27	36	48
-42	27	-18
-57	24	15
-39	3	24
-60	3	6
0	21	57
-42	9	48
9	42	51
15	6	75
48	27	-15
48	42	0
51	18	12
36	27	-6
-54	-6	45
-54	6	-12
-63	-42	15
-54	-42	-9
-48	-48	-9
-33	-66	57
-36	-78	42
-45	-63	51
0	-48	30
-18	-93	24
-39	-78	36
-3	-69	18
27	-90	24
30	-90	15
12	-99	3
-3	54	30
-12	57	27
-27	24	45
-45	45	-6
-57	21	15
0	21	57
-33	9	30
3	33	45
45	42	0
39	18	30
39	24	-6
-54	-3	42
-54	-42	-9
-51	-51	-9
-33	-66	57
-33	-72	51
-45	-63	51
-3	-45	33
-39	-78	36
-3	-69	18
-9	-60	15
45	-36	-21
9	-39	24
27	-90	24
-6	27	30
0	-6	36
0	69	9
-24	21	54
-27	9	57
-42	27	-18
-57	18	12
-36	6	6
-48	3	9
-30	-9	6
-3	-3	75
-42	9	48
3	33	24
3	-33	30
6	60	3
39	39	6
45	21	-12
48	42	0
36	27	-6
30	-9	6
9	9	9
6	-15	78
54	6	45
9	-30	63
-21	-36	75
-51	9	-15
-66	-39	15
-63	-42	-9
-51	-57	-18
-21	-57	66
-42	-60	51
-63	-24	27
-45	-72	30
-3	-45	33
-21	-69	33
-39	-78	36
-24	-87	-9
-6	-63	15
-3	-54	12
0	-72	30
-21	-21	-27
-6	-84	-9
-3	-63	-6
15	-51	72
51	-36	6
57	-66	0
51	-72	-6
27	-63	-15
9	-21	12
24	-75	51
42	-33	48
51	-30	42
45	-63	30
33	-72	42
42	-81	3
48	-75	-12
12	-63	12
9	-66	66
21	-87	39
15	-96	-9
3	-48	0
-12	-6	48
-3	48	42
-12	72	6
-24	21	48
-39	30	-15
-57	24	15
-39	6	21
-27	33	-18
-60	0	9
0	9	66
-42	9	48
9	-39	33
6	57	30
18	66	21
36	45	3
42	36	-12
45	45	0
60	18	36
36	24	-3
15	-6	18
-54	-6	45
-54	9	-6
-60	0	0
-60	-42	-12
-51	-48	-9
-21	-81	48
-36	-72	48
-39	-63	48
-3	-45	33
-33	-81	36
-3	-66	18
-6	-69	36
-3	-84	24
-12	-84	-6
-3	-63	-6
63	-27	-3
30	-72	-15
45	-54	48
45	-66	30
33	-75	42
27	-93	3
30	-87	-6
27	-69	3
12	-66	36
9	-93	15
15	-99	-9
-3	-51	6

// Sandberg C, 2014: Aphasia Patient 3 (AP3)
// Subjects=1
-6	30	57
-15	33	51
-42	12	45
-51	33	-3
-27	21	-3
-33	3	36
12	30	24
9	18	45
6	45	45
21	66	3
36	45	21
33	30	-6
48	18	-18
33	18	3
9	15	6
-60	-39	-3
-57	-51	-9
-36	-78	45
-45	-60	42
-45	-75	36
-27	-78	-9
-3	-54	45
66	-45	0
45	-54	-9
3	-21	3
54	-48	48
54	-42	39
54	-60	24
24	-96	6
36	-93	-3
6	-90	0
15	-66	39
18	-99	9
-3	45	18
-3	-12	39
-6	33	45
-15	33	51
-27	21	51
-39	39	-3
-30	21	-3
-6	-12	75
-33	3	36
12	30	24
6	-12	33
12	54	30
21	66	3
51	18	48
48	45	-3
48	18	18
33	24	-18
15	9	-6
9	6	6
-63	-33	12
-63	-39	-3
-6	-51	21
-3	-84	45
-24	-99	9
0	-69	45
-21	-24	-21
-12	-36	-18
45	-12	-9
66	-45	0
60	-21	-18
18	-24	-12
54	-51	48
60	-45	36
39	-57	42
6	-87	0
15	-66	39
12	-102	9
0	-42	-18
-12	48	3
-6	-36	45
-12	48	12
-24	45	42
-30	36	48
9	42	0
6	-51	33
9	66	12
21	45	36
33	33	39
39	-15	-3
48	-27	18
6	18	66
27	-21	75
6	-27	75
-51	-69	18
-18	-48	72
-9	-48	27
-18	-78	27
-36	-75	24
-54	-69	-3
-3	-90	15
-3	-69	36
-24	-48	-6
-3	-48	-15
54	-15	30
60	0	-9
66	-51	9
48	-66	-3
33	-33	-3
15	-57	57
48	-33	48
66	-21	21
48	-63	33
21	-66	45
30	-63	6
12	-54	42
3	-78	39
15	-66	-9
-3	45	18
-3	27	57
-15	33	54
-27	21	54
-39	42	-3
-51	33	0
-30	21	-3
-6	-9	75
12	54	30
24	63	6
45	51	0
42	42	-6
51	42	0
9	12	0
3	21	57
-60	-48	0
-27	-69	-12
-57	-57	30
-42	-78	30
0	-63	51
-18	-27	-18
-15	-51	0
-3	-48	-15
66	-15	-6
54	-66	21
60	-45	-12
57	-51	42
63	-45	39
-6	33	54
-39	24	-3
-33	30	0
-27	28	-6
-3	12	60
-51	-3	30
6	42	12
30	6	54
42	30	-9
51	24	21
57	21	12
45	3	0
6	15	57
57	3	48
-54	-63	9
54	-36	6
57	-45	42
-3	12	27
-3	-9	36
-3	30	57
-12	57	27
-27	45	15
-42	42	-6
-45	33	0
-27	21	-3
-30	-12	3
-33	3	36
6	-21	33
15	54	30
24	15	42
33	6	54
27	33	-18
48	18	18
63	21	27
48	12	-9
12	15	12
9	-15	75
57	3	48
-60	3	18
-66	-21	9
-60	-48	-3
-51	-54	-15
-36	-66	-12
-33	-78	45
-3	-39	30
-27	-69	27
-45	-75	-9
-3	-69	42
27	-27	60
72	-30	-3
48	-54	-12
39	-60	-12
9	-6	6
30	-78	51
54	-48	45
57	-27	39
39	-57	39
33	-93	9
27	-96	-3
18	-102	0
3	-54	48
21	-99	9
27	-87	-6
-36	33	-9
57	-3	9
60	6	33
-54	-72	18
-9	-51	30
-9	-99	12
-39	-75	21
-9	-63	15
-6	-57	15
54	-12	9
51	-69	0
12	-75	21
-3	45	18
0	-12	36
-3	30	57
-12	51	30
-33	57	6
-39	39	-3
-45	33	0
-36	0	-6
-9	3	0
-3	15	63
-45	6	36
12	30	24
6	48	45
24	66	6
33	9	57
45	48	-3
48	18	18
39	15	33
36	21	-3
21	18	-6
9	6	6
60	9	30
-54	-18	21
-51	-33	21
-63	-48	-3
-45	-36	-21
-36	-24	-21
-36	-78	42
-51	-66	24
-3	-39	30
-12	-60	15
-3	-72	42
-12	-39	0
51	-15	6
45	-57	15
66	-42	-9
36	-42	-15
54	-51	42
57	-45	33
39	-57	39
42	-84	-3
3	-60	18
3	-54	45
12	-45	0

// Sandberg C, 2014: Neurologically Healthy Older Adult 1 (NHOA1)
// Subjects=1
-9	45	45
-12	45	36
-51	21	0
-51	-60	15
-51	-12	-27
-51	-69	24
-12	60	24
-54	21	0
-51	-66	21
-54	-3	-36
-33	-39	-21
-45	-72	27
-3	-51	24
-6	-57	15
3	33	33
-21	27	39
-27	18	45
-48	42	-9
-45	6	27
-33	21	-9
0	12	45
3	21	39
30	24	-12
-51	-45	-6
-42	-57	45
0	30	33
-21	27	39
-30	18	48
-45	42	-12
33	18	-21
-51	-42	18
-54	-42	-6
-45	-69	36
15	-78	-39
0	27	36
-15	48	30
-21	30	39
-54	24	-3
-54	33	0
-66	-36	-6
-60	-9	-30
-45	-69	33
12	-78	-39

// Sandberg C, 2014: Neurologically Healthy Older Adult 2 (NHOA2)
// Subjects=1
-12	60	30
-15	54	42
-33	33	51
-36	30	-12
-48	27	9
-51	-66	18
-42	-72	45
-3	-45	30
-42	-72	27
-27	27	57
-36	33	-9
-45	30	9
-51	-66	15
-39	-72	27
-36	12	63
-48	33	-3
-36	33	25
-6	24	66
-51	-66	15

// Sandberg C, 2014: Neurologically Healthy Older Adult 3 (NHOA3)
// Subjects=1
-24	-54	48
-54	27	-3
-54	-66	6
-45	-69	18
-51	27	0
-3	18	48
48	30	18
-66	-39	15
-51	-30	0
-39	-57	-12
-18	-90	-21
-3	39	39
-51	18	27
-27	24	-6
0	21	51
-39	3	57
33	48	18
48	30	18
54	18	36
33	24	0
-66	-39	15
-54	-36	-6
-39	-57	-12
57	-30	-21
30	-72	27
9	-87	30
-45	-69	12

// Allin M P G, 2010: Bipolar Disorder
// Subjects=18
1.48	-47.36	28.88
1.48	-47.36	28.88
1.47	-56.33	22.94
1.56	-55.39	35.13
-41.77	24	-7.83
-44.79	13.81	12.02
-41.52	6.86	18.14
1.48	-47.36	28.88
1.47	-56.33	22.94
-2.71	-58.59	35.45
-44.62	3.55	30.72
-41.52	6.86	18.14
1.68	-73.91	43.37
1.68	-73.91	43.37
-6.62	55.94	-10.91
-17.84	-48.42	16.93

// Allin M P G, 2010: Relatives of Bipolar Disorder
// Subjects=19
8.92	-59.89	17.58
-2.73	-51.19	34.83
-3.4	63.87	-4.92
0.84	60.21	-11.36
-41.52	6.86	18.14
5.53	-25.53	8.05
-44.71	2.61	18.53
-6.62	55.94	-10.91
-17.84	-48.42	16.93
8.95	-56.29	22.85
-6.62	55.94	-10.91

// Allin M P G, 2010: Healthy Controls
// Subjects=19
5.71	-47.85	22.18
8.89	-52.49	16.96
5.6	-44.56	9.64
-2.77	-42.73	34.12
-2.7	-46.44	41.12
1.48	-47.36	28.88
5.72	-52.08	22.54
-2.71	-58.59	35.45
-44.62	3.55	30.72
5.53	-25.53	8.05
-44.71	2.61	18.53
1.68	-73.91	43.37
1.68	-73.91	43.37
8.95	-56.29	22.85
-6.62	55.94	-10.91

// Barbour T, 2012: Positive > Control, All Participants
// Subjects=19
-6	-36	-16
4	60	36
30	52	-14

// Dannon P N, 2011: Alternation learning task > Control
// Dannon P N, 2011: Parametric modulation by number of alternations
// Dannon P N, 2011: Parametric modulation by South Oaks Gambling Screen 
// (SOGS)
// Subjects=10
42	-66	48
54	-54	36
21	-72	57
36	54	-6
45	33	27
-3	27	42
-54	-57	45
-30	-66	50
-48	-42	39
-42	51	0
-48	42	-9
-21	54	27
-33	18	57
-42	30	36
-36	12	30
9	72	6
-18	-81	6
9	-78	21
42	-60	45
54	-27	45
45	-39	48
48	39	15
42	33	15
39	51	12
-27	-69	51
-36	-60	45
-54	-27	42
-39	-51	42
-12	-75	48
-15	-87	39
-21	-69	51
-36	24	6
-48	51	6
-42	57	-6

// Power Y, 2012: Pathological Gamblers > Healthy Controls, High-risk > 
// Low-risk
// Power Y, 2012: Healthy Controls > Pathological Gamblers, High-risk > 
// Low-risk
// Subjects=13
16	14	10
36	38	-18
18	-2	-26
8	20	2
2	48	44
-14	-18	-3
46	-80	-18
20	-92	-18

// Whalley H C, 2012: Genotype x Group Interaction
// Whalley H C, 2012: Main Effect of Genotype
// Subjects=18
-44	-10	30
12	-14	62

// Worhunsky P D, 2014: Avg. Regional Brain Activity: Winning outcome > 
// Baseline
// Worhunsky P D, 2014: Avg. Regional Brain Activity: Final-reel spin 
// (matched) > Final-reel spin (unmatched)
// Worhunsky P D, 2014: Avg. Regional Brain Activity: Final-reel spin 
// (matched) < Final-reel spin (unmatched)
// Worhunsky P D, 2014: Avg. Regional Brain Activity: Non-sequential miss > 
// Full-loss
// Worhunsky P D, 2014: Avg. Regional Brain Activity: Sequential-miss > 
// Second-reel matched stop
// Worhunsky P D, 2014: Regional Group Differences: Final-reel spin (matched) 
// > Final-reel spin (unmatched)
// Worhunsky P D, 2014: Regional Group Differences: Non-sequential miss > 
// Full-loss
// Worhunsky P D, 2014: Regional Group Differences: Sequential-miss > 
// Second-reel matched stop
// Subjects=24
27	-70	-11
3	-34	31
-48	11	28
45	14	28
-30	23	-17
-21	-1	-26
15	5	-17
9	35	22
-3	11	49
42	-82	4
-42	-76	-5
30	-76	28
18	-76	-26
39	26	10
-30	29	1
6	-19	1
0	5	64
-54	-43	28
-9	-79	-2
-39	-43	34
51	-43	58
30	-79	-8
-9	-100	7
30	-79	-8
-9	-100	7
12	-73	-47
6	26	55
27	-22	4
-54	-52	-38
36	29	-11
45	-49	7
-33	-25	-14
21	-46	43
9	11	-2
-42	29	1
-18	-58	46
-60	-46	37
-30	-43	40
-39	-79	7
-63	-7	4
-27	-55	-23
60	-22	-11
-15	38	-5
-9	47	28
48	-10	-29
-36	-79	4
21	-85	-11
15	-58	-47
51	-49	55
39	44	-14
51	41	22
18	-73	61
24	8	-11
48	23	-2

// Burke M J, 2014: Symptomatic stimulation > Asymptomatic stimulation
// Subjects=10
59.15	-36.44	27.3
43.91	-18.5	-.79
32.26	24.27	30.33
19.12	73.58	8.5
10.72	8.08	1.82
16.15	-1.94	9.29
3.1	49.36	-.44
43.24	-56.11	35.83
-37.09	20.57	43.7
-46.49	-60.79	38.37

// Ponseti J, 2014: Preferred faces > Non-preferred faces, All Subjects
// Subjects=24
10	-76	8
-10	-78	12
42	-66	-6
-40	-64	-10
34	-50	-20
-40	-56	-18
-22	-12	18
-20	6	16
-44	44	8

// Schlumpf Y R, 2013: Dissociative Identity Disorder (DID) > Controls: 
// Neutral > Scrambled, EP (Emotional Parts)
// Subjects=13
-12	-26	-18
40	32	32
-28	32	48
-26	-54	-6

// Vandewalle G, 2013: Blue light > Darkness
// Vandewalle G, 2013: Darkness > Rest
// Vandewalle G, 2013: Darkness < Rest
// Subjects=3
28	52	6
58	38	0
54	44	14
-56	30	14
-12	60	-2
10	54	18
-12	50	30
18	40	36
18	54	0
16	38	50
-18	56	16
8	-74	58
10	-82	-4
-18	-98	-4
32	-80	-22
10	38	10
-10	-20	12
-48	46	14
-38	10	30
48	26	30
-38	0	52
36	2	56
8	14	50
-6	16	50
-60	-30	4
52	-38	8
-32	-42	42
40	-34	38
34	-44	46
-16	-66	60
16	-68	50
-24	-98	-8
20	-98	-12
-46	-80	4
-44	-78	-8
-46	-60	-14
-32	28	0
-26	-2	8
26	-6	4
-12	-16	4
14	-14	4
24	-66	-50
-32	-52	-56
10	-74	-40
-12	52	6
6	56	8
-6	44	8
44	42	8
-30	-34	-12
28	34	-14
-52	-74	30
46	-70	28
4	-54	36
-4	-40	34
6	-32	40
6	-50	16
-10	-56	16
-26	-20	14
-28	-34	-16

// Barke A, 2012: Chronic Low Back Pain Patients (CLBP), Low fear-avoidance
// Subjects=15
30.04	-33.72	-3.81
-7.08	-25.58	36.08
-53.22	-64.09	-3.66
52.55	-63.71	-8.25
-8.12	-25.33	39.41
-56.11	-38.85	47.79
33.81	-45.48	64.04
-43.26	-37.46	50.87
-59.48	-29.58	30.32

// Barke A, 2012: Chronic Low Back Pain Patients (CLBP), High fear-avoidance
// Subjects=15
-57.37	-32.11	24.93
-65.84	-32.45	35.1
72.94	-32.98	15.7
-23.85	-61.86	63.85
-43.26	-37.46	50.87
-46.83	-64.31	-7.06
-49.89	-75.99	7.34
30.3	-74.99	13.03
-24.22	-95.38	1.98
-2.14	21.93	3.04
-11.59	51.04	36.39
7.61	60.68	35.36
39.75	18.86	28.47
-56.62	37.09	11.32
-36.98	-2.52	47.87
48.97	28.01	-19.25
-40.73	24.81	-11.26
43.08	0.36	36.67
-49.77	-2.26	52.45
4.71	-54.83	28.36
27.23	-40.72	43.64
-1.76	-19.2	35.48
1.2	17.86	18.96
42.73	16.56	-1.49
-40.5	4.15	10.55
-43.75	-32.57	-9.76
17.41	-16.43	28.34
17.22	-5.28	7.33
-5.21	-15.19	5.07
33.18	-15.73	-5.36
-18.13	-3.09	-2.48
69.78	-45.69	16.81
-43.54	-40.28	14.31
52.62	-62.94	1.72
-36.99	-55.34	25.53
42.77	-42.33	-19.97
-40.53	-55.52	-17.9
-62.76	-23.77	23.18
65.59	-38.26	30.73
-56.27	-42.76	24.7
4.9	-72.58	46.57
1.61	-56.99	41.96
-53.12	-69.66	6.85
4.63	-88.61	4.43
-4.96	-95.01	5.07
7.92	-84.39	17.42
13.91	-19.53	-11.51
-5.28	-25.73	-7.42
39.47	-33.44	-28.48
-40.6	-43.09	-22.29
46.1	-77.3	-18.19
-8.43	-74.62	-20.02
-7.08	-25.58	36.08
-53.22	-64.09	-3.66
52.55	-63.71	-8.25
-8.12	-25.33	39.41
-56.11	-38.85	47.79
33.81	-45.48	64.04
-43.26	-37.46	50.87
-59.48	-29.58	30.32

// Barke A, 2012: Pain-free Spider Phobics
// Subjects=15
7.91	14.38	55.97
-27.72	49.92	23.29
23.32	28.91	-19.03
-30.57	-9.09	45
55.42	21.87	-16.58
-37.42	32.46	4.79
49.57	-2.01	46.83
-43.47	-3.33	37.97
4.46	24.99	28.36
1.36	9.62	36.37
-2.05	37.13	20.72
4.59	-29.71	22.91
45.9	-29.97	-25.5
-38.51	-30.39	-23.38
36.28	19.44	-5
-34.21	16.1	-.56
39.55	-3	-6.5
-30.98	16.38	2.72
7.64	-14.86	8.24
-24.47	-22.16	-.81
68.47	-2.06	3.12
-34.4	10.79	-28
49.32	-63.99	-11.54
-40.39	-67.18	-3.55
24.08	-23.59	58.97
-17.6	-27.27	56.41
46.55	-44.06	53.74
-56.29	-32.99	27.23
14.4	-60.6	35.42
-17.7	-57.88	32.22
20.61	-89.02	-2.41
-17.95	-73.65	-6.61
8.03	-93.13	28.18
-24.17	-68.46	19.79
7.33	-31.23	-38.33
-2.22	-27.26	-27.41
7.54	-58.66	-21.54
-21.44	-37.15	-29.7
20.42	-74.45	-20.36
-27.61	-80.82	-15.93
-37.41	29.29	5.06
4.58	-33.14	19.85
11.06	-25.73	32.53
1.36	9.62	36.37
39.5	16.29	-4.77
39.52	-3.26	-9.82
1.2	-8.55	7.79
-30.88	-22.2	-.74
-20.81	-27.29	56.45
-5.25	-25.48	-4.1
-5.45	-27.53	-30.69
-11.74	-52.69	-25.16
-7.08	-25.58	36.08
-53.22	-64.09	-3.66
52.55	-63.71	-8.25
-8.12	-25.33	39.41
-56.11	-38.85	47.79
33.81	-45.48	64.04
-53.22	-64.09	-3.66
-62.65	-32.51	33.95
-7.08	-25.58	36.08

// Barke A, 2012: Pain-free Controls
// Subjects=15
23.74	-55.71	1.45
-40.38	-60.58	-.75
-20.74	-52.93	55.25
23.66	-74.17	-17.08
-37.41	29.29	5.06
4.58	-33.14	19.85
11.06	-25.73	32.53
1.36	9.62	36.37
39.5	16.29	-4.77
39.52	-3.26	-9.82
1.2	-8.55	7.79
-30.88	-22.2	-.74
-20.81	-27.29	56.45
-5.25	-25.48	-4.1
-5.45	-27.53	-30.69
-11.74	-52.69	-25.16
-7.08	-25.58	36.08
-53.22	-64.09	-3.66
52.55	-63.71	-8.25
-8.12	-25.33	39.41
-56.11	-38.85	47.79
33.81	-45.48	64.04
-53.22	-64.09	-3.66
-62.65	-32.51	33.95
-7.08	-25.58	36.08

// Lloyd D M, 2014: Chronic Low Back Pain Patients with High Levels of Illness 
// Behavior (WS-H)
// Subjects=11
52	14	-12
-54	10	-20
44	22	-16
-44	22	-8
40	16	-12
10	-2	-18
30	-2	-8
-52	0	-2
-4	-56	-18
6	-52	-20
-54	-20	28
26	-4	-14
46	20	-18
42	14	-16
52	4	-14

// Lloyd D M, 2014: Chronic Low Back Pain Patients with Low Levels of Illness 
// Behavior (WS-L)
// Subjects=13
48	14	0
-48	30	8
36	22	-4
-38	4	2
50	14	-6
-46	18	22
-14	8	0
30	6	-2
26	-4	-14
46	20	-18
42	14	-16
52	4	-14

// Seminowicz D A, 2011: All Subjects: MSIT > Control
// Seminowicz D A, 2011: All Subjects: MSIT < Control
// Subjects=16
-42	-82	-10
40	-84	-2
-32	-58	54
30	-54	48
-44	6	32
52	12	28
-26	22	6
28	28	4
-8	16	46
0	-42	40
-48	-78	32
60	-62	26
-2	60	8
-24	32	42

// Shimo K, 2011: Low Back Pain
// Subjects=11
-48.7	-36.23	-14.74
-60.57	-46.05	-15.81
-33.04	13.79	37.19
32.16	-18.15	59.41
-48.14	27.02	41.75
-32.74	19.27	61.3
-41.51	23.83	53.15
-24.69	-24.5	6.1
27.08	-27.17	-2.36
-28.9	-31.33	13.57
42.19	-35.93	-5.11
31.57	-25.91	10.89
38.1	-17.81	16.7
-6.49	-50.42	72.23
20.74	-64.41	1.43
-5.22	-75.66	-2.61
-37.68	-44.41	0.45
35.77	-55.2	-4.22
31.32	-43.08	-12.06
44.45	-35.2	2.62
-32.81	-74.25	36.94
-39.23	-80.35	41.01
-43.56	-71.64	42.46
-63.71	-36.51	-5.49
-9.18	-39.07	33.05
-2.59	-40.45	40.92
-25.04	-32.62	-23.34
25.22	-32.54	20.62
22.81	-22.41	2.85
-3.17	-16.33	0.45
12.74	-15.88	61.76
-11.08	-22.86	57.26
-52.59	5.24	27.17
22.87	-30.71	5.91
9.88	-91.12	-8.06
-5.11	13.81	24.39
44.22	-7.42	-10.21

// Shimo K, 2011: Healthy Controls
// Subjects=11
-48.7	-36.23	-14.74
-60.57	-46.05	-15.81
-33.04	13.79	37.19
32.16	-18.15	59.41
-48.14	27.02	41.75
-32.74	19.27	61.3
-41.51	23.83	53.15
-24.69	-24.5	6.1
27.08	-27.17	-2.36
-28.9	-31.33	13.57
42.19	-35.93	-5.11
31.57	-25.91	10.89
38.1	-17.81	16.7
-6.49	-50.42	72.23
20.74	-64.41	1.43
-5.22	-75.66	-2.61
-37.68	-44.41	0.45
35.77	-55.2	-4.22
31.32	-43.08	-12.06
44.45	-35.2	2.62
-32.81	-74.25	36.94
-39.23	-80.35	41.01
-43.56	-71.64	42.46
-63.71	-36.51	-5.49
-9.18	-39.07	33.05
-2.59	-40.45	40.92
-25.04	-32.62	-23.34
25.22	-32.54	20.62

// Suda M, 2014: Anorexia Nervosa (AN)
// Subjects=20
24.34	64.67	-10.89
25.15	-66.45	41.36
29.4	-65.54	39.01
0.66	-54.66	58.5
28.18	-72.63	16.2
33.26	-44.62	-7.4

// Suda M, 2014: Healthy Controls (HC)
// Subjects=24
24.34	64.67	-10.89
25.15	-66.45	41.36
40.52	59.7	6.07

// Balodis I M, 2014: Post-treatment > Pre-treatment, A1Win
// Balodis I M, 2014: Post-treatment < Pre-treatment, A1Win
// Balodis I M, 2014: Post-treatment > Pre-treatment, A1Loss
// Balodis I M, 2014: Post-treatment < Pre-treatment, A1Loss
// Balodis I M, 2014: Post-treatment > Pre-treatment, A2Win
// Balodis I M, 2014: Post-treatment > Pre-treatment, A2Loss
// Balodis I M, 2014: Post-treatment < Pre-treatment, A2Loss
// Balodis I M, 2014: Post-treatment > Pre-treatment, OCWin
// Balodis I M, 2014: Post-treatment < Pre-treatment, OCWin
// Balodis I M, 2014: Post-treatment > Pre-treatment, OCLoss
// Balodis I M, 2014: Post-treatment < Pre-treatment, OCLoss
// Subjects=19
39	-27	42
-27	-3	45
-42	30	-12
-9	66	27
-57	-72	-6
24	-15	60
30	-63	21
-24	-51	42
-9	66	27
-9	66	27
45	42	-12
-39	42	0
21	18	-6
-21	-51	-33
30	-63	45
-36	-45	48
-27	-99	3
-27	-60	39
9	-33	6
-42	42	0
6	42	15
-63	-9	0
-48	-48	57
-33	-12	69
63	-39	9
9	-6	39
-3	45	24
51	-27	60
-54	3	-9
-51	-21	42
24	-3	39
-24	-3	33

// Balodis I M, 2013: Binge Eating Disorder (BED)
// Subjects=11
36	15	0
-33	-42	-9
-57	-72	12
27	-87	-39
6	-87	-39
33	57	-18
-42	-87	9
-72	-36	6
45	-87	15
60	-63	-12
75	-18	15
-30	36	9
-33	-84	31
51	-23	5
33	0	-39
-51	12	-39
-3	24	-15
-18	-45	-6
-21	-90	-30
-30	-24	-15
18	60	30
54	-63	-39

// Balodis I M, 2013: Obesity
// Subjects=13
36	15	0
-33	-42	-9
-57	-72	12
27	-87	-39
6	-87	-39
33	57	-18
-42	-87	9
-72	-36	6
45	-87	15
60	-63	-12
75	-18	15
-30	36	9
-24	12	39
-51	45	6
0	15	45
-12	-87	-18
0	-27	36
18	-78	12
-60	-66	-12
57	-57	30
-24	-75	54
-24	30	-21
54	-54	-18
-9	-24	-36
-3	-36	48
15	21	39
-57	15	24
27	21	24
60	-6	21

// Balodis I M, 2013: Lean Comparison (LC)
// Subjects=11
36	15	0
-33	-42	-9
-57	-72	12
27	-87	-39
6	-87	-39
-33	-84	31
51	-23	5
-24	12	39
-51	45	6
0	15	45
-12	-87	-18
0	-27	36
27	36	-15
48	42	6
24	6	57
54	-30	48
18	21	3
-18	72	0
27	-69	-15

// Capek C M, 2010: Main effect of group: Deaf > Hearing
// Capek C M, 2010: Main effect of group: Hearing > Deaf
// Capek C M, 2010: Main effect of condition: Speechreading > Signs
// Capek C M, 2010: Main effect of condition: Signs > Speechreading
// Capek C M, 2010: Group x Condition
// Subjects=13
47.6	-26.03	-2.82
-57.08	-17.92	9.36
-45.16	-65.71	2.68
56.1	-15.03	-11.9
-57.14	-13.97	5.61
-49.15	-2.01	41.27
-49.48	-65.73	2.76
47.69	-61.44	-2.68
63.96	-29.19	8.42
-61.4	-29.94	7.27

// Corina D P, 2013: Deaf
// Subjects=21
1	10	26
10	39	8
-2	-36	-43
-53	21	26
-67	-36	0
-13	43	4
34	-94	8

// Corina D P, 2013: Subgroup of Deaf, Proficient Readers
// Subjects=11
1	10	26
10	39	8
-2	-36	-43
-53	21	26
-67	-36	0
-13	43	4
34	-94	8
-10	10	44
-60	-15	11
-60	-40	29
62	-26	26
-38	-54	-21
-49	-36	0
37	-44	-25
26	-69	15
-20	28	40
16	36	51
-38	-44	-21
62	-11	-7
8	10	23
-67	-40	0
66	-33	-3
8	-94	15
-31	36	-7
-53	21	15
34	-94	8

// Corina D P, 2013: Subgroup of Deaf, Less proficient Readers
// Subjects=10
1	10	26
10	39	8
-2	-36	-43
-53	21	26
-67	-36	0
-13	43	4
34	-94	8
-10	10	44
-60	-15	11
-60	-40	29
62	-26	26
-38	-54	-21
-49	-36	0
37	-44	-25
26	-69	15
12	39	11
48	21	18
-53	21	26
12	-29	15
30	-33	-28
-38	-90	-3

// Emmorey K, 2013: Deaf
// Subjects=14
-.71	26.76	51.69
6.71	26.2	43.84
-48.93	14.1	29.88
-46.08	44.5	-3.92
-52.4	37.66	4.53
-41.66	30.66	9.45
-56.68	22.23	-1.94
-41.37	2.85	35.2
-48.78	-.82	43.4
-26.84	33.7	-7.7
-26.73	22.75	2.14
3.44	4.64	26.73
-27.02	19.67	-37.75
-60.74	-52.42	-3.44
-34.27	-16.45	-22.37
-34.22	-31.25	-21.13
-45.88	-50.1	-16.07
-56.46	-36.99	3.03
-60.84	-57.85	-18.59
-45.84	39.24	24.39
-41.8	44.52	-3.98
-52.43	37.4	1.2
-38.41	27.77	13
-53.26	21.22	25.99
-49.31	13.41	-20.24
-34.22	26.93	1.87
-45.75	6.11	22.71
-33.79	-.48	46.54
-48.78	-.82	43.4
6.71	26.2	43.84
14.29	16.27	52.39
6.92	12.94	65.03
-.75	22.99	44.2
-.85	32.96	35.56
-.65	11.95	52.93
51.53	10.47	29.03
43.84	51.06	17.91
36.45	51.96	30.19
40.77	32.61	27.3
51.68	12.01	48.98
48.23	21.48	20.34
40.57	19.64	-2.84
-38.55	-24.22	-26.13
-41.13	-45.19	47.03
-30.41	-55.7	47.79
33.68	-55.66	42.59
48.63	-44.65	45.96
-.85	32.96	35.56
-48.8	3.41	43.05
62.97	14.94	-10.51
-37.93	-45.17	46.99
44.32	-45.02	41.58
-38.71	32.43	-23.07
-53.34	28.02	17.61
-45.84	39.24	24.39
43.93	36.6	23.58
43.72	45.38	-.57
48.47	4.25	45.2
51.33	16.07	5.15
51.51	10.21	25.71
-.61	9.12	57.63
14.28	19.45	52.13
-48.77	3.66	46.37
-33.7	-41.26	42.16
-37.86	-47.74	55.02
36.9	-52.12	46.72
29.39	-67.91	35.86
41.08	-41.07	37.94

// Emmorey K, 2013: Hearing Controls
// Subjects=14
-3.94	34.14	51.1
6.77	19.14	48.89
36.3	19.61	-2.78
-45.67	10.23	34.63
-52.54	36.2	-14.31
-38.57	37.14	-3.39
-49.13	35.1	12.51
-50.25	26.84	2.07
-53.26	21.22	25.99
-31.02	34.61	4.54
-31.03	22.38	-2.24
-41.77	-13.32	-22.54
-45.85	-42.1	-8.93
-53.24	-41.2	3.34
51.45	32.67	27.17
-.69	15.93	49.25
6.79	15.97	49.16
-48.94	9.61	26.91
-53.52	44.8	0.6
-26.73	30.41	4.84
-38.5	19.16	-1.89
-53.35	-53.31	-15.71
-56.11	-33.39	49.56
48.77	-58.6	58.28
-33.67	-48.66	42.78
-.85	32.96	35.56
-48.8	3.41	43.05
62.97	14.94	-10.51
-37.93	-45.17	46.99
44.32	-45.02	41.58
-49.26	37.08	-3.27
-3.91	34.48	55.54
-33.76	16.33	57.4

// Filbey F M, 2012: High-calorie > Control
// Filbey F M, 2012: Positive Correlation between Binge Eating Scale (BES) and 
// High-calorie > Control
// Filbey F M, 2012: Positive Correlation between Sugar content of 
// High-calorie cues & High-calorie > Control
// Subjects=26
-16	-78	-2
2	-82	8
2	-86	6
-24	-70	-14
24	-76	-10
-10	-94	16
2	-10	58
6	10	52
4	-24	58
-40	6	26
4	24	50
-4	10	38
-16	6	-18
22	20	-18
-20	-4	-18
-38	6	16
16	-4	24
20	16	-16
-18	22	-8
10	-30	20
12	4	16
42	-72	-8
38	-74	-4
32	-64	-14
40	-76	18
52	-60	14
54	-54	0
12	-44	34
8	-42	34
8	-36	36
-16	-42	32
2	-44	34
-30	-14	-10
0	-30	30
48	-16	-6
-32	-26	4
-28	-18	-10
8	24	12
10	-6	-4
20	10	10
0	-64	44
12	6	8
6	-16	-10
-36	-4	-2
-32	-6	-4
-18	-6	56
14	-32	46
12	-24	42
2	-2	36
22	-36	66
-8	-48	62
-6	-34	48

// Hu Z, 2011: Word signing > Baseline
// Hu Z, 2011: Picture signing > Baseline
// Hu Z, 2011: Word signing & Picture signing > Baseline
// Hu Z, 2011: Word signing > Picture signing
// Hu Z, 2011: Picture signing > Word signing
// Subjects=12
-46	6	31
-36	44	20
-18	-5	62
-5	2	64
-41	-14	53
-5	18	36
-31	15	5
-44	-57	-7
-45	-58	-4
-44	-52	-19
-53	-31	47
-35	-61	51
-54	-30	49
-46	-34	29
-36	-81	-13
-38	-81	-9
-29	-44	-26
2	15	44
2	-6	63
30	-21	66
2	15	44
40	11	4
40	-43	-22
40	-57	-18
25	-93	-9
23	-56	-24
-40	5	28
-29	-2	57
-18	-2	61
-7	7	48
-46	7	37
-7	15	40
-32	21	2
-44	-53	-9
-44	-56	-3
-32	-43	-17
-31	-53	49
-22	-66	35
-46	-29	55
-40	-70	-10
-31	-78	20
-9	-82	40
-5	-86	34
-40	-50	-23
2	7	55
42	-56	-12
38	-62	-17
38	-80	-3
26	-87	0
22	-59	35
19	-54	-16
-42	7	28
-29	-3	56
-5	16	43
-7	9	48
-46	7	35
-7	15	40
-44	-53	-7
-47	-55	-4
-42	-43	-18
-38	-39	33
-44	-29	53
-38	-73	-12
-28	-65	34
-38	-71	-21
0	4	56
40	-44	-22
38	-42	-22
25	-89	-6
19	-54	-20
-51	15	23
-41	-47	41
32	-70	-31
42	-55	-9
43	-71	11
-36	-48	-19
29	-62	-14
43	-57	-13
-42	-73	4
45	-75	5
-21	-92	15
-29	-40	-23
29	-31	-21

// Husain F T, 2012: Deaf
// Subjects=14
-50	-32	2
-64	-40	2
-50	-40	-6
-42	12	50
-26	-2	61
48	-14	-14
62	-8	-18
6	54	-12
-56	-62	-10
-46	-30	28
-60	-30	38
-52	-46	30
-42	-4	6
-58	2	16
36	-58	-38
36	-80	14
30	-50	-6
-24	-58	68
-2	-78	42
-4	-54	52
-30	-62	-8
-26	-50	-6
-28	-56	4
-28	-10	66
-42	-12	54
-16	-16	70
-42	-82	-18
-46	-82	-2
-48	-78	10
-58	-64	14
-60	-56	28
-54	-68	30
-2	-56	48

// Husain F T, 2012: Hearing Controls
// Subjects=16
-50	-32	2
-64	-40	2
-50	-40	-6
-42	12	50
-26	-2	61
48	-14	-14
62	-8	-18
6	54	-12
-56	-62	-10
-46	-30	28
-60	-30	38
-52	-46	30
-42	-4	6
-58	2	16
36	-58	-38
36	-80	14
30	-50	-6
-24	-58	68
-2	-78	42
-4	-54	52
-30	-62	-8
-26	-50	-6
-28	-56	4
-28	-10	66
-42	-12	54
-16	-16	70
-42	-82	-18
-46	-82	-2
-48	-78	10
-96	-4	26
-100	-2	16
-88	8	12
34	-70	-22
48	-72	-12
46	-56	-22
-42	-76	-18
-50	-72	-16
-38	-62	-22
-24	-50	42
-34	-34	34
-16	-80	50
52	0	22
50	2	34
38	4	16
-42	2	20
-34	-4	30
-32	-14	34
50	-48	52
44	-42	36
56	-36	46

// Lock J, 2011: Anorexia Nervosa (AN)
// Subjects=14
61	-51	34
48	-60	47
50	-64	50
44	50	20
40	51	16
48	10	18
0	18	42
4	4	-7
50	30	15

// Lock J, 2011: Binge Eaters
// Subjects=13
46	10	36
34	26	2
24	14	-8
16	12	0
4	36	26
4	24	49
46	-56	45
56	-34	-4
8	-71	48
44	-58	49
-10	-18	64
10	-18	64
8	28	15
50	-55	-2
4	4	-7
50	30	15
4	4	-7
50	30	15

// Lock J, 2011: Healthy Controls (HC)
// Subjects=13
42	15	-6
42	15	-2
48	13	-7
67	-41	4
66	-38	-4
24	48	36
42	49	12
-10	-18	64
10	-18	64
8	28	15
50	-55	-2
4	4	-7
50	30	15

// Sharma H A, 2011: Chronic Low Back Pain
// Subjects=6
-8.99	-27.68	64.15
6.55	28.89	23.54
12.99	-8.14	12.08
15.04	14.08	10.19
41.74	4.21	4.02

// Archila-Suerte P, 2013: Subgroup of Bilingual Children, Younger Group
// Subjects=16
-50	-22	10
62	-6	0
18	-4	-18
-38	16	48
32	30	50
-52	-34	-6
36	-80	-4

// Archila-Suerte P, 2013: Subgroup of Bilingual Children, Older Group
// Subjects=22
18	-4	-18
-38	16	48
32	30	50
-52	-34	-6
-18	-62	52
28	-54	50
4	-56	54
34	0	50
20	2	32
-22	-22	-38
2	-44	-4
-4	-70	-10
-46	-66	-6
-34	-6	56
-58	-22	8
60	-12	6
54	-4	46
34	-60	54
56	-38	50
-42	-44	42
-36	10	30
44	20	30
6	-30	70
-24	-64	52

// Archila-Suerte P, 2013: Bilingual Adults
// Subjects=19
-18	-62	52
28	-54	50
4	-56	54
34	0	50
20	2	32
-22	-22	-38
2	-44	-4
-4	-70	-10
-46	-66	-6
-34	-6	56
36	-80	-4

// Chu W C, 2012: Subgroup of IBS, Sham Acupuncture
// Subjects=15
-50.55	-78.8	0.71
-1.32	-14.97	60.79
-43.51	-58.15	48.97
-27.31	-77.86	43.92
33.73	-71.81	1.95
-47.39	19.11	14.5
1.19	28.85	12.71
-50.84	-61.22	-17.83
50.21	12.37	40.4
37.47	-77.95	39.47
46.65	29.64	18.58
16.88	-60.28	-45.97
-48.04	-12.02	-42.92
-22.04	-63.92	-48.31
13.77	-16.63	-26.71
-28.37	-82.46	-39.65
49.8	42.1	13.93
56.45	-35.39	11.4
36.67	50.69	3.22
62.93	20.43	22.58
-37.12	-55.56	41.88

// Chu W C, 2012: Subgroup of IBS, True Acupuncture
// Subjects=15
20.44	57.01	2.87
59.2	13.49	-17.01
-63.7	-30.99	-3.8
14.67	-72.27	32.57
-7.85	-48.14	50.74
53.69	-25.28	50.79
59.48	-13.98	-.85
33.57	25.46	9.13
-53.69	-5.82	23.8
69.38	-2.81	14.68
31.1	-73.84	49.26
43.89	3.71	51.45
-8.52	48.59	17.65
-30.56	-41.84	50.5
-63.98	-3.52	-19.96
-12.06	59.47	-3.54
50.49	-47.94	49.72
-28.33	-36.24	-27.41
-1.82	-64.62	11.92
69.32	0.07	11.04
31.07	-77.35	46.24
56.24	-13.99	-.8
-66.68	-55.28	12.1
14.88	-24.8	58.12
37.55	-31.41	55.03

// Colorado R A, 2012: Right: Multiple Sclerosis (MS) > Healthy Controls (HC)
// Colorado R A, 2012: Left: MS > HC
// Colorado R A, 2012: 2-Back: MS > HC
// Subjects=23
8	-41	57
18	-21	59
-4	-27	67
16	47	33
20	55	19
2	11	29
28	17	19
44	-5	-17
24	21	13
40	23	31
20	43	11
36	45	7

// Ernst A, 2012: After rehab > Before rehab
// Ernst A, 2012: Before rehab > After rehab
// Subjects=4
14.72	-95.98	31.55
-37.61	-77.8	-.73
-36.93	-74.94	52.76
-63.4	-54.96	15.38
-50.65	-21.5	5.13
63.54	-1.69	-18.95
56.67	17.27	-45.36
31.08	70.05	-7.56
14.23	-12.14	9.82
-35.56	-32.71	-.74
-35.92	-57.3	-34.16
9.59	-78	-28.41
-16.44	-74.46	-35.04
-16.21	-83.64	-18.45
18.25	51.27	-1.01
37.8	32.41	2.77
57.65	9.23	29.38
3.37	24.61	13.09
-.56	34.09	45.84
44.32	-8.82	-2.23
22.51	22.39	-11.67
12.02	13.79	11.77

// Marsh R, 2011: Congruent > Incongruent, Healthy Controls (HC) > Bulimia 
// Nervosa (BN)
// Marsh R, 2011: Congruent > Incongruent, BN > HC (deactivations)
// Marsh R, 2011: Postcongruent interference, HC > BN
// Marsh R, 2011: Postcongruent interference, BN > HC (deactivations)
// Marsh R, 2011: Postincongruent interference, HC > BN
// Subjects=18
30	-16	8
25	-23	-14
54	20	16
7	53	8
20	54	38
-52	22	8
23	35	52
-19	50	39
14	-52	36
54	20	16
20	52	38
-54	21	16
26	18	67
26	-16	8

// Rocca M A, 2012: Healthy Controls (HC)
// Subjects=18
-16	-72	42
24	-66	50
18	-70	44
36	42	22
-28	-48	40
-22	-86	18

// Rocca M A, 2012: Benign Multiple Sclerosis
// Subjects=17
-26	-72	-18
-16	-70	42
24	-86	52
-36	34	30
48	2	22
-58	-16	-12
60	-14	-18
-34	14	56

// Rocca M A, 2012: Relapsing-remitting (RR) Multiple Sclerosis
// Subjects=17
-16	-72	42
24	-66	50
18	-70	44
36	42	22
-28	-48	40
-22	-86	18
-20	-80	-10
-16	-34	38
-16	-70	40
-30	30	28
24	44	22
-22	-82	28
20	-86	16
60	2	-10
-62	-16	-12
-34	6	58
-26	-72	-18
-16	-70	42
24	-86	52
-36	34	30
48	2	22
-58	-16	-12
60	-14	-18
-34	14	56

// Rocca M A, 2012: Secondary Progressive (SP) Multiple Sclerosis
// Subjects=23
-20	-80	-10
-16	-34	38
-16	-70	40
-30	30	28
24	44	22
-22	-82	28
20	-86	16
60	2	-10
-62	-16	-12
-34	6	58

// Ashworth F, 2011: Bulimia Nervosa (BN)
// Subjects=12
-32	-98	-6
50	18	26
-50	14	30
-34	-96	-6
42	36	12
-44	26	22

// Ashworth F, 2011: Healthy Controls (HC)
// Subjects=16
40	-74	-16
42	14	24
-48	46	-4
40	-84	-10
46	14	22
-40	6	28
54	-78	19

// Bohon C, 2011: Anticipatory Reward: Healthy Controls (HC) > Bulimina 
// Nervosa (BN)
// Bohon C, 2011: Consummatory Reward: HC > BN
// Subjects=13
60	-12	39
45	-9	-6
60	-15	36
-24	42	-3
-12	-27	-3

// Joos A A B, 2011: Bulimia Nervosa (BN)
// Subjects=13
15	48	24
45	12	-27
-9	-18	48

// Joos A A B, 2011: Healthy Controls (HC)
// Subjects=13
-6	45	6
-18	24	57
27	18	-12
-3	-30	33
48	-57	36
15	48	24
45	12	-27
-9	-18	48

// Meintjes E M, 2010: Fetal Alcohol Syndrome (FAS)
// Subjects=15
43.26	-58.14	37.11
40.04	-71.45	30.46
-4.89	-57.97	29.85
29.82	25.49	-8.78
11.84	40.47	21.4
8.74	39.36	34.91
-11.55	31.67	33.56
-13.75	16.71	19.22
-20.99	16.95	50.51
-24.21	-9.56	38.27
-52.2	-45.93	-2.96
16.25	-78.9	-8.79
-6	-88.07	12.31
-25.65	26.19	5.18
31.2	-27.32	10.13
-6.2	-23.14	12.44
3.2	-19.85	-14.71
5.74	-31.05	33.04
-43.25	-64.75	42.01
42.2	-59.12	38.32
10.11	-55.25	36.14
-10.25	-53.77	29.55
-44.26	-50.95	55.36
27.66	47.23	-2.77
-19.48	56.58	-15.28
-48.71	-58.32	29.26
1.07	-20.84	-13.48
1.07	-20.84	-13.48
29.44	-74	39.72
15.43	11.51	59.47
-51.02	12.4	35.63
35.73	-51.04	33.26
23.05	-36.46	57.83
18.59	-35.03	35.46
-2.89	-30.81	23.08
-7.89	-63.51	54.88
-12.48	-22.95	29.23
-13.38	-60.68	36.86
-18.59	-39.62	61.92
-27.21	-29.44	56.7
-31.57	-70.99	29.01
-32.59	-63.88	38.47
-40.2	-44.35	30.22
32.08	46.51	15.08
24.84	0.62	27.94
13	22.76	26.22
0.4	15.13	52.65
-8.32	19.88	32.28
-17.95	9.8	26.54
-41.52	26.57	25.41
-44.73	11.15	18.93
44.94	-24.38	-8.12
32.89	14.19	-31.29
20.44	-35.9	-3.52
-39.36	-32.48	4.68
29.24	-59.6	19.55
16.25	-53.64	1.36
2.6	-77.56	23.6
-13.55	-69.08	10.8
-26.45	-52.33	8.43
24.44	-32.1	-37.34
-2.12	-35.03	-17.83
-27.95	-40.33	-42.74
29.91	26.35	2.3
-32.02	7.83	2.33
-32.85	-30.36	17.81
27.81	2.64	-1.26
-13.84	-2.89	-.32
31.45	-73.07	24
32.33	31.56	41.98
32.9	16.48	-29.25
15.33	-80.71	9.22
-15.7	-69.18	9.72
4.37	-57.2	-16.05
32.99	-33.1	-37.36
-21.48	-28.77	-31.52
-24.54	-47.05	-19.91
0.91	-17.01	-32.76
0.91	-17.01	-32.76
-9.67	-51.16	-33.12

// Meintjes E M, 2010: Healthy Controls (HC)
// Subjects=18
44.36	-44.59	47.12
34.75	-66.57	39.03
-9.1	-68.32	34.11
34.4	24.28	30.3
6.66	26.75	37.11
-45.72	16.4	31.88
29.9	21.95	0.44
-23.48	26.45	8.48
-18	0.48	16.17
5.74	-31.05	33.04
-43.25	-64.75	42.01
42.2	-59.12	38.32
10.11	-55.25	36.14
-10.25	-53.77	29.55
-44.26	-50.95	55.36
27.66	47.23	-2.77
-19.48	56.58	-15.28
-48.71	-58.32	29.26
1.07	-20.84	-13.48
1.07	-20.84	-13.48
29.44	-74	39.72
15.43	11.51	59.47
-51.02	12.4	35.63
-40.18	-44.18	32.44
-31.52	-60.53	40.4
4.75	-59.86	32.12
5.55	28.51	32.51
-4.16	20.91	17.65
-47.93	20.02	23.8
17.17	8.47	6.18
-14.86	4.21	9.13
31.45	-73.07	24
32.33	31.56	41.98
32.9	16.48	-29.25
15.33	-80.71	9.22
-15.7	-69.18	9.72
4.37	-57.2	-16.05
32.99	-33.1	-37.36
-21.48	-28.77	-31.52
-24.54	-47.05	-19.91
0.91	-17.01	-32.76
0.91	-17.01	-32.76
-9.67	-51.16	-33.12

// Mohr H M, 2011: Bulimia Nervosa (BN)
// Subjects=15
-24.43	32.13	26.97
19.64	-26.48	35.84
26.14	-48.56	38.74
-25.52	30.81	23.75
34.14	22.69	-4.13
-28.86	12.88	-1.47
13.15	15.5	42.44
-37.18	-8.98	19.42
46.55	-22.14	61.94
-37.91	-25.19	57.59
20.32	-46.96	-22.67
-25.58	2.67	3.81

// Mohr H M, 2011: Healthy Controls (HC)
// Subjects=16
-24.43	32.13	26.97
19.64	-26.48	35.84
26.14	-48.56	38.74
-25.52	30.81	23.75
-54.11	-74.36	15.06
34.14	22.69	-4.13
-28.86	12.88	-1.47
13.15	15.5	42.44
-37.18	-8.98	19.42
46.55	-22.14	61.94
-37.91	-25.19	57.59
20.32	-46.96	-22.67

// Norman A L, 2013: Heavy Prenatal Alcohol Exposure (ALC)
// Subjects=18
37.85	-23.74	42.1
19.91	99.28	-17.08
41.65	2.13	-9.19
-39.09	-15.4	46.74
37.85	-23.74	42.1
-1.1	85.32	24.48

// Norman A L, 2013: Family History of Alcohol Use Disorders (FHP)
// Subjects=18
-31.03	-2.88	-12.39
-1.17	31.82	-6.72

// Norman A L, 2013: Healthy Controls (CON)
// Subjects=17
37.85	-23.74	42.1
19.91	99.28	-17.08
41.65	2.13	-9.19
-39.09	-15.4	46.74
37.85	-23.74	42.1
-1.1	85.32	24.48
-31.03	-2.88	-12.39
-1.17	31.82	-6.72

// Spangler D L, 2012: Bulimia Nervosa (BN)
// Subjects=12
-11	-53	50
-53	1	39
3	45	-1
-51	-38	48
3	46	0

// Spangler D L, 2012: Healthy Controls (HC)
// Subjects=12
45	20	38
-47	30	37
-10	56	29
13	50	24
53	23	9
3	46	0

// Vocks S, 2010: Own Body > Fixation, All Participants
// Vocks S, 2010: Own Body > Fixation, Healthy Controls (HC) > Anorexia 
// Nervosa (AN)
// Vocks S, 2010: Own Body > Fixation, HC > Bulimia Nervosa (BN)
// Vocks S, 2010: Own Body > Fixation, BN > AN
// Vocks S, 2010: Other Body > Fixation, All Participants
// Vocks S, 2010: Other Body > Fixation, AN > HC
// Vocks S, 2010: Other Body > Fixation, HC > AN
// Vocks S, 2010: Other Body > Fixation, BN > HC
// Vocks S, 2010: Other Body > Fixation, HC > BN
// Vocks S, 2010: Other Body > Fixation, AN > BN
// Vocks S, 2010: Other Body > Fixation, Depressive > Non-depressive
// Vocks S, 2010: Other Body > Fixation, Non-depressive > Depressive
// Subjects=1
-33.99	-13.04	-43.06
-41.28	-44.55	56.55
-44.79	-6.49	-41.28
-42.77	7.79	-49.45
-31.83	-13.03	-43.1
-44.83	-4.57	-43.71
-44.93	7.78	-49.41
-41.28	-44.55	56.55
-36.73	-53.72	73.07
-49.8	-41.42	67.59
-14.29	39.28	-12.71
-61.91	-20.61	-30.63
26.65	16.7	-26.86
-4.73	37.45	59.02
-22.6	-39.25	-2.56
-25.19	18.85	-23.95
28.81	-11.78	-33.05
47.21	-55.91	44.97
26.58	27.12	-30.13
-40.69	7.17	-56.15
-46.96	-10.96	-43.04
-55.65	-6.94	-45.53
9.22	61.51	-28.76
-57.01	-51.3	8.18
-53.36	2.82	-33.09
-42.79	5.45	-51.46
-47.04	-7.12	-47.9
3.45	-55.76	3.11
-41.18	-28.42	68.4
-55.12	-40.19	-10.88
-24.77	-43.72	-4.32
57	6.58	-21.9
31.02	-2.64	-27.26
4.34	-42.52	75.75
47.29	-39.99	54.59
41.58	2.12	-45.84
-63.92	-21.7	-19.28
30.2	-62.61	66.09
12.01	-34.46	0.86
-48.15	-56.2	24.21
-36.9	-24.35	65.69
56.97	6.38	-24.12
50.64	-3.45	-14.07
20.7	-3.4	11.09
11.95	-4.26	2.36
4.33	-40.4	75.54
2.14	-31.9	74.73
3.45	-55.76	3.11
12.01	-34.46	0.86
7.67	-45.52	-2.45
-24.78	-41.59	-4.53
31.02	-2.64	-27.26
-21	-12.79	-41.06
-48.36	-46.81	9.83
-50.35	-54.29	21.81
-57.01	-51.3	8.18
-53.36	2.82	-33.09
-46.9	-6.08	-36.8
-55.12	-40.19	-10.88
-41.79	-11.09	24.12
6.24	-5.06	63.04
-0.05	-16.81	75.52
-42.01	-25.93	3.18
-23.22	-11.08	-45.68
-33.29	5.33	15.62
-26.18	-16.22	60.22
-19.63	-11.32	66.34
-63.94	-24.04	-21.29
45.91	0.01	-45.71
56.71	-6.54	-47.49
47.97	10.23	-51.24
35.78	2.83	7.97
41.79	-22.58	-34.44
53.66	-12.31	51.75
22.91	-22.75	10.72
-29.42	-26.46	-26.12
-58.88	-38.18	33.81
-15.99	-5.45	14.15
-11.69	7.54	15.04
-44.9	-7.32	-50.16
-7.4	-82.36	-5.28
-11.85	-85.54	-16.09
-31.73	-3.48	-32.84
21.65	-40.13	77.46
28.79	-22.83	-36.43
-28.97	-62.46	2.09
-20.87	-31.51	-34.73
-56.51	-56.28	46.77
-52.86	-8.75	3.9
-54.53	-9.48	42.1
-13.49	-72.89	27.51
-47.98	10.73	51.2
-54.52	-64.11	31.82
70.5	-22.16	14.34
-43.49	-40.51	53.95
25.78	-28.39	65.02
37.48	-26.85	-33.94
24.44	29.45	-28.09
30.2	-62.61	66.09
47.29	-39.99	54.59
47.42	-43.41	63.89
-35.95	-13.72	-27.27
59.3	36.11	-4.69
-61.33	-51.32	8.26
-53.33	3.03	-30.87
-42.79	5.45	-51.46
-49.15	-4.58	-43.64
-57.28	-40.2	-10.84
-61.67	-23.2	-12.45
-70.23	-31.32	-7.01
37.22	4.02	-48.2
-54.39	-52.23	44.09
-45.8	-52.61	39.5
-52.8	-8.33	8.34
-56.82	-41.13	25.1
-21.02	-15.12	-43.07
28.89	-2.44	-25.01
61.4	-29.98	-22.84
19.04	-28.15	44.94
25.88	-62.63	66.16
-32.97	3.36	40.47
-46.88	33.45	-27.27
-50.17	-11.38	44.46
10.53	-49.04	51.63
44.32	-24.12	-5.2
54.75	8.08	-28.73
-39.13	-27.11	59.27
-32.72	-23.25	54.3
-43.34	-26.3	68.23
-59.54	-23.4	-14.7
14.38	15.25	27.28

// Zhu Y, 2014: Irritable Bowel Syndrome (IBS), Moxibustion Group
// Subjects=15
-20	64	-12
-20	60	-20
6	36	30
14	22	60
26	40	-24
26	72	-8
52	50	-10
52	34	34
52	46	40
50	22	-6
-12	-14	60
10	30	-12
6	60	-6
4	-52	24

// Zhu Y, 2014: Irritable Bowel Syndrome, Placebo Group
// Subjects=13
-38	38	-16
-28	28	-20
-36	14	36
-2	-42	30
-6	-52	8
58	24	12
-24	64	-8
-22	38	46
-52	18	0
-38	34	-14
-24	40	-16
54	-2	24
-12	46	6
-20	-66	10
10	-20	34

// McNealy K, 2011: 6-year-olds
// Subjects=16
-23.02	32.03	-20.81
46.61	9.66	11.59
-67.99	-13.26	2.37
55.13	-10.91	-2.2
-50.57	-27.47	10.2
48.78	-23.07	5.83
-46.22	-27.24	12.34
40.18	-25.02	8.41
-44.48	-12.92	-18.24
-43.66	-33.04	42.01
40.39	-27.82	24.37
-17.64	-5.97	54.58
19.11	-10.1	54.36
-28.19	-32.63	68.6
21.18	-8.59	47.45
-30.9	-1.71	31.97
-26.22	-14.3	57.79
48.99	-10.56	24.76
-67.78	-9.47	19.92
44.76	-12.08	31.71
-12.08	26.52	-11.49
14.66	-13.28	43.54
15.96	32.8	-14.83
23.26	-17.92	39.37
-39.94	-2.53	0.83
31.7	-30.39	20.29
-33.4	-10.8	3.78
16.3	2.55	6.09
20.55	-6.77	-2.02
14.15	-21.48	1.78
34.07	-33.19	36.22
26.69	-53.03	-37.89
-61.53	-6.86	1.62
59.79	-30.29	19.8
-48.29	-28.76	19.25
42.41	-28.85	13.23
-24.21	-11.08	46.23
42.32	-5.45	10.92
40.24	-18.01	14.44
66.01	-21.3	0.88
66.32	-29.86	24.13
-63.7	-20.04	-1.52
55.2	-27.92	-.52
44.57	-28.84	13.2
40.3	-19.73	19.09
-54.76	-30.91	19.57
46.77	-30.75	15.59
53.17	-24.77	10.41
44.54	-20.33	12.36
-26.11	-41.96	60.52
34.15	-23.85	44.26
19.31	-45.84	62.37
-15.4	-9.8	59.4
14.85	-9.7	58.87
-17.59	-25.32	54.25
14.87	-9.49	61.09
55.57	-5.46	33.11
-19.78	-18.95	53.65
64.11	-8.38	24.29
-39.46	-9.84	37.4
27.68	-12.82	47.76
-20.04	-3.39	36.43
21.03	1.22	37.52
-22.08	-11.28	43.97
25.38	-35.76	32.14
-33.17	-19.99	20.37
40.15	-9.92	9.16
44.54	-20.33	12.36
-41.36	-40.71	51.69
36.31	-23.84	44.22
-26.14	-42.16	58.3
-15.47	0.62	56.13
12.75	-11.42	63.56
-17.62	-25.53	52.03
55.28	-12	9.11
57.71	-7.78	31.06
-34.9	-25.59	52.33
-17.85	-18.48	35.65
21.04	-.91	37.73
-19.96	-15.94	39.91
21.19	-26.02	44.69
-31.07	-9.55	17.06
40.28	-22.06	17.08
-41.43	-43.46	45.24
-34.67	-41.36	67.33
-13.08	-37.03	66.54
8.62	-38.46	73.03
63.87	-18.97	2.93
44.9	-32.94	38.25
-23.8	-43.04	71.79
-10.92	-37.03	66.5
63.85	-21.3	0.92
-41.43	-43.46	45.24
-21.64	-45.16	71.97
27.95	-39.22	63.81
8.62	-38.46	73.03
-32.5	-36.89	69.09

// McNealy K, 2011: 10-year-olds (Time 1)
// Subjects=78
-41.43	-43.46	45.24
-34.67	-41.36	67.33
-13.08	-37.03	66.54
8.62	-38.46	73.03

// McNealy K, 2011: 13-year-olds, (Time 2)
// Subjects=39
11.57	65.1	-13.47
-18.12	51.72	28.7
-15.7	38.29	45.68
-26.25	9.51	59.91
26.67	34.34	-21.88
-28.73	18.06	36.7
-24.31	21.03	45.29
-24.24	4.02	46.98
25.59	5.23	57.21
-14.45	51.21	-22.85
18.03	32.18	-21.52
-52.72	14.19	19.56
35.32	25.65	-23.41
-59.39	-9.18	-.42
57.37	-16.87	2.83
-63.61	-14.96	6.94
35.93	-37.59	11.97
-68.14	-27.48	-11.91
-35.01	-35.14	42.07
42.81	-28.07	44.53
25.73	-9.04	65.35
-54.52	-2.89	43.69
55.56	-3.33	32.9
-24.11	-23.43	51.93
34.34	-13.68	61.18
62.14	-20.12	36.69
10.25	3.52	39.71
-11.98	22.89	-4.41
7.49	23.17	-2.52
-43.98	-33.2	17.38
59.47	-8.56	-.27
-70.07	-19.23	7.48
66.11	-18.34	9.55
-52.93	-18.08	-4.14
-70.06	-21.36	7.69
53.24	-28.6	15.27
-50.65	-34.68	1.95
-54.76	-30.91	19.57
46.77	-30.75	15.59
53.17	-24.77	10.41
44.54	-20.33	12.36
-26.11	-41.96	60.52
34.15	-23.85	44.26
19.31	-45.84	62.37
-15.4	-9.8	59.4
14.85	-9.7	58.87
-17.59	-25.32	54.25
14.87	-9.49	61.09
55.57	-5.46	33.11
-19.78	-18.95	53.65
64.11	-8.38	24.29
-39.46	-9.84	37.4
27.68	-12.82	47.76
-20.04	-3.39	36.43
21.03	1.22	37.52
-22.08	-11.28	43.97
25.38	-35.76	32.14
-33.17	-19.99	20.37
40.15	-9.92	9.16
63.87	-18.97	2.93
44.9	-32.94	38.25
-23.8	-43.04	71.79
-10.92	-37.03	66.5

// McNealy K, 2011: Adults
// Subjects=27
44.54	-20.33	12.36
-41.36	-40.71	51.69
36.31	-23.84	44.22
-26.14	-42.16	58.3
-15.47	0.62	56.13
12.75	-11.42	63.56
-17.62	-25.53	52.03
55.28	-12	9.11
57.71	-7.78	31.06
-34.9	-25.59	52.33
-17.85	-18.48	35.65
21.04	-.91	37.73
-19.96	-15.94	39.91
21.19	-26.02	44.69
-31.07	-9.55	17.06
40.28	-22.06	17.08
63.85	-21.3	0.92
-41.43	-43.46	45.24
-21.64	-45.16	71.97
27.95	-39.22	63.81
8.62	-38.46	73.03
-32.5	-36.89	69.09

// McNealy K, 2011: Subgroup of 10-year-olds, second language proficient
// Subjects=53
-63.44	-35.61	15.71
50.92	-31.99	2.19
-54.8	-26.86	16.93
63.93	-27.27	5.99
-41.79	-30.86	19.35

// Pierce L J, 2014: International Adoptees (IA)
// Subjects=21
-62	-12	2
-64	-14	2
-60	-22	4
-64	-4	-4
-60	-8	0
-60	-4	-4
-60	-8	0
-66	-22	6
-64	-26	4
-62	-28	2
60	-4	0
64	-12	4
56	-32	2
64	-8	0

// Pierce L J, 2014: Bilingual
// Subjects=12
-62	-12	2
-64	-14	2
-60	-22	4

// Pierce L J, 2014: Subgroup of IA, matched IA
// Subjects=10
-64	-6	-4
-62	-10	-2
-60	-24	4
64	-2	-8

// Pierce L J, 2014: Subgroup of Bilingual, matched Bilingual
// Subjects=10
-58	-10	2
-62	-12	4
-46	-42	8
60	-6	-2

// Pierce L J, 2014: Subgroup of Monolingual, matched Monolingual
// Subjects=10
64	-16	-4
52	-38	10
48	-86	0
28	-10	-18

// Fairchild G, 2014: Healthy Controls (HC)
// Subjects=20
52	-38	6
-42	-40	-16
44	-42	-16
52	34	0
-52	-54	4
30	-26	54
40	-12	20
-16	-78	4
36	26	6
-28	-12	58
28	-12	52
-10	-102	2
10	-76	16
10	12	52
46	-58	-2
24	-82	-20
28	-70	-2
46	-26	42

// Fairchild G, 2014: Conduct Disorder (CD)
// Subjects=20
52	-38	6
-42	-40	-16
44	-42	-16
52	34	0
-52	-54	4
30	-26	54
40	-12	20
-16	-78	4
36	26	6
-28	-12	58
28	-12	52
-10	-102	2
10	-76	16
10	12	52
46	-58	-2
24	-82	-20
28	-70	-2
46	-26	42
-52	-4	-8
42	-6	-14
-32	36	42
-28	-54	-12
40	-14	-26
24	-48	-14
-22	-76	40
-40	-78	6
-10	-4	56
14	-12	-22

// Finger E C, 2011: Diagnosis-by-phase Interactions, All Participants
// Finger E C, 2011: Diagnosis-by-response type Interactions, All Participants
// Finger E C, 2011: Main Effect of Diagnosis, Healthy Controls > Conduct 
// Disorder
// Subjects=15
23	36	-13
-32	41	25
-17	46	44
-29	-4	45
50	38	11
-59	13	20
-41	-69	45
47	-58	10
44	3	-33
-50	-54	3
-2	16	13
-4	-50	-25
5	64	-8
-44	12	49
35	-41	-10
11	26	66
-8	1	68
47	2	49
37	14	66
11	27	43
-35	47	28
44	13	13
-41	14	0
-35	-72	45
-53	-33	4
44	-64	19
-20	-88	-13
32	-81	-20
20	-10	-26
-8	7	16
5	-30	8

// Kim K R, 2012: Anorexia Nervosa (AN)
// Subjects=18
-51	15	4
59	9	18
15	7	60
-3	21	40
-35	11	-4
-13	-47	42
-15	-83	8
17	-75	-20
-1	-69	-28
-7	-85	26
37	-37	-40
59	9	14
13	7	58
-7	-1	46
-7	13	34
11	-35	-26
13	-75	-16
49	-31	48
35	-73	36
1	19	42
-11	17	32
53	-63	12

// Kim K R, 2012: Bulimia Nervosa (BN)
// Subjects=20
-35	23	6
3	-75	6
5	-41	-8
41	-71	-24
-39	-67	-22
41	21	28
5	-41	-8
11	-41	66
-27	-59	42
1	19	42
-11	17	32
53	-63	12

// Kim K R, 2012: Healthy Controls (HC)
// Subjects=20
-5	-93	10
-1	-85	-6
-37	-65	-20
-45	27	26
59	9	14
13	7	58
-7	-1	46
-7	13	34
11	-35	-26
13	-75	-16
49	-31	48
35	-73	36
41	21	28
5	-41	-8
11	-41	66
-27	-59	42

// Richlan F, 2010: Words > Baseline, Healthy controls > Dyselxia
// Richlan F, 2010: Words > Baseline, Dyslexia > Healthy controls
// Richlan F, 2010: Pseudowords > Baselines, Healthy controls > Dyslexia
// Richlan F, 2010: Pseudowords > Baseline, Dyslexia > Healthy controls
// Subjects=15
22	-90	-6
36	-86	-6
-42	-46	-16
-16	-80	8
-2	4	54
-14	-20	12
-16	0	10
18	16	6
30	-56	-30
22	-90	-4
36	-84	-6
-18	-92	-8
24	-86	18
-16	-92	16
-34	-62	50
-44	-44	40
-44	-48	-18
-46	-46	4
-52	14	14
36	4	28
-48	28	-4
34	22	12
-2	24	44
10	30	26
-16	-66	40
16	2	56
-20	2	58
-58	-2	16
-48	-4	52
32	44	34
18	2	10
-18	14	12
16	18	6
-12	-6	-6
-8	-22	16
-38	-12	-24
-28	-8	-10
-20	-2	8
-28	-50	-32
10	-58	-22
32	-54	-32
14	-18	-8

// Peyrin C, 2012: Skilled Readers
// Subjects=14
-42	-59	-12
-45	-42	41
-27	-62	35
-48	16	22
-48	-59	-9
-30	-62	51
-27	-68	29
-42	-50	44
27	-68	39
-33	-78	7
-9	-75	20
9	-79	1
9	8	51

// Peyrin C, 2012: LL
// Subjects=1
-45	-50	-12
42	-53	-12
-59	-43	18
-53	-42	25
-21	-67	49
-30	-54	35
-50	13	32
45	-56	-9
-15	-79	56
-26	-72	28
-39	-45	41
18	-79	52
30	-71	42
36	45	30
33	-15	49
-53	5	42
50	-4	39
-36	-61	64
-33	18	12
36	-32	53
3	11	54
-56	-40	25
-9	-48	28
30	-12	49
33	10	29
-18	-76	52
18	-82	49
45	-56	-9
-36	-45	41
56	-43	18

// Peyrin C, 2012: FG
// Subjects=1
53	-58	9
-21	-78	46
-45	-55	58
-53	-44	51
-27	-65	39
27	-68	42
-30	-85	-2
-33	24	8
-53	5	42
-53	19	35
-45	36	18
-50	-12	55
0	14	48
0	14	48
-45	-54	-11
-21	-71	45
-27	-80	33
-53	5	42
50	-4	39
-36	-61	64
-33	18	12
36	-32	53
3	11	54
-56	-40	25
-9	-48	28
30	-12	49
33	10	29
-18	-76	52
18	-82	49
45	-56	-9
-36	-45	41
56	-43	18

// Mohammadi B, 2011: Amyotropic Lateral Sclerosis with no right hand weakness 
// (ALS-MRC-5)
// Subjects=11
-35.84	-24.81	48.61
35.79	-8.63	58.7
0.43	0.07	50.57
-52.05	-23.53	25.27
58.03	-22.7	26.16
-27.68	-10.12	3.79
-12.72	-11.09	3.7
15.1	-9.44	8.82
-26.12	-26.98	60.95
26.25	-14.52	65.99
1.52	2.45	53.7
-28.73	-12.07	6.2
-4.12	-11.67	9.23
14.05	-15.87	8.25

// Mohammadi B, 2011: Healthy Controls
// Subjects=22
-37.95	-21.22	53.91
-.61	-2.94	53.06
-54.19	-21.34	26.22
59.08	-22.87	23.94
-26.59	-13.2	5.15
-13.77	-14.18	5.09
-26.12	-26.98	60.95
26.25	-14.52	65.99
1.52	2.45	53.7
-28.73	-12.07	6.2
-4.12	-11.67	9.23
14.05	-15.87	8.25

// Pecini C, 2011: Developmental Dyslexia
// Subjects=13
-47.89	11.56	24.51
44.02	33.14	33.91
43.87	45.86	19.46
-37.93	-56.17	42.34
-1.76	9.4	47.58
-27.22	-80.06	35.3
-42.69	-70.05	-26.7

// Pecini C, 2011: Healthy Controls
// Subjects=13
-44.74	19.87	21.54
43.79	18.69	-1.68
49.02	55.98	-1.52
56.97	3.78	38.45
43.98	38.26	31.25
44.91	52.13	17.81
-33.65	-51.74	44.15
51.83	-31.51	50.39
-.74	17.61	43.53
-61.86	-34.28	-2.71
28.38	-66.18	44.65
-4.97	-78.55	11.5
10.9	-77.96	-9.92

// Elsenbrunch S, 2010: Irritable Bowel Syndrome (IBS)
// Subjects=15
18	-52	-44
-12	-54	-42
-46	4	32
-48	36	28
-64	-24	34
68	-26	32
-40	-2	-6
-4	-76	-14
44	4	8
-42	34	12
48	36	8
-50	4	28
-50	2	14
62	-56	26
-8	-66	20
30	48	14
8	24	-4
-22	-50	-38
-18	-64	-42
-20	-58	46

// Elsenbrunch S, 2010: Healthy Controls (HC)
// Subjects=12
18	-52	-44
-12	-54	-42
-46	4	32
-48	36	28
-64	-24	34
68	-26	32
-40	-2	-6
-4	-76	-14
44	4	8
-42	34	12
48	36	8
-50	4	28
-50	2	14
62	-56	26
-8	-66	20
30	48	14
8	24	-4
-22	-50	-38
-18	-64	-42
-20	-58	46
-26	-40	50
-16	-6	-2
8	-10	-14
-12	-80	6
-18	-62	44

// Georgiou-Karistianis N, 2013: Healthy Controls (HC)
// Subjects=23
56	-20	12
-54	-34	16
22	44	30
-36	-76	16
2	42	16
-6	32	36
32	-30	42
18	-58	-20
-26	-56	-20
-36	6	6
60	-2	14
-60	8	16
-16	8	-4
-14	14	-4
46	22	4
-32	22	8
-32	26	0
34	26	-4
40	46	22
24	42	-12
54	16	10
26	14	58
46	32	34
-30	0	58
32	26	0
-32	18	6
-40	-68	-26
34	-66	44
-28	-66	26
6	18	48
-30	-26	62
-32	-28	48
48	8	24
-32	-24	54
4	-60	54
-4	-60	52
42	-48	50
-34	-58	42
56	-38	40
-42	-44	44
-52	-40	18
-56	-52	10
-16	10	20
16	8	20
-18	-6	2
20	-2	2
-6	-14	0
10	0	10
28	-56	-30
-28	-58	-32
12	-26	-16
-2	-30	-20

// Georgiou-Karistianis N, 2013: Pre-Huntington's Disease (Pre-HD)
// Subjects=27
56	-20	12
-54	-34	16
22	44	30
-36	-76	16
2	42	16
-6	32	36
32	-30	42
18	-58	-20
-26	-56	-20
-36	6	6
60	-2	14
-60	8	16
-16	8	-4
-14	14	-4
40	20	4
-32	24	8
-30	28	-2
32	28	-4
42	50	18
26	42	-14
52	12	10
28	10	58
42	32	34
-32	0	62
32	26	4
-30	20	4
-38	-68	-26
32	-66	46
-28	-70	32
6	20	48
52	8	22
2	-54	46
-8	-68	54
38	-54	50
-34	-58	42
54	-40	54
-42	-42	44
30	-54	-32
-28	-58	-32

// Georgiou-Karistianis N, 2013: Symptomatic Huntington's Disease (Symp-HD)
// Subjects=17
40	20	4
-32	16	12
-30	28	-2
32	28	6
46	36	28
26	42	-18
50	12	18
24	18	58
46	32	38
-30	0	58
32	26	4
-30	26	4
-42	-68	-26
40	-58	54
-24	-64	32
6	24	48
48	4	48
8	-66	54
-4	-60	54
48	-56	52
-42	-46	50
42	-46	46
-52	-48	16
-48	-38	18
-56	-52	10
-26	-62	-36

// Georgiou-Karistianis N, 2014: Healthy Controls (HC) 1-back
// Subjects=32
-50	12	-2
-48	10	-2
42	14	4
-42	0	16
64	-14	14
-42	-1	4
38	8	6
-46	2	20
-58	-10	18
60	-16	22
-50	8	-6
-54	-16	6
52	-10	6
-54	-34	14
56	-22	12
28	-48	-10
18	-60	-8
-12	12	-4
10	18	2
-20	18	-8
18	6	-6
-22	-4	-6
16	6	-4
30	20	-2
-34	-24	54
-50	-28	56
42	14	-20
-48	-62	0
34	-78	12
28	-50	-24

// Georgiou-Karistianis N, 2014: HC 2-back
// Subjects=22
-10	-2	46
8	-4	56
18	16	-16
-42	12	0
38	12	6
-42	0	10
50	-18	20
-38	-12	-8
40	-8	-10
-4	12	42
8	16	40
-8	-2	46
10	12	34
-8	-26	44
4	-22	26
-28	-20	62
52	0	36
-66	-10	24
60	-16	24
-62	-22	30
58	-24	24
-54	-42	20
66	-42	14
-44	-46	56
-44	8	-14
44	10	-18
-54	-18	6
50	-16	10
-54	-40	16
58	-26	16
-48	-62	4
60	-44	12
-42	-56	-4
44	-54	-10
-46	-76	26
48	-68	16
-10	8	-4
10	10	-2
-16	12	-2
16	10	-2
-12	6	-2
16	8	-2
-14	-20	4
4	-16	6
-4	-62	-18
20	-62	-24
-2	-14	56
6	-12	62
52	22	10
42	22	-10
32	16	12
-60	-10	10
54	-16	18
30	14	8
-36	-18	10
-2	10	44
6	18	38
-2	0	44
10	14	34
-4	-18	46
4	-16	42
-28	-22	56
62	6	26
-42	-30	62
60	-16	22
-58	-24	32
58	-26	40
-62	-46	16
66	-42	12
-52	-20	10
48	-20	12
-58	-20	8
56	-26	14
-48	-62	2
52	-52	8
-46	-64	-14
-46	-74	26
44	-74	16
-10	14	8
14	-10	20
-18	18	-8
24	6	0
-14	6	-4
20	0	-6
-14	-8	16
8	-2	12
-14	-58	-16
30	-58	-24

// Georgiou-Karistianis N, 2014: Pre-Huntington's (Pre-HD) 1-back
// Subjects=35
-50	12	-2
-48	10	-2
42	14	4
-42	0	16
64	-14	14
-42	-1	4
38	8	6
-46	2	20
-58	-10	18
60	-16	22
-50	8	-6
-54	-16	6
52	-10	6
-54	-34	14
56	-22	12
28	-48	-10
18	-60	-8
-12	12	-4
10	18	2
-20	18	-8
18	6	-6
-22	-4	-6
16	6	-4

// Georgiou-Karistianis N, 2014: Pre-HD 2-back
// Subjects=22
-10	-2	46
8	-4	56
18	16	-16
-42	12	0
38	12	6
-42	0	10
50	-18	20
-38	-12	-8
40	-8	-10
-4	12	42
8	16	40
-8	-2	46
10	12	34
-8	-26	44
4	-22	26
-28	-20	62
52	0	36
-66	-10	24
60	-16	24
-62	-22	30
58	-24	24
-54	-42	20
66	-42	14
-44	-46	56
-44	8	-14
44	10	-18
-54	-18	6
50	-16	10
-54	-40	16
58	-26	16
-48	-62	4
60	-44	12
-42	-56	-4
44	-54	-10
-46	-76	26
48	-68	16
-10	8	-4
10	10	-2
-16	12	-2
16	10	-2
-12	6	-2
16	8	-2
-14	-20	4
4	-16	6
-4	-62	-18
20	-62	-24
-46	-64	-16
-30	-72	-24
32	-56	-26

// Georgiou-Karistianis N, 2014: Symptomatic Huntington's Disease (Symp-HD) 
// 1-back
// Subjects=23
30	20	-2
-34	-24	54
-50	-28	56
42	14	-20
-48	-62	0
34	-78	12
28	-50	-24

// Georgiou-Karistianis N, 2014: Symp-HD 2-back
// Subjects=17
-2	-14	56
6	-12	62
52	22	10
42	22	-10
32	16	12
-60	-10	10
54	-16	18
30	14	8
-36	-18	10
-2	10	44
6	18	38
-2	0	44
10	14	34
-4	-18	46
4	-16	42
-28	-22	56
62	6	26
-42	-30	62
60	-16	22
-58	-24	32
58	-26	40
-62	-46	16
66	-42	12
-52	-20	10
48	-20	12
-58	-20	8
56	-26	14
-48	-62	2
52	-52	8
-46	-64	-14
-46	-74	26
44	-74	16
-10	14	8
14	-10	20
-18	18	-8
24	6	0
-14	6	-4
20	0	-6
-14	-8	16
8	-2	12
-14	-58	-16
30	-58	-24
-46	-64	-16
-30	-72	-24
32	-56	-26

// Gray M A, 2013: Healthy Controls
// Subjects=33
24	42	-14
16	50	-16
-6	16	44
6	16	42
-22	8	60
26	8	56
-4	14	48
2	14	50
-44	4	32
48	18	2
-48	10	-4
62	-42	20
-30	-78	18
36	-74	22
-30	18	8
30	24	4
-4	14	48
4	6	56
-28	-10	54
52	14	8
-24	-70	42
14	-68	54
-44	-46	42
46	-38	46
-24	-72	40
22	-70	46
-26	-76	38
34	-76	32
-44	-84	-6
40	-74	-8
-24	-70	42
8	-70	52
-16	-12	24
14	-14	22
-20	-4	14
24	0	12
-22	-12	4
18	-6	0
-8	-16	4
14	-10	8
-34	-68	-26
32	-66	-26
-6	-74	-24
-38	26	-12
-2	20	32
6	22	30
-2	14	54
18	14	54
-2	44	34
4	56	22
-38	26	2
-48	18	-10
-38	16	0
-2	14	54
2	14	52
30	-8	52
-10	-58	32
2	-48	44
12	16	6
-30	-16	0
16	12	-4
-20	-4	2
12	4	-4
-8	-8	4
2	-12	8
-40	22	-2
-44	10	-10
-38	20	0
-44	18	10
-6	8	8
-24	12	-2
-14	4	2
18	12	-18
-14	14	-20
16	10	-18
0	22	-10
4	14	-12
-10	32	-12
12	24	-14
-18	8	-20
-4	12	-6
-12	6	-12
-38	36	-18
40	38	-16
-8	40	-18
4	44	-18
-6	28	-12
4	36	-10
-2	-12	38
2	-12	36
-12	40	42
12	34	56
-10	40	-16
4	56	22
-46	26	-10
38	22	-20
-42	-60	26
36	18	-36
-50	-66	20
60	4	-26
-38	-22	20
38	-10	14
-8	-6	50
-16	-32	62
58	-6	8
-24	-40	64
-38	-78	44
-14	-68	28
-42	-76	28
-10	-58	32
10	-56	32
-6	14	-4
12	20	-2
-16	4	-8
16	12	-4
-20	0	-6
-4	-6	4
12	-32	4

// Gray M A, 2013: Pre-Huntington's Disease (Pre-HD)
// Subjects=32
-26	48	-12
20	50	-12
-20	52	-12
16	50	-16
-6	10	46
6	16	42
-22	8	60
24	4	58
-2	12	48
2	14	50
-46	2	26
46	22	2
-48	8	-2
50	12	-4
-46	-64	-4
58	-48	-2
-32	22	0
32	24	-2
-2	12	48
10	16	44
-40	0	32
56	14	8
-24	-70	42
30	-66	50
-44	-44	42
48	-44	46
-24	-72	40
28	-80	36
-26	-66	30
32	-74	40
-46	-68	-18
38	-74	-8
-24	-72	40
8	-70	52
-16	16	6
16	0	22
-18	0	14
16	4	6
-16	-6	-6
14	4	2
-14	-10	8
20	-22	16
-28	-70	-26
28	-62	-30
-4	-74	-26
-40	22	-2
-44	10	-10
-38	20	0
-44	18	10
-6	8	8
-24	12	-2
-14	4	2
-38	36	-18
20	26	-18
-10	38	-18
4	44	-18
-12	48	-2
4	28	-16
-4	46	12
2	44	10
-10	60	2
8	62	2
-10	38	-16
6	54	14
-50	38	-10
42	34	-10
-44	20	-28
44	14	-28
-50	12	-34
42	6	-36
-38	-16	18
40	-12	14
-50	-14	12
62	-6	28
-52	-62	40
-14	-68	28
14	-96	26
-46	-74	32
34	-90	28
-2	-54	32
8	-56	32
-8	16	-4
10	18	-6
-16	10	-10
16	12	-10
-14	-34	2

// Gray M A, 2013: Symptomatic Huntington's Disease (Symp-HD)
// Subjects=20
-38	26	-12
22	40	-18
-2	10	46
4	16	42
-2	14	54
0	16	54
-2	12	48
2	14	50
-46	2	30
52	18	0
-48	8	-2
48	12	-4
-60	-62	-2
54	-54	-12
-32	20	0
36	16	6
-2	12	46
2	14	50
-52	-8	40
48	6	14
-10	-78	52
36	-60	50
-42	-42	36
48	-44	38
-12	-76	42
30	-68	44
-28	-76	32
34	-76	32
-48	-70	-18
40	-86	-2
-10	-78	52
32	-70	42
6	4	6
-26	6	2
18	6	2
-20	-4	2
16	4	-2
-10	-16	6
18	-26	10
-30	-62	-22
36	-68	-30
-6	-76	-24
-38	26	-12
-2	20	32
6	22	30
-2	14	54
18	14	54
-2	44	34
4	56	22
-38	26	2
-48	18	-10
-38	16	0
-2	14	54
2	14	52
30	-8	52
-10	-58	32
2	-48	44
12	16	6
-30	-16	0
16	12	-4
-20	-4	2
12	4	-4
-8	-8	4
2	-12	8
18	12	-18
-14	14	-20
16	10	-18
0	22	-10
4	14	-12
-10	32	-12
12	24	-14
-18	8	-20
-4	12	-6
-12	6	-12
-22	24	-24
18	24	-16
-8	44	-18
6	28	-22
-6	28	-12
8	26	-12
-8	44	10
-8	60	26
-10	34	-12
10	26	-12
-24	26	-24
38	14	-20
-42	-60	26
36	18	-36
-64	-14	-8
60	2	-20
-38	-76	40
-40	-74	28
-10	-62	26
0	-62	20
-4	12	-6
8	18	-6
-12	6	-12
14	8	-12

// Hillen R, 2013: All Conditions > Rest
// Hillen R, 2013: S, N, PWS, PW > Landolt Sentences (LS)
// Hillen R, 2013: LS > Pseudowords (PW), Pseudoword Sentences (PWS), Nouns 
// (N), Complete Sentences (S)
// Hillen R, 2013: (S and N) > (PWS and PW)
// Hillen R, 2013: (S > N) and (PWS > PW)
// Subjects=20
-32	-98	-6
34	0	66
30	-52	46
2	14	52
38	38	24
-30	-4	52
-18	-10	22
-38	-48	-20
-50	-6	50
-64	-36	4
24	-64	-50
22	-64	-24
38	-46	54
62	-18	32
24	-34	66
-46	-62	12
48	-52	8
-40	-14	-20
10	86	24
-54	2	-14
-2	10	54
52	16	-14
22	-66	56
16	-66	28
34	-2	66

// Van den Eynde F, 2013: Bulimia Nervosa
// Subjects=21
-2.74	62.48	23.85
1.28	31.66	33.74
-13.97	-89.02	3.56
8.73	-40.31	-26.55
24.03	84.18	-2.15
-22.35	83.9	-1.59
55.53	12.43	34.73
28.26	-29.69	1.78
-40.83	-38.45	47.47
39.74	-58.81	-17.99
-29.52	24.22	42.08
20.98	-33.6	53.71
4.92	-43.54	-22.55
39.59	-19.58	-21.28
-2.74	-59.63	-24.8
43.66	-70.24	-13.4
51.36	-66	-10.16
-21.55	-58.28	45.23
28.72	-53.5	51.61
16.71	-85.77	-8.11
12.65	-22.8	-9.66
4.8	48.71	-.85
12.64	-35.11	-15.99
-2.3	-55.1	33.7
54.99	-.2	-26.76
-52.75	-57.66	5.05
-21.94	-29.7	6.04
28.05	41.3	3.19
-18.29	37.39	7.73
51.38	11.55	23.81
-52.75	3.39	29.38
-48.82	-65.93	-1.66
47.53	-61.82	-6.79
-33.67	21.09	1.91
55.48	-48.06	17.73
28.19	-42.55	-11.86
-45.5	66.94	-16.52
47.13	68.34	-6.66

// Van den Eynde F, 2013: Healthy Controls
// Subjects=23
-2.46	16.56	42.41
24.66	-80.11	13.41
-18.03	7.51	28.63
-6.6	-55.74	-25.08
24.03	84.18	-2.15
-22.35	83.9	-1.59
47.5	15.16	19.88
-44.92	3.72	32.94
4.96	66.72	27.08
43.47	-6.54	-11.38
-10.45	-47.55	-22.04
39.59	-19.58	-21.28
-2.74	-59.63	-24.8
43.66	-70.24	-13.4
51.36	-66	-10.16
-21.55	-58.28	45.23
28.72	-53.5	51.61
24.17	4.37	-15.75
47.37	42.27	13.92
16.78	-89.11	-.47
32.54	-53.76	47.91
47.72	9.32	46.13
-21.8	32.66	48.65
-45.49	50.73	-22.52
-14.23	-14.31	0.75
-37.23	-49.18	11.52
-41.31	29.71	12.32
-2.87	4.21	-15.43
20.44	-18.84	-10.08
5.11	-17.24	12.04
-41.09	7.65	32.56
47.57	-65.45	-2.81
-45	-66.29	-5.35
47.56	11.81	27.52
-33.86	2.89	-29.68
43.97	-71.04	27.15
-25.92	-39.25	-15.2
-45.5	66.94	-16.52
47.13	68.34	-6.66

// Wolf R C, 2012: Healthy Controls
// Subjects=18
22.54	13.88	-10.83
44.5	40.68	22.01
-2.48	0.88	58.12
-17.41	-6.44	72.55
-2.54	0.46	53.68

// Wolf R C, 2012: Pre-Huntington's Disease far from onset (preHDfar)
// Subjects=9
31.16	11.58	-12.99
20.8	-94.61	-0.06
-15.25	-6.43	72.51
-2.54	0.46	53.68

// Wolf R C, 2012: Pre-Huntington's Disease near onset (preHDnear)
// Subjects=9
22.54	13.88	-10.83
44.5	40.68	22.01
-2.48	0.88	58.12
-17.41	-6.44	72.55
-2.54	0.46	53.68
31.16	11.58	-12.99
20.8	-94.61	-0.06
-15.25	-6.43	72.51
-2.54	0.46	53.68

// Centeno M, 2012: Healthy Controls (HC)
// Subjects=18
27	-27	-6
-30	-24	-9
48	6	48
-45	3	54
-31	-21	-10
-48	3	42
18	-6	-22
19	-15	-18
-21	0	-24
42	9	42
45	24	24
-18	-18	-15
-39	39	24
3	-9	69
57	3	15
39	39	30
-57	-3	24
54	3	3
39	39	50
3	-9	72
-36	39	21
0	3	72
-54	1	0
30	3	-24
26	-6	-21
-24	-3	-24
-27	-12	-21
-39	36	21
54	3	3
-57	5	5
3	-9	69
42	39	27

// Centeno M, 2012: Frontal Lobe Epilepsy (FLE)
// Subjects=32
-24	-18	-15
24	-27	-9
-51	0	45
-51	6	33
-51	15	-6
45	0	54
47	9	27
51	15	-9
-30	-24	-12
-48	0	45
-51	9	33
-48	24	-9
18	-3	-21
24	-21	-12
-21	0	-21
48	21	21
45	24	21
45	33	3
48	15	39
-45	0	45
-39	39	24
3	-9	69
57	3	15
39	39	30
-57	-3	24

// Centeno M, 2012: Subgroup of FLE, Right Frontal Lobe Epilepsy (RFLE)
// Subjects=13
-36	39	21
0	3	72
-54	1	0

// Centeno M, 2012: Subgroup of FLE, Left Frontal Lobe Epilepsy (LFLE)
// Subjects=19
54	3	3
39	39	50
3	-9	72

// Centeno M, 2012: Subgroup of FLE, Memory Impairment
// Subjects=7
30	3	-24
26	-6	-21
-24	-3	-24
-27	-12	-21
24	0	-24
24	-12	-21
54	30	27
39	9	42
-24	-6	-18
-24	-12	-24

// Centeno M, 2012: Subgroup of FLE, No Memory Impairment (FLENM)
// Subjects=25
24	0	-24
24	-12	-21
54	30	27
39	9	42
-24	-6	-18
-24	-12	-24
-39	36	21
54	3	3
-57	5	5
3	-9	69
42	39	27

// Stretton J, 2012: Temporal Lobe Epilepsy with Left Hippocampal Sclerosis 
// (LHS)
// Subjects=19
-26	12	66
20	14	62
-22	6	54
34	14	58
38	22	44
18	-68	68
-30	-66	64
-30	-64	62
18	-68	68
-6	-74	56
20	10	66
-22	12	68
-36	28	32
40	30	32
20	-68	66
50	-12	6
-2	56	-12
22	-12	-24
6	-46	36

// Stretton J, 2012: Temporal Lobe Epilepsy with Right Hippocampal Sclerosis 
// (RHS)
// Subjects=19
-50	-56	54
40	26	40
-44	26	32
20	-66	66
12	-104	6
-4	-64	30
-2	66	8
-46	-18	-2
-28	-20	-20

// Stretton J, 2012: Healthy Controls (HC)
// Subjects=15
20	-70	66
32	2	56
-28	-66	62
-30	6	64
18	-68	68
-30	-66	64
-30	-64	62
18	-68	68
20	-68	64
28	8	64
-30	6	64
34	24	-4
-32	30	-4
20	-68	66
20	-66	66
12	-104	14
6	-56	32
-44	-2	-18
-8	60	36
52	-8	-2
-28	-12	-22
24	-4	-22

// Virani K, 2013: Behavioral variant of Frontotemporal Dementia (bvFTD) < 
// Healthy Controls (HC), Angry
// Virani K, 2013: bvFTD > HC, Angry
// Virani K, 2013: bvFTD > HC, Disgusted
// Virani K, 2013: bvFTD > HC, Happy
// Virani K, 2013: bvFTD < HC, Fearful
// Virani K, 2013: bvFTD < HC, Sad
// Virani K, 2013: bvFTD > HC, 100% intensity
// Virani K, 2013: bvFTD > HC, 40% intensity, p<0.005 corrected
// Virani K, 2013: bvFTD > HC, 40% intensity, p<0.005 uncorrected
// Subjects=18
23	9	-22
-35	-51	-14
23	-89	8
-2	-46	26
38	-62	32
38	14	7
-35	23	4
-20	-73	-5
23	-89	11
41	-69	38
-2	-4	52
-5	-91	-17
-20	-92	11
23	-89	8
-2	7	51
-17	73	-5
44	-14	8
23	-89	8
-8	-81	44
32	49	35
41	34	34
38	-62	32
47	-65	35
2	12	46
-5	-59	26
-5	-65	35

// Zheng J, 2012: Temporal Lobe Epilepsy (TLE)
// Subjects=12
50	-76	0
50	-54	56
12	-14	12
-46	28	20
-8	4	28
-30	-2	58
2	-68	-18
42	-78	-14
-36	-78	-28
20	-36	-28
50	22	-8
12	-30	-12

// Zheng J, 2012: Healthy Controls (HC)
// Subjects=8
-38	-80	-28
48	-70	-12
24	2	-32
-36	8	-28
-2	-84	-44
-16	-30	-4
2	-68	-18
42	-78	-14
-36	-78	-28
20	-36	-28
50	22	-8
12	-30	-12

// Baumeister S, 2014: Peak activations for NoGo > Neutral, fMRI
// Baumeister S, 2014: Peak deactivations for covariation of event-related 
// potentials during NoGo trials (N2) and brain activity across all 
// conditions, Combined fMRI & EEG analysis
// Baumeister S, 2014: Peak deactivations for covariation of event-related 
// potentials during NoGo trials (P3) and brain activity across all 
// conditions, Combined fMRI & EEG analysis
// Baumeister S, 2014: Peak areas of clusters for conjunction of N2 modulation 
// at Cz and pooled channels, Combined fMRI & EEG analysis
// Baumeister S, 2014: Peak areas of clusters for conjunction of P3 modulation 
// at Cz and pooled channels, Combined fMRI & EEG analysis
// Subjects=17
33.66	17.02	-9.26
29.7	26.96	-4.71
-33.66	23.08	-4.52
9.9	15.95	47.1
31.68	45.58	17.99
-27.72	49.63	21.47
33.66	17.53	0.97
-33.66	17.53	0.97
-11.88	24.45	22.73
54.45	-43.46	24.28
45.54	-41.33	27.86
25.74	-61.64	49.14
63.36	-43.19	29.8
-63.36	-43	33.47
-57.42	-45.21	28.05
-25.74	-75.73	0.43
-33.66	25.02	-4.62
31.68	17.35	-2.55
-33.66	17.53	0.97
-57.42	-37.19	33.18
-61.38	-47.06	30
63.36	-43.19	29.8
13.86	50.65	2.99
55.44	1.93	38.59
-1.98	3.29	-11.94
13.86	58.22	-1.07
5.94	-.56	66.35
9.9	17.43	37.82
-47.52	-51.22	-14.26
53.46	-65.51	10.65
-35.64	-78.71	18.87
-43.56	-75.11	12.97
57.42	-39.77	20.41
51.48	-36.08	16.54
-63.36	-45.95	13.35
-49.5	-11.08	50.3
13.86	73.35	47.89
-15.84	-78.52	22.35
-21.78	-68.32	-6.67
-27.72	-50.96	-9.22
27.72	-78.01	-6.19
-11.88	-68.24	-5
5.94	-87.53	-2.35
23.76	-87.69	-5.7
25.74	-87.28	2.69
-45.54	-74.13	-6.38
-33.66	21.77	8.12
-41.58	18	10
5.94	-15.97	30.28
-13.86	-16.43	-21.09
15.84	58.13	-2.91
13.86	-75.48	44.31
-23.76	-66.55	-10.13
23.76	-93.59	-7.09
23.76	-91.23	1.2
23.76	-78.17	-9.54
9.9	-89.63	-5.61
-45.54	-72.36	-9.84
-41.58	-82.95	-11.52
13.86	56.11	-4.49
18.77	19.28	35.88
13.86	-75.48	44.31
-17.82	-80.64	18.77
-23.76	-66.55	-10.13
23.76	-93.59	-7.09
23.76	-91.23	1.2
27.72	-78.17	-9.54
9.9	-89.63	-5.61
-45.54	-72.36	-9.84
-41.58	-82.95	11.52
15.84	58.13	-2.91
53.46	-.1	36.85
-29.7	-21.88	67.42
5.94	-.66	64.51
-47.52	-59.05	-15.55
13.86	-75.48	44.31
23.76	-93.59	-7.09
23.76	-91.23	1.2
23.76	-78.17	-9.54
9.9	-89.63	-5.61
-41.58	-83.04	9.68
-25.74	-64.7	-11.9
1.98	1.27	-13.52
13.86	56.11	-4.49
55.44	-.19	35.01
-43.56	-13.2	46.72
-29.7	-21.88	67.42
5.94	-.66	64.51
18.77	19.28	35.88
61.38	-27.46	-5.35
-61.38	-47.98	11.61
61.38	-41.89	16.83
9.9	-17.86	-7.52
13.86	-75.48	44.31
-17.82	-80.64	18.77
-23.76	-66.55	-10.13
27.72	-78.17	-9.54
-45.54	-72.36	-9.84
-25.74	-94.94	4.75
51.48	-67.63	7.07
-41.58	-82.95	11.52
17.82	-41.19	-8.03
-43.56	23.53	4.35
-39.6	19.65	4.54
3.96	-19.93	28.63
-15.84	-20.49	17.61
-43.56	23.53	4.35
5.94	-15.97	30.28
-39.6	19.65	4.54
3.96	-19.93	28.63
-15.84	-20.49	17.61

// Dong G, 2014: Incon_Con > Con_Con (lower activated)
// Dong G, 2014: Con_Incon > Incon_Incon (higher activated)
// Subjects=30
24	-63	39
-63	-18	-6
-3	-30	36
-39	51	6
-33	18	30
33	39	39
33	-9	39
15	48	-15
48	33	18

// Grandjean J, 2012: Incongruent > neutral
// Grandjean J, 2012: Incongruent > neutral, mostly congruent (MC)
// Grandjean J, 2012: Incongruent > neutral, mostly neutral (MN)
// Grandjean J, 2012: Incongruent trials, MC > Neutral trials, MN
// Grandjean J, 2012: Incongruent trials, mostly incongruent (MI) > Neutral 
// trials, MN
// Subjects=25
-42	14	26
-54	20	34
-44	38	34
-24	4	68
-2	18	50
-34	20	2
32	22	4
30	24	-10
-24	-70	42
-32	-50	48
-8	-64	62
30	-50	44
-44	-86	-8
-48	-56	-20
-42	-68	-10
-54	-46	14
30	-64	-34
10	-76	-28
46	-52	-42
-48	-36	54
-32	-52	50
-32	-54	66
-26	-68	38
-26	-10	54
-52	16	28
-6	18	46
-34	14	-6
14	10	6
-48	-68	-6
-44	14	28
-56	20	34
-32	22	0
-26	46	16
60	6	32
-24	-70	42
-42	-88	-10
-40	-70	-12
-50	-58	-20
44	-84	-10
8	-76	-30
-26	-68	38
-50	-36	50
-36	-40	40
-32	20	-2
-48	14	28
-6	20	44
34	20	4
32	24	-10
16	10	8
-40	-88	-6
68	-42	16
-42	14	26

// Jimura K, 2014: Mirrow-Switch (MR-SW) > Mirror-Repeat (MR-RP), Pre-Training
// Jimura K, 2014: Plain-Switch (PL-SW) > Plain-Repeat (PL-RP), Pre-training
// Jimura K, 2014: MP-RP > PL-RP, Pre-training > Post-training
// Jimura K, 2014: MR-SW > MR-RP, Pre-training > Post-training
// Subjects=14
52	-32	22
4	-12	30
14	-54	62
8	-40	24
4	4	38
-54	-40	32
-20	4	-12
-8	4	8
64	-34	12
-12	-32	38
-4	-4	50
-60	-26	8
50	-16	36
6	-68	8
36	-58	52
36	-52	38
48	8	32
-12	-82	2
40	2	56
-42	-70	-8
34	-70	38
48	-54	-14
28	-58	52
-34	-62	60
-12	-78	52
38	-82	10
32	0	60
-46	6	30
-30	-52	46
-24	-68	48
-26	-84	36
12	-72	50
-40	-38	36
-32	-88	12
24	2	46
54	-72	-2
42	-44	50
36	-92	-2
-28	-82	20
-24	-66	32
46	-80	-18
-22	6	-10

// Feng X, 2014: 1-relational > 0-relational
// Feng X, 2014: 2-relational > 0-relational
// Feng X, 2014: 2-relational > 1-relational
// Subjects=20
9	12	48
-45	3	27
-6	9	60
9	27	36
-33	-48	42
48	9	27
33	24	-3
33	-51	42
48	9	27
45	33	21
9	12	48
-45	3	27
-33	-48	42
-27	-66	48
45	-42	45
-45	-69	-9
33	-87	0
18	12	6
-18	6	6
-42	39	6
-15	3	9
-45	24	21

// Floden D, 2011: Activation Clusters for Latent Variable 1 Positive 
// Saliences/ Bootstrap Ratios
// Floden D, 2011: Activation Clusters for Latent Variable 1 Negative 
// Saliences/ Bootstrap Ratios
// Floden D, 2011: Clusters indentifed in the SPM analysis
// Subjects=9
14	-.98	8.12
-37.45	47.52	6.87
-28.11	-69.38	63.41
26.72	32.04	7.44
14	16.53	14.46
-2.82	-27.92	32.88
48.29	8.96	23.62
-53.33	32.51	20.58
55.55	45.16	9.35
35.94	-66.42	54.62
9.75	3.56	12.25
44.03	13.43	26.64
60.38	-41.32	46.66
-53.3	25.19	22.31
-53.37	36.48	16.91
27.21	-60.7	33.05
10	-27.85	32.72
-57.58	33.88	24.98
52.95	-45.25	51.53
-32.63	-47.77	40.46
1.42	-19.44	32.12
-33.17	35.57	3.37
-57.12	-54.72	49.13
48.45	-61.85	16.18
-61.69	-20.5	24.01
5.74	-92.57	8.09
10.19	-28.08	57.28
23.08	-14.11	71.57
10.02	11.93	51.69
-2.96	26.69	37.22
-2.67	5.48	65.76
-49.98	13.2	32.2
-53.31	11.9	15.62
-41.74	17.74	-6.19
-46.11	20.03	-17.49
-33.13	27.2	5.18
56.1	-33.69	49.41
40.16	-53.79	52.4
40.12	-58.62	45
35.78	-51.59	39.99
43.77	22.83	-3.14

// Kirschen M P, 2010: High load > Low load
// Kirschen M P, 2010: Audtiory: High load > Low load
// Kirschen M P, 2010: Visual: High load > Low load
// Kirschen M P, 2010: Visual > Auditory
// Kirschen M P, 2010: Auditory > Visual
// Subjects=16
-62.22	-59.75	21.44
-53.44	-29.14	38.43
-24.06	-40.99	-32.62
-7.85	-62.39	47.66
-33.6	32.59	-2.76
-38.5	11.13	31.95
-68.25	35.14	-8.02
31.79	28.98	-44.97
7.98	11.5	33.36
35.88	38.63	23.48
32.36	33.24	0.54
55.38	58.77	31.24
47.87	51.51	34.32
21.83	17.3	-66.06
33.87	37.53	34.83
51.98	54.32	18.29
-52.5	-1.69	33.45
-60.36	10.24	12.24
-23.99	-62.37	-31.62
-5.75	1.72	55.85
-32.5	28.34	-2.35
-36.08	-48.22	40.02
-67.99	-24.21	0.09
20.35	-66.26	-29.75
7.99	20.32	35.85
42.31	40.46	19.82
34.49	22.1	-4
55.68	-3.56	41.88
46.04	-47.83	39.7
24.29	-67.98	-59.9
34.17	-52.12	40.33
47.86	6.55	24.21
-61.64	-4.39	-6.46
-62.52	-32.39	4.17
-63.7	-24.4	-2.21
-22.13	-58.06	-54.49
-29.65	-62.13	-51.72
-35.72	24.08	-1.88
-40.24	-58.38	-33.98
-23.89	-63.77	-23.64
-9.49	27.52	21.99
-8.28	19.74	30.58
-51.62	9.94	19.96
-48.46	6.03	12.45
-47.94	-41.46	44.04
-29.52	-7.52	-30.23
-34.53	-31.95	-4.2
59.53	-30.04	-.39
58.45	-19.09	1.91
32.47	26.42	7.93
7.85	27.99	26.13
22.16	-60.13	-56.16
57.54	4.04	19.81
52.37	-8.45	35.7
59.92	-1.94	36.05
42.28	35.79	15.8
35.92	35.64	26.01
53.72	-17.76	-29.52
6.09	8.04	53.9
44.02	-43.5	51.64
48.38	-64	50.23
-46.46	-64.08	-14.26
-33.91	-52.47	40.4
-28.53	-74.55	33.53
-40.33	1.6	56.45
-48.27	7.49	27.99
-43.6	-41.79	-40.05
42.28	-72.51	-5.98
36.34	-52.45	-43.72
37.59	-65.45	-33.49
27.87	-69.84	-34.01
43.91	-49.75	42.17
36.32	-47.86	39.87
24.32	-69.9	-57.47
46.03	-33.69	41.67
45.64	8.26	19.59
-37.7	-76.29	-7.6
-41.87	-86.11	2.41
-40.05	-75.53	-22.2
-41.99	-68.45	-3.82
-37.71	-84.05	-10.19
-24.2	-77.72	33.77
-28.46	-52.13	43.64
-15.91	-97.83	2
-40.3	-42.43	-35.56
44.42	-73.77	-8.13
35.78	-85.82	-10.15
32.08	-58.2	44.33
24.18	-97.92	10.29
35.53	-65.79	-25.58
-60.31	-22.18	9.84
-60.44	-10.04	1.92
-56.31	1.7	-10.52
-42.44	5.92	-23.5
-63.77	-6.32	-4
-41.93	-24.25	9.73
-60.26	-41.53	9.51
-63.73	-20.25	-3.74
-11.88	-56.2	-12.27
-9.66	41.58	11.63
-29.52	-4.23	-29.44
63.89	-14.4	5.84
56.39	-26.03	8.23
68.15	-18.1	0.53
54.01	-15.58	-6.21
51.83	32.35	1.42

// Lao-Kaim N P, 2014: Healthy Controls
// Subjects=31
43.75	-60.79	-38.5
39.98	-42.47	33.61
-44.44	-42.98	34.62
-21.82	-66.22	48.57
1.45	12.68	48.38
43.91	38.55	21.19
-25.22	0.89	49.68
-44.69	23.64	29.03
-29.92	49.22	14.45
28.23	5.87	54.22
-13.85	1.42	0.43
16.1	6.26	5.26
-25.69	24.61	-1.38
36.3	21.81	-1.85
8.37	60.77	-4.8
-6.07	-52.58	17.14
-10.67	58.31	20.16
12.88	58.88	25.42
-5.97	-30.6	39.83
1.44	-11.52	38.14
51.72	-15.02	43.44

// Lao-Kaim N P, 2014: Anorexia Nervosa
// Subjects=31
-53.44	-23.53	-15.98
47.51	-41.91	40.16
-33.76	-42.91	34.49
-25.04	-62.01	48.26
16.65	-65.99	48.11
28.17	9.67	48.33
-25.24	5.12	49.32
-41.51	31.06	28.38
39.69	35.78	27.05
-29.98	53.02	8.56
31.82	63.57	-11.99
1.45	12.68	48.38
-29.98	28.82	-1.68
32.01	24.96	-2.07
0.89	60.73	-4.71
-6.12	-53.09	10.49
-56.29	-16.61	32.54
-6.37	62.99	25.29
-6.22	48.07	38.81
-5.97	-30.6	39.83

// Raabe M, 2013: Load 4 > load 1
// Raabe M, 2013: Load 1 > Load 4
// Raabe M, 2013: Conjunction of load-4 and load-1 tasks
// Raabe M, 2013: MVPA: Regions that correctly predicted target target 
// quadrant
// Subjects=12
-34	22	-2
28	-4	48
-10	26	32
-8	-66	52
42	-32	48
-40	-80	10
-40	-80	10
-22	-70	56
-28	-2	64
22	-4	56
44	-48	-14
-46	-76	-4
28	-64	60
-8	-80	12
-14	-68	-16
34	-36	-24
-54	-10	38

// Rocca M A, 2014: Healthy Controls
// Subjects=52
-36	-52	46
-24	-70	46
40	-52	40
30	-66	52
-44	6	38
-34	50	22
-48	14	26
32	6	58
38	54	22
52	22	32
-34	20	2
34	24	-4
-2	18	50
-4	8	58
36	-62	-28
-36	-66	-26
-6	-52	26
4	-52	24
-50	-26	12
58	-18	12
-6	52	-6
8	60	6
-44	-74	30
56	-64	18
26	-16	-22
22	-46	-12
-38	-46	50
38	-40	44
-54	8	24
-34	46	32
-32	46	34
40	16	48
-36	22	-4
36	24	-4
28	-62	54
-4	10	58
-34	46	32
-38	-46	48
-26	-68	48
40	-42	46
-46	2	36
-50	10	16
-44	6	50
-6	8	58
36	22	-6
40	16	48
-50	6	-34
28	-64	-6
-48	-22	14
-52	-66	26
-4	-46	30
8	-56	28
-6	-34	52
-26	-34	-12
26	-18	-24
-8	-38	50
0	-42	32
-24	-36	-14
28	-64	-6

// Rocca M A, 2014: Multiple Sclerosis Patients
// Subjects=42
-46	-48	52
-28	-66	38
40	-44	40
26	-68	58
-46	4	44
-46	12	30
-34	48	18
42	4	28
46	36	28
30	14	60
42	54	10
-32	24	-2
32	24	-4
-2	16	56
-4	26	44
34	-64	-26
-4	-48	28
6	-48	28
-44	-22	10
64	-26	20
-10	52	42
2	54	30
-52	-66	14
54	-64	10
-38	-46	50
38	-40	44
-54	8	24
-34	46	32

// Rocca M A, 2014: Subgroup of Multiple Sclerosis Patients, Cognitively 
// Impaired (CI)
// Subjects=20
-44	-50	54
-20	-72	54
36	-56	58
20	-70	52
-48	6	38
-46	18	26
2	20	48
-6	2	52
-6	-48	26
8	-46	26
-58	-28	14
64	-20	16
-36	22	-4
36	24	-4
28	-62	54
-4	10	58
-34	46	32
-38	-46	48
-26	-68	48
40	-42	46
-46	2	36
-50	10	16
44	8	48
-36	4	52
-8	10	58
-8	6	60
-44	6	50
-6	8	58
36	22	-6
40	16	48
-50	6	-34
28	-64	-6
-48	-22	14
-52	-66	26
-4	-46	30
8	-56	28
-6	-34	52
-26	-34	-12
26	-18	-24
-18	-52	-4
26	-62	-6
56	6	-6
-38	-14	-4
2	-40	36
58	-32	4
-8	-38	50
0	-42	32
-24	-36	-14
28	-64	-6

// Rocca M A, 2014: Subgroup of Multiple Sclerosis Patients, Cognitively 
// Preserved (CP)
// Subjects=22
-40	-44	46
-28	-70	38
38	-46	42
20	-62	50
-44	4	42
-52	28	32
-20	16	60
42	6	34
46	38	30
32	14	60
40	22	50
-2	14	58
8	34	40
32	22	-6
-36	22	-4
-4	-46	32
-2	-58	26
-44	-22	6
62	-30	22
-12	54	44
4	58	14
40	-36	-24
-32	46	34
40	16	48
44	8	48
-36	4	52
-8	10	58
-8	6	60
-44	6	50
-6	8	58
36	22	-6
40	16	48
-18	-52	-4
26	-62	-6
56	6	-6
-38	-14	-4
2	-40	36
58	-32	4
-8	-38	50
0	-42	32
-24	-36	-14
28	-64	-6

// Rosner Z, 2012: Generate hit > Read hit
// Rosner Z, 2012: Generate > Read (high confidence interval)
// Rosner Z, 2012: Read > Generate (high confidence interval)
// Subjects=24
0	0	28
-52	14	28
50	34	16
-46	-56	-16
46	-54	-10
32	0	10
-24	-76	26
28	-76	32
-54	14	34
52	24	26
-32	-90	8
34	-92	2
-44	4	24
42	8	26
-12	-62	42
18	-58	42
-38	-42	44
28	-56	48
-46	6	2
-4	40	18
4	30	22
-42	26	-6
-42	38	-14
-48	34	6
42	16	24
-58	-60	-20
54	-56	-14
-32	18	6
-24	-76	28
32	-72	26
10	-88	-6
-44	30	26
54	10	42
-40	-74	-20
30	-80	-4
-34	-94	10
34	-92	2
-4	16	48
12	32	28
48	-28	48
56	-20	46
-48	6	26
44	8	26
-16	-70	-30
24	-64	30
-6	38	42
-4	28	48
-36	-48	46
32	-54	48
-44	-44	46
44	-36	48
-44	-56	-16
44	-58	-12
-48	-68	26
-40	-84	36
8	-68	36
-42	-68	36
-10	-68	26
8	-68	36
4	-64	48

// Witt S T, 2013: Switch > Non-switch
// Witt S T, 2013: Non-switch > Switch
// Witt S T, 2013: High complexity > Low complexity
// Witt S T, 2013: Low complexity > High complexity
// Witt S T, 2013: Modulatory effects of stimulus complexity on switch trials
// Witt S T, 2013: Modulatory effects of stimulus complexity on non-switch 
// trials
// Witt S T, 2013: Positive correlation between BOLD response and number of 
// response options
// Witt S T, 2013: Negative correlation between BOLD response and number of 
// response options
// Witt S T, 2013: Main effects of increasing number of preceding non-switch 
// trials
// Subjects=83
10	20	44
-6	20	50
-30	8	60
30	8	62
26	0	56
-44	24	26
-42	6	30
-50	36	8
44	10	30
-34	20	-4
34	22	-2
-24	-64	48
26	-72	54
-46	-58	52
-6	-74	42
32	-68	38
0	-30	32
6	-80	2
44	-82	2
-58	-52	6
-16	-22	-4
8	-12	0
4	-20	2
-14	54	14
-10	-100	20
2	24	48
-24	4	52
26	4	52
46	34	24
-42	6	28
46	10	28
-32	22	0
32	24	-4
-22	-62	54
24	-62	54
-40	-38	42
46	-32	46
-26	-86	22
30	-82	22
-36	-76	-8
42	-80	-4
-6	-94	-6
8	-84	-6
-6	4	12
8	10	10
-12	-22	14
20	-24	16
12	-6	18
-14	50	44
12	52	44
-4	52	0
-10	60	10
-40	4	14
42	-8	14
-12	-28	44
6	-26	44
-2	-46	30
-54	-66	32
-64	-36	34
-62	-28	22
62	-26	22
62	-52	32
4	-84	28
-20	-10	-20
22	-10	-20
-64	-54	10
66	-50	4
54	0	2
-28	-2	66
32	4	62
6	20	50
58	12	16
58	12	16
-34	16	4
-40	-4	10
38	18	0
-42	-18	62
-38	-8	64
44	-8	34
-32	-14	70
-46	-36	54
-42	-38	48
46	-34	48
-24	-64	60
24	-64	60
-46	-74	-10
44	-82	-6
2	-94	-2
-20	-30	4
-12	-22	8
22	-30	0
14	-12	10
22	0	12
-30	-84	-22
24	-72	-18
-4	60	12
-2	34	0
-2	-44	40
4	-22	42
-48	-72	42
50	-68	42
-60	-18	-16
52	-14	-24
-24	-18	-22
26	-16	-26
-6	6	52
8	18	46
-24	-2	20
26	2	58
-50	4	34
48	8	30
-32	22	-2
34	22	2
-24	-58	56
26	-58	50
-46	-32	40
40	-36	46
-38	-88	10
34	-84	20
-44	-74	-8
52	-62	-10
14	-92	-6
-10	8	2
10	10	0
-10	8	2
-12	-20	10
8	-14	10
8	-26	6
-10	46	50
-16	56	34
20	48	42
-40	16	48
-50	30	-6
-52	-60	48
-52	-58	36
56	-60	42
0	-90	24
-58	-44	-4
68	-40	-2
-22	-2	62
12	12	70
32	8	60
-48	4	44
54	12	20
50	38	14
40	14	16
-54	2	16
-28	20	-2
-54	-24	52
-22	-62	56
22	-66	54
28	-74	46
-44	-40	46
46	-44	56
8	-28	28
-48	-14	-4
-28	-18	-6
18	4	-8
10	8	10
-10	-24	12
12	-20	12

// Zurawska vel Grajewska B, 2011: Homogeneous > Mixed
// Zurawska vel Grajewska B, 2011: Interaction effect between block 
// homogeneity (homegenous > mixed) and compatibility ratio (70% > 30%)
// Zurawska vel Grajewska B, 2011: Incompatible > Compatible
// Subjects=18
-22	-42	-40
-4	-52	-44
46	-52	-42
4	-34	-12
-22	-14	-6
38	30	46
40	58	14
38	10	60
-32	46	16
-34	-26	-22
32	-24	-20
-10	38	16
8	38	8
10	40	28
48	42	-2
34	20	-22
-48	-48	36
58	-46	50
14	64	12
2	-18	38
-16	12	66
-50	-40	8
8	-88	2
18	50	40
18	38	16
8	-44	16
-38	24	10
-32	-14	70
-38	-2	62
-56	-18	16
22	-52	-30
-40	-34	44

// Chiong W, 2013: Healthy Controls
// Subjects=16
50	-60	26
0	-78	42
8	60	-4
-4	34	-14
56	-64	26
4	-58	24
-20	4	-12
34	-84	16
-22	-96	4
40	-2	62
36	-46	48
-34	-24	66
-32	-60	44
40	-58	46
-36	14	30
46	38	14
-26	-72	30
8	0	52
44	20	40
4	26	48
4	-42	38
18	-54	34

// Chiong W, 2013: Behavioral variant Frontotemporal Dementia (bvFTD)
// Subjects=10
4	-42	38
18	-54	34

// Alain C, 2010: 2-back > 1-back
// Alain C, 2010: Left hand response > Right hand response
// Alain C, 2010: Right hand response > Left hand response
// Subjects=28
0.38	19.28	51.19
-28.35	3.93	61.73
-43.58	7.61	28.14
-32.03	24.2	7.65
-41.2	-36.01	41.8
-40.15	-37.24	39.66
-28.96	-65.08	-46.23
5.7	20.2	48.82
38.93	6.1	56.31
38.51	23.65	8
67.42	-34.9	-8.61
37.89	-44.17	39.35
28.46	-64.26	55.64
-.69	-3.79	41.98
-39.17	24.41	52.33
-20.3	-46.23	-23.38
-20.51	-55.06	-54.97
-23.7	-29.64	-42.57
6.77	2.6	41.36
38.01	-17.71	65.01
47.57	-18.25	57.14
39.7	-6.92	11.67
19.36	-11.78	5.62
32.81	-49.12	72.16
5.88	-32.85	51.03
-37.92	-19.82	58.25
-40.05	-19.75	59.38

// Christensen A T, 2011: Main effects of voice task
// Christensen A T, 2011: Main effects of semantic task
// Christensen A T, 2011: Voice: Incongruent > Neutral words
// Christensen A T, 2011: Semantic: Incongruent > Neutral words
// Christensen A T, 2011: Voice: Congruent > Neutral words
// Christensen A T, 2011: Semantic: Congruent > Neutral words
// Subjects=26
48.25	28.34	26.46
-39.09	4.41	55.12
-34.59	-60.24	58.26
-37.9	-58.03	45.84
-35.26	19.53	2.51
30.97	20.81	-.59
4.14	39.25	-7.41
-57.53	-18.33	10.4
4.54	35.71	43.07
-51.78	-48.17	50.75
49.18	24.69	6.68
-36.32	22.95	5.58
-1.33	58.8	-15.67
-52.21	-13.1	8.78
66.41	-14.5	7.54
-37.47	13.28	-9.21
9.51	34.08	-5.92
23.47	15.05	-5.6
-49.18	23.59	1.21
42.68	34.71	-.78
-42.81	12.19	-9.06
-4.49	53.75	-11.87
12.82	15.41	0.07
18.32	26.93	24.69
5.49	52.03	33.88

// Goldin P, 2013: Mindfulness-based stress reduction (MBSR)
// Subjects=23
23.38	49.31	-2.9
27.45	-70.27	60.62
57.29	-55.55	55.69
63.6	-37.87	49.68
-21.11	-71.04	-.1
1.15	-38.73	-10.87
-9.16	-5.19	52.23
-54.02	-34.95	42.98
-28.39	-69.03	26.58

// Goldin P, 2013: Aerobic exercise (AE)
// Subjects=19
23.38	49.31	-2.9
27.45	-70.27	60.62
57.29	-55.55	55.69
63.6	-37.87	49.68
-21.11	-71.04	-.1
1.15	-38.73	-10.87

// Holzel B K, 2013: Generalized Anxiety Disorder (GAD), Mindfulness based 
// stress reduction (MBSR)
// Subjects=15
34	-45	-19
9	-49	45
-43	-75	-10

// Holzel B K, 2013: Generalized Anxiety Disorder (GAD), Stress management 
// education (SME)
// Subjects=11
55	-31	2
-57	-46	-2
-36	10	24
-50	19	12

// Holzel B K, 2013: Healthy Controls
// Subjects=26
-17	-17	-99
-38	-38	-68
14	14	-93
-40	-40	-75

// Hayashi A, 2014: Concrete > Control
// Hayashi A, 2014: Abstract > Control
// Hayashi A, 2014: Concrete > Abstract
// Hayashi A, 2014: Abstract > Concrete
// Subjects=16
-6	4	60
14	4	68
-40	36	10
56	22	22
-28	28	-6
36	32	0
-20	6	4
30	6	0
-40	-6	50
-36	-8	66
-22	-56	44
-50	-88	-14
-24	16	-8
-4	16	52
-46	20	24
56	28	20
-44	-2	48
-46	42	-12
-30	-60	48
-48	-54	-14
-26	-86	-2
38	-82	-4
-38	42	36
-24	38	50
26	4	68
-6	-64	60
-24	-34	-22
-50	-64	12
-12	-38	-16
-52	22	6
-46	-40	28

// Zhang J, 2013: PTSD > Control: Negative > Neutral
// Zhang J, 2013: PTSD < Control: Negative > Neutral
// Subjects=20
-36	-61	-11
34	-64	-10
-1	-45	5
-18	-1	-14
-20	-63	64
-28	6	-27
41	11	-28
-52	-54	31
-36	18	30
-31	37	12
41	34	3
44	2	13

// Zoccatelli G, 2010: Stroop color-word > Fixation
// Zoccatelli G, 2010: Stroop arrow-position > Fixation
// Zoccatelli G, 2010: Stroop > Fixation
// Subjects=10
1.26	8.6	23.08
6.73	16.52	42.42
46.48	-46.95	43.94
-33.69	-60.89	36
49.34	18.66	25.03
-43.57	8.84	30.26
36.2	48.25	-4.07
-27.86	54.98	6.14
39.44	25.55	-8.89
-31.04	19.04	-4.19
-59.81	-36.35	-15.95
42.8	-71.66	-27.55
-21.41	-53.26	-31.7
7.35	54.68	-.93
-4.91	7.7	53.33
11.03	-45.79	20.83
-36.83	-56.97	45.74
-34.01	24.76	28.82
26.68	22.81	-1.83
-27.85	15.63	-7.29
52.55	-37.31	2.92
-24.07	-80.64	27.51
-5.03	-85.75	0.95
-43.54	-66.69	3.14
-53.04	-29.28	33.57
26.72	-78.87	-36.79
-43.59	15.19	29.73
7.84	13.61	46
-33.66	-60.63	39.32
10.59	45.18	-.17
33.1	-75.91	-40.46

// Georgiou-Karistianis N, 2012: Friedreich Ataxia (FRDA)
// Subjects=13
35	2	53
-36	-3	52
7	6	55
-8	4	54
45	-6	55
-53	2	42
40	-19	54
-41	-15	52
53	-18	53
-45	-28	47
34	18	7
-32	17	7
63	-29	26
-52	-47	14
48	-76	1
-23	-95	3
-10	-19	8
-16	0	18
23	7	-6
-27	2	-5
17	-49	-21
-19	-49	-19
31	-52	-23
-28	-64	-22
32	-53	-49
-30	-55	-47
-38	-70	-24
9	-75	-36
-5	-77	-34
0	-75	-20
4	23	49
-4	16	50
49	9	40
-26	-1	52
7	6	52
-3	0	58
44	-9	60
-40	-14	56
36	-20	51
-32	-21	55
43	-30	52
-47	-35	58
34	23	1
-33	19	3
24	-68	57
-13	-68	62
46	-35	54
-50	-37	52
49	-68	-3
-43	-80	-1
10	-16	10
-10	-16	11
22	10	5
-24	6	5
28	-60	-22
-24	-66	-21
32	-55	-50
-30	-54	-50
-44	-64	-25
8	-75	-38
-5	-79	-36
4	23	50
-5	20	47
49	10	40
-25	-1	53
33	27	-1
-32	24	-1
23	-67	57
-12	-68	63
36	-46	51
-50	-39	51
34	-78	31
-33	-78	37
29	-61	-23
46	29	32
-27	42	32
24	58	28
-19	54	23
-43	23	-9
49	-71	12
-44	-78	6
55	-54	12
-49	15	-15
62	-44	25
1	-26	46
-1	-35	34
-32	17	-7
15	-10	21
-15	-5	19
-12	-58	-16
-29	-64	-24

// Georgiou-Karistianis N, 2012: Controls
// Subjects=14
25	-1	60
-5	12	56
40	2	58
-32	-1	52
51	24	-5
-50	22	-3
8	5	54
-5	-1	62
52	6	40
-53	4	43
51	-5	41
-57	-17	36
56	-12	45
-58	-18	38
23	-64	63
-16	-69	59
64	-35	36
-52	-39	33
44	-77	-4
-44	-79	6
13	-10	11
-14	-12	12
18	1	21
-11	-1	18
28	5	-2
-27	7	-1
33	-55	-24
-32	-58	-27
32	-47	-49
-33	-63	-47
28	-79	-22
-42	-66	-26
7	-77	-35
-5	-78	-30
0	-68	-25
5	16	52
-3	16	52
-33	1	55
54	15	21
-53	7	22
4	5	59
-4	1	58
49	10	38
-50	1	44
53	-3	43
-56	-21	31
54	-13	44
-56	-22	42
0	33	25
0	-24	33
35	22	5
-32	25	6
39	2	49
-30	-57	56
39	-40	47
-41	-40	48
44	-78	-3
-48	-76	-3
7	-12	12
-8	-19	11
11	2	14
-12	6	11
24	11	-1
-23	9	1
7	-63	-13
-9	-59	-15
32	-57	-26
-32	-57	-27
29	-67	-46
-33	-65	-48
40	-69	-25
-37	-70	-24
8	-78	-37
-9	-76	-35
0	-68	-26
4	17	53
-2	16	51
48	10	40
-49	9	37
53	14	18
-51	7	22
0	-17	33
36	21	4
-34	25	4
14	-68	58
-15	-70	59
41	-53	52
-43	-42	48
44	-79	-3
-43	-79	6
5	-21	5
-6	-15	9
11	1	14
-11	7	11
3	-62	-15
-10	-59	-16
22	-65	-25
-26	-62	-25
40	-70	-25
-38	-69	-25
10	-79	-37
-8	-77	-37
46	29	32
-27	42	32
24	58	28
-19	54	23
-43	23	-9
49	-71	12
-44	-78	6
55	-54	12
-49	15	-15
62	-44	25
1	-26	46
-1	-35	34
-32	17	-7
15	-10	21
-15	-5	19
-12	-58	-16
-29	-64	-24

// Beaton E A, 2010: Turner Syndrome
// Subjects=11
9.27	-56.21	65.22
23.36	-12.38	-30.06
-14.51	-85.49	18.88
-31.85	-79.36	-10.43
-25.27	-60.01	19.1
33.94	39.29	-23.37
-23	-82.74	27.67
26.18	-77.88	31.16
8.81	-34.6	14.35
58.1	-4.41	42.47
10.72	-54.59	-24.15
-10.14	-91.13	28.23
45.29	-76.85	15.24
41.23	-65.84	47.82
42.75	-21.64	-13.9
-30.16	25.88	-25.96
64.1	4.55	-7.42
-14.57	-94.98	6.3
4.64	-90.64	5.71
-29.99	-22.94	-24.1
36.71	21.7	51.68
13.11	-58.52	7.38
59.92	23.15	13.38
-22.81	-63.26	59.49
-38.22	-59.17	3.56
-31.52	-3.41	63.49
-30.04	-19.05	-28.89
36.71	21.7	51.68
15.19	-43.7	6.11
14.88	51.98	4.78
55.97	-2.14	44.54
68.53	-15.72	5.38
4.64	-88.52	5.53
-49.03	20.73	19.29
-16.54	-22.86	58.26
25.5	-12.37	-30.09
-8.1	-34.93	39.1
-62.02	-5.18	-11.84
30.05	-7.32	7.35
32.59	-51.43	42.25
-51.44	6.89	-21.9
64.39	-18.77	21.3
-40.61	-59.64	-29.83
55.49	21.41	-8.73
-24.6	-9.19	-11.94
26.26	-26.5	62.53
29.68	37.15	-23.14
7.45	-21.23	-19.1
2.17	31.1	11.14
-10.28	-59.58	23.35
19.22	-41.85	-25.31
24.53	-8.09	-15.94
-14.39	-20.57	60.27
-51.17	20.72	19.32
-12.69	-14.09	6.18
30.05	-7.32	7.35
-8.1	-34.93	39.1
-31.43	-26.67	65.44
-29.92	-11.16	-9.48
-42.55	-35.59	6.1
21.94	-24.75	57.98
-59.88	-5.17	-11.87
23.72	-70.23	-7.37
-19.05	-68.54	-9.25
34.46	-71.77	-.68
2.21	-60.81	-21.3
-10.57	-51.57	-10.77
13.09	-58.69	5.16

// Beaton E A, 2010: Healthy Controls
// Subjects=13
-22.82	-61.14	59.31
-18.73	-3.67	58.91
26.14	-7.98	54.29
17.03	49.88	4.94
-40.35	30.95	40.64
-17.18	45.1	1.27
-55.72	6.86	-21.85
40.35	-4.68	-42.06
-46.88	20.91	21.48
2.01	68.99	5.74
19.63	-61.68	20.95
59.92	-3.25	2.21
-8.1	-34.93	39.1
57.98	-5.61	26.96
-38.39	-21.45	-4.06
-14.59	-59.94	18.97
-22.81	-63.26	59.49
-38.22	-59.17	3.56
-31.52	-3.41	63.49
-30.04	-19.05	-28.89
36.71	21.7	51.68
15.19	-43.7	6.11
14.88	51.98	4.78
55.97	-2.14	44.54
68.53	-15.72	5.38
4.64	-88.52	5.53
-49.03	20.73	19.29
-16.54	-22.86	58.26
25.5	-12.37	-30.09
-8.1	-34.93	39.1
-62.02	-5.18	-11.84
30.05	-7.32	7.35
32.59	-51.43	42.25
-51.44	6.89	-21.9
64.39	-18.77	21.3
-40.61	-59.64	-29.83
55.49	21.41	-8.73
-24.6	-9.19	-11.94
26.26	-26.5	62.53
29.68	37.15	-23.14
7.45	-21.23	-19.1
2.17	31.1	11.14
-10.28	-59.58	23.35
19.22	-41.85	-25.31
24.53	-8.09	-15.94
-14.39	-20.57	60.27
-51.17	20.72	19.32
-12.69	-14.09	6.18
30.05	-7.32	7.35
-8.1	-34.93	39.1
-31.43	-26.67	65.44
-29.92	-11.16	-9.48
-42.55	-35.59	6.1
21.94	-24.75	57.98
-59.88	-5.17	-11.87
23.72	-70.23	-7.37
-19.05	-68.54	-9.25
34.46	-71.77	-.68
2.21	-60.81	-21.3
-10.57	-51.57	-10.77
13.09	-58.69	5.16

// Chinier E, 2014: Motor Imagery > Baseline, Cerebral Palsy (CP) Patients
// Chinier E, 2014: Unaffected hand > Affected hand, CP Patients
// Chinier E, 2014: CP with Right lesions > CP with Left lesions, Motor 
// Imagery > Baseline
// Subjects=9
3	-87	3
-21	-66	0
18	-72	0
-12	-60	3
60	-15	6
54	0	0
51	-6	-6
66	-27	18
54	6	-3
45	-33	0
48	-24	-3
51	27	-6
45	36	-12
63	-42	36
57	-42	51
-63	-12	3
-60	-24	21
-51	21	-6
-63	-27	6
-57	-36	6
-51	9	6
-57	12	3
-45	-18	3
-48	-30	3
-48	-21	6
-39	24	3
0	6	60
-6	21	45
0	-6	63
-6	3	72
-12	9	66
15	-3	66
-21	15	66
-18	12	63
6	-6	54
24	-3	57
-12	-9	21
-21	12	21
-18	9	18
-15	15	12
18	-15	-12
30	15	6
18	12	3
21	9	6
48	6	9
57	-57	30
33	-54	66
57	-51	39
45	-42	63
57	-42	36
48	-54	54
42	-57	57
57	-42	51
57	-36	51
36	-30	60
42	-51	36
21	-9	6
-21	3	6
-21	-3	9
6	-9	6
-9	-3	12
-18	12	-6
-30	3	-3
-12	-15	12
0	15	54
-6	12	57
-6	24	42
-6	30	36
-3	-48	-18
6	-51	-18
15	-57	-21
24	-69	-24
-51	12	18
-39	12	15
-39	0	9
42	6	51
48	0	54

// Cservenka A, 2012: Family History of Alcoholism (FHA)
// Subjects=19
-6.74	-62.73	64.84
32.57	12.04	64.81
29.01	-55.31	-7.57
-.76	-50.69	13.57
13.47	-86.61	43.19
-1.21	61.14	0.86
41.42	63.46	-14.33
-.66	-10.05	43.62
41.56	61.65	3.67
-33.15	52.2	12.01
13.05	32.07	36.59
57.88	18.62	23.82

// Cservenka A, 2012: Healthy Controls (HC)
// Subjects=16
35.01	70.02	-11.46
-3.55	-52.94	67.32
16.69	-89.77	43.42
41.56	61.65	3.67
-33.15	52.2	12.01
13.05	32.07	36.59
57.88	18.62	23.82

// Dinomais M, 2013: Observation > Rest
// Dinomais M, 2013: Nonparetic observation > Paretic observation
// Dinomais M, 2013: Paretic observation > Nonparetic observation
// Subjects=19
48	-72	0
-45	-69	6
18	-78	-15
30	-69	-15
24	-78	-15
-27	-75	-15
42	-48	-18
42	-57	-15
-42	-66	-12
45	-63	-15
12	-87	6
-36	-18	60
-42	-36	55
42	-24	63
42	-24	57
57	-9	51
48	-21	27
57	-15	15
54	-15	21
18	-45	69
63	-15	21
57	-15	51
66	-9	30
57	-12	36
21	-66	-51
15	-69	-45
21	-60	-45
9	-75	-42
6	-6	69
-24	36	12
-33	33	0
45	-18	57
27	-21	72
-42	-18	60

// Enzi B, 2012: Healthy Controls (HC)
// Subjects=15
-9	12	-3
12	6	-9
-18	-24	9
12	-18	12
-33	21	9
33	24	6
-42	45	18
-18	-75	6
18	-72	6
-9	9	3
12	9	0
-9	-15	0
-27	27	3
33	24	6
-51	9	30
48	3	36
-12	-78	6
21	-78	12
18	12	-9
-9	18	-6

// Enzi B, 2012: Huntington's Disease gene carriers near to symptom onset 
// (Pre-HD near)
// Subjects=15
15	9	-3
-39	51	0
-33	24	3
-60	6	18
-42	-48	39
-3	-21	33
-33	33	6
-42	36	9
9	45	6
-57	6	21
48	9	27
18	12	-9
-9	18	-6
-45	30	12

// Enzi B, 2012: Huntington's Disease gene carriers far from symptom onset 
// (Pre-HD far)
// Subjects=15
18	12	-3
-18	3	-9
18	15	-3
-18	-18	9
9	-18	0
-30	27	9
42	12	6
-45	30	12

// Pringle A, 2011: Bulimia Nervosa
// Subjects=11
-32	-92	-12
16	0	14
0	0	53
-32	-92	-12
0	-2	54
36	-96	-6
38	-62	16
30	-10	-4
38	-46	62
18	-96	16
-6	-58	26
16	18	66
-14	-96	-2

// Pringle A, 2011: Healthy Controls
// Subjects=16
-26	-96	-4
-26	-98	4
38	-62	16
30	-10	-4
38	-46	62
18	-96	16
-6	-58	26
16	18	66
-14	-96	-2

// Van de Winckel A, 2013: Cerebral Palsy
// Subjects=17
56	-28	28
34	-28	46
-36	-26	66
-30	-20	70
4	-4	48
30	-16	60
46	0	6
-50	-2	2
14	-2	-6
-58	-22	10
58	-60	0
48	-60	-6
-46	-18	-20
-50	-74	-12
12	-50	-28
0	-64	-14
12	-56	-20
-26	-50	-36
58	-36	22
58	-42	44
44	-32	62
-44	-34	56
-42	-24	60
0	-24	46
8	-22	40
-60	30	38
46	4	12
-30	-12	4
18	2	-4
-24	6	-8
46	-46	6
-64	-30	16
60	-60	-4
64	-26	16
-66	-26	18
36	-48	46
56	-24	38
38	-38	56
-36	-30	50
-30	0	48
48	-4	4
-50	-4	0
-12	0	6
34	4	-22
-22	10	-20
38	-12	-16
-18	-26	2
34	8	-14
56	10	-4
-24	-76	-26
24	-60	66
-18	-36	52
34	-24	68
20	-14	62
-18	-18	54
-2	18	-8
24	-50	-2
-44	-54	6
48	-64	-8
-44	-20	-20
-40	-36	-12
20	-92	12
-18	-84	22
-22	-90	-2
-50	-76	12
-16	-94	-6
-50	-72	-10
0	-22	-14
-10	-44	-16
-24	-82	-36
-36	-24	64
40	-10	60
-30	-20	54
2	-4	50
30	-16	60
-10	-14	56
-40	-40	-12
-2	-62	-14
4	-50	-18
-46	-18	56
28	-20	70
30	-20	72
-38	-24	64
-6	-40	-52
-8	-8	56
30	-16	60
16	-56	-20
0	-66	-12

// Van de Winckel A, 2013: Healthy Controls
// Subjects=19
60	-30	22
-44	-18	54
-38	-24	66
-4	-2	50
40	8	2
-48	2	2
18	-2	-2
-32	-4	-4
-60	-20	10
12	-54	-18
24	-52	-28
-32	-52	-34
16	-62	-46
50	-24	20
56	-36	22
-32	-32	64
-26	-40	58
-42	-18	50
-8	-4	54
-30	-14	58
-14	-20	42
-46	2	0
-50	-28	14
26	-46	-28
16	-66	-44
58	-28	22
-60	-24	14
-34	-34	68
-52	-26	26
-40	-26	52
64	-26	14
-44	-26	20
-52	-4	0
24	-50	-30
24	-60	66
-18	-36	52
34	-24	68
20	-14	62
-18	-18	54
-2	18	-8
24	-50	-2
-44	-54	6
48	-64	-8
-44	-20	-20
-40	-36	-12
20	-92	12
-18	-84	22
-22	-90	-2
-50	-76	12
-16	-94	-6
-50	-72	-10
0	-22	-14
-10	-44	-16
-24	-82	-36
-40	-22	56
10	6	48
10	16	36
-6	18	36
40	8	2
56	8	-8
8	-56	-14
20	-54	-26
2	-64	-18
-24	-56	-26
56	-40	44
-34	-20	44
-44	-16	56
2	0	60
36	-6	50
8	6	44
-8	12	38
50	6	2
-60	4	8
16	-8	16
-16	-2	12
18	-2	-2
-18	-14	-4
-32	-4	-6
6	-58	-12
2	-66	-18
-24	-56	-26
-36	-54	-34

// Van de Winckel A, 2013: Healthy Controls
// Subjects=18
-20	-62	54
-60	-18	42
-52	8	28
-6	2	48
46	6	22
-54	8	16
40	0	0
-40	-2	2
16	-26	10
-10	-20	6
10	-20	0
-54	-58	0
-54	-62	-18
6	-56	-12
-20	-72	-26
-18	-74	-46
12	-74	-42
12	-54	-52
-40	-62	-34
-58	10	12
-18	2	62
-6	2	46
-36	2	52
32	-52	-34
12	-54	-52
-16	-20	52

// Van de Winckel A, 2013: Cerebral Palsy
// Subjects=16
14	-58	56
-20	-62	54
56	-28	44
-62	-28	40
-48	-34	54
-38	-34	44
-52	2	34
28	-8	60
48	8	18
-42	-10	0
-50	-26	14
-58	-28	16
48	-64	2
-50	-56	0
52	-60	-10
-18	-68	-30
-18	-74	-44
10	-70	-46
16	-64	-46
-34	-68	-32
-58	10	12
-18	2	62
-6	2	46
-36	2	52
32	-52	-34
12	-54	-52
-16	-20	52

// Acheson A, 2014: Family History of Substance Use Disorders (FH+) > Healthy 
// Controls (FH-): Go > Baseline
// Acheson A, 2014: FH+ > FH-: NoGo > Baseline
// Subjects=32
-4	-40	48
14	-42	46
18	-48	34
18	20	-6
42	26	-12
36	30	-6
56	-28	2
68	-24	-2
64	-10	-16
-20	20	52
-14	40	44
-24	40	42
-2	-60	48
-2	-70	50
-8	-76	42
-56	-44	14
-50	-42	6
-64	-50	10
-16	8	-12
-20	16	-12
-26	26	6
-4	-40	48
14	-44	46
26	-38	48
68	-24	-2
58	-28	4
64	-10	-16
-20	20	52
-10	34	52
-10	38	44
-54	-44	14
-62	-48	10
-56	-42	4
-4	48	0
-8	40	-4
-14	20	-12

// Barnett A J, 2014: Experiment 1 Normals
// Subjects=22
-34	-66	72
18	-42	0
-10	-38	72
4	-28	56
-4	-20	64
18	-46	64
-44	-46	48
0	8	64
24	-60	62
-52	-60	60
-12	18	56
30	-2	30
36	4	50
-48	-48	12
64	-28	44
-56	-54	42
44	-52	40
8	-38	34
10	-50	14
-4	-10	40
36	36	34
-16	68	14
26	-90	28
36	10	24
-16	68	14
26	-30	22
36	48	18
-10	50	18
-38	36	22
38	-30	18
-14	48	18
14	50	12
-36	12	12
38	14	16
-62	-38	12
44	8	10
0	-14	8
-12	-78	8
26	-64	2
-40	-18	6
-52	-24	4
58	-8	2
42	-58	4
-22	8	-38
50	38	-10
-6	-38	-60
0	8	64
0	-14	8
18	-22	74
-16	-22	42
12	2	72
-4	26	58
10	-44	72
-14	-38	68
4	4	66
26	-46	64
34	8	62
-36	22	42
10	-60	52
54	-64	38
-36	-64	12
52	14	32
0	4	32
-42	-80	32
2	-20	28
-64	-56	26
-16	-8	22
14	-2	20
20	-98	22
-14	-14	16
14	-18	16
46	-32	16
32	-26	14
-36	-16	12
-42	-14	12
-54	-24	12
-26	56	10
22	62	8
-54	-20	10
70	-24	10
-66	-28	6
0	22	-2
30	-36	-4
-14	-34	-4
-6	-72	-4
12	-86	-6
-20	-2	-42
22	-32	-34
0	4	32
0	22	-2
-2	42	-18
-30	2	38
-38	-4	64
-58	14	24
-34	12	14
-54	40	4
44	20	36
44	14	26
42	14	10
48	38	8
38	-84	36
62	-48	44
-8	-78	-44
-12	22	40
-26	-94	-8

// Barnett A J, 2014: Experiment 2 Normals
// Subjects=20
-4	-24	78
-10	-10	74
-2	-12	70
-6	-56	70
-18	46	48
0	-26	46
-6	8	40
6	-86	34
28	32	28
16	-86	22
-8	-96	22
-12	-50	-2
2	28	-4
2	54	-14
-24	-10	-14
-24	-20	-14
-26	-4	-24
58	-8	-40
60	-34	48
56	0	40
66	-50	24
50	-16	18
36	-4	12
56	-32	10
56	-72	8
66	-56	2
58	-10	0
24	-40	0
26	8	-20
50	8	-20
40	-2	-20
32	2	-22
16	2	-26
-44	-18	-8
-62	-36	36
-44	-80	36
-36	-60	26
-46	-42	20
-62	-30	18
-58	-20	16
-58	-38	12
-66	-54	-4
-42	-2	-10
-54	-16	-24
36	-80	-32
22	-72	-6
-14	-78	-10
-46	-12	-44
-44	20	-34
-28	40	-16
0	-26	46
-40	20	16
-26	-64	30
-50	2	52
-2	30	-2
-28	-40	-6
32	-42	-2
32	14	-30
40	12	56
48	12	20
32	42	-4
38	38	-8
12	36	16
-32	16	-14
12	-6	4
22	14	38
22	-78	2
20	70	-2
14	46	-6
6	44	8
58	-40	38
4	28	-2
0	16	-20
0	16	-20
54	20	-6
22	28	-14
36	16	-32
34	8	60
-4	6	58
-4	22	54
4	16	54
8	20	44
-4	12	44
38	44	32
-8	12	32
46	6	30
54	16	14
36	22	6
44	16	-8
46	22	-10
-36	-96	-6
-24	36	-12
62	-42	-14
28	52	0
32	-52	36
66	-16	-20

// Cservenka A, 2014: Family History Positive (FHP)
// Subjects=19
-61.74	-25.42	15.5
-58.88	8.41	-15.25
22.62	58.02	40.99
31.82	73.51	-7.25
3.31	4.32	8.91
22.62	58.02	40.99
-49.16	45.76	12.73
22.3	-22.25	-33.68
-39.32	41.53	39.74
55.05	-67.59	37.77
3.5	35.96	46.41
-7.13	-99.68	-0.09
-7.81	55.79	-26.5
-55.06	-15.95	54.78
6.99	1.57	69.32
42.23	1.52	65.58
3.31	-16.54	0.63
29.03	-98	-22.95
-13.55	36.37	53.26
-.26	-25.74	88.43
31.82	73.51	-7.25
54.4	22.29	-11.02
-36.54	66.76	-5.9
55.1	-40.67	55.59
-49.34	24.07	-20.02
31.82	73.51	-7.25
31.83	34.08	-21.79
58.33	-53.6	53.29
3.32	0.09	9.27

// Cservenka A, 2014: Family History Negative (FHN)
// Subjects=17
-61.74	-25.42	15.5
-58.88	8.41	-15.25
22.62	58.02	40.99
31.82	73.51	-7.25
3.31	4.32	8.91
22.62	58.02	40.99
-49.16	45.76	12.73
22.3	-22.25	-33.68
-39.32	41.53	39.74
55.05	-67.59	37.77
3.5	35.96	46.41
54.26	-3.28	-38.99
-49.4	-17.11	-43.33
-16.91	57.78	41.46
38.12	6.43	-49.65
32.52	-91.73	16.63
-42.5	-91.14	-10.43
-42.18	-8.76	64.06
-32.46	-37.25	66.34
-11.03	52.34	-29.52
-.91	31.22	26.78
19.74	-104.49	17.85
7.2	-68.74	68.53

// Dager A D, 2013: Heavy Drinkers > Light Drinkers, Alcohol > Non-alcohol
// Dager A D, 2013: No Family History of Alcoholism (FHN) > Family History of 
// Alcoholism (FHP), Alcohol > Non-alcohol
// Dager A D, 2013: Heavy Drinkers > Light Drinkers, Alcohol (second image) > 
// Alcohol (first image)
// Dager A D, 2013: FHP > FHN, Alcohol (second image) > Alcohol (first image)
// Subjects=10
30	-78	12
-9	-45	9
-15	-21	42
3	54	0
-15	9	18
15	-12	3
-21	-27	-6
42	-9	48
33	27	-21
42	-3	-27
-36	-36	-21
-15	-42	-15
9	15	60
45	12	42
57	18	9
48	15	12
60	-45	36
66	-39	-6
51	-63	-21
15	15	12
-48	-78	-12
-48	-18	-15
-30	-57	-6
36	-39	-21
30	-15	-15
-45	-15	-12
51	-3	-12
39	-42	42
-9	-48	-18
39	-18	33

// Kalpakidou A K, 2014: Verbal fluency task: Hard > Easy, Very Preterm (VPT) 
// > Normals
// Kalpakidou A K, 2014: N-back task: 3-back > 1-back, Periventricular 
// haemorrhage and ventricular dilatation (PVH+VD) < Uncomplicated 
// periventricular haemorrhage (UPVH)
// Subjects=12
23.78	-28.96	17.05
-41.47	7.37	24.79

// Marvel C L, 2010: Encoding > Baseline (positive activations)
// Marvel C L, 2010: Encoding > Baseline (negative activations)
// Marvel C L, 2010: Maintenance > Baseline (positive activations)
// Marvel C L, 2010: Maintenance > Baseline (negative activations)
// Marvel C L, 2010: Retrieval > Baseline (positive activations)
// Marvel C L, 2010: Retrieval > Baseline (negative activations)
// Marvel C L, 2010: Positive Correlation between Accuracy and Maintenance > 
// Baseline
// Subjects=16
47	43	6
-7	43	32
13	35	47
47	26	-12
-29	16	-7
17	2	39
-41	0	-32
-53	-4	-8
-40	-7	23
53	-15	2
-9	-22	36
34	-23	8
-27	-24	-15
-42	-29	53
-48	-31	19
43	-32	20
-20	-33	40
58	-34	40
-24	-42	52
12	-56	-36
-53	-60	23
16	34	-21
-7	13	5
-51	8	2
-2	-5	61
-5	-21	9
-7	-37	2
45	-58	-17
40	-64	-36
-46	-70	-52
4	-72	48
-10	-74	-20
-9	-88	1
6	68	16
-9	62	30
5	57	3
-24	27	57
-21	20	-27
-18	5	8
19	4	3
60	-6	-10
56	-8	10
45	-10	46
-42	-16	40
20	-17	-13
-21	-20	-21
0	-41	38
-58	-54	-16
16	-55	66
-57	-59	-4
-11	-61	18
-50	-70	26
32	-79	8
-27	-84	16
-40	21	40
-29	20	-3
31	19	-1
4	18	53
62	11	24
-50	10	37
-53	7	17
-5	0	24
-36	-9	19
-31	-15	62
-52	-26	39
-28	-32	64
12	-56	-14
-6	-64	-40
14	-70	-46
31	24	7
-29	22	11
-40	19	23
-5	5	53
12	-57	-40
17	38	41
8	34	56
42	29	11
23	6	0
-46	-12	35
20	-15	-17
-62	-41	1
43	-50	29
-52	-53	33
43	-63	31
-42	9	35
31	22	7
-29	22	11
6	11	45
14	-58	-42

// de Greck M, 2013: Somatoform Disorder
// Subjects=15
-25.93	42.99	-25.22
24.35	27.43	-24.49
-26.62	-10.2	2.67
-55.82	-2.97	-38.86

// de Greck M, 2013: Subgroup of Somatoform Disorder, Unmedicated
// Subjects=10
-25.93	42.99	-25.22
-24.85	40.97	-23.95
24.35	27.43	-24.49
26.49	28.59	-23.5
-26.62	-10.2	2.67
-28.77	-11.44	0.57
-55.82	-2.97	-38.86
-51.57	-8.66	-44.01

// de Greck M, 2011: Somatoform Disorder
// Subjects=20
-46.71	30.37	47.45
7.81	17.75	44.54
7.19	73.91	-13.69
17	23.21	-9.56
-43.55	29.87	40.77
14.25	4.84	42.2
4.52	26.73	37.13

// de Greck M, 2011: Subgroup of Somatoform Disorder, Unmedicated
// Subjects=20
-46.73	30.11	44.13
7.81	17.75	44.54
7.19	73.91	-13.69
17	23.21	-9.56

// de Greck M, 2011: Subgroup of Somatoform Disorder, Second Scan
// Subjects=15
-43.55	29.87	40.77
14.25	4.84	42.2
4.52	26.73	37.13

// de Greck M, 2011: Normals
// Subjects=20
-11.83	-3.11	-17.05
17.03	0.49	-14.34
7.81	17.75	44.54
-4.98	17.93	48.02
14.23	30.99	50.05
-53.17	10.01	32.5
-46.71	30.37	47.45
-14.57	44.54	62.62
62.03	-1.38	-1.32
-14.98	23.79	0.8
10.63	26.86	-3.1
-5.53	32.08	-16.73
-46.71	30.37	47.45
7.81	17.75	44.54
7.19	73.91	-13.69
17	23.21	-9.56
-46.73	30.11	44.13
7.81	17.75	44.54
7.19	73.91	-13.69
17	23.21	-9.56

// Hardee J E, 2014: Family History of Alcohol Use Disorder (FH+)
// Subjects=43
44	16	-2
-40	18	-6
56	-46	26
-62	-54	32
10	-68	38
58	-26	-8
46	2	-40
-30	42	24
44	16	-2
-34	22	6
56	-44	24
-28	10	-4
-64	52	22
-70	-28	-6

// Hardee J E, 2014: No Family History of Alcohol Use Disorder (FH-)
// Subjects=30
44	16	-2
-40	18	-6
56	-46	26
-62	-54	32
10	-68	38
58	-26	-8
46	2	-40
50	22	0
-26	44	22
-40	18	-6
46	-54	36
-60	-54	30
10	-68	38
-48	-54	36
-10	8	8
-16	2	-4
64	-34	-2
46	0	-40
-58	-28	-6
32	2	-36

// Lythe K E, 2012: Rested wakefulness: N-back > Control
// Lythe K E, 2012: Rested wakefulness: 1-back < 2-back < 3-back
// Lythe K E, 2012: Rested wakefulness: 1-back > 2-back > 3-back
// Lythe K E, 2012: Sleep deprivation: N-back > Control
// Lythe K E, 2012: Sleep deprivation: 1-back < 2-back < 3-back
// Lythe K E, 2012: Sleep deprivation: 1-back > 2-back > 3-back
// Lythe K E, 2012: Rested wakefulness > Sleep deprivation: N-back > Control
// Lythe K E, 2012: Rested wakefulness: Sustained Attention > Control
// Lythe K E, 2012: Rested wakefulness: Divided Attention > Control
// Subjects=20
42	30	36
32	2	62
-30	-2	44
32	-56	38
-28	-58	44
30	2	58
36	-50	42
-2	56	6
4	-10	42
-8	-52	16
-52	-26	14
46	4	-36
26	-42	-20
-24	-34	-18
48	-18	20
-40	-20	60
-50	14	28
34	6	52
-22	0	60
46	-44	42
-30	-46	40
46	30	34
-20	0	50
42	-42	46
-30	-48	40
-4	42	50
-1	-22	38
-8	-54	24
36	-28	12
-66	-34	0
30	-18	-26
-38	-36	68
24	-92	24
40	46	-8
54	-50	42
46	-16	-2
-58	-26	6
44	6	34
0	6	54
56	-10	2
-60	-12	6
-28	-88	-6

// Nakai T, 2014: Linear-Match
// Nakai T, 2014: Quad - Simple, masked with Linear - Match
// Nakai T, 2014: Simple-Match
// Nakai T, 2014: Linear-Simple
// Subjects=20
-27	5	55
33	5	58
-45	11	25
-51	32	22
-30	26	1
-6	20	46
-45	-40	43
-33	-52	40
48	-31	46
36	-55	43
-6	-70	46
-51	-55	-11
-24	5	55
30	5	58
-45	5	37
-45	11	25
-30	23	1
-6	20	43
0	11	55
-48	-37	43
-33	-49	40
-27	-70	43
45	-31	43
39	-52	43
33	-61	34
-12	-61	52
9	-70	49
-45	11	25
-48	-37	46
-30	-70	46
39	-55	43
-3	-70	43

// Neuner I, 2010: Tourette's Syndrome
// Subjects=19
-36	2	54
-34	-18	52
-48	-28	54
-40	-34	50
56	-18	34
16	44	28
12	32	42
12	32	42
-28	-2	54
-28	-2	54
-40	46	-6
62	18	2
50	12	16
-38	6	22
-52	10	20
62	18	2
50	12	16
-38	6	22
-52	10	20
46	38	26
46	38	14
38	24	14
-40	34	14
6	8	48
-2	18	46
60	-20	26
-8	-68	46
-26	-98	10
36	-58	-20
-38	-56	-20
4	-34	24
24	-32	-6
-40	-2	6
28	-6	-16
-28	-6	-10
16	-22	22
-24	-12	10
-16	2	10
14	-28	4
54	-18	36
-52	-26	54
-52	-10	52
-42	-32	48
26	2	44
16	42	30
48	32	32
48	48	6
38	12	44
-38	48	-8
50	12	32
50	12	32
54	40	10
-4	22	44
-28	-64	46
50	-40	48
38	-58	52
-24	-100	10
36	-58	-20
-38	-58	-20
26	-30	-6
-30	-8	-12
-18	-36	4
-30	0	-24
30	0	-24
-28	-16	8
-58	12	34
56	-16	36
-50	-22	54
-34	-34	50
4	64	24
-4	26	38
-4	26	38
4	64	24
30	32	-16
-28	28	-16
-42	50	-6
-2	56	-14
-42	50	-6
54	14	16
48	12	32
-52	10	18
30	32	16
54	14	16
48	12	32
-52	10	18
-28	28	16
52	40	8
-54	24	28
-38	32	14
-46	46	12
-48	36	14
0	6	50
48	20	-22
52	-10	-12
-60	40	-10
48	-40	48
40	-44	44
-46	-44	40
-36	-48	50
30	-56	46
12	-68	40
6	-74	44
-8	-68	46
44	-80	-10
34	-58	-18
-38	-58	-20
26	-26	8
20	-28	-14
20	-40	-8
24	-4	-14
-26	-12	10
24	6	4
-30	-4	-10
-16	6	8
20	-26	2
-12	-16	2
-32	-18	52
-48	-28	54
56	-16	36
50	-24	48
30	64	18
16	42	30
18	30	34
-14	16	38
-2	26	40
46	36	30
-40	48	-6
50	12	34
-52	12	18
64	18	12
50	12	34
-52	12	18
42	34	-14
-26	28	-14
44	36	16
38	24	14
-54	24	28
10	6	48
-22	-64	52
48	-38	50
32	-58	50
-24	-82	-14
34	-56	-18
-38	-56	20
26	-30	-4
-20	-30	-2
-38	2	18
26	-4	-14
-28	-8	-12
-24	-16	0
12	-34	2
52	-26	48
58	-16	38
-34	-24	52
-48	-22	54
-6	20	42
-36	6	20
28	32	-16
54	40	8
-44	34	14
-2	0	52
50	-42	48
-34	-48	50
32	-52	46
28	-66	48
14	-34	2
-42	-80	-10
40	-50	-24
-38	-58	-20
24	-32	-6
38	2	8
26	-6	-14
-24	-14	10
6	-24	6
-34	-18	54
-50	-28	54
-38	46	-8
-50	10	20
-36	6	22
26	32	-14
-44	36	14
-58	-20	38
38	-88	0
-40	-82	-10
-38	58	-20
28	-32	-4
-28	-10	-10
-20	-36	2
-28	26	-8
26	-6	-14
-30	4	-2
-30	-14	8
-16	-22	12
-36	0	54
24	18	42
16	42	28
32	62	18
-2	66	24
28	34	42
28	54	28
-36	6	20
48	14	0
36	24	12
-64	48	16
56	-28	-12
60	-52	10
54	-14	-18
-46	-58	0
-36	-58	14
-38	-46	50
50	-44	54
-34	-38	48
36	-52	20
38	-56	32
54	-46	32
58	-40	26
66	-46	24
-62	-56	30
0	-72	48
-12	-100	16
-38	-76	32
14	-90	4
-6	-80	4
-44	-58	-20
-14	-60	28
14	-100	10
-6	-92	14
2	38	12
2	-34	50
0	-34	26
4	-48	10
24	-30	-4
-2	-4	-12
32	-4	-18
38	-12	38
-54	-8	50
28	18	42
26	2	42
-16	18	38
-12	32	40
-22	32	-14
-24	20	38
46	32	34
48	14	14
-52	16	14
-36	34	12
52	-22	-10
-58	-36	52
-34	-74	52
-48	-70	42
0	-66	38
-42	-62	6
-36	-68	6
-30	-76	6
16	-88	6
26	-30	-8
22	-2	-14
38	-10	40
54	-16	34
62	-6	40
-40	-32	16
-44	-16	18
60	-6	14
0	64	26
-12	64	30
-6	30	32
-20	32	-14
16	34	-14
-2	58	-14
10	46	-10
30	20	40
24	12	42
-36	6	20
-58	22	26
-34	32	-14
56	2	-16
-46	58	2
-54	-32	6
0	-70	40
14	-88	4
-6	28	-8
-6	46	12
24	-4	-14
28	-8	-12
-36	4	20
-28	-36	50
-18	18	40
26	28	14
20	10	42
-48	12	16
36	24	12
50	-38	-12
54	-22	-10
-44	-62	2
-52	-58	10
-38	-48	52
58	-34	26
-8	-68	48
2	-72	48
0	-66	38
-12	-100	18
-28	-76	8
16	-88	6
-4	-94	14
-2	-42	32
-22	-32	-42
6	-28	-6
-22	26	14
24	-6	-16
-18	2	-14
-24	-16	-2
-28	-40	48
22	14	44
-34	8	18
-40	32	14
-36	-62	12
-6	66	46
2	-74	50
-10	-86	40
-30	-66	20
0	-34	48
24	-30	-6
28	-8	-14
-26	-40	50
6	46	-10
-34	6	20
62	-44	2
2	-74	48
-40	-66	2
-32	66	-4
-28	-12	-10
-14	4	-14

// Neuner I, 2010: Healthy Controls
// Subjects=19
-36	0	54
24	18	42
16	42	28
32	62	18
-2	66	24
28	34	42
28	54	28
-36	6	20
48	14	0
36	24	12
-64	48	16
56	-28	-12
60	-52	10
54	-14	-18
-46	-58	0
-36	-58	14
-38	-46	50
50	-44	54
-34	-38	48
36	-52	20
38	-56	32
54	-46	32
58	-40	26
66	-46	24
-62	-56	30
0	-72	48
-12	-100	16
-38	-76	32
14	-90	4
-6	-80	4
-44	-58	-20
-14	-60	28
14	-100	10
-6	-92	14
2	38	12
2	-34	50
0	-34	26
4	-48	10
24	-30	-4
-2	-4	-12
32	-4	-18
38	-12	38
-54	-8	50
28	18	42
26	2	42
-16	18	38
-12	32	40
-22	32	-14
-24	20	38
46	32	34
48	14	14
-52	16	14
-36	34	12
52	-22	-10
-58	-36	52
-34	-74	52
-48	-70	42
0	-66	38
-42	-62	6
-36	-68	6
-30	-76	6
16	-88	6
26	-30	-8
22	-2	-14
38	-10	40
54	-16	34
62	-6	40
-40	-32	16
-44	-16	18
60	-6	14
0	64	26
-12	64	30
-6	30	32
-20	32	-14
16	34	-14
-2	58	-14
10	46	-10
30	20	40
24	12	42
-36	6	20
-58	22	26
-34	32	-14
56	2	-16
-46	58	2
-54	-32	6
0	-70	40
14	-88	4
-6	28	-8
-6	46	12
24	-4	-14
28	-8	-12
-36	4	20
-28	-36	50
-18	18	40
26	28	14
20	10	42
-48	12	16
36	24	12
50	-38	-12
54	-22	-10
-44	-62	2
-52	-58	10
-38	-48	52
58	-34	26
-8	-68	48
2	-72	48
0	-66	38
-12	-100	18
-28	-76	8
16	-88	6
-4	-94	14
-2	-42	32
-22	-32	-42
6	-28	-6
-22	26	14
24	-6	-16
-18	2	-14
-24	-16	-2
-28	-40	48
22	14	44
-34	8	18
-40	32	14
-36	-62	12
-6	66	46
2	-74	50
-10	-86	40
-30	-66	20
0	-34	48
24	-30	-6
28	-8	-14
-26	-40	50
6	46	-10
-34	6	20
62	-44	2
2	-74	48
-40	-66	2
-32	66	-4
-28	-12	-10
-14	4	-14

// Hong D S, 2014: Turner Syndrome
// Subjects=14
-31	-4	-28
-34	19	-31
-36	1	-33
34	-10	-26
42	-41	-13
28	-8	-10
33	-7	-17
43	12	-31
0	-44	24
-1	-40	10
46	-80	3
45	-71	15
40	-66	25
40	-7	-30
27	-4	-15
45	10	-26
-37	-11	-26
42	-41	-13
45	-30	-20
56	17	17

// Hong D S, 2014: Healthy Controls
// Subjects=16
21	-12	-12
10	11	8
46	-63	25
46	-33	9
46	-41	17
52	25	6
45	18	38
-56	21	7
-39	22	9
40	-46	-14
-37	18	31
-37	6	40
34	-3	-26
25	-6	-11
36	-5	-34
53	-63	17
46	-66	17
40	-86	1
7	28	29
0	27	51
7	22	54
-46	-82	-1
-46	-75	7

// Kim S, 2013: Fragile X Premutation
// Subjects=24
44	-46	48
36	-44	40
30	-70	40
24	-62	46
36	-56	48
46	4	24
54	12	22
40	14	8
56	14	36
36	18	-6
4	26	38
-2	22	44
4	18	50
-2	12	48
10	30	24
26	4	50
20	8	54
12	22	28
-40	14	2
-42	-40	40
-42	-46	42
-34	-46	50
-20	-70	8
-8	-80	14
18	-62	6
14	-68	4
-52	0	36
-50	6	34
-48	8	40
-54	-8	42
52	-38	46
54	-34	46
38	-50	46
42	-56	50
58	-40	30
34	-62	42
-44	-42	46
-44	-56	54
-28	-62	46
-40	-50	46
-36	-62	50
-28	-54	44
-36	-50	36
-22	-58	40
-32	0	44
-28	-16	48
-30	-16	54
44	24	-6
46	18	-12
32	10	-14
56	-54	42
8	-18	34
52	-44	28
52	-40	34
32	-62	58
58	-50	32
26	46	26
38	40	36
40	26	46
48	26	30
-36	-52	62
-50	-42	40
-46	-44	32

// Kim S, 2013: Healthy Controls
// Subjects=19
32	24	0
4	22	40
48	18	2
38	20	36
10	28	22
-38	16	2
-44	2	32
-52	16	16
46	-48	46
42	-54	54
34	-58	52
28	-58	46
28	-60	52
30	-62	38
58	-44	32
28	-66	46
-46	-42	48
-32	-60	50
-30	-52	48
-30	-58	58
-24	-66	42
-60	-48	38
10	-12	6
10	-26	6
20	-6	2
-10	6	-2
-18	-28	8
-34	-2	52
-42	28	28
-52	0	36
-50	6	34
-48	8	40
-54	-8	42
52	-38	46
54	-34	46
38	-50	46
42	-56	50
58	-40	30
34	-62	42
-44	-42	46
-44	-56	54
-28	-62	46
-40	-50	46
-36	-62	50
-28	-54	44
-36	-50	36
-22	-58	40

// Lee J A, 2010: Trichotillomania
// Subjects=9
-46.19	-67.53	6.24
45.57	-69.96	-1.8
-54.1	-7.76	-8.5
47.85	-67.95	8.05
-55.7	-22.22	32.18
-33.8	-39.62	51.46
-31.81	-27.79	40.17
30.28	-58.08	-11.68
-3.87	-48.5	23.81
-8.16	-29.7	29.87
-27.53	-74	27.86
-33.53	-9.61	-6.43
-39.93	-3.49	2.04
49.98	-68.15	5.79
56.41	-57.6	3.51
-46.17	-64.13	8.15
-41.66	-46.29	26.48
-54.1	-7.76	-8.5
-45.5	-5.92	-12.19
-26.47	-74.2	25.62
-33.5	-10.47	-4.1
20.37	-41.59	61.93
-24.17	-40.32	43.52
-5.92	-28.01	36.39

// Lee J A, 2010: Healthy Controls
// Subjects=10
45.54	-63.58	-2.43
28.5	-85.89	12.39
-22.13	-79.51	26.07
31.8	-79.94	18.47
-39.75	-72.18	2.11
-22.29	-86.18	12.16
-33.67	-46.34	59.96
-38.08	-41.56	53.96
45.8	13.86	33.6
-39.75	-72.18	2.11
26.35	-85.8	13.54
45.55	-65.7	-2.22
-20.12	-88.29	12.34
48.25	-24.44	48.56
53.61	-16.02	46.51
37.56	-35.66	55.45
-45.63	-31.6	57.59
-40.37	-31.55	46.29
-54.42	-21.82	47.81
30.23	-70.5	-18.3
-46.17	-64.13	8.15
-41.66	-46.29	26.48
-54.1	-7.76	-8.5
-45.5	-5.92	-12.19
-26.47	-74.2	25.62
-33.5	-10.47	-4.1
20.37	-41.59	61.93
-24.17	-40.32	43.52
-5.92	-28.01	36.39

// Moeller S J, 2014: Healthy Controls (HC) < Intermittent Explosive Disorder 
// (IED) and Cocaine Use Disorder (CUD), Error > Correct
// Moeller S J, 2014: IED > HC and CUD, Error > Correct
// Moeller S J, 2014: HC > IED and CUD, Incongruent > Congruent
// Moeller S J, 2014: HC < IED and CUD, Incongruent > Congruent
// Subjects=11
-39	47	28
-30	59	22
-6	23	37
21	-58	-44
-15	59	34
51	-34	31
-54	-46	46
45	-10	1
-27	-25	-5

// Roessner V, 2012: Healthy Controls
// Subjects=16
42.65	51.97	2.24
-36.89	-14.7	55.58
33.71	-20.11	61.91
24.12	-13.31	68.14
-50.13	0.66	7.6
-4.96	0.58	43.89
-8.06	-1.58	57.49
-43.57	-17.56	19.09
-37.32	3.91	7.19
42.77	7.05	-.69
-31.01	25.9	1.92
29.97	20.43	8.37
-24.54	3.47	0.38
20.41	4.51	9.82
-14.79	-18.16	8.78
52.61	-33.36	12.62
24.14	-32.85	63.09
59.34	-33.33	53.81
-46.69	-26.59	26.58
52.89	-30.54	49.18
24.06	-50.26	44.48
46	-42.06	-16.68
-33.92	-89.61	-5.08
26.96	-92.93	-12.2
-17.69	-97.4	16.57
17.39	-99.07	-8.23
13.96	-45.42	-16.03
55.77	-47.06	0.35
49.24	24.23	14.52
43.22	-31.11	42.65
36.9	-43.32	50.44
17.73	-59.3	52
-14.35	-13.54	68.61
17.24	37.76	27.14
-11.66	20.69	15.52

// Roessner V, 2012: Tourette Syndrome
// Subjects=19
1.44	17	49.14
-36.86	-14.44	58.9
36.74	-12.11	41.13
-1.84	9.61	36.41
4.58	-6.73	31.02
7.69	25.27	31.64
-4.86	-4.99	54.4
-40.52	10.49	10.02
45.99	10.5	2.33
39.78	-10.46	20.89
-27.79	6.37	-3.17
-18.06	17.48	15.86
17.22	14.52	15.71
-14.8	-14.99	8.51
24.08	-23.59	58.97
39.75	-76.73	-10.36
-24.26	-92.47	-1.61
20.6	-85.85	-2.68
-40.51	-68.47	-20.16
17.15	-42.23	-16.34
1.44	17	49.14
55.77	-47.06	0.35
49.24	24.23	14.52
43.22	-31.11	42.65
36.9	-43.32	50.44
17.73	-59.3	52
-14.35	-13.54	68.61
17.24	37.76	27.14
-11.66	20.69	15.52

// Carpenter-Thompson J R, 2014: Hearing Loss with Tinnitus (TIN)
// Subjects=13
-18	-58	42
12	-66	44
46	-62	22
36	-58	42
-44	-36	26
-36	42	20
-34	-68	20
6	54	4
-4	52	2
-4	38	4
-26	-68	42
4	-22	26
-32	16	26
-36	22	20
24	-20	-12
18	-62	44
-26	-68	42
8	-60	28
58	-30	4
-8	52	-2
4	40	6
-8	-54	32
-40	-44	22
-56	-16	10
-48	-22	14
-56	-4	0
-4	58	14
6	-62	28
-54	12	2
-58	-16	12
-48	-24	16
64	-10	10
56	-12	10
54	-30	4

// Carpenter-Thompson J R, 2014: Hearing Loss (HL)
// Subjects=12
-18	-58	42
12	-66	44
46	-62	22
36	-58	42
-44	-36	26
-36	42	20
-34	-68	20
6	54	4
-4	52	2
-4	38	4
8	-60	28
44	-60	22
42	30	18
-14	34	26
16	-64	44
-18	-58	40
-8	32	6
14	42	6
62	-8	12
56	-22	12
58	4	-10
48	10	-6
56	8	-20
8	54	18
8	62	16
-26	-16	-4
-52	-6	4
-54	2	-4
-54	-14	52
10	8	4

// Carpenter-Thompson J R, 2014: Normal Hearing (NH)
// Subjects=12
-18	-58	42
12	-66	44
46	-62	22
36	-58	42
-44	-36	26
-36	42	20
-34	-68	20
6	54	4
-4	52	2
-4	38	4
-26	-68	42
4	-22	26
-32	16	26
-36	22	20
24	-20	-12
18	-62	44
-26	-68	42
44	-60	22
42	30	18
-14	34	26
16	-64	44
-18	-58	40
58	2	-8
64	-10	12
66	-26	6
-54	-6	0
-50	-22	16
-8	34	6
4	38	4
18	-20	-24
4	58	20
-54	-10	-2
-56	-2	-14
58	-8	-8
62	-16	-2
64	-10	12

// Seydell-Greenwald A, 2012: Tinnitus
// Subjects=20
13.79	16.59	-12.31
13.79	17.65	-12.4

// Boiteau T W, 2014: Normals: Experiment 1
// Subjects=19
-46	-70	-40
14	-86	-16
14	-86	-18
12	-88	-21
-40	-81	-41
-41	-79	-41
24	-64	30
-17	-61	30
27	-74	42
32	-72	42
-25	-64	28
-35	-54	24

// Boiteau T W, 2014: Normals: Experiment 2
// Subjects=28
26	-100	-4
48	-86	-8
38	-66	-12
2	-106	-12
2	-104	-12
58	-72	-8
-36	-80	-20
-18	-76	-14
-34	-88	-20
-36	-70	-18
-30	-86	10
-4	-98	-4
58	-70	-4
42	-66	-16
44	-74	-14
26	-84	-16
48	-70	-14
28	-70	-14
-26	-106	-10
-22	-104	-8
-32	-96	-8
-30	-100	-10
-44	-88	-10
-36	-88	-20

// Hammer A, 2011: All Conditions> Baseline
// Subjects=10
-47.89	14.9	26.46
47.32	5.58	35.07
-53.32	-9.13	5.12
-58.57	-38.94	5.45
-0.01	40.51	9.26

// Matchin W, 2014: Long > Short
// Matchin W, 2014: Interaction: Long > Short and BA > WH
// Matchin W, 2014: BA > WH
// Matchin W, 2014: WH > BA
// Matchin W, 2014: BA-Long > BA-Short
// Matchin W, 2014: (Long > Short) > ART
// Subjects=26
-52.21	19.91	22.74
-39.4	8.9	16.83
-46.82	-3.75	19.09
-54.62	-.54	-21.24
-48.7	-63.69	28.6
53.25	9.37	-26.65
-2.76	-54.7	30.66
56.02	-63.07	27.34
-42.4	-0.07	38.8
-52.23	20.79	20.44
54.61	-27.15	-3.53
3.6	18.32	52.34
-3.92	-82.06	7.32
13.36	-85.61	28.61
-8.06	-90.57	21.46
-51.37	24.12	-5.5
-54.4	21.5	15.94
-58.6	-33.74	3.9

// McMillan C T, 2012: Undetermined (Gender-Biased and Gender-Neutral) > 
// Directly Determined (Explicit decision)
// McMillan C T, 2012: Undetermined (Gender-Biased and Gender-Neutral) > 
// Directly determined (Passive reading)
// McMillan C T, 2012: Gender Neutral > Directly Determined
// McMillan C T, 2012: Gender Biased > Directly determined
// McMillan C T, 2012: Gender Biased > Gender Neutral
// McMillan C T, 2012: Gender Neutral > Gender Biased
// McMillan C T, 2012: Indirectly determined > Directly determined
// Subjects=16
54	22	17
-54	20	8
-44	-50	14
54	-53	28
-55	28	13
-36	12	40
-48	-37	0
54	22	17
-44	16	18
-48	-44	7
-14	-95	1
-4	35	35
48	-48	21
22	-93	5
-57	-11	-18
52	25	-6
36	-91	8
-6	23	39
-40	-59	23
55	20	17
-57	20	8
-2	39	37
-46	-46	8
-38	6	44
-10	16	51
52	-50	21
-55	-1	13
-20	2	4
20	-13	56
-10	-33	48
-14	34	11
-48	30	13
50	22	21
16	-97	7
-18	-95	5
-51	33	-10
-30	-93	3
34	15	21

// Santi A, 2010: Conjunction Analysis of areas responsive to both embedding 
// position and movement type: (DMDE - SMSE) and (SMDE - SMSE) and (DMSE 
// -SMSE)
// Santi A, 2010: Conjunction Analysis of areas responsive to movement type 
// only: (DMDE - SMSE) and (DMDE - SMDE) and (DMSE - SMSE) and (DMSE -SMDE)
// Subjects=17
-42.52	14.14	29.81
52.59	25.71	33.32
-54.34	-34.95	1.72
-50.21	32.81	10.49

// Santi A, 2012: [(WHO-WHS) & (PAR-WHS) & (PRO-WHS)]
// Santi A, 2012: Wh-Object (WHO) > Wh-Subject (WHS)
// Santi A, 2012: Parasitic (PAR) > Pronoun (PRO)
// Santi A, 2012: PRO > WHO
// Subjects=14
-48.18	41.57	-.31
41.57	-.93	-21.2
26.68	53.62	11.2
27.84	1.84	2.15
23.48	-18.84	-17.25
12.68	28.22	-13.27
-23.43	1.71	4.98
-33.33	36.14	-16.75
-42.78	48.72	9.07
-50.99	7.2	37.18
-53.51	-2.3	-16.64
-57.73	9.28	-4.18
-53.46	-12.79	-14.65
31.96	36.51	-4.15
-41.34	4.25	39.54
-44.42	-40.61	37.76

// Wang C, 2013: Independent > Calculation
// Wang C, 2013: Interdependent > Calculation
// Wang C, 2013: Control > Calculation
// Wang C, 2013: Interdependent > Independent
// Wang C, 2013: Control > Independent
// Subjects=18
10	60	8
4	-48	24
-52	-4	-10
6	44	-10
4	-44	24
-68	-34	2
52	2	-24
46	-54	28
6	62	8
4	-46	24
46	-54	28
12	32	34
-24	54	12
-36	22	34
26	-44	-26
22	-60	-36
0	38	52
-24	48	30
-38	4	14
18	-90	30

// Wei W, 2014: Frequency Adverbs > Baseline
// Wei W, 2014: Quantity Pronouns/Nouns > Baseline
// Wei W, 2014: Animal Names > Baseline
// Wei W, 2014: Arabic Digits > Baseline
// Wei W, 2014: Number Words > Baseline
// Wei W, 2014: Dot Arrays > Baseline
// Subjects=20
27	-93	6
-18	-99	0
-21	-90	3
-6	15	51
-42	6	33
-27	-3	48
-45	21	27
39	3	66
30	0	51
39	-3	48
-27	-54	42
-45	-39	42
24	-96	6
18	-102	12
-21	-99	9
-42	3	30
-30	24	3
-33	0	48
30	-60	48
42	-42	45
45	3	30
33	-3	39
33	-3	48
-27	-60	45
-27	-48	39
-3	-72	45
24	-96	3
9	-75	-27
-24	-93	9
27	-60	45
21	-72	57
39	-42	42
-45	9	30
-45	21	27
-27	-3	51
-27	-63	48
27	-60	48
-15	-99	9
-24	-3	51
-45	6	27
-9	12	51
30	21	3
-30	21	3
-30	27	12
-27	-63	51
-27	-54	45
-33	-48	42
-45	6	27
-30	21	6
-45	21	27
-6	9	54
12	12	51
9	21	48
-27	-3	51
-39	0	63
-15	-99	9
15	-102	12
18	-99	0
51	9	27
60	12	39
-45	6	27
48	33	24
-6	15	51
9	18	51
36	-3	51

// Yokoyama S, 2012: All conditions > Baseline
// Subjects=15
-45	18	21
-48	24	15
-54	18	27
-33	27	-12
-57	-45	-3
-6	18	45

// Yu X, 2013: (Concrete Classifier (CCL) - Concrete Aspect (CASP)) and 
// (Abstract Classifier (ACL) - Abstract Aspect (AASP))
// Yu X, 2013: (CASP-CCL) and (AASP-ACL)
// Subjects=20
-15	-93	-9
9	-87	0
-39	12	30
-33	30	-15
27	27	-9
-6	27	45
-57	-48	12
-57	-48	12

// Dinomais M, 2013: Passive Movements > Rest
// Dinomais M, 2013: Video-guided passive movement > Nonvideo-guided passive 
// movement
// Dinomais M, 2013: Nonparetic hand movement > Paretic hand movement
// Dinomais M, 2013: Paretic hand movement > Nonparetic hand movement
// Subjects=18
39	-18	57
45	-27	60
48	-27	24
54	-18	18
-39	-18	60
-51	-30	27
-60	-21	18
27	-15	72
9	-6	60
48	3	9
51	-9	51
-18	-51	-21
21	-48	-24
18	-51	-21
15	-81	9
21	-66	-21
-18	-72	-6
6	-75	12
12	-69	-12
-3	-60	-6
18	-75	0
18	-60	-3
51	-63	3
-21	-57	-51
-9	-75	-42
-42	-66	6
24	-57	-51
15	-21	6
-18	-24	9
48	-72	-3
-45	-72	3
-45	-75	-3
-39	-75	-15
9	-87	0
39	-78	-18
-6	-90	-3
45	-57	-24
45	-72	-21
6	-75	12
24	-81	-15
21	3	66
15	21	63
6	-48	66
9	-72	51
33	-60	51
30	-51	48
39	-18	57
36	-30	69
24	-42	75
-18	-48	-24
-21	-57	-51
9	-15	51
51	-18	24
-39	-21	60
-36	-33	69
-9	-18	54
-18	-51	66
18	-48	-21
27	-33	-36
27	-57	-42
24	-45	-51
9	-63	-39
21	-57	-45
15	-60	-45
-45	-18	21
-15	-24	6

// Eck J, 2011: Migraine
// Subjects=10
16	-84	-16
-46	48	-8
50	50	-6
-4	16	54
-24	36	-16
-26	30	-14
38	-36	-18
-34	-80	-20
-44	6	30
50	10	30
-6	14	50
40	-22	30
-8	-60	56

// Eck J, 2011: Healthy Controls (HC)
// Subjects=10
-14	-88	-12
-40	26	10
-6	10	56
-56	-54	-8
8	-58	40
60	-62	16
-26	30	-14
38	-36	-18
-34	-88	-8
-44	6	30
52	4	46
-4	8	56
-48	-66	20
-6	-56	16

// Ferraro S, 2012: Medication Overuse Headache (MOH)
// Subjects=8
7	22	31
-5	22	31
37	36	33
-36	29	28
15	8	6
-19	7	3
11	49	9
-10	49	4
2	-14	-12
8	-50	36
14	46	9
8	-14	-12
8	-50	36
8	-17	-3
-11	49	3
17	49	2
8	-53	36

// Ferraro S, 2012: Detoxified Medication Overuse Headache (D-MOH)
// Subjects=8
10	24	29
-8	25	30
45	14	12
-39	41	22
16	7	9
-18	6	6
11	49	9
-10	49	4
2	-14	-12
8	-50	36
-11	49	3
17	49	2
8	-53	36
2	-14	-12

// Ferraro S, 2012: Chronic Migraine (CM)
// Subjects=8
8	23	30
-7	21	31
42	32	28
-37	19	33
7	-15	-10
-9	-15	-10
16	7	9
-15	8	9
11	49	9
-10	49	4
2	-14	-12
8	-50	36
8	-17	-3
11	49	9
-1	52	3

// Ferraro S, 2012: Healthy Controls (HC)
// Subjects=8
9	27	32
-4	27	33
33	23	10
-30	49	24
9	-14	-9
-5	-14	-10
16	10	9
-18	6	9
11	49	9
-10	49	4
2	-14	-12
8	-50	36
14	46	9
8	-14	-12
8	-50	36
2	-14	-12
11	49	9
-1	52	3

// Bhattacharyya S, 2012: Delta9-THC > Placebo: Oddball > Control
// Bhattacharyya S, 2012: Delta9-THC < Placebo: Oddball > Control
// Bhattacharyya S, 2012: CBD > Placebo: Oddball > Control
// Bhattacharyya S, 2012: CBD < Placebo: Oddball > Control
// Bhattacharyya S, 2012: Delta9-THC< Placebo <CBD: Oddball > Control
// Bhattacharyya S, 2012: Delta9-THC> Placebo >CBD: Oddball > Control
// Bhattacharyya S, 2012: Delta-9-THC, Placebo, and CBD: Oddball > Control
// Subjects=15
39.32	47.33	-16.29
43.73	45.55	1.65
12.71	69.14	6.72
31.75	55.23	-23.56
15.81	72.45	-5.86
20.27	21.72	-1.66
27.97	-1.19	18.01
47.18	-4.67	12.51
27.95	-21.16	7.42
24.83	-17.07	19.38
43.91	-26.24	-4.6
39.49	12.86	-7.83
51.4	-5.16	5.81
24.77	-13.27	13.49
-18.35	35.35	-14.63
-22.31	2.31	12.72
-22.46	29.29	3.77
-13.87	17.71	4.64
-22.18	-32.58	15.65
-29.72	-42.03	4.26
-29.77	-42.54	-2.39
-17.99	-33.5	3.41
-18.01	-42.47	-2.53
31.83	60.4	-11.73
31.88	60.91	-5.08
43.52	51.07	-23.35
43.71	52.95	1.03
55.37	27.87	-21.54
43.72	24.52	-8.86
31.8	31.53	-27.15
-13.94	24.68	-1.52
20.46	7.23	17.4
-22.37	6.03	5.72
27.87	2.1	5.47
-53.18	7.73	30.47
-33.34	55.78	-10.59
-13.8	38.2	21.88
-33.03	-38.76	-8.24
32.17	-42.6	-8.67
-29.98	-11.76	-17.23
32.25	-37.43	3.16
27.71	-7.19	-18.28
47.3	-24.34	19.73
-32.98	-1.98	13.21
-18.04	-9.81	7
12.98	-4.88	12.92
39.51	-44.01	-27.6
24.55	-68.31	-37.65
31.96	-61.29	-43.9
47.61	-45.2	52.71
55.66	-50.37	-14.98

// Bourque J, 2013: Schizophrenia
// Subjects=14
46	-60	-10
-46	-66	-7
49	-70	4
42	-74	-7
-38	-77	4
14	-98	10
7	-91	10
35	-38	-24
-42	-80	0
-42	-49	-32
-18	-7	-21
-60	-21	35
-52	-35	38
46	-56	-21
60	-35	10
-4	-91	28
7	-98	14
52	28	18
-35	-77	-21
4	-32	7
-46	-56	7
49	-42	-10
49	-56	24
35	-18	0
-60	-28	21
52	24	-4
21	-32	10
42	0	4
46	-56	21
0	-94	7
60	18	24

// Bourque J, 2013: Cannabis Use Disorder and Schizophrenia
// Subjects=14
42	-77	-14
-14	-102	7
-4	-88	38
46	24	-18
52	28	18
49	0	52
21	-21	-10
18	-70	63
-35	-18	70
63	-4	-24
10	-84	-14
0	-94	4
46	-56	-24
52	28	32
46	21	21
18	-10	-14
46	-56	-21
60	-35	10
-4	-91	28
7	-98	14
52	28	18
-35	-77	-21
4	-32	7
-46	-56	7
49	-42	-10
49	-56	24
35	-18	0
-60	-28	21
52	24	-4
21	-32	10
42	0	4
46	-56	21
0	-94	7
60	18	24

// Bourque J, 2013: Healthy Controls
// Subjects=21
46	-70	-7
42	-46	-18
-42	-52	-14
-46	-74	4
-46	-74	-7
42	35	-10
24	-7	-10
-28	-4	-14
52	21	28
42	4	32
-10	-91	-14
32	-32	7
24	-28	0
-10	-102	7
10	-94	7
42	-46	-18
32	-32	0
-18	-10	-10
18	-18	21
-21	-18	18
56	21	32
46	4	32
-24	0	-10
38	32	10

// Schwedt T J, 2014: Migraine > Healthy Controls
// Schwedt T J, 2014: Migraine < Healthy Controls
// Subjects=24
-2	-8	32
-22	2	-2
22	12	4
46	-22	26
-36	-50	-12
42	2	54
-38	-20	-10
34	12	24
12	-16	-10
64	-50	8
-14	-18	70

// Havrankova P, 2010: Active: After real rTMS > Before real rTMS
// Havrankova P, 2010: Passive: After real r-TMS > Before real r-TMS
// Subjects=11
-32	-48	60
-46	-52	42
-6	-58	62
4	-22	68
26	-36	64
46	-40	58
50	-58	40
32	18	6
-36	-56	60
40	-54	58

// Bannbers E, 2012: Premenstrual dysphoric disorder (PMDD)
// Subjects=14
62.16	-29.79	36.52
-55.58	-26.81	40.47
40.68	-22.34	48.48
-14.44	-54.42	41.39
31	-50.55	45.83
-43.76	-37.07	33.44
20.55	21.71	4.12
-44.26	-7.96	0.32

// Bannbers E, 2012: Healthy Controls (HC)
// Subjects=13
62.16	-29.79	36.52
-55.58	-26.81	40.47
40.68	-22.34	48.48
-14.44	-54.42	41.39
31	-50.55	45.83
-43.76	-37.07	33.44
20.55	21.71	4.12
-12.69	-32.34	13.4
-18.92	-22.12	-49.14

// Carrillo B, 2010: Male-to-female transsexuals
// Subjects=18
-24	-72.98	50.11
-20.66	-58	60.89
-7.75	-49.55	58.72
34.27	-30.56	52.76
40.92	-32.59	65.18
24.73	-44.55	64.39
-42.63	-23.57	39.93
7.21	62.65	-16.51
-15.35	60.21	-6.92
-12	62.11	1.8
23.77	31.4	4.23
17.4	28.91	12.43
23.9	22.55	12.95
20.26	53.43	-12.46

// Carrillo B, 2010: Control females
// Subjects=19
1.33	-36.86	10.24
-5.26	-45.36	-0.01
-42.63	-23.57	39.93
7.21	62.65	-16.51
-15.35	60.21	-6.92
-12	62.11	1.8
23.77	31.4	4.23
17.4	28.91	12.43
23.9	22.55	12.95
20.26	53.43	-12.46

// Carrillo B, 2010: Control males
// Subjects=23
1.33	-36.86	10.24
-5.26	-45.36	-0.01
-24	-72.98	50.11
-20.66	-58	60.89
-7.75	-49.55	58.72
34.27	-30.56	52.76
40.92	-32.59	65.18
24.73	-44.55	64.39

// Dickey C C, 2010: Schizotypal Personality Disorder (SPD)
// Subjects=16
56	-40	4
-52	-10	4
-18	-26	-20
-46	-6	52
-2	-4	66
56	4	28
42	-6	46
38	-20	60
-38	30	-4

// Dickey C C, 2010: Healthy Controls (HC)
// Subjects=13
64	-20	-8
-50	-26	-2
-52	-44	14
24	-74	58
-46	16	26
10	6	62
-34	26	2

// Huang J, 2013: All Participants: Happiness appearing > Mosaic
// Huang J, 2013: All Participants: Happiness disappearing > Mosaic
// Huang J, 2013: All Participants: Praise > Blame
// Huang J, 2013: All Participants: Happiness appearing > Disappearing
// Huang J, 2013: All Participants: Incongruent (Happiness appearing with 
// blame and happiness disappearing with praise) > Congruent (Happiness 
// appearing with praise and happiness disappearing with blame)
// Subjects=14
46	-70	-10
-40	-80	-12
-42	-48	-22
6	-70	8
8	-36	2
48	-72	-10
48	36	14
-44	-80	-10
28	-58	-4
34	22	16
10	-4	2
62	-20	42
42	-44	18
-16	-8	-2
-30	22	6
-20	-62	44
-26	44	36
24	-46	44
44	-48	38
26	-30	38
-22	-52	14
26	-76	-6
16	54	48
-2	-56	6
58	26	32
-22	-38	76
-8	-30	14
18	68	28
10	-2	76
-36	-76	-44
-6	16	2
-20	-88	-26
50	-78	26
24	-20	-8
-44	24	-20
-34	-86	42
-34	30	54
0	-96	12
40	20	-22
20	32	60

// Kim S, 2014: Fragile X Premutation
// Subjects=18
-54	-60	28
-54	-66	34
-42	-52	30
-42	-66	44
-36	-68	44
-50	-74	18
-40	-74	34

// Kim S, 2014: Healthy Controls
// Subjects=18
12	-56	36
-10	-58	30
-4	-82	8
14	-78	32
-12	-54	28
14	-36	28
-56	-40	42
-40	-60	30
-38	-60	22
-56	-50	34
-50	-56	16
56	-46	38
58	-58	14
50	-60	22
52	-38	26
54	-42	46
48	-68	34
52	-38	22
64	-26	40
64	-32	38
32	-60	60
28	-30	18
48	-24	52
20	-2	20
42	-40	16
16	-22	6
14	-52	38
58	-26	24
-14	-52	8
-24	-24	4
-36	-30	-16
-24	-28	-20
-40	-20	8
-60	-4	-2
-36	-58	22
-38	-26	42
-44	-16	60
-42	-26	28
-36	-50	26
-8	-38	46
-34	-8	22

// Taylor J J, 2013: Subgroup of Normals, Naloxone
// Subjects=7
17.66	38.54	35
63.4	-41.72	46.65
-24.04	-82.45	-39.72
-34.61	-85.08	-21.35
23.81	-64.59	-12.05

// Taylor J J, 2013: Subgroup of Normals, Saline
// Subjects=7
-8.57	53.7	14.9
-29.43	47.84	-12.18
22.66	45.43	5.1
-48.68	-3.28	-6.79
-1.87	-85.77	3.93
-49.61	2.21	6.13
25.59	1.94	56.42
54.18	-32.93	3.35
6.53	34.94	8.65
-7.76	-24.9	-22.16
22.93	-27	11.14
19.36	-17.39	-12.16
4.32	-76.98	-17.21
33.64	-40.76	1.12

// Jungblut M, 2012: Conjunction: Common activation for all three conditions
// Jungblut M, 2012: Regression: Effects of Complexity
// Jungblut M, 2012: Vowel changes with regular groupings and rests > Vowel 
// changes with regular groupings
// Jungblut M, 2012: Vowel changes with irregular vowel changes > Vowel 
// changes with regular groupings
// Jungblut M, 2012: Vowel changes with irregular vowel changes > Vowel 
// changes with regular groupings and rests
// Subjects=30
-.3	14.17	62.37
-59.09	1.82	25.38
-56.98	-4.01	20.31
-4.94	16.12	37.61
6.18	14.19	62.26
55.49	-.55	28.14
61.85	-3.7	17.14
14	-37.93	-13.4
23.65	6.44	-10.11
14.24	-3.32	12.31
-47.75	17.47	-14.47
-32.55	26.87	-6.69
-8.14	23.01	42.58
33.25	24.14	-16.51
32.18	20.95	-16.17
-34.73	21.23	-9.46
-46.01	11.51	36.52
36.54	21.27	-12.92
53.13	41.67	20.64
43.99	-44.77	49.52
-31.53	24.22	-12.05
-29.36	22.1	-11.88
-43.93	10.9	29.82
-37.9	57.87	3.78
-2.77	22.82	40.27
-37.09	-42.18	47.28
-24.03	-54.58	51.65
-37.89	-67.87	-20.76
36.49	24.15	-16.56
33.29	21.16	-13.97
49.95	43.24	26.14
30.95	15.89	56.07
7.75	31.63	19.05
40.81	-47.66	53.22
27.74	-51.73	44.88
46.41	-73.95	-21.59
-34.77	24.21	-11.99
-30.44	21.04	-11.75
-40.75	7.2	24.53
-8.14	23.01	42.58
33.25	24.14	-16.51
25.72	22.19	-13.94
7.87	33.62	28.93

// Kleber B, 2013: Singer
// Subjects=14
-42	-15	36
45	-9	36
-42	-15	33
48	-9	30
63	3	3
-57	-6	15
-3	-3	60
51	-6	39
-54	-6	39
-57	3	15
45	-18	3
-39	-33	15
-36	6	12
48	6	3
27	-3	-6
-24	-6	-3
21	9	3
-24	0	9
-9	3	45
12	-15	3
-42	-15	36
45	-9	36
60	0	15
-54	-3	24
-54	-6	15
66	-24	18
-3	-3	60
54	-3	48
-51	-9	48
-51	9	3
63	-27	9
-39	-36	15
48	6	3
24	-6	-6
27	-6	-6
-42	-12	33
48	-9	39
-45	12	30
48	-3	-3
-33	-45	-39
15	-39	-51
27	0	-3
-3	-15	6

// Kleber B, 2013: Nonsinger
// Subjects=12
-42	-15	36
45	-9	36
-42	-15	33
48	-9	30
63	3	3
-57	-6	15
-3	-3	60
51	-6	39
-54	-6	39
-57	3	15
45	-18	3
-39	-33	15
-36	6	12
48	6	3
27	-3	-6
-24	-6	-3
21	9	3
-24	0	9
-9	3	45
12	-15	3
-42	-15	36
45	-9	36
60	0	15
-54	-3	24
-54	-6	15
66	-24	18
-3	-3	60
54	-3	48
-51	-9	48
-51	9	3
63	-27	9
-39	-36	15
48	6	3
24	-6	-6
27	-6	-6
-15	3	-3
-15	-18	9
15	-6	-6

// Golfinopoulos E, 2011: normal speech > baseline
// Golfinopoulos E, 2011: perturbed non-speech > baseline
// Subjects=13
-6	-12	74
-56	-12	50
-62	-4	34
-58	-10	40
-56	-10	10
62	-6	46
46	-12	42
60	-6	36
66	-4	30
52	-12	58
44	6	6
48	-12	22
-4	6	46
-6	-2	46
-2	24	28
-8	4	76
10	2	48
0	-2	68
2	20	36
-46	-38	26
48	-30	22
-48	-20	10
-68	-32	10
56	8	-6
48	-20	10
68	-22	2
60	-14	4
-40	-6	8
36	4	4
-12	-54	-18
-26	-60	-22
18	-56	-18
-22	0	-6
-24	-6	8
-12	-18	8
-14	-20	-2
18	0	4
30	-12	6
24	-12	20
10	-12	10
18	-22	-2
-44	-14	62
-62	-2	36
-58	-10	42
-46	-10	22
8	-8	72
64	6	28
62	-8	36
44	-4	12
48	-10	18
4	0	52
2	-4	60
2	8	40
-64	-22	30
-46	-36	24
60	-22	26
56	-32	28
-42	-18	6
-56	-42	22
42	-24	14
44	-10	-6
58	-58	-2
-38	-4	14
46	-2	-2
-22	-58	-24
-16	-60	-52
20	-58	-24
-24	2	-4
24	0	-10
12	-12	10

// Azevedo R T, 2013: Normals
// Subjects=27
-58	-26	38
-38	-50	58
62	-18	36
34	-58	58
28	-52	52
54	-32	42
-60	8	28
62	12	16
-48	76	4
-44	-70	0
-36	-70	-20
32	-80	26
48	-70	2
24	-90	-14
32	-90	-4
-48	-76	-14
46	-70	-10
-30	20	-2
0	34	28

// Baumgartner T, 2012: Behavior DC: Outgroup > Ingroup, p<0.005
// Baumgartner T, 2012: Behavior DC: Outgroup > Ingroup, p<0.0005
// Baumgartner T, 2012: Behavior DC: Ingroup > Outgroup, p<0.005
// Baumgartner T, 2012: Behavior DC: Ingroup > Outgroup, p<0.0005
// Baumgartner T, 2012: All Behaviors: Outgroup > Ingroup, p<0.005
// Baumgartner T, 2012: All Behaviors: Outgroup > Ingroup, p<0.0005
// Baumgartner T, 2012: All Behaviors: Outgroup > Ingroup, p<0.00005
// Baumgartner T, 2012: All Behaviors: Ingroup > Outgroup, p<0.005
// Baumgartner T, 2012: All Behaviors: Ingroup > Outgroup, p<0.0005
// Baumgartner T, 2012: All Behaviors: Ingroup > Outgroup, p<0.00005
// Subjects=16
27	-6	36
33	-6	21
-24	30	3
15	-21	18
-21	-24	12
-18	-30	18
27	-12	45
-15	39	3
6	0	-9
-51	27	-3
-48	27	-18
-36	6	60
-12	30	27
-6	39	9
54	15	15
36	24	6
51	24	3
-36	18	3
6	-12	-18
6	21	18
63	-3	24
66	-3	15
60	3	-21
57	-6	-9
63	0	-6
-45	-12	-30
-33	-6	-24
6	-24	63
12	54	-15
-57	-6	27
63	-21	-3
42	-54	-15
-33	-6	-24
-57	-27	3

// Bruneau E G, 2010: Subgroup of Normals, Jewish Israeli
// Subjects=16
0	-64	36
62	-52	30
-46	-54	30
4	64	20
46	-64	42
56	0	-36
46	26	38
-40	-58	42
-52	6	-54
50	32	16
48	-58	-6
-50	-60	-12
30	-56	8
28	-94	8
-44	36	24
-22	52	14
-50	-54	48
-40	16	50
44	14	52
-6	30	40

// Bruneau E G, 2010: Subgroup of Normals, non-Israeli Arab
// Subjects=16
8	-56	30
-4	-54	20
-48	-62	24
-2	52	28
32	18	-24
-28	14	-22
8	18	70
-62	-26	-8
-2	-12	8
-4	50	-10
46	-48	-18
6	-38	-4
-36	-44	-2
8	2	46
-26	-48	54
42	-70	16
-2	-54	34
-56	-52	30
46	-58	38
-52	-60	46
48	36	26
6	56	32
6	32	58

// Bruneau E G, 2012: All Participants: Physical Pain > Control
// Bruneau E G, 2012: All Participants: Emotional Pain > Control
// Bruneau E G, 2012: All Participants: All Physical Pain > All Emotional Pain
// Bruneau E G, 2012: All Participants: All Emotional Pain > All Physical Pain
// Bruneau E G, 2012: All Participants: South American Physical Pain > Control
// Bruneau E G, 2012: All Participants: South American Emotional Pain > 
// Control
// Bruneau E G, 2012: All Participants: Emotional Suffering of Conflict Group 
// > Ingroup
// Subjects=10
0	6	30
-38	-6	-10
40	8	-18
-62	-24	30
68	-26	32
-50	-66	0
-10	48	20
-2	56	-10
-8	-50	40
-56	-58	30
54	-60	30
-58	-20	-14
58	-18	-16
-2	4	34
-38	-8	-12
38	-2	16
-62	-34	38
62	-34	36
-58	-66	-6
-8	48	20
-4	54	-6
0	-56	32
-48	-62	28
50	-64	24
-62	-12	-20
58	-6	-18
-64	-30	30
66	-26	34
-58	-58	-4
-4	54	28
-2	56	-10
-2	-56	32
-54	-60	24
48	-62	24
-64	-12	-18
52	-16	-12
-26	-66	32

// Cheon B K, 2011: All Participants: Ingroup Bias in empathy [(Ingroup Pain > 
// Ingroup Neutral) > (Outgroup Pain > Outgroup Neutral)]
// Cheon B K, 2011: All Participants: Outgroup Bias in empathy [(Outgroup Pain 
// > Outgroup Neutral) > (Ingroup Pain > Ingroup Neutral)]
// Cheon B K, 2011: Caucasian > Korean: Ingroup Bias in empathy [(Ingroup Pain 
// > Ingroup Neutral) > (Outgroup Pain > Outgroup Neutral)]
// Cheon B K, 2011: Korean > Caucasian: Ingroup Bias in empathy [(Ingroup Pain 
// > Ingroup Neutral) > (Outgroup Pain > Outgroup Neutral)]
// Subjects=13
-6	-66	18
30	-51	-6
12	-54	9
-24	-51	-6
-21	-81	18
33	-75	18
-9	60	30
42	-42	48
-36	-45	45
27	-81	30
-48	36	9
27	27	42
15	-66	3
-42	-51	42
57	-42	45
3	-24	39
-54	-63	15
-54	-54	-3

// Contreras-Huerta L S, 2013: Pain > Non-painful touch
// Contreras-Huerta L S, 2013: (Pain > touch of same race) > (Pain > touch of 
// other race)
// Subjects=20
36	28	2
-28	22	-12
-8	20	42
-10	30	26
-38	-24	56
-60	-22	28
-32	-52	46
-56	10	10
-42	-66	-10
36	-60	-28
-28	24	8

// Contreras J M, 2013: Normals
// Subjects=17
0	-61	-16
-28	15	-20
20	61	-6
4	-29	34
-16	33	-8
14	35	-12
-12	-57	-32
-20	-31	44
-16	-45	22
-18	-81	2
48	-53	34

// Contreras J M, 2013: Subgroup of Normals, n=16
// Subjects=16
38.8	-44.3	-18.5
-37.1	-47.6	-17.3
49.8	-43.4	13.9
23.4	-39.5	-7.4
-24.1	-42.9	-4.8

// Contreras J M, 2013: Subgroup of Normals, n=14
// Subjects=14
33.3	-76.7	-8.9

// Contreras J M, 2013: Subgroup of Normals, n=11
// Subjects=11
-33.1	-77	-6.55

// Contreras J M, 2013: Subgroup of Normals, n=10
// Subjects=10
-42	-63.7	-6.7

// Contreras J M, 2013: Subgroup of Normals, n=9
// Subjects=9
-49.8	-52.8	21.3

// Contreras J M, 2013: Subgroup of Normals, n=8
// Subjects=17
40.5	-66.3	-5

// Earls H A, 2013: Own-race > Other-race
// Subjects=20
58	-26	28
-58	-30	26
46	-68	2
-46	-72	4
-30	-46	44

// Ebner N C, 2013: Normals
// Subjects=62
15	51	24
-39	51	0
21	45	9
9	39	42
-36	27	36
18	12	3
-36	6	-3
60	3	-18
-54	-30	-3
-45	-69	24
-45	-75	0

// Falk E B, 2012: my candidate > opponent, p<0.005
// Falk E B, 2012: my candidate > opponent, p<0.05
// Falk E B, 2012: opponent > my candidate, p<0.005
// Falk E B, 2012: opponent > my candidate, p<0.05
// Subjects=23
-3	-24	36
-3	-30	-27
6	-24	30
63	-51	36
-63	-36	36
60	6	12
39	12	12
39	12	12

// Feng L, 2011: Chinese faces > Caucasian faces
// Subjects=30
44	26	20
6	20	46
42	10	18
44	6	26

// Fox G R, 2013: Pain-Hateful > Pain-Likeable
// Subjects=16
6.63	20.95	30.9
-10.49	27.19	30.57
-32.08	8.37	-4.4
-31.75	-11.26	30.7
19.98	-36.17	75.68
-15.27	-32.95	79.17
-41.65	31.8	10.47
28.9	45.69	18.53
-5.8	-8.03	70.28
-41.29	9.25	49.16
-60.87	-7.66	-2.73
-25.01	-57.27	54.55
-6.02	-86.13	9.92
-29.94	8.38	-4.43
28.92	6.34	5.11
-12.73	19.55	14.51
12.9	9.67	8.36
-13.04	-26.58	-45.18
-9.5	-49.36	-9.86
9.61	-50.53	-26.7

// Gilbert S J, 2012: White > Black Faces (Collapsed over Trait and Friendship 
// Judgments)
// Gilbert S J, 2012: Trait > Friendship
// Gilbert S J, 2012: Friendship > Trait
// Subjects=16
15	-91	10
-12	-82	-5
-42	-79	49
-36	-79	-20
30	-64	-20
63	-40	-14
24	-4	-38
51	17	46
-6	29	55
-3	65	22
-36	50	-17

// Hein G, 2010: high - low self pain
// Hein G, 2010: [high - low self pain] and [(high - low ingroup pain) and 
// (high - low outgroup pain)]
// Hein G, 2010: [high - low self pain] and [high - low ingroup pain]
// Hein G, 2010: [high - low self pain] and [high - low outgroup pain]
// Hein G, 2010: [high - low ingroup pain] versus [high - low outgroup pain]
// Hein G, 2010: [high - low ingroup pain]
// Hein G, 2010: [high - low outgroup pain]
// Hein G, 2010: [high - low ingroup pain] and [high - low outgroup pain]
// Subjects=16
-36	12	-9
-30	18	12
48	18	6
57	15	0
42	18	-9
33	12	12
33	-18	12
-9	45	12
-9	24	45
0	-9	45
39	-27	69
24	-42	69
27	-27	84
-12	-48	-21
15	-60	-33
9	-6	6
-6	-36	0
-51	15	-3
-51	36	3
-32	16	-9
-3	60	30
0	48	27
-6	39	24
6	-30	51
0	-18	42
-9	-39	9
3	-42	27
54	14	5
-6	-81	-15
-9	-33	0
-51	15	-3
-36	18	12
-38	17	-1
0	54	30
-6	36	27
6	-30	51
3	-21	45
6	-33	42
0	-42	30
45	18	9
-3	-66	-3
12	-36	42
0	-45	30
-6	57	30
-6	39	30
-24	9	-27
-50	-42	9
-50	-30	6
21	-93	6
-33	-78	12
-33	-66	-24
33	-42	-24
-15	-18	6
-39	12	15
-39	18	-3
-48	15	-3
-27	24	15
45	18	9
9	18	18
6	-27	39
-6	24	36
-6	-15	42
-30	18	-33
48	18	9
30	27	-9
-6	72	6
-27	6	-30
48	12	-27
21	0	-27
57	-18	-6
-55	-30	18
-18	-59	24
-48	-81	21
-12	21	3
12	-18	6
-24	63	24
36	36	0
12	-42	39
3	-42	27
-6	57	30
-12	39	21
-18	36	45
27	48	12
-51	42	6
-51	15	-3
-30	18	-12
-36	-6	-12
33	36	0
-6	51	33
-9	36	21
-3	-21	39
0	-45	30
-6	24	66
57	30	3
42	18	27
-30	18	-33
54	12	-30
57	6	-18
51	-42	12
-54	-69	21
-66	-6	-12
51	-69	3
36	-15	-24
-21	-9	-15
48	-69	-21
-6	-81	-15
-6	-27	0

// Losin E A R, 2012: Imitate Gesture: European American (EA) > Chinese Han 
// (CH)
// Losin E A R, 2012: Imitate Gesture: African American (AA) > EA
// Losin E A R, 2012: Imitate Gesture: AA > CH
// Losin E A R, 2012: View Portrait: EA > CH
// Losin E A R, 2012: View Portrait: EA > AA
// Losin E A R, 2012: View Portrait: CH > AA
// Losin E A R, 2012: View Portrait: AA > CH
// Losin E A R, 2012: Observe Gesture: EA > CH
// Losin E A R, 2012: Observe Gesture: AA >CH
// Losin E A R, 2012: [Imitate Gesture (EA > CH)] > Observe Gesture (EA > CH)]
// Losin E A R, 2012: [Imitate Gesture (AA>EA) > Observe Gesture (AA>EA)]
// Losin E A R, 2012: [Imitate Gesture (AA>EA) > View Portrait (AA>EA)]
// Losin E A R, 2012: [Imitate Gesture (AA>CH) > Observe Gesture (AA>CH)]
// Losin E A R, 2012: [Imitate Gesture (AA>CH) > View Portrait (AA>CH)]
// Subjects=20
-22	-34	48
14	-58	26
30	-34	-22
-2	-86	32
18	-72	-2
-18	-62	-6
-48	-74	-12
34	-86	30
-18	-24	0
14	-80	-42
-36	-48	-42
-6	18	46
42	42	14
-40	2	32
22	2	70
52	10	26
-46	32	22
-26	4	66
28	-56	50
54	-20	44
-48	-34	54
56	-56	-4
-44	-46	-14
-28	-72	-10
30	-72	-8
-30	-78	20
36	-72	24
-16	-52	-46
-44	2	34
24	-4	44
-20	14	56
-48	36	20
-28	52	0
38	24	46
42	0	2
54	-20	44
-24	-54	52
38	-50	42
10	-62	22
-18	-34	-6
42	-40	-22
-44	-46	-16
-58	-56	10
-30	-74	-10
32	-66	-10
-32	-74	20
-2	-90	34
36	-82	16
-16	16	6
20	-30	8
-16	-52	-46
2	-80	-26
50	38	16
62	10	22
60	-42	-12
34	-74	-12
-26	-82	-20
-8	-92	14
24	-82	28
-20	-76	44
52	14	26
54	38	8
-28	26	-6
46	0	56
8	14	44
-14	4	72
-36	10	36
-10	-50	28
58	-28	24
36	-42	-24
52	20	-16
-10	-94	4
10	-80	-32
-12	-82	40
62	-62	0
38	-84	32
10	-10	2
-28	-20	2
-20	-62	-46
0	40	-8
-2	-54	14
8	6	0
-14	0	20
24	-96	24
-12	-98	26
32	-44	-12
24	-76	-6
-20	-98	-4
42	-64	20
-10	-90	-32
28	-74	-12
26	-88	34
-28	-72	-6
-4	-84	42
22	-44	-10
2	-94	14
52	-74	12
-6	-78	24
42	46	14
40	4	32
48	-24	56
36	-52	60
-30	-60	-14
34	-84	0
-30	-80	20
44	-62	20
-34	-76	-42
46	10	32
0	20	46
-42	11	18
40	40	16
-50	6	44
18	0	68
30	-56	54
56	-20	48
-28	-54	52
-50	-26	48
36	-42	-22
66	-16	0
60	-54	10
-22	-38	-6
-32	-68	-10
36	-72	-10
-26	-78	26
30	-76	30
12	-54	-8
-14	-94	-6
-10	-12	4
-6	-74	-36
-48	30	16
-12	0	72
-6	24	46
-30	-42	38
52	-20	40
-60	-22	34
-18	-36	-4
-30	0	-20
-36	-70	-10
-30	-78	20
-26	-70	-44
30	-64	-38
-48	6	38
-22	24	52
2	46	-8
-56	22	8
-36	-88	30
-2	-48	38
40	-38	62
-24	-54	66
-50	-48	52
-50	-52	14
30	-50	-8
-32	-30	-18
26	-22	-20
-66	-26	-12
64	-48	-8
-28	-70	-10
6	-86	26
28	-70	56
-4	-72	-36
34	-72	-48

// Losin E A R, 2012: Imitate gesture: own gender > other gender
// Losin E A R, 2012: [Imitate gesture (own gender > other gender) > [Observe 
// gesture (own gender > other gender)]
// Losin E A R, 2012: [Imitate gesture (own gender > other gender) > [View 
// portrait (own gender > other gender)]
// Subjects=19
14	14	-8
18	18	-12
-8	14	-8
18	18	2
20	18	-2
16	14	-10
18	18	-12
20	16	6
16	4	-16
18	18	-10
28	20	-8
32	20	-6
14	16	-10

// Mathur V A, 2012: African American > Caucasian: Ingroup > Outgroup
// Mathur V A, 2012: Caucasian > African American: Ingroup > Outgroup
// Mathur V A, 2012: Ingroup > Outgroup
// Mathur V A, 2012: Outgroup > Ingroup
// Subjects=10
6	-11	14
0	-65	34
50	43	-5
0	54	28
0	-47	2
-33	22	-19
42	-65	-12
0	40	50
24	-79	-16
-45	46	-15
0	-13	39
-33	-47	-3
62	-34	21
-21	-57	-35
27	11	38
-21	50	9
24	34	-9
-42	-54	-33
24	-65	-22
-24	9	58
-24	2	30
36	36	26
15	-19	31
30	15	2
0	-10	39
-3	-50	47
-6	52	-3
-6	-8	9
-3	20	60
-3	25	29
0	40	50
-3	-49	8
65	-31	24
-33	-50	-3
-27	-44	49
65	-7	25
33	-44	-5
-27	-59	42
-36	-37	21
21	-48	25
27	14	38
27	-60	25

// Mathur V A, 2010: Pain > No Pain
// Mathur V A, 2010: Ingroup (Pain + No Pain) > Outgroup (Pain + No Pain)
// Mathur V A, 2010: Outgroup (Pain + No Pain) > Ingroup (Pain + No Pain)
// Mathur V A, 2010: Participant Race (AA > CA)] x [Target Race (Ingroup Pain 
// > Outgroup Pain)
// Mathur V A, 2010: Participant Race (CA > AA)] x [Target Race (Ingroup Pain 
// > Outgroup Pain)
// Mathur V A, 2010: Positive Correlation between Ingroup Pain > Outgroup Pain 
// and Behavioral Empathy
// Mathur V A, 2010: Positive Correlation between Ingroup Pain > Outgroup Pain 
// and Willingness to donate money
// Mathur V A, 2010: Positive Correlation between Ingroup Pain > Outgroup Pain 
// and Willingness to donate time
// Subjects=14
-30	-9	61
48	-33	46
-6	14	49
-50	7	27
-33	-54	-23
-6	-14	12
-48	14	-8
0	-46	8
53	7	30
39	18	2
-48	-70	3
30	-68	34
-45	36	23
-18	-80	-31
-6	37	-12
27	3	3
-3	-44	-8
-45	15	2
-15	-9	-5
0	13	24
-18	9	-3
-53	-17	9
-3	-50	47
0	58	3
30	48	25
0	-3	6
-30	55	-15
27	55	-3
-21	-12	-9
0	43	39
-3	-46	11
0	-12	42
-15	-8	17
-21	40	37
30	-47	-5
-33	-47	-5
21	-54	19
-56	-4	42
-56	-61	1
-27	-78	20
56	-12	42
56	-14	9
-18	-54	19
-42	-34	13
-48	2	50
-24	-72	-42
6	-33	35
-9	-36	38
21	-77	26
-50	-14	3
39	-28	15
18	-27	37
-12	57	30
21	62	11
30	48	31
-18	58	-8
18	2	-10
3	24	21
9	62	22
-9	57	30
-9	65	11
9	54	33
33	48	28
-9	57	33
21	65	11
18	51	36
6	62	22

// Molenberghs P, 2014: Reward > Neutral
// Molenberghs P, 2014: Reward In-group (RI) > Reward Out-group (RO)
// Molenberghs P, 2014: Shock > Neutral
// Molenberghs P, 2014: Positive Correlation between Perspective Taking Scores 
// and Shock > Neutral
// Molenberghs P, 2014: Positive Correlation between Psychopathy Scores and 
// Shock > Neutral
// Subjects=48
-27	8	1
27	5	-5
0	23	-5
-24	11	-2
27	5	-8
-3	26	-2
-3	53	28
-48	23	-8
45	29	-8
57	-25	-5
-3	56	25
-45	23	-8
48	26	-8
57	-22	-5
-6	53	31
-45	26	-5
42	32	-11
57	-25	-2

// Molenberghs P, 2014: My Team > Other Team
// Subjects=20
-9	41	25

// Morrison S, 2012: Social > non-social words, p<0.001
// Morrison S, 2012: Social > non-social words, p=0.022
// Morrison S, 2012: Social > non-social words, p=0.008
// Morrison S, 2012: Social > non-social words, p=0.005
// Morrison S, 2012: Social > non-social words, p=0.002
// Morrison S, 2012: Social > non-social words, p=0.015
// Morrison S, 2012: Social > non-social words, p=0.016
// Morrison S, 2012: My team > other team words, p=0.012
// Morrison S, 2012: My team > other team words, p=0.018
// Morrison S, 2012: My team > other team words, p=0.016
// Subjects=20
-45	-64	31
-3	-46	28
-3	44	-17
-63	-13	-14
-45	35	-5
-66	-34	1
-6	56	16
36	-64	43
-3	32	7
12	50	-5
-18	-1	52

// Baeken C, 2011: Positive > Neutral face
// Baeken C, 2011: Neutral > Positive face
// Baeken C, 2011: Negative > Neutral face
// Baeken C, 2011: Neutral > Negative face
// Baeken C, 2011: Positive > Neutral face, Before < After Intervention
// Baeken C, 2011: Negative > Neutral face, Before < After Intervention
// Baeken C, 2011: Positive > Neutral face, Interaction (Active > Sham rTMS) x 
// (Before > After Intervention)
// Baeken C, 2011: Negative > Neutral face, Interaction (Active > Sham rTMS) x 
// (Before > After Intervention)
// Baeken C, 2011: Positive > Neutral face, Before < After Intervention, 
// Active rTMS
// Baeken C, 2011: Positive > Neutral face, Before > After Intervention, Sham 
// rTMS
// Baeken C, 2011: Negative > Neutral face, Before > After Intervention, 
// Active rTMS
// Subjects=19
6	10	20
40	-82	-12
-44	-84	-10
16	-104	4
4	12	58
22	-54	54
26	-58	54
-22	-66	48
22	-54	54
26	-58	54
-22	-66	48
28	-92	-8
-42	-48	-20
4	14	58
-44	20	-20
-44	40	-14
-60	-52	30
28	-48	-6
56	32	-4
30	-40	10
6	6	22
-40	-36	56
-34	-14	28
-62	-38	26
-28	42	8
14	-28	44
-20	14	40
-28	60	-10
14	-34	26
-54	26	-8
-30	-68	60
38	-64	22
32	12	20
12	50	44
-20	10	-6
-28	60	-10
38	-64	22
-28	60	-10
-54	26	-8
14	-34	26
32	12	20

// Hayashi T, 2013: Smoking > Neutral
// Hayashi T, 2013: Smoking < Neutral
// Hayashi T, 2013: Positive correlation between Craving and Smoking > Neutral
// Hayashi T, 2013: Positive correlation between Intention and Smoking > 
// Neutral
// Hayashi T, 2013: Positive correlation between Craving and Smoking > Neutal 
// (Immediate > Delayed)
// Hayashi T, 2013: Positive correlation between Intention and Smoking > 
// Neutal (Immediate > Delayed)
// Hayashi T, 2013: Negative correlation between Craving and Smoking > Neutral 
// (Sham > Active rTMS)
// Hayashi T, 2013: Interaction rTMS x Cigarette Abailability, Smoking > 
// Neutral associated to Craving, Smokers
// Subjects=10
-26	42	34
16	44	46
-4	20	60
-2	58	12
-18	66	10
0	32	18
0	40	-8
58	-50	30
-54	-58	32
-2	14	-2
-6	-84	-8
46	-40	6
-56	-28	-10
-56	-58	34
-16	-84	-40
-58	-22	30
20	-62	60
62	-22	30
-20	-58	54
-48	-64	-8
50	-66	-14
-56	10	28
58	10	26
38	-4	12
-38	-4	10
-4	46	-22
-34	50	-6
28	30	-16
-30	36	40
-26	28	48
40	36	14
12	4	0
20	2	18
-28	-8	16
2	0	42
-20	28	52
-18	-30	78
-2	-52	14
52	-54	6
46	-44	-20
-26	-62	56
18	-60	56
-22	14	46
0	20	24
-22	68	12
-50	-66	40
6	-92	-2
-10	-92	-14
-26	2	-2
-38	32	40
-30	36	-16
0	56	-10
-6	28	-8
-16	6	-14
-50	-62	-8
46	36	20
-28	2	32
-6	-8	36
14	32	-12
-30	-38	-6
0	16	24
-4	64	-14
-18	36	48
-48	-74	38

// Kornysheva K, 2011: Synchronization > Control, Normals
// Kornysheva K, 2011: Synchronization > Control, Conjunction of [PMv MS > PMv 
// no TMS and PMv TMS > AG TMS and PMv > AG no TMS]
// Subjects=16
-52.21	11.11	19.02
-45.86	-12.6	0.86
-55.37	-21.41	11.75
47.09	-8.87	-.52
66.44	-17.5	10.02
-58.46	-33.34	22.82
50.62	7.69	48.24
50.27	20.47	7.02
-39.52	19.67	4.77
30.98	26.44	3.4
-26.73	-76.1	-37.53
63.2	5.2	14.84
2.34	-63.84	-5.43

// Luber B, 2013: Working Memory > Baseline
// Luber B, 2013: Working Memory > Baseline, Active > Sham
// Luber B, 2013: Working Memory > Baseline, Sham > Active
// Subjects=27
23.35	-78.52	34.16
-41.85	-24.69	16.5
20.75	-66.54	1.64
20.62	-66.41	-8.45
46.58	-22.32	2.43
56.14	-11.42	-7.77
60.59	-2.82	3.63
53.4	-29.59	27.69
42.71	-18.91	39.14
60.94	-34.13	24.65
27.12	-31.21	0.28
29.19	-34.06	-7.32
22.84	22.65	14.07
-62.28	-39.34	21.66
-52.57	-41.64	19.48
73.72	-23.42	12.16
73.81	-12.92	21.21
27.79	-53.54	48.42
15.03	-48.84	64.98
17.08	-35.42	59.14
15.14	-56.73	72.49
-22.43	-66.38	5.73
-13.67	-73.17	12.97
-9.55	-75.78	-3.65
7.5	-29.34	-13.02
-9.77	-31.42	-11.4
-39.72	-53.37	8.09
37.92	-40	-2.4

// van den Heuvel O A, 2013: Planning > Baseline, Sham rTMS
// van den Heuvel O A, 2013: Planning > Baseline, Active rTMS
// van den Heuvel O A, 2013: Main Effect of Task load for Planning > Baseline, 
// Sham rTMS
// van den Heuvel O A, 2013: Main Effect of Task load for Planning > Baseline, 
// Active rTMS
// van den Heuvel O A, 2013: Planning > Baseline, Sham > Active rTMS
// van den Heuvel O A, 2013: Task load Effects for Planning > Baseline, Sham > 
// Active rTMS
// Subjects=11
-20	2	-20
28	-2	66
36	30	40
-42	16	38
-36	30	28
54	34	26
-54	8	4
34	24	2
-28	20	2
-16	16	2
14	16	-2
10	-64	58
-56	-42	40
42	-40	58
-66	-32	30
62	-28	38
-44	-78	20
44	-70	16
-60	-64	-12
-40	-64	6
-22	-8	64
24	-4	68
-2	16	50
48	28	44
-40	28	32
52	36	26
-36	46	10
32	58	-2
32	26	-6
-30	22	0
-10	8	-4
10	14	-2
10	2	10
12	-66	58
40	-42	54
-66	-32	34
62	-36	36
-42	-80	36
44	-52	34
42	-74	22
-42	26	34
-20	-2	66
44	28	42
28	12	56
-2	22	42
-42	46	6
24	58	-12
52	48	-10
-54	12	8
-44	18	16
-32	24	-2
-14	6	16
-20	2	0
-16	12	2
18	20	-2
14	4	-4
10	-62	60
-62	-32	34
-58	-38	46
-42	-50	52
48	-46	48
62	-44	34
-38	-62	38
-48	-80	24
52	-66	22
-42	26	36
-24	-2	68
40	30	42
24	2	64
-24	58	6
22	54	-20
32	60	2
-54	8	16
-30	22	-4
-22	34	-22
-16	8	20
-16	8	0
14	18	4
18	18	8
0	-4	6
-4	-26	10
-6	-68	56
-66	-32	34
44	-56	34
64	-32	36
54	-50	42
-38	-64	38
-44	-80	36
44	-76	24
-38	-2	50
-46	2	32
-42	16	18
-54	16	30
26	52	20
-12	42	44
50	38	0
-8	-54	70
-4	-46	46
8	-54	56
14	-82	30
-48	-60	40
44	-52	44
-40	0	24

// Rule N O, 2010: Election Losers > Winner
// Rule N O, 2010: Japanese Target > American Target
// Rule N O, 2010: Voted > Not Voted
// Rule N O, 2010: Culture x Participant Interaction
// Subjects=14
19.14	-56.96	-41.89
-7.57	-59.24	-41.39
47.52	-35.23	44.06
29.18	29.85	47.74
24.41	-2.78	-29.76
-22.57	-7.03	-25.52
-42.87	1.74	-20.45
-30.07	10.27	-21.31
-19.08	45.37	32.49
-8.55	-36.3	-19.88

// Scheepers D, 2013: Self > Familiar
// Scheepers D, 2013: Ingroup > Outgroup
// Scheepers D, 2013: Familiar > Self
// Subjects=41
48	42	8
50	8	22
40	26	16
-50	4	32
-46	46	8
30	-62	50
54	-24	40
-42	-38	48
-24	-68	42
44	-64	-10
-34	-60	-4
46	8	40
40	-46	38
30	-78	44
-12	-64	-6
4	54	-14
54	-16	-10
6	-54	32
54	-2	-30

// Sheng F, 2014: Pain > Neutral
// Sheng F, 2014: Asian face (Pain - Neutral) > Caucasian face (Pain - 
// Neutral)
// Sheng F, 2014: (Pain - Neutral) pain judgment > (Pain - Neutral) race 
// judgment
// Sheng F, 2014: Pain judgment > Race judgment
// Sheng F, 2014: Race judgment > Pain judgment
// Subjects=21
9	36	2
-40	30	-16
-54	16	6
54	38	0
-12	-10	10
24	20	4
46	-58	-6
-28	-92	2
40	-78	18
-40	-72	-20
4	30	52
2	46	12
38	22	-10
-40	6	-12
68	-36	26
-66	-36	28
20	-50	60
0	50	22

// Wilson S J, 2011: Speech > Rest
// Wilson S J, 2011: Sing > Rest
// Subjects=26
-5.72	7.45	59.77
-53.67	6.4	28.19
-26.22	-9.95	58.48
-24.23	-72.51	32.14
-44.49	-40.34	-24.49
37.72	19.77	-6.06
-33.54	15.47	-2.18
-18.19	-3.54	11.76
-.43	-49.6	-45.61
-40.37	-51.66	-42.49
-2.26	-4.05	74.29
-57.97	-50.37	18.19

// Zarate J M, 2010: Singing > Voice perception (before training)
// Zarate J M, 2010: Melodic singing > Simple singing (before training)
// Zarate J M, 2010: Simple singing > Voice perception (before training)
// Subjects=20
-56	-8	6
-54	4	-2
-56	-24	12
-2	4	44
-4	10	40
-56	-6	26
-46	-14	40
-54	-2	46
-56	4	26
-36	6	8
-44	-16	38
-12	-24	-2
-28	-4	-4
-16	-62	-20
60	-8	6
50	-28	10
4	4	46
2	-2	56
52	-8	46
32	16	12
40	4	6
44	-16	40
18	-14	6
22	-6	8
22	-12	6
10	-62	-20
2	-56	-18
2	-60	-24
-56	-16	6
-56	-2	0
-62	-14	6
-52	-26	12
-42	-34	24
-6	-80	10
-10	-60	0
32	-70	-22
56	2	-4
66	-10	2
60	-18	4
10	-74	14
36	-76	-16
-46	-20	4
-54	-8	6
-48	-26	12
-2	8	42
-60	0	28
-36	14	10
-34	-2	8
-34	16	12
-46	-14	40
-56	-8	18
-58	-36	34
-10	-16	4
-22	-4	-4
-30	-16	4
-26	-58	-22
-14	-60	-18
0	-64	-32
0	-58	-24
48	-22	6
58	-16	4
54	-28	10
2	-2	58
4	16	32
2	-4	42
54	-8	46
60	0	34
38	4	6
38	-10	-6
34	16	12
44	-16	40
12	-14	6
22	-6	8
26	-62	-24

// de Borst A W, 2012: Imagery > Baseline
// Subjects=7
-35.22	51.82	20.99
-43.65	28.85	27.47
35.37	45.18	25.19
-42.46	1.53	31.98
48.37	5.42	32.84
-32.63	-9.39	55.08
35.73	-3.77	52.71
2.51	9.34	46.42
-32.04	18.66	4.77
37.41	21.1	2.65
-9.47	-16.19	6.32
10.83	-12.81	6.92
-16.03	11.9	-1.54
18.19	11.3	1.47
-4.2	-23.44	-5.4
7.56	-22.23	-4.52
-19.12	-25.3	-.61
20.42	-25.07	-1.08
-54.35	-20.77	6.1
58.88	-18.32	0.14
-28.82	-37.22	-16.23
29.95	-32.55	-16.18
-47.96	-55.05	-11.17
-17.56	-69.62	45.47
20.91	-66.14	45.85
-35.82	-45.5	42.54
20.91	-66.14	45.85
-2.61	-76.31	40.28
5.96	-74.94	43.41
-16.69	-66.22	20.64
18.58	-63.72	22.25
-4.96	-79.61	11.59
5.77	-80.17	17.09
-8.33	-81.25	-9.43
12	-82.02	-7.36
-24.25	-89.04	1.45
-29.48	-80.21	19.73
1.4	-76.82	5.7

// Ashkenazi S, 2012: Developmental dyscalculia (DD)
// Subjects=17
-8	38	-6
6	44	-6
2	12	-6
60	-60	18
44	-60	58
32	-74	54
2	-64	62
56	-72	4
60	-60	36
58	-62	38
60	-58	18
-50	-64	-26
-58	-60	-18
-58	-70	-2
-58	-36	-16
-62	-24	-18
50	-62	-20
52	-48	-26
56	16	40
30	26	-20
36	20	-38
36	52	10
-52	30	30
-42	36	38
-38	48	18
0	-32	38
2	-16	12
56	-72	4
58	-62	38
6	-76	44
-2	-86	42
2	-64	64
-58	-70	2
36	64	2
42	58	10
-20	66	20
-50	32	32
-38	40	4
36	20	-40
54	20	40
54	6	48
2	-34	38
44	-60	58
-58	-60	-18
-50	-64	-26
-58	-38	-16
-44	28	-18
56	-72	4
58	-62	38
6	-78	44
2	-64	64
-58	-70	2
36	64	4
42	58	10
30	52	36
-20	66	20
-50	32	32
-38	40	4
54	20	40
54	6	48
44	-60	58
-58	-60	-18
-50	-64	-26
-58	-38	-16
-44	28	-18
-58	-70	0
-42	28	-18
54	22	38

// Ashkenazi S, 2012: Typically developing (TD)
// Subjects=17
-24	-82	48
-20	-84	48
-28	-70	50
2	-68	56
-4	-66	44
36	-62	58
44	-50	58
-22	-94	-18
-22	-102	-4
-36	-92	-14
50	28	26
26	60	-4
8	32	44
54	12	44
-54	22	32
-46	52	4
-36	42	4
-28	2	60
-32	18	2
2	-10	34
-2	-30	32
4	6	30
0	-14	-8
44	-60	58
32	-74	54
2	-64	62
56	-72	4
60	-60	36
58	-62	38
60	-58	18
-50	-64	-26
-58	-60	-18
-58	-70	-2
-58	-36	-16
-62	-24	-18
50	-62	-20
52	-48	-26
56	16	40
30	26	-20
36	20	-38
36	52	10
-52	30	30
-42	36	38
-38	48	18
0	-32	38
2	-16	12
56	-72	4
58	-62	38
6	-76	44
-2	-86	42
2	-64	64
-58	-70	2
36	64	2
42	58	10
-20	66	20
-50	32	32
-38	40	4
36	20	-40
54	20	40
54	6	48
2	-34	38
44	-60	58
-58	-60	-18
-50	-64	-26
-58	-38	-16
-44	28	-18
56	-72	4
58	-62	38
6	-78	44
2	-64	64
-58	-70	2
36	64	4
42	58	10
30	52	36
-20	66	20
-50	32	32
-38	40	4
54	20	40
54	6	48
44	-60	58
-58	-60	-18
-50	-64	-26
-58	-38	-16
-44	28	-18
-58	-70	0
-42	28	-18
54	22	38

// Berteletti I, 2014: Math Learning Disability (MD)
// Subjects=20
-46	20	-10
-48	-32	-6
26	-68	46
-42	18	-22
-56	-50	6
28	-64	50
16	-70	54

// Berteletti I, 2014: Typically Developing (TD)
// Subjects=20
-46	20	-10
-48	-32	-6
26	-68	46
-42	18	-22
-56	-50	6
-48	32	2
-56	-50	6
28	-64	50

// Soohyun C, 2011: Retrievers > Counters (univariate)
// Soohyun C, 2011: Retrievers > Counters (multivariate)
// Subjects=17
-36	36	4
-24	-6	-36
-24	-16	-22
22	-14	-18
-44	38	0
-32	26	6
-62	-38	26
64	-26	38
42	-42	42

// Cho S, 2012: Positive Correlation between Retrieval Fluency and Addition > 
// Control
// Cho S, 2012: Addition > Control task
// Cho S, 2012: Positive Correlation between Retrieval Fluency and Addition > 
// Control with Accuracy and Reaction Time as Covariates
// Cho S, 2012: Positive Correlation between Accuracy and Addition > Control 
// tasks
// Cho S, 2012: Negative Correlation between Reaction Time and Addition > 
// Control tasks
// Cho S, 2012: Positive Correlation between Age and Addition > Control
// Cho S, 2012: Positive Correlation between Education and Addition > Control
// Cho S, 2012: Positive Correlation between Retrieval Fluency and Addition > 
// Control task with Age and IQ as covariates
// Subjects=86
-42	-78	18
-36	38	6
26	-42	-6
24	-86	38
34	24	46
40	-68	26
-34	24	52
12	18	-10
0	-44	-16
32	24	0
0	14	54
-30	22	2
-34	-36	36
54	32	26
-46	0	30
32	8	56
28	-94	-4
0	14	54
-30	22	2
-34	-36	36
54	32	26
-46	0	30
32	8	56
-42	-80	18
-36	38	6
28	-42	-6
24	-86	36
-40	22	52
54	-62	20
-10	44	-8
22	-86	20
24	34	-14
-64	-2	2
2	-20	58
-42	-68	38
-46	-14	62
-34	8	58
-44	-72	44
-2	-44	36
-32	4	-42
52	-64	42
28	-12	-20
60	-2	0
60	20	10
-52	-52	4
-28	26	54
22	-74	52
-22	-66	4
-48	30	36
66	-52	22
-32	-58	60
42	-34	-2
-22	-32	4
36	-32	-4
-6	22	52
-42	-78	18
-36	38	6
26	-42	-6
24	-86	38
36	24	46
-32	-64	-24
-34	24	52

// De Smedt B, 2011: Small > Large Math Problems
// De Smedt B, 2011: Large > Small Math Problems
// De Smedt B, 2011: Addition > Subtraction
// De Smedt B, 2011: Subtraction > Addition
// De Smedt B, 2011: Problem size x Operation interaction
// De Smedt B, 2011: Group x Problem size interaction
// Subjects=8
-5.46	31.62	-8.89
-56.43	-14.73	15.66
-44.05	7.13	-33.15
55.5	-3.68	-16.66
59.13	-61.87	14.94
-1.76	-12.6	38.27
52.64	-13.3	24.32
-53.08	-59.37	16.02
39.79	-13.64	21.15
-21.39	-16.83	-14.68
39.27	23.75	-32.16
-30.42	-56.93	45.66
7.7	28.7	34.7
-49.94	12.49	36.72
-27.38	13.91	53.07
-31.04	19.04	-4.19
30.44	-50.47	41.08
33.08	26.02	-2.17
-43.94	54.37	-.32
-18.23	-10.72	-18.57
-17.6	-56.85	45.51
4.46	31.59	31.15
27.17	8.15	56.27
-31.04	19.04	-4.19
40.14	-36.44	56.52
-40.67	35.36	1.24
-53.2	-63.83	-.33
-2.05	-71.67	-23.68
-46.75	9.08	33.62
-24.16	4.15	50.51
14.52	-59.32	52.04
36.31	19.7	-1.68
42.78	30.28	10.74
-34.11	-71.86	-23.3
36.34	-59.01	-28.53
37	-68.7	52.57
31.59	-59.56	47.4
32.53	-65.24	28.91

// Du F, 2013: Abacus-trained group
// Subjects=20
18	42	18
27	36	15
12	39	36
66	-33	9
66	-24	3
63	-42	0
15	18	15
18	21	-3
57	-63	27
48	-57	27
12	-3	3
18	-12	6
-24	3	69
-27	-63	42
66	-48	-3
-3	30	-6
-51	-33	-3
51	-18	-12
-3	-39	60
-42	-3	42
-6	0	57
-36	-6	36
-30	15	27

// Du F, 2013: Non-trained group
// Subjects=19
9	15	48
-6	0	57
-6	9	51
-12	-15	3
-15	6	9
15	12	12
-24	-75	30
-51	-45	54
-30	-63	48
57	15	36
54	6	39
33	-63	33
39	-54	54
33	-66	45
-33	-81	-21
-42	-60	-27
-27	-87	-18
-6	-75	45
18	42	18
27	36	15
12	39	36
66	-33	9
66	-24	3
63	-42	0
15	18	15
18	21	-3
57	-63	27
48	-57	27
12	-3	3
18	-12	6
-51	-33	-3
51	-18	-12
-3	-39	60
-42	-3	42
-6	0	57
-36	-6	36
-30	15	27

// Metcalfe A W S, 2013: Complex > Control
// Metcalfe A W S, 2013: Control > Complex
// Metcalfe A W S, 2013: Positive Correlation between Visuospatial Working 
// Memory and Complex > Control
// Metcalfe A W S, 2013: Positive Correlation between Central Executive 
// Working Memory and Complex > Control
// Metcalfe A W S, 2013: Positive Correlation between Phonological Working 
// Memory and Complex > Control
// Metcalfe A W S, 2013: Negative Correlation between Phonological Working 
// Memory and Complex > Control
// Subjects=74
16	-84	6
38	-68	-12
38	22	0
-54	-6	48
-28	22	2
-44	-44	46
-4	48	-4
2	56	18
-52	-46	32
40	42	-14
8	2	64
38	-50	32
-42	34	32
-28	-48	52
26	-50	68
-20	-82	28
16	-88	14
26	-64	-20
30	-62	38
58	-46	24
42	22	46
30	-18	-10
22	-18	60
-54	-50	34
6	-22	-6
40	-48	-26
-24	-46	54
-8	-86	-2
-22	-74	32
-20	56	2

// Mondt K, 2011: School language bilinguals
// Subjects=16
-22	-78	6
-50	-4	42
-16	-84	-18
-8	14	60
-48	10	38
-22	-78	6
-48	-4	42
28	-68	66
-14	-84	-18
-8	14	60
-48	10	38
-30	-66	54
20	12	40
-48	30	24
-10	-84	-12
-30	6	58
-10	14	56
-22	-80	60
-28	16	66
-12	-86	-18
34	-74	14

// Mondt K, 2011: Home-language bilinguals
// Subjects=8
10	-82	-14
18	12	38
30	-76	42
-46	28	24
-36	4	54
24	-84	20
-32	-4	64
4	14	24
-42	0	32
36	28	-2
12	6	34
-22	-78	6
-48	-4	42
28	-68	66
-14	-84	-18
-8	14	60
-48	10	38
-30	-66	54
20	12	40
-48	30	24
-10	-84	-12
-30	6	58
-10	14	56
-22	-80	60
-28	16	66
-12	-86	-18
34	-74	14

// Prado J, 2014: Positive Correlation between Grade and Smaller Subtraction > 
// Fixation
// Prado J, 2014: Positive Correlation between Grade and Smaller Subtraction > 
// Smaller Multiplication
// Prado J, 2014: Larger Subtraction > Smaller Subtraction
// Prado J, 2014: Larger Multiplication > Smaller Multiplication
// Prado J, 2014: Smaller Problems > Larger Problems
// Subjects=34
32	-74	38
-32	-94	2
-20	-100	6
32	-74	34
32	-84	-2
4	-52	50
-38	-46	50
2	-66	50
-30	-58	42
-40	26	26
-4	18	46
-16	-80	14
2	54	6
2	-40	42
-62	-38	34
64	-42	26

// Rosenberg-Lee M, 2011: All Children: Complex > Simple
// Rosenberg-Lee M, 2011: All Children: Simple > Complex
// Rosenberg-Lee M, 2011: 2nd Grade > 3rd Grade: Complex > Simple
// Rosenberg-Lee M, 2011: 3rd Grade > 2nd Grade: Complex > Simple
// Subjects=45
0	-36	-10
26	-94	-6
32	24	0
0	16	52
-32	20	2
-10	54	40
-6	62	8
-58	-68	8
-50	8	-20
8	-48	32
22	48	2
-48	30	34
38	-86	-8
18	-76	58
52	-70	20
2	-72	10
36	-34	-4
-10	-74	-26
-16	-86	-2

// Zvyagintsev M, 2013: Auditory > Baseline, p=0
// Zvyagintsev M, 2013: Auditory > Baseline, p=0.000001
// Zvyagintsev M, 2013: Auditory > Baseline, p=0.000024
// Zvyagintsev M, 2013: Auditory > Baseline, p=0.000041
// Zvyagintsev M, 2013: Auditory > Baseline, p=0.000161
// Zvyagintsev M, 2013: Baseline > Auditory, p<0.000009
// Zvyagintsev M, 2013: Baseline > Auditory, p<0.000067
// Zvyagintsev M, 2013: Baseline > Auditory, p<0.000004
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000004
// Zvyagintsev M, 2013: Visual > Baseline, p=0
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000126
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000008
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000007
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000005
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000017
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000036
// Zvyagintsev M, 2013: Visual > Baseline, p=0.000053
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000013
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000011
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000212
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000003
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000055
// Zvyagintsev M, 2013: Baseline > Visual, p=0
// Zvyagintsev M, 2013: Baseline > Visual, p=0.000001
// Zvyagintsev M, 2013: (Auditory > Baseline) and (Visual > Baseline), p=0
// Zvyagintsev M, 2013: (Auditory > Baseline) and (Visual > Baseline), 
// p=0.000003
// Zvyagintsev M, 2013: (Auditory > Baseline) and (Visual > Baseline), 
// p=0.000001
// Zvyagintsev M, 2013: (Auditory > Baseline) and (Visual > Baseline), 
// p=0.000122
// Zvyagintsev M, 2013: (Auditory < Baseline) and (Visual < Baseline), 
// p=0.000037
// Zvyagintsev M, 2013: (Auditory < Baseline) and (Visual < Baseline), p=0
// Zvyagintsev M, 2013: (Auditory < Baseline) and (Visual < Baseline), 
// p=0.000001
// Zvyagintsev M, 2013: Auditory > Visual, p=0
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000007
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000084
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000013
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000037
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000159
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000041
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000006
// Zvyagintsev M, 2013: Auditory > Visual, p=0.000058
// Zvyagintsev M, 2013: Visual > Auditory, p=0.000004
// Zvyagintsev M, 2013: Visual > Auditory, p=0
// Zvyagintsev M, 2013: Visual > Auditory, p=0.000022
// Zvyagintsev M, 2013: Visual > Auditory, p=0.000002
// Subjects=15
51.15	33.99	-10.85
-25.67	-31.2	-21.23
-51.47	42.81	-11.53
35.27	-79.96	-37.91
22.56	-12.99	3.45
-3.43	55.87	-12.06
-41.24	-66.02	25.36
-21.83	-57.5	51.19
-41.19	-35.93	42.91
32.7	-63.52	51.07
54.48	35.3	5.73
32.03	-30.85	-21.92
-32.08	-31.24	-21.15
-48.17	40.51	-.22
41.6	-70.92	-45.44
19.02	-36.24	-49.2
35.7	-2.97	49.3
-18.79	16.5	58.33
-15.36	-56.95	57.76
-37.92	-81.35	33.3
-41.22	-69.19	25.63
54.65	-28.92	1.08
51.87	-47.55	49.51
21.62	-84.16	-8.41
22.51	-62.89	-22.47
19.94	-26.65	74.89
-22.16	-90.68	-6.25
-63.84	1.32	31.13
-5.91	0.72	59.51
54.48	35.3	5.73
-51.38	40.49	-.18
38.45	-73.6	-38.48
28.83	-30.87	-21.88
-5.58	52.43	-15.09
-9.29	-90.09	0.25
-60.62	1.51	33.3
51.87	-47.55	49.51
-60.62	1.51	33.3
51.87	-47.55	49.51
45.13	-41.15	8.9
41.52	4.1	-24.96
25.73	3.14	5.41
-18.93	-90.4	-2.96
-34.09	4.1	9.36
-71.37	-28.9	12.56
0.55	1.27	66.08
58.11	0.08	45.44
44.78	31.04	-7.19
27.02	-85.64	-.54
23.07	-20.8	67.67
16.67	-89.94	41.2
-6.32	-.22	6.06
-8.99	-93.52	38.45
-35.33	61.71	11.24
54.67	-55.07	-6.77
26.26	-57.22	50.61
29.31	-2.76	52.7
-18.6	-57.23	54.47
-28.44	-3.62	46.75
-54.29	-65.24	-4.66
35.31	-36.66	-14.78
-35.34	-25.17	-24.97

// Vogel S E, 2015: Correlation between age and the extent of the ratio 
// dependent neural recovery effect
// Vogel S E, 2015: Parametric regressor of numerical ratio vs. Baseline 
// activation
// Subjects=19
-44.27	-64.24	48.67
41.92	8.21	28.22
35.93	-69.85	51.56
35.25	21.98	0.38
-47.83	11.1	32.35
-41.55	-49.56	-9.47

// Aybek S, 2015: NE > Neutral
// Subjects=12
-4	-28	-20
-2	-22	-2
8	-32	-10
-16	22	60
2	30	52
-5	22	34

// Blasi G, 2015: Subgroup of healthy controls, performing working memory task
// Subjects=322
-48	40	14
-50	46	10
44	14	16
-56	36	14

// Blasi G, 2015: Subgroup of healthy controls, performing attentional control 
// task
// Subjects=265
36	14	30
48	34	12
-44	8	38
-54	-40	36
-52	34	6

// Mazza M, 2015: Healthy Controls (HC)
// Subjects=10
39.39	44.84	-7.17
11.14	-100.74	12.06
-27.62	11.34	19.83
4.62	16.76	45.77
-47.04	17.08	-.5
-24.57	-3.39	-5.73
39.4	35.06	-9.69
-43.83	16.05	-.45
39.39	44.84	-7.17
-47.04	17.08	-.5
-43.84	19.22	-.72
29.73	36.61	-16.4
29.73	37.67	-16.49
61.89	9.31	-14.48
-46.91	10.71	13.42

// Mazza M, 2015: PTSD Sufferers (PTSD)
// Subjects=7
11.12	-54.79	28.28
-53.37	10.16	6.85
-66.02	-7.92	21.89
4.62	16.76	45.77
-47.04	17.08	-.5
-24.57	-3.39	-5.73
39.4	35.06	-9.69
-66.02	-7.92	21.89
46.13	14.15	22.1
-47.04	17.08	-.5
-43.84	19.22	-.72
33.19	-78.31	-30.22
38.58	-64.57	-18.05
61.89	9.31	-14.48
-46.91	10.71	13.42

// Coull J T, 2015: Temporal static - Spatial static
// Coull J T, 2015: Spatial dynamic -Temporal dynamic (Block 2 only)
// Coull J T, 2015: Temporal dynamic - Spatial dynamic (All blocks)
// Coull J T, 2015: Static - Dynamic
// Coull J T, 2015: Spatial static - Temporal static
// Coull J T, 2015: Time x Duration
// Coull J T, 2015: Space x Distance
// Coull J T, 2015: (Time x Duration) - (Space x Distance)
// Coull J T, 2015: (Space x Distance) - (Time x Duration)
// Coull J T, 2015: (Space x Duration) - (Time x Distance)
// Subjects=16
-3	-4	67
-57	2	10
57	5	16
-36	23	1
-54	-46	19
60	-25	-8
18	-4	1
6	-7	73
-3	2	55
-3	2	55
-45	11	-8
-15	-73	46
30	-76	55
-6	56	22
-36	-49	52
36	-55	52
-48	-76	-11
9	-82	7
0	-4	64
30	-97	-5
0	-88	19
-24	-61	-20
15	-67	-11
3	-4	64
9	-88	22
15	-70	-8
-30	-97	-8
30	-97	-5
-30	-97	-8

// Monaco S, 2015: Adaptation effects
// Subjects=11
-23.97	-12.54	68.63
3.68	-8.28	52.34
-12.25	-86.48	33.44
-17.49	-66.74	55.26
-30.39	-27.01	61
-55.08	-39.27	42.24
-44.66	-70.55	-5.44

// Robertson B D, 2015: Main effect of congruency: (incongruent vs. congruent 
// vs. control) and physical size (close vs. far)
// Robertson B D, 2015: Incongruent - Congruent contrast
// Robertson B D, 2015: Control - Congruent contrast
// Robertson B D, 2015: Main effect of physical size difference: (Far - Close)
// Robertson B D, 2015: Close - Far contrast
// Robertson B D, 2015: (Incongruent - Congruent) and (Close - Far)
// Robertson B D, 2015: (Incongruent - Control) and (Close - Far)
// Robertson B D, 2015: (Incongruent - Congruent) masked with (Close - Far), 
// p<0.005
// Robertson B D, 2015: (Incongruent - Congruent) masked with (Close - Far), 
// p<0.05
// Robertson B D, 2015: (Close - Far) masked with (Incongruent - Congruent)
// Robertson B D, 2015: Incongruent - Congruent, Positive Correlation
// Robertson B D, 2015: Incongruent - Congruent, Negative Correlation
// Robertson B D, 2015: Incongruent - Control, Positve Correlation
// Robertson B D, 2015: Incongruent - Control, Negative Correlation
// Robertson B D, 2015: Close - far, Positive Correlation
// Robertson B D, 2015: Close - far, Negative Correlation
// Subjects=16
27	-7	1
66	-7	13
36	-31	40
45	-37	61
57	-19	52
-60	-4	-1
-33	-34	46
-18	-58	-17
-9	-31	-23
60	-58	-11
48	-22	-23
45	-25	-20
48	-55	-20
21	-25	-11
18	32	-17
18	2	-20
-51	-31	7
12	5	46
0	-91	22
-39	2	-17
-33	-25	16
-18	-49	55
-15	-25	34
51	-28	13
24	-67	46
-21	-19	-11
33	14	16
30	29	10
39	44	28
30	38	-17
39	5	-17
15	-31	37
12	-19	4
21	5	25
-57	-4	25
-42	-28	-17
21	5	25
-18	-4	19
-30	-1	10
66	-7	13
27	-7	1
-60	-4	1
-18	-22	19
-33	-34	46
-18	-58	-17
60	-58	-11
48	-22	-23
21	-25	-11
18	32	-17
-12	5	46
0	-91	22
-39	2	-17
-21	-19	-11
39	44	28
30	29	10
12	-19	4
21	-31	7
-42	-28	-17
39	-13	-23
3	-43	4
3	-34	28
-39	38	34
-36	-49	19
-54	-67	-11
48	50	13
24	-61	-14
0	-70	7
30	-82	-20
-36	-76	-23
-18	-31	4
-15	-46	-5
-45	-52	-5
-12	17	-11
24	-61	10
45	32	7
12	-88	-11
-24	-40	-29
21	-25	58
3	-49	61
-6	-85	37
69	-25	31
-63	-7	-2
18	32	-17
18	-19	7
-30	-25	16
-18	-28	-32
-24	8	-23
21	59	-5
27	47	40
33	32	10
-30	44	37
-30	-31	-23
18	-22	-11
-51	14	-20
-3	38	-14
63	-37	-11
48	29	10
-21	-4	-17
-42	-28	40
63	-52	-11
42	50	13
-27	-7	-23
30	38	-17
54	-55	11
-45	-55	-8
45	8	25
-45	2	28
48	38	16
-45	-76	34
-27	-55	49
-3	-73	-23
-6	-37	43
-15	2	43
3	32	-17
21	47	-14
18	-91	4
69	-22	28
57	17	7
9	-55	10
-12	-58	16
-9	-22	-32
-45	35	19
-30	32	16
-6	53	-2
-63	-10	1
54	-55	-11
-45	-55	-8
45	8	25
-45	2	28
-33	-4	43
48	38	16
-27	-55	49
-3	-73	-23
-15	2	43
21	47	-14
36	53	-14
36	62	1
36	44	-17
69	-22	28
-9	-22	-32
-45	35	19
-63	-10	1
-21	-76	7
-45	47	-14
6	-37	61
-39	-49	-26
60	-22	-2
-36	-4	-29
6	-91	25
-12	-19	-29
39	-1	-20
12	-70	-14
27	-58	4
15	2	55
21	8	25
24	-13	10
15	26	7
18	-31	1
-24	-70	28
-27	-73	25
-66	-25	-5
60	-58	-11
36	-31	37
-12	2	43
48	2	25
69	-22	28
-36	-37	43
-51	-31	49
60	17	7
-54	-67	-11
-63	-10	1
48	50	13
24	-49	55
36	-76	-23
42	41	25
54	-58	-11
42	-34	31
45	-49	58
48	-76	-11
-39	-40	46
-51	-31	49
18	-7	16
66	-7	13
27	-7	1
-60	-4	1
-33	-34	46
-18	-58	-17
0	-70	7
-15	-46	-5
21	-25	-11
18	32	-17
30	29	10
0	-91	22
-39	2	-17
-21	-19	-11
-12	-1	43
39	44	28
48	-22	-23
54	-43	-14
12	-19	4
-42	-28	-17
3	-43	4
-39	38	34
48	-43	43
-36	-49	19
24	-61	-14
-18	-31	4
48	41	4
24	-61	10
18	-10	19
-18	-4	19
66	-7	13
27	-7	1
33	-28	40
54	-22	58
-18	-58	-17
-15	-46	-5
-42	-25	40
-36	-28	58
21	-25	-11
18	32	-17
30	38	-17
-57	-1	4
0	-88	25
-39	2	-17
-15	-25	34
-21	-19	-11
48	-22	-23
54	-40	-14
27	47	37
15	-31	37
6	-43	4
3	-34	28
12	-16	4
21	-31	7
-42	-28	-17
-9	-1	40
33	29	10
69	-34	31
-39	38	34
-15	5	49
-36	-49	19
-51	-37	43
-51	-31	34
0	-70	7
-18	-31	4
-18	-22	16
39	-13	-23
12	-79	43
3	-49	61
18	-67	43
-12	17	-11
24	-61	10
6	-73	-8
12	-88	-11
24	-61	-11
21	-25	58
24	-67	-14
-57	-67	-2
51	-58	-14
-45	-55	-8
45	8	25
-45	2	28
48	38	16
-27	-55	49
-3	-73	-23
-15	2	40
21	47	-14
-45	35	19
-45	47	-14
6	-37	61
-57	-28	46
60	-22	-2
15	26	7
36	2	1
-57	-43	49
48	23	4
57	17	10
60	-43	13
39	50	31
-18	-7	22
6	-4	19
-6	-25	19
0	-64	31
-57	-13	-17
27	-13	-11
18	-16	13
39	14	-26
-45	-16	-26
-39	32	-14
39	50	31
-39	-40	58
-27	-58	52
60	23	10
-51	26	-5
-54	-43	49
-42	8	40
27	-85	1
18	-13	25
24	-13	-11
0	-28	13
-12	-43	46
-30	-85	25
-39	-7	34
-60	-13	13
-27	-58	58
-15	47	31

// Yoder K J, 2015: Implicit Moral Evaluation, Nonpsychopaths > Psychopaths
// Yoder K J, 2015: Implicit Moral Evaluation, Psychopaths > Nonpsychopaths
// Yoder K J, 2015: Explicit Moral Evaluation, Nonpsychopaths > Psychopaths
// Yoder K J, 2015: Explicit Moral Evaluation, Psychopaths > Nonpsychopaths
// Subjects=28
4	14	18
34	38	30
-36	-6	36
-34	-70	-6
44	2	-32
-2	26	-6
-38	-16	10
0	-28	-40
28	-2	-32
-6	-40	-30
6	-16	-24
-12	-6	-20
16	-96	-14
-34	-54	34
-60	-14	36
-18	18	38
-22	-42	52
-22	18	-6
16	-28	4
-24	-12	48

// Wen X, 2016: Beauty distance effect: Low Scene vs High Scene & Low Face vs 
// High Face [(BCSL-BCSH) + (BCFL-BCFH)]
// Wen X, 2016: Beauty distance effect: (RT covariate) [(BCSL-BCSH) + 
// (BCFL-BCFH)] , p<0.05
// Wen X, 2016: Beauty distance effect: (RT covariate) [(BCSL-BCSH) + 
// (BCFL-BCFH)] , p>0.05
// Wen X, 2016: Size distance effect: Low Scene vs High Scene & Low Face vs 
// High Face [(SCSL-SCSH) + (SCFL-SCFH)]
// Wen X, 2016: Distance effect in the size comparison (RT covariate) 
// [(SCSL-SCSH) + (SCFL-SCFH)], p<0.05
// Wen X, 2016: Distance effect in the size comparison (RT covariate) 
// [(SCSL-SCSH) + (SCFL-SCFH)], p>0.05
// Wen X, 2016: Distance effect in beauty and size comparison
// Wen X, 2016: Distance effect in beauty and size comparison (RT covariate), 
// p<0.05
// Wen X, 2016: Distance effect in beauty and size comparison (RT covariate), 
// p>0.05
// Wen X, 2016: Beauty comparison interaction effect [(BCSL-BCSH) > 
// (BCFL-BCFH)]
// Wen X, 2016: Beauty comparison interaction effect [(BCSL-BCSH) > 
// (BCFL-BCFH)] (RT covariate)
// Wen X, 2016: Beauty comparison interaction effect [(BCSL-BCSH) < 
// (BCFL-BCFH)]
// Wen X, 2016: Beauty comparison interaction effect [(BCSL-BCSH) < 
// (BCFL-BCFH)] (RT Covariate)
// Wen X, 2016: Distance effect in moral beauty comparison (BCSL-BCSH)
// Wen X, 2016: Distance effect in facial beauty comparison (BCFL-BCFH)
// Wen X, 2016: Conjunction analyses beauty comparison distance effects 
// (BCSL-BCSH) and (BCFL-BCFH), p<0.05
// Wen X, 2016: Conjunction analyses beauty comparison distance effects 
// (BCSL-BCSH) and (BCFL-BCFH), p>0.05
// Subjects=28
-45	-45	48
33	-66	54
-3	21	48
-30	21	3
30	24	-3
0	-33	27
-33	-60	-30
-3	21	51
-30	21	3
30	24	-3
51	-45	57
3	-36	27
-42	-63	-48
-33	-48	51
36	-42	45
9	27	39
-30	21	3
30	21	3
-6	-75	-24
-45	-63	-6
48	-57	-6
15	-12	3
-30	-51	48
24	-66	45
9	27	39
-30	21	3
33	24	3
-6	-72	-21
48	-54	-6
-24	-63	42
33	-63	54
0	21	51
-30	21	3
30	24	-3
-33	-60	-30
-45	9	27
-36	-48	39
39	-54	45
3	18	51
-30	21	3
30	21	3
-30	-54	-30
-51	9	30
-33	12	-18
54	6	-24
-39	-81	33
48	-75	27
-9	-57	15
-3	30	-9
-33	12	-18
51	3	-24
-39	-81	33
48	-75	27
-12	-57	18
12	21	-9
-30	0	0
30	-6	15
-30	-3	18
30	-6	15
0	30	51
-27	24	-3
30	24	-3
-45	54	-3
54	30	18
6	-42	9
36	-81	33
-33	-45	-33
6	21	45
-30	18	3
30	21	3
42	-57	54
-45	6	30
-27	-69	-48
-9	-90	12
6	30	42
27	27	-3
-27	21	-6
51	33	21

// Kleinhans N M, 2016: Healthy Controls
// Subjects=25
32	48	4
20	-78	-26
-6	52	20
-24	36	-18

// Kleinhans N M, 2016: Autism Spectrum Disorder ASD patients
// Subjects=27
40	-50	-24
42	-58	-22
44	-76	-12
42	-62	18
-38	-50	-22
-42	-74	-10
-44	-68	-20
12	-36	6
12	-36	-8
10	-38	-2
-8	-38	4
8	-48	-32
-6	-48	-30
4	-42	-22
12	-52	-42
14	-54	-34
-28	-50	-8
-22	-60	-10
-38	-72	-4
-32	-82	12
-26	-74	-4
-36	-48	-22
32	-50	-10
30	-42	-16
38	-64	-14
22	-44	-8
42	-70	-10
30	-84	24
36	-78	10
30	-74	22
4	-70	44
-6	52	20
-24	36	-18

// Tseng A, 2016: Autistic Participants (ASD)
// Subjects=51
39	-28	67
-6	47	25
-6	-61	-20
-21	20	58
21	41	49
-51	20	13
-3	-52	-38
9	-55	-38
30	-58	4
12	-88	-5
-18	62	10
24	62	10
24	-16	-14
15	53	1
39	-22	-23
-15	-55	10
-9	35	-5
27	-40	1
-39	-31	-14
-3	20	-2
30	44	46
27	32	-11
-54	20	13
-60	-4	19
-54	5	28
-60	-7	13
-33	23	10
24	-70	49
-48	-40	43
63	-13	31
27	5	55
-36	53	13
36	-82	34
12	11	46
45	-40	40
39	5	43
45	14	34
0	29	43
54	-67	-8
63	-55	-2
-9	-88	-8
54	20	1
-48	41	-5
-24	38	46
12	50	49
57	26	16
18	14	13
21	-28	-5
27	-1	-17
12	44	16
12	-46	64
-42	17	49
-15	14	61
-27	-70	52
-45	17	10
-6	-64	52
-9	8	13
27	-55	49
18	23	61
66	-28	-11
-60	-25	-14
33	-40	-23
45	29	22
12	-52	-38
-6	-61	-38
-6	-64	43
51	-25	52
3	-1	37
-6	-22	40
36	-49	58
-3	-70	-8
0	-19	52
-24	-55	67
-6	17	-8
-12	-67	-8
-51	-34	37
6	20	-8
24	-40	-2
9	-79	-2
-30	-94	16
33	44	43
39	23	25
57	20	34
15	47	34
30	-37	-26
-24	-91	-17
-48	-61	7
39	-88	7
-48	-61	-5
0	-88	34
-9	-88	7
-21	-82	-14
21	-58	19
-3	-82	43
-21	53	16
-6	-46	25
36	-82	34
-45	-10	10
42	8	55
15	11	-11
-54	23	13
21	32	58
39	11	34
9	38	46
60	-16	31
48	-67	34

// Tseng A, 2016: Typically Developing Subjects (TD)
// Subjects=84
27	62	19
51	41	16
30	-76	52
39	56	4
57	11	34
-44	-46	48
-42	-55	61
12	-70	64
21	-85	46
48	20	34
-39	-13	10
36	26	-2
15	8	16
-3	-88	-5
-60	-10	-17
18	-34	10
-21	2	7
12	-97	4
21	-100	10
0	56	-8
0	-58	19
-15	-103	1
3	59	10
45	-73	-5
-3	26	-11
-42	-73	-5
-30	-31	-26
18	-76	58
-45	-55	58
0	20	58
9	-61	49
18	8	70
-30	-52	37
39	-19	22
-51	-49	55
-6	-79	43
-9	11	40
51	-10	52
30	-31	67
-6	17	43
-15	-85	-8
63	-55	7
-6	-85	34
-39	5	37
-48	41	1
-36	44	28
54	-40	13
36	35	22
-6	-19	34
-9	26	28
12	-22	34
-48	41	-5
-24	38	46
12	50	49
57	26	16
18	14	13
21	-28	-5
27	-1	-17
12	44	16
12	-46	64
-42	17	49
-15	14	61
-27	-70	52
-45	17	10
-6	-64	52
-9	8	13
27	-55	49
18	23	61
66	-28	-11
-60	-25	-14
33	-40	-23
45	29	22
12	-52	-38
-18	-100	-11
54	35	25
-36	-61	49
-51	26	25
-6	-76	49
30	-61	-32
-6	17	52
27	-97	4
-45	14	19
45	-52	49
36	59	7
-45	5	34
-27	5	64
-24	11	64
12	11	10
-39	-88	19
-12	14	16
-39	-82	-14
54	2	31
-15	-28	-11
12	-88	7
3	-91	22
-39	-28	67
3	-13	61
9	-76	1
-3	-10	55
15	-67	10
36	-46	67
63	-16	25
-63	-34	34
-39	5	4
9	-13	43
-48	11	-32
-3	-28	49
-9	-82	-20
9	-82	-29
-54	20	31
-51	-58	-14
-15	20	67
-45	-1	58
3	-58	-35
6	-13	13
-48	26	37
24	-94	-8
39	2	64
-6	23	46
-12	62	-2
36	-43	-8
-15	-19	16
0	-88	34
-9	-88	7
-21	-82	-14
21	-58	19
-3	-82	43
-21	53	16
-6	-46	25
36	-82	34
-45	-10	10
42	8	55
15	11	-11
-54	23	13
21	32	58
39	11	34
9	38	46
60	-16	31
48	-67	34

// Kana R K, 2015: Theory of Mind ToM > Random, Healthy controls > ASD 
// patients
// Subjects=13
-4	36	34
-24	22	-12
-40	4	34
-42	-56	40
-22	-86	-26
-6	-44	40
2	-8	18

// Moseley R, 2016: Emotion words, Healthy controls > ASD patients
// Moseley R, 2016: Abstract verbs, Healthy controls > ASD patients
// Moseley R, 2016: Animal names, Healthy controls > ASD patients
// Subjects=18
-54	4	24
-58	-18	22
-52	-8	44
-42	-42	-12
-44	-58	-10
56	0	42
50	-14	50
-56	-36	2
-2	4	60
-8	16	18
-4	6	28
10	16	28
30	18	14
-56	6	20
-54	2	40
-42	-8	50
-42	-40	-16
-46	-74	-10
-42	-50	-26
-52	36	2
-14	38	18
-6	0	64
-62	-18	18
-8	-84	20
2	-74	10
-60	-36	2
-52	-28	-2
38	54	18
32	44	20
22	50	16
-42	26	18
-32	18	0
-46	38	0
36	50	18
28	44	18
-42	-48	-16
-38	-44	-24
-38	-34	-20
-60	-38	2
-30	32	-16
-20	30	-16
14	14	2
6	4	-2
-18	10	6
-10	4	6
-18	14	-4

// Chantiluke K, 2015: Controls < Autism Spectrum Disorder (ASD), Placebo
// Chantiluke K, 2015: Controls and Attention Deficit Hyperactivity Disorder 
// (ADHD) < ASD, Placebo
// Chantiluke K, 2015: Controls and ASD > ADHD, Placebo
// Chantiluke K, 2015: Controls > ADHD > ASD, Placebo
// Chantiluke K, 2015: Controls and ASD > ADHD, Fluoxetine
// Chantiluke K, 2015: Controls < ASD and ADHD, Fluoxetine
// Chantiluke K, 2015: ADHD < Controls < ASD, Fluoxetine
// Chantiluke K, 2015: Controls and ASD > ADHD, Fluoxetine
// Chantiluke K, 2015: Controls < ASD < ADHD, Fluoxetine
// Subjects=18
58.94	19.6	22.61
-41.59	34.6	19.16
-30.17	10.39	-33.59
-29.49	-18.85	42.46
-10.17	10.72	65.41
-10.17	10.72	65.41
40.04	-62.65	34.18
-48.68	-63.52	30.81
9.18	-65.95	49.31

// Shafritz K M, 2015: High-Functioning Autistic Participants
// Subjects=15
30	32	20
12	18	46
48	8	28
12	14	52
46	10	16
42	22	-4
34	-58	40
46	-60	-18
-38	-72	-18
38	18	16
38	36	22
34	24	0
-30	24	2
8	22	44
-4	22	44
40	-56	42
38	-50	-16
-42	-52	-16
6	20	46
42	34	30
-42	4	32
32	24	4
-30	20	8
42	-58	44
40	-68	-10
6	18	46
32	26	2
34	-58	48
42	-58	-24
2	40	8
2	48	0
16	-54	14
-14	-64	10
18	-70	-4
-14	-74	-8
-46	6	-18
-36	-74	40
-24	2	-20
-14	-86	-14
34	-58	-20
14	-80	-20
6	-74	6
44	18	-2
-20	18	-14
-24	10	-18
-20	-68	4
14	-70	4
-26	2	-18
2	46	0
-24	14	4
30	-84	-16
4	-84	10

// Shafritz K M, 2015: Healthy Controls
// Subjects=15
32	38	24
8	18	42
32	24	6
-38	10	8
40	6	34
10	14	44
32	2	48
36	34	24
32	26	4
-34	16	10
38	-50	38
2	22	46
44	8	42
42	26	4
-38	18	4
34	-58	44
10	16	42
-10	20	36
42	36	18
32	2	50
38	18	8
-36	16	8
34	-60	40
12	-8	8
4	18	46
38	24	2
-30	42	-8
-42	44	-8
-18	20	-14
-26	4	-14
-34	52	12
-36	-54	-20
36	-56	-22
-22	-76	-18
20	-74	-16
44	18	-2
-20	18	-14
-24	10	-18
-20	-68	4
14	-70	4
-26	2	-18
2	46	0
-24	14	4
30	-84	-16
4	-84	10

// Heim S, 2016: Phonological awareness, Control > Dyslexia
// Heim S, 2016: Magnocellular motion detection, Dyslexia > Controls
// Heim S, 2016: Magnocellular motion detection, Control > Dyslexia
// Heim S, 2016: Attention shifting, Dyslexia > Control
// Heim S, 2016: Auditory discrimination, Dyslexia > Control
// Heim S, 2016: Auditory discrimination, Control > Dyslexia
// Subjects=20
-48	18	21
46	34	17
-32	-78	17
36	-72	13
-40	-72	15
48	-60	15
-32	50	32
42	32	17
48	-26	49
36	-68	29
-22	-68	-27
24	-64	-31
20	28	27
-12	-104	9
62	-24	9

// Brown G G, 2015: Face > Shape matching, GroupxTime Interaction, Alprazolam 
// group decreases
// Brown G G, 2015: Affective Anticipation > Baseline, GroupxTime Interaction, 
// Alprazolam group increases
// Brown G G, 2015: Affective Anticipation > Baseline, GroupxTime Interaction, 
// Alprazolam group decreases
// Subjects=11
2.5	-57.73	18.59
0.37	-57.74	18.61
20.4	26.35	16.91
-36.23	40.35	24.19
49.17	24.6	5.57
34.02	61.01	-4
-37.24	16.83	22.83
7.49	34.13	8.6
-16.05	33.73	5.56
24.59	70.5	23.19
-15.12	87.21	8.87
35.67	25.29	56.97

// Cisler J M, 2016: All Fear > All Neutral, Treatment Prediction
// Cisler J M, 2016: Covert Fear > All Neutral, Treatment Prediction
// Subjects=23
23	2	-3
-22	-1	-7
22	-32	-5
26	3	-9

// Gingnell M, 2016: Escitalopram (ESCIT) + Cognitive Behavioral Therapy 
// (ICBT) > Placebo + ICBT, Faces; Post < Pre
// Gingnell M, 2016: Responders > Non-Responders, Faces; Post < Pre-treatment
// Gingnell M, 2016: Symptom improvement, Faces; Post < Pre-treatment
// Subjects=24
21	-16	55
0	-88	7
-15	-22	61
-21	-73	7
54	-40	37
-60	-43	34
18	47	40
-48	5	1
42	-52	46
45	-37	-11
60	-43	-2
33	2	40
33	2	43

// Strakowski S M, 2016: Emotional distracters > Targets, Nonremitters > 
// Remitters (Baseline)
// Strakowski S M, 2016: Emotional distracters > Targets, Nonremitters > 
// Remitters (Week 1)
// Strakowski S M, 2016: Emotional distracters > Targets, Nonremitters > 
// Remitters (Week 8)
// Subjects=21
42.26	-14.6	63.58
15.04	54.75	26.85
-35.58	51.39	-25.81
26.39	46.13	-30.54
-58.88	7.27	-16.27
-5.92	-59.84	33.36
2.32	-55.21	-3.93
14.84	37.2	-7.36
0.19	-55.22	-3.9
3.23	22.21	6.3
-11.61	2.46	13.7
53.63	-18.47	12.48

// van Rooij S J, 2015: Cued Trial > Go Trial, Group x Time Interaction
// Subjects=17
-48	-24	40

// Culbreth A, 2016: Loseshift-Winstay, Healthy controls > Schizophrenia
// Culbreth A, 2016: Loseshift-Winstay, Healthy controls
// Culbreth A, 2016: Loseshift-Winstay, Schizophrenia
// Culbreth A, 2016: Loseshift, Healthy controls > Schizophrenia
// Culbreth A, 2016: Winstay, Healthy controls > Schizophrenia
// Subjects=36
44.73	48.13	-6.39
5.53	39.26	33.84
-44.96	49.42	4.57
42.92	40.45	32.19
49.21	15.09	6.37
21.76	23.89	53.9
41.98	7.75	36.06
4.62	29.96	51.36
38.99	-49.28	41.99
-40.02	-50.21	50.79
58.32	-46.02	54.88
14.56	-72.09	51.99
33.69	-69.75	39.31
43.44	-59.6	59.54
54.97	-51.9	34.22
4.66	-24.62	33.63
5.71	-44.5	24.13
55.71	-58.66	-12.06
69.53	-27.49	-9.25
56.77	-42.2	-5.64
-1.87	-96.1	-9.37
13.18	-92.96	2.46
10.13	-99.01	20.85
12.99	-16.94	8.36
-15.89	-12.97	7.24
29.97	-5.89	-1.69
33.23	-24.02	-2.44
1.08	-26.29	-15.26
-37.55	-68.82	-52.51
-5.31	-84.26	-34.86
-24.56	-76.89	-34.14
6.56	-84.13	-20.51
44.73	48.13	-6.39
5.53	39.26	33.84
-44.96	49.42	4.57
42.92	40.45	32.19
49.21	15.09	6.37
21.76	23.89	53.9
41.98	7.75	36.06
4.62	29.96	51.36
38.99	-49.28	41.99
-40.02	-50.21	50.79
58.32	-46.02	54.88
14.56	-72.09	51.99
33.69	-69.75	39.31
43.44	-59.6	59.54
54.97	-51.9	34.22
4.66	-24.62	33.63
5.71	-44.5	24.13
55.71	-58.66	-12.06
69.53	-27.49	-9.25
56.77	-42.2	-5.64
-1.87	-96.1	-9.37
13.18	-92.96	2.46
10.13	-99.01	20.85
12.99	-16.94	8.36
-15.89	-12.97	7.24
29.97	-5.89	-1.69
33.23	-24.02	-2.44
1.08	-26.29	-15.26
-37.55	-68.82	-52.51
-5.31	-84.26	-34.86
-24.56	-76.89	-34.14
6.56	-84.13	-20.51
44.73	48.13	-6.39
5.53	39.26	33.84
-44.96	49.42	4.57
42.92	40.45	32.19
49.21	15.09	6.37
21.76	23.89	53.9
41.98	7.75	36.06
4.62	29.96	51.36
38.99	-49.28	41.99
-40.02	-50.21	50.79
58.32	-46.02	54.88
14.56	-72.09	51.99
33.69	-69.75	39.31
43.44	-59.6	59.54
54.97	-51.9	34.22
4.66	-24.62	33.63
5.71	-44.5	24.13
55.71	-58.66	-12.06
69.53	-27.49	-9.25
56.77	-42.2	-5.64
-1.87	-96.1	-9.37
13.18	-92.96	2.46
10.13	-99.01	20.85
12.99	-16.94	8.36
-15.89	-12.97	7.24
29.97	-5.89	-1.69
33.23	-24.02	-2.44
1.08	-26.29	-15.26
-37.55	-68.82	-52.51
-5.31	-84.26	-34.86
-24.56	-76.89	-34.14
6.56	-84.13	-20.51
44.73	48.13	-6.39
5.53	39.26	33.84
-44.96	49.42	4.57
42.92	40.45	32.19
49.21	15.09	6.37
21.76	23.89	53.9
41.98	7.75	36.06
4.62	29.96	51.36
38.99	-49.28	41.99
-40.02	-50.21	50.79
58.32	-46.02	54.88
14.56	-72.09	51.99
33.69	-69.75	39.31
43.44	-59.6	59.54
54.97	-51.9	34.22
4.66	-24.62	33.63
5.71	-44.5	24.13
55.71	-58.66	-12.06
69.53	-27.49	-9.25
56.77	-42.2	-5.64
-1.87	-96.1	-9.37
13.18	-92.96	2.46
10.13	-99.01	20.85
12.99	-16.94	8.36
-15.89	-12.97	7.24
29.97	-5.89	-1.69
33.23	-24.02	-2.44
1.08	-26.29	-15.26
-37.55	-68.82	-52.51
-5.31	-84.26	-34.86
-24.56	-76.89	-34.14
6.56	-84.13	-20.51
44.73	48.13	-6.39
5.53	39.26	33.84
-44.96	49.42	4.57
42.92	40.45	32.19
49.21	15.09	6.37
21.76	23.89	53.9
41.98	7.75	36.06
4.62	29.96	51.36
38.99	-49.28	41.99
-40.02	-50.21	50.79
58.32	-46.02	54.88
14.56	-72.09	51.99
33.69	-69.75	39.31
43.44	-59.6	59.54
54.97	-51.9	34.22
4.66	-24.62	33.63
5.71	-44.5	24.13
55.71	-58.66	-12.06
69.53	-27.49	-9.25
56.77	-42.2	-5.64
-1.87	-96.1	-9.37
13.18	-92.96	2.46
10.13	-99.01	20.85
12.99	-16.94	8.36
-15.89	-12.97	7.24
29.97	-5.89	-1.69
33.23	-24.02	-2.44
1.08	-26.29	-15.26
-37.55	-68.82	-52.51
-5.31	-84.26	-34.86
-24.56	-76.89	-34.14
6.56	-84.13	-20.51

// Wang J, 2015: 2-Negative Feedback (NF) vs 1-Negative Feedback(NF), p < 0.05 
// FDR corrected
// Wang J, 2015: 2-NF vs. 1-NF, p < 0.001 uncorrected
// Wang J, 2015: 2-NF vs 1-NF conjunction 1-NF vs 0-NF, p < 0.05 FDR corrected
// Wang J, 2015: 2-NF vs 1-NF conjunction 1-NF vs 0-NF, p < 0.001 uncorrected
// Subjects=16
48	18	9
-57	12	15
48	15	39
-27	12	45
15	24	45
51	-36	42
-54	-39	45
42	-69	42
36	-60	51
15	-66	45
30	21	-3
-6	18	48
-39	21	12
33	9	54
-45	-39	42
-27	24	6
33	18	0
-21	-12	0

// White D M, 2015: Schizophrenia
// Subjects=22
35	30	24
14	14	-2
18	11	15
6	-23	3
15	-36	-38

// White D M, 2015: Healthy controls
// Subjects=19
35	30	24
14	14	-2
18	11	15
6	-23	3
15	-36	-38
-3	-3	51
-34	12	-3
35	12	-3
50	6	-10
-21	-66	54
-42	-33	45
36	-63	-37
-3	-3	51
-4	-10	-14
8	-21	-1
6	-30	-18
18	27	1.5
-22	-22	24
-21	-93	3

// Wotruba D, 2017: Reward anticipation, At-risk Psychosis > Healthy controls
// Subjects=21
3	-45	27
9	57	30
30	24	48
-24	24	45

// Choi M H, 2017: Driving only - Control
// Choi M H, 2017: Driving with sub-task - Control
// Choi M H, 2017: Sub-task only - Control
// Choi M H, 2017: Driving only - Driving with sub-task
// Choi M H, 2017: Driving only - Driving with sub-task
// Subjects=15
51	-62	-10
37	-4	60
33	-28	65
22	-6	65
8	-57	65
16	-68	55
44	-61	0
50	-34	30
11	10	40
31	-67	5
34	-75	25
51	0	45
-30	-28	60
-28	-48	55
-56	7	25
-51	0	5
-44	-6	15
-31	-89	-10
-23	-4	15
0	-62	-30
41	-62	-20
-12	-46	-45
30	-32	20
9	-4	0
33	5	-10
33	-26	60
45	11	-10
45	-32	60
34	-4	-5
9	-25	20
22	7	30
25	-82	10
50	-40	-10
-28	-31	60
-31	-40	25
-55	3	30
-50	-1	5
-11	-84	-10
-28	19	10
-42	-76	-5
-30	38	30
-20	-81	25
-9	-3	25
-28	53	-5
-25	-6	55
28	-36	-40
0	-59	-35
42	46	-5
36	21	10
58	30	10
16	3	-5
22	-34	30
61	-7	-5
48	-43	60
55	8	5
59	7	-5
17	7	70
-31	41	25
-59	5	20
-30	-37	5
-51	-54	-5
-9	-3	65
0	-61	-30
2	-45	-5
-5	-70	-15
-34	-71	-25
36	-3	60
51	-62	-10
45	-62	0
23	-28	70
28	-87	20
17	-70	55
23	-20	70
34	-75	25
31	-67	5
17	-64	40
9	-3	50
-30	-45	55
-23	-87	15
-50	-65	10
-66	-37	10
-53	-32	45
-5	2	50
-16	-59	-5
-31	-89	-10
8	-67	-30
37	-64	-15
-11	-67	-35
-34	-46	-40
-9	-71	-20
9	-4	0
31	-34	10
45	11	-10
44	-28	-5
19	-39	25
2	-31	0
33	7	-10
-14	-6	10
-9	-3	25
-30	25	15
-55	-1	25
-28	52	-5
-62	-28	5
2	-40	0
-44	-68	-20

// Denkova E, 2015: Brain regions common to Context and Emotion conditions
// Denkova E, 2015: [Context vs Sematic memory (SM)] > [Emotion vs SM] 
// inclusively masked with [Context vs SM]
// Denkova E, 2015: [Emotion vs SM] > [Context vs SM] inclusively masked with 
// [Emotion vs SM]
// Denkova E, 2015: Negative correlation between Context and Emotion ratings
// Denkova E, 2015: Positive correlation between Context and Emotion ratings
// Denkova E, 2015: Positive correlation between Emotion condition and Emotion 
// ratings
// Subjects=17
-45.9	21.06	46.78
60.43	31.01	-1.96
-51.17	35.88	-24.07
-46.86	18.25	-29.13
48.24	31.97	-25.38
43.99	29.18	-20.55
39.56	9.74	-33.12
-6.82	28.07	62.23
-7.42	64.1	22.81
0.78	58.58	-13.76
5.85	45.6	42.35
-62.53	-35.78	2.26
-58.66	-10.71	-28.3
-54.38	-2.19	-29.22
64.52	-5.71	-27.53
22.74	-40.46	-6.57
-50.14	-56.03	37.67
44.93	-55.69	36.02
10.22	-83.1	20.27
10.07	-72.23	10.23
10.35	-42.74	38.69
-7.14	-79.32	15.71
-6.89	-51.2	40.94
1.34	-42.28	9.66
9.27	48.75	-27.5
53.73	-66.53	45.9
-33.44	-40.66	-5.6
-50.18	12.64	48.81
-33.72	20.71	-15.03
44.06	34.06	-14.31
1.61	38.56	47.6
14.57	38.6	47.37
-16.38	64.98	-1.77
-53.94	-27.35	0.16
-41.93	-39.55	6.77
60.65	-39.6	0.54
-20.57	-20.51	-8.93
-20.73	-5.29	-18.28
2.1	-59.52	66.26
-2.95	-93.42	2.47
-19.97	-82.79	25.24
27.48	-65.71	21.62
-3.38	0.72	-12.44
18.46	-48.88	-4.55
-3.63	57.94	-20.34
9.78	50.36	12.68
-53.25	-49.58	49.41
-11.53	-75.5	10.92
-33.76	20.4	-18.36
1.84	23.85	62.5
-11.39	-83.18	20.65
31.62	-81.29	4.04
6.01	-60.39	33.78

// Toyomura A, 2015: Stutterers
// Subjects=10
-54	-26	8
46	-24	-2
-66	-18	-6
58	-16	-18
14	6	0
20	10	-8
18	-40	6
-44	-10	38
54	-4	28
-60	-6	20
-12	-64	-24
14	-66	-22
-22	2	10
22	6	10
-28	-18	-6
16	-4	-6
-36	10	-26
-20	-32	76
-10	16	6
10	-50	-20
-18	-26	64
28	2	-14

// Toyomura A, 2015: Healthy Controls
// Subjects=10
-54	-26	8
46	-24	-2
-66	-18	-6
58	-16	-18
14	6	0
20	10	-8
18	-40	6
-44	-10	38
54	-4	28
-60	-6	20
-12	-64	-24
14	-66	-22
-22	2	10
22	6	10
-28	-18	-6
16	-4	-6
-36	10	-26
-20	-32	76
-10	16	6
10	-50	-20
-18	-26	64
28	2	-14
-32	16	-2
-12	48	22
8	48	18
-10	2	38
10	-14	40
-24	-18	62
-28	-12	8
54	-50	30
-26	-72	6

// Wiener M, 2016: Reproduction > Production, Onset-locked
// Wiener M, 2016: Reproduction > Production, Offset-locked
// Wiener M, 2016: Parametric effect of distance during Reproduction versus 
// Production
// Wiener M, 2016: Regression analysis for Reproduction > Production, 
// Onset-locked
// Wiener M, 2016: Regression analysis for Reproduction > Production, 
// Offset-locked
// Wiener M, 2016: Regression analysis for Production > Reproduction, 
// Onset-locked
// Wiener M, 2016: Production > Reproduction, Onset-locked
// Wiener M, 2016: Production > Reproductioin, Offset-locked
// Subjects=24
-42	15	-12
-39	3	0
-36	0	15
0	9	39
0	-6	42
3	24	30
45	15	-9
57	15	-3
39	3	15
-30	-18	60
-45	-24	45
-36	-42	54
-63	-27	15
60	-15	27
63	-21	21
-27	-63	3
-15	-54	-12
-48	-72	9
15	0	0
6	0	9
-12	-24	39
15	-57	-12
15	-54	-30
24	-42	-3
24	-42	6
36	-57	0
42	-66	6
-36	-60	-45
-3	-21	-6
0	-27	3
-24	-9	-6
-18	-3	-3
54	-30	48
54	-30	39
48	39	-9
33	-18	-9
21	-45	-18
15	-63	-18
-15	-48	-12
-12	-60	-12
-33	-60	-51
6	-57	-6
51	21	24
45	24	12
45	18	6
0	27	45
-21	-54	39
-30	-57	36
-9	-63	24
45	-3	27
54	-3	27
21	-3	-21
33	3	-9
24	0	-6
51	-42	6
60	-45	6
24	33	30
21	21	30
-45	-42	-3
-42	-33	-9
21	12	-9
-15	6	-9
-30	6	-12
-21	6	0
21	-84	-12
12	-81	-3
36	-84	-15
18	-87	-18
39	-69	-12
15	-84	-12
36	-75	-15
30	-75	-21
12	-87	-15
33	-81	-21
24	-84	-15
45	9	33
42	30	21
36	12	60

// Spinelli S, 2017: ADHD
// Subjects=13
-14	-72	-26
-28	-66	-38
-16	-48	-26
20	46	28
20	44	18
-22	6	28
-24	14	18
-26	-4	8
-12	18	10
-12	12	18
-12	0	24
22	48	28
20	44	20
24	50	2
-18	-64	-30
-18	-54	-28
-22	-58	-38
-50	30	-2
-46	36	-14
-54	36	-10

// Spinelli S, 2017: controls
// Subjects=17
42	-82	28
44	-70	34
44	-62	26
20	-6	-28
36	-16	-22
28	-10	-24
22	30	36
22	24	42
14	30	48
-2	-62	22
18	-56	6
22	48	28
20	44	20
24	50	2
-18	-64	-30
-18	-54	-28
-22	-58	-38
-50	30	-2
-46	36	-14
-54	36	-10

// Sharma A, 2016: Healthy Controls
// Subjects=38
16	10	-10
-12	8	-10
24	32	-16
-38	44	-6
10	50	6
44	-44	54
28	-54	44
-20	36	50
2	38	38

// Sharma A, 2016: Unipolar Depression
// Subjects=24
16	10	-10
-12	8	-10
24	32	-16
-38	44	-6
10	50	6
44	-44	54
28	-54	44
-20	36	50
2	38	38
-16	8	-6
16	10	-10
-26	40	-10
0	66	4
28	-54	42
44	-46	34

// Sharma A, 2016: Bipolar Depression
// Subjects=24
16	10	-10
-12	8	-10
24	32	-16
-38	44	-6
10	50	6
44	-44	54
28	-54	44
-20	36	50
2	38	38
-16	8	-6
16	10	-10
-26	40	-10
0	66	4
-34	10	32
-16	8	-12
-40	36	-8
16	10	-10
44	-46	34

// Fuentes-Claramonte P, 2015: Switch > Repeat
// Fuentes-Claramonte P, 2015: Positive correlation between Sensitivity to 
// Reward (SR) Scores and Activation for Switch > Repeat
// Fuentes-Claramonte P, 2015: Negative correlation between SR socres and 
// Activation for Switch > Repeat
// Subjects=28
0	3	9
0	3	9
9	3	6
-9	3	6
-12	9	0
12	9	0
-48	-24	39
-42	-45	33
-48	-33	42
-54	24	21
-51	15	36
-42	-6	54
39	36	21
33	45	24
0	36	18
0	21	24
6	15	36
-3	-69	3
3	-69	3
-3	-60	9
3	-60	9
-9	-33	48
9	-33	48
42	-81	-6
42	-81	6
51	-72	-9
-9	-51	33
-6	-45	15
-3	-54	12
21	-48	66
30	-42	63
18	-42	57
-45	30	12
6	27	39
15	24	36
9	33	27
48	42	9
39	27	15
30	42	24
33	30	33
42	27	33
57	-30	36
48	-15	42
48	-12	57
-36	-33	45
-33	-24	57
-30	-9	51

// Joseph J E, 2015: Face > Texture, Combined Typically Developing Group (TD)
// Subjects=42
-22	-11	-15
25	-10	-16
52	-4	45
-39	-46	-21
2	42	-15
-39	-78	-9
40	-70	-10
38	-59	-17
41	-75	-6

// Kana R K, 2016: Autism Spectrum Disorder Participants (ASD)
// Subjects=17
46	22	22
46	-74	0
-34	-90	16
52	-42	0
-54	38	4
50	-68	8
-42	-70	2
8	-60	66

// Kana R K, 2016: Typically Developing Controls (TD)
// Subjects=15
56	-64	-2
-48	-74	-8
42	4	48
4	-78	-4
-16	-24	0
-48	34	-8
48	-38	4
30	16	28
24	-74	14
-40	-90	0
-16	-64	-8
-20	-28	8
-50	-50	2
-58	18	22
-30	-54	54
4	-68	20
56	-26	-10
-22	16	-6

// Morita T, 2016: Autistic Subjects (ASD)
// Subjects=14
-36	28	0
-42	10	10
-40	2	26
36	-68	-12
18	-70	-4

// Morita T, 2016: Healthy Controls (HC)
// Subjects=18
48	10	28
42	32	10
36	24	0
8	12	60
4	2	34
0	36	6
-32	16	8
40	-66	-12
42	-54	-12
36	-82	6
2	-16	-18
26	-30	-12
8	-18	2
36	-68	-12
18	-70	-4

// Young J S, 2015: Faces > Scenes
// Young J S, 2015: Scenes > Faces
// Subjects=44
48	-76	-16
42	-80	-12
42	-76	-10
40	-70	-18
-40	-82	-16
-40	-72	-22
16	-6	-14
12	-4	-16
18	0	-10
-18	-2	-12
32	-6	-42
-18	-10	-14
0	54	22
-18	58	36
-32	56	26
-10	52	22
-26	-48	-14
26	-40	-14
30	-44	-12
30	-48	-12
-28	-54	-12
22	-36	-18
-22	6	50
-24	4	58
-24	-6	44
-24	18	42
-34	52	2
-42	50	8
20	8	52
22	16	54
22	14	50
20	12	66

// Hodgson T L, 2015: Flip > Hold
// Hodgson T L, 2015: Eye > Hand
// Hodgson T L, 2015: Hand > Eye
// Subjects=15
-30.48	-59.82	53.4
10.55	-75.19	47.5
-30.49	1.4	65.27
-53.06	52.53	85.25
-39.45	66.79	53.35
-36.93	-26.79	62.57
40.42	-36.33	25.21
-3.25	52.03	8.25
-48.56	28.26	9.13
-24.12	2.72	56.07
-19.69	3.57	64.87
-17.68	13.38	54.9
-19.65	-81.47	50.87
-26.4	-92.29	27.41
-13.21	-92.7	45.15
-24.74	-60.94	-4.86
42.68	-83.74	23.14
21.41	-90.04	48.78
34.22	-86.78	37.03
33.58	-60.95	-8.09
14.98	-52.45	60.86
-52.18	-21.19	54.43
-52.27	-13.1	49.15
22.96	-109.91	-3.07
38.09	-103.27	-1.74
31.68	-107.13	3.23
-52.74	-7.91	12.78
-54.84	-16.22	15.88
47.47	-27.69	71.3
58.17	-24.02	64.03
57.45	-20.7	7.69

// Lyu C, 2015: Target-switching > Distractor-switching
// Lyu C, 2015: Target-switching condition > No-switching condition
// Lyu C, 2015: Distractor switching > No-switching condition
// Subjects=19
-18	10	67
30	15	27
-31	-56	58
36	-59	55
6	-72	0
-6	-72	0
-30	10	58
40	10	48
-39	25	-1
54	22	-3
-22	-69	40
39	-57	54
6	-63	-2
-6	-63	-2
-47	-40	9
-8	4	30
-33	24	-3
36	33	-9

// Sekutowicz M, 2016: Task switch > Repetition
// Sekutowicz M, 2016: Correlation of behavioral task switching costs for 
// Switch > Repeat
// Subjects=108
-27	-1	58
-48	14	22
-36	32	16
-51	5	37
-30	20	7
-18	8	1
-3	14	52
12	23	31
-6	20	37
-9	-73	43
-27	-70	43
-27	-67	34
12	-70	49
33	26	7
-15	-16	7
15	-13	10
24	-1	52
24	-7	52
30	-91	7
-21	-34	-2
-3	11	25
21	-34	1
-57	17	31
-51	5	37
-24	-4	58
-18	8	10
-42	20	16
-33	-22	52
-30	26	4
30	26	4
21	17	13
57	17	34
45	29	28
0	14	49
-6	-13	4
-30	-67	46
27	-7	55
6	-31	22
24	-22	16
-9	-70	46
9	-10	7

// Stelzel C, 2017: Abstract rule switching (task switch > task repetition)
// Stelzel C, 2017: Response hand switching (hand switch > hand repetition)
// Stelzel C, 2017: Conjunction (response hand switching and abstract rule 
// switching)
// Subjects=48
-50	12	22
-52	6	38
-26	-4	54
-12	-68	54
-32	-68	48
-52	0	38
-22	-4	50
-44	-26	40
36	-32	40
12	-26	16
12	-58	62
-44	-76	28
16	-22	8
20	2	20
-22	-8	-26
30	-50	-32
2	-54	-10
-26	-30	-28
-52	4	38
-14	-68	56
-26	-4	54

// Vallesi A, 2015: Task switching > Single task (spatial)
// Vallesi A, 2015: Task switching > Single task (verbal)
// Vallesi A, 2015: Task switching > Single task (Conjunction)
// Subjects=31
-38	-48	-4
-48	-46	54
-34	-64	54
-4	12	52
4	18	50
-6	24	40
44	38	26
6	-28	28
-4	-24	26
-44	30	30
-46	30	28
-42	8	26
-34	4	56
-6	12	52
-6	20	46
-48	-46	56
-40	-48	42
-30	-74	50
-4	12	52
4	18	50
-48	-46	54
-40	-48	42
-32	-56	44
-44	30	30

// Ludersdorfer P, 2015: Orthographic > Pitch Evaluation (Auditory words > 
// Auditory tones)
// Ludersdorfer P, 2015: Semantic > Pitch Evaluation (Auditory words > 
// Auditory tones)
// Subjects=24
-48	32	7
-42	5	25
-48	20	22
-60	-28	-5
-45	-64	-11
-27	-67	40
-12	-85	34
60	-22	-5
-60	-34	5
-48	20	19
-33	-67	40
36	26	-11
60	-22	5
9	-76	7

// Armbruster D J N, 2017: Task Switching > Implicit Baseline
// Armbruster D J N, 2017: Distractor Inhibition > Implicit Baseline
// Armbruster D J N, 2017: Task Switching > Distractor Inhibition
// Subjects=20
-46	-2	44
44	4	34
-46	32	36
44	30	30
42	42	12
32	22	-4
0	0	56
-6	16	42
-30	-52	46
54	-36	52
-2	-84	8
-20	0	14
18	2	14
18	-22	4
-2	-60	-12
-48	4	36
44	30	24
40	4	30
46	42	12
34	24	-6
-6	16	46
-42	-36	40
-44	-70	-10
46	-32	44
-44	-2	44
26	-8	52
-58	-28	50
56	-22	44
-54	-2	4
50	0	4
0	10	28
2	32	12
-6	-38	24
12	-8	64
10	-82	0
24	4	14
12	-18	12

// Liu Z, 2015: Rule learning > Rule application
// Liu Z, 2015: Rule Application > Rule Learning
// Liu Z, 2015: Switching > Rule Application
// Liu Z, 2015: Switching > Hypothesis Testing
// Liu Z, 2015: Hypothesis testing > Switching
// Liu Z, 2015: Feature Cued + Externally Cued > Feedback Cued
// Liu Z, 2015: Externally Cued > Feature Cued
// Subjects=12
43	26	36
-32	12	59
-55	11	33
49	13	3
-33	18	-6
-39	59	10
26	56	-17
10	7	5
-16	-2	16
30	-57	44
-38	-57	49
-42	-60	-21
68	-6	2
-6	-53	19
0	50	-16
-49	18	-39
-26	-19	-26
52	40	14
29	-57	7
-19	-59	22
-22	-49	-6
-19	9	-8
-16	9	-9
8	15	52
-8	6	59
60	11	35
-47	2	54
-63	-2	45
70	-13	54
24	-67	30
28	-53	48
-27	-67	34
-50	10	30
33	42	-12
30	36	-34
-32	39	-37
27	35	-14
-41	17	6
43	-46	-23
-47	-58	-10
37	-86	34
27	-62	9
-24	-40	4
20	19	-9
14	20	8
-15	4	-4
-44	53	-18
-14	44	49
30	70	19
-41	41	-10
69	-2	-34
69	20	-30
59	-46	-26
1	-95	-21
-54	-75	-25
-31	-28	-34
-18	3	27
24	-26	19
55	-60	-20
23	-89	-20
36	-66	-19
35	-41	-25
-55	-59	-8
21	18	60
-33	58	4
-34	2	63
-49	40	16
-22	21	57
10	9	-2
-3	7	5
20	-46	-4
0	-59	-6
17	-95	18
-39	-90	5
71	-3	-2
14	-20	61
-9	-49	64

// Manza P, 2016: Stop Signal Task (SST) SST25 > SST75 (Stop Success (SS) > Go 
// Success (GS))
// Manza P, 2016: Brain regions showing a significant correlation between SS > 
// GS and Stop-signal reaction time (SSRT)
// Subjects=16
-33	20	4
-42	14	4
-54	8	13
36	20	-8
48	38	25
9	-16	-11
-54	-37	37
-60	-40	46
-45	-49	55
60	-40	40
63	-34	22
30	-55	40
6	32	34
6	14	46
-6	17	43
-54	-58	-2
-42	-55	-11
-63	-55	13
54	-22	-8
-24	-70	-44
-33	-67	-44
-18	-61	-32
0	-22	-26
51	-49	-11
0	-58	-21
-9	23	46
9	26	37
12	14	58
15	11	34
-6	-19	-2
-9	-22	13
6	-13	1

// Wylie G R, 2017: Color Repeat > Baseline + Motion Repeat > Baseline
// Wylie G R, 2017: Color Switch Cue > Color Repeat Cue
// Wylie G R, 2017: Color Switch Cue > Motion Repeat Cue
// Wylie G R, 2017: Imperative Stimuli vs. Color Repeat Targets
// Wylie G R, 2017: Motion Switch Targets > Motion Repeat Targets
// Subjects=13
-.69	12.67	48.41
-56.34	7.08	36.13
-26.13	-60.07	45.88
-51.73	-46.51	58.42
-13.51	-97.26	4.24
-.9	-59.8	-7.96
7.92	-96.45	12.85
33.25	-64.51	-16.88
28.87	-47.96	-22.68
-39.41	23.07	21.21
-22.59	7.06	-22.24
-52	7.79	44.95
-47.78	-41.11	17.77
-39.44	-60.72	-16.37
20.47	58.98	39.82
25.27	-71.77	55.19
59.02	-62.99	0.54
33.64	-86.81	25.13
46.12	-68.32	-12.25
16.51	-96.05	17.18
-.29	-75.47	64.72
63.25	-59.08	-4.3
-47.69	-.64	45.6
-26.3	21.66	56.87
-26.76	60.87	13.44
-43.63	36.76	33.5
-5.52	59.63	-4.54
-21.71	-62.91	63.91
-60.74	-24.95	7.64
54.81	12.32	38.88
37.36	61.26	12.67
28.64	50.69	-13.11
41.97	25.27	42.4
50.82	-55.04	49.03
59.14	-48.59	21.63
20.44	-51.21	-8.93
-47.67	-79.52	16.53
-.58	-34.54	43.44
-5.33	8.87	-.29
8.26	-40.21	79.5
20.22	16.8	-10.17
-56.1	-29.96	52.62
-35.34	-40.57	-31.48
41.75	49.28	22.55
24.44	-32.1	-37.34

// Xu B, 2015: Stop-inhibit > StGo
// Xu B, 2015: Switch > SwGo
// Xu B, 2015: Stop-inhibit > Switch
// Xu B, 2015: Switch > Stop-inhibit
// Xu B, 2015: Stop-inhibit + Switch
// Subjects=18
64	-44	14
-54	-42	39
54	16	15
-50	12	26
-32	18	6
-12	18	5
-12	12	6
10	-6	5
48	-20	-7
16	13	66
3	49	17
4	28	38
24	52	32
-40	34	36
48	-41	41
-45	-42	48
30	-62	57
-32	-57	60
55	13	12
52	21	0
3	18	48
2	-21	30
30	6	58
-32	7	65
39	31	48
26	49	39
52	21	15
58	-51	32
6	25	57
37	24	5
28	-92	-12
-26	-98	-9
-32	-26	70
-40	-21	51
21	-57	-24
28	-48	-54
64	0	17
-15	-90	24
3	18	48
52	21	0
37	20	0
3	27	36
33	7	57
48	-41	41
-52	-39	39

// Ma J, 2017: ADHD > Control for No-go > Go
// Subjects=15
44	-64	-8
4	-12	-14
34	0	28
32	-60	12
32	-74	-2
-32	-76	12
4	-40	-22
2	-80	-30
-54	-4	16
-48	34	18
32	-28	-8
28	-90	14
-40	-84	-12

// MacDonald A D, 2015: Unprimed > Long-term
// MacDonald A D, 2015: Long-term > Unprimed
// MacDonald A D, 2015: Short-term > Unprimed
// MacDonald A D, 2015: Short-term > Unfacilitated
// Subjects=18
-45	33	15
42	24	21
54	0	21
-48	-51	-15
45	-45	57
0	-66	57
6	-57	48
39	33	39
42	-27	45

// van Rooij D, 2017: Controls = Sibs > ADHD on Successful stop - Go
// van Rooij D, 2017: Controls > Sibs= ADHD on Successful stop - Go
// van Rooij D, 2017: Controls > Sibs > ADHD on Failed stop - Go
// van Rooij D, 2017: Controls > Sibs = ADHD on Failed stop - Go
// van Rooij D, 2017: Controls = Sibs > ADHD on Failed stop - Go
// Subjects=111
-38	20	-18
-2	60	38
-58	-20	34
42	-24	52
48	-42	14
-52	18	-12
-50	-50	-12
48	-44	14
-18	42	30
-2	12	22
-58	-24	26

// Nigri A, 2015: Healthy controls
// Subjects=28
42	32	2
-39	29	3
12	-49	-13

// Nigri A, 2015: Disorder of Consciousness (DOC) patients
// Subjects=42
-30	23	-7

// Richey J A, 2015: Think Positive > Pre-Instruction, Controls > ASD
// Richey J A, 2015: Think Negative > Pre-Instruction, Controls > ASD
// Richey J A, 2015: Think Positive or Negative > Pre-Instruction, Controls > 
// ASD
// Subjects=15
12	7	-9
-23	5	-7
-19	1	-17
25	2	-25
-43	22	30
41	17	33
-23	29	53

// Mutic S, 2017: Aggression > Exercise Chemosignals, All emotional Stroop 
// conditions
// Mutic S, 2017: Aggression Chemosignals > No odor, All emotional Stroop 
// conditions
// Mutic S, 2017: Aggression > Exercise Chemosignals, Threat-related Stroop 
// conditions
// Mutic S, 2017: Aggression Chemosignals > No odor, Threat-related Stroop 
// conditions
// Subjects=18
-6	-1	-7
27	-4	68
48	-25	17
-9	2	-1
15	-28	8
-9	-28	-1
27	-4	68
-12	-1	-7
-3	-10	-10
6	-4	-7
-6	17	32
9	-61	-4
36	-61	20
12	-28	5
18	-22	8
9	-16	2
18	44	29
-24	23	29
-21	-10	-7
-9	-4	-10
60	-4	11

// Segarra N, 2016: Controls
// Subjects=21
14	30	56
8	6	-2
-6	-80	2
-48	40	-22
62	-26	-22
-20	-100	6
0	-24	30
-14	-76	-34
54	-54	40
-40	-62	40
14	30	56
8	6	-2
-6	-80	2
-48	40	-22
62	-26	-22

// Segarra N, 2016: Depression
// Subjects=24
14	30	56
8	6	-2
-6	-80	2
-48	40	-22
62	-26	-22
14	30	56
54	-54	40
-40	-62	40

// Segarra N, 2016: Schizophrenia
// Subjects=21
14	30	56
8	6	-2
-6	-80	2
-48	40	-22
62	-26	-22
-20	-100	6
0	-24	30
-14	-76	-34
54	-54	40
-40	-62	40
14	30	56
54	-54	40
-40	-62	40

// Walter H, 2017: Schizophrenia
// Subjects=16
-15	-9	-9
12	12	6
-6	12	30
-6	42	-6
-12	9	-3
27	-75	-27

// Walter H, 2017: Healthy Controls
// Subjects=16
-12	6	-3
9	6	-3
15	-15	-12
9	-27	-12
-6	-24	-12
-6	12	30
-39	27	-6
-21	-66	21
21	-72	15
-9	-99	6
-6	12	30
-3	51	-6
42	24	-15
9	39	21
42	36	21
39	21	-51

// Yan C, 2016: Gain > Non-gain anticipation, Controls > Negative schizotypy
// Yan C, 2016: Gain > Non-gain outcomes, Controls > Negative schizotypy
// Subjects=15
-30	-48	-42
12	-99	0
0	-90	-3
-63	-36	-6
-15	21	-3
-15	27	-12
66	-21	45
-18	0	-15
-6	-18	-15
-21	-51	-18

// Chou T L, 2015: ADHD patients treated with Atomoxetine
// Subjects=22
30	-15	60
12	-57	60
-18	-51	60
-3	9	42
3	12	42
-39	15	-3
48	-72	12
-24	39	36
30	-27	54
-30	12	15
33	12	0
0	15	39
-21	42	36
18	-48	63
-21	-45	60
-27	-24	63
-3	6	45
-27	39	39
6	33	60
45	42	0
42	12	-27
-45	-9	-15

// Chou T L, 2015: ADHD patients treated with OROS methylphenidate
// Subjects=20
-63	-48	15
36	-39	66
3	30	54
36	-39	66
42	-24	48
-51	15	-6
-39	21	27
36	-69	51
-45	33	24
27	-45	63
-39	-66	57
-42	36	21
18	57	6
42	12	-27
-45	-9	-15

// Chou T L, 2015: Healthy Controls
// Subjects=20
18	-48	63
-21	-45	60
-27	-24	63
-3	6	45
-27	39	39
6	33	60
45	42	0
27	-45	63
-39	-66	57
-42	36	21
18	57	6

// Melchers M, 2017: Vicarious embarrassment films > Control films
// Melchers M, 2017: Control films > Vicarious Embarrassment films
// Subjects=60
-51	-73	-2
48	-58	1
-60	-28	31
63	-21	37
48	35	7
-3	47	-23
-27	-49	-8
27	-46	-8
-36	82	37
42	-76	34

// Takahashi H, 2017: Guilt - Neutral
// Takahashi H, 2017: Embarassment - Neutral
// Takahashi H, 2017: (Guilt > Neutral) + (Embarrassment > Neutral)
// Takahashi H, 2017: Embarrassment - Guilt
// Takahashi H, 2017: Guilt - Embarrassment
// Subjects=19
-6	-95	12
2	-85	6
-16	49	9
4	57	16
-44	-61	20
20	-70	0
-8	50	25
-42	-59	18
-51	-31	-7
-53	1	-24
48	-7	-27
-44	31	-7
-34	-18	-18
-2	-89	4
2	59	17
-12	-77	6
2	-85	6
-10	36	52
4	57	16
-44	-61	20
12	-83	8
38	-68	-5
-10	-62	-2
-8	-80	1
42	-3	-27
32	-18	-13
-20	-14	-9
-16	49	14

// Ely A V, 2015: Non-Dieters
// Subjects=10
-22	16	58
-58	-2	-36
-34	-34	-4
-58	-14	-4
60	-4	6
-26	-6	-6

// Ely A V, 2015: Historical Dieters
// Subjects=10
-22	16	58
-58	-2	-36
62	-42	0
-52	-2	-12
16	-22	-14
8	16	-2
-16	-50	38
-56	-72	-6
50	22	26
-26	14	-14
52	-66	-2
-42	-12	28
-28	-48	-18
-4	56	-14
-2	-14	28
-24	-8	-12
40	24	-12

// Gao X, 2016: Lean Women
// Subjects=13
-1.64	11.66	63
42.75	33.2	7.15
-33.8	3.84	47.3
36.76	-5.25	47.25
-34.03	14.64	21.86
52.6	12.59	28.84
4.08	30.91	-18.97
-15.03	-4.1	-15.82
-17.06	13.46	5.04
36.15	-4.99	-31.94
-18.12	-6.26	-2.22
17.07	-6.82	-12.61
-4.95	-51.97	24.88
-18.01	-28.21	2.97
17.23	-28.26	-.78
-59.9	-7.54	-15.01
-20.72	-65.87	52.99
-33.57	-56.35	53.46
-24.02	-75.64	37.12
17.74	-59.21	53.11
-41.63	-49.27	-19.53
36.32	-35.06	-21.62
-44.47	-47.64	29.43
-45.6	-64.79	14.16
52.19	68.78	-1.51
-40.3	-65.18	8.55
43.04	-64.86	5.34
-40.33	-76.53	-.53
43	-76.2	-3.75
29.97	-75.16	-30.45
1.45	14.88	49.31
5.9	9.05	69.82
0.87	67.07	-5.24
5.1	56.81	-14.47
-52.11	9.93	31.38
57.95	10.59	30.06
43.86	33.72	13.79
-12.08	-49.56	70.49
0.98	10	-13.84
-.67	-46.49	26.6
-.81	25.73	38.39
7.67	11.89	23.84
6	-72.31	49.88
-16.98	9.83	13.15
19.37	4.76	13.15
-9.58	-.75	-.55
-32.25	-3.29	-31.3
30.81	-2.82	-30.95
-10.52	-15.94	9.66
15.12	-15.87	8.24
-1.05	59.51	21.06
6.06	-63.97	61.45
1.47	-59.59	22.1
-15.62	-84.87	13.27
-20.98	-88.33	10.27
-2.11	59.59	22.18
-14.61	-95.32	1.86
14.27	-94.89	4.84
26.87	-83.93	-19.64
3.58	14.9	49.29
-22.06	3.74	44.94
-18.4	31.49	-23.23
1.34	30.23	41.34
3.48	28.13	41.49
-24.62	32.36	2.42
33.09	27.25	-0.04
28.86	14.54	1.07
-33.29	-10.69	-30.67
-35.4	-8.25	-26.39
32.94	-2.9	-32.08
1.3	13.34	29.37
3.48	6.12	32.18
-3.39	38.7	-13.97
19.02	41.83	-16.72
1.39	-62.56	11.2
8.74	-13.36	13.68
-31.1	-10.17	-24.05
-30.94	-33.72	-12.04
-17.96	-40.81	5.14
-22.72	6.83	-38.95
-30.92	-43.41	-13.45
36.34	-34.89	-19.4
-16.36	-52.93	68.59
11.41	-61.65	63.42
-30.5	-37.98	42.96
-9	-57.43	51.04
1.41	-76.65	7.92
3.58	-82.9	9.53
-30.53	-88.85	18.23
-30.71	-90.73	-6.14
-9.56	-63.25	-24.3
1.03	-46.61	-30.28

// Gao X, 2016: Overweight Women
// Subjects=16
-46.06	47.93	-.87
51.26	43.91	7.27
-49.1	27.7	13.13
44.92	24.84	8.95
-30.79	-24.52	10.61
38.31	32.6	-13.93
-49.95	11.35	35.7
53.68	8.37	29.19
-3.88	11.76	50.75
7.98	5.2	61.2
-37.14	15.65	35.19
41.94	5.12	29.59
-37.4	-32.16	-18.78
36.3	-32.06	-24.1
-32.21	-5.14	-27.8
32.96	-2.64	-28.76
-14.83	6.67	13.39
-20.2	-2.33	7.51
-19.13	-1.27	7.41
20.4	-1.12	5.83
-18.02	-30.5	0.93
19.38	-28.07	1.41
-32.48	-53.97	56.59
34.81	-53.82	52.46
-10.02	-71.18	52.2
8.15	-73.27	51.05
-33.56	-55.2	54.48
36.94	-53.98	50.22
-20.95	-91.33	12.75
23.93	-91.06	12.22
-42.49	-58.05	4.63
45.16	-57.27	6.91
-41.63	-48.13	-18.51
38.57	-53.73	-15.62
-33.77	-91.41	12.91
36.79	-87.39	17.34
-32.81	-92.52	-1.51
33.42	-92.38	-5.63
-5.27	-70.71	-24.84
-10.63	60.85	25.52
-49.87	5.52	42.88
50.51	5.43	32.81
-38.4	33.4	16.99
48.14	33.74	13.74
-52.31	22.14	10.29
44.92	26.95	8.77
-41.84	41.98	-9.34
37.27	35.05	-9.67
-50	11.89	28.97
45.03	25.95	23.35
-4.92	16.42	55.95
5.83	5.02	59.01
-37.06	2.16	39.67
50.58	-2.68	37.95
-35.42	-2.96	-26.83
32.98	-2.47	-26.54
-16.93	-26.98	5.08
-32.48	-53.97	56.59
27.4	-53.18	61.41
-24.17	-56.4	24.36
16.71	-58.79	58.66
-33.53	-53.8	58.82
-19.86	-91.15	14.96
21.79	-90.02	12.15
-43.42	-63.2	20.69
50.62	-62.64	19.56
-41.61	-42.5	-14.52
41.72	-38.83	-15.79
-32.78	-91.12	2.83
34.55	-84.03	5.93
-32.81	-92.52	-1.51
33.44	-91.06	-2.39
-7.43	-74.24	-28.98
51.35	39.31	16.58
19.08	10.57	-21.9
40.9	1.06	32.18
-26.06	-62.56	55.01
33.79	-62.2	54.29
36.3	19.61	-2.78
-21.87	-64.53	42.86
28.3	-60.43	36.36
-33.74	-81.21	20.97
31.4	-81.25	14.65
-15.8	-87.81	-11.02
16.33	-86.94	-2.54
-38.43	-65.8	-27.1
-4.39	25.11	-10.58
1	21.26	-5.86
11.14	-79.88	20.35
-2.78	-80.22	17.19
58.05	-51.05	17.39

// Jackson T, 2017: Exercise - Landscape
// Jackson T, 2017: Sedentary - Landscape
// Jackson T, 2017: Exercise - Sedentary
// Jackson T, 2017: (Overweight (OW) > Average weight (AW)) x (Exercise - 
// landscape)
// Jackson T, 2017: (AW > OW) x (Sedentary - landscape)
// Jackson T, 2017: OW > AW
// Subjects=13
-17.6	-7.47	64.79
24.04	-4.3	60.7
-46.71	-63.02	9.56
52.66	-65.86	5.31
-33.61	-40.31	54.34
-1.79	3.52	40.27
29.68	0.97	-36.83
-34.37	-2.07	-29.15
29.82	-.92	-19.95
-24.48	7.42	10.09
23.62	4.53	9.78
17.24	-24.83	2.28
52.31	32.74	0.39
-43.48	-56.14	15.64
52.33	-0.01	-10.24
52.66	-65.86	5.31
-40.55	-42.58	-15.64
-27.89	-1.26	-19.25
29.83	-4.09	-19.68
17.26	-24.57	5.6
-56.18	-23.07	45.35
62.42	-21.48	41.62
0.29	-9.13	27.92
33.55	11.1	52.61
-27.53	-27.24	16.38
-30.68	-36.52	20.54

// Kurosaki M, 2017: Lean Females
// Subjects=11
6	-79	-34
12	-77	-24
31	10	28
-20	-3	-15
-31	12	29
-20	-3	-15
-31	12	29
-31	3	25
-40	26	6
-45	34	-6
-17	-79	-38
-22	-79	-33
-8	-77	-31
-13	20	50
-1	20	39
-8	18	43
-38	16	8
-45	26	8
-36	43	-2

// Kurosaki M, 2017: Lean Males
// Subjects=11
-20	-75	-22
-29	-69	-25
31	-52	31
26	-67	31
17	-67	31
36	-85	4
3	-89	-5
12	-81	-11
-38	-81	-11
-13	-93	-17
-29	-83	-17
3	-93	7
34	-69	-13
36	-50	-15
26	-63	30

// Puzziferri N, 2016: Obese Females
// Subjects=15
42	-20	4
46	-2	12
34	-32	2
-38	-2	-24
-38	18	-26
-36	16	-34
18	8	42
12	14	56
26	-6	48
-4	-30	-36
14	-36	-38
0	-38	-42
48	28	-2
52	16	-4
-18	-36	-28
-16	-38	-16
-14	-44	-26
32	14	-24
34	26	-16
-32	-4	64
-40	-14	48
-36	-10	54
8	-76	-34
14	-76	-44
8	-82	-22
-32	46	8
-20	50	14
-16	62	14
36	-6	38
-28	10	68
-22	18	30
-32	34	44
8	-48	-16
-2	-50	-22
10	32	14
6	44	12
12	28	36
40	-60	-46
30	-52	-48
14	-50	14
8	-54	18
-12	-58	18
26	32	48
26	18	42
6	40	50
-8	34	52
10	40	42
-8	-68	42
-2	-26	-4
6	-24	-2
-6	-36	48
-12	-50	38
-10	-48	30

// Puzziferri N, 2016: Lean Females
// Subjects=15
8	-50	-18
16	-88	-4
10	-12	10
14	-36	3
14	-50	16
-6	-56	16
8	40	46
-26	24	44
-2	66	24
-64	-22	36
-10	-20	36
4	-34	-46
2	-30	-38
8	-76	-34
14	-76	-44
8	-82	-22
-32	46	8
-20	50	14
-16	62	14
36	-6	38
-28	10	68
-22	18	30
-32	34	44
8	-48	-16
-2	-50	-22
10	32	14
6	44	12
12	28	36
40	-60	-46
30	-52	-48
14	-50	14
8	-54	18
-12	-58	18
26	32	48
26	18	42
6	40	50
-8	34	52
10	40	42
-8	-68	42
-2	-26	-4
6	-24	-2
-6	-36	48
-12	-50	38
-10	-48	30

// Tuulari J J, 2015: Entire Cohort: Inhibition > Passive viewing
// Tuulari J J, 2015: Entire Cohort: Inhibition > Imaginary eating
// Tuulari J J, 2015: Entire Cohort: Imaginary eating > Passive viewing
// Tuulari J J, 2015: Entire Cohort: Imaginary eating > Inhibition
// Tuulari J J, 2015: Entire Cohort: Passive viewing > Inhibition
// Tuulari J J, 2015: Entire Cohort: Passive viewing > Imaginary eating
// Tuulari J J, 2015: (Healthy > Obese) x (Inhibition > Passive viewing)
// Tuulari J J, 2015: (Obese > Healthy) x (Inhibition > Passive viewing)
// Tuulari J J, 2015: (Healthy > Obese) x (Imaginary eating > Passive viewing)
// Tuulari J J, 2015: (Healthy > Obese) x (Inhibition > Imaginary eating)
// Subjects=14
-18	52	32
-2	6	60
-8	2	74
50	24	6
-46	-36	18
64	-32	18
8	-74	32
40	-16	-40
48	-62	40
27	-72	-24
-12	4	72
-50	-34	48
-24	-72	42
6	-38	40
44	-74	26
40	8	46
36	14	62
30	20	62
56	-52	24
52	-62	22
6	-76	38
24	16	48
38	52	24
30	20	62
-50	28	8
-66	-28	8
-60	-16	-2
28	32	-6
44	38	-2
44	22	26
6	-38	12
-4	-32	12
38	14	-10
-14	16	30
20	6	22

// Gilead M, 2016: Self-conscious > Basic
// Gilead M, 2016: Basic > Self-conscious
// Gilead M, 2016: Guilt > Other
// Gilead M, 2016: Pride > Other
// Gilead M, 2016: Anger > Other
// Gilead M, 2016: Joy > Other
// Gilead M, 2016: Social > Non-social
// Gilead M, 2016: Negative > Positive
// Subjects=19
-8	46	36
-38	14	46
-28	-38	-24
14	-50	6
-46	-80	32
64	-16	30
-50	-6	-8
8	8	8
58	26	14
-6	16	68
-52	20	8
46	38	-14
-48	-38	-8
-42	-64	42
14	-86	2
-24	-80	-38
22	-80	-24
-2	62	24
-40	-60	26
-52	-6	-28
40	-84	32
-36	-86	36
-8	52	28
-50	26	-10
-38	10	50
-34	52	8
-50	-64	18
-2	-62	38
-22	-80	-44
26	-80	-42
-42	10	52
2	40	52
42	30	-18
-50	-64	20
-52	-8	-28
-20	-86	-32

// Chung Y S, 2016: Healthy Controls
// Subjects=27
46.22	8.58	32.6
41.93	34.7	40.49
52.53	30.57	27.34
-47.83	8.9	31.42
56.85	-41.42	4.33
-10.54	-82.04	-19.37
-25.64	-68.18	-31.51
33.82	-58.6	59.56
-19.68	-62.86	50.5
-11.73	-82.27	-36.07
47.6	-46.43	50.58
-35.73	-53.36	51
17.7	-63.95	46.82
16.09	-80.62	-30.95
-52.85	-42.63	53.64
-35.31	-53.43	-32.64
4.22	-58.83	-37.1
53.79	-47.56	21.61
-42.6	-64.71	-12.65
-42.69	-49.19	-18.41
-30.81	-76.36	-12.92
49.47	-60.16	10.45
44.1	-77	-.35
-27.26	-74.94	32.64
49.3	-56.41	-9.94
38.94	-81.66	22.41
-25.18	-89.79	19.36
31.56	-73.02	38.49
34.35	-69.62	-14.24
-27.69	-57.48	-16.77
35.32	-50.84	-19.17

// Chung Y S, 2016: Schizophrenia
// Subjects=36
35.1	35.84	-13.05
24.5	30.03	-4.64
46.22	8.58	32.6
41.93	34.7	40.49
52.53	30.57	27.34
-47.83	8.9	31.42
56.85	-41.42	4.33
-10.54	-82.04	-19.37
-25.64	-68.18	-31.51
33.82	-58.6	59.56
-19.68	-62.86	50.5
-11.73	-82.27	-36.07
47.6	-46.43	50.58
-35.73	-53.36	51
17.7	-63.95	46.82
16.09	-80.62	-30.95
-52.85	-42.63	53.64
-35.31	-53.43	-32.64
4.22	-58.83	-37.1
53.79	-47.56	21.61
-42.6	-64.71	-12.65
-42.69	-49.19	-18.41
-30.81	-76.36	-12.92
49.47	-60.16	10.45
44.1	-77	-.35
-27.26	-74.94	32.64
49.3	-56.41	-9.94
38.94	-81.66	22.41
-25.18	-89.79	19.36
31.56	-73.02	38.49
34.35	-69.62	-14.24
-27.69	-57.48	-16.77
35.32	-50.84	-19.17

// Nielson M O, 2017: Salience:(Uncertain gain (ug) + Uncertain loss (ul) > 
// Certain neutral (cn) + Uncertain neutral (un))
// Nielson M O, 2017: Behavioral salience: (ug + ul > Certain gain (cg) + 
// Certain loss (cl))
// Nielson M O, 2017: Valence anticipation: (cg + ug > cl + ul)
// Nielson M O, 2017: Winning (Certain win (cw) + Uncertain win (uw) > Zero 
// neutral (zn))
// Nielson M O, 2017: Losing outcome (Certain lose (ocl) + Uncertain lose 
// (oul) > zn)
// Subjects=31
51.82	-48.06	42.86
48.13	6.19	1.55
12.82	5.47	-4.67
38.68	37.51	35.83
35.62	-69.76	11.41
32.07	28.82	6.53
29.04	-25.39	7.76
19.84	-34.28	58.8
19.26	45.37	15.33
0.75	-39.45	76.18
-31.98	-17.01	-2.27
-31.85	30.49	33.89
24.57	-51.59	-27.9
23.95	-95.29	12.57
13	-5.85	14.12
2.59	-4.14	50.89
1.44	-87.4	6.59
-29.91	3.18	-2.88
-29.33	-11.68	66.39
-34.21	-55.28	-29.15
-43.32	-13.85	53.35
-45.43	-28.92	51.29
-49.82	-26.89	36.68
11.67	9.01	-13.88
-1.92	-17.57	15.27
-11.78	9.47	-5.84
70.61	-39.37	-11.61
45.46	-60.79	44
48.26	33.88	29.34
48.39	12.19	37.85
47.99	57.46	3.94
38.73	-87.14	-7.24
26.11	-91.77	16.71
6.72	-86.82	-.21
6.5	42.64	22.39
-0.02	-54.02	-29.65
-16	-73.41	-31.18
-32.11	-71.1	-41.23
10.95	-78.51	-3.19
-1.3	50.25	-16.07

// Sabharwak A, 2016: Psychosis group
// Subjects=46
-48	36	-4
-64	-48	14
-32	-4	-12
50	-10	44
-10	38	30
-42	22	38
-64	-44	-8
-36	-64	26
-26	28	10
-12	18	38
32	-68	-42
-8	2	2
10	48	6
-36	52	12
10	48	4
-60	-18	-22

// Simon J J, 2015: Expectation of reward: Large reward > No reward, All 
// subjects
// Simon J J, 2015: Expectation of reward: Small reward > No reward, All 
// subjects
// Subjects=23
-9	-87	-4
-12	0	-4
9	6	-8
-39	18	0
36	27	0
-6	27	20
-12	12	8
9	-9	12
-42	0	32
-39	33	28
42	45	24
38	-30	-54
29	3	-63
54	3	-30
12	-30	-81
9	-45	3
55	-9	-75
51	-6	12
-9	6	0
12	6	-4
-39	18	4
36	21	-4
0	12	28
24	-54	-20

// Arrondo G, 2015: Healthy Controls
// Subjects=21
-2	-56	-18
10	10	56
-14	-8	12
10	16	-4
32	32	-6
-26	24	-4
-30	-22	-4
-38	42	-4
24	-68	-26
-12	-18	-14
46	0	44
26	-70	-56
36	0	48
50	-42	16
24	52	0
-32	-40	34
-34	-8	42
34	58	-10
-40	-58	-20
8	-74	-36
-4	14	20
20	-12	-10
50	18	-8
-32	58	-10
-40	-4	54
26	-58	-22
34	34	20
-28	-4	42
2	36	30

// Paulus F M, 2015: Vicarious embarrassment ((Embarrassment WITH > Neutral) 
// AND (Embarrassment FOR > Neutral))
// Paulus F M, 2015: Vicarious Embarrassment (Parametric modulations)
// Paulus F M, 2015: Embarrassment WITH > Embarrassment FOR
// Paulus F M, 2015: Embarrassment FOR > Embarrassment WITH
// Subjects=32
-3	14	55
-6	-10	7
-36	26	-2
-6	56	22
45	17	-29
33	-61	-26
-3	-22	-17
-48	14	22
12	11	10
-39	-55	-26
-30	-16	-8
51	2	46
-30	23	7
69	-37	22
3	-1	61
-54	-37	28
51	-37	4
33	26	7
-9	23	28
-51	-31	25
-54	-58	16
51	-49	7
-15	-88	7
66	-43	13
-21	-7	-14

// Gunther V, 2017: Happy > Neutral
// Gunther V, 2017: Neutral > No-face
// Gunther V, 2017: Sad > Neutral, High > Low Social Anhedonia
// Subjects=18
54	-46	37
48	20	31
-51	-49	31
66	-37	-2
57	-52	1
-60	-37	34
15	8	52
48	-4	37
-33	32	31
18	-46	-44
-6	-28	1
-39	41	31

// Kirschner M, 2016: Reward anticipation > No reward anticipation
// Subjects=25
10	15	-3
12	6	3
-14	20	-14
4	-6	3
9	24	-5
-6	20	-5
-36	-30	52
12	-91	4
9	-87	4
-48	-30	45
-9	8	1
-42	-19	52
-46	-24	49
-38	-28	57
-42	-25	46
4	8	49
-33	36	30
30	28	21
34	34	31
33	31	43
36	-15	-13
-34	-6	-6
34	1	-6
42	-61	3
46	46	4
64	-21	15
-42	-51	-12
-63	-21	12

// Makowski C S, 2016: Schizophrenia
// Subjects=15
14	-90	-38
36	-86	-36
64	-20	40
4	32	-10
-4	36	-10
-4	22	-12
-28	56	24
-20	50	24
-48	28	-16
10	-44	38
18	-44	40
46	-58	40
36	-54	56
40	-40	54
-14	-44	58
30	12	-18
34	18	-22
24	2	-12
10	34	38
22	20	50
30	24	52
-24	-48	24
-30	-54	26
-8	-8	34
42	22	-18
-40	4	36
-54	20	20
56	14	10
56	-20	36
12	-54	14
-6	-56	8
-8	-54	10
-38	-64	32
32	-68	-10
48	-20	38
60	-12	40
-46	30	-16
-46	18	-12
-40	-66	34
-44	0	36
-40	12	34

// Makowski C S, 2016: Healthy Controls
// Subjects=15
-34	-92	8
-30	16	-22
-10	-8	-8
-12	-10	-14
-14	14	2
10	8	0
36	20	-24
28	16	-22
24	34	-16
44	-86	6
10	-48	40
-14	-46	42
-2	-42	38
34	-66	-12
26	-84	-2
40	-84	-14
-14	56	0
8	34	36
6	24	18
-42	-60	-8
-48	-60	-16
52	38	2
10	-44	38
18	-44	40
46	-58	40
36	-54	56
40	-40	54
-14	-44	58
30	12	-18
34	18	-22
24	2	-12
10	34	38
22	20	50
30	24	52
-24	-48	24
-30	-54	26
-40	30	0
-30	22	-14
-14	-4	-14
20	-24	-16
32	-24	-20
-6	-54	14
-26	14	-22
-34	20	-18
-24	22	-10
42	-82	24
26	-72	42
32	20	-30
30	34	-14
30	22	-18
30	34	-14
-44	-60	-10
-48	-54	-22
-32	-88	4
-24	-92	-10
0	36	-4
8	46	18
6	36	40
2	4	30
0	-12	36

// Richter A, 2015: Schizophrenia
// Subjects=16
-12	6	9
12	0	3
-9	-18	-15
6	-24	-18
-30	42	12
36	42	12
-36	51	21
-33	39	21
39	33	33
-42	3	33
51	6	30
-36	-15	63
27	-6	51
-30	21	0
33	21	0
-27	-57	42
33	-54	42
-36	-45	45
-15	24	-9
-33	36	30
36	42	33
-33	15	33
42	-6	48
-36	-18	63
27	-3	51
-30	24	-12
-33	-57	27
33	-72	36
-36	-42	51
36	63	9
-39	54	18

// Richter A, 2015: Healthy Controls
// Subjects=16
-15	6	6
12	6	3
-6	-18	-18
6	-24	-18
-36	42	12
27	45	0
-36	51	21
-33	39	21
36	30	30
-42	3	33
42	3	42
-36	-15	63
24	-9	48
-30	18	3
33	21	3
-30	-51	45
33	-54	45
-39	-48	63
-15	24	-9
-33	36	30
36	42	33
-33	15	33
42	-6	48
-36	-18	63
27	-3	51
-30	24	-12
-33	-57	27
33	-72	36
-36	-42	51
36	63	9
-39	54	18

// Schmidt A, 2018: Healthy Controls
// Subjects=13
12	-74	14
-2	-84	20
22	-70	6
-6	-24	-10
6	-22	-10
-48	-54	-4
-46	12	-16
-14	-74	24
-26	-76	20
-8	-78	6
-14	-70	44
52	10	2
44	8	6
18	-96	8
24	-86	6
54	-36	34
6	6	44
-30	-44	36
-50	2	36
12	0	8
12	-14	8
-36	-4	12
-20	-34	54
-14	-26	54
-14	8	-8
-4	-20	12
12	-74	14
-4	-36	-46
22	-18	12
14	0	8
-40	-16	-22
26	-68	-4
-18	34	14
-14	-2	6
46	6	14
2	-60	-6
40	-40	16
-20	-50	2
28	34	8
-6	10	-2
-14	-36	-8
2	-58	-10
-8	-30	-8
-46	-64	0
-46	14	-14
-48	-6	40
44	6	-2
-16	6	-8
-6	-12	40
46	-8	44
4	6	46
10	10	40
54	-2	36
26	-10	8
-40	0	10
-12	-80	6
-6	-74	4
-30	-10	-8
-16	32	16
-32	20	18
-47	-52	-40
10	18	-2
-18	-40	34
-4	-12	12
-4	-14	0
-26	-26	30
38	-48	-38
20	-94	10
-20	-86	14
30	-24	28

// Schmidt A, 2018: Ultra-high-risk for Psychosis (UHR)
// Subjects=23
12	-74	14
-2	-84	20
22	-70	6
-6	-24	-10
6	-22	-10
-48	-54	-4
-46	12	-16
-14	-74	24
-26	-76	20
-8	-78	6
-14	-70	44
52	10	2
44	8	6
18	-96	8
24	-86	6
54	-36	34
6	6	44
-30	-44	36
-50	2	36
12	0	8
12	-14	8
-36	-4	12
-20	-34	54
-14	-26	54
-14	8	-8
-4	-20	12
12	-74	14
-4	-36	-46
22	-18	12
14	0	8
-40	-16	-22
26	-68	-4
-18	34	14
-14	-2	6
46	6	14
2	-60	-6
40	-40	16
-20	-50	2
28	34	8
-6	10	-2
-14	-36	-8
2	-58	-10
-8	-30	-8
-46	-64	0
-46	14	-14
-48	-6	40
44	6	-2
-16	6	-8
-6	-12	40
46	-8	44
4	6	46
10	10	40
54	-2	36
26	-10	8
-40	0	10
-12	-80	6
-6	-74	4
-30	-10	-8
-16	32	16
-32	20	18
-47	-52	-40
10	18	-2
-18	-40	34
-4	-12	12
-4	-14	0
-26	-26	30
38	-48	-38
20	-94	10
-20	-86	14
30	-24	28
20	-20	64
0	-16	58
-10	-4	70
4	-6	64
18	6	-6

// Smieskova R, 2015: Healthy Controls
// Subjects=19
56	-32	44
36	-40	38
56	-40	38
-8	-14	42
-22	-10	56
-14	-24	50
48	6	20
54	6	10
32	16	8
38	24	-4
48	6	20
36	18	8
18	38	22
6	22	32
0	32	26
-62	-24	26
-64	-38	36
-60	-34	42
-66	-40	30
-62	-38	44
-64	-22	26
24	-82	22
34	-78	14
18	-88	34
-46	6	6
-10	4	-6
10	2	-6
24	-98	-6
54	-32	42
58	-24	36
42	-40	42
4	28	28
4	26	26
-28	-56	-30
-42	-62	-30
-26	-64	-26
-52	-28	22
-62	-24	38
-52	-56	-8
-48	-58	2
-44	-46	-14
-28	-12	72
-20	-8	60
-38	-10	58
-6	-4	56
4	-2	42
-8	-8	42
-26	-96	-6
8	-24	-10
8	-20	-20
12	-14	-14
-38	-38	14
54	-36	18
46	-42	18
36	-42	-36
30	-72	8
-46	-38	48
-46	-36	62
-58	-34	52
2	-56	-34

// Smieskova R, 2015: Clinical At-risk Mental State (ARMS)
// Subjects=34
56	-32	44
36	-40	38
56	-40	38
8	40	24
-2	32	26
4	50	4
-62	-24	26
-64	-38	36
-60	-34	42
64	-36	12
64	-24	4
58	-18	0
-40	-32	14
-64	-44	18
-62	-44	18
-24	-100	-8
-40	26	2
-2	42	10
4	54	-2
-6	30	-6
50	14	22
64	8	20
24	-98	-6
-6	6	-6

// Smieskova R, 2015: First-episode Psychosis (FEP)
// Subjects=29
48	6	20
54	6	10
32	16	8
-66	-40	30
-62	-38	44
-64	-22	26
-60	-32	6
-52	-24	4
-46	-32	10
58	-26	6
-52	8	16
-34	20	-2
46	6	34
-12	2	-4
-50	-4	-8
-28	-96	-10
-18	-100	-2
-22	-104	-2
60	12	6

// Smieskova R, 2015: Subgroup of FEP, Medicated (FEP-M)
// Subjects=12
38	24	-4
48	6	20
36	18	8
18	38	22
6	22	32
0	32	26
8	40	24
-2	32	26
4	50	4
66	-24	38
-52	-50	-12
-58	-34	-6
-64	-32	4
-34	-48	-50

// Smieskova R, 2015: Subgroup of FEP, Unmedicated (FEP-UM)
// Subjects=17
-8	-14	42
-22	-10	56
-14	-24	50
24	-82	22
34	-78	14
18	-88	34
40	30	-2
-52	10	18
-14	0	-2
-18	-6	-6
-58	-30	6
-32	22	0
-26	16	-2
60	12	6
52	16	4
-44	40	22
-38	30	18
-46	30	12
60	-30	10
-34	94	-6
44	50	10

// Stip E, 2016: Subgroup of Schizophrenia, Ziprasidone
// Subjects=13
1.28	15.37	28.08
-30.14	26.05	-23.75
10.96	-59.76	5.28
-5.02	-65.94	9.33
36.25	22.36	-8.59
-34.29	25.11	-8.01
55.9	-62.15	11.65
33	25.25	-12.14
17.41	-62.64	8.79
8.12	-95.53	38.42
7.73	22.35	35.23
1.66	6.11	73.47
-37.46	15.57	-7.17
-40.61	-33.32	-19.77
-43.73	-65.32	-20.39
-53.11	-72.83	7.11
-53.48	-7.5	-15.09

// Stip E, 2016: Healthy Controls
// Subjects=15
68.66	-52.81	7.38
39.43	-40.47	-36.81
45.83	45.13	-3.92
36.25	22.36	-8.59
23.56	13.79	5.66
20.3	-62.53	-31.4
-8.19	-13.95	35.11
-8.38	51.06	36.35
-40.67	15.55	-7.14
-56.29	-72.6	10.47
-56.55	-24.73	-3.57
10.96	-79.57	-3.1
-14.48	-100.64	15.69
36.25	22.36	-8.59
-34.29	25.11	-8.01
55.9	-62.15	11.65
33	25.25	-12.14
17.41	-62.64	8.79
8.12	-95.53	38.42
7.73	22.35	35.23
1.66	6.11	73.47
-37.46	15.57	-7.17
-40.61	-33.32	-19.77
-43.73	-65.32	-20.39
-53.11	-72.83	7.11
-53.48	-7.5	-15.09

// Subramaniam K, 2015: Reward anticipation > Baseline, Healthy Controls + 
// Schizophrenia, p< .05
// Subramaniam K, 2015: Reward outcome > Neutral outcome, Healthy Controls + 
// Schizophrenia, p< .05
// Subramaniam K, 2015: Punishment anticipation > Baseline, Healthy Controls + 
// Schizophrenia, p< .05
// Subramaniam K, 2015: Reward anticipation > Baseline, Healthy Controls > 
// Schizophrenia, p< .001
// Subramaniam K, 2015: Loss outcome > Neutral outcome, Healthy Controls > 
// Schizophrenia p< .001
// Subjects=20
12	-88	2
12	-92	-4
12	-94	-22
10	8	-4
-42	-36	42
-50	2	40
40	-6	50
-8	-28	-14
-2	-34	-12
-20	10	-8
20	12	-6
-8	36	-8
-6	38	10
-36	-40	38
46	-32	40
-20	-82	-10
-20	-96	0
54	10	42
-24	56	20
-14	54	6
24	22	62

// Winton-Brown T, 2017: Healthy Controls
// Subjects=32
-21	-13	-8
18	-7	-5
-15	-16	-11
-21	-31	-5
-39	-85	-8
-30	-88	13
-39	-64	-8
36	-85	10
42	-79	-5
42	-64	-5
6	-28	-17
-30	20	-8
-33	32	-5
-24	29	-14
-24	-70	34
45	29	-2
51	29	10
36	29	-2
24	-40	-14
24	-28	-17
42	-64	-5
-24	-40	-14
-27	-70	-8
-18	-25	-20
39	-85	10
33	-88	19
27	11	-26
27	2	-23
36	2	-20
21	-7	-14
18	-7	-5
12	-7	-5
45	-76	-5
-39	-46	-20
42	-52	-17
-39	29	-14
-48	20	19
-48	26	7
39	11	25
51	29	13
51	17	28
-6	50	28
-9	29	46
-51	-7	-17
-3	41	-17
-3	50	-14

// Winton-Brown T, 2017: Ultra High Risk for Psychosis (UHR)
// Subjects=29
-21	-13	-8
18	-7	-5
-15	-16	-11
-21	-31	-5
42	-70	-11
36	-82	-11
30	-82	10
-36	-79	-17
-27	-61	-8
-27	-85	4
48	38	7
0	-34	34
-3	-46	19
-12	-52	16
-12	-13	-11
-18	-28	-5
6	-22	-17
9	-31	-11
-45	38	7
-3	26	-8
18	-10	-8
6	-7	-11
27	-31	-2
-39	23	-2
30	2	-23
-27	-58	-14
-39	-67	-8
48	-67	-5
42	-52	-8
36	-70	-8
33	-79	13
-15	-34	22
-42	8	31
-39	-55	-17
-39	-67	-14
-42	-64	16
42	-76	-2
39	-49	-17
42	-61	-11
0	50	-17
39	8	31
39	35	-14
48	32	10
0	56	22
-15	38	37
15	-31	1
-3	-55	19
-39	17	-35
-45	8	-35
57	-4	-17
48	-13	-14
42	17	-32
24	-52	43
-54	-7	-17
39	-13	-29

// Lu J, 2017: Familiar > Baseline
// Lu J, 2017: Unfamiliar > Baseline
// Lu J, 2017: Unfamiliar > Familiar
// Subjects=29
-3	3	69
1	3	69
-48	-3	51
54	0	48
-60	0	16
-39	-45	42
48	-39	48
-15	-75	51
21	-70	51
-54	9	18
63	13	30
-21	3	65
24	0	54
-27	5	57
32	1	58
-27	-66	39
30	-63	36
-23	-74	39
26	-68	39
-52	12	-3
60	-33	12
-3	3	69
2	3	69
-48	0	54
57	6	45
-56	-1	41
-39	-45	42
46	-49	42
-21	-72	48
22	-68	55
-51	9	18
50	12	18
-24	-2	65
22	6	55
-30	4	55
33	3	58
-30	-71	40
33	-73	40
-18	-76	41
26	-73	41
-53	13	-8
-54	10	36
-42	-39	45
32	-52	44
-23	-62	44
26	-65	51
-57	12	27
-23	-3	53
-33	-84	-4
32	-86	-3
-35	-87	-3
31	-86	4
-14	-92	3
27	-67	42
57	-29	17

// McPherson M J, 2016: NegImprov > NegChrom
// McPherson M J, 2016: NegChrom > NegImprov
// McPherson M J, 2016: AmbImprov > AmbChrom
// McPherson M J, 2016: AmbChrom > AmbImprov
// McPherson M J, 2016: PosImprov > PosChrom
// McPherson M J, 2016: PosChrom > PosImprov
// Subjects=12
-4	0	66
-52	12	32
-54	10	16
-54	10	20
4	14	64
-30	-36	-8
-34	58	2
-30	30	38
-44	18	40
-6	36	48
-4	50	24
-2	-42	36
-54	-58	38
-52	-60	24
-8	-64	38
32	-16	-14
40	50	4
4	-42	32
48	-64	46
48	-66	42
6	-64	38
-2	12	60
-2	-8	62
-54	8	12
-50	18	16
52	16	12
54	18	15
54	-26	0
-28	54	18
-36	22	40
-38	34	42
-14	40	20
2	-38	36
-54	-56	42
-52	-66	32
-4	-60	42
28	-16	-20
10	64	15
46	24	40
24	22	42
-2	-38	36
8	38	28
50	-54	48
46	-70	34
8	-62	44
-56	10	34
-52	10	22
-26	-36	-2
-25	60	2
-30	32	42
-2	30	54
-6	46	20
-2	-44	34
-8	42	16
-56	-58	30
-58	-88	28
-2	-64	36
32	56	2
38	24	40
32	26	46
2	30	52
6	46	38
4	-38	34
6	42	16
60	-48	40
58	-58	24
10	-64	32

// Derbyshire S W G, 2017: Patients
// Subjects=13
-4	-26	-16
-18	-26	0
14	-16	0
-22	-20	14
-54	0	-2
48	14	-4
-56	22	32
48	24	20
-46	-34	52
54	-34	44
-56	-4	18
52	-62	0
-46	-36	52
8	-8	-12
6	-4	-2
8	6	14
-22	2	0
-22	-2	-14
-30	14	-8
10	18	32
10	0	0
16	-6	20
-38	-2	-8
16	20	30
-52	20	18
46	52	-2
62	-12	38
66	-8	8
6	-6	0
10	16	2
12	32	-4
14	-4	16
12	12	4
4	32	14

// Derbyshire S W G, 2017: Healthy Controls
// Subjects=15
8	-18	-14
8	-6	2
14	8	18
-6	-80	48
4	-78	44
0	-28	26
-20	30	40
30	44	30
0	8	68
-8	20	32
2	16	46
10	12	34
6	20	36
6	46	22
-10	46	2
6	30	48
50	42	22
-48	-56	44
38	-46	44

// Bianchi F, 2018: High Frequency (HF), Musicians > Non-musicians
// Bianchi F, 2018: HF and Low Frequency (LF), Musicians > Non-musicians
// Bianchi F, 2018: HF and LF, Non-musicians > Musicians
// Subjects=15
-3	-37	-11
48	2	13
39	-1	13
51	8	22
-27	-82	34
54	23	16
6	-13	25
-63	-19	7
51	-22	1
51	-22	1
51	8	22
39	-1	13
-3	-34	-11
-63	-19	7
-48	-49	-14
-54	-37	-5
39	44	7
24	56	10
-48	5	19
60	-43	-5
-3	-10	25
51	-64	-5
33	-73	40
3	-37	34
-36	44	1
33	-34	-2
-30	-40	1

// Bogert B, 2016: Main Effect of Emotion
// Bogert B, 2016: Implicit > Explicit
// Bogert B, 2016: Explicit > Implicit
// Subjects=56
56	-2	-4
-50	-10	-2
-18	-8	-19
2	48	-14
-6	24	36
-6	16	54
-32	48	8
30	-64	-32
-44	8	30
48	-42	54
48	38	20
10	10	2
-26	4	63
36	-76	42
-58	-54	-18
30	10	58
-2	20	44
-50	-34	38
52	10	36
-40	-80	-12
44	-78	-8
-6	62	36
12	62	36

// Karmonik C, 2016: Bach > Baseline
// Karmonik C, 2016: Gagaku > Baseline
// Karmonik C, 2016: Bach Visual > Baseline
// Karmonik C, 2016: Self > Baseline
// Karmonik C, 2016: Cronkite > Baseline
// Karmonik C, 2016: Click > Baseline
// Karmonik C, 2016: Chaplin > Baseline
// Subjects=12
-1.58	77.03	-0.03
59.31	19.9	1.61
-60.48	18.27	2.34
43.39	-45.47	4.15
-.98	33.38	46.56
-49.83	-44.59	0.47
-61.35	21.39	1.42
55.04	17.7	1.06
-1.54	99.05	-27.75
-57.29	76.32	9.48
3.22	63.81	48.76
19.92	79	45.51
17.62	-23.2	-16.6
43.01	31.87	13.4
-49.85	28.84	12.82
-11.71	10.1	3.7
13.93	-2.08	11.89
-31.63	92.68	-23.52
-5.47	55.28	-27.82
30.03	40.27	51.65
-28.18	21.38	6.62
17.5	77.61	-19.14
47.88	12.55	-.21
-55.33	10.75	2.25
-.77	-24.52	50.63
20.82	58.48	-41.11
-36.44	58.24	-37.64
-53.25	9.88	50.14
-3.75	56.77	-40.35
2.26	26.17	34.19
-55.52	2.62	1.81
59.66	12.16	1.92
37.46	64.83	41.03
19.98	58.82	-38
-9.32	-48.08	41.22
-20.62	75.37	-44.61
24.78	-15.03	0.36
4.73	-37.27	24.21
42.13	-31.12	-15.32
-18.4	-1.96	19.06
-57.33	11.57	6.21
60.89	19.12	-1.69
53.36	-9.52	36.04
51.59	-36.34	3.07
59.87	15.56	3.31
-59.73	13.74	1.38
40.17	-17.73	27.29
-7.14	7.05	68.58
-52.19	-31.93	4.67
27.95	-42.87	25.41
-57.03	-14.59	21.56
16.8	-11.53	-34.97

// Sikka R, 2015: Main effect of Melody Recognition
// Subjects=20
-47	6	4
-41	22	4
-54	9	14
-41	6	24
39	29	1
49	9	1
45	19	24
-24	26	-9
55	13	-13
55	-7	-6
9	-7	4
-21	6	4
-21	0	-13
-31	-14	-3
22	9	4
29	-17	-3
-11	-17	-9
-4	-24	1
9	-24	-3
-50	-40	24
-1	-1	63
-4	13	53
6	13	40
-8	13	37
65	-34	14
-50	-7	47
-44	-4	57
52	3	50

// Mueller K, 2015: Forward Consonant (FC) > Backward Dissonant (BD)
// Mueller K, 2015: Correlation between BOLD and Pleasantness rating
// Subjects=23
52	-17	0
52	0	-8
50	3	-15
-56	-17	0
-53	0	-8
-50	-10	-5
0	-10	0
-6	-30	-8
12	-27	-10
2	-24	0
-23	-10	-12
-13	-14	-20
-18	-2	-10
22	10	0
54	-14	0
54	-2	-5
62	-27	5
-53	-14	0
-53	-2	-8
-53	-22	-5
-18	-2	-12
14	-27	-10
-13	-14	-18
-6	-30	-8
-16	-27	-12
-3	-10	-10
7	-10	-5
0	-7	2
14	0	-12
17	3	2

// Feldker K, 2017: Panic-related scenes > Neutral scenes: Patients > Controls
// Subjects=26
2.28	-40.24	-2.95
19.48	-43.51	8.28
-9.55	-31.22	-9.15
27.02	-54.92	11.38
-49.2	9.07	-7.61
-39.58	-.73	-11.36
-64.02	7.18	10.56
-36.4	-8.63	-17.42
-50.09	5.49	15.01

// Feldker K, 2016: Disorder-related scenes > Neutral scenes: Patients > 
// Controls
// Subjects=11
32.47	4.41	48.72
55.95	-2.31	42.32
23.95	9.1	55.11
40.95	16.98	45.34
38.68	15.59	27.64
55.82	9.52	30.18
-33.67	-76.12	31.7
-42.26	-76.52	27.37
-27.2	-73.28	40.31
-44.54	16.46	46.36
-29.64	33.47	44.76
-23.25	39.86	44.16
-27.54	26.46	36.41
-23.07	8.82	55.68
-42.45	26.88	43.23
-3.86	26.2	58.46
-38.02	6.61	56.04
2.41	13.78	34.9
4.35	24.93	13.86
-2.06	33.7	17.66
-4.03	24.48	36.3
11.12	30.86	62.36
-8.48	62.18	28.73
0.52	7.53	64.44
-4.11	52.15	36.21
-1.85	40.33	48.33
-8.63	47.44	3.21
-30.11	52.8	-8.15
-2.2	65.25	12.79
-13	55.18	-6.32
-4.44	37.8	-11.65
-2	-31.63	-1.39
-8.63	-29.5	-28.26
-6.25	-2.79	14.08
-23.52	1.91	-6.19
-17.05	17.95	8.01
-34.27	9.96	-11.2
-36.34	6.23	-4.17
17.19	5.46	8.66
2.1	-33.32	-23.6
-8.53	4.45	-2.11
-14.89	-32.39	-10.1
-32.2	29.01	-12.82
-23.67	9.17	-22.41
6.57	-7.12	12.07
-8.56	-11.21	-11.95

// Fitzgerald J M, 2017: Main Effect of Group
// Fitzgerald J M, 2017: Main effect of Condition
// Fitzgerald J M, 2017: Group x Condition Interaction
// Subjects=30
-50	6	54
-2	16	62
38	-64	-32
52	24	18
-36	26	-6
42	30	-14
50	-60	16
52	2	-30
-40	-62	20
-20	-78	-30
42	30	-14
14	-76	-26
56	-6	2
-50	-4	6
-10	0	44
-58	-40	0
0	-56	-38
20	-46	-10
-26	-4	-20
-22	-86	-2
-20	34	-16
-40	14	12
-42	-20	18

// Moon C M, 2015: Healthy Controls (HC) > General Anxiety Disorder (GAD), 
// Neutral distractors
// Moon C M, 2015: GAD > HC, Anxiety distractors
// Moon C M, 2015: HC > GAD, Anxiety distractors
// Subjects=18
-12	-66	4
12	-66	12
18	-34	-20
20	-32	-18
20	-33	-13
-16	-57	15
-12	-80	48
22	-92	24
-7	-79	19
-30	-40	2
16	-74	54
-8	-72	62
-20	-95	24
-36	44	34
-36	-56	-22
42	-60	-16

// Reinecke A, 2015: Main effect of task across groups: Reappraise > Maintain
// Reinecke A, 2015: Main effect of task across groups: Maintain > Reappraise
// Reinecke A, 2015: Main effect of group: Patients > Controls
// Reinecke A, 2015: Group x Task Interaction: Maintain vs. Reappraise
// Subjects=18
-4	20	50
-36	-64	-28
36	-60	-52
16	22	-16
26	-32	22
-20	-42	24
-8	28	38
-46	30	28
-56	-28	-12
-32	-68	40
20	36	54
48	56	-2
14	-42	4

// Aue T, 2015: Phobics > Controls: Snakes > Spiders
// Subjects=17
6	-61	55
12	-61	67
21	-70	55
-21	-76	40
-24	-61	55
-24	-76	31
9	-70	25
0	-82	25
-9	-64	61
-3	-55	61
33	41	22
-48	35	16
-39	23	19
42	-79	10
33	-67	25
30	-79	10
18	26	37
18	17	64
9	17	58
-15	17	67
-21	8	70

// Binelli C, 2016: Social Anxiety Disorder (SAD) Patients
// Subjects=20
18	-98	2
-14	-98	2
46	-78	-2
38	-54	-24
-40	-54	-18
44	18	26
66	-16	10
44	-24	12
-58	-32	12
0	30	32
-8	18	56
-42	24	24
30	-74	-16
-28	-74	-10
-4	-68	42
68	-28	-10
-62	-44	-14
12	-56	-46
48	-68	2
-4	50	16
-24	30	40
-52	-42	-14
64	-20	-18
-58	-46	-12

// Binelli C, 2016: Williams-Beuren Syndrome (WBS) Patients
// Subjects=20
36	-96	-8
-36	-94	-8
40	-48	-20
64	-18	-16
-20	-8	-10
44	22	34
-40	24	24
12	18	42
18	-98	6
-16	-98	-2
42	-62	8
64	-18	-16
12	-18	68
48	-68	2
-4	50	16
-24	30	40
-52	-42	-14
64	-20	-18
-58	-46	-12

// Binelli C, 2016: Healthy Controls (HC)
// Subjects=20
30	-94	-6
-26	-96	-6
44	-82	-6
40	-50	-24
-38	-54	-20
16	-6	-20
-16	-4	-22
48	18	28
-54	20	32
-54	-28	10
4	-26	54
-8	18	56
-42	24	24
30	-74	-16
-28	-74	-10
-4	-68	42
68	-28	-10
-62	-44	-14
12	-56	-46
18	-98	6
-16	-98	-2
42	-62	8
64	-18	-16
12	-18	68

// Heitmann C Y, 2018: Disorder-related scenes > Neutral scenes, Social 
// Anxiety Disorder (SAD) > Healthy Controls (HC)
// Subjects=30
-45.45	-76.36	29.62
-10.62	-44.43	-14.72
-5.22	46.25	28.91
-26.9	59.42	-5.4
-57.56	-40.59	-2.23
-1.68	-39.21	38.27
-10.26	-53.86	28.45
-41.39	8.14	34.76
-10.06	-52.95	54.02
-22.41	0.14	-1.59
17.8	-49.81	64.59
-4.23	-11.64	-4.16

// Yin D, 2017: Generalized anxiety disorder (GAD) Patients
// Subjects=20
24	-4.8	-15
-21	-9	-18
34	-18	15
9	45	-18
-3	54	24
9	-51	12
3	0	42
12	-18	6
54	-63	3
-48	-75	12
-42	-45	-18
42	-39	-21
39	-18	57
48	18	15

// Yin D, 2017: Healthy Controls
// Subjects=14
57	27	18
36	-12	15
48	-60	9
-39	-45	-15
-48	-78	3
42	-30	60
48	18	15

// Fonzo G A, 2015: Positive relationship between [Trait Anxiety and (Fear > 
// Happy)], All Participants
// Fonzo G A, 2015: Positive relationship between [Trait Anxiety and (Angry > 
// Happy)], All Participants
// Fonzo G A, 2015: Faces > Shapes: Patients > Healthy Controls (HC)
// Fonzo G A, 2015: Faces > Shapes: Panic Disorder (PD) > HC, Generalized 
// Anxiety (GAD), and Social Anxiety (SAD)
// Fonzo G A, 2015: Faces > Shapes: GAD,  HC, and SAD > PD
// Fonzo G A, 2015: Faces > Shapes: PD and GAD > HC and SAD
// Fonzo G A, 2015: Fear > Happy: GAD, SAD, and PD > HC
// Fonzo G A, 2015: Angry > Happy: PD and SAD > GAD and HC
// Fonzo G A, 2015: Angry > Happy: PD > GAD, HC, and SAD
// Subjects=14
33.26	20.25	19.5
39.57	-23.61	-11.46
-20.03	20.24	37.96
-9.28	9.99	42.04
-30.55	-23.18	41.72
-50.82	-40.47	40.06
40.14	-48.5	51.95
-18.7	-8.87	60.46
-36.35	-72.9	-36.57
-38.43	28.74	11.81
-34.68	-62.33	45.05
-1.11	-67.49	-38.54
-36.87	-28.79	52.3
-19.73	-10.74	63.97

// Heitmann C Y, 2017: Disorder-related scenes > Neutral scenes: Social 
// Anxiety Disorder (SAD) > Healthy Controls (HC)
// Subjects=24
-38.38	14.91	11.85
-63.8	-46.58	17.3
5.96	-50.74	53.65
44.9	-21.55	-12.81
26.82	-28.46	-4.22
39.48	27.03	-3.44
48.01	23.66	-6.6
9.89	25.97	40.48
6.66	43.21	43.53
43.11	11.7	45.75

// Aviram-Friedman R, 2018: [Obese Binge Eating Disorder (BED) > Obese], 
// Visual cues of food > Nonfood
// Aviram-Friedman R, 2018: [Obese BED > Obese], High energy processed food 
// (HEPF) > Low energy processed food (LEUF)
// Subjects=14
34	-4	12
8	8	44
-38	-64	18
24	-60	8
-38	-64	18
-38	-64	18
16	-84	26
24	-60	8
-66	-22	22
16	-84	26
54	-38	24
8	8	44
-16	-8	50
-16	-8	50
-16	-8	50

// Demos K E, 2017: Short sleep > Long Sleep, Food > Nonfood
// Subjects=30
24	22	-19
3	54	-30

// Janssen L K, 2017: Main effect: Food > Neutral
// Janssen L K, 2017: Interaction effect: [Food > Neutral] > [Emotion > 
// Neutral]
// Subjects=69
-36	-62	38
-44	-60	34
-58	-52	30
-56	-38	-8
-48	-42	-6
-48	-52	-14
-30	32	-10
-34	10	44
-22	34	-14
38	-58	34
38	-52	40
46	-48	30
60	-42	-2
54	-34	-8
52	34	24
44	30	24
34	26	18
-4	-34	36
-6	-64	40
-4	-42	32
14	-84	-34
30	30	-20
-34	-62	38

// Lee J E, 2017: Bulimia Nervosa
// Subjects=12
-18	44	48
-24	20	-8
-42	8	54
18	16	-4
6	6	2
60	0	26
16	-92	-4
20	44	48
-16	34	58
8	14	8
-42	8	54
-48	-44	-4
26	-70	2
-34	-72	34
20	44	48
-16	34	58
6	14	10
-40	8	52
-48	-44	-4
26	-70	2
-34	-72	34
60	0	28
-28	-86	0

// Lee J E, 2017: Binge Eating Disorder
// Subjects=13
-18	44	48
-24	20	-8
-42	8	54
18	16	-4
6	6	2
60	0	26
16	-92	-4
6	6	2
60	0	28
20	44	48
-16	34	58
6	14	10
-40	8	52
-48	-44	-4
26	-70	2
-34	-72	34
60	0	28
-28	-86	0

// Lee J E, 2017: Healthy Controls
// Subjects=14
-18	44	48
-24	20	-8
-42	8	54
18	16	-4
6	6	2
60	0	26
16	-92	-4
20	44	48
-16	34	58
8	14	8
-42	8	54
-48	-44	-4
26	-70	2
-34	-72	34
6	6	2
60	0	28

// Opel N, 2015: Obese > Controls; Reward > Control
// Opel N, 2015: Group x Condition [Obese vs. Controls x Reward/Loss vs. 
// Control]
// Subjects=28
36	18	-14
-28	24	-8
50	-70	28
12	-80	24
34	-72	-32
-36	32	24
-28	60	6
6	42	6
-38	-56	34
-26	22	-10
-26	40	16

// Reiter A M F, 2017: Exploitation > Exploration, All Participants
// Reiter A M F, 2017: Conjuction Single- Update and Double- Update RPE, All 
// Participants
// Reiter A M F, 2017: Double- Update RPE, All Participants
// Reiter A M F, 2017: Single-Update RPE, All Participants
// Subjects=22
-28	26	-2
32	24	-8
-4	16	46
44	22	-10
-32	20	-8
-6	52	-12
32	36	-12
-4	18	-8
-40	-68	30
2	50	-12
-8	54	-2
8	12	-10
14	6	-14
28	-4	4
30	-12	4
30	6	4
-12	6	-14
-18	-6	-18
-26	-4	-18
28	-18	-18
26	-6	-20
18	-8	-18
-34	36	-16
30	36	-14
26	30	-18
-14	60	-2
-14	66	-6
-6	60	-8
-6	50	-14
6	-48	30
-4	-36	38
-60	-40	-12
-62	-32	-14
-56	-58	-8
-40	-70	-42
-40	-78	-30
-28	-86	-28
44	-74	-32
44	-68	-42

// Stice E, 2018: Intervention > Control: High-Calorie > Low-Calorie; Baseline 
// > Follow-up
// Subjects=20
48	-24	24
36	-12	9
-48	-12	-6
-45	0	12
-46	0	-12
-57	-39	27
33	0	-6
42	6	0
51	0	6

// Verdejo-Romn J, 2017: Willingness to pay task: Highly palatable foods > 
// Plain foods; All Participants
// Verdejo-Romn J, 2017: Activations during Monetary Incentive delay task 
// anticipation: All Participants
// Verdejo-Romn J, 2017: Deactivations during Monetary Incentive delay task 
// anticipation, All Participants
// Verdejo-Romn J, 2017: Activations during Monetary Incentive delay task 
// feedback, All Participants
// Verdejo-Romn J, 2017: Deactivations during Monetary Incentive delay task 
// feedback, All Participants
// Subjects=37
16	-80	0
-10	-68	22
-2	28	40
-6	26	34
2	-10	-8
-10	16	-4
-6	4	0
62	-44	28
-8	50	0
-30	58	6
0	60	0
-36	14	-14
-14	18	-4
-26	32	-10
-36	14	34
-32	26	24
32	20	-6
40	16	-8
30	30	-10
10	-68	22
2	28	40
6	26	34
-2	-10	-8
8	50	0
-12	90	0
8	-12	-8
-6	-16	-10
-4	0	42
0	-8	56
8	-26	0
-22	-26	10
-16	-88	-20
22	-72	-20
-14	-36	-10
-38	-22	-16
38	-20	-16
12	12	-4
-12	8	-2
-32	30	-6
34	26	-8
-26	24	6
34	26	-2
40	-8	38
-40	-16	50
-20	-2	12
20	4	16
16	-68	42
-10	-76	40
-36	-36	48
54	12	-6
20	6	-12
-20	2	-10
-32	38	28
36	32	24
12	90	0
4	0	42
56	-58	28
-46	-62	28
2	-62	30
-2	-62	30
-30	-86	-2
30	-84	8
-28	-64	38
32	-66	32
-4	-38	30
-34	-60	-16
34	-48	-20
-6	-58	12
-18	-36	-8
20	-34	-4
-16	14	-12
18	18	-8
-26	-12	0
28	-18	-2
-44	-44	38
40	-36	26
20	12	6
-18	14	0
-42	2	24
48	36	18
-44	48	-4
-20	20	56
4	-38	30
6	-58	12
46	18	0
-32	22	-10

// Kleint N I, 2015: Heartbeats > Tones
// Kleint N I, 2015: 100 bpm > 50 bpm
// Kleint N I, 2015: 50 bpm > 100 bpm
// Kleint N I, 2015: Heartbeat: 50 bpm > 100 bpm
// Kleint N I, 2015: Heartbeat: 100 bpm > 50 bpm
// Kleint N I, 2015: Tones: 100 bpm > 50 bpm
// Subjects=36
42	39	3
36	0	27
-42	24	6
9	48	39
39	-57	57
15	-3	24
-33	39	9
45	3	54
-30	-78	-42
-39	-72	-30
21	-60	-21
-51	-6	48
-3	3	60
-48	6	3
-6	-27	63
-9	-21	66
21	-60	-24
-30	-27	24
33	-75	0
-51	-6	48
-54	0	33

// Minkova L, 2017: Harsh > Neutral distractors, Entire Cohort
// Subjects=15
42	-52	-20
40	-42	-22
42	-26	-20
-50	20	10
-42	28	4
-36	26	-14
-6	14	58
20	-10	-12
-40	-58	26
54	-38	8
52	-34	0
44	-42	16
-10	54	34
-42	4	44
-34	8	40
-20	-12	-10
-42	-36	-16
54	32	2
4	48	-18

// Kraus J, 2018: Social Anxiety Disorder (SAD) > Healthy Controls (HC), 
// Aversive/fearful > Neutral stimuli
// Kraus J, 2018: SAD < HC, Aversive/fearful > Neutral stimuli
// Subjects=12
30	0	-16
32	-2	-14

// Misra G, 2015: Force Only > Baseline
// Misra G, 2015: Pain Only > Baseline
// Misra G, 2015: Conjunction Analysis: Force Only and Pain Only
// Misra G, 2015: Force Pain > Force Only
// Misra G, 2015: Force Pain > Pain Only
// Misra G, 2015: Force Pain > Force Warm
// Subjects=15
5	13	45
0	-3	60
1	6	48
-43	2	6
-27	-4	2
-14	-19	9
-38	-15	56
-28	-92	-3
-42	-72	-1
-30	-51	57
-18	-75	-47
39	11	6
28	3	5
12	-19	7
38	-6	56
30	-96	-3
35	-85	4
45	-39	49
33	-46	52
16	-74	-45
23	-56	-21
58	9	28
47	-62	-1
62	-22	38
63	-32	22
0	26	31
-1	0	61
0	12	57
-47	-13	13
-26	-5	8
-22	8	-6
-16	17	6
-60	-33	24
-39	-40	47
-28	-52	51
-21	-74	-50
-30	-91	-1
-45	-70	3
39	16	3
24	10	-5
11	8	8
13	17	0
62	-28	20
50	-35	46
33	-60	-23
31	-87	-2
43	-76	-10
28	-68	35
40	5	-13
55	5	31
0	9	48
1	0	62
2	7	57
-44	1	8
-24	9	1
-26	-5	5
-44	-71	4
-28	-92	-2
-15	-76	-45
38	18	4
39	2	12
47	-63	5
34	-87	-2
57	7	29
62	-21	37
63	-32	22
43	-41	49
-1	13	39
-7	11	56
-1	33	27
-55	-20	14
-19	-71	43
-27	-58	-24
-5	-59	-7
-3	-5	57
-44	-20	52
-13	-19	7
-15	-69	-48
39	-8	55
62	-17	36
37	-43	54
37	-85	4
0	15	39
15	-80	-12

// Sevel L S, 2015: Pain > Rest
// Subjects=24
-6	8	41
6	5	56
0	-4	62
-6	23	26
15	-13	5
-21	14	-1
48	-34	23
21	17	2
60	-16	23
6	29	23
9	-25	-16
54	-46	29
54	-27	24
15	-49	71
-9	-19	2
33	44	29
33	-22	17
54	11	-7
54	-37	44
6	-25	23
-57	-22	14
-48	-37	50
33	2	5
18	11	11
-9	-79	5
0	-58	-7
12	-13	-13
33	23	2

// Matsuo Y, 2017: Healthy Controls
// Subjects=13
35.36	13.23	11.14
0.29	28.28	43.74
0.38	6.07	45.6
38.69	27.74	33.31
-2.83	-69.73	15.2
-28.41	-72.54	22.42
16.43	-56.16	23.87
-6.01	-13.51	40.63
-25.38	21.27	37.93

// Matsuo Y, 2017: Patients
// Subjects=11
-38.09	-56.74	21.2
26.08	-29.44	38.25
-18.83	19.42	54.74
-6.01	-13.51	40.63
-25.38	21.27	37.93

// Perlaki G, 2015: VAS 7 > VAS 1 (Activation)
// Perlaki G, 2015: VAS 7 < VAS 1 (Deactivation)
// Subjects=18
-32	-20	18
36	8	6
-4	0	44
4	-12	-2
54	-2	6
38	-16	8
-36	4	10
-56	-2	8
-4	8	-10
10	34	-14

// Petschow C, 2016: Healthy Controls
// Subjects=13
-63	-31	19
-48	-31	19
-51	-19	22
45	-28	22
54	-37	19
63	-19	25
-21	-10	61
-12	-16	70
-33	-19	19
-57	-22	31
-54	-28	19
57	-19	16
45	-31	22
57	-43	19
15	-7	67
0	-13	67
-15	-7	67
51	2	7
51	17	1
36	11	7
-39	2	-14
-39	-1	-5
-33	8	7
0	5	40
-6	2	46
12	-52	46
9	-70	37
3	-49	61
-6	-55	43
-15	-46	46
6	-31	22
6	-46	13
27	41	28
-15	-25	4
-9	-25	13
21	-28	7

// Petschow C, 2016: Parkinson's Disease Patients
// Subjects=13
6	17	46
6	8	37
6	8	55
-33	-22	16
-51	-1	4
-39	5	7
51	-1	7
51	11	13
36	-1	10
-30	26	4
45	-19	22
63	-19	16
51	-28	25
-63	-22	19
-60	-28	28
-54	-34	13
-33	-19	16
12	-25	4
-45	-19	10
42	-1	-17
57	-16	19
39	-13	10
-6	8	40
3	8	43
-3	17	31
-6	-49	61
9	-52	64
-18	-43	64
6	-31	25
12	-52	46
9	-70	37
3	-49	61
-6	-55	43
-15	-46	46
6	-31	22
6	-46	13
27	41	28
-15	-25	4
-9	-25	13
21	-28	7

// Asghar M S, 2016: Placebo: Pain > Baseline (Activation)
// Asghar M S, 2016: Placebo: Pain > Baseline (Deactivation)
// Asghar M S, 2016: CGRP: Pain > Baseline (Activation)
// Asghar M S, 2016: CGRP: Pain > Baseline (Deactivation)
// Asghar M S, 2016: Sumatriptan + CGRP: Pain > Baseline (Activation)
// Asghar M S, 2016: Sumatriptan + CGRP: Pain > Baseline (Deactivation)
// Subjects=27
-34	10	42
-12	8	50
66	-18	24
-56	-22	26
46	-32	38
50	-44	52
-50	2	6
40	-18	22
60	-30	-4
-36	-74	-18
38	-10	22
-44	-10	4
6	-18	-20
-2	-58	-18
40	-68	-30
44	-78	-34
26	-80	-24
30	-78	-20
36	-80	-42
28	-12	66
40	-14	62
28	-20	66
22	-32	70
-2	-40	64
-40	-42	-24
-12	-46	2
-40	-50	10
-6	-40	42
-24	4	-32
-10	20	4
10	18	0
-6	16	6
10	14	0
-6	6	-6
6	6	-8
-26	-36	-26
24	-62	-56
-40	12	12
-30	32	4
40	22	-2
32	22	-2
-32	0	16
14	-20	-24
-14	-22	-24
6	18	64
-8	-38	62
-30	-8	62
32	-32	54
-52	0	46
-30	0	50
-24	12	44
-36	16	42
-24	36	40
-40	24	34
-28	34	32
-48	24	22
-46	32	8
48	6	18
-36	24	-16
34	-46	60
30	-50	52
-46	-36	50
-40	-36	40
42	-36	56
38	-34	50
-34	-34	62
-42	-42	58
-24	-46	56
-54	-12	50
-34	-24	48
-58	-14	16
-60	-24	16
-4	-46	38
-6	-54	18
-52	-52	34
-6	-54	18
-4	-66	26
10	-70	18
10	-60	18
12	-66	10
-12	-62	14
0	-40	50
-2	-40	42
0	-26	40
0	28	34
0	-48	24
-14	14	6
-14	-26	6
-24	10	-8
28	2	-12
32	-6	20
30	-80	-44
-14	-82	-24
10	-66	-46
-4	6	44
-38	34	44
-22	26	48
-52	22	24
-52	22	10
-50	-18	36
-54	-26	54
-42	-58	24
-38	18	-6
-6	-14	14
42	-74	-40

// Bagdanov V B, 2015: Early Cold > Baseline
// Bagdanov V B, 2015: Sustained Cold > Baseline (Activation)
// Bagdanov V B, 2015: Sustained Cold > Baseline (Deactivation)
// Bagdanov V B, 2015: Laser > Baseline
// Subjects=24
-3	-73	49
-57	-70	-75
45	5	58
27	-4	-8
6	-40	46
3	-43	16
12	47	-11
-9	29	-17
48	23	28
-21	-25	25
18	-16	28
-18	-1	25
-18	-13	28
12	-37	13
-33	-22	19
-21	-25	25
-12	-19	19
-12	29	-17
3	35	-17
36	17	-2
-30	20	-5
45	-16	16
-39	-7	-2
-30	14	7
42	-7	10
48	11	19
18	-4	-14
-21	-4	-14
-15	8	-11
9	2	4
3	-22	31
-60	-28	22
63	-22	22
0	20	25
-60	-49	43
33	-49	43
60	-40	37
48	38	7
-15	-34	-8
-18	-7	-14
6	-28	4
12	-10	10
54	-10	16
27	29	-17
12	-64	31
-48	38	19
36	53	31
6	11	61
0	-31	-5
-60	-60	7
-18	-73	-32
12	-91	-26
-9	8	4
9	5	7

// Sinke C, 2017: Pain > Control
// Sinke C, 2017: Control > Pain
// Sinke C, 2017: Postive Expectancy > Negative Expectancy
// Sinke C, 2017: Stimulation X Expectancy (Positive Expectancy 
// [Pain>Control]) > (Negative Expectancy [Pain>Control])
// Subjects=21
-36	8	6
-4	14	50
0	24	30
38	-18	18
54	-2	8
34	8	14
54	-22	24
14	-10	8
8	-16	28
6	14	36
2	8	40
2	24	28
20	-44	68
-20	-10	-24
28	-28	-24
32	-14	-22
-24	-74	-8
-2	38	8
-4	22	-8
-6	46	2
-30	-36	-2
58	-54	40
8	44	22
32	-38	2

// Aue T, 2018: Spider Phobic Patients
// Subjects=20
45	44	-14
6	41	43
-30	23	-8
-39	26	34
-27	-67	46
48	-52	43
12	-85	7
-9	-76	-29
27	-61	-32
-27	-67	-32
0	-55	-35
-6	-55	46
-18	-61	13
-15	-91	-11
18	-97	-2
48	11	-26
-9	-4	31
-27	47	40
42	-1	34
-60	-37	16
9	-82	34
12	-97	7
-24	-55	46
-12	-1	16
-21	-76	-41
18	-97	-2
45	-13	-26
6	-43	55
51	2	43
36	47	37
-39	41	34
9	17	64
-36	14	-8
0	32	13
-18	56	31
-6	-49	31
-48	-70	34
0	35	13
-42	29	1
39	32	4
-36	20	-20
-51	-61	10
57	-55	13
-27	47	25
-12	-34	40
18	-43	55
66	-31	31
-57	-43	28
-24	-73	-41
0	32	13
-21	56	31
-24	44	46
48	35	-11
-36	20	-20
36	11	-17
-3	-13	34
-6	-49	28
66	-31	31
-60	-40	28
-51	-58	10
-24	-76	-38
30	23	-5
39	29	22
-6	-79	-5
45	-79	-2
42	-46	43
-27	-64	40
-6	-79	-5
36	-85	-8
15	-97	25
3	-91	22
30	-79	-17
-12	-49	-5
51	32	34
-45	20	40
-39	53	-2
-21	14	-17
42	14	-47
9	-16	-26
9	11	10
-54	-64	31
45	-46	52
3	-91	19
66	-46	25
30	62	16
42	23	-17
-21	14	-17
9	29	55
60	-58	10
45	8	-47
9	-1	13
3	-94	19
-45	-64	-38
21	-40	-50
21	-103	13
-30	-76	-17
18	-82	-14

// Aue T, 2018: Healthy Controls
// Subjects=19
45	44	-14
6	41	43
-30	23	-8
-39	26	34
-27	-67	46
48	-52	43
12	-85	7
-9	-76	-29
27	-61	-32
-27	-67	-32
0	-55	-35
-6	-55	46
-18	-61	13
-15	-91	-11
18	-97	-2
48	11	-26
-9	-4	31
-27	47	40
42	-1	34
-60	-37	16
9	-82	34
12	-97	7
-24	-55	46
-12	-1	16
-21	-76	-41
-15	-91	-8
42	29	13
0	32	13
-18	56	31
-6	-49	31
-48	-70	34
0	35	13
-42	29	1
39	32	4
-36	20	-20
-51	-61	10
57	-55	13
-27	47	25
-12	-34	40
18	-43	55
66	-31	31
-57	-43	28
-24	-73	-41
30	23	-5
39	29	22
-6	-79	-5
45	-79	-2
42	-46	43
-27	-64	40
27	26	-5
42	8	28
48	-76	1
-24	-79	28
24	-58	52
-39	-43	-20
39	-46	-32
-3	-61	-38
15	-97	25
3	-91	22
30	-79	-17
-12	-49	-5
51	32	34
-45	20	40
-39	53	-2
-21	14	-17
42	14	-47
9	-16	-26
9	11	10
-54	-64	31
45	-46	52
3	-91	19
66	-46	25
51	32	34
-42	20	40
9	53	34
-51	-49	49
24	-97	22
3	-91	16
21	-103	13
-30	-76	-17
18	-82	-14

// Br?scher A K, 2016: Uncontrollable Pain > Uncontrollable Warm
// Br?scher A K, 2016: Controllable Pain > Controllable Warm
// Br?scher A K, 2016: Positive Correlation between Pain Rating and Activation 
// during Uncontrollable Pain
// Br?scher A K, 2016: (Uncontrollable Pain > Uncontrollable Warm) > 
// (Controllable Pain > Controllable Warm)
// Subjects=23
-28	-66	-28
-28	-66	-28
24	-58	-28
38	8	8
14	-20	10
-18	-20	14
6	20	30
36	14	6
-32	16	4
56	-20	22
-36	-10	64
-36	-10	64
22	-2	54
-42	-36	54
-36	-26	56
16	-64	42
16	-64	42
10	-62	60
-16	-62	58
42	-12	14
42	-12	14
38	-14	16
-38	12	-4
56	0	4
4	12	44
12	-6	6
-14	-18	16
6	18	60
-26	-62	-22
10	28	50
10	28	50
10	22	32
2	38	16
46	20	-10
46	20	-10
50	20	-4
44	20	0
54	8	0
44	10	-2
8	-84	-10
8	-84	-10
-44	16	-2
-44	16	-2
-32	20	-14
-38	10	0
4	-2	6
4	-2	6
14	0	2
-34	-26	54
-34	-26	54
-38	-30	52

// Jensen K B, 2015: High Pain > Low Pain
// Jensen K B, 2015: Placebo Main Effect: Low Pain > Control Pain
// Jensen K B, 2015: Placebo: Nonconscious > Conscious
// Jensen K B, 2015: Placebo: Conscious > Nonconscious
// Jensen K B, 2015: Nocebo Main Effect: High Pain > Control Pain
// Jensen K B, 2015: Nocebo: Nonconscious > Conscious
// Subjects=24
36	5	7
-33	-16	16
0	17	34
0	-16	7
9	26	-8
36	29	-2
-3	-91	28
0	-13	31
-42	-4	4
42	2	-14
39	-1	-2
-6	-19	-5
9	-16	-5
6	-1	10
30	-4	-14
33	-10	-14

// Chevrier A, 2015: Stop > Rest
// Chevrier A, 2015: Respond > Rest
// Subjects=14
-5.96	-74.53	22.32
-29.29	-52.98	55.36
29.21	-89.52	4.22
-38.3	-64.43	-9.38
21.96	-21.23	62.14
18.86	-37.74	69.14
51.59	-25.2	21.99
53.63	-16.27	13.41
-4.93	-57.34	24.22
-5.94	-52.26	34.95
-9.23	-44.42	26.53
11.05	-57.76	17.38
46.55	-41.86	54.67
-5.94	14.72	61.68
-1.74	6.23	47.84
-9.27	-11.84	34.95
8.63	37.11	19.49
22.45	56.22	17.72
32.95	51.06	-8.73
-25.27	-89.67	7.09
46.85	-14.7	-34.6
17.43	-93.1	0.19
-22.38	12.54	7.4
-14.95	-7.73	-7.71
22.43	6.58	-4.88
17.28	-7.94	14.24
-30.95	-72.27	-28.88
-5.86	-64.61	40.45
1.59	-79.17	30.43
-48.06	-22.02	-10.59
48.07	-8.67	-11.7
3.08	12.93	-17.45
-25.82	22.19	-19.01
-7.69	63.68	-7.09
-0.05	4.96	-10.06

// Schreiber K L, 2017: Cuff Stimulation: Patients > Healthy Controls
// Schreiber K L, 2017: Postoffset: Patients > Healthy Controls
// Schreiber K L, 2017: Positive Correlation: PAS Pain Rating and Postoffset 
// brain responses
// Subjects=15
20	2	-24
20	-2	-22
38	18	-42
20	-2	-34
26	-10	-22
40	0	-42
54	-56	-20
-16	62	20
48	-74	-32
8	36	-8
-2	2	72
-22	40	50
20	64	24
-4	-6	42
-28	-8	66
-52	-6	50
-36	-22	-22
-46	-72	-24
-28	12	-16
-6	44	8
16	44	50
-32	-20	42
20	-14	-26
-10	28	28
22	-20	-16
-14	-8	-20
30	-24	-24
-16	-12	-18
8	8	-10
-6	14	-4
-18	-6	-32
16	-6	-20
0	-60	62
8	-66	66
-24	16	-8
-56	36	0
-20	-4	-16
-12	20	2
-42	-6	-12
-22	-16	-20
-36	-10	6
14	-98	14
-8	-94	4
-4	52	24
0	48	14

// Shinozaki T, 2016: Healthy Controls
// Subjects=15
-34	-22	4
42	-44	18
-32	16	4
-26	-10	64
8	-16	58
12	20	54
-20	-58	-24
4	20	28
12	-64	-28
-52	-24	28
46	2	40
12	-76	12
-28	2	2
50	44	16
-26	-60	-28
48	-52	42
18	-80	-28
-58	-12	40
-6	-40	32
-12	-34	-26
36	4	-26

// Shinozaki T, 2016: Patients
// Subjects=16
34	-12	16
-36	8	-10
26	2	50
32	-38	38
-40	14	38
-66	-16	-12
46	-70	-14
46	-44	-4
56	-64	6
16	-76	24
0	-26	32
18	8	46
16	-20	44
16	-68	34
-8	-8	30
-12	-48	34
42	-52	28
-8	-70	-30
-48	-58	-16
16	-20	44
-18	-20	-24
0	-2	54

// Hu J, 2016: Go > 0, Correlation with stop signal anticipation
// Hu J, 2016: Go < 0, Correlation with stop signal anticipation
// Subjects=78
-15	-16	10
-42	-25	52
-48	-43	55
-48	-37	49
24	59	25
36	59	1
39	47	25
12	-13	7
3	32	58
6	20	49
12	8	55
45	-49	55
57	-43	49
36	-46	37
-33	-70	-26
-27	-70	-21
-12	-79	-26
6	41	-14
-3	50	-5
-21	29	43
-39	11	55
-9	-58	19
-9	-52	10
9	-58	22
-27	-34	-14
-21	-22	-17
-42	-76	34
-24	-85	34
21	32	40
30	32	52
51	-70	4
33	-85	7
27	-22	-17
30	-31	-17

// Hu S, 2015: Alcohol Dependent (AD)
// Subjects=24
6	26	61
48	29	-14
57	-46	25
63	-22	-11
42	17	31
-51	-46	28
-42	26	-8
-6	-16	1
-18	-43	1
-3	14	-8
-18	-46	25
30	-37	-11
57	-55	22
18	38	37
-6	-1	-2
3	50	22
-42	-76	22
54	5	-17
-18	-13	-17
-12	-22	61
-21	38	43

// Hu S, 2015: Healthy Controls (HC)
// Subjects=70
60	-46	43
36	59	-2
-57	-46	40
3	-22	28
-12	-82	-26
6	23	61
-30	-37	-11
-21	-13	-17
48	-70	1
-21	14	49
54	-1	-8
24	23	46
57	-55	22
18	38	37
-6	-1	-2
3	50	22
-42	-76	22
54	5	-17
-18	-13	-17
-12	-22	61
-21	38	43

// Hu S, 2015: Regional activations to Stop Signal Anticipation
// Hu S, 2015: Regional activations to Prediction Error
// Hu S, 2015: Regional activations to Reaction Time
// Subjects=114
57	-43	49
33	56	-5
-57	-46	40
-24	-70	49
9	-70	49
3	-25	28
3	35	52
51	17	1
54	-40	43
39	17	-2
39	50	4
48	11	40
15	-13	10
24	-1	-2
-57	-40	49
51	-25	-8
-36	17	-2
-18	-19	7
-51	8	10
-36	17	-2
-18	-19	7
-51	8	10
-36	41	19
-39	-55	-26
48	-31	-8
6	29	31
33	23	4
-33	20	7
12	5	61

// Veverka T, 2016: W4 > W0: Passive flexion-extension movement of the 
// affected wrist > Rest
// Veverka T, 2016: W4 > W11: Passive flexion-extension movement of the 
// affected wrist > Rest
// Veverka T, 2016: W0 > W11: Passive flexion-extension movement of the 
// affected wrist > Rest
// Subjects=7
10	-102	6
40	-72	-12
-30	-76	-32
32	-76	-24
-14	-38	-22
-6	10	56
-12	-38	50
0	-10	60
-28	-46	72
-2	-14	64

// Boraxbekk C J, 2016: Training related improvements across all groups
// Boraxbekk C J, 2016: Untrained sequence conjunction
// Boraxbekk C J, 2016: Motor training > Imagery training
// Boraxbekk C J, 2016: Imagery training > Motor training
// Subjects=18
36	-20	52
36	-22	62
-4	-64	-28
-6	-56	-16
-16	-54	-22
8	-10	64
-2	-6	66
40	-30	50
28	-8	60
32	-16	54
36	-20	64
-24	-54	-24
12	-4	60
-40	-14	58
-8	-6	62
24	-54	-26
56	8	24
30	-98	-10

// Walz A D, 2015: Conjunction over task and time: Fist clenching
// Walz A D, 2015: Conjunction over task and time: Finger sequence
// Walz A D, 2015: Conjunction over task and time: Writing
// Subjects=15
-51	-24	42
-36	-12	54
-3	-6	60
9	-2	60
-57	6	27
-36	-45	57
-33	-42	54
-51	-31	44
-42	-69	3
45	-66	0
27	-65	-19
-45	-27	42
45	-30	45
-42	-36	45
42	36	45
-27	-6	51
27	-6	51
-6	-3	60
0	3	57
-57	3	39
54	3	39
-12	-96	-3
15	-96	3
-33	-12	48
-27	-51	57
33	-48	54
-36	-9	54
27	-6	54
-3	-6	60
-57	6	27
57	9	21
-35	-45	57
30	-54	54
-51	-27	39
-42	-72	0

// Alonso-Lana S, 2016: Healthy Controls
// Subjects=28
-50	8	28
36	22	4
44	-44	52
6	-76	40
2	66	-8
60	-10	-16
-52	10	24
-2	40	-8
2	-50	26
28	-46	76
-34	-62	-32
-32	16	-30
26	12	-26
40	-22	70

// Alonso-Lana S, 2016: Bipolar Disorder, Cognitively Preserved
// Subjects=27
-32	-48	42
2	4	58
-42	-66	-8
30	-52	42
46	-68	-10
8	-52	-16
-24	-6	4
10	-56	22
4	64	0
-20	26	44
60	-64	18
-42	-44	42
-4	-56	22
-2	54	-10
-32	8	-24
30	10	-20
-52	-68	28
26	-40	76
46	-10	0
-26	-58	50
-32	16	-30
26	12	-26
40	-22	70

// Alonso-Lana S, 2016: Bipolar Disorder, Cognitively Impaired
// Subjects=23
-30	-54	44
10	16	40
32	-48	48
8	-52	32
60	-60	20
10	-80	-28
-4	-54	26
50	-6	-36
28	-38	74
-42	-58	-24
30	-4	52
-14	72	4
-6	32	-2
32	0	-42

// Brooks J O, 2015: Memory Load: Bipolar II Depressed < Healthy Controls
// Subjects=19
-33.99	53.21	-22.52
-30.84	65.47	-12.28
-38.69	-56.44	48.28
-49.23	-76.65	29.75
-45	-74.11	36.21
-28.09	-65.87	47.75
-17.51	-67.68	51.14
16.22	-49.95	43.07

// Cerullo M A, 2016: Bipolar I Disorder (BP-I)
// Subjects=25
27.99	104.9	-7.05
-3.43	71.78	63
-51.67	69.95	43.63
24.61	103.08	-30.28
-20.09	108.04	-3.42
-38.73	-1.3	29.38
57.48	42.57	51.37
-13.56	30.15	-20.38
15.24	29.81	-27.37
44.53	64.18	43.01
9.48	20.07	53.8
63.76	24.69	26.03
70.06	13.67	6.81
-23	51.69	11.38
-7.29	38.67	-34.55
-54.98	22.69	10.83
6.01	76.64	42.41
-32.09	-54.94	37.15
-45.56	40.5	-7.5
2.59	100.71	23.7
21.65	23.24	-30.24
41.3	1.32	14.86
-26.07	-6.2	6.23
-39.39	57.77	-32.44
18.36	108.01	-7.2
-38.7	-4.22	32.97
-55.13	-5.25	-20.28
-16.7	-2.11	-24.33
32.07	8.55	67.89
-13.65	25.95	-33.41
2.8	37.01	25.69

// Cerullo M A, 2016: Major Depressive Disorder (MDD)
// Subjects=25
27.99	104.9	-7.05
-3.43	71.78	63
-51.67	69.95	43.63
24.61	103.08	-30.28
-20.09	108.04	-3.42
-38.73	-1.3	29.38
57.48	42.57	51.37
-13.56	30.15	-20.38
15.24	29.81	-27.37
44.53	64.18	43.01
9.48	20.07	53.8
63.76	24.69	26.03
63.58	9.69	-2.82
-38.95	-13.39	-3.06
-.44	26.71	16.56
24.61	103.08	-30.28
18.43	19.79	-33.26
-45.56	89.88	11.78
3.13	-2.43	52.42
-26.57	51.25	-35.38
-42.62	64.1	-32.93
-64.71	-1.63	-13.78
-26.17	-33.63	-18.23
41.18	-13.17	-7.34
35.14	43.46	64.93
-29.08	-60.14	10.79
-58.51	-.47	-40.72

// Cerullo M A, 2016: Healthy Controls
// Subjects=25
70.06	13.67	6.81
-23	51.69	11.38
-7.29	38.67	-34.55
-54.98	22.69	10.83
6.01	76.64	42.41
-32.09	-54.94	37.15
-45.56	40.5	-7.5
2.59	100.71	23.7
21.65	23.24	-30.24
41.3	1.32	14.86
-26.07	-6.2	6.23
-39.39	57.77	-32.44
18.36	108.01	-7.2
-38.7	-4.22	32.97
-55.13	-5.25	-20.28
-16.7	-2.11	-24.33
63.58	9.69	-2.82
-38.95	-13.39	-3.06
-.44	26.71	16.56
24.61	103.08	-30.28
18.43	19.79	-33.26
-45.56	89.88	11.78
3.13	-2.43	52.42
-26.57	51.25	-35.38
-42.62	64.1	-32.93
-64.71	-1.63	-13.78
-26.17	-33.63	-18.23
32.07	8.55	67.89
-13.65	25.95	-33.41
2.8	37.01	25.69
41.18	-13.17	-7.34
35.14	43.46	64.93
-29.08	-60.14	10.79
-58.51	-.47	-40.72

// Pomarol-Clotet E, 2015: Subgroup of Bipolar Disorder, Mania
// Subjects=38
-30	-2	62
24	6	58
18	8	16
-18	-10	18
30	-44	-32
-44	-70	-10
-2	46	-28
-46	-42	56
26	-50	56

// Pomarol-Clotet E, 2015: Subgroup of Bipolar Disorder, Depression
// Subjects=38
-32	-2	50
8	-64	62
-32	-54	-30
0	46	-20
40	-44	56

// Pomarol-Clotet E, 2015: Subgroup of Bipolar Disorder, Euthymia
// Subjects=38
-6	16	-10
-46	-42	56
26	-50	56
40	-44	56

// Pomarol-Clotet E, 2015: Healthy Controls
// Subjects=38
-30	-2	62
24	6	58
18	8	16
-18	-10	18
30	-44	-32
-44	-70	-10
-2	46	-28
-32	-2	50
8	-64	62
-32	-54	-30
0	46	-20
-6	16	-10

// Sepede G, 2015: Healthy Controls
// Subjects=24
48.36	5.25	30.62
-49.94	3.69	33
48.24	21.65	22.56
41.06	-3.83	51.54
0.4	7.39	48.84
41.94	-77.26	-3.65
-40.35	-79.96	-3.59
-14.88	-27.82	-6.02
-13.73	-18.24	7.66
-24.52	-.67	1.85
18.22	-53.23	-21
-28.82	-47.08	-19.86
4.37	-64.94	-19.86
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
48.36	5.25	30.62
-49.94	3.69	33
-43.31	-18.17	52.6
0.4	7.39	48.84
33.47	-85.26	3.81
-26.35	-89.76	5.99
13.14	-90.04	-1.13
-8.27	-91.65	-6.32
28.36	-68.63	40.39
-26.13	-62.27	44.95
-14.88	-27.82	-6.02
-24.52	-.67	1.85
19.28	-52.16	-21.1
4.36	-65.03	-20.97
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
45.21	-67.76	8.9
-46.7	-70.6	7.97
40.68	-53.98	-18.97
-34.09	0.84	8.52
35.34	-26.55	-7.82
-55.57	-2.6	-6.56
-10.57	-24.19	-.8
49.55	-54.99	22.28
-29.82	-48.6	-11.92
-6.9	-85.22	35.5
-.79	-72.95	0.94
-3.17	-61.19	-25.66
41.91	28.99	35.4
0.99	38.69	-.63
40.86	25.89	36.78
18.11	62.11	11.7
-9.06	-65.69	40.58
48.49	-38.45	29.83
-48.11	3.87	-6.07
23.73	38.65	38.14
5.68	28.74	49.22
24.9	-66.82	9.06

// Sepede G, 2015: Euthymic Borderline Personality Disorder Patients
// Subjects=23
48.36	5.25	30.62
-49.94	3.69	33
48.24	21.65	22.56
41.06	-3.83	51.54
0.4	7.39	48.84
41.94	-77.26	-3.65
-40.35	-79.96	-3.59
-14.88	-27.82	-6.02
-13.73	-18.24	7.66
-24.52	-.67	1.85
18.22	-53.23	-21
-28.82	-47.08	-19.86
4.37	-64.94	-19.86
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
48.36	5.25	30.62
-49.94	3.69	33
-43.31	-18.17	52.6
0.4	7.39	48.84
33.47	-85.26	3.81
-26.35	-89.76	5.99
13.14	-90.04	-1.13
-8.27	-91.65	-6.32
28.36	-68.63	40.39
-26.13	-62.27	44.95
-14.88	-27.82	-6.02
-24.52	-.67	1.85
19.28	-52.16	-21.1
4.36	-65.03	-20.97
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
45.21	-67.76	8.9
-46.7	-70.6	7.97
40.68	-53.98	-18.97
-34.09	0.84	8.52
35.34	-26.55	-7.82
-55.57	-2.6	-6.56
-10.57	-24.19	-.8
49.55	-54.99	22.28
-29.82	-48.6	-11.92
-6.9	-85.22	35.5
-.79	-72.95	0.94
-3.17	-61.19	-25.66
41.91	28.99	35.4
0.99	38.69	-.63
-9.06	-65.69	40.58
48.49	-38.45	29.83
-48.11	3.87	-6.07
23.73	38.65	38.14
5.68	28.74	49.22
24.9	-66.82	9.06

// Sepede G, 2015: Relatives of Borderline Personality Disorder Patients
// Subjects=22
48.36	5.25	30.62
-49.94	3.69	33
48.24	21.65	22.56
41.06	-3.83	51.54
0.4	7.39	48.84
41.94	-77.26	-3.65
-40.35	-79.96	-3.59
-14.88	-27.82	-6.02
-13.73	-18.24	7.66
-24.52	-.67	1.85
18.22	-53.23	-21
-28.82	-47.08	-19.86
4.37	-64.94	-19.86
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
48.36	5.25	30.62
-49.94	3.69	33
-43.31	-18.17	52.6
0.4	7.39	48.84
33.47	-85.26	3.81
-26.35	-89.76	5.99
13.14	-90.04	-1.13
-8.27	-91.65	-6.32
28.36	-68.63	40.39
-26.13	-62.27	44.95
-14.88	-27.82	-6.02
-24.52	-.67	1.85
19.28	-52.16	-21.1
4.36	-65.03	-20.97
50.67	-58.87	27.05
-47.62	-63.6	29.69
-0.08	49.69	4.03
-.62	-55.83	29.62
45.21	-67.76	8.9
-46.7	-70.6	7.97
40.68	-53.98	-18.97
-34.09	0.84	8.52
35.34	-26.55	-7.82
-55.57	-2.6	-6.56
-10.57	-24.19	-.8
49.55	-54.99	22.28
-29.82	-48.6	-11.92
-6.9	-85.22	35.5
-.79	-72.95	0.94
-3.17	-61.19	-25.66
41.91	28.99	35.4
0.99	38.69	-.63
40.86	25.89	36.78
18.11	62.11	11.7
48.49	-38.45	29.83
-48.11	3.87	-6.07
23.73	38.65	38.14
5.68	28.74	49.22
24.9	-66.82	9.06

// Young K D, 2016: Healthy Controls
// Subjects=16
-25.31	18.69	45.95
28.09	27.47	44.6
0.39	-39.96	28.27
-17.14	-13.71	-16.1
53.31	45.18	-4.01
36.41	16.33	9.76
-20.37	-5.27	-16.77
0.39	-39.96	28.27
36.41	16.33	9.76
-31.58	-63.42	30.61
60.16	-66.7	7.53
-17.14	-13.71	-16.1
4.68	15.16	52.6
2.29	19.09	21.07
-17.21	-3.48	-21.42
-18.8	-61.57	25.85
-19.12	55.94	31.61
2.29	19.09	21.07
-18.8	-61.57	25.85

// Young K D, 2016: Major Depressive Patients
// Subjects=16
-25.31	18.69	45.95
28.09	27.47	44.6
0.39	-39.96	28.27
-17.14	-13.71	-16.1
-25.31	18.69	45.95
28.09	27.47	44.6
53.31	45.18	-4.01
36.41	16.33	9.76
-20.37	-5.27	-16.77
53.31	45.18	-4.01
0.39	-39.96	28.27
36.41	16.33	9.76
-31.58	-63.42	30.61
60.16	-66.7	7.53
-20.37	-5.27	-16.77
4.68	15.16	52.6
-19.12	55.94	31.61
-17.21	-3.48	-21.42
2.29	19.09	21.07
-18.8	-61.57	25.85
2.29	19.09	21.07
-18.8	-61.57	25.85

// Young K D, 2016: Bipolar Patients
// Subjects=16
-25.31	18.69	45.95
28.09	27.47	44.6
53.31	45.18	-4.01
0.39	-39.96	28.27
36.41	16.33	9.76
-31.58	-63.42	30.61
60.16	-66.7	7.53
-20.37	-5.27	-16.77
0.39	-39.96	28.27
36.41	16.33	9.76
-31.58	-63.42	30.61
60.16	-66.7	7.53
-17.14	-13.71	-16.1
2.29	19.09	21.07
-17.21	-3.48	-21.42
-18.8	-61.57	25.85
-19.12	55.94	31.61
-19.12	55.94	31.61
-17.21	-3.48	-21.42
2.29	19.09	21.07
-18.8	-61.57	25.85

// Alonso-Lana S, 2019: Bipolar Patients
// Subjects=26
-54	6	22
-6	2	56
-28	-54	42
38	-4	52
2	-66	30
0	64	10
50	-72	28
-38	-52	54
38	-58	-32
44	-42	42
8	-60	18
-50	-66	24
-8	68	16
-7	-36	-13
-2	-16	70
34	44	30
-44	-28	40
-62	-18	48
12	46	-24
-24	-58	2
-4	54	26
-40	-36	24
-14	-42	26
-32	-4	58
-24	-60	14
-44	-4	59
-9	-70	52
-7	-36	-13
-4	34	-16
-7	-36	-13
24	28	-16
-44	-4	59
-9	-70	52
-32	-6	54
10	-70	52
-44	-18	60
10	-68	50
-6	-78	52

// Alonso-Lana S, 2019: Healthy Controls
// Subjects=26
0	4	52
34	20	4
36	-48	42
-46	-82	-10
2	-52	32
-4	60	-8
54	0	-26
-58	-6	-24
34	22	4
38	-48	48
46	-74	-6
16	-60	24
0	64	8
-40	-84	34
52	-70	20
64	-10	-16
-8	68	16
-7	-36	-13
-44	-28	40
-62	-18	48
12	46	-24
-24	-58	2
-14	-42	26
-32	-4	58
-24	-60	14
-44	-4	59
-9	-70	52
-7	-36	-13
-4	34	-16
-7	-36	-13
24	28	-16
-44	-4	59
-9	-70	52
-32	-6	54
10	-70	52
-44	-18	60
10	-68	50
-6	-78	52

// Goikolea J M, 2019: First Episode Mania Patients
// Subjects=31
-43.67	6.28	49.32
51.14	12.3	28.06
-50.56	37.15	23.97
-44.5	53.72	-5.78
55.82	-33.13	47.05
-28.29	-57.37	56.48
42.05	23.19	-4.23
-48.43	-64.87	0.42
-31.46	-66.03	-24.41
3.82	-40.94	35.26
-9.89	45.34	-5.54
-3.57	54	-16.59

// Goikolea J M, 2019: Healthy Controls
// Subjects=31
-30.67	3.35	51.63
40.52	3.83	41.41
55.28	33.92	18.01
40.01	48.13	10.14
51.51	-37.4	47.54
-28.35	-55.66	51.83
-37.82	21.3	2.92
35.56	26.35	-4.44
-39.77	-62.5	2.28
-3.26	-56.38	-14.64
31.24	-67.73	-23.07
-1.4	51.88	-16.42
3.19	44.09	3.32
-5.54	41.2	-4.09
-9.14	-54.06	33.42
3.8	-43.28	33.25
16.74	-56.52	28.74
-47.89	-69.53	42.33
32.99	13.45	-38.98
-31.84	8.76	-39.65
-9.89	45.34	-5.54
-3.57	54	-16.59

// Han X, 2018: Healthy Controls
// Subjects=10
-30	-75	-6
-12	-96	6
-18	-87	-9
24	-78	-6
15	-99	6
-6	-96	6
39	-57	-12
6	-87	-3
27	-9	-12
27	-4	-12
57	21	30
-48	9	-21
-39	24	-6
-45	6	12
-12	0	15
45	-3	-6
57	-12	24
15	18	57
15	3	66
63	-36	21
69	-27	21
54	-33	39
-57	-33	27
-27	-42	48
-48	-54	27
-6	-18	42
-36	-3	12
-33	-51	-24
-60	9	15
-60	15	24
3	-84	-3
24	-72	-9
21	-90	-6
3	-87	-3
-21	-90	12
6	-78	3

// Han X, 2018: Bipolar Disorder
// Subjects=10
18	-93	3
21	-96	12
-21	-99	9
-9	-90	0
36	-90	0
15	-90	15
27	-9	-12
27	-4	-12
57	21	30
-48	9	-21
57	-51	30
-2	23	47
5	22	41
-34	25	-4
-36	-3	12
-33	-51	-24
-60	9	15
-60	15	24
54	-66	0
-36	-78	12
-36	-81	-21
27	-78	15
42	-84	0
48	6	42
-42	0	57
-45	3	45
-51	18	36

// Kryza-Lacombe M, 2019: Age Group x Diagnosis
// Kryza-Lacombe M, 2019: HC Youths < HC Adults, Time Course
// Kryza-Lacombe M, 2019: BD Youths > BD Adults, Time Course
// Kryza-Lacombe M, 2019: Diagnosis, Time Averaged
// Kryza-Lacombe M, 2019: Age Group, Time Averaged
// Kryza-Lacombe M, 2019: Age Group x Diagnosis, Time Averaged
// Kryza-Lacombe M, 2019: BD Youths < BD Adults, Time Averaged
// Kryza-Lacombe M, 2019: BD Youths < HC Youths, Time Averaged
// Kryza-Lacombe M, 2019: HC Adults < BD Adults, Time Averaged
// Kryza-Lacombe M, 2019: HC Adults < HC Youths, Time Averaged
// Kryza-Lacombe M, 2019: Face Emotion, Time Averaged
// Kryza-Lacombe M, 2019: Diagnosis x Face Emotion, Time Averaged
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Face Emotion, Time Averaged
// Kryza-Lacombe M, 2019: Negative Valence, HC Youths > HC Adults, Time 
// Averaged
// Kryza-Lacombe M, 2019: Neutral Valence, BD Youths > BD Adults, Time 
// Averaged
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Face Emotion, Time Averaged, 
// Sphericity-corrected
// Kryza-Lacombe M, 2019: Diagnosis, Time Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Age Group, Time Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Face Emotion, Time Averaged, Emotion Intensity 
// Included
// Kryza-Lacombe M, 2019: Intensity (Linearly), Time Averaged, Emotion 
// Intensity Included
// Kryza-Lacombe M, 2019: Intensity (Quadratically), Time Averaged, Emotion 
// Intensity Included
// Kryza-Lacombe M, 2019: Intensity (Cubically), Time Averaged, Emotion 
// Intensity Included
// Kryza-Lacombe M, 2019: Age Group x Diagnosis, Time Averaged, Emotion 
// Intensity Included
// Kryza-Lacombe M, 2019: Diagnosis x Face Emotion, Time Averaged, Emotion 
// Intensity Included
// Kryza-Lacombe M, 2019: Face Emotion x Intensity (Modeled Linearly), Time 
// Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Diagnosis x Intensity (Modeled Quadratically), Time 
// Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Face Emotion, Time Averaged, 
// Emotion Intensity Included
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Intensity (Linearly), Time 
// Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Diagnosis x Face Emotion x Intensity (Linearly), 
// Time Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Age Group x Face Emotion x Intensity 
// (Quadratically), Time Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Diagnosis x Face Emotion x Intensity (Cubically), 
// Time Averaged, Emotion Intensity Included
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Face Emotion x Intensity 
// (Linearly),  Time Averaged, Em Int Included
// Kryza-Lacombe M, 2019: Age Group x Diagnosis x Face Emotion x Intensity 
// (Quadratically), Time Averaged, Em Int Included
// Subjects=22
0.16	42.31	32.53
2.41	-82.87	-3.84
28.77	-55.68	-39.88
0.16	42.31	32.53
2.41	-82.87	-3.84
0.16	42.31	32.53
2.41	-82.87	-3.84
-13.29	-68.54	45.33
-64.02	-43.35	-9.73
-8.68	36.98	-8.18
-40.6	-41.95	-21.27
66.56	-18.42	25.71
61.01	-20.59	-1.93
-7.28	40.41	36.12
-32.18	55.67	1.67
-7.28	40.41	36.12
-32.18	55.58	0.56
-7.28	40.41	36.12
-32.18	55.58	0.56
-7.28	40.41	36.12
-32.18	55.58	0.56
-32.18	55.58	0.56
-10.41	-82.95	-3.68
50.39	20.61	22.62
53.92	-38.53	42.04
2.03	53.76	1.44
-8.19	-54.62	18.45
14.85	-61.48	-44.81
-24.33	32.02	39.25
-29.84	-8.19	1.42
-58.8	-14.94	-14.41
-15.97	-37.94	-12.97
-5	-27.31	27.28
-15.93	-21.05	-1
10.98	-66.11	5.81
-15.77	-79.81	-3.88
29.33	-75.11	25.31
-53.03	-65.46	19.87
-15.77	-79.81	-3.88
-53.03	-65.46	19.87
-53.03	-65.46	19.87
-15.77	-79.81	-3.88
-53.01	-65.2	23.2
-64.02	-43.35	-9.73
-13.29	-68.54	45.33
-26.39	-51.73	16.19
37.61	-50.34	0.84
-8.68	36.98	-8.18
-40.6	-41.95	-21.27
66.56	-18.42	25.71
61.01	-20.59	-1.93
-18.97	-79.83	-3.85
-29.96	23.53	-1.24
50.39	20.61	22.62
-47.64	-15.45	46.84
-2.87	19.89	45.6
-5.45	64.72	6.18
56.1	-32.63	49.32
32.35	27.33	42.34
-21.08	27.01	42.98
-8.17	-54.36	21.77
24.01	-63.89	33.36
-24.05	-3.45	62.29
-58.79	-17.05	-14.23
12.65	-51.17	-48.99
-47.82	-47	10.46
-2.71	-38.87	42.72
-5	-27.31	27.28
-36.86	-36.36	50.7
-26.79	56.13	7.15
-10.43	-79.78	-3.95
-29.35	-19.6	60.36
44.76	45.13	-3.91
50.42	-33.98	4.89
23.53	-49.14	-23.64
21.63	-79.59	-4.33
16.67	-62.48	52.28
16.38	-56.76	16.12
37.93	-71.21	33.81
-50.82	-11.87	52.16
-29.84	-8.19	1.42
32.18	-42.51	-7.56
50.73	-14.26	53.42
18.05	-64.89	-47.9
28.77	-9.55	-21.44
-13.79	-21.04	-1.03
-40.1	-36.81	45.2
18.39	-69.03	-5.18
-32.11	26.69	-1.48
39.5	23.95	-2.07
-4.92	-20.91	41.23
53.92	-66.08	29.85
-50.78	-49.99	40.86
-36.83	-25.1	58.68
-2.87	19.89	45.6
22.04	-62.19	55.54
-34.78	-42.49	40.04
-8.75	43.95	-14.34
-29.68	31.99	39.31
-58.78	-14.76	-12.19
-26.68	-3.14	-2.38
34.5	-87.8	-1.56
23.38	-61.68	-48.23
-21.04	-95.53	-.28
-61.77	-42.22	4.64
-8.11	-23.04	41.45
-63.76	-24.23	31.04
48.56	-55.28	32.35
5.23	53.78	1.4
-21.14	29.75	37.17
34.47	30.51	42.05
48.3	13.45	26.59
16.1	-46.47	-15.97
-13.54	-82.11	7.43
10.96	-77.36	-2.17
42.71	27.31	-.16
-40.39	12.92	27.65
-8.35	40.4	36.13
-32.18	55.67	1.67
-45.42	-22.24	55.19
50.69	-25.69	43.23
-42.64	22.8	17.93
-15.79	-80.07	-7.21
45.09	13.43	26.63
18.56	-87.04	9.71
45.06	-58.3	-6.39
-3.28	59.61	8.81
-50.83	-15.3	49.1
-40.51	-46.55	-11.97
-3.37	38.87	-11.75
61.26	-10.36	34.01
16	-71.61	-38.39
-24.35	-78	-7.28
29.28	-77.83	17.74
29.04	-67.11	-8.81
-29.52	-81.78	13.17
-53	-67.32	23.38
-15.78	-77.7	-4.06
5.63	-71.68	2.99
55.86	-18.65	23.62
-56.4	-23.18	16.37
7.83	3.66	41.26
-8.71	38.83	-11.69
2.46	-73.56	6.53
-50.82	-66.88	28.89

// Moser D A, 2018: Healthy Volunteers
// Subjects=48
-44	-36	40
-6	14	56
-40	20	-4
60	-52	-10
-8	-14	8
-2	-26	-12
-32	-60	-28
-4	-44	-18
6	-72	-42
28	-56	-34
-44	-36	40
-6	14	56
-40	20	-4
60	-52	-10
-32	-60	-28
28	-56	-34
-44	-36	40
-6	14	56
28	-56	-34
-30	-84	-2
44	-38	42
-42	-48	44
28	8	58
-28	4	60
2	22	44
-2	24	44
4	12	26
-12	-94	0
16	-90	-8
-28	-86	-16
-50	-38	-6
50	-42	-2
40	-50	-22
32	-96	-2
-26	-96	-6
-38	-56	-20
18	-4	-12
-16	-4	-12
46	12	30
-44	20	24
8	-84	2
-6	-84	0
48	-40	12
-42	28	-14
32	36	-10
2	-64	34

// Moser D A, 2018: Bipolar Disorder
// Subjects=37
-44	-36	40
-6	14	56
-40	20	-4
60	-52	-10
-8	-14	8
-2	-26	-12
-32	-60	-28
-4	-44	-18
6	-72	-42
28	-56	-34
-44	-36	40
-6	14	56
28	-56	-34
-30	-84	-2
44	-38	42
-42	-48	44
28	8	58
-28	4	60
2	22	44
-2	24	44
4	12	26
-12	-94	0
16	-90	-8
-28	-86	-16
-50	-38	-6
50	-42	-2
40	-50	-22
32	-96	-2
-26	-96	-6
-38	-56	-20
18	-4	-12
-16	-4	-12
46	12	30
-44	20	24
8	-84	2
-6	-84	0
48	-40	12
-42	28	-14
32	36	-10
2	-64	34

// Moser D A, 2018: Schizophrenia
// Subjects=92
-44	-36	40
-6	14	56
-40	20	-4
60	-52	-10
-8	-14	8
-2	-26	-12
-32	-60	-28
-4	-44	-18
6	-72	-42
28	-56	-34
-44	-36	40
-6	14	56
-40	20	-4
60	-52	-10
-32	-60	-28
28	-56	-34
-30	-84	-2
44	-38	42
-42	-48	44
28	8	58
-28	4	60
2	22	44
-2	24	44
4	12	26
-12	-94	0
16	-90	-8
-28	-86	-16
-50	-38	-6
50	-42	-2
40	-50	-22
32	-96	-2
-26	-96	-6
-38	-56	-20
18	-4	-12
-16	-4	-12
46	12	30
-44	20	24
8	-84	2
-6	-84	0
48	-40	12
-42	28	-14
32	36	-10
2	-64	34

// Rodriguez-Cano E, 2017: Major Depressive Disorder
// Subjects=26
0	6	56
-32	-58	54
-50	-74	-10
36	-58	50
4	-78	50
-8	64	32
-44	-70	30
44	-80	28
4	18	48
-30	-48	42
46	-50	48
6	-56	18
-2	52	-10
0	48	-18
-16	-86	8
-2	50	-16

// Rodriguez-Cano E, 2017: Bipolar Depressive Disorder
// Subjects=26
-42	-44	44
38	34	24
34	-58	54
6	-66	60
-40	-46	42
34	-50	42
6	-50	30
4	68	32
-4	-68	20
-2	50	-16
22	-66	-38
-40	12	18
-2	50	-16

// Rodriguez-Cano E, 2017: Healthy Controls
// Subjects=26
-54	-2	48
-38	-44	44
36	-2	50
-42	-72	-12
34	-50	42
4	-78	50
-4	68	26
-42	-76	36
-62	-12	-18
2	16	48
-2	50	-14
6	-52	18
18	-92	36
0	48	-18
-16	-86	8
4	68	32
-4	-68	20
-2	50	-16
22	-66	-38
-40	12	18
-2	50	-16

// Zhang L, 2019: Healthy Controls
// Subjects=15
-44	28	-8
-28	58	22
0	26	40
-50	10	-20
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
58	6	-22
-30	16	35
36	-90	-4
-52	28	14
40	34	16
-42	16	38
-52	24	0
-42	28	-10
54	26	-4
44	4	-32
50	18	-14
-4	2	64
-2	14	60
10	10	62
-22	48	22
-60	-32	2
-54	-58	16
-56	-48	-2
12	-10	0
-8	-14	2
0	-18	-4
-44	28	-8
-28	58	22
0	26	40
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
58	6	-22
-30	16	35
36	-90	-4
-52	28	14
40	34	16
-46	30	-6
2	14	50

// Zhang L, 2019: Schizophrenia
// Subjects=16
-44	28	-8
-28	58	22
0	26	40
-50	10	-20
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
36	-90	-4
-52	28	14
40	34	16
-42	16	38
-52	24	0
-42	28	-10
54	26	-4
44	4	-32
50	18	-14
-4	2	64
-2	14	60
10	10	62
-22	48	22
-60	-32	2
-54	-58	16
-56	-48	-2
12	-10	0
-8	-14	2
0	-18	-4
-44	28	-8
-28	58	22
0	26	40
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
26	54	18
36	-90	-4
-52	28	14
40	34	16
-48	34	2
2	14	50
-46	30	-6
2	14	50
-48	30	-4
2	14	50

// Zhang L, 2019: Bipolar Disorder
// Subjects=15
-44	28	-8
-28	58	22
0	26	40
-50	10	-20
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
58	6	-22
-30	16	35
-42	16	38
-52	24	0
-42	28	-10
54	26	-4
44	4	-32
50	18	-14
-4	2	64
-2	14	60
10	10	62
-22	48	22
-60	-32	2
-54	-58	16
-56	-48	-2
12	-10	0
-8	-14	2
0	-18	-4
-44	28	-8
-28	58	22
0	26	40
50	20	-14
-56	-32	-2
-54	-60	20
-2	4	66
-48	34	2
28	-92	-2
2	14	50
26	54	18
58	6	-22
-30	16	35
-48	34	2
2	14	50
-46	30	-6
2	14	50
-48	30	-4
2	14	50

// Kirschner M, 2019: High Reward > No Reward, All Subjects
// Kirschner M, 2019: High Reward > No Reward, Healthy Controls > Bipolar 
// Disorder
// Subjects=25
-40	-19	51
-45	-30	46
-39	-22	61
-8	24	-12
-10	21	0
-30	-88	-14
-18	-81	-18
-12	-88	-12
14	-93	4
15	-90	-9
12	-88	12
40	24	-2
32	34	0
34	28	-8
8	27	-9
10	18	-5
10	6	9
-30	30	-5
2	17	43
-2	3	57
3	11	52
26	-3	54
32	-3	46
36	0	55
33	33	28
-12	-67	46
-4	-72	49
-6	-66	57
38	-51	-33
-34	-51	54
-27	-49	51
-21	-55	57
12	-67	48
15	-60	48
-36	-81	24
-27	-81	31
-26	-69	31
8	-75	-23
15	-82	-21
15	-3	15
46	-46	-11
-22	-61	-5
-6	-57	-2
-10	-49	-2
42	-12	36
32	-9	37
45	-6	31
-9	-49	34
-16	-45	33
-24	-82	4
-33	-73	9
-16	-87	1
-27	-78	40
-33	-70	33

// Manelis A, 2018: Healthy Controls (HC) < Bipolar Disorder, Loss 
// Anticipation, Longitudinal
// Subjects=17
48	-72	-8

// D'Cruz A M, 2016: Healthy Controls
// Subjects=23
16	14	-6
-14	14	-6
10	-18	4
-10	-20	4
-10	8	6
-28	58	-12
34	26	-6
-30	22	-6
2	16	40
-2	16	42
-8	22	24
10	38	20
-8	32	20
40	26	26
-46	30	30
52	8	26
-56	2	30
8	0	56
-10	2	54
46	-30	42
-46	-36	46
18	-74	8
-10	-90	0
28	-66	44
-16	68	54
10	-70	46
-10	-68	52
12	-76	-6
-14	-70	-6
10	8	-2
12	-18	6
-6	-8	4
2	16	40
-10	12	40
2	34	30
-2	36	30
2	36	20
-2	40	20
-46	30	30
40	-8	34
-28	10	42
2	20	56
-2	20	56
42	-38	46
-42	-54	46
32	86	14
4	-74	46
-4	-74	46

// D'Cruz A M, 2016: Autism Spectrum Disorder (ASD)
// Subjects=17
26	0	50
-24	-6	50
-6	6	44
-58	6	28
44	-30	44
-40	-32	44
10	8	-2
12	-18	6
-6	-8	4
2	16	40
-10	12	40
2	34	30
-2	36	30
2	36	20
-2	40	20
-46	30	30
40	-8	34
-28	10	42
2	20	56
-2	20	56
42	-38	46
-42	-54	46
32	86	14
4	-74	46
-4	-74	46

// Sullivan D R, 2018: Mild Traumatic Brain Injury (mTBI)
// Subjects=17
-8	8	48
22	-60	60
-26	-58	56
32	-36	38
42	22	-6
-8	-86	8
-32	20	4
52	-40	50
32	38	24
-36	-50	38
-4	-30	36
-36	-70	40
-28	26	50
-4	60	28
-54	22	18
40	-76	-50
-54	22	18
-4	-92	12

// Sullivan D R, 2018: Controls, non-mTBI
// Subjects=16
52	-26	50
4	24	42
42	24	-8
-54	16	-8
-46	6	42
-8	-75	50
-34	54	6
-4	-30	36
-36	-70	40
-28	26	50
-4	60	28
-54	22	18
40	-76	-50
-54	22	18
-4	-92	12

// Velasquez F, 2017: Autism Spectrum Disorder (ASD)
// Subjects=19
4	38	12
18	-40	46
44	-76	22
-50	-50	18
-16	-72	-34
40	-64	20
10	-22	-4
20	44	26
-24	-88	8
56	-54	48
-20	-98	24
12	-50	42
-10	48	-4
-46	-62	20
-62	-6	26
-38	-22	18
22	66	-8
18	-20	78
70	-24	22
40	-88	-6
-26	58	-14
46	-82	14
38	50	-12
-58	-12	44
42	-12	36
24	30	42

// Velasquez F, 2017: Healthy Controls (HC)
// Subjects=22
4	38	12
18	-40	46
44	-76	22
-50	-50	18
-16	-72	-34
40	-64	20
10	-22	-4
20	44	26
-24	-88	8

// Cortese B M, 2018: Combat Veterans with PTSD (CV+PTSD)
// Subjects=21
40	-30	22
54	-18	26
50	-28	22
44	-14	18
36	-30	48
44	-32	50
-28	-70	26
-36	-72	26
-22	-62	28
-38	-78	32
-40	-74	18
-18	-68	28
-48	-36	54
-42	-26	30
-46	-24	20
-58	-28	22
-52	-30	52
-58	-26	30
0	-46	56
12	-36	56
6	-46	58
10	-46	56
10	-50	62
-14	-60	56
-38	-52	22
-18	-54	22
-38	-64	28
-34	-60	24
-56	-70	26
14	-52	36
60	-30	28
60	-30	18
36	-42	32
42	-44	22
52	-40	28
32	-42	34
-28	-54	62
-56	-26	30
-36	-50	60
-42	-30	34
-48	-40	50
-44	-44	56

// Cortese B M, 2018: Combat Veterans without PTSD (CV-PTSD)
// Subjects=27
40	-30	22
54	-18	26
50	-28	22
44	-14	18
36	-30	48
44	-32	50
-28	-70	26
-36	-72	26
-22	-62	28
-38	-78	32
-40	-74	18
-18	-68	28
-48	-36	54
-42	-26	30
-46	-24	20
-58	-28	22
-52	-30	52
-58	-26	30
0	-46	56
12	-36	56
6	-46	58
10	-46	56
10	-50	62
-14	-60	56
-38	-52	22
-18	-54	22
-38	-64	28
-34	-60	24
-56	-70	26
14	-52	36
60	-30	28
60	-30	18
36	-42	32
42	-44	22
52	-40	28
32	-42	34
-50	-24	36
-46	-26	42
-46	-18	54
-52	-16	26
-40	-28	32
-52	-22	18

// Dretsch M N, 2016: Unpredictable > Predictable, Deployment-Exposed Controls 
// (DEC) > PTSD
// Subjects=33
63.28	-33.47	10.28
-59.7	-19.75	6.08
46.37	-55.81	25.73
-51.14	-31.75	1.41
43.79	-8.78	-12.76
37.34	-13.65	-20.08
-22.54	-2.29	-19.23

// Fonzo G A, 2016: Incongruent > Congruent, All Groups
// Fonzo G A, 2016: Post-Congruent Incongruent (cI) > Post-Incongruent 
// Incongruent (iI), All Groups
// Fonzo G A, 2016: Happy > Fearful words, All Groups
// Fonzo G A, 2016: Face Valence > Word Valence, All Groups
// Subjects=20
-40	10	23
-40	-54	29
39	17	7
54	-42	22
34	-45	43
0	-23	27
0	-23	27
20	5	12
-20	-5	48
27	-59	51
2	-79	6
-37	-69	-15
32	54	5
-14	-78	-37
-32	-94	10
13	-84	-2
-13	-81	-6
4	-81	-5
-4	-81	-5

// Moser D A, 2015: Interpersonal Violence-Related PTSD (IPV-PTSD)
// Subjects=17
-6	29	10
54	-22	-20
42	2	28
-27	5	58

// Moser D A, 2015: Healthy Controls
// Subjects=21
-9	-1	28
-48	17	1
-15	-7	52
-6	29	10
54	-22	-20
-45	8	25
-39	-10	43
18	-70	52

// Moser D A, 2015: Emotional > Neutral: IPV-PTSD > Controls
// Moser D A, 2015: Emotional > Neutral: Controls > IPV-PTSD
// Moser D A, 2015: Group x Film Condition
// Moser D A, 2015: Menacing > Prosocial, Entire Cohort
// Moser D A, 2015: Prosocial > Menacing, Entire Cohort
// Subjects=16
30	-10	-17
-15	41	-14
-33	-34	58
42	-49	46
-60	-16	40
30	37	29
36	50	16
36	26	43
-18	26	55
39	-31	19
-54	11	34
48	-58	52
3	-58	-5
-9	50	28
27	8	55
3	17	22
-51	35	-2
42	-76	19
-21	8	64
-36	-22	19
39	-19	19
9	-7	28
-6	22	64
51	-28	1
-45	-70	46
45	-64	49
60	-1	7

// Nguyen-Louie T T, 2018: Positive Correlation between age of weekly drinking 
// and (6 dot > 2 dot) at Follow-up
// Subjects=133
-7.6	68.93	5.85
-44.94	29.87	-.48
0.51	-37.54	45.91
11.68	62.96	9.48
13.29	-24.77	44.7

// Wesley M J, 2017: Healthy Controls
// Subjects=11
-23.92	-62.47	59.15
49.45	-29.03	56.83
-52.49	4.9	35.04
-7.01	-41.19	33.23
-3.42	-46.24	59.44
44.51	38.55	22.22
-2.99	58.36	30.03
21.22	25.63	57.51
29.96	-57.9	47.7
-32.66	-79.7	47.56
-53.15	-42.26	58.77
-12.19	43.23	-16.5
11.6	27.05	-18.67
-56.17	43.23	8.9
24.61	67.9	-7.24
-12.03	43.31	-4.18
-67.03	20.88	0.09
9.62	21.8	-5.79
3.19	44.09	3.32
-29.49	36.47	-18.9
-44.27	28.07	6.84
9.56	21.38	-10.23
-10.1	31.77	-24.37

// Wesley M J, 2017: Heavy Drinkers who were Alcohol Non-Dependent (A-ND)
// Subjects=11
-39.26	10.22	56.7
42.86	-37.54	46.58
-2.8	26.97	38.74
38.57	13.03	59.58
-32.68	-60.14	50.11
-48.31	11.53	25.35
-11.26	-42.81	39.06
-7.49	65.71	17.05
-48.06	-61	30.28
3.69	43.47	42.6
-44.37	50.3	3.52
-39.06	-57.2	58.89
37.69	19.56	-8.28
47.24	-44.76	49.46
-42.35	23.02	-12.87
1.96	-68.21	53.68
37.67	54.43	-2.77
27.8	15.43	62.89
55.3	30.83	19.44
-36.93	-76	52.87
3.19	44.09	3.32
-29.49	36.47	-18.9
-44.27	28.07	6.84
9.56	21.38	-10.23
-10.1	31.77	-24.37

// Wesley M J, 2017: Heavy Drinkers who were Alcohol Dependent (A-D)
// Subjects=13
34.37	-55.03	55.18
-36.99	-44.75	54.26
-41.63	14.18	41.78
40.57	15.09	47.02
-39.95	39.03	9.04
55.36	-14.67	14.97
-4.91	-63.49	24.19
-3.35	45.78	-1.21
31.18	-21.16	-18.71
-52.61	-26.64	19.12
-55.62	-63.15	30.62
-7.34	-34.86	9.07
44.7	25.76	34.69
-37.53	-49.86	11.07
47.08	-40.48	37.84
-3.01	45.08	25.74
-36.93	-76	52.87
11.6	27.05	-18.67
-56.17	43.23	8.9
24.61	67.9	-7.24
-12.03	43.31	-4.18
-67.03	20.88	0.09
9.62	21.8	-5.79

// Reckless G E, 2015: Motivation > Neutral
// Subjects=18
-27	23	-23
6	14	61
-9	-16	-14
30	29	-26
27	-88	-20

// Jurick S M, 2018: Mild Cognitive Impairment (MCI)
// Subjects=20
28.98	43.2	27.66
3.38	3.95	17.87
16.01	41.58	7.87
24.62	2.71	-.12
3.18	19.5	-1.28
3.36	16.98	21.23
11.93	4	17.76
3.34	3.61	13.43
28.97	10.11	12.6

// Jurick S M, 2018: Healthy Controls
// Subjects=29
28.98	43.2	27.66
3.38	3.95	17.87
16.01	41.58	7.87
24.62	2.71	-.12
3.18	19.5	-1.28
3.36	16.98	21.23
11.93	4	17.76
3.34	3.61	13.43

// Jurick S M, 2018: Subgroup of MCI, Amnestic Mild Cognitive Impairment 
// (aMCI)
// Subjects=12
28.97	10.11	12.6

// Rajmohan R, 2017: Healthy Controls > Alzheimer's Disease Patients
// Subjects=4
-1	33	47
0	-48	11

// Ammons C J, 2018: Autism Spectrum Disorder (ASD)
// Subjects=14
20	-64	-10
-24	8	0
-28	-22	-8
-54	18	2
62	-46	8
-20	-62	-8
-44	-76	4
30	4	-6
4	58	24
-40	-52	-20
44	-52	38
-6	82	8
10	-78	-2
44	-52	50
0	22	48
-44	-52	46
-16	-20	56
16	-52	48
-16	-60	14
54	-14	-12
-52	-4	-14
52	-34	6
20	-90	-8
-10	50	12
-44	-74	22
6	60	8
62	-16	8
-6	30	52
-10	-40	40
-16	20	42
24	26	42
-2	-66	34
32	-10	2
-2	-44	62
467	-60	26
-26	50	30
6	-10	38
-8	0	36
8	24	-4
26	-36	62
-38	-74	30
44	-70	34

// Ammons C J, 2018: Healthy Controls
// Subjects=14
14	-88	16
60	-40	12
-38	14	52
26	-30	-2
-36	-58	8
56	26	22
-56	-42	12
-2	38	46
-26	-34	-2
12	-90	16
-20	-32	2
6	58	34
44	-76	0
-46	-66	-20
-56	-42	18
-46	12	46
-52	-22	0
-6	82	8
12	-72	-6
-40	-68	20
-30	-48	-12
52	-52	6
24	-90	-6
4	-8	40
6	60	20
56	-24	2
-10	46	16
8	8	68
-6	30	52
-10	-40	40
-16	20	42
24	26	42
-2	-66	34
32	-10	2
-2	-44	62
467	-60	26
-26	50	30
6	-10	38
-8	0	36
8	24	-4
26	-36	62
-38	-74	30
44	-70	34

// Chouinard B, 2017: Autism Spectrum Disorder (ASD)
// Subjects=12
-54	18	18
52	30	-8
-48	6	38
-6	12	58
6	20	58
-52	4	38
-38	-24	66
-24	-6	36
10	30	32
-42	-62	54
-62	-24	-2
64	-36	2
-60	-16	-2
70	-16	-2
-46	-58	42
-18	-4	6
-14	-2	6
-32	-80	-28
28	-74	-30
-26	-84	18
16	-90	20
-12	-16	6
14	-18	6
60	-52	-10
-10	-74	-26
-14	18	56
52	30	-8
4	-18	14
44	-54	56

// Chouinard B, 2017: Healthy Controls
// Subjects=12
-44	26	-18
-46	12	38
-10	48	28
-24	-14	68
-42	-22	48
32	18	18
-54	-22	-4
58	36	0
-44	-40	-2
32	-34	-2
-16	-18	22
24	-2	24
-2	-26	10
6	-82	-18
-26	-84	18
16	-90	20
-12	-16	6
14	-18	6
60	-52	-10
-10	-74	-26
-12	28	30
12	-12	32

// Cooper R A, 2017: Encoding - Baseline, All Subjects
// Cooper R A, 2017: Encoding - Baseline, Healthy Controls > ASD
// Cooper R A, 2017: Positive Correlation between Encoding and Subsequent 
// Memory Success, All Subjects
// Cooper R A, 2017: Positive Correlation between Encoding and Subsequent 
// Memory Success, Healthy Controls > ASD
// Cooper R A, 2017: Retrieval - Baseline, All Subjects
// Cooper R A, 2017: Retrieval - Baseline, Healthy Controls > ASD
// Cooper R A, 2017: Successful > Unsuccessful Retrieval, All Subjects
// Cooper R A, 2017: Positive Correlation between Retrieval and Precision, All 
// Subjects
// Subjects=20
42	-72	-12
-45	3	33
-6	9	57
54	33	27
51	9	30
30	0	51
60	-21	42
45	-72	-12
-48	-69	-9
-6	6	60
-51	3	48
-51	33	6
-24	-3	60
-57	-39	-18
33	-87	12
-51	6	33
54	12	33
30	18	6
48	30	24
9	-78	24
-6	6	-6
60	9	6
63	-18	21
-66	-24	-15
-24	-24	57
6	-6	51
-9	-81	24
54	-24	-21
51	-51	51
-66	-30	-15
-57	-48	48

// Cygan H B, 2019: All Conditions > Fixation, All Subjects
// Cygan H B, 2019: All Conditions > Fixation, ASD > Healthy Controls
// Cygan H B, 2019: Past-Self - Fixation, ASD > Healthy Controls
// Subjects=15
14.75	-35.61	45.75
32.93	36.44	46.16
6.27	46.15	-9.26
-40	-18.25	-6.58
39.75	-4.11	-20.54
44.29	44.54	5.94
55.34	-19.23	12.06
59.46	-20.67	-3.55
59.68	-49.72	7.16
-12.62	-72.31	10.63
-62.7	-14.07	-6.61
-62.36	-46.55	13.41
36.97	-19.3	12.38

// Ewbank M P, 2017: Different-Identity > Same-Identity, Healthy Controls > 
// Autism Spectrum Conditions (ASC)
// Ewbank M P, 2017: Different-Identity > Same-Identity, Positive correlation 
// with Cambridge Face Memory Test (CFMT)
// Subjects=15
38	-54	-6
-30	-64	34
-24	26	-14
-46	42	18
-54	34	6
2	26	-22
42	-20	-22
-10	62	26
24	-6	-22

// Hsu C, 2018: Mimicking > Anti-Mimicking, All Subjects
// Hsu C, 2018: Mimicking > Anti-Mimicking, Healthy Controls > ASD
// Hsu C, 2018: Mimicking > Anti-Mimicking, Positive correlation with Empathy 
// Quotient (EQ)
// Subjects=26
-42	-62	-9
-51	-59	-12
-35	-55	-12
32	-17	59
32	-78	46

// Kestemont J, 2016: Autism Spectrum Disorder (ASD)
// Subjects=12
-36	18	46
8	4	64
8	0	64
8	4	64
-50	0	28
8	2	64
8	4	64
8	4	64
8	4	64
24	-54	54
-24	-84	6
8	4	64
24	-54	54
-28	-82	6
22	-90	-6
26	-96	-4
10	2	62
28	-78	0
8	4	64
8	2	62
-38	-54	32
26	-96	-4

// Kestemont J, 2016: Subclinical Autism
// Subjects=18
-10	56	32
-20	48	34
-50	32	2
-40	16	52
-8	14	66
40	-20	24
-4	-20	32
6	-22	32
-6	-44	24
24	-74	-30
-26	-82	-34
8	0	64
-50	0	30
8	2	62
-30	-94	-8
-50	0	28
8	2	64
8	4	64
8	2	62
26	-94	-2
8	4	64
24	-54	54
-28	-82	6
22	-90	-6
24	-92	-6
26	-96	-4
8	2	62
10	2	62
28	-78	0
6	4	62
24	-90	-6
8	2	62
-38	-54	32
26	-96	-4

// Kestemont J, 2016: Healthy Controls
// Subjects=20
8	4	64
8	0	64
-50	0	30
8	2	62
-30	-94	-8
8	4	64
-50	0	28
8	2	64
8	4	64
8	4	64
8	2	62
26	-94	-2
8	4	64
24	-54	54
-24	-84	6
8	4	64
24	-54	54
-28	-82	6
22	-90	-6
24	-92	-6
8	2	62
10	2	62
6	4	62
24	-90	-6
8	4	64
8	2	62

// Lassalle A, 2017: Autism Spectrum Disorder (ASD)
// Subjects=27
-38	18	20
-50	24	26
-34	42	-14
48	-70	-8
40	-66	-12
62	-40	6
42	-38	-24
40	-52	-16
66	-42	6
52	-38	8
4	-40	34
-2	-34	32
6	-56	28
-2	-56	28
30	-94	6
56	-8	-14
44	-56	30
48	-40	-22
32	-94	14
-40	-76	-12
-42	-44	-14
-22	-12	-20
-38	-46	-16
-30	-6	-26
-48	-56	-14
-18	-96	-18
-20	-8	-34
28	6	12
4	52	20
0	54	30
2	66	10
-2	68	22
-46	32	-6
-48	24	-2
-42	42	2
-44	32	0
-16	10	20
4	-26	38
-6	-30	34
-24	-4	-32
-12	14	4
-50	-2	-32
-54	-42	-16
-34	-24	-16
-38	-12	-34
-6	-18	48
2	-10	2
-8	-10	0
-24	-14	-4
-30	-4	-22
-30	-12	-36
-14	14	12
4	-14	-20
-32	-14	-8
-34	-20	10
14	-50	20
-8	-52	14
8	40	32
-2	40	32
42	16	38
2	36	42
0	46	44
10	40	36
46	-48	22
2	42	6
-4	38	20
58	-60	32
50	-48	14
54	-42	14
48	20	26
-38	-54	38
-12	-68	34
-48	-46	42
-34	-58	52
-36	-64	52
42	-58	-16
64	-44	2
66	-38	6
46	-66	-12
66	-38	-2
46	-76	-16
36	-66	-16
54	-50	16
40	-62	14
-20	-12	-12
-40	-44	-18
-40	-56	-18
-26	-10	6
6	-12	4
-10	-22	-4
-24	-4	0
-34	-26	-12
-10	-28	-6
-48	-56	-16
62	-62	4
60	-58	8
42	-54	-10
38	-56	-18
38	-90	6
42	-58	-6
46	-70	-8
28	-78	-16
22	-90	30
46	-50	-4
34	-58	-14
20	-74	30
-22	18	52
-36	40	18
-30	12	50
-10	30	16
-4	28	42
-50	36	20
-48	32	20
-50	38	16
-46	4	6
-36	0	-2
-24	2	-20
-28	0	-8
36	16	50
34	-14	40
44	-46	20
22	-18	54
-20	18	8
-26	32	28
-22	38	30
-12	30	34
-4	-30	60
-14	-36	60
6	-30	38
-14	-26	36
-20	-10	6
-24	-10	12
8	40	32
0	40	24
10	30	24
-4	38	20
16	40	44
10	10	18
68	-12	-10
66	-8	-6
0	-22	-40
-60	-8	34
-52	-8	48
24	-8	-30
36	-12	-38
-40	-34	6
-22	-4	-32
-24	-10	-22
-20	-10	-16
4	-10	2
-8	-8	2
-14	-68	36
32	-28	-26
30	-26	-18
-34	24	-24
-52	10	6
-48	36	20
-48	52	-6
-52	10	30
-36	4	-14
-30	0	-12
-22	0	-4
-46	12	-10
-36	16	8
24	-94	20
28	-60	-6
22	-74	-4
20	-72	6
30	-54	-16
42	-64	0
46	-60	2
16	-30	-18
-16	-30	-16
0	-22	-20
18	-32	-6
-18	-34	-2
16	12	-12
30	-4	-16
18	10	-24
26	-16	-4
12	-46	-10
20	-32	-2
-50	-52	-8
-40	-68	-6
-26	-82	-6
-50	-56	10
-54	-56	18
-32	-54	-8
48	8	4
40	4	24
44	-8	6
48	12	2
58	12	8
56	18	22
42	-4	44
44	-90	4
-22	-98	14
12	-28	78
20	-32	78
-2	-58	8
-6	-62	6
54	20	-24
64	2	-12
-24	-76	46
-20	-30	66
-18	-24	74
-20	-58	-2
-6	0	54
8	14	50
8	12	54
-4	18	62
44	32	2

// Lassalle A, 2017: Healthy Controls
// Subjects=21
18	0	20
18	12	2
40	10	24
24	20	-12
-50	18	30
-40	2	38
-42	12	26
16	-98	12
38	-88	26
48	-78	-10
50	-44	-14
44	-54	-12
14	-98	0
-18	-100	10
32	-86	26
-30	-84	6
22	-80	-12
-24	-92	8
8	-94	6
-12	-86	-6
6	-86	2
-44	-70	-8
-38	-32	-20
-52	-48	-6
-44	-32	-18
-16	-26	-16
-10	-28	-14
-14	-34	-12
-16	-42	-12
-26	-32	-10
-28	28	-18
-34	38	-6
-50	32	12
-8	42	-16
-48	8	16
-44	52	-10
-38	4	40
-48	10	38
-32	26	-6
-50	34	14
-50	18	30
-50	40	12
-36	0	32
-32	30	-8
58	-58	8
60	-40	12
62	-46	10
42	-78	-8
32	-68	-20
-32	-78	-22
-48	-80	-2
-30	-102	4
-40	-60	-18
-38	-54	-20
-6	-14	-8
-10	-12	18
12	14	4
-16	-4	20
18	-4	2
-12	-10	-16
-50	6	18
-46	26	16
-46	10	34
-44	0	40
-40	8	24
-46	30	22
-44	38	16
52	36	14
48	2	40
62	22	6
50	12	36
52	-44	-12
64	-48	6
44	-80	-2
46	-54	-18
70	-42	10
30	-80	-20
-38	-56	44
-40	-48	40
-28	-66	44
-28	-56	44
46	-70	-8
28	-78	-16
22	-90	30
46	-50	-4
34	-58	-14
20	-74	30
-22	18	52
-36	40	18
-30	12	50
-10	30	16
-4	28	42
-50	36	20
-48	32	20
-50	38	16
-46	4	6
-36	0	-2
-24	2	-20
-28	0	-8
36	16	50
34	-14	40
44	-46	20
22	-18	54
-20	18	8
-26	32	28
-22	38	30
-12	30	34
-4	-30	60
-14	-36	60
6	-30	38
-14	-26	36
-20	-10	6
-24	-10	12
8	40	32
0	40	24
10	30	24
-4	38	20
16	40	44
10	10	18
68	-12	-10
66	-8	-6
0	-22	-40
-60	-8	34
-52	-8	48
24	-8	-30
36	-12	-38
-40	-34	6
-22	-4	-32
-24	-10	-22
-20	-10	-16
4	-10	2
-8	-8	2
-14	-68	36
32	-28	-26
30	-26	-18
-34	24	-24
-52	10	6
-48	36	20
-48	52	-6
-52	10	30
-36	4	-14
-30	0	-12
-22	0	-4
-46	12	-10
-36	16	8
24	-94	20
28	-60	-6
22	-74	-4
20	-72	6
30	-54	-16
42	-64	0
46	-60	2
16	-30	-18
-16	-30	-16
0	-22	-20
18	-32	-6
-18	-34	-2
16	12	-12
30	-4	-16
18	10	-24
26	-16	-4
12	-46	-10
20	-32	-2
-50	-52	-8
-40	-68	-6
-26	-82	-6
-50	-56	10
-54	-56	18
-32	-54	-8
48	8	4
40	4	24
44	-8	6
48	12	2
58	12	8
56	18	22
42	-4	44
44	-90	4
-22	-98	14
12	-28	78
20	-32	78
-2	-58	8
-6	-62	6
54	20	-24
64	2	-12
-24	-76	46
-20	-30	66
-18	-24	74
-20	-58	-2
-6	0	54
8	14	50
8	12	54
-4	18	62
44	32	2

// Nijhof A D, 2018: False Belief (FB) > True Belief (TB), Healthy Controls > 
// ASD
// Nijhof A D, 2018: FB > TB, All Subjects
// Nijhof A D, 2018: (FB > TB Explicit) > (FB > TB Spontaneous), All Subjects
// Nijhof A D, 2018: Agent False Belief of Present Ball (P-A+) > Agent False 
// Belief of Absent Ball (P+A-), All Subjects
// Subjects=21
57	-1	-20
57	-52	34
12	-70	1
45	32	37
-21	50	31
48	-46	31
48	32	31

// Tietze F A, 2019: Incongruent > Congruent
// Tietze F A, 2019: Healthy Controls > Asperger's Sydrome
// Subjects=16
53.32	25.55	-10.17
52.56	-24.02	9.61
0.09	-19.99	-2.39
0.23	33.14	37.76
-45.73	-26.64	12.07
-55.63	23.12	-4.25
-43.6	-24.51	11.87

// Lelieveld G, 2016: Justifiable Lies > Unjustifiable Lies
// Lelieveld G, 2016: Justifiable Lies > Honest Reports
// Lelieveld G, 2016: Unjustifiable Lies > Honest Reports
// Lelieveld G, 2016: (Justifiable Lies > Unjustifiable Lies) large deviance > 
// (JL > UL) small deviance
// Lelieveld G, 2016: Justifiable Lies > Unjustifiable Lies for large deviance
// Subjects=44
3	26	19
9	41	-5
21	17	-2
-3	23	22
3	32	13
-24	23	7
0	17	46
-15	8	-2
-24	26	4
12	-70	52
45	-34	43
42	-37	40
-3	14	49
12	20	1
-39	5	28
-15	-70	55
-21	-70	49
45	-37	40
30	53	28
27	56	25
-3	26	25
27	44	34
6	32	22
-9	32	22
30	50	28

// Ofen N, 2017: Conjunction Analysis: Lie > True, Episodic and Belief
// Ofen N, 2017: Deception Main Effects: Belief-lie > Belief-true & 
// Episodic-lie > Episodic-true
// Ofen N, 2017: Preparation-lie > Preparation-true
// Ofen N, 2017: Negative Correlation between Preparation-lie > 
// Preparation-true and Deception Index
// Subjects=18
-62	-52	28
-54	-54	30
-58	-62	26
56	-48	30
56	-42	44
14	12	58
-10	14	58
46	-10	42
54	4	-40
26	-18	2
30	-2	-14
6	-78	40
46	12	-30
-26	-56	36
-30	-70	50
36	-84	-4
-44	-92	-8
34	-56	50
26	-70	32
28	-64	38
-22	-24	24
-32	-4	50
34	4	44
22	10	26
-18	60	8
-46	-82	-2
4	-50	14
-56	-44	8
-52	-56	-2
-50	30	26
70	-38	4
-18	-22	-4
-16	-94	8
58	32	8
-16	-96	-14
-44	32	0
-8	62	16

// Peth J, 2015: Guilty Action
// Subjects=20
-52	32	-4
-36	24	-2
-44	18	24
34	26	-4
42	8	34
4	24	52
-62	-50	32
66	-40	34
48	18	28
52	-46	32

// Peth J, 2015: Guilty Intention
// Subjects=20
52	22	-6

// Peth J, 2015: Innocent
// Subjects=20
-8	16	52
-48	20	10
40	22	-6

// Pornpattananangkul N, 2018: Opportunity (O) > No-Opportunity (N-O) 
// (covariate: Overall Dishonesty)
// Pornpattananangkul N, 2018: N-O > O (covariate: Overall Dishonesty)
// Pornpattananangkul N, 2018: Opportunity-Self (O-S) > No-Opportunity-Self 
// (N-O-S) (covariate: O-S Dishonesty)
// Pornpattananangkul N, 2018: N-O-S > O-S (covariate: O-S Dishonesty)
// Pornpattananangkul N, 2018: Opportunity-Donation (O-D) > 
// No-Opportunity-Donation (N-O-D) (covariate: O-D Dishonesty)
// Pornpattananangkul N, 2018: O-S > O-D (covariate: Self Serving Dishonesty)
// Pornpattananangkul N, 2018: Self > Donation (covariate: Self Serving 
// Dishonesty)
// Pornpattananangkul N, 2018: O > N-O
// Pornpattananangkul N, 2018: N-O > O
// Pornpattananangkul N, 2018: O-S > O-D
// Pornpattananangkul N, 2018: O-D > O-S
// Pornpattananangkul N, 2018: S > D
// Pornpattananangkul N, 2018: D > S
// Pornpattananangkul N, 2018: N-O-S > N-O-D
// Pornpattananangkul N, 2018: N-O-D > N-O-S
// Subjects=31
-66	-18	6
36	-30	69
-60	-6	36
60	-21	15
3	57	-6
27	-78	-21
9	27	27
39	-81	36
36	-24	72
-9	39	-15
-12	-27	57
6	-87	-9
27	-51	54
0	45	-9
-60	-6	36
-24	-24	63
-18	-72	-3
-42	-78	15
-15	-48	12
9	12	12
18	15	-12
-15	27	12
-21	24	-3
9	9	15
18	12	-15
57	-63	39
-60	-60	30
-6	51	21
-6	39	57
-39	18	51
12	39	54
-63	-15	-18
9	-60	-12
3	42	42
45	-48	36
9	-84	-6
-60	3	12
66	3	15
9	6	42
9	12	3
-3	39	24
42	24	0
51	-48	39
-9	-84	-9
0	33	-21
51	-33	63
-51	-15	57
9	12	3
3	33	33
-9	-84	-9
-6	-54	21
-39	-63	30
-36	-42	-27
-9	42	-12
15	-105	9

// Shao R, 2017: Dishonest (D) > Truthful (T); Cue Phase
// Shao R, 2017: Low (L) > High Psycopathic Personality Inventory (H), D > T; 
// Cue Phase
// Shao R, 2017: Initial Session (T1) > Testing Session (T2), D > T; Cue Phase
// Shao R, 2017: (L(T2(D>T)>T1(D>T)) > H(T2(D>T)>T1(D>T)); Cue Phase
// Shao R, 2017: D > T; Face-responding Phase
// Shao R, 2017: T1(D>T) > T2(D>T)); Face-responding Phase
// Shao R, 2017: L(T2(D>T) > T1(D>T)) > H(T2(D>T) > T1(D>T))); Face-responding 
// Phase
// Shao R, 2017: T1 > T2; Control Visuo-spatial Control Task
// Shao R, 2017: H(T2-T1) > L(T2-T1); Control Visuo-spatial Control Task
// Shao R, 2017: L-H; Control Visuo-spatial Control Task
// Shao R, 2017: T1 > T2; Control Visuo-spatial Control Task
// Shao R, 2017: T2 > T1; Control Visuo-spatial Control Task
// Shao R, 2017: Familiar (F) > Unfamiliar (UF)
// Shao R, 2017: UF > F
// Shao R, 2017: L(F>UF) > H(F>UF)
// Subjects=23
39	-69	9
12	-51	54
33	-33	42
-39	-78	18
-42	-3	51
-30	6	0
-45	6	24
33	-72	42
-48	-69	3
-48	33	12
24	-39	63
51	15	27
18	-42	-6
-15	-45	66
-21	-57	12
48	-12	-18
-54	6	-18
9	12	66
33	51	24
-42	24	-9
-3	-57	54
24	24	42
-6	12	57
-57	-48	30
-33	-60	-30
-6	-18	-18
51	-45	42
-27	9	63
-57	-45	3
60	21	9
-48	-60	39
-6	-51	-6
-12	24	27
12	-60	-30
-24	0	-12
-27	-45	-18
24	15	-3
27	-42	-18
-6	-27	51
-24	-9	60
-39	9	18
3	9	36
-21	-75	42
21	-21	69
-9	-90	24
-9	-63	6
-27	-57	-6
27	-57	48
27	-6	63
-21	9	-3
9	-51	27
57	-3	-18
-6	57	-6
3	-54	27
-54	-9	-18
-54	-60	12
24	-84	0
9	15	6
-57	-39	21

// Suchotzki K, 2015: Main effect of Proportion (1:1 > 1:4)
// Subjects=32
-44	-34	52
-36	-6	62

// Sun D, 2015: Main effect of Face (Unfamiliar (U) > Familiar (F))
// Sun D, 2015: Main effect of face (F>U)
// Sun D, 2015: Main effect of Response Type (Lie (L) > (Truth) (T))
// Sun D, 2015: Interaction effect between Response Type and Face (F(L-T) > 
// U(L-T))
// Subjects=17
46	14	2
-8	-56	20
-2	60	-4
54	-6	-24
-44	-68	20
50	-58	12
-48	18	0
-48	-54	52
-42	10	50
8	16	62
50	16	0
-46	18	0

// Sun P, 2017: Main effects of decision (lying > honest)
// Sun P, 2017: Interaction between financial position & decision 
// (lying-honest)non-deprived>(lying-honest)deprived
// Subjects=21
8	-38	32
-6	-36	30
-10	-54	22
8	-48	38
50	24	28

// Sun D, 2015: Dishonest > Honest (positive effect)
// Sun D, 2015: Dishonest > Honest (negative effect)
// Sun D, 2015: Main effect of Detection (Not Detected > Detected)
// Subjects=25
39	23	7
9	35	19
-33	23	-5
45	-1	46
9	-28	43
45	-55	31
63	-4	22
15	2	-8
-12	5	-8
0	-22	25
-3	53	1

// Yin L, 2016: S_Lie_InC, S_Truth_InC, S_Truth_C > Fixation
// Subjects=44
3	42	26
9	24	63
-5	30	-3
5	28	-3
40	21	-10
45	55	-4
-39	18	-10
45	-42	48
-60	-48	36
44	20	42
-24	49	21
48	30	26
42	48	17

// Yin L, 2017: Self-benefit lie > Charity-benefit lie
// Yin L, 2017: Self-benefit lie > Charity-benefit lie
// Yin L, 2017: Charity-harm truth > Self-harm truth
// Subjects=47
36	24	-4
34	24	-6
-2	42	-18

// Yin L, 2016: Main effect of means (Lies>Truth)
// Yin L, 2016: Main effect of means (Truth>Lies)
// Yin L, 2016: Main effect of ends (Beneficial>Harmful outcome)
// Subjects=38
58	-48	12
-3	22	60
-36	22	9
40	16	24
12	-65	-3
-12	4	-10
12	12	-6
-10	7	-7

// Gu X, 2015: Empathetic Pain (Painful > Non-Painful), Both Groups
// Gu X, 2015: Empathetic Pain (Painful > Non-Painful), ASD > Healthy Controls
// Gu X, 2015: Empathetic Pain (Painful > Non-Painful), ASD < Healthy Controls
// Gu X, 2015: All Images (Painful & Non-Painful), ASD > Healthy Controls
// Gu X, 2015: All Images (Painful & Non-Painful), ASD < Healthy Controls
// Gu X, 2015: Correlation with Skin Conductance Responses, ASD > Healthy 
// Controls
// Gu X, 2015: Correlation with Skin Conductance Responses, ASD < Healthy 
// Controls
// Subjects=17
-32	-90	6
-46	-46	-14
-62	-28	38
-34	-42	48
-38	-46	58
52	-62	-8
30	-88	2
36	-86	10
-38	-4	14
-50	6	22
-38	0	2
-38	20	2
62	-24	40
54	-32	48
40	-34	42
54	36	0
54	10	40
20	-84	12
-24	-26	-4
-6	-28	-20
10	-26	-18
14	-54	10
12	-42	18
-6	-50	6
-12	-78	10
-24	-92	12
32	-36	-4
30	-22	-10
34	-36	-12
42	28	8
34	28	14
30	26	-2
-34	22	-14
-38	12	-12
-42	-54	2
-48	-50	6
-46	-66	12
-16	-58	-40
-26	-48	-34
52	-30	8
40	-38	8
60	20	14
54	18	30
-20	-6	58
-20	-18	52
-28	6	48
14	-62	46
-8	-38	24
-14	-44	36
-42	-74	36
-32	-64	24
58	-8	-6
24	-90	2
30	-68	24
24	-82	12
-8	-24	-38
22	-34	-36
-12	-34	-40
-16	-70	-22
-24	-68	-22
-34	-66	-18
-38	-84	8
-22	-94	4
-30	-82	14
54	-36	34
40	6	-8
38	22	-12
-8	16	42
-16	10	42
-6	-30	56
-10	-40	68
-10	-48	64
-26	10	16
-12	-46	12
24	28	2
22	24	14
14	22	12
26	-56	-44
32	-60	-40
14	-64	-40
-54	-16	-26
-52	12	-24
-44	2	-30
34	-4	-30
40	14	-26
34	-6	-22
-54	-64	14
-52	-68	28
-44	-78	14
-4	-46	-50
0	-50	-44
-42	-50	-16
-52	-62	-16
-42	-70	-16

// Okamoto Y, 2018: Autism Spectrum Disorder (ASD)
// Subjects=18
-16	50	14
6	36	10
-30	-88	-10
-36	-60	-10
28	-76	2
34	-54	-16
8	-78	-4
-6	-80	-8
-18	-76	-10
-10	-100	6
16	-98	10
18	-84	-26
12	-58	-42
-6	-54	-46
36	-76	46
-36	-64	46

// Okamoto Y, 2018: Healthy Controls
// Subjects=18
-16	50	14
6	36	10
-30	-88	-10
-36	-60	-10
28	-76	2
34	-54	-16
8	-78	-4
-6	-80	-8
-18	-76	-10
-10	-100	6
16	-98	10

// Pantelis P C, 2015: Awkward > Baseline, All Participants
// Pantelis P C, 2015: Awkward > Baseline, Healthy Controls > ASD
// Subjects=17
28	22	-16
48	26	-12
48	6	-40
48	8	-22
4	40	28
28	48	26
54	-44	20
64	-48	18
56	-54	38
48	-26	-12
8	-90	10
6	-86	4
4	-88	-10
20	-78	-18
-28	-76	-14
-34	16	-26
-34	18	-12
4	-52	48
18	-72	26
-26	46	20
-34	48	14
2	-24	40
4	-18	26
-8	-50	-12
2	-62	-18
40	-2	52
52	-36	2
56	-44	18
56	-42	20

// Rosenblau G, 2017: Emotional > Neutral, Healthy Controls
// Rosenblau G, 2017: Emotional > Neutral, ASD
// Rosenblau G, 2017: Explicit > Implicit Emotional, Healthy Controls
// Rosenblau G, 2017: Explicit > Implicit Emotional, ASD
// Rosenblau G, 2017: Implicit > Explicit Emotional, Healthy Controls
// Rosenblau G, 2017: Implicit > Explicit Emotional, ASD
// Rosenblau G, 2017: Basic > Complex Emotional, ASD
// Rosenblau G, 2017: Emotional > Neutral, All Participants
// Rosenblau G, 2017: Complex > Basic Emotional, Healthy Controls > ASD
// Rosenblau G, 2017: Complex > Basic Emotional, Female ASD > Male ASD
// Rosenblau G, 2017: Implicit > Explicit Emotional, Healthy Controls > ASD
// Rosenblau G, 2017: Emotional > Neutral, Correlation with task performance, 
// ASD > Healthy Controls
// Subjects=6
48	-18	0
52	-26	4
56	-18	0
48	-22	0
66	-30	6
58	-24	-2
56	24	0
-42	-26	2
-48	-14	-2
-46	-18	0
-46	-24	-4
-48	-12	-6
-64	-28	6
46	30	2
58	34	8
52	32	4
50	4	-22
58	20	20
52	4	-18
-66	-34	6
-68	-26	4
-60	-22	4
-54	-18	-14
-38	4	-32
-46	-4	-6
16	-72	6
0	-88	2
16	-72	14
-10	-76	20
-18	-60	-2
14	-86	16
56	-14	-8
58	-8	-4
54	-32	0
60	-16	-2
54	28	-4
56	28	0
-52	2	-20
-52	-2	-20
-50	-10	-2
-48	-38	6
-60	-26	8
-64	-26	6
54	-16	-8
52	-20	-2
52	-16	-4
50	-10	-4
42	-20	-4
-2	-48	38
-44	-70	40
-22	36	36
14	50	-4
24	32	36
2	46	-8
-50	-26	24
-48	-26	20
-4	-46	38
-4	-48	42
-2	-30	48
10	-4	48
12	62	0
6	42	-8
10	48	-4
-26	-26	-18
-26	-26	-22
40	-14	12
40	-16	16
36	-10	2
36	-20	2
38	-14	2
46	-12	10
-64	-6	-2
-60	-10	-6
-64	-8	-8
-56	-22	0
42	-28	8
42	-32	12
38	-32	8
38	-28	8
62	-12	-2
64	-28	6
20	-56	-4
-64	-22	12
-62	-22	6
-20	-58	-6
-64	-26	16
-38	-48	20
10	-2	40
-10	-10	36
-12	-26	44
-12	-30	44
-10	4	40
-8	-36	50
38	-34	10
42	-30	10
52	-18	6
44	-34	24
46	2	-14
44	-12	-4
56	-38	10
26	-4	-22
-44	-22	2
-64	-8	-6
-64	-6	0
-50	-22	2
-58	-8	8
-56	-4	6
-38	-4	10
58	-18	6
46	-26	36
64	-30	4
66	-32	8
38	-34	14
52	-30	10
-44	-68	44
-46	-68	40
-60	-56	26
-48	-68	44
-56	-62	34
-58	-64	24
-16	58	4
-24	48	-10
-26	48	-4
-22	68	-8
-6	46	22
6	42	20
-24	36	52
-20	28	30
-20	30	26
-20	28	22
-18	36	54
-14	34	56
52	-18	-10
52	16	12
58	8	-22
56	-44	20

// Sato W, 2017: Supraliminal Averted > Supraliminal Straight, All 
// Participants
// Sato W, 2017: Supraliminal Averted > Supraliminal Straight, Healthy 
// Controls > ASD
// Sato W, 2017: Subliminal Averted > Subliminal Straight, Healthy Controls > 
// ASD
// Subjects=16
-52	-58	40
50	-48	46
56	-52	26
34	46	-6
-14	50	-2
-40	6	-28
-32	-6	-24
-8	-64	22

// Schelinski S, 2016: Autism Spectrum Disorder (ASD)
// Subjects=16
39	-25	10
-36	-34	10
0	-37	-2
-6	-37	-41
-15	-76	-47
-42	-64	-29
15	-79	-41
24	-61	-23
-39	26	4
21	-7	-14
54	-1	46
15	-13	7
6	5	64
21	-49	-44
-60	-34	4
63	-16	-2
54	5	43
-48	-10	40
-39	23	4
-36	8	10
27	-61	-23
18	-76	-41
6	2	67
-18	-7	-14
-36	2	-17
51	-22	7
-36	-34	13
3	-40	-11
12	-37	-44
-6	-37	-41
-21	-82	-41
15	-79	-44
24	32	-17
-39	29	-14
-48	-64	-23
-27	-40	-20
27	-37	-17
45	2	7
-60	-31	10
9	-40	55
-57	-22	7
66	-25	10
-15	-76	-44
27	-58	-26
-27	23	4
30	23	4
-6	5	58
-51	-7	43
54	2	43
-21	-1	10
-51	-31	55
-48	20	25
39	-52	43
3	-61	28
-24	-76	-32
27	-85	-41
54	-31	-11
-6	65	16
42	32	31
39	-52	43
3	-73	43
18	-52	-41
-6	-55	-41
-39	-64	-26
51	-19	-2
66	-34	7
6	29	37
6	-94	4
30	14	46
-24	11	52
-57	-22	7
66	-25	10
24	-61	-23
18	-64	-44
-15	-76	-44
-30	-58	-29
54	2	43
33	23	7
-27	23	1
21	2	10
33	-76	-41
-45	-61	-8
24	-1	-5
18	-52	-41
33	-46	-29
-18	-58	-23
-9	-91	-5
60	2	28
-51	-4	34
-12	-22	46
-9	-19	4
51	-19	10
6	-34	40
6	-1	37
-6	59	22
3	-61	1
12	-82	-5
36	8	10
30	-58	13

// Schelinski S, 2016: Healthy Controls
// Subjects=16
51	-13	4
-63	-19	1
0	-34	-2
-15	-79	-44
21	-79	-38
21	-49	-44
-63	-22	-2
60	-4	-8
-18	-76	-35
48	-13	7
-42	-28	13
0	-40	-5
-15	-88	-35
-15	-79	-44
-9	-91	-29
21	-85	34
-39	-76	22
-30	-34	-26
24	-28	-17
27	50	31
36	41	19
-9	-52	4
-3	-40	52
54	-37	37
45	2	7
-60	-31	10
9	-40	55
-63	-19	4
54	-16	1
-12	-79	-32
27	-58	-29
24	-64	-44
-30	26	7
-9	-1	58
42	32	28
-48	41	-2
-51	-4	49
39	-52	40
12	-10	10
9	-19	-11
-36	-52	43
3	-61	28
-24	-76	-32
27	-85	-41
54	-31	-11
-6	65	16
9	-67	46
30	14	49
-51	26	31
-27	8	52
-39	-67	-29
-9	-55	-44
-33	17	-5
-30	47	13
-39	-55	43
54	-46	19
3	-73	43
18	-52	-41
-6	-55	-41
-39	-64	-26
51	-19	-2
66	-34	7
6	29	37
6	-94	4
30	14	46
-24	11	52
45	-34	7
6	-58	37
48	-28	-5
-9	-1	58
-63	-19	4
54	-16	4
21	-58	-23
-12	-79	-32
-30	-58	-29
39	23	13
-48	-37	40
-24	-7	52
42	26	28
33	-76	-41
-48	-49	-5
54	-61	-2
-24	-4	-5
18	-61	-20
33	-22	-14
27	-1	-14
63	5	19
-33	-16	67
-51	-7	-14
42	-19	37
12	-7	40
-6	8	37
-48	-7	-29
-3	-13	55
21	-61	-5
51	-25	22
-6	-52	13

// Schipul S E, 2016: Autism Spectrum Disorder (ASD)
// Subjects=16
10	-90	-8
26	0	60
-24	-4	64
54	12	14
-24	-36	-42
40	38	18
-56	6	36
10	24	44
22	-30	-6
-24	26	0
-2	-48	-26
64	-6	22
6	2	26
-62	-8	32
-8	-30	72
-46	50	0
-24	-36	10
36	18	-2
32	2	34
-8	12	52
16	-26	14
-58	-14	44
8	-80	-2
68	-6	24
-10	-48	-24
42	-6	60
-22	-84	-12
18	-26	-32
-40	-4	62
-62	-8	30
-6	0	72
-52	-78	4
-10	-28	72
-26	28	2
-40	-70	-26
-12	-92	36
10	8	56
-28	-76	52
34	40	12
44	50	0
-52	-6	8
-28	-34	4
34	-66	-30
-2	32	-2
38	-20	34
52	-42	32
-54	-32	0
-12	8	-12
50	-28	-12
42	12	34
44	16	-24
14	-10	40
6	-36	44
48	24	-6
-26	56	-8
-22	50	24
-4	-38	22
32	32	-8
-24	-10	14
62	-36	-2
2	20	52
10	-64	38
48	-34	16
38	-20	40
8	32	20
-64	-28	2
-32	-46	68
-2	-16	60
-12	6	-14
-20	52	24
-14	-50	72
34	34	-10
50	-36	16
12	-54	64
56	-6	-6
62	-38	-4
-30	56	-6
34	16	34
10	46	-6
36	6	42
-2	16	54
-34	-36	48
0	28	0
-18	-46	0
38	-56	18
10	-32	-38
32	-12	28
22	-46	-2
24	-74	14
-32	56	28
-36	14	-14
6	-22	26
-8	-4	-2
-24	-52	-40
-46	-2	-28
10	0	-8
6	-42	40
4	-76	-18
10	-6	4
-30	-20	14
-14	-58	-12
6	-70	-38
52	-10	-2
-6	-70	-2
44	-50	10
-26	-22	20
4	-20	10
-44	-66	32
-44	10	52
-6	42	56
-20	-16	-14
32	34	-22
-62	-46	16
44	-30	30
-62	-18	-18
-2	8	72
-52	24	32
60	10	0
18	-32	-36
-62	-6	6
-8	-18	-6
60	-58	-4
-18	-30	-8
-56	24	0
-10	40	38
34	24	10
38	-44	-36
64	-50	20
-32	-20	38
-6	-8	42
-8	-56	-30
-34	-32	6
4	-56	66
58	6	-20
-38	-28	-10
30	-40	-46
-12	-30	-14
-46	-52	-34
-26	-56	18
12	-58	-40
-26	12	-24
16	-36	-48
-16	-32	-34
-6	-86	-34
-44	-66	28
-62	-14	-26
8	-52	74
-8	-98	28
24	-2	-40
-14	64	30
-24	-48	30
-22	-66	-36
46	-60	-40
-16	24	12
-20	-52	-42
40	-44	-30
34	-62	16
36	-36	10
12	-14	-10
24	-48	-30
-36	8	-14
40	-48	-8

// Schipul S E, 2016: Healthy Controls
// Subjects=16
18	-88	-6
48	6	22
32	10	58
-22	-2	56
40	60	-8
50	46	20
28	42	-16
44	56	12
-48	2	36
-58	-14	44
8	-80	-2
68	-6	24
-10	-48	-24
42	-6	60
-22	-84	-12
18	-26	-32
-40	-4	62
-62	-8	30
-6	0	72
-52	-78	4
-10	-28	72
-26	28	2
-40	-70	-26
-12	-92	36
10	8	56
-28	-76	52
34	40	12
44	50	0
-52	-6	8
12	-30	8
36	-22	24
-40	-34	46
-22	-6	56
54	-60	-22
40	-76	-2
-42	-22	30
30	-30	0
-56	10	40
-44	-72	0
34	42	-16
24	-100	12
28	-70	30
-8	-22	76
-42	-78	30
-14	-62	22
-38	8	62
-6	-42	44
0	-54	4
-12	16	4
38	-20	40
8	32	20
-64	-28	2
-32	-46	68
-2	-16	60
-12	6	-14
-20	52	24
-14	-50	72
34	34	-10
50	-36	16
12	-54	64
56	-6	-6
62	-38	-4
-30	56	-6
34	16	34
10	46	-6
36	6	42
-2	16	54
-34	-36	48
-6	-70	-2
44	-50	10
-26	-22	20
4	-20	10
-44	-66	32
-44	10	52
-6	42	56
-20	-16	-14
32	34	-22
-62	-46	16
44	-30	30
-62	-18	-18
-2	8	72
-52	24	32
60	10	0
18	-32	-36
-62	-6	6
-8	-18	-6
60	-58	-4
-18	-30	-8
-56	24	0
-10	40	38
34	24	10
38	-44	-36
64	-50	20
-32	-20	38
-6	-8	42
-8	-56	-30
-34	-32	6
4	-56	66
58	6	-20
62	12	2
-54	-38	12
6	-62	16
-62	-4	6
50	-48	6
-44	10	50
-28	20	4
26	-36	-36
-26	-24	12
-2	-42	42
-36	-62	36
32	32	-22
30	-4	-12
-40	-14	8
36	4	28
44	-30	30
6	-22	10
64	-6	-28
4	-74	-26
-36	-10	36
-40	-72	46
-6	2	6
60	-58	28
-60	42	52
-8	-74	34
26	-72	-24
-10	-4	72
36	-20	6
6	-82	48
44	32	-16
12	-84	-12
22	-86	-8
60	-60	-2
8	-90	4
18	-36	28
20	-50	16
42	-34	-8
36	-56	-4
-26	-46	-4
54	-36	10
-18	-34	20

// Stanfield A C, 2017: Social > Gender, All Participants
// Stanfield A C, 2017: Social > Gender, Healthy Controls
// Stanfield A C, 2017: Social > Gender, ASD
// Stanfield A C, 2017: Social > Gender, Schizotypal Personality Disorder 
// (SPD)
// Stanfield A C, 2017: Social > Gender, ASD < Healthy Controls
// Stanfield A C, 2017: Social > Gender, ASD < SPD
// Stanfield A C, 2017: Social > Gender, ASD < SPD (voxel-based inference P < 
// .05 FWE corrected)
// Stanfield A C, 2017: Social > Gender, ASD < Comorbid (CM)
// Stanfield A C, 2017: Social > Gender, ASD < SPD (only antipsychotic naive 
// participants)
// Stanfield A C, 2017: Social > Gender, Negative Correlation with Positive 
// Symptoms (PANSS), ASD
// Stanfield A C, 2017: Social > Gender, Positive Correlation with Negative 
// Symptoms, CM
// Stanfield A C, 2017: Gender > Baseline, ASD > SPD and Healthy Controls
// Stanfield A C, 2017: Gender > Baseline, ASD > CM and Healthy Controls
// Subjects=9
-54	32	-2
51	29	-5
-9	-32	58
-48	2	-35
-57	-43	1
-9	-85	1
-39	-67	-44
9	32	58
12	56	34
12	-82	1
-36	-70	-44
30	-82	-44
-9	-85	4
-12	32	58
-6	56	34
-54	17	4
51	35	25
-48	-1	-38
-63	-40	1
-9	-85	1
-15	5	-5
-3	-25	-26
30	-58	-44
-45	-55	-41
-24	-52	31
-15	-40	-38
33	-64	-44
33	-64	-44
51	35	25
-18	-19	49
24	-55	-41
18	35	-17
33	-64	-44
-18	-10	-14
-18	-19	49
-18	-10	-14
-18	-19	49

// Ciaramidaro A, 2018: Autism Spectrum Disorder (ASD)
// Subjects=33
44	-46	-22
-40	-46	-22
42	36	-12
-48	26	-10
56	-62	8
-56	-54	6
-48	-76	32
2	46	-20
4	56	32
8	50	46
48	22	22
-50	22	16
22	-4	-20
-20	-6	-18
52	-20	-10
-54	-22	-12
4	-54	24
-2	72	-2
42	-46	-22
-40	-48	-20
28	32	-14
-36	30	-20
56	-64	8
56	-54	32
-46	-70	28
2	56	-12
2	54	36
2	54	36
48	22	22
24	-2	-24
-20	-6	-18
4	-56	26
4	-78	0
42	-46	-22
-40	-46	-22
28	32	-14
-32	32	-16
58	-60	16
-48	-74	32
2	46	-18
8	56	32
52	28	16
22	-4	-20
-22	-6	-20
58	-4	-22
6	-56	26
-4	-72	0
54	-46	-18
-36	-56	-14
26	30	-18
-38	28	-14
66	-46	-2
-58	-48	-2
-60	-56	18
-10	38	-14
-4	52	0
-8	44	50
42	16	30
-50	20	24
20	-8	-22
-18	-12	-22
-58	-14	-28
0	-88	12

// Ciaramidaro A, 2018: Paranoid Schizophrenia (SCZ)
// Subjects=20
44	-46	-22
-42	-48	-22
-38	30	-16
58	-54	6
-58	-58	6
48	-64	16
-56	-70	10
0	50	-18
6	58	36
58	28	20
-40	14	22
20	-4	-24
-16	-10	-22
56	-4	-24
-50	-16	-18
2	-50	26
0	-82	2
42	-46	-22
-42	-48	-22
36	38	-16
50	-50	6
54	-60	22
-54	-68	34
-2	54	-16
10	62	18
6	60	34
44	22	24
20	-6	-22
-22	-6	-24
50	-14	-16
-56	-8	-18
0	-60	38
-6	-84	-8
-40	-46	-22
38	40	-14
-38	32	-16
60	-46	2
-56	-70	10
0	40	-24
6	58	34
40	22	24
18	-12	-22
-30	-16	-20
52	-2	-28
0	-58	36
-2	-90	4
-34	-56	-14
-12	-4	-16

// Ciaramidaro A, 2018: Healthy Controls
// Subjects=25
42	-42	-22
-40	-46	-22
54	32	-4
-48	34	-4
60	-58	6
-58	-46	4
-56	-70	12
0	40	-26
-2	50	-15
-4	38	46
52	26	18
-48	24	16
22	-6	-18
-20	-8	-20
50	-12	-16
2	-62	34
4	-80	2
42	-40	-24
-40	-48	-22
26	32	-16
-36	30	-18
52	-48	4
-66	-44	4
58	-64	22
-42	-68	24
0	48	-16
12	64	16
-14	62	22
-6	26	48
44	18	28
-46	26	16
22	-6	-20
-22	-6	-20
48	-16	-14
-50	-18	-14
2	-62	34
6	-80	0
42	-40	-24
-40	-48	-22
26	32	-16
-34	34	-14
62	-60	4
-64	-46	4
60	-62	26
-44	-64	22
0	48	-16
12	64	12
14	36	48
44	18	30
-44	20	38
22	-6	-18
-18	-10	-20
56	-4	-24
2	-62	34
6	-74	2
-34	-56	-14
-12	-4	-16
54	-46	-18
-36	-56	-14
26	30	-18
-38	28	-14
66	-46	-2
-58	-48	-2
-60	-56	18
-10	38	-14
-4	52	0
-8	44	50
42	16	30
-50	20	24
20	-8	-22
-18	-12	-22
-58	-14	-28
0	-88	12

// Sun D, 2016: Dishonest > Honest
// Sun D, 2016: Human > Computer
// Sun D, 2016: Computer (Dishonest-Honest) > Human (Dishonest-Honest)
// Subjects=25
-3	-13	7
12	5	-2
-12	8	-3
-27	29	-2
42	23	4
9	8	58
45	-49	-17
-42	-64	-17
9	44	-14
6	-88	-5
-9	50	37
0	-55	31
-39	2	-5

// Yin L, 2019: Lying  > Truth-telling
// Yin L, 2019: Truth-telling > Lying
// Yin L, 2019: Negative Correlation between Lying and Lying Percentages
// Yin L, 2019: Negative Correlation between Lying > Truth-telling and Lying 
// Percentages
// Subjects=37
-24	-4	56
-12	-64	54
28	2	62
-10	-90	-8
-14	-94	24
-12	42	12
-36	54	14
2	16	60
44	36	0
-28	12	38
-12	-48	16
38	54	6
-2	-4	-2
50	-48	50
-12	12	-2
-50	20	6
8	-34	40
34	28	-6
6	28	32
-64	-46	28
8	-12	-2
2	-32	-18
44	2	54

// Barbeau E B, 2015: Autism Spectrum (AS)
// Subjects=22
34	-24	70
-38	-28	64
50	-66	2
42	-66	12
18	-76	12
-42	-74	10
-38	-22	64
10	18	64
52	20	-2
-18	-44	70
40	-26	62
-12	-92	30
-12	-78	14
16	-76	12
14	-66	14
-6	-80	26
6	-74	24
8	-60	-2

// Barbeau E B, 2015: Healthy Controls
// Subjects=24
40	-24	64
-36	-22	66
26	-70	-12
-46	-74	8
-20	-76	-8
-26	-80	20
-20	-58	50
-38	-22	64
10	18	64
52	20	-2
-18	-44	70
40	-26	62
-12	-92	30
-12	-78	14
16	-76	12
14	-66	14
-6	-80	26
6	-74	24
8	-60	-2

// Hames E C, 2016: Session 1 VV2 - VA2, ASD > Healthy Controls
// Hames E C, 2016: Session 1 AA2 - VV2, Healthy Controls > ASD
// Hames E C, 2016: Session 2 AA_MM2 - AA2, Healthy Controls > ASD
// Subjects=10
36	-65	-2
25	-91	3
-56	-30	9
46	-50	-9

// Lassalle A, 2019: Autism Spectrum Disorders (ASD)
// Subjects=19
-8	-88	-6
-6	-98	-4
-22	-84	-10
2	-20	36
4	4	46
4	2	34
0	-2	32
16	-94	-8
-24	-94	6
24	-78	-2
-22	-90	-14
50	-76	-2
40	-56	-14
-2	-70	18
18	-84	10
-2	-72	14
-8	-86	14
32	-38	-26
16	-56	14
-12	-72	30
-48	38	6
-42	14	22
-50	8	20
-46	34	-8
-40	16	28
-42	18	2
-48	26	28
-46	10	28
-42	8	26
4	-22	4
-12	-10	0
2	-26	-4
6	-34	26

// Lassalle A, 2019: Healthy Controls
// Subjects=20
-6	-90	-4
16	-64	-4
-8	-86	-6
-26	-70	-6
-22	-88	24
-4	-32	-4
8	-84	14
12	-84	32
-18	-28	0
-2	-56	6
-30	-54	-8
16	-40	2
-2	-42	30
18	-28	-8
-12	-40	-6
-8	2	10
4	48	32
0	50	34
8	66	14
-4	62	16
2	54	16
0	52	12
-6	34	22
4	46	-16
4	20	-22
-4	20	-24
-54	24	10
-46	22	-12
-42	8	32
-50	38	6
-28	26	-2
-52	18	-16
-40	-52	16
-56	-48	32
-44	-54	26
-44	-54	6
12	-86	-4
0	-74	-4
14	-86	4
-12	-80	6
24	-64	-8
-34	-70	-14
14	-90	2
-18	-96	-4
2	-28	-4
34	-88	-12
16	-78	-8
30	-58	-6
22	-30	0
-2	-26	0
22	-66	20
-4	-88	12
6	-78	34
0	-76	24
-50	-48	32
20	-64	28
-4	-68	26
10	-48	4
-16	-48	4
-14	-40	-6
-54	-40	8
-38	-38	-18
22	-36	2
-32	-76	-6
-50	-66	40
-36	-56	36
2	52	12
-4	54	16
-28	28	-4
-52	24	12
-28	28	0
-4	54	22
0	62	12
-4	58	40
-42	18	0
-36	12	34
-36	4	32
6	30	28
-4	34	22
0	22	-4
-4	26	-4
-48	18	-14
-10	22	0
-10	8	56
-4	50	-12
36	28	4
44	28	-8
36	12	-8
-48	38	6
-42	14	22
-50	8	20
-46	34	-8
-40	16	28
-42	18	2
-48	26	28
-46	10	28
-42	8	26
4	-22	4
-12	-10	0
2	-26	-4
6	-34	26

// Murphy C M, 2017: Delayed Reward > Immediate Reward, Healthy Controls > ASD
// Subjects=38
35.12	-.17	-24.53
11.7	65.33	12.62
47.37	-7.1	36.13
39.77	-85.28	-10.76

// Perkins T J, 2015: Action Observation > Baseline, High-Functioning Autism 
// (HFA)/Asperger's (AS) > Controls, p<0.05
// Perkins T J, 2015: Action Observation > Baseline, HFA/Asperger's > 
// Controls, p<0.001
// Perkins T J, 2015: Action Observation > Baseline, Healthy Controls > HFA/AS
// Subjects=12
34	-10	56
12	38	-12
12	26	-4
24	-58	10
18	-74	12
34	-60	10

// Simard I, 2015: Autistic (AUT)
// Subjects=15
-44	28	28
-42	4	34
-26	0	56
-24	-64	50
-28	-90	-6
-26	-72	34
-28	22	-4
-4	-24	-10
-6	-74	-26
50	10	30
40	32	24
30	0	56
36	-76	-14
28	-94	-4
34	-86	12
30	24	0
10	-74	-26
34	-66	-50
2	-54	-38
-16	-82	26
-22	-90	20
-42	20	34
-2	-58	38
2	-56	54

// Simard I, 2015: Healthy Controls
// Subjects=18
-48	24	34
-48	26	24
-44	16	30
-32	-88	-10
-28	26	-2
-10	8	12
-16	-2	0
-4	-22	-10
36	60	8
30	8	56
50	28	34
46	8	28
30	26	-2
18	-66	58
28	-94	-4
16	-2	0
6	-22	-8
-16	-82	26
-22	-90	20
-42	20	34
-2	-58	38
2	-56	54

// Solomon M, 2015: Early Stimulus, Healthy Controls > Autism Spectrum 
// Disorders
// Solomon M, 2015: Stimulus, Healthy Controls > Autism Spectrum Disorders
// Solomon M, 2015: Feedback, Autism Spectrum Disorders > Healthy Controls
// Subjects=22
14	52.95	5.62
0.97	52.38	0.3
40.38	32.34	36.35
33.46	62.9	7.67
-5.59	28.78	-10.7
0.8	37.96	-16.2
-9.04	22.85	-27.98

// Sommer M, 2018: Autism Spectrum Disorders (ASD)
// Subjects=15
-8	6	66
-50	-10	42
-42	18	24
42	-66	-6
-6	6	66
-46	-4	44
50	-2	34
-60	-26	0
52	-38	16
-40	-68	8
46	-60	-8
-8	-28	-2
-4	6	64
32	28	10
-6	54	-10
-12	80	18
14	-56	-2
-22	52	0
38	48	-12
-42	4	60
-40	-30	8
-58	-46	36
6	-4	8

// Sommer M, 2018: Healthy Controls
// Subjects=15
8	8	66
-40	0	42
-64	-32	2
50	-40	14
48	-58	-8
-8	-28	-2
-6	6	66
-46	-4	44
50	-2	34
-60	-26	0
52	-38	16
-40	-68	8
46	-60	-8
-8	-28	-2
42	20	-6
42	-44	2
14	40	-14
26	24	54
-20	26	54
68	-24	26
12	-56	26
-12	80	18
14	-56	-2
-22	52	0
38	48	-12
-42	4	60
-40	-30	8
-58	-46	36

// Travers B G, 2015: Autism Spectrum Disorder (ASD)
// Subjects=15
30	-4	64
18	68	6
4	10	54
-22	-96	-2
24	-78	-22
22	-46	62

// Travers B G, 2015: Healthy Controls
// Subjects=15
-22	-6	56
32	-8	62
16	-6	54
-52	0	42
-30	-12	60
-16	-62	62
20	-62	60
-46	-30	50
30	-46	54
52	-72	-6
50	-68	4
24	-86	-18
28	-62	-22
-24	-6	62
-6	4	52
-50	2	40
-58	6	20
-42	0	34
22	-60	58
-44	-30	48
44	-26	60
28	-38	48
-28	-54	54
38	-32	40
34	-88	16
46	-76	-6
32	-90	-10
10	-100	-8
-14	-104	-10
14	-78	-20
30	-58	-24
22	-46	62

// Jia B, 2015: Mild Cognitive Impairment (MCI) < Healthy Controls (HC), KI3 + 
// Baseline
// Jia B, 2015: MCI > HC, KI3 + Baseline
// Jia B, 2015: MCI < HC, Sham + Baseline
// Jia B, 2015: MCI > HC, KI3 > Baseline
// Jia B, 2015: MCI > HC, Sham > Baseline
// Jia B, 2015: MCI < HC, Sham > Baseline
// Jia B, 2015: MCI > HC, KI3 > Sham
// Jia B, 2015: MCI < HC, KI3 > Sham
// Subjects=8
10.5	-40.5	-12.5
10.5	37.5	-12.5
19.5	-34.5	-27.5
-13.5	-73.5	8.5
-4.5	-22.5	77.5
-4.5	-25.5	74.5
1.5	-4.5	68.5
-13.5	-13.5	-9.5
28.5	7.5	32.5
-25.5	1.5	29.5
-25.5	-10.5	38.5
10.5	-16.5	-3.5
-46.5	-7.5	32.5
13.5	34.5	35.5
-10.5	-19.5	53.5
49.5	-31.5	11.5
55.5	-28.5	5.5
7.5	-43.5	38.5
-43.5	19.5	20.5

// Doll A, 2016: [Attention to breath(ATB)-Passive viewing(PV)]picture - 
// [ATB-PV]no-picture
// Doll A, 2016: ATB - PV
// Doll A, 2016: [PV-ATB]picture - [PV-ATB]no-picture
// Doll A, 2016: PV - ATB
// Doll A, 2016: [PV-ATB]picture
// Doll A, 2016: [ATB-PV]picture
// Subjects=26
-60	-40	25
-60	-40	16
-57	-55	7
0	-46	52
66	-34	28
60	-46	13
63	-40	46
6	23	40
-6	32	25
-36	-49	16
-48	-28	-2
-63	-46	22
-9	50	37
-15	26	52
-6	23	37
-12	35	28
-36	23	46
24	-7	-14
30	-7	-14
30	-4	-17
-45	-31	-2
-45	-49	22
-60	-37	37
-57	-46	16
-9	-49	43
0	-70	28
9	-34	43
0	-46	55
-24	14	55
-15	8	64
12	-7	67
18	2	67
0	-1	40
3	2	49
-6	23	37
-6	32	25
-51	5	10
-48	11	-5
51	-40	22
69	-28	31

// Abe N, 2018: Negative Correlation between PCL-R and Op-Win > No-Op Win
// Subjects=67
-2	28	20
-14	60	14
-12	-8	4

// Anderson N E, 2018: Standard stimuli > Baseline, Negative Correlation with 
// PCL-R scores
// Subjects=222
-9	3	63
15	9	54
-27	57	-3
39	18	-12
-30	18	-12
48	-18	39
-24	-24	66
-15	-21	69
-42	-27	36
-54	-18	39
51	-21	9
45	0	-18
51	6	-9
42	-57	0
-6	3	42
-36	-9	-3
-27	6	-21
33	-54	-9
24	-63	0
-6	-93	-3
-33	-78	6
-39	-66	3
-36	-18	9
-6	15	0
3	-30	-15
-12	-48	-24
6	-27	-24
-3	-60	-12
9	-48	-21
3	-30	-33

// Godinez D A, 2015: Attention Deficit/Hyperactivity Disorder(ADHD)
// Subjects=20
-64	-32	30
36	6	-14
30	34	-10
-28	40	-12
32	-70	52
-8	-78	-6
28	-40	60
-10	-30	40
14	-88	26
38	-52	28
-44	50	12
-22	-46	-10
-68	-30	40
-20	10	52
6	-94	-8
48	-8	42
14	-42	56
-66	-28	30
-48	-8	26
-36	6	-10
38	-14	38
30	34	-12
14	-20	40
-28	36	-14
54	-6	12
34	6	-14
-52	-64	0
6	18	22
-36	-66	-4
-64	-30	30
50	-8	44
26	-78	44
-8	-78	-6
-28	38	-8
14	-18	36
42	46	-4
-8	14	28
-38	-38	62
50	-38	52
-20	-46	-12
68	2	12
40	-70	-16
6	28	32
-14	-30	40
-50	-46	40
36	6	-14
-6	12	26
30	34	-10
-38	-2	-8
-28	42	-2
14	-56	58
-50	-62	-6
28	-78	44
-10	-78	-4
38	-50	34
-42	48	12
-44	-52	-24
48	-10	38
-68	-30	36
-44	48	10
-8	-78	-6
22	-78	-4
-68	-38	40
48	-6	14
-46	52	6

// Godinez D A, 2015: Control Co-twins of ADHD
// Subjects=20
40	10	-14
-28	20	-18
-2	-4	34
16	-2	-14
-44	-16	48
-68	-30	40
-20	10	52
6	-94	-8
48	-8	42
14	-42	56
-28	-74	-18
48	-10	38
42	10	-10
-38	10	-14
-10	14	66
0	-2	36
24	2	-14
-44	-10	48
-34	8	-16
-32	54	-12
-68	-30	36
-44	48	10
-8	-78	-6
22	-78	-4
-68	-38	40
48	-6	14
-46	52	6

// Godinez D A, 2015: Healthy Controls
// Subjects=20
-64	-32	30
36	6	-14
30	34	-10
-28	40	-12
32	-70	52
-8	-78	-6
28	-40	60
-10	-30	40
14	-88	26
38	-52	28
-44	50	12
-22	-46	-10
40	10	-14
-28	20	-18
-2	-4	34
16	-2	-14
-44	-16	48
-28	-74	-18
-66	-28	30
-48	-8	26
-36	6	-10
38	-14	38
30	34	-12
14	-20	40
-28	36	-14
54	-6	12
34	6	-14
-52	-64	0
6	18	22
-36	-66	-4
-64	-30	30
50	-8	44
26	-78	44
-8	-78	-6
-28	38	-8
14	-18	36
42	46	-4
-8	14	28
-38	-38	62
50	-38	52
-20	-46	-12
68	2	12
40	-70	-16
6	28	32
-14	-30	40
-50	-46	40
36	6	-14
-6	12	26
30	34	-10
-38	-2	-8
-28	42	-2
14	-56	58
-50	-62	-6
28	-78	44
-10	-78	-4
38	-50	34
-42	48	12
-44	-52	-24
42	10	-10
-38	10	-14
-10	14	66
0	-2	36
24	2	-14
-44	-10	48
-34	8	-16
-32	54	-12

// Ko C H, 2018: Attention Deficit Hyperactivity Disorder (ADHD)
// Subjects=29
32	-54	46
-30	-56	38
-36	-48	42
-42	8	36
-42	0	30
48	4	24
40	30	28
36	30	30
-6	8	54
8	12	52
-28	26	2
-44	-56	-12
-54	6	18
54	8	12
-42	-50	34
34	-48	-20
-56	-26	24
58	-24	28
-2	-44	34
-36	-52	-20
-26	-60	0
-44	32	18
-20	-62	2
-36	14	22

// Ko C H, 2018: Healthy Controls
// Subjects=21
-54	6	18
54	8	12
-42	-50	34
-20	-62	2
-36	14	22

// Lindholm P, 2019: Fearful > Baseline, ADHD > Healthy Controls
// Subjects=23
-28	-74	50

// Materna L, 2019: Negative View > Neutral View, ADHD > Healthy Controls
// Materna L, 2019: Negative View > Neutral View
// Materna L, 2019: Negative Reappraise > Negative View
// Subjects=30
14	44	22
10	44	-4
-16	34	20
-50	-62	6
50	-64	2
-26	-4	58
-32	28	-2
-42	6	50
-52	-34	-2
52	32	-4
-50	-54	22
40	12	48
58	-52	36
48	-36	0
-16	6	12
20	52	34
-26	50	26

// Salmi J, 2018: Visual Bimodal > Unimodal Focused Attention, ADHD > Healthy 
// Controls
// Salmi J, 2018: Auditory Focused Attention > Control Task, ADHD > Healthy 
// Controls
// Salmi J, 2018: Divided Attention > Control Task, ADHD > Healthy Controls
// Salmi J, 2018: Visual Distractors, ADHD > Healthy Controls
// Salmi J, 2018: Auditory Distractors, ADHD > Healthy Controls
// Subjects=16
42	68	66
66	25	28
50	23	41
33	21	31
42	87	58
50	36	39
45	33	20
35	34	70
24	36	37
42	49	56

// Schulz K P, 2017: Stimulus Conflict > Fixation, ADHD
// Schulz K P, 2017: Stimulus Conflict > Fixation, Healthy Controls
// Schulz K P, 2017: Response Conflict > Fixation, Healthy Controls
// Schulz K P, 2017: Combined Conflicts > Fixation, ADHD
// Schulz K P, 2017: Combined Conflicts > Fixation, Healthy Controls
// Schulz K P, 2017: Combined Conflicts > Fixation, ADHD < Healthy Controls
// Schulz K P, 2017: Combined Conflicts > Fixation, Persistent ADHD < Remitted 
// ADHD
// Subjects=11
-6	-82	42
-10	-76	48
10	-78	50
-54	26	22
-42	10	30
-26	14	54
-28	64	-16
44	14	26
34	14	58
50	30	20
12	-78	50
-4	-68	54
-22	-74	50
-44	10	28
-52	22	26
-42	10	52
26	56	-10
38	62	0
50	34	28
36	12	56
48	32	36
-54	-46	54
-28	-64	62
30	-62	40
-16	-66	54
-28	-64	52
-22	-70	46
36	-60	50
14	-78	52
8	-74	50
30	-86	32
-6	-82	44
-24	12	48
-50	12	28
-40	4	36
-18	-38	-20
-46	8	-22
8	-46	-38
20	-78	0
42	16	-20
54	6	-20
16	50	-12
32	-86	30
10	-72	40
54	-62	20
44	-80	20
-30	-50	50
-2	-32	50
-14	30	22
-32	38	0
-52	28	20
24	34	-12
46	2	-14
32	12	44
38	46	-16
42	-68	22
42	-40	42
26	-46	50
-30	-56	-2
-30	-34	-30

// Tajima-Pozo K, 2018: Unpleasant > Neutral, Healthy Controls > ADHD
// Subjects=9
-36	44	18

// Tanaka S C, 2018: Loss > Gain, ADHD < Healthy Controls
// Tanaka S C, 2018: Group x Condition Interaction
// Subjects=14
38	-56	-22
20	-72	54
38	12	-36
-40	16	-30

// Wilbertz G, 2017: Loss > Gain Anticipation, ADHD > Healthy Controls
// Subjects=28
-36	11	-26

// Anderson N E, 2017: Emotion implicit > Neutral implicit
// Anderson N E, 2017: Emotion explicit > Neutral explicit
// Anderson N E, 2017: Emotion explicit > Emotion implicit
// Anderson N E, 2017: Neutral explicit > neutral implicit
// Subjects=120
48	-75	-6
-45	-72	-3
51	-63	6
-45	24	12
51	36	9
18	-57	0
-15	-66	3
-24	0	-25
24	0	-15
-9	54	18
-6	54	24
-48	24	-6
-9	24	63
-54	-63	21
-3	27	36
42	-63	-6
39	21	-12
-12	33	57
15	24	66
-51	24	-9
27	54	24
0	45	36
-60	-54	36
45	24	-15
-18	51	33
33	18	-24
3	-15	42
0	48	9
54	-57	45
0	-51	30
21	-105	0
-30	-102	0
60	-9	3
27	-51	-15
-6	-36	54
-60	-9	3
15	-81	36
-21	-93	33
-24	-69	-15
-18	-72	0
3	-3	51
15	51	3
9	39	48
6	42	-12
-24	9	-21
24	6	-33

// Deming P, 2018: Self > Case
// Deming P, 2018: Self < Case
// Deming P, 2018: Other > Case
// Deming P, 2018: Other < Case
// Deming P, 2018: Self > Other
// Deming P, 2018: Self < Other
// Deming P, 2018: Positive Correlation between Other > Case with PCL-R Facet 
// 3 Scores
// Deming P, 2018: Negative Correlation between Self > Other with PCL-R Factor 
// 2 Scores
// Subjects=57
-5.2	-60.5	45
-5.2	3.05	31
-29.8	20	-11
33.2	20	-14.5
-47.2	-60.5	27.5
-22.8	-11.5	-11
-5.2	-50	24
-1.8	-11.5	34.5
-8.8	-95.5	17
8.8	-85	31
19.2	-74.5	-35.5
-19.2	-74.5	-35.5
5.2	-46.5	-35.5
43.8	34	20.5
-36.8	27	27.5
-29.8	-4.5	52
26.2	-1	48.5
47.2	2.5	24
-43.8	2.5	24
-19.2	41	-4
50.8	-43	-11
-57.9	-50	-7.5
33.2	-60.5	45
5.2	-39.5	41.5
-12.2	58.5	27.5
-47.2	20	6.5
36.8	27	-11
-47.2	-57	20.5
-22.8	-11.5	-11
-5.2	-50	27.5
8.8	-81.5	-7.5
-8.8	-95.5	13.5
19.2	-74.5	-35.5
-26.2	-67.5	-32
-8.8	-50	-35.5
43.8	30.5	20.5
29.8	-4.5	45
-36.8	27	27.5
-29.8	-4.5	52
-43.8	2.5	24
47.2	2.5	27.5
-54.2	-50	-7.5
43.8	-46.5	45
-26.2	-67.5	31
8.8	-36	38
-33.2	-64	-4
8.8	51.5	24
-5.2	37.5	-11
-57.8	-4.5	-11
19.2	-81.5	-7.5
1.8	-57	27.5
12.2	48	6.5
36.8	-57	13.5
12.2	-53.5	24
-1.8	-50	24
36.8	-74.5	20.5

// Volman I, 2016: Healthy Male Controls (HCs)
// Subjects=19
-16	-96	24
-30	-76	34
-52	22	-10
18	-98	16
30	58	12
54	-42	54
10	10	2
-34	6	-10
18	-76	-38

// Volman I, 2016: Psychopathic Patients (PPs)
// Subjects=15
-16	-96	24
-30	-76	34
-52	22	-10
18	-98	16
8	-82	38
-30	-72	34
-32	-32	6
28	-74	46
-24	-66	-38
30	58	12
54	-42	54
10	10	2
-34	6	-10
18	-76	-38
52	-40	54
6	22	66
6	6	4

// De Martino M, 2019: Conjugation effect in regular verbs (2nd and 3rd 
// conjugations > 1st conjugation)
// De Martino M, 2019: Main effect of regularity (irregular > regular)
// De Martino M, 2019: Conjugation effect independent of regularity (2nd 
// conjugation > 3rd conjugation)
// De Martino M, 2019: Regularity x Conjugation
// Subjects=23
-46.64	-3.01	42.44
-1.74	10.63	49.71
-50	1.95	24.22
-47.02	32.66	8.23
-5.44	31.88	-5.56
-43.43	-12.85	38.77
49.46	-6.46	30.48

// Nevat M, 2017: Inflection > Repetition
// Subjects=17
29	-82	0
-11	12	-2
-5	14	52
12	14	-2
-42	6	32
-20	-67	28

// Prehn K, 2017: L1 (Native) German Speakers
// Subjects=20
-6	38	46
30	17	55
12	32	55
-21	23	52
-15	29	43
-9	53	25
-9	-55	22
12	-52	19
9	-61	28

// Prehn K, 2017: L2 (Non-Native) German Speakers
// Subjects=20
-6	38	46
30	17	55
12	32	55
45	-43	55
-27	-4	46
39	-55	58
51	-34	49
-27	2	64
-6	26	49

// Schultz D H, 2016: Image with 500 ms shock (CS+) > Image without shock 
// (CS-)
// Schultz D H, 2016: Psycopathy > Controls
// Schultz D H, 2016: High Anxiety > Low Anxiety
// Schultz D H, 2016: Low Anxiety > High Anxiety
// Schultz D H, 2016: Positive Correlation between Anxiety (WAS) and (CS+ > 
// CS-), Psychopathy
// Schultz D H, 2016: Negative Correlation between Anxiety (WAS) and (CS+ > 
// CS-), Psychopathy
// Schultz D H, 2016: Positive Correlation between Anxiety (WAS) and (CS+ > 
// CS-), Controls
// Schultz D H, 2016: Negative Correlation between Anxiety (WAS) and (CS+ > 
// CS-), Controls
// Schultz D H, 2016: Psychopathy (Low Anxiety > High Anxiety), Controls (High 
// Anxiety > Low Anxiety)
// Schultz D H, 2016: Psychopathy (High Anxiety > Low Anxiety), Controls (Low 
// Anxiety > High Anxiety)
// Subjects=9
-13.04	70.64	-19.77
-5.96	-6.4	50.07
31.67	64.23	-31.01
-56.75	65.47	6.71
1.11	4.77	1.1
44.48	46.62	-39.71
2.58	16.63	58.07
20.51	63.72	46.11
19.09	9.59	-20.7
-4.02	-12.75	22.7
-12.87	63.07	13.09
51.64	0.58	38.78
8.39	43.42	-8.92
-5.6	89.49	-3.7
-.33	36.12	-33.86
14.58	62.01	-30.62
57.62	48.89	2.32
-18.26	25.2	-8.2
-.77	-47.51	13.31
13.84	80.75	19.11
40.53	-22.6	-26.06
28.67	-13.84	-35.58
51.32	-14.82	-8.99
10.99	55.89	55.8
-7.59	38.3	-4.96
38.82	-50.02	18.64
-41.73	-16.23	-18.95
-27.43	12.25	45.4
45.5	65.83	-39.11
-6.47	48.76	6.41
23.37	6.36	-21.6
-31.29	61.45	-20.01
29.58	54.87	-27.97
13.75	46.88	-5.93
27.42	71.06	-24.84
-35.1	58.56	39.38
-5.27	-10.24	0.2
-21.98	-5.26	52.39
16.22	62.47	44.04
-12.85	79.79	22.84
-44.48	-.54	46.67
31.98	69.6	10.92
-22.44	-8.92	-8.64
54.57	12.03	7.68
23.87	41.17	56.89
-46.23	0.09	-41.46
16.64	57.91	-42.57
34.44	-54.42	3.45
45.75	60.82	-7.46
35.64	-50.84	22.09
6.54	25.46	20.49
-7.44	-35.86	-14.36
2.37	-55.84	1.7
-18.15	14.26	1.64
12.61	2.18	-33.39
-36.43	34.95	-4.35
-43.73	64.26	31.19
-9.23	22.65	54.36
-36.43	34.95	-4.35
-43.73	64.26	31.19
-9.23	22.65	54.36
35.64	-50.84	22.09
6.54	25.46	20.49
-7.44	-35.86	-14.36
2.37	-55.84	1.7
-18.15	14.26	1.64
12.61	2.18	-33.39
32.44	-58.52	19.43
-34.87	-63.15	20.59
-29.12	102.47	1.06
20.09	105.57	9.15
-44.99	88.6	15.78
-7.09	-65.19	19.32
5.55	-13.21	15.93
4.82	-51.51	43.69
-18.15	14.26	1.64
3.35	-28.17	1.6
-42.68	65.15	28.88
52	67.95	-25.98
0.62	-23.22	65.9
-14.85	69.09	36.03

// Sethi A, 2018: Primary
// Subjects=50
-14	-68	24
-20	-58	18
-6	-42	44
16	-54	22
8	-64	20
10	-46	6
-38	2	-12
-56	-18	18
-38	-16	2
38	-16	0
46	0	4
58	4	6
-30	20	36
8	32	10
-4	32	28
48	0	-12
46	0	4
46	-8	-8
-40	0	-16
-50	4	-16
-38	-16	2
-26	26	24
8	32	20
-14	30	28

// Sethi A, 2018: Secondary
// Subjects=100
48	0	-12
46	0	4
46	-8	-8
-40	0	-16
-50	4	-16
-38	-16	2
-12	52	-8
-4	36	8
-6	32	-4
36	-20	2
20	-8	2
-6	-16	-10
-46	-28	10
-30	-34	14
-42	-36	24
-2	-42	42
-8	-48	20
8	-44	24
-26	26	24
8	32	20
-14	30	28

// Sethi A, 2018: Comparison
// Subjects=82
-14	-68	24
-20	-58	18
-6	-42	44
16	-54	22
8	-64	20
10	-46	6
-38	2	-12
-56	-18	18
-38	-16	2
38	-16	0
46	0	4
58	4	6
-30	20	36
8	32	10
-4	32	28
-12	52	-8
-4	36	8
-6	32	-4
36	-20	2
20	-8	2
-6	-16	-10
-46	-28	10
-30	-34	14
-42	-36	24
-2	-42	42
-8	-48	20
8	-44	24
-26	26	24
8	32	20
-14	30	28

// Whitehead J C, 2018: Instrumental music > Speech (Continuous multiband 
// sequence)
// Whitehead J C, 2018: Singing > Speech (Continuous multiband sequence)
// Whitehead J C, 2018: [Instrumental music and singing] > Speech (Continuous 
// multiband sequence)
// Whitehead J C, 2018: Speech > Instrumental music (Continuous multiband 
// sequence)
// Whitehead J C, 2018: Singing > Instrumental music (Continuous multiband 
// sequence)
// Whitehead J C, 2018: [Speech and singing] > Instrumental music (Continuous 
// multiband sequence)
// Whitehead J C, 2018: Speech > Singing (Continuous multiband sequence)
// Whitehead J C, 2018: Instrumental music > Speech (Interleaved silent steady 
// state)
// Whitehead J C, 2018: Speech > Instrumental music (Interleaved silent steady 
// state)
// Subjects=24
66	-28	12
46	-6	-6
-48	-6	-4
50	4	-8
66	-26	10
-48	0	-6
66	-26	10
48	4	-8
-48	-6	-4
64	-8	-4
-62	-12	0
62	-20	-2
-60	-12	2
62	-20	-2
-60	-12	1
64	-8	-4
-60	-22	-2
48	-32	24
42	-12	-10
-48	-6	0
56	-28	-2
-64	-28	4

// Dhakal K, 2019: Improvised > Prelearned
// Dhakal K, 2019: Improvised > Rest
// Dhakal K, 2019: Prelearned > Rest
// Dhakal K, 2019: Vocalized improvised > Vocalized prelearned
// Dhakal K, 2019: Imagine improvised > Imagine prelearned
// Dhakal K, 2019: Vocalize > Rest
// Dhakal K, 2019: Imagine > Rest
// Subjects=24
-9	5	68
-57	11	17
-54	11	29
-24	-10	53
30	-67	-22
63	-4	14
63	-10	2
51	-34	11
-3	2	71
-57	-4	-4
-57	-13	2
-9	-40	-40
54	-13	-1
63	-4	14
-54	-16	2
-63	-25	5
-60	11	23
-57	11	17
-45	2	41
-45	-1	29
12	2	59
-3	5	62
-12	5	50
-24	-10	59
63	-4	14
45	-22	8
54	-13	2
-42	-16	35
3	-1	68
-3	-7	71

// Heath S, 2015: Aphasia Patient 1 (P01)
// Subjects=1
-12	-51	81
3	-7	-9
51	-54	-12
60	-3	30
-9	-48	81
54	-54	-15
-3	48	0
6	-75	-9

// Heath S, 2015: Aphasia Patient 2 (P02)
// Subjects=1
-9	-69	39
-3	-66	36
-39	-54	42
63	-27	-15
54	-54	21
3	54	-3
-21	-78	-36
-27	-60	24
-9	-63	57
-24	-63	21
-39	33	9
-3	-33	-21
36	51	-9
-9	-81	-30
66	-33	-3
45	-54	48
-24	-63	21

// Karcher N R, 2019: Unexpected reward and Unexpected punishment > Fixation
// Karcher N R, 2019: Unexpected reward and Unexpected punishment > Fixation, 
// Psychosis > Healthy Controls
// Karcher N R, 2019: Unexpected reward > Fixation
// Karcher N R, 2019: Unexpected reward > Fixation, Psychosis > Healthy 
// Controls
// Karcher N R, 2019: Unexpected punishment > Fixation
// Karcher N R, 2019: Unexpected reward > Unexpected punishment
// Karcher N R, 2019: Unexpected reward > Unexpected punishment, Psychosis > 
// Healthy Controls
// Subjects=20
18	14	-6
14	2	4
14	12	4
14	8	2
-12	12	2
-22	10	0
14	10	8
14	4	4
14	4	4
12	10	6

// Knolle F, 2018: Psychosis
// Subjects=13
-24	-90	-20
4	-94	-4
-26	-96	-4
46	-50	-38
-50	-68	-32
52	-60	-28
-8	-96	-6
-48	-82	4
6	-86	-2
-10	2	-20
44	-72	10
-26	-2	-12
-46	-76	-26
16	-40	-46
-12	-16	-6
-40	16	4
2	16	18
-14	-14	-24
-8	6	36

// Knolle F, 2018: Healthy Controls
// Subjects=34
-24	-90	-20
4	-94	-4
-26	-96	-4
46	-50	-38
-50	-68	-32
52	-60	-28
-8	-96	-6
-48	-82	4
6	-86	-2
-10	2	-20
44	-72	10
-26	-2	-12
-46	-76	-26
16	-40	-46
-12	-16	-6
-40	16	4
2	16	18
-14	-14	-24
-8	6	36
44	22	-12
42	-70	12
0	-76	14
2	-84	0
8	-72	16
36	-74	28
-38	-20	-2

// Martinsen S, 2018: Fibromyalgia (FM)
// Subjects=19
-40	-60	-34
-22	6	2
-24	-56	-50
22	-18	24
42	-2	-16
20	-68	-18
-64	-36	20
-46	-2	-20
-6	-84	-16
42	-12	0
-14	6	22
48	-58	0
-44	-32	2
-22	4	-14
26	0	-14
62	-32	14

// Martinsen S, 2018: Healthy Controls (HC)
// Subjects=20
-40	-60	-34
-22	6	2
-24	-56	-50
22	-18	24
42	-2	-16
20	-68	-18
-64	-36	20
-46	-2	-20
-6	-84	-16
42	-12	0
-14	6	22
48	-58	0
-44	-32	2

// Schwarzmeier H, 2019: Full Acquisition: ACS+ > ACS-
// Schwarzmeier H, 2019: Early Acquisition: A1CS+ > A1CS-
// Schwarzmeier H, 2019: Late Acquisition: A2CS+ > A2CS-
// Schwarzmeier H, 2019: Full Extinction Training: ETCS+ > ETCS-
// Schwarzmeier H, 2019: Early Extinction Training: ET1CS+ > ET1CS-
// Schwarzmeier H, 2019: Late Extinction Training: ET3CS+ > ET3CS-
// Schwarzmeier H, 2019: Early Extinction Recall: ER1CS+ > ER1CS-
// Schwarzmeier H, 2019: Panic Disorder (PD) > Healthy Controls (HC), ACS+ > 
// ACS-
// Schwarzmeier H, 2019: PD > HC, A1CS+ > A1CS-
// Schwarzmeier H, 2019: PD > HC, ER2CS+ > ER2CS-
// Schwarzmeier H, 2019: PD > HC, ER3CS+ > ER3CS-
// Schwarzmeier H, 2019: HC > PD, A1CS+ > A1CS-
// Schwarzmeier H, 2019: HC > PD, A2CS+ > A2CS-
// Schwarzmeier H, 2019: HC > PD, ETCS+ > ETCS-
// Schwarzmeier H, 2019: HC > PD, ET1CS+ > ET1CS-
// Schwarzmeier H, 2019: HC > PD, ER1CS+ > ER1CS-
// Subjects=10
15	2	70
-33	-28	16
48	-19	7
-45	-4	40
-6	-46	52
45	-1	46
-9	5	49
48	-4	49
6	-13	-20
12	-1	73
-45	-34	10
39	-31	16
6	-52	52
-12	2	-2
9	-22	1
18	11	1
15	-13	1
27	44	13
-36	20	7
45	20	1
45	2	55
0	11	55
51	2	34
33	26	4
-42	14	10
0	11	55
-27	20	4
51	2	37
30	59	13
-3	-22	-5
30	-46	40
-54	-28	34
21	-70	43
-48	37	46
33	-4	-17
45	-4	-11
-36	-25	-20
33	-4	-14
-30	-13	19
-3	-55	-26
-12	-64	-14
42	5	-5
-42	14	19
-30	41	-2
24	29	37
42	-25	22
-42	-19	43
-60	-19	22
-54	-4	13
-57	-37	46
39	-4	40
-54	-34	-14
-3	29	61
-6	-52	34
-15	2	34
0	20	64
6	-73	43
45	-43	25
54	-43	31
39	11	37

// Balodis I M, 2018: Pos. Correlation between Iowa Gambling Task Scores (IGT) 
// & Win Prospect (A1W) > Neutral, All
// Balodis I M, 2018: Pos. Correlation between IGT Scores and A1W > Neutral, 
// Gambling Disorder (GD)
// Balodis I M, 2018: Neg. Correlation between IGT Scores & Loss Anticipation 
// (A2L) > Neutral, GD
// Balodis I M, 2018: Neg. Correlation between IGT Scores & Loss Prospect 
// (A1L) > Neutral, All Non-smokers
// Subjects=14
-12	36	6
-6	-54	3
-18	-44	30
-9	6	-6
0	30	6
-9	-99	21
12	-40	60
59	-5	42
-33	0	-33
18	-27	45
-18	51	-7.5
12	-15.5	33
-60.5	-57	24

// Brevers D, 2015: Pathological Gamblers (PG)
// Subjects=10
24.66	-8.92	0.86
24.66	-8.92	0.86
23.59	-2.33	3.66

// Brevers D, 2015: Healthy Controls (HC)
// Subjects=10
23.69	51.43	38.19
-11.75	66.93	21.68
48.09	49.69	13.52
-67.12	-21.39	12.99
28.93	-6.78	0.63
-51.31	14.86	-1.38
-37.89	-22.82	60.73
-67.11	-22.36	14.19
-39.31	-22.11	14.97
-67.09	-40.85	9.05
32.95	58.72	-6.02
2.43	41.5	49.3
-41.49	6.05	21.55
32.98	63.46	0.27
-45.89	-29.32	-8.89
18.28	-9.76	4.35
45.98	18.15	5.03
-44.32	-26.29	57.75
40.09	-22.61	56.47
-14.77	-2.59	17.51
40.83	-20.57	13.92
-60.57	-58.36	16.02
-22.37	8.23	6.65
31.12	-14.97	4.64
-18.12	-57.85	-22.43
24.66	-8.92	0.86
24.66	-8.92	0.86
23.59	-2.33	3.66

// Kaldewaij R, 2019: Main Effect of Group (Panic Disorder (PD) > Healthy 
// Controls (HC))
// Kaldewaij R, 2019: Happy > Neutral, PD > HC
// Kaldewaij R, 2019: Fearful > Neutral, PD > HC
// Subjects=17
6	54	6
6	62	14
38	-86	14
-40	-86	-20
-6	-56	18

// Kober H, 2016: Initial Video Viewing: Females > Males
// Kober H, 2016: Initial Video Viewing: Cocaine videos > Sad and Gambling 
// videos
// Kober H, 2016: Initial Video Viewing, Cocaine-dependent Group: Cocaine 
// videos > Sad and Gambling videos
// Kober H, 2016: Final Video Viewing: Females > Males
// Kober H, 2016: Final Video Viewing: Gambling videos > Sad and Cocaine 
// videos
// Kober H, 2016: Final Video Viewing, Pathological Gamblers (PG): Gambling 
// videos > Cocaine and Sad videos
// Kober H, 2016: Final Video Viewing, Female PG > Male PG: Gambling videos
// Kober H, 2016: Final Video Viewing, Male PG > Female PG: Sad videos > 
// Cocaine videos
// Subjects=8
32	-42	7
43	-68	4
17	-36	1
43	30	3
-49	25	16
-49	-3	32
37	-3	24
-3	38	8
38	-48	2
48	-25	4
46	8	25
-6	37	41
3	10	59
-20	28	17
-34	-19	3
-9	54	21

// Massau C, 2017: Moral > Control, All Participants
// Massau C, 2017: General Offenses (GO), All Participants
// Massau C, 2017: Sexual offenses against adults (SOA) > Control, All 
// Participants
// Massau C, 2017: Child sexual abuse (SOC) > Control, All Participants
// Subjects=15
18.64	-94.62	-0.02
-2.69	-48.83	31.67
-61.76	-6.39	-16.35
-3.73	44.04	-31.29
-11.65	-92.81	-1.93
24.65	-84.95	-34.7
63.48	0.02	-23.6
-7.35	62.39	27.47
-42.5	33.89	-22.9
-50.06	4.76	56.31
-25.03	-87.25	-33.63
53.06	-32.19	-0.06
52.46	18.08	-36.4
-45.64	-73.26	48.26
25.19	-39.34	16.81
18.64	-94.62	-0.02
-61.76	-6.39	-16.35
-2.69	-48.83	31.67
-1.57	44.04	-31.33
-9.49	-92.8	-1.97
24.65	-84.95	-34.7
-48.07	-62.17	29.28
61.35	-1.91	-21.13
-7.35	62.39	27.47
-42.5	33.89	-22.9
-53.09	31.05	-6.75
-50.06	4.76	56.31
18.64	-94.62	-0.02
-61.79	-6.6	-18.57
-.56	-46.9	29.2
-1.57	44.04	-31.33
-11.65	-92.81	-1.93
61.32	0.01	-23.56
24.66	-87.07	-34.49
-7.35	62.39	27.47
-40.35	36.02	-23.15
-50.06	4.76	56.31
53.06	-32.19	-0.06
52.47	15.96	-36.19
-25.03	-89.38	-33.42
48.11	17.86	-38.55
20.78	-46.57	8.63
18.64	-94.62	-0.02
-2.69	-48.83	31.67
-61.79	-6.6	-18.57
-3.71	46.37	-29.28
-11.68	-93.01	-4.15
24.65	-84.95	-34.7
61.32	0.01	-23.56
-40.35	36.02	-23.15
-50.06	4.76	56.31
-25.03	-87.25	-33.63
37.93	-38.83	-1.39
53.06	-32.19	-0.06
52.46	18.08	-36.4
25.19	-39.34	16.81
40.04	-34.77	-4.07

// Ponseti J, 2016: Pedophiles > Healthy Controls, Girls > Women
// Ponseti J, 2016: Pedophiles > Healthy Controls, Boys > Men
// Subjects=24
-14	-4	-16
34	-70	-12
-38	-46	-20
-34	-66	-12
14	-38	-4
30	-50	-22
20	-28	0
32	-84	-8
-8	-82	-8
-34	-70	16
-16	-12	14
-12	50	22
10	36	22
-4	30	24
14	52	24
-10	14	62
-26	-62	54
-42	-68	-14
-30	-46	-22
-42	-72	-4
-38	-60	0
-26	-48	50
-36	-2	54
42	-68	-8
40	-58	-18
46	-56	-16
-12	14	-8

// Powers S J, 2016: Family History of Developmental Dyslexia (FHD+)
// Subjects=29
-36	-60	-20
36	-70	-10
-42	38	-12
32	4	-28
54	-6	32
-42	34	-8
-42	30	24
30	-68	-10
58	-4	30

// Powers S J, 2016: Healthy Controls
// Subjects=21
-36	-60	-20
36	-70	-10
-42	38	-12
32	4	-28
-38	24	-12
30	-70	-10
32	10	-28
-42	34	-8
-42	30	24
30	-68	-10
58	-4	30

// Ristow I, 2019: Main effect of stimulus age, Child > Adult
// Ristow I, 2019: Main effect of condition, Expectancy > Picture-viewing
// Ristow I, 2019: Main effect of group, Pedophilic Sex Offenders (PSO) > 
// Healthy Controls (HC)
// Ristow I, 2019: PSO > HC, Child > Adult
// Ristow I, 2019: PSO > HC, Expectancy > Picture-viewing
// Ristow I, 2019: Expectancy-adults > Picture-viewing adult, Expectancy-child 
// > Picture-viewing child
// Ristow I, 2019: PSO > HC: Expectancy-adults > Picture-viewing adult, 
// Expectancy-child > Picture-viewing child
// Ristow I, 2019: HC > PSO: Expectancy-adults > Expectancy-child
// Ristow I, 2019: HC > PSO: Picture-viewing adult > Picture-viewing child
// Subjects=13
20	-84	-8
-14	-94	2
-38	-48	58
8	-50	30
66	-20	34
-8	-82	8
-36	-4	50
-32	22	0
-8	6	58
4	-20	-2
6	-16	30
42	-62	4
58	-26	-10
-32	-52	38
20	4	4
-42	-70	30
10	-68	44
-32	52	16
-50	-20	-20
30	58	-8
44	-60	26
44	44	-18
-62	-24	-22
-26	-64	54
-28	24	4
26	-64	40
-44	-76	-8
2	-84	8
62	-42	28
-36	16	-4
2	24	38
-5	12	35
-10	-70	25
26	48	30
0	24	38
40	-2	52
-28	26	4
28	-66	52
-28	54	20
-30	-80	26
34	28	-4
-42	-46	50
-48	-62	-12
24	-84	-20
-30	-88	22
32	-82	16
40	-74	0
-18	-32	-4
48	-70	-10

// Worhunsky P D, 2017: Regional integration of loss-chase-related functional 
// brain networks
// Subjects=18
-6	41	10
24	2	-2
-21	2	-11
57	-55	40
36	17	52
-30	-76	25
30	-85	25
-57	-13	4
57	-10	1
-33	-85	31
36	-79	43
27	47	13
-21	50	10
15	-55	-2

// Bauer C, 2015: Early Blind
// Subjects=8
46	10	50
-24	-64	64
36	-72	-18
-56	-30	44
-42	-66	-4
-36	-64	-6
42	-76	-16
-16	-92	14
40	-78	20
-22	-66	-12
-22	-60	-2
-18	-86	22
8	-70	3
40	-80	4
12	-70	3
4	-42	3
-12	-68	3
-24	-62	64
38	-50	52
48	12	50
28	-58	58
0	28	50
40	-80	4
8	-52	4
4	-56	3

// Bauer C, 2015: Sighted Controls
// Subjects=7
2	-80	-12
-28	28	4
-30	26	-8
30	-6	42
-12	-80	50
54	-18	28
-6	16	50
8	-48	74
24	-34	-18
-36	-72	30
30	-30	-18
-26	6	-24
-56	-44	-8
-40	12	44
22	-86	28
42	-76	-16
-16	-92	14
40	-78	20
-22	-66	-12
-22	-60	-2
-18	-86	22
8	-70	3
40	-80	4
12	-70	3
4	-42	3
-12	-68	3
-24	-62	64
38	-50	52
48	12	50
28	-58	58
0	28	50
40	-80	4
8	-52	4
4	-56	3

// Begue I, 2018: All Subjects: Movement > Rest
// Subjects=10
48	-61	1
-48	-73	1
-36	-10	52
9	-16	4
-3	-25	-8
18	14	-5
51	11	19
-6	-16	52
36	-43	49
30	-7	52
-9	-19	4
-6	-1	55
33	23	1
-30	-94	1

// Chechko N, 2018: Healthy Controls
// Subjects=27
34	-34	-2
-36	34	40
-2	26	48
6	22	36
6	38	16
-44	32	20
-38	34	38
-48	20	-14
-50	22	-10
-34	20	-4
48	28	-6
-38	42	-2
-48	44	-10
46	18	34
-46	16	40
-36	12	28
50	-50	44
-24	16	66
-12	14	64
12	-82	-32
-42	0	42
-52	-46	52
36	62	2
50	32	22
24	54	26
-20	34	50

// Chechko N, 2018: Dissociative Amnesia
// Subjects=1
34	-34	-2
-36	34	40
54	-46	1
62	-10	-26
-58	-30	-16
56	-52	-20
-32	-36	-20
-28	-34	78
64	2	14
60	-2	34
-30	-34	76
-2	26	48
6	22	36
6	38	16
-44	32	20
-38	34	38
-48	20	-14
-50	22	-10
-34	20	-4
48	28	-6
-38	42	-2
-48	44	-10
46	18	34
-46	16	40
-36	12	28
50	-50	44
-24	16	66
-12	14	64
12	-82	-32
-42	0	42
-52	-46	52
36	62	2
50	32	22
24	54	26
-20	34	50
-50	-68	30
-42	-78	36
-58	-64	14
-4	-56	38
0	-72	30
-4	-70	14
-4	-70	14
44	-80	26
50	-72	20
40	-68	20
54	-46	10
-2	54	4
6	66	10
-10	-56	8
-14	-42	0
-32	-80	-38
-26	36	42
-64	-10	-24
22	-12	-18
18	-28	-10
-12	60	-20
-2	54	-20
-32	-36	-20
50	18	-20
62	-10	-26
40	30	0
56	-56	-32
-24	-18	-16
-36	8	30
-32	36	-20
-58	-30	-16
56	-52	-20
-24	60	4
-48	22	-16

// Gagnon L, 2015: Tastes > Saliva, All Subjects
// Gagnon L, 2015: Tastes > Saliva, Sighted Controls > Congenitally Blind
// Subjects=9
-40	8	-8
-40	-36	54
-36	-44	52
32	-8	24
44	-16	22
18	-10	38
-22	-18	38
-46	-44	30
2	-2	-6

// Kargel C, 2017: Nogo > Go, All Subjects
// Kargel C, 2017: Group by condition interaction
// Kargel C, 2017: P-CSO (child sexual abuse) > P+CSO (no child sexual abuse), 
// Nogo > Go
// Subjects=37
-50	-57	49
-57	-29	-11
51	-52	52
62	-32	-2
32	19	-14
-41	26	43
46	24	46
30	51	34
5	10	61
-25	54	34
-32	17	-20
5	-22	34
3	37	22
-43	-71	-8
-37	-55	-14
35	-78	-5
8	-20	24
-7	-45	25
-7	-61	28
-20	24	43

// Sojka P, 2019: Functional Movement Disorder (FMD) > Healthy Controls (HC): 
// Negative Look > Neutral Look
// Sojka P, 2019: FMD > HC: Negative Regulate > Negative Look
// Subjects=15
-22	-32	76
28	-42	64
-12	-34	44
-40	-8	20
42	-14	-8
20	-58	-50
16	-70	64
-22	-32	76

// Dogonowski A, 2019: Finger Tapping: Baseline < Recovery
// Dogonowski A, 2019: Finger Tapping: Baseline > Recovery
// Subjects=1
14	-4	74
-20	-8	72
6	60	32

// Gibbels C, 2019: All Participants: No-go > Baseline
// Subjects=31
-22	24	8
-4	34	22
46	-42	-8
-54	-22	-14
2	24	46

// Horndasch S, 2018: Adults with Anorexia > Adult Controls, High-calorie
// Horndasch S, 2018: Adolescents with Anorexia > Adolescent Controls, 
// High-calorie
// Horndasch S, 2018: Adults with Anorexia > Adult Controls, Low-calorie
// Horndasch S, 2018: Adolescents with Anorexia > Adolescent Controls, 
// Low-calorie
// Horndasch S, 2018: Adults with Anorexia > Adult Controls, Negative
// Horndasch S, 2018: Adolescents with Anorexia > Adolescent Controls, 
// Negative
// Horndasch S, 2018: Adults with Anorexia > Adult Controls, Neutral
// Horndasch S, 2018: Adolescents with Anorexia > Adolescent Controls, Neutral
// Horndasch S, 2018: Adults with Anorexia > Adult Controls, Positive
// Horndasch S, 2018: Adolescents with Anorexia > Adolescent Controls, 
// Positive
// Subjects=15
-27.4	13.65	49.75
35.62	19.23	47.44
-44.56	1.95	37.54
-19.66	-83.56	44.43
-2.79	-85.85	13.2
21.71	-89.82	0.99
-24.24	-90.09	1.54
52.28	3.88	-15.03
7.33	1.78	-24.37
31.08	-74.73	-24.92
-18.08	-75.02	-24.33
-3.81	4.7	55.8
34.23	-45.64	-20.71
-37.37	-51.53	-21.62
-44.56	1.95	37.54
-19.66	-83.56	44.43
-2.79	-85.85	13.2
21.71	-89.82	0.99
-24.24	-90.09	1.54
52.28	3.88	-15.03
7.33	1.78	-24.37
31.08	-74.73	-24.92
-18.08	-75.02	-24.33
-3.81	4.7	55.8
34.23	-45.64	-20.71
-42.64	-72.8	-20.89
-33.61	-7.31	68.3
30.39	9.4	58.36
-43.55	4.61	30.62
-45.78	25.66	27.76
-24.5	36.91	19.88
-.9	10.53	20.71
4.44	12.67	20.47
33.63	-85.75	25.04
-14.4	-85.52	32.27
6.66	-66.65	-.79
24.46	30.75	-9.16
25.39	66.7	-12.18
-43.64	-47.91	-1.78
-19.36	30.4	-9.74
26.45	41.36	-23.45
21.2	3.81	-26.93
-27.75	29.77	10.48
51.49	16.64	26.29
-60.71	9.37	24.84
-46.68	-37.42	24.14
10.68	36.18	7.27
-3.83	-86.66	16.63
-43.41	-88.38	11.65
-22.61	56.27	-5.18
22.79	-88.5	4.21
18.09	2.61	-14.53
34.23	-45.64	-20.71
31.08	-74.73	-24.92
-42.64	-72.8	-20.89
27.97	-31.99	4.99
-8.96	-32.79	66.81
-32.96	44.31	33.86
58.19	-40.79	39.95
-57.21	-42.45	42.53
-1.73	-35.32	33.49
-11.79	62.19	15.39
-10.64	39.91	16.13
-51.19	19.4	16.08
12.24	-81.73	23.83
-16.56	-83.51	31.01
34.67	-84.94	21.62
16.33	-48.47	13.19
-12.51	-49.61	14.73
13.93	33.37	11.93
-13.87	40.77	13.86
-51.21	18.09	12.85
42.81	22.88	11.37
-5.23	-5.5	6.49
19.46	-33.82	9.7
16.32	-47.5	12
-13.59	-50.76	13.73
6.66	-66.65	-.79
8.87	-82.32	2.73
6.66	-66.65	-.79
8.87	-82.32	2.73
21.73	-93.96	2.45
-18.86	-95.18	4.13
26.45	41.36	-23.45
-24.41	-79.75	-16.06
17.22	-90.93	-26.75
47.51	-25.37	47.7
21.84	-35.72	39.94
19.51	-4.78	27.34
-17.85	-15.58	28.67
-61.77	9.45	25.96
65.4	5.89	23.68
50.27	50.13	19.03
-49.1	45.31	20.58
-43.45	-38.28	26.41
19.56	-29.53	23.83
-10.39	-29.97	20.87
42.75	42	10.88
31.09	16.55	13.15
49.18	22.49	5.75
-27.5	-49.96	11.59
-8.22	-80.14	4.98
51.58	-71.41	2.44
-41.28	-87.4	10.43
22.75	-67.01	6.87
-29.95	7.16	-6.55
10.95	-76.31	-2.25
-27.59	-88.31	-16.42
-12.73	-74.9	-23.29
17.29	-89.1	-16.87
7.76	21.55	38.64
-10.58	3.18	9.17
-13.36	-84.63	29.95
13.33	-81.47	27.15
-8.47	5.14	6.75
7.53	8.24	4.08
-17.78	-96.14	5.31
19.58	-94.06	1.37
8.82	-69.63	1.67
44.7	35.73	-15.38
50.64	9	51.47
5.21	55.72	-.99
29.69	66.99	-8.91
-32.3	63.19	-11.23
58.71	15	-9.35
8.79	-68.92	-2.85
49.35	18.74	26.13
-9.29	80.23	69.6
18.62	-69.89	25
42.67	54.34	5.38
-4.92	-85.78	14.33
-43.42	-87.41	10.45
20.63	-87.71	0.82
-32.03	-20.78	-9.76
36.37	-43.34	-18.69
25.73	-72.64	-25.04
-27.59	-88.31	-16.42
-12.73	-74.9	-23.29
48.33	19.25	32.79
7.59	37.36	22.82
40.57	44.9	7.31
-40.63	53.3	13.12
29.3	-81.97	19.2
-17.65	-82.71	27.61
10.04	-85.69	14.16
44.01	-64.73	-6.95
-31.27	52.9	-20.41
33.91	52.15	-22.21
-2.24	-6.65	-22.44
25.37	43.38	-24.73
8.79	-68.92	-2.85
28.06	46.94	48.55
-3.8	2.68	57.09
24.2	-59.72	59.77
-48.81	15.3	45.39
-61.63	-9.96	36.51
-31	57.93	17.08
-3.87	-82.69	12.95
33.56	-74.46	19.63
20.6	-85.77	-1.57
47.28	-73.97	-2.87
17.29	-89.1	-16.87
-27.59	-88.31	-16.42
-12.73	-74.9	-23.29
25.73	-72.64	-25.04
-58.77	1.87	-3.55
9.4	24.17	-24.05
9.49	-6.84	-25.91
44.67	5.72	-31.83
39.56	-43.5	-20.95
1.22	54.29	35.97
5.58	28.77	35.83
-19.71	-64.26	46.16
26.19	-59.05	40.73
-10.81	73.31	7.75
-0.06	44.4	4.48
7.53	8.24	4.08
-10.58	3.18	9.17
27.81	7.04	0.6
5.81	-86.34	19.83
1.27	-9.98	16.83
-24.49	-4.73	4.42
29.75	58.78	-4.88
4.1	62.95	-3.82
-24.78	54.86	-9.5
36.13	55.22	-10.23
44.7	35.73	-15.38
-42.92	35.2	-14.33
25.73	-72.64	-25.04
8.79	-68.92	-2.85
-23.25	-76.6	-2.95
66.3	-26.62	-11.52
-65.13	-31.72	-10.7
25.37	43.38	-24.73
29.87	-18.01	-20.74
-37.51	-18.92	-26.58
58.71	15	-9.35
-59.99	-11.83	-29.15

// Fonville L, 2015: Anorexia Nervosa
// Subjects=32
-2.6	-61.88	47.99
-44.97	48.19	2.44
47.12	35.39	21.42
-29.5	12.92	54.29
-34.16	-60.31	-25.38
1.34	28.03	40.4
40.04	-46.19	40.61
39.88	21.37	47.21
-5.76	-61.38	54.68
-29.51	-47.55	29.25

// Fonville L, 2015: Healthy Controls
// Subjects=32
1.72	-73.48	48.91
51.3	-63.4	-31.68
5.62	24.88	40.62
-49.25	23.96	-7.74
55.77	20.01	28.18
1.54	-26.96	45.01
16.04	9	-.55
40.1	-25.78	56.74
-5.76	-61.38	54.68
-29.51	-47.55	29.25

// Phillipou A, 2016: Anorexia Nervosa (AN)
// Subjects=24
14	-84	8
24	-8	54
-24	-10	58
-10	-86	12
-8	8	54
-25	-2	52
-8	8	54
28	-98	-4

// Phillipou A, 2016: Healthy Controls (HC)
// Subjects=25
16	-76	6
-24	-10	56
-26	-10	56
24	-6	60
30	-54	52
-8	-80	8
-10	4	54
28	-10	32
30	-10	34

// Emmorey K, 2016: Subgroup of Deaf, Skilled readers
// Subjects=14
-.71	26.76	51.69
6.71	26.2	43.84
-48.93	14.1	29.88
-27.02	19.67	-37.75
-60.74	-52.42	-3.44
3.44	4.64	26.73
-45.84	39.24	24.39
-.75	22.99	44.2
6.71	26.2	43.84
51.53	10.47	29.03
-41.13	-45.19	47.03
33.68	-55.66	42.59
-38.55	-24.22	-26.13

// Emmorey K, 2016: Subgroup of Deaf, Less-skilled readers
// Subjects=14
3.54	26.53	48.31
-34.3	37.17	-3.44
-49.04	28.3	20.89
58.93	25.06	24.38
-30.99	19.55	2.46
33.11	23.11	1.42
-56.49	-44.99	-4.11
3.54	18.78	44.5
47.97	57.29	1.73
48.29	29.83	31.91
-45.76	32.43	32.77
28.67	44.35	-12.58
-48.87	7.04	34.94
-30.92	9.23	6.67
36.29	22.78	-3.05
-41.15	-40.96	46.68
50.77	-36.89	49.74
-26.85	-17	-30.21

// Kaneko H, 2017: Subgroup of CLBP, His Group
// Subjects=10
64.44	-28.12	24.32
49.46	-24.07	23.03
40.59	23.15	1.33
-36.3	14.32	4.07
42.27	-57.38	47.1
34.22	58.66	20.73
5.86	11.96	66.23
5.62	24.88	40.62
46.29	16.92	44.17
51.42	35.68	24.69
45.23	23.6	48.08
4.56	27.16	42.67
42.69	21.68	-4.15
18.8	-29.63	64
46.51	-55.49	43.54
54.57	-24.23	-7.12
50.49	-22.29	18.41
47.18	33.79	28.24
31.13	53.24	33.49
-45.75	29.18	31.93
42.72	24.14	0.11
24.18	-65.43	54.67
1.3	38.6	39.52
24	18.33	64.38
7.07	-26.1	69.41
2.53	-35.47	31.22
-8.7	49.92	-5.92
-28.98	62.2	3.32
-11.76	21.78	2.05
-50.19	5.52	1.62

// Kaneko H, 2017: Subgroup of CLBP, Non-His Group
// Subjects=11
66.53	-49.48	9.35
51.62	9.13	39.18
53.97	-49.02	44.03
45.48	-64.93	45.46
14.5	-32.11	59.79
1.39	24.14	45.19
0.92	25.86	-15.17
-50.25	38.98	7.74
-47.05	19.11	-1.78
-56.55	11.45	10.12
55.89	-29.31	23.4
48.14	-15.64	-5.54
66.32	-26.45	-9.3
47.6	-54.17	46.77
-42.15	-64.4	46.43
54.57	9.83	6.75
-45.92	5.46	0.46
35.22	23.92	-2.02
16.64	-26.55	62.65
18.13	9.56	-7.31
13.89	22.02	2.85
-4.06	34	35.51
-2.23	49.5	1.84
-.71	12.5	46.19
-5.27	58.94	27.85
-25.72	25.41	-4.79
-29.94	60.05	16.89
-38.16	47.94	53.69
51.38	-31.74	-7.57
-59.7	-40.69	-3.31
-62.95	-25.74	-2.3
67.58	-46.39	7.97
46.14	24.18	27.95
20.37	55.67	24.49
-5.32	65.03	24
46.25	-27.43	21.12
49.47	11.23	39.03
-2.61	-9.24	68.11
-39.12	11.72	53.39
-53.14	3.75	34.14
-10.74	22.42	-3.59
36.81	-79.47	23.36
22.03	-37.01	64.58
16.64	-72.68	44.21
8.18	-65.27	58.19
3.48	30.33	42.42
-51.08	22.71	31.42
0.4	-90.32	10.19
-40.03	-62.44	44.01
-47.76	-29.94	24.64

// Le H, 2018: Deaf Signers
// Subjects=12
-32.98	-45.91	-4.3
-28.49	-19.53	33.58
-7.1	-25.75	33.86
16.37	-53.5	16.96
-20.22	-33.4	-8.84
-3.74	-21.99	54.69
-13.93	88.5	25.47
19.2	82.1	22.28
-16.22	73.65	-1.14
15.92	68.1	6.77
-10.46	-28.54	11.83
-45.72	-12.2	19.78
18.51	-56.74	16.09
-7.19	-26.78	20.56
18.35	-27.65	6.96
12.73	61.74	7.34
-52.39	51.03	12.33
60.69	38.74	-19.17
-7.58	38.38	-3.85
25.49	44.58	-9.21
12.73	61.74	7.34
-7.22	-24.83	18.17
-52.36	52.35	15.56
-23.02	-16.02	51.07
-45.71	-12.12	20.89
-3.97	-44.1	16.4
-4.09	-32.19	5.37
15.76	69.82	-12.33
-4.21	82.98	35.86

// Le H, 2018: Hearing Nonsigners
// Subjects=12
-32.98	-45.91	-4.3
-28.49	-19.53	33.58
-7.1	-25.75	33.86
16.37	-53.5	16.96
-20.22	-33.4	-8.84
-3.74	-21.99	54.69
-13.93	88.5	25.47
19.2	82.1	22.28
-16.22	73.65	-1.14
15.92	68.1	6.77
-10.46	-28.54	11.83
-45.72	-12.2	19.78
18.51	-56.74	16.09
-7.19	-26.78	20.56
18.35	-27.65	6.96
12.73	61.74	7.34
-52.39	51.03	12.33
60.69	38.74	-19.17
-7.58	38.38	-3.85
25.49	44.58	-9.21
12.73	61.74	7.34
-7.22	-24.83	18.17
-52.36	52.35	15.56
-23.02	-16.02	51.07
-45.71	-12.12	20.89
-3.97	-44.1	16.4
-4.09	-32.19	5.37
15.76	69.82	-12.33
-4.21	82.98	35.86
-26.48	-41.67	8.65
21.78	-47.32	27.53
-14.65	-57.29	12.06
19.53	-47.39	13.06
-29.65	-47.94	10.33
-10.46	-28.54	11.83
6.62	-27.46	10.43
15.93	64.93	7.03
-6.47	81.68	19.27
19.2	82.1	22.28
-52.39	52.09	12.24

// Aguirre N, 2019: 2-back: Trained groups < Untrained groups (S2 > S1)
// Aguirre N, 2019: 3-back: Trained groups < Untrained groups (S2 > S1)
// Aguirre N, 2019: 2-back: Trained groups < Untrained groups (S3 > S1)
// Subjects=14
36	-61	44
48	-37	41
48	-43	56
39	53	8
-54	-55	41
-45	-37	62
6	35	41
42	8	59
24	23	53
-15	29	53
9	20	62
0	17	62
-51	17	29
-48	11	47
-42	8	56
-45	14	14
39	-52	38
60	-43	35
54	-40	47
45	8	41
39	17	29
33	53	23
3	32	32
9	23	44

// Akbar N, 2016: Pediatric-onset Multiple Sclerosis
// Subjects=20
28	2	44
-26	-96	-14
28	2	44
38	-86	-14
-4	6	32
12	-56	74
16	16	8
-10	-86	46
-48	-76	24

// Akbar N, 2016: Healthy Controls
// Subjects=16
-20	-96	-12
42	30	28
-48	-76	24

// Bartholdy S, 2019: Healthy Controls (HC)
// Subjects=43
20	42	10
18	39	10
12	33	15
8	44	12

// Bartholdy S, 2019: Developers
// Subjects=43
20	42	10
18	39	10
12	33	15
8	44	12
9	3	15
0	-2	15
16	-4	14
48	-46	32
58	-57	22
54	-64	26
30	20	38
24	15	50
24	26	57

// Bartholdy S, 2019: Recoverers
// Subjects=43
20	42	10
9	3	15
0	-2	15
16	-4	14
48	-46	32
58	-57	22
54	-64	26
30	20	38
24	15	50
24	26	57

// Bartholdy S, 2019: Maintainers
// Subjects=43
20	42	10

// Oliva R, 2019: No-Go: Binge Eaters (BE) > Healthy Controls (HC)
// Oliva R, 2019: No-Go: HC > BE
// Oliva R, 2019: Go: BE > HC
// Oliva R, 2019: Go: HC > BE
// Oliva R, 2019: No-Go food: BE > HC
// Oliva R, 2019: No-Go food: HC > BE
// Oliva R, 2019: No-Go neutral: BE > HC
// Oliva R, 2019: No-Go neutral: HC > BE
// Oliva R, 2019: Stop: BE > HC
// Oliva R, 2019: Stop: HC > BE
// Oliva R, 2019: Go (SST): BE > HC
// Oliva R, 2019: Go (SST): HC > BE
// Oliva R, 2019: Stop food: BE > HC
// Oliva R, 2019: Stop neutral: BE > HC
// Oliva R, 2019: Stop neutral: HC > BE
// Subjects=21
36	-88	-6
19	-91	30
-45	-67	-22
-27	-84	-26
1	-70	50
1	-63	42
43	53	-2
12	7	-2
26	14	-2
36	-88	-6
-45	-67	-22
-34	-84	-38
36	-74	46
29	-67	58
1	-63	42
5	-70	50
43	53	-2
33	56	2
-13	-70	-46
-13	-53	-46
36	-88	-6
-45	-67	-22
-24	-81	-26
5	-70	50
5	-63	42
-13	-70	-46
-13	-39	-38
26	14	-2
12	7	-2
-38	-21	58
36	-88	-6
-34	-84	-38
-45	-67	-22
43	53	2
33	56	2
1	-63	42
5	-67	54
-20	-70	-22
-31	49	26
-48	-39	18
-34	42	22
36	-28	46
29	-25	42
-17	-74	-18
36	-28	46
19	-25	46
36	-11	46
-20	-21	70
-10	-18	54
-31	49	26
-45	42	42
-17	-74	-22
36	-28	46
15	-25	46
22	-25	42

// Skunde M, 2016: Healthy Controls > Bulimia Nervosa: No-go > Go
// Subjects=28
33	-25	38
15	-28	70
33	-28	66
18	11	18
27	17	10

// Cyr M, 2016: Bulimia Nervosa (BN)
// Subjects=27
33	-16	-29
0	-16	-2
-30	-1	-8
-15	26	64
30	32	55
-48	26	10
51	14	34
0	-16	-2
57	20	37
36	-19	-20
-15	26	64
36	-19	-20
0	-13	1
-21	32	55
-54	17	-2
0	-13	1
0	-13	1
-21	32	55
-54	17	-2
0	-13	1

// Cyr M, 2016: Healthy Controls (HC)
// Subjects=27
33	-16	-29
0	-16	-2
-30	-1	-8
-15	26	64
30	32	55
-48	26	10
51	14	34
0	-16	-2
57	20	37
36	-19	-20
-15	26	64
0	-13	1
-21	32	55
-54	17	-2
0	-13	1

// Guleria A, 2017: Diarrhea-predominant irritable bowel syndrome (IBS-D)
// Subjects=10
-60	-46	28
-42	14	1
6	5	64
-33	32	-8
57	-37	1
-54	-25	-2
-24	-61	-23
-24	-88	-23
-39	-52	-23
36	-82	-17
-42	14	4
-57	-27	-8
-24	-61	23
-33	32	-5
6	-52	61
-18	-61	58
-15	-58	7
-39	-49	-23
60	-16	-11
12	-16	52
6	-28	52

// Guleria A, 2017: Constipation-predominant irritable bowel syndrome (IBS-C)
// Subjects=10
-63	-43	31
-42	14	4
6	-13	49
6	-1	64
-60	-28	-11
-42	14	4
-57	-27	-8
-24	-61	23
-33	32	-5
6	-52	61
-18	-61	58
-15	-58	7
-39	-49	-23
60	-16	-11
12	-16	52
6	-28	52

// Guleria A, 2017: Healthy Controls (HC)
// Subjects=10
-60	-34	25
6	4	64
-12	-85	-23
6	-52	61
-18	-61	58
-42	14	4
-57	-27	-8
-24	-61	23
-33	32	-5
6	-52	61
-18	-61	58

// Miyake Y, 2016: Bulimia Nervosa (BN)
// Subjects=15
-10	54	12
-2	50	14
14	48	20
14	42	18
10	44	28
-12	22	18
-14	60	42
-36	32	-14
10	42	54
40	-10	14
-42	-40	16
-64	-42	28
-58	-62	20
16	38	-10
-2	-18	30
-18	-60	52
-22	30	48
32	44	30

// Miyake Y, 2016: Healthy Controls (HC)
// Subjects=20
14	42	18
10	44	28
-12	22	18
-14	60	42

// Ip K I, 2017: Bilingual
// Subjects=14
-32	16	-4
-52	16	30
0	38	38
-8	38	52
-40	-38	8
-36	10	20
-50	12	40
-12	30	44
-54	-44	-8
-12	-8	32

// Ip K I, 2017: Monolingual
// Subjects=11
-42	30	30
54	18	-6
-44	12	40
-54	26	24
38	-4	66
-4	2	68
-52	-28	52
36	-18	70
-54	-40	-14
54	-66	-66
-50	-36	32
-18	-68	-8
22	-54	0
16	-46	-46
-50	-62	-12
-44	-42	16
-14	-66	-66
44	-72	-34
-4	-26	2

// Meng X, 2016: Typical readers
// Subjects=13
-60	-14	2
-48	24	18
64	-12	2
-44	-48	-14
10	-78	-20
-4	26	42
-10	2	16
-44	2	58
56	0	50
56	34	20
-28	-62	-24
36	16	-4
34	-10	-26
-14	-84	10
-26	-66	-50
-24	-64	36
-48	-62	-16
12	-78	-18
-40	0	58
-42	8	34
58	-44	-8
34	-64	58
-26	-72	56
-30	-78	-20

// Meng X, 2016: Impaired readers
// Subjects=12
-56	-10	0
-18	-26	-22
-36	22	-4
-10	-68	-18
-4	22	38
64	-12	2
-20	-80	-2
-34	-60	-46
38	20	10
20	-90	6
-42	-24	-22
52	4	52
42	-22	-24
-12	6	18
-48	-62	-16
12	-78	-18
-40	0	58
-42	8	34
58	-44	-8
34	-64	58
-26	-72	56
-30	-78	-20

// Pierce L J, 2015: International Adoptees
// Subjects=21
-38	28	6
-30	22	-10
-54	8	-14
-44	-50	26
-60	-18	-16
-40	-44	52
-18	-54	26
40	-8	48
56	6	-2
52	-36	-2
34	-46	48
12	-66	36
-4	16	50
-38	-46	46
-8	-54	22
-6	-54	16
34	20	0
4	18	-8
28	4	56
-48	46	-4
-38	28	6
-40	-44	52
52	-36	-4
62	-38	-4
34	-46	48
-62	-16	-16
-44	-50	32
-18	-56	26
-8	-84	-2
40	-10	42
56	6	-2
12	-68	34
46	-62	52
-4	16	50
-38	-46	46
32	20	6
28	4	56
34	20	0
28	4	56
4	18	-8
-6	14	-10
-8	-54	22
-2	14	50
-34	20	2
-46	14	-8
-60	-18	8
-50	-54	52
36	58	16
66	-20	8
50	-50	50
-32	22	4
-60	-16	8
-34	-50	40
4	20	50
46	30	34
32	22	6
46	6	-8
66	-22	10
62	-34	-14
40	-50	46
-32	54	16
-32	22	2
-40	26	30
-30	2	56
-2	14	22
-58	-22	2
-62	-30	-16
-34	-50	40
-28	-60	-32
30	10	58
32	22	6
4	16	22
4	-6	18
64	-22	8
42	-50	44
28	-62	-28
-34	-50	42
38	32	36
36	30	30
16	4	0
18	-4	22
40	-46	48
-2	22	50
-18	0	22
-32	-48	36
-44	-56	54
-40	-60	60
-54	-60	-28
32	0	70
34	28	28
36	28	0
36	58	16
60	-20	-10
44	-52	48
38	30	34
36	6	38
12	-4	16
44	-46	50

// Pierce L J, 2015: Bilinguals
// Subjects=12
-38	28	6
-30	22	-10
-54	8	-14
-44	-50	26
-60	-18	-16
-40	-44	52
-18	-54	26
40	-8	48
56	6	-2
52	-36	-2
34	-46	48
12	-66	36
-4	16	50
-38	-46	46
-8	-54	22
-6	-54	16
34	20	0
4	18	-8
28	4	56
-38	28	6
-30	22	-10
40	22	14
50	22	30
52	-36	-2
46	-42	14
-44	-50	26
-18	-54	26
56	8	-2
48	-6	2
12	-66	36
46	-62	52
-4	16	50
-38	-46	46
32	20	6
28	4	56
34	20	0
28	4	56
4	18	-8
-6	14	-10
-8	-54	22
-62	-28	10
62	-12	2
24	-40	20
-62	-26	10
8	20	50
34	22	8
62	-12	4
-2	16	54
-32	22	4
-28	4	58
-12	18	38
-64	-28	8
-34	-48	40
-26	-64	-30
34	58	12
48	32	34
28	14	60
34	22	6
62	-24	4
56	-30	-10
38	-50	46
28	16	48
30	8	56
38	-42	48
-2	22	50
-18	0	22
-32	-48	36
-44	-56	54
-40	-60	60
-54	-60	-28
32	0	70
34	28	28
36	28	0
36	58	16
60	-20	-10
44	-52	48
38	30	34
36	6	38
12	-4	16
44	-46	50

// Pierce L J, 2015: Monolinguals
// Subjects=10
-38	28	6
-30	22	-10
-54	8	-14
-44	-50	26
-60	-18	-16
-40	-44	52
-18	-54	26
40	-8	48
56	6	-2
52	-36	-2
34	-46	48
12	-66	36
-4	16	50
-38	-46	46
-8	-54	22
-6	-54	16
34	20	0
4	18	-8
28	4	56
-38	28	6
-30	22	-10
40	22	14
50	22	30
52	-36	-2
46	-42	14
-48	46	-4
-38	28	6
-40	-44	52
52	-36	-4
62	-38	-4
34	-46	48
-44	-50	26
-18	-54	26
56	8	-2
48	-6	2
12	-66	36
-62	-16	-16
-44	-50	32
-18	-56	26
-8	-84	-2
40	-10	42
56	6	-2
12	-68	34
-4	16	50
-38	-46	46
32	20	6
28	4	56
34	20	0
28	4	56
4	18	-8
-6	14	-10
-8	-54	22
-6	10	60
-36	28	6
-42	22	30
-54	16	24
-44	6	-16
-60	-30	10
0	18	52
4	38	36
50	22	30
34	22	4
56	-16	4
42	-50	52
-32	22	2
-60	-30	10
2	18	52
32	24	-2
60	-12	2
48	-40	12
52	-36	-2
42	-50	52
-2	18	50
-32	22	2
-42	22	30
-44	6	-14
-62	-30	10
-40	-44	50
48	32	36
32	22	0
54	-36	-2
38	-50	46

// Dong D, 2017: Conduct Disorder (CD)
// Subjects=30
-9	0	42
-40	-30	18
-27	-21	51
-57	-6	0

// Dong D, 2017: Healthy Controls (HC)
// Subjects=36
12	-39	30
36	-33	18
6	-60	42
42	-63	39
-33	-60	39
39	-54	27
30	15	54
27	30	51
-24	54	9
60	-3	30
54	-30	-24
60	-45	-9
42	-45	18

// Fehlbaum L V, 2018: Main Effect of Group, Healthy Controls (HC) > Conduct 
// Disorder (CD)
// Fehlbaum L V, 2018: Main Effect of Group, CD > HC
// Fehlbaum L V, 2018: Main Effect of Task, Incongruent (IC) > Congruent (C)
// Fehlbaum L V, 2018: Main Effect of Task, IC > Blank screen (B)
// Fehlbaum L V, 2018: Main Effect of Task, B > IC
// Fehlbaum L V, 2018: Main Effect of Task, C > B
// Fehlbaum L V, 2018: Main Effect of Task, B > C
// Subjects=39
40	-10	20
-62	-2	26
50	-18	-4
16	-16	-2
-30	-82	26
-30	12	22
-32	-44	-26
48	34	28
32	-54	8
4	26	44
4	-2	32
-28	-24	30
54	-34	18
-46	-82	-8
42	-52	-14
-18	14	62
4	-82	0
34	-86	0
-46	-36	58
42	-40	52
-24	0	-8
-54	8	38
26	6	-8
-2	-34	44
-40	-84	28
36	-16	44
42	-80	30
-28	-36	-18
-44	-38	-38
32	-88	-88
-38	-90	-90
44	-40	-40
-18	0	0
6	-38	50
36	-20	56
-44	-82	22
64	-52	6
28	-44	-12
36	-12	6

// Klapwijk E T, 2016: Autism Spectrum Disorders (ASD)
// Subjects=23
22	-10	-26
34	-22	62
-6	-14	44
-14	-72	12
48	-10	-10
10	44	-2
28	-24	-18
-24	-18	-22
-20	-4	-18
28	-30	58
30	-92	12
-18	-88	0
-16	2	22
58	-8	-18
32	-16	-22
48	-68	20
-4	64	10
2	-46	24
22	-10	-26
38	-22	52
-4	-12	44
-12	-86	44
4	32	20
46	-22	-14
66	-42	28
12	44	-2
-22	-46	0
-20	-4	-18
26	-34	-8
-48	-52	54
56	-8	-18
-4	64	10
52	-54	14

// Klapwijk E T, 2016: Conduct Disorder & Callous-Unemotional traits (CD/CU+)
// Subjects=23
4	-74	-8
14	-24	10
-14	-72	12
48	-10	-10
10	44	-2
28	-92	12
-30	-92	4
-36	22	4
-4	-24	-14
-20	-8	-14
-2	16	44
-48	-52	54
30	-92	12
-18	-88	0
-16	2	22
58	-8	-18
32	-16	-22
48	-68	20
-4	64	10
2	-46	24
-14	-74	10
46	-22	-14
66	-42	28
12	44	-2
40	-80	0
-30	-92	4
-42	14	24
-48	-52	54
-48	-52	54
56	-8	-18
-4	64	10
52	-54	14

// Klapwijk E T, 2016: Healthy Controls (HC)
// Subjects=33
22	-10	-26
34	-22	62
-6	-14	44
4	-74	-8
14	-24	10
28	-24	-18
-24	-18	-22
-20	-4	-18
28	-30	58
28	-92	12
-30	-92	4
-36	22	4
-4	-24	-14
-20	-8	-14
-2	16	44
-48	-52	54
22	-10	-26
38	-22	52
-4	-12	44
-12	-86	44
4	32	20
-14	-74	10
-22	-46	0
-20	-4	-18
26	-34	-8
40	-80	0
-30	-92	4
-42	14	24
-48	-52	54

// Klapwijk E T, 2016: Happiness > Anger & Disappointment, Healthy Controls 
// (HC) > Conduct Disorder (CD)
// Klapwijk E T, 2016: Happiness > Anger, HC > CD
// Klapwijk E T, 2016: Happiness > Disappointment, HC > CD
// Subjects=32
58	-38	50
-2	-32	66
-40	-56	60
-40	-56	60
38	22	52
38	-38	52
56	-36	48

// Michalska K J, 2016: Harm > No Harm (Inverse Quadratic relationship with 
// Conduct Disorder (CD) Symptoms)
// Michalska K J, 2016: Harm > No Harm (Inverse Quadratic relationship with 
// Callousness)
// Michalska K J, 2016: Intentional > Unintentional Harm (Inverse Linear 
// relationship with CD Symptoms)
// Michalska K J, 2016: Intentional > Unintentional Harm (Inverse Quadratic 
// relationship with CD Symptoms)
// Michalska K J, 2016: Pain > No Pain
// Michalska K J, 2016: Intentional Pain > Unintentional Pain, p<0.05 
// corrected
// Michalska K J, 2016: Intentional Pain > Unintentional Pain, p<0.001 
// uncorrected
// Michalska K J, 2016: Pain > No Pain (Inverse Linear relationship with CD 
// Symptoms)
// Michalska K J, 2016: Pain > No Pain (Inverse Quadratic relationship with CD 
// Symptoms)
// Michalska K J, 2016: Pain > No Pain (Inverse Quadratic relationship with 
// Callousness)
// Michalska K J, 2016: Intentional Pain > Unintentional Pain (Inverse 
// Quadratic relationship with CD Symptoms)
// Michalska K J, 2016: Intentional Pain > Unintentional Pain (Inverse Linear 
// relationship with Callousness)
// Michalska K J, 2016: Pain > No Pain (Positive Linear relationship with 
// Reactive Aggression)
// Michalska K J, 2016: Intentional Pain > Unintentional Pain (Negative Linear 
// relationship with Reactive Aggression)
// Subjects=107
26	-20	16
28	-10	10
34	-18	10
28	-22	14
38	26	-8
-26	16	-18
-34	20	8
-8	48	8
-8	20	30
-6	-30	-10
22	-6	-16
-20	-8	-16
54	-40	22
-54	-32	26
12	4	12
38	6	12
-36	-4	18
22	-6	-10
-22	-8	-16
34	6	-20
2	24	24
-2	40	4
-56	-18	18
2	56	32
6	18	6
-12	22	10
-12	18	14
-26	-16	18
30	-36	-4
-10	54	-8
-6	40	46
36	-14	8
36	-6	11
-28	-32	20
-12	52	-14
10	0	58
-6	-12	48
4	-30	-14
-2	-30	-16
-36	0	10
36	-16	10
0	-28	-22

// Kreczmanski P, 2019: Migraine with Aura
// Subjects=8
-20	-62	-2
20	-62	-2
-24	-26	-4
-26	-30	-2
-24	-46	-18
-22	-40	-18
-4	-84	-46
-54	-22	-24
10	-20	-6
-2	-62	-46
38	-44	2
-8	-92	0
8	-92	0
-26	-28	-4
-26	-28	-22
24	-26	-2
-2	-36	-28
2	-36	-28
10	-52	-30
-32	58	-2

// Kreczmanski P, 2019: Migraine without Aura
// Subjects=8
-12	-92	-6
12	-92	-6
14	-86	-16
26	-72	-14
-18	-48	-48
10	-20	-6
-2	-62	-46
38	-44	2
-30	-62	-18
8	-96	-4
4	-36	-30
-4	-36	-30
34	-80	-26
40	-68	-8
-2	-36	-28
2	-36	-28
10	-52	-30
-32	58	-2

// Russo A, 2017: Migraine without aura with cutaneous allodynia (MwoA CA+)
// Subjects=20
-5.37	44.71	8.97
-41.77	53.67	4.18
-54.14	-26.29	31.1

// Russo A, 2017: Migraine without aura with cutaneous allodynia (MwoA CA-)
// Subjects=20
42.09	-29.51	35.84

// Russo A, 2017: Healthy Controls (HC)
// Subjects=20
-5.37	44.71	8.97
-41.77	53.67	4.18
-54.14	-26.29	31.1
42.09	-29.51	35.84

// Russo A, 2019: Migraine with Aura (MwA) > Migraine without Aura (MwoA), 51 
// C
// Russo A, 2019: MwA > Healthy Controls, 51 C
// Subjects=17
-8.98	53.61	-40.8
1.45	-94.97	5
-46.44	-53.59	48.91
-37.19	11.8	26.6
-5.18	44.48	33.52

// Schwenck C, 2017: Conduct Problems
// Subjects=19
-4	34	-14
-20	-82	-4
8	12	-6
-8	12	-6
10	52	-2
-22	-16	-20
-26	26	-10
48	-72	24
0	10	-8
54	34	8
54	-42	24

// Schwenck C, 2017: Healthy Controls
// Subjects=24
8	12	-4
-12	10	-8
20	56	24
64	-44	20
-22	-12	-18
10	52	-2
-22	-16	-20
-26	26	-10
48	-72	24
54	-46	22
44	16	26
-36	46	14
-8	12	48
-10	26	30
54	34	8
54	-42	24

// Szab E, 2019: Migraine
// Subjects=41
39	32	32
27	59	2
48	35	26
45	47	11
39	50	-4
51	-16	32
57	-16	41
57	-13	29
51	-1	23
48	-4	29
57	-10	21
60	-13	17
45	-25	53
42	-37	50
12	11	-1
12	20	-4
9	14	8
24	5	5
30	11	-1
42	-58	32
45	-28	50
54	-16	44
-36	-79	13
-24	-85	-13
39	-85	-1
-39	-61	-16
-33	-88	2
-27	-91	5
45	-61	-16
-27	-91	-4
-33	-88	8
-42	-79	-1
-30	-85	20
-30	-64	-13
30	-76	-16
21	-82	-13
36	-85	14
24	-94	8
21	-4	-13
30	17	-22
45	23	23
48	8	32
51	35	11
42	32	-10
51	-1	20
42	2	56
-21	-4	-16
-33	-19	-10
-21	-25	-7
30	-88	8
27	-91	11
42	-70	-10
36	-49	-16
45	-55	-13
39	-37	-19
27	-64	35
30	-67	29
-30	-82	8
-27	-88	5
-39	-85	-1
-42	-67	-10
-33	-55	-13
-33	-61	-10
-39	-61	-10
-42	-55	-16
-21	-85	-10
-24	-67	32
-21	-64	38
27	-4	-16
33	-16	-13
-33	-88	8
-27	-88	17
-33	-85	14
-24	-70	-10
-18	-79	-13
-12	-94	17
-42	-79	-4
3	-85	-1
36	-79	11
21	-73	-13
30	-82	17
9	-85	-10
12	-91	17
45	-55	-16
39	-64	-13
45	-67	-10
51	32	8
39	32	-1
48	11	29
45	29	2
54	29	2
54	8	44
45	2	47
42	5	56
51	11	-25
24	-1	-19
24	-16	-13
42	-10	-25
51	-13	-13
51	-4	-19
39	32	32
30	59	2
48	32	29
45	47	11
39	50	-4
51	-16	32
57	-16	29
57	-16	41
51	-1	23
57	-10	20
60	-13	17
12	11	-1
12	20	-4
9	14	8
24	5	5
30	11	-1
21	11	-1
42	-58	32

// Szab E, 2019: Healthy Controls
// Subjects=49
39	32	32
27	59	2
48	35	26
45	47	11
39	50	-4
-36	-79	13
-24	-85	-13
39	-85	-1
-39	-61	-16
-33	-88	2
-27	-91	5
45	-61	-16
-27	-91	-4
-33	-88	8
-42	-79	-1
-30	-85	20
-30	-64	-13
30	-76	-16
21	-82	-13
36	-85	14
24	-94	8
21	-4	-13
30	17	-22
45	23	23
48	8	32
51	35	11
42	32	-10
51	-1	20
42	2	56
-21	-4	-16
-33	-19	-10
-21	-25	-7
-33	-88	8
-27	-88	17
-33	-85	14
-24	-70	-10
-18	-79	-13
-12	-94	17
-42	-79	-4
3	-85	-1
36	-79	11
21	-73	-13
30	-82	17
9	-85	-10
12	-91	17
45	-55	-16
39	-64	-13
45	-67	-10
51	32	8
39	32	-1
48	11	29
45	29	2
54	29	2
54	8	44
45	2	47
42	5	56
51	11	-25
24	-1	-19
24	-16	-13
42	-10	-25
51	-13	-13
51	-4	-19
39	32	32
30	59	2
48	32	29
45	47	11
39	50	-4

// Ware A L, 2015: Go: Healthy Controls (HC) > Fetal Alcohol Syndrome (FAS) & 
// ADHD
// Ware A L, 2015: Go > Stop: FAS & ADHD > HC
// Ware A L, 2015: Medium: FAS & ADHD > HC
// Ware A L, 2015: Hard: FAS & ADHD > HC
// Ware A L, 2015: Hard > Easy: FAS & ADHD > HC
// Ware A L, 2015: Go > Control: HC
// Ware A L, 2015: Go < Control: HC
// Ware A L, 2015: Go > Stop: HC
// Ware A L, 2015: Go < Stop: HC
// Ware A L, 2015: Easy > Control: HC
// Ware A L, 2015: Easy < Control: HC
// Ware A L, 2015: Medium < Control: HC
// Ware A L, 2015: Hard > Control: HC
// Ware A L, 2015: Hard < Control: HC
// Ware A L, 2015: Hard < Easy: HC
// Ware A L, 2015: Go < Control: FAS & ADHD
// Ware A L, 2015: Go > Stop: FAS & ADHD
// Ware A L, 2015: Medium: FAS & ADHD
// Ware A L, 2015: Hard: FAS & ADHD
// Ware A L, 2015: Hard > Easy: FAS & ADHD
// Subjects=7
53.61	1.24	30.68
-46.81	-8.01	32.83
-48.81	-9.9	36.13
53.44	-2.82	34.59
-28.72	-6.6	-4.19
-6.21	4.81	50.47
14.28	-10.15	39.67
-36.92	-1.9	-12.96
54.31	2.38	-30.43
-43.26	-15.77	46.37
58.02	-12.64	29.67
-7.41	2.86	45.96
-25.91	-1.2	29.56
-13.4	-7.18	13.08
1.78	1.72	31.79
12.15	26.12	56.05
-.72	12.33	43.98
7.91	-83.42	16.22
-44.76	-13.99	46.13
-.19	4.76	54.86
-57.56	-13.96	7.8
-25.42	-5.27	8.49
63.56	-32.51	18.56
55.45	-11.89	0.98
53.42	0.06	33.23
-2.65	-90.42	2.21
38.08	-53.91	46.85
55.38	-35.59	-4.06
49.98	-11.99	40.19
52.39	-6.01	36.09
-32.12	-17.29	7.79
-22.5	-86.52	21.51
-45.69	-8.72	11.13
41.37	-46.96	45.68
4.56	31.41	30.16
52.7	-33.43	-3.43
2.36	-22.07	28.31
42.48	8.38	31.77
34.25	52.34	7.77
41.78	40.32	23.63
-28.54	-81.57	-39.28
-30.42	-54.59	47.03
-50.09	-10.79	35.66
-7.1	-56.8	20.4
51.57	-6.8	41.08
16.75	-52.89	10.99
-2.21	30.06	38.05
-10.73	-19.8	64.4
-22.79	-15.84	-15.53
-49.96	-9.84	39.71
-54.91	-7.37	7.44
49.65	-5.38	41.76
-.6	0.68	55.77
-26.96	-9.38	0.93
57.51	-7.74	6.29
41.08	-61.56	44
-44.32	-12.82	48.93
-20.14	-86.41	22.7
-2.35	-69.83	22.11
21.89	-63.07	22.05
4.5	27.67	34.04
42.76	22.48	4.82
33.2	52.52	10.22
1.75	0.11	-28.97
5.14	-27.7	39.24
18.06	33.05	35
16.12	-3.34	4.95
50.51	26.64	0.14
54.65	-40.9	10
19.94	-8.55	12.93
61.24	-26.69	25.24
1.96	-25.33	57.7
-14.26	-37.92	69.76
-49.36	-18.12	44.08

// Zhang J, 2015: Healthy Controls > Conduct Disorder, Stop > Rest
// Subjects=29
50	18	-14
62	-18	-12
18	8	6
40	48	2
54	-72	2
58	-36	20
36	-64	-30
6	34	18
6	-18	12
-62	-42	30
-38	-4	54
-46	22	8
-22	-72	-24
-66	-24	-12
-20	2	14
-52	-52	-18
-2	6	62
-30	-94	16

// Lemire-Rodger S, 2019: Working memory > Control
// Lemire-Rodger S, 2019: Inhibtion > Control
// Lemire-Rodger S, 2019: Task switching > Control
// Lemire-Rodger S, 2019: Working memory + Inhibition + Task switching > 
// Control, Univariate Contrast
// Lemire-Rodger S, 2019: Working memory + Inhibition + Task switching > 
// Control, Conjunction Analysis
// Lemire-Rodger S, 2019: Task switching > Control + Inhibition + Working 
// Memory
// Lemire-Rodger S, 2019: Task switching < Control + Inhibition + Working 
// Memory
// Lemire-Rodger S, 2019: Inhibition > Control + Task switching + Working 
// Memory
// Lemire-Rodger S, 2019: Inhibition < Control + Task switching + Working 
// Memory
// Subjects=22
33	3	54
33	3	54
-48	3	45
18	3	21
36	36	30
30	45	9
-30	21	3
-36	57	15
-12	0	3
51	-39	45
51	-39	45
-42	-48	51
57	-54	9
-33	-66	-27
39	-60	-30
51	12	24
33	0	42
9	24	45
-24	-63	48
57	-42	27
30	-57	33
45	-54	-9
-42	-69	-12
9	-87	3
21	-75	-6
36	51	0
-3	-33	45
-3	-33	45
3	18	48
-33	0	45
-42	30	33
-30	0	60
-41	44	17
28	9	51
-48	15	0
9	-66	45
9	-66	45
36	-69	45
-45	-42	48
9	-12	15
-51	-39	-9
-51	-39	-9
63	-42	-3
33	6	51
33	6	51
42	27	33
33	57	6
-36	57	12
-39	27	36
6	24	45
21	18	0
21	18	0
-30	24	3
9	-69	51
9	-69	51
39	-48	45
-36	-60	45
60	-48	-6
-27	-72	-24
6	-48	-18
39	-57	-26
40	23	3
47	12	24
34	52	10
37	-57	49
58	-48	-9
-36	-72	45
-3	-69	42
0	-30	36
3	6	54
-24	0	63
36	-72	42
9	-87	6
9	-78	15
21	-24	-12
-42	42	18
66	-42	-3
48	30	3
-3	51	12
-39	33	-3
18	24	45
42	42	-6
-39	24	-9
-6	42	51
51	21	12
-30	-9	57
-3	0	51
-57	6	27
-15	-27	6
24	-51	-18
18	6	0
-18	-75	-12
30	-6	54
-15	-57	15
12	-93	15
9	36	0
30	-51	6
42	-33	18
-33	-15	-3
18	-12	12
51	-33	51
36	-42	36

// Dominguez J F, 2017: Healthy Controls (HC): Alternate > Baseline, Avg 
// across all time points
// Dominguez J F, 2017: Pre-Huntington's Disease (Pre-HD): Alternate > 
// Baseline, Avg across all time points
// Dominguez J F, 2017: Symptomatic Huntington's Disease (Symp-HD): Alternate 
// > Baseline, Avg across all time points
// Dominguez J F, 2017: HC: Alternate < Baseline, Avg across all time points
// Dominguez J F, 2017: Pre-HD: Alternate < Baseline, Avg across all time 
// points
// Dominguez J F, 2017: Symp-HD: Alternate < Baseline, Avg across all time 
// points
// Dominguez J F, 2017: HC > Symp-HD: Alternate > Baseline (longitudinal)
// Subjects=16
-30	24	8
32	26	2
-24	-2	62
26	8	54
-46	14	36
40	36	34
-42	28	20
48	20	4
-44	6	26
54	14	6
-42	2	36
36	-2	62
-60	-40	14
48	-26	-2
46	-30	-4
-48	-60	-2
58	-50	-4
-46	-38	-18
-44	-60	-6
52	-58	-14
-46	-34	46
48	-32	52
-38	-42	44
44	-40	56
-46	-38	40
50	-34	52
-36	-44	38
52	-42	44
-40	-52	48
50	-50	50
-24	-68	54
18	-68	52
-42	-76	-14
42	-74	14
-4	6	60
4	8	60
-10	14	50
4	16	52
-6	18	30
10	14	32
-8	-68	56
10	-66	52
-18	-76	32
-28	30	0
32	28	0
-4	-76	-14
10	-64	-10
-40	-36	-22
-34	-62	-18
32	-60	-18
-32	-66	-16
32	-64	-18
-30	20	10
38	22	6
-46	8	4
46	10	0
-60	-38	24
62	-34	28
-56	-38	14
56	-36	22
-32	-90	20
-14	-24	16
14	-14	0
-18	2	22
18	-4	22
-24	-10	6
22	-2	6
-18	-6	2
14	2	0
-30	24	6
32	26	2
-4	12	54
28	4	58
-46	14	36
34	42	32
-38	30	18
48	20	4
-44	6	26
48	12	16
-42	8	30
36	-2	62
-54	-42	8
46	-34	6
-52	-58	-6
58	-50	-4
-48	-62	-12
48	-50	-8
-46	-38	50
48	-32	52
-40	-44	46
34	-44	46
-42	-40	40
46	-34	46
-40	-42	42
44	-38	48
-40	-52	48
40	-52	52
-24	-68	54
30	-70	44
-42	-68	-14
40	-78	8
-12	-76	14
12	-70	10
-4	8	58
8	8	54
-4	12	54
2	14	54
-8	18	28
8	28	24
-8	-68	48
10	-66	52
-30	26	-2
32	28	0
-6	-72	-12
10	-68	-12
-38	-44	-26
-38	-58	-22
32	-62	-18
-34	-64	-18
34	-68	-20
-36	16	10
32	20	12
-48	6	6
46	10	0
-48	-40	24
62	-34	24
-50	-40	20
0	-76	12
4	-78	12
-14	-94	-4
34	-90	2
-16	-16	14
14	-6	12
-18	4	18
18	0	22
-24	6	10
24	-4	10
-20	-8	4
16	-2	4
-30	24	8
32	26	2
-4	12	54
28	4	60
-46	14	36
44	32	36
48	20	4
-56	10	14
50	18	0
-44	4	34
50	6	22
-52	-58	-4
58	-52	-6
-42	-60	-6
44	-54	-6
-34	-38	40
52	-28	50
-40	-44	46
28	-54	48
-42	-40	40
52	-34	50
-38	-48	44
52	-42	44
-46	-52	48
36	-54	50
-32	-66	52
12	-70	56
-40	-82	2
48	-70	-6
-10	-64	6
12	-72	10
-4	8	58
6	8	54
-4	8	56
6	12	52
-4	8	28
8	22	28
-6	-68	56
10	-68	56
-30	28	2
34	28	0
-10	-62	4
10	-68	-12
-36	-58	-22
34	-58	-20
-24	-88	-8
38	-62	-18
-32	24	8
46	20	0
-38	8	12
46	10	0
0	-84	10
4	-72	16
-22	-94	-10
-10	-16	10
10	-18	10
-20	2	6
24	12	8
-18	2	6
18	-2	4
-36	-16	18
36	-18	18
-14	38	48
6	56	20
-16	40	48
24	36	48
-48	32	-2
0	-30	68
2	-32	66
-48	8	-28
44	12	-26
-54	-6	-8
58	-4	-14
-58	-8	-10
56	-12	-10
-60	-6	-18
58	-4	-16
-60	-10	-20
56	-12	-12
44	-16	-28
0	-34	66
2	-34	66
22	-42	68
-48	-54	24
58	-54	22
-44	-66	34
52	-66	32
-12	-62	10
-8	-8	48
10	-10	46
-8	30	-8
2	30	-4
-4	58	0
8	38	-6
-2	40	-2
6	34	-4
-6	-52	18
8	-52	30
-6	-52	16
8	-54	18
-2	-88	32
4	-88	34
-36	32	-14
14	24	-14
-20	-18	-22
20	-16	-22
-30	-36	-12
26	-32	-14
-16	-42	-6
12	-88	-6
-30	-36	-16
40	-14	-24
-26	-46	-10
22	-78	-8
-36	-14	22
36	-16	20
-34	-26	22
36	-20	20
-50	-4	-8
48	0	-6
-52	-16	2
36	-26	16
-40	-32	6
40	-30	16
-20	-62	18
-10	-92	32
14	-98	18
-12	-34	6
22	-34	2
-14	20	-6
10	18	2
-14	6	-8
14	10	-6
-16	4	-6
24	-2	-4
-30	-34	-10
30	-18	-12
-24	-8	-18
28	-10	-14
-12	16	-8
12	10	-6
-34	-16	16
36	-16	18
-4	56	18
6	56	20
-16	52	38
-4	-24	66
2	-32	66
-50	8	-24
52	8	-28
-56	-8	-10
58	-4	-14
-58	-8	-10
56	-8	-12
-62	-6	-18
58	-6	-16
-60	-10	-20
58	-8	-14
44	-16	-28
0	-34	66
16	-38	68
-24	-42	66
20	-44	70
-38	-58	28
52	-58	30
-50	-66	38
52	-66	32
56	-66	14
-8	-10	50
10	-10	46
-8	30	-8
4	26	-6
-4	58	0
8	38	-6
-4	38	-2
2	34	-2
-4	-52	28
8	-52	24
-4	-56	30
2	-54	28
0	-86	36
4	-86	36
-36	32	-14
18	26	-16
-18	-16	-22
22	-22	-20
-30	-30	-16
24	-30	-16
-30	-42	-8
26	-38	-10
-30	-32	-20
40	-12	-28
-30	-44	-10
28	-44	-12
-36	-16	20
36	-14	20
-34	-24	20
38	-20	22
-56	-6	2
60	2	4
-36	-24	10
50	-20	12
-60	-14	4
52	-22	12
-12	-102	12
8	-88	34
-12	-34	6
22	-34	2
-10	20	-2
12	22	-4
-14	12	-8
14	10	-8
-24	-8	-6
-24	-18	-16
28	-20	-12
-24	-10	-16
16	-4	-16
-12	16	-8
12	8	-8
-34	-16	18
36	-16	18
-10	38	54
4	56	24
-18	60	22
-8	-28	48
-54	4	-24
48	6	-26
-60	-8	-6
58	-4	-14
-60	-10	-6
56	-10	-12
-62	-6	-18
58	-6	-16
-60	-10	-20
56	-8	-16
44	-20	-22
-48	-60	30
-50	-66	38
22	-84	44
-6	28	-8
4	26	-6
-4	58	0
2	46	-8
-2	38	-4
2	34	-2
-4	-50	34
8	-48	36
-8	-54	16
8	-48	38
0	-88	34
8	-86	38
-20	10	-16
20	14	-16
-20	-20	-22
20	-20	-20
-30	-36	-14
28	-32	-18
-28	-42	-8
-30	-36	-16
42	-20	-22
-30	-44	-10
-44	-20	22
38	-18	20
-48	-26	18
38	-34	22
-58	-6	2
-54	-16	8
-60	-12	2
-10	-92	32
10	-90	32
-12	-34	6
10	-30	6
-14	20	-6
-18	16	-10
14	8	-8
-18	-4	-8
-28	-36	-8
28	-16	-12
-18	-4	-12
30	-6	-22
-12	16	-8
12	10	-6
-48	-70	-10
-6	-68	16
10	-64	14
-8	54	4
12	54	10
-2	30	18
12	34	18
-8	-40	46
10	-66	40
-32	-40	-10
-22	-46	-6
-32	-54	-16
50	-10	10
52	-14	8
-10	-30	12
8	14	8
10	6	16
24	6	8
30	-2	10
-24	-28	-12

// Kano M, 2017: Healthy Controls (HC)
// Subjects=29
15	-39	-14
6	-32	48
14	-42	42
3	5	27
11	-32	3
-6	-41	30
9	-44	6
-9	11	32
-18	-18	18
-29	-29	-17
-3	-3	-8
12	12	9
-9	-9	17
33	-53	-33
-12	-51	41
-6	-42	32
17	-42	41
-41	-66	-44
5	-45	32
17	-59	26
-6	-54	32
-8	-60	44
-45	12	-12
-33	18	6
-50	9	12
-44	3	-9
-15	2	0
45	15	-11
35	38	27
51	26	24
39	2	-17
5	-20	30

// Kano M, 2017: Irritable Bowel Syndrome (IBS)
// Subjects=26
15	-39	-14
6	-32	48
14	-42	42
3	5	27
11	-32	3
-6	-41	30
9	-44	6
-9	11	32
-18	-18	18
-29	-29	-17
-3	-3	-8
12	12	9
-9	-9	17
-56	5	-3
-44	-17	18
-32	-15	15
-56	-3	13
-56	-17	0
-20	-24	14
-18	-86	18
-32	-77	-8
9	-72	1
-23	-54	-2
-24	-68	-17
-9	-86	27
6	-21	74
-44	-47	59
-35	-56	59
-36	-66	44
5	-45	32
17	-59	26
-6	-54	32
-8	-60	44
15	54	4
-27	42	42
-27	20	60
17	41	36
-41	-36	62
-42	-57	56
-59	20	23
-44	-12	59
62	-11	-3
56	-53	12
62	3	-9
48	-56	30
39	-81	-2
6	-42	32
20	-56	26
-2	-74	41
-8	-17	56
-12	-74	35
-6	-20	33

// Labuschagne I, 2018: Huntington's Disease (HD)
// Subjects=9
-38	10	48
-18	58	4
-10	28	40
-22	-20	6
-28	-2	8
-50	48	-2
-36	60	0

// Miro-Padilla A, 2019: Trained Group (S1>S2) >Control Group (S1>S2), 2-back
// Miro-Padilla A, 2019: Trained Group (S1>S3) > Control Group (S1>S3), 2-back
// Miro-Padilla A, 2019: Trained Group (S1>S2) > Control Group (S1>S2), 3-back
// Miro-Padilla A, 2019: Trained Group (S1>S3) > Control Group (S1>S3), 3-back
// Subjects=25
-24	-1	59
42	53	8
51	-49	47
0	14	53
-42	26	29
3	44	44
54	-40	44
24	26	59
-54	2	38
36	-70	50
6	29	41
-36	53	11
30	2	53
-39	-55	47
48	-43	44
-66	-43	2
6	29	38
-33	17	-7
36	11	-1
48	5	29
-39	8	29
36	-52	47
-33	1	53

// Schmid J, 2015: IBS
// Subjects=17
22	20	2
22	-66	-24
-40	6	-10
68	-12	20
4	-44	10
46	-54	60
-34	-76	50
46	-54	60
-36	-16	-12
-10	-48	32
5	-50	32
4	-48	10
66	-12	18
-38	-16	-4
-42	-10	4
-46	-64	38
-42	-60	48
4	-46	10
26	-30	-12
4	-44	10
34	12	-24
-8	34	58
22	-66	-24

// Schmid J, 2015: IBS Control
// Subjects=17
8	-72	-34
-8	-74	-32
0	-40	-40
-16	-40	-42
30	-8	-26
36	-20	-10
24	-24	-12
12	-58	-32
-20	-62	-30
-38	-18	12
-34	-16	10
-40	14	-8
-62	-46	22
26	2	-14
8	-50	32
-18	0	10
6	-10	18
14	-30	10
-14	-6	6
-38	-16	10
-64	-38	22
8	-8	16
2	-48	10
44	-22	42
4	-48	2
4	-46	10
44	-22	42
52	-8	28
-42	-34	64
-50	-12	24
46	-54	60
-34	-76	50
46	-54	60
-36	-16	-12
-10	-48	32
5	-50	32
4	-48	10
66	-12	18

// Schmid J, 2015: Ulcerative Colitis (UC)
// Subjects=15
-18	38	54
14	36	60
-52	24	14
56	26	18
-18	38	54
-52	24	14
-44	0	46
32	-28	48
-62	-18	40
-62	-18	40
-58	4	14
4	-46	10
26	-30	-12
4	-44	10
34	12	-24
-8	34	58
22	-66	-24

// Schmid J, 2015: UC Control
// Subjects=15
-62	-18	40
-62	-18	40
-58	4	14

// Siemann J, 2018: INC > CON (Valid, Invalid, Neutral)
// Siemann J, 2018: INC > CON (Valid, Invalid)
// Siemann J, 2018: INC > CON, spatial cueing
// Siemann J, 2018: INC > CON, feature-based cueing
// Siemann J, 2018: INC > CON, subset of valid cued trials, spatial cueing
// Siemann J, 2018: INC > CON, subset of valid cues, feature-based cueing
// Siemann J, 2018: Conjunction Analysis: INC > CON, spatial and feature-based 
// cuing
// Subjects=21
-43.76	-74.27	25.92
-41.82	-83.57	6.64
-30.74	-83.69	27.75
-30.57	-.29	58.71
-21.81	-4.85	66.86
-49.98	-15.45	58.31
-2.69	3.68	42.16
-11.47	4.84	32.11
-9.05	-18.37	47.81
-55.78	8.94	32.46
-27.17	-56.44	-25.43
0.97	52.38	0.3
-17.34	-53	68.19
31.17	60.89	-2.18
29.03	-51.68	-23.5
29.13	-60.83	-18.11
21.32	11.05	62.31
-43.76	-74.27	25.92
-.47	-7.91	44.39
-23.98	-53.1	55.99
-26.45	-2.89	42.09
-17.34	-53	68.19
-30.57	-.29	58.71
-23.92	-54.82	60.64
-24.28	1.58	43.86
-13.12	-60.3	58.75
-26.43	3.8	44.79
-24.06	-5.58	59.13

// Veroude K, 2016: Main effect of Reward Anticipation, All Subjects
// Veroude K, 2016: Main effect of Reward Reciept, All Subjects
// Subjects=40
2	-4	58
-4	-92	18
4	44	-4
44	-56	-14
0	-36	38
-50	-52	-12
-50	14	34
-20	26	52

// Gonzalvez G G, 2016: Healthy Controls (HC)
// Subjects=23
-54	14	-14
-22	-18	-20
-32	-24	-22
-56	-64	12
36	-8	-26
-52	0	-18
24	-4	-28
-28	-8	-22
-46	-20	-2
-26	-2	28
32	-10	-18
-46	-4	-2
44	-16	0
68	-38	2
26	-54	-14

// Gonzalvez G G, 2016: Left Temporal Lobe Epilepsy (LTLE)
// Subjects=20
52	10	-22
-58	-38	-2
20	-20	-22
-58	-4	-18
-22	-20	-20
34	-28	-12
-48	24	-6
50	14	-20
-58	-30	0
-32	-48	-16
32	-56	-14
-28	-16	-24
-32	-24	-22
-56	-64	12
36	-8	-26
-52	0	-18
24	-4	-28
-28	-8	-22
-46	-20	-2
-26	-2	28
32	-10	-18
-46	-4	-2
44	-16	0
68	-38	2
26	-54	-14

// Gonzalvez G G, 2016: Right Temporal Lobe Epilepsy (RTLE)
// Subjects=13
-56	16	-8
-58	10	-8
-48	-32	-2
-34	-8	-44
-54	-16	-16
-26	-16	-20
40	-54	-22

// Hennion S, 2016: Subgroup of Mesial Temporal Lobe Epilepsy, Left MTLE
// Subjects=13
28	4	62
16	0	-38

// Hennion S, 2016: Subgroup of Mesial Temporal Lobe Epilepsy, Right MTLE
// Subjects=12
10	-64	18
34	-8	-34
8	54	40
-14	-64	-30
-8	30	-14
0	36	-18
-14	48	-14
-64	-42	34
-62	-50	34

// Hennion S, 2016: Healthy Controls
// Subjects=25
10	-64	18
34	-8	-34
8	54	40
-14	-64	-30
28	4	62
16	0	-38
-8	30	-14
0	36	-18
-14	48	-14
-64	-42	34
-62	-50	34
58	-50	12
28	-40	-16
36	-84	4
-44	-70	20
-40	-48	-14
30	-92	-4
-46	-60	-10
-32	-76	22
42	-78	14

// Oyegbile T O, 2018: All Participants: 2-back > 0-back
// Oyegbile T O, 2018: Healthy Controls (HC) > Temporal Lobe Epilepsy (TLE): 
// 2-back > 0-back
// Oyegbile T O, 2018: All Participants: Negative Correlation between 2-back > 
// 0-back and N-back Accuracy
// Oyegbile T O, 2018: All Participants: Negative Correlation between 2-back > 
// 0-back and N-back Speed
// Oyegbile T O, 2018: All Participants: Negative Correlation between 2-back > 
// 0-back and D-KEFS Interference Inhibition Accuracy
// Oyegbile T O, 2018: All Participants: Negative Correlation between 2-back > 
// 0-back and D-KEFS Interference Inhibition Speed
// Oyegbile T O, 2018: All Participants: Negative Correlation between 2-back > 
// 0-back and Speeded Dexterity
// Subjects=15
-39	-40	50
-30	5	62
-54	14	32
-45	-61	-10
-30	8	56
-30	8	56
-36	-37	44
36	11	50
-30	8	56
-36	-37	44
-30	8	56
36	11	50
-54	14	32
-42	-61	-7
-12	-88	-7
3	-79	11
-27	-64	56
-51	14	32
21	11	65
-24	-67	41
-51	14	32
21	11	65
-45	-64	-7
-24	-67	41
-51	14	32
21	11	65
-42	-64	-4

// Armbruster D J N, 2016: Negative correlation with error costs in task 
// switching
// Armbruster D J N, 2016: Negative correlation with error costs in distractor 
// inhibition
// Armbruster D J N, 2016: Positive correlation with reaction time in 
// distractor inhibition
// Armbruster D J N, 2016: Positive correlation with intra-individual 
// coefficient of variation (ICV) in ongoing
// Armbruster D J N, 2016: Negative correlation with ICV in task switching
// Subjects=76
-34	6	40
-36	32	34
2	40	16
-2	62	2
-2	10	46
6	-38	46
44	-22	24
34	26	12
2	-96	0
-16	-28	2
6	32	-10
0	60	8
56	28	10
2	-50	44
-52	-62	36
62	-50	28
14	-86	42
-42	12	40
-34	8	40
6	22	30
48	-14	32
52	-14	0
56	-58	14
42	-78	-12
-12	-2	22
-2	-18	16
36	-14	40
-52	-10	14
2	-2	50
48	-6	4
-42	-16	10
-63	-30	28

// Berron D, 2015: Flanker, Incongruent > Congruent
// Berron D, 2015: Garner, Filtering > Baseline
// Berron D, 2015: Interaction, Filtering (incongruent > congruent) > Baseline 
// (incongruent > congruent)
// Berron D, 2015: Flanker, Incongruent > Congruent, first experimental run
// Berron D, 2015: Garner, Filtering > Baseline, first experimental run
// Berron D, 2015: Interaction, Filtering (incongruent > congruent) > Baseline 
// (incongruent > congruent), first experimental run
// Berron D, 2015: Flanker, Incongruent > Congruent, second experimental run
// Berron D, 2015: Interaction, Filtering (incongruent > congruent) > Baseline 
// (incongruent > congruent), second experimental run
// Subjects=24
-4	32	54
50	18	27
0	-48	43
2	-42	48
4	2	1
-4	8	-2
6	20	-5
0	-44	-2
12	-34	-5
-4	-22	9
44	-50	-2
48	-60	-2
64	-50	-7
-30	-58	54
-34	-50	54
-30	-60	-5
-34	-72	-2
48	0	-15
-18	-14	-15
-14	-24	-13
-24	-58	-15
28	-44	-23
16	-40	-23
30	-44	-31
-32	-48	-26
4	-38	35
-2	-24	35
-4	26	-2
2	34	-2
2	36	9
-22	-78	46
-34	-70	32
22	6	46
22	-6	54
24	-16	48
16	-18	56
26	-38	51
26	-56	51
18	-54	46
42	52	-10
28	16	-13
-10	32	38
-8	40	35
34	-66	43
32	-66	51
40	-50	38
32	-60	-15
-28	-78	-15
-12	-76	-15
-14	-84	-15
2	-42	43
18	-78	46
34	-34	-7
-28	-38	-10
28	-50	-10
-58	-28	-1
-66	-30	3
16	18	-2

// Campanella S, 2017: Correct Inhibitions during Neutral Context, All 
// Participants
// Campanella S, 2017: Correct Inhibitions during Alcohol-related Context, All 
// Participants
// Campanella S, 2017: Correct Inhibitions during Non-alcohol Context, All 
// Participants
// Campanella S, 2017: Correct Inhibitions during all Contexts, All 
// Participants
// Campanella S, 2017: Failed Inhibitions during all Contexts, All 
// Participants
// Campanella S, 2017: Failed Inhibitions during all Contexts, Light > Heavy 
// drinkers
// Campanella S, 2017: Failed Inhibitions during all Contexts, Heavy > Light 
// drinkers
// Subjects=17
48	60	42
50	50	-4
-46	56	40
62	26	-2
-44	52	-12
-50	36	-18
-50	66	44
-66	26	-14
-16	56	34
-40	46	-14
-4	46	44
-50	68	42
50	66	44
36	44	-16
-66	22	-18
-50	68	38
-44	52	-12
4	34	26
48	26	-10
-44	18	-14
58	-42	50
-58	-60	32
50	22	-14
-48	18	-16
8	30	30
18	-36	-20
-26	-92	22
-14	4	-14
-26	-6	26

// Aasen I, 2018: High load > control cue
// Aasen I, 2018: High load > control association
// Aasen I, 2018: High load > low load association
// Aasen I, 2018: Low load > control cue
// Aasen I, 2018: Low load > high load cue
// Aasen I, 2018: Low load > control association
// Aasen I, 2018: Control > low load cue
// Aasen I, 2018: Control > high load association
// Aasen I, 2018: Control > low load association
// Subjects=17
26	-70	30
-8	1	-3
-18	-58	26
-30	-66	34
28	22	2
4	30	42
40	60	-32
0	-20	30
44	-70	34
-34	-50	40
-34	-86	-2
20	-36	-48
38	20	24
2	14	54
-30	96	2
32	-54	38
36	-42	-26
52	18	28
30	-52	32
-40	22	20
0	14	48
-36	52	40
20	36	-48
-58	-54	18
62	-18	10
52	-64	28
6	62	12
0	58	4
-40	-14	-4
60	-36	42
0	-24	44
-62	-40	4
-40	-12	-4
40	-16	-4
0	58	6
-4	-22	46

// Daamen M, 2015: Very Preterm and Very Low Birth Weight (VP/VLBW) Group
// Subjects=73
16	-62	22
37	-76	26
16	-72	44
-6	-90	18
-17	-94	11
12	-58	51
34	-47	-25
19	-44	-10
19	-69	-21
23	-29	-21
23	-69	-43
16	-69	-39
16	-62	-32
16	-62	22
19	-44	-14
23	-29	-21
30	-47	-25
55	18	11
62	0	26
59	-51	8
55	-44	44
59	-40	26
-35	-51	44

// Daamen M, 2015: Control Group
// Subjects=73
16	-62	22
37	-76	26
16	-72	44
-6	-90	18
-17	-94	11
12	-58	51
34	-47	-25
19	-44	-10
19	-69	-21
23	-29	-21
23	-69	-43
16	-69	-39
16	-62	-32
16	-62	22
19	-44	-14
23	-29	-21
30	-47	-25

// Duggirala S X, 2016: 2-back words > 0-back words
// Duggirala S X, 2016: 2-back objects > 0-back objects
// Duggirala S X, 2016: 2-back faces > 0-back faces
// Duggirala S X, 2016: 2-back faces and 2-back words > 0-back faces and 
// 0-back words
// Subjects=50
32	24	2
-30	-58	-34
-42	-70	-20
-46	-48	-28
-36	-50	44
-36	-44	38
-36	-44	38
-44	2	28
-48	22	26
-38	20	26
-30	24	-2
-44	16	4
-54	12	2
-10	-76	-32
-8	12	48
-26	4	50
8	16	46
8	22	40
38	48	12
32	24	0
46	16	4
-30	-56	-34
-42	-50	-26
-34	-72	-26
-34	-50	42
-44	-48	46
-30	-72	24
-32	20	4
-12	-74	-32
-42	2	30
-46	20	30
-44	30	36
-44	6	30
-26	-64	-32
-10	-76	-32
-14	-68	-32
-42	-48	54
-36	-48	38
-52	-36	46
32	26	2
42	20	8
-30	28	2
-2	-60	-30
10	22	38
-30	-82	20
-40	-78	-18
-40	-66	-14
-26	-64	-32
-36	-48	38
-50	-40	42
-34	-62	38
-44	6	30
32	26	2
-30	28	2

// Geiger L S, 2018: Novel > Practice
// Geiger L S, 2018: Practice > Novel
// Geiger L S, 2018: Novel (encoding > retrieval) > Practiced (encoding > 
// retrieval)
// Geiger L S, 2018: Practice (encoding > retrieval) > Novel (encoding > 
// retrieval)
// Subjects=74
33	23	6
18	14	6
6	8	60
-36	23	3
9	20	36
-18	8	6
-3	11	54
-6	17	42
-42	-7	48
48	-1	45
6	-4	3
-6	-7	3
-45	32	18
27	-64	45
45	-40	48
36	-85	12
45	-61	-15
45	-61	-15
-24	-64	54
-27	-76	24
-42	-40	42
-48	-61	-15
-30	-64	-12
39	41	27
-39	-58	-24
36	-52	-27
-6	-58	27
-51	-70	39
54	-67	36
21	14	6
33	23	6
6	5	63
48	-1	45
-18	8	3
9	20	36
-36	23	3
-6	17	39
-3	5	63
-54	8	18
48	11	18
-51	-1	36
9	-7	0
-6	-10	0
36	-85	12
45	-64	-6
45	-37	48
39	-61	-12
-36	-88	3
-21	-64	54
-30	-64	-12
27	-61	51
-45	-73	-6
-39	-40	45
-48	-70	42
-6	-58	24
54	-64	36

// Kodama K, 2015: 3-back > 2-back
// Subjects=33
-10	-76	-4
-12	-72	-4

// Li X, 2019: Schizophrenia Patients (SCZ)
// Subjects=20
0	24	45
-30	3	63
-27	12	60
36	-42	39
45	-48	54
27	-57	39
33	27	3
-30	60	18
-45	48	6
-33	-48	39
-45	-48	54
-27	-66	42
42	39	30
39	54	18
42	6	27
33	6	63
27	6	51
-30	27	0
-3	-39	-33
36	-6	-27
39	15	-27
33	-15	-21
48	15	36
18	-54	69
30	-45	69
57	-36	51

// Li X, 2019: Healthy Controls (HC)
// Subjects=24
-30	24	3
51	15	36
33	24	3
-33	-45	42
-45	-39	42
-39	-54	57
30	-60	-30
12	-72	-27
-9	-75	-27
36	-6	-27
39	15	-27
33	-15	-21
48	15	36
18	-54	69
30	-45	69
57	-36	51

// Liu S, 2018: Higher capacity group
// Subjects=16
34	-56	62
-18	-68	44
-28	-72	36
2	22	48
-30	-8	70
56	-58	-8
-52	16	26
24	2	56
-32	-74	-28
0	22	48
-6	50	16
36	-52	60
-18	-64	62
10	4	46
4	56	0
2	-32	34

// Liu S, 2018: Lower capacity group
// Subjects=15
-18	-64	62
-14	-54	-4
32	-68	40
48	-32	58
20	-60	64
-8	-56	52
-20	0	54
-32	-80	32
20	-10	72
-56	14	32
-24	-66	-24
-2	4	58
-12	-6	16
44	36	30
8	-74	-26
38	-60	-28
52	-48	10

// Liu S, 2018: Higher capacity group (alternate criteria)
// Subjects=17
22	-62	68
-28	-58	64
10	6	46
-6	48	16
-22	56	28
66	-32	32
-8	-24	38

// Liu S, 2018: Lower capacity group (alternate criteria)
// Subjects=11
52	-48	10

// Nayyeri M D, 2019: Main effect of 'Pressure'
// Nayyeri M D, 2019: Main effect of 'n-back'
// Nayyeri M D, 2019: 2-back > 0-back
// Nayyeri M D, 2019: 0-back > 2-back
// Nayyeri M D, 2019: Pressure > No Pressure
// Subjects=24
52	-20	23
54	-16	48
-4	60	14
-40	-44	44
-62	-12	-20
-2	-50	28
32	4	60
40	-44	44
-50	-64	26
62	-6	-18
30	-82	-34
32	22	0
-28	24	0
38	-66	-28
-8	-74	-24
56	-64	30
66	-30	30
-32	-82	-34
-34	-66	-28
-20	-96	22
-64	-48	-4
-40	-44	44
32	4	60
32	22	0
-28	24	0
38	-66	-28
-8	-74	14
-34	-66	28
-4	60	14
-2	-50	28
-50	-64	30
62	-6	-18
30	-82	-34
56	-64	30
66	-30	30
28	-92	20
-32	-82	-34
-20	-96	22
-64	-48	-4
44	-12	60
52	-20	23
54	-16	48

// Omata K, 2018: voluntary stop > forced stop
// Omata K, 2018: voluntary start > forced start
// Omata K, 2018: forced stop > voluntary stop
// Omata K, 2018: forced start > voluntary start
// Omata K, 2018: voluntary stop > fixation
// Omata K, 2018: forced stop > fixation
// Omata K, 2018: Conjunction analysis: voluntary > forced
// Omata K, 2018: Conjunction analysis: voluntary and forced stop > fixation
// Subjects=26
26	12	58
42	40	22
54	-40	46
-30	-62	-30
-32	58	14
-8	-90	2
56	8	18
-34	12	2
32	-60	-26
-46	-48	50
20	12	6
-8	2	66
46	12	6
-16	4	10
-40	-60	-32
-38	52	22
56	-36	44
-50	-38	22
40	-56	-16
-44	-70	-12
-24	-70	44
-10	6	58
-44	4	34
-50	-8	48
48	-64	14
-8	2	62
-50	-76	8
54	0	40
-18	0	4
-24	48	28
14	-16	38
22	48	26
64	6	18
20	8	2
-12	10	32
34	-52	54
2	10	44
8	2	70
42	8	-2
56	-38	52
-42	6	0
38	10	6
38	-54	-18
62	-42	18
-36	20	6
8	14	44
-40	-56	-16
-14	0	68
-8	2	66
20	12	62
-2	18	46
56	-36	44
54	12	20
28	56	22
-34	12	2
-18	10	4
-34	58	16
-34	-60	-34
-6	-90	8
20	12	6
-46	-44	50
-54	12	10
8	2	70
2	8	46
42	12	-2
54	16	12
-42	10	0
58	-30	48

// Peterburs J, 2019: Significant activations for high>low load during 
// maintenance
// Peterburs J, 2019: Significant deactivations for high>low load during 
// maintenance
// Subjects=20
26.44	-76.8	-62.43
26.99	-70.52	-18.24
-.25	12.35	65.91
-46.21	29.72	24.64
-54.48	-.34	47.92
-24.48	-61.2	15.33
40	-37.32	-8.3
47.25	-29.35	53.54
-20.8	-87.86	-40.36
31.16	-82.59	-32.8
-22.43	-99.22	-1.11
-30.69	32.69	55.45
-39.22	-78.11	41.91
-50.69	-17.45	2.49
29.47	-103.09	0.63
53.81	-57.19	53.94
12.55	-41.35	41.87
61.62	-13.01	-2.11

// Peterburs J, 2016: Significant activations for high > low load during 
// encoding
// Peterburs J, 2016: Significant deactivations for high > low load during 
// encoding
// Peterburs J, 2016: Significant activations for the eye regressor during 
// encoding
// Peterburs J, 2016: Significant deactivations for the eye regressor during 
// encoding
// Subjects=15
-65.54	-37.32	20.39
38.29	-84.28	17.67
21.7	-62.05	-7.78
56.41	-57.6	3.51
-23.46	-40.89	14.43
-16.53	-3.97	-27.44
-37.12	-85.11	35.84
-41.38	-21.15	54.24
33.56	-65.41	-9.89
34.45	-56.63	60.94
62.05	3.28	34.37
48.99	13.46	29.11
38.48	9.12	52.13
5.38	-33.39	-10.34
-24.77	-74.33	-10.26
-7.15	24.52	35.69
-19.85	-89.51	33.74
-3.2	-35.13	-5.54
50.56	-85.06	-37.37
62.38	-53.32	48.93
29.39	-44.62	6.05
59.44	23.97	3.24
40.84	-79.13	49.61
70.92	-40.94	43.08
-37.06	-19.01	53.96
-26.87	-45.44	0.37
-.72	46.02	35.7
-44.23	4.26	4.71
-37.24	-55.33	32.9
-9.26	-10.15	32.43
-52.71	-16.42	13.62

// Philip N S, 2016: Healthy Controls
// Subjects=13
-46.38	67.73	-33.75
38.93	24.77	63.67
-26.7	87.79	31.25
3.43	61.59	47.6
67.24	22.63	-7.85
38.43	88.81	24.84
-.81	-44.6	9.72
-65.13	10	5.88
57.97	42.63	45.22
-55.77	63.47	-5.4
-1.54	37.91	-51.84
3.66	0.26	52.74
35.44	74.47	46.15
-32.96	-19.41	7.98
35.74	14.97	61.18
-36.17	70.62	43.96
38.1	58.98	-30.64
32.25	-18.77	10.52
9.74	11.22	14.95
-.66	-56.26	24.08
51.22	78.6	15.52
-45.88	-23.78	-6.01
-45.85	73.22	37.16
57.69	69.38	19.56
12.9	86.51	38.71

// Philip N S, 2016: Early Life Stress (ELS) Group
// Subjects=13
42.1	34.3	62.83
-7.76	99.17	-2.26
3.35	54.22	34.84
-46.02	84.62	19.47
-65.13	10	5.88
57.97	42.63	45.22
-55.77	63.47	-5.4
-42.3	-26.42	42.13
-36.14	66.56	46.53
3.54	-57.01	14.05
-49.1	36.5	16.85
3.23	52.94	18.22
51.4	-32.71	-6.38
-45.88	-23.78	-6.01
-45.85	73.22	37.16
57.69	69.38	19.56
12.9	86.51	38.71

// Shi Y, 2018: Instruction (reversal > nonreversal)
// Shi Y, 2018: Task Switch > Task Repetition
// Shi Y, 2018: Reversal (late - early) > Nonreversal (late - early)
// Shi Y, 2018: Conjunction (reversal (late-early), nonreversal (late-early)
// Subjects=32
-42	44	16
-42	32	34
-42	14	22
45	11	22
-27	23	-20
-39	-10	61
27	-4	55
12	26	31
-48	-37	43
42	-43	34
9	-64	52
-18	5	-11
18	17	-8
-33	20	7
36	14	-5
-12	-16	4
6	-19	7
-15	-76	10
-24	-88	-17
3	-97	-2
-36	47	22
-45	32	31
-48	8	34
42	26	28
-27	-4	58
36	-4	55
-6	20	46
-36	-52	46
36	-58	37
-3	70	52
-18	-4	-5
15	2	1
-30	20	1
33	20	7
-12	-16	10
18	-13	10
-9	-79	7
-21	-94	-11
0	-91	4
-30	-61	-32
33	-67	-32
15	-19	67
-24	-34	58
-6	-19	55
33	8	4
-36	-16	13
48	-19	19
-3	53	-2
-39	11	-23

// Siemann J, 2016: Incongruent > Congruent, all cue types
// Siemann J, 2016: Incongruent > Congruent (valid cues)
// Siemann J, 2016: All Congruent > Fixation
// Siemann J, 2016: All Incongruent > Fixation
// Siemann J, 2016: All Congruent & Incongruent > Fixation
// Subjects=20
-23.98	-53.1	55.99
-26.45	-2.89	42.09
-23.92	-54.82	60.64
25.82	-57.62	62.31
55.14	-38.22	-7.35
-46.31	-73.89	-4.33
-18.72	62.56	-16.06
-41.8	-48.4	15.48
-15.26	-66.69	59.42
-24.28	1.58	43.86
-62.36	11.48	25.6
-59.89	-14.71	43.83
-50.45	-20.05	20.67
-35.5	-18.05	6.77
-39.63	-65.82	12.69
-32.61	-4.88	67.05
-33.45	17.26	5.48
67.21	13.55	17.58
53.69	-26.34	50.89
63.08	-29.87	24.19
31.5	-46.09	1.68
-62.35	9.35	25.81
-59.87	-14.5	46.05
-34.8	-5.1	64.87
-31.29	17.27	5.44
-32.72	-53.86	48.36
-23.95	-41.95	60.48
-4.96	16.02	36.5
33.66	-46.08	1.64
67.25	13.86	20.91
51.51	-24.33	49.61
65.22	-30.07	21.93
-42.01	-.74	8.53
-31.09	-49.08	7.52
-35.92	-44.12	-30.98
-2.61	5.36	48.72
24.85	-62.66	-14.5
25.06	-38.15	6.61
25.19	-41.57	15.91
37.55	-41.63	-31.36
44.27	3.95	-3.49

// Soylu F, 2016: two-digit > one-digit
// Soylu F, 2016: one-digit > two-digit
// Soylu F, 2016: Main effect of tapping
// Soylu F, 2016: Interaction between tapping and addition difficulty
// Subjects=13
-40	6	30
-2	18	46
30	-54	50
-28	-56	54
-4	40	34
-44	-66	40
-42	-12	0
-56	-42	28
60	-12	24
6	54	36
-32	-24	58
18	-60	6
48	-60	34
48	-60	34
-42	-68	40
-36	-22	54
-28	-56	54
8	54	42
-4	-40	34
38	-34	14

// Uehara S, 2019: Switch > Repeated
// Uehara S, 2019: Flip analysis for Switch > Repeated
// Subjects=32
-30	-48	50
-18	-72	50
-42	-44	48
-54	-34	40
-52	-40	56
-48	4	28
-42	-8	38
-56	4	38
-50	6	14
-24	-6	54
-44	-42	54
-32	-40	58
-32	-52	44

// Walitt B, 2016: Healthy Controls
// Subjects=13
0	16	54
-36	-56	40
44	36	32
-42	54	8
-30	22	4
32	22	8
-24	6	6
32	-2	32
32	22	8
-22	8	14
34	-2	30
-22	6	14

// Walitt B, 2016: Fibromyalgia patients
// Subjects=16
44	-46	40
28	14	54
-30	22	-8
-36	-54	-34
32	22	8
66	-30	30
48	-80	8
-42	-40	-6
30	-34	-16
-36	-74	16
-22	6	14

// Ward N, 2019: Dual Task Only > Baseline
// Ward N, 2019: Switch Only > Baseline
// Ward N, 2019: Switch/Dual > Switch Only
// Ward N, 2019: Switch/Dual > Dual-Task Only
// Ward N, 2019: Switch/Dual > Baseline
// Ward N, 2019: (Dual-Task Only > Baseline) > (Switch Only > Baseline)
// Subjects=30
54	-40	54
38	58	6
-32	-50	44
-24	-6	52
36	-60	56
-2	6	64
-44	-28	46
-26	-8	50
50	-26	62
-36	-48	44
-40	10	30
42	-50	46
32	4	62
-4	12	54
32	-82	4

// Yin S, 2018: Task Switching > Repetition
// Subjects=26
-30	42	18
-51	9	6
-6	18	45
-27	-6	57
-51	-3	39
-60	-45	24
-39	-39	45
-15	-63	51
-18	-75	6
48	15	0
21	-3	63
66	-36	30
33	-36	45
18	-57	57
9	-75	12

// Zhang H, 2018: Go trials comparison (all go < go bias < no-go bias)
// Zhang H, 2018: No-go trials comparison (no-go bias < go bias)
// Zhang H, 2018: Positive correlation b/w reaction time & fMRI activation for 
// go trials (no-go bias, go bias, all go)
// Zhang H, 2018: Negative correlation b/w reaction time & fMRI activation for 
// go trials (no-go bias, go bias, all go)
// Zhang H, 2018: Negative correlation b/w commission error rate & fMRI 
// activation for no-go trials (go & no-go bias)
// Zhang H, 2018: All Go > Baseline
// Zhang H, 2018: Go > Baseline (Bias Conditions)
// Zhang H, 2018: No-Go > Baseline (Bias Conditions)
// Zhang H, 2018: Positive correlation b/w reaction time & fMRI activation for 
// All Go < Go Bias < No-Go Bias
// Zhang H, 2018: Negative correlation b/w reaction time & fMRI activation for 
// All Go < Go Bias < No-Go Bias
// Zhang H, 2018: Negative correlation b/w error rate and Go bias > No-go bias
// Subjects=20
44	48	6
-42	44	2
52	30	4
44	28	36
36	26	-4
-36	24	-6
10	22	62
40	16	-4
-38	8	-8
32	8	-40
-32	6	-42
28	0	-42
-32	-2	-42
46	-26	-4
66	-28	-6
-2	22	34
8	-36	46
-6	-44	18
48	-24	-24
-54	-36	46
64	-40	38
-6	-38	46
8	-74	46
22	60	30
-6	36	20
4	34	26
-4	44	28
10	28	64
30	22	-14
44	20	-2
42	18	-6
52	16	4
-32	20	-16
-46	18	-4
-40	18	-6
-52	16	-2
-56	-36	-10
-58	-50	36
40	28	-6
-36	22	-12
34	22	-6
-18	-6	-8
20	-6	-6
4	-16	-22
-34	-82	-12
-4	-82	-14
-8	-102	-2
22	-4	62
24	-6	50
66	-16	22
60	-22	28
58	-28	26
8	-48	54
20	-48	68
18	-64	58
-22	-82	42
6	-62	4
-8	-72	0
-46	-82	0
34	-82	0
22	-72	30
30	-90	30
24	-4	62
6	-6	44
8	-12	46
26	-22	64
30	-32	62
4	-52	-14
-10	-40	-18
-48	38	8
-52	14	4
52	14	4
-66	-24	8
60	-32	12
30	-44	-16
20	-62	-20
-42	-66	-10
40	-76	-10
-34	-80	-18
-42	42	8
42	42	8
-52	14	4
52	14	4
-66	-24	8
60	-32	12
30	-44	-16
-44	-84	0
40	-76	-10
-34	-80	-18
-52	36	18
52	36	18
-40	32	22
40	32	22
-52	32	20
52	32	20
38	-54	-16
40	-78	-10
-42	-86	0
20	54	32
-4	30	42
-46	32	22
-10	-6	66
-6	-8	64
-24	-14	66
-30	-38	58
-30	-42	66
8	-50	-8
-8	-62	-2
10	-64	0
-64	-18	16
-60	-18	14
-68	-24	6
-64	-24	10

// Kumfor F, 2019: Positive films > Baseline, All Participants
// Kumfor F, 2019: Neutral films > Baseline, All Participants
// Kumfor F, 2019: Negative films > Baseline, All Participants
// Kumfor F, 2019: Positive, Neutral, and Negative films > Baseline, All 
// Participants
// Kumfor F, 2019: Positive Correlation between facial EMG response and 
// Positive films > Baseline, All Participants
// Kumfor F, 2019: Positive Correlation between facial EMG response and 
// Neutral films > Baseline, All Participants
// Kumfor F, 2019: Positive Correlation between facial EMG response and 
// Negative films > Baseline, All Participants
// Kumfor F, 2019: Positive Correlation between skin conductance levels and 
// Positive films > Neutral films, All Participants
// Kumfor F, 2019: Positive Correlation between skin conductance levels and 
// Negative films > Neutral films, All Participants
// Subjects=14
38	-16	8
-30	-28	-12
-22	14	48
36	-10	4
-22	-32	-32
-70	-12	14
-54	2	-24
-38	32	42
-28	-14	-48
-12	12	-18
38	-16	8
-30	-28	-12
-22	14	48
-53	13	-18
-52	14	-24
-18	4	26
-20	-12	22
-18	0	-12
24	26	48

// Clark C M, 2017: Working Memory Traning Group (WMTG)
// Subjects=25
-16	-62	60
14	-78	-32
8	38	58
34	24	-28
22	-58	48
-44	18	22
-10	-52	24
-4	40	20
16	-56	50
-36	36	6
8	-50	68
-40	46	-20
-24	56	-12
10	52	6
18	30	56
42	-6	-8
-38	2	-24
14	-44	32
36	-2	-6
-2	-30	26
-44	22	-22
-36	36	6
-46	-22	54

// Clark C M, 2017: Processing Speed Training Group (PSTG)
// Subjects=24
46	-54	-18
26	24	48
46	10	32
38	-78	34
60	-52	36
-54	-64	32
-24	-56	-12
10	52	6
18	30	56
42	-6	-8
-38	2	-24
14	-44	32
36	-2	-6
-2	-30	26
-44	22	-22
-36	36	6
-46	-22	54

// Baumann A, 2018: Patients with Parkinson's Disease (PD)
// Subjects=11
-4	-10	38
6	0	60
0	-4	66
52	0	2
28	-2	4
54	-10	18
-44	-32	18
-44	-8	22
-58	4	12
-40	22	18
-28	22	10
52	-22	-8
52	-28	6
56	-2	46
-48	22	2
-40	18	0
-54	6	-10
12	-8	64
-2	-14	68
-10	0	68
62	-8	6
52	-14	26
-62	8	16
-52	34	14
-56	14	10
36	-76	-12
8	-86	4
14	-82	-8
-28	-10	-18
-34	-42	-22
-36	-70	-10
60	2	18
48	14	-8
56	18	8
52	26	0
-62	-36	0
-56	-40	10
-50	-52	-2
-8	-2	62
30	-12	36
-54	12	10
-40	18	18
-42	24	12
34	-40	-24
-58	-40	22
36	-76	-10
28	2	40
38	-6	28
30	6	20
-26	-44	46
-24	-62	34
-18	-52	34
30	-46	42
44	-36	34

// Baumann A, 2018: Healthy Controls (HC)
// Subjects=11
-4	-10	38
6	0	60
0	-4	66
52	0	2
28	-2	4
54	-10	18
-44	-32	18
-44	-8	22
-58	4	12
-40	22	18
-28	22	10
52	-22	-8
52	-28	6
56	-2	46
-48	22	2
-40	18	0
-54	6	-10
12	-8	64
-2	-14	68
-10	0	68
24	-78	-14
-36	-86	-8
38	-66	-20
-44	14	20
-46	4	44
-54	2	16
-28	-46	44
-46	-40	36
-48	-44	18
30	-50	52
34	-56	34
28	-70	46
-8	14	50
8	18	46
0	-6	62
62	8	14
46	10	22
-38	-86	-6
-38	-66	-12
34	-78	-18
-44	4	44
-2	10	46
0	-2	62
32	-2	58
28	-4	44
50	10	46
-58	-32	4
-20	6	8
-50	10	14
30	-50	48
34	-58	40
28	-72	44
-26	-46	44
-20	-68	50

// Brabenec L, 2019: BOLD response to Reading > Baseline
// Subjects=16
-57	-22	-5
42	-25	7
9	5	67
-9	-19	-2
21	-61	7
15	-61	-20

// Bomyea J, 2019: Interference control activation during stimulus encoding
// Bomyea J, 2019: Interference control activation during stimulus recall
// Bomyea J, 2019: PTSD - SI > PTSD + SI during stimulus recall
// Bomyea J, 2019: Inference coding during encoding and recall, PCL and BDI-II 
// covariates
// Bomyea J, 2019: Healthy Controls > Patients, Encoding
// Bomyea J, 2019: Healthy Controls > PTSD patients, Recall
// Subjects=9
-7	16	45
-11	10	5
-29	39	28
14	-95	8
35	-70	-31
-13	-67	6
-31	-15	56
-25	-1	-4
-39	-34	48
20	-57	51
-28	-57	57
28	-3	34
-48	-44	-14
28	-3	34
30	0	32
-48	-44	-14
-47	-44	-16
-42	-77	8
20	19	56
1	-61	2

// Jiang J, 2016: Conscious: Incongruent > Congruent
// Jiang J, 2016: Unconscious: Incongruent > Congruent
// Jiang J, 2016: Congruent > Fixation
// Jiang J, 2016: Unconscious > Fixation
// Subjects=24
8	18	48
-45	-36	42
33	21	6
45	9	33
-27	42	27
36	-63	45
-42	-57	-12
45	33	30
21	-63	24
-24	-96	-9
9	-54	48
-15	-63	24
-9	-3	51
3	18	48
45	-54	-18
33	18	6
-27	-9	60
-36	15	6
36	45	15
-51	-60	-15
36	-87	-9
-36	48	18
48	9	33
15	-57	9
21	-63	24
9	-54	48
12	-78	51
9	-39	45
-3	-63	63
-9	-54	48
-9	-81	48
18	-54	12
18	-63	66
-3	-75	36
-24	-96	-9
-15	-63	24
-18	-72	6
-21	-54	0
-9	-3	51
0	0	48
9	3	48
39	-87	-6
27	-81	-6
33	-84	3
60	-30	42
60	-30	42
57	-21	54
48	39	9
45	-54	-18
45	-66	-6
33	-66	27
27	-63	42
60	12	33
45	3	33
-60	-42	21
-63	-24	18
-51	-42	24
-66	-48	9
-69	-21	9
24	0	57
24	0	57
27	-12	72
12	6	69
36	0	60
3	18	24
-30	-69	27
57	-39	21
57	0	-3
57	9	0
57	9	-9
60	15	9
-33	-57	-18
-39	-66	-9
36	-42	45
-39	-24	63

// Mattheiss S R, 2018: Words > Nonwords
// Mattheiss S R, 2018: Nonwords > Words
// Subjects=20
-38.41	2.59	3.96
-49.72	-22.52	51.92
15	9.25	2.79
50.4	14.18	22.04
-2.85	13.54	46.13
-4.28	-19.9	-14.62
30.79	52.99	-11.1
28.97	-25.01	-1.19
-46.91	35.97	23.56
41.64	-46.28	-29.66
-2.06	-77.21	-26.56
-30.72	-90.82	-7.25
26.02	-93.77	4.61
-32.04	-46.13	-21.02
-34.32	-12.47	-26.05
33.72	-60.69	46.36
-9.26	-53.48	19.48
-46.47	-78.14	34.24
2.16	37.53	11.72
3.06	70.94	3.33
5.28	9.22	-10.48
13.33	-93.61	21.47
67.18	-3.32	-26.86
38.19	24.8	-32.24
-25.37	26.81	40.81
-18.02	60.69	37.89
-25.61	-29.46	-12.46
42.85	-11.9	2.01
28.81	-16.78	-18.6
28.03	25.73	35.83
42.11	-18.34	42.71
-58.85	-2.33	-16.58

// Vachon-Presseau E, 2016: chronic back pain (CBP)
// Subjects=14
-36	-2	-6
44	-22	-2
-20	-10	-14
-50	42	-10
-2	54	4
6	-14	40
-18	-50	0
2	36	-4
50	48	-2
18	14	0
-62	-46	6
-54	-30	16
6	-74	28
-34	-88	22
34	18	12
-50	2	18
54	-32	22
20	2	24
-50	22	30
36	-84	28
-60	-46	30
-38	-16	40
66	-32	28
-44	-38	34
52	-56	42
-18	-86	36
6	18	64
-46	-10	48
-34	-30	-18
10	-96	4
52	10	-14
-50	-62	-10
-4	-86	-8
-14	-54	-10
46	0	-30
-36	-26	-14
-38	-76	-10
42	-68	-10
46	-68	-6
-36	-32	16
-22	-84	16
14	-94	18
16	-72	38
52	-10	42
-48	-14	44
14	10	42
4	-4	52
-2	-74	46
-8	-36	60
18	22	52
40	-40	58
14	14	60
34	-28	66
6	-54	64
-18	-6	68
16	-14	74
-22	-24	74
-48	0	-16
48	-4	-20
-26	-22	-20
-22	-42	-6
24	-44	-4
0	54	0
-44	-84	0
50	-72	12
2	36	-2
-26	-62	4
-30	-92	12
26	64	12
16	-92	28
36	-82	28
22	-80	34
6	-46	34
4	-36	40
-28	36	42
26	36	44
54	-56	42
2	44	48
16	-74	48
58	-32	50
26	-44	54
-6	-58	54
-2	-46	60
10	-54	62
-14	-54	68

// Vachon-Presseau E, 2016: Healthy controls (HC)
// Subjects=16
-28	-16	46
-46	-10	48
40	-12	-20
-16	-86	-12
36	-72	-8
-18	-70	38
-14	-52	52
24	32	50
14	14	62
-18	6	66
46	0	-30
-36	-26	-14
-38	-76	-10
42	-68	-10
46	-68	-6
-36	-32	16
-22	-84	16
14	-94	18
16	-72	38
52	-10	42
-48	-14	44
14	10	42
4	-4	52
-2	-74	46
-8	-36	60
18	22	52
40	-40	58
14	14	60
34	-28	66
6	-54	64
-18	-6	68
16	-14	74
-22	-24	74
-48	0	-16
48	-4	-20
-26	-22	-20
-22	-42	-6
24	-44	-4
0	54	0
-44	-84	0
50	-72	12
2	36	-2
-26	-62	4
-30	-92	12
26	64	12
16	-92	28
36	-82	28
22	-80	34
6	-46	34
4	-36	40
-28	36	42
26	36	44
54	-56	42
2	44	48
16	-74	48
58	-32	50
26	-44	54
-6	-58	54
-2	-46	60
10	-54	62
-14	-54	68

// Errante A, 2019: Cerebral Palsy
// Subjects=10
-36	-44	48
32	-54	52
26	-4	50
26	-4	6
18	-2	-2
28	-56	51
-28	-60	42
34	2	52
28	-12	11

// Errante A, 2019: Healthy Controls
// Subjects=12
-26	-62	64
22	-60	56
-42	-42	46
30	-44	44
28	-2	50
60	-36	30
54	12	-2
-32	-60	-20
30	-58	-20

// Mickleborough M J S, 2016: Healthy Controls > Migraine: Voluntary Attention 
// > Rest
// Mickleborough M J S, 2016: Migraine > Healthy Controls: Voluntary Attention 
// > Rest
// Mickleborough M J S, 2016: Healthy Controls > Migraine: Reflexive Attention 
// > Rest
// Mickleborough M J S, 2016: Migraine > Healthy Controls: Reflexive Attention 
// > Rest
// Subjects=16
48.47	-55.08	21.18
-5.05	-77.2	1.35
-61.77	-55.34	0.17
-13.34	-94.4	27.42
55.98	-64.64	20.78
-7.26	-87.85	-12.23

// Sgandurra G, 2018: Cerebral Palsy
// Subjects=12
-45.68	-67.84	2.15
-49.98	-35.12	12.83
-45.46	-38.07	43.14
-36.84	-42.79	50.13
-15.39	-64.87	51.73
-35.86	-6.32	53.75
-41.37	8.4	38.08
-52.21	17.71	21.81
-23.13	-88.52	8.08
51.53	-63.2	-1.59
57.92	-32.62	8.04
52.81	-33.51	38.28
41.21	-47.35	52.96
25.2	-60.4	50.89
38.95	-3.58	54.89
47.33	11.13	37.95
44.94	27.21	12.09
49.08	35.72	-2.05
24.98	-86.91	10.74

// Sgandurra G, 2018: Healthy Controls
// Subjects=12
48.35	-62.97	1.77
54.76	-39.87	10.91
62.33	-28.93	27.75
36.92	-42.01	53.68
26.3	-62.33	53.27
35.76	-8.98	54.26
47.3	6.47	32.76
47.13	21.22	17.03
44.82	26.01	-3.42
27.07	-86.27	5.09
-45.69	-66.79	2.06
-53.17	-40.51	12.21
-58.39	-29.4	32.52
-32.53	-41.28	55.53
-24.99	-65.9	53.04
-33.69	-11.51	55.27
-48.87	1.49	32.05
-40.57	42.98	17.33
-34.26	25.45	-3.58
-22.08	-86.48	6.78
-41.1	-29.44	57.98
46.52	-25.66	57.77
-52.06	-24.67	24.25
59.04	-17.75	21.28
-59.52	-.34	36.79
-2.71	-21.27	50.16
22.42	-56.09	-30.85
42.24	-26.91	55.69
-41.11	-20.81	59.49
54.79	-23.06	21.77
-56.28	-28.5	30.19
46.35	-4.4	43.72
2.65	-13.4	55.02
-12.75	-65.3	-22.98

// Sgandurra G, 2018: Subgroup of Cerebral Palsy, Contralateral Hemisphere
// Subjects=7
-36.85	-23.07	57.4
-52.02	-27.59	27.84
-58.51	0.12	28.94
-45.76	-9.37	15.09
39	-25.07	52.23
54.81	-17.35	26.87
52.62	7.3	29.29
36.58	-22.54	16.36

// Sgandurra G, 2018: Subgroup of Cerebral Palsy, Ipsilateral Hemisphere
// Subjects=5
41.13	-25.15	51.1
55.88	-21.74	24.99
16.05	-55.7	-25.23
-42.27	-18.42	49.26
-52.03	-27.68	26.73
-56.37	-1.98	29.09
-47.94	-11.93	9.75
-13.85	-55.71	-22.66

// Bugden S, 2019: (NA) Nonsymbolic Addition > NA Control
// Bugden S, 2019: Symbolic Addition (SA) > SA Control
// Bugden S, 2019: Conjunction between SA > SA Control and NA > NA Control
// Bugden S, 2019: (SA > SA Control) - (NA > NA Control)
// Bugden S, 2019: (NA > NA Control) - (SA > SA Control)
// Subjects=24
57.19	-31.31	52.55
-39.03	-41.12	44.44
60	-54.06	-8.03
-51.09	-61.96	-3.86
26.26	-64.96	46.8
52.53	7.5	18.12
49.24	38.49	20.02
44.34	-37.1	47.6
-37.97	-41.2	43.32
-25.07	-70.01	41.12
33.67	-70	35.99
54.63	-51.1	-10.45
-52.21	-60.28	-9.56
28.22	3.58	52.18
-26.27	2.2	52.92
20.38	7.51	7.34
-16.93	6.03	19.04
-25.67	20.47	0.09
-2.83	14.86	49.36
-43.63	2.7	19.63
44.37	-36.85	50.93
-39.03	-41.12	44.44
54.63	-52.15	-10.36
-52.18	-61.08	-6.15
21.99	-65.96	48.05
15.13	-2.58	14.93
-11.66	0.89	7.14
1.47	7.48	49.93
18.64	8.27	58.59
-24.02	0.07	66.46
-48.98	2.58	18.58
-5.07	-58.71	6.49
-8.04	-84.86	26.56
2.11	-59.64	-33.66
1.47	7.48	49.93
-14.55	-100.18	7.85
-38.2	-76.6	-1.67
31.05	-40.92	-14.38
-26.55	-77.56	-15.1
-52.89	-57.4	41.5

// Eiler W J A, 2017: Main Effect of Sucrose > Water
// Subjects=37
-36	-6	6
-36	4	-12
-30	16	4
38	-4	10
38	6	-12
38	18	-2
22	32	-18
-60	-18	26
60	-12	28
60	6	28
-24	36	-16
40	42	8
48	48	8
20	-2	-12
-62	-54	34
-60	-52	44
-42	42	10
12	8	-2
-12	8	-2
-22	-6	-12

// Hauser T U, 2016: Novel > Repeated
// Hauser T U, 2016: Repeated > Novel
// Hauser T U, 2016: Active > Sham: Novel > Repeated
// Subjects=20
-45	-39	52
-26	-63	30
-26	-66	63
42	-37	43
20	-67	63
29	-63	32
35	-48	49
53	6	25
-44	3	25
6	20	51
33	2	66
-26	2	46
-53	2	45
-51	-60	31
59	-61	27
-9	30	54
-6	54	25
68	-39	39
-5	82	33
14	-49	33
-18	47	39
56	39	7

// Otto T, 2018: 3 back > 1 back
// Otto T, 2018: [Post-helicopter training (3-back > 1-back) > Pre-training 
// (3-back > 1-back)]
// Subjects=16
33.71	-66.32	42.37
55.85	13.12	35.45
33.08	26.02	-2.17
30.36	4.74	53.18
13.93	10.3	2.71
-4.96	13.79	49.48
10.88	-17.75	11.79
-8.42	-8.61	7.9
-14.9	3.79	3.59
-30.52	-1.97	54.44
-43.29	-44.31	44.75
-34.26	22.19	-4.42
-50.01	24.92	32.33
-46.76	5.65	30.57
-8.42	34.17	24.39
-17.66	1.79	60.67
-24.43	7.93	16.74
-34.22	32.48	4.75
-36.89	-8.1	58.37

// Salavert J, 2018: ADHD, 1-back > baseline
// Salavert J, 2018: Controls, 1-back > baseline
// Salavert J, 2018: ADHD, 1 back < baseline ADHD
// Salavert J, 2018: Controls, 1 back < baseline
// Salavert J, 2018: ADHD, 2 back > baseline
// Salavert J, 2018: Controls, 2 back > baseline
// Salavert J, 2018: ADHD, 2 back < baseline
// Salavert J, 2018: Controls, 2 back < baseline
// Subjects=15
-4	6	54
36	2	64
-42	-70	0
40	-46	42
-46	2	32
-42	-72	-2
48	18	44
4	-46	40
-8	70	14
-40	-82	30
56	-10	-12
-68	-14	-16
2	-52	30
-2	56	-2
-44	4	26
-44	4	28
-4	-54	14
-50	-68	22
0	46	-8

// Thothathiri M, 2017: Sentence Generation > Word Generation
// Subjects=14
-18	-78	46
-16	-82	50
20	-84	42
10	10	50
8	14	36
6	8	48
-46	0	44
-44	10	26
-54	-2	42
40	-6	52
28	-6	56
54	6	40

// Eddy C M, 2016: All Participants, False Belief > False Photo
// Eddy C M, 2016: Controls > Patients, False Belief > False Photo
// Eddy C M, 2016: Controls > Patients, False Belief and False Photo > Rest
// Eddy C M, 2016: All Participants, False Photo > False Belief
// Subjects=25
8	-52	34
52	-54	18
-48	-60	18
-50	4	-32
58	-6	-20
-2	62	-12
-38	22	40
-20	40	30
0	-18	34
-36	56	-14
0	-18	34
44	-48	16
34	4	-26
6	-40	36
-12	-104	8
-20	18	54
-30	12	-28
44	4	-24
-58	8	6
20	-60	-16
64	-6	14
56	-44	42
4	26	18
-40	-42	46
2	-4	28
-4	2	52
-44	2	42
-40	40	20
28	-6	46
44	26	42
-26	16	62
-22	-72	10
-44	-42	-26
12	-72	42
-18	-84	50
-48	-28	22
-46	-68	28
-54	-56	-8
-14	-70	34
-56	-64	-8
30	-36	-20
58	-52	-12
-34	-36	-20
50	40	8
-48	6	20
64	-8	2
-50	36	10
-28	-80	32
62	-26	42
-46	-48	54
-40	-16	0
-60	-2	10

// Filippi I, 2019: Family History of Alcohol Use Disorder (FH+)
// Subjects=37
6	-1	53
6	-7	47
-6	-4	44
0	38	8
0	29	2
-24	-40	-13
24	-55	-13
21	-52	-10
-9	-67	-4
-9	-58	-10
30	-31	-13
24	-34	-10
-24	-49	2

// Filippi I, 2019: No Family History of Alcohol Use Disorder (FH-)
// Subjects=36
6	-1	53
6	-7	47
-6	-4	44
0	38	8
0	29	2

// Hardee J E, 2017: Family History of Alcoholism
// Subjects=36
-44	26	-2
-30	16	-18
-16	-54	28
-2	-48	24
-8	50	14
-6	56	20
-2	48	34
48	24	-8
32	20	-16
46	20	-16
-50	-30	-6
-56	-16	-12
-8	58	24
-12	46	36
-4	52	36
26	-94	-6
16	-50	-22
30	-46	-28
-20	-96	-8
-40	-76	-18
-38	-62	-14
-44	28	-4
-38	-20	52
-26	-30	-4
-6	12	52
-8	26	62
-6	2	68
26	-28	-2
30	-40	4
26	-96	-6
14	-50	-22
44	-70	-26
-22	-98	-10
-40	-78	-20
-40	-66	-16
-38	-20	52
-26	-20	72
-4	12	52
-10	50	38
-12	38	52
-42	28	0
-46	22	18
-52	16	-6
32	-38	4
28	-28	-2
20	18	16
6	2	-8
10	10	-6
16	0	-8
2	-36	-24
26	-94	-6
14	-50	-22
4	-64	18
-20	-98	-10
-42	-78	-18
-44	-58	-16
-38	-20	52
-38	-24	68
-48	-20	60
-4	12	52
-4	12	66
-4	30	62
-12	-20	4
-28	-28	-4
-28	-6	-4
-6	-22	-14
-16	-12	-16
26	-26	-4
32	-38	2
16	16	-2
20	18	18
20	18	8

// Martz M E, 2018: No-Go (correct inhibition) > Baseline, p<0.05
// Martz M E, 2018: No-Go (correct inhibition) > Baseline, p<0.00005
// Martz M E, 2018: Reward Anticipation > Neutral, p<0.05
// Martz M E, 2018: Reward Anticipation > Neutral, p<0.00005
// Subjects=57
-52	-8	42
54	-8	38
58	-50	42
60	-32	-18
6	8	50
40	44	26
48	46	-10
-4	-4	56
-38	-16	52
14	-44	-24
-10	4	2
8	10	0

// Peraza J, 2015: No Family History Alcoholism (FHN) > Family History of 
// Alcholism (FHP): Fearful > Neutral
// Subjects=14
-3.48	-42.39	79.82

// Takeuchi H, 2018: Positive correlation between 0-back > Fixation and 
// Raven's Advanced Progressive Matrices (RAPM) score
// Takeuchi H, 2018: Negative correlation between 0-back > Fixation and RAPM 
// score
// Takeuchi H, 2018: Positive correlation between 2-back > Fixation and RAPM 
// score
// Takeuchi H, 2018: Negative correlation between 2-back > Fixation and RAPM 
// score
// Takeuchi H, 2018: Positive correlation between 2-back > 0-back and RAPM 
// score
// Takeuchi H, 2018: Positive correlation between 0-back > Fixation and Digit 
// Span Score
// Takeuchi H, 2018: Positive correlation between 2-back > 0-back and Digit 
// Span Score
// Subjects=1235
24	69	9
36	-36	45
27	-12	57
6	-72	30
9	9	69
12	42	54
36	-39	48
18	-6	12
6	6	69
6	30	51
24	-15	-21
-30	-30	75
51	-12	15
-18	-3	-24

// Aarts E, 2018: Gilles de la Tourette syndrome
// Subjects=11
-60	-20	-8
-11	47	46
-23	-90	-14
58	-4	-20
65	-17	-2
32	57	7
56	33	16
6	-46	-8
47	11	37
-54	9	7
-38	-2	1
6	53	-5
10	46	-2
-16	51	43
-23	22	58
6	62	31
6	46	31
-5	0	67
8	7	52
-36	7	7
58	11	10
28	4	13
32	-55	-26
60	-24	28
23	-59	-23
-5	-4	64

// Aarts E, 2018: Healthy Controls
// Subjects=19
-54	11	7
-38	9	1
28	-2	61
34	22	10
54	15	10
47	20	1
-25	-6	7
-13	-2	14
65	-24	31
43	-35	46
-38	-44	55
8	0	70
-8	0	61
-32	-6	55
30	51	37
6	53	-5
10	46	-2
-16	51	43
-23	22	58
6	62	31
6	46	31
-5	0	67
8	7	52
-36	7	7
58	11	10
28	4	13
32	-55	-26
60	-24	28
-16	-46	-2
8	-61	19
14	-55	7
3	13	-5
3	22	-8
8	40	-8
-5	64	-8

// Klabunde M, 2015: All Participants: Symmetry > Trained
// Klabunde M, 2015: Fragile X Syndrome > Healthy Controls: 
// Transitivity/Equivalence > Fixation
// Subjects=8
-46.24	-30.34	27.67
-42.01	-28.06	29.71
-44.18	-15.68	25.54
40.53	-62.11	30.44
-17.69	-2.18	69.97
-17.63	-20.24	67.87
-17.52	-56.43	62.58
-1.75	-26.28	70.41

// McCloskey M S, 2016: Intermittent Explosive Disorder
// Subjects=20
-18	-24	-20
24	-10	18
6	-38	-24
-26	6	46
-36	4	75
16	-28	10
22	-18	27
-50	-2	19

// McCloskey M S, 2016: Healthy Controls
// Subjects=20
-18	-24	-20
24	-10	18
6	-38	-24
-30	-58	-26
30	-62	-26
-14	-56	-50
-28	-46	-50
12	-42	24
0	-84	44
24	-10	18
-8	-74	-6
16	24	20
36	12	28

// McKechanie A G, 2019: Fragile X Syndrome (FXS) > Fragile X Syndrome with 
// Autism (FXS+): Fearful > Fixation
// McKechanie A G, 2019: All Participants: Positive Correlation between ADOS 
// Calibrated Severity Score and Faces > Fixation
// Subjects=7
-64	-30	22
-24	-42	-34

// Moon H I, 2016: All Participants: Swallow > Rest
// Moon H I, 2016: Healthy Elderly > Healthy Young: Swallow > Rest
// Subjects=15
-3	41	-19
-48	38	-7
-51	5	-28
-51	-49	53
33	-13	2
60	-46	41
63	-49	-4
-51	35	14
-24	26	-13
-12	5	11
-42	-58	-40
9	5	35
-15	-100	5
-33	38	-7
-57	-55	5
18	62	14
-21	-82	-7
-18	-91	-4
-9	-85	29

// Carreiras M, 2015: All Phrases> Baseline
// Carreiras M, 2015: Number Mismatch > Number Match
// Carreiras M, 2015: Number Match > Number Mismatch
// Carreiras M, 2015: Match, Determiner-Noun > Mismatch, Determiner-Noun
// Carreiras M, 2015: Mismatch, Determiner-Noun > Match, Determiner-Noun
// Carreiras M, 2015: Interaction between Word Type and Agreement Pattern
// Subjects=32
26	-70	32
27	-91	8
16	-66	10
35	-59	-13
42	-73	-6
54	-38	14
46	-34	44
28	-55	51
32	20	4
32	14	-2
17	7	-1
19	-27	1
44	8	28
28	-4	52
40	-4	58
-14	-72	6
-42	-76	36
-20	-76	29
-35	-80	-4
-18	-62	-4
-35	-64	-12
-21	-29	-3
-56	-6	-10
-28	14	-2
-10	-18	5
-53	-45	13
-58	-4	-8
-54	12	-18
-10	-78	26
-23	-59	50
-6	10	48
-56	-18	24
-40	-5	49
-40	30	10
-48	7	17
-38	-4	14
32	26	-2
28	20	4
-36	-42	42
-28	24	0
-50	10	26
-42	20	-4
-40	14	28
-46	-2	48
-6	4	62
32	-92	-10
58	-12	-22
44	12	-30
46	-72	36
2	-36	40
8	-52	38
6	28	-12
2	56	-4
-26	-96	-4
-34	-90	-12
0	-52	36
-60	-8	-16
-60	-20	-24
-22	-18	-26
-44	-66	48
-24	38	46
-24	30	54
-4	46	-18
-6	36	-12
-4	50	8
14	-52	36
-58	-6	-14
-48	6	30
-46	0	24
-8	-72	30
-56	-6	-10

// Hartung F, 2017: Normals
// Subjects=52
18	-30	58
26	-32	56
8	-30	56
-20	-28	54
-22	-26	62
-18	-36	54
-44	-74	-4
18	-86	-16
-40	-6	-22
-34	-12	-22

// Hartung F, 2017: Subgroup of Normals, Observers
// Subjects=14
16	60	10
18	58	2
-10	-96	0
-16	-92	8
-18	-86	-2
26	-86	8
16	-92	-2
36	-80	-12
38	34	22
54	26	30
48	28	22
-54	-18	48
-58	-36	16
-56	-24	20
-34	-60	-50
52	-40	10
50	-32	2
64	-38	14
44	2	-26
56	-6	-22
62	-14	-18
38	42	-12
46	46	-12
24	40	-12
20	2	22
22	-8	22
28	-12	32
16	-72	-12
18	-28	64
-4	-26	70
-24	-20	64
4	-38	50
-6	-32	48
44	-6	6
48	2	10
58	0	14
18	-40	6
14	-22	6
24	-44	14
50	-52	-6
54	-58	-12
52	-42	-8
18	-18	70
32	-10	66
28	-50	64
-12	56	4
8	58	0
6	62	8
24	-44	2
20	-48	-6
16	-42	6
38	24	54
34	28	48
20	26	58
-4	30	2
-12	34	-4
-14	58	4
18	-16	70
18	6	70
26	-8	66
14	60	10
8	58	0
-14	-10	70
-22	-12	66
-12	-18	74
-6	-72	42
-10	-72	34

// Hartung F, 2017: Subgroup of Normals, Enactors
// Subjects=15
16	60	10
18	58	2
-10	-96	0
-16	-92	8
-18	-86	-2
26	-86	8
16	-92	-2
36	-80	-12
38	34	22
54	26	30
48	28	22
-54	-18	48
-58	-36	16
-56	-24	20
-34	-60	-50
52	-40	10
50	-32	2
64	-38	14
44	2	-26
56	-6	-22
62	-14	-18
38	42	-12
46	46	-12
24	40	-12
20	2	22
22	-8	22
28	-12	32
16	-72	-12
18	-28	64
-4	-26	70
-24	-20	64
4	-38	50
-6	-32	48
44	-6	6
48	2	10
58	0	14
18	-40	6
14	-22	6
24	-44	14
50	-52	-6
54	-58	-12
52	-42	-8
30	-46	0
28	-42	8
14	-40	-4
2	-22	70
-16	-46	68
-12	-20	74
-16	32	46
-2	36	52
6	36	50
-40	32	34
-36	36	26
-32	24	30
-14	-94	12
-2	-96	12
-18	-98	20
62	-6	-20
58	2	-20
46	18	8
56	28	2
58	20	10
36	-14	68
40	-18	54
44	-8	58
-32	-56	-14
-28	-50	-10
24	-56	66
30	-48	70
36	-52	62
30	-38	-18
32	-40	-26
32	-28	-18
-28	-14	62
22	-82	42
14	-86	42
34	-76	44
14	-24	22
12	-28	14
14	-22	4
-26	-80	42
30	-90	10
24	-96	16
2	24	12
-54	-24	18
-60	-16	16
-14	-98	8
-10	-96	24
-16	-100	16
38	-86	-10
56	-50	4
18	-74	-14
0	-20	72
-8	-24	70
16	-40	54
20	-32	56
10	-42	60
-24	-88	-14
-10	-88	-12
18	2	28
26	-22	34
34	-28	40
-30	-34	62
12	-20	54
-2	-20	52

// Hartung F, 2017: Subgroup of Normals, Hypersimulators
// Subjects=12
30	-46	0
28	-42	8
14	-40	-4
2	-22	70
-16	-46	68
-12	-20	74
-16	32	46
-2	36	52
6	36	50
-40	32	34
-36	36	26
-32	24	30
-14	-94	12
-2	-96	12
-18	-98	20
62	-6	-20
58	2	-20
46	18	8
56	28	2
58	20	10
36	-14	68
40	-18	54
44	-8	58
-32	-56	-14
-28	-50	-10
24	-56	66
30	-48	70
36	-52	62
30	-38	-18
32	-40	-26
32	-28	-18
-28	-14	62
22	-82	42
14	-86	42
34	-76	44
14	-24	22
12	-28	14
14	-22	4
-26	-80	42
18	-18	70
32	-10	66
28	-50	64
-12	56	4
8	58	0
6	62	8
24	-44	2
20	-48	-6
16	-42	6
38	24	54
34	28	48
20	26	58
-4	30	2
-12	34	-4
30	-90	10
24	-96	16
2	24	12
-54	-24	18
-60	-16	16
-14	-98	8
-10	-96	24
-16	-100	16
38	-86	-10
56	-50	4
18	-74	-14
0	-20	72
-8	-24	70
16	-40	54
20	-32	56
10	-42	60
-24	-88	-14
-10	-88	-12
18	2	28
26	-22	34
34	-28	40
-30	-34	62
12	-20	54
-2	-20	52
-14	58	4
18	-16	70
18	6	70
26	-8	66
14	60	10
8	58	0
-14	-10	70
-22	-12	66
-12	-18	74
-6	-72	42
-10	-72	34

// Hubers F, 2016: Social Norm Violation > Neutral
// Hubers F, 2016: Grammatical Norm Violation > Truly Grammatical
// Hubers F, 2016: Truly Ungrammatical > Truly Grammatical
// Hubers F, 2016: (Social Norm Violation > Neutral)> (Grammatical Norm > 
// Truly Grammatical)
// Hubers F, 2016: Grammatical Norm Violation > Grammatical (incl. Truly 
// Ungrammatical > Truly Grammatical)
// Hubers F, 2016: Grammatical Norm Violation >Truly Ungrammatical (incl. 
// Truly Grammatical > Truly Ungrammatical)
// Hubers F, 2016: Social Norm Violation > Semantic Violation  (incl. Neutral  
// > Semantic Violation)
// Hubers F, 2016: Disgust > Neutral Face
// Hubers F, 2016: Contempt > Neutral Face
// Subjects=30
-10	48	40
-8	48	26
-8	58	24
-52	14	-4
-50	10	6
-46	24	-2
8	16	66
-6	18	48
-8	12	56
44	26	0
50	20	-8
40	16	-2
-52	14	-4
-52	12	4
-52	10	12
54	16	14
52	24	26
48	14	20
-2	10	58
-8	18	46
10	10	62
-34	-56	44
-28	-62	46
-42	-42	36
32	-62	44
-56	-32	0
50	-32	0
-52	8	-36
-48	-18	-10
-54	-2	-30
-10	50	36
-16	46	40
-12	40	44
-52	14	-4
-50	10	6
-46	24	-2
8	16	66
-6	18	48
-8	12	56
44	26	0
50	20	-8
40	16	-2
-4	64	24
0	52	48
-4	44	52
-46	-68	28
-46	-80	32
-8	48	16
-12	60	8
-12	42	8
-6	-50	30
4	-52	26
-60	-18	-18
-62	-26	-14
10	-22	44
0	-30	44
-8	-30	42
-10	54	42
-20	42	44
-24	32	42
64	-8	-16
58	-2	-18
46	6	-40
-50	-56	26
-56	-64	28
-46	-64	28
50	-34	4
50	-16	-8
52	-26	-2
-24	-104	2
50	-34	4
50	-16	-8
52	-26	-2
-24	-104	2

// Moser J S, 2017: I > Own Name
// Subjects=50
2	53	22

// Pi?ango M M, 2016: Condition A, Event 1 > Condition D, Event 1
// Pi?ango M M, 2016: Condition B, Event 1 > Condition D, Event 1
// Pi?ango M M, 2016: Condition A, Event 1 > Condition D, Event 1 VS Condition 
// A, Event 2 > Condition D, Event 2
// Pi?ango M M, 2016: Condition B, Event 2 > Condition C, Event 2
// Pi?ango M M, 2016: Condition A, Event 2 > Condition D, Event 2
// Pi?ango M M, 2016: Condition B, Event 2 > Condition D, Event 2
// Pi?ango M M, 2016: Condition B, Event 2 > Condition C, Event 2 VS Condition 
// B, Event 2 > Condition D, Event 2
// Pi?ango M M, 2016: Condition B, Event 2 > Condition C, Event 2 VS Condition 
// B, Event 1 > Condition C, Event 1
// Pi?ango M M, 2016: Condition B, Event 2 > Condition C, Event 2 VS Condition 
// A, Event 2 > Condition D, Event 2
// Subjects=15
-54	18	-3
-9	-66	45
-6	15	45
-51	30	-6
0	-63	36
24	-69	-33
-39	-18	57
15	-87	-6
18	21	6
-24	-9	57
-18	-69	-9
-30	21	0
-12	-87	-3
-33	-18	60
15	-87	-6
-39	-27	57
15	-87	-6
18	21	12
-51	-18	51
18	-84	-12

// Pliatsikas C, 2017: Extraction across a verb phrase (EVP) + Extraction 
// across a noun phrase (ENP) > Non-extraction with embedded verb phrase (NVP) 
// + Non-extraction with embedded noun phrase (NNP)
// Subjects=23
-48	-44	6
-60	-48	12
-56	-34	0
-58	-30	2
-60	-26	2
-60	-34	2
-20	-62	-10
-6	-66	-2
-26	-76	-4
-28	-72	-12
-26	-64	-12
-38	-72	-14
-10	-84	6
6	-68	14
-10	-74	10
10	-60	2
10	-64	2
14	-68	18

// Shibata H, 2018: Sentence > Picture
// Shibata H, 2018: Picture > Sentence
// Shibata H, 2018: First Perspective (1 PP) > Second Perspective (2 PP)
// Subjects=12
12	-76	5
-15	-94	-7
-9	-82	-1
-51	2	47
-42	11	29
-57	-37	2
51	-64	-4
36	-82	14
45	-49	-16
-51	-67	-1
54	-22	41
-63	-25	41
-21	-13	50
-15	32	-1

// Yang X, 2018: Two back > Zero back
// Yang X, 2018: Two back < Zero back
// Yang X, 2018: Positive Correlation between Discourse > Fixation and Context 
// Length
// Subjects=24
-45	-42	42
-48	3	36
-6	6	63
-30	0	63
24	6	60
42	-45	42
-12	-51	21
-9	39	6
15	-99	12
6	-9	39
36	-15	18
30	-33	-12
-30	-30	-12
36	-72	-12
-57	0	24
54	3	-27
-15	-96	0
-33	-18	18
45	-30	21
45	-18	45
-45	-72	30
36	36	15
36	-60	54
0	30	33
-30	-57	39
12	3	-3
3	-27	27
-24	9	12
-54	9	-6

// van der Burght  C L, 2019: ProsOnly1 > BL_ProsOnly
// van der Burght  C L, 2019: GramOnly > BL_GramOnly
// van der Burght  C L, 2019: ProsOnly1 > BL_ProsOnly, Lateralisation Analysis
// van der Burght  C L, 2019: BL ProsNoChoice > ProsOnly2, Lateralisation 
// Analysis
// Subjects=26
-45	29	-4
-57	-16	2
-51	11	8
-54	29	5
30	-19	56
54	-4	8
-6	23	50
-51	-34	2
9	23	50
6	-55	41
48	44	8
51	20	8
-39	-16	50
57	-37	8

// Chen N, 2015: Migraine with cutaneous allodynia (MWCA)
// Subjects=15
-6	-66	-15
9	-66	-15
-30	-18	-6
-21	-33	-33
-18	-15	-18
24	-3	-15
42	-57	18
57	-33	42
3	-33	-30

// Chen N, 2015: Migraine without cutaneous allodynia (MWoCA)
// Subjects=19
-9	-39	-27
18	-60	-24
-18	-18	-6
-9	45	24
-21	-27	6
57	-33	42
3	-33	-30

// Chen N, 2015: Controls
// Subjects=20
-6	-66	-15
9	-66	-15
-30	-18	-6
-21	-33	-33
-18	-15	-18
24	-3	-15
42	-57	18
-9	-39	-27
18	-60	-24
-18	-18	-6
-9	45	24
-21	-27	6

// Conforto A B, 2017: All Participants: Finger tapping at 1 Hz > Rest
// Conforto A B, 2017: All Participants: Finger tapping at 2 Hz > Rest
// Subjects=10
-14	-92	-6
52	-12	-8
-14	-24	58
42	-72	-8
-1	-90	24

// Cremers H, 2016: All Participants: Faces > Fixation
// Cremers H, 2016: Healthy Controls (HC) > Intermittent Explosive Disorder 
// (IED): Faces > Fixation
// Cremers H, 2016: Escitalopram > Placebo: Faces > Fixation
// Cremers H, 2016: Group x Drug Interaction: Faces > Fixation
// Subjects=14
40	-46	-28
-22	-32	-8
-52	30	10
32	-10	-22
24	-30	-6
56	32	10
-18	-6	-16
6	58	18
-10	26	62
-2	-60	-42
34	-10	-40
-4	54	30
44	-64	32
-28	-64	46
-44	46	10
10	-82	-44
10	-52	-38
-26	56	-20
-22	-82	52
-48	-48	18
-60	24	14
-4	-82	54
12	0	16
-34	22	-24
-46	-60	18
38	-40	-50

// Zhu C, 2017: All Participants: 0-Back > Baseline
// Zhu C, 2017: All Participants: 1-Back > Baseline
// Zhu C, 2017: All Participants: 2-Back > Baseline
// Subjects=18
10.23	-21.13	64.5
0.21	47.14	39.93
51.48	14.27	23.14
-38.95	-44.66	53.65
-41.25	-25.53	39.81
3.48	-5.94	27.62
-28.76	23.85	16.57
1	4.8	-12.29
22.63	-38.63	2.26
-.79	-5.96	27.67
1	4.8	-12.29
29.11	24.77	37.01
-28.41	18.65	59.38
16.26	40.89	40.27
-22.06	21.34	52.39
-12.57	40.98	43.94
-28.64	14.05	27.42
39.01	-43.65	45.98
-28.46	-42.25	28.8
3.71	-40.95	42.82
-.57	-40.97	42.87
6.33	6.86	-13.64
-19.1	26.54	22.92
-28.74	-33.11	-4.31
48.05	-33.13	-25.26
-58.77	-57.46	-27.57
22.6	10.58	19.32
32.56	-14.45	52.53
-28.41	18.65	59.38
13.16	34.33	52.01
-12.52	38.15	48.64
45.26	-27.72	31.19
-47.53	-34.05	53.98
2.58	-38.29	35.92
0.44	-38.31	35.94
2.3	10.46	19.56
0.16	10.45	19.59
25.83	-38.61	2.22
-6.23	-35.54	3.45
-38.37	-29.99	-4.46
42.24	-66.44	40.05
-2.7	-67.31	32.83

// Luo Y, 2016: Healthy Controls (HC) > Persistent Somatoform Pain Disorder 
// (PSPD), Negative pictures without pinprick pain > Rest
// Luo Y, 2016: PSPD > HC, Negative pictures without pinprick pain > Rest
// Luo Y, 2016: HC > PSPD, Positive pictures without pinprick pain > Rest
// Luo Y, 2016: PSPD > HC, Positive pictures without pinprick pain > Rest
// Luo Y, 2016: HC > PSPD, Neutral pictures with pinprick pain > Rest
// Luo Y, 2016: PSPD > HC, Positive pictures with pinprick pain > Rest
// Luo Y, 2016: PSPD > HC, Negative pictures with pinprick pain > Rest
// Luo Y, 2016: HC > PSPD, Neutral pictures with pinprick pain > Neutral 
// pictures without pinprick pain
// Luo Y, 2016: PSPD > HC, Neutral pictures with pinprick pain > Neutral 
// pictures without pinprick pain
// Luo Y, 2016: HC > PSPD, Positive pictures with pinprick pain > Positive 
// Pictures without pinprick pain
// Luo Y, 2016: PSPD > HC, Negative pictures with pinprick pain > Negative 
// pictures without pinprick pain
// Subjects=10
-45	-9	42
-48	-6	51
-60	-48	12
-30	-57	54
-27	-78	-12
-54	12	6
63	-9	36
63	-3	30
-9	42	-6
-48	-66	15
12	45	-6
0	51	-6
48	-21	0
48	-48	15
-30	-54	51
6	-66	48
9	-60	42
-15	-48	69
-33	24	3
-42	3	6
48	-6	-6
57	2	-6
54	18	0
42	6	-15
-9	-24	42
-42	-18	18
-48	-18	6
-48	0	-9
-27	-81	-12
-21	-75	-3
6	-12	39
27	-18	-12
42	0	6
42	0	15
-6	-72	-39
-30	-72	-39
-33	30	-12
27	-66	-39
24	15	-9
39	24	45
42	18	33
9	-3	21
-9	-72	-36
-24	-57	-36
-45	-63	15
-45	-57	-30
-45	-42	-9
-15	-6	27
-24	-12	27
33	-45	-36
48	-63	24
24	-36	24
51	15	48
3	-9	-9
48	-51	12
48	-48	21
-21	6	42
-24	-87	39
-12	-78	45
-21	42	3
-24	45	12
45	45	21
39	48	30
60	-42	42
12	-39	45
0	30	15
-21	42	3
-24	45	12
-15	-51	72
-27	-45	72
-27	-81	-12
-36	-69	-12
-3	63	24
36	-81	-12
51	39	24
-18	-48	-39
-21	-33	-36
-36	54	21
-30	54	30
-33	60	12
-24	-72	-39
-27	-63	-39
-12	-60	-36
-6	21	66
-60	-45	30
-60	-51	18
-66	-39	24
-57	21	24
-42	27	3
39	6	27
36	12	15
30	-45	-39
48	9	54
30	-87	24
48	-57	-27
0	-69	-42
9	21	66
30	-63	42

// Sandstr?m A, 2019: Rheumatoid Arthritis
// Subjects=31
58	-38	34
34	10	6
14	-18	52
34	-26	58
60	-38	34
30	28	4
16	-16	52
-12	-8	42
32	-14	36
14	-98	-2
22	-78	0
16	-20	52
-18	-80	-2
52	-16	20
20	-80	2
-26	12	-16
36	-22	46
6	-8	50
-58	0	2
40	-18	16
14	-16	0
-20	-52	-26
-10	-18	0
6	-38	20
-6	-30	-16
40	-18	40
-28	-42	18
-46	-22	16
38	-18	46
-16	-54	-20
42	-16	16
6	-8	50
56	4	4
-60	0	2
8	-8	58
-44	-18	12
54	6	6
8	-22	0
-18	-58	-22
-16	-82	0
-14	-68	2
12	-22	34

// Sandstr?m A, 2019: Healthy Controls
// Subjects=23
58	-38	34
34	10	6
14	-18	52
34	-26	58
60	-38	34
30	28	4
16	-16	52
36	-22	46
6	-8	50
-58	0	2
40	-18	16
14	-16	0
-20	-52	-26
-10	-18	0
6	-38	20
-6	-30	-16
40	-18	40
-28	-42	18
32	-16	60
-56	0	4
34	-1	10
36	4	6
60	-38	38
12	-16	0
-22	-54	-28
34	28	4
42	-22	34
-56	2	4
44	34	-2
-60	-32	26
8	-32	-18
-24	-58	-26
-16	-10	38
-8	4	32
-42	-28	-6
-36	-20	12
-12	-68	28
-18	66	-54

// Wilcox S L, 2016: Migraine > Controls, Neutral
// Wilcox S L, 2016: Migraine > Controls, Negative
// Subjects=23
4	-74	-10
-4	-66	0
8	-86	2
14	-76	-6
24	-70	0
-2	-68	4
-12	-60	50
0	-88	32
-4	-14	6
-2	-64	2
-14	-60	46
10	-52	4
2	50	-22
12	34	-14
-14	42	-24
-12	46	-14
8	56	-4
4	54	-10
22	38	40
22	30	38
16	40	40
38	2	40
26	10	68
40	6	40
-30	22	54
-30	18	56
-52	12	44
-48	14	40
-42	4	56
-26	32	36

// Zapparoli L, 2016: Gilles de la Tourette syndrome (GTS)
// Subjects=24
-38	-18	62
-30	-12	62
-58	4	32
-36	-26	54
-44	-30	46
-54	-22	30
-2	-2	54
-26	-52	62
-54	-22	22
-48	-64	6
-18	-50	-26
-4	-56	-14
-22	0	10
-14	-22	8
-12	-20	4
54	-22	20
34	-12	60
40	-20	56
34	-36	48
30	-46	62
60	-16	24
60	-28	22
18	-52	-24
14	-18	4
26	4	58
20	8	58
-30	-4	50
-34	40	26
-38	40	14
-42	38	14
-50	8	6
-52	8	38
-10	2	58
-6	4	54
-18	-66	56
-42	-38	40
-38	-52	54
-34	-56	56
-56	-36	34
-32	18	0
-40	12	-2
26	4	58
20	8	58
56	12	8
52	8	18
50	6	40
32	-2	50
50	6	30
46	2	44
18	-68	60
36	-48	48
44	-36	42
48	-34	44
-32	28	40
-34	30	34
-32	34	36
-38	34	16
28	-4	64
22	-12	58
34	32	30
34	42	28
38	32	38
32	8	54
32	10	46
-10	42	44
-6	46	22
18	42	46
20	26	32
10	54	30
2	50	32
14	50	28
12	34	52
-26	44	34
-24	36	44
16	26	30
14	16	38
30	30	36
24	50	30
40	16	-10
52	-52	30
58	-54	30
58	-46	14
60	-50	20
46	-44	12
46	-38	10
44	16	-18
40	-32	2
0	56	26
-16	-18	70
-12	-10	62
14	-8	74
2	-8	64
16	-2	68
-18	-6	62
-20	-12	58
-26	-16	62
-32	-14	66
-12	-8	64
-6	-10	64
28	-2	58
28	12	58
34	2	62
12	-8	66
4	-10	62
30	-62	60
18	-70	52
-52	22	-34
62	-10	24
-52	8	-2
-4	2	66

// Zapparoli L, 2016: Healthy Controls
// Subjects=24
-38	-18	62
-30	-12	62
-58	4	32
-36	-26	54
-44	-30	46
-54	-22	30
-2	-2	54
-26	-52	62
-54	-22	22
-48	-64	6
-18	-50	-26
-4	-56	-14
-22	0	10
-14	-22	8
-12	-20	4
54	-22	20
34	-12	60
40	-20	56
34	-36	48
30	-46	62
60	-16	24
60	-28	22
18	-52	-24
14	-18	4
26	4	58
20	8	58
-30	-4	50
-34	40	26
-38	40	14
-42	38	14
-50	8	6
-52	8	38
-10	2	58
-6	4	54
-18	-66	56
-42	-38	40
-38	-52	54
-34	-56	56
-56	-36	34
-32	18	0
-40	12	-2
26	4	58
20	8	58
56	12	8
52	8	18
50	6	40
32	-2	50
50	6	30
46	2	44
18	-68	60
36	-48	48
44	-36	42
48	-34	44
-32	28	40
-34	30	34
-32	34	36
-38	34	16
28	-4	64
22	-12	58
34	32	30
34	42	28
38	32	38
32	8	54
32	10	46
-10	42	44
-6	46	22
18	42	46
20	26	32
10	54	30
2	50	32
14	50	28
12	34	52
-26	44	34
-24	36	44
16	26	30
14	16	38
30	30	36
24	50	30
40	16	-10
52	-52	30
58	-54	30
58	-46	14
60	-50	20
46	-44	12
46	-38	10
44	16	-18
40	-32	2
0	56	26

// Dlabac-de Lange J J, 2015: Planning > Fixation, After active rTMS > After 
// sham rTMS
// Dlabac-de Lange J J, 2015: Planning > Counting, After sham rTMS > After 
// active rTMS
// Subjects=11
56	8	42
6	4	56
-4	-54	14

// Buse J, 2018: All Participants: Disharmonic > Harmonic
// Buse J, 2018: Group x Condition Interaction
// Subjects=17
4.04	-46.94	51.54
57.41	-10.07	6.64
31.43	-56.49	-6.26
25.23	46.32	37.47
-39.57	11.23	33.08
51.23	-45.01	23.65
-29.09	-59.04	-7.21
9.84	11.45	9.8
-63.52	-38.36	9.26
-24.56	41.06	29.87
1.19	28.85	12.71
-26.26	18.23	61.29
16.77	-13.69	39.06
-14	-50.48	-8.32
-16.22	-26.88	-8.37
-31.33	-24.6	-6.1
53.5	1.75	41.39
27.03	-43.95	-9.66
48.53	5.67	-8.22

// Eddy C M, 2017: Tourette Syndrome
// Subjects=25
22	-72	-2
-58	4	36
-52	-44	50
-24	-22	46
28	-52	-22
-38	28	-8
-12	-52	20
26	-4	-8
54	-46	22
4	0	58
-26	-60	6
-62	10	0
-36	-44	64
-30	-18	40
16	-82	42
22	-72	-4
10	-74	8
32	-54	-24
6	-60	26
8	58	16
-30	-72	48
-50	22	16
-20	-92	34
66	-44	22
-64	-62	8
56	16	24
-32	-82	16
18	-82	0
60	-24	14
-44	-6	46

// Eddy C M, 2017: Healthy Controls
// Subjects=25
22	-72	-2
-58	4	36
-52	-44	50
-24	-22	46
28	-52	-22
-38	28	-8
-12	-52	20
26	-4	-8
54	-46	22
4	0	58
-26	-60	6
-62	10	0
-36	-44	64
-30	-18	40
16	-82	42
22	-72	-4
10	-74	8
32	-54	-24
6	-60	26
8	58	16
-30	-72	48
-50	22	16
-20	-92	34
66	-44	22
-64	-62	8
56	16	24
-32	-82	16
18	-82	0
60	-24	14
-44	-6	46
26	-68	-12
56	18	26
22	-28	0
-20	-30	-2
-40	10	26
-4	14	48
-16	8	8
-50	-36	2
14	4	12
-12	-14	10
12	-12	8
-14	8	26
0	-16	-22
18	-10	20
-16	-8	-10
0	14	72
-8	-32	-24
26	-70	-14
20	-30	2
-4	20	44
34	20	2
0	-46	8
-28	26	0
36	10	28
32	0	58
-28	0	58
-46	10	34
-4	6	28
4	-34	-26
-38	20	26
4	-64	60
0	-46	8

// Huang J S, 2016: Group x Pain Anticipation
// Huang J S, 2016: Group x Pain Experience
// Subjects=10
-6.23	36.99	33.05
-3.05	-11.58	10.32
-36.5	20.01	-18.71
36.23	19.98	-11.74
38.24	-0.03	-36.84
34.97	9.21	-40.93
-12.79	-63.44	-26.48
-29.86	-8.36	-.79
43.28	-37.02	48.72
10.08	-61.06	29.93
41.72	35.82	13.64
2.2	-44.44	-15.98
-23.09	-63.88	23.86
-18.39	54.64	-12.9

// Kim T, 2016: Female and Male pictures > Neutral pictures
// Kim T, 2016: Female pictures > Male pictures
// Kim T, 2016: Male pictures > Female pictures
// Subjects=11
-58	10	24
48	-56	-14
-32	-46	44
-44	-36	46
64	-18	32
64	-17	33
46	-59	-11
46	12	34
48	-54	-18
30	-52	46
-32	-45	41
-56	-26	42
-48	-34	49
46	-60	-14
5	58	20
0	26	40
-8	23	26
-1	26	37
6	0	-12
46	10	36
-52	10	30
48	-66	-4
47	-53	-18
30	-53	42
-12	-62	62
26	-76	47
38	-87	10
16	-74	-44
5	-78	-31

// Marshall C R, 2019: All Participants: Facial emotions > Fixation
// Marshall C R, 2019: All Participants: Facial emotions > Mosaic
// Marshall C R, 2019: All Participants: Positive > Negative emotions
// Marshall C R, 2019: All Participants: Negative > Positive emotions
// Subjects=9
15	-94	14
-12	91	2
51	-70	2
57	-34	2
63	-58	14
54	-67	-4
60	-55	11
-3	-88	23
6	-82	38
24	-88	2
15	-91	-4
21	-82	-7

// Belyk M, 2018: Phonation > Rest
// Belyk M, 2018: Low pitch > Rest
// Belyk M, 2018: Comfortable pitch > Rest
// Belyk M, 2018: Middle pitch > Rest
// Belyk M, 2018: High pitch > Rest
// Subjects=12
-43	-18	46
48	-13	42
6	-2	63
2	7	62
2	-3	70
-3	-3	61
-43	-18	44
6	2	64
-4	-3	61
18	2	64
-42	-19	47
48	-14	41
6	-2	64
-47	-17	43
47	-15	40
40	-16	35
-7	-4	61
2	-3	70
40	-15	35
-42	-18	46
52	-13	48
47	-14	41
-5	-2	61
3	6	63
26	-73	25

// Kryshtopava M, 2017: Comfortable phonation > Rest
// Kryshtopava M, 2017: High-pitched phonation > Rest
// Kryshtopava M, 2017: Prolonged exhalation > Rest
// Kryshtopava M, 2017: Comfortable Phonation > Prolonged exhalation
// Kryshtopava M, 2017: High-pitched phonation > Prolonged exhalation
// Subjects=15
45.23	-4.92	37.09
-44.52	-13.03	36.57
24.9	28.77	47.88
-22.11	28.49	48.44
-28.49	23.33	51.18
-50.38	48.53	-6.44
28.24	-40.17	36.89
7.85	-54.35	20.47
-1.75	-54.24	22.8
40.91	-77.9	2
62.13	-16.81	5.55
-55.3	-34.98	15.11
44.22	-69.19	17.96
-41.22	-76.85	22.92
14.09	-8.84	16.59
3.26	-87.38	-34.69
-28.83	-59.31	-26.64
49.5	-3.83	36.95
-46.64	-13.93	38.9
9.9	40.31	47.08
-7.2	40.21	47.29
-54.68	48.33	-8.61
4.06	57.06	-11.13
7.85	-54.35	20.47
-1.73	-51.87	25.95
42.96	-75.57	-9.38
-47.59	-76.46	28.54
57.81	-13.93	2.01
-58.52	-34.03	13.96
14.09	-8.84	16.59
3.33	-85.47	-23.7
-29.9	-60.37	-26.54
-3.15	-28.01	-9.49
5.4	-27.96	-9.59
46.26	-6.4	31.62
50.31	5.58	7.15
-43.43	-13.91	38.86
42.98	-73.11	-5.12
-43.18	-52	55.43
15.05	-5.64	2.92
12.86	-36.97	-16.73
-19.22	-36.28	-18.65
57.87	-21.07	5.96
-49	-24	5.2
34.49	-33.04	18.38
55.72	-20.11	4.79
-51.16	-23.12	2.92
36.63	-33.03	18.36
-4.21	-29.07	-9.39

// Kleber B, 2017: Singers
// Subjects=11
-36	-30	12
42	-27	12
51	-39	36
57	-45	48
-48	-48	36
-60	-51	36
39	-51	36
-30	-63	39
54	15	3
-12	3	72
0	21	51
-15	9	63
9	15	57
48	9	-9
33	27	3
42	-66	-27
39	-75	-30

// Kleber B, 2017: Non-singers
// Subjects=11
-33	-30	15
36	-24	9
45	-18	6
66	-24	21
57	-27	21
-63	-42	24
-45	-39	42
-57	15	-3
-12	-6	72
-36	-18	36
-27	-36	60
-39	-9	45
-36	-12	42
-48	0	48
-6	6	30
-36	-6	9
-15	-66	-48
-30	-54	-21
12	-60	-15
12	-15	6
-9	-12	9
24	-27	9
-12	-27	-3
24	3	12

// Berlingeri M, 2016: Main Effect: Painful > Neutral, p<0.001
// Berlingeri M, 2016: Main Effect: Painful > Neutral, p<0.05
// Berlingeri M, 2016: Painful > Neutral (stimulus phase), p<0.05
// Berlingeri M, 2016: Painful > Neutral (stimulus phase/significant in-group 
// effect), p<0.001
// Berlingeri M, 2016: Painful > Neutral (response phase), p<0.001
// Berlingeri M, 2016: Painful > Neutral (response phase), p<0.05
// Berlingeri M, 2016: Painful > Neutral (response phase/significant out-group 
// effect)
// Berlingeri M, 2016: Main Effect: Stimulus > Response, p<0.001
// Berlingeri M, 2016: Main Effect: Stimulus > Response, p<0.05
// Subjects=25
-36	58	6
-44	46	2
-2	-44	36
-2	-64	22
-6	-58	12
48	-56	10
-4	24	40
-48	0	28
-34	24	-8
-30	22	6
-54	-26	34
-42	-36	38
40	42	18
44	30	26
50	10	30
50	14	16
0	-38	50
62	-22	38
64	-20	34
42	-44	52
50	-32	48
-58	-24	24
-56	-24	30
64	-18	34
-58	-24	24
-56	-24	30
64	-18	34
-52	22	28
-50	10	12
-50	-42	46
-40	-54	46
-34	6	50
-4	26	40
-34	52	12
-44	50	2
-38	20	-8
6	22	50
2	36	44
46	42	10
48	30	24
48	18	16
44	-48	46
-50	0	24
-34	6	50
-34	52	12
-44	50	2
36	16	50
48	30	24
48	18	16
-46	6	28
-20	30	44
-28	-80	12
-44	-72	4
-24	-70	-10
-40	-18	46
-6	-16	46
0	-78	20

// Bestelmeyer P E G, 2015: Normals
// Subjects=40
54	-19	1
63	-16	1
-60	-16	4
-24	8	-20
33	-1	-20
60	-19	16
0	23	22

// Brown T I, 2017: Normals
// Subjects=19
-44	-60	56
-20	20	60
-44	-52	-12
-28	-16	-12
-28	16	4
-8	16	52
-52	16	28
40	-44	-16
28	-12	-16

// Cao Y, 2015: Painful > Non-painful
// Cao Y, 2015: Chinese > Caucasian
// Subjects=30
-32	22	-12
40	32	-2
-2	22	56
-42	-26	56
0	58	28
16	42	14

// Chen P A, 2015: Main effect of Group: In-group > Out-group
// Subjects=22
48	-72	-3
-12	-84	-30
36	-66	-30
12	6	0
-18	-3	6
-42	-72	-3

// Smucny J, 2018: Target > Nontarget cues: Controls > Psychiatric patients 
// (BPD and SZ)
// Smucny J, 2018: Target > Nontarget cues: Controls > BPD > SZ
// Subjects=24
-40	22	48
-44	30	40
-48	36	28
22	10	52
38	10	52
26	24	56
50	-46	48
52	-50	38
48	-62	46
-46	-52	40
-32	-48	52
6	36	50
8	20	48
14	18	42
-40	22	46
42	20	42
26	12	50
42	28	44
48	-50	52

// Firat R B, 2017: Middle-class Whites > Blacks
// Subjects=13
12.8	-27.62	-19.74

// Fourie M M, 2017: Normals
// Subjects=38
1.64	5.85	70.14
-5.17	28.11	28.21
52.31	32.74	0.39
-43.82	22.65	2.34
55.69	14.75	15.24
49.57	-2.01	46.83
-49.91	2.97	37.52
-37.33	0.48	4.13
55.83	-62.92	1.68
-46.75	-73.31	0.39
42.78	-45.51	-19.7
17.12	6.89	-.38
-8.51	10.17	2.98
17.33	-7.43	20.89
-11.6	-1.77	14.06
-5.21	-28.39	-.51
1.64	5.85	70.14
-4.91	20.9	58.92
39.47	32.41	-2.78
46.32	4.06	43.01
-40.24	3.54	44.05
-4.74	-79.49	40.57
-1.75	-15.77	38.54
-17.55	-76.14	43.78
49.29	-14.86	4.42
-56.53	-15.75	2.36
48.87	13.78	-38.13
-50.44	7.35	-29.75
-47.17	17.91	-17.3
55.59	-19.28	-12.01
-56.61	-23.13	-10.4
-21.43	-7.31	-15.48
10.81	1.28	10.2
-8.5	13.6	6.04
20.48	-27.72	5.83
-21.24	-28.49	-.32
-5.28	-25.73	-7.42
-49.85	-59.1	19.3
7.91	20.98	58.76
8.08	-79.42	40.42
4.66	-15.73	38.46
52.73	-58.48	18.07
1.61	-63.59	39.16
1.27	-47.39	1.01
-11.97	66.91	-6.2
1.61	-63.59	39.16
1.27	-47.39	1.01
7.91	-48.29	30
-40.57	16.58	6.16
52.76	-45.02	26.98
20.78	8.37	59.67
-59.84	-23.4	-13.69
-23.91	-69.06	53.3
10.82	4.71	13.26
-1.83	-89.16	-2.15
-4.92	-48.37	30.16
-8.42	4.6	13.49
4.58	-89.12	-2.22

// Hein G, 2016: Subgroup of Normals, Control Group
// Subjects=18
-30	17	-4
-30	26	-13
-33	11	-13
36	-13	-1
-12	-22	11
-21	29	35
39	47	20
45	-25	44
-27	17	-13
-30	26	-13
-33	14	-1
42	8	-1
42	-16	20
42	-40	56
-33	14	32
48	44	8
51	-43	32
-39	-22	2
-21	-10	-10
-51	-54	11
54	-46	11
-27	-70	29
21	-73	17

// Hein G, 2016: Subgroup of Normals, Experimental Group
// Subjects=20
-39	26	-7
-27	17	-13
-42	-49	32
54	-40	50
-51	11	-4
-45	-34	-1
30	-76	17
-33	17	-4
-27	17	-13
-30	26	-13
-33	14	-1
42	8	-1
42	-16	20
42	-40	56
-33	14	32
48	44	8
51	-43	32
-39	-22	2
-21	-10	-10
-51	-54	11
54	-46	11
-27	-70	29
21	-73	17

// Izuma K, 2019: South Korea > Japan
// Subjects=70
12	-97	-2
-18	-106	-5

// Jiang X, 2018: Confident > Doubtful
// Jiang X, 2018: Doubtful > Neutral
// Jiang X, 2018: In-group > Out-group (Regional + Foreign)
// Jiang X, 2018: Out-group (Regional + Foreign) > In-group
// Jiang X, 2018: Out-group/Regional (Confident>Neutral) > In-group 
// (Confident>Neutral)
// Jiang X, 2018: Out-group/Regional (Confident>Doubtful) > In-group 
// (Confident>Doubtful)
// Jiang X, 2018: Out-group/Foreign (Confident>Neutral) > In-group 
// (Confident>Neutral)
// Jiang X, 2018: Out-group/Foreign (Confident>Doubtful) > In-group 
// (Confident>Doubtful)
// Jiang X, 2018: Out-group/Foreign (Doubtful>Neutral) > In-group 
// (Doubtful>Neutral)
// Jiang X, 2018: In-group (Confidence>Neutral) > Out-group/Regional 
// (Confident>Neutral)
// Subjects=25
-32	-38	16
24	-34	-12
46	-24	0
-64	-26	2
-14	62	20
-34	-76	12
40	-62	14
0	-22	52
50	-18	0
-50	-22	2
18	-4	26
12	18	48
-6	-86	26
29	-45	-12
38	-54	58
64	-42	6
-16	-48	-48
-8	38	34

// Kim K, 2015: Ingroup > Outgroup
// Subjects=24
-8	42	-22
-22	-60	6
26	-62	0
32	-80	26
6	-82	2
-42	44	-16
44	-28	56

// Krosch A R, 2019: Black > White
// Krosch A R, 2019: White > Black
// Krosch A R, 2019: Control > Scarce
// Krosch A R, 2019: Scarcity x Race
// Subjects=30
-15	-54	9
33	30	42
-39	27	42
36	-57	-3
18	12	0
-15	-21	-21
42	9	9
-20	-36	-36
-9	69	69
3	18	18

// Lau T, 2017: Out-group/In-group > (Identical In-group, Different In-group): 
// Repetition Suppression
// Lau T, 2017: (Identical In-group and Different In-group) > 
// Out-group/In-group: Repetition Enhancement
// Subjects=22
40	-58	48
-40	-54	54
48	34	38
-44	30	28
64	-28	-12
-58	-40	-12
-42	-30	66
36	-18	66
40	-38	24
48	2	10

// Li T, 2016: White > Black
// Li T, 2016: Negative > Positive
// Li T, 2016: White Negative > White Positive
// Li T, 2016: Black Negative > Black Positive
// Li T, 2016: White Positive > Black Positive
// Li T, 2016: White Positive and Black Negative > White Negative and Black 
// Positive
// Subjects=44
-24	-57	-24
24	-54	-15
36	-69	-27
-9	-90	0
-54	-39	0
-57	-39	0
-12	-96	0
-3	45	30
-42	18	-18
-9	-93	12
27	-48	-24
-30	-45	-27
18	-63	24
27	-78	27
33	-30	72
39	-63	-6
-3	0	33
18	-66	24

// Lin L C, 2018: Ingroup > Outgroup
// Subjects=45
-34	20	-16
-20	2	-20
-28	20	-20
-8	10	-6
-54	2	-24
50	42	-6
48	42	26
28	20	-18
-4	60	-18
-2	60	32
6	54	0
-10	48	12
6	-30	6
66	-28	-8
64	-32	-10
12	-44	-44
-6	-38	-54

// Liu Y, 2015: [(Disgusted Out-group > Neutral Out-group) > (Disgusted 
// In-group > Neutral In-group)]
// Liu Y, 2015: Disgust > Neutral
// Liu Y, 2015: Out-group > In-group
// Subjects=26
30	0	-18
45	21	-6
-15	33	-18
51	24	-6
39	9	-3
-33	15	0
48	3	51
-33	12	57
54	39	3
57	-39	51
44	-46	-20
-42	-57	-18
51	-54	0
-51	-57	3
45	-77	-6
-36	-84	-6
-12	-78	-45
-27	-6	-12
27	-84	-12
-32	-74	-18
51	-54	0
-51	-72	12
27	-96	-9
-15	-96	-9
18	-96	0
-15	-96	-3
18	-12	0
-3	-21	0
-63	-21	33
51	-3	45
-12	-30	-45
-9	-42	-54

// Luo S, 2015: Subgroup of Normals, G/G Individuals
// Subjects=30
-4	24	42
-36	20	-12
32	24	-14
-56	-22	24
64	-22	24
52	6	40
36	-54	60
-40	-54	-20
34	-62	-26
2	18	60
-58	12	16
60	8	18
58	10	40
-56	-26	28
56	-22	26
28	-56	56
52	-62	-10
-32	-94	0
0	36	42

// Luo S, 2015: Subgroup of Normals, A/A Individuals
// Subjects=30
4	10	36
-40	12	-8
40	32	-10
-38	-2	-6
40	-2	8
-56	-22	22
60	-20	32
-46	-52	-16
-38	-84	20
-8	18	34
-32	20	6
36	30	-2
-40	-2	14
38	-4	-8
62	12	10
-62	-22	28
60	-22	32
30	-52	60
-4	12	-8

// Marsh L E, 2016: Imitative compatibility (Incompatible > Compatible), 
// p<0.001
// Marsh L E, 2016: Imitative compatibility (Incompatible > Compatible), 
// p=0.002
// Marsh L E, 2016: Imitative compatibility (Incompatible > Compatible), 
// p=0.02
// Marsh L E, 2016: Imitative compatibility (Incompatible > Compatible), 
// p=0.014
// Marsh L E, 2016: Spatial compatibility (Incompatible > Compatible)
// Marsh L E, 2016: Gaze x Spatial compatibility
// Marsh L E, 2016: Group x Gaze x Spatial compatibility
// Marsh L E, 2016: General compatibility (Incompatible > Compatible), p<0.001
// Marsh L E, 2016: General compatibility (Incompatible > Compatible), p=0.041
// Marsh L E, 2016: Group x Gaze x General compatibility
// Subjects=24
62	6	16
62	6	34
52	8	24
60	-26	42
50	-18	46
-50	-28	26
-44	-32	22
-42	-40	32
10	12	48
18	4	48
10	20	40
-14	-58	68
-56	-26	46
-38	-38	56
56	-26	42
20	-56	68
60	-32	38
22	-4	66
24	-10	58
-16	-6	54
38	-10	64
40	-24	54
25	-15	55
30	56	24
56	-26	48
64	-28	40
52	-26	38
30	0	48
22	-4	66
56	12	6
-54	-32	30
-54	-24	20
-60	4	26
36	50	30
40	60	2
40	58	16
28	62	12

// Mattan B D, 2018: White > Black
// Mattan B D, 2018: Black > White
// Mattan B D, 2018: low-status Black - high-status Black > low-status White - 
// high-status White
// Subjects=60
-42	-39	75
36	-99	-3
6	60	9
33	-51	9

// McCutcheon R, 2018: Subgroup of Normals, Black Ethnicity
// Subjects=17
33	-58	-26

// Molapour T, 2015: Acquisition: Conditioned Stimulus (CS+) > Unconditioned 
// Stimulus (CS )
// Molapour T, 2015: Acquisition: CS- > CS+
// Molapour T, 2015: Acquisition: Black > White
// Molapour T, 2015: Acquisition: White > Black
// Molapour T, 2015: Acquisition: [(White CS+ > White CS-) > (Black CS+ - 
// Black CS-)]
// Molapour T, 2015: Extinction: CS+ > CS-
// Molapour T, 2015: Extinction: CS- > CS+
// Molapour T, 2015: Extinction: Black > White
// Molapour T, 2015: Extinction: White > Black
// Molapour T, 2015: Extinction: [(Black CS+ > Black CS-) > (White CS+ > White 
// CS-)]
// Molapour T, 2015: Acquisition: CS+ > CS- (Linear change over time)
// Molapour T, 2015: Acquisition: CS- > CS+ (Linear change over time)
// Molapour T, 2015: Acquisition: Black > White (Linear change over time)
// Molapour T, 2015: Acquisition: White > Black (Linear change over time)
// Molapour T, 2015: Acquisition: [(White CS+ > White CS-) > (Black CS+ - 
// Black CS-)] (Linear change over time)
// Molapour T, 2015: Extinction: CS+ > CS- (Linear change over time)
// Molapour T, 2015: Extinction: CS- > CS+ (Linear change over time)
// Molapour T, 2015: Extinction: Black > White (Linear change over time)
// Molapour T, 2015: Acquisition: (Black CS+ > Black CS-) and (White CS+ > 
// White CS-)
// Subjects=20
42	-13	40
46	-15	33
9	6	40
28	8	34
50	-54	-23
44	-57	-9
39	-64	-12
-56	-27	0
-48	-49	12
-50	-19	-8
32	-87	25
14	-76	34
10	-76	52
30	-52	48
32	-51	39
68	-24	-5
69	-37	-5
-16	-66	-3
-4	-72	-11
-32	-67	-2
27	-15	-8
34	-12	-14
-26	-64	24
-21	-66	36
-30	-12	-11
-27	-84	-9
18	-58	-8
-24	11	13
-15	-7	67
57	18	33
28	0	-33
-40	24	43
-50	-30	16
12	-49	1
-28	-48	37
-12	-70	9
-36	-55	33
-33	-49	54
-38	-33	52
24	6	-15
9	-70	13
-24	-42	9
-27	-22	-6
18	-27	-20
42	-46	28
60	-1	-17
-14	-40	34
22	-24	55
-30	18	-6
33	-37	4
42	9	6
62	-40	-12
40	-60	56
-39	-70	40
-42	-55	34
33	14	51
-42	6	33
69	-30	10
-30	12	49
-39	12	54
-38	6	60
-18	33	48
-6	-54	18
54	-37	31
-16	3	48
-62	-33	42
-66	-39	31
-18	0	63
34	-3	60
-18	-54	49
-51	-43	55
-46	-49	58
51	2	28
34	-49	63
-4	-15	19
-20	-21	1
-27	12	-17
14	-22	21
64	-48	34
51	-46	33
-42	15	10
40	44	12
21	-42	3
33	12	-2
-58	3	33
-20	17	63
-6	30	58
-30	-4	58
-4	-10	67
32	-51	3
-24	-52	69
16	3	66
10	-82	-24
-36	-13	66
-21	-18	60
44	3	58
36	-16	49
62	-6	36
58	6	39
-57	-9	28
-58	-1	40
-58	-16	46
-21	-81	48
28	-79	43
58	-30	6
-51	-18	13
34	-40	51
9	-21	28
12	-55	21
-40	-30	9
12	-39	36
63	-18	-2
26	30	36
-30	-28	16
-27	18	18
-14	-1	24
10	-81	-26
-6	-70	-9
-14	-60	-29
-50	-48	12
18	-70	1
16	-42	58
-22	-6	-27
45	-22	16
9	-9	45
-42	-13	6
-34	-7	6
-58	15	10
22	-3	-3
60	15	10
-66	-46	13
-33	53	19
-64	-3	27
62	3	28
-20	-67	42
-22	-64	31
-20	-76	51
-42	-43	-9
-30	-40	-3
-51	-51	-9
22	-67	42
26	-67	52
27	-57	60
18	-13	-18
22	-33	6
-36	-13	-20
46	-12	-8
-27	35	-9
45	-6	-14
58	-4	-20
36	-4	-18
52	-39	-17
33	-63	-11
32	-52	-5
27	-48	-12
14	-4	-20
22	28	-12
-36	-51	-12
-28	-58	-2
-30	-58	-11
-22	-42	-12
-16	36	54
45	-3	30
-34	-82	-17
-33	-85	7
-38	-82	19
-32	76	12
-9	42	-12
-45	5	-39
-52	0	-38
-38	17	-23
48	-54	0
-34	35	-17
-22	-75	24
24	-42	49
52	3	-32
30	-75	6
15	-15	46
-52	-66	-5
33	-37	-24
39	24	-21
-15	38	34
-33	-67	16
45	-13	31
-46	-1	40
45	24	9
6	3	40
44	11	28
-9	9	0
-60	8	-2
24	51	16
24	33	-15
50	-52	-23
6	44	-12
-18	50	18
-9	3	33
-6	-24	48
2	-4	67
-10	-34	52
10	12	1
-30	36	31
45	20	16
60	3	7
58	2	19
40	28	-5
52	-67	-2

// Moradi Z, 2017: Rival > In-group
// Subjects=20
-36	14	31
-42	32	4
-51	20	10
-33	-61	-14
-42	-40	64
-21	-76	46

// Rauchbauer B, 2015: Incongruent > Congruent
// Rauchbauer B, 2015: Happy (Incongruent > Congruent)
// Rauchbauer B, 2015: Angry (Incongruent > Congruent)
// Rauchbauer B, 2015: Out-group (Incongruent > Congruent)
// Rauchbauer B, 2015: In-group (Incongruent > Congruent)
// Subjects=41
-32	-46	44
12	-64	52
58	-40	32
40	18	-6
26	-10	54
-30	-8	-62
-34	14	-10
-56	-64	2
2	8	46
-12	2	68
28	34	24
4	-48	-12
-24	-58	-20
6	28	26
30	-52	68
64	-46	38
22	-8	56
-8	-6	68
4	-52	-8
-38	-74	-7
-34	-42	40
32	24	4
22	-8	56
2	8	46
-52	2	10
-28	22	12
-48	-58	-2
4	-64	-14

// Richins M T, 2019: Painful > Neutral
// Richins M T, 2019: Exeter > Cardiff + Sussex > Cardiff
// Richins M T, 2019: [(Exeter Pain > Exeter Neutral + Cardiff Neutral > 
// Cardiff Pain) + (Sussex Pain > Sussex Neutral + Cardiff Neutral > Cardiff 
// Pain)]
// Richins M T, 2019: Other-focussed > Self-focused
// Subjects=69
48	-74	2
0	56	26
-44	-56	-18
-52	18	-12
43	24	-2
-2	-62	32
60	-10	-14
-40	-68	36
2	10	40
-14	-26	18
-20	20	-16
0	-50	20
-40	12	52
30	-54	34
20	-60	-30
-38	48	2
0	-8	12
-44	48	-4
-38	24	-32
22	62	18
56	-10	-20
58	-50	16
-36	-74	-32
42	-62	-34
66	-50	-2
-4	8	68
-30	54	-12
-56	16	24
36	18	-10
-10	66	-6
-54	-54	16
-32	46	26
-52	-14	-10
20	60	-16
-56	-72	6
-46	0	-10
0	-50	2
-10	-20	20
36	-32	10
48	-42	52
2	28	20
0	16	46
-30	-2	44
-32	20	-8
46	-64	-8
-68	-30	-8
0	40	36
-52	-72	2
-54	16	28
58	20	22
48	-28	-4
50	38	-12
50	-64	-6
50	-68	16
-38	-30	14
-42	-48	-20
-10	-88	-24
40	-48	54
-52	-38	26
66	-18	26
-4	-12	16
-50	-22	32
0	-54	48
-62	-10	0
34	58	0
48	-42	-20
50	-22	34
26	68	4
-40	6	-12
0	48	0
-44	-44	50
-36	-24	-24
-4	8	66
-26	16	56
-32	-98	-8
28	-10	-18
0	-2	-16
46	12	-16
-30	-40	-24
0	56	-12
62	-40	-4
-58	-30	-14
-8	-44	38
-22	-88	-12
-38	-84	12
-18	0	6
44	-30	28
-40	-78	-30
-26	36	34
58	-48	30
42	-72	0
8	-42	28
-64	-2	24
-12	26	0
-54	-32	46
16	44	16
0	34	12
-2	56	26
2	-66	32
-46	26	36
48	-60	26
-54	-68	28
54	12	-32
-62	-16	-14
-8	6	10
60	-12	-12
-32	62	2
58	26	6
10	-56	-38
-38	-68	-30
-28	24	-20
-4	-16	6
-38	-12	-14
-48	8	38
-4	0	50
64	8	16
4	-24	-26
-2	-34	60
32	-42	38
-34	-44	42

// Ruckmann J, 2015: Pain > Neutral
// Ruckmann J, 2015: Ingroup > Outgroup
// Ruckmann J, 2015: Main effect of gender
// Ruckmann J, 2015: Pain x Condition Interaction
// Ruckmann J, 2015: Pain x Gender Interaction
// Subjects=15
-54	6	20
-58	-22	28
64	-22	38
58	12	14
-4	26	36
-44	44	10
-12	-92	-22
-10	-82	2
26	-68	-28
12	-90	22
-18	6	2
16	-86	-4
-14	-100	20
46	-60	16
38	10	28
-36	-56	56
36	-86	6
-30	-92	12
28	-78	42
-4	-84	12
-28	-74	46
60	8	38
-2	-96	-4
12	-88	-2
-24	-26	0
14	-6	-2
2	-66	-36
16	-78	-36
22	-20	-6
-32	-28	6
6	-46	76
20	-2	32

// Telzer E H, 2015: Donations > Pure Reward
// Telzer E H, 2015: In-group Donations > Outgroup Donations
// Telzer E H, 2015: In-group Donations > Pure Reward
// Telzer E H, 2015: Out-group Donations > Pure Reward
// Telzer E H, 2015: Group Identity (Out-group > In-group)
// Telzer E H, 2015: Chinese > American
// Subjects=13
6	17	5
45	-43	46
-40	-46	46
9	23	37
-32	58	1
-24	41	28
33	17	10
33	53	28
30	5	1
-30	5	-2
-27	26	7
-42	-22	40
2	-81	16
18	20	-8
12	22	-2
-33	56	19
33	44	34
3	17	46
45	-22	61
-12	-55	49
12	-97	7
28	-1	-14
-38	8	-2
-6	5	58
-33	53	22
30	53	25
-42	-22	37
-27	-34	49
42	-10	40
-18	-28	58
8	-85	20
-48	-67	31
-15	41	46
15	41	49
9	41	13
57	-19	-26
45	50	-5
-39	53	-12
-48	-58	21
50	-67	37
60	-52	25
63	-28	-5
-12	-70	40

// Wang C, 2015: Painful > Non-painful
// Wang C, 2015: Priming x Race interaction
// Subjects=30
9	2	67
-3	8	70
0	-1	34
-57	5	1
-42	-4	13
60	11	7
57	11	22
51	-55	-11
57	-22	34
36	-52	-23
-33	-61	-26
-3	26	52
-50	17	31
51	-52	31

// Watson R, 2017: Shape Categorisation: Black bodies > White bodies
// Watson R, 2017: Shape Categorisation: White angry bodies > Black angry 
// bodies
// Watson R, 2017: Shape Categorisation: Black happy bodies > White happy 
// bodies
// Watson R, 2017: Emotion Categorisation: Black bodies > White bodies
// Watson R, 2017: Emotion Categorisation: White bodies > Black bodies
// Watson R, 2017: Emotion Categorisation: Black happy bodies > White happy 
// bodies
// Watson R, 2017: Emotion + Shape Categorisation: Black bodies > White bodies
// Watson R, 2017: Emotion + Shape Categorisation: White angry bodies > Black 
// angry bodies
// Watson R, 2017: Emotion + Shape Categorisation: Black happy bodies > White 
// happy bodies
// Subjects=21
15.19	-30.5	11.7
47.31	3.3	33.03
-23.17	-64.74	12.78
-22.87	-79.26	45.22
-1.79	12.32	43.99
-16.86	39.72	41.86
-31.59	-85.42	21.3
-53.21	-64	-2.55
44.97	-47.18	-14.01
-53.13	-49.94	14.11
55.66	-20.71	-2.97
49.41	-65.16	0.83
-51.01	-45.7	13.73
-59.63	-39.92	6.66
62.36	-46.28	23.63
11.31	-72.54	46.49
2.72	-64.3	43.67
-7.94	-68.42	46.37
-14.48	-69.83	28.72
-22.97	-71.49	35.65
23.97	-82.98	20.46
17.81	-62.84	61.22
30.52	-59.56	47.42
-44.41	-26.17	45.48
-37.93	-40.77	48.86
-44.28	-42.41	55.76
-1.67	-15	48.51
-3.71	-33.7	54.56
-24.99	-35.09	66.07
-42.52	-70.45	-4.36
36.67	-81.98	4.62
-31.72	-86.8	3.58
-35.94	-84.02	12.31
36.56	-76.5	-6.99
-31.46	-84.05	39.03
19.36	-49.11	-9.09
-19.12	-49.51	-10.85
-1.78	3.69	42.48
-1.75	-31.18	32.02
36.33	26.56	4.44
0.45	11.25	57.44
-1.83	22.89	43.1
27.7	-11.67	-21.25
49.36	13.37	25.47
-38.26	10.73	26.7
34.18	26.37	2.25
-38.49	21.54	1.26
4.67	12.87	50.56
-48.98	-62.2	-7.21
-61.63	-25.36	29.99
47.11	-47.17	-14.04
53.75	-11.81	29.76
38.72	5.02	28.52
53.52	3.4	6.18
-33.95	11.1	31.08
-24.98	-32.8	68.11
-55.01	-29.78	54.82
-50.86	-28.84	39.08
19.96	-64.94	61.37
-21.41	-73.07	-40.07
-33.59	-66.46	46.5
6.8	15	50.36
30.45	-.92	62.57
-44.65	-76.98	-6.02
-31.61	-79.08	20.77
36.84	-80.27	26.78
-38.07	-84.03	12.34
-33.61	-84.24	36.84
-14.64	-78.06	4.88
-42.19	-62.63	41.82
-34.16	-41.65	-18.03
-42.73	-55.08	-25.72
-44.84	-48.23	-19.58
32.04	26.36	2.28
-36.36	19.26	-.8
-4.47	-30.67	-43.82

// Wu C, 2018: SAME-DM2 > COM-DM2
// Wu C, 2018: DIFF-DM2 > COM-DM2
// Wu C, 2018: COM-DM2 > SAME-DM2
// Wu C, 2018: COM-DM2 > DIFF-DM2
// Wu C, 2018: SAME-DM2 > DIFF-DM2
// Wu C, 2018: Humanoid-DM2 > non-humanoid-DM2 [(SAME-DM2 > COM-DM2)  
// (DIFF-DM2 > COM-DM2)]
// Wu C, 2018: Non-humanoid-DM2 > humanoid-DM2 [(COM-DM2 > SAME-DM2)  (COM-DM2 
// > DIFF-DM2)]
// Wu C, 2018: Reciprocate > Defect
// Wu C, 2018: Defect > Reciprocate
// Wu C, 2018: SAME-DM2 defects > SAME-DM2 reciprocates
// Wu C, 2018: DIFF-DM2 reciprocates > DIFF-DM2 defects
// Subjects=54
42	16	58
-40	18	54
16	50	40
-4	62	32
-54	-66	30
2	-50	28
56	-68	10
-46	-78	2
0	52	-14
-30	18	-14
38	-50	-20
-40	18	56
46	20	50
20	44	42
2	-50	28
-46	-62	28
58	-64	18
-50	-10	-20
54	-2	-24
-36	-88	22
-26	-44	-14
-34	-88	24
30	-46	-10
-30	-44	-10
-26	-62	-16
-2	12	12
6	18	10
42	16	58
20	46	50
-46	-64	30
56	-66	28
6	-54	28
30	-46	-10
-36	-88	22
-26	-44	-16
-24	-94	-10
-4	4	64
6	14	60
-36	4	48
48	-24	-6
2	18	58
-4	10	52
46	-42	2
0	12	12
-2	20	12

// Kryshtopava M, 2019: Comfortable phonation > Rest
// Kryshtopava M, 2019: High-pitched phonation > Rest
// Kryshtopava M, 2019: Prolonged exhalation > Rest
// Kryshtopava M, 2019: Phonation > Rest
// Subjects=4
45.24	-10.29	36.42
57.09	-6.02	49.31
-42.42	-13.44	31
32.49	22.18	58.38
-26.31	29.23	58.46
28.18	-44.11	27.19
40.91	-77.9	2
-38.16	-78.37	2.94
62.15	-26.42	5.24
-59.67	-27.15	6.7
38.49	-62.25	-29.4
-36.32	-62.7	-28.5
-4.51	-27.75	-47.41
50.63	-3.23	44.69
-51.97	-4.01	43.7
29.05	48.37	39.5
-26.51	48.04	40.16
11.99	45.27	42.18
-9.39	45.14	42.44
-4	2.82	31.43
40.91	-77.9	2
48.92	25.29	-26.82
30.75	6.44	-35.07
-31.21	-.28	-33.8
-46.2	20.15	-29.76
-65.1	-13.86	0.07
3.32	-6.51	6.48
3.15	-47.83	-32.43
-1.12	-47.85	-32.38
0.95	-27.67	-32.98
46.26	-6.4	31.62
50.31	5.58	7.15
-43.43	-13.91	38.86
42.98	-73.11	-5.12
-43.18	-52	55.43
15.05	-5.64	2.92
12.86	-36.97	-16.73
-19.22	-36.28	-18.65
46.23	-3.39	29.14
57.12	-16.59	50.2
-43.53	-3.93	30.22
-54.01	-17.26	51.53
58.93	-23.35	3.9
-55.25	-42.13	19.06

// Boccia M, 2015: Visuo-spatial Imagination (Imagery) > Baseline
// Subjects=15
-45	-64	37
-15	-97	-2
9	-82	7
3	-76	28
-21	-37	-17
24	-37	-17
27	-34	-2
-51	5	28
48	-4	16
-39	-43	49
42	-40	49
54	-58	-14
-3	-76	4
30	-4	52
-24	-4	49
30	-64	34
-30	-40	-14
30	-31	-14
39	-22	61
-3	-79	46
-18	-61	16
15	-55	10
-24	-67	55
27	-61	61

// Fulford J, 2018: Low-Vividness Group > High-Vividness Group, Imagery > 
// Imagery Control
// Fulford J, 2018: High-Vividness Group > Low-Vividness Group, Imagery > 
// Imagery Control
// Fulford J, 2018: Positive Correlation between BOLD signal and vividness of 
// individual images, All Participants
// Fulford J, 2018: Negative correlation between BOLD signal and vividness of 
// individual images, All Participants
// Fulford J, 2018: Low-Vividness Group > High-Vividness Group, Perception > 
// Perception Control
// Subjects=14
-48.03	-38.9	37.06
-18.71	60.43	-15.85
-37.56	37.41	25.97
-13.56	11.94	39.29
-28.84	-81.19	8.42
-39.52	-49.68	24.54
-35.32	-5.75	23.48
-55.86	5.02	25
-9.26	-10.15	32.43
-52.16	-45.11	51.19
-17.81	-11.68	39.45
-20.13	-15.06	26.38
-37.31	-65.73	24.97
-3.25	59.68	9.73
-37.31	-65.73	24.97
-3.25	59.68	9.73
50.77	-17.82	-7.05
49.82	-11.37	4.65
38.06	49.68	26.83
42.33	44.93	21.62
21.04	-87.32	20.5
25.48	-87.54	29.41
20.57	13.1	3.85
53.19	7.12	18.46
23.32	-55.77	36.39
11.96	33.04	10.99
34.01	-61.02	25.53
3.32	43.96	13.42
-4.71	33.19	59.44
-28.79	-34.86	21.77
-43.69	-77.04	30.67
-36.28	-55.2	22.78
-46.01	-55.23	22.95
-.38	-50.97	43.05
4.15	-43.98	60.21
7.83	-48.74	9.07
-39.9	-75.55	-11
-9.29	-55.21	21.21
-17.83	-52.28	30.03
-9.23	-45.97	28.13
28.13	-42.68	-7.57
22.57	-35.12	-18.3
42.41	-44.16	10.27
46.92	-52.57	23.35
60.55	55.96	12.38
29.28	-78.29	-9.66
27.33	-54.84	11.58
-17.79	-47.61	34.05
58.84	-54.45	25.57
63.59	-5.74	-16.31
53	26.49	7.58
-9.25	-76.79	19.98
10.16	-73.74	17.1
-7.59	34.37	3.35
-52.82	-11.73	6.44
-50.45	-37.58	16.8
38.1	-90.09	1.44
28.36	-94.58	-.19
30.06	-48.35	57.96
52.91	31.29	1.5
55.31	-19.44	9.84
55.22	-14.64	3.77
48.64	-18.69	-4.69
-43.95	7.5	27.92
55.31	2.45	14.4
-29.04	-42.26	0.09
-26.1	-55.03	58.45
-24.1	-52.87	47
46.8	-65.52	11.18
-54.81	-55.34	10.79
56.28	-68.41	-8.86

// de Wit S J, 2015: Obsessive Compulsive Disorder (OCD) Patients
// Subjects=39
18	17	4
-18	2	7
-15	14	7
-51	-34	-8
-57	-9	-8
-57	8	10
39	14	7
-45	-82	10
9	-40	-11
18	-10	4
-24	-31	4
-21	-10	4
-39	2	58
-45	5	-35
18	-43	64
45	-67	43
51	-25	34
-21	-46	-2
51	2	13
48	-76	16
15	-37	-20
-15	-34	-23
12	-91	31
3	-85	37
-9	2	34
-12	-7	37
57	-19	4
-48	2	7

// de Wit S J, 2015: Healthy Controls
// Subjects=38
-48	-10	52
-51	5	22
45	11	10
-21	20	46
30	-37	-5
33	-79	-2
-30	-88	-8
45	-34	34
-33	-61	-32
-39	-49	-26
-36	-52	-14
51	-37	43
54	-1	19

// Berteletti I, 2015: Positive Correlation between Number Line estimation 
// error and Subtraction Small > Large
// Subjects=39
-56	-56	2
4	-66	58
-20	-16	-6
-38	-40	46
16	14	-2
56	-54	6

// Luculano T, 2015: Mathematical Learning Disabilities (MLD)
// Subjects=15
-14	26	60
-30	50	6
-30	30	0
40	12	-12
12	56	6
-20	44	36
20	26	58
-58	-36	46
-34	-58	60
6	-76	46
24	-80	-14
-30	-32	-24
-36	-62	-34
36	-68	-32
6	12	-12
-30	16	-8
-28	-20	-20
-52	20	30
-8	12	58
32	2	66
36	2	-6
-30	28	0
36	-64	54
-26	-50	46
18	-74	-16
-22	-68	-20
-36	-60	-30
36	-64	-28
44	28	14
-42	-8	32
40	12	-12
-8	14	58
-54	10	8
-20	50	8
46	30	30
-36	-4	-2
2	30	58
-30	-56	64
-30	-32	-24
-36	-62	-34
36	-70	-30
-28	-18	-20
-30	-16	-8
-22	52	10
44	30	32
-48	6	44
-4	12	58
-50	22	-10
34	-60	50
-20	-70	46
48	-52	-24
-10	-68	6
-50	-44	-8

// Luculano T, 2015: Typically Developing (TD)
// Subjects=15
-14	26	60
-30	50	6
-30	30	0
40	12	-12
12	56	6
-20	44	36
20	26	58
-58	-36	46
-34	-58	60
6	-76	46
24	-80	-14
-30	-32	-24
-36	-62	-34
36	-68	-32
6	12	-12
-30	16	-8
-28	-20	-20
-36	2	28
30	-54	38
-36	-84	-4
44	28	14
-42	-8	32
40	12	-12
-8	14	58
-54	10	8
-20	50	8
46	30	30
-36	-4	-2
2	30	58
-30	-56	64
-30	-32	-24
-36	-62	-34
36	-70	-30
-28	-18	-20
-30	-16	-8

// Matejko A, 2019: Adults
// Subjects=26
41.36	38.03	25.27
36.26	20.76	2.11
-6.32	-75.21	-5.85
34.29	58.86	29.5
1.83	-14.09	12.38
-0.08	14.98	47.63
-40.06	17.31	26.97
-33.06	-12.37	39.07
57.59	-39.93	23.13
34.61	-85.74	0.81
35.43	-63.14	-13.87
10.48	-74.1	37.71
-21.81	-96.07	2
-53.73	15.1	25.35
32.4	-57.59	-28.71
29.88	-67.86	29.76
-.69	-84.66	1.42
-.95	-26.18	-29.86
-19.31	-63.05	42.31
-12.43	-3.05	12
-38.75	25.14	19.6
-2.73	-86.57	2.2
-25.39	-57.08	39.54
-42.24	32.64	27.45
-14.58	-98.16	1.92
-41.94	37.07	24.97
55.16	-13.73	2.13
40.9	-35	40.93
31.54	24.74	0.77
26.88	1.94	42.32
-3.51	19.76	43.52
1.2	35.51	-9.08
2.41	-73.13	-25.3
-7.73	-83.55	3.59
-31.62	-46.72	41.65
-32.33	-63.62	-27.82
-30.82	1.26	43.74
-49.62	-26.59	20.43
-42.11	39.16	16.29

// Matejko A, 2019: Children
// Subjects=42
56.09	-39.7	-10.42
33.88	-53.16	48.27
36.89	26.31	26.45
-3.08	-76.32	-8.71
0.65	21.1	43.5
-32.67	-51.74	47.95
-39.17	17.99	24.27
-37.33	55.04	0.05
-6.85	-77.76	-8.02
28.02	-65.3	54.15
16.62	-60.45	6.06
-24.62	-62.3	51.06
-41.16	-34.91	48.71
-43.59	12.54	35.04
6.23	-72.45	31.05
33.53	21.26	2.04
5	18.57	43.38
-32.21	-70.89	-17.34
-33.51	19.63	4.83
29.26	-57.25	48.02
32.97	22.74	0.54
-4.27	-89.9	1.67
-.44	45.06	-4.28
1.95	20.17	43.35
-8.4	58.76	25.69
-24.14	-62.31	50.35
24.17	-68.25	54.53
-.98	-91.6	4.51
-23.52	-61.47	51.97
-41.94	37.07	24.97
57.67	-18.16	7.03
38.73	-40.93	45.25
4.2	7.31	-7.24
0.79	57.16	9.85
-11.13	-38.93	44.06
-25.44	1.66	-14.55
-40.48	-43.25	45.44
-44.5	-40.19	20.95
-57.29	-3.54	9.53

// Polspoel B, 2019: Large Problem Size > Small Problem Size (corrected)
// Polspoel B, 2019: Small Problem Size > Large Problem Size (uncorrected)
// Polspoel B, 2019: Large Problem Size > Small Problem Size (uncorrected)
// Polspoel B, 2019: Low Interference > High Interference (uncorrected)
// Polspoel B, 2019: High Interference > Low Interference (uncorrected)
// Subjects=20
42	-60	-18
-34	-78	-18
18	-96	4
22	-86	-20
-6	-84	48
-28	0	56
46	-82	-6
20	36	-6
-18	42	-4
42	-60	-18
-36	-78	-18
-6	-84	48
-28	0	56
-28	-66	56
24	-64	48
64	-54	-8
-38	0	20
58	-64	38
8	-22	26
-6	14	56

// Polspoel B, 2017: Retrieval > Procedural
// Polspoel B, 2017: Procedural > Retrieval
// Polspoel B, 2017: Multiplication > Subtraction
// Polspoel B, 2017: Hard retrieval > Easy procedural
// Polspoel B, 2017: Easy procedural > Hard retrieval
// Subjects=20
-6	-50	-4
-52	-4	-32
-54	-58	36
70	-48	8
66	-44	42
-12	16	50
-44	-46	52
32	-62	54
-50	6	38
24	-90	-6
-22	-96	4
52	10	26
-34	20	4
36	20	8
32	6	66
-50	46	10
18	-96	4
-22	-96	2
64	-40	38
-6	34	0
-56	-22	-8
-48	-4	-30
4	56	2
54	-56	38
-20	4	60
-48	4	34
-48	-40	50
28	-56	50
24	-4	48
-52	46	12
-50	32	40
-34	18	4
52	10	26
-28	-94	6
-22	-90	-12
20	-98	10
58	30	30
22	-88	-6

// Huang J, 2016: Schizophrenia patients
// Subjects=23
3	12	3
23	-43	16
-2	-73	52
12	-36	33
-12	0	70

// Huang J, 2016: Healthy controls
// Subjects=23
3	12	3
23	-43	16
-2	-73	52
12	-36	33
-12	0	70
24	-96	-6
8	15	1
-2	15	4
-35	42	33
-5	18	7
8	18	6
26	-96	-8
-27	-97	18
29	-42	13

// Tiksz A, 2019: Effect of effort: Schizophrenia (SZ) > Healthy Controls 
// (HC)
// Tiksz A, 2019: Effect of success: SZ > HC
// Tiksz A, 2019: Effect of reward: SZ > HC
// Subjects=23
-11.64	50.53	29.75
39.81	-79.39	-3.44
20.79	-90.4	21.12
-24.44	4.5	13.68
-37.07	-89.11	1.6
-50.08	1.17	14.25
-65.99	-24.04	19.9
26.75	10.38	2.56
10.93	15.77	32.4
-8.24	6.39	36.75
-7.93	-6.9	71.32
-24.5	13.76	9.56
-31.13	8.24	-20.01
-30.8	31.38	31.57
-43.39	-38.74	34.25

// Yang X, 2016: Healthy controls
// Subjects=25
0	-60	-4
-21	-18	32
-24	-3	48
-45	-36	40
-18	-6	52
9	-36	4
3	3	40
24	-30	16
-45	-33	12
9	15	8
9	15	8
3	-18	16
27	-87	-20
0	-12	12
-30	36	28
-36	-78	-20
-30	0	48
-3	9	48
12	18	0
30	-54	40
-9	15	0
-3	-87	-4
-57	15	20
-36	0	44
-9	15	0
12	18	0
9	3	12
-3	9	48
-6	57	0
-45	-30	12
-18	-33	52
24	-30	16
18	-81	-36
-33	-78	-40
-18	27	0
18	-45	48
0	-15	16
54	-15	8
9	15	4
-12	-90	-16
-21	-75	-24
24	-30	20
-36	-66	28
-18	-33	52
42	-18	12
45	-51	20
-39	-33	16
24	-81	-36
-63	-39	16
-6	-48	36

// Yang X, 2016: Depressive patients
// Subjects=25
0	-60	-4
-21	-18	32
-24	-3	48
-45	-36	40
-18	-6	52
9	-36	4
3	3	40
24	-30	16
-45	-33	12
9	15	8
9	15	8
3	-18	16
0	-63	-40
-33	-24	48
-27	-93	-12
-30	-72	-16
-54	21	12
-39	-3	44
6	54	-8
15	-84	-40
-30	-72	-12
-42	24	28
6	54	-8

// Ceceli A O, 2020: Attention-Deficit/Hyperactivity Disorder (ADHD)
// Subjects=25
-12	-14	-20
-14	-34	-20
-12	-16	-24
-30	-38	-18
6	-26	-34
-8	-38	-16
-32	-26	0
-46	-12	18
-38	2	-8
-62	2	8
-58	-14	18
-38	4	-26
-46	-8	0
-30	-4	-28
8	16	14
-8	16	68
12	62	34
0	56	-8
-46	-58	32
-50	-72	32
50	-66	44
62	-54	40
40	-78	-26

// Ceceli A O, 2020: Healthy Controls
// Subjects=25
-12	-14	-20
-14	-34	-20
-12	-16	-24
-30	-38	-18
6	-26	-34
-8	-38	-16
-32	-26	0
-46	-12	18
-38	2	-8
-62	2	8
-58	-14	18
-38	4	-26
-46	-8	0
-30	-4	-28
-24	34	50
-40	24	48
-12	60	34
6	26	-16
-6	26	-16
2	58	-14
-46	-68	38
-54	-64	30
40	-74	-28

// Pretus C, 2020: Distractor > Baseline, ADHD > Healthy Controls
// Pretus C, 2020: Non-distractor > Baseline, ADHD < Healthy Controls
// Subjects=21
6	45	-24
18	-30	60
9	21	66

// Salmi J, 2020: Attention-Deficit Hyperactivity Disorder (ADHD)
// Subjects=39
58	-14	-18
24	-82	-26
12	-60	38
26	-82	-28
-12	-56	32
52	-28	-16
-28	-76	-44
12	54	-8
16	-32	-6
-50	30	-2
6	4	42
20	-6	-26
2	-56	-34
-28	62	4
-30	-6	56
36	-62	34
30	60	12
34	2	48
22	0	62
38	32	14
-8	-74	34
10	38	26
-48	-50	44
-22	-72	42

// Salmi J, 2020: Healthy Controls
// Subjects=18
58	-14	-18
24	-82	-26
12	-60	38
26	-82	-28
-12	-56	32
52	-28	-16
-28	-76	-44
12	54	-8
16	-32	-6
-50	30	-2
6	4	42
20	-6	-26
2	-56	-34

// Deming P, 2020: Fear > Neutral
// Deming P, 2020: Fear > (Anger + Happiness + Sadness)
// Subjects=94
-37	-78	31
-30	-64	52
9	-19	-15
5	-50	56
-30	13	-15
30	-75	28
-37	-8	45
33	-43	52
9	-64	52
30	-85	14
-26	-36	-11
-40	-33	52

// Massaccesi C, 2021: Controls (CTR) > Autism Spectrum Disorder (ASD)
// Massaccesi C, 2021: ASD > CTR
// Subjects=20
0	-92	4
-2	-90	22
44	-62	4
46	14	28
-32	-10	66
6	12	56
-18	-100	-2

// Vandewouw M M, 2020: Typically Developing (TD)
// Subjects=93
52	34	30
60	-40	4
-28	34	28
14	4	14
-40	10	-4
-16	-6	-12
-20	-86	6
24	-54	-10
28	-76	-2
58	-38	4
4	-62	28
8	56	24
-46	-8	-18
-32	-78	-4
44	-62	-8
50	-66	-2
-26	-90	6
42	40	38
-42	36	30
66	-6	14
-64	-16	34
34	-64	-40

// Vandewouw M M, 2020: Autism Spectrum Disorder (ASD)
// Subjects=107
-4	-6	-10
58	-22	-8
58	-44	26
-20	-86	6
24	-54	-10
28	-76	-2
44	-34	-4
26	20	8
-50	-54	18
-32	-78	-4
44	-62	-8
50	-68	0
-60	-4	44
-6	-76	6
66	-6	14
-64	-16	34
34	-64	-40

// Bashford-Largo J, 2021: Generalized Anxiety Disorder (GAD)
// Subjects=20
32.62	-10.51	62.24
-18.63	-16.91	66.71
-51.08	-1.4	22.29
3.8	-7	68.96
-6.57	43.33	-8.74
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56
32.62	-10.51	62.24
-18.64	-13.73	66.44
6.86	-1.92	51.77
-6.25	-41.26	-1.65
18.42	-59.89	2.97
23.13	-45.46	65.28

// Bashford-Largo J, 2021: Healthy Controls
// Subjects=34
32.62	-10.51	62.24
-18.63	-16.91	66.71
-51.08	-1.4	22.29
3.8	-7	68.96
-6.57	43.33	-8.74
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56
32.62	-10.51	62.24
-18.64	-13.73	66.44
6.86	-1.92	51.77
-6.25	-41.26	-1.65
18.42	-59.89	2.97
23.13	-45.46	65.28
32.62	-10.51	62.24
-18.63	-16.91	66.71
3.8	-7	68.96
-6.57	43.33	-8.74
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56
32.65	-13.43	65.83
-18.61	-13.48	69.76
3.8	-7	68.96
-9.47	-38.11	-1.88
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56
32.62	-10.51	62.24
-18.64	-20.33	63.65
3.8	-7	68.96
-6.28	-41.52	-4.97
3.73	-70.35	34.13
23.09	-42.55	61.69

// Bashford-Largo J, 2021: GAD comorbid with Major Depressive Disorder (MDD)
// Subjects=15
32.62	-10.51	62.24
-18.63	-16.91	66.71
-51.08	-1.4	22.29
3.8	-7	68.96
-6.57	43.33	-8.74
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56

// Bashford-Largo J, 2021: Subgroup of GAD, Excluding Participants on 
// Stimulants
// Subjects=31
32.62	-10.51	62.24
-18.63	-16.91	66.71
3.8	-7	68.96
-6.57	43.33	-8.74
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56

// Bashford-Largo J, 2021: Subgroup of GAD, Excluding Participants on 
// Anti-psychotics
// Subjects=31
32.65	-13.43	65.83
-18.61	-13.48	69.76
3.8	-7	68.96
-9.47	-38.11	-1.88
13.29	-74.24	24.31
19.91	-48.91	62.26
-15.92	-61.63	-16.56

// Bashford-Largo J, 2021: Subgroup of GAD, Excluding Participants on SSRIs
// Subjects=24
32.62	-10.51	62.24
-18.64	-20.33	63.65
3.8	-7	68.96
-6.28	-41.52	-4.97
3.73	-70.35	34.13
23.09	-42.55	61.69

// Bashford-Largo J, 2021: Group (Healthy Controls, GAD) x Reinforcement 
// (Reward, Punishment)
// Subjects=51
0.17	-1.61	15.02
22.39	9.41	-9.58
-22.12	32.8	49.2
-15.5	-1.28	62.01
0.59	-3.84	68.74
6.96	-27.3	53.9
-57.72	6.02	-5.02
-67.1	-31.08	11.58
-18.92	-95.78	-3.62
51.53	-69.72	-3.27
29.39	-73.37	34.09
25.87	-79.9	-8.82
-48.23	31.2	-10.59

// Collin G, 2021: Familial High-Risk Psychosis (FHR)
// Subjects=15
-6	-62	32
16	-40	26
-20	-34	-8

// Collin G, 2021: Healthy Controls
// Subjects=19
-4	36	-8
16	-40	26
-20	-34	-8

// Cui H, 2020: Heartbeat > Fixation, Generalized Anxiety Disorder (GAD) > 
// Healthy Controls (HC)
// Cui H, 2020: Pure tones > Fixation, HC > GAD
// Cui H, 2020: Heartbeat > Pure tones, GAD > HC
// Subjects=30
-33	0	18
45	-87	3
-21	48	30
-9	39	9
48	-18	60
-39	-39	12
0	-45	39
-36	-24	24
-35	0	18
27	-12	75
30	-12	18

// Frangos E, 2021: Control > Baseline during Heat Stimulation, All 
// Participants
// Frangos E, 2021: Placebo > Baseline during Heat Stimulation, All 
// Participants
// Frangos E, 2021: Control > Placebo during Heat Stimulation, All 
// Participants
// Frangos E, 2021: Control > Baseline during Anticipation, All Participants
// Frangos E, 2021: Placebo > Baseline during Anticipation, All Participants
// Frangos E, 2021: Placebo > Control during Anticipation, All Participants
// Subjects=32
28	65	39
39	68	34
49	70	53
60	72	38
53	21	27
28	17	43
37	43	70
74	52	44
18	51	45
40	59	38
18	65	35
40	67	33
49	73	51
27	74	34
64	54	39
52	20	29
31	16	43
39	44	70
76	51	44
15	49	47
53	12	37
37	14	39
26	55	42
27	70	38
20	49	45
79	50	44
39	14	38
32	50	32
15	63	36
55	14	38
34	17	32
62	17	39
32	17	38

// Gonzalez-Vivas C, 2020: Healthy Controls
// Subjects=13
-28	16	58
-12	46	44
-46	8	34
-32	16	34
-38	16	-24
48	34	-16
-38	40	34
-64	-32	8
62	-12	10
52	2	50
-20	-8	-20
28	-66	-26
-40	-6	40
-52	-42	26
4	31	-71
-66	-28	-4
62	-12	-10
-40	26	0
52	4	50
46	22	26
52	30	-2
10	2	66
-28	-16	-14
-54	18	12

// Gonzalez-Vivas C, 2020: Psychosis
// Subjects=13
-28	16	58
-12	46	44
-46	8	34
-32	16	34
-38	16	-24
48	34	-16
-38	40	34
-64	-22	-2
62	-14	-8
52	26	18
-52	-40	26
22	-4	-22
64	-38	26
-50	-52	22
-8	10	-2
22	-1	-19
-64	-22	-2
64	-24	-2
-48	20	22
54	16	18
52	26	-6
-25	1	-19
-6	32	48
62	-38	24
26	8	-28

// Schmidt A, 2020: Placebo > Oxytocinergic (OT), Social Emotion > Control
// Schmidt A, 2020: Belief > Control
// Schmidt A, 2020: Social Emotion > Control
// Schmidt A, 2020: Placebo > OT, Belief > Control
// Schmidt A, 2020: Placebo < OT, Belief > Control
// Schmidt A, 2020: OT > Placebo, Social Emotion > Control
// Subjects=27
-48	18	-4
-30	36	-8
-56	16	2
48	26	-4
32	34	-8
30	-10	-28
20	-10	-16
58	-42	-4
66	-36	-2
64	-44	-10
42	-22	34
36	-26	42
42	-28	58
-60	-38	6
-26	-70	8
-24	-62	12
-34	-10	-4
12	-22	-12
-8	-42	-22
2	-62	38
-46	-60	32
-40	-56	52
-46	-52	38
-30	16	42
-36	10	50
52	-68	14
56	-64	22
-54	22	26
-42	22	26
-32	22	20
-56	24	16
-48	42	-2
-46	36	-14
56	-56	16
48	-60	10
48	-68	-4
-6	54	28
-8	18	58
-6	54	40
-60	-54	8
-52	-60	26
-48	14	-34
56	26	2
46	30	-10
56	24	20
-2	-60	32
12	-78	-34
28	-78	-36
32	-70	-32
-14	4	12
-10	14	6
50	24	40
48	10	46
-18	-76	-36
16	6	12
22	-2	64
26	-20	14
-18	8	48
-36	-8	2
-50	-22	34
-44	-14	5
-16	-40	30
14	-44	30
14	64	24
10	58	34
-14	-88	32
-20	0	36
14	-84	38
-48	10	-20
-18	-24	30
56	56	20

// Jin H, 2020: Panic Disorder (PD) > Healthy Controls (HC), Hearbeat > Rest
// Jin H, 2020: PD > HC, Pure tones > Rest
// Subjects=18
28	-68	26
-28	-74	-10
-26	-62	30
-16	-84	-8
-32	-54	50
-24	-30	-2
-2	32	52
-54	-24	50
42	-44	38
28	2	56
-2	36	30
46	16	34
48	34	18
32	-54	40
-38	18	34
26	-60	-50

// Lopes F L, 2021: Panic Disorder (PD)
// Subjects=12
-39	-6	-13
51	-6	9
-26	53	5
39	1	27
-56	-46	40
-22	55	0
-36	0	-12
57	-3	24

// Lopes F L, 2021: Healthy Controls (HC)
// Subjects=14
-31	20	-7
-27	-5	-5
-54	1	21
-53	3	24
-7	47	-8

// Araneda R, 2021: Auditory Modality: Beat > No beat
// Araneda R, 2021: Auditory Modality: Early Blindness > Sighted Controls (SC)
// Araneda R, 2021: Auditory Modality: Interaction (Beat vs No beat x EB vs 
// SC)
// Araneda R, 2021: Vibro-tactile Modality: Beat > No beat
// Araneda R, 2021: Vibro-tactile Modality: EB > SC
// Araneda R, 2021: Vibro-tactile Modality: Interaction (Beat vs No beat x EB 
// vs SC)
// Subjects=12
62.28	-27.25	22.04
29.96	-58.79	-25.13
23.58	7.45	6.19
-8.03	-7.92	58.03
-11.52	18.81	32.4
-27.63	-1.86	14.25
-30.44	-50.58	45.13
-40.48	40.58	27.57
-49.81	-2.6	48.02
-42.68	10.22	6.72
-49.89	-42.98	21.3
62.06	-8.7	0.41
39.46	19.2	-8.36
39.53	36.35	6.93
-5.17	-41.08	0.55
-43.35	-35.06	40.63
-53.27	-51.4	-4.72
-54.24	-70.18	0.21
23.74	-76.57	-6.84
7.76	-82.76	-2.79
46.17	-66.67	-4.58
-1.94	-73.81	-10.12
-43.47	-72.52	10.32
-43.56	-76.72	-2.71
31.64	-42.58	60.48
30.08	-14.72	7.97
26.76	43.39	16.52
-21.24	-5.34	10.01
-37.09	-23.36	26.2
-50.18	13.35	6.54
17.2	-41.72	-9.69
23.94	-67.92	22.54
8.09	-46.41	54.38
-.7	-77.55	10.25
-27.54	-60.33	1.31
-27.68	-41.99	-9.15
62.06	11.11	8.79
42.72	46.14	9.42
42.7	3.1	-10.39
29.96	23.6	8.11
14.28	-2.47	43.93
4.84	-.73	67.31
55.83	-66.18	0.84
-8.21	26.46	48.45
-40.59	-6.65	-5.27
-51.22	33.4	18.25
-50.18	8.86	3.57

// Hufner K, 2021: Blind Subjects
// Subjects=11
2	32	28
-22	-80	18
-18	-64	18
-8	-92	22
-9	-95	21
-10	-58	4
34	-34	74
24	-82	16
22	-86	18
-22	-82	-10
16	-66	-10
-34	0	66
-38	10	58
-48	0	56
-22	-80	18
28	-82	16
2	26	30
-46	-42	-28
-14	-20	76
-14	-42	76
-14	-28	78
-12	-52	74
-16	-38	76
16	-26	78
-66	-50	2
-64	-62	10
4	38	52
42	52	24

// Hufner K, 2021: Healthy Controls
// Subjects=12
2	32	28
-22	-80	18
-18	-64	18
-8	-92	22
-9	-95	21
-10	-58	4
34	-34	74
24	-82	16
22	-86	18
-22	-82	-10
16	-66	-10

// Kikuchi H, 2021: Dissociative Amnesia Patient #1
// Subjects=1
28	60	16
50	24	-10
8	8	66
10	-18	74
0	-90	0
-50	20	-8
-66	-40	34
28	8	34
34	-36	-34
38	-64	-50
8	-64	-24
-32	4	50
-30	-10	-12
-46	-16	30
-20	-26	12
-20	-52	72
-36	-76	32
64	-32	40
54	28	-6
42	14	38
-38	48	20
-50	40	-8

// Kikuchi H, 2021: Dissociative Amnesia Patient #2
// Subjects=1
28	60	16
50	24	-10
8	8	66
10	-18	74
0	-90	0
-50	20	-8
-66	-40	34
28	8	34
34	-36	-34
38	-64	-50
8	-64	-24
-32	4	50
-30	-10	-12
-46	-16	30
-20	-26	12
-20	-52	72
-36	-76	32
64	-32	40
30	48	30
-30	60	28
-34	-48	-44
-4	-68	4
-36	-68	-30
-8	-90	-22
-4	-94	12
32	-6	-18
32	-84	-2
-42	-72	20
-28	-88	-10
30	50	30
6	2	54
12	-80	44
-36	54	26
-26	-68	-26
14	16	-14
26	-4	-18
40	-10	-42
54	-14	58
28	-92	-2
0	46	-22
-18	-96	-8

// Doose A, 2020: Time Point 1 < Time Point 2
// Doose A, 2020: Time Point 1 > Time Point 2
// Subjects=22
22	-98	14
-54	-68	32
56	-56	25
6	-54	20
8	54	26

// Lloyd D M, 2021: Subgroup of Nonspecific Low Back Pain, High levels of Pain 
// Behavior (WS-H)
// Subjects=13
-42	-50	50
-52	-44	42
-38	-56	50
-28	-64	38
-22	-30	58
-4	-22	28
-12	-20	50
56	-44	18
50	-52	16
44	-62	4
42	-60	6
-4	-24	48
-22	-32	48
8	-46	62
22	-38	64
6	-98	14
3	12	0
42	40	8
0	40	4
-12	52	9
-4	-80	46
-12	-82	44
14	-68	48
6	-78	10
62	6	36
10	-82	54
-66	-22	28
-12	-16	-18
60	6	36
64	-6	36
50	-40	12
10	-82	32

// Lloyd D M, 2021: Subgroup of Nonspecific Low Back Pain, Low levels of Pain 
// Behavior (WS-L)
// Subjects=16
-4	-24	48
-22	-32	48
8	-46	62
22	-38	64
6	-98	14
3	12	0
42	40	8
0	40	4
-12	52	9
-4	-80	46
-12	-82	44
14	-68	48
6	-78	10
62	6	36
10	-82	54
-66	-22	28
-12	-16	-18
60	6	36
64	-6	36
50	-40	12
10	-82	32

// Lul D, 2021: Anorexia Patients
// Subjects=11
-5	-29	42
31	-44	-12
17	-4	16
2	32	48
38	28	-6
-5	50	-3

// Lul D, 2021: Healthy Controls
// Subjects=11
-5	-29	42
31	-44	-12
17	-4	16
2	32	48
38	28	-6

// Noda T, 2021: Anorexia Nervosa
// Subjects=23
10	-68	38
46	24	42
-30	20	-6
-2	20	62
-22	-96	-10
14	-96	-2
22	-40	-6
42	4	26
46	-52	30
34	12	-6
-10	-76	38
-6	-8	2
-42	24	-42
30	-76	10
-2	-72	6
-2	-56	22
-18	-68	-10
-2	-76	30
-34	-16	50
-22	12	34
58	-12	14
62	4	26
-6	0	58
54	-24	42

// Noda T, 2021: Healthy Controls
// Subjects=17
-30	24	-2
30	16	-10
62	-48	34
-2	-72	6
-2	-56	22
-18	-68	-10
-2	-76	30
-46	-28	50
58	-20	34
62	4	26
-54	0	22
10	-56	-14
-18	-28	6
-14	-68	-18

// Stopyra M A, 2021: Anorexia Nervosa (AN)
// Subjects=25
-6	-49	14
-15	-4	22
21	5	26
-6	-55	10
-36	-82	-2
-33	-43	38
-27	-49	50
-33	-49	-18
-3	-58	22
-9	-40	-2
-18	56	10
-6	35	-18
-15	44	6

// Stopyra M A, 2021: Healthy Controls (HC)
// Subjects=25
-6	-55	10
-36	-82	-2
-33	-43	38
-27	-49	50
-33	-49	-18
-3	-58	22
-9	-40	-2
-18	56	10
-6	35	-18
-15	44	6

// Suttkus S, 2021: Anorexia Nervosa (AN)
// Subjects=16
26	1	-18
24	-16	-15
6	-55	48.5
-1.5	-61	51.5
-54	-40	23
-61.5	-40	11
-67.5	-29.5	6.5
-7.5	-46	-43
-39	-58	-14.5
-7.5	8	-2.5
37.5	-80.5	-1
37.5	-88	-8.5
27	-91	-13
-28.5	-4	-8.5
-42	-2.5	3.5
-24	21.5	5
57	-44.5	30.5
43.5	-37	50
-24	-44.5	59
-37.5	-44.5	44
0	35	15.5
13.5	33.5	23
-10.5	35	6.5
-25.5	-5.5	57.5
-61.5	-13	-7
-49.5	-26.5	-13
-30	44	20
-22.5	36.5	23

// Suttkus S, 2021: Healthy Controls (HC)
// Subjects=21
26	1	-18
24	-16	-15
45	-13	40
2	11	40
1	10	39
-3	3.5	41
-5	-42	53
17	17	-3
-32	26	5
0	-7	7
-3	-28	-19
35	26	2
-5	-85	17
9	-13	2
-2	13	1
-26	41	40
23	-45	-49
-36	8	49
-63	-33	-9
-20	16	-1
3	35	52
5	10	28
56	34	5
-53	-52	31
12	10	-13
21	-7	-12
0	-66	47
50	-34	-3
6	-55	48.5
-1.5	-61	51.5
-54	-40	23
-61.5	-40	11
-67.5	-29.5	6.5
-7.5	-46	-43
-39	-58	-14.5
-7.5	8	-2.5
37.5	-80.5	-1
37.5	-88	-8.5
27	-91	-13
-28.5	-4	-8.5
-42	-2.5	3.5
-24	21.5	5
57	-44.5	30.5
43.5	-37	50
-24	-44.5	59
-37.5	-44.5	44
0	35	15.5
13.5	33.5	23
-10.5	35	6.5
-25.5	-5.5	57.5
-61.5	-13	-7
-49.5	-26.5	-13
-30	44	20
-22.5	36.5	23

// Tan W, 2020: Chronic Low Back Pain (CLBP)
// Subjects=14
27	-33	-42
51	12	0
9	66	24
69	-21	18
0	-48	72
24	69	15
-57	-45	-18
57	24	18
0	-51	21
-51	21	36
-48	-60	48
63	-30	30
0	-3	72
27	-30	-21
24	69	15
-24	-81	39
9	-54	3
57	39	-6

// Tan W, 2020: Healthy Controls
// Subjects=20
57	18	-6
-57	9	-3
-33	57	27
-57	-54	48
27	-30	-21
24	69	15
-24	-81	39
9	-54	3
57	39	-6

// Benetti S, 2021: Hearing groups: Horizontal + Radial > Static
// Benetti S, 2021: Deaf group: Horizontal + Radial > Static
// Benetti S, 2021: Deaf > Hearing: Horizontal + Radial > Static
// Benetti S, 2021: Deaf & Hearing: Horizontal > Stochastic
// Benetti S, 2021: Deaf & Hearing: Radial > Stochastic
// Benetti S, 2021: Deaf & Hearing: Radial > Horizontal
// Benetti S, 2021: Deaf > Hearing: Radial > Horizontal
// Subjects=13
-48	-73	8
-30	-70	-7
54	-70	8
36	-67	2
-27	-55	53
30	-52	50
45	11	32
-39	-64	2
45	-64	2
30	20	8
-42	-34	47
60	-37	11
48	-34	50
54	-22	-1
60	-34	11
-42	-70	2
-42	-70	-1
48	-61	-10
48	-55	-13
-33	-61	-13
69	-19	-1
27	38	38
-66	-37	14

// Simon M, 2020: Deaf
// Subjects=16
-54	2	43
-39	-43	-20
30	-46	49
-12	-16	7
6	-22	-11
36	-4	-41
66	-28	7
-54	-34	10
-57	-1	43
18	17	4
-33	-58	7
-3	-61	-32
57	8	37
66	-25	4
-60	-31	7
-54	2	43
18	17	4
66	-28	7
-51	-37	10
66	-28	7
-63	-31	7
-57	-1	46

// Simon M, 2020: Hearing
// Subjects=16
39	-43	-20
-51	-70	1
30	26	1
-12	-73	-44
-9	-16	4
27	-49	49
66	-28	7
-54	-34	10
-57	-1	43
18	17	4
-33	-58	7
-3	-61	-32
57	8	37
66	-25	4
-60	-31	7
-54	2	43
18	17	4
66	-28	7
-51	-37	10

// Miranda-Olivos R, 2021: Now > Later: Binge Eating Disorder (BED) & Non-BED 
// > Healthy Controls
// Subjects=10
-50	4	10

// Gool J K, 2020: Task > Baseline, All Subjects
// Gool J K, 2020: Difficult > Baseline, Controls > Patients
// Gool J K, 2020: Error-related Activations, Controls > Patients
// Subjects=11
22	-62	-22
48	16	-10
4	2	52
-28	-74	-20
-38	-18	52
-12	-6	12
30	-86	4
36	-68	-12
64	-44	16
34	6	-8
-34	-4	-10
26	54	18
-22	2	4
-40	20	-8
-32	-18	0
-28	-54	52
44	-82	-10
-2	-74	0
54	14	-4
0	24	52
46	14	34
52	-50	-26
-54	16	-4
-42	-16	50
-60	-60	8
-44	10	40
6	-16	12
-62	-36	2
-46	-70	-12
54	-56	32
-24	-92	16
-30	62	16
0	24	52
-42	-4	36

// Grothe M, 2020: Multiple Sclerosis (MS)
// Subjects=20
-18	-90	-6
-21	-63	48
21	-87	-3
-3	6	57
9	12	51
-45	-9	42
48	-6	33
-24	-3	51
-30	0	66
30	0	57

// Grothe M, 2020: Healthy Controls (HC)
// Subjects=20
-18	-63	57
-24	-63	48
21	-66	51
-45	-9	-42
-33	0	63
-24	-3	51
48	-6	36
-3	6	60
33	0	60
9	15	39
48	-27	3

// Lewis C E, 2021: Fetal Alcohol Syndrome (FAS)
// Subjects=11
-22	-66	54
-22	-60	46
20	-64	52
44	-78	26
32	-82	26
32	-86	10
52	-62	-12
42	-62	-8
-42	-84	24
-48	-60	-8
-48	-52	-14
-48	-72	-4
52	-52	-10
-30	-84	28
-20	-36	-12
-26	-30	-20
-30	-40	-14
32	-38	-12
24	-36	-14
34	-48	-18
18	-34	-2
-14	-32	68
-2	-36	64
4	-40	52
-14	-32	68
-22	-28	66
-28	-28	54
-12	-38	52
-2	-42	48
40	-64	20
36	-54	24

// Lewis C E, 2021: Heavily Exposed Non-syndromal (HE)
// Subjects=14
-22	-66	54
-22	-60	46
20	-64	52
44	-78	26
32	-82	26
32	-86	10
52	-62	-12
42	-62	-8
-42	-84	24
-48	-60	-8
-48	-52	-14
-48	-72	-4
52	-52	-10
-30	-84	28
-20	-36	-12
-26	-30	-20
-30	-40	-14
32	-38	-12
24	-36	-14
34	-48	-18
18	-34	-2
-14	-32	68
-22	-28	66
-28	-28	54
-12	-38	52
-2	-42	48
40	-64	20
36	-54	24

// Lewis C E, 2021: Healthy Controls (HC)
// Subjects=26
-22	-66	54
-22	-60	46
20	-64	52
44	-78	26
32	-82	26
32	-86	10
52	-62	-12
42	-62	-8
-42	-84	24
-48	-60	-8
-48	-52	-14
-48	-72	-4
52	-52	-10
-30	-84	28
-20	-36	-12
-26	-30	-20
-30	-40	-14
32	-38	-12
24	-36	-14
34	-48	-18
18	-34	-2
-14	-32	68
-2	-36	64
4	-40	52

// Baumann S, 2021: Attention Deficit Hyperactivity Disorder (ADHD)
// Subjects=19
30	-10	-6
24	0	0
28	6	-6
40	22	-8

// Baumann S, 2021: Conduct Disorder and Attention Deficit Hyperactivity 
// Disorder (CD + ADHD)
// Subjects=45
10	12	8
14	2	12
10	4	4
-42	14	36
-52	18	22
-44	-60	54
30	-10	-6
24	0	0
28	6	-6
40	22	-8

// Baumann S, 2021: Healthy Controls (HC)
// Subjects=61
10	12	8
14	2	12
10	4	4
-42	14	36
-52	18	22
-44	-60	54

// Bitan T, 2020: Developmental dyslexia
// Subjects=21
-40	-78	-12
56	-26	12
-8	56	-4
-4	14	52
-30	36	-10
36	38	-8
14	14	38
-44	-40	42
-26	-76	22
-20	28	48
8	8	-8
-14	52	40
0	60	30
0	60	30

// Bitan T, 2020: Healthy controls
// Subjects=22
-58	-12	26
-32	-88	-4
62	-6	12
-36	34	-12
34	-92	-8
52	-70	26
24	22	48

// Menks W M, 2021: Emotional Face Processing: Healthy Controls (HC) > Conduct 
// Disorder (CD)
// Menks W M, 2021: Emotional Face Processing: HC > CD, corrected for eye gaze 
// behavior
// Menks W M, 2021: Emotional Face Processing: HC (matched) > CD (matched)
// Menks W M, 2021: Emotional Face Processing: HC (matched) > CD (matched), 
// corrected for eye gaze behavior
// Subjects=18
58	-20	18
22	-48	-2
-22	-48	-2
-50	-76	0
-16	-50	0
44	-30	58
22	-48	-2
-50	-76	0
14	-90	-6
-14	-90	-6
-10	-58	-4
56	-18	18
24	-48	-2
40	-40	64
-48	-78	0
34	-86	6
-34	-36	66
-54	-24	-14
16	-86	-12
24	-48	-2
-18	-48	0
-16	-72	32
-48	-78	0

// Carvalho G F, 2021: Main effect of Roller Coaster Ride, Migraine
// Carvalho G F, 2021: Healthy Controls > Migraine
// Carvalho G F, 2021: Migraine > Healthy Controls
// Carvalho G F, 2021: Migraine without aura > Migraine with aura
// Subjects=10
5	-82	-2
-11	-19	43
37	-30	20
46	5	35
-37	-32	20
27	-4	51
-27	-7	52
-52	5	38
-16	-7	1
30	-27	-28
19	15	-23
21	6	-31
28	26	-4
57	-35	22
24	16	6
-23	-25	-27
4	-4	41
-34	53	-4
-32	-66	-45
28	-90	10
-37	-71	-6
-5	-27	-38
-25	-41	-30
24	-76	9
11	-14	51
25	39	-16
51	40	-12
57	-29	24
48	-31	5
-30	-30	61
60	-11	-1
-53	-38	31
54	-62	-35

// Soloveva M V, 2020: Stop > Go, All Participants
// Soloveva M V, 2020: Stop > Go, Pre-Huntington's Disease > Healthy Controls
// Subjects=15
56	-14	6
-48	-24	4
-58	-44	6
60	-36	6
60	-44	24
-56	-48	28
16	-62	12
-14	-66	10
54	-40	54
-58	-44	38
-34	16	0
32	20	-10
-6	-64	4
24	-54	0
-6	-46	52
10	-44	50
-42	14	30
52	24	30
-58	-60	24
52	-52	32
12	-78	38
-10	-80	38
-40	12	30
46	10	30
-42	12	30
44	8	30
-8	16	44
6	2	54
42	10	58
-32	-2	52
14	-82	48
-28	-66	52
-22	4	66
18	16	60
10	-4	44
-4	-10	44
18	-80	36
-10	-80	42
18	14	-4
-18	4	-8
-42	-78	12
30	-72	30
-14	6	12
12	14	4
24	-10	-32
2	-22	-26
20	-26	0
-18	-48	70
60	-26	36
-8	20	30
-4	-14	62
2	-52	-38
-8	-78	4
18	-74	4

// Trimmel K, 2021: Left Temporal Lobe Epilepsy (LTLE)
// Subjects=41
-46	30	14
-10	50	48
-4	18	54
-48	-52	-18
-52	-34	-4
-42	24	-18
-20	-20	-22
-6	-56	0
-24	-80	34
20	-18	18
-48	-64	40
-62	-48	38
-62	-56	18
-30	48	-2
-46	-38	12
4	-74	38
34	-74	54
30	18	62
18	62	16
32	-10	52
58	-62	-14
-44	8	28
-4	16	54
-34	-46	-24
-42	-74	-8
-36	-88	-4
42	-84	-4
-56	-68	24
-48	-18	2
-54	2	-32
2	-68	42
44	-78	40
30	24	60
-16	14	24
-2	10	64
-54	0	44
-26	-70	40
-36	-66	-26
44	16	-6
26	-100	10
36	-66	-28
-44	-56	36
-10	-48	34
-56	-66	32
-50	10	-36
-46	6	-44
-28	-34	-20
-44	-16	10
-40	-88	22
4	-64	32
6	-52	32
24	36	42
2	58	-2
52	-26	20
52	-68	18
24	-18	-30
34	4	10
44	-76	34
-46	-56	-14
32	-66	-26
40	36	38
-34	-50	-14
28	12	50
-38	12	44
-34	10	-32
-54	-12	-22
-34	36	6
-66	-26	26
6	-82	42
-54	-12	-22
-34	36	4
-54	22	32
-66	-26	26
6	-82	52
52	-50	8
-48	30	6
-58	0	-18
-44	8	-26
-38	30	-20
-40	10	-44
4	-54	48
-44	-56	34
-42	-30	36
-52	-42	58
-52	-22	24
-36	-46	-16
-30	-98	10
-48	-74	-10
-40	-60	-14
-4	-66	52
4	-64	60
32	-52	36
-38	-46	-18
-46	-84	-8
-34	-10	-28
-48	30	4
-36	40	-14
-44	12	-20
-38	30	-20
-42	8	-44
-34	8	-36
4	-54	48
-46	-68	-4
-36	-54	-8
-30	-98	12
-40	-42	-14
-4	-66	52
32	-52	36

// Trimmel K, 2021: Right Temporal Lobe Epilepsy (RTLE)
// Subjects=31
-46	30	14
-10	50	48
-4	18	54
-48	-52	-18
-52	-34	-4
-42	24	-18
-20	-20	-22
-6	-56	0
-24	-80	34
20	-18	18
-48	-64	40
-62	-48	38
-62	-56	18
-30	48	-2
-46	-38	12
4	-74	38
34	-74	54
30	18	62
18	62	16
32	-10	52
58	-62	-14
-44	8	28
-4	16	54
-34	-46	-24
-42	-74	-8
-36	-88	-4
42	-84	-4
-56	-68	24
-48	-18	2
-54	2	-32
2	-68	42
44	-78	40
30	24	60
-16	14	24
-2	10	64
-54	0	44
-26	-70	40
-36	-66	-26
44	16	-6
26	-100	10
36	-66	-28
-44	-56	36
-10	-48	34
-56	-66	32
-50	10	-36
-46	6	-44
-28	-34	-20
-44	-16	10
-40	-88	22
4	-64	32
6	-52	32
24	36	42
2	58	-2
52	-26	20
52	-68	18
24	-18	-30
34	4	10
44	-76	34
-46	-56	-14
32	-66	-26
40	36	38
-34	-50	-14
28	12	50
-38	12	44
-34	10	-32
-54	-12	-22
-34	36	6
-66	-26	26
6	-82	42
-54	-12	-22
-34	36	4
-54	22	32
-66	-26	26
6	-82	52
52	-50	8
-38	30	-20
-40	10	-44
-52	-42	58
-52	-22	24
-48	-74	-10
-40	-60	-14
-34	-10	-28
-38	30	-20
-42	8	-44
-34	8	-36
-40	-42	-14
32	-52	36

// Trimmel K, 2021: Healthy Controls (HC)
// Subjects=36
-46	30	14
-10	50	48
-4	18	54
-48	-52	-18
-52	-34	-4
-42	24	-18
-20	-20	-22
-6	-56	0
-24	-80	34
20	-18	18
-48	-64	40
-62	-48	38
-62	-56	18
-30	48	-2
-46	-38	12
4	-74	38
34	-74	54
30	18	62
18	62	16
32	-10	52
58	-62	-14
-44	8	28
-4	16	54
-34	-46	-24
-42	-74	-8
-36	-88	-4
42	-84	-4
-56	-68	24
-48	-18	2
-54	2	-32
2	-68	42
44	-78	40
30	24	60
-16	14	24
-2	10	64
-54	0	44
-26	-70	40
-36	-66	-26
44	16	-6
26	-100	10
36	-66	-28
-44	-56	36
-10	-48	34
-56	-66	32
-50	10	-36
-46	6	-44
-28	-34	-20
-44	-16	10
-40	-88	22
4	-64	32
6	-52	32
24	36	42
2	58	-2
52	-26	20
52	-68	18
24	-18	-30
34	4	10
44	-76	34
-46	-56	-14
32	-66	-26
40	36	38
-34	-50	-14
28	12	50
-38	12	44

// Caseras X, 2022: Chronic Fatigue Syndrome (CFS)
// Subjects=17
31.94	57.2	1.92
5.93	-69.74	41.86
40.11	-57.56	44.91
55.53	21.84	-3.19
51.19	24.48	-10.05
25.15	-74.11	38.66
43.78	49.32	9.14
5.14	63.84	-6.13
-14.07	51.83	-8.25
5.24	69.18	7.91
8.46	57.31	5.53
-6.51	52.74	2.74
31.9	61.17	-1.76
-30.11	60.45	-5.45
-13.98	33.06	-3.33
55.71	-49.86	-8.33
31.9	61.17	-1.76
-34.38	60.43	-5.39
-17.58	-78.6	39.53
20.95	-69.05	49.44
58.79	-39.07	-20.43

// Caseras X, 2022: Healthy Controls
// Subjects=12
-2.59	-69.45	46.39
43.87	42.52	17.51
8.75	-85.81	-14.82
47.24	27.79	33.21
1.64	-74.25	38.94
32.53	13.81	60.2
35.22	62.3	12.61
5.6	27.88	38.14
44.3	-50.73	36.48
55.64	30.7	15.02
31.9	61.17	-1.76
-34.38	60.43	-5.39
-17.58	-78.6	39.53
20.95	-69.05	49.44
58.79	-39.07	-20.43

// Damestrani N L, 2021: Deviant+Novel>Silent; GRE-EPI Session 1
// Damestrani N L, 2021: Deviant+Novel>Silent; GRE-EPI Session 2
// Damestrani N L, 2021: Deviant+Novel>Silent; Looping Star Session 1
// Damestrani N L, 2021: Deviant+Novel>Silent; Looping Star Session 2
// Damestrani N L, 2021: Deviant>All; GRE-EPI Session 1
// Damestrani N L, 2021: Deviant>All; GRE-EPI Session 2
// Damestrani N L, 2021: Deviant>All; Looping Star Session 1
// Damestrani N L, 2021: Deviant>All; Looping Star Session 2
// Damestrani N L, 2021: Novel>All; GRE-EPI Session 1
// Damestrani N L, 2021: Novel >All; GRE-EPI Session 2
// Damestrani N L, 2021: Novel>All; Looping Star Session 1
// Damestrani N L, 2021: Novel>All; Looping Star Session 2
// Damestrani N L, 2021: Novel> Deviant; GRE-EPI Session 1
// Damestrani N L, 2021: Novel> Deviant; GRE-EPI Session 2
// Damestrani N L, 2021: Novel> Deviant; Looping Star Session 1
// Damestrani N L, 2021: Novel> Deviant; Looping Star Session 2
// Damestrani N L, 2021: Deviant> Novel; GRE-EPI Session 1
// Damestrani N L, 2021: Deviant> Novel; Looping Star Session 1
// Damestrani N L, 2021: Deviant> Novel; Looping Star Session 2
// Damestrani N L, 2021: Deviant+Novel>All; GRE-EPI Session 1
// Damestrani N L, 2021: Deviant+Novel>All; GRE-EPI Session 2
// Damestrani N L, 2021: Deviant+Novel>All; Looping Star Session 1
// Damestrani N L, 2021: Deviant+Novel>All; Looping Star Session 2
// Subjects=12
-46	-28	10
66	-20	10
42	-32	46
34	28	26
58	-20	18
-62	-20	18
-6	0	58
6	-84	-10
-14	24	6
50	-32	14
2	-76	-22
34	-52	-26
-2	4	50
-34	-4	58
-46	6	-6
-58	-20	22
6	-64	-14
62	-12	6
50	16	-10
2	4	66
-50	-28	10
34	8	34
54	8	-2
62	-16	18
10	-92	-6
-58	-16	50
2	12	58
-62	-20	22
10	28	-2
-2	0	66
-50	-24	10
-54	4	-2
54	-20	22
30	0	-6
2	-76	-22
-50	-20	42
-6	-40	-22
-6	-80	10
-58	-20	18
-10	-48	-2
-42	-36	-10
-34	36	26
30	32	26
-46	-20	58
-58	-24	14
-2	0	62
62	-20	18
54	-32	14
-2	-72	-18
-2	0	66
-43	4	-6
-62	-20	10
-14	-20	2
-18	-28	78
-54	-24	42
58	-16	6
14	-44	-14
54	12	-6
54	-24	30
-46	12	18
22	-84	26
-18	-92	26
-18	-8	22
-46	-40	10
58	-32	15
42	-44	14
14	-64	46
22	12	14
-38	-36	-6
-50	-28	10
54	12	-2
30	-4	18
2	12	58
62	-20	18
-46	-20	58
2	-84	-10
-6	28	2
-62	-20	18
-2	0	66
50	-32	14
2	-76	-22
-62	-20	6
-54	8	-6
-50	-20	42
-6	-80	10
50	16	-10
-46	12	18
-6	-40	-22

// Di X, 2020: 2-back > 1-back
// Di X, 2020: 2-back < 1-back
// Subjects=49
24	11	56
-24	8	50
-48	5	32
-6	-61	44
-18	-70	50
21	-67	53
48	5	23
27	-61	-37
9	-73	-31
-18	5	11
-30	26	2
-33	50	2
-42	50	2
-3	-16	32
0	-37	20
0	-28	44
39	-19	20
36	-16	2
39	2	-1
12	59	20
-6	62	8
-9	53	-1
-36	-10	-4
-63	-25	5
-39	-19	17
21	38	-1

// Li G, 2021: 2-back > 0-back, positive correlation with Critical Success 
// Index (CSI)
// Li G, 2021: 2-back > 0-back, negative correlation with CSI
// Li G, 2021: 2-back > 0-back, positive correlation with reaction time (RT)
// Li G, 2021: 2-back > 0-back, negative correlation with RT
// Li G, 2021: 2-back > 0-back, positive correlation with Ravens Standard 
// Progressive Matrices (PMAT24_A_CR)
// Li G, 2021: 2-back > 0-back
// Li G, 2021: 2-back < 0-back
// Subjects=949
-2	-2	46
4	26	46
-42	8	42
44	-54	40
34	18	2
-36	-54	42
-6	16	48
-35	-54	42
-16	0	20
52	-28	26
-2	-6	46
-2	-52	26
-38	-16	20
-10	48	40
38	-20	46
-44	-14	34
44	-46	44
-45	-38	44
-2	10	48
30	8	54
-28	-58	48
-22	10	60
-4	-62	48
34	28	2
24	6	58
42	-44	48
2	-28	-2
-2	12	24
-2	-44	-16
-18	-38	14
-2	-48	30
-12	52	36
8	52	38
0	-14	6

// Schmidt C, 2020: Incongruent > Congruent (right hand > left hand)
// Schmidt C, 2020: Incongruent > Congruent (left hand > right hand)
// Schmidt C, 2020: Incongruent > Congruent (right visual field > left visual 
// field)
// Schmidt C, 2020: Incongruent > Congruent (left visual field > right visual 
// field)
// Schmidt C, 2020: Incongruent > Congruent
// Subjects=13
-48	-20	60
16	-48	-20
42	-14	68
-20	-48	-28
46	-14	14
-10	-92	0
14	-92	6
16	26	32
20	24	6
-12	18	14
50	-16	12

// Talanow T, 2020: go/no-go task
// Subjects=19
12	-86	-8
4	-92	-8
16	-88	0
-16	-80	-10
-14	-98	6
-8	-80	-8
50	44	10
34	38	14
12	54	28
-10	48	30
-16	30	48
-54	-38	34
-58	-26	42
-64	-30	34
26	-96	14
40	-80	24
12	-92	28
56	-34	40
68	-26	30
66	-40	32
4	-92	-8
-16	-80	-10
-6	-92	-12
-58	-26	42
-52	-30	54
-64	-20	32
58	-52	44
64	-50	30
52	-60	46
0	-92	0
8	-76	-10
-4	-96	10
-10	-74	-10
16	-96	2
2	-88	18
-2	-78	22
20	-100	14
-2	-85	36
0	-86	30
2	-72	14
0	-68	14
10	-84	38
-10	-62	6
0	-56	4
-22	-88	12

// Talanow T, 2020: prosaccade/antisaccade task
// Subjects=21
-56	-16	12
-62	-20	18
-14	-94	22
16	-92	24
26	-90	22
-56	-16	10
-40	-36	14
-48	-20	36
64	-22	12
66	-32	8
10	28	44
24	28	34
30	28	28
20	44	28
-14	50	28
-20	34	42
48	2	36
46	-8	36
50	22	16

// Weigard A, 2020: No-go (successful inhibitions) > Go
// Weigard A, 2020: No-go (failed inhibitions) > Go
// Weigard A, 2020: Positive relation between No-go (failed inhibitions) > Go 
// and mean of drift rates on go & no-go trials
// Subjects=143
58	-44	28
40	42	22
34	20	0
-58	-48	34
-62	-50	24
-62	-44	12
-34	38	26
-34	46	24
-40	38	40
-22	58	-14
8	-10	28
4	-22	24
-10	-22	30
-36	-20	50
-32	-12	56
-44	-26	48
12	20	-22
4	30	26
44	14	-4
-28	50	22
-44	14	-6
-32	18	-12
-60	-42	30
60	-42	26
52	-30	-8
54	-40	-2
-32	-60	-28
-30	-48	-32
38	-52	-32
2	-72	-20
2	-60	-8
46	2	-40
12	-68	36
-12	-68	32
12	-76	8
-6	-74	6
10	-36	-34
-10	-48	-32
26	54	-16
50	24	0
32	24	-10
34	16	-6
8	38	18
4	48	8
-10	34	14
-10	40	2
62	-30	-8
58	-16	-10

// Narayana S, 2020: Typical Speakers
// Subjects=19
-50	-10	40
-52	-8	34
-52	4	4
-12	-12	60
0	0	62
10	12	42
56	-6	38
52	-4	38
52	14	4
8	12	-20
-62	-30	2
-56	-18	10
52	-36	12
68	-22	6
62	-6	0
46	-24	10
-56	-4	16
-24	-62	52
60	-6	20
18	-42	52
-32	-38	18
-40	10	6
-30	8	12
44	6	6
-12	-96	8
-2	90	0
4	-84	-2
-22	-58	-26
-8	-68	-44
18	-64	-16
12	-40	-30
10	-70	-42
-56	-6	42
-52	-10	28
-52	2	48
-2	6	42
-16	10	34
6	6	64
54	-8	32
56	-2	42
58	-4	8
-64	-18	-2
-56	-42	6
50	-30	2
66	-26	2
-58	-4	16
56	-6	18
-28	22	12
22	14	12
-2	-96	-2
-6	-84	-2
8	-80	0
10	-98	2
-22	-62	-22
-12	-62	-18
-8	-72	-38
16	-66	-22
26	-56	-26
12	-70	-40
-52	-8	34
-12	-12	60
60	-6	20
-46	-34	18
-54	-24	18
-22	-56	-22
-42	-56	48
-54	-4	38
-40	-16	34
-58	-8	16
-40	-58	52
-46	-70	38

// Narayana S, 2020: Parkinson's Disease (PD) with Hypokinetic Dysarthria 
// (HKD), PET study
// Subjects=10
-46	-14	42
-62	0	22
-46	-2	48
-6	0	68
-4	16	50
-10	20	32
-48	6	8
50	-2	38
2	6	60
-54	12	-8
-48	-32	-4
24	-70	54
-40	18	8
-2	-86	-4
-22	-96	-8
-26	92	2
-48	-66	-14
2	-86	0
22	-96	0
-16	-72	-20
-30	-50	-24
-24	-70	-40
12	-68	-18
28	-62	-24
12	-76	-40
-52	-8	34
-12	-12	60
60	-6	20
-46	-34	18
-54	-24	18
-22	-56	-22
-42	-56	48

// Narayana S, 2020: Parkinson's Disease (PD) with Hypokinetic Dysarthria 
// (HKD), fMRI study
// Subjects=21
-52	-8	48
-58	-6	20
-46	4	48
-10	4	66
-2	12	66
-10	14	40
50	-8	42
60	-4	30
52	14	6
6	12	52
44	16	26
50	4	44
8	20	42
-62	-14	4
-54	-24	-2
56	-18	6
58	-26	0
52	-24	-6
-30	-58	50
28	-66	42
-12	-16	4
12	-14	4
-6	-84	-12
-16	-102	2
18	-100	2
6	-80	0
14	-94	-12
-28	-64	-22
26	-64	-24
36	-74	-22
-54	-4	38
-40	-16	34
-58	-8	16
-40	-58	52
-46	-70	38

// Allen M D, 2022: Faces > Rest, Unmedicated
// Allen M D, 2022: Faces > Rest, Medicated
// Subjects=1
28	-21	-21
-33	-18	-20
-24	-2	-18
48	17	41
36	48	17
15	26	60
47	24	32
50	-4	45
39	-18	59
-47	13	48
-17	46	48
-18	4	72
-46	21	19
-55	1	41
35	-76	-4
26	-62	-14
21	-98	-11
33	-95	1
-35	-57	-19
-31	-84	-16
-16	-89	-17
-38	-77	-17
-18	-100	-10
-43	-84	-3
33	-51	64
-49	-46	56
39	-22	-16
-29	-17	-21
0	17	49
40	3	53
41	30	38
51	16	25
45	5	26
-48	15	49
-32	5	63
-49	30	38
-15	10	68
-52	23	30
-51	10	41
28	-71	-8
35	-77	-15
17	-97	-10
25	-90	-13
36	-89	-10
42	-85	10
-33	-58	-13
-24	-89	-12
-31	-68	-8
-36	-83	11
23	-67	63
33	-50	43
-25	-71	43

// Araneda R, 2022: Right hand + Left hand + Both hands > Rest
// Araneda R, 2022: Right hand > Rest, post HABIT-ILE > pre HABIT-ILE
// Araneda R, 2022: Left hand > Rest, post HABIT-ILE > pre HABIT-ILE
// Araneda R, 2022: Both hands > Rest, post HABIT-ILE > pre HABIT-ILE
// Subjects=25
1.45	3.97	45.77
1.52	2.45	53.7
57.04	-5.39	43.68
49.72	-23.53	57.55
43.32	-30.08	55.95
34.78	-6.9	67.48
60.19	-3.77	36.82
62.01	10.59	2.14
61.13	-18.25	14.6
44.91	-2.8	-4.35
14.03	-18.25	5.11
16.1	-55.18	-18.58
-36.85	-17.61	59.17
-32.55	-23.93	59.65
-21.32	-52.32	-19.51
-30.41	-15.03	64.45
-35.72	-33.47	60.49
1.46	4.05	46.87
1.51	4.57	53.52
55.98	-5.31	44.8
50.8	-23.43	58.65
43.39	-43.57	60.42
33.72	-6.9	67.5
62.17	10.02	22.26
58.78	12.52	-.22
14.03	-18.25	5.11
13.97	-55.2	-18.56
45.98	3.81	-1.57
-35.77	-13.12	62.13
-40.02	-20.55	62.8
-21.32	-52.32	-19.51
-34.65	-35.58	60.65
-30.43	-5.43	64.76
1.46	4.05	46.87
1.57	-4.69	57.64
36.91	-7.06	65.24
55.98	-8.57	43.96
46.53	-25.57	58.88
66.53	-19.82	21.36
-44.33	-17.66	59.26
-33.6	-23.68	62.99
-18.1	-52.22	-18.44
1.45	3.97	45.77
1.52	2.45	53.7
1.46	4.05	46.87
1.51	4.57	53.52
1.46	4.05	46.87
1.57	-4.69	57.64
-37.02	13.59	49.86
-56.36	2.51	32.06
-18.21	45.52	6.82
-11.52	-43.78	7.54
-11.3	-54.67	31.87
60.11	-2.43	26.67
49.28	-1.75	8.9
23.75	45.42	43.15
-2.05	50.33	26.31
4.37	50.37	26.23
1.71	-42.76	60.83
40.1	-19.27	58.42
47.56	-27.05	53.41
60.11	3.12	29.55
33.29	24.91	24.69
20.45	-5	10.61
13.93	3.7	-0.08
46.09	-4.85	10.31
36.86	-66.81	35.68
11.12	-54.79	28.28
-21.39	45.76	10.18
-41.21	-64.62	29.7
-11.3	-54.67	31.87
23.7	31.71	30.92
17.1	46.25	13.05
33.76	-72.4	46.22
20.73	-44.96	30.69
13.94	0.53	0.19
30.08	-71.76	-14.01
-49.8	-2.51	49.13
-17.97	28.29	31.68
-50.21	29.47	8.54
-34.2	49.11	13.4
-17.58	-33.62	56.94
-46.72	-59.85	9.29
-20.89	-47.87	38.1
-14.75	-30.85	9.84

// Kesler S R, 2022: Turner Syndrome
// Subjects=13
38.2	-79.48	11.59
-43.96	-82.31	8.79
36.55	-41.74	59.43
46.93	-29.51	28.91
40.54	-34.33	35.1
-24.3	3.6	42.54
3.61	31.9	33.66
3.73	-29.56	30.77
0.76	58.48	-14.87
-56.33	-21.47	-17.19

// Kesler S R, 2022: Healthy Controls
// Subjects=13
-46.12	-81.25	8.72
25.85	-64.01	62.94
40.68	-39.88	44.61
48.72	-73.86	-9.31
-41.74	-81.89	13.19
34.46	-68.54	59.88
6.07	14.42	53.27
-24.27	3.81	44.76
46.93	-29.51	28.91
40.54	-34.33	35.1
-24.3	3.6	42.54
3.61	31.9	33.66
3.73	-29.56	30.77
0.76	58.48	-14.87
-56.33	-21.47	-17.19

// Donnelly B, 2022: Healthy Controls (HC) > Binge Eating Group (BEG): Low 
// energy disgust > Neutral
// Donnelly B, 2022: BEG > HC: Low energy fear > Neutral
// Donnelly B, 2022: HC > BEG: Low energy fear > Neutral
// Donnelly B, 2022: BEG > HC: Low energy happy > Neutral
// Donnelly B, 2022: HC > BEG: High energy disgust > Neutral
// Donnelly B, 2022: HC > BEG: High energy fear > Neutral
// Donnelly B, 2022: HC > BEG: High energy happy > Neutral
// Subjects=19
20	-36	-22
-34	-68	-8
8	-65	-10
38	-2	30
10	-88	22
-44	40	-6
-16	-6	48
-10	-42	68
38	-12	-22
-30	-70	6
14	-46	-8
46	-22	24
38	-70	10
-34	-32	-26
4	4	64
32	50	26
-22	-82	-38
50	22	-2
-28	-68	28
10	-58	4
0	-4	-12
-12	-60	-2
-40	-71	10
42	4	-34
10	2	66
48	36	-8
-2	2	-6

// Schneider E, 2022: Placebo > LDX, Food > Non-food
// Schneider E, 2022: Food > Non-food
// Subjects=22
10	-8	3
-35	-48	-10
-10	-10	8
30	30	3
-37.5	-5	7.5
-35	35	20
-5	-50	17.5
-30	32.5	-5
-47.5	-47.5	-20
-25	-65	37.5
37.5	0	7.5
-15	30	52.5
-2.5	-10	7.5
-2.5	0	32.5
-47.5	10	35
-45	-65	37.5
17.5	40	42.5
37.5	37.5	17.5

// Bhikram T, 2021: Tourette Syndrome
// Subjects=39
48	-34	22
15	-37	41
-12	38	43
15	-7	58
-6	-22	16
32	-37	-2
15	-9	24
-45	-50	19
27	-46	4
-4	-41	37
-39	5	-2
-34	-3	15
-7	-5	0
-30	32	7
-39	-16	16
39	41	-5
3	-52	-47
-36	-25	-11
-6	-34	58
15	-22	52
-44	-37	28
39	-16	49
-48	-55	1
-51	-40	28
39	-30	40
12	23	49
-48	-8	40
48	-12	40
33	23	34
-18	-67	-11
30	-16	7
-6	-1	46
36	20	1
-60	-7	1

// Bhikram T, 2021: Healthy Controls (HC)
// Subjects=20
48	-34	22
15	-37	41

// Gool J K, 2022: All Participants: Active sleep resistance > Waking rest
// Gool J K, 2022: All Participants: Waking rest > Active sleep resistance
// Subjects=12
-20	-30	-2
56	-44	-4
36	-68	42
44	32	18
-48	-54	-6
56	-66	0
42	-18	-30

// Openneer T J C, 2021: Tourette Syndrome without ADHD
// Subjects=28
-44	-44	12
-44	-46	12

// Openneer T J C, 2021: Tourette Syndrome with ADHD
// Subjects=23
-44	-44	12
-44	-46	12
52	-4	-18
38	32	-10
-40	-18	-8
56	8	-14

// Openneer T J C, 2021: Healthy Controls
// Subjects=52
52	-4	-18
38	32	-10
-40	-18	-8
56	8	-14

// Zapparoli L, 2020: Healthy Controls
// Subjects=25
-26	-24	58
-28	-24	64
-26	-22	68
-40	-22	56
-12	-54	-14
-20	-52	-20
-14	-58	-16
-22	-56	-18
-26	-54	-20
-50	14	0
-52	18	22
-46	8	26
-46	4	28
-42	36	20
-46	28	20
-52	22	20
-36	44	14
-42	34	8
-36	52	16
-2	2	50
-14	-68	48
-24	-64	38
-20	-62	48
-22	-68	46
-48	10	-2
-34	-66	-12
-24	-64	30
-40	-80	4
-32	-90	16
-36	-68	-8
-2	-72	6
-10	-84	12
-22	-68	-18
44	8	14
44	12	16
44	10	22
52	10	32
40	12	12
38	38	30
30	52	20
36	4	60
36	-4	62
36	-4	62
38	-16	64
42	-10	58
48	-8	50
4	0	58
32	-20	48
32	-16	44
36	-14	42
40	-16	54
46	-28	42
38	-20	46
36	-20	50
42	-24	44
38	24	0
40	20	0
38	14	4
46	12	0
46	-32	44
48	-38	44
52	-40	42
24	-82	32
30	-88	6
28	-70	34
32	-80	-6
36	-64	-24
32	-42	-28
-2	-14	54
-34	-22	60
-32	-82	16
-40	-78	0
-18	-56	-16
38	44	24
0	12	44
8	12	40
0	-10	52
24	-66	48
30	-88	6
28	-52	-20
4	-70	-14
-58	-26	22
-58	-30	24
-58	-46	10
48	-60	14
52	-60	12
54	-60	24
52	-66	24
-46	-28	20
-46	-64	14
-48	-60	14
52	-28	24
-48	24	2
-44	28	4
-54	22	0
-18	4	64
-14	10	54
-28	-12	62
-26	-8	66
-16	8	64
-4	18	62
-8	10	54
-6	14	54
-4	18	56
-40	-20	58
-38	-18	62
-40	12	2
-40	4	-8
-42	6	-4
-20	-30	-4
-18	-34	-6
-14	-44	-10
-2	-38	-10
-20	-2	-4
-22	-8	0
-24	-16	-2
-18	-8	2
10	44	44
58	22	-2
60	16	0
14	26	48
14	22	50
18	32	48
38	-38	62
34	-40	64
52	-30	50
32	-40	68
36	-42	60
40	22	-6
46	14	-4
22	-34	-10
10	-46	-6
10	-44	-10
12	-40	-10
16	-10	-2
8	-4	-6

// Zapparoli L, 2020: Gilles de la Tourette Syndrome
// Subjects=25
-26	-24	58
-28	-24	64
-26	-22	68
-40	-22	56
-12	-54	-14
-20	-52	-20
-14	-58	-16
-22	-56	-18
-26	-54	-20
-50	14	0
-52	18	22
-46	8	26
-46	4	28
-42	36	20
-46	28	20
-52	22	20
-36	44	14
-42	34	8
-36	52	16
-2	2	50
-14	-68	48
-24	-64	38
-20	-62	48
-22	-68	46
-48	10	-2
-34	-66	-12
-24	-64	30
-40	-80	4
-32	-90	16
-36	-68	-8
-2	-72	6
-10	-84	12
-22	-68	-18
44	8	14
44	12	16
44	10	22
52	10	32
40	12	12
38	38	30
30	52	20
36	4	60
36	-4	62
36	-4	62
38	-16	64
42	-10	58
48	-8	50
4	0	58
32	-20	48
32	-16	44
36	-14	42
40	-16	54
46	-28	42
38	-20	46
36	-20	50
42	-24	44
38	24	0
40	20	0
38	14	4
46	12	0
46	-32	44
48	-38	44
52	-40	42
24	-82	32
30	-88	6
28	-70	34
32	-80	-6
36	-64	-24
32	-42	-28
-2	-14	54
-34	-22	60
-32	-82	16
-40	-78	0
-18	-56	-16
38	44	24
0	12	44
8	12	40
0	-10	52
24	-66	48
30	-88	6
28	-52	-20
4	-70	-14
-58	-26	22
-58	-30	24
-58	-46	10
48	-60	14
52	-60	12
54	-60	24
52	-66	24
-46	-28	20
-46	-64	14
-48	-60	14
52	-28	24

// Uddn J, 2022: Healthy Controls: Visual
// Subjects=102
-52	-30	-4
-56	2	-16
-50	-36	-2
-54	8	-18
-48	28	0
-56	18	14
-50	-54	16
-54	-56	18
-52	-54	12
48	-16	8
44	-24	10
-38	30	12

// Uddn J, 2022: Healthy Controls: Auditory
// Subjects=102
-52	-30	-4
-56	2	-16
-50	-36	-2
-54	8	-18
-48	28	0
-56	18	14
-50	-54	16
-54	-56	18
-52	-54	12
48	-16	8
44	-24	10
-38	30	12
-38	-30	12
-48	-20	8
50	-16	8
-32	-38	-10

// Zhang S, 2022: Zero Pronoun_GLM > Non-Zero Pronoun_GLM
// Zhang S, 2022: Zero Pronoun_MVPA > Rest
// Zhang S, 2022: Non-Zero Pronoun_MVPA > Rest
// Subjects=35
-50	-58	-14
-60	-20	6
5	-74	47
-11	-61	60
-24	43	37
-43	-80	34
-65	-30	-7
-27	65	9
52	-74	22
27	2	-29
-52	-42	-19
24	68	3
43	5	-48
33	-45	-23
30	-55	63
-21	15	-19
-5	59	-23
24	15	66
-5	46	41
14	-23	-35

// Castro M, 2020: Composers: familiar own music (OM) > unfamiliar other music 
// (UM) and familiar other music (FM) > UM
// Castro M, 2020: Composers: OM > UM
// Castro M, 2020: Composers: FM > UM
// Castro M, 2020: Composers: OM > FM
// Castro M, 2020: Composers: familiar own name after the presentation of 
// familiar own music (ONaOM) > familiar own name after the presentation of 
// unfamiliar other music (ONaUM)
// Castro M, 2020: Composers: ONaOM > familiar own name after the presentation 
// of familiar other music (ONaFM)
// Castro M, 2020: Composers: familiar other name after the presentation of 
// familiar own music (FNaOM) > familiar other name after the presentation of 
// unfamiliar other music (FNaUM)
// Castro M, 2020: Composers: FNaOM > familiar other name after the 
// presentation of familiar other music (FNaFM)
// Castro M, 2020: Composers: FNaFM > FNaUM
// Subjects=16
-8	-66	60
12	-64	56
28	4	64
-44	-40	38
54	-36	48
46	8	2
2	26	24
-14	-60	52
14	-62	52
26	2	56
-58	-34	52
54	-36	44
-58	10	18
4	-42	6
-4	-4	62
-60	4	26
-20	-62	-18
12	-62	46
28	2	66
-56	-32	34
60	-40	52
50	8	4
12	-34	26
12	-10	-4
-4	-6	-10
22	-50	36
-6	64	6
10	64	18
-52	0	40
-48	-42	-14
-2	-88	28
-32	-26	28
14	-60	48
-30	-36	40
-22	-74	-8
-20	-62	-18
-12	-40	64
22	-32	46
20	-58	42
18	-44	36
6	24	24
-50	-20	24
-4	-20	56
-30	-22	-16
-30	0	8
-12	-42	70
-34	-22	50
-12	-70	22
-12	6	34
28	2	6

// Bouhali F, 2022: Musicians
// Subjects=19
-53	-59	-9
-50	-52	-12

// Bouhali F, 2022: Non-musicians
// Subjects=21
-52	-60	-9
-47	-56	-13

// Koelsch S, 2021: Joy > Fear
// Subjects=24
48	-28	2
68	-25	11
52	-12	4
54	-24	20
38	-23	19
34	-24	10
54	-4	44
-48	-22	-2
-62	-13	-1
-48	-18	5
-38	-18	5
-54	-18	14
-34	-26	17
-48	38	20
-46	38	14
-48	0	54
-51	-28	59
21	32	52
0	56	5
15	-43	-43
-33	-58	-49
54	-64	5
-15	32	56
-6	11	65
-48	-64	-14
51	29	2
-27	-1	50
-15	-49	71

// Matthews T E, 2020: All Participants: Medium > High rythmic complexity
// Matthews T E, 2020: Musicians > Non- Musicians
// Subjects=25
-14	10	-2
-2	-2	8
22	4	8
-42	-48	44
-28	-58	40
-36	-54	40
-6	20	48
-4	12	52
-58	-40	-18
38	-58	50
34	-66	56
36	-50	38
-24	14	68
-8	-10	60
8	-4	68
34	6	52
58	-36	-16
-14	-92	-22
-40	26	28
-38	36	16
38	-68	16
6	-20	-44
0	-82	-12
-20	64	0
-28	0	50
-32	-60	-62
-14	26	-22
-22	24	-22
-12	32	28
-16	-18	72
4	-4	30
-46	8	32
12	-88	-28
-16	66	2
42	-50	-8
-36	6	46
-46	14	2
-46	-4	54
-38	-42	20
-40	-44	12
46	-6	48
-2	2	64
44	18	24
56	-8	6
-4	12	4
-58	-48	18
22	-12	32
56	-36	26

// Toiviainen P, 2020: Increased centrality during high beat salience
// Toiviainen P, 2020: Increased centrality during low beat salience
// Subjects=77
34	34	44
34	14	34
6	42	8
2	54	48
6	58	24
-18	34	72
-50	18	48
-38	10	60
-62	10	12
-10	-94	20
-50	22	4
46	-78	-16
58	-14	8

// Mungoven T J, 2022: Migraineurs (24 hr prior to migraine) > Healthy 
// Controls, Noxious heat > Baseline
// Subjects=7
-46	40	16
-52	24	29
-66	-48	75
-62	-20	22
-48	24	55
-48	10	20
10	6	23

// Baksa D, 2022: Study 1: Fear > Neutral, p=0.013
// Baksa D, 2022: Study 1: Fear > Neutral, Evening > Morning, p<0.001
// Baksa D, 2022: Study 1: Fear > Neutral, Evening > Morning, p=0.022
// Baksa D, 2022: Study 1: Fear > Neutral, Evening > Morning, p=0.013
// Baksa D, 2022: Study 2: Fear > Neutral, Morning > Varying
// Baksa D, 2022: Study 1: Fear > Neutral, p<0.001
// Baksa D, 2022: Study 1: Fear > Neutral, p=0.004
// Baksa D, 2022: Study 1: Fear > Neutral, p=0.006
// Baksa D, 2022: Study 1: Fear > Neutral, p=0.009
// Baksa D, 2022: Study 1: Fear < Neutral, p=0.006
// Baksa D, 2022: Study 1: Fear < Neutral, p=0.017
// Baksa D, 2022: Study 1: Fear < Neutral, p=0.001
// Baksa D, 2022: Study 1: Happy > Neutral, p<0.001
// Baksa D, 2022: Study 1: Happy > Neutral, p=0.014
// Baksa D, 2022: Study 1: Sad > Neutral, p<0.001
// Baksa D, 2022: Study 1: Sad > Neutral, p=0.035
// Baksa D, 2022: Study 1: Sad < Neutral
// Baksa D, 2022: Study 2: Fear > Neutral, p<0.001
// Baksa D, 2022: Study 2: Fear > Neutral, p=0.001
// Baksa D, 2022: Study 2: Fear < Neutral, p<0.001
// Baksa D, 2022: Study 2: Happy > Neutral, p<0.001
// Baksa D, 2022: Study 2: Happy > Neutral, p=0.013
// Baksa D, 2022: Study 2: Sad > Neutral, p<0.001
// Subjects=8
-57	-37	17
-45	-37	20
-51	-40	20
-63	-34	23
-45	-37	20
-57	-34	17
-60	-31	23
-51	-22	29
-60	-25	23
-57	-31	32
-60	-40	29
54	-19	11
45	-25	14
42	-28	11
48	-31	14
-9	-40	35
-9	-34	32
-15	-46	35
-18	-43	32
-12	-43	38
-6	-43	32
3	-46	41
6	-34	65
18	-31	74
9	-19	62
-3	-37	68
45	-46	-16
-36	-55	-13
45	-55	-13
-24	-94	8
-33	-73	-13
-27	-85	8
42	-70	-16
-30	-76	-19
-39	-67	-16
-39	-79	-10
39	-85	-1
36	-61	-7
42	-82	-4
-15	-88	-10
36	-70	-7
33	-88	5
21	-7	-13
30	-4	-19
33	-10	-10
30	-22	-4
48	11	35
45	26	23
45	11	29
51	32	29
57	23	26
-51	26	26
-48	20	29
-54	29	20
-57	26	14
-36	5	35
-36	11	35
-48	41	-4
-42	26	-16
-45	29	-13
-51	29	-10
-21	-4	-16
-3	38	50
9	23	53
-6	23	50
21	-46	8
-21	-49	5
3	-43	41
6	-34	41
-27	-88	11
-39	-79	-7
-30	-70	-4
-33	-76	-1
-33	-61	-7
-33	-73	-7
-36	-79	5
-39	-64	-7
-39	-70	-10
-15	-94	-1
-42	-58	-16
-27	-61	-10
-45	-49	-19
-27	-88	-7
-33	-88	-7
-27	-82	35
24	-88	8
39	-49	-16
36	-64	-10
39	-37	-22
48	-67	-7
24	-37	-25
6	-73	-1
18	-76	11
30	-70	29
30	-76	41
42	-70	17
9	-34	-28
54	-58	11
51	-73	8
-6	-37	-31
3	-34	-31
24	-1	-13
30	5	-22
27	-16	-10
42	32	11
42	26	20
48	32	14
48	26	20
42	5	23
39	8	29
39	8	35
54	29	20
57	23	23
-24	-4	-22
-27	-1	-16
-15	8	-13
-27	-70	-7
36	-82	2
-30	-85	17
-18	-82	-13
-27	-61	-7
-15	-94	17
45	-52	-13
-45	-52	-16
-42	-49	-7
-39	-85	5
21	-91	20
42	-37	-19
33	-61	-10
18	-79	-13
39	-67	-10
9	-85	-10
51	32	14
39	17	17
39	23	17
39	8	26
-42	-40	17
-63	-31	14
24	-79	-7
30	-91	8
33	-76	-10
39	-85	-1
-39	-46	-16
36	-85	-7
-27	-91	8
-21	-85	-7
-21	-88	-1
-33	-76	-10
3	-85	-7
-33	-85	-4
30	-61	-10
39	-49	-16
-42	-58	-10
12	-91	-4
54	38	8
42	17	23
42	23	20
36	8	23
39	-1	38
45	2	32
54	35	20
39	32	2
54	29	29
-33	5	29
-36	20	17
-51	11	20
-45	14	23
-57	14	11
-42	17	20
9	35	11
-15	50	2
0	32	23
-15	41	-1
6	32	-4
6	41	-7
9	35	-1
21	41	11
-3	41	5
6	44	17
-21	-94	11
-39	-76	-13
-36	-55	-16
-39	-85	2
-24	-82	-13
-27	-64	-10
-30	-67	-13
-9	-88	-10
30	-85	8
18	-97	17
21	-94	14
36	-52	-13
45	-61	-19
42	-52	-19
42	-76	-7
33	-76	-13
45	-73	-10
45	-82	2
24	-61	-7
51	-58	8
36	-61	56
27	-55	44
42	-34	-16
-9	-76	-40
-18	-70	-49
-24	-67	-49
24	-76	-10
45	-76	-1
39	-34	-19
-24	-70	-7
-24	-79	-10
-21	-82	-7
-24	-94	23
-36	-88	11
-33	-88	17
12	-94	11
-30	-85	8
-21	-82	-13
-39	-85	2
-36	-58	-13
-42	-82	-1
0	-88	-4
45	32	-4
54	38	8
48	38	14
42	11	20
30	2	-19
42	41	-13
39	2	38
42	26	17
51	-4	-13
45	20	-22
57	23	29
57	23	17
48	-7	-16
39	20	-28
51	8	-13
6	-34	-7
-48	35	11
-36	-1	32
-54	17	29
-45	17	-22
-51	-1	-16
-48	20	23
-39	32	-7
-42	20	-13
-39	17	26
-51	41	-7
-45	8	23
-36	14	-4
-24	20	-4
-45	53	-4
-54	20	2
-51	5	-22

// Brown S, 2021: Vocalization > Fixation
// Brown S, 2021: Jaw lowering > Fixation
// Brown S, 2021: Jaw clenching > Fixation
// Subjects=23
-42.35	-15.93	40.13
46.35	-15.4	39.07
50.62	-7.71	41.72
-58.39	-.79	44.62
60.25	-2.03	45.59
-42.35	-14.87	40.04
46.35	-15.4	39.07
63.41	-.32	39.84
-51.97	-12.82	39.98
47.27	-3.73	24.7
-51.89	-8.62	53.01
-40.23	-15.03	37.8
-57.31	-10.56	42.08
59.14	-6.86	38.21
-49.97	-5.37	25.95
-51.89	-8.62	53.01
-56.32	0.73	36.66

// Coccaro E F, 2022: Encoding: Intermittent Explosive Disorder (IED) < 
// Healthy Controls (HC)
// Coccaro E F, 2022: Attribution: IED < HC
// Coccaro E F, 2022: Emotional response: IED < HC
// Subjects=19
2	38	2
-62	-56	10
24	-88	-40
40	20	26
-42	24	26
-38	12	50
56	-44	-14
-16	26	62
-18	60	32
10	-24	-14

// Matt E, 2022: Migraine
// Subjects=10
-44	-38	34
48	-10	24
52	-28	24
-30	20	14
-32	-70	48
40	-62	50
64	28	-88
31	40	-62
38	26	-74
-44	-38	34
44	-74	30
22	32	50
28	-88	26
-14	-86	14
-4	-84	42
26	-80	-20
-18	-82	-22
-4	-96	-2
30	-78	-6
34	24	2
-32	20	10
28	-88	24

// Matt E, 2022: Healthy Controls
// Subjects=11
34	6	28
12	-82	18
34	24	2
-16	-48	-4
2	-84	14
-42	72	6
22	34	50
38	6	24
34	24	2
-32	20	10
28	-88	24

// Carollo A, 2023: Chinese > Arabic + Indian + Caucasian
// Carollo A, 2023: Chinese > Indian
// Carollo A, 2023: Chinese > Arabic
// Subjects=43
36	-70	2
39	-31	38
39	-31	38
30	-88	23
39	-73	-1
45	-61	-4
54	-67	-13
-39	-58	5
-39	-73	-1
33	-25	26
-3	-7	-4
-3	5	-7
27	-37	5

// Cui F, 2023: Scarcity > Abundance
// Cui F, 2023: Abundance > Scarcity
// Cui F, 2023: [(Scarcity in-group > Scarcity out-group) > (Abundance 
// in-group > Abundance out-group)]
// Cui F, 2023: Scarcity in-group > Scarcity out-group
// Subjects=28
14	-64	52
-22	-56	-26
-28	-60	-56
42	-34	40
6	0	54
48	6	28
-34	-46	44
-46	-68	4
-28	-60	40
-16	-92	-16
-24	-2	52
-38	-30	52
14	-56	-20
-14	-68	32
12	22	30
6	22	18
-2	34	22
2	40	26
-14	2	16
-20	-10	18
-8	56	30
2	-86	18
0	38	0
-2	34	8
20	46	32

// Farmer H, 2020: White > Black
// Farmer H, 2020: Face > Scrambled
// Subjects=25
-8	6	10
38	-42	-20
42	-58	-18
-38	-50	-26
-42	-86	-6
-6	18	48
42	28	22

// Handley G, 2023: White > Black
// Subjects=58
12	-99	15
15	-93	6
18	-81	15

// Li X, 2023: Experiment 2 Healthy Controls
// Subjects=40
-6	20	28
54	2	37
57	-61	4
3	32	25
60	-58	4
57	-4	37
51	-64	-8
-24	-94	-5

// Li X, 2023: Subgroup of Experiment 2 Healthy Controls, Mortality Salience
// Subjects=20
-6	20	40
57	-1	34

// Li X, 2023: Subgroup of Experiment 2 Healthy Controls, Negative Affect
// Subjects=20
36	-73	43

// Li Z, 2020: Group effect: In-group > Out-group
// Li Z, 2020: Observe > Commit
// Li Z, 2020: Commit > Observe
// Subjects=31
-27	47	-11
-36	14	-11
-6	26	34
36	17	-11
48	-25	52
12	14	58
0	-61	25
-60	-4	-26
54	-61	22
-45	-70	28
-24	23	46
0	56	-17
-57	29	4
-3	8	43

// Nugiel T, 2020: Ingroup > Outgroup
// Nugiel T, 2020: Outgroup > Ingroup
// Subjects=50
-18	-90	24
-8	34	-10
-50	-28	0
-36	-80	-22
-38	26	-8

// Rubien-Thomas E, 2021: Correct No-go > Correct Go
// Rubien-Thomas E, 2021: Go > No-go
// Rubien-Thomas E, 2021: Black Faces > White Faces
// Rubien-Thomas E, 2021: Black > White Participants in Black > White Faces
// Subjects=50
-32	-43	-24
-56	22	22
-8	42	50
52	-16	58
62	-50	42
-58	-60	38
6	-26	60
-54	-38	6
-42	-2	-32
62	-10	-14
-40	-20	50
16	-50	-20
20	-60	-46
-46	-4	8
-18	-70	-18
-56	4	24
42	-54	-14
32	20	4
-32	-42	-24
50	-70	28
-30	-84	40
-2	68	-6
8	-60	18

// van Gils S, 2023: Sacrifice Outgroup > Ingroup
// van Gils S, 2023: Handholding > Alone
// van Gils S, 2023: Condition x Block Interaction
// Subjects=17
-8.02	-100.09	22.26
10.97	-49.73	11.13
-17.55	-6.95	71.44

// Brignoni-Perez E, 2021: Arithmetic > Control, Monolinguals
// Brignoni-Perez E, 2021: Arithmetic > Control, Bilinguals
// Subjects=18
-30	22	-2
40	20	2
-6	12	50
-66	-46	14
52	-44	54
-46	-2	40
-26	-52	38
30	22	-2

// Declercq M, 2022: Untrained (UN) > Trained (TR), (Post-training)
// Declercq M, 2022: TR > Single Related (SR), (Pre-training)
// Declercq M, 2022: UN > SR, (Pre-training)
// Declercq M, 2022: UN > SR, (Post-training)
// Declercq M, 2022: SR > TR, (Pre-training)
// Declercq M, 2022: SR > UN, (Pre-training)
// Declercq M, 2022: SR > UN, (Post-training)
// Subjects=26
-34	-50	48
-42	-40	46
-28	-40	46
-6	-76	-30
-6	12	52
8	18	42
4	26	42
-42	2	32
28	8	56
52	16	34
-48	-56	-16
40	-42	46
42	-36	42
-38	-50	52
-30	-62	48
-34	-52	42
-30	-62	-28
-26	2	54
-22	-94	-4
-8	8	60
10	14	48
-50	-54	-12
28	-64	42
20	-66	44
34	-56	46
34	22	0
-4	10	52
10	20	40
6	16	52
-48	26	30
-40	4	34
-34	-48	42
-30	-56	52
-30	-62	46
-4	-70	-30
-38	-78	-14
38	18	-4
28	-64	-28
-54	-2	-18
0	56	-12
-56	-58	26
4	54	-8
-56	-4	-22
-8	50	8
-4	62	24
-2	-28	50
0	56	-16

// Matejko A A, 2021: Adults
// Subjects=26
40.9	-35	40.93
31.54	24.74	0.77
26.88	1.94	42.32
-3.51	19.76	43.52
2.41	-73.13	-25.3
-7.73	-83.55	3.59
-31.62	-46.72	41.65
-32.33	-63.62	-27.82
-30.82	1.26	43.74
-42.11	39.16	16.29
1.56	-61.2	25.55
42.95	4.91	23.75
29.9	-2.25	56.15
32.57	21.11	2.03
-30.11	-1.87	48.56
40.98	-34.78	41.1
33.11	22.67	0.65
-30.99	-44.24	42.3
-27.31	-1.14	52.57
68.15	-31.12	12.6
54.18	-54.55	20
39.47	-79.31	-4.32
1.32	-70.37	-31.89
-23.61	-44.93	39.2
-24.98	-70.28	28.89
-37.92	-80.62	-7.4
-27.04	-3.4	49.62

// Matejko A A, 2021: Children
// Subjects=38
36.19	-44.96	45.43
30.64	23.06	3.21
-.68	26.01	42.95
-40.52	-45.25	46.86
31.34	-60.31	35.13
50.18	8.5	28.2
29.38	0.15	55.85
5.9	-71.23	-17.92
14.84	-16.9	9.45
-18.03	0.2	49.82
-21.84	-56.69	49.56
-18.38	-26.93	8.91
-33.14	-80.7	7.44
-46.68	0.41	33.7
-45.64	-65.15	-2.17
35.27	-45.31	45.15
68.15	-31.12	12.6
54.18	-54.55	20
39.47	-79.31	-4.32
1.32	-70.37	-31.89
-23.61	-44.93	39.2
-24.98	-70.28	28.89
-37.92	-80.62	-7.4
-27.04	-3.4	49.62

// Newman S D, 2021: Structured Block Play
// Subjects=22
44	-36	6
38	-30	-6
-36	-30	6
-22	-16	6
6	-32	34
2	-18	32
-46	28	20
-42	-22	60
26	24	10
44	16	22
-42	-18	36
-32	-22	36
-26	-6	12
-36	-10	38

// Newman S D, 2021: Free Block Play
// Subjects=21
-52	-52	-2
-60	-34	26
-10	-52	50
-26	-6	12
-36	-10	38

// Qin S, 2024: Children
// Subjects=28
-32	16	2
40	20	-8
-38	20	26
40	20	22
-38	14	10
40	16	10
-2	6	56
-20	-40	-4
-20	-36	-2
24	-38	0
30	-20	-16
-46	-48	46
-36	-60	44
20	-100	0
-18	-2	2
12	-30	-18
-4	-52	-18
-26	-24	-16
-16	-20	-18
28	-18	-18
32	-14	-20
20	-68	-22
-44	18	52
-32	30	50
40	22	54
48	14	36
44	-72	26
-22	-64	64
46	32	40
44	42	34
-34	42	42
-30	40	40
-30	-68	54
-30	-76	50
32	-16	-18
14	-30	18
-40	16	34
-54	20	14
-42	-38	-16
40	-74	-14
62	-32	-8
-40	-18	44
-46	-22	36
-26	-14	-20
-22	-32	-2
20	-16	-16
32	-6	-18
-38	-8	-6
16	-66	18
-20	-30	0
10	-22	-2
-8	-32	-10

// Qin S, 2024: Adolescents
// Subjects=20
52	10	16
50	20	14
-38	4	26
10	12	42
46	10	2
36	20	-8
-2	18	48
-24	-66	48
32	-16	-18
14	-30	18
-40	16	34
-54	20	14
-42	-38	-16
40	-74	-14
62	-32	-8
-40	-18	44
-46	-22	36
-26	-14	-20
-22	-32	-2
20	-16	-16
32	-6	-18
-38	-8	-6
16	-66	18
-20	-30	0
10	-22	-2
-8	-32	-10

// Qin S, 2024: Adults
// Subjects=20
42	12	24
-46	6	28
-42	8	36
8	16	44
2	18	48
-32	-54	36
-24	-72	34
32	-16	-18
14	-30	18
-40	16	34
-54	20	14
-42	-38	-16
40	-74	-14
62	-32	-8
-40	-18	44
-46	-22	36
-26	-14	-20
-22	-32	-2
20	-16	-16
32	-6	-18
-38	-8	-6
16	-66	18
-20	-30	0
10	-22	-2
-8	-32	-10

// Surez-Pellicioni M, 2021: Math Attitudes x Improvement in Small 
// Multiplication Problems
// Subjects=25
-12	-64	-6
30	-76	-16
30	-80	20
26	-82	28
6	-6	2
-4	-18	12

// Surez-Pellicioni M, 2020: [(Large subtraction problems > Control) (Time 2 
// > Time 1) (Non-improvers > Improvers)]
// Subjects=23
-2	-81	22
-2	-91	18
2	-83	6
32	-33	38
40	-35	46
44	-23	42
-38	-53	6
-36	-65	2
-36	-67	22

// Bi R, 2022: High effort > Low effort, All Participants
// Bi R, 2022: Other > Self, All Participants
// Bi R, 2022: Healthy Control (HC) [self] - HC[other] > Subthreshold 
// Depression (SD) [self] - SD[other]
// Bi R, 2022: high[self] - high[other] > low[self] - low[other], All 
// Participants
// Bi R, 2022: High effort > Low effort, All Participants (TFCE-FWE)
// Bi R, 2022: Other > Self, All Participants (TFCE-FWE)
// Bi R, 2022: (HC[self] - HC[other] > SD[self] - SD[other]), All Participants 
// (TFCE-FWE)
// Bi R, 2022: (high [self] - high [other]) > (low [self] - low [other]), All 
// Participants (TFCE-FWE)
// Subjects=30
20	-8	64
-20	-10	68
30	-10	62
-18	-18	24
-16	-26	22
-14	-8	24
20	-24	22
-18	18	16
-16	10	20
14	48	24
18	40	46
30	40	-16
30	54	-12
16	52	-4
-30	36	-16
-28	46	-6
38	-54	22
-18	50	8
-12	40	30
14	32	42
-12	8	60
-60	-12	-24
-54	30	-2
-50	40	-8
-52	-28	6
-12	-16	42
66	-14	-2
-8	38	54
2	56	38
46	-24	56
-30	18	-18
-36	16	-10
32	16	-12
-48	24	14
-44	18	10
48	30	0
50	10	10
56	16	10
-42	-36	22
-4	40	22
-2	50	30
6	36	4
10	40	16
-58	-48	36
-32	28	34
-14	-46	42
-16	-44	34
52	10	-16
44	18	-30
2	56	-14
-34	-10	18
-50	8	-14
-68	-22	2
28	-72	-38
-18	-82	-30
14	64	26
-10	36	38
-6	56	38
62	14	14
56	10	4
-54	32	-2
-52	40	6
24	18	38
46	14	52
6	-14	56
10	-14	74
28	-16	64
38	-56	24
38	-58	36
2	64	12
29	-46	2
12	10	18
14	-2	20
8	16	10
-12	46	18
-36	10	32
-6	-70	-44
24	56	2
28	48	12
48	40	4
58	32	8
40	36	-12
44	28	-8
-4	-60	66
-30	8	40
54	-44	30
60	-46	42
58	-50	24
4	42	18
-30	20	44
-30	42	40
-28	34	50
-38	32	-16
-30	24	-16
-28	-80	42
-36	-84	34
-14	2	52
-34	-70	26
42	-18	-26
50	-42	-18
30	-14	-18
2	-60	-48
14	44	16
54	-32	40
-36	4	64
-50	-74	-6
-58	10	18
-50	-52	6
22	-40	62
-64	-50	12
-64	-54	2
-22	-68	62
-34	50	0
56	-66	18
26	34	44
28	30	52
24	-70	46
34	-70	54
-52	-64	-14
52	-64	32
-22	-64	-44
-16	0	62
20	-70	62
-8	-14	42
-44	-66	-36
34	-86	28
-60	-40	32
20	-8	64
30	-10	62
30	-18	64
-34	-82	-22
-32	-82	-42
-40	-74	-22
16	26	-2
22	18	16
6	16	4
38	-54	22
-30	18	-18
-30	16	-10
-46	22	14
32	16	-12
48	28	0
50	10	10
-4	40	22
-2	50	30
10	40	16
-6	20	54
-12	18	62
4	24	60
-24	50	24
-30	56	24
-22	52	16
-32	28	34
-14	-46	42
52	10	-16
42	-12	-12
-60	-14	22
-68	-22	2
-50	8	-14
-18	-82	-30
-24	-90	-34
-30	-82	-44
-6	56	38
-6	58	22
-12	64	20
28	-72	-38
30	-66	-44
30	-82	-36
-54	32	-2
-50	42	-12
-52	40	6
26	18	38
44	18	46
26	34	44
-4	-60	66
-4	-58	56
38	-56	24
38	-58	36
-36	-24	-10
-30	8	40
-38	8	42
-24	0	46
-22	-68	62
-14	-76	60
54	-44	30
60	-46	42
-50	-74	-6
-52	-64	-16
-54	-62	-8
-60	-40	32
-46	-40	34
-48	-32	36
-36	4	64
-32	-80	4
-44	-84	0

// Culbreth A J, 2020: Main Effect of Task (Hard > Easy Decisions) for All 
// Groups, p<0.01
// Culbreth A J, 2020: Main Effect of Task (Hard > Easy Decisions) for All 
// Groups, p=0.02
// Culbreth A J, 2020: Main Effect of Task (Hard > Easy Decisions) for All 
// Groups, p=0.04
// Subjects=28
-46	-80	-6
40	-82	-18
-34	-26	75
0	14	48
-26	-80	45
8	-58	9

// Prettyman G E, 2021: Whole-brain activation during task correlated with 
// clinical amotivation across all participants
// Prettyman G E, 2021: Healthy Controls > Schizophrenia
// Subjects=21
6	12	2
6	16	2
-14	8	-6

// Pretus C, 2021: Group (HC > SZ) x reward (high > low), p=0.06
// Pretus C, 2021: Group (HC > SZ) x reward (high > low), p=0.001
// Pretus C, 2021: Group (HC > SZ) x effort (high > low), p=0.009
// Pretus C, 2021: Group (HC > SZ) x effort (high > low), p<0.001
// Subjects=20
-18	24	12
-26	18	20
-16	34	14
18	12	22
22	30	18
30	14	22
-18	24	12
-24	-2	28
-26	18	20
30	12	22
18	8	26
24	30	20

